PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	RP	EM	RI	OI	FU	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	D2	EA	PG	WC	SC	GA	UT	PM	OA	HC	HP	DA
J	Hehar, H; Yeates, K; Kolb, B; Esser, MJ; Mychasiuk, R				Hehar, Harleen; Yeates, Keith; Kolb, Bryan; Esser, Michael J.; Mychasiuk, Richelle			Impulsivity and Concussion in Juvenile Rats: Examining Molecular and Structural Aspects of the Frontostriatal Pathway	PLOS ONE			English	Article							TRAUMATIC BRAIN-INJURY; ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; DEFICIT HYPERACTIVITY DISORDER; SEX-DIFFERENCES; INHIBITORY CONTROL; PREFRONTAL CORTEX; NUCLEUS-ACCUMBENS; CHILDREN; ADHD; DOPAMINE	Impulsivity and poor executive control have been implicated in the pathogenesis of many developmental and neuropsychiatric disorders. Similarly, concussions/mild traumatic brain injuries (mTBI) have been associated with increased risk for neuropsychiatric disorders and the development of impulsivity and inattention. Researchers and epidemiologists have therefore considered whether or not concussions induce symptoms of attention-deficit/hyperactivity disorder (ADHD), or merely unmask impulsive tendencies that were already present. The purpose of this study was to determine if a single concussion in adolescence could induce ADHD-like impulsivity and impaired response inhibition, and subsequently determine if inherent impulsivity prior to a pediatric mTBI would exacerbate post-concussion symptomology with a specific emphasis on impulsive and inattentive behaviours. As these behaviours are believed to be associated with the frontostriatal circuit involving the nucleus accumbens (NAc) and the prefrontal cortex (PFC), the expression patterns of 8 genes (Comt, Drd2, Drd3, Drd4, Maoa, Sert, Tph1, and Tph2) from these two regions were examined. In addition, Golgi-Cox staining of medium spiny neurons in the NAc provided a neuroanatomical examination of mTBI-induced structural changes. The study found that a single early brain injury could induce impulsivity and impairments in response inhibition that were more pronounced in males. Interestingly, when animals with inherent impulsivity experienced mTBI, injury-related deficits were exacerbated in female animals. The single concussion increased dendritic branching, but reduced synaptic density in the NAc, and these changes were likely associated with the increase in impulsivity. Finally, mTBI-induced impulsivity was associated with modifications to gene expression that differed dramatically from the gene expression pattern associated with inherent impulsivity, despite very similar behavioural phenotypes. Our findings suggest the need to tailor treatment strategies for mTBI in light of an individual's premorbid characteristics, given significant differences in molecular profiles of the frontostriatal circuits that depend upon sex and the etiology of the behavioural phenotype.	[Hehar, Harleen; Esser, Michael J.; Mychasiuk, Richelle] Univ Calgary, Fac Med, Res Inst, Alberta Childrens Hosp, Calgary, AB, Canada; [Yeates, Keith] Univ Calgary, Dept Psychol, Alberta Childrens Hosp, Res Inst, Calgary, AB T2N 1N4, Canada; [Kolb, Bryan] Univ Lethbridge, Canadian Ctr Behav Neurosci, Lethbridge, AB T1K 3M4, Canada	Mychasiuk, R (corresponding author), Univ Calgary, Fac Med, Res Inst, Alberta Childrens Hosp, Calgary, AB, Canada.	rmmychas@ucalgary.ca	Yeates, Keith/AAJ-4223-2020	Yeates, Keith/0000-0001-7680-2892	Alberta Children's Hospital Research Institute (ACHRI); Alberta Children's Hospital Foundation; Canadian Institute for Health Research (CIHR)Canadian Institutes of Health Research (CIHR); Markin USRP for Health and Wellness	The authors would like to thank the Alberta Children's Hospital Research Institute (ACHRI), the Alberta Children's Hospital Foundation, the Canadian Institute for Health Research (CIHR) and the Markin USRP for Health and Wellness for their financial support.	American Psychiatric Association, 2013, DIAGN STAT MAN MENT, V5, DOI [10.1176/appi.books.9780890425596., DOI 10.1176/APPI.BOOKS.9780890425596, 10.1176/appi.books.9780890425596]; Bari A, 2008, NAT PROTOC, V3, P759, DOI 10.1038/nprot.2008.41; Barlow KM, 2010, PEDIATRICS, V126, pE374, DOI 10.1542/peds.2009-0925; Belin D, 2008, SCIENCE, V320, P1352, DOI 10.1126/science.1158136; Biederman J, 2002, AM J PSYCHIAT, V159, P36, DOI 10.1176/appi.ajp.159.1.36; Bonefeld BE, 2008, SYNAPSE, V62, P302, DOI 10.1002/syn.20496; Clacy A, 2013, OA SPORTS MED, V1, P4; Cortese S, 2012, AM J PSYCHIAT, V169, P1038, DOI 10.1176/appi.ajp.2012.11101521; Covassin T, 2007, NEUROSURGERY, V61, P345, DOI 10.1227/01.NEU.0000279972.95060.CB; Dalley JW, 2012, NEUROSCIENCE, V215, P42, DOI 10.1016/j.neuroscience.2012.03.065; Dalley JW, 2007, SCIENCE, V315, P1267, DOI 10.1126/science.1137073; Dalley JW, 2011, NEURON, V69, P680, DOI 10.1016/j.neuron.2011.01.020; Dias TGC, 2013, EUR NEUROPSYCHOPHARM, V23, P33, DOI 10.1016/j.euroneuro.2012.10.015; Durston S, 2008, J AM ACAD CHILD PSY, V47, P61, DOI 10.1097/chi.0b013e31815a5f17; Eagle DM, 2008, PSYCHOPHARMACOLOGY, V199, P439, DOI 10.1007/s00213-008-1127-6; Eucker SA, 2011, EXP NEUROL, V227, P79, DOI 10.1016/j.expneurol.2010.09.015; Faul M.D., 2010, TRAUMATIC BRAIN INJU; Gibb R, 1998, J NEUROSCI METH, V79, P1, DOI 10.1016/S0165-0270(97)00163-5; Halperin JM, 2011, NEUROSCI BIOBEHAV R, V35, P621, DOI 10.1016/j.neubiorev.2010.07.006; Hayes DJ, 2011, NEUROSCI BIOBEHAV R, V35, P1419, DOI 10.1016/j.neubiorev.2011.03.005; Hooper SR, 2004, NEUROREHABILITATION, V19, P175; Howell D, 2013, MED SCI SPORT EXER, V45, P1030, DOI 10.1249/MSS.0b013e3182814595; Iaboni F, 1997, PSYCHOPHYSIOLOGY, V34, P116, DOI 10.1111/j.1469-8986.1997.tb02422.x; Itohara S, 2015, CURR OPIN BEHAV SCI, V2, P46, DOI 10.1016/j.cobeha.2014.09.002; Johansen EB, 2002, BEHAV BRAIN RES, V130, P37, DOI 10.1016/S0166-4328(01)00434-X; Kane MJ, 2012, J NEUROSCI METH, V203, P41, DOI 10.1016/j.jneumeth.2011.09.003; Konrad KN, 2000, BRAIN INJURY, V14, P859; Martel MM, 2011, J ABNORM CHILD PSYCH, V39, P1, DOI 10.1007/s10802-010-9439-5; Max JE, 2005, J AM ACAD CHILD PSY, V44, P1041, DOI 10.1097/01.chi.0000173292.05817.f8; Max JE, 1998, BRAIN INJURY, V12, P41; MAXWELL WL, 1993, ACTA NEUROPATHOL, V86, P136, DOI 10.1007/BF00334880; McCarthy MM, 2009, J NEUROSCI, V29, P12815, DOI 10.1523/JNEUROSCI.3331-09.2009; Mychasiuk R, 2015, NEUROSCIENCE, V288, P145, DOI 10.1016/j.neuroscience.2014.12.034; Mychasiuk R, 2014, JOVE, V8; Mychasiuk R, 2015, BEHAV BRAIN RES, V286, P285, DOI 10.1016/j.bbr.2015.03.010; Mychasiuk R, 2015, FRONT BEHAV NEUROSCI, V9, DOI 10.3389/fnbeh.2015.00017; Mychasiuk R, 2014, J NEUROTRAUM, V31, P749, DOI 10.1089/neu.2013.3132; Mychasiuk R, 2013, JOVE-J VIS EXP, DOI 10.3791/50694; Palasis S, 2013, J PEDIATR NEURORADIO, V2, P87, DOI 10.3233/PNR-13049; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pinto PS, 2012, J NEUROIMAGING, V22, pe18, DOI 10.1111/j.1552-6569.2011.00690.x; Purper-Ouakil D, 2011, PEDIATR RES, V69, p69R, DOI 10.1203/PDR.0b013e318212b40f; Robinson TE, 1999, EUR J NEUROSCI, V11, P1598, DOI 10.1046/j.1460-9568.1999.00576.x; Rommelse NNJ, 2008, AM J MED GENET B, V147B, P1524, DOI 10.1002/ajmg.b.30845; Ryan LM, 2003, INT REV PSYCHIATR, V15, P310, DOI 10.1080/09540260310001606692; Sagiv SK, 2013, J ATTEN DISORD, V17, P47, DOI 10.1177/1087054711427563; Sanchez F, 2011, SYNAPSE, V65, P198, DOI 10.1002/syn.20837; Scholes KE, 2007, NEUROPSYCHOPHARMACOL, V32, P1600, DOI 10.1038/sj.npp.1301262; Shiloh R, 2002, ATLAS PSYCHIAT PHARM; Simon NW, 2013, EUR J NEUROSCI, V37, P1779, DOI 10.1111/ejn.12191; Sinopoli KJ, 2012, INT J DEV NEUROSCI, V30, P207, DOI 10.1016/j.ijdevneu.2011.08.006; Smits M, 2011, NEURORADIOLOGY, V53, P553, DOI 10.1007/s00234-010-0774-6; Sonuga-Barke EJS, 2007, J AM ACAD CHILD PSY, V46, P701, DOI 10.1097/chi.0b013e31804659f1; Sonuga-Barke EJS, 2005, BIOL PSYCHIAT, V57, P1231, DOI 10.1016/j.biopsych.2004.09.008; White RD, 2014, SPORTS HEALTH, V6, P149, DOI 10.1177/1941738113484679; Yeates KO, 2005, J AM ACAD CHILD PSY, V44, P574, DOI 10.1097/01.chi.0000159947.50523.64; Zilles K., 1985, CORTEX RAT STEREOTAX	57	22	22	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2015	10	10							e0139842	10.1371/journal.pone.0139842			24	Multidisciplinary Sciences	Science & Technology - Other Topics	CT0TW	WOS:000362511000058	26448536	DOAJ Gold, Green Published			2021-06-18	
J	Hugentobler, JA; Vegh, M; Janiszewski, B; Quatman-Yates, C				Hugentobler, Jason A.; Vegh, Meredith; Janiszewski, Barbara; Quatman-Yates, Catherine			PHYSICAL THERAPY INTERVENTION STRATEGIES FOR PATIENTS WITH PROLONGED MILD TRAUMATIC BRAIN INJURY SYMPTOMS: A CASE SERIES	INTERNATIONAL JOURNAL OF SPORTS PHYSICAL THERAPY			English	Article						Concussion; post-concussion syndrome; physical therapy		Background And Purpose: Although most patients recover from a mild traumatic brain injury (mTBI) within 7-14 days, 10-30% of people will experience prolonged mTBI symptoms. Currently, there are no standardized treatment protocols to guide physical therapy interventions for this population. The purpose of this case series was to describe the unique, multimodal evaluation and treatment approaches for each of the patients with post-concussion syndrome (PCS). Case Description: Six pediatric athletes with PCS who had participated in physical therapy and fit the inclusion criteria for review were retrospectively chosen for analysis. Patients received a cervical evaluation, an aerobic activity assessment, an oculomotor screen, and postural control assessment. Each patient participated in an individualized physical therapy treatment plan-of-care based on their presentation during the evaluation. Outcomes: Patients were treated for a mean of 6.8 treatment sessions over 9.8 weeks. Four of six patients returned to their pre-injury level of activity while two returned to modified activity upon completion of physical therapy. Improvements were observed in symptom scores, gaze stability, balance and postural control measures, and patient self-management of symptoms. All patients demonstrated adequate selfmanagement of symptoms upon discharge from physical therapy. Discussion/Conclusions: Physical therapy interventions for pediatric athletes with PCS may facilitate recovery and improve function. Further research is needed to validate effective tools for assessment of patients who experience prolonged concussion symptoms as well as to establish support for specific post-mTBI physical therapy interventions.	[Hugentobler, Jason A.; Janiszewski, Barbara; Quatman-Yates, Catherine] Cincinnati Childrens Hosp Med Ctr, Dept Occupat Therapy & Phys Therapy, Cincinnati, OH 45229 USA; [Vegh, Meredith] Providence St Johns Hlth Ctr, Performance Therapy, Santa Monica, CA USA; [Quatman-Yates, Catherine] Univ Cincinnati, Coll Med, Dept Pediat, Cincinnati, OH USA; [Quatman-Yates, Catherine] Cincinnati Childrens Hosp Med Ctr, Dept Sports Med, Cincinnati, OH 45229 USA	Hugentobler, JA (corresponding author), Cincinnati Childrens Hosp Med Ctr, 2800 Winslow Ave,Suite 3100,MLC 10001, Cincinnati, OH 45206 USA.	Jason.hugentobler@cchmc.org	Quatman-Yates, Catherine/U-9580-2019; Quatman-Yates, Catherine/AAK-4507-2021				Abstracts from the Canadian Athletic Therapists Association, 2012, ATHLETIC TRAINING S, V4, P141; Alla S, 2009, BRIT J SPORT MED, V43, pI3, DOI 10.1136/bjsm.2009.058339; Alsalaheen BA, 2013, PHYSIOTHER RES INT, V18, P100, DOI 10.1002/pri.1532; Alsalaheen BA, 2010, J NEUROL PHYS THER, V34, P87, DOI 10.1097/NPT.0b013e3181dde568; Association APT, 2003, GUID PHYS THER PRACT; Association APT, 2011, PHYS THER PROV UN CO; Baker JG, 2012, REHABILITATION REP, V2012; Bell DR, 2011, SPORTS HEALTH, V3, P287, DOI 10.1177/1941738111403122; BORG GAV, 1982, MED SCI SPORT EXER, V14, P377, DOI 10.1249/00005768-198205000-00012; Broglio SP, 2005, MED SCI SPORT EXER, V37, P689, DOI 10.1249/01.MSS.0000159019.14919.09; Broglio SP, 2009, CLIN J SPORT MED, V19, P377, DOI 10.1097/JSM.0b013e3181b625fe; Capo-Aponte JE, 2012, MIL MED, V177, P804, DOI 10.7205/MILMED-D-12-00061; Cavanaugh JT, 2006, J ATHL TRAINING, V41, P305; Cavanaugh JT, 2005, SPORTS MED, V35, P935, DOI 10.2165/00007256-200535110-00002; Cavanaugh JT, 2005, BRIT J SPORT MED, V39, P805, DOI 10.1136/bjsm.2004.015909; Choe MC, 2012, CURR OPIN PEDIATR, V24, P689, DOI 10.1097/MOP.0b013e32835a1a44; Gagnon I, 2004, ARCH PHYS MED REHAB, V85, P444, DOI 10.1016/j.apmr.2003.06.014; Gagnon I, 2009, BRAIN INJURY, V23, P956, DOI 10.3109/02699050903373477; Gall B, 2004, BRIT J SPORT MED, V38, P773, DOI 10.1136/bjsm.2003.009530; Gall B, 2004, MED SCI SPORT EXER, V36, P1269, DOI 10.1249/01.MSS.0000135787.73757.4D; Gao JH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024446; Gilchrist Julie, 2011, Morbidity and Mortality Weekly Report, V60, P1337; Gillach MC, 1989, PEDIATR EXERC SCI, P1; Goodman CC, 2013, PATHOLOGY IMPLICATIO; Grady MF, 2010, CURR PROB PEDIATR AD, V40, P154, DOI 10.1016/j.cppeds.2010.06.002; Graham R, 2014, TREATMENT MANAGEMENT; Greenwald BD, 2012, BRAIN INJURY, V26, P1338, DOI 10.3109/02699052.2012.706356; Guskiewicz Kevin M, 2003, Curr Sports Med Rep, V2, P24; Guskiewicz KM, 2013, BRIT J SPORT MED, V47, P289, DOI 10.1136/bjsports-2013-092225; Guskiewicz KM, 2001, CLIN J SPORT MED, V11, P182, DOI 10.1097/00042752-200107000-00009; Iverson GL, 2006, BRAIN INJURY, V20, P245, DOI 10.1080/02699050500487910; Iverson GL, 2003, CLIN NEUROPSYCHOL, V17, P460, DOI 10.1076/clin.17.4.460.27934; Jull G, 2002, SPINE, V27, P1835, DOI 10.1097/00007632-200209010-00004; Kirkwood MW, 2006, PEDIATRICS, V117, P1359, DOI 10.1542/peds.2005-0994; Kutcher JS, 2010, CURR SPORT MED REP, V9, P16, DOI 10.1249/JSR.0b013e3181caa89d; Kuznetsov N, 2014, NONLINEAR TIME SERIE; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Leddy JJ, 2007, NEUROREHABILITATION, V22, P199; Leddy JJ, 2012, SPORTS HEALTH, V4, P147, DOI 10.1177/1941738111433673; Leddy JJ, 2011, CLIN J SPORT MED, V21, P89, DOI 10.1097/JSM.0b013e3181fdc721; Leddy JJ, 2010, CLIN J SPORT MED, V20, P21, DOI 10.1097/JSM.0b013e3181c6c22c; Lowell L, 2010, J BEHAV OPTOMETRY, P21; Lucas S, 2011, PM&R, V3, pS406, DOI 10.1016/j.pmrj.2011.07.016; McCrory P, 2013, BR J SPORTS MED; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Mihalik JP, 2013, AM J SPORT MED, V41, P1490, DOI 10.1177/0363546513487982; Mittenberg W, 2001, J CLIN EXP NEUROPSYC, V23, P829, DOI 10.1076/jcen.23.6.829.1022; Quatman-Yates C, 2014, J ORTHOPAEDIC SPORTS, pA1; Quatman-Yates CC, 2013, INT J SPORTS PHYS TH, V8, P741; Riley M.A., 2011, SCI MOTRICITE, V74, P5, DOI [10.1051/sm/2011117, DOI 10.1051/SM/2011117]; Sigurdardottir S, 2009, BRAIN INJURY, V23, P489, DOI 10.1080/02699050902926309; Sosnoff JJ, 2008, EXP BRAIN RES, V187, P563, DOI 10.1007/s00221-008-1324-x; Sosnoff JJ, 2011, J ATHL TRAINING, P46; Vidal PG, 2012, PEDIATR ANN, V41, pE186, DOI 10.3928/00904481-20120827-10; West TA, 2014, J NEUROTRAUM, V31, P159, DOI 10.1089/neu.2013.3031; Willer Barry, 2006, Curr Treat Options Neurol, V8, P415, DOI 10.1007/s11940-006-0031-9; Zemek RL, 2013, JAMA PEDIATR, V167, P259, DOI 10.1001/2013.jamapediatrics.216	57	22	22	1	8	AMER PHYSICAL THERAPY ASSOC	ALEXANDRIA	1111 N FAIRFAX ST, ALEXANDRIA, VA 22314 USA	2159-2896			INT J SPORTS PHYS TH	Int. J. Sports Phys. Ther.	OCT	2015	10	5					676	689					14	Sport Sciences	Sport Sciences	VA2EZ	WOS:000409721600011	26491618				2021-06-18	
J	Park, Y; Liu, CL; Luo, TF; Dietrich, WD; Bramlett, H; Hu, BR				Park, Yujung; Liu, Chunli; Luo, Tianfei; Dietrich, W. Dalton; Bramlett, Helen; Hu, Bingren			Chaperone-Mediated Autophagy after Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						chaperone-mediated autophagy; HSC70; HSP70; Iba-1; LAMP2; lysosome; ubiquitin; traumatic brain injury	TRANSIENT CEREBRAL-ISCHEMIA; NEURONAL CELL-DEATH; ALZHEIMERS-DISEASE; ALPHA-SYNUCLEIN; POSTSYNAPTIC DENSITIES; PROTEIN AGGREGATION; THERAPEUTIC TARGET; SELECTIVE UPTAKE; BETA DEPOSITION; RAT	Chaperone-mediated autophagy (CMA) and the ubiquitin-proteasomal system (UPS) are two major protein degradation systems responsible for maintaining cellular homeostasis, but how these two systems are regulated after traumatic brain injury (TBI) remains unknown. TBI produces primary mechanical damage that must be repaired to maintain neuronal homeostasis. The level of lysosomal-associated membrane protein type 2A (LAMP2A) is the hallmark of CMA activity. The level of polyubiquitinated proteins (ubi-proteins) reflects UPS activity. This study utilized a moderate fluid percussion injury model in rats to investigate the changes in CMA and the UPS after TBI. Induction of CMA was manifested by significant upregulation of LAMP2A and secondary lysosomes during the periods of 1-15 days of recovery after TBI. In comparison, the levels of ubi-proteins were increased only moderately after TBI. The increases in the levels of LAMP2A and 70kDa heat-shock protein for CMA after TBI were seen mainly in the secondary lysosome-containing fractions. Confocal and electron microscopy further showed that increased LAMP2A or lysosomes were found mainly in neurons and proliferated microglia. Because CMA and the UPS are two major routes for elimination of different types of cellular aberrant proteins, the consecutive activation of these two pathways may serve as a protective mechanism for maintaining cellular homeostasis after TBI.	[Park, Yujung; Liu, Chunli; Luo, Tianfei; Hu, Bingren] Univ Maryland, Sch Med, Shock Trauma & Anesthesiol Res Ctr, Neurochem Lab Brain Injury, Baltimore, MD 21201 USA; [Dietrich, W. Dalton; Bramlett, Helen] Univ Miami, Sch Med, Dept Neurol Surg, Miami Project Cure Paralysis, Miami, FL 33136 USA	Hu, BR (corresponding author), Univ Maryland, Sch Med, Shock Trauma & Anesthesiol Res Ctr, Baltimore, MD 21201 USA.	bhu@anes.umm.edu			National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS040407, NS030291]; AHA EIAAmerican Heart Association [0940042N]; Veteran Affair Merit Award [I01BX001696-01]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R56NS036810, R01NS040407, R01NS036810, P50NS030291, R29NS036810] Funding Source: NIH RePORTER; Veterans AffairsUS Department of Veterans Affairs [I01BX001696] Funding Source: NIH RePORTER	This work was supported by National Institutes of Health grants NS040407 and NS030291, AHA EIA grant 0940042N and Veteran Affair Merit Award I01BX001696-01.	Aoyama N, 2008, BRAIN RES, V1230, P310, DOI 10.1016/j.brainres.2008.07.006; Bandyopadhyay U, 2008, MOL CELL BIOL, V28, P5747, DOI 10.1128/MCB.02070-07; Bao HJ, 2015, NEUROCHEM RES, V40, P89, DOI 10.1007/s11064-014-1469-x; Beynon SB, 2012, NEUROSCIENCE, V225, P162, DOI 10.1016/j.neuroscience.2012.07.029; Blaya MO, 2014, J NEUROTRAUM, V31, P476, DOI [10.1089/NEU.2013.3135, 10.1089/neu.2013.3135]; Bramlett HM, 2004, J CEREBR BLOOD F MET, V24, P133, DOI 10.1097/01.WCB.0000111614.19196.04; Buczek M, 2002, METAB BRAIN DIS, V17, P153, DOI 10.1023/A:1019973921217; Clark RSB, 2008, AUTOPHAGY, V4, P88, DOI 10.4161/auto.5173; Cordaro M, 2015, J NEUROTRAUMA; Cuervo AM, 1997, J BIOL CHEM, V272, P5606, DOI 10.1074/jbc.272.9.5606; Cuervo AM, 2000, J CELL SCI, V113, P4441; Cuervo AM, 1996, SCIENCE, V273, P501, DOI 10.1126/science.273.5274.501; Cuervo AM, 2014, CELL RES, V24, P92, DOI 10.1038/cr.2013.153; Cuervo AM, 2011, NAT REV MOL CELL BIO, V12, P535, DOI 10.1038/nrm3150; De Matteis MA, 2008, NAT REV MOL CELL BIO, V9, P273, DOI 10.1038/nrm2378; Dietrich WD, 1996, NEUROSURGERY, V38, P533, DOI 10.1097/00006123-199603000-00023; Farkas O, 2007, PROG BRAIN RES, V161, P43, DOI 10.1016/S0079-6123(06)61004-2; Hall ED, 2010, NEUROTHERAPEUTICS, V7, P51, DOI 10.1016/j.nurt.2009.10.021; Hartl FU, 2002, SCIENCE, V295, P1852, DOI 10.1126/science.1068408; Hayashi Takeshi, 2006, Current Alzheimer Research, V3, P351, DOI 10.2174/156720506778249498; Hu BR, 2004, J CEREBR BLOOD F MET, V24, P934, DOI 10.1097/01.WCB.0000125888.56462.A1; Hu BR, 2001, J CEREBR BLOOD F MET, V21, P865, DOI 10.1097/00004647-200107000-00012; Hu BR, 1998, J NEUROSCI, V18, P625; Hu BR, 2000, J NEUROSCI, V20, P3191, DOI 10.1523/JNEUROSCI.20-09-03191.2000; Kanai M, 1997, MICROSC RES TECHNIQ, V39, P444, DOI 10.1002/(SICI)1097-0029(19971201)39:5<444::AID-JEMT7>3.3.CO;2-W; Kaushik S, 2012, TRENDS CELL BIOL, V22, P407, DOI 10.1016/j.tcb.2012.05.006; Kawai N, 2013, BRAIN INJURY, V27, P1026, DOI 10.3109/02699052.2013.794963; King JS, 2012, TRENDS MOL MED, V18, P583, DOI 10.1016/j.molmed.2012.08.002; Koga H, 2011, NEUROBIOL DIS, V43, P29, DOI 10.1016/j.nbd.2010.07.006; Lee SM, 1999, ANN NY ACAD SCI, V893, P337, DOI 10.1111/j.1749-6632.1999.tb07849.x; Lin CJ, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.123; Liu CL, 2008, J CEREBR BLOOD F MET, V28, P674, DOI 10.1038/sj.jcbfm.9600587; Lotocki G, 2009, J NEUROTRAUM, V26, P1123, DOI 10.1089/neu.2008.0802; Luo TF, 2013, TRANSL STROKE RES, V4, P581, DOI 10.1007/s12975-013-0299-5; Malkus KA, 2012, NEUROBIOL DIS, V46, P732, DOI 10.1016/j.nbd.2012.03.017; Marklund N, 2006, NEUROCHEM RES, V31, P1085, DOI 10.1007/s11064-006-9120-0; Martone ME, 1999, J NEUROSCI, V19, P1988; MCINTOSH TK, 1990, ACT NEUR S, V51, P263; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; Mondello S, 2013, NEUROLOGY, V80, P1662, DOI 10.1212/WNL.0b013e3182904d43; Muehlfeld C, 2010, CARDIOVASC PATHOL, V19, P65, DOI 10.1016/j.carpath.2008.10.015; Natarajan R, 2004, MOL BIOL CELL, V15, P4798, DOI 10.1091/mbc.E04-05-0366; PONTEN U, 1973, J NEUROCHEM, V21, P1121, DOI 10.1111/j.1471-4159.1973.tb07566.x; Roscoe W, 2005, J BIOL CHEM, V280, P11458, DOI 10.1074/jbc.M409564200; Sadasivan S, 2008, BIOCHEM BIOPH RES CO, V373, P478, DOI 10.1016/j.bbrc.2008.05.031; Sakai K, 2014, AM J FOREN MED PATH, V35, P38, DOI 10.1097/PAF.0000000000000067; Sarkar C, 2014, AUTOPHAGY, V10, P2208, DOI 10.4161/15548627.2014.981787; Shahaduzzaman M, 2013, MED HYPOTHESES, V81, P675, DOI 10.1016/j.mehy.2013.07.025; Sharp DJ, 2014, NAT REV NEUROL, V10, P156, DOI 10.1038/nrneurol.2014.15; Sivanandam TM, 2012, NEUROSCI BIOBEHAV R, V36, P1376, DOI 10.1016/j.neubiorev.2012.02.013; Sullivan PG, 1998, J NEUROTRAUM, V15, P789, DOI 10.1089/neu.1998.15.789; Sun LQ, 2014, NEUROL SCI, V35, P677, DOI 10.1007/s10072-013-1575-6; Tomura S, 2012, J CEREBR BLOOD F MET, V32, P1939, DOI 10.1038/jcbfm.2012.99; Treusch S, 2004, P NATL ACAD SCI USA, V101, P4483, DOI 10.1073/pnas.0400709101; Tsigelny IF, 2004, CELL BIOCHEM BIOPHYS, V40, P263, DOI 10.1385/CBB:40:3:263; Uryu K, 2002, J NEUROSCI, V22, P446, DOI 10.1523/JNEUROSCI.22-02-00446.2002; Vaccari JPD, 2014, J CEREBR BLOOD F MET, V34, P369, DOI 10.1038/jcbfm.2013.227; Van Den Heuvel C, 2007, PROG BRAIN RES, V161, P303, DOI 10.1016/S0079-6123(06)61021-2; Wei JS, 2009, AM J PATHOL, V174, P1891, DOI 10.2353/ajpath.2009.080680; Winchester B G, 2001, Eur J Paediatr Neurol, V5 Suppl A, P11, DOI 10.1053/ejpn.2000.0428; Xilouri M, 2013, AUTOPHAGY, V9, P2166, DOI 10.4161/auto.26451; Yabu T, 2011, FEBS J, V278, P673, DOI 10.1111/j.1742-4658.2010.07989.x; Yao XL, 2007, BRAIN RES, V1182, P116, DOI 10.1016/j.brainres.2007.08.076	63	22	26	0	13	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	OCT 1	2015	32	19					1449	1457		10.1089/neu.2014.3694			9	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	CR8NC	WOS:000361609500003	25891649	Green Published			2021-06-18	
J	MacManus, DB; Pierrat, B; Murphy, JG; Gilchrist, MD				MacManus, D. B.; Pierrat, B.; Murphy, J. G.; Gilchrist, M. D.			Dynamic mechanical properties of murine brain tissue using micro-indentation	JOURNAL OF BIOMECHANICS			English	Article						Traumatic brain injury (TBI); Cortex; Cerebellum; Sneddon; Finite element analysis	IN-VIVO; HEAD; BIOMECHANICS; COMPRESSION; VALIDATION; MATTER	In the past 50 years significant advances have been made in determining the macro-scale properties of brain tissue in compression, tension, shear and indentation. There has also been significant work done at the nanoscale using the AFM method to characterise the properties of individual neurons. However, there has been little published work on the micro-scale properties of brain tissue using an appropriate indentation methodology to characterise the regional differences at dynamic strain rates. This paper presents the development and use of a novel micro-indentation device to measure the dynamic mechanical properties of brain tissue. The device is capable of applying up to 30/s strain rates with a maximum indentation area of 2500 mu m(2). Indentation tests were carried out to determine the shear modulus of the cerebellum (2.11 +/- 1.26 kPa, 3.15 +/- 1.66 kPa, 3.71 +/- 1.23 kPa) and cortex (4.06 +/- 1.69 kPa, 6.14 +/- 3.03 kPa, 7.05 +/- 3.92 kPa) of murine brain tissue at 5, 15, and 30/s up to 14% strain. Numerical simulations were carried out to verify the experimentally measured force-displacement results. (C) 2015 Elsevier Ltd. All rights reserved.	[MacManus, D. B.; Pierrat, B.; Gilchrist, M. D.] Univ Coll Dublin, Sch Mech & Mat Engn, Dublin 2, Ireland; [Murphy, J. G.] Dublin City Univ, Dept Mech & Mfg Engn, Dublin 9, Ireland	Gilchrist, MD (corresponding author), Univ Coll Dublin, Sch Mech & Mat Engn, Dublin 2, Ireland.	david.mac-manus@ucdconnect.ie; baptiste.pierrat@ucd.ie; jeremiah.murphy@dcu.ie; michael.gilchrist@ucd.ie		MacManus, David/0000-0003-2959-698X; Pierrat, Baptiste/0000-0001-8064-8496	Science Foundation IrelandScience Foundation IrelandEuropean Commission [12/IP/1732]	This work was supported by Science Foundation Ireland (Grant no. 12/IP/1732).	Atkin R. J., 1980, INTRO THEORY ELASTIC, P72; Bernick KB, 2011, ACTA BIOMATER, V7, P1210, DOI 10.1016/j.actbio.2010.10.018; Budday S, 2015, J MECH BEHAV BIOMED, V46, P318, DOI 10.1016/j.jmbbm.2015.02.024; Cheng S, 2007, J BIOMECH, V40, P117, DOI 10.1016/j.jbiomech.2005.11.004; El Sayed T, 2008, COMPUT METHOD APPL M, V197, P4692, DOI 10.1016/j.cma.2008.06.006; Elkin BS, 2011, J BIOMECH ENG-T ASME, V133, DOI 10.1115/1.4004494; Faul M.D., 2010, TRAUMATIC BRAIN INJU; Ferrer I, 2007, J NEUROPATH EXP NEUR, V66, P35, DOI 10.1097/nen.0b013e31802c3e7d; Finan JD, 2014, BIOMECH MODEL MECHAN, V13, P573, DOI 10.1007/s10237-013-0519-7; Fountoulakis M, 2001, EXP NEUROL, V167, P86, DOI 10.1006/exnr.2000.7529; Gaetz M, 2004, CLIN NEUROPHYSIOL, V115, P4, DOI 10.1016/S1388-2457(03)00258-X; Gefen A, 2004, J BIOMECH, V37, P1339, DOI 10.1016/j.jbiomech.2003.12.032; Giordano C, 2014, J BIOMECH, V47, P1052, DOI 10.1016/j.jbiomech.2013.12.036; Haslach HW, 2014, J MECH BEHAV BIOMED, V29, P138, DOI 10.1016/j.jmbbm.2013.08.027; Horgan TJ, 2003, INT J CRASHWORTHINES, V8, P353, DOI 10.1533/cras.8.4.353.19278; Jin X, 2013, J BIOMECH, V46, P2795, DOI 10.1016/j.jbiomech.2013.09.001; Johnson J K, 1985, CONTACT MECH; Kleiven S, 2002, J BIOMECH, V35, P153, DOI 10.1016/S0021-9290(01)00202-0; Lin DC, 2009, BIOMECH MODEL MECHAN, V8, P345, DOI 10.1007/s10237-008-0139-9; Lu YB, 2006, P NATL ACAD SCI USA, V103, P17759, DOI 10.1073/pnas.0606150103; Mao HJ, 2013, J BIOMECH ENG-T ASME, V135, DOI 10.1115/1.4025101; Mustata M, 2010, J NEUROSCI METH, V186, P35, DOI 10.1016/j.jneumeth.2009.10.021; Pervin F, 2009, J BIOMECH, V42, P731, DOI 10.1016/j.jbiomech.2009.01.023; PHARR GM, 1992, J MATER RES, V7, P613, DOI 10.1557/JMR.1992.0613; Prevost TP, 2011, ACTA BIOMATER, V7, P83, DOI 10.1016/j.actbio.2010.06.035; Rashid B, 2013, J MECH BEHAV BIOMED, V28, P71, DOI 10.1016/j.jmbbm.2013.07.017; Rashid B, 2012, J MECH BEHAV BIOMED, V10, P23, DOI 10.1016/j.jmbbm.2012.01.022; Sanborn B, 2012, J BIOMECH, V45, P434, DOI 10.1016/j.jbiomech.2011.12.017; Sharp AA, 2009, IEEE T BIO-MED ENG, V56, P45, DOI 10.1109/TBME.2008.2003261; Sneddon I.N., 1965, INT J ENG SCI, V3, P47, DOI [DOI 10.1016/0020-7225(65)90019-4, 10.1016/0020-7225(65)90019-4]; Willinger R, 1999, CR ACAD SCI II B, V327, P125, DOI 10.1016/S1287-4620(99)80021-0; Zhang M., 2014, J APPL MECH, V81, P9	32	22	22	0	31	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0021-9290	1873-2380		J BIOMECH	J. Biomech.	SEP 18	2015	48	12					3213	3218		10.1016/j.jbiomech.2015.06.028			6	Biophysics; Engineering, Biomedical	Biophysics; Engineering	CT8ME	WOS:000363069900039	26189093				2021-06-18	
J	Cawsey, T; Duflou, J; Weickert, CS; Gorrie, CA				Cawsey, Thomas; Duflou, Johan; Weickert, Cynthia Shannon; Gorrie, Catherine Anne			Nestin-Positive Ependymal Cells Are Increased in the Human Spinal Cord after Traumatic Central Nervous System Injury	JOURNAL OF NEUROTRAUMA			English	Article						postmortem; neural progenitor cells; GFAP; trauma; tanyctye	BETA-APP IMMUNOHISTOCHEMISTRY; NEURAL PRECURSOR CELLS; CNS STEM-CELLS; ADULT-RAT; STEM/PROGENITOR CELLS; CEREBRAL-CORTEX; GLIAL-CELLS; PROLIFERATION; NEUROGENESIS; DIFFERENTIATION	Endogenous neural progenitor cell niches have been identified in adult mammalian brain and spinal cord. Few studies have examined human spinal cord tissue for a neural progenitor cell response in disease or after injury. Here, we have compared cervical spinal cord sections from 14 individuals who died as a result of nontraumatic causes (controls) with 27 who died from injury with evidence of trauma to the central nervous system. Nestin immunoreactivity was used as a marker of neural progenitor cell response. There were significant increases in the percentage of ependymal cells that were nestin positive between controls and trauma cases. When sections from lumbar and thoracic spinal cord were available, nestin positivity was seen at all three spinal levels, suggesting that nestin reactivity is not simply a localized reaction to injury. There was a positive correlation between the percentage of ependymal cells that were nestin positive and post-injury survival time but not for age, postmortem delay, or glial fibrillary acidic protein (GFAP) immunoreactivity. No double-labelled nestin and GFAP cells were identified in the ependymal, subependymal, or parenchymal regions of the spinal cord. We need to further characterize this subset of ependymal cells to determine their role after injury, whether they are a population of neural progenitor cells with the potential for proliferation, migration, and differentiation for spinal cord repair, or whether they have other roles more in line with hypothalamic tanycytes, which they closely resemble.	[Cawsey, Thomas; Gorrie, Catherine Anne] Univ Technol Sydney, Sch Med & Mol Biosci, Sydney, NSW 2007, Australia; [Duflou, Johan] NSW Hlth Pathol, Dept Forens Med, Sydney, NSW, Australia; [Weickert, Cynthia Shannon] Neurosci Res Australia, Sydney, NSW, Australia; [Weickert, Cynthia Shannon] Schizophrenia Res Inst, Sydney, NSW, Australia; [Weickert, Cynthia Shannon] Univ New S Wales, Sch Psychiat, Sydney, NSW, Australia	Gorrie, CA (corresponding author), Univ Technol Sydney, Sch Med & Mol Biosci, POB 123, Sydney, NSW 2007, Australia.	catherine.gorrie@uts.edu.au	Gorrie, Catherine/S-6591-2019; Duflou, Johan/AAK-2331-2020	Duflou, Johan/0000-0001-5863-635X; Gorrie, Catherine/0000-0001-5934-2492; Shannon Weickert, Cynthia/0000-0002-4560-0259	University of Maryland, Baltimore, Maryland [HHSN275200900011C, N01-HD-0-0011]; University of Technology, Sydney; Schizophrenia Research Institute from the NSW Ministry of Health; Schizophrenia Research Institute from the Macquarie Group Foundation; University of New South Wales; Neuroscience Research Australia; National Health and Medical Research Council (Australia)National Health and Medical Research Council of Australia	Ethics approval was granted from Sydney Local Health District Human Research Ethics Committee and University of Technology Human Ethics Committees. Human tissue was obtained from Department of Forensic Medicine Sydney, NSW Health Pathology and the NICHD brain and tissue bank for developmental disorders at the University of Maryland, Baltimore, Maryland, contract HHSN275200900011C Ref. No. N01-HD-0-0011. This study was funded by an early career researcher grant to Dr. Catherine Gorrie from the University of Technology, Sydney. Cynthia Shannon Weickert's work was supported by Schizophrenia Research Institute (utilizing infrastructure funding from the NSW Ministry of Health and the Macquarie Group Foundation), the University of New South Wales, and Neuroscience Research Australia. Cynthia Shannon Weickert is a recipient of a National Health and Medical Research Council (Australia) Senior Research Fellowship.	Alfaro-Cervello C, 2012, J COMP NEUROL, V520, P3528, DOI 10.1002/cne.23104; Barnabe-Heider F, 2010, CELL STEM CELL, V7, P470, DOI 10.1016/j.stem.2010.07.014; Blasko J, 2012, CENT EUR J BIOL, V7, P397, DOI 10.2478/s11535-012-0027-2; BRUNI JE, 1987, J ANAT, V152, P55; BRUNI JE, 1985, BRAIN RES REV, V9, P1, DOI 10.1016/0165-0173(85)90016-5; Bruni JE, 1998, MICROSC RES TECHNIQ, V41, P2, DOI 10.1002/(SICI)1097-0029(19980401)41:1<2::AID-JEMT2>3.0.CO;2-Z; Cizkova D, 2009, CELL MOL NEUROBIOL, V29, P999, DOI 10.1007/s10571-009-9387-1; Dromard C, 2008, J NEUROSCI RES, V86, P1916, DOI 10.1002/jnr.21646; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; FRISEN J, 1995, J CELL BIOL, V131, P453, DOI 10.1083/jcb.131.2.453; Gorrie C, 2002, J NEUROTRAUM, V19, P1171, DOI 10.1089/08977150260337976; Hamilton LK, 2009, NEUROSCIENCE, V164, P1044, DOI 10.1016/j.neuroscience.2009.09.006; Horner PJ, 2000, J NEUROSCI, V20, P2218; Hortobagyi T, 2007, NEUROPATH APPL NEURO, V33, P226, DOI 10.1111/j.1365-2990.2006.00794.x; Johansson CB, 1999, CELL, V96, P25, DOI 10.1016/S0092-8674(00)80956-3; JORDAN FL, 1987, DEV BRAIN RES, V35, P97, DOI 10.1016/0165-3806(87)90012-5; Kehl LJ, 1997, SCIENCE, V276, P586, DOI 10.1126/science.276.5312.586; Kojima A, 2000, J NEUROPATH EXP NEUR, V59, P687, DOI 10.1093/jnen/59.8.687; LENDAHL U, 1990, CELL, V60, P585, DOI 10.1016/0092-8674(90)90662-X; Li Y, 1999, BRAIN RES, V838, P1, DOI 10.1016/S0006-8993(99)01502-4; Meletis K, 2008, PLOS BIOL, V6, P1494, DOI 10.1371/journal.pbio.0060182; Moreno-Manzano V, 2009, STEM CELLS, V27, P733, DOI 10.1002/stem.24; Mothe AJ, 2005, NEUROSCIENCE, V131, P177, DOI 10.1016/j.neuroscience.2004.10.011; Mothe AJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027079; Nakayama D, 2010, EUR J NEUROSCI, V31, P90, DOI 10.1111/j.1460-9568.2009.07043.x; Namiki J, 1999, J NEUROPATH EXP NEUR, V58, P489, DOI 10.1097/00005072-199905000-00008; RAFOLS JA, 1985, ANAT REC, V211, P75, DOI 10.1002/ar.1092110112; Rodriguez EM, 2005, INT REV CYTOL, V247, P89, DOI 10.1016/S0074-7696(05)47003-5; Sakakibara A, 2007, PATHOL INT, V57, P358, DOI 10.1111/j.1440-1827.2007.02108.x; Snethen H, 2008, REGEN MED, V3, P835, DOI 10.2217/17460751.3.6.835; Takahashi M, 2003, J NEUROPATH EXP NEUR, V62, P185, DOI 10.1093/jnen/62.2.185; Takano T, 1997, NEUROPATH APPL NEURO, V23, P3, DOI 10.1111/j.1365-2990.1997.tb01180.x; Taupin P, 2002, J NEUROSCI RES, V69, P745, DOI 10.1002/jnr.10378; Tzeng SF, 2002, J BIOMED SCI, V9, P10, DOI 10.1007/BF02256573; Weiss S, 1996, J NEUROSCI, V16, P7599; Xu RS, 2008, INT J DEV NEUROSCI, V26, P813, DOI 10.1016/j.ijdevneu.2008.06.002; Xu Y, 2005, EXP NEUROL, V192, P251, DOI 10.1016/j.expneurol.2004.12.021; Zai LJ, 2005, GLIA, V50, P247, DOI 10.1002/glia.20176	38	22	24	1	20	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	SEP 15	2015	32	18					1393	1402		10.1089/neu.2014.3575			10	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	CQ8AR	WOS:000360828900002	25599268	Green Published			2021-06-18	
J	Rocchi, L; Niccolini, F; Politis, M				Rocchi, Lorenzo; Niccolini, Flavia; Politis, Marios			Recent imaging advances in neurology	JOURNAL OF NEUROLOGY			English	Article						Magnetic resonance imaging; Positron emission tomography; Movement disorders; Dementia; Epilepsy; Traumatic brain injury; Multiple sclerosis	POSITRON-EMISSION-TOMOGRAPHY; TRAUMATIC BRAIN-INJURY; MAGNETIC-RESONANCE-SPECTROSCOPY; MILD COGNITIVE IMPAIRMENT; AMYLOID-BETA DEPOSITION; SEROTONIN 1A RECEPTORS; RESTING STATE NETWORKS; IN-VIVO DETECTION; FLORBETAPIR F 18; PARKINSONS-DISEASE	Over the recent years, the application of neuroimaging techniques such as magnetic resonance imaging (MRI) and positron emission tomography (PET) has considerably advanced the understanding of complex neurological disorders. PET is a powerful molecular imaging tool, which investigates the distribution and binding of radiochemicals attached to biologically relevant molecules; as such, this technique is able to give information on biochemistry and metabolism of the brain in health and disease. MRI uses high intensity magnetic fields and radiofrequency pulses to provide structural and functional information on tissues and organs in intact or diseased individuals, including the evaluation of white matter integrity, grey matter thickness and brain perfusion. The aim of this article is to review the most recent advances in neuroimaging research in common neurological disorders such as movement disorders, dementia, epilepsy, traumatic brain injury and multiple sclerosis, and to evaluate their contribution in the diagnosis and management of patients.	[Rocchi, Lorenzo; Niccolini, Flavia; Politis, Marios] Kings Coll London, Dept Basic & Clin Neurosci, Inst Psychiat Psychol & Neurosci IoPPN, Neurodegenerat Imaging Grp, London SE5 8AF, England	Politis, M (corresponding author), Kings Coll London, Dept Basic & Clin Neurosci, Inst Psychiat Psychol & Neurosci IoPPN, Neurodegenerat Imaging Grp, London SE5 8AF, England.	marios.politis@imperial.ac.uk	Rocchi, Lorenzo/K-7983-2016	Rocchi, Lorenzo/0000-0003-3979-156X	Parkinson&apos;s UKParkinson&apos;s UK [G-1303] Funding Source: Medline; Parkinson&quot;s UKParkinson&apos;s UK [G-1303] Funding Source: researchfish		Abbas K, 2015, BRAIN CONNECT, V5, P91, DOI 10.1089/brain.2014.0279; Abela E, 2014, CLIN NEURORADIOL, V24, P5, DOI 10.1007/s00062-014-0284-8; Adlard PA, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00327; Agosta F, 2014, HUM BRAIN MAPP, V35, P1921, DOI 10.1002/hbm.22302; Baudrexel S, 2014, MOVEMENT DISORD, V29, P380, DOI 10.1002/mds.25749; Beach TG, 2014, J NEUROPATH EXP NEUR, V73, P948, DOI 10.1097/NEN.0000000000000114; Benzinger TLS, 2013, P NATL ACAD SCI USA, V110, pE4502, DOI 10.1073/pnas.1317918110; Berg D, 2008, LANCET NEUROL, V7, P1044, DOI 10.1016/S1474-4422(08)70239-4; Bertholdo D, 2013, NEUROIMAG CLIN N AM, V23, P359, DOI 10.1016/j.nic.2012.10.002; Binnewijzend MAA, 2014, EUR RADIOL, V24, P2326, DOI 10.1007/s00330-014-3172-3; Bohnen NI, 2014, MOVEMENT DISORD, V29, P1118, DOI 10.1002/mds.25929; Bohnen NI, 2013, NEUROLOGY, V81, P1611, DOI 10.1212/WNL.0b013e3182a9f558; Bohnen NI, 2013, MOVEMENT DISORD, V28, P1492, DOI 10.1002/mds.25534; Bouwmans AEP, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-002613; Bunzeck N, 2013, PARKINSONISM RELAT D, V19, P1136, DOI 10.1016/j.parkreldis.2013.08.011; Butler T, 2013, J NEUROIMAGING, V23, P129, DOI 10.1111/j.1552-6569.2010.00572.x; Cataldi M, 2013, EPILEPSIA, V54, P2048, DOI 10.1111/epi.12400; Chen S, 2014, EUR J RADIOL, V83, P564, DOI 10.1016/j.ejrad.2013.11.024; Chen SH, 2012, NEUROIMAGE, V60, P299, DOI 10.1016/j.neuroimage.2011.11.092; Cherubini A, 2014, MOVEMENT DISORD, V29, P266, DOI 10.1002/mds.25737; Chhatwal JP, 2012, J ALZHEIMERS DIS, V31, pS155, DOI 10.3233/JAD-2012-120730; Chien DT, 2014, J ALZHEIMERS DIS, V38, P171, DOI 10.3233/JAD-130098; Cho H, 2013, J ALZHEIMERS DIS, V35, P813, DOI 10.3233/JAD-121927; Choi IY, 2011, MULT SCLER J, V17, P289, DOI 10.1177/1352458510384010; Chugani HT, 2013, NEUROLOGY, V81, P674, DOI 10.1212/WNL.0b013e3182a08f3f; Colasanti A, 2014, J NUCL MED, V55, P1112, DOI 10.2967/jnumed.113.135129; Deng BM, 2013, AM J ALZHEIMERS DIS, V28, P154, DOI 10.1177/1533317512470207; Deoni SCL, 2008, J MAGN RESON IMAGING, V27, P1421, DOI 10.1002/jmri.21079; Deoni SCL, 2007, J MAGN RESON IMAGING, V25, P570, DOI 10.1002/jmri.20836; Di Paola M, 2014, HUM BRAIN MAPP, V35, P3143, DOI 10.1002/hbm.22391; Dominguez JF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074131; Doraiswamy PM, 2014, MOL PSYCHIATR, V19, P1044, DOI 10.1038/mp.2014.9; Dukart J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018111; Edison P, 2013, NEUROPSYCHOPHARMACOL, V38, P938, DOI 10.1038/npp.2012.255; Eierud C, 2014, NEUROIMAGE-CLIN, V4, P283, DOI 10.1016/j.nicl.2013.12.009; Fan Z, 2015, ALZHEIMERS DEMENT, V11, P608, DOI 10.1016/j.jalz.2014.06.016; Filippi M, 2013, MULT SCLER J, V19, P418, DOI 10.1177/1352458512457842; Fleisher AS, 2012, LANCET NEUROL, V11, P1057, DOI 10.1016/S1474-4422(12)70227-2; Fling BW, 2013, BRAIN, V136, P2405, DOI 10.1093/brain/awt172; Fozouni N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076343; Gaenslen A, 2008, LANCET NEUROL, V7, P417, DOI 10.1016/S1474-4422(08)70067-X; Georgiou-Karistianis N, 2013, BRAIN COGNITION, V83, P80, DOI 10.1016/j.bandc.2013.07.004; Giannetti P, 2015, BRAIN, V138, P110, DOI 10.1093/brain/awu331; Giannetti P, 2014, NEUROBIOL DIS, V65, P203, DOI 10.1016/j.nbd.2014.01.018; Gomperts SN, 2013, NEUROLOGY, V80, P85, DOI 10.1212/WNL.0b013e31827b1a07; Hanganu A, 2014, BRAIN, V137, P1120, DOI 10.1093/brain/awu036; Hara K, 2014, PARKINSONISM RELAT D, V20, P157, DOI 10.1016/j.parkreldis.2013.10.007; Hardy J, 2006, ALZHEIMER'S DISEASE: A CENTURY OF SCIENTIFIC AND CLINICAL RESEARCH, P151; Harrison DM, 2013, J NEUROL, V260, P397, DOI 10.1007/s00415-012-6638-8; Hatashita S, 2014, EUR J NUCL MED MOL I, V41, P290, DOI 10.1007/s00259-013-2564-y; Hellwig S, 2012, NEUROLOGY, V79, P1314, DOI 10.1212/WNL.0b013e31826c1b0a; Herz DM, 2014, ANN NEUROL, V75, P829, DOI 10.1002/ana.24138; Hong JY, 2014, PARKINSONISM RELAT D, V20, P999, DOI 10.1016/j.parkreldis.2014.06.011; Hong JY, 2014, NEUROLOGY, V82, P1597, DOI 10.1212/WNL.0000000000000385; Hong YT, 2014, JAMA NEUROL, V71, P23, DOI 10.1001/jamaneurol.2013.4847; Hsiao IT, 2014, JAMA NEUROL, V71, P758, DOI 10.1001/jamaneurol.2014.290; Ilvesmaki T, 2014, BRAIN, V137, P1876, DOI 10.1093/brain/awu095; Iraji A, 2015, J NEUROTRAUM, V32, P1031, DOI 10.1089/neu.2014.3610; Jack CR, 2014, NEUROLOGY, V82, P1605, DOI 10.1212/WNL.0000000000000386; Jilka SR, 2014, J NEUROSCI, V34, P10798, DOI 10.1523/JNEUROSCI.0518-14.2014; Josephs KA, 2008, ANN NEUROL, V64, P4, DOI 10.1002/ana.21426; Kandiah N, 2014, PARKINSONISM RELAT D, V20, P1203, DOI 10.1016/j.parkreldis.2014.08.024; Kawai N, 2013, BRAIN INJURY, V27, P1026, DOI 10.3109/02699052.2013.794963; Kearney H, 2014, MULT SCLER J, V20, P72, DOI 10.1177/1352458513492245; Kiferle L, 2011, EUR J NEUROL, V18, P226, DOI 10.1111/j.1468-1331.2010.03154.x; Kitzler HH, 2012, NEUROIMAGE, V59, P2670, DOI 10.1016/j.neuroimage.2011.08.052; Klawiter Eric C, 2013, Continuum (Minneap Minn), V19, P1058, DOI 10.1212/01.CON.0000433283.00221.37; Kung HF, 2010, J MED CHEM, V53, P933, DOI 10.1021/jm901039z; Lenfeldt N, 2013, J NEUROL, V260, P2823, DOI 10.1007/s00415-013-7080-2; Lim YY, 2014, BRAIN, V137, P221, DOI 10.1093/brain/awt286; Lin SC, 2014, J NUCL MED, V55, P73, DOI 10.2967/jnumed.113.121897; Ling JM, 2013, NEUROLOGY, V81, P2121, DOI 10.1212/01.wnl.0000437302.36064.b1; Lipp A, 2013, NEUROIMAGE-CLIN, V3, P381, DOI 10.1016/j.nicl.2013.09.006; Liu P, 2014, NEUROSCI LETT, V582, P99, DOI 10.1016/j.neulet.2014.08.053; Llufriu S, 2014, JAMA NEUROL, V71, P840, DOI 10.1001/jamaneurol.2014.895; Loane C, 2013, NEUROLOGY, V80, P1850, DOI 10.1212/WNL.0b013e318292a31d; Loane C, 2011, AM J TRANSL RES, V3, P323; Londono AC, 2014, NEUROL-NEUROIMMUNOL, V1, DOI 10.1212/NXI.0000000000000045; Luo J, 2014, MULT SCLER J, V20, P349, DOI 10.1177/1352458513495935; Mak E, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/alzrt248; Malkki H, 2014, NAT REV NEUROL, V10, P243, DOI [10.1038/nrneurol.2013.267, 10.1038/nrneurol.2014.168, 10.1038/nrneurol.2013.250, 10.1038/nrneurol.2014.142, 10.1038/nrneurol.2014.63, 10.1038/nrneurol.2014.61, 10.1038/nrneurol.2014.21, 10.1038/nrneurol.2014.209]; Martinez A, 2013, NEUROLOGY, V80, P1465, DOI 10.1212/WNL.0b013e31828cf809; Maruyama M, 2013, NEURON, V79, P1094, DOI 10.1016/j.neuron.2013.07.037; Matsuura K, 2013, EUR NEUROL, V70, P70, DOI 10.1159/000350291; Mattsson N, 2014, BRAIN, V137, P1550, DOI 10.1093/brain/awu043; McConathy J, 2015, BIOL PSYCHIAT, V77, P685, DOI 10.1016/j.biopsych.2014.08.024; McKeith IG, 2006, J ALZHEIMERS DIS, V9, P417, DOI 10.1212/wnl.47.5.1113; Mishra AK, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0086852, 10.1371/journal.pone.0095280]; Mitsis EM, 2014, TRANSL PSYCHIAT, V4, DOI 10.1038/tp.2014.91; Morales DA, 2013, PSYCHIAT RES-NEUROIM, V213, P92, DOI 10.1016/j.pscychresns.2012.06.001; Moshe SL, 2015, LANCET, V385, P884, DOI 10.1016/S0140-6736(14)60456-6; Muller MLTM, 2013, MOVEMENT DISORD, V28, P296, DOI 10.1002/mds.25213; Nathan DE, 2015, BRAIN CONNECT, V5, P102, DOI 10.1089/brain.2014.0273; Niccolini F, 2014, EUR J NEUROL, V21, P694, DOI 10.1111/ene.12362; Niccolini F, 2014, J NEUROL, V261, P2251, DOI 10.1007/s00415-014-7302-2; Niccolini F, 2014, WORLD J RADIOL, V6, P301, DOI 10.4329/wjr.v6.i6.301; Niethammer M, 2013, NEUROIMAGE, V78, P204, DOI 10.1016/j.neuroimage.2013.03.070; O'Sullivan SS, 2011, BRAIN, V134, P969, DOI 10.1093/brain/awr003; Ogisu K, 2013, NEURORADIOLOGY, V55, P719, DOI 10.1007/s00234-013-1171-8; Oh U, 2011, J NEUROIMMUNE PHARM, V6, P354, DOI 10.1007/s11481-010-9243-6; Ohtsuka C, 2014, PARKINSONISM RELAT D, V20, P755, DOI 10.1016/j.parkreldis.2014.04.005; Okamura N, 2014, BRAIN, V137, P1762, DOI 10.1093/brain/awu064; Ong KT, 2015, J NEUROL NEUROSUR PS, V86, P431, DOI 10.1136/jnnp-2014-308094; Pagonabarraga J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054980; Pereira JB, 2014, NEUROLOGY, V82, P2017, DOI [10.1212/01.wnl.0000457455.74798.9a, 10.1212/WNL.0000000000000483]; Petrou M, 2012, NEUROLOGY, V79, P1161, DOI 10.1212/WNL.0b013e3182698d4a; Politis M, 2010, NEUROLOGY, V75, P1920, DOI 10.1212/WNL.0b013e3181feb2ab; Politis M, 2014, NAT REV NEUROL, V10, P708, DOI 10.1038/nrneurol.2014.205; Politis M, 2014, J CLIN INVEST, V124, P1340, DOI 10.1172/JCI71640; Politis M, 2013, BRAIN, V136, P400, DOI 10.1093/brain/aws326; Politis M, 2012, J NEUROL, V259, P1769, DOI 10.1007/s00415-012-6428-3; Politis M, 2012, NEUROLOGY, V79, P523, DOI 10.1212/WNL.0b013e3182635645; Politis M, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00096; Politis M, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003391; Politis M, 2011, THESCIENTIFICWORLDJO, V11, P1726, DOI 10.1100/2011/172893; Politis M, 2011, MOVEMENT DISORD, V26, P1997, DOI 10.1002/mds.23743; Politis M, 2011, NEUROBIOL DIS, V43, P609, DOI 10.1016/j.nbd.2011.05.009; Politis M, 2011, HUM BRAIN MAPP, V32, P258, DOI 10.1002/hbm.21008; Politis M, 2010, NEUROBIOL DIS, V40, P216, DOI 10.1016/j.nbd.2010.05.028; Politis M, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000976; Polotis M, 2015, BEHAV BRAIN RES, V277, P136, DOI 10.1016/j.bbr.2014.07.037; Poudel GR, 2014, J PSYCHIATR NEUROSCI, V39, P87, DOI 10.1503/jpn.120226; Prestia A, 2013, NEUROLOGY, V80, P1048, DOI 10.1212/WNL.0b013e3182872830; Prodoehl J, 2013, MOVEMENT DISORD, V28, P1816, DOI 10.1002/mds.25491; Putcha D, 2011, J NEUROSCI, V31, P17680, DOI 10.1523/JNEUROSCI.4740-11.2011; Ramlackhansingh AF, 2011, ANN NEUROL, V70, P374, DOI 10.1002/ana.22455; Ratchford JN, 2012, J NEUROL, V259, P1199, DOI 10.1007/s00415-011-6337-x; Rissanen E, 2014, J NUCL MED, V55, P939, DOI 10.2967/jnumed.113.131698; Rovira A, 2013, NEUROIMAG CLIN N AM, V23, P459, DOI 10.1016/j.nic.2013.03.005; Salvatore C, 2014, J NEUROSCI METH, V222, P230, DOI 10.1016/j.jneumeth.2013.11.016; Sanchez-Castaneda C, 2015, HUM BRAIN MAPP, V36, P50, DOI 10.1002/hbm.22612; Sanzaro E, 2014, J ULTRAS MED, V33, P1635, DOI 10.7863/ultra.33.9.1635; Sbardella E, 2013, MULT SCLER INT, V2013, DOI 10.1155/2013/671730; Scherfler C, 2013, BRAIN, V136, P3028, DOI 10.1093/brain/awt234; Sharp DJ, 2011, BRAIN, V134, P2233, DOI 10.1093/brain/awr175; Sheline YI, 2013, BIOL PSYCHIAT, V74, P340, DOI 10.1016/j.biopsych.2012.11.028; Shine JM, 2013, BRAIN, V136, P3671, DOI 10.1093/brain/awt272; Siderowf A, 2014, BMC NEUROL, V14, DOI 10.1186/1471-2377-14-79; Stankoff B, 2011, ANN NEUROL, V69, P673, DOI 10.1002/ana.22320; Stocchetti N, 2014, LANCET NEUROL, V13, P14, DOI 10.1016/S1474-4422(13)70280-1; Storti SF, 2014, NEUROIMAGE, V102, P49, DOI 10.1016/j.neuroimage.2013.06.028; Stromillo ML, 2013, NEUROLOGY, V80, P2090, DOI 10.1212/WNL.0b013e318295d707; Tabrizi SJ, 2013, LANCET NEUROL, V12, P637, DOI 10.1016/S1474-4422(13)70088-7; Takano A, 2013, EJNMMI RES, V3, DOI 10.1186/2191-219X-3-30; Tang CC, 2013, J CLIN INVEST, V123, P4076, DOI 10.1172/JCI69411; Teipel S, 2014, NEUROBIOL AGING, V35, P482, DOI 10.1016/j.neurobiolaging.2013.09.029; Temel S, 2013, NEURORADIOL J, V26, P3; Teune LK, 2014, NEUROIMAGE-CLIN, V5, P240, DOI 10.1016/j.nicl.2014.06.007; Theodore WH, 2012, J NUCL MED, V53, P1375, DOI 10.2967/jnumed.112.103093; Theodore WH, 2012, EPILEPSIA, V53, P129, DOI 10.1111/j.1528-1167.2011.03309.x; Tiwari VN, 2012, J CHILD NEUROL, V27, P598, DOI 10.1177/0883073811422751; Toledo JB, 2014, ACTA NEUROPATHOL COM, V2, DOI 10.1186/2051-5960-2-26; Ulla M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057904; Unschuld PG, 2012, NEUROSCI LETT, V514, P204, DOI 10.1016/j.neulet.2012.02.095; Villemagne VL, 2011, J NUCL MED, V52, P1210, DOI 10.2967/jnumed.111.089730; Vivash L, 2013, J NUCL MED, V54, P1270, DOI 10.2967/jnumed.112.107359; Winter Y, 2011, PARKINSONISM RELAT D, V17, P265, DOI 10.1016/j.parkreldis.2011.01.003; Wintermark P, 2013, J CHILD NEUROL, V28, P1474, DOI 10.1177/0883073813488666; Xia CF, 2013, ALZHEIMERS DEMENT, V9, P666, DOI 10.1016/j.jalz.2012.11.008; Yuh EL, 2014, J NEUROTRAUM, V31, P1457, DOI 10.1089/neu.2013.3171; Zarei M, 2013, J NEUROL NEUROSUR PS, V84, P875, DOI 10.1136/jnnp-2012-304126; Ziegler E, 2014, NEUROIMAGE, V99, P498, DOI 10.1016/j.neuroimage.2014.06.033	162	22	22	1	24	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0340-5354	1432-1459		J NEUROL	J. Neurol.	SEP	2015	262	9					2182	2194		10.1007/s00415-015-7711-x			13	Clinical Neurology	Neurosciences & Neurology	CT7ZV	WOS:000363035400023	25808503				2021-06-18	
J	Saika, A; Bansal, S; Philip, M; Devi, BI; Shukla, DP				Saika, Amrit; Bansal, Sonia; Philip, Mariamma; Devi, Bhagavatula Indira; Shukla, Dhaval P.			Prognostic value of FOUR and GCS scores in determining mortality in patients with traumatic brain injury	ACTA NEUROCHIRURGICA			English	Article						Traumatic brain injury; Full Outline Of Unresponsiveness (FOUR) score; Glasgow Coma Scale (GCS); Coma	GLASGOW COMA SCALE; IMPAIRED CONSCIOUSNESS; VALIDATION	Background The Glasgow Coma Scale (GCS) is considered the gold standard for assessment of unconsciousness in patients with traumatic brain injury (TBI) against which other scales are compared. To overcome the disadvantages of GCS, the Full Outline Of Unresponsiveness (FOUR) score was proposed. We aimed to compare the predictability of FOUR score and GCS for early mortality, after moderate and severe TBI. Methods This is a prospective observational study of patients with moderate and severe TBI. Both FOUR and GCS scores were determined at admission. The primary outcome was mortality at the end of 2 weeks of injury. Results A total of 138 (117 males) patients were included in the study. Out of these, 17 (12.3 %) patients died within 2 weeks of injury. The mean GCS and FOUR scores were 9.5 (range, 3-13) and 11 (0-16), respectively. The total GCS and FOUR scores were significantly lower in patients who did not survive. At a cut-off score of 7 for FOUR score, the AUC was 0.97, with sensitivity of 97.5 and specificity of 88.2 % (p<0.0001). For GCS score, AUC was 0.95, with sensitivity of 98.3 % and specificity of 82.4 % with cut-off score of 6 (p<0.0001). The correlation coefficient was 0.753 (p<0.001) between the GCS and FOUR scores. Conclusions The predictive value of the FOUR score on admission of patients with TBI is no better than the GCS score.	[Saika, Amrit; Devi, Bhagavatula Indira; Shukla, Dhaval P.] Natl Inst Mental Hlth & Neurosci NIMHANS, Dept Neurosurg, Bangalore 560029, Karnataka, India; [Bansal, Sonia] Natl Inst Mental Hlth & Neurosci NIMHANS, Dept Neuroanesthesiol & Neurocrit Care, Bangalore 560029, Karnataka, India; [Philip, Mariamma] Natl Inst Mental Hlth & Neurosci NIMHANS, Dept Biostat, Bangalore 560029, Karnataka, India	Shukla, DP (corresponding author), Natl Inst Mental Hlth & Neurosci NIMHANS, Dept Neurosurg, Bangalore 560029, Karnataka, India.	neurodhaval@rediffmail.com	Philip, Mariyamma/AAR-4349-2020	Philip, Mariyamma/0000-0001-6047-1494			BASTOS PG, 1993, CRIT CARE MED, V21, P1459, DOI 10.1097/00003246-199310000-00012; BHATTY GB, 1993, ACTA NEUROCHIR, V120, P132, DOI 10.1007/BF02112031; BISHARA S N, 1992, Brain Injury, V6, P373, DOI 10.3109/02699059209034952; Chen BX, 2013, ACTA NEUROCHIR, V155, P2133, DOI 10.1007/s00701-013-1854-2; GENNARELLI TA, 1994, J TRAUMA, V37, P962, DOI 10.1097/00005373-199412000-00016; Jalali R, 2014, CRIT CARE RES PRACT, V2014, DOI 10.1155/2014/289803; McNett M, 2014, NEUROCRIT CARE, V21, P52, DOI 10.1007/s12028-013-9947-6; Okasha AS, 2014, NEUROCRIT CARE, V21, P496, DOI 10.1007/s12028-014-9995-6; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Poon WS, 2005, ACT NEUR S, V93, P207; Sadaka F, 2012, NEUROCRIT CARE, V16, P95, DOI 10.1007/s12028-011-9617-5; Shukla D, 2010, J NEUROSCI RURAL PRA, V1, P82, DOI 10.4103/0976-3147.71723; Shukla D, 2011, CLIN NEUROL NEUROSUR, V113, P435, DOI 10.1016/j.clineuro.2011.02.013; Stead LG, 2009, NEUROCRIT CARE, V10, P50, DOI 10.1007/s12028-008-9145-0; TEASDALE G, 1974, LANCET, V2, P81; Widjicks EF, 2015, CRIT CARE MED, V43, P439; Wijdicks EFM, 2005, ANN NEUROL, V58, P585, DOI 10.1002/ana.20611	17	22	23	0	8	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0001-6268	0942-0940		ACTA NEUROCHIR	Acta Neurochir.	SEP	2015	157	8					1323	1328		10.1007/s00701-015-2469-6			6	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	CM9JR	WOS:000358025200008	26077394				2021-06-18	
J	Kroshus, E; Baugh, CM; Hawrilenko, MJ; Daneshvar, DH				Kroshus, Emily; Baugh, Christine M.; Hawrilenko, Matthew J.; Daneshvar, Daniel H.			Determinants of Coach Communication About Concussion Safety in US Collegiate Sport	ANNALS OF BEHAVIORAL MEDICINE			English	Article						Concussion; Sport; Communication; Coach; Gender	TRAUMATIC BRAIN-INJURY; HIGH-SCHOOL; YOUTH SPORTS; SOCIAL SUPPORT; ICE HOCKEY; CDC HEADS; PAIN; SOCIALIZATION; KNOWLEDGE; RISK	Communication between coaches and athletes about concussion safety can reinforce or undermine a sport culture in which concussion under-reporting is often endemic. This study tested a model in which self-reported coach communication about concussion safety was predicted by factors including concussion knowledge, attitudes and beliefs, sex of the coach, and sex of the team coached. Participants were 997 coaches of contact and collision sports teams competing in National Collegiate Athletic Association Division I, II, or III. Concussion attitudes and beliefs were the strongest predictors of communication, and the small effect of knowledge on communication was transmitted nearly entirely through its effect on attitudes and beliefs. Much of the variability in communication was attributable to the sex of the coach and the sex of the team coached. These results serve as a starting point for the design of coach-targeted interventions that encourage communication about health and safety with athletes.	[Kroshus, Emily] Harvard Univ, Sch Publ Hlth, Dept Social & Behav Sci, Boston, MA 02116 USA; [Kroshus, Emily] Natl Collegiate Athlet Assoc, Sport Sci Inst, Indianapolis, IN USA; [Kroshus, Emily; Baugh, Christine M.] Harvard Univ, Edmond J Safra Ctr Eth, Cambridge, MA 02138 USA; [Baugh, Christine M.] Harvard Univ, Interfac Initiat Hlth Policy, Cambridge, MA 02138 USA; [Baugh, Christine M.] Boston Childrens Hosp, Div Sports Med, Boston, MA USA; [Hawrilenko, Matthew J.] Clark Univ, Dept Clin Psychol, Worcester, MA 01610 USA; [Daneshvar, Daniel H.] Boston Univ, Sch Med, Ctr Study Traumat Encephalopathy, Boston, MA 02118 USA; [Daneshvar, Daniel H.] Sports Legacy Inst, Waltham, MA USA	Kroshus, E (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Social & Behav Sci, 221 Columbus Ave, Boston, MA 02116 USA.	emk329@mail.harvard.edu	Baugh, Christine/AAG-2324-2020	Baugh, Christine/0000-0002-9340-6338; Daneshvar, Daniel/0000-0003-3691-9513			Adams A, 2010, J LANG SOC PSYCHOL, V29, P278, DOI 10.1177/0261927X10368833; Ajzen I, 2011, BASIC APPL SOC PSYCH, V33, P101, DOI 10.1080/01973533.2011.568834; Anderson E, 2009, ROUTL RES GEND SOC, P1; Anderson E, 2008, SEX ROLES, V58, P104, DOI 10.1007/s11199-007-9337-7; Anderson E, 2011, J HOMOSEXUAL, V58, P565, DOI 10.1080/00918369.2011.563652; Anderson E, 2010, J GENDER STUD, V19, P249, DOI 10.1080/09589236.2010.494341; [Anonymous], 2013 14 NCAA SPORTS; Atkinson Michael., 2010, SEXUAL SPORTS RHETOR; Baugh CM, 2015, AM J SPORT MED, V43, P47, DOI 10.1177/0363546514553090; Baugh CM, 2014, J LAW MED ETHICS, V42, P314, DOI 10.1111/jlme.12148; Bazarian JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094734; Bianco T, 2001, RES Q EXERCISE SPORT, V72, P376, DOI 10.1080/02701367.2001.10608974; Blumer Herbert, 1969, SYMB INTERACT; Boden BP, 2007, AM J SPORT MED, V35, P1075, DOI 10.1177/0363546507299239; Chrisman SP, 2013, J ADOLESCENT HEALTH, V52, P330, DOI 10.1016/j.jadohealth.2012.10.271; Chrisman SP, 2011, CLIN PEDIATR, V50, P1031, DOI 10.1177/0009922811410970; Cleveland J.N., 2000, WOMEN MEN ORG SEX GE; Covassin T, 2013, AM J SPORT MED, V41, P2885, DOI 10.1177/0363546513499230; Covassin T, 2012, J SCHOOL HEALTH, V82, P233, DOI 10.1111/j.1746-1561.2012.00692.x; CURRY TJ, 1993, SYMB INTERACT, V16, P273, DOI 10.1525/si.1993.16.3.273; Daneshvar DH, 2011, CLIN SPORT MED, V30, P1, DOI 10.1016/j.csm.2010.08.006; Deschamps J.-C., 1982, SOCIAL IDENTITY INTE, P85; Donnelly P., 2000, HDB SPORTS STUDIES, P77, DOI DOI 10.4135/9781848608382.N5; Echlin PS, 2010, NEUROSURG FOCUS, V29, DOI 10.3171/2010.10.FOCUS10222; Eckner JT, 2014, BRIT J SPORT MED, V48, P112, DOI 10.1136/bjsports-2012-091579; ELY RJ, 1995, ACAD MANAGE J, V38, P589, DOI 10.2307/256740; Fenton LT, 2010, RES Q EXERCISE SPORT, V81, P212; Fisher A. Craig, 1993, Journal of Athletic Training, V28, P48; Fogel C., 2011, CANADA SOCIAL SCI, V7, P1; Glang A, 2010, INT J SPORTS SCI COA, V5, P1, DOI 10.1260/1747-9541.5.1.1; Guilmette TJ, 2007, BRAIN INJURY, V21, P1039, DOI 10.1080/02699050701633080; Hammond LE, 2014, QUAL RES SPORT EXERC, V6, P161, DOI 10.1080/2159676X.2013.796488; Hinyard LJ, 2007, HEALTH EDUC BEHAV, V34, P777, DOI 10.1177/1090198106291963; Kauer K., 2006, WOMEN SPORT PHYS ACT, V15, P42, DOI [https://doi.org/10.1123/wspaj.15.1.42, DOI 10.1123/WSPAJ.15.1.42]; Kerr ZY, 2014, BRAIN INJURY, V28, P1009, DOI 10.3109/02699052.2014.904049; Koester MC, 2000, J ATHL TRAINING, V35, P466; Kroshus E, J ATHL TRAI IN PRESS; Kroshus E, 2015, ANN BEHAV MED, V49, P95, DOI 10.1007/s12160-014-9636-5; Kroshus E, 2014, EAT DISORD, V22, P193, DOI 10.1080/10640266.2013.874827; Kroshus E, 2014, J ADOLESCENT HEALTH, V54, P269, DOI 10.1016/j.jadohealth.2013.11.011; Kroshus E, 2014, BRIT J SPORT MED, V48, P135, DOI 10.1136/bjsports-2013-092498; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lapchick R, 2010 RACIAL GENDER R; LaVoi N., 2013, DECLINE WOMEN COACHE; Liston K, 2006, SPORT SOC, V9, P388, DOI 10.1080/17430430600673407; Llewellyn T, 2014, CLIN J SPORT MED, V24, P76, DOI 10.1097/01.jsm.0000432853.77520.3d; Malcom NL, 2006, J CONTEMP ETHNOGR, V35, P495, DOI 10.1177/0891241605283571; Marchi N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056805; McLeod TCV, 2007, CLIN J SPORT MED, V17, P140; Merriam S. B., 2001, NEW DIRECTIONS ADULT, V2001, P3, DOI 10.1002/ace.3; MEZIROW J, 1981, ADULT ED, V32, P3, DOI 10.1177/074171368103200101; Miller JL, 1996, SEX ROLES, V35, P111, DOI 10.1007/BF01548178; Mrazik M, 2011, CLIN J SPORT MED, V21, P315, DOI 10.1097/JSM.0b013e31821e2b78; NIXON HL, 1994, SOCIOL SPORT J, V11, P79, DOI 10.1123/ssj.11.1.79; Partridge B, 2014, J BIOETHIC INQ, V11, P65, DOI 10.1007/s11673-013-9491-2; Pike E.C.J., 2005, INT REV SOCIOL SPORT, V40, P201, DOI [10.1177/1012690205057199, DOI 10.1177/1012690205057199]; Podlog L, 2007, PSYCHOL SPORT EXERC, V8, P535, DOI 10.1016/j.psychsport.2006.07.008; Prins ML, 2013, J NEUROTRAUM, V30, P30, DOI 10.1089/neu.2012.2399; Raftery AE, 1995, SOCIOL METHODOL, V25, P111, DOI 10.2307/271063; Roderick M, 2006, SOCIOL HEALTH ILL, V28, P76, DOI 10.1111/j.1467-9566.2005.00483.x; Rudman LA, 2008, RES ORGAN BEHAV, V28, P61, DOI 10.1016/j.riob.2008.04.003; Safai P, 2003, SOCIOL SPORT J, V20, P127, DOI 10.1123/ssj.20.2.127; Sarmiento K, 2010, J SCHOOL HEALTH, V80, P112, DOI 10.1111/j.1746-1561.2010.00491.x; Seichepine DR, 2013, J NEUROTRAUM, V30, P1299, DOI 10.1089/neu.2012.2690; Sherman Roberta Trattner, 2005, Eat Disord, V13, P447; Smith PM, 2006, FAM CONSUM SCI RES J, V34, P276, DOI 10.1177/1077727X05283598; Sundgot-Borgen J, 2010, SCAND J MED SCI SPOR, V20, P112, DOI 10.1111/j.1600-0838.2010.01190.x; Talavage TM, 2014, J NEUROTRAUM, V31, P327, DOI 10.1089/neu.2010.1512; Tomlinson A., 1997, Journal of Sport and Social Issues, V21, P134, DOI 10.1177/019372397021002003; Torres Daniel M, 2013, Neurol Clin Pract, V3, P279; Voracek M, 2010, SCAND J MED SCI SPOR, V20, P853, DOI 10.1111/j.1600-0838.2009.01031.x; Waldron JJ, 2005, QUEST, V57, P315, DOI 10.1080/00336297.2005.10491860; Wiebe DJ, 2011, INJURY PREV, V17, P69, DOI 10.1136/ip.2010.031211; Wiese-Bjornstal DM, 2010, SCAND J MED SCI SPOR, V20, P103, DOI 10.1111/j.1600-0838.2010.01195.x; Yang JZ, 2010, J ATHL TRAINING, V45, P372, DOI 10.4085/1062-6050-45.4.372	75	22	23	1	22	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0883-6612	1532-4796		ANN BEHAV MED	Ann. Behav. Med.	AUG	2015	49	4					532	541		10.1007/s12160-014-9683-y			10	Psychology, Multidisciplinary	Psychology	CM4ZJ	WOS:000357695400005	25712480				2021-06-18	
J	Lu, KT; Huang, TC; Wang, JY; You, YS; Chou, JL; Chan, MWY; Wo, PYY; Amstislavskaya, TG; Tikhonova, MA; Yang, YL				Lu, Kwok-Tung; Huang, Tai-Chun; Wang, Jia-Yi; You, Ya-Shen; Chou, Jian-Liang; Chan, Michael W. Y.; Wo, Peter Y. Y.; Amstislavskaya, Tamara G.; Tikhonova, Maria A.; Yang, Yi-Ling			NKCC1 mediates traumatic brain injury-induced hippocampal neurogenesis through CREB phosphorylation and HIF-1 alpha expression	PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY			English	Article						TBI; Neurogenesis; NKCC1; CREB; Hippocampus	K-CL COTRANSPORTER; GROWTH-FACTOR EXPRESSION; NEWLY GENERATED NEURONS; CAMP RESPONSE; NA+-K+-2CL(-) COTRANSPORTER; SUBVENTRICULAR ZONE; CELL-PROLIFERATION; NEWBORN NEURONS; PROTEIN-KINASE; DENTATE GYRUS	Traumatic brain injury (TBI) is one of the most prevalent causes of worldwide mortality and morbidity. We previously had evidenced that TBI induced Na-K-2Cl co-transporter (NKCC1) upregulation in hippocampus. Here, we aim to investigate the role of NKCC1 in TBI-induced neurogenesis and the detailed mechanisms. The TBI-associated alternations in the expression of NKCC1, HIF-1 alpha, VEGF, MAPK cascade, and CREB phosphorylation were analyzed by Western blot. TBI-induced neurogenesis was determined by immuno-fluorescence labeling. Chromatin immunoprecipitation was used to elucidate whether HIF-1 alpha would activate VEGF gene after TBI. We found that the level of hippocampal NKCC1 and VEGF began to rise 8 h after TBI, and both of them reached maxima at day 7. Along with the upregulation of NKCC1 and VEGF, MAPK cascade was activated and hippocampal neurogenesis was promoted. Administration of CREB antisense oligonucleotide significantly attenuated the expression of HIF-1 alpha, while HIF-1 alpha antisense oligonucleotide exhibited little effect on the expression of CREB. However, HIF-1 alpha antisense oligonucleotide administration did effectively suppress the expression of VEGF. Our results of the chromosome immunoprecipitation also indicated that HIF-1 alpha could directly act on the VEGF promoter and presumably would elevate the VEGF expression after TBI. All these results have illustrated the correlation between NKCC1 upregulation and TBI-associated neurogenesis. The pathway involves the activation of Raf/MEK/ERK cascade, CREB phosphorylation, and HIF-1 alpha upregulation, and finally leads to the stimulation of VEGF expression and the induction of neurogenesis.	[Lu, Kwok-Tung; Huang, Tai-Chun] Natl Taiwan Normal Univ, Dept Life Sci, Taipei, Taiwan; [Wang, Jia-Yi] Taipei Med Univ, Dept Physiol, Taipei, Taiwan; [You, Ya-Shen; Wo, Peter Y. Y.; Yang, Yi-Ling] Natl Chia Yi Univ, Dept Biochem Sci & Technol, Chiayi, Taiwan; [Chou, Jian-Liang; Chan, Michael W. Y.] Natl Chung Cheng Univ, Dept Life Sci, Chiayi, Taiwan; [Amstislavskaya, Tamara G.; Tikhonova, Maria A.] State Res Inst Physiol & Fundamental Med SB RAMS, Lab Biol Psychiat, Novosibirsk, Russia	Yang, YL (corresponding author), Natl Chia Yi Univ, Dept Biochem Sci & Technol, Chiayi, Taiwan.	ylyang@mail.ncyu.edu.tw	Amstislavskaya, Tamara G/K-4149-2018; Tikhonova, Maria A/K-3455-2018; Chan, Michael/F-9615-2018	Tikhonova, Maria A/0000-0002-4265-8981; Chan, Michael/0000-0003-1431-322X; Chan, Michael/0000-0003-0314-2437; Wang, Jia-Yi/0000-0002-9106-3351	Ministry of Science and Technology of TaiwanMinistry of Science and Technology, Taiwan [NSC 97-2320-B-415-006-MY3]; State Research Institute of Physiology and Fundamental Medicine SB RAMS [053]	Supported by grants from the Ministry of Science and Technology of Taiwan (NSC 97-2320-B-415-006-MY3) and partially by the project No. 053 of the State Research Institute of Physiology and Fundamental Medicine SB RAMS.	Adams JP, 2000, ACTA NEUROBIOL EXP, V60, P377; Alvarez-Leefmans FJ, 2001, NEUROSCIENCE, V104, P569, DOI 10.1016/S0306-4522(01)00091-4; Ben-Ari Y, 2002, NAT REV NEUROSCI, V3, P728, DOI 10.1038/nrn920; Braveman Melissa W., 2004, V277, P261; Chen H, 2005, NEUROL RES, V27, P280, DOI 10.1179/016164105X25243; Chen H, 2005, J CEREBR BLOOD F MET, V25, P54, DOI 10.1038/sj.jcbfm.9600006; Chirumamilla S, 2002, J NEUROTRAUM, V19, P693, DOI 10.1089/08977150260139084; Dash PK, 2001, J NEUROSCI RES, V63, P313, DOI 10.1002/1097-4547(20010215)63:4<313::AID-JNR1025>3.0.CO;2-4; Fournier NM, 2012, NEUROPHARMACOLOGY, V63, P642, DOI 10.1016/j.neuropharm.2012.04.033; Fujioka T, 2004, J NEUROSCI, V24, P319, DOI 10.1523/JNEUROSCI.1065.03.2004; Galvan V, 2007, CLIN INTERV AGING, V2, P605; Ge SY, 2006, NATURE, V439, P589, DOI 10.1038/nature04404; Giachino C, 2005, J NEUROSCI, V25, P10105, DOI 10.1523/JNEUROSCI.3512-05.2005; GONZALEZ GA, 1989, NATURE, V337, P749, DOI 10.1038/337749a0; Gur TL, 2007, J NEUROSCI, V27, P7860, DOI 10.1523/JNEUROSCI.2051-07.2007; Haas M, 2000, ANNU REV PHYSIOL, V62, P515, DOI 10.1146/annurev.physiol.62.1.515; Herold S, 2011, MOL CELL NEUROSCI, V46, P79, DOI 10.1016/j.mcn.2010.08.008; Huang GJ, 2005, NEUROSCIENCE, V135, P803, DOI 10.1016/j.neuroscience.2005.05.056; Jagasia R, 2009, J NEUROSCI, V29, P7966, DOI 10.1523/JNEUROSCI.1054-09.2009; Jin KL, 2001, P NATL ACAD SCI USA, V98, P4710, DOI 10.1073/pnas.081011098; Liu XX, 2005, NAT NEUROSCI, V8, P1179, DOI 10.1038/nn1522; Lonze BE, 2002, NEURON, V35, P605, DOI 10.1016/S0896-6273(02)00828-0; Lu KT, 2008, CRIT CARE MED, V36, P917, DOI 10.1097/CCM.0B013E31816590C4; Lu KT, 2007, NEUROL RES, V29, P404, DOI 10.1179/016164107X204738; Lu KT, 2006, EUR J PHARMACOL, V548, P99, DOI 10.1016/j.ejphar.2006.07.048; Lu KT, 2011, J NEUROTRAUM, V28, P441, DOI 10.1089/neu.2010.1473; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Marshall LF, 2000, NEUROSURGERY, V47, P546, DOI 10.1097/00006123-200009000-00002; Mejia-Gervacio S, 2011, NEURAL DEV, V6, DOI 10.1186/1749-8104-6-4; Merz K, 2011, EUR J NEUROSCI, V33, P1078, DOI 10.1111/j.1460-9568.2011.07606.x; Miljan EA, 2009, CURR OPIN MOL THER, V11, P394; MINCHENKO A, 1994, LAB INVEST, V71, P374; MISGELD U, 1986, SCIENCE, V232, P1413, DOI 10.1126/science.2424084; MONTMINY MR, 1986, P NATL ACAD SCI USA, V83, P6682, DOI 10.1073/pnas.83.18.6682; Nakagawa S, 2002, J NEUROSCI, V22, P3673; Obermuller N, 1996, J CLIN INVEST, V98, P635, DOI 10.1172/JCI118834; ODONNELL ME, 1995, AM J PHYSIOL-CELL PH, V268, pC747; Pages G, 2005, CARDIOVASC RES, V65, P564, DOI 10.1016/j.cardiores.2004.09.032; Panet R, 2006, J CELL PHYSIOL, V206, P578, DOI 10.1002/jcp.20506; Panet R, 2002, J CELL PHYSIOL, V190, P227, DOI 10.1002/JCP.10055; Parent JM, 2002, ANN NEUROL, V52, P802, DOI 10.1002/ana.10393; PAYNE JA, 1995, CURR OPIN CELL BIOL, V7, P493, DOI 10.1016/0955-0674(95)80005-0; Plotkin MD, 1997, AM J PHYSIOL-CELL PH, V272, pC173; Rao MS, 2005, EUR J NEUROSCI, V21, P464, DOI 10.1111/j.1460-9568.2005.03853.x; Richardson RM, 2007, NEUROSURG CLIN N AM, V18, P169, DOI 10.1016/j.nec.2006.10.007; Sahay A, 2007, NAT NEUROSCI, V10, P1110, DOI 10.1038/nn1969; Shors TJ, 2001, NATURE, V410, P372, DOI 10.1038/35066584; Takahashi H, 2005, CLIN SCI, V109, P227, DOI 10.1042/CS20040370; Tsankova NM, 2004, J NEUROSCI, V24, P5603, DOI 10.1523/JNEUROSCI.0589-04.2004; Wu D, 2007, ONCOGENE, V26, P5070, DOI 10.1038/sj.onc.1210316	50	22	23	2	13	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0031-6768	1432-2013		PFLUG ARCH EUR J PHY	Pflugers Arch.	AUG	2015	467	8					1651	1661		10.1007/s00424-014-1588-x			11	Physiology	Physiology	CM9WD	WOS:000358059300003	25201604				2021-06-18	
J	Nudi, ET; Jacqmain, J; Dubbs, K; Geeck, K; Salois, G; Searles, MA; Smith, JS				Nudi, Evan T.; Jacqmain, Justin; Dubbs, Kelsey; Geeck, Katalin; Salois, Garrick; Searles, Madeleine A.; Smith, Jeffrey S.			Combining Enriched Environment, Progesterone, and Embryonic Neural Stem Cell Therapy Improves Recovery after Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						enriched environment; eNSC; progesterone; TBI	CONTROLLED CORTICAL IMPACT; RANDOMIZED CLINICAL-TRIAL; SEVERE HEAD-INJURY; CONTUSION INJURY; FUNCTIONAL RECOVERY; COGNITIVE DEFICITS; FEMALE RATS; SUBVENTRICULAR ZONE; PREFRONTAL CORTEX; TRANSPLANTATION	Millions of persons every year are affected by traumatic brain injury (TBI), and currently no therapies have shown efficacy in improving outcomes clinically. Recent research has suggested that enriched environments (EE), embryonic neural stem cells (eNSC), and progesterone (PROG) improve functional outcomes after TBI, and further, several investigators have suggested that a polytherapuetic approach may have greater efficacy than a single therapy. The purpose of the current study was to determine if varying combinations of post-injury EE, progesterone therapy, or eNSC transplantation would improve functional outcomes over just a single therapy. A controlled cortical impact was performed in rats to create a lesion in the medial frontal cortex. The rats were then placed in either EE or standard environments and administered 10mg/kg progesterone or vehicle injections 4h post-injury and every 12h for 72h after the initial injection. Seven days after the surgery, rats were transplanted with either eNSCs or media. Rats were then tested on the open field test, Barnes maze, Morris water maze, and Rotor-Rod tasks. Improved functional outcomes were shown on a majority of the behavioral tasks in animals that received a combination of therapies. This effect was especially prominent with therapies that were combined with EE. Immunohistochemistry showed that the transplanted eNSCs survived, migrated, and displayed neural phenotypes. These data suggest that a poly-therapeutic approach after TBI improves functional recovery to a greater magnitude. Moreover, when polytherapies are combined with EE, the effects on recovery are enhanced, leading to greater recovery of function.	[Nudi, Evan T.; Jacqmain, Justin; Dubbs, Kelsey; Geeck, Katalin; Salois, Garrick; Searles, Madeleine A.; Smith, Jeffrey S.] Saginaw Valley State Univ, Brain Res Lab, University Ctr, MI 48710 USA	Smith, JS (corresponding author), Saginaw Valley State Univ, Crystal M Lange Coll Hlth & Human Serv, Dept Hlth Sci, 7400 Bay Rd, University Ctr, MI 48710 USA.	jsmith12@svsu.edu		Smith, Jeffrey/0000-0001-5499-4475	Dow Student Research and Creativity Institute; Field Neuroscience Institute	This study was funded, in part, by a Dow Student Research and Creativity Institute grant, awarded to E.T.N. and a Field Neuroscience Institute research contract, awarded to J.S.S. The authors would like to thank Jennica Young, Ivy Hiatt, Tim Pionk, and Kimberly Meerschaert for their help with animal care and assistance throughout the course of the study.	Adekoya N., 2002, SURVEILLANCE TRAUMAT; Angelucci F, 2009, CEREBELLUM, V8, P499, DOI 10.1007/s12311-009-0129-1; BARNES CA, 1979, J COMP PHYSIOL PSYCH, V93, P74, DOI 10.1037/h0077579; Bilotta F, 2008, NEUROCRIT CARE, V9, P159, DOI 10.1007/s12028-008-9084-9; Bramlett HM, 2001, J NEUROTRAUM, V18, P891, DOI 10.1089/089771501750451811; Cao QL, 2002, J NEUROSCI RES, V68, P501, DOI 10.1002/jnr.10240; CATTANEO E, 1990, NATURE, V347, P762, DOI 10.1038/347762a0; Champion HR, 2009, J TRAUMA, V66, P1468, DOI 10.1097/TA.0b013e3181a27e7f; Clifton GL, 2001, NEW ENGL J MED, V344, P556, DOI 10.1056/NEJM200102223440803; COGGESHALL RE, 1992, TRENDS NEUROSCI, V15, P9, DOI 10.1016/0166-2236(92)90339-A; Coronado VG, 2012, J SAFETY RES, V43, P299, DOI 10.1016/j.jsr.2012.08.011; Curtiss G, 2001, J INT NEUROPSYCH SOC, V7, P574, DOI 10.1017/S1355617701755051; DIXON CE, 1991, J NEUROSCI METH, V39, P253; Fox GB, 1998, J NEUROTRAUM, V15, P599, DOI 10.1089/neu.1998.15.599; Galani R, 1997, NEUROBIOL LEARN MEM, V67, P43, DOI 10.1006/nlme.1996.3745; Gleave JA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072039; Gold EM, 2013, REGEN MED, V8, P483, DOI 10.2217/rme.13.41; Griesbach GS, 2009, BRAIN RES, V1288, P105, DOI 10.1016/j.brainres.2009.06.045; Griesbach GS, 2004, NEUROSCIENCE, V125, P129, DOI 10.1016/j.neuroscience.2004.01.030; Guo QM, 2006, EXP NEUROL, V198, P469, DOI 10.1016/j.expneurol.2005.12.013; HAMM RJ, 1992, J NEUROTRAUM, V9, P11, DOI 10.1089/neu.1992.9.11; HAMM RJ, 1994, J NEUROTRAUM, V11, P187, DOI 10.1089/neu.1994.11.187; He J, 2004, EXP NEUROL, V189, P404, DOI 10.1016/j.expneurol.2004.06.008; Hicks AU, 2007, NEUROSCIENCE, V146, P31, DOI 10.1016/j.neuroscience.2007.01.020; Hoane MR, 2004, J NEUROTRAUM, V21, P163, DOI 10.1089/089771504322778622; HOFFMAN SW, 1994, J NEUROTRAUM, V11, P417, DOI 10.1089/neu.1994.11.417; Ikonomidou C, 2002, LANCET NEUROL, V1, P383, DOI 10.1016/S1474-4422(02)00164-3; Itoh T, 2005, NEUROREPORT, V16, P1687, DOI 10.1097/01.wnr.0000183330.44112.ab; Jones TA, 2012, J NEUROTRAUM, V29, P1455, DOI 10.1089/neu.2011.2207; Ke MT, 2013, NAT NEUROSCI, V16, P1154, DOI 10.1038/nn.3447; Kesner RP, 2011, NEUROBIOL LEARN MEM, V96, P417, DOI 10.1016/j.nlm.2011.07.002; Kline AE, 2012, J NEUROTRAUM, V29, P1960, DOI 10.1089/neu.2012.2385; Kline AE, 2010, J NEUROTRAUM, V27, P2021, DOI 10.1089/neu.2010.1535; KOLB B, 1984, BRAIN RES REV, V8, P65, DOI 10.1016/0165-0173(84)90018-3; Komitova M, 2005, STROKE, V36, P1278, DOI 10.1161/01.STR.0000166197.94147.59; Kozlowski DA, 2004, J NEUROTRAUM, V21, P513, DOI 10.1089/089771504774129856; LABBE R, 1983, SCIENCE, V221, P470, DOI 10.1126/science.6683427; Lighthall JW, 1988, J NEUROTRAUM, V5, P1, DOI 10.1089/neu.1988.5.1; Maas AIR, 2006, LANCET NEUROL, V5, P38, DOI 10.1016/S1474-4422(05)70253-2; Maas AIR, 2010, NEUROTHERAPEUTICS, V7, P115, DOI 10.1016/j.nurt.2009.10.022; Maegele M, 2005, EUR J NEUROSCI, V21, P2406, DOI 10.1111/j.1460-9568.2005.04070.x; McDonald JW, 1999, NAT MED, V5, P1410, DOI 10.1038/70986; Molcanyi M, 2007, J NEUROTRAUM, V24, P625, DOI 10.1089/neu.2006.0180; Monaco CM, 2013, EXP NEUROL, V247, P410, DOI 10.1016/j.expneurol.2013.01.007; Morales DM, 2005, NEUROSCIENCE, V136, P971, DOI 10.1016/j.neuroscience.2005.08.030; Morris GF, 1999, J NEUROSURG, V91, P737, DOI 10.3171/jns.1999.91.5.0737; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; National Institute of Neurological Disorders and Stroke, 2014, TRAUM BRAIN INJ RES; Nudi E. T., 2013, J NEUROTRAUM, V30; Passineau MJ, 2001, EXP NEUROL, V168, P373, DOI 10.1006/exnr.2000.7623; Peruzzaro ST, 2013, RESTOR NEUROL NEUROS, V31, P431, DOI 10.3233/RNN-120299; Peterson TC, 2012, J NEUROTRAUM, V29, P2823, DOI 10.1089/neu.2012.2471; Pettus EH, 2005, BRAIN RES, V1049, P112, DOI 10.1016/j.brainres.2005.05.004; Pierce JES, 1998, NEUROSCIENCE, V87, P359, DOI 10.1016/S0306-4522(98)00142-0; Ramic M, 2006, BRAIN RES, V1111, P176, DOI 10.1016/j.brainres.2006.06.063; Riess P, 2002, NEUROSURGERY, V51, P1043, DOI 10.1097/00006123-200210000-00035; Riess P, 2007, J NEUROTRAUM, V24, P216, DOI 10.1089/neu.2006.0141; Risedal A, 2002, BRAIN RES BULL, V58, P315, DOI 10.1016/S0361-9230(02)00796-7; Roberts I, 1998, J NEUROL NEUROSUR PS, V65, P729, DOI 10.1136/jnnp.65.5.729; Robertson CL, 2006, EXP NEUROL, V197, P235, DOI 10.1016/j.expneurol.2005.09.014; ROOF RL, 1994, EXP NEUROL, V129, P64, DOI 10.1006/exnr.1994.1147; Ruttan L, 2008, ARCH PHYS MED REHAB, V89, pS69, DOI 10.1016/j.apmr.2008.07.007; SAUL TG, 1981, J NEUROSURG, V54, P596, DOI 10.3171/jns.1981.54.5.0596; Sayeed L, 2007, RESTOR NEUROL NEUROS, V25, P151; Scheff SW, 1997, J NEUROTRAUM, V14, P615, DOI 10.1089/neu.1997.14.615; Shaw CL, 2013, BEHAV BRAIN RES, V236, P94, DOI 10.1016/j.bbr.2012.08.024; Shear DA, 2002, EXP NEUROL, V178, P59, DOI 10.1006/exnr.2002.8020; Shear DA, 2011, RESTOR NEUROL NEUROS, V29, P215, DOI 10.3233/RNN-2011-0593; Sozda CN, 2010, J NEUROTRAUM, V27, P1047, DOI 10.1089/neu.2010.1313; Stein DG, 2001, TRENDS NEUROSCI, V24, P386, DOI 10.1016/S0166-2236(00)01821-X; SUTTON RL, 1993, J NEUROTRAUM, V10, P135, DOI 10.1089/neu.1993.10.135; Temkin NR, 2007, LANCET NEUROL, V6, P29, DOI 10.1016/S1474-4422(06)70630-5; van Praag H, 2000, NAT REV NEUROSCI, V1, P191, DOI 10.1038/35044558; Will B, 2004, PROG NEUROBIOL, V72, P167, DOI 10.1016/j.pneurobio.2004.03.001; Wright DW, 2007, ANN EMERG MED, V49, P391, DOI 10.1016/j.annemergmed.2006.07.932; Wright DW, 2001, J NEUROTRAUM, V18, P901, DOI 10.1089/089771501750451820	76	22	23	0	9	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUL 15	2015	32	14					1117	1129		10.1089/neu.2014.3618			13	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	CV0TB	WOS:000363965000011	25268854				2021-06-18	
J	Lee, JH; Won, S; Stein, DG				Lee, Jeong Hun; Won, Soonmi; Stein, Donald G.			Progesterone attenuates thrombin-induced endothelial barrier disruption in the brain endothelial cell line bEnd.3: The role of tight junction proteins and the endothelial protein C receptor	BRAIN RESEARCH			English	Article						Thrombin; Progesterone; Blood-brain barrier; bEnd.3 endothelial cell; Tight junction protein; Endothelial protein C receptor	FOCAL CEREBRAL-ISCHEMIA; SUBARACHNOID HEMORRHAGE; ACTIVATED RECEPTOR-1; NEURONAL DAMAGE; INJURY; RATS; ASTROCYTES; EXPRESSION; DISEASES; MODEL	This study examines the effects of progesterone on blood-brain barrier (BBB) integrity following thrombin administration. Thrombin is expressed in many diseases which affect neural tissue and is associated with breakdown of the BBB. Progesterone has shown protective effects on the BBB in stroke and traumatic brain injury. Methods: Mouse brain endothelial (bEnd.3) cells were treated with progesterone (20 mu mol/l) for 24 h before thrombin administration (60 U/ml). BBB permeability was measured by transendothelial electrical resistance (TEER), because TEER decrease is associated with BBB compromise. Tight junction (TJ) proteins (occludin, claudin-5, and zonula occludens-1) and endothelial protein C receptor (EPCR) were analyzed. Results: Thrombin decreased TEER and progesterone prevented that decrease. TJ proteins and EPCR were also decreased after thrombin treatment and progesterone treatment blocked that effect. Conclusion: Progesterone can attenuate thrombin-induced BBB disruption by blocking the degradation of TJ proteins and EPCR in bEnd.3 cells. (C) 2015 Elsevier B.V. All rights reserved.	[Lee, Jeong Hun] Donggulz Univ, Sch Med, Dept Emergency Med, Goyang Si, Gyeonggi Do, South Korea; [Won, Soonmi; Stein, Donald G.] Emory Univ, Dept Emergency Med, Brain Res Lab, Atlanta, GA 30322 USA	Stein, DG (corresponding author), Emory Univ, Dept Emergency Med, Brain Res Lab, 1365B Clifton Rd NE,Suite 5100, Atlanta, GA 30322 USA.	dstei04@emory.edu	Stein, Donald/AAJ-5139-2020		Allen and Company gifts; AHAAmerican Heart Association [14POST20130024]; Laney Graduate School of Emory University; Dongguk University	This work was supported by Allen and Company gifts; AHA 14POST20130024 to SW; the Laney Graduate School of Emory University, and Dongguk University.	Alabanza LM, 2012, J NEUROIMMUNOL, V245, P48, DOI 10.1016/j.jneuroim.2012.02.004; Anderson GD, 2011, J NEUROTRAUM, V28, P1827, DOI 10.1089/neu.2011.1911; Bae JS, 2008, THROMB HAEMOSTASIS, V100, P101, DOI 10.1160/TH08-02-0127; Ballabh P, 2004, NEUROBIOL DIS, V16, P1, DOI 10.1016/j.nbd.2003.12.016; Cekic M., 2012, RESTOR NEUROL NEUROS, V28, P1; Chapman J, 2006, AUTOIMMUN REV, V5, P528, DOI 10.1016/j.autrev.2006.02.011; Chen B, 2012, J NEUROSCI, V32, P7622, DOI 10.1523/JNEUROSCI.0369-12.2012; Chen B, 2010, STROKE, V41, P2348, DOI 10.1161/STROKEAHA.110.584920; Chen T, 2014, SCI REP-UK, V4, DOI 10.1038/srep05531; Choi SH, 2003, J NEUROSCI, V23, P5877; Ciriza I, 2006, J NEUROBIOL, V66, P916, DOI 10.1002/neu.20293; Czupalla CJ, 2014, METHODS MOL BIOL, V1135, P415, DOI 10.1007/978-1-4939-0320-7_34; Deli MA, 2005, CELL MOL NEUROBIOL, V25, P59, DOI 10.1007/s10571-004-1377-8; Domotor E, 2003, BLOOD, V101, P4797, DOI 10.1182/blood-2002-12-3680; Donovan FM, 1997, J NEUROSCI, V17, P5316; Feistritzer C, 2005, BLOOD, V105, P3178, DOI 10.1182/blood-2004-10-3985; Fernandes S, 2014, MOL NEUROBIOL; Gaillard PJ, 2001, EUR J PHARM SCI, V12, P215, DOI 10.1016/S0928-0987(00)00123-8; Gingrich MB, 2000, J NEUROSCI, V20, P4582, DOI 10.1523/JNEUROSCI.20-12-04582.2000; Grammas P, 2006, J ALZHEIMERS DIS, V9, P51; Hawkins BT, 2005, PHARMACOL REV, V57, P173, DOI 10.1124/pr.57.2.4; Hua Y, 2009, STROKE, V40, pS88, DOI 10.1161/STROKEAHA.108.533281; Ishida Y, 2006, J NEUROPATH EXP NEUR, V65, P66, DOI 10.1097/01.jnen.0000195941.48033.eb; Ishrat T, 2010, EXP NEUROL, V226, P183, DOI 10.1016/j.expneurol.2010.08.023; Ishrat T, 2009, BRAIN RES, V1257, P94, DOI 10.1016/j.brainres.2008.12.048; Kameda K, 2012, BRIT J PHARMACOL, V165, P106, DOI 10.1111/j.1476-5381.2011.01485.x; Kawkitinarong K, 2004, AM J RESP CELL MOL, V31, P517, DOI 10.1165/rcmb.2003-0432OC; Kondo N, 2009, EXP CELL RES, V315, P2879, DOI 10.1016/j.yexcr.2009.07.031; Liu DZ, 2010, ANN NEUROL, V67, P526, DOI 10.1002/ana.21924; Mhatre M, 2004, NEUROBIOL AGING, V25, P783, DOI 10.1016/j.neurobiolaging.2003.07.007; Park KW, 2009, J IMMUNOL, V183, P4666, DOI 10.4049/jimmunol.0803392; Rabiet MJP, 1996, ARTERIOSCL THROM VAS, V16, P488, DOI 10.1161/01.ATV.16.3.488; Rosenberg GA, 2012, J CEREBR BLOOD F MET, V32, P1139, DOI 10.1038/jcbfm.2011.197; Shin JA, 2014, NEUROBIOL AGING; Sokolova E, 2008, THROMB HAEMOSTASIS, V100, P576, DOI 10.1160/TH08-03-0131; Wan WB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113126; Wang JP, 2009, BRAIN RES BULL, V79, P426, DOI 10.1016/j.brainresbull.2009.05.018; Wei J, 2013, ACTA PHARMACOL SIN, V34, P1485, DOI 10.1038/aps.2013.160; Won S, 2014, J CEREBR BLOOD F MET, V34, P72, DOI 10.1038/jcbfm.2013.163; Xue MZ, 2001, STROKE, V32, P2164, DOI 10.1161/hs0901.095408; Yan F, 2013, NEUROSCI LETT, V543, P163, DOI 10.1016/j.neulet.2013.03.005; Zhao C, 2011, CHIN J NEUROMED, V10	42	22	22	0	9	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	JUL 10	2015	1613						73	80		10.1016/j.brainres.2015.04.002			8	Neurosciences	Neurosciences & Neurology	CK9IG	WOS:000356553200007	25862570				2021-06-18	
J	Li, SJ; Marks, JA; Eisenstadt, R; Kumasaka, K; Samadi, D; Johnson, VE; Holena, DN; Allen, SR; Browne, KD; Smith, DH; Pascual, JL				Li, Shengjie; Marks, Joshua A.; Eisenstadt, Rachel; Kumasaka, Kenichiro; Samadi, Davoud; Johnson, Victoria E.; Holena, Daniel N.; Allen, Steven R.; Browne, Kevin D.; Smith, Douglas H.; Pascual, Jose L.			Enoxaparin ameliorates post-traumatic brain injury edema and neurologic recovery, reducing cerebral leukocyte endothelial interactions and vessel permeability in vivo	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article; Proceedings Paper	28th Annual Scientific Assembly of the Eastern-Association-for-the-Surgery-of-Trauma	JAN 13-17, 2015	Lake Buena Vista, FL	Eastern Assoc Surg Trauma		Enoxaparin; traumatic brain injury; leukocyte; blood-brain barrier; mice	MOLECULAR-WEIGHT HEPARIN; CONTROLLED CORTICAL IMPACT; UNFRACTIONATED HEPARIN; NEUTROPHIL ACTIVATION; HYPERTONIC SALINE; ENDOTOXEMIC RATS; INFARCT SIZE; HEAD-INJURY; INFLAMMATION; MICROCIRCULATION	BACKGROUND Traumatic brain injury (TBI) confers a high risk of venous thrombosis, but early prevention with heparinoids is often withheld, fearing cerebral hematoma expansion. Yet, studies have shown heparinoids not only to be safe but also to limit brain edema and contusion size after TBI. Human TBI data also suggest faster radiologic and clinical neurologic recovery with earlier heparinoid administration. We hypothesized that enoxaparin (ENX) after TBI blunts in vivo leukocyte (LEU) mobilization to injured brain and cerebral edema, while improving neurologic recovery without increasing the size of the cerebral hemorrhagic contusion. METHODS CD1 male mice underwent either TBI by controlled cortical impact (CCI, 1-mm depth, 6 m/s) or sham craniotomy. ENX (1 mg/kg) or vehicle (VEH, 0.9% saline, 1 mL/kg) was administered at 2, 8, 14, 23, and 32 hours after TBI. At 48 hours, intravital microscopy was used to visualize live LEUs interacting with endothelium and microvascular leakage of fluorescein isothiocyanate-albumin. Neurologic function (Neurological Severity Score, NSS), activated clotting time, hemorrhagic contusion size, as well as brain and lung wet-to-dry ratios were evaluated post mortem. Analysis of variance with Bonferroni correction was used for statistical comparisons between groups. RESULTS Compared with VEH, ENX significantly reduced in vivo LEU rolling on endothelium (72.7 28.3 LEU/100 m/min vs. 30.6 +/- 18.3 LEU/100 m/min, p = 0.02) and cerebrovascular albumin leakage (34.5% +/- 8.1% vs. 23.8% +/- 5.5%, p = 0.047). CCI significantly increased ipsilateral cerebral hemisphere edema, but ENX treatment reduced post-CCI edema to near control levels (81.5% +/- 1.5% vs. 77.6% +/- 0.6%, p < 0.01). Compared with VEH, ENX reduced body weight loss at 24 hours (8.7% +/- 1.2% vs. 5.8% +/- 1.1%, p < 0.01) and improved NSS at 24 hours (14.5 +/- 0.5 vs. 16.2 +/- 0.4, p < 0.01) and 48 hours (15.1 +/- 0.4 vs. 16.7 +/- 0.5, p < 0.01) after injury. There were no significant differences in activated clotting time, hemorrhagic contusion size, and lung water content between the groups. CONCLUSION ENX reduces LEU recruitment to injured brain, diminishing visible microvascular permeability and edema. ENX may also accelerate neurologic recovery without increasing cerebral contusion size. Further study in humans is necessary to determine safety, appropriate dosage, and timing of ENX administration early after TBI.	[Li, Shengjie; Marks, Joshua A.; Eisenstadt, Rachel; Kumasaka, Kenichiro; Samadi, Davoud; Holena, Daniel N.; Allen, Steven R.; Pascual, Jose L.] Univ Penn, Dept Surg, Div Traumatol Surg Crit Care & Emergency Surg, Ctr Brain Injury & Repair,Perelman Sch Med, Philadelphia, PA 19104 USA; [Browne, Kevin D.; Smith, Douglas H.; Pascual, Jose L.] Univ Penn, Dept Neurosurg, Ctr Brain Injury & Repair, Perelman Sch Med, Philadelphia, PA 19104 USA; [Li, Shengjie; Johnson, Victoria E.] Tianjin Med Univ, Gen Hosp, Tianjin Neurol Inst, Dept Neurosurg, Tianjin, Peoples R China	Pascual, JL (corresponding author), Dept Surg, Div Traumatol Surg Crit Care & Emergency Surg, 3400 Spruce St, Philadelphia, PA 19104 USA.	Jose.pascual@uphs.upenn.edu	Pascual, Jose/ABI-2291-2020	Pascual, Jose/0000-0002-1613-7912; Holena, Daniel/0000-0003-3424-5754	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS092398] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01 NS092398] Funding Source: Medline		Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS32, DOI 10.1089/neu.2007.9991; Cavusoglu Erdal, 2005, J Invasive Cardiol, V17, P416; DiStasi MR, 2009, TRENDS IMMUNOL, V30, P539, DOI 10.1016/j.it.2009.07.012; Dudley RR, 2010, J NEUROTRAUM, V27, P2165, DOI 10.1089/neu.2010.1366; Farooqui A, 2013, J NEUROSURG, V119, P1576, DOI 10.3171/2013.8.JNS13424; Gavins F, 2007, MICROCIRCULATION, V14, P667, DOI 10.1080/10739680701404903; Gikakis N, 1996, CIRCULATION, V94, P341; Gould MK, 2012, CHEST, V141, pE227S, DOI 10.1378/chest.11-2297; Hunt RF, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00089; Iba T, 2009, SHOCK, V32, P530, DOI 10.1097/SHK.0b013e3181a2e279; Kim J, 2002, J TRAUMA, V53, P38, DOI 10.1097/00005373-200207000-00008; Kim Luke, 2014, J Emerg Trauma Shock, V7, P141, DOI 10.4103/0974-2700.136846; Knudson M Margaret, 2004, Curr Opin Crit Care, V10, P539, DOI 10.1097/01.ccx.0000144941.09650.9f; Knudson MM, 1996, J TRAUMA, V41, P446, DOI 10.1097/00005373-199609000-00010; Kubes P, 2000, BRAIN PATHOL, V10, P127; Li LF, 2009, CRIT CARE, V13, DOI 10.1186/cc7949; Libersan D, 1998, CARDIOVASC RES, V37, P656, DOI 10.1016/S0008-6363(97)00292-7; Lucas SM, 2006, BRIT J PHARMACOL, V147, pS232, DOI 10.1038/sj.bjp.0706400; Lukaszewicz AC, 2011, CURR OPIN ANESTHESIO, V24, P138, DOI 10.1097/ACO.0b013e32834458af; Manduteanu I, 2003, EUR J PHARMACOL, V477, P269, DOI 10.1016/j.ejphar.2003.08.016; Manduteanu I, 2002, PHARMACOLOGY, V65, P32, DOI 10.1159/000056183; Marks JA, 2012, J TRAUMA ACUTE CARE, V73, P351, DOI 10.1097/TA.0b013e3182592f76; Mary V, 2001, STROKE, V32, P993, DOI 10.1161/01.STR.32.4.993; McKeating EG, 1998, ACT NEUR S, V71, P200; Morganti-Kossmann MC, 2001, SHOCK, V16, P165, DOI 10.1097/00024382-200116030-00001; Moxon-Emre I, 2011, J NEUROPATH EXP NEUR, V70, P218, DOI 10.1097/NEN.0b013e31820d94a5; Nguyen HX, 2007, J NEUROCHEM, V102, P900, DOI 10.1111/j.1471-4159.2007.04643.x; Ouartermain D, 2000, NEUROSCI LETT, V288, P155, DOI 10.1016/S0304-3940(00)01223-4; Pascual JL, 2003, J TRAUMA, V54, pS133, DOI 10.1097/01.TA.0000064526.33647.63; Pascual JL, 2013, AM J SURG, V206, P840, DOI 10.1016/j.amjsurg.2013.07.016; Pratt J, 1998, HAEMOSTASIS, V28, P78; Quartermain D, 2003, CEREBROVASC DIS, V16, P346, DOI 10.1159/000072556; Rosenfeld JV, 2012, LANCET, V380, P1088, DOI 10.1016/S0140-6736(12)60864-2; Schaar Krystal L, 2010, Exp Transl Stroke Med, V2, P13, DOI 10.1186/2040-7378-2-13; Schoettle R J, 1990, J Neurotrauma, V7, P207, DOI 10.1089/neu.1990.7.207; Schwarzmaier SM, 2010, J NEUROTRAUM, V27, P121, DOI 10.1089/neu.2009.1114; Semple BD, 2010, NEUROBIOL DIS, V40, P394, DOI 10.1016/j.nbd.2010.06.015; Semple BD, 2010, J CEREBR BLOOD F MET, V30, P769, DOI 10.1038/jcbfm.2009.262; Shojo H, 2010, NEUROSCIENCE, V171, P1273, DOI 10.1016/j.neuroscience.2010.10.018; Simard JM, 2012, TRANSL STROKE RES, V3, pS155, DOI 10.1007/s12975-012-0166-9; SMITH DH, 1995, J NEUROTRAUM, V12, P169, DOI 10.1089/neu.1995.12.169; Soares HD, 1995, J NEUROSCI, V15, P8223; Stanimirovic DB, 1997, ACT NEUR S, V70, P12; Stutzmann JM, 2002, CNS DRUG REV, V8, P1; Tanne D, 2008, NEUROBIOL DIS, V30, P56, DOI 10.1016/j.nbd.2007.12.004; van Buul JD, 2004, ARTERIOSCL THROM VAS, V24, P824, DOI 10.1161/01.ATV.0000122854.76267.5c; Wahl F, 2000, J NEUROTRAUM, V17, P1055, DOI 10.1089/neu.2000.17.1055; Whalen MJ, 1998, ACT NEUR S, V71, P212; Yeh YC, 2012, CRIT CARE, V16, DOI 10.1186/cc11303; Zupan Z, 2011, PROG NEURO-PSYCHOPH, V35, P1846, DOI 10.1016/j.pnpbp.2011.08.005	50	22	23	0	11	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2163-0755	2163-0763		J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	JUL	2015	79	1					78	84		10.1097/TA.0000000000000697			7	Critical Care Medicine; Surgery	General & Internal Medicine; Surgery	CL7LN	WOS:000357153700012	26091318	Green Accepted			2021-06-18	
J	Nusbaum, DM; Wu, SM; Frankfort, BJ				Nusbaum, Derek M.; Wu, Samuel M.; Frankfort, Benjamin J.			Elevated intracranial pressure causes optic nerve and retinal ganglion cell degeneration in mice	EXPERIMENTAL EYE RESEARCH			English	Article						Retina; Retinal ganglion cell; Optic nerve; Intracranial pressure; Intraocular pressure: glaucoma; Visual impairment intracranial pressure; syndrome (VIIP syndrome); Idiopathic intracranial hypertension (IIH)	CEREBROSPINAL-FLUID PRESSURE; OPEN-ANGLE GLAUCOMA; INDUCED OCULAR HYPERTENSION; TRAUMATIC BRAIN-INJURY; INTRAOCULAR-PRESSURE; MOUSE MODEL; RATS; DYSFUNCTION; DIFFERENCE; NEUROPATHY	The purpose of this study was to develop a novel experimental system for the modulation and measurement of intracranial pressure (ICP), and to use this system to assess the impact of elevated ICP on the optic nerve and retinal ganglion cells (RGCs) in CD1 mice. This system involved surgical implantation of an infusion cannula and a radiowave based pressure monitoring probe through the skull and into the subarachnoid space. The infusion cannula was used to increase ICP, which was measured by the probe and transmitted to a nearby receiver. The system provided robust and consistent ICP waveforms, was well tolerated, and was stable over time. ICP was elevated to approximately 30 mmHg for one week, after which we assessed changes in optic nerve structure with transmission electron microscopy in cross section and RGC numbers with antibody staining in retinal flat mounts. ICP elevation resulted in optic nerve axonal loss and disorganization, as well as RGC soma loss. We conclude that the controlled manipulation of ICP in active, awake mice is possible, despite their small size. Furthermore, ICP elevation results in visual system phenotypes of optic nerve and RGC degeneration, suggesting that this model can be used to study the impact of ICP on the visual system. Potentially, this model can also be used to study the relationship between ICP and IOP, as well diseases impacted by ICP variation such as glaucoma, idiopathic intracranial hypertension, and the spaceflight-related visual impairment intracranial pressure syndrome. (C) 2015 Elsevier Ltd. All rights reserved.	[Nusbaum, Derek M.] Baylor Coll Med, Dept Internal Med, Houston, TX 77030 USA; [Nusbaum, Derek M.; Frankfort, Benjamin J.] Baylor Coll Med, Ctr Space Med, Houston, TX 77030 USA; [Nusbaum, Derek M.; Wu, Samuel M.] Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA; [Wu, Samuel M.; Frankfort, Benjamin J.] Baylor Coll Med, Dept Ophthalmol, Houston, TX 77030 USA	Frankfort, BJ (corresponding author), Baylor Coll Med, Dept Ophthalmol, 6565 Fannin,NC 205, Houston, TX 77030 USA.	benjamin.frankfort@bcm.edu			NASANational Aeronautics & Space Administration (NASA) [NNX 10AK70G]; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [EY021479, EY019908, EY02520]; Retina Research Foundation; Research to Prevent BlindnessResearch to Prevent Blindness (RPB); Oshman Foundation; NATIONAL EYE INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI) [R01EY019908, P30EY002520, K08EY021479] Funding Source: NIH RePORTER	This work was supported byNASA Grant NNX 10AK70G (DMN), NIH Grants EY021479 (BJF), EY019908 (SMW), and EY02520 (Ophthalmology Core Grant to Baylor College of Medicine), the Retina Research Foundation (BJF and SMW), Research to Prevent Blindness (BJF and Baylor College of Medicine), and the Oshman Foundation (BJF). We thank Ralph Nichols for expert assistance with optic nerve preparations, staining, and imaging, and Guofu Shen for helpful discussion.	Acheson JF, 2006, BRIT MED BULL, V79-80, P233, DOI 10.1093/bmb/ldl019; BARTH KNM, 1992, NEUROSURGERY, V30, P138, DOI 10.1227/00006123-199201000-00028; Berdahl JP, 2008, OPHTHALMOLOGY, V115, P763, DOI 10.1016/j.ophtha.2008.01.013; Berdahl JP, 2008, INVEST OPHTH VIS SCI, V49, P5412, DOI 10.1167/iovs.08-2228; Bragin DE, 2013, STROKE, V44, P177, DOI 10.1161/STROKEAHA.112.668293; Buckingham BP, 2008, J NEUROSCI, V28, P2735, DOI 10.1523/JNEUROSCI.4443-07.2008; Chavko M, 2007, J NEUROSCI METH, V159, P277, DOI 10.1016/j.jneumeth.2006.07.018; Chen HH, 2011, INVEST OPHTH VIS SCI, V52, P36, DOI 10.1167/iovs.09-5115; Chowdhury UR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082151; Cone FE, 2012, EXP EYE RES, V99, P27, DOI 10.1016/j.exer.2012.04.006; Cone FE, 2010, EXP EYE RES, V91, P415, DOI 10.1016/j.exer.2010.06.018; Crish SD, 2010, P NATL ACAD SCI USA, V107, P5196, DOI 10.1073/pnas.0913141107; Cui Q, 2003, MOL CELL NEUROSCI, V22, P49, DOI 10.1016/S1044-7431(02)00037-4; Feiler S, 2010, J NEUROSCI METH, V190, P164, DOI 10.1016/j.jneumeth.2010.05.005; Fleischman David, 2014, Int Ophthalmol Clin, V54, P73, DOI 10.1097/IIO.0b013e3182aabef4; Fleischman D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052664; Frankfort BJ, 2013, INVEST OPHTH VIS SCI, V54, P762, DOI 10.1167/iovs.12-10581; Fu CT, 2010, INVEST OPHTH VIS SCI, V51, P980, DOI 10.1167/iovs.09-4324; Gordon MO, 2002, ARCH OPHTHALMOL-CHIC, V120, P714; GROSS RL, 2003, T AM OPHTHAL SOC, V101, P169; Gross Ronald L, 2003, Trans Am Ophthalmol Soc, V101, P163; Grozdanic SD, 2003, INVEST OPHTH VIS SCI, V44, P4337, DOI 10.1167/iovs.03-0015; Han Y, 2008, ANN NEUROL, V64, P221, DOI 10.1002/ana.21416; Holcombe DJ, 2008, BRIT J OPHTHALMOL, V92, P683, DOI 10.1136/bjo.2007.133223; Ji JZ, 2005, VISION RES, V45, P169, DOI 10.1016/j.visres.2004.08.008; Kawoos U, 2014, IEEE T BIO-MED ENG, V61, P841, DOI 10.1109/TBME.2013.2291239; Keltner JL, 2014, INVEST OPHTH VIS SCI, V55, P3200, DOI 10.1167/iovs.14-14243; Khan AK, 2015, EXP EYE RES, V130, P29, DOI 10.1016/j.exer.2014.11.007; Kusaka G, 2004, J NEUROSCI METH, V135, P121, DOI 10.1016/j.jneumeth.2003.12.013; Levkovitch-Verbin H, 2002, INVEST OPHTH VIS SCI, V43, P402; Lin JS, 2010, INVEST OPHTH VIS SCI, V51, P5739, DOI 10.1167/iovs.10-5542; Mabuchi F, 2003, INVEST OPHTH VIS SCI, V44, P4321, DOI 10.1167/iovs.03-0138; Mader TH, 2011, OPHTHALMOLOGY, V118, P2058, DOI 10.1016/j.ophtha.2011.06.021; Marzoli SB, 2013, NEUROL SCI, V34, pS143, DOI 10.1007/s10072-013-1373-1; McKinnon SJ, 2009, EXP EYE RES, V88, P816, DOI 10.1016/j.exer.2008.12.002; Monteiro MLR, 2014, EYE, V28, P390, DOI 10.1038/eye.2013.301; MORROW BA, 1990, AM J PHYSIOL, V258, pR1170; Padhye LV, 2013, J NEUROL SCI, V332, P80, DOI 10.1016/j.jns.2013.06.022; Pang JJ, 2015, P NATL ACAD SCI USA, V112, P2593, DOI 10.1073/pnas.1419921112; Pang JJ, 2011, INVEST OPHTH VIS SCI, V52, P4886, DOI 10.1167/iovs.10-5921; Park YS, 2011, CHILD NERV SYST, V27, P903, DOI 10.1007/s00381-011-1398-9; Pease ME, 2011, INVEST OPHTH VIS SCI, V52, P858, DOI 10.1167/iovs.10-5556; Quigley HA, 2006, BRIT J OPHTHALMOL, V90, P262, DOI 10.1136/bjo.2005.081224; Ren RJ, 2011, GRAEF ARCH CLIN EXP, V249, P1057, DOI 10.1007/s00417-011-1657-1; Ren RJ, 2010, OPHTHALMOLOGY, V117, P259, DOI 10.1016/j.ophtha.2009.06.058; Ren ZG, 2013, J CEREBR BLOOD F MET, V33, P834, DOI 10.1038/jcbfm.2013.30; Ruiz-Ederra J, 2006, EXP EYE RES, V82, P879, DOI 10.1016/j.exer.2005.10.019; Sajjadi SA, 2006, ANN NEUROL, V59, P867, DOI 10.1002/ana.20856; Samsel PA, 2011, INVEST OPHTH VIS SCI, V52, P1671, DOI 10.1167/iovs.09-3921; Samuels BC, 2012, INVEST OPHTH VIS SCI, V53, P7328, DOI 10.1167/iovs.12-10632; Sappington RM, 2010, INVEST OPHTH VIS SCI, V51, P207, DOI 10.1167/iovs.09-3947; Silasi G, 2009, CURR NEUROVASC RES, V6, P62, DOI 10.2174/156720209787466046; Soto I, 2008, J NEUROSCI, V28, P548, DOI 10.1523/JNEUROSCI.3714-07.2008; Wall M, 2014, JAMA NEUROL, V71, P693, DOI 10.1001/jamaneurol.2014.133; Welsbie DS, 2013, P NATL ACAD SCI USA, V110, P4045, DOI 10.1073/pnas.1211284110; Xu H, 2012, BMC NEUROSCI, V13, DOI 10.1186/1471-2202-13-148; Yang DY, 2014, INVEST OPHTH VIS SCI, V55, P3067, DOI 10.1167/iovs.13-13657; Zhang LF, 2014, AVIAT SPACE ENVIR MD, V85, P78, DOI 10.3357/ASEM.3789.2014	58	22	24	0	16	ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD	LONDON	24-28 OVAL RD, LONDON NW1 7DX, ENGLAND	0014-4835	1096-0007		EXP EYE RES	Exp. Eye Res.	JUL	2015	136						38	44		10.1016/j.exer.2015.04.014			7	Ophthalmology	Ophthalmology	CK9LR	WOS:000356562100006	25912998	Green Accepted			2021-06-18	
J	Rovegno, M; Soto, PA; Saez, PJ; Naus, CC; Saez, JC; von Bernhardi, R				Rovegno, Maximiliano; Soto, Paola A.; Saez, Pablo J.; Naus, Christian C.; Saez, Juan C.; von Bernhardi, Rommy			Connexin43 Hemichannels Mediate Secondary Cellular Damage Spread from the Trauma Zone to Distal Zones in Astrocyte Monolayers	GLIA			English	Article						traumatic brain injury; connexins; P2 receptors; astroglia; apoptosis	GAP-JUNCTION HEMICHANNELS; STRETCH-INDUCED INJURY; CENTRAL-NERVOUS-SYSTEM; BRAIN-INJURY; CULTURED ASTROCYTES; PANNEXIN 1; CORTICAL ASTROCYTES; ATP RELEASE; NEURONS; CHANNELS	The mechanism of secondary damage spread after brain trauma remains unsolved. In this work, we redirected the attention to astrocytic communication pathways. Using an in vitro trauma model that consists of a scratch injury applied to an astrocyte monolayer, we found a significant and transient induction of connexin43 (Cx43) hemichannel activity in regions distal from the injury, which was maximal approximate to 1 h after scratch. Two connexin hemichannel blockers, La3+ and the peptide Gap26, abolished the increased activity, which was also absent in Cx43 KO astrocytes. In addition, the scratch-induced increase of hemichannel activity was prevented by inhibition of P2 purinergic receptors. Changes in hemichannel activity took place with a particular spatial distribution, with cells located at approximate to 17 mm away from the scratch presenting the highest activity (dye uptake). In contrast, the functional state of gap junction channels (dye coupling) was not significantly affected. Cx43 hemichannel activity was also enhanced by the acute extracellular application of 60 mM K+. The increase in hemichannel activity was associated with an increment in apoptotic cells at 24 h after scratch that was totally prevented by Gap26 peptide. These findings suggest that Cx43 hemichannels could be a new approach to prevent or reduce the secondary cell damage of brain trauma. GLIA 2015;63:1185-1199	[Rovegno, Maximiliano; von Bernhardi, Rommy] Pontificia Univ Catolica Chile, Fac Med, Dept Neurol, Lab Neurociencias, Santiago, Chile; [Rovegno, Maximiliano] Pontificia Univ Catolica Chile, Fac Med, Dept Med Intens, Santiago, Chile; [Soto, Paola A.; Saez, Pablo J.; Saez, Juan C.] Pontificia Univ Catolica Chile, Fac Ciencias Biol, Dept Fisiol, Santiago, Chile; [Naus, Christian C.] Univ British Columbia, Inst Life Sci, Dept Cellular & Physiol Sci, Vancouver, BC V6T 1Z3, Canada; [Saez, Juan C.] Ctr Interdisciplinario Neurociencias Valparaiso, Inst Milenio, Valparaiso, Chile	Rovegno, M (corresponding author), Pontificia Univ Catolica Chile, Fac Med, Dept Med Intens, Marcoleta 367, Santiago, Chile.	maxrovegno@uc.cl	Saez, Pablo J./AAB-4458-2019	Saez, Pablo J./0000-0003-0521-9426; von Bernhardi, Rommy/0000-0002-9022-7676	Direccion de Investigacion de la Facultad de Medicina-PUC [PMD-09/09]; CONICYTComision Nacional de Investigacion Cientifica y Tecnologica (CONICYT) [AT-24100202]; FONDECYTComision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT [1131025]; AnilloComision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT PIA/ANILLOS [ACT-71]; FONDEF [D07I1086]; Instituto Milenio, Centro Interdisciplinario de Neurociencia de Valparaiso [P09-022-F]; Heart & Stroke Foundation of BC Yukon	Grant sponsor: Direccion de Investigacion de la Facultad de Medicina-PUC; Grant number: PMD-09/09; Grant sponsor: CONICYT; Grant number: AT-24100202; Grant sponsor: FONDECYT; Grant number: 1131025; Grant sponsor: Anillo; Grant number: ACT-71; Grant sponsor: FONDEF; Grant number: D07I1086; Grant sponsor: Instituto Milenio, Centro Interdisciplinario de Neurociencia de Valparaiso; Grant number: P09-022-F; Grant sponsor: Heart & Stroke Foundation of BC & Yukon.	Ahmed SM, 2000, J NEUROCHEM, V74, P1951, DOI 10.1046/j.1471-4159.2000.741951000000000.x; Allen NJ, 2004, PFLUG ARCH EUR J PHY, V449, P132, DOI 10.1007/s00424-004-1318-x; Amadio S, 2002, NEUROPHARMACOLOGY, V42, P489, DOI 10.1016/S0028-3908(01)00197-6; Barres BA, 2008, NEURON, V60, P430, DOI 10.1016/j.neuron.2008.10.013; Bennett MVL, 2012, BRAIN RES, V1487, P3, DOI 10.1016/j.brainres.2012.08.042; Bezzi P, 2001, CURR OPIN NEUROBIOL, V11, P387, DOI 10.1016/S0959-4388(00)00223-3; Burnstock G, 2008, NAT REV DRUG DISCOV, V7, P575, DOI 10.1038/nrd2605; Chekeni FB, 2010, NATURE, V467, P863, DOI 10.1038/nature09413; Contreras JE, 2002, P NATL ACAD SCI USA, V99, P495, DOI 10.1073/pnas.012589799; Corvalan LA, 2007, J CELL PHYSIOL, V211, P649, DOI 10.1002/jcp.20971; Decrock E, 2009, CELL DEATH DIFFER, V16, P151, DOI 10.1038/cdd.2008.138; DERMIETZEL R, 1991, J NEUROSCI, V11, P1421; Dobrenis K, 2005, J NEUROSCI RES, V82, P306, DOI 10.1002/jnr.20650; ELLIS EF, 1995, J NEUROTRAUM, V12, P325, DOI 10.1089/neu.1995.12.325; Evans WH, 2006, BIOCHEM J, V397, P1, DOI 10.1042/BJ20060175; Fields RD, 2002, SCIENCE, V298, P556, DOI 10.1126/science.298.5593.556; Finnie JW, 2013, INFLAMMOPHARMACOLOGY, V21, P309, DOI 10.1007/s10787-012-0164-2; Fischer W, 2007, CURR MED CHEM, V14, P2429, DOI 10.2174/092986707782023695; Fischer W, 2009, NEUROSCIENCE, V160, P767, DOI 10.1016/j.neuroscience.2009.02.026; Franike H, 2009, GLIA, V57, P1031, DOI 10.1002/glia.20827; Frantseva MV, 2002, J NEUROSCI, V22, P644, DOI 10.1523/JNEUROSCI.22-03-00644.2002; Garre JM, 2010, P NATL ACAD SCI USA, V107, P22659, DOI 10.1073/pnas.1013793107; GIAUME C, 1991, NEURON, V6, P133, DOI 10.1016/0896-6273(91)90128-M; Helmy A, 2011, PROG NEUROBIOL, V95, P352, DOI 10.1016/j.pneurobio.2011.09.003; Helmy A, 2011, J CEREBR BLOOD F MET, V31, P658, DOI 10.1038/jcbfm.2010.142; Huang Y, 2007, GLIA, V55, P46, DOI 10.1002/glia.20435; Huang YJ, 2007, P NATL ACAD SCI USA, V104, P6436, DOI 10.1073/pnas.0611280104; Iglesias R, 2009, J NEUROSCI, V29, P7092, DOI 10.1523/JNEUROSCI.6062-08.2009; Jackson DG, 2014, SCI REP-UK, V4, DOI 10.1038/srep04576; Jain KK, 2008, DRUG DISCOV TODAY, V13, P1082, DOI 10.1016/j.drudis.2008.09.006; Jeong HK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013756; Kawamata Tatsuro, 2007, Neurosurg Focus, V22, pE5, DOI 10.3171/foc.2007.22.5.6; Kumaria A, 2008, BRIT J NEUROSURG, V22, P200, DOI 10.1080/02688690701772413; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lau LT, 2001, J NEUROTRAUM, V18, P351, DOI 10.1089/08977150151071035; Lin JHC, 1998, NAT NEUROSCI, V1, P494, DOI 10.1038/2210; Morita M, 2007, GLIA, V55, P508, DOI 10.1002/glia.20471; Nagy JI, 1999, NEUROSCIENCE, V88, P447, DOI 10.1016/S0306-4522(98)00191-2; Nagy JI, 2001, J COMP NEUROL, V441, P302, DOI 10.1002/cne.1414; Neary JT, 2005, J NEUROTRAUM, V22, P491, DOI 10.1089/neu.2005.22.491; NILSSON P, 1993, J CEREBR BLOOD F MET, V13, P183, DOI 10.1038/jcbfm.1993.22; O'Carroll SJ, 2008, CELL COMMUN ADHES, V15, P27, DOI 10.1080/15419060802014164; Ohsumi A, 2006, ACTA NEUROCHIR SUPPL, V96, P148; Ohsumi A, 2010, J NEUROTRAUM, V27, P1255, DOI 10.1089/neu.2009.1234; Orellana JA, 2012, GLIA, V60, P53, DOI 10.1002/glia.21246; Orellana JA, 2011, J NEUROSCI, V31, P4962, DOI 10.1523/JNEUROSCI.6417-10.2011; Orellana JA, 2011, J NEUROCHEM, V118, P826, DOI 10.1111/j.1471-4159.2011.07210.x; Orellana JA, 2010, GLIA, V58, P329, DOI 10.1002/glia.20926; Orellana JA, 2009, ANTIOXID REDOX SIGN, V11, P369, DOI 10.1089/ars.2008.2130; Pelegrin P, 2006, EMBO J, V25, P5071, DOI 10.1038/sj.emboj.7601378; Penuela S, 2009, MOL BIOL CELL, V20, P4313, DOI 10.1091/mbc.E09-01-0067; Pfeiffer S, 1997, J BIOL CHEM, V272, P3465, DOI 10.1074/jbc.272.6.3465; Rao VLR, 2001, NEUROCHEM RES, V26, P497; REAUME AG, 1995, SCIENCE, V267, P1831, DOI 10.1126/science.7892609; Retamal MA, 2006, P NATL ACAD SCI USA, V103, P4475, DOI 10.1073/pnas.0511118103; Retamal MA, 2007, J NEUROSCI, V27, P13781, DOI 10.1523/JNEUROSCI.2042-07.2007; Rossi DJ, 2007, NAT NEUROSCI, V10, P1377, DOI 10.1038/nn2004; Roth TL, 2014, NATURE, V505, P223, DOI 10.1038/nature12808; Rothstein JD, 1996, NEURON, V16, P675, DOI 10.1016/S0896-6273(00)80086-0; Rovegno M, 2012, MED INTENSIVA, V36, P37, DOI 10.1016/j.medin.2011.06.008; Saez JC, 2003, ACTA PHYSIOL SCAND, V179, P9, DOI 10.1046/j.1365-201X.2003.01196.x; Saez PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071361; Silverman WR, 2009, J BIOL CHEM, V284, P18143, DOI 10.1074/jbc.M109.004804; Srinivas M, 2006, J GEN PHYSIOL, V127, P67, DOI 10.1085/jgp.200509397; Stout C, 2003, GLIA, V43, P265, DOI 10.1002/glia.10257; Suadicani SO, 2012, GLIA, V60, P1106, DOI 10.1002/glia.22338; Taruno A, 2013, NATURE, V495, P223, DOI 10.1038/nature11906; TECOMA ES, 1989, NEURON, V2, P1541, DOI 10.1016/0896-6273(89)90042-1; Theis M, 2012, BRAIN RES, V1487, P88, DOI 10.1016/j.brainres.2012.06.045; Theodoric N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047311; Udawatte C, 2005, APOPTOSIS, V10, P1019, DOI 10.1007/s10495-005-0776-8; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Yue TL, 1998, J MOL CELL CARDIOL, V30, P495, DOI 10.1006/jmcc.1997.0614	73	22	22	1	21	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0894-1491	1098-1136		GLIA	Glia	JUL	2015	63	7					1185	1199		10.1002/glia.22808			15	Neurosciences	Neurosciences & Neurology	CG6IC	WOS:000353402100006	25731866				2021-06-18	
J	Xu, L; Yang, Y; Gao, LX; Zhao, JH; Cai, YL; Huang, J; Jing, S; Bao, XH; Wang, Y; Gao, JW; Xu, HW; Fan, XT				Xu, Le; Yang, Yang; Gao, Lixiong; Zhao, Jinghui; Cai, Yulong; Huang, Jing; Jing, Sheng; Bao, Xiaohang; Wang, Ying; Gao, Junwei; Xu, Haiwei; Fan, Xiaotang			Protective effects of resveratrol on the inhibition of hippocampal neurogenesis induced by ethanol during early postnatal life	BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE			English	Article						Ethanol; Neurogenesis; Hippocampal development; Neural precursor cell; Resveratrol	RADIAL GLIAL-CELLS; NEURAL PROGENITOR CELLS; TRAUMATIC BRAIN-INJURY; ALCOHOL EXPOSURE; NEURONAL DIFFERENTIATION; STRUCTURAL PLASTICITY; CYCLE PROGRESSION; DENDRITIC SPINES; CEREBRAL-CORTEX; DENTATE GYRUS	Ethanol (EtOH) exposure during early postnatal life triggers obvious neurotoxic effects on the developing hippocampus and results in long-term effects on hippocampal neurogenesis. Resveratrol (RSV) has been demonstrated to exert potential neuroprotective effects by promoting hippocampal neurogenesis. However, the effects of RSV on the EtOH-mediated impairment of hippocampal neurogenesis remain undetermined. Thus, mice were pretreated with RSV and were later exposed to EtOH to evaluate its protective effects on EtOH-mediated toxicity during hippocampal development. The results indicated that a brief exposure of EtOH on postnatal day 7 resulted in a significant impairment in hippocampal neurogenesis and a depletion of hippocampal neural precursor cells (NPCs). This effect was attenuated by pretreatment with RSV. Furthermore, EtOH exposure resulted in a reduction in spine density on the granular neurons of the dentate gyrus (DG), and the spines exhibited a less mature morphological phenotype characterized by a higher proportion of stubby spines and a lower proportion of mushroom spines. However, RSV treatment effectively reversed these responses. We further confirmed that RSV treatment reversed the EtOH-induced down-regulation of hippocampal pERK and Hesl protein levels, which may be related to the proliferation and maintenance of NPCs. Furthermore, EtOH exposure in the C17.2 NPCs also diminished cell proliferation and activated apoptosis, which could be reversed by pretreatment of RSV. Overall, our results suggest that RSV pretreatment protects against EtOH-induced defects in neurogenesis in postnatal mice and may thus play a critical role in preventing EtOH-mediated toxicity in the developing hippocampus. (C) 2015 Elsevier B.V. All rights reserved.	[Xu, Le; Zhao, Jinghui; Cai, Yulong; Wang, Ying; Gao, Junwei; Fan, Xiaotang] Third Mil Med Univ, Sch Psychol, Dept Dev Neuropsychol, Chongqing 400038, Peoples R China; [Xu, Le] Third Mil Med Univ, Battal Cadet Brigade 5, Chongqing 400038, Peoples R China; [Yang, Yang] Third Mil Med Univ, Southwest Hosp, Dept Neurosurg, Chongqing 400038, Peoples R China; [Gao, Lixiong; Xu, Haiwei] Third Mil Med Univ, Southwest Hosp, Southwest Eye Hosp, Chongqing 400038, Peoples R China; [Huang, Jing; Jing, Sheng; Bao, Xiaohang] Third Mil Med Univ, Xinqiao Hosp, Dept Anesthesiol, Chongqing 400037, Peoples R China	Xu, HW (corresponding author), Third Mil Med Univ, Southwest Hosp, Southwest Eye Hosp, Chongqing 400038, Peoples R China.	haiweixu2001@163.com; fanxiaotang2005@163.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81371197, 31271051]; Natural Science Foundation Project of CQ CSTCNatural Science Foundation Project of CQ CSTC [2013jjB10028]	This study was supported by the National Natural Science Foundation of China (no. 81371197 and no. 31271051) and the Natural Science Foundation Project of CQ CSTC (no. 2013jjB10028).	Ates O, 2007, MOL CELL BIOCHEM, V294, P137, DOI 10.1007/s11010-006-9253-0; Basavarajappa BS, 2008, J NEUROCHEM, V107, P1001, DOI 10.1111/j.1471-4159.2008.05685.x; Berman RE, 2000, HIPPOCAMPUS, V10, P94, DOI 10.1002/(SICI)1098-1063(2000)10:1<94::AID-HIPO11>3.0.CO;2-T; BONTHIUS DJ, 1990, ALCOHOL CLIN EXP RES, V14, P107, DOI 10.1111/j.1530-0277.1990.tb00455.x; Bosch M, 2012, CURR OPIN NEUROBIOL, V22, P383, DOI 10.1016/j.conb.2011.09.002; Bourne J, 2007, CURR OPIN NEUROBIOL, V17, P381, DOI 10.1016/j.conb.2007.04.009; Brunne B, 2010, GLIA, V58, P1553, DOI 10.1002/glia.21029; Chakraborti A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040844; Chen X, 2014, CELL PHYSIOL BIOCHEM, V34, P1109, DOI 10.1159/000366325; CLARREN SK, 1978, NEW ENGL J MED, V298, P1063, DOI 10.1056/NEJM197805112981906; Coleman LG, 2012, ALCOHOL, V46, P603, DOI 10.1016/j.alcohol.2012.01.003; Cullen CL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054924; ECKENHOFF MF, 1984, J COMP NEUROL, V223, P1, DOI 10.1002/cne.902230102; Fournier NM, 2012, NEUROPHARMACOLOGY, V63, P642, DOI 10.1016/j.neuropharm.2012.04.033; Gehm BD, 1997, P NATL ACAD SCI USA, V94, P14138, DOI 10.1073/pnas.94.25.14138; Hamilton GF, 2011, BRAIN RES, V1412, P88, DOI 10.1016/j.brainres.2011.07.027; Hao YL, 2004, J NEUROSCI, V24, P6590, DOI 10.1523/JNEUROSCI.5747-03.2004; Harada N, 2011, J NUTR BIOCHEM, V22, P1150, DOI 10.1016/j.jnutbio.2010.09.016; HARRIS KM, 1992, J NEUROSCI, V12, P2685; Hatakeyama J, 2004, DEVELOPMENT, V131, P5539, DOI 10.1242/dev.01436; Hsieh J, 2004, P NATL ACAD SCI USA, V101, P16659, DOI 10.1073/pnas.0407643101; Huang J., 2015, MOL NEUROBIOL; Ieraci A, 2007, NEUROBIOL DIS, V26, P597, DOI 10.1016/j.nbd.2007.02.011; Kamakura S, 2004, NAT CELL BIOL, V6, P547, DOI 10.1038/ncb1138; Komatsu S, 2001, ACTA NEUROPATHOL, V101, P22; Livy DJ, 2003, NEUROTOXICOL TERATOL, V25, P447, DOI 10.1016/S0892-0362(03)00030-8; Madhyastha S, 2013, INT J DEV NEUROSCI, V31, P580, DOI 10.1016/j.ijdevneu.2013.06.010; Menard C, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00281; Mo ZC, 2012, ALCOHOL CLIN EXP RES, V36, P1374, DOI 10.1111/j.1530-0277.2012.01736.x; Mooney SM, 2004, CEREB CORTEX, V14, P1071, DOI 10.1093/cercor/bhh066; Morgado-Bernal I, 2011, NEUROSCIENCE, V176, P12, DOI 10.1016/j.neuroscience.2010.12.056; Moriya J, 2011, BIOL PHARM BULL, V34, P354, DOI 10.1248/bpb.34.354; Nelson BR, 2013, J NEUROSCI, V33, P9122, DOI 10.1523/JNEUROSCI.0791-13.2013; Ohtsuka T, 2001, J BIOL CHEM, V276, P30467, DOI 10.1074/jbc.M102420200; Park HR, 2012, J BIOL CHEM, V287, P42588, DOI 10.1074/jbc.M112.406413; Parnass Z, 2000, HIPPOCAMPUS, V10, P561, DOI 10.1002/1098-1063(2000)10:5<561::AID-HIPO6>3.3.CO;2-O; Pasinetti GM, 2015, BBA-MOL BASIS DIS, V1852, P1202, DOI 10.1016/j.bbadis.2014.10.006; Patterson M, 2011, BRIT J PHARMACOL, V163, P1626, DOI 10.1111/j.1476-5381.2011.01328.x; PETERS A, 1970, AM J ANAT, V127, P321, DOI 10.1002/aja.1001270402; Pevny LH, 2010, INT J BIOCHEM CELL B, V42, P421, DOI 10.1016/j.biocel.2009.08.018; Quincozes-Santos A, 2011, ANN NY ACAD SCI, V1215, P72, DOI 10.1111/j.1749-6632.2010.05857.x; Ramadori G, 2008, J NEUROSCI, V28, P9989, DOI 10.1523/JNEUROSCI.3257-08.2008; Rice JP, 2012, ALCOHOL, V46, P577, DOI 10.1016/j.alcohol.2011.11.008; RICKMANN M, 1987, J COMP NEUROL, V264, P449, DOI 10.1002/cne.902640403; Romero AM, 2013, NEUROTOX RES, V24, P532, DOI 10.1007/s12640-013-9409-0; Rubert G, 2006, J NEUROSCI RES, V84, P483, DOI 10.1002/jnr.20963; Samudio-Ruiz SL, 2009, J NEUROCHEM, V109, P1311, DOI 10.1111/j.1471-4159.2009.06049.x; SCHLESSINGER AR, 1975, J COMP NEUROL, V159, P149, DOI 10.1002/cne.901590202; Shimojo H, 2008, NEURON, V58, P52, DOI 10.1016/j.neuron.2008.02.014; Singh AK, 2009, ALCOHOL ALCOHOLISM, V44, P185, DOI 10.1093/alcalc/agn109; Singh N, 2013, ACS CHEM NEUROSCI, V4, P1151, DOI 10.1021/cn400094w; Sonmez U, 2007, NEUROSCI LETT, V420, P133, DOI 10.1016/j.neulet.2007.04.070; Sovak M., 2001, J MED FOOD, V4, P93, DOI DOI 10.1089/109662001300341752; Spacek J, 1997, J NEUROSCI, V17, P190; Spanos M, 2012, BEHAV BRAIN RES, V230, P158, DOI 10.1016/j.bbr.2012.02.010; Steelman LS, 2004, LEUKEMIA, V18, P189, DOI 10.1038/sj.leu.2403241; Subbanna S, 2013, J NEUROSCI, V33, P6350, DOI 10.1523/JNEUROSCI.3786-12.2013; Taffe MA, 2010, P NATL ACAD SCI USA, V107, P11104, DOI 10.1073/pnas.0912810107; Temple S, 1999, CURR OPIN NEUROBIOL, V9, P135, DOI 10.1016/S0959-4388(99)80017-8; Tiberi L, 2012, NAT NEUROSCI, V15, P1627, DOI 10.1038/nn.3264; Ungerer M, 2013, ALCOHOL RES-CURR REV, V35, P37; Valles S, 1996, J NEUROCHEM, V67, P2425; Wang SJ, 2014, J MEMBRANE BIOL, V247, P493, DOI 10.1007/s00232-014-9659-7; West T, 2007, DEV NEUROSCI-BASEL, V29, P363, DOI 10.1159/000105477; Wood CE, 2007, EXP PHYSIOL, V92, P821, DOI 10.1113/expphysiol.2007.038448; Xu L, 2015, MOL NEUROBIOL, V51, P131, DOI 10.1007/s12035-014-8692-y; Yang Y, 2014, MOL NEUROBIOL, V49, P176, DOI 10.1007/s12035-013-8510-y; Yousuf S, 2009, BRAIN RES, V1250, P242, DOI 10.1016/j.brainres.2008.10.068; Zhang F, 2010, EUR J PHARMACOL, V636, P1, DOI 10.1016/j.ejphar.2010.03.043; Zou J, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00077	70	22	24	0	26	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0925-4439	1879-260X		BBA-MOL BASIS DIS	Biochim. Biophys. Acta-Mol. Basis Dis.	JUL	2015	1852	7					1298	1310		10.1016/j.bbadis.2015.03.009			13	Biochemistry & Molecular Biology; Biophysics; Cell Biology	Biochemistry & Molecular Biology; Biophysics; Cell Biology	CJ7YB	WOS:000355715200009	25817400	Bronze			2021-06-18	
J	de Kloet, AJ; Lambregts, SAM; Berger, MAM; van Markus, F; Wolterbeek, R; Vlieland, TPMV				de Kloet, Arend J.; Lambregts, Suzanne A. M.; Berger, Monique A. M.; van Markus, Frederike; Wolterbeek, Ron; Vlieland, Thea P. M. Vliet			Family Impact of Acquired Brain Injury in Children and Youth	JOURNAL OF DEVELOPMENTAL AND BEHAVIORAL PEDIATRICS			English	Article							QUALITY-OF-LIFE; OUTCOME 30 MONTHS; FUNCTIONAL RECOVERY; YOUNG-ADULTS; PREDICTORS; RELIABILITY; VALIDITY; PARTICIPATION; ADOLESCENTS; PEDSQL(TM)	Objective: To assess the parental view on the impact of pediatric traumatic brain injury (TBI) and nontraumatic brain injury (NTBI) on the family and its determinants. Methods: Follow-up study including parents of children with a hospital-based diagnosis of acquired brain injury (ABI) aged 4-20 years at onset of ABI. Parents completed the Pediatric Quality of Life Inventory Family Impact Module (PedsQL FIM), which measures Parent Health-Related Quality of Life, Family Functioning, Communication, and Worry. Additional assessments included the Pediatric Stroke Outcome Measure (PSOM), the Child & Family Follow-up Survey (CFFS), PedsQL General Core and Multiple Fatigue Scales, and sociodemographic and disease characteristics. Results: Parents of 108 patients, median age 13 years (range 5-22), completed the questionnaires 24-30 months after diagnosis. There were 81 patients with TBI of whom 11 (14%) with moderate/severe TBI and 27 patients with NTBI of whom 5 (19%) with moderate/severe NTBI. The median PedsQL FIM Total Scale was 80.4 (SD 16.1). The PedsQL FIM Total Scale and 4 out of 5 Subscale Scores were statistically significantly better in the TBI group than in the NTBI group and in patients with severe NTBI than with mild/moderate NTBI. Moreover, in the total group, there were significant univariate associations between the FIM Total Scale and/or one or more Subscale Scores and age, preinjury patient health problems, and the PSOM, CFFS, PedsQL General Core, and Multiple Fatigue Scales. In the multivariable analysis, the FIM Total Scale was significantly associated with type and severity of injury and preinjury patient health problems. Conclusions: Two years after onset, the parent-reported that impact of ABI on the family as measured by the PedsQL FIM was considerable especially in patients with moderate/severe NTBI.	[de Kloet, Arend J.; Berger, Monique A. M.] Hague Univ Appl Sci, The Hague, Netherlands; [de Kloet, Arend J.; van Markus, Frederike; Vlieland, Thea P. M. Vliet] Sophia Rehabil, NL-2543 SW The Hague, Netherlands; [Lambregts, Suzanne A. M.] Revant Rehabil Ctr, Breda, Netherlands; [Wolterbeek, Ron] Leiden Univ, Med Ctr, Dept Med Stat, Leiden, Netherlands; [Vlieland, Thea P. M. Vliet] Leiden Univ, Med Ctr, Dept Orthopaed, Leiden, Netherlands	de Kloet, AJ (corresponding author), Sophia Rehabil, Vrederustlaan 180, NL-2543 SW The Hague, Netherlands.	a.dekloet@sophiarevalidatie.nl	Vlieland, Thea Vliet/AAJ-8119-2020	Vlieland, Thea Vliet/0000-0001-6322-3859	Revalidatiefonds [2010029]; Johanna KinderFonds [0075-1403]; Stichting Kinderrevalidatie Fonds Adriaanstichting [0075-1403]	This study was supported by the Revalidatiefonds (project number 2010029), Johanna KinderFonds (0075-1403), and Stichting Kinderrevalidatie Fonds Adriaanstichting (0075-1403).	Aarsen FK, 2006, CANCER-AM CANCER SOC, V106, P396, DOI 10.1002/cncr.21612; Ab Rahman A, 2011, MALAYS J MED SCI, V18, P63; Abidin R.R., 1997, EVALUATING STRESS BO, P277; Anderson VA, 2006, NEUROPSYCHOLOGY, V20, P42, DOI 10.1037/0894-4105.20.1.42; Anderson VA, 2005, J NEUROL NEUROSUR PS, V76, P401, DOI 10.1136/jnnp.2003.019174; Barlow KM, 2010, PEDIATRICS, V126, pE374, DOI 10.1542/peds.2009-0925; Bedell GM, 2005, AM J OCCUP THER, V59, P273, DOI 10.5014/ajot.59.3.273; Bedell GM, 2004, NEUROREHABILITATION, V19, P191; BONITA R, 1988, STROKE, V19, P1497, DOI 10.1161/01.STR.19.12.1497; Braga LW, 2005, BRAIN INJURY, V19, P819, DOI 10.1080/02699050500110165; Catroppa C, 2008, J PEDIATR PSYCHOL, V33, P707, DOI 10.1093/jpepsy/jsn006; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Cohen J., 1988, STAT POWER ANAL BEHA, V2nd; de Kloet AJ, 2013, BRAIN INJURY, V27, P843, DOI 10.3109/02699052.2013.775496; de Kloet AJ, 2015, DEV NEUROREHABIL, V18, P357, DOI 10.3109/17518423.2013.850749; Delsing BJP, 2001, PEDIATR NEUROL, V24, P283, DOI 10.1016/S0887-8994(01)00245-4; deVeber GA, 2000, J CHILD NEUROL, V15, P316, DOI 10.1177/088307380001500508; Di Battista A, 2012, J NEUROTRAUM, V29, P1717, DOI 10.1089/neu.2011.2157; Galvin J, 2010, AUST OCCUP THER J, V57, P118, DOI 10.1111/j.1440-1630.2009.00822.x; Gan C, 2006, BRAIN INJURY, V20, P587, DOI 10.1080/02699050600743725; Green L, 2013, BRAIN INJURY, V27, P872, DOI 10.3109/02699052.2013.775506; Greenwald BA, 2003, ARCH PHYS MED REHAB, V84, pS3, DOI 10.1053/apmr.2003.50052; Hawley CA, 2003, INJURY, V34, P256, DOI 10.1016/S0020-1383(02)00193-6; Horneman G, 2005, INT J REHABIL RES, V28, P245, DOI 10.1097/00004356-200509000-00007; IBM Corporation, 2012, IBM SPSS STAT WIND V; Josie KL, 2008, J HEAD TRAUMA REHAB, V23, P357, DOI 10.1097/01.HTR.0000341431.29133.a8; Kuhlthau KA, 2011, ACAD PEDIATR, V11, P136, DOI 10.1016/j.acap.2010.12.014; Langlois JA, 2005, J HEAD TRAUMA REHAB, V20, P229, DOI 10.1097/00001199-200505000-00006; LITTLE RJA, 1993, J AM STAT ASSOC, V88, P125, DOI 10.1080/01621459.1993.10594302; Mano KEJ, 2011, J PEDIATR PSYCHOL, V36, P517, DOI 10.1093/jpepsy/jsp099; Max JE, 1998, J AM ACAD CHILD PSY, V37, P83, DOI 10.1097/00004583-199801000-00021; McCarthy ML, 2005, ARCH PHYS MED REHAB, V86, P1901, DOI 10.1016/j.apmr.2005.03.026; Medrano GR, 2013, QUAL LIFE RES, V22, P2899, DOI 10.1007/s11136-013-0422-9; Micklewright JL, 2012, J INT NEUROPSYCH SOC, V18, P343, DOI 10.1017/S1355617711001792; Milroy G, 2008, J PEDIATR PSYCHOL, V33, P242, DOI 10.1093/jpepsy/jsm099; Neuner B, 2011, ANN NEUROL, V70, P70, DOI 10.1002/ana.22381; Oakes JM, 2003, SOC SCI MED, V56, P769, DOI 10.1016/S0277-9536(02)00073-4; Pecoraro K, 2010, THESIS U FLORIDA GAI; Prigatano GP, 2007, BRAIN INJURY, V21, P721, DOI 10.1080/02699050701481605; Rivara FP, 2012, AM J PUBLIC HEALTH, V102, P2074, DOI 10.2105/AJPH.2012.300696; Rivara JB, 1996, ARCH PHYS MED REHAB, V77, P754, DOI 10.1016/S0003-9993(96)90253-1; Ruff R, 2005, J HEAD TRAUMA REHAB, V20, P5, DOI 10.1097/00001199-200501000-00003; Scarpelli AC, 2008, HEALTH QUAL LIFE OUT, V6, DOI 10.1186/1477-7525-6-35; Stein REK, 2005, DEV BEHAV PEDIAT, V24, P9; Streiner DL, 2003, HEATH MEASUREMENT SC; TEASDALE G, 1974, LANCET, V2, P81; Varni JW, 2008, QUAL LIFE RES, V17, P105, DOI 10.1007/s11136-007-9282-5; Varni JW, 2007, HEALTH QUAL LIFE OUT, V5, DOI 10.1186/1477-7525-5-1; Varni JW, 1999, MED CARE, V37, P126, DOI 10.1097/00005650-199902000-00003; Varni JW, 2004, HEALTH QUAL LIFE OUT, V2, P1; Wade SL, 2006, J PEDIATR PSYCHOL, V31, P1072, DOI 10.1093/jpepsy/jsj077; Wade SL, 2002, J HEAD TRAUMA REHAB, V17, P96, DOI 10.1097/00001199-200204000-00003; Wade SL, 1996, J LEARN DISABIL, V29, P652, DOI 10.1177/002221949602900609; Walker W, 2005, ED CHILDREN ACQUIRED; Yeates KO, 2004, J INT NEUROPSYCH SOC, V10, P412, DOI 10.1017/S1355617704103093	55	22	22	0	10	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0196-206X	1536-7312		J DEV BEHAV PEDIATR	J. Dev. Behav. Pediatr.	JUN	2015	36	5					342	351		10.1097/DBP.0000000000000169			10	Behavioral Sciences; Psychology, Developmental; Pediatrics	Behavioral Sciences; Psychology; Pediatrics	CK5FM	WOS:000356248100006	25961902				2021-06-18	
J	Jourdan, C; Bayen, E; Darnoux, E; Ghout, I; Azerad, S; Ruet, A; Vallat-Azouvi, C; Pradat-Diehl, P; Aegerter, P; Weiss, JJ; Azouvi, P				Jourdan, Claire; Bayen, Eleonore; Darnoux, Emmanuelle; Ghout, Idir; Azerad, Sylvie; Ruet, Alexis; Vallat-Azouvi, Claire; Pradat-Diehl, Pascale; Aegerter, Philippe; Weiss, Jean-Jacques; Azouvi, Philippe			Patterns of post-acute health care utilization after a severe traumatic brain injury: Results from the PariS-TBI cohort	BRAIN INJURY			English	Article						Brain injuries; cohort studies; health services research; healthcare surveys; rehabilitation; vocational rehabilitation	SERVICE UTILIZATION; MEDICAL-CARE; PRACTICAL SCALE; REHABILITATION; OUTCOMES; HOSPITALIZATION; DISABILITY; VALIDITY; ADULTS; DAMAGE	Objective: To assess brain injury services utilization and their determinants using Andersen's model. Methods: Prospective follow-up of the PariS-TBI inception cohort. Out of 504 adults with severe traumatic brain injury (TBI), 245 survived and 147 received a 4-year outcome assessment (mean age 33 years, 80% men). Provision rates of medical, rehabilitation, social and re-entry services and their relations to patients' characteristics were assessed. Results: Following acute care discharge, 78% of patients received physiotherapy, 61% speech/cognitive therapy, 50% occupational therapy, 41% psychological assistance, 63% specialized medical follow-up, 21% community re-entry assistance. Health-related need factors, in terms of TBI severity, were the main predictors of services. Provision of each therapy was significantly associated with corresponding speech, motor and psychological impairments. However, care provision did not depend on cognitive impairments and cognitive therapy was related to predisposing and geographical factors. Community re-entry assistance was provided to younger and more independent patients. Conclusions: These quantitative findings illustrate strengths and weaknesses of late brain injury care provision in urban France and highlight the need to improve treatment of cognitive impairments.	[Jourdan, Claire; Ruet, Alexis; Vallat-Azouvi, Claire; Azouvi, Philippe] Hop Raymond Poincare, AP HP, Serv Med Phys & Readaptat, F-92380 Garches, France; [Jourdan, Claire; Ruet, Alexis; Aegerter, Philippe; Azouvi, Philippe] Univ Versailles, EA ECIPSY 4047, St Quentin en Yvelines, France; [Bayen, Eleonore] Univ Paris 09, Lab Econ & Gest Org Sante LEDa LEGOS, Paris, France; [Bayen, Eleonore; Pradat-Diehl, Pascale] Univ Paris 06, Paris, France; [Bayen, Eleonore; Pradat-Diehl, Pascale] Hop Univ Pitie Salpetriere Charles Foix, AP HP, Paris, France; [Darnoux, Emmanuelle; Azerad, Sylvie; Weiss, Jean-Jacques] CRFTC, Paris, France; [Darnoux, Emmanuelle; Ghout, Idir; Azerad, Sylvie; Aegerter, Philippe] Hop Ambroise Pare, AP HP, URC, Boulogne, France; [Vallat-Azouvi, Claire] Hop Raymond Poincare, Antenne UEROS UGECAM IDF SAMSAH92, F-92380 Garches, France	Jourdan, C (corresponding author), Hop Raymond Poincare, Serv Med Phys & Readaptat, 104 Bd Raymond Poincare, F-92380 Garches, France.	claire.jourdan@rpc.aphp.fr	RUET, Alexis/L-8726-2015	RUET, Alexis/0000-0002-5080-5734; AEGERTER, Philippe/0000-0002-9156-5028	French Ministry of Health (Programme Hospitalier de Recherche Clinique) [AOM04084]; AP-HP (Departement de la Recherche Clinique et du Developpement); Institut de Recherche en Sante Publique (IRESP)	The first part of this study was funded by a grant from the French Ministry of Health (Programme Hospitalier de Recherche Clinique 2004, AOM04084) and sponsored by AP-HP (Departement de la Recherche Clinique et du Developpement). The second part of this study was funded by a grant from the Institut de Recherche en Sante Publique (IRESP).	ANDERSEN RM, 1995, J HEALTH SOC BEHAV, V36, P1, DOI 10.2307/2137284; Bayen E, 2013, J HEAD TRAUMA REHAB, V28, P408, DOI 10.1097/HTR.0b013e31825413cf; BROOKS CA, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199508000-00002; Burgess PW, 1998, J INT NEUROPSYCH SOC, V4, P547, DOI 10.1017/S1355617798466037; Cicerone KD, 2011, ARCH PHYS MED REHAB, V92, P519, DOI 10.1016/j.apmr.2010.11.015; Cohen J., 1988, STAT POWER ANAL BEHA, V2nd; Corrigan JD, 2004, J HEAD TRAUMA REHAB, V19, P205, DOI 10.1097/00001199-200405000-00002; Heinemann AW, 2002, ARCH PHYS MED REHAB, V83, P1052, DOI 10.1053/apmr.2002.34283; HIGH WM, 1995, J HEAD TRAUMA REHAB, V10, P64, DOI 10.1097/00001199-199508000-00007; Hodgkinson A, 2000, J HEAD TRAUMA REHAB, V15, P1208, DOI 10.1097/00001199-200012000-00003; Horn W, 2000, DISABIL REHABIL, V22, P358, DOI 10.1080/096382800296601; INSEE, REV SAL NIV VIE MED; INSEE, REV COMM NIV EC VAR; INSEE, 2007, FRENCH POP IL DE FRA; INSEE, POP POP AG 2007 2040; JENNETT B, 1975, LANCET, V1, P480; Jourdan C, 2013, BRAIN INJURY, V27, P1000, DOI 10.3109/02699052.2013.794971; Jourdan C, 2013, NEUROREHAB NEURAL RE, V27, P35, DOI 10.1177/1545968312440744; Kadushin G, 2004, HEALTH SOC WORK, V29, P219, DOI 10.1093/hsw/29.3.219; Le Gall C., 2007, Annales de Readaptation et de Medecine Physique, V50, P5, DOI 10.1016/j.annrmp.2006.06.007; Leibson CL, 2012, J NEUROTRAUM, V29, P2038, DOI 10.1089/neu.2010.1713; MAHONEY F I, 1965, Md State Med J, V14, P61; McCauley SR, 2001, J NEUROL NEUROSUR PS, V71, P643, DOI 10.1136/jnnp.71.5.643; Mellick D, 2003, BRAIN INJURY, V17, P55, DOI 10.1080/0269905021000010159; Mittelmann M, 1991, J Insur Med, V23, P55; Ordre National des Medecins, ATL DEM MED 2012; Phillips VL, 2004, J HEAD TRAUMA REHAB, V19, P217, DOI 10.1097/00001199-200405000-00003; Pradat-Diehl P., 2012, Annals of Physical and Rehabilitation Medicine, V55, P546, DOI 10.1016/j.rehab.2012.07.002; Prang KH, 2012, BRAIN INJURY, V26, P1611, DOI 10.3109/02699052.2012.698790; R Core Team, 2013, R LANG ENV STAT COMP; Ragnarsson KT, 1999, JAMA-J AM MED ASSOC, V282, P974; Rocichill CM, 2012, J NEUROTRAUM, V29, P1038; Simpson G, 2005, DISABIL REHABIL, V27, P901, DOI 10.1080/09638280500030589; Soury S, 2005, REV SCI SOC FRANCAIS, V48, P61; TEASDALE G, 1974, LANCET, V2, P81; Turner BJ, 2008, DISABIL REHABIL, V30, P1153, DOI 10.1080/09638280701532854; TURNERSTOKES L, 2005, COCHRANE DB SYST REV, V3, DOI DOI 10.1016/S0079-6123(09)17707-5; van Buuren S, 2011, MICE MULTIVARIATE IM, P45; Vangel SJ, 2005, AM J PHYS MED REHAB, V84, P153, DOI 10.1097/01.PHM.0000154896.55045.E7; White IR, 2011, STAT MED, V30, P377, DOI 10.1002/sim.4067; Whiteneck G, 2004, ARCH PHYS MED REHAB, V85, pS73, DOI 10.1016/j.apmr.2003.08.107; Willemse-van Son AHP, 2009, J REHABIL MED, V41, P59, DOI 10.2340/16501977-0294; Wrona RM, 2010, DISABIL REHABIL, V32, P650, DOI 10.3109/09638280903186327; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	44	22	23	0	19	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	JUN	2015	29	6					701	708		10.3109/02699052.2015.1004646			8	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	CL8RL	WOS:000357241700004	25789712				2021-06-18	
J	Nichol, A; Gantner, D; Presneill, J; Murray, L; Trapani, T; Bernard, S; Cameron, P; Capellier, G; Forbes, A; McArthur, C; Newby, L; Rashford, S; Rosenfeld, JV; Smith, T; Stephenson, M; Varma, D; Walker, T; Webb, S; Cooper, DJ				Nichol, Alistair; Gantner, Dashiell; Presneill, Jeffrey; Murray, Lynnette; Trapani, Tony; Bernard, Stephen; Cameron, Peter; Capellier, Gilles; Forbes, Andrew; McArthur, Colin; Newby, Lynette; Rashford, Stephen; Rosenfeld, Jeffrey V.; Smith, Tony; Stephenson, Michael; Varma, Dinesh; Walker, Tony; Webb, Steve; Cooper, D. James			Protocol for a multicentre randomised controlled trial of early and sustained prophylactic hypothermia in the management of traumatic brain injury	CRITICAL CARE AND RESUSCITATION			English	Article							THERAPEUTIC HYPOTHERMIA; MODERATE HYPOTHERMIA; CLINICAL-TRIALS; EPIDEMIOLOGY; INDUCTION; IMPACT; RISKS	Introduction: Traumatic brain injury (TBI) is a leading cause of death and disability worldwide. Prophylactic hypothermia is effective in laboratory models, but clinical studies to date have been inconclusive, partly because of methodological limitations. Our Prophylactic Hypothermia Trial to Lessen Traumatic Brain Injury (POLAR) randomised controlled trial is currently underway comparing early, sustained hypothermia versus standard care in patients with severe TBI. We describe our study protocol and the challenges in conducting prophylactic hypothermia research in TBI. Design: We aim to randomise 500 patients to either prophylactic 33 degrees C hypothermia initiated within 3 hours of injury and continued for at least 72 hours, or standard normothermic management. Patients will be enrolled by paramedic services in the prehospital setting, or by emergency department staff at participating sites in Australia, New Zealand and Europe. The primary outcome will be the eight-level extended Glasgow outcome scale (GOSE), dichotomised to favourable and unfavourable outcomes at 6 months after injury. Secondary outcomes will include mortality at hospital discharge and at 6 months, ordinal analyses of 6-month GOSE outcomes, quality of life with health economic evaluations and the differential proportion of adverse events. We will predefine subgroup and interaction analyses. Discussion: After a run-in phase, recruitment for our main study began in December 2010. When the study is completed, we aim to provide evidence on the efficacy of prophylactic hypothermia in TBI to guide clinicians in their management of this devastating condition.	[Nichol, Alistair; Gantner, Dashiell; Presneill, Jeffrey; Murray, Lynnette; Trapani, Tony; Forbes, Andrew; McArthur, Colin; Stephenson, Michael; Webb, Steve; Cooper, D. James] Monash Univ, Australian & New Zealand Intens Care Res Ctr, Melbourne, Vic 3004, Australia; [Nichol, Alistair; Trapani, Tony; Bernard, Stephen; Cooper, D. James] Alfred Hosp, Dept Intens Care, Melbourne, Vic, Australia; [Nichol, Alistair] St Vincents Univ Hosp, Dept Anaesthesia & Intens Care Med, Dublin 4, Ireland; [Nichol, Alistair] Univ Coll Dublin, Sch Med & Med Sci, Dublin 2, Ireland; [Gantner, Dashiell; Bernard, Stephen; Cameron, Peter] Monash Univ, Alfred Hosp, Ctr Excellence Traumat Brain Injury Res, Melbourne, Vic 3181, Australia; [Gantner, Dashiell] Monash Univ, Dept Anaesthesia & Perioperat Med, Melbourne, Vic 3004, Australia; [Gantner, Dashiell] Western Hlth, Dept Intens Care, Melbourne, Vic, Australia; [Presneill, Jeffrey; Bernard, Stephen; Walker, Tony] Royal Brisbane & Womens Hosp, Dept Intens Care, Brisbane, Qld, Australia; [Cameron, Peter] Hamad Med Corp, Emergency Med, Doha, Qatar; [Capellier, Gilles] Hop Jean Minjoz, Reanimat Med CHRU, F-25030 Besancon, France; [Capellier, Gilles] Univ Franche Comte, F-25030 Besancon, France; [McArthur, Colin; Newby, Lynette; Smith, Tony] Auckland City Hosp, Dept Crit Care Med, Auckland, New Zealand; [Rashford, Stephen] Queensland Ambulance Serv, Brisbane, Qld, Australia; [Rosenfeld, Jeffrey V.; Varma, Dinesh] Monash Univ, Dept Surg, Melbourne, Vic 3004, Australia; [Rosenfeld, Jeffrey V.] Alfred Hosp, Dept Neurosurg, Melbourne, Vic, Australia; [Rosenfeld, Jeffrey V.] Uniformed Serv Univ Hlth Sci, F Edward Hebert Sch Med, Dept Surg, Bethesda, MD 20814 USA; [Stephenson, Michael] Ambulance Victoria, Melbourne, Vic, Australia; [Varma, Dinesh] Alfred Hosp, Dept Radiol, Melbourne, Vic, Australia; [Webb, Steve] Univ Western Australia, Sch Med & Pharmacol, Perth, WA 6009, Australia	Cooper, DJ (corresponding author), Monash Univ, Australian & New Zealand Intens Care Res Ctr, Melbourne, Vic 3004, Australia.	Jamie.cooper@monash.edu	Cooper, D. James/G-7961-2013	Cooper, D. James/0000-0002-5872-9051; Nichol, Alistair Dualta/0000-0002-4771-5615; Cameron, Peter/0000-0002-1443-557X; Forbes, Andrew/0000-0003-4269-914X; Gantner, Dashiell/0000-0001-9465-5910; Nichol, Alistair/0000-0002-4689-1238	Australian National Health and Medical Research CouncilNational Health and Medical Research Council of Australia; Victorian Transport Accident Commission	The POLAR RCT is funded by the Australian National Health and Medical Research Council and the Victorian Transport Accident Commission. The cooling vests and blankets are purchased and maintained using project grant funds. Funding agencies and cooling device suppliers and manufacturers have not had and will not have any role in study design, data collection, data analysis or writing of manuscripts.	Adelson PD, 2013, LANCET NEUROL, V12, P546, DOI 10.1016/S1474-4422(13)70077-2; Aibiki M, 2000, CRIT CARE MED, V28, P3902, DOI 10.1097/00003246-200012000-00029; Andrews PJD, 2011, TRIALS, V12, DOI 10.1186/1745-6215-12-8; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Clifton GL, 2001, NEW ENGL J MED, V344, P556, DOI 10.1056/NEJM200102223440803; Clifton GL, 2002, J NEUROTRAUM, V19, P293, DOI 10.1089/089771502753594864; CLIFTON GL, 1993, J NEUROTRAUM, V10, P263, DOI 10.1089/neu.1993.10.263; Clifton GL, 2012, J NEUROSURG, V117, P714, DOI 10.3171/2012.6.JNS111690; Clifton GL, 2011, LANCET NEUROL, V10, P131, DOI 10.1016/S1474-4422(10)70300-8; Cook D, 2008, CAN MED ASSOC J, V178, P1181, DOI 10.1503/cmaj.071366; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; Cooper DJ, 2004, JAMA-J AM MED ASSOC, V291, P1350, DOI 10.1001/jama.291.11.1350; Crossley S, 2014, CRIT CARE, V18, DOI 10.1186/cc13835; Cummings P., 2014, BMJ, V348; EuroQol Group, 2014, EQ 5D INSTR DESCR VA; Faul M.D., 2010, TRAUMATIC BRAIN INJU; Fergusson D, 2002, BMJ-BRIT MED J, V325, P652, DOI 10.1136/bmj.325.7365.652; Finkelstein EA., 2006, INCIDENCE EC BURDEN; Gantner D, 2014, CURR OPIN CRIT CARE, V20, P385, DOI 10.1097/MCC.0000000000000114; Georgiou AP, 2013, BRIT J ANAESTH, V110, P357, DOI 10.1093/bja/aes500; Grant RL, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.f7450; Hosmer DW., 2013, APPL LOGISTIC REGRES, V3rd ed.; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Jiang J., RANDOMIZED CONTROLLE; Jiang JY, 2000, J NEUROSURG, V93, P546, DOI 10.3171/jns.2000.93.4.0546; Karnatovskaia LV, 2014, NEUROHOSPITALIST, V4, P153, DOI 10.1177/1941874413519802; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Marion DW, 2014, CRIT CARE, V18, DOI 10.1186/cc13955; Marion DW, 1997, NEW ENGL J MED, V336, P540, DOI 10.1056/NEJM199702203360803; Markgraf CG, 2001, J NEUROSURG, V95, P979, DOI 10.3171/jns.2001.95.6.0979; Myburgh JA, 2008, J TRAUMA, V64, P854, DOI 10.1097/TA.0b013e3180340e77; Nichol AD, 2011, LANCET NEUROL, V10, P405, DOI 10.1016/S1474-4422(11)70085-0; Norton EC, 2013, STATA J, V13, P492, DOI 10.1177/1536867X1301300304; Polderman KH, 2011, LANCET NEUROL, V10, P404, DOI 10.1016/S1474-4422(11)70084-9; Povlishock JT, 2009, J NEUROTRAUM, V26, P333, DOI 10.1089/neu.2008.0604; Qiu Wu-si, 2005, Chin J Traumatol, V8, P27; Roozenbeek B, 2011, CRIT CARE, V15, DOI 10.1186/cc10240; Sahuquillo J, 2007, CURR PHARM DESIGN, V13, P2310; Shankaran S, 2014, JAMA-J AM MED ASSOC, V312, P2629, DOI 10.1001/jama.2014.16058; Stocchetti N, 2014, NEW ENGL J MED, V370, P2121, DOI 10.1056/NEJMra1208708; SYDENHAM E, 2009, COCHRANE DATABASE SY; Teasdale GM, 1998, J NEUROTRAUM, V15, P587, DOI 10.1089/neu.1998.15.587; Ware JE, 1996, MED CARE, V34, P220, DOI 10.1097/00005650-199603000-00003	43	22	22	0	8	AUSTRALASIAN MED PUBL CO LTD	PYRMONT	LEVEL 2, 26-32 PYRMONT BRIDGE RD, PYRMONT, NSW 2009, AUSTRALIA	1441-2772			CRIT CARE RESUSC	Crit Care Resusc.	JUN	2015	17	2					92	100					9	Critical Care Medicine	General & Internal Medicine	CJ0ID	WOS:000355158100008	26017126				2021-06-18	
J	Shatillo, A; Salo, RA; Giniatullin, R; Grohn, OH				Shatillo, Artem; Salo, Raimo A.; Giniatullin, Rashid; Groehn, Olli H.			Involvement of NMDA receptor subtypes in cortical spreading depression in rats assessed by fMRI	NEUROPHARMACOLOGY			English	Article						Spreading depression; BOLD; fMRI; Glutamate; NMDA receptors	METHYL-D-ASPARTATE; CEREBRAL-BLOOD-FLOW; TRAUMATIC BRAIN-INJURY; NEUROLOGICAL DISORDERS; DIZOCILPINE MK-801; MIGRAINE HEADACHE; GLUTAMATE RELEASE; FUNCTIONAL MRI; IFENPRODIL; ANTAGONIST	Cortical spreading depression (CSD) is a phenomenon implicated in migraine with aura and associated with other neurological disorders (e.g. stroke, brain trauma). Current evidence points to the essential role of NMDA receptors in CSD mechanisms. However, the roles of multiple subunits of NMDA receptors expressed in neurons, glia and blood vessels in vivo, are little explored. Using BOLD fMRI of urethane anesthetized rats as an integrative CSD readout, we tested the involvement of different NMDA receptor subtypes in CSD induction and propagation. Rats were treated with a non-selective NMDA blocker (MK-801), NR2B antagonist (ifenprodil) or a NR2A selective antagonist (TCN-201). CSD was induced during fMRI scanning by application of KCl onto the cerebral cortex and fMRI data were collected by 9.41 MRI. The non-specific NMDA antagonist MK-801 coinpletely blocked CSD, which was not observed in the NR2A group where TCN-201 did not alter the CSD features. Unexpectedly, the NR2B specific antagonist ifenprodil largely promoted the initial negative phase of the BOLD CSD response, likely due to altered neurovascular coupling. Our data suggest key roles and differential involvement of NMDA receptor subtypes in CSD generation and propagation, highlighting an important role for the NR2B subtype. (C) 2015 Elsevier Ltd. All rights reserved.	[Shatillo, Artem; Salo, Raimo A.; Giniatullin, Rashid; Groehn, Olli H.] Univ Eastern Finland, AI Virtanen Inst Mol Sci, Dept Neurobiol, Kuopio 70700, Finland; [Giniatullin, Rashid] Kazan Fed Univ, Neurobiol Lab, Kazan 420008, Republic Of Tat, Russia	Shatillo, A (corresponding author), Univ Eastern Finland, AI Virtanen Inst Mol Sci, Dept Neurobiol, Neulaniementie 2, Kuopio 70700, Finland.	artem.shatillo@uef.fi; raimo.salo@uef.fi; rashid.giniatullin@uef.fi; olli.grohn@uef.fi	Giniatullin, Rashid/Y-9687-2018		Academy of FinlandAcademy of FinlandEuropean Commission [252511]; University of Eastern Finland; UEF-Brain strategic funding; Center for International Mobility (CIMO) [TM-09-6241]; program of competitive growth of Kazan Federal UniversityMinistry of Education and Science, Russian FederationProject 5-100, Ministry of Education and Science, Russian Federation	This work was supported by the Academy of Finland (252511), University of Eastern Finland and UEF-Brain strategic funding and Center for International Mobility (CIMO) TM-09-6241 fund. RG was partially supported by the program of competitive growth of Kazan Federal University.	ARAI Y, 1991, NEUROPHARMACOLOGY, V30, P809, DOI 10.1016/0028-3908(91)90190-M; Autio JA, 2014, J CEREBR BLOOD F MET, V34, P768, DOI 10.1038/jcbfm.2014.16; Ayata C, 2013, STROKE, V44, pS87, DOI 10.1161/STROKEAHA.112.680264; Bandettini Peter A, 2012, Neuroimage, V61, pA3, DOI 10.1016/j.neuroimage.2012.01.130; Brennan KC, 2007, J NEUROPHYSIOL, V97, P4143, DOI 10.1152/jn.00028.2007; Brittain MK, 2012, NEUROPHARMACOLOGY, V63, P974, DOI 10.1016/j.neuropharm.2012.07.012; Busija DW, 2007, BRAIN RES REV, V56, P89, DOI 10.1016/j.brainresrev.2007.05.011; Chang JC, 2010, BRAIN, V133, P996, DOI 10.1093/brain/awp338; Charles AC, 2013, NAT REV NEUROL, V9, P637, DOI 10.1038/nrneurol.2013.192; Comon P, 1994, SIGNAL PROCESS, V36, P287; Cull-Candy S, 2001, CURR OPIN NEUROBIOL, V11, P327, DOI 10.1016/S0959-4388(00)00215-4; Dempsey RJ, 2000, NEUROSURGERY, V47, P399, DOI 10.1097/00006123-200008000-00024; Dreier JP, 2011, NAT MED, V17, P439, DOI 10.1038/nm.2333; Dzamba D, 2013, CURR NEUROPHARMACOL, V11, P250, DOI 10.2174/1570159X11311030002; Eikermann-Haerter K, 2008, CURR OPIN NEUROL, V21, P294, DOI 10.1097/WCO.0b013e3282fc25de; Faria LC, 2004, J NEUROPHYSIOL, V92, P2610, DOI 10.1152/jn.00466.2004; GARDNERMEDWIN AR, 1994, J CEREBR BLOOD F MET, V14, P7, DOI 10.1038/jcbfm.1994.2; GRAFSTEIN B, 1956, J NEUROPHYSIOL, V19, P154; Hadjikhani N, 2001, P NATL ACAD SCI USA, V98, P4687, DOI 10.1073/pnas.071582498; Hardingham GE, 2010, NAT REV NEUROSCI, V11, P682, DOI 10.1038/nrn2911; Iijima T, 1998, NEUROSCI RES, V32, P201, DOI 10.1016/S0168-0102(98)00090-X; Kudo C., 2008, EXP NEUROL; LAURITZEN M, 1994, BRAIN, V117, P199, DOI 10.1093/brain/117.1.199; LAURITZEN M, 1992, J CEREBR BLOOD F MET, V12, P223, DOI 10.1038/jcbfm.1992.32; Lauritzen M, 2011, J CEREBR BLOOD F MET, V31, P17, DOI 10.1038/jcbfm.2010.191; Leao A., 1945, J NERV MENT DIS, V102, P512; Leao AAP, 1944, J NEUROPHYSIOL, V7, P359; LeMaistre JL, 2012, J CEREBR BLOOD F MET, V32, P537, DOI 10.1038/jcbfm.2011.161; Loftis JM, 2003, PHARMACOL THERAPEUT, V97, P55, DOI 10.1016/S0163-7258(02)00302-9; Logothetis NK, 2001, NATURE, V412, P150, DOI 10.1038/35084005; Ma JY, 1996, AM J PHYSIOL-HEART C, V270, pH1085; MCCOOL BA, 1995, NEUROPHARMACOLOGY, V34, P621, DOI 10.1016/0028-3908(95)00030-A; MCLACHLAN RS, 1992, CAN J NEUROL SCI, V19, P487, DOI 10.1017/S0317167100041688; Menniti FS, 2000, NEUROPHARMACOLOGY, V39, P1147, DOI 10.1016/S0028-3908(99)00211-7; MILNER PM, 1958, ELECTROEN CLIN NEURO, V10, P705, DOI 10.1016/0013-4694(58)90073-7; Monaghan DT, 2012, NEUROCHEM INT, V61, P581, DOI 10.1016/j.neuint.2012.01.004; MONYER H, 1992, SCIENCE, V256, P1217, DOI 10.1126/science.256.5060.1217; NEHLS DG, 1990, BRAIN RES, V511, P271, DOI 10.1016/0006-8993(90)90172-8; OBRENOVITCH TP, 1995, J NEUROPHYSIOL, V73, P2107; OGAWA S, 1990, P NATL ACAD SCI USA, V87, P9868, DOI 10.1073/pnas.87.24.9868; OLESEN J, 1981, ANN NEUROL, V9, P344, DOI 10.1002/ana.410090406; Paoletti P, 2007, CURR OPIN PHARMACOL, V7, P39, DOI 10.1016/j.coph.2006.08.011; Peeters M, 2007, J PHARMACOL EXP THER, V321, P564, DOI 10.1124/jpet.106.117101; Pietrobon D, 2013, ANNU REV PHYSIOL, V75, P365, DOI 10.1146/annurev-physiol-030212-183717; Roberts TJ, 2008, NEUROSCI LETT, V444, P42, DOI 10.1016/j.neulet.2008.07.090; ROD MR, 1989, CAN J NEUROL SCI, V16, P340, DOI 10.1017/S031716710002919X; Sanz-Clemente A, 2013, NEUROSCIENTIST, V19, P62, DOI 10.1177/1073858411435129; Sharp CD, 2003, BMC NEUROSCI, V4, DOI 10.1186/1471-2202-4-28; Shatillo A, 2013, NEUROSCIENCE, V253, P341, DOI 10.1016/j.neuroscience.2013.09.002; Shmuel A, 2006, NAT NEUROSCI, V9, P569, DOI 10.1038/nn1675; Smith JM, 2006, BIOL REV, V81, P457, DOI 10.1017/S1464793106007081; Somjen GG, 2001, PHYSIOL REV, V81, P1065; Sonn J, 2000, BRAIN RES, V882, P212, DOI 10.1016/S0006-8993(00)02827-4; Sukhotinsky I, 2008, J CEREBR BLOOD F MET, V28, P1369, DOI 10.1038/jcbfm.2008.35; Toda N, 2009, CAN J PHYSIOL PHARM, V87, P581, DOI [10.1139/y09-048, 10.1139/Y09-048]; Verkhratsky A, 2007, NEUROSCIENTIST, V13, P28, DOI 10.1177/1073858406294270; Wang MY, 2012, BRIT J PHARMACOL, V165, P235, DOI 10.1111/j.1476-5381.2011.01553.x; WOODS RP, 1994, NEW ENGL J MED, V331, P1689, DOI 10.1056/NEJM199412223312505; YOUNG AR, 1981, J CEREBR BLOOD F MET, V1, P117, DOI 10.1038/jcbfm.1981.12; Zhou N, 2013, J CEREBR BLOOD F MET, V33, P1582, DOI 10.1038/jcbfm.2013.113	60	22	22	0	17	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0028-3908	1873-7064		NEUROPHARMACOLOGY	Neuropharmacology	JUN	2015	93						164	170		10.1016/j.neuropharm.2015.01.028			7	Neurosciences; Pharmacology & Pharmacy	Neurosciences & Neurology; Pharmacology & Pharmacy	CH0RK	WOS:000353729900016	25688928				2021-06-18	
J	Liu, MD; Zhang, C; Liu, WB; Luo, P; Zhang, L; Wang, Y; Wang, ZJ; Fei, Z				Liu, Mengdong; Zhang, Chi; Liu, Wenbo; Luo, Peng; Zhang, Lei; Wang, Yuan; Wang, Zhanjiang; Fei, Zhou			A novel rat model of blast-induced traumatic brain injury simulating different damage degree: implications for morphological, neurological, and biomarker changes	FRONTIERS IN CELLULAR NEUROSCIENCE			English	Article						blast-induced traumatic brain injury; animal model; biomarker; inflammation; metabolic change	COGNITIVE DEFICITS; OXIDATIVE STRESS; MOUSE MODEL; EXPLOSIONS; INFLAMMATION; MANAGEMENT; CASUALTIES; DIAGNOSIS; MICE	In current military conflicts and civilian terrorism, blast-induced traumatic brain injury (bIBI) is the primary cause of neurotrauma. However, the effects and mechanisms of bTBI are poorly understood. Although previous researchers have made significant contributions to establishing animal models for the simulation of bTBI, the precision and controllability of blast-induced injury in animal models must be improved. Therefore, we established a novel rat model to simulate blast-wave injury to the brain. To simulate different extents of bTBI injury, the animals were divided into moderate and severe injury groups. The miniature spherical explosives (pentaerythritol tetranitrate) used in each group were of different sizes (2.5 mm diameter in the moderate injury group and 3.0 mm diameter in the severe injury group). A specially designed apparatus was able to precisely adjust the positions of the miniature explosives and create eight rats with bTBI simultaneously, using a single electric detonator. Neurological functions, gross pathologies, histopathological changes and the expression levels of various biomarkers were examined after the explosion. Compared with the moderate injury group, there were significantly more neurological dysfunctions, cortical contusions, intraparenchymal hemorrhages, cortical expression of S-100 beta, myelin basic protein, neuron-specific enolase, IL-8, IL-10, inducible nitric oxide synthase, and HIF-1 alpha in the severe injury group. These results demonstrate that we have created a reliable and reproducible bTBI model in rats. This model will be helpful for studying the mechanisms of bTBI and developing strategies for clinical bTBI treatment.	[Liu, Mengdong; Zhang, Chi; Liu, Wenbo; Luo, Peng; Zhang, Lei; Wang, Yuan; Fei, Zhou] Fourth Mil Med Univ, Xijing Hosp, Dept Neurosurg, Xian 710032, Peoples R China; [Wang, Zhanjiang] Northwest Inst Nucl Technol, Xian 710024, Peoples R China	Wang, ZJ (corresponding author), Northwest Inst Nucl Technol, Hong Qing Bao Rd, Xian 710024, Peoples R China.	wangzhanjiangnint@126.com; zhoufeifmmu@126.com		Luo, Peng/0000-0003-0746-939X	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81430043]; National Science and Technology Major Project of China [2013ZX 09J13109-02C]; National Science and Technology Pillar Program of China [2012BAI11B02]; Research Foundation of PLA [2010gxjs078, AWS11J008]	The work was supported by National Natural Science Foundation of China (No. 81430043), National Science and Technology Major Project of China (2013ZX 09J13109-02C), National Science and Technology Pillar Program of China (No. 2012BAI11B02), and Research Foundation of PLA (No. 2010gxjs078 and No. AWS11J008).	Abdul-Muneer PM, 2013, FREE RADICAL BIO MED, V60, P282, DOI 10.1016/j.freeradbiomed.2013.02.029; Agoston Denes V, 2012, Front Neurol, V3, P107, DOI 10.3389/fneur.2012.00107; Alley MD, 2011, NEUROIMAGE, V54, pS45, DOI 10.1016/j.neuroimage.2010.05.030; Belanger HG, 2009, J INT NEUROPSYCH SOC, V15, P1, DOI 10.1017/S1355617708090036; Bhattacharjee Y, 2008, SCIENCE, V319, P406, DOI 10.1126/science.319.5862.406; Bochicchio GV, 2008, AM SURGEON, V74, P267; Bolzenius JD, 2015, APPL NEUROPSYCH-ADUL, V22, P79, DOI 10.1080/23279095.2013.845823; Cernak I, 2011, NEUROBIOL DIS, V41, P538, DOI 10.1016/j.nbd.2010.10.025; Chen YC, 2009, J NEUROTRAUM, V26, P861, DOI 10.1089/neu.2008.0645; Cheng JM, 2010, J NEUROL SCI, V294, P23, DOI 10.1016/j.jns.2010.04.010; Cho HJ, 2013, NEUROSCIENCE, V253, P9, DOI 10.1016/j.neuroscience.2013.08.037; de Ceballos JPG, 2005, CRIT CARE, V9, P104, DOI 10.1186/cc2995; de Lanerolle NC, 2011, J NEUROPATH EXP NEUR, V70, P1046, DOI 10.1097/NEN.0b013e318235bef2; DePalma RG, 2005, NEW ENGL J MED, V352, P1335, DOI 10.1056/NEJMra042083; Finkel MF, 2006, J NEUROL SCI, V249, P63, DOI 10.1016/j.jns.2006.06.005; Frykberg ER, 2002, J TRAUMA, V53, P201, DOI 10.1097/00005373-200208000-00001; Gyorgy A, 2011, J NEUROTRAUM, V28, P1121, DOI 10.1089/neu.2010.1561; Higashida T, 2011, J NEUROSURG, V114, P92, DOI 10.3171/2010.6.JNS10207; Jaffee MS, 2009, J REHABIL RES DEV, V46, P655, DOI 10.1682/JRRD.2008.09.0114; Kluger Yoram, 2007, Am J Disaster Med, V2, P21; Kochanek PM, 2011, J TRAUMA, V71, pS15, DOI 10.1097/TA.0b013e31822117fe; Koliatsos VE, 2011, J NEUROPATH EXP NEUR, V70, P399, DOI 10.1097/NEN.0b013e3182189f06; Kuehn R, 2011, J NEUROTRAUM, V28, P2155, DOI 10.1089/neu.2010.1532; Li AH, 2013, J MOL NEUROSCI, V51, P1052, DOI 10.1007/s12031-013-0084-7; Long JB, 2010, IFMBE PROC, V32, P26, DOI 10.1007/978-3-642-14998-6_7; Long JB, 2009, J NEUROTRAUM, V26, P827, DOI 10.1089/neu.2008.0748; Lucca JJD, 2012, J NEUROL SCI, V318, P146, DOI 10.1016/j.jns.2012.02.002; Milman A, 2005, J NEUROTRAUM, V22, P1003, DOI 10.1089/neu.2005.22.1003; Neher MD, 2014, SOUTH MED J, V107, P248, DOI 10.1097/SMJ.0000000000000086; Oran ES, 2012, PHILOS T R SOC A, V370, P534, DOI 10.1098/rsta.2011.0385; Readnower RD, 2010, J NEUROSCI RES, V88, P3530, DOI 10.1002/jnr.22510; Risling Marten, 2012, Front Neurol, V3, P30, DOI 10.3389/fneur.2012.00030; Ritenour AE, 2008, CRIT CARE MED, V36, pS311, DOI 10.1097/CCM.0b013e31817e2a8c; Rubovitch V, 2011, EXP NEUROL, V232, P280, DOI 10.1016/j.expneurol.2011.09.018; Saljo A, 2000, J NEUROTRAUM, V17, P719, DOI 10.1089/089771500415454; Salonia R, 2010, J NEUROTRAUM, V27, P1819, DOI 10.1089/neu.2010.1402; Shohami E, 1996, J CEREBR BLOOD F MET, V16, P378, DOI 10.1097/00004647-199605000-00004; Taber KH, 2006, J NEUROPSYCH CLIN N, V18, P141, DOI 10.1176/appi.neuropsych.18.2.141; Wang ZL, 2003, MIL MED, V168, P330; Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398, DOI 10.1097/00001199-200609000-00004; Wightman JM, 2001, ANN EMERG MED, V37, P664, DOI 10.1067/mem.2001.114906; Zohar O, 2003, NEUROSCIENCE, V118, P949, DOI 10.1016/S0306-4522(03)00048-4	42	22	23	0	8	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1662-5102			FRONT CELL NEUROSCI	Front. Cell. Neurosci.	MAY 1	2015	9								138	10.3389/fincel.2015.00168			12	Neurosciences	Neurosciences & Neurology	CI5LW	WOS:000354799000001	25983677	DOAJ Gold			2021-06-18	
J	Schiraldi, M; Patil, CG; Mukherjee, D; Ugiliweneza, B; Nuno, M; Lad, SP; Boakye, M				Schiraldi, Michael; Patil, Chirag G.; Mukherjee, Debraj; Ugiliweneza, Beatrice; Nuno, Miriam; Lad, Shivanand P.; Boakye, Maxwell			Effect of Insurance and Racial Disparities on Outcomes in Traumatic Brain Injury	JOURNAL OF NEUROLOGICAL SURGERY PART A-CENTRAL EUROPEAN NEUROSURGERY			English	Article						traumatic brain Injury (TBI); disparities; length of stay (LOS); discharge disposition; resource utilization	ETHNIC DISPARITIES; SOCIOECONOMIC DISPARITIES; RACE; MORTALITY; DISEASES; MODERATE; IMPACT; RISK; CARE	Introduction We evaluated outcome and resource utilization disparities between commercially insured, Medicaid, and Medicare patients. We further analyzed racial disparities in a subset cohort. Methods We reviewed the MarketScan database (2000-2009) for adult traumatic brain injury (TBI) patients. Analyses were performed to evaluate outcome differences by insurance type and race. Outpatient service utilization disparities by insurance and race were also evaluated. Results Our study included 92,159 TBI patients, 44,108 (47.9%) of whom utilized commercial insurance, 19,743 (21.4%) utilized Medicaid, and 28,308 (30.7%) utilized Medicare. In-hospital mortality was lowest for commercially insured (5.0%) versus 7.6% and 8.5% for Medicaid and Medicare patients, respectively (p < 0.0001). Medicaid patients had a longer hospitalization than commercially insured (12 days versus 6 days; p < 0.0001). Medicaid patients were 1.29 and 1.78 times more likely to die and experience complications than the commercially insured. Females had a lower mortality risk (odds ratio [OR]: 0.80, p < 0.0001) and less complications (OR: 0.67; p < 0.0001) than males. Higher comorbidities increased mortality risk (OR: 2.71; p < 0.0001) and complications (OR: 2.96, p < 0.0001). Mild injury patients had lower mortality (OR: 0.01; p < 0.0001) and less complications (OR: 0.07; p < 0.0001). Medicare (OR: 1.33; p < 0.0001) and higher comorbidity (OR: 1.26; p < 0.0001) patients utilized outpatient rehabilitation services more frequently. Medicare patients had twice the emergency department visits as the commercially insured (p < 0.0001). Medicare (16.6%) patients utilized more rehabilitation than commercially insured (13.4%) and Medicaid (9.1%) patients. Racial disparities were analyzed in a subset of 12,847 white and 4,780 African American (AA) patients. Multivariate analysis showed that AAs were more likely to experience a complication than white patients (OR: 1.13; p = 0.0024) and less likely to utilize outpatient rehabilitation services (OR: 0.83; p = 0.0025) than whites. Conclusions Insurance and racial disparities continue to exist for TBI patients. Insurance status appears to have an impact on short-and long-term outcomes to a greater degree than patient race.	[Schiraldi, Michael; Patil, Chirag G.; Mukherjee, Debraj; Nuno, Miriam] Cedars Sinai Med Ctr, Dept Neurosurg, Maxine Dunitz Neurosurg Inst, Los Angeles, CA 90048 USA; [Ugiliweneza, Beatrice; Boakye, Maxwell] Univ Louisville, Dept Neurosurg, Louisville, KY 40292 USA; [Lad, Shivanand P.] Duke Univ, Med Ctr, Dept Surg, Div Neurosurg, Durham, NC 27710 USA	Patil, CG (corresponding author), Cedars Sinai Med Ctr, Dept Neurosurg, Ctr Neurosurg Outcomes Res, 127 South San Vicente Blvd,Suite A6600, Los Angeles, CA 90048 USA.	chiragpatil@gmail.com					Arango-Lasprilla JC, 2010, J HEAD TRAUMA REHAB, V25, P128, DOI 10.1097/HTR.0b013e3181d36ca3; Augenstein JS, 1997, J TRAUMA, V43, P256; Bazarian JJ, 2003, ACAD EMERG MED, V10, P1209, DOI 10.1197/S1069-6563(03)00491-3; Berry C, 2010, J SURG RES, V163, P303, DOI 10.1016/j.jss.2010.03.018; Betancourt JR, 2003, PUBLIC HEALTH REP, V118, P293, DOI 10.1093/phr/118.4.293; Bowman SM, 2007, MED CARE, V45, P686, DOI 10.1097/MLR.0b013e31803dcdf3; BURSTIN HR, 1992, JAMA-J AM MED ASSOC, V268, P2383, DOI 10.1001/jama.268.17.2383; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Cryer C, 2005, INJURY PREV, V11, P53, DOI 10.1136/ip.2003.004143; Curry WT, 2010, NEUROSURGERY, V66, P427, DOI 10.1227/01.NEU.0000365265.10141.8E; Curry WT, 2009, J NEURO-ONCOL, V93, P25, DOI 10.1007/s11060-009-9840-5; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; Downing SR, 2011, J TRAUMA, V70, P130, DOI 10.1097/TA.0b013e3182032b34; Eden SV, 2008, NEUROCRIT CARE, V9, P55, DOI 10.1007/s12028-007-9039-6; Falcone RA, 2008, J PEDIATR SURG, V43, P1858, DOI 10.1016/j.jpedsurg.2008.01.058; Gary KW, 2009, BRAIN INJURY, V23, P775, DOI 10.1080/02699050903200563; Greene WR, 2010, AM J SURG, V199, P554, DOI 10.1016/j.amjsurg.2009.11.005; Haider AH, 2008, ARCH SURG-CHICAGO, V143, P945, DOI 10.1001/archsurg.143.10.945; Haider AH, 2007, J TRAUMA, V62, P1259, DOI 10.1097/TA.0b013e31803c760e; Hakmeh W, 2010, ACAD EMERG MED, V17, P809, DOI 10.1111/j.1553-2712.2010.00819.x; Heffernan DS, 2011, J TRAUMA, V70, P527, DOI 10.1097/TA.0b013e31820d0ed7; Jager TE, 2000, ACAD EMERG MED, V7, P134, DOI 10.1111/j.1553-2712.2000.tb00515.x; KRAUS JF, 1986, AM J PUBLIC HEALTH, V76, P1345, DOI 10.2105/AJPH.76.11.1345; Langley John, 2003, Traffic Inj Prev, V4, P291, DOI 10.1080/714040487; Maybury RS, 2010, SURGERY, V148, P202, DOI 10.1016/j.surg.2010.05.010; Mukherjee D, 2010, ARCH SURG-CHICAGO, V145, P247, DOI 10.1001/archsurg.2009.288; Mukherjee D, 2010, CHILD NERV SYST, V26, P305, DOI 10.1007/s00381-009-1014-4; Nirula R, 2009, J TRAUMA, V66, P255, DOI 10.1097/TA.0b013e31815ede46; Osler TM, 1997, J TRAUMA, V43, P253, DOI 10.1097/00005373-199708000-00008; Rosen H, 2009, ARCH SURG-CHICAGO, V144, P1006, DOI 10.1001/archsurg.2009.195; Rosen H, 2009, J PEDIATR SURG, V44, P1952, DOI 10.1016/j.jpedsurg.2008.12.026; Shafi S, 2007, J TRAUMA, V63, P1263, DOI 10.1097/TA.0b013e31815b8f00; Shafi S, 2007, J TRAUMA, V63, P1138, DOI 10.1097/TA.0b013e3181568cd4; Shermer CR, 2007, J TRAUMA, V63, P1268; Stallion A, 2007, J TRAUMA, V62, P1262; Staudenmayer KL, 2007, J TRAUMA, V63, P1364, DOI 10.1097/TA.0b013e31815b897b; Wong MD, 2002, NEW ENGL J MED, V347, P1585, DOI 10.1056/NEJMsa012979	37	22	22	0	8	THIEME MEDICAL PUBL INC	NEW YORK	333 SEVENTH AVE, NEW YORK, NY 10001 USA	2193-6315	2193-6323		J NEUROL SURG PART A	J. Neurol. Surg. Part A	MAY	2015	76	3					224	232		10.1055/s-0034-1543958			9	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	CI0GQ	WOS:000354415500007	25798799				2021-06-18	
J	Sullivan, KA; Edmed, SL; Allan, AC; Smith, SS; Karlsson, LJE				Sullivan, Karen A.; Edmed, Shannon L.; Allan, Alicia C.; Smith, Simon S.; Karlsson, Lina J. E.			The Role of Psychological Resilience and mTBI as Predictors of Postconcussional Syndrome Symptomatology	REHABILITATION PSYCHOLOGY			English	Article						head injury; neurocognitive disorder; resilience; postconcussional syndrome; mild traumatic brain injury	TRAUMATIC BRAIN-INJURY; COGNITIVE RESERVE; HEAD-INJURY; SYMPTOMS; SCALE; RELIABILITY; COMPLAINTS; INVENTORY; RECOVERY; SAMPLE	Objective: Resilience is 1 of several factors that are thought to contribute to outcome following mild traumatic brain injury (mTBI). This study explored the predictors of the postconcussional syndrome (PCS) symptoms that can occur following mTBI. We hypothesized that a reported recent mTBI and lower psychological resilience would predict worse reported PCS symptomatology. Method: 233 participants completed the Neurobehavioral Symptom Inventory (NSI) and the Brief Resilience Scale (BRS). Three NSI scores were used to define PCS symptomatology. A total of 35 participants reported an mTBI (as operationally defined by the World Health Organization) that was sustained between 1 and 6 months prior to their participation (positive mTBI history); the remainder reported having never had an mTBI. Results: Regression analyses revealed that a positive reported recent mTBI history and lower psychological resilience were significant independent predictors of reported PCS symptomatology. These results were found for the 3 PCS scores from the NSI, including using a stringent caseness criterion, p<.05. Demographic variables (age and gender) were not related to outcome, with the exception of education in some analyses. Conclusion: The results demonstrate that: (a) both perceived psychological resilience and mTBI history play a role in whether or not PCS symptoms are experienced, even when demographic variables are considered, and (b) of these 2 variables, lower perceived psychological resilience was the strongest predictor of PCS-like symptomatology.	[Sullivan, Karen A.; Edmed, Shannon L.] Queensland Univ Technol, Sch Psychol & Counselling, Clin Neuropsychol Res Grp, Kelvin Grove, Qld 4059, Australia; [Allan, Alicia C.; Smith, Simon S.] Queensland Univ Technol, Sch Psychol & Counselling, Inst Hlth & Biomed Innovat, Clin Neuropsychol Res Grp, Kelvin Grove, Qld 4059, Australia; [Allan, Alicia C.; Smith, Simon S.] Queensland Univ Technol, Ctr Accid Res & Rd Safety, Kelvin Grove, Qld 4059, Australia; [Karlsson, Lina J. E.] Queensland Univ Technol, Clin Neuropsychol Res Grp, Kelvin Grove, Qld 4059, Australia	Sullivan, KA (corresponding author), Queensland Univ Technol, Sch Psychol & Counselling, O Block B Wing,Kelvin Grove Campus,Victoria Pk Rd, Kelvin Grove, Qld 4059, Australia.	karen.sullivan@qut.edu.au	Smith, Simon/P-1859-2017	Smith, Simon/0000-0002-0362-9045	School of Psychology and Counselling, Queensland University of Technology	The Human Research Ethics Committee of Queensland University of Technology (QUT-HREC #1300000224) approved this research. This project was granted occupational workplace health and safety clearance. Funding for this project was provided by the School of Psychology and Counselling, Queensland University of Technology.	American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Bonanno GA, 2004, AM PSYCHOL, V59, P20, DOI 10.1037/0003-066X.59.1.20; Bonanno GA, 2013, J CHILD PSYCHOL PSYC, V54, P378, DOI 10.1111/jcpp.12021; Cassidy J David, 2014, Arch Phys Med Rehabil, V95, pS132, DOI 10.1016/j.apmr.2013.08.299; Cassidy J David, 2014, Arch Phys Med Rehabil, V95, pS278, DOI 10.1016/j.apmr.2013.08.295; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Connor KM, 2003, DEPRESS ANXIETY, V18, P76, DOI 10.1002/da.10113; Davydov DM, 2010, CLIN PSYCHOL REV, V30, P479, DOI 10.1016/j.cpr.2010.03.003; Field A., 2013, DISCOVERING STAT USI, V4; Garden N, 2010, NEUROPSYCHOLOGY, V24, P168, DOI 10.1037/a0017431; Godwin EE, 2013, BRAIN INJURY, V27, P637, DOI 10.3109/02699052.2012.750745; GOUVIER WD, 1992, ARCH CLIN NEUROPSYCH, V7, P193, DOI 10.1016/0887-6177(92)90162-G; Hemphill JF, 2003, AM PSYCHOL, V58, P78, DOI 10.1037/0003-066X.58.1.78; Iverson GL, 2003, APPL NEUROPSYCHOL, V10, P137, DOI 10.1207/S15324826AN1003_02; Iverson GL, 2013, BRAIN INJURY MEDICINE: PRINCIPLES AND PRACTICE, SECOND EDITION, P470; Kerr ZY, 2012, MED SCI SPORT EXER, V44, P377, DOI 10.1249/MSS.0b013e31823240f2; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; King P., 2011, THESIS; King PR, 2012, J REHABIL RES DEV, V49, P879, DOI 10.1682/JRRD.2011.03.0051; Kraus J, 2005, J HEAD TRAUMA REHAB, V20, P239, DOI 10.1097/00001199-200505000-00007; McCauley SR, 2013, J NEUROTRAUM, V30, P642, DOI 10.1089/neu.2012.2393; McCrea M, 2009, CLIN NEUROPSYCHOL, V23, P1368, DOI 10.1080/13854040903074652; McMahon P, 2014, J NEUROTRAUM, V31, P26, DOI 10.1089/neu.2013.2984; Mooney G, 2001, BRAIN INJURY, V15, P865, DOI 10.1080/02699050110065286; Oppenheimer DM, 2009, J EXP SOC PSYCHOL, V45, P867, DOI 10.1016/j.jesp.2009.03.009; Richardson GE, 2002, J CLIN PSYCHOL, V58, P307, DOI 10.1002/jclp.10020; Salmond CH, 2006, J NEUROTRAUM, V23, P1049, DOI 10.1089/neu.2006.23.1049; Smith BW, 2008, INT J BEHAV MED, V15, P194, DOI 10.1080/10705500802222972; Stern Y, 2009, NEUROPSYCHOLOGIA, V47, P2015, DOI 10.1016/j.neuropsychologia.2009.03.004; Sullivan K. A., 2015, J NEUROTRAUMA; Vanderploeg RD, 2014, J HEAD TRAUMA REHAB, V29, P1, DOI 10.1097/HTR.0b013e318281966e; White B, 2008, REHABIL PSYCHOL, V53, P9, DOI 10.1037/0090-5550.53.1.9; Wilde EA, 2010, ARCH PHYS MED REHAB, V91, P1650, DOI 10.1016/j.apmr.2010.06.033; Windle G, 2011, HEALTH QUAL LIFE OUT, V9, DOI 10.1186/1477-7525-9-8; Windle G, 2011, REV CLIN GERONTOL, V21, P152, DOI 10.1017/S0959259810000420; World Health Organization, 1992, ICD 10 INT STAT CLAS	36	22	22	0	9	EDUCATIONAL PUBLISHING FOUNDATION-AMERICAN PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST, NE, WASHINGTON, DC 20002-4242 USA	0090-5550	1939-1544		REHABIL PSYCHOL	Rehabil. Psychol.	MAY	2015	60	2					147	154		10.1037/rep0000037			8	Psychology, Clinical; Rehabilitation	Psychology; Rehabilitation	CL5CG	WOS:000356976800006	25822180				2021-06-18	
J	Xydakis, MS; Mulligan, LP; Smith, AB; Olsen, CH; Lyon, DM; Belluscio, L				Xydakis, Michael S.; Mulligan, Lisa P.; Smith, Alice B.; Olsen, Cara H.; Lyon, Dina M.; Belluscio, Leonardo			Olfactory impairment and traumatic brain injury in blast-injured combat troops A cohort study	NEUROLOGY			English	Article							HEAD-INJURY; DYSFUNCTION; DEFICITS; MILD; TOMOGRAPHY; DEMENTIA; ANOSMIA; IMPACT; DAMAGE	Objective: To determine whether a structured and quantitative assessment of differential olfactory performance-recognized between a blast-injured traumatic brain injury (TBI) group and a demographically comparable blast-injured control group-can serve as a reliable antecedent marker for preclinical detection of intracranial neurotrauma. Methods: We prospectively and consecutively enrolled 231 polytrauma inpatients, acutely injured from explosions during combat operations in either Afghanistan or Iraq and requiring immediate stateside evacuation and sequential admission to our tertiary care medical center over a 21/2-year period. This study correlates olfactometric scores with both contemporaneous neuroimaging findings as well as the clinical diagnosis of TBI, tabulates population-specific incidence data, and investigates return of olfactory function. Results: Olfactometric score predicted abnormal neuroimaging significantly better than chance alone (area under the curve = 0.78, 95% confidence interval [CI] 0.70-0.87). Normosmia was present in all troops with mild TBI (i. e., concussion) and all control subjects. Troops with radiographic evidence of frontal lobe injuries were 3 times more likely to have olfactory impairment than troops with injuries to other brain regions (relative risk 3.0, 95% CI 0.98-9.14). Normalization of scores occurred in all anosmic troops available for follow-up testing. Conclusion: Quantitative identification olfactometry has limited sensitivity but high specificity as a marker for detecting acute structural neuropathology from trauma. When considering whether to order advanced neuroimaging, a functional disturbance with central olfactory impairment should be regarded as an important tool to inform the decision process. Classification of evidence: This study provides Class III evidence that central olfactory dysfunction identifies patients with TBI who have intracranial radiographic abnormalities with a sensitivity of 35% (95% CI 20.6%-51.7%) and specificity of 100% (95% CI 97.7%-100.0%).	[Xydakis, Michael S.] Walter Reed Natl Mil Med Ctr, Otorhinolaryngol Head & Neck Surg, Bethesda, MD 20889 USA; [Mulligan, Lisa P.] Walter Reed Natl Mil Med Ctr, Neurosurg, Bethesda, MD USA; [Smith, Alice B.] Walter Reed Natl Mil Med Ctr, Neuroradiol, Bethesda, MD USA; [Xydakis, Michael S.; Mulligan, Lisa P.; Lyon, Dina M.] Uniformed Serv Univ Hlth Sci, Traumat Brain Injury Surg Res Program, Bethesda, MD 20814 USA; [Xydakis, Michael S.] Uniformed Serv Univ Hlth Sci, Otorhinolaryngol Head & Neck Surg, Bethesda, MD 20814 USA; [Mulligan, Lisa P.] Uniformed Serv Univ Hlth Sci, Neurosurg, Bethesda, MD 20814 USA; [Smith, Alice B.] Uniformed Serv Univ Hlth Sci, Neuroradiol, Bethesda, MD 20814 USA; [Olsen, Cara H.] Uniformed Serv Univ Hlth Sci, Prevent Med & Biostat, Bethesda, MD 20814 USA; [Xydakis, Michael S.; Mulligan, Lisa P.; Smith, Alice B.; Lyon, Dina M.] Uniformed Serv Univ Hlth Sci, Bethesda, MD 20814 USA; [Belluscio, Leonardo] NIH, Neurol Disorders & Stroke, Bethesda, MD 20892 USA	Xydakis, MS (corresponding author), Walter Reed Natl Mil Med Ctr, Otorhinolaryngol Head & Neck Surg, Bethesda, MD 20889 USA.	michael.xydakis@usuhs.edu			US Department of Defense Combat Casualty Care Medical Research and Development Program [DMRDP: ID-D10-I-AR-J6-626]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [ZIANS003116] Funding Source: NIH RePORTER	US Department of Defense Combat Casualty Care Medical Research and Development Program (DMRDP: ID-D10-I-AR-J6-626).	ADAMS JH, 1980, J CLIN PATHOL, V33, P1132, DOI 10.1136/jcp.33.12.1132; Berendse HW, 2001, ANN NEUROL, V50, P34, DOI 10.1002/ana.1049; Callahan CD, 2002, J HEAD TRAUMA REHAB, V17, P251, DOI 10.1097/00001199-200206000-00006; Carney N, 2014, NEUROSURGERY, V75, pS3, DOI 10.1227/NEU.0000000000000433; Charland-Verville V, 2012, AM J RHINOL ALLERGY, V26, P222, DOI 10.2500/ajra.2012.26.3769; de Kruijk JR, 2003, BRAIN INJURY, V17, P73, DOI 10.1080/0269905021000010221; Defense and Veterans Brain Injury Center, 2013, VA DOD CLIN PRACT GU; Department of Defense, 2012, DOD POL GUID MAN MIL; Devanand DP, 2015, NEUROLOGY, V84, P182, DOI 10.1212/WNL.0000000000001132; Doty RL, 1995, CHEM SENSES, V20, P645, DOI 10.1093/chemse/20.6.645; Coello AF, 2010, J NEUROSURG, V113, P547, DOI 10.3171/2010.6.JNS091620; Fortin A, 2010, BRAIN INJURY, V24, P27, DOI 10.3109/02699050903446815; Green P, 2003, BRAIN INJURY, V17, P479, DOI 10.1080/0269905031000070242; Gudziol V, 2014, EUR ARCH OTO-RHINO-L, V271, P1533, DOI 10.1007/s00405-013-2687-6; Haxel BR, 2008, J HEAD TRAUMA REHAB, V23, P407, DOI 10.1097/01.HTR.0000341437.59627.ec; Haydel MJ, 2000, NEW ENGL J MED, V343, P100, DOI 10.1056/NEJM200007133430204; Heyanka DJ, 2014, APPL NEUROPSYCH-ADUL, V21, P176, DOI 10.1080/09084282.2013.782031; JAFEK BW, 1989, ARCH NEUROL-CHICAGO, V46, P300, DOI 10.1001/archneur.1989.00520390066018; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Kern RC, 2000, LARYNGOSCOPE, V110, P2106, DOI 10.1097/00005537-200012000-00025; LEVIN HS, 1985, BRAIN, V108, P579, DOI 10.1093/brain/108.3.579; LEVIN HS, 1987, J NEUROSURG, V66, P706, DOI 10.3171/jns.1987.66.5.0706; Maruta J, 2014, MIL MED, V179, P619, DOI 10.7205/MILMED-D-13-00420; McAllister Thomas W, 2011, Dialogues Clin Neurosci, V13, P287; Murphy C, 2002, JAMA-J AM MED ASSOC, V288, P2307, DOI 10.1001/jama.288.18.2307; POTTER H, 1980, NEUROPSYCHOLOGIA, V18, P621, DOI 10.1016/0028-3932(80)90101-3; Riechers RG, 2005, J NEUROTRAUM, V22, P1327, DOI 10.1089/neu.2005.22.1327; Riemann BL, 2000, J ATHL TRAINING, V35, P19; Rolet A, 2013, EUR NEUROL, V69, P166, DOI 10.1159/000345482; Ruff RL, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2011-000312; Sandford AA, 2006, INT J PEDIATR OTORHI, V70, P1015, DOI 10.1016/j.ijporl.2005.10.013; Schofield PW, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00005; Stiell IG, 2001, LANCET, V357, P1391, DOI 10.1016/S0140-6736(00)04561-X; Teasdale G, 2014, LANCET NEUROL, V13, P844, DOI 10.1016/S1474-4422(14)70120-6; USAISR, JOINT TRAUM SYST PRA; Vent J, 2010, BRAIN RES, V1320, P1, DOI 10.1016/j.brainres.2010.01.007; Wilson DA, 2003, TRENDS NEUROSCI, V26, P243, DOI 10.1016/S0166-2236(03)00076-6; Xydakis MS, 2007, NEW ENGL J MED, V357, P830, DOI 10.1056/NEJMc076071; Xydakis MS, 2013, ANN NEUROL, V74, P152, DOI 10.1002/ana.23895; Xydakis MS, 2012, ANN NEUROL, V72, P673, DOI 10.1002/ana.23757	40	22	23	0	14	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0028-3878	1526-632X		NEUROLOGY	Neurology	APR 14	2015	84	15					1559	1567		10.1212/WNL.0000000000001475			9	Clinical Neurology	Neurosciences & Neurology	CG1OH	WOS:000353042100012	25788559	Other Gold, Green Published			2021-06-18	
J	Cristofori, I; Zhong, WT; Chau, A; Solomon, J; Krueger, F; Grafman, J				Cristofori, Irene; Zhong, Wanting; Chau, Aileen; Solomon, Jeffrey; Krueger, Frank; Grafman, Jordan			White and gray matter contributions to executive function recovery after traumatic brain injury	NEUROLOGY			English	Article							POST-ACUTE REHABILITATION; PENETRATING HEAD-INJURY; NEUROTROPHIC FACTOR; COGNITIVE RESERVE; APHASIA; ADULTS; TRACTOGRAPHY; PREDICTORS; ASYMMETRY; ATTENTION	Objective: We investigated the association between regional white and gray matter volume loss and performance on executive functions (EFs) in patients with penetrating traumatic brain injury (pTBI). Methods: We studied 164 pTBI patients and 43 healthy controls from the Vietnam Head Injury Study. We acquired CT scans for pTBI patients and divided them according to lesion localization (left and right prefrontal cortex [PFC]). We administered EF tests (Verbal Fluency, Trail Making, Twenty Questions) and used voxel-based lesion symptom mapping (VLSM) and group-based correlational and multiple regression analyses to examine the relative influence of gray and white matter lesions on EF recovery. Results: The VLSM analysis revealed that white and gray white matter lesions were associated with impaired EFs. In the left PFC lesion group, damage to the PFC gray matter, anterior corona radiata, and superior longitudinal fasciculus (SLF) were most correlated with functional recovery. Verbal Fluency, which involves a broad fronto-temporo-parietal network, was best predicted by SLF lesion volume. Trail Making and Twenty Questions, which is associated with more focal left frontal damage, was better predicted by PFC lesions. Conclusions: Our results indicated that whitematter volume loss can be a superior predictor of recovery and a crucial factor driving clinical outcome in functions involving a broad network such as Verbal Fluency. White matter damage may place additional burden on recovery by deteriorating signal transmission between cortical areas within a functional network.	[Cristofori, Irene; Zhong, Wanting; Chau, Aileen; Grafman, Jordan] Rehabil Inst Chicago, Brain Injury Res, Cognit Neurosci Lab, Chicago, IL USA; [Cristofori, Irene; Zhong, Wanting; Grafman, Jordan] Northwestern Univ, Dept Phys Med & Rehabil, Evanston, IL 60208 USA; [Solomon, Jeffrey] Expert Image Anal LLC, Potomac, MD USA; George Mason Univ, Mol Neurosci Dept, Fairfax, VA 22030 USA; George Mason Univ, Dept Psychol, Fairfax, VA 22030 USA	Cristofori, I (corresponding author), Rehabil Inst Chicago, Brain Injury Res, Cognit Neurosci Lab, Chicago, IL USA.	irene.cristofori@northwestern.edu		Cristofori, Irene/0000-0003-2339-1457; Zhong, Wanting/0000-0002-6025-1739	National Naval Medical Center; National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)	The authors thank the Vietnam veterans for their participation in the study; A. Salazar, V. Raymont, S. Bonifant, B. Cheon, C. Ngo, A. Greathouse, K. Reding, and G. Tasick for testing and evaluating participants; and the National Naval Medical Center and the National Institute of Neurological Disorders and Stroke for providing their facilities and supporting the research.	Almairac F., 2014, BRAIN STRUCT FUNCT; Barbey AK, 2012, BRAIN, V135, P1154, DOI 10.1093/brain/aws021; Bath KG, 2006, COGN AFFECT BEHAV NE, V6, P79, DOI 10.3758/CABN.6.1.79; Bernal B, 2009, BRAIN, V132, P2309, DOI 10.1093/brain/awp206; Binder DK, 2004, GROWTH FACTORS, V22, P123, DOI 10.1080/08977190410001723308; BROOKS DN, 1986, J NEUROL NEUROSUR PS, V49, P549, DOI 10.1136/jnnp.49.5.549; CDC, 2006, INJ FACT BOOK; Constantinidou F, 2008, J HEAD TRAUMA REHAB, V23, P312, DOI 10.1097/01.HTR.0000336844.99079.2c; Delis D.C., 2001, DELIS KAPLAN EXECUTI; Draper K, 2008, NEUROPSYCHOLOGY, V22, P618, DOI 10.1037/0894-4105.22.5.618; Elliott R, 2003, BRIT MED BULL, V65, P49, DOI 10.1093/bmb/65.1.49; Forkel SJ, 2014, BRAIN, V137, P2027, DOI 10.1093/brain/awu113; JACOBS HE, 1988, ARCH PHYS MED REHAB, V69, P425; Koenigs M, 2009, J NEUROSCI, V29, P14980, DOI 10.1523/JNEUROSCI.3706-09.2009; Krueger F, 2011, J NEUROSCI, V31, P598, DOI 10.1523/JNEUROSCI.1399-10.2011; Levack WMM, 2009, BRAIN INJURY, V23, P192, DOI 10.1080/02699050802695582; LEVIN H, 1994, J NEUROPSYCH CLIN N, V6, P443; Levin H. S., 1991, FRONTAL LOBE FUNCTIO; LUDLOW CL, 1986, BRAIN, V109, P55, DOI 10.1093/brain/109.1.55; Makris N, 2005, CEREB CORTEX, V15, P854, DOI 10.1093/cercor/bhh186; McAllister TW, 2010, PM&R, V2, pS241, DOI 10.1016/j.pmrj.2010.10.005; Miller EK, 2000, NAT REV NEUROSCI, V1, P59, DOI 10.1038/35036228; Mori S, 2008, NEUROIMAGE, V40, P570, DOI 10.1016/j.neuroimage.2007.12.035; Petrides M, 2002, PRINCIPLES FRONTAL L, V1, P31, DOI DOI 10.1093/ACPROF:OSO/9780195134971.003.0003; Raymont V, 2008, BRAIN, V131, P543, DOI 10.1093/brain/awm300; Raymont V, 2006, PROG BRAIN RES, V157, P199, DOI 10.1016/S0079-6123(06)57013-X; Rudrauf D, 2008, CORTEX, V44, P1084, DOI 10.1016/j.cortex.2008.05.005; Sander AM, 2002, BRAIN INJURY, V16, P649, DOI 10.1080/02699050210128889; Stern Y, 2009, NEUROPSYCHOLOGIA, V47, P2015, DOI 10.1016/j.neuropsychologia.2009.03.004; Stuss D.T., 1986, FRONTAL LOBES; Thiebaut de Schotten M, 2011, NAT NEUROSCI, V14, P1245, DOI 10.1038/nn.2905; Thiebaut de Schotten M, 2011, NEUROIMAGE, V54, P49, DOI 10.1016/j.neuroimage.2010.07.055; Tost H, 2013, NEUROPSYCHOPHARMACOL, V38, P525, DOI 10.1038/npp.2012.214; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Weaver SM, 2014, BRAIN IMAGING BEHAV, V8, P420, DOI 10.1007/s11682-012-9197-9; Whalley LJ, 2004, AGEING RES REV, V3, P369, DOI 10.1016/j.arr.2004.05.001; Whitnall L, 2006, J NEUROL NEUROSUR PS, V77, P640, DOI 10.1136/jnnp.2005.078246; Wilson BA, 2005, BRAIN INJURY, V19, P891, DOI 10.1080/02699050400002363; Yin XT, 2013, HUM BRAIN MAPP, V34, P796, DOI 10.1002/hbm.21477; Ziegler E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069290	40	22	22	0	19	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0028-3878	1526-632X		NEUROLOGY	Neurology	APR 7	2015	84	14					1394	1401		10.1212/WNL.0000000000001446			8	Clinical Neurology	Neurosciences & Neurology	CF4BP	WOS:000352493700006	25746558	Green Published			2021-06-18	
J	Chen, YR; Tymofiyeva, O; Hess, CP; Xu, D				Chen, Yiran; Tymofiyeva, Olga; Hess, Christopher P.; Xu, Duan			Effects of rejecting diffusion directions on tensor-derived parameters	NEUROIMAGE			English	Article						MRI; Brain; DTI; Anisotropy; Motion	TRAUMATIC BRAIN-INJURY; WEIGHTED MRI; FRACTIONAL ANISOTROPY; THEORETICAL-ANALYSIS; FIBER ORIENTATION; ROBUST ESTIMATION; MEAN DIFFUSIVITY; SCHEMES; SPECTROSCOPY; ARCHITECTURE	Diffusion Tensor Imaging (DTI) is adversely affected by subject motion. It is necessary to discard the corrupted images before diffusion parameter estimation. However, the consequences of rejecting those images are not well understood. In this study, we investigated the effects of excluding one or more volumes of diffusion weighted images by analyzing the changes in fractional anisotropy (FA), mean diffusivity (MD), axial diffusivity (AD), radial diffusivity (RD) and the primary eigenvector (V1). Based on the full set of diffusion images acquired by the Jones30 diffusion scheme, we generated incomplete sets of at least six in three different ways: random, uniform and clustered rejections. The results showed that MD was not significantly affected by rejecting diffusion directions. In the cases of random rejections, FA, AD, RD and V1 were overestimated more greatly with increasing number of rejections and the overestimations were worse in low FA regions than high FA regions. For uniform rejections, at which the remaining diffusion directions are evenly distributed on a sphere, little change was observed in FA and in V1. Clustered rejections, on the other hand, displayed the most significant overestimation of the parameters, and the resulting accuracy depended on the relative orientation of the underlying fibers with respect to the excluded directions. In practice, if diffusion direction data is excluded, it is important to note the number and location of directions rejected, in order to make a more precise analysis of the data. (C) 2015 Elsevier Inc. All rights reserved.	[Chen, Yiran; Tymofiyeva, Olga; Hess, Christopher P.; Xu, Duan] Univ Calif San Francisco, Dept Radiol & Biomed Imaging, San Francisco, CA 94143 USA	Xu, D (corresponding author), 1700 4th St,BH102,UCSF Box 2512, San Francisco, CA 94143 USA.	Duan.Xu@ucsf.edu		Xu, Duan/0000-0003-0550-4235	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01EB009756, R01HD072074, P01NS082330]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD072074] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB) [R01EB009756] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P01NS082330] Funding Source: NIH RePORTER	This study is supported by NIH R01EB009756, R01HD072074 and P01NS082330.	Assaf Y, 2008, J MOL NEUROSCI, V34, P51, DOI 10.1007/s12031-007-0029-0; Barkovich AJ, 2001, AM J NEURORADIOL, V22, P1786; Basser PJ, 2000, MAGNET RESON MED, V44, P625, DOI 10.1002/1522-2594(200010)44:4<625::AID-MRM17>3.0.CO;2-O; BASSER PJ, 1994, BIOPHYS J, V66, P259, DOI 10.1016/S0006-3495(94)80775-1; Batchelor PG, 2003, MAGN RESON MED, V49, P1143, DOI 10.1002/mrm.10491; Chang LC, 2005, MAGN RESON MED, V53, P1088, DOI 10.1002/mrm.20426; Counsell SJ, 2003, PEDIATRICS, V112, P1, DOI 10.1542/peds.112.1.1; Dietrich O, 2000, NEURORADIOLOGY, V42, P85, DOI 10.1007/s002340050020; Frank LR, 2002, MAGN RESON MED, V47, P1083, DOI 10.1002/mrm.10156; Hasan KM, 2007, MAGN RESON IMAGING, V25, P1196, DOI 10.1016/j.mri.2007.02.011; Hasan KM, 2003, MAGNET RESON MED, V50, P589, DOI 10.1002/mrm.10552; Hasan KM, 2001, J MAGN RESON IMAGING, V13, P769, DOI 10.1002/jmri.1107; Hess CP, 2006, MAGN RESON MED, V56, P104, DOI 10.1002/mrm.20931; Jiang SZ, 2009, MAGN RESON MED, V62, P645, DOI 10.1002/mrm.22032; Jones DK, 2003, MAGN RESON MED, V49, P7, DOI 10.1002/mrm.10331; Jones DK, 1999, MAGNET RESON MED, V42, P515, DOI 10.1002/(SICI)1522-2594(199909)42:3<515::AID-MRM14>3.3.CO;2-H; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Landman BA, 2007, NEUROIMAGE, V36, P1123, DOI 10.1016/j.neuroimage.2007.02.056; Lipton ML, 2008, J NEUROTRAUM, V25, P1335, DOI 10.1089/neu.2008.0547; Liu CL, 2004, MAGN RESON MED, V51, P924, DOI 10.1002/mrm.20071; Lu S, 2003, AM J NEURORADIOL, V24, P937; Mori S, 2002, NMR BIOMED, V15, P468, DOI 10.1002/nbm.781; ORDIDGE RJ, 1994, MAGN RESON IMAGING, V12, P455, DOI 10.1016/0730-725X(94)92539-9; Papadakis NG, 2000, MAGN RESON IMAGING, V18, P671, DOI 10.1016/S0730-725X(00)00151-X; Rose SE, 2000, J NEUROL NEUROSUR PS, V69, P528, DOI 10.1136/jnnp.69.4.528; Skare S, 2001, MAGN RESON IMAGING, V19, P1125, DOI 10.1016/S0730-725X(01)00415-5; Skare S, 2000, J MAGN RESON, V147, P340, DOI 10.1006/jmre.2000.2209; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Tournier JD, 2004, NEUROIMAGE, V23, P1176, DOI 10.1016/j.neuroimage.2004.07.037; Tuch DS, 2005, PHILOS T R SOC B, V360, P869, DOI 10.1098/rstb.2005.1651; Tuch DS, 2004, MAGN RESON MED, V52, P1358, DOI 10.1002/mrm.20279; Tymofiyeva O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063310; Wedeen VJ, 2005, MAGN RESON MED, V54, P1377, DOI 10.1002/mrm.20642	33	22	23	0	10	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1053-8119	1095-9572		NEUROIMAGE	Neuroimage	APR 1	2015	109						160	170		10.1016/j.neuroimage.2015.01.010			11	Neurosciences; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	CB9SB	WOS:000349971600016	25585018	Green Accepted			2021-06-18	
J	Kelly, ML; Banerjee, A; Nowak, M; Steinmetz, M; Claridge, JA				Kelly, Michael L.; Banerjee, Aman; Nowak, Michael; Steinmetz, Michael; Claridge, Jeffrey A.			Decreased mortality in traumatic brain injury following regionalization across hospital systems	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article; Proceedings Paper	73rd Annual Meeting of the American-Association-for-the-Surgery-of-Trauma / Clinical Congress of Acute Care Surgery	SEP 09-13, 2014	Philadelphia, PA	Amer Assoc Surg Trauma		Traumatic brain injury; regionalization; health systems; outcomes; mortality	UNITED-STATES; HEAD-INJURY; LEVEL I; CARE; OUTCOMES; ADMISSION; TRENDS; IMPACT	BACKGROUND: The Northern Ohio Trauma System (NOTS) was established to improve outcomes of trauma patients across the region. We hypothesized that mortality in patients with traumatic brain injury (TBI) would improve after regionalization. METHODS: All patients older than 14 years with a TBI were identified from NOTS, a regional trauma system consisting of two large health care systems and regional emergency medical services providers. Data from 2008 through 2012 were analyzed before and after NOTS formation in 2010. Multivariate logistic regression analysis was performed to evaluate independent predictors of survival. RESULTS: A total of 11,220 patients were identified with TBI in the NOTS database, 4,507 (40%) before NOTS and 6,713 (60%) after NOTS formation. Admissions to the regional Level 1 center post-NOTS formation increased from 36% to 46% (p < 0.0001). Injury Severity Scores (ISSs) and Abbreviated Injury Scale (AIS) scores were similar between periods. The mortality rate decreased from 6.2% to 4.9% (p = 0.005) among all TBIs and from 19% to 14% (p < 0.0001) in TBIs with a head AIS score of 3 or greater (n = 3,538). Craniotomy procedures increased from 1.8% to 2.7% (p = 0.003) overall and from 5.9% to 8.1% (p = 0.02) in TBIs with head AIS score of 3 or greater. Logistic regression analysis demonstrated an independent effect on survival for post-NOTS period in all patients (odds ratio, 0.76; 95% confidence interval, 0.62-0.94; C statistic = 0.96) and in TBIs with head AIS score of 3 or greater (odds ratio, 0.72; 95% confidence interval, 0.58-0.89; C statistic = 0.86). CONCLUSION: Regionalization of trauma care across hospital systems is associated with a reduced mortality rate for patients with TBI, particularly for patients with a head AIS score of 3 or greater. Mortality decreased by 24% for all TBIs and by 28% for severe TBIs. These findings support regionalization of trauma care with collaboration and consolidation of care across health care systems. Copyright (C) 2015 Wolters Kluwer Health, Inc. All rights reserved.	[Kelly, Michael L.] Cleveland Clin, Dept Neurosurg, Neurol Inst, Cleveland, OH 44106 USA; [Steinmetz, Michael] Case Western Reserve Univ, Sch Med, Dept Neurosurg, Cleveland, OH 44109 USA; [Banerjee, Aman; Nowak, Michael; Claridge, Jeffrey A.] Case Western Reserve Univ, Sch Med, Metrohlth Med Ctr, Cleveland, OH 44109 USA; [Banerjee, Aman; Nowak, Michael; Claridge, Jeffrey A.] Case Western Reserve Univ, Sch Med, Northern Ohio Trauma Syst, Cleveland, OH 44109 USA; [Banerjee, Aman; Nowak, Michael; Claridge, Jeffrey A.] Case Western Reserve Univ, Sch Med, Dept Surg, Cleveland, OH 44109 USA	Claridge, JA (corresponding author), Case Western Reserve Univ, Sch Med, Metrohlth Med Ctr, Northern Ohio Trauma Syst,Dept Surg, Cleveland, OH 44109 USA.	jclaridge@metrohealth.org					[Anonymous], 2010, OH TRAUM REG ANN DAT; Bailey J, 2012, SURG CLIN N AM, V92, P1009, DOI 10.1016/j.suc.2012.04.008; Claridge JA, 2013, SURGERY, V154, P875, DOI 10.1016/j.surg.2013.07.013; Farhad K, 2013, J NEUROTRAUM, V30, P84, DOI 10.1089/neu.2011.2283; Gabbe BJ, 2012, ANN SURG, V255, P1009, DOI 10.1097/SLA.0b013e31824c4b91; Gabbe BJ, 2011, ANN SURG, V253, P138, DOI 10.1097/SLA.0b013e3181f6685b; Maas AIR, 2013, LANCET NEUROL, V12, P1200, DOI 10.1016/S1474-4422(13)70234-5; Moore L, 2010, WORLD J SURG, V34, P2069, DOI 10.1007/s00268-010-0588-z; MULLINS RJ, 1994, JAMA-J AM MED ASSOC, V271, P1919, DOI 10.1001/jama.271.24.1919; Narayan RK, 2002, J NEUROTRAUM, V19, P503, DOI 10.1089/089771502753754037; Patel HC, 2005, LANCET, V366, P1538, DOI 10.1016/S0140-6736(05)67626-X; Rivara FP, 2008, J TRAUMA, V64, P1594, DOI 10.1097/TA.0b013e3181493099; STONE JL, 1986, J TRAUMA, V26, P445, DOI 10.1097/00005373-198605000-00006; Sugerman DE, 2012, J TRAUMA ACUTE CARE, V73, P1491, DOI 10.1097/TA.0b013e3182782675; Tiesman H, 2007, J NEUROTRAUM, V24, P1189, DOI 10.1089/neu.2006.0196; TRUNKEY D, 1995, JAMA-J AM MED ASSOC, V273, P421, DOI 10.1001/jama.273.5.421; Twijnstra MJ, 2010, ANN SURG, V251, P339, DOI 10.1097/SLA.0b013e3181c0e910	17	22	22	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2163-0755	2163-0763		J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	APR	2015	78	4					715	720		10.1097/TA.0000000000000590			6	Critical Care Medicine; Surgery	General & Internal Medicine; Surgery	CE8EJ	WOS:000352074000009	25807401				2021-06-18	
J	Major, BP; Rogers, MA; Pearce, AJ				Major, Brendan P.; Rogers, Mark A.; Pearce, Alan J.			Using transcranial magnetic stimulation to quantify electrophysiological changes following concussive brain injury: A systematic review	CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY			English	Article						concussion; evoked potential; mild traumatic brain injury; systematic review; transcranial magnetic stimulation	SPORT-RELATED CONCUSSION; HUMAN MOTOR CORTEX; CHRONIC TRAUMATIC ENCEPHALOPATHY; IMPAIRED CORTICAL INHIBITION; SILENT PERIOD; HEAD-INJURY; LONG-TERM; INTRACORTICAL INHIBITION; FOOTBALL CODES; EXCITABILITY	Mild traumatic brain injury (mTBI) and sports concussion are a growing public health concern, with increasing demands for more rigorous methods to quantify changes in the brain post-injury. Electrophysiology, and in particular, transcranial magnetic stimulation (TMS), have been demonstrated to provide prognostic value in a range of neurological conditions; however, no review has quantified the efficacy of TMS in mTBI/concussion. In the present study, we present a systematic review and critical evaluation of the scientific literature from 1990 to 2014 that has used TMS to investigate corticomotor excitability responses at short-term (<12months), medium-term (1-5years), and long-term (>5years) post-mTBI/concussion. Thirteen studies met the selection criteria, with six studies presenting short-term changes, five studies presenting medium-term changes, and two studies presenting long-term changes. Irrespective of time post-concussion, change in intracortical inhibition was the most reported observation. Other findings included increased stimulation threshold, and slowed neurological conduction time. Although currently limited, the data suggest that TMS has prognostic value in detecting neurophysiological changes post-mTBI/concussion.	[Major, Brendan P.; Rogers, Mark A.; Pearce, Alan J.] Deakin Univ, Sch Psychol, Melbourne, Vic, Australia	Pearce, AJ (corresponding author), Deakin Univ, Sch Psychol, 221 Burwood Highway, Burwood, Vic 3125, Australia.	alan.pearce@deakin.edu.au	Pearce, Alan J/W-1195-2018	Pearce, Alan J/0000-0002-9264-9880; Rogers, Mark/0000-0002-6808-9545; Major, Brendan/0000-0003-0991-5656			Alwis DS, 2013, CLIN EXP PHARMACOL P, V40, P473, DOI 10.1111/1440-1681.12100; Assocation AMO, 2011, MAN CONC AUSTR FOOTB; Bajbouj M, 2006, BIOL PSYCHIAT, V59, P395, DOI 10.1016/j.biopsych.2005.07.036; Benwell NM, 2007, EXP BRAIN RES, V179, P255, DOI 10.1007/s00221-006-0790-2; Birbaumer N, 2008, CURR OPIN NEUROL, V21, P634, DOI 10.1097/WCO.0b013e328315ee2d; BRASILNETO JP, 1995, ACTA NEUROL SCAND, V92, P383; Chen R, 2000, MUSCLE NERVE, pS26; Chen R, 2008, CLIN NEUROPHYSIOL, V119, P504, DOI 10.1016/j.clinph.2007.10.014; Chipchase L, 2012, CLIN NEUROPHYSIOL, V123, P1698, DOI 10.1016/j.clinph.2012.05.003; Chistyakov AV, 2001, J NEUROL NEUROSUR PS, V70, P580, DOI 10.1136/jnnp.70.5.580; Chistyakov AV, 1999, CLIN NEUROPHYSIOL, V110, P1080, DOI 10.1016/S1388-2457(99)00029-2; Collie A, 2001, BRIT J SPORT MED, V35, P297, DOI 10.1136/bjsm.35.5.297; Corp DT, 2014, NEUROSCI BIOBEHAV R, V43, P74, DOI 10.1016/j.neubiorev.2014.03.017; Daneshvar DH, 2011, PHYS MED REH CLIN N, V22, P683, DOI 10.1016/j.pmr.2011.08.009; Darling SR, 2014, CLIN J SPORT MED, V24, P128, DOI 10.1097/JSM.0000000000000026; Daskalakis ZJ, 2002, ARCH GEN PSYCHIAT, V59, P347, DOI 10.1001/archpsyc.59.4.347; Davis GA, 2009, BRIT J SPORT MED, V43, pI36, DOI 10.1136/bjsm.2009.058123; De Beaumont L, 2007, NEUROSURGERY, V61, P329, DOI 10.1227/01.NEU.0000280000.03578.B6; De Beaumont L, 2011, J ATHL TRAINING, V46, P234; De Beaumont L, 2009, BRAIN, V132, P695, DOI 10.1093/brain/awn347; Dimou S, 2014, J NEUROTRAUM, V31, P413, DOI 10.1089/neu.2013.3050; Eldaief Mark C, 2013, Neurol Clin Pract, V3, P519; Gilbert F, 2012, MED J AUSTRALIA, V196, P561, DOI 10.5694/mja11.11218; Giza CC, 2001, J ATHL TRAINING, V36, P228; Grindel SH, 2001, CLIN J SPORT MED, V11, P134, DOI 10.1097/00042752-200107000-00003; Hallett M, 2000, NATURE, V406, P147, DOI 10.1038/35018000; INGHILLERI M, 1993, J PHYSIOL-LONDON, V466, P521; Iverson GL, 2004, BRAIN INJURY, V18, P433, DOI 10.1080/02699050310001617352; Jordan BD, 2013, NAT REV NEUROL, V9, P222, DOI 10.1038/nrneurol.2013.33; Kelly JP, 1997, NEUROLOGY, V48, P575, DOI 10.1212/WNL.48.3.575; Killane I, 2013, ENG MED BIOL SOC EMB; Kobayashi M, 2003, LANCET NEUROL, V2, P145, DOI 10.1016/S1474-4422(03)00321-1; KUJIRAI T, 1993, J PHYSIOL-LONDON, V471, P501, DOI 10.1113/jphysiol.1993.sp019912; Kutcher JS, 2013, BRIT J SPORT MED, V47, P299, DOI 10.1136/bjsports-2013-092257; Livingston SC, 2012, J CLIN NEUROPHYSIOL, V29, P23, DOI 10.1097/WNP.0b013e318246ae46; Livingston SC, 2010, BRAIN INJURY, V24, P904, DOI 10.3109/02699051003789245; McCrory P, 2005, BRIT J SPORT MED, V39, pI78, DOI 10.1136/bjsm.2005.018614; McDonnell MN, 2007, EXP BRAIN RES, V180, P181, DOI 10.1007/s00221-006-0849-0; McGinley M, 2010, EXP GERONTOL, V45, P671, DOI 10.1016/j.exger.2010.04.005; McKee AC, 2014, ACTA NEUROPATHOL, V127, P29, DOI 10.1007/s00401-013-1230-6; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Mez J, 2013, CURR NEUROL NEUROSCI, V13, DOI 10.1007/s11910-013-0407-7; Miller NR, 2014, BRAIN INJURY, P1; Moher D, 2009, PHYS THER, V89, P873, DOI 10.1093/ptj/89.9.873; Muller-Dahlhaus JFM, 2008, J PHYSIOL-LONDON, V586, P495, DOI 10.1113/jphysiol.2007.142059; Partridge B, 2014, NEUROETHICS-NETH, V7, P63, DOI 10.1007/s12152-013-9182-z; Pearce A. J., 2011, CLIN EXERCISE REHABI, P68; Pearce AJ, 2015, J SCI MED SPORT, V18, P500, DOI 10.1016/j.jsams.2014.07.010; Pearce AJ, 2014, J NEUROTRAUM, V31, P1139, DOI 10.1089/neu.2013.3219; Pearce AJ, 2012, J SCI MED SPORT, V15, P164, DOI 10.1016/j.jsams.2011.09.001; Philpott AL, 2013, NEUROSCI BIOBEHAV R, V37, P1420, DOI 10.1016/j.neubiorev.2013.05.009; Powers KC, 2014, BRAIN INJURY, V28, P465, DOI 10.3109/02699052.2014.888759; Rabadi MH, 2001, CLIN J SPORT MED, V11, P194, DOI 10.1097/00042752-200107000-00011; Ropper AH, 2007, NEW ENGL J MED, V356, P166, DOI 10.1056/NEJMcp064645; Siebner HR, 1998, MUSCLE NERVE, V21, P1209, DOI 10.1002/(SICI)1097-4598(199809)21:9<1209::AID-MUS15>3.3.CO;2-O; SLAVIN RE, 1995, J CLIN EPIDEMIOL, V48, P9, DOI 10.1016/0895-4356(94)00097-A; Tallus J, 2012, ACTA NEUROL SCAND, V126, P178, DOI 10.1111/j.1600-0404.2011.01623.x; Tallus J, 2013, J NEUROTRAUM, V30, P1270, DOI 10.1089/neu.2012.2760; Tremblay S, 2014, CLIN NEUROPHYSIOL, V125, P1371, DOI 10.1016/j.clinph.2013.11.040; Tremblay S, 2011, J NEUROTRAUM, V28, P493, DOI 10.1089/neu.2010.1615; Vucic S, 2013, J NEUROL NEUROSUR PS, V84, P1161, DOI 10.1136/jnnp-2012-304019; Werhahn KJ, 1999, J PHYSIOL-LONDON, V517, P591, DOI 10.1111/j.1469-7793.1999.0591t.x; WILSON SA, 1993, J NEUROL SCI, V114, P216, DOI 10.1016/0022-510X(93)90301-E; World Health Organization, 2006, NEUR DIS PUBL HLTH C; Ziemann U, 1998, NEUROLOGY, V51, P1320, DOI 10.1212/WNL.51.5.1320; Ziemann U, 1996, ANN NEUROL, V40, P367, DOI 10.1002/ana.410400306; Ziemann U., 2008, OXFORD HDB TRANSCRAN, P91; Ziemann U., 2008, OXFORD HDB TRANSCRAN, P135	69	22	23	1	20	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1440-1681			CLIN EXP PHARMACOL P	Clin. Exp. Pharmacol. Physiol.	APR	2015	42	4					394	405		10.1111/1440-1681.12363			12	Pharmacology & Pharmacy; Physiology	Pharmacology & Pharmacy; Physiology	CE4WY	WOS:000351832200011	25603731				2021-06-18	
J	Ramos-Alvarez, I; Mantey, SA; Nakamura, T; Nuche-Berenguer, B; Moreno, P; Moody, TW; Maderdrut, JL; Coy, DH; Jensen, RT				Ramos-Alvarez, Irene; Mantey, Samuel A.; Nakamura, Taichi; Nuche-Berenguer, Bernardo; Moreno, Paola; Moody, Terry W.; Maderdrut, Jerome L.; Coy, David H.; Jensen, Robert T.			A structure-function study of PACAP using conformationally restricted analogs: Identification of PAC1 receptor-selective PACAP agonists	PEPTIDES			English	Article						PACAP; Vasoactive intestinal peptide; Neuroprotection; Stroke; Traumatic brain injury; Structure-function study	CYCLASE-ACTIVATING POLYPEPTIDE; VASOACTIVE-INTESTINAL-PEPTIDE; INTRACELLULAR CYCLIC-AMP; 4 SPLICE VARIANTS; ADENYLATE-CYCLASE; SIGNAL-TRANSDUCTION; MULTIPLE-MYELOMA; IN-VITRO; RAT; VIP	Pituitary adenylate cyclase-activating polypeptide (PACAP) has widespread physiological/pathophysiological actions and there is increased interest for its use therapeutically, especially in the CNS (neuroprotection). Unfortunately, no selective PACAP-analogs exist for PACAP-preferring PAC1-receptors, primarily because of its high sequence identity to VIP and particularly, because of the inability of structure-function studies to separate the pharmacophore of PAC1-R from VPAC1-R, which has high affinity for PACAP and VIP. The present study attempted to develop PAC1-R-selective agonists primarily by making conformationally restricted PACAP-analogs in positions important for receptor-selectivity/affinity. Forty-six PACAP-related-analogs were synthesized with substitutions in positions 1-4, 14-17, 20-22, 28, 34,38 and receptor-selectivity determined in PAC1-R,VPAC1-R,VPAC2R-transfected or native cells from binding or cAMP-generation experiments. Fifteen PACAP-analogs had 6-78-fold higher affinities for PAC1-R than VPAC1-R and 13 were agonists. Although binding-affinities correlated significantly with agonist potency, the degree of receptor-spareness varied markedly for the different PACAP-analogs, resulting in selective potencies for activating the PAC1 receptor over the VPAC1 receptor from 0- to 103-fold. In addition, a number of PACAP-analogs were identified that had high selectivity for PAC1-R over VPAC2-R as well as PACAP-analogs that could prove more useful therapeutically because of substitutions known to extend their half-lives (substitutions at potential sites of proteolysis and attachment of long-chain fatty acids). This study provides for the first time a separation of the pharmacophores for PAC1-R and VPAC1-R, resulting in PACAP-related analogs that are PAC1-R-preferring. Some of these analogs, or their modifications, could prove useful as therapeutic agents for various diseases. Published by Elsevier Inc.	[Ramos-Alvarez, Irene; Mantey, Samuel A.; Nakamura, Taichi; Nuche-Berenguer, Bernardo; Moreno, Paola; Jensen, Robert T.] NIDDK, Digest Dis Branch, NIH, Bethesda, MD 20892 USA; [Moody, Terry W.] NCI, Ctr Canc Res, Off Director, NIH, Bethesda, MD 20892 USA; [Maderdrut, Jerome L.; Coy, David H.] Tulane Univ, Hlth Sci Ctr, Peptide Res Lab, Dept Med, New Orleans, LA 70112 USA	Jensen, RT (corresponding author), NIDDK, Digest Dis Branch, NIH, Bldg 10,Room 9C-103,10 Ctr Dr,MSC 1804, Bethesda, MD 20892 USA.	robertj@bdg10.niddk.nih.gov			NIDDK branch of the National Institutes of Health; National Institute of General Medical Sciences of the National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [1 U54 GM104940]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK) [ZIADK053100, ZIADK053101] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [U54GM104940] Funding Source: NIH RePORTER	This work was supported in part by intramural funds from the NIDDK branch of the National Institutes of Health. This work was also supported in part by 1 U54 GM104940 from the National Institute of General Medical Sciences of the National Institutes of Health, which funds the Louisiana Clinical and Translational Science Center. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ahren B, 2008, ANN NY ACAD SCI, V1144, P28, DOI 10.1196/annals.1418.003; ALVAREZ R, 1992, ANAL BIOCHEM, V203, P76, DOI 10.1016/0003-2697(92)90045-9; Banki E, 2013, PEPTIDES, V42, P125, DOI 10.1016/j.peptides.2013.02.002; BANKS WA, 1993, J PHARMACOL EXP THER, V267, P690; Baun M, 2012, CEPHALALGIA, V32, P337, DOI 10.1177/0333102412439354; BENYA RV, 1993, J BIOL CHEM, V268, P20285; Bourgault S, 2009, CURR MED CHEM, V16, P4462, DOI 10.2174/092986709789712899; Bourgault S, 2008, PEPTIDES, V29, P919, DOI 10.1016/j.peptides.2008.01.022; Bourgault S, 2009, J MED CHEM, V52, P3308, DOI 10.1021/jm900291j; Bourgault S, 2008, J MOL NEUROSCI, V36, P260, DOI 10.1007/s12031-008-9081-7; Dickson L, 2006, NEUROPHARMACOLOGY, V51, P1086, DOI 10.1016/j.neuropharm.2006.07.017; Dickson L, 2009, PHARMACOL THERAPEUT, V121, P294, DOI 10.1016/j.pharmthera.2008.11.006; Doan ND, 2011, BIOCHEM PHARMACOL, V81, P552, DOI 10.1016/j.bcp.2010.11.015; Dogrukol-Ak D, 2004, CURR PHARM DESIGN, V10, P1325, DOI 10.2174/1381612043384934; Germano PM, 2001, PEPTIDES, V22, P861, DOI 10.1016/S0196-9781(01)00410-7; Gourlet P, 1997, PEPTIDES, V18, P1539, DOI 10.1016/S0196-9781(97)00228-3; Gourlet P, 1997, PEPTIDES, V18, P403, DOI 10.1016/S0196-9781(96)00322-1; Gourlet P, 1996, REGUL PEPTIDES, V62, P125, DOI 10.1016/0167-0115(96)00010-9; Gourlet P, 1998, EUR J PHARMACOL, V348, P95, DOI 10.1016/S0014-2999(98)00133-2; Harmar AJ, 2012, BRIT J PHARMACOL, V166, P4, DOI 10.1111/j.1476-5381.2012.01871.x; Holz GG, 2003, CURR MED CHEM, V10, P2471, DOI 10.2174/0929867033456648; HOU X, 1994, NEUROPHARMACOLOGY, V33, P1189, DOI 10.1016/S0028-3908(05)80009-7; Igarashi H, 2005, J PHARMACOL EXP THER, V315, P370, DOI 10.1124/jpet.105.088823; Igarashi H, 2002, J PHARMACOL EXP THER, V301, P37, DOI 10.1124/jpet.301.1.37; Igarashi H, 2002, J PHARMACOL EXP THER, V303, P445, DOI 10.1124/jpet.102.038075; Inooka H, 2001, NAT STRUCT BIOL, V8, P161, DOI 10.1038/84159; Ito T, 2000, AM J PHYSIOL-GASTR L, V278, pG64; Kim Y, 2006, J IMMUNOL, V176, P2969, DOI 10.4049/jimmunol.176.5.2969; LERNER EA, 1991, J BIOL CHEM, V266, P11234; Li M, 2008, REGUL PEPTIDES, V145, P24, DOI 10.1016/j.regpep.2007.09.012; Li M, 2007, PEPTIDES, V28, P1891, DOI 10.1016/j.peptides.2007.05.002; Li SY, 2005, INT J ONCOL, V27, P1329; Missig G, 2014, NEUROPHARMACOLOGY, V86, P38, DOI 10.1016/j.neuropharm.2014.06.022; MIYATA A, 1989, BIOCHEM BIOPH RES CO, V164, P567, DOI 10.1016/0006-291X(89)91757-9; MIYATA A, 1990, BIOCHEM BIOPH RES CO, V170, P643, DOI 10.1016/0006-291X(90)92140-U; Moody TW, 2011, CURR OPIN ENDOCRINOL, V18, P61, DOI 10.1097/MED.0b013e328342568a; Moody TW, 2003, PEPTIDES, V24, P163, DOI 10.1016/S0196-9781(02)00290-5; MUSSO GF, 1988, BIOCHEMISTRY-US, V27, P8174, DOI 10.1021/bi00421a028; Myers SR, 1997, DIABETES, V46, P637, DOI 10.2337/diabetes.46.4.637; Nicole P, 2000, J BIOL CHEM, V275, P24003, DOI 10.1074/jbc.M002325200; Onoue S, 2008, N-S ARCH PHARMACOL, V377, P579, DOI 10.1007/s00210-007-0232-0; Pisegna Joseph R, 2007, Curr Opin Endocrinol Diabetes Obes, V14, P58, DOI 10.1097/MED.0b013e328012d605; PISEGNA JR, 1993, P NATL ACAD SCI USA, V90, P6345, DOI 10.1073/pnas.90.13.6345; Pisegna JR, 1996, J BIOL CHEM, V271, P17267, DOI 10.1074/jbc.271.29.17267; Pisegna JR, 1996, ANN NY ACAD SCI, V805, P54; Reglodi D, 2011, CURR PHARM DESIGN, V17, P962, DOI 10.2174/138161211795589355; Ressler KJ, 2011, NATURE, V470, P492, DOI 10.1038/nature09856; Reubi JC, 2000, CANCER RES, V60, P3105; ROBBERECHT P, 1992, MOL PHARMACOL, V42, P347; ROWLEY WH, 1990, AM J PHYSIOL, V259, pG655; SPENGLER D, 1993, NATURE, V365, P170, DOI 10.1038/365170a0; Sun CH, 2007, P NATL ACAD SCI USA, V104, P7875, DOI 10.1073/pnas.0611397104; Uchida D, 1998, ANN NY ACAD SCI, V865, P253, DOI 10.1111/j.1749-6632.1998.tb11185.x; Vaudry D, 2000, PHARMACOL REV, V52, P269; Vaudry D, 2009, PHARMACOL REV, V61, P283, DOI 10.1124/pr.109.001370; Ward BP, 2013, MOL METAB, V2, P468, DOI 10.1016/j.molmet.2013.08.008; Waschek JA, 2013, BRIT J PHARMACOL, V169, P512, DOI 10.1111/bph.12181; Wray V, 1998, ANN NY ACAD SCI, V865, P37, DOI 10.1111/j.1749-6632.1998.tb11160.x; WRAY V, 1993, BIOCHEMISTRY-US, V32, P5832, DOI 10.1021/bi00073a016; Xia M, 1997, J PHARMACOL EXP THER, V281, P229; Yung SL, 2003, J BIOL CHEM, V278, P10273, DOI 10.1074/jbc.M211945200; ZHOU ZC, 1989, AM J PHYSIOL, V256, pG283	62	22	23	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0196-9781	1873-5169		PEPTIDES	Peptides	APR	2015	66						26	42		10.1016/j.peptides.2015.01.009			17	Biochemistry & Molecular Biology; Endocrinology & Metabolism; Pharmacology & Pharmacy	Biochemistry & Molecular Biology; Endocrinology & Metabolism; Pharmacology & Pharmacy	CH1NE	WOS:000353787700005	25698233	Green Accepted			2021-06-18	
J	Terre, R; Mearin, F				Terre, R.; Mearin, F.			A randomized controlled study of neuromuscular electrical stimulation in oropharyngeal dysphagia secondary to acquired brain injury	EUROPEAN JOURNAL OF NEUROLOGY			English	Article						aspiration; dysphagia; neuromuscular electrical stimulation; rehabilitation; stroke; traumatic brain injury; videofluoroscopy	TRACHEAL ASPIRATION; INTERRATER RELIABILITY; PHARYNGEAL DYSPHAGIA; STROKE PATIENTS; RESOLUTION; DISORDERS; THERAPY; SCALE	Background and purposeTo evaluate the effectiveness of neuromuscular electrical stimulation (NMES) treatment in patients with oropharyngeal dysphagia secondary to acquired brain injury. MethodsTwenty patients with neurological oropharyngeal dysphagia (14 stroke and six severe traumatic brain injury) were enrolled in a prospective randomized study, with patients and assessors blinded (to group allocation): 10 patients underwent NMES and conventional swallowing therapy and 10 patients underwent sham electrical stimulation (SES) and conventional swallowing therapy. Both groups completed 20 sessions. At baseline, at the end of treatment (1month) and at 3-month follow-up, clinical, videofluoroscopic and esophageal manometric analyses were done. Feeding swallowing capacity was evaluated using the functional oral intake scale (FOIS). ResultsMean FOIS score before treatment was 1.9 for the NMES group and 2.1 for the SES group. After treatment, the NMES group increased by 2.6 points (4.5 points) compared with only 1 point (3.1 points) for the SES group (P=0.005). At 3months of follow-up, mean scores were 5.3 and 4.6 respectively; thus, both groups improved similarly. At that time point (3months), tracheal aspiration persisted in six patients in each group. However, a significant improvement in relation to the bolus viscosity at which aspiration appeared was found in the NMES group versus the SES group (P=0.015). Also, a significant increase (P=0.04) in pharyngeal amplitude contraction was observed at the end of treatment (1month) in the NMES group compared with the SES group. ConclusionNeuromuscular electrical stimulation significantly accelerated swallowing function improvement in patients with oropharyngeal dysphagia secondary to acquired brain injury.	[Terre, R.; Mearin, F.] Neurorehabil Hosp, Inst Guttmann, Funct Digest Rehabil Unit, Barcelona, Spain; [Terre, R.; Mearin, F.] Inst Univ Neurorehabil, Inst Guttmann, Bellaterra, Cerdanyola Del, Spain; [Terre, R.; Mearin, F.] Univ Autonoma Barcelona, Bellaterra, Cerdanyola Del, Spain; [Terre, R.; Mearin, F.] Fundacio Inst Invest Ciencies Salut Germans Trias, Barcelona, Spain	Terre, R (corresponding author), Inst Guttmann, Unit Funct Digest Rehabil, Cami Can Ruti S-N, Barcelona 08916, Spain.	rterre@guttmann.com			FUNDACION MAPFRE	We thank Ms Raquel Lopez for statistical analysis and the Speech Therapy Department (Ms Montse Martinell, Beatriz Gonzalez and Judith Ejarque) for its assistance in the technical performance of NMES. We are also indebted to Ms Christine O'Hara who helped to prepare the manuscript. This research was supported by a grant of the FUNDACION MAPFRE.	Blumenfeld L, 2006, OTOLARYNG HEAD NECK, V135, P754, DOI 10.1016/j.otohns.2006.04.016; Bulow M, 2008, DYSPHAGIA, V23, P302, DOI 10.1007/s00455-007-9145-9; Clark H, 2009, AM J SPEECH-LANG PAT, V18, P361, DOI 10.1044/1058-0360(2009/08-0088); Crary MA, 2005, ARCH PHYS MED REHAB, V86, P1516, DOI 10.1016/j.apmr.2004.11.049; Crary MA, 2007, DYSPHAGIA, V22, P165, DOI 10.1007/s00455-006-9068-x; Doeltgen SH, 2012, ARCH PHYS MED REHAB, V93, P207, DOI 10.1016/j.apmr.2011.08.030; Fraser C, 2002, NEURON, V34, P831, DOI 10.1016/S0896-6273(02)00705-5; Ghosh SK, 2006, AM J PHYSIOL-GASTR L, V291, pG525, DOI 10.1152/ajpgi.00081.2006; Grupo Espanol para el Estudio de la Motilidad Digestiva (GEEMD), 1997, TECNICAS ESTUDIO ACT, P11; Hagen CMD, 1999, REHABILITATION HEAD, P70; Hamdy S, 2010, PERSPECTIVES SWALLOW, V19, P3, DOI DOI 10.1044/SASD19.1.3; Hara Yukihiro, 2010, Brain and Nerve (Tokyo), V62, P113; Kimberley TJ, 2004, EXP BRAIN RES, V154, P450, DOI 10.1007/s00221-003-1695-y; Korfage JAM, 2001, ARCH ORAL BIOL, V46, P821, DOI 10.1016/S0003-9969(01)00042-5; Kushner DS, 2013, AM J PHYS MED REHAB, V92, P486, DOI 10.1097/PHM.0b013e31828762ec; Laufer Y, 2011, NEUROREHAB NEURAL RE, V25, P799, DOI 10.1177/1545968310397205; Leelamanit V, 2002, LARYNGOSCOPE, V112, P2204, DOI 10.1097/00005537-200212000-00015; Leonard R, 2008, DYSPHAGIA ASSESSMENT, P295; Logemann J., 1993, MANUAL VIDEOFLUOROGR, P115; Logemann JA, 1998, EVALUATION TREATMENT, P307; Mackay LE, 1999, ARCH PHYS MED REHAB, V80, P365, DOI 10.1016/S0003-9993(99)90271-X; Mann G, 1999, STROKE, V30, P744, DOI 10.1161/01.STR.30.4.744; Pena-Casanova J., 1991, PROGRAMA INTEGRADO E; Permsirivanich Wutichai, 2009, Journal of the Medical Association of Thailand, V92, P259; Power M, 2004, AM J PHYSIOL-GASTR L, V286, pG45, DOI 10.1152/ajpgi.00114.2003; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; Rofes L, 2013, NEUROGASTROENT MOTIL, V25, P888, DOI 10.1111/nmo.12211; Scott A, 1998, DYSPHAGIA, V13, P223, DOI 10.1007/PL00009576; Singh S, 2006, POSTGRAD MED J, V82, P383, DOI 10.1136/pgmj.2005.043281; Smith GV, 2003, EXP BRAIN RES, V150, P33, DOI 10.1007/s00221-003-1405-9; Spechler SJ, 1999, GASTROENTEROLOGY, V117, P233, DOI 10.1016/S0016-5085(99)70573-1; Stevens-Lapsley JE, 2012, PHYS THER, V92, P210, DOI 10.2522/ptj.20110124; Stoeckli SJ, 2003, DYSPHAGIA, V18, P53, DOI 10.1007/s00455-002-0085-0; Terre R, 2012, NEUROGASTROENT MOTIL, V24, P414, DOI 10.1111/j.1365-2982.2011.01869.x; Terre R, 2009, NEUROGASTROENT MOTIL, V21, P361, DOI 10.1111/j.1365-2982.2008.01208.x; Terre R, 2013, MED CLIN-BARCELONA, V140, P157, DOI 10.1016/j.medcli.2012.09.037; Terre R, 2009, AM J GASTROENTEROL, V104, P923, DOI 10.1038/ajg.2008.160; Terrte R, 2007, BRAIN INJURY, V21, P1411, DOI 10.1080/02699050701785096; Uniform Data System for Medical Rehabilitation, 1990, GUID US UN DAT SET M	39	22	23	0	26	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1351-5101	1468-1331		EUR J NEUROL	Eur. J. Neurol.	APR	2015	22	4					687	E44		10.1111/ene.12631			10	Clinical Neurology; Neurosciences	Neurosciences & Neurology	CD9DX	WOS:000351398900014	25573027				2021-06-18	
J	Zhang, BF; Wang, J; Liu, ZW; Zhao, YL; Li, DD; Huang, TQ; Gu, H; Song, JN				Zhang, Bin-Fei; Wang, Jiao; Liu, Zun-Wei; Zhao, Yong-Lin; Li, Dan-Dong; Huang, Ting-Qin; Gu, Hua; Song, Jin-Ning			Meta-Analysis of the Efficacy and Safety of Therapeutic Hypothermia in Children with Acute Traumatic Brain Injury	WORLD NEUROSURGERY			English	Article						Arrhythmia; Children; Hypothermia; Meta-analysis; Mortality; Traumatic brain injury	MODERATE HYPOTHERMIA; HEAD-INJURY; ADULTS; TRIAL	OBJECTIVE: To evaluate the efficacy and safety of therapeutic hypothermia in children with acute traumatic brain injury (TBI). METHODS: A systematic literature review using PubMed, Embase, Cochrane Library, Chinese National Knowledge Infrastructure, Wanfang, VIP, and Chinese Biomedical Database was performed to retrieve studies of randomized controlled trials (RCTs) on therapeutic hypothermia for children with TBI published before March 2014. Data extraction and quality evaluation of RCTs were performed by 2 investigators independently. A meta-analysis was performed by RevMan 5.2.7. RESULTS: There were 7 RCTs comprising 442 children (218 in hypothermia group and 224 in normothermia group). Meta-analysis showed therapeutic hypothermia could increase mortality compared with the normothermia group (relative risk [RR][1.84, 95% confidence interval [CI][1.15-2.93, P = 0.01). On the Glasgow Outcome Scale (GOS), the following scores did not differ between the hypothermia group and normothermia group: 3-month GOS 4-5 (RR = 0.89, 95% CI = 0.68-1.16, P = 0.39), 3-month GOS 1-3 (RR = 1.19, 95% CI = 0.80-1.76, P = 0.39), 6-month GOS 4e5 (RR = 0.91, 95% CI = 0.78-1.07, P = 0.26), and 6-month GOS 1-3 (RR = 1.18, 95% CI = 0.88-1.59, P = 0.27). Hypothermia did not increase the rate of pneumonia (RR = 0.84, 95% CI = 0.63-1.12, P = 0.23) or bleeding (RR = 0.94, 95% CI = 0.39-2.26, P = 0.89), but the incidence of arrhythmias was higher in the hypothermia group (RR = 2.60, 95% CI = 1.06-6.41, P = 0.04). CONCLUSIONS: No benefit of therapeutic hypothermia in children with TBI is shown in this study; therapeutic hypothermia may increase the risk of mortality and arrhythmia. There is no evidence that therapeutic hypothermia improves prognosis of children with TBI; there is also no evidence that therapeutic hypothermia increases the risk of pneumonia and coagulation dysfunction. These results are limited by the quality of the included studies and need to be considered with caution. Further large-scale, well-designed RCTs on this topic are needed.	[Zhang, Bin-Fei; Liu, Zun-Wei; Zhao, Yong-Lin; Li, Dan-Dong; Huang, Ting-Qin; Gu, Hua; Song, Jin-Ning] Xi An Jiao Tong Univ, Sch Med, Affiliated Hosp 1, Dept Neurosurg, Xian, Shaanxi, Peoples R China; [Wang, Jiao] Xi An Jiao Tong Univ, Sch Med, Affiliated Hosp 1, Dept Pediat, Xian, Shaanxi, Peoples R China	Song, JN (corresponding author), Xi An Jiao Tong Univ, Sch Med, Affiliated Hosp 1, Dept Neurosurg, Xian, Shaanxi, Peoples R China.	jinningsong@126.com		Li, Dan-Dong/0000-0003-4973-8818	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [30870844]; Key Scientific and Technological Innovation Special Projects of Shaanxi "13115" [2008ZDKG-66]; Special Research Fund for the Doctoral Disciplinary Points in Universities of Ministry of Education [20110201110060]	This work was supported by the National Natural Science Foundation of China (Grant No. 30870844), the Key Scientific and Technological Innovation Special Projects of Shaanxi "13115" (Grant No. 2008ZDKG-66), and the Special Research Fund for the Doctoral Disciplinary Points in Universities of Ministry of Education (Grant No. 20110201110060).	Adelson PD, 2013, LANCET NEUROL, V12, P546, DOI 10.1016/S1474-4422(13)70077-2; Adelson PD, 2005, NEUROSURGERY, V56, P740, DOI 10.1227/01.NEU.0000156471.50726.26; Armitage P., 2008, STAT METHODS MED RES, P83; Biswas AK, 2002, CRIT CARE MED, V30, P2742, DOI 10.1097/00003246-200212000-00020; Bourdages M, 2010, PEDIATR CRIT CARE ME, V11, P408, DOI 10.1097/PCC.0b013e3181c51dea; Chambers IR, 2006, J NEUROL NEUROSUR PS, V77, P234, DOI 10.1136/jnnp.2005.072215; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; Feigin VL, 2013, LANCET NEUROL, V12, P53, DOI 10.1016/S1474-4422(12)70262-4; Georgiou AP, 2013, BRIT J ANAESTH, V110, P357, DOI 10.1093/bja/aes500; Henker RA, 1998, NEUROSURGERY, V42, P1071, DOI 10.1097/00006123-199805000-00071; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins JPT, 2011, COCHRANE HDB SYSTEMA; Hutchison JS, 2008, NEW ENGL J MED, V358, P2447, DOI 10.1056/NEJMoa0706930; Jacobs S, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003311.pub2; Li H, 2009, J NEUROTRAUM, V26, P1905, DOI 10.1089/neu.2008-0828; McCully SP, 2013, SEMIN THROMB HEMOST, V39, P896, DOI 10.1055/s-0033-1357484; Mtaweh H, 2014, PEDIATR CRIT CARE ME, V15, P242, DOI 10.1097/PCC.0000000000000041; Milani WRO, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006638.pub2; Peterson K, 2008, J NEUROTRAUM, V25, P62, DOI 10.1089/neu.2007.0424; Salonia R, 2010, J NEUROTRAUM, V27, P1819, DOI 10.1089/neu.2010.1402; Winqvist S, 2007, NEUROEPIDEMIOLOGY, V29, P136, DOI 10.1159/000110741	21	22	23	1	6	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	APR	2015	83	4					567	573		10.1016/j.wneu.2014.12.010			7	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	CG1NJ	WOS:000353039500035	25514616				2021-06-18	
J	Moreno, E; Fernandez-Marrero, Y; Meyer, P; Rhiner, C				Moreno, Eduardo; Fernandez-Marrero, Yuniel; Meyer, Patricia; Rhiner, Christa			Brain Regeneration in Drosophila Involves Comparison of Neuronal Fitness	CURRENT BIOLOGY			English	Article							ADULT MIDGUT REGENERATION; CELL COMPETITION; IMAGINAL DISCS; PATHWAY; STEM; MECHANISMS; MYC; PROLIFERATION; APOPTOSIS; WINGLESS	Darwinian-like cell selection has been studied during development and cancer [1-11]. Cell selection is often mediated by direct intercellular comparison of cell fitness, using "fitness fingerprints" [12-14]. In Drosophila, cells compare their fitness via several iso-forms of the transmembrane protein Flower [12, 13]. Here, we studied the role of intercellular fitness comparisons during regeneration. Regeneration-competent organisms are traditionally injured by amputation [15, 16], whereas in clinically relevant injuries such as local ischemia or traumatic injury, damaged tissue remains within the organ [17-19]. We reasoned that "Darwinian" interactions between old and newly formed tissues may be important in the elimination of damaged cells. We used a model of adult brain regeneration in Drosophila in which mechanical puncture activates regenerative neurogenesis based on damage-responsive stem cells [20]. We found that apoptosis after brain injury occurs in damage-exposed tissue located adjacent to zones of de novo neurogenesis. Injury-affected neurons start to express isoforms of the Flower cell fitness indicator protein not found on intact neurons. We show that this change in the neuronal fitness fingerprint is required to recognize and eliminate such neurons. Moreover, apoptosis is inhibited if all neurons express "low-fitness" markers, showing that the availability of new and healthy cells drives tissue replacement. In summary, we found that elimination of impaired tissue during brain regeneration requires comparison of neuronal fitness and that tissue replacement after brain damage is coordinated by injury-modulated fitness fingerprints. Intercellular fitness comparisons between old and newly formed tissues could be a general mechanism of regenerative tissue replacement.	[Moreno, Eduardo; Fernandez-Marrero, Yuniel; Meyer, Patricia; Rhiner, Christa] Univ Bern, Inst Cell Biol IZB, CH-3012 Bern, Switzerland	Rhiner, C (corresponding author), Univ Bern, Inst Cell Biol IZB, CH-3012 Bern, Switzerland.	christa.rhiner@izb.unibe.ch		Fernandez-Marrero, Yuniel/0000-0003-4102-6955; Rhiner, Christa/0000-0001-7577-8042; moreno, eduardo/0000-0001-5040-452X	University of Bern; European Research CouncilEuropean Research Council (ERC)European Commission; Swiss National Science FoundationSwiss National Science Foundation (SNSF)European Commission; Josef Steiner Cancer Research Foundation	We thank Dr. Alain Hauser for help with statistical analysis; H. Bellen, B. Thompson, K. Basler, I. Hariharan, and the Bloomington stock center for providing flies; and the Hybridoma Bank for antibodies. Research in this paper was supported by the University of Bern (C.R.) and grants of the European Research Council, the Swiss National Science Foundation, and the Josef Steiner Cancer Research Foundation to E.M.	Alvarado AS, 2006, NAT REV GENET, V7, P873, DOI 10.1038/nrg1923; Andriessen TMJC, 2010, J CELL MOL MED, V14, P2381, DOI 10.1111/j.1582-4934.2010.01164.x; Bach EA, 2007, GENE EXPR PATTERNS, V7, P323, DOI 10.1016/j.modgep.2006.08.003; Bergantinos C, 2010, DEVELOPMENT, V137, P1169, DOI 10.1242/dev.045559; Bondar T, 2010, CELL STEM CELL, V6, P309, DOI 10.1016/j.stem.2010.03.002; Carmichael ST, 2006, ANN NEUROL, V59, P735, DOI 10.1002/ana.20845; Chatterjee N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034063; Classen AK, 2009, NAT GENET, V41, P1150, DOI 10.1038/ng.445; Claveria C, 2013, NATURE, V500, P39, DOI 10.1038/nature12389; Cordero JB, 2012, EMBO J, V31, P3901, DOI 10.1038/emboj.2012.248; de la Cova C, 2004, CELL, V117, P107, DOI 10.1016/S0092-8674(04)00214-4; Fernandez-Hernandez I, 2013, CELL REP, V3, P1857, DOI 10.1016/j.celrep.2013.05.034; Freeman MR, 2014, CURR OPIN NEUROBIOL, V27, P224, DOI 10.1016/j.conb.2014.05.001; Grusche FA, 2011, DEV BIOL, V350, P255, DOI 10.1016/j.ydbio.2010.11.020; HOLM S, 1979, SCAND J STAT, V6, P65; Karpowicz P, 2010, DEVELOPMENT, V137, P4135, DOI 10.1242/dev.060483; Loane DJ, 2010, TRENDS PHARMACOL SCI, V31, P596, DOI 10.1016/j.tips.2010.09.005; Martins VC, 2014, NATURE, V509, P465, DOI 10.1038/nature13317; Merino MM, 2015, CELL, V160, P461, DOI 10.1016/j.cell.2014.12.017; Merino MM, 2013, CURR BIOL, V23, P1300, DOI 10.1016/j.cub.2013.05.053; MORATA G, 1975, DEV BIOL, V42, P211, DOI 10.1016/0012-1606(75)90330-9; Moreno E, 2004, CELL, V117, P117, DOI 10.1016/S0092-8674(04)00262-4; Moreno E, 2002, NATURE, V416, P755, DOI 10.1038/416755a; Noselli S, 1999, CURR OPIN GENET DEV, V9, P466, DOI 10.1016/S0959-437X(99)80071-9; Oertel M, 2006, GASTROENTEROLOGY, V130, P507, DOI 10.1053/j.gastro.2005.10.049; Petrova E, 2012, DIS MODEL MECH, V5, P553, DOI 10.1242/dmm.008623; RAFF MC, 1992, NATURE, V356, P397, DOI 10.1038/356397a0; Rhiner C, 2010, DEV CELL, V18, P985, DOI 10.1016/j.devcel.2010.05.010; ROBINOW S, 1988, DEV BIOL, V126, P294, DOI 10.1016/0012-1606(88)90139-X; Sancho M, 2013, DEV CELL, V26, P19, DOI 10.1016/j.devcel.2013.06.012; Shaw RL, 2010, DEVELOPMENT, V137, P4147, DOI 10.1242/dev.052506; Smith-Bolton RK, 2009, DEV CELL, V16, P797, DOI 10.1016/j.devcel.2009.04.015; Tamori Y, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000422; Tanaka EM, 2011, DEV CELL, V21, P172, DOI 10.1016/j.devcel.2011.06.016; Thompson BJ, 2006, CELL, V126, P767, DOI 10.1016/j.cell.2006.07.013; Tornini VA, 2014, DEV CELL, V29, P139, DOI 10.1016/j.devcel.2014.04.007; Vermeulen L, 2013, SCIENCE, V342, P995, DOI 10.1126/science.1243148; Vincent JP, 2013, NAT REV MOL CELL BIO, V14, P581, DOI 10.1038/nrm3639; Yao CK, 2009, CELL, V138, P947, DOI 10.1016/j.cell.2009.06.033	39	22	22	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0960-9822	1879-0445		CURR BIOL	Curr. Biol.	MAR 30	2015	25	7					955	963		10.1016/j.cub.2015.02.014			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CE8KL	WOS:000352091100034	25754635	Green Published, Other Gold			2021-06-18	
J	Roth, RM; Erdodi, LA; McCulloch, LJ; Isquith, PK				Roth, Robert M.; Erdodi, Laszlo A.; McCulloch, Laura J.; Isquith, Peter K.			Much ado about norming: The Behavior Rating Inventory of Executive Function	CHILD NEUROPSYCHOLOGY			English	Article						Assessment; Children; Executive function	WHITE-MATTER ABNORMALITIES; TRAUMATIC BRAIN-INJURY; VELOCARDIOFACIAL SYNDROME; EXTERNALIZING BEHAVIOR; EARLY-CHILDHOOD; WORKING-MEMORY; CHILDREN; ATTENTION; ADOLESCENTS; PERFORMANCE	The Behavior Rating Inventory of Executive Function (BRIEF) is a rating scale designed to assess executive functions in everyday life that is widely used in school and clinical settings and in research studies. It has been recently suggested, however, that the limited geographic stratification of the standardization sample renders the measure overly sensitive. We evaluated this hypothesis by examining BRIEF scores across studies of typically developing children and adolescents. Thirty-nine studies were identified that included at least one of three possible index scores. Mean scores across studies were (a) within one to two T-score units from the standardization sample mean of 50, (b) tended to be slightly lower than 50, and (c) were unrelated to geographic location (US Census regions or internationally). These findings refute recent claims that the BRIEF is overly sensitive and further add to the large body of literature supporting the validity of the measure.	[Roth, Robert M.; Erdodi, Laszlo A.; McCulloch, Laura J.; Isquith, Peter K.] Geisel Sch Med Dartmouth, Dept Psychiat, Neuropsychol Program, Lebanon, NH 03756 USA	Roth, RM (corresponding author), Geisel Sch Med Dartmouth, Dept Psychiat, Neuropsychol Program, One Med Ctr Dr, Lebanon, NH 03756 USA.	robert.m.roth@dartmouth.edu	Isquith, Peter/AAY-4851-2020				Acevedo SF, 2010, PEDIATR RES, V67, P293, DOI 10.1203/PDR.0b013e3181cb8e68; Adamson C, 2013, BRAIN INJURY, V27, P454, DOI 10.3109/02699052.2012.750756; Alloway TP, 2009, CHILD PSYCHIAT HUM D, V40, P353, DOI 10.1007/s10578-009-0131-3; Anderson B, 2009, PEDIATRICS, V123, pE701, DOI 10.1542/peds.2008-1182; Anderson V, 2005, J INT NEUROPSYCH SOC, V11, P817, DOI 10.1017/S1355617705051052; Anderson V, 2012, DISABIL REHABIL, V34, P1639, DOI 10.3109/09638288.2012.656789; Antshel KM, 2005, PSYCHIAT RES-NEUROIM, V138, P235, DOI 10.1016/j.pscychresns.2005.02.003; Antshel KM, 2003, NEUROPSYCHOLOGY, V17, P458, DOI 10.1037/0894-4105.17.3.458; Bourke RS, 2011, SLEEP MED, V12, P222, DOI 10.1016/j.sleep.2010.08.011; Brown TM, 2008, CHILD NEUROPSYCHOL, V14, P118, DOI 10.1080/09297040601147605; Chevignard MP, 2012, BRAIN INJURY, V26, P1033, DOI 10.3109/02699052.2012.666366; Clark DB, 2012, ADDICTION, V107, P206, DOI 10.1111/j.1360-0443.2011.03566.x; Duerden EG, 2013, DEV MED CHILD NEUROL, V55, P952, DOI 10.1111/dmcn.12198; Egeland J, 2010, CHILD NEUROPSYCHOL, V16, P326, DOI 10.1080/09297041003601462; Gioia G. A., 2000, BRIEF BEHAV RATING I; Gioia GA, 2000, CHILD NEUROPSYCHOL, V6, P235, DOI 10.1076/chin.6.3.235.3152; Goldstein S., 2001, APPL NEUROPSYCHOL, V8, P255, DOI [10.1207/S15324826AN0804_10, DOI 10.1207/S15324826AN0804_10]; Goldweber A, 2011, J CLIN CHILD ADOLESC, V40, P715, DOI 10.1080/15374416.2011.597088; Hughes DM, 2009, INT J LANG COMM DIS, V44, P901, DOI [10.3109/13682820802425693, 10.1080/13682820802425693]; Isquith PK, 2014, APPL NEUROPSYCH-CHIL, V3, P197, DOI 10.1080/21622965.2013.870014; Isquith PK, 2013, APPL NEUROPSYCH-CHIL, V2, P125, DOI 10.1080/21622965.2013.748389; Jarratt KP, 2005, APPL NEUROPSYCHOL, V12, P83, DOI 10.1207/s15324826an1202_4; Kiley-Brabeck K, 2006, APPL NEUROPSYCHOL, V13, P258, DOI 10.1207/s15324826an1304_7; Kral MC, 2004, J PEDIATR PSYCHOL, V29, P185, DOI 10.1093/jpepsy/jsh020; Krivitzky LS, 2011, J INT NEUROPSYCH SOC, V17, P1143, DOI 10.1017/S1355617711001226; Kurowski B, 2009, J PEDIATR REHAB MED, V2, P273, DOI 10.3233/PRM-2009-0093; Lajiness-O'Neill R, 2006, ARCH CLIN NEUROPSYCH, V21, P175, DOI 10.1016/j.acn.2005.09.001; Lande MB, 2010, J PEDIATR-US, V157, P114, DOI 10.1016/j.jpeds.2009.12.053; Lande MB, 2009, J PEDIATR-US, V154, P207, DOI 10.1016/j.jpeds.2008.08.017; Lax ID, 2013, BRAIN STRUCT FUNCT, V218, P575, DOI 10.1007/s00429-012-0417-2; Locascio G, 2010, J LEARN DISABIL-US, V43, P441, DOI 10.1177/0022219409355476; Maillard-Wermelinger A, 2009, DEV NEUROREHABIL, V12, P330, DOI 10.3109/17518420903087251; Mangeot S, 2002, CHILD NEUROPSYCHOL, V8, P271, DOI 10.1076/chin.8.4.271.13503; Memisevic H, 2014, J INTELL DISABIL RES, V58, P830, DOI 10.1111/jir.12098; Naglieri J. A., 2012, COMPREHENSIVE EXECUT; Payne JM, 2011, CHILD NEUROPSYCHOL, V17, P313, DOI 10.1080/09297049.2010.542746; Piper BJ, 2011, PHARMACOL BIOCHEM BE, V98, P432, DOI 10.1016/j.pbb.2011.02.013; Pride NA, 2012, DEV NEUROPSYCHOL, V37, P590, DOI 10.1080/87565641.2012.695831; Pulsipher DT, 2009, EPILEPSIA, V50, P1210, DOI 10.1111/j.1528-1167.2008.01952.x; Reddy LA, 2011, SCHOOL PSYCHOL QUART, V26, P45, DOI 10.1037/a0022585; Rocke K, 2008, AM J OCCUP THER, V62, P528, DOI 10.5014/ajot.62.5.528; Roth R. M., 2014, HDB EXECUTIVE FUNCTI, P301, DOI DOI 10.1007/978-1-4614-8106-5_18; Roy A, 2009, ENVIRON HEALTH PERSP, V117, P1607, DOI 10.1289/ehp.0900625; Semrud-Clikeman M, 2010, J AUTISM DEV DISORD, V40, P1017, DOI 10.1007/s10803-010-0951-9; Sesma HW, 2008, PEDIATRICS, V121, pE1686, DOI 10.1542/peds.2007-2461; Shear PK, 2002, CHILD NEUROPSYCHOL, V8, P285, DOI 10.1076/chin.8.4.285.13511; Shimoni M, 2012, RES DEV DISABIL, V33, P858, DOI 10.1016/j.ridd.2011.12.014; Strauss E., 2006, COMPENDIUM NEUROPSYC, V3rd; Tarazi RA, 2008, CLIN NEUROPSYCHOL, V22, P585, DOI 10.1080/13854040701425940; Toplak ME, 2009, CHILD NEUROPSYCHOL, V15, P53, DOI 10.1080/09297040802070929; US Census Bureau, 2010, GEOGR DEF; Viner RM, 2012, LANCET NEUROL, V11, P774, DOI 10.1016/S1474-4422(12)70180-1; Waber DP, 2007, J INT NEUROPSYCH SOC, V13, P729, DOI 10.1017/S1355617707070841; Walz NC, 2008, J NEUROTRAUM, V25, P94, DOI 10.1089/neu.2007.0362; Wang Y, 2012, PSYCHIAT RES-NEUROIM, V202, P245, DOI 10.1016/j.pscychresns.2012.01.005; Yerys BE, 2009, AUTISM RES, V2, P322, DOI 10.1002/aur.103; Ziegler G, 2013, NEUROIMAGE, V82, P284, DOI 10.1016/j.neuroimage.2013.05.088	57	22	22	0	28	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0929-7049	1744-4136		CHILD NEUROPSYCHOL	Child Neuropsychol.	MAR 4	2015	21	2					225	233		10.1080/09297049.2014.897318			9	Clinical Neurology	Neurosciences & Neurology	AW5XO	WOS:000346344500006	24650292				2021-06-18	
J	Dickert, NW; Scicluna, VM; Baren, JM; Biros, MH; Fleischman, RJ; Govindarajan, PR; Jones, EB; Pancioli, AM; Wright, DW; Pentz, RD				Dickert, Neal W.; Scicluna, Victoria M.; Baren, Jill M.; Biros, Michelle H.; Fleischman, Ross J.; Govindarajan, Prasanthi R.; Jones, Elizabeth B.; Pancioli, Arthur M.; Wright, David W.; Pentz, Rebecca D.			Patients' Perspectives of Enrollment in Research Without Consent: The Patients' Experiences in Emergency Research-Progesterone for the Treatment of Traumatic Brain Injury Study	CRITICAL CARE MEDICINE			English	Article						acute care research; bioethics; emergency research; informed consent; research ethics; traumatic brain injury	RANDOMIZED CONTROLLED-TRIAL; INFORMED-CONSENT; COMMUNITY CONSULTATION; RANDOM ALLOCATION; EXCEPTION; RESUSCITATION; PERCEPTIONS; SETTINGS; MEDICINE; CARE	Objective: Research in acute illness often requires an exception from informed consent. Few studies have assessed the views of patients enrolled in exception from informed consent trials. This study was designed to assess the views of patients and their surrogates of exception from informed consent enrollment within the context of a randomized, placebo-controlled trial of an investigational agent for traumatic brain injury. Design: Interactive interview study. Setting: Nested within the Progesterone for the Treatment of Traumatic Brain Injury trial, a Phase III randomized controlled trial in acute traumatic brain injury. Subjects: Patients and surrogates (for patients incapable of being interviewed) enrolled in Progesterone for the Treatment of Traumatic Brain Injury under exception from informed consent at 12 sites. Interventions: None. Measurements and Main Results: Interviews focused on respondents' acceptance of exception from informed consent enrollment in Progesterone for the Treatment of Traumatic Brain Injury, use of placebo and randomization, understanding of major study elements, and views regarding regulatory protections. Descriptive statistical analysis was performed; textual data were analyzed thematically. Eighty-five individuals were interviewed. Eighty-four percent had positive attitudes toward Progesterone for the Treatment of Traumatic Brain Injury inclusion. Seventy-eight percent found their inclusion under exception from informed consent acceptable, and 72% found use of exception from informed consent in Progesterone for the Treatment of Traumatic Brain Injury acceptable in general. Only two respondents clearly disagreed with both personal and general exception from informed consent enrollment. The most common concerns (26%) related to absence of consent. Eighty percent and 92% were accepting of placebo use and randomization, respectively. Although there were few black respondents (n = 11), they were less accepting of personal exception from informed consent enrollment than white respondents (55% vs 83%; p= 0.0494). Conclusions: Acceptance of exception from informed consent in this placebo-controlled trial of an investigational agent was high and exceeded acceptance among community consultation participants. Exception from informed consent enrollment appears generally consistent with patients' preferences.	[Dickert, Neal W.; Scicluna, Victoria M.] Emory Univ, Sch Med, Dept Med, Div Cardiol, Atlanta, GA 30322 USA; [Dickert, Neal W.] Rollins Sch Publ Hlth, Dept Epidemiol, Atlanta, GA USA; [Dickert, Neal W.] Atlanta VA Med Ctr, Atlanta, GA USA; [Baren, Jill M.] Univ Penn, Perelman Sch Med, Dept Emergency Med, Philadelphia, PA 19104 USA; [Biros, Michelle H.] Hennepin Cty Med Ctr, Dept Emergency Med, Minneapolis, MN 55415 USA; [Biros, Michelle H.] Univ Minnesota, Sch Med, Minneapolis, MN 55455 USA; [Fleischman, Ross J.] Harbor UCLA Med Ctr, Dept Emergency Med, Torrance, CA 90509 USA; [Govindarajan, Prasanthi R.] Univ Calif San Francisco, Sch Med, Dept Emergency Med, San Francisco, CA USA; [Jones, Elizabeth B.] Univ Texas Houston, Dept Emergency Med, Med Sch Houston, Houston, TX USA; [Pancioli, Arthur M.] Univ Cincinnati, Sch Med, Dept Emergency Med, Cincinnati, OH USA; [Wright, David W.] Emory Univ, Sch Med, Dept Emergency Med, Atlanta, GA USA; [Pentz, Rebecca D.] Emory Univ, Sch Med, Winship Canc Inst, Atlanta, GA USA	Dickert, NW (corresponding author), Emory Univ, Sch Med, Dept Med, Div Cardiol, Atlanta, GA 30322 USA.	njr@emory.edu			Greenwall Foundation; National Heart, Lung, and Blood InstituteUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [F32HL095358-01A1]; National Institute for Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [5U01NS062778]; National Institutes of Health (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA; National Institute for Neurological Disorders and Stroke (NINDS)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS); National Institute for Child Health and Human DevelopmentUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); NIH-NINDSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS); Department of DefenseUnited States Department of Defense; NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [F32HL095358] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [U01NS062778, U10NS058930, U10NS059032] Funding Source: NIH RePORTER	Supported, in part, by the Greenwall Foundation and the National Heart, Lung, and Blood Institute (F32HL095358-01A1). The parent trial was supported by the National Institute for Neurological Disorders and Stroke (5U01NS062778). Study sponsors played no role in the design or conduct of the study; collection, management, analysis, or interpretation of the data; preparation, review, or approval of the article; or decision to submit the article for publication.; Dr. Dickert received support for article research from the National Institutes of Health (NIH) and the Greenwall Foundation. His institution received grant support from the Greenwall Foundation and the NIH. Ms. Scicluna's institution received grant support from the NIH. Dr. Baren's institution received support from the National Institute for Neurological Disorders and Stroke (NINDS), the National Heart, Lung, and Blood Institute, and the National Institute for Child Health and Human Development. Dr. Biros received royalties from Rosen's Textbook of Emergency Medicine and Up to Date. Her institution received grant support from the NINDS. Dr. Jones received support for article research and travel support from the NIH-NINDS. Her institution received grant support from the NIH-NINDS. Dr. Pancioli received support for article research from the NIH. His institution received grant support from the NIH. Dr. Wright is entitled to royalty through Emory University, derived from any BHR Pharma sales of progesterone for use in traumatic brain injury. The terms of this arrangement have been reviewed and approved by Emory University in accordance with its conflict of interest policies. Dr. Wright received support for article research from the NIH and grant support from NIH and the Department of Defense. Dr. Pentz received support for article research from the NIH. Her institution received grant support from the NIH. The remaining authors have disclosed that they do not have any potential conflicts of interest.	Abboud PA, 2006, J MED ETHICS, V32, P468, DOI 10.1136/jme.2005.012633; Appelbaum Paul S, 2004, IRB, V26, P1, DOI 10.2307/3564231; Biros MH, 2009, RESUSCITATION, V80, P1382, DOI 10.1016/j.resuscitation.2009.08.019; Bulger EM, 2009, ANN EMERG MED, V53, P341, DOI 10.1016/j.annemergmed.2008.07.021; Cassell C, 2008, SAGE DICT QUALITATIV; Contant C, 2006, CRIT CARE MED, V34, P2049, DOI 10.1097/01.CCM.0000227649.72651.F1; Dickert NW, 2014, CRIT CARE MED, V42, P272, DOI 10.1097/CCM.0b013e3182a27759; Dickert NW, 2013, RESUSCITATION, V84, P1416, DOI 10.1016/j.resuscitation.2013.04.006; Dickert NW, 2009, SOC SCI MED, V68, P183, DOI 10.1016/j.socscimed.2008.10.001; Emanuel EJ, 2000, JAMA-J AM MED ASSOC, V283, P2701, DOI 10.1001/jama.283.20.2701; Falagas ME, 2009, AM J SURG, V198, P420, DOI 10.1016/j.amjsurg.2009.02.010; Fallowfield LJ, 1998, EUR J CANCER, V34, P1554, DOI 10.1016/S0959-8049(98)00193-2; Featherstone K, 1998, BRIT MED J, V317, P1177, DOI 10.1136/bmj.317.7167.1177; Govindarajan P, 2013, ACAD EMERG MED, V20, P98, DOI 10.1111/acem.12039; Holloway KFC, 2006, AM J BIOETHICS, V6, P7, DOI 10.1080/15265160600685556; Horng Sam, 2003, IRB, V25, P11, DOI 10.2307/3564408; Kamarainen A, 2012, RESUSCITATION, V83, P81, DOI 10.1016/j.resuscitation.2011.07.018; Kasner SE, 2011, ANN EMERG MED, V57, P346, DOI 10.1016/j.annemergmed.2010.07.009; Kim Scott Y H, 2013, IRB, V35, P1; Largent EA, 2010, ARCH INTERN MED, V170, P668, DOI 10.1001/archinternmed.2010.80; Lecouturier Jan, 2008, BMC Med Ethics, V9, P9, DOI 10.1186/1472-6939-9-9; Lo B, 2006, CRIT CARE MED, V34, P2236, DOI 10.1097/01.CCM.0000229632.85246.3A; Mason J., 2002, QUALITATIVE RES; Nishimura A, 2013, BMC MED ETHICS, V14, DOI 10.1186/1472-6939-14-28; Potter JE, 2013, INTENS CARE MED, V39, P472, DOI 10.1007/s00134-012-2732-8; Schmidt TA, 2003, ANN EMERG MED, V41, P79, DOI 10.1067/mem.2003.17; Snowdon C, 1997, SOC SCI MED, V45, P1337, DOI 10.1016/S0277-9536(97)00063-4; United States Department of Health and Human Services, 2013, GUID I REV BOARDS CL	28	22	22	0	5	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0090-3493	1530-0293		CRIT CARE MED	Crit. Care Med.	MAR	2015	43	3					603	612		10.1097/CCM.0000000000000747			10	Critical Care Medicine	General & Internal Medicine	CB9PI	WOS:000349963600025	25574795	Green Accepted			2021-06-18	
J	Fernandez-Rodriguez, E; Bernabeu, I; Castro, AI; Casanueva, FF				Fernandez-Rodriguez, Eva; Bernabeu, Ignacio; Castro, Ana I.; Casanueva, Felipe F.			Hypopituitarism After Traumatic Brain Injury	ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA			English	Article						Traumatic brain injury; Hypopituitarism; Growth hormone deficiency; Hormone replacement therapy	ANTERIOR-PITUITARY FUNCTION; ANEURYSMAL SUBARACHNOID HEMORRHAGE; GROWTH-HORMONE REPLACEMENT; LONG-TERM; HYPOTHALAMOPITUITARY DYSFUNCTION; POSTTRAUMATIC HYPOPITUITARISM; COGNITIVE REHABILITATION; CONSENSUS GUIDELINES; SPONTANEOUS-RECOVERY; HIGH-RISK	The prevalence of hypopituitarism after traumatic brain (TBI) injury is widely variable in the literature; a meta-analysis determined a pooled prevalence of anterior hypopituitarism of 27.5%. Growth hormone deficiency is the most prevalent hormone insufficiency after TBI; however, the prevalence of each type of pituitary deficiency is influenced by the assays used for diagnosis, severity of head trauma, and time of evaluation. Recent studies have demonstrated improvement in cognitive function and cognitive quality of life with substitution therapy in GH-deficient patients after TBI.	[Fernandez-Rodriguez, Eva; Bernabeu, Ignacio; Castro, Ana I.; Casanueva, Felipe F.] Univ Santiago Compostela, Complejo Hosp, SERGAS, Dept Med,Endocrinol Div, Santiago De Compostela 15706, A Coruna, Spain; [Castro, Ana I.; Casanueva, Felipe F.] Inst Salud Carlos III, Res Ctr Physiopathol Obes & Nutr, Santiago De Compostela, Spain	Casanueva, FF (corresponding author), Univ Santiago Compostela, Hosp Clin, Div Endocrinol, Travesia da Choupana S-N, Santiago De Compostela 15706, A Coruna, Spain.	endocrine@usc.es	Bernabeu, Ignacio/P-2049-2014	Bernabeu, Ignacio/0000-0001-8421-7394; CASANUEVA, FELIPE F./0000-0002-9052-8161			Agha A, 2005, AM J PHYS MED REHAB, V84, P381, DOI 10.1097/01.PHM.0000156898.47097.93; Agha A, 2004, J CLIN ENDOCR METAB, V89, P5987, DOI 10.1210/jc.2004-1058; Agha A, 2004, J CLIN ENDOCR METAB, V89, P4929, DOI 10.1210/jc.2004-0511; Agha Amar, 2005, Am J Med, V118, P1416; Aimaretti G, 2005, J CLIN ENDOCR METAB, V90, P6085, DOI 10.1210/jc.2005-0504; Aimaretti G, 2004, CLIN ENDOCRINOL, V61, P320, DOI 10.1111/j.1365-2265.2004.02094.x; BECKER DP, 1977, J NEUROSURG, V47, P491, DOI 10.3171/jns.1977.47.4.0491; Benvenga S, 2000, J CLIN ENDOCR METAB, V85, P1353, DOI 10.1210/jc.85.4.1353; Blair JC, 2010, BRIT J NEUROSURG, V24, P10, DOI 10.3109/02688690903536637; Bondanelli M, 2004, J NEUROTRAUM, V21, P685, DOI 10.1089/0897715041269713; Bondanelli M, 2007, J NEUROTRAUM, V24, P1687, DOI 10.1089/neu.2007.0343; Bondanelli M, 2010, J CLIN ENDOCR METAB, V95, P4660, DOI 10.1210/jc.2010-0611; Bullock R, 1996, Eur J Emerg Med, V3, P109, DOI 10.1097/00063110-199606000-00010; Bushnik T, 2004, J HEAD TRAUMA REHAB, V19, P296, DOI 10.1097/00001199-200407000-00004; Castro AI, 2007, J ENDOCRINOL INVEST, V30, P224, DOI 10.1007/BF03347429; DANIEL PM, 1959, LANCET, V2, P927; Dusick JR, 2012, PITUITARY, V15, P2, DOI 10.1007/s11102-008-0130-6; Gasco V, 2012, PITUITARY, V15, P20, DOI 10.1007/s11102-010-0235-6; Ghigo E, 2005, BRAIN INJURY, V19, P711, DOI 10.1080/02699050400025315; Glynn N, 2013, CLIN ENDOCRINOL, V78, P17, DOI 10.1111/cen.12010; Hamrahian AH, 2004, NEW ENGL J MED, V350, P1629, DOI 10.1056/NEJMoa020266; Heather NL, 2012, J CLIN ENDOCR METAB, V97, P599, DOI 10.1210/jc.2011-2284; Hellawell DJ, 2001, DISABIL REHABIL, V23, P300, DOI 10.1080/769979114; Herrmann BL, 2006, EXP CLIN ENDOCR DIAB, V114, P316, DOI 10.1055/s-2006-924254; High WM, 2010, J NEUROTRAUM, V27, P1565, DOI 10.1089/neu.2009.1253; Ho KKY, 2007, EUR J ENDOCRINOL, V157, P695, DOI 10.1530/EJE-07-0631; Jochberger S, 2006, J CLIN ENDOCR METAB, V91, P4381, DOI 10.1210/jc.2005-2830; Kelestimur F, 2004, J ENDOCRINOL INVEST, V27, pRC28, DOI 10.1007/BF03345299; Kelly DF, 2006, J NEUROTRAUM, V23, P928, DOI 10.1089/neu.2006.23.928; Kelly DF, 2000, J NEUROSURG, V93, P743, DOI 10.3171/jns.2000.93.5.0743; Khan F, 2003, MED J AUSTRALIA, V178, P290, DOI 10.5694/j.1326-5377.2003.tb05199.x; Klose M, 2008, PITUITARY, V11, P255, DOI 10.1007/s11102-008-0102-x; Klose M, 2007, CLIN ENDOCRINOL, V67, P598, DOI 10.1111/j.1365-2265.2007.02931.x; Klose M, 2014, J CLIN ENDOCR METAB, V99, P101, DOI 10.1210/jc.2013-2397; Kokshoorn NE, 2011, EUR J ENDOCRINOL, V165, P225, DOI 10.1530/EJE-11-0365; Kokshoorn NE, 2010, EUR J ENDOCRINOL, V162, P11, DOI 10.1530/EJE-09-0601; KORNBLUM RN, 1969, ARCH PATHOL, V88, P242; Kreitschmann-Andermahr I, 2008, GROWTH HORM IGF RES, V18, P472, DOI 10.1016/j.ghir.2008.08.007; Leal-Cerro A, 2005, CLIN ENDOCRINOL, V62, P525, DOI 10.1111/j.1365-2265.2005.02250.x; Lieberman SA, 2001, J CLIN ENDOCR METAB, V86, P2752, DOI 10.1210/jc.86.6.2752; Lorenzo Monica, 2005, Pituitary, V8, P233, DOI 10.1007/s11102-006-6046-0; Maiya B, 2008, INTENS CARE MED, V34, P468, DOI 10.1007/s00134-007-0902-x; Moreau OK, 2013, J NEUROTRAUM, V30, P998, DOI 10.1089/neu.2012.2705; Popovic V, 2004, J ENDOCRINOL INVEST, V27, P1048, DOI 10.1007/BF03345308; Popovic V, 2000, LANCET, V356, P1137, DOI 10.1016/S0140-6736(00)02755-0; Reimunde P, 2011, BRAIN INJURY, V25, P65, DOI 10.3109/02699052.2010.536196; Ruggeri RM, 2010, HORM-INT J ENDOCRINO, V9, P332, DOI 10.14310/horm.2002.1285; Salazar AM, 2000, JAMA-J AM MED ASSOC, V283, P3075, DOI 10.1001/jama.283.23.3075; Salehi F, 2007, BRAIN INJURY, V21, P651, DOI 10.1080/02699050701426956; Schneider HJ, 2011, J NEUROTRAUM, V28, P1693, DOI 10.1089/neu.2011.1887; Schneider HJ, 2007, JAMA-J AM MED ASSOC, V298, P1429, DOI 10.1001/jama.298.12.1429; Schneider HJ, 2006, EUR J ENDOCRINOL, V154, P259, DOI 10.1530/eje.1.02071; Schneider M, 2008, CLIN ENDOCRINOL, V68, P206, DOI 10.1111/j.1365-2265.2007.03020.x; Sundaram NK, 2013, ENDOCRIN METAB CLIN, V42, P565, DOI 10.1016/j.ecl.2013.05.003; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Tanriverdi F, 2010, PITUITARY, V13, P111, DOI 10.1007/s11102-009-0204-0; Tanriverdi F, 2008, EUR J ENDOCRINOL, V159, P7, DOI 10.1530/EJE-08-0050; Tanriverdi F, 2008, ANN INTERN MED, V148, P827, DOI 10.7326/0003-4819-148-11-200806030-00005; Tanriverdi F, 2008, CLIN ENDOCRINOL, V68, P573, DOI 10.1111/j.1365-2265.2007.03070.x; Tanriverdi F, 2006, J CLIN ENDOCR METAB, V91, P2105, DOI 10.1210/jc.2005-2476; Tanriverdi F, 2013, J NEUROTRAUM, V30, P1426, DOI 10.1089/neu.2012.2752; Tanriverdi F, 2010, J NEUROTRAUM, V27, P301, DOI 10.1089/neu.2009.1102; TEASDALE G, 1974, LANCET, V2, P81; Van den Berghe G, 1998, J CLIN ENDOCR METAB, V83, P1827, DOI 10.1210/jc.83.6.1827; Wachter D, 2009, J CLIN NEUROSCI, V16, P202, DOI 10.1016/j.jocn.2008.01.009	65	22	22	0	8	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0889-8529	1558-4410		ENDOCRIN METAB CLIN	Endocrinol. Metabol. Clin. North Amer.	MAR	2015	44	1					151	+		10.1016/j.ecl.2014.10.012			11	Endocrinology & Metabolism	Endocrinology & Metabolism	CE4MN	WOS:000351804800018	25732651				2021-06-18	
J	Trahanas, DM; Cuda, CM; Perlman, H; Schwulst, SJ				Trahanas, Diane M.; Cuda, Carla M.; Perlman, Harris; Schwulst, Steven J.			DIFFERENTIAL ACTIVATION OF INFILTRATING MONOCYTE-DERIVED CELLS AFTER MILD AND SEVERE TRAUMATIC BRAIN INJURY	SHOCK			English	Article						Flow cytometry; mouse brain; traumatic brain injury	CENTRAL-NERVOUS-SYSTEM; MYELOID CELLS; SPINAL-CORD; STEM-CELLS; IN-VIVO; MICROGLIA; MACROPHAGES; CNS; FATE; PLAY	Microglia are the resident innate immune cells of the brain. Although embryologically and functionally distinct, they are morphologically similar to peripheral monocyte-derived cells, resulting in a poor ability to discriminate between the two cell types. The purpose of this study was to develop a rapid and reliable method to simultaneously characterize, quantify, and discriminate between whole populations of myeloid cells from the brain in a murine model of traumatic brain injury. Male C57BL/6 mice underwent traumatic brain injury (n = 16) or sham injury (n = 14). Brains were harvested at 24 h after injury. Multiparameter flow cytometry and sequential gating analysis were performed, allowing for discrimination between microglia and infiltrating leukocytes as well as for the characterization and quantification of individual subtypes within the infiltrating population. The proportion of infiltrating leukocytes within the brain increased with the severity of injury, and the predominant cell types within the infiltrating population were monocyte derived (P = 0.01). In addition, the severity of injury altered the overall makeup of the infiltrating monocyte-derived cells. In conclusion, we describe a flow cytometry-based technique for gross discrimination between infiltrating leukocytes and microglia as well as the ability to simultaneously characterize and quantify individual myeloid subtypes and their maturation states within these populations.	[Trahanas, Diane M.; Schwulst, Steven J.] Northwestern Univ, Dept Surg, Div Trauma & Crit Care, Chicago, IL 60611 USA; [Cuda, Carla M.; Perlman, Harris] Northwestern Univ, Dept Med, Div Rheumatol, Chicago, IL 60611 USA	Schwulst, SJ (corresponding author), Northwestern Univ, Dept Surg, Div Trauma & Crit Care, 676 N St Clair St,Suite 650, Chicago, IL 60611 USA.	sschwuls@nmh.org		Cuda, Carla/0000-0002-2022-8171	Shock Society Research Fellowship; American Association for the Surgery of Trauma Research and Education Foundation; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [AR050250, AR054796, AI092490, HL108795]; Solovy/Arthritis Research Society; NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [P01HL108795] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID) [R21AI092490] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS) [R01AR054796, R01AR050250, K01AR064313] Funding Source: NIH RePORTER	This study was supported by the Shock Society Research Fellowship for Early Career Investigators and a grant from the American Association for the Surgery of Trauma Research and Education Foundation (to S.J.S.) and by National Institutes of Health grants (AR050250, AR054796, AI092490, and HL108795) and funds provided by Solovy/Arthritis Research Society Professor (to H.P.).	Abumaree MH, 2013, STEM CELL REV REP, V9, P620, DOI 10.1007/s12015-013-9455-2; Aguzzi A, 2013, SCIENCE, V339, P156, DOI 10.1126/science.1227901; Ajami B, 2007, NAT NEUROSCI, V10, P1538, DOI 10.1038/nn2014; Bedi SS, 2013, J NEUROSCI METH, V219, P176, DOI 10.1016/j.jneumeth.2013.07.017; Bessis A, 2007, GLIA, V55, P233, DOI 10.1002/glia.20459; Flierl MA, 2009, NAT PROTOC, V4, P1328, DOI 10.1038/nprot.2009.148; FORD AL, 1995, J IMMUNOL, V154, P4309; Ginhoux F, 2010, SCIENCE, V330, P841, DOI 10.1126/science.1194637; Gordon R, 2011, J NEUROSCI METH, V194, P287, DOI 10.1016/j.jneumeth.2010.11.001; Jin XM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041892; Jung S, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00089; London A, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00034; London A, 2011, J EXP MED, V208, P23, DOI 10.1084/jem.20101202; Mildner A, 2009, BRAIN, V132, P2487, DOI 10.1093/brain/awp144; Misharin AV, 2013, AM J RESP CELL MOL, V49, P503, DOI 10.1165/rcmb.2013-0086MA; Nikodemova M, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-147; Nimmerjahn A, 2005, SCIENCE, V308, P1314, DOI 10.1126/science.1110647; Perdiguero EG, 2013, GLIA, V61, P112, DOI 10.1002/glia.22393; Pineau I, 2007, J COMP NEUROL, V500, P267, DOI 10.1002/cne.21149; Rose S, 2012, CYTOM PART A, V81A, P343, DOI 10.1002/cyto.a.22012; Schulz C, 2012, SCIENCE, V336, P86, DOI 10.1126/science.1219179; Schwulst SJ, 2013, J TRAUMA ACUTE CARE, V75, P780, DOI 10.1097/TA.0b013e318299616a; Shechter R, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000113; Simard AR, 2006, NEURON, V49, P489, DOI 10.1016/j.neuron.2006.01.022; Stirling DP, 2008, J NEUROSCI RES, V86, P1944, DOI 10.1002/jnr.21659; Streit WJ, 2002, GLIA, V40, P133, DOI 10.1002/glia.10154; Turtzo LC, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-82; Wake H, 2009, J NEUROSCI, V29, P3974, DOI 10.1523/JNEUROSCI.4363-08.2009	28	22	22	0	10	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1073-2322	1540-0514		SHOCK	Shock	MAR	2015	43	3					255	260		10.1097/SHK.0000000000000291			6	Critical Care Medicine; Hematology; Surgery; Peripheral Vascular Disease	General & Internal Medicine; Hematology; Surgery; Cardiovascular System & Cardiology	CB1UE	WOS:000349412700009	26091024	Green Accepted			2021-06-18	
J	Kiers, H; van Dieen, JH; Brumagne, S; Vanhees, L				Kiers, Henri; van Dieen, Jaap H.; Brumagne, Simon; Vanhees, Luc			Postural sway and integration of proprioceptive signals in subjects with LBP	HUMAN MOVEMENT SCIENCE			English	Article						Low back pain; Postural control; Proprioception; Center of pressure; Nonlinear methods	LOW-BACK-PAIN; OF-PRESSURE TRAJECTORIES; TEST-RETEST RELIABILITY; MUSCLE VIBRATION; CEREBRAL CONCUSSION; TENDON VIBRATION; MOVEMENT; BALANCE; VARIABILITY; REGULARITY	Patients with non-specific low back pain (LBP) may use postural control strategies that differ from healthy subjects. To study these possible differences, we measured the amount and structure of postural sway, and the response to muscle vibration in a working cohort of 215 subjects. Subjects were standing on a force plate in bipedal stance. In the first trial the eyes were open, no perturbation applied. In the following 6 trials, vision was occluded and subjects stood under various conditions of vibration/no vibration of the lumbar spine or m. Triceps Surae (TSM) on firm surface and on foam surface. We performed a factor analysis to reduce the large amount of variables that are available to quantify all effects. Subjects with LBP showed the same amount of sway as subjects without LBP, but the structure of their sway pattern was less regular with higher frequency content. Subjects with LBP also showed a smaller response to TSM vibration, and a slower balance recovery after cessation of vibration when standing on a solid surface. There was a weak but significant association between smaller responses to TSM vibration and an irregular, high frequency sway pattern, independent from LBP. A model for control of postural sway is proposed. This model suggests that subjects with LBP use more co-contraction and less cognitive control, to maintain a standing balance when compared to subjects without LBP. In addition, a reduced weighting of proprioceptive signals in subjects with LBP is suggested as an explanation for the findings in this study. (C) 2014 Published by Elsevier B.V.	[Kiers, Henri; Vanhees, Luc] Univ Appl Sci Utrecht, Res Grp Lifestyle & Hlth, Utrecht, Netherlands; [van Dieen, Jaap H.] Vrije Univ Amsterdam, Fac Human Movement Sci, Amsterdam, Netherlands; [Brumagne, Simon; Vanhees, Luc] Katholieke Univ Leuven, Dept Rehabil Sci, Leuven, Belgium	Kiers, H (corresponding author), Bolognalaan 101, NL-3584 CJ Utrecht, Netherlands.	henri.kiers@hu.nl	van Dieen, Jaap/B-3937-2013	van Dieen, Jaap/0000-0002-7719-5585; Brumagne, Simon/0000-0002-0251-9338			Andersson G, 2002, BRAIN RES BULL, V58, P135, DOI 10.1016/S0361-9230(02)00770-0; Brumagne S, 2004, NEUROSCI LETT, V366, P63, DOI 10.1016/j.neulet.2004.05.013; Brumagne S, 1999, J ORTHOP SPORT PHYS, V29, P345, DOI 10.2519/jospt.1999.29.6.345; Brumagne S, 2008, EUR SPINE J, V17, P1177, DOI 10.1007/s00586-008-0709-7; BURKE D, 1976, J PHYSIOL-LONDON, V261, P673, DOI 10.1113/jphysiol.1976.sp011580; Carpenter MG, 2010, NEUROSCIENCE, V171, P196, DOI 10.1016/j.neuroscience.2010.08.030; Casadio M, 2005, GAIT POSTURE, V21, P410, DOI 10.1016/j.gaitpost.2004.05.005; Cavanaugh JT, 2006, J ATHL TRAINING, V41, P305; Cavanaugh JT, 2005, BRIT J SPORT MED, V39, P805, DOI 10.1136/bjsm.2004.015909; Claeys K, 2011, EUR J APPL PHYSIOL, V111, P115, DOI 10.1007/s00421-010-1637-x; Cordo PJ, 2005, EXP BRAIN RES, V167, P324, DOI 10.1007/s00221-005-0034-x; Donker SF, 2008, EXP BRAIN RES, V184, P363, DOI 10.1007/s00221-007-1105-y; Donker SF, 2007, EXP BRAIN RES, V181, P1, DOI 10.1007/s00221-007-0905-4; Gautier G, 2008, J MOTOR BEHAV, V40, P400, DOI 10.3200/JMBR.40.5.400-408; Gill KP, 1998, SPINE, V23, P371, DOI 10.1097/00007632-199802010-00017; GOODWIN GM, 1972, SCIENCE, V175, P1382, DOI 10.1126/science.175.4028.1382; Hodges PW, 2011, PAIN, V152, pS90, DOI 10.1016/j.pain.2010.10.020; Ivanenko YP, 1999, EUR J NEUROSCI, V11, P647, DOI 10.1046/j.1460-9568.1999.00471.x; Johanson E, 2011, EUR SPINE J, V20, P2152, DOI 10.1007/s00586-011-1825-3; Kiers H, 2014, GAIT POSTURE, V40, P166, DOI 10.1016/j.gaitpost.2014.03.184; Kiers H, 2012, EUR J APPL PHYSIOL, V112, P1577, DOI 10.1007/s00421-011-2124-8; MASSION J, 1992, PROG NEUROBIOL, V38, P35, DOI 10.1016/0301-0082(92)90034-C; Mazaheri M, 2013, GAIT POSTURE, V37, P12, DOI 10.1016/j.gaitpost.2012.06.013; Mazaheri M, 2010, GAIT POSTURE, V31, P116, DOI 10.1016/j.gaitpost.2009.09.009; Costa LDM, 2013, SPINE, V38, P148, DOI 10.1097/BRS.0b013e318267a92f; Mok NW, 2004, SPINE, V29, pE107, DOI 10.1097/01.BRS.0000115134.97854.C9; Nafati G, 2011, RES Q EXERCISE SPORT, V82, P634, DOI 10.1080/02701367.2011.10599800; Negahban H, 2014, KNEE SURG SPORT TR A, V22, P1491, DOI 10.1007/s00167-013-2501-4; Nijs J, 2012, CLIN J PAIN, V28, P175, DOI 10.1097/AJP.0b013e318225daf3; O'Sullivan PB, 2003, SPINE, V28, P1074, DOI 10.1097/00007632-200305150-00022; Proske U, 2012, PHYSIOL REV, V92, P1651, DOI 10.1152/physrev.00048.2011; Rigoldi C, 2013, RES DEV DISABIL, V34, P840, DOI 10.1016/j.ridd.2012.11.007; Riley MA, 2003, BRAIN RES BULL, V62, P191, DOI 10.1016/j.brainresbull.2003.09.012; Roerdink M, 2006, EXP BRAIN RES, V174, P256, DOI 10.1007/s00221-006-0441-7; ROLL JP, 1982, EXP BRAIN RES, V47, P177; ROLL JP, 1989, EXP BRAIN RES, V76, P213; Ruhe A, 2013, J BACK MUSCULOSKELET, V26, P401, DOI 10.3233/BMR-130399; Ruhe A, 2012, BMC MUSCULOSKEL DIS, V13, DOI 10.1186/1471-2474-13-39; Ruhe A, 2011, BMC MUSCULOSKEL DIS, V12, DOI 10.1186/1471-2474-12-162; Ruhe A, 2011, CHIROPR MAN THER, V19, DOI 10.1186/2045-709X-19-13; Ruhe A, 2010, GAIT POSTURE, V32, P436, DOI 10.1016/j.gaitpost.2010.09.012; Schmit JM, 2006, EXP BRAIN RES, V168, P357, DOI 10.1007/s00221-005-0094-y; Simoneau M, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-68; Sipko T., 2012, EUROPEAN J PAIN; van Dieen JH, 2003, J ELECTROMYOGR KINES, V13, P333, DOI 10.1016/S1050-6411(03)00041-5; van Drunen P, 2013, J BIOMECH, V46, P1440, DOI 10.1016/j.jbiomech.2013.03.007; Vuillerme N, 2001, NEUROSCI LETT, V311, P73, DOI 10.1016/S0304-3940(01)02147-4; Willigenburg NW, 2013, HUM MOVEMENT SCI, V32, P228, DOI 10.1016/j.humov.2012.12.007; Winter DA, 1998, J NEUROPHYSIOL, V80, P1211; Yilmaz B, 2010, TURK J RHEUMATOL, V25, P68, DOI 10.5152/tjr.2010.04; Zatsiorsky VM, 2000, MOTOR CONTROL, V4, P185, DOI 10.1123/mcj.4.2.185	51	22	22	0	13	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0167-9457	1872-7646		HUM MOVEMENT SCI	Hum. Mov. Sci.	FEB	2015	39						109	120		10.1016/j.humov.2014.05.011			12	Neurosciences; Psychology; Psychology, Experimental; Sport Sciences	Neurosciences & Neurology; Psychology; Sport Sciences	CA2NY	WOS:000348746100010	25436915	Green Published			2021-06-18	
J	Pechmann, A; Anastasopoulos, C; Korinthenberg, R; van Velthoven-Wurster, V; Kirschner, J				Pechmann, Astrid; Anastasopoulos, Constantin; Korinthenberg, Rudolf; van Velthoven-Wurster, Vera; Kirschner, Janbernd			Decompressive Craniectomy after Severe Traumatic Brain Injury in Children: Complications and Outcome	NEUROPEDIATRICS			English	Article						traumatic brain injury; decompressive craniectomy; children; complications; outcome	INTRACRANIAL HYPERTENSION; CLINICAL ARTICLE; RISK-FACTORS; PEDIATRIC-PATIENTS; SUBDURAL HYGROMA; ADULTS; CRANIOPLASTY; MANAGEMENT; SEIZURES; INFANTS	Decompressive craniectomy (DC) is a controversially discussed neurosurgical procedure to reduce elevated intracranial pressure after severe traumatic brain injury (TBI). In contrast to adults, several studies could show a benefit for the pediatric population, but still DC is considered as an emergency procedure only. The aim of our study was to identify secondary complications and long-term sequelae of the procedure. All children presenting to the University Medical Center Freiburg between 2005 and 2013 who underwent DC after severe TBI were retrospectively reviewed with respect to complications and outcome. Twelve children were included with a mean Glasgow Coma Scale of 4.5 +/- 1.7. The most frequent complications after TBI and DC were formation of hygroma (83%), aseptic bone resorption of the reimplanted bone flap (50%), post-traumatic hydrocephalus (42%), secondary infection or dysfunction of ventriculoperitoneal shunt (25%) or cranioplasty (33%), and epilepsy (33%). Because of these complications, 75% of patients required further surgery in addition to cranioplasty with up to eight interventions. At follow-up, mean Glasgow Outcome Scale was 3.3 +/- 1.2. Within our patient population, we demonstrated high incidence of complications after DC, leading to further surgical procedures and longer hospitalization. These potential complications have to be considered in any decision about DC as an emergency procedure.	[Pechmann, Astrid; Anastasopoulos, Constantin; Korinthenberg, Rudolf; Kirschner, Janbernd] Univ Med Ctr Freiburg, Div Neuropediat & Muscle Disorders, D-79106 Freiburg, Germany; [van Velthoven-Wurster, Vera] Univ Med Ctr Freiburg, Dept Neurosurg, Freiburg, Germany	Kirschner, J (corresponding author), Univ Med Ctr Freiburg, Div Neuropediat & Muscle Disorders, Mathildenstr 1, D-79106 Freiburg, Germany.	Janbernd.Kirschner@uniklinik-freiburg.de	Kirschner, Janbernd/H-7418-2016; Kirschner, Janbernd/Q-1493-2019; Korinthenberg, Rudolf/A-9796-2009	Kirschner, Janbernd/0000-0003-1618-7386; Kirschner, Janbernd/0000-0003-1618-7386; Korinthenberg, Rudolf/0000-0002-4638-3460			Aarabi B, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/2009.3.FOCUS0947; Adamo MA, 2009, J NEUROSURG-PEDIATR, V3, P334, DOI 10.3171/2008.12.PEDS08310; Annegers JF, 1998, NEW ENGL J MED, V338, P20, DOI 10.1056/NEJM199801013380104; Bowers CA, 2013, J NEUROSURG-PEDIATR, V11, P526, DOI 10.3171/2013.1.PEDS12483; Cambra FJ, 2010, AN PEDIATR, V73, P12, DOI 10.1016/j.anpedi.2010.02.011; Chang V, 2010, J NEUROSURG, V112, P1120, DOI 10.3171/2009.6.JNS09133; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; Figaji AA, 2003, CHILD NERV SYST, V19, P666, DOI 10.1007/s00381-003-0804-3; Frey LC, 2003, EPILEPSIA, V44, P11, DOI 10.1046/j.1528-1157.44.s10.4.x; Giza CC, 2007, CURR OPIN CRIT CARE, V13, P143, DOI 10.1097/MCC.0b013e32808255dc; Grant GA, 2004, J NEUROSURG, V100, P163, DOI 10.3171/ped.2004.100.2.0163; HAHN YS, 1988, NEUROSURGERY, V22, P864, DOI 10.1227/00006123-198805000-00008; HAINES DE, 1993, NEUROSURGERY, V32, P111, DOI 10.1227/00006123-199301000-00017; Honeybul S, 2012, J NEUROTRAUM, V29, P1872, DOI 10.1089/neu.2012.2356; Honeybul S, 2011, J NEUROTRAUM, V28, P929, DOI 10.1089/neu.2010.1612; Jagannathan J, 2007, J NEUROSURG, V106, P268, DOI 10.3171/ped.2007.106.4.268; JENNETT B, 1975, LANCET, V1, P480; Jeon SW, 2011, J KOREAN NEUROSURG S, V49, P355, DOI 10.3340/jkns.2011.49.6.355; Kan P, 2006, J NEUROSURG, V105, P337, DOI 10.3171/ped.2006.105.5.337; Kochanek PM, 2012, PEDIATR CRIT CARE ME, V13, pS1, DOI 10.1097/PCC.0b013e31823f435c; KRAUS JF, 1990, AM J DIS CHILD, V144, P684, DOI 10.1001/archpedi.1990.02150300082022; Liu YG, 2009, INJURY, V40, P968, DOI 10.1016/j.injury.2009.01.006; Maas AIR, 1997, ACTA NEUROCHIR, V139, P286, DOI 10.1007/BF01808823; Martin KD, 2014, ACTA NEUROCHIR, V156, P813, DOI 10.1007/s00701-014-2021-0; Mehta A, 2010, DEV NEUROSCI-BASEL, V32, P413, DOI 10.1159/000316804; Suarez EP, 2011, J TRAUMA, V71, P133, DOI 10.1097/TA.0b013e318211071f; Piedra MP, 2012, J NEUROSURG-PEDIATR, V10, P268, DOI 10.3171/2012.6.PEDS1268; Ruf B, 2003, CRIT CARE, V7, pR133, DOI 10.1186/cc2361; Rutigliano D, 2006, J PEDIATR SURG, V41, P83, DOI 10.1016/j.jpedsurg.2005.10.010; Sahuquillo J, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003983.pub2; Shi SS, 2011, CHIN J TRAUMATOL, V14, P343, DOI 10.3760/cma.j.issn.1008-1275.2011.06.004; Shukla D, 2011, CLIN NEUROL NEUROSUR, V113, P435, DOI 10.1016/j.clineuro.2011.02.013; Taylor A, 2001, CHILD NERV SYST, V17, P154, DOI 10.1007/s003810000410	33	22	26	0	10	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0174-304X	1439-1899		NEUROPEDIATRICS	Neuropediatrics	FEB	2015	46	1					5	12		10.1055/s-0034-1393707			8	Clinical Neurology; Pediatrics	Neurosciences & Neurology; Pediatrics	AZ3OK	WOS:000348136600003	25343328				2021-06-18	
J	Kelso, ML; Elliott, BR; Haverland, NA; Mosley, RL; Gendelman, HE				Kelso, Matthew L.; Elliott, Bret R.; Haverland, Nicole A.; Mosley, R. Lee; Gendelman, Howard E.			Granulocyte-Macrophage Colony Stimulating Factor Exerts Protective and Immunomodulatory Effects in Cortical Trauma	JOURNAL OF NEUROIMMUNOLOGY			English	Article						Traumatic brain injury; Immunity; Microglia; Neuroinflammation; T cell	REGULATORY T-CELLS; EXPERIMENTAL MYASTHENIA-GRAVIS; BRAIN-INJURY; GM-CSF; PARKINSONS-DISEASE; IN-VIVO; NEUROPROTECTIVE ACTIVITIES; MICROGLIAL ACTIVATION; CEREBRAL-ISCHEMIA; MICE	Neurodegeneration after traumatic brain injury is facilitated by innate and adaptive immunity and can be harnessed to affect brain repair. In mice subjected to controlled cortical impact (CCI), we show that treatment with granulocyte macrophage colony stimulating factor (GM-CSF) affects regulatory T cell numbers in the cervical lymph nodes coincident with decreased lesion volumes and increased cortical tissue sparing. This paralleled increases in neurofilament and diminished reactive microglial staining. Transcriptomic analysis showed that GM-CSF induces robust immune neuroprotective responses seven days following CCI. Together, these results support the therapeutic potential of GM-CSF for TBI. (C) 2014 Elsevier B.V. All rights reserved.	[Kelso, Matthew L.] Univ Nebraska Med Ctr, Coll Pharm, Dept Pharm Practice, Omaha, NE 68198 USA; [Elliott, Bret R.; Haverland, Nicole A.; Mosley, R. Lee; Gendelman, Howard E.] Univ Nebraska Med Ctr, Coll Med, Dept Pharmacol & Expt Neurosci, Omaha, NE 68198 USA	Kelso, ML (corresponding author), Univ Nebraska Med Ctr, Coll Pharm, Dept Pharm Practice, Omaha, NE 68198 USA.	hegendel@unmc.edu			Carol Swarts Neuroscience Research Laboratory; Frances and Louie Blumkin Foundation; Department of DefenseUnited States Department of Defense [W81XWH11-1-0700]; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [1P01DA028555, 2R01NS034239, 2R01NS36126, P01NS43985, P01MH64570]; Centers of Biomedical Research Excellence grant [P20GM103480]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [P20GM103480] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [P30MH062261, P01MH064570] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS036126, R01NS070190, P01NS043985, R01NS034239, T32NS007488, P01NS031492, R13NS083315, R37NS036126] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R01AG043540] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission [P01DA026146, P01DA028555] Funding Source: NIH RePORTER	We thank Dr. Pawel Ciborowski, Department of Pharmacology and Experimental Neuroscience, for support provided for the transcriptome analyses. Acquisition of flow cytometric data was performed by the UNMC Cell Analysis Facility. This work was supported by the Carol Swarts Neuroscience Research Laboratory, the Frances and Louie Blumkin Foundation, Department of Defense Grant W81XWH11-1-0700, and National Institutes of Health grants (1P01DA028555, 2R01NS034239, 2R01NS36126, P01NS43985, and P01MH64570) to H.E.G. and a Centers of Biomedical Research Excellence grant (P20GM103480) to M.K. and H.E.G.	Boulet T, 2013, J NEUROTRAUM, V30, P1512, DOI 10.1089/neu.2012.2788; Buchsel Patricia C, 2002, Clin J Oncol Nurs, V6, P198; Burda JE, 2014, NEURON, V81, P229, DOI 10.1016/j.neuron.2013.12.034; Carlos TM, 1997, J LEUKOCYTE BIOL, V61, P279; Clausen F, 2009, EUR J NEUROSCI, V30, P385, DOI 10.1111/j.1460-9568.2009.06820.x; Cole JT, 2011, J NEUROTRAUM, V28, P359, DOI 10.1089/neu.2010.1427; Dash PK, 2011, J NEUROSCI, V31, P3148, DOI 10.1523/JNEUROSCI.5473-10.2011; Davalos D, 2005, NAT NEUROSCI, V8, P752, DOI 10.1038/nn1472; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; Gendelman HE, 2011, TRENDS MOL MED, V17, P687, DOI 10.1016/j.molmed.2011.08.005; Hall ED, 2008, J NEUROTRAUM, V25, P235, DOI 10.1089/neu.2007.0383; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Jin XM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041892; Kelso ML, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-108; Kelso ML, 2006, BRAIN RES, V1083, P204, DOI 10.1016/j.brainres.2006.01.127; Kim NK, 2009, EUR J NEUROSCI, V29, P891, DOI 10.1111/j.1460-9568.2009.06653.x; Kong T, 2009, J NEUROSURG, V111, P155, DOI 10.3171/2008.12.JNS08172; Kosloski LM, 2013, J NEUROIMMUNOL, V265, P1, DOI 10.1016/j.jneuroim.2013.10.009; Kox M, 2008, NEUROLOGY, V70, P480, DOI 10.1212/01.wnl.0000279479.69502.3e; Lagraoui Mouna, 2012, Front Neurol, V3, P155, DOI 10.3389/fneur.2012.00155; Laird MD, 2014, GLIA, V62, P26, DOI 10.1002/glia.22581; Li PY, 2013, ANN NEUROL, V74, P458, DOI 10.1002/ana.23815; Liesz A, 2013, J NEUROSCI, V33, P17350, DOI 10.1523/JNEUROSCI.4901-12.2013; Liesz A, 2009, NAT MED, V15, P192, DOI 10.1038/nm.1927; Liljefors M, 2008, CANCER IMMUNOL IMMUN, V57, P379, DOI 10.1007/s00262-007-0377-1; Liu YW, 2006, NAT MED, V12, P518, DOI 10.1038/nm1402; Loane DJ, 2014, J NEUROPATH EXP NEUR, V73, P14, DOI 10.1097/NEN.0000000000000021; Mangano EN, 2011, NEUROBIOL DIS, V43, P99, DOI 10.1016/j.nbd.2011.02.011; Marshall SA, 2013, NEUROBIOL DIS, V54, P239, DOI 10.1016/j.nbd.2012.12.016; Mi HY, 2013, NUCLEIC ACIDS RES, V41, pD377, DOI 10.1093/nar/gks1118; Nakagawa T, 2006, BRAIN RES, V1089, P179, DOI 10.1016/j.brainres.2006.03.059; Nimmerjahn A, 2005, SCIENCE, V308, P1314, DOI 10.1126/science.1110647; Nishihara T, 2011, EXP NEUROL, V229, P507, DOI 10.1016/j.expneurol.2011.04.006; PALMER AM, 1993, J NEUROCHEM, V61, P2015, DOI 10.1111/j.1471-4159.1993.tb07437.x; Raivich G, 1999, BRAIN RES REV, V30, P77, DOI 10.1016/S0165-0173(99)00007-7; Ramlackhansingh AF, 2011, ANN NEUROL, V70, P374, DOI 10.1002/ana.22455; Reynolds AD, 2007, J LEUKOCYTE BIOL, V82, P1083, DOI 10.1189/jlb.0507296; Reynolds AD, 2010, J IMMUNOL, V184, P2261, DOI 10.4049/jimmunol.0901852; Reynolds AD, 2009, J PROTEOME RES, V8, P3497, DOI 10.1021/pr9001614; Ridwan S, 2012, J NEURAL TRANSM, V119, P1389, DOI 10.1007/s00702-012-0794-y; Schabitz WR, 2008, J CEREBR BLOOD F MET, V28, P29, DOI 10.1038/sj.jcbfm.9600496; Schwarzmaier SM, 2010, J NEUROTRAUM, V27, P121, DOI 10.1089/neu.2009.1114; Segev-Amzaleg N, 2013, BRAIN BEHAV IMMUN, V30, P176, DOI 10.1016/j.bbi.2012.12.016; Sheng JR, 2008, CLIN IMMUNOL, V128, P172, DOI 10.1016/j.clim.2008.03.509; Sheng JR, 2011, J NEUROIMMUNOL, V240, P65, DOI 10.1016/j.jneuroim.2011.10.010; Shultz SR, 2014, J NEUROTRAUM, V31, P976, DOI 10.1089/neu.2013.3106; Soares HD, 1995, J NEUROSCI, V15, P8223; Trajkovic V, 2004, GLIA, V47, P168, DOI 10.1002/glia.20046; Wang GH, 2013, J CEREBR BLOOD F MET, V33, P1864, DOI 10.1038/jcbfm.2013.146; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Ziebell J. M., 2014, METAB BRAIN DIS; Zou T, 2011, TRANSFUSION, V51, p160S, DOI 10.1111/j.1537-2995.2011.03379.x	52	22	22	0	6	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0165-5728	1872-8421		J NEUROIMMUNOL	J. Neuroimmunol.	JAN 15	2015	278						162	173		10.1016/j.jneuroim.2014.11.002			12	Immunology; Neurosciences	Immunology; Neurosciences & Neurology	CA9UC	WOS:000349269300021	25468272	Green Accepted			2021-06-18	
J	Addington, CP; Roussas, A; Dutta, D; Stabenfeldt, SE				Addington, Caroline P.; Roussas, Adam; Dutta, Dipankar; Stabenfeldt, Sarah E.			Endogenous Repair Signaling after Brain Injury and Complementary Bioengineering Approaches to Enhance Neural Regeneration	BIOMARKER INSIGHTS			English	Article						stem cells; traumatic brain injury; transplantation; controlled release	FIBROBLAST-GROWTH-FACTOR; NECROSIS-FACTOR-ALPHA; MESENCHYMAL STEM-CELLS; CENTRAL-NERVOUS-SYSTEM; CONTROLLED CORTICAL IMPACT; FOCAL CEREBRAL-ISCHEMIA; MARROW STROMAL CELLS; ADULT-RAT BRAIN; NEUROTROPHIC FACTORS BDNF; VEGF GENE-TRANSFER	Traumatic brain injury (TBI) affects 5.3 million Americans annually. Despite the many long-term deficits associated with TBI, there currently are no clinically available therapies that directly address the underlying pathologies contributing to these deficits. Preclinical studies have investigated various therapeutic approaches for TBI: two such approaches are stem cell transplantation and delivery of bioactive factors to mitigate the biochemical insult affiliated with TBI. However, success with either of these approaches has been limited largely due to the complexity of the injury microenvironment. As such, this review outlines the many factors of the injury microenvironment that mediate endogenous neural regeneration after TBI and the corresponding bioengineering approaches that harness these inherent signaling mechanisms to further amplify regenerative efforts.	[Addington, Caroline P.; Roussas, Adam; Dutta, Dipankar; Stabenfeldt, Sarah E.] Arizona State Univ, Sch Biol & Hlth Syst Engn, Tempe, AZ USA	Stabenfeldt, SE (corresponding author), Arizona State Univ, Sch Biol & Hlth Syst Engn, Tempe, AZ USA.	sarah.stabenfeldt@asu.edu		Addington, Caroline/0000-0003-4534-8222; Dutta, Dipankar/0000-0001-9864-1452	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [DP2HD084067] Funding Source: NIH RePORTER; NICHD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [DP2 HD084067] Funding Source: Medline		Acarin L, 2000, EUR J NEUROSCI, V12, P3505, DOI 10.1046/j.1460-9568.2000.00226.x; Addington CP, 2014, BIOMATERIALS, V35, P3263, DOI 10.1016/j.biomaterials.2013.12.102; Agasse F, 2007, EUR J NEUROSCI, V26, P3036, DOI 10.1111/j.1460-9568.2007.05915.x; AHMED S, 1995, J NEUROSCI, V15, P5765; Ahn MJ, 2004, J NEUROTRAUM, V21, P1431, DOI 10.1089/neu.2004.21.1431; Alagappan D, 2009, ASN NEURO, V1, DOI 10.1042/AN20090002; Alcala-Barraza SR, 2010, J DRUG TARGET, V18, P179, DOI 10.3109/10611860903318134; ALTMAN J, 1967, NATURE, V214, P1098, DOI 10.1038/2141098a0; Anthony D, 1998, CURR BIOL, V8, P923, DOI 10.1016/S0960-9822(07)00373-9; ARAUJO DM, 1992, J NEUROSCI, V12, P1668; Arbour RB, 2013, CRIT CARE NURS CLIN, V25, P297, DOI 10.1016/j.ccell.2013.02.010; Arguello AA, 2009, NEUROSCIENCE, V159, P1003, DOI 10.1016/j.neuroscience.2009.01.020; Bang OY, 2012, CELL MED, V4, P65, DOI 10.3727/215517912X647172; Barone FC, 2006, CLIN NEUROSCI RES, V6, P329, DOI 10.1016/j.cnr.2006.09.010; Basu A, 2002, J NEUROSCI, V22, P6071; Batchelor PE, 1999, J NEUROSCI, V19, P1708; Baumann L, 2012, J CONTROL RELEASE, V162, P68, DOI 10.1016/j.jconrel.2012.04.049; Ben-Hur T, 2003, MOL CELL NEUROSCI, V24, P623, DOI 10.1016/S1044-7431(03)00218-5; BENVENISTE EN, 1995, INT J DEV NEUROSCI, V13, P341, DOI 10.1016/0736-5748(94)00061-7; Bernardino L, 2005, J NEUROSCI, V25, P6734, DOI 10.1523/JNEUROSCI.1510-05.2005; Berry M, 2011, BRAIN RES BULL, V84, P289, DOI 10.1016/j.brainresbull.2010.08.004; Bertram JP, 2010, PHARM RES-DORDR, V27, P82, DOI 10.1007/s11095-009-0009-x; Bicker J, 2014, EUR J PHARM BIOPHARM, V87, P409, DOI 10.1016/j.ejpb.2014.03.012; BOGDAN C, 1992, J BIOL CHEM, V267, P23301; Bovetti S, 2007, J NEUROSCI, V27, P5976, DOI 10.1523/JNEUROSCI.0678-07.2007; Buckwalter MS, 2006, AM J PATHOL, V169, P154, DOI 10.2353/ajpath.2006.051272; Bush TG, 1999, NEURON, V23, P297, DOI 10.1016/S0896-6273(00)80781-3; Buttini M, 1996, NEUROSCIENCE, V71, P1, DOI 10.1016/0306-4522(95)00414-9; Cacci E, 2008, GLIA, V56, P412, DOI 10.1002/glia.20616; Calderon TM, 2006, J NEUROIMMUNOL, V177, P27, DOI 10.1016/j.jneuroim.2006.05.003; CASSATELLA MA, 1994, J EXP MED, V179, P1695, DOI 10.1084/jem.179.5.1695; Chao CC, 1995, BRAIN BEHAV IMMUN, V9, P355, DOI 10.1006/brbi.1995.1033; Chen XG, 2002, J NEUROSCI RES, V69, P687, DOI 10.1002/jnr.10334; Cheng AW, 2003, DEV BIOL, V258, P319, DOI 10.1016/S0012-1606(03)00120-9; Cheng TY, 2013, BIOMATERIALS, V34, P2005, DOI 10.1016/j.biomaterials.2012.11.043; Chiaretti A, 2005, CHILD NERV SYST, V21, P185, DOI 10.1007/s00381-004-1032-1; Ching S, 2005, BRAIN BEHAV IMMUN, V19, P127, DOI 10.1016/j.bbi.2004.06.001; Chirumamilla S, 2002, J NEUROTRAUM, V19, P693, DOI 10.1089/08977150260139084; Chodobski A, 2003, NEUROSCIENCE, V122, P853, DOI 10.1016/j.neuroscience.2003.08.055; Clausen F, 2011, EUR J NEUROSCI, V34, P110, DOI 10.1111/j.1460-9568.2011.07723.x; Cook JL, 1998, MOL BRAIN RES, V55, P9, DOI 10.1016/S0169-328X(97)00350-1; Cooke MJ, 2011, BIOMATERIALS, V32, P5688, DOI 10.1016/j.biomaterials.2011.04.032; Coronado VG, 2012, J SAFETY RES, V43, P299, DOI 10.1016/j.jsr.2012.08.011; Cross DP, 2011, PHARM RES-DORDR, V28, P2477, DOI 10.1007/s11095-011-0474-x; Csuka E, 1999, J NEUROIMMUNOL, V101, P211, DOI 10.1016/S0165-5728(99)00148-4; Cui M, 2011, GLIA, V59, P641, DOI 10.1002/glia.21134; DACUNHA A, 1992, J NEUROIMMUNOL, V36, P157; Delcroix GJR, 2010, BIOMATERIALS, V31, P2105, DOI 10.1016/j.biomaterials.2009.11.084; Dietrich WD, 1996, J NEUROTRAUM, V13, P309, DOI 10.1089/neu.1996.13.309; Doetsch F, 2002, NEURON, V36, P1021, DOI 10.1016/S0896-6273(02)01133-9; Doetsch F, 1997, J NEUROSCI, V17, P5046; Doetsch F, 2003, CURR OPIN GENET DEV, V13, P543, DOI 10.1016/j.gde.2003.08.012; Downen M, 1999, GLIA, V28, P114, DOI 10.1002/(SICI)1098-1136(199911)28:2<114::AID-GLIA3>3.0.CO;2-O; Dziegielewska KM, 2000, CELL TISSUE RES, V299, P335; Emerich DF, 2010, NEUROTOX RES, V17, P66, DOI 10.1007/s12640-009-9079-0; Endres M, 2000, J CEREBR BLOOD F MET, V20, P139, DOI 10.1097/00004647-200001000-00018; Faigle R, 2013, BBA-GEN SUBJECTS, V1830, P2435, DOI 10.1016/j.bbagen.2012.09.002; Fassbender K, 2000, NEUROSCI LETT, V284, P135, DOI 10.1016/S0304-3940(00)00977-0; Fee D, 2000, CYTOKINE, V12, P655, DOI 10.1006/cyto.1999.0599; Filippo TRM, 2013, STEM CELL RES, V11, P913, DOI 10.1016/j.scr.2013.06.003; FINCH CE, 1993, J CELL BIOCHEM, V53, P314, DOI 10.1002/jcb.240530408; FINKLESTEIN SP, 1988, BRAIN RES, V460, P253, DOI 10.1016/0006-8993(88)90370-8; Folkersma H, 2008, ACTA NEUROCHIR, V150, P1277, DOI 10.1007/s00701-008-0151-y; Fon D, 2014, BIOMATERIALS, V35, P2692, DOI 10.1016/j.biomaterials.2013.12.016; FRAUTSCHY SA, 1991, BRAIN RES, V553, P291, DOI 10.1016/0006-8993(91)90837-L; Freire-de-Lima CG, 2006, J BIOL CHEM, V281, P38376, DOI 10.1074/jbc.M605146200; Friedman WJ, 2005, MOL NEUROBIOL, V32, P133, DOI 10.1385/MN:32:2:133; Fujio M, 2011, BONE, V49, P693, DOI 10.1016/j.bone.2011.06.024; Gabay C, 2010, NAT REV RHEUMATOL, V6, P232, DOI 10.1038/nrrheum.2010.4; GADIENT RA, 1990, NEUROSCI LETT, V117, P335, DOI 10.1016/0304-3940(90)90687-5; Galderisi U, 2013, STEM CELL RES, V10, P85, DOI 10.1016/j.scr.2012.09.001; Gao JL, 2006, EXP NEUROL, V201, P281, DOI 10.1016/j.expneurol.2006.04.039; Gao X, 2009, J NEUROTRAUM, V26, P1325, DOI 10.1089/neu.2008-0744; Giraudo E, 1996, J IMMUNOL, V157, P2618; Godbout JP, 2004, J NEUROIMMUNOL, V147, P141, DOI 10.1016/j.jneuroim.2003.10.031; Goldberg JS, 2009, REGEN MED, V4, P879, DOI [10.2217/rme.09.61, 10.2217/RME.09.61]; Gourin CG, 1997, J TRAUMA, V42, P1101, DOI 10.1097/00005373-199706000-00020; Green HF, 2012, MOL CELL NEUROSCI, V49, P311, DOI 10.1016/j.mcn.2012.01.001; Grigoriadis N, 2011, EXP NEUROL, V230, P78, DOI 10.1016/j.expneurol.2011.02.021; Gritti A, 1996, J NEUROSCI, V16, P1091; Guan J, 2013, BIOMATERIALS, V34, P5937, DOI 10.1016/j.biomaterials.2013.04.047; Hall ED, 2005, J NEUROTRAUM, V22, P252, DOI 10.1089/neu.2005.22.252; Hamann MCJ, 2005, EXP NEUROL, V194, P106, DOI 10.1016/j.expneurol.2005.01.030; Harting MT, 2008, SURGERY, V144, P803, DOI 10.1016/j.surg.2008.05.017; Harting MT, 2009, J SURG RES, V153, P188, DOI 10.1016/j.jss.2008.03.037; Hatic H, 2012, J NEUROTRAUM, V29, P1188, DOI 10.1089/neu.2011.1806; Hayamizu TF, 2001, NEUROL RES, V23, P353, DOI 10.1179/016164101101198550; HAYES RL, 1992, J NEUROTRAUM, V9, pS173; He XZ, 2010, INT J PHARMACEUT, V390, P107, DOI 10.1016/j.ijpharm.2009.12.063; Heese K, 1998, J NEUROCHEM, V70, P699; Heffernan J.M., 2014, ANN BIOMED ENG; Helmy A, 2011, PROG NEUROBIOL, V95, P352, DOI 10.1016/j.pneurobio.2011.09.003; Henderson PW, 2011, WOUND REPAIR REGEN, V19, P420, DOI 10.1111/j.1524-475X.2011.00687.x; Hensler T, 2000, INFLAMM RES, V49, P524, DOI 10.1007/s000110050626; Herx LM, 2000, J IMMUNOL, V165, P2232, DOI 10.4049/jimmunol.165.4.2232; Herx LM, 2001, J NEUROPATH EXP NEUR, V60, P961, DOI 10.1093/jnen/60.10.961; Hicks RR, 1999, EXP NEUROL, V160, P469, DOI 10.1006/exnr.1999.7216; Hicks RR, 1997, MOL BRAIN RES, V48, P401, DOI 10.1016/S0169-328X(97)00158-7; Higashino K, 2011, TISSUE ENG PT A, V17, P523, DOI 10.1089/ten.tea.2010.0168; Hill WD, 2004, J NEUROPATH EXP NEUR, V63, P84, DOI 10.1093/jnen/63.1.84; Horne MK, 2010, STEM CELLS DEV, V19, P843, DOI 10.1089/scd.2009.0158; Huang F, 2013, NEUROREPORT, V24, P101, DOI 10.1097/WNR.0b013e32835c93c5; Huang YC, 2012, ACTA BIOMATER, V8, P1048, DOI 10.1016/j.actbio.2011.12.009; Iadecola C, 1999, J EXP MED, V189, P719, DOI 10.1084/jem.189.4.719; Imitola J, 2004, P NATL ACAD SCI USA, V101, P18117, DOI 10.1073/pnas.0408258102; Iosif RE, 2006, J NEUROSCI, V26, P9703, DOI 10.1523/JNEUROSCI.2723-06.2006; Itoh T, 2009, NEUROL RES, V31, P90, DOI 10.1179/174313208X332995; Jacques TS, 1998, DEVELOPMENT, V125, P3167; Jaerve A, 2012, STEM CELL TRANSL MED, V1, P732, DOI 10.5966/sctm.2012-0068; Jeon O, 2006, BIOMATERIALS, V27, P1598, DOI 10.1016/j.biomaterials.2005.08.030; Jin KL, 2002, P NATL ACAD SCI USA, V99, P11946, DOI 10.1073/pnas.182296499; Kamei N, 2007, SPINE, V32, P1272, DOI 10.1097/BRS.0b013e318059afab; Kawahara N, 1999, J CEREBR BLOOD F MET, V19, P307, DOI 10.1097/00004647-199903000-00009; Kim HJ, 2010, J NEUROTRAUM, V27, P131, DOI [10.1089/neu.2008.0818, 10.1089/neu.2008-0818]; KIRSCHENBAUM B, 1995, P NATL ACAD SCI USA, V92, P210, DOI 10.1073/pnas.92.1.210; Kita T, 1997, INT J LEGAL MED, V110, P305, DOI 10.1007/s004140050093; Knoblach SM, 1998, EXP NEUROL, V153, P143, DOI 10.1006/exnr.1998.6877; Knuckey NW, 1996, MOL BRAIN RES, V40, P1; Kokovay E, 2010, CELL STEM CELL, V7, P163, DOI 10.1016/j.stem.2010.05.019; Koo JW, 2008, P NATL ACAD SCI USA, V105, P751, DOI 10.1073/pnas.0708092105; Kopec AM, 2013, LEARN MEMORY, V20, P531, DOI 10.1101/lm.031377.113; Kornblum HI, 1999, EUR J NEUROSCI, V11, P3236, DOI 10.1046/j.1460-9568.1999.00744.x; KOSSMANN T, 1995, SHOCK, V4, P311, DOI 10.1097/00024382-199511000-00001; Kremlev SG, 2005, J NEUROIMMUNOL, V162, P71, DOI 10.1016/j.jneuroim.2005.01.010; Krum JM, 1998, EXP NEUROL, V154, P57, DOI 10.1006/exnr.1998.6930; Kuhn HG, 1997, J NEUROSCI, V17, P5820; Kuhn HG, 1996, J NEUROSCI, V16, P2027; Kuldo JM, 2005, AM J PHYSIOL-CELL PH, V289, pC1229, DOI 10.1152/ajpcell.00620.2004; Lachyankar MB, 1997, EXP NEUROL, V144, P350, DOI 10.1006/exnr.1997.6434; LAPCHAK PA, 1993, NEUROSCIENCE, V54, P445, DOI 10.1016/0306-4522(93)90265-H; Lau TT, 2011, EXPERT OPIN BIOL TH, V11, P189, DOI 10.1517/14712598.2011.546338; Lee C, 2010, J NEUROTRAUM, V27, P541, DOI 10.1089/neu.2009.0905; Lee K, 2011, J R SOC INTERFACE, V8, P153, DOI 10.1098/rsif.2010.0223; LEHRMANN E, 1995, EXP NEUROL, V131, P114, DOI 10.1016/0014-4886(95)90013-6; Leker RR, 2007, STROKE, V38, P153, DOI 10.1161/01.STR.0000252156.65953.a9; Li AH, 2013, J MOL NEUROSCI, V51, P1052, DOI 10.1007/s12031-013-0084-7; Li ZW, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-71; Li ZW, 2011, NEUROCHEM INT, V58, P812, DOI 10.1016/j.neuint.2011.03.007; Liberto CM, 2004, J NEUROCHEM, V89, P1092, DOI 10.1111/j.1471-4159.2004.02420.x; LINDVALL O, 1992, P NATL ACAD SCI USA, V89, P648, DOI 10.1073/pnas.89.2.648; LOGAN A, 1991, ANN NY ACAD SCI, V638, P474, DOI 10.1111/j.1749-6632.1991.tb49073.x; LOGAN A, 1992, J NEUROSCI, V12, P3828; Loganadane LD, 1997, CYTOKINE, V9, P740, DOI 10.1006/cyto.1997.0229; LOIS C, 1993, P NATL ACAD SCI USA, V90, P2074, DOI 10.1073/pnas.90.5.2074; Loscher W, 2005, PROG NEUROBIOL, V76, P22, DOI 10.1016/j.pneurobio.2005.04.006; Lu DY, 2007, NEUROSURGERY, V61, P596, DOI 10.1227/01.NEU.0000290908.38438.B2; Lu YB, 2006, P NATL ACAD SCI USA, V103, P17759, DOI 10.1073/pnas.0606150103; Ma HY, 2012, NEUROCHEM RES, V37, P69, DOI 10.1007/s11064-011-0584-1; Ma MM, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-117; Maegele M, 2007, INFLAMM RES, V56, P318, DOI 10.1007/s00011-007-6141-3; Mahmood A, 2003, NEUROSURGERY, V53, P697, DOI 10.1227/01.NEU.0000079333.61863.AA; Mahmood A, 2001, NEUROSURGERY, V49, P1196, DOI 10.1097/00006123-200111000-00031; Mahmood A, 2014, J NEUROSURG, V120, P1147, DOI 10.3171/2013.12.JNS131362; Mani N, 2010, J NEUROSCI RES, V88, P248, DOI 10.1002/jnr.22197; Martens DJ, 2002, EUR J NEUROSCI, V16, P1045, DOI 10.1046/j.1460-9568.2002.02181.x; McAllister Thomas W, 2011, Dialogues Clin Neurosci, V13, P287; MCINTOSH TK, 1994, CEREBROVAS BRAIN MET, V6, P109; McPherson CA, 2011, BRAIN BEHAV IMMUN, V25, P850, DOI 10.1016/j.bbi.2010.09.003; Mirzadeh Z, 2008, CELL STEM CELL, V3, P265, DOI 10.1016/j.stem.2008.07.004; Monje ML, 2003, SCIENCE, V302, P1760, DOI 10.1126/science.1088417; Morganti-Kossmann MC, 2007, INJURY, V38, P1392, DOI 10.1016/j.injury.2007.10.005; Morganti-Kossmann MC, 2001, SHOCK, V16, P165, DOI 10.1097/00024382-200116030-00001; Mudo G, 2009, J NEURAL TRANSM, V116, P995, DOI 10.1007/s00702-009-0207-z; Nag S, 1997, J NEUROPATH EXP NEUR, V56, P912, DOI 10.1097/00005072-199708000-00009; Nakaguchi K, 2012, STEM CELLS INT, V2012, DOI 10.1155/2012/915160; Nakanishi M, 2007, EUR J NEUROSCI, V25, P649, DOI 10.1111/j.1460-9568.2007.05309.x; Ninomiya M, 2006, NEUROSCI LETT, V403, P63, DOI 10.1016/j.neulet.2006.04.039; Nolan Y, 2004, J NEUROIMMUNOL, V151, P12, DOI 10.1016/j.jneuroim.2004.02.001; Overstreet DJ, 2012, J POLYM SCI POL PHYS, V50, P881, DOI 10.1002/polb.23081; Oyagi A, 2011, NEUROSCIENCE, V185, P116, DOI 10.1016/j.neuroscience.2011.04.034; Palmer TD, 1997, MOL CELL NEUROSCI, V8, P389, DOI 10.1006/mcne.1996.0595; Papavassiliou E, 1997, J NEUROSCI RES, V49, P451, DOI 10.1002/(SICI)1097-4547(19970815)49:4<451::AID-JNR6>3.0.CO;2-7; Park KI, 2002, NAT BIOTECHNOL, V20, P1111, DOI 10.1038/nbt751; Parpura V, 2000, P NATL ACAD SCI USA, V97, P8629, DOI 10.1073/pnas.97.15.8629; Patel T, 2012, ADV DRUG DELIVER REV, V64, P701, DOI 10.1016/j.addr.2011.12.006; Pencea V, 2001, J NEUROSCI, V21, P6706; Peng H, 2006, GLIA, V54, P619, DOI 10.1002/glia.20409; Prokoph S, 2012, BIOMATERIALS, V33, P4792, DOI 10.1016/j.biomaterials.2012.03.039; Public Health Economics Program Eric A Finkelstein Senior Health Economist DHSSPRRTI Economist NCIPCCDCPPSCSH Scientist CTRMPR Site Director Pacific Institute for Research Evaluation M, 2006, INC EC BURD INJ US; Qu CS, 2008, BRAIN RES, V1208, P234, DOI 10.1016/j.brainres.2008.02.042; Qu CS, 2011, BRAIN RES, V1371, P129, DOI 10.1016/j.brainres.2010.10.088; Quintana A, 2005, J NEUROSCI RES, V82, P701, DOI 10.1002/jnr.20680; Rabbany SY, 2010, CELL TRANSPLANT, V19, P399, DOI 10.3727/096368909X481782; Rabchevsky AG, 1998, J NEUROSCI, V18, P10541, DOI 10.1523/jneurosci.18-24-10541.1998; Ramaswamy S, 2005, BRAIN RES, V1053, P38, DOI 10.1016/j.brainres.2005.06.042; Ramos-Cejudo J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052121; REYNOLDS BA, 1992, J NEUROSCI, V12, P4565, DOI 10.1523/jneurosci.12-11-04565.1992; Riess P, 2002, NEUROSURGERY, V51, P1043, DOI 10.1097/00006123-200210000-00035; Robinson R, 2011, ACS NANO, V5, P4392, DOI 10.1021/nn103146p; Romano M, 1997, IMMUNITY, V6, P315, DOI 10.1016/S1074-7613(00)80334-9; Sanchez-Ramos J, 2000, EXP NEUROL, V164, P247, DOI 10.1006/exnr.2000.7389; Sawada M, 1999, J NEUROCHEM, V72, P1466, DOI 10.1046/j.1471-4159.1999.721466.x; Schanzer A, 2004, BRAIN PATHOL, V14, P237; Schmidt NO, 2009, BRAIN RES, V1268, P24, DOI 10.1016/j.brainres.2009.02.065; Segers VFM, 2007, CIRCULATION, V116, P1683, DOI 10.1161/CIRCULATIONAHA.107.718718; Selassie AW, 2008, J HEAD TRAUMA REHAB, V23, P123, DOI 10.1097/01.HTR.0000314531.30401.39; Semple BD, 2010, NEUROBIOL DIS, V40, P394, DOI 10.1016/j.nbd.2010.06.015; Shear DA, 2004, BRAIN RES, V1026, P11, DOI 10.1016/j.brainres.2004.07.087; Shear DA, 2011, RESTOR NEUROL NEUROS, V29, P215, DOI 10.3233/RNN-2011-0593; Shen F, 2008, GENE THER, V15, P30, DOI 10.1038/sj.gt.3303048; Shen Q, 2004, SCIENCE, V304, P1338, DOI 10.1126/science.1095505; Shen Q, 2008, CELL STEM CELL, V3, P289, DOI 10.1016/j.stem.2008.07.026; Shetty AK, 2004, J NEUROSCI RES, V78, P520, DOI 10.1002/jnr.20302; Shimonkevitz R, 1999, SHOCK, V12, P10, DOI 10.1097/00024382-199907000-00002; SHOHAMI E, 1994, J CEREBR BLOOD F MET, V14, P615, DOI 10.1038/jcbfm.1994.76; Shojo H, 2010, NEUROSCIENCE, V171, P1273, DOI 10.1016/j.neuroscience.2010.10.018; SIEBERBLUM M, 1991, NEURON, V6, P949, DOI 10.1016/0896-6273(91)90235-R; Silver JM., 2011, TXB TRAUMATIC BRAIN, V2nd ed.; Skold MK, 2005, J NEUROTRAUM, V22, P353, DOI 10.1089/neu.2005.22.353; Skop NB, 2013, ACTA BIOMATER, V9, P6834, DOI 10.1016/j.actbio.2013.02.043; Smith ED, 2014, J BIOL CHEM, V289, P20615, DOI 10.1074/jbc.M114.568659; Snyder EY, 2011, EXP NEUROL, V230, P75, DOI 10.1016/j.expneurol.2011.03.012; Song BW, 2002, J PHARMACOL EXP THER, V301, P605, DOI 10.1124/jpet.301.2.605; Stover JF, 2000, NEUROSCI LETT, V288, P25, DOI 10.1016/S0304-3940(00)01187-3; Sugiura S, 2005, STROKE, V36, P859, DOI 10.1161/01.STR.0000158905.22871.95; Sun D, 2010, J NEUROTRAUM, V27, P923, DOI 10.1089/neu.2009.1209; Sun D, 2009, EXP NEUROL, V216, P56, DOI 10.1016/j.expneurol.2008.11.011; Sun WF, 2014, INFLAMM RES, V63, P287, DOI 10.1007/s00011-013-0699-8; Sun YJ, 2003, J CLIN INVEST, V111, P1843, DOI 10.1172/JCI200317977; Suzuki S, 2009, J CEREBR BLOOD F MET, V29, P464, DOI 10.1038/jcbfm.2008.141; Tate CC, 2009, J TISSUE ENG REGEN M, V3, P208, DOI 10.1002/term.154; TAUPIN V, 1993, J NEUROIMMUNOL, V42, P177, DOI 10.1016/0165-5728(93)90008-M; Tavazoie M, 2008, CELL STEM CELL, V3, P279, DOI 10.1016/j.stem.2008.07.025; Thau-Zuchman O, 2012, J MOL NEUROSCI, V47, P166, DOI 10.1007/s12031-012-9706-8; Thau-Zuchman O, 2010, J CEREBR BLOOD F MET, V30, P1008, DOI 10.1038/jcbfm.2009.271; Thomsen GM, 2014, STEM CELL RES, V13, P48, DOI 10.1016/j.scr.2014.04.013; Thored P, 2006, STEM CELLS, V24, P739, DOI 10.1634/stemcells.2005-0281; Thurman D, 1999, JAMA-J AM MED ASSOC, V282, P954, DOI 10.1001/jama.282.10.954; Tian YY, 2007, NEUROSCI LETT, V421, P239, DOI 10.1016/j.neulet.2007.05.033; Tong LQ, 2008, NEUROBIOL AGING, V29, P1380, DOI 10.1016/j.neurobiolaging.2007.02.027; Tong LQ, 2012, J NEUROSCI, V32, P17714, DOI 10.1523/JNEUROSCI.1253-12.2012; Truettner J, 1999, J NEUROTRAUM, V16, P471, DOI 10.1089/neu.1999.16.471; Uchida K, 2012, SPINE, V37, P2125, DOI 10.1097/BRS.0b013e3182600ef7; Vallieres L, 2002, J NEUROSCI, V22, P486, DOI 10.1523/JNEUROSCI.22-02-00486.2002; Wachs FP, 2006, J NEUROPATH EXP NEUR, V65, P358, DOI 10.1097/01.jnen.0000218444.53405.f0; Wagner JP, 1999, J NEUROSCI, V19, P6006, DOI 10.1523/JNEUROSCI.19-14-06006.1999; Wang XF, 2007, MOL CELL NEUROSCI, V36, P343, DOI 10.1016/j.mcn.2007.07.005; Wang YM, 2007, J NEUROSCI RES, V85, P740, DOI 10.1002/jnr.21169; Wang Y, 2011, PHARM RES-DORDR, V28, P1406, DOI 10.1007/s11095-011-0452-3; Wang YF, 2013, J CONTROL RELEASE, V172, P1, DOI 10.1016/j.jconrel.2013.07.032; Wang Z, 2015, STEM CELLS, V33, P456, DOI 10.1002/stem.1878; Wang ZT, 2013, J MOL NEUROSCI, V49, P409, DOI 10.1007/s12031-012-9908-0; Weinstein DE, 1996, BRAIN RES, V743, P11, DOI 10.1016/S0006-8993(96)00979-1; Wennersten A, 2004, J NEUROSURG, V100, P88, DOI 10.3171/jns.2004.100.1.0088; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Widera D, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-64; WOODROOFE MN, 1991, J NEUROIMMUNOL, V33, P227, DOI 10.1016/0165-5728(91)90110-S; Wu DF, 2002, J DRUG TARGET, V10, P239, DOI 10.1080/10611860290022679; Wu HT, 2010, J NEUROSURG, V113, P591, DOI 10.3171/2009.9.JNS09859; Xiong Y, 2009, BRAIN RES, V1263, P183, DOI 10.1016/j.brainres.2009.01.032; Xu Q, 2007, CLIN EXP PHARMACOL P, V34, P624, DOI 10.1111/j.1440-1681.2007.04619.x; Xue LP, 2014, CELL BIOCHEM BIOPHYS, V70, P1609, DOI 10.1007/s12013-014-0103-5; Yamashita T, 2006, J NEUROSCI, V26, P6627, DOI 10.1523/JNEUROSCI.0149-06.2006; Yan HQ, 2000, BRAIN RES, V887, P134, DOI 10.1016/S0006-8993(00)03002-X; Yang JP, 2009, NEUROSCI LETT, V461, P212, DOI 10.1016/j.neulet.2009.06.060; Yang JP, 2009, NEUROSCI LETT, V449, P108, DOI 10.1016/j.neulet.2008.10.090; Yao JHS, 2006, BIOCHEM BIOPH RES CO, V342, P1396, DOI 10.1016/j.bbrc.2006.02.100; Yi X, 2014, J CONTROL RELEASE, V190, P637, DOI 10.1016/j.jconrel.2014.06.017; Yoshimura S, 2001, P NATL ACAD SCI USA, V98, P5874, DOI 10.1073/pnas.101034998; Yu PP, 2012, METHODS MOL BIOL, V814, P327, DOI 10.1007/978-1-61779-452-0_21; Yu ZH, 2014, J NEUROCHEM, V130, P41, DOI 10.1111/jnc.12710; Zhang HX, 2003, J CELL BIOL, V163, P1375, DOI 10.1083/jcb.200308040; Zhang RL, 2004, J CEREBR BLOOD F MET, V24, P441, DOI 10.1097/00004647-200404000-00009; Zhang RL, 2009, J CEREBR BLOOD F MET, V29, P1240, DOI 10.1038/jcbfm.2009.55; Zheng J, 2008, J BIOL CHEM, V283, P13280, DOI 10.1074/jbc.M709930200; Zhu Y, 2000, BRAIN RES, V866, P286, DOI 10.1016/S0006-8993(00)02240-X; Ziebell JM, 2010, NEUROTHERAPEUTICS, V7, P22, DOI 10.1016/j.nurt.2009.10.016	267	22	24	0	8	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1177-2719			BIOMARK INSIGHTS	Biomark. Insights		2015	10			1			43	60		10.4137/BMIMI.S20062			18	Medicine, Research & Experimental	Research & Experimental Medicine	DB5UQ	WOS:000368579500004	25983552	DOAJ Gold			2021-06-18	
B	Cole, JT		Rajendram, R; Preedy, VR; Patel, VB		Cole, Jeffrey T.			Metabolism BCAAs	BRANCHED CHAIN AMINO ACIDS IN CLINICAL NUTRITION, VOL 1	Nutrition and Health Series		English	Article; Book Chapter						Traumatic brain injury; BCATm; BCKD; Astroglial-neuronal nitrogen cycle; Transamination; Michaelis constant; Nitrogen	BRANCHED-CHAIN AMINOTRANSFERASE; AMINO-ACID-METABOLISM; BCATC MESSENGER-RNA; LEUCINE METABOLISM; NEUROTRANSMITTER METABOLISM; EXPRESSION; BRAIN; ENZYMES; RAT; CELLS		Uniformed Serv Univ Hlth Sci, Dept Neurol, Bethesda, MD 20814 USA	Cole, JT (corresponding author), Uniformed Serv Univ Hlth Sci, Dept Neurol, Bethesda, MD 20814 USA.	Jeffrey.cole@usuhs.edu					Berkich DA, 2007, J NEUROSCI RES, V85, P3367, DOI 10.1002/jnr.21500; Bixel MG, 2001, J HISTOCHEM CYTOCHEM, V49, P407, DOI 10.1177/002215540104900314; Bixel MG, 1997, J HISTOCHEM CYTOCHEM, V45, P685, DOI 10.1177/002215549704500506; Brosnan JT, 2006, J NUTR, V136, p207S, DOI 10.1093/jn/136.1.207S; Castellano S, 2007, GENE EXPR PATTERNS, V7, P485, DOI 10.1016/j.modgep.2006.10.010; Castellano S, 2006, BRAIN RES, V1108, P12, DOI 10.1016/j.brainres.2006.06.012; Cole JT, 2012, FRONT NEUROANAT, V6, DOI 10.3389/fnana.2012.00018; Cole JT, 2010, P NATL ACAD SCI USA, V107, P366, DOI 10.1073/pnas.0910280107; DeSantiago S, 1998, J NUTR, V128, P1165; Dillon EL, 2013, AMINO ACIDS, V45, P431, DOI 10.1007/s00726-012-1438-0; Drown PM, 2000, BBA-BIOMEMBRANES, V1468, P273, DOI 10.1016/S0005-2736(00)00266-2; FANELLI FR, 1986, GUT, V27, P111, DOI 10.1136/gut.27.Suppl_1.111; Faure M, 2001, J NUTR, V131, P1528; Garcia-Espinosa MA, 2007, J NEUROCHEM, V100, P1458, DOI 10.1111/j.1471-4159.2006.04332.x; Goichon A, 2013, J PROTEOMICS, V78, P535, DOI 10.1016/j.jprot.2012.10.024; Islam MM, 2007, J BIOL CHEM, V282, P11893, DOI 10.1074/jbc.M700198200; Islam MM, 2010, J BIOL CHEM, V285, P265, DOI 10.1074/jbc.M109.048777; Lang CH, 2003, AM J PHYSIOL-ENDOC M, V285, pE1205, DOI 10.1152/ajpendo.00177.2003; Lang CH, 2010, AM J PHYSIOL-REG I, V299, pR935, DOI 10.1152/ajpregu.00297.2010; Lynch CJ, 2003, AM J PHYSIOL-ENDOC M, V285, pE854, DOI 10.1152/ajpendo.00153.2003; Lynch CJ, 2001, J NUTR, V131, p861S; MARCHESINI G, 1991, CLIN NUTR, V10, P105, DOI 10.1016/0261-5614(91)90096-U; Mersey BD, 2005, HUM MOL GENET, V14, P3371, DOI 10.1093/hmg/ddi368; PELLETIER V, 1991, AM J CLIN NUTR, V54, P402; Perez-Villasefor G, 2005, LIFE SCI, V78, P334, DOI 10.1016/j.lfs.2005.04.079; Purpera MN, 2012, J ENDOCRINOL, V212, P85, DOI 10.1530/JOE-11-0270; Richardson MA, 2004, J CLIN PSYCHIAT, V65, P92; She PX, 2007, AM J PHYSIOL-ENDOC M, V293, pE1552, DOI 10.1152/ajpendo.00134.2007; Sweatt AJ, 2004, J COMP NEUROL, V477, P360, DOI 10.1002/cne.20200; Sweatt AJ, 2004, AM J PHYSIOL-ENDOC M, V286, pE64, DOI 10.1152/ajpendo.00276.2003; Yudkoff M, 2005, J NUTR, V135, p1531S, DOI 10.1093/jn/135.6.1531S; Yudkoff M, 1996, J NEUROCHEM, V66, P378; YUDKOFF M, 1994, J NEUROCHEM, V62, P1192	33	22	22	0	2	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DR, STE 208, TOTOWA, NJ 07512-1165 USA			978-1-4939-1923-9; 978-1-4939-1922-2	NUTR HEALTH SER	Nutr. Health Ser.		2015							13	24		10.1007/978-1-4939-1923-9_2	10.1007/978-1-4939-1923-9		12	Nutrition & Dietetics	Nutrition & Dietetics	BD1EW	WOS:000357985700003					2021-06-18	
J	de Koning, ME; Spikman, JM; Coers, A; Schonherr, MC; van der Naalt, J				de Koning, Myrthe E.; Spikman, Jacoba M.; Coers, Annemieke; Schonherr, Marleen C.; van der Naalt, Joukje			Pathways of care the first year after moderate and severe traumatic brain injury-Discharge destinations and outpatient follow-up	BRAIN INJURY			English	Article						Discharge destinations; outcome; outpatient visit; post-acute care; rehabilitation; return to work; traumatic brain injury	INPATIENT REHABILITATION; OUTCOMES; ADULTS; NEEDS; TRANSITION; HEALTH; RETURN; HOME	Primary objective: To determine the pathways of care within the first year after traumatic brain injury (TBI) and to explore whether provided care is related to residual impairments. Research design: Retrospective study of 343 patients with moderate and severe TBI admitted to a Level-1 trauma centre. Methods and procedures: Discharge destinations from hospital to home and frequency of outpatient visits were determined. Outcome was defined 1 year after injury by the Extended Glasgow Outcome Scale and Return to Work. Results: Most (94%) patients had returned home 1-year after injury despite cognitive (76%), behavioural (67%) and physical (55%) impairments. One in four patients was severely disabled and 32% had resumed work on a previous level. Two-thirds of all patients went home as secondary discharge destination and 50% needed inpatient rehabilitation. Almost half of patients needed outpatient care, mostly for behavioural and cognitive impairments. One in 10 patients consulted a psychiatrist, with 55% unfavourable outcome. Of those patients initially discharged to home without follow-up, eventually 10% needed outpatient rehabilitation. Conclusions: One-year after injury most patients had returned home with residual impairments and frequent medical consultations. This finding warrants further investigation to define appropriate aftercare by various medical specialists aimed at long-term community integration.	[de Koning, Myrthe E.; Coers, Annemieke; van der Naalt, Joukje] Univ Groningen, Univ Med Ctr Groningen, Dept Neurol, Groningen, Netherlands; [Spikman, Jacoba M.] Univ Groningen, Univ Med Ctr Groningen, Dept Clin Neuropsychol, Groningen, Netherlands; [Schonherr, Marleen C.] Univ Groningen, Univ Med Ctr Groningen, Dept Rehabil Med, Groningen, Netherlands	van der Naalt, J (corresponding author), Univ Med Ctr Groningen, Dept Neurol, Hanzepl 1, NL-9713 GZ Groningen, Netherlands.	j.van.der.naalt@umcg.nl		Spikman, Jacoba/0000-0002-6477-0763			Andelic N, 2012, J NEUROTRAUM, V29, P66, DOI 10.1089/neu.2011.1811; Benedictus MR, 2010, ARCH PHYS MED REHAB, V91, P1436, DOI 10.1016/j.apmr.2010.06.019; Ciurli P, 2011, J HEAD TRAUMA REHAB, V26, P116, DOI 10.1097/HTR.0b013e3181dedd0e; Corrigan JD, 2014, J HEAD TRAUMA REHAB, V29, P125; Cuthbert JP, 2011, ARCH PHYS MED REHAB, V92, P721, DOI 10.1016/j.apmr.2010.12.023; de Guise E, 2006, J HEAD TRAUMA REHAB, V21, P527, DOI 10.1097/00001199-200611000-00007; Draper K, 2007, J HEAD TRAUMA REHAB, V22, P278, DOI 10.1097/01.HTR.0000290972.63753.a7; Esselman PC, 2004, ARCH PHYS MED REHAB, V85, P1445, DOI 10.1016/j.apmr.2003.10.018; Fleming J, 2013, J HEAD TRAUMA REHABI; Foster M, 2004, SOC SCI MED, V59, P1867, DOI 10.1016/j.socscimed.2004.02.017; Fraas M, 2007, BRAIN INJURY, V21, P1267, DOI 10.1080/02699050701721794; Ghajar J, 2000, LANCET, V356, P923, DOI 10.1016/S0140-6736(00)02689-1; Heinemann AW, 2002, ARCH PHYS MED REHAB, V83, P1052, DOI 10.1053/apmr.2002.34283; Huebner RA, 2003, AM J OCCUP THER, V57, P177, DOI 10.5014/ajot.57.2.177; Jourdan C, 2013, NEUROREHAB NEURAL RE, V27, P35, DOI 10.1177/1545968312440744; Kim E, 2007, J NEUROPSYCH CLIN N, V19, P106, DOI 10.1176/appi.neuropsych.19.2.106; Kim H, 2006, CAN J NEUROL SCI, V33, P48, DOI 10.1017/S0317167100004686; Koponen S, 2011, BRAIN INJURY, V25, P1029, DOI 10.3109/02699052.2011.607783; Leblanc J, 2006, BRAIN INJURY, V20, P779, DOI 10.1080/02699050600831835; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Malec JF, 2009, BRAIN INJURY, V23, P22, DOI 10.1080/02699050802590320; McCarthy ML, 2006, ARCH PHYS MED REHAB, V87, P953, DOI 10.1016/j.apmr.2006.03.007; Mellick D, 2003, BRAIN INJURY, V17, P55, DOI 10.1080/0269905021000010159; Mosenthal AC, 2002, J TRAUMA, V52, P907, DOI 10.1097/00005373-200205000-00015; Nalder E, 2012, J HEAD TRAUMA REHAB, V27, P143, DOI 10.1097/HTR.0b013e3182168fb1; Pickelsimer EE, 2007, J HEAD TRAUMA REHAB, V22, P1, DOI 10.1097/00001199-200701000-00001; Rusconi S, 2003, DISABIL REHABIL, V25, P1281, DOI 10.1080/09638280310001608582; Schootman M, 1999, BRAIN INJURY, V13, P995; Sinnakaruppan I, 2001, BRAIN INJURY, V15, P653; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; TEASDALE G, 1974, LANCET, V2, P81; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Turner BJ, 2008, DISABIL REHABIL, V30, P1153, DOI 10.1080/09638280701532854; Turner BJ, 2011, DISABIL REHABIL, V33, P818, DOI 10.3109/09638288.2010.513422; Van Baalen B, 2008, BRAIN INJURY, V22, P25, DOI 10.1080/02699050701810662; van der Naalt J, 1999, J NEUROL NEUROSUR PS, V66, P207, DOI 10.1136/jnnp.66.2.207; Willemse-Van Son AHP, 2009, J REHABIL MED, V41, P521, DOI 10.2340/16501977-0377; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573	38	22	22	0	14	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2015	29	4					423	429		10.3109/02699052.2014.982188			7	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	CF8JE	WOS:000352803300002	25437043				2021-06-18	
J	DeMatteo, C; McCauley, D; Stazyk, K; Harper, J; Adamich, J; Randall, S; Missiuna, C				DeMatteo, Carol; McCauley, Dayle; Stazyk, Kathy; Harper, Jessica; Adamich, John; Randall, Sarah; Missiuna, Cheryl			Post-concussion return to play and return to school guidelines for children and youth: a scoping methodology	DISABILITY AND REHABILITATION			English	Article						Concussion; children; guidelines; participation; school	TRAUMATIC BRAIN-INJURY; SPORTS-RELATED CONCUSSION; TO-PLAY; INTERNATIONAL-CONFERENCE; CONSENSUS STATEMENT; RECOVERY; SYMPTOMS; PATHOPHYSIOLOGY; RECOMMENDATIONS; ABNORMALITIES	Purpose: The objective of this study was to identify and describe management strategies to ensure safe return to activity (RTA) and return to school (RTS) of children with mild traumatic brain injury (MTBI) and determine whether they are evidence-based. Methods: A scoping methodology was conducted using research published between 1990 and 2013, gray literature and clinical expertise. Once the data had been charted, an expert panel of physicians and clinicians was consulted to inform and validate study findings. An analytical and thematic framework was used to examine the study findings. Results: A total of 400 potentially relevant published articles, 100 websites and 24 iPad Applications were found. Ten articles and three web-based resources met inclusion criteria and were included in the final review. Nine articles recommended a more conservative approach to RTA, as well as identified a step-wise or severity-oriented approach. General recommendations were also found regarding safe RTS. One study recommended a stepwise RTS protocol for children. Conclusions: This scoping methodology determined that the most comprehensive guidelines for management are focused on adults. Evidence concerning prolonged recovery patterns in children and the impact of concussion on the developing brain suggests that pediatric-specific guidelines are needed for RTA and RTS after MTBI/concussion.	[DeMatteo, Carol; McCauley, Dayle; Stazyk, Kathy; Missiuna, Cheryl] McMaster Univ, Sch Rehabil Sci, Hamilton, ON L8S 1C7, Canada; [DeMatteo, Carol; McCauley, Dayle; Stazyk, Kathy; Harper, Jessica; Adamich, John; Randall, Sarah; Missiuna, Cheryl] Ctr Childhood Disabil Res, CanChild, Hamilton, ON, Canada	DeMatteo, C (corresponding author), McMaster Univ, Sch Rehabil Sci, 1400 Main St West,IAHS 433, Hamilton, ON L8S 1C7, Canada.	dematteo@mcmaster.ca			Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR) [115228]	This scoping methodology was funded as part of a knowledge translation study funded through the Canadian Institutes of Health Research (funding reference number: 115228).	Alexander M.P., 1992, J HEAD TRAUMA REHAB, V7, P60, DOI DOI 10.1097/00001199-199206000-00009; [Anonymous], 1991, COL MED SOC REP SPOR; Arbogast KB, 2013, CLIN PEDIATR, V52, P397, DOI 10.1177/0009922813478160; Arksey H., 2005, INT J SOC RES METHOD, V8, P19, DOI [DOI 10.1080/1364557032000119616, 10.1080/1364557032000119616]; Baillargeon A, 2012, BRAIN INJURY, V26, P211, DOI 10.3109/02699052.2012.654590; Baker JG, 2012, REHABIL RES PRACT, V2012, DOI 10.1155/2012/705309; Barlow KM, 2010, PEDIATRICS, V126, pE374, DOI 10.1542/peds.2009-0925; Barr WB, 2012, BRAIN INJURY, V26, P58, DOI 10.3109/02699052.2011.608216; Berlin AA, 2006, PSYCHOSOM MED, V68, P224, DOI 10.1097/01.psy.0000204628.73273.23; Buzzini SRR, 2006, CURR OPIN PEDIATR, V18, P376, DOI 10.1097/01.mop.0000236385.26284.ec; Canadian Pediatric Society, 2006, PAEDIAT CHILD HLTH, V11, P420; Cantu RC, 1998, CLIN SPORT MED, V17, P37, DOI 10.1016/S0278-5919(05)70059-4; Cantu RC, 2001, J ATHL TRAINING, V36, P244; Cantu RC, 2011, PM&R, V3, pS440, DOI 10.1016/j.pmrj.2011.07.013; Cotman CW, 2007, TRENDS NEUROSCI, V30, P464, DOI 10.1016/j.tins.2007.06.011; Daneshvar DH, 2011, PHYS MED REH CLIN N, V22, P683, DOI 10.1016/j.pmr.2011.08.009; Doolan AW, 2012, ANN BIOMED ENG, V40, P106, DOI 10.1007/s10439-011-0413-3; Faul M, 2010, CTR DIS CONTROL PREV; Fay TB, 2009, NEUROPSYCHOLOGY, V23, P271, DOI 10.1037/a0014936; Field M, 2003, J PEDIATR-US, V142, P546, DOI 10.1067/mpd.2003.190; Friedman D, 2011, MONTREAL CHILDRENS H; Grey Literature Network Service, 1999, 4 INT C GREY LIT OCT; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Guskiewicz KM, 2011, PM&R, V3, P353, DOI 10.1016/j.pmrj.2010.12.006; Guskiewicz KM, 2001, CLIN J SPORT MED, V11, P182, DOI 10.1097/00042752-200107000-00009; Halstead ME, 2010, PEDIATRICS, V126, P597, DOI 10.1542/peds.2010-2005; Iverson GL, 2005, CURR OPIN PSYCHIATR, V18, P301, DOI 10.1097/01.yco.0000165601.29047.ae; Johnston Karen M, 2004, Curr Sports Med Rep, V3, P316; Johnston KM, 2000, CLIN J SPORT MED, V10, P209; Karlin AM, 2011, PM&R, V3, pS369, DOI 10.1016/j.pmrj.2011.07.015; Kelly JP, 1997, NEUROLOGY, V48, P581; Kinnaman KA, 2013, ACTA PAEDIATR, V102, pE424, DOI 10.1111/apa.12315; Kirkwood MW, 2008, CLIN NEUROPSYCHOL, V22, P769, DOI 10.1080/13854040701543700; Kissick J, 2005, NEW CONCUSSION MANAG; Laker SR, 2011, PHYS MED REH CLIN N, V22, P619, DOI 10.1016/j.pmr.2011.08.004; Leddy JJ, 2007, NEUROREHABILITATION, V22, P199; Lovell MR, 2007, NEUROSURGERY, V61, P352, DOI 10.1227/01.NEU.0000279985.94168.7F; Lovell MR, 2003, J NEUROSURG, V98, P296, DOI 10.3171/jns.2003.98.2.0296; Maillard-Wermelinger A, 2009, DEV NEUROREHABIL, V12, P330, DOI 10.3109/17518420903087251; Master CL, 2012, PEDIATR ANN, V41, pE180, DOI 10.3928/00904481-20120827-09; Maugans TA, 2012, PEDIATRICS, V129, P28, DOI 10.1542/peds.2011-2083; Max JE, 2012, J NEUROPSYCH CLIN N, V24, P427, DOI 10.1176/appi.neuropsych.12060149; Mayer AR, 2012, J NEUROSCI, V32, P17961, DOI 10.1523/JNEUROSCI.3379-12.2012; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrory P, 2009, BRIT J SPORT MED, V43, pI76, DOI 10.1136/bjsm.2009.058248; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Mittenberg W, 1996, ARCH CLIN NEUROPSYCH, V11, P139, DOI 10.1016/0887-6177(95)00006-2; Morin D, 2011, AM AC PED NAT C EXH; Ponsford J, 2001, PEDIATRICS, V108, P1297, DOI 10.1542/peds.108.6.1297; Ponsford J, 2011, J NEUROTRAUM, V28, P937, DOI 10.1089/neu.2010.1516; Popay, 2001, STUDYING ORG DELIVER, P188; Purcell L, 2009, BRIT J SPORT MED, V43, pI51, DOI 10.1136/bjsm.2009.058214; Purcell LK, 2012, PAED CHILD HEALT-CAN, V17, P36; Ryu WHA, 2009, CAN J NEUROL SCI, V36, P429, DOI 10.1017/S0317167100007745; Sady MD, 2011, PHYS MED REH CLIN N, V22, P701, DOI 10.1016/j.pmr.2011.08.008; Signoretti S, 2011, PM&R, V3, pS359, DOI 10.1016/j.pmrj.2011.07.018; Sroufe NS, 2010, PEDIATRICS, V125, pE1331, DOI 10.1542/peds.2008-2364; Taylor HG, 2010, NEUROPSYCHOLOGY, V24, P148, DOI 10.1037/a0018112; Toledo E, 2012, NEUROSCI BIOBEHAV R, V36, P1510, DOI 10.1016/j.neubiorev.2012.03.007; Wu TC, 2010, J NEUROTRAUM, V27, P303, DOI 10.1089/neu.2009.1110; Yeates Keith Owen, 2005, Pediatr Rehabil, V8, P5; Yeates KO, 2010, J INT NEUROPSYCH SOC, V16, P953, DOI 10.1017/S1355617710000986; Yeates KO, 2009, PEDIATRICS, V123, P735, DOI 10.1542/peds.2008-1056	63	22	23	0	12	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0963-8288	1464-5165		DISABIL REHABIL	Disabil. Rehabil.		2015	37	12					1107	1112		10.3109/09638288.2014.952452			6	Rehabilitation	Rehabilitation	CG2SK	WOS:000353125000012	25144831				2021-06-18	
J	Deutsch, MB; Mendez, MF; Teng, E				Deutsch, Mariel B.; Mendez, Mario F.; Teng, Edmond			Interactions between Traumatic Brain Injury and Frontotemporal Degeneration	DEMENTIA AND GERIATRIC COGNITIVE DISORDERS			English	Article						Brain injuries; Frontotemporal degeneration; Frontotemporal dementia; Frontotemporal lobar degeneration; Primary progressive aphasia; Neuropsychological features in subjects with dementia	ENVIRONMENTAL RISK-FACTORS; DATA SET UDS; HEAD-INJURY; FUNCTIONAL-ACTIVITIES; CLINICAL PHENOTYPE; LOBAR DEGENERATION; ALZHEIMERS-DISEASE; DEMENTIA	Background/Aims: Prior work in smaller cohorts suggests that traumatic brain injury (TBI) may be a risk factor for frontotemporal degeneration (FTD). We sought to confirm and extend these results using the National Alzheimer's Coordinating Center Uniform Data Set. Methods: We compared the TBI prevalence between FTD subjects and matched normal controls. Indices of cognitive, behavioral, functional, and global dementia severity were compared between FTD subjects with and without prior TBI. Results: Remote TBI with extended loss of consciousness (TBI-ext) was more common in individuals with FTD than in controls (OR: 1.67; 95% CI: 1.004-2.778). With TBI-ext, less functional and global impairment was seen in the behavioral variant of FTD, but more behavioral pathology was seen in the semantic variant. Conclusion: TBI may increase the FTD risk and influence clinical symptomatology and severity in FTD sub-types. (C) 2014 S. Karger AG, Basel	[Deutsch, Mariel B.; Mendez, Mario F.; Teng, Edmond] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurol Sci, Los Angeles, CA 90095 USA; [Mendez, Mario F.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Psychiat & Biobehav Sci, Los Angeles, CA 90095 USA; [Deutsch, Mariel B.; Mendez, Mario F.; Teng, Edmond] Vet Affairs Greater Los Angeles Healthcare Syst, Los Angeles, CA 90073 USA	Deutsch, MB (corresponding author), Vet Affairs Greater Los Angeles Healthcare Syst, Neurobehav Serv 116AF, 11301 Wilshire Blvd, Los Angeles, CA 90073 USA.	mdeutsch@mednet.ucla.edu	Deutsch, Mariel/V-3876-2019	Deutsch, Mariel/0000-0003-1228-8868	NIAUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [P50 AG16570, K08 AG34628, R01AG034499-05, U01 AG016976]; NIA (American Federation for Aging Research); NIA (John A. Hartford Foundation); NIA (Atlantic Philanthropies); NIA (Starr Foundation); Alzheimer's Disease Research Centers of California; Sidell-Kagan Foundation; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R01AG034499, K08AG034628, P50AG016570, U01AG016976] Funding Source: NIH RePORTER	This study was supported by the NIA (P50 AG16570 and K08 AG34628 to E.T.; jointly sponsored by the NIA, the American Federation for Aging Research, the John A. Hartford Foundation, the Atlantic Philanthropies, the Starr Foundation, and an anonymous donor) and R01AG034499-05 (M. F. M., principle investigator), the Alzheimer's Disease Research Centers of California, and the Sidell-Kagan Foundation. The NACC database is funded by the NIA (U01 AG016976).	Bahia Valéria Santoro, 2013, Dement. neuropsychol., V7, P19, DOI 10.1590/S1980-57642013DN70100004; Bazarian JJ, 2009, J HEAD TRAUMA REHAB, V24, P439, DOI 10.1097/HTR.0b013e3181c15600; Bower JH, 2003, NEUROLOGY, V60, P1610, DOI 10.1212/01.WNL.0000068008.78394.2C; BUTTERS N, 1987, J CLIN EXP NEUROPSYC, V9, P479, DOI 10.1080/01688638708410764; Chen HL, 2007, AM J EPIDEMIOL, V166, P810, DOI 10.1093/aje/kwm153; Dams-O'Connor K, 2013, NEUROREHABILITATION, V32, P199, DOI 10.3233/NRE-130838; Davies RR, 2005, BRAIN, V128, P1984, DOI 10.1093/brain/awh582; Finch N, 2009, BRAIN, V132, P583, DOI 10.1093/brain/awn352; FOLSTEIN MF, 1983, ARCH GEN PSYCHIAT, V40, P812; Galimberti Daniela, 2012, Front Neurol, V3, P52, DOI 10.3389/fneur.2012.00052; Goldman SM, 2006, ANN NEUROL, V60, P65, DOI 10.1002/ana.20882; Grossman M, 2007, ARCH NEUROL-CHICAGO, V64, P1449, DOI 10.1001/archneur.64.10.1449; Hou CE, 2006, DEMENT GERIATR COGN, V22, P42, DOI 10.1159/000093217; Hsiao JJ, 2015, DEMENT GERIATR COGN, V39, P12, DOI 10.1159/000365587; Ishibe N, 2009, J HEAD TRAUMA REHAB, V24, P424, DOI 10.1097/HTR.0b013e3181c13426; Jawaid A, 2009, NEURODEGENER DIS, V6, P219, DOI 10.1159/000258704; Jordan BD, 2000, SEMIN NEUROL, V20, P179, DOI 10.1055/s-2000-9826; Kalkonde YV, 2012, ALZHEIMERS DEMENT, V8, P204, DOI 10.1016/j.jalz.2011.03.011; Kaplan E., 1983, BOSTON NAMING TEST; Kaufer DI, 2000, J NEUROPSYCH CLIN N, V12, P233, DOI 10.1176/jnp.12.2.233; Leger GC, 2014, DEMENT GERIATR COGN, V37, P104, DOI 10.1159/000354368; McKee AC, 2014, ACTA NEUROPATHOL, V127, P29, DOI 10.1007/s00401-013-1230-6; McKee AC, 2010, J NEUROPATH EXP NEUR, V69, P918, DOI 10.1097/NEN.0b013e3181ee7d85; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Mendez MF, 2013, NEUROLOGY, V80, P561, DOI 10.1212/WNL.0b013e3182815547; Mesulam MM, 2001, ANN NEUROL, V49, P425, DOI 10.1002/ana.91.abs; Mesulam MM, 2003, NEW ENGL J MED, V349, P1535, DOI 10.1056/NEJMra022435; MORRIS JC, 1993, NEUROLOGY, V43, P2412, DOI 10.1212/WNL.43.11.2412-a; Morris JC, 2006, ALZ DIS ASSOC DIS, V20, P210, DOI 10.1097/01.wad.0000213865.09806.92; Neary D, 1998, NEUROLOGY, V51, P1546, DOI 10.1212/WNL.51.6.1546; Nemetz PN, 1999, AM J EPIDEMIOL, V149, P32; Onyike CU, 2013, INT REV PSYCHIATR, V25, P130, DOI 10.3109/09540261.2013.776523; Perry DC, 2013, SEMIN NEUROL, V33, P336, DOI 10.1055/s-0033-1359316; PFEFFER RI, 1982, J GERONTOL, V37, P323, DOI 10.1093/geronj/37.3.323; Plassman BL, 2000, NEUROLOGY, V55, P1158, DOI 10.1212/WNL.55.8.1158; Pressman PS, 2014, BIOL PSYCHIAT, V75, P574, DOI 10.1016/j.biopsych.2013.11.006; Reitan RM., 1985, HALSTEAD REITAN NEUR; Rosen HJ, 2006, NEUROLOGY, V67, P1752, DOI 10.1212/01.wnl.0000247630.29222.34; Rosso SM, 2003, J NEUROL NEUROSUR PS, V74, P1574, DOI 10.1136/jnnp.74.11.1574; Sayed N, 2013, J NEUROTRAUM, V30, P1117, DOI 10.1089/neu.2012.2638; Shirk SD, 2011, ALZHEIMERS RES THER, V3, DOI 10.1186/alzrt94; Smith C, 2003, NEUROPATH APPL NEURO, V29, P496, DOI 10.1046/j.1365-2990.2003.00488.x; Strickland D, 1996, ACTA NEUROL SCAND, V94, P45, DOI 10.1111/j.1600-0404.1996.tb00038.x; Teng E, 2010, ALZ DIS ASSOC DIS, V24, P348, DOI 10.1097/WAD.0b013e3181e2fc84; Teng E, 2010, DEMENT GERIATR COGN, V30, P189, DOI 10.1159/000313540; Wechsler D., 1987, WECHSLER ADULT INTEL; Wechsler D., 1987, WECHSLER MEMORY SCAL	47	22	22	0	11	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	1420-8008	1421-9824		DEMENT GERIATR COGN	Dement. Geriatr. Cogn. Disord.		2015	39	3-4					143	153		10.1159/000369787			11	Geriatrics & Gerontology; Clinical Neurology; Psychiatry	Geriatrics & Gerontology; Neurosciences & Neurology; Psychiatry	CB5UJ	WOS:000349692800003	25531628	Green Accepted, Bronze			2021-06-18	
J	Joseph, B; Pandit, V; Aziz, H; Kulvatunyou, N; Zangbar, B; Green, DJ; Haider, A; Tang, A; O'Keeffe, T; Gries, L; Friese, RS; Rhee, P				Joseph, Bellal; Pandit, Viraj; Aziz, Hassan; Kulvatunyou, Narong; Zangbar, Bardiya; Green, Donald J.; Haider, Ansab; Tang, Andrew; O'Keeffe, Terence; Gries, Lynn; Friese, Randall S.; Rhee, Peter			Mild traumatic brain injury defined by Glasgow Coma Scale: Is it really mild?	BRAIN INJURY			English	Article						Glasgow Coma Scale; mild brain injury; outcome trauma; traumatic brain injury	NEW-ORLEANS CRITERIA; MINOR HEAD-INJURY; COMPUTED-TOMOGRAPHY; CT; PREDICTORS; RULE	Introduction: Conventionally, a Glasgow Coma Scale (GCS) score of 13-15 defines mild traumatic brain injury (mTBI). The aim of this study was to identify the factors that predict progression on repeat head computed tomography (RHCT) and neurosurgical intervention (NSI) in patients categorized as mild TBI with intracranial injury (intracranial haemorrhage and/or skull fracture). Methods: This study performed a retrospective chart review of all patients with traumatic brain injury who presented to a level 1 trauma centre. Patients with blunt TBI, an intracranial injury and admission GCS of 13-15 without anti-platelet and anti-coagulation therapy were included. The outcome measures were: progression on RHCT and need for neurosurgical intervention (craniotomy and/or craniectomy). Results: A total of 1800 patients were reviewed, of which 876 patients were included. One hundred and fifteen (13.1%) patients had progression on RHCT scan. Progression on RHCT was 8-times more likely in patients with subdural haemorrhage >= 10 mm, 5-times more likely with epidural haemorrhage >= 10 mm and 3-times more likely with base deficit >= 4. Forty-seven patients underwent a neurosurgical intervention. Patients with displaced skull fracture were 10-times more likely and patients with base deficit >4 were 21-times more likely to have a neurosurgical intervention. Conclusion: In patients with intracranial injury, a mild GCS score (GCS 13-15) in patients with an intracranial injury does not preclude progression on repeat head CT and the need for a neurosurgical intervention. Base deficit greater than four and displaced skull fracture are the greatest predictors for neurosurgical intervention in patients with mild TBI and an intracranial injury.	[Joseph, Bellal; Pandit, Viraj; Aziz, Hassan; Kulvatunyou, Narong; Zangbar, Bardiya; Green, Donald J.; Haider, Ansab; Tang, Andrew; O'Keeffe, Terence; Gries, Lynn; Friese, Randall S.; Rhee, Peter] Univ Arizona, Dept Surg, Div Trauma Crit Care Emergency Surg & Burns, Tucson, AZ 85727 USA	Joseph, B (corresponding author), Univ Arizona, Dept Surg, Div Trauma Crit Care Burns & Emergency Surg, 1501 N Campbell Ave,Room 5411,POB 245063, Tucson, AZ 85727 USA.	bjoseph@surgery.arizona.edu	Zangbar, Bardiya/K-7147-2014	Zangbar, Bardiya/0000-0003-1215-1693			Carlson AP, 2010, NEUROSURG FOCUS, V29, DOI 10.3171/2010.8.FOCUS10182; Centers for Disease Control and Prevention, 2003, REP C MILD TRAUM BRA; Faul M.D., 2010, TRAUMATIC BRAIN INJU; Jagoda AS, 2008, ANN EMERG MED, V52, P714, DOI 10.1016/j.annemergmed.2008.08.021; JERET JS, 1993, NEUROSURGERY, V32, P9, DOI 10.1227/00006123-199301000-00002; Joseph B, 2014, J TRAUMA ACUTE CARE, V76, P965, DOI 10.1097/TA.0000000000000161; Joseph B, 2014, J TRAUMA ACUTE CARE, V76, P817, DOI 10.1097/TA.0b013e3182aafcf0; Joseph B, 2014, AM SURGEON, V80, P43; Joseph B, 2014, J SURG RES, V186, P287, DOI 10.1016/j.jss.2013.08.009; Joseph B, 2013, J TRAUMA ACUTE CARE, V75, P102, DOI 10.1097/TA.0b013e3182946667; Kisat M, 2012, J SURG RES, V173, P31, DOI 10.1016/j.jss.2011.04.059; MENDELOW AD, 1983, BRIT MED J, V287, P1173, DOI 10.1136/bmj.287.6400.1173; Rixen D, 2001, SHOCK, V15, P83, DOI 10.1097/00024382-200115020-00001; Shukla D, 2010, J NEUROSCI RURAL PRA, V1, P82, DOI 10.4103/0976-3147.71723; SIEGEL JH, 1995, J NEUROTRAUM, V12, P579, DOI 10.1089/neu.1995.12.579; Smits M, 2005, JAMA-J AM MED ASSOC, V294, P1519, DOI 10.1001/jama.294.12.1519; Stiell IG, 2005, JAMA-J AM MED ASSOC, V294, P1511, DOI 10.1001/jama.294.12.1511; Velmahos GC, 2006, J TRAUMA, V60, P494, DOI 10.1097/01.ta.0000203546.14824.0d; Vos PE, 2012, EUR J NEUROL, V19, P191, DOI 10.1111/j.1468-1331.2011.03581.x; Vos PE, 2002, EUR J NEUROL, V9, P207, DOI 10.1046/j.1468-1331.2002.00407.x; Washington CW, 2012, J NEUROSURG, V116, P549, DOI 10.3171/2011.11.JNS111092	21	22	23	0	10	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2015	29	1					11	16		10.3109/02699052.2014.945959			6	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	AW1WC	WOS:000346078000002	25111571				2021-06-18	
J	Kim, C; Searson, PC				Kim, Chloe; Searson, Peter C.			Magnetic bead-quantum dot assay for detection of a biomarker for traumatic brain injury	NANOSCALE			English	Article							IMMUNOMAGNETIC SEPARATION; SANDWICH ASSAY; NANOPARTICLES; CANCER; S-100B	Current diagnostic methods for traumatic brain injury (TBI), which accounts for 15% of all emergency room visits, are limited to neuroimaging modalities. The challenges of accurate diagnosis and monitoring of TBI have created the need for a simple and sensitive blood test to detect brain-specific biomarkers. Here we report on an assay for detection of S100B, a putative biomarker for TBI, using antibody-conjugated magnetic beads for capture of the protein, and antibody-conjugated quantum dots for optical detection. From Western Blot, we show efficient antigen capture and concentration by the magnetic beads. Using magnetic bead capture and quantum dot detection in serum samples, we show a wide detection range and detection limit below the clinical cut-off level.	[Kim, Chloe; Searson, Peter C.] Johns Hopkins Univ, Dept Mat Sci & Engn, Baltimore, MD 21218 USA; [Kim, Chloe; Searson, Peter C.] Johns Hopkins Univ, Inst Nanobiotechnol, Baltimore, MD 21218 USA	Searson, PC (corresponding author), Johns Hopkins Univ, Dept Mat Sci & Engn, 3400 North Charles St, Baltimore, MD 21218 USA.	searson@jhu.edu		Searson, Peter/0000-0002-5417-0828			Astrand R., 2012, TRAUMATIC BRAIN INJU, P176, DOI [10.1039/9781849734745-00176, DOI 10.1039/9781849734745-00176]; Bazarian JJ, 2006, BRAIN INJURY, V20, P759, DOI 10.1080/02699050500488207; Bettermann K., 2012, TRAUMATIC BRAIN INJU, P1, DOI [10.1039/9781849734745-00001, DOI 10.1039/9781849734745-00001]; Bruno JG, 2009, J FLUORESC, V19, P427, DOI 10.1007/s10895-008-0429-8; Dambinova S. A., 2012, TRAUMATIC BRAIN INJU, P200, DOI [10.1039/9781849734745-00200, DOI 10.1039/9781849734745-00200]; Dash PK, 2010, NEUROTHERAPEUTICS, V7, P100, DOI 10.1016/j.nurt.2009.10.019; Dimopoulou I, 2003, NEUROLOGY, V60, P947, DOI 10.1212/01.WNL.0000049931.77887.7F; Dobson J, 2006, DRUG DEVELOP RES, V67, P55, DOI 10.1002/ddr.20067; Franzreb M, 2006, APPL MICROBIOL BIOT, V70, P505, DOI 10.1007/s00253-006-0344-3; Galloway JF, 2012, NANOMED-NANOTECHNOL, V8, P1190, DOI 10.1016/j.nano.2011.12.002; Goncalves CA, 2008, CLIN BIOCHEM, V41, P755, DOI 10.1016/j.clinbiochem.2008.04.003; Hama H, 2011, NAT NEUROSCI, V14, P1481, DOI 10.1038/nn.2928; HAUSER H, 1981, BIOCHIM BIOPHYS ACTA, V650, P21, DOI 10.1016/0304-4157(81)90007-1; Huang KW, 2013, NANOSCALE RES LETT, V8, DOI 10.1186/1556-276X-8-413; Jin T, 2010, MOL BIOSYST, V6, P2325, DOI 10.1039/c0mb00056f; Kalkhof S, 2008, ANAL BIOANAL CHEM, V392, P305, DOI 10.1007/s00216-008-2231-5; Kim C, 2014, BIOCONJUGATE CHEM, V25, P1893, DOI 10.1021/bc5003778; Kim DK, 2001, J MAGN MAGN MATER, V225, P256, DOI 10.1016/S0304-8853(00)01255-5; Kovesdi E, 2010, ACTA NEUROCHIR, V152, P1, DOI 10.1007/s00701-009-0463-6; KONDO A, 1994, APPL MICROBIOL BIOT, V41, P99; Lee KH, 2012, NANOMED-NANOTECHNOL, V8, P1043, DOI 10.1016/j.nano.2012.01.005; Li N, 2013, ANAL CHEM, V85, P9699, DOI 10.1021/ac402082s; Lisi F, 2012, ADV HEALTHC MATER, V1, P631, DOI 10.1002/adhm.201200072; Mondello S, 2011, EXPERT REV MOL DIAGN, V11, P65, DOI 10.1586/ERM.10.104; Nagle JF, 2000, BBA-REV BIOMEMBRANES, V1469, P159, DOI 10.1016/S0304-4157(00)00016-2; Pamme N, 2006, LAB CHIP, V6, P974, DOI 10.1039/b604542a; Park H, 2013, INT J NANOMED, V8, P4543, DOI 10.2147/IJN.S51893; Park H, 2013, NANOSCALE, V5, P8609, DOI 10.1039/c3nr02357e; Park H, 2013, NANOTECHNOLOGY, V24, DOI 10.1088/0957-4484/24/28/285103; Pei XM, 2013, ANAL CHIM ACTA, V758, P1, DOI 10.1016/j.aca.2012.10.060; Petryayeva E, 2013, APPL SPECTROSC, V67, P215, DOI 10.1366/12-06948; Pham N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012691; Schiavi Paolo, 2012, Acta Biomed, V83, P5; Su XL, 2004, ANAL CHEM, V76, P4806, DOI 10.1021/ac049442+; Tennico YH, 2010, ANAL CHEM, V82, P5591, DOI 10.1021/ac101269u; Vacklin HP, 2005, BBA-BIOMEMBRANES, V1668, P17, DOI 10.1016/j.bbamem.2004.11.001; WRIGHT DJ, 1994, EPIDEMIOL INFECT, V113, P31, DOI 10.1017/S0950268800051438; Yu LSL, 2001, J IMMUNOL METHODS, V256, P11, DOI 10.1016/S0022-1759(01)00372-6; Yu MK, 2012, THERANOSTICS, V2, P3, DOI 10.7150/thno.3463; Yu X, 2013, BIOSENS BIOELECTRON, V41, P129, DOI 10.1016/j.bios.2012.08.007; Zhu XS, 2010, ANALYST, V135, P381, DOI 10.1039/b918623a; Zrazhevskiy P, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2635	42	22	23	0	48	ROYAL SOC CHEMISTRY	CAMBRIDGE	THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS, ENGLAND	2040-3364	2040-3372		NANOSCALE	Nanoscale		2015	7	42					17820	17826		10.1039/c5nr05608j			7	Chemistry, Multidisciplinary; Nanoscience & Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied	Chemistry; Science & Technology - Other Topics; Materials Science; Physics	CU6OB	WOS:000363650700029	26457768				2021-06-18	
J	Lam, KC; Valier, ARS; McLeod, TCV				Lam, Kenneth C.; Valier, Alison R. Snyder; McLeod, Tamara C. Valovich			Injury and Treatment Characteristics of Sport-Specific Injuries Sustained in Interscholastic Athletics: A Report From the Athletic Training Practice-Based Research Network	SPORTS HEALTH-A MULTIDISCIPLINARY APPROACH			English	Article						medical coverage; practice characteristics; adolescent athletes	STATES HIGH-SCHOOL; US HIGH-SCHOOL; SURVEILLANCE SYSTEM; DESCRIPTIVE EPIDEMIOLOGY; SOCCER INJURIES; FOOTBALL INJURIES; KNEE INJURIES; CONCUSSIONS	Background: The inclusion of clinical practice factors, beyond epidemiologic data, may help guide medical coverage and care decisions. Hypothesis: Trends in injury and treatment characteristics of sport-specific injuries sustained by secondary school athletes will differ based on sport. Study Design: Retrospective analysis of electronic patient records. Methods: Participants consisted of 3302 boys and 2293 girls who were diagnosed with a sport-related injury or condition during the study years. Injury (sport, body part, diagnosis via ICD-9 codes) and treatment (type, amount, and duration of care) characteristics were grouped by sport and reported using summary statistics. Results: Most injuries and treatments occurred in football, girls' soccer, basketball, volleyball, and track and field. Sprain or strain of the ankle, knee, and thigh/hip/groin and concussion were the most commonly documented injuries across sports. The injury pattern for boys' wrestling differed from other sports and included sprain or strain of the elbow and neck and general medical skin conditions. The most frequently reported service was athletic training evaluation/reevaluation treatment, followed by hot/cold pack, therapeutic exercise, manual therapy techniques, electrical stimulation, and strapping of lower extremity joints. Most sports required 4 to 5 services per injury. With the exception of boys' soccer and girls' softball, duration of care ranged from 10 to 14 days. Girls' soccer and girls' and boys' track and field reported the longest durations of care. Conclusion: Injury and treatment characteristics are generally comparable across sports, suggesting that secondary school athletic trainers may diagnose and treat similar injuries regardless of sport.	[Lam, Kenneth C.; Valier, Alison R. Snyder; McLeod, Tamara C. Valovich] AT Still Univ, Dept Interdisciplinary Hlth Sci, Athlet Training Program, Mesa, AZ USA	Lam, KC (corresponding author), AT Still Univ, Dept Interdisciplinary Hlth Sci, Clin Res, 5850 East Still Circle, Mesa, AZ 85206 USA.	klam@atsu.edu	McLeod, Tamara/AAU-9435-2020; Lam, Kenny/ABB-9733-2020	Lam, Kenneth/0000-0002-2185-0990			Agel J, 2007, J ATHL TRAINING, V42, P303; Agel J, 2007, J ATHL TRAINING, V42, P295; Agel J, 2007, J ATHL TRAINING, V42, P270; Agel J, 2007, J ATHL TRAINING, V42, P202; Almquist J, 2008, J ATHL TRAINING, V43, P416, DOI 10.4085/1062-6050-43.4.416; American Orthopaedic Society for Sports Medicine, PRINC SEL TEAM MED C; Badgeley MA, 2013, J PHYS ACT HEALTH, V10, P160, DOI 10.1123/jpah.10.2.160; Borowski L, 2008, AM J SPORTS MED, V36, P2328; Comstock R, 2012, NATL HIGH SCH SPORTS; Courson R, INTERASSOCIATION CON; Dick R, 1988, J ATHL TRAIN; Dick R, 2007, J ATHL TRAINING, V42, P278; Dick R, 2007, J ATHL TRAINING, V42, P221; DiFiori JP, 2014, CLIN J SPORT MED, V24, P3, DOI 10.1097/JSM.0000000000000060; Dragoo JL, 2012, AM J SPORT MED, V40, P990, DOI 10.1177/0363546512442336; Fernandez WG, 2007, ACAD EMERG MED, V14, P641, DOI [10.1197/j.aem.2007.03.1354, 10.1111/j.1553-2712.2007.tb01851.x]; Frommer LJ, 2011, J ATHL TRAINING, V46, P76, DOI 10.4085/1062-6050-46.1.76; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Ingram JG, 2008, AM J SPORT MED, V36, P1116, DOI 10.1177/0363546508314400; Krajnik S, 2010, PEDIATRICS, V125, P497, DOI 10.1542/peds.2009-0961; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; McLeod TCV, 2013, J ATHL TRAINING, V48, P483, DOI 10.4085/1062-6050-48.4.04; McLeod TCV, 2012, J ATHL TRAINING, V47, P557, DOI 10.4085/1062-6050-47.5.05; National Federation of State High School Associations, 2012 2013 HIGH SCH A; National Institutes of Health, RES REP DAT HIPAA PR; Nelson AJ, 2007, J ATHL TRAINING, V42, P381; Rindal DB, 2010, J DENT, V38, P1027, DOI 10.1016/j.jdent.2010.09.003; Roos KG, 2014, SPORTS MED, V44, P405, DOI 10.1007/s40279-013-0124-z; Shankar PR, 2007, AM J SPORT MED, V35, P1295, DOI 10.1177/0363546507299745; Swenson DM, 2013, MED SCI SPORT EXER, V45, P462, DOI 10.1249/MSS.0b013e318277acca; Yard EE, 2008, AM J SPORT MED, V36, P1930, DOI 10.1177/0363546508318047; Yardt EE, 2008, AM J SPORT MED, V36, P57, DOI 10.1177/0363546507307507	32	22	22	2	15	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1941-7381	1941-0921		SPORTS HEALTH	Sports Health	JAN-FEB	2015	7	1					67	74		10.1177/1941738114555842			8	Sport Sciences	Sport Sciences	V20GY	WOS:000214876300008	25553215	Green Published			2021-06-18	
J	McCammack, KC; Sadler, C; Guo, YY; Ramaswamy, RS; Farid, N				McCammack, Kevin C.; Sadler, Charlotte; Guo, Yueyang; Ramaswamy, Raja S.; Farid, Nikdokht			Routine Repeat Head CT may not be Indicated in Patients on Anticoagulant/Antiplatelet Therapy Following Mild Traumatic Brain Injury	WESTERN JOURNAL OF EMERGENCY MEDICINE			English	Article						Anticoagulation; antiplatelet; mild traumatic brain injury; head computed tomography; intracranial hemorrhage	CRANIAL COMPUTED-TOMOGRAPHY; INTRACRANIAL HEMORRHAGE; SUBARACHNOID HEMORRHAGE; ANTICOAGULATED PATIENTS; DIAGNOSIS; WARFARIN; RISK	Introduction: Evaluation recommendations for patients on anticoagulant and antiplatelet ( ACAP) therapy that present after mild traumatic brain injury (TBI) are controversial. At our institution, an initial noncontrast head computed tomography (HCT) is performed, with a subsequent HCT performed six hours later to exclude delayed intracranial hemorrhage (ICH). This study was performed to evaluate the yield and advisability of this approach. Methods: We performed a retrospective review of subjects undergoing evaluation for ICH after mild TBI in patients on ACAP therapy between January of 2012 and April of 2013. We assessed for the frequency of ICH on both the initial noncontrast HCT and on the routine six-hour follow-up HCT. Additionally, chart review was performed to evaluate the clinical implications of ICH, when present, and to interrogate whether pertinent clinical and laboratory data may predict the presence of ICH prior to imaging. We used multivariate generalized linear models to assess whether presenting Glasgow Coma Score (GCS), loss of consciousness (LOC), neurological or physical examination findings, international normalized ratio, prothrombin time, partial thromboplastin time, platelet count, or specific ACAP regimen predicted ICH. Results: 144 patients satisfied inclusion criteria. Ten patients demonstrated initial HCT positive for ICH, with only one demonstrating delayed ICH on the six-hour follow-up HCT. This patient was discharged without any intervention required or functional impairment. Presenting GCS deviation (p<0.001), LOC (p=0.04), neurological examination findings (p<0.001), clopidogrel (p=0.003), aspirin (p=0.03) or combination regimen (p=0.004) use were more commonly seen in patients with ICH. Conclusion: Routine six-hour follow-up HCT is likely not indicated in patients on ACAP therapy, as our study suggests clinically significant delayed ICH does not occur. Additionally, presenting GCS deviation, LOC, neurological examination findings, clopidogrel, aspirin or combination regimen use may predict ICH, and, in the absence of these findings, HCT may potentially be forgone altogether.	[McCammack, Kevin C.; Guo, Yueyang; Ramaswamy, Raja S.; Farid, Nikdokht] Univ Calif San Diego, Dept Radiol, 200 W Arbor Dr,8756, San Diego, CA 92103 USA; [Sadler, Charlotte] Univ Calif San Diego, Dept Emergency Med, San Diego, CA 92103 USA; [Guo, Yueyang] Univ Calif San Diego, Sch Med, San Diego, CA 92103 USA	McCammack, KC (corresponding author), Univ Calif San Diego, Dept Radiol, 200 W Arbor Dr,8756, San Diego, CA 92103 USA.	kmccammack@ucsd.edu					Brewer ES, 2011, J TRAUMA, V70, pE1, DOI 10.1097/TA.0b013e3181e5e286; Byyny RL, 2008, ANN EMERG MED, V51, P697, DOI 10.1016/j.annemergmed.2007.10.007; Garra G, 1999, ACAD EMERG MED, V6, P121, DOI 10.1111/j.1553-2712.1999.tb01048.x; Gittleman AM, 2005, AM J NEURORADIOL, V26, P603; HART RG, 1995, STROKE, V26, P1471, DOI 10.1161/01.STR.26.8.1471; Ivascu FA, 2005, J TRAUMA, V59, P1131, DOI 10.1097/01.ta.0000189067.16368.83; Kaen A, 2010, J TRAUMA, V68, P895, DOI 10.1097/TA.0b013e3181b28a76; Kirley K, 2012, CIRC-CARDIOVASC QUAL, V5, P615, DOI 10.1161/CIRCOUTCOMES.112.967299; Li J, 2001, LANCET, V357, P771, DOI 10.1016/S0140-6736(00)04163-5; Mack LR, 2003, J EMERG MED, V24, P157, DOI 10.1016/S0736-4679(02)00714-X; McLaughlin GE, 2002, ANN INTERN MED, V137, P622, DOI 10.7326/0003-4819-137-7-200210010-00024; Morgenstern LB, 1998, ANN EMERG MED, V32, P297; Nayak NV, 2013, J TRAUMA ACUTE CARE, V75, P273, DOI 10.1097/TA.0b013e3182905eb4; Nishijima DK, 2012, ANN EMERG MED, V59, P460, DOI 10.1016/j.annemergmed.2012.04.007; Peck KA, 2011, J TRAUMA, V71, P1600, DOI 10.1097/TA.0b013e31823b9ce1; Reynolds FD, 2003, J TRAUMA, V54, P492, DOI 10.1097/01.TA.0000051601.60556.FC; Sidman R, 1996, ACAD EMERG MED, V3, P827, DOI 10.1111/j.1553-2712.1996.tb03526.x; Sifri ZC, 2006, J TRAUMA, V61, P862, DOI 10.1097/01.ta.0000224225.54982.90; Tauber M, 2009, J TRAUMA, V67, P521, DOI 10.1097/TA.0b013e3181a7c184; Thomas KE, 2008, J SAFETY RES, V39, P269, DOI 10.1016/j.jsr.2008.05.001; Velmahos GC, 2006, J TRAUMA, V60, P494, DOI 10.1097/01.ta.0000203546.14824.0d	21	22	22	0	3	WESTJEM	ORANGE	C/O SHAHRAM LOTFIPOUR, MD, MPH, 333 CITY BLVD W STE 640, RT 128-01, ORANGE, CA 92868 USA	1936-900X	1936-9018		WEST J EMERG MED	West. J. Emerg. Med.	JAN	2015	16	1					43	49		10.5811/westjem.2014.10.19488			7	Emergency Medicine	Emergency Medicine	DH9IH	WOS:000373109200008	25671007	DOAJ Gold, Green Published			2021-06-18	
J	Merritt, VC; Lange, RT; French, LM				Merritt, Victoria C.; Lange, Rael T.; French, Louis M.			Resilience and symptom reporting following mild traumatic brain injury in military service members	BRAIN INJURY			English	Article						Mild traumatic brain injury; military service members; post-concussion symptoms; post-traumatic stress disorder; resilience	PERSISTENT POSTCONCUSSIVE SYMPTOMS; POSTTRAUMATIC-STRESS-DISORDER; POST-CONCUSSION SYMPTOMS; QUALITY-OF-LIFE; PTSD CHECKLIST; PSYCHOMETRIC PROPERTIES; PSYCHOLOGICAL RESILIENCE; SOCIAL SUPPORT; RISK; VETERANS	Primary objective: The purpose of this study was to examine the relationship between resilience and symptom reporting following mild traumatic brain injury (mTBI). It was hypothesized that, as resilience increases, self-reported symptoms would decrease. Research design: Cross-sectional design. Methods and procedures: Participants were 142 US military service members who sustained a mTBI, divided into three resilience groups based on participants' responses on the Response to Stressful Experiences Scale: Moderate (n = 42); High (n = 51); and Very High (n = 49). Participants completed the Neurobehavioral Symptom Inventory (NSI) and PTSD Checklist-Civilian Version (PCL-C) within 12 months following injury. Main outcomes and results: There were significant main effects for the NSI total score, cognitive cluster and affective cluster, as well as for the PCL-C total score, avoidance cluster and hyperarousal cluster. Pairwise comparisons revealed that there was a negative relationship between resilience and self-reported symptoms overall. Specifically, participants with higher resilience reported fewer post-concussion and PTSD-related symptoms than participants with lower levels of resilience. Conclusions: These findings underscore the important role that resilience plays in symptom expression in military service members with mTBI and suggest that research on targeted interventions to increase resilience in the acute phase following injury is indicated.	[Merritt, Victoria C.] Penn State Univ, University Pk, PA 16802 USA; [Lange, Rael T.; French, Louis M.] Def & Vet Brain Injury Ctr, Bethesda, MD USA; [Lange, Rael T.; French, Louis M.] Walter Reed Natl Mil Med Ctr, Bethesda, MD USA; [Lange, Rael T.] Univ British Columbia, Vancouver, BC V5Z 1M9, Canada; [Lange, Rael T.; French, Louis M.] Ctr Neurosci & Regenerat Med, Bethesda, MD USA; [French, Louis M.] Uniformed Serv Univ Hlth Sci, Bethesda, MD 20814 USA	Merritt, VC (corresponding author), Penn State Univ, Dept Psychol, 372 Moore Bldg, University Pk, PA 16802 USA.	vca106@psu.edu	french, louis/AAB-2083-2020	Merritt, Victoria/0000-0001-5683-4168; french, louis/0000-0002-9451-0604			Adler AB, 2009, MIL MED, V174, P21, DOI 10.7205/MILMED-D-00-2208; Adler AB, 2009, J CONSULT CLIN PSYCH, V77, P928, DOI 10.1037/a0016877; Agaibi CE, 2005, TRAUMA VIOLENCE ABUS, V6, P195, DOI 10.1177/1524838005277438; American Psychiatric Association, 2000, DIAGNOSTIC AND STATI; Belanger HG, 2013, CLIN NEUROPSYCHOL, V27, P159, DOI 10.1080/13854046.2012.758780; Bensimon M, 2012, PERS INDIV DIFFER, V52, P782, DOI 10.1016/j.paid.2012.01.011; Blanchard EB, 1996, BEHAV RES THER, V34, P669, DOI 10.1016/0005-7967(96)00033-2; Block J, 1996, J PERS SOC PSYCHOL, V70, P349, DOI 10.1037/0022-3514.70.2.349; Boyle Eleanor, 2014, Arch Phys Med Rehabil, V95, pS230, DOI 10.1016/j.apmr.2013.08.297; Bryan CJ, 2013, JAMA PSYCHIAT, V70, P686, DOI 10.1001/jamapsychiatry.2013.1093; Burke HS, 2009, J REHABIL, V75, P5; Caplan LJ, 2010, J HEAD TRAUMA REHAB, V25, P447, DOI 10.1097/HTR.0b013e3181d5bdbd; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Davis CH, 2002, AM J PHYS MED REHAB, V81, P609, DOI 10.1097/00002060-200208000-00009; Department of Defense, 2014, DOD NUMB TRAUM BRAIN; Dolan CA, 2006, MIL MED, V171, P93, DOI 10.7205/MILMED.171.2.93; Forbes D, 2001, BEHAV RES THER, V39, P977, DOI 10.1016/S0005-7967(00)00084-X; Franke LM, 2015, J HEAD TRAUMA REHAB, V30, pE34, DOI 10.1097/HTR.0000000000000042; French LM, 2012, J HEAD TRAUMA REHAB, V27, P63, DOI 10.1097/HTR.0b013e3182248344; Garden N, 2010, NEUROPSYCHOLOGY, V24, P168, DOI 10.1037/a0017431; Garden N, 2010, APPL NEUROPSYCHOL, V17, P1, DOI 10.1080/09084280903297495; Graham DP, 2013, J PSYCHIATR RES, V47, P835, DOI 10.1016/j.jpsychires.2013.02.006; Hoge EA, 2007, DEPRESS ANXIETY, V24, P139, DOI 10.1002/da.20175; Iverson GL, 2011, LITTLE BLACK BOOK OF NEUROPSYCHOLOGY: A SYNDROME-BASED APPROACH, P697, DOI 10.1007/978-0-387-76978-3_22; Iverson GL, 2011, LITTLE BLACK BOOK OF NEUROPSYCHOLOGY: A SYNDROME-BASED APPROACH, P745, DOI 10.1007/978-0-387-76978-3_24; Johnsen BH, 2002, SCAND J PSYCHOL, V43, P181, DOI 10.1111/1467-9450.00285; Johnson DC, 2014, AM J PSYCHIAT, V171, P844, DOI 10.1176/appi.ajp.2014.13040502; Johnson DC, 2011, MIL MED, V176, P161, DOI 10.7205/MILMED-D-10-00258; Keen SM, 2008, J REHABIL RES DEV, V45, P465, DOI 10.1682/JRRD.2007.09.0138; King LA, 1998, J PERS SOC PSYCHOL, V74, P420, DOI 10.1037/0022-3514.74.2.420; King NS, 2011, BRAIN INJURY, V25, P462, DOI 10.3109/02699052.2011.558042; King PR, 2012, J REHABIL RES DEV, V49, P879, DOI 10.1682/JRRD.2011.03.0051; KOBASA SC, 1979, J PERS SOC PSYCHOL, V37, P1, DOI 10.1037/0022-3514.37.1.1; Kontos AP, 2013, J NEUROTRAUM, V30, P680, DOI 10.1089/neu.2012.2506; Lang AJ, 2003, J TRAUMA STRESS, V16, P257, DOI 10.1023/A:1023796007788; Lange RT, 2014, ARCH CLIN NEUROPSYCH, V29, P329, DOI 10.1093/arclin/acu013; Lange RT, 2013, J NEUROTRAUM, V30, P958, DOI 10.1089/neu.2012.2743; Lange RT, 2013, J NEUROTRAUM, V30, P237, DOI 10.1089/neu.2012.2685; Lange RT, 2011, J HEAD TRAUMA REHAB, V26, P127, DOI 10.1097/HTR.0b013e3181e4622a; Lange RT, PSYCHOMETRIC PROPERT; Leners C, 2014, ISSUES MENT HEALTH N, V35, P497, DOI 10.3109/01612840.2014.887164; Luthar SS, 2000, CHILD DEV, V71, P543, DOI 10.1111/1467-8624.00164; Management of Concussion/mTBI Working Group, 2009, J Rehabil Res Dev, V46, pCP1; Masten AS, 2001, AM PSYCHOL, V56, P227, DOI 10.1037/0003-066X.56.3.227; McCauley SR, 2013, J NEUROTRAUM, V30, P642, DOI 10.1089/neu.2012.2393; McGrath JC, 2006, BRAIN INJURY, V20, P767, DOI 10.1080/02699050600664566; Morissette SB, 2011, REHABIL PSYCHOL, V56, P340, DOI 10.1037/a0025462; Pietrzak RH, 2011, J AFFECT DISORDERS, V133, P560, DOI 10.1016/j.jad.2011.04.028; Pietrzak RH, 2010, J AFFECT DISORDERS, V123, P102, DOI 10.1016/j.jad.2009.08.001; Pietrzak RH, 2009, DEPRESS ANXIETY, V26, P745, DOI 10.1002/da.20558; Ponsford J, 2012, NEUROPSYCHOLOGY, V26, P304, DOI 10.1037/a0027888; Ponsford J, 2011, J NEUROTRAUM, V28, P937, DOI 10.1089/neu.2010.1516; Regehr C, 2000, J NERV MENT DIS, V188, P333, DOI 10.1097/00005053-200006000-00003; Rizzo Albert, 2013, MILITARY BEHAV HLTH, V1, P52, DOI DOI 10.1080/21635781.2012.721064; Roy A, 2007, ARCH SUICIDE RES, V11, P211, DOI 10.1080/13811110701250150; Ruggiero KJ, 2003, J TRAUMA STRESS, V16, P495, DOI 10.1023/A:1025714729117; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Schok ML, 2010, AGING MENT HEALTH, V14, P328, DOI 10.1080/13607860903228812; Sharkansky EJ, 2000, J ABNORM PSYCHOL, V109, P188, DOI 10.1037/0021-843X.109.2.188; Shively SB, 2012, J HEAD TRAUMA REHAB, V27, P234, DOI 10.1097/HTR.0b013e318250e9dd; Silver RC, 2002, JAMA-J AM MED ASSOC, V288, P1235, DOI 10.1001/jama.288.10.1235; Suhr JA, 2005, J INT NEUROPSYCH SOC, V11, P23, DOI 10.1017/S1355617705050010; Tugade M. M., 2007, J HAPPINESS STUD, V8, P311; Ursano RJ, 2014, PSYCHIATRY, V77, P107, DOI 10.1521/psyc.2014.77.2.107; Wilk JE, 2010, J HEAD TRAUMA REHAB, V25, P9, DOI 10.1097/HTR.0b013e3181bd090f; Wilkins KC, 2011, DEPRESS ANXIETY, V28, P596, DOI 10.1002/da.20837; Yeh PH, 2014, HUM BRAIN MAPP, V35, P2652, DOI 10.1002/hbm.22358; Yehuda R, 2007, J TRAUMA STRESS, V20, P435, DOI 10.1002/jts.20260; Ying LH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089401	69	22	23	0	12	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2015	29	11					1325	1336		10.3109/02699052.2015.1043948			12	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	CR4MF	WOS:000361306100007	26204318				2021-06-18	
J	Singh, T; Adekoya, OA; Jayaram, B				Singh, Tanya; Adekoya, Olayiwola Adedotun; Jayaram, B.			Understanding the binding of inhibitors of matrix metalloproteinases by molecular docking, quantum mechanical calculations, molecular dynamics simulations, and a MMGBSA/MMBappl study	MOLECULAR BIOSYSTEMS			English	Article							ENERGY COMPONENT ANALYSIS; PROTEIN-LIGAND COMPLEXES; TRAUMATIC BRAIN-INJURY; SPINAL-CORD-INJURY; COMPUTATIONAL PROTOCOL; RECEPTOR FLEXIBILITY; TISSUE INHIBITOR; PHYSICOCHEMICAL DESCRIPTORS; BARRIER DISRUPTION; FORCE-FIELD	Matrix metalloproteinases (MMPs) consist of a class of proteins required for normal tissue function. Their over expression is associated with many disease states and hence the interest in MMPs as drug targets. Almost all MMP inhibitors have been reported to fail in clinical trials due to lack of specificity. Zinc in the binding site of metalloproteinases performs essential biological functions and contributes to the binding affinity of inhibitors. The multiple possibilities for coordination geometry and the consequent charge on the zinc atom indicate that parameters developed are not directly transferable across different families of zinc metalloproteinases with different zinc coordination geometries, active sites and ligand architectures which makes it difficult to evaluate metal-ligand interactions. In order to assist in drug design endeavors for MMP targets, a computationally tractable pathway is presented, comprising docking of small molecule inhibitors against the target MMPs, derivation of quantum mechanical charges on the zinc ion in the active site and the amino acids coordinating with zinc including the inhibitor molecule, molecular dynamics simulations on the docked ligand-MMP complexes and evaluation of binding affinities of the ligand-MMP complexes via an accurate scoring function for zinc containing metalloprotein-ligand complexes. The above pathway was applied to study the interaction of inhibitor Batimastat with MMPs, which resulted in a high correlation between the predicted binding free energies and experiment, suggesting the potential applicability of the pathway. We then proceeded to formulate a few design principles which identify the key protein residues for generating molecules with high affinity and specificity against each of the MMPs.	[Singh, Tanya; Jayaram, B.] Indian Inst Technol, Dept Chem, New Delhi 110016, India; [Singh, Tanya; Jayaram, B.] Indian Inst Technol, Supercomp Facil Bioinformat & Computat Biol, New Delhi 110016, India; [Singh, Tanya; Jayaram, B.] Indian Inst Technol, Kusuma Sch Biol Sci, New Delhi 110016, India; [Adekoya, Olayiwola Adedotun] Univ Tromso, Dept Pharm, N-9001 Tromso, Norway	Adekoya, OA (corresponding author), Univ Tromso, Dept Pharm, N-9001 Tromso, Norway.	tanya@scfbio-iitd.res.in; olayiwola.adekoya@uit.no; bjayaram@chemistry.iitd.ac.in	Jayaram, B/G-9130-2011	Jayaram, B/0000-0002-5495-2213	Department of Biotechnology, Govt. of IndiaDepartment of Biotechnology (DBT) India; Council of Scientific & Industrial Research, Govt. of IndiaCouncil of Scientific & Industrial Research (CSIR) - India; Norwegian research councilResearch Council of NorwayEuropean Commission	This work is supported by grants from the Department of Biotechnology, Govt. of India. Tanya Singh is a recipient of Senior Research Fellowship from Council of Scientific & Industrial Research, Govt. of India. Adekoya Olayiwola acknowledges the support from Norwegian research council. The authors thank Prof. N. G. Ramesh for commenting on the synthesizability of the molecules designed.	Adcock SA, 2006, CHEM REV, V106, P1589, DOI 10.1021/cr040426m; Amantea D, 2008, NEUROSCIENCE, V152, P8, DOI 10.1016/j.neuroscience.2007.12.030; Amaro RE, 2008, J COMPUT AID MOL DES, V22, P693, DOI 10.1007/s10822-007-9159-2; Ardi VC, 2007, P NATL ACAD SCI USA, V104, P20262, DOI 10.1073/pnas.0706438104; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bertini I, 2006, ANGEW CHEM INT EDIT, V45, P7952, DOI 10.1002/anie.200603100; Berynskyy M., 2013, CURR PHYS CHEM, V3, P27; Blavier L, 1999, ANN NY ACAD SCI, V878, P108, DOI 10.1111/j.1749-6632.1999.tb07677.x; Cai QW, 2012, MOL MED REP, V5, P1438, DOI 10.3892/mmr.2012.849; Cawson T, 1998, MOL MED TODAY, V4, P130, DOI 10.1016/S1357-4310(97)01192-1; Chang C, 2001, TRENDS CELL BIOL, V11, pS37, DOI 10.1016/S0962-8924(01)82222-4; CORNELL WD, 1995, J AM CHEM SOC, V117, P5179, DOI 10.1021/ja00124a002; Dudev T, 2009, J PHYS CHEM B, V113, P11754, DOI 10.1021/jp904249s; Durrant JD, 2010, J MOL RECOGNIT, V23, P173, DOI 10.1002/jmr.989; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; Elkington P, 2011, J CLIN INVEST, V121, P1827, DOI 10.1172/JCI45666; Elkins PA, 2002, ACTA CRYSTALLOGR D, V58, P1182, DOI 10.1107/S0907444902007849; Feng YQ, 2002, BBA-PROTEINS PROTEOM, V1598, P10, DOI 10.1016/S0167-4838(02)00307-2; Fingleton B, 2007, CURR PHARM DESIGN, V13, P333, DOI 10.2174/138161207779313551; Fisher JF, 2006, CANCER METAST REV, V25, P115, DOI 10.1007/s10555-006-7894-9; Fleming JC, 2006, BRAIN, V129, P3249, DOI 10.1093/brain/awl296; Fujimoto M, 2008, J CEREBR BLOOD F MET, V28, P1674, DOI 10.1038/jcbfm.2008.59; Giangreco I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025597; Greenidge PA, 2013, J CHEM INF MODEL, V53, P201, DOI [10.1021/ci300425v, 10.1021/cI300025v]; Gupta A, 2007, PROTEIN PEPTIDE LETT, V14, P632; Horn HW, 2004, J CHEM PHYS, V120, P9665, DOI 10.1063/1.1683075; Hu JL, 2007, NAT REV DRUG DISCOV, V6, P480, DOI 10.1038/nrd2308; Hu X, 2003, J MOL GRAPH MODEL, V22, P115, DOI 10.1016/S1093-3263(03)00153-0; Jain T, 2005, FEBS LETT, V579, P6659, DOI 10.1016/j.febslet.2005.10.031; Jain T, 2007, PROTEINS, V67, P1167, DOI 10.1002/prot.21332; Jakalian A, 2000, J COMPUT CHEM, V21, P132, DOI 10.1002/(SICI)1096-987X(20000130)21:2<132::AID-JCC5>3.3.CO;2-G; Jayaram B, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-S17-S7; Jayaram B, 1999, J COMPUT PHYS, V151, P333, DOI 10.1006/jcph.1998.6173; Jayaram B, 2002, J COMPUT CHEM, V23, P1, DOI 10.1002/jcc.10009; Kalra P, 2001, J MED CHEM, V44, P4325, DOI 10.1021/jm010175z; Kalva S, 2014, J MOL GRAPH MODEL, V49, P25, DOI 10.1016/j.jmgm.2013.12.008; Kawasaki Y, 2008, NAT MED, V14, P331, DOI 10.1038/nm1723; Kessenbrock K, 2010, CELL, V141, P52, DOI 10.1016/j.cell.2010.03.015; Kleifeld O, 2001, J BIOL CHEM, V276, P17125, DOI 10.1074/jbc.M011604200; Kofla-Dlubacz A, 2012, DIGEST DIS SCI, V57, P706, DOI 10.1007/s10620-011-1936-z; Kokh DB, 2011, WIRES COMPUT MOL SCI, V1, P298, DOI 10.1002/wcms.29; Kumar MS, 2006, J PERIODONTOL, V77, P1803, DOI 10.1902/jop.2006.050293; Langley DR, 2007, J VIROL, V81, P3992, DOI 10.1128/JVI.02395-06; Lavery R, 2010, NUCLEIC ACIDS RES, V38, P299, DOI 10.1093/nar/gkp834; Liu H, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-583; Liu LY, 2008, NEUROSCI LETT, V434, P155, DOI 10.1016/j.neulet.2007.12.052; Lovejoy B, 1999, NAT STRUCT BIOL, V6, P217; Mukherjee G, 2013, PHYS CHEM CHEM PHYS, V15, P9107, DOI 10.1039/c3cp44697b; Murphy G, 2002, ARTHRITIS RES THER, V4, DOI 10.1186/ar572; Noble LJ, 2002, J NEUROSCI, V22, P7526; Pannu R, 2007, J NEUROCHEM, V101, P182, DOI 10.1111/j.1471-4159.2006.04354.x; PEARLMAN DA, 1995, COMPUT PHYS COMMUN, V91, P1, DOI 10.1016/0010-4655(95)00041-D; Ramer R, 2008, J NATL CANCER I, V100, P59, DOI 10.1093/jnci/djm268; Rodrigues WF, 2012, BRIT J PHARMACOL, V165, P2140, DOI 10.1111/j.1476-5381.2011.01686.x; Rouffet M, 2009, ORG BIOMOL CHEM, V7, P3817, DOI 10.1039/b910543c; Rowsell S, 2002, J MOL BIOL, V319, P173, DOI 10.1016/S0022-2836(02)00262-0; Sagel SD, 2005, PEDIATR PULM, V39, P224, DOI 10.1002/ppul.20165; Shaikh SA, 2007, CURR PHARM DESIGN, V13, P3454, DOI 10.2174/138161207782794220; Shaikh SA, 2004, ARCH BIOCHEM BIOPHYS, V429, P81, DOI 10.1016/j.abb.2004.05.019; Shaikh SA, 2007, J MED CHEM, V50, P2240, DOI 10.1021/jm060542c; Shibata N, 2005, NEUROBIOL AGING, V26, P1011, DOI 10.1016/j.neurobiolaging.2004.09.004; Shubayev VI, 2000, BRAIN RES, V855, P83, DOI 10.1016/S0006-8993(99)02321-5; Singh T, 2011, J CHEM INF MODEL, V51, P2515, DOI 10.1021/ci200193z; Skiles JW, 2004, CURR MED CHEM, V11, P2911, DOI 10.2174/0929867043364018; Sommer C, 1997, NEUROSCI LETT, V237, P45, DOI 10.1016/S0304-3940(97)00813-6; Soni A, 2013, CURR PHARM DESIGN, V19, P4687, DOI 10.2174/13816128113199990379; STOTE RH, 1995, PROTEINS, V23, P12, DOI 10.1002/prot.340230104; Sunami E, 2000, Oncologist, V5, P108, DOI 10.1634/theoncologist.5-2-108; Truettner JS, 2005, J CEREBR BLOOD F MET, V25, P1505, DOI 10.1038/sj.jcbfm.9600150; Tu GG, 2008, CURR MED CHEM, V15, P1388, DOI 10.2174/092986708784567680; Vilalta A, 2008, INTENS CARE MED, V34, P1384, DOI 10.1007/s00134-008-1056-1; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035; Warner RL, 2004, EXP MOL PATHOL, V76, P189, DOI 10.1016/j.yexmp.2004.01.003; WARSHEL A, 1976, J MOL BIOL, V103, P227, DOI 10.1016/0022-2836(76)90311-9; WEINSTATSASLOW DL, 1994, CANCER RES, V54, P6504; Whittaker M, 1999, CHEM REV, V99, P2735, DOI 10.1021/cr9804543; Wong S, 2009, J CHEM THEORY COMPUT, V5, P422, DOI 10.1021/ct8003707; Wysocki AB, 1999, WOUND REPAIR REGEN, V7, P154, DOI 10.1046/j.1524-475X.1999.00154.x; Yang HJ, 2011, TOXICOL IN VITRO, V25, P1638, DOI 10.1016/j.tiv.2011.06.015; Yong VW, 2005, NAT REV NEUROSCI, V6, P931, DOI 10.1038/nrn1807	81	22	22	0	18	ROYAL SOC CHEMISTRY	CAMBRIDGE	THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS, ENGLAND	1742-206X	1742-2051		MOL BIOSYST	Mol. Biosyst.		2015	11	4					1041	1051		10.1039/c5mb00003c			11	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	CE0KQ	WOS:000351493300006	25611160	Other Gold, Green Published			2021-06-18	
J	Zhang, X; Jiang, XY				Zhang, Xuan; Jiang, Xiaoying			Effects of Enteral Nutrition on the Barrier Function of the Intestinal Mucosa and Dopamine Receptor Expression in Rats With Traumatic Brain Injury	JOURNAL OF PARENTERAL AND ENTERAL NUTRITION			English	Article						enteral nutrition; traumatic brain injury; intestinal mucosa; dopamine receptor; bacterial translocation	BLOOD-FLOW; D1; SUPPLEMENTATION; PERMEABILITY; DOPEXAMINE; GLUTAMINE; AMYGDALA; SEPSIS; IMMUNE	Background: Impaired intestinal mucosal barrier (IMB) function is common in traumatic brain injury (TBI), but dopamine receptors (DRs) change in intestinal mucosa after TBI, and effects of enteral nutrition (EN) and supplements on IMB function remain unclear. Our purpose was to study the effects of EN and supplements on intestinal mucosal permeability (IMPB) and the expression of DRs DRD1 and DRD2 in the intestinal mucosa of rats with TBI. Methods: Forty-eight rats were divided into 8 groups; control, animals with TBI, dopamine group, animals with TBI treated with dopamine antagonist, EN alone, or EN combined with glutamine, probiotics, or a combination of probiotics and glutamine daily after TBI. Results: The IMPB was improved in the glutamine, probiotics, and combination groups. Including probiotics improved IMPB more than adding glutamine, and bacterial translocation in the intestines after TBI was reduced in the probiotics and combination groups (all Ps < .01). TBI led to elevated DRD1 and DRD2 mRNA and protein levels, which were reduced in the DA antagonist, glutamine, probiotics, and combination groups. DRD2 mRNA and protein levels in the probiotics and combination groups were decreased more than in the DA antagonist group (all Ps < .01). The increased IMPB after TBI correlated with increased DRD1 and DRD2 levels in the rat intestinal mucosa. Conclusion: EN supplemented with probiotics or combining glutamine and probiotics lowers the increased IMPB, bacterial translocation, and DRD1 and DRD2 mRNA and protein expression in rat intestinal mucosa caused by TBI.	[Zhang, Xuan; Jiang, Xiaoying] Fujian Med Univ, Sch Nursing, Fuzhou 350108, Peoples R China	Jiang, XY (corresponding author), Fujian Med Univ, Sch Nursing, 1 Xueyuan Rd Shangjie Zhen Minhou Cty, Fuzhou 350108, Peoples R China.	zhangxuan1203@163.com			Natural Science Foundation of Fujian Province of ChinaNatural Science Foundation of Fujian Province [2009J01151]	This project was supported by the Natural Science Foundation of Fujian Province of China (No. 2009J01151).	Bales JW, 2011, EXP NEUROL, V229, P300, DOI 10.1016/j.expneurol.2011.02.013; Beaulieu JM, 2011, PHARMACOL REV, V63, P182, DOI 10.1124/pr.110.002642; Bernal S, 2009, BEHAV BRAIN RES, V205, P183, DOI 10.1016/j.bbr.2009.06.032; Birnbaum J, 2006, CRIT CARE, V10, DOI 10.1186/cc5011; Briassoulis G, 2005, INTENS CARE MED, V31, P851, DOI 10.1007/s00134-005-2631-3; dos Santos RDC, 2010, JPEN-PARENTER ENTER, V34, P408, DOI 10.1177/0148607110362530; Chaiseha Y, 2003, NEUROENDOCRINOLOGY, V77, P105, DOI 10.1159/000068649; Charrueau C, 2009, J NEUROTRAUM, V26, P1911, DOI 10.1089/neu.2008.0737; Eizaguirre I, 2010, Cir Pediatr, V23, P118; Feng D, 2007, J INT MED RES, V35, P644, DOI 10.1177/147323000703500509; Forsyth CB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028032; Garcia-Rodenas CL, 2006, J PEDIATR GASTR NUTR, V43, P16, DOI 10.1097/01.mpg.0000226376.95623.9f; Gu Rong-min, 2012, Zhonghua Wei Chang Wai Ke Za Zhi, V15, P468; Guerin JP, 2005, SHOCK, V23, P18, DOI 10.1097/01.shk.0000150549.45338.6c; Gun F, 2005, SURG TODAY, V35, P760, DOI 10.1007/s00595-005-3023-6; Guzman JA, 2003, AM J PHYSIOL-HEART C, V284, pH668, DOI 10.1152/ajpheart.00636.2002; Guzman JA, 2001, J APPL PHYSIOL, V91, P596; Hiltebrand LB, 2004, ANESTHESIOLOGY, V100, P1188, DOI 10.1097/00000542-200405000-00022; Le Foll B, 2009, BEHAV PHARMACOL, V20, P1, DOI 10.1097/FBP.0b013e3283242f05; Louin G, 2004, J NEUROSCI METH, V138, P73, DOI 10.1016/j.jneumeth.2004.03.010; Mcvay MR, 2008, J PEDIATR SURG, V43, P25, DOI 10.1016/j.jpedsurg.2007.09.013; Nahidi L, 2012, J GASTROENTEROL, V47, P107, DOI 10.1007/s00535-011-0471-1; Ozturk H, 2006, DIGEST DIS SCI, V51, P1454, DOI 10.1007/s10620-005-9060-6; Peng Xi, 2002, Zhonghua Shao Shang Za Zhi, V18, P339; Pinto A, 2008, BRAIN STRUCT FUNCT, V213, P159, DOI 10.1007/s00429-008-0180-6; Schmidt H, 1996, BRIT J ANAESTH, V76, P707; Schwarz A, 2004, J BIOL CHEM, V279, P5641, DOI 10.1074/jbc.M309317200; Sun DA, 2008, EUR J NEUROSCI, V27, P1659, DOI 10.1111/j.1460-9568.2008.06156.x; Takahashi H, 2010, J NEUROSCI, V30, P3043, DOI 10.1523/JNEUROSCI.5689-09.2010; TIBERI M, 1991, P NATL ACAD SCI USA, V88, P7491, DOI 10.1073/pnas.88.17.7491; Vallone D, 2000, NEUROSCI BIOBEHAV R, V24, P125, DOI 10.1016/S0149-7634(99)00063-9; Vaughan CJ, 2000, AM J PHYSIOL-REG I, V279, pR599; Yang De-lin, 2007, Chin J Traumatol, V10, P145; Yasuda T, 2006, J SURG RES, V135, P18, DOI 10.1016/j.jss.2006.02.050; Zou XP, 2010, JPEN-PARENTER ENTER, V34, P554, DOI 10.1177/0148607110362691	35	22	24	1	11	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0148-6071	1941-2444		JPEN-PARENTER ENTER	J. Parenter. Enter. Nutr.	JAN	2015	39	1					114	123		10.1177/0148607113501881			10	Nutrition & Dietetics	Nutrition & Dietetics	AZ3GF	WOS:000348114800012	24047867				2021-06-18	
J	Campolo, M; Esposito, E; Ahmad, A; Di Paola, R; Paterniti, I; Cordaro, M; Bruschetta, G; Wallace, JL; Cuzzocrea, S				Campolo, Michela; Esposito, Emanuela; Ahmad, Akbar; Di Paola, Rosanna; Paterniti, Irene; Cordaro, Marika; Bruschetta, Giuseppe; Wallace, John L.; Cuzzocrea, Salvatore			Hydrogen sulfide-releasing cyclooxygenase inhibitor ATB-346 enhances motor function and reduces cortical lesion volume following traumatic brain injury in mice	JOURNAL OF NEUROINFLAMMATION			English	Article						Brain trauma; Hydrogen sulfide; Neurotrophic factor; Inflammation; Motor recovery; Infarct area; Infarct volume; Nitrosative stress; Astrogliosis; Neuroprotection	UP-REGULATION; NITRIC-OXIDE; NEUROTROPHIC FACTOR; GROWTH-FACTOR; SIGNALING MOLECULE; KAPPA-B; EXPRESSION; PROTECTS; H2S; NEURONS	Background: Traumatic brain injury (TBI) induces secondary injury mechanisms, including dynamic interplay between ischemic, inflammatory and cytotoxic processes. We recently reported that administration of ATB-346 (2-(6-methoxynapthalen-2-yl)-propionic acid 4-thiocarbamoyl-phenyl ester), a hydrogen sulfide-releasing cyclooxygenase inhibitor, showed marked beneficial effects in an animal model of spinal cord injury, significantly enhancing recovery of motor function and reducing the secondary inflammation and tissue injury. Methods: Here we evaluated the neuroprotective potential of ATB-346, a hydrogen sulfide-releasing derivative of naproxen, using the controlled cortical impact (CCI) injury model in mice, one of the most common models of TBI. Moreover, the aim of the present study was to carefully investigate molecular pathways and subtypes of glial cells involved in the protective effect of ATB-346 on inflammatory reaction associated with an experimental model of TBI. In these studies, TBI was induced in mice by CCI and mice were orally administered ATB-346, naproxen (both at 30 mu mol/ kg) or vehicle (dimethylsulfoxide: 1% carboxymethylcellulose [5:95] suspension) one and six hours after brain trauma and once daily for 10 days. Results: Results revealed that ATB-346 attenuated TBI-induced brain edema, suppressed TBI-induced neural cell death and improved neurological function. ATB-346 also significantly reduced the severity of inflammation and restored neurotrophic factors that characterized the secondary events of TBI. Conclusions: These data demonstrate that ATB-346 can be efficacious in a TBI animal model by reducing the secondary inflammation and tissue injury. Therefore, ATB-346 could represent an interesting approach for the management of secondary damage following CNS diseases, counteracting behavioral changes and inflammatory process.	[Campolo, Michela; Esposito, Emanuela; Ahmad, Akbar; Di Paola, Rosanna; Paterniti, Irene; Cordaro, Marika; Bruschetta, Giuseppe; Cuzzocrea, Salvatore] Univ Messina, Dept Biol & Environm Sci, I-98166 Messina, Italy; [Wallace, John L.] Univ Calgary, Inflammat Res Network, Calgary, AB T2N 4N1, Canada; [Cuzzocrea, Salvatore] Univ Manchester, Manchester Royal Infirm, Sch Med, Manchester Biomed Res Ctr, Manchester M13 9WU, Lancs, England	Cuzzocrea, S (corresponding author), Univ Messina, Dept Biol & Environm Sci, Viale Ferdinando Stagno DAlcontres, I-98166 Messina, Italy.	salvator@unime.it	Cordaro, Marika/K-7329-2016; Wallace, John/AAL-3763-2021; Campolo, Michela/K-6432-2016; di paola, rosanna/U-4356-2019	Cordaro, Marika/0000-0002-3980-0043; Cuzzocrea, Salvatore/0000-0001-6131-3690; di paola, rosanna/0000-0001-6725-8581; Ahmad, Akbar/0000-0003-1841-9670			Altaany Z, 2013, J CELL MOL MED, V17, P879, DOI 10.1111/jcmm.12077; Anisimova I. E., 2004, Sudebno-Meditsinskaya Ekspertiza, V47, P37; BEDERSON JB, 1986, STROKE, V17, P1304, DOI 10.1161/01.STR.17.6.1304; Bethea JR, 1998, J NEUROSCI, V18, P3251; Blackman RK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029798; Campolo M, 2013, FASEB J, V27, P4489, DOI 10.1096/fj.13-234716; Cernak I, 2004, NEUROBIOL DIS, V17, P29, DOI 10.1016/j.nbd.2004.05.011; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; Cui X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080358; DEKOSKY ST, 1994, EXP NEUROL, V130, P173, DOI 10.1006/exnr.1994.1196; Geng B, 2004, BIOCHEM BIOPH RES CO, V313, P362, DOI 10.1016/j.bbrc.2003.11.130; Goss JR, 1998, EXP NEUROL, V149, P301, DOI 10.1006/exnr.1997.6712; Hall ED, 2012, EXP NEUROL, V238, P176, DOI 10.1016/j.expneurol.2012.08.024; Hermann DM, 2001, NEUROBIOL DIS, V8, P964, DOI 10.1006/nbdi.2001.0448; Kamat PK, 2013, NEUROSCIENCE, V252, P302, DOI 10.1016/j.neuroscience.2013.07.051; Kawai T, 2007, TRENDS MOL MED, V13, P460, DOI 10.1016/j.molmed.2007.09.002; Kim BT, 2001, J NEUROSURG, V95, P674, DOI 10.3171/jns.2001.95.4.0674; Kimura H, 2005, ANTIOXID REDOX SIGN, V7, P778, DOI 10.1089/ars.2005.7.778; Kimura H, 2002, MOL NEUROBIOL, V26, P13, DOI 10.1385/MN:26:1:013; Kimura H, 2012, ANTIOXID REDOX SIGN, V17, P45, DOI 10.1089/ars.2011.4345; Kimura Y, 2004, FASEB J, V18, P1165, DOI 10.1096/fj.04-1815fje; Kondo K, 2013, CIRCULATION, V127, P1116, DOI 10.1161/CIRCULATIONAHA.112.000855; Kram L, 2013, THROMB RES, V132, pE112, DOI 10.1016/j.thromres.2013.07.010; Li L, 2009, FREE RADICAL BIO MED, V47, P103, DOI 10.1016/j.freeradbiomed.2009.04.014; Liao YL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068963; Lundblad C, 2009, J NEUROTRAUM, V26, P1953, DOI 10.1089/neu.2009.0955; MOCCHETTI I, 1995, J NEUROTRAUM, V12, P853, DOI 10.1089/neu.1995.12.853; Morales DM, 2005, NEUROSCIENCE, V136, P971, DOI 10.1016/j.neuroscience.2005.08.030; Morgan K, 2000, P NATL ACAD SCI USA, V97, P2308, DOI 10.1073/pnas.030362197; Pedersen MO, 2009, HISTOL HISTOPATHOL, V24, P573, DOI 10.14670/HH-24.573; Polhemus DJ, 2014, CIRC RES, V114, P730, DOI 10.1161/CIRCRESAHA.114.300505; Rhodes J, 2011, CURR OPIN CRIT CARE, V17, P122, DOI 10.1097/MCC.0b013e3283447948; Rosenfeld JV, 2012, LANCET, V380, P1088, DOI 10.1016/S0140-6736(12)60864-2; Salloway S, 2009, NEUROLOGY, V73, P2061, DOI 10.1212/WNL.0b013e3181c67808; Schabitz WR, 2000, STROKE, V31, P2212, DOI 10.1161/01.STR.31.9.2212; Schomacher M, 2008, BRAIN RES, V1240, P213, DOI 10.1016/j.brainres.2008.09.019; Shore PM, 2004, NEUROSURGERY, V54, P605, DOI 10.1227/01.NEU.0000108642.88724.DB; Sullivan PG, 2011, J NEUROTRAUM, V28, P311, DOI 10.1089/neu.2010.1646; Wallace JL, 2014, ANTIOXID REDOX SIGNA; Wallace JL, 2007, TRENDS PHARMACOL SCI, V28, P501, DOI 10.1016/j.tips.2007.09.003; Wallace JL, 2007, GASTROENTEROLOGY, V132, P261, DOI 10.1053/j.gastro.2006.11.042; Wallace JL, 2010, BRIT J PHARMACOL, V159, P1236, DOI 10.1111/j.1476-5381.2009.00611.x; WARENYCIA MW, 1989, BIOCHEM PHARMACOL, V38, P973, DOI 10.1016/0006-2952(89)90288-8; Zanardo RCO, 2006, FASEB J, V20, P2118, DOI 10.1096/fj.06-6270fje; Zhao WM, 2001, EMBO J, V20, P6008, DOI 10.1093/emboj/20.21.6008	46	22	24	0	5	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND		1742-2094		J NEUROINFLAMM	J. Neuroinflamm.	DEC 4	2014	11								196	10.1186/s12974-014-0196-1			15	Immunology; Neurosciences	Immunology; Neurosciences & Neurology	AW6LJ	WOS:000346380700001	25472548	DOAJ Gold, Green Published			2021-06-18	
J	Jonsson, CCA; Emanuelson, IM; Smedler, AC				Jonsson, Catherine C. Aaro; Emanuelson, Ingrid M.; Smedler, Ann Charlotte			Variability in quality of life 13 years after traumatic brain injury in childhood	INTERNATIONAL JOURNAL OF REHABILITATION RESEARCH			English	Article						children; long-term outcomes; quality of life; traumatic brain injury	PORTLAND ADAPTABILITY INVENTORY; CHILDREN; ADOLESCENTS; OUTCOMES; HEALTH; REHABILITATION; EPIDEMIOLOGY; DISABILITY; DEFICITS; RATINGS	With the aim of describing variability in the long-term outcome of quality of life after neurosurgically treated pediatric traumatic brain injury, mostly self-reports of 21 individuals with mild or moderate/severe injury were gathered using Mayo-Portland Adaptability Inventory in telephone interviews 13 years aftyer injury. A majority of the participants reported brain injury-related problems. The median outcome on Mayo-Portland Adaptability Inventory was mild to moderate limitations. The variation within the moderate/severe group varied between relatively good outcome and moderate/severe limitations. Concentration, irritability, fatigue, and transportation were reported as the most problematic areas, whereas self-care was reported as well functioning. Societal participation appeared to be the best functional domain in this Swedish study. Examples of individual reports of the life-situation at various outcome levels were provided. Variability in outcome is large within severity groups, and research may gain by addressing both outcomes of the individuals and groups. Objective questions of outcome should be accompanied by questions of actual functioning in everyday life. To ensure long-term support for quality of life for those with remaining dysfunction after pediatric traumatic brain injury, healthcare systems should implement systematic routines for referral to rehabilitation and support. (C) 2014 Wolters Kluwer Health vertical bar Lippincott Williams & Wilkins.	[Jonsson, Catherine C. Aaro] Ostersund Hosp, Jamtland Cty Council Child & Youth Rehabil, Res & Dev Unit, S-83183 Ostersund, Sweden; [Emanuelson, Ingrid M.] Univ Gothenburg, Dept Pediat, Inst Clin Sci, Gothenburg, Sweden; [Smedler, Ann Charlotte] Stockholm Univ, Dept Psychol, S-10691 Stockholm, Sweden	Jonsson, CCA (corresponding author), Ostersund Hosp, Jamtland Cty Council Child & Youth Rehabil, Res & Dev Unit, S-83183 Ostersund, Sweden.	catherine.aaro.jonsson@jll.se					Aaro Jonsson C, 2010, THESIS STOCKHOLM U S; Anderson V, 2006, AM J PHYS MED REHAB, V85, P767, DOI 10.1097/01.phm.0000233176.08480.22; Anderson V, 2012, J NEUROTRAUM, V29, P143, DOI 10.1089/neu.2011.2012; Anderson V, 2011, NEUROPSYCHOLOGY, V25, P176, DOI 10.1037/a0021217; Anderson V, 2009, J HEAD TRAUMA REHAB, V24, P303, DOI 10.1097/HTR.0b013e3181ada830; Beardmore S, 1999, NEUROPSYCHOL REHABIL, V9, P45, DOI 10.1080/713755588; Cattelani R, 1998, BRAIN INJURY, V12, P283, DOI 10.1080/026990598122584; Chapman SB, 2001, J HEAD TRAUMA REHAB, V16, P441, DOI 10.1097/00001199-200110000-00004; Di Battista A, 2012, J NEUROTRAUM, V29, P1717, DOI 10.1089/neu.2011.2157; Dijkers MP, 2004, ARCH PHYS MED REHAB, V85, pS21, DOI 10.1016/j.apmr.2003.08.119; Donders J, 2007, J HEAD TRAUMA REHAB, V22, P296, DOI 10.1097/01.HTR.0000290974.01872.82; Emanuelson I, 1998, Pediatr Rehabil, V2, P65; Emanuelson I, 1997, ACTA PAEDIATR, V86, P730, DOI 10.1111/j.1651-2227.1997.tb08576.x; Fay TB, 2009, NEUROPSYCHOLOGY, V23, P271, DOI 10.1037/a0014936; Feigin VL, 2013, LANCET NEUROL, V12, P53, DOI 10.1016/S1474-4422(12)70262-4; Green L, 2012, DEV NEUROREHABIL, V15, P105, DOI 10.3109/17518423.2011.638331; Hanten G, 2004, DEV NEUROPSYCHOL, V25, P85, DOI 10.1207/s15326942dn2501&2_6; Horneman G, 2005, INT J REHABIL RES, V28, P245, DOI 10.1097/00004356-200509000-00007; Jacobsson LJ, 2011, NEUROPSYCHOL REHABIL, V21, P383, DOI 10.1080/09602011.2011.566711; Johansson B, 2012, BRAIN INJURY, V26, P1621, DOI 10.3109/02699052.2012.700082; Jonsson CA, 2009, BRAIN INJURY, V23, P1008, DOI 10.3109/02699050903379354; Keenan HT, 2006, DEV NEUROSCI-BASEL, V28, P256, DOI 10.1159/000094152; KOSKINIEMI M, 1995, ARCH PEDIAT ADOL MED, V149, P249, DOI 10.1001/archpedi.1995.02170150029004; Lexell J, 2012, J REHABIL MED, V44, P65, DOI 10.2340/16501977-0897; Malec JF, 2004, BRAIN INJURY, V18, P563, DOI 10.1080/02699050310001646134; Malec JF, 2003, J HEAD TRAUMA REHAB, V18, P479, DOI 10.1097/00001199-200311000-00002; Martin-Herz SP, 2012, CLIN CHILD FAM PSYCH, V15, P192, DOI 10.1007/s10567-012-0115-x; McCauley SR, 2012, J NEUROTRAUM, V29, P678, DOI 10.1089/neu.2011.1838; Nybo T, 2004, J INT NEUROPSYCH SOC, V10, P719, DOI 10.1017/S1355617704105109; Oddson B, 2006, DEV MED CHILD NEUROL, V48, P918, DOI 10.1017/S0012162206002003; Renstrom B, 2012, BRAIN INJURY, V26, P1405, DOI 10.3109/02699052.2012.694559; Segui-Gomez M, 2003, EPIDEMIOL REV, V25, P3, DOI 10.1093/epirev/mxg007; Stancin T, 2002, PEDIATRICS, V109, DOI 10.1542/peds.109.2.e34; STARMARK JE, 1988, ACTA NEUROCHIR, V91, P12, DOI 10.1007/BF01400521; Walther SM, 2003, INTENS CARE MED, V29, P933, DOI 10.1007/s00134-003-1757-4	35	22	22	0	11	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0342-5282	1473-5660		INT J REHABIL RES	Int. J. Rehabil. Res.	DEC	2014	37	4					317	322		10.1097/MRR.0000000000000073			6	Rehabilitation	Rehabilitation	AT4NM	WOS:000344916100006	25153788				2021-06-18	
J	Shih, J; Liu, L; Mason, A; Higashimori, H; Donmez, G				Shih, Jennifer; Liu, Lei; Mason, Andrew; Higashimori, Haruki; Donmez, Gizem			Loss of SIRT4 decreases GLT-1-dependent glutamate uptake and increases sensitivity to kainic acid	JOURNAL OF NEUROCHEMISTRY			English	Article						excitotoxicity; GLT-1; glutamate transport; kainic acid; sirtuins	SACCHAROMYCES-CEREVISIAE; CALORIE RESTRICTION; TRANSPORTER GLT1; SIRTUINS; EXCITOTOXICITY; METABOLISM; ASTROCYTES; PHYSIOLOGY; SYNAPSES; NEURONS	Glutamate transport is a critical process in the brain that maintains low extracellular levels of glutamate to allow for efficient neurotransmission and prevent excitotoxicity. Loss of glutamate transport function is implicated in epilepsy, traumatic brain injury, and amyotrophic lateral sclerosis. It remains unclear whether or not glutamate transport can be modulated in these disease conditions to improve outcome. Here, we show that sirtuin (SIRT)4, a mitochondrial sirtuin, is up-regulated in response to treatment with the potent excitotoxin kainic acid. Loss of SIRT4 leads to a more severe reaction to kainic acid and decreased glutamate transporter expression and function in the brain. Together, these results indicate a critical and novel stress response role for SIRT4 in promoting proper glutamate transport capacity and protecting against excitotoxicity.	[Shih, Jennifer; Liu, Lei; Mason, Andrew; Higashimori, Haruki; Donmez, Gizem] Tufts Univ, Sch Med, Dept Neurosci, Boston, MA 02111 USA; [Shih, Jennifer] Tufts Univ, Sackler Sch Biomed Sci, Neurosci Program, Boston, MA 02111 USA	Donmez, G (corresponding author), Tufts Univ, Sch Med, Dept Neurosci, 136 Harrison Ave, Boston, MA 02111 USA.	gizem.donmez@tufts.edu	Yalcin, Gizem Donmez/AAG-5056-2019; Liu, Lei/P-8355-2016	Yalcin, Gizem Donmez/0000-0002-5121-8232; Liu, Lei/0000-0001-5992-7423	Tufts University Department of Neuroscience startup fund; Tufts Center for Neuroscience Research Pilot Award; Charlton Research Award	We thank Dr Yongjie Yang for help with the glutamate uptake assay and for providing reagents and antibodies for pilot studies. We thank Dr Laura Liscum and members of the Liscum laboratory for use of radioactivity facilities. We thank Dr Rob Jackson, Dr Chris Dulla, Dr Michele Jacob, and Dr Yongjie Yang for critical reading of manuscript drafts. This study was supported by funds from the Tufts University Department of Neuroscience startup fund (to G.D.), the Tufts Center for Neuroscience Research Pilot Award (to G.D.), and the Charlton Research Award (to G.D.). The authors disclose that they have no conflicts of interest.	Ahuja N, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M705488200; Bai Fengju, 2007, V43, P77, DOI 10.1007/978-1-4020-5943-8_6; Berdichevsky A, 2006, CELL CYCLE, V5, P2588, DOI 10.4161/cc.5.22.3513; CHOI DW, 1988, NEURON, V1, P623, DOI 10.1016/0896-6273(88)90162-6; CHOI DW, 1992, J NEUROBIOL, V23, P1261, DOI 10.1002/neu.480230915; Conti F, 1999, TRENDS NEUROSCI, V22, P451, DOI 10.1016/S0166-2236(99)01445-9; Danbolt NC, 2001, PROG NEUROBIOL, V65, P1, DOI 10.1016/S0301-0082(00)00067-8; Doble A, 1999, PHARMACOL THERAPEUT, V81, P163, DOI 10.1016/S0163-7258(98)00042-4; Donmez G, 2012, TRENDS PHARMACOL SCI, V33, P494, DOI 10.1016/j.tips.2012.05.007; Donmez G, 2010, AGING CELL, V9, P285, DOI 10.1111/j.1474-9726.2010.00548.x; Finkel T, 2009, NATURE, V460, P587, DOI 10.1038/nature08197; Gimenez-Cassina A, 2012, NEURON, V74, P719, DOI 10.1016/j.neuron.2012.03.032; Haigis MC, 2006, GENE DEV, V20, P2913, DOI 10.1101/gad.1467506; Haigis MC, 2006, CELL, V126, P941, DOI 10.1016/j.cell.2006.06.057; Higashimori H, 2013, HUM MOL GENET, V22, P2041, DOI 10.1093/hmg/ddt055; Jabaudon D, 2000, P NATL ACAD SCI USA, V97, P5610, DOI 10.1073/pnas.97.10.5610; Jeong SM, 2013, CANCER CELL, V23, P450, DOI 10.1016/j.ccr.2013.02.024; Kaeberlein M, 1999, GENE DEV, V13, P2570, DOI 10.1101/gad.13.19.2570; KENNEDY BK, 1995, CELL, V80, P485, DOI 10.1016/0092-8674(95)90499-9; Komlos D, 2013, GLIA, V61, P394, DOI 10.1002/glia.22442; Laurent G, 2013, MOL CELL, V50, P686, DOI 10.1016/j.molcel.2013.05.012; Ho L, 2013, AGING-US, V5, P835, DOI 10.18632/aging.100616; Matute C, 2002, EUR J PHARMACOL, V447, P239, DOI 10.1016/S0014-2999(02)01847-2; Michishita E, 2005, MOL BIOL CELL, V16, P4623, DOI 10.1091/mbc.E05-01-0033; NOVELLI A, 1988, BRAIN RES, V451, P205, DOI 10.1016/0006-8993(88)90765-2; Pellerin L, 2004, NEUROSCIENTIST, V10, P53, DOI 10.1177/1073858403260159; RACINE RJ, 1972, ELECTROEN CLIN NEURO, V32, P281, DOI 10.1016/0013-4694(72)90177-0; Robinson MB, 2002, J NEUROCHEM, V80, P1, DOI 10.1046/j.0022-3042.2001.00698.x; Rothstein J. D., 1994, ADV NEUROL, V68, P7; ROTHSTEIN JD, 1994, NEURON, V13, P713, DOI 10.1016/0896-6273(94)90038-8; Rothstein JD, 1996, NEURON, V16, P675, DOI 10.1016/S0896-6273(00)80086-0; Shih Jennifer, 2013, Genes Cancer, V4, P91, DOI 10.1177/1947601912474931; Tanaka K, 1997, SCIENCE, V276, P1699, DOI 10.1126/science.276.5319.1699; Trotti D, 1999, NAT NEUROSCI, V2, P427, DOI 10.1038/8091; Voutsinos-Porche B, 2003, NEURON, V37, P275, DOI 10.1016/S0896-6273(02)01170-4; Wang F, 2007, AGING CELL, V6, P505, DOI 10.1111/j.1474-9726.2007.00304.x; Xu NJ, 2003, J NEUROSCI, V23, P4775	37	22	23	0	10	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-3042	1471-4159		J NEUROCHEM	J. Neurochem.	DEC	2014	131	5					573	581		10.1111/jnc.12942			9	Biochemistry & Molecular Biology; Neurosciences	Biochemistry & Molecular Biology; Neurosciences & Neurology	AU0YQ	WOS:000345348500005	25196144	Bronze			2021-06-18	
J	Garber, BG; Rusu, C; Zamorski, MA				Garber, Bryan G.; Rusu, Corneliu; Zamorski, Mark A.			Deployment-related mild traumatic brain injury, mental health problems, and post-concussive symptoms in Canadian armed forces personnel	BMC PSYCHIATRY			English	Article							POSTTRAUMATIC-STRESS-DISORDER; COLLEGIATE FOOTBALL PLAYERS; OEF/OIF SERVICE MEMBERS; POSTCONCUSSION SYNDROME; DIAGNOSTIC-CRITERIA; NCAA CONCUSSION; PTSD CHECKLIST; NATIONAL-GUARD; WAR VETERANS; PRIMARY-CARE	Background: Up to 20% of US military personnel deployed to Iraq or Afghanistan experience mild traumatic brain injury (mTBI) while deployed; up to one-third will experience persistent post-concussive symptoms (PCS). The objective of this study was to examine the epidemiology of deployment-related mTBI and its relationship to PCS and mental health problems (MHPs) in Canadian Armed Forces (CAF) personnel. Methods: Participants were 16153 personnel who underwent post-deployment screening (median = 136 days after return) following deployment in support of the mission in Afghanistan from 2009 - 2012. The screening questionnaire assessed mTBI and other injuries while deployed, using the Brief Traumatic Brain Injury Screening Tool. Current MHPs and PCS were assessed using items from the Patient Health Questionnaire, the Patient Checklist for PTSD, and the Cognitive Failures Questionnaire. Log-binomial regression explored the association of mTBI, other injuries, and MHPs with PCS, using the presence of 3 or more of 7 PCS as the outcome. Results are expressed as adjusted prevalence ratios (PR). Results: mTBI while deployed was reported in 843 respondents (5.2%). Less severe forms of mTBI (associated only with having been dazed or confused or having "seen stars") predominated. Blast was reported as a mechanism of injury in half of those with mTBI. Multiple PCS were present in 21% of those with less severe forms of mTBI and in 27% of those with more severe forms of mTBI (i.e., mTBI associated with loss of consciousness or post-traumatic amnesia). After adjustment for confounding, mTBI had no statistically significant association with PCS relative to non-TBI injury. In contrast, MHPs had a strong association with reporting 3 or more PCS (adjusted prevalence ratio (PR) = 7.77). Conclusion: Deployment-related mTBI prevalence was lower than in many US reports; most of those who had had mTBI were free of multiple PCS. PCS was strongly associated with MHPs but not with mTBI. Careful assessment of MHPs is essential in personnel with a history of combat-related mTBI and PCS.	[Garber, Bryan G.; Rusu, Corneliu; Zamorski, Mark A.] Canadian Forces Hlth Serv Grp Headquarters, Deployment Hlth Sect, Directorate Mental Hlth, Ottawa, ON K1A 0K6, Canada	Garber, BG (corresponding author), Canadian Forces Hlth Serv Grp Headquarters, Deployment Hlth Sect, Directorate Mental Hlth, 1745 Alta Vista Dr, Ottawa, ON K1A 0K6, Canada.	bryan.garber@forces.gc.ca			Canadian Forces Surgeon General's Health Research Program [2012-08-089-003-001]	This study was funded by The Canadian Forces Surgeon General's Health Research Program Protocol# 2012-08-089-003-001. Role of Funders in the Study: The investigators developed the study protocol, which was accepted by the study sponsor without modification. The sponsor had no direct role in the collection, or analysis of the data. The sponsor did provide contextual information that assisted in the interpretation of the results. In accordance with Department of National Defence policy, the paper was reviewed and approved for submission without modification by the Canadian Forces Deputy Surgeon General. The authors can however attest that no undue influence on the part of the Department of National Defence, the Canadian Forces, or the Government of Canada occurred at any part of this research project.	Afari N, 2009, HEADACHE, V49, P1267, DOI 10.1111/j.1526-4610.2009.01517.x; [Anonymous], 2012, VA DOD CLIN PRACTICE; Belanger HG, 2011, CLIN NEUROPSYCHOL, V25, P702, DOI 10.1080/13854046.2011.566892; Belanger HG, 2010, J INT NEUROPSYCH SOC, V16, P262, DOI 10.1017/S1355617709991287; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P345, DOI 10.1017/S1355617705050411; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P215, DOI 10.1017/S1355617705050277; Black DW, 2004, EPIDEMIOLOGY, V15, P135, DOI 10.1097/01.EDE.0000103188.18059.21; Blanchard EB, 1996, BEHAV RES THER, V34, P669, DOI 10.1016/0005-7967(96)00033-2; Boake C, 2005, J NEUROPSYCH CLIN N, V17, P350, DOI 10.1176/appi.neuropsych.17.3.350; Boake C, 2004, J NEUROPSYCH CLIN N, V16, P493, DOI 10.1176/appi.neuropsych.16.4.493; Boulos D, 2013, CAN MED ASSOC J, V185, pE545, DOI 10.1503/cmaj.122120; Brenner LA, 2010, J HEAD TRAUMA REHAB, V25, P307, DOI 10.1097/HTR.0b013e3181cada03; BROADBENT DE, 1982, BRIT J CLIN PSYCHOL, V21, P1, DOI 10.1111/j.2044-8260.1982.tb01421.x; Bryant RA, 2008, NEW ENGL J MED, V358, P525, DOI 10.1056/NEJMe078235; Bryant RA, 2010, AM J PSYCHIAT, V167, P312, DOI 10.1176/appi.ajp.2009.09050617; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Comper P, 2005, BRAIN INJURY, V19, P863, DOI 10.1080/02699050400025042; Cooper DB, 2012, MIL MED, V177, P1157, DOI 10.7205/MILMED-D-12-00098; Cooper DB, 2011, BRAIN INJURY, V25, P1, DOI 10.3109/02699052.2010.531692; Fann Jesse, 2013, Arch Phys Med Rehabil, V94, P801, DOI 10.1016/j.apmr.2012.04.001; Fear NT, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-797; Ferrari R, 2003, CLIN NEUROL NEUROSUR, V105, P146, DOI 10.1016/S0303-8467(02)00108-7; Friedman MJ, 2006, AM J PSYCHIAT, V163, P586, DOI 10.1176/appi.ajp.163.4.586; Garber B. G., 2008, CANADIAN FORCES HLTH; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Hickling EJ, 1998, BRAIN INJURY, V12, P265, DOI 10.1080/026990598122566; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hoge CW, 2009, NEW ENGL J MED, V360, P1588, DOI 10.1056/NEJMp0810606; Hoge CW, 2004, NEW ENGL J MED, V351, P13, DOI 10.1056/NEJMoa040603; Hourani L, 2012, MIL MED, V177, P643, DOI 10.7205/MILMED-D-11-00421; Iverson GL, 2005, CURR OPIN PSYCHIATR, V18, P301, DOI 10.1097/01.yco.0000165601.29047.ae; Iverson GL, 2006, ARCH CLIN NEUROPSYCH, V21, P303, DOI 10.1016/j.acn.2005.12.008; Jones E, 2002, BMJ-BRIT MED J, V324, P321, DOI 10.1136/bmj.324.7333.321; Kashluba S, 2006, J INT NEUROPSYCH SOC, V12, P111, DOI 10.1017/S1355617706060036; Kennedy JE, 2007, J REHABIL RES DEV, V44, P895, DOI 10.1682/JRRD.2006.12.0166; Kroenke K, 2003, MED CARE, V41, P1284, DOI 10.1097/01.MLR.0000093487.78664.3C; Kroenke K, 2002, PSYCHOSOM MED, V64, P258, DOI 10.1097/00006842-200203000-00008; Lang AJ, 2005, BEHAV RES THER, V43, P585, DOI 10.1016/j.brat.2004.04.005; Lange RT, 2012, J INT NEUROPSYCH SOC, V18, P595, DOI 10.1017/S1355617712000239; Lange RT, 2011, J HEAD TRAUMA REHAB, V26, P127, DOI 10.1097/HTR.0b013e3181e4622a; Levin HS, 2005, ARCH GEN PSYCHIAT, V62, P523, DOI 10.1001/archpsyc.62.5.523; Marx BP, 2009, ARCH GEN PSYCHIAT, V66, P996, DOI 10.1001/archgenpsychiatry.2009.109; McCauley SR, 2006, BRAIN INJURY, V20, P519, DOI 10.1080/02699050600676651; McCauley SR, 2005, J NERV MENT DIS, V193, P540, DOI 10.1097/01.nmd.0000172592.05801.71; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; Meares S, 2008, J NEUROL NEUROSUR PS, V79, P300, DOI 10.1136/jnnp.2007.126565; Meares S, 2006, J INT NEUROPSYCH SOC, V12, P792, DOI 10.1017/S1355617706060978; Office of the Surgeon General UAMC, 2006, FIN REP MENT HLTH AD; Okie S, 2005, NEW ENGL J MED, V352, P2043, DOI 10.1056/NEJMp058102; Ontario Neurotrauma Foundation, 2011, GUID MILD TRAUM BRAI; Pietrzak RH, 2009, J NERV MENT DIS, V197, P748, DOI 10.1097/NMD.0b013e3181b97a75; Polusny MA, 2011, ARCH GEN PSYCHIAT, V68, P79, DOI 10.1001/archgenpsychiatry.2010.172; Rogers JM, 2007, BRAIN INJURY, V21, P1321, DOI 10.1080/02699050701765700; Rona RJ, 2012, J HEAD TRAUMA REHAB, V27, P33, DOI 10.1097/HTR.0b013e318212f814; Rona RJ, 2012, J HEAD TRAUMA REHAB, V27, P75, DOI 10.1097/HTR.0b013e31823029f6; Ryan LM, 2003, INT REV PSYCHIATR, V15, P310, DOI 10.1080/09540260310001606692; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Schwab KA, 2007, J HEAD TRAUMA REHAB, V22, P377, DOI 10.1097/01.HTR.0000300233.98242.87; Silverberg ND, 2013, J NEUROTRAUM, V30, P1398, DOI 10.1089/neu.2012.2827; Silverberg ND, 2011, NEUROREHABILITATION, V29, P317, DOI 10.3233/NRE-2011-0708; Spitzer RL, 1999, JAMA-J AM MED ASSOC, V282, P1737, DOI 10.1001/jama.282.18.1737; *STAT CAN, 2003, DAIL CAN COMM HLTH S; Summers CR, 2009, MT SINAI J MED, V76, P105, DOI 10.1002/msj.20100; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; Terrio HP, 2011, REHABIL PSYCHOL, V56, P26, DOI 10.1037/a0022685; Vanderploeg RD, 2012, ARCH PHYS MED REHAB, V93, P1887, DOI 10.1016/j.apmr.2012.05.024; Vanderploeg RD, 2009, ARCH PHYS MED REHAB, V90, P1084, DOI 10.1016/j.apmr.2009.01.023; Warner CH, 2011, ARCH GEN PSYCHIAT, V68, P1065, DOI 10.1001/archgenpsychiatry.2011.112; Wilk JE, 2012, PSYCHOSOM MED, V74, P249, DOI 10.1097/PSY.0b013e318244c604; Zamorski M. A., 2011, REPORT FINDINGS ENHA; Zamorski MA, 2014, CAN J PSYCHIAT, V59, P319	71	22	22	0	11	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1471-244X			BMC PSYCHIATRY	BMC Psychiatry	NOV 20	2014	14								325	10.1186/s12888-014-0325-5			10	Psychiatry	Psychiatry	AW1EK	WOS:000346033100001	25410348	DOAJ Gold, Green Published			2021-06-18	
J	Cocchi, MN; Boone, MD; Giberson, B; Giberson, T; Farrell, E; Salciccioli, JD; Talmor, D; Williams, D; Donnino, MW				Cocchi, Michael N.; Boone, Myles D.; Giberson, Brandon; Giberson, Tyler; Farrell, Emily; Salciccioli, Justin D.; Talmor, Daniel; Williams, Donna; Donnino, Michael W.			Fever After Rewarming: Incidence of Pyrexia in Postcardiac Arrest Patients Who Have Undergone Mild Therapeutic Hypothermia	JOURNAL OF INTENSIVE CARE MEDICINE			English	Article						cardiac arrest; fever; therapeutic hypothermia	HOSPITAL CARDIAC-ARREST; BRAIN-INJURY; STROKE; HYPERTHERMIA; TEMPERATURE; RESUSCITATION; METAANALYSIS; SURVIVORS	Background: Induction of mild therapeutic hypothermia (TH; temperature 32-34 degrees C) has become standard of care in many hospitals for comatose survivors of cardiac arrest. Pyrexia, or fever, is known to be detrimental in patients with neurologic injuries such as stroke or trauma. The incidence of pyrexia in the postrewarming phase of TH is unknown. We attempted to determine the incidence of fever after TH and hypothesized that those patients who were febrile after rewarming would have worse clinical outcomes than those who maintained normothermia in the postrewarming period. Methods: Retrospective data analysis of survivors of out-of-hospital cardiac arrest (OHCA) over a period of 29 months (December 2007 to April 2010). Inclusion criteria: OHCA, age >18, return of spontaneous circulation, and treatment with TH. Exclusion criteria: traumatic arrest and pregnancy. Data collected included age, sex, neurologic outcome, mortality, and whether the patient developed fever (temperature >100.4 degrees F, 38 degrees C) within 24 hours after being fully rewarmed to a normal core body temperature after TH. We used simple descriptive statistics and Fisher exact test to report our findings. Results: A total of 149 patients were identified; of these, 82 (55%) underwent TH. The mean age of the TH cohort was 66 years, and 28 (31%) were female. In all, 54 patients survived for >24 hours after rewarming and were included in the analysis. Among the analyzed cohort, 28 (52%) of 54 developed fever within 24 hours after being rewarmed. Outcome measures included in-hospital mortality as well as neurologic outcome as defined by a dichotomized Cerebral Performance Category (CPC) score. When comparing neurologic outcomes between the groups, 16 (57%) of 28 in the postrewarming fever group had a poor outcome (CPC score 3-5), while 15 (58%) of 26 in the no-fever group had a favorable outcome (P = .62). In the fever group, 15 (52%) of 28 died, while in the no-fever group, 14 (54%) of 26 died (P = .62). Conclusion: Among a cohort of patients who underwent mild TH after OHCA, more than half of these patients developed pyrexia in the first 24 hours after rewarming. Although there were no significant differences in outcomes between febrile and nonfebrile patients identified in this study, these findings should be further evaluated in a larger cohort. Future investigations may be needed to determine whether postrewarming temperature management will improve the outcomes in this population.	[Cocchi, Michael N.; Giberson, Brandon; Giberson, Tyler; Farrell, Emily; Salciccioli, Justin D.; Donnino, Michael W.] Beth Israel Deaconess Med Ctr, Dept Emergency Med, Boston, MA 02215 USA; [Cocchi, Michael N.; Boone, Myles D.; Talmor, Daniel] Beth Israel Deaconess Med Ctr, Div Crit Care, Dept Anesthesia Crit Care, Boston, MA 02215 USA; [Williams, Donna] Beth Israel Deaconess Med Ctr, Div Cardiol, Dept Med, Boston, MA 02215 USA; [Donnino, Michael W.] Beth Israel Deaconess Med Ctr, Div Pulm Crit Care, Dept Med, Boston, MA 02215 USA	Cocchi, MN (corresponding author), Beth Israel Deaconess Med Ctr, Dept Emergency Med, West CC 2,One Deaconess Rd, Boston, MA 02215 USA.	mcocchi@bidmc.harvard.edu			Harvard Clinical and Translational Science Center, from the National Center for Research ResourcesUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [UL1 RR025758]; American Heart AssociationAmerican Heart Association [10CRP2640126]; NHLBIUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [1K02HL107447-01A1]; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [UL1RR025758] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [K02HL107447] Funding Source: NIH RePORTER	The author(s) disclosed receipt of the following financial support for the research, authorship and/or publication of this article: The project described was supported, in part, by Grant Number UL1 RR025758-Harvard Clinical and Translational Science Center, from the National Center for Research Resources. Dr Cocchi was funded by the American Heart Association during the time of this investigation (10CRP2640126). Dr Donnino is supported by NHLBI (1K02HL107447-01A1).	[Anonymous], 2002, N ENGL J MED, V346, P549; Bernard SA, 2002, NEW ENGL J MED, V346, P557, DOI 10.1056/NEJMoa003289; Castillo J, 1997, LANCET, V349, P79, DOI 10.1016/S0140-6736(96)04453-4; Chatzipanteli K, 2000, J CEREBR BLOOD F MET, V20, P531, DOI 10.1097/00004647-200003000-00012; Corbett D, 2000, BRAIN PATHOL, V10, P145; CUMMINS RO, 1991, CIRCULATION, V84, P960, DOI 10.1161/01.CIR.84.2.960; Dietrich WD, 2007, PROG BRAIN RES, V162, P201, DOI 10.1016/S0079-6123(06)62011-6; Greer DM, 2008, STROKE, V39, P3029, DOI 10.1161/STROKEAHA.108.521583; Hajat C, 2000, STROKE, V31, P410, DOI 10.1161/01.STR.31.2.410; Herlitz J, 2000, EUR HEART J, V21, P1251, DOI 10.1053/euhj.2000.2150; Jiang JY, 2002, J NEUROTRAUM, V19, P869, DOI 10.1089/08977150260190456; MALKINSON TJ, 1990, AM J PHYSIOL, V258, pR783; Pusswald G, 2000, RESUSCITATION, V47, P241, DOI 10.1016/S0300-9572(00)00240-9; SATOH T, 1989, INT J HYPERTHER, V5, P683, DOI 10.3109/02656738909140493; Stocchetti N, 2002, INTENS CARE MED, V28, P1555, DOI 10.1007/s00134-002-1513-1; Takasu A, 2001, RESUSCITATION, V49, P273, DOI 10.1016/S0300-9572(00)00360-9; TAKINO M, 1991, INTENS CARE MED, V17, P419, DOI 10.1007/BF01720680; Thornhill J, 2001, CAN J PHYSIOL PHARM, V79, P254, DOI 10.1139/cjpp-79-3-254; Wang Y, 2000, STROKE, V31, P404, DOI 10.1161/01.STR.31.2.404; Zeiner A, 2001, ARCH INTERN MED, V161, P2007, DOI 10.1001/archinte.161.16.2007; Zheng ZJ, 2001, CIRCULATION, V104, P2158, DOI 10.1161/hc4301.098254	21	22	22	0	4	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0885-0666	1525-1489		J INTENSIVE CARE MED	J. Intensive Care Med.	NOV-DEC	2014	29	6					365	369		10.1177/0885066613491932			5	Critical Care Medicine	General & Internal Medicine	AS6LR	WOS:000344375600007	23783999	Green Accepted			2021-06-18	
J	Hazra, A; Macolino, C; Elliott, MB; Chin, J				Hazra, Anupam; Macolino, Christine; Elliott, Melanie B.; Chin, Jeannie			Delayed Thalamic Astrocytosis and Disrupted Sleep-Wake Patterns in a Preclinical Model of Traumatic Brain Injury	JOURNAL OF NEUROSCIENCE RESEARCH			English	Article						sleep-wake; traumatic brain injury; thalamus; sleep fragmentation; inflammation	LESS-THAN-1 HZ OSCILLATION; CORTICAL IMPACT INJURY; FDG-PET; MILD; NEURONS; DISTURBANCES; METABOLISM; DISORDERS; MICE; NEURODEGENERATION	Traumatic brain injury (TBI) involves diffuse axonal injury and induces subtle but persistent changes in brain tissue and function and poses challenges for early detection of neurological injury. The present study uses an automated behavioral analysis system to assess alterations in rodent behavior in the subacute phase in a preclinical mouse model of TBI, controlled cortical impact (CCI) injury. In the first few weeks following CCI, mice demonstrated normal exploratory behaviors and other typical home-cage behaviors. However, beginning 4 weeks post-injury, CCI mice developed disruptions in sleep-wake patterns, including an increased number of awakenings from sleep. Such impaired sleep maintenance was accompanied by an increased latency to reach peak sleep in CCI mice. These sleep disruptions implicate involvement of the thalamocortical network, the activity of which must be tightly regulated to control sleep maintenance. After injury, there was an increase in reactive microglia in thalamic regions as well as delayed reactive astrocytosis that was evident in the thalamic reticular nucleus, which preceded the development of sleep disruptions. These data suggest that cortical injury may trigger inflammatory responses in deeper neuroanatomical structures, including the thalamic reticular nucleus. Such engagement of the thalamus may perturb the thalamocortical network that regulates sleep/awake patterns and contribute to sleep disruptions observed in this model as well as those documented in patients with TBI. (C) 2014 Wiley Periodicals, Inc.	[Hazra, Anupam; Elliott, Melanie B.; Chin, Jeannie] Thomas Jefferson Univ, Dept Neurosci, Philadelphia, PA 19107 USA; [Hazra, Anupam; Macolino, Christine; Elliott, Melanie B.; Chin, Jeannie] Thomas Jefferson Univ, Farber Inst Neurosci, Philadelphia, PA 19107 USA; [Macolino, Christine; Elliott, Melanie B.] Thomas Jefferson Univ, Dept Neurol Surg, Philadelphia, PA 19107 USA	Chin, J (corresponding author), Thomas Jefferson Univ, Dept Neurosci, 900 Walnut St,Rm 444, Philadelphia, PA 19107 USA.	jeannie.chin@jefferson.edu	Ritter, Stefanie L/D-9312-2012; Hazra, Anupam/ABD-6774-2020	Chin, Jeannie/0000-0001-9902-3744; Hazra, Anupam/0000-0002-3679-7950	Alzheimer's AssociationAlzheimer's Association; Margaret Q. Landenberger Research Foundation; DODUnited States Department of Defense [PR110389]	Contract grant sponsor: Alzheimer's Association; Contract grant sponsor: Margaret Q. Landenberger Research Foundation; Contract grant sponsor: DOD; Contract grant sponsor: PR110389 (to M.B.E.).	Acosta SA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053376; Adamah-Biassi EB, 2013, BEHAV BRAIN RES, V243, P306, DOI 10.1016/j.bbr.2013.01.003; Ajao DO, 2012, J NEUROTRAUM, V29, P2060, DOI 10.1089/neu.2011.1883; Amenta PS, 2012, J NEUROSCI RES, V90, P2293, DOI 10.1002/jnr.23114; Anderson MP, 2005, P NATL ACAD SCI USA, V102, P1743, DOI 10.1073/pnas.0409644102; Arciniegas DB, 2008, CRIT CARE CLIN, V24, P737, DOI 10.1016/j.ccc.2008.06.001; Beenhakker MP, 2009, NEURON, V62, P612, DOI 10.1016/j.neuron.2009.05.015; Ben Achour S, 2012, NEUROCHEM RES, V37, P2464, DOI 10.1007/s11064-012-0807-0; Blethyn KL, 2006, J NEUROSCI, V26, P2474, DOI 10.1523/JNEUROSCI.3607-05.2006; Bogdanova Y, 2012, NEUROPSYCHOL REV, V22, P4, DOI 10.1007/s11065-012-9192-3; BOHNEN N, 1994, BRAIN INJURY, V8, P701, DOI 10.3109/02699059409151024; Bouilleret V, 2009, J NEUROTRAUM, V26, P1999, DOI 10.1089/neu.2009.0943; Carbonnel WS, 1999, ACTA NEUROPATHOL, V98, P396, DOI 10.1007/s004010051100; Carter MD, 2011, AUTISM RES, V4, P57, DOI 10.1002/aur.180; Castriotta RJ, 2007, J CLIN SLEEP MED, V3, P349; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; Crabtree JW, 2013, EUR J NEUROSCI, V37, P850, DOI 10.1111/ejn.12098; Cueni L, 2008, NAT NEUROSCI, V11, P683, DOI 10.1038/nn.2124; Daneshvar DH, 2011, CLIN SPORT MED, V30, P1, DOI 10.1016/j.csm.2010.08.006; Elliott MB, 2012, HEADACHE, V52, P966, DOI 10.1111/j.1526-4610.2012.02160.x; Elliott MB, 2011, J NEUROTRAUM, V28, P973, DOI 10.1089/neu.2010.1672; Elliott MB, 2009, BRAIN RES, V1305, P183, DOI 10.1016/j.brainres.2009.09.104; Faul M.D., 2010, TRAUMATIC BRAIN INJU; Fujita M., 2010, NAT COMMUN, V1110, P1; Garcia-Panach J, 2011, J NEUROTRAUM, V28, P1707, DOI 10.1089/neu.2011.1851; Grossman EJ, 2012, J NEUROTRAUM, V29, P2318, DOI 10.1089/neu.2011.1763; Hall ED, 2008, J NEUROTRAUM, V25, P235, DOI 10.1089/neu.2007.0383; Hirsch Lawrence J, 2008, Epilepsy Curr, V8, P97, DOI 10.1111/j.1535-7511.2008.00254.x; Hunt RF, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00089; Ito S, 2013, NEUROBIOL DIS, V49, P29, DOI 10.1016/j.nbd.2012.08.003; Jacobowitz DM, 2012, BRAIN RES, V1465, P80, DOI 10.1016/j.brainres.2012.05.008; Jhuang H, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1064; Ji RR, 2013, PAIN S1, V154; Jones EG, 2009, ANN NY ACAD SCI, V1157, P10, DOI 10.1111/j.1749-6632.2009.04534.x; Kasturi BS, 2009, J NEUROTRAUM, V26, P1315, DOI [10.1089/neu.2008.0751, 10.1089/neu.2008-0751]; Laird MD, 2008, NEUROSIGNALS, V16, P154, DOI 10.1159/000111560; Lange RT, 2013, J NEUROTRAUM, V30, P958, DOI 10.1089/neu.2012.2743; Lee J, 2004, P NATL ACAD SCI USA, V101, P18195, DOI 10.1073/pnas.0408089101; Llinas RR, 2006, J NEUROPHYSIOL, V95, P3297, DOI 10.1152/jn.00166.2006; Lull N, 2010, BRAIN INJURY, V24, P1098, DOI 10.3109/02699052.2010.494592; Martinowich K, 2011, MOL BRAIN, V4, DOI 10.1186/1756-6606-4-11; Mathias JL, 2012, SLEEP MED, V13, P898, DOI 10.1016/j.sleep.2012.04.006; McMahon PJ, 2013, J NEUROTRAUMA; Mochel F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018336; Nakayama N, 2006, J NEUROL NEUROSUR PS, V77, DOI 10.1136/jnnp.2005.080523; Nardone R, 2011, J NEUROTRAUM, V28, P1165, DOI 10.1089/neu.2010.1748; NILSSON P, 1994, BRAIN RES, V637, P227, DOI 10.1016/0006-8993(94)91237-8; Onyszchuk G, 2009, NEUROSCI LETT, V452, P204, DOI 10.1016/j.neulet.2009.01.049; Orff HJ, 2009, J HEAD TRAUMA REHAB, V24, P155, DOI 10.1097/HTR.0b013e3181a0b281; Ouellet MC, 2006, SLEEP MED, V7, P486, DOI 10.1016/j.sleep.2006.03.017; Parcell DL, 2006, ARCH PHYS MED REHAB, V87, P278, DOI 10.1016/j.apmr.2005.10.024; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Ryan LM, 2003, INT REV PSYCHIATR, V15, P310, DOI 10.1080/09540260310001606692; Sandhir R, 2008, EXP NEUROL, V213, P372, DOI 10.1016/j.expneurol.2008.06.013; Santarnecchi E, 2013, J SLEEP RES, V22, P337, DOI 10.1111/jsr.12006; Sayer NA, 2012, ANNU REV MED, V63, P405, DOI 10.1146/annurev-med-061610-154046; Statler KD, 2008, EPILEPSY RES, V80, P163, DOI 10.1016/j.eplepsyres.2008.04.001; Steele AD, 2007, P NATL ACAD SCI USA, V104, P1983, DOI 10.1073/pnas.0610779104; STERIADE M, 1993, J NEUROSCI, V13, P3284; STERIADE M, 1993, SCIENCE, V262, P679, DOI 10.1126/science.8235588; Tang L, 2011, RADIOLOGY, V260, P831, DOI 10.1148/radiol.11110014; Taylor RA, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/746068; THOMAS WE, 1992, BRAIN RES REV, V17, P61; Vanderploeg RD, 2013, J HEAD TRAUMA REHAB, V28, P211, DOI 10.1097/HTR.0b013e31828b50db; Verma A, 2007, J CLIN SLEEP MED, V3, P357; Vespa PM, 2010, NEUROLOGY, V75, P792, DOI 10.1212/WNL.0b013e3181f07334; Vespa PM, 1999, J NEUROSURG, V91, P750, DOI 10.3171/jns.1999.91.5.0750; Washington PM, 2012, J NEUROTRAUM, V29, P2283, DOI 10.1089/neu.2012.2456; Wortzel HS, 2012, CURR TREAT OPTION NE, V14, P493, DOI 10.1007/s11940-012-0193-6; Zafonte RD, 1997, AM J PHYS MED REHAB, V76, P246, DOI 10.1097/00002060-199705000-00018; Zhou Y, 2013, J MAGN RESO IN PRESS	71	22	23	1	15	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0360-4012	1097-4547		J NEUROSCI RES	J. Neurosci. Res.	NOV	2014	92	11					1434	1445		10.1002/jnr.23430			12	Neurosciences	Neurosciences & Neurology	AN4CJ	WOS:000340534900003	24964253				2021-06-18	
J	Miyamoto, K; Tsumuraya, T; Ohtaki, H; Dohi, K; Satoh, K; Xu, ZF; Tanaka, S; Murai, N; Watanabe, J; Sugiyama, K; Aruga, T; Shioda, S				Miyamoto, Kazuyuki; Tsumuraya, Tomomi; Ohtaki, Hirokazu; Dohi, Kenji; Satoh, Kazue; Xu, Zhifang; Tanaka, Sachiko; Murai, Norimitsu; Watanabe, Jun; Sugiyama, Koichi; Aruga, Tohru; Shioda, Seiji			PACAP38 Suppresses Cortical Damage in Mice with Traumatic Brain Injury by Enhancing Antioxidant Activity	JOURNAL OF MOLECULAR NEUROSCIENCE			English	Article						PACAP38; Traumatic brain injury (TBI); Antioxidant enzyme; Superoxide dismutase-2 (SOD-2, Mn-SOD); Glutathione peroxidase 1 (GPx-1)	CYCLASE-ACTIVATING POLYPEPTIDE; STRESS-INDUCED APOPTOSIS; VASOACTIVE-INTESTINAL-PEPTIDE; NEURONAL CELL-DEATH; ADENYLATE-CYCLASE; IN-VITRO; ISCHEMIA/REPERFUSION INJURY; DEFICIENT MICE; INFARCT SIZE; RAT MODEL	The production of reactive oxygen species (ROS) and the resulting oxidative stress in mice in response to a controlled cortical impact (CCI) are typical exacerbating factors associated with traumatic brain injury (TBI). Pituitary adenylate cyclase-activating polypeptide 38 (PACAP38) is a multifunctional peptide that has been shown to exhibit neuroprotective effects in response to a diverse range of injuries to neuronal cells. We recently reported that PACAP38 might regulate oxidative stress in mice. The aim of the present study was to determine whether PACAP38 exerts neuroprotective effects by regulating oxidative stress in mice with TBI. Reactive oxidative metabolites (ROMs) and biological antioxidant potential (BAP) were measured in male C57Bl/6 mice before and 3, 4, and 24 h after CCI. PACAP38 was administered intravenously immediately following CCI, and immunostaining for the oxidative stress indicator nitrotyrosine (NT), and for neuronal death as an indicator of the area affected by TBI, was measured 24 h later. Western blot experiments to determine antioxidant activity [as indicated by superoxide dismutase-2 (SOD-2) and glutathione peroxidase 1 (GPx-1)] in the neocortical region were also performed 3 h post-CCI. Results showed that plasma BAP and ROM levels were dramatically increased 3 h after CCI. PACAP38 suppressed the extent of TBI and NT-positive regions 24 h after CCI, and increased SOD-2 and GPx-1 levels in both hemispheres. Taken together, these results suggest that increasing antioxidant might be involving in the neuroprotective effect of PACAP38 in mice subjected to a CCI.	[Miyamoto, Kazuyuki; Tsumuraya, Tomomi; Ohtaki, Hirokazu; Dohi, Kenji; Satoh, Kazue; Xu, Zhifang; Murai, Norimitsu; Watanabe, Jun; Sugiyama, Koichi; Shioda, Seiji] Showa Univ, Sch Med, Dept Anat, Shinagawa Ku, Tokyo 1428555, Japan; [Miyamoto, Kazuyuki; Aruga, Tohru] Showa Univ, Dept Emergency & Crit Care Med, Sch Med, Tokyo 1428555, Japan; [Tanaka, Sachiko] Showa Univ, Dept Pharmacol Toxicol & Therapeut, Div Toxicol, Sch Pharm, Tokyo 1428555, Japan	Shioda, S (corresponding author), Showa Univ, Sch Med, Dept Anat, Shinagawa Ku, 1-5-8 Hatanodai, Tokyo 1428555, Japan.	shioda@med.showa-u.ac.jp	Xu, Zhifang/AAF-4798-2019	dohi, kenji/0000-0002-4451-0382	Japanese Ministry of Education, Culture, Sports, Science and TechnologyMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT); MEXTMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT); Grants-in-Aid for Scientific ResearchMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI) [26870587, 24791954] Funding Source: KAKEN	The project was supported by a Grant-in-Aid from the Japanese Ministry of Education, Culture, Sports, Science and Technology. This work was also supported in part by the MEXT-Supported Program for the Strategic Research Foundation at Private Universities, 2008-2012.	Abad C, 2002, NEUROIMMUNOMODULAT, V10, P177, DOI 10.1159/000067180; Arimura A, 2006, BLOOD, V107, P661, DOI 10.1182/blood-2005-03-1186; Crack PJ, 2003, J CEREBR BLOOD F MET, V23, P19, DOI 10.1097/01.WCB.0000035181.38851.71; Crack PJ, 2001, J NEUROCHEM, V78, P1389, DOI 10.1046/j.1471-4159.2001.00535.x; Delgado M, 2001, J IMMUNOL, V167, P966, DOI 10.4049/jimmunol.167.2.966; Dohi K, 2002, REGUL PEPTIDES, V109, P83, DOI 10.1016/S0167-0115(02)00190-8; Dohi K, 2006, J NEUROTRAUM, V23, P1591, DOI 10.1089/neu.2006.23.1591; Dohi K, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-41; Farkas O, 2004, REGUL PEPTIDES, V123, P69, DOI 10.1016/j.regpep.2004.05.014; Flynn JM, 2013, FREE RADICAL BIO MED, V62, P4, DOI 10.1016/j.freeradbiomed.2013.05.027; Frechilla D, 2001, NEUROREPORT, V12, P919, DOI 10.1097/00001756-200104170-00011; Ganea D, 2002, CRIT REV ORAL BIOL M, V13, P229, DOI 10.1177/154411130201300303; Gasz B, 2006, PEPTIDES, V27, P87, DOI 10.1016/j.peptides.2005.06.022; Kovesdi E, 2008, NEUROTOX RES, V13, P71, DOI 10.1007/BF03033558; Lebovitz RM, 1996, P NATL ACAD SCI USA, V93, P9782, DOI 10.1073/pnas.93.18.9782; Lewen A, 2000, J NEUROTRAUM, V17, P871, DOI 10.1089/neu.2000.17.871; Manno EM, 2008, CRIT CARE, V12, DOI 10.1186/cc7112; Mao SS, 2012, J NEUROTRAUM, V29, P1941, DOI 10.1089/neu.2011.2244; Martinez C, 2002, P NATL ACAD SCI USA, V99, P1053, DOI 10.1073/pnas.012367999; Miyamoto K, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/379206; MIYATA A, 1989, BIOCHEM BIOPH RES CO, V164, P567, DOI 10.1016/0006-291X(89)91757-9; Mori H, 2010, CIRC J, V74, P1183, DOI 10.1253/circj.CJ-09-1024; Nakamachi T, 2012, J MOL NEUROSCI, V48, P518, DOI 10.1007/s12031-012-9819-0; Ohtaki H, 2006, P NATL ACAD SCI USA, V103, P7488, DOI 10.1073/pnas.0600375103; Ohtaki H, 2010, J MOL NEUROSCI, V42, P397, DOI 10.1007/s12031-010-9350-0; Ohtaki H, 2008, J MOL NEUROSCI, V36, P16, DOI 10.1007/s12031-008-9077-3; Park E, 2009, J CEREBR BLOOD F MET, V29, P575, DOI 10.1038/jcbfm.2008.151; Racz B, 2007, GEN COMP ENDOCR, V153, P115, DOI 10.1016/j.ygcen.2006.12.006; Ravni A, 2006, J NEUROCHEM, V98, P1229, DOI 10.1111/j.1471-4159.2006.03962.x; Reglodi D, 2000, STROKE, V31, P1411, DOI 10.1161/01.STR.31.6.1411; Reglodi D, 2012, J MOL NEUROSCI, V48, P482, DOI 10.1007/s12031-012-9762-0; Reglodi D, 2011, CURR PHARM DESIGN, V17, P962, DOI 10.2174/138161211795589355; Reglodi D, 2002, PEPTIDES, V23, P2227, DOI 10.1016/S0196-9781(02)00262-0; Reglodi D, 2000, ANN NY ACAD SCI, V921, P119; Skoglosa Y, 1999, NEUROSCIENCE, V90, P235, DOI 10.1016/S0306-4522(98)00414-X; Tamas A, 2006, J NEUROTRAUM, V23, P686, DOI 10.1089/neu.2006.23.686; Tamas A, 2012, INT J MOL SCI, V13, P8430, DOI 10.3390/ijms13078430; Tan YV, 2009, P NATL ACAD SCI USA, V106, P2012, DOI 10.1073/pnas.0812257106; Tanaka J, 1997, REGUL PEPTIDES, V72, P1, DOI 10.1016/S0167-0115(97)01038-0; Tsuchikawa D, 2012, J MOL NEUROSCI, V48, P508, DOI 10.1007/s12031-012-9817-2; van Landeghem FKH, 2007, ACTA NEUROPATHOL, V113, P683, DOI 10.1007/s00401-007-0208-7; Vaudry D, 2002, EUR J NEUROSCI, V15, P1451, DOI 10.1046/j.1460-9568.2002.01981.x; Waschek JA, 2013, BRIT J PHARMACOL, V169, P512, DOI 10.1111/bph.12181	43	22	22	0	6	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	0895-8696	1559-1166		J MOL NEUROSCI	J. Mol. Neurosci.	NOV	2014	54	3					370	379		10.1007/s12031-014-0309-4			10	Biochemistry & Molecular Biology; Neurosciences	Biochemistry & Molecular Biology; Neurosciences & Neurology	AT3ZN	WOS:000344875700010	24907941				2021-06-18	
J	Morris, DC; Cui, Y; Cheung, WL; Lu, M; Zhang, L; Zhang, ZG; Chopp, M				Morris, D. C.; Cui, Y.; Cheung, W. L.; Lu, M.; Zhang, L.; Zhang, Z. G.; Chopp, M.			A dose-response study of thymosin beta 4 for the treatment of acute stroke	JOURNAL OF THE NEUROLOGICAL SCIENCES			English	Article						Thymosin; Rat model; Embolic stroke; Neurorestorative therapy; Actin-binding protein; Oligodendrocyte	TRAUMATIC BRAIN-INJURY; ACUTE ISCHEMIC-STROKE; MULTIPLE-SCLEROSIS; ANIMAL-MODELS; RAT MODEL; REMYELINATION; BIOLOGY; CNS	Background: Thymosin beta 4 (T beta 4) is a 5 K actin binding peptide. T beta 4 improves neurological outcome in a rat model of embolic stroke and research is now focused on optimizing its dose for clinical trials. The purpose of this study was to perform a dose-response study of T beta 4 to determine the optimal dose of neurological improvement in a rat model of embolic stroke. Methods: Male Wistar rats were subjected to embolic middle cerebral artery occlusion (MCAo). Rats were divided into 4 groups of 10 animals/group: control, 2,12 and 18 mg/kg. T beta 4 was administered intraperitoneally 24 h after MCAo and then every 3 days for 4 additional doses in a randomized controlled fashion. Neurological tests were performed after MCAo and before treatment and up to 8 weeks after treatment. The rats were sacrificed 56 days after MCAo and lesion volumes measured. Generalized estimating equation was used to compare the treatment effect on long term functional recovery at day 56. A quartic regression model was used for an optimal dose determination. Results: T beta 4 significantly improved neurological outcome at dose of 2 and 12 mg/kg at day 14 and extended to day 56 (p-values <0.05). The higher dose of 18 mg/kg did not show significant improvement. The estimated optimal dose of 3.75 mg/kg would provide optimal neurological improvement. Conclusions: This study shown that T beta 4 significantly improved the long term neurological functional recovery at day 56 after MCAo with an optimal dose of 3.75 mg/kg. These results provide preclinical data for human clinical trials. (C) 2014 Elsevier B.V. All rights reserved.	[Morris, D. C.; Cheung, W. L.] Henry Ford Hlth Syst, Dept Emergency Med, Detroit, MI 48202 USA; [Cui, Y.; Zhang, L.; Zhang, Z. G.; Chopp, M.] Henry Ford Hlth Syst, Dept Neurol, Detroit, MI 48202 USA; [Lu, M.] Henry Ford Hlth Syst, Dept Publ Hlth Sci, Detroit, MI 48202 USA; [Chopp, M.] Oakland Univ, Dept Phys, Rochester, MI 48309 USA	Morris, DC (corresponding author), Henry Ford Hosp, Dept Emergency Med, 2799 West Grand Blvd,CFP-2, Detroit, MI 48202 USA.	morris@neuro.hfh.edu; yisheng@neuro.hfh.edu; wcheung1@hfhs.org; mlu1@hfhs.org; lzhang@neuro.hfh.edu; zhazh@neuro.hfh.edu; michael.chopp@gmail.com			NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01 AG038648, R01 NS079612, R01 AG037506]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS079612] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R01AG037506, R01AG038648] Funding Source: NIH RePORTER	Grant support: NIH, R01 AG038648 (DM), R01 NS079612 (ZG) and R01 AG037506 (MC).	Bock-Marquette I, 2004, NATURE, V432, P466, DOI 10.1038/nature03000; Box G.E., 1987, EMPIRICAL MODEL BUIL, V424; Cenci MA, 2002, NAT REV NEUROSCI, V3, P574, DOI 10.1038/nrn877; Chen J, 2006, NEUROSCIENCE, V141, P737, DOI 10.1016/j.neuroscience.2006.04.042; Crockford D, 2007, ANN NY ACAD SCI, V1112, P385, DOI 10.1196/annals.1415.051; Feigin VL, 2009, LANCET NEUROL, V8, P355, DOI 10.1016/S1474-4422(09)70025-0; Franklin RJM, 2002, NAT REV NEUROSCI, V3, P705, DOI 10.1038/nrn917; Franklin RJM, 2008, NAT REV NEUROSCI, V9, P839, DOI 10.1038/nrn2480; Franklin RJM, 2008, J NEUROL, V255, P19, DOI 10.1007/s00415-008-1004-6; Hacke W, 2008, NEW ENGL J MED, V359, P1317, DOI 10.1056/NEJMoa0804656; Kleindorfer D, 2009, STROKE, V40, P3580, DOI 10.1161/STROKEAHA.109.554626; Lu M, 2003, J NEUROSCI METH, V128, P183, DOI 10.1016/S0165-0270(03)00188-2; Malinda KM, 1999, J INVEST DERMATOL, V113, P364, DOI 10.1046/j.1523-1747.1999.00708.x; MARLER JR, 1995, NEW ENGL J MED, V333, P1581, DOI 10.1056/nejm199512143332401; Mitka M, 2010, JAMA-J AM MED ASSOC, V303, P17, DOI 10.1001/jama.2009.1862; Morris DC, 2010, NEUROSCIENCE, V169, P674, DOI 10.1016/j.neuroscience.2010.05.017; Nait-Oumesmar B, 2008, J NEUROL SCI, V265, P26, DOI 10.1016/j.jns.2007.09.032; Pantoni L, 1996, STROKE, V27, P1641, DOI 10.1161/01.STR.27.9.1641; Ruff D, 2010, ANN NY ACAD SCI, V1194, P223, DOI 10.1111/j.1749-6632.2010.05474.x; SAS Institute I, 2010, US GUID SAS STAT 9 2; Smart N, 2007, NATURE, V445, P177, DOI 10.1038/nature05383; Xiong Y, 2011, J NEUROSURG, V114, P102, DOI 10.3171/2010.4.JNS10118; Zhang J, 2009, NEUROSCIENCE, V164, P1887, DOI 10.1016/j.neuroscience.2009.09.054; Zhang L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011016; Zhang RL, 2002, STROKE, V33, P2675, DOI 10.1161/01.STR.0000034399.95249.59; Zhang RL, 1997, BRAIN RES, V766, P83, DOI 10.1016/S0006-8993(97)00580-5; Zhang ZG, 2009, LANCET NEUROL, V8, P491, DOI 10.1016/S1474-4422(09)70061-4	27	22	25	0	8	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0022-510X	1878-5883		J NEUROL SCI	J. Neurol. Sci.	OCT 15	2014	345	1-2					61	67		10.1016/j.jns.2014.07.006			7	Clinical Neurology; Neurosciences	Neurosciences & Neurology	AR6JJ	WOS:000343689600009	25060418	Green Accepted			2021-06-18	
J	Marhong, J; Fan, E				Marhong, Jonathan; Fan, Eddy			Carbon Dioxide in the Critically Ill: Too Much or Too Little of a Good Thing?	RESPIRATORY CARE			English	Article						hypercapnia; hypocapnia; intensive care units; respiration; artificial; respiratory acidosis; respiratory distress syndrome; adult	CEREBRAL-BLOOD-FLOW; PROVIDING PERMISSIVE HYPERCAPNIA; HEAD-INJURY; DECOMPRESSIVE CRANIECTOMY; 6 ML/KG; LUNG; VENTILATION; ACIDOSIS; VOLUME; HYPOCAPNIA	Hypercapnia and hypocapnia commonly complicate conditions that are present in critically ill patients. Both conditions have important physiologic effects that may impact the clinical management of these patients. For instance, hypercapnia results in bronchodilation and enhanced hypoxic vasoconstriction, leading to improved ventilation/perfusion matching. Hypocapnia reduces cerebral blood volume through arterial vasoconstriction. These effects have also been exploited for therapeutic aims. In patients with traumatic brain injury (TB!), hypocapnia is often utilized to control intracranial pressure. However, this effect is not sustained, and prolonged hypocapnia increases the risk of mortality and severe disability in patients with TBI. Hypercapnia and hypercapnic acidosis are common consequences of lung-protective ventilation in ARDS. Hypercapnic acidosis reduces ischemic lung injury and preserves lung compliance, but concern has arisen over hypercapnia-induced immunosuppression and the potential for bacterial proliferation in sepsis. Experimental studies suggest that buffering hypercapnic acidosis attenuates these effects, whereas hypocapnia appears to potentiate lung injury through increased capillary permeability and decreased lung compliance. Several areas of uncertainty surround the role of hypercapnia/hypocapnia in treating TB! and ARDS. Current data support recommendations to avoid hypocapnia in treating TB!, with the exception of emergent treatment of elevated intracranial pressure, while awaiting definitive management. Permissive hypercapnia is commonly accepted as a consequence of lung-protective ventilation in ARDS, but there is insufficient evidence to support the induction of hypercapnic acidosis in clinical practice. Buffering hypercapnic acidosis should be considered only for a specific clinical indication (eg, hemodynamic instability). For clinicians choosing to buffer hypercapnic acidosis, tris-hydroxymethyl aminomethane is recommended over sodium bicarbonate, as it is more effective in correcting pH and is not associated with increased carbon dioxide production. Future studies should aim to address these areas of uncertainty to help guide clinicians in the therapeutic use and management of hypercapnia/hypocapnia in critically ill patients.	[Marhong, Jonathan; Fan, Eddy] Univ Toronto, Interdept Div Crit Care Med, Toronto, ON, Canada; [Marhong, Jonathan; Fan, Eddy] Univ Hlth Network, Dept Med, Toronto, ON, Canada; [Marhong, Jonathan; Fan, Eddy] Mt Sinai Hosp, Toronto, ON M5G 1X5, Canada	Fan, E (corresponding author), Toronto Gen Hosp, 585 Univ Ave,PMB 11-123, Toronto, ON M5G 2N2, Canada.	eddy.fan@uhn.ca					ALEXANDER SC, 1968, J APPL PHYSIOL, V24, P66; Amato MBP, 1998, NEW ENGL J MED, V338, P347, DOI 10.1056/NEJM199802053380602; Bein T, 2013, INTENS CARE MED, V39, P847, DOI 10.1007/s00134-012-2787-6; Beitler JR, 2013, J PHYSIOL-LONDON, V591, P2767, DOI 10.1113/jphysiol.2013.252619; Bor-Seng-Shu E, 2013, BIOMED RES INT, V2013, P750; BOUMA GJ, 1992, J NEUROSURG, V77, P360, DOI 10.3171/jns.1992.77.3.0360; Brodie D, 2011, NEW ENGL J MED, V365, P1905, DOI 10.1056/NEJMct1103720; Brower RG, 2000, NEW ENGL J MED, V342, P1301, DOI 10.1056/nejm200005043421801; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Coakley RJ, 2002, J LEUKOCYTE BIOL, V71, P603; Coles JP, 2007, CRIT CARE MED, V35, P568, DOI 10.1097/01.CCM.0000254066.37187.88; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; CULLEN DJ, 1974, ANESTHESIOLOGY, V41, P345, DOI 10.1097/00000542-197410000-00006; Curley G, 2010, CRIT CARE, V14, DOI 10.1186/cc8926; Curley G, 2010, CRIT CARE MED, V38, P1348, DOI 10.1097/CCM.0b013e3181d8cf2b; Curley G, 2010, ANESTHESIOLOGY, V112, P462, DOI 10.1097/ALN.0b013e3181ca361f; Curley GF, 2013, J PHYSIOL-LONDON, V591, P2763, DOI 10.1113/jphysiol.2013.252601; Davis DP, 2006, CRIT CARE MED, V34, P1202, DOI 10.1097/01.CCM.0000208359.74623.1C; Del Sorbo L, 2014, LANCET RESP MED, V2, P154, DOI 10.1016/S2213-2600(13)70197-8; Doerr CH, 2005, AM J RESP CRIT CARE, V171, P1371, DOI 10.1164/rccm.200309-1223OC; DOMINO KB, 1993, J APPL PHYSIOL, V75, P1306; Domino KB, 1998, RESP PHYSIOL, V111, P89, DOI 10.1016/S0034-5687(97)00103-5; Fee JP, 2004, PHYSL ANAESTHESIOLOG; Forsythe SM, 2000, CHEST, V117, P260, DOI 10.1378/chest.117.1.260; GRUBB RL, 1974, STROKE, V5, P630, DOI 10.1161/01.STR.5.5.630; Guyton A.C., 2006, TXB MED PHYSL; Ito H, 2005, J CEREBR BLOOD F MET, V25, P852, DOI 10.1038/sj.jcbfm.9600076; Kraut JA, 2010, NAT REV NEPHROL, V6, P274, DOI 10.1038/nrneph.2010.33; Kregenow DA, 2006, CRIT CARE MED, V34, P1, DOI 10.1097/01.CCM.0000194533.75481.03; Kregenow DA, 2002, EUR RESPIR J, V20, P6, DOI 10.1183/09031936.02.00400802; Laffey JG, 2000, AM J RESP CRIT CARE, V162, P2287, DOI 10.1164/ajrccm.162.6.2003066; Laffey JG, 2000, AM J RESP CRIT CARE, V162, P399, DOI 10.1164/ajrccm.162.2.9911026; Laffey JG, 2004, INTENS CARE MED, V30, P347, DOI 10.1007/s00134-003-2051-1; Laffey JG, 2003, CRIT CARE MED, V31, P2634, DOI 10.1097/01.CCM.0000089646.52395.BA; Laffey JG, 2000, AM J RESP CRIT CARE, V161, P141, DOI 10.1164/ajrccm.161.1.9905080; LAHIRI S, 1975, RESP PHYSIOL, V24, P267, DOI 10.1016/0034-5687(75)90018-3; Lee C, 2013, KOREAN J ANESTHESIOL, V65, P337, DOI 10.4097/kjae.2013.65.4.337; Mazzeo AT, 2004, PEDIATR ANESTH, V14, P596, DOI 10.1111/j.1460-9592.2004.01260.x; McCrimmon DR, 2003, AM J PHYSIOL-REG I, V285, pR1274, DOI 10.1152/ajpregu.00428.2003; McLaughlin MR, 1996, J NEUROSURG, V85, P871, DOI 10.3171/jns.1996.85.5.0871; MUIZELAAR JP, 1991, J NEUROSURG, V75, P731, DOI 10.3171/jns.1991.75.5.0731; Nahas GG, 1998, DRUGS, V55, P191, DOI 10.2165/00003495-199855020-00003; Peek GJ, 2009, LANCET, V374, P1351, DOI 10.1016/S0140-6736(09)61069-2; Pugin J, 2008, AM J RESP CELL MOL, V38, P362, DOI 10.1165/rcmb.2007-0114OC; Quinn TM, 2011, ACTA NEUROL SCAND, V123, P239, DOI 10.1111/j.1600-0404.2010.01397.x; RAICHLE ME, 1970, ARCH NEUROL-CHICAGO, V23, P394, DOI 10.1001/archneur.1970.00480290014002; RICHARDSON DW, 1972, AM J PHYSIOL, V223, P1308; Rubenfeld GD, 2005, NEW ENGL J MED, V353, P1685, DOI 10.1056/NEJMoa050333; SAMRA SK, 1989, ANESTHESIOLOGY, V70, P523, DOI 10.1097/00000542-198903000-00024; Shibata K, 1998, AM J RESP CRIT CARE, V158, P1578, DOI 10.1164/ajrccm.158.5.9804039; Smith CA, 2006, J APPL PHYSIOL, V100, P13, DOI 10.1152/japplphysiol.00926.2005; Terragni PP, 2009, ANESTHESIOLOGY, V111, P826, DOI 10.1097/ALN.0b013e3181b764d2; Vadasz I, 2012, AM J RESP CELL MOL, V46, P417, DOI 10.1165/rcmb.2011-0395PS; Weber T, 2000, AM J RESP CRIT CARE, V162, P1361, DOI 10.1164/ajrccm.162.4.9808092; West JB, 1996, RESP PHYSL PEOPLE ID; Zwienenberg M, 1999, J NEUROTRAUM, V16, P937, DOI 10.1089/neu.1999.16.937	56	22	25	0	12	DAEDALUS ENTERPRISES INC	IRVING	9425 N MAC ARTHUR BLVD, STE 100, IRVING, TX 75063-4706 USA	0020-1324	1943-3654		RESP CARE	Respir. Care	OCT	2014	59	10					1597	1605		10.4187/respcare.03405			9	Critical Care Medicine; Respiratory System	General & Internal Medicine; Respiratory System	CA8WB	WOS:000349200500018	25261559	Bronze			2021-06-18	
J	Mir, IN; Chalak, LF				Mir, Imran N.; Chalak, Lina F.			Serum biomarkers to evaluate the integrity of the neurovascular unit	EARLY HUMAN DEVELOPMENT			English	Article							NEURON-SPECIFIC ENOLASE; HYPOXIC-ISCHEMIC ENCEPHALOPATHY; FIBRILLARY ACIDIC PROTEIN; TRAUMATIC BRAIN-INJURY; C-TERMINAL HYDROLASE; WHITE-MATTER INJURY; NEONATAL ENCEPHALOPATHY; CEREBROSPINAL-FLUID; PERINATAL ASPHYXIA; CARDIAC-SURGERY	Biomarkers have the potential to enable the clinicians to screen infants for brain injury, monitor progression of disease, identify injured brain regions, assess efficacy of neuroprotective therapies, and offer hope to identify the timing of the injury, thus shedding light on the potential pathophysiology and the most effective therapy. Currently, clinicians do not routinely use biomarkers to care for neonates with Neonatal Encephalopathy (NE) and brain injury due to prenatal hypoxia-asphyxia. This review will cover potential biomarkers of the neurovascular unit in the setting of NE that (i) can help assess the degree or severity of encephalopathy at birth; (ii) can help monitor progression of disease process and efficacy of neuroprotective therapy; (iii) can help assess neurodevelopmental outcome. These biomarkers will be summarized in two categories: 1) Specific biomarkers targeting the neurovascular unit such as glial fibrillary acidic protein (GFAP), ubiquitin carboxyl-terminal hydrolase L1 (UCH-L1), S100B, and neuron specific enolase (NSE) and 2) general inflammatory cytokines, such as interleuldn-6 (IL-6), interleukin-1b (IL-1b), and pNF-H, among others. (C) 2014 Elsevier Ireland Ltd. All rights reserved.	[Mir, Imran N.; Chalak, Lina F.] Univ Texas SW Med Ctr Dallas, Dept Pediat, Dallas, TX 75390 USA	Chalak, LF (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Pediat, Dallas, TX 75390 USA.	lina.chalak@utsouthwestern.edu	Mir, Imran Nazir/K-1447-2019	Mir, Imran Nazir/0000-0002-6343-0337	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K23HD069521] Funding Source: NIH RePORTER; NICHD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K23 HD069521] Funding Source: Medline		Abbott NJ, 2006, NAT REV NEUROSCI, V7, P41, DOI 10.1038/nrn1824; Bailey SL, 2006, CRIT REV IMMUNOL, V26, P149, DOI 10.1615/CritRevImmunol.v26.i2.40; Bartha AI, 2004, PEDIATR RES, V56, P960, DOI 10.1203/01.PDR.0000144819.45689.BB; Basile AM, 2001, EUR NEUROL, V45, P151, DOI 10.1159/000052114; Berger RP, 2005, J NEUROSURG, V103, P61, DOI 10.3171/ped.2005.103.1.0061; Celtik C, 2004, BRAIN DEV-JPN, V26, P398, DOI 10.1016/j.braindev.2003.12.007; Chalak LF, 2014, J PEDIATR-US, V164, P468, DOI 10.1016/j.jpeds.2013.10.067; Chiesa C, 2003, EUR J CLIN INVEST, V33, P352, DOI 10.1046/j.1365-2362.2003.01136.x; Dammann O, 2008, CLIN PERINATOL, V35, P643, DOI 10.1016/j.clp.2008.07.011; de Vries LS, 2010, ARCH DIS CHILD-FETAL, V95, pF220, DOI 10.1136/adc.2008.148205; Douglas-Escobar M, 2013, FRONT NEUROL, V3, DOI 10.3389/fneur.2012.00185; Douglas-Escobar M, 2010, PEDIATR RES, V68, P531, DOI 10.1203/PDR.0b013e3181f85a03; Ellison VJ, 2005, PEDIATR RES, V57, P282, DOI 10.1203/01.PDR.0000148286.53572.95; Elovitz MA, 2011, INT J DEV NEUROSCI, V29, P663, DOI 10.1016/j.ijdevneu.2011.02.011; Ennen CS, 2011, AM J OBSTET GYNECOL, V205, DOI 10.1016/j.ajog.2011.06.025; Fairchild KD, 2000, J INTERF CYTOK RES, V20, P1049, DOI 10.1089/107999000750053708; FINER NN, 1981, J PEDIATR-US, V98, P112, DOI 10.1016/S0022-3476(81)80555-0; Foster-Barber A, 2001, DEV NEUROSCI-BASEL, V23, P213, DOI 10.1159/000046146; Gazzolo D, 2004, CRIT CARE MED, V32, P131, DOI 10.1097/01.CCM.0000104116.91462.CD; Gazzolo D, 2010, J MATERN-FETAL NEO M, V23, P66, DOI 10.3109/14767058.2010.507960; Gazzolo D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004298; Gonzalez FF, 2006, ARCH DIS CHILD-FETAL, V91, pF454, DOI 10.1136/adc.2005.092445; Hagberg H, 1996, PEDIATR RES, V40, P603, DOI 10.1203/00006450-199610000-00015; HAY E, 1984, J NEUROL NEUROSUR PS, V47, P724, DOI 10.1136/jnnp.47.7.724; HELLSTROMWESTAS L, 1995, ARCH DIS CHILD-FETAL, V72, pF34, DOI 10.1136/fn.72.1.F34; Kaneko T, 2009, RESUSCITATION, V80, P790, DOI 10.1016/j.resuscitation.2009.04.003; Kurinczuk JJ, 2010, EARLY HUM DEV, V86, P329, DOI 10.1016/j.earlhumdev.2010.05.010; Lehnardt S, 2010, GLIA, V58, P253, DOI 10.1002/glia.20928; Leviton A, 1999, PEDIATR RES, V46, P566, DOI 10.1203/00006450-199911000-00013; Lewis SB, 2010, J NEUROSCI RES, V88, P1475, DOI 10.1002/jnr.22323; Liu XH, 1999, J CEREBR BLOOD F MET, V19, P1099, DOI 10.1097/00004647-199910000-00006; Lumpkins KM, 2008, J TRAUMA, V65, P778, DOI 10.1097/TA.0b013e318185db2d; Malaeb S, 2009, J CHILD NEUROL, V24, P1119, DOI 10.1177/0883073809338066; Marlow N, 2005, ARCH DIS CHILD-FETAL, V90, pF380, DOI 10.1136/adc.2004.067520; Massaro AN, 2013, PEDIATR CRIT CARE ME, V14, P310, DOI 10.1097/PCC.0b013e3182720642; McAdams RM, 2012, NEUROL RES INT, V2012, DOI 10.1155/2012/561494; PAHLMAN S, 1984, TUMOUR BIOL, V5, P127; Papa L, 2010, CRIT CARE MED, V38, P138, DOI 10.1097/CCM.0b013e3181b788ab; Pelinka LE, 2004, J TRAUMA, V57, P1006, DOI 10.1097/01.TA.0000108998.48026.C3; Pelinka LE, 2004, J NEUROTRAUM, V21, P1553, DOI 10.1089/0897715042441846; PERLMAN JM, 1989, AM J DIS CHILD, V143, P617, DOI 10.1001/archpedi.1989.02150170119037; Qian J, 2009, EUR J PEDIATR, V168, P71, DOI 10.1007/s00431-008-0711-4; Ramaswamy V, 2009, PEDIATR NEUROL, V40, P215, DOI 10.1016/j.pediatrneurol.2008.09.026; Risso FM, 2013, ACTA PAEDIATR, V102, pE467, DOI 10.1111/apa.12343; ROINE RO, 1989, ARCH NEUROL-CHICAGO, V46, P753, DOI 10.1001/archneur.1989.00520430047015; Rostene W, 2011, J NEUROCHEM, V118, P680, DOI 10.1111/j.1471-4159.2011.07371.x; Rundgren M, 2009, RESUSCITATION, V80, P784, DOI 10.1016/j.resuscitation.2009.03.025; Russwurm S, 2002, J INTERF CYTOK RES, V22, P215, DOI 10.1089/107999002753536185; SARNAT HB, 1976, ARCH NEUROL-CHICAGO, V33, P696, DOI 10.1001/archneur.1976.00500100030012; Savman K, 1998, PEDIATR RES, V43, P746; Schmitt B, 1998, BRAIN DEV-JPN, V20, P536, DOI 10.1016/S0387-7604(98)00046-1; Shah P, 2004, ARCH DIS CHILD-FETAL, V89, P152, DOI 10.1136/adc.2002.023093; Shalak LF, 2002, MENT RETARD DEV D R, V8, P14, DOI 10.1002/mrdd.10006; SHANKARAN S, 1991, EARLY HUM DEV, V25, P135, DOI 10.1016/0378-3782(91)90191-5; Siman R, 2008, BRAIN RES, V1213, P1, DOI 10.1016/j.brainres.2008.03.034; Tayal V, 2008, EUR J PHARMACOL, V579, P1, DOI 10.1016/j.ejphar.2007.10.049; THOMPSON RJ, 1983, BRAIN RES, V278, P224, DOI 10.1016/0006-8993(83)90241-X; Thoresen M, 2010, PEDIATRICS, V126, pE131, DOI 10.1542/peds.2009-2938; Vela JM, 2002, MOL CELL NEUROSCI, V20, P489, DOI 10.1006/mcne.2002.1127; Volpe JJ, 2003, PEDIATRICS, V112, P176, DOI 10.1542/peds.112.1.176; Vos PE, 2004, NEUROLOGY, V62, P1303, DOI 10.1212/01.WNL.0000120550.00643.DC; Yoon BH, 2003, BJOG-INT J OBSTET GY, V110, P124, DOI 10.1016/S1470-0328(03)00063-6	62	22	22	0	10	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0378-3782	1872-6232		EARLY HUM DEV	Early Hum. Dev.	OCT	2014	90	10					707	711		10.1016/j.earlhumdev.2014.06.010			5	Obstetrics & Gynecology; Pediatrics	Obstetrics & Gynecology; Pediatrics	AR1YA	WOS:000343379300026	25064445				2021-06-18	
J	Radic, JAE; Chou, SHY; Du, R; Lee, JW				Radic, Julia Anne Elisabeth; Chou, Sherry H-Y.; Du, Rose; Lee, Jong Woo			Levetiracetam Versus Phenytoin: A Comparison of Efficacy of Seizure Prophylaxis and Adverse Event Risk Following Acute or Subacute Subdural Hematoma Diagnosis	NEUROCRITICAL CARE			English	Article						Antiepileptic drug; Seizure; Subdural hematoma	TRAUMATIC BRAIN-INJURY; POSTOPERATIVE SEIZURES; CLINICAL ARTICLE; PREVENTION; TUMORS; TRIAL	Although both levetiracetam and phenytoin are used for seizure prophylaxis in subdural hematomas (SDHs), there is little data on their comparative efficacies. We compared the efficacy and risk of using levetiracetam versus phenytoin for seizure prophylaxis following acute or subacute SDH diagnosis. In this retrospective cohort study, the clinical data registry at a tertiary care hospital was searched for all cases of acute or subacute SDHs that were admitted to hospital in 2002, 2003, or 2011. Risk of clinical and/or electrographic seizures, and risk of adverse drug events were compared between the two exposure arms. 124 subjects in the phenytoin arm and 164 subjects in the levetiracetam arm were included. There was no significant difference in clinical and/or electrographic seizure risk, though there was a decreased risk of adverse events in the levetiracetam arm (p < 0.001). In subjects with midline shift > 0 mm, levetiracetam was associated with an increased risk of electrographic seizures during hospitalization (p = 0.028) and a decreased risk of adverse drug effects (p = 0.001), compared with phenytoin use. Levetiracetam generally appears to have a similar efficacy to phenytoin in preventing clinical and/or electrographic seizures following acute/subacute SDH diagnosis, though patients with midline shift > 0 mm may have associated with a higher risk of electrographic seizures on levetiracetam compared with patients on phenytoin. Levetiracetam is associated with a lower risk of adverse drug effects. A prospective, randomized study would more definitively determine any difference in efficacy and risk between phenytoin and levetiracetam.	[Radic, Julia Anne Elisabeth; Chou, Sherry H-Y.; Du, Rose; Lee, Jong Woo] Brigham & Womens Hosp, Edward B Bromfield Epilepsy Program, Dept Neurol, Boston, MA 02115 USA; [Radic, Julia Anne Elisabeth] Dalhousie Univ, Div Neurosurg, Halifax, NS, Canada; [Chou, Sherry H-Y.] Dept Neurol, Boston, MA USA; [Du, Rose] Dept Neurosurg, Boston, MA USA	Lee, JW (corresponding author), Brigham & Womens Hosp, Edward B Bromfield Epilepsy Program, Dept Neurol, 75 Francis St, Boston, MA 02115 USA.	jar334@mail.harvard.edu; schou1@partners.org; rdu@partners.org; jlee38@partners.org	Chou, Sherry/G-5779-2015; Radic, Julia/AAV-4075-2020; Lee, Jongwoo/AAI-3617-2020; Du, Rose/AAJ-2873-2020; Du, Rose/I-5402-2012	Du, Rose/0000-0003-2641-6496	UCB, Inc.UCB Pharma SA; Sunovion, Inc.	Julia A. E. Radic declares that she has no conflict of interest. Rose Du declares that she has no conflict of interest. Sherry H-Y. Chou declares that she has no conflict of interest. Jong Woo Lee has received research grants from UCB, Inc. and Sunovion, Inc.	Chang BS, 2003, NEUROLOGY, V60, P10, DOI 10.1212/01.WNL.0000031432.05543.14; Chen CW, 2004, J CLIN NEUROSCI, V11, P706, DOI 10.1016/j.jocn.2004.03.019; Cotton BA, 2011, J TRAUMA, V71, P375, DOI 10.1097/TA.0b013e318224d307; JONES GL, 1983, MED RES REV, V3, P383, DOI 10.1002/med.2610030403; Jones KE, 2008, NEUROSURG FOCUS, V25, DOI 10.3171/FOC.2008.25.10.E3; Kern K, 2012, J CLIN NEUROSCI, V19, P99, DOI 10.1016/j.jocn.2011.07.021; Messe S, 2009, NEUROCRIT CARE, V11, P38, DOI 10.1007/s12028-009-9207-y; Naidech AM, 2005, STROKE, V36, P583, DOI 10.1161/01.STR.0000141936.36596.1e; Naidech AM, 2009, STROKE, V40, P3810, DOI 10.1161/STROKEAHA.109.559948; Nalichowski R, 2006, BETH ANN S P AMIA S, P1044; OHNO K, 1993, J NEUROL NEUROSUR PS, V56, P1231, DOI 10.1136/jnnp.56.11.1231; Rabinstein AA, 2010, J NEUROSURG, V112, P455, DOI 10.3171/2009.7.JNS09392; Ramael S, 2006, EPILEPSIA, V47, P1128, DOI 10.1111/j.1528-1167.2006.00586.x; SABO RA, 1995, SURG NEUROL, V43, P579, DOI 10.1016/0090-3019(95)00155-7; Schierhout G, 2001, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD000173; Szaflarski JP, 2010, NEUROCRIT CARE, V12, P165, DOI 10.1007/s12028-009-9304-y; TEMKIN NR, 1990, NEW ENGL J MED, V323, P497, DOI 10.1056/NEJM199008233230801; Varelas PN, 2013, NEUROCRIT CARE, V19, P4, DOI 10.1007/s12028-013-9840-3; Wiedemayer H, 2002, BRAIN INJURY, V16, P323, DOI 10.1080/02699050110102077; Wu AS, 2013, J NEUROSURG, V118, P873, DOI 10.3171/2012.12.JNS111970; Zafar SN, 2012, BMC NEUROL, V12, DOI 10.1186/1471-2377-12-30	21	22	23	0	9	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care	OCT	2014	21	2					228	237		10.1007/s12028-013-9951-x			10	Critical Care Medicine; Clinical Neurology	General & Internal Medicine; Neurosciences & Neurology	AQ9AR	WOS:000343132900009	24549935				2021-06-18	
J	Lui, YW; Xue, YY; Kenul, D; Ge, YL; Grossman, RI; Wang, Y				Lui, Yvonne W.; Xue, Yuanyi; Kenul, Damon; Ge, Yulin; Grossman, Robert I.; Wang, Yao			Classification algorithms using multiple MRI features in mild traumatic brain injury	NEUROLOGY			English	Article							MAGNETIC-FIELD CORRELATION; DIFFUSION TENSOR; UNIFIED DEFINITION; MUTUAL INFORMATION; INTEGRITY; PERFUSION; SEARCH; VOLUME; TBI; DTI	Objective: The purpose of this study was to develop an algorithm incorporating MRI metrics to classify patients with mild traumatic brain injury (mTBI) and controls. Methods: This was an institutional review board-approved, Health Insurance Portability and Accountability Act-compliant prospective study. We recruited patients with mTBI and healthy controls through the emergency department and general population. We acquired data on a 3.0T Siemens Trio magnet including conventional brain imaging, resting-state fMRI, diffusion-weighted imaging, and magnetic field correlation (MFC), and performed multifeature analysis using the following MRI metrics: mean kurtosis (MK) of thalamus, MFC of thalamus and frontal white matter, thalamocortical resting-state networks, and 5 regional gray matter and white matter volumes including the anterior cingulum and left frontal and temporal poles. Feature selection was performed using minimal-redundancy maximal-relevance. We used classifiers including support vector machine, naive Bayesian, Bayesian network, radial basis network, and multilayer perceptron to test maximal accuracy. Results: We studied 24 patients with mTBI and 26 controls. Best single-feature classification uses thalamic MK yielding 74% accuracy. Multifeature analysis yields 80% accuracy using the full feature set, and up to 86% accuracy using minimal-redundancy maximal-relevance feature selection (MK thalamus, right anterior cingulate volume, thalamic thickness, thalamocortical resting-state network, thalamic microscopic MFC, and sex). Conclusion: Multifeature analysis using diffusion-weighted imaging, MFC, fMRI, and volumetrics may aid in the classification of patients with mTBI compared with controls based on optimal feature selection and classification methods. Classification of evidence: This study provides Class III evidence that classification algorithms using multiple MRI features accurately identifies patients with mTBI as defined by American Congress of Rehabilitation Medicine criteria compared with healthy controls.	[Lui, Yvonne W.; Kenul, Damon; Ge, Yulin; Grossman, Robert I.] NYU, Dept Radiol, Sch Med, New York, NY 10016 USA; [Xue, Yuanyi; Wang, Yao] NYU, Polytech Sch Engn, Dept Elect Engn, Brooklyn, NY USA	Lui, YW (corresponding author), NYU, Dept Radiol, Sch Med, 560 1St Ave, New York, NY 10016 USA.	Yvonne.lui@nyumc.org	Ge, Yulin/L-7052-2019; Ge, Yulin/D-9060-2019	Ge, Yulin/0000-0002-2320-6031; Wang, Yao/0000-0003-3199-3802	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [UL1 TR000038, 2 RO1 NS039135-11]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR000038] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS039135, R21NS090349] Funding Source: NIH RePORTER	Supported in part by NIH grants UL1 TR000038 and 2 RO1 NS039135-11.	Anderson CV, 1996, J NEUROTRAUM, V13, P35, DOI 10.1089/neu.1996.13.35; Arciniegas DB, 2001, BRAIN INJURY, V15, P649, DOI 10.1080/02699050010019800; BATTITI R, 1994, IEEE T NEURAL NETWOR, V5, P537, DOI 10.1109/72.298224; Bianchi A, 2013, IEEE T MED IMAGING; Bogner J, 2009, J HEAD TRAUMA REHAB, V24, P279, DOI 10.1097/HTR.0b013e3181a66356; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Faul M, TRAUMATIC BRAIN INJU; Fischl B, 2004, CEREB CORTEX, V14, P11, DOI 10.1093/cercor/bhg087; Ge YL, 2009, BRAIN INJURY, V23, P666, DOI 10.1080/02699050903014899; Grossman EJ, 2013, AM J NEURORADIOL, V34, P951, DOI 10.3174/ajnr.A3358; Grossman EJ, 2014, J NEUROTRAUM, V29, P2318; Hastie T., 2001, ELEMENTS STAT LEARNI, DOI [DOI 10.1007/B94608, 10.1007/978-0-387-84858-7, DOI 10.1007/978-0-387-84858-7]; HECKERMAN D, 1996, TUTORIAL LEARNING BA; Hulkower MB, 2013, AM J NEURORADIOL, V34, P2064, DOI 10.3174/ajnr.A3395; Jensen JH, 2006, MAGN RESON MED, V55, P1350, DOI 10.1002/mrm.20907; Jensen JH, 2009, MAGN RESON MED, V61, P481, DOI 10.1002/mrm.21823; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Luther N, 2012, NEUROSURGERY, V71, pE558, DOI 10.1227/01.neu.0000417733.09300.04; Manning C., 2008, INTRO INFORM RETRIEV; Marr AL., 2004, CENTRAL NERVOUS SYST; Mayer AR, 2010, NEUROLOGY, V74, P643, DOI 10.1212/WNL.0b013e3181d0ccdd; McMahon P, 2014, J NEUROTRAUM, V31, P26, DOI 10.1089/neu.2013.2984; Miles L, 2008, BRAIN INJURY, V22, P115, DOI 10.1080/02699050801888816; Peng HC, 2005, IEEE T PATTERN ANAL, V27, P1226, DOI 10.1109/TPAMI.2005.159; Power JD, 2012, NEUROIMAGE, V59, P2142, DOI 10.1016/j.neuroimage.2011.10.018; Raz E, 2011, AM J NEURORADIOL, V32, P1851, DOI 10.3174/ajnr.A2637; Ruff RM, 1999, BRAIN INJURY, V13, P943; Rumelhart D.E., 1986, PARALLEL DISTRIBUTED, V1; Scholkopf B., 1999, ADV KERNEL METHODS S; Tang L, 2011, RADIOLOGY, V260, P831, DOI 10.1148/radiol.11110014; TEASDALE G, 1974, LANCET, V2, P81; Voller B, 2001, BRAIN INJURY, V15, P107, DOI 10.1080/026990501458344; WOOD DMG, 1995, BRAIN RES BULL, V38, P545, DOI 10.1016/0361-9230(95)02026-0; Yuh EL, 2013, ANN NEUROL, V73, P224, DOI 10.1002/ana.23783; Zhou YX, 2013, RADIOLOGY, V267, P880, DOI 10.1148/radiol.13122542	36	22	22	1	9	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0028-3878	1526-632X		NEUROLOGY	Neurology	SEP 30	2014	83	14					1235	1240		10.1212/WNL.0000000000000834			6	Clinical Neurology	Neurosciences & Neurology	AT3UN	WOS:000344860700008	25171930	Green Published			2021-06-18	
J	Meng, YL; Chopp, M; Zhang, YL; Liu, ZW; An, A; Mahmood, A; Xiong, Y				Meng, Yuling; Chopp, Michael; Zhang, Yanlu; Liu, Zhongwu; An, Aaron; Mahmood, Asim; Xiong, Ye			Subacute Intranasal Administration of Tissue Plasminogen Activator Promotes Neuroplasticity and Improves Functional Recovery following Traumatic Brain Injury in Rats	PLOS ONE			English	Article							CONTROLLED CORTICAL IMPACT; FOCAL CEREBRAL-ISCHEMIA; CENTRAL-NERVOUS-SYSTEM; MARROW STROMAL CELLS; NEUROTROPHIC FACTOR; INFARCT VOLUME; DENTATE GYRUS; UP-REGULATION; SPINAL-CORD; ERYTHROPOIETIN RECEPTOR	Traumatic brain injury (TBI) is a major cause of death and long-term disability worldwide. To date, there are no effective pharmacological treatments for TBI. Recombinant human tissue plasminogen activator (tPA) is the effective drug for the treatment of acute ischemic stroke. In addition to its thrombolytic effect, tPA is also involved in neuroplasticity in the central nervous system. However, tPA has potential adverse side effects when administered intravenously including brain edema and hemorrhage. Here we report that tPA, administered by intranasal delivery during the subacute phase after TBI, provides therapeutic benefit. Animals with TBI were treated intranasally with saline or tPA initiated 7 days after TBI. Compared with saline treatment, subacute intranasal tPA treatment significantly 1) improved cognitive (Morris water maze test) and sensorimotor (footfault and modified neurological severity score) functional recovery in rats after TBI, 2) reduced the cortical stimulation threshold evoking ipsilateral forelimb movement, 3) enhanced neurogenesis in the dentate gyrus and axonal sprouting of the corticospinal tract originating from the contralesional cortex into the denervated side of the cervical gray matter, and 4) increased the level of mature brain-derived neurotrophic factor. Our data suggest that subacute intranasal tPA treatment improves functional recovery and promotes brain neurogenesis and spinal cord axonal sprouting after TBI, which may be mediated, at least in part, by tPA/plasmin-dependent maturation of brain-derived neurotrophic factor.	[Meng, Yuling; Zhang, Yanlu; An, Aaron; Mahmood, Asim; Xiong, Ye] Henry Ford Hosp, Dept Neurosurg, Detroit, MI 48202 USA; [Chopp, Michael; Liu, Zhongwu] Henry Ford Hosp, Dept Neurol, Detroit, MI 48202 USA; [Chopp, Michael] Oakland Univ, Dept Phys, Rochester, MI USA	Xiong, Y (corresponding author), Henry Ford Hosp, Dept Neurosurg, Detroit, MI 48202 USA.	yxiong1@hfhs.org		Xiong, Ye/0000-0001-9770-6031	National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [RO1 NS062002]; National Institute on AgingUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [RO1 AG037506]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS062002] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R01AG037506] Funding Source: NIH RePORTER	The research presented herein was supported by National Institute of Neurological Disorders and Stroke RO1 NS062002 (YX), and National Institute on Aging RO1 AG037506 (MC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adibhatla RM, 2008, CNS NEUROL DISORD-DR, V7, P243, DOI 10.2174/187152708784936608; Ahn MY, 1999, BRAIN RES, V837, P169, DOI 10.1016/S0006-8993(99)01645-5; Armstead WM, 2013, J NEUROTRAUM, V30, P1898, DOI 10.1089/neu.2013.2962; Armstead WM, 2012, J NEUROTRAUM, V29, P1794, DOI 10.1089/neu.2012.2328; Armstead WM, 2011, NEUROL RES, V33, P726, DOI 10.1179/016164110X12807570509853; Barha CK, 2011, EXP NEUROL, V231, P72, DOI 10.1016/j.expneurol.2011.05.016; Barnes P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003248; Baskin YK, 2003, J NEUROSCI METH, V129, P87, DOI 10.1016/S0165-0270(03)00212-7; Bukhari N, 2011, J NEUROSCI, V31, P14931, DOI 10.1523/JNEUROSCI.3339-11.2011; Chen JL, 2005, J CEREBR BLOOD F MET, V25, P281, DOI 10.1038/sj.jcbfm.9600034; Chen JL, 2001, STROKE, V32, P2682, DOI 10.1161/hs1101.098367; Cho E, 2012, NEUROBIOL DIS, V46, P215, DOI 10.1016/j.nbd.2012.01.010; Choi SH, 2006, J NEUROSCI METH, V156, P182, DOI 10.1016/j.jneumeth.2006.03.002; Cutler SM, 2007, J NEUROTRAUM, V24, P1475, DOI 10.1089/neu.2007.0294; Dhuria SV, 2010, J PHARM SCI-US, V99, P1654, DOI 10.1002/jps.21924; Ding Q, 2011, NEUROSCIENCE, V192, P773, DOI 10.1016/j.neuroscience.2011.06.032; DIXON CE, 1991, J NEUROSCI METH, V39, P253; FESTOFF BW, 1994, J CELL PHYSIOL, V159, P11, DOI 10.1002/jcp.1041590103; Figurov A, 1996, NATURE, V381, P706, DOI 10.1038/381706a0; Fox GB, 1998, J NEUROTRAUM, V15, P599, DOI 10.1089/neu.1998.15.599; FRIBERGER P, 1978, HAEMOSTASIS, V7, P138; Gao X, 2009, J NEUROTRAUM, V26, P1325, DOI 10.1089/neu.2008-0744; Garcia AN, 2011, PM&R, V3, pS18, DOI 10.1016/j.pmrj.2011.03.017; Gean AD, 2010, NEUROIMAG CLIN N AM, V20, P527, DOI 10.1016/j.nic.2010.08.001; Glover LE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033646; Goto H, 2007, J NEUROTRAUM, V24, P745, DOI 10.1089/neu.2006.0183; Greenberg ME, 2009, J NEUROSCI, V29, P12764, DOI 10.1523/JNEUROSCI.3566-09.2009; Griesbach GS, 2004, NEUROSCIENCE, V125, P129, DOI 10.1016/j.neuroscience.2004.01.030; Hall ED, 2005, J NEUROTRAUM, V22, P252, DOI 10.1089/neu.2005.22.252; Han XD, 2011, J NEUROTRAUM, V28, P995, DOI 10.1089/neu.2010.1563; Je HS, 2012, P NATL ACAD SCI USA, V109, P15924, DOI 10.1073/pnas.1207767109; Kaplan GB, 2010, BEHAV PHARMACOL, V21, P427, DOI 10.1097/FBP.0b013e32833d8bc9; KARTJETILLOTSON G, 1985, BRAIN RES, V332, P103, DOI 10.1016/0006-8993(85)90393-2; Khan M, 2009, J NEUROINFLAMM, V6, DOI 10.1186/1742-2094-6-32; KORTE M, 1995, P NATL ACAD SCI USA, V92, P8856, DOI 10.1073/pnas.92.19.8856; Koshimizu H, 2009, MOL BRAIN, V2, DOI 10.1186/1756-6606-2-27; Levin HS, 2003, BRAIN INJURY, V17, P665, DOI 10.1080/0269905031000107151; LIN TN, 1993, STROKE, V24, P117, DOI 10.1161/01.STR.24.1.117; Liu ZW, 2008, STROKE, V39, P2571, DOI 10.1161/STROKEAHA.107.511659; Liu ZW, 2007, BRAIN RES, V1149, P172, DOI 10.1016/j.brainres.2007.02.047; Liu ZW, 2012, NEUROBIOL DIS, V45, P804, DOI 10.1016/j.nbd.2011.11.004; Loane DJ, 2010, TRENDS PHARMACOL SCI, V31, P596, DOI 10.1016/j.tips.2010.09.005; Lu B, 2005, NAT REV NEUROSCI, V6, P603, DOI 10.1038/nrn1726; Lu DY, 2007, NEUROSURGERY, V61, P596, DOI 10.1227/01.NEU.0000290908.38438.B2; Lu DY, 2003, J NEUROSURG, V99, P351, DOI 10.3171/jns.2003.99.2.0351; Mahmood A, 2007, NEUROSURGERY, V60, P546, DOI 10.1227/01.NEU.0000255346.25959.99; Mahmood A, 2011, J NEUROTRAUM, V28, P1199, DOI 10.1089/neu.2010.1694; Marklund N, 2009, NEUROSCIENCE, V163, P540, DOI 10.1016/j.neuroscience.2009.06.042; Mast TG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031978; Meng YL, 2011, J NEUROSURG, V115, P550, DOI 10.3171/2011.3.JNS101721; Minor K, 2009, J NEUROCHEM, V109, P706, DOI 10.1111/j.1471-4159.2009.05977.x; MISKIN R, 1981, ANAL BIOCHEM, V118, P252, DOI 10.1016/0003-2697(81)90187-1; Mori T, 2001, NEUROREPORT, V12, P4117, DOI 10.1097/00001756-200112210-00051; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; Nagai T, 2004, P NATL ACAD SCI USA, V101, P10554, DOI 10.1073/pnas.0400417101; Narayan RK, 2002, J NEUROTRAUM, V19, P503, DOI 10.1089/089771502753754037; NEAFSEY EJ, 1986, BRAIN RES REV, V11, P77, DOI 10.1016/0165-0173(86)90011-1; Ning RZ, 2011, BRAIN RES, V1384, P140, DOI 10.1016/j.brainres.2011.01.099; Obiang P, 2011, NEUROBIOL LEARN MEM, V96, P121, DOI 10.1016/j.nlm.2011.03.004; Pang PT, 2004, SCIENCE, V306, P487, DOI 10.1126/science.1100135; Qu CS, 2010, J NEUROTRAUM, V27, P1625, DOI 10.1089/neu.2010.1359; Richardson RM, 2007, NEUROSURG CLIN N AM, V18, P169, DOI 10.1016/j.nec.2006.10.007; Rodier M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092416; Samson AL, 2006, NEURON, V50, P673, DOI 10.1016/j.neuron.2006.04.013; Sashindranath M, 2012, BRAIN, V135, P3251, DOI 10.1093/brain/aws178; Shen LH, 2011, STROKE, V42, P459, DOI 10.1161/STROKEAHA.110.593863; Singleton RH, 2010, J NEUROTRAUM, V27, P1091, DOI 10.1089/neu.2010.1291; Stein SC, 2009, J NEUROTRAUM, V26, P1585, DOI [10.1089/neu.2008.0720, 10.1089/neu.2008-0720]; Sun D, 2005, J NEUROTRAUM, V22, P95, DOI 10.1089/neu.2005.22.95; Sun Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035883; SWANSON LW, 1980, NEUROENDOCRINOLOGY, V31, P410, DOI 10.1159/000123111; SWANSON RA, 1990, J CEREBR BLOOD F MET, V10, P290, DOI 10.1038/jcbfm.1990.47; Tamas A, 2006, J NEUROTRAUM, V23, P686, DOI 10.1089/neu.2006.23.686; Thau-Zuchman O, 2010, J CEREBR BLOOD F MET, V30, P1008, DOI 10.1038/jcbfm.2009.271; Thorne RG, 2004, NEUROSCIENCE, V127, P481, DOI 10.1016/j.neuroscience.2004.05.029; Toni N, 2007, NAT NEUROSCI, V10, P727, DOI 10.1038/nn1908; Vivar C, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00015; Vivien D, 2000, J CEREBR BLOOD F MET, V20, P755, DOI 10.1097/00004647-200005000-00001; Wang Y, 2007, BRIT J PHARMACOL, V151, P1377, DOI 10.1038/sj.bjp.0707285; Wu HT, 2008, J NEUROTRAUM, V25, P130, DOI 10.1089/neu.2007.0369; Wu YP, 2000, J CELL BIOL, V148, P1295, DOI 10.1083/jcb.148.6.1295; Xin HQ, 2011, J CEREBR BLOOD F MET, V31, P2181, DOI 10.1038/jcbfm.2011.116; Xin HQ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009027; Xiong Y, 2008, BRAIN RES, V1230, P247, DOI 10.1016/j.brainres.2008.06.127; Xiong Y, 2008, J NEUROSURG, V109, P510, DOI 10.3171/JNS/2008/109/9/0510; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Xiong Y, 2012, J NEUROSURG, V116, P1081, DOI 10.3171/2012.1.JNS111729; Xiong Y, 2011, J NEUROSURG, V114, P102, DOI 10.3171/2010.4.JNS10118; Xiong Y, 2010, J NEUROSURG, V113, P598, DOI 10.3171/2009.9.JNS09844; Xiong Y, 2010, J NEUROTRAUM, V27, P205, DOI 10.1089/neu.2009.1001; Yang JM, 2014, CELL REP, V7, P796, DOI 10.1016/j.celrep.2014.03.040; Yepes M, 2004, EXP BIOL MED, V229, P1097; Yi JH, 2012, J COMP NEUROL, V520, P3295, DOI 10.1002/cne.23156; Zhang C, 1998, J NEUROSCI RES, V52, P342, DOI 10.1002/(SICI)1097-4547(19980501)52:3<342::AID-JNR10>3.0.CO;2-8; Zhang RL, 2002, STROKE, V33, P2675, DOI 10.1161/01.STR.0000034399.95249.59; Zhang RL, 1998, J NEUROL SCI, V160, P1, DOI 10.1016/S0022-510X(98)00155-5; Zhang YL, 2010, BRAIN RES, V1353, P249, DOI 10.1016/j.brainres.2010.07.046; Zhang YL, 2009, BRAIN RES, V1294, P153, DOI 10.1016/j.brainres.2009.07.077; Zhang Y, 2006, BRAIN RES, V1111, P227, DOI 10.1016/j.brainres.2006.07.005; Zhao CM, 2008, CELL, V132, P645, DOI 10.1016/j.cell.2008.01.033; Zhao CM, 2006, J NEUROSCI, V26, P3, DOI 10.1523/JNEUROSCI.3648-05.2006; Zheng WM, 2013, J NEUROTRAUM, V30, P1872, DOI 10.1089/neu.2010.1579	102	22	24	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2014	9	9							e106238	10.1371/journal.pone.0106238			14	Multidisciplinary Sciences	Science & Technology - Other Topics	AO3TB	WOS:000341257700043	25184365	DOAJ Gold, Green Published			2021-06-18	
J	Hendricks, S; Karpul, D; Lambert, M				Hendricks, Sharief; Karpul, David; Lambert, Mike			Momentum and Kinetic Energy before the Tackle in Rugby Union	JOURNAL OF SPORTS SCIENCE AND MEDICINE			English	Article						Tackle; rugby union; contact sports; momentum; kinetic energy	PROFESSIONAL FOOTBALL; MATCH PLAY; INJURY; RECONSTRUCTION; IMPACTS; MOTION; ACCELERATION; EPIDEMIOLOGY; CONCUSSION; STRATEGIES	Understanding the physical demands of a tackle in match situations is important for safe and effective training, developing equipment and research. Physical components such as momentum and kinetic energy, and it relationship to tackle outcome is not known. The aim of this study was to compare momenta between ball-carrier and tackler, level of play (elite, university and junior) and position (forwards vs. backs), and describe the relationship between ball-carrier and tackler mass, velocity and momentum and the tackle outcome. Also, report on the ball-carrier and tackler kinetic energy before contact and the estimated magnitude of impact (energy distributed between ballcarrier and tackler upon contact). Velocity over 0.5 seconds before contact was determined using a 2-dimensional scaled version of the field generated from a computer alogorithm. Body masses of players were obtained from their player profiles. Momentum and kinetic energy were subsequently calculated for 60 tackle events. Ball-carriers were heavier than the tacklers (ball-carrier 100 +/- 14 kg vs. tackler 93 +/- 11 kg, d = 0.52, p = 0.0041, n = 60). Ball-carriers as forwards had a significantly higher momentum than backs (forwards 563 +/- 226 Kg center dot m center dot s(-1) n = 31 vs. backs 438 +/- 135 Kg center dot m center dot s(-1), d = 0.63, p = 0.0012, n = 29). Tacklers dominated 57% of tackles and ball-carriers dominated 43% of tackles. Despite the ball-carrier having a mass advantage before contact more frequently than the tackler, momentum advantage and tackle dominance between the ball-carrier and tackler was proportionally similar. These findings may reflect a characteristic of the modern game of rugby where efficiently heavier players (particularly forwards) are tactically predetermined to carry the ball in contact.	[Hendricks, Sharief] Univ Cape Town, MRC UCT Res Unit Exercise Sci & Sports Med, Dept Human Biol, Fac Hlth Sci, ZA-7925 Cape Town, South Africa; Sports Sci Inst South Africa, Cape Town, South Africa	Hendricks, S (corresponding author), Univ Cape Town, MRC UCT Res Unit Exercise Sci & Sports Med, Dept Human Biol, Fac Hlth Sci, ZA-7925 Cape Town, South Africa.	sharief.hendricks01@gmail.com; mike.lambert@uct.ac.za	Hendricks, Sharief/U-3278-2019	Hendricks, Sharief/0000-0002-3416-6266; Lambert, Michael/0000-0001-8979-1504; Karpul, David/0000-0002-5197-4038	National Research Foundation/German Academic Exchange ServiceDeutscher Akademischer Austausch Dienst (DAAD); Medical Research Council of South AfricaUK Research & Innovation (UKRI)Medical Research Council UK (MRC); Frank Foreman Scholarship; Glickman/Elliot Scholarship; University of Cape Town Equity Scholarship; Doctoral Research Scholarship; Exercise Science and Sports Medicine Scholarship	The authors of this paper would like to thank the National Research Foundation/German Academic Exchange Service, Medical Research Council of South Africa, Frank Foreman Scholarship, Glickman/Elliot Scholarship, University of Cape Town Equity Scholarship, Doctoral Research Scholarship, and the Exercise Science and Sports Medicine Scholarship for support during the study.	Alcock A, 2009, SPORT BIOMECH, V8, P129, DOI 10.1080/14763140902829342; Austin D, 2011, J SCI MED SPORT, V14, P259, DOI 10.1016/j.jsams.2011.01.003; Batterham AM, 2006, INTJ SPORT PHYSIOL, V1, P50, DOI 10.1123/ijspp.1.1.50; BLAZEVICH A., 2007, SPORTS BIOMECHANICS; Brewin MA, 2003, J APPL BIOMECH, V19, P79, DOI 10.1123/jab.19.1.79; Brooks JHM, 2005, BRIT J SPORT MED, V39, P757, DOI 10.1136/bjsm.2005.018135; Burkett B., 2010, SPORT MECH COACHES; Duma SM, 2005, CLIN J SPORT MED, V15, P3, DOI 10.1097/00042752-200501000-00002; Duthie G, 2003, SPORTS MED, V33, P973, DOI 10.2165/00007256-200333130-00003; Eaton C, 2006, PHYS THER SPORT, V7, P30, DOI 10.1016/j.ptsp.2005.07.001; Edgecomb SJ, 2006, J SCI MED SPORT, V9, P25, DOI 10.1016/j.jsams.2006.01.003; Frechede B, 2009, MED SCI SPORT EXER, V41, P390, DOI 10.1249/MSS.0b013e318186b1c5; Fuller CW, 2010, BRIT J SPORT MED, V44, P159, DOI 10.1136/bjsm.2008.050864; Gabbett T, 2009, INT J SPORTS SCI COA, V4, P521, DOI 10.1260/174795409790291402; Garraway WM, 1999, BRIT J SPORT MED, V33, P37, DOI 10.1136/bjsm.33.1.37; Headey J, 2007, AM J SPORT MED, V35, P1537, DOI 10.1177/0363546507300691; Hendricks S, 2012, J SPORT SCI, V30, P1215, DOI 10.1080/02640414.2012.707328; Hendricks S, 2012, SAFETY SCI, V50, P266, DOI 10.1016/j.ssci.2011.08.061; Hendricks S, 2010, INT J SPORTS SCI COA, V5, P117, DOI 10.1260/1747-9541.5.1.117; Kwon YH, 2006, SPORT BIOMECH, V5, P95, DOI 10.1080/14763141.2006.9628227; Mcintosh AS, 2010, MED SCI SPORT EXER, V42, P977, DOI 10.1249/MSS.0b013e3181c07b5b; McIntosh AS, 2000, MED SCI SPORT EXER, V32, P1980, DOI 10.1097/00005768-200012000-00002; McLellan CP, 2012, J STRENGTH COND RES, V26, P1431, DOI 10.1519/JSC.0b013e318231a627; Newman JA, 2005, J BIOMECH, V38, P1469, DOI 10.1016/j.jbiomech.2004.06.025; Olds T, 2001, J SPORT SCI, V19, P253, DOI 10.1080/026404101750158312; Pellman EJ, 2003, NEUROSURGERY, V53, P1328, DOI 10.1227/01.NEU.0000093499.20604.21; Pellman EJ, 2003, NEUROSURGERY, V53, P799, DOI 10.1093/neurosurgery/53.3.799; Quarrie KL, 2008, AM J SPORT MED, V36, P1705, DOI 10.1177/0363546508316768; Sedeaud A, 2012, BRIT J SPORT MED, V46, P580, DOI 10.1136/bjsports-2011-090506; Sundaram A, 2011, J SCI MED SPORT, V14, P111, DOI 10.1016/j.jsams.2010.08.005; Takarada Y, 2003, BRIT J SPORT MED, V37, P416, DOI 10.1136/bjsm.37.5.416; Usman J, 2011, J SCI MED SPORT, V14, P547, DOI 10.1016/j.jsams.2011.05.006; Varley MC, 2012, J SPORT SCI, V30, P121, DOI 10.1080/02640414.2011.627941; Wheeler K, 2009, INT J SPORTS SCI COA, V4, P535, DOI 10.1260/174795409790291420; Wheeler KW, 2010, EUR J SPORT SCI, V10, P237, DOI 10.1080/17461391.2010.482595	35	22	22	0	19	JOURNAL SPORTS SCIENCE & MEDICINE	BURSA	MEDICAL FACULTY ULUDAG UNIV, DEPT SPORTS MEDICINE, BURSA, 16059, TURKEY	1303-2968			J SPORT SCI MED	J. Sport. Sci. Med.	SEP	2014	13	3					557	563					7	Sport Sciences	Sport Sciences	AN7BL	WOS:000340753400014	25177182	DOAJ Gold			2021-06-18	
J	Karamanos, E; Teixeira, PG; Sivrikoz, E; Varga, S; Chouliaras, K; Okoye, O; Hammer, P				Karamanos, Efstathios; Teixeira, Pedro G.; Sivrikoz, Emre; Varga, Stephen; Chouliaras, Konstantinos; Okoye, Obi; Hammer, Peter			Intracranial pressure versus cerebral perfusion pressure as a marker of outcomes in severe head injury: a prospective evaluation	AMERICAN JOURNAL OF SURGERY			English	Article						Intracranial pressure monitoring; Cerebral perfusion pressure; Severe traumatic brain injury; Outcomes; Mortality	TRAUMATIC BRAIN-INJURY; HYPERTENSION; AUTOREGULATION; MANAGEMENT; VARIABLES	BACKGROUND: Intracranial pressure (ICP) monitoring is a standard of care in severe traumatic brain injury when clinical features are unreliable. It remains unclear, however, whether elevated ICP or decreased cerebral perfusion pressure (CPP) predicts outcome. METHODS: This is a prospective observational study of patients sustaining severe blunt head injury, admitted to the surgical intensive care unit at the Los Angeles County and University of Southern California Medical Center between January 2010 and December 2011. The study population was stratified according to the findings of ICP and CPP. Primary outcomes were overall in-hospital mortality and mortality because of cerebral herniation. Secondary outcomes were development of complications during the hospitalization. RESULTS: A total of 216 patients met Brain Trauma Foundation guidelines for ICP monitoring. Of those, 46.8% (n = 101) were subjected to the intervention. Sustained elevated ICP significantly increased all in-hospital mortality (adjusted odds ratio [95% confidence interval]: 3.15 [1.11, 8.91], P = .031) and death because of cerebral herniation (adjusted odds ratio [95% confidence interval]: 9.25 [1.19, 10.48], P = .035). Decreased CPP had no impact on mortality. CONCLUSIONS: A single episode of sustained increased ICP is an accurate predictor of poor outcomes. Decreased CPP did not affect survival. (C) 2014 Elsevier Inc. All rights reserved.	[Karamanos, Efstathios; Teixeira, Pedro G.; Sivrikoz, Emre; Varga, Stephen; Chouliaras, Konstantinos; Okoye, Obi; Hammer, Peter] Univ So Calif, Keck Sch Med, Los Angeles Cty Gen Hosp LAC USC, Div Acute Care Surg Trauma Emergency Surg & Surg, Los Angeles, CA 90033 USA	Karamanos, E (corresponding author), Univ So Calif, Keck Sch Med, Los Angeles Cty Gen Hosp LAC USC, Div Acute Care Surg Trauma Emergency Surg & Surg, 2051 Marengo St,C5L100, Los Angeles, CA 90033 USA.	ef.karamanos@gmail.com	Karamanos, Efstathios/AAU-8082-2020; Teixeira, Pedro/H-2239-2011; Sivrikoz, Emre/F-1844-2016	Karamanos, Efstathios/0000-0002-5118-4642; Teixeira, Pedro/0000-0002-7258-7977; 			Andrews PJD, 2002, J NEUROSURG, V97, P326, DOI 10.3171/jns.2002.97.2.0326; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS55; CHAN KH, 1992, J NEUROSURG ANESTH, V4, P188, DOI 10.1097/00008506-199207000-00007; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Clifton GL, 2002, CRIT CARE MED, V30, P739, DOI 10.1097/00003246-200204000-00003; Contant CF, 2001, J NEUROSURG, V95, P560, DOI 10.3171/jns.2001.95.4.0560; Ghajar J, 2000, LANCET, V356, P923, DOI 10.1016/S0140-6736(00)02689-1; Howells T, 2005, J NEUROSURG, V102, P311, DOI 10.3171/jns.2005.102.2.0311; JONES PA, 1994, J NEUROSURG ANESTH, V6, P4; Juul N, 2000, J NEUROSURG, V92, P1, DOI 10.3171/jns.2000.92.1.0001; MARMAROU A, 1991, J NEUROSURG, V75, pS59, DOI 10.3171/sup.1991.75.1s.0s59; MARSHALL LF, 1983, J NEUROSURG, V58, P566, DOI 10.3171/jns.1983.58.4.0566; ROSNER MJ, 1990, J TRAUMA, V30, P933, DOI 10.1097/00005373-199008000-00001; Sahuquillo J, 2000, ACTA NEUROCHIR SUPPL, V76, P485; Sahuquillo J, 2000, ACT NEUR S, V76, P457; SAUL TG, 1982, AM SURGEON, V48, P477; Schreiber MA, 2002, ARCH SURG-CHICAGO, V137, P285, DOI 10.1001/archsurg.137.3.285; Struchen MA, 2001, J NEUROTRAUM, V18, P115, DOI 10.1089/08977150150502569	18	22	22	0	7	EXCERPTA MEDICA INC-ELSEVIER SCIENCE INC	BRIDGEWATER	685 ROUTE 202-206 STE 3, BRIDGEWATER, NJ 08807 USA	0002-9610	1879-1883		AM J SURG	Am. J. Surg.	SEP	2014	208	3					363	371		10.1016/j.amjsurg.2013.10.026			9	Surgery	Surgery	AO2KG	WOS:000341149900006	24524863				2021-06-18	
J	Kumar, NS; Chin, M; O'Neill, C; Jakoi, AM; Tabb, L; Wolf, M				Kumar, Neil S.; Chin, Matthew; O'Neill, Craig; Jakoi, Andre M.; Tabb, Loni; Wolf, Michael			On-Field Performance of National Football League Players After Return From Concussion	AMERICAN JOURNAL OF SPORTS MEDICINE			English	Article						concussion; football; National Football League; return to play	SPORT-RELATED CONCUSSION; PROFESSIONAL FOOTBALL; BASKETBALL ASSOCIATION; INJURIES; OUTCOMES; MICROFRACTURE; STATEMENT; RECOVERY; NFL	Background: There are few data examining the short-term effects of concussions on player performance upon return to play. This study examined changes in on-field performance and the influence of epidemiologic factors on performance and return to play. Hypothesis: On-field performance is different in players who return within 7 days after concussion compared with players who miss at least 1 game. Study Design: Case-control study; Level of evidence, 3. Methods: Players in the National Football League who were active during the 2008 to 2012 seasons were considered for inclusion. Weekly injury reports identified concussed players. All players played in at least 4 games before and after the game of injury (sentinel game) within the year of injury (sentinel year). Players who had missed games secondary to another injury or had sustained a second concussion within the sentinel year were excluded. The players' league profiles were used to determine age, position, body mass index, career experience, and games missed. ProFootballFocus performance scores determined player ratings. Statistical analysis used 2-sided t tests and both univariate and multivariate logistic regression models. Results: There were a total of 131 concussions in the 124 players who qualified for this study; 55% of these players missed no games. Defensive secondary, wide receiver, and offensive line were the most commonly affected positions. Players who missed at least 1 game were younger and less experienced. Preinjury ProFootballFocus performance scores were similar to postinjury performance in players without games missed (0.16 vs 0.33; P = .129) and players who missed at least 1 game (-0.06 vs 0.10; P = .219). Age, body mass index, experience, and previous concussion did not correlate with changes in postinjury scores (P > .05). Older, more experienced players and players with late-season concussions were more likely to return to play without missing games (P < .05). The odds of returning within 7 days increased by 18% for each career year and by 40% for each game before the sentinel game within the sentinel year; these same odds decreased by 85% after introduction of newer treatment guidelines in 2009. Conclusion: No difference in player performance after concussion was found whether the player did or did not miss games before return. Return without missing games may be associated with experience and timing of injury within a season and less likely after newer guidelines.	[Kumar, Neil S.; Chin, Matthew; O'Neill, Craig; Jakoi, Andre M.; Tabb, Loni; Wolf, Michael] Drexel Univ, Coll Med, Philadelphia, PA 19102 USA	Kumar, NS (corresponding author), Drexel Univ, Coll Med, Dept Orthopaed Surg, 245 N 15th St, Philadelphia, PA 19102 USA.	neilskumar1@gmail.com	Jakoi, Andre/K-8338-2019	Kumar, Neil/0000-0003-0634-2442			Amin NH, 2013, AM J SPORT MED, V41, P1864, DOI 10.1177/0363546513490659; Asplund CA, 2004, CLIN J SPORT MED, V14, P339, DOI 10.1097/00042752-200411000-00003; Benson BW, 2013, BRIT J SPORT MED, V47, P321, DOI 10.1136/bjsports-2013-092216; Casson IR, 2011, SPORTS HEALTH, V3, P130, DOI 10.1177/1941738110397876; Casson IR, 2011, SPORTS HEALTH, V3, P11, DOI 10.1177/1941738110391413; Casson IR, 2010, SPORTS HEALTH, V2, P471, DOI 10.1177/1941738110383963; Cerynik DL, 2009, KNEE SURG SPORT TR A, V17, P1135, DOI 10.1007/s00167-009-0765-5; Collie A, 2003, CLIN J SPORT MED, V13, P28, DOI 10.1097/00042752-200301000-00006; Duhaime AC, 2012, J NEUROSURG, V117, P1092, DOI 10.3171/2012.8.JNS112298; Erickson BJ, 2014, AM J SPORT MED, V42, P536, DOI 10.1177/0363546513510890; Hamberger A, 2009, NEUROSURGERY, V64, P1174, DOI 10.1227/01.NEU.0000316855.40986.2A; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Harris JD, 2013, SPORTS HEALTH, V5, P562, DOI 10.1177/1941738113495788; Hazrati LN, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00222; Hinton-Bayre AD, 2002, NEUROLOGY, V59, P1068, DOI 10.1212/WNL.59.7.1068; Klossner D, 2013, 2013 14 NCAA SPORTS; Kontos AP, 2013, AM J SPORT MED, V41, P1497, DOI 10.1177/0363546513488751; Lazarus Arthur, 2011, Physician Exec, V37, P6; Makdissi M, 2009, AM J SPORT MED, V37, P877, DOI 10.1177/0363546508328118; McCrory P, 2001, CLIN J SPORT MED, V11, P144, DOI 10.1097/00042752-200107000-00004; McCrory P, 2013, J AM COLL SURGEONS, V216, pE55, DOI 10.1016/j.jamcollsurg.2013.02.020; Mulligan I, 2012, J ORTHOP SPORT PHYS, V42, P625, DOI 10.2519/jospt.2012.3798; Namdari S, 2011, PHYSICIAN SPORTSMED, V39, P36, DOI 10.3810/psm.2011.02.1860; Namdari S, 2009, AM J SPORT MED, V37, P943, DOI 10.1177/0363546508330150; National Football League Head Neck and Spine Committee, 2014, NFL HEAD NECK SPIN C; Pellman E, 2004, NEUROSURGERY, V55, P860, DOI 10.1227/01.NEU.0000137657.00146.7D; Pellman EJ, 2006, NEUROSURGERY, V58, P263, DOI 10.1227/01.NEU.0000200272.56192.62; Pellman EJ, 2004, NEUROSURGERY, V55, P1290, DOI 10.1227/01.NEU.0000149244.97560.91; Pellman EJ, 2004, NEUROSURGERY, V55, P1100, DOI 10.1227/01.NEU.0000147063.12873.F5; Pellman EJ, 2004, NEUROSURGERY, V54, P81, DOI 10.1227/01.NEU.0000097267.54786.54; Pellman EJ, 2003, NEUROSURGERY, V53, P1328, DOI 10.1227/01.NEU.0000093499.20604.21; Post A, 2013, COMPUT METHODS BIOME; Viano DC, 2005, NEUROSURGERY, V57, P891, DOI 10.1227/01.NEU.0000186950.54075.3B; Viano DC, 2005, NEUROSURGERY, V56, P266, DOI 10.1227/01.neu.0000150035.54230.3C	34	22	22	0	31	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0363-5465	1552-3365		AM J SPORT MED	Am. J. Sports Med.	SEP	2014	42	9					2050	2055		10.1177/0363546514539449			6	Orthopedics; Sport Sciences	Orthopedics; Sport Sciences	AP9GQ	WOS:000342387400002	25008256				2021-06-18	
J	Bragge, P; Pattuwage, L; Marshall, S; Pitt, V; Piccenna, L; Stergiou-Kita, M; Tate, RL; Teasell, R; Wiseman-Hakes, C; Kua, A; Ponsford, J; Velikonja, D; Bayley, M				Bragge, Peter; Pattuwage, Loyal; Marshall, Shawn; Pitt, Veronica; Piccenna, Loretta; Stergiou-Kita, Mary; Tate, Robyn L.; Teasell, Robert; Wiseman-Hakes, Catherine; Kua, Ailene; Ponsford, Jennie; Velikonja, Diana; Bayley, Mark			Quality of Guidelines for Cognitive Rehabilitation Following Traumatic Brain Injury	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						clinical practice guidelines; cognitive rehabilitation; traumatic brain injury	CLINICAL-PRACTICE GUIDELINES; INCOG RECOMMENDATIONS; AGREE II; MANAGEMENT; MEDICINE; MODERATE	Introduction: Cognitive rehabilitation following traumatic brain injury can aid in optimizing function, independence, and quality of life by addressing impairments in attention, executive function, cognitive communication, and memory. This study aimed to identify and evaluate the methodological quality of clinical practice guidelines for cognitive rehabilitation following traumatic brain injury. Methods: Systematic searching of databases and Web sites was undertaken between January and March 2012 to identify freely available, English language clinical practice guidelines from 2002 onward. Eligible guidelines were evaluated using the validated Appraisal of Guidelines for Research and Evaluation II instrument. Results: The 11 guidelines that met inclusion criteria were independently rated by 4 raters. Results of quality appraisal indicated that guidelines generally employed systematic search and appraisal methods and produced unambiguous, clearly identifiable recommendations. Conversely, only 1 guideline incorporated implementation and audit information, and there was poor reporting of processes for formulating, reviewing, and ensuring currency of recommendations and incorporating patient preferences. Intraclass correlation coefficients for agreement between raters showed high agreement (intraclass correlation coefficient > 0.80) for all guidelines except for 1 (moderate agreement; intraclass correlation coefficient = 0.76). Conclusion: Future guidelines should address identified limitations by providing implementation information and audit criteria, along with better reporting of guideline development processes and stakeholder engagement.	[Bragge, Peter; Pattuwage, Loyal; Pitt, Veronica; Piccenna, Loretta] Monash Univ, Natl Trauma Res Inst, Melbourne, Vic 3004, Australia; [Bragge, Peter; Pattuwage, Loyal; Pitt, Veronica; Piccenna, Loretta] Alfred Hosp, Melbourne, Vic, Australia; [Marshall, Shawn] Univ Ottawa, Ottawa Hosp Rehabil Ctr, Ottawa, ON, Canada; [Stergiou-Kita, Mary] Univ Toronto, Toronto, ON, Canada; [Stergiou-Kita, Mary] Toronto Rehabil Inst, Toronto, ON, Canada; [Bayley, Mark] Univ Toronto, Dept Med, UHN Toronto Rehabil Inst, Toronto, ON, Canada; [Bayley, Mark] Univ Toronto, Dept Med, Div Physiatry, Toronto, ON, Canada; [Tate, Robyn L.] Univ Sydney, Sydney Med Sch Northern, Rehabil Studies Unit, Sydney, NSW 2006, Australia; [Teasell, Robert] St Josephs Hlth Ctr, Lawson Res Inst, London, ON, Canada; [Teasell, Robert] Univ Western Ontario, London, ON, Canada; [Wiseman-Hakes, Catherine] Holland Bloorview Kids Rehabil Hosp, Bloorview Res Inst, Toronto, ON, Canada; [Kua, Ailene] Toronto Rehabil Inst, Toronto, ON, Canada; [Ponsford, Jennie] Epworth Med Fdn, Monash Epworth Rehabil Res Ctr, Richmond, Vic, Australia; [Ponsford, Jennie] Monash Univ, Sch Psychol Sci, Clayton, Vic 3800, Australia; [Velikonja, Diana] McMaster Univ, DeGroote Sch Med, Hamilton Hlth Sci, Acquired Brain Injury Program, Hamilton, ON, Canada	Bragge, P (corresponding author), Monash Univ, Natl Trauma Res Inst, Level 4,89 Commercial Rd, Melbourne, Vic 3004, Australia.	peter.bragge@monash.edu	Wiseman-Hakes, Catherine/AAC-8303-2021; piccenna, Loretta/I-2533-2014	Wiseman-Hakes, Catherine/0000-0001-8441-884X; piccenna, Loretta/0000-0003-3895-8145; Bragge, Peter/0000-0003-0745-5131; Bayley, Mark/0000-0001-7860-9463	Monash UniversityMonash University; Ontario Neurotrauma Foundation	This project was funded through Monash University's Strategic Grants Scheme (Lead CI: Peter Bragge) and the Ontario Neurotrauma Foundation (Lead CI: Mark Bayley).	Abelson-Mitchell N, 2008, J CLIN NURS, V17, P46, DOI 10.1111/j.1365-2702.2007.01941.x; ABIEBR Project, 2007, ABIKUS GUID; Access Economics, 2009, EC COST SPIN CORD IN, P115; AGREE Next Steps Consortium, APPR GUID RES EV 2 A; Bayley MT, 2014, J HEAD TRAUMA REHAB, V29, P290, DOI 10.1097/HTR.0000000000000070; Berrigan L, 2011, BRAIN INJURY, V25, P742, DOI 10.3109/02699052.2011.580317; Brouwers MC, 2010, CAN MED ASSOC J, V182, pE839, DOI 10.1503/cmaj.090449; Brouwers MC, 2010, CAN MED ASSOC J, V182, pE472, DOI 10.1503/cmaj.091716; Brouwers MC, 2010, CAN MED ASSOC J, V182, P1045, DOI 10.1503/cmaj.091714; Cappa SF, 2005, EUR J NEUROL, V12, P665; Cicerone KD, 2011, ARCH PHYS MED REHAB, V92, P519, DOI 10.1016/j.apmr.2010.11.015; Alarcon JD, 2013, J TRAUMA ACUTE CARE, V75, P311, DOI 10.1097/TA.0b013e3182924bf8; Ehlhardt LA, 2008, NEUROPSYCHOL REHABIL, V18, P300, DOI 10.1080/09602010701733190; Faul M, 2007, J TRAUMA, V63, P1271, DOI 10.1097/TA.0b013e3181493080; Field MJ, 1990, CLIN PRACTICE GUIDEL; Glasziou P, 2011, BMJ QUAL SAF, V20, pI13, DOI 10.1136/bmjqs.2010.046524; Hurdowar A, 2007, J EVAL CLIN PRACT, V13, P657, DOI 10.1111/j.1365-2753.2007.00708.x; International Committee of Medical Journal Editors, 2014, AUTH RESP CONFL INT; Kalechstein AD, 2003, J CLIN EXP NEUROPSYC, V25, P1186, DOI 10.1076/jcen.25.8.1186.16723; Katrak Persis, 2004, BMC Med Res Methodol, V4, P22, DOI 10.1186/1471-2288-4-22; Kennedy MRT, 2008, NEUROPSYCHOL REHABIL, V18, P257, DOI 10.1080/09602010701748644; Keris V, 2007, WORLD J SURG, V31, P1352, DOI 10.1007/s00268-007-9002-x; Khan F, 2003, MED J AUSTRALIA, V178, P290, DOI 10.5694/j.1326-5377.2003.tb05199.x; Lawson JH, 2004, SEMIN HEMATOL, V41, P55, DOI 10.1053/j.seminhematol.2003.11.012; Murray CJL, 1996, GLOBAL HLTH STAT; New Zealand Guidelines Group, 2006, TRAUM BRAIN INJ GUID, P244; Ponsford J, 2008, J INT NEUROPSYCH SOC, V14, P233, DOI 10.1017/S1355617708080272; Ponsford J, 2014, J HEAD TRAUMA REHAB, V29, P307, DOI 10.1097/HTR.0000000000000074; Ponsford J, 2014, J HEAD TRAUMA REHAB, V29, P321, DOI 10.1097/HTR.0000000000000072; Rees L, 2007, BRAIN INJURY, V21, P161, DOI 10.1080/02699050701201813; RIMEL RW, 1982, NEUROSURGERY, V11, P344, DOI 10.1227/00006123-198209000-00002; Royal College of Physicians and British Society of Rehabilitation Medicine, 2003, REH FOLL ACQ BRAIN I, P81; Rusnak M, 2008, BRATISL MED J, V109, P374; Sackett DL, 1996, BRIT MED J, V312, P71, DOI 10.1136/bmj.312.7023.71; Satz P, 1998, BRAIN INJURY, V12, P555, DOI 10.1080/026990598122322; Scottish Intercollegiate Guidelines Network, 2013, SIGN PUBL, V130; Sohlberg MM, 2007, J MED SPEECH-LANG PA, V15, pXV; Sohlberg MM, 2003, J MED SPEECH-LANG PA, V11, pXIX; Tate R, 2014, J HEAD TRAUMA REHAB, V29, P338, DOI 10.1097/HTR.0000000000000068; Tavender EJ, 2011, ACAD EMERG MED, V18, P880, DOI 10.1111/j.1553-2712.2011.01134.x; Togher L, 2014, J HEAD TRAUMA REHAB, V29, P353, DOI 10.1097/HTR.0000000000000071; Turkstra L, 2005, J MED SPEECH-LANG PA, V13, pIX; Velikonja D, 2014, J HEAD TRAUMA REHAB, V29, P369, DOI 10.1097/HTR.0000000000000069; Warden DL, 2006, J NEUROTRAUM, V23, P1468, DOI 10.1089/neu.2006.23.1468; Woolf SH, 1999, BRIT MED J, V318, P527, DOI 10.1136/bmj.318.7182.527	45	22	22	0	16	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	JUL-AUG	2014	29	4					277	289		10.1097/HTR.0000000000000066			13	Clinical Neurology; Rehabilitation	Neurosciences & Neurology; Rehabilitation	AM2AK	WOS:000339650300006	24984092				2021-06-18	
J	Ewing-Cobbs, L; Bloom, DR; Prasad, MR; Waugh, JK; Cox, CS; Swank, PR				Ewing-Cobbs, Linda; Bloom, Douglas R.; Prasad, Mary R.; Waugh, Jane K.; Cox, Charles S., Jr.; Swank, Paul R.			Assessing Recovery and Disability After Physical Trauma: The Pediatric Injury Functional Outcome Scale	JOURNAL OF PEDIATRIC PSYCHOLOGY			English	Article						disability; functional outcome; orthopedic injury; recovery; traumatic brain injury	QUALITY-OF-LIFE; BRAIN-INJURY; ADOLESCENTS 6; SHORT-TERM; FOLLOW-UP; CHILDREN; PREDICTORS; DEFICITS	Objective To establish reliability and validity of the Pediatric Injury Functional Outcome Scale (PIFOS), a brief injury-specific rating scale covering motor, self-care, communication, social-emotional, cognition, physical, and academic areas. Methods In a prospective longitudinal study, the PIFOS structured interview was administered to parents of children 3-15 years of age at 3 and 12 months after hospitalization for traumatic brain injury (TBI) or orthopedic injury (OI). Results The total score had good internal consistency (alpha = .90-.93) and inter-rater reliability (alpha = .90) and correlated significantly with injury severity and neurodevelopmental outcomes. Generalized linear modeling showed the PIFOS was sensitive to the type and severity of injury, showed specific initial and persisting difficulties following TBI and OI, and was responsive to change during the first year after injury. Both groups had residual difficulties with coordination, emotionality, social participation, and discomfort. Conclusion The PIFOS is useful in examining recovery in natural history and intervention studies.	[Ewing-Cobbs, Linda; Prasad, Mary R.; Waugh, Jane K.; Swank, Paul R.] Univ Texas Hlth Sci Ctr Houston, Dept Pediat, Houston, TX 77030 USA; [Ewing-Cobbs, Linda] Univ Texas Hlth Sci Ctr Houston, Dept Psychiat & Behav Sci, Houston, TX 77030 USA; [Bloom, Douglas R.] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; [Cox, Charles S., Jr.] Univ Texas Hlth Sci Ctr Houston, Dept Pediat Surg, Houston, TX 77030 USA	Ewing-Cobbs, L (corresponding author), Univ Texas Hlth Sci Ctr Houston, Childrens Learning Inst, 7000 Fannin St,Suite 2401, Houston, TX 77030 USA.	linda.ewing-cobbs@uth.tmc.edu			NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR000371] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS029462, R01NS046308] Funding Source: NIH RePORTER; NCATS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1 TR000371] Funding Source: Medline; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS029462, R01 NS046308] Funding Source: Medline		Aaronson N, 2002, QUAL LIFE RES, V11, P193; Achenbach T. M., 1991, MANUAL CHILD BEHAV C; Anderson V, 2011, NEUROPSYCHOLOGY, V25, P176, DOI 10.1037/a0021217; Ardolino A, 2012, INJURY, V43, P1662, DOI 10.1016/j.injury.2012.05.008; Association for the Advancement of Automotive Medicine, 1990, ABBR INJ SCAL; Babikian T, 2009, NEUROPSYCHOLOGY, V23, P283, DOI 10.1037/a0015268; Beers SR, 2012, J NEUROTRAUM, V29, P1126, DOI 10.1089/neu.2011.2272; Brennan R.L., 1983, ELEMENTS GEN THEORY; Cattelani R, 1998, BRAIN INJURY, V12, P283, DOI 10.1080/026990598122584; CHADWICK O, 1981, PSYCHOL MED, V11, P49, DOI 10.1017/S0033291700053277; Cronbach L. J., 1972, DEPENDABILITY BEHAV; Crouchman M, 2001, ARCH DIS CHILD, V84, P120, DOI 10.1136/adc.84.2.120; DeVellis RF, 1991, SCALE DEV THEORY APP, V26; Di Battista A, 2012, J NEUROTRAUM, V29, P1717, DOI 10.1089/neu.2011.2157; Ding R, 2006, J PEDIATR ORTHOPED, V26, P157, DOI 10.1097/01.bpo.0000218521.98244.7e; Ewing-Cobbs L, 1998, J CLIN EXP NEUROPSYC, V20, P769, DOI 10.1076/jcen.20.6.769.1109; Ewing-Cobbs L, 1997, J Int Neuropsychol Soc, V3, P581; Ewing-Cobbs L, 2006, J NEUROSURG, V105, P287, DOI 10.3171/ped.2006.105.4.287; Faul M.D., 2010, TRAUMATIC BRAIN INJU; FAY GC, 1994, ARCH PHYS MED REHAB, V75, P733; Fay TB, 2009, NEUROPSYCHOLOGY, V23, P271, DOI 10.1037/a0014936; Gioia G.A., 2000, BEHAV RATING INVENTO; Gioia GA, 2002, CHILD NEUROPSYCHOL, V8, P121, DOI 10.1076/chin.8.2.121.8727; HALEY SM, 1992, PEDIATRIC EVALUATION; Harrison P., 2003, ADAPTIVE BEHAV ASSES; Holbrook TL, 2005, J TRAUMA, V58, P764, DOI 10.1097/01.TA.0000159247.48547.7D; Holbrook TL, 2007, J TRAUMA, V62, P577, DOI 10.1097/TA.0b013e318031aa97; Hollingshead A. B., 1975, 4 FACTOR INDEX SOCIA; JAFFE KM, 1995, ARCH PHYS MED REHAB, V76, P17, DOI 10.1016/S0003-9993(95)80037-9; Janssens L, 2008, QUAL LIFE RES, V17, P701, DOI 10.1007/s11136-008-9339-0; JENNETT B, 1975, LANCET, V1, P480; JENNETT B, 1976, LANCET, V1, P1031; KlOve H, 1963, MED CLIN N AM; Landgraf JM, 1999, CHILD HLTH QUESTIONN; Langlois JA, 2005, J HEAD TRAUMA REHAB, V20, P229, DOI 10.1097/00001199-200505000-00006; Levin HS, 2008, J NEUROSURG-PEDIATR, V1, P461, DOI 10.3171/PED/2008/1/6/461; Max JE, 2006, J NEUROPSYCH CLIN N, V18, P21, DOI 10.1176/appi.neuropsych.18.1.21; Max JE, 2005, J AM ACAD CHILD PSY, V44, P1041, DOI 10.1097/01.chi.0000173292.05817.f8; McCarthy ML, 2006, ARCH PEDIAT ADOL MED, V160, P252, DOI 10.1001/archpedi.160.3.252; McCauley SR, 2012, J NEUROTRAUM, V29, P678, DOI 10.1089/neu.2011.1838; MSALL ME, 1994, CLIN PEDIATR, V33, P431, DOI 10.1177/000992289403300709; Nybo T, 2004, J INT NEUROPSYCH SOC, V10, P719, DOI 10.1017/S1355617704105109; Osler T, 1997, J TRAUMA, V43, P922, DOI 10.1097/00005373-199712000-00009; Rivara FP, 2011, PEDIATRICS, V128, pE1129, DOI 10.1542/peds.2011-0840; Sparrow SS, 2009, VINELAND ADAPTIVE BE; Spector P. E., 1992, SUMMATED RATING SCAL, V82; Stancin T, 2001, J TRAUMA, V51, P69, DOI 10.1097/00005373-200107000-00011; Stancin T, 1998, J TRAUMA, V45, P1031, DOI 10.1097/00005373-199812000-00010; Taylor HG, 2002, NEUROPSYCHOLOGY, V16, P15, DOI 10.1037//0894-4105.16.1.15; Taylor HG, 2001, J INT NEUROPSYCH SOC, V7, P755, DOI 10.1017/S1355617701766118; TEASDALE G, 1974, LANCET, V2, P81; Thorndike RL., 1986, STANFORD BINET INTEL, V4; Varni JW, 1999, MED CARE, V37, P126, DOI 10.1097/00005650-199902000-00003; Wechsler D., 2003, WECHSLER INTELLIGENC; Wechsler D., 2011, WECHLSER ABBREVIATED; Wiederholt JL, 2001, GRAY ORAL READING TE; Willis CD, 2006, INJURY, V37, P1185, DOI 10.1016/j.injury.2006.07.011; Winthrop AL, 2005, J TRAUMA, V58, P468, DOI 10.1097/01.TA.0000153940.23471.B7; Winthrop AL, 2010, CURR OPIN PEDIATR, V22, P346, DOI 10.1097/MOP.0b013e3283394351; Yeates KO, 2004, J INT NEUROPSYCH SOC, V10, P412, DOI 10.1017/S1355617704103093	60	22	24	0	8	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0146-8693	1465-735X		J PEDIATR PSYCHOL	J. Pediatr. Psychol.	JUL	2014	39	6					653	665		10.1093/jpepsy/jsu018			13	Psychology, Developmental	Psychology	AK9QR	WOS:000338762200008	24748647	Bronze, Green Published			2021-06-18	
J	Watts, R; Thomas, A; Filippi, CG; Nickerson, JP; Freeman, K				Watts, Richard; Thomas, Alex; Filippi, Christopher G.; Nickerson, Joshua P.; Freeman, Kalev			Potholes and Molehills: Bias in the Diagnostic Performance of Diffusion-Tensor Imaging in Concussion	RADIOLOGY			English	Article							TRAUMATIC BRAIN-INJURY; AXONAL INJURY; ABNORMALITIES; VALIDATION; ANISOTROPY	Purpose: To investigate the extent of bias in a clinical study involving "pothole analysis" of diffusion-tensor imaging (DTI) data used to quantify white matter lesion load in diseases with a heterogeneous spatial distribution of pathologic findings, such as mild traumatic brain injury (TBI), and create a mathematical model of the bias. Materials and Methods: Use of the same reference population to define normal findings and make comparisons with a patient group introduces bias, which potentially inflates reported diagnostic performance. In this institutional review board-approved prospective observational cohort study, DTI data were obtained in 20 patients admitted to the emergency department with mild TBI and in 16 control subjects. Potholes and molehills were defined as clusters of voxels with fractional anisotropy values more than 2 standard deviations below and above the mean of the corresponding voxels in the reference population, respectively. The number and volume of potholes and molehills in the two groups were compared by using a Mann-Whitney U test. Results: Standard analysis showed significantly more potholes in mild TBI than in the control group (102.5 +/- 34.3 vs 50.6 +/- 28.9, P < .001). Repeat analysis by using leave-one-out cross-validation decreased the apparent difference in potholes between groups (mild TBI group, 102.5 +/- 34.3; control group, 93.4 +/- 27.2; P = .369). It was demonstrated that even with 100 subjects, this bias can decrease the voxelwise false-positive rate by more than 30% in the control group. Conclusion: The pothole approach to neuroimaging data may introduce bias, which can be minimized by independent training and test groups or cross-validation methods. This bias is sufficient to call into question the previously reported diagnostic performance of DTI for mild TBI.	[Watts, Richard; Filippi, Christopher G.; Nickerson, Joshua P.] Univ Vermont, Dept Radiol, Burlington, VT 05405 USA; [Thomas, Alex; Freeman, Kalev] Univ Vermont, Dept Surg, Burlington, VT 05405 USA; [Filippi, Christopher G.] Univ Vermont, Dept Neurol, Burlington, VT 05405 USA	Freeman, K (corresponding author), Univ Vermont, Dept Surg, Given Med Bldg E301,89 Beaumont Ave, Burlington, VT 05405 USA.	kalev.freeman@uvm.edu	Filippi, Christopher/AAA-5493-2021		NHLBI NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [UM1 HL120877] Funding Source: Medline; NIGMS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [K08 GM098795] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [K08GM098795] Funding Source: NIH RePORTER		Bazarian JJ, 2007, J NEUROTRAUM, V24, P1447, DOI 10.1089/neu.2007.0241; Davenport ND, 2012, NEUROIMAGE, V59, P2017, DOI 10.1016/j.neuroimage.2011.10.050; Fernandez-Miranda JC, 2012, NEUROSURGERY, V71, P430, DOI 10.1227/NEU.0b013e3182592faa; Inglese M, 2005, J NEUROSURG, V103, P298, DOI 10.3171/jns.2005.103.2.0298; Ioannidis JPA, 2005, PLOS MED, V2, P696, DOI 10.1371/journal.pmed.0020124; Jorge RE, 2012, AM J PSYCHIAT, V169, P1284, DOI 10.1176/appi.ajp.2012.12050600; Kasahara K, 2012, MAGN RESON IMAGING, V30, P496, DOI 10.1016/j.mri.2011.12.018; Kim N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059382; Lange RT, 2012, J HEAD TRAUMA REHAB, V27, P188, DOI 10.1097/HTR.0b013e318217f0ad; Ling JM, 2012, BRAIN, V135, P1281, DOI 10.1093/brain/aws073; Lipton ML, 2012, BRAIN IMAGING BEHAV, V6, P329, DOI 10.1007/s11682-012-9175-2; Lipton ML, 2009, RADIOLOGY, V252, P816, DOI 10.1148/radiol.2523081584; Mac Donald CL, 2011, NEW ENGL J MED, V364, P2091, DOI 10.1056/NEJMoa1008069; Matsushita M, 2011, J NEUROSURG, V115, P130, DOI 10.3171/2011.2.JNS101547; Mayer AR, 2010, NEUROLOGY, V74, P643, DOI 10.1212/WNL.0b013e3181d0ccdd; Mayer AR, 2012, J NEUROSCI, V32, P17961, DOI 10.1523/JNEUROSCI.3379-12.2012; Miles L, 2008, BRAIN INJURY, V22, P115, DOI 10.1080/02699050801888816; PICARD RR, 1984, J AM STAT ASSOC, V79, P575, DOI 10.2307/2288403; Raffelt D, 2012, NEUROIMAGE, V59, P3976, DOI 10.1016/j.neuroimage.2011.10.045; Rosenbaum SB, 2012, BRAIN IMAGING BEHAV, V6, P255, DOI 10.1007/s11682-012-9162-7; White T, 2009, PSYCHIAT RES-NEUROIM, V174, P110, DOI 10.1016/j.pscychresns.2009.04.014; Yeh FC, 2010, IEEE T MED IMAGING, V29, P1626, DOI 10.1109/TMI.2010.2045126; Zhuo JC, 2012, NEUROIMAGE, V59, P467, DOI 10.1016/j.neuroimage.2011.07.050	23	22	22	0	0	RADIOLOGICAL SOC NORTH AMERICA	OAK BROOK	820 JORIE BLVD, OAK BROOK, IL 60523 USA	0033-8419			RADIOLOGY	Radiology	JUL	2014	272	1					217	223		10.1148/radiol.14131856			7	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	AM7GU	WOS:000340034300023	24635677	Green Published			2021-06-18	
J	Gudziol, V; Hoenck, I; Landis, B; Podlesek, D; Bayn, M; Hummel, T				Gudziol, Volker; Hoenck, Irene; Landis, Basile; Podlesek, Dino; Bayn, Maria; Hummel, Thomas			The impact and prospect of traumatic brain injury on olfactory function: a cross-sectional and prospective study	EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY			English	Article						Trauma; Smell; Olfactory sensitivity; Odor identification; Odor threshold	UPPER RESPIRATORY-TRACT; TERM-FOLLOW-UP; ODOR IDENTIFICATION; HEAD-INJURY; DISCRIMINATION; ANOSMIA; BULB; NEUROGENESIS; RELIABILITY; DYSFUNCTION	Traumatic brain injury (TBI) can cause olfactory loss. The aim of this cross-sectional and prospective study was to determine the prevalence of olfactory loss among 110 patients with TBI within 3 months after the trauma. In 81 patients ("cross-sectional"-group), olfactory function could be measured using the validated "Sniffin' Sticks" test for odor threshold and odor identification. In addition, the prospective change of olfactory function was studied in 36 patients ("follow-up"-group) by means of a validated odor threshold, discrimination and identification test. Olfactory function was significantly better in patients with TBI IA degrees compared to individuals with TBI IIA degrees and IIIA degrees. Clinically significant improvement of olfactory function was found in 36 % of the patients, most frequently during the first 6 months after the injury, in a median follow-up interval of 21 months. TBI IA degrees has in general no major effect on olfaction. In contrast, patients with TBI IIA degrees and IIIA degrees exhibit smell loss in 57 %. Chances for olfactory recovery were highest within the first 6 months after the trauma.	[Gudziol, Volker; Hoenck, Irene; Hummel, Thomas] Univ Dresden, Sch Med, Smell & Taste Clin, Dept Otorhinolaryngol, D-01307 Dresden, Germany; [Landis, Basile] Univ Geneva, Sch Med, Univ Hosp Geneva, Dept Otorhinolaryngol,Geneva Neurosci Ctr CMU, CH-1211 Geneva 4, Switzerland; [Podlesek, Dino] Univ Dresden, Sch Med, Dept Neurosurg, D-01307 Dresden, Germany; [Bayn, Maria] Klin Bavaria, Dept Neurol, D-01731 Kreischa, Germany	Gudziol, V (corresponding author), Univ Dresden, Sch Med, Smell & Taste Clin, Dept Otorhinolaryngol, Fetscherstr 74, D-01307 Dresden, Germany.	volker.gudziol@uniklinikum-dresden.de	Podlesek, D/O-5236-2019				ALTMAN J, 1965, J COMP NEUROL, V124, P319, DOI 10.1002/cne.901240303; [Anonymous], 1994, PSCHYREMBEL, V257; Callahan CD, 1999, J HEAD TRAUMA REHAB, V14, P581, DOI 10.1097/00001199-199912000-00006; Costanzo RM, 1986, CLIN MEASUREMENTS TA, P565; Curtis MA, 2007, SCIENCE, V315, P1243, DOI 10.1126/science.1136281; Damm M, 2004, HNO, V52, P112, DOI 10.1007/s00106-003-0877-z; Doty RL, 1997, ARCH NEUROL-CHICAGO, V54, P1131, DOI 10.1001/archneur.1997.00550210061014; DUNCAN HJ, 1995, ARCH OTOLARYNGOL, V121, P1183; Ehrenstein W. H., 1999, MODERN TECHNIQUES NE, P1211; ESKENAZI B, 1986, NEUROPSYCHOLOGIA, V24, P553, DOI 10.1016/0028-3932(86)90099-0; Feghali J G, 1998, Ear Nose Throat J, V77, P282; Feghali JG, 1998, ENT-EAR NOSE THROAT, V77, P282; Feghali JG, 1998, ENT-EAR NOSE THROAT, V77, P280; Coello AF, 2010, J NEUROSURG, V113, P547, DOI 10.3171/2010.6.JNS091620; GRAZIADEI PP, 1971, Z ZELLFORSCH MIK ANA, V116, P305, DOI 10.1007/BF00330630; GRAZIADEI PP, 1973, J CELL BIOL, V59, P525, DOI 10.1083/jcb.59.2.525; Green P, 2003, BRAIN INJURY, V17, P479, DOI 10.1080/0269905031000070242; Gudziol V, 2009, BRAIN, V132, P3096, DOI 10.1093/brain/awp243; Gudziol V, 2006, LARYNGOSCOPE, V116, P1858, DOI 10.1097/01.mlg.0000234915.51189.cb; Haehner A, 2009, CHEM SENSES, V34, P705, DOI 10.1093/chemse/bjp057; Ho WK, 2002, AM J OTOLARYNG, V23, P209, DOI 10.1053/ajot.2002.123436; Hummel T, 1997, CHEM SENSES, V22, P39, DOI 10.1093/chemse/22.1.39; Hummel T, 2001, ANN OTO RHINOL LARYN, V110, P976, DOI 10.1177/000348940111001015; Hummel T, 1996, BRAIN RES, V717, P160, DOI 10.1016/0006-8993(96)00094-7; Hummel T, 2009, LARYNGOSCOPE, V119, P496, DOI 10.1002/lary.20101; Kobal G, 2000, EUR ARCH OTO-RHINO-L, V257, P205, DOI 10.1007/s004050050223; Koster EP, 1991, HUMAN SENSE SMELL, P199, DOI DOI 10.1007/978-3-642-76223-9_; Landis BN, 2003, CHEM SENSES, V28, P691, DOI 10.1093/chemse/bjg061; Leigh AD, 1943, LANCET, V1, P38; MIFKA P, 1964, Wien Med Wochenschr, V114, P793; Mueller Christian A, 2009, J Med Case Rep, V3, P9283, DOI 10.4076/1752-1947-3-9283; Nissant A, 2009, NAT NEUROSCI, V12, P728, DOI 10.1038/nn.2298; Plant GW, 2011, EXP NEUROL, V229, P99, DOI 10.1016/j.expneurol.2010.09.010; Reden J, 2006, ARCH OTOLARYNGOL, V132, P265, DOI 10.1001/archotol.132.3.265; SUMNER D, 1964, BRAIN, V87, P107, DOI 10.1093/brain/87.1.107; Vennemann MM, 2008, J NEUROL, V255, P1121, DOI 10.1007/s00415-008-0807-9; Welge-Lussen A, 2012, RHINOLOGY, V50, P67, DOI 10.4193/Rhino11.141; ZUSHO H, 1982, ARCH OTOLARYNGOL, V108, P90	38	22	24	1	4	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0937-4477	1434-4726		EUR ARCH OTO-RHINO-L	Eur. Arch. Oto-Rhino-Laryn.	JUN	2014	271	6					1533	1540		10.1007/s00405-013-2687-6			8	Otorhinolaryngology	Otorhinolaryngology	AH0AS	WOS:000335782000029	24071856				2021-06-18	
J	Wilson, M; Staniforth, A; Till, R; das Nair, R; Vesey, P				Wilson, Michelle; Staniforth, Andrew; Till, Richard; das Nair, Roshan; Vesey, Patrick			The psychosocial outcomes of anoxic brain injury following cardiac arrest	RESUSCITATION			English	Article						Anoxic brain injury; Cardiac arrest; Psychological outcome	QUALITY-OF-LIFE; EVENT SCALE; PSYCHOMETRIC PROPERTIES; HOSPITAL ANXIETY; EVERYDAY MEMORY; INTENSIVE-CARE; DEPRESSION; IMPACT; RESUSCITATION; SURVIVORS	Aim of the study: This exploratory study aimed to investigate the psychosocial outcomes for cardiac arrest survivors and explore if there is a greater impact on psychosocial outcome for individuals experiencing anoxic brain injury as a result of the cardiac arrest. Methods: Self-report measures were used to compare the quality of life, social functioning and symptoms of anxiety, depression and post-traumatic stress of individuals with and without anoxic brain injury. Secondary measures of subjective memory and executive difficulties were also used. Fifty-six participants (27 with anoxia, 29 without anoxia) took part in the study between six months and four years after experiencing cardiac arrest. Results: A MANOVA identified a significant difference between the two groups, with the anoxia group reporting more psychosocial difficulties. They reported more social functioning difficulties and more anxiety, depression and post-traumatic stress symptoms. There was, however, no significant difference in self-reported quality of life between the two groups. Conclusion: As the first known study to compare psychosocial outcomes for cardiac arrest survivors experiencing anoxic brain injury with those without anoxia, the current results suggest that cardiac arrest survivors with subsequent acquired brain injury experience more psychosocial difficulties. This could be due to a combination of neuropsychological, social and psychological factors. (C) 2014 Elsevier Ireland Ltd. All rights reserved.	[Wilson, Michelle] Lincoln Univ, Trent Doctorate Clin Psychol, Hull Community Stroke Team, Highlands Hlth Ctr, Kingston Upon Hull HU7 5DD, N Humberside, England; [Staniforth, Andrew] Nottingham Univ Hosp NHS Trust, Linby Cardiol, City Hosp Campus, Nottingham NG5 1PB, England; [Till, Richard] Basildon & Thurrock NHS Trust, Essex Cardiothorac Ctr, Basildon Univ Hosp, Basildon SS16 5NL, Essex, England; [das Nair, Roshan] Univ Nottingham, Inst Work Hlth & Org, Nottingham NG8 1BB, England; [Vesey, Patrick] Nottingham Univ Hosp NHS Trust, Queens Med Ctr, Nottingham NG7 2UH, England	Wilson, M (corresponding author), Lincoln Univ, Trent Doctorate Clin Psychol, Hull Community Stroke Team, Highlands Hlth Ctr, Lothian Way, Kingston Upon Hull HU7 5DD, N Humberside, England.	micmichelle.wilson5@nhs.net		das Nair, Roshan/0000-0001-8143-7893			Balestreri M, 2004, J NEUROL NEUROSUR PS, V75, P161; Barth J, 2004, PSYCHOSOM MED, V66, P802, DOI 10.1097/01.psy.0000146332.53619.b2; Baumert J, 2004, J AFFECT DISORDERS, V82, P29, DOI 10.1016/j.jad.2003.09.006; Beck JG, 2008, J ANXIETY DISORD, V22, P187, DOI 10.1016/j.janxdis.2007.02.007; Burckhardt Carol S, 2003, Health Qual Life Outcomes, V1, P60, DOI 10.1186/1477-7525-1-60; BURCKHARDT CS, 1989, RES NURS HEALTH, V12, P347, DOI 10.1002/nur.4770120604; Burgess P. W., 1996, BEHAV ASSESSMENT DYS; Caine D, 2000, J INT NEUROPSYCH SOC, V6, P86, DOI 10.1017/S1355617700611116; COHAN SL, 1989, STROKE, V20, P761, DOI 10.1161/01.STR.20.6.761; Creamer M, 2003, BEHAV RES THER, V41, P1489, DOI 10.1016/j.brat.2003.07.010; Cronberg T, 2009, RESUSCITATION, V80, P1119, DOI 10.1016/j.resuscitation.2009.06.021; Garcia-Molina A, 2006, BRAIN INJURY, V20, P1139, DOI 10.1080/02699050600983248; Gray J A, 1996, Nebr Symp Motiv, V43, P61; Herrmann C, 1997, J PSYCHOSOM RES, V42, P17, DOI 10.1016/S0022-3999(96)00216-4; Hirsch KG, 2009, CONTINUUM LIFELONG L, V15, P100; HOROWITZ M, 1979, PSYCHOSOM MED, V41, P209, DOI 10.1097/00006842-197905000-00004; Jennett B, 2005, NEPAL J NEUROSCI, V2, P24; Ladwig KH, 1999, AM J PSYCHIAT, V156, P912, DOI 10.1176/ajp.156.6.912; Lundgren-Nilsson A, 2005, RESUSCITATION, V66, P285, DOI 10.1016/j.resuscitation.2005.04.001; Meyer NJ, 2006, CRIT CARE, V10, DOI 10.1186/cc4980; Middelkamp W, 2007, CLIN REHABIL, V21, P425, DOI 10.1177/0269215507075307; Moulaert VRMP, 2010, J REHABIL MED, V42, P553, DOI 10.2340/16501977-0547; Moulaert VRMP, 2009, RESUSCITATION, V80, P297, DOI 10.1016/j.resuscitation.2008.10.034; Nolan JP, 2008, RESUSCITATION, V79, P350, DOI 10.1016/j.resuscitation.2008.09.017; Ownsworth TL, 1998, BRAIN INJURY, V12, P735, DOI 10.1080/026990598122133; Penninx BWJH, 2001, ARCH GEN PSYCHIAT, V58, P221, DOI 10.1001/archpsyc.58.3.221; Rattray JE, 2008, J ADV NURS, V64, P2, DOI 10.1111/j.1365-2648.2008.04767.x; Royle J, 2008, DISABIL REHABIL, V30, P114, DOI 10.1080/09638280701223876; Saner H, 2002, RESUSCITATION, V53, P7, DOI 10.1016/S0300-9572(02)00002-3; Schefold JC, 2009, RESUSCITATION, V80, P658, DOI 10.1016/j.resuscitation.2009.03.006; Snaith R.P., 1994, HOSP ANXIETY DEPRESS; SUNDERLAND A, 1983, J VERB LEARN VERB BE, V22, P341, DOI 10.1016/S0022-5371(83)90229-3; Sunnerhagen KS, 1996, RESUSCITATION, V31, P135, DOI 10.1016/0300-9572(95)00903-5; Tyrer P, 2005, INT J SOC PSYCHIATR, V51, P265, DOI 10.1177/0020764005057391; Tyrer P, 1990, MEASURING HUMAN PROB, P119; Wachelder EM, 2009, RESUSCITATION, V80, P517, DOI 10.1016/j.resuscitation.2009.01.020; Weiss Daniel S., 1997, P399; Weiss DS., 2007, CROSS CULTURAL ASSES, P219; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	39	22	23	0	10	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0300-9572	1873-1570		RESUSCITATION	Resuscitation	JUN	2014	85	6					795	800		10.1016/j.resuscitation.2014.02.008			6	Critical Care Medicine; Emergency Medicine	General & Internal Medicine; Emergency Medicine	AJ0GY	WOS:000337329600030	24560827	Green Accepted			2021-06-18	
J	Lannin, N; Carr, B; Allaous, J; Mackenzie, B; Falcon, A; Tate, R				Lannin, Natasha; Carr, Belinda; Allaous, Jeanine; Mackenzie, Bronwyn; Falcon, Alex; Tate, Robyn			A randomized controlled trial of the effectiveness of handheld computers for improving everyday memory functioning in patients with memory impairments after acquired brain injury	CLINICAL REHABILITATION			English	Article						handheld; executive function; Memory; rehabilitation; computers	ELECTRONIC MEMORY; REHABILITATION; AID; TECHNOLOGY; MODERATE; ADULTS	Objective: To determine the effectiveness of personal digital assistant devices on achievement of memory and organization goals in patients with poor memory after acquired brain injury. Design: Assessor blinded randomized controlled trial. Setting: Specialist brain injury rehabilitation hospital (inpatients and outpatients). Participants: Adults with acquired brain impairments (85% traumatic brain injury; aged >= 17 years) who were assessed as having functional memory impairment on the Rivermead Behavioural Memory Test (General Memory Index). Interventions: Training and support to use a personal digital assistant for eight weeks to compensate for memory failures by an occupational therapist. The control intervention was standard rehabilitation, including use of non-electronic memory aids. Main outcome measures: Goal Attainment Scale which assessed achievement of participants' daily memory functioning goals and caregiver perception of memory functioning; and General Frequency of Forgetting subscale of the Memory Functioning Questionnaire administered at baseline (pre-randomization) and post intervention (eight weeks later). Results: Forty-two participants with memory impairment were recruited. Use of a personal digital assistant led to greater achievement of functional memory goals (mean difference 1.6 (95% confidence interval (CI) 1.0 to 2.2), P = 0.0001) and improvement on the General Frequency of Forgetting subscale (mean difference 12.5 (95% CI 2.0 to 22.9), P = 0.021). Conclusions: Occupational therapy training in the use of a handheld computer improved patients' daily memory function more than standard rehabilitation.	[Lannin, Natasha] La Trobe Univ, Occupat Therapy Dept, Prahran, Vic 3181, Australia; [Lannin, Natasha] Alfred Hlth, Occupat Therapy Dept, Prahran, Vic, Australia; [Lannin, Natasha; Tate, Robyn] Univ Sydney, Fac Med, Northern Clin Sch, Rehabil Studies Unit, Ryde, NSW, Australia; [Carr, Belinda; Allaous, Jeanine; Falcon, Alex; Tate, Robyn] Royal Rehabil Ctr Sydney, Ryde, NSW, Australia; [Mackenzie, Bronwyn] All About Rehab, Camden, NSW, Australia	Lannin, N (corresponding author), La Trobe Univ, Alfred Ctr, Alfred Clin Sch, 99 Commercial Rd, Prahran, Vic 3181, Australia.	n.lannin@latrobe.edu.au	Lannin, Natasha A/A-4195-2013	Lannin, Natasha A/0000-0002-2066-8345	Royal Rehabilitation Centre Sydney Foundation	This work was supported by a grant from the Royal Rehabilitation Centre Sydney Foundation.	Benton AL, 1978, MULTILINGUAL APHASIA; Boman IL, 2010, DISABIL REHABIL-ASSI, V5, P339, DOI 10.3109/17483100903131777; Cicerone K, 2005, ARCH PHYS MED REHAB, P86; de Frias CM, 2005, PSYCHOL ASSESSMENT, V17, P168, DOI 10.1037/1040-3590.17.2.168; de Joode E, 2010, CLIN REHABIL, V24, P701, DOI 10.1177/0269215510367551; Delis D.C., 2001, DELIS KAPLAN EXECUTI; DePompei R, 2008, NEUROREHABILITATION, V23, P487; Dowds MM, 2011, J HEAD TRAUMA REHAB, V26, P339, DOI 10.1097/HTR.0b013e3181f2bf1d; Fleming JM, 2005, BRAIN INJURY, V19, P1, DOI 10.1080/02699050410001720059; Gentry T, 2008, BRAIN INJURY, V22, P19, DOI 10.1080/02699050701810688; GILEWSKI MJ, 1990, PSYCHOL AGING, V5, P482, DOI 10.1037/0882-7974.5.4.482; Gillette Y, 2004, NEUROREHABILITATION, V19, P233; Hutchinson J, 1997, TOP LANG DISORD, V18, P45, DOI 10.1097/00011363-199711000-00006; Inglis EA, 2004, NEUROPSYCHOL REHABIL, V14, P77, DOI 10.1080/09602010343000129; JOYCE BM, 1994, AM J PHYS MED REHAB, V73, P10, DOI 10.1097/00002060-199473010-00003; Kessels RPC, 2003, J CLIN EXP NEUROPSYC, V25, P805, DOI 10.1076/jcen.25.6.805.16474; Khan F, 2003, MED J AUSTRALIA, V178, P290, DOI 10.5694/j.1326-5377.2003.tb05199.x; Kiresuk T., 1994, GOAL ATTAINMENT SCAL; Maher CG, 2003, PHYS THER, V83, P713, DOI 10.1093/ptj/83.8.713; Mathias JL, 2005, BRAIN INJURY, V19, P271, DOI 10.1080/02699050400005028; Roche NL, 2002, BRAIN INJURY, V16, P931, DOI 10.1080/02699050210138581; Savage KR, 2013, CLIN REHABIL, V27, P521, DOI 10.1177/0269215512464230; Schmitter-Edgecombe M, 2004, NEUROPSYCHOLOGY, V18, P353, DOI 10.1037/0894-4105.18.2.353; Schulz KF, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c332; SOHLBERG MM, 1989, J CLIN EXP NEUROPSYC, V11, P871, DOI 10.1080/01688638908400941; Svoboda E, 2012, NEUROPSYCHOL REHABIL, V22, P408, DOI 10.1080/09602011.2011.652498; Tate R. L., 2010, COMPENDIUM TESTS SCA; Thone-Otto AIT, 2003, INT J PSYCHOL, V38, P236, DOI 10.1080/00207590344000169; van den Broek MD, 2000, BRAIN INJURY, V14, P455; Vickers AJ, 2001, BMJ-BRIT MED J, V323, P1123, DOI 10.1136/bmj.323.7321.1123; Wade TK, 2001, BRAIN INJURY, V15, P305, DOI 10.1080/026990501750111256; Wechsler D., 1997, WAIS 3 ADM SCORING M; Wechsler D., 2001, WECHSLER TEST ADULT; Wilson B, 1986, RIVERMEAD BEHAV MEMO; Wilson BA, 1997, J NEUROL NEUROSUR PS, V63, P113, DOI 10.1136/jnnp.63.1.113; Wilson BA, 1996, BEHAV ASSESSMENT DYS; Wright P, 2001, INT J REHABIL RES, V24, P299, DOI 10.1097/00004356-200112000-00006; ZWEBER B, 1990, Occupational Therapy in Health Care, V7, P45, DOI 10.1080/J003v07n01_05	38	22	23	1	15	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0269-2155	1477-0873		CLIN REHABIL	Clin. Rehabil.	MAY	2014	28	5					470	481		10.1177/0269215513512216			12	Rehabilitation	Rehabilitation	AE5HF	WOS:000334017700007	24452701				2021-06-18	
J	Rivkin, MA; Saraiya, PV; Woodrow, SI				Rivkin, Mark A.; Saraiya, Piya V.; Woodrow, Sarah I.			Sinovenous thrombosis associated with skull fracture in the setting of blunt head trauma	ACTA NEUROCHIRURGICA			English	Article						Cerebral sinus; Sinus thrombosis; Skull fracture; Head trauma	DURAL SINUS THROMBOSIS; INJURY	Emerging literature suggests that closed head injuries may be an important etiology of cerebral venous sinus thrombosis (CVST). Fractures over the dural sinuses, in particular, may predispose such patients to this secondary complication. The purpose of this study was to determine the incidence and characteristics of CVST resulting from skull fractures overlying cerebral venous sinuses at a single tertiary care center. A retrospective review of consecutive patients presenting to our institution with skull fractures from blunt head trauma between 1 January 2009 and 31 December 2011 who underwent either a computed tomography (CT) or magnetic resonance (MR) venogram. Patient demographics, associated intracranial injuries, admission Glasgow Coma Scale (GCS), presence of CVST, and post-hospital disposition were recorded. Overall, 908 patients with skull fractures presented to the institution. Of those, 63 had fractures over a sinus and a venogram satisfying inclusion criteria. Twenty-two (34.9 %) patients demonstrated a thrombus in at least one sinus. There was no statistical difference in patient demographics, presenting GCS, length of stay (LOS), or outcome between patients with or without a thrombus. Pediatric patients had significantly shorter LOS (11 vs. 4 days, p < 0.01) compared to adults. Adults had a greater incidence of total sinus occlusions while children had more non-occlusive thrombus formations; both were statistically significant (p = 0.035 and p = 0.037, respectively). This report suggests that over 10 % of skull fractures involve cerebral venous sinuses, thus emphasizing the need to rule out CVST in patients suffering blunt head trauma. We propose including a venogram as part of the initial trauma work-up for these patients. Moreover, our data suggest that pediatric patients may be predisposed to less severe injuries than their adult counterparts.	[Rivkin, Mark A.; Woodrow, Sarah I.] Cooper Univ Hosp, Dept Neurosurg, Camden, NJ 08103 USA; [Saraiya, Piya V.] Cooper Univ Hosp, Dept Radiol, Camden, NJ 08103 USA	Rivkin, MA (corresponding author), 32 Conshohocken State Rd,F-3, Bala Cynwyd, PA 19004 USA.	rivkin@comcast.net; Saraiya-Piya@CooperHealth.edu; Woodrow-Sarah@CooperHealth.edu					Almandoz JED, 2010, RADIOLOGY, V255, P570, DOI 10.1148/radiol.10091565; Bousser MG, 2007, LANCET NEUROL, V6, P162, DOI 10.1016/S1474-4422(07)70029-7; Daligic A, 2008, TURK NEUROSURG, V18, P70; Einhaupl K, 2010, EUR J NEUROL, V17, P1229, DOI 10.1111/j.1468-1331.2010.03011.x; Ferro JM, 2004, STROKE, V35, P664, DOI 10.1161/01.STR.0000117571.76197.26; Ferro JM, 2003, PRACT NEUROL, V3, P214; Filippidis A, 2009, NEUROSURG FOCUS, V27, DOI 10.3171/2009.8.FOCUS09167; Fujii Y, 2009, J TRAUMA, V66, P1002, DOI 10.1097/TA.0b013e31819a0277; Holzmann D, 1999, LARYNGOSCOPE, V109, P645, DOI 10.1097/00005537-199904000-00024; Meltzer H, 2000, J TRAUMA, V49, P981, DOI 10.1097/00005373-200011000-00035; MILLER JD, 1968, LANCET, V2, P991; Muthukumar N, 2005, CHILD NERV SYST, V21, P86, DOI 10.1007/s00381-004-0926-2; Nehme J, 2009, INT J PEDIATR OTORHI, V73, P629, DOI 10.1016/j.ijporl.2008.10.025; Rahman M, 2009, NEUROSURG FOCUS, V27, DOI 10.3171/2009.7.FOCUS09146; Saposnik G, 2011, STROKE, V42, P1158, DOI 10.1161/STR.0b013e31820a8364; Stam J, 2005, NEW ENGL J MED, V352, P1791, DOI 10.1056/NEJMra042354; Stiefel D, 2000, EUR J PEDIATR SURG, V10, P41, DOI 10.1055/s-2008-1072321; TAHA JM, 1993, NEUROSURGERY, V32, P541, DOI 10.1227/00006123-199304000-00008; Takahashi S, 2012, J STROKE CEREBROVASC, V21, P338, DOI 10.1016/j.jstrokecerebrovasdis.2009.12.011; Yokota H, 2006, J NEUROSURG, V104, P849, DOI 10.3171/jns.2006.104.5.849; Yuen HW, 2005, ANN ACAD MED SINGAP, V34, P639; Zhao X, 2008, J NEUROTRAUM, V25, P104, DOI 10.1089/neu.2007.0351	22	22	25	0	2	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0001-6268	0942-0940		ACTA NEUROCHIR	Acta Neurochir.	MAY	2014	156	5					999	1007		10.1007/s00701-014-2025-9			9	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	AF0TC	WOS:000334426000023	24573982				2021-06-18	
J	Smith, JE; Kehoe, A; Harrisson, SE; Russell, R; Midwinter, M				Smith, J. E.; Kehoe, A.; Harrisson, S. E.; Russell, R.; Midwinter, M.			Outcome of penetrating intracranial injuries in a military setting	INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED			English	Article						Military; Multiple trauma; Traumatic brain injury	CRANIOCEREBRAL INJURIES; SEVERITY SCORE; CARE; BRAIN; CONSCIOUSNESS; MANAGEMENT; SCALE; COMA; WAR	Background: Penetrating intracranial injuries are common in the deployed military medical environment. Early assessment of prognosis includes initial conscious level. There has been no previous identification of different outcomes depending on mechanism of penetrating injury. The aim of this study was to define outcome from penetrating head injury in our population, and to compare outcome between gunshot wound (GSW) and blast fragment injury, in order to detect a difference in survival. Methods: A retrospective database review was undertaken using the UK Joint Theatre Trauma Registry (JTTR) between the dates 2003 and 2011 to identify all cases of penetrating head injury. Data collected included mechanism of injury, first recorded GCS, injury severity score (ISS), abbreviated injury scale (AIS) head score, concomitant extracranial injury, surgical intervention, hospital length of stay, and survival. Results: 813 patients sustained a penetrating head injury, of whom 625 were injured by blast fragmentation and 188 were injured by GSW; overall 336 patients (41.3%) died. There was a significant difference between survival from GSW (41.5%) and blast fragment (63.8%; p < 0.001). In addition, the GCS in patients injured by GSW was significantly lower than that in patients injured by blast fragment. 157 cases sustained isolated head injury (79 GSW, 78 blast). The difference in injury severity between these groups was marked; median AIS was higher in the GSW group, survival lower (42% vs. 88%; p < 0.001) and distribution of GCS categories less favourable (p < 0.001). 338 of 343 patients (98.5%) with a best recorded GCS > 5, survived to discharge. Conclusion: Most patients who present following penetrating intracranial injury, who have a GCS > 5, survive to discharge. There is a significant difference in survival to hospital discharge following penetrating injury caused by blast fragment compared to those caused by GSW, partly attributable to a difference in injury severity. This is the first study to specifically highlight and define this difference. (C) 2013 Elsevier Ltd. All rights reserved.	[Smith, J. E.; Russell, R.] Royal Ctr Def Med Res & Acad, Acad Dept Mil Emergency Med, Med Directorate, Joint Med Command, Birmingham, W Midlands, England; [Smith, J. E.; Kehoe, A.] Derriford Hosp, Emergency Dept, Plymouth PL6 8DH, Devon, England; [Harrisson, S. E.; Midwinter, M.] Royal Ctr Def Med Res & Acad, Acad Dept Mil Surg & Trauma, Med Directorate, Joint Med Command, Birmingham, W Midlands, England; [Harrisson, S. E.] Wessex Neurol Ctr, Dept Neurosurg, Southampton, Hants, England	Smith, JE (corresponding author), Royal Ctr Def Med, Inst Res & Dev, Acad Dept Mil Emergency Med, Vincent Dr, Birmingham B15 2SQ, W Midlands, England.	jasonesmith@doctors.org.uk	Smith, Jason Edward/H-9380-2013; Midwinter, Mark/AAB-6527-2019; Midwinter, Mark J/P-6264-2015	Smith, Jason Edward/0000-0002-6143-0421; Midwinter, Mark/0000-0003-1836-7137; Midwinter, Mark J/0000-0003-1836-7137; Harrisson, Stuart/0000-0003-4995-4270			AARABI B, 1990, NEUROSURGERY, V27, P692, DOI 10.1227/00006123-199011000-00004; Aarabi B, 2005, HEAD INJURY PATHOPHY, P384; Armonda RA, 2009, NEUROTRAUMA CRITICAL, P238; Association for the Advancement of Automotive Medicine, 2008, ABBR INJ SCAL 2008; Balogh ZJ, 2003, J ORTHOP TRAUMA, V17, P508, DOI 10.1097/00005131-200308000-00006; BOYD CR, 1987, J TRAUMA, V27, P370, DOI 10.1097/00005373-198704000-00005; BRANDVOLD B, 1990, J NEUROSURG, V72, P15, DOI 10.3171/jns.1990.72.1.0015; CAIRNS H, 1947, Br J Surg, V55, P9; CAREY ME, 1987, MIL MED, V152, P6; CHAMPION HR, 1990, J TRAUMA, V30, P539, DOI 10.1097/00005373-199005000-00003; Holcomb JB, 2006, J TRAUMA, V60, P397, DOI 10.1097/01.ta.0000203581.75241.f1; LEVI L, 1990, ISRAEL J MED SCI, V26, P548; Mackay CA, 2000, PREHOSPITAL IMMEDIAT, V4, P17; Marcikic M, 1998, INJURY, V29, P613, DOI 10.1016/S0020-1383(98)00146-6; McNarry AF, 2004, ANAESTHESIA, V59, P34, DOI 10.1111/j.1365-2044.2004.03526.x; Osler T, 1997, J TRAUMA, V43, P922, DOI 10.1097/00005373-199712000-00009; POLIN RS, 1995, NEUROSURG CLIN N AM, V6, P689; Roberts P, 2004, BRIT MILITARY SURG P; Russell RJ, 2011, PHILOS T R SOC B, V366, P171, DOI 10.1098/rstb.2010.0232; Santiago LA, 2012, BRAIN INJURY, V26, P107, DOI 10.3109/02699052.2011.635363; SICCARDI D, 1991, SURG NEUROL, V35, P455, DOI 10.1016/0090-3019(91)90179-D; TEASDALE G, 1974, LANCET, V2, P81; Wani AA, 2012, NEUROSURG QUART, V22, P94, DOI 10.1097/WNQ.0b013e3182001874; Weisbrod AB, 2012, J TRAUMA ACUTE CARE, V73, P1525, DOI 10.1097/TA.0b013e318270e179	24	22	22	0	6	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0020-1383	1879-0267		INJURY	Injury-Int. J. Care Inj.	MAY	2014	45	5					874	878		10.1016/j.injury.2013.12.004			5	Critical Care Medicine; Emergency Medicine; Orthopedics; Surgery	General & Internal Medicine; Emergency Medicine; Orthopedics; Surgery	AD2AS	WOS:000333035500013	24398079				2021-06-18	
J	Kavalci, C; Aksel, G; Salt, O; Yilmaz, MS; Demir, A; Kavalci, G; Ozel, BA; Altinbilek, E; Durdu, T; Yel, C; Durukan, P; Isik, B				Kavalci, Cemil; Aksel, Gokhan; Salt, Omer; Yilmaz, M. Serkan; Demir, Ali; Kavalci, Gulsum; Ozel, Betul Akbuga; Altinbilek, Ertugrul; Durdu, Tamer; Yel, Cihat; Durukan, Polat; Isik, Bahattin			Comparison of the Canadian CT head rule and the new orleans criteria in patients with minor head injury	WORLD JOURNAL OF EMERGENCY SURGERY			English	Article						Emergency; Head injury; CT rules	TRAUMATIC BRAIN-INJURY; COMPUTED-TOMOGRAPHY; EXTERNAL VALIDATION; UNITED-STATES; PERFORMANCE; MANAGEMENT	Aim: The aim of the study was to compare the New Orleans Criteria and the New Orleans Criteria according to their diagnostic performance in patients with mild head injury. Methods: The study was designed and conducted prospectively after obtaining ethics committee approval. Data was collected prospectively for patients presenting to the ED with Minor Head Injury. After clinical assessment, a standard CT scan of the head was performed in patients having at least one of the risk factors stated in one of the two clinical decision rules. Patients with positive traumatic head injury according to BT results defined as Group 1 and those who had no intracranial injury defined as Group 2. Statistical analysis was performed with SPSS 11.00 for Windows. ROC analyze was performed to determine the effectiveness of detecting intracranial injury with both decision rules. p < 0.05 was considered statistically significant. Results: 175 patients enrolled the study. Male to female ratio was 1.5. The mean age of the patients was 45 +/- 21,3 in group 1 and 49 +/- 20,6 in group 2. The most common mechanism of trauma was falling. The sensitivity and specificity of CCHR were respectively 76.4% and 41.7%, whereas sensitivity and specificity of NOC were 88.2% and 6.9%. Conclusion: The CCHR has higher specificity, PPV and NPV for important clinical outcomes than does the NOC.	[Kavalci, Cemil; Aksel, Gokhan; Ozel, Betul Akbuga] Baskent Univ, Fac Med, Emergency Dept, TR-06490 Ankara, Turkey; [Salt, Omer] State Hosp, Emergency Dept, Yozgat, Turkey; [Yilmaz, M. Serkan; Durdu, Tamer; Yel, Cihat] Ankara Numune Training & Res Hosp, Emergency Dept, Ankara, Turkey; [Demir, Ali] Yenimahalle State Hosp, Emergency Dept, Ankara, Turkey; [Kavalci, Gulsum] Yenimahalle State Hosp, Dept Anesthesia, Ankara, Turkey; [Altinbilek, Ertugrul] Sisli Hamidiye Etfal Training & Res Hosp, Emergency Dept, Istanbul, Turkey; [Durukan, Polat] Erciyes Univ, Fac Med, Emergency Dept, Kayseri, Turkey; [Isik, Bahattin] Kecioren Training & Res Hosp, Emergency Dept, Ankara, Turkey	Kavalci, C (corresponding author), Baskent Univ, Fac Med, Emergency Dept, TR-06490 Ankara, Turkey.	cemkavalci@yahoo.com	altinbilek, ertugrul/AAB-1368-2019	ALTINBILEK, ERTUGRUL/0000-0003-4201-8850; Aksel, Gokhan/0000-0002-5580-3201			Bazarian JJ, 2005, BRAIN INJURY, V19, P85, DOI 10.1080/02699050410001720158; Bouida W, 2013, ANN EMERG MED, V61, P521, DOI 10.1016/j.annemergmed.2012.07.016; Brenner DJ, 2007, NEW ENGL J MED, V357, P2277, DOI 10.1056/NEJMra072149; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Hung RH, 2011, TINTINALLIS EMERGENC, P888; Klement W, 2012, ARTIF INTELL MED, V54, P163, DOI 10.1016/j.artmed.2011.11.005; Melnick ER, 2012, JT COMM J QUAL PATIE, V38, P483, DOI 10.1016/S1553-7250(12)38064-1; Papa L, 2012, ACAD EMERG MED, V19, P2, DOI 10.1111/j.1553-2712.2011.01247.x; Ro YS, 2011, ACAD EMERG MED, V18, P597, DOI 10.1111/j.1553-2712.2011.01094.x; SHACKFORD SR, 1992, J TRAUMA, V33, P385, DOI 10.1097/00005373-199209000-00009; Smits M, 2005, JAMA-J AM MED ASSOC, V294, P1519, DOI 10.1001/jama.294.12.1519; Smits M, 2010, RADIOLOGY, V254, P532, DOI 10.1148/radiol.2541081672; STEIN SC, 1990, NEUROSURGERY, V26, P638, DOI 10.1227/00006123-199004000-00012; Stein SC, 2009, ANN EMERG MED, V53, P180, DOI 10.1016/j.annemergmed.2008.01.002; Stiell IG, 2005, JAMA-J AM MED ASSOC, V294, P1511, DOI 10.1001/jama.294.12.1511; Stiell IG, 2001, LANCET, V357, P1391, DOI 10.1016/S0140-6736(00)04561-X	16	22	24	1	8	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1749-7922			WORLD J EMERG SURG	World J. Emerg. Surg.	APR 17	2014	9								31	10.1186/1749-7922-9-31			5	Emergency Medicine; Surgery	Emergency Medicine; Surgery	AF6DV	WOS:000334805500001	24742359	DOAJ Gold, Green Published			2021-06-18	
J	Luoto, TM; Silverberg, ND; Kataja, A; Brander, A; Tenovuo, O; Ohman, J; Iverson, GL				Luoto, Teemu M.; Silverberg, Noah D.; Kataja, Anneli; Brander, Antti; Tenovuo, Olli; Ohman, Juha; Iverson, Grant L.			Sport Concussion Assessment Tool 2 in a Civilian Trauma Sample with Mild Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						Military Acute Concussion Evaluation; traumatic brain injury; concussion; Sport Concussion Assessment Tool	ERROR SCORING SYSTEM; HEAD-INJURY; INTERNATIONAL-CONFERENCE; STANDARDIZED ASSESSMENT; POSTTRAUMATIC AMNESIA; EMERGENCY-DEPARTMENT; CONSENSUS STATEMENT; ANKLE INSTABILITY; FOOTBALL PLAYERS; MANAGEMENT	The aim of the study was to evaluate the validity of the Sport Concussion Assessment Tool-Second Edition (SCAT2) in patients with acute mild traumatic brain injuries (mTBIs) in a civilian trauma setting. In addition, the SCAT2 was compared to the Military Acute Concussion Evaluation (MACE). All the participants of the study were prospectively recruited from the emergency department of Tampere University Hospital (Tampere, Finland). Patients (n=49) between the ages of 18 and 60 years, with no premorbid medical or psychiatric conditions, who met the World Health Organization criteria for mTBI, were enrolled. Trauma controls (n=33) were recruited using similar study criteria. The main measures of the study consisted of SCAT2, MACE, and mTBI severity markers, including neuroimaging (computed tomography and conventional magnetic resonance imaging [MRI]), and 1-month clinical outcomes (postconcussion syndrome diagnosis and return to work status). The scoreable components of the SCAT2 performed variably across five dimensions of validity (diagnostic, criterion, divergent, predictive, and responsiveness). The Standardized Assessment of Concussion component reasonably discriminated mTBI patients from controls, was associated with MRI lesions, improved over time, and predicted return to work. Symptom scores differentiated patients with mTBIs from controls, and elevated initial symptom scores in patients with mTBI were associated with a greater risk of persistent postconcussion symptoms. The SCAT2 was superior to the MACE. The SCAT2 appears useful for detecting acute mTBI-related symptoms and cognitive impairment, refining prognosis, and monitoring recovery.	[Luoto, Teemu M.; Ohman, Juha] Tampere Univ Hosp, Dept Neurosci & Rehabil, FI-33521 Tampere, Finland; [Silverberg, Noah D.] Univ British Columbia, Dept Med, Div Phys Med & Rehabil, Vancouver, BC, Canada; [Silverberg, Noah D.] GF Strong Rehab Ctr, Vancouver, BC, Canada; [Kataja, Anneli; Brander, Antti] Tampere Univ Hosp, Dept Radiol, Med Imaging Ctr, FI-33521 Tampere, Finland; [Tenovuo, Olli] Univ Turku, Dept Neurol, FIN-20520 Turku, Finland; [Tenovuo, Olli] Turku Univ, Cent Hosp, Turku, Finland; [Iverson, Grant L.] Harvard Univ, Sch Med, Dept Phys Med & Rehabil, Boston, MA USA; [Iverson, Grant L.] Red Sox Fdn, Boston, MA USA; [Iverson, Grant L.] Home Base Program, Massachusetts Gen Hosp, Boston, MA USA; [Iverson, Grant L.] Def & Vet Brain Injury Ctr, Bethesda, MD USA	Luoto, TM (corresponding author), Tampere Univ Hosp, Dept Neurosci & Rehabil, POB 2000, FI-33521 Tampere, Finland.	teemu.luoto@pshp.fi	Luoto, Teemu/W-6468-2018	Luoto, Teemu/0000-0002-7329-3284; Ohman, Juha/0000-0002-6592-1367; Iverson, Grant/0000-0001-7348-9570	Medical Research Fund of Tampere University Hospital; Maire Taponen Foundation; Emil Aaltonen Foundation; Vancouver Coastal Health Research Institute	The authors thank research assistants Anne Simi and Marika Suopanki-Ervasti for their contribution in data collection. This study was done as part of the first author's PhD thesis research program. This study was presented at the 4th International Consensus Conference on Concussion in Sport in Zurich, November 2012. This study has been supported by the Medical Research Fund of Tampere University Hospital, the Maire Taponen Foundation, and the Emil Aaltonen Foundation. N.D.S. receives funding from the Vancouver Coastal Health Research Institute. G. L. I. notes that the views expressed in this article are those of the authors and do not reflect the official policy of the Department of Defense or U.S. government.	Aubry M, 2002, CLIN J SPORT MED, V12, P6, DOI 10.1097/00042752-200201000-00005; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Bender R, 2001, J CLIN EPIDEMIOL, V54, P343, DOI 10.1016/S0895-4356(00)00314-0; Benjamini Y, 2001, BEHAV BRAIN RES, V125, P279, DOI 10.1016/S0166-4328(01)00297-2; Coldren RL, 2010, MIL MED, V175, P477, DOI 10.7205/MILMED-D-09-00258; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Docherty CL, 2006, CLIN J SPORT MED, V16, P203, DOI 10.1097/00042752-200605000-00003; Giza CC, 2013, NEUROLOGY, V80, P2250, DOI 10.1212/WNL.0b013e31828d57dd; Grubenhoff JA, 2010, PEDIATRICS, V126, P688, DOI 10.1542/peds.2009-2804; Guskiewicz KM, 2013, BRIT J SPORT MED, V47, P289, DOI 10.1136/bjsports-2013-092225; Guskiewicz KM, 2011, CLIN SPORT MED, V30, P89, DOI 10.1016/j.csm.2010.09.004; Guskiewicz KM, 2001, CLIN J SPORT MED, V11, P182, DOI 10.1097/00042752-200107000-00009; Herbert David L, 2007, Curr Sports Med Rep, V6, P20, DOI 10.1007/s11932-007-0007-x; Hertel J, 2008, CLIN SPORT MED, V27, P353, DOI 10.1016/j.csm.2008.03.006; Holm L, 2005, J REHABIL MED, V37, P137, DOI 10.1080/16501970510027321; Hunt TN, 2009, CLIN J SPORT MED, V19, P471, DOI 10.1097/JSM.0b013e3181c12c7b; Ingebrigtsen T, 2000, J TRAUMA, V48, P760, DOI 10.1097/00005373-200004000-00029; Iverson GL, 2013, BRAIN INJURY, V27, P596, DOI 10.3109/02699052.2013.772237; Iverson GL, 2013, BRAIN INJURY MEDICINE: PRINCIPLES AND PRACTICE, SECOND EDITION, P470; Kennedy CH, 2012, ARCH CLIN NEUROPSYCH, V27, P817, DOI 10.1093/arclin/acs092; King NS, 1997, J NEUROL NEUROSUR PS, V62, P38, DOI 10.1136/jnnp.62.1.38; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; Lundin A, 2006, BRAIN INJURY, V20, P799, DOI 10.1080/02699050600744327; Luoto TM, 2013, J NEUROTRAUM, V30, P11, DOI 10.1089/neu.2012.2611; Marion DW, 2011, J NEUROTRAUM, V28, P517, DOI 10.1089/neu.2010.1638; McCrea M, 1997, NEUROLOGY, V48, P586, DOI 10.1212/WNL.48.3.586; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrory P, 2009, BRIT J SPORT MED, V43, pI76, DOI 10.1136/bjsm.2009.058248; McCrory Paul, 2005, Clin J Sport Med, V15, P48; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McLean SA, 2009, AM J EMERG MED, V27, P182, DOI 10.1016/j.ajem.2008.01.054; MedCalc Software, 2013, MEDCALC STAT SOFTW V; Naunheim RS, 2008, J HEAD TRAUMA REHAB, V23, P116, DOI 10.1097/01.HTR.0000314530.30401.70; Peterson CL, 2003, CLIN J SPORT MED, V13, P230, DOI 10.1097/00042752-200307000-00006; Ponsford J, 2002, J NEUROL NEUROSUR PS, V73, P330, DOI 10.1136/jnnp.73.3.330; Ruff RM, 2009, ARCH CLIN NEUROPSYCH, V24, P3, DOI 10.1093/arclin/acp006; SAUNDERS JB, 1993, ADDICTION, V88, P791, DOI 10.1111/j.1360-0443.1993.tb02093.x; SHORES EA, 1986, MED J AUSTRALIA, V144, P569, DOI 10.5694/j.1326-5377.1986.tb112311.x; TEASDALE G, 1976, ACTA NEUROCHIR, V34, P45, DOI 10.1007/BF01405862; Vos PE, 2012, EUR J NEUROL, V19, P191, DOI 10.1111/j.1468-1331.2011.03581.x; Whittaker R, 2007, J NEUROL NEUROSUR PS, V78, P644, DOI 10.1136/jnnp.2006.101105	41	22	22	1	21	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	APR 15	2014	31	8					728	738		10.1089/neu.2013.3174			11	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	AD7PX	WOS:000333457200004	24502622				2021-06-18	
J	Agrawal, R; Tyagi, E; Vergnes, L; Reue, K; Gomez-Pinilla, F				Agrawal, Rahul; Tyagi, Ethika; Vergnes, Laurent; Reue, Karen; Gomez-Pinilla, Fernando			Coupling energy homeostasis with a mechanism to support plasticity in brain trauma	BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE			English	Article						Anxiety; Brain Trauma; Metabolism; Mitochondria; Omega-3; Plasticity	NEUROPEPTIDE-Y; MITOCHONDRIAL DYSFUNCTION; FATTY-ACIDS; DEPRESSION; INJURY; SUPPLEMENTATION; PGC-1-ALPHA; CREB; DHA; OMEGA-3-FATTY-ACIDS	Metabolic dysfunction occurring after traumatic brain injury (TBI) is an important risk factor for the development of psychiatric illness. In the present study, we utilized an omega-3 diet during early life as a metabolic preconditioning to alter the course of TBI during adulthood. TBI animals under omega-3 deficiency were more prone to alterations in energy homeostasis (adenosine monophosphate-activated protein kinase; AMPK phosphorylation and cytochrome C oxidase II; COII levels) and mitochondrial biogenesis (peroxisome proliferator-activated receptor gamma coactivator 1-alpha; PGC-1 alpha and mitochondrial transcription factor A; TFAM). A similar response was found for brain-derived neurotrophic factor (BDNF) and its signaling through tropomyosin receptor kinase B (TrkB). The results from in vitro studies showed that 7,8-dihydroxyflavone (7,8-DHF), a TrkB receptor agonist, upregulates the levels of biogenesis activator PGC-1 alpha, and CREB phosphorylation in neuroblastoma cells suggesting that BDNF-TrkB signaling is pivotal for engaging signals related to synaptic plasticity and energy metabolism. The treatment with 7,8-DHF elevated the mitochondrial respiratory capacity, which emphasizes the role of BDNF-TrkB signaling as mitochondrial bioenergetics stimulator. Omega-3 deficiency worsened the effects of TBI on anxiety-like behavior and potentiated a reduction of anxiolytic neuropeptide Y1 receptor (NPY1R). These results highlight the action of metabolic preconditioning for building long-term neuronal resilience against TBI incurred during adulthood. Overall, the results emphasize the interactive action of metabolic and plasticity signals for supporting neurological health. (C) 2013 Published by Elsevier B.V.	[Agrawal, Rahul; Tyagi, Ethika; Gomez-Pinilla, Fernando] Univ Calif Los Angeles, Dept Integrat Biol & Physiol, Los Angeles, CA 90095 USA; [Vergnes, Laurent; Reue, Karen] Univ Calif Los Angeles, David Geffen Sch Med, Dept Human Genet, Los Angeles, CA 90095 USA; [Gomez-Pinilla, Fernando] Univ Calif Los Angeles, Brain Injury Res Ctr, Dept Neurosurg, Los Angeles, CA 90095 USA	Gomez-Pinilla, F (corresponding author), Univ Calif Los Angeles, Dept Integrat Biol & Physiol, 621 Charles E Young Dr South, Los Angeles, CA 90095 USA.	fgomezpi@ucla.edu	Agrawal, Rahul/F-6412-2015	Agrawal, Rahul/0000-0001-8128-3724; vergnes, laurent/0000-0002-8804-589X	National Institute of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS050465, NS056413]; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [S10RR026744] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [P01HL090553] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS056413] Funding Source: NIH RePORTER	This work was supported by the National Institute of Health Grants NS050465 and NS056413. We are thankful to Ms. Rusvelda Cruz for her help in animal feeding.	Alonso M, 2002, CELL MOL NEUROBIOL, V22, P663, DOI 10.1023/A:1021848706159; Assies J, 2011, JAMA-J AM MED ASSOC, V305, P360, DOI 10.1001/jama.2011.18; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Burkhalter J, 2003, J NEUROSCI, V23, P8212; Campbell CT, 2012, BBA-GENE REGUL MECH, V1819, P921, DOI 10.1016/j.bbagrm.2012.03.002; Casey PA, 2008, J NEUROTRAUM, V25, P603, DOI 10.1089/neu.2007.0481; Chen SD, 2011, INT J MOL SCI, V12, P7199, DOI 10.3390/ijms12107199; Chowdhury SKR, 2012, BRAIN, V135, P1751, DOI 10.1093/brain/aws097; Cohen BA, 2007, AM J NEURORADIOL, V28, P907; Dwivedi Y, 2009, NEUROPSYCH DIS TREAT, V5, P433; Finkbeiner S, 1997, NEURON, V19, P1031, DOI 10.1016/S0896-6273(00)80395-5; Gomez-Pinilla F, 2008, EUR J NEUROSCI, V28, P2278, DOI 10.1111/j.1460-9568.2008.06524.x; Greiner RS, 2003, LIPIDS, V38, P431, DOI 10.1007/s11745-003-1080-2; Gupta VK, 2013, J MOL NEUROSCI, V49, P96, DOI 10.1007/s12031-012-9899-x; Harris LK, 2001, J NEUROTRAUM, V18, P993, DOI 10.1089/08977150152693692; Herzig S, 2001, NATURE, V413, P179, DOI 10.1038/35093131; Innis SM, 2008, BRAIN RES, V1237, P35, DOI 10.1016/j.brainres.2008.08.078; Kiecolt-Glaser JK, 2007, PSYCHOSOM MED, V69, P217, DOI 10.1097/PSY.0b013e3180313a45; Lakshmanan R, 2010, NEUROCRIT CARE, V12, P324, DOI 10.1007/s12028-010-9342-5; Lands B, 2012, NUTR METAB, V9, DOI 10.1186/1743-7075-9-46; Makrides M, 2010, JAMA-J AM MED ASSOC, V304, P1675, DOI 10.1001/jama.2010.1507; Manji H, 2012, NAT REV NEUROSCI, V13, P293, DOI 10.1038/nrn3229; Markham A, 2004, EUR J NEUROSCI, V20, P1189, DOI 10.1111/j.1460-9568.2004.03578.x; Martinowich K, 2007, NAT NEUROSCI, V10, P1089, DOI 10.1038/nn1971; Nguyen AD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040191; Painsipp E, 2010, J PSYCHOPHARMACOL, V24, P1541, DOI 10.1177/0269881109104851; Pandey DK, 2009, BEHAV BRAIN RES, V205, P436, DOI 10.1016/j.bbr.2009.07.027; Pandey SC, 2003, TRENDS PHARMACOL SCI, V24, P456, DOI 10.1016/S0165-6147(03)00226-8; Pandey SC, 2006, J NEUROSCI, V26, P8320, DOI 10.1523/JNEUROSCI.4988-05.2006; Peet M, 2005, DRUGS, V65, P1051, DOI 10.2165/00003495-200565080-00002; Reusens B, 2011, WORLD J DIABETES, V2, P149, DOI 10.4239/wjd.v2.i9.149; Rodgers JT, 2008, FEBS LETT, V582, P46, DOI 10.1016/j.febslet.2007.11.034; Scaglia F, 2010, DEV DISABIL RES REV, V16, P136, DOI 10.1002/ddrr.115; Schwetz TA, 2013, AM J PHYSIOL-ENDOC M, V304, pE211, DOI 10.1152/ajpendo.00374.2012; Sharma S, 2009, NEUROSCIENCE, V161, P1037, DOI 10.1016/j.neuroscience.2009.04.042; Signoretti S, 2010, NEUROSURG FOCUS, V29, DOI 10.3171/2010.9.FOCUS10183; Vagnozzi R, 2010, BRAIN, V133, P3232, DOI 10.1093/brain/awq200; Valle I, 2005, CARDIOVASC RES, V66, P562, DOI 10.1016/j.cardiores.2005.01.026; Walf AA, 2007, NAT PROTOC, V2, P322, DOI 10.1038/nprot.2007.44; Wu AG, 2011, J NEUROTRAUM, V28, P2113, DOI 10.1089/neu.2011.1872; Wu M, 2007, AM J PHYSIOL-CELL PH, V292, pC125, DOI 10.1152/ajpcell.00247.2006; Yamanaka M, 2007, DIABETES OBES METAB, V9, P59, DOI 10.1111/j.1463-1326.2006.00572.x; Zhang L, 2012, DIABETES OBES METAB, V14, P727, DOI 10.1111/j.1463-1326.2012.01592.x	43	22	22	0	9	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0925-4439	1879-260X		BBA-MOL BASIS DIS	Biochim. Biophys. Acta-Mol. Basis Dis.	APR	2014	1842	4					535	546		10.1016/j.bbadis.2013.12.004			12	Biochemistry & Molecular Biology; Biophysics; Cell Biology	Biochemistry & Molecular Biology; Biophysics; Cell Biology	AD8JC	WOS:000333511300001	24345766	Bronze			2021-06-18	
J	Kwon, HG; Jang, SH				Kwon, Hyeok Gyu; Jang, Sung Ho			Delayed gait disturbance due to injury of the corticoreticular pathway in a patient with mild traumatic brain injury	BRAIN INJURY			English	Article						Brain injury; corticoreticulospinal tract; corticoreticular pathway; corticospinal tract; diffusion tensor imaging; head trauma	DIFFUSE AXONAL INJURY; TENSOR TRACTOGRAPHY; PROXIMAL WEAKNESS; HEAD TRAUMA; ABNORMALITIES; RECOVERY; HUMANS; FORNIX; COMA	Background: Many studies have demonstrated neural injury in patients with mild traumatic brain injury, using diffusion tensor imaging (DTI). However, knowledge regarding injury of the corticoreticular pathway (CRP) is limited. This study reports on a patient with mild TBI who showed delayed gait disturbance due to injury of the CRP following head trauma, which was demonstrated by DTI. Methods: A 14-year-old female patient suffered from an in-car accident: her head was hit with the backseat during hyperextension after flexion movement when her sedan was struck by another sedan from behind. She showed mild quadriparesis after onset. At 29 days after onset, she noted gait disturbance and aggravated quadriparesis with more severe weakness of the proximal joints. Results: No abnormality was observed on brain MRI and electromyography study performed at 10 weeks after onset. Both CRPs were discontinued at the midbrain level on 10-week DTI. Conclusion: It appears that the proximal weakness of this patient was attributed to injury of both CRPs following head trauma. It is assumed that the mild weakness at the onset of head trauma was caused by the primary traumatic axonal injury and the aggravated weakness that started from 29 days might be ascribed to the secondary traumatic axonal injury.	[Kwon, Hyeok Gyu; Jang, Sung Ho] Yeungnam Univ, Coll Med, Dept Phys Med & Rehabil, Taegu 705717, South Korea	Jang, SH (corresponding author), Yeungnam Univ, Coll Med, Dept Phys Med & Rehabil, 317-1 Daemyungdong, Taegu 705717, South Korea.	strokerehab@hanmail.net			National Research Foundation of Korea (NRF)National Research Foundation of Korea; Ministry of Education, Science and TechnologyMinistry of Education, Science and Technology, Republic of Korea [2012R1A1A4A01001873]	This research was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (2012R1A1A4A01001873).	ADAMS JH, 1982, ANN NEUROL, V12, P557, DOI 10.1002/ana.410120610; ALEXANDER MP, 1995, NEUROLOGY, V45, P1253, DOI 10.1212/WNL.45.7.1253; Bazarian JJ, 2007, J NEUROTRAUM, V24, P1447, DOI 10.1089/neu.2007.0241; Blumbergs PC, 1998, J CLIN NEUROSCI, V5, P123, DOI 10.1016/S0967-5868(98)90026-1; Buki A, 2006, ACTA NEUROCHIR, V148, P181, DOI 10.1007/s00701-005-0674-4; Corbo J, 2004, ANN EMERG MED, V44, P57, DOI 10.1016/j.annemergmed.2003.11.010; de Kruijk JR, 2001, BRAIN INJURY, V15, P99, DOI 10.1080/026990501458335; Do KH, 2013, NEUROSCI LETT, V546, P21, DOI 10.1016/j.neulet.2013.04.040; Gieron MA, 1998, PEDIATR NEUROL, V19, P382, DOI 10.1016/S0887-8994(98)00072-1; Hofman PAM, 2001, AM J NEURORADIOL, V22, P441; Hong JH, 2010, J REHABIL MED, V42, P979, DOI 10.2340/16501977-0603; Hughes DG, 2004, NEURORADIOLOGY, V46, P550, DOI 10.1007/s00234-004-1227-x; Jackson CFE, 1970, STROKE, V1, P278, DOI 10.1161/01.STR.1.4.278; Jang SH, 2013, STROKE, V44, P1099, DOI 10.1161/STROKEAHA.111.000269; Jang SH, 2010, NEURAL REGEN RES, V5, P1829, DOI 10.3969/j.issn.1673-5374.2010.23.011; Jang SH, 2009, NEUROREHABILITATION, V25, P229, DOI 10.3233/NRE-2009-0519; Jo HM, 2012, NEUROREHABILITATION, V31, P207, DOI 10.3233/NRE-2012-0790; Kasahara K, 2012, MAGN RESON IMAGING, V30, P496, DOI 10.1016/j.mri.2011.12.018; Kurca E, 2006, NEURORADIOLOGY, V48, P661, DOI 10.1007/s00234-006-0109-9; Lipton ML, 2008, J NEUROTRAUM, V25, P1335, DOI 10.1089/neu.2008.0547; Medical Research Council (Great Britain), 1976, AIDS EX PER NERV SYS, P62; Mendoza JE, 2007, CLIN NEUROANATOMY NE, P704; Palacios EM, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-24; POVLISHOCK JT, 1995, J NEUROTRAUM, V12, P555, DOI 10.1089/neu.1995.12.555; Povlishock JT, 2005, J HEAD TRAUMA REHAB, V20, P76, DOI 10.1097/00001199-200501000-00008; Rutgers DR, 2008, AM J NEURORADIOL, V29, P514, DOI 10.3174/ajnr.A0856; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; SNOEK JW, 1984, BRAIN, V107, P15, DOI 10.1093/brain/107.1.15; TEASDALE G, 1974, LANCET, V2, P81; Van Zijl PCM, 2004, MRI ATLAS HUMAN WHIT; Williams JM, 1991, MAS MEMORY ASSESSMEN, P127; Yeo SS, 2013, J REHABIL MED, V45, P595, DOI 10.2340/16501977-1145; Yeo SS, 2013, NEUROREHABILITATION, V32, P665, DOI 10.3233/NRE-130889; Yeo SS, 2012, NEUROSCI LETT, V508, P9, DOI 10.1016/j.neulet.2011.11.030	34	22	22	0	2	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	APR	2014	28	4					511	514		10.3109/02699052.2014.887228			4	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	AF5GL	WOS:000334741900016	24564187				2021-06-18	
J	Kirkwood, MW; Connery, AK; Kirk, JW; Baker, DA				Kirkwood, Michael W.; Connery, Amy K.; Kirk, John W.; Baker, David A.			Detecting performance invalidity in children: Not quite as easy as A, B, C, 1, 2, 3 but automatized sequences appears promising	CHILD NEUROPSYCHOLOGY			English	Article						Response bias; Mild traumatic brain injury; Performance validity testing; Postconcussion; Automatized sequences	DISABILITY CONSULTATIVE EXAM; SYMPTOM VALIDITY TEST; DIGIT SPAN; PEDIATRIC SAMPLE; BRAIN-INJURY; TOMM; ADOLESCENTS; RECOVERY; CAPACITY; EPILEPSY	In adult populations, embedded performance validity indicators are well established, as they are time efficient, resistant to coaching, and allow for more continuous monitoring of effort than standalone measures. Although several recent studies have demonstrated the appropriateness of using standalone validity tests with school-age children, a paucity of pediatric work has examined embedded indicators. The present study investigated the value of a simple automatized sequences task to detect performance invalidity in 439 clinically referred patients with mild head injury aged 8 through 17 years. Sixteen percent of the participants failed the Medical Symptom Validity Test (MSVT). Thirteen percent failed the MSVT and also performed below established cutoffs on either the Test of Memory Malingering or Wechsler Digit Span subtest. The group classified as providing invalid data performed significantly worse than the group passing the MSVT across all sequencing conditions. Sensitivity and specificity for the total time on the sequencing task compared favorably to data produced for many respected adult-based embedded indicators (i.e., sensitivity around 50% when specificity >= 90%). Classification statistics for any embedded performance validity test can be expected to be worse in more severely affected populations; however, the current sequencing task appears to have value in detecting invalid performance in relatively high-functioning older children and adolescents. The fact that the task takes less than a couple of minutes to administer makes it especially appealing.	Univ Colorado Denver, Dept Phys Med & Rehabil, Sch Med, Aurora, CO USA; Childrens Hosp Colorado, Aurora, CO USA	Kirkwood, MW (corresponding author), ABPP CN Childrens Hosp Colorado, Concuss Program, 13123 E 16th Ave, Aurora, CO 80045 USA.	Michael.Kirkwood@childrenscolorado.org					Babikian T, 2009, NEUROPSYCHOLOGY, V23, P283, DOI 10.1037/a0015268; Blaskewitz N, 2008, ARCH CLIN NEUROPSYCH, V23, P379, DOI 10.1016/j.acn.2008.01.008; Boone, 2007, ASSESSMENT FEIGNED C; Brooks B. L., 2012, ARCH CLIN NEUROPSYCH; Brooks BL, 2012, ARCH CLIN NEUROPSYCH, V27, P23, DOI 10.1093/arclin/acr086; Carone DA, 2008, BRAIN INJURY, V22, P960, DOI 10.1080/02699050802491297; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Chafetz MD, 2008, CLIN NEUROPSYCHOL, V22, P529, DOI 10.1080/13854040701346104; Chafetz MD, 2007, ARCH CLIN NEUROPSYCH, V22, P1, DOI 10.1016/j.acn.2006.10.003; Cohen J., 1988, STAT POWER ANAL BEHA, V2nd; Donders J, 2005, CHILD NEUROPSYCHOL, V11, P221, DOI 10.1080/09297040490917298; FAUST D, 1988, J CONSULT CLIN PSYCH, V56, P578, DOI 10.1037/0022-006X.56.4.578; FAUST D, 1988, PROF PSYCHOL-RES PR, V19, P508, DOI 10.1037/0735-7028.19.5.508; Flaro L., 2009, NEUROPSYCHOLOGY MALI, P369; Green P, 2001, BRAIN INJURY, V15, P1045, DOI 10.1080/02699050110088254; Green P., 2004, MANUAL MED SYMPTOM V; Henry G. K., 2005, FORENSIC NEUROPSYCHO, P205; Kirk JW, 2011, CHILD NEUROPSYCHOL, V17, P242, DOI 10.1080/09297049.2010.533166; Kirkwood M. W, 2012, PEDIAT FORENSIC NEUR, P136; Kirkwood MW, 2008, CLIN NEUROPSYCHOL, V22, P769, DOI 10.1080/13854040701543700; Kirkwood MW, 2012, PSYCHOL ASSESSMENT, V24, P36, DOI 10.1037/a0024628; Kirkwood MW, 2011, ARCH CLIN NEUROPSYCH, V26, P377, DOI 10.1093/arclin/acr040; Kirkwood MW, 2010, CHILD NEUROPSYCHOL, V16, P604, DOI 10.1080/09297049.2010.495059; Kirkwood MW, 2010, CLIN NEUROPSYCHOL, V24, P860, DOI 10.1080/13854040903527287; Larrabee G.J., 2007, ASSESSMENT MALINGERE; Larrabee GJ, 2012, J INT NEUROPSYCH SOC, V18, P625, DOI 10.1017/S1355617712000240; Loughan AR, 2012, ARCH CLIN NEUROPSYCH, V27, P716, DOI 10.1093/arclin/acs072; Lu PH, 2002, CLIN NEUROPSYCHOL, V16, P90, DOI 10.1076/clin.16.1.90.8328; MacAllister WS, 2009, CHILD NEUROPSYCHOL, V15, P521, DOI 10.1080/09297040902748226; McCaffrey R. J., 2009, NEUROPSYCHOLOGY MALI, P377; Tombaugh TN, 1996, TEST MEMORY MALINGER; Welsh AJ, 2012, ARCH CLIN NEUROPSYCH, V27, P735, DOI 10.1093/arclin/acs063; Yeates K. O., 2012, MILD TRAUMATIC BRAIN, P124	33	22	22	0	4	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0929-7049	1744-4136		CHILD NEUROPSYCHOL	Child Neuropsychol.	MAR 4	2014	20	2					245	252		10.1080/09297049.2012.759553			8	Clinical Neurology	Neurosciences & Neurology	AB0ZB	WOS:000331519900008	23297668				2021-06-18	
J	Alharfi, IM; Stewart, TC; Al Helali, I; Daoud, H; Fraser, DD				Alharfi, Ibrahim M.; Stewart, Tanya Charyk; Al Helali, Ibrahim; Daoud, Hani; Fraser, Douglas D.			Infection Rates, Fevers, and Associated Factors in Pediatric Severe Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						children; nosocomial infection; severe traumatic brain injury; treatment	POSTTRAUMATIC-STRESS-DISORDER; WHITE-MATTER; WAR VETERANS; AXONAL INJURY; MULTIPLE-SCLEROSIS; DIFFUSION MRI; STEADY-STATE; HEAD-INJURY; FDG-PET; IMAGES	Infections can increase medical costs and worsen patient outcomes. Our aims in pediatric severe traumatic brain injury (sTBI) patients were to determine the infection and fever rates, and to report on associated clinical, imaging, treatment, and outcome factors. We included 180 sTBI patients (presedation Glasgow Coma Scale <= 8 and Maximum Abbreviated Injury Scale >= 4) admitted to our pediatric intensive care unit. Overall, 17% of sTBI patients (n=30 of 180) developed 36 infections, consisting primarily of urinary tract infections (UTIs; n=13 of 36) and ventilator-associated pneumonias (n=11 of 36). Most infections were nosocomial, occurring >2 days after admission. Fever was found in 36% of sTBI patients during the first few hospital days, but fewer than 7% of patients had infections. Infections occurred more frequently in sTBI patients who were older, heavier, and with a higher injury severity score (ISS; p<0.05). Admission head computed tomography imaging abnormalities (subarachnoid hemorrhage, intraventricular hemorrhage, and diffuse axonal injury), placement of an intracranial pressure (ICP) monitor, and administration of ICP-lowering therapies (hypertonic saline, mannitol, and thiopental) were associated with infections (p<0.05). Those with infections had fewer ventilator-free days, greater hospital lengths of stays, and were less likely to be discharged home. Logistic regression demonstrated that infections were independently associated with use of hypertonic saline (odds ratio [OR], 4.46; p=0.001) and higher ISS (OR, 1.05; p=0.028). In summary, infections were prevalent in sTBI patients and were associated with greater head-imaging abnormalities and use of ICP-lowering therapies. Hypertonic saline administration was strongly associated with infection, but further analyses are required to determine the nature of this relationship. Fever was a poor indicator of infection after sTBI.	[Alharfi, Ibrahim M.; Al Helali, Ibrahim; Daoud, Hani; Fraser, Douglas D.] Univ Western Ontario, Dept Paediat, London, ON, Canada; [Stewart, Tanya Charyk] Univ Western Ontario, Dept Surg, London, ON N6A 3K7, Canada; [Fraser, Douglas D.] Univ Western Ontario, London, ON, Canada; [Alharfi, Ibrahim M.] King Fahad Med City, Dept Pediat Crit Care, Riyadh, Saudi Arabia; [Stewart, Tanya Charyk] London Hlth Sci Ctr, Trauma Program, London, ON, Canada; [Fraser, Douglas D.] Translat Res Ctr, London, ON, Canada; [Fraser, Douglas D.] Childrens Hlth Res Inst, London, ON, Canada; [Fraser, Douglas D.] Ctr Crit Illness Res, London, ON, Canada	Fraser, DD (corresponding author), Childrens Hosp, London Hlth Sci Ctr, Room C2-C82 800 Commissioners Rd East, London, ON N6A 5W9, Canada.	Douglas.Fraser@lhsc.on.ca					ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; Ayling E, 2012, CURR PSYCHIAT REP, V14, P197, DOI 10.1007/s11920-012-0273-z; Bagley LJ, 2000, J MAGN RESON IMAGING, V11, P1, DOI 10.1002/(SICI)1522-2586(200001)11:1<1::AID-JMRI1>3.0.CO;2-H; Bergsneider M, 2001, J HEAD TRAUMA REHAB, V16, P135, DOI 10.1097/00001199-200104000-00004; BLAKE DD, 1995, J TRAUMA STRESS, V8, P75, DOI 10.1002/jts.2490080106; BOOKSTEIN FL, 1989, IEEE T PATTERN ANAL, V11, P567, DOI 10.1109/34.24792; Bookstein FL, 2001, NEUROIMAGE, V14, P1454, DOI 10.1006/nimg.2001.0770; Broglio SP, 2011, J NEUROTRAUM, V28, P2061, DOI 10.1089/neu.2011.1905; Bush K, 1998, ARCH INTERN MED, V158, P1789, DOI 10.1001/archinte.158.16.1789; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Chappell MH, 2006, J MAGN RESON IMAGING, V24, P537, DOI 10.1002/jmri.20656; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Clark WEL, 1936, J ANAT, V71, P7; Davenport ND, 2012, NEUROIMAGE, V59, P2017, DOI 10.1016/j.neuroimage.2011.10.050; Doty RL, 1996, LARYNGOSCOPE, V106, P353, DOI 10.1097/00005537-199603000-00021; Edden RA, 2011, J NEUROSCI METH, V201, P213, DOI 10.1016/j.jneumeth.2011.07.025; Eibner C, 2009, NEW ENGL J MED, V361, P537; First MB., 2002, STRUCTURED CLIN INTE; Forbes D, 2001, BEHAV RES THER, V39, P977, DOI 10.1016/S0005-7967(00)00084-X; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; Hofman PAM, 2002, J NEUROPSYCH CLIN N, V14, P176, DOI 10.1176/appi.neuropsych.14.2.176; Hoge CW, 2009, NEW ENGL J MED, V360, P1588, DOI 10.1056/NEJMp0810606; Hosaka K, 2005, EUR J NUCL MED MOL I, V32, P92, DOI 10.1007/s00259-004-1576-z; Jones DK, 2010, NMR BIOMED, V23, P803, DOI 10.1002/nbm.1543; Jorge RE, 2012, AM J PSYCHIAT, V169, P1284, DOI 10.1176/appi.ajp.2012.12050600; Kang XJ, 2012, MAGN RESON IMAGING, V30, P1111, DOI 10.1016/j.mri.2012.04.004; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Killgore WDS, 2008, J PSYCHIATR RES, V42, P1112, DOI 10.1016/j.jpsychires.2008.01.001; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Levin HS, 2010, J NEUROTRAUM, V27, P683, DOI 10.1089/neu.2009.1073; Ling G, 2009, J NEUROTRAUM, V26, P815, DOI 10.1089/neu.2007.0484; Liu ZX, 2009, 2009 IEEE INTERNATIONAL SYMPOSIUM ON BIOMEDICAL IMAGING: FROM NANO TO MACRO, VOLS 1 AND 2, P807, DOI 10.1109/ISBI.2009.5193172; Mac Donald CL, 2011, NEW ENGL J MED, V364, P2091, DOI 10.1056/NEJMoa1008069; Mamere AE, 2009, AM J NEURORADIOL, V30, P947, DOI 10.3174/ajnr.A1477; MARTINEZMARTIN P, 1994, MOVEMENT DISORD, V9, P76, DOI 10.1002/mds.870090112; Maxwell WL, 1997, J NEUROTRAUM, V14, P419, DOI 10.1089/neu.1997.14.419; McGowan JC, 2000, AM J NEURORADIOL, V21, P875; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; MINOSHIMA S, 1995, J NUCL MED, V36, P1238; MINOSHIMA S, 1992, J NUCL MED, V33, P1579; MINOSHIMA S, 1993, J NUCL MED, V34, P322; MINOSHIMA S, 1994, J NUCL MED, V35, P949; MINOSHIMA S, 1994, J NUCL MED, V35, P1528; Minoshima S, 2002, J GERIATR PSYCH NEUR, V15, P200, DOI 10.1177/089198870201500405; Minoshima S., 2009, PRINCIPLES AND PRACT, P500; Morey RA, 2013, HUM BRAIN MAPP, V34, P2986, DOI 10.1002/hbm.22117; Oishi K., 2011, MRI ATLAS HUMAN WHIT; Omalu B, 2011, NEUROSURG FOCUS, V31, DOI 10.3171/2011.9.FOCUS11178; Peskind ER, 2011, NEUROIMAGE, V54, pS76, DOI 10.1016/j.neuroimage.2010.04.008; Rausch M, 2009, MULT SCLER, V15, P16, DOI 10.1177/1352458508096006; Samsonov A, 2012, NEUROIMAGE, V62, P1390, DOI 10.1016/j.neuroimage.2012.05.077; Schmierer K, 2007, J MAGN RESON IMAGING, V26, P41, DOI 10.1002/jmri.20984; Sigford B, 2009, NEW ENGL J MED, V361, P536, DOI 10.1056/NEJMc096180; Sinson G, 2001, AM J NEURORADIOL, V22, P143; Skinner TE, 1997, MAGN RESON MED, V37, P628, DOI 10.1002/mrm.1910370426; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Stern RA, 2011, PM&R, V3, pS460, DOI 10.1016/j.pmrj.2011.08.008; STRICH SJ, 1956, J NEUROL NEUROSUR PS, V19, P163, DOI 10.1136/jnnp.19.3.163; Talairach J., 1988, COPLANAR STEREOTAXIC; Tustison NJ, 2012, HUM BRAIN MAPP; Underhil HR, 2009, NEUROIMAGE, V47, P1568, DOI 10.1016/j.neuroimage.2009.05.075; Underhill HR, 2011, NEUROIMAGE, V54, P2052, DOI 10.1016/j.neuroimage.2010.10.065; Weathers FW, 1999, PSYCHOL ASSESSMENT, V11, P124, DOI 10.1037/1040-3590.11.2.124; WORSLEY KJ, 1992, J CEREBR BLOOD F MET, V12, P900, DOI 10.1038/jcbfm.1992.127; Yarnykh VL, 2007, MAGN RESON MED, V57, P192, DOI 10.1002/mrm.21120; Yarnykh VL, 2012, MAGN RESON MED, V68, P166, DOI 10.1002/mrm.23224; Yarnykh VL, 2010, MAGN RESON MED, V63, P1610, DOI 10.1002/mrm.22394; Yarnykh VL, 2004, NEUROIMAGE, V23, P409, DOI 10.1016/j.neuroimage.2004.04.029; Yarnykh VL, 2002, MAGNET RESON MED, V47, P929, DOI 10.1002/mrm.10120	71	22	27	0	6	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	MAR 1	2014	31	5					452	458		10.1089/NEU.2013.2904			7	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	AB4ZV	WOS:000331799600243	24093309				2021-06-18	
J	Cunningham, TL; Cartagena, CM; Lu, XCM; Konopko, M; Dave, JR; Tortella, FC; Shear, DA				Cunningham, Tracy L.; Cartagena, Casandra M.; Lu, Xi-Chun M.; Konopko, Melissa; Dave, Jitendra R.; Tortella, Frank C.; Shear, Deborah A.			Correlations between Blood-Brain Barrier Disruption and Neuroinflammation in an Experimental Model of Penetrating Ballistic-Like Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						blood-brain barrier dysfunction; inflammation; penetrating brain injury; PBBI; traumatic brain injury	FLUID PERCUSSION INJURY; CENTRAL-NERVOUS-SYSTEM; INFLAMMATORY RESPONSE; FUNCTIONAL NEUROANATOMY; INSULA ACTIVATION; PREFRONTAL CORTEX; AFFECTED FORELIMB; INNATE SENSE; RAT MODEL; ANXIETY	Blood-brain barrier (BBB) disruption is a pathological hallmark of severe traumatic brain injury (TBI) and is associated with neuroinflammatory events contributing to brain edema and cell death. The goal of this study was to elucidate the profile of BBB disruption after penetrating ballistic-like brain injury (PBBI) in conjunction with changes in neuroinflammatory markers. Brain uptake of biotin-dextran amine (BDA; 3kDa) and horseradish peroxidase (HRP; 44kDa) was evaluated in rats at 4h, 24h, 48h, 72h, and 7 days post-PBBI and compared with the histopathologic and molecular profiles for inflammatory markers. BDA and HRP both displayed a uniphasic profile of extravasation, greatest at 24h post-injury and which remained evident out to 48h for HRP and 7 days for BDA. This profile was most closely associated with markers for adhesion (mRNA for intercellular adhesion molecule-1) and infiltration of peripheral granulocytes (mRNA for matrix metalloproteinase-9 [MMP-9] and myeloperoxidase staining). Improvement of BBB dysfunction coincided with increased expression of markers implicated in tissue remodeling and repair. The results of this study reveal a uniphasic and gradient opening of the BBB after PBBI and suggest MMP-9 and resident inflammatory cell activation as candidates for future neurotherapeutic intervention after PBBI.	[Cunningham, Tracy L.; Cartagena, Casandra M.; Lu, Xi-Chun M.; Konopko, Melissa; Dave, Jitendra R.; Tortella, Frank C.; Shear, Deborah A.] Walter Reed Army Inst Res, Ctr Mil Psychiat & Neurosci, Branch Brain Trauma Neuroprotect & Neurorestorat, Silver Spring, MD 20910 USA	Cunningham, TL (corresponding author), Walter Reed Army Inst Res, Ctr Mil Psychiat & Neurosci, 503 Robert Grant Ave, Silver Spring, MD 20910 USA.	Tracy.L.Cunningham2.ctr@us.army.mil		Konopko, Melissa/0000-0001-9515-398X			Alessandri B, 2002, J NEUROTRAUM, V19, P829, DOI 10.1089/08977150260190429; Bianchi ME, 2007, J LEUKOCYTE BIOL, V81, P1, DOI 10.1189/jlb.0306164; Bland ST, 2001, BEHAV BRAIN RES, V126, P33, DOI 10.1016/S0166-4328(01)00243-1; Bland ST, 2000, STROKE, V31, P1144, DOI 10.1161/01.STR.31.5.1144; BREMNER JD, 1995, AM J PSYCHIAT, V152, P973; Byrnes KR, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-43; Campbell JN, 2012, J NEUROTRAUM, V29, P201, DOI 10.1089/neu.2011.1761; Carlson JM, 2011, SOC COGN AFFECT NEUR, V6, P74, DOI 10.1093/scan/nsq017; Chen SF, 2007, LIFE SCI, V81, P288, DOI 10.1016/j.lfs.2007.05.023; Cho Y, 2010, P NATL ACAD SCI USA, V107, P11313, DOI 10.1073/pnas.1002716107; Clausen F, 2009, EUR J NEUROSCI, V30, P385, DOI 10.1111/j.1460-9568.2009.06820.x; Colangelo AM, 2012, BIOTECHNOL ADV, V30, P261, DOI 10.1016/j.biotechadv.2011.06.016; Cole JT, 2011, J NEUROTRAUM, V28, P359, DOI 10.1089/neu.2010.1427; Connor TJ, 1998, NEUROSCIENCE, V84, P923, DOI 10.1016/S0306-4522(97)00533-2; Cragnolini AB, 2006, PEPTIDES, V27, P1451, DOI 10.1016/j.peptides.2005.10.020; D'Ambrosio R, 2004, BRAIN, V127, P304, DOI 10.1093/brain/awh038; Davidson RJ, 2002, BIOL PSYCHIAT, V51, P68, DOI 10.1016/S0006-3223(01)01328-2; Davis M, 2006, AM PSYCHOL, V61, P741, DOI 10.1037/0003-066X.61.8.741; Deb S, 1999, AM J PSYCHIAT, V156, P374; Elder GA, 2012, J NEUROTRAUM, V29, P2564, DOI 10.1089/neu.2012.2510; Ellis A. L., 2008, 38 ANN M SOC NEUR WA; FANSELOW MS, 1986, LEARN MOTIV, V17, P16, DOI 10.1016/0023-9690(86)90018-4; Faul M.D., 2010, TRAUMATIC BRAIN INJU; Frey LC, 2009, J NEUROSCI METH, V177, P267, DOI 10.1016/j.jneumeth.2008.10.022; Gallucci S, 2001, CURR OPIN IMMUNOL, V13, P114, DOI 10.1016/S0952-7915(00)00191-6; GEHRMANN J, 1993, J NEUROIMMUNOL, V48, P189, DOI 10.1016/0165-5728(93)90191-Z; GEHRMANN J, 1995, BRAIN RES REV, V20, P269, DOI 10.1016/0165-0173(94)00015-H; Gentleman SM, 2004, FORENSIC SCI INT, V146, P97, DOI 10.1016/j.forsciint.2004.06.027; Gibson LCD, 2006, EUR J PHARMACOL, V538, P39, DOI 10.1016/j.ejphar.2006.02.053; Grady MS, 2003, J NEUROTRAUM, V20, P929, DOI 10.1089/089771503770195786; GRAEBER MB, 1988, J NEUROCYTOL, V17, P209, DOI 10.1007/BF01674208; Griffin WST, 1998, BRAIN PATHOL, V8, P65; Gueorguieva I, 2008, BRIT J CLIN PHARMACO, V65, P317, DOI 10.1111/j.1365-2125.2007.03026.x; Hailer NP, 2008, PROG NEUROBIOL, V84, P211, DOI 10.1016/j.pneurobio.2007.12.001; Hanisch UK, 2002, GLIA, V40, P140, DOI 10.1002/glia.10161; Hanisch UK, 2007, NAT NEUROSCI, V10, P1387, DOI 10.1038/nn1997; Herber DL, 2006, GLIA, V53, P382, DOI 10.1002/glia.20272; Hill SJ, 1996, J NEUROPATH EXP NEUR, V55, P1221, DOI 10.1097/00005072-199612000-00005; Hiott DW, 2002, NEUROREHABILITATION, V17, P345; Hirsiger S, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/315941; Hoge EA, 2009, DEPRESS ANXIETY, V26, P447, DOI 10.1002/da.20564; Homsi S, 2010, J NEUROTRAUM, V27, P911, DOI 10.1089/neu.2009.1223; Homsi S, 2009, BRAIN RES, V1291, P122, DOI 10.1016/j.brainres.2009.07.031; Iravani MM, 2005, EUR J NEUROSCI, V22, P317, DOI 10.1111/j.1460-9568.2005.04220.x; Konuk N, 2007, MEDIAT INFLAMM, V2007, DOI 10.1155/2007/65704; Koponen S, 2002, AM J PSYCHIAT, V159, P1315, DOI 10.1176/appi.ajp.159.8.1315; Kovesdi Erzsebet, 2012, Front Neurol, V3, P111, DOI 10.3389/fneur.2012.00111; Landeira-Fernandez J, 2006, BEHAV NEUROSCI, V120, P873, DOI 10.1037/0735-7044.120.4.873; Lee HF, 2012, RESP PHYSIOL NEUROBI, V182, P1, DOI 10.1016/j.resp.2012.01.016; Li B, 2009, NEUROSURGERY, V65, P179, DOI 10.1227/01.NEU.0000346272.76537.DC; Lopez NE, 2012, BRAIN RES, V1489, P140, DOI 10.1016/j.brainres.2012.10.031; Loram LC, 2009, J NEUROSCI, V29, P14015, DOI 10.1523/JNEUROSCI.3447-09.2009; Matzinger P, 1998, SEMIN IMMUNOL, V10, P399, DOI 10.1006/smim.1998.0143; Matzinger P, 2002, ANN NY ACAD SCI, V961, P341, DOI 10.1111/j.1749-6632.2002.tb03118.x; McCann MJ, 1996, NEUROSCIENCE, V72, P273, DOI 10.1016/0306-4522(95)00526-9; Milad MR, 2009, BIOL PSYCHIAT, V66, P1075, DOI 10.1016/j.biopsych.2009.06.026; Mizuno T, 2004, NEUROPHARMACOLOGY, V46, P404, DOI 10.1016/j.neuropharm.2003.09.009; MORRISSEY TK, 1989, BEHAV BRAIN RES, V35, P195, DOI 10.1016/S0166-4328(89)80141-X; MORTON MV, 1995, BRAIN INJURY, V9, P81, DOI 10.3109/02699059509004574; Nagamoto-Combs K, 2007, J NEUROTRAUM, V24, P1719, DOI 10.1089/neu.2007.0377; Namas R, 2009, LIBYAN J MED, V4, P97, DOI 10.4176/090325; NITZ AJ, 1986, EXP NEUROL, V94, P264, DOI 10.1016/0014-4886(86)90101-9; Nonaka M, 1999, J NEUROTRAUM, V16, P1023, DOI 10.1089/neu.1999.16.1023; OLESEN SP, 1987, ACTA PHYSIOL SCAND, V130, P63, DOI 10.1111/j.1748-1716.1987.tb08112.x; Olson JK, 2004, J IMMUNOL, V173, P3916, DOI 10.4049/jimmunol.173.6.3916; Oppenheim JJ, 2005, CURR OPIN IMMUNOL, V17, P359, DOI 10.1016/j.coi.2005.06.002; Oppenheim JJ, 2007, ADV EXP MED BIOL, V601, P185; PELLIS SM, 1991, BEHAV BRAIN RES, V46, P151, DOI 10.1016/S0166-4328(05)80108-1; PELLIS SM, 1991, BEHAV BRAIN RES, V45, P185, DOI 10.1016/S0166-4328(05)80084-1; Pugin J, 2012, ANN INTENSIVE CARE, V2, DOI 10.1186/2110-5820-2-27; Raison CL, 2003, AM J PSYCHIAT, V160, P1554, DOI 10.1176/appi.ajp.160.9.1554; Ramlackhansingh AF, 2011, ANN NEUROL, V70, P374, DOI 10.1002/ana.22455; Rao V, 2000, PSYCHOSOMATICS, V41, P95, DOI 10.1176/appi.psy.41.2.95; Rauch SL, 1997, BIOL PSYCHIAT, V42, P446, DOI 10.1016/S0006-3223(97)00145-5; Reger ML, 2012, BIOL PSYCHIAT, V71, P335, DOI 10.1016/j.biopsych.2011.11.007; Rodgers KM, 2012, J NEUROTRAUM, V29, P1886, DOI 10.1089/neu.2011.2273; Rohleder N, 2004, BIOL PSYCHIAT, V55, P745, DOI 10.1016/j.biopsych.2003.11.018; Rolan P, 2009, EXPERT OPIN PHARMACO, V10, P2897, DOI 10.1517/14656560903426189; Rosen JB, 1998, PSYCHOL REV, V105, P325, DOI 10.1037/0033-295X.105.2.325; Rosen Jeffrey B, 2004, Behav Cogn Neurosci Rev, V3, P23, DOI 10.1177/1534582304265945; Rudy JW, 2001, COGN AFFECT BEHAV NE, V1, P66, DOI 10.3758/CABN.1.1.66; Samuels ER, 2008, CURR NEUROPHARMACOL, V6, P235, DOI 10.2174/157015908785777229; SANBERG PR, 1988, BEHAV NEUROSCI, V102, P748, DOI 10.1037/0735-7044.102.5.748; Sapolsky RM, 2000, ARCH GEN PSYCHIAT, V57, P925, DOI 10.1001/archpsyc.57.10.925; SCHALLERT T, 1979, EXP NEUROL, V64, P33, DOI 10.1016/0014-4886(79)90003-7; Schallert T, 2000, NEUROPHARMACOLOGY, V39, P777, DOI 10.1016/S0028-3908(00)00005-8; Schallert Timothy, 2006, NeuroRx, V3, P497, DOI 10.1016/j.nurx.2006.08.001; Shin LM, 2006, ANN NY ACAD SCI, V1071, P67, DOI 10.1196/annals.1364.007; Shin LM, 2010, NEUROPSYCHOPHARMACOL, V35, P169, DOI 10.1038/npp.2009.83; Simmons A, 2006, BIOL PSYCHIAT, V60, P402, DOI 10.1016/j.biopsych.2006.04.038; Siopi E, 2012, NEUROSCI LETT, V511, P110, DOI 10.1016/j.neulet.2012.01.051; Sokolova E S, 2007, Neurosci Behav Physiol, V37, P499, DOI 10.1007/s11055-007-0042-3; Spivak B, 1997, BIOL PSYCHIAT, V42, P345, DOI 10.1016/S0006-3223(96)00375-7; Stein MB, 2007, AM J PSYCHIAT, V164, P318, DOI 10.1176/appi.ajp.164.2.318; Sternberg EM, 1997, J CLIN INVEST, V100, P2641, DOI 10.1172/JCI119807; Streit WJ, 2004, J NEUROINFLAMM, V1, DOI 10.1186/1742-2094-1-14; Szelenyi J, 2007, ANN NY ACAD SCI, V1113, P311, DOI 10.1196/annals.1391.026; Thompson HJ, 2005, J NEUROTRAUM, V22, P42, DOI 10.1089/neu.2005.22.42; Tucker P, 2004, BIOL PSYCHIAT, V56, P121, DOI 10.1016/j.biopsych.2004.03.009; Vaishnavi S, 2009, PSYCHOSOMATICS, V50, P198, DOI 10.1176/appi.psy.50.3.198; van Reekum R, 2000, J NEUROPSYCH CLIN N, V12, P316, DOI 10.1176/appi.neuropsych.12.3.316; von Kanel R, 2007, J PSYCHIATR RES, V41, P744, DOI 10.1016/j.jpsychires.2006.06.009; Wang FZ, 2011, ANESTHESIOLOGY, V114, P643, DOI 10.1097/ALN.0b013e31820a4bf3; Woodlee MT, 2005, EXP NEUROL, V191, P310, DOI 10.1016/j.expneurol.2004.09.005; Xiong Y, 2010, J NEUROSURG, V113, P598, DOI 10.3171/2009.9.JNS09844; Yatsiv I, 2005, FASEB J, V19, P1701, DOI 10.1096/fj.05-3907fje; Yu I, 2010, J NEUROTRAUM, V27, P1463, DOI 10.1089/neu.2009.1196; Zhang D, 2010, MOL NEUROBIOL, V41, P232, DOI 10.1007/s12035-010-8098-4; Zubareva O E, 2009, Neurosci Behav Physiol, V39, P21, DOI 10.1007/s11055-008-9090-6	109	22	22	1	8	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	MAR 1	2014	31	5					505	514		10.1089/neu.2013.2965			10	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	AB4ZV	WOS:000331799600249	24138024	Green Published			2021-06-18	
J	Max, JE				Max, Jeffrey E.			Neuropsychiatry of Pediatric Traumatic Brain Injury	PSYCHIATRIC CLINICS OF NORTH AMERICA			English	Article						Pediatric traumatic brain injury; Novel psychiatric disorder; Risk factors; Treatment; Review; Brain imaging	CLOSED-HEAD-INJURY; ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; DEFICIT-HYPERACTIVITY DISORDER; 1ST 6 MONTHS; PSYCHIATRIC-DISORDERS; PERSONALITY-CHANGE; POSTCONCUSSIVE SYMPTOMS; SUBSEQUENT DEVELOPMENT; EXECUTIVE DYSFUNCTION; SPATIAL-DISTRIBUTION	Pediatric traumatic brain injury (TBI) is a major public health problem. Psychiatric disorders with onset before the injury are more common than population base rates. Novel (postinjury onset) psychiatric disorders (NPD) are also common and complicate child function after injury. Novel disorders include personality change due to TBI, secondary attention-deficit/hyperactivity disorder, other disruptive behavior disorders, and internalizing disorders. This article reviews preinjury psychiatric disorders as well as biopsychosocial risk factors and treatments for NPD.	Rady Childrens Hosp, San Diego, CA 92123 USA	Max, JE (corresponding author), Rady Childrens Hosp, 3020 Childrens Way,MC 5018, San Diego, CA 92123 USA.	jmax@ucsd.edu			NICHD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01 HD068432, R-01 1R01HD068432-01A1] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD068432] Funding Source: NIH RePORTER		ASARNOW RF, 1991, J PEDIATR PSYCHOL, V16, P543, DOI 10.1093/jpepsy/16.5.543; BIJUR P, 1988, AM J DIS CHILD, V142, P1307, DOI 10.1001/archpedi.1988.02150120061041; BROWN G, 1981, PSYCHOL MED, V11, P63, DOI 10.1017/S0033291700053289; Cohen ML, 2012, J PEDIATR PSYCHOL, V37, P251, DOI 10.1093/jpepsy/jsr086; Dennis M, 2001, BRAIN LANG, V78, P1, DOI 10.1006/brln.2000.2431; Dennis M, 2008, J INT NEUROPSYCH SOC, V14, P673, DOI 10.1017/S1355617708080983; Ewing-Cobbs L, 2006, J NEUROSURG, V105, P287, DOI 10.3171/ped.2006.105.4.287; Ewing-Cobbs L, 2012, INT J DEV NEUROSCI, V30, P247, DOI 10.1016/j.ijdevneu.2011.07.004; FLETCHER JM, 1990, J CONSULT CLIN PSYCH, V58, P93, DOI 10.1037/0022-006X.58.1.93; Ganesalingam K, 2008, J PEDIATR PSYCHOL, V33, P621, DOI 10.1093/jpepsy/jsm133; Gerring J, 2000, BRAIN INJURY, V14, P205; Gerring JP, 2009, BRAIN INJURY, V23, P944, DOI 10.3109/02699050903285531; Gerring JP, 1998, J AM ACAD CHILD PSY, V37, P647, DOI 10.1097/00004583-199806000-00015; Gerring JP, 2002, J AM ACAD CHILD PSY, V41, P157, DOI 10.1097/00004583-200202000-00009; Glang A, 2007, J HEAD TRAUMA REHAB, V22, P198, DOI 10.1097/01.HTR.0000271121.42523.3a; Grados MA, 2008, DEPRESS ANXIETY, V25, P398, DOI 10.1002/da.20398; Herskovits EH, 1999, RADIOLOGY, V213, P389, DOI 10.1148/radiology.213.2.r99nv45389; Herskovits EH, 2002, RADIOLOGY, V224, P345, DOI 10.1148/radiol.2242011439; HOON AH, 1992, DEV MED CHILD NEUROL, V34, P252; Jin C, 2004, CNS SPECTRUMS, V9, P217, DOI 10.1017/S1092852900009019; JORGE RE, 1993, J NEUROPSYCH CLIN N, V5, P369; Josie KL, 2008, J HEAD TRAUMA REHAB, V23, P357, DOI 10.1097/01.HTR.0000341431.29133.a8; Kesler SR, 2003, APPL NEUROPSYCHOL, V10, P153, DOI 10.1207/S15324826AN1003_04; Kirkwood M, 2000, CHILD NEUROPSYCHOL, V6, P195, DOI 10.1076/chin.6.3.195.3157; Kline AE, 2008, NEUROSCI LETT, V448, P263, DOI 10.1016/j.neulet.2008.10.076; Kochanek PM, 2006, DEV NEUROSCI-BASEL, V28, P244, DOI 10.1159/000094151; Kochanek PM, 2010, DEV NEUROSCI-BASEL, V32, P335, DOI 10.1159/000323016; KRAUS JF, 1990, AM J DIS CHILD, V144, P684, DOI 10.1001/archpedi.1990.02150300082022; Kraus JF, 1995, EPIDEMIOLOGICAL FEAT, P22; Kurowski BG, 2013, PEDIATRICS, V132, pE158, DOI 10.1542/peds.2012-4040; Kurowski BG, 2011, PM&R, V3, P836, DOI 10.1016/j.pmrj.2011.05.016; Langlois JA, 2005, J HEAD TRAUMA REHAB, V20, P229, DOI 10.1097/00001199-200505000-00006; LEHMKUHL G, 1990, BRAIN BEHAV CHILD PS, P267; Levi RB, 1999, J CLIN CHILD PSYCHOL, V28, P232, DOI 10.1207/s15374424jccp2802_10; LEVIN HS, 1992, NEUROSURGERY, V31, P435, DOI 10.1227/00006123-199209000-00008; LEVIN HS, 1993, ARCH NEUROL-CHICAGO, V50, P897, DOI 10.1001/archneur.1993.00540090008004; Luis CA, 2002, J CLIN EXP NEUROPSYC, V24, P270, DOI 10.1076/jcen.24.3.270.982; Malaspina D, 2001, AM J PSYCHIAT, V158, P440, DOI 10.1176/appi.ajp.158.3.440; Massagli TL, 2004, ARCH PHYS MED REHAB, V85, P1428, DOI 10.1016/j.apmr.2003.12.036; Max JE, 1998, J NERV MENT DIS, V186, P589, DOI 10.1097/00005053-199810000-00001; Max JE, 1998, J AM ACAD CHILD PSY, V37, P841, DOI 10.1097/00004583-199808000-00014; Max JE, 2006, J NEUROPSYCH CLIN N, V18, P21, DOI 10.1176/appi.neuropsych.18.1.21; Max JE, 2005, J AM ACAD CHILD PSY, V44, P1032, DOI 10.1097/01.chi.0000173293.05817.b1; Max JE, 2005, J AM ACAD CHILD PSY, V44, P1041, DOI 10.1097/01.chi.0000173292.05817.f8; Max JE, 1998, J AM ACAD CHILD PSY, V37, P83, DOI 10.1097/00004583-199801000-00021; Max JE, 2004, DEV NEUROPSYCHOL, V25, P159, DOI 10.1207/s15326942dn2501&2_9; Max JE, 1998, J AM ACAD CHILD PSY, V37, P832, DOI 10.1097/00004583-199808000-00013; Max JE, 1997, J AM ACAD CHILD PSY, V36, P404, DOI 10.1097/00004583-199703000-00020; Max JE, 1998, J AM ACAD CHILD PSY, V37, P297, DOI 10.1097/00004583-199803000-00015; Max JE, 1997, J AM ACAD CHILD PSY, V36, P1278, DOI 10.1097/00004583-199709000-00021; Max JE, 2000, J INT NEUROPSYCH SOC, V6, P279, DOI 10.1017/S1355617700633039; Max JE, 1997, J AM ACAD CHILD PSY, V36, P94, DOI 10.1097/00004583-199701000-00022; Max JE, 1997, NEUROCASE, V3, P119; Max JE, 1998, BRAIN INJURY, V12, P41; Max JE, 1998, J NERV MENT DIS, V186, P325, DOI 10.1097/00005053-199806000-00001; Max JE, 2001, J NEUROPSYCH CLIN N, V13, P161, DOI 10.1176/appi.neuropsych.13.2.161; MAX JE, 1995, J AM ACAD CHILD PSY, V34, P472, DOI 10.1097/00004583-199504000-00014; MAX JE, 1995, J AM ACAD CHILD PSY, V34, P45, DOI 10.1097/00004583-199501000-00012; Max JE, 2010, COGNITIVE BEHAV ABNO, P647; Max JE, 2013, J NEUROPSYCH CLIN N, V25, P187, DOI 10.1176/appi.neuropsych.12010011; Max JE, 2012, J NEUROPSYCH CLIN N, V24, P427, DOI 10.1176/appi.neuropsych.12060149; Max JE, 2012, J AM ACAD CHILD PSY, V51, P1208, DOI 10.1016/j.jaac.2012.08.026; Max JE, 2012, INT J DEV NEUROSCI, V30, P239, DOI 10.1016/j.ijdevneu.2011.12.005; Max JE, 2011, J NEUROPSYCH CLIN N, V23, P29, DOI 10.1176/appi.neuropsych.23.1.29; Mayberg HS, 1997, J NEUROPSYCH CLIN N, V9, P471; McKinlay A, 2002, J NEUROL NEUROSUR PS, V73, P281, DOI 10.1136/jnnp.73.3.281; Moran LM, 2009, J NEUROTRAUM, V26, P1489, DOI 10.1089/neu.2008.0767; Ornstein TJ, 2013, J NEUROPSYCHOL, V7, P1, DOI 10.1111/j.1748-6653.2012.02027.x; Pangilinan PH, 2010, PM&R, V2, P1127, DOI 10.1016/j.pmrj.2010.07.007; Rivara JB, 1996, ARCH PHYS MED REHAB, V77, P754, DOI 10.1016/S0003-9993(96)90253-1; RIVARA JB, 1993, ARCH PHYS MED REHAB, V74, P1047, DOI 10.1016/0003-9993(93)90060-N; Rune V, 1970, ACTA PAEDIATR SC   S, V209, P3; Sayal K, 2000, J AM ACAD CHILD PSY, V39, P525, DOI 10.1097/00004583-200004000-00023; Schachar R, 2004, DEV NEUROPSYCHOL, V25, P179, DOI 10.1207/s15326942dn2501&2_10; Scott LK, 2009, J NEUROS-PEDIATR, V3, P484, DOI 10.3171/2009.2.PEDS08292; Senior HEJ, 2013, BMC PEDIATR, V13, DOI 10.1186/1471-2431-13-89; Sinopoli KJ, 2011, J CLIN EXP NEUROPSYC, V33, P805, DOI 10.1080/13803395.2011.562864; Slomine BS, 2005, J INT NEUROPSYCH SOC, V11, P645, DOI 10.1017/S1355617705050769; Taylor HG, 2001, J INT NEUROPSYCH SOC, V7, P755, DOI 10.1017/S1355617701766118; Taylor HG, 1999, NEUROPSYCHOLOGY, V13, P76, DOI 10.1037/0894-4105.13.1.76; Vasa RA, 2004, BIOL PSYCHIAT, V55, P208, DOI 10.1016/S0006-3223(03)00708-X; Vasa RA, 2002, J AM ACAD CHILD PSY, V41, P148, DOI 10.1097/00004583-200202000-00008; Wade SL, 2012, HEALTH PSYCHOL, V31, P767, DOI 10.1037/a0028440; Wade SL, 2011, PEDIATRICS, V128, pE947, DOI 10.1542/peds.2010-3721; Wade SL, 2010, J HEAD TRAUMA REHAB, V25, P409, DOI 10.1097/HTR.0b013e3181fb900d; Wade SL, 2013, CHILD NEUROPSYCHOL; Wade SL, 2013, J HEAD TRAUMA REHABI; Warden DL, 2006, J NEUROTRAUM, V23, P1468, DOI 10.1089/neu.2006.23.1468; Wassenberg R, 2004, BRAIN INJURY, V18, P751, DOI 10.1080/02699050410001671775; WILCOX JA, 1987, PSYCHIAT RES, V21, P303, DOI 10.1016/0165-1781(87)90013-8; Yeates K O, 1997, J Int Neuropsychol Soc, V3, P617; Yeates KO, 2012, ARCH PEDIAT ADOL MED, V166, P615, DOI 10.1001/archpediatrics.2011.1082; Yeates KO, 2009, PEDIATRICS, V123, P735, DOI 10.1542/peds.2008-1056; Yeates KO, 2005, J AM ACAD CHILD PSY, V44, P574, DOI 10.1097/01.chi.0000159947.50523.64; Yeates KO, 1999, J HEAD TRAUMA REHAB, V14, P337, DOI 10.1097/00001199-199908000-00003; Ylvisaker M, 2007, BRAIN INJURY, V21, P769, DOI 10.1080/02699050701482470	96	22	22	0	22	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0193-953X	1558-3147		PSYCHIAT CLIN N AM	Psychiatr. Clin. North Amer.	MAR	2014	37	1					125	+		10.1016/j.psc.2013.11.003			18	Psychiatry	Psychiatry	AD8UM	WOS:000333541200010	24529428	Green Accepted			2021-06-18	
J	Rosario, ER; Kaplan, SE; Khonsari, S; Patterson, D				Rosario, Emily R.; Kaplan, Stephanie E.; Khonsari, Sepehr; Patterson, David			Predicting and Assessing Fall Risk in an Acute Inpatient Rehabilitation Facility	REHABILITATION NURSING			English	Article						Rehabilitation; fall risk; stroke; brain injury; inpatient rehabilitation facility	FUNCTIONAL INDEPENDENCE MEASURE; OLDER-ADULTS; HOSPITALIZED-PATIENTS; ASSESSMENT TOOLS; STROKE PATIENTS; COMMUNITY; FEAR; SETTINGS; INJURIES; VALIDATION	PurposeUnintentional falls account for 70% of all hospital accidents. The objective of this study was to identify risk factors for falls and develop an assessment tool specific for an inpatient rehabilitation facility setting. Design/MethodDiagnosis and Functional Independence Measure (FIM) scores were collected for 174 patients to assess predictors for fall risk. Independent t-tests, chi-square, and logistic regression analysis were conducted to examine differences between fallers and nonfallers. FindingsWe identified several risk factors for falls including 4 FIM items: toileting, bed transfer, tub/shower transfer, and stairs; and three diagnoses: right stroke, traumatic brain injury, and amputation. From these findings, we completed initial development of a risk assessment tool. ConclusionsEvaluation of the tool suggests good specificity with 20%-30% of the patient population identified as high risk and good sensitivity by correctly predicting nearly 90% of patient falls. Clinical RelevanceContinued evaluation of this assessment tool is needed to identify effectiveness in predicting patients who are at high risk for falling.	[Rosario, Emily R.; Kaplan, Stephanie E.; Khonsari, Sepehr; Patterson, David] Casa Colina Hosp Rehabilitat Med, Pomona, CA 91769 USA	Rosario, ER (corresponding author), Casa Colina Hosp Rehabilitat Med, Res Inst, 255 E Bonita Ave, Pomona, CA 91769 USA.	erosario@casacolina.org			Casa Colina Centers for Rehabilitation Foundation	The authors thank the Casa Colina Centers for Rehabilitation Foundation for supporting this research.	Adkin AL, 2002, EXP BRAIN RES, V143, P160, DOI 10.1007/s00221-001-0974-8; BATES DW, 1995, AM J MED, V99, P137, DOI 10.1016/S0002-9343(99)80133-8; Englander F, 1996, J FORENSIC SCI, V41, P733; Fischer ID, 2005, INFECT CONT HOSP EP, V26, P822, DOI 10.1086/502500; Gates S, 2008, J REHABIL RES DEV, V45, P1105, DOI 10.1682/JRRD.2008.04.0057; Gilewski MJ, 2007, REHABIL NURS, V32, P234, DOI 10.1002/j.2048-7940.2007.tb00180.x; Haines TP, 2007, J GERONTOL A-BIOL, V62, P664, DOI 10.1093/gerona/62.6.664; HEINEMANN AW, 1993, ARCH PHYS MED REHAB, V74, P566, DOI 10.1016/0003-9993(93)90153-2; Hendrich AL, 2003, APPL NURS RES, V16, P9, DOI 10.1053/apnr.2003.YAPNR2; Kim EAN, 2007, J ADV NURS, V60, P427, DOI 10.1111/j.1365-2648.2007.04419.x; KING MB, 1995, J AM GERIATR SOC, V43, P1146, DOI 10.1111/j.1532-5415.1995.tb07017.x; Kressig RW, 2001, J AM GERIATR SOC, V49, P1456, DOI 10.1046/j.1532-5415.2001.4911237.x; Kwan F, 2012, REHABIL NURS, V37, P30, DOI 10.1002/RNJ.00004; Lee JE, 2008, AM J PHYS MED REHAB, V87, P341, DOI 10.1097/PHM.0b013e31816ddc01; Legters K, 2002, PHYS THER, V82, P264, DOI 10.1093/ptj/82.3.264; MAYO NE, 1989, AM J PHYS MED REHAB, V68, P139, DOI 10.1097/00002060-198906000-00008; McKee KJ, 2002, DISABIL REHABIL, V24, P327, DOI 10.1080/09638280110093686; Medley A, 2006, BRAIN INJURY, V20, P1403, DOI 10.1080/02699050601082057; MORGAN VR, 1985, AM J PUBLIC HEALTH, V75, P775, DOI 10.2105/AJPH.75.7.775; Morrison G, 2011, DISABIL REHABIL, V33, P900, DOI 10.3109/09638288.2010.514019; MORSE JM, 1996, PREVENTING PATIENT F; Nakai Akihito, 2006, Journal of Nippon Medical School, V73, P265, DOI 10.1272/jnms.73.265; Nyberg L, 1996, STROKE, V27, P1821, DOI 10.1161/01.STR.27.10.1821; OCZKOWSKI WJ, 1993, ARCH PHYS MED REHAB, V74, P1291, DOI 10.1016/0003-9993(93)90081-K; Oliver D, 2004, AGE AGEING, V33, P122, DOI 10.1093/ageing/afh017; Oliver David, 2007, Br J Community Nurs, V12, P500; Rabadi MH, 2008, REHABIL NURS, V33, P104, DOI 10.1002/j.2048-7940.2008.tb00213.x; RAPPORT LJ, 1993, ARCH PHYS MED REHAB, V74, P621, DOI 10.1016/0003-9993(93)90160-C; Rapport LJ, 1998, ARCH PHYS MED REHAB, V79, P629, DOI 10.1016/S0003-9993(98)90035-1; Saverino A, 2006, Eura Medicophys, V42, P179; Schwendimann R, 2006, BMC HEALTH SERV RES, V6, DOI 10.1186/1472-6963-6-69; Scott V, 2007, AGE AGEING, V36, P130, DOI 10.1093/ageing/afl165; Sebastia E, 2006, J REHABIL MED, V38, P204, DOI 10.1080/16501970500540939; Stevens JA, 2006, INJURY PREV, V12, P290, DOI 10.1136/ip.2005.011015; Teasell R, 2002, ARCH PHYS MED REHAB, V83, P329, DOI 10.1053/apmr.2002.29623; TINETTI ME, 1988, NEW ENGL J MED, V319, P1701, DOI 10.1056/NEJM198812293192604; Vassallo M, 2003, AGE AGEING, V32, P338, DOI 10.1093/ageing/32.3.338; Vieira ER, 2011, CLIN REHABIL, V25, P788, DOI 10.1177/0269215511400639; VLAHOV D, 1990, ARCH PHYS MED REHAB, V71, P8	39	22	22	0	10	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0278-4807	2048-7940		REHABIL NURS	Rehabil. Nurs.	MAR	2014	39	2					86	93		10.1002/rnj.114			8	Nursing; Rehabilitation	Nursing; Rehabilitation	AC3DH	WOS:000332394700005	23813799				2021-06-18	
J	Wang, F; Franco, R; Skotak, M; Hu, G; Chandra, N				Wang, Fang; Franco, Rodrigo; Skotak, Maciej; Hu, Gang; Chandra, Namas			Mechanical stretch exacerbates the cell death in SH-SY5Y cells exposed to paraquat: mitochondrial dysfunction and oxidative stress	NEUROTOXICOLOGY			English	Article						Traumatic brain injury; Paraquat; Mitochondria; Reactive oxygen species; MnSOD	TRAUMATIC BRAIN-INJURY; PARKINSONS-DISEASE; PESTICIDE EXPOSURE; HEAD-INJURY; STRAIN-RATE; GLUTATHIONE; NEURONS; MODEL; RISK; VULNERABILITY	Recent studies suggest that traumatic brain injury (TBI) and pesticide exposure increase the risk of Parkinson's disease (PD), but the molecular mechanisms involved remain unclear. Using an in vitro model of TBI, we evaluated the role of mitochondrial membrane potential (Delta psi m) and mitochondrial reactive oxygen species (ROS) induced by stretch on dopaminergic cell death upon paraquat exposure. Human dopaminergic neuroblastoma SH-SY5Y cells grown on silicone membrane were stretched at mild (25%) and moderate (50%) strain prior to paraquat exposure. We observed that moderate stretch (50% strain) increased the vulnerability of cells to paraquat demonstrated by the loss of plasma membrane integrity (propidium iodide-uptake) and decreased mitochondrial activity (MTT assay). Mitochondrial depolarization occurred immediately after stretch, while mitochondrial ROS increased rapidly and remained elevated for up to 4 h after the stretch injury. Intracellular glutathione (GSH) stores were also transiently decreased immediately after moderate stretch. Cells treated with paraquat, or moderate stretch exhibited negligible mitochondrial depolarization at 48 h post treatment, whereas in cells stretched prior to paraquat exposure, a significant mitochondria] depolarization occurred compared to samples exposed to either paraquat or stretch. Moderate stretch also increased mitochondrial ROS formation, as well as exacerbated intracellular GSH loss induced by paraquat. Overexpression of manganese superoxide dismutase (MnSOD) markedly diminished the deleterious effects of stretch in paraquat neurotoxicity. Our findings demonstrate that oxidative stress induced by mitochondrial dysfunction plays a critical role in the synergistic toxic effects of stretch (TBI) and pesticide exposure. Mitigation of oxidative stress via mitochondria-targeted antioxidants appears an attractive route for treatment of neurodegeneration mediated by TBI. Published by Elsevier Inc.	[Wang, Fang; Hu, Gang] Nanjing Med Univ, Jiangsu Key Lab Neurodegenerat, Dept Pharmacol, Nanjing 210029, Jiangsu, Peoples R China; [Wang, Fang; Skotak, Maciej] Univ Nebraska, Dept Mech & Mat Engn, Lincoln, NE 68588 USA; [Franco, Rodrigo] Univ Nebraska, Redox Biol Ctr, Lincoln, NE 68583 USA; [Franco, Rodrigo] Univ Nebraska, Sch Vet Med & Biomed Sci, Lincoln, NE 68583 USA; [Chandra, Namas] New Jersey Inst Technol, Dept Biomed Engn, Newark, NJ 07102 USA	Hu, G (corresponding author), Nanjing Med Univ, Jiangsu Key Lab Neurodegenerat, Dept Pharmacol, Nanjing 210029, Jiangsu, Peoples R China.	ghu@njmu.edu.cn; namas.chandra@njit.edu	Franco, Rodrigo/D-9470-2013; Skotak, Maciej/H-4769-2019	Franco, Rodrigo/0000-0003-3241-8615; Skotak, Maciej/0000-0003-2584-7294	US Army Research Office project "Army-UNL Center of Trauma Mechanics" [W911NF08-10483]; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [P20RR17675]; Centers of Biomedical Research Excellence (COBRE)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR); NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [P20RR017675] Funding Source: NIH RePORTER	This work was supported by the US Army Research Office project "Army-UNL Center of Trauma Mechanics" (Contract No.W911NF08-10483) and the National Institutes of Health Grant P20RR17675, Centers of Biomedical Research Excellence (COBRE). We are grateful to Dr. Charles A. Kuszynski, and Zhi Hong Gill at the Nebraska Center for Virology for their help with flow cytometry analyses.	Abdul-Muneer PM, 2013, FREE RADICAL BIO MED, V60, P282, DOI 10.1016/j.freeradbiomed.2013.02.029; Ahmed SM, 2000, J NEUROCHEM, V74, P1951, DOI 10.1046/j.1471-4159.2000.741951000000000.x; Allen MT, 2013, CRIT REV TOXICOL, V43, P515, DOI 10.3109/10408444.2013.798719; Arif IA, 2010, TOXICOL IND HEALTH, V26, P121, DOI 10.1177/0748233710362382; Arundine M, 2004, J NEUROSCI, V24, P8106, DOI 10.1523/JNEUROSCI.1362-04.2004; Bayir H, 2002, PEDIATR RES, V51, P571, DOI 10.1203/00006450-200205000-00005; Betarbet R, 2000, NAT NEUROSCI, V3, P1301, DOI 10.1038/81834; Bower JH, 2003, NEUROLOGY, V60, P1610, DOI 10.1212/01.WNL.0000068008.78394.2C; Chaturvedi RK, 2013, FREE RADICAL BIO MED, V63, P1, DOI 10.1016/j.freeradbiomed.2013.03.018; Cheng G, 2012, BRIT J PHARMACOL, V167, P699, DOI 10.1111/j.1476-5381.2012.02025.x; Cheung YT, 2009, NEUROTOXICOLOGY, V30, P127, DOI 10.1016/j.neuro.2008.11.001; Franco R, 2012, ANTIOXID REDOX SIGN, V17, P1694, DOI 10.1089/ars.2012.4553; Freire C, 2012, NEUROTOXICOLOGY, V33, P947, DOI 10.1016/j.neuro.2012.05.011; Geddes DM, 2003, J NEUROTRAUM, V20, P1039, DOI 10.1089/089771503770195885; Geddes DM, 2001, J BIOMECH ENG-T ASME, V123, P247, DOI 10.1115/1.1374201; Goldman SM, 2006, ANN NEUROL, V60, P65, DOI 10.1002/ana.20882; Goldman SM, 2012, ANN NEUROL, V71, P40, DOI 10.1002/ana.22499; Hussain SP, 2004, CANCER RES, V64, P2350, DOI 10.1158/0008-5472.CAN-2287-2; Hutson CB, 2011, J NEUROTRAUM, V28, P1783, DOI 10.1089/neu.2010.1723; Jafari B, 2004, RESPIROLOGY, V9, P43, DOI 10.1111/j.1440-1843.2003.00527.x; Kieburtz K, 2013, MOVEMENT DISORD, V28, P8, DOI 10.1002/mds.25150; Lee PC, 2012, NEUROLOGY, V79, P2061, DOI 10.1212/WNL.0b013e3182749f28; Morales DM, 2005, NEUROSCIENCE, V136, P971, DOI 10.1016/j.neuroscience.2005.08.030; Onizuka S, 2011, J ANESTH, V25, P229, DOI 10.1007/s00540-010-1079-y; PEREZOTANO I, 1994, NEUROSCI LETT, V175, P121, DOI 10.1016/0304-3940(94)91094-4; Redell JB, 2013, J NEUROTRAUM, V30, P752, DOI 10.1089/neu.2012.2437; Rodriguez-Rocha H, 2013, FREE RADICAL BIO MED, V61, P370, DOI 10.1016/j.freeradbiomed.2013.04.021; Sabirov RZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055646; Sauerbeck A, 2012, EXP NEUROL, V234, P85, DOI 10.1016/j.expneurol.2011.12.012; Schneider L, 2011, FREE RADICAL BIO MED, V51, P2007, DOI 10.1016/j.freeradbiomed.2011.08.030; Schulz JB, 2000, EUR J BIOCHEM, V267, P4904, DOI 10.1046/j.1432-1327.2000.01595.x; Shin SS, 2011, BRAIN RES, V1369, P208, DOI 10.1016/j.brainres.2010.10.096; Skotak M, 2012, J NEUROSCI METH, V205, P159, DOI 10.1016/j.jneumeth.2012.01.001; Stack EC, 2008, BBA-MOL BASIS DIS, V1782, P151, DOI 10.1016/j.bbadis.2007.12.006; Szczygielski J, 2005, J NEURAL TRANSM, V112, P1547, DOI 10.1007/s00702-005-0326-0; Tanner CM, 2011, ENVIRON HEALTH PERSP, V119, P866, DOI 10.1289/ehp.1002839; Uryu K, 2003, EXP NEUROL, V184, P214, DOI 10.1016/S0014-4886(03)00245-0; Uryu K, 2007, EXP NEUROL, V208, P185, DOI 10.1016/j.expneurol.2007.06.018	38	22	24	0	18	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0161-813X	1872-9711		NEUROTOXICOLOGY	Neurotoxicology	MAR	2014	41						54	63		10.1016/j.neuro.2014.01.002			10	Neurosciences; Pharmacology & Pharmacy; Toxicology	Neurosciences & Neurology; Pharmacology & Pharmacy; Toxicology	AE6HW	WOS:000334092200006	24462953	Green Accepted			2021-06-18	
J	Su, SH; Wang, F; Hai, J; Liu, NT; Yu, F; Wu, YF; Zhu, YH				Su, Shao-Hua; Wang, Fei; Hai, Jian; Liu, Ning-Tao; Yu, Fei; Wu, Yi-Fang; Zhu, You-Hou			The Effects of Intracranial Pressure Monitoring in Patients with Traumatic Brain Injury	PLOS ONE			English	Article							SEVERE HEAD-INJURY; INTENSIVE-CARE; EUROPEAN-BRAIN; MANAGEMENT; MORTALITY	Background: Although international guideline recommended routine intracranial pressure (ICP) monitoring for patients with severe traumatic brain injury(TBI), there were conflicting outcomes attributable to ICP monitoring according to the published studies. Hence, we conducted a meta-analysis to evaluate the efficacy and safety of ICP monitoring in patients with TBI. Methods: Based on previous reviews, PubMed and two Chinese databases (Wangfang and VIP) were further searched to identify eligible studies. The primary outcome was mortality. Secondary outcomes included unfavourable outcome, adverse events, length of ICU stay and length of hospital stay. Weighted mean difference (WMD), odds ratio (OR) and 95% confidence intervals (CIs) were calculated and pooled using fixed-effects or random-effects model. Results: two randomized controlled trials (RCTs) and seven cohort studies involving 11,038 patients met the inclusion criteria. ICP monitoring was not associated with a significant reduction in mortality (OR, 1.16; 95% CI, 0.87-1.54), with substantial heterogeneity (I-2 = 80%, P < 0.00001), which was verified by the sensitivity analyses. No significant difference was found in the occurrence of unfavourable outcome (OR, 1.40; 95% CI, 0.99-1.98; I-2 = 4%, P = 0.35) and advese events (OR, 1.04; 95% CI, 0.64-1.70; I-2 = 78%, P = 0.03). However, we should be cautious to the result of adverse events because of the substantial heterogeneity in the comparison. Furthermore, longer ICU and hospital stay were the consistent tendency according to the pooled studies. Conclusions: No benefit was found in patients with TBI who underwent ICP monitoring. Considering substantial clinical heterogeneity, further large sample size RCTs are needed to confirm the current findings.	[Su, Shao-Hua; Wang, Fei; Hai, Jian; Liu, Ning-Tao; Yu, Fei; Wu, Yi-Fang; Zhu, You-Hou] Tongji Univ, Sch Med, Tongji Hosp, Dept Neurosurg, Shanghai 200092, Peoples R China	Wang, F (corresponding author), Tongji Univ, Sch Med, Tongji Hosp, Dept Neurosurg, Shanghai 200092, Peoples R China.	wangfeidoc@163.com					Andrews PJD, 2008, INTENS CARE MED, V34, P1362, DOI 10.1007/s00134-008-1103-y; Biersteker HAR, 2012, CRIT CARE MED, V40, P1914, DOI 10.1097/CCM.0b013e3182474bde; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS37; Bulger EM, 2002, CRIT CARE MED, V30, P1870, DOI 10.1097/00003246-200208000-00033; Chesnut RM, 2012, NEW ENGL J MED, V367, P2471, DOI 10.1056/NEJMoa1207363; Cremer OL, 2005, CRIT CARE MED, V33, P2207, DOI 10.1097/01.CCM.0000181300.99078.B5; Enblad P, 2004, INTENS CARE MED, V30, P1058, DOI 10.1007/s00134-004-2206-8; Forsyth RJ, 2010, COCHRANE DB SYST REV, V17; Griesdale DEG, 2010, CAN J NEUROL SCI, V37, P43, DOI 10.1017/S031716710000963X; Higgins J, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.ED000049; Hozo Stela Pudar, 2005, BMC Med Res Methodol, V5, P13, DOI 10.1186/1471-2288-5-13; Kostic Aleksandar, 2011, Med Pregl, V64, P461; Kristiansson H, 2013, J NEUROSURG ANESTH, V25, P372, DOI 10.1097/ANA.0b013e31829795ce; Lane PL, 2000, CAN J SURG, V43, P442; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Maas AIR, 1997, ACTA NEUROCHIR, V139, P286, DOI 10.1007/BF01808823; Mauritz W, 2008, INTENS CARE MED, V34, P1208, DOI 10.1007/s00134-008-1079-7; Mauritz W, 2007, WIEN KLIN WOCHENSCHR, V119, P46, DOI 10.1007/s00508-006-0763-2; Mendelson AA, 2012, CAN J NEUROL SCI, V39, P571, DOI 10.1017/S0317167100015286; MILLER JD, 1977, J NEUROSURG, V47, P503, DOI 10.3171/jns.1977.47.4.0503; Padayachy LC, 2010, CHILD NERV SYST, V26, P441, DOI 10.1007/s00381-009-1034-0; Shafi S, 2008, J TRAUMA, V64, P335, DOI 10.1097/TA.0b013e31815dd017; Stocchetti N, 2001, INTENS CARE MED, V27, P400, DOI 10.1007/s001340000825; Thompson HJ, 2008, CRIT CARE MED, V36, P282, DOI 10.1097/01.CCM.0000297884.86058.8A; Wells GA., 2011, NEWCASTLE OTTAWA SCA	25	22	25	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2014	9	2							e87432	10.1371/journal.pone.0087432			13	Multidisciplinary Sciences	Science & Technology - Other Topics	AB3VI	WOS:000331717900011	24586276	DOAJ Gold, Green Published			2021-06-18	
J	Mechtler, LL; Shastri, KK; Crutchfield, KE				Mechtler, Laszlo L.; Shastri, Kalyan K.; Crutchfield, Kevin E.			Advanced Neuroimaging of Mild Traumatic Brain Injury	NEUROLOGIC CLINICS			English	Article						Mild traumatic brain injury; Concussion; Diffuse axonal injury; Diffusion tensor imaging; Susceptibility-weighted imaging; Magnetic resonance spectroscopy	DIFFUSE AXONAL INJURY; CT HEAD RULE; MAGNETIC-RESONANCE SPECTROSCOPY; PROTON MR SPECTROSCOPY; NEW-ORLEANS CRITERIA; COMPUTED-TOMOGRAPHY; WHITE-MATTER; COGNITIVE IMPAIRMENT; CEREBRAL MICROBLEEDS; FUNCTIONAL NETWORKS	This article focuses on advancements in neuroimaging techniques, compares the advantages of each of the modalities in the evaluation of mild traumatic brain injury, and discusses their contribution to our understanding of the pathophysiology as it relates to prognosis. Advanced neuroimaging techniques discussed include anatomic/structural imaging techniques, such as diffusion tensor imaging and susceptibility-weighted imaging, and functional imaging techniques, such as functional magnetic resonance imaging, perfusion-weighted imaging, magnetic resonance spectroscopy, and positron emission tomography.	[Mechtler, Laszlo L.] SUNY Buffalo, Dept Neurol & Neurooncol, Buffalo, NY 14223 USA; [Mechtler, Laszlo L.; Shastri, Kalyan K.] Dent Neurol Inst, Amherst, NY 14226 USA; [Crutchfield, Kevin E.] Sandra & Malcolm Berman Brain & Spine Inst, Comprehens Sports Concuss Program, Baltimore, MD 21209 USA	Mechtler, LL (corresponding author), Dent Neurol Inst, 3980A Sheridan Dr,Suite 101, Amherst, NY 14226 USA.	lmechtler@dentinstitute.com					ALEXANDER MP, 1995, NEUROLOGY, V45, P1253, DOI 10.1212/WNL.45.7.1253; Almandoz JED, 2010, RADIOLOGY, V254, P236, DOI 10.1148/radiol.09090693; Almenawer SA, 2013, NEUROSURGERY, V72, P56, DOI 10.1227/NEU.0b013e318276f899; American College of Radiology, 1996, ACR APPR CRIT HEAD T; Aoki Y, 2012, J NEUROL NEUROSUR PS, V83, P870, DOI 10.1136/jnnp-2012-302742; Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Babikian T, 2005, PEDIATR NEUROL, V33, P184, DOI 10.1016/j.pediatrneurol.2005.03.015; Bagley LJ, 2000, J MAGN RESON IMAGING, V11, P1, DOI 10.1002/(SICI)1522-2586(200001)11:1<1::AID-JMRI1>3.0.CO;2-H; Barkhoudarian G, 2011, CLIN SPORT MED, V30, P33, DOI 10.1016/j.csm.2010.09.001; Beauchamp MH, 2013, CORTEX, V49, P591, DOI 10.1016/j.cortex.2012.08.015; Bigler ED, 2008, J INT NEUROPSYCH SOC, V14, P1, DOI 10.1017/S135561770808017X; Brenner DJ, 2007, NEW ENGL J MED, V357, P2277, DOI 10.1056/NEJMra072149; Brody AS, 2007, PEDIATRICS, V120, P677, DOI 10.1542/peds.2007-1910; Brooks WM, 2001, J HEAD TRAUMA REHAB, V16, P149, DOI 10.1097/00001199-200104000-00005; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Centers for Disease Control and Prevention, HEADS CONC; Chen HF, 2004, BRAIN TOPOGR, V17, P39, DOI 10.1023/B:BRAT.0000047335.00110.6a; Cohen BA, 2007, AM J NEURORADIOL, V28, P907; Colbert CA, 2010, RADIOLOGY, V256, P898, DOI 10.1148/radiol.10091842; Cubon VA, 2011, J NEUROTRAUM, V28, P189, DOI 10.1089/neu.2010.1430; Delfaut EM, 1999, RADIOGRAPHICS, V19, P373, DOI 10.1148/radiographics.19.2.g99mr03373; Depreitere B, 2008, ACTA NEUROCHIR SUPPL, V102, P259, DOI 10.1007/978-3-211-85578-2_49; Duckworth JL, 2010, CURR OPIN CRIT CARE, V16, P92, DOI 10.1097/MCC.0b013e3283374900; Enterline DS, 2006, TECH VASC INTERV RAD, V9, P192, DOI 10.1053/j.tvir.2007.03.003; Fearnside M, 1998, AUST NZ J SURG, V68, P58, DOI 10.1111/j.1445-2197.1998.tb04638.x; Fodero-Tavoletti MT, 2011, BRAIN, V134, P1089, DOI 10.1093/brain/awr038; Frush DP, 2003, PEDIATRICS, V112, P951, DOI 10.1542/peds.112.4.951; Gale SD, 2005, J NEUROL NEUROSUR PS, V76, P984, DOI 10.1136/jnnp.2004.036210; Gallagher CN, 2007, CURR OPIN NEUROL, V20, P403, DOI 10.1097/WCO.0b013e32821b987b; Galloway NR, 2008, J NEUROTRAUM, V25, P1153, DOI 10.1089/neu.2007.0494; Garnett MR, 2000, BRAIN, V123, P2046, DOI 10.1093/brain/123.10.2046; Gasparovic C, 2009, J NEUROTRAUM, V26, P1635, DOI [10.1089/neu.2009.0896, 10.1089/neu.2009-0896]; Ge YL, 2009, BRAIN INJURY, V23, P666, DOI 10.1080/02699050903014899; Gean AD, 2010, NEUROIMAG CLIN N AM, V20, P527, DOI 10.1016/j.nic.2010.08.001; Ginde AA, 2008, ACAD EMERG MED, V15, P780, DOI 10.1111/j.1553-2712.2008.00192.x; Giza CC, 2001, J ATHL TRAINING, V36, P228; GOLDSTEIN M, 1990, ANN NEUROL, V27, P327, DOI 10.1002/ana.410270315; Greenberg SM, 2009, LANCET NEUROL, V8, P165, DOI 10.1016/S1474-4422(09)70013-4; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Haacke EM, 2009, AM J NEURORADIOL, V30, P19, DOI 10.3174/ajnr.A1400; Hasiloglu ZI, 2011, AM J NEURORADIOL, V32, P99, DOI 10.3174/ajnr.A2250; Haydel MJ, 2000, NEW ENGL J MED, V343, P100, DOI 10.1056/NEJM200007133430204; Haydel MJ, 2003, ANN EMERG MED, V42, P507, DOI 10.1067/S0196-0644(03)00512-2; Henry LC, 2010, J NEUROTRAUM, V27, P65, DOI 10.1089/neu.2009.0962; Hernandez-Ontiveros DG, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00030; Holshouser BA, 2005, AM J NEURORADIOL, V26, P1276; Jagoda AS, 2008, ANN EMERG MED, V52, P714, DOI 10.1016/j.annemergmed.2008.08.021; Jellison BJ, 2004, AM J NEURORADIOL, V25, P356; Jorge RE, 2012, AM J PSYCHIAT, V169, P1284, DOI 10.1176/appi.ajp.2012.12050600; Kay T., 1993, J HEAD TRAUMA REHABI, V8, P86, DOI [10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; Kim J, 2010, J NEUROTRAUM, V27, P1399, DOI 10.1089/neu.2009.1215; King MA, 2009, PEDIATR RADIOL, V39, P1059, DOI 10.1007/s00247-009-1327-1; Kinnunen KM, 2011, BRAIN, V134, P449, DOI 10.1093/brain/awq347; Le TH, 2009, MT SINAI J MED, V76, P145, DOI 10.1002/msj.20102; Li X, 2012, NEUROIMAGE, V62, P314, DOI 10.1016/j.neuroimage.2012.04.042; Lin AP, 2012, BRAIN IMAGING BEHAV, V6, P208, DOI 10.1007/s11682-012-9181-4; Ling Geoffrey S F, 2010, Continuum (Minneap Minn), V16, P27, DOI 10.1212/01.CON.0000391451.30299.bc; Liu CL, 2013, FRONT INTEGR NEUROSC, V7, DOI 10.3389/fnint.2013.00011; Liu T, 2012, RADIOLOGY, V262, P269, DOI 10.1148/radiol.11110251; Lovell MR, 2007, NEUROSURGERY, V61, P352, DOI 10.1227/01.NEU.0000279985.94168.7F; MacKenzie JD, 2002, AM J NEURORADIOL, V23, P1509; Martland HS, 1928, J AMER MED ASSOC, V91, P1103, DOI 10.1001/jama.1928.02700150029009; Mayer AR, 2010, NEUROLOGY, V74, P643, DOI 10.1212/WNL.0b013e3181d0ccdd; McCullough BJ, 2011, PHYS MED REH CLIN N, V22, P635, DOI 10.1016/j.pmr.2011.08.005; McDonald BC, 2012, BRAIN IMAGING BEHAV, V6, P193, DOI 10.1007/s11682-012-9173-4; McGowan JC, 2000, AM J NEURORADIOL, V21, P875; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Medana IM, 2003, BRAIN, V126, P515, DOI 10.1093/brain/awg061; Melnick ER, 2012, JT COMM J QUAL PATIE, V38, P483, DOI 10.1016/S1553-7250(12)38064-1; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Metting Z, 2009, ANN NEUROL, V66, P809, DOI 10.1002/ana.21785; Mittal S, 2009, AM J NEURORADIOL, V30, P232, DOI 10.3174/ajnr.A1461; National Center for Injury Prevention and Control, 2003, REP C MILD TRAUM BRA; National Institute for Clinical Excellence, 2007, HEAD INJ TRIAG ASS I; Niogi SN, 2008, AM J NEURORADIOL, V29, P967, DOI 10.3174/ajnr.A0970; Pasco A, 2007, J NEUROTRAUM, V24, P1321, DOI 10.1089/neu.2006.0136; Pettus EH, 1996, BRAIN RES, V722, P1, DOI 10.1016/0006-8993(96)00113-8; Ptito A, 2007, NEUROREHABILITATION, V22, P217; Rosenbaum SB, 2012, BRAIN IMAGING BEHAV, V6, P255, DOI 10.1007/s11682-012-9162-7; Ross DE, 2011, BRAIN INJURY, V25, P1271, DOI 10.3109/02699052.2011.624568; Ruff R, 2005, J HEAD TRAUMA REHAB, V20, P5, DOI 10.1097/00001199-200501000-00003; Ruff RM, 2009, ARCH CLIN NEUROPSYCH, V24, P3, DOI 10.1093/arclin/acp006; Schafer PW, 2004, RADIOLOGY, V233, P58, DOI 10.1148/radiol.2323031173; Shah NB, 2008, CURR OPIN PEDIATR, V20, P243, DOI 10.1097/MOP.0b013e3282ffafd2; Shumskaya E, 2012, NEUROLOGY, V79, P175, DOI 10.1212/WNL.0b013e31825f04fb; Simon B, 2001, J TRAUMA, V51, P231, DOI 10.1097/00005373-200108000-00004; Sinson G, 2001, AM J NEURORADIOL, V22, P143; Small GW, 2013, AM J GERIAT PSYCHIAT, V21, P138, DOI 10.1016/j.jagp.2012.11.019; Smith DH, 2003, J HEAD TRAUMA REHAB, V18, P307, DOI 10.1097/00001199-200307000-00003; Smith-Bindman R, 2009, ARCH INTERN MED, V169, P2078, DOI 10.1001/archinternmed.2009.427; Smits M, 2005, JAMA-J AM MED ASSOC, V294, P1519, DOI 10.1001/jama.294.12.1519; Smits M, 2011, NEURORADIOLOGY, V53, P553, DOI 10.1007/s00234-010-0774-6; Stein S. C., 1996, NEUROTRAUMA, P31; Stiell IG, 2005, JAMA-J AM MED ASSOC, V294, P1511, DOI 10.1001/jama.294.12.1511; Stiell IG, 2001, LANCET, V357, P1391, DOI 10.1016/S0140-6736(00)04561-X; Stippler M, 2012, EMERG MED J, V29, P528, DOI 10.1136/emermed-2011-200162; Suh DY, 2001, NEUROSURGERY, V49, P309, DOI 10.1097/00006123-200108000-00011; Tang L, 2011, RADIOLOGY, V260, P831, DOI 10.1148/radiol.11110014; TEASDALE G, 1974, LANCET, V2, P81; Terry DP, 2012, BRAIN INJURY, V26, P1684, DOI 10.3109/02699052.2012.722259; Tong KA, 2003, RADIOLOGY, V227, P332, DOI 10.1148/radiol.2272020176; Vagnozzi R, 2008, NEUROSURGERY, V62, P1286, DOI 10.1227/01.neu.0000333300.34189.74; Warmuth C, 2003, RADIOLOGY, V228, P523, DOI 10.1148/radiol.2282020409; Washington CW, 2012, J NEUROSURG, V116, P549, DOI 10.3171/2011.11.JNS111092; Wiest PW, 2002, SEMIN ULTRASOUND CT, V23, P402, DOI 10.1016/S0887-2171(02)90011-9; Wilde EA, 2008, NEUROLOGY, V70, P948, DOI 10.1212/01.wnl.0000305961.68029.54; Wintermark M, 2004, RADIOLOGY, V232, P211, DOI 10.1148/radiol.2321030824; World Health Organization, 2012, INT CLASS DIS REL HL; Zappala G, 2012, CORTEX, V48, P156, DOI 10.1016/j.cortex.2011.06.020; Zhang K, 2010, EXP BRAIN RES, V204, P57, DOI 10.1007/s00221-010-2294-3; Zhou YX, 2013, RADIOLOGY, V267, P880, DOI 10.1148/radiol.13122542	111	22	25	0	29	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0733-8619	1557-9875		NEUROL CLIN	Neurol. Clin.	FEB	2014	32	1					31	+		10.1016/j.ncl.2013.08.002			29	Clinical Neurology; Neurosciences	Neurosciences & Neurology	278VI	WOS:000328917600003	24287384				2021-06-18	
J	Menon, K; Ward, R				Menon, Kusum; Ward, Roxanne		Canadian Critical Care Trials Grp	A study of consent for participation in a non-therapeutic study in the pediatric intensive care population	JOURNAL OF MEDICAL ETHICS			English	Article						Children; Research Ethics; Research on Special Populations; Informed Consent; Minors; Parental Consent	TRAUMATIC BRAIN-INJURY; CLINICAL-RESEARCH; UNIT; TRIALS; CHALLENGES; EMERGENCY; ADMISSION	Objective To document the legal guardian-related barriers to consent procurement, and their stated reasons for non-participation in a paediatric critical care research study. Study design A multicentre, prospective, cohort study. Participants Legal guardians of children who participated in a multicentre study on adrenal insufficiency in paediatric critical illness. Data were collected on all consent encounters in the main study. Methods Screening data, reasons for consent not being obtained, paediatric risk of mortality (illness severity) scores and age were collected on all 1707 patients eligible for participation in the Adrenal Insufficiency Study. Results The main barriers to approaching legal guardians for consent were lack of availability of the legal guardians (321/1707) and language barriers (84/1707). Legal guardians of 917 patients were approached with an overall consent rate of 42% (range 14-56% across the seven sites). 81% of the 528 legal guardians who declined consent provided an unsolicited reason for refusal. The three most commonly stated reasons were: being overwhelmed (117/429), not wanting anything else done to their child (63/429) and not wanting an additional medication (53/429). In addition, 14.2% cited research-related concerns as the reason for their non-participation. Conclusions Barriers to consent procurement in a non-therapeutic paediatric critical care study appear to occur at many levels with lack of availability of legal guardians, and legal guardians feeling overwhelmed, being the most commonly recorded reasons. Further research into the impact of these findings on the validity and generalisability of the results of such studies is necessary prior to the development and study of future consent models.	[Menon, Kusum] Childrens Hosp Eastern Ontario, Dept PICU, Ottawa, ON K1H 8L1, Canada; [Ward, Roxanne] CHEORI, Dept Pediat, Ottawa, ON, Canada	Menon, K (corresponding author), Childrens Hosp Eastern Ontario, Dept PICU, Ottawa, ON K1H 8L1, Canada.	menon@cheo.on.ca			Canadian Institutes for Health ResearchCanadian Institutes of Health Research (CIHR)	This study and the original AIP study were funded by the Canadian Institutes for Health Research which had no role in the design, implementation, analysis or write-up of this manuscript.	Ballard Hubert O, 2004, J Perinatol, V24, P409, DOI 10.1038/sj.jp.7211142; Baren JM, 1999, ACAD EMERG MED, V6, P1210, DOI 10.1111/j.1553-2712.1999.tb00135.x; Board R, 2002, HEART LUNG, V31, P53, DOI 10.1067/mhl.2002.121246; BRESLOW N.E., 1987, STAT METHODS CANC RE, VII; Burgess E, 2003, ARCH DIS CHILD-FETAL, V88, P280; Campbell H, 1998, ARCH DIS CHILD, V79, P192, DOI 10.1136/adc.79.2.192; Choong K, 2009, AM J RESP CRIT CARE, V180, P632, DOI 10.1164/rccm.200902-0221OC; Glickman SW, 2008, ANN EMERG MED, V51, P775, DOI 10.1016/j.annemergmed.2007.11.002; Huckabay L M, 1999, Dimens Crit Care Nurs, V18, P36, DOI 10.1097/00003465-199903000-00009; Hulst JM, 2005, INTENS CARE MED, V31, P880, DOI 10.1007/s00134-005-2647-8; Hutchison JS, 2008, NEW ENGL J MED, V358, P2447, DOI 10.1056/NEJMoa0706930; Lacroix J, 2007, NEW ENGL J MED, V356, P1609, DOI 10.1056/NEJMoa066240; Menon K, 2012, INTENS CARE MED, V38, P153, DOI 10.1007/s00134-011-2412-0; Menon K, 2010, AM J RESP CRIT CARE, V182, P246, DOI 10.1164/rccm.200911-1738OC; Natale JE, 2006, DEV NEUROSCI-BASEL, V28, P276, DOI 10.1159/000094154; Needle JS, 2009, PEDIATR CRIT CARE ME, V10, P668, DOI 10.1097/PCC.0b013e3181a706c9; Pollack MM, 1997, J PEDIATR-US, V131, P575, DOI 10.1016/S0022-3476(97)70065-9; Preissig CM, 2010, CRIT CARE, V14, DOI 10.1186/cc8865; Raymond TT, 2010, PEDIATRICS, V125, pE866, DOI 10.1542/peds.2009-2427; Rees G, 2004, INTENS CARE MED, V30, P1607, DOI 10.1007/s00134-004-2310-9; Simon CM, 2004, J CLIN ONCOL, V22, P2708, DOI 10.1200/JCO.2004.10.034; Singhal Nalini, 2002, J Perinatol, V22, P57, DOI 10.1038/sj.jp.7210608; Stenson BJ, 2004, ARCH DIS CHILD-FETAL, V89, pF321, DOI 10.1136/adc.2002.021931; Sturdivant L, 2009, CRIT CARE NURS Q, V32, P149, DOI 10.1097/CNQ.0b013e3181a27f6d	24	22	22	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0306-6800	1473-4257		J MED ETHICS	J. Med. Ethics	FEB	2014	40	2					123	126		10.1136/medethics-2012-101075			4	Ethics; Medical Ethics; Social Issues; Social Sciences, Biomedical	Social Sciences - Other Topics; Medical Ethics; Social Issues; Biomedical Social Sciences	AA5ZA	WOS:000331177200015	23345569				2021-06-18	
J	Ponsford, J; Kelly, A; Couchman, G				Ponsford, Jennie; Kelly, Amber; Couchman, Grace			Self-concept and self-esteem after acquired brain injury: A control group comparison	BRAIN INJURY			English	Article						Traumatic brain injury; self-concept; self-esteem	PSYCHIATRIC-DISORDERS; DEPRESSION SCALE; HOSPITAL ANXIETY; HEAD-INJURY; BODY-IMAGE; REHABILITATION; STROKE; PSYCHOTHERAPY; FREQUENCY; VALIDITY	Primary objective: This study examined the multidimensional self-concept, global self-esteem and psychological adjustment of individuals with traumatic brain injury (TBI) as compared with healthy controls. Research design: Group comparison on self-report questionnaires. Methods and procedures: Forty-one individuals who had sustained a TBI were compared with an age-and gender-matched sample of 41 trauma-free control participants on the Rosenberg Self Esteem Scale, the Tennessee Self Concept Scale (second edition) and the Hospital Anxiety and Depression Scales (HADS). Main outcomes and results: Participants with TBI rated significantly lower mean levels of global self-esteem and self-concept on the Rosenberg Self Esteem Scale and Tennessee Self Concept Scale than the control group. Survivors of TBI rated themselves more poorly on a range of self-dimensions, including social, family, academic/work and personal self-concept compared to controls. They also reported higher mean levels of depression and anxiety on the Hospital Anxiety and Depression Scale. Overall self-concept was most strongly associated with depressive symptoms and anxiety. Conclusions: Self-concept may be lowered following TBI and is associated with negative emotional consequences. Clinicians may improve the emotional adjustment of survivors of TBI by considering particular dimensions of self-concept for intervention focus.	[Ponsford, Jennie; Kelly, Amber; Couchman, Grace] Monash Univ, Sch Psychol & Psychiat, Clayton, Vic, Australia; [Ponsford, Jennie] Epworth Healthcare, Monash Epworth Rehabil Res Ctr, Melbourne, Vic, Australia	Ponsford, J (corresponding author), Monash Univ, Bld 17,Wellington Rd, Clayton, Vic, Australia.	jennie.ponsford@monash.edu					Battle J., 1992, CULTURE FREE SELF ES; Ben-Yishay Y, 2008, NEUROPSYCHOL REHABIL, V18, P513, DOI 10.1080/09602010802141525; Bjelland I, 2002, J PSYCHOSOM RES, V52, P69, DOI 10.1016/S0022-3999(01)00296-3; Bracken BA., 1992, MULTIDIMENSIONAL SEL; Cooper-Evans S, 2008, NEUROPSYCHOL REHABIL, V18, P607, DOI 10.1080/09602010801948516; Coopersmith S., 1967, ANTECEDENTS SELF EST; Crawford JR, 2001, BRIT J CLIN PSYCHOL, V40, P429, DOI 10.1348/014466501163904; Curran CA, 2000, J HEAD TRAUMA REHAB, V15, P1256, DOI 10.1097/00001199-200012000-00006; Davison KK, 2001, PEDIATRICS, V107, P46, DOI 10.1542/peds.107.1.46; Dawkins N, 2006, BRAIN INJURY, V20, P1235, DOI 10.1080/02699050601076414; Draper K, 2007, NEUROPSYCHOL REHABIL, V19, P645; Draper K, 2007, J HEAD TRAUMA REHAB, V22, P278, DOI 10.1097/01.HTR.0000290972.63753.a7; Ellis-Hill CS, 2000, CLIN REHABIL, V14, P279, DOI 10.1191/026921500671231410; Fitts WH, 1992, TENNESSEE SELFCONCEP; Gould KR, 2011, PSYCHOL MED, V41, P2099, DOI 10.1017/S003329171100033X; Gould KR, 2011, J HEAD TRAUMA REHAB, V26, P79, DOI 10.1097/HTR.0b013e3182036799; Gracey F, 2008, NEUROPSYCHOL REHABIL, V18, P627, DOI 10.1080/09602010802041238; Gracey F, 2009, NEUROPSYCHOL REHABIL, V19, P867, DOI 10.1080/09602010903027763; Hart T, 2009, NEUROPSYCHOL REHABIL, V19, P161, DOI 10.1080/09602010802188393; Hibbard MR, 1998, J HEAD TRAUMA REHAB, V13, P24, DOI 10.1097/00001199-199808000-00003; Howes HFR, 2005, BRAIN INJURY, V19, P403, DOI 10.1080/02699050400025158; Judd D, 2005, BRAIN INJURY, V19, P437, DOI 10.1080/02699050400010994; Keppel CC, 2000, NEUROPSYCHOL REHABIL, V10, P15, DOI 10.1080/096020100389273; KRAVETZ S, 1995, BRAIN INJURY, V9, P131, DOI 10.3109/02699059509008186; Kreutzer JS, 2001, BRAIN INJURY, V15, P563, DOI 10.1080/02699050010009108; LITTLEFIELD CH, 1992, DIABETES CARE, V15, P90, DOI 10.2337/diacare.15.1.90; Man DWK, 2003, BRAIN INJURY, V17, P775, DOI 10.1080/0269905031000088577; MCGUIRE B, 1981, APPL PSYCH MEAS, V5, P449, DOI 10.1177/014662168100500402; PELHAM BW, 1989, J PERS SOC PSYCHOL, V57, P672, DOI 10.1037/0022-3514.57.4.672; Piers EV, 1991, PIERS HARRIS CHILDRE; Ponsford J, 2012, TRAUMATIC BRAIN INJU; Port A, 2002, BRAIN INJURY, V16, P277, DOI 10.1080/02699050110103274; Robins RW, 2001, PERS SOC PSYCHOL B, V27, P151, DOI 10.1177/0146167201272002; ROSENBERG M, 1995, AM SOCIOL REV, V60, P141, DOI 10.2307/2096350; ROSENBERG M, 1989, SOC FORCES, V68, P34, DOI 10.2307/2579218; Rosenberg M., 1965, SOC ADOLESCENT SELF, DOI 10.1126/science.148.3671.804; Snaith R.P., 1994, HADS HOSP ANXIETY DE; Snaith R.P., 1994, HOSP ANXIETY DEPRESS; Tabachnik B. G., 2001, USING MULTIVARIATE S; TYERMAN A, 1984, INT J REHABIL RES, V7, P11, DOI 10.1097/00004356-198403000-00002; Vickery CD, 2006, REHABIL PSYCHOL, V51, P30, DOI 10.1037/0090-5550.51.1.30; Vickery CD, 2005, BRAIN INJURY, V19, P657, DOI 10.1080/02699050400005218; Vickery CD, 2008, CLIN REHABIL, V22, P179, DOI 10.1177/0269215507080142; Vickery CD, 2008, REHABIL PSYCHOL, V53, P101, DOI 10.1037/0090-5550.53.1.101; Vickery CD, 2006, CLIN REHABIL, V20, P1075, DOI 10.1177/0269215506071269; Walsh JA, 1989, CRIM JUSTICE BEHAV, V13, P50; Whelan-Goodinson R, 2009, J HEAD TRAUMA REHAB, V24, P324, DOI 10.1097/HTR.0b013e3181a712aa; Wright JC, 1996, BRIT J CLIN PSYCHOL, V35, P399, DOI 10.1111/j.2044-8260.1996.tb01194.x	48	22	22	0	39	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	FEB	2014	28	2					146	154		10.3109/02699052.2013.859733			9	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	302XR	WOS:000330638900003	24456054				2021-06-18	
J	Dunkerson, J; Moritz, KE; Young, J; Pionk, T; Fink, K; Rossignol, J; Dunbar, G; Smith, JS				Dunkerson, Jacob; Moritz, Kasey E.; Young, Jennica; Pionk, Tim; Fink, Kyle; Rossignol, Julien; Dunbar, Gary; Smith, Jeffrey S.			Combining enriched environment and induced pluripotent stem cell therapy results in improved cognitive and motor function following traumatic brain injury	RESTORATIVE NEUROLOGY AND NEUROSCIENCE			English	Article							SENSORIMOTOR FUNCTION; CORTICAL CONTUSION; RECOVERY; RATS; NEURONS; STROKE; TRANSPLANTATION; INTEGRATE; PROGRESS; TBI	Purpose: Despite advances towards potential clinically viable therapies there has been only limited success in improving functional recovery following traumatic brain injury (TBI). In rats, exposure to an enriched environment (EE) improves learning and fosters motor skill development. Induced pluripotent stem cells (iPSC) have been shown to survive transplantation and influence the recovery process. The current study evaluated EE and iPSC as a polytherapy for remediating cognitive deficits following medial frontal cortex (mFC) controlled cortical impact (CCI) injury. Methods: Sixty adult male rats received a midline mFC CCI or sham injury and were randomly placed in either EE or standard environment (SE). Seven days post-injury rats received bilateral transplantation of iPSCs or media. Behavioral measures were conducted throughout the remainder of the study. Following behavioral analysis, brains were extracted and prepared for histological analysis. Results: Open-field data revealed that combined therapy resulted in typical Sham/EE activity rearing patterns by the conclusion of the study. On the Vermicelli Handling task, rats with EE/iPSC polytherapy performed better than media-treated rats. Furthermore, rats treated with polytherapy performed equivalently to Sham/EE rats on the Morris water maze. Proficiency on the Rotarod was consistently better in EE when compared to SE counterparts. Confocal microscopy confirmed that iPSCs survived and migrated away from the transplantation site. Conclusions: Overall, EE or iPSC therapy improved cognition and motor performance, however, full cognitive restoration was seen only with the EE/iPSC treatment. These data suggest that EE/iPSC therapy should be explored as a potential, clinically relevant, treatment for TBI.	[Dunkerson, Jacob; Moritz, Kasey E.; Young, Jennica; Pionk, Tim; Smith, Jeffrey S.] Saginaw Valley State Univ, Brain Res Lab, University Ctr, MI 48710 USA; [Fink, Kyle; Rossignol, Julien; Dunbar, Gary] Cent Michigan Univ, Field Neurosci Inst, Lab Restorat Neurol, Mt Pleasant, MI 48859 USA	Smith, JS (corresponding author), Saginaw Valley State Univ, Crystal M Lange Coll Hlth & Human Serv, Dept Hlth Sci, Malcolm & Lois Field Endowed Chair Hlth Sci, 7400 Bay Rd, University Ctr, MI 48710 USA.	jsmith12@svsu.edu	Rossignol, Julien/I-1013-2019	Smith, Jeffrey/0000-0001-5499-4475; Rossignol, Julien/0000-0002-8662-0547	Field Neuroscience Institute	This study was generously funded through a contract with the Field Neuroscience Institute to Jeffrey Smith. The authors would like to thank Madeleine Searles and Evan Nudi for their countless contributions for technical support throughout the duration of the study.	Allred RP, 2008, FUTUR NEUROL, V3, P189, DOI 10.2217/14796708.3.2.189; Barrash J, 2011, J CLIN EXP NEUROPSYC, V33, P833, DOI 10.1080/13803395.2011.561300; Bayona Nestor A, 2005, Top Stroke Rehabil, V12, P1; Bilic J, 2012, STEM CELLS, V30, P33, DOI 10.1002/stem.700; Coronado VG, 2012, J SAFETY RES, V43, P299, DOI 10.1016/j.jsr.2012.08.011; Dobrossy MD, 2006, EUR J NEUROSCI, V24, P3223, DOI 10.1111/j.1460-9568.2006.05182.x; Englund U, 2002, P NATL ACAD SCI USA, V99, P17089, DOI 10.1073/pnas.252589099; Fares RP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053888; Fink KD, 2014, CELL TRANSPLANT, V23, P1407, DOI 10.3727/096368913X670958; Gogel S, 2011, GENE THER, V18, P1, DOI 10.1038/gt.2010.130; Harting MT, 2008, NEUROSURG FOCUS, V24, DOI 10.3171/FOC/2008/24/3-4/E17; Hicks AU, 2007, NEUROSCIENCE, V146, P31, DOI 10.1016/j.neuroscience.2007.01.020; Hoane MR, 2004, J NEUROTRAUM, V21, P163, DOI 10.1089/089771504322778622; HOFFMAN SW, 1994, J NEUROTRAUM, V11, P417, DOI 10.1089/neu.1994.11.417; Janssen H, 2010, NEUROREHAB NEURAL RE, V24, P802, DOI 10.1177/1545968310372092; Ke MT, 2013, NAT NEUROSCI, V16, P1154, DOI 10.1038/nn.3447; Kolb B, 2000, DEV NEUROPSYCHOL, V18, P423, DOI 10.1207/S1532694208Kolb; Lee MY, 2013, NEUROREHAB NEURAL RE, V27, P561, DOI 10.1177/1545968313481277; Maegele M, 2005, J NEUROTRAUM, V22, P772, DOI 10.1089/neu.2005.22.772; Majdan M, 2011, BRAIN INJURY, V25, P797, DOI 10.3109/02699052.2011.581642; Miura K, 2009, NAT BIOTECHNOL, V27, P743, DOI 10.1038/nbt.1554; Moppett IK, 2007, BRIT J ANAESTH, V99, P18, DOI 10.1093/bja/aem128; Morales DM, 2005, NEUROSCIENCE, V136, P971, DOI 10.1016/j.neuroscience.2005.08.030; Murphy MP, 2012, NEUROREHABILITATION, V31, P85, DOI 10.3233/NRE-2012-0777; NEISTADT ME, 1994, AM J OCCUP THER, V48, P421, DOI 10.5014/ajot.48.5.421; O'Connor WT, 2011, PHARMACOL THERAPEUT, V130, P106, DOI 10.1016/j.pharmthera.2011.01.001; Oki K, 2012, STEM CELLS, V30, P1120, DOI 10.1002/stem.1104; Peruzzaro ST, 2013, RESTOR NEUROL NEUROS, V31, P431, DOI 10.3233/RNN-120299; Pham TM, 1999, NEUROSCIENCE, V94, P279, DOI 10.1016/S0306-4522(99)00316-4; Rezanejad H, 2012, CELL REPROGRAM, V14, P459, DOI 10.1089/cell.2012.0039; Shear DA, 2004, BRAIN RES, V1026, P11, DOI 10.1016/j.brainres.2004.07.087; Smith JS, 2000, NEURAL PLAST, V7, P73, DOI 10.1155/NP.2000.73; Sozda CN, 2010, J NEUROTRAUM, V27, P1047, DOI 10.1089/neu.2010.1313; Stadtfeld M, 2010, GENE DEV, V24, P2239, DOI 10.1101/gad.1963910; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tennant Kelly A, 2010, J Vis Exp, DOI 10.3791/2076; Wernig M, 2008, P NATL ACAD SCI USA, V105, P5856, DOI 10.1073/pnas.0801677105	37	22	22	0	9	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	0922-6028	1878-3627		RESTOR NEUROL NEUROS	Restor. Neurol. Neurosci.		2014	32	5					675	687		10.3233/RNN-140408			13	Neurosciences	Neurosciences & Neurology	AR2NP	WOS:000343424900009	25079980				2021-06-18	
J	Gubata, ME; Packnett, ER; Blandford, CD; Piccirillo, AL; Niebuhr, DW; Cowan, DN				Gubata, Marlene E.; Packnett, Elizabeth R.; Blandford, Caitlin D.; Piccirillo, Amanda L.; Niebuhr, David W.; Cowan, David N.			Trends in the Epidemiology of Disability Related to Traumatic Brain Injury in the US Army and Marine Corps: 2005 to 2010	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						military personnel; traumatic brain injury; disability evaluation	OPERATION ENDURING FREEDOM; POSTTRAUMATIC-STRESS-DISORDER; LONG-TERM DISABILITY; IRAQI FREEDOM; UNITED-STATES; RISK-FACTORS; U.S. ARMY; MILITARY; AFGHANISTAN; PREVALENCE	Background: Traumatic brain injury (TBI) has been recognized as a major public health issue for several decades. Despite technological advancements in protective equipment and medical care available during recent military conflicts, TBI is the most common neurological condition among Soldiers and Marines evaluated for discharge from service. This study describes the demographic, service-related, and disability characteristics of Soldiers and Marines referred for combat-related TBI disability evaluation. Methods: Cross-sectional analysis of Soldiers and Marines evaluated for combat-related disability between October 1, 2004 and September 30, 2010 was performed. Traumatic brain injury cases were identified using the Veterans Affairs Schedule for Rating Disabilities code for TBI and compared with other combat-related disabilities. Results: Combat-related TBI disability rates have significantly increased in both the Army and the Marine Corps since 2005. Significantly more unfitting conditions are present on average in combat-related TBI cases than in other combat-related disability cases. Combat-related TBI disability cases are more likely to be medically retired than other types of combat-related disability. Conclusions: Because veterans with combat-related TBI disabilities are likely to require chronic care for TBI-associated medical conditions, disability evaluation policy and programs must ensure that combat-related TBI disabilities are accurately identified and compensated, and the potential long-term care needs are addressed.	[Gubata, Marlene E.; Packnett, Elizabeth R.; Blandford, Caitlin D.; Piccirillo, Amanda L.; Niebuhr, David W.; Cowan, David N.] Walter Reed Army Inst Res, Dept Epidemiol, Prevent Med Program, Silver Spring, MD 20910 USA; [Packnett, Elizabeth R.; Blandford, Caitlin D.; Piccirillo, Amanda L.; Cowan, David N.] Allied Technol Grp Inc, Rockville, MD USA	Gubata, ME (corresponding author), Walter Reed Army Inst Res, Dept Epidemiol, Prevent Med Program, 503 Robert Grant Ave, Silver Spring, MD 20910 USA.	marlene.gubata@us.army.mil			Defense Health Program	This study was supported by funds provided by the Defense Health Program.	Amoroso P J, 1999, Mil Med, V164, P1; [Anonymous], 2011, ANN BEN REP FISC YEA; [Anonymous], 2006, SECR DEF PERS READ P; Armed Forces Health Surveillance Center, 2008, MED SURV MONTHL REP, V15, P28; Armed Forces Health Surveillance Center, 2009, MSMR MED SURVEILL MO, V16, P24; Bell N, 2008, TALE 2 DISABILITY CO; Bell NS, 2011, J TRAUMA STRESS, V24, P34, DOI 10.1002/jts.20612; Bell NS, 2008, DISABIL HEALTH J, V1, P163, DOI 10.1016/j.dhjo.2008.05.002; Bell RS, 2010, NEUROSURG FOCUS, V28, DOI 10.3171/2010.2.FOCUS1025; Bell RS, 2010, NEUROSURG FOCUS, V28, DOI 10.3171/2010.2.FOCUS1022; Bell RS, 2009, J TRAUMA, V66, pS104, DOI 10.1097/TA.0b013e31819d88c8; Bohnker BK, 2003, MIL MED, V168, P482; Brown AW, 2011, J NEUROTRAUM, V28, P167, DOI 10.1089/neu.2010.1400; Brown S, 2011, BRAIN INJURY, V25, P453, DOI 10.3109/02699052.2011.556581; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; Cross JD, 2011, J AM ACAD ORTHOP SUR, V19, pS1, DOI 10.5435/00124635-201102001-00002; Defense Manpower Data Center, 2011, CONT TRACK SYST DEPL; Eisenburg MF, 2010, NEUROSURG FOCUS, V28, DOI 10.3171/2010.2.FOCUS108; Faul M.D., 2010, TRAUMATIC BRAIN INJU; Feuerstein M, 1997, J OCCUP ENVIRON MED, V39, P68, DOI 10.1097/00043764-199701000-00013; Gubata ME, 2012, TRISERVICE DISABILIT; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hoge CW, 2005, AM J PSYCHIAT, V162, P585, DOI 10.1176/appi.ajp.162.3.585; Hollander IE, 2010, MIL MED, V175, P705, DOI 10.7205/MILMED-D-09-00214; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Langlois Jean A, 2003, MMWR Surveill Summ, V52, P1; MacGregor AJ, 2010, J HEAD TRAUMA REHAB, V25, P1, DOI 10.1097/HTR.0b013e3181c2993d; Masini BD, 2009, J ORTHOP TRAUMA, V23, P261, DOI 10.1097/BOT.0b013e31819dfa04; Niebuhr DW, 2011, MIL MED, V176, P170, DOI 10.7205/MILMED-D-10-00114; Okie S, 2005, NEW ENGL J MED, V352, P2043, DOI 10.1056/NEJMp058102; Owens BD, 2008, J TRAUMA, V64, P295, DOI 10.1097/TA.0b013e318163b875; Packnett ER, 2012, J TRAUMA STRESS, V25, P485, DOI 10.1002/jts.21743; Patzkowski JC, 2012, J AM ACAD ORTHOP SUR, V20, pS23, DOI 10.5435/JAAOS-20-08-S23; Pickelsimer EE, 2006, J HEAD TRAUMA REHAB, V21, P491, DOI 10.1097/00001199-200611000-00004; Ragel BT, 2010, NEUROSURG FOCUS, V28, DOI 10.3171/2010.3.FOCUS09324; Rivera JC, 2012, J AM ACAD ORTHOP SUR, V20, pS64, DOI 10.5435/JAAOS-20-08-S64; Rogers JM, 2007, BRAIN INJURY, V21, P1321, DOI 10.1080/02699050701765700; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Schwartz C, 2007, RISK FACTORS DISCHAR; Seel RT, 2003, ARCH PHYS MED REHAB, V84, P177, DOI 10.1053/apmr.2003.50106; Selassie AW, 2008, J HEAD TRAUMA REHAB, V23, P123, DOI 10.1097/01.HTR.0000314531.30401.39; Sikorski C, 2012, MIL MED, V177, P128, DOI 10.7205/MILMED-D-11-00250; Songer TJ, 2000, AM J PREV MED, V18, P33, DOI 10.1016/S0749-3797(00)00107-0; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398, DOI 10.1097/00001199-200609000-00004; Zaloshnja E, 2008, J HEAD TRAUMA REHAB, V23, P394, DOI 10.1097/01.HTR.0000341435.52004.ac	46	22	23	0	12	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	JAN-FEB	2014	29	1					65	75		10.1097/HTR.0b013e318295f590			11	Clinical Neurology; Rehabilitation	Neurosciences & Neurology; Rehabilitation	AH1OC	WOS:000335889400012	23756433				2021-06-18	
J	Kang, XG; Li, L; Wei, D; Xu, XX; Zhao, R; Jing, YY; Su, YY; Xiong, LZ; Zhao, G; Jiang, W				Kang, Xiao-gang; Li, Li; Wei, Dong; Xu, Xiao-xia; Zhao, Rui; Jing, Yun-yun; Su, Ying-ying; Xiong, Li-ze; Zhao, Gang; Jiang, Wen			Development of a simple score to predict outcome for unresponsive wakefulness syndrome	CRITICAL CARE			English	Article							NEURON-SPECIFIC ENOLASE; PERSISTENT VEGETATIVE STATE; MINIMALLY CONSCIOUS STATES; TRAUMATIC BRAIN-INJURY; CARDIAC-ARREST; SLEEP SPINDLES; COMA; DISORDERS; RECOVERY; EEG	Introduction: Accurate assessment of prognosis for patients with unresponsive wakefulness syndrome (UWS; formerly vegetative state) may help clinicians and families guide the type and intensity of therapy; however, there is no suitable and accurate means to predict the outcome so far. We aimed to develop a simple bedside scoring system to predict the likelihood of awareness recovery in patients with UWS. Methods: We prospectively enrolled 56 patients (age range 10 to 73 years) with UWS 3 to 12 weeks post-onset. We collected demographic data and performed neurological, serological and neurophysiological tests at study entry. Each patient received a one year follow-up, during which awareness recovery was assessed by experienced physicians on the basis of clinical criteria. Univariate and multivariable analyses were employed to assess the relationships between predictors and awareness recovery. Results: A total of 56 participants were included in the study; of these, 24 patients recovered awareness, 3 with moderate disabilities, 8 with severe disabilities, 12 were in a minimally conscious state, and 1 died after recovery. During the study, 23 patients remained in UWS and 9 died in UWS. Motor response, type of brain injury, electroencephalogram reactivity, sleep spindles and N20 were shown to be independent predictors for awareness recovery. Based on their coefficients in the model, we assigned these predictors with 1 point each and created a 5-point score for prediction of awareness recovery. The resulting score showed good predictive accuracy in the derivation cohort. The area under the receiver operating characteristic curve for the score was 0.918 with 87.50% sensitivity. Conclusion: This simple bedside prognostic score can be used to predict the probability of awareness recovery in UWS, thus provide families and clinicians with useful outcome information.	[Kang, Xiao-gang; Li, Li; Wei, Dong; Xu, Xiao-xia; Zhao, Rui; Jing, Yun-yun; Zhao, Gang; Jiang, Wen] Fourth Mil Med Univ, Xijing Hosp, Dept Neurol, Xian 710032, Peoples R China; [Su, Ying-ying] Capital Med Univ, Xuanwu Hosp, Div Neurocrit Care, Beijing 100053, Peoples R China; [Xiong, Li-ze] Fourth Mil Med Univ, Xijing Hosp, Dept Anaesthesia, Xian 710032, Peoples R China	Jiang, W (corresponding author), Fourth Mil Med Univ, Xijing Hosp, Dept Neurol, Xian 710032, Peoples R China.	jiangwen@fmmu.edu.cn			Xijing Hospital Research Foundation [XKZT09Z07]; Program for Changjiang Scholars and Innovative Research Team in University from the Ministry of Education of China [IRT1053]	This work is supported by the Xijing Hospital Research Foundation (grant number XKZT09Z07, to W Jiang) and the Program for Changjiang Scholars and Innovative Research Team in University from the Ministry of Education of China (IRT1053).	Amantini A, 2005, CLIN NEUROPHYSIOL, V116, P229, DOI 10.1016/j.clinph.2004.07.008; Andrillon T, 2011, J NEUROSCI, V31, P17821, DOI 10.1523/JNEUROSCI.2604-11.2011; ASHWAL S, 1994, NEW ENGL J MED, V330, P1499; Beaumont JG, 2005, NEUROPSYCHOL REHABIL, V15, P184, DOI 10.1080/09602010443000489; Bernat JL, 2006, LANCET, V367, P1181, DOI 10.1016/S0140-6736(06)68508-5; Beuthien-Baumann B, 2005, NEUROPSYCHOL REHABIL, V15, P276, DOI 10.1080/09602010443000290; Chen R, 1996, CRIT CARE MED, V24, P672, DOI 10.1097/00003246-199604000-00020; CHILDS NL, 1993, NEUROLOGY, V43, P1465, DOI 10.1212/WNL.43.8.1465; Courjon J, 1971, Rev Electroencephalogr Neurophysiol Clin, V1, P133, DOI 10.1016/S0370-4475(71)80054-0; Cronberg T, 2011, NEUROLOGY, V77, P623, DOI 10.1212/WNL.0b013e31822a276d; Cruse D, 2011, LANCET, V378, P2088, DOI 10.1016/S0140-6736(11)61224-5; Daubin C, 2011, BMC CARDIOVASC DISOR, V11, DOI 10.1186/1471-2261-11-48; Estraneo A, 2010, NEUROLOGY, V75, P239, DOI 10.1212/WNL.0b013e3181e8e8cc; Estraneo A, 2013, NEUROLOGY, V80, P464, DOI 10.1212/WNL.0b013e31827f0f31; Fugate JE, 2010, ANN NEUROL, V68, P907, DOI 10.1002/ana.22133; Giacino JT, 2002, NEUROLOGY, V58, P349, DOI 10.1212/WNL.58.3.349; Heiss WD, 2012, EUR J NEUROL, V19, P207, DOI 10.1111/j.1468-1331.2011.03489.x; Hirschberg R, 2011, NEUROL CLIN, V29, P773, DOI 10.1016/j.ncl.2011.07.009; HULIHAN JF, 1994, NEUROLOGY, V44, P758, DOI 10.1212/WNL.44.4.758; Johnston MV, 2009, BRAIN DEV-JPN, V31, P1, DOI 10.1016/j.braindev.2008.03.014; Kampfl A, 1998, LANCET, V351, P1763, DOI 10.1016/S0140-6736(97)10301-4; Kaplan PW, 2006, SEMIN NEUROL, V26, P403, DOI 10.1055/s-2006-948321; Katz DI, 2009, PROG BRAIN RES, V177, P73, DOI 10.1016/S0079-6123(09)17707-5; Laureys S, 2004, LANCET NEUROL, V3, P537, DOI 10.1016/S1474-4422(04)00852-X; Laureys S, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-68; Lee YC, 2010, NEUROLOGY, V74, P572, DOI 10.1212/WNL.0b013e3181cff761; Leithner C, 2010, NEUROLOGY, V74, P965, DOI 10.1212/WNL.0b013e3181d5a631; Logi F, 2011, BRAIN INJURY, V25, P972, DOI 10.3109/02699052.2011.589795; Luaute J, 2010, NEUROLOGY, V75, P246, DOI 10.1212/WNL.0b013e3181e8e8df; Machado C, 2010, NEUROLOGY, V75, P751, DOI 10.1212/WNL.0b013e3181ec67bb; Monti MM, 2010, NEW ENGL J MED, V362, P579, DOI 10.1056/NEJMoa0905370; Oddo M, 2011, CURR OPIN CRIT CARE, V17, P254, DOI 10.1097/MCC.0b013e328344f2ae; Olivecrona M, 2009, J NEUROL NEUROSUR PS, V80, P1241, DOI 10.1136/jnnp.2008.158196; Owen AM, 2007, ARCH NEUROL-CHICAGO, V64, P1098, DOI 10.1001/archneur.64.8.1098; Owen AM, 2006, SCIENCE, V313, P1402, DOI 10.1126/science.1130197; Rabinstein AA, 2012, LANCET NEUROL, V11, P414, DOI 10.1016/S1474-4422(12)70060-1; Racine E, 2010, CAN J NEUROL SCI, V37, P758, DOI 10.1017/S0317167100051416; Rech TH, 2006, CRIT CARE, V10, DOI 10.1186/cc5046; Robinson LR, 2003, CRIT CARE MED, V31, P960, DOI 10.1097/01.CCM.0000053643.21751.3B; Rossetti AO, 2010, ANN NEUROL, V67, P301, DOI 10.1002/ana.21984; Rovlias A, 2004, J NEUROTRAUM, V21, P886, DOI 10.1089/0897715041526249; Schnakers C, 2009, BMC NEUROL, V9, DOI 10.1186/1471-2377-9-35; Thenayan EAL, 2010, J CRIT CARE, V25, P300, DOI 10.1016/j.jcrc.2009.06.049; Urakami Y, 2012, CLIN EEG NEUROSCI, V43, P39, DOI 10.1177/1550059411428718; Young GB, 2000, J CLIN NEUROPHYSIOL, V17, P473, DOI 10.1097/00004691-200009000-00006	45	22	24	0	6	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1466-609X	1364-8535		CRIT CARE	Crit. Care		2014	18	1							R37	10.1186/cc13745			8	Critical Care Medicine	General & Internal Medicine	AL2YP	WOS:000338991900074	24571596	DOAJ Gold, Green Published			2021-06-18	
J	Yokobori, S; Mazzeo, AT; Gajavelli, S; Bullock, MR				Yokobori, Shoji; Mazzeo, Anna T.; Gajavelli, Shyam; Bullock, Malcolm R.			Mitochondrial Neuroprotection in Traumatic Brain Injury: Rationale and Therapeutic Strategies	CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS			English	Article						Apoptosis; astrocyte-neuron lactate shuttle; cyclosporine A; mitochondrial dysfunction; mitochondrial permeability transition pore; secondary brain injury; traumatic brain injury	EXCITATORY AMINO-ACIDS; TRANSIENT FOREBRAIN ISCHEMIA; CYCLOSPORINE-A TREATMENT; INDUCED AXONAL DAMAGE; PERMEABILITY TRANSITION; CELL-DEATH; CEREBRAL-ISCHEMIA; CYTOCHROME-C; IMPAIRED MITOCHONDRIAL; MAGNETIC-RESONANCE	Traumatic brain injury (TBI) is still the worldwide, leading cause of mortality and morbidity in young adults. The prognosis of TBI patients is strongly affected by secondary brain damage including mitochondrial dysfunctions. In many basic and clinical studies, mitochondrial dysfunctions, including the opening of mitochondrial permeability transition (mPT) pore, and treatments including cyclosporine A (CsA) have been studied. These evidences suggest an important role for mitochondria as therapeutic targets for neuroprotection after TBI. This review summarizes the data about normal and pathological mitochondrial function after TBI, TBI pathobiology relating to mitochondrial dysfunction and therapeutic strategies including drug treatment. This review also mentioned about glucose, lactate, and pyruvate metabolisms in TBI, including the "astrocyte-neuron lactate shuttle (ANLS)" hypothesis. Mitochondrial pathophysiology in TBI is still unclear. Thus, the pharmacological treatment in TBI patient is still challenging. This review could help further understanding of this topic. Hopefully, this could help further development and innovation for drug therapies in TBI.	[Yokobori, Shoji; Gajavelli, Shyam; Bullock, Malcolm R.] Univ Miami, Miller Sch Med, Dept Neurosurg, Miami, FL 33136 USA; [Yokobori, Shoji] Nippon Med Sch, Dept Emergency & Crit Care Med, Tokyo 113, Japan; [Mazzeo, Anna T.] Univ Messina, Dept Neurosci Anesthesiol & Psychiat Sci, I-98100 Messina, Italy	Bullock, MR (corresponding author), Univ Miami, Miller Sch Med, Dept Neurosurg, Lois Pope LIFE Ctr, Room 3-20,1095 NW 14th Terrace, Miami, FL 33136 USA.	RBullock@med.miami.edu	Gajavelli, Shyam/AAI-1374-2019	Gajavelli, Shyam/0000-0002-5947-6973; Mazzeo, Anna Teresa/0000-0002-8454-7243			Alessandri B, 2002, J NEUROTRAUM, V19, P829, DOI 10.1089/08977150260190429; ANDERSEN BJ, 1992, BRAIN RES, V585, P190, DOI 10.1016/0006-8993(92)91206-T; ANDERSEN BJ, 1992, BRAIN RES, V585, P184, DOI 10.1016/0006-8993(92)91205-S; ANKARCRONA M, 1995, NEURON, V15, P961, DOI 10.1016/0896-6273(95)90186-8; Aubert A, 2005, P NATL ACAD SCI USA, V102, P16448, DOI 10.1073/pnas.0505427102; Bergersen LH, 2007, NEUROSCIENCE, V145, P11, DOI 10.1016/j.neuroscience.2006.11.062; Binder S, 2005, J HEAD TRAUMA REHAB, V20, P189, DOI 10.1097/00001199-200505000-00002; Bullock R, 1995, ANN NY ACAD SCI, V765, P290, DOI 10.1111/j.1749-6632.1995.tb16586.x; Chen T, 2000, J NEUROTRAUM, V17, P135, DOI 10.1089/neu.2000.17.135; Clausen T, 2001, BRAIN RES, V908, P35, DOI 10.1016/S0006-8993(01)02566-5; Clausen T, 2001, CURR PHARM DESIGN, V7, P1517, DOI 10.2174/1381612013397267; Colley BS, 2010, EXP NEUROL, V224, P241, DOI 10.1016/j.expneurol.2010.03.026; Correia SC, 2010, FRONT AGING NEUROSCI, V2, DOI 10.3389/fnagi.2010.00138; Correia SC, 2010, J ALZHEIMERS DIS, V20, pS475, DOI 10.3233/JAD-2010-100669; Costa T, 2010, J NEUROSCI RES, V88, P1329, DOI 10.1002/jnr.22300; Dash PK, 2009, NEUROSCI LETT, V460, P103, DOI 10.1016/j.neulet.2009.04.028; Davis DP, 2003, CURR OPIN ANESTHESIO, V16, P447, DOI 10.1097/00001503-200310000-00002; Dirnagl U, 2009, LANCET NEUROL, V8, P398, DOI 10.1016/S1474-4422(09)70054-7; Ehrenreich H, 2009, STROKE, V40, pE647, DOI 10.1161/STROKEAHA.109.564872; Ferrand-Drake M, 2003, J NEUROCHEM, V85, P1431, DOI 10.1046/j.1471-4159.2003.01794.x; Fiskum G, 2000, J NEUROTRAUM, V17, P843, DOI 10.1089/neu.2000.17.843; Friberg H, 1998, J NEUROSCI, V18, P5151; Friess SH, 2011, NEUROSURGERY, V69, P1139, DOI 10.1227/NEU.0b013e3182284aa1; Fu ES, 2005, CURR OPIN ANESTHESIO, V18, P181, DOI 10.1097/01.aco.0000162838.56344.88; Gaetz M, 2004, CLIN NEUROPHYSIOL, V115, P4, DOI 10.1016/S1388-2457(03)00258-X; Gallagher CN, 2009, BRAIN, V132, P2839, DOI 10.1093/brain/awp202; Genc S, 2004, RESTOR NEUROL NEUROS, V22, P105; Gilmer LK, 2009, J NEUROTRAUM, V26, P1271, DOI 10.1089/neu.2008.0857; Goodman JC, 1996, J NEUROTRAUM, V13, P549, DOI 10.1089/neu.1996.13.549; Greco T, 2011, FREE RADICAL BIO MED, V51, P2164, DOI 10.1016/j.freeradbiomed.2011.09.017; Greco T, 2010, J ALZHEIMERS DIS, V20, pS427, DOI 10.3233/JAD-2010-100519; Green D, 1998, TRENDS CELL BIOL, V8, P267, DOI 10.1016/S0962-8924(98)01273-2; Guicciardi ME, 2004, ONCOGENE, V23, P2881, DOI 10.1038/sj.onc.1207512; Halestrap AP, 2002, BIOCHIMIE, V84, P153, DOI 10.1016/S0300-9084(02)01375-5; Hansson MJ, 2011, J NEUROTRAUM, V28, P143, DOI 10.1089/neu.2010.1613; Hansson MJ, 2004, J NEUROCHEM, V89, P715, DOI 10.1111/j.1471-4159.2004.02400.x; Hatton J, 2008, J NEUROSURG, V109, P699, DOI 10.3171/JNS/2008/109/10/0699; Holloway R, 2007, ACTA NEUROCHIR, V149, P919, DOI 10.1007/s00701-007-1241-y; Hu SL, 2010, NEUROL RES, V32, P173, DOI 10.1179/174313209X414524; INAO S, 1988, J NEUROSURG, V69, P736, DOI 10.3171/jns.1988.69.5.0736; JANOFF A, 1964, Int Anesthesiol Clin, V2, P251, DOI 10.1097/00004311-196402000-00008; Jung JE, 2009, J NEUROSCI, V29, P7003, DOI 10.1523/JNEUROSCI.1110-09.2009; Kasischke KA, 2004, SCIENCE, V305, P99, DOI 10.1126/science.1096485; KAWAMATA T, 1995, BRAIN RES, V674, P196, DOI 10.1016/0006-8993(94)01444-M; Kilbaugh TJ, 2011, J NEUROTRAUM, V28, P763, DOI 10.1089/neu.2010.1635; Kottenberg E, 2012, ACTA ANAESTH SCAND, V56, P30, DOI 10.1111/j.1399-6576.2011.02585.x; Kristal BS, 2004, J BIOENERG BIOMEMBR, V36, P309, DOI 10.1023/B:JOBB.0000041759.35731.70; Kroemer G, 1998, ANNU REV PHYSIOL, V60, P619, DOI 10.1146/annurev.physiol.60.1.619; Krysko DV, 2008, METHODS, V44, P205, DOI 10.1016/j.ymeth.2007.12.001; Langlois JA, 2005, J HEAD TRAUMA REHAB, V20, P196, DOI 10.1097/00001199-200505000-00003; Lee JS, 2004, J NEUROTRAUM, V21, P549, DOI 10.1089/089771504774129883; Lemasters JJ, 1998, BBA-BIOENERGETICS, V1366, P177, DOI 10.1016/S0005-2728(98)00112-1; Levasseur JE, 2006, NEUROSURGERY, V59, P1122, DOI 10.1227/01.NEU.0000245581.00908.AF; Li PA, 2000, EXP NEUROL, V165, P153, DOI 10.1006/exnr.2000.7459; Lifshitz J, 2004, MITOCHONDRION, V4, P705, DOI 10.1016/j.mito.2004.07.021; Loaiza A, 2003, J NEUROSCI, V23, P7337; Longhi L, 2011, J CEREBR BLOOD F MET, V31, P1919, DOI 10.1038/jcbfm.2011.42; Lulic D, 2011, NEUROSURGERY, V68, P1172, DOI 10.1227/NEU.0b013e31820c6cdc; Luo CL, 2010, J NEUROSCI RES, V88, P2847, DOI 10.1002/jnr.22453; Maas AI, 2007, LANCET NEUROL, V6, P20, DOI 10.1016/S1474-4422(06)70668-8; Maas AIR, 2010, NEUROTHERAPEUTICS, V7, P115, DOI 10.1016/j.nurt.2009.10.022; Mammis A, 2009, SURG NEUROL, V71, P527, DOI 10.1016/j.surneu.2008.02.040; Matsumoto S, 1999, J CEREBR BLOOD F MET, V19, P736, DOI 10.1097/00004647-199907000-00002; Mattiasson G, 2003, J NEUROCHEM, V87, P532, DOI 10.1046/j.1471-4159.2003.02026.x; Mazzeo AT, 2008, ACTA NEUROCHIR, V150, P1019, DOI 10.1007/s00701-008-0021-7; Mazzeo AT, 2006, J NEUROTRAUM, V23, P962, DOI 10.1089/neu.2006.23.962; Mazzeo AT, 2009, J NEUROTRAUM, V26, P2195, DOI 10.1089/neu.2009.1012; Mazzeo AT, 2009, EXP NEUROL, V218, P363, DOI 10.1016/j.expneurol.2009.05.026; Mirzayan MJ, 2008, NEUROL RES, V30, P476, DOI 10.1179/174313208X276916; Moore EM, 2011, ANAESTH INTENS CARE, V39, P356, DOI 10.1177/0310057X1103900306; Nakai A, 2004, PEDIATR NEUROL, V30, P247, DOI 10.1016/j.pediatrneurol.2003.09.006; Nelson DW, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-21; Newmeyer DD, 2003, CELL, V112, P481, DOI 10.1016/S0092-8674(03)00116-8; Okonkwo DO, 1999, NEUROREPORT, V10, P353, DOI 10.1097/00001756-199902050-00026; Okonkwo DO, 1999, J CEREBR BLOOD F MET, V19, P443, DOI 10.1097/00004647-199904000-00010; Panickar KS, 2002, NEUROCHEM RES, V27, P161, DOI 10.1023/A:1014875210852; Papadopoulos V, 2006, NEUROSCIENCE, V138, P749, DOI 10.1016/j.neuroscience.2005.05.063; Papadopoulos V, 2009, EXP NEUROL, V219, P53, DOI 10.1016/j.expneurol.2009.04.016; Parker MA, 2002, J NEUROSCI RES, V69, P39, DOI 10.1002/jnr.10235; PELLERIN L, 1994, P NATL ACAD SCI USA, V91, P10625, DOI 10.1073/pnas.91.22.10625; Pellerin L, 1997, GLIA, V21, P74, DOI 10.1002/(SICI)1098-1136(199709)21:1<74::AID-GLIA8>3.0.CO;2-1; Pellerin L, 2012, J CEREBR BLOOD F MET, V32, P1152, DOI 10.1038/jcbfm.2011.149; Perez-Pinzon MA, 2004, J BIOENERG BIOMEMBR, V36, P323, DOI 10.1023/B:JOBB.0000041762.47544.ff; Petronilli V, 2001, J BIOL CHEM, V276, P12030, DOI 10.1074/jbc.M010604200; Porras OH, 2004, J NEUROSCI, V24, P9669, DOI 10.1523/JNEUROSCI.1882-04.2004; Povlishock JT, 1996, ACT NEUR S, V66, P81; Ravati A, 2000, BRAIN RES, V866, P23, DOI 10.1016/S0006-8993(00)02210-1; REHNCRONA S, 1981, J CEREBR BLOOD F MET, V1, P297, DOI 10.1038/jcbfm.1981.34; Rice AC, 2002, BRAIN RES, V928, P156, DOI 10.1016/S0006-8993(01)03299-1; Robertson CL, 2007, J NEUROCHEM, V101, P1248, DOI 10.1111/j.1471-4159.2007.04489.x; Robertson CL, 2009, EXP NEUROL, V218, P371, DOI 10.1016/j.expneurol.2009.04.030; Saugstad JA, 2010, J CEREBR BLOOD F MET, V30, P1564, DOI 10.1038/jcbfm.2010.101; Scafidi S, 2010, DEV NEUROSCI-BASEL, V32, P480, DOI 10.1159/000323178; Schurr A, 1997, BRAIN RES, V774, P221, DOI 10.1016/S0006-8993(97)81708-8; Scorrano L, 2002, DEV CELL, V2, P55, DOI 10.1016/S1534-5807(01)00116-2; SHIGA Y, 1992, BRAIN RES, V595, P145, DOI 10.1016/0006-8993(92)91465-Q; SIEGEL JH, 1990, ARCH SURG-CHICAGO, V125, P498; SIESJO BK, 1981, J CEREBR BLOOD F MET, V1, P155, DOI 10.1038/jcbfm.1981.18; Signoretti S, 2004, J NEUROTRAUM, V21, P1154, DOI 10.1089/neu.2004.21.1154; Signoretti S, 2008, J NEUROSURG, V108, P42, DOI 10.3171/JNS/2008/108/01/0042; Simard JM, 2007, LANCET NEUROL, V6, P258, DOI 10.1016/S1474-4422(07)70055-8; Singh IN, 2006, J CEREBR BLOOD F MET, V26, P1407, DOI 10.1038/sj.jcbfm.9600297; Soane L, 2007, J NEUROSCI RES, V85, P3407, DOI 10.1002/jnr.21498; Soustiel JF, 2007, NEUROL RES, V29, P654, DOI 10.1179/016164107X240017; Starkov AA, 2004, CELL CALCIUM, V36, P257, DOI 10.1016/j.ceca.2004.02.012; Stavrovskaya IG, 2005, FREE RADICAL BIO MED, V38, P687, DOI 10.1016/j.freeradbiomed.2004.11.032; Stoica B, 2009, NEUROTHERAPEUTICS, V6, P14, DOI 10.1016/j.nurt.2008.10.029; Sullivan PG, 2011, J NEUROTRAUM, V28, P311, DOI 10.1089/neu.2010.1646; Sullivan PG, 2000, NEUROSCIENCE, V101, P289, DOI 10.1016/S0306-4522(00)00380-8; Sullivan PG, 1998, J NEUROTRAUM, V15, P789, DOI 10.1089/neu.1998.15.789; Sullivan PG, 1999, EXP NEUROL, V160, P226, DOI 10.1006/exnr.1999.7197; Sullivan PG, 2000, EXP NEUROL, V161, P631, DOI 10.1006/exnr.1999.7282; Sullivan PG, 2005, J NEUROSCI RES, V79, P231, DOI 10.1002/jnr.20292; SZABO I, 1991, J BIOL CHEM, V266, P3376; Tsujimoto Y, 2007, APOPTOSIS, V12, P835, DOI 10.1007/s10495-006-0525-7; Turkyilmaz C, 2002, BRAIN RES, V955, P133, DOI 10.1016/S0006-8993(02)03395-4; Uchino H, 1995, ACTA PHYSIOL SCAND, V155, P469, DOI 10.1111/j.1748-1716.1995.tb09999.x; Uchino H, 1998, BRAIN RES, V812, P216, DOI 10.1016/S0006-8993(98)00902-0; Valadka AB, 1998, J NEUROTRAUM, V15, P509, DOI 10.1089/neu.1998.15.509; Veenman L, 2007, CURR PHARM DESIGN, V13, P2385; Vespa P, 2005, J CEREBR BLOOD F MET, V25, P763, DOI 10.1038/sj.jcbfm.9600073; Vespa PM, 2003, J CEREBR BLOOD F MET, V23, P865, DOI 10.1097/01.WCB.0000076701.45782.EF; Vink R, 2002, EXPERT OPIN INV DRUG, V11, P1375, DOI 10.1517/13543784.11.10.1375; Vink R, 2009, NEUROTHERAPEUTICS, V6, P28, DOI 10.1016/j.nurt.2008.10.036; Waldmeier PC, 2003, CURR MED CHEM, V10, P1485, DOI 10.2174/0929867033457160; Xiong Y, 1997, J NEUROTRAUM, V14, P23, DOI 10.1089/neu.1997.14.23; Xiong Y, 2009, NEUROL RES, V31, P496, DOI 10.1179/174313208X353703; Yokobori S, 2011, J TRAUMA, V71, P1235, DOI 10.1097/TA.0b013e3182140dd7; YUAN XQ, 1993, J NEUROTRAUM, V10, P307, DOI 10.1089/neu.1993.10.307; Zauner A, 1997, NEUROL RES, V19, P265, DOI 10.1080/01616412.1997.11740812; Zauner A, 1997, NEUROSURGERY, V41, P1082, DOI 10.1097/00006123-199711000-00011; Zhang John H, 2005, Pathophysiology, V12, P63, DOI 10.1016/j.pathophys.2005.01.003; Zhao JB, 2011, CYTOKINE, V56, P343, DOI 10.1016/j.cyto.2011.07.018; Zhao QJ, 2011, J CRIT CARE, V26, P311, DOI 10.1016/j.jcrc.2010.08.014; Zhao XR, 2007, STROKE, V38, P3280, DOI 10.1161/STROKEAHA.107.486506; ZORATTI M, 1995, BBA-REV BIOMEMBRANES, V1241, P139, DOI 10.1016/0304-4157(95)00003-A	136	22	24	0	10	BENTHAM SCIENCE PUBL LTD	SHARJAH	EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB EMIRATES	1871-5273	1996-3181		CNS NEUROL DISORD-DR	CNS Neurol. Disord.-Drug Targets		2014	13	4					606	619		10.2174/187152731304140702112805			14	Neurosciences; Pharmacology & Pharmacy	Neurosciences & Neurology; Pharmacology & Pharmacy	AN8EO	WOS:000340836200008	24168363				2021-06-18	
J	Zhang, W; Qian, CY; Li, SQ				Zhang, Wei; Qian, Chuan yun; Li, Shu qing			Protective Effect of SGK1 in Rat Hippocampal Neurons Subjected to Ischemia Reperfusion	CELLULAR PHYSIOLOGY AND BIOCHEMISTRY			English	Article						Neurons; Hippocampus; Ischemia reperfusion; SGK1; Apoptosis; Necrosis	CEREBRAL ISCHEMIA/REPERFUSION INJURY; TRAUMATIC BRAIN-INJURY; NERVE GROWTH-FACTOR; KINASE GENE FAMILY; PROTEIN-KINASE; PHOSPHATIDYLINOSITOL 3-KINASE; POSTCONDITIONING PROTECTS; TRANSCRIPTION FACTOR; SIGNALING PATHWAY; CELL-DEATH	Background/Aims: To investigate the protective effect of SGK1 (serum- and glucocorticoidinducible protein kinase 1) in rat hippocampal neurons in vitro and in vivo following ischemia reperfusion (I/R). Methods: Isolated rat hippocampal neurons were subjected to 2 h of oxygen and glucose deprivation (OGD) then returned to normoxic conditions for 10, 30 or 60 min. Cell apoptosis and protein expression of SGK1 were analyzed. To examine SGK1 function, we overexpressed SGK1 in rat hippocampal neurons. Finally we examined the involvement of PI3K/Akt/GSK3 beta signaling by treating the cells (untransfected or transfected with expression vector encoding SGK1) with the PI3K inhibitor LY294002. Findings were confirmed in vivo in a rat model of middle cerebral artery occlusion. Resuits:I/R caused a time-dependent increase in apoptosis, both in vitro and in vivo. SGK1 protein levels decreased significantly under the same conditions. Overexpression of SGK1 reduced apoptosis following OGD or I/R compared to cells transfected with empty vector and subjected to the same treatment, or sham-operated animals. Addition of LY294002 revealed that the action of SGK1 in suppressing apoptosis was mediated by the PI3K/Akt/GSK3 beta pathway. Conclusion: SGK1 plays a protective role in ischemia reperfusion in rat hippocampal neurons, exerting its effects via the PI3K/Akt/GSK313 pathway. Copyright (C) 2014 S Karger AG, Basel	[Zhang, Wei; Qian, Chuan yun] Kunming Med Univ, Affiliated Hosp 1, Dept Emergency Med, Kunming 650500, Yunnan, Peoples R China; [Li, Shu qing] Kunming Med Univ, Teaching & Res Sect Pathophysiol, Kunming 650500, Yunnan, Peoples R China	Li, SQ (corresponding author), Kunming Med Univ, Teaching & Res Sect Pathophysiol, 1168 West Chunrong Rd,Yuhua Ave, Kunming 650500, Yunnan, Peoples R China.	shuqinq28@hotmail.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [30971171]; National Key Technology RD ProgramNational Key Technology R&D Program [2014BAIO11300]; Education Department of Yunnan province [2013Y281]; Dr. Innovation of Kunming Medical University [2012D12]	This study was supported by grants from the National Natural Science Foundation of China (NO. 30971171), National Key Technology R&D Program (2014BAIO11300), the Education Department of Yunnan province (NO. 2013Y281), and the Dr. Innovation of Kunming Medical University (NO. 2012D12).	Andres-Mateos E, 2013, EMBO MOL MED, V5, P80, DOI 10.1002/emmm.201201443; Brunet A, 2001, CURR OPIN NEUROBIOL, V11, P297, DOI 10.1016/S0959-4388(00)00211-7; Brunet A, 2001, MOL CELL BIOL, V21, P952, DOI 10.1128/MCB.21.3.952-965.2001; Chen J, 1998, J NEUROSCI, V18, P4914; Cheng J, 2007, J CEREBR BLOOD F MET, V27, P1553, DOI 10.1038/sj.jcbfm.9600457; Cheng JA, 2011, J CEREBR BLOOD F MET, V31, P339, DOI 10.1038/jcbfm.2010.98; Choi DW, 1996, CURR OPIN NEUROBIOL, V6, P667, DOI 10.1016/S0959-4388(96)80101-2; Crowder RJ, 1998, J NEUROSCI, V18, P2933; Dirnagl U, 1999, TRENDS NEUROSCI, V22, P391, DOI 10.1016/S0166-2236(99)01401-0; Eves EM, 1998, MOL CELL BIOL, V18, P2143, DOI 10.1128/MCB.18.4.2143; Firestone GL, 2003, CELL PHYSIOL BIOCHEM, V13, P1, DOI 10.1159/000070244; Hokari M, 2010, NEUROPATHOLOGY, V30, P401, DOI 10.1111/j.1440-1789.2009.01086.x; Hu Q, 2011, BRAIN RES, V1367, P347, DOI 10.1016/j.brainres.2010.10.002; Hu SX, 2009, NEUROBIOL DIS, V33, P193, DOI 10.1016/j.nbd.2008.10.007; IMAIZUMI K, 1994, MOL BRAIN RES, V26, P189, DOI 10.1016/0169-328X(94)90090-6; Itoh T, 2010, NEUROCHEM RES, V35, P348, DOI 10.1007/s11064-009-0061-2; Jacobs Keith M, 2012, Int J Cell Biol, V2012, P930710, DOI 10.1155/2012/930710; Johnston SC, 2003, NEUROLOGY, V60, P1429, DOI 10.1212/01.WNL.0000063309.41867.0F; KIRINO T, 1982, BRAIN RES, V239, P57, DOI 10.1016/0006-8993(82)90833-2; Kotliarova S, 2008, CANCER RES, V68, P6643, DOI 10.1158/0008-5472.CAN-08-0850; Lang F, 2006, PHYSIOL REV, V86, P1151, DOI 10.1152/physrev.00050.2005; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Macas J, 2006, J NEUROSCI, V26, P13114, DOI 10.1523/JNEUROSCI.4667-06.2006; Murray CJL, 2013, NEW ENGL J MED, V369, P448, DOI 10.1056/NEJMra1201534; Nishida Y, 2004, MOL BRAIN RES, V123, P121, DOI 10.1016/j.molbrainres.2004.01.008; NITATORI T, 1995, J NEUROSCI, V15, P1001; Peng B, 2012, BRAIN RES, V1445, P92, DOI 10.1016/j.brainres.2012.01.033; PETITO CK, 1987, NEUROLOGY, V37, P1281, DOI 10.1212/WNL.37.8.1281; Pignataro G, 2008, J CEREBR BLOOD F MET, V28, P232, DOI 10.1038/sj.jcbfm.9600559; Salma J, 2012, J NEUROSCI, V32, P2790, DOI 10.1523/JNEUROSCI.3609-11.2012; Sheng H, 2012, MOL CELL ENDOCRINOL, V362, P157, DOI 10.1016/j.mce.2012.06.003; Sonni S, 2013, CLEV CLIN J MED, V80, P566, DOI 10.3949/ccjm.80a.12141; Sun BZ, 2011, BIOCHEM BIOPH RES CO, V409, P808, DOI 10.1016/j.bbrc.2011.05.095; Uchida M, 2009, J CEREBR BLOOD F MET, V29, P1454, DOI 10.1038/jcbfm.2009.60; Waldegger S, 1997, P NATL ACAD SCI USA, V94, P4440, DOI 10.1073/pnas.94.9.4440; Watcharasit P, 2002, P NATL ACAD SCI USA, V99, P7951, DOI 10.1073/pnas.122062299; WEBSTER MK, 1993, MOL CELL BIOL, V13, P2031, DOI 10.1128/MCB.13.4.2031; Wu XM, 2013, INT J CLIN EXP PATHO, V6, P1282; YAO RJ, 1995, SCIENCE, V267, P2003, DOI 10.1126/science.7701324; Yuan YJ, 2011, BRAIN RES, V1367, P85, DOI 10.1016/j.brainres.2010.10.017	40	22	26	0	6	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	1015-8987	1421-9778		CELL PHYSIOL BIOCHEM	Cell. Physiol. Biochem.		2014	34	2					299	312		10.1159/000363000			14	Cell Biology; Physiology	Cell Biology; Physiology	AR7MT	WOS:000343764600007	25034177	DOAJ Gold			2021-06-18	
J	Imam, AM; Jin, G; Sillesen, M; Duggan, M; Jepsen, CH; Hwabejire, JO; Lu, J; Liu, BL; DeMoya, MA; Velmahos, GC; Alam, HB				Imam, Ayesha M.; Jin, Guang; Sillesen, Martin; Duggan, Michael; Jepsen, Cecilie H.; Hwabejire, John O.; Lu, Jennifer; Liu, Baoling; DeMoya, Marc A.; Velmahos, George C.; Alam, Hasan B.			Early treatment with lyophilized plasma protects the brain in a large animal model of combined traumatic brain injury and hemorrhagic shock	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article; Proceedings Paper	43rd Annual Meeting of the Western-Trauma-Association	MAR 03-08, 2013	Snowmass, CO	Western Trauma Assoc		Traumatic brain injury; hemorrhage; edema; swine; shock	SEVERE HEAD-INJURY; FOCAL CEREBRAL-ISCHEMIA; INTRACRANIAL-PRESSURE; FLUID RESUSCITATION; BLOOD; MORTALITY; AGE; HEMODILUTION; COAGULOPATHY; COAGULATION	BACKGROUND: Combination of traumatic brain injury (TBI) and hemorrhagic shock (HS) can result in significant morbidity and mortality. We have previously shown that early administration of fresh frozen plasma (FFP) in a large animal model of TBI and HS reduces the size of the brain lesion as well as the associated edema. However, FFP is a perishable product that is not well suited for use in the austere prehospital settings. In this study, we tested whether a shelf-stable, low-volume, lyophilized plasma (LSP) product was as effective as FFP. METHODS: Yorkshire swine (42-50 kg) were instrumented to measure hemodynamic parameters, intracranial pressure, and brain tissue oxygenation. A prototype, computerized, cortical impact device was used to create TBI through a 20-mm craniotomy: 15-mm cylindrical tip impactor at 4 m/s velocity, 100-millisecond dwell time, and 12-mm penetration depth. Volume-controlled hemorrhage was induced (40-45% total blood volume) concurrent with the TBI. After 2 hours of shock, animals were treated with (1) normal saline (NS, n = 5), (2) FFP (n = 5), and (3) LSP (n = 5). The volume of FFP and LSP matched the shed blood volume, whereas NS was 3 times the volume. Six hours after resuscitation, brains were sectioned and stained with TTC (2, 3, 5-Triphenyltetrazolium chloride), and lesion size (mm(3)) and swelling (percent change in volume compared with the contralateral, uninjured side) were measured. RESULTS: This protocol resulted in a highly reproducible brain injury, with clinically relevant changes in blood pressure, cardiac output, tissue hypoperfusion, intracranial pressure, and brain tissue oxygenation. Compared with NS, treatment with LSP significantly (p < 0.05) decreased brain lesion size and swelling (51% and 54%, respectively). CONCLUSION: In a clinically realistic combined TBI + HS model, early administration of plasma products decreases brain lesion size and edema. LSP is as effective as FFP, while offering many logistic advantages. (Copyright (C) 2013 by Lippincott Williams & Wilkins)	[Imam, Ayesha M.; Jin, Guang; Sillesen, Martin; Duggan, Michael; Jepsen, Cecilie H.; Hwabejire, John O.; Lu, Jennifer; DeMoya, Marc A.; Velmahos, George C.; Alam, Hasan B.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Div Trauma Emergency Surg & Surg Crit Care,Dept S, Boston, MA USA; [Jin, Guang; Liu, Baoling; Alam, Hasan B.] Univ Michigan Hosp, Dept Surg, Ann Arbor, MI 48109 USA	Alam, HB (corresponding author), Univ Michigan Hosp, Taubman Ctr 5331 2920, 1500 E Med Ctr Dr, Ann Arbor, MI 48109 USA.	alamh@med.umich.edu		Sillesen, Martin/0000-0001-9494-5475			Adamides AA, 2006, ANZ J SURG, V76, P163, DOI 10.1111/j.1445-2197.2006.03674.x; Aucar John A, 2009, Am J Surg, V198, P900, DOI 10.1016/j.amjsurg.2009.05.034; Badjatia N, 2008, PREHOSP EMERG CARE, V12, pS1, DOI 10.1080/10903120701732052; Borgman MA, 2007, J TRAUMA, V63, P805, DOI 10.1097/TA.0b013e3181271ba3; Bourguignon PR, 1998, ARCH SURG-CHICAGO, V133, P390, DOI 10.1001/archsurg.133.4.390; *BRAIN TRAUM FDN, 2000, J NEUROTRAUM, V17, P471; Bulger EM, 2011, ANN SURG, V253, P431, DOI 10.1097/SLA.0b013e3181fcdb22; Butcher I, 2007, J NEUROTRAUM, V24, P294, DOI 10.1089/neu.2006.0032; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Crookes BA, 2004, J TRAUMA, V57, P547, DOI 10.1097/01.TA.0000135162.85859.4C; Exo JL, 2009, J NEUROTRAUM, V26, P2403, DOI 10.1089/neu.2009.0980; FEARNSIDE MR, 1993, BRIT J NEUROSURG, V7, P267, DOI 10.3109/02688699309023809; Grande PO, 1997, J TRAUMA, V42, pS23, DOI 10.1097/00005373-199705001-00005; Holcomb JB, 2007, J TRAUMA, V62, P307, DOI 10.1097/TA.0b013e3180324124; Holcomb JB, 2013, JAMA SURG, V148, P127, DOI 10.1001/2013.jamasurg.387; HUNT J, 1995, AUST NZ J SURG, V65, P83, DOI 10.1111/j.1445-2197.1995.tb07266.x; Jin G, 2012, J TRAUMA ACUTE CARE, V73, P1461, DOI 10.1097/TA.0b013e3182782641; Jin G, 2012, SHOCK, V38, P49, DOI 10.1097/SHK.0b013e3182574778; Jin G, 2010, TRANSL STROKE RES, V1, P65, DOI 10.1007/s12975-009-0009-5; Jin G, 2009, EXP NEUROL, V217, P165, DOI 10.1016/j.expneurol.2009.02.004; Johnson VV, 2007, CURR OPIN HEMATOL, V14, P694, DOI 10.1097/MOH.0b013e3282ef477f; Khan F, 2003, MED J AUSTRALIA, V178, P290, DOI 10.5694/j.1326-5377.2003.tb05199.x; King DR, 2004, SURGERY, V136, P355, DOI 10.1016/j.surg.2004.05.011; Miller J D, 1982, J R Coll Surg Edinb, V27, P292; Myburgh J, 2007, NEW ENGL J MED, V357, P874; Navarro JC, 2012, J NEUROTRAUM, V29, P322, DOI 10.1089/neu.2011.1979; Offner PJ, 2004, CRIT CARE, V8, pS24, DOI 10.1186/cc2405; OHTAKI M, 1993, SURG NEUROL, V40, P196, DOI 10.1016/0090-3019(93)90068-C; Pati S, 2010, J TRAUMA, V69, pS55, DOI 10.1097/TA.0b013e3181e453d4; Peiniger S, 2011, CRIT CARE, V15, DOI 10.1186/cc10048; Prevost TP, 2011, ACTA BIOMATER, V7, P4090, DOI 10.1016/j.actbio.2011.06.032; Purdy FR, 1997, CAN J ANAESTH, V44, P1256, DOI 10.1007/BF03012772; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; Shuja F, 2008, J TRAUMA, V65, P975, DOI 10.1097/TA.0b013e3181801cd9; Spoerke N, 2009, ARCH SURG-CHICAGO, V144, P829, DOI 10.1001/archsurg.2009.154; Takano K, 1997, STROKE, V28, P1255, DOI 10.1161/01.STR.28.6.1255; TU YK, 1988, J NEUROSURG, V69, P72, DOI 10.3171/jns.1988.69.1.0072; WALD SL, 1993, J TRAUMA, V34, P377, DOI 10.1097/00005373-199303000-00012; Wald SL, 1993, J TRAUMA, V34, P381; Zallen G, 1999, AM J SURG, V178, P570, DOI 10.1016/S0002-9610(99)00239-1	40	22	22	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	2163-0755	2163-0763		J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	DEC	2013	75	6					976	983		10.1097/TA.0b013e31829e2186			8	Critical Care Medicine; Surgery	General & Internal Medicine; Surgery	300IR	WOS:000330458100010	24256669				2021-06-18	
J	Roitman, P; Gilad, M; Ankri, YLE; Shalev, AY				Roitman, Pablo; Gilad, Moran; Ankri, Yahel L. E.; Shalev, Arieh Y.			Head Injury and Loss of Consciousness Raise the Likelihood of Developing and Maintaining PTSD Symptoms	JOURNAL OF TRAUMATIC STRESS			English	Article							TRAUMATIC BRAIN-INJURY; POSTTRAUMATIC-STRESS-DISORDER; ROAD TRAFFIC ACCIDENTS; POSTCONCUSSIVE SYMPTOMS; AMNESIA; HEALTH; SCALE; IRAQ; CARE; FEAR	Mild traumatic brain injury has been associated with higher prevalence of posttraumatic stress disorder (PTSD). The extent to which head injury or loss of consciousness predicts PTSD is unknown. To evaluate the contribution of head injury and loss of consciousness to the occurrence of PTSD, we made a longitudinal evaluation of 1,260 road accident survivors admitted to the emergency department with head injury (n = 287), head injury and loss of consciousness (n = 115), or neither (n = 858). A telephone-administered posttraumatic symptoms scale inferred PTSD and quantified PTSD symptoms at 10 days and 8 months after admission. The study groups had similar heart rate, blood pressure, and pain levels in the emergency department. Survivors with loss of consciousness and head injury had higher prevalence of PTSD and higher levels of PTSD symptoms, suggesting that patients with head injury and loss of consciousness reported in the emergency department are at higher risk for PTSD.	[Roitman, Pablo; Gilad, Moran; Ankri, Yahel L. E.; Shalev, Arieh Y.] Hadassah Univ Hosp, Dept Psychiat, IL-91120 Jerusalem, Israel; [Shalev, Arieh Y.] NYU, Dept Psychiat, Langone Med Ctr, Steven & Alexandra Cohen Vet Ctr Study Posttrauma, New York, NY 10016 USA	Roitman, P (corresponding author), Hadassah Univ Hosp, Dept Psychiat, Ein Kerem Campus, IL-91120 Jerusalem, Israel.	pablo@hadassah.org.il		Shalev, Arieh/0000-0001-9425-050X	NIMH NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R34 MH071652] Funding Source: Medline		American Psychiatric Association, 1994, DIAGN STAT MAN MENT; Beck JG, 2007, PROF PSYCHOL-RES PR, V38, P629, DOI 10.1037/0735-7028.38.6.629; Bigler ED, 2008, J INT NEUROPSYCH SOC, V14, P1, DOI 10.1017/S135561770808017X; BISHARA S N, 1992, Brain Injury, V6, P373, DOI 10.3109/02699059209034952; BLAKE DD, 1995, J TRAUMA STRESS, V8, P75, DOI 10.1002/jts.2490080106; Blanchard E. B., 2004, CRASH PSYCHOL ASSESS; Bombardier CH, 2006, J NEUROPSYCH CLIN N, V18, P501, DOI 10.1176/appi.neuropsych.18.4.501; Borg J, 2004, J REHABIL MED, V36, P61, DOI 10.1080/16501960410023822; Broomhall LGJ, 2009, J NERV MENT DIS, V197, P178, DOI 10.1097/NMD.0b013e318199fe7f; Bryant B, 1997, MED SCI LAW, V37, P326, DOI 10.1177/002580249703700408; Bryant RA, 1999, J NERV MENT DIS, V187, P302, DOI 10.1097/00005053-199905000-00006; Bryant RA, 2003, J NERV MENT DIS, V191, P191, DOI 10.1097/00005053-200303000-00009; Bryant RA, 1999, BRAIN INJURY, V13, P15, DOI 10.1080/026990599121836; Bryant Richard, 2011, Dialogues Clin Neurosci, V13, P251; Bryant RA, 2010, AM J PSYCHIAT, V167, P312, DOI 10.1176/appi.ajp.2009.09050617; Bryant RA, 2009, J INT NEUROPSYCH SOC, V15, P862, DOI 10.1017/S1355617709990671; Capruso D. X., 2000, HEAD INJURY, P525; Creamer M, 2005, BEHAV RES THER, V43, P1383, DOI 10.1016/j.brat.2004.11.001; Culotta VP, 1996, NEUROSURGERY, V38, P245, DOI 10.1097/00006123-199602000-00002; De Guise E, 2005, BRAIN INJURY, V19, P1087, DOI 10.1080/02699050500149882; Foa EB, 2000, J TRAUMA STRESS, V13, P181, DOI 10.1023/A:1007781909213; Freedman SA, 2002, J TRAUMA STRESS, V15, P407, DOI 10.1023/A:1020189425935; Glaesser J, 2004, BMC PSYCHIATRY, V4, DOI 10.1186/1471-244X-4-5; Gomez PA, 1996, BRIT J NEUROSURG, V10, P453, DOI 10.1080/02688699647078; Gosselin N, 2011, J NEUROTRAUM, V28, P329, DOI 10.1089/neu.2010.1493; Guy W, 1976, CLIN GLOBAL IMPRESSI; Hoffman SW, 2009, CLIN NEUROPSYCHOL, V23, P1400, DOI 10.1080/13854040903369433; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hoge CW, 2009, NEW ENGL J MED, V360, P1588, DOI 10.1056/NEJMp0810606; Howe LLS, 2009, CLIN NEUROPSYCHOL, V23, P1315, DOI 10.1080/13854040903266928; Jennings PA, 2009, EMERG MED J, V26, P552, DOI 10.1136/emj.2008.062539; Jones C, 2005, J TRAUMA STRESS, V18, P181, DOI 10.1002/jts.20031; Kristensen P, 2012, PSYCHIATRY, V75, P76, DOI 10.1521/psyc.2012.75.1.76; Liberzon I, 2007, PROG BRAIN RES, V167, P151, DOI 10.1016/S0079-6123(07)67011-3; Luethcke CA, 2011, J INT NEUROPSYCH SOC, V17, P36, DOI 10.1017/S1355617710001207; MacGregor AJ, 2010, J HEAD TRAUMA REHAB, V25, P1, DOI 10.1097/HTR.0b013e3181c2993d; MAYOU R, 1993, BRIT MED J, V307, P647, DOI 10.1136/bmj.307.6905.647; MAYOU R, 1995, J PSYCHOSOM RES, V39, P789, DOI 10.1016/0022-3999(95)00031-D; Mayou RA, 2000, BRIT J PSYCHIAT, V177, P540, DOI 10.1192/bjp.177.6.540; Milad MR, 2007, BIOL PSYCHIAT, V62, P1191, DOI 10.1016/j.biopsych.2007.04.032; Mora AG, 2009, J TRAUMA, V66, pS178, DOI 10.1097/TA.0b013e31819ce2d6; Niogi SN, 2008, AM J NEURORADIOL, V29, P967, DOI 10.3174/ajnr.A0970; Parker RS, 1996, BRAIN INJURY, V10, P287, DOI 10.1080/026990596124467; Salmond CH, 2006, NEUROIMAGE, V29, P117, DOI 10.1016/j.neuroimage.2005.07.012; SCHACTER DL, 1977, CORTEX, V13, P150, DOI 10.1016/S0010-9452(77)80006-3; Schiller D, 2010, TRENDS COGN SCI, V14, P268, DOI 10.1016/j.tics.2010.04.002; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Schonberger M, 2009, J NEUROTRAUM, V26, P2157, DOI 10.1089/neu.2009.0939; Schwartz I, 2008, BRAIN INJURY, V22, P255, DOI 10.1080/02699050801941763; Shalev AY, 2012, ARCH GEN PSYCHIAT, V69, P166, DOI 10.1001/archgenpsychiatry.2011.127; Shalev AY, 2011, PSYCHIAT SERV, V62, P765, DOI 10.1176/ps.62.7.pss6207_0765; Shin LM, 2009, J TRAUMA STRESS, V22, P409, DOI 10.1002/jts.20442; Vasterling JJ, 2012, BRIT J PSYCHIAT, V201, P186, DOI 10.1192/bjp.bp.111.096461; Wessa M, 2007, AM J PSYCHIAT, V164, P1684, DOI 10.1176/appi.ajp.2007.07030525; Zatzick DF, 2010, ARCH GEN PSYCHIAT, V67, P1291, DOI 10.1001/archgenpsychiatry.2010.158	55	22	23	0	13	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0894-9867	1573-6598		J TRAUMA STRESS	J. Trauma Stress	DEC	2013	26	6					727	734		10.1002/jts.21862			8	Psychology, Clinical; Psychiatry	Psychology; Psychiatry	273WL	WOS:000328566900011	24265212				2021-06-18	
J	Cuomo, O; Rispoli, V; Leo, A; Politi, GB; Vinciguerra, A; di Renzo, G; Cataldi, M				Cuomo, Ornella; Rispoli, Vincenzo; Leo, Antonio; Politi, Giovanni Bosco; Vinciguerra, Antonio; di Renzo, Gianfranco; Cataldi, Mauro			The Antiepileptic Drug Levetiracetam Suppresses Non-Convulsive Seizure Activity and Reduces Ischemic Brain Damage in Rats Subjected to Permanent Middle Cerebral Artery Occlusion	PLOS ONE			English	Article							LONG-TERM TREATMENT; SPREADING DEPRESSION; CALCIUM-CHANNELS; UCB L059; RELEASE; MODEL; EPILEPSY; DEPOLARIZATION; ETHOSUXIMIDE; INHIBITION	The antiepileptic drug Levetiracetam (Lev) has neuroprotective properties in experimental stroke, cerebral hemorrhage and neurotrauma. In these conditions, non-convulsive seizures (NCSs) propagate from the core of the focal lesion into perilesional tissue, enlarging the damaged area and promoting epileptogenesis. Here, we explore whether Lev neuroprotective effect is accompanied by changes in NCS generation or propagation. In particular, we performed continuous EEG recordings before and after the permanent occlusion of the middle cerebral artery (pMCAO) in rats that received Lev (100 mg/kg) or its vehicle immediately before surgery. Both in Lev-treated and in control rats, EEG activity was suppressed after pMCAO. In control but not in Lev-treated rats, EEG activity reappeared approximately 30-45 min after pMCAO. It initially consisted in single spikes and, then, evolved into spike-and-wave and polyspike-and-wave discharges. In Lev-treated rats, only rare spike events were observed and the EEG power was significantly smaller than in controls. Approximately 24 hours after pMCAO, EEG activity increased in Lev-treated rats because of the appearance of polyspike events whose power was, however, significantly smaller than in controls. In rats sacrificed 24 hours after pMCAO, the ischemic lesion was approximately 50% smaller in Lev-treated than in control rats. A similar neuroprotection was observed in rats sacrificed 72 hours after pMCAO. In conclusion, in rats subjected to pMCAO, a single Lev injection suppresses NCS occurrence for at least 24 hours. This electrophysiological effect could explain the long lasting reduction of ischemic brain damage caused by this drug.	[Cuomo, Ornella; Vinciguerra, Antonio; di Renzo, Gianfranco; Cataldi, Mauro] Univ Naples Federico II, Dept Neurosci Reprod & Odontostomatol Sci, Div Pharmacol, Naples, Italy; [Rispoli, Vincenzo; Leo, Antonio; Politi, Giovanni Bosco] Magna Graecia Univ Catanzaro, Dept Hlth Sci, Catanzaro, Italy	Cataldi, M (corresponding author), Univ Naples Federico II, Dept Neurosci Reprod & Odontostomatol Sci, Div Pharmacol, Naples, Italy.	cataldi@unina.it	Cataldi, Mauro/AAB-3642-2019; Vinciguerra, Antonio/AAA-8094-2019; Leo, Antonio/AAC-4052-2020; Di Renzo, Gian C./P-3819-2017	Cataldi, Mauro/0000-0001-7787-3406; Vinciguerra, Antonio/0000-0003-0746-4935; Leo, Antonio/0000-0002-0061-1608; Di Renzo, Gian C./0000-0003-4467-240X; CUOMO, ORNELLA/0000-0002-6459-2530	UCB PharmaUCB Pharma SA; Ricerca FinalizzataMinistry of Health, ItalyMinistry of Health Italy - Ricerca Finalizzata (MOH-RF) [RF-FSL-352059]; Ministero dell'Istruzione, dell'Universita e della Ricerca, Programma Operativo Nazionale [PON_01602, 20089BARSR_002]; European CommunityEuropean Commission; European Social FundEuropean Social Fund (ESF); Regione CalabriaRegione Calabria	The present study was partially supported by a research grant by UCB Pharma. The funding company did not have any role in designing, performing or analyzing the data but approved both the initial protocol and the final manuscript. This economical support does not alter our adherence to all the PLOS ONE policies on sharing data and materials. Additional support was received from the following grants: Ricerca Finalizzata 2009 [Grant RF-FSL-352059], and Ministero dell'Istruzione, dell'Universita e della Ricerca, Programma Operativo Nazionale [Grants PON_01602 and 20089BARSR_002]. A. L. is recipient of a Ph.D. fellowship grant from the European Community, the European Social Fund and the Regione Calabria.	Angehagen M, 2003, NEUROREPORT, V14, P471, DOI 10.1097/01.wnr.0000059774.23521.b7; Belcastro V, 2011, BRAIN DEV-JPN, V33, P289, DOI 10.1016/j.braindev.2010.06.008; Burn J, 1997, BRIT MED J, V315, P1582, DOI 10.1136/bmj.315.7122.1582; Camilo O, 2004, STROKE, V35, P1769, DOI 10.1161/01.STR.0000130989.17100.96; Canals S, 2008, J CEREBR BLOOD F MET, V28, P1835, DOI 10.1038/jcbfm.2008.71; Cataldi M, 2005, J PHARMACOL EXP THER, V313, P720, DOI 10.1124/jpet.104.079327; Cataldi M, 2013, CURR NEUROPHARMACOL, V11, P276, DOI 10.2174/1570159X11311030004; Chang WP, 2009, J NEUROSCI, V29, P883, DOI 10.1523/JNEUROSCI.4521-08.2009; Clark WM, 1997, NEUROL RES, V19, P641; Costa C, 2006, STROKE, V37, P1319, DOI 10.1161/01.STR.0000217303.22856.38; Crepeau AZ, 2010, EXPERT REV NEUROTHER, V10, P159, DOI [10.1586/ern.10.5, 10.1586/ERN.10.3]; Cuomo O, 2008, J NEUROSCI, V28, P2053, DOI 10.1523/JNEUROSCI.4912-07.2008; Cuomo O, 2007, STROKE, V38, P3272, DOI 10.1161/STROKEAHA.107.488486; Custer KL, 2006, J NEUROSCI, V26, P1303, DOI 10.1523/JNEUROSCI.2699-05.2006; Doheny HC, 1999, EPILEPSY RES, V34, P161, DOI 10.1016/S0920-1211(98)00104-1; Dreier JP, 2012, BRAIN, V135, P259, DOI 10.1093/brain/awr303; Eikermann-Haerter K, 2012, CIRCULATION, V125, P335, DOI 10.1161/CIRCULATIONAHA.111.045096; Eyal S, 2004, EPILEPSIA, V45, P737, DOI 10.1111/j.0013-9580.2004.00104.x; Fleidervish IA, 2001, J NEUROSCI, V21, P4600, DOI 10.1523/JNEUROSCI.21-13-04600.2001; Fukuyama K, 2012, NEUROSCI LETT, V518, P69, DOI 10.1016/j.neulet.2012.03.056; GILL R, 1992, J CEREBR BLOOD F MET, V12, P371, DOI 10.1038/jcbfm.1992.54; Hanon E, 2001, SEIZURE-EUR J EPILEP, V10, P287, DOI 10.1053/seiz.2000.0511; Hartings JA, 2003, EXP NEUROL, V179, P139, DOI 10.1016/S0014-4886(02)00013-4; Herman ST, 2002, NEUROLOGY, V59, pS21, DOI 10.1212/WNL.59.9_suppl_5.S21; Kilicdag H, 2013, EARLY HUM DEV, V89, P355, DOI 10.1016/j.earlhumdev.2012.12.002; LEAO AAP, 1947, J NEUROPHYSIOL, V10, P409, DOI 10.1152/jn.1947.10.6.409; Leker RR, 2003, BRAIN RES REV, V42, P187, DOI 10.1016/S0165-0173(03)00170-X; Loscher W, 1998, J PHARMACOL EXP THER, V284, P474; Lu XCM, 2001, NEUROPATH APPL NEURO, V27, P481, DOI 10.1046/j.1365-2990.2001.00357.x; Lukyanetz EA, 2002, EPILEPSIA, V43, P9, DOI 10.1046/j.1528-1157.2002.24501.x; Lynch BA, 2003, P NATL ACAD SCI USA, V26, P9861; Margineanu DG, 2009, SEIZURE-EUR J EPILEP, V18, P453, DOI 10.1016/j.seizure.2009.01.002; Marini H, 2004, LIFE SCI, V74, P1253, DOI 10.1016/j.lfs.2003.08.006; Meehan AL, 2012, EPILEPSIA, V53, P469, DOI 10.1111/j.1528-1167.2011.03392.x; Meehan AL, 2011, J NEUROPHYSIOL, V106, P1227, DOI 10.1152/jn.00279.2011; Muller M, 1998, BRAIN RES, V812, P1, DOI 10.1016/S0006-8993(98)00812-9; Nagarkatti N, 2008, NEUROSCI LETT, V436, P289, DOI 10.1016/j.neulet.2008.02.076; Nakamura H, 2010, BRAIN, V133, P1994, DOI 10.1093/brain/awq117; Pignataro G, 2012, NEUROBIOL DIS, V45, P616, DOI 10.1016/j.nbd.2011.10.007; Rekling JC, 2003, NEUROSCI LETT, V335, P167, DOI 10.1016/S0304-3940(02)01193-X; Rigo JM, 2002, BRIT J PHARMACOL, V136, P659, DOI 10.1038/sj.bjp.0704766; Russo E, 2011, EPILEPSIA, V52, P1341, DOI 10.1111/j.1528-1167.2011.03112.x; Russo E, 2010, EPILEPSIA, V51, P1560, DOI 10.1111/j.1528-1167.2009.02400.x; Stratton SC, 2003, EPILEPSY RES, V53, P95, DOI 10.1016/S0920-1211(02)00254-1; Vinogradova LV, 2008, EPILEPSIA, V49, P1160, DOI 10.1111/j.1528-1167.2008.01594.x; Wang HC, 2006, NEUROCRIT CARE, V5, P71, DOI 10.1385/NCC:5:1:71; Williams AJ, 2004, J PHARMACOL EXP THER, V311, P220, DOI 10.1124/jpet.104.069146; Williams AJ, 2008, NEUROSCI LETT, V430, P7, DOI 10.1016/j.neulet.2007.09.052; Williams AJ, 2006, J PHARMACOL EXP THER, V318, P947, DOI 10.1124/jpet.106.105999; Yao J, 2010, J NEUROSCI, V30, P5569, DOI 10.1523/JNEUROSCI.4781-09.2010	50	22	22	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e80852	10.1371/journal.pone.0080852			11	Multidisciplinary Sciences	Science & Technology - Other Topics	255QK	WOS:000327254700208	24236205	DOAJ Gold, Green Published			2021-06-18	
J	Kolmodin, L; Sekhon, MS; Henderson, WR; Turgeon, AF; Griesdale, DEG				Kolmodin, Leif; Sekhon, Mypinder S.; Henderson, William R.; Turgeon, Alexis F.; Griesdale, Donald E. G.			Hypernatremia in patients with severe traumatic brain injury: a systematic review	ANNALS OF INTENSIVE CARE			English	Article						Traumatic brain injury; Hypernatremia; Hyperosmolar therapy; Hypertonic saline	INTENSIVE-CARE-UNIT; HYPERTONIC SALINE SOLUTIONS; ACQUIRED HYPONATREMIA; MORTALITY; EPIDEMIOLOGY; MANNITOL; THERAPY; SODIUM; ILL	Background: Hypernatremia is common following traumatic brain injury (TBI) and occurs from a variety of mechanisms, including hyperosmotic fluids, limitation of free water, or diabetes insipidus. The purpose of this systematic review was to assess the relationship between hypernatremia and mortality in patients with TBI. Methods: We searched the following databases up to November 2012: MEDLINE, EMBASE, and CENTRAL. Using a combination of MeSH and text terms, we developed search filters for the concepts of hypernatremia and TBI and included studies that met the following criteria: (1) compared hypernatremia to normonatremia, (2) adult patients with TBI, (3) presented adjusted outcomes for mortality or complications. Results: Bibliographic and conference search yielded 1,152 citations and 11 abstracts, respectively. Sixty-five articles were selected for full-text review with 5 being included in our study. All were retrospective cohort studies totaling 5,594 (range 100-4,296) patients. There was marked between-study heterogeneity. The incidence of hypernatremia ranged between 16% and 40%. Use of hyperosmolar therapy was presented in three studies (range 14-85% of patients). Hypernatremia was associated with increased mortality across all four studies that presented this outcome. Only one study considered diabetes insipidus (DI) in their analysis where hypernatremia was associated with increased mortality in patients who did not receive DDAVP. Conclusions: Although hypernatremia was associated with increased mortality in the included studies, there was marked between-study heterogeneity. DI was a potential confounder in several studies. Considering these limitations, the clinical significance of hypernatremia in TBI is difficult to establish at this stage.	[Kolmodin, Leif; Sekhon, Mypinder S.; Henderson, William R.; Griesdale, Donald E. G.] Univ British Columbia, Dept Med, Div Crit Care Med, Vancouver, BC, Canada; [Griesdale, Donald E. G.] Univ British Columbia, Dept Anesthesia Pharmacol & Therapeut, Vancouver, BC, Canada; [Turgeon, Alexis F.] Univ Laval, Dept Anesthesiol, Div Crit Care, Quebec City, PQ, Canada; [Griesdale, Donald E. G.] Vancouver Coastal Hlth Res Inst, Ctr Clin Epidemiol & Evaluat, Vancouver, BC, Canada; [Sekhon, Mypinder S.; Henderson, William R.; Griesdale, Donald E. G.] Vancouver Gen Hosp, Vancouver, BC V5Z 1M9, Canada	Griesdale, DEG (corresponding author), Univ British Columbia, Dept Med, Div Crit Care Med, Vancouver, BC, Canada.	donald.griesdale@vch.ca		Griesdale, Donald/0000-0001-5985-8624	Vancouver Coastal Health Research Institute; Vancouver Hospital Department of Anesthesia; Fonds de recherche du Quebec-Sante (FRQ-S)	Dr. Griesdale is supported through a Clinician Scientist Award from the Vancouver Coastal Health Research Institute and through the Vancouver Hospital Department of Anesthesia. Dr. Turgeon is supported in part by a research career award from the Fonds de recherche du Quebec-Sante (FRQ-S).	Adrogue HJ, 2000, NEW ENGL J MED, V342, P1493, DOI 10.1056/NEJM200005183422006; Aiyagari V, 2006, J CRIT CARE, V21, P163, DOI 10.1016/j.jcrc.2005.10.002; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS7; Bulger EM, 2010, JAMA-J AM MED ASSOC, V304, P1455, DOI 10.1001/jama.2010.1405; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Chodobski A, 2011, TRANSL STROKE RES, V2, P492, DOI 10.1007/s12975-011-0125-x; Francony G, 2008, CRIT CARE MED, V36, P795, DOI 10.1097/CCM.0B013E3181643B41; Froelich M, 2009, CRIT CARE MED, V37, P1433, DOI 10.1097/CCM.0b013e31819c1933; Griesdale DEG, 2010, CAN J NEUROL SCI, V37, P43, DOI 10.1017/S031716710000963X; Hadjizacharia P, 2008, J AM COLL SURGEONS, V207, P477, DOI 10.1016/j.jamcollsurg.2008.04.017; Harutjunyan L, 2005, CRIT CARE, V9, pR530, DOI 10.1186/cc3767; Helmy A, 2007, BRIT J ANAESTH, V99, P32, DOI 10.1093/bja/aem139; Himmelseher S, 2007, CURR OPIN ANESTHESIO, V20, P414, DOI 10.1097/ACO.0b013e3282eff9ea; Kamel H, 2011, CRIT CARE MED, V39, P554, DOI 10.1097/CCM.0b013e318206b9be; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lannoo E, 2000, J NEUROTRAUM, V17, P403, DOI 10.1089/neu.2000.17.403; Lescot T, 2006, CRIT CARE MED, V34, P3029, DOI 10.1097/01.CCM.0000243797.42346.64; Li M, 2012, HYPERNATREMIA SEVERI; Liberati A, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2700; Lindner G, 2007, AM J KIDNEY DIS, V50, P952, DOI 10.1053/j.ajkd.2007.08.016; Maggiore U, 2009, CRIT CARE, V13, DOI 10.1186/cc7953; MARMAROU A, 1991, J NEUROSURG, V75, pS59, DOI 10.3171/sup.1991.75.1s.0s59; Myburgh JA, 2008, J TRAUMA, V64, P854, DOI 10.1097/TA.0b013e3180340e77; Platt RW, 2009, AM J EPIDEMIOL, V170, P687, DOI 10.1093/aje/kwp175; Qureshi AI, 2000, CRIT CARE MED, V28, P3301, DOI 10.1097/00003246-200009000-00032; Ropper AH, 2012, NEW ENGL J MED, V367, P746, DOI 10.1056/NEJMct1206321; Rosenfeld JV, 2012, LANCET, V380, P1088, DOI 10.1016/S0140-6736(12)60864-2; Salas M, 1999, AM J EPIDEMIOL, V149, P981; Selassie AW, 2008, J HEAD TRAUMA REHAB, V23, P123, DOI 10.1097/01.HTR.0000314531.30401.39; Shehata M, 2010, CRIT CARE, V14, P355; Stelfox HT, 2010, CAN J ANAESTH, V57, P650, DOI 10.1007/s12630-010-9309-1; Stelfox HT, 2008, CRIT CARE, V12, DOI 10.1186/cc7162; Turgeon AF, 2011, CAN MED ASSOC J, V183, P1581, DOI 10.1503/cmaj.101786; Vialet R, 2003, CRIT CARE MED, V31, P1683, DOI 10.1097/01.CCM.0000063268.91710.DF; Wells G, 2009, NEWCASTLE OTTAWA SCA; Zygun DA, 2009, CRIT CARE, V13, DOI 10.1186/cc8014	36	22	24	0	2	SPRINGEROPEN	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	2110-5820			ANN INTENSIVE CARE	Ann. Intensive Care	NOV 6	2013	3								35	10.1186/2110-5820-3-35			7	Critical Care Medicine	General & Internal Medicine	AT7ZY	WOS:000345154600001	24196399	DOAJ Gold, Green Published			2021-06-18	
J	Du, XP; Ewert, DL; Cheng, WH; West, MB; Lu, JZ; Li, W; Floyd, RA; Kopke, RD				Du, Xiaoping; Ewert, Donald L.; Cheng, Weihua; West, Matthew B.; Lu, Jianzhong; Li, Wei; Floyd, Robert A.; Kopke, Richard D.			Effects of Antioxidant Treatment on Blast-Induced Brain Injury	PLOS ONE			English	Article							FOCAL CEREBRAL-ISCHEMIA; IMPULSE NOISE BLAST; REDUCES OXIDATIVE STRESS; N-ACETYLCYSTEINE; C-FOS; RAT-BRAIN; INDUCED NEUROTRAUMA; COCHLEAR NUCLEUS; SPIRAL GANGLION; ANIMAL-MODEL	Blast-induced traumatic brain injury has dramatically increased in combat troops in today's military operations. We previously reported that antioxidant treatment can provide protection to the peripheral auditory end organ, the cochlea. In the present study, we examined biomarker expression in the brains of rats at different time points (3 hours to 21 days) after three successive 14 psi blast overpressure exposures to evaluate antioxidant treatment effects on blast-induced brain injury. Rats in the treatment groups received a combination of antioxidants (2,4-disulfonyl alpha-phenyl tertiary butyl nitrone and N-acetylcysteine) one hour after blast exposure and then twice a day for the following two days. The biomarkers examined included an oxidative stress marker (4-hydroxy-2-nonenal, 4-HNE), an immediate early gene (c-fos), a neural injury marker (glial fibrillary acidic protein, GFAP) and two axonal injury markers [amyloid beta (A4) precursor protein, APP, and 68 kDa neurofilament, NF-68]. The results demonstrate that blast exposure induced or up-regulated the following: 4-HNE production in the dorsal hippocampus commissure and the forceps major corpus callosum near the lateral ventricle; c-fos and GFAP expression in most regions of the brain, including the retrosplenial cortex, the hippocampus, the cochlear nucleus, and the inferior colliculus; and NF-68 and APP expression in the hippocampus, the auditory cortex, and the medial geniculate nucleus (MGN). Antioxidant treatment reduced the following: 4-HNE in the hippocampus and the forceps major corpus callosum, c-fos expression in the retrosplenial cortex, GFAP expression in the dorsal cochlear nucleus (DCN), and APP and NF-68 expression in the hippocampus, auditory cortex, and MGN. This preliminary study indicates that antioxidant treatment may provide therapeutic protection to the central auditory pathway (the DCN and MGN) and the non-auditory central nervous system (hippocampus and retrosplenial cortex), suggesting that these compounds have the potential to simultaneously treat blast-induced injuries in the brain and auditory system.	[Du, Xiaoping; Ewert, Donald L.; Cheng, Weihua; West, Matthew B.; Lu, Jianzhong; Li, Wei; Kopke, Richard D.] Hough Ear Inst, Oklahoma City, OK 73112 USA; [Floyd, Robert A.; Kopke, Richard D.] Oklahoma Med Res Fdn, Oklahoma City, OK 73104 USA; [Kopke, Richard D.] Univ Oklahoma, Hlth Sci Ctr, Dept Physiol, Oklahoma City, OK USA; [Kopke, Richard D.] Univ Oklahoma, Hlth Sci Ctr, Dept Otolaryngol, Oklahoma City, OK USA	Kopke, RD (corresponding author), Hough Ear Inst, Oklahoma City, OK 73112 USA.	rkopke@houghear.org			United States Department of Navy, Office of Naval Research [N00014-09-1-0999]	This research was supported by grant N00014-09-1-0999 from the United States Department of Navy, Office of Naval Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdul-Muneer PM, 2013, FREE RADICAL BIO MED, V60, P282, DOI 10.1016/j.freeradbiomed.2013.02.029; Abi-Hachem Ralph N, 2010, Recent Pat CNS Drug Discov, V5, P147; Ahmed F, 2012, ELECTROPHORESIS, V33, P3705, DOI 10.1002/elps.201200299; Armstrong KL, 1998, BIOCHEM BIOPH RES CO, V253, P114, DOI 10.1006/bbrc.1998.9762; Baalman KL, 2013, J NEUROTRAUM, V30, P741, DOI 10.1089/neu.2012.2478; Baki SGA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012490; Bemeur C, 2010, METAB BRAIN DIS, V25, P241, DOI 10.1007/s11011-010-9201-2; Bhattacharjee Y, 2008, SCIENCE, V319, P406, DOI 10.1126/science.319.5862.406; BROWN MC, 1995, J COMP NEUROL, V357, P85, DOI 10.1002/cne.903570109; BROWN RFR, 1993, INT J EXP PATHOL, V74, P151; Cernak I, 2000, J NEUROTRAUM, V17, P53, DOI 10.1089/neu.2000.17.53; Cernak I, 2001, J TRAUMA, V50, P695, DOI 10.1097/00005373-200104000-00017; Cernak I, 2001, BRAIN INJURY, V15, P593, DOI 10.1080/02699050010009559; Cernak I, 1999, BRAIN INJURY, V13, P1005; Cernak I, 2010, J CEREBR BLOOD F MET, V30, P255, DOI 10.1038/jcbfm.2009.203; Chang EY, 2011, J MATERN-FETAL NEO M, V24, P732, DOI 10.3109/14767058.2010.528089; Chavko M, 2009, SHOCK, V32, P325, DOI 10.1097/SHK.0b013e31819c38f1; Chen G, 2008, MEDIAT INFLAMM, V2008, DOI 10.1155/2008/716458; Choi CH, 2011, FREE RADICAL RES, V45, P1162, DOI 10.3109/10715762.2011.605360; Clausen F, 2008, J NEUROTRAUM, V25, P1449, DOI 10.1089/neu.2008.0585; CORNELIUS C, 2013, ANTIOXID REDOX SIGNA; Courtney AC, 2009, MED HYPOTHESES, V72, P76, DOI 10.1016/j.mehy.2008.08.015; De Gasperi Rita, 2012, Front Neurol, V3, P177, DOI 10.3389/fneur.2012.00177; DELLANNA ME, 1995, EXP NEUROL, V131, P144, DOI 10.1016/0014-4886(95)90016-0; Dennis AM, 2009, J NEUROTRAUM, V26, P889, DOI 10.1089/neu.2008.0512; DeWitt DS, 2009, J NEUROTRAUM, V26, P877, DOI 10.1089/neu.2007.0439; DRAGUNOW M, 1989, J NEUROSCI METH, V29, P261, DOI 10.1016/0165-0270(89)90150-7; Du Xiaoping, 2011, Int J Otolaryngol, V2011, P612690, DOI 10.1155/2011/612690; Du XP, 2012, HEARING RES, V283, P1, DOI 10.1016/j.heares.2011.11.013; DunnMeynell AA, 1997, BRAIN RES, V761, P25, DOI 10.1016/S0006-8993(97)00210-2; EHRET G, 1991, BRAIN RES, V567, P350, DOI 10.1016/0006-8993(91)90819-H; Elsayed NM, 2003, TOXICOLOGY, V189, P63, DOI 10.1016/S0300-483X(03)00153-7; Elsayed NM, 2000, TOXICOLOGY, V155, P91, DOI 10.1016/S0300-483X(00)00281-X; Elsayed NM, 1997, TOXICOLOGY, V121, P1, DOI 10.1016/S0300-483X(97)03651-2; Ewert DL, 2012, HEARING RES, V285, P29, DOI 10.1016/j.heares.2012.01.013; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; Floyd RA, 2008, FREE RADICAL BIO MED, V45, P1361, DOI 10.1016/j.freeradbiomed.2008.08.017; Franke LM, 2012, J REHABIL RES DEV, V49, P985, DOI 10.1682/JRRD.2011.12.0250; Garman RH, 2011, J NEUROTRAUM, V28, P947, DOI 10.1089/neu.2010.1540; Gleich O, 1995, NEUROREPORT, V7, P29, DOI 10.1097/00001756-199512290-00006; Gorbunov NV, 1997, AM J PHYSIOL-LUNG C, V272, pL320; Haase GM, 2011, AM J OTOLARYNG, V32, P55, DOI 10.1016/j.amjoto.2009.09.002; Han M, 2003, CELL MOL BIOL, V49, P1249; Harch PG, 2012, J NEUROTRAUM, V29, P168, DOI 10.1089/neu.2011.1895; Hausmann R, 2000, INT J LEGAL MED, V113, P70, DOI 10.1007/PL00007711; Herrera DG, 1996, PROG NEUROBIOL, V50, P83, DOI 10.1016/S0301-0082(96)00021-4; Hicdonmez T, 2006, NEUROCHEM RES, V31, P473, DOI 10.1007/s11064-006-9040-z; Hicks RR, 2010, J TRAUMA, V68, P1257, DOI 10.1097/TA.0b013e3181d8956d; Hoffer ME, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054163; Holland MA, 2008, J NEUROTRAUM, V25, P140, DOI 10.1089/neu.2007.0312; Hoshino S, 2003, NEUROL MED-CHIR, V43, P165, DOI 10.2176/nmc.43.165; Idrizbegovic E, 1998, BRAIN RES, V800, P86, DOI 10.1016/S0006-8993(98)00504-6; Jatana M, 2006, PEDIATR RES, V59, P684, DOI 10.1203/01.pdr.0000215045.91122.44; Kamnaksh A, 2012, ELECTROPHORESIS, V33, P3680, DOI 10.1002/elps.201200319; Kamnaksh A, 2011, J NEUROTRAUM, V28, P2145, DOI 10.1089/neu.2011.1983; Kato K, 2007, J NEUROSURG, V106, P667, DOI 10.3171/jns.2007.106.4.667; Kaur C, 1997, NEUROSCI RES, V27, P317, DOI 10.1016/S0168-0102(97)01164-4; Kaur C., 1997, Annals Academy of Medicine Singapore, V26, P27; KAUR C, 1995, NEUROPATH APPL NEURO, V21, P369, DOI 10.1111/j.1365-2990.1995.tb01073.x; Khan M, 2004, J NEUROSCI RES, V76, P519, DOI 10.1002/jnr.20087; KOCHANEK PM, 2013, J NEUROTRAUMA; Koliatsos VE, 2011, J NEUROPATH EXP NEUR, V70, P399, DOI 10.1097/NEN.0b013e3182189f06; Kopke RD, 2007, HEARING RES, V226, P114, DOI 10.1016/j.heares.2006.10.008; KOVESDI E, 2012, NEUROLOGIST, V3, P111, DOI DOI 10.3389/FNEUR.2012.00111; Kovesdi E, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00042; Kraus KS, 2010, NEUROSCIENCE, V167, P1216, DOI 10.1016/j.neuroscience.2010.02.071; Kuehn R, 2011, J NEUROTRAUM, V28, P2155, DOI 10.1089/neu.2010.1532; Kuroda S, 1999, J CEREBR BLOOD F MET, V19, P778, DOI 10.1097/00004647-199907000-00008; Lee TF, 2008, PEDIATR RES, V64, P256, DOI 10.1203/PDR.0b013e31817cfcc0; Lenzlinger PM, 2001, MOL NEUROBIOL, V24, P169; Leung Lai Yee, 2008, Molecular & Cellular Biomechanics, V5, P155; Li DR, 2012, LEGAL MED-TOKYO, V14, P84, DOI 10.1016/j.legalmed.2011.12.007; Liu JQ, 2010, J NEUROTRAUM, V27, P1865, DOI 10.1089/neu.2010.1325; Long JB, 2009, J NEUROTRAUM, V26, P827, DOI 10.1089/neu.2008.0748; Lu J, 2012, J NEUROTRAUM, V29, P1434, DOI 10.1089/neu.2010.1591; Magnuson J, 2012, CURR NEUROL NEUROSCI, V12, P570, DOI 10.1007/s11910-012-0303-6; Marshall JWB, 2001, STROKE, V32, P190, DOI 10.1161/01.STR.32.1.190; Miller JM, 2007, J NEUROSCI RES, V85, P1959, DOI 10.1002/jnr.21320; Moochhala SM, 2004, J TRAUMA, V56, P393, DOI 10.1097/01.TA.0000066181.50879.7A; Nakagawa A, 2011, J NEUROTRAUM, V28, P1101, DOI 10.1089/neu.2010.1442; Nakagawa A, 2008, ACTA NEUROCHIR SUPPL, V102, P421, DOI 10.1007/978-3-211-85578-2_82; Niu YL, 2011, ARCH BIOCHEM BIOPHYS, V515, P89, DOI 10.1016/j.abb.2011.07.016; Olucha F E, 1997, Acta Otorrinolaringol Esp, V48, P85; Patterson JH, 1997, TOXICOLOGY, V121, P29, DOI 10.1016/S0300-483X(97)03653-6; Paxinos G., 2007, RAT BRAIN STEREOTAXI, V6th ed.; Perez-Polo JR, 2013, J NEUROTRAUM, V30, P727, DOI 10.1089/neu.2012.2650; Peskind ER, 2011, NEUROIMAGE, V54, pS76, DOI 10.1016/j.neuroimage.2010.04.008; Phillips Y Y, 1989, Ann Otol Rhinol Laryngol Suppl, V140, P17; PODE D, 1989, MIL MED, V154, P288; Pun Pamela B L, 2011, Front Neurol, V2, P19, DOI 10.3389/fneur.2011.00019; Ray SK, 2002, HISTOL HISTOPATHOL, V17, P1137, DOI 10.14670/HH-17.1137; Readnower RD, 2010, J NEUROSCI RES, V88, P3530, DOI 10.1002/jnr.22510; Risling M, 2011, NEUROIMAGE, V54, pS89, DOI 10.1016/j.neuroimage.2010.05.031; ROBERTO M, 1989, ANN OTO RHINOL LARYN, V98, P23; Saint Marie RL, 1999, J COMP NEUROL, V404, P258, DOI 10.1002/(SICI)1096-9861(19990208)404:2<258::AID-CNE9>3.0.CO;2-U; Saljo A, 2002, J NEUROTRAUM, V19, P379, DOI 10.1089/089771502753594945; Saljo A, 2000, J NEUROTRAUM, V17, P719, DOI 10.1089/089771500415454; Saljo A, 2010, J NEUROTRAUM, V27, P383, DOI 10.1089/neu.2009.1053; SATO K, 1993, ACTA OTO-LARYNGOL, P18; Sayer NA, 2012, ANNU REV MED, V63, P405, DOI 10.1146/annurev-med-061610-154046; Sekhon B, 2003, BRAIN RES, V971, P1, DOI 10.1016/S0006-8993(03)02244-3; Sekiya T, 2009, EXP NEUROL, V218, P117, DOI 10.1016/j.expneurol.2009.04.014; Singh V, 2007, INDIAN J EXP BIOL, V45, P1037; SKOTAK M, 2013, J NEUROTRAUMA; Svetlov Stanislav I, 2012, Front Neurol, V3, P15, DOI 10.3389/fneur.2012.00015; Svetlov SI, 2010, J TRAUMA, V69, P795, DOI 10.1097/TA.0b013e3181bbd885; Svetlov SI, 2009, J NEUROTRAUM, V26, P913, DOI 10.1089/neu.2008.0609; Tumer N, 2013, NEUROSCI LETT, V544, P62, DOI 10.1016/j.neulet.2013.03.042; Tyurin VA, 2000, J NEUROCHEM, V75, P2178, DOI 10.1046/j.1471-4159.2000.0752178.x; Valiyaveettil M, 2013, NEUROSCI LETT, V539, P1, DOI 10.1016/j.neulet.2013.01.028; Valiyaveettil M, 2012, J REHABIL RES DEV, V49, P1153, DOI 10.1682/JRRD.2011.09.0182; Valiyaveettil M, 2012, NEUROSCI LETT, V506, P141, DOI 10.1016/j.neulet.2011.10.067; VandeVord PJ, 2012, ANN BIOMED ENG, V40, P227, DOI 10.1007/s10439-011-0420-4; Wallhausser-Franke E, 2003, EXP BRAIN RES, V153, P649, DOI 10.1007/s00221-003-1614-2; Wang XY, 2007, ANN NEUROL, V61, P263, DOI 10.1002/ana.21066; Wu AG, 2006, EXP NEUROL, V197, P309, DOI 10.1016/j.expneurol.2005.09.004; Wu JA, 2011, AM J OTOLARYNG, V32, P8, DOI 10.1016/j.amjoto.2009.08.012; Xiong Y, 1999, J NEUROTRAUM, V16, P1067, DOI 10.1089/neu.1999.16.1067; Yi JH, 2006, J NEUROTRAUM, V23, P86, DOI 10.1089/neu.2006.23.86; Zhao ZG, 2001, BRAIN RES, V909, P46, DOI 10.1016/S0006-8993(01)02618-X	120	22	23	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2013	8	11							e80138	10.1371/journal.pone.0080138			17	Multidisciplinary Sciences	Science & Technology - Other Topics	247EE	WOS:000326597400113	24224042	DOAJ Gold, Green Published			2021-06-18	
J	Chen, XY; Li, K; Light, AR; Fu, KY				Chen, Xin-Yi; Li, Kai; Light, Alan R.; Fu, Kai-Yuan			Simvastatin Attenuates Formalin-Induced Nociceptive Behaviors by Inhibiting Microglial RhoA and p38 MAPK Activation	JOURNAL OF PAIN			English	Article						Formalin pain model; microglia; p38 mitogen-activated protein kinase; RhoA; statins	TRAUMATIC BRAIN-INJURY; COA REDUCTASE INHIBITORS; PERIPHERAL-NERVE INJURY; LONG-TERM HYPERALGESIA; SPINAL-CORD; NEUROPATHIC PAIN; PROTEIN-KINASE; STATINS; RAT; ATORVASTATIN	Several recent studies have revealed that statins exert anti-inflammatory effects in addition to their lipid-lowering property in vivo and in vitro. Recently, statins were shown to alleviate pain associated trauma in a neuropathic pain model. The aim of the present study was to investigate the underlying mechanisms of analgesia caused by the lipophilic statin simvastatin in an animal model of formalin-induced pain in the rat. Intrathecal pretreatment with simvastatin significantly attenuated the second phase of the acute nociceptive response to formalin injection, and daily administration of simvastatin for 7 days inhibited the long-term mechanical hyperalgesia caused by formalin injection. Spinal microglial activation (detected by lba-1 and CD11 b immunohistochemistry and Western blot), and phosphorylated-p38 mitogen-activated protein kinase (detected by immunohistochemistry and Western blot) were significantly inhibited by simvastatin treatment at day 7 after formalin injection. In addition, peripheral formalin injection induced a significant increase in microglial RhoA activation (detected by membrane RhoA translocation ratio using Western blot) in the spinal cord. The spinal RhoA activation in microglia was reversed by simvastatin treatment. These findings suggest that simvastatin attenuates formalin-induced nociceptive behaviors, at least in part, by inhibiting microglial RhoA and p38 mitogen-activated protein kinase activation. Perspective: Our novel findings indicated that simvastatin attenuated formalin-induced nociceptive responses by inhibiting micro glial RhoA and p38 mitogen-activated protein kinase activation. Inactivation of RhoA-p38 signaling pathway may be a pharmacologic target for treating microglia-directed central nervous system inflammation and chronic pain conditions. (C) 2013 by the American Pain Society	[Chen, Xin-Yi; Li, Kai; Fu, Kai-Yuan] Peking Univ, Sch & Hosp Stomatol, Ctr TMD & Orofacial Pain, Beijing 100081, Peoples R China; [Li, Kai] Peking Univ, Sch & Hosp Stomatol, Dept Gen Dent 2, Beijing 100081, Peoples R China; [Light, Alan R.] Univ Utah, Dept Anesthesiol, Salt Lake City, UT USA	Fu, KY (corresponding author), Peking Univ, Sch & Hosp Stomatol, Ctr TMD & Orofacial Pain, Zhong Guan Cun South Ave 22, Beijing 100081, Peoples R China.	kqkyfu@bjmu.edu.cn		Fu, Kai-Yuan/0000-0001-7049-9888	NSFCNational Natural Science Foundation of China (NSFC) [30973337, 81271172]; Beijing Natural Science FoundationBeijing Natural Science Foundation [7122201]	The research was supported by NSFC grant no. 30973337 and no. 81271172 (K.-Y.F.), and Beijing Natural Science Foundation 7122201 (K.-Y.F.).	Balduini W, 2003, STROKE, V34, P2007, DOI 10.1161/01.STR.0000080677.24419.88; Bi XN, 2004, J BIOL CHEM, V279, P48238, DOI 10.1074/jbc.M405442200; Blanco-Colio LM, 2003, KIDNEY INT, V63, P12, DOI 10.1046/j.1523-1755.2003.00744.x; Carlin CM, 2007, AM J RESP CELL MOL, V37, P447, DOI 10.1165/rcmb.2007-0012OC; Chen SF, 2007, LIFE SCI, V81, P288, DOI 10.1016/j.lfs.2007.05.023; Chu LW, 2012, INT J IMMUNOPATH PH, V25, P219, DOI 10.1177/039463201202500124; Clarke R, 2007, SIGHT SOUND, V17, P52; Cordle A, 2005, J BIOL CHEM, V280, P34202, DOI 10.1074/jbc.M505268200; Cordle A, 2005, J NEUROSCI, V25, P299, DOI 10.1523/JNEUROSCI.2544-04.2005; Coyle DE, 1998, GLIA, V23, P75; Fu KY, 2001, J PAIN, V2, P2, DOI 10.1054/jpai.2001.9804; Fu KY, 2000, NEUROSCIENCE, V101, P1127, DOI 10.1016/S0306-4522(00)00376-6; Garcia GG, 2011, PHARMACOL BIOCHEM BE, V100, P125, DOI 10.1016/j.pbb.2011.08.007; Ghittoni R, 2005, FASEB J, V19, P605, DOI 10.1096/fj.04-2702fje; Ginsberg HN, 1998, AM J CARDIOL, V81, p32B, DOI 10.1016/S0002-9149(98)00035-6; GOLDSTEIN JL, 1990, NATURE, V343, P425, DOI 10.1038/343425a0; Greenwood J, 2006, NAT REV IMMUNOL, V6, P358, DOI 10.1038/nri1839; Hains BC, 2006, J NEUROSCI, V26, P4308, DOI 10.1523/JNEUROSCI.0003-06.2006; Inoue M, 2004, NAT MED, V10, P712, DOI 10.1038/nm1060; Jin SX, 2003, J NEUROSCI, V23, P4017; Kwak B, 2000, NAT MED, V6, P1399; Lennernas H, 1997, CLIN PHARMACOKINET, V32, P403, DOI 10.2165/00003088-199732050-00005; Li B, 2009, NEUROSURGERY, V65, P179, DOI 10.1227/01.NEU.0000346272.76537.DC; Li K, 2010, J PAIN, V11, P1056, DOI 10.1016/j.jpain.2010.01.268; Liao JK, 2002, J CLIN INVEST, V110, P285, DOI 10.1172/JCI200216421; Lindberg C, 2005, J NEUROSCI RES, V82, P10, DOI 10.1002/jnr.20615; MELLER ST, 1994, NEUROPHARMACOLOGY, V33, P1471, DOI 10.1016/0028-3908(94)90051-5; Ohsawa M, 2008, PAIN, V134, P285, DOI 10.1016/j.pain.2007.04.031; Ohsawa M, 2012, J PHARMACOL SCI, V119, P102, DOI 10.1254/jphs.12007SC; Ohsawa M, 2011, PAIN, V152, P114, DOI 10.1016/j.pain.2010.10.005; Ramer LM, 2004, J NEUROSCI, V24, P10796, DOI 10.1523/JNEUROSCI.3337-04.2004; Ren K, 1999, PHYSIOL BEHAV, V67, P711, DOI 10.1016/S0031-9384(99)00136-5; Ruperez M, 2007, HYPERTENSION, V50, P377, DOI 10.1161/HYPERTENSIONAHA.107.091264; Sanchez-Aguilar M, 2013, J NEUROSURG, V118, P669, DOI 10.3171/2012.12.JNS121084; Senokuchi T, 2005, J BIOL CHEM, V280, P6627, DOI 10.1074/jbc.M412531200; Shi XQ, 2011, PAIN, V152, P1033, DOI 10.1016/j.pain.2011.01.006; Song JX, 2011, J CARDIOVASC PHARM, V57, P213, DOI 10.1097/FJC.0b013e31820376ac; Storkson RV, 1996, J NEUROSCI METH, V65, P167, DOI 10.1016/0165-0270(95)00164-6; Stuve O, 2003, CURR OPIN NEUROL, V16, P393, DOI 10.1097/01.wco.0000073942.19076.d1; Takai Y, 2001, PHYSIOL REV, V81, P153; Tatsumi S, 2005, NEUROSCIENCE, V131, P491, DOI 10.1016/j.neuroscience.2004.10.022; Tristano AG, 2006, INT IMMUNOPHARMACOL, V6, P1833, DOI 10.1016/j.intimp.2006.08.006; Tsuda M, 2004, GLIA, V45, P89, DOI 10.1002/glia.10308; VanAelst L, 1997, GENE DEV, V11, P2295, DOI 10.1101/gad.11.18.2295; Wang HC, 2007, EXP NEUROL, V206, P59, DOI 10.1016/j.expneurol.2007.03.031; Watkins LR, 2001, TRENDS NEUROSCI, V24, P450, DOI 10.1016/S0166-2236(00)01854-3; Weitz-Schmidt G, 2002, TRENDS PHARMACOL SCI, V23, P482, DOI 10.1016/S0165-6147(02)02077-1; Weitz-Schmidt G, 2001, NAT MED, V7, P687, DOI 10.1038/89058	48	22	25	1	11	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	1526-5900			J PAIN	J. Pain	NOV	2013	14	11					1310	1319		10.1016/j.jpain.2013.05.011			10	Clinical Neurology; Neurosciences	Neurosciences & Neurology	252YD	WOS:000327047900005	23900131				2021-06-18	
J	de Guise, E; LeBlanc, J; Champoux, MC; Couturier, C; Alturki, AY; Lamoureux, J; Desjardins, M; Marcoux, J; Maleki, M; Feyz, M				de Guise, Elaine; LeBlanc, Joanne; Champoux, Marie-Claude; Couturier, Celine; Alturki, Abdulrahman Yaqub; Lamoureux, Julie; Desjardins, Monique; Marcoux, Judith; Maleki, Mohammed; Feyz, Mitra			The mini-mental state examination and the montreal cognitive assessment after traumatic brain injury: An early predictive study	BRAIN INJURY			English	Article						Montreal cognitive assessment; mini-mental state examination; level 1 trauma centre; outcome; traumatic brain injury	SEVERE HEAD-INJURY; ELDERLY-PATIENTS; ACUTE-CARE; PARKINSONS-DISEASE; SUBACUTE STROKE; MORTALITY; REHABILITATION; IMPAIRMENT; SCALE; COMA	Primary objective: To compare results on the Montreal Cognitive Assessment (MoCA) to those on the Mini-Mental State Examination (MMSE) in patients with traumatic brain injury (TBI) and to predict the outcome at discharge from the acute care setting. Research design: A retrospective study. Methods and procedures: The MoCA and the MMSE were administered to 214 patients with TBI during their acute care hospitalization in a Level I trauma centre. Outcome was measured with the Disability Rating Scale (DRS). Main outcomes and results: A linear regression determined that the MoCA, the MMSE, TBI severity, education level and presence of diffuse injuries predicted 57% of the total variability of the DRS scores. The model without the MMSE had a R-2 of 53.7% and the model without the MoCA had a R-2 of 55.0%. The models without the MMSE or the MoCA had a R-2 of 24.9%. Conclusions: These results indicated that the MoCA and the MMSE function as similar predictors of the DRS at discharge.	[de Guise, Elaine; Alturki, Abdulrahman Yaqub; Marcoux, Judith; Maleki, Mohammed] McGill Univ, Ctr Hlth, Montreal Gen Hosp, Neurol & Neurosurg Dept, Montreal, PQ H3G 1A4, Canada; [de Guise, Elaine] Univ Montreal, Dept Psychol, Montreal, PQ H3C 3J7, Canada; [LeBlanc, Joanne; Champoux, Marie-Claude; Couturier, Celine; Feyz, Mitra] McGill Univ, Ctr Hlth, Montreal Gen Hosp, Traumat Brain Injury Program, Montreal, PQ H3G 1A4, Canada; [Alturki, Abdulrahman Yaqub] Natl Neurosci Inst, Riyadh, Saudi Arabia; [Lamoureux, Julie] Univ Montreal, Social & Prevent Med Dept, Montreal, PQ, Canada; [Desjardins, Monique] McGill Univ, Ctr Hlth, Montreal Gen Hosp, Dept Psychiat, Montreal, PQ H3G 1A4, Canada	de Guise, E (corresponding author), McGill Univ, Ctr Hlth, Montreal Gen Hosp Site,Room D13-124,1650 Cedar Av, Montreal, PQ H3G 1A4, Canada.	elainedeguise@hotmail.ca			Research Institute of the McGill University Health Center	We thank the Research Institute of the McGill University Health Center for their support.	Cameron J, 2012, HEART LUNG CIRC, V21, P806, DOI 10.1016/j.hlc.2012.07.050; De Guise E, 2005, BRAIN INJURY, V19, P1087, DOI 10.1080/02699050500149882; de Guise E, 2006, J HEAD TRAUMA REHAB, V21, P527, DOI 10.1097/00001199-200611000-00007; DIKMEN S, 1986, ARCH PHYS MED REHAB, V67, P507; Dong YH, 2012, INT PSYCHOGERIATR, V24, P1749, DOI 10.1017/S1041610212001068; Feickert HJ, 1999, J TRAUMA, V47, P33, DOI 10.1097/00005373-199907000-00008; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Fork M, 2005, BRAIN INJURY, V19, P101, DOI 10.1080/02699050410001726086; Godefroy O, 2011, STROKE, V42, P1712, DOI 10.1161/STROKEAHA.110.606277; HAAS JF, 1987, J NEUROL NEUROSUR PS, V50, P52, DOI 10.1136/jnnp.50.1.52; Heruti RJ, 2002, ARCH PHYS MED REHAB, V83, P742, DOI 10.1053/apmr.2002.32739; Hoffmann M, 2012, BRIT J SURG, V99, P122, DOI 10.1002/bjs.7707; Jaillard A, 2009, STROKE, V40, P2473, DOI 10.1161/STROKEAHA.108.541144; KATZ DI, 1994, ARCH NEUROL-CHICAGO, V51, P661, DOI 10.1001/archneur.1994.00540190041013; Kesler SR, 2003, APPL NEUROPSYCHOL, V10, P153, DOI 10.1207/S15324826AN1003_04; Leblanc J, 2006, BRAIN INJURY, V20, P779, DOI 10.1080/02699050600831835; Marmarou A, 2003, ACT NEUR S, V86, P7; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; Mosenthal AC, 2002, J TRAUMA, V52, P907, DOI 10.1097/00005373-200205000-00015; Nasreddine ZS, 2005, J AM GERIATR SOC, V53, P695, DOI 10.1111/j.1532-5415.2005.53221.x; Nazem S, 2009, J AM GERIATR SOC, V57, P304, DOI 10.1111/j.1532-5415.2008.02096.x; Olson R, 2011, SUPPORT CARE CANCER, V19, P1849, DOI 10.1007/s00520-010-1028-1; Pendlebury ST, 2010, STROKE, V41, P1290, DOI 10.1161/STROKEAHA.110.579888; Popovic IM, 2007, J NEUROL SCI, V257, P185, DOI 10.1016/j.jns.2007.01.029; Rabadi MH, 2008, ARCH PHYS MED REHAB, V89, P441, DOI 10.1016/j.apmr.2007.11.014; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; Ritchie PD, 2000, J CLIN NEUROSCI, V7, P301, DOI 10.1054/jocn.1999.0198; Susman M, 2002, J TRAUMA, V53, P219, DOI 10.1097/00005373-200208000-00004; Timmons SD, 2011, J TRAUMA, V71, P1172, DOI 10.1097/TA.0b013e31822b0f4b; Toglia J, 2011, ARCH PHYS MED REHAB, V92, P792, DOI 10.1016/j.apmr.2010.12.034; Wallesch CW, 2001, J NEUROTRAUM, V18, P11, DOI 10.1089/089771501750055730; Zadikoff C, 2008, MOVEMENT DISORD, V23, P297, DOI 10.1002/mds.21837; Zwecker M, 2002, ARCH PHYS MED REHAB, V83, P342, DOI 10.1053/apmr.2002.29641	33	22	23	0	20	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	NOV	2013	27	12					1428	1434		10.3109/02699052.2013.835867			7	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	235UF	WOS:000325745500014	24102622				2021-06-18	
J	Ding, ZY; Zhang, JM; Xu, JY; Sheng, GJ; Huang, GR				Ding, Zhongyang; Zhang, Jiaming; Xu, Jinyu; Sheng, Guangjie; Huang, Guorong			Propofol Administration Modulates AQP-4 Expression and Brain Edema After Traumatic Brain Injury	CELL BIOCHEMISTRY AND BIOPHYSICS			English	Article						Propofol; Brain edema; AQP-4; IL-1 beta; TNF-alpha	SEVERE HEAD-INJURY; OXIDATIVE STRESS; AQUAPORIN-4; WATER; RATS; MICE; RECEPTOR; NEUROPROTECTION; ENCEPHALOPATHY; INFLAMMATION	The increased intracranial pressure caused by brain edema following traumatic brain injury (TBI) always leads to poor patient prognosis. Aquaporin-4 (AQP-4) plays an important role in edema formation and resolution, which may provide a novel therapeutic target for edema treatment. In this present study, we found that propofol treatment, within a short time, after TBI significantly reduced brain edema in a controlled cortical injury rat model and suppressed in vivo expression of AQP-4. The ameliorating effect of propofol was associated with attenuated expression of interleukin-1 beta (IL-1 beta) and tumor necrosis factor-alpha (TNF-alpha). In addition, the regulatory effect of propofol on AQP-4 expression was investigated in cultured astrocytes. Results showed that propofol could block the stimulatory effect of IL-1 beta and TNF-alpha on AQP-4 expression in cultured astrocytes. We also found that both NF kappa B and p38/MAPK pathways were involved in IL-1 beta and TNF-alpha-induced AQP-4 expression and that propofol functions as a dual inhibitor of NF kappa B and p38/MAPK pathways. In conclusion, treatment with propofol, within a short time, after TBI attenuates cerebral edema and reduces the expression of AQP-4. Propofol modulates acute AQP-4 expression by attenuating IL-1 beta and TNF-alpha expression and inhibiting IL-1 beta and TNF-alpha induced AQP-4 expression.	[Ding, Zhongyang; Zhang, Jiaming; Xu, Jinyu; Sheng, Guangjie; Huang, Guorong] Nanjing Med Univ, Affiliated Wuxi Peoples Hosp, Emergency Ctr, Wuxi 214023, Peoples R China	Ding, ZY (corresponding author), Nanjing Med Univ, Affiliated Wuxi Peoples Hosp, Emergency Ctr, Wuxi 214023, Peoples R China.	drzyding@gmail.com					Agre P, 2004, NEUROSCIENCE, V129, P849, DOI 10.1016/j.neuroscience.2004.10.001; Alexander JJ, 2008, NEUROCHEM INT, V52, P447, DOI 10.1016/j.neuint.2007.08.006; Bemeur C, 2010, NEUROCHEM INT, V56, P213, DOI 10.1016/j.neuint.2009.11.010; Chen MJ, 2008, CURR NEUROPHARMACOL, V6, P102, DOI 10.2174/157015908784533879; Dalgard CL, 2012, FRONT MOL NEUROSCI, V5, DOI 10.3389/fnmol.2012.00006; Di Giorgio AM, 2008, RESTOR NEUROL NEUROS, V26, P501; Feng Chun-sheng, 2004, Zhonghua Yi Xue Za Zhi, V84, P2110; Guo QM, 2006, EXP NEUROL, V198, P469, DOI 10.1016/j.expneurol.2005.12.013; Haddad SH, 2012, SCAND J TRAUMA RESUS, V20, DOI 10.1186/1757-7241-20-12; Hewett SJ, 2006, J PHARMACOL EXP THER, V319, P1219, DOI 10.1124/jpet.106.109876; Iijima T, 2006, BRAIN RES, V1099, P25, DOI 10.1016/j.brainres.2006.04.117; Ito H, 1999, ACTA ANAESTH SCAND, V43, P153, DOI 10.1034/j.1399-6576.1999.430206.x; Ito H, 2006, J NEUROCHEM, V99, P107, DOI 10.1111/j.1471-4159.2006.04036.x; Ito J, 1996, J NEUROSURG, V84, P97, DOI 10.3171/jns.1996.84.1.0097; KIMELBERG HK, 1992, J NEUROTRAUM, V9, pS71; KOCHS E, 1992, ANESTHESIOLOGY, V76, P245, DOI 10.1097/00000542-199202000-00014; Laird MD, 2010, J NEUROCHEM, V113, P637, DOI 10.1111/j.1471-4159.2010.06630.x; Lazovic J, 2005, STROKE, V36, P2226, DOI 10.1161/01.STR.0000182255.08162.6a; Liang Danny, 2007, Neurosurg Focus, V22, pE2, DOI 10.3171/foc.2007.22.5.3; Manley GT, 2000, NAT MED, V6, P159, DOI 10.1038/72256; MILLER JD, 1977, J NEUROSURG, V47, P503, DOI 10.3171/jns.1977.47.4.0503; Nielsen S, 1997, J NEUROSCI, V17, P171; [潘彩飞 PAN Cai-fei], 2010, [中国病理生理杂志, Chinese Journal of Pathophysiology], V26, P96; Rajeevan MS, 2001, METHODS, V25, P443, DOI 10.1006/meth.2001.1266; Sanchez-Conde P, 2008, ANESTH ANALG, V106, P371, DOI 10.1213/ane.0b013e318160580b; SAUL TG, 1982, J NEUROSURG, V56, P498, DOI 10.3171/jns.1982.56.4.0498; Tait MJ, 2008, TRENDS NEUROSCI, V31, P37, DOI 10.1016/j.tins.2007.11.003; Tang J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027890; Tyurin VA, 2000, J NEUROCHEM, V75, P2178, DOI 10.1046/j.1471-4159.2000.0752178.x; Vizuete ML, 1999, NEUROBIOL DIS, V6, P245, DOI 10.1006/nbdi.1999.0246; Yang BX, 2008, J BIOL CHEM, V283, P15280, DOI 10.1074/jbc.M801425200; Zhang XJ, 2006, NEUROL INDIA, V54, P402; ZHU S, 2009, ANESTHESIA ANALGESIA, V109, P1436	33	22	32	0	14	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1085-9195	1559-0283		CELL BIOCHEM BIOPHYS	Cell Biochem. Biophys.	NOV	2013	67	2			SI		615	622		10.1007/s12013-013-9549-0			8	Biochemistry & Molecular Biology; Biophysics; Cell Biology	Biochemistry & Molecular Biology; Biophysics; Cell Biology	242YP	WOS:000326282900039	23494261				2021-06-18	
J	Klein, AM; Howell, K; Straube, A; Pfefferkorn, T; Bender, A				Klein, Anke-Maria; Howell, Kaitlen; Straube, Andreas; Pfefferkorn, Thomas; Bender, Andreas			Rehabilitation outcome of patients with severe and prolonged disorders of consciousness after aneurysmal subarachnoid hemorrhage (aSAH)	CLINICAL NEUROLOGY AND NEUROSURGERY			English	Article						Aneurysmal subarachnoid hemorrhage; Outcome; Clinical course; Recovery of consciousness; Predicting outcome; Neurorehabilitation	RUPTURED INTRACRANIAL ANEURYSMS; TRAUMATIC BRAIN-INJURY; VEGETATIVE STATE; FOLLOW-UP; STROKE; MANAGEMENT; RECOVERY; IMPACT; LIFE; FIM	Objectives: Our objectives were to evaluate rehabilitation outcome of aSAH survivors with severe disorders of consciousness (DOC) and to examine potential predictors of long-term outcome. Severe DOC includes patients in a vegetative state (VS) and in a minimally conscious state (MCS). Patients and methods: This is a retrospective single-center cohort study of consecutive aSAH patients with severe and prolonged DOC upon admission to neurorehabilitation. Clinical assessments started right after discharge from ICU, a median of 26 days after the aSAH. Two different outcome criteria were used, one addressing the functional aspect (assessed by the Functional Independence Measure [FIM]) the other one addressing the level of consciousness ("behavioral outcome", assessed by the Coma Remission Scale [CRS]). Improved outcome was defined by an increase in FIM scores of at least 22 points (minimal clinically important difference) or by reaching a full score of 24 points on the CRS. Separate least square linear regression models were calculated to examine potential predictors for functional and behavioral outcome. Results: Out of 63 patients, 19.0% and 39.7% of the patients achieved an improved functional and behavioral outcome, respectively. Age and level of consciousness upon admission to neurorehabilitation were independent prognostic factors for both outcome definitions. Both groups reached the better outcome category after a median of 11 and 9 weeks, respectively. In an individual patient, the longest delay to achievement of improved functional outcome was 30 weeks and to favorable behavioral outcome was 22 weeks after rehabilitation admission. Conclusion: About one-third of severely affected aSAH patients with DOC regained at least a favorable behavioral status during early neurorehabilitation. It is interesting to note that in our study population, the beginning of clinical improvement took up to 6 months after aSAH. (C) 2013 Elsevier B.V. All rights reserved.	[Klein, Anke-Maria; Howell, Kaitlen; Straube, Andreas; Pfefferkorn, Thomas; Bender, Andreas] Univ Munich, Dept Neurol, D-81377 Munich, Germany; [Klein, Anke-Maria] Univ Munich, Dept Phys Med & Rehabil, D-81377 Munich, Germany; [Howell, Kaitlen; Bender, Andreas] Therapiezentrum Burgau, Dept Neurol, D-89331 Burgau, Germany	Bender, A (corresponding author), Univ Munich, Dept Neurol, Marchioninistr 15, D-81377 Munich, Germany.	anke-maria.klein@med.uni-muenchen.de; kshowell@fulbrightmail.org; andreas.straube@med.uni-muenchen.de; thomas.pfefferkorn@med.uni-muenchen.de; anbender@med.uni-muenchen.de		Bender, Andreas/0000-0002-6328-7104			Al-Khindi T, 2010, STROKE, V41, pE519, DOI 10.1161/STROKEAHA.110.581975; ASHWAL S, 1994, NEW ENGL J MED, V330, P1499; Bederson JB, 2009, STROKE, V40, P994, DOI 10.1161/STROKEAHA.108.191395; Beninato M, 2006, ARCH PHYS MED REHAB, V87, P32, DOI 10.1016/j.apmr.2005.08.130; Berger E, 1999, RESTOR NEUROL NEUROS, V14, P93; Canovas D, 2012, EUR J NEUROL, V19, P457, DOI 10.1111/j.1468-1331.2011.03542.x; Clinchot DM, 1997, ARCH PHYS MED REHAB, V78, P346, DOI 10.1016/S0003-9993(97)90223-9; Dombovy ML, 1998, BRAIN INJURY, V12, P887; Douds GL, 2012, NEUROLOGY RES INT, V2012, P6; FOGELHOLM R, 1993, STROKE, V24, P1649, DOI 10.1161/01.STR.24.11.1649; Giacino JT, 2002, NEUROLOGY, V58, P349, DOI 10.1212/WNL.58.3.349; Gnanalingham KK, 2006, CLIN NEUROL NEUROSUR, V108, P117, DOI 10.1016/j.clineuro.2005.11.001; Goddard AJP, 2004, J NEUROL NEUROSUR PS, V75, P868, DOI 10.1136/jnnp.2003.033068; Granger CV, 1998, ARCH PHYS MED REHAB, V79, P235, DOI 10.1016/S0003-9993(98)90000-4; Grill E, 2013, ARCH PHYS MED REHAB, DOI [10.1016/j.apmr.2012.10.040, DOI 10.1016/J.APMR.2012.10.040.[EPUB]; HAMILTON BB, 1994, SCAND J REHABIL MED, V26, P115; Helbok R, 2012, J NEUROLOGY NEUROSUR; Hutter BO, 1998, NEUROPSY NEUROPSY BE, V11, P22; Jaja BNR, 2013, NEUROCRIT CARE, V18, P143, DOI 10.1007/s12028-012-9792-z; JENNETT B, 1975, LANCET, V1, P480; Katz DI, 2009, PROG BRAIN RES, V177, P73, DOI 10.1016/S0079-6123(09)17707-5; Kwakkel G, 1996, AGE AGEING, V25, P479, DOI 10.1093/ageing/25.6.479; Lanzino G, 1996, J NEUROSURG, V85, P410, DOI 10.3171/jns.1996.85.3.0410; Laureys S, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-68; Lovelock CE, 2010, NEUROLOGY, V74, P1494, DOI 10.1212/WNL.0b013e3181dd42b3; Lule D, 2009, PROG BRAIN RES, V177, P339, DOI 10.1016/S0079-6123(09)17723-3; Rosengart AJ, 2007, STROKE, V38, P2315, DOI 10.1161/STROKEAHA.107.484360; Saciri BM, 2002, J NEUROL NEUROSUR PS, V72, P334, DOI 10.1136/jnnp.72.3.334; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Voss A, 1993, SPECTRUM NEUROREHABI, P112; Wang YM, 2012, BMC SURG, V12, DOI 10.1186/1471-2482-12-12	31	22	23	0	10	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0303-8467	1872-6968		CLIN NEUROL NEUROSUR	Clin. Neurol. Neurosurg.	OCT	2013	115	10					2136	2141		10.1016/j.clineuro.2013.08.004			6	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	236XQ	WOS:000325833200037	23993657				2021-06-18	
J	Nalder, E; Fleming, J; Cornwell, P; Shields, C; Foster, M				Nalder, Emily; Fleming, Jennifer; Cornwell, Petrea; Shields, Cassandra; Foster, Michele			Reflections on life: Experiences of individuals with brain injury during the transition from hospital to home	BRAIN INJURY			English	Article						Community integration; life course; lived experience	POSTTRAUMATIC GROWTH; ADJUSTMENT; IDENTITY	Background: The transition from hospital to home has been described as a distinct rehabilitation phase for individuals with brain injury. As most research to date has quantitatively measured outcomes or used a sample with mixed brain injury diagnoses, less is known about the experience of transition following traumatic brain injury (TBI). Aims: This study aimed to examine the lived experiences of individuals with TBI during the first 6 months following discharge from hospital. Design: A qualitative investigation was conducted with 16 individuals with TBI using semi-structured interviews. Data analysis: Data were analysed thematically using a Framework approach. Results: Transition experiences were characterized by a desire to return to normality and a changed perspective on life, by accepting change or altering priorities. The process of transition was dynamic as individuals experienced the dominant themes in cyclical patterns. Conclusions: Research has highlighted the significant adjustment for individuals with TBI, particularly in relation to identity change, appraisal and coping. The themes of wanting normality and changing life perspective which were dominant in the current study highlight the significance of the transition phase in the process of adjustment and that transition is characterized by adapting to a new normality.	[Nalder, Emily; Fleming, Jennifer; Shields, Cassandra] Univ Queensland, Sch Hlth & Rehabil Sci, Brisbane, Qld, Australia; [Nalder, Emily; Fleming, Jennifer] Queensland Hlth, Ctr Functioning & Hlth Res, Brisbane, Qld, Australia; [Fleming, Jennifer] Princess Alexandra Hosp, Queensland Hlth, Occupat Therapy Dept, Brisbane, Qld 4102, Australia; [Cornwell, Petrea] Griffith Univ, Griffith Hlth Inst, Brisbane, Qld 4111, Australia; [Cornwell, Petrea] Queensland Hlth, Metro North Hlth Serv Dist, Brisbane, Qld, Australia; [Foster, Michele] Univ Queensland, Sch Social Work & Human Serv, Brisbane, Qld, Australia	Nalder, E (corresponding author), Baycrest Hosp, Rotman Res Inst, 3560 Bathurst St, Toronto, ON M6A 2E1, Canada.	emily.nalder@uqconnect.edu.au	Cornwell, Petrea/AAE-5547-2019		Australian Research Council Linkage GrantAustralian Research Council [LP0776294]; Department of Communities (Disability Services); Acquired Brain Injury Outreach service	We wish to acknowledge the funding support for this project by way of an Australian Research Council Linkage Grant (LP0776294) and partner organizations Department of Communities (Disability Services) and Acquired Brain Injury Outreach service.	Byrne-Armstrong H., 2001, CRITICAL MOMENTS QUA; Carroll E, 2011, NEUROPSYCHOL REHABIL, V21, P289, DOI 10.1080/09602011.2011.555972; Chamberlain DJ, 2006, J ADV NURS, V54, P407, DOI 10.1111/j.1365-2648.2006.03840.x; Chua KSG, 2007, ANN ACAD MED SINGAP, V36, P31; Colantonio A, 2004, DISABIL REHABIL, V26, P253, DOI 10.1080/09638280310001639722; Creswell J. W., 2017, DESIGNING CONDUCTING; DAWSON DR, 1995, BRAIN INJURY, V9, P339, DOI 10.3109/02699059509005774; Elder G.H., 2009, CRAFT LIFE COURSE RE; ELDER GH, 1975, ANNU REV SOCIOL, V1, P165, DOI 10.1146/annurev.so.01.080175.001121; Fortune N, 1999, DEFINITION INCIDENCE; Goodman J., 2006, COUNSELING ADULTS TR; Gracey F, 2009, NEUROPSYCHOL REHABIL, V19, P867, DOI 10.1080/09602010903027763; Hawley CA, 2008, BRAIN INJURY, V22, P427, DOI 10.1080/02699050802064607; Heller W, 2006, J REHABIL, V72, P44; Levack WMM, 2010, DISABIL REHABIL, V32, P986, DOI 10.3109/09638281003775394; MARKUS H, 1986, AM PSYCHOL, V41, P954, DOI 10.1037/0003-066X.41.9.954; McGrath JC, 2006, BRAIN INJURY, V20, P767, DOI 10.1080/02699050600664566; Muenchberger H, 2008, BRAIN INJURY, V22, P979, DOI 10.1080/02699050802530532; Nalder E, 2012, BRAIN INJURY, V26, P1381, DOI 10.3109/02699052.2012.676225; Nalder E, 2012, J HEAD TRAUMA REHAB, V27, P143, DOI 10.1097/HTR.0b013e3182168fb1; Nochi M, 1998, SOC SCI MED, V46, P869, DOI 10.1016/S0277-9536(97)00211-6; Padilla R, 2003, AM J OCCUP THER, V57, P413, DOI 10.5014/ajot.57.4.413; Patton MQ., 1990, QUALITATIVE EVALUATI; Powell T, 2007, BRAIN INJURY, V21, P31, DOI 10.1080/02699050601106245; Powers L., 2006, J DISABIL POLICY STU, V17, P66, DOI DOI 10.1177/10442073060170020301; QSR International Pty Ltd, 2010, NVIVO QUAL DAT AN SO; Ritchie J., 2003, QUALITATIVE RES PRAC; Rittman M, 2007, TOP STROKE REHABIL, V14, P21, DOI 10.1310/tsr1402-21; Shotton L, 2007, BRAIN INJURY, V21, P857, DOI 10.1080/02699050701481621; Turner B, 2007, BRAIN INJURY, V21, P1119, DOI 10.1080/02699050701651678; Turner B, 2011, NEUROPSYCHOL REHABIL, V21, P64, DOI 10.1080/09602011.2010.527747; Turner BJ, 2008, DISABIL REHABIL, V30, P1153, DOI 10.1080/09638280701532854	32	22	22	0	13	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	OCT	2013	27	11					1294	1303		10.3109/02699052.2013.823560			10	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	217YQ	WOS:000324399800009	23924357				2021-06-18	
J	Chiu, HY; Chen, PY; Chen, NH; Chuang, LP; Tsai, PS				Chiu, Hsiao-Yean; Chen, Pin-Yuan; Chen, Ning-Hung; Chuang, Li-Pang; Tsai, Pei-Shan			Trajectories of sleep changes during the acute phase of traumatic brain injury: A 7-day actigraphy study	JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION			English	Article						hierarchical linear model; sleep; symptom trajectory; traumatic brain injury	GENDER DIFFERENCES; HEAD-INJURY; DISTURBANCES; PREVALENCE; DISORDERS; HYPERSOMNIA; PARAMETERS; INSOMNIA; RHYTHMS; SERIES	Background/Purpose: To examine trajectories of change in sleep during the acute phase of traumatic brain injury (TB, and whether specific demographic and disease characteristics predicted the initial levels of sleep and the trajectories of change in sleep parameters. Methods: This was a prospective observational study. Fifty-two patients with first-ever TBI were enrolled. Sleep parameters were measured using actigraphy for 7 consecutive days after admission. Hierarchical linear modeling was used for data analyses in 52 TBI patients and in a subgroup of mild TBI patients (n = 31). Results: Participants had significant lower sleep efficiency, longer wake time after sleep onset, and longer 24-hour total sleep time (TST) than the normative data (all p < 0.05). Seventy-two percent of participants experienced prolonged 24-hour TST. Both daytime and 24-hour TST showed a significant downward trend across the study period. An initial Glasgow Coma Scale score < 11 significantly predicted the slope of change of daytime TST over time. Without initial loss of consciousness and age < 40 years were independent predictors of the change pattern of 24-hour TST over time. In the mild TBI subgroup, 24-hour TST significantly and gradually declined over time. Gender significantly predicted the trajectory of 24-hour sleep duration. Conclusion: Poor sleep efficiency and longer sleep duration are common symptoms in acute TB! patients. Both head injury severity and age predicted the trajectories of daytime and 24-hour sleep duration during the acute phase of TBI, whereas gender predicted the trajectories of 24-hour sleep duration in the mild TBI subgroup. Copyright (C) 2013, Elsevier Taiwan LLC & Formosan Medical Association. All rights reserved.	[Chiu, Hsiao-Yean; Tsai, Pei-Shan] Taipei Med Univ, Grad Inst Nursing, Coll Nursing, Taipei 110, Taiwan; [Chen, Pin-Yuan] Chang Gung Mem Hosp, Dept Neurosurg, Tao Yuan, Taiwan; [Chen, Pin-Yuan; Chuang, Li-Pang] Chang Gung Univ, Coll Med, Grad Inst Clin Med Sci, Tao Yuan, Taiwan; [Chen, Ning-Hung; Chuang, Li-Pang] Chang Gung Mem Hosp, Sleep Ctr, Tao Yuan, Taiwan; [Chen, Ning-Hung; Chuang, Li-Pang] Chang Gung Mem Hosp, Dept Pulm & Crit Care Med, Tao Yuan, Taiwan; [Tsai, Pei-Shan] Taipei Med Univ Hosp, Sleep Sci Ctr, Taipei, Taiwan; [Tsai, Pei-Shan] Taipei Med Univ, Wan Fang Hosp, Dept Nursing, Taipei 110, Taiwan	Tsai, PS (corresponding author), Taipei Med Univ, Grad Inst Nursing, 250 Wu Hsing St, Taipei 110, Taiwan.	ptsai@tmu.edu.tw	Chuang, Li-Pang/L-8929-2019	Chuang, Li-Pang/0000-0001-5466-8995			Ancoli-Israel S, 2003, SLEEP, V26, P342, DOI 10.1093/sleep/26.3.342; Ancoli-Israel S, 2009, SLEEP MED, V10, pS7, DOI 10.1016/j.sleep.2009.07.004; Balestreri M, 2004, J NEUROL NEUROSUR PS, V75, P161; Baumann CR, 2007, BRAIN, V130, P1873, DOI 10.1093/brain/awm109; Baumann CR, 2005, NEUROLOGY, V65, P147, DOI 10.1212/01.wnl.0000167605.02541.f2; Bryan-Hancock C, 2010, INJURY PREV, V16, pA17, DOI 10.1136/ip.2010.029215.61; Campbell CGN, 2004, CAN J NEUROL SCI, V31, P213, DOI 10.1017/S0317167100053853; CAMPBELL SS, 1989, SLEEP, V12, P529; Carmichael ST, 2002, J NEUROSCI, V22, P6062; Castriotta RJ, 2007, J CLIN SLEEP MED, V3, P349; ENGLANDER J, 1992, Brain Injury, V6, P161, DOI 10.3109/02699059209029654; Fichtenberg NL, 2000, BRAIN INJURY, V14, P659; GRAHAM DI, 1988, J CLIN PATHOL, V41, P34, DOI 10.1136/jcp.41.1.34; Guilleminault C, 2000, NEUROLOGY, V54, P653, DOI 10.1212/WNL.54.3.653; Hagen C, 1998, LEVELS COGNITIVE FUN; Hagen C., 1979, LEVELS COGNITIVE FUN; KATZ DI, 1994, ARCH NEUROL-CHICAGO, V51, P661, DOI 10.1001/archneur.1994.00540190041013; Kempf J, 2010, J NEUROL NEUROSUR PS, V81, P1402, DOI 10.1136/jnnp.2009.201913; Kuo JR, 2011, J FORMOS MED ASSOC, V110, P258, DOI 10.1016/S0929-6646(11)60038-7; Lee TT, 1997, ACTA NEUROCHIR, V139, P1042, DOI 10.1007/BF01411558; Lindberg E, 1997, SLEEP, V20, P381, DOI 10.1093/sleep/20.6.381; Littner M, 2003, SLEEP, V26, P337, DOI 10.1093/sleep/26.3.337; Makley MJ, 2008, NEUROREHAB NEURAL RE, V22, P341, DOI 10.1177/1545968308315598; Makley MJ, 2009, NEUROREHAB NEURAL RE, V23, P320, DOI 10.1177/1545968308325268; McAllister TW, 2001, NEUROIMAGE, V14, P1004, DOI 10.1006/nimg.2001.0899; Morgado Fabiana Lenharo, 2011, Radiol Bras, V44, P35, DOI 10.1590/S0100-39842011000100010; Ohayon MM, 2004, SLEEP, V27, P1255, DOI 10.1093/sleep/27.7.1255; Ohayon MM, 2005, SLEEP, V28, P981; Ouellet MC, 2006, J HEAD TRAUMA REHAB, V21, P199, DOI 10.1097/00001199-200605000-00001; Parcell DL, 2006, ARCH PHYS MED REHAB, V87, P278, DOI 10.1016/j.apmr.2005.10.024; Rao V, 2008, BRAIN INJURY, V22, P381, DOI 10.1080/02699050801935260; Raudenbush S. W., 2010, HLM7 HIERARCHICAL LI; Raudenbush SW, 2001, ANNU REV PSYCHOL, V52, P501, DOI 10.1146/annurev.psych.52.1.501; Raudenbush SW., 2002, HIERARCHICAL LINEAR, V2nd ed; SADEH A, 1994, SLEEP, V17, P201, DOI 10.1093/sleep/17.3.201; Saper CB, 2005, NATURE, V437, P1257, DOI 10.1038/nature04284; Saper CB, 2005, J COMP NEUROL, V493, P92, DOI 10.1002/cne.20770; Sowers MF, 2008, SLEEP, V31, P1339; Stickgold R, 2001, SCIENCE, V294, P1052, DOI 10.1126/science.1063530; Verma A, 2007, J CLIN SLEEP MED, V3, P357; Watson NF, 2007, J CLIN SLEEP MED, V3, P363; Wolkove N, 2007, CAN MED ASSOC J, V176, P1299, DOI 10.1503/cmaj.060792; Zollman FS, 2010, BRAIN INJURY, V24, P748, DOI 10.3109/02699051003692167	43	22	22	0	5	ELSEVIER TAIWAN	TAIPEI	RM N-412, 4F, CHIA HSIN BUILDING 11, NO 96, ZHONG SHAN N ROAD SEC 2, TAIPEI, 10449, TAIWAN	0929-6646	1876-0821		J FORMOS MED ASSOC	J. Formos. Med. Assoc.	SEP	2013	112	9					545	553		10.1016/j.jfma.2013.06.007			9	Medicine, General & Internal	General & Internal Medicine	237XY	WOS:000325906200007	23906685				2021-06-18	
J	Katzenell, U; Lipsky, AM; Abramovich, A; Huberman, D; Sergeev, I; Deckel, A; Kreiss, Y; Glassberg, E				Katzenell, Udi; Lipsky, Ari M.; Abramovich, Amir; Huberman, David; Sergeev, Ilia; Deckel, Avishai; Kreiss, Yitshak; Glassberg, Elon			Prehospital intubation success rates among Israel Defense Forces providers: Epidemiologic analysis and effect on doctrine	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article						Advanced airway management; prehospital; endotracheal intubation; cricothyroidotomy	OPERATION-ENDURING-FREEDOM; TRAUMATIC BRAIN-INJURY; ENDOTRACHEAL INTUBATION; IRAQI-FREEDOM; AIRWAY; REGISTRY	BACKGROUND: Advanced airway management is composed of a set of vital yet potentially difficult skills for the prehospital provider, with widely different clinical guidelines. In the military setting, there are few data available to inform guideline development. We reevaluated our advanced airway protocol in light of our registry data to determine if there were a preferred maximum number of endotracheal intubation (ETI) attempts; our success with cricothyroidotomy (CRIC) as a backup procedure; and whether there were cases where advanced airway interventions should possibly be avoided. METHODS: This is a descriptive, registry-based study conducted using records of the Israel Defense Forces Trauma Registry at the research section of the Trauma and Combat Medicine Branch, Surgeon General's Headquarters. We included all casualties for whom ETI was the initial advanced airway maneuver, and the number of ETI attempts was known. Descriptive statistics were used. RESULTS: Of 5,553 casualties in the Israel Defense Forces Trauma Registry, 406 (7.3%) met the inclusion criteria. Successful ETI was performed in 317 casualties (78%) after any number of ETI attempts; an additional 46 (11%) underwent CRIC, and 43 (11%) had advanced airway efforts discontinued. ETI was successful in 45%, 36%, and 31% of the first, second, and third attempts, respectively, with an average of 28% success over all subsequent attempts. CRIC was successful in 43 (93%) of 46 casualties in whom it was attempted. Of the 43 casualties in whom advanced airway efforts were discontinued, 29 (67%) survived to hospital discharge. CONCLUSION: After the first ETI attempt, success with subsequent attempts tended to fall, with minimal improvement in overall ETI success seen after the third attempt. Because CRIC exhibited excellent success as a backup airway modality, we advocate controlling the airway with CRIC if ETI efforts have failed after two or three attempts. We recommend that providers reevaluate whether definitive airway control is truly necessary before each attempt to control the airway. Copyright (C) 2013 by Lippincott Williams & Wilkins	[Katzenell, Udi; Lipsky, Ari M.; Abramovich, Amir; Sergeev, Ilia; Deckel, Avishai; Kreiss, Yitshak; Glassberg, Elon] Israel Def Forces, Med Corps, Trauma & Combat Med Branch, IL-02149 Rehovot, Israel; [Huberman, David] Israel Def Forces, Med Corps, Med Informat Branch, IL-02149 Rehovot, Israel; [Katzenell, Udi] Kaplan Med Ctr, Dept Otolaryngol Head & Neck Surg, Rehovot, Israel	Glassberg, E (corresponding author), Israel Def Forces, Surg Gen Headquarters, Med Corps, Mil POB 02149, IL-02149 Rehovot, Israel.	idf_trauma@idf.gov.il					Adams BD, 2008, J TRAUMA, V64, P1548, DOI 10.1097/TA.0b013e3181728c41; [Anonymous], 1981, BAS TEXT, P23; Bennett BL, 2011, MIL MED, V176, P1311, DOI 10.7205/MILMED-D-11-00054; Bochicchio GV, 2003, J TRAUMA, V54, P307, DOI 10.1097/01.TA.0000046252.97590.BE; Butler FK, 2010, PHTLS PREHOSPITAL TR; Committee on Trauma American College of Surgeons, 2008, ATLAS ADV TRAUM LIF; Cudnik MT, 2007, PREHOSP EMERG CARE, V11, P224, DOI 10.1080/10903120701205208; Davis DP, 2011, PREHOSP EMERG CARE, V15, P184, DOI 10.3109/10903127.2010.545473; Davis DP, 2005, J TRAUMA, V58, P933, DOI 10.1097/01.TA.0000162731.53812.58; Hubble MW, 2010, PREHOSP EMERG CARE, V14, P377, DOI 10.3109/10903121003790173; Hussmann B, 2011, CRIT CARE, V15, DOI 10.1186/cc10442; Irvin CB, 2010, PREHOSP DISASTER MED, V25, P541, DOI 10.1017/S1049023X00008736; Kelly JF, 2008, J TRAUMA, V64, pS21, DOI 10.1097/TA.0b013e318160b9fb; King DR, 2012, AM J EMERG MED, V30, P1429, DOI 10.1016/j.ajem.2011.10.026; Mabry Robert L, 2012, J Spec Oper Med, V12, P17; Mabry RL, 2010, PREHOSP EMERG CARE, V14, P272, DOI 10.3109/10903120903537205; Macdonald JC, 2008, CAN MED ASSOC J, V178, P1133, DOI 10.1503/cmaj.080036; Mort TC, 2004, ANESTH ANALG, V99, P607, DOI 10.1213/01.ANE.0000122825.04923.15; Rocca B, 2000, Prehosp Emerg Care, V4, P164, DOI 10.1080/10903120090941443; Stockinger ZT, 2004, J TRAUMA, V56, P531, DOI 10.1097/01.TA.0000111755.94642.29; Walls RM, 2010, ROSENS EMERGENCY MED; Wang HE, 2006, ACAD EMERG MED, V13, P372, DOI 10.1197/j.aem.2005.11.001; Wang HE, 2011, RESUSCITATION, V82, P378, DOI 10.1016/j.resuscitation.2010.12.014; Warner KJ, 2009, J EMERG MED, V36, P257, DOI 10.1016/j.jemermed.2007.10.058	24	22	22	1	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	2163-0755	2163-0763		J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	AUG	2013	75			2			S178	S183		10.1097/TA.0b013e318299d650			6	Critical Care Medicine; Surgery	General & Internal Medicine; Surgery	300JV	WOS:000330461100016	23883905				2021-06-18	
J	Du, Q; Yang, DB; Shen, YF; Yu, WH; Zhang, ZY; Zhu, Q; Che, ZH; Liu, QJ; Wang, H; Dong, XQ				Du, Quan; Yang, Ding-Bo; Shen, Yong-Feng; Yu, Wen-Hua; Zhang, Zu-Yong; Zhu, Qiang; Che, Zhi-Hao; Liu, Qun-Jie; Wang, Hao; Dong, Xiao-Qiao			Plasma leptin level predicts hematoma growth and early neurological deterioration after acute intracerebral hemorrhage	PEPTIDES			English	Article						Leptin; Intracerebral hemorrhage; Hematoma growth; Early neurological deterioration; Biomarker	TRAUMATIC BRAIN-INJURY; CLINICAL-OUTCOMES; STROKE; INFLAMMATION	Higher plasma leptin levels have been associated with poor clinical outcomes after intracerebral hemorrhage. Nevertheless, their links with hematoma growth and early neurological deterioration are unknown. Therefore, we aimed to investigate the relationship between plasma leptin levels, hematoma growth, and early neurological deterioration in patients with acute intracerebral hemorrhage. We prospectively studied 102 consecutive patients with acute spontaneous basal ganglia hemorrhage presenting within 6 h from symptoms onset. Significant hematoma growth was defined as hematoma enlargement >33% at 24 h. Early neurological deterioration was defined as an increase of >= 4 points in National Institute of Health Stroke Scale score at 24 h from symptoms onset. We measured plasma leptin levels on admission using an enzyme-linked immunosorbent assay in a blinded fashion. In multivariate logistic regression analysis, plasma leptin level emerged as the independent predictor of hematoma growth (odds ratio, 1.182; 95% confidence interval, 1.061-2.598; P = 0.008) and early neurological deterioration (odds ratio, 1.193; 95% confidence interval, 1.075-2.873; P = 0.004). Using receiver operating characteristic curves, we calculated areas under the curve for hematoma growth (area under curve, 0.844; 95% confidence interval, 0.759-0.908) and early neurological deterioration (area under curve, 0.857; 95% confidence interval, 0.774-0.918). The predictive performance of leptin was similar to, but did not obviously improve that of hematoma volume. Thus, leptin may help in the prediction of hematoma growth and early neurological deterioration after intracerebral hemorrhage. (c) 2013 Elsevier Inc. All rights reserved.	[Du, Quan; Yang, Ding-Bo; Shen, Yong-Feng; Yu, Wen-Hua; Zhang, Zu-Yong; Zhu, Qiang; Che, Zhi-Hao; Liu, Qun-Jie; Wang, Hao; Dong, Xiao-Qiao] Nanjing Med Univ, Peoples Hosp Hangzhou 1, Dept Neurosurg, Hangzhou 310006, Zhejiang, Peoples R China	Dong, XQ (corresponding author), Nanjing Med Univ, Peoples Hosp Hangzhou 1, Dept Neurosurg, 261 Huansha Rd, Hangzhou 310006, Zhejiang, Peoples R China.	dxqhyy@163.com			Hangzhou Medical Research Fund Scheme A Class Project [2011A014]	This study was supported by a grant from Hangzhou Medical Research Fund Scheme A Class Project (No. 2011A014).	Brott T, 1997, STROKE, V28, P1, DOI 10.1161/01.STR.28.1.1; Brown R, 2008, NEUROSCI LETT, V432, P73, DOI 10.1016/j.neulet.2007.12.008; Carbone F, 2012, BIOCHIMIE, V94, P2082, DOI 10.1016/j.biochi.2012.05.018; Carlton ED, 2012, HORM BEHAV, V62, P272, DOI 10.1016/j.yhbeh.2012.04.010; Davis SM, 2006, NEUROLOGY, V66, P1175, DOI 10.1212/01.wnl.0000208408.98482.99; Delcourt C, 2012, NEUROLOGY, V79, P314, DOI 10.1212/WNL.0b013e318260cbba; DENNIS MS, 1993, STROKE, V24, P796, DOI 10.1161/01.STR.24.6.796; Dong XQ, 2010, WORLD NEUROSURG, V74, P286, DOI 10.1016/j.wneu.2010.02.019; Kim CK, 2013, J CEREBR BLOOD F MET, V33, P944, DOI 10.1038/jcbfm.2013.35; Kothari U, 1996, STROKE, V27, P1304, DOI 10.1161/01.STR.27.8.1304; La Cava Antonio, 2012, Inflammation & Allergy Drug Targets, V11, P298; Lin C, 2012, PEPTIDES, V35, P166, DOI 10.1016/j.peptides.2012.03.024; Otero M, 2006, RHEUMATOLOGY, V45, P944, DOI 10.1093/rheumatology/kel157; Paz G, 2012, ARQ BRAS ENDOCRINOL, V56, P597, DOI 10.1590/S0004-27302012000900001; Rajendran K, 2012, THROMB J, V10, DOI 10.1186/1477-9560-10-13; Soderberg S, 2003, CEREBROVASC DIS, V15, P63, DOI 10.1159/000067128; Soderberg S, 1999, STROKE, V30, P328, DOI 10.1161/01.STR.30.2.328; Valerio A, 2009, STROKE, V40, P610, DOI 10.1161/STROKEAHA.108.528588; Wang J, 2007, J CEREBR BLOOD F MET, V27, P894, DOI 10.1038/sj.jcbfm.9600403; Wang JA, 2010, PROG NEUROBIOL, V92, P463, DOI 10.1016/j.pneurobio.2010.08.001; Wei YZ, 2008, J PHARM PHARMACOL, V60, P1667, DOI 10.1211/jpp/60.12.0013; Zhang X, 2013, PEPTIDES, V43, P133, DOI 10.1016/j.peptides.2013.03.010; Zhao QJ, 2012, CLIN EXP HYPERTENS, V34, P161, DOI 10.3109/10641963.2011.561902	23	22	24	0	10	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0196-9781	1873-5169		PEPTIDES	Peptides	JUL	2013	45						35	39		10.1016/j.peptides.2013.04.017			5	Biochemistry & Molecular Biology; Endocrinology & Metabolism; Pharmacology & Pharmacy	Biochemistry & Molecular Biology; Endocrinology & Metabolism; Pharmacology & Pharmacy	170KW	WOS:000320850300006	23659863				2021-06-18	
J	Ferrario, CR; Ndukwe, BO; Ren, JH; Satin, LS; Goforth, PB				Ferrario, Carrie R.; Ndukwe, Blaise O.; Ren, Jianhua; Satin, Leslie S.; Goforth, Paulette B.			Stretch injury selectively enhances extrasynaptic, GluN2B-containing NMDA receptor function in cortical neurons	JOURNAL OF NEUROPHYSIOLOGY			English	Article						traumatic brain injury; NMDA receptors; GluN2B; cortical injury	D-ASPARTATE RECEPTORS; TRAUMATIC BRAIN-INJURY; LONG-TERM DEPRESSION; CA2+-PERMEABLE AMPA RECEPTORS; SUBUNIT COMPOSITION; SYNAPTIC PLASTICITY; MECHANICAL INJURY; DIFFERENTIAL ROLES; CREB SHUTOFF; IN-VITRO	Alterations in the function and expression of NMDA receptors are observed after in vivo and in vitro traumatic brain injury. We recently reported that mechanical stretch injury in cortical neurons transiently increases the contribution of NMDA receptors to network activity and results in an increase in calcium-permeable AMPA (CP-AMPA) receptor-mediated transmission 4 h postinjury (Goforth et al. 2011). Here, we evaluated changes in the function of synaptic vs. extrasynaptic GluN2B-containing NMDA receptors after injury. We also determined whether postinjury treatment with the GluN2B-selective antagonist Ro 25-6981 or memantine prevents injury-induced increases in CP-AMPA receptor activity. We found that injury increased extrasynaptic, GluN2B-containing NMDA receptor-mediated whole cell currents. In contrast, we found no differences in synaptic NMDA receptor-mediated transmission after injury. Furthermore, treatment with Ro 25-6981 or memantine after injury prevented injury-induced increases in CP-AMPA receptor-mediated activity. Together, our data suggest that increased NMDA receptor activity after injury is predominantly due to alterations in extrasynaptic, GluN2B-containing NMDA receptors and that activation of these receptors may contribute to the appearance of CP-AMPA receptors after injury.	[Ferrario, Carrie R.; Ndukwe, Blaise O.; Ren, Jianhua; Satin, Leslie S.; Goforth, Paulette B.] Univ Michigan, Dept Pharmacol, Ann Arbor, MI 48105 USA	Goforth, PB (corresponding author), Univ Michigan, Dept Pharmacol, Ann Arbor, MI 48105 USA.	pgoforth@umich.edu	Ferrario, Carrie/L-7372-2016	Ferrario, Carrie/0000-0002-9673-7028	National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [RO1-NS-49519, NS-069629]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS069629, R01NS049519] Funding Source: NIH RePORTER	Research was supported by National Institute of Neurological Disorders and Stroke Grants RO1-NS-49519 (to L. S. Satin) and NS-069629 (to C. R. Ferrario).	Atkins CM, 2009, NEUROSCI LETT, V459, P52, DOI 10.1016/j.neulet.2009.04.064; Bartlett TE, 2007, NEUROPHARMACOLOGY, V52, P60, DOI 10.1016/j.neuropharm.2006.07.013; Bell JD, 2009, CELL DEATH DIFFER, V16, P1665, DOI 10.1038/cdd.2009.106; Bengtson CP, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-11; Berberich S, 2005, J NEUROSCI, V25, P6907, DOI 10.1523/JNEUROSCI.1905-05.2005; Biegon A, 2004, P NATL ACAD SCI USA, V101, P5117, DOI 10.1073/pnas.0305741101; Cohen AS, 2007, PROG BRAIN RES, V161, P143, DOI 10.1016/S0079-6123(06)61010-8; Collingridge GL, 2009, NEUROPHARMACOLOGY, V56, P2, DOI 10.1016/j.neuropharm.2008.06.063; Conrad KL, 2008, NATURE, V454, P118, DOI 10.1038/nature06995; Cull-Candy S, 2006, CURR OPIN NEUROBIOL, V16, P288, DOI 10.1016/j.conb.2006.05.012; DeRidder MN, 2006, NEUROBIOL DIS, V22, P165, DOI 10.1016/j.nbd.2005.10.011; Ferrario CR, 2011, NEUROPHARMACOLOGY, V61, P1141, DOI 10.1016/j.neuropharm.2011.01.021; Fischer G, 1997, J PHARMACOL EXP THER, V283, P1285; Flint AC, 1997, J NEUROSCI, V17, P2469; Ge YA, 2010, P NATL ACAD SCI USA, V107, P16697, DOI 10.1073/pnas.1008200107; Goforth PB, 2011, J NEUROPHYSIOL, V105, P2350, DOI 10.1152/jn.00467.2010; Goforth PB, 1999, J NEUROSCI, V19, P7367, DOI 10.1523/JNEUROSCI.19-17-07367.1999; Groc L, 2009, NEUROSCIENCE, V158, P4, DOI 10.1016/j.neuroscience.2008.05.029; Hardingham GE, 2002, BBA-PROTEINS PROTEOM, V1600, P148, DOI 10.1016/S1570-9639(02)00455-7; Hardingham GE, 2002, NAT NEUROSCI, V5, P405, DOI 10.1038/nn835; Hardingham GE, 2003, TRENDS NEUROSCI, V26, P81, DOI 10.1016/S0166-2236(02)00040-1; Hardingham GE, 2009, BIOCHEM SOC T, V37, P1147, DOI 10.1042/BST0371147; Harris AZ, 2008, J NEUROPHYSIOL, V99, P524, DOI 10.1152/jn.01169.2007; HUETTNER JE, 1986, J NEUROSCI, V6, P3044; HUETTNER JE, 1988, P NATL ACAD SCI USA, V85, P1307, DOI 10.1073/pnas.85.4.1307; Ivanov A, 2006, J PHYSIOL-LONDON, V572, P789, DOI 10.1113/jphysiol.2006.105510; Kohr G, 2006, CELL TISSUE RES, V326, P439, DOI 10.1007/s00441-006-0273-6; Kumar A, 2002, J NEUROSCI RES, V67, P781, DOI 10.1002/jnr.10181; Lea PM, 2003, J NEUROTRAUM, V20, P1233, DOI 10.1089/089771503770802907; Leveille F, 2008, FASEB J, V22, P4258, DOI 10.1096/fj.08-107268; Li JH, 1998, EUR J NEUROSCI, V10, P1704, DOI 10.1046/j.1460-9568.1998.00169.x; Li YX, 1996, NEUROSCIENCE, V71, P397, DOI 10.1016/0306-4522(95)00483-1; Liu LD, 2004, SCIENCE, V304, P1021, DOI 10.1126/science.1096615; Liu SJ, 2007, TRENDS NEUROSCI, V30, P126, DOI 10.1016/j.tins.2007.01.006; Luo JH, 1997, MOL PHARMACOL, V51, P79; Man HY, 2011, CURR OPIN NEUROBIOL, V21, P291, DOI 10.1016/j.conb.2011.01.001; Martel MA, 2009, NEUROSCIENCE, V158, P334, DOI 10.1016/j.neuroscience.2008.01.080; Massey PV, 2004, J NEUROSCI, V24, P7821, DOI 10.1523/JNEUROSCI.1697-04.2004; McKinney JS, 1996, STROKE, V27, P934, DOI 10.1161/01.STR.27.5.934; MONYER H, 1994, NEURON, V12, P529, DOI 10.1016/0896-6273(94)90210-0; Morishita W, 2007, NEUROPHARMACOLOGY, V52, P71, DOI 10.1016/j.neuropharm.2006.07.005; Osteen CL, 2004, NEUROSCIENCE, V128, P305, DOI 10.1016/j.neuroscience.2004.06.034; Papouin T, 2012, CELL, V150, P633, DOI 10.1016/j.cell.2012.06.029; Park E, 2008, CAN MED ASSOC J, V178, P1163, DOI 10.1503/cmaj.080282; PorteraCailliau C, 1996, J NEUROCHEM, V66, P692, DOI 10.1046/j.1471-4159.1996.66020692.x; Prybylowski K, 2004, J BIOL CHEM, V279, P9673, DOI 10.1074/jbc.R300029200; Rumbaugh G, 1999, J NEUROSCI, V19, P10603; Schumann J, 2008, J NEUROTRAUM, V25, P945, DOI 10.1089/neu.2008.0521; SHENG M, 1994, NATURE, V368, P144, DOI 10.1038/368144a0; Spaethling J, 2012, NEUROBIOL DIS, V46, P646, DOI 10.1016/j.nbd.2012.03.003; Spaethling JM, 2008, J NEUROTRAUM, V25, P1207, DOI 10.1089/neu.2008.0532; Steigerwald F, 2000, J NEUROSCI, V20, P4573, DOI 10.1523/JNEUROSCI.20-12-04573.2000; Tavalin SJ, 1995, J NEUROPHYSIOL, V74, P2767; Turrigiano GG, 2008, CELL, V135, P422, DOI 10.1016/j.cell.2008.10.008; Wroge CM, 2012, J NEUROSCI, V32, P6732, DOI 10.1523/JNEUROSCI.6371-11.2012; Xia P, 2010, J NEUROSCI, V30, P11246, DOI 10.1523/JNEUROSCI.2488-10.2010; Zhang L, 1996, SCIENCE, V274, P1921, DOI 10.1126/science.274.5294.1921; Zhang SJ, 2007, NEURON, V53, P549, DOI 10.1016/j.neuron.2007.01.025	58	22	22	0	7	AMER PHYSIOLOGICAL SOC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0022-3077			J NEUROPHYSIOL	J. Neurophysiol.	JUL	2013	110	1					131	140		10.1152/jn.01011.2012			10	Neurosciences; Physiology	Neurosciences & Neurology; Physiology	174ZI	WOS:000321197400014	23576693	Green Published			2021-06-18	
J	Gubata, ME; Piccirillo, AL; Packnett, ER; Cowan, DN				Gubata, Marlene E.; Piccirillo, Amanda L.; Packnett, Elizabeth R.; Cowan, David N.			Military Occupation and Deployment: Descriptive Epidemiology of Active Duty U.S. Army Men Evaluated for a Disability Discharge	MILITARY MEDICINE			English	Article							POSTTRAUMATIC-STRESS-DISORDER; US ARMY; HEALTH PROBLEMS; IRAQ; AFGHANISTAN; WAR; PERSONNEL; VETERANS; INJURY; CARE	Objective: Physically demanding jobs and history of deployment put Soldiers at increased risk for injury, hospitalizations, and disability. Characterizing differences in disability outcomes by occupation and deployment history may identify specific military populations for targeted prevention and intervention programs as well as potential areas of future research. Methods: A cross-sectional analysis was conducted on U.S. Army enlisted men evaluated in the Department of Defense's Disability Evaluation System (DES) between fiscal years 2005 and 2011, comparing those assigned a Combat Arms military occupational specialty (MOS) to individuals with any other MOS (Other). Results: Among deployed Soldiers, those with Combat Arms MOS were substantially and significantly more likely to receive medical disability retirement than Other MOS and were more likely to be evaluated for conditions compatible with combat exposures, including post-traumatic stress disorder, residuals of traumatic brain injury, and paralysis. Among nondeployed Soldiers, Combat Arms MOS were only slightly more likely to receive medical disability than Other MOS, and no substantial differences in medical conditions were noted between the two MOS groups. Conclusions: Combat Arms MOS is a significant risk factor for disability retirement primarily among deployed men. Further research is needed to identify specific military occupations most at risk for disability retirement.	[Gubata, Marlene E.; Piccirillo, Amanda L.; Packnett, Elizabeth R.; Cowan, David N.] Walter Reed Army Inst Res, Div Prevent Med, Silver Spring, MD 20910 USA; [Piccirillo, Amanda L.; Packnett, Elizabeth R.; Cowan, David N.] Allied Technol Grp Inc, Rockville, MD 20850 USA	Gubata, ME (corresponding author), Walter Reed Army Inst Res, Div Prevent Med, 503 Robert Grant Ave, Silver Spring, MD 20910 USA.				Defense Health Board	This work was funded by the Defense Health Board.	Amoroso P J, 1999, Mil Med, V164, P1; *ARM FORC HLTH SUR, 2009, MSMR, V15, P14; *ARM MED SURV ACT, 2007, MED SURVEILL MON REP, V13, P15; Bell N, 2008, TALE 2 DISABILITY CO; Bell NS, 2011, J TRAUMA STRESS, V24, P34, DOI 10.1002/jts.20612; Bell NS, 2008, DISABIL HEALTH J, V1, P163, DOI 10.1016/j.dhjo.2008.05.002; Bell NS, 2008, DISABIL HEALTH J, V1, P14, DOI 10.1016/j.dhjo.2007.11.007; Berkowitz SM, 1999, MIL MED, V164, P412; Brundage JF, 2002, AM J IND MED, V41, P279, DOI 10.1002/ajim.10075; *DEP ARM, 1999, ARM PAMPHL 611 21 PE; Feuerstein M, 1997, J OCCUP ENVIRON MED, V39, P68, DOI 10.1097/00043764-199701000-00013; Friedman MJ, 2005, NEW ENGL J MED, V352, P1287, DOI 10.1056/NEJMp058028; Gubata ME, 2012, TRI SERVICE DISABILI; Hoge CW, 2007, AM J PSYCHIAT, V164, P150, DOI 10.1176/appi.ajp.164.1.150; Hoge CW, 2006, JAMA-J AM MED ASSOC, V295, P1023, DOI 10.1001/jama.295.9.1023; Hoge CW, 2004, NEW ENGL J MED, V351, P13, DOI 10.1056/NEJMoa040603; Hoge CW, 2005, AM J PSYCHIAT, V162, P585, DOI 10.1176/appi.ajp.162.3.585; Hollander IE, 2010, MIL MED, V175, P705, DOI 10.7205/MILMED-D-09-00214; Knapik JJ, 2012, PUBLIC HEALTH, V126, P498, DOI 10.1016/j.puhe.2012.01.031; Larson GE, 2008, AM J EPIDEMIOL, V167, P1269, DOI 10.1093/aje/kwn084; Niebuhr DW, 2011, MIL MED, V176, P170, DOI 10.7205/MILMED-D-10-00114; NIEBUHR DW, 2012, ANNUAL REPORT 2011; NIEBUHR DW, 2011, TRI SERVICE DISABILI; Packnett ER, 2012, J TRAUMA STRESS, V25, P485, DOI 10.1002/jts.21743; Songer TJ, 2000, AM J PREV MED, V18, P33, DOI 10.1016/S0749-3797(00)00107-0; Wilson J, 2009, AM J EPIDEMIOL, V169, P1362, DOI 10.1093/aje/kwp044	26	22	22	0	6	ASSOC MILITARY SURG US	BETHESDA	9320 OLD GEORGETOWN RD, BETHESDA, MD 20814 USA	0026-4075	1930-613X		MIL MED	Milit. Med.	JUL	2013	178	7					708	714		10.7205/MILMED-D-12-00542			7	Medicine, General & Internal	General & Internal Medicine	AN7UA	WOS:000340805300003	23820342	Bronze			2021-06-18	
J	Sela-Kaufman, M; Rassovsky, Y; Agranov, E; Levi, Y; Vakil, E				Sela-Kaufman, Michal; Rassovsky, Yuri; Agranov, Eugenia; Levi, Yifat; Vakil, Eli			Premorbid personality characteristics and attachment style moderate the effect of injury severity on occupational outcome in traumatic brain injury: Another aspect of reserve	JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY			English	Article						Traumatic brain injury; Brain reserve; Cognitive reserve; Functional outcome; Personality	BRIEF SYMPTOM INVENTORY; COGNITIVE RESERVE; RESILIENCE PROCESSES; FIT INDEXES; IMPACT; TBI; TEMPERAMENT; PREDICTORS; VALIDITY; BEHAVIOR	The concept of reserve has been proposed to account for the mismatch between brain pathology and its clinical expression. Prior efforts to characterize this concept focused mostly on brain or cognitive reserve measures. The present study was a preliminary attempt to evaluate premorbid personality and emotional aspects as potential moderators in moderate-to-severe traumatic brain injury. Using structural equation modeling and multiple regression analyses, we found that premorbid personality characteristics provided the most robust moderator of injury severity on occupational outcome. Findings offer preliminary support for premorbid personality features as another relevant reserve construct in predicting outcome in this population.	[Sela-Kaufman, Michal] Acad Coll Tel Aviv Yaffo, Dept Behav Sci, Tel Aviv, Israel; [Rassovsky, Yuri; Levi, Yifat; Vakil, Eli] Bar Ilan Univ, Dept Psychol, IL-52900 Ramat Gan, Israel; [Rassovsky, Yuri; Vakil, Eli] Bar Ilan Univ, Susan Gonda Multidisciplinary Brain Res Ctr, IL-52900 Ramat Gan, Israel; [Rassovsky, Yuri] Univ Calif Los Angeles, Semel Inst Neurosci & Human Behav, Dept Psychiat & Biobehav Sci, Los Angeles, CA 90024 USA; [Agranov, Eugenia] Chaim Sheba Med Ctr, Ramat Gan, Israel; [Agranov, Eugenia] Tel Aviv Univ, Fac Med, IL-69978 Tel Aviv, Israel	Rassovsky, Y (corresponding author), Bar Ilan Univ, Dept Psychol, IL-52900 Ramat Gan, Israel.	yurir@biu.ac.il		Rassovsky, Yuri/0000-0002-6362-9944			Aiken L.S., 1991, MULTIPLE REGRESSION; Ainsworth M. D. S., 1978, PATTERNS ATTACHMENT; BENTLER PM, 1990, PSYCHOL BULL, V107, P238, DOI 10.1037/0033-2909.107.2.238; BENTLER PM, 1996, EQS STRUCTURAL EQUAT; Bigler E. D., 2007, COGNITIVE RESERVE TH, P85; Bowlby J., 1973, ATTACHMENT LOSS SEPA; Bowlby J., 1969, ATTACHMENT LOSS ATTA; Brickman AM, 2011, NEUROBIOL AGING, V32, P1588, DOI 10.1016/j.neurobiolaging.2009.10.013; Buss Arnold H., 1984, TEMPERAMENT EARLY DE; Campbell-Sills L, 2006, BEHAV RES THER, V44, P585, DOI 10.1016/j.brat.2005.05.001; CICERONE KD, 2000, TRAUMATIC BRAIN INJU, P95; Costa PT, 1992, NEO PI R PROFESSIONA; Costa PT, 1992, PSYCHOLASSESS, V4, P5, DOI [10.1037/1040-3590.4.1.5, DOI 10.1037/1040-3590.4.1.5, DOI 10.1037//1040-3590.4.1.5]; Davey M, 2003, J ADOLESCENT RES, V18, P347, DOI 10.1177/0743558403018004002; DEROGATIS LR, 1983, PSYCHOL MED, V13, P595, DOI 10.1017/S0033291700048017; DEROGATIS LR, 1983, SYMPTOM CHECKLIST 90; Dikmen S S, 1995, J Int Neuropsychol Soc, V1, P67; Eisenberg, 1987, NEUROBEHAVIORAL RECO, P215; Faul M.D., 2010, TRAUMATIC BRAIN INJU; Friborg O, 2005, INT J METH PSYCH RES, V14, P29, DOI 10.1002/mpr.15; Gilbar O, 2002, INT J STRESS MANAGE, V9, P1, DOI 10.1023/A:1013097816238; Handel SF, 2007, PSYCHOSOMATICS, V48, P67, DOI 10.1176/appi.psy.48.1.67; Holmbeck GN, 1997, J CONSULT CLIN PSYCH, V65, P599, DOI 10.1037/0022-006X.65.4.599; Hoofien D, 2002, BRAIN INJURY, V16, P9, DOI 10.1080/02699050110088227; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Jamshidian M, 1999, J EDUC BEHAV STAT, V24, P21, DOI 10.2307/1165260; KATZMAN R, 1989, ANN NEUROL, V25, P317, DOI 10.1002/ana.410250402; KURTZKE JF, 1984, ANN NEUROL, V16, P265, DOI 10.1002/ana.410160302; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Levi Y., 2013, J INT NEUROPSYCH SOC, V19, P1; LEVIN HS, 1990, J NEUROSURG, V73, P699, DOI 10.3171/jns.1990.73.5.0699; Little TD, 2006, STRUCT EQU MODELING, V13, P59, DOI 10.1207/s15328007sem1301_3; Macmillan PJ, 2002, BRAIN INJURY, V16, P41, DOI 10.1080/0269905011008812; Magai C, 1997, INT J GERIATR PSYCH, V12, P1092; Malec JF, 2004, REHABIL PSYCHOL, V49, P55, DOI 10.1037/0090-5550.49.1.55; Mathiesen KS, 2006, EUR J DEV PSYCHOL, V3, P357, DOI 10.1080/17405620600557797; Mathiesen KS, 2000, J ABNORM CHILD PSYCH, V28, P15, DOI 10.1023/A:1005165916906; McCauley SR, 2013, J NEUROTRAUM, V30, P642, DOI 10.1089/neu.2012.2393; MIKULINCER M, 1995, PERS SOC PSYCHOL B, V21, P406, DOI 10.1177/0146167295214011; MIKULINCER M, 1990, J PERS SOC PSYCHOL, V58, P273, DOI 10.1037/0022-3514.58.2.273; Mikulincer M, 1998, J PERS SOC PSYCHOL, V75, P420, DOI 10.1037/0022-3514.75.2.420; Mikulincer M, 1999, PERS INDIV DIFFER, V27, P831, DOI 10.1016/S0191-8869(99)00032-X; Mikulincer M., 2000, J PERS SOC PSYCHOL, V79, P240; Nelson LD, 1998, ARCH CLIN NEUROPSYCH, V13, P549, DOI 10.1016/S0887-6177(97)00052-8; Novack TA, 2001, ARCH PHYS MED REHAB, V82, P300, DOI 10.1053/apmr.2001.18222; Ping RA, 1996, PSYCHOL BULL, V119, P166, DOI 10.1037/0033-2909.119.1.166; PRIGATANO GP, 1992, J CONSULT CLIN PSYCH, V60, P360, DOI 10.1037/0022-006X.60.3.360; Prigatano GP., 1999, PRINCIPLES NEUROPSYC; Rassovsky Y, 2006, J CLIN EXP NEUROPSYC, V28, P581, DOI 10.1080/13803390500434474; Rassovsky Y, 2006, J CLIN EXP NEUROPSYC, V28, P567, DOI 10.1080/13803390500434466; Riolli L, 2002, J APPL SOC PSYCHOL, V32, P1604, DOI 10.1111/j.1559-1816.2002.tb02765.x; Roe A., 1956, PSYCHOL OCCUPATIONS; Ropacki MT, 2003, ARCH CLIN NEUROPSYCH, V18, P643, DOI 10.1016/S0887-6177(02)00153-1; Rothbart M. K., 1981, ADV DEVELOPMENTAL PS, V1, P37; Rush BK, 2006, REHABIL PSYCHOL, V51, P257, DOI 10.1037/0090-5550.51.3.257; Salmond CH, 2006, J NEUROTRAUM, V23, P1049, DOI 10.1089/neu.2006.23.1049; Satz P., 1993, NEUROPSYCHOLOGY, V7, P273, DOI DOI 10.1037/0894-4105.7.3.273; Satz P, 2011, J CLIN EXP NEUROPSYC, V33, P121, DOI 10.1080/13803395.2010.493151; Schretlen DJ, 2000, REHABIL PSYCHOL, V45, P260, DOI 10.1037/0090-5550.45.3.260; Solomon Z, 1998, EUR J PERSONALITY, V12, P271, DOI 10.1002/(SICI)1099-0984(199807/08)12:4<271::AID-PER309>3.0.CO;2-U; Stern Y, 2002, J INT NEUROPSYCH SOC, V8, P448, DOI 10.1017/S1355617702813248; Stern Y, 2006, ALZ DIS ASSOC DIS, V20, P112, DOI 10.1097/01.wad.0000213815.20177.19; Sumowski JF, 2009, J INT NEUROPSYCH SOC, V15, P606, DOI 10.1017/S1355617709090912; Svanberg OG., 1998, J MENTAL HLTH, V7, P543, DOI DOI 10.1080/09638239817716; Tate RL, 2003, NEUROPSYCHOL REHABIL, V13, P43, DOI 10.1080/09602010244000372; Tate RL, 1999, PSYCHOL MED, V29, P713, DOI 10.1017/S0033291799008466; TEASDALE G, 1974, LANCET, V2, P81; Temkin NR, 2009, J HEAD TRAUMA REHAB, V24, P460, DOI 10.1097/HTR.0b013e3181c13413; Ullman J. B., 2001, USING MULTIVARIATE S, V4th, P653; Vakil E, 2005, J CLIN EXP NEUROPSYC, V27, P977, DOI 10.1080/13803390490919245; Whittle S, 2006, NEUROSCI BIOBEHAV R, V30, P511, DOI 10.1016/j.neubiorev.2005.09.003; Williamson D. J. G., 1996, NEUROPSYCHOLOGY CLIN, P9, DOI [10.1037/10198-001, DOI 10.1037/10198-001]; ZILLMER E. A., 2008, PRINCIPLES NEUROPSYC	73	22	22	0	17	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1380-3395	1744-411X		J CLIN EXP NEUROPSYC	J. Clin. Exp. Neuropsychol.	JUL 1	2013	35	6					584	595		10.1080/13803395.2013.799123			12	Psychology, Clinical; Clinical Neurology; Psychology	Psychology; Neurosciences & Neurology	238BH	WOS:000325914900003	23701271				2021-06-18	
J	Hayakawa, M; Gando, S; Ieko, M; Honma, Y; Homma, T; Yanagida, Y; Kubota, N; Uegaki, S; Sawamura, A; Asakura, H				Hayakawa, Mineji; Gando, Satoshi; Ieko, Masahiro; Honma, Yoshinori; Homma, Taeko; Yanagida, Yuichiro; Kubota, Nobuhiko; Uegaki, Shinji; Sawamura, Atsushi; Asakura, Hidesaku			MASSIVE AMOUNTS OF TISSUE FACTOR INDUCE FIBRINOGENOLYSIS WITHOUT TISSUE HYPOPERFUSION IN RATS	SHOCK			English	Article						Fibrin fibrinogen degradation products; fibrinolysin; fibrinolysis; multiple trauma; thromboplastin	TRAUMATIC BRAIN-INJURY; ACUTE COAGULOPATHY; MOLECULAR-MECHANISMS; HEAD-INJURY; PROTEIN-C; COAGULATION; MODELS; FIBRINOLYSIS; PATHOPHYSIOLOGY; DISORDERS	Trauma-induced tissue factor (TF) release into the systemic circulation is considered to play an important role in the development of disseminated intravascular coagulation (DIC) immediately after severe trauma. However, the relationship between TF and hyperfibrinolysis, especially fibrinogenolysis, has been unclear. A total of 18 rats were divided into three groups: (a) the control group was infused with normal saline; (b) the low-dose group was infused with 4 U/kg TF; and (c) the high-dose group was infused with 16 U/kg TF. Arterial blood was drawn immediately and 2 and 4 h after the start of TF infusion. At each sampling point, arterial blood gases, platelet counts, and coagulation variables were measured. The fibrinogen degradation products were evaluated by a Western blot analysis. Hypotension, hypoxemia, and lactic acidosis were not observed in any of the three groups. In proportion to the doses of TF, the platelet counts, coagulation, and fibrinolysis variables deteriorated in line with DIC. The alpha 2-plasmin inhibitor levels significantly decreased in the high-dose group compared with the other groups. The amounts of fibrinogen degradation products increased in proportion to the doses of TF. The plasmin-alpha 2-plasmin inhibitor complex level in the high-dose group increased more than that of the other groups. In conclusion, TF can induce DIC associated with fibrinolysis and fibrinogenolysis without tissue hypoperfusion. The decrease in the alpha 2-plasmin inhibitor level and the significant increase in the plasmin level may be the two main factors underlying the pathogenesis of hyperfibrin(ogen)olysis after TF administration.	[Hayakawa, Mineji; Gando, Satoshi; Honma, Yoshinori; Homma, Taeko; Yanagida, Yuichiro; Kubota, Nobuhiko; Uegaki, Shinji; Sawamura, Atsushi] Hokkaido Univ, Grad Sch Med, Dept Anesthesiol & Crit Care Med, Div Acute & Crit Care Med, Sapporo, Hokkaido, Japan; [Ieko, Masahiro] Hlth Sci Univ Hokkaido, Sch Dent, Dept Internal Med, Sapporo, Hokkaido, Japan; [Asakura, Hidesaku] Kanazawa Univ, Sch Med, Dept Internal Med 3, Kanazawa, Ishikawa 920, Japan	Hayakawa, M (corresponding author), Hokkaido Univ Hosp, Emergency & Crit Care Ctr, Kita Ku, N14W5, Sapporo, Hokkaido 0608648, Japan.	mineji@dream.com	Gando, Satoshi/T-7407-2019	Gando, Satoshi/0000-0002-3525-0750	Japan Society for the Promotion of ScienceMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science [23792068]; Grants-in-Aid for Scientific ResearchMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI) [25462818] Funding Source: KAKEN	Financial support was received from Grant-in-Aid for Young Scientists (B) (no. 23792068) from the Japan Society for the Promotion of Science.	Asakura H, 2003, BLOOD COAGUL FIBRIN, V14, P221, DOI 10.1097/01.mbc.0000061290.28953.57; Asakura H, 2002, CRIT CARE MED, V30, P161, DOI 10.1097/00003246-200201000-00023; Brohi K, 2008, J TRAUMA, V64, P1211, DOI 10.1097/TA.0b013e318169cd3c; Brohi K, 2007, ANN SURG, V245, P812, DOI 10.1097/01.sla.0000256862.79374.31; Chandler WL, 2010, AM J CLIN PATHOL, V134, P90, DOI 10.1309/AJCP3WPOYSKK6BFE; Cohen MJ, 2012, ANN SURG, V255, P379, DOI 10.1097/SLA.0b013e318235d9e6; DRAKE TA, 1989, AM J PATHOL, V134, P1087; Dunbar NM, 2009, TRANSFUSION, V49, P2652, DOI 10.1111/j.1537-2995.2009.02335.x; Frith D, 2012, THROMB RES, V129, P551, DOI 10.1016/j.thromres.2011.11.053; Gando S, 1999, J TRAUMA, V46, P1070, DOI 10.1097/00005373-199906000-00018; GANDO S, 1992, CRIT CARE MED, V20, P594, DOI 10.1097/00003246-199205000-00009; Gando S, 2011, ANN SURG, V254, P10, DOI 10.1097/SLA.0b013e31821221b1; Gando S, 2009, J TRAUMA, V67, P381, DOI 10.1097/TA.0b013e3181a84f63; Hardy JF, 2005, VOX SANG, V89, P123, DOI 10.1111/j.1423-0410.2005.00678.x; Harhangi BS, 2008, ACTA NEUROCHIR, V150, P165, DOI 10.1007/s00701-007-1475-8; Hess JR, 2008, J TRAUMA, V65, P748, DOI 10.1097/TA.0b013e3181877a9c; Kashuk JL, 2010, ANN SURG, V252, P434, DOI 10.1097/SLA.0b013e3181f09191; KOOISTRA T, 1994, INT J HEMATOL, V59, P233; Kushimoto S, 2003, J NEUROTRAUM, V20, P357, DOI 10.1089/089771503765172318; Lustenberger T, 2010, J TRAUMA, V69, P1410, DOI 10.1097/TA.0b013e3181cdae81; Medved L, 2003, THROMB HAEMOSTASIS, V89, P409; Parr MJ, 2008, J TRAUMA, V65, P766, DOI 10.1097/TA.0b013e31818606d2; Rijken DC, 2009, J THROMB HAEMOST, V7, P4, DOI 10.1111/j.1538-7836.2008.03220.x; RISBERG B, 1986, CRIT CARE MED, V14, P917, DOI 10.1097/00003246-198611000-00001; Sawamura A, 2009, THROMB RES, V124, P608, DOI 10.1016/j.thromres.2009.06.034; Tsurupa G, 2001, BIOCHEMISTRY-US, V40, P801, DOI 10.1021/bi001789t; Wada H, 2010, THROMB RES, V125, P6, DOI 10.1016/j.thromres.2009.08.017; WEITZ JI, 1991, J CLIN INVEST, V87, P1082, DOI 10.1172/JCI115069	28	22	22	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	1073-2322			SHOCK	Shock	JUN	2013	39	6					514	519		10.1097/SHK.0b013e318293980d			6	Critical Care Medicine; Hematology; Surgery; Peripheral Vascular Disease	General & Internal Medicine; Hematology; Surgery; Cardiovascular System & Cardiology	147WL	WOS:000319200700008	23542400				2021-06-18	
J	Picetti, E; Antonini, MV; Lucchetti, MC; Pucciarelli, S; Valente, A; Rossi, I; Schiavi, P; Servadei, F; Caspani, ML; Mergoni, M				Picetti, Edoardo; Antonini, Marta Velia; Lucchetti, Maria Chiara; Pucciarelli, Serena; Valente, Adriana; Rossi, Ilaria; Schiavi, Paolo; Servadei, Franco; Caspani, Maria Luisa; Mergoni, Mario			Intra-hospital Transport of Brain-Injured Patients: A Prospective, Observational Study	NEUROCRITICAL CARE			English	Article						Intra-hospital transport; Traumatic brain injury; Intensive care; Neurocritical care; Complications; Monitoring	CRITICALLY-ILL PATIENTS; SECONDARY INSULTS; STROKE COUNCIL; CARE; COMPLICATIONS; GUIDELINES; MANAGEMENT; HEMORRHAGE; EVENTS; SAFETY	Discrepant data exist regarding the incidence and severity of clinical problems related to intra-hospital transport of brain-injured patients and no consensus exists whether modern-day intra-hospital transport represents a safe or potentially problematic environment for neurointensive care unit (NICU) patients. We examined the incidence of clinical complications and physiological derangements that occurred in 160 neurologically injured patients (90 males, 70 females, mean age 57 +/- A 17 years) who underwent intra-hospital transport (288 cases, 237 scheduled, 51 unscheduled) for computed tomography scans. Our findings indicate that (1) at least one significant complication (predominantly hemodynamic) occurred in over one-third (36 %) of all transports (p = n.s scheduled vs. unscheduled) necessitating the deployment of interventions designed to treat changes in arterial pressure (2) despite the presence of trained medical personnel and availability of specialized equipment, intra-cranial pressure was not adequately monitored during transports (especially in patients with intra-cranial hypertension prior to transport) (3) intra-hospital transfer was associated with minor but statistically significant clinical changes, including a reduction in arterial partial pressure of oxygen ()/inspired oxygen fraction () (only in the scheduled transport population), decreased arterial lactate levels (scheduled transport population), lowered body temperature (scheduled transport population), and increased arterial partial pressure of carbon dioxide () (scheduled transport population). Intra-hospital transport of brain-injured NICU patients may present some hazards even if performed by skilled personnel with specialized equipment. In Trauma Centers such as ours, an improvement in the frequency of neuromonitoring [intra-cranial pressure (ICP) and end-tidal CO2 ()] during transport is recommended.	[Picetti, Edoardo; Antonini, Marta Velia; Rossi, Ilaria; Caspani, Maria Luisa; Mergoni, Mario] Azienda Osped Univ Parma, Serv Anestesia & Rianimaz 1, I-43100 Parma, Italy; [Lucchetti, Maria Chiara; Pucciarelli, Serena; Valente, Adriana] Univ Parma, Scuola Specializzaz Anestesia & Rianimaz, I-43100 Parma, Italy; [Schiavi, Paolo; Servadei, Franco] Azienda Osped Univ Parma, Serv Anestesia & Rianimaz 1, I-43100 Parma, Italy	Picetti, E (corresponding author), Azienda Osped Univ Parma, Serv Anestesia & Rianimaz 1, Via Gramsci 14, I-43100 Parma, Italy.	edoardopicetti@hotmail.com		Servadei, Franco/0000-0002-3595-3464			Adams HP, 2007, STROKE, V38, P1655, DOI 10.1161/STROKEAHA.107.181486; ANDREWS PJD, 1990, LANCET, V335, P327, DOI 10.1016/0140-6736(90)90614-B; Beckmann U, 2004, INTENS CARE MED, V30, P1579, DOI 10.1007/s00134-004-2177-9; Bederson JB, 2009, STROKE, V40, P994, DOI 10.1161/STROKEAHA.108.191395; Bekar A, 1998, NEUROSURG REV, V21, P98, DOI 10.1007/BF02389312; BRAMAN SS, 1987, ANN INTERN MED, V107, P469, DOI 10.7326/0003-4819-107-4-469; Broderick J, 2007, STROKE, V38, P2001, DOI 10.1161/STROKEAHA.107.183689; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Crommett John W, 2002, Respir Care Clin N Am, V8, P105, DOI 10.1016/S1078-5337(02)00019-9; Damm C, 2005, ANN FR ANESTH, V24, P24, DOI 10.1016/j.annfar.2004.10.026; Ferdinande P, 1999, INTENS CARE MED, V25, P1441, DOI 10.1007/s001340051096; Gillman L, 2006, EMERG MED J, V23, P858, DOI 10.1136/emj.2006.037697; Gunnarsson T, 2000, J NEUROSURG, V93, P432, DOI 10.3171/jns.2000.93.3.0432; Haupt MT, 2000, CRIT CARE CLIN, V16, P1, DOI 10.1016/S0749-0704(05)70094-4; HURST JM, 1992, J TRAUMA, V33, P582, DOI 10.1097/00005373-199210000-00015; INSEL J, 1986, CRIT CARE MED, V14, P539, DOI 10.1097/00003246-198606000-00004; JONES PA, 1994, J NEUROSURG ANESTH, V6, P4; Lahner D, 2007, WIEN KLIN WOCHENSCHR, V119, P412, DOI 10.1007/s00508-007-0813-4; Marshall LF, 2000, NEUROSURGERY, V47, P546, DOI 10.1097/00006123-200009000-00002; Morgenstern LB, 2010, STROKE, V41, P2108, DOI 10.1161/STR.0b013e3181ec611b; Papson JPN, 2007, ACAD EMERG MED, V14, P574, DOI 10.1197/j.aem.2007.02.034; Shirley PJ, 2004, INTENS CARE MED, V30, P1508, DOI 10.1007/s00134-004-2293-6; SMITH I, 1990, CRIT CARE MED, V18, P278, DOI 10.1097/00003246-199003000-00006; Stocchetti N, 1993, J NEUROTRAUMA S, V10, P187; Swanson EW, 2010, NEUROSURGERY, V66, P925, DOI 10.1227/01.NEU.0000368543.59446.A4; SZEM JW, 1995, CRIT CARE MED, V23, P1660, DOI 10.1097/00003246-199510000-00009; Teasdale GM, 1998, NEUROSURGERY, V43, P723, DOI 10.1097/00006123-199810000-00001; WALLEN E, 1995, CRIT CARE MED, V23, P1588, DOI 10.1097/00003246-199509000-00020; Warren J, 2004, CRIT CARE MED, V32, P256, DOI 10.1097/01.CCM.0000104917.39204.0A; Waydhas C, 1999, CRIT CARE, V3, pR83, DOI 10.1186/cc362; WAYDHAS C, 1995, INTENS CARE MED, V21, P784, DOI 10.1007/BF01700959; YOSHIHARA M, 1995, J NEUROSURG, V82, P386, DOI 10.3171/jns.1995.82.3.0386	33	22	24	0	3	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care	JUN	2013	18	3					298	304		10.1007/s12028-012-9802-1			7	Critical Care Medicine; Clinical Neurology	General & Internal Medicine; Neurosciences & Neurology	147II	WOS:000319159600003	23208448				2021-06-18	
J	Bouzat, P; Millet, A; Boue, Y; Pernet-Gallay, K; Trouve-Buisson, T; Gaide-Chevronnay, L; Barbier, EL; Payen, JF				Bouzat, Pierre; Millet, Anne; Boue, Yvonnick; Pernet-Gallay, Karin; Trouve-Buisson, Thibaut; Gaide-Chevronnay, Lucie; Barbier, Emmanuel L.; Payen, Jean-Francois			Changes in Brain Tissue Oxygenation After Treatment of Diffuse Traumatic Brain Injury by Erythropoietin	CRITICAL CARE MEDICINE			English	Article						BOLD; brain edema; brain oxygenation; erythropoietin; MR diffusion-weighted imaging; MRI; traumatic brain injury	CEREBRAL PERFUSION; BLOOD-VOLUME; VESSEL SIZE; HEAD-INJURY; EDEMA; METABOLISM; PRESSURE; MANNITOL; PENUMBRA; HYPOXIA	Objectives: To investigate the effects of recombinant human erythropoietin on brain oxygenation in a model of diffuse traumatic brain injury. Design: Adult male Wistar rats. Setting: Neurosciences and physiology laboratories. Interventions: Thirty minutes after diffuse traumatic brain injury (impact-acceleration model), rats were intravenously administered with either a saline solution or a recombinant human erythropoietin (5000 IU/kg). A third group received no traumatic brain injury insult (sham-operated). Measurements and Main Results: Three series of experiments were conducted 2 hours after traumatic brain injury to investigate: 1) the effect of recombinant human erythropoietin on brain edema using diffusion-weighted magnetic resonance imaging and measurements of apparent diffusion coefficient (n = 11 rats per group); local brain oxygen saturation, mean transit time, and blood volume fraction were subsequently measured using a multiparametric magnetic resonance-based approach to estimate brain oxygenation and brain perfusion in the neocortex and caudoputamen; 2) the effect of recombinant human erythropoietin on brain tissue PO2 in similar experiments (n = 5 rats per group); and 3) the cortical ultrastructural changes after treatment (n = 1 rat per group). Compared with the sham-operated group, traumatic brain injury saline rats showed a significant decrease in local brain oxygen saturation and in brain tissue PO2 alongside brain edema formation and microvascular lumen collapse at H2. Treatment with recombinant human erythropoietin reversed all of these traumatic brain injury-induced changes. Brain perfusion (mean transit time and blood volume fraction) was comparable between the three groups of animals. Conclusion: Our findings indicate that brain hypoxia can be related to microcirculatory derangements and cell edema without evidence of brain ischemia. These changes were reversed with post-traumatic administration of recombinant human erythropoietin, thus offering new perspectives in the use of this drug in brain injury. (Crit Care Med 2013; 41:1316-1324)	[Bouzat, Pierre; Millet, Anne; Boue, Yvonnick; Pernet-Gallay, Karin; Trouve-Buisson, Thibaut; Gaide-Chevronnay, Lucie; Barbier, Emmanuel L.; Payen, Jean-Francois] INSERM, U836, Grenoble, France; [Bouzat, Pierre; Millet, Anne; Boue, Yvonnick; Pernet-Gallay, Karin; Trouve-Buisson, Thibaut; Gaide-Chevronnay, Lucie; Barbier, Emmanuel L.; Payen, Jean-Francois] Univ Grenoble 1, Grenoble Inst Neurosci, Grenoble, France; [Bouzat, Pierre; Boue, Yvonnick; Trouve-Buisson, Thibaut; Gaide-Chevronnay, Lucie; Payen, Jean-Francois] Hop Michallon, Pole Anesthesie Reanimat, Grenoble, France; [Millet, Anne] Hop Couple Enfant, Dept Reanimat Pediat, Grenoble, France	Payen, JF (corresponding author), INSERM, U836, Grenoble, France.	jfpayen@ujf-grenoble.fr	Payen, Jean-Francois/L-6667-2014; Bouzat, Pierre/L-6881-2014; Barbier, Emmanuel/E-6302-2011; Bouzat, Pierre/AAC-4105-2019	Barbier, Emmanuel/0000-0002-4952-1240; Bouzat, Pierre/0000-0003-4667-6738	Institut National de la Sante et de la Recherche Medicale (INSERM), FranceInstitut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS), FranceCentre National de la Recherche Scientifique (CNRS); Fondation des Gueules-Cassees, France; Association pour la Recherche en Neonatologie, France; Ministere de l'Education, de la Recherche et de la Technologie, France; Hutchinson Tech.; NovonordiskNovo Nordisk	Supported, in part, by grants from Institut National de la Sante et de la Recherche Medicale (INSERM), Centre National de la Recherche Scientifique (CNRS), Fondation des Gueules-Cassees, Association pour la Recherche en Neonatologie, and Ministere de l'Education, de la Recherche et de la Technologie, France.; Dr. Payen consulted for Biocodex, S.A., Baxter; has received grant support from Hutchinson Tech., Novonordisk; and received payment for lectures from Abbott, LFB, GE Healthcare, and Integra Lifescience. The remaining authors have not disclosed any potential conflicts of interest.	Abate MG, 2008, NEUROCRIT CARE, V9, P319, DOI 10.1007/s12028-008-9119-2; An HY, 2009, STROKE, V40, P2165, DOI 10.1161/STROKEAHA.108.540864; Barbier EL, 2001, J MAGN RESON IMAGING, V13, P496, DOI 10.1002/jmri.1073; Bouzat P, 2011, CRIT CARE MED, V39, P2099, DOI 10.1097/CCM.0b013e31821cb7b2; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS59, DOI 10.1089/neu.2007.9990; BULLOCK R, 1991, J NEUROL NEUROSUR PS, V54, P427, DOI 10.1136/jnnp.54.5.427; Chang JJJ, 2009, CRIT CARE MED, V37, P283, DOI 10.1097/CCM.0b013e318192fbd7; Cherian L, 2007, J PHARMACOL EXP THER, V322, P789, DOI 10.1124/jpet.107.119628; Christen T, 2012, MAGN RESON MED, V67, P1458, DOI 10.1002/mrm.23094; Christen T, 2012, RADIOLOGY, V262, P495, DOI 10.1148/radiol.11110518; Christen T, 2011, NMR BIOMED, V24, P393, DOI 10.1002/nbm.1603; DIETRICH WD, 1994, J NEUROTRAUM, V11, P289, DOI 10.1089/neu.1994.11.289; Diringer MN, 2011, NEUROCRIT CARE, V14, P11, DOI 10.1007/s12028-010-9465-8; Francony G, 2008, CRIT CARE MED, V36, P795, DOI 10.1097/CCM.0B013E3181643B41; Gunnarson E, 2009, P NATL ACAD SCI USA, V106, P1602, DOI 10.1073/pnas.0812708106; He X, 2007, MAGN RESON MED, V57, P115, DOI 10.1002/mrm.21108; Jespersen SN, 2012, J CEREBR BLOOD F MET, V32, P264, DOI 10.1038/jcbfm.2011.153; Johnston AJ, 2005, CRIT CARE MED, V33, P189, DOI 10.1097/01.CCM.0000149837.09225.BD; Kilic E, 2005, FASEB J, V19, P2026, DOI 10.1096/fj.05-3941fje; Kroppenstedt SN, 2003, CRIT CARE MED, V31, P2211, DOI 10.1097/01.CCM.0000080482.06856.62; Lemasson B, 2011, NMR BIOMED, V24, P473, DOI 10.1002/nbm.1611; Lifshitz J, 2004, MITOCHONDRION, V4, P705, DOI 10.1016/j.mito.2004.07.021; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Masamoto K, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3184694; Menon DK, 2004, CRIT CARE MED, V32, P1384, DOI 10.1097/01.CCM.0000127777.16609.08; Menon DK, 2003, ANESTHESIOLOGY, V98, P805, DOI 10.1097/00000542-200304000-00002; Moriyama M, 2010, J NEUROSCI RES, V88, P2450, DOI 10.1002/jnr.22400; Narotam PK, 2009, J NEUROSURG, V111, P672, DOI 10.3171/2009.4.JNS081150; Oddo M, 2011, NEUROSURGERY, V69, P1037, DOI 10.1227/NEU.0b013e3182287ca7; Ponce Lucido L, 2013, Pathophysiology, V20, P31, DOI 10.1016/j.pathophys.2012.02.005; Rao KVR, 2010, GLIA, V58, P1490, DOI 10.1002/glia.21023; Robertson CS, 2013, J NEUROTRAUM, V30, P765, DOI 10.1089/neu.2012.2431; Rodriguez-Baeza A, 2003, ANAT REC PART A, V273A, P583, DOI 10.1002/ar.a.10069; Rosenthal G, 2008, CRIT CARE MED, V36, P1917, DOI 10.1097/CCM.0b013e3181743d77; Sakowitz OW, 2007, J TRAUMA, V62, P292, DOI 10.1097/01.ta.0000203560.03937.2d; Schwarzmaier SM, 2010, J NEUROTRAUM, V27, P121, DOI 10.1089/neu.2009.1114; Shimosegawa E, 2005, ANN NEUROL, V57, P495, DOI 10.1002/ana.20427; Spees WM, 2001, MAGN RESON MED, V45, P533, DOI 10.1002/mrm.1072; Stiefel MF, 2005, J NEUROSURG, V103, P805, DOI 10.3171/jns.2005.103.5.0805; Tropres I, 2001, MAGN RESON MED, V45, P397, DOI 10.1002/1522-2594(200103)45:3<397::AID-MRM1052>3.0.CO;2-3; Valable S, 2010, J CEREBR BLOOD F MET, V30, P361, DOI 10.1038/jcbfm.2009.222; Valable S, 2008, NMR BIOMED, V21, P1043, DOI 10.1002/nbm.1278; Vaz R, 1997, ACTA NEUROCHIR, V139, P215, DOI 10.1007/BF01844754; Velly L, 2010, PHARMACOL THERAPEUT, V128, P445, DOI 10.1016/j.pharmthera.2010.08.002; Verdonck O, 2007, J CEREBR BLOOD F MET, V27, P1369, DOI 10.1038/sj.jcbfm.9600443; Xiong Y, 2010, J NEUROTRAUM, V27, P205, DOI 10.1089/neu.2009.1001; Yatsiv I, 2005, FASEB J, V19, P1701, DOI 10.1096/fj.05-3907fje	47	22	23	0	11	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0090-3493	1530-0293		CRIT CARE MED	Crit. Care Med.	MAY	2013	41	5					1316	1324		10.1097/CCM.0b013e31827ca64e			9	Critical Care Medicine	General & Internal Medicine	126ZB	WOS:000317661000035	23591210				2021-06-18	
J	Brown, RT; Kiely, DK; Bharel, M; Mitchell, SL				Brown, Rebecca T.; Kiely, Dan K.; Bharel, Monica; Mitchell, Susan L.			Factors Associated with Geriatric Syndromes in Older Homeless Adults	JOURNAL OF HEALTH CARE FOR THE POOR AND UNDERSERVED			English	Article						Homeless people; aged; middle aged; geriatric syndromes	MINI-MENTAL-STATE; TRAUMATIC BRAIN-INJURY; SERVICES TASK-FORCE; RISK-FACTORS; SAN-FRANCISCO; HEALTH-STATUS; PRIMARY-CARE; ALCOHOL-USE; POPULATION; FALLS	Although older homeless adults have high rates of geriatric syndromes, risk factors for these syndromes are not known. We used multivariable regression models to estimate the association of subject characteristics with the total number of geriatric syndromes in 250 homeless adults aged 50 years and older. Geriatric syndromes included falls, cognitive impairment, frailty, major depression, sensory impairment, and urinary incontinence. A higher total number of geriatric syndromes was associated with having less than a high school education, medical comorbidities (diabetes and arthritis), alcohol and drug use problems, and difficulty performing one or more activities of daily living. Clinicians who care for older homeless patients with these characteristics should consider screening them for geriatric syndromes. Moreover, this study identifies potentially modifiable risk factors associated with the total number of geriatric syndromes in older homeless adults. This knowledge may provide targets for clinical interventions to improve the health of older homeless patients.	[Brown, Rebecca T.] Univ Calif San Francisco, Div Geriatr, San Francisco, CA 94143 USA; [Brown, Rebecca T.] San Francisco VA Med Ctr, San Francisco, CA 94122 USA; [Kiely, Dan K.; Mitchell, Susan L.] Hebrew SeniorLife Inst Aging Res, Boston, MA USA; [Bharel, Monica] Boston Healthcare Homeless Program, Boston, MA USA; [Bharel, Monica] Boston Med Ctr, Dept Med, Boston, MA USA; [Bharel, Monica] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; [Mitchell, Susan L.] Beth Israel Deaconess Med Ctr, Div Gerontol, Boston, MA 02215 USA	Brown, RT (corresponding author), San Francisco VA Med Ctr, 4150 Clement St,181G, San Francisco, CA 94122 USA.	rebecca.brown@ucsf.edu		Brown, Rebecca/0000-0001-7483-4137	NIA NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [T32 AG023480, T32 AG000212, K24 AG033640] Funding Source: Medline; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [T32AG000212, K24AG033640, T32AG023480] Funding Source: NIH RePORTER		Avery K, 2004, NEUROUROL URODYNAM, V23, P322, DOI 10.1002/nau.20041; Blazer DG, 2011, AM J GERIAT PSYCHIAT, V19, P685, DOI 10.1097/JGP.0b013e3182006a96; Bleijenberg N, 2012, BMC GERIATR, V12, DOI 10.1186/1471-2318-12-16; Brown RT, 2012, J GEN INTERN MED, V27, P16, DOI 10.1007/s11606-011-1848-9; Burra TA, 2009, CAN J PSYCHIAT, V54, P123, DOI 10.1177/070674370905400210; Burt MarthaR., 1999, HOMELESSNESS PROGRAM; Calonge N, 2009, ANN INTERN MED, V151, P37, DOI 10.7326/0003-4819-151-1-200907070-00007; Cawthon PM, 2006, J AM GERIATR SOC, V54, P1649, DOI 10.1111/j.1532-5415.2006.00912.x; CHERPITEL CJ, 1995, ACCIDENT ANAL PREV, V27, P651, DOI 10.1016/0001-4575(95)00011-N; Cigolle CT, 2007, ANN INTERN MED, V147, P156, DOI 10.7326/0003-4819-147-3-200708070-00004; Cigolle CT, 2011, J GEN INTERN MED, V26, P272, DOI 10.1007/s11606-010-1510-y; COHEN CI, 1988, J AM GERIATR SOC, V36, P492, DOI 10.1111/j.1532-5415.1988.tb04018.x; CRUM RM, 1993, JAMA-J AM MED ASSOC, V269, P2386, DOI 10.1001/jama.269.18.2386; Culhane D. P., 2010, AGE STRUCTURE CONT H; CUMMINGS SR, 1988, J AM GERIATR SOC, V36, P613, DOI 10.1111/j.1532-5415.1988.tb06155.x; Dietz TL, 2009, J APPL GERONTOL, V28, P235, DOI 10.1177/0733464808326006; ESCOBAR JI, 1986, J NERV MENT DIS, V174, P607, DOI 10.1097/00005053-198610000-00005; Fazel S, 2008, PLOS MED, V5, P1670, DOI 10.1371/journal.pmed.0050225; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; FRATIGLIONI L, 1993, ANN NEUROL, V33, P258, DOI 10.1002/ana.410330306; Fried LP, 2001, J GERONTOL A-BIOL, V56, pM146, DOI 10.1093/gerona/56.3.M146; Garibaldi B, 2005, J GEN INTERN MED, V20, P726, DOI 10.1111/j.1525-1497.2005.0142.x; GELBERG L, 1990, J AM GERIATR SOC, V38, P1220, DOI 10.1111/j.1532-5415.1990.tb01503.x; Hahn JA, 2006, J GEN INTERN MED, V21, P775, DOI 10.1111/j.1525-1497.2006.00493.x; Heaton RK, 2004, REVISED COMPREHENSIV; Hwang SW, 2008, CAN MED ASSOC J, V179, P779, DOI 10.1503/cmaj.080341; Inouye SK, 2007, J AM GERIATR SOC, V55, P780, DOI 10.1111/j.1532-5415.2007.01156.x; Inouye SK, 1999, NEW ENGL J MED, V340, P669, DOI 10.1056/NEJM199903043400901; INOUYE SK, 1990, ANN INTERN MED, V113, P941, DOI 10.7326/0003-4819-113-12-941; Kannus P, 2005, AM J PUBLIC HEALTH, V95, P422, DOI 10.2105/AJPH.2004.047779; KATZ S, 1970, GERONTOLOGIST, V10, P20, DOI 10.1093/geront/10.1_Part_1.20; Kessler RC, 2004, BIOL PSYCHIAT, V56, P730, DOI 10.1016/j.biopsych.2004.06.034; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Kushel MB, 2001, JAMA-J AM MED ASSOC, V285, P200, DOI 10.1001/jama.285.2.200; MALMIVAARA A, 1993, AM J EPIDEMIOL, V138, P384, DOI 10.1093/oxfordjournals.aje.a116871; MCLELLAN AT, 1992, J SUBST ABUSE TREAT, V9, P199, DOI 10.1016/0740-5472(92)90062-S; Michael YL, 2010, ANN INTERN MED, V153, P815, DOI 10.7326/0003-4819-153-12-201012210-00008; MOR V, 1994, AM J PUBLIC HEALTH, V84, P1274, DOI 10.2105/AJPH.84.8.1274; Mukamal KJ, 2004, J AM GERIATR SOC, V52, P1174, DOI 10.1111/j.1532-5415.2004.52318.x; Pitz S, 2005, OPHTHALMOLOGICA, V219, P345, DOI 10.1159/000088376; Quirk M, 2009, HOMELESSNESS CITY BO; Razani J, 2007, ARCH CLIN NEUROPSYCH, V22, P333, DOI 10.1016/j.acn.2007.01.008; Reitan RM., 1985, HALSTEAD REITAN NEUR; Rockwood K, 2007, J GERONTOL A-BIOL, V62, P722, DOI 10.1093/gerona/62.7.722; Rockwood K, 2011, CAN MED ASSOC J, V183, pE487, DOI 10.1503/cmaj.101271; Rubenstein LZ, 2006, AGE AGEING, V35, P37, DOI 10.1093/ageing/afl084; SAUNDERS PA, 1991, BRIT J PSYCHIAT, V159, P213, DOI 10.1192/bjp.159.2.213; Schiller Jeannine S, 2007, Adv Data, P1; Slaughter B, 2003, BRAIN INJURY, V17, P731, DOI 10.1080/0269905031000088649; Sullivan G, 2001, PSYCHIATR SERV, V52, P1097, DOI 10.1176/appi.ps.52.8.1097; Tinetti ME, 2003, NEW ENGL J MED, V348, P42, DOI 10.1056/NEJMcp020719; Tschanz JT, 2004, NEUROLOGY, V62, P1156, DOI 10.1212/01.WNL.0000118210.12660.C2; United States Interagency Council on Homelessness, 2010, OP DOORS FED STRAT P; White MC, 1997, J COMMUN HEALTH, V22, P271, DOI 10.1023/A:1025152403545	54	22	22	0	11	JOHNS HOPKINS UNIV PRESS	BALTIMORE	JOURNALS PUBLISHING DIVISION, 2715 NORTH CHARLES ST, BALTIMORE, MD 21218-4363 USA	1049-2089			J HEALTH CARE POOR U	J. Health Care Poor Underserved	MAY	2013	24	2					456	468		10.1353/hpu.2013.0077			13	Health Policy & Services; Public, Environmental & Occupational Health	Health Care Sciences & Services; Public, Environmental & Occupational Health	153VU	WOS:000319631400005	23728022	Green Accepted			2021-06-18	
J	O'Sullivan, DM; Fife, GP; Pieter, W; Shin, I				O'Sullivan, David M.; Fife, Gabriel P.; Pieter, Willy; Shin, Insik			Safety performance evaluation of taekwondo headgear	BRITISH JOURNAL OF SPORTS MEDICINE			English	Article							BLOWS	Background With over 20 years of taekwondo concussion research highlighting the high incidence of injury, previous studies recommend an investigation of headgear impact attenuation performance. Objective To examine impact attenuation differences between the anterior, posterior and sides of selected taekwondo headgear brands. Design Between-groups. Setting Biomechanics laboratory. Methods Five different commercially available taekwondo headgear were selected for impact testing. A 50th percentile Hybrid II Dummy Crash Test head and neck was fitted with the selected helmet and was bolted to a 25 kg steel torso-like structure. Each headgear model was impacted eight times to the anterior, posterior and sides by a 6.75 kg bowling ball at three heights to produce 52.25, 85 and 144 J strikes. Main outcome measurements Resultant head linear acceleration. Results Two-way (HelmetxLocation) mixed analysis of variance with repeated measures on the second factor was performed to determine the differences between headgear by location of impact. There was a two-way (HelmetxLocation) interaction for acceleration (eta(2)=0.368). Conclusions Taekwondo headgear manufacturers and sport governing bodies must consider improving the design of especially anterior helmet properties.	[O'Sullivan, David M.] Chung Ang Univ, Dept Phys Educ, Anseong, South Korea; [Fife, Gabriel P.] Yonsei Univ, Dept Phys Educ, Integrat Sport Sci Lab, Seoul 120749, South Korea; [Pieter, Willy] Keimyung Univ, Dept Taekwondo, Taegu, South Korea; [Shin, Insik] Seoul Natl Univ, Dept Phys Educ, Seoul, South Korea	Fife, GP (corresponding author), Yonsei Univ, Dept Phys Educ, Integrat Sport Sci Lab, 50 Yonsei Ro, Seoul 120749, South Korea.	fifeg.yonsei@gmail.com			Yonsei University Research Fund	This study was supported by the Yonsei University Research Fund.	Aare M, 2004, INT J CRASHWORTHINES, V9, P15, DOI 10.1533/ijcr.2004.0268; [Anonymous], 2013, WORLD TAEKWONDO 0101; [Anonymous], F 2397 04 SPEC PROT; [Anonymous], 2008, WORLD TAEKW HEADQ; Chiu PH, 2007, J BIOMECH; Cohen J., 1988, STAT POWER ANAL BEHA, V2nd; Cohen JE, 2010, ISR MED ASSOC J, V12, P509; Duncan J M, 1874, Br Med J, V2, P763; Fife GP, 2013, BRIT J SPORT MED, V47, P1161, DOI 10.1136/bjsports-2012-090979; Fife GP, INT SPORT M IN PRESS; Foster KJ, 1977, 770938 SAE INT, DOI [10.4271/770938, DOI 10.4271/770938]; GURDJIAN ES, 1947, JAMA-J AM MED ASSOC, V134, P1072, DOI 10.1001/jama.1947.02880300014005; Hamel A, 2013, INT J LEGAL MED, V127, P111, DOI 10.1007/s00414-011-0627-9; Hanson O, 2011, P 3 INT S TAEKW STUD, P108; Hertzberg HE, 1969, P 13 STAPP CAR CRASH; Hopkins GW, NEW VIEW STAT; Kim SB, 1997, KOREAN J PHYS ED, V36, P348; Koh JO, 2004, CLIN J SPORT MED, V14, P72, DOI 10.1097/00042752-200403000-00004; Koh JO, 2002, J SPORT MED PHYS FIT, V42, P348; KOH JO, 2002, CROSSING BOUND INTER, V1, P79; Koh JO, 2011, P 3 INT S TAEKW STUD, P202; Leopold J., 1999, LOS ANGELES TIM 0111; Levy ML, 2004, NEUROSURGERY, V55, P649, DOI 10.1227/01.NEU.0000134598.06114.89; Lieu D, 1995, THESIS U CALIFORNIA; McElhaney JH, 1962, P S HUM IMP RESP WAR; McIntosh AS, 2000, BRIT J SPORT MED, V34, P337, DOI 10.1136/bjsm.34.5.337; McIntosh AS, 2001, BRIT J SPORT MED, V35, P167, DOI 10.1136/bjsm.35.3.167; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; National Highway Traffic Safety Administration, 2013, THOR ADV CRASH TEST; National Operating Committee on Standards for Athletic Equipment (NOCSAE), 2009, 00108M10 NOCSAE DOC; O'Sullivan D, 2009, J SPORT SCI MED, V8, P13; Pieter W, 1998, J ROY SOC HEALTH, V118, P272, DOI 10.1177/146642409811800512; Pieter W, 2012, BRIT J SPORT MED, V46, P485, DOI 10.1136/bjsports-2012-091011; PINTAR FA, 1990, 34TH P STAPP CAR CRA, P55; Queck C, 2009, STRAITS TIMES S 0711; Scott MW, 1993, 930094 SAE INC; Siana J E, 1986, Br J Sports Med, V20, P165; Society of Automotive Engineers (SAE), 1995, J2111 SAE; Spittle, 1991, HYBRID 2 HYBRID 3 DU; Van Mechelen W, 1992, AETIOLOGY PREVENTION; Yoganandan N, 2004, CLIN BIOMECH, V19, P225, DOI 10.1016/j.clinbiomech.2003.12.014	41	22	22	0	18	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0306-3674	1473-0480		BRIT J SPORT MED	Br. J. Sports Med.	MAY	2013	47	7					447	451		10.1136/bjsports-2012-091416			5	Sport Sciences	Sport Sciences	124OW	WOS:000317475200010	23349318				2021-06-18	
J	Ponsford, JL; Downing, MG; Stolwyk, R				Ponsford, Jennie L.; Downing, Marina G.; Stolwyk, Rene			Factors Associated With Sexuality Following Traumatic Brain Injury	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						sexual changes; sexuality; sexuality questionnaire; traumatic brain injury	PSYCHIATRIC-DISORDERS; INDIVIDUALS; DYSFUNCTION; VALIDATION	Background: Previous research has demonstrated that sexuality is compromised following traumatic brain injury (TBI). Objectives: The aim of this study was to determine the association between sexuality following TBI and demographic, injury-related, and postinjury variables (age, gender, time since injury, posttraumatic amnesia duration, independence in activities of daily activities (ADL), antidepressant use, depression, and self-esteem). Methods: Participants included 986 individuals with predominantly moderate to severe TBI, who completed the Brain Injury Questionnaire of Sexuality (BIQS), the Hospital Anxiety and Depression Scale, and the Rosenberg Self-Esteem Scale and an ADL assessment on 1 or more occasions, providing a total of 1673 assessments across 1, 2, 3, 5, 10, and 20 years postinjury. Results: Being depressed, older in age, at shorter time postinjury, and less independent in ADL significantly predicted poorer overall BIQS scores as well as the Sexual Functioning subscale score. Poorer Relationship Quality and Self-esteem scores on the BIQS were predicted by older age at injury and higher levels of depression. Lower Mood score on the BIQS was associated with shorter posttraumatic amnesia duration, younger age, and higher levels of depression. Self-esteem was associated positively with sexuality outcome. Conclusions: Therapeutic interventions for sexuality need to focus on depression where indicated and self-esteem and address specific barriers to social participation and opportunities for sexual contact in individuals who are less independent in ADL.	[Ponsford, Jennie L.; Downing, Marina G.; Stolwyk, Rene] Monash Univ, Sch Psychol & Psychiat, Melbourne, Vic 3004, Australia; [Ponsford, Jennie L.; Downing, Marina G.] Monash Epworth Rehabil Res Ctr, Melbourne, Vic, Australia; [Ponsford, Jennie L.] Natl Trauma Res Inst, Melbourne, Vic, Australia	Ponsford, JL (corresponding author), Monash Univ, Sch Psychol & Psychiat, Bldg 17,Wellington Rd, Clayton, Vic 3800, Australia.	jennie.ponsford@monash.edu	Downing, Marina/AAX-2380-2020	Downing, Marina/0000-0002-3126-6632	Transport Accident Commission, through the Institute for Safety, Compensation and Recovery Research	This project is funded by the Transport Accident Commission, through the Institute for Safety, Compensation and Recovery Research.	Anson K, 2006, BRAIN INJURY, V20, P1, DOI 10.1080/02699050500309791; Basson R, 2007, LANCET, V369, P409, DOI 10.1016/S0140-6736(07)60197-4; Cooper-Evans S, 2008, NEUROPSYCHOL REHABIL, V18, P607, DOI 10.1080/09602010801948516; Corona G, 2009, J SEX MED, V6, P1259, DOI 10.1111/j.1743-6109.2009.01248.x; Downing MG, 2013, J HEAD TRAUMA REHAB, V28, P171, DOI 10.1097/HTR.0b013e31828b4f63; Gaudet L, 2001, SEX DISABIL, V19, P111, DOI 10.1023/A:1010673722429; Gill CJ, 2011, J HEAD TRAUMA REHAB, V26, P56, DOI 10.1097/HTR.0b013e3182048ee9; Gould KR, 2011, PSYCHOL MED, V41, P2099, DOI 10.1017/S003329171100033X; Gould KR, 2011, J NEUROTRAUM, V28, P1155, DOI 10.1089/neu.2010.1528; Horn LJ, 1990, J HEAD TRAUMA REHAB, V5, P1; Howes H, 2005, BRAIN INJURY, V19, P135, DOI 10.1080/02699050410001720077; Howes HFR, 2005, BRAIN INJURY, V19, P403, DOI 10.1080/02699050400025158; KOSTELJANETZ M, 1981, ACTA NEUROL SCAND, V63, P169; Kreuter M, 1998, BRAIN INJURY, V12, P349, DOI 10.1080/026990598122494; Kreutzer J S, 1989, Brain Inj, V3, P177, DOI 10.3109/02699058909004550; Lindau ST, 2007, NEW ENGL J MED, V357, P762, DOI 10.1056/NEJMoa067423; O'CARROLL R E, 1991, Brain Injury, V5, P303, DOI 10.3109/02699059109008100; PFEIFFER E, 1972, J AM GERIATR SOC, V20, P151, DOI 10.1111/j.1532-5415.1972.tb00789.x; Ponsford J, 2003, NEUROPSYCHOL REHABIL, V13, P275, DOI 10.1080/09602010244000363; Ponsford J, 2013, BRAIN INJURY MEDICINE: PRINCIPLES AND PRACTICE, SECOND EDITION, P1067; PONSFORD JL, 1995, BRAIN INJURY, V9, P1, DOI 10.3109/02699059509004565; Rosenberg M., 1965, SOC ADOLESCENT SELF, DOI 10.1126/science.148.3671.804; Sandel ME, 1996, BRAIN INJURY, V10, P719, DOI 10.1080/026990596123981; SHORES EA, 1986, MED J AUSTRALIA, V144, P569, DOI 10.5694/j.1326-5377.1986.tb112311.x; Shoshan L, 2012, REHABIL NURS, V37, P11, DOI 10.1002/RNJ.00002; SIMPSON GK, 1999, YOU ME ED PROGRAM SE; Snaith R.P., 1994, HOSP ANXIETY DEPRESS; Stolwyk RJ, 2013, J HEAD TRAUMA REHAB, V28, P164, DOI 10.1097/HTR.0b013e31828197d1; Verschuren JEA, 2010, J SEX RES, V47, P153, DOI 10.1080/00224491003658227; Whelan-Goodinson R, 2009, J HEAD TRAUMA REHAB, V24, P324, DOI 10.1097/HTR.0b013e3181a712aa	30	22	22	0	10	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	MAY-JUN	2013	28	3					195	201		10.1097/HTR.0b013e31828b4f7b			7	Clinical Neurology; Rehabilitation	Neurosciences & Neurology; Rehabilitation	149PS	WOS:000319334000006	23661071				2021-06-18	
J	Sander, AM; Maestas, KL; Nick, TG; Pappadis, MR; Hammond, FM; Hanks, RA; Ripley, DL				Sander, Angelle M.; Maestas, Kacey Little; Nick, Todd G.; Pappadis, Monique R.; Hammond, Flora M.; Hanks, Robin A.; Ripley, David L.			Predictors of Sexual Functioning and Satisfaction 1 Year Following Traumatic Brain Injury: A TBI Model Systems Multicenter Study	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						sexual dysfunction; traumatic brain injury	PARTICIPATION ASSESSMENT; DEPRESSIVE SYMPTOMS; SELF-REPORT; REHABILITATION; MEN; ADENOCARCINOMA; PRETREATMENT; DYSFUNCTION; BEHAVIOR	Objective: To investigate predictors of sexual functioning 1 year following traumatic brain injury (TBI). Design: Prospective cohort study. Setting: Community. Participants: A total of 255 persons with TBI (187 males; 68 females) who had been treated at 1 of 6 TBI Model Systems inpatient rehabilitation units and were living in the community. Main Measures: Derogatis Interview for Sexual Functioning-Self-Report (DISF-SR); Global Satisfaction With Sexual Functioning (Global Sexual Satisfaction Index); Participation Assessment With Recombined Tools-Objective; Patient Health Questionnaire-9. Results: Older age, female gender, and more severe injury were associated with greater sexual dysfunction 1 year following injury. As age increased from 24 to 49 years, the odds of sexual impairment increased more than 3-fold (95% confidence interval: 1.82-5.88). Females had a 2.5 increase in odds of sexual impairment compared with males (95% confidence interval: 1.23-5.26). Greater social participation was predictive of better sexual functioning. Dissatisfaction with sexual functioning was predicted by older age and depression. Conclusions and Implications: Older persons and females appear to be at greater risk for sexual dysfunction after TBI and may benefit from specialized assessment and treatment services. Relationships were identified between social participation and sexual function and between depression and sexual satisfaction that may serve as clinical indicators for further assessment and intervention. Further research is needed to elucidate these relationships and identify effective clinical approaches.	[Sander, Angelle M.] TIRR Mem Hermann, Brain Injury Res Ctr, Baylor Coll Med, Dept Phys Med & Rehabil,Harris Hlth Syst, Houston, TX USA; [Maestas, Kacey Little] TIRR Mem Hermann, Brain Injury Res Ctr, Baylor Coll Med, Dept Phys Med & Rehabil, Houston, TX USA; [Nick, Todd G.] Univ Arkansas Med Sci, Coll Med & Publ Hlth, Dept Pediat, Little Rock, AR 72205 USA; [Nick, Todd G.] Univ Arkansas Med Sci, Coll Med & Publ Hlth, Dept Biostat, Little Rock, AR 72205 USA; [Pappadis, Monique R.] Univ Houston, Grad Coll Social Work, TIRR Mem Hermann, Brain Injury Res Ctr, Houston, TX USA; [Hammond, Flora M.] Indiana Univ Sch Med, Dept Phys Med & Rehabil, Carolinas HealthCare Syst, Carolinas Rehabil, Indianapolis, IN USA; [Hanks, Robin A.] Wayne State Univ, Sch Med, Rehabil Inst Michigan, Dept Phys Med & Rehabil, Detroit, MI USA; [Ripley, David L.] Craig Hosp, Rehabil Inst Chicago, Chicago, IL USA	Sander, AM (corresponding author), Brain Injury Res Ctr, 2323 South Shepherd Dr,Ste 907, Houston, TX 77019 USA.	asander@bcm.edu	Pappadis, Monique/Q-8639-2016	Pappadis, Monique/0000-0003-4742-4380; Ripley, David/0000-0002-5349-1830	National Institute on Disability and Rehabilitation Research, US Department of EducationUS Department of Education [H133A070043, H133B031117, H133A080044, H133A070042, H133A070013, H133A080045, H133A070022]	This work was supported by grants from the National Institute on Disability and Rehabilitation Research, US Department of Education (grant nos. H133A070043, H133B031117, H133A080044, H133A070042, H133A070013, H133A080045, H133A070022).	Aloni A, 1999, BRAIN INJURY, V13, P89, DOI 10.1080/026990599121755; Aloni R, 1999, BRAIN INJURY, V13, P269, DOI 10.1080/026990599121647; Bogner JA, 2011, ARCH PHYS MED REHAB, V92, P552, DOI 10.1016/j.apmr.2010.11.014; Chandler BJ, 1998, J NEUROL NEUROSUR PS, V65, P877, DOI 10.1136/jnnp.65.6.877; Cyranowski JM, 2004, J PSYCHIATR RES, V38, P267, DOI 10.1016/j.jpsychires.2003.08.003; Derogatis L, 1987, DEROGATIS INTERVIEW; Derogatis L. R., 1975, DEROGATIS SEXUAL FUN; Derogatis LR, 1997, J SEX MARITAL THER, V23, P291; DISCALA C, 1992, AM J PHYS MED REHAB, V71, P145, DOI 10.1097/00002060-199206000-00004; Frohlich P, 2002, J SEX RES, V39, P321, DOI 10.1080/00224490209552156; Garden F. H., 1990, J HEAD TRAUMA REHAB, V5, P52, DOI DOI 10.1097/00001199-199005020-00009; Grinnon ST, 2012, CLIN TRIALS, V9, P322, DOI 10.1177/1740774512438980; Hall KM., 1993, J HEAD TRAUMA REHAB, V8, DOI [DOI 10.1097/00001199-199308020-00008, 10.1097/00001199-199308020-00008]; HAMILTON B B, 1991, Archives of Physical Medicine and Rehabilitation, V72, P790; HEINEMANN AW, 1994, ARCH PHYS MED REHAB, V75, P133; Hibbard MR, 2000, NEUROREHABILITATION, V15, P109; Jackson WT, 1998, ARCH PHYS MED REHAB, V79, P718, DOI 10.1016/S0003-9993(98)90051-X; Kreuter M, 1998, BRAIN INJURY, V12, P349, DOI 10.1080/026990598122494; Kreutzer J S, 1989, Brain Inj, V3, P177, DOI 10.3109/02699058909004550; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; LINACRE JM, 1994, ARCH PHYS MED REHAB, V75, P127; Nelson CJ, 2007, J SEX MED, V4, P1422, DOI 10.1111/j.1743-6109.2007.00547.x; Nicolosi A, 2004, J AFFECT DISORDERS, V82, P235, DOI 10.1016/j.jad.2003.12.008; NOFZINGER EA, 1993, ARCH GEN PSYCHIAT, V50, P24; O'CARROLL R E, 1991, Brain Injury, V5, P303, DOI 10.3109/02699059109008100; Ponsford J, 2003, NEUROPSYCHOL REHABIL, V13, P275, DOI 10.1080/09602010244000363; SABHESAN S, 1989, ARCH SEX BEHAV, V18, P349, DOI 10.1007/BF01541953; Sandel ME, 1996, BRAIN INJURY, V10, P719, DOI 10.1080/026990596123981; Sander AM, 2012, ARCH PHYS MED REHAB, V93, P1331, DOI 10.1016/j.apmr.2012.03.037; Spitzer RL, 1999, JAMA-J AM MED ASSOC, V282, P1737, DOI 10.1001/jama.282.18.1737; *STAT U NEW YORK, 1996, GUID UN DAT SET MED; Tan G, 1998, SEX DISABIL, V16, P77, DOI 10.1023/A:1023023924804; TEASDALE G, 1974, LANCET, V2, P81; Whiteneck GG, 2011, ARCH PHYS MED REHAB, V92, P540, DOI 10.1016/j.apmr.2010.12.002; Whiteneck GG, 2011, ARCH PHYS MED REHAB, V92, P542, DOI 10.1016/j.apmr.2010.08.002; Wilde EA, 2010, ARCH PHYS MED REHAB, V91, P1650, DOI 10.1016/j.apmr.2010.06.033; ZINREICH ES, 1990, INT J RADIAT ONCOL, V19, P729, DOI 10.1016/0360-3016(90)90503-C; ZINREICH ES, 1990, INT J RADIAT ONCOL, V19, P1001, DOI 10.1016/0360-3016(90)90025-F	38	22	22	0	7	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	MAY-JUN	2013	28	3					186	194		10.1097/HTR.0b013e31828b4f91			9	Clinical Neurology; Rehabilitation	Neurosciences & Neurology; Rehabilitation	149PS	WOS:000319334000005	23661070				2021-06-18	
J	Vanderploeg, RD; Belanger, HG				Vanderploeg, Rodney D.; Belanger, Heather G.			Screening for a Remote History of Mild Traumatic Brain Injury: When a Good Idea Is Bad	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						mass screening; TBI; US Department of Defense; US Veterans Administration	SERVICES TASK-FORCE; HEAD-INJURY; POSTCONCUSSION SYNDROME; PROSTATE-CANCER; SYMPTOMS; CONCUSSION; ASSOCIATIONS; METAANALYSIS; EXPECTATION; DIAGNOSIS	Background: Both the Departments of Defense and Veterans Health Administration have developed and implemented screening procedures for identification of possible deployment-related traumatic brain injury (TBI). Objective: To review population-based screening procedures for TBI, particularly mild TBIs, and discuss potential harms/costs versus benefits of such TBI screening. Methods: The principles commonly used in population-based screening for various medical conditions are identified. These principles are applied to screening for TBI. The potential harms and costs are compared with potential benefits of screening for mild TBI. Results: The core conditions essential for beneficial medical screening-progressive disease, symptoms related to the identified disease, suitable tests or examinations for accurate diagnosis, and accepted and effective treatment-are not present within the context of TBI screening. Potential harms/costs outweigh any potential benefits of population-based screening for TBI. Conclusion: On the basis of generally accepted medical screening principles and assumptions, population screening for mild TBI is unnecessary at best and potentially harmful at worst. Because nonspecific, postconcussion-like symptoms can be effectively treated in a symptom-specific manner, tying them to concussion through a screening and evaluation process is wasteful and potentially harmful.	[Vanderploeg, Rodney D.; Belanger, Heather G.] James A Haley VA Hosp, Dept Mental Hlth & Behav Sci, Tampa, FL 33612 USA; [Vanderploeg, Rodney D.; Belanger, Heather G.] James A Haley VA Hosp, Dept Hlth Serv Res & Dev HSR&D, Rehabil Res & Dev RR&D Ctr Excellence Maximizing, Tampa, FL 33612 USA; [Vanderploeg, Rodney D.; Belanger, Heather G.] James A Haley VA Hosp, Dept Psychol, Tampa, FL 33612 USA; [Vanderploeg, Rodney D.] Univ S Florida, Tampa, FL USA; [Vanderploeg, Rodney D.; Belanger, Heather G.] Def & Vet Brain Injury Ctr, Tampa, FL USA	Vanderploeg, RD (corresponding author), James A Haley VA Hosp, Dept Mental Hlth & Behav Sci, 13000 N Bruce B Downs Blvd, Tampa, FL 33612 USA.	rodney.vanderploeg@va.gov					Amara JH, 2011, 3 FED INT C TRAUM BR; Barry MJ, 2001, NEW ENGL J MED, V344, P1373, DOI 10.1056/NEJM200105033441806; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P345, DOI 10.1017/S1355617705050411; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P215, DOI 10.1017/S1355617705050277; Belanger HG, HDB NEUROPSYCHOLOGY; Borg J, 2004, J REHABIL MED, V36, P61, DOI 10.1080/16501960410023822; Chou R, 2011, ANN INTERN MED, V155, P762, DOI 10.7326/0003-4819-155-11-201112060-00375; Cifu DX, 2010, VHA POL C ORL FL; Department of Veterans Affairs and Department of Defense, 2009, VA DOD CLIN PRACT GU, V2009; Donnell AJ, 2012, CLIN NEUROPSYCHOL, V26, P1092, DOI 10.1080/13854046.2012.713984; Donnelly KT, 2011, J HEAD TRAUMA REHAB, V26, P439, DOI 10.1097/HTR.0b013e3182005de3; Ferguson RJ, 1999, NEUROPSYCHOLOGY, V13, P582, DOI 10.1037/0894-4105.13.4.582; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Iverson GL, 2010, J HEAD TRAUMA REHAB, V25, P23, DOI 10.1097/HTR.0b013e3181b4b6ab; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; Meares S, 2008, J NEUROL NEUROSUR PS, V79, P300, DOI 10.1136/jnnp.2007.126565; Meares S, 2011, NEUROPSYCHOLOGY, V25, P454, DOI 10.1037/a0022580; Mittenberg W, 1996, ARCH CLIN NEUROPSYCH, V11, P139, DOI 10.1016/0887-6177(95)00006-2; Mittenberg W, 2001, J CLIN EXP NEUROPSYC, V23, P829, DOI 10.1076/jcen.23.6.829.1022; MITTENBERG W, 1992, J NEUROL NEUROSUR PS, V55, P200, DOI 10.1136/jnnp.55.3.200; Moyer VA, 2012, ANN INTERN MED, V157, P120, DOI 10.7326/0003-4819-157-2-201207170-00459; Pavawalla SP, 2013, J INT NEUROPSYCH SOC, V19, P305, DOI 10.1017/S135561771200135X; Ponsford J, 2002, J NEUROL NEUROSUR PS, V73, P330, DOI 10.1136/jnnp.73.3.330; Ponsford J, 2012, NEUROPSYCHOLOGY, V26, P304, DOI 10.1037/a0027888; Post-Deployment Health Group, 2012, ANN VA HLTH CAR UT O, V2012; Sayer NA, 2011, J HEAD TRAUMA REHAB, V26, P454, DOI 10.1097/HTR.0b013e3181ff393c; Schretlen DJ, 2003, INT REV PSYCHIATR, V15, P341, DOI 10.1080/09540260310001606728; Streiner DL, 2003, J PERS ASSESS, V81, P209, DOI 10.1207/S15327752JPA8103_03; Suhr JA, 2005, J INT NEUROPSYCH SOC, V11, P23, DOI 10.1017/S1355617705050010; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; Vanderploeg RD, 2006, PSYCHOLOGICAL KNOWLEDGE IN COURT: PTSD, PAIN, AND TBI, P279, DOI 10.1007/0-387-25610-5_16; Vanderploeg RD, 2007, J CLIN EXP NEUROPSYC, V29, P585, DOI 10.1080/13803390600826587; Vanderploeg RD, 2012, ARCH PHYS MED REHAB, V93, P1887, DOI 10.1016/j.apmr.2012.05.024; Vanderploeg RD, 2009, ARCH PHYS MED REHAB, V90, P1084, DOI 10.1016/j.apmr.2009.01.023; Whittaker R, 2007, J NEUROL NEUROSUR PS, V78, P644, DOI 10.1136/jnnp.2006.101105; WILSON J.M.G., 1968, PRINCIPLES PRACTICE	36	22	22	0	7	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	MAY-JUN	2013	28	3					211	218		10.1097/HTR.0b013e31828b50db			8	Clinical Neurology; Rehabilitation	Neurosciences & Neurology; Rehabilitation	149PS	WOS:000319334000008	23661073				2021-06-18	
J	Rashid, B; Destrade, M; Gilchrist, MD				Rashid, Badar; Destrade, Michel; Gilchrist, Michael D.			Influence of preservation temperature on the measured mechanical properties of brain tissue	JOURNAL OF BIOMECHANICS			English	Article						Traumatic brain injury (TBI); Post-mortem; Shear; Ogden model; Temperature	DEFORMATION; BEHAVIOR	The large variability in experimentally measured mechanical properties of brain tissue is due to many factors including heterogeneity, anisotropy, age dependence and post-mortem time. Moreover, differences in test protocols also influence these measured properties. This paper shows that the temperature at which porcine brain tissue is stored or preserved prior to testing has a significant effect on the mechanical properties of brain tissue, even when tests are conducted at the same temperatures. Three groups of brain tissue were stored separately for at least 1 h at three different preservation temperatures, i.e., ice cold, room temperature (22 degrees C) and body temperature (37 degrees C), prior to them all being tested at room temperature (similar to 22 degrees C). Significant differences in the corresponding initial elastic shear modulus mu (Pa) (at various amounts of shear, 0 <= K <= 1.0) were observed. The initial elastic moduli were 1043 +/- 271 Pa, 714 +/- 210 Pa and 497 +/- 156 Pa (mean +/- SD) at preservation temperatures of ice cold, 22 degrees C and 37 degrees C, respectively. Based on this investigation, it is strongly recommended that brain tissue samples must be preserved at an ice-cold temperature prior to testing in order to minimize the difference between the measured in vitro test results and the in vivo properties. A by-product of the study is that simple shear tests allow for large, almost perfectly homogeneous deformation of brain matter. (C) 2013 Elsevier Ltd. All rights reserved.	[Rashid, Badar; Destrade, Michel; Gilchrist, Michael D.] Natl Univ Ireland Univ Coll Dublin, Sch Mech & Mat Engn, Dublin 4, Ireland; [Destrade, Michel] Natl Univ Ireland Galway, Sch Math Stat & Appl Math, Galway, Ireland	Gilchrist, MD (corresponding author), Natl Univ Ireland Univ Coll Dublin, Sch Mech & Mat Engn, Dublin 4, Ireland.	Badar.Rashid@ucdconnect.ie; michel.destrade@nuigalway.ie; michael.gilchrist@ucd.ie	Destrade, Michel/O-5825-2019; Gilchrist, Michael D/B-6100-2017	Destrade, Michel/0000-0002-6266-1221; Gilchrist, Michael D/0000-0003-1765-429X	Irish Research Council for Science, Engineering and Technology (IRCSET), IrelandIrish Research Council for Science, Engineering and Technology	This work was supported for the first author by a Postgraduate Research Scholarship awarded in 2009 by the Irish Research Council for Science, Engineering and Technology (IRCSET), Ireland. The authors are most grateful to the reviewers for constructive comments on an earlier version of the paper.	BRANDS DWA, 2000, P 44 STAPP CAR CRASH, P249; Darvish KK, 2001, MED ENG PHYS, V23, P633, DOI 10.1016/S1350-4533(01)00101-1; Garo A, 2007, BIORHEOLOGY, V44, P51; Hrapko M, 2008, J BIOMECH ENG-T ASME, V130, DOI 10.1115/1.2907746; McElhaney JH, 1973, PERSPECTIVES BIOMEDI, P215, DOI DOI 10.1007/978-1-349-01604-4_34; METZ H, 1970, J BIOMECH, V3, P453, DOI 10.1016/0021-9290(70)90017-5; Miller K, 1997, J BIOMECH, V30, P1115, DOI 10.1016/S0021-9290(97)00092-4; Miller K, 2002, J BIOMECH, V35, P483, DOI 10.1016/S0021-9290(01)00234-2; Miller K, 2000, J BIOMECH, V33, P1369, DOI 10.1016/S0021-9290(00)00120-2; Nicolle Stephane, 2004, Stapp Car Crash J, V48, P239; Ogden R., 1997, NONLINEAR ELASTIC DE; Pervin F, 2011, NEUROIMAGE, V54, pS98, DOI 10.1016/j.neuroimage.2010.03.077; Pervin F, 2009, J BIOMECH, V42, P731, DOI 10.1016/j.jbiomech.2009.01.023; Peters GWM, 1997, BIORHEOLOGY, V34, P127, DOI 10.1016/S0006-355X(97)00009-7; Rashid B., 2012, THESIS U COLL DUBLIN; Rashid B., J MECH BEHAV BIOMED, DOI DOI 10.1016/JJMBBM.2012.07.015; Rashid B, 2012, J MECH BEHAV BIOMED, V14, P113, DOI 10.1016/j.jmbbm.2012.04.005; Rashid B, 2012, COMP MATER SCI, V64, P295, DOI 10.1016/j.commatsci.2012.05.030; Rashid B, 2012, J MECH BEHAV BIOMED, V10, P23, DOI 10.1016/j.jmbbm.2012.01.022; Shen F, 2006, J BIOMECH ENG-T ASME, V128, P797, DOI 10.1115/1.2264393; Tamura A, 2007, J BIOMECH SCI ENG, V2, P115, DOI [10.1299/jbse.2.115, DOI 10.1299/JBSE.2.115]; Tamura A., 2008, J BIOMECH SCI ENG, V3, P263, DOI DOI 10.1299/JBSE.3.263; Zhang JY, 2011, J BIOMECH, V44, P391, DOI 10.1016/j.jbiomech.2010.10.024	23	22	22	0	19	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0021-9290	1873-2380		J BIOMECH	J. Biomech.	APR 26	2013	46	7					1276	1281		10.1016/j.jbiomech.2013.02.014			6	Biophysics; Engineering, Biomedical	Biophysics; Engineering	139LI	WOS:000318583800009	23523381				2021-06-18	
J	Clond, MA; Lee, BS; Yu, JJ; Singer, MB; Amano, T; Lamb, AW; Drazin, D; Kateb, B; Ley, EJ; Yu, JS				Clond, Morgan A.; Lee, Bong-Seop; Yu, Jeffrey J.; Singer, Matthew B.; Amano, Takayuki; Lamb, Alexander W.; Drazin, Doniel; Kateb, Babak; Ley, Eric J.; Yu, John S.			Reactive Oxygen Species-Activated Nanoprodrug of Ibuprofen for Targeting Traumatic Brain Injury in Mice	PLOS ONE			English	Article							CONTROLLED CORTICAL IMPACT; CLOSED-HEAD INJURY; ALZHEIMERS-DISEASE; OXIDATIVE STRESS; VITAMIN-E; NEURODEGENERATIVE DISEASES; MICROGLIAL ACTIVATION; PARKINSONS-DISEASE; UNITED-STATES; CARE-UNIT	Traumatic brain injury (TBI) is an enormous public health problem, with 1.7 million new cases of TBI recorded annually by the Centers for Disease Control. However, TBI has proven to be an extremely challenging condition to treat. Here, we apply a nanoprodrug strategy in a mouse model of TBI. The novel nanoprodrug contains a derivative of the nonsteroidal anti-inflammatory drug (NSAID) ibuprofen in an emulsion with the antioxidant a-tocopherol. The ibuprofen derivative, Ibu(2)TEG, contains a tetra ethylene glycol (TEG) spacer consisting of biodegradable ester bonds. The biodegradable ester bonds ensure that the prodrug molecules break down hydrolytically or enzymatically. The drug is labeled with the fluorescent reporter Cy5.5 using nonbiodegradable bonds to 1-octadecanethiol, allowing us to reliably track its accumulation in the brain after TBI. We delivered a moderate injury using a highly reproducible mouse model of closed-skull controlled cortical impact to the parietal region of the cortex, followed by an injection of the nanoprodrug at a dose of 0.2 mg per mouse. The blood brain barrier is known to exhibit increased permeability at the site of injury. We tested for accumulation of the fluorescent drug particles at the site of injury using confocal and bioluminescence imaging of whole brains and brain slices 36 hours after administration. We demonstrated that the drug does accumulate preferentially in the region of injured tissue, likely due to an enhanced permeability and retention (EPR) phenomenon. The use of a nanoprodrug approach to deliver therapeutics in TBI represents a promising potential therapeutic modality.	[Clond, Morgan A.; Singer, Matthew B.; Lamb, Alexander W.; Ley, Eric J.] Cedars Sinai Med Ctr, Dept Surg, Div Trauma & Crit Care, Los Angeles, CA 90048 USA; [Lee, Bong-Seop; Yu, Jeffrey J.; Amano, Takayuki; Drazin, Doniel; Kateb, Babak; Yu, John S.] Cedars Sinai Med Ctr, Dept Neurosurg, Los Angeles, CA 90048 USA	Yu, JS (corresponding author), Cedars Sinai Med Ctr, Dept Neurosurg, Los Angeles, CA 90048 USA.	John.Yu@cshs.org		Kateb, Babak/0000-0001-7546-7543; Clond, Morgan/0000-0002-3036-4193; Yu, John/0000-0003-1230-8494	American Association for the Surgery of Trauma; Department of Health Services Division of Trauma Research	This study was sponsored by grants from the American Association for the Surgery of Trauma and the Department of Health Services Division of Trauma Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta SA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053376; Afshari D, 2012, CLIN NEUROLOGY NEURO; [Anonymous], 1999, WISQARS YEARS POT LI; Bernardi A, 2012, INT J NANOMED, V7, P4927, DOI 10.2147/IJN.S35333; Bonina FP, 2001, EUR J PHARM SCI, V14, P123, DOI 10.1016/S0928-0987(01)00163-4; Botteri M, 2008, CRIT CARE MED, V36, P3089, DOI 10.1097/CCM.0b013e31818bd7df; BREITNER JCS, 1995, NEUROBIOL AGING, V16, P523, DOI 10.1016/0197-4580(95)00049-K; Brody DL, 2007, J NEUROTRAUM, V24, P657, DOI 10.1089/neu.2006.0011; BURTON GW, 1982, LANCET, V2, P327; Cernak I, 2002, EXP BRAIN RES, V147, P193, DOI 10.1007/s00221-002-1245-z; Chassidim Y, 2013, FLUIDS BARRIERS CNS, V10, DOI 10.1186/2045-8118-10-9; Chung ES, 2012, BRAIN RES, V1451, P110, DOI 10.1016/j.brainres.2012.02.058; CLIFTON GL, 1983, J NEUROSURG, V59, P447, DOI 10.3171/jns.1983.59.3.0447; Cote S, 2012, ALZHEIMERS DEMENT, V8, P219, DOI 10.1016/j.jalz.2011.03.012; Dannhardt G, 2001, EUR J MED CHEM, V36, P109, DOI 10.1016/S0223-5234(01)01197-7; Faul M.D., 2010, TRAUMATIC BRAIN INJU; FEENEY DM, 1981, BRAIN RES, V211, P67, DOI 10.1016/0006-8993(81)90067-6; Fink KB, 1999, NEUROSCIENCE, V94, P1213, DOI 10.1016/S0306-4522(99)00345-0; Fox GB, 1998, J NEUROTRAUM, V15, P599, DOI 10.1089/neu.1998.15.599; Gilgun-Sherki Y, 2001, NEUROPHARMACOLOGY, V40, P959, DOI 10.1016/S0028-3908(01)00019-3; Glass CK, 2010, CELL, V140, P918, DOI 10.1016/j.cell.2010.02.016; Goldman SM, 2006, ANN NEUROL, V60, P65, DOI 10.1002/ana.20882; HALLIWELL B, 1989, ACTA NEUROL SCAND, V80, P23, DOI 10.1111/j.1600-0404.1989.tb01779.x; Halliwell B, 2006, J NEUROCHEM, V97, P1634, DOI 10.1111/j.1471-4159.2006.03907.x; Hein AM, 2009, MOL NEUROBIOL, V40, P15, DOI 10.1007/s12035-009-8066-z; Homsi S, 2009, BRAIN RES, V1291, P122, DOI 10.1016/j.brainres.2009.07.031; Iadecola C, 2005, STROKE, V36, P182, DOI 10.1161/01.STR.0000153797.33611.d8; Jain KK, 2008, DRUG DISCOV TODAY, V13, P1082, DOI 10.1016/j.drudis.2008.09.006; Khaksari M, 2011, CAN J PHYSIOL PHARM, V89, P31, DOI 10.1139/y10-103; Koliatsos VE, 2011, J NEUROPATH EXP NEUR, V70, P399, DOI 10.1097/NEN.0b013e3182189f06; Kovesdi Erzsebet, 2012, Front Neurol, V3, P111, DOI 10.3389/fneur.2012.00111; Langham J., 2003, COCHRANE DATABASE SY; Lee BS, 2011, J DRUG DELIV, V2011, DOI 10.1155/2011/980720; Lee BS, 2009, INT J PHARMACEUT, V372, P112, DOI 10.1016/j.ijpharm.2008.12.037; Lee PC, 2012, NEUROLOGY, V79, P2061, DOI 10.1212/WNL.0b013e3182749f28; Lighthall JW, 1988, J NEUROTRAUM, V5, P1, DOI 10.1089/neu.1988.5.1; Lin Y, 2012, NANOTECHNOLOGY, V23, DOI 10.1088/0957-4484/23/16/165101; LINDGREN S, 1966, RADIAT ENVIRON BIOPH, V3, P174, DOI DOI 10.1007/BF01191611; Liu ML, 2012, NEUROSCI LETT, V508, P31, DOI 10.1016/j.neulet.2011.12.010; Long JB, 2009, J NEUROTRAUM, V26, P827, DOI 10.1089/neu.2008.0748; Lu WY, 1997, NEUROSURGERY, V41, P416, DOI 10.1097/00006123-199708000-00017; Lye TC, 2000, NEUROPSYCHOL REV, V10, P115, DOI 10.1023/A:1009068804787; Maas AIR, 2006, LANCET NEUROL, V5, P38, DOI 10.1016/S1474-4422(05)70253-2; Maeda H, 2001, ADV ENZYME REGUL, V41, P189, DOI 10.1016/S0065-2571(00)00013-3; Marik PE, 2002, CHEST, V122, P699, DOI 10.1378/chest.122.2.699; Morganti-Kossmann Maria Cristina, 2002, Curr Opin Crit Care, V8, P101; Muehlschlegel S, 2009, NEUROCRIT CARE, V10, P103, DOI 10.1007/s12028-008-9133-4; Narayan RK, 2002, J NEUROTRAUM, V19, P503, DOI 10.1089/089771502753754037; Niki E, 2004, ACCOUNTS CHEM RES, V37, P45, DOI 10.1021/ar030069m; Nogawa S, 1997, J NEUROSCI, V17, P2746; Okie S, 2005, NEW ENGL J MED, V352, P2043, DOI 10.1056/NEJMp058102; Pham LDD, 2012, GLIA, V60, P875, DOI 10.1002/glia.22320; Prabhakar U, 2013, CANCER RES, V73, P2412, DOI 10.1158/0008-5472.CAN-12-4561; Ravin R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039421; Rigotti A, 2007, MOL ASPECTS MED, V28, P423, DOI 10.1016/j.mam.2007.01.002; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; Sangiorgi S, 2013, J NEUROSURG, V118, P763, DOI 10.3171/2012.11.JNS12627; Sen AP, 2010, NEUROTHERAPEUTICS, V7, P91, DOI 10.1016/j.nurt.2009.10.014; Shlosberg D, 2010, NAT REV NEUROL, V6, P393, DOI 10.1038/nrneurol.2010.74; Siskou IC, 2007, BIOORGAN MED CHEM, V15, P951, DOI 10.1016/j.bmc.2006.10.056; Stahel PF, 2000, J CEREBR BLOOD F MET, V20, P369, DOI 10.1097/00004647-200002000-00019; Strauss KI, 2000, J NEUROTRAUM, V17, P695, DOI 10.1089/089771500415436; Summers CR, 2009, MT SINAI J MED, V76, P105, DOI 10.1002/msj.20100; TAMMARA VK, 1993, PHARM RES-DORDR, V10, P1191, DOI 10.1023/A:1018976520391; Tehranian R, 2002, J NEUROTRAUM, V19, P939, DOI 10.1089/089771502320317096; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; Thurman DJ, 2001, EPIDEMIOLOGY EC HEAD, P1193; Uttara B, 2009, CURR NEUROPHARMACOL, V7, P65, DOI 10.2174/157015909787602823; Vink R, 2009, NEUROTHERAPEUTICS, V6, P28, DOI 10.1016/j.nurt.2008.10.036; Viscomi MT, 2008, CEREBELLUM, V7, P401, DOI 10.1007/s12311-008-0042-z; Wallenquist U, 2012, RESTOR NEUROL NEUROS, V30, P9, DOI 10.3233/RNN-2011-0606; Warden SJ, 2010, PHYSICIAN SPORTSMED, V38, P132, DOI 10.3810/psm.2010.04.1770; Xu J, NATL VITAL STAT REPO, V58, P19; Yu SJ, 2009, BRAIN RES, V1287, P157, DOI 10.1016/j.brainres.2009.06.067; Ziebell JM, 2010, NEUROTHERAPEUTICS, V7, P22, DOI 10.1016/j.nurt.2009.10.016	75	22	22	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2013	8	4							e61819	10.1371/journal.pone.0061819			10	Multidisciplinary Sciences	Science & Technology - Other Topics	136DE	WOS:000318340400053	23637912	DOAJ Gold, Green Published			2021-06-18	
J	Apfelbaum, HL; Ross, NC; Bowers, AR; Peli, E				Apfelbaum, Henry L.; Ross, Nicole C.; Bowers, Alex R.; Peli, Eli			Considering Apical Scotomas, Confusion, and Diplopia When Prescribing Prisms for Homonymous Hemianopia	TRANSLATIONAL VISION SCIENCE & TECHNOLOGY			English	Article						low vision; rehabilitation; prism treatment; perimetry; visual field loss; hemianopia; traumatic brain injury; TBI; stroke		Purpose: While prisms are commonly prescribed for homonymous hemianopia to extend or expand the visual field, they cause potentially troubling visual side effects, including nonveridical location of perceived images, diplopia, and visual confusion. In addition, the field behind a prism at its apex is lost to an apical scotoma equal in magnitude to the amount of prism shift. The perceptual consequences of apical scotomas and the other effects of various designs were examined to consider parameters and designs that can mitigate the impact of these effects. Methods: Various configurations of sector and peripheral prisms were analyzed, in various directions of gaze, and their visual effects were illustrated using simulated perimetry. A novel "percept'' diagram was developed that yielded insights into the patient's view through the prisms. The predictions were verified perimetrically with patients. Results: The diagrams distinguish between potentially beneficial field expansion via visual confusion and the pericentrally disturbing and useless effect of diplopia, and their relationship to prism power and gaze direction. They also illustrate the nonexpanding substitution of field segments of some popular prism designs. Conclusions: Yoked sector prisms have no effect at primary gaze or when gaze is directed toward the seeing hemifield, and they introduce pericentral field loss when gaze is shifted into them. When fitted unilaterally, sector prisms also have an effect only when the gaze is directed into the prism and may cause a pericentral scotoma and/or central diplopia. Peripheral prisms are effective at essentially all gaze angles. Since gaze is not directed into them, they avoid problematic pericentral effects. We derive useful recommendations for prism power and position parameters, including novel ways of fitting prisms asymmetrically. Translational Relevance: Clinicians will find these novel diagrams, diagramming techniques, and analyses valuable when prescribing prismatic aids for hemianopia and when designing new prism devices for patients with various types of field loss.	[Apfelbaum, Henry L.; Ross, Nicole C.; Bowers, Alex R.; Peli, Eli] Harvard Med Sch, Massachusetts Eye & Ear, Schepens Eye Res Inst, Boston, MA USA; [Ross, Nicole C.; Bowers, Alex R.; Peli, Eli] New England Coll Optometry, Boston, MA USA	Peli, E (corresponding author), Schepens Eye Res Inst, 20 Staniford St, Boston, MA 02114 USA.	eli_peli@meei.harvard.edu		Bowers, Alex/0000-0002-6038-0178	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [EY12890, P30EY003790]; NATIONAL EYE INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI) [R24EY012890, P30EY003790, R01EY012890] Funding Source: NIH RePORTER	Supported by the National Institutes of Health Grants EY12890 and P30EY003790.	BAHILL AT, 1975, INVEST OPHTH VISUAL, V14, P468; Bailey IL, 1978, OPTOM MONTHLY, V69, P99; Bailey IL., 2007, ROSENBLOOM MORGANS V, P133; Bishop PO., 1998, ADLERS PHYSL EYE CLI, P575; Blake R.R., 2001, BRAIN MIND, V2, P5, DOI DOI 10.1023/A:1017925416289; Bowers A. R., 2012, STROKE RES TREAT, V2012, P10; Bowers AR, 2008, ARCH OPHTHALMOL-CHIC, V126, P657, DOI 10.1001/archopht.126.5.657; Bowers AR, 2009, INVEST OPHTH VIS SCI, V50, P5137, DOI 10.1167/iovs.09-3799; Bowers AR, JAMA OPHTAL IN PRESS; Cardenal MS, 2012, OPTOM VIS SCI, V89; Cohen J M, 1993, J Am Optom Assoc, V64, P60; Cohen JM, 1996, REMEDIATION MANAGEME, P1; Cotter SA, 1995, CLIN USES PRISM SPEC, P279; Dickinson C., 1998, LOW VISION PRINCIPLE, P189; Fannin T. E., 1996, CLIN OPTICS, P109; Gall C, 2010, HEALTH QUAL LIFE OUT, V8, DOI 10.1186/1477-7525-8-33; Giorgi RG, 2009, OPTOMETRY VISION SCI, V86, P492, DOI 10.1097/OPX.0b013e31819f9e4d; Good Gregory W, 2005, Optometry, V76, P285, DOI 10.1016/S1529-1839(05)70311-0; GOODLAW E, 1982, AM J OPTOM PHYS OPT, V59, P617; Gottlieb D D, 1992, J Am Optom Assoc, V63, P581; Hoppe E, 1993, J Am Optom Assoc, V64, P46; Iorizzo DB, 2011, VISION RES, V51, P1173, DOI 10.1016/j.visres.2011.03.006; Katz Milton, 2004, Optometry, V75, P503, DOI 10.1016/S1529-1839(04)70175-X; Lee A G, 1999, J Am Optom Assoc, V70, P624; LOVIEKITCHIN J, 1990, CLIN VISION SCI, V5, P249; Luo G, 2008, J VISION, V8, DOI 10.1167/8.14.25; Morgan MW., 1963, AM J OPTOM, V40, P111; O'Neill EC, 2011, OPTOMETRY VISION SCI, V88, P263, DOI 10.1097/OPX.0b013e318205a3b8; Papageorgiou E, 2007, GRAEF ARCH CLIN EXP, V245, P1749, DOI 10.1007/s00417-007-0644-z; Peli E, 2000, OPTOMETRY VISION SCI, V77, P453, DOI 10.1097/00006324-200009000-00006; Peli E., 2008, United States patent, Patent No. [US 7,374,284 B2, 7374284, 7,374,284 B2]; Perez AM, 2003, J VISUAL IMPAIR BLIN, V97, P173, DOI 10.1177/0145482X0309700306; Perlin R R, 1991, J Am Optom Assoc, V62, P58; ROSSI PW, 1990, NEUROLOGY, V40, P1597, DOI 10.1212/WNL.40.10.1597; Satgunam P, 2012, OPTOMETRY VISION SCI, V89, pE1353, DOI 10.1097/OPX.0b013e3182678d42; Smith AJ, 1976, OPT J REV OPTOM, V12, P33; SMITH JL, 1982, J CLIN NEURO-OPHTHAL, V2, P19; Somani S, 2006, CAN J OPHTHALMOL, V41, P27, DOI 10.1016/S0008-4182(06)80062-1; Szlyk JP, 2005, OPHTHAL PHYSL OPT, V25, P128, DOI 10.1111/j.1475-1313.2004.00265.x; van Waveren M, 2013, GRAEF ARCH CLIN EXP, V251, P575, DOI 10.1007/s00417-012-2045-1; Vargas-Martin F, 2005, OPTOMETRY VISION SCI, V82, P675, DOI 10.1097/01.opx.0000175624.34252.73; WEISS NJ, 1972, AMER J OPT ARCH AM A, V49, P261; Wiener A., 1925, ARCH OPTHALMOL, V55; WOO GC, 1983, AM J OPTOM PHYS OPT, V60, P739; Woods RL, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3292015; Young CA, 1929, ARCH OPHTHALMOL-CHIC, V2, P560; Zhang X, 2006, NEUROLOGY, V66, P901, DOI 10.1212/01.wnl.0000203338.54323.22	47	22	22	0	0	ASSOC RESEARCH VISION OPHTHALMOLOGY INC	ROCKVILLE	12300 TWINBROOK PARKWAY, ROCKVILLE, MD 20852-1606 USA	2164-2591			TRANSL VIS SCI TECHN	Transl. Vis. Sci. Technol.	APR	2013	2	4							2	10.1167/tvst.2.4.2			18	Ophthalmology	Ophthalmology	V45JN	WOS:000209813000002	24049719	Green Published			2021-06-18	
J	Mioni, G; Mattalia, G; Stablum, F				Mioni, G.; Mattalia, G.; Stablum, F.			Time perception in severe traumatic brain injury patients: A study comparing different methodologies	BRAIN AND COGNITION			English	Article						Traumatic brain injury; Time perception; Time reproduction; Time production; Time discrimination	FRONTAL-LOBE LESIONS; CLOSED HEAD-INJURY; WORKING-MEMORY; TEMPORAL PERCEPTION; DIVIDED ATTENTION; PROCESSING SPEED; PRACTICAL SCALE; DURATION; INTERVALS; TASK	In this study, we investigated time perception in patients with traumatic brain injury (TBI). Fifteen TBI patients and 15 matched healthy controls participated in the study. Participants were tested with durations above and below 1 s on three different temporal tasks that involved time reproduction, production, and discrimination tasks. Data variables analyzed included amount of errors, relative errors, and coefficient of variation. Both groups completed a neuropsychological battery that included measures of attention, working memory, and executive functions. Results revealed significant differences between groups on the time reproduction and discrimination tasks, whereas groups showed similar performance on the time production task. Correlation analyses showed involvement of attention, working memory and executive functions on the time reproduction and time discrimination tasks, but there was no involvement on the time production task. These findings suggest that TBI does not impact specific temporal function. Rather, impairments in attention, working memory and executive function abilities may explain lower temporal performance in people with TBI. (C) 2013 Elsevier Inc. All rights reserved.	[Mioni, G.; Mattalia, G.; Stablum, F.] Univ Padua, Dipartimento Psicol Gen, I-35131 Padua, Italy	Mioni, G (corresponding author), Univ Padua, Dipartimento Psicol Gen, Via Venezia 8, I-35131 Padua, Italy.	giovanna.mioni@unipd.it		Stablum, Franca/0000-0003-0123-5090; mioni, Giovanna/0000-0002-1212-4591			Anderson CV, 1995, J CLIN EXP NEUROPSYC, V17, P900, DOI 10.1080/01688639508402438; Anderson JW, 2011, NEUROPSYCHOLOGY, V25, P36, DOI 10.1037/a0020333; Azouvi P, 1996, J CLIN EXP NEUROPSYC, V18, P317, DOI 10.1080/01688639608408990; Baudouin A, 2006, ACTA PSYCHOL, V121, P285, DOI 10.1016/j.actpsy.2005.07.004; Block, 1996, TIME INTERNAL CLOCKS, V115, P143, DOI DOI 10.1016/S0166-4115(96)80057-4; Block R. A., 1990, COGNITIVE MODELS PSY, P1; Block R.A., 1990, COGNITIVE MODELS PSY, P59; Block RA, 1996, TIME AND MIND, P171; Block RA, 1998, PSYCHOL AGING, V13, P584, DOI 10.1037/0882-7974.13.4.584; Block RA, 2006, TIMING THE FUTURE: THE CASE FOR A TIME-BASED PROSPECTIVE MEMORY, P25, DOI 10.1142/9789812707123_0002; Boelen DHE, 2009, NEUROPSYCHOL REHABIL, V19, P625, DOI 10.1080/09602010802613853; BROUWER WH, 1989, CORTEX, V25, P219, DOI 10.1016/S0010-9452(89)80038-3; Brown SW, 1997, PERCEPT PSYCHOPHYS, V59, P1118, DOI 10.3758/BF03205526; Buhusi CV, 2005, NAT REV NEUROSCI, V6, P755, DOI 10.1038/nrn1764; Casini L, 1999, NEUROPSYCHOLOGY, V13, P10, DOI 10.1037/0894-4105.13.1.10; CLAUSEN J, 1950, J EXP PSYCHOL, V40, P756, DOI 10.1037/h0056354; Craik FIM, 1999, PERCEPT PSYCHOPHYS, V61, P549, DOI 10.3758/BF03211972; Eisler H, 2008, PSYCHOLOGY OF TIME, P75, DOI 10.1016/B978-0-08046-977-5.00003-X; Fontaine A, 1999, NEUROLOGY, V53, P1963, DOI 10.1212/WNL.53.9.1963; FRAISSE P, 1984, ANNU REV PSYCHOL, V35, P1, DOI 10.1146/annurev.ps.35.020184.000245; Gibbon J., 1984, TIMING TIME PERCEPTI, P52; Grondin S, 2004, CAN J EXP PSYCHOL, V58, P1, DOI 10.1037/h0087436; Grondin S, 1999, J EXP PSYCHOL HUMAN, V25, P993, DOI 10.1037/0096-1523.25.4.993; Grondin S, 2010, ATTEN PERCEPT PSYCHO, V72, P561, DOI 10.3758/APP.72.3.561; Harrington DL, 1998, J NEUROSCI, V18, P1085; Ivry RB, 2004, CURR OPIN NEUROBIOL, V14, P225, DOI 10.1016/j.conb.2004.03.013; Laiacona M, 2000, NEUROL SCI, V21, P279, DOI 10.1007/s100720070065; Lejeune H, 2009, EUR J COGN PSYCHOL, V21, P941, DOI 10.1080/09541440802453006; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; Lewis PA, 2003, NEUROPSYCHOLOGIA, V41, P1583, DOI 10.1016/S0028-3932(03)00118-0; Lewis PA, 2003, CURR OPIN NEUROBIOL, V13, P250, DOI 10.1016/S0959-4388(03)00036-9; Meck WH, 2005, BRAIN COGNITION, V58, P1, DOI 10.1016/j.bandc.2004.09.004; Meck WH, 1996, COGNITIVE BRAIN RES, V3, P227, DOI 10.1016/0926-6410(96)00009-2; MEYERS CA, 1992, NEUROPSY NEUROPSY BE, V5, P28; Nichelli P, 1995, ANN NY ACAD SCI, V769, P183, DOI 10.1111/j.1749-6632.1995.tb38139.x; NOVELLI G, 1986, Archivio di Psicologia Neurologia e Psichiatria, V47, P477; Penney TB, 2008, PSYCHOLOGY OF TIME, P261, DOI 10.1016/B978-0-08046-977-5.00008-9; Perbal S, 2003, NEUROPSYCHOLOGIA, V41, P1599, DOI 10.1016/S0028-3932(03)00110-6; Perbal S, 2002, AGING NEUROPSYCHOL C, V9, P201, DOI 10.1076/anec.9.3.201.9609; Poppel E, 1997, TRENDS COGN SCI, V1, P56, DOI 10.1016/S1364-6613(97)01008-5; Poppel E, 2004, ACTA NEUROBIOL EXP, V64, P295; Rammsayer TH, 2001, EUR J COGN PSYCHOL, V13, P549, DOI 10.1080/09541440042000322; Rubia K, 2004, ACTA NEUROBIOL EXP, V64, P329; Rubia K, 2006, TIMING THE FUTURE: THE CASE FOR A TIME-BASED PROSPECTIVE MEMORY, P213, DOI 10.1142/9789812707123_0009; Schmitter-Edgecombe M, 2008, J CLIN EXP NEUROPSYC, V30, P212, DOI 10.1080/13803390701363803; TEASDALE G, 1974, LANCET, V2, P81; TREISMAN M, 1963, PSYCHOL MONOGR, V77, P1, DOI 10.1037/h0093864; Wechsler D., 1981, WAIS R MANUAL WECHSL; ZAKAY D, 1993, PERCEPTION, V22, P91, DOI 10.1068/p220091; Zimmermann P, 2002, APPLIED NEUROPSYCHOLOGY OF ATTENTION: THEORY DIAGNOSIS AND REHABILITATION, P110	50	22	23	0	16	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0278-2626	1090-2147		BRAIN COGNITION	Brain Cogn.	APR	2013	81	3					305	312		10.1016/j.bandc.2012.12.005			8	Neurosciences; Psychology, Experimental	Neurosciences & Neurology; Psychology	112LF	WOS:000316593000001	23395855				2021-06-18	
J	Niskanen, JP; Airaksinen, AM; Sierra, A; Huttunen, JK; Nissinen, J; Karjalainen, PA; Pitkanen, A; Grohn, OH				Niskanen, Juha-Pekka; Airaksinen, Antti M.; Sierra, Alejandra; Huttunen, Joanna K.; Nissinen, Jari; Karjalainen, Pasi A.; Pitkanen, Asla; Grohn, Olli H.			Monitoring Functional Impairment and Recovery after Traumatic Brain Injury in Rats by fMRI	JOURNAL OF NEUROTRAUMA			English	Article						electrophysiology; MRI; recovery; sensory function; TBI	CEREBRAL BLOOD-VOLUME; POSTTRAUMATIC EPILEPSY; NEURONAL DAMAGE; IN-VIVO; INHIBITION; MODELS	The present study was designed to test a hypothesis that functional magnetic resonance imaging (fMRI) can be used to monitor functional impairment and recovery after moderate experimental traumatic brain injury (TBI). Moderate TBI was induced by lateral fluid percussion injury in adult rats. The severity of brain damage and functional recovery in the primary somatosensory cortex (S1) was monitored for up to 56 days using fMRI, cerebral blood flow (CBF) by arterial spin labeling, local field potential measurements (LFP), behavioral assessment, and histology. All the rats had reduced blood-oxygen-level-dependent (BOLD) responses during the 1st week after trauma in the ipsilateral S1. Forty percent of these animals showed recovery of the BOLD response during the 56 day follow-up. Unexpectedly, no association was found between the recovery in BOLD response and the volume of the cortical lesion or thalamic neurodegeneration. Instead, the functional recovery occurred in rats with preserved myelinated fibers in layer VI of S1. This is, to our knowledge, the first study demonstrating that fMRI can be used to monitor post-TBI functional impairment and consequent spontaneous recovery. Moreover, the BOLD response was associated with the density of myelinated fibers in the S1, rather than with neurodegeneration. The present findings encourage exploration of the usefulness of fMRI as a noninvasive prognostic biomarker for human post-TBI outcomes and therapy responses.	[Niskanen, Juha-Pekka; Airaksinen, Antti M.; Sierra, Alejandra; Huttunen, Joanna K.; Grohn, Olli H.] Univ Eastern Finland, Dept Neurobiol, FI-70211 Kuopio, Finland; [Nissinen, Jari; Pitkanen, Asla] Univ Eastern Finland, AI Virtanen Inst Mol Sci, Dept Neurobiol, Epilepsy Res Lab, FI-70211 Kuopio, Finland; [Niskanen, Juha-Pekka; Karjalainen, Pasi A.] Univ Eastern Finland, Dept Appl Phys, FI-70211 Kuopio, Finland; [Pitkanen, Asla] Kuopio Univ Hosp, Dept Neurol, SF-70210 Kuopio, Finland	Grohn, OH (corresponding author), Univ Eastern Finland, AI Virtanen Inst Mol Sci, Dept Neurobiol, POB 1627, FI-70211 Kuopio, Finland.	olli.grohn@uef.fi	Karjalainen, Pasi A/G-4043-2016; Karjalainen, Pasi/AAC-5465-2019; Huttunen, Joanna/F-1645-2011	Karjalainen, Pasi A/0000-0002-1267-493X; Karjalainen, Pasi/0000-0002-1267-493X; Huttunen, Joanna/0000-0002-1188-5604; Sierra Lopez, Alejandra/0000-0001-5399-2056	Academy of FinlandAcademy of FinlandEuropean Commission [123579, 252511, 132970]; Juselius Foundation; Orion-Farmos Research Foundation; University of Eastern Finland (UEF-Brain)	This work was supported by Academy of Finland (grant numbers 123579, 252511, 132970), the Juselius Foundation, Orion-Farmos Research Foundation, and the strategic funding of the University of Eastern Finland (UEF-Brain). We thank Jarmo Hartikainen and Maarit Pulkkinen for technical assistance, and Dr. Nick Hayward of Scientific English, UK, for revising the language of this manuscript.	Chaiwat O, 2009, J NEUROTRAUM, V26, P657, DOI 10.1089/neu.2008.0770; Cullen DK, 2011, J NEUROTRAUM, V28, P2219, DOI 10.1089/neu.2011.1841; Dijkhuizen RM, 2003, J NEUROSCI, V23, P510; Ding MC, 2011, J NEUROSCI, V31, P14085, DOI 10.1523/JNEUROSCI.3572-11.2011; Frey LC, 2003, EPILEPSIA, V44, P11, DOI 10.1046/j.1528-1157.44.s10.4.x; Garnett MR, 2001, J NEUROTRAUM, V18, P585, DOI 10.1089/089771501750291828; Goldstein LB, 2003, BRAIN INJURY, V17, P685, DOI 10.1080/0269905031000107179; Graham DI, 2000, ACTA NEUROPATHOL, V99, P117, DOI 10.1007/PL00007414; GRUETTER R, 1993, MAGNET RESON MED, V29, P804, DOI 10.1002/mrm.1910290613; Hattori N, 2003, ACTA NEUROCHIR SUPPL, V86, P49; Hayward NMEA, 2010, J NEUROTRAUM, V27, P2203, DOI 10.1089/neu.2010.1448; Hayward NMEA, 2011, J CEREBR BLOOD F MET, V31, P166, DOI 10.1038/jcbfm.2010.67; Henninger N, 2007, CRIT CARE MED, V35, P2607, DOI 10.1097/01.CCM.0000286395.79654.8D; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Immonen R, 2010, J CEREBR BLOOD F MET, V30, P1318, DOI 10.1038/jcbfm.2010.15; Kawai N, 2010, J NEUROTRAUM, V27, P2131, DOI 10.1089/neu.2010.1464; Kharatishvili I, 2006, NEUROSCIENCE, V140, P685, DOI 10.1016/j.neuroscience.2006.03.012; Kharatishvili I, 2009, EXP NEUROL, V217, P154, DOI 10.1016/j.expneurol.2009.01.026; Kim J, 2010, J NEUROTRAUM, V27, P1399, DOI 10.1089/neu.2009.1215; Laatsch L, 2006, BRAIN INJURY, V20, P1367, DOI 10.1080/02699050600983743; Lehto LJ, 2012, NEUROIMAGE, V61, P761, DOI 10.1016/j.neuroimage.2012.03.002; Liao CC, 2008, ANAT REC, V291, P960, DOI 10.1002/ar.20696; Liu YR, 2010, J NUCL MED, V51, P1788, DOI 10.2967/jnumed.110.078626; Loane DJ, 2010, TRENDS PHARMACOL SCI, V31, P596, DOI 10.1016/j.tips.2010.09.005; Mayer AR, 2011, HUM BRAIN MAPP, V32, P1825, DOI 10.1002/hbm.21151; Mayer AR, 2009, HUM BRAIN MAPP, V30, P4152, DOI 10.1002/hbm.20836; McAllister Thomas W, 2011, Dialogues Clin Neurosci, V13, P287; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; Morales D, 2006, J NEUROTRAUM, V23, P976, DOI 10.1089/neu.2006.23.976; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Pitkanen A, 2006, J NEUROTRAUM, V23, P241, DOI 10.1089/neu.2006.23.241; Pitkanen A, 1996, EPILEPSY RES, V24, P29, DOI 10.1016/0920-1211(95)00093-3; Pitkanen A, 2011, LANCET NEUROL, V10, P173, DOI 10.1016/S1474-4422(10)70310-0; Pitkanen A, 2009, EPILEPSIA, V50, P21, DOI 10.1111/j.1528-1167.2008.02007.x; Silva AC, 2007, MAGN RESON MED, V57, P1110, DOI 10.1002/mrm.21246; Thompson HJ, 2005, J NEUROTRAUM, V22, P42, DOI 10.1089/neu.2005.22.42; WILLIAMS DS, 1992, P NATL ACAD SCI USA, V89, P212, DOI 10.1073/pnas.89.1.212	37	22	22	1	11	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	APR	2013	30	7					546	556		10.1089/neu.2012.2416			11	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	133PD	WOS:000318150300006	23259713	Green Published			2021-06-18	
J	Al Nimer, F; Strom, M; Lindblom, R; Aeinehband, S; Bellander, BM; Nyengaard, JR; Lidman, O; Piehl, F				Al Nimer, Faiez; Strom, Mikael; Lindblom, Rickard; Aeinehband, Shahin; Bellander, Bo-Michael; Nyengaard, Jens R.; Lidman, Olle; Piehl, Fredrik			Naturally Occurring Variation in the Glutathione-S-Transferase 4 Gene Determines Neurodegeneration After Traumatic Brain Injury	ANTIOXIDANTS & REDOX SIGNALING			English	Article							NON-MHC GENES; MULTIPLE-SCLEROSIS; RHEUMATOID-ARTHRITIS; PARKINSONS-DISEASE; LIPID-PEROXIDATION; OXIDATIVE STRESS; SUSCEPTIBILITY; RATS; INFLAMMATION; EXPRESSION	Aim: Genetic factors are important for outcome after traumatic brain injury (TBI), although exact knowledge of relevant genes/pathways is still lacking. We here used an unbiased approach to define differentially activated pathways between the inbred DA and PVG rat strains. The results prompted us to study further if a naturally occurring genetic variation in glutathione-S-transferase alpha 4 (Gsta4) affects the outcome after TBI. Results: Survival of neurons after experimental TBI is increased in PVG compared to the DA strain. Global expression profiling analysis shows the glutathione metabolism pathway to be the most regulated between the strains, with increased Gsta4 in PVG among top regulated transcripts. A congenic strain (R5) with a PVG genomic insert containing the Gsta4 gene on DA background displays a reversal of the strain pattern for Gsta4 expression and increased survival of neurons compared to DA. Gsta4 is known to effectively reduce 4-hydroxynonenal (4-HNE), a noxious by-product of lipid peroxidation. Immunostaining of 4-HNE was evident in both rat and human TBI. Intracerebral injection of 4-HNE resulted in neurodegeneration with increased levels of a marker for nerve injury in cerebrospinal fluid of DA compared to R5. Innovation: These findings provide strong support for the notion that the inherent capability of coping with increased 4-HNE after TBI affects outcome in terms of nerve cell loss. Conclusion: A naturally occurring variation in Gsta4 expression in rats affects neurodegeneration after TBI. Further studies are needed to explore if genetic variability in Gsta4 can be associated to outcome also in human TBI. Antioxid. Redox Signal. 18, 784-794.	[Al Nimer, Faiez; Strom, Mikael; Lindblom, Rickard; Aeinehband, Shahin; Lidman, Olle; Piehl, Fredrik] Karolinska Univ Hosp, Neuroimmunol Unit, Dept Clin Neurosci, Stockholm, Sweden; [Bellander, Bo-Michael] Karolinska Univ Hosp, Sect Neurosurg, Dept Clin Neurosci, Stockholm, Sweden; [Nyengaard, Jens R.] Aarhus Univ Hosp, Stereol & Electron Microscopy Lab, Ctr Stochast Geometry & Adv Bioimaging, DK-8000 Aarhus, Denmark	Al Nimer, F (corresponding author), Karolinska Inst, Neuroimmunol Unit, Dept Clin Neurosci, Karolinska Univ Hosp Solna, CMM L08 04, S-17176 Stockholm, Sweden.	faiez.al.nimer@ki.se	Piehl, Fredrik/E-3451-2013; Nimer, Faiez Al/ABB-9465-2020	Al Nimer, Faiez/0000-0003-0937-5995; Lindblom, Rickard/0000-0001-7913-4981	European UnionEuropean Commission [LSHM-CT-2005-018637, LSHG-CT-2005019015, HEALTH-F4-2010-241504]; Swedish Research CouncilSwedish Research CouncilEuropean Commission; Swedish Brain Foundation; Swedish Association of Persons with Neurological Disabilities; Villum Foundation	This study was supported by the 6th Framework Program of the European Union, NeuroproMiSe, LSHM-CT-2005-018637, EURATools, LSHG-CT-2005019015, and the 7th Framework Program of the European Union, EURATrans, HEALTH-F4-2010-241504, by the Swedish Research Council, the Swedish Brain Foundation and the Swedish Association of Persons with Neurological Disabilities. Centre for Stochastic Geometry and Advanced Bioimaging is supported by Villum Foundation.	Abel EL, 2010, JNCI-J NATL CANCER I, V102, P1663, DOI 10.1093/jnci/djq392; Al Nimer F, 2011, BRAIN BEHAV IMMUN, V25, P981, DOI 10.1016/j.bbi.2010.10.017; Arakawa M, 2007, NEUROSCI RES, V57, P220, DOI 10.1016/j.neures.2006.10.011; Balogh LM, 2011, DRUG METAB REV, V43, P165, DOI 10.3109/03602532.2011.558092; Beyeen AD, 2010, J IMMUNOL, V185, P6883, DOI 10.4049/jimmunol.1001392; Coppede F, 2005, MUTAT RES-FUND MOL M, V579, P107, DOI 10.1016/j.mrfmmm.2005.02.020; Costantini D, 2012, J EXP BIOL, V215, P374, DOI 10.1242/jeb.062034; Dahlman I, 1998, EUR J IMMUNOL, V28, P2188, DOI 10.1002/(SICI)1521-4141(199807)28:07<2188::AID-IMMU2188>3.0.CO;2-B; Di Pietro G, 2010, EXPERT OPIN DRUG MET, V6, P153, DOI 10.1517/17425250903427980; Dorph-Petersen KA, 2001, J MICROSC-OXFORD, V204, P232, DOI 10.1046/j.1365-2818.2001.00958.x; Ferguson S, 2010, NEUROSCIENCE, V168, P811, DOI 10.1016/j.neuroscience.2010.01.031; Galvani S, 2008, FREE RADICAL BIO MED, V45, P1457, DOI 10.1016/j.freeradbiomed.2008.08.026; Gillett A, 2010, J IMMUNOL, V185, P442, DOI 10.4049/jimmunol.0904101; Gilmer LK, 2010, J NEUROTRAUM, V27, P939, DOI 10.1089/neu.2009.1181; Gulko PS, 2007, GENES IMMUN, V8, P523, DOI 10.1038/sj.gene.6364419; Hall ED, 2010, NEUROTHERAPEUTICS, V7, P51, DOI 10.1016/j.nurt.2009.10.021; Hwang JJ, 2008, J NEUROSCI, V28, P3114, DOI 10.1523/JNEUROSCI.0199-08.2008; Itoh T, 2010, NEUROCHEM RES, V35, P348, DOI 10.1007/s11064-009-0061-2; Lidman O, 2003, J NEUROSCI, V23, P9817; Lingsma HF, 2010, LANCET NEUROL, V9, P543, DOI 10.1016/S1474-4422(10)70065-X; Liu HL, 2004, ANN NY ACAD SCI, V1019, P346, DOI 10.1196/annals.1297.059; Lundberg C, 2001, J COMP NEUROL, V431, P75; Maes OC, 2010, NEUROBIOL AGING, V31, P34, DOI 10.1016/j.neurobiolaging.2008.03.007; Marklund N, 2006, CURR PHARM DESIGN, V12, P1645, DOI 10.2174/138161206776843340; Matsuda S, 2009, J NEURAL TRANSM, V116, P395, DOI 10.1007/s00702-009-0194-0; McAllister TW, 2010, PM&R, V2, pS241, DOI 10.1016/j.pmrj.2010.10.005; McCracken E, 2000, J CEREBR BLOOD F MET, V20, P1529, DOI 10.1097/00004647-200011000-00002; McGlynn KA, 2003, CANCER RES, V63, P4594; Ockinger J, 2010, GENES IMMUN, V11, P142, DOI 10.1038/gene.2009.82; Perez-Pastene C, 2007, NEUROSCI LETT, V418, P181, DOI 10.1016/j.neulet.2007.03.024; Piehl F, 2009, NEUROSCIENCE, V158, P1143, DOI 10.1016/j.neuroscience.2008.08.031; Qian J, 2009, MOL CARCINOGEN, V48, P253, DOI 10.1002/mc.20478; Radu RA, 2011, J BIOL CHEM, V286, P18593, DOI 10.1074/jbc.M110.191866; Reid WM, 2010, J NEUROTRAUM, V27, P1243, DOI 10.1089/neu.2010.1270; Salzer J, 2010, MULT SCLER J, V16, P287, DOI 10.1177/1352458509359725; Sawcer S, 2010, EUR J HUM GENET, V18, P746, DOI 10.1038/ejhg.2010.17; Schulz JB, 2000, EUR J BIOCHEM, V267, P4904, DOI 10.1046/j.1432-1327.2000.01595.x; Selley ML, 1998, FREE RADICAL BIO MED, V25, P169, DOI 10.1016/S0891-5849(98)00021-5; Selley ML, 2002, NEUROBIOL AGING, V23, P383, DOI 10.1016/S0197-4580(01)00327-X; Shao CX, 2006, FREE RADICAL BIO MED, V41, P77, DOI 10.1016/j.freeradbiomed.2006.03.007; Simpson EP, 2004, NEUROLOGY, V62, P1758, DOI 10.1212/WNL.62.10.1758; Strom M, 2012, NEUROMOL MED, V14, P15, DOI 10.1007/s12017-011-8164-8; Swanberg M, 2005, NAT GENET, V37, P486, DOI 10.1038/ng1544; Swanberg M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005906; Tan AA, 2009, J NEUROTRAUM, V26, P539, DOI 10.1089/neu.2008.0611; Tang SC, 2007, J NEUROCHEM, V101, P729, DOI 10.1111/j.1471-4159.2006.04412.x; Townsend DM, 2003, BIOMED PHARMACOTHER, V57, P145, DOI 10.1016/S0753-3322(03)00043-X; Yao XM, 2009, NEUROTOXICOLOGY, V30, P121, DOI 10.1016/j.neuro.2008.11.002; Zhou WD, 2008, J NEUROTRAUM, V25, P279, DOI 10.1089/neu.2007.0489	49	22	22	0	14	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1523-0864	1557-7716		ANTIOXID REDOX SIGN	Antioxid. Redox Signal.	MAR	2013	18	7					784	794		10.1089/ars.2011.4440			11	Biochemistry & Molecular Biology; Endocrinology & Metabolism	Biochemistry & Molecular Biology; Endocrinology & Metabolism	076PB	WOS:000313968000005	22881716	Green Published			2021-06-18	
J	Alharfi, IM; Stewart, TC; Kelly, SH; Morrison, GC; Fraser, DD				Alharfi, Ibrahim M.; Stewart, Tanya Charyk; Kelly, Shawn H.; Morrison, Gavin C.; Fraser, Douglas D.			Hypernatremia Is Associated with Increased Risk of Mortality in Pediatric Severe Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						hypernatremia; mortality, children; severe TBI; TBI interventions	SEVERE HEAD-INJURY; CRITICALLY-ILL; INTRACRANIAL HYPERTENSION; DIABETES-INSIPIDUS; HYPERTONIC SALINE; CHILDREN; THERAPY; SODIUM; COMPLICATIONS; POPULATION	Acquired hypernatremia in hospitalized patients is often associated with poorer outcomes. Our aim was to evaluate the relationship between acquired hypernatremia and outcome in children with severe traumatic brain injury (sTBI). We performed a retrospective cohort study of all severely injured trauma patients (Injury Severity Score >= 12) with sTBI (Glasgow Coma Scale [GCS] <= 8 and Maximum Abbreviated Injury Scale [MAIS] >= 4) admitted to a Pediatric Critical Care Unit ([PCCU]; 2000-2009). In a cohort of 165 patients, 76% had normonatremia (135-150 mmol/L), 18% had hypernatremia (151-160 mmol/L), and 6% had severe hypernatremia (> 160 mmol/L). The groups were similar except for lower GCS (p = 0.002) and increased incidence of fixed pupil(s) on admission in both hypernatremia groups (p < 0.001). Mortality rate was four-fold and six-fold greater with hypernatremia and severe hypernatremia, respectively (p < 0.001), and mortality rates were unchanged when patients with fixed pupils or those with central diabetes insipidus were excluded (p < 0.001). Hypernatremic patients had fewer ventilator-free days (p < 0.001). Survivors with hypernatremia had greater PCCU (p = 0.001) and hospital (p = 0.031) lengths of stays and were less frequently discharged home (p = 0.008). Logistic regression analyses of patient characteristics and sTBI interventions demonstrated that hypernatremia was independently associated with the presence of fixed pupil(s) on admission (odds ratio [OR] 5.38; p = 0.003); administration of thiopental (OR 8.64; p = 0.014), and development of central diabetes insipidus (OR 5.66; p = 0.005). Additional logistic regression analyses demonstrated a significant association between hypernatremia and mortality (OR 6.660; p = 0.034). In summary, acquired hypernatremia appears to signal higher risk of mortality in pediatric sTBI and is associated with a higher discharge level of care in sTBI survivors.	[Alharfi, Ibrahim M.; Kelly, Shawn H.; Morrison, Gavin C.; Fraser, Douglas D.] Univ Western Ontario, Dept Paediat, London, ON, Canada; [Alharfi, Ibrahim M.] King Fahad Med City, Dept Pediat Crit Care, Riyadh, Saudi Arabia; [Stewart, Tanya Charyk] Univ Western Ontario, Dept Surg, London, ON N6A 3K7, Canada; [Stewart, Tanya Charyk] LHSC, Trauma Program, London, ON N6A 5W9, Canada; [Fraser, Douglas D.] Translat Res Ctr, London, ON, Canada; [Fraser, Douglas D.] Childrens Hlth Res Inst, London, ON, Canada; [Fraser, Douglas D.] Univ Western Ontario, London, ON, Canada; [Fraser, Douglas D.] Ctr Crit Illness Res, London, ON, Canada	Fraser, DD (corresponding author), LHSC, Childrens Hosp, Room C2-C82,800 Commissioners Rd East, London, ON N6A 5W9, Canada.	Douglas.Fraser@lhsc.on.ca					Adelson P David, 2003, Pediatr Crit Care Med, V4, pS2, DOI 10.1097/01.CCM.0000066600.71233.01; Adelson P David, 2003, Pediatr Crit Care Med, V4, pS65; Aiyagari V, 2006, J CRIT CARE, V21, P163, DOI 10.1016/j.jcrc.2005.10.002; Alharfi I.M., 2013, PEDIAT CRIT CARE MED; An HS, 2010, J KOREAN NEUROSURG S, V47, P252, DOI 10.3340/jkns.2010.47.4.252; [Anonymous], 1995, ABBR INJ SCAL MAN; Bahloul M, 2009, INJURY, V40, P535, DOI 10.1016/j.injury.2008.04.018; BARZILAY Z, 1988, J MED, V19, P47; Boughey JC, 2004, AM SURGEON, V70, P500; CHAN KH, 1990, CHILD NERV SYST, V6, P27, DOI 10.1007/BF00262262; Dunn K, 1997, J PAEDIATR CHILD H, V33, P26, DOI 10.1111/j.1440-1754.1997.tb00986.x; Fisher LA, 2006, NEUROCRIT CARE, V5, P180, DOI 10.1385/NCC:5:3:180; Hoorn EJ, 2008, NEPHROL DIAL TRANSPL, V23, P1562, DOI 10.1093/ndt/gfm831; Hosmer D, 1989, APPL LOGISTIC REGRES; Huynh F, 2009, THER DRUG MONIT, V31, P153, DOI 10.1097/FTD.0b013e318196fb9f; Javouhey E, 2006, EUR J PEDIATR, V165, P519, DOI 10.1007/s00431-006-0118-z; Khanna S, 2000, CRIT CARE MED, V28, P1144, DOI 10.1097/00003246-200004000-00038; Lekmanov A. U., 2010, Anesteziologiya i Reanimatologiya, P41; Lindner G, 2007, AM J KIDNEY DIS, V50, P952, DOI 10.1053/j.ajkd.2007.08.016; Lindner G, 2010, INTENS CARE MED, V36, P1718, DOI 10.1007/s00134-010-1968-4; Maggiore U, 2009, CRIT CARE, V13, DOI 10.1186/cc7953; Moritz ML, 1999, PEDIATRICS, V104, P435, DOI 10.1542/peds.104.3.435; Moro N, 2007, SURG NEUROL, V68, P387, DOI 10.1016/j.surneu.2006.11.052; Ngo QN, 2009, PEDIATR CRIT CARE ME, V10, P346, DOI 10.1097/PCC.0b013e3181a320cd; Peterson B, 2000, CRIT CARE MED, V28, P1136, DOI 10.1097/00003246-200004000-00037; Ralston M, 2006, PALS PROVIDER MANUAL; SCHALEN W, 1992, ACTA ANAESTH SCAND, V36, P369, DOI 10.1111/j.1399-6576.1992.tb03483.x; Shore PM, 2006, CRIT CARE MED, V34, P1981, DOI 10.1097/01.CCM.0000220765.22184.ED; Simma B, 1998, CRIT CARE MED, V26, P1265, DOI 10.1097/00003246-199807000-00032; TEPAS JJ, 1990, J PEDIATR SURG, V25, P92, DOI 10.1016/S0022-3468(05)80170-8; Tisdall M, 2006, J NEUROSURG ANESTH, V18, P57, DOI 10.1097/01.ana.0000191280.05170.0f; Melo JRT, 2010, NEUROSURGERY, V67, P1542, DOI 10.1227/NEU.0b013e3181fa7049; Yanay O, 2004, J CRIT CARE, V19, P174, DOI 10.1016/j.jcrc.2004.07.008; Zygun DA, 2009, CRIT CARE, V13, DOI 10.1186/cc8014	34	22	25	0	8	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	MAR	2013	30	5					361	366		10.1089/neu.2012.2410			6	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	103CI	WOS:000315891600006	23057958				2021-06-18	
J	Karaca, Z; Tanriverdi, F; Dagli, AT; Selcuklu, A; Casanueva, FF; Unluhizarci, K; Kelestimur, F				Karaca, Z.; Tanriverdi, F.; Dagli, A. T.; Selcuklu, A.; Casanueva, F. F.; Unluhizarci, K.; Kelestimur, F.			Three years prospective investigation of pituitary functions following subarachnoid haemorrhage	PITUITARY			English	Article						Subarachnoid haemorrhage; Pituitary; Cortisol; Growth hormone	TRAUMATIC BRAIN-INJURY; NEUROENDOCRINE DYSFUNCTION; ACUTE-PHASE; HIGH-RISK; HYPOPITUITARISM	Subarachnoid haemorrhage (SAH) is known to be related to pituitary dysfuntion in retrospective and short-term prospective studies. We aimed to investigate pituitary functions in patients with SAH in longer follow-up periods to demonstrate if pituitary hormone deficiencies recover, persist or new hormone deficiencies occur. Twenty patients with SAH, who were followed up for 3 years, were included in the present study. Patients were evaluated with basal hormone levels and glucagon stimulation test (GST). Serum basal cortisol and adrenocorticotropic hormone (ACTH) levels were found to be significantly elevated at 3rd year of SAH compared to 1st year. Other basal hormone levels at 3rd year did not show a significant change from the levels found at 1st year. One of the patients had ACTH deficiency at 1st year of SAH and recovered at 3rd year. Growth hormone (GH) deficiency, according to GST, was diagnosed in 4 patients. One patient with GH deficiency at first year was still deficient, 3 of them recovered and 3 patients were found to have new-onset GH deficiency 3 years after SAH. SAH is associated with anterior pituitary dysfunction and GH is the most frequently found deficient hormone in the patients. Although one year after SAH seems to be an appropriate time for the evaluation of pituitary functions, further follow-up may be required at least in some cases due to recovered and new-onset hormone deficiencies at 3rd year of SAH.	[Karaca, Z.; Tanriverdi, F.; Unluhizarci, K.; Kelestimur, F.] Erciyes Univ, Sch Med, Dept Endocrinol, TR-38039 Kayseri, Turkey; [Dagli, A. T.; Selcuklu, A.] Erciyes Univ, Sch Med, Dept Neurosurg, TR-38039 Kayseri, Turkey; [Casanueva, F. F.] Univ Santiago de Compostela, Santiago De Compostela 15705, Spain	Kelestimur, F (corresponding author), Erciyes Univ, Sch Med, Dept Endocrinol, TR-38039 Kayseri, Turkey.	fktimur@erciyes.edu.tr					Aimaretti G, 2005, J CLIN ENDOCR METAB, V90, P6085, DOI 10.1210/jc.2005-0504; Aimaretti G, 2004, CLIN ENDOCRINOL, V61, P320, DOI 10.1111/j.1365-2265.2004.02094.x; Bendel S, 2008, CRIT CARE, V12, DOI 10.1186/cc7084; BURKE CW, 1992, CLIN ENDOCRINOL, V36, P133, DOI 10.1111/j.1365-2265.1992.tb00946.x; Dimopoulou I, 2004, STROKE, V35, P2884, DOI 10.1161/01.STR.0000147716.45571.45; FISHER CM, 1980, NEUROSURGERY, V6, P1, DOI 10.1227/00006123-198001000-00001; HUNT WE, 1968, J NEUROSURG, V28, P14, DOI 10.3171/jns.1968.28.1.0014; Jovanovic V, 2010, HORM-INT J ENDOCRINO, V9, P235, DOI 10.14310/horm.2002.1273; Klose M, 2010, CLIN ENDOCRINOL, V73, P95, DOI 10.1111/j.1365-2265.2010.03791.x; Kreitschmann-Andermahr I, 2004, J CLIN ENDOCR METAB, V89, P4986, DOI 10.1210/jc.2004-0146; Kreitschmann-Andermahr I, 2011, EXP CLIN ENDOCR DIAB, V119, P15, DOI 10.1055/s-0030-1253414; Lamberts SWJ, 1998, LANCET, V352, P127; Lammert A, 2011, EXP CLIN ENDOCR DIAB, V119, P111, DOI 10.1055/s-0030-1262815; Parenti G, 2011, J ENDOCRINOL INVEST, V34, P361, DOI [10.1007/BF03347460, 10.3275/7242]; Schneider HJ, 2011, J NEUROTRAUM, V28, P1693, DOI 10.1089/neu.2011.1887; Schneider HJ, 2007, JAMA-J AM MED ASSOC, V298, P1429, DOI 10.1001/jama.298.12.1429; Shin IY, 2011, STRESS, V14, P156, DOI 10.3109/10253890.2010.522630; Tanriverdi F, 2010, PITUITARY, V13, P111, DOI 10.1007/s11102-009-0204-0; Tanriverdi F, 2008, J NEUROTRAUM, V25, P1071, DOI 10.1089/neu.2007.0456; Tanriverdi F, 2008, EUR J ENDOCRINOL, V159, P7, DOI 10.1530/EJE-08-0050; Tanriverdi F, 2007, CLIN ENDOCRINOL, V67, P931, DOI 10.1111/j.1365-2265.2007.02989.x; Tanriverdi F, 2007, CLIN ENDOCRINOL, V66, P360, DOI 10.1111/j.1365-2265.2006.02737.x; Tanriverdi F, 2010, J NEUROTRAUM, V27, P301, DOI 10.1089/neu.2009.1102; van Gijn J, 2001, BRAIN, V124, P249, DOI 10.1093/brain/124.2.249; Weant KA, 2008, NEUROSURGERY, V63, P645, DOI 10.1227/01.NEU.0000325728.50939.15	25	22	22	0	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1386-341X	1573-7403		PITUITARY	Pituitary	MAR	2013	16	1					76	82		10.1007/s11102-012-0377-9			7	Endocrinology & Metabolism	Endocrinology & Metabolism	087HM	WOS:000314752100009	22315089				2021-06-18	
J	Nakagawa, H; Ueno, M; Itokazu, T; Yamashita, T				Nakagawa, H.; Ueno, M.; Itokazu, T.; Yamashita, T.			Bilateral movement training promotes axonal remodeling of the corticospinal tract and recovery of motor function following traumatic brain injury in mice	CELL DEATH & DISEASE			English	Article						traumatic brain injury; rehabilitative training; functional recovery; corticospinal tract	SPINAL-CORD; STRUCTURAL PLASTICITY; CORTICAL PLASTICITY; PYRAMIDAL TRACT; STAIRCASE TEST; RAT FORELIMB; ADULT RATS; STROKE; TASK; SYSTEM	Traumatic brain injury (TBI) results in severe motor function impairment, and subsequent recovery is often incomplete. Rehabilitative training is considered to promote restoration of the injured neural network, thus facilitating functional recovery. However, no studies have assessed the effect of such trainings in the context of neural rewiring. Here, we investigated the effects of two types of rehabilitative training on corticospinal tract (CST) plasticity and motor recovery in mice. We injured the unilateral motor cortex with contusion, which induced hemiparesis on the contralesional side. After the injury, mice performed either a single pellet-reaching task (simple repetitive training) or a rotarod task (bilateral movement training). Multiple behavioral tests were then used to assess forelimb motor function recovery: staircase, ladder walk, capellini handling, single pellet, and rotarod tests. The TBI+rotarod group performed most forelimb motor tasks (staircase, ladder walk, and capellini handling tests) better than the TBI-only group did. In contrast, the TBI+reaching group did not perform better except in the single pellet test. After the injury, the contralateral CST, labeled by biotinylated dextran amine, formed sprouting fibers into the denervated side of the cervical spinal cord. The number of these fibers was significantly higher in the TBI+rotarod group, whereas it did not increase in the TBI+reaching group. These results indicate that bilateral movement training effectively promotes axonal rewiring and motor function recovery, whereas the effect of simple repetitive training is limited. Cell Death and Disease (2013) 4, e534; doi:10.1038/cddis.2013.62; published online 7 March 2013	[Nakagawa, H.; Ueno, M.; Itokazu, T.; Yamashita, T.] Osaka Univ, Dept Mol Neurosci, Grad Sch Med, Suita, Osaka 5650871, Japan; [Nakagawa, H.; Ueno, M.; Itokazu, T.; Yamashita, T.] Japan Sci & Technol Agcy JST, CREST, Chiyoda Ku, Tokyo, Japan; [Itokazu, T.] Kyoto Univ, Dept Neurol, Grad Sch Med, Sakyo Ku, Kyoto, Japan	Yamashita, T (corresponding author), Osaka Univ, Dept Mol Neurosci, Grad Sch Med, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	yamashita@molneu.med.osaka-u.ac.jp	Ueno, Masaki/J-1216-2019	Itokazu, Takahide/0000-0003-2977-7190; Yamashita, Toshihide/0000-0003-4559-7018	Core Research for Evolutional Science and Technology (CREST) from Japan Science and Technology Agency (JST)Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST)	We thank Dr. J Patrick Card (University of Pittsburgh) and Lynn W Enquist (Princeton University) for their kind gift of PRV. This work was supported by Core Research for Evolutional Science and Technology (CREST) from Japan Science and Technology Agency (JST).	Allred RP, 2008, J NEUROSCI METH, V170, P229, DOI 10.1016/j.jneumeth.2008.01.015; Baird AL, 2001, BRAIN RES BULL, V54, P243, DOI 10.1016/S0361-9230(00)00457-3; CALLISTER RJ, 1987, J COMP NEUROL, V255, P369, DOI 10.1002/cne.902550305; Cauraugh JH, 2005, PROG NEUROBIOL, V75, P309, DOI 10.1016/j.pneurobio.2005.04.001; Conner JM, 2005, NEURON, V46, P173, DOI 10.1016/j.neuron.2005.03.003; Ding Y, 2004, NEUROSCIENCE, V123, P667, DOI 10.1016/j.neuroscience.2003.08.031; Dobkin BH, 2009, CURR OPIN NEUROL, V22, P563, DOI 10.1097/WCO.0b013e3283314b11; Flavell SW, 2008, ANNU REV NEUROSCI, V31, P563, DOI 10.1146/annurev.neuro.31.060407.125631; French B, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006073.pub2; Garcia-Alias G, 2009, NAT NEUROSCI, V12, P1145, DOI 10.1038/nn.2377; Girgis J, 2007, BRAIN, V130, P2993, DOI 10.1093/brain/awm245; Jacobsson LJ, 2009, ACTA NEUROL SCAND, V120, P389, DOI 10.1111/j.1600-0404.2009.01238.x; Jones TA, 1999, J NEUROSCI, V19, P10153; Kiehn O, 1998, ANN NY ACAD SCI, V860, P110, DOI 10.1111/j.1749-6632.1998.tb09043.x; Kjaerulff O, 1996, J NEUROSCI, V16, P5777; Krajacic A, 2010, BEHAV BRAIN RES, V214, P323, DOI 10.1016/j.bbr.2010.05.053; Krajacic A, 2009, EUR J NEUROSCI, V29, P641, DOI 10.1111/j.1460-9568.2008.06600.x; Lee HJ, 2007, STEM CELLS, V25, P1204, DOI 10.1634/stemcells.2006-0409; LEMON RN, 1993, EXP PHYSIOL, V78, P263, DOI 10.1113/expphysiol.1993.sp003686; Liu ZW, 2008, STROKE, V39, P2571, DOI 10.1161/STROKEAHA.107.511659; Luft AR, 2004, JAMA-J AM MED ASSOC, V292, P1853, DOI 10.1001/jama.292.15.1853; Maier IC, 2008, J NEUROSCI, V28, P9386, DOI 10.1523/JNEUROSCI.1697-08.2008; Martinowich K, 2007, NAT NEUROSCI, V10, P1089, DOI 10.1038/nn1971; McKenna JE, 2000, J COMP NEUROL, V419, P286, DOI 10.1002/(SICI)1096-9861(20000410)419:3<286::AID-CNE2>3.0.CO;2-3; Metz GA, 2002, J NEUROSCI METH, V115, P169, DOI 10.1016/S0165-0270(02)00012-2; Miklyaeva EI, 1996, BEHAV NEUROSCI, V110, P117; MONTOYA CP, 1991, J NEUROSCI METH, V36, P219, DOI 10.1016/0165-0270(91)90048-5; NAKAYAMA H, 1994, ARCH PHYS MED REHAB, V75, P852, DOI 10.1016/0003-9993(94)90108-2; Omoto S, 2010, J NEUROSCI, V30, P13045, DOI 10.1523/JNEUROSCI.3228-10.2010; Ploughman M, 2007, EUR J NEUROSCI, V25, P3453, DOI 10.1111/j.1460-9568.2007.05591.x; Quinlan KA, 2007, J NEUROSCI, V27, P6521, DOI 10.1523/JNEUROSCI.1618-07.2007; Ramanathan D, 2006, P NATL ACAD SCI USA, V103, P11370, DOI 10.1073/pnas.0601065103; Smith JM, 2007, BRAIN, V130, P915, DOI 10.1093/brain/awl393; Starkey ML, 2011, EXP NEUROL, V232, P81, DOI 10.1016/j.expneurol.2011.08.006; Starkey ML, 2012, BRAIN, V135, P3265, DOI 10.1093/brain/aws270; Stinear CM, 2008, BRAIN, V131, P1381, DOI 10.1093/brain/awn051; SWANSON RA, 1990, J CEREBR BLOOD F MET, V10, P290, DOI 10.1038/jcbfm.1990.47; Tabuse M, 2010, J CLIN NEUROSCI, V17, P1412, DOI 10.1016/j.jocn.2010.01.056; Tennant Kelly A, 2010, J Vis Exp, DOI 10.3791/2076; Ueno M, 2012, BRAIN, V135, P1253, DOI 10.1093/brain/aws053; Vavrek R, 2006, BRAIN, V129, P1534, DOI 10.1093/brain/awl087; Wang L, 2011, P NATL ACAD SCI USA, V108, P2545, DOI 10.1073/pnas.1014335108; WHISHAW IQ, 1993, BEHAV BRAIN RES, V56, P59, DOI 10.1016/0166-4328(93)90022-I; Whishaw IQ, 1996, BEHAV BRAIN RES, V77, P135, DOI 10.1016/0166-4328(95)00209-X; Whishaw IQ, 1998, BEHAV BRAIN RES, V93, P167, DOI 10.1016/S0166-4328(97)00152-6; Whitall J, 2000, STROKE, V31, P2390, DOI 10.1161/01.STR.31.10.2390; Will B, 2004, PROG NEUROBIOL, V72, P167, DOI 10.1016/j.pneurobio.2004.03.001; Woldag H, 2003, CLIN REHABIL, V17, P723, DOI 10.1191/0269215503cr669oa; Wolpaw JR, 1997, TRENDS NEUROSCI, V20, P588, DOI 10.1016/S0166-2236(97)01133-8; Xu TH, 2009, NATURE, V462, P915, DOI 10.1038/nature08389; ZAFRA F, 1990, EMBO J, V9, P3545, DOI 10.1002/j.1460-2075.1990.tb07564.x	51	22	22	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2041-4889			CELL DEATH DIS	Cell Death Dis.	MAR	2013	4								e534	10.1038/cddis.2013.62			9	Cell Biology	Cell Biology	116FR	WOS:000316868700013	23470541	DOAJ Gold, Green Published			2021-06-18	
J	Rozzelle, CJ; Aarabi, B; Dhall, SS; Gelb, DE; Hurlbert, RJ; Ryken, TC; Theodore, N; Walters, BC; Hadley, MN				Rozzelle, Curtis J.; Aarabi, Bizhan; Dhall, Sanjay S.; Gelb, Daniel E.; Hurlbert, R. John; Ryken, Timothy C.; Theodore, Nicholas; Walters, Beverly C.; Hadley, Mark N.			Spinal Cord Injury Without Radiographic Abnormality (SCIWORA)	NEUROSURGERY			English	Article						Pediatric patient population; SCIWORA; Spinal immobilization	RESONANCE-IMAGING CORRELATION; CHILDREN; CONCUSSION; YOUNG		[Rozzelle, Curtis J.] Univ Alabama Birmingham, Childrens Hosp Alabama, Div Neurol Surg, Birmingham, AL USA; [Aarabi, Bizhan] Univ Maryland, Dept Neurosurg, Baltimore, MD 21201 USA; [Gelb, Daniel E.] Univ Maryland, Dept Orthopaed, Baltimore, MD 21201 USA; [Dhall, Sanjay S.] Emory Univ, Dept Neurosurg, Atlanta, GA 30322 USA; [Hurlbert, R. John] Univ Calgary, Dept Clin Neurosci, Univ Calgary Spine Program, Fac Med, Calgary, AB, Canada; [Ryken, Timothy C.] Univ Iowa, Iowa Spine & Brain Inst, Waterloo, ON, Canada; [Theodore, Nicholas] Barrow Neurol Inst, Div Neurol Surg, Phoenix, AZ 85013 USA; [Walters, Beverly C.; Hadley, Mark N.] Univ Alabama Birmingham, Div Neurol Surg, Birmingham, AL USA; [Walters, Beverly C.] Inova Hlth Syst, Dept Neurosci, Falls Church, VA USA	Hadley, MN (corresponding author), UAB Div Neurol Surg, 510 20th St S,FOT 1030, Birmingham, AL 35294 USA.	mhadley@uabmc.edu	Walters, Beverly/R-8411-2019	Walters, Beverly/0000-0002-5244-4282; Theodore, Nicholas/0000-0001-5355-2683			[Anonymous], 2002, NEUROSURGERY S, V50, pS100; Bosch PP, 2002, SPINE, V27, P2788, DOI 10.1097/00007632-200212150-00009; BRACKEN MB, 1990, NEW ENGL J MED, V322, P1405, DOI 10.1056/NEJM199005173222001; BRUCE DA, 1989, PEDIATR NEUROSCI, V15, P216, DOI 10.1159/000120471; Dare AO, 2002, J NEUROSURG, V97, P33, DOI 10.3171/spi.2002.97.1.0033; DAVIS PC, 1993, AM J NEURORADIOL, V14, P607; DELBIGIO MR, 1989, SPINE, V14, P37, DOI 10.1097/00007632-198901000-00007; DICKMAN CA, 1991, J SPINAL DISORD, V4, P296, DOI 10.1097/00002517-199109000-00006; Eleraky MA, 2000, J NEUROSURG, V92, P12, DOI 10.3171/spi.2000.92.1.0012; GRABB PA, 1994, NEUROSURGERY, V35, P406, DOI 10.1227/00006123-199409000-00007; HADLEY MN, 1988, J NEUROSURG, V68, P18, DOI 10.3171/jns.1988.68.1.0018; HAMILTON MG, 1992, J NEUROSURG, V77, P700, DOI 10.3171/jns.1992.77.5.0700; Liao CC, 2005, J NEUROSURG, V103, P17, DOI 10.3171/ped.2005.103.1.0017; OSENBACH RK, 1989, PEDIATR NEUROSCI, V15, P168, DOI 10.1159/000120464; OSENBACH RK, 1992, NEUROSURGERY, V30, P385, DOI 10.1227/00006123-199203000-00012; Pang D, 2004, NEUROSURGERY, V55, P1325, DOI 10.1227/01.NEU.0000143030.85589.E6; PANG D, 1989, J TRAUMA, V29, P654, DOI 10.1097/00005373-198905000-00021; PANG D, 1982, J NEUROSURG, V57, P114, DOI 10.3171/jns.1982.57.1.0114; POLLACK IF, 1988, J NEUROSURG, V69, P177, DOI 10.3171/jns.1988.69.2.0177; Pollina J, 1999, PEDIATR NEUROSURG, V30, P263, DOI 10.1159/000028808; Ramon S, 1997, SPINAL CORD, V35, P664, DOI 10.1038/sj.sc.3100490; RATHBONE D, 1992, J PEDIATR ORTHOPED, V12, P616; ROSSITCH E, 1992, PEDIATR NEUROSURG, V18, P149; RUGE JR, 1988, J NEUROSURG, V68, P25, DOI 10.3171/jns.1988.68.1.0025; Torg JS, 1996, J BONE JOINT SURG AM, V78A, P1308, DOI 10.2106/00004623-199609000-00003; Torg JS, 1997, J NEUROSURG, V87, P843, DOI 10.3171/jns.1997.87.6.0843; Turgut M, 1996, Eur Spine J, V5, P148, DOI 10.1007/BF00395505	27	22	28	0	10	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0148-396X			NEUROSURGERY	Neurosurgery	MAR	2013	72			2			227	233		10.1227/NEU.0b013e3182770ebc			7	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	103TP	WOS:000315942300022	23417193				2021-06-18	
J	Loov, C; Shevchenko, G; Nadadhur, AG; Clausen, F; Hillered, L; Wetterhall, M; Erlandsson, A				Loov, Camilla; Shevchenko, Ganna; Nadadhur, Aishwarya Geeyarpuram; Clausen, Fredrik; Hillered, Lars; Wetterhall, Magnus; Erlandsson, Anna			Identification of Injury Specific Proteins in a Cell Culture Model of Traumatic Brain Injury	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; IN-VITRO MODELS; HEAD-INJURY; MEMBRANE; FUSION; ASSOCIATION; EXPRESSION; MOLECULES; MIGRATION; CYTOKINES	The complicated secondary molecular and cellular mechanisms following traumatic brain injury (TBI) are still not fully understood. In the present study, we have used mass spectrometry to identify injury specific proteins in an in vitro model of TBI. A standardized injury was induced by scalpel cuts through a mixed cell culture of astrocytes, oligodendrocytes and neurons. Twenty-four hours after the injury, cell culture medium and whole-cell fractions were collected for analysis. We found 53 medium proteins and 46 cell fraction proteins that were specifically expressed after injury and the known function of these proteins was elucidated by an extensive literature survey. By using time-lapse microscopy and immunostainings we could link a large proportion of the proteins to specific cellular processes that occur in response to trauma; including cell death, proliferation, lamellipodia formation, axonal regeneration, actin remodeling, migration and inflammation. A high percentage of the proteins uniquely expressed in the medium after injury were actin-related proteins, which normally are situated intracellularly. We show that two of these, ezrin and moesin, are expressed by astrocytes both in the cell culture model and in mouse brain subjected to experimental TBI. Interestingly, we found many inflammation-related proteins, despite the fact that cells were present in the culture. This study contributes with important knowledge about the cellular responses after trauma and identifies several potential cell-specific biomarkers.	[Loov, Camilla; Nadadhur, Aishwarya Geeyarpuram; Clausen, Fredrik; Hillered, Lars; Erlandsson, Anna] Uppsala Univ, Dept Neurosci, Uppsala, Sweden; [Shevchenko, Ganna; Wetterhall, Magnus] Uppsala Univ, Dept Chem BMC, Uppsala, Sweden	Erlandsson, A (corresponding author), Uppsala Univ, Dept Neurosci, Uppsala, Sweden.	anna.erlandsson@neuro.uu.se		Clausen, Fredrik/0000-0003-3592-4417; G Nadadhur, Aishwarya/0000-0003-0468-9135; Hillered, Lars/0000-0002-2808-9292	Jeanssons Foundation; Tore Nilssons Foundation; Swedish Society of Medicine [SLS-251631]; Magnus Bergvall foundation [24942*1*2011]; Medical Faculty Foundation for Psychological and Neurological Research at Uppsala University; Uppsala University Hospital	This study was supported by grants from Jeanssons Foundation, Tore Nilssons Foundation, the Swedish Society of Medicine (SLS-251631), Magnus Bergvall foundation (24942*1*2011) and the Medical Faculty Foundation for Psychological and Neurological Research at Uppsala University and Uppsala University Hospital. MW further acknowledges Lars Hiertas Minne Foundation (FO2009-0695) and Signe och Olof Wallenius Foundation (R103). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Campbell JN, 2011, J NEUROTRAUMA; Castoreno AB, 2005, P NATL ACAD SCI USA, V102, P13129, DOI 10.1073/pnas.0506716102; Chastain EML, 2011, BBA-MOL BASIS DIS, V1812, P265, DOI 10.1016/j.bbadis.2010.07.008; Chen XQ, 2005, J CEREBR BLOOD F MET, V25, P338, DOI 10.1038/sj.jcbfm.9600032; Chianale F, 2010, P NATL ACAD SCI USA, V107, P4182, DOI 10.1073/pnas.0908326107; Clausen F, 2007, J NEUROTRAUM, V24, P1295, DOI 10.1089/neu.2006.0258; Fiedler LR, 2009, BIOCHEM SOC T, V37, P1243, DOI 10.1042/BST0371243; Groves E, 2008, CELL MOL LIFE SCI, V65, P1957, DOI 10.1007/s00018-008-7578-4; Helmy A, 2011, PROG NEUROBIOL, V95, P352, DOI 10.1016/j.pneurobio.2011.09.003; Hoffman-Kim D, 2010, ANNU REV BIOMED ENG, V12, P203, DOI 10.1146/annurev-bioeng-070909-105351; Huynh KK, 2007, EMBO J, V26, P313, DOI 10.1038/sj.emboj.7601511; Ingebrigtsen T, 2003, RESTOR NEUROL NEUROS, V21, P171; Johnson V. E., 2010, NAT REV NEUROSCI; Kang CB, 2008, NEUROSIGNALS, V16, P318, DOI 10.1159/000123041; Korobova F, 2008, MOL BIOL CELL, V19, P1561, DOI 10.1091/mbc.E07-09-0964; Kreipke CW, 2006, MICROVASC RES, V71, P197, DOI 10.1016/j.mvr.2006.02.002; Kumaria A, 2008, BRIT J NEUROSURG, V22, P200, DOI 10.1080/02688690701772413; Lee SH, 2010, MOL CELLS, V29, P311, DOI [10.1007/s10059-010-0053-8, 10.1007/s10059-010-0069-0]; Loov C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033090; Louvet-Vallee S, 2000, BIOL CELL, V92, P305, DOI 10.1016/S0248-4900(00)01078-9; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Marion S, 2011, TRAFFIC, V12, P421, DOI 10.1111/j.1600-0854.2011.01158.x; Marklund N, 2011, BRIT J PHARMACOL, V164, P1207, DOI 10.1111/j.1476-5381.2010.01163.x; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Moalem G, 1999, FASEB J, V13, P1207; Moon Y, 2011, NEUROREPORT, V22, P304, DOI 10.1097/WNR.0b013e3283460265; Morrison B, 1998, J NEUROTRAUM, V15, P911, DOI 10.1089/neu.1998.15.911; Morrison B, 2011, ANNU REV BIOMED ENG, V13, P91, DOI 10.1146/annurev-bioeng-071910-124706; Peri F, 2008, CELL, V133, P916, DOI 10.1016/j.cell.2008.04.037; Qi YX, 2008, CARDIOVASC RES, V80, P114, DOI 10.1093/cvr/cvn158; Rao MS, 1999, ANAT RECORD, V257, P137; Ravin R, 2008, CELL STEM CELL, V3, P670, DOI 10.1016/j.stem.2008.09.012; Riddell JR, 2010, J IMMUNOL, V184, P1022, DOI 10.4049/jimmunol.0901945; Shevchenko G, 2012, J PROTEOME RES, V11, P2441, DOI 10.1021/pr201169q; Tran HT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025475; Wisniewski JR, 2009, NAT METHODS, V6, P359, DOI [10.1038/NMETH.1322, 10.1038/nmeth.1322]; Wojciak-Stothard B, 2007, J CELL SCI, V120, P929, DOI 10.1242/jcs.002212; Wolk K, 2005, GENES IMMUN, V6, P452, DOI 10.1038/sj.gene.6364224; Wright KT, 2010, BIOCHEM BIOPH RES CO, V398, P79, DOI 10.1016/j.bbrc.2010.06.039; Xiong Y, 2011, J NEUROSURG, V114, P102, DOI 10.3171/2010.4.JNS10118; Yamaguchi H, 2009, J CELL PHYSIOL, V220, P748, DOI 10.1002/jcp.21822; Zhang W, 2011, P NATL ACAD SCI USA, V108, P4956, DOI 10.1073/pnas.1102527108	43	22	22	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2013	8	2							e55983	10.1371/journal.pone.0055983			13	Multidisciplinary Sciences	Science & Technology - Other Topics	092XV	WOS:000315157200097	23409102	DOAJ Gold, Green Published			2021-06-18	
J	Fernandez-Rodriguez, E; Lopez-Raton, M; Andujar, P; Martinez-Silva, IM; Cadarso-Suarez, C; Casanueva, FF; Bernabeu, I				Fernandez-Rodriguez, E.; Lopez-Raton, M.; Andujar, P.; Martinez-Silva, I. M.; Cadarso-Suarez, C.; Casanueva, F. F.; Bernabeu, I.			Epidemiology, mortality rate and survival in a homogeneous population of hypopituitary patients	CLINICAL ENDOCRINOLOGY			English	Article							ANEURYSMAL SUBARACHNOID HEMORRHAGE; ANTERIOR-PITUITARY FUNCTION; TRAUMATIC BRAIN-INJURY; GH-DEFICIENT ADULTS; GROWTH-HORMONE; CARDIOVASCULAR RISK; METABOLIC SYNDROME; CEREBROVASCULAR MORTALITY; PREMATURE MORTALITY; EXCESS MORTALITY	Introduction Hypopituitarism is associated with higher prevalence of cardiovascular risk factors and premature death. Furthermore, some clinical and therapeutic features of hypopituitarism have been associated with a worse prognosis. Objective We reviewed, retrospectively, a large series of adult patients with hypopituitarism using stringent epidemiological criteria. Prevalence, association with cardiovascular risk factors, mortality and survival have been analysed. Design and Methods Two hundred and nine adult hypopituitary patients (56.9% females) from a population of 405 218 inhabitants, followed for 10 years. Results Prevalence of hypopituitarism at the end of the study was 37.5 cases/100 000 inhabitants. Incidence of hypopituitarism was 2.07 cases/100 000 inhabitants and year. Thirty-two patients died during the period of the study. Standardized mortality rate (SMR) was 8.05, higher in males (8.92 vs 7.34) and in younger patients (84.93 vs 5.26). Diagnosis of acromegaly (P = 0.033), previous radiotherapy (P = 0.02), higher BMI (P = 0.04), diabetes mellitus (P = 0.03) and cancer (P < 0.0001) were associated with mortality. A lower survival was associated with older age at diagnosis, nontumoural causes, previous radiotherapy, diabetes mellitus with poor metabolic control and malignant disease. Conclusions Prevalence of hypopituitarism was 37.5 cases/100 000 inhabitants, and annual incidence was 2.07 cases/100 000 inhabitants. SMR was 8 times higher in hypopituitarism than in general population and was also higher in males and younger patients. Reduced survival was significantly related to cancer, nontumoural causes of hypopituitarism, older age at diagnosis, previous radiotherapy and diabetes mellitus with poor metabolic control.	[Fernandez-Rodriguez, E.; Andujar, P.; Casanueva, F. F.; Bernabeu, I.] Univ Santiago de Compostela SERGAS, Complejo Hosp, Dept Endocrinol, Santiago De Compostela, Spain; [Fernandez-Rodriguez, E.; Andujar, P.; Casanueva, F. F.; Bernabeu, I.] Univ Santiago de Compostela, Inst Invest Sanitaria Santiago Compostela IDIS, Santiago De Compostela 15706, Spain; [Lopez-Raton, M.; Martinez-Silva, I. M.; Cadarso-Suarez, C.] Univ Santiago de Compostela, Fac Med, Biostat Unit, Stat & Operat Res Dept, Santiago De Compostela 15706, Spain; [Casanueva, F. F.] Inst Salud Carlos III, Ctr Invest Biomed Red CIBER Fisiopatol Obesidad &, Santiago De Compostela, Spain	Bernabeu, I (corresponding author), Univ Santiago de Compostela, Complejo Hosp, Dept Endocrinol, Travesia de la Choupana S-N, Santiago De Compostela 15706, Spain.	ignacio.bernabeu.moron@sergas.es	Bernabeu, Ignacio/P-2049-2014	Bernabeu, Ignacio/0000-0001-8421-7394; cadarso-suarez, carmen/0000-0002-9893-9520	Spanish Ministry of Science and InnovationSpanish Government [FISS 11/00161, MTM 2008-01603, MTM2010-09213-E, MTM2011-28285-C02-00]; PfizerPfizer; NovartisNovartis; IpsenIpsen; NovonordiskNovo Nordisk	This work was supported by the Spanish Ministry of Science and Innovation under the grants FISS 11/00161 (to IB) and grants MTM 2008-01603, MTM2010-09213-E and MTM2011-28285-C02-00 (to M L-R, IM M-S and C C-S).; I. B. holds research grant from Pfizer and has received lecture fees from Novartis, Ipsen and Pfizer. F.F.C. holds research grants from Pfizer and Novartis has and received lecture fees from Pfizer, Novartis and Novonordisk. The remaining authors do not have any conflicts of interest that could be perceived as prejudicing the impartiality of the research reported.	Abdu TAM, 2001, CLIN ENDOCRINOL, V55, P209, DOI 10.1046/j.1365-2265.2001.01320.x; Abs R, 2006, EUR J ENDOCRINOL, V155, P79, DOI 10.1530/eje.1.02179; Attanasio AF, 2010, J CLIN ENDOCR METAB, V95, P74, DOI 10.1210/jc.2009-1326; Ayuk J, 2004, J CLIN ENDOCR METAB, V89, P1613, DOI 10.1210/jc.2003-031584; Bates AS, 1999, CLIN ENDOCRINOL, V50, P315, DOI 10.1046/j.1365-2265.1999.00650.x; Bates AS, 1996, J CLIN ENDOCR METAB, V81, P1169, DOI 10.1210/jc.81.3.1169; BESHYAH SA, 1995, CLIN ENDOCRINOL, V42, P179, DOI 10.1111/j.1365-2265.1995.tb01860.x; Brada M, 2002, CLIN ENDOCRINOL, V57, P713, DOI 10.1046/j.1365-2265.2002.01570.x; Bulow B, 1997, CLIN ENDOCRINOL, V46, P75, DOI 10.1046/j.1365-2265.1997.d01-1749.x; Bulow B, 1998, J CLIN ENDOCR METAB, V83, P3897, DOI 10.1210/jc.83.11.3897; Collet D, 1994, MODELLING SURVIVAL D; COX DR, 1972, J R STAT SOC B, V34, P187; Dekkers OM, 2008, J CLIN ENDOCR METAB, V93, P61, DOI 10.1210/jc.2007-1191; Erfurth E M, 2000, Pituitary, V3, P77, DOI 10.1023/A:1009901707125; Erfurth EM, 2004, EUR J ENDOCRINOL, V150, P497, DOI 10.1530/eje.0.1500497; Fernandez-Rodriguez E, 2011, NEUROENDOCRINOLOGY, V93, P181, DOI 10.1159/000324087; FLICKINGER JC, 1989, CANCER, V63, P2404, DOI 10.1002/1097-0142(19890615)63:12<2404::AID-CNCR2820631205>3.0.CO;2-3; Gsponer J, 1999, MEDICINE, V78, P236, DOI 10.1097/00005792-199907000-00004; Heagerty PJ, 2000, BIOMETRICS, V56, P337, DOI 10.1111/j.0006-341X.2000.00337.x; Kaji H, 2007, ENDOCR J, V54, P239, DOI 10.1507/endocrj.K06-129; KISSEBAH AH, 1982, J CLIN ENDOCR METAB, V54, P254, DOI 10.1210/jcem-54-2-254; Lindholm J, 2006, CLIN ENDOCRINOL, V65, P51, DOI 10.1111/j.1365-2265.2006.02545.x; Maison P, 2004, J CLIN ENDOCR METAB, V89, P2192, DOI 10.1210/jc.2003-030840; MARKUSSIS V, 1992, LANCET, V340, P1188, DOI 10.1016/0140-6736(92)92892-J; Mottillo S, 2010, J AM COLL CARDIOL, V56, P1113, DOI 10.1016/j.jacc.2010.05.034; Nielsen EH, 2007, CLIN ENDOCRINOL, V67, P693, DOI 10.1111/j.1365-2265.2007.02947.x; Nielsen EH, 2007, PITUITARY, V10, P67, DOI 10.1007/s11102-007-0018-x; Nilsson B, 2000, J CLIN ENDOCR METAB, V85, P1420, DOI 10.1210/jc.85.4.1420; Nyenwe EA, 2009, AM J MED SCI, V338, P190, DOI 10.1097/MAJ.0b013e3181a84bde; Regal M, 2001, CLIN ENDOCRINOL, V55, P735, DOI 10.1046/j.1365-2265.2001.01406.x; ROSEN T, 1990, LANCET, V336, P285, DOI 10.1016/0140-6736(90)91812-O; Schneider HJ, 2007, JAMA-J AM MED ASSOC, V298, P1429, DOI 10.1001/jama.298.12.1429; Schneider HJ, 2007, LANCET, V369, P1461, DOI 10.1016/S0140-6736(07)60673-4; Stearne MR, 1998, BMJ-BRIT MED J, V317, P703; Stochholm K, 2007, EUR J ENDOCRINOL, V157, P9, DOI 10.1530/EJE-07-0013; Svensson J, 2004, J CLIN ENDOCR METAB, V89, P3306, DOI 10.1210/jc.2003-031601; Swerdlow AJ, 2002, LANCET, V360, P273, DOI 10.1016/S0140-6736(02)09519-3; Tanriverdi F, 2008, CLIN ENDOCRINOL, V68, P573, DOI 10.1111/j.1365-2265.2007.03070.x; Tanriverdi F, 2007, CLIN ENDOCRINOL, V67, P931, DOI 10.1111/j.1365-2265.2007.02989.x; Tichomirowa MA, 2011, EUR J ENDOCRINOL, V165, P509, DOI 10.1530/EJE-11-0304; Tomlinson JW, 2001, LANCET, V357, P425, DOI 10.1016/S0140-6736(00)04006-X; Wachter D, 2009, J CLIN NEUROSCI, V16, P202, DOI 10.1016/j.jocn.2008.01.009	42	22	23	0	25	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0300-0664	1365-2265		CLIN ENDOCRINOL	Clin. Endocrinol.	FEB	2013	78	2					278	284		10.1111/j.1365-2265.2012.04516.x			7	Endocrinology & Metabolism	Endocrinology & Metabolism	067AT	WOS:000313264900018	22845165				2021-06-18	
J	Zhang, JL; Li, DB; Shen, AG; Mao, H; Jin, H; Huang, W; Xu, DW; Fan, JB; Chen, JJ; Yang, LF; Cui, ZM				Zhang, Jinlong; Li, Debao; Shen, Aiguo; Mao, Hui; Jin, Huricha; Huang, Wei; Xu, Dawei; Fan, Jianbo; Chen, Jiajia; Yang, Longfei; Cui, Zhiming			Expression of RBMX After Spinal Cord Injury in Rats	JOURNAL OF MOLECULAR NEUROSCIENCE			English	Article						Spinal cord injury; RBMX; Glial proliferation; Apoptosis; Rats	NUCLEAR RIBONUCLEOPROTEIN-G; ASTROGLIAL SCAR FORMATION; TRAUMATIC BRAIN-INJURY; BCL-2 FAMILY PROTEINS; FUNCTIONAL RECOVERY; BAX TRANSLOCATION; NEURONAL APOPTOSIS; COMPRESSION INJURY; NEURITE OUTGROWTH; SIGNALING PATHWAY	RBMX (RNA-binding motif gene, X chromosome) is a heterogeneous nuclear ribonucleoprotein that associates with the spliceosome, binds RNA, and influences alternative splicing. The gene encoding RBMX is located on chromosome Xq26 and is ubiquitously expressed. However, its expression and function in spinal cord injury are still unclear. In this study, we performed an acute spinal cord contusion injury (SCI) model in adult rats and investigated the dynamic changes of RBMX expression in spinal cord. Western blot and immunohistochemistry analysis revealed that RBMX was present in normal spinal cord. It gradually increased, reached a peak at 1 day, and then declined to basal levels at 14 days after spinal cord injury. Double immunofluorescence staining showed that RBMX immunoreactivity was found in neurons and astrocytes, but not in microglia. Interestingly, RBMX expression was increased predominantly in neurons and astrocytes. Moreover, colocalization of RBMX/proliferating cell nuclear antigen (PCNA) and RBMX/active caspase-3 was detected in GFAP and NeuN, respectively. We also examined the expression profiles of active caspase-3, bcl-2, Bax, and PCNA, whose changes were correlated with the expression profiles of RBMX. In conclusion, this is the first description of RBMX expression in spinal cord injury. Our results suggested that RBMX might play crucial roles in CNS pathophysiology after SCI.	[Zhang, Jinlong; Li, Debao; Jin, Huricha; Huang, Wei; Xu, Dawei; Fan, Jianbo; Chen, Jiajia; Yang, Longfei; Cui, Zhiming] Nantong Univ, Affiliated Hosp 2, Dept Spine Surg, Nantong 226001, Jiangsu, Peoples R China; [Shen, Aiguo] Nantong Univ, Coll Med, Dept Immunol, Nantong 226001, Jiangsu, Peoples R China; [Mao, Hui] Nantong Univ, Affiliated Hosp, Dept Neurosurg, Nantong 226001, Jiangsu, Peoples R China	Cui, ZM (corresponding author), Nantong Univ, Affiliated Hosp 2, Dept Spine Surg, Nantong 226001, Jiangsu, Peoples R China.	cuizhiming2012@hotmail.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81271367]	This work was supported by the National Natural Science Foundation of China (No. 81271367).	Adamson B, 2012, NAT CELL BIOL, V14, P318, DOI 10.1038/ncb2426; Adhami VM, 2003, CLIN CANCER RES, V9, P3176; Bao Y, 2012, J CEREBR BLOOD F MET, V32, P1567, DOI 10.1038/jcbfm.2012.52; Barreiro-Iglesias A, 2012, ENZYME RES, V2012; BASSO DM, 1995, J NEUROTRAUM, V12, P1, DOI 10.1089/neu.1995.12.1; Berens HM, 2011, J VIROL, V85, P3858, DOI 10.1128/JVI.01958-10; Bhattarai G, 2012, BIOL PHARM BULL, V35, P1711, DOI 10.1248/bpb.b12-00297; Cao GD, 2001, J CEREBR BLOOD F MET, V21, P321, DOI 10.1097/00004647-200104000-00001; Ceruti S, 2009, BRAIN, V132, P2206, DOI 10.1093/brain/awp147; Chen KB, 2011, SPINE, V36, P1350, DOI 10.1097/BRS.0b013e3181f014ec; Choi DC, 2010, NEUROBIOL DIS, V39, P272, DOI 10.1016/j.nbd.2010.04.003; Cort A, 2012, J PHYSIOL BIOCHEM, V68, P555, DOI 10.1007/s13105-012-0173-z; FRISEN J, 1995, NEUROSCIENCE, V65, P293, DOI 10.1016/0306-4522(94)00467-J; Ghatan S, 2000, J CELL BIOL, V150, P335, DOI 10.1083/jcb.150.2.335; GRUNER JA, 1992, J NEUROTRAUM, V9, P123, DOI 10.1089/neu.1992.9.123; GRUNER JA, 1992, J NEUROTRAUM, V9, P126; Harris CA, 2001, J BIOL CHEM, V276, P37754; Huan WP, 2012, J MOL HISTOL, V43, P527, DOI 10.1007/s10735-012-9411-5; Jana A, 2009, J NEUROL SCI, V278, P5, DOI 10.1016/j.jns.2008.12.010; Torres BBJ, 2010, INT J EXP PATHOL, V91, P530, DOI 10.1111/j.1365-2613.2010.00738.x; Karimi-Abdolrezaee S, 2012, MOL NEUROBIOL, V46, P251, DOI 10.1007/s12035-012-8287-4; Khalatbary AR, 2012, IRAN RED CRESCENT ME, V14, P229; Liu CJ, 2011, BRAIN RES, V1374, P100, DOI 10.1016/j.brainres.2010.11.061; Liu L, 2012, EUR J PHARMACOL, V691, P61, DOI 10.1016/j.ejphar.2012.07.031; Liu Y, 2010, NEUROBIOL DIS, V37, P384, DOI 10.1016/j.nbd.2009.10.018; Liu YL, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000707; LIUZZI FJ, 1987, SCIENCE, V237, P642, DOI 10.1126/science.3603044; Lopez-Vales R, 2010, J NEUROSCI, V30, P3220, DOI 10.1523/JNEUROSCI.5770-09.2010; Marani M, 2002, MOL CELL BIOL, V22, P3577, DOI 10.1128/MCB.22.11.3577-3589.2002; Marriott JB, 2003, CANCER RES, V63, P593; Martin-Garabato E., 2008, Cancer Genomics & Proteomics, V5, P169; Martinez-Arribas F, 2006, J CELL BIOCHEM, V97, P1275, DOI 10.1002/jcb.20725; Martinou JC, 2011, DEV CELL, V21, P92, DOI 10.1016/j.devcel.2011.06.017; MCKEON RJ, 1991, J NEUROSCI, V11, P3398; Min KJ, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-100; Naseer MI, 2011, SYNAPSE, V65, P562, DOI 10.1002/syn.20875; Ola MS, 2011, MOL CELL BIOCHEM, V351, P41, DOI 10.1007/s11010-010-0709-x; Park OH, 2007, EUR J NEUROSCI, V26, P1421, DOI 10.1111/j.1460-9568.2007.05787.x; Putcha GV, 1999, J NEUROSCI, V19, P7476, DOI 10.1523/JNEUROSCI.19-17-07476.1999; Rahman MA, 2012, MOL CELL BIOCHEM, V369, P95, DOI 10.1007/s11010-012-1372-1; Rong W, 2012, NEUROCHEM RES, V37, P1615, DOI 10.1007/s11064-012-0756-7; RUDGE JS, 1990, J NEUROSCI, V10, P3594; Saadoun S, 2008, BRAIN, V131, P1087, DOI 10.1093/brain/awn014; Sergeant KA, 2007, J CELL SCI, V120, P309, DOI 10.1242/jcs.03344; Shen AU, 2008, NEUROCHEM INT, V52, P1266, DOI 10.1016/j.neuint.2008.01.011; Shin KH, 2008, NITRIC OXIDE-BIOL CH, V19, P125, DOI 10.1016/j.niox.2008.04.012; Shin KH, 2008, BIOCHEM BIOPH RES CO, V372, P880, DOI 10.1016/j.bbrc.2008.05.175; Shin KH, 2007, DNA REPAIR, V6, P830, DOI 10.1016/j.dnarep.2007.01.013; Shin KH, 2006, CLIN CANCER RES, V12, P3222, DOI 10.1158/1078-0432.CCR-05-2656; Song MS, 2009, BRAIN RES, V1271, P114, DOI 10.1016/j.brainres.2009.03.032; Steckley D, 2007, J NEUROSCI, V27, P12989, DOI 10.1523/JNEUROSCI.3400-07.2007; Sun W, 2004, J NEUROSCI, V24, P11205, DOI 10.1523/JNEUROSCI.1436-04.2004; Sunkaria A, 2012, CHEM RES TOXICOL, V25, P1762, DOI 10.1021/tx300234n; Sutherland LC, 2005, J CELL BIOCHEM, V94, P5, DOI 10.1002/jcb.20204; Ullah N, 2011, NEUROPHARMACOLOGY, V61, P1248, DOI 10.1016/j.neuropharm.2011.06.031; White RE, 2008, RESTOR NEUROL NEUROS, V26, P197; White RE, 2011, J NEUROSCI, V31, P15173, DOI 10.1523/JNEUROSCI.3441-11.2011; White RE, 2010, J COMP NEUROL, V518, P1370, DOI 10.1002/cne.22282; Wisniewski ML, 2011, J VIROL, V85, P296, DOI 10.1128/JVI.01982-10; Wu G, 2011, NEUROMOL MED, V13, P187, DOI 10.1007/s12017-011-8150-1; Wu JF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042129; Wu JF, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-169; Wu XM, 2012, J MOL NEUROSCI, V47, P357, DOI 10.1007/s12031-012-9761-1; Xu T, 2012, J MOL HISTOL, V43, P335, DOI 10.1007/s10735-012-9408-0; Yin X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038381; Zhang SW, 2013, J CELL BIOCHEM, V114, P354, DOI 10.1002/jcb.24371; Zhao W, 2011, J MOL HISTOL, V42, P195, DOI 10.1007/s10735-011-9324-8	67	22	23	2	13	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	0895-8696			J MOL NEUROSCI	J. Mol. Neurosci.	FEB	2013	49	2					417	429		10.1007/s12031-012-9914-2			13	Biochemistry & Molecular Biology; Neurosciences	Biochemistry & Molecular Biology; Neurosciences & Neurology	070OW	WOS:000313519900020	23180094				2021-06-18	
J	Baraniuk, JN; Adewuyi, O; Merck, SJ; Ali, M; Ravindran, MK; Timbol, CR; Ray-Han, R; Zheng, Y; Le, U; Esteitie, R; Petrie, KN				Baraniuk, James N.; Adewuyi, Oluwatoyin; Merck, Samantha Jean; Ali, Mushtaq; Ravindran, Murugan K.; Timbol, Christian R.; Ray-Han, Rakib; Zheng, Yin; Le, Uyenphuong; Esteitie, Rania; Petrie, Kristina N.			A Chronic Fatigue Syndrome (CFS) severity score based on case designation criteria	AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH			English	Article						Fatigue; pain; fibromyalgia; myalgic encephalomyelitis; proteomics	TRAUMATIC BRAIN-INJURY; ASTHMA SYMPTOM SCORE; MYALGIC ENCEPHALOMYELITIS; DEFINITION; ILLNESS; NEUROPATHOLOGY; FIBROMYALGIA; POPULATION; PREVALENCE; VETERANS	Background: Chronic Fatigue Syndrome case designation criteria are scored as physicians' subjective, nominal interpretations of patient fatigue, pain (headaches, myalgia, arthralgia, sore throat and lymph nodes), cognitive dysfunction, sleep and exertional exhaustion. Methods: Subjects self-reported symptoms using an anchored ordinal scale of 0 (no symptom), 1 (trivial complaints), 2 (mild), 3 (moderate), and 4 (severe). Fatigue of 3 or 4 distinguished "Fatigued" from "Not Fatigued" subjects. The sum of the 8(Sum8) ancillary criteria was tested as a proxy for fatigue. All subjects had history and physical examinations to exclude medical fatigue, and ensure categorization as healthy or CFS subjects. Results: Fatigued subjects were divided into CFS with >= 4 symptoms or Chronic Idiopathic Fatigue (CIF) with <= 3 symptoms. ROC of Sum8 for CFS and Not Fatigued subjects generated a threshold of 14 (specificity=0.934; sensitivity=0.928). CFS (n=256) and CIF (n=55) criteria were refined to include Sum8 >= 14 and <= 13, respectively. Not Fatigued subjects had highly skewed Sum8 responses. Healthy Controls (HC; n=269) were defined by fatigue <= 2 and Sum8 <= 13. Those with Sum8 >= 14 were defined as CFS-Like With Insufficient Fatigue Syndrome (CFSLWIFS; n=20). Sum8 and Fatigue were highly correlated (R-2=0.977; Cronbach's alpha=0.924) indicating an intimate relationship between symptom constructs. Cluster analysis suggested 4 clades each in CFS and HC. Translational utility was inferred from the clustering of proteomics from cerebrospinal fluid. Conclusions: Plotting Fatigue severity versus Sum8 produced an internally consistent classifying system. This is a necessary step for translating symptom profiles into fatigue phenotypes and their pathophysiological mechanisms.	[Baraniuk, James N.; Adewuyi, Oluwatoyin; Ray-Han, Rakib; Le, Uyenphuong; Esteitie, Rania; Petrie, Kristina N.] Georgetown Univ, Div Rheumatol Immunol & Allergy, Washington, DC 20007 USA; [Merck, Samantha Jean] Univ Penn, Sch Med, Philadelphia, PA 19104 USA; [Ali, Mushtaq] Internal Med Residency Program, Des Moines, IA 50309 USA; [Ravindran, Murugan K.] Norwalk Hosp, Dept Internal Med, Norwalk, CT 06856 USA; [Timbol, Christian R.] Georgetown Univ, Sch Med, Washington, DC 20007 USA; [Zheng, Yin] Univ S Florida, Sch Med, Tampa, FL 33620 USA	Baraniuk, JN (corresponding author), Georgetown Univ, Med Ctr, Div Rheumatol Immunol & Allergy, Room 3004F,3rd Floor PHC Bldg,3800 Reservoir Rd N, Washington, DC 20007 USA.	baraniuj@georgetown.edu			National Institute of Environmental and Health Sciences (NIEHS)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS) [RO1 ES015382]; Congressionally Directed Medical Research Program (CDMRP)United States Department of Defense [W81XWH-07-1-0618, W81XWH-09-1-0526]; National Center for Advancing Translational Sciences (NCATS), National Institutes of Health (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR000101, UL1RR031975]	Funding: This work was funded by the National Institute of Environmental and Health Sciences (NIEHS) (RO1 ES015382) and the Congressionally Directed Medical Research Program (CDMRP awards W81XWH-07-1-0618 and W81XWH-09-1-0526). This project has been funded in whole or in part with Federal funds (Grant # UL1TR000101, previously UL1RR031975) from the National Center for Advancing Translational Sciences (NCATS), National Institutes of Health (NIH), through the Clinical and Translational Science Awards Program (CTSA), a trademark of DHHS, part of the Roadmap Initiative, "Re-Engineering the Clinical Research Enterprise." Competing interests: The authors declare they have no competing interests.	Arpino C, 1999, Ann Ist Super Sanita, V35, P435; Baraniuk JN, 2005, BMC NEUROL, V5, DOI 10.1186/1471-2377-5-22; Baraniuk JN, 1998, ANN ALLERG ASTHMA IM, V81, P359, DOI 10.1016/S1081-1206(10)63129-8; Baraniuk JN, 2005, AM J RESP CRIT CARE, V171, P5, DOI 10.1164/rccm.200403-357OC; Baraniuk JN, 2000, J CFS, V7, P33; Baraniuk JN, 2011, 10 INT ME CFS C OTT; Baraniuk JN, 2000, J CFS, V7, P3; Barnden LR, 2011, NMR BIOMED, V24, P1302, DOI 10.1002/nbm.1692; Bhui KS, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-26; Carruthers BM, 2007, J CLIN PATHOL, V60, P117, DOI 10.1136/jcp.2006.042754; Carruthers BM, 2011, J INTERN MED, V270, P327, DOI 10.1111/j.1365-2796.2011.02428.x; Carruthers BM, 2003, J CHRONIC FATIGUE SY, V11, P7, DOI [10.1300/J092v11n01_02, DOI 10.1300/J092V11N01_02, DOI 10.1300/J092v11n01_02]; Ciccone DS, 2010, J NERV MENT DIS, V198, P486, DOI 10.1097/NMD.0b013e3181e4ce0b; Darbishire L, 2003, BRIT J GEN PRACT, V53, P441; De Luca C, 2010, TOXICOL APPL PHARM, V248, P285, DOI 10.1016/j.taap.2010.04.017; Eglinton R, 2011, PSYCHIAT RES, V188, P245, DOI 10.1016/j.psychres.2011.04.012; Evengard B, 2005, PSYCHOL MED, V35, P1317, DOI 10.1017/S0033291705005052; Fang H, 2006, PHARMACOGENOMICS, V7, P429, DOI 10.2217/14622416.7.3.429; Fletcher MA, 2010, BEHAV BRAIN FUNCT, V6, DOI 10.1186/1744-9081-6-76; Frampton D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016872; FUKUDA K, 1994, ANN INTERN MED, V121, P953, DOI 10.7326/0003-4819-121-12-199412150-00009; Fukuda K, 1998, JAMA-J AM MED ASSOC, V280, P981, DOI 10.1001/jama.280.11.981; Furberg H, 2005, J PSYCHOSOM RES, V59, P283, DOI 10.1016/j.jpsychores.2005.05.008; Heltemes KJ, 2012, INJURY, V43, P1990, DOI 10.1016/j.injury.2011.07.021; Janal MN, 2006, BIOL PSYCHOL, V73, P124, DOI 10.1016/j.biopsycho.2006.01.003; Jason LA, 2005, NEUROPSYCHOL REV, V15, P29, DOI 10.1007/s11065-005-3588-2; Jason LA, 2012, J CLIN PSYCHOL, V68, P41, DOI 10.1002/jclp.20827; Jones JF, 2009, BMC MED, V7, DOI 10.1186/1741-7015-7-57; KLOCKARS AJ, 1995, PSYCHOL BULL, V118, P300, DOI 10.1037/0033-2909.118.2.300; Latremoliere A, 2009, J PAIN, V10, P895, DOI 10.1016/j.jpain.2009.06.012; Mac Donald CL, 2011, NEW ENGL J MED, V364, P2091, DOI 10.1056/NEJMoa1008069; McGeary D, 2011, J CLIN PSYCHOL MED S, V18, P155, DOI 10.1007/s10880-011-9236-5; MCHORNEY CA, 1993, MED CARE, V31, P247, DOI 10.1097/00005650-199303000-00006; MELZACK R, 1987, PAIN, V30, P191, DOI 10.1016/0304-3959(87)91074-8; Miller G, 2011, SCIENCE, V333, P517, DOI 10.1126/science.333.6042.517; Naranch K, 2002, OTOLARYNG HEAD NECK, V127, P387, DOI 10.1067/mhn.2002.129038; National Institute of Standards and Technology, ENG STAT HDB; Neu D, 2008, J SLEEP RES, V17, P427, DOI 10.1111/j.1365-2869.2008.00679.x; Ravindran MK, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-30; Reeves WC, 2003, BMC HEALTH SERV RES, V3, DOI 10.1186/1472-6963-3-25; Reeves WC, 2005, BMC MED, V3, DOI 10.1186/1741-7015-3-19; Reeves William C, 2007, Popul Health Metr, V5, P5; Rowe PC, 2007, AM J MED, V120, pE13, DOI 10.1016/j.amjmed.2006.02.033; Schmaling KB, 2003, PSYCHOSOM MED, V65, P1047, DOI 10.1097/01.PSY.0000088587.29901.69; Schutzer SE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017287; Silberstein SD, 2004, CEPHALALGIA, V24, P2, DOI 10.1111/j.1468-2982.2004.00892.x; SMETS EMA, 1995, J PSYCHOSOM RES, V39, P315, DOI 10.1016/0022-3999(94)00125-O; Steele L, 2000, AM J EPIDEMIOL, V152, P992, DOI 10.1093/aje/152.10.992; Steele Lea, 1998, American Journal of Medicine, V105, p83S, DOI 10.1016/S0002-9343(98)00158-2; Sullivan PF, 2005, PSYCHOL MED, V35, P1337, DOI 10.1017/S0033291705005210; VanNess JM, 2003, MED SCI SPORT EXER, V35, P908, DOI 10.1249/01.MSS.0000069510.58763.E8; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; Wasserfallen JB, 1999, J ASTHMA, V36, P459, DOI 10.3109/02770909909087288; Wasserfallen JB, 1997, J ALLERGY CLIN IMMUN, V100, P16, DOI 10.1016/S0091-6749(97)70189-1; WOLFE F, 1990, ARTHRITIS RHEUM-US, V33, P160, DOI 10.1002/art.1780330203; Wolfe F, 2010, ARTHRIT CARE RES, V62, P600, DOI 10.1002/acr.20140; Zheng Y, 2010, 10 INT ME CFS C OTT	57	22	23	0	21	E-CENTURY PUBLISHING CORP	MADISON	40 WHITE OAKS LN, MADISON, WI 53711 USA	1943-8141			AM J TRANSL RES	Am. J. Transl. Res.		2013	5	1					53	68					16	Oncology; Medicine, Research & Experimental	Oncology; Research & Experimental Medicine	135IB	WOS:000318280700006	23390566				2021-06-18	
J	Hooson, JM; Coetzer, R; Stew, G; Moore, A				Hooson, J. Marian; Coetzer, R.; Stew, G.; Moore, A.			Patients' experience of return to work rehabilitation following traumatic brain injury: A phenomenological study	NEUROPSYCHOLOGICAL REHABILITATION			English	Article						Brain injury; Community vocational rehabilitation	EMPLOYMENT; INDIVIDUALS; RECOVERY	Many persons with traumatic brain injury (TBI) are young adults who, prior to their TBI, were in paid employment. Psychosocial outcome after TBI, for many, remains poor. This includes low rates of return to pre-injury work or education, among others. This qualitative study explored the experience of return to work (RTW) rehabilitation with 10 individuals who sustained TBI. Data were collected from semi-structured interviews. Transcripts were analysed using interpretative phenomenological analysis (IPA). Some of the main findings from this study included the following: Individuals find the RTW experience difficult and painful. They experience a distinct grief reaction in the process of exploring re-engagement in occupation following TBI. In view of these and other findings, changes to RTW rehabilitation should be considered to facilitate the optimal support for patients with TBI engaging in the RTW rehabilitation process.	[Hooson, J. Marian; Coetzer, R.] Colwyn Bay Hosp, North Wales Brain Injury Serv, Colwyn Bay, Wales; [Stew, G.; Moore, A.] Univ Brighton, Sch Hlth Profess, Eastbourne, England	Hooson, JM (corresponding author), Betsi Cadwaladr Univ Hlth Board NHS Wales, Colwyn Bay Hosp, North Wales Brain Injury Serv, Hesketh Rd, Colwyn Bay LL29 8AY, Wales.	Marian.hooson@wales.nhs.uk					ALLEN K, 1994, REHABIL PSYCHOL, V39, P29, DOI 10.1037/h0080313; Aras MD, 2004, INT J REHABIL RES, V27, P257, DOI 10.1097/00004356-200412000-00001; Baillie C, 2000, BRIT J HEALTH PSYCH, V5, P377, DOI 10.1348/135910700168991; Barnes MP, 2001, J REHABIL MED, V33, P244; *BRIT SOC REH MED, 1998, REH TRAUM BRAIN INJ; British Society of Rehabilitation Medicine, 2003, REH ACQ BRAIN INJ; Brown D, 2006, BRAIN INJURY, V20, P937, DOI 10.1080/02699050600909821; Bryden J., 1997, MODELS BRAIN INJURY; Coelho CA, 2002, J SPEECH LANG HEAR R, V45, P1232, DOI 10.1044/1092-4388(2002/099); Coetzer B. R., 2003, J COGNITIVE REHABILI, V21, P4; COPE D N, 1991, Brain Injury, V5, P111, DOI 10.3109/02699059109008083; Darragh AR, 2001, AM J OCCUP THER, V55, P191, DOI 10.5014/ajot.55.2.191; Deegan P, 1996, PSYCHIATR REHABIL J, V19, P91, DOI 10.1037/h0101301; Drake AI, 2000, J HEAD TRAUMA REHAB, V15, P1103, DOI 10.1097/00001199-200010000-00004; ELLERD DA, 1992, J APPL REHABILITATIO, V23, P48; Finlay L., 2006, QUALITATIVE RES ALLI; Kersel DA, 2001, BRAIN INJURY, V15, P683, DOI 10.1080/02699050010013662; Kissinger DB, 2008, WORK, V31, P309; Kolakowsky-Hayner SA, 2001, NEUROREHABILITATION, V16, P41; KUBLERROSS E, 1986, DEATH DYING; Lezak M.D., 2004, NEUROPSYCHOLOGICAL A, Vfourth; Malec JF, 2007, J NEUROTRAUM, V24, P1417, DOI 10.1089/neu.2006.0245; Marks D. F., 2004, RES METHODS CLIN HLT; McCrimmon S, 2006, BRAIN INJURY, V20, P1037, DOI 10.1080/02699050600909656; MCMORDIE W R, 1990, Brain Injury, V4, P57, DOI 10.3109/02699059009026149; Nantulya VM, 2002, BRIT MED J, V324, P1139, DOI 10.1136/bmj.324.7346.1139; O'Hara CC, 1991, REHABILITATION BRAIN; Oppermann JD, 2004, BRAIN INJURY, V18, P941, DOI 10.1080/02699050410001671919; PARENTE R, 1991, J HEAD TRAUMA REHAB, V6, P35; Petrella L, 2005, BRAIN INJURY, V19, P643, DOI 10.1080/02699050410001671874; PONSFORD JL, 1995, BRAIN INJURY, V9, P11, DOI 10.3109/02699059509004566; Porter S, 1996, J ADV NURS, V24, P413, DOI 10.1046/j.1365-2648.1996.19126.x; Power PW, 2003, BRAIN INJURY, V17, P1021, DOI 10.1080/0269905031000110526; Rapp CA, 1998, STRENGTHS MODEL CASE; Rotondi AJ, 2007, J HEAD TRAUMA REHAB, V22, P14, DOI 10.1097/00001199-200701000-00002; SALTER S, 1997, ALTERED BODY IMAGE, P1; Shames J, 2007, DISABIL REHABIL, V29, P1387, DOI 10.1080/09638280701315011; Sherer M, 1998, J HEAD TRAUMA REHAB, V13, P52, DOI 10.1097/00001199-199810000-00007; Smith J.A., 2006, RES METHODS PSYCHOL, P322; Stroebe M.S., 2001, HDB BEREAVEMENT RES; Vanderploeg RD, 2008, ARCH PHYS MED REHAB, V89, P2227, DOI 10.1016/j.apmr.2008.06.015; Wehman P, 2005, J HEAD TRAUMA REHAB, V20, P115, DOI 10.1097/00001199-200503000-00001; Willig C., 2008, INTRO QUALITATIVE RE; Yasuda S, 2001, AM J PHYS MED REHAB, V80, P852, DOI 10.1097/00002060-200111000-00011	44	22	25	0	28	PSYCHOLOGY PRESS	HOVE	27 CHURCH RD, HOVE BN3 2FA, EAST SUSSEX, ENGLAND	0960-2011			NEUROPSYCHOL REHABIL	Neuropsychol. Rehabil.	JAN 1	2013	23	1					19	44		10.1080/09602011.2012.713314			26	Neurosciences; Psychology	Neurosciences & Neurology; Psychology	096BD	WOS:000315377800002	22905786				2021-06-18	
J	Moll, LR; Cott, CA				Moll, Laura R.; Cott, Cheryl A.			The paradox of normalization through rehabilitation: growing up and growing older with cerebral palsy	DISABILITY AND REHABILITATION			English	Article						Aging with disability; cerebral palsy (CP); normalization; rehabilitation; the Life Course Perspective	TRAUMATIC BRAIN-INJURY; SPINAL-CORD-INJURY; HEALTH-CARE; ADULTS; DISABILITY; BODY; PERSPECTIVES; EXPERIENCES; LOCOMOTION; MOBILITY	Purpose: To examine the experience of normalization through rehabilitation for persons growing up & growing older with lifelong physical impairment (cerebral palsy [CP]). Method: A qualitative methodology consisting of narrative inquiry informed by the Life Course Perspective. Multiple (3-4), indepth interviews were completed with each participant in order to co-construct their life stories. Data were systematically compared for themes and categories, as well as the central plot that weaves the participants' experiences together. Results: Nine community-dwelling individuals (three men; six women), aged 26-70, with mild to severe CP participated. Their common narrative involved intensive rehabilitation in childhood that focused on "normalizing" movement, particularly walking. In adolescence they were deemed to have achieved their functional potentials and "nothing further could be done". After transitioning out of pediatric health services many start to lose the gains they achieved in rehabilitation (particularly around walking). In their 30's and 40's they begin to slow down and lose functional abilities but no longer have access to rehabilitation to help them manage their aging bodies. Conclusions: Many of the assumptions that underlie the organization and delivery of rehabilitation services for people with long term impairments may contribute to difficulties encountered in adulthood and old age by focusing on normalizing physical function at the expense of learning to manage their bodies across the life course.	[Moll, Laura R.; Cott, Cheryl A.] Univ Toronto, Fac Med, Grad Dept Rehabil Sci, Toronto, ON M5G 1V7, Canada; [Cott, Cheryl A.] Univ Toronto, Fac Med, Dept Phys Therapy, Toronto, ON M5G 1V7, Canada	Moll, LR (corresponding author), Univ Toronto, Fac Med, Grad Dept Rehabil Sci, Toronto, ON M5G 1V7, Canada.	lrmoll@gmail.com			University of TorontoUniversity of Toronto; Toronto Rehabilitation Institute TRI Student Scholarship Fund; TD Grants in Medical Excellence	This study was funded by the University of Toronto (2004-2005), Toronto Rehabilitation Institute TRI Student Scholarship Fund (2005-2006), and TD Grants in Medical Excellence (2006-2011).	Andersson C, 2001, DEV MED CHILD NEUROL, V43, P76, DOI 10.1017/S0012162201; Andren E, 2000, DISABIL REHABIL, V22, P299, DOI 10.1080/096382800296656; BACK KW, 1970, J GERONTOL, V25, P249, DOI 10.1093/geronj/25.3.249; Barnes Colin., 1999, EXPLORING DISABILITY; Bauman W, 2004, AGING DISABILITY WHA, P196; Bury M., 1996, EXPLORING DIVIDE ILL, P18; Charlifue S, 2004, ARCH PHYS MED REHAB, V85, P1848, DOI 10.1016/j.apmr.2004.03.017; Clandinin D. J., 2000, NARRATIVE INQUIRY EX; Clausen J., 1972, AGING SOC SOCIOLOGY, P457; Clausen J.A., 1998, METHODS LIFE COURSE, P189; Colantonio A, 2004, INT J REHABIL RES, V27, P209, DOI 10.1097/00004356-200409000-00006; Davis Lennard, 1995, ENFORCING NORMALCY D, V1st; De Kleijn-de Vrankrijker MW, 2003, DISABIL REHABIL, V25, P561, DOI 10.1080/09638280110110879; Dean S, 2000, PSYCHOL REP, V86, P653, DOI 10.2466/pr0.2000.86.2.653; Elder, 1998, METHODS LIFE COURSE; Foucault Michel, 2003, BIRTH CLIN ARCHEOLOG; Fougeyrollas P, 2002, TOP SPINAL CORD INJU, V7, P56; Frank A., 1995, WOUNDED STORYTELLER; Furumasu J., 1996, TECHNOL DISABIL, V5, P41; Gajdosik Carrie Giller, 2001, Physical and Occupational Therapy in Pediatrics, V21, P49, DOI 10.1300/J006v21n04_04; Hammel KW., 2006, PERSPECTIVES DISABIL; Harrison Tracie, 2003, J Holist Nurs, V21, P242, DOI 10.1177/0898010103254917; Harrison Tracie C, 2005, Health Care Women Int, V26, P731, DOI 10.1080/07399330500179689; Harrison Tracie Culp, 2006, ANS Adv Nurs Sci, V29, pE1; Hewitt M., 1991, BODY SOCIAL PROCESS, P225; Hilberink SR, 2007, J REHABIL MED, V39, P605, DOI 10.2340/16501977-0103; Hughes B, 2009, DISABIL SOC, V24, P399, DOI 10.1080/09687590902876144; Hurst R, 2003, DISABIL REHABIL, V25, P572, DOI 10.1080/0963828031000137072; Jahnsen R, 2004, CLIN REHABIL, V18, P309, DOI 10.1191/0269215504cr735oa; Jahnsen R, 2002, DISABIL REHABIL, V24, P511, DOI 10.1080/09638280110108805; JAHNSEN R, 2003, ADV PHYSIOTHER, V5, P21, DOI DOI 10.1080/14038190310005779; JOHNSTONE D, 1998, INTRO DISABILITY STU; Kemp B., 2001, TOP SPINAL CORD INJU, V6, P116; Kemp B. J., 2004, AGING DISABILITY WHA; KIELHOFNER G, 2004, CONCEPTUAL FDN OCCUP; Kohler-Riessman C., 2008, NARRATIVE METHODS HU; Kuzel AJ., 1999, DOING QUALITATIVE RE, V2nd, P33; Lammertse DP, 2001, TOP SPINAL CORD INJ, V6, P1; Lankasky K., 2004, AGING DISABILITY WHA, P9; Lankasky K., 2004, AGING DISABILITY WHA; Liem NR, 2004, ARCH PHYS MED REHAB, V85, P1567, DOI 10.1016/j.apmr.2003.12.038; Liptak GS, 2008, CURR OPIN NEUROL, V21, P136, DOI 10.1097/WCO.0b013e3282f6a499; Morris Jenny., 2001, HYPATIA, V16, P1, DOI [10.1111/j.1527-2001.2001.tb00750.x, DOI 10.1111/J.1527-2001.2001.TB00750.X]; Neri MT, 2003, DISABIL REHABIL, V25, P85, DOI 10.1080/0963828021000007941; Nicholls David A., 2010, Physiotherapy Theory and Practice, V26, P497, DOI 10.3109/09593981003710316; Nochi M, 2000, SOC SCI MED, V51, P1795, DOI 10.1016/S0277-9536(00)00111-8; Oliver M, 1998, BRIT MED J, V317, P1446, DOI 10.1136/bmj.317.7170.1446; Oliver M., 1996, DEFINING IMPAIRMENT; Oliver M., 1990, POLITICS DISABLEMENT; Opheim A, 2012, PHYS THER, V92, P279, DOI 10.2522/ptj.20100432; Opheim A, 2009, DEV MED CHILD NEUROL, V51, P381, DOI 10.1111/j.1469-8749.2008.03250.x; Patton M., 2002, QUALITATIVE RES EVAL, P223; Perry J, 2004, AGING DISABILITY WHA, P175; Pimm P., 1992, ED CHILD PSYCHOL, V9, P27; Priestley M., 2003, DISABILITY LIFE COUR; Roebroeck ME, 2009, DEV MED CHILD NEUROL, V51, P670, DOI 10.1111/j.1469-8749.2009.03322.x; Sandstrom K, 2007, CLIN REHABIL, V21, P432, DOI 10.1177/0269215507073489; Schanke HK, 1997, DISABIL REHABIL, V19, P108, DOI 10.3109/09638289709166835; Seymour W, 1998, REMAKING BODY REHABI; Smith B, 2004, DISABIL SOC, V19, P613, DOI 10.1080/0968759042000252533; Strauss D, 2004, NEUROREHABILITATION, V19, P69; Sullivan M., 2005, FOUCAULT GOVT DISABI, P340; Thomas C., 1999, FEMALE FORMS EXPERIE; Thomas C., 2002, DISABILITY STUDIES T; Turner B. S., 1992, REGULATING BODIES ES; VALVANO J, 1991, PEDIATRIC PHYSICAL T, V3, P125, DOI DOI 10.1097/00001577-199100330-00004; Wiart L, 2002, DISABIL REHABIL, V24, P492, DOI 10.1080/09638280110105240; Wilkins S, 1993, AGING CHRONIC ILLNES, P363; Zaffuto-Sforza Celeste D, 2005, Phys Med Rehabil Clin N Am, V16, P235, DOI 10.1016/j.pmr.2004.06.014	69	22	22	0	25	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0963-8288	1464-5165		DISABIL REHABIL	Disabil. Rehabil.		2013	35	15					1276	1283		10.3109/09638288.2012.726689			8	Rehabilitation	Rehabilitation	169VM	WOS:000320808700004	23066918				2021-06-18	
J	Wu, XM; Mao, H; Liu, J; Xu, J; Cao, JH; Gu, XX; Cui, G				Wu, Xinmin; Mao, Hui; Liu, Jiao; Xu, Jian; Cao, Jianhua; Gu, Xingxing; Cui, Gang			Dynamic change of SGK expression and its role in neuron apoptosis after traumatic brain injury	INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY			English	Article						SGK; GSK3 beta/beta-catenin signaling pathway; traumatic brain injury (TBI); neuron apoptosis	GLYCOGEN-SYNTHASE KINASE-3-BETA; CELL-SURVIVAL RESPONSE; PKB/SGK-RESISTANT GSK3; PROTEIN-KINASE; SIGNALING PATHWAYS; BETA-CATENIN; RAT-BRAIN; ACTIVATION; PHOSPHORYLATION; SERUM	Aims: Activation of specific signaling pathways in response to mechanical trauma causes delayed neuronal apoptosis; GSK-3 beta/beta-catenin signaling plays a critical role in the apoptosis of neurons in CNS diseases, SGK was discovered as a regulator of GSK-3 beta/beta-catenin pathway, The goal of this study was to determine if the mechanism of cell death or survival mediated by the SGK/GSK-3 beta/beta-catenin pathway is involved in a rat model of TBI. Main methods: Here, an acute traumatic brain injury model was applied to investigate the expression change and possible roles of SGK, Expression of SGK, and total-GSK-3 beta, phospho-GSK3 beta on ser-9, beta-catenin, and caspase-3 were examined by immunohistochemistry and Western blot analysis. Double immunofluorescent staining was used to observe the SGK localizations. Si-RNA was performed to identify whether SGK regulates neuron apoptosis via GSK3 beta/beta-catenin pathway, ultimately inhibit caspase-3 activation. Key findings: Temporally, SGK expression showed an increase pattern after TBI and reached a peak at day 3. Spatially, SGK was widely expressed in the neuron, rarely in astrocytes and oligodendrocytes; in addition, the expression patterns of active caspase-3 and phospho-GSK3 beta were parallel with that of SGK, at the same time, the expression of beta-catenin shows similarity with SGK. In vitro, to further investigate the function of SGK, a neuronal cell line PC12 was employed to establish an apoptosis model. We analyzed the association of SGK with apoptosis on PC12 cells by western blot, immunofluorescent labeling and siRNA. Significance: the results implied that SGK plays an important role in neuron apoptosis via the regulation of GSK3 beta/beta-catenin signaling pathway; ultimately inhibit caspase-3 activation. Taken together, we inferred traumatic brain injury induced an upregulation of SGK in the central nervous system, which show a protective role in neuron apoptosis.	[Wu, Xinmin] Nantong Univ, Affiliated Hosp, Dept Neurol, Nantong 226001, Jiangsu, Peoples R China; [Mao, Hui] Nantong Univ, Affiliated Hosp, Dept Neurosurg, Nantong 226001, Jiangsu, Peoples R China; [Liu, Jiao] Nantong Univ, Dept Publ Hlth, Nantong 226001, Jiangsu, Peoples R China; [Xu, Jian; Cao, Jianhua] Nantong Univ, Affiliated Mental Hlth Ctr, Nantong 226001, Jiangsu, Peoples R China; [Gu, Xingxing] Nantong Univ, Key Lab Neurosci, Nantong 226001, Peoples R China; [Cui, Gang] Soochow Univ, Affiliated Hosp 1, Dept Neurosurg, Suzhou 215006, Peoples R China	Gu, XX (corresponding author), Nantong Univ, Key Lab Neurosci, Nantong 226001, Peoples R China.	cuigang@suda.edu.cn			Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81070992]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	This work was supported by the Natural Science Foundation of China (81070992); and A Project Funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD).	Andriessen TMJC, 2011, J NEUROTRAUM, V28, P2019, DOI 10.1089/neu.2011.2034; BelAiba RS, 2006, CIRC RES, V98, P828, DOI 10.1161/01.RES.0000210539.54861.27; Beurel E, 2006, PROG NEUROBIOL, V79, P173, DOI 10.1016/j.pneurobio.2006.07.006; Bhat RV, 2000, P NATL ACAD SCI USA, V97, P11074, DOI 10.1073/pnas.190297597; Bhavsar SK, 2012, BIOCHEM BIOPH RES CO, V425, P6, DOI 10.1016/j.bbrc.2012.07.030; Brunet A, 2001, MOL CELL BIOL, V21, P952, DOI 10.1128/MCB.21.3.952-965.2001; Carmichael J, 2002, J BIOL CHEM, V277, P33791, DOI 10.1074/jbc.m204861200; Chen J, 2013, J MOL HISTOL, V44, P1, DOI 10.1007/s10735-012-9444-9; Cho JH, 2004, J BIOL CHEM, V279, P54716, DOI 10.1074/jbc.M403364200; Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5; Dudek H, 1997, SCIENCE, V275, P661, DOI 10.1126/science.275.5300.661; Endo H, 2006, STROKE, V37, P2140, DOI 10.1161/01.STR.0000229888.55078.72; Foller M, 2011, J AM SOC NEPHROL, V22, P873, DOI 10.1681/ASN.2010070757; Frame S, 2001, BIOCHEM J, V359, P1, DOI 10.1042/0264-6021:3590001; Hartigan JA, 1999, J BIOL CHEM, V274, P21395, DOI 10.1074/jbc.274.30.21395; Hartings JA, 2011, LANCET NEUROL, V10, P1058, DOI 10.1016/S1474-4422(11)70243-5; Hetman M, 2000, J NEUROSCI, V20, P2567; Hilton GD, 2008, J CEREBR BLOOD F MET, V28, P1845, DOI 10.1038/jcbfm.2008.75; Hu SX, 2009, NEUROBIOL DIS, V33, P193, DOI 10.1016/j.nbd.2008.10.007; IMAIZUMI K, 1994, MOL BRAIN RES, V26, P189, DOI 10.1016/0169-328X(94)90090-6; Jin Y, 2012, ACTA PHARMACOL SIN, V33, P861, DOI 10.1038/aps.2012.59; Jope RS, 2004, TRENDS BIOCHEM SCI, V29, P95, DOI 10.1016/j.tibs.2003.12.004; Kaytor MD, 2002, CURR OPIN NEUROBIOL, V12, P275, DOI 10.1016/S0959-4388(02)00320-3; Kochanek Patrick M., 2000, Pediatr Crit Care Med, V1, P4, DOI 10.1097/00130478-200007000-00003; Lang F, 2010, J PHYSIOL-LONDON, V588, P3349, DOI 10.1113/jphysiol.2010.190926; Leong MLL, 2003, J BIOL CHEM, V278, P5871, DOI 10.1074/jbc.M211649200; Liu YH, 2010, J NEUROTRAUM, V27, P361, DOI 10.1089/neu.2008.0581; Loane DJ, 2010, TRENDS PHARMACOL SCI, V31, P596, DOI 10.1016/j.tips.2010.09.005; LOGAN A, 1992, J NEUROSCI, V12, P3828; Maggirwar SB, 1999, J NEUROCHEM, V73, P578, DOI 10.1046/j.1471-4159.1999.0730578.x; Park J, 1999, EMBO J, V18, P3024, DOI 10.1093/emboj/18.11.3024; Polakis P, 1999, CURR OPIN GENET DEV, V9, P15, DOI 10.1016/S0959-437X(99)80003-3; Reilly P, 2007, PROG BRAIN RES, V161, P3, DOI 10.1016/S0079-6123(06)61001-7; RINK A, 1995, AM J PATHOL, V147, P1575; Sakoda H, 2003, J BIOL CHEM, V278, P25802, DOI 10.1074/jbc.M301127200; Schoenebeck B, 2005, MOL CELL NEUROSCI, V30, P249, DOI 10.1016/j.mcn.2005.07.017; Siraskar B, 2011, PFLUG ARCH EUR J PHY, V462, P811, DOI 10.1007/s00424-011-1006-6; Tong N, 2001, EUR J NEUROSCI, V13, P1913, DOI 10.1046/j.0953-816x.2001.01572.x; Weber JT, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00060; Yuan J, 2005, CELL DEATH DIFFER, V12, P1097, DOI 10.1038/sj.cdd.4401652; Zhao SF, 2012, NEUROL RES, V34, P400, DOI 10.1179/1743132812Y.0000000025; Zhu D, 2009, NEUROL RES, V31, P200, DOI 10.1179/174313209X393915	42	22	22	0	5	E-CENTURY PUBLISHING CORP	MADISON	40 WHITE OAKS LN, MADISON, WI 53711 USA	1936-2625			INT J CLIN EXP PATHO	Int. J. Clin. Exp. Pathol.		2013	6	7					1282	1293					12	Oncology; Pathology	Oncology; Pathology	216VQ	WOS:000324314000007	23826409				2021-06-18	
J	Kontos, PC; Miller, KL; Gilbert, JE; Mitchell, GJ; Colantonio, A; Keightley, ML; Cott, C				Kontos, Pia C.; Miller, Karen-Lee; Gilbert, Julie E.; Mitchell, Gail J.; Colantonio, Angela; Keightley, Michelle L.; Cott, Cheryl			Improving Client-Centered Brain Injury Rehabilitation Through Research-Based Theater	QUALITATIVE HEALTH RESEARCH			English	Article						brain injury; emotions / emotion work; health care, interprofessional; performance; research, qualitative	GENERAL INTERNAL-MEDICINE; HEALTH-PROFESSIONALS; BREAST-CANCER; EMOTION WORK; FAMILIES; NURSES; DRAMA; COLLABORATION; COMMUNICATION; PERFORMANCE	Traumatic brain injury often results in physical, behavioral, and cognitive impairments perceived by health care practitioners to limit or exclude clients' full participation in treatment decision making. We used qualitative methods to evaluate the short- and long-term impact of "After the Crash: A Play About Brain Injury," a research-based drama designed to teach client-centered care principles to brain injury rehabilitation staff. We conducted interviews and observations with staff of two inpatient neurorehabilitation units in Ontario, Canada. Findings demonstrate the effectiveness of the play in influencing practice through the avoidance of medical jargon to improve clients' understanding and participation in treatment; newfound appreciation for clients' needs for emotional expression and sexual intimacy; increased involvement of family caregivers; and avoidance of staff discussions as if clients were unaware. These findings suggest that research-based drama can effect reflexivity, empathy, and practice change to facilitate a client-centered culture of practice in brain injury rehabilitation.	[Kontos, Pia C.; Miller, Karen-Lee] Toronto Rehabil Inst UHN, Toronto, ON M5G 2A2, Canada; [Gilbert, Julie E.] Canc Care Ontario, Res & Evaluat, Toronto, ON, Canada; [Mitchell, Gail J.] York Univ, Sch Nursing, Toronto, ON M3J 2R7, Canada; [Colantonio, Angela; Keightley, Michelle L.; Cott, Cheryl] Univ Toronto, Dept Occupat Sci & Occupat Therapy, Toronto, ON, Canada; [Cott, Cheryl] Univ Toronto, Dept Phys Therapy, Toronto, ON, Canada	Kontos, PC (corresponding author), Toronto Rehabil Inst UHN, 550 Univ Ave,Suite 11-171, Toronto, ON M5G 2A2, Canada.	pia.kontos@uhn.ca		Kontos, Pia/0000-0002-8893-2544; Colantonio, Angela/0000-0003-2094-4765; Miller, Karen-Lee/0000-0001-7583-6724	Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR) [86624, MOP-86624, MSH -87726, 87726] Funding Source: Medline		Abreu BC, 2002, BRAIN INJURY, V16, P691, DOI 10.1080/02699050210128942; Al-Adawi S, 2007, BRAIN INJURY, V21, P385, DOI 10.1080/02699050701311059; Armstrong J., 2008, NZ J OCCUP THER, V55, P20; Bagley C, 2008, QUAL RES, V8, P53, DOI 10.1177/1468794107085296; Barone T, 2000, AESTHETICS POLITICS; Becker H., 1993, J HEAD TRAUMA REHAB, V8, P88; Blackmer J., 2003, BMC MED ETHICS, P4; Boal A., 1979, THEATRE OPPRESSED; Bolton SC, 2000, J ADV NURS, V32, P580, DOI 10.1046/j.1365-2648.2000.01516.x; BOURHIS RY, 1989, SOC SCI MED, V28, P339, DOI 10.1016/0277-9536(89)90035-X; Bournes DA, 2002, RES NURS HEALTH, V25, P58, DOI 10.1002/nur.10019; Boydell K.M., 2011, FORUM QUALITATIVE SO, V12; Bryant RA, 2001, J NERV MENT DIS, V189, P109, DOI 10.1097/00005053-200102000-00006; Cancienne M., 2001, QUALITATIVE INQUIRY, V7, P221, DOI DOI 10.1177/107780040100700205; Caro D. H., 2011, GLOBAL J HLTH SCI, V3, P19, DOI DOI 10.5539/GJHS.V3N1P19; CHARON R, 1995, ANN INTERN MED, V122, P599, DOI 10.7326/0003-4819-122-8-199504150-00008; Colantonio A, 2008, J CONTIN EDUC HEALTH, V28, P180, DOI 10.1002/chp.177; Colantonio A, 2011, J REHABIL MED, V43, P311, DOI 10.2340/16501977-0783; Conn LG, 2009, QUAL HEALTH RES, V19, P943, DOI 10.1177/1049732309338282; Corring D J, 1999, Can J Occup Ther, V66, P71; Cott CA, 2004, DISABIL REHABIL, V26, P1411, DOI 10.1080/09638280400000237; Cullen N, 2007, BRAIN INJURY, V21, P113, DOI 10.1080/02699050701201540; Denzin N.K., 2003, PERFORMANCE ETHNOGRA; Denzin N. K., 1997, INTERPRETIVE ETHNOGR; Denzin N.K., 1998, COLLECTING INTERPRET; Denzin NK, 2003, SYMB INTERACT, V26, P187, DOI 10.1525/si.2003.26.1.187; Dupuis SL, 2011, FAM RELAT, V60, P104, DOI 10.1111/j.1741-3729.2010.00636.x; Eakin Joan M, 2006, Healthc Policy, V2, P54; Eisner E.W., 1997, EDUC RESEARCHER, V26, P4, DOI DOI 10.3102/0013189X026006004; Eisner E.W., 1993, ED RES, V22, P5, DOI DOI 10.3102/0013189X022007005; Ergh TC, 2002, J HEAD TRAUMA REHAB, V17, P155, DOI 10.1097/00001199-200204000-00006; Gallagher K, 2005, J AESTHET EDUC, V39, P82, DOI 10.1353/jae.2005.0038; Gesler W. M., 2003, HEALING PLACES; Gold R., 1997, QUALITATIVE INQUIRY, V3, P387, DOI DOI 10.1177/107780049700300401; Gray J, 2011, CAN THEATRE REV, V146, P66, DOI 10.3138/CTR.146.66; Gray RE, 2003, J CANCER EDUC, V18, P223, DOI 10.1207/s15430154jce1804_10; Gray RE, 2001, HEALTH, V5, P233, DOI 10.1177/136345930100500205; Gray Ross, 2000, Health Expect, V3, P137, DOI 10.1046/j.1369-6513.2000.00071.x; Green J., 2004, QUALITATIVE METHODS; Grimshaw J, 2003, QUAL SAF HEALTH CARE, V12, P298, DOI 10.1136/qhc.12.4.298; Grimshaw JM, 1998, J ROY SOC MED, V91, P20, DOI 10.1177/014107689809135S06; Hanley J, 2003, DIRECTIONS PSYCHIAT, V23, P151; Hawley CA, 2003, INJURY, V34, P256, DOI 10.1016/S0020-1383(02)00193-6; Hobson S. J. G., 1999, CLIENT CTR PRACTICE, P51; Hochschild A, 1983, MANAGED HEART COMMER; Holm G., 2008, FORUM QUALITATIVE SO, V9; Jackson D, 2009, BRAIN INJURY, V23, P433, DOI 10.1080/02699050902788451; Jamieson Margaret, 2006, Can J Occup Ther, V73, P76; Jonas-Simpson C, 2012, J ADV NURS, V68, P1944, DOI 10.1111/j.1365-2648.2011.05877.x; Jorge RE, 2004, ARCH GEN PSYCHIAT, V61, P42, DOI 10.1001/archpsyc.61.1.42; Jumisko Eija, 2005, J Neurosci Nurs, V37, P42; Karlawish JHT, 2003, NEW ENGL J MED, V348, P1389, DOI 10.1056/NEJMsb030172; Knowles J.G., 2008, HDB ARTS QUALITATIVE; Kontos P.C., 2006, QUAL RES, V6, DOI [10.1177/1468794106065005, DOI 10.1177/1468794106065005]; Kontos PC, 2007, QUAL HEALTH RES, V17, P799, DOI 10.1177/1049732307302838; Kontos PC, 2010, INT J OLDER PEOPLE N, V5, P159, DOI 10.1111/j.1748-3743.2010.00221.x; Kontos PC, 2009, IMPLEMENT SCI, V4, DOI 10.1186/1748-5908-4-1; Kreutzer JS, 2009, ARCH PHYS MED REHAB, V90, P939, DOI 10.1016/j.apmr.2009.01.010; Kreutzer JS, 1997, J HEAD TRAUMA REHAB, V12, P63, DOI 10.1097/00001199-199712000-00006; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Law M, 1995, Can J Occup Ther, V62, P250; Lawlor MC, 1998, AM J OCCUP THER, V52, P259, DOI 10.5014/ajot.52.4.259; LECOMPTE MD, 1993, ETHNOGRAPHIC QUALITA; Lefebvre H, 2005, BRAIN INJURY, V19, P585, DOI 10.1080/02699050400025026; Lefebvre Helene, 2007, J Trauma Nurs, V14, P100; Lincoln Y.S., 1985, NATURALISTIC INQUIRY, V75; Long D., 2007, DISCOURSE HOSP COMMU, P182; Lorenz KA, 2004, ACAD MED, V79, P481, DOI 10.1097/00001888-200405000-00020; Maitra KK, 2006, AM J OCCUP THER, V60, P298, DOI 10.5014/ajot.60.3.298; Marsh NV, 1998, BRAIN INJURY, V12, P225, DOI 10.1080/026990598122700; McClure Robert, 2007, J Health Organ Manag, V21, P101, DOI 10.1108/14777260710736813; McCormack B, 2002, J ADV NURS, V38, P94, DOI 10.1046/j.1365-2648.2002.02150.x; McCreight BS, 2005, INT J NURS STUD, V42, P439, DOI 10.1016/j.ijnurstu.2004.07.004; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Mienczakowski J, 1999, STUD EDUC ETHNOG, V2, P145; Miller KL, 2008, J ADV NURS, V64, P332, DOI 10.1111/j.1365-2648.2008.04768.x; Mitchell GJ, 2011, QUAL INQ, V17, P379, DOI 10.1177/1077800411401200; Miyata H., 2009, INT J QUAL METHODS, V8, P64, DOI [DOI 10.1177/160940690900800106, 10.1177/160940690900800106]; National Institute of Neurological Disorders and Stroke, 2002, TRAUM BRAIN INJ HOP; Nochi M, 1998, SOC SCI MED, V46, P869, DOI 10.1016/S0277-9536(97)00211-6; Norris J., 2009, PLAYBUILDING QUALITA; Norris J., 2000, YOUTH THEATRE J, V30, DOI [DOI 10.1080/08929092.2000.10012516, 10.1080/08929092.2016.1227189, DOI 10.1080/08929092.2016.1227189]; Nussbaum M., 1997, CULTIVATING HUMANITY; Nussbaum M. C., 2004, LIBERAL EDUCATION, V90, P42; Nussbaum Martha, 2001, UPHEAVALS THOUGHT IN; Oandasan I., 2009, PRIMARY HLTH CARE RE, V10, DOI [DOI 10.1017/S1463423609001091, 10.1017/S1463423609001091]; Paget M., 1993, COMPLEX SORROW REFLE; Papadimitriou C, 2008, DISABIL REHABIL, V30, P365, DOI 10.1080/09638280701336306; Patton MQ., 1990, QUALITATIVE EVALUATI; Payne S, 2000, J ADV NURS, V32, P277, DOI 10.1046/j.1365-2648.2000.01474.x; Pegg PO, 2005, REHABIL PSYCHOL, V50, P366, DOI 10.1037/0090-5550.50.4.366; RAFAELI A, 1987, ACAD MANAGE REV, V12, P23, DOI 10.2307/257991; RAPPORT F, 2008, FORUM QUALITATIVE SO, V9; Reeves S., 2010, INTERPROFESSIONAL TE; Reeves S, 2009, J INTERPROF CARE, V23, P633, DOI 10.3109/13561820902886295; Roberts B., 2008, FORUM QUALITATIVE SO, V9, P58; Rosenbaum ME, 2005, MED EDUC, V39, P622, DOI 10.1111/j.1365-2929.2005.02181.x; Rossiter K, 2008, SOC SCI MED, V66, P130, DOI 10.1016/j.socscimed.2007.07.021; Rossiter K, 2008, J HEALTH PSYCHOL, V13, P277, DOI 10.1177/1359105307086707; Rossiter K, 2011, J CONTEMP ETHNOGR, V40, P648, DOI 10.1177/0891241611418970; Salda?a J., 2005, ETHNODRAMA ANTHOLOGY; Sandelowski M, 2006, QUAL HEALTH RES, V16, P1350, DOI 10.1177/1049732306294274; Shapiro J, 2003, MED EDUC, V37, P922, DOI 10.1046/j.1365-2923.2003.01634.x; Sinding C, 2002, QUAL HEALTH RES, V12, P61, DOI 10.1177/1049732302012001005; Smith C., 2008, FORUM QUALITATIVE SO, V9; Spano R, 2005, SOC SCI RES, V34, P591, DOI 10.1016/j.ssresearch.2004.05.003; Stetler CB, 2006, J GEN INTERN MED, V21, pS1, DOI [10.1111/j.1525-1497.2006.00355.x, 10.1007/s11606-006-0267-9]; Sudore Rebecca L, 2009, J Clin Outcomes Manag, V16, P20; Sumsion T, 2000, Can J Occup Ther, V67, P15; Sumsion T, 1999, CLIENT CTR PRACTICE, P1; Thomson O'Brien MA, 2001, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD003030; Toglia J, 2000, NEUROREHABILITATION, V15, P57; Townsend E., 1999, GOOD INTENTIONS OVER; Turk M. A., 2007, BRAIN INJURY MED PRI, P27; van den Broek MD, 2005, J HEAD TRAUMA REHAB, V20, P464, DOI 10.1097/00001199-200509000-00007; Verhaeghe S, 2005, J CLIN NURS, V14, P1004, DOI 10.1111/j.1365-2702.2005.01126.x; Warren N, 2008, J CONTEMP ETHNOGR, V37, P180, DOI 10.1177/0891241607312493; Webster G, 1999, BRAIN INJURY, V13, P593; Webster J., 2007, Practice Development in Health Care, V6, P97, DOI 10.1002/pdh.222; Wilkins S, 2001, Can J Occup Ther, V68, P70; Winston J, 1999, J MORAL EDUC, V28, P459, DOI 10.1080/030572499103016; Wolf Z R, 1989, Holist Nurs Pract, V4, P78	122	22	22	0	19	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1049-7323	1552-7557		QUAL HEALTH RES	Qual. Health Res.	DEC	2012	22	12			SI		1612	1632		10.1177/1049732312458370			21	Information Science & Library Science; Social Sciences, Interdisciplinary; Social Sciences, Biomedical	Information Science & Library Science; Social Sciences - Other Topics; Biomedical Social Sciences	027TX	WOS:000310377700002	22941919	Green Accepted			2021-06-18	
J	Ok, JH; Kim, YH; Ha, KY				Ok, Ji-Hoon; Kim, Young-Hoon; Ha, Kee-Yong			Neuroprotective Effects of Hypothermia After Spinal Cord Injury in Rats Comparative Study Between Epidural Hypothermia and Systemic Hypothermia	SPINE			English	Article						spinal cord injury; epidural hypothermia; systemic hypothermia; apoptosis	TRAUMATIC BRAIN-INJURY; POSTTRAUMATIC HYPOTHERMIA; THERAPEUTIC HYPOTHERMIA; LEUKOCYTE ACCUMULATION; CONTUSION; ACTIVATION; EXPRESSION	Study Design. An experimental comparative study on moderate epidural hypothermia (MEH) versus moderate systemic hypothermia (MSH) after spinal cord injury (SCI). Objective. To compare neuroprotective effects of hypothermia between MEH and MSH after SCI in rats. Summary of Background Data. Experimental MEH or MSH has been attempted for neuroprotection after ischemic or traumatic SCI. However, there is no comparative study on neuroprotective effect of MEH and MSH after SCI. If hypothermia is to be considered as 1 modality for treating SCI, further studies on the advantages and disadvantages of hypothermia will be mandatory. Methods. A spinal cord contusion was produced in all 32 rats, and these rats were randomly divided into 4 groups-8 rats in each group: (1) the control group (spinal cord contusion only), (2) the methylprednisolone group, (3) the MEH group (28 degrees C for 48 hr), and (4) the MSH group (32 degrees C for 48 hr). The functional recovery was assessed using Basso, Beattie, Bresnahan scale and antiapoptotic and anti-inflammatory effects were assessed. Results. The Basso, Beattie, Bresnahan scale scores in both the hypothermia groups were significantly higher than that in the control group at 6 weeks. The numbers of terminal deoxynucleotidyl transferase dUTP nick end labeling-positive cells and OX-42 positive cells were significantly lower in both the MEH and MSH groups than that in the control group. The p38 mitogen-activated protein kinases expression of the treated groups was significantly lower than that of the control group. The expression of caspase-8 and caspase-9 significantly decreased in the treated groups compared with that of the control group. However, in terms of caspase-3, only the MSH group has shown to be significantly lower than that of the control group. Conclusion. This study presented that both systemic and epidural hypothermia demonstrated neuroprotective effects after SCI. Systemic hypothermia showed more neuroprotective effect by antiapoptotic and anti-inflammatory effects.	[Ok, Ji-Hoon; Kim, Young-Hoon; Ha, Kee-Yong] Catholic Univ Korea, Coll Med, Seoul St Marys Hosp, Dept Orthoped Surg, Seoul 137701, South Korea	Ha, KY (corresponding author), Catholic Univ Korea, Coll Med, Seoul St Marys Hosp, Dept Orthoped Surg, 505 Banpo Dong, Seoul 137701, South Korea.	kyh@catholic.ac.kr		Kim, Young-Hoon/0000-0003-1237-4600	Catholic Medical Center Research Foundation	Catholic Medical Center Research Foundation funds were received to support this work.	Basso DM, 1996, EXP NEUROL, V139, P244, DOI 10.1006/exnr.1996.0098; Botel U, 1997, SPINAL CORD, V35, P420, DOI 10.1038/sj.sc.3100407; Cappuccino A, 2010, SPINE, V35, pE57, DOI 10.1097/BRS.0b013e3181b9dc28; Chatzipanteli K, 2000, J NEUROTRAUM, V17, P321, DOI 10.1089/neu.2000.17.321; Dietrich WD, 2009, J NEUROTRAUM, V26, P301, DOI 10.1089/neu.2008.0806; Dimar JR, 2000, SPINE, V25, P2294, DOI 10.1097/00007632-200009150-00006; Gebauer CM, 2006, PEDIATRICS, V117, P843, DOI 10.1542/peds.2004-1587; GOSS JR, 1995, J NEUROTRAUM, V12, P159, DOI 10.1089/neu.1995.12.159; Ha KY, 2008, SPINE, V33, P2059, DOI 10.1097/BRS.0b013e31818018f6; Ha KY, 2008, EUR SPINE J, V17, P864, DOI 10.1007/s00586-008-0653-6; HANSEBOUT RR, 1985, CAN J NEUROL SCI, V12, P83, DOI 10.1017/S0317167100046758; Kinoshita K, 2002, NEUROSURGERY, V51, P195, DOI 10.1097/00006123-200207000-00027; Lo TP, 2009, J COMP NEUROL, V514, P433, DOI 10.1002/cne.22014; Lotocki G, 2006, EUR J NEUROSCI, V24, P2283, DOI 10.1111/j.1460-9568.2006.05123.x; Lotocki G, 2009, J NEUROTRAUM, V26, P1123, DOI 10.1089/neu.2008.0802; Marion D, 2009, J NEUROTRAUM, V26, P455, DOI 10.1089/neu.2008.0582; Pineau I, 2007, J COMP NEUROL, V500, P267, DOI 10.1002/cne.21149; SAKAMOTO T, 1990, AM J PHYSIOL, V259, pH1649; Sayer Faisal T, 2006, Spine J, V6, P335, DOI 10.1016/j.spinee.2005.11.001; Shibuya S, 2004, SPINAL CORD, V42, P29, DOI 10.1038/sj.sc.3101516; TATOR CH, 1995, BRAIN PATHOL, V5, P407, DOI 10.1111/j.1750-3639.1995.tb00619.x; Weaver LC, 2005, J NEUROTRAUM, V22, P1375, DOI 10.1089/neu.2005.22.1375; Yenari MA, 2002, J CEREBR BLOOD F MET, V22, P29, DOI 10.1097/00004647-200201000-00004; Yu CG, 2000, J NEUROSURG, V93, P85, DOI 10.3171/spi.2000.93.1.0085; Yu WR, 2009, EUR J NEUROSCI, V29, P114, DOI 10.1111/j.1460-9568.2008.06555.x	25	22	24	0	10	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0362-2436			SPINE	SPINE	DEC 1	2012	37	25					E1551	E1559		10.1097/BRS.0b013e31826ff7f1			9	Clinical Neurology; Orthopedics	Neurosciences & Neurology; Orthopedics	047MI	WOS:000311844600002	22926281				2021-06-18	
J	Prodam, F; Caputo, M; Belcastro, S; Garbaccio, V; Zavattaro, M; Sama, MT; Bellone, S; Pagano, L; Bona, G; Aimaretti, G				Prodam, F.; Caputo, M.; Belcastro, S.; Garbaccio, V.; Zavattaro, M.; Sama, M. T.; Bellone, S.; Pagano, L.; Bona, G.; Aimaretti, G.			Quality of life, mood disturbances and psychological parameters in adult patients with GH deficiency	PANMINERVA MEDICA			English	Article						Hypopituitarism; Quality of life; Mental disorders	TRAUMATIC BRAIN-INJURY; GROWTH-HORMONE DEFICIENCY; PHOTON EMISSION CT; HEALTHY OLDER MEN; COGNITIVE FUNCTION; PITUITARY DISEASE; FACTOR-I; PLASMA-LEVELS; MILD; CHILDHOOD	An increased prevalence of depression, emotional lability, decreased energy levels, and poor quality of life have been reported in adults with GH deficiency (GHD). The impairment of psychological parameters depends on the aetiology of GHD and the presence of other pituitary hormone deficiencies because of hormonal effects on neural cell metabolism. Cognitive dysfunctions appear to be specifically related to GHD itself, whereas the lower emotional well-being and reduced motor performance are attributed to other pituitary hormone deficiencies. Traumatic Brain Injury causes very often hypopituitarism and GHD as well as other many psychological symptoms: cognitive impairment, sleeping disorders, and depression. Many neurobehavioral symptoms of post-concussion syndrome (PCS) are the same suffered by adult GHD and hypopituitaric patients but there are no data about the occurrence of hypopituitarism in PCS. In some studies treatment with rhGH is reported to have a beneficial effect and GHD could contribute itself to the global impairment of psychological dysfunctions. The link between psychosocial impairments and GHD is not fully understood. The effects of long-term rhGH therapy on cognitive functions are largely unknown. Thus, long-term placebo-controlled double-blind studies are required to investigate whether psychological dysfunctions are reversible on GH substitution.	[Prodam, F.; Caputo, M.; Belcastro, S.; Garbaccio, V.; Zavattaro, M.; Sama, M. T.; Pagano, L.; Aimaretti, G.] Amedeo Avogadro Univ, Dept Translat Med, Novara, Italy; [Prodam, F.; Bellone, S.; Bona, G.] Amedeo Avogadro Univ, Dept Hlth Sci, Div Pediat, Novara, Italy	Aimaretti, G (corresponding author), Univ Piemonte Orientale, Dept Translat Med, Via Solaroli 17, I-28100 Novara, Italy.	gianluca.aimaretti@med.unipmn.it	Prodam, Flavia/B-8844-2013	Prodam, Flavia/0000-0001-9660-5335			Agha A, 2006, CLIN ENDOCRINOL, V64, P481, DOI 10.1111/j.1365-2265.2006.02517.x; Aimaretti G, 2007, NAT CLIN PRACT ENDOC, V3, P318, DOI 10.1038/ncpendmet0460; Aleman A, 1999, J CLIN ENDOCR METAB, V84, P471, DOI 10.1210/jc.84.2.471; Aleman A, 2000, NEUROPSYCHOBIOLOGY, V41, P73, DOI 10.1159/000026636; ALEXANDER MP, 1995, NEUROLOGY, V45, P1253, DOI 10.1212/WNL.45.7.1253; Arwert LI, 2006, NEUROENDOCRINOLOGY, V83, P12, DOI 10.1159/000093337; Arwert LI, 2005, NEUROENDOCRINOLOGY, V82, P32, DOI 10.1159/000090123; Arwert LI, 2005, HORM BEHAV, V47, P343, DOI 10.1016/j.yhbeh.2004.11.015; Attanasio AF, 2005, J CLIN ENDOCR METAB, V90, P4525, DOI 10.1210/jc.2005-0439; Baum HBA, 1998, J CLIN ENDOCR METAB, V83, P3184, DOI 10.1210/jc.83.9.3184; Binder LM, 1997, J CLIN EXP NEUROPSYC, V19, P421, DOI 10.1080/01688639708403870; Bryant RA, 2001, J CLIN EXP NEUROPSYC, V23, P718, DOI 10.1076/jcen.23.6.718.1024; Bulow B, 2002, CLIN ENDOCRINOL, V56, P183, DOI 10.1046/j.0300-0664.2001.01461.x; Bushnik T, 2007, BRAIN INJURY, V21, P559, DOI 10.1080/02699050701426915; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Cook D M, 2000, Adv Intern Med, V45, P297; Copinschi G, 2010, J CLIN ENDOCR METAB, V95, P2195, DOI 10.1210/jc.2009-2080; Corneli Ginevra, 2007, Curr Opin Endocrinol Diabetes Obes, V14, P301, DOI 10.1097/MED.0b013e3281e7e6e6; CUNEO RC, 1992, CLIN ENDOCRINOL, V37, P387, DOI 10.1111/j.1365-2265.1992.tb02347.x; Dam PS, 2010, NEUROBIOL AGING, P17; DEAN HJ, 1985, AM J DIS CHILD, V139, P1105, DOI 10.1001/archpedi.1985.02140130043027; DEBOER H, 1995, ENDOCR REV, V16, P63, DOI 10.1210/er.16.1.63; DONOVAN BT, 1978, PSYCHOL MED, V8, P305, DOI 10.1017/S0033291700014355; Fink G, 1996, CELL MOL NEUROBIOL, V16, P325, DOI 10.1007/BF02088099; Giusti M, 1998, EUR J CLIN INVEST, V28, P13; GONZALEZCLEMENTE JM, 1994, MED CLIN-BARCELONA, V102, P220; Gowda NK, 2006, AM J NEURORADIOL, V27, P447; Gururaj G, 2002, NEUROL RES, V24, P24, DOI 10.1179/016164102101199503; Harvey S, 2003, J MOL NEUROSCI, V20, P1, DOI 10.1385/JMN:20:1:1; High WM, 2010, J NEUROTRAUM, V27, P1565, DOI 10.1089/neu.2009.1253; Hoffman AR, 2005, GROWTH HORM IGF RES, V15, pS48, DOI 10.1016/j.ghir.2005.06.010; Hofman PAM, 2001, AM J NEURORADIOL, V22, P441; Hughes DG, 2004, NEURORADIOLOGY, V46, P550, DOI 10.1007/s00234-004-1227-x; JACOBSON RR, 1995, J PSYCHOSOM RES, V39, P675, DOI 10.1016/0022-3999(95)00006-5; Johannsson G, 1996, CLIN ENDOCRINOL, V45, P305, DOI 10.1046/j.1365-2265.1996.00820.x; JOHANSSON JO, 1995, NEUROENDOCRINOLOGY, V61, P57, DOI 10.1159/000126813; KAWAI K, 1994, ENDOCR J, V41, P275, DOI 10.1507/endocrj.41.275; Kay T., 1993, J HEAD TRAUMA REHABI, V8, P86, DOI [10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; Klose M, 2007, J CLIN ENDOCR METAB, V92, P3861, DOI 10.1210/jc.2007-0901; Korn A, 2005, J CLIN NEUROPHYSIOL, V22, P1, DOI 10.1097/01.WNP.0000150973.24324.A7; KORNBLUM RN, 1969, ARCH PATHOL, V88, P242; Kurca E, 2006, NEURORADIOLOGY, V48, P661, DOI 10.1007/s00234-006-0109-9; LAI ZN, 1991, BRAIN RES, V546, P222, DOI 10.1016/0006-8993(91)91485-J; Lasaite Lina, 2004, Medicina (Kaunas), V40, P740; Lawrance D, 2001, EUR J ENDOCRINOL, V56, P439; Lijffijt M, 2003, NEUROSCI LETT, V353, P123, DOI 10.1016/j.neulet.2003.09.028; Maric NP, 2010, J ENDOCRINOL INVEST, V33, P770, DOI [10.1007/BF03350340, 10.3275/7045]; McKenna SP, 1999, QUAL LIFE RES, V8, P373, DOI 10.1023/A:1008987922774; Molitch ME, 2011, J CLIN ENDOCR METAB, V96, P1587, DOI 10.1210/jc.2011-0179; Paterakis K, 2000, J TRAUMA, V49, P1071, DOI 10.1097/00005373-200012000-00016; Pavlovic D, 2010, EUR J NEUROL, V17, P696, DOI 10.1111/j.1468-1331.2009.02910.x; Peace KA, 1997, CLIN ENDOCRINOL, V46, P445, DOI 10.1046/j.1365-2265.1997.1600971.x; Popovic V, 2006, PITUITARY, V8, P239; Quik EH, 2010, NEUROSCI BIOBEHAV R, V34, P1137, DOI 10.1016/j.neubiorev.2010.01.001; Rollero A, 1998, NEUROPSYCHOBIOLOGY, V38, P73, DOI 10.1159/000026520; ROSEN T, 1994, CLIN ENDOCRINOL, V40, P111, DOI 10.1111/j.1365-2265.1994.tb02452.x; Ross JL, 2005, HORM RES, V64, P89, DOI 10.1159/000089323; Schneider HJ, 2006, EUR J ENDOCRINOL, V154, P259, DOI 10.1530/eje.1.02071; STABLER B, 1992, CLIN ENDOCRINOL, V36, P467, DOI 10.1111/j.1365-2265.1992.tb02247.x; Stalnacke BM, 2007, J REHABIL MED, V39, P405, DOI 10.2340/16501977-0057; Sterr A, 2006, BMC NEUROL, V6, DOI 10.1186/1471-2377-6-7; Urban RJ, 2006, GROWTH HORM IGF RES, V16, pS25, DOI 10.1016/j.ghir.2006.03.017; van Dam PS, 2000, GROWTH HORM IGF RES, V10, P69, DOI 10.1016/S1096-6374(00)80013-1; van der Veen E, 1996, PSYCHONEUROENDOCRINO, V23, P45; van Nieuwpoort IC, 2008, EUR J ENDOCRINOL, V159, pS53, DOI 10.1530/EJE-08-0279; Wallymahmed ME, 1999, CLIN ENDOCRINOL, V51, P333; WOLKOWITZ OM, 1985, NEUROPSYCHOBIOLOGY, V14, P133, DOI 10.1159/000118219; Zenker S, 2002, EUR J ENDOCRINOL, V147, P165, DOI 10.1530/eje.0.1470165; Zitzmann M, 2001, EUR J ENDOCRINOL, V144, P183, DOI 10.1530/eje.0.1440183	69	22	23	0	11	EDIZIONI MINERVA MEDICA	TURIN	CORSO BRAMANTE 83-85 INT JOURNALS DEPT., 10126 TURIN, ITALY	0031-0808	1827-1898		PANMINERVA MED	Panminerva Medica	DEC	2012	54	4					323	331					9	Medicine, General & Internal	General & Internal Medicine	058BF	WOS:000312608400009	23123585				2021-06-18	
J	Wagner, AK; Hatz, LE; Scanlon, JM; Niyonkuru, C; Miller, MA; Ricker, JH; Conley, YP; Ferrell, RE				Wagner, Amy K.; Hatz, Laura E.; Scanlon, Joelle M.; Niyonkuru, Christian; Miller, Megan A.; Ricker, Joseph H.; Conley, Yvette P.; Ferrell, Robert E.			Association of KIBRA rs17070145 polymorphism and episodic memory in individuals with severe TBI	BRAIN INJURY			English	Article						Traumatic brain injury; cognition; memory; KIBRA; genetic polymorphism	DISABILITY RATING-SCALE; TRAUMATIC BRAIN-INJURY; HEAD-INJURY; GENE VARIANTS; PERFORMANCE; RECOVERY; MODERATE; LIFE; AGE	Background: Studies implicate single nucleotide polymorphism (SNP) rs17070145, a common T --> C polymorphism on the KIBRA gene, in mediating differences in episodic memory. In healthy adults, T-allele carriers perform better than non-carriers on episodic memory measures. However, this association is reversed in adults with subjective memory complaints and populations vulnerable to memory deficits, a problem common in traumatic brain injury (TBI). Methods: This study assessed associations between variation in the KIBRA gene and cognitive function in 129 adults with severe TBI. In addition to other executive functioning and functional/global outcomes, the Buschke Selective Reminding Test (SRT), Rey-Osterrieth Complex Figure Test and California Verbal Learning Test-II (CVLT-II) were administered 6 and 12 months post-injury. Results: T-allele non-carriers performed better than carriers on multiple episodic memory measures. At 6 months, T-allele non-carriers performed better for delayed recall measures on the SRT. At 12 months, T-allele non-carriers performed better on multiple SRT measures and on List-B learning with CVLT-II. No associations occurred with executive function or global outcome measures. Conclusion: These results suggest that rs17070145 T-allele effects are specific to episodic memory and support the hypothesis that associations between rs17070145 variation and memory are disparate between healthy and impaired populations.	[Wagner, Amy K.; Hatz, Laura E.; Scanlon, Joelle M.; Niyonkuru, Christian; Miller, Megan A.; Ricker, Joseph H.] Univ Pittsburgh, Dept Phys Med & Rehabil, Pittsburgh, PA 15213 USA; [Wagner, Amy K.; Conley, Yvette P.] Univ Pittsburgh, Safar Ctr Resuscitat Res, Pittsburgh, PA 15213 USA; [Conley, Yvette P.] Univ Pittsburgh, Sch Nursing, Pittsburgh, PA 15213 USA; [Ferrell, Robert E.] Univ Pittsburgh, Dept Human Genet, Pittsburgh, PA 15213 USA	Wagner, AK (corresponding author), Univ Pittsburgh, Dept Phys Med & Rehabil, 3471 5th Ave,Suite 202, Pittsburgh, PA 15213 USA.	wagnerak@upmc.edu		Ricker, Joseph/0000-0003-3415-991X; Hatz, Laura/0000-0002-8695-8222; Conley, Yvette/0000-0002-1784-6067	 [R01 HD048162];  [DODW81XWH-071-0701];  [R01NR008424];  [P01NS030318]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD048162] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P01NS030318] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NURSING RESEARCHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR) [R01NR008424] Funding Source: NIH RePORTER	This work was supported in part by R01 HD048162, DODW81XWH-071-0701, R01NR008424 and P01NS030318.	Almeida OP, 2008, J CELL MOL MED, V12, P1672, DOI 10.1111/j.1582-4934.2008.00229.x; Bell KR, 2005, ARCH PHYS MED REHAB, V86, P851, DOI 10.1016/j.apmr.2004.09.015; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Blakesley RE, 2009, NEUROPSYCHOLOGY, V23, P255, DOI 10.1037/a0012850; Bombardier CH, 2010, JAMA-J AM MED ASSOC, V303, P1938, DOI 10.1001/jama.2010.599; Burgess JD, 2011, NEUROBIOL AGING, V32, DOI 10.1016/j.neurobiolaging.2010.11.004; BUSCHKE H, 1973, J VERB LEARN VERB BE, V12, P543, DOI 10.1016/S0022-5371(73)80034-9; Buther K, 2004, BIOCHEM BIOPH RES CO, V317, P703, DOI 10.1016/j.bbrc.2004.03.107; Chen XN, 1999, GENOME RES, V9, P492; CLIFTON GL, 1992, NEUROSURGERY, V31, P975, DOI 10.1227/00006123-199211000-00028; Corneveaux JJ, 2010, NEUROBIOL AGING, V31, P901, DOI 10.1016/j.neurobiolaging.2008.07.014; Delis DC, 2000, CALIFORNIA VERBAL LE; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; GOUVIER WD, 1987, ARCH PHYS MED REHAB, V68, P94; Granger CV, 1986, GUIDE USE UNIFORM DA; HALL K, 1985, ARCH PHYS MED REHAB, V66, P35; Ikonomovic MD, 2004, EXP NEUROL, V190, P192, DOI 10.1016/j.expneurol.2004.06.011; Jacobsen LK, 2009, BIOL PSYCHIAT, V65, P671, DOI 10.1016/j.biopsych.2008.10.024; JENNETT B, 1975, LANCET, V1, P480; Johannsen S, 2008, NEUROSCIENCE, V155, P1165, DOI 10.1016/j.neuroscience.2008.06.054; Kremerskothen J, 2003, BIOCHEM BIOPH RES CO, V300, P862, DOI 10.1016/S0006-291X(02)02945-5; LEVIN HS, 1987, J NEUROL NEUROSUR PS, V50, P183, DOI 10.1136/jnnp.50.2.183; LEVIN HS, 1979, J NEUROSURG, V50, P412, DOI 10.3171/jns.1979.50.4.0412; LINACRE JM, 1994, ARCH PHYS MED REHAB, V75, P127; McClearn GE, 1997, SCIENCE, V276, P1560, DOI 10.1126/science.276.5318.1560; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; MILLIS SR, 1994, J CLIN EXP NEUROPSYC, V16, P498, DOI 10.1080/01688639408402661; Nacmias B, 2008, NEUROSCI LETT, V436, P145, DOI 10.1016/j.neulet.2008.03.008; Nebes RD, 2000, PSYCHOL MED, V30, P679, DOI 10.1017/S0033291799001968; Need AC, 2008, AM J MED GENET B, V147B, P667, DOI 10.1002/ajmg.b.30658; Osterrieth PA, 1944, ARCH PSYCHOLOGIE, V30, P205; PANIAK CE, 1989, J CLIN EXP NEUROPSYC, V11, P631, DOI 10.1080/01688638908400921; Papassotiropoulos A, 2006, SCIENCE, V314, P475, DOI 10.1126/science.1129837; Preuschhof C, 2010, NEUROPSYCHOLOGIA, V48, P402, DOI 10.1016/j.neuropsychologia.2009.09.031; RAPPAPORT M, 1989, ARCH PHYS MED REHAB, V70, P885; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; Reitan RM., 1985, HALSTEAD REITAN NEUR; Ricker JH, 2001, J CLIN EXP NEUROPSYC, V23, P196, DOI 10.1076/jcen.23.2.196.1204; Rodriguez-Rodriguez E, 2009, NEUROBIOL AGING, V30, P322, DOI 10.1016/j.neurobiolaging.2007.07.003; Rogers E, 2009, J NEUROTRAUM, V26, pA25; Russell KC, 2011, J CLIN EXP NEUROPSYC, V33, P538, DOI 10.1080/13803395.2010.537253; Schaper K, 2008, NEUROBIOL AGING, V29, P1123, DOI 10.1016/j.neurobiolaging.2007.02.001; Smith DH, 2003, J NEUROSURG, V98, P1072, DOI 10.3171/jns.2003.98.5.1072; Teasdale GM, 2005, BRAIN, V128, P2556, DOI 10.1093/brain/awh595; Wagner AK, 2000, AM J PHYS MED REHAB, V79, P235, DOI 10.1097/00002060-200005000-00004; Wagner AK, 2000, J TRAUMA, V49, P411, DOI 10.1097/00005373-200009000-00005; Wagner AK, 2011, J CEREBR BLOOD F MET, V31, P1886, DOI 10.1038/jcbfm.2011.31; Wagner AK, 2011, J NEUROTRAUM, V28, P871, DOI 10.1089/neu.2010.1586; Wiegner S, 1999, J CLIN EXP NEUROPSYC, V21, P159, DOI 10.1076/jcen.21.2.159.925; Wright BD, 1997, SCAND J REHABIL MED, V29, P267; Yasuda Y, 2010, WORLD J BIOL PSYCHIA, V11, P852, DOI 10.3109/15622971003797258; Zafonte R, 2009, J NEUROTRAUM, V26, P2207, DOI 10.1089/neu.2009.1015	52	22	22	0	11	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	DEC	2012	26	13-14					1658	1669		10.3109/02699052.2012.700089			12	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	041RU	WOS:000311419700012	22794909				2021-06-18	
J	Jung, S; Yang, H; Kim, BS; Chu, K; Lee, SK; Jeon, D				Jung, Seungmoon; Yang, Hyunwoo; Kim, Byung Sun; Chu, Kon; Lee, Sang Kun; Jeon, Daejong			The immunosuppressant cyclosporin A inhibits recurrent seizures in an experimental model of temporal lobe epilepsy	NEUROSCIENCE LETTERS			English	Article						Cyclosporin A; Temporal lobe epilepsy; Recurrent seizure; Electroencephalography; Status epilepticus; Chronic period	MITOCHONDRIAL PERMEABILITY TRANSITION; TRAUMATIC BRAIN-INJURY; MOLECULAR-MECHANISMS; REFRACTORY EPILEPSY; CALCINEURIN; RAT; NEUROPROTECTION; EPILEPTOGENESIS; DYSFUNCTION; INJECTION	The immunosuppressant, cyclosporin A (CsA), is neuroprotective following brain injury. Previous studies suggest that CsA treatment ameliorates seizure severity during status epilepticus (SE) or cell death following SE. The antiepileptic effects of CsA on recurrent seizures, however, have not been investigated. In the present study, the effects of CsA on spontaneous recurrent seizures (SRSs) in a kainate (KA)-induced mouse model of mesial temporal lobe epilepsy (TLE) were examined. Moreover, the effects of CsA on epileptiform activity in a 4-aminopyridine (4-AP)-induced in vitro seizure model were investigated. A mesial TLE mouse model was generated with a unilateral intrahippocampal injection of KA. SRSs were determined in the ipsilateral hippocampal CA1 region with a long-term video-EEG. CsA was systemically administrated to the epileptic mice exhibiting a stable occurrence of SRSs. A 1-mg/kg dose of CsA did not have any effect on SRSs in the epileptic mice. However, a 5-mg/kg dose of CsA significantly reduced the number of SRSs and decreased the severity of the seizures in the epileptic mice. Additionally, CsA treatment inhibited spontaneous burst discharges in 4-AP-treated hippocampal slices. The results of the present study demonstrate that CsA inhibits recurrent seizures in a mouse model of mesial TLE and suggest that CsA may afford both neuroprotection against SE and antiepileptic effects during the chronic period of epilepsy. (C) 2012 Elsevier Ireland Ltd. All rights reserved.	[Jung, Seungmoon; Yang, Hyunwoo; Kim, Byung Sun; Jeon, Daejong] Korea Adv Inst Sci & Technol, Lab Brain Behav & Therapeut, Dept Bio & Brain Engn, Taejon 305701, South Korea; [Chu, Kon; Lee, Sang Kun] Seoul Natl Univ, Coll Med, Dept Neurol, Comprehens Epilepsy Ctr,Biomed Res Inst,Seoul Nat, Seoul, South Korea	Jeon, D (corresponding author), Korea Adv Inst Sci & Technol, Lab Brain Behav & Therapeut, Dept Bio & Brain Engn, 291 Daehak Ro, Taejon 305701, South Korea.	clark@kaist.ac.kr	Jeon, Daejong/C-1814-2011; Lee, Sang Kun/J-5578-2012		National Research Foundation of Korea (NRF)National Research Foundation of Korea; Ministry of Education, Science and TechnologyMinistry of Education, Science and Technology, Republic of Korea [2011-0014893]	This study was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (2011-0014893).	Albensi BC, 2000, EXP NEUROL, V162, P385, DOI 10.1006/exnr.1999.7338; Bernardi P, 1998, BIOFACTORS, V8, P273, DOI 10.1002/biof.5520080315; BOREL JF, 1976, AGENTS ACTIONS, V6, P468, DOI 10.1007/BF01973261; Borlongan CV, 2005, LIFE SCI, V76, P1503, DOI 10.1016/j.lfs.2004.09.022; Bouilleret V, 1999, NEUROSCIENCE, V89, P717, DOI 10.1016/S0306-4522(98)00401-1; Bragin A, 1999, EPILEPSIA, V40, P1210, DOI 10.1111/j.1528-1157.1999.tb00849.x; Cook AM, 2009, EXPERT OPIN DRUG SAF, V8, P411, DOI 10.1517/14740330903066742; Domanska-Janik K, 2004, MOL BRAIN RES, V121, P50, DOI 10.1016/j.molbrainres.2003.11.006; Engel J, 1996, EPILEPSY RES, V26, P141, DOI 10.1016/S0920-1211(96)00043-5; Fabene PF, 2008, NAT MED, V14, P1377, DOI 10.1038/nm.1878; FALCONER MA, 1964, ARCH NEUROL-CHICAGO, V10, P233, DOI 10.1001/archneur.1964.00460150003001; Folbergrova J, 2012, MITOCHONDRION, V12, P35, DOI 10.1016/j.mito.2011.04.004; French JA, 2007, EPILEPSIA, V48, P3, DOI 10.1111/j.1528-1167.2007.00992.x; Fritschy JM, 2008, FRONT MOL NEUROSCI, V1, DOI 10.3389/neuro.02.005.2008; Gijtenbeek JMM, 1999, J NEUROL, V246, P339, DOI 10.1007/s004150050360; Herman ST, 2002, NEUROLOGY, V59, pS21, DOI 10.1212/WNL.59.9_suppl_5.S21; Jeon D, 2008, J BIOL CHEM, V283, P12093, DOI 10.1074/jbc.M800816200; Jeon D, 2011, EPILEPSIA, V52, P1617, DOI 10.1111/j.1528-1167.2011.03182.x; Jeon D, 2010, NAT NEUROSCI, V13, P482, DOI 10.1038/nn.2504; KAHAN BD, 1989, NEW ENGL J MED, V321, P1725; Kaminska B, 2004, J CELL MOL MED, V8, P45, DOI 10.1111/j.1582-4934.2004.tb00259.x; Kann O, 2007, AM J PHYSIOL-CELL PH, V292, pC641, DOI 10.1152/ajpcell.00222.2006; Kudin AP, 2009, EXP NEUROL, V218, P326, DOI 10.1016/j.expneurol.2009.02.014; Kunz WS, 2002, CURR OPIN NEUROL, V15, P179, DOI 10.1097/00019052-200204000-00009; Kurz JE, 2001, J NEUROCHEM, V78, P304, DOI 10.1046/j.1471-4159.2001.00426.x; Kwan P, 2000, NEW ENGL J MED, V342, P314, DOI 10.1056/NEJM200002033420503; Martina M, 1996, NEUROSCI LETT, V215, P95, DOI 10.1016/S0304-3940(96)12957-8; MOIA LJMP, 1994, BRAIN RES, V648, P337, DOI 10.1016/0006-8993(94)91138-X; Okonkwo DO, 1999, J CEREBR BLOOD F MET, V19, P443, DOI 10.1097/00004647-199904000-00010; Osman MM, 2011, NEUROPEPTIDES, V45, P359, DOI 10.1016/j.npep.2011.04.002; RACINE RJ, 1972, ELECTROEN CLIN NEURO, V32, P281, DOI 10.1016/0013-4694(72)90177-0; Santos JB, 2003, EPILEPSIA, V44, P995, DOI 10.1046/j.1528-1157.2003.66302.x; Schmidt D, 2005, EPILEPSIA, V46, P858, DOI 10.1111/j.1528-1167.2005.54904.x; Setkowicz Z, 2007, EPILEPSY RES, V73, P151, DOI 10.1016/j.eplepsyres.2006.09.001; Smart TG, 1997, CURR OPIN NEUROBIOL, V7, P358, DOI 10.1016/S0959-4388(97)80063-3; Sullivan PG, 2000, NEUROSCIENCE, V101, P289, DOI 10.1016/S0306-4522(00)00380-8; TRAUB RD, 1995, J PHYSIOL-LONDON, V489, P127, DOI 10.1113/jphysiol.1995.sp021036; Uchino H, 2002, NEUROBIOL DIS, V10, P219, DOI 10.1006/nbdi.2002.0514; Uchino H, 2008, J ANESTH, V22, P253, DOI 10.1007/s00540-008-0617-3; Vezzani A, 2005, EPILEPSIA, V46, P1724, DOI 10.1111/j.1528-1167.2005.00298.x; Waldbaum S, 2010, EPILEPSY RES, V88, P23, DOI 10.1016/j.eplepsyres.2009.09.020; WHITE DJG, 1982, IMMUNOL REV, V65, P115, DOI 10.1111/j.1600-065X.1982.tb00430.x; Yu Y, 2007, ACTA PHARMACOL SIN, V28, P1891, DOI 10.1111/j.1745-7254.2007.00730.x; ZORATTI M, 1995, BBA-REV BIOMEMBRANES, V1241, P139, DOI 10.1016/0304-4157(95)00003-A	44	22	23	1	13	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0304-3940			NEUROSCI LETT	Neurosci. Lett.	NOV 7	2012	529	2					133	138		10.1016/j.neulet.2012.08.087			6	Neurosciences	Neurosciences & Neurology	039RK	WOS:000311264000007	22981977				2021-06-18	
J	Rashid, B; Destrade, M; Gilchrist, MD				Rashid, Badar; Destrade, Michel; Gilchrist, Michael D.			Inhomogeneous deformation of brain tissue during tension tests	COMPUTATIONAL MATERIALS SCIENCE			English	Article; Proceedings Paper	21st International Workshop on Computational Mechanics of Materials (IWCMM)	AUG 22-24, 2011	Univ Limerick, Limerick, IRELAND		Univ Limerick	Traumatic Brain Injury (TBI); Impact; Compression; Shear; Ogden; Hyperelastic; Elastic	MODEL; BEHAVIOR; STRETCH; COMPRESSION; STRAIN	Mechanical characterization of brain tissue has been investigated extensively by various research groups over the past 50 years. These properties are particularly important for modeling Traumatic Brain Injury (TBI). In this research, we present the design and calibration of a High Rate Tension Device (HRTD) capable of performing tests up to a maximum strain rate of 90/s. We use experimental and numerical methods to investigate the effects of inhomogeneous deformation of porcine brain tissue during tension at different specimen thicknesses (4.0-14.0 mm), by performing tension tests at a strain rate of 30/s. One-term Ogden material parameters (mu = 4395.0 Pa, alpha = -2.8) were derived by performing an inverse finite element analysis to model all experimental data. A similar procedure was adopted to determine Young's modulus (E = 11200 Pa) of the linear elastic regime. Based on this analysis, brain specimens of aspect ratio (diameter/thickness) S <= 1.0 are required to minimise the effects of inhomogeneous deformation during tension tests. (C) 2012 Elsevier B.V. All rights reserved.	[Rashid, Badar; Destrade, Michel; Gilchrist, Michael D.] Univ Coll Dublin, Sch Mech & Mat Engn, Dublin 4, Ireland; [Destrade, Michel] Natl Univ Ireland Galway, Sch Math Stat & Appl Math, Galway, Ireland	Gilchrist, MD (corresponding author), Univ Coll Dublin, Sch Mech & Mat Engn, Dublin 4, Ireland.	Badar.Rashid@ucdconnect.ie; michel.destrade@nuigalway.ie; michael.gilchrist@ucd.ie	Destrade, Michel/O-5825-2019; Gilchrist, Michael D/B-6100-2017	Destrade, Michel/0000-0002-6266-1221; Gilchrist, Michael D/0000-0003-1765-429X			Bain AC, 2000, J BIOMECH ENG-T ASME, V122, P615, DOI 10.1115/1.1324667; Bayly PV, 2006, J BIOMECH, V39, P1086, DOI 10.1016/j.jbiomech.2005.02.014; Cheng S, 2007, J BIOMECH, V40, P117, DOI 10.1016/j.jbiomech.2005.11.004; Coats B, 2006, J BIOMECH, V39, P2521, DOI 10.1016/j.jbiomech.2005.07.020; Garo A, 2007, BIORHEOLOGY, V44, P51; Gilchrist MD, 2004, STRAIN, V40, P180, DOI 10.1111/j.1475-1305.2004.00168.x; Lin DC, 2009, BIOMECH MODEL MECHAN, V8, P345, DOI 10.1007/s10237-008-0139-9; Miller K, 2002, J BIOMECH, V35, P483, DOI 10.1016/S0021-9290(01)00234-2; Morrison B, 2006, J NEUROSCI METH, V150, P192, DOI 10.1016/j.jneumeth.2005.06.014; Morrison B, 2000, J BIOMECH ENG-T ASME, V122, P224, DOI 10.1115/1.429650; Morrison B., 2003, STAPP CAR CRASH J, V47, P93; Nicolle S, 2005, BIORHEOLOGY, V42, P209; Ogden R., 1997, NONLINEAR ELASTIC DE; Pervin F, 2009, J BIOMECH, V42, P731, DOI 10.1016/j.jbiomech.2009.01.023; Pfister BJ, 2003, ANN BIOMED ENG, V31, P589, DOI 10.1114/1.1566445; Prange MT, 2002, J BIOMECH ENG-T ASME, V124, P244, DOI 10.1115/1.1449907; Rashid B., J SPORTS EN IN PRESS, V226; Rashid B, 2012, J MECH BEHAV BIOMED, V10, P23, DOI 10.1016/j.jmbbm.2012.01.022; Raul JS, 2006, INT J LEGAL MED, V120, P212, DOI 10.1007/s00414-005-0018-1; Takhounts E., 2003, STAPP CAR CRASH J, V47, P107, DOI DOI 10.4271/2003-22-0007; Tamura A, 2007, J BIOMECH SCI ENG, V2, P115, DOI [10.1299/jbse.2.115, DOI 10.1299/JBSE.2.115]; Tamura A., 2008, J BIOMECH SCI ENG, V3, P263, DOI DOI 10.1299/JBSE.3.263; van Dommelen JAW, 2010, J MECH BEHAV BIOMED, V3, P158, DOI 10.1016/j.jmbbm.2009.09.001; Velardi F, 2006, BIOMECH MODEL MECHAN, V5, P53, DOI 10.1007/s10237-005-0007-9	24	22	23	0	23	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0927-0256	1879-0801		COMP MATER SCI	Comput. Mater. Sci.	NOV	2012	64						295	300		10.1016/j.commatsci.2012.05.030			6	Materials Science, Multidisciplinary	Materials Science	000OO	WOS:000308396200062					2021-06-18	
J	Wolf, EG; Prye, J; Michaelson, R; Brower, G; Profenna, L; Boneta, O				Wolf, E. George; Prye, Jennifer; Michaelson, Robert; Brower, Gerry; Profenna, Leonardo; Boneta, Otto			Hyperbaric side effects in a traumatic brain injury randomized clinical trial	UNDERSEA AND HYPERBARIC MEDICINE			English	Article							ACUTE ISCHEMIC-STROKE; OXYGEN THERAPY	Objective: To catalog the side effects of 2.4 atmospheres absolute (atm abs) hyperbaric oxygen (HBO2) vs. sham on post-concussion symptoms in military service members with combat-related, mild traumatic brain injury (TBI). Methods: Fifty subjects diagnosed with TBI were randomized to either a sham (1.3 atm abs breathing air) or treatment (2.4 atm abs breathing 100% oxygen) hyperbaric profile. Forty-eight subjects completed 30 exposures. Medical events during hyperbaric exposures were separately annotated by medical staff and chamber operators. After the blind was broken, events were segregated into the exposure groups. Results: These side effects were observed as rate (sham/treatment): ear block (ear barotrauma) 5.51% (1.09%/5.91%), sinus squeeze 0.14% (0.0%/0.27%), and confinement anxiety 0.27% (0.27%/0.27%). Other conditions that occurred included: headache 0.61% (0.68%/0.54%); nausea 0.2% (0.14%/0.27%); numbness 0.07% (0%/0.13%); heartburn 0.07% (0.14%/0%); musculoskeletal chest pain 0.07% (0%/0.13%); latex allergy 0.07% (0.14%/0%); and hypertension 0.07% (0.14%/0%). Conclusion: This study demonstrated no major adverse events, such as pulmonary barotraumas, pulmonary edema or seizure. Given the infrequent, mild side effect profile, the authors feel the study demonstrated that hyperbaric oxygen therapy (HBO2T) was safe at a relatively high treatment pressure in TBI subjects, and these data can be used to evaluate the risk/benefit calculation when deciding to utilize HBO2T for treatment of various diseases in the TBI population.	[Wolf, E. George; Prye, Jennifer; Michaelson, Robert; Brower, Gerry; Profenna, Leonardo] USAF Sch Aerosp Med, Hyperbar Med Dept, Lackland AFB, TX USA; [Boneta, Otto] Evan Army Community Hosp, Ft Carson, CO USA	Wolf, EG (corresponding author), USAF Sch Aerosp Med, Hyperbar Med Dept, Lackland AFB, TX USA.	earl.wolf.ctr@us.af.mil			Air Force Medical Service; U.S. Navy Bureau of Medicine and Surgery; U.S. Army Medical Materiel Development Activity	The authors would like to recognize and thank the Air Force Medical Service for funding this research project; the U.S. Navy Bureau of Medicine and Surgery for funding temporary duty requirements; the U.S. Army Medical Materiel Development Activity for end of study funding; Ms. Sheila Galvin, Traumatic Brain Injury Program Coordinator for the Wounded Warrior Regiment USMC for her superb service in coordinating subject requirements; Ms. Karen Guenther and the Injured Marine Semper Fi Fund for transportation support for subjects; and Dr. Jason Cromar, USAFSAM, for coordinating the protocol.	Churchill S, 1997, UNDERSEA HYPERB MED; Clark J, 2009, HYPERBARIC OXYGEN TH, P217; Clarke D, 2009, UNDERSEA HYPERBAR M, V36, P13; Dedi D, 1998, UNDERSEA HYPERBAR M, V25, p[93, 34]; Kindwall EP, 2008, HYPERBARIC MED PRACT, P284; Kinney J, 1974, 793 NAV SUBM MED RES; Lin JW, 2008, ACTA NEUROCHIR SUPPL, V101, P145; McDonagh MS, 2003, AHRQ PUBLICATION, V03-E050; NIGHOGHOSSIAN N, 1995, STROKE, V26, P1369, DOI 10.1161/01.STR.26.8.1369; Rockswold GL, 2010, J NEUROSURG, V112, P1079; Rockswold SB, 2010, J NEUROSURG, V112, P1080, DOI 10.3171/2009.7.JNS09363; Rusyniak DE, 2003, STROKE, V34, P571, DOI 10.1161/01.STR.0000050644.48393.D0; Smerz R, 2009, UNDERSEA HYPERB MED, V36; Stone JA, 1991, UND HYP MED SOC ANN, P80; van Ophoven A, 2006, J UROLOGY, V176, P1442, DOI 10.1016/j.juro.2006.06.065	15	22	25	0	7	UNDERSEA & HYPERBARIC MEDICAL SOC INC	DURHAM	21 WEST COLONY PLACE, STE 280, DURHAM, NC 27705 USA	1066-2936			UNDERSEA HYPERBAR M	Undersea Hyperb. Med.	NOV-DEC	2012	39	6					1075	1082					8	Marine & Freshwater Biology; Medicine, Research & Experimental	Marine & Freshwater Biology; Research & Experimental Medicine	250BV	WOS:000326826100004	23342764				2021-06-18	
J	Leonardi, AD; Keane, NJ; Bir, CA; Ryan, AG; Xu, LS; VandeVord, PJ				Leonardi, Alessandra Dal Cengio; Keane, Nickolas J.; Bir, Cynthia A.; Ryan, Anne G.; Xu, Liaosa; VandeVord, Pamela J.			Head orientation affects the intracranial pressure response resulting from shock wave loading in the rat	JOURNAL OF BIOMECHANICS			English	Article						Blast; Traumatic brain injury; Skull flexure; Orientation; Intracranial pressure	TRAUMATIC BRAIN-INJURY; BLAST INJURY; EXPOSURE; NEUROSCIENCE; MECHANISM	Since an increasing number of returning military personnel are presenting with neurological manifestations of traumatic brain injury (TB!), there has been a great focus on the effects resulting from blast exposure. It is paramount to resolve the physical mechanism by which the critical stress is being inflicted on brain tissue from blast wave encounters with the head. This study quantitatively measured the effect of head orientation on intracranial pressure (ICP) of rats exposed to a shock wave. Furthermore, the study examined how skull maturity affects ICP response of animals exposed to shock waves at various orientations. Results showed a significant increase in ICP values in larger rats at any orientation. Furthermore, when side-ICP values were compared to the other orientations, the peak pressures were significantly lower suggesting a relation between ICP and orientation of the head due to geometry of the skull and location of sutures. This finding accentuates the importance of skull dynamics in explaining possible injury mechanisms during blast. Also, the rate of pressure change was measured and indicated that the rate was significantly higher when the top of the head was facing the shock front. The results confirm that the biomechanical response of the superior rat skull is distinctive compared to other areas of the skull, suggesting a skull flexure mechanism. These results not only present insights into the mechanism of brain injury, but also provide information which can be used for designing more effective protective head gear. (C) 2012 Elsevier Ltd. All rights reserved.	[Leonardi, Alessandra Dal Cengio; Keane, Nickolas J.; Bir, Cynthia A.; VandeVord, Pamela J.] Wayne State Univ, Dept Biomed Engn, Detroit, MI 48201 USA; [Leonardi, Alessandra Dal Cengio; VandeVord, Pamela J.] John D Dingell VA Med Ctr, Res & Dev Serv, Detroit, MI 48201 USA; [Ryan, Anne G.; Xu, Liaosa] Virginia Tech, Dept Stat, Blacksburg, VA 24061 USA	VandeVord, PJ (corresponding author), Virginia Tech Univ, Sch Biomed Engn & Sci, Blacksburg, VA 24061 USA.	adc.leonardi@gmail.com; nickolasjkeane@gmail.com; cbir@wayne.edu; agryan@vt.edu; liaosax@vt.edu; pvord@vt.edu		Bir, Cynthia/0000-0002-0777-0951	Department of DefenseUnited States Department of Defense [W81XWH-08-2-0207]	We would like to thank the WSU Bioengineering Center Staff for assisting with this project, and especially Dr. Wu, Mr. Mathie, and Mr. Ritzel. This project was partially funded by the Department of Defense (Award No. W81XWH-08-2-0207).	Bauman RA, 2009, J NEUROTRAUM, V26, P841, DOI 10.1089/neu.2009-0898; Bhattacharjee Y, 2008, SCIENCE, V319, P406, DOI 10.1126/science.319.5862.406; Bolander R, 2011, ANN BIOMED ENG, V39, P2550, DOI 10.1007/s10439-011-0343-0; Born CT, 2005, SCAND J SURG, V94, P279, DOI 10.1177/145749690509400406; Cernak I, 2001, J TRAUMA, V50, P695, DOI 10.1097/00005373-200104000-00017; CLEMEDSON C, 1961, ACTA PHYSIOL SCAND, V51, P47, DOI 10.1111/j.1748-1716.1961.tb02112.x; CLEMEDSON CJ, 1956, ACTA PHYSL SCAND, V37, P204, DOI DOI 10.1111/J.1748-1716.1956.TB01356.X); Courtney AC, 2009, MED HYPOTHESES, V72, P76, DOI 10.1016/j.mehy.2008.08.015; Gefen A, 2003, J NEUROTRAUM, V20, P1163, DOI 10.1089/089771503770802853; Hicks RR, 2010, J TRAUMA, V68, P1257, DOI 10.1097/TA.0b013e3181d8956d; Hoffman SW, 2009, CLIN NEUROPSYCHOL, V23, P1400, DOI 10.1080/13854040903369433; JASLOW CR, 1990, J BIOMECH, V23, P313, DOI 10.1016/0021-9290(90)90059-C; Leonardi A.D., 2011, THESIS WAYNE STATE U; Leonardi AD, 2011, J NEUROTRAUM, V28, P85, DOI 10.1089/neu.2010.1324; Okie S, 2005, NEW ENGL J MED, V352, P2043, DOI 10.1056/NEJMp058102; Romba J.J., 1961, 1761 US ARM ORDN HUM; Saljo A, 2008, J NEUROTRAUM, V25, P1397, DOI 10.1089/neu.2008.0602; Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398, DOI 10.1097/00001199-200609000-00004; YOUNG MW, 1945, WAR MED, V8, P73	19	22	22	0	10	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0021-9290			J BIOMECH	J. Biomech.	OCT 11	2012	45	15					2595	2602		10.1016/j.jbiomech.2012.08.024			8	Biophysics; Engineering, Biomedical	Biophysics; Engineering	024KE	WOS:000310107300016	22947434				2021-06-18	
J	Boyko, M; Stepensky, D; Gruenbaum, BF; Gruenbaum, SE; Melamed, I; Ohayon, S; Glazer, M; Shapira, Y; Zlotnik, A				Boyko, Matthew; Stepensky, David; Gruenbaum, Benjamin F.; Gruenbaum, Shaun E.; Melamed, Israel; Ohayon, Sharon; Glazer, Michael; Shapira, Yoram; Zlotnik, Alexander			Pharmacokinetics of Glutamate-Oxaloacetate Transaminase and Glutamate-Pyruvate Transaminase and Their Blood Glutamate-Lowering Activity in Naive Rats	NEUROCHEMICAL RESEARCH			English	Article						Glutamate-oxaloacetate transaminase and glutamate-pyruvate transaminase enzymes; Pharmacokinetics and glutamate-lowering activity; Neuroprotective activity in traumatic brain injury and stroke	ACUTE ISCHEMIC-STROKE; CLOSED-HEAD INJURY; SCAVENGING ACTIVITY; EXCESS GLUTAMATE; BRAIN-BARRIER; AMINO-ACIDS; CEREBROSPINAL-FLUID; PLASMA; MODEL; NEUROPROTECTION	Traumatic brain injury (TBI) and stroke lead to elevated levels of glutamate in the brain that negatively affect the neurological outcomes in both animals and humans. Intravenous administration of glutamate-oxaloacetate transaminase (GOT) and glutamate-pyruvate transaminase (GPT) enzymes can be used to lower the blood glutamate levels and to improve the neurological outcome following TBI and stroke. The objective of this study was to analyze the pharmacokinetics and to determine the glutamate-lowering effects of GOT and GPT enzymes in naive rats. We determined the time course of serum GOT, GPT, and glutamate levels following a single intravenous administration of two different doses of each one of the studied enzymes. Forty-six male rats were randomly assigned into one of 5 treatment groups: saline (control), human GOT at dose 0.03 and 0.06 mg/kg and porcine GPT at dose 0.6 and 1.2 mg/kg. Blood samples were collected at baseline, 5 min, and 2, 4, 8, 12, and 24 h after the drug injection and GOT, GPT and glutamate levels were determined. The pharmacokinetics of both GOT and GPT followed one-compartment model, and both enzymes exhibited substantial glutamate-lowering effects following intravenous administration. Analysis of the pharmacokinetic data indicated that both enzymes were distributed predominantly in the blood (central circulation) and did not permeate to the peripheral organs and tissues. Several-hour delay was present between the time course of the enzyme levels and the glutamate-lowering effects (leading to clock-wise hysteresis on concentration-effect curves), apparently due to the time that is required to affect the pool of serum glutamate. We conclude that the interaction between the systemically-administered enzymes (GOT and GPT) and the glutamate takes place in the central circulation. Thus, glutamate-lowering effects of GOT and GPT apparently lead to redistribution of the excess glutamate from the brain's extracellular fluid into the blood and can reduce secondary brain injury due to glutamate neurotoxicity. The outcomes of this study regarding the pharmacokinetic and pharmacodynamic properties of the GOT and GPT enzymes will be subsequently verified in clinical studies that can lead to design of effective neuroprotective treatment strategies in patients with traumatic brain diseases and stroke.	[Boyko, Matthew; Gruenbaum, Benjamin F.; Ohayon, Sharon; Glazer, Michael; Shapira, Yoram; Zlotnik, Alexander] Ben Gurion Univ Negev, Fac Hlth Sci, Soroka Med Ctr, Dept Anesthesiol & Crit Care, Beer Sheva, Israel; [Stepensky, David] Ben Gurion Univ Negev, Dept Pharmacol, IL-84105 Beer Sheva, Israel; [Gruenbaum, Shaun E.] Yale Univ, Sch Med, Dept Anesthesiol, New Haven, CT 06510 USA; [Melamed, Israel] Ben Gurion Univ Negev, Fac Hlth Sci, Soroka Med Ctr, Dept Neurosurg, Beer Sheva, Israel	Zlotnik, A (corresponding author), Ben Gurion Univ Negev, Fac Hlth Sci, Soroka Med Ctr, Dept Anesthesiol & Crit Care, Beer Sheva, Israel.	zlotnika@bgumail.bgu.ac.il	Stepensky, David/F-3277-2012	Stepensky, David/0000-0001-7206-8352; Boyko, Matthew/0000-0003-3116-1643	European Society of Anesthesiologists	The authors gratefully acknowledge Valeria Frishman (laboratory assistant at the Department of Clinical Bio-chemistry, Faculty of Health Sciences, Ben-Gurion University of the Negev) for her outstanding help with the biochemical analysis. The help of Dr. Shira Ovadia (Director of Animal Resources Unit, Faculty of Health Sciences, Ben-Gurion University of the Negev) is also gratefully acknowledged. We want to thank Dr. A. Alir and the staff of the Critical Care Unit, Soroka Medical Center, for their support and helpful discussions. This work was supported in part by grants to AZ from European Society of Anesthesiologists.	Ahlstrom C, 2011, THESIS U GOTHENBURG; Boyko M, 2011, EUR J NEUROSCI, V34, P1432, DOI 10.1111/j.1460-9568.2011.07864.x; Campos F, 2011, J CEREBR BLOOD F MET, V31, P1378, DOI 10.1038/jcbfm.2011.3; Campos F, 2011, J CEREBR BLOOD F MET, V31, P1387, DOI 10.1038/jcbfm.2011.4; Campos F, 2011, CLIN SCI, V121, P11, DOI 10.1042/CS20100427; Castellanos M, 2008, NEUROLOGY, V71, P1862, DOI 10.1212/01.wnl.0000326064.42186.7e; Castillo J, 1997, LANCET, V349, P79, DOI 10.1016/S0140-6736(96)04453-4; Castillo J, 1996, STROKE, V27, P1060, DOI 10.1161/01.STR.27.6.1060; Ferrarese C, 2001, NEUROLOGY, V57, P671, DOI 10.1212/WNL.57.4.671; GRAHAM LT, 1966, ANAL BIOCHEM, V15, P487, DOI 10.1016/0003-2697(66)90110-2; Hammarlund-Udenaes M, 2008, PHARM RES-DORDR, V25, P1737, DOI 10.1007/s11095-007-9502-2; Johnston MV, 2001, PEDIATR RES, V49, P735, DOI 10.1203/00006450-200106000-00003; JUSKO WJ, 1994, CLIN PHARMACOL THER, V56, P406, DOI 10.1038/clpt.1994.155; Klin Y, 2010, BIOCHEM BIOPH RES CO, V399, P694, DOI 10.1016/j.bbrc.2010.07.144; Koura SS, 1998, ACT NEUR S, V71, P244; Laurer HL, 2000, EUR J TRAUMA, V26, P95, DOI DOI 10.1007/S000680050007; Liu XR, 2005, J PHARMACOL EXP THER, V313, P1254, DOI 10.1124/jpet.104.079319; Lloyd-Jones D, 2010, CIRCULATION, V121, pE46, DOI 10.1161/CIRCULATIONAHA.109.192667; O'Kane RL, 1999, J BIOL CHEM, V274, P31891, DOI 10.1074/jbc.274.45.31891; SHAW PJ, 1995, NEURODEGENERATION, V4, P209, DOI 10.1006/neur.1995.0026; Spranger M, 1996, J NEUROL SCI, V143, P126, DOI 10.1016/S0022-510X(96)00197-9; Teichberg VI, 2009, NEUROSCIENCE, V158, P301, DOI 10.1016/j.neuroscience.2008.02.075; Teichberg VI, 2007, P NATL ACAD SCI USA, V104, P7315, DOI 10.1073/pnas.0702450104; Teichberg VI, 2011, J CEREBR BLOOD F MET, V31, P1376, DOI 10.1038/jcbfm.2011.46; Zauner A, 1996, ACT NEUR S, V67, P40; Zhang H, 2001, CLIN CHEM, V47, P1458; Zhang Y, 2010, COMPUT METH PROG BIO, V99, P306, DOI 10.1016/j.cmpb.2010.01.007; Zlotnik A, 2008, NEUROCHEM RES, V33, P1044, DOI 10.1007/s11064-007-9548-x; Zlotnik A, 2007, EXP NEUROL, V203, P213, DOI 10.1016/j.expneurol.2006.08.021; Zlotnik A, 2011, J NEUROSURG ANESTH, V23, P45, DOI 10.1097/ANA.0b013e3181f82a8f; Zlotnik A, 2010, EXP NEUROL, V224, P465, DOI 10.1016/j.expneurol.2010.05.009; Zlotnik A, 2009, J NEUROSURG ANESTH, V21, P235, DOI 10.1097/ANA.0b013e3181a2bf0b	32	22	22	0	12	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0364-3190	1573-6903		NEUROCHEM RES	Neurochem. Res.	OCT	2012	37	10					2198	2205		10.1007/s11064-012-0843-9			8	Biochemistry & Molecular Biology; Neurosciences	Biochemistry & Molecular Biology; Neurosciences & Neurology	004SK	WOS:000308701200016	22846966				2021-06-18	
J	Lian, H; Shim, DJ; Gaddam, SSK; Rodriguez-Rivera, J; Bitner, BR; Pautler, RG; Robertson, CS; Zheng, H				Lian, Hong; Shim, David J.; Gaddam, Samson S. K.; Rodriguez-Rivera, Jennifer; Bitner, Brittany R.; Pautler, Robia G.; Robertson, Claudia S.; Zheng, Hui			I kappa B alpha deficiency in brain leads to elevated basal neuroinflammation and attenuated response following traumatic brain injury: implications for functional recovery	MOLECULAR NEURODEGENERATION			English	Article						NF kappa B; I kappa B alpha; Conditional knockout mice; TBI; Neuroinflammation; Cerebral blood flow; MRI	UBIQUITIN-PROTEASOME PATHWAY; CENTRAL-NERVOUS-SYSTEM; TRANSCRIPTION FACTOR; CELL-DEATH; INFLAMMATORY RESPONSE; SYNAPTIC PLASTICITY; CEREBRAL-ISCHEMIA; MEMORY FORMATION; C-REL; ACTIVATION	Background: The transcription factor NF kappa B is an important mediator of cell survival and inflammation in the immune system. In the central nervous system (CNS), NF kappa B signaling has been implicated in regulating neuronal survival following acute pathologic damage such as traumatic brain injury (TBI) and stroke. NF kappa B is normally bound by the principal inhibitory protein, I kappa B alpha, and sequestered in the cytoplasm. Activation of NF kappa B requires the degradation of I kappa B alpha, thereby freeing NF kappa B to translocate to the nucleus and activate the target genes. Mice deficient in I kappa B alpha display deregulated and sustained NF kappa B activation and early postnatal lethality, highlighting a critical role of I kappa B alpha in NF kappa B regulation. Results: We investigated the role of I kappa B alpha in regulating NF kappa B activity in the brain and the effects of the NF kappa B/I kappa B alpha pathway in mediating neuroinflammation under both physiological and brain injury conditions. We report that astrocytes, but not neurons, exhibit prominent NF kappa B activity, and that basal NF kappa B activity in astrocytes is elevated in the absence of I kappa B alpha. By generating mice with brain-specific deletion of I kappa B alpha, we show that I kappa B alpha deficiency does not compromise normal brain development. However, basal neuroinflammation detected by GFAP and Iba1 immunoreactivity is elevated. This leads to impaired inflammatory responses following TBI and worsened brain damage including higher blood brain barrier permeability, increased injury volumes and enlarged ventricle volumes. Conclusions: We conclude that, in the CNS, astrocyte is the primary cell type subject to NF kappa B regulation. We further demonstrate that I kappa B alpha plays an important role in regulating NF kappa B activity in the brain and a robust NF kappa B/I kappa B alpha-mediated neuroinflammatory response immediately following TBI is beneficial.	[Lian, Hong; Shim, David J.; Rodriguez-Rivera, Jennifer; Zheng, Hui] Baylor Coll Med, Huffington Ctr Aging, Houston, TX 77030 USA; [Lian, Hong; Zheng, Hui] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Shim, David J.; Zheng, Hui] Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA; [Shim, David J.; Zheng, Hui] Baylor Coll Med, Med Sci Training Program, Houston, TX 77030 USA; [Gaddam, Samson S. K.; Robertson, Claudia S.] Baylor Coll Med, Dept Neurosurg, Houston, TX 77030 USA; [Bitner, Brittany R.; Pautler, Robia G.] Baylor Coll Med, Dept Mol Physiol & Biophys, Houston, TX 77030 USA; [Bitner, Brittany R.; Pautler, Robia G.; Zheng, Hui] Baylor Coll Med, Interdept Program Translat Biol & Mol Med, Houston, TX 77030 USA	Zheng, H (corresponding author), Baylor Coll Med, Huffington Ctr Aging, Houston, TX 77030 USA.	huiz@bcm.edu			 [P01 NS38660];  [R01 AG020670];  [AG032051];  [NS076117];  [R01 AG 029977];  [F30 NS061428]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS076117, P01NS038660, F30NS061428] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R01AG032051, R01AG029977, R01AG020670] Funding Source: NIH RePORTER	We are grateful to N. Aithmitti and X. Chen for expert technical support and members of the Zheng laboratory for constructive discussions and help with the manuscript. This work was supported by P01 NS38660 (to CSR), R01 AG020670, AG032051 and NS076117 (to HZ), R01 AG 029977 (to RGP), and F30 NS061428 (to DS).	Ahn HJ, 2008, LEARN MEMORY, V15, P539, DOI 10.1101/lm.866408; ALKALAY I, 1995, P NATL ACAD SCI USA, V92, P10599, DOI 10.1073/pnas.92.23.10599; Bajenaru ML, 2002, MOL CELL BIOL, V22, P5100, DOI 10.1128/MCB.22.14.5100-5113.2002; BEG AA, 1995, GENE DEV, V9, P2736, DOI 10.1101/gad.9.22.2736; Blondeau N, 2001, J NEUROSCI, V21, P4668, DOI 10.1523/JNEUROSCI.21-13-04668.2001; Browne KD, 2006, EXP NEUROL, V201, P301, DOI 10.1016/j.expneurol.2006.04.008; CHEN ZJ, 1995, GENE DEV, V9, P1586, DOI 10.1101/gad.9.13.1586; CHIAO PJ, 1994, P NATL ACAD SCI USA, V91, P28, DOI 10.1073/pnas.91.1.28; De Keyser J, 2008, J NEUROL SCI, V267, P3, DOI 10.1016/j.jns.2007.08.044; Foehr ED, 2000, J NEUROSCI, V20, P7556; Fridmacher V, 2003, J NEUROSCI, V23, P9403; Guo GW, 2006, ANTIOXID REDOX SIGN, V8, P911, DOI 10.1089/ars.2006.8.911; Hang CH, 2004, BRAIN RES, V1026, P23, DOI 10.1016/j.brainres.2004.07.090; Herkenham M, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-141; Hinson SR, 2010, NEUROSCIENCE, V168, P1009, DOI 10.1016/j.neuroscience.2009.08.032; Hoffmann A, 2002, SCIENCE, V298, P1241, DOI 10.1126/science.1071914; Johnson VE, 2010, NAT REV NEUROSCI, V11, P361, DOI 10.1038/nrn2808; Kaltschmidt B, 2000, EXP BRAIN RES, V130, P100, DOI 10.1007/s002210050011; Kaltschmidt B, 2006, MOL CELL BIOL, V26, P2936, DOI 10.1128/MCB.26.8.2936-2946.2006; KALTSCHMIDT C, 1993, MECH DEVELOP, V43, P135, DOI 10.1016/0925-4773(93)90031-R; KALTSCHMIDT C, 1994, MOL CELL BIOL, V14, P3981, DOI 10.1128/MCB.14.6.3981; KALTSCHMIDT C, 1995, P NATL ACAD SCI USA, V92, P9618, DOI 10.1073/pnas.92.21.9618; Kassed CA, 2002, EXP NEUROL, V176, P277, DOI 10.1006/exnr.2002.7967; Klement JF, 1996, MOL CELL BIOL, V16, P2341; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lee M, 2011, GLIA, V59, P152, DOI 10.1002/glia.21087; Lennon VA, 2005, J EXP MED, V202, P473, DOI 10.1084/jem.20050304; Lenzlinger PM, 2001, MOL NEUROBIOL, V24, P169; Levenson JM, 2004, J NEUROSCI, V24, P3933, DOI 10.1523/JNEUROSCI.5646-03.2004; Li HM, 2010, P NATL ACAD SCI USA, V107, P17362, DOI 10.1073/pnas.1012568107; Lloyd E, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-28; Longhi L, 2001, J CEREBR BLOOD F MET, V21, P1241, DOI 10.1097/00004647-200111000-00001; Mao XRR, 2009, J NEUROINFLAMM, V6, DOI 10.1186/1742-2094-6-16; Mattson MP, 2006, CELL DEATH DIFFER, V13, P852, DOI 10.1038/sj.cdd.4401837; Meffert MK, 2003, NAT NEUROSCI, V6, P1072, DOI 10.1038/nn1110; Morganti-Kossmann Maria Cristina, 2002, Curr Opin Crit Care, V8, P101; Nomoto Y, 2001, NEUROSURGERY, V48, P158, DOI 10.1097/00006123-200101000-00027; Nonaka M, 1999, J NEUROTRAUM, V16, P1023, DOI 10.1089/neu.1999.16.1023; Penkowa M, 2003, EXP NEUROL, V181, P130, DOI 10.1016/S0014-4886(02)00051-1; Plesnila N, 2007, CELL DEATH DIFFER, V14, P1529, DOI 10.1038/sj.cdd.4402159; Readnower RD, 2010, J NEUROSCI RES, V88, P3530, DOI 10.1002/jnr.22510; Rocha SM, 2012, NEUROBIOL DIS, V47, P407, DOI 10.1016/j.nbd.2012.04.014; Rojo AI, 2004, J NEUROSCI, V24, P7324, DOI 10.1523/JNEUROSCI.2111-04.2004; Rupec RA, 2005, IMMUNITY, V22, P479, DOI 10.1016/j.immuni.2005.02.009; Sanz O, 2002, J NEUROSCI RES, V67, P772, DOI 10.1002/jnr.10140; Schneider A, 1999, NAT MED, V5, P554; Shlosberg D, 2010, NAT REV NEUROL, V6, P393, DOI 10.1038/nrneurol.2010.74; Stamatovic SM, 2006, ACTA NEUROCHIR SUPPL, V96, P444; Swartz KR, 2001, BRAIN RES, V896, P86, DOI 10.1016/S0006-8993(01)02013-3; Tam WF, 2001, J BIOL CHEM, V276, P7701, DOI 10.1074/jbc.C000916200; Tronche F, 1999, NAT GENET, V23, P99, DOI 10.1038/12703; Utagawa A, 2008, EXP NEUROL, V211, P283, DOI 10.1016/j.expneurol.2008.02.001; Zhang W, 2005, J CEREBR BLOOD F MET, V25, P30, DOI 10.1038/sj.jcbfm.9600004; Ziebell JM, 2011, BRAIN RES, V1414, P94, DOI 10.1016/j.brainres.2011.07.056; Ziebell JM, 2010, NEUROTHERAPEUTICS, V7, P22, DOI 10.1016/j.nurt.2009.10.016; Zlokovic BV, 2008, NEURON, V57, P178, DOI 10.1016/j.neuron.2008.01.003	56	22	22	0	3	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1750-1326			MOL NEURODEGENER	Mol. Neurodegener.	SEP 19	2012	7								47	10.1186/1750-1326-7-47			11	Neurosciences	Neurosciences & Neurology	021ER	WOS:000309868600001	22992283	DOAJ Gold, Green Published			2021-06-18	
J	Bartsch, A; Benzel, E; Miele, V; Morr, D; Prakash, V				Bartsch, Adam; Benzel, Edward; Miele, Vincent; Morr, Douglas; Prakash, Vikas			Hybrid III anthropomorphic test device (ATD) response to head impacts and potential implications for athletic headgear testing	ACCIDENT ANALYSIS AND PREVENTION			English	Article						Hybrid III; NOCSAE; Helmet; Head Impact; Concussion	TRAUMATIC BRAIN-INJURY; HUMAN CERVICAL-SPINE; PROFESSIONAL FOOTBALL; STRUCTURAL-PROPERTIES; GAME IMPACTS; CONCUSSION; RECONSTRUCTION; ACCELERATION; BIOMECHANICS; PERFORMANCE	The Hybrid III 50th percentile male anthropomorphic test device (ATD) is the most widely used human impact testing surrogate and has historically been used in automotive or military testing. More recently, this ATD is finding use in applications evaluating athletic helmet protectivity, quantifying head impact dosage and estimating injury risk. But ATD head-neck response has not been quantified in omnidirectional athletic-type head impacts absent axial preload. It is probable that headgear injury reduction that can be quantified in a laboratory, including in American football, boxing, hockey, lacrosse and soccer, is related to a number of interrelated kinetic and kinematic factors, such as head center of gravity linear acceleration, head angular acceleration, head angular velocity, occipito-cervical mechanics and neck stiffness. Therefore, we characterized ATD head-neck dynamic response to direct head impacts in a series of front, oblique front and lateral head impacts. Key findings were: (1) impacts producing highest ATD resultant center of gravity linear acceleration resulted in the lowest resultant occipito-cervical spine bending moment/force. (2) Resultant ATD head angular velocity and angular acceleration did not appear coupled to impact direction at lower impact energy levels; these parameters were coupled at higher energy levels. (3) The ATD had progressively increasing occipito-cervical stiffness in extension, torsion and lateral bending, respectively. Because the ATD neck influenced head and neck impact dosage parameters, testing agencies, manufacturers and researchers should consider using the Hybrid III head form attached to a neck as a means to quantify head and neck injury risks as opposed to systems that do not utilize a neck. This heightened understanding of Hybrid III ATD head-neck response, and consideration of order of stiffest axes in the lateral, oblique and extension directions, respectively, should aid in the development of head and neck injury impact testing standards. (C) 2012 Elsevier Ltd. All rights reserved.	[Bartsch, Adam; Benzel, Edward] Cleveland Clin, Spine Res Lab, Cleveland, OH 44113 USA; [Bartsch, Adam; Benzel, Edward; Prakash, Vikas] Cleveland Traumat Neuromech Consortium, Cleveland, OH USA; [Benzel, Edward; Miele, Vincent] Cleveland Clin, Dept Neurol Surg, Neurol Inst, Cleveland, OH 44113 USA; [Miele, Vincent] United Hosp Ctr, Clarksburg, WV USA; [Miele, Vincent] Neurosurg Spine Ctr, Clarksburg, WV USA; [Prakash, Vikas] Case Western Reserve Univ, Dept Mech Engn, Cleveland, OH 44106 USA; [Morr, Douglas] SEA Ltd, Columbus, OH USA	Bartsch, A (corresponding author), Cleveland Clin, Spine Res Lab, Luth 2-C,1730 W 25th St, Cleveland, OH 44113 USA.	bartsca@ccf.org			NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS) [T32AR050959] Funding Source: NIH RePORTER; NIAMS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS) [T32 AR050959] Funding Source: Medline		Agaram V., 2001, P 17 INT TECHN C EXP, P1; Bartsch A, 2012, J NEUROSURG, V116, P222, DOI 10.3171/2011.9.JNS111059; Beckwith JG, 2007, J APPL BIOMECH, V23, P238, DOI 10.1123/jab.23.3.238; Camacho D. L. A., 1997, P 41 STAPP CAR CRASH, V41, P473, DOI [10.4271/973345, DOI 10.4271/973345]; Casson IR, 2009, PHYS MED REH CLIN N, V20, P195, DOI 10.1016/j.pmr.2008.10.006; Clemens H. J., 1972, STAPP CAR CRASH J, P76; Dibb Alan T, 2006, Stapp Car Crash J, V50, P567; Duma SM, 2005, CLIN J SPORT MED, V15, P3, DOI 10.1097/00042752-200501000-00002; Duma SM, 2003, ACCIDENT ANAL PREV, V35, P811, DOI 10.1016/S0001-4575(02)00085-4; Frechede B, 2009, MED SCI SPORT EXER, V41, P390, DOI 10.1249/MSS.0b013e318186b1c5; Funk J. R., 2009, P 2009 SAE WORLD C S; Gennarelli TA, 2005, ABBREVIATED INJURY S; GOEL VK, 1990, SPINE, V15, P990, DOI 10.1097/00007632-199015100-00002; Got C., 1978, STAPP CAR CRASH J, P441; Greenwald RM, 2008, NEUROSURGERY, V62, P789, DOI 10.1227/01.neu.0000318162.67472.ad; Gwin JT, 2010, J BIOMECH ENG-T ASME, V132, DOI 10.1115/1.4000249; HAN C, 1992, J ORTHOPAED RES, V10, P446, DOI 10.1002/jor.1100100318; Hu A. S., 1977, STAPP CAR CRASH J, p[1977, 589]; Kang J., 2001, P SOC AUT ENG 2001 W; LYSELL E, 1969, ACTA ORTHOP SCAND, VS, P4; Manoogian S, 2006, BIOMED SCI INSTRUM, V42, P383; MARGULIES SS, 1992, J BIOMECH, V25, P917, DOI 10.1016/0021-9290(92)90231-O; McIntosh AS, 2007, ACCIDENT ANAL PREV, V39, P326, DOI 10.1016/j.aap.2006.09.001; Mertz H., 1967, STAPP CAR CRASH J, P267; MERTZ HJ, 1971, P 15 STAPP CAR CRASH, P207; MYERS BS, 1991, SPINE, V16, P870, DOI 10.1097/00007632-199108000-00002; Nahum AM, 1968, P 12 STAPP CAR CRASH, P302; National Committee on Standards for Athletic Equipment, 2006, 08104M04 NOCSAE DOC, P1; National Operating Committee on Standards for Athletic Equipment, 2009, ND00298M09 NOCSAE, P1; National Operating Committee on Standards for Athletic Equipment (NOCSAE), 2008, 00108M08B NOCSAE, P1; Newman J, 2000, 44 STAPP CAR CRASH C; Newman JA, 2005, J BIOMECH, V38, P1469, DOI 10.1016/j.jbiomech.2004.06.025; Nightingale RW, 2007, J BIOMECH, V40, P535, DOI 10.1016/j.jbiomech.2006.02.015; Nightingale RW, 2002, J BIOMECH, V35, P725, DOI 10.1016/S0021-9290(02)00037-4; OMMAYA AK, 1971, J BIOMECH, V4, P13, DOI 10.1016/0021-9290(71)90011-X; Ommaya AK, 2002, BRIT J NEUROSURG, V16, P220, DOI 10.1080/02688690220148824; PANJABI M, 1988, SPINE, V13, P726, DOI 10.1097/00007632-198807000-00003; Panjabi MM, 2001, SPINE, V26, P2692, DOI 10.1097/00007632-200112150-00012; Patrick L. M., 1976, VRI73 SOC AUT ENG, P1; Pellman EJ, 2006, NEUROSURGERY, V58, P78, DOI 10.1227/01.NEU.0000196265.35238.7C; Pellman EJ, 2003, NEUROSURGERY, V53, P799, DOI 10.1093/neurosurgery/53.3.799; Pincemaille Y, 1989, P 33 STAPP CAR CRASH, P177; Pintar Frank A, 2005, Stapp Car Crash J, V49, P33; Rousseau P, 2009, P I MECH ENG P-J SPO, V223, P89, DOI 10.1243/17543371JSET34; Rousseau Philippe, 2010, Stapp Car Crash J, V54, P37; Rowson S, 2011, ANN BIOMED ENG, V39, P2130, DOI 10.1007/s10439-011-0322-5; Rowson S, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3130454; Seemann M. R., 1986, P 30 STAPP CAR CRASH, V30, P291; SHEA M, 1991, J BIOMECH, V24, P95, DOI 10.1016/0021-9290(91)90354-P; Smith T, 1988, 3 DIMENSIONAL ANAL L, P271; *SOC AUT ENG, 1994, J1733 SAE; Society of Automotive Engineers, 2003, J2111 SAE; Stojsih S, 2010, BRIT J SPORT MED, V44, P725, DOI 10.1136/bjsm.2008.052845; Thiabault LE, 1990, 34 ANN P ASS ADV AUT, V34, P337; Viano DC, 2006, NEUROSURGERY, V59, P591, DOI 10.1227/01.NEU.0000231851.97287.C2; Viano DC, 2005, NEUROSURGERY, V57, P1154, DOI 10.1227/01.NEU.0000187541.87937.D9; Walilko TJ, 2005, BRIT J SPORT MED, V39, P710, DOI 10.1136/bjsm.2004.014126; Wismans J., 1983, STAPP CAR CRASH J, V27, DOI [10.4271/831613, DOI 10.4271/831613]; Wismans J, 1986, STAPP CAR CRASH J, V30, P313; Withnall C, 2005, BRIT J SPORT MED, V39, pI49, DOI 10.1136/bjsm.2005.019182; Yoganandan N, 2000, Stapp Car Crash J, V44, P189; Zhang LY, 2004, J BIOMECH ENG-T ASME, V126, P226, DOI 10.1115/1.1691446	62	22	22	0	21	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0001-4575	1879-2057		ACCIDENT ANAL PREV	Accid. Anal. Prev.	SEP	2012	48				SI		285	291		10.1016/j.aap.2012.01.032			7	Ergonomics; Public, Environmental & Occupational Health; Social Sciences, Interdisciplinary; Transportation	Engineering; Public, Environmental & Occupational Health; Social Sciences - Other Topics; Transportation	983TB	WOS:000307140500032	22664692				2021-06-18	
J	Lefebvre, H; Levert, MJ				Lefebvre, Helene; Levert, Marie-Josee			The close relatives of people who have had a traumatic brain injury and their special needs	BRAIN INJURY			English	Article						Caregivers needs; services; continuum of care; brain injury; developing reflexive analysis for partnership; qualitative research	INDIVIDUALS; EXPERIENCES; FAMILIES; CARERS	Primary objective: This study aims to paint a picture of the needs of people close to individuals with a TBI and the services offered to answer these needs, from the point of view of the individuals with a TBI and health professionals. Research design: This study has a qualitative design and a reflexive group was used to collect data. The demarche reflexive d'analyse en partenariat, DRAP (developing reflexive analysis for partnership) was used as a data collection method. The sample comprised Montreal family members (n = 4), Outaouais family members (n = 8), Abitibi family members (n = 7); Montreal care providers (n = 9), Outaouais care providers (n = 11) and Abitibi care providers (n = 9). Main outcomes and results: The results show that people close to individuals with a TBI need information on the health problem, specifically with regard to the diagnostic, the prognostic, and the factors that influence it, as well as the steps towards rehabilitation, and care and services. The results show that close ones need specific, quality services and continuity of services. Conclusion: In conclusion, the pertinence of this study lies in the desire of close ones and health professionals to ease the adaptation process imposed by a TBI, and to promote the well-being of informal caregivers.	[Lefebvre, Helene; Levert, Marie-Josee] Univ Montreal, Fac Nursing, Montreal, PQ H3C 3J7, Canada; [Lefebvre, Helene; Levert, Marie-Josee] Montreal Ctr Interdisciplinary Res Rehabil CRIR, Montreal, PQ, Canada; [Lefebvre, Helene; Levert, Marie-Josee] Hop Sacre Coeur, Res Ctr, Montreal, PQ H4J 1C5, Canada; [Lefebvre, Helene; Levert, Marie-Josee] Grp Interreseaux Rech Adaptat Famille & Son Envir, Montreal, PQ, Canada	Lefebvre, H (corresponding author), Univ Montreal, Fac Nursing, Box 6128,Downtown Stn, Montreal, PQ H3C 3J7, Canada.	helene.lefebvre@umontreal.ca			Consortium en traumatologie du Quebec (FRSQ)	This study was supported by the Consortium en traumatologie du Quebec (FRSQ).	Agence Nationale d'Accreditation: Et d'Evaluation en Sante, 2005, SORT MOND RET DOM PE; Baribeau C., 1996, REV SCI ED, V22, P577; Bond A Elaine, 2003, Crit Care Nurse, V23, P63; Boudreault P., 2006, ANIMATION GROUPES DE; Carriere M, 2005, ANAL COUT EFFICACITE; Degeneffe CE, 2001, HEALTH SOC WORK, V26, P257, DOI 10.1093/hsw/26.4.257; Deslauriers J. P., 2000, METHODES RECHERCHE I, P159; Duchesne S., 2005, ENTRETIEN COLLECTIF; Ergh TC, 2003, J CLIN EXP NEUROPSYC, V25, P1090, DOI 10.1076/jcen.25.8.1090.16735; Fallowfield LJ, 2002, PALLIATIVE MED, V16, P297, DOI 10.1191/0269216302pm575oa; Gervais M, 1999, ETUDE EXPLORATOIRE B; Guba E.G., 1989, 4 GENERATION EVALUAT; Jillings C., 2001, METASTUDY QUALITATIV; Kolakowsky-Hayner SA, 2001, J HEAD TRAUMA REHAB, V16, P374, DOI 10.1097/00001199-200108000-00007; Krueger KA, 1994, FOCUS GROUP PRACTICA; Lawlor MC, 1998, AM J OCCUP THER, V52, P259, DOI 10.5014/ajot.52.4.259; Lefebvre H, 2005, BRAIN INJURY, V19, P585, DOI 10.1080/02699050400025026; Lefebvre H, 2004, PARTICIPATION SOCIAL; Leith KH, 2004, BRAIN INJURY, V18, P1191, DOI 10.1080/02699050410001719943; Man DWK, 2002, BRAIN INJURY, V16, P1025, DOI 10.1080/0269905021000010087; McLennan M, 1996, PATIENT EDUC COUNS, V27, P191, DOI 10.1016/0738-3991(95)00799-7; Ministere de la Sante: des Services Sociaux, 1999, PAR ORG; MUCHIELLI A, 1996, DICT METHODES QUALIT; Nolte ML, 1999, DISSERTATION ABSTR I, V60, P4900; O'Connell Bev, 2004, Int J Nurs Pract, V10, P121, DOI 10.1111/j.1440-172X.2004.00469.x; Perlesz A, 2000, J HEAD TRAUMA REHAB, V15, P909, DOI 10.1097/00001199-200006000-00005; PIRES A, 1997, RECHERCHE QUALITATIV, P173; Poupart J, 1997, ENJEUX EPISTEMOLOGIQ; Sinnakaruppan I, 2001, BRAIN INJURY, V15, P653; Strauss A., 1990, BASICS QUALITATIVE R; TOCHON FV, 1996, REV SCI ED, V22, P467, DOI DOI 10.7202/031889AR; Wiles R, 1998, J ADV NURS, V28, P794, DOI 10.1046/j.1365-2648.1998.00709.x	32	22	22	0	11	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	AUG	2012	26	9					1084	1097		10.3109/02699052.2012.666364			14	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	971GI	WOS:000306191400005	22624724				2021-06-18	
J	Marshall, KR; Holland, SL; Meyer, KS; Martin, EM; Wilmore, M; Grimes, JB				Marshall, Kathryn R.; Holland, Sherray L.; Meyer, Kimberly S.; Martin, Elisabeth Moy; Wilmore, Michael; Grimes, Jamie B.			Mild Traumatic Brain Injury Screening, Diagnosis, and Treatment	MILITARY MEDICINE			English	Article								The majority of combat-related traumatic brain injury (TBI) within the U.S. Armed Forces is mild TBI (mTBI). This article focuses specifically on the screening, diagnosis, and treatment aspects of mTBI within the military community. Aggressive screening measures were instituted in 2006 to ensure that the mTBI population is identified and treated. Screenings occur in-theater, outside the contiguous United States, and in-garrison. We discuss specific screening procedures at each screening setting. Current diagnosis of mTBI is based upon self-report or through witnesses to the event. TBI severity is determined by specific Department of Defense criteria. Abundant clinician resources are available for mTBI in the military health care setting. Education resources for both the patient and the clinician are discussed in detail. An evidence-based clinical practice guideline for the care of mTBI was created through collaborative efforts of the DoD and the U.S. Department of Veterans Affairs. Although symptoms following mTBI generally resolve with time, active treatment is centered on symptom management, supervised rest, recovery, and patient education. Medical specialty care, ancillary services, and other therapeutic services may be required.	[Marshall, Kathryn R.; Holland, Sherray L.; Meyer, Kimberly S.; Martin, Elisabeth Moy; Wilmore, Michael; Grimes, Jamie B.] Def & Vet Brain Injury Ctr, Silver Spring, MD 20919 USA; [Meyer, Kimberly S.] Univ Louisville Hosp, Trauma Inst, Louisville, KY 40202 USA	Marshall, KR (corresponding author), Def & Vet Brain Injury Ctr, 1335 East West Highway,Suite 6-100, Silver Spring, MD 20919 USA.		Meyer, Kimberly/L-5430-2019				Ahlers Stephen Thomas, 2012, Front Neurol, V3, P32, DOI 10.3389/fneur.2012.00032; [Anonymous], 2012, TBI NUMBERS SEVERITY; [Anonymous], 2012, CONCUSSION MANAGEMEN; [Anonymous], 2009, VA DOD CLIN PRACTICE; [Anonymous], 2009, TRAUM BRAIN INJ CAR; [Anonymous], 2011, IND COND INTH POST N; [Anonymous], TBI CLIN TOOLS RES; Barth J, 2010, MIL NEUROPSYCHOL, V1, P135; Betthauser LM, 2012, NEUROPSYCHOL REV, V22, P35, DOI 10.1007/s11065-012-9191-4; Brenner Lisa A, 2012, Front Neurol, V3, P31, DOI 10.3389/fneur.2012.00031; Brenner LA, 2009, REHABIL PSYCHOL, V54, P239, DOI 10.1037/a0016908; Chu JJ, 2012, ANN BIOMED ENG, V40, P203, DOI 10.1007/s10439-011-0410-6; Davenport ND, 2012, NEUROIMAGE, V59, P2017, DOI 10.1016/j.neuroimage.2011.10.050; DCoE Resources, DCOE RES; Defense and Veterans Brain Injury Center, 2011, DOD NUMB TRAUM BRAIN; Dempsey KE, 2009, J TRAUMA NURS, V16, P10; Dempsey Kenneth E, 2009, J Trauma Nurs, V16, P6, DOI 10.1097/01.JTN.0000348063.41099.a7; DoD, 2007, ASS SECR DEF MEM TRA; Dolan S, 2012, NEUROPSYCHOL REV, V22, P21, DOI 10.1007/s11065-012-9190-5; Drag LL, 2012, J INT NEUROPSYCH SOC, V6, P1; Dutton RP, 2002, J TRAUMA, V53, P857, DOI 10.1097/00005373-200211000-00009; DVBIC, 2012, MIL AC CONC EV MACE; Heltemes KJ, 2011, INJURY IN PRESS; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hou RH, 2012, J NEUROL NEUROSUR PS, V83, P217, DOI 10.1136/jnnp-2011-300767; Ivins BJ, 2009, J HEAD TRAUMA REHAB, V24, P24, DOI 10.1097/HTR.0b013e3181957042; Kennedy JE, 2010, NEUROREHABILITATION, V26, P191, DOI 10.3233/NRE-2010-0555; Krainin Benjamin M, 2011, J Spec Oper Med, V11, P38; Lew HL, 2009, J REHABIL RES DEV, V46, P697, DOI 10.1682/JRRD.2009.01.0006; Lippa SM, 2010, J INT NEUROPSYCH SOC, V16, P856, DOI 10.1017/S1355617710000743; Luethcke CA, 2011, J INT NEUROPSYCH SOC, V17, P36, DOI 10.1017/S1355617710001207; Mac Donald CL, 2011, NEW ENGL J MED, V364, P2091, DOI 10.1056/NEJMoa1008069; Marion DW, 2011, J NEUROTRAUM, V28, P517, DOI 10.1089/neu.2010.1638; Maruta J, 2010, ANN NY ACAD SCI, V1208, P58, DOI 10.1111/j.1749-6632.2010.05695.x; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; Messe A, 2011, HUM BRAIN MAPP, V32, P999, DOI 10.1002/hbm.21092; Meyer KS, 2010, PSYCHIAT CLIN N AM, V33, P783, DOI 10.1016/j.psc.2010.08.007; Military Health System Conference, 2011, MIL HLTH SYST C; Peskind ER, 2011, NEUROIMAGE, V54, pS76, DOI 10.1016/j.neuroimage.2010.04.008; Ponsford J, 2002, J NEUROL NEUROSUR PS, V73, P330, DOI 10.1136/jnnp.73.3.330; Ponsford J, 2012, NEUROPSYCHOLOGY, V26, P304, DOI 10.1037/a0027888; Ruff RL, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2011-000312; Sayer NA, 2012, ANNU REV MED, V63, P405, DOI 10.1146/annurev-med-061610-154046; Sharif-Alhoseini Mahdi, 2011, J Emerg Trauma Shock, V4, P472, DOI 10.4103/0974-2700.86631; Shenton ME, 2012, BRAIN IMAGI IN PRESS; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; Terrio HP, 2011, REHABIL PSYCHOL, V56, P26, DOI 10.1037/a0022685; Topolovec-Vranic J, 2011, J TRAUMA, V71, pS478, DOI 10.1097/TA.0b013e318232fa70; VA Healthcare, MILD TRAUM BRAIN INJ; Vanderploeg RD, 2009, ARCH PHYS MED REHAB, V90, P1084, DOI 10.1016/j.apmr.2009.01.023; Wilk JE, 2012, PSYCHOSOM MED, V74, P249, DOI 10.1097/PSY.0b013e318244c604; Zatzick DF, 2010, ARCH GEN PSYCHIAT, V67, P1291, DOI 10.1001/archgenpsychiatry.2010.158	52	22	22	0	7	ASSOC MILITARY SURG US	BETHESDA	9320 OLD GEORGETOWN RD, BETHESDA, MD 20814 USA	0026-4075	1930-613X		MIL MED	Milit. Med.	AUG	2012	177	8		S	SI		67	75		10.7205/MILMED-D-12-00110			9	Medicine, General & Internal	General & Internal Medicine	V33OB	WOS:000209027000010	22953443	Bronze			2021-06-18	
J	Carthew, HL; Ziebell, JM; Vink, R				Carthew, H. L.; Ziebell, J. M.; Vink, R.			SUBSTANCE P-INDUCED CHANGES IN CELL GENESIS FOLLOWING DIFFUSE TRAUMATIC BRAIN INJURY	NEUROSCIENCE			English	Article						traumatic brain injury; substance P; neurogenesis; microglia; hippocampus; subventricular zone	FOCAL CEREBRAL-ISCHEMIA; ADULT MAMMALIAN BRAIN; HIPPOCAMPAL NEUROGENESIS; NEURAL PROGENITOR; MURINE MICROGLIA; STEM-CELLS; RATS; PATHOPHYSIOLOGY; PROLIFERATION; INFLAMMATION	Inhibition of substance P (SP) activity through the use of NK1 receptor antagonists has been shown to be a promising neuroprotective therapy following traumatic brain injury (TBI). Conversely, recent research has implicated SP in the stimulation of neurogenesis, suggesting that the neuropeptide has the potential to promote recovery following TBI. This study characterised the effects of SP and the NK1 antagonist, n-acetyl tryptophan (NAT), on cell proliferation following diffuse TBI. Adult male Sprague-Dawley rats were injured using the impact acceleration model of TBI and randomly assigned to one of five treatment groups: sham, vehicle control, NAT alone, SP alone or SP with NAT. Cellular proliferation was assessed with immunostaining for bromodeoxyuridine (BrdU) and cell-specific markers. Infusion of SP (+/- NAT) promoted cellular proliferation in the subventricular zone and dentate gyrus following TBI. This increase was largely associated with microglial proliferation and did not correspond with functional improvements. These results suggest that NAT treatment results in neuro-protection following TBI, mediated in part via inhibition of microglia. (c) 2012 IBRO. Published by Elsevier Ltd. All rights reserved.	[Carthew, H. L.; Ziebell, J. M.; Vink, R.] Univ Adelaide, Sch Med Sci, Adelaide Ctr Neurosci Res, Adelaide, SA 5000, Australia	Vink, R (corresponding author), Univ Adelaide, Sch Med Sci, Adelaide Ctr Neurosci Res, Adelaide, SA 5000, Australia.	Robert.Vink@adelaide.edu.au	Vink, Robert/J-7351-2012; AM, Robert Vink/S-5616-2019; Ziebell, Jenna/Y-4496-2019	Vink, Robert/0000-0002-4885-0667; AM, Robert Vink/0000-0002-4885-0667; Ziebell, Jenna/0000-0003-2497-4347	National Health and Medical Research Council of AustraliaNational Health and Medical Research Council of AustraliaUK Research & Innovation (UKRI)Medical Research Council UK (MRC); Neurosurgical Research Foundation (Australia)	Supported, in part, by the National Health and Medical Research Council of Australia and the Neurosurgical Research Foundation (Australia).	Bener A, 2010, BRAIN INJURY, V24, P74, DOI 10.3109/02699050903508192; Bruno G, 2003, INT J IMMUNOPATH PH, V16, P67, DOI 10.1177/039463200301600110; Bye N., 2009, INJURY, V40, pS6; Chirumamilla S, 2002, J NEUROTRAUM, V19, P693, DOI 10.1089/08977150260139084; Das S, 2008, J NEUROSCI RES, V86, P1199, DOI 10.1002/jnr.21585; DEFELIPE C, 1995, SCIENCE, V267, P899, DOI 10.1126/science.7531367; Delgado AV, 2005, EXP BIOL MED, V230, P271; Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7; Donkin JJ, 2011, J NEUROTRAUM, V28, P217, DOI 10.1089/neu.2010.1632; Donkin JJ, 2009, J CEREBR BLOOD F MET, V29, P1388, DOI 10.1038/jcbfm.2009.63; Ekdahl CT, 2003, P NATL ACAD SCI USA, V100, P13632, DOI 10.1073/pnas.2234031100; Hoehn BD, 2005, STROKE, V36, P2718, DOI 10.1161/01.STR.0000190020.30282.cc; Lai Xi-nan, 2003, Zhonghua Yi Xue Za Zhi, V83, P1433; LAURENZI MA, 1990, SCAND J IMMUNOL, V31, P529, DOI 10.1111/j.1365-3083.1990.tb02801.x; Liu ZY, 2007, STROKE, V38, P146, DOI 10.1161/01.STR.0000251791.64910.cd; Liu ZP, 2003, J COMP NEUROL, V459, P368, DOI 10.1002/cne.10664; Maeda K, 1997, GERONTOLOGY, V43, P11; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Monje ML, 2003, SCIENCE, V302, P1760, DOI 10.1126/science.1088417; Ng SY, 2012, J NEUROTRAUMA; NILSSON J, 1985, NATURE, V315, P61, DOI 10.1038/315061a0; O'Connor CA, 2003, J NEUROTRAUM, V20, P533, DOI 10.1089/089771503767168465; Parent JM, 2003, NEUROSCIENTIST, V9, P261, DOI 10.1177/1073858403252680; Park SW, 2007, J NEUROSURG, V107, P593, DOI 10.3171/JNS-07/09/0593; Rasley A, 2002, GLIA, V37, P258, DOI 10.1002/glia.10034; Richardson RM, 2007, NEUROSURG CLIN N AM, V18, P169, DOI 10.1016/j.nec.2006.10.007; RICHARDSON RM, 2009, J NEUROSURG; Rola R, 2006, EXP NEUROL, V202, P189, DOI 10.1016/j.expneurol.2006.05.034; Sun HB, 2010, CHIN J TRAUMATOL, V13, P46, DOI 10.3760/cma.j.issn.1008-1275.2010.01.009; Turner RJ, 2006, ACTA NEUROCHIR SUPPL, V96, P263; van Praag H, 2002, NATURE, V415, P1030, DOI 10.1038/4151030a; Vink R, 2009, NEUROTHERAPEUTICS, V6, P28, DOI 10.1016/j.nurt.2008.10.036; Wieloch T, 2006, CURR OPIN NEUROBIOL, V16, P258, DOI 10.1016/j.conb.2006.05.011; Zhang RL, 2005, NEUROSCIENTIST, V11, P408, DOI 10.1177/1073858405278865; Zhu CL, 2009, J CEREBR BLOOD F MET, V29, P342, DOI 10.1038/jcbfm.2008.124; Ziebell JM, 2011, BRAIN RES, V1414, P94, DOI 10.1016/j.brainres.2011.07.056; Ziebell JM, 2010, NEUROTHERAPEUTICS, V7, P22, DOI 10.1016/j.nurt.2009.10.016	37	22	22	0	4	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0306-4522			NEUROSCIENCE	Neuroscience	JUL 12	2012	214						78	83		10.1016/j.neuroscience.2012.04.028			6	Neurosciences	Neurosciences & Neurology	962LV	WOS:000305547500008	22531375				2021-06-18	
J	Belanger, HG; Vanderploeg, RD; Soble, JR; Richardson, M; Groer, S				Belanger, Heather G.; Vanderploeg, Rodney D.; Soble, Jason R.; Richardson, Matthew; Groer, Shirley			Validity of the Veterans Health Administration's Traumatic Brain Injury Screen	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						Brain concussion; Brain injuries; Diagnosis; Mass screening; Rehabilitation; Veterans Affairs (US)	CARE	Belanger HG, Vanderploeg RD, Sob le JR, Richardson M, Groer S. Validity of the Veterans Health Administration's traumatic brain injury screen. Arch Phys Med Rehabil 2012;93:1234-9. Objective: To compare the results of Veterans Affairs' (VA's) initial traumatic brain injury (TBI) Clinical Reminder Screen with the more extensive second-level Comprehensive TBI Evaluation in a national sample. Design: Criterion-standard. Setting: Veterans Health Administration system of polytrauma care. Participants: The data were from VA's centralized database Patient Care Services on the TBI Clinical Reminder Screen and Comprehensive TBI Evaluation results of veterans (N=48,175). Interventions: None. Main Outcome Measures: Sensitivity, specificity, positive predictive value, and negative predictive value of the TBI Clinical Reminder Screen were calculated by using the Comprehensive TBI Evaluation findings as the comparative standard for TBI confirmation. Results: The TBI Clinical Reminder Screen has generally good sensitivity (.87-.90) but poor specificity (.13-.18). In addition, the TBI Clinical Reminder Screen, when compared with the Comprehensive TBI Evaluation by a clinician, has generally poor negative predictive power (.31-.49) in this sample. However, negative predictive power is good with an estimated Veterans Health Administration system-wide TBI prevalence rate of 15% (.89). Positive predictive power was acceptable (.77) in this sample. The screen performs comparably across patient demographic and symptom severity characteristics, as well as across level of polytrauma care. Systematic evaluations by clinicians primarily reveal mental health perceived causes of ongoing symptoms. Conclusions: In summary, VA's Clinical Reminder Screen, when evaluated against the follow-up Comprehensive TBI Evaluation, has good sensitivity but poor specificity.	[Belanger, Heather G.] James A Haley Vet Hosp, Psychol Serv 116B, Dept Mental Hlth & Behav Sci, Tampa, FL 33612 USA; [Belanger, Heather G.; Vanderploeg, Rodney D.; Richardson, Matthew; Groer, Shirley] James A Haley Vet Hosp, HSR&D RR&D Ctr Excellence Maximizing Rehabil Outc, Tampa, FL 33612 USA; [Belanger, Heather G.; Vanderploeg, Rodney D.] Univ S Florida, Dept Psychol, Tampa, FL 33620 USA; [Vanderploeg, Rodney D.] Univ S Florida, Dept Psychiat, Tampa, FL USA; [Belanger, Heather G.; Vanderploeg, Rodney D.] Def & Vet Brain Injury Ctr, Tampa, FL USA	Belanger, HG (corresponding author), James A Haley Vet Hosp, Psychol Serv 116B, Dept Mental Hlth & Behav Sci, Tampa, FL 33612 USA.	Heather.Belanger@va.gov			Department of Veterans Affairs, Veterans Health Administration, through SDR HSR&D, Screening Instruments and ProcessesUS Department of Veterans Affairs [08-411-TBI]; Defense and Veterans Brain Injury CenterUS Department of Veterans Affairs; James A. Haley Veterans' HospitalUS Department of Veterans Affairs	Supported by the Department of Veterans Affairs, Veterans Health Administration, through SDR HSR&D (no. 08-411-TBI) Screening Instruments and Processes, and the Defense and Veterans Brain Injury Center. Further support was provided by the James A. Haley Veterans' Hospital. The views expressed herein are those of the authors and do not necessarily reflect the views or the official policy of the Department of Army. Department of Defense, Department of Veterans Affairs, or US Government.	Belanger HG, 2009, J HEAD TRAUMA REHAB, V24, P4, DOI 10.1097/HTR.0b013e3181957032; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P215, DOI 10.1017/S1355617705050277; Donnelly KT, 2011, J HEAD TRAUMA REHAB, V26, P439, DOI 10.1097/HTR.0b013e3182005de3; Fleiss JL, 1981, STAT METHODS RATES P, V2nd; Frencham KAR, 2005, J CLIN EXP NEUROPSYC, V27, P334, DOI 10.1080/13803390490520328; Grimes DA, 2002, LANCET, V359, P881, DOI 10.1016/S0140-6736(02)07948-5; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hoge CW, 2009, NEW ENGL J MED, V360, P1588, DOI 10.1056/NEJMp0810606; Rohling ML, 2011, CLIN NEUROPSYCHOL, V25, P608, DOI 10.1080/13854046.2011.565076; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Schretlen DJ, 2003, INT REV PSYCHIATR, V15, P341, DOI 10.1080/09540260310001606728; Terrio HP, 2011, REHABIL PSYCHOL, V56, P26, DOI 10.1037/a0022685; Van Dyke SA, 2010, MIL MED, V175, P947, DOI 10.7205/MILMED-D-10-00337	13	22	22	0	0	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	JUL	2012	93	7					1234	1239		10.1016/j.apmr.2012.03.003			6	Rehabilitation; Sport Sciences	Rehabilitation; Sport Sciences	971MU	WOS:000306208800018	22426242				2021-06-18	
J	Lee, CY; Jaw, T; Tseng, HC; Chen, IC; Liou, HH				Lee, Chun-Yao; Jaw, Thomas; Tseng, Huan-Chin; Chen, I-Chun; Liou, Horng-Huei			Lovastatin Modulates Glycogen Synthase Kinase-3 beta Pathway and Inhibits Mossy Fiber Sprouting after Pilocarpine-Induced Status Epilepticus	PLOS ONE			English	Article							TEMPORAL-LOBE EPILEPSY; GRANULE CELL DISPERSION; TRAUMATIC BRAIN-INJURY; HIPPOCAMPAL SEIZURES; RAT HIPPOCAMPUS; DENTATE GYRUS; STATINS; MODEL; PHOSPHORYLATION; NEUROGENESIS	This study was undertaken to assay the effect of lovastatin on the glycogen synthase kinase-3 beta (GSK-3 beta) and collapsin responsive mediator protein-2 (CRMP-2) signaling pathway and mossy fiber sprouting (MFS) in epileptic rats. MFS in the dentate gyrus (DG) is an important feature of temporal lobe epilepsy (TLE) and is highly related to the severity and the frequency of spontaneous recurrent seizures. However, the molecular mechanism of MFS is mostly unknown. GSK-3 beta and CRMP-2 are the genes responsible for axonal growth and neuronal polarity in the hippocampus, therefore this pathway is a potential target to investigate MFS. Pilocarpine-induced status epilepticus animal model was taken as our researching material. Western blot, histological and electrophysiological techniques were used as the studying tools. The results showed that the expression level of GSK-3 beta and CRMP-2 were elevated after seizure induction, and the administration of lovastatin reversed this effect and significantly reduced the extent of MFS in both DG and CA3 region in the hippocampus. The alteration of expression level of GSK-3 beta and CRMP-2 after seizure induction proposes that GSK-3 beta and CRMP-2 are crucial for MFS and epiletogenesis. The fact that lovastatin reversed the expression level of GSK-3 beta and CRMP-2 indicated that GSK-3 beta and CRMP-2 are possible to be a novel mechanism of lovatstain to suppress MFS and revealed a new therapeutic target and researching direction for studying the mechanism of MFS and epileptogenesis.	[Liou, Horng-Huei] Natl Taiwan Univ Hosp, Dept Neurol, Taipei, Taiwan; [Lee, Chun-Yao; Jaw, Thomas; Tseng, Huan-Chin; Chen, I-Chun; Liou, Horng-Huei] Natl Taiwan Univ, Coll Med, Dept Pharmacol, Taipei 10764, Taiwan	Lee, CY (corresponding author), Coll France, Ctr Interdisciplinaire Rech Biol, UMR CNRS 7241, INSERM U1050, F-75231 Paris, France.	hhl@ntu.edu.tw		Liou, Horng-Huei/0000-0001-6537-5346	National Science Council Taipei, TaiwanMinistry of Science and Technology, Taiwan [NSC 96-2323-B-002-014]	This work was supported by the National Science Council (NSC 96-2323-B-002-014) Taipei, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arevalo JC, 2005, CURR OPIN CELL BIOL, V17, P112, DOI 10.1016/j.ceb.2005.01.004; Bagetta G, 2002, BIOCHEM BIOPH RES CO, V291, P255, DOI 10.1006/bbrc.2002.6424; Buckmaster PS, 2009, J NEUROSCI, V29, P8259, DOI 10.1523/JNEUROSCI.4179-08.2009; Calabresi P, 2003, ANN NEUROL, V53, P693, DOI 10.1002/ana.10603; Chang BS, 2003, NEW ENGL J MED, V349, P1257, DOI 10.1056/NEJMra022308; Cilio MR, 2003, EPILEPSIA, V44, P518, DOI 10.1046/j.1528-1157.2003.48802.x; De Simoni MG, 2000, EUR J NEUROSCI, V12, P2623, DOI 10.1046/j.1460-9568.2000.00140.x; Dudek FE, 2011, NEUROSCI LETT, V497, P240, DOI 10.1016/j.neulet.2011.03.071; Fahrner A, 2007, EXP NEUROL, V203, P320, DOI 10.1016/j.expneurol.2006.08.023; George SJ, 2002, AM J CARDIOL, V90, P1237, DOI 10.1016/S0002-9149(02)02841-2; Gobbo OL, 2004, NEUROSCIENCE, V125, P317, DOI 10.1016/j.neuroscience.2004.01.045; GOSHIMA Y, 1995, NATURE, V376, P509, DOI 10.1038/376509a0; Graber KD, 2004, ANN NEUROL, V55, P860, DOI 10.1002/ana.20124; Grimes CA, 2001, PROG NEUROBIOL, V65, P391, DOI 10.1016/S0301-0082(01)00011-9; Han Y, 2005, BIOCHEM BIOPH RES CO, V327, P431, DOI 10.1016/j.bbrc.2004.12.028; Inagaki N, 2001, NAT NEUROSCI, V4, P781, DOI 10.1038/90476; Kuo LW, 2008, NEUROIMAGE, V41, P789, DOI 10.1016/j.neuroimage.2008.03.013; Lee CY, 2009, BRIT J PHARMACOL, V158, P1753, DOI 10.1111/j.1476-5381.2009.00463.x; Lee JK, 2008, NEUROSCI LETT, V440, P260, DOI 10.1016/j.neulet.2008.05.112; Leite JP, 2002, EPILEPSY RES, V50, P93, DOI 10.1016/S0920-1211(02)00072-4; Longo BM, 1999, EPILEPSY RES, V36, P233, DOI 10.1016/S0920-1211(99)00054-6; Lynch M, 2000, J NEUROPHYSIOL, V83, P693; McKenney JM, 2003, ANN PHARMACOTHER, V37, P1063, DOI 10.1345/aph.1C499; Nadler JV, 2003, NEUROCHEM RES, V28, P1649, DOI 10.1023/A:1026004904199; Planavila A, 2008, BBA-MOL CELL BIOL L, V1781, P26, DOI 10.1016/j.bbalip.2007.10.009; RACINE RJ, 1972, ELECTROEN CLIN NEURO, V32, P281, DOI 10.1016/0013-4694(72)90177-0; Scharfman HE, 2000, J NEUROSCI, V20, P6144, DOI 10.1523/JNEUROSCI.20-16-06144.2000; Sironi L, 2003, ARTERIOSCL THROM VAS, V23, P322, DOI 10.1161/01.ATV.0000044458.23905.3B; Sutula T, 1996, J NEUROSCI, V16, P7398; Sutula Thomas, 2002, Epilepsy Curr, V2, P86, DOI 10.1046/j.1535-7597.2002.00032.x; Suzuki F, 2005, EPILEPSIA, V46, P193, DOI 10.1111/j.0013-9580.2005.35504.x; Takei Y, 2001, BRAIN DEV-JPN, V23, P406, DOI 10.1016/S0387-7604(01)00253-4; Takemiya T, 2003, PROSTAG OTH LIPID M, V71, P205, DOI 10.1016/S1098-8823(03)00040-6; Vaughan CJ, 2001, CNS DRUGS, V15, P589, DOI 10.2165/00023210-200115080-00002; Williams PA, 2002, J NEUROPHYSIOL, V88, P2075, DOI 10.1152/jn.2002.88.4.2075; Wu HT, 2008, J NEUROSURG, V109, P691, DOI 10.3171/JNS/2008/109/10/0691; Wu HT, 2008, J NEUROTRAUM, V25, P130, DOI 10.1089/neu.2007.0369; Xie CC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024966; Yoshimura T, 2005, CELL, V120, P137, DOI 10.1016/j.cell.2004.11.012; Zacco A, 2003, J NEUROSCI, V23, P11104	40	22	23	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2012	7	6							e38789	10.1371/journal.pone.0038789			8	Multidisciplinary Sciences	Science & Technology - Other Topics	966AK	WOS:000305808700011	22761705	DOAJ Gold, Green Published			2021-06-18	
J	Caricato, A; Mignani, V; Bocci, MG; Pennisi, MA; Sandroni, C; Tersali, A; Antonaci, A; de Waure, C; Antonelli, M				Caricato, Anselmo; Mignani, Vittorio; Bocci, Maria Grazia; Pennisi, Mariano Alberto; Sandroni, Claudio; Tersali, Alessandra; Antonaci, Alessandra; de Waure, Chiara; Antonelli, Massimo			Usefulness of transcranial echography in patients with decompressive craniectomy: A comparison with computed tomography scan	CRITICAL CARE MEDICINE			English	Article						brain injury imaging; cerebral hemorrhage; cerebral ultrasound; decompressive craniectomy; sonographic imaging; transcranial echography	CODED DUPLEX-SONOGRAPHY; SPACE-OCCUPYING STROKE; REAL-TIME ULTRASONOGRAPHY; TRAUMATIC BRAIN-INJURY; INTRACEREBRAL HEMORRHAGE; MIDLINE SHIFT; ULTRASOUND; PERFUSION; DIFFERENTIATION; 3RD-VENTRICLE	Objective: To assess the agreement between computed tomography and transcranial sonography in patients after decompressive craniectomy. Design: Prospective study. Setting: The medical intensive care unit of a university-affiliated teaching hospital. Patients: Thirty head-injured patients consecutively admitted to the intensive care unit of "A. Gemelli" Hospital who underwent decompressive craniectomy were studied. Immediately before brain cranial tomography, transcranial ultrasonography was performed. Measurements and Main Results: The mean difference between computed tomography and echography in measuring the dislocation of midline structures was 0.3 +/- 1.6 mm (95% confidence interval 0.2-0.9 mm; intraclass correlation coefficient, 0.979; p < .01). An excellent correlation was found between computed tomography and transcranial sonography in assessing volumes of hyperdense lesions (intraclass correlation coefficient, 0.993; p < .01). Lesions that appear hypodense on computed tomography scan were divided in ischemic and late hemorrhagic. No ischemic lesion was localized on echography; a poor correlation was found between computed tomography and echography in assessing the volume of late hemorrhagic lesions (intraclass correlation coefficient, 0.151; p = .53). A quite good correlation between transcranial ultrasonography and computed tomography was found in measuring lateral ventricles width (intraclass correlation coefficient, 0.967; p < .01). Sensitivity and specificity of transcranial ultrasonography in comparison with computed tomography to detect the position of intracranial pressure catheter was 100% and 78%. Conclusions: Echography may be a valid option to computed tomography in patients with decompressive craniectomy to assess the size of acute hemorrhagic lesions, to measure midline structures and the width of lateral ventricles, and to visualize the tip of the ventricular catheter. (Crit Care Med 2012; 40:1745-1752)	[Caricato, Anselmo; Mignani, Vittorio; Bocci, Maria Grazia; Pennisi, Mariano Alberto; Sandroni, Claudio; Tersali, Alessandra; Antonaci, Alessandra; de Waure, Chiara; Antonelli, Massimo] Catholic Univ, Sch Med, Inst Anesthesiol & Intens Care, Rome, Italy; [de Waure, Chiara] Catholic Univ, Sch Med, Inst Hyg, Rome, Italy	Caricato, A (corresponding author), Catholic Univ, Sch Med, Inst Anesthesiol & Intens Care, Rome, Italy.	anselmo.caricato@rm.unicatt.it	Bocci, Maria Grazia/AAL-1170-2020; Sandroni, Claudio/A-7320-2019; Antonelli, Massimo/K-9915-2016; Dewaure, Chiara/K-7192-2016	Bocci, Maria Grazia/0000-0001-6100-8442; Sandroni, Claudio/0000-0002-8878-2611; Antonelli, Massimo/0000-0003-3007-1670; PENNISI, Mariano Alberto/0000-0001-8761-5144			AASLID R, 1982, J NEUROSURG, V57, P769, DOI 10.3171/jns.1982.57.6.0769; BECKER A, 1995, NEUROLOGY, V45, pA460; Becker G, 1999, ANN NEUROL, V46, P260, DOI 10.1002/1531-8249(199908)46:2<260::AID-ANA18>3.0.CO;2-6; Becker G, 1993, J Neuroimaging, V3, P41; Becker G, 2001, MOVEMENT DISORD, V16, P23, DOI 10.1002/1531-8257(200101)16:1<23::AID-MDS1003>3.0.CO;2-2; Becker G, 1994, J Neuroimaging, V4, P17; Becker G, 1993, TRANSCRANIAL DOPPLER, P51; Behnke Stefanie, 2002, Eur J Ultrasound, V16, P73, DOI 10.1016/S0929-8266(02)00039-3; Bullock MR, 2006, NEUROSURGERY, V58, P25; Caricato A, 2010, INTENS CARE MED, V36, P1091, DOI 10.1007/s00134-010-1801-0; Coles JP, 2007, BRIT J ANAESTH, V99, P49, DOI 10.1093/bja/aem141; Dohrmann GJ, 1997, NEUROL RES, V19, P317, DOI 10.1080/01616412.1997.11740819; Fatar M, 2008, ULTRASOUND MED BIOL, V34, P1414, DOI 10.1016/j.ultrasmedbio.2008.02.008; Gerriets T, 2001, STROKE, V32, P442, DOI 10.1161/01.STR.32.2.442; Heppner P, 2006, J NEUROSURG, V104, P738, DOI 10.3171/jns.2006.104.5.738; Jungehulsing GJ, 2008, ULTRASOUND MED BIOL, V34, P147, DOI 10.1016/j.ultrasmedbio.2007.07.006; Kern R, 2005, ULTRASOUND MED BIOL, V31, P311, DOI 10.1016/j.ultrasmedbio.2004.12.006; Kern R, 2006, CEREBROVASC DIS, V21, P34; Kern R, 2008, CEREBROVASC DIS, V26, P277, DOI 10.1159/000147456; Kothari U, 1996, STROKE, V27, P1304, DOI 10.1161/01.STR.27.8.1304; Maurer M, 1998, STROKE, V29, P2563, DOI 10.1161/01.STR.29.12.2563; Meyer-Wiethe Karsten, 2009, Cerebrovasc Dis, V27 Suppl 2, P40, DOI 10.1159/000203125; OSTRUP R, 1983, NEUROSURGERY, V12, P225, DOI 10.1227/00006123-198302000-00018; Perez ES, 2009, STROKE, V40, P987, DOI 10.1161/STROKEAHA.108.524249; Pou JAL, 2004, INTENS CARE MED, V30, P1672, DOI 10.1007/s00134-004-2348-8; Santa M, 1990, Zentralbl Neurochir, V51, P194; Sara M, 2009, ULTRASOUND MED BIOL, V35, P169, DOI 10.1016/j.ultrasmedbio.2008.05.008; Seidel G, 1996, J NEUROIMAGING, V6, P227, DOI 10.1111/jon199664227; Seidel G, 1995, J Neuroimaging, V5, P105; SEIDEL G, 1993, STROKE, V24, P1519, DOI 10.1161/01.STR.24.10.1519; Stolz E, 1999, AM J NEURORADIOL, V20, P1567; Stroick M, 2006, ULTRASOUND MED BIOL, V32, P1377, DOI 10.1016/j.ultrasmedbio.2006.05.027; Wijnhoud AD, 2008, ULTRASOUND MED BIOL, V34, P923, DOI 10.1016/j.ultrasmedbio.2007.11.022	33	22	28	0	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0090-3493	1530-0293		CRIT CARE MED	Crit. Care Med.	JUN	2012	40	6					1745	1752		10.1097/CCM.0b013e318246b6ea			8	Critical Care Medicine	General & Internal Medicine	946EZ	WOS:000304335600008	22610180				2021-06-18	
J	Garcia-Molina, A; Tormos, JM; Bernabeu, M; Junque, C; Roig-Rovira, T				Garcia-Molina, A.; Tormos, J. M.; Bernabeu, M.; Junque, C.; Roig-Rovira, T.			Do traditional executive measures tell us anything about daily-life functioning after traumatic brain injury in Spanish-speaking individuals?	BRAIN INJURY			English	Article						Traumatic brain injury; executive functioning; activities of daily living	ECOLOGICAL VALIDITY; SELF-AWARENESS; PSYCHOSOCIAL ADJUSTMENT; INSTRUMENTAL ACTIVITIES; NEUROPSYCHOLOGICAL TESTS; DYSEXECUTIVE SYNDROME; ALZHEIMERS-DISEASE; PERFORMANCE; COMPETENCE; PREDICTORS	Primary objective: To examine the relationship between traditional executive function measures and everyday competence in Spanish-speaking individuals with moderate-to-severe traumatic brain injury (TBI). Methods and procedures: Thirty-two TBI patients (24 men, eight women) with an age range of 17-59 years (mean age = 30.73 years; SD = 13.34) were administered a battery of performance-based executive function measures. Such measures included the Trail Making Test part B, Wisconsin Card Sorting Test, Stroop Colour Word Interference Test, Controlled Oral Word Association Test and Letter-Number Sequencing. Behavioural manifestations of executive deficits were assessed by the Behaviour Rating Inventory of Executive Function-Adult version (BRIEF-A). Patient's everyday functioning was examined with the Patient Competency Rating Scale (PCRS). Main outcomes and results: Traditional performance-based executive measures correlated significantly, although moderately, with the PCRS; this relationship was more significant in the Controlled Oral Word Association Test and Trail Making Test part B. A significant correlation was obtained between the BRIEF-A clinical scales and patient's everyday competence as measured by the PCRS. Conclusions: The current findings suggest that traditional performance-based executive measures reveal some degree of ecological validity or real-world relevance, providing relevant information for predicting everyday competence after moderate-to-severe TBI.	[Garcia-Molina, A.; Tormos, J. M.; Bernabeu, M.; Roig-Rovira, T.] Inst Univ Neurorehabil Guttmann UAB, Badalona 08916, Spain; [Junque, C.] Univ Barcelona, Dept Psychiat & Clin Psychobiol, Barcelona, Spain	Garcia-Molina, A (corresponding author), Inst Univ Neurorehabil Guttmann UAB, C Cami de Can Ruti S-N, Badalona 08916, Spain.	agarciam@guttmann.com	Junque, Carme/B-4400-2011	Junque, Carme/0000-0002-6381-3063; Tormos Munoz, Jose Maria/0000-0002-8764-2289			Anderson VA, 2002, CHILD NEUROPSYCHOL, V8, P231, DOI 10.1076/chin.8.4.231.13509; Artiola i Fortuny L., 1999, MANUAL NORMAS PROCED; Bell-McGinty S, 2002, INT J GERIATR PSYCH, V17, P828, DOI 10.1002/gps.646; Benge JF, 2007, BRAIN INJURY, V21, P395, DOI 10.1080/02699050701311091; Bennett PC, 2005, J INT NEUROPSYCH SOC, V11, P606, DOI 10.1017/S1355617705050721; Bivona U, 2008, J INT NEUROPSYCH SOC, V14, P862, DOI 10.1017/S1355617708081125; Brown D, 2006, BRAIN INJURY, V20, P937, DOI 10.1080/02699050600909821; Burgess PW, 1998, J INT NEUROPSYCH SOC, V4, P547, DOI 10.1017/S1355617798466037; Chan RCK, 2008, ARCH CLIN NEUROPSYCH, V23, P201, DOI 10.1016/j.acn.2007.08.010; Chaytor N, 2006, ARCH CLIN NEUROPSYCH, V21, P217, DOI 10.1016/j.acn.2005.12.002; Chaytor N, 2003, NEUROPSYCHOL REV, V13, P181, DOI 10.1023/B:NERV.0000009483.91468.fb; Engberg AW, 2004, BRAIN INJURY, V18, P533, DOI 10.1080/02699050310001645829; Evans JJ, 1997, PSYCHOL MED, V27, P635, DOI 10.1017/S0033291797004790; Fischer S, 2004, J INT NEUROPSYCH SOC, V10, P190, DOI 10.1017/S1355617704102051; Garcia-Molina A, 2007, ANALES PSIQUIATRIA, V23, P217; Golden C. J., 1994, STROOP TEST COLORES; Goverover Y, 2004, J CLIN EXP NEUROPSYC, V26, P737, DOI 10.1080/13803390490509321; Goverover Y, 2002, AM J OCCUP THER, V56, P509, DOI 10.5014/ajot.56.5.509; Hall KM, 2001, ARCH PHYS MED REHAB, V82, P367, DOI 10.1053/apmr.2001.21525; Hanks RA, 1999, ARCH PHYS MED REHAB, V80, P1030, DOI 10.1016/S0003-9993(99)90056-4; Heaton RK, 1997, W TEST CLASIFICACION; INE, 2001, ENC DISC DEF EST SAL; Jefferson AL, 2006, ARCH CLIN NEUROPSYCH, V21, P311, DOI 10.1016/j.acn.2006.03.007; Jurado MB, 2007, NEUROPSYCHOL REV, V17, P213, DOI 10.1007/s11065-007-9040-z; Kennedy MRT, 2008, NEUROPSYCHOL REHABIL, V18, P257, DOI 10.1080/09602010701748644; Kibby MY, 1998, ARCH CLIN NEUROPSYCH, V13, P523, DOI 10.1016/S0887-6177(97)00038-3; Kim J, 2005, J INT NEUROPSYCH SOC, V11, P434, DOI 10.1017/S1355617705050563; Leathem JM, 1998, J CLIN EXP NEUROPSYC, V20, P694, DOI 10.1076/jcen.20.5.694.1122; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; Lye TC, 2000, NEUROPSYCHOL REV, V10, P115, DOI 10.1023/A:1009068804787; Manchester D, 2004, BRAIN INJURY, V18, P1067, DOI 10.1080/02699050410001672387; Mathias JL, 2007, NEUROPSYCHOLOGY, V21, P212, DOI 10.1037/0894-4105.21.2.212; Mazaux JM, 1997, ARCH PHYS MED REHAB, V78, P1316, DOI 10.1016/S0003-9993(97)90303-8; McClure MM, 2007, SCHIZOPHR RES, V89, P330, DOI 10.1016/j.schres.2006.07.024; McCrimmon S, 2006, BRAIN INJURY, V20, P1037, DOI 10.1080/02699050600909656; McMurtray A, 2006, DEMENT GERIATR COGN, V21, P59, DOI 10.1159/000089546; Milders M, 2008, J INT NEUROPSYCH SOC, V14, P318, DOI 10.1017/S1355617708080351; Millis S R, 1994, Int J Neurosci, V79, P165; Murray CJL, 1997, LANCET, V349, P1498, DOI 10.1016/S0140-6736(96)07492-2; Norris G, 2000, NEUROPSYCHOL REHABIL, V10, P33, DOI 10.1080/096020100389282; Odhuba RA, 2005, BRIT J CLIN PSYCHOL, V44, P269, DOI 10.1348/014466505X29431; Ownsworth T, 2008, BRAIN INJURY, V22, P858, DOI 10.1080/02699050802446697; Ownsworth T, 2008, J REHABIL MED, V40, P81, DOI 10.2340/16501977-0124; Perez C, 2010, LESIONES MEDULARES T; Ponsford J, 2008, J INT NEUROPSYCH SOC, V14, P233, DOI 10.1017/S1355617708080272; Prigatano G. P., 1986, NEUROPSYCHOLOGICAL R; Prigatano GP, 2005, ACT NEUR S, V93, P39; Prigatano GP, 2005, J HEAD TRAUMA REHAB, V20, P19, DOI 10.1097/00001199-200501000-00004; Prigatano GP, 1998, J HEAD TRAUMA REHAB, V13, P29, DOI 10.1097/00001199-199810000-00005; Roth R., 2005, BRIEF A BEHAV RATING; Sbordone RJ, 1999, STUD NEUROPSYCHOL DE, P227; Shotton L, 2007, BRAIN INJURY, V21, P857, DOI 10.1080/02699050701481621; SOHLBERG MM, 1993, J HEAD TRAUMA REHAB, V8, P45, DOI DOI 10.1097/00001199-199303000-00006; Struchen MA, 2008, NEUROREHABILITATION, V23, P185; Sveen U, 2008, CLIN REHABIL, V22, P45, DOI 10.1177/0269215507080768; Tate RL, 1999, PSYCHOL MED, V29, P713, DOI 10.1017/S0033291799008466; TEASDALE G, 1974, LANCET, V2, P81; Tirapu J, 1997, ANALES SISTEMA SANIT, V20, P101; Vakil E, 2005, J CLIN EXP NEUROPSYC, V27, P977, DOI 10.1080/13803390490919245; Van Den Heuvel C, 2007, PROG BRAIN RES, V161, P303, DOI 10.1016/S0079-6123(06)61021-2; Wechsler D., 1999, ESCALA INTELIGENCIA, V3; Wilson BA, 1998, NEUROPSYCHOL REHABIL, V8, P213, DOI 10.1080/713755570; Wolfson D., 1993, HALSTEAD REITAN NEUR; Wood RL, 2006, J NEUROL NEUROSUR PS, V77, P71, DOI 10.1136/jnnp.2005.065540; Wood RL, 2006, ARCH CLIN NEUROPSYCH, V21, P429, DOI 10.1016/j.acn.2005.06.014	65	22	22	0	13	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	JUN	2012	26	6					864	874		10.3109/02699052.2012.655362			11	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	943EO	WOS:000304103500008	22583177				2021-06-18	
J	Riera, A; Chen, L				Riera, Antonio; Chen, Lei			Ultrasound Evaluation of Skull Fractures in Children A Feasibility Study	PEDIATRIC EMERGENCY CARE			English	Article						ultrasound; head injuries; fractures; computed tomography	MINOR HEAD TRAUMA; BEDSIDE ULTRASOUND; INTRACRANIAL INJURY; X-RAY; DIAGNOSIS; ULTRASONOGRAPHY; INSTRUMENT; REDUCTION; RISK	Objective: The objective of this study was to investigate feasibility and evaluate test characteristics of bedside ultrasound for the detection of skull fractures in children with closed head injury (CHI). Methods: This was a prospective, observational study conducted in a pediatric emergency department of an urban tertiary care children's hospital. A convenience sample of children younger than 18 years were enrolled if they presented with an acute CHI, and a computed tomography (CT) scan was performed. Ultrasound was performed by pediatric emergency medicine physicians with at least 1 month of training in bedside ultrasound. Ultrasound interpretation as either positive or negative for the presence of skull fracture was compared with attending radiologist CT scan dictation. Test characteristics (sensitivity, specificity, and positive and negative predictive values) were calculated. Results: Forty-six patients were enrolled. The median age was 2 years (range, 2 months to 17 years). Eleven patients (24%) were diagnosed with skull fractures on CT scan. Bedside ultrasound had a sensitivity of 82% (95% confidence interval [CI], 48%-97%), specificity of 94% (95% CI, 79%-99%), positive predictive value of 82% (95% CI, 48%-97%), and negative predictive value of 94% (95% CI, 79%-99%). Conclusions: Bedside ultrasonography can be used by pediatric emergency medicine physicians to detect skull fractures in children with acute CHI. Larger studies are needed to validate these findings. Future studies should investigate the role of this modality as an adjunct to clinical decision rules to reduce unnecessary CT scans in the evaluation of acute CHI in children.	[Riera, Antonio; Chen, Lei] Yale Univ, Sch Med, New Haven, CT 06511 USA	Riera, A (corresponding author), Yale Univ, Sch Med, 100 York St,Suite 1F, New Haven, CT 06511 USA.	Antonio.riera@yale.edu			CTSAUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS); National Center for Research Resources, National Institutes of Health (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [KL2 RR024138]; NIH Roadmap for Medical ResearchUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [KL2RR024138] Funding Source: NIH RePORTER	This study was supported in part by CTSA, grant KL2 RR024138 from the National Center for Research Resources, a component of the National Institutes of Health (NIH), and NIH Roadmap for Medical Research.	Arnholz D, 1998, J TRAUMA, V45, P172, DOI 10.1097/00005373-199807000-00039; Bergman DA, 1999, PEDIATRICS, V104, P1407; Brenner DJ, 2007, NEW ENGL J MED, V357, P2277, DOI 10.1056/NEJMra072149; Brody AS, 2007, PEDIATRICS, V120, P677, DOI 10.1542/peds.2007-1910; Chen L, 2007, PEDIATR EMERG CARE, V23, P528, DOI 10.1097/PEC.0b013e318128f85d; Cho KH, 2010, KOREAN J RADIOL, V11, P84, DOI 10.3348/kjr.2010.11.1.84; CRADY SK, 1993, ANN EMERG MED, V22, P1125, DOI 10.1016/S0196-0644(05)80976-X; Cross KP, 2010, ACAD EMERG MED, V17, P687, DOI 10.1111/j.1553-2712.2010.00788.x; Decarie JC, 1999, CHILD NERV SYST, V15, P740, DOI 10.1007/s003810050463; Dunning J, 2004, ARCH DIS CHILD, V89, P653, DOI 10.1136/adc.2003.027722; Greenes DS, 2001, PEDIATR EMERG CARE, V17, P88, DOI 10.1097/00006565-200104000-00002; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; Levy JA, 2008, CURR OPIN PEDIATR, V20, P235, DOI 10.1097/MOP.0b013e3282ff1317; MASTERS SJ, 1987, NEW ENGL J MED, V316, P84, DOI 10.1056/NEJM198701083160205; Mower WR, 2005, J TRAUMA, V59, P954, DOI 10.1097/01.ta.0000187813.79047.42; Palchak MJ, 2003, ANN EMERG MED, V42, P492, DOI 10.1067/S0196-0644(03)00425-6; Patel DD, 2009, PEDIATR EMERG CARE, V25, P221, DOI 10.1097/PEC.0b013e31819e34f7; Quayle KS, 1999, PEDIATR CLIN N AM, V46, P1189, DOI 10.1016/S0031-3955(05)70182-6; Quayle KS, 1999, PEDIATR CLIN N AM, V46, pvii; Ramirez-Schrempp D, 2011, PEDIATR EMERG CARE, V27, P312, DOI 10.1097/PEC.0b013e3182131579; RODRIGUEZ JG, 1990, AM J DIS CHILD, V144, P627; Schutzman SA, 2001, PEDIATRICS, V107, P983, DOI 10.1542/peds.107.5.983; Steiner S, 1996, ROFO-FORTSCHR RONTG, V165, P353, DOI 10.1055/s-2007-1015768; Sun BC, 2007, ANN EMERG MED, V49, P325, DOI 10.1016/j.annemergmed.2006.08.032; Trenchs V, 2009, EUR J EMERG MED, V16, P150, DOI 10.1097/MEJ.0b013e328321b7b5; Weinberg ER, 2010, INJURY, V41, P862, DOI 10.1016/j.injury.2010.04.020	26	22	22	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0749-5161	1535-1815		PEDIATR EMERG CARE	Pediatr. Emerg. Care	MAY	2012	28	5					420	425		10.1097/PEC.0b013e318252da3b			6	Emergency Medicine; Pediatrics	Emergency Medicine; Pediatrics	937RT	WOS:000303676700004	22531195				2021-06-18	
J	Riganello, F; Dolce, G; Sannita, WG				Riganello, Francesco; Dolce, Giuliano; Sannita, Walter G.			HEART RATE VARIABILITY AND THE CENTRAL AUTONOMIC NETWORK IN SEVERE DISORDER OF CONSCIOUSNESS	JOURNAL OF REHABILITATION MEDICINE			English	Article; Proceedings Paper	Workshop on Consciousness and the Vegetative State - Today/2nd Conference on Consciousness and Coma	JUL 06, 2010	Salerno, ITALY			disorder of consciousness; brain injury; heart rate variability; HRV; vegetative state; minimally conscious state; central autonomic network	TRAUMATIC BRAIN-INJURY; VEGETATIVE STATE; NEUROVISCERAL INTEGRATION; ORGAN DYSFUNCTION; ARTIFICIAL-INTELLIGENCE; CINGULATE CORTEX; NEURAL-CONTROL; VAGAL TONE; OWN NAME; DYSAUTONOMIA	Objective: To review the applicability of heart rate variability measures in research on severe disorder of consciousness. Methods: The available evidence on the correlation between heart rate variability measures and the outcome or residual functional state/responsiveness of severely brain-injured patients (including those in vegetative or minimally conscious states) are reviewed and discussed with reference to the central autonomic network model. Results and conclusion: Heart rate variability analyses appear to be applicable to assess residual or emerging (higher level) function in brain-injured patients with disordered consciousness and to predict outcome. In this regard, the central autonomic network model is heuristic in the understanding of heart rate variability descriptors of the central nervous system/autonomic systems relationship.	[Riganello, Francesco; Dolce, Giuliano] S Anna Inst, Crotone, Italy; [Sannita, Walter G.] Univ Genoa, Dept Neurosci Ophthalmol & Genet, Genoa, Italy; [Sannita, Walter G.] SUNY Stony Brook, Dept Psychiat, Stony Brook, NY 11794 USA; [Riganello, Francesco; Dolce, Giuliano] RAN, Crotone, Italy	Dolce, G (corresponding author), S Anna Inst, Crotone, Italy.	giulianodolce@libero.it	Riganello, Francesco/N-2615-2014; Riganello, Francesco/AAC-3976-2020	Riganello, Francesco/0000-0003-0678-9252; Riganello, Francesco/0000-0003-0678-9252			ALBENTOSA M, 1994, AQUACULTURE, V126, P315, DOI 10.1016/0044-8486(94)90048-5; Allerdings MD, 2006, BRAIN COGNITION, V60, P193, DOI 10.1016/j.bandc.2004.09.018; Appelhans BM, 2008, BIOL PSYCHOL, V77, P174, DOI 10.1016/j.biopsycho.2007.10.004; Appelhans BM, 2006, REV GEN PSYCHOL, V10, P229, DOI 10.1037/1089-2680.10.3.229; ASHWAL S, 1994, NEW ENGL J MED, V330, P1499; ASHWAL S, 1994, NEW ENGL J MED, V330, P1572; Baguley IJ, 2006, BRAIN INJURY, V20, P437, DOI 10.1080/02699050600664715; Baguley IJ, 2009, ARCH PHYS MED REHAB, V90, P580, DOI 10.1016/j.apmr.2008.10.020; Benarroch E.E., 2007, CONTINUUM LIFELONG L, V13, P13, DOI [10.1212/01.CON.0000299964.20642.9a, DOI 10.1212/01.CON.0000299964.20642.9A]; Benarroch EE, 1997, CENTRAL AUTONOMIC NE, P29; BERNE C, 1992, DIABETOLOGIA, V35, P873, DOI 10.1007/BF00399935; Biswas AK, 2000, CRIT CARE MED, V28, P3907, DOI 10.1097/00003246-200012000-00030; Boly M, 2008, ANN NY ACAD SCI, V1129, P119, DOI 10.1196/annals.1417.015; Candelieri A, 2011, HEALTHINF 2011: PROCEEDINGS OF THE INTERNATIONAL CONFERENCE ON HEALTH INFORMATICS, P138; Carney RM, 2005, ARCH INTERN MED, V165, P1486, DOI 10.1001/archinte.165.13.1486; Chambers AS, 2002, PSYCHOPHYSIOLOGY, V39, P861, DOI 10.1111/1469-8986.3960861; Cohen H, 2000, PSYCHIAT RES, V96, P1, DOI 10.1016/S0165-1781(00)00195-5; Coleman MR, 2007, BRAIN, V130, P2494, DOI 10.1093/brain/awm170; Cooke WH, 2006, AVIAT SPACE ENVIR MD, V77, P1107; Critchley HD, 2003, BRAIN, V126, P2139, DOI 10.1093/brain/awg216; Cuny E, 2001, BRAIN INJURY, V15, P917, DOI 10.1080/02699050110065277; De Jong Marla J, 2005, J Cardiovasc Nurs, V20, P186; De Jong MJ, 2005, J CARDIOVASC NURS, V20, P196; DEVINSKY O, 1995, BRAIN, V118, P279, DOI 10.1093/brain/118.1.279; Di HB, 2007, NEUROLOGY, V68, P895, DOI 10.1212/01.wnl.0000258544.79024.d0; Dolce G, 2008, J PSYCHOPHYSIOL, V22, P150, DOI 10.1027/0269-8803.22.3.150; Dolce G, 2021, J NEUROTRAUM, V38, P1441, DOI 10.1089/neu.2008.0536; Draper K, 2007, J HEAD TRAUMA REHAB, V22, P278, DOI 10.1097/01.HTR.0000290972.63753.a7; Eckberg DL, 2003, J PHYSIOL-LONDON, V548, P339, DOI 10.1113/jphysiol.2002.037192; ESLER M, 1993, PHARMACOL TOXICOL, V73, P243, DOI 10.1111/j.1600-0773.1993.tb00579.x; Friedman BH, 2007, BIOL PSYCHOL, V74, P185, DOI 10.1016/j.biopsycho.2005.08.009; Garan H, 2009, CARDIOLOGY, V114, P273, DOI 10.1159/000235567; Gehi A, 2005, ARCH GEN PSYCHIAT, V62, P661, DOI 10.1001/archpsyc.62.6.661; Giacino JT, 2004, ARCH PHYS MED REHAB, V85, P2020, DOI 10.1016/j.apmr.2004.02.033; Glass L., 1988, CLOCKS CHAOS RHYTHMS; GOLDSTEIN B, 1993, CRIT CARE MED, V21, P228, DOI 10.1097/00003246-199302000-00014; Goldstein B, 1996, CRIT CARE MED, V24, P234, DOI 10.1097/00003246-199602000-00009; Grossman P, 2007, BIOL PSYCHOL, V74, P263, DOI 10.1016/j.biopsycho.2005.11.014; Gutierrez J., 2010, INT J DISABIL HUM DE, V9, P357, DOI [DOI 10.1515/IJDHD.2010.041, 10.1515/IJDHD.2010.041]; Hui-Min W, 2010, CIRC SYST ISCAS P 20; JENNETT B, 1972, LANCET, V1, P734; Kawahara E, 2003, CIRC J, V67, P753; Kemp CD, 2008, AM SURGEON, V74, P866; Keren O, 2005, BRAIN INJURY, V19, P605, DOI 10.1080/02699050400024946; King DR, 2009, J TRAUMA, V67, P436, DOI 10.1097/TA.0b013e3181ad67de; King ML, 1997, BRAIN INJURY, V11, P445; Lane RD, 2009, NEUROIMAGE, V44, P213, DOI 10.1016/j.neuroimage.2008.07.056; Laureys S, 2004, LANCET NEUROL, V3, P537, DOI 10.1016/S1474-4422(04)00852-X; Laureys S, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-68; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; Lemke DM, 2007, CRIT CARE NURSE, V27, P30; Levy MN, 1997, BAILLIERE CLIN NEUR, V6, P227; Lippert-Gruner M, 2006, BRAIN INJURY, V20, P569, DOI 10.1080/02699050600664467; LOWENSOHN RI, 1977, LANCET, V1, P626; Machado C, 2007, CLIN EEG NEUROSCI, V38, P124, DOI 10.1177/155005940703800306; Machado C, 2011, CLIN NEUROPHYSIOL, V122, P1059, DOI 10.1016/j.clinph.2010.08.022; Vanderlei LCM, 2009, REV BRAS CIR CARDIOV, V24, P205, DOI 10.1590/S0102-76382009000200018; Mashin VA, 2000, HUMAN PHYSL, V26, P420, DOI [10.1007/BF02760270, DOI 10.1007/BF02760270]; Monti MM, 2010, NEW ENGL J MED, V362, P579, DOI 10.1056/NEJMoa0905370; Morris JA, 2006, J TRAUMA, V60, P1165, DOI 10.1097/01.ta.0000220384.04978.3b; Mowery NT, 2008, J TRAUMA, V65, P621, DOI 10.1097/TA.0b013e3181837980; Napadow V, 2008, NEUROIMAGE, V42, P169, DOI 10.1016/j.neuroimage.2008.04.238; Nolan J, 1998, CIRCULATION, V98, P1510, DOI 10.1161/01.CIR.98.15.1510; Norris PR, 2005, J SURG RES, V129, P122, DOI 10.1016/j.jss.2005.04.024; Owen AM, 2006, SCIENCE, V313, P1402, DOI 10.1126/science.1130197; Papaioannou VE, 2006, J CRIT CARE, V21, P95, DOI 10.1016/j.jcrc.2005.12.007; Perkes I, 2010, ANN NEUROL, V68, P126, DOI 10.1002/ana.22066; Perrin F, 2006, ARCH NEUROL-CHICAGO, V63, P562, DOI 10.1001/archneur.63.4.562; Porges SW, 2007, BIOL PSYCHOL, V74, P116, DOI 10.1016/j.biopsycho.2006.06.009; Porges Stephen W, 2009, Cleve Clin J Med, V76 Suppl 2, pS86, DOI 10.3949/ccjm.76.s2.17; Qiu J, 2007, LANCET NEUROL, V6, P946, DOI 10.1016/S1474-4422(07)70255-7; Rapenne T, 2001, J NEUROSURG ANESTH, V13, P260, DOI 10.1097/00008506-200107000-00016; Riganelllo F, 2010, HEALTH 2010 P 3 INT; Riganello F, 2010, CLIN NEUROPHYSIOL, V121, P2024, DOI 10.1016/j.clinph.2010.05.010; Riganello F, 2008, J PSYCHOPHYSIOL, V22, P166, DOI 10.1027/0269-8803.22.4.166; Riganello F, 2011, CLIN NEUROPHYSIOL, V122, P1061, DOI 10.1016/j.clinph.2010.09.006; Riganello F, 2009, J PSYCHOPHYSIOL, V23, P18, DOI 10.1027/0269-8803.23.1.18; Riordan WP, 2007, J TRAUMA, V63, P503, DOI 10.1097/TA.0b013e3181271c34; Riordan WP, 2009, J SURG RES, V156, P283, DOI 10.1016/j.jss.2009.03.086; Ryan ML, 2011, ANESTHESIOLOGY  0210; Saper CB, 2002, ANNU REV NEUROSCI, V25, P433, DOI 10.1146/annurev.neuro.25.032502.111311; Seely AJE, 2004, CRIT CARE, V8, pR367, DOI 10.1186/cc2948; Su CF, 2005, CLIN NEUROPHYSIOL, V116, P1273, DOI 10.1016/j.clinph.2005.01.010; Thayer J. F., 2004, CRIT PERSPECT, P567; Thayer JF, 2000, J AFFECT DISORDERS, V61, P201, DOI 10.1016/S0165-0327(00)00338-4; Thayer JF, 2007, PSYCHOL TOPICS, V16, P241, DOI DOI 10.1016/J.IJCARD.2012.02.004; Thayer JF, 2007, BIOL PSYCHOL, V74, P224, DOI 10.1016/j.biopsycho.2005.11.013; Thayer JF, 2009, ANN BEHAV MED, V37, P141, DOI 10.1007/s12160-009-9101-z; Thayer JF, 2009, NEUROSCI BIOBEHAV R, V33, P81, DOI 10.1016/j.neubiorev.2008.08.004; Toni R, 2004, J Endocrinol Invest, V27, P35; Valkonen-Korhonen M, 2003, PSYCHOPHYSIOLOGY, V40, P716, DOI 10.1111/1469-8986.00072; van Leeuwen P, 2000, HERZSCHR ELEKTROPHYS, V11, P127; Vanhaudenhuyse A, 2008, NEUROLOGY, V71, P1374, DOI 10.1212/01.wnl.0000320110.70134.60; Wallin BG, 2007, MUSCLE NERVE, V36, P595, DOI 10.1002/mus.20831; Wijnen VJM, 2006, CLIN NEUROPHYSIOL, V117, P1794, DOI 10.1016/j.clinph.2006.03.006; Wijnen VJ, 2006, CLIN NEUROPHYSIOL, V118, P597; Zygun DA, 2005, CRIT CARE MED, V33, P654, DOI 10.1097/01.ccm.0000155911.01844.54	97	22	23	2	9	FOUNDATION REHABILITATION INFORMATION	UPPSALA	TRADGARDSGATAN 14, UPPSALA, SE-753 09, SWEDEN	1650-1977	1651-2081		J REHABIL MED	J. Rehabil. Med.	MAY	2012	44	6			SI		495	501		10.2340/16501977-0975			7	Rehabilitation; Sport Sciences	Rehabilitation; Sport Sciences	956TW	WOS:000305113000004	22660999	DOAJ Gold			2021-06-18	
J	Rohlwink, UK; Zwane, E; Fieggen, AG; Argent, AC; le Roux, PD; Figaji, AA				Rohlwink, Ursula K.; Zwane, Eugene; Fieggen, A. Graham; Argent, Andrew C.; le Roux, Peter D.; Figaji, Anthony A.			The Relationship Between Intracranial Pressure and Brain Oxygenation in Children With Severe Traumatic Brain Injury	NEUROSURGERY			English	Article						Brain oxygenation; Children; Head injury; Intracranial monitoring; Intracranial pressure; Traumatic brain injury	SEVERE HEAD-INJURY; CEREBRAL-BLOOD-FLOW; TISSUE OXYGEN; DECOMPRESSIVE CRANIECTOMY; PERFUSION-PRESSURE; NEUROCRITICAL CARE; DIFFUSION; TENSION; MICRODIALYSIS; SATURATION	BACKGROUND: Intracranial pressure (ICP) monitoring is a cornerstone of care for severe traumatic brain injury (TBI). Management of ICP can help ensure adequate cerebral blood flow and oxygenation. However, studies indicate that brain hypoxia may occur despite normal ICP and the relationship between ICP and brain oxygenation is poorly defined. This is particularly important for children in whom less is known about intracranial dynamics. OBJECTIVE: To examine the relationship between ICP and partial pressure of brain tissue oxygen (PbtO2) in children with severe TBI (Glasgow Coma Scale score <= 8) admitted to Red Cross War Memorial Children's Hospital, Cape Town. METHODS: The relationship between time-linked hourly and high-frequency ICP and PbtO2 data was examined using correlation, regression, and generalized estimating equations. Thresholds for ICP were examined against reduced PbtO2 using age bands and receiver-operating characteristic curves. RESULTS: Analysis using more than 8300 hourly (n = 75) and 1 million high-frequency data points (n = 30) demonstrated a weak relationship between ICP and PbtO2 (r = 0.05 and r = 0.04, respectively). No critical ICP threshold for low PbtO2 was identified. Individual patients revealed a strong relationship between ICP and PbtO2 at specific times, but different relationships were evident over longer periods. CONCLUSION: The relationship between ICP and PbtO2 appears complex, and several factors likely influence both variables separately and in combination. Although very high ICP is associated with reduced PbtO2, in general, absolute ICP has a poor relationship with PbtO2. Because reduced PbtO2 is independently associated with poor outcome, a better understanding of ICP and PbtO2 management in pediatric TBI seems to be needed.	[Rohlwink, Ursula K.; Fieggen, A. Graham; Figaji, Anthony A.] Univ Cape Town, Red Cross War Mem Childrens Hosp, Sch Child & Adolescent Hlth, Div Neurosurg, ZA-7925 Cape Town, South Africa; [Zwane, Eugene] Univ Swaziland, Dept Biostat, Kwaluseni, Swaziland; [Argent, Andrew C.] Univ Cape Town, Red Cross War Mem Childrens Hosp, Div Pediat Crit Care, ZA-7925 Cape Town, South Africa; [le Roux, Peter D.] Univ Penn, Dept Neurosurg, Philadelphia, PA 19104 USA	Figaji, AA (corresponding author), Univ Cape Town, Red Cross War Mem Childrens Hosp, Sch Child & Adolescent Hlth, Div Neurosurg, ICH Bldg,Room 617,Klipfontein Rd, ZA-7925 Cape Town, South Africa.	Anthony.Figaji@uct.ac.za	Argent, Andrew/J-1605-2019; Rohlwink, Ursula Karin/U-8917-2019; Rohlwink, Ursula/AAE-2513-2020	Argent, Andrew/0000-0001-9333-2036; Figaji, Anthony/0000-0002-3357-6490	Integra Foundation; Integra; National Research Foundation; Wellcome TrustWellcome TrustEuropean Commission	Drs Figaji and le Roux have received funding from the Integra Foundation for the study of cerebral perfusion pressure in children in 2006. Dr le Roux also received research support from Integra and is a consultant for Codman and a member of Edge Therapeutics Scientific Advisory Board. Dr Figaji received honoraria for speaking engagements from Codman and Integra Neurosciences and funding from the National Research Foundation. Ms. Rohlwink receives funding from the Wellcome Trust. The other authors have no personal financial or institutional interest in any of the drugs, materials, or devices described in this article.	Adelson P David, 2003, Pediatr Crit Care Med, V4, pS25; Adelson P David, 2003, Pediatr Crit Care Med, V4, pS19; Adelson P David, 2003, Pediatr Crit Care Med, V4, pS65; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS65; Carney NA, 2003, PEDIATR CRIT CARE ME, V4, P1; Chambers IR, 2006, J NEUROL NEUROSUR PS, V77, P234, DOI 10.1136/jnnp.2005.072215; Chambers IR, 2001, J NEUROSURG, V94, P412, DOI 10.3171/jns.2001.94.3.0412; Chang JJJ, 2009, CRIT CARE MED, V37, P283, DOI 10.1097/CCM.0b013e318192fbd7; Chang TP, 2010, J TRAUMA, V68, P1401, DOI 10.1097/TA.0b013e3181bb9a87; Charalambides C, 2010, CHILD NERV SYST, V26, P215, DOI 10.1007/s00381-009-1031-3; Chesnut R M, 1995, New Horiz, V3, P366; Chesnut RM, 2007, SURG CLIN N AM, V87, P119, DOI 10.1016/j.suc.2006.09.018; Elf K, 2002, CRIT CARE MED, V30, P2129, DOI 10.1097/00003246-200209000-00029; Figaji AA, 2008, ACTA NEUROCHIR SUPPL, V102, P77, DOI 10.1007/978-3-211-85578-2_15; Figaji AA, 2008, NEUROSURGERY, V63, P83, DOI 10.1227/01.NEU.0000335074.39728.00; Figaji AA, 2009, CHILD NERV SYST, V25, P1325, DOI 10.1007/s00381-009-0822-x; Ghajar J, 2000, LANCET, V356, P923, DOI 10.1016/S0140-6736(00)02689-1; Giza CC, 2007, CURR OPIN CRIT CARE, V13, P143, DOI 10.1097/MCC.0b013e32808255dc; Goodman JC, 2009, CURR OPIN CRIT CARE, V15, P110, DOI 10.1097/MCC.0b013e328325d142; GRAHAM DI, 1989, J NEUROL NEUROSUR PS, V52, P346, DOI 10.1136/jnnp.52.3.346; Gupta AK, 1999, ANESTH ANALG, V88, P549, DOI 10.1097/00000539-199903000-00016; Hlatky R, 2004, J NEUROTRAUM, V21, P894, DOI 10.1089/0897715041526195; Hlatky Roman, 2003, Neurosurg Focus, V14, pe2; Ho CL, 2008, J NEUROSURG, V108, P943, DOI 10.3171/JNS/2008/108/5/0943; Huchzermeyer C, 2008, J NEUROSCI, V28, P1153, DOI 10.1523/JNEUROSCI.4105-07.2008; Jaeger M, 2005, ACTA NEUROCHIR, V147, P51, DOI 10.1007/s00701-004-0408-z; Lang EW, 2007, NEUROSURG REV, V30, P99, DOI 10.1007/s10143-006-0062-4; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Maloney-Wilensky E, 2010, CHILD NERV SYST, V26, P419, DOI 10.1007/s00381-009-1037-x; Maloney-Wilensky E, 2009, CRIT CARE MED, V37, P2057, DOI 10.1097/CCM.0b013e3181a009f8; Menon DK, 2004, CRIT CARE MED, V32, P1384, DOI 10.1097/01.CCM.0000127777.16609.08; Narotam PK, 2006, J PEDIATR SURG, V41, P505, DOI 10.1016/j.jpedsurg.2005.11.069; Narotam PK, 2009, J NEUROSURG, V111, P672, DOI 10.3171/2009.4.JNS081150; Rosenthal G, 2008, CRIT CARE MED, V36, P1917, DOI 10.1097/CCM.0b013e3181743d77; Scheufler KM, 2004, J NEUROSURG ANESTH, V16, P210, DOI 10.1097/00008506-200407000-00005; Spiotta AM, 2010, J NEUROSURG, V113, P571, DOI 10.3171/2010.1.JNS09506; Stiefel MF, 2006, J NEUROSURG, V105, P568, DOI 10.3171/jns.2006.105.4.568; Suazo JAC, 2000, CRIT CARE MED, V28, P3268, DOI 10.1097/00003246-200009000-00024; Tang ME, 2009, MT SINAI J MED, V76, P119, DOI 10.1002/msj.20106; Vajkoczy P, 2000, J NEUROSURG, V93, P265, DOI 10.3171/jns.2000.93.2.0265; Valadka AB, 1998, CRIT CARE MED, V26, P1576, DOI 10.1097/00003246-199809000-00029; Valadka AB, 2002, ACT NEUR S, V81, P299; van den Brink WA, 2000, NEUROSURGERY, V46, P868, DOI 10.1097/00006123-200004000-00018; vanSantbrink H, 1996, NEUROSURGERY, V38, P21, DOI 10.1097/00006123-199601000-00007; Wartenberg KE, 2007, CRIT CARE CLIN, V23, P507, DOI 10.1016/j.ccc.2007.06.002; ZWEIG MH, 1993, CLIN CHEM, V39, P561	46	22	22	0	4	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0148-396X	1524-4040		NEUROSURGERY	Neurosurgery	MAY	2012	70	5					1220	1230		10.1227/NEU.0b013e318243fc59			11	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	933VA	WOS:000303390400046	22134142				2021-06-18	
J	Cha, SM; Shin, HD; Kim, KC; Han, SC				Cha, Soo Min; Shin, Hyun Dae; Kim, Kyung Cheon; Han, Sun Cheol			Percutaneous reduction and leverage fixation using K-wires in paediatric angulated radial neck fractures	INTERNATIONAL ORTHOPAEDICS			English	Article							CLOSED REDUCTION; CHILDREN; OSTEOSYNTHESIS; HEAD	We evaluated the usefulness of percutaneous reduction and leverage fixation using K-wires in children with radial neck fractures. Between 2006 and 2008, we evaluated 13 paediatric patients with radial neck fractures who had been observed for at least two years and underwent percutaneous reduction and leverage fixation using K-wires. We measured radial angulation and radial translation using preoperative, postoperative and final follow-up radiographs, and we clinically investigated range of motion and carrying angle according to Steele's grading system. Excellent clinical results were achieved in 11 (84.6%) patients, good results in one (7.6%) and fair results in one (7.6%). There were no poor results. The patient in whom fair results were achieved also had an olecranon fracture, which was treated conservatively. Complications such as nonunion, infection, iatrogenic nerve injury and periarticular ossification were minimal. Radioulnar synostosis was absent between the radial neck fracture and the greenstick fracture of the olecranon. Growth arrest in the proximal radial epiphysis was also absent. Percutaneous reduction and leverage fixation using K-wires in children with radial neck fractures is a recommended surgical treatment that can achieve recovery of normal radial angulation and elbow motion.	[Cha, Soo Min; Shin, Hyun Dae; Kim, Kyung Cheon; Han, Sun Cheol] Chungnam Natl Univ Hosp, Taejon, South Korea	Shin, HD (corresponding author), Chungnam Natl Univ Hosp, Taejon, South Korea.	csm9827@hanmail.net; hyunsd@cnu.ac.kr		Shin, Hyun Dae/0000-0003-4290-1125; Cha, Soo Min/0000-0003-1663-406X			Angelov A., 1981, NEW METHOD TREATMENT, P192; BERNSTEIN SM, 1993, J PEDIATR ORTHOPED, V13, P85, DOI 10.1097/01241398-199301000-00017; Eberl R, 2010, EUR J PEDIATR SURG, V20, P250, DOI 10.1055/s-0030-1249104; FERAY C, 1969, PRESSE MED, V77, P2155; GonzalezHerranz P, 1997, J PEDIATR ORTHOPED, V17, P325, DOI 10.1097/00004694-199705000-00011; Green NE, 1994, SKELETAL TRAUMA CHIL, P213; JONES E R L, 1971, Journal of Bone and Joint Surgery British Volume, V53, P429; JUDET J, 1962, Ann Chir, V16, P1377; KAPANDJI A, 1987, Annales de Chirurgie de la Main, V6, P57, DOI 10.1016/S0753-9053(87)80011-X; KAUFMAN B, 1989, J BONE JOINT SURG BR, V71, P66; Klitscher D, 2009, J PEDIATR ORTHOPED, V29, P698, DOI 10.1097/BPO.0b013e3181b76895; Metaizeau JP, 2005, INJURY, V36, pA75, DOI 10.1016/j.injury.2004.12.016; METAIZEAU JP, 1980, REV CHIR ORTHOP, V66, P47; METAIZEAU JP, 1993, J PEDIATR ORTHOPED, V13, P355, DOI 10.1097/01241398-199305000-00015; O'Brien P I, 1965, Clin Orthop Relat Res, V41, P51; PESUDO JV, 1982, CLIN ORTHOP RELAT R, P215; Schmittenbecher PP, 2005, J PEDIATR ORTHOPED, V25, P45; STEELE JA, 1992, J BONE JOINT SURG BR, V74, P760; STEINBERG EL, 1988, J PEDIATR ORTHOPED, V8, P35, DOI 10.1097/01241398-198801000-00009; Tollet P, 1997, Acta Orthop Belg, V63, P245; Ugutmen E, 2010, J PEDIATR ORTHOP B, V19, P289, DOI 10.1097/BPB.0b013e32833918a0; Vocke AK, 1998, J PEDIATR ORTHOP B, V7, P217, DOI 10.1097/01202412-199807000-00007	22	22	26	0	4	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0341-2695	1432-5195		INT ORTHOP	Int. Orthop.	APR	2012	36	4					803	809		10.1007/s00264-011-1387-3			7	Orthopedics	Orthopedics	917JP	WOS:000302171000018	22038445	Green Published			2021-06-18	
J	Hadjibashi, AA; Berry, C; Ley, EJ; Bukur, M; Mirocha, J; Stolpner, D; Salim, A				Hadjibashi, Anoushiravan Amini; Berry, Cherisse; Ley, Eric J.; Bukur, Marko; Mirocha, James; Stolpner, Dennis; Salim, Ali			Alcohol is Associated with a Lower Pneumonia Rate After Traumatic Brain Injury	JOURNAL OF SURGICAL RESEARCH			English	Article; Proceedings Paper	Annual Meeting of the Association-of-Academic-Surgery (AAS)/6th Annual Academic-Surgical Congress	FEB 01-03, 2011	Huntington Beach, CA	Assoc Acad Surg (AAS), Acad Surg		traumatic brain injury; alcohol; ethanol; pneumonia; infection; outcome	SEVERE HEAD-INJURY; SERUM ETHANOL LEVELS; MODERATE; INTOXICATION; MORTALITY; DEFICITS; LEVEL	Background. Recent evidence supports the beneficial effect of alcohol on patients with traumatic brain injury (TBI). Pneumonia is a known complication following TBI; thus, the purpose of this study was to evaluate the effects of alcohol on pneumonia rates following moderate to severe TBI. Methods. From 2005 to 2009, the Los Angeles County Trauma Database was queried for all patients >= 14 y of age with isolated moderate to severe TBI and admission serum alcohol levels. The incidence of pneumonia was compared between TBI patients with and without a positive blood alcohol concentration (BAC) level. The study population was then stratified into four BAC levels: None (0 mg/dL), low (0-100 mg/dL), moderate (100-230 mg/dL), and high (>= 230 mg/dL). Pneumonia rates were compared across these levels. Results. A total of 3547 patients with isolated, moderate to severe TBI were evaluated. Nearly 66% tested positive for alcohol. The pneumonia rate was significantly lower in the TBI patients who tested positive for alcohol (2.5%) compared with those who tested negative (4.0%, P = 0.017). The pneumonia rate also decreased across increasing BAC levels (linear trend P = 0.03). After logistic regression analysis, a positive ethanol (ETOH) level was associated with a reduced incidence of pneumonia (AOR = 0.62; 95% CI: 0.41-0.93; P = 0.020). Conclusion. A positive serum alcohol level was associated with a significantly lower pneumonia rate in isolated, moderate to severe TBI patients. This may explain the observed mortality reduction in TBI patients who test positive for alcohol. Additional research is warranted to investigate the potential therapeutic implications of this association. (C) 2012 Elsevier Inc. All rights reserved.	[Hadjibashi, Anoushiravan Amini; Berry, Cherisse; Ley, Eric J.; Bukur, Marko; Mirocha, James; Stolpner, Dennis; Salim, Ali] Cedars Sinai Med Ctr, Dept Surg, Div Trauma & Crit Care, Los Angeles, CA 90048 USA	Salim, A (corresponding author), Cedars Sinai Med Ctr, Dept Surg, Div Trauma & Crit Care, 8700 Beverly Blvd,Suite 8215N, Los Angeles, CA 90048 USA.	ali.salim@cshs.org	Berry, Cherisse/AAO-5701-2020	Bukur, Marko/0000-0002-1850-7147			Acosta JA, 1998, J AM COLL SURGEONS, V186, P528, DOI 10.1016/S1072-7515(98)00082-9; Albrecht RF, 1998, MAYO CLIN PROC, V73, P629; Berrouane Y, 1998, J HOSP INFECT, V40, P275, DOI 10.1016/S0195-6701(98)90303-6; Berry C, 2010, AM SURGEON, V76, P1067; Boddie DE, 2003, BRIT J NEUROSURG, V17, P405, DOI 10.1080/02688690310001611198; BRAMLETT HM, 1995, J NEUROTRAUM, V12, P289, DOI 10.1089/neu.1995.12.289; Bronchard G, 2004, ANESTHESIOLOGY, V100, P234, DOI 10.1097/00000542-200402000-00009; Cazzadori A, 1997, RESP MED, V91, P193, DOI 10.1016/S0954-6111(97)90038-X; CHANDLER LJ, 1993, ALCOHOL CLIN EXP RES, V17, P54, DOI 10.1111/j.1530-0277.1993.tb00726.x; Dziedzic T, 2004, CRIT CARE, V8, P266, DOI 10.1186/cc2828; Gottesfeld Z, 2002, J NEUROTRAUM, V19, P317, DOI 10.1089/089771502753594882; HAMILL RW, 1987, ANN NEUROL, V21, P438, DOI 10.1002/ana.410210504; Heffernan DS, 2010, J TRAUMA, V69, P1602, DOI 10.1097/TA.0b013e3181f2d3e8; HSIEH AHH, 1992, AM REV RESPIR DIS, V146, P290, DOI 10.1164/ajrccm/146.2.290; Leone M, 2002, CRIT CARE MED, V30, P1741, DOI 10.1097/00003246-200208000-00011; Nylen K, 2006, J NEUROL SCI, V240, P85, DOI 10.1016/j.jns.2005.09.007; O'Phelan K, 2008, J TRAUMA, V65, P674, DOI 10.1097/TA.0b013e31817db0a5; PIEK J, 1992, J NEUROSURG, V77, P901, DOI 10.3171/jns.1992.77.6.0901; QUATTROCCHI K B, 1991, Neurological Research, V13, P13; QUATTROCCHI K B, 1990, Journal of Neurotrauma, V7, P77, DOI 10.1089/neu.1990.7.77; QUATTROCCHI KB, 1992, J NEUROTRAUM, V9, P1, DOI 10.1089/neu.1992.9.1; RELLO J, 1992, EUR RESPIR J, V5, P1249; Salim A, 2009, J TRAUMA, V67, P697, DOI 10.1097/TA.0b013e3181b5dcf2; Salim A, 2009, ARCH SURG-CHICAGO, V144, P865, DOI 10.1001/archsurg.2009.158; Sall JM, 1996, EXP NEUROL, V139, P257, DOI 10.1006/exnr.1996.0099; Taylor AN, 2002, J NEUROTRAUM, V19, P1597, DOI 10.1089/089771502762300256; Woiciechowsky C, 1999, CRIT CARE, V3, pR107, DOI 10.1186/cc375; WOOLF PD, 1990, ALCOHOL CLIN EXP RES, V14, P205, DOI 10.1111/j.1530-0277.1990.tb00473.x	28	22	23	0	4	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0022-4804	1095-8673		J SURG RES	J. Surg. Res.	APR	2012	173	2					212	215		10.1016/j.jss.2011.05.029			4	Surgery	Surgery	906IQ	WOS:000301339100010	21737096				2021-06-18	
J	Weng, YL; Sun, SJ				Weng, Yinlun; Sun, Shijie			Therapeutic Hypothermia After Cardiac Arrest in Adults: Mechanism of Neuroprotection, Phases of Hypothermia, and Methods of Cooling	CRITICAL CARE CLINICS			English	Article						Cardiac arrest; Cardiopulmonary resuscitation; Hypothermia; Neurologic function	TRAUMATIC BRAIN-INJURY; COLD INTRAVENOUS FLUID; MICROVESSEL ENDOTHELIAL-CELLS; PROMISING TREATMENT MODALITY; AMERICAN-HEART-ASSOCIATION; 4-DEGREES-C NORMAL SALINE; GLOBAL CEREBRAL-ISCHEMIA; INDUCED AXONAL INJURY; ADVANCED LIFE-SUPPORT; MILD HYPOTHERMIA	Mild therapeutic hypothermia (32 degrees C-34 degrees C) has been shown to improve survival and neurologic outcomes after sudden cardiac arrest in clinical studies. Its use is recommended by the American Heart Association for unconscious adult patients with spontaneous circulation after out-of-hospital ventricular fibrillation. It decreases cerebral metabolism and protects the brain after ischemia by reduction of brain metabolism, attenuation of neuroexcitotoxic cascade, abolition of reactive oxygen species, and inhibition of apoptosis. This article addresses the mechanism of neuroprotection, phases of hypothermia, and noninvasive and invasive cooling methods.	[Weng, Yinlun; Sun, Shijie] Weil Inst Crit Care Med, Rancho Mirage, CA 92270 USA; [Sun, Shijie] Univ So Calif, Keck Sch Med, Los Angeles, CA 90089 USA	Sun, SJ (corresponding author), Weil Inst Crit Care Med, 35100 Bob Hope Dr, Rancho Mirage, CA 92270 USA.	shijiesun@aol.com			American Heart AssociationAmerican Heart Association [11IRG 487001]	The authors have received financial support through an American Heart Association grant (11IRG 487001). The authors have no relationship with any commercial company that has a direct financial interest in the subject matter or materials discussed in their article or with a company making a competing product.	Adachi M, 2001, PEDIATR RES, V50, P590, DOI 10.1203/00006450-200111000-00010; Agnew DM, 2003, PEDIATR RES, V54, P253, DOI 10.1203/01.PDR.0000072783.22373.FF; AKRIOTIS V, 1985, J LEUKOCYTE BIOL, V37, P51; Al-Senani FM, 2004, RESUSCITATION, V62, P143, DOI 10.1016/j.resuscitation.2004.02.016; Alam HB, 2006, J TRAUMA, V60, P134, DOI 10.1097/01.ta.0000198469.95292.ec; Alzaga AG, 2006, RESUSCITATION, V70, P369, DOI 10.1016/j.resuscitation.2006.01.017; [Anonymous], 2004, ANN INTERN MED, V140, P182; AOKI M, 1993, ANN THORAC SURG, V55, P1093, DOI 10.1016/0003-4975(93)90014-9; Asensio VC, 1999, TRENDS NEUROSCI, V22, P504, DOI 10.1016/S0166-2236(99)01453-8; Bernard S, 2003, RESUSCITATION, V56, P9, DOI 10.1016/S0300-9572(02)00276-9; Bernard SA, 2002, NEW ENGL J MED, V346, P557, DOI 10.1056/NEJMoa003289; Bissonnette B, 2000, ANESTHESIOLOGY, V93, P611, DOI 10.1097/00000542-200009000-00008; Boddicker KA, 2005, CIRCULATION, V111, P3195, DOI 10.1161/CIRCULATIONAHA.104.492108; BROMONT C, 1989, STROKE, V20, P918, DOI 10.1161/01.STR.20.7.918; Bruel C, 2008, CRIT CARE, V12, DOI 10.1186/cc6809; Busch M, 2006, ACTA ANAESTH SCAND, V50, P1277, DOI 10.1111/j.1399-6576.2006.01147.x; BUSTO R, 1989, STROKE, V20, P904, DOI 10.1161/01.STR.20.7.904; Callaway CW, 2008, CRIT CARE MED, V36, P2607, DOI 10.1097/CCM.0b013e318184443b; Chi OZ, 2001, ANESTHESIOLOGY, V95, P933, DOI 10.1097/00000542-200110000-00023; Cobb LA, 2002, JAMA-J AM MED ASSOC, V288, P3008, DOI 10.1001/jama.288.23.3008; Colbourne F, 1997, MOL NEUROBIOL, V14, P171, DOI 10.1007/BF02740655; COLBOURNE F, 1994, BRAIN RES, V654, P265, DOI 10.1016/0006-8993(94)90488-X; COLBOURNE F, 1995, J NEUROSCI, V15, P7250; DANZL DF, 1994, NEW ENGL J MED, V331, P1756, DOI 10.1056/NEJM199412293312607; DEMPSEY RJ, 1987, NEUROSURGERY, V21, P177, DOI 10.1227/00006123-198708000-00007; DIETRICH WD, 1993, J CEREBR BLOOD F MET, V13, P541, DOI 10.1038/jcbfm.1993.71; Ehrlich MP, 2002, ANN THORAC SURG, V73, P191, DOI 10.1016/S0003-4975(01)03273-8; Erecinska M, 2003, J CEREBR BLOOD F MET, V23, P513, DOI 10.1097/01.WCB.0000066287.21705.21; Field JM, 2010, CIRCULATION, V122, pS640, DOI 10.1161/CIRCULATIONAHA.110.970889; Fischer S, 1999, AM J PHYSIOL-CELL PH, V276, pC812; Fischer S, 1999, MOL BRAIN RES, V74, P135, DOI 10.1016/S0169-328X(99)00272-7; Gal R, 2009, BRATISL MED J, V110, P222; Galea S, 2007, AM J EPIDEMIOL, V166, P534, DOI 10.1093/aje/kwm102; GLOBUS MYT, 1995, J NEUROCHEM, V65, P1704; GLOBUS MYT, 1995, J NEUROCHEM, V65, P1250; Gunn AJ, 2000, CURR OPIN PEDIATR, V12, P111, DOI 10.1097/00008480-200004000-00004; Gunn AJ, 1998, EARLY HUM DEV, V53, P19, DOI 10.1016/S0378-3782(98)00033-4; Gupta AK, 2002, BRIT J ANAESTH, V88, P188, DOI 10.1093/bja/88.2.188; HAGERDAL M, 1975, J NEUROCHEM, V24, P311, DOI 10.1111/j.1471-4159.1975.tb11881.x; Hammer MD, 2003, NEUROLOGIST, V9, P280, DOI 10.1097/01.nrl.0000094628.29312.2b; Haugk M, 2007, RESUSCITATION, V75, P76, DOI 10.1016/j.resuscitation.2007.03.001; Hickey RW, 2000, CRIT CARE MED, V28, P3511, DOI 10.1097/00003246-200010000-00027; Hildebrand F, 2005, CYTOKINE, V31, P382, DOI 10.1016/j.cyto.2005.06.008; Holzer M, 2005, CRIT CARE MED, V33, P1346, DOI 10.1097/01.CCM.0000166356.45902.A2; Holzer M, 2002, NEW ENGL J MED, V346, P549; Holzer M, 2006, STROKE, V37, P1792, DOI 10.1161/01.STR.0000227265.52763.16; Hong SB, 2002, ANESTH ANALG, V94, P157, DOI 10.1097/00000539-200201000-00030; HOSSMANN KA, 1988, CRIT CARE MED, V16, P964, DOI 10.1097/00003246-198810000-00007; Howes D, 2010, RESUSCITATION, V81, P388, DOI 10.1016/j.resuscitation.2009.12.025; Huang ZG, 1999, CAN J NEUROL SCI, V26, P298, DOI 10.1017/S0317167100000421; ILLIEVICH UM, 1994, ANESTH ANALG, V78, P905; Janata A, 2009, PROG CARDIOVASC DIS, V52, P168, DOI 10.1016/j.pcad.2009.07.001; Kamarainen A, 2008, RESUSCITATION, V79, P205, DOI 10.1016/j.resuscitation.2008.07.003; Katz LM, 2004, BRAIN RES, V1017, P85, DOI 10.1016/j.brainres.2004.05.020; Katz LM, 2004, CRIT CARE MED, V32, P806, DOI 10.1097/01.CCM.0000114998.00860.FD; Kawahara F, 2003, ACTA ANAESTH SCAND, V47, P419, DOI 10.1034/j.1399-6576.2003.00063.x; Kim F, 2005, CIRCULATION, V112, P715, DOI 10.1161/CIRCULATIONAHA.105.544528; Kim F, 2007, CIRCULATION, V115, P3064, DOI 10.1161/CIRCULATIONAHA.106.655480; Kliegel A, 2005, RESUSCITATION, V64, P347, DOI 10.1016/j.resuscitation.2004.09.002; Kliegel A, 2007, RESUSCITATION, V73, P46, DOI 10.1016/j.resuscitation.2006.08.023; KOMARA JS, 1986, ANN EMERG MED, V15, P384, DOI 10.1016/S0196-0644(86)80171-8; LANIER WL, 1995, J NEUROSURG ANESTH, V7, P216, DOI 10.1097/00008506-199507000-00021; LAPTOOK AR, 1995, STROKE, V26, P1240, DOI 10.1161/01.STR.26.7.1240; LAPTOOK AR, 1995, PEDIATR RES, V38, P919, DOI 10.1203/00006450-199512000-00015; LeDucq N, 1998, BIOCHEM J, V336, P501, DOI 10.1042/bj3360501; Leker RR, 2002, BRAIN RES REV, V39, P55, DOI 10.1016/S0165-0173(02)00157-1; Liou AKF, 2003, PROG NEUROBIOL, V69, P103, DOI 10.1016/S0301-0082(03)00005-4; Lloyd-Jones D, 2010, CIRCULATION, V121, P948, DOI 10.1161/CIRCULATIONAHA.109.192666; Markarian GZ, 1996, NEUROSURGERY, V38, P542; Markgraf CG, 2001, J NEUROSURG, V95, P979, DOI 10.3171/jns.2001.95.6.0979; Maxwell WL, 2005, J NEUROTRAUM, V22, P873, DOI 10.1089/neu.2005.22.873; Merrill JE, 1996, TRENDS NEUROSCI, V19, P331, DOI 10.1016/0166-2236(96)10047-3; MILDE LN, 1992, J NEUROSURG ANESTH, V4, P211, DOI 10.1097/00008506-199207000-00012; NAKASHIMA K, 1995, ANESTHESIOLOGY, V82, P1199, DOI 10.1097/00000542-199505000-00015; Nolan JP, 2003, RESUSCITATION, V57, P231, DOI 10.1016/S0300-9572(03)00184-9; Nordmark J, 2005, RESUSCITATION, V66, P357, DOI 10.1016/j.resuscitation.2005.04.002; Novack TA, 1996, J CLIN EXP NEUROPSYC, V18, P685, DOI 10.1080/01688639608408292; Nozari A, 2006, CIRCULATION, V113, P2690, DOI 10.1161/CIRCULATIONAHA.106.613349; Oddo M, 2008, CRIT CARE MED, V36, P2296, DOI 10.1097/CCM.0b013e3181802599; PALMER C, 1989, ANESTHESIOLOGY, V71, P730, DOI 10.1097/00000542-198911000-00017; Polderman KH, 2008, LANCET, V371, P1955, DOI 10.1016/S0140-6736(08)60837-5; Polderman KH, 2009, CRIT CARE MED, V37, pS186, DOI 10.1097/CCM.0b013e3181aa5241; Polderman KH, 2005, CRIT CARE MED, V33, P2744, DOI 10.1097/01.CCM.0000190427.88735.19; Polderman KH, 2004, INTENS CARE MED, V30, P556, DOI 10.1007/s00134-003-2152-x; Polderman KH, 2001, J NEUROSURG, V94, P697, DOI 10.3171/jns.2001.94.5.0697; Polderman KH, 2004, INTENS CARE MED, V30, P757, DOI 10.1007/s00134-003-2151-y; Povlishock JT, 2009, J NEUROTRAUM, V26, P333, DOI 10.1089/neu.2008.0604; Povlishock JT, 1999, ACT NEUR S, V73, P15; Proulx CI, 2006, EUR J APPL PHYSIOL, V96, P434, DOI 10.1007/s00421-005-0063-y; Quinones-Hinojosa A, 2003, NEUROSURGERY, V52, P1178, DOI 10.1227/01.NEU.0000057836.64972.A0; Raghupathi R, 2000, J NEUROTRAUM, V17, P927, DOI 10.1089/neu.2000.17.927; Raghupathi R, 1998, P W PHARMACOL SOC, V41, P241; Riter HG, 2009, RESUSCITATION, V80, P561, DOI 10.1016/j.resuscitation.2009.01.016; Sakoh M, 2003, AM J PHYSIOL-HEART C, V285, pH17, DOI 10.1152/ajpheart.01112.2002; Schmidt OI, 2005, BRAIN RES REV, V48, P388, DOI 10.1016/j.brainresrev.2004.12.028; Schratter A, 2007, AM J EMERG MED, V25, P420, DOI 10.1016/j.ajem.2007.02.044; Shintani Y., 2010, STROKE RES TREAT, V2011, P809; SIESJO BK, 1989, ANN NY ACAD SCI, V568, P234; Silfvast T, 2003, RESUSCITATION, V57, P109, DOI 10.1016/S0300-9572(02)00438-0; Small DL, 1999, PROG CARDIOVASC DIS, V42, P185, DOI 10.1016/S0033-0620(99)70002-2; Smith SL, 1996, J NEUROTRAUM, V13, P1, DOI 10.1089/neu.1996.13.1; Staffey KS, 2008, RESUSCITATION, V78, P77, DOI 10.1016/j.resuscitation.2008.02.008; Sterz F, 1996, J NEUROSURG ANESTH, V8, P88, DOI 10.1097/00008506-199601000-00028; STERZ F, 1991, CRIT CARE MED, V19, P379, DOI 10.1097/00003246-199103000-00017; Sterz Fritz, 2006, Acute Card Care, V8, P25, DOI 10.1080/14628840600621371; Straus SMJM, 2004, J CLIN EPIDEMIOL, V57, P98, DOI 10.1016/S0895-4356(03)00210-5; Suehiro E, 2001, J NEUROSURG, V94, P493, DOI 10.3171/jns.2001.94.3.0493; Sun SJ, 2010, CRIT CARE MED, V38, P2282, DOI 10.1097/CCM.0b013e3181f9f9e3; Tsai MS, 2008, J AM COLL CARDIOL, V51, P1988, DOI 10.1016/j.jacc.2007.12.057; Uray T, 2008, RESUSCITATION, V77, P331, DOI 10.1016/j.resuscitation.2008.01.005; Wang GJ, 2002, NEUROSCIENCE, V114, P1081, DOI 10.1016/S0306-4522(02)00350-0; Weng Y, 2011, CRIT CARE MED; Williams GD, 1997, PEDIATR RES, V42, P700, DOI 10.1203/00006450-199711000-00024; Wolff B, 2009, INT J CARDIOL, V133, P223, DOI 10.1016/j.ijcard.2007.12.039; Xu LJ, 2002, J CEREBR BLOOD F MET, V22, P21, DOI 10.1097/00004647-200201000-00003	115	22	24	0	10	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0749-0704	1557-8232		CRIT CARE CLIN	Crit. Care Clin.	APR	2012	28	2					231	+		10.1016/j.ccc.2011.10.012			15	Critical Care Medicine	General & Internal Medicine	926IC	WOS:000302823500008	22433485				2021-06-18	
J	Hyde, P; Mackenzie, R; Ng, G; Reid, C; Pearson, G				Hyde, Philip; Mackenzie, Rod; Ng, Gail; Reid, Cliff; Pearson, Gale			Availability and utilisation of physician-based pre-hospital critical care support to the NHS ambulance service in England, Wales and Northern Ireland	EMERGENCY MEDICINE JOURNAL			English	Article							TRAUMATIC BRAIN-INJURY; ADVANCED LIFE-SUPPORT; HEAD-INJURY; MORTALITY; SURVIVAL; IMPACT; TEAM	Background Every day throughout the UK, ambulance services seek medical assistance in providing critically ill or injured patients with pre-hospital care. Objective To identify the current availability and utilisation of physician-based pre-hospital critical care capability across England, Wales and Northern Ireland. Design A postal and telephone survey was undertaken between April and December 2009 of all 13 regional NHS ambulance services, 17 air ambulance charities, 34 organisations affiliated to the British Association for Immediate Care and 215 type 1 emergency departments in England, Wales and Northern Ireland. The survey focused on the availability and use of physician-based pre-hospital critical care support. Results The response rate was 100%. Although nine NHS ambulance services recorded physician attendance at 6155 incidents, few could quantify doctor availability and utilisation. All but one of the British Association for Immediate Care organisations deployed 'only when available' and only 45% of active doctors could provide critical care support. Eleven air ambulance services (65%) operated with a doctor but only 5 (29%) operated 7 days a week. Fifty-nine EDs (27%) had a pre-hospital team but only 5 (2%) had 24 h deployable critical care capability and none were used regularly. Conclusion There is wide geographical and diurnal variability in availability and utilisation of physician-based pre-hospital critical care support. Only London ambulance service has access to NHS-commissioned 24 h physician-based pre-hospital critical care support. Throughout the rest of the UK, extensive use is made of volunteer doctors and charity sector providers of varying availability and capability.	[Hyde, Philip] Southampton Gen Hosp, Paediat Intens Care Unit, Southampton SO16 6YD, Hants, England; [Mackenzie, Rod] Univ Leicester, Leicester, Leics, England; [Ng, Gail] Leicester Royal Infirm, Emergency Dept, Leicester, Leics, England; [Reid, Cliff] Ambulance Serv New S Wales, Helicopter Retrieval Serv, Sydney, NSW, Australia; [Pearson, Gale] Birmingham Childrens Hosp, Paediat Intens Care Unit, Birmingham, England	Hyde, P (corresponding author), Southampton Gen Hosp, Paediat Intens Care Unit, Tremona Rd, Southampton SO16 6YD, Hants, England.	prhyde@doctors.org.uk		Reid, Clifford/0000-0002-1152-8551			[Anonymous], 2010, NHS CLIN ADV GROUPS; [Anonymous], 2000, COMPR CRIT CAR REV A; *ASS AN GREAT BRIT, 2009, AAGBI SAF GUID PREH; BAXT WG, 1987, JAMA-J AM MED ASSOC, V257, P3246, DOI 10.1001/jama.257.23.3246; BAXT WG, 1987, J TRAUMA, V27, P365, DOI 10.1097/00005373-198704000-00004; Berlot G, 2009, EUR J EMERG MED, V16, P312, DOI 10.1097/MEJ.0b013e32832d3aa1; Botker MT, 2009, SCAND J TRAUMA RESUS, V17, DOI 10.1186/1757-7241-17-12; Department of Health, 2009, NAT HLTH SERV CONST; Department of Health, 2009, NHS EM PLANN GUID PL; Findlay G, 2007, TRAUMA WHO CARES REP; Garner A, 2001, INJURY, V32, P455, DOI 10.1016/S0020-1383(01)00013-4; Hyde P, 2009, PAEDIAT CHILD HLTH, V19, P487; Intercollegiate Group of Trauma Standards, 2009, REG TRAUM SYST INT G; Klemen P, 2006, ACTA ANAESTH SCAND, V50, P1250, DOI 10.1111/J.1399-6576.2006.01039.X; Lossius HM, 2002, ACTA ANAESTH SCAND, V46, P771, DOI 10.1034/j.1399-6576.2002.460703.x; Mackenzie R, 2009, EMERG MED J, V26, P365, DOI 10.1136/emj.2008.062588; National Audit Office, 2010, MAJ TRAUM CAR ENGL; Nicholl J, 2003, REV COSTS BENEFITS H; Oppe S, 2001, ACCIDENT ANAL PREV, V33, P129, DOI 10.1016/S0001-4575(00)00023-3; Osterwalder JJ, 2003, J TRAUMA, V55, P355, DOI 10.1097/01.TA.0000034231.94460.1F; Royal College of Surgeons of England and the British Orthopaedic Society, 2000, BETT CAR SEV INJ; Secretary of State for Health, 2008, HIGH QUAL CAR ALL NH; WILDEN JN, 1993, LANCET, V342, P1378, DOI 10.1016/0140-6736(93)92750-N	23	22	22	0	7	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1472-0205			EMERG MED J	Emerg. Med. J.	MAR	2012	29	3					177	181		10.1136/emj.2010.106963			5	Emergency Medicine	Emergency Medicine	897GV	WOS:000300637000003	21427108	Green Published, Other Gold			2021-06-18	
J	Turner-Stokes, L; Sutch, S; Dredge, R; Eagar, K				Turner-Stokes, Lynne; Sutch, Stephen; Dredge, Robert; Eagar, Kathy			International casemix and funding models: lessons for rehabilitation	CLINICAL REHABILITATION			English	Article							PROSPECTIVE-PAYMENT SYSTEM; TRAUMATIC BRAIN-INJURY; INPATIENT REHABILITATION; MEDICAL REHABILITATION; CARE; CHALLENGES; DISABILITY; EFFICIENCY; SERVICES	Background: Payment for treatment in healthcare systems around the world is increasingly based on fixed tariff models to drive up efficiency and contain costs. Casemix classifications, however, must account adequately for the resource implications of varying case complexity. Rehabilitation poses some particular challenges for casemix development. Objective: The objectives of this educational narrative review are (a) to provide an overview of the development of casemix in rehabilitation, (b) to describe key characteristics of some well-established casemix and payment models in operation around the world and (c) to explore opportunities for future development arising from the lessons learned. Results: Diagnosis alone does not adequately describe cost variation in rehabilitation. Functional dependency is considered a better cost indicator, and casemix classifications for inpatient rehabilitation in the United States and Australia rely on the Functional Independence Measure (FIM). Fixed episode-based prospective payment systems are shown to contain costs, but at the expense of poorer functional outcomes. More sophisticated models incorporating a mixture of episode and weighted per diem rates may offer greater flexibility to optimize outcome, while still providing incentive for throughput. Conclusion: The development of casemix in rehabilitation poses similar challenges for healthcare systems all around the world. Well-established casemix systems in the United States and Australia have afforded valuable lessons for other countries to learn from, but have not provided all the answers. A range of casemix and payment models is required to cater for different healthcare cultures, and casemix tools must capture all the key cost-determinants of treatment for patients with complex needs.	[Turner-Stokes, Lynne] Kings Coll London, Sch Med, Dept Palliat Care Policy & Rehabil, London WC2R 2LS, England; [Turner-Stokes, Lynne] Northwick Pk Hosp & Clin Res Ctr, Reg Rehabil Unit, Harrow HA1 3UJ, Middx, England; [Sutch, Stephen] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Baltimore, MD USA; [Dredge, Robert] Keele Univ, Sch Publ Policy, Keele ST5 5BG, Staffs, England; [Eagar, Kathy] Univ Wollongong, Ctr Hlth Serv Dev, Wollongong, NSW, Australia	Turner-Stokes, L (corresponding author), Northwick Pk Hosp & Clin Res Ctr, Reg Rehabil Unit, Watford Rd, Harrow HA1 3UJ, Middx, England.	lynne.turner-stokes@dial.pipex.com	Turner-Stokes, Lynne/F-4418-2012	Turner-Stokes, Lynne/0000-0002-3302-9462; Eagar, Kathy/0000-0001-5802-8995; Sutch, Stephen/0000-0003-3202-6718	National Institute for Health Research (NIHR) under its Programme Grants for Applied Research funding schemeNational Institute for Health Research (NIHR) [RP-PG-0407-10185]; Dunhill Medical TrustDunhill Medical Trust; Luff Foundation; National Institute for Health ResearchNational Institute for Health Research (NIHR) [RP-PG-0407-10185] Funding Source: researchfish	This article presents independent research commissioned by the National Institute for Health Research (NIHR) under its Programme Grants for Applied Research funding scheme (RP-PG-0407-10185). The views expressed in this article are those of the authors and not necessarily those of the NHS, the NIHR or the Department of Health. Financial support for the preparation of this manuscript was also provided by the Dunhill Medical Trust, the Luff Foundation.	[Anonymous], 2009, NAT DEF SET SPEC SER; Arling G, 2007, HEALTH SERV RES, V42, P827, DOI 10.1111/j.1475-6773.2006.00627.x; BATAVIA AI, 1988, ARCH PHYS MED REHAB, V69, P377; Bjorkgren MA, 1999, SCAND J PUBLIC HEALT, V27, P228, DOI 10.1177/14034948990270030201; Boyle S., 2005, EURO OBSERVER, V7, P1; Braddom RL, 2005, ARCH PHYS MED REHAB, V86, P1287, DOI 10.1016/j.apmr.2005.01.004; CARPENTER GI, 1995, AGE AGEING, V24, P5, DOI 10.1093/ageing/24.1.5; *DEP HLTH, 2007, OPT FUT PAYM RES 200; Department of Health, 2002, REF NHS FIN FLOWS IN; DISLER PB, 1993, ARCH PHYS MED REHAB, V74, P139; Duckett SJ, 1998, MED J AUSTRALIA, V169, pS17, DOI 10.5694/j.1326-5377.1998.tb123470.x; Eagar K, 1999, Aust Health Rev, V22, P180; Eagar K, 1997, Aust Health Rev, V20, P26; Evans R L, 1990, Int J Rehabil Res, V13, P27, DOI 10.1097/00004356-199003000-00003; Fetter RB, 1991, DRGS THEIR DESIGN DE; FRIES BE, 1994, MED CARE, V32, P668, DOI 10.1097/00005650-199407000-00002; Green J, 2007, AUST HEALTH REV, V31, pS68; Hall KM, 1996, J HEAD TRAUMA REHAB, V11, P27, DOI 10.1097/00001199-199610000-00004; HEINEMANN AW, 1995, AM J PHYS MED REHAB, V74, P315, DOI 10.1097/00002060-199507000-00011; HEINEMANN AW, 1993, ARCH PHYS MED REHAB, V74, P566, DOI 10.1016/0003-9993(93)90153-2; Heinemann AW, 1997, ARCH PHYS MED REHAB, V78, P143, DOI 10.1016/S0003-9993(97)90255-0; Hirdes J P, 1996, Healthc Manage Forum, V9, P40; Hoffman JM, 2003, ARCH PHYS MED REHAB, V84, P1165, DOI 10.1016/S0003-9993(03)00232-6; Information Standards Board for Health and Social Care, 2008, HEALTHC RES GROUP 4, V4; Lee LA, 1998, MED J AUSTRALIA, V169, P19; Nyein K, 2007, J HEAD TRAUMA REHAB, V22, P239, DOI 10.1097/01.HTR.0000281840.85096.1f; Office of Population, 2006, CENS SURV CLASS SURG; Royal College of Physicians, 1986, PHYS DIS 1986; Saitto C, 2005, MED CARE, V43, P844, DOI 10.1097/01.mlr.0000173567.80190.32; Saitto C, 2005, MED CARE, V43, P856, DOI 10.1097/01.mlr.0000173568.67805.70; Schreyogg J, 2005, Eur J Health Econ, VSuppl, P2; Stineman MG, 2005, MED CARE, V43, P841, DOI 10.1097/01.mlr.0000178392.96014.cf; Stineman MG, 1997, HEALTH SERV RES, V32, P529; Sutherland JM, 2008, HEALTH POLICY, V85, P336, DOI 10.1016/j.healthpol.2007.09.006; Turner-Stokes L, 2006, J NEUROL NEUROSUR PS, V77, P634, DOI 10.1136/jnnp.2005.073411; Turner-Stokes L, 2010, CLIN REHABI IN PRESS; Turner-Stokes L, 2007, CLIN MED, V7, P593, DOI 10.7861/clinmedicine.7-6-593; Turner-Stokes L, 2007, BRAIN INJURY, V21, P1015, DOI 10.1080/02699050701591445; Turner-Stokes L, 2010, J NEUROL NEUROSUR PS, V81, P146, DOI 10.1136/jnnp.2009.173716; VLADECK BC, 1988, ANNU REV PUBL HEALTH, V9, P333, DOI 10.1146/annurev.pu.09.050188.002001; Webster F, 1996, Aust Health Rev, V19, P81; Wikipedia, CAS MIX; World Health Organization, 2007, INT STAT CLASS DIS R; Zorowitz RD, 2009, EUR J PHYS REHAB MED, V45, P259	44	22	22	0	9	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0269-2155	1477-0873		CLIN REHABIL	Clin. Rehabil.	MAR	2012	26	3					195	208		10.1177/0269215511417468			14	Rehabilitation	Rehabilitation	260GN	WOS:000327583100002	22070989	Other Gold			2021-06-18	
J	Zhang, MY; Shan, HY; Gu, ZY; Wang, DL; Wang, T; Wang, ZW; Tao, LY				Zhang, Mingyang; Shan, Haiyan; Gu, Zhenyong; Wang, Donglin; Wang, Tao; Wang, Zhiwei; Tao, Luyang			Increased Expression of Calcium/Calmodulin-Dependent Protein Kinase Type II Subunit Delta after Rat Traumatic Brain Injury	JOURNAL OF MOLECULAR NEUROSCIENCE			English	Article						Calcium/calmodulin-dependent protein kinase type II subunit delta; Traumatic brain injury; Apoptosis; Rat	IN-VIVO; NEUROTROPHIC FACTOR; ISOFORM REGULATION; MESSENGER-RNAS; HEART-FAILURE; CELL-DEATH; ACTIVATION; APOPTOSIS; DIFFERENTIATION; HYPERTROPHY	Many cellular responses to Ca2+ signals are mediated by Ca2+/calmodulin-dependent enzymes, among which is the Ca2+/calmodulin-dependent protein kinase II (CaMKII). CaMKII was originally described in rat brain tissue. In rat brain, four different subunits of the kinase have been identified: alpha, beta, gamma, and delta. This study aims to investigate changes of CaMKII delta after traumatic brain injury and its possible role. Rat traumatic brain injury (TBI) model was established by controlled cortical injury system. In the present study, we mainly investigated the expression and cellular localization of CaMKII delta after traumatic brain injury. Western blot analysis revealed that CaMKII delta was present in normal rat brain cortex. It gradually increased, reached a peak at the third day after TBI, and then decreased. Importantly, more CaMKII delta was colocalized with neuron. In addition, Western blot detection showed that the third day postinjury was also the apoptosis peak indicated by the elevated expression of caspase-3.Importantly, immunohistochemistry analysis revealed that injury-induced expression of CaMKII delta was colabeled by caspase-3 (apoptosis cells marker). Moreover, pretreatment with the CaMKII inhibitor (KN62) reduced the injury-induced activation of caspase-3. Noticeably, the CaMKII inhibitor KN-62 could reduce TBI-induced cell injury assessed with lesion volume and attenuate behavioral outcome evaluated by motor test. These data suggested that CaMKII delta may be implicated in the apoptosis of neuron and the recovery of neurological outcomes. However, the inherent mechanisms remained unknown. Further studies are needed to confirm the exact role of CaMKII delta after brain injury.	[Zhang, Mingyang; Wang, Tao; Tao, Luyang] Soochow Univ, Inst Forens Sci, Suzhou 215123, Jiangsu, Peoples R China; [Zhang, Mingyang; Gu, Zhenyong; Wang, Donglin] Nantong Univ, Coll Med, Dept Forens Sci, Nantong 226001, Jiangsu, Peoples R China; [Shan, Haiyan; Wang, Zhiwei] Nantong Univ, Affiliated Hosp, Dept Gen Surg, Nantong 226001, Jiangsu, Peoples R China	Tao, LY (corresponding author), Soochow Univ, Inst Forens Sci, Suzhou 215123, Jiangsu, Peoples R China.	ghost8469@gmail.com	Mingyang, Zhang/J-7412-2019	Mingyang, Zhang/0000-0001-7084-6237; Zhang, Mingyang/0000-0003-1612-0763	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [30872666, 81172911]; Natural Science Foundation of Medical College of Nantong University [Y200905, Y201003]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	This work was supported by the National Natural Science Foundation of China (No.30872666, No.81172911); Natural Science Foundation of Medical College of Nantong University (No.Y200905, No.Y201003); A Project Funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD).	Banno Y, 2008, J NEUROCHEM, V104, P1372, DOI 10.1111/j.1471-4159.2007.05085.x; Chang L, 2007, CIRCULATION, V116, P2976, DOI 10.1161/CIRCULATIONAHA.107.707257; Chen JA, 2011, CELL MOL NEUROBIOL, V31, P269, DOI 10.1007/s10571-010-9617-6; Chen YJ, 2008, NEUROCHEM RES, V33, P2092, DOI 10.1007/s11064-008-9690-0; Clark RSB, 2000, J NEUROCHEM, V74, P740, DOI 10.1046/j.1471-4159.2000.740740.x; Clark RSB, 1997, J NEUROSCI, V17, P9172; Currie S, 2011, PHARMACOL THERAPEUT, V131, P204, DOI 10.1016/j.pharmthera.2011.02.006; Donai H, 2000, MOL BRAIN RES, V85, P189, DOI 10.1016/S0169-328X(00)00221-7; Elliott MB, 2009, BRAIN RES, V1305, P183, DOI 10.1016/j.brainres.2009.09.104; Erhardt L, 1996, EUR HEART J, V17, P1781; Garic A, 2011, J NEUROCHEM, V118, P646, DOI 10.1111/j.1471-4159.2011.07273.x; Han JH, 2011, MOL CELL BIOL, V31, P793, DOI 10.1128/MCB.01117-10; House SJ, 2008, ARTERIOSCL THROM VAS, V28, P441, DOI 10.1161/ATVBAHA.107.156810; House SJ, 2007, AM J PHYSIOL-CELL PH, V292, pC2276, DOI 10.1152/ajpcell.00606.2006; Houston CM, 2008, J NEUROSCI, V28, P7574, DOI 10.1523/JNEUROSCI.5531-07.2008; Huang TT, 2009, J NEUROTRAUM, V26, P1535, DOI [10.1089/neu.2008.0743, 10.1089/neu.2008-0743]; Jackson KJ, 2009, J PHARMACOL EXP THER, V330, P541, DOI 10.1124/jpet.109.153171; Jeruc J, 2006, AM J KIDNEY DIS, V48, P410, DOI 10.1053/j.ajkd.2006.05.019; Ji XT, 2010, BRAIN RES, V1354, P196, DOI 10.1016/j.brainres.2010.07.038; Ju BG, 2004, CELL, V119, P815, DOI 10.1016/j.cell.2004.11.017; Kamata A, 2006, J NEUROCHEM, V96, P195, DOI 10.1111/j.1471-4159.2005.03531.x; Kline AE, 2007, CRIT CARE MED, V35, P919, DOI 10.1097/01.CCM.0000256722.88854.C0; KONIGSMARK BW, 1970, METHODS COUNTING NEU, P315; Li WW, 2011, J BIOL CHEM, V286, P7990, DOI 10.1074/jbc.M110.163006; LOGAN A, 1992, J NEUROSCI, V12, P3828; Ma Y, 2009, BRIT J PHARMACOL, V157, P705, DOI 10.1111/j.1476-5381.2009.00212.x; Maier LS, 2005, BRAZ J MED BIOL RES, V38, P1293, DOI 10.1590/S0100-879X2005000900002; Moreno-Delgado D, 2009, NEUROSCIENCE, V164, P1244, DOI 10.1016/j.neuroscience.2009.08.068; Mouton-Liger F, 2011, J COMP NEUROL, V519, P2779, DOI 10.1002/cne.22651; Nomura K, 2003, J NEUROSCI RES, V72, P384, DOI 10.1002/jnr.10581; Nozawa Y, 2004, J PHARMACOL SCI, V94, P233, DOI 10.1254/jphs.94.233; Polster BM, 2004, J NEUROCHEM, V90, P1281, DOI 10.1111/j.1471-4159.2004.02572.x; Qin Y, 2011, BIOCHEM BIOPH RES CO, V409, P287, DOI 10.1016/j.bbrc.2011.05.003; Raghupathi R, 2002, NEUROSCIENCE, V110, P605, DOI 10.1016/S0306-4522(01)00461-4; Reshef A, 2008, J NEUROTRAUM, V25, P569, DOI 10.1089/neu.2007.0341; Rochlitz H, 2000, DIABETOLOGIA, V43, P465, DOI 10.1007/s001250051330; Rokita AG, 2011, HERZ, V36, P94, DOI 10.1007/s00059-010-3415-2; Salas MA, 2010, J MOL CELL CARDIOL, V48, P1298, DOI 10.1016/j.yjmcc.2009.12.015; Scafidi S, 2010, DEV NEUROSCI-BASEL, V32, P480, DOI 10.1159/000323178; Schnabel R, 1999, NEUROPHARMACOLOGY, V38, P605, DOI 10.1016/S0028-3908(98)00229-9; SCHWORER CM, 1993, J BIOL CHEM, V268, P14443; Shein NA, 2009, FASEB J, V23, P4266, DOI 10.1096/fj.09-134700; Shen GF, 2010, NEUROPSYCHOPHARMACOL, V35, P1897, DOI 10.1038/npp.2010.61; Takeuchi Y, 1999, J NEUROCHEM, V72, P815, DOI 10.1046/j.1471-4159.1999.0720815.x; Tan SE, 1996, BRAIN RES, V711, P234, DOI 10.1016/0006-8993(95)01411-X; TOBIMATSU T, 1989, J BIOL CHEM, V264, P17907; Toko H, 2010, CIRCULATION, V122, P891, DOI 10.1161/CIRCULATIONAHA.109.935296; Tombes RM, 1999, BBA-MOL CELL RES, V1452, P1, DOI 10.1016/S0167-4889(99)00113-5; Torkkeli PH, 2011, EUR J NEUROSCI, V33, P1186, DOI 10.1111/j.1460-9568.2011.07624.x; Wagner S, 2011, CIRC RES, V108, P555, DOI 10.1161/CIRCRESAHA.110.221911; Wang XH, 2010, CIRCULATION, V122, P1308, DOI 10.1161/CIRCULATIONAHA.110.964684; Yang CX, 2011, NEUROSURGERY, V68, P691, DOI 10.1227/NEU.0b013e3182098a8a; Zhang T, 2004, RECENT PROG HORM RES, V59, P141, DOI 10.1210/rp.59.1.141; Zhao W, 2011, J MOL HISTOL, V42, P195, DOI 10.1007/s10735-011-9324-8	54	22	26	0	7	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	0895-8696			J MOL NEUROSCI	J. Mol. Neurosci.	MAR	2012	46	3					631	643		10.1007/s12031-011-9651-y			13	Biochemistry & Molecular Biology; Neurosciences	Biochemistry & Molecular Biology; Neurosciences & Neurology	893HE	WOS:000300346100022	22048920				2021-06-18	
J	Harris, JE; Colantonio, A; Bushnik, T; Constantinidou, F; Dawson, D; Goldin-Lauretta, Y; Swaine, B; Warren, J				Harris, Jocelyn E.; Colantonio, Angela; Bushnik, Tamara; Constantinidou, Fofi; Dawson, Deirdre; Goldin-Lauretta, Yelena; Swaine, Bonnie; Warren, Jane			Advancing the health and quality-of-life of girls and women after traumatic brain injury: Workshop summary and recommendations	BRAIN INJURY			English	Article						Traumatic brain injury; gender; quality-of-life; advocacy; health; outcome	GENDER-DIFFERENCES; SEX-DIFFERENCES; MODERATE; OUTCOMES; TBI; HOSPITALIZATIONS; EPIDEMIOLOGY; SYMPTOMS; IMPACT	Purpose: To disseminate findings from an international workshop regarding priority issues for girls' and women's health and quality-of-life after sustaining a traumatic brain injury (TBI). Methods: A workshop was held prior to the American Congress of Rehabilitation Medicine Conference 2010. The purpose of the workshop was to highlight the unique health issues experienced by women after a TBI, to identify research, education and policy gaps and to develop strategies to promote women's health. Presentations by researchers and consumers as well as large group discussions formed the basis of the recommendations. Results: Twenty researchers, clinicians, consumers and community agency personnel attended from five countries. Significant gaps in service provision in the community were identified as were unique issues for the short-and long-term effects on maturation and ageing, reproductive and sexual health, mental health and life satisfaction. The workshop led to the development of an international task force and recommendations for future directions. Conclusion: Women and girls experience unique outcomes after a TBI. The workshop identified research, policy, education and service priorities for the promotion of health and quality-of-life within this population.	[Colantonio, Angela; Dawson, Deirdre] Univ Toronto, Dept Occupat Sci & Occupat Therapy, Toronto, ON M5G 1V7, Canada; [Harris, Jocelyn E.] McMaster Univ, Sch Rehabil Sci, Hamilton, ON, Canada; [Colantonio, Angela] Toronto Rehabil Inst, Toronto, ON, Canada; [Bushnik, Tamara] Rusk Inst, New York, NY USA; [Bushnik, Tamara] NYU, Langone Med Ctr, New York, NY USA; [Constantinidou, Fofi] Univ Cypress, Toronto, ON, Canada; [Dawson, Deirdre] Baycrest, Kunin Lunenfeld Appl Res Unit, Toronto, ON, Canada; [Goldin-Lauretta, Yelena] Mt Sinai Sch Med, New York, NY USA; [Swaine, Bonnie] Univ Montreal, Fac Med, Ecole Readaptat, Programme Physiotherapie, Montreal, PQ H3C 3J7, Canada; [Swaine, Bonnie] Ctr Rech Interdisciplinaire Readaptat, Montreal, PQ, Canada; [Warren, Jane] Brain Injury Assoc Canada, Ottawa, ON, Canada; [Warren, Jane] DAWN Canada, Halifax, NS, Canada	Colantonio, A (corresponding author), Univ Toronto, Dept Occupat Sci & Occupat Therapy, 160-500 Univ Ave, Toronto, ON M5G 1V7, Canada.	angela.colantonio@utoronto.ca	Dawson, Deirdre R/I-8882-2014	Dawson, Deirdre R/0000-0001-7517-6121; Bushnik, Tamara/0000-0003-3328-257X; Constantinidou, Fofi/0000-0002-7928-8363; Colantonio, Angela/0000-0003-2094-4765	Corinne Kagan; Ontario Neurotrauma Foundation; American Congress of Rehabilitation Medicine; Canadian Institutes for Health ResearchCanadian Institutes of Health Research (CIHR) [200603MOP]; Ontario Ministry of Health and Long Term Care to the Toronto Rehabilitation Institute; Toronto Rehabilitation Institute Foundation	Special thanks to Marilyn Spivack who inspired the idea of a task force and future directions. We recognize the support of Corinne Kagan at the workshop and the Ontario Neurotrauma Foundation for funding subsequent knowledge mobilization activities. We thank Alana Officer who began the workshop with a global perspective on women with disability. We also acknowledge support from the American Congress of Rehabilitation Medicine, including staff support; Harry Zarins and the Brain Injury Association of Canada; and Bonnie Brayton and the DisAbled Women's Network (DAWNRAFH) Canada. We thank all those who assisted at the workshop including Sara Salehi and Sandra Sokoloff for her support with workshop development and manuscript preparation. We thank all the workshop participants and the women with lived experience of traumatic brain injury who contributed to the workshop. Lastly, we acknowledge the contributions of the late Dr Jane Gillette and dedicate this article to her.; Funding for this study for AC, JEH, BRW, DD, DV, HL, KKY and PK was obtained from a Canadian Institutes for Health Research Meetings, Planning and Dissemination Grant: Gender, Sex and Health (201006MHG). Funding for JEH was obtained by a CIHR Fellowship Award and a Strategic Training Fellowship in Health Care, Technology and Place (FRN: STP 53911). Additional funding for AC was obtained from the Canadian Institutes for Health Research (200603MOP). We recognize a grant from the Ontario Ministry of Health and Long Term Care to the Toronto Rehabilitation Institute and the support of the Toronto Rehabilitation Institute Foundation. The authors report no conflicts of interest.	Adamo MA, 2009, J NEUROSURG-PEDIATR, V4, P414, DOI 10.3171/2009.6.PEDS0939; Babikian T, 2009, NEUROPSYCHOLOGY, V23, P283, DOI 10.1037/a0015268; Bay E, 2009, J NEUROSCI NURS, V41, P298, DOI 10.1097/JNN.0b013e3181b6be81; Bernabeu M, 2009, NEUROREHAB NEURAL RE, V23, P464, DOI 10.1177/1545968308328725; Blinman TA, 2009, J PEDIATR SURG, V44, P1223, DOI 10.1016/j.jpedsurg.2009.02.027; Bowman SM, 2008, PEDIATRICS, V122, P988, DOI 10.1542/peds.2007-3511; Bushnik T, 2008, ARCH PHYS MED REHAB, V89, P894, DOI 10.1016/j.apmr.2008.03.001; Casteel C, 2008, INJURY PREV, V14, P87, DOI 10.1136/ip.2007.016451; Colantonio A, 2010, BMC NEUROL, V10, DOI 10.1186/1471-2377-10-102; Colantonio A, 2010, CAN J NEUROL SCI, V37, P783, DOI 10.1017/S0317167100051441; Colantonio A, 2010, J WOMENS HEALTH, V19, P1109, DOI 10.1089/jwh.2009.1740; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Goldin-Lauretta Y, 2010, ANN C AM C REH MED 2; Max JE, 2000, J INT NEUROPSYCH SOC, V6, P279, DOI 10.1017/S1355617700633039; Morrison Wynne E, 2004, Pediatr Crit Care Med, V5, P145, DOI 10.1097/01.PCC.0000112373.71645.2A; Niederland T, 2007, J NEUROTRAUM, V24, P119, DOI 10.1089/neu.2005.369ER; Niemeier JP, 2007, NEUROPSYCHOL REHABIL, V17, P293, DOI 10.1080/09602010600814729; Noggle CA, 2010, APPL NEUROPSYCHOL, V17, P110, DOI 10.1080/09084281003708977; Ripley DL, 2008, ARCH PHYS MED REHAB, V89, P1090, DOI 10.1016/j.apmr.2007.10.038; Rosen DB, 2006, ANN NY ACAD SCI, V1087, P170, DOI 10.1196/annals.1385.002; Schopp LH, 2001, J CLIN PSYCHOL MED S, V8, P181, DOI 10.1023/A:1011369620254; Semrud-Clikeman M, 2010, APPL NEUROPSYCHOL, V17, P116, DOI 10.1080/09084281003708985; Slewa-Younan S, 2008, J NEUROL NEUROSUR PS, V79, P1197, DOI 10.1136/jnnp.2008.147983; Srinivasan L, 2009, BRAIN INJURY, V23, P639, DOI 10.1080/02699050902970778; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Tate D G, 2001, Phys Med Rehabil Clin N Am, V12, P23	27	22	22	0	10	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	FEB	2012	26	2					177	182		10.3109/02699052.2011.635361			6	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	897NP	WOS:000300658200006	22360523				2021-06-18	
J	Kerman, M; Kanter, M; Coskun, KK; Erboga, M; Gurel, A				Kerman, Memduh; Kanter, Mehmet; Coskun, Kerim Kenan; Erboga, Mustafa; Gurel, Ahmet			Neuroprotective effects of Caffeic acid phenethyl ester on experimental traumatic brain injury in rats	JOURNAL OF MOLECULAR HISTOLOGY			English	Article						Traumatic brain injury; CAPE; Oxidative stress; Apoptosis; Rats	CLOSED-HEAD TRAUMA; LIPID-PEROXIDATION; REPERFUSION INJURY; N-ACETYLCYSTEINE; MECHANISMS; CASPASE-3; ISCHEMIA; DYSFUNCTION; STRESS; IMPACT	The aim of this study was to evaluate the therapeutic efficacy of caffeic acid phenethyl ester (CAPE) with an experimental traumatic brain injury (TBI) model in rats. Twenty-four adult male Sprague-Dawley rats were randomly divided into three groups of 8 rats each: control, TBI, and TBI + CAPE treatment. In TBI and TBI + CAPE treatment groups, a cranial impact was delivered to the skull from a height of 7 cm at a point just in front of the coronal suture and over the right hemisphere. Rats were sacrificed at 4 h after the onset of injury. Brain tissues were removed for biochemical and histopathological investigation. To date, no biochemical and histopathological changes of neurodegeneration in the frontal cortex after TBI in rats by CAPE treatment have been reported. The TBI significantly increased tissue malondialdehyde (MDA) levels, and significantly decreased tissue superoxide dismutase (SOD) and glutathione peroxidase (GPx) activities, but not tissue catalase (CAT) activity, when compared with controls. The administration of a single dose of CAPE (10 mu mol/kg) 15 min after the trauma has shown protective effect via decreasing significantly the elevated MDA levels and also significantly increasing the reduced antioxidant enzyme (SOD and GPx) activities, except CAT activity. In the TBI group, severe degenerative changes, shrunken cytoplasma and extensively dark picnotic nuclei in neurons, as well as vacuolization indicating tissue edema formation. The morphology of neurons in the CAPE treatment group was well protected. The number of neurons in the trauma alone group was significantly less than that of both the control and TBI +CAPE treatment groups. The caspase 3 immunopositivity was increased in degenerating neurons of the traumatic brain tissue. Treatment of CAPE markedly reduced the immunoreactivity of degenerating neurons. TBI caused severe degenerative changes, shrunken cytoplasma, severely dilated cisternae of endoplasmic reticulum, markedly swollen mitochondria with degenerated cristae and nuclear membrane breakdown with chromatin disorganization in neurons of the frontal cortex. In conclusion, the CAPE treatment might be beneficial in preventing trauma-induced oxidative brain tissue damage, thus showing potential for clinical implications. We believe that further preclinical research into the utility of CAPE may indicate its usefulness as a potential treatment on neurodegeneration after TBI in rats.	[Kerman, Memduh; Coskun, Kerim Kenan] Private Sema Hosp, Dept Neurosurg, Istanbul, Turkey; [Kanter, Mehmet; Erboga, Mustafa] Trakya Univ, Dept Histol & Embryol, Fac Med, TR-22030 Edirne, Turkey; [Gurel, Ahmet] Private Sema Hosp, Dept Biochem, Istanbul, Turkey	Kerman, M (corresponding author), Private Sema Hosp, Dept Neurosurg, Istanbul, Turkey.	memduhkerman@yahoo.com.tr; mkanter65@yahoo.com					AEBI H, 1984, METHOD ENZYMOL, V105, P121; BAETHMANN A, 1989, J NEUROSURG, V70, P578, DOI 10.3171/jns.1989.70.4.0578; Bramlett HM, 2004, J CEREBR BLOOD F MET, V24, P133, DOI 10.1097/01.WCB.0000111614.19196.04; Cernak I, 2002, J CLIN NEUROSCI, V9, P565, DOI 10.1054/jocn.2002.1132; Clark RSB, 2000, J NEUROCHEM, V74, P740, DOI 10.1046/j.1471-4159.2000.740740.x; Clark RSB, 1999, FASEB J, V13, P813; Cristofori L, 2001, J INVEST MED, V49, P450, DOI 10.2310/6650.2001.33790; Erhardt L, 1996, EUR HEART J, V17, P1781; Fadillioglu E, 2004, J APPL TOXICOL, V24, P47, DOI 10.1002/jat.945; Fadillioglu E, 2010, PROG NEURO-PSYCHOPH, V34, P1440, DOI 10.1016/j.pnpbp.2010.07.034; Gaetz M, 2004, CLIN NEUROPHYSIOL, V115, P4, DOI 10.1016/S1388-2457(03)00258-X; Hepsen IF, 1997, J CATARACT REFR SURG, V23, P1572, DOI 10.1016/S0886-3350(97)80031-4; Hicdonmez T, 2006, NEUROCHEM RES, V31, P473, DOI 10.1007/s11064-006-9040-z; HSU SM, 1981, J HISTOCHEM CYTOCHEM, V29, P577, DOI 10.1177/29.4.6166661; IKEDA Y, 1990, NEUROSURGERY, V27, P1; Ilhan A, 1999, EUR J CARDIO-THORAC, V16, P458, DOI 10.1016/S1010-7940(99)00246-8; Irmak MK, 2001, UROL RES, V29, P190, DOI 10.1007/s002400100185; Keane RW, 2001, J CEREBR BLOOD F MET, V21, P1189, DOI 10.1097/00004647-200110000-00007; Khan M, 2007, J NEUROCHEM, V102, P365, DOI 10.1111/j.1471-4159.2007.04526.x; Koltuksuz U, 1999, J PEDIATR SURG, V34, P1458, DOI 10.1016/S0022-3468(99)90103-3; Kus L, 2004, ACTA HISTOCHEM, V106, P289, DOI 10.1016/j.acthis.2004.05.002; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lewen A, 2001, J CEREBR BLOOD F MET, V21, P344, DOI 10.1097/00004647-200104000-00003; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Lu J, 2003, NEUROPHARMACOLOGY, V44, P253, DOI 10.1016/S0028-3908(02)00380-5; Marshall L F, 2000, Clin Neurosurg, V46, P105; Marshall LF, 1998, J NEUROSURG, V89, P519, DOI 10.3171/jns.1998.89.4.0519; Marshall LF, 2000, NEUROSURGERY, V47, P546, DOI 10.1097/00006123-200009000-00002; McCall J.M., 1987, ACTA ANAESTH BELG, V38, P279; MCCORD JM, 1969, J BIOL CHEM, V244, P6049; McIntosh TK, 1998, J NEUROTRAUM, V15, P731, DOI 10.1089/neu.1998.15.731; McIntosh TK, 1998, NEUROPATH APPL NEURO, V24, P251; Montpied P, 2003, MOL BRAIN RES, V115, P111, DOI 10.1016/S0169-328X(03)00178-5; Nagaoka T, 2002, BIOORGAN MED CHEM, V10, P3351, DOI 10.1016/S0968-0896(02)00138-4; Nicholson DW, 1999, CELL DEATH DIFFER, V6, P1028, DOI 10.1038/sj.cdd.4400598; Nortje J, 2004, CURR OPIN NEUROL, V17, P711, DOI 10.1097/00019052-200412000-00011; Ogeturk M, 2005, J ETHNOPHARMACOL, V97, P273, DOI 10.1016/j.jep.2004.11.019; OHKAWA H, 1979, ANAL BIOCHEM, V95, P351, DOI 10.1016/0003-2697(79)90738-3; Ozen S, 2004, J APPL TOXICOL, V24, P27, DOI 10.1002/jat.941; Ozisik PA, 2007, SURG NEUROL, V68, P547, DOI 10.1016/j.surneu.2007.01.030; Ozsuer H, 2005, NEUROSURG REV, V28, P143, DOI 10.1007/s10143-004-0374-1; Ozyurt H, 2001, CELL BIOCHEM FUNCT, V19, P259, DOI 10.1002/cbf.923; PAGLIA DE, 1967, J LAB CLIN MED, V70, P158; Porter AG, 1999, CELL DEATH DIFFER, V6, P99, DOI 10.1038/sj.cdd.4400476; RINK A, 1995, AM J PATHOL, V147, P1575; Russo A, 2002, FITOTERAPIA, V73, pS21, DOI 10.1016/S0367-326X(02)00187-9; SCATTON B, 1991, CEREBROVASC DIS, V1, P121, DOI 10.1159/000108829; SHAPIRA Y, 1988, CRIT CARE MED, V16, P258, DOI 10.1097/00003246-198803000-00010; SIESJO BK, 1993, ANN EMERG MED, V22, P959, DOI 10.1016/S0196-0644(05)82736-2; Stoica BA, 2010, NEUROTHERAPEUTICS, V7, P3, DOI 10.1016/j.nurt.2009.10.023; SUN Y, 1988, CLIN CHEM, V34, P497; Teasdale GM, 1998, NEUROSURGERY, V43, P723, DOI 10.1097/00006123-199810000-00001; Thomale UW, 2006, INTENS CARE MED, V32, P149, DOI 10.1007/s00134-005-2845-4; Ustun ME, 2001, INTENS CARE MED, V27, P264, DOI 10.1007/s001340000780; Vagnozzi R, 1999, J NEUROTRAUM, V16, P903, DOI 10.1089/neu.1999.16.903; Yakovlev AG, 1997, J NEUROSCI, V17, P7415	56	22	24	0	14	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	1567-2379	1567-2387		J MOL HISTOL	J. Mol. Histol.	FEB	2012	43	1					49	57		10.1007/s10735-011-9376-9			9	Cell Biology	Cell Biology	880AL	WOS:000299376400006	22124729				2021-06-18	
J	Wecht, JM; Rosado-Rivera, D; Jegede, A; Cirnigliaro, CM; Jensen, MA; Kirshblum, S; Bauman, WA				Wecht, Jill M.; Rosado-Rivera, Dwindally; Jegede, Adejoke; Cirnigliaro, Christopher M.; Jensen, Marley A.; Kirshblum, Steve; Bauman, William A.			Systemic and cerebral hemodynamics during cognitive testing	CLINICAL AUTONOMIC RESEARCH			English	Article						Paraplegia; Tetraplegia; Blood pressures; Transcranial Doppler ultrasound; Cerebral blood flow; Mental stimulation	SPINAL-CORD-INJURY; BLOOD-FLOW-VELOCITY; WHITE-MATTER HYPERINTENSITIES; CLOSED HEAD-INJURY; TRANSCRANIAL DOPPLER; ORTHOSTATIC HYPOTENSION; ARTERIAL STIFFNESS; MENTAL STRESS; PERFORMANCE; PRESSURE	Objective Cognitive deficits are reported in 10-60% of individuals with SCI, the primary etiology of these deficits is believed to be concomitant traumatic brain injury (TBI). We recently documented diminished memory and marginally deficient attention and processing speed in individuals with SCI discordant for hypotension but matched for TBI. Methods Twenty-nine individuals participated: 16 non-SCI controls, 6 paraplegic (T2-T10) and 7 tetraplegic (C4-C8). The Stroop test was used to measure cognitive function and transcranial Doppler ultrasound was used to measure cerebral blood flow (CBF) while resting (5 min) and continuously during cognitive testing. Mean arterial pressure (MAP) was calculated from three brachial blood pressures and cerebral vascular resistance index was calculated as: CVRi = MAP/CBF. Results The paraplegia group (54 +/- 6) was marginally older than the non-SCI (42 +/- 15; p = 0.06) and tetraplegic (42 +/- 11; p = 0.09) groups. Compared to non-SCI group, normalized t-score on the Stroop Color (SC) task was significantly lower in the paraplegic group (p < 0.05). In the tetraplegic group, MAP was significantly lower (p < 0.05) than the non-SCI and paraplegic groups, and related to SC t-score (r(2) = 0.873; p < 0.01). In the paraplegic group, CBF was reduced (p < 0.05) and CVRi increased (p < 0.05) compared to the non-SCI group, and CVRi was increased compared to the tetraplegic group (p < 0.05). A significant inverse relationship was noted between change in CVRi and SC t-score in the non-SCI group. Conclusion Asymptomatic hypotension relates to cognitive performance in persons with tetraplegia; therefore, BP normalization should be considered. The inappropriate cerebral vascular response to cognitive testing and poor test performance should be investigated in persons with paraplegia.	[Wecht, Jill M.; Rosado-Rivera, Dwindally; Jegede, Adejoke; Cirnigliaro, Christopher M.; Jensen, Marley A.; Bauman, William A.] James J Peters VA Med Ctr, Ctr Excellence Med Consequences Spinal Cord Injur, Bronx, NY 10468 USA; [Wecht, Jill M.; Bauman, William A.] James J Peters VAMC, Med Serv, Bronx, NY USA; [Wecht, Jill M.; Bauman, William A.] Mt Sinai Sch Med, Dept Med, New York, NY USA; [Wecht, Jill M.; Bauman, William A.] Mt Sinai Sch Med, Dept Rehabil Med, New York, NY USA; [Cirnigliaro, Christopher M.; Jensen, Marley A.; Kirshblum, Steve] Kessler Inst Rehabil, W Orange, NJ USA	Wecht, JM (corresponding author), James J Peters VA Med Ctr, Ctr Excellence Med Consequences Spinal Cord Injur, Rm 7A-13,130 W Kingsbridge Rd, Bronx, NY 10468 USA.	jm.wecht@va.gov			Veterans Affairs Rehabilitation Research and Development ServiceUS Department of Veterans Affairs [A6161W, B3203R, B4162C]; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA; NHS	This research was supported by the Veterans Affairs Rehabilitation Research and Development Service (grant no. A6161W, B3203R and B4162C).; We certify that no party having a direct interest in the results of the research supporting this article has or will confer a benefit on us or on any organization with which we are associated AND, if applicable, we certify that all financial and material support for this research (e. g., NIH or NHS grants) and work are clearly identified in the title page of the manuscript.	AASLID R, 1982, J NEUROSURG, V57, P769, DOI 10.3171/jns.1982.57.6.0769; Barbosa DF, 2010, ARQ BRAS CARDIOL, V94, P507, DOI 10.1590/S0066-782X2010005000006; BAUMAN WA, 1994, METABOLISM, V43, P749, DOI 10.1016/0026-0495(94)90126-0; Bauman WA, 1999, ASSIST TECHNOL, V11, P88, DOI 10.1080/10400435.1999.10131993; BAUMAN WA, 1993, ARCH PHYS MED REHAB, V74, P740, DOI 10.1016/0003-9993(93)90036-A; BAUMAN WA, 1994, ARCH PHYS MED REHAB, V75, P946; Bernardi L, 2000, J AM COLL CARDIOL, V35, P1462, DOI 10.1016/S0735-1097(00)00595-7; BISHOP CCR, 1986, STROKE, V17, P913, DOI 10.1161/01.STR.17.5.913; BROWN TE, 1993, J APPL PHYSIOL, V75, P2310; Carral JMC, 2007, GERONTOLOGY, V53, P340, DOI 10.1159/000104098; Chodzko-Zajko W J, 1994, Exerc Sport Sci Rev, V22, P195; Claydon VE, 2006, SPINAL CORD, V44, P341, DOI 10.1038/sj.sc.3101855; Claydon VE, 2006, J NEUROTRAUM, V23, P1713, DOI 10.1089/neu.2006.23.1713; Colcombe SJ, 2004, P NATL ACAD SCI USA, V101, P3316, DOI 10.1073/pnas.0400266101; DAVIDOFF G, 1988, ARCH PHYS MED REHAB, V69, P869; DAVIDOFF G, 1985, ARCH PHYS MED REHAB, V66, P489; Davidoff G, 1990, Arch Clin Neuropsychol, V5, P77, DOI 10.1016/0887-6177(90)90009-E; DAVIDOFF GN, 1992, ARCH PHYS MED REHAB, V73, P275; DAVIDOFF GN, 1990, ARCH PHYS MED REHAB, V71, P326; de Leeuw FE, 2000, STROKE, V31, P425, DOI 10.1161/01.STR.31.2.425; DEARWATER SR, 1986, MED SCI SPORT EXER, V18, P541; Dowler R N, 1995, Appl Neuropsychol, V2, P124, DOI 10.1207/s15324826an0203&4_4; Dowler RN, 1997, J INT NEUROPSYCH SOC, V3, P464, DOI 10.1017/S1355617797004645; DROSTE DW, 1989, NEUROPSYCHOLOGIA, V27, P1221, DOI 10.1016/0028-3932(89)90034-1; DROSTE DW, 1989, STROKE, V20, P1005, DOI 10.1161/01.STR.20.8.1005; Duschek S, 2005, BEHAV MED, V30, P149, DOI 10.3200/BMED.30.4.149-160; Duschek S, 2004, PSYCHOPHYSIOLOGY, V41, P905, DOI 10.1111/j.1469-8986.2004.00249.x; Duschek S, 2003, CLIN AUTON RES, V13, P427, DOI 10.1007/s10286-003-0124-4; Duschek S, 2007, CLIN AUTON RES, V17, P69, DOI 10.1007/s10286-006-0379-7; Duschek S, 2007, PSYCHOPHYSIOLOGY, V44, P145, DOI 10.1111/j.1469-8986.2006.00472.x; Duschek S, 2009, BIOL PSYCHOL, V81, P110, DOI 10.1016/j.biopsycho.2009.03.003; Duschek S, 2008, HYPERTENS RES, V31, P1873, DOI 10.1291/hypres.31.1873; Garde E, 2000, LANCET, V356, P628, DOI 10.1016/S0140-6736(00)02604-0; Handrakis JP, 2009, CLIN AUTON RES, V19, P39, DOI 10.1007/s10286-008-0496-6; HARDERS AG, 1989, INT J NEUROSCI, V47, P91, DOI 10.3109/00207458908987421; HILL RD, 1993, J GERONTOL, V48, pP12, DOI 10.1093/geronj/48.1.P12; Hoshikawa Y, 1997, AM J PHYSIOL-HEART C, V272, pH1113; Jegede AB, 2010, CLIN AUTON RES, V20, P3, DOI 10.1007/s10286-009-0036-z; Karlsson AK, 1998, BRAIN, V121, P1711, DOI 10.1093/brain/121.9.1711; Kearney-Schwartz A, 2009, STROKE, V40, P1229, DOI 10.1161/STROKEAHA.108.532853; Kramer AF, 1999, NATURE, V400, P418, DOI 10.1038/22682; Krassioukov A, 2006, PROG BRAIN RES, V152, P223, DOI 10.1016/S0079-6123(05)52014-4; Kuo HK, 2007, GERONTOLOGY, V53, P102, DOI 10.1159/000096792; LARSEN FS, 1994, STROKE, V25, P1985, DOI 10.1161/01.STR.25.10.1985; Moody M, 2005, AM J PHYSIOL-REG I, V288, pR1581, DOI 10.1152/ajpregu.00837.2004; Morris MC, 2002, NEUROEPIDEMIOLOGY, V21, P123, DOI 10.1159/000054809; Myers J, 2007, AM J PHYS MED REHAB, V86, P142, DOI 10.1097/PHM.0b013e31802f0247; Raji MA, 2004, ETHNIC DIS, V14, P26; RICHARDS JS, 1988, AM J PHYS MED REHAB, V67, P211, DOI 10.1097/00002060-198810000-00005; Rose KM, 2010, NEUROEPIDEMIOLOGY, V34, P1, DOI 10.1159/000255459; ROTH E, 1989, PARAPLEGIA, V27, P480, DOI 10.1038/sc.1989.75; Sorond FA, 2008, CORTEX, V44, P179, DOI 10.1016/j.cortex.2006.01.003; SPIRDUSO WW, 1980, J GERONTOL, V35, P850, DOI 10.1093/geronj/35.6.850; Stefani A, 2009, J NEUROL SCI, V283, P109, DOI 10.1016/j.jns.2009.02.343; Triantafyllidi H, 2009, AM J HYPERTENS, V22, P525, DOI 10.1038/ajh.2009.35; van Gijn J, 2000, LANCET, V356, P612, DOI 10.1016/S0140-6736(00)02599-X; Vingerhoets G, 1999, STROKE, V30, P2152, DOI 10.1161/01.STR.30.10.2152; Wecht JM, 2006, CLIN AUTON RES, V16, P378, DOI 10.1007/s10286-006-0367-y; Wecht JM, 2005, J SPINAL CORD MED, V28, P103, DOI 10.1080/10790268.2005.11753806; Wecht JM, 2004, J SPINAL CORD MED, V27, P255, DOI 10.1080/10790268.2004.11753757; Wecht JM, 2003, AM J PHYSIOL-HEART C, V284, pH2393, DOI 10.1152/ajpheart.01115.2002; WILMOT CB, 1985, ARCH PHYS MED REHAB, V66, P227, DOI 10.1016/0003-9993(85)90148-0; Winker R, 2010, WIEN KLIN WOCHENSCHR, V122, P704, DOI 10.1007/s00508-010-1485-z; Yaffe K, 2009, NEUROLOGY, V72, P2029, DOI 10.1212/WNL.0b013e3181a92c36; Zhang R, 2009, J PHYSIOL-LONDON, V587, P2567, DOI 10.1113/jphysiol.2008.168302; Zlomanczuk P, 2006, J PHYSIOL PHARMACOL, V57, P417	66	22	22	0	4	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0959-9851	1619-1560		CLIN AUTON RES	Clin. Auton. Res.	FEB	2012	22	1					25	33		10.1007/s10286-011-0139-1			9	Clinical Neurology; Neurosciences	Neurosciences & Neurology	899XE	WOS:000300849200004	21792728				2021-06-18	
J	Chen, ZY; Leung, LY; Mountney, A; Liao, ZL; Yang, WH; Lu, XCM; Dave, J; Deng-Bryant, Y; Wei, G; Schmid, K; Shear, DA; Tortella, FC				Chen, Zhiyong; Leung, Lai Yee; Mountney, Andrea; Liao, Zhilin; Yang, Weihong; Lu, Xi-Chun May; Dave, Jitendra; Deng-Bryant, Ying; Wei, Guo; Schmid, Kara; Shear, Deborah A.; Tortella, Frank C.			A Novel Animal Model of Closed-Head Concussive-Induced Mild Traumatic Brain Injury: Development, Implementation, and Characterization	JOURNAL OF NEUROTRAUMA			English	Article						biomarker; brain injury; closed-head injury; concussion; mild traumatic projectile concussive impact; motor function; rat helmet	PROFESSIONAL FOOTBALL; COGNITIVE DEFICITS; BIOMECHANICS; IMPACT	Closed-head concussive injury is one of the most common causes of traumatic brain injury (TBI). While single concussions result in short-term neurologic dysfunction, multiple concussions can result in cumulative damage and increased risk for neurodegenerative disease. Despite the prevalence of concussion, knowledge about what occurs in the brain following this injury is limited, in part due to the limited number of appropriate animal research models. To study clinically relevant concussion we recently developed a simple, non-invasive rodent model of closed-head projectile concussive impact (PCI) TBI. For this purpose, anesthetized rats were placed on a platform positioned above a torque-sealed microcentrifuge tube packed with fixed amounts of dry ice. Upon heating, rapid sublimation of the dry ice produced a build-up of compressed CO2 that triggered an eruptive force causing the cap to launch as an intact projectile, resulting in a targeted PCI head injury. A stainless steel helmet was implemented to protect the head from bruising, yet allowing the brain to sustain a mild PCI event. Depending on the injury location and the application of the helmet, PCI-induced injuries ranged from severe (i.e., head injury with subdural hematomas, intracranial hemorrhage, and brain tissue damage), to mild (no head injury, intracranial hemorrhage, or gross morphological pathology). Although no gross pathology was evident in mild PCI-induced injury, the following protein changes and behavioral abnormalities were detected between 1 and 24h after PCI injury: (1) upregulation of glial fibrillary acidic protein (GFAP) in hippocampal regions; (2) upregulation of ubiquitin carboxyl-terminal hydrolase L1 (UCHL-1) in cortical tissue; and (3) significant sensorimotor abnormalities. Overall, these results indicated that this PCI model was capable of replicating salient pathologies of a clinical concussion, and could generate reproducible and quantifiable outcome measures.	[Tortella, Frank C.] Walter Reed Army Inst Res, Ctr Mil Psychiat & Neurosci, Brain Trauma Neuroprotect & Neurorestorat Branch, Silver Spring, MD 20910 USA	Tortella, FC (corresponding author), Walter Reed Army Inst Res, Ctr Mil Psychiat & Neurosci, Brain Trauma Neuroprotect & Neurorestorat Branch, 503 Robert Grant Ave, Silver Spring, MD 20910 USA.	Frank.Tortella@AMEDD.ARMY.MIL	Leung, Lai Yee/H-8204-2013; Dave, Jitendra R/A-8940-2011; Shear, Deborah/B-3607-2011		U.S. Army Medical Research and Materiel CommandU.S. Army Medical Research & Materiel Command (USAMRMC)	This work was supported by core funding provided by the U.S. Army Medical Research and Materiel Command, Combat Casualty Care Research Program.	Armed Forces Health Surveillance Center, 2011, DOD WORLDW NUMB TRAU; Brophy GM, 2011, J NEUROTRAUM, V28, P861, DOI 10.1089/neu.2010.1564; BROWN IR, 1990, J NEUROSCI RES, V27, P247, DOI 10.1002/jnr.490270302; Cole JT, 2011, J NEUROTRAUM, V28, P359, DOI 10.1089/neu.2010.1427; Creed JA, 2011, J NEUROTRAUM, V28, P547, DOI 10.1089/neu.2010.1729; DIXON CE, 1994, J NEUROTRAUM, V11, P275, DOI 10.1089/neu.1994.11.275; Gao XA, 2011, J NEUROPATH EXP NEUR, V70, P183, DOI 10.1097/NEN.0b013e31820c6878; Gerberding J.L., 2003, REPORT C MILD TRAUMA; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Lee M, 2006, INT J IMPACT ENG, V33, P364, DOI 10.1016/j.ijimpeng.2006.09.075; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Martini DN, 2011, ARCH PHYS MED REHAB, V92, P585, DOI 10.1016/j.apmr.2010.11.029; Mondello S., 2011, CRITICAL CA IN PRESS; Owens BD, 2008, J TRAUMA, V64, P295, DOI 10.1097/TA.0b013e318163b875; Papa L., 2011, NAT NEUR S; Shear DA, 2010, J NEUROTRAUM, V27, P1911, DOI 10.1089/neu.2010.1399; Spain A, 2010, J NEUROTRAUM, V27, P1429, DOI 10.1089/neu.2010.1288; Statler KD, 2001, J NEUROTRAUM, V18, P1195, DOI 10.1089/089771501317095232; Tellier A, 2009, BRAIN INJURY, V23, P879, DOI 10.1080/02699050903200555; Viano DC, 2007, NEUROSURGERY, V61, P313, DOI 10.1227/01.NEU.0000279969.02685.D0; Viano DC, 2005, NEUROSURGERY, V57, P1154, DOI 10.1227/01.NEU.0000187541.87937.D9	21	22	22	1	13	MARY ANN LIEBERT INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151			J NEUROTRAUM	J. Neurotrauma	JAN 20	2012	29	2					268	280		10.1089/neu.2011.2057			13	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	885SO	WOS:000299801300007	21988140				2021-06-18	
J	Navarro, JC; Pillai, S; Cherian, L; Garcia, R; Grill, RJ; Robertson, CS				Navarro, Jovany Cruz; Pillai, Shibu; Cherian, Leela; Garcia, Robert; Grill, Raymond J.; Robertson, Claudia S.			Histopathological and Behavioral Effects of Immediate and Delayed Hemorrhagic Shock after Mild Traumatic Brain Injury in Rats	JOURNAL OF NEUROTRAUMA			English	Article						cerebral ischemia; hypotension; mild traumatic brain injury; shock	CORTICAL IMPACT INJURY; RANDOMIZED CONTROLLED-TRIAL; CEREBRAL-BLOOD-FLOW; HEAD TRAUMA; FLUID RESUSCITATION; SECONDARY INSULT; PROGNOSTIC VALUE; HYPOTENSION; PRESSURE; MODEL	The purpose of this study was to investigate the increased susceptibility of the brain, after a controlled mild cortical impact injury, to a secondary ischemic insult. The effects of the duration and the timing of the secondary insult after the initial cortical injury were studied. Rats anesthetized with isoflurane underwent a 3 m/sec, 2.5-mm deformation cortical impact injury followed by hypotension to 40 mm Hg induced by withdrawing blood from a femoral vein. The duration of hypotension was varied from 40 to 60 mm. The timing of 60 min of hypotension was varied from immediately post-injury to 7 days after the injury. Outcome was assessed by behavioral tasks and histological examination at 2 weeks post-injury. A separate group of animals underwent measurement of the acute physiology including mean blood pressure (MAP), intracranial pressure (ICP), and cerebral blood flow (CBF) using a laser Doppler technique. Increasing durations of hypotension resulted in marked expansion of the contusion, from 6.5 +/- 1.8 mm(3) with sham hypotension to 27.1 +/- 3.9 mm(3) with 60 min of hypotension. This worsening of the contusion was found only when then hypotension occurred immediately after injury or at 1 h after injury. CA3 neuron loss followed a similar pattern, but the injury group differences were not significant. Motor tasks, including beam balance and beam walking, were significantly worse following 50 and 60 min of hypotension. Performance on the Morris water maze task was also significantly related to the injury group. Studies of the acute cerebral hemodynamics demonstrated that CBF was significantly more impaired during hypotension in the animals that underwent the mild TBI compared to those that underwent sham TBI. The perfusion deficit was worst at the impact site, but also significant in the pericontusional brain. With 50 and 60 min of hypotension, CBF did not recover following resuscitation at the impact site, and recovered only transiently in the pericontusional brain. These results demonstrate that mild TBI, like more severe levels of TBI, can impair the brain's ability to maintain CBF during a period of hypotension, and result in a worse outcome.	[Navarro, Jovany Cruz; Pillai, Shibu; Cherian, Leela; Garcia, Robert; Robertson, Claudia S.] Baylor Coll Med, Dept Neurosurg, Houston, TX 77030 USA; [Grill, Raymond J.] Univ Texas Hlth Sci Ctr Houston, Dept Integrat Biol & Pharmacol, Houston, TX USA	Robertson, CS (corresponding author), Baylor Coll Med, Dept Neurosurg, 1 Baylor Plaza, Houston, TX 77030 USA.	claudiar@bcm.edu			United States ArmyUnited States Department of Defense [W81XWH-08-2-0132, W81XWH-08-20-150]	This work was funded by United States Army Award numbers W81XWH-08-2-0132 (C.S.R.) and W81XWH-08-20150 (R.J.G.).	Abdel-Dayem HM, 1998, CLIN NUCL MED, V23, P309, DOI 10.1097/00003072-199805000-00009; Ahn ES, 2008, J NEUROSURG, V108, P124, DOI 10.3171/JNS/2008/108/01/0124; Audenaert Kurt, 2003, Med Sci Monit, V9, pMT112; Baker AJ, 2008, J TRAUMA, V64, P348, DOI 10.1097/01.ta.0000245973.71929.db; Bulger EM, 2011, ANN SURG, V253, P431, DOI 10.1097/SLA.0b013e3181fcdb22; Bulger EM, 2010, JAMA-J AM MED ASSOC, V304, P1455, DOI 10.1001/jama.2010.1405; Butcher I, 2007, J NEUROTRAUM, V24, P294, DOI 10.1089/neu.2006.0032; Carrillo P, 1998, J TRAUMA, V45, P239, DOI 10.1097/00005373-199808000-00007; Cherian L, 1996, J NEUROTRAUM, V13, P371, DOI 10.1089/neu.1996.13.371; CHERIAN L, 1994, J NEUROTRAUM, V11, P573, DOI 10.1089/neu.1994.11.573; CHESNUT RM, 1993, ACTA NEUROCHIR, P121; Cooper DJ, 2004, JAMA-J AM MED ASSOC, V291, P1350, DOI 10.1001/jama.291.11.1350; Dennis AM, 2009, J NEUROTRAUM, V26, P889, DOI 10.1089/neu.2008.0512; DEWITT DS, 1992, J NEUROSURG, V76, P812, DOI 10.3171/jns.1992.76.5.0812; DEWITT DS, 1992, AM J PHYSIOL, V263, pH1276; Exo JL, 2009, J NEUROTRAUM, V26, P2403, DOI 10.1089/neu.2009.0980; Feldman Z, 1997, J TRAUMA, V43, P667, DOI 10.1097/00005373-199710000-00017; Fritz HG, 2005, J NEUROTRAUM, V22, P807, DOI 10.1089/neu.2005.22.807; Geeraerts T, 2008, INTENS CARE MED, V34, P551, DOI 10.1007/s00134-007-0863-0; Giri BK, 2000, STROKE, V31, P961, DOI 10.1161/01.STR.31.4.961; Golding EM, 1998, J NEUROTRAUM, V15, P973, DOI 10.1089/neu.1998.15.973; GOODMAN JC, 1994, J NEUROTRAUM, V11, P587, DOI 10.1089/neu.1994.11.587; Gowda NK, 2006, AM J NEURORADIOL, V27, P447; Henninger N, 2005, EXP NEUROL, V195, P447, DOI 10.1016/j.expneurol.2005.06.013; Hlatky R, 2002, J NEUROSURG, V97, P1054, DOI 10.3171/jns.2002.97.5.1054; Hosseini AH, 2009, MED SCI SPORT EXER, V41, P1687, DOI 10.1249/MSS.0b013e31819fcd1b; Junger EC, 1997, J NEUROSURG, V86, P425, DOI 10.3171/jns.1997.86.3.0425; Kroppenstedt SN, 1999, J NEUROSURG, V90, P520, DOI 10.3171/jns.1999.90.3.0520; Lorberboym M, 2002, AM J EMERG MED, V20, P310, DOI 10.1053/ajem.2002.34201; MARMAROU A, 1991, J NEUROSURG, V75, pS59, DOI 10.3171/sup.1991.75.1s.0s59; Mathew BP, 1999, J NEUROTRAUM, V16, P1177, DOI 10.1089/neu.1999.16.1177; Matsushita Y, 2001, J CEREBR BLOOD F MET, V21, P847, DOI 10.1097/00004647-200107000-00010; Meier J, 2004, SHOCK, V22, P240, DOI 10.1097/01.shk.0000131192.02909.4c; Metting Z, 2009, ANN NEUROL, V66, P809, DOI 10.1002/ana.21785; Miller J D, 1982, J R Coll Surg Edinb, V27, P292; MILLER JD, 1978, JAMA-J AM MED ASSOC, V240, P439, DOI 10.1001/jama.240.5.439; MOREHEAD M, 1994, J NEUROTRAUM, V11, P657, DOI 10.1089/neu.1994.11.657; Myburgh J, 2007, NEW ENGL J MED, V357, P874; Nariai T, 2001, J NEUROTRAUM, V18, P1323, DOI 10.1089/08977150152725623; O'Connor WT, 2011, PHARMACOL THERAPEUT, V130, P106, DOI 10.1016/j.pharmthera.2011.01.001; Paul M, 2010, TRAUMATIC BRAIN INJU; Schmidt RH, 2000, J NEUROTRAUM, V17, P1129, DOI 10.1089/neu.2000.17.1129; Schutz C, 2006, CRIT CARE MED, V34, P492, DOI 10.1097/01.CCM.0000198326.32049.7F; Sell SL, 2008, ANESTHESIOLOGY, V108, P873, DOI 10.1097/ALN.0b013e31816c8a15; Statler KD, 2000, CRIT CARE MED, V28, pA53	45	22	24	0	6	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JAN 20	2012	29	2					322	334		10.1089/neu.2011.1979			13	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	885SO	WOS:000299801300011	22077317				2021-06-18	
J	Sarntinoranont, M; Lee, SJ; Hong, Y; King, MA; Subhash, G; Kwon, J; Moore, DF				Sarntinoranont, Malisa; Lee, Sung J.; Hong, Yu; King, Michael A.; Subhash, Ghatu; Kwon, Jiwoon; Moore, David F.			High-Strain-Rate Brain Injury Model Using Submerged Acute Rat Brain Tissue Slices	JOURNAL OF NEUROTRAUMA			English	Article						acute brain slice model; digital image correlation; high-strain-rate loading; hippocampal injury	FLUORO-JADE-C; MECHANICAL STRETCH; NEURONS; CARE	Blast-induced traumatic brain injury (bTBI) has received increasing attention in recent years due to ongoing military operations in Iraq and Afghanistan. Sudden impacts or explosive blasts generate stress and pressure waves that propagate at high velocities and affect sensitive neurological tissues. The immediate soft tissue response to these stress waves is difficult to assess using current in vivo imaging technologies. However, these stress waves and resultant stretching and shearing of tissue within the nano- to microsecond time scale of blast and impact are likely to cause initial injury. To visualize the effects of stress wave loading, we have developed a new ex vivo model in which living tissue slices from rat brain, attached to a ballistic gelatin substrate, were subjected to high-strain-rate loads using a polymer split Hopkinson pressure bar (PSHPB) with real-time highspeed imaging. In this study, average peak fluid pressure within the test chamber reached a value of 1584 +/- 63.3 psi. Cavitation due to a trailing underpressure wave was also observed. Time-resolved images of tissue deformation were collected and large maximum eigenstrains (0.03-0.42), minimum eigenstrains (-0.33 to -0.03), maximum shear strains (0.09-0.45), and strain rates (8.4x10(3)/sec) were estimated using digital image correlation (DIC). Injury at 4 and 6 h was quantified using Fluoro-Jade C. Neuronal injury due to PSHPB testing was found to be significantly greater than injury associated with the tissue slice paradigm alone. While large pressures and strains were encountered for these tests, this system provides a controllable test environment to study injury to submerged brain slices over a range of strain rate, pressure, and strain loads.	[Sarntinoranont, Malisa; Lee, Sung J.; Hong, Yu; Subhash, Ghatu; Kwon, Jiwoon] Univ Florida, Dept Mech & Aerosp Engn, Gainesville, FL 32611 USA; [King, Michael A.] Univ Florida, Dept Pharmacol & Therapeut, Gainesville, FL 32611 USA; [King, Michael A.] Malcolm Randall VA Med Ctr, Gainesville, FL USA; [Moore, David F.] Tulane Univ, Sch Med, Dept Neurol, New Orleans, LA 70112 USA	Subhash, G (corresponding author), Univ Florida, Dept Mech & Aerosp Engn, 129 NEB,POB 116250, Gainesville, FL 32611 USA.	subhash@ufl.edu	Subhash, Ghatu/J-4851-2017	Subhash, Ghatu/0000-0002-5996-0909	Army Research Office [W911NF-10-1-0276]	The authors would like to thank Dr. Stephen Blackband for kindly allowing us to use his laboratory facilities for animal surgery, and Dr. Jeremy Flint for providing guidance for brain slice experiments. The authors would like to thank Drs. Stan Svetlov and Bruce LaMattina for helpful discussions on bTBI. This research was funded in part by the Army Research Office (award number W911NF-10-1-0276).	Bauman RA, 2009, J NEUROTRAUM, V26, P841, DOI 10.1089/neu.2009-0898; Bian GL, 2007, BRAIN RES, V1150, P55, DOI 10.1016/j.brainres.2007.02.078; Cernak I, 2001, J TRAUMA, V50, P695, DOI 10.1097/00005373-200104000-00017; Chen YC, 2009, J NEUROTRAUM, V26, P861, DOI 10.1089/neu.2008.0645; Elkin BS, 2007, J NEUROTRAUM, V24, P812, DOI 10.1089/neu.2006.0169; Geddes DM, 2003, J NEUROTRAUM, V20, P1039, DOI 10.1089/089771503770195885; Jaffee MS, 2009, J REHABIL RES DEV, V46, P655, DOI 10.1682/JRRD.2008.09.0114; Kwon J, 2010, J BIOMECH, V43, P420, DOI 10.1016/j.jbiomech.2009.10.008; Langlois JA, 2006, TRAUMATIC BRAIN INJU; Lauret C, 2009, MED ENG PHYS, V31, P392, DOI 10.1016/j.medengphy.2008.05.004; Lee SJ, 2011, J BIOMED MATER RES B, V97B, P84, DOI 10.1002/jbm.b.31789; Liu QL, 2006, MECH MATER, V38, P1105, DOI 10.1016/j.mechmat.2006.01.001; Long JB, 2009, J NEUROTRAUM, V26, P827, DOI 10.1089/neu.2008.0748; Meythaler JM, 2001, ARCH PHYS MED REHAB, V82, P1461, DOI 10.1053/apmr.2001.25137; Miller DL, 2007, PROG BIOPHYS MOL BIO, V93, P314, DOI 10.1016/j.pbiomolbio.2006.07.027; Moore DF, 2009, NEUROIMAGE, V47, pT10, DOI 10.1016/j.neuroimage.2009.02.019; Morales DM, 2005, NEUROSCIENCE, V136, P971, DOI 10.1016/j.neuroscience.2005.08.030; Morrison B, 2000, J BIOMECH ENG-T ASME, V122, P224, DOI 10.1115/1.429650; Nishimura N, 2006, NAT METHODS, V3, P99, DOI 10.1038/NMETH844; Nyein MK, 2010, P NATL ACAD SCI USA, V107, P20703, DOI 10.1073/pnas.1014786107; Pan B, 2009, MEAS SCI TECHNOL, V20, DOI 10.1088/0957-0233/20/6/062001; RUAN JS, 1991, J BIOMECH ENG-T ASME, V113, P276, DOI 10.1115/1.2894885; Schmued LC, 2005, BRAIN RES, V1035, P24, DOI 10.1016/j.brainres.2004.11.054; Schmued LC, 1997, BRAIN RES, V751, P37, DOI 10.1016/S0006-8993(96)01387-X; Smith DH, 1999, J NEUROSCI, V19, P4263; Subhash G, 2006, INT J IMPACT ENG, V32, P1113, DOI 10.1016/j.ijimpeng.2004.11.006; Subhash G., 2000, ASM HDB MECH TESTING, V8, P519; Subhash G., 2000, MECH TEST EVAL, P497, DOI [10.31399/asm.hb.v08, DOI 10.31399/ASM.HB.V08]; Taylor PA, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3118765; Vogel A, 2005, APPL PHYS B-LASERS O, V81, P1015, DOI 10.1007/s00340-005-2036-6; Yanik MF, 2004, NATURE, V432, P822, DOI 10.1038/432822a; Zhang LY, 2004, J BIOMECH ENG-T ASME, V126, P226, DOI 10.1115/1.1691446	32	22	22	0	30	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JAN 20	2012	29	2					418	429		10.1089/neu.2011.1772			12	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	885SO	WOS:000299801300021	21970544				2021-06-18	
J	Belwadi, A; Siegel, JH; Singh, A; Smith, JA; Yang, KH; King, AI				Belwadi, Aditya; Siegel, John H.; Singh, Aadarsh; Smith, Joyce A.; Yang, King H.; King, Albert I.			Finite Element Aortic Injury Reconstruction of Near Side Lateral Impacts Using Real World Crash Data	JOURNAL OF BIOMECHANICAL ENGINEERING-TRANSACTIONS OF THE ASME			English	Article						aortic injury; CIREN; accident reconstruction; finite element; isthmus; strain; failure; biomechanics	MOTOR-VEHICLE CRASHES; TRAUMATIC RUPTURE; FAILURE PROPERTIES; MECHANISM; TISSUE	Traumatic rupture of the aorta (TRA) remains the second most common cause of death associated with motor vehicle crashes, only less prevalent than brain injury. On average, nearly 8000 people die annually in the United States due to blunt injury to the aorta. It is observed that over 80% of occupants who suffer an aortic injury die at the scene due to exsanguination into the chest cavity. In the current study, eight near side lateral impacts, in which TRA occurred, were reconstructed using a combination of real world crash data reported in the Crash Injury Research and Engineering Network (CIREN) database, finite element (FE) models of vehicles, and the Wayne State Human Body Model - II (WSHBM). For the eight CIREN cases reconstructed, the high strain regions in the aorta closely matched with the autopsy data provided. The peak average maximum principal strains in all of the eight CIREN cases were localized in the isthmus region of the aorta, distal to the left subclavian artery, and averaged at 22+/-6.2% while the average maximum pressure in the aorta was found to be 117+/-14.7 kPa. [DOI: 10.1115/1.4005684]	[Belwadi, Aditya; Singh, Aadarsh; Yang, King H.; King, Albert I.] Wayne State Univ, Detroit, MI 48201 USA; [Siegel, John H.; Smith, Joyce A.] New Jersey Med Sch UMDNJ, Newark, NJ 07101 USA; [Smith, Joyce A.] Univ Rochester, Med Ctr, Sch Nursing, Rochester, NY 14627 USA	Belwadi, A (corresponding author), Wayne State Univ, Detroit, MI 48201 USA.	adityabn@gmail.com; Jhsiegelmd@aol.com; aadarshdeep@gmail.com; JoyceA_Smith@urmc.rochester.edu; king.yang@wayne.edu; albert.king@wayne.edu			Southern Consortium for Injury Biomechanics (SCIB); Drs. Anthony and Kales scholarship	The authors are grateful to the Southern Consortium for Injury Biomechanics (SCIB) for funding the project. The authors would also like to thank ESTECO North America for providing mode-FRONTIER 4.0. The primary author was supported by the 2009 Drs. Anthony and Kales scholarship.	[Anonymous], 1980, J224 SAE; Augenstein J. S., 1997, SOC AUTOMOT ENG SPEC; Bass C R, 2001, Stapp Car Crash J, V45, P143; Bertrand S, 2008, TRAFFIC INJ PREV, V9, P153, DOI 10.1080/15389580701775777; Bonnet LM, 1903, REV MED, V23, P108; Burkhart HM, 2001, J TRAUMA, V50, P113, DOI 10.1097/00005373-200101000-00020; Demetriades D, 2008, J TRAUMA, V64, P1415, DOI 10.1097/TA.0b013e3181715e32; Franklyn Melanie, 2003, Traffic Inj Prev, V4, P263, DOI 10.1080/15389580309883; Fung Y., 1993, BIOMECHANICS MECH PR; Guan F., 2009, P IMECE2009 ASME INT; Hardy WN, 2008, STAPP CAR C, V52, P233; Huang Y., 1994, STAPP CAR CRASH J, P35; Iwamoto M, 2000, Stapp Car Crash J, V44, P281; IWAMOTO M, 2002, P IRCOBI C, P31; Katyal D, 1997, J TRAUMA, V42, P769, DOI 10.1097/00005373-199705000-00002; Kroell C. K., 1974, P 18 STAPP CAR CRASH, P383; Lee J B, 2001, Stapp Car Crash J, V45, P79; LIZEE E, 1998, P 42 STAPP CAR CRASH, P115; LUNDEVALL J, 1964, ACTA PATHOL MIC SC, V62, P34, DOI 10.1111/apm.1964.62.1.34; MOHAN D, 1983, J BIOMECH, V16, P31, DOI 10.1016/0021-9290(83)90044-1; MOHAN D, 1982, J BIOMECH, V15, P887, DOI 10.1016/0021-9290(82)90055-0; Niehoff P., 2006, ANN P ASS ADV AUTOMO, V50, P1540; Oppenheim F., 1918, GIBT SPONTANE RUPTUR, P1234; Pesola GR, 2001, AM J EMERG MED, V19, P43, DOI 10.1053/ajem.2001.20021; Plank G.R., 1991, 13 INT TECHN C EXP S, P902; ROBERTS SB, 1970, J BIOMECH, V3, P527, DOI 10.1016/0021-9290(70)90037-0; SAUAIA A, 1995, J TRAUMA, V38, P185, DOI 10.1097/00005373-199502000-00006; Schneider LW, 1983, UMTRI83532 NHTSA, V2; Shah C, 2007, THESIS WAYNE STATE U; Shah C S, 2001, Stapp Car Crash J, V45, P161; Shah C. S., 2005, OCC SAF SAF CRIT SYS; Shah C.S., 2007, P 2007 INT RES COUNC, P349; Shah Chirag S, 2006, Stapp Car Crash J, V50, P217; Siegel JH, 2004, J TRAUMA, V57, P760, DOI 10.1097/01.TA.0000147502.50248.C4; Siegel JH, 2010, J TRAUMA, V68, P1375, DOI 10.1097/TA.0b013e3181dcd42d; SMITH RS, 1986, AM J SURG, V152, P660, DOI 10.1016/0002-9610(86)90444-7; SUNDARAM SH, 1977, J BIOMECH, V10, P505, DOI 10.1016/0021-9290(77)90104-X; Viano D. C., 1989, STAPP CAR CRASH J, P113; Viano D. C., 1983, P 27 STAPP CAR CRASH, P109; Wang K, 1995, THESIS WAYNE STATE U; ZEHNDER M A, 1960, Thoraxchirurgie, V8, P47	41	22	23	0	16	ASME	NEW YORK	TWO PARK AVE, NEW YORK, NY 10016-5990 USA	0148-0731	1528-8951		J BIOMECH ENG-T ASME	J. Biomech. Eng.-Trans. ASME	JAN	2012	134	1							011006	10.1115/1.4005684			10	Biophysics; Engineering, Biomedical	Biophysics; Engineering	922XO	WOS:000302582100006	22482661				2021-06-18	
J	Crane, AT; Fink, KD; Smith, JS				Crane, Andrew T.; Fink, Kyle D.; Smith, Jeffrey S.			The effects of acute voluntary wheel running on recovery of function following medial frontal cortical contusions in rats	RESTORATIVE NEUROLOGY AND NEUROSCIENCE			English	Article						Traumatic brain injury; physiotherapy; executive function	TRAUMATIC BRAIN-INJURY; INHIBITORY CONTROL; EXERCISE; PLASTICITY; MOTOR; ENRICHMENT; LESIONS; CORTEX	Purpose: Traumatic brain injury (TBI) produces significant deficits in executive function, sensory-motor function, and on spatial learning tasks. We wish to study if recovery from TBI can be benefited by voluntary exercise. Methods: A variation of the stop-signal reaction time (SSRT) task was employed to measure rats ability to obtain maximum reinforcers in a complex behavioral task. A 2x2 (lesion x treatment) experimental design was constructed with 31 weight restricted male Long-Evans rats which received either bilateral cortical contusions to the medial frontal cortex or sham preparations following the acquisition of the SSRT task (matched based on pre-surgical performance). Following surgery, rats were randomly assigned to either an environment with free access to running wheels or traditional single housing without running wheels. Results: Rats receiving a bilateral TBI performed significantly worse than sham operated rats on a complex task. Contrary to our original hypothesis, acute exercise following injury exacerbated the deficits in the complex task that did not return to levels of the injured rats without access to running wheels until post-TBI day 13. Conclusion: We found a significant interaction between severe bilateral TBI and the introduction of voluntary exercise immediately post-injury. In this paradigm, voluntary wheel running exacerbated the TBI-induced deficit, rather than reducing it.	[Smith, Jeffrey S.] Saginaw Valley State Univ, Malcolm & Lois Field Endowed Chair Hlth Sci, Dept Hlth Sci, Crystal M Lange Coll Hlth & Human Serv, University Ctr, MI 48710 USA; [Crane, Andrew T.; Fink, Kyle D.] Cent Michigan Univ, Neurosci Grad Program, Mt Pleasant, MI USA	Smith, JS (corresponding author), Saginaw Valley State Univ, Malcolm & Lois Field Endowed Chair Hlth Sci, Dept Hlth Sci, Crystal M Lange Coll Hlth & Human Serv, 7400 Bay Rd, University Ctr, MI 48710 USA.	jsmith12@svsu.edu		Crane, Andrew/0000-0003-3452-2766; Smith, Jeffrey/0000-0001-5499-4475	Support of Mentors and their Students (SOMAS) program; M.J. Murdock Charitable Trust; National Science Foundation (NSF)National Science Foundation (NSF) [0633459]	This work was supported by funding from the Support of Mentors and their Students (SOMAS) program, the M.J. Murdock Charitable Trust, and the National Science Foundation (NSF award #0633459 to JSS, 2008). The authors would like to thank the students of the 2008 Principle and Procedures in Neuroscience class. ATC and KDF both provided the same amount of effort on this manuscript and therefore both deserve to share co-first authorship.	Anderson BJ, 2000, PHYSIOL BEHAV, V70, P425, DOI 10.1016/S0031-9384(00)00282-1; Anderson BJ, 2002, LEARN MEMORY, V9, P1, DOI 10.1101/lm.43402; Chytrova G, 2008, EUR J NEUROSCI, V27, P1, DOI 10.1111/j.1460-9568.2007.05982.x; Cole JT, 2011, J NEUROTRAUM, V28, P359, DOI 10.1089/neu.2010.1427; Dalley JW, 2004, NEUROSCI BIOBEHAV R, V28, P771, DOI 10.1016/j.neubiorev.2004.09.006; Eagle DM, 2003, BEHAV BRAIN RES, V146, P131, DOI 10.1016/j.bbr.2003.09.022; Eagle DM, 2003, BEHAV NEUROSCI, V117, P1302, DOI 10.1037/0735-7044.117.6.1302; ETNIER JL, 1995, SPORTS MED, V19, P81, DOI 10.2165/00007256-199519020-00001; Faul M.D., 2010, TRAUMATIC BRAIN INJU; Floyd CL, 2007, PROG BRAIN RES, V161, P61, DOI 10.1016/S0079-6123(06)61005-4; Fujimoto ST, 2004, NEUROSCI BIOBEHAV R, V28, P365, DOI 10.1016/j.neubiorev.2004.06.002; Griesbach GS, 2007, J NEUROTRAUM, V24, P1161, DOI 10.1089/neu.2006.0255; Griesbach GS, 2004, BRAIN RES, V1016, P154, DOI 10.1016/j.brainres.2004.04.079; Hall ED, 2008, J NEUROTRAUM, V25, P235, DOI 10.1089/neu.2007.0383; Hicks RR, 1998, RESTOR NEUROL NEUROS, V12, P41; HOFFMAN SW, 1994, J NEUROTRAUM, V11, P417, DOI 10.1089/neu.1994.11.417; Kleim JA, 2003, NEUROCHEM RES, V28, P1757, DOI 10.1023/A:1026025408742; KOLB B, 1983, CAN J PSYCHOL, V37, P211, DOI 10.1037/h0080724; Marin R, 2003, PHYSIOL BEHAV, V80, P167, DOI 10.1016/j.physbeh.2003.06.001; Oyesiku NM, 1999, BRAIN RES, V833, P161, DOI 10.1016/S0006-8993(99)01501-2; Ploughman M, 2007, BRAIN RES, V1150, P207, DOI 10.1016/j.brainres.2007.02.065; Smith JS, 2000, NEURAL PLAST, V7, P73, DOI 10.1155/NP.2000.73; Stein DG, 2003, J HEAD TRAUMA REHAB, V18, P317, DOI 10.1097/00001199-200307000-00004; Urrea C, 2007, RESTOR NEUROL NEUROS, V25, P65; Vaynman S, 2004, J NEUROSCI RES, V76, P356, DOI 10.1002/jnr.20077; Vaynman S, 2003, NEUROSCIENCE, V122, P647, DOI 10.1016/j.neuroscience.2003.08.001; Will B, 2004, PROG NEUROBIOL, V72, P167, DOI 10.1016/j.pneurobio.2004.03.001	27	22	23	0	10	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	0922-6028	1878-3627		RESTOR NEUROL NEUROS	Restor. Neurol. Neurosci.		2012	30	4					325	333		10.3233/RNN-2012-120232			9	Neurosciences	Neurosciences & Neurology	973OA	WOS:000306368300006	22596352				2021-06-18	
J	Donovan, V; Bianchi, A; Hartman, R; Bhanu, B; Carson, MJ; Obenaus, A				Donovan, Virginia; Bianchi, Anthony; Hartman, Richard; Bhanu, Bir; Carson, Monica J.; Obenaus, Andre			Computational analysis reveals increased blood deposition following repeated mild traumatic brain injury	NEUROIMAGE-CLINICAL			English	Article						Edema; Hemorrhagic progression; Histogram; T2; Quantitative magnetic resonance imaging		Mild traumatic brain injury (mTBI) has become an increasing public health concern as subsequent injuries can exacerbate existing neuropathology and result in neurological deficits. This study investigated the temporal development of cortical lesions using magnetic resonance imaging (MRI) to assess two mTBIs delivered to opposite cortical hemispheres. The controlled cortical impact model was used to produce an initial mTBI on the right cortex followed by a second injury induced on the left cortex at 3 (rmTBI 3d) or 7 (rmTBI 7d) days later. Histogram analysis was combined with a novel semi-automated computational approach to perform a voxel-wise examination of extravascular blood and edema volumes within the lesion. Examination of lesion volume 1d post last injury revealed increased tissue abnormalities within rmTBI 7d animals compared to other groups, particularly at the site of the second impact. Histogram analysis of lesion T2 values suggested increased edematous tissue within the rmTBI 3d group and elevated blood deposition in the rm TBI 7d animals. Further quantification of lesion composition for blood and edema containing voxels supported our histogram findings, with increased edema at the site of second impact in rmTBI 3d animals and elevated blood deposition in the rmTBI 7d group at the site of the first injury. Histological measurements revealed spatial overlap of regions containing blood deposition and microglial activation within the cortices of all animals. In conclusion, our findings suggest that there is a window of tissue vulnerability where a second distant mTBI, induced 7d after an initial injury, exacerbates tissue abnormalities consistent with hemorrhagic progression. (C) 2012 The Authors. Published by Elsevier Inc. Open access under CC BY-NC-ND license.	[Donovan, Virginia; Carson, Monica J.; Obenaus, Andre] Univ Calif Riverside, Cell Mol & Dev Biol Program, Riverside, CA 92521 USA; [Donovan, Virginia; Carson, Monica J.; Obenaus, Andre] Univ Calif Riverside, Sch Med, Ctr Glial Neuronal Interact, Riverside, CA 92521 USA; [Bianchi, Anthony; Bhanu, Bir] Univ Calif Riverside, Ctr Res Intelligent Syst, Riverside, CA 92521 USA; [Hartman, Richard] Loma Linda Univ, Dept Psychol, Loma Linda, CA 92354 USA; [Carson, Monica J.] Univ Calif Riverside, Div Biomed Sci, Riverside, CA 92521 USA; [Obenaus, Andre] Loma Linda Univ, Dept Pediat, Loma Linda, CA 92354 USA	Obenaus, A (corresponding author), Loma Linda Univ, Dept Pediat, 11175 Campus St,Rm A1120, Loma Linda, CA 92354 USA.	aobenaus@llu.edu		Bhanu, Bir/0000-0001-8971-6416	Department of Defense (DCMRP) [DR080470]; National Science Foundation Integrative Graduate Education and Research Traineeship (IGERT)National Science Foundation (NSF) [DGE 0903667]	This study was supported by funding from Department of Defense (DCMRP #DR080470 to AO) and in part by National Science Foundation Integrative Graduate Education and Research Traineeship (IGERT) in Video Bioinformatics (DGE 0903667 to VD, AB and BB).	Alahmadi H, 2010, J NEUROSURG, V112, P1139, DOI 10.3171/2009.5.JNS081369; Belanger HG, 2010, J INT NEUROPSYCH SOC, V16, P262, DOI 10.1017/S1355617709991287; Belayev L, 2007, BRAIN RES, V1157, P146, DOI 10.1016/j.brainres.2007.04.077; Benson RR, 2007, J NEUROTRAUM, V24, P446, DOI 10.1089/neu.2006.0153; BOJE KM, 1992, BRAIN RES, V587, P250, DOI 10.1016/0006-8993(92)91004-X; Chang EF, 2006, NEUROSURGERY, V58, P647, DOI 10.1227/01.NEU.0000197101.68538.E6; Colgan NC, 2010, J NEUROTRAUM, V27, P1265, DOI 10.1089/neu.2009.1267; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; de la Plata CDM, 2011, J INT NEUROPSYCH SOC, V17, P24, DOI 10.1017/S1355617710001189; DeFord SM, 2002, J NEUROTRAUM, V19, P427, DOI 10.1089/08977150252932389; del Zoppo GJ, 2012, J CEREBR BLOOD F MET, V32, P919, DOI 10.1038/jcbfm.2012.11; Ding JY, 2009, BRAIN RES, V1268, P125, DOI 10.1016/j.brainres.2009.02.060; Emblem KE, 2008, AM J NEURORADIOL, V29, P1664, DOI 10.3174/ajnr.A1182; Faul M.D., 2010, TRAUMATIC BRAIN INJU; Fukuda S, 2004, STROKE, V35, P998, DOI 10.1161/01.STR.0000119383.76447.05; Gerzanich V, 2009, NAT MED, V15, P185, DOI 10.1038/nm.1899; Gidday JM, 2005, AM J PHYSIOL-HEART C, V289, pH558, DOI 10.1152/ajpheart.01275.2004; Gong C, 2000, BRAIN RES, V871, P57, DOI 10.1016/S0006-8993(00)02427-6; Gupta RK, 2012, NEURORADIOLOGY, V54, P565, DOI 10.1007/s00234-011-0952-1; HAMANN GF, 1995, STROKE, V26, P2120, DOI 10.1161/01.STR.26.11.2120; Hayashi T, 2009, BRAIN RES, V1280, P172, DOI 10.1016/j.brainres.2009.05.040; Homsi S, 2009, BRAIN RES, V1291, P122, DOI 10.1016/j.brainres.2009.07.031; Immonen RJ, 2009, NEUROIMAGE, V45, P1, DOI 10.1016/j.neuroimage.2008.11.022; Inglese M, 2005, J NEUROSURG, V103, P298, DOI 10.3171/jns.2005.103.2.0298; Irimia A, 2011, J NEUROTRAUM, V28, P2287, DOI 10.1089/neu.2011.1920; Kane MJ, 2012, J NEUROSCI METH, V203, P41, DOI 10.1016/j.jneumeth.2011.09.003; Kharatishvili I, 2009, EXP NEUROL, V217, P154, DOI 10.1016/j.expneurol.2009.01.026; Kopelman R, 2005, J MAGN MAGN MATER, V293, P404, DOI 10.1016/j.jmmm.2005.02.061; Kurland D, 2012, J NEUROTRAUM, V29, P19, DOI 10.1089/neu.2011.2122; Laurer HL, 2001, J NEUROSURG, V95, P859, DOI 10.3171/jns.2001.95.5.0859; Lee H, 2008, J NEUROTRAUM, V25, P1049, DOI 10.1089/neu.2008.0566; Lipton ML, 2008, J NEUROTRAUM, V25, P1335, DOI 10.1089/neu.2008.0547; Longhi L, 2005, NEUROSURGERY, V56, P364, DOI 10.1227/01.NEU.0000149008.73513.44; Narayan RK, 2008, J NEUROTRAUM, V25, P629, DOI 10.1089/neu.2007.0385; Nevo U, 2001, MAGN RESON MED, V45, P1, DOI 10.1002/1522-2594(200101)45:1<1::AID-MRM1001>3.0.CO;2-I; Obenaus A, 2008, RADIAT RES, V169, P149, DOI 10.1667/RR1135.1; Obenaus A, 2007, J NEUROTRAUM, V24, P1147, DOI 10.1089/neu.2006.0211; Obenaus A, 2011, ANN NEUROL, V69, P282, DOI 10.1002/ana.22168; Oehmichen M, 2003, J NEUROTRAUM, V20, P87, DOI 10.1089/08977150360517218; Rosidi NL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026612; Schmued LC, 2000, TOXICOL PATHOL, V28, P91, DOI 10.1177/019262330002800111; Shanmuganathan K, 2004, AM J NEURORADIOL, V25, P539; Shitaka Y, 2011, J NEUROPATH EXP NEUR, V70, P551, DOI 10.1097/NEN.0b013e31821f891f; Shultz SR, 2012, J NEUROTRAUM, V29, P281, DOI 10.1089/neu.2011.2123; Sifri ZC, 2004, AM J SURG, V187, P338, DOI 10.1016/j.amjsurg.2003.12.015; Sifri ZC, 2006, J TRAUMA, V61, P862, DOI 10.1097/01.ta.0000224225.54982.90; Simard JM, 2010, J NEUROSURG, V113, P622, DOI 10.3171/2009.11.JNS081052; Simard JM, 2009, J NEUROTRAUM, V26, P2257, DOI 10.1089/neu.2009.1021; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; THULBORN KR, 1990, AM J ROENTGENOL, V154, P1053, DOI 10.2214/ajr.154.5.2108542; VA/DoD, 2009, MAN CONC MILD TRAUM; Vagnozzi R, 2008, NEUROSURGERY, V62, P1286, DOI 10.1227/01.neu.0000333300.34189.74; Vagnozzi R, 2007, NEUROSURGERY, V61, P379, DOI 10.1227/01.NEU.0000280002.41696.D8; Veltkamp R, 2005, BRAIN RES, V1037, P134, DOI 10.1016/j.brainres.2005.01.006; Wang XY, 2000, J NEUROSCI, V20, P7037, DOI 10.1523/JNEUROSCI.20-18-07037.2000; Xue MZ, 2000, NEUROSCI LETT, V283, P230, DOI 10.1016/S0304-3940(00)00971-X	56	22	22	0	3	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	2213-1582			NEUROIMAGE-CLIN	NeuroImage-Clin.		2012	1	1					18	28		10.1016/j.nicl.2012.08.001			11	Neuroimaging	Neurosciences & Neurology	V37LG	WOS:000209276700003	24179733	DOAJ Gold, Green Published			2021-06-18	
J	Echemendia, RJ; Iverson, GL; McCrea, M; Broshek, DK; Gioia, GA; Sautter, SW; Macciocchi, SN; Barr, WB				Echemendia, Ruben J.; Iverson, Grant L.; McCrea, Michael; Broshek, Donna K.; Gioia, Gerard A.; Sautter, Scott W.; Macciocchi, Stephen N.; Barr, William B.			Role of Neuropsychologists in the Evaluation and Management of Sport-Related Concussion: An Inter-Organization Position Statement	ARCHIVES OF CLINICAL NEUROPSYCHOLOGY			English	Article						Concussion; Traumatic brain injury; Children; Legislation	TRAUMATIC BRAIN-INJURY; HIGH-SCHOOL; FOOTBALL PLAYERS; NEUROCOGNITIVE PERFORMANCE; INTERNATIONAL-CONFERENCE; SEX-DIFFERENCES; RECOVERY; SYMPTOMS; IMPACT; DEFICITS	Over the past 20 years, clinical neuropsychologists have been at the forefront of both scientific and clinical initiatives aimed at developing evidence-based approaches to the evaluation and management of sport-related concussion (SRC). These efforts have directly impacted current policy on strategies for injury assessment and return-to-play by athletes after concussion. Many states are considering legislation requiring (a) education of athletes, parents, coaches, and school/organization officials on the recognition, evaluation, and management of SRCs; (b) removal from play of any youth athlete that is suspected of having sustained a concussion; and (c) not allowing the student to return to participation until the student is evaluated and cleared for return to participation in writing by an appropriate healthcare professional. It is the official position of the American Academy of Clinical Neuropsychology (AACN), American Board of Professional Neuropsychology (ABN), Division 40 (Neuropsychology) of the American Psychological Association (APA), and the National Academy of Neuropsychology (NAN) that neuropsychologists should be included among the licensed healthcare professionals authorized to evaluate, clinically manage, and provide return to play clearance for athletes who sustain a SRC.	[Echemendia, Ruben J.] Psychol & Neurobehav Associates Inc, State Coll, PA 16801 USA; [Iverson, Grant L.] Univ British Columbia, Vancouver, BC V5Z 1M9, Canada; [McCrea, Michael] Med Coll Wisconsin, Milwaukee, WI 53226 USA; [Broshek, Donna K.] Univ Virginia, Sch Med, Charlottesville, VA 22908 USA; [Gioia, Gerard A.] Childrens Natl Med Ctr, Rockville, MD USA; [Gioia, Gerard A.] George Washington Univ, Sch Med, Rockville, MD USA; [Sautter, Scott W.] Hampton Rd Neuropsychol Inc, Virginia Beach, VA USA; [Macciocchi, Stephen N.] Shepherd Ctr, Atlanta, GA USA; [Barr, William B.] NYU, Sch Med, New York, NY USA	Echemendia, RJ (corresponding author), Psychol & Neurobehav Associates Inc, 204 E Calder Way,Suite 205, State Coll, PA 16801 USA.	rechemendia@comcast.net		Iverson, Grant/0000-0001-7348-9570; Barr, William/0000-0001-7711-7758			Barr WB, 2001, J INT NEUROPSYCH SOC, V7, P693, DOI 10.1017/S1355617701766052; Barth JT, 2003, ARCH CLIN NEUROPSYCH, V18, P551, DOI 10.1016/S0887-6177(02)00146-4; Broglio SP, 2007, J ATHL TRAINING, V42, P504; Broshek DK, 2005, J NEUROSURG, V102, P856, DOI 10.3171/jns.2005.102.5.0856; Bruce JM, 2003, NEUROPSYCHOLOGY, V17, P622, DOI 10.1037/0894-4105.17.4.622; Collie A, 2006, J NEUROL NEUROSUR PS, V77, P241, DOI 10.1136/jnnp.2005.073155; Collins MW, 2003, CLIN J SPORT MED, V13, P222, DOI 10.1097/00042752-200307000-00005; Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P964, DOI 10.1001/jama.282.10.964; Covassin T, 2007, NEUROSURGERY, V61, P345, DOI 10.1227/01.NEU.0000279972.95060.CB; DeKosky ST, 2007, ARCH NEUROL-CHICAGO, V64, P541, DOI 10.1001/archneur.64.4.541; DeKosky ST, 2010, NEW ENGL J MED, V363, P1293, DOI 10.1056/NEJMp1007051; Echemendia RJ, 2009, BRIT J SPORT MED, V43, pI32, DOI 10.1136/bjsm.2009.058164; Echemendia RJ, 2001, CLIN J SPORT MED, V11, P23, DOI 10.1097/00042752-200101000-00005; Echemendia RJ, 2006, SPORTS NEUROPSYCHOLO; Echlin PS, 2010, NEUROSURG FOCUS, V29, DOI 10.3171/2010.9.FOCUS10186; Erlanger D, 2003, J NEUROSURG, V98, P477, DOI 10.3171/jns.2003.98.3.0477; Fazio VC, 2007, NEUROREHABILITATION, V22, P207; Gilchrist J., 2007, Morbidity and Mortality Weekly Report, V56, P733; Gioia GA, 2009, BRIT J SPORT MED, V43, pI13, DOI 10.1136/bjsm.2009.058255; Gioia GA, 2008, J HEAD TRAUMA REHAB, V23, P230, DOI 10.1097/01.HTR.0000327255.38881.ca; Guskiewicz KM, 2001, J ATHL TRAINING, V36, P263; Iverson GL, 2006, BRAIN INJURY, V20, P245, DOI 10.1080/02699050500487910; Iverson GL, 2003, CLIN NEUROPSYCHOL, V17, P460, DOI 10.1076/clin.17.4.460.27934; Kelly JP, 1999, JAMA-J AM MED ASSOC, V282, P989, DOI 10.1001/jama.282.10.989; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lovell M, 1999, SPORTS RELATED CONCU; Lovell MR, 2006, APPL NEUROPSYCHOL, V13, P166, DOI 10.1207/s15324826an1303_4; Lovell MR, 1998, J HEAD TRAUMA REHAB, V13, P9, DOI 10.1097/00001199-199804000-00004; Lovell MR, 2004, AM J SPORT MED, V32, P47, DOI 10.1177/0363546503260723; Lovell MR, 2003, J NEUROSURG, V98, P296, DOI 10.3171/jns.2003.98.2.0296; LOVELL MR, 1996, NEW DEV SPORTS REL C; Macciocchi SN, 1996, NEUROSURGERY, V39, P510, DOI 10.1097/00006123-199609000-00014; Makdissi M, 2001, BRIT J SPORT MED, V35, P354, DOI 10.1136/bjsm.35.5.354; Matser JT, 2001, J CLIN EXP NEUROPSYC, V23, P770, DOI 10.1076/jcen.23.6.770.1029; McClincy MP, 2006, BRAIN INJURY, V20, P33, DOI 10.1080/02699050500309817; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrea M, 1998, J HEAD TRAUMA REHAB, V13, P27, DOI 10.1097/00001199-199804000-00005; McCrory P, 2005, BRIT J SPORT MED, V39, pI78, DOI 10.1136/bjsm.2005.018614; McCrory P, 2009, BRIT J SPORT MED, V43, pI76, DOI 10.1136/bjsm.2009.058248; Randolph C, 2009, ARCH CLIN NEUROPSYCH, V24, P219, DOI 10.1093/arclin/acp025; Sosnoff JJ, 2007, NEUROPSYCHOLOGY, V21, P796, DOI 10.1037/0894-4105.21.6.796; Van Kampen DA, 2006, AM J SPORT MED, V34, P1630, DOI 10.1177/0363546506288677	43	22	22	0	14	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0887-6177			ARCH CLIN NEUROPSYCH	Arch. Clin. Neuropsychol.	JAN	2012	27	1					119	122		10.1093/arclin/acr077			4	Psychology, Clinical; Psychology	Psychology	885TE	WOS:000299802900011	22180540	Bronze			2021-06-18	
J	Gardner, A; Shores, EA; Batchelor, J; Honan, CA				Gardner, Andrew; Shores, E. Arthur; Batchelor, Jennifer; Honan, Cynthia A.			Diagnostic Efficiency of ImPACT and CogSport in Concussed Rugby Union Players Who Have Not Undergone Baseline Neurocognitive Testing	APPLIED NEUROPSYCHOLOGY-ADULT			English	Article						CogSport; computerized neuropsychological testing; ImPACT; sports-related concussion	NEUROPSYCHOLOGICAL TEST-PERFORMANCE; PROCESSING SPEED; FOOTBALL; SCHOOL; SPECIFICITY; RELIABILITY; SENSITIVITY; HISTORY	The current study endeavored to replicate the approach to sports-related concussion management adopted by some community-based sporting organizations by examining the diagnostic efficiency of CogSport and ImPACT in athletes without baseline test data and assessed only once postinjury. Recently concussed nonelite-level rugby union players (N = 51) were tested within 72 hours of sustaining a concussion and were compared to nonconcussed matched controls (N = 41). Demographic information and history of recent concussion were also collected. Logistic regression analysis and receiver-operating characteristic curve analysis were conducted to evaluate the most accurate scores at identifying group membership. Overall, the classification accuracy of CogSport and ImPACT represented only very minimal improvements over a demographic-only (age, estimated premorbid Full-Scale IQ, and number of previous concussions) model. Positive predictive power and negative predictive power of composite scores were modest. The ImPACT postconcussion symptoms total (severity) score was most accurate at classifying concussed athletes. Where neuropsychological tests are utilized on a single occasion postconcussion and in the absence of baseline testing, postinjury testing does not improve diagnostic utility beyond the demographic model. These results do not validate this approach as a useful method of managing sports-related concussion.	[Gardner, Andrew; Shores, E. Arthur; Batchelor, Jennifer; Honan, Cynthia A.] Macquarie Univ, Dept Psychol, N Ryde, NSW 2109, Australia	Shores, EA (corresponding author), Macquarie Univ, Dept Psychol, N Ryde, NSW 2109, Australia.	arthur.shores@mq.edu.au	Gardner, Andrew/J-5162-2013; Honan, Cynthia/O-6332-2017	Batchelor, Jennifer/0000-0003-4438-4993; Shores, Edwin A/0000-0003-1553-5131; Honan, Cynthia/0000-0001-5735-4270			Aubry M, 2002, CLIN J SPORT MED, V12, P6, DOI 10.1097/00042752-200201000-00005; Barr WB, 2001, J INT NEUROPSYCH SOC, V7, P693, DOI 10.1017/S1355617701766052; Barth JT., 1989, MILD HEAD INJURY, P257; Belanger HG, 2010, J INT NEUROPSYCH SOC, V16, P262, DOI 10.1017/S1355617709991287; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Collie A, 2006, J NEUROL NEUROSUR PS, V77, P241, DOI 10.1136/jnnp.2005.073155; Collie A, 2003, CLIN J SPORT MED, V13, P28, DOI 10.1097/00042752-200301000-00006; Collie A, 2001, BRIT J SPORT MED, V35, P297, DOI 10.1136/bjsm.35.5.297; Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P964, DOI 10.1001/jama.282.10.964; Colvin AC, 2009, AM J SPORT MED, V37, P1699, DOI 10.1177/0363546509332497; Covassin T, 2010, J NEUROL NEUROSUR PS, V81, P597, DOI 10.1136/jnnp.2009.193797; Diaz-Asper CM, 2004, J INT NEUROPSYCH SOC, V10, P82; Echemendia RJ, 2001, CLIN J SPORT MED, V11, P23, DOI 10.1097/00042752-200101000-00005; Gardner A, 2010, ARCH CLIN NEUROPSYCH, V25, P174, DOI 10.1093/arclin/acq007; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Iverson G, 2002, ARCH CLIN NEUROPSYCH, V17, P769; Lovell M.R., 2007, CLIN INTERPRETATION; Lovell M, 2008, NEUROL CLIN, V26, P45, DOI 10.1016/j.ncl.2007.12.001; Lovell MR, 2006, APPL NEUROPSYCHOL, V13, P166, DOI 10.1207/s15324826an1303_4; Lovell MR., 2000, IMPACT IMMEDIATE POS; McCrory P, 2005, BRIT J SPORT MED, V39, pI78, DOI 10.1136/bjsm.2005.018614; McCrory P, 2009, J SCI MED SPORT, V12, P340, DOI 10.1016/j.jsams.2009.02.004; Moser RS, 2005, NEUROSURGERY, V57, P300, DOI 10.1227/01.NEU.0000166663.98616.E4; Moser RS, 2002, ARCH CLIN NEUROPSYCH, V17, P91, DOI 10.1016/S0887-6177(01)00108-1; Pellman EJ, 2006, NEUROSURGERY, V58, P263, DOI 10.1227/01.NEU.0000200272.56192.62; Schatz P, 2006, ARCH CLIN NEUROPSYCH, V21, P91, DOI 10.1016/j.acn.2005.08.001; Shuttleworth-Rdwards AB, 2008, ARCH CLIN NEUROPSYCH, V23, P511, DOI 10.1016/j.acn.2008.05.002; Wechsler D., 2001, WECHSLER TEST ADULT; Wechsler D, 1997, WAIS 3 ADM SCORING M	29	22	22	0	9	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	2327-9095	2327-9109		APPL NEUROPSYCH-ADUL	Appl. Neuropsychol.-Adult		2012	19	2					90	97		10.1080/09084282.2011.643945			8	Clinical Neurology; Psychology	Neurosciences & Neurology; Psychology	949SL	WOS:000304596100003	23373575				2021-06-18	
J	Green, L; Godfrey, C; Soo, C; Anderson, V; Catroppa, C				Green, Laura; Godfrey, Celia; Soo, Chery; Anderson, Vicki; Catroppa, Cathy			Agreement between parent-adolescent ratings on psychosocial outcome and quality-of-life following childhood traumatic brain injury	DEVELOPMENTAL NEUROREHABILITATION			English	Article						Childhood TBI; agreement; insight; proxy; PedsQL; SPRS-C	SHORT-TERM; SELF-REPORT; CHILDREN; HEALTH; AWARENESS; BEHAVIOR; RECOVERY; QUESTIONNAIRE; RELIABILITY; RELATIVES	Objective: This study investigated parent-adolescent agreement in long-term psychosocial and quality-of-life (QoL) outcomes. The sample comprised adolescents aged 15-18 years, who sustained childhood traumatic brain injury (TBI) between birth and 5 years of age. Methods: Thirty-three participants (17 adolescents with TBI and 16 TBI parent-proxies) were involved in the study which compared parent and adolescent ratings on the Sydney Psychosocial Reintegration Scale-Child form (SPRS-C) and the Pediatric Quality-of-Life Inventory (PedsQL). The questionnaires were administered through phone interviews. Results: As hypothesized, parent-adolescent agreement was acceptable for psychosocial outcome (intra-class coefficient [ICC] of 0.844, p < 0.001), whereas discrepancies were found for ratings of QoL (ICC of 0.506, p = 0.092). Conclusion: The finding that parents and adolescents agree on psychosocial outcome is promising for those instances when the patient is unable to report; however, discrepancies regarding QoL suggest caution needs to be taken when interpreting parent-rated QoL data.	[Godfrey, Celia; Soo, Chery; Anderson, Vicki; Catroppa, Cathy] Murdoch Childrens Res Inst, Melbourne, Vic, Australia; [Green, Laura; Catroppa, Cathy] Univ Melbourne, Melbourne, Vic 3010, Australia; [Catroppa, Cathy] Royal Childrens Hosp, Melbourne, Vic, Australia	Catroppa, C (corresponding author), Murdoch Childrens Res Inst, Flemington Rd, Parkville, Vic 3052, Australia.	cathy.catroppa@mcri.edu			Murdoch Children's Research Institute; Royal Children's Hospital, Melbourne; Victorian Government's Operational Infrastructure Support Program; Australian National Health and Medical Research CouncilNational Health and Medical Research Council of Australia	This research was supported by the Murdoch Children's Research Institute, the Royal Children's Hospital, Melbourne and the Victorian Government's Operational Infrastructure Support Program. Funding was also provided from the Australian National Health and Medical Research Council.	Alonso EM, 2010, J PEDIATR-US, V156, P270, DOI 10.1016/j.jpeds.2009.08.048; Anderson V, 2005, BRAIN INJURY, V19, P459, DOI 10.1080/02699050400004823; Anderson V, 1995, CHILD NEUROPSYCHOL, V1, P187, DOI 10.1080/09297049508400224; Anderson V, 2007, BRAIN INJURY, V21, P1399, DOI 10.1080/02699050701785070; Anderson V, 2010, NEUROPSYCHOLOGIA, V48, P2041, DOI 10.1016/j.neuropsychologia.2010.03.025; Anderson V, 2009, PEDIATRICS, V124, pE1064, DOI 10.1542/peds.2009-0365; ASARNOW RF, 1991, J PEDIATR PSYCHOL, V16, P543, DOI 10.1093/jpepsy/16.5.543; Berg-Nielsen TS, 2003, CHILD CARE HLTH DEV, V29, P207, DOI 10.1046/j.1365-2214.2003.00332.x; Brown M, 2000, BRAIN INJURY, V14, P5, DOI 10.1080/026990500120899; Cattelani R, 1998, BRAIN INJURY, V12, P283, DOI 10.1080/026990598122584; Chevignard M, 2010, CHILD CARE HLTH DEV, V36, P31, DOI 10.1111/j.1365-2214.2009.00949.x; Cicchetti DV, 2001, J CLIN EXP NEUROPSYC, V23, P695, DOI 10.1076/jcen.23.5.695.1249; Coghill D, 2009, J CHILD PSYCHOL PSYC, V50, P544, DOI 10.1111/j.1469-7610.2009.02008.x; Crooks Carol Y, 2007, Phys Med Rehabil Clin N Am, V18, P681, DOI 10.1016/j.pmr.2007.06.005; Daniel A. E., 1983, POWER PRIVILEGE PRES; Dijkers MP, 2004, ARCH PHYS MED REHAB, V85, pS21, DOI 10.1016/j.apmr.2003.08.119; Eiser C, 2001, QUAL LIFE RES, V10, P347, DOI 10.1023/A:1012253723272; Gan C, 2002, BRAIN INJURY, V16, P311, DOI 10.1080/02699050110104426; GODFREY HPD, 1993, J CLIN EXP NEUROPSYC, V15, P503, DOI 10.1080/01688639308402574; Hart T, 2010, J HEAD TRAUMA REHAB, V25, P339, DOI 10.1097/HTR.0b013e3181c7e60b; Hartung CM, 2005, J PSYCHOPATHOL BEHAV, V27, P159, DOI 10.1007/s10862-005-0632-8; Hellawell DJ, 2000, DISABIL REHABIL, V22, P446, DOI 10.1080/09638280050045910; KINSELLA G, 1991, J NEUROL NEUROSUR PS, V54, P422, DOI 10.1136/jnnp.54.5.422; Kramer TL, 2004, J CHILD PSYCHOL PSYC, V45, P248, DOI 10.1111/j.1469-7610.2004.00217.x; Kuipers P, 2004, BRAIN INJURY, V18, P161, DOI 10.1080/0269905031000149524; Leathem JM, 1998, J CLIN EXP NEUROPSYC, V20, P694, DOI 10.1076/jcen.20.5.694.1122; LOEBER R, 1989, DEV PSYCHOPATHOL, V1, P317, DOI DOI 10.1017/S095457940000050X; McCarthy ML, 2005, ARCH PHYS MED REHAB, V86, P1901, DOI 10.1016/j.apmr.2005.03.026; MCKINLAY WW, 1984, J CLIN NEUROPSYCHOL, V6, P87, DOI 10.1080/01688638408401199; Ownsworth T, 2007, NEUROPSYCHOL REHABIL, V17, P129, DOI 10.1080/09602010600615506; Ownsworth T, 2006, CLIN PSYCHOL REV, V26, P783, DOI 10.1016/j.cpr.2006.05.003; Port A, 2002, BRAIN INJURY, V16, P277, DOI 10.1080/02699050110103274; Prasad MR, 2002, PEDIATR NEUROSURG, V36, P64, DOI 10.1159/000048355; Prigatano GP, 1996, CLIN NEUROPSYCHOL, V10, P191, DOI 10.1080/13854049608406680; Salter K, 2008, BRAIN INJURY, V22, P820, DOI 10.1080/02699050802425428; Sbordone RJ, 1998, BRAIN INJURY, V12, P505, DOI 10.1080/026990598122467; Sherer M, 1998, J INT NEUROPSYCH SOC, V4, P380, DOI 10.1017/S1355617798003804; Snow AL, 2005, HEALTH SERV RES, V40, P1676, DOI 10.1111/j.1475-6773.2005.00447.x; Soo C, ADAPTING SYDNE UNPUB; Tate R, 1999, J HEAD TRAUMA REHAB, V14, P543, DOI 10.1097/00001199-199912000-00003; Taylor HG, 2002, NEUROPSYCHOLOGY, V16, P15, DOI 10.1037//0894-4105.16.1.15; TEASDALE G, 1974, LANCET, V2, P81; Teasdale TW, 1997, BRAIN INJURY, V11, P543, DOI 10.1080/026990597123250; Varni JW, 2007, HEALTH QUAL LIFE OUT, V5, DOI 10.1186/1477-7525-5-1; Varni JW, 2007, HEALTH QUAL LIFE OUT, P5; Waters E, 2003, CHILD CARE HLTH DEV, V29, P501, DOI 10.1046/j.1365-2214.2003.00370.x; Wehmeier PM, 2008, CHILD ADOL PSYCH CL, V2, P1; Yeates K O, 1997, J Int Neuropsychol Soc, V3, P617; Yeates KO, 2005, J AM ACAD CHILD PSY, V44, P574, DOI 10.1097/01.chi.0000159947.50523.64; Yeates KO, 2004, J INT NEUROPSYCH SOC, V10, P412, DOI 10.1017/S1355617704103093; Yeates KO, 2002, NEUROPSYCHOLOGY, V16, P514, DOI 10.1037//0894-4105.16.4.514	51	22	22	0	17	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1751-8423	1751-8431		DEV NEUROREHABIL	Dev. Neurorehabil.		2012	15	2					105	113		10.3109/17518423.2011.638331			9	Clinical Neurology; Pediatrics; Rehabilitation	Neurosciences & Neurology; Pediatrics; Rehabilitation	923SB	WOS:000302638100004	22432599				2021-06-18	
J	Hayes, A; Chen, CS; Clarke, G; Thompson, A				Hayes, Allison; Chen, Celia S.; Clarke, Gayle; Thompson, Annette			Functional improvements following the use of the NVT Vision Rehabilitation program for patients with hemianopia following stroke	NEUROREHABILITATION			English	Article						Neurological vision deficits; acquired brain injury; hemianopia; stroke; traumatic brain injury; mobility; activities of daily living; quality of life; compensatory visual scanning	QUALITY-OF-LIFE; HOMONYMOUS HEMIANOPIA; VISUAL FUNCTION; OUTCOMES; NEGLECT	The incidence of visual deficits following stroke ranges from 20%-68% and has significant impact on activities of daily living. The NVT system is a compensatory visual scanning training program that consists of combined static and mobility training and transfer to activities of daily living. The study aims to evaluate functional changes following the NVT program for people who have homonymous hemianopia (HH) following stroke. Method: Interventional case series of 13 consecutive participants with HH undergoing NVT vision rehabilitation. The primary outcome measure was the number of targets missed on a standardized Mobility Assessment Course (MAC). Other outcome measures included assessment of visual scanning, vision specific Quality of Life questionnaires and reading performance. Results: The average number of targets (sd) missed on the MAC course was 39.6 +/- 20.9% before intervention, 27.5 +/- 16.3% immediately post intervention and 20.8 +/- 15.5% at 3 months post rehabilitation. The study showed a statistically significant trend in improvement in mobility related subscales of National Eye Institute Visual Function Questionnaire-NEI VFQ-25 (p = 0.003) and the Veteran Affairs Low Vision Visual Function Questionnaire-VA LVFQ-48 (p = 0.036) at 3 months post rehabilitation. Discussion: The NVT intervention resulted in functional improvements in mobility post rehabilitation. The NVT training showed improvement in vision specific quality of life. There is a need for standardised vision therapy intervention, in conjunction with existing rehabilitation services, for patients with stroke and traumatic brain injury.	[Hayes, Allison; Clarke, Gayle] NVT Syst, Torrensville, SA 5031, Australia; [Chen, Celia S.] Flinders Univ S Australia, Bedford Pk, SA 5042, Australia; [Chen, Celia S.] Flinders Med Ctr, Dept Ophthalmol, Bedford Pk, SA, Australia; [Thompson, Annette] Royal Soc Blind, Adelaide, SA, Australia	Hayes, A (corresponding author), NVT Syst, POB 131, Torrensville, SA 5031, Australia.	ahayes@nvtsystems.com.au	Chen, Celia/AAM-7110-2020; Chen, Celia/ABD-7054-2020	Chen, Celia/0000-0002-7723-4812			CHEDRU F, 1973, Cortex, V9, P94; Chen CS, 2009, TOP STROKE REHABIL, V16, P445, DOI 10.1310/tsr1606-445; Coupar F, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006432.pub2; DENES G, 1982, BRAIN, V105, P543, DOI 10.1093/brain/105.3.543; Faul M.D., 2010, TRAUMATIC BRAIN INJU; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; GASSEL MM, 1963, BRAIN, V86, P1, DOI 10.1093/brain/86.1.1; GIANUTSOS R, 1988, ARCH PHYS MED REHAB, V69, P573; Haymes SA, 2006, INVEST OPHTH VIS SCI, V47, P2739, DOI 10.1167/iovs.05-1419; ISHIAI S, 1987, NEUROPSYCHOLOGIA, V25, P675, DOI 10.1016/0028-3932(87)90058-3; Kerkhoff G, 1999, RESTOR NEUROL NEUROS, V15, P255; Kerkhoff G, 2000, J NEUROL NEUROSUR PS, V68, P691, DOI 10.1136/jnnp.68.6.691; Kingston J, 2010, J VISUAL IMPAIR BLIN, V104, P603, DOI 10.1177/0145482X1010401006; Kinsella G, 1985, Int Rehabil Med, V7, P102; Koons P, 2010, EYE BRAIN, V2, P47; Landers J, 2010, CLIN EXP OPHTHALMOL, V38, P273, DOI 10.1111/j.1442-9071.2010.02246.x; Lloyd-Jones D, 2010, CIRCULATION, V121, pE46, DOI 10.1161/CIRCULATIONAHA.109.192667; Malec JF, 2004, BRAIN INJURY, V18, P563, DOI 10.1080/02699050310001646134; Mangione CM, 2001, ARCH OPHTHALMOL-CHIC, V119, P1050, DOI 10.1001/archopht.119.7.1050; Margolis MK, 2002, PHARMACOECONOMICS, V20, P791, DOI 10.2165/00019053-200220120-00001; Pambakian ALM, 1997, BRIT J OPHTHALMOL, V81, P324, DOI 10.1136/bjo.81.4.324; Parton A, 2004, J NEUROL NEUROSUR PS, V75, P13; Rowe F, 2009, AGE AGEING, V38, P188, DOI 10.1093/ageing/afn230; STELMACK J, 1987, AM J OPTOM PHYS OPT, V64, P829; Stelmack JA, 2002, INVEST OPHTH VIS SCI, V43, P2859; Stelmack JA, 2007, OPTOMETRY VISION SCI, V84, P705, DOI 10.1097/OPX.0b013e3181339f1a; Stelmack JA, 2006, INVEST OPHTH VIS SCI, V47, P3253, DOI 10.1167/iovs.05-1319; STONE SP, 1993, AGE AGEING, V22, P46, DOI 10.1093/ageing/22.1.46; Verlander D., 2000, VIS IMPAIR RES, V2, P129; WILSON B, 1987, ARCH PHYS MED REHAB, V68, P98; ZIHL J, 1995, NEUROPSYCHOLOGIA, V33, P287, DOI 10.1016/0028-3932(94)00119-A; ZIHL J, 1994, LOW VISION; Zihl J., 1999, VIS IMPAIR RES, V1, P23, DOI [10.1076/vimr.1.1.23.4450, DOI 10.1076/VIMR.1.1.23.4450]	33	22	22	0	12	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1053-8135	1878-6448		NEUROREHABILITATION	Neurorehabilitation		2012	31	1					19	30		10.3233/NRE-2012-0771			12	Clinical Neurology; Rehabilitation	Neurosciences & Neurology; Rehabilitation	976SU	WOS:000306605900003	22523012				2021-06-18	
J	Mills, PH; Hitchens, TK; Foley, LM; Link, T; Ye, Q; Weiss, CR; Thompson, JD; Gilson, WD; Arepally, A; Melick, JA; Kochanek, PM; Ho, C; Bulte, JWM; Ahrens, ET				Mills, Parker H.; Hitchens, T. Kevin; Foley, Lesley M.; Link, Thomas; Ye, Qing; Weiss, Clifford R.; Thompson, Joe D.; Gilson, Wesley D.; Arepally, Aravind; Melick, John A.; Kochanek, Patrick M.; Ho, Chien; Bulte, Jeff W. M.; Ahrens, Eric T.			Automated detection and characterization of SPIO-labeled cells and capsules using magnetic field perturbations	MAGNETIC RESONANCE IN MEDICINE			English	Article						SPIO; magnetic moment; MRI; cell tracking; magnetocapsules; susceptibility	POSITIVE-CONTRAST VISUALIZATION; IN-VIVO MRI; IRON-OXIDE; STEM-CELLS; RESONANCE; SUSCEPTIBILITY; TRACKING; MIGRATION; AGENTS; MACROPHAGES	Understanding how individual cells behave inside living systems will help enable new diagnostic tools and cellular therapies. Superparamagnetic iron oxide particles can be used to label cells and theranostic capsules for noninvasive tracking using MRI. Contrast changes from superparamagnetic iron oxide are often subtle relative to intrinsic sources of contrast, presenting a detection challenge. Here, we describe a versatile postprocessing method, called Phase map cross-correlation Detection and Quantification (PDQ), that automatically identifies localized deposits of superparamagnetic iron oxide, estimating their volume magnetic susceptibility and magnetic moment. To demonstrate applicability, PDQ was used to detect and characterize superparamagnetic iron oxide-labeled magnetocapsules implanted in porcine liver and suspended in agarose gel. PDQ was also applied to mouse brains infiltrated by MPIO-labeled macrophages following traumatic brain injury; longitudinal, in vivo studies tracked individual MPIO clusters over 3 days, and tracked clusters were corroborated in ex vivo brain scans. Additionally, we applied PDQ to rat hearts infiltrated by MPIO-labeled macrophages in a transplant model of organ rejection. PDQ magnetic measurements were signal-to-noise ratio invariant for images with signal-to-noise ratio > 11. PDQ can be used with conventional gradient-echo pulse sequences, requiring no extra scan time. The method is useful for visualizing biodistribution of cells and theranostic magnetocapsules and for measuring their relative iron content. Magn Reson Med, 2011. (C) 2011 Wiley-Liss, Inc.	[Mills, Parker H.; Hitchens, T. Kevin; Foley, Lesley M.; Ye, Qing; Ho, Chien; Ahrens, Eric T.] Carnegie Mellon Univ, Dept Biol Sci, Pittsburgh, PA 15213 USA; [Mills, Parker H.; Hitchens, T. Kevin; Foley, Lesley M.; Ye, Qing; Ho, Chien; Ahrens, Eric T.] Carnegie Mellon Univ, Pittsburgh NMR Ctr Biomed Res, Pittsburgh, PA 15213 USA; [Link, Thomas; Weiss, Clifford R.; Arepally, Aravind; Bulte, Jeff W. M.] Johns Hopkins Univ, Sch Med, Russell H Morgan Dept Radiol & Radiol Sci, Baltimore, MD USA; [Link, Thomas; Bulte, Jeff W. M.] Johns Hopkins Univ, Sch Med, Dept Biomed Engn, Baltimore, MD 21205 USA; [Link, Thomas; Bulte, Jeff W. M.] Johns Hopkins Univ, Sch Med, Inst Cell Engn, Cellular Imaging Sect, Baltimore, MD USA; [Link, Thomas; Bulte, Jeff W. M.] Johns Hopkins Univ, Sch Med, Inst Cell Engn, Vasc Biol Program, Baltimore, MD USA; [Thompson, Joe D.] Los Alamos Natl Lab, Div Mat Sci & Technol, Grp 10, Los Alamos, NM 87545 USA; [Gilson, Wesley D.] Siemens Corp Res, Baltimore, MD USA; [Melick, John A.; Kochanek, Patrick M.] Univ Pittsburgh, Safar Ctr Resuscitat Res, Pittsburgh, PA USA; [Bulte, Jeff W. M.] Johns Hopkins Univ, Sch Med, Dept Chem & Biomol Engn, Baltimore, MD USA	Ahrens, ET (corresponding author), Carnegie Mellon Univ, Dept Biol Sci, 4400 5th Ave, Pittsburgh, PA 15213 USA.	eta@andrew.cmu.edu	Kochanek, Patrick M/D-2371-2015; Bulte, Jeff W.M./A-3240-2008; Mills, Parker Henry/I-4563-2012; Ho, Chien/O-6112-2016	Kochanek, Patrick M/0000-0002-2627-913X; Bulte, Jeff W.M./0000-0003-1202-1610; Mills, Parker Henry/0000-0002-0715-3531; Ho, Chien/0000-0002-4094-9232	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01-EB005740, R01-CA134633, R01-EB003453, R01-HL081349, R01-EB007825, P41-EB001977]; NATIONAL CANCER INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [R01CA134633] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [R01HL081349] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB) [R01EB007825, R01EB003453, R01EB005740, P41EB001977] Funding Source: NIH RePORTER	Grant sponsor: National Institutes of Health; Grant numbers: R01-EB005740, R01-CA134633, R01-EB003453, R01-HL081349, R01-EB007825, P41-EB001977.	Bakker CJG, 2008, PHYS MED BIOL, V53, pN349, DOI 10.1088/0031-9155/53/18/N02; Bakker CJG, 2006, MAGN RESON MED, V56, P1107, DOI 10.1002/mrm.21069; Bakker CJG, 2006, MAGNET RESON MED, V55, P92, DOI 10.1002/mrm.20733; BANKS MA, 1991, COMP BIOCHEM PHYS B, V100, P795, DOI 10.1016/0305-0491(91)90292-L; Barnett BP, 2007, NAT MED, V13, P986, DOI 10.1038/nm1581; Bomati-Miguel O, 2005, BIOMATERIALS, V26, P5695, DOI 10.1016/j.biomaterials.2005.02.020; Bos C, 2003, MAGNET RESON MED, V50, P400, DOI 10.1002/mrm.10505; Bulte JWM, 2009, AM J ROENTGENOL, V193, P314, DOI 10.2214/AJR.09.3107; Bulte JWM, 1999, P NATL ACAD SCI USA, V96, P15256, DOI 10.1073/pnas.96.26.15256; Chavez S, 2002, IEEE T MED IMAGING, V21, P966, DOI 10.1109/TMI.2002.803106; Cunningham CH, 2005, MAGNET RESON MED, V53, P999, DOI 10.1002/mrm.20477; Dixon WT, 2009, MAGN RESON MED, V61, P1132, DOI 10.1002/mrm.21930; Foley LM, 2009, J NEUROTRAUM, V26, P1509, DOI 10.1089/neu.2008.0747; Foster-Gareau P, 2003, MAGN RESON MED, V49, P968, DOI 10.1002/mrm.10417; Frank JA, 2003, RADIOLOGY, V228, P480, DOI 10.1148/radiol.2281020638; Griffiths DJ, 1999, INTRO ELECTRODYNAMIC, P269; Haacke EM, 2004, MAGN RESON MED, V52, P612, DOI 10.1002/mrm.20198; Jenkinson M, 2003, MAGNET RESON MED, V49, P193, DOI 10.1002/mrm.10354; Lai S, 1996, MAGNET RESON MED, V36, P781, DOI 10.1002/mrm.1910360518; Mani V, 2006, MAGN RESON MED, V55, P126, DOI 10.1002/mrm.20739; McAuley G, 2010, MAGN RESON MED, V63, P106, DOI 10.1002/mrm.22185; MENDONCADIAS MH, 1983, SEMIN NUCL MED, V13, P364, DOI 10.1016/S0001-2998(83)80048-8; Mills PH, 2008, MAGN RESON IMAGING, V26, P618, DOI 10.1016/j.mri.2008.01.007; Mills PH, 2009, MAGN RESON MED, V62, P1349, DOI 10.1002/mrm.22127; Mowat P, 2007, NMR BIOMED, V20, P21, DOI 10.1002/nbm.1084; Muja N, 2009, PROG NUCL MAG RES SP, V55, P61, DOI 10.1016/j.pnmrs.2008.11.002; Nieman BJ, 2010, NEUROIMAGE, V50, P456, DOI 10.1016/j.neuroimage.2009.12.107; Pawelczyk E, 2006, NMR BIOMED, V19, P581, DOI 10.1002/nbm.1038; Qiu BS, 2010, MAGN RESON MED, V63, P1437, DOI 10.1002/mrm.22348; Robson MD, 2003, J COMPUT ASSIST TOMO, V27, P825, DOI 10.1097/00004728-200311000-00001; Schenck JF, 1996, MED PHYS, V23, P815, DOI 10.1118/1.597854; Seppenwoolde JH, 2003, MAGNET RESON MED, V50, P784, DOI 10.1002/mrm.10574; SHEN T, 1993, MAGN RESON MED, V29, P599, DOI 10.1002/mrm.1910290504; Stuber M, 2007, MAGN RESON MED, V58, P1072, DOI 10.1002/mrm.21399; Walczak P, 2005, MAGN RESON MED, V54, P769, DOI 10.1002/mrm.20701; Warren WS, 1998, SCIENCE, V281, P247, DOI 10.1126/science.281.5374.247; Williams JB, 2007, J MAGN RESON IMAGING, V25, P1210, DOI 10.1002/jmri.20930; Wu YL, 2006, P NATL ACAD SCI USA, V103, P1852, DOI 10.1073/pnas.0507198103; Yang JX, 2010, CYTOTHERAPY, V12, P251, DOI 10.3109/14653240903446910; Ye Q, 2008, CIRCULATION, V118, P149, DOI 10.1161/CIRCULATIONAHA.107.746354	40	22	22	0	18	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0740-3194	1522-2594		MAGN RESON MED	Magn. Reson. Med.	JAN	2012	67	1					278	289		10.1002/mrm.22998			12	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	867VL	WOS:000298482800032	21656554	Green Accepted, Bronze			2021-06-18	
J	Sandhaug, M; Andelic, N; Berntsen, SA; Seiler, S; Mygland, A				Sandhaug, Maria; Andelic, Nada; Berntsen, Svein A.; Seiler, Stephen; Mygland, Aase			Self and near relative ratings of functional level one year after traumatic brain injury	DISABILITY AND REHABILITATION			English	Article						Patient competency rating scale; relatives; self; traumatic brain injury	CLOSED-HEAD INJURY; IMPAIRED AWARENESS; POSTTRAUMATIC AMNESIA; COMPETENCE; SEVERITY; SCALE; AGE; LIMITATIONS; MORTALITY	Purpose: To quantify traumatic brain injury (TBI) patients' perceptions of own function by the Patient Competency Rating Scale (PCRS) one year after injury, and to examine self-awareness of functional deficits by comparing PCRS ratings from patients (PCRS-P) and PCRS ratings from near relatives (PCRS-R), and to identify predictors of awareness deficits. Method: A cohort of 50 severe (n = 33) and moderate (n = 17) TBI patients. Awareness of deficits was investigated by subtracting PCRS relative ratings from PCRS patient ratings. Predictors of PCRS ratings and differences were assessed by stepwise multiple regression analyses. Results: The average patient PCRS sum score was 122/150 (95% CI = 115; 129) as compared to a sum score of 117/150 (95% CI = 110; 125), given by their relatives (p = 0.93). The patients scored themselves slightly higher than their relatives in the domains of activities of daily living (ADL) and cognitive function (p < 0.001, p < 0.001). Regression analyses showed that Glasgow Coma Scale (GCS) score at admission to rehabilitation was the strongest predictor of patient PCRS (B = 3.314, p = 0.008). The strongest predictor of differences between patient and relative PCRS was GCS score acute (B = -3.530, p = 0.001). Conclusions: TBI patients demonstrated a slight "awareness gap" in ADL and cognitive function. Low GCS score in the acute phase and high age were the strongest predictors of self-awareness deficits.	[Sandhaug, Maria; Seiler, Stephen] Agder Univ, Fac Hlth & Sports, N-4604 Kristiansand, Norway; [Sandhaug, Maria] Sorlandet Hosp, Dept Res, Kristiansand, Norway; [Andelic, Nada; Mygland, Aase] Oslo Univ Hosp, Dept Phys Med & Rehabil, Oslo, Norway; [Berntsen, Svein A.] Sorlandet Hosp, Dept Phys Med & Rehabil, Kristiansand, Norway; [Mygland, Aase] Univ Bergen, Inst Clin Med, Bergen, Norway	Sandhaug, M (corresponding author), Agder Univ, Fac Hlth & Sports, Serv Box 422, N-4604 Kristiansand, Norway.	maria.sandhaug@uia.no		Andelic, Nada/0000-0002-3719-4406	Norwegian Foundation for Health and Rehabilitation	This study has been financed with the aid of extra funds from the Norwegian Foundation for Health and Rehabilitation. No previous presentation of the research, manuscript or abstract exists.	Arango-Lasprilla JC, 2008, BRAIN INJURY, V22, P565, DOI 10.1080/02699050802172004; BISHARA S N, 1992, Brain Injury, V6, P373, DOI 10.3109/02699059209034952; BOAKE C, 1995, BRAIN INJURY, V9, P273, DOI 10.3109/02699059509008198; Coronado VG, 2005, J HEAD TRAUMA REHAB, V20, P215, DOI 10.1097/00001199-200505000-00005; Czosnyka M, 2005, J NEUROSURG, V102, P450, DOI 10.3171/jns.2005.102.3.0450; Pagulayan KF, 2007, J INT NEUROPSYCH SOC, V13, P561, DOI 10.1017/S1355617707070713; Fischer S, 2004, J INT NEUROPSYCH SOC, V10, P190, DOI 10.1017/S1355617704102051; Flashman LA, 2002, NEUROREHABILITATION, V17, P285; Hart T, 2004, ARCH PHYS MED REHAB, V85, P1450, DOI 10.1016/j.apmr.2004.01.030; Hart T, 2009, NEUROPSYCHOL REHABIL, V19, P161, DOI 10.1080/09602010802188393; Hukkelhoven CWPM, 2003, J NEUROSURG, V99, P666, DOI 10.3171/jns.2003.99.4.0666; Hurley Robin A., 2002, Curr Treat Options Neurol, V4, P59, DOI 10.1007/s11940-002-0005-5; Leathem JM, 1998, J CLIN EXP NEUROPSYC, V20, P694, DOI 10.1076/jcen.20.5.694.1122; McMillan TM, 1996, J NEUROL NEUROSUR PS, V60, P422, DOI 10.1136/jnnp.60.4.422; Mosenthal AC, 2002, J TRAUMA, V52, P907, DOI 10.1097/00005373-200205000-00015; Prigatano GP, 2005, ACT NEUR S, V93, P39; PRIGATANO GP, 1990, ARCH PHYS MED REHAB, V71, P1058; Prigatano GP, 1997, NEUROPSY NEUROPSY BE, V10, P135; Prigatano GP, 1998, J HEAD TRAUMA REHAB, V13, P29, DOI 10.1097/00001199-199810000-00005; Ruff RM, 2009, ARCH CLIN NEUROPSYCH, V24, P3, DOI 10.1093/arclin/acp006; RUSSELL WR, 1961, ARCH NEUROL-CHICAGO, V5, P4, DOI 10.1001/archneur.1961.00450130006002; Sherer M, 1998, J INT NEUROPSYCH SOC, V4, P380, DOI 10.1017/S1355617798003804; Sherer M, 2003, BRAIN INJURY, V17, P25, DOI 10.1080/0269905021000010113; Sherer M, 2009, ARCH PHYS MED REHAB, V19, P161; SHORES EA, 1986, MED J AUSTRALIA, V144, P569, DOI 10.5694/j.1326-5377.1986.tb112311.x; Stocchetti N, 2004, J NEUROTRAUM, V21, P1131, DOI 10.1089/neu.2004.21.1131; Susman M, 2002, J TRAUMA, V53, P219, DOI 10.1097/00005373-200208000-00004; Sveen U, 2010, SCAND J OCCUP THER, V17, P225, DOI 10.3109/11038120903171295	28	22	22	0	5	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	0963-8288			DISABIL REHABIL	Disabil. Rehabil.		2012	34	11					904	909		10.3109/09638288.2011.626484			6	Rehabilitation	Rehabilitation	919YZ	WOS:000302369400003	22148905				2021-06-18	
J	Vallat-Azouvi, C; Pradat-Diehl, P; Azouvi, P				Vallat-Azouvi, Claire; Pradat-Diehl, Pascale; Azouvi, Philippe			The Working Memory Questionnaire: A scale to assess everyday life problems related to deficits of working memory in brain injured patients	NEUROPSYCHOLOGICAL REHABILITATION			English	Article						Working memory; Ecological assessment; Stroke; Traumatic brain injury	EXECUTIVE FUNCTION; PRACTICAL SCALE; HEAD-INJURY; REHABILITATION; DYSFUNCTION; DAMAGE; COMA	The objective of the present study was to develop a scale designed to assess the consequences of working memory deficits in everyday life. The Working Memory Questionnaire (WMQ) is a self-administered scale, addressing three dimensions of working memory: short-term storage, attention, and executive control. The normative sample included 313 healthy participants. The patient group included 69 brain injured patients, who were compared to a subsample of 69 matched healthy controls. The questionnaire was found to have a good internal consistency, both in healthy participants and in patients with brain injury (Cronbach's alpha = .89 and .94, respectively). In healthy participants, significant effects of age (p<.0001) and education (p<.01) were found, due to more complaints in participants aged 60 or more and (unexpectedly) in those aged below 30, and for less educated participants, below high school level. The WMQ was found to have the sensitivity to discriminate patients from matched controls, in the three domains (p<.0001). A good concurrent validity was found with the Cognitive Failure Questionnaire and the Rating Scale of Attentional Behaviour (Spearman's Rho = .90 and .81, respectively, both ps<.0001). In addition, the total complaint score significantly correlated with neuropsychological measures of working memory (visual spans and short-term memory with interference) and with global intellectual efficiency (Raven's Matrices) but not with digit spans. Further studies are needed to measure the internal structure of the scale, and to compare self-and proxy-ratings.	[Vallat-Azouvi, Claire] Hop Raymond Poincare, Antenne UEROS, SAMSAH 92, UGECAM, F-92380 Garches, France; [Vallat-Azouvi, Claire; Pradat-Diehl, Pascale; Azouvi, Philippe] UPMC, ER 6, Paris, France; [Pradat-Diehl, Pascale] Salpetriere Hosp, AP HP, Dept Phys Med & Rehabil, Paris, France; [Azouvi, Philippe] Hop Raymond Poincare, AP HP, Dept Phys Med & Rehabil, Garches, France; [Azouvi, Philippe] Univ Versailles St Quentin, EA 4497, St Quentin en Yvelines, France	Vallat-Azouvi, C (corresponding author), Hop Raymond Poincare, Antenne UEROS, SAMSAH 92, UGECAM, F-92380 Garches, France.	claire.vallat@rpc.aphp.fr			FTC (France Traumatisme Cranien); SOFMER (the French society of Physical Medicine and Rehabilitation)	This work was supported by a grant from FTC (France Traumatisme Cranien) and SOFMER (the French society of Physical Medicine and Rehabilitation) attributed to the first author. We are grateful to the students who contributed to data collection. We thank Johanna Robertson, PhD, for translating the Working Memory Questionnaire into English.	Azouvi P, 2009, PROG BRAIN RES, V177, P89, DOI 10.1016/S0079-6123(09)17708-7; Baddeley A. D., 1986, WORKING MEMORY; Bennett PC, 2005, J INT NEUROPSYCH SOC, V11, P376, DOI 10.1017/S1355617705050423; Best JR, 2010, CHILD DEV, V81, P1641, DOI 10.1111/j.1467-8624.2010.01499.x; BROADBENT DE, 1982, BRIT J CLIN PSYCHOL, V21, P1, DOI 10.1111/j.2044-8260.1982.tb01421.x; BROOKS DN, 1983, J NEUROL NEUROSUR PS, V46, P336, DOI 10.1136/jnnp.46.4.336; Burgess PW, 2006, J INT NEUROPSYCH SOC, V12, P194, DOI 10.1017/S1355617706060310; Burgess PW, 1998, J INT NEUROPSYCH SOC, V4, P547, DOI 10.1017/S1355617798466037; Cazalis F, 2001, J INT NEUROPSYCH SOC, V7, P795, DOI 10.1017/S1355617701777028; Chevignard M, 2000, CORTEX, V36, P649, DOI 10.1016/S0010-9452(08)70543-4; Couillet J, 2010, NEUROPSYCHOL REHABIL, V20, P321, DOI 10.1080/09602010903467746; ESLINGER PJ, 1985, NEUROLOGY, V35, P1731, DOI 10.1212/WNL.35.12.1731; Godefroy O, 2010, ANN NEUROL, V68, P855, DOI 10.1002/ana.22117; JENNETT B, 1975, LANCET, V1, P480; Lezak MD, 1995, NEUROPSYCHOLOGICAL A; Manly T, 2002, NEUROPSYCHOLOGIA, V40, P271, DOI 10.1016/S0028-3932(01)00094-X; PONSFORD J, 1991, NEUROPSYCHOL REHABIL, V1, P241, DOI DOI 10.1080/09602019108402257; PRIGATANO GP, 1990, ARCH PHYS MED REHAB, V71, P1058; Robertson I H, 1996, J Int Neuropsychol Soc, V2, P525; SHALLICE T, 1991, BRAIN, V114, P727, DOI 10.1093/brain/114.2.727; Spikman JM, 2010, J INT NEUROPSYCH SOC, V16, P118, DOI 10.1017/S1355617709991020; TEASDALE G, 1974, LANCET, V2, P81; Vallat C, 2005, BRAIN INJURY, V19, P1157, DOI 10.1080/02699050500110595; Vallat-Azouvi C, 2007, J INT NEUROPSYCH SOC, V13, P770, DOI 10.1017/S1355617707070993; Vallat-Azouvi C, 2009, BRAIN INJURY, V23, P585, DOI 10.1080/02699050902970711; VANZOMEREN AH, 1985, J NEUROL NEUROSUR PS, V48, P21, DOI 10.1136/jnnp.48.1.21; Whyte J, 1996, J Int Neuropsychol Soc, V2, P274; Whyte J, 2006, NEUROPSYCHOLOGIA, V44, P2007, DOI 10.1016/j.neuropsychologia.2006.02.012; Wilson BA, 1996, BEHAV ASSESSMENT DYS	29	22	22	0	19	PSYCHOLOGY PRESS	HOVE	27 CHURCH RD, HOVE BN3 2FA, EAST SUSSEX, ENGLAND	0960-2011			NEUROPSYCHOL REHABIL	Neuropsychol. Rehabil.		2012	22	4					634	649		10.1080/09602011.2012.681110			16	Neurosciences; Psychology	Neurosciences & Neurology; Psychology	995SC	WOS:000308031600009	22537095				2021-06-18	
J	Auxemery, Y; Fidelle, G				Auxemery, Y.; Fidelle, G.			Psychosis and trauma. Theorical links between post-traumatic and psychotic symptoms	ENCEPHALE-REVUE DE PSYCHIATRIE CLINIQUE BIOLOGIQUE ET THERAPEUTIQUE			French	Article						Post-traumatic stress disorder; Psychosis; Schizophrenia; Trauma	SEVERE MENTAL-ILLNESS; STRESS-DISORDER; BRAIN-INJURY; SCHIZOPHRENIA; VETERANS; FEATURES; SEVERITY; HISTORY; ABUSE; PTSD	Introduction. - The co-occurrence between post-traumatic symptoms and psychotic symptoms is well described in the immediate suites of a trauma but can also be chronic. This symptomatic co-occurrence, rarely studied in the literature, is often approached under the sole angle of a primary post-traumatic stress disorder (PTSD) or of a primary psychosis, without federative will to unify the psychotic and post-traumatic symptoms within the same nosological framework. Individuals with schizophrenia or schizoaffective disorder report higher rates of trauma and assault than the general population. Literature findings. - High rates of PTSD have been noted in severe mental illness cohorts. Psychotic phenomena may be a relatively common manifestation in patients with chronic PTSD. Aim. The purpose of this paper is to expose the various theorical psychopathological aspects between the symptoms of psychosis and PTSD. In populations of veterans, positive and negative symptoms of psychosis in PTSD are described as delusional thoughts and hallucinations often combat-specific. Clinical findings. - When a PTSD becomes established at a subject to the personality of neurotic structure, the intensity of the PTSD's symptoms lead to a psychotic expression which constitutes a factor of seriousness. Besides, PTSD often induces a risk of substance use disorder supplying psychotic symptoms. Cannabis increases the hallucinations, cocaine strengthens an underlying paranoid tone, and alcohol implies withdrawal hallucinosis. Moreover, such consumption could be a risk factor for the future development of chronic psychosis. From another point of view, by basing themselves on the plasma dopamine beta-hydroxylase activity, some authors made the analogy between psychotic major depression and PTSD with psychotic features (also characterized as a distinct psychotic subtype of PTSD). However, other studies found no correlation between PTSD with psychotic features and family predisposition for schizophrenia or schizoaffective disorder. Discussion. - The determination of the structure of personality seems fundamental in the understanding of the symptoms. A personality of psychotic structure increases the risk of traumatization and PTSD. At the same time, the fragility of this structure causes an increased sensitivity to the trauma, which takes on a particular echo. Moreover, a trauma can test a Latent psychotic structure to reveal its existence. The experience of psychosis may be traumatic in itself for patients with, notably, seclusion and sedation during hospitalization. Lastly, the symptoms of this post-traumatic psychosis will be differentiated from neurological confusion caused by a traumatic brain injury. Clinicians often fail to screen routinely for trauma and PTSD symptoms in patients with severe mental illness because few systematic guidelines exist for the identification and treatment of this comorbidity. Conclusion. - The links between psychotic and psycho-traumatic symptoms are complex and multidirectional; this co-occurrence is a factor of seriousness. The clinician, while paying attention to these symptoms, has to distinguish the structure of the personality of the subject to articulate the psychotherapy and the pharmacological treatment. Further investigational studies may determine whether antipsychotics will enhance treatment response in PTSD patients with psychotic features. (C) L'Encephale, Paris, 2010.	[Auxemery, Y.] Hop Instruct Armees Legouest, Serv Psychiat & Psychol Clin, F-57077 Metz 3, France; [Fidelle, G.] Hop Instruct Armees Percy, F-92141 Clamart, France	Auxemery, Y (corresponding author), Hop Instruct Armees Legouest, Serv Psychiat & Psychol Clin, 27 Ave Plantieres,BP 90001, F-57077 Metz 3, France.	yann.auxemery@hotmail.fr					Ahmed II, 1998, SEMIN CLIN NEUROPSYC, V3, P23; American Psychiatric Association, 1980, DIAGN STAT MAN MENT, V3rd; Auxemery Y., 2010, REV FRANCOPHONE STRE, V10, P169; Bennouna M, 2007, ENCEPHALE, V33, P616; Bessoles P, 2006, ENCEPHALE, V32, P729; Braakman MH, 2009, ACTA PSYCHIAT SCAND, V119, P15, DOI 10.1111/j.1600-0447.2008.01252.x; Brady KT, 2000, J CLIN PSYCHIAT, V61, P22; BRENDE JO, 1985, VIETNAM VETERANS ROA; Calhoun PS, 2007, SCHIZOPHR RES, V91, P210, DOI 10.1016/j.schres.2006.12.011; Caspi A, 2006, NAT REV NEUROSCI, V7, P583, DOI 10.1038/nrn1925; Crocq L., 1992, PSYCHOL MED, V24, P427; Crocq L., 1999, TRAUMATISMES PSYCHIQ; De Mol J, 1982, Encephale, V8, P17; Goodman LA, 1997, SCHIZOPHRENIA BULL, V23, P685, DOI 10.1093/schbul/23.4.685; GREENFIELD SF, 1994, BRIT J PSYCHIAT, V164, P831, DOI 10.1192/bjp.164.6.831; Hamner MB, 1998, PSYCHIAT RES, V77, P175, DOI 10.1016/S0165-1781(98)00002-X; Hamner MB, 1999, BIOL PSYCHIAT, V45, P846, DOI 10.1016/S0006-3223(98)00301-1; Hamner MB, 2000, J NERV MENT DIS, V188, P217, DOI 10.1097/00005053-200004000-00004; Kozaric-Kovacic D, 2005, J CLIN PSYCHIAT, V66, P922, DOI 10.4088/JCP.v66n0716; LAVIE M, 2007, REV FRANCOPHONE STRE, V7, P11; Mueser KT, 1998, J CONSULT CLIN PSYCH, V66, P493, DOI 10.1037/0022-006X.66.3.493; Mueser KT, 2002, SCHIZOPHR RES, V53, P123, DOI 10.1016/S0920-9964(01)00173-6; Resnick SG, 2003, J ABNORM PSYCHOL, V112, P415, DOI 10.1037/0021-843X.112.3.415; Sachdev P, 2001, PSYCHOL MED, V31, P231, DOI 10.1017/S0033291701003336; Sareen J, 2005, J TRAUMA STRESS, V18, P313, DOI 10.1002/jts.20040; Sautter FJ, 2003, BIOL PSYCHIAT, V54, P1382, DOI 10.1016/S0006-3223(03)00571-7; Sautter FJ, 2002, AM J PSYCHIAT, V159, P1775, DOI 10.1176/appi.ajp.159.10.1775; Senninger JL, 1987, REV FR DOMMAGE CORP, V13, P131; Shaw K, 1997, J NERV MENT DIS, V185, P434, DOI 10.1097/00005053-199707000-00003; Shaw K, 2002, J TRAUMA STRESS, V15, P39, DOI 10.1023/A:1014331211311; Stewart SH, 1996, PSYCHOL BULL, V120, P83, DOI 10.1037/0033-2909.120.1.83; Strauss JL, 2006, SCHIZOPHR RES, V84, P165, DOI 10.1016/j.schres.2006.02.010; Thomas G, 2009, NEUROCHIRURGIE, V55, P36, DOI 10.1016/j.neuchi.2008.09.002; Vergnes C, 2007, REV FRANCOPHONE STRE, V7, P27; Zhang Qingchen, 2003, Curr Psychiatry Rep, V5, P197, DOI 10.1007/s11920-003-0042-0; Zimmerman M, 1999, J CLIN PSYCHIAT, V60, P311, DOI 10.4088/JCP.v60n0508	36	22	23	2	39	MASSON EDITEUR	MOULINEAUX CEDEX 9	21 STREET CAMILLE DESMOULINS, ISSY, 92789 MOULINEAUX CEDEX 9, FRANCE	0013-7006			ENCEPHALE	Enceph.-Rev. Psychiatr. Clin. Biol. Ther.	DEC	2011	37	6					433	438		10.1016/j.encep.2010.12.001			6	Neurosciences; Psychiatry	Neurosciences & Neurology; Psychiatry	869CF	WOS:000298572600006	22137215				2021-06-18	
J	Stewart, TC; Polgar, D; Gilliland, J; Tanner, DA; Girotti, MJ; Parry, N; Fraser, DD				Stewart, Tanya Charyk; Polgar, Denise; Gilliland, Jason; Tanner, David A.; Girotti, Murray J.; Parry, Neil; Fraser, Douglas D.			Shaken Baby Syndrome and a Triple-Dose Strategy for Its Prevention	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article						Shaken Baby Syndrome; Epidemiology; Evaluation; Geographic information systems	NONACCIDENTAL HEAD-INJURY; TRAUMATIC BRAIN-INJURY; CHANGE KNOWLEDGE; YOUNG-CHILDREN; INFANTS; MALTREATMENT	Objectives: Inflicted traumatic brain injury associated with Shaken Baby Syndrome (SBS) is a leading cause of injury mortality and morbidity in infants. A triple-dose SBS prevention program was implemented with the aim to reduce the incidence of SBS. The objectives of this study were to describe the epidemiology of SBS, the triple-dose prevention program, and its evaluation. Methods: Descriptive and spatial epidemiologic profiles of SBS cases treated at Children's Hospital, London Health Sciences Centre, from 1991 to 2010 were created. Dose 1 (in-hospital education): pre-post impact evaluation of registered nurse training, with a questionnaire developed to assess parents' satisfaction with the program. Dose 2 (public health home visits): process evaluation of additional education given to new parents. Dose 3 (media campaign): a questionnaire developed to rate the importance of factors on a 7-point Likert scale. These factors were used to create weights for statistical modeling and mapping within a geographic information system to target prevention ads. Results: Forty-three percent of severe infant injuries were intentional. A total of 54 SBS cases were identified. The mean age was 6.7 months (standard deviation, 10.9 months), with 61% of infant males. The mean Injury Severity Score was 26.3 (standard deviation, 5.5) with a 19% mortality rate. Registered nurses learned new information on crying patterns and SBS, with a 47% increase in knowledge posttraining (p < 0.001). Over 10,000 parents were educated in-hospital, a 93% education compliance rate. Nearly all parents (93%) rated the program as useful, citing "what to do when the crying becomes frustrating" as the most important message. Only 6% of families needed to be educated during home visits. Locations of families with a new baby, high population density, and percentage of lone parents were found to be the most important factors for selecting media sites. The spatial analysis revealed six areas needed to be targeted for ad locations. Conclusions: SBS is a devastating intentional injury that often results in poor outcomes for the child. Implementing a triple-dose prevention program that provides education on crying patterns, coping strategies, and the dangers of shaking is key to SBS prevention. The program increased knowledge. Parents rated the program as useful. The media campaign allowed us to extend the primary prevention beyond new parents to help create a cultural change in the way crying, the primary trigger for SBS, is viewed. Targeting our intervention increased the likelihood that our message was reaching the population in greatest need.	[Stewart, Tanya Charyk; Polgar, Denise; Tanner, David A.; Girotti, Murray J.] London Hlth Sci Ctr, Trauma Program, London, ON, Canada; Childrens Hosp, London, ON, Canada; [Stewart, Tanya Charyk; Girotti, Murray J.; Parry, Neil] Univ Western Ontario, Dept Surg, Schulich Sch Med & Dent, London, ON N6A 3K7, Canada; [Gilliland, Jason] Univ Western Ontario, Dept Geog, Human Environm Anal Lab, London, ON N6A 5C2, Canada; [Gilliland, Jason; Fraser, Douglas D.] Univ Western Ontario, Schulich Sch Med & Dent, Childrens Hlth Res Inst, London, ON, Canada; [Gilliland, Jason; Fraser, Douglas D.] Univ Western Ontario, Schulich Sch Med & Dent, Lawson Hlth Res Inst, London, ON, Canada; [Parry, Neil] Univ Western Ontario, Schulich Sch Med & Dent, Div Crit Care Med, London, ON, Canada; [Fraser, Douglas D.] Univ Western Ontario, Schulich Sch Med & Dent, Ctr Crit Illness Res, London, ON, Canada; [Fraser, Douglas D.] Univ Western Ontario, Schulich Sch Med & Dent, Dept Paediat, London, ON, Canada	Stewart, TC (corresponding author), London Hlth Sci Ctr, Trauma Program, London, ON, Canada.	tanya.charyk@lhsc.on.ca	University, HEAL Western/T-1323-2019; El-Bagdady, Moe/S-8621-2019; Gilliland, Jason A/E-3393-2019	Gilliland, Jason A/0000-0002-2909-2178	Children's Health Foundation; Middlesex-London Health Unit for media campaign; LHSC	Supported by The Children's Health Foundation, whose grant has allowed our team to increase the injury prevention programming for children in Southwestern Ontario. Supported also by the Middlesex-London Health Unit for media campaign and donated media time from 1031 FRESH FM in London, Ontario, Canada.; We thank Bonnie Wooten for her involvement in this endeavor. We appreciate the collaborative efforts of the National Center for Shaken Baby Syndrome throughout this project. We also thank Joyce Williamson, Cynthia Dettloff, and Jane Harrington of the Trauma Program, LHSC for providing data and support for the preparation of this manuscript.	ALEXANDER R, 1990, AM J DIS CHILD, V144, P724, DOI 10.1001/archpedi.1990.02150300124032; Barlow KM, 2000, LANCET, V356, P1571, DOI 10.1016/S0140-6736(00)03130-5; Barr R.G, 2004, PERIOD PURPLE CRYING; Barr RG, 2009, CAN MED ASSOC J, V180, P727, DOI 10.1503/cmaj.081419; Barr RG, 2009, PEDIATRICS, V123, P972, DOI 10.1542/peds.2008-0908; BILLMIRE ME, 1985, PEDIATRICS, V75, P340; Brewster AL, 1998, CHILD ABUSE NEGLECT, V22, P91, DOI 10.1016/S0145-2134(97)00132-4; CAFFEY J, 1972, AM J DIS CHILD, V124, P161, DOI 10.1001/archpedi.1972.02110140011001; Canada Health, 2001, JOINT STAT SHAK BAB; Case ME, 2001, AM J FOREN MED PATH, V22, P112, DOI 10.1097/00000433-200106000-00002; Charyk Stewart T, 2010, CHILDRENS HLTH ENV; Cusimano MD, 2007, INJURY PREV, V13, P51, DOI 10.1136/ip.2006.012468; Dias MS, 2005, PEDIATRICS, V115, DOI 10.1542/peds.2004-1896; DUHAIME AC, 1992, PEDIATRICS, V90, P179; Duhaime AC, 1998, NEW ENGL J MED, V338, P1822, DOI 10.1056/NEJM199806183382507; DYKES LJ, 1986, CHILD ABUSE NEGLECT, V10, P211, DOI 10.1016/0145-2134(86)90082-7; Ernst JS, 2000, CHILD WELFARE, V79, P555; Ettaro L, 2004, CHILD ABUSE NEGLECT, V28, P1099, DOI 10.1016/j.chiabu.2004.06.006; Feldman KW, 2001, PEDIATRICS, V108, P636, DOI 10.1542/peds.108.3.636; Goulet C, 2009, JOGNN-J OBST GYN NEO, V38, P7, DOI 10.1111/j.1552-6909.2008.00301.x; Kairys SW, 2001, PEDIATRICS, V108, P206; Karandikar S., 2004, CHILD ABUSE REV, V13, P178, DOI DOI 10.1002/CAR.850; Keenan HT, 2003, JAMA-J AM MED ASSOC, V290, P621, DOI 10.1001/jama.290.5.621; King WJ, 2003, CAN MED ASSOC J, V168, P155; Levitt CJ, 1994, CHILD ABUSE MED DIAG, P1; LUDWIG S, 1984, ANN EMERG MED, V13, P104, DOI 10.1016/S0196-0644(84)80571-5; Minns RA, 2008, AM J PREV MED, V34, pS126, DOI 10.1016/j.amepre.2008.01.016; Nagler J, 2002, CURR OPIN PEDIATR, V14, P251, DOI 10.1097/00008480-200204000-00019; Noar SM, 2006, J HEALTH COMMUN, V11, P21, DOI 10.1080/10810730500461059; Reece RM, 2010, WHITE PAPER SHAKEN B; Reijneveld SA, 2004, LANCET, V364, P1340, DOI 10.1016/S0140-6736(04)17191-2; Runyan DK, 2008, AM J PREV MED, V34, pS112, DOI 10.1016/j.amepre.2008.01.011; Runyan DK, 2009, SOC MARK Q, V15, P2, DOI 10.1080/15245000903304635; Russell BS, 2008, CHILD ABUSE NEGLECT, V32, P949, DOI 10.1016/j.chiabu.2008.05.002	34	22	22	1	18	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0022-5282	1529-8809		J TRAUMA	J. Trauma-Injury Infect. Crit. Care	DEC	2011	71	6					1801	1807		10.1097/TA.0b013e31823c484a			7	Critical Care Medicine; Surgery	General & Internal Medicine; Surgery	869RT	WOS:000298616400066	22182892				2021-06-18	
J	Lin, CY; Wright, J; Bushnik, T; Shem, K				Lin, Cindy Y.; Wright, Jerry; Bushnik, Tamara; Shem, Kazuko			Traumatic Spinal Cord Injuries in Horseback Riding A 35-Year Review	AMERICAN JOURNAL OF SPORTS MEDICINE			English	Article						horseback riding; traumatic spinal cord injury; spine fractures; accidental falls; athletic injuries	EQUESTRIAN INJURIES; UNITED-STATES; RISK-FACTORS; PREVENTION; ACCIDENTS; PATTERNS; SPORTS; RIDERS	Background: Spinal cord injury (SCI) is a potentially disabling neurologic injury that can occur in horseback riding. To date, no published study has examined the epidemiology of SCI from horseback riding in the United States, and few international studies exist on this topic. Several studies have described traumatic brain injuries, spine fractures, and extremity injuries; however, SCI patterns and outcomes in horseback riders are poorly understood. Purpose: This study was undertaken to characterize the demographics, SCI patterns, and neurologic outcomes of persons with SCIs related to horseback riding. Study Design: Descriptive epidemiologic study. Methods: This is a retrospective review of 121 SCI cases from horseback riding in the National SCI Statistical Center database from 1973 to 2008. The treatment setting was 26 U.S. SCI Model Systems of Care. The number of injuries, gender, age, and SCI type for horseback riding were compared with other sports and activities. The level of preserved neurologic function, SCI completeness, American Spinal Injury Association classification, and mechanical ventilation use at discharge were examined in the horseback riding group. Results: The mean age of injury was 37.8 years (standard deviation, 15.2). The majority of patients were white (88%) and female (50.4%). Compared with diving, motorcycle riding, football, and gymnastics, horseback riding involved a significantly higher number of women (P < .005), a higher mean age of injury, and an equal likelihood of resulting in paraplegia and tetraplegia. The most common levels of preserved neurologic function were C4-C6, T12, and L1. Spinal cord injury from horseback riding most commonly resulted in incomplete tetraplegia (41%) followed by complete paraplegia (24%). Only 4 patients required mechanical ventilation on discharge from acute inpatient rehabilitation. Conclusion: Spinal cord injury from horseback riding affects an equal proportion of women and men, has a wide age range, and most commonly results in incomplete tetraplegia followed by complete paraplegia. Study findings improve awareness of the demographics and neurologic outcomes of individuals with SCI from horseback riding and can help guide future studies evaluating SCI mechanisms in horseback riders to improve injury prevention and management.	[Lin, Cindy Y.; Wright, Jerry; Bushnik, Tamara; Shem, Kazuko] Santa Clara Valley Med Ctr, Rehabil Res Ctr, San Jose, CA 95128 USA	Lin, CY (corresponding author), Rehabil Inst Chicago, Spine & Sports Rehabil Ctr, 1030 N Clark St,Suite 500, Chicago, IL 60610 USA.	cindy.lin@post.harvard.edu		Lin, Cindy/0000-0002-1662-8295	National Spinal Cord Injury Statistical Center (NSCISC); Spinal Cord Injury Model Systems (SCIMS); National Institute on Disability and Rehabilitation Research (NIDRR), U.S. Department of EducationUS Department of Education	One or more of the authors has declared the following potential conflict of interest or source of funding: Funding was provided by the National Spinal Cord Injury Statistical Center (NSCISC), Spinal Cord Injury Model Systems (SCIMS), and the National Institute on Disability and Rehabilitation Research (NIDRR), U.S. Department of Education.	Balendra G, 2008, BRIT J SPORT MED, V42, DOI 10.1136/bjsm.2007.038950; Ball CG, 2007, AM J SURG, V193, P636, DOI 10.1016/j.amjsurg.2007.01.016; Ball Jill E, 2009, J Trauma Manag Outcomes, V3, P2, DOI 10.1186/1752-2897-3-2; Banerjee R, 2004, AM J SPORT MED, V32, P1760, DOI 10.1177/0363546504268931; Bixby-Hammett D. M., 1989, SPORTS NEUROLOGY, P229; Boden BP, 2008, NEUROL CLIN, V26, P63, DOI 10.1016/j.ncl.2007.12.005; BROOKS WH, 1988, PHYSICIAN SPORTSMED, V16, P84, DOI 10.1080/00913847.1988.11709646; BROOKS WH, 1998, SPORTS NEUROLOGY, P381; Butterwick DJ, 2002, AM J SPORT MED, V30, P193, DOI 10.1177/03635465020300020801; CAMPAGNOLO D, 2002, SPINAL CORD MED, P96; Cardenas DD, 2004, ARCH PHYS MED REHAB, V85, P1757, DOI 10.1016/j.apmr.2004.03.016; CORDELL K, RECREATION STAT UPDA; Franz T, 2008, BRIT J SPORT MED, V42, DOI 10.1136/bjsm.2007.038166; Ghosh A, 2000, J PEDIATR SURG, V35, P1766, DOI 10.1053/jpsu.2000.19247; KELLY P, 2004, J BONE JOINT SURG S, V86, P122; Lim J, 2003, ANZ J SURG, V73, P567, DOI 10.1046/j.1445-2197.2003.02707.x; Loder RT, 2008, J TRAUMA, V65, P447, DOI 10.1097/TA.0b013e31817dac43; Macciocchi S, 2008, ARCH PHYS MED REHAB, V89, P1350, DOI 10.1016/j.apmr.2007.11.055; Marino RJ., 2003, J SPINAL CORD MED, V26, pS50, DOI [10.1080/10790268.2003.11754575, DOI 10.1080/10790268.2003.11754575]; Mayberry JC, 2007, J TRAUMA, V62, P735, DOI 10.1097/ta.0b013e318031b5d4; McCrory P, 2005, MED SPORT SCI, V48, P8, DOI 10.1159/000084280; Moss PS, 2002, EMERG MED J, V19, P412, DOI 10.1136/emj.19.5.412; Murray JK, 2005, VET J, V170, P318, DOI 10.1016/j.tvjl.2005.05.003; National Spinal Cord Injury Statistical Center, 2006, SPIN CORD INJ MOD SY; National Spinal Cord Injury Statistical Center, SPIN CORD INJ FACTS; *PAR VET AM, 1999, CONS SPIN CORD MED C; Roe JP, 2003, ANZ J SURG, V73, P331, DOI 10.1046/j.1445-2197.2003.t01-1-02618.x; Schmitt H, 2001, CLIN J SPORT MED, V11, P17, DOI 10.1097/00042752-200101000-00004; SCHNECK C, 2002, SPINAL CORD MED, P27; Siebenga J, 2006, EUR SPINE J, V15, P465, DOI 10.1007/s00586-005-1012-5; Silver J R, 1991, Br J Sports Med, V25, P105; Silver JR, 2002, SPINAL CORD, V40, P264, DOI 10.1038/sj.sc.3101280; Sorli J M, 2000, Inj Prev, V6, P59, DOI 10.1136/ip.6.1.59; THOMAS K, 2008, NY TIMES        0409; Thomas KE, 2006, BRIT J SPORT MED, V40, P619, DOI 10.1136/bjsm.2006.025858; Turner M, 2002, BRIT J SPORT MED, V36, P403, DOI 10.1136/bjsm.36.6.403; *US EQ FED, 2009, 2010 US EQ FED RUL B, P85; ZAFONTE RD, 2002, SPINAL CORD MED, P261; US CONSUMER PRODUCT; 1990, MMWR WEEKLY, V39, P329	40	22	23	0	16	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0363-5465			AM J SPORT MED	Am. J. Sports Med.	NOV	2011	39	11					2441	2446		10.1177/0363546511419280			6	Orthopedics; Sport Sciences	Orthopedics; Sport Sciences	838KG	WOS:000296287900022	21856930				2021-06-18	
J	Tlustos, SJ; Chiu, CYP; Walz, NC; Taylor, HG; Yeates, KO; Wade, SL				Tlustos, Sarah J.; Chiu, C. -Y. Peter; Walz, Nicolay Chertkoff; Taylor, H. Gerry; Yeates, Keith Owen; Wade, Shari L.			Emotion Labeling and Socio-Emotional Outcomes 18 Months after Early Childhood Traumatic Brain Injury	JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY			English	Article						Head injury; Emotion; Longitudinal studies; Social adjustment; Pediatric; Chronic brain injury	NONVERBAL-COMMUNICATION; FUNCTIONAL RECOVERY; READING EMOTIONS; SOCIAL OUTCOMES; HEAD-INJURY; SHORT-TERM; RECOGNITION; CHILDREN; VULNERABILITY; PREDICTORS	A growing body of literature has documented evidence for emotion labeling (EL) deficits after traumatic brain injury (TBI); however, long-term effects of TBI on EL abilities, particularly among young children, are unclear. We investigated EL abilities and socio-emotional outcomes in 32 children with moderate-severe TBI, 23 with complicated-mild TBI, and 82 children with orthopedic injuries (OI), shortly after injury and at 18 months post-injury. All children were between 3: 0 and 6: 11 years of age at the time of injury. Repeated measures analyses indicated that all groups showed improved EL performance between acute and 18-month assessments, but that the moderate-severe TBI group improved at a slower rate than the OI group, so that the two groups showed significantly different performance at 18 months. Emotion labeling ability did not significantly contribute to the prediction of socio-emotional outcomes after controlling for pre-injury functioning. These results provide preliminary evidence of emerging EL deficits after early childhood TBI that are related to injury severity but that do not predict social and behavioral outcomes. (JINS, 2011, 17, 1132-1142)	[Wade, Shari L.] Cincinnati Childrens Hosp Med Ctr, Dept Pediat, Div Phys Med & Rehabil, Cincinnati, OH 45229 USA; [Tlustos, Sarah J.; Chiu, C. -Y. Peter] Univ Cincinnati, Dept Psychol, Cincinnati, OH 45221 USA; [Chiu, C. -Y. Peter] Univ Cincinnati, Dept Commun Sci & Disorders, Cincinnati, OH USA; [Walz, Nicolay Chertkoff] Cincinnati Childrens Hosp Med Ctr, Div Behav Med & Clin Psychol, Dept Pediat, Cincinnati, OH 45229 USA; [Walz, Nicolay Chertkoff; Wade, Shari L.] Univ Cincinnati, Coll Med, Cincinnati, OH USA; [Taylor, H. Gerry] Case Western Reserve Univ, Dept Pediat, Div Dev & Behav Pediat & Psychol, Cleveland, OH 44106 USA; [Taylor, H. Gerry] Univ Hosp Case Med Ctr, Rainbow Babies & Childrens Hosp, Cleveland, OH USA; [Yeates, Keith Owen] Ohio State Univ, Dept Pediat, Div Psychol, Columbus, OH 43210 USA; [Yeates, Keith Owen] Nationwide Childrens Hosp, Res Inst, Ctr Biobehav Hlth, Columbus, OH USA	Wade, SL (corresponding author), Cincinnati Childrens Hosp Med Ctr, Dept Rehabil, 3333 Burnet Ave,MLC 4009, Cincinnati, OH 45229 USA.	shari.wade@cchmc.org	Yeates, Keith/AAJ-4223-2020	Yeates, Keith/0000-0001-7680-2892	NICHDUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01 HD42729]; State of Ohio Emergency Medical Services; NIH/NCRRUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [1UL1RR026314]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD042729] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [UL1RR026314] Funding Source: NIH RePORTER	This work is supported by grant R01 HD42729 from NICHD and by Trauma Research grants from the State of Ohio Emergency Medical Services. This publication was also supported by an Institutional Clinical and Translational Science Award, NIH/NCRR Grant Number 1UL1RR026314. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the NIH. Portions of this work have been presented at the 8th World Congress on Brain Injury in Washington, DC (March 2010). The information in this manuscript is an original contribution to the literature and has not previously been published, electronically or in print. The authors certify that we know of no conflict of interest, and we adhere to the ethical guidelines of the Helsinki Declaration.	Achenbach T. M., 2000, MANUAL ASEBA PRESCHO; Achenbach TM, 2001, MANUAL ASEBA SCH AGE; Adolphs R, 2001, CURR OPIN NEUROBIOL, V11, P231, DOI 10.1016/S0959-4388(00)00202-6; Anderson V, 2005, PEDIATRICS, V116, P1374, DOI 10.1542/peds.2004-1728; Anderson VA, 2006, NEUROPSYCHOLOGY, V20, P42, DOI 10.1037/0894-4105.20.1.42; Anderson VA, 2004, BRAIN, V127, P2608, DOI 10.1093/brain/awh320; Beauchamp MH, 2010, PSYCHOL BULL, V136, P39, DOI 10.1037/a0017768; Bornhofen C, 2008, J INT NEUROPSYCH SOC, V14, P511, DOI 10.1017/S1355617708080703; Caldarella, 2002, HOME COMMUNITY SOCIA; Catroppa C, 2008, J PEDIATR PSYCHOL, V33, P707, DOI 10.1093/jpepsy/jsn006; Chapman LA, 2010, REHABIL PSYCHOL, V55, P48, DOI 10.1037/a0018418; Chapman SB, 2000, J COMMUN DISORD, V33, P333, DOI 10.1016/S0021-9924(00)00029-0; Crick NR, 1996, CHILD DEV, V67, P993, DOI 10.2307/1131875; Croker V, 2005, BRAIN INJURY, V19, P787, DOI 10.1080/02699050500110033; Denham SA, 2003, CHILD DEV, V74, P238, DOI 10.1111/1467-8624.00533; Eisenberg N, 2009, DEV PSYCHOL, V45, P988, DOI 10.1037/a0016213; Elliott C.D., 1990, DIFFERENTIAL ABILITI; Frith U, 2001, CURR DIR PSYCHOL SCI, V10, P151, DOI 10.1111/1467-8721.00137; Ganesalingam K, 2006, J INT NEUROPSYCH SOC, V12, P609, DOI 10.1017/S1355617706060796; Gouick J, 2004, TRAUMA, V6, P285, DOI DOI 10.1191/1460408604TA3230A; Green REA, 2004, NEUROPSYCHOLOGIA, V42, P133, DOI 10.1016/j.neuropsychologia.2003.07.005; Hanten G, 2008, NEUROPSYCHOLOGY, V22, P357, DOI 10.1037/0894-4105.22.3.357; Harrison P., 2003, ADAPTIVE BEHAV ASSES; Herba C, 2004, J CHILD PSYCHOL PSYC, V45, P1185, DOI 10.1111/j.1469-7610.2004.00316.x; Ietswaart M, 2008, NEUROPSYCHOLOGIA, V46, P148, DOI 10.1016/j.neuropsychologia.2007.08.002; Janusz JA, 2002, CHILD NEUROPSYCHOL, V8, P179, DOI 10.1076/chin.8.3.179.13499; Kilts CD, 2003, NEUROIMAGE, V18, P156, DOI 10.1006/nimg.2002.1323; Leerkes EM, 2008, MERRILL PALMER QUART, V54, P102, DOI 10.1353/mpq.2008.0009; Lemerise EA, 2000, CHILD DEV, V71, P107, DOI 10.1111/1467-8624.00124; McKinlay A, 2010, INJURY PREV, V16, P31, DOI 10.1136/ip.2009.022483; Merrell K.W., 2002, PRESCHOOL KINDERGART; Milders M, 2008, J INT NEUROPSYCH SOC, V14, P318, DOI 10.1017/S1355617708080351; NOWICKI S, 1994, J NONVERBAL BEHAV, V18, P9, DOI 10.1007/BF02169077; Nowicki S, 2003, MANUAL RECEPTIVE TES; Saarni C., 2007, HDB CHILD PSYCHOL, P226, DOI [DOI 10.1002/9780470147658.CHPSY0305, 10.1002/9780470147658.chpsy0305]; Schmidt AT, 2010, NEUROPSYCHOLOGIA, V48, P2869, DOI 10.1016/j.neuropsychologia.2010.05.029; Spell LA, 2000, J NONVERBAL BEHAV, V24, P285, DOI 10.1023/A:1006675230193; TEASDALE G, 1974, LANCET, V2, P81; Tonks J, 2008, BRAIN INJURY, V22, P325, DOI 10.1080/02699050801968303; Tonks J, 2007, BRAIN INJURY, V21, P731, DOI 10.1080/02699050701426899; Tonks J, 2009, DEV MED CHILD NEUROL, V51, P8, DOI 10.1111/j.1469-8749.2008.03219.x; Weatherington C.E., 2006, EXCEPTIONALITY, V14, P155; Wilde EA, 2005, J NEUROTRAUM, V22, P333, DOI 10.1089/neu.2005.22.333; Wilde EA, 2006, J CHILD NEUROL, V21, P769, DOI 10.1177/08830738060210090201; WILLIAMS DH, 1990, NEUROSURGERY, V27, P422, DOI 10.1227/00006123-199009000-00014; Yeates KO, 2007, PSYCHOL BULL, V133, P535, DOI 10.1037/0033-2909.133.3.535; Yeates KO, 2004, J INT NEUROPSYCH SOC, V10, P412, DOI 10.1017/S1355617704103093; Yeates KO, 2002, NEUROPSYCHOLOGY, V16, P514, DOI 10.1037//0894-4105.16.4.514	48	22	22	0	15	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1355-6177	1469-7661		J INT NEUROPSYCH SOC	J. Int. Neuropsychol. Soc.	NOV	2011	17	6					1132	1142		10.1017/S1355617711001202			11	Clinical Neurology; Neurosciences; Psychiatry; Psychology	Neurosciences & Neurology; Psychiatry; Psychology	848DF	WOS:000297028500020	21923972	Green Accepted			2021-06-18	
J	Doig, E; Fleming, J; Kuipers, P; Cornwell, P; Khan, A				Doig, Emmah; Fleming, Jennifer; Kuipers, Pim; Cornwell, Petrea; Khan, Asad			Goal-directed outpatient rehabilitation following TBI: A pilot study of programme effectiveness and comparison of outcomes in home and day hospital settings	BRAIN INJURY			English	Article						Brain injury; occupational therapy; goals	TRAUMATIC BRAIN-INJURY; OCCUPATIONAL PERFORMANCE-MEASURE; SELF-IDENTIFIED GOALS; THERAPY; ADULTS; ACHIEVEMENT; PATIENT; UTILITY; PEOPLE	Primary objective: To determine (i) the effectiveness of a goal-directed, environment-focused occupational therapy intervention and (ii) to compare rehabilitation gains across a day hospital (outpatient) setting and home setting. Research design: Repeated measures cross-over design with pre-post test measures and a baseline control period, random allocation to a treatment setting sequence and an independent outcome assessor who was blinded to treatment sequence. Methods and procedures: Descriptive and non-parametric comparative analyses employed. Fourteen participants with severe traumatic brain injury completed a 12 week outpatient occupational therapy programme. The programme was directed by the participant's chosen goals, which were established using a client-centred, structured, goal-planning process. Outcome measures included Goal attainment scaling, the Canadian Occupational Performance Measure, the Sydney Psychosocial Reintegration Scale, the Mayo-Portland Adaptability Index, the Craig Hospital Inventory of Environmental Factors and self-rated satisfaction with therapy. Main outcomes and results: The therapy programme resulted in significant improvements in goal attainment, occupational performance, psychosocial reintegration and ability and adjustment levels, compared with baseline. Differences in gains made in home vs day hospital settings were not statistically significant, with the exception of higher levels of patient satisfaction with therapy at home. Conclusions: To assist further with decision-making about where to conduct therapy, further research is needed to compare the outcomes and determine the cost effectiveness of therapy at home and in day hospital settings.	[Doig, Emmah; Fleming, Jennifer; Cornwell, Petrea; Khan, Asad] Univ Queensland, Sch Hlth & Rehabil Sci, Brisbane, Qld 4072, Australia; [Kuipers, Pim] Griffith Univ, Ctr Functioning Disabil & Hlth Res, Princess Alexandra Hosp, Meadowbrook, Qld 4131, Australia; [Kuipers, Pim] Griffith Univ, Griffith Abil Res Programme, Meadowbrook, Qld 4131, Australia; Griffith Univ, Griffith Hlth Inst, Metro No Hlth Serv Dist N, Queensland Hlth, Mt Gravatt, Qld 4122, Australia	Doig, E (corresponding author), Univ Queensland, Sch Hlth & Rehabil Sci, Brisbane, Qld 4072, Australia.	emmah.doig@optusnet.com.au	Khan, Asad/N-7481-2019; Doig, Emmah/AAG-6674-2021; Cornwell, Petrea/AAE-5547-2019; Khan, Asad/R-8484-2016; Khan, Asaduzzaman/F-8739-2010	Khan, Asad/0000-0003-4188-2065; Doig, Emmah/0000-0002-7020-053X; Khan, Asad/0000-0003-4188-2065; Khan, Asaduzzaman/0000-0003-4188-2065; Kuipers, Pim/0000-0003-0340-2286	Princess Alexandra Hospital Foundation; Queensland Health Community Rehabilitation Research Scheme; University of QueenslandUniversity of Queensland	We thank the Princess Alexandra Hospital Foundation and the Queensland Health Community Rehabilitation Research Scheme for providing grants to undertake this research. The principal researcher was in receipt of a University of Queensland Postgraduate Research Scholarship whilst conducting this research.	*AM OCC THER ASS, 1997, AM J OCCUPATIONAL TH, V51, P564; [Anonymous], 1994, Am J Occup Ther, V48, P1047; Bodiam C., 1999, BR J OCCUP THER, V62, P123, DOI DOI 10.1177/030802269906200310; Craig Hospital Research Department, 2001, CRAIG HOSP INV ENV F; Dawson DR, 2009, CAN J OCCUP THER, V76, P115, DOI 10.1177/000841740907600209; Doig E, 2001, BRAIN INJURY, V15, P747, DOI 10.1080/02699050110034343; Doig E, 2011, DISABIL REHABIL, V33, P1203, DOI 10.3109/09638288.2010.525286; Doig E, 2010, AM J OCCUP THER, V64, P904, DOI 10.5014/ajot.2010.08156; Doig E, 2010, DISABIL REHABIL, V32, P2061, DOI 10.3109/09638281003797356; Doig E, 2009, AM J OCCUP THER, V63, P559, DOI 10.5014/ajot.63.5.559; GAUGGEL S, 2004, HDB MOTIVATIONAL COU; Jenkinson N, 2007, BRAIN INJURY, V21, P1283, DOI 10.1080/02699050701739531; JOYCE BM, 1994, AM J PHYS MED REHAB, V73, P10, DOI 10.1097/00002060-199473010-00003; KIRESUK TJ, 1968, COMMUNITY MENT HLT J, V4, P443, DOI 10.1007/BF01530764; KREUTZER JS, 1992, ARCH PHYS MED REHAB, V73, P771; KUIPERS P, 1999, J COGNITIVE REHABILI, V17, P6; Landa-Gonzalez BELKIS, 2001, Occup Ther Int, V8, P49, DOI 10.1002/oti.131; Lannin Natasha, 2003, Occup Ther Health Care, V17, P43, DOI 10.1080/J003v17n01_04; Law M, 1998, CANADIAN OCCUPATIONA; Law M., 1996, CANADIAN J OCCUPATIO, V63, P9, DOI [10.1177/000841749606300103, DOI 10.1177/000841749606300103]; Law M., 1994, CANADIAN OCCUPATIONA; Leach E, 2010, DISABIL REHABIL, V32, P159, DOI 10.3109/09638280903036605; Leathem J, 1996, BRAIN INJURY, V10, P27; Malec J. F., 2003, MANUAL MAYO PORTLAND; Malec JF, 2003, J HEAD TRAUMA REHAB, V18, P479, DOI 10.1097/00001199-200311000-00002; MALEC JF, 1991, ARCH PHYS MED REHAB, V72, P138; McPherson KM, 2009, CLIN REHABIL, V23, P296, DOI 10.1177/0269215509102980; OCONNOR P, 2002, HOSPITALISATION DUE; OTTENBACHER KJ, 1990, AM J OCCUP THER, V44, P519, DOI 10.5014/ajot.44.6.519; Phipps S, 2007, AM J OCCUP THER, V61, P328, DOI 10.5014/ajot.61.3.328; Ponsford J, 2006, NEUROPSYCHOL REHABIL, V16, P315, DOI 10.1080/09602010500176534; Portney L., 2015, FDN CLIN RES APPL PR, V3rd ed.; Rockwood K, 1997, J CLIN EPIDEMIOL, V50, P581, DOI 10.1016/S0895-4356(97)00014-0; Schneidert M, 2003, DISABIL REHABIL, V25, P588, DOI 10.1080/0963828031000137090; Siegert R, 2004, DISABIL REHABIL, V26, P1, DOI 10.1080/09638280410001644932; SPSS Inc, 2007, STAT PACK SOC SCI; TATE RL, 1999, J HEAD TRAUMA REHAB, V14, P453; Trombly CA, 1998, AM J OCCUP THER, V52, P810, DOI 10.5014/ajot.52.10.810; Trombly CA, 2002, AM J OCCUP THER, V56, P489, DOI 10.5014/ajot.56.5.489; TURNERSTOKES L, 2005, COCHRANE DB SYST REV, V3, DOI DOI 10.1016/S0079-6123(09)17707-5; Von Koch L, 1998, DISABIL REHABIL, V20, P367, DOI 10.3109/09638289809166095; Wade DT, 2009, CLIN REHABIL, V23, P291, DOI 10.1177/0269215509103551; WEBB PM, 1994, REHABIL PSYCHOL, V39, P179, DOI 10.1037/h0080321; Willer B, 1999, ARCH PHYS MED REHAB, V80, P399, DOI 10.1016/S0003-9993(99)90276-9; WILSON BA, 2003, BRAIN IMPAIR, V4, P25, DOI DOI 10.1375/BRIM.4.1.25.27030; Wressle E, 2002, J REHABIL MED, V34, P5, DOI 10.1080/165019702317242640	46	22	24	0	12	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	OCT	2011	25	11					1114	1125		10.3109/02699052.2011.607788			12	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	829WC	WOS:000295614900010	21902462				2021-06-18	
J	Findling, O; Schuster, C; Sellner, J; Ettlin, T; Allum, JHJ				Findling, O.; Schuster, C.; Sellner, J.; Ettlin, T.; Allum, J. H. J.			Trunk sway in patients with and without, mild traumatic brain injury after whiplash injury	GAIT & POSTURE			English	Article						Balance; Posture; Whiplash; Mild traumatic brain injury	DIZZINESS HANDICAP INVENTORY; POSTURAL STABILITY; HEAD-INJURY; BALANCE; PAIN; GAIT; RELIABILITY; MANAGEMENT; SYMPTOMS; STANCE	Objective: This study assessed the addition effect of mild traumatic brain injury (MTBI) on the balance control of patients who simultaneously suffered a whiplash associated disorder (WAD). Background: Dizziness is common in patients suffering from whiplash injury with or without a MTBI, but data is lacking about the additional balance problems and dizziness caused by MTBI. Methods: 44 patients with WAD and MTBI and 36 WAD patients without MTBI participated in the study. A dizziness handicap index (DHI) was used to quantify self-perceived handicap. Balance control was assessed using measures of trunk sway for a battery of stance and gait tests. Results: Patients with WAD and MTBI perceived significantly higher dizziness and unsteadiness (higher score in DHI Emotional category) and had greater trunk sway than WAD patients without MTBI for stance tasks and complex gait tasks (e.g. walking up and down stairs). Both groups had greater sway than controls for these tasks. Both groups of patients showed equal reductions in trunk sway with respect to controls for simple gait tasks (e.g. walking while rotating the head). Conclusions: A similar pattern of balance impairment was present in patients with whiplash injury with and without MTBI. However, the impairment was greater for stance and complex gait tasks in WAD patients with MTBI. (C) 2011 Elsevier B.V. All rights reserved.	[Allum, J. H. J.] Univ Basel, Univ Basel Hosp, Dept Otorhinolaryngol, CH-4031 Basel, Switzerland; [Findling, O.; Schuster, C.; Ettlin, T.] Reha Rheinfelden, Rheinfelden, Switzerland; [Findling, O.] Univ Hosp Bern, Dept Neurol, Inselspital, Bern, Switzerland; [Findling, O.] Univ Bern, CH-3012 Bern, Switzerland; [Sellner, J.] Tech Univ Munich, Klinikum Rechts Isar, Dept Neurol, D-81675 Munich, Germany	Allum, JHJ (corresponding author), Univ Basel, Univ Basel Hosp, Dept Otorhinolaryngol, Petersgraben 4, CH-4031 Basel, Switzerland.	jallum@uhbs.ch	Schuster, Corina/B-6939-2008; Selllner, Johann/AAB-1263-2019; Findling, Oliver/AAE-3815-2019	Schuster-Amft, Corina/0000-0003-1120-4423	Swiss National Research FoundationSwiss National Science Foundation (SNSF) [31.104212/1]; Swiss Accident Insurance Organisation (SUVA)	This work was supported by grants from the Swiss National Research Foundation (Grant No. 31.104212/1) and Swiss Accident Insurance Organisation (SUVA) to JHJ Allum.	ALEXANDER MP, 1995, NEUROLOGY, V45, P1253, DOI 10.1212/WNL.45.7.1253; Allum JHJ, 2005, CURR OPIN NEUROL, V18, P15, DOI 10.1097/00019052-200502000-00005; Bazarian JJ, 2007, J NEUROTRAUM, V24, P1447, DOI 10.1089/neu.2007.0241; CDC (Centers for Disease Control) and Prevention NCf1PaC, 2003, MILD TRAUM BRAIN INJ; DEANS GT, 1986, BRIT MED J, V292, P94, DOI 10.1136/bmj.292.6513.94-a; Dolinis J, 1997, INJURY, V28, P173, DOI 10.1016/S0020-1383(96)00186-6; Endo K, 2006, EUR SPINE J, V15, P886, DOI 10.1007/s00586-005-0970-y; Evans R, 2000, PROGNOSIS NEUROLOGIC, P152; FERRAZ MB, 1990, J RHEUMATOL, V17, P1022; Giacomini P, 1997, Acta Otorhinolaryngol Ital, V17, P409; Hegeman J, 2007, J VESTIBUL RES-EQUIL, V17, P75; HILDINGSSON C, 1990, ACTA ORTHOP SCAND, V61, P357, DOI 10.3109/17453679008993536; Horlings CGC, 2009, NEUROSCIENCE, V161, P904, DOI 10.1016/j.neuroscience.2009.04.005; JACOBSON GP, 1990, ARCH OTOLARYNGOL, V116, P424; Karlsborg M, 1997, ACTA NEUROL SCAND, V95, P65, DOI 10.1111/j.1600-0404.1997.tb00071.x; Konrad C, 2011, PSYCHOL MED, V41, P1197, DOI 10.1017/S0033291710001728; Kurre A, 2009, OTOL NEUROTOL, V30, P359, DOI 10.1097/MAO.0b013e3181977e09; Lange RT, 2010, J CLIN EXP NEUROPSYC, V32, P961, DOI 10.1080/13803391003645657; Loudon JK, 1997, SPINE, V22, P865, DOI 10.1097/00007632-199704150-00008; Mallinson AI, 1998, AM J OTOL, V19, P814; Obelieniene D, 1999, J NEUROL NEUROSUR PS, V66, P279, DOI 10.1136/jnnp.66.3.279; Polusny MA, 2011, ARCH GEN PSYCHIAT, V68, P79, DOI 10.1001/archgenpsychiatry.2010.172; RADANOV BP, 1995, MEDICINE, V74, P281, DOI 10.1097/00005792-199509000-00005; Riemann BL, 2000, J ATHL TRAINING, V35, P19; Sjostrom H, 2003, SPINE, V28, P1725, DOI 10.1097/00007632-200308010-00018; Slobounov S, 2008, CLIN NEUROPHYSIOL, V119, P281, DOI 10.1016/j.clinph.2007.10.006; SPITZER WO, 1995, SPINE, V20, pS1; STEIN SC, 1995, BRAIN INJURY, V9, P437, DOI 10.3109/02699059509008203; Tolonen A, 2007, J REHABIL MED, V39, P622, DOI 10.2340/16501977-0101; Van de Warrenburg BPC, 2005, MOVEMENT DISORD, P1006; Vonk J, 2010, AUDIOL NEURO-OTOL, V15, P261, DOI 10.1159/000258682; Williamson E, 2008, PAIN, V135, P20, DOI 10.1016/j.pain.2007.04.035	32	22	22	0	7	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0966-6362	1879-2219		GAIT POSTURE	Gait Posture	OCT	2011	34	4					473	478		10.1016/j.gaitpost.2011.06.021			6	Neurosciences; Orthopedics; Sport Sciences	Neurosciences & Neurology; Orthopedics; Sport Sciences	841AQ	WOS:000296484800006	21803583				2021-06-18	
J	Jackson, JC; Archer, KR; Bauer, R; Abraham, CM; Song, YN; Greevey, R; Guillamondegui, O; Ely, EW; Obremskey, W				Jackson, James C.; Archer, Kristin R.; Bauer, Rebecca; Abraham, Christine M.; Song, Yanna; Greevey, Robert; Guillamondegui, Oscar; Ely, E. Wesley; Obremskey, William			A Prospective Investigation of Long-Term Cognitive Impairment and Psychological Distress in Moderately Versus Severely Injured Trauma Intensive Care Unit Survivors Without Intracranial Hemorrhage	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article						Trauma; Delirium; Cognitive impairment; Neuropsychological assessment; Pain; Quality of life; PTSD; Depression; Critical care	POSTTRAUMATIC-STRESS-DISORDER; MINI-MENTAL-STATE; INFORMANT QUESTIONNAIRE; ELDERLY IQCODE; DELIRIUM; DECLINE; HEALTH; MILD; VALIDATION; OUTCOMES	Background: The primary objective was to prospectively determine the 12-month prevalence of cognitive impairment and psychologic difficulties in moderately versus severely injured adult trauma intensive care unit (TICU) survivors without intracranial hemorrhage. Methods: We conducted a prospective cohort study in which patients were followed for 1 year after hospital discharge. A total of 173 patients from the Vanderbilt TICU who had an Injury Severity Score (ISS) of > 15 (indicative of moderately severe trauma) were enrolled between July 2006 and June 2007. Patients were screened for delirium on a daily basis in the TICU by study personnel via the confusion assessment method of the ICU, and preexisting cognitive impairment was assessed through a surrogate-based evaluation using the short form of the Informant Questionnaire for Cognitive Decline in the Elderly. Of these patients, 108 were evaluated 1 year after hospital discharge with a comprehensive battery of neuropsychological tests and depression and posttraumatic stress disorder (PTSD) instruments. Cognitive impairment was defined as having two neuropsychological test scores 1.5 SD below the mean or one neuropsychological test score 2 SD below the mean. Results: Fifty-nine patients (55%) demonstrated cognitive impairment at 12-month follow-up, with three of these patients (5.5%) having preexisting impairment. Clinically significant symptoms of depression and PTSD occurred in 40% and 26% of patients, respectively. No significant differences in cognitive impairment (59% vs. 50%), depressive symptoms (35% vs. 44%), and symptoms of PTSD (22% vs. 28%) were identified between moderately (ISS 15-25) and severely (ISS > 25) injured TICU survivors, respectively (all p > 0.05). In addition, multivariate logistic regression analysis found that moderately injured trauma patients had a similar rate of cognitive impairment when compared with those with severe injury at 12-month follow-up (p = 0.25). Conclusion: Long-term cognitive impairment is highly prevalent in TICU survivors without intracranial hemorrhage as are psychologic difficulties. Injury severity, concussion status, and delirium duration were not risk factors for the development of neuropsychological deficits in this cohort. Individuals with moderately severe injuries seem to be as likely as their more severely injured counterparts to experience marked cognitive impairment and psychologic difficulties; thus, screening efforts should focus on this potentially overlooked patient group.	[Jackson, James C.; Ely, E. Wesley] Vanderbilt Univ, Med Ctr, Div Allergy Pulm Crit Care Med, Ctr Hlth Serv Res, Nashville, TN 37232 USA; [Jackson, James C.] Vanderbilt Univ, Med Ctr, Dept Psychiat, Nashville, TN 37232 USA; [Archer, Kristin R.; Bauer, Rebecca; Abraham, Christine M.; Greevey, Robert; Obremskey, William] Vanderbilt Univ, Med Ctr, Div Trauma & Surg Crit Care, Nashville, TN 37232 USA; Vanderbilt Univ, Med Ctr, Dept Orthoped & Rehabil, Nashville, TN 37232 USA; [Song, Yanna; Greevey, Robert] Vanderbilt Univ, Med Ctr, Dept Biostat, Nashville, TN 37232 USA; [Jackson, James C.; Greevey, Robert; Ely, E. Wesley] Middle TN VA Med Ctr, Geriatr Educ & Clin Ctr GRECC, Nashville, TN USA	Jackson, JC (corresponding author), Vanderbilt Univ, Med Ctr, Div Allergy Pulm Crit Care Med, Ctr Hlth Serv Res, 6th Floor,Med Ctr E 6109, Nashville, TN 37232 USA.	james.c.jackson@vanderbilt.edu	Ely, E. Wesley/Z-2018-2019	Ely, E. Wesley/0000-0003-3957-2172	Orthopedic Research and Education Foundation	Orthopedic Research and Education Foundation support and Internal Orthopedic Trauma funding was provided for the completion of this study.	Beck AT, 1996, BDI 2 DEPRESSION INV; CRICHLOW RJ, 2010, J BONE JOINT SURG, V88, P1927; CRUM RM, 1993, JAMA-J AM MED ASSOC, V269, P2386, DOI 10.1001/jama.269.18.2386; Davidson JRT, 1997, PSYCHOL MED, V27, P153, DOI 10.1017/S0033291796004229; DAVIDSON JRT, 1991, PSYCHOL MED, V21, P713, DOI 10.1017/S0033291700022352; DAVIDSON JRT, 1996, DAVIDSON TRAUMA SCAL, P1; Davydow DS, 2008, GEN HOSP PSYCHIAT, V30, P421, DOI 10.1016/j.genhosppsych.2008.05.006; Dossett LA, 2009, INJURY, V40, P993, DOI 10.1016/j.injury.2009.03.004; Ely EW, 2001, CRIT CARE MED, V29, P1370, DOI 10.1097/00003246-200107000-00012; Ely EW, 2001, J AM GERIATR SOC, V49, pS2; FILDES JJ, 2005, NATL TRAUMA DATA BAN; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; GIRARD TD, 2009, AM J RESP CRIT CARE, V179, pA5477; GIRARD TD, 2006, P AM THORAC SOC, V3, pA739; Gordon SM, 2004, INTENS CARE MED, V30, P1997, DOI 10.1007/s00134-004-2418-y; Heaton RK, 2004, REVISED COMPREHENSIV; Heskestad B, 2008, J TRAUMA, V65, P1309, DOI 10.1097/TA.0b013e31815e40cd; Hilsabeck RC, 2002, HEPATOLOGY, V35, P440, DOI 10.1053/jhep.2002.31257; Hopkins RO, 2006, CHEST, V130, P869, DOI 10.1378/chest.130.3.869; Hopkins RO, 2005, AM J RESP CRIT CARE, V171, P340, DOI 10.1164/rccm.200406-763OC; Hopkins RO, 1999, AM J RESP CRIT CARE, V160, P50, DOI 10.1164/ajrccm.160.1.9708059; Jackson JC, 2007, CRIT CARE, V11, DOI 10.1186/cc5707; Jackson JC, 2007, J TRAUMA, V62, P80, DOI 10.1097/TA.0b013e31802ce9bd; Jackson JC, 2004, NEUROPSYCHOL REV, V14, P87, DOI 10.1023/B:NERV.0000028080.39602.17; Jackson JC, 2004, INTENS CARE MED, V30, P2009, DOI 10.1007/s00134-004-2422-2; Jackson JC, 2003, CRIT CARE MED, V31, P1226, DOI 10.1097/01.CCM.0000059996.30263.94; JORM AF, 1994, PSYCHOL MED, V24, P145, DOI 10.1017/S003329170002691X; Jorm AF, 2004, INT PSYCHOGERIATR, V16, P275, DOI 10.1017/S1041610204000390; Kay T., 1993, J HEAD TRAUMA REHABI, V8, P86, DOI [10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; Levin HS, 2008, J NEUROSURG-PEDIATR, V1, P461, DOI 10.3171/PED/2008/1/6/461; Lezak MD, 1995, NEUROPSYCHOLOGICAL A; Mathiesen HK, 2006, ARCH NEUROL-CHICAGO, V63, P533, DOI 10.1001/archneur.63.4.533; MILLER L, 2010, BMC HEALTH SERV RES, V4, P7; Pandharipande P, 2008, J TRAUMA, V65, P34, DOI 10.1097/TA.0b013e31814b2c4d; Quale AJ, 2009, INJURY, V40, P498, DOI 10.1016/j.injury.2008.11.006; Reitan RM., 1985, HALSTEAD REITAN NEUR; Rey A, 1964, EXAMEN CLIN PSYCHOL; Rey A, 1941, ARCH PSYCHOLOGIE, V28, P286; Soberg HL, 2010, ARCH PHYS MED REHAB, V91, P481, DOI 10.1016/j.apmr.2009.11.007; Spreen O., 1998, COMPENDIUM NEUROPSYC; Sukantarat KT, 2005, ANAESTHESIA, V60, P847, DOI 10.1111/j.1365-2044.2005.04148.x; Vardy J, 2006, SUPPORT CARE CANCER, V14, P1111, DOI 10.1007/s00520-006-0037-6; WECHSLER D, 1997, WAIS 3 TECHNICAL MAN; WILLIAMS DH, 1990, NEUROSURGERY, V27, P422, DOI 10.1227/00006123-199009000-00014; Wong DT, 1996, CRIT CARE MED, V24, P1642, DOI 10.1097/00003246-199610000-00007	45	22	23	0	6	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0022-5282	1529-8809		J TRAUMA	J. Trauma-Injury Infect. Crit. Care	OCT	2011	71	4					860	866		10.1097/TA.0b013e3182151961			7	Critical Care Medicine; Surgery	General & Internal Medicine; Surgery	833ZT	WOS:000295925700021	21537211				2021-06-18	
J	Viswanathan, V; Eugster, EA				Viswanathan, Vidhya; Eugster, Erica A.			Etiology and Treatment of Hypogonadism in Adolescents	PEDIATRIC CLINICS OF NORTH AMERICA			English	Article						Hypergonadotropic hypogonadism; Hypogonadotropic hypogonadism; Adolescents; Delayed puberty; Treatment	ADRENAL HYPOPLASIA CONGENITA; FOLLICLE-STIMULATING-HORMONE; TRAUMATIC BRAIN-INJURY; PRADER-WILLI-SYNDROME; IDIOPATHIC HYPOGONADOTROPIC HYPOGONADISM; COMPLETE ANDROGEN INSENSITIVITY; GENOTYPE-PHENOTYPE CORRELATIONS; TESTICULAR REGRESSION SYNDROME; ACUTE LYMPHOBLASTIC-LEUKEMIA; VAGINAL LENGTH MEASUREMENT	Adequate functioning at all levels of the hypothalamic-pituitary-gonadal axis is necessary for normal gonadal development and subsequent sex steroid production. Deficiencies at any level of the axis can lead to a hypogonadal state. The causes of hypogonadism are heterogeneous and may involve any level of the reproductive system. This review discusses various causes of hypogonadism, describes the evaluation of hypogonadal states, and outlines treatment options for the induction of puberty in affected adolescents. Whereas some conditions are clearly delineated, the exact etiology and underlying pathogenesis of many disorders is unknown.	[Viswanathan, Vidhya; Eugster, Erica A.] Indiana Univ Sch Med, Sect Pediat Endocrinol, Dept Pediat, Riley Hosp Children, Indianapolis, IN 46202 USA	Viswanathan, V (corresponding author), Indiana Univ Sch Med, Sect Pediat Endocrinol, Dept Pediat, Riley Hosp Children, Room 5960,702 Barnhill Dr, Indianapolis, IN 46202 USA.	vviswana@iupui.edu			NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK) [T32DK065549] Funding Source: NIH RePORTER; NIDDK NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK) [T32 DK065549] Funding Source: Medline		Abulhasan SJ, 1999, ANN HUM GENET, V63, P199, DOI 10.1046/j.1469-1809.1999.6330199.x; Achermann JC, 2001, MOL CELL ENDOCRINOL, V179, P89, DOI 10.1016/S0303-7207(01)00474-9; AHONEN P, 1987, J CLIN ENDOCR METAB, V64, P494, DOI 10.1210/jcem-64-3-494; AITTOMAKI K, 1994, AM J HUM GENET, V54, P844; Akefeldt A, 1999, DEV MED CHILD NEUROL, V41, P789, DOI 10.1017/S0012162299221573; al Kandari Hessa, 2006, J Clin Endocrinol Metab, V91, P2821, DOI 10.1210/jc.2005-2230; Andreu JAL, 2000, PEDIATR HEMAT ONCOL, V17, P21, DOI 10.1080/088800100276631; Ankarberg-Lindgren C, 2001, J CLIN ENDOCR METAB, V86, P3039, DOI 10.1210/jc.86.7.3039; APTER D, 1993, J CLIN ENDOCR METAB, V76, P940, DOI 10.1210/jc.76.4.940; Arnhold IJP, 1999, CLIN ENDOCRINOL, V51, P701, DOI 10.1046/j.1365-2265.1999.00863.x; Arslanian S, 1997, J CLIN ENDOCR METAB, V82, P3213, DOI 10.1210/jc.82.10.3213; Baker BY, 2006, J CLIN ENDOCR METAB, V91, P4781, DOI 10.1210/jc.2006-1565; Benvenga S, 2000, J CLIN ENDOCR METAB, V85, P1353, DOI 10.1210/jc.85.4.1353; BERGADA I, 1995, J PEDIATR ENDOCR MET, V8, P117; Biason-Lauber A, 2000, AM J HUM GENET, V67, P1563, DOI 10.1086/316893; Bojesen A, 2003, J CLIN ENDOCR METAB, V88, P622, DOI 10.1210/jc.2002-021491; Bondy CA, 2007, J CLIN ENDOCR METAB, V92, P10, DOI 10.1210/jc.2006-1374; BOYAR R, 1972, NEW ENGL J MED, V287, P582, DOI 10.1056/NEJM197209212871203; Buzi F, 2003, J CLIN ENDOCR METAB, V88, P3146, DOI 10.1210/jc.2002-021495; Chan JL, 2005, LANCET, V366, P74, DOI 10.1016/S0140-6736(05)66830-4; CHETKOWSKI RJ, 1986, NEW ENGL J MED, V314, P1615, DOI 10.1056/NEJM198606193142505; CONSTINE LS, 1993, NEW ENGL J MED, V328, P87, DOI 10.1056/NEJM199301143280203; Costa-Santos M, 2004, J CLIN ENDOCR METAB, V89, P49, DOI 10.1210/jc.2003-031021; Crino A, 2003, EUR J PEDIATR, V162, P327, DOI 10.1007/s00431-002-1132-4; Dasen JS, 2001, GENE DEV, V15, P3193, DOI 10.1101/gad.932601; Dattani MT, 1998, NAT GENET, V19, P125, DOI 10.1038/477; de Roux N, 2003, P NATL ACAD SCI USA, V100, P10972, DOI 10.1073/pnas.1834399100; de Roux N, 2001, MOL CELL ENDOCRINOL, V179, P83, DOI 10.1016/S0303-7207(01)00471-3; deRoux N, 1997, NEW ENGL J MED, V337, P1597, DOI 10.1056/NEJM199711273372205; DEZEGHER F, 1995, PEDIATR RES, V37, P395; Donaldson MDC, 2006, ARCH DIS CHILD, V91, P513, DOI 10.1136/adc.2003.035907; Eiholzer U, 2007, HORM RES, V68, P178, DOI 10.1159/000100925; Farooqi IS, 2007, NEW ENGL J MED, V356, P237, DOI 10.1056/NEJMoa063988; Farooqi IS, 2002, J CLIN INVEST, V110, P1093, DOI 10.1172/JCI200215693; Fechner PY, 2006, J CLIN ENDOCR METAB, V91, P4896, DOI 10.1210/jc.2006-1157; FRANCO B, 1991, NATURE, V353, P529, DOI 10.1038/353529a0; Fujieda K, 1997, J CLIN INVEST, V99, P1265, DOI 10.1172/JCI119284; FURUI K, 1994, J CLIN ENDOCR METAB, V78, P107, DOI 10.1210/jc.78.1.107; Gelfand IM, 2006, J PEDIATR-US, V149, P877, DOI 10.1016/j.jpeds.2006.08.050; Gonc EN, 2004, PEDIATR NEUROSURG, V40, P112, DOI 10.1159/000079852; GOODPASTURE JC, 1993, CLIN OBSTET GYNECOL, V36, P773, DOI 10.1097/00003081-199309000-00034; Habiby RL, 1996, J CLIN INVEST, V98, P1055, DOI 10.1172/JCI118866; Haddad NG, 2005, J PEDIATR ENDOCR MET, V18, P853; Hoek A, 1997, ENDOCR REV, V18, P107, DOI 10.1210/er.18.1.107; Holland C M, 2001, J Pediatr Adolesc Gynecol, V14, P77, DOI 10.1016/S1083-3188(01)00075-4; Hovatta O, 1999, ANN MED, V31, P106, DOI 10.3109/07853899708998785; IMBEAUD S, 1995, EUR J PEDIATR, V154, P187, DOI 10.1007/BF01954268; JEFFCOATE WJ, 1980, CLIN ENDOCRINOL, V12, P81, DOI 10.1111/j.1365-2265.1980.tb03136.x; KASSMANN K, 1992, CLIN NEPHROL, V37, P148; KAUFMAN FR, 1981, NEW ENGL J MED, V304, P994, DOI 10.1056/NEJM198104233041702; Kelberman D, 2006, J CLIN INVEST, V116, P2442, DOI 10.1172/JCI28658; Kelly DF, 2000, J NEUROSURG, V93, P743, DOI 10.3171/jns.2000.93.5.0743; Kohler B, 2008, HUM MUTAT, V29, P59, DOI 10.1002/humu.20588; KREMER H, 1995, NAT GENET, V9, P160, DOI 10.1038/ng0295-160; Larsen EC, 2003, J CLIN ENDOCR METAB, V88, P5307, DOI 10.1210/jc.2003-030352; Latronico AC, 1996, NEW ENGL J MED, V334, P507, DOI 10.1056/NEJM199602223340805; Law H, 2006, FETAL PEDIATR PATHOL, V25, P119, DOI 10.1080/15513810600788806; Layman LC, 1997, NEW ENGL J MED, V337, P607, DOI 10.1056/NEJM199708283370905; Lazar L, 2003, HORM RES, V60, P227, DOI 10.1159/000074036; Lee PA, 2006, PEDIATRICS, V118, pE488, DOI 10.1542/peds.2006-0738; Lieberman SA, 2001, J CLIN ENDOCR METAB, V86, P2752, DOI 10.1210/jc.86.6.2752; LIN HJ, 1993, AM J MED GENET, V45, P761, DOI 10.1002/ajmg.1320450619; LINDEN MG, 1988, PEDIATRICS, V82, P619; Lindstedt G, 1998, CLIN CHEM LAB MED, V36, P663, DOI 10.1515/CCLM.1998.118; Mantovani G, 2006, EUR J ENDOCRINOL, V154, P685, DOI 10.1530/eje.1.02132; MATTHEWS CH, 1993, NAT GENET, V5, P83, DOI 10.1038/ng0993-83; Mauras N, 2007, J CLIN ENDOCR METAB, V92, P4154, DOI 10.1210/jc.2007-0671; Mayo A, 2004, J CLIN ENDOCR METAB, V89, P681, DOI 10.1210/jc.2003-031086; Meacham LR, 1997, MED PEDIATR ONCOL, V29, P86, DOI 10.1002/(SICI)1096-911X(199708)29:2<86::AID-MPO4>3.0.CO;2-N; Merchant TE, 2002, INT J RADIAT ONCOL, V54, P45, DOI 10.1016/S0360-3016(02)02888-2; Michala L, 2008, BJOG-INT J OBSTET GY, V115, P737, DOI 10.1111/j.1471-0528.2008.01703.x; Mills JL, 1997, J PEDIATR-US, V131, P598, DOI 10.1016/S0022-3476(97)70069-6; MORTON MV, 1995, BRAIN INJURY, V9, P81, DOI 10.3109/02699059509004574; MUSCATELLI F, 1994, NATURE, V372, P672, DOI 10.1038/372672a0; Nabhan ZM, 2009, J CLIN ENDOCR METAB, V94, P2009, DOI 10.1210/jc.2008-2123; Nandagopal R, 2008, HORM RES, V69, P65, DOI 10.1159/000111809; NIELSEN J, 1991, HUM GENET, V87, P81, DOI 10.1007/BF01213097; Oakes MB, 2008, J PEDIATR ADOL GYNEC, V21, P305, DOI 10.1016/j.jpag.2007.09.006; Oliveira LMB, 2001, J CLIN ENDOCR METAB, V86, P1532, DOI 10.1210/jc.86.4.1532; Pasquino AM, 1997, J CLIN ENDOCR METAB, V82, P1810, DOI 10.1210/jc.82.6.1810; Perniola R, 2000, EUR J ENDOCRINOL, V143, P497, DOI 10.1530/eje.0.1430497; Pfaeffle RW, 2008, J CLIN ENDOCR METAB, V93, P1062, DOI 10.1210/jc.2007-1525; Pfaffle RW, 1999, ACTA PAEDIATR, V88, P33, DOI 10.1111/j.1651-2227.1999.tb14401.x; Piippo S, 2004, J CLIN ENDOCR METAB, V89, P3241, DOI 10.1210/jc.2003-032069; Pitteloud N, 2007, P NATL ACAD SCI USA, V104, P17447, DOI 10.1073/pnas.0707173104; Prestoz LLC, 1997, EUR J PEDIATR, V156, P116, DOI 10.1007/s004310050568; Priebe C, 2005, J PEDIATR SURG, V40, P136; Rahhal SN, 2008, J PEDIATR-US, V152, P289, DOI 10.1016/j.jpeds.2007.10.052; Raivio T, 2007, NEW ENGL J MED, V357, P863, DOI 10.1056/NEJMoa066494; RAPPAPORT R, 1982, J CLIN ENDOCR METAB, V54, P1164, DOI 10.1210/jcem-54-6-1164; RICHMAN RA, 1988, NEW ENGL J MED, V319, P1563, DOI 10.1056/NEJM198812153192402; Rizzolio F, 2006, HUM REPROD, V21, P1477, DOI 10.1093/humrep/dei495; Rogol Alan D, 2005, Pediatr Endocrinol Rev, V2, P383; Rosenfield RL, 1998, PEDIATRICS, V102, P486; Sarpel U, 2005, J PEDIATR SURG, V40, P133, DOI 10.1016/j.jpedsurg.2004.09.012; Sato N, 2004, J CLIN ENDOCR METAB, V89, P1079, DOI 10.1210/jc.2003-030476; Schatz DA, 2002, ENDOCRIN METAB CLIN, V31, P339, DOI 10.1016/S0889-8529(01)00012-3; Schulze A, 2001, ACTA PAEDIATR, V90, P455, DOI 10.1080/080352501750126474; Sedlmeyer IL, 2002, J CLIN ENDOCR METAB, V87, P1613, DOI 10.1210/jc.87.4.1613; SHALET SM, 1989, J ENDOCRINOL, V120, P161, DOI 10.1677/joe.0.1200161; Sinisi AA, 1997, INT J ANDROL, V20, P23, DOI 10.1046/j.1365-2605.1997.00101.x; SMITH NM, 1991, HISTOPATHOLOGY, V19, P269, DOI 10.1111/j.1365-2559.1991.tb00033.x; SOLIMAN AT, 1995, METABOLISM, V44, P1013, DOI 10.1016/0026-0495(95)90098-5; Steffens M, 2008, CLIN ENDOCRINOL, V69, P819, DOI 10.1111/j.1365-2265.2008.03283.x; Tanriverdi F, 2006, J CLIN ENDOCR METAB, V91, P2105, DOI 10.1210/jc.2005-2476; UIBO R, 1994, J CLIN ENDOCR METAB, V78, P323, DOI 10.1210/jc.78.2.323; Vinci G, 2004, J CLIN ENDOCR METAB, V89, P6282, DOI 10.1210/jc.2004-0891; VOGL TJ, 1994, RADIOLOGY, V191, P53, DOI 10.1148/radiology.191.1.8134597; VONKALCKREUTH G, 1991, HORM RES, V35, P222; Wallace WHB, 2003, HUM REPROD, V18, P117, DOI 10.1093/humrep/deg016; WEISS J, 1992, NEW ENGL J MED, V326, P179, DOI 10.1056/NEJM199201163260306; Welt CK, 2004, NEW ENGL J MED, V351, P987, DOI 10.1056/NEJMoa040388; Wharton Robert H., 1996, Current Opinion in Pediatrics, V8, P618, DOI 10.1097/00008480-199612000-00013; Wolff ASB, 2007, J CLIN ENDOCR METAB, V92, P595, DOI 10.1210/jc.2006-1873; Yang F, 2009, EUR J PEDIATR, V168, P329, DOI 10.1007/s00431-008-0779-x; Yang J, 2006, J CLIN ENDOCR METAB, V91, P3619, DOI 10.1210/jc.2005-2283; Zielinska D, 2007, J PEDIATR SURG, V42, P1721, DOI 10.1016/j.jpedsurg.2007.05.029	117	22	26	0	3	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0031-3955	1557-8240		PEDIATR CLIN N AM	Pediatr. Clin. N. Am.	OCT	2011	58	5					1181	+		10.1016/j.pcl.2011.07.009			21	Pediatrics	Pediatrics	843NM	WOS:000296678700008	21981955	Green Accepted			2021-06-18	
J	Dowds, MM; Lee, PH; Sheer, JB; O'Neil-Pirozzi, TM; Xenopoulos-Oddsson, A; Goldstein, R; Zainea, KL; Glenn, MB				Dowds, Murdo M.; Lee, Patricia H.; Sheer, Jeffrey B.; O'Neil-Pirozzi, Therese M.; Xenopoulos-Oddsson, Annette; Goldstein, Richard; Zainea, Kathryn L.; Glenn, Mel B.			Electronic Reminding Technology Following Traumatic Brain Injury: Effects on Timely Task Completion	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						cognitive disability; cognitive impairment; functional independence; handheld computers; memory disorders; prospective memory; rehabilitation; traumatic brain injury	MEMORY AID; HEAD-INJURY; REHABILITATION; DEVICES; ADULTS; PDAS	Objective: To determine whether automated reminders from 2 contemporary personal digital assistant (PDA) devices produce higher rates of timely task completion in people with traumatic brain injury (TBI). Setting: Outpatient and community rehabilitation settings. Participants: Thirty-six adults aged 18 to 66 years with TBI and self-determined complaints of memory impairment. Measures: Timely completion rates for assigned memory tasks under 4 randomly assigned memory aid conditions. Results: Significantly, higher completion rates were found when using either PDA device when compared with a combined baseline and paper memory aid condition (for Palm OS device, Incidence Rate Ratio [IRR] = 2.14, P < .0005, CI [confidence interval] = 1.77-2.59; for Microsoft Pocket PCOS device, IRR = 1.47, P < .001, CI = 1.18-1.82). A significant difference in completion rates was also found between the 2 PDA devices (IRR = 1.46, P < .0005, CI = 1.26-1.70), with the Palm version producing the better scores. Conclusions: Substantially higher rates of task completion (more than double in some cases) when using either PDA device suggest that rehabilitation clinicians can make productive use of PDA-based memory aids in their TBI patient populations. The strength of the effects of PDA device usage argues for further investigation of the impact of device usage on quality-of-life and costs of care, and of personal and caregiver factors predictive of successful and sustained device usage.	[Lee, Patricia H.] Univ Massachusetts, Dept Psychol, Boston, MA 02125 USA; [Sheer, Jeffrey B.] Harvard Univ, Sch Med, Dept Psychiat, Massachusetts Gen Hosp, Boston, MA 02115 USA; [O'Neil-Pirozzi, Therese M.] Northeastern Univ, Speech Language Pathol & Audiol Dept, Boston, MA 02115 USA; [Xenopoulos-Oddsson, Annette; Goldstein, Richard; Glenn, Mel B.] Harvard Univ, Sch Med, Dept PM&R, Spaulding Rehabil Hosp, Boston, MA 02115 USA; [Zainea, Kathryn L.] Spaulding Rehabil Hosp, Assist Technol Ctr, Boston, MA USA	Dowds, MM (corresponding author), 5 Whittier Pl,Suite 101, Boston, MA 02114 USA.	murdomdowdsphd@verizon.net			National Institute on Disability and Rehabilitation Research, US Department of EducationUS Department of Education [H113A0101607A]	This study was funded by grant# H113A0101607A from the National Institute on Disability and Rehabilitation Research, US Department of Education. The authors wish to thank Roberta DePompei, PhD, for her leadership of the Assistive Technology Collaborative, and for her support for this component of the project.	BADDELEY A, 1987, NEUROBEHAVIORAL RECO, P295; BROOKS N, 1986, J NEUROL NEUROSUR PS, V49, P764, DOI 10.1136/jnnp.49.7.764; Carey AC, 2005, MENT RETARD, V43, P322; Constantinidou F., 2004, TRAUMATIC BRAIN INJU, P337; DePompei R, 2004, LEARNING COGNITIVE C; DePompei R, 2008, NEUROREHABILITATION, V23, P487; DOWDS MM, 1999, ELECT MEMORY AIDS OU; DOWDS MM, 2005, REH PSYCH 2005 7 ANN; Ellis J, 2000, APPL COGNITIVE PSYCH, V14, pS1, DOI 10.1002/acp.767; Fleming JM, 2005, BRAIN INJURY, V19, P1, DOI 10.1080/02699050410001720059; Gentry T, 2008, BRAIN INJURY, V22, P19, DOI 10.1080/02699050701810688; Gillette Y, 2008, PSYCHOL SCHOOLS, V45, P665, DOI 10.1002/pits.20316; Hart T, 2004, J HEAD TRAUMA REHAB, V19, P351, DOI 10.1097/00001199-200409000-00001; Hart T, 2003, BRAIN INJURY, V17, P401, DOI 10.1080/0269905021000038438; Hart T, 2002, J HEAD TRAUMA REHAB, V17, P556, DOI 10.1097/00001199-200212000-00007; Hersh N A, 1994, NeuroRehabilitation, V4, P187, DOI 10.3233/NRE-1994-4309; Hilbe J. M., 2007, NEGATIVE BINOMIAL RE; Inglis EA, 2004, NEUROPSYCHOL REHABIL, V14, P77, DOI 10.1080/09602010343000129; KENNEDY M, 2008, ASHA LEADER, V11, P34; Kim HJ, 1999, BRAIN INJURY, V13, P147, DOI 10.1080/026990599121818; Kim HJ, 2000, BRAIN INJURY, V14, P187, DOI 10.1080/026990500120844; Manchester D, 2004, BRAIN INJURY, V18, P1067, DOI 10.1080/02699050410001672387; Mathias JL, 2005, BRAIN INJURY, V19, P271, DOI 10.1080/02699050400005028; McKinlay W, 1999, REHABILITATION ADULT, V3, P74; Bryen DN, 2007, INTELLECT DEV DISAB, V45, P1, DOI 10.1352/1934-9556(2007)45[1:CPUBAW]2.0.CO;2; O'Neil-Pirozzi TM, 2004, BRAIN INJURY, V18, P179, DOI 10.1080/0269905031000149560; ODDY M, 1985, J NEUROL NEUROSUR PS, V48, P564, DOI 10.1136/jnnp.48.6.564; ONEILPIROZZI TM, J HEAD TRAU IN PRESS; PARENTE R, 1991, COGNITIVE REHABILITA, P147; Ragnarsson KT, 1999, JAMA-J AM MED ASSOC, V282, P974; Rothman K.J., 1998, MODERN EPIDEMIOLOGY, V2nd ed.; RYAN T V, 1992, Brain Injury, V6, P175, DOI 10.3109/02699059209029656; Sohlberg M. M., 2001, COGNITIVE REHABILITA; Sohlberg M. M., 2005, REHABILITATION TRAUM, P47; Sohlberg MM, 2007, J MED SPEECH-LANG PA, V15, pXV; THONEOTTO AIT, 2003, INT J PSYCHOL, V38, P1, DOI DOI 10.1080/00207590344000169; van den Broek MD, 2000, BRAIN INJURY, V14, P455; Wade TK, 2001, BRAIN INJURY, V15, P305, DOI 10.1080/026990501750111256; Wechsler D., 2011, WECHLSER ABBREVIATED; Wechsler D., 1997, WMS 3 WECHSLER MEMOR; Wilkinson G. S., 1993, WIDE RANGE ACHIEVEME; Wilson BA, 1999, REHABIL PSYCHOL, V44, P284, DOI 10.1037/0090-5550.44.3.284; Wilson BA, 2001, J NEUROL NEUROSUR PS, V70, P477, DOI 10.1136/jnnp.70.4.477; Wright P, 2001, BRAIN INJURY, V15, P787, DOI 10.1080/02699050110045161	44	22	22	1	12	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	SEP-OCT	2011	26	5					339	347		10.1097/HTR.0b013e3181f2bf1d			9	Clinical Neurology; Rehabilitation	Neurosciences & Neurology; Rehabilitation	814VO	WOS:000294485500002	21464734				2021-06-18	
J	Grubenhoff, JA; Kirkwood, MW; Deakyne, S; Wathen, J				Grubenhoff, Joseph A.; Kirkwood, Michael W.; Deakyne, Sara; Wathen, Joe			Detailed concussion symptom analysis in a paediatric ED population	BRAIN INJURY			English	Article						Brain concussion; closed head injury; traumatic brain injury	TRAUMATIC BRAIN-INJURY; EMERGENCY-DEPARTMENT ASSESSMENT; SPORT-RELATED CONCUSSION; GLASGOW COMA SCALE; POSTCONCUSSION SYNDROME; STANDARDIZED ASSESSMENT; EARLY IDENTIFICATION; UNITED-STATES; HEAD-INJURY; PREDICTION	Primary objective: To examine the frequency of acute mild traumatic brain injury (mTBI) symptoms in children using a concussion symptom inventory and to identify which symptoms are most useful in identifying mTBI. It was hypothesized that symptoms associated with mTBI are more common in children with head injury than orthopaedic injury and certain symptoms are more useful than others in identifying mTBI. Research design: Prospective case-control study conducted in a paediatric trauma centre emergency department. Methods and procedures: Children of 6-18 years old with head injury or a minor extremity injury were enrolled. Symptoms were assessed using a graded symptom checklist. Symptom frequency was compared using a chi-square test. The association between individual symptoms with AMS was evaluated with logistic regression analysis. Main outcomes and results: Children with head injury displayed more frequent symptoms than controls. Head-injured cases with altered mental status (AMS) demonstrated the most frequent and severe symptoms (median symptom scores: control 1, cases without AMS 5, cases with AMS 10; p < 0.001). Headache, nausea, dizziness, blurred/double vision and not feeling 'sharp' were associated with AMS. Conclusions: Symptoms associated with mTBI are more frequent in children with head injury. AMS magnifies this effect. A symptom inventory is integral to the evaluation of mTBI in children; a smaller set of dichotomized symptoms may be as useful as and more easily administered than lengthier symptom scales.	[Grubenhoff, Joseph A.; Deakyne, Sara; Wathen, Joe] Univ Colorado, Sch Med, Dept Pediat, Sect Emergency Med, Aurora, CO USA; [Kirkwood, Michael W.] Childrens Hosp Colorado, Aurora, CO USA	Grubenhoff, JA (corresponding author), 13123 E 16th Ave,B-251, Aurora, CO 80045 USA.	grubenhoff.joe@tchden.org		Grubenhoff, Joseph/0000-0001-5072-4064			Ahmed S, 2000, BRAIN INJURY, V14, P765; Barlow KM, 2010, PEDIATRICS, V126, pE374, DOI 10.1542/peds.2009-0925; Bazarian JJ, 2005, BRAIN INJURY, V19, P85, DOI 10.1080/02699050410001720158; Bazarian JJ, 2005, EMERG MED J, V22, P473, DOI 10.1136/emj.2004.019273; Broglio SP, 2007, NEUROSURGERY, V60, P1050, DOI 10.1227/01.NEU.0000255479.90999.C0; Cantu RC, 2001, J ATHL TRAINING, V36, P244; Drake AI, 2006, BRAIN INJURY, V20, P469, DOI 10.1080/02699050600676370; Erlanger D, 2003, J NEUROSURG, V98, P477, DOI 10.3171/jns.2003.98.3.0477; GARDEN N, 2001, APL NEUROPSYCHOLOGY, V17, P1; Gouvier W D, 1988, Arch Clin Neuropsychol, V3, P273, DOI 10.1016/0887-6177(88)90019-4; Grubenhoff JA, 2010, PEDIATRICS, V126, P688, DOI 10.1542/peds.2009-2804; Guskiewicz KM, 2004, J ATHL TRAINING, V39, P280; Iverson GL, 2003, APPL NEUROPSYCHOL, V10, P137, DOI 10.1207/S15324826AN1003_02; Iverson GL, 2006, ARCH CLIN NEUROPSYCH, V21, P303, DOI 10.1016/j.acn.2005.12.008; Iverson GL, 2010, J HEAD TRAUMA REHAB, V25, P23, DOI 10.1097/HTR.0b013e3181b4b6ab; Kelly JP, 1997, NEUROLOGY, V48, P581; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; Lange R. T., 2010, J CLIN EXPT NEUROPSY, V30, P1; Leclerc S, 2001, SPORTS MED, V31, P629, DOI 10.2165/00007256-200131080-00007; Lees-Haley PR, 2001, ARCH CLIN NEUROPSYCH, V16, P689, DOI 10.1016/S0887-6177(00)00092-5; Lovell MR, 2006, APPL NEUROPSYCHOL, V13, P166, DOI 10.1207/s15324826an1303_4; Machulda MM, 1998, ARCH CLIN NEUROPSYCH, V13, P415, DOI 10.1016/S0887-6177(97)00031-0; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrea M, 1998, J HEAD TRAUMA REHAB, V13, P27, DOI 10.1097/00001199-199804000-00005; McCrea M, 2002, NEUROSURGERY, V50, P1032, DOI 10.1097/00006123-200205000-00017; Mittenberg W, 1997, NEUROPSYCHOLOGY, V11, P447, DOI 10.1037/0894-4105.11.3.447; Naunheim RS, 2008, J HEAD TRAUMA REHAB, V23, P116, DOI 10.1097/01.HTR.0000314530.30401.70; Randolph C, 2009, ARCH CLIN NEUROPSYCH, V24, P219, DOI 10.1093/arclin/acp025; Roe C, 2009, DISABIL REHABIL, V31, P1235, DOI 10.1080/09638280802532720; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; Ryu WHA, 2009, CAN J NEUROL SCI, V36, P429, DOI 10.1017/S0317167100007745; Sheedy J, 2006, J CLIN EXP NEUROPSYC, V28, P755, DOI 10.1080/13803390591000864; Sheedy J, 2009, J HEAD TRAUMA REHAB, V24, P333, DOI 10.1097/HTR.0b013e3181aea51f; Shores EA, 2008, J NEUROL NEUROSUR PS, V79, P1100, DOI 10.1136/jnnp.2007.132571; Suhr JA, 2002, J CLIN EXP NEUROPSYC, V24, P981, DOI 10.1076/jcen.24.8.981.8372; Taylor HG, 2010, NEUROPSYCHOLOGY, V24, P148, DOI 10.1037/a0018112; Yang CC, 2009, BRAIN INJURY, V23, P299, DOI 10.1080/02699050902788543; Yeates KO, 2009, PEDIATRICS, V123, P735, DOI 10.1542/peds.2008-1056	38	22	22	0	7	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.	SEP	2011	25	10					943	949		10.3109/02699052.2011.597043			7	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	801TZ	WOS:000293464800003	21749192				2021-06-18	
J	Zhang, Y; Liao, YH; Wang, DS; He, Y; Cao, DY; Zhang, FQ; Dou, KF				Zhang, Yi; Liao, Yonghui; Wang, Desheng; He, Yong; Cao, Dayong; Zhang, Fuqin; Dou, Kefeng			Altered Expression Levels of miRNAs in Serum as Sensitive Biomarkers for Early Diagnosis of Traumatic Injury	JOURNAL OF CELLULAR BIOCHEMISTRY			English	Article						miRNA; BIOMARKER; SERUM; TRAUMATIC INJURY; PARTIAL HEPATECTOMY	CIRCULATING MICRORNAS; SURGICAL TRAUMA; LIVER; MECHANISM; CANCER	MicroRNAs (miRNAs) are small non-coding RNAs of approximately 22 nucleotides in length which regulate gene expression negatively and play important roles in many pathological processes. It has been demonstrated that circulating miRNAs hold promise to serve as practicable molecular markers for diverse physiological and pathological conditions. In this investigation, we chose partial hepatectomy (PH) as traumatic injury model. There were significantly differential expression of miRNAs in rat serum post-traumatic injury (21 miRNAs were more than twofold up-regulated). Especially, the expression of miR-9 showed the highest up-regulated (>70-fold), and it possessed the characteristics of biomarker that was more sensitive than aspartate aminotransferase and alanine aminotransferase and C-reactive protein for traumatic liver injury. There was also a prominent increase in the expression levels of miR-9 in different brain areas after traumatic injury. Our data suggest that serum miR-9 may serve as promising biomarker for traumatic injury with high sensitivity. Furthermore, these findings may help to elucidate the complex network which mediates stress response to traumatic injury.J.Cell.Biochem. 112:2435-2442, 2011. (C) 2011Wiley-Liss, Inc.	[Zhang, Yi; Liao, Yonghui; Wang, Desheng; He, Yong; Cao, Dayong; Zhang, Fuqin; Dou, Kefeng] Fourth Mil Med Univ, Xijing Hosp, Dept Hepatobiliary Surg, Xian 710032, Peoples R China	Dou, KF (corresponding author), Fourth Mil Med Univ, Xijing Hosp, Dept Hepatobiliary Surg, 15 Changlexi Rd, Xian 710032, Peoples R China.	gdwkgwx@fmmu.edu.cn	Xia, Xianfeng/F-9169-2011		Key Program of National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81030010]	Grant sponsor: Key Program of National Natural Science Foundation of China; Grant number: 81030010.	Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bartels CL, 2009, CLIN CHEM, V55, P623, DOI 10.1373/clinchem.2008.112805; Bazzoni F, 2009, P NATL ACAD SCI USA, V106, P5282, DOI 10.1073/pnas.0810909106; BOTHA AJ, 1995, SURGERY, V118, P358, DOI 10.1016/S0039-6060(05)80345-9; Chen X, 2008, CELL RES, V18, P997, DOI 10.1038/cr.2008.282; Coolen M, 2009, CURR OPIN NEUROBIOL, V19, P461, DOI 10.1016/j.conb.2009.09.006; Desborough JP, 2000, BRIT J ANAESTH, V85, P109, DOI 10.1093/bja/85.1.109; Evans DC, 2007, CAN J SURG, V50, P364; Giannini EG, 2005, CAN MED ASSOC J, V172, P367, DOI 10.1503/cmaj.1040752; Gilad S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003148; Higgins GM, 1931, ARCH PATHOL, V12, P186; Hunter MP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003694; Keel M, 2005, INJURY, V36, P691, DOI 10.1016/j.injury.2004.12.037; Kloosterman WP, 2006, DEV CELL, V11, P441, DOI 10.1016/j.devcel.2006.09.009; Laterza OF, 2009, CLIN CHEM, V55, P1977, DOI 10.1373/clinchem.2009.131797; Lei P, 2009, BRAIN RES, V1284, P191, DOI 10.1016/j.brainres.2009.05.074; Leucht C, 2008, NAT NEUROSCI, V11, P641, DOI 10.1038/nn.2115; Li JN, 2009, AM J PATHOL, V175, P947, DOI 10.2353/ajpath.2009.090043; Liu NK, 2009, EXP NEUROL, V219, P424, DOI 10.1016/j.expneurol.2009.06.015; MacKenzie EJ, 2000, EPIDEMIOL REV, V22, P112, DOI 10.1093/oxfordjournals.epirev.a018006; MARUSZYNSKI M, 1995, SURG ENDOSC-ULTRAS, V9, P882; Menges T, 2008, CRIT CARE MED, V36, P1456, DOI 10.1097/CCM.0B013E318170ABB6; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Borque AM, 2007, AN MED INTERN, V24, P38; Neumaier M, 2006, ACTA ORTHOP, V77, P788, DOI 10.1080/17453670610013006; O'Hara SP, 2009, GASTROENTEROLOGY, V136, P17, DOI 10.1053/j.gastro.2008.11.028; Pasquale MD, 1996, CRIT CARE MED, V24, P1238, DOI 10.1097/00003246-199607000-00029; Pespeni M, 2005, J SURG RES, V126, P41, DOI 10.1016/j.jss.2005.01.012; Rinaldi A, 2010, BEHAV BRAIN RES, V208, P265, DOI 10.1016/j.bbr.2009.11.012; Rosell R, 2009, CLIN LUNG CANCER, V10, P8, DOI 10.3816/CLC.2009.n.001; Tsitsiou E, 2009, CURR OPIN PHARMACOL, V9, P514, DOI 10.1016/j.coph.2009.05.003; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Wang GK, 2010, EUR HEART J, V31, P659, DOI 10.1093/eurheartj/ehq013; Wang JF, 2010, BIOCHEM BIOPH RES CO, V394, P184, DOI 10.1016/j.bbrc.2010.02.145; Wang K, 2009, P NATL ACAD SCI USA, V106, P4402, DOI 10.1073/pnas.0813371106; Yu CH, 2009, DIGEST DIS SCI, V54, P2362, DOI 10.1007/s10620-008-0629-8	36	22	24	0	14	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0730-2312	1097-4644		J CELL BIOCHEM	J. Cell. Biochem.	SEP	2011	112	9					2435	2442		10.1002/jcb.23168			8	Biochemistry & Molecular Biology; Cell Biology	Biochemistry & Molecular Biology; Cell Biology	818QN	WOS:000294769500026	21538484				2021-06-18	
J	Russell, KL; Kutchko, KM; Fowler, SC; Berman, NEJ; Levant, B				Russell, Kristin L.; Kutchko, Katrina M.; Fowler, Stephen C.; Berman, Nancy E. J.; Levant, Beth			Sensorimotor behavioral tests for use in a juvenile rat model of traumatic brain injury: Assessment of sex differences	JOURNAL OF NEUROSCIENCE METHODS			English	Article						Traumatic brain injury; Juvenile; Forelimb; Hind limb; Actometer; Beam walk; Controlled cortical impact; Sensorimotor	CONTROLLED CORTICAL IMPACT; SPINAL-CORD-INJURY; IMMATURE RAT; POSTNATAL-DEVELOPMENT; COGNITIVE FUNCTION; MOTOR DEFICITS; ANIMAL-MODELS; MOUSE MODEL; ADULT-RATS; MECHANISMS	Modeling juvenile traumatic brain injury (TBI) in rodents presents several unique challenges compared to adult TBI, one of which is selecting appropriate sensorimotor behavioral tasks that enable the assessment of the extent of injury and recovery over time in developing animals. To address this challenge, we performed a comparison of common sensorimotor tests in Long-Evans rats of various sizes and developmental stages (postnatal days 16-45,35-190 g). Tests were compared and selected for their developmental appropriateness, scalability for growth, pre-training requirements, and throughput capability. Sex differences in response to TBI were also assessed. Grid walk, automated gait analysis, rotarod, beam walk, spontaneous forelimb elevation test, and measurement of motor activity using the force-plate actometer were evaluated. Grid walk, gait analysis. and rotarod failed to meet one or more of the evaluation criteria. Beam walk, spontaneous forelimb elevation test, and measurement of motor activity using the force-plate actometer satisfied all criteria and were capable of detecting motor abnormalities in rats subjected to controlled cortical impact on postnatal day 17. No sex differences were detected in the acute effects of TBI or functional recovery during the 28 days after injury using these tests. This demonstrates the utility of these tests for the evaluation of sensorimotor function in studies using rat models of pediatric TBI, and suggests that pre-pubertal males and females respond similarly to TBI with respect to sensorimotor outcomes. (C) 2011 Elsevier B.V. All rights reserved.	[Russell, Kristin L.; Kutchko, Katrina M.; Levant, Beth] Univ Kansas, Med Ctr, Dept Pharmacol Toxicol & Therapeut, Kansas City, KS 66160 USA; [Fowler, Stephen C.] Univ Kansas, Dept Pharmacol & Toxicol, Lawrence, KS 66045 USA; [Berman, Nancy E. J.] Univ Kansas, Med Ctr, Dept Anat & Cell Biol, Kansas City, KS 66160 USA	Levant, B (corresponding author), Univ Kansas, Med Ctr, Dept Pharmacol, Mail Stop 1018,3901 Rainbow Blvd, Kansas City, KS 66160 USA.	krussel@kumc.edu; katrina.kutchko@coloradocollege.edu; scfowler@ku.edu; nberman@kumc.edu; blevant@kumc.edu			NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [HD059939, HD02528, RR016475, ES007079]; University of Kansas Medical Center; ASPET SURF program; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [P30HD002528] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R03HD059939] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [P20RR016475] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS) [T32ES007079] Funding Source: NIH RePORTER	Supported by NIH HD059939 (B.L.), HD02528 (B.L., N.E.J.B., S.C.F.), RR016475 (B.L.), ES007079 (K.L.R.), the University of Kansas Medical Center Biomedical Research Training Program (K.L.R.), and the ASPET SURF program (K.M.K.).	Adelson PD, 1998, ACT NEUR S, V71, P104; Adelson PD, 1997, J NEUROTRAUM, V14, P99, DOI 10.1089/neu.1997.14.99; Adelson PD, 2000, J NEUROTRAUM, V17, P273, DOI 10.1089/neu.2000.17.273; Adelson PD, 1999, EXP TOXICOL PATHOL, V51, P130; ALTMAN J, 1975, ANIM BEHAV, V23, P896, DOI 10.1016/0003-3472(75)90114-1; Appelberg KS, 2009, J NEUROTRAUM, V26, P497, DOI 10.1089/neu.2008.0664; Arnold AP, 2009, HORM BEHAV, V55, P570, DOI 10.1016/j.yhbeh.2009.03.011; Baskin YK, 2003, J NEUROSCI METH, V129, P87, DOI 10.1016/S0165-0270(03)00212-7; Bazarian JJ, 2010, J NEUROTRAUM, V27, P527, DOI 10.1089/neu.2009.1068; Bilgen M, 2005, NEUROREHAB NEURAL RE, V19, P219, DOI 10.1177/1545968305278635; Bolton SJ, 1998, EXP NEUROL, V154, P231, DOI 10.1006/exnr.1998.6927; Bretzner F, 2008, EUR J NEUROSCI, V28, P1795, DOI 10.1111/j.1460-9568.2008.06462.x; Chen SF, 2008, BRIT J PHARMACOL, V155, P1279, DOI 10.1038/bjp.2008.345; Cole JT, 2011, J NEUROTRAUM, V28, P359, DOI 10.1089/neu.2010.1427; Davis AS, 2010, APPL NEUROPSYCHOL, V17, P104, DOI 10.1080/09084281003708951; Ek CJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012021; FAGIOLINI M, 1994, VISION RES, V34, P709, DOI 10.1016/0042-6989(94)90210-0; Faul M.D., 2010, TRAUMATIC BRAIN INJU; Fineman I, 2000, J NEUROTRAUM, V17, P739, DOI 10.1089/neu.2000.17.739; FINGER FW, 1969, J COMP PHYSIOL PSYCH, V68, P461, DOI 10.1037/h0027490; Fowler SC, 2001, J NEUROSCI METH, V107, P107, DOI 10.1016/S0165-0270(01)00359-4; Fowler SC, 2009, BEHAV BRAIN RES, V202, P130, DOI 10.1016/j.bbr.2009.03.022; Fujimoto ST, 2004, NEUROSCI BIOBEHAV R, V28, P365, DOI 10.1016/j.neubiorev.2004.06.002; Gaetz M, 2004, CLIN NEUROPHYSIOL, V115, P4, DOI 10.1016/S1388-2457(03)00258-X; Ginstfeldt T, 2010, BRAIN INJURY, V24, P1123, DOI 10.3109/02699052.2010.506853; Giza CC, 2006, DEV NEUROSCI-BASEL, V28, P364, DOI 10.1159/000094163; Grossman KJ, 2011, BEHAV BRAIN RES, V217, P202, DOI 10.1016/j.bbr.2010.09.029; Hamm RJ, 2001, J NEUROTRAUM, V18, P1207, DOI 10.1089/089771501317095241; HAMM RJ, 1994, J NEUROTRAUM, V11, P187, DOI 10.1089/neu.1994.11.187; Hickey RW, 2007, PEDIATR RES, V62, P271, DOI 10.1203/PDR.0b013e3180db2902; Horton AM, 2010, APPL NEUROPSYCHOL, V17, P99, DOI 10.1080/09084281003708944; Huh JW, 2008, EXP NEUROL, V213, P84, DOI 10.1016/j.expneurol.2008.05.009; KALONIA H, 2010, PROG NEUROPSYCHOPHAR; KUNKELBAGDEN E, 1992, EXP NEUROL, V116, P40, DOI 10.1016/0014-4886(92)90174-O; Lajiness-O'Neill R, 2010, APPL NEUROPSYCHOL, V17, P83, DOI 10.1080/09084281003708837; Levant B, 2010, PHYSIOL BEHAV, V101, P176, DOI 10.1016/j.physbeh.2010.04.038; Li XL, 2004, EXP NEUROL, V187, P94, DOI 10.1016/j.expneurol.2004.01.004; LUERSSEN TG, 1988, J NEUROSURG, V68, P409, DOI 10.3171/jns.1988.68.3.0409; Lynn DA, 2009, DEV PSYCHOBIOL, V51, P513, DOI 10.1002/dev.20386; Mank JE, 2009, AM NAT, V173, P141, DOI 10.1086/595754; Narayana PA, 2004, J NEUROSCI RES, V78, P749, DOI 10.1002/jnr.20275; National Institute of Neurological Disorders and Stroke, 2002, TRAUM BRAIN INJ HOP; Noggle CA, 2010, APPL NEUROPSYCHOL, V17, P110, DOI 10.1080/09084281003708977; Ochalski PG, 2010, J NEUROTRAUM, V27, P647, DOI 10.1089/neu.2009.1142; Onyszchuk G, 2008, J NEUROTRAUM, V25, P153, DOI 10.1089/neu.2007.0430; Onyszchuk G, 2007, J NEUROSCI METH, V160, P187, DOI 10.1016/j.jneumeth.2006.09.007; Pajoohesh-Ganji A, 2010, NEUROSCI RES, V67, P117, DOI 10.1016/j.neures.2010.02.009; Paxinos G, 1986, RAT BRAIN STEREOTAXI; Pitzer C, 2010, J NEUROCHEM, V113, P930, DOI 10.1111/j.1471-4159.2010.06659.x; Prins ML, 1998, J NEUROTRAUM, V15, P799, DOI 10.1089/neu.1998.15.799; Prins ML, 2003, J NEUROTRAUM, V20, P123, DOI 10.1089/08977150360547053; Raghupathi R, 2007, J NEUROTRAUM, V24, P1596, DOI 10.1089/neu.2007.3790; Roof RL, 2000, J NEUROTRAUM, V17, P367, DOI 10.1089/neu.2000.17.367; Scafidi S, 2010, DEV NEUROSCI-BASEL, V32, P480, DOI 10.1159/000323178; Schallert T, 2000, NEUROPHARMACOLOGY, V39, P777, DOI 10.1016/S0028-3908(00)00005-8; Sgado P, 2011, NEUROTOX RES, V20, P170, DOI 10.1007/s12640-010-9232-9; Shahrokhi N, 2010, CAN J PHYSIOL PHARM, V88, P414, DOI [10.1139/Y09-126, 10.1139/y09-126]; Sherwood N.M., 1970, STEREOTAXIC ATLAS DE; Siegel C, 2010, J NEUROSCI RES, V88, P2765, DOI 10.1002/jnr.22406; SPEAR LP, 1983, DEV PSYCHOBIOL, V16, P83, DOI 10.1002/dev.420160203; Springer JE, 2010, J NEUROTRAUM, V27, P139, DOI 10.1089/neu.2009.0952; Sullivan JR, 2010, APPL NEUROPSYCHOL, V17, P93, DOI 10.1080/09084281003708852; Vandeputte C, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-92; Wagner AK, 2007, J NEUROTRAUM, V24, P1308, DOI 10.1089/neu.2007.0274; Walker PA, 2009, J TRAUMA, V67, pS120, DOI 10.1097/TA.0b013e3181ad323a; WESTERGA J, 1990, DEV BRAIN RES, V57, P163, DOI 10.1016/0165-3806(90)90042-W; Ylvisaker M, 2001, J HEAD TRAUMA REHAB, V16, P76, DOI 10.1097/00001199-200102000-00009; Zhu CL, 2006, J NEUROCHEM, V96, P1016, DOI 10.1111/j.1471-4159.2005.03639.x	68	22	22	0	6	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0165-0270			J NEUROSCI METH	J. Neurosci. Methods	AUG 15	2011	199	2					214	222		10.1016/j.jneumeth.2011.05.008			9	Biochemical Research Methods; Neurosciences	Biochemistry & Molecular Biology; Neurosciences & Neurology	799VN	WOS:000293314300006	21600923	Green Accepted, Green Published			2021-06-18	
J	Genet, F; Jourdan, C; Lautridou, C; Chehensse, C; Minooee, K; Denormandie, P; Schnitzler, A				Genet, Francois; Jourdan, Claire; Lautridou, Christine; Chehensse, Clement; Minooee, Kambiz; Denormandie, Philippe; Schnitzler, Alexis			The Impact of Preoperative Hip Heterotopic Ossification Extent on Recurrence in Patients with Head and Spinal Cord Injury: A Case Control Study	PLOS ONE			English	Article							TRAUMATIC BRAIN-INJURY; BONE-FORMATION; EARLY EXCISION; RESECTION; ELBOW; HEMIPLEGIA; ANTIGENS; COMA; KNEE	Background: The preoperative Heterotopic Ossification (HO) extent is usually one of the main used criteria to predict the recurrence before excision. Brooker et al built a radiologic scale to assess this pre operative extent around the hip. The aim of this study is to investigate the relationship between the recurrence risk after hip HO excision in Traumatic Brain Injury (TBI) and Spinal Cord Injury (SCI) patients and the preoperative extent of HO. Methodology/Principal Findings: A case control study including TBI or SCI patients following surgery for troublesome hip HO with (case, n = 19) or without (control, n = 76) recurrence. Matching criteria were: sex, pathology (SCI or TBI) and age at the time of surgery (+/-4.5 years). For each etiology (TBI and SCI), the residual cognitive and functional status (Garland classification), the preoperative extent (Brooker status), the modified radiological and functional status (GCG-BD classification), HO localization, side, mean age at the CNS damage, mean delay for the first HO surgery, and for the case series, the mean operative delay for recurrence after the first surgical intervention were noted. Conclusions/Significance: The median delay for first HO surgery was 38.6 months (range 4.5 to 414.5;) for the case subgroup and 17.6 months (range 5.7 to 339.6) for the control group. No significant link was found between recurrence and operative delay (p = 0.51); the location around the joint (0.07); the Brooker (p = 0.52) or GCG-BD status (p = 0.79). Including all the matching factors, no significant relationship was found between the recurrence HO risk and the preoperative extent of troublesome hip HO using Brooker status (OR = 1.56(95% CI: 0.47-5.19)) or GCG-BD status (OR class 3 versus 2 = 0.67(95% CI: 0.11-4.24) and OR class 4 versus 2 = 0.79(95% CI: 0.09-6.91)). Until the pathophysiology of HO development is understood, it will be difficult to create tools which can predict HO recurrence.	[Genet, Francois; Jourdan, Claire; Chehensse, Clement; Schnitzler, Alexis] CHU R Poincare, Serv Med Phys & Readaptat, Garches, France; [Lautridou, Christine; Denormandie, Philippe] CHU R Poincare, Serv Chirurg Orthoped, Garches, France; [Minooee, Kambiz] CHU Erasme, Serv Rhumatol & Med Phys, Brussels, Belgium	Genet, F (corresponding author), CHU R Poincare, Serv Med Phys & Readaptat, Garches, France.	francois.genet@rpc.aphp.fr					BROOKER AF, 1973, J BONE JOINT SURG AM, VA 55, P1629; Carlier RY, 2005, J BONE JOINT SURG BR, V87B, P301, DOI 10.1302/0301-620X.87B3.14737; Chalidis B, 2007, J NEUROTRAUM, V24, P1675, DOI 10.1089/neu.2007.0342; Charnley G, 1996, INJURY, V27, P125, DOI 10.1016/0020-1383(95)00180-8; Cipriano CA, 2009, J AM ACAD ORTHOP SUR, V17, P689, DOI 10.5435/00124635-200911000-00003; Denormandie P, 1999, Chir Main, V18, P99; Ebinger T, 2000, J TRAUMA, V48, P1058, DOI 10.1097/00005373-200006000-00010; Frischhut B, 1993, Acta Neurol (Napoli), V15, P114; Fuller DA, 2005, CLIN ORTHOP RELAT R, P197, DOI 10.1097/01.blo.0000170718.86747.da; GACON G, 1978, REV CHIR ORTHOP, V64, P375; GARLAND DE, 1984, ARCH PHYS MED REHAB, V65, P531; GARLAND DE, 1989, CLIN ORTHOP RELAT R, P169; GARLAND DE, 1985, J BONE JOINT SURG AM, V67A, P1261, DOI 10.2106/00004623-198567080-00019; GARLAND DE, 1980, J BONE JOINT SURG AM, V62, P1143, DOI 10.2106/00004623-198062070-00012; Genet F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016632; HAJEK VE, 1987, ARCH PHYS MED REHAB, V68, P313; Hendricks HT, 2010, EUR J NEUROL, V17, P1172, DOI 10.1111/j.1468-1331.2010.02989.x; Ippolito E, 1999, J HAND SURG-AM, V24A, P546; Ippolito E, 1999, CLIN ORTHOP RELAT R, P130, DOI 10.1097/00003086-199908000-00018; Lazarus MD, 1999, NEUROREHABILITATION, V12, P145; McAuliffe JA, 1997, J BONE JOINT SURG AM, V79A, P749, DOI 10.2106/00004623-199705000-00015; MINAIRE P, 1980, ARCH PHYS MED REHAB, V61, P214; Moore T J, 1993, J Orthop Trauma, V7, P11, DOI 10.1097/00005131-199302000-00003; ROBERTS JB, 1979, J BONE JOINT SURG AM, V61, P760, DOI 10.2106/00004623-197961050-00018; ROSIN AJ, 1975, ANN RHEUM DIS, V34, P499, DOI 10.1136/ard.34.6.499; Sarafis KA, 1999, J TRAUMA, V46, P104, DOI 10.1097/00005373-199901000-00017; SAZBON L, 1981, J BONE JOINT SURG BR, V63, P120; Seegenschmiedt MH, 2008, MED RADIOL RADIAT ON, P333, DOI 10.1007/978-3-540-68943-0_18; Simonsen LL, 2007, INJURY, V38, P1146, DOI 10.1016/j.injury.2007.03.019; Sorriaux G, 2005, REV CHIR ORTHOP, V91, P415, DOI 10.1016/S0035-1040(05)84358-2; STOVER SL, 1991, CLIN ORTHOP RELAT R, P71; Tsur A, 1996, BRAIN INJURY, V10, P259, DOI 10.1080/026990596124430; Vanden Bossche L, 2005, J REHABIL MED, V37, P129, DOI 10.1080/16501970510027628	33	22	24	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2011	6	8							e23129	10.1371/journal.pone.0023129			7	Multidisciplinary Sciences	Science & Technology - Other Topics	827UM	WOS:000295454200044	21853078	DOAJ Gold, Green Published			2021-06-18	
J	Morrison, LJ; Baker, AJ; Rhind, SG; Kiss, A; MacDonald, RD; Schwartz, B; Perreira, T; Simitciu, M; Trompeo, A; Black, SE; Stuss, DT; Rizoli, SB				Morrison, Laurie J.; Baker, Andrew J.; Rhind, Shawn G.; Kiss, Alex; MacDonald, Russell D.; Schwartz, Brian; Perreira, Tyrone; Simitciu, Merita; Trompeo, Anna; Black, Sandra E.; Stuss, Donald T.; Rizoli, Sandro B.			The Toronto prehospital hypertonic resuscitation-head injury and multiorgan dysfunction trial: Feasibility study of a randomized controlled trial	JOURNAL OF CRITICAL CARE			English	Article						Traumatic brain injury; Hypertonic saline; Emergency medical services; Organ failure; Neurofunctional and neurocognitive outcomes; Immune modulation; Neuro Imaging; Feasibility	7.5-PERCENT SODIUM-CHLORIDE; TRAUMATIC BRAIN-INJURY; SALINE RESUSCITATION; ORGAN DYSFUNCTION; FLUID RESUSCITATION; HEMORRHAGIC-SHOCK; MULTICENTER TRIAL; DEXTRAN; HYPOTENSION; RECOMMENDATIONS	Objective: The aim of the study was to evaluate the feasibility of a prehospital trial comparing hypertonic saline and dextran (HSD) with normal saline (NS) in blunt head injury patients. Design: The study used a double blind randomized trial. Setting: The study was conducted in air and land emergency medical services and 2 trauma centers serving a population of 4 million people. Patients: The study population consisted of head injured, blunt trauma adult patients with a Glasgow Coma Scale of lower than 9. Interventions: We used 250 mL of HSD vs NS given within 4 hours of the accident. Measurements: The specific objectives were to assess protocol-related logistical issues, randomization, HSD safety, and follow up rates and to obtain survival and neurocognitive end point estimates. Main Results: Of 132 eligible patients, 113 were randomized. Nineteen eligible patients were missed because of lack of time (9 [22%]), paramedic discretion (3 [7%]), the paramedic forgot (6 [15%]), and the paramedic refused (1 [2%]). Randomization compliance was 96% (109/113). Four randomized cases met exclusion criteria: penetrating trauma (1), cardiac arrest (2), and fall from standing (1). Three randomized patients were excluded from the final analysis: 2 patients received less than 50 mL of study solution due to an interstitial intravenous line and 1 lost randomization identification. Fifty patients (47%) were randomized to HSD and 56 (53%) to NS. Mean injury severity score was 32.7 for HSD and 32.6 for NS. There was no difference in length of stay, Sequential Organ Failure Assessment maximum, Multiple Organ Dysfunction Score maximum, delta Multiple Organ Dysfunction Score, or Apache scores. Initial head scans scored 3 or higher by Marshall classification for 12 HSD and 11 NS patients. Zero adverse events occurred, and follow-up for the primary outcome was 100%. Alive at 30 days for HSD and NS, respectively, was 70% (35/50) and 75% (42/56) and at discharge was 68% (34/50) and 73% (41/56). Only 49.3% (37/77) of surviving patients consented to follow-up at 4 months and 89% (33/37) completed the assessment. Disability rating scale (median, interquartile range) was 3 (0, 6) for HSD and was 0 (0, 6) for NS. Glasgow Outcome Scale Evaluation was higher than 4 for HSD (12/12 [100%]) and NS (15/21 [72%]). Functional Independence Measure (mean, SD) was 62 (37) for HSD and 80 (32) for NS. Conclusions: It is feasible to conduct a prehospital randomized controlled trial with HSD for treatment of blunt trauma patients with head injuries; however, consent for neurofunctional outcomes in this cohort is problematic and threatens the feasibility of definitive trials using these potentially meaningful end points. (C) 2011 Elsevier Inc. All rights reserved.	[Morrison, Laurie J.; Baker, Andrew J.; Perreira, Tyrone] St Michaels Hosp, Li Ka Shing Knowledge Inst, Keenan Res Ctr, Rescu, Toronto, ON M5B 1W8, Canada; [Morrison, Laurie J.; MacDonald, Russell D.] Univ Toronto, Dept Med, Div Emergency Med, Toronto, ON, Canada; [Baker, Andrew J.; Simitciu, Merita] Univ Toronto, St Michaels Hosp, Dept Anaesthesia, Toronto, ON M5B 1W8, Canada; [Baker, Andrew J.; Rizoli, Sandro B.] Univ Toronto, Interdept Div Crit Care Med, Toronto, ON M5B 1W8, Canada; [Rhind, Shawn G.] Def Res & Dev Canada, Toronto, ON, Canada; [Kiss, Alex] Univ Toronto, Inst Clin & Evaluat Sci, Toronto, ON, Canada; [MacDonald, Russell D.] Ornge Transport Med, Toronto, ON, Canada; [Kiss, Alex; MacDonald, Russell D.; Schwartz, Brian; Black, Sandra E.; Rizoli, Sandro B.] Sunnybrook Hlth Sci Ctr, Toronto, ON M4N 3M5, Canada; [Schwartz, Brian] Sunnybrook Osler Ctr Prehosp Care, Toronto, ON, Canada; [Schwartz, Brian] Univ Toronto, Dept Family & Community Med, Toronto, ON M5S 1A1, Canada; [Trompeo, Anna] Univ Turin, Turin, Italy; [Stuss, Donald T.] Rotman Res Inst, Toronto, ON, Canada; [Rizoli, Sandro B.] Univ Toronto, Dept Surg, Toronto, ON, Canada	Morrison, LJ (corresponding author), St Michaels Hosp, Li Ka Shing Knowledge Inst, Keenan Res Ctr, Rescu, 30 Bond St, Toronto, ON M5B 1W8, Canada.	morrisonl@smh.ca	morrison, laurie J/A-6325-2012	morrison, laurie J/0000-0001-8369-9774; Black, Sandra/0000-0001-7093-8289; Rhind, Shawn/0000-0003-2300-0620	DRDC (Government of Canada) [w7711-027801/001/TOR]	Funding for this study was provided in part from the DRDC grant no. w7711-027801/001/TOR (Government of Canada). The investigators would like to acknowledge the assistance of Sandy Malhi, Vincenza Notarangelo, Jennifer Long, Boris Bojilov, Amanda White-McFarlan, and Jane Topolovec-Vranic for the trial coordination and data abstraction. In addition, the investigators acknowledge the outstanding contribution by the Ornge Transport Medicine critical care air medics and staff and Toronto Emergency Medical Services and the advance life support paramedics and staff in the implementation and completion of the study.	*AM ASS NEUR SURG, 2000, J NEUROTRAUM, V17, P591; BEAL AL, 1994, JAMA-J AM MED ASSOC, V271, P226, DOI 10.1001/jama.271.3.226; Cooper DJ, 2004, JAMA-J AM MED ASSOC, V291, P1350, DOI 10.1001/jama.291.11.1350; GRAHAM DI, 1978, J NEUROL SCI, V39, P213, DOI 10.1016/0022-510X(78)90124-7; Holcroft J W, 1989, Prog Clin Biol Res, V299, P331; HOLCROFT JW, 1987, ANN SURG, V206, P279, DOI 10.1097/00000658-198709000-00006; Khanna S, 2000, CRIT CARE MED, V28, P1144, DOI 10.1097/00003246-200004000-00038; Lancaster GA, 2004, J EVAL CLIN PRACT, V10, P307, DOI 10.1111/j..2002.384.doc.x; MANINGAS PA, 1989, AM J SURG, V157, P528, DOI 10.1016/0002-9610(89)90654-5; MANINGAS PA, 1989, AM J SURG, V157, P533; MARSHALL JC, 1995, CRIT CARE MED, V23, P1638, DOI 10.1097/00003246-199510000-00007; MATTOX KL, 1991, ANN SURG, V213, P482, DOI 10.1097/00000658-199105000-00014; Morrison LJ, 2009, TRIALS, V10, DOI 10.1186/1745-6215-10-105; Rhee P, 2003, J TRAUMA, V54, pS52, DOI 10.1097/01.TA.0000064507.80390.10; Rizoli SB, 2006, ANN SURG, V243, P47, DOI 10.1097/01.sla.0000193608.93127.b1; RIZOLI SB, 2002, 2002 YB INTENSIVE CA, P446; SAMPALIS J, 2002, HLTH INFRASTRUCTURE; Shackford SR, 1998, J TRAUMA, V44, P50, DOI 10.1097/00005373-199801000-00004; Simma B, 1998, CRIT CARE MED, V26, P1265, DOI 10.1097/00003246-199807000-00032; Sosin DM, 1996, BRAIN INJURY, V10, P47; Tremblay LN, 2001, CAN J SURG, V44, P172; VASSAR MJ, 1991, ARCH SURG-CHICAGO, V126, P1065; VASSAR MJ, 1993, J TRAUMA, V34, P622, DOI 10.1097/00005373-199305000-00003; VASSAR MJ, 1993, ARCH SURG-CHICAGO, V128, P1003; VASSAR MJ, 1993, ARCH SURG-CHICAGO, V128, P1011; VASSAR MJ, 1993, J TRAUMA, V34, P632	26	22	23	0	6	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0883-9441			J CRIT CARE	J. Crit. Care	AUG	2011	26	4					363	372		10.1016/j.jcrc.2010.08.021			10	Critical Care Medicine	General & Internal Medicine	816NG	WOS:000294608400007	21106341				2021-06-18	
J	Schliemann, B; Muder, D; Gessmann, J; Schildhauer, TA; Seybold, D				Schliemann, Benedikt; Muder, Daniel; Gessmann, Jan; Schildhauer, Thomas A.; Seybold, Dominik			Locked posterior shoulder dislocation: treatment options and clinical outcomes	ARCHIVES OF ORTHOPAEDIC AND TRAUMA SURGERY			English	Article						Locked posterior shoulder dislocation; Shoulder instability; McLaughlin procedure; Reverse Hill-Sachs lesion; Malgaigne fracture	FRACTURE-DISLOCATIONS; ANTERIOR DISLOCATION; EXTERNAL ROTATION; HUMERAL HEAD; IMMOBILIZATION; RECONSTRUCTION; ARTHROPLASTY; MANAGEMENT; ALLOGRAFT	Posterior dislocation of the shoulder is a rare injury and often misdiagnosed during the initial presentation to a physician. Misdiagnosis is due to a lack of clear clinical signs compared to anterior dislocation and inappropriate radiographs. In contrast to anterior dislocations, the humeral head defect accounts for recurrent instability. Depending on the size of the defect and the duration of dislocation, different treatment options include elevation of the defect, bone grafting, McLaughlin procedure, rotation osteotomy or arthroplasty. We reviewed 35 patients who presented to our institution with a locked posterior dislocation of the shoulder between January 1999 and August 2009. In 6 patients, the shoulder remained stable after closed reduction, so the treatment was conservative; 29 patients underwent surgery. The mean follow-up was 55 months (range 11-132 months). The interval between trauma and the diagnosis of posterior shoulder dislocation was 66 days (min. 0, max. 365). Patients treated conservatively achieved a Constant Score of 85 points; patients who underwent operative treatment had a slightly worse outcome with an average Constant Score of 79 points. There was a high correlation between the time to the correct diagnosis and the outcome. Although locked posterior shoulder dislocation is uncommon and often initially misdiagnosed, satisfying results can be achieved by different surgical treatment options. Early diagnosis by detailed clinical examination and sufficient radiographic evaluation with true anterior-posterior and axillary views is essential to improve clinical results. Levl of evidence: IV.	[Muder, Daniel; Gessmann, Jan; Schildhauer, Thomas A.; Seybold, Dominik] BG Univ Hosp Bergmannsheil Bochum, Dept Trauma Surg, D-44789 Bochum, Germany; [Schliemann, Benedikt] Univ Hosp Munster, Dept Trauma Hand & Reconstruct Surg, D-48149 Munster, Germany	Seybold, D (corresponding author), BG Univ Hosp Bergmannsheil Bochum, Dept Trauma Surg, Burkle de la Camp Pl 1, D-44789 Bochum, Germany.	dseybold@mac.com		Schildhauer, Thomas/0000-0002-3232-9869			BLASIER RB, 1988, CLIN ORTHOP RELAT R, P197; BROWN RJ, 1984, INJURY, V15, P267, DOI 10.1016/0020-1383(84)90012-3; Cheng SL, 1997, J SHOULDER ELB SURG, V6, P11, DOI 10.1016/S1058-2746(97)90065-3; Cooper A., 1839, GUYS HOSP REP, V4, P265; Diklic ID, 2010, J BONE JOINT SURG BR, V92B, P71, DOI 10.1302/0301-620X.92B1.22142; DORGAN JA, 1955, AM J SURG, V89, P890, DOI 10.1016/0002-9610(55)90159-8; ENGELHARDT MB, 1978, SOUTHERN MED J, V71, P425, DOI 10.1097/00007611-197804000-00024; Gavriilidis I, 2010, INT ORTHOP, V34, P79, DOI 10.1007/s00264-009-0762-9; Gerber C, 1996, J BONE JOINT SURG AM, V78A, P376, DOI 10.2106/00004623-199603000-00008; HAMADA K, 1990, CLIN ORTHOP RELAT R, P92; HAWKINS RJ, 1987, J BONE JOINT SURG AM, V69A, P9, DOI 10.2106/00004623-198769010-00003; HILL N A, 1963, J Trauma, V3, P225, DOI 10.1097/00005373-196305000-00004; Hughes M, 1975, Phys Ther, V55, P850; Irlenbusch L, 2008, UNFALLCHIRURG, V111, P464, DOI 10.1007/s00113-007-1363-y; Itoi E, 1999, J BONE JOINT SURG AM, V81A, P385, DOI 10.2106/00004623-199903000-00011; Itoi E, 2003, J SHOULDER ELB SURG, V12, P413, DOI 10.1016/S1058-2746(03)00171-X; KELLGREN JH, 1957, ANN RHEUM DIS, V16, P494, DOI 10.1136/ard.16.4.494; KELLY JP, 1954, J BONE JOINT SURG BR, V36, P70; Kirchhoff C, 2007, UNFALLCHIRURG, V110, P1059, DOI 10.1007/s00113-007-1285-8; Malgaigne J., 1855, TRAITE FRACTURES LUX; MCLAUGHLIN H, 1952, J BONE JOINT SURG AM, V24, P584; MCLAUGHLIN HL, 1963, SURG CLIN N AM, V43, P1615; MESTDAGH H, 1994, ANN CHIR, V48, P355; OCONNOR SJ, 1956, ARCH SURG-CHICAGO, V72, P479; ROWE CR, 1982, J BONE JOINT SURG AM, V64, P494, DOI 10.2106/00004623-198264040-00004; Schliemann B, 2009, SPORTVERLETZ SPORTSC, V23, P100, DOI 10.1055/s-0028-1109418; Seybold D, 2006, CHIRURG, V77, P821, DOI 10.1007/s00104-006-1181-8; SEYBOLD D, 2007, C GERM ASS SHOULD EL; Spencer EE, 2005, J SHOULDER ELB SURG, V14, P650, DOI 10.1016/j.jse.2004.11.008; Sperling JW, 2004, J SHOULDER ELB SURG, V13, P522, DOI 10.1016/j.jse.2004.02.012; WEBER BG, 1984, J BONE JOINT SURG AM, V66A, P1443, DOI 10.2106/00004623-198466090-00019; Wiedemann E, 2010, SCHULTERCHIRURGIE, P437; WILSON JC, 1949, J BONE JOINT SURG AM, V31-A, P160, DOI 10.2106/00004623-194931010-00018	33	22	24	0	6	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0936-8051			ARCH ORTHOP TRAUM SU	Arch. Orthop. Trauma Surg.	AUG	2011	131	8					1127	1134		10.1007/s00402-011-1310-9			8	Orthopedics; Surgery	Orthopedics; Surgery	794EK	WOS:000292878100015	21567148				2021-06-18	
J	Charash, WE; Caputo, MP; Clark, H; Callas, PW; Rogers, FB; Crookes, BA; Alborg, MS; Ricci, MA				Charash, William E.; Caputo, Michael P.; Clark, Harry; Callas, Peter W.; Rogers, Frederick B.; Crookes, Bruce A.; Alborg, Monica S.; Ricci, Michael A.			Telemedicine to a Moving Ambulance Improves Outcome After Trauma in Simulated Patients	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article; Proceedings Paper	66th Annual Meeting of the American-Association-for-the-Surgery-of-Trauma	SEP 27-29, 2007	Las Vegas, NV	Amer Assoc Surg Trauma		Telemedicine; Mobile; Simulation; Outcomes	CARE	Background: Rural trauma victims often require prolonged transport by s with limited scopes of practice. We evaluated the impact of telemedicine (TM) to a moving ambulance on outcomes in simulated trauma patients. Methods: This is an institutional review board approved, prospective double-blind study. Three trauma scenarios (blunt torso trauma, epigastric stab wound, and closed head injury) were created for a human patient simulator. Intermediate emergency medical technicians (EMTs; n = 20) managed the human patient simulator, in a moving ambulance. In the TM group, physicians (n = 12) provided consultation. In the non-TM group, EMTs communicated with medical control by radio, as necessary. We tabulated the fraction of 13 key signs, 5 pathologic processes, and 12 key interventions that were performed. Vital signs and SaO(2) (%) were recorded. Data were compared using the Wilcoxon rank-sum test. Results: Lowest SaO(2) (84 +/- 0.7 vs. 78 +/- 0), lowest systolic blood pressure (70 +/- 1 vs. 53 +/- 1), and highest heart rate (144 +/- 0.9 vs. 159 +/- 0.5) were significantly improved in the TM group (p < 0.001). Recognition rates for key signs (0.96 +/- 0.01 vs. 0.79 +/- 0.05), processes (0.98 +/- 0.02 vs. 0.75 +/- 0.05), and critical interventions (0.92 +/- 0.02 vs. 0.49 +/- 0.03) were higher in the TM group (p < 0.003). EMTs were successfully guided through needle decompression procedures in 22 of 24 cases (zero in the non-TM group). Conclusion: TM to a moving ambulance improved the care of simulated trauma patients. Furthermore, procedurally naive EMTs were able to perform needle thoracostomy and pericardiocentesis with TM guidance.	[Charash, William E.; Clark, Harry] Fletcher Allen Hlth Care, Burlington, VT 05401 USA; [Charash, William E.; Callas, Peter W.; Crookes, Bruce A.; Alborg, Monica S.; Ricci, Michael A.] Univ Vermont, Coll Med, Burlington, VT USA; [Rogers, Frederick B.] Lancaster Gen Hosp, Lancaster, PA USA; [Caputo, Michael P.] Washington Univ, Sch Med, St Louis, MO USA	Charash, WE (corresponding author), Fletcher Allen Hlth Care, 111 Colchester Ave,MCHV Campus,Fletcher 466, Burlington, VT 05401 USA.	bill.charash@vtmednet.org					CAPUTO MP, 2004, TELEHEALTH PRACTICE, V9, P7; CERTO TF, 1983, J TRAUMA, V23, P559, DOI 10.1097/00005373-198307000-00003; Esposito TJ, 1999, J TRAUMA, V47, P243, DOI 10.1097/00005373-199908000-00004; Hobbs F, 2002, CENSR4 US CENS BUR; ILLI OJ, 2001, TELEMED J E-HEALTH, V7, P148; Muelleman RL, 2007, J TRAUMA, V62, P221, DOI 10.1097/01.ta.0000231696.65548.06; *NAT HIGHW TRAFF S, 810657 NHTSA DOT HS; *NAT HIGHW TRAFF S, 809524 NHTSA DOT HS; *NAT HIGHW TRAFF S, 808806 NHTSA DOT HS; Ricci MA, 2003, TELEMED J E-HEALTH, V9, P3, DOI 10.1089/153056203763317602; Robertson R, 1996, AM J SURG, V172, P564, DOI 10.1016/S0002-9610(96)00247-4; Rogers FB, 1999, J TRAUMA, V47, P802, DOI 10.1097/00005373-199910000-00038; Rogers FB, 2001, J TRAUMA, V51, P1037, DOI 10.1097/00005373-200112000-00002; Sibert K, 2008, TELEMED J E-HEALTH, V14, P266, DOI 10.1089/tmj.2007.0050; *US C OFF TECHN AS, 1989, OTAH445 US C OFF TEC; Xiao Y, 2000, J HIGH SPEED NETW, V9, P47	16	22	23	0	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0022-5282	1529-8809		J TRAUMA	J. Trauma-Injury Infect. Crit. Care	JUL	2011	71	1					49	54		10.1097/TA.0b013e31821e4690			6	Critical Care Medicine; Surgery	General & Internal Medicine; Surgery	790RR	WOS:000292607400017	21818014				2021-06-18	
J	Chou, PCT; Shunmugavel, A; El Sayed, H; Desouki, MM; Nguyen, SA; Khan, M; Singh, I; Bilgen, M				Chou, Peter Cheng-te; Shunmugavel, Anandakumar; El Sayed, Hanaa; Desouki, Mohamed Mokhtar; Nguyen, Shaun A.; Khan, Mushfiquddin; Singh, Inderjit; Bilgen, Mehmet			Preclinical Use of Longitudinal MRI for Screening the Efficacy of S-Nitrosoglutathione in Treating Spinal Cord Injury	JOURNAL OF MAGNETIC RESONANCE IMAGING			English	Article						spinal cord injury; preclinical screening; drug treatment efficacy; translational research	TRAUMATIC BRAIN-INJURY; NITRIC-OXIDE; INFLAMMATORY RESPONSE; EXPERIMENTAL STROKE; RAT MODEL; NITROSYLATION; PROTECTS; NITROSATION; DISEASE	Purpose: To evaluate the therapeutic efficacy of S-nitrosoglutathione (GSNO) in spinal cord injury (SCI) using in vivo MRI in combination with neuorobehavioral testing and postmortem tissue analysis. Materials and Methods: Sixteen female rats were mildly injured at the vertebral T10 level and randomized into control (n = 8) and GSNO-treatment (n = 8) groups. GSNO was delivered at 0.05 mg/kg dose in saline by means of tail vein at 1 hr postinjury and then given orally on the following days. On postinjury days 1, 3, 7, and 28, the rats were tested behaviorally, then scanned using sagittal T2-weighted MRI for the quantification of lesion, edema, and hemorrhagic regions at the injury site. Excised cords were analyzed using histology and immunohistochemistry. Results: Treatment with GSNO was feasible in rats with SCI. On the average, the GSNO group at each scan day 1, 3, 7, and 28 exhibited better functional recovery as indicated by the behavioral performance of 52%, 33%, 19%, and 18%, and had smaller lesions of -4%, -16%, -20%, and -17% compared with the controls, respectively. Edema trend was parallel to the lesion volumes in both groups. Ex vivo data demonstrated that GSNO plays a role in neuronal tissue preservation and sparing. Conclusion: The data collectively provided the preliminary evidence that the injured rats responded favorably to GSNO treatment. Longitudinal MRI provides critical quantitative information regarding the changes in lesion properties, which helps evaluating the efficacy of an exogenous intervention in SCI.	[Bilgen, Mehmet] Univ Malaya, Fac Med, Kuala Lumpur 50603, Malaysia; [Chou, Peter Cheng-te; El Sayed, Hanaa] Med Univ S Carolina, Preclin Imaging Translat Res Lab, Charleston, SC 29425 USA; [Bilgen, Mehmet] Univ Malaya, Univ Malaya Res Imaging Ctr, Kuala Lumpur 50603, Malaysia	Bilgen, M (corresponding author), Univ Malaya, Fac Med, Kuala Lumpur 50603, Malaysia.	mehmet.bilgen@yahoo.com			NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS052610, NS054019]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R21NS054019, R21NS052610] Funding Source: NIH RePORTER	Contract grant sponsor: NIH; Contract grant number: NS052610, NS054019.	BASSO DM, 1995, J NEUROTRAUM, V12, P1, DOI 10.1089/neu.1995.12.1; Beckmann N, 2001, ANAT RECORD, V265, P85, DOI 10.1002/ar.1059; Bilgen M, 2005, NEUROREHAB NEURAL RE, V19, P219, DOI 10.1177/1545968305278635; Bilgen M, 2007, MAGN RESON IMAGING, V25, P657, DOI 10.1016/j.mri.2006.10.009; Campbell SJ, 2008, NEUROPHARMACOLOGY, V55, P780, DOI 10.1016/j.neuropharm.2008.06.074; Chiueh Chuang C., 2002, Pediatric Research, V51, P414, DOI 10.1203/00006450-200204000-00002; CHOU P, 2009, P 17 ANN SCI M EXH I; CHOU PC, 2008, NEUROANATOMY, V7, P83; Ditor DS, 2008, J NEUROSURG-SPINE, V9, P301, DOI 10.3171/SPI/2008/9/9/301; Ek CJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012021; Fortenberry JD, 2001, INFLAMM RES, V50, P89; Foster MW, 2003, TRENDS MOL MED, V9, P160, DOI 10.1016/S1471-4914(03)00028-5; Gu ZZ, 2002, SCIENCE, V297, P1186, DOI 10.1126/science.1073634; Kaposzta Z, 2002, CIRCULATION, V105, P1480, DOI 10.1161/01.CIR.0000012347.47001.97; Khan M, 2005, J CEREBR BLOOD F MET, V25, P177, DOI 10.1038/sj.jcbfm.9600012; Khan M, 2006, NITRIC OXIDE-BIOL CH, V15, P114, DOI 10.1016/j.niox.2006.01.008; Khan M, 2009, J NEUROINFLAMM, V6, DOI 10.1186/1742-2094-6-32; Lammertse D, 2007, J SPINAL CORD MED, V30, P205, DOI 10.1080/10790268.2007.11753928; Martinez-Ruiz A, 2004, CARDIOVASC RES, V62, P43, DOI 10.1016/j.cardiores.2004.01.013; Massa SM, 2010, J CLIN INVEST, V120, P1774, DOI 10.1172/JCI41356; Mihai G, 2008, J NEUROTRAUM, V25, P1, DOI 10.1089/neu.2007.0338; Mohr S, 1997, BIOCHEM BIOPH RES CO, V238, P387, DOI 10.1006/bbrc.1997.7304; Neumann M, 2009, J NEUROSCI METH, V176, P34, DOI 10.1016/j.jneumeth.2008.08.026; Nout YS, 2009, CRIT CARE MED, V37, P2160, DOI 10.1097/CCM.0b013e3181a05d41; Patel CB, 2009, J NEUROTRAUM, V26, P1005, DOI 10.1089/neu.2008.0860; Prasad R, 2007, GLIA, V55, P65, DOI 10.1002/glia.20436; Rauhala P, 1998, FASEB J, V12, P165; Savidge TC, 2007, GASTROENTEROLOGY, V132, P1344, DOI 10.1053/j.gastro.2007.01.051; Schrammel A, 2003, FREE RADICAL BIO MED, V34, P1078, DOI 10.1016/S0891-5849(03)00038-8; Schwartz M, 2006, J NEUROTRAUM, V23, P360, DOI 10.1089/neu.2006.23.360; Shen J, 2009, ACAD RADIOL, V16, P1142, DOI 10.1016/j.acra.2009.03.016; Shunmugavel A, 2010, J INFLAMM-LOND, V7, DOI 10.1186/1476-9255-7-17; Tatar Ilkan, 2009, BMC Med Imaging, V9, P10, DOI 10.1186/1471-2342-9-10; Wong DF, 2009, NEUROPSYCHOPHARMACOL, V34, P187, DOI 10.1038/npp.2008.166	34	22	22	0	6	WILEY-BLACKWELL	MALDEN	COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA	1053-1807			J MAGN RESON IMAGING	J. Magn. Reson. Imaging	JUN	2011	33	6					1301	1311		10.1002/jmri.22574			11	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	772WD	WOS:000291267700004	21590998				2021-06-18	
J	Sun, D; Gugliotta, M; Rolfe, A; Reid, W; McQuiston, AR; Hu, WH; Young, H				Sun, Dong; Gugliotta, Marinella; Rolfe, Andrew; Reid, Wendy; McQuiston, A. Rory; Hu, Wenhui; Young, Harold			Sustained Survival and Maturation of Adult Neural Stem/Progenitor Cells after Transplantation into the Injured Brain	JOURNAL OF NEUROTRAUMA			English	Article						neural stem/progenitor cells; subventricular zone; transplantation; traumatic brain injury	MARROW STROMAL CELLS; PROGENITOR CELLS; STEM-CELLS; INFLAMMATORY RESPONSE; COGNITIVE RECOVERY; RAT-BRAIN; DIFFERENTIATION; NEURONS; MIGRATION; IMPROVES	Multipotent neural stem/progenitor cells (NS/NPCs) that are capable of generating neurons and glia offer enormous potential for treating neurological diseases. Adult NS/NPCs that reside in the mature mammalian brain can be isolated and expanded in vitro, and could be a potential source for autologous transplantation to replace cells lost to brain injury or disease. When these cells are transplanted into the normal brain, they can survive and become region-specific cells. However, it has not been reported whether these cells can survive for an extended period and become functional cells in an injured heterotypic environment. In this study, we tested survival, maturation fate, and electrophysiological properties of adult NS/NPCs after transplantation into the injured rat brain. NS/NPCs were isolated from the subventricular zone of adult Fisher 344 rats and cultured as a monolayer. Recipient adult Fisher 344 rats were first subjected to a moderate fluid percussive injury. Two days later, cultured NS/NPCs were injected into the injured brain in an area between the white matter tracts and peri-cortical region directly underneath the injury impact. The animals were sacrificed 2 or 4 weeks after transplantation for immunohistochemical staining or patch-clamp recording. We found that transplanted cells survived well at 2 and 4 weeks. Many cells migrated out of the injection site into surrounding areas expressing astrocyte or oligodendrocyte markers. Whole cell patch-clamp recording at 4 weeks showed that transplanted cells possessed typical mature glial cell properties. These data demonstrate that adult NS/NPCs can survive in an injured heterotypic environment for an extended period and become functional cells.	[Sun, Dong; Gugliotta, Marinella; Rolfe, Andrew; Reid, Wendy; Young, Harold] Virginia Commonwealth Univ, Dept Neurosurg, Richmond, VA 23298 USA; [McQuiston, A. Rory] Virginia Commonwealth Univ, Dept Anat & Neurobiol, Richmond, VA 23298 USA; [Hu, Wenhui] Temple Univ, Dept Neurosci, Philadelphia, PA 19122 USA	Sun, D (corresponding author), Virginia Commonwealth Univ, Dept Neurosurg, POB 980631,Med Coll Virginia Campus, Richmond, VA 23298 USA.	dsun@vcu.edu	McQuiston, Adam Rory/A-3072-2008		A.D. William Fund; National Institutes of Health/National Institute of Neurological Disorders and Stroke (NIH/NINDS)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS062369, NS055086, 5P30NS047463]; Virginia Commonwealth Neurotrauma Initiative Trust [RFP07-302]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P30NS047463, R01NS055086, R21NS062369] Funding Source: NIH RePORTER	Sponsored by the A.D. William Fund (Sun), National Institutes of Health/National Institute of Neurological Disorders and Stroke (NIH/NINDS) grant NS062369 (Sun), NIH/NINDS grant NS055086 (Sun), and the Virginia Commonwealth Neurotrauma Initiative Trust Fund (RFP07-302, Sun). Microscopy work was performed at the VCU-Department of Anatomy and Neurobiology Microscopy Facility, supported in part by funding from NIH/NINDS center core grant 5P30NS047463.	ALTMAN J, 1965, J COMP NEUROL, V124, P319, DOI 10.1002/cne.901240303; Bjorklund A, 2000, BRAIN RES, V886, P82, DOI 10.1016/S0006-8993(00)02915-2; Boockvar JA, 2005, NEUROSURGERY, V56, P163, DOI 10.1227/01.NEU.0000145866.25433.FF; Dziewczapolski G, 2003, EXP NEUROL, V183, P653, DOI 10.1016/S0014-4886(03)00212-7; GAGE FH, 1995, P NATL ACAD SCI USA, V92, P11879, DOI 10.1073/pnas.92.25.11879; Gage FH, 1998, J NEUROBIOL, V36, P249, DOI 10.1002/(SICI)1097-4695(199808)36:2<249::AID-NEU11>3.0.CO;2-9; Gao JL, 2006, EXP NEUROL, V201, P281, DOI 10.1016/j.expneurol.2006.04.039; Gates M A, 2000, Prog Brain Res, V127, P115; Hagan M, 2003, NEUROSCI LETT, V351, P149, DOI 10.1016/j.neulet.2003.07.021; Herrera DG, 1999, ANN NEUROL, V46, P867, DOI 10.1002/1531-8249(199912)46:6<867::AID-ANA9>3.0.CO;2-Z; Hill-Felberg SJ, 1999, J NEUROSCI RES, V57, P271, DOI 10.1002/(SICI)1097-4547(19990715)57:2<271::AID-JNR13>3.0.CO;2-Z; Hoane MR, 2004, J NEUROTRAUM, V21, P163, DOI 10.1089/089771504322778622; Hu W, 2006, BIOCHEM BIOPH RES CO, V343, P1038, DOI 10.1016/j.bbrc.2006.03.079; Klassen H, 2003, VISION RES, V43, P947, DOI 10.1016/S0042-6989(03)00094-4; Lenzlinger PM, 2001, MOL NEUROBIOL, V24, P169; Li Y, 2009, NEUROSCI LETT, V456, P120, DOI 10.1016/j.neulet.2008.03.096; Ligon KL, 2004, J NEUROPATH EXP NEUR, V63, P499, DOI 10.1093/jnen/63.5.499; LOIS C, 1993, P NATL ACAD SCI USA, V90, P2074, DOI 10.1073/pnas.90.5.2074; Mahmood A, 2006, J NEUROSURG, V104, P272, DOI 10.3171/jns.2006.104.2.272; Mahmood A, 2004, J NEUROTRAUM, V21, P33, DOI 10.1089/089771504772695922; Mahmood A, 2003, NEUROSURGERY, V53, P697, DOI 10.1227/01.NEU.0000079333.61863.AA; Mahmood A, 2001, NEUROSURGERY, V49, P1196, DOI 10.1097/00006123-200111000-00031; Mahmood A, 2001, J NEUROSURG, V94, P589, DOI 10.3171/jns.2001.94.4.0589; McKay R, 1997, SCIENCE, V276, P66, DOI 10.1126/science.276.5309.66; McQuiston AR, 2007, J NEUROPHYSIOL, V97, P2301, DOI 10.1152/jn.01179.2006; Molcanyi M, 2007, J NEUROTRAUM, V24, P625, DOI 10.1089/neu.2006.0180; PALMER TD, 1995, MOL CELL NEUROSCI, V6, P474, DOI 10.1006/mcne.1995.1035; Philips MF, 2001, J NEUROSURG, V94, P765, DOI 10.3171/jns.2001.94.5.0765; Qu CS, 2009, J NEUROSURG, V111, P658, DOI 10.3171/2009.4.JNS081681; Reid WM, 2010, J NEUROTRAUM, V27, P1243, DOI 10.1089/neu.2010.1270; Richardson RM, 2005, MOL CELL NEUROSCI, V28, P674, DOI 10.1016/j.mcn.2004.11.013; Richardson RM, 2005, BRAIN RES, V1032, P11, DOI 10.1016/j.brainres.2004.10.043; Riess P, 2002, NEUROSURGERY, V51, P1043, DOI 10.1097/00006123-200210000-00035; Riess P, 2007, J NEUROTRAUM, V24, P216, DOI 10.1089/neu.2006.0141; Shear DA, 2004, BRAIN RES, V1026, P11, DOI 10.1016/j.brainres.2004.07.087; Sinson G, 1996, J NEUROSURG, V84, P655, DOI 10.3171/jns.1996.84.4.0655; Soares HD, 1995, J NEUROSCI, V15, P8223; SONTHEIMER H, 1994, GLIA, V11, P156, DOI 10.1002/glia.440110210; Studer L, 1998, NAT NEUROSCI, V1, P290; Suhonen JO, 1996, NATURE, V383, P624, DOI 10.1038/383624a0; Sun D, 2007, EXP NEUROL, V204, P264, DOI 10.1016/j.expneurol.2006.11.005; Sun D, 2010, J NEUROTRAUM, V27, P923, DOI 10.1089/neu.2009.1209; Sun D, 2009, EXP NEUROL, V216, P56, DOI 10.1016/j.expneurol.2008.11.011; Tate CC, 2009, J TISSUE ENG REGEN M, V3, P208, DOI 10.1002/term.154; Tate MC, 2002, CELL TRANSPLANT, V11, P283; Wallenquist U, 2009, RESTOR NEUROL NEUROS, V27, P323, DOI 10.3233/RNN-2009-0481; Wennersten A, 2004, J NEUROSURG, V100, P88, DOI 10.3171/jns.2004.100.1.0088	47	22	24	0	6	MARY ANN LIEBERT INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151			J NEUROTRAUM	J. Neurotrauma	JUN	2011	28	6					961	972		10.1089/neu.2010.1697			12	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	788PT	WOS:000292457600010	21332258	Green Published			2021-06-18	
J	Wong, GKC; Yeung, JHH; Graham, CA; Zhu, XL; Rainer, TH; Poon, WS				Wong, George K. C.; Yeung, Janice H. H.; Graham, Colin A.; Zhu, Xian-lun; Rainer, Timothy H.; Poon, Wai S.			Neurological outcome in patients with traumatic brain injury and its relationship with computed tomography patterns of traumatic subarachnoid hemorrhage Clinical article	JOURNAL OF NEUROSURGERY			English	Article						mortality rate; multiple trauma; neurosurgery; neurological outcome; subarachnoid hemorrhage; traumatic brain injury	MODERATE HEAD-INJURY; ADMISSION; CLASSIFICATION; MULTICENTER; PROGRESSION; PREDICTION; VALIDATION; DIAGNOSIS; IMPACT; SCORE	Object. Traumatic subarachnoid hemorrhage (SAH) is a poor prognostic factor for traumatic brain injury. The authors aimed to further investigate neurological outcome among head injury patients by examining the prognostic values of CT patterns of traumatic SAH, in particular, the thickness and distribution. Methods. The study was conducted using a database in a regional trauma center in Hong Kong. Data had been prospectively collected in consecutive trauma patients between January 2006 and December 2008. Patients included in the study had significant head injury (as defined by a head Abbreviated Injury Scale [AIS] score of 2 or more) with traumatic SAH according to admission CT. Results. Over the 36-month period, 661 patients with significant head injury were admitted to the Prince of Wales Hospital in Hong Kong. Two hundred fourteen patients (32%) had traumatic SAH on admission CT. The mortality rate was significantly greater and a 6-month unfavorable outcome was significantly more frequent in patients with traumatic SAH. Multivariate analysis showed that the maximum thickness (mm) of traumatic SAH was independently associated with neurological outcome (OR 0.8.95% CI 0.7-0.9) and death (OR 1.3, 95% CI 1.2-1.5) but not with the extent or location of hemorrhage. Conclusions: Maximum thickness of traumatic SAH was a strong independent prognostic factor for death and clinical outcome. Anatomical distribution per se did not affect clinical outcome. (DOI: 10.3171/2011.1.JNS101102)	[Wong, George K. C.] Chinese Univ Hong Kong, Prince Wales Hosp, Div Neurosurg, Dept Surg, Shatin, Hong Kong, Peoples R China; [Yeung, Janice H. H.; Graham, Colin A.; Rainer, Timothy H.] Chinese Univ Hong Kong, Prince Wales Hosp, Accident & Emergency Med Acad Unit, Shatin, Hong Kong, Peoples R China	Wong, GKC (corresponding author), Chinese Univ Hong Kong, Prince Wales Hosp, Div Neurosurg, Dept Surg, Shatin, Hong Kong, Peoples R China.	georgewong@surgery.cuhk.edu.hk	Poon, Wai Sang/F-1558-2011; Rainer, Timothy H/I-2591-2013; Wong, George KC/A-6378-2011; Wong, George Kwok Chu/L-4344-2016; Graham, Colin A/B-4535-2013	Rainer, Timothy H/0000-0003-3355-3237; Wong, George KC/0000-0002-6078-2548; Graham, Colin A/0000-0002-4381-7470			*ASS ADV AUT MED, 1985, ABBR INJ SCAL 1985 V; Azian AA, 2001, ACTA NEUROCHIR, V143, P711, DOI 10.1007/s007010170051; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; CHAMPION HR, 1989, J TRAUMA, V29, P623, DOI 10.1097/00005373-198905000-00017; Chang EF, 2006, NEUROSURGERY, V58, P647, DOI 10.1227/01.NEU.0000197101.68538.E6; Cheng CH, 2008, ANN SURG, V247, P335, DOI 10.1097/SLA.0b013e31815ccc2e; Chieregato A, 2005, NEUROSURGERY, V56, P671, DOI 10.1227/01.NEU.0000156200.76331.7A; Choi JH, 2008, J TRAUMA, V65, P1028, DOI 10.1097/TA.0b013e31815eba9b; Claassen J, 2001, STROKE, V32, P2012, DOI 10.1161/hs0901.095677; Compagnone C, 2009, NEUROSURGERY, V64, P690, DOI 10.1227/01.NEU.0000340796.18738.F7; Fabbri A, 2008, J NEUROL NEUROSUR PS, V79, P567, DOI 10.1136/jnnp.2007.120162; Fainardi E, 2004, ACTA NEUROCHIR, V146, P257, DOI 10.1007/s00701-003-0207-y; FISHER CM, 1980, NEUROSURGERY, V6, P1, DOI 10.1227/00006123-198001000-00001; Greene KA, 1996, J TRAUMA, V41, P964, DOI 10.1097/00005373-199612000-00004; Hanlon RE, 2005, BRAIN INJURY, V19, P257, DOI 10.1080/02699050400004955; Hukkelhoven CWPM, 2005, J NEUROTRAUM, V22, P1025, DOI 10.1089/neu.2005.22.1025; JENNETT B, 1975, LANCET, V1, P480; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; Mattioli C, 2003, J NEUROSURG, V98, P37, DOI 10.3171/jns.2003.98.1.0037; Miki T, 1998, J CLIN NEUROSCI, V5, P49, DOI 10.1016/S0967-5868(98)90202-8; Morris GF, 1997, CLIN NEUROL NEURO S1, V99, pS16; Murray GD, 2007, J NEUROTRAUM, V24, P329, DOI 10.1089/neu.2006.0035; Patel HC, 1999, HOSP MED, V60, P497, DOI 10.12968/hosp.1999.60.7.1155; Servadei F, 2002, ACT NEUR S, V81, P81; Servadei F, 2002, NEUROSURGERY, V50, P261, DOI 10.1097/00006123-200202000-00006; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Tasaki O, 2009, J TRAUMA, V66, P304, DOI 10.1097/TA.0b013e31815d9d3f; TEASDALE G, 1974, LANCET, V2, P81; Vergouwen MDI, 2006, LANCET NEUROL, V5, P1029, DOI 10.1016/S1474-4422(06)70582-8; Wang HC, 2006, NEUROCRIT CARE, V5, P71, DOI 10.1385/NCC:5:1:71; Wardlaw JM, 2002, J NEUROL NEUROSUR PS, V72, P188, DOI 10.1136/jnnp.72.2.188; Wong GK, 2009, BRIT J NEUROSURG, V23, P601, DOI 10.3109/02688690902948184; Zacharia TT, 2010, EMERG RADIOL, V17, P97, DOI 10.1007/s10140-009-0842-6	34	22	22	0	0	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.	JUN	2011	114	6					1510	1515		10.3171/2011.1.JNS101102			6	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	770YB	WOS:000291123300005	21332291				2021-06-18	
J	Bauer, DF; McGwin, G; Melton, SM; George, RL; Markert, JM				Bauer, David F.; McGwin, Gerald, Jr.; Melton, Sherry M.; George, Richard L.; Markert, James M.			The Relationship Between INR and Development of Hemorrhage With Placement of Ventriculostomy	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article; Proceedings Paper	Meeting of the American-College-of-Surgeons-Committee-on-Trauma	NOV, 2009	New Orleans, LA	Amer Coll Surg Comm Trauma		Hemorrhage; ICP; INR; Trauma; Ventriculostomy	INTRACRANIAL-PRESSURE MONITORS; BRAIN-INJURY; COMPLICATIONS; COAGULOPATHY	Background: This study seeks to evaluate the relationship between the risk of symptomatic hemorrhage from ventriculostomy placement and International Normalized Ratio (INR) in patients who received a ventriculostomy after traumatic brain injury. Methods: Patients who received a ventriculostomy after traumatic brain injury between June 2007 and July 2008 were identified and their medical records were abstracted for information. Results: At the time of ventriculostomy placement, 32 patients had an INR <1.2, 26 patients had an INR 1.2 to 1.4, 12 patients had an INR 1.4 to 1.6, and one patient had an INR >1.6 (INR = 1.61). No significant difference in the risk of hemorrhage between the groups was observed: 9.4%, 3.9%, 8.3%, and 0%, respectively (p = 0.73). In a subgroup analysis of patients who received ventriculostomy in the Neurosurgical Intensive Care Unit within 24 hours of admission (n = 54), the average time between admission and ventriculostomy placement in patients who did not receive fresh frozen plasma was 6.8 hours compared with 9.3 hours (p = 0.03) for those who did. Conclusions: In this retrospective study, INRs between 1.2 and 1.6 appeared to be acceptable for a neurosurgeon to place an emergent ventriculostomy in a patient with traumatic brain injury.	[Bauer, David F.; Markert, James M.] Univ Alabama Birmingham, Div Neurosurg, Birmingham, AL 35294 USA; [McGwin, Gerald, Jr.] Univ Alabama Birmingham, Sch Publ Hlth, Dept Epidemiol, Birmingham, AL 35294 USA; [McGwin, Gerald, Jr.; Melton, Sherry M.; George, Richard L.] Univ Alabama Birmingham, Dept Surg, Sect Trauma Burns & Surg Crit Care, Birmingham, AL 35294 USA	Markert, JM (corresponding author), Univ Alabama Birmingham, Div Neurosurg, FOT 1060,1530 3rd Ave S, Birmingham, AL 35294 USA.	markert@uab.edu		Bauer, David/0000-0003-3548-0887			Anderson RCE, 2004, J NEUROSURG, V101, P53, DOI 10.3171/ped.2004.101.2.0053; Blaha M, 2003, PEDIATR NEUROSURG, V39, P27, DOI 10.1159/000070877; BRAIN TRAUM FD, 2000, J NEUROTRAUM, V17, P457; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS37; *BRIT COMM STAND H, 2004, J BR SOC HAEMATOL, V126, P11; BULLOCK MR, 2006, NEUROSURGERY S, V58; CIAVARELLA D, 1987, BRIT J HAEMATOL, V67, P365, DOI 10.1111/j.1365-2141.1987.tb02359.x; Davis JW, 2004, J TRAUMA, V57, P1173, DOI 10.1097/01.TA.0000151257.79108.FB; Goldstein JN, 2006, STROKE, V37, P151, DOI 10.1161/01.STR.0000195047.21562.23; Greenberg MS, 2006, HDB NEUROSURGERY; Halpern CH, 2008, J NEUROTRAUM, V25, P997, DOI 10.1089/neu.2008.0548; HEYMANN CV, 2006, ANESTH ANALG, V103, P969; Holland LL, 2006, AM J CLIN PATHOL, V126, P133, DOI 10.1309/NQXHUG7HND78LFFK; Kakarla UK, 2008, NEUROSURGERY, V63, P162, DOI 10.1227/01.NEU.0000312390.83127.7F; Kakarla UK, 2008, NEUROSURGERY S1, V63; KELLY DF, 1995, OPERATIVE NEUROSURGI, P47; Maniker AH, 2006, NEUROSURGERY, V59, P419, DOI 10.1227/01.NEU.0000222817.99752.E6; MARSHALL LF, 1991, J NEUROSURG, V75, pS28, DOI 10.3171/sup.1991.75.1s.0s28; MILLER JD, 1981, J NEUROSURG, V54, P289, DOI 10.3171/jns.1981.54.3.0289; Reiss R F, 2000, Am J Crit Care, V9, P158; Roitberg BZ, 2001, BRIT J NEUROSURG, V15, P324; SCHMIDEK HH, 2005, SCHMIDEK SWEETS OPER; Segal JB, 2005, TRANSFUSION, V45, P1413, DOI 10.1111/j.1537-2995.2005.00546.x; STEIN SC, 1992, NEUROSURGERY, V30, P160, DOI 10.1227/00006123-199202000-00002; Talving P, 2009, J TRAUMA, V66, P55, DOI 10.1097/TA.0b013e318190c3c0; VANDERSANDE JJ, 1978, J NEUROSURG, V49, P357, DOI 10.3171/jns.1978.49.3.0357; VESPA PM, 2000, OPERATIVE NEUROSURGE, P1205; Wiesmann M, 2001, J CLIN NEUROSCI, V8, P126, DOI 10.1054/jocn.2000.0749; 2006, NATL NEUROSURGICAL P	29	22	22	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0022-5282	1529-8809		J TRAUMA	J. Trauma-Injury Infect. Crit. Care	MAY	2011	70	5					1112	1117		10.1097/TA.0b013e3181e7c2ae			6	Critical Care Medicine; Surgery	General & Internal Medicine; Surgery	762LQ	WOS:000290480300030	20805772				2021-06-18	
J	Kennedy, MRT; Krause, MO				Kennedy, Mary R. T.; Krause, Miriam O.			Self-Regulated Learning in a Dynamic Coaching Model for Supporting College Students With Traumatic Brain Injury: Two Case Reports	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						brain injury; cognitive rehabilitation; college students; self-regulation; supported education	COGNITIVE REHABILITATION; POSTSECONDARY STUDENTS; ADULTS; EXPERIENCES; TRANSITION; RETURN	Objective: To describe a program that integrates self-regulated learning theory with supported education for college students with traumatic brain injury using a dynamic coaching model; to demonstrate the feasibility of developing and implementing such a program; and to identify individualized outcomes. Design: Case study comparisons. Setting: University setting. Participants: Two severely injured students with cognitive impairments. Interventions: A dynamic coaching model of supported education which incorporated self-regulated learning was provided for students with traumatic brain injury while attending college. Outcomes: Outcomes were both short and long term including decontextualized standardized test scores, self-reported academic challenges, number and specificity of reported strategies, grades on assignments, number of credits completed versus attempted, and changes in academic status and campus life. Results: Students improved on graded assignments after strategy instruction and reported using more strategies by the end of the year. Students completed most of the credits they attempted, were in good academic standing, and made positive academic decisions. Performance on decontextualized tests pre- and postintervention was variable. Conclusions: It is feasible to deliver a hybrid supported education program that is dynamically responsive to individual students' needs and learning styles. Reasons for including both functional and standardized test outcomes are discussed.	[Kennedy, Mary R. T.; Krause, Miriam O.] Univ Minnesota, Dept Speech Language Hearing Sci, Minneapolis, MN 55455 USA	Kennedy, MRT (corresponding author), Univ Minnesota, Dept Speech Language Hearing Sci, 115 Shevlin Hall,164 Pillsbury Dr SE, Minneapolis, MN 55455 USA.	kenne047@umn.edu		Krause, Miriam/0000-0002-6798-3991	Office of the Vice President for Research; Graduate School, University of Minnesota, Minneapolis, MinnesotaUniversity of Minnesota System	The authors thank Disability Services at the University of Minnesota-Twin Cities, Minneapolis, MN, Marie Meyer and Valerie Blouch for their contribution to the study and manuscript preparation. This study was made possible in part due to a Grant-in-Aid awarded to the first author by the Office of the Vice President for Research and the Graduate School, University of Minnesota, Minneapolis, Minnesota.	Bandura A., 1997, SELF EFFICACY EXERCI; BUETHE C, 1989, J COLL STUDENT DEV, V30, P172; Centers for Disease Control and Prevention, 2010, INJ PREV CONTR TRAUM; Cicerone KD, 2005, ARCH PHYS MED REHAB, V86, P1681, DOI 10.1016/j.apmr.2005.03.024; Cicerone KD, 2000, ARCH PHYS MED REHAB, V81, P1596, DOI 10.1053/apmr.2000.19240; COOK J, 1991, J HEAD TRAUMA REHAB, V6, P64; Dawson DR, 2007, DISABIL REHABIL, V29, P301, DOI 10.1080/09638280600756687; Dunlosky J., 2009, METACOGNITION; Dunlosky J., 2005, COGNITIVE TECHNOLOGY, V10, P4; Ehlhardt LA, 2008, NEUROPSYCHOL REHABIL, V18, P300, DOI 10.1080/09602010701733190; Getzel E, 2006, GOING COLL, P139; Getzel EE, 2008, CAREER DEV TRANSIT E, V31, P77, DOI 10.1177/0885728808317658; Harrington D E, 1987, Brain Inj, V1, P65, DOI 10.3109/02699058709034447; Harris JR, 1997, J HEAD TRAUMA REHAB, V12, P67, DOI 10.1097/00001199-199704000-00007; Hart T, 2006, J HEAD TRAUMA REHAB, V21, P142, DOI 10.1097/00001199-200603000-00007; IP RY, 1995, BRAIN INJURY, V9, P517, DOI 10.3109/02699059509008211; JOHNSTONE B, 1994, J CLIN PSYCHOL MED S, V1, P375, DOI 10.1007/BF01991080; Kennedy MRT, 2008, NEUROPSYCHOL REHABIL, V18, P257, DOI 10.1080/09602010701748644; Kennedy Mary R. T, 2005, Seminars in Speech and Language, V26, P242, DOI 10.1055/s-2005-922103; Kennedy MRT, 2008, NEUROREHABILITATION, V23, P511; Kennedy MRT, 2004, NEUROPSYCHOL REHABIL, V14, P449, DOI 10.1080/09602010443000038; Kennedy MRT, 2003, BRAIN INJURY, V17, P1043, DOI 10.1080/0269905031000110436; Kennedy MRT, 2001, BRAIN INJURY, V15, P469, DOI 10.1080/02699050120517; KENNEDY MRT, 2010, BRAIN INJURY, V24, P325; Kirby JR, 2008, J LEARN DISABIL-US, V41, P85, DOI 10.1177/0022219407311040; Krause M, 2009, BRAIN INJURY, V23, P965, DOI 10.3109/02699050903373485; Macdonald S., 2005, FUNCTIONAL ASSESSMEN; McKay C, 2007, ARCH CLIN NEUROPSYCH, V22, P91, DOI 10.1016/j.acn.2006.11.003; MOWBRAY CT, 1993, PSYCHOSOC REHABIL, V17, P129, DOI DOI 10.1037/H0095619; NELSON HE, 1991, NATL ADULT READING; RANDOLPH C, PEARSON ED, V1; Randolph C, 1998, REPEATABLE BATTERY A; Riley GA, 2003, BRIT J CLIN PSYCHOL, V42, P319, DOI 10.1348/01446650360703410; Savage RC, 1987, J HEAD TRAUMA REHAB, V2, P1; Schlund MW, 1999, BRAIN INJURY, V13, P375, DOI 10.1080/026990599121566; Schunk D. H., 2000, HDB SELF REGULATION, P631, DOI DOI 10.1016/B978-012109890-2/50048-2; Sohlberg MM, 2007, J MED SPEECH-LANG PA, V15, pXV; Stewart-Scott AM, 1998, BRAIN INJURY, V12, P317, DOI 10.1080/026990598122629; Todis B, 2008, J HEAD TRAUMA REHAB, V23, P252, DOI 10.1097/01.HTR.0000327257.84622.bc; Turkstra L, 2005, J MED SPEECH-LANG PA, V13, pIX; Wagner M., 2005, HIGH SCH 1 LOOK POST; Winne PH, 1998, EDUC PSYCHOL SER, P277; World Health Organization, 2001, INT CLASS FUNCT DIS; Ylvisaker M., 1998, COLLABORATIVE BRAIN; Ylvisaker M, 2007, BRAIN INJURY, V21, P769, DOI 10.1080/02699050701482470	45	22	23	0	8	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	MAY-JUN	2011	26	3					212	223		10.1097/HTR.0b013e318218dd0e			12	Clinical Neurology; Rehabilitation	Neurosciences & Neurology; Rehabilitation	760CY	WOS:000290301800005	21552070				2021-06-18	
J	Wu, HT; Jiang, H; Lu, DY; Qu, CS; Xiong, Y; Zhou, D; Chopp, M; Mahmood, A				Wu, Hongtao; Jiang, Hao; Lu, Dunyue; Qu, Changsheng; Xiong, Ye; Zhou, Dong; Chopp, Michael; Mahmood, Asim			Induction of Angiogenesis and Modulation of Vascular Endothelial Growth Factor Receptor-2 by Simvastatin After Traumatic Brain Injury	NEUROSURGERY			English	Article						Angiogenesis; Simvastatin; Traumatic brain injury; VEGFR-2	NITRIC-OXIDE SYNTHASE; CEREBRAL-ISCHEMIA; KINASE AKT; NEUROGENESIS; STROKE; RATS; INCREASE; STATINS; CELLS; PATHOPHYSIOLOGY	BACKGROUND: Our previous studies demonstrated that simvastatin reduced neuronal death, increased neurogenesis, and promoted functional recovery after traumatic brain injury (TBI). OBJECTIVE: To investigate the effect of simvastatin on angiogenesis after TBI and the related signaling pathways. METHODS: Saline or simvastatin (1 mg/kg) was administered orally to rats starting at day 1 after TBI or sham surgery and then daily for 14 days. Rats were sacrificed at 3 and 14 days after treatment. Brain sections and tissues were prepared for immunohistochemical staining, enzyme-linked immunosorbent assay, and Western blot analysis. Cultured rat brain microvascular endothelial cells were subjected to oxygen-glucose deprivation followed by immunocytochemical staining with phallotoxins and vascular endothelial growth factor receptor-2 (VEGFR-2). Western blot analysis was carried out to examine the simvastatin-induced activation of the v-akt murine thymoma viral oncogene homolog (Akt) signaling pathway. The expression of VEGFR-2 was detected by enzyme-linked immunosorbent assay. RESULTS: Simvastatin significantly increased the length of vascular perimeter, promoted the proliferation of endothelial cells, and improved the sensorimotor function after TBI. Simvastatin stimulated endothelial cell tube formation after oxygen-glucose deprivation in vitro. VEGFR-2 expression in both brain tissues and cultured rat brain microvascular endothelial cells was enhanced after simvastatin treatment, which may be modulated by activation of Akt. Akt-dependent endothelial nitric oxide synthase phosphorylation was also induced by simvastatin in vivo and in vitro. CONCLUSION: Simvastatin augments TBI-induced angiogenesis in the lesion boundary zone and hippocampus and improves functional recovery. Simvastatin also promotes angiogenesis in vitro. These beneficial effects on angiogenesis may be related to simvastatin-induced activation of the VEGFR-2/Akt/endothelial nitric oxide synthase signaling pathway.	[Wu, Hongtao; Qu, Changsheng; Xiong, Ye; Mahmood, Asim] Henry Ford Hosp, Dept Neurosurg, Detroit, MI 48202 USA; [Jiang, Hao; Chopp, Michael] Henry Ford Hosp, Dept Neurol, Detroit, MI 48202 USA; [Wu, Hongtao] Sichuan Univ, W China Hosp, Dept Neurol, Chengdu 610064, Peoples R China; [Lu, Dunyue] Suny Downstate Med Ctr, Dept Psychiat, Brooklyn, NY USA; [Chopp, Michael] Oakland Univ, Dept Phys, Rochester, MI USA	Mahmood, A (corresponding author), Henry Ford Hosp, Dept Neurosurg, 2799 W Grand Blvd, Detroit, MI 48202 USA.	nsaam@neuro.hfh.edu		Xiong, Ye/0000-0001-9770-6031	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01NS052280-01A1, PO1NS23345]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS052280, R01NS023345] Funding Source: NIH RePORTER	This work was supported by National Institutes of Health grants R01NS052280-01A1 (Dr Mahmood) and PO1NS23345 (Dr Chopp). The authors have no personal financial or institutional interest in any of the drugs, materials, or devices described in this article.	Ackah E, 2005, J CLIN INVEST, V115, P2119, DOI 10.1172/JCI24726; Beck H, 2009, ACTA NEUROPATHOL, V117, P481, DOI 10.1007/s00401-009-0483-6; Chen JL, 2009, STROKE, V40, P2532, DOI 10.1161/STROKEAHA.108.545095; Chen JL, 2003, ANN NEUROL, V53, P743, DOI 10.1002/ana.10555; Coles JP, 2004, J CEREBR BLOOD F MET, V24, P202, DOI 10.1097/01.WCB.0000103022.98348.24; del Zoppo GJ, 2006, NEW ENGL J MED, V354, P553, DOI 10.1056/NEJMp058312; Freitas-Andrade M, 2008, J NEUROCHEM, V107, P756, DOI 10.1111/j.1471-4159.2008.05660.x; Greve MW, 2009, MT SINAI J MED, V76, P97, DOI 10.1002/msj.20104; Guo XB, 2009, J NEUROTRAUM, V26, P1337, DOI [10.1089/neu.2008.0733, 10.1089/neu.2008-0733]; HERNANDEZ TD, 1988, EXP NEUROL, V102, P318, DOI 10.1016/0014-4886(88)90226-9; Hicklin DJ, 2005, J CLIN ONCOL, V23, P1011, DOI 10.1200/JCO.2005.06.081; Iadecola C, 2004, NAT REV NEUROSCI, V5, P347, DOI 10.1038/nrn1387; Jain KK, 2008, DRUG DISCOV TODAY, V13, P1082, DOI 10.1016/j.drudis.2008.09.006; Karki K, 2009, STROKE, V40, P3384, DOI 10.1161/STROKEAHA.108.544395; Kashiwagi S, 2005, J CLIN INVEST, V115, P1816, DOI 10.1172/JCI24015; Khan M, 2009, J NEUROINFLAMM, V6, DOI 10.1186/1742-2094-6-32; Kureishi Y, 2000, NAT MED, V6, P1004, DOI 10.1038/79510; Lafuente JV, 2006, J NEURAL TRANSM, V113, P487, DOI 10.1007/s00702-005-0407-0; Lampugnani MG, 2006, J CELL BIOL, V174, P593, DOI 10.1083/jcb.200602080; Lu DY, 2007, J NEUROTRAUM, V24, P1132, DOI 10.1089/neu.2007.0288; Lu DY, 2004, J NEUROTRAUM, V21, P21, DOI 10.1089/089771504772695913; Mahmood A, 2002, J NEUROTRAUM, V19, P1609, DOI 10.1089/089771502762300265; Morales-Ruiz M, 2000, CIRC RES, V86, P892, DOI 10.1161/01.RES.86.8.892; Morgan R, 2007, NEUROL RES, V29, P375, DOI 10.1179/016164107X204693; Murohara T, 1998, J CLIN INVEST, V101, P2567, DOI 10.1172/JCI1560; Palmer TD, 2000, J COMP NEUROL, V425, P479, DOI 10.1002/1096-9861(20001002)425:4<479::AID-CNE2>3.0.CO;2-3; Paxinos G., 2007, RAT BRAIN STEREOTAXI, V6th ed.; Schmitz C, 2005, NEUROSCIENCE, V130, P813, DOI 10.1016/j.neuroscience.2004.08.050; Shimamura M, 2007, STROKE, V38, P3251, DOI 10.1161/STROKEAHA.107.485045; Shiojima I, 2002, CIRC RES, V90, P1243, DOI 10.1161/01.RES.0000022200.71892.9F; Sugawara T, 2008, J NEUROSCI RES, V86, P3635, DOI 10.1002/jnr.21807; Wang HC, 2007, EXP NEUROL, V206, P59, DOI 10.1016/j.expneurol.2007.03.031; Weis M, 2002, CIRCULATION, V105, P739, DOI 10.1161/hc0602.103393; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Wu HT, 2008, J NEUROSURG, V109, P691, DOI 10.3171/JNS/2008/109/10/0691; Wu HT, 2008, J NEUROTRAUM, V25, P130, DOI 10.1089/neu.2007.0369; Xiong Y, 2008, BRAIN RES, V1230, P247, DOI 10.1016/j.brainres.2008.06.127	37	22	23	0	6	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0148-396X			NEUROSURGERY	Neurosurgery	MAY	2011	68	5					1363	1371		10.1227/NEU.0b013e31820c06b9			9	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	746GE	WOS:000289230300065	21307798	Green Accepted			2021-06-18	
J	Stein, DM; Kufera, JA; Lindell, A; Murdock, KR; Menaker, J; Bochicchio, GV; Aarabi, B; Scalea, TM				Stein, Deborah M.; Kufera, Joseph A.; Lindell, Allison; Murdock, Karen R.; Menaker, Jay; Bochicchio, Grant V.; Aarabi, Bizhan; Scalea, Thomas M.			Association of CSF Biomarkers and Secondary Insults Following Severe Traumatic Brain Injury	NEUROCRITICAL CARE			English	Article						Traumatic brain injury; Biomarkers; Cerebral perfusion pressure; Intracranial pressure; Secondary insults	NEURON-SPECIFIC ENOLASE; SEVERE HEAD-INJURY; INTRACTABLE INTRACRANIAL HYPERTENSION; DECOMPRESSIVE LAPAROTOMY; CEREBROSPINAL-FLUID; PROTEIN FAMILY; SERUM-LEVELS; PRESSURE; S100B; CHILDREN	Management of severe traumatic brain injury (TBI) focuses on mitigating secondary insults. There are a number of biomarkers that are thought to play a part in secondary injury following severe TBI. Two of these, S100 beta and neuron-specific enolase (NSE), have been extensively studied in the setting of neurological injury. This pilot study was undertaken to investigate the relationship of S100 beta and NSE to clinical markers of severity and poor outcome: intracranial hypertension (ICH), and cerebral hypoperfusion (CH). Patients at the R Adams Cowley Shock Trauma Center were prospectively enrolled over an 18-month period. Inclusion criteria were: age > 18, admission within the first 6 h after injury, Glasgow Coma Scale (GCS) < 9 on admission, isolated TBI, and placement of an intraventricular catheter (IVC). Patients were managed according to an institutional protocol based on the Brain Trauma Foundation Guidelines. CSF was collected from the IVC on admission and twice daily for 7 days. S100 beta and NSE levels were analyzed by ELISA. CSF levels drawn before (PRE) and after (POST) 12-h time periods were compared to percentage time intracranial pressure (ICP) > 20 mmHg (% ICP(20)) and cerebral perfusion pressure (CPP) < 60 mmHg (% CPP(60)), and cumulative "Pressure times Time Dose" (PTD) for episodes of ICP > 20 mmHg (PTD ICP(20)) and CPP < 60 mmHg (PTD CPP(60)). Statistical analysis was performed using the Student's t test to compare means and non-parametric Wilcoxon statistic to compare ranked data. Linear regression methods were applied to compare levels of S100 beta and NSE with ICP and CPP(.) Twenty-three patients were enrolled. The cohort of patients was severely injured and neurologically compromised on admission (admission GCS = 5.6 +/- A 3.1, Injury Severity Score (ISS) = 31.9 +/- A 10.6, head Abbreviated Injury Scale (AIS) = 4.4 +/- A 0.7, Marshall score = 2.6 +/- A 0.9). Elevated levels of S100 beta and NSE were found in all 223 CSF samples analyzed. ICH was found to be associated with PRE and POST S100 beta levels when measured as % ICP(20) (r = 0.20 and r = 0.23, P < 0.01) and PTD ICP(20) (r = 0.35 and r = 0.26, P < 0.001). POST increasing NSE levels were weakly correlated with increasing PTD ICP(20) (r = 0.17, P = 0.01). PRE S100 beta levels were associated with episodes of CH as measured by % CPP(60) (r = 0.20, P = 0.002) and both PRE and POST S100 beta levels were associated with PTD CPP(60) (r = 0.24 and r = 0.23, P < 0.001). PRE and POST NSE levels were also associated with episodes of CH as measured by % CPP(60) (r = 0.22 and r = 0.18, P < 0.01) and PTD CPP(60) (r = 0.20 and r = 0.21, P < 0.01). In this preliminary analysis, S100 beta levels were associated with ICH and CH over a full week of ICP monitoring. We also found associations between CH and NSE levels in CSF of patients with severe TBI. Our results suggest that there is an association between levels of ICH and CH and these biomarkers when measured before episodes of clinically significant secondary insults. These markers of neuronal cell death demonstrate promise as both indicators of impending clinical deterioration and targets of future therapeutic interventions.	[Stein, Deborah M.; Menaker, Jay; Bochicchio, Grant V.; Aarabi, Bizhan; Scalea, Thomas M.] Univ Maryland, Sch Med, Div Crit Care, Program Trauma,R Adams Cowley Shock Trauma Ctr, Baltimore, MD 21201 USA; [Stein, Deborah M.; Kufera, Joseph A.; Lindell, Allison; Murdock, Karen R.; Menaker, Jay; Bochicchio, Grant V.; Scalea, Thomas M.] Univ Maryland, Sch Med, Shock Trauma & Anesthesiol Res Organized Res Ctr, Baltimore, MD 21201 USA	Stein, DM (corresponding author), Univ Maryland, Sch Med, Div Crit Care, Program Trauma,R Adams Cowley Shock Trauma Ctr, 22 S Greene St, Baltimore, MD 21201 USA.	dstein@umm.edu; jkufera@som.umaryland.edu; alindell@stapa.umm.edu; kmurdock@som.umaryland.edu; jmenaker@umm.edu; gbochicchio@umm.edu; baarabi@smail.umaryland.edu; tscalea@umm.edu		Stein, Deborah/0000-0003-3683-3963	 [W81XWH-07-2-0118]	This study was funded in part by W81XWH-07-2-0118.	Association for the Advancement of Automotive Medicine, 2005, ABBR INJ SCAL 2005; Berger RP, 2002, PEDIATRICS, V109, DOI 10.1542/peds.109.2.e31; BOYD CR, 1987, J TRAUMA, V27, P370, DOI 10.1097/00005373-198704000-00005; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS59, DOI 10.1089/neu.2007.9990; Bridges E, 2010, AACN ADV CRIT CARE, V21, P260, DOI 10.1097/NCI.0b013e3181e67385; Chambers IR, 2000, BRIT J NEUROSURG, V14, P424; CHANGARIS DG, 1987, J TRAUMA, V27, P1007, DOI 10.1097/00005373-198709000-00009; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Donato R, 2001, INT J BIOCHEM CELL B, V33, P637, DOI 10.1016/S1357-2725(01)00046-2; EISENBERG HM, 1988, J NEUROSURG, V69, P15, DOI 10.3171/jns.1988.69.1.0015; FANO G, 1995, PROG NEUROBIOL, V46, P71, DOI 10.1016/0301-0082(94)00062-M; Ghajar J, 2000, LANCET, V356, P923, DOI 10.1016/S0140-6736(00)02689-1; Goodman MD, 2010, J SURG RES, V164, P286, DOI 10.1016/j.jss.2009.07.040; Hayakata T, 2004, SHOCK, V22, P102, DOI 10.1097/01.shk.0000131193.80038.f1; Joseph DK, 2004, J TRAUMA, V57, P687, DOI 10.1097/01.TA.0000140645.84897.F2; Kahraman S, 2010, J TRAUMA, V69, P110, DOI 10.1097/TA.0b013e3181c99853; KENNEDY CS, 2004, CLIN PEDIAT EMERG ME, V5, P224; Kirchhoff C, 2008, EUR J MED RES, V13, P511; KRAMER M, 2008, STAT MED, V27, P6137; Kraus J, 2006, NEUROLOGY AND TRAUMA, P3; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; MARANGOS PJ, 1987, ANNU REV NEUROSCI, V10, P269, DOI 10.1146/annurev.ne.10.030187.001413; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; McAdory BS, 1998, BRAIN RES, V813, P211, DOI 10.1016/S0006-8993(98)01014-2; MILLER JD, 1978, JAMA-J AM MED ASSOC, V240, P432; NARAYAN RK, 1982, J NEUROSURG, V56, P650, DOI 10.3171/jns.1982.56.5.0650; Nguyen DN, 2006, CRIT CARE MED, V34, P1967, DOI 10.1097/01.CCM.0000217218.51381.49; Pelinka LE, 2004, J NEUROTRAUM, V21, P1553, DOI 10.1089/0897715042441846; PERSSON L, 1987, STROKE, V18, P911, DOI 10.1161/01.STR.18.5.911; Pleines UE, 2001, J NEUROTRAUM, V18, P491, DOI 10.1089/089771501300227297; Robertson CS, 1999, CRIT CARE MED, V27, P2086, DOI 10.1097/00003246-199910000-00002; Rotondo MF, 2004, J TRAUMA, V57, P693; Scalea TM, 2007, J TRAUMA, V62, P647, DOI 10.1097/TA.0b013e31802ee542; Schreiber MA, 2002, ARCH SURG-CHICAGO, V137, P285, DOI 10.1001/archsurg.137.3.285; Signorini DF, 1999, J NEUROL NEUROSUR PS, V66, P26, DOI 10.1136/jnnp.66.1.26; Spinella PC, 2003, CRIT CARE MED, V31, P939, DOI 10.1097/01.CCM.0000053644.16336.52; Stocchetti N, 1996, J TRAUMA, V40, P764, DOI 10.1097/00005373-199605000-00014; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Vik A, 2008, J NEUROSURG, V109, P678, DOI 10.3171/JNS/2008/109/10/0678; Vos PE, 2004, NEUROLOGY, V62, P1303, DOI 10.1212/01.WNL.0000120550.00643.DC; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Xu RH, 2003, STAT MED, V22, P3527, DOI 10.1002/sim.1572; ZIMMER DB, 1995, BRAIN RES BULL, V37, P417, DOI 10.1016/0361-9230(95)00040-2	43	22	24	0	6	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933			NEUROCRIT CARE	Neurocrit. Care	APR	2011	14	2					200	207		10.1007/s12028-010-9496-1			8	Critical Care Medicine; Clinical Neurology	General & Internal Medicine; Neurosciences & Neurology	738SY	WOS:000288663800009	21210304				2021-06-18	
J	Yeung, JHH; Mikocka-Walus, AA; Cameron, PA; Poon, WS; Ho, HF; Chang, A; Graham, CA; Rainer, TH				Yeung, Janice H. H.; Mikocka-Walus, Antonina A.; Cameron, Peter A.; Poon, Wai S.; Ho, Hiu F.; Chang, Annice; Graham, Colin A.; Rainer, Timothy H.			Protection From Traumatic Brain Injury in Hormonally Active Women vs Men of a Similar Age A Retrospective International Study	ARCHIVES OF SURGERY			English	Article							GENDER-DIFFERENCES; MALE-RATS; HEAD-INJURY; HONG-KONG; PROGESTERONE; EDEMA; CNS; MULTICENTER; VALIDATION; AUSTRALIA	Background: It has been suggested that women with traumatic brain injury have more favorable outcomes than do men because of higher levels of circulating estrogen and progesterone that may reduce brain edema. Objectives: To determine whether there is any association between sex and mortality in TBI patients and whether there is any association between sex and brain edema. Design: Retrospective cohort study using data from 2001 to 2007 collected from a trauma registry in Hong Kong and the Victorian State Trauma Registry. Setting: Two regional trauma centers in Hong Kong and 2 adult major trauma centers and 1 pediatric trauma center in Victoria, Australia. Main Outcome Measures: Mortality and brain edema. Patients: Trauma patients with an Abbreviated Injury Scale score (head) of at least 3 who were aged 12 to 45 years were included. Patients with minor head injury and undisplaced closed skull fracture were excluded. Results: Both the Hong Kong and Victorian data showed no significant difference in sex-related mortality. Increased mortality was associated with decreased systolic blood pressure and Glasgow Coma Scale score and with increased New Injury Severity Score or Injury Severity Score. In Hong Kong, brain edema was associated with female sex (P=.02), and the odds of brain edema in females were greater than for males. However, this association was not found in Victorian patients. Conclusion: This study found no significant association between sex and mortality in either Victoria or Hong Kong and does not support the concept that females have better outcomes after traumatic brain injury.	[Yeung, Janice H. H.; Graham, Colin A.; Rainer, Timothy H.] Chinese Univ Hong Kong, Accid & Emergency Med Acad Unit, Hong Kong, Hong Kong, Peoples R China; [Poon, Wai S.] Chinese Univ Hong Kong, Div Neurosurg, Dept Surg, Hong Kong, Hong Kong, Peoples R China; [Ho, Hiu F.; Chang, Annice] Queen Elizabeth Hosp, Dept Accid & Emergency, Hong Kong, Hong Kong, Peoples R China; [Mikocka-Walus, Antonina A.; Cameron, Peter A.] Monash Univ, Dept Epidemiol & Prevent Med, Clayton, Vic 3800, Australia; [Cameron, Peter A.] Monash Univ, Alfred Hosp, Emergency & Trauma Ctr, Melbourne, Vic 3181, Australia	Rainer, TH (corresponding author), Chinese Univ Hong Kong, Accid & Emergency Med Acad Unit, Trauma & Emergency Ctr, Prince Wales Hosp, Room 02C44,2-F Main Clin Block & Trauma Ctr, Shatin, Hong Kong, Peoples R China.	thrainer@cuhk.edu.hk	Poon, Wai Sang/F-1558-2011; Graham, Colin A/B-4535-2013; Rainer, Timothy H/I-2591-2013; Mikocka-Walus, Antonina/R-2363-2017; Mikocka-Walus, Antonina/B-4160-2010	Graham, Colin A/0000-0002-4381-7470; Rainer, Timothy H/0000-0003-3355-3237; Cameron, Peter/0000-0002-1443-557X; Mikocka-Walus, Antonina/0000-0003-4864-3956			Cameron PA, 2004, ANZ J SURG, V74, P424, DOI 10.1111/j.1445-1433.2004.03029.x; Cheng CH, 2008, ANN SURG, V247, P335, DOI 10.1097/SLA.0b013e31815ccc2e; Coimbra R, 2003, J TRAUMA, V54, P689, DOI 10.1097/01.TA.0000058314.31655.5F; Coughlan T, 2009, INT J NEUROSCI, V119, P1718, DOI 10.1080/00207450903116430; Deitch EA, 2007, ANN SURG, V246, P447, DOI 10.1097/SLA.0b013e318148566; Demetriades D, 2006, J TRAUMA, V61, P868, DOI 10.1097/01.ta.0000219135.33398.f3; Farace E, 2000, J NEUROSURG, V93, P539, DOI 10.3171/jns.2000.93.4.0539; Farin A, 2003, J NEUROSURG, V98, P32, DOI 10.3171/jns.2003.98.1.0032; Foreman BP, 2007, J TRAUMA, V62, P946, DOI 10.1097/01.ta.0000229796.14717.3a; Gannon CJ, 2002, J AM COLL SURGEONS, V195, P11, DOI 10.1016/S1072-7515(02)01187-0; Gibson CL, 2008, BRAIN, V131, P318, DOI 10.1093/brain/awm183; Guo QM, 2006, EXP NEUROL, V198, P469, DOI 10.1016/j.expneurol.2005.12.013; Hu ZY, 2009, CURR MED CHEM, V16, P1418, DOI 10.2174/092986709787846523; Kasturi BS, 2009, RESTOR NEUROL NEUROS, V27, P265, DOI [10.3233/RNN-2009-0475, 10.3233/RNN-2009-0476]; Kirkness Catherine J, 2004, Biol Res Nurs, V5, P299, DOI 10.1177/1099800404263050; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Ponsford JL, 2008, INJURY, V39, P67, DOI 10.1016/j.injury.2007.08.028; Rappold JF, 2002, J TRAUMA, V53, P436, DOI 10.1097/00005373-200209000-00007; Roof RL, 2000, J NEUROTRAUM, V17, P367, DOI 10.1089/neu.2000.17.367; ROOF RL, 1994, EXP NEUROL, V129, P64, DOI 10.1006/exnr.1994.1147; Sayeed I, 2009, PROG BRAIN RES, V175, P219, DOI 10.1016/S0079-6123(09)17515-5; Shafi S, 2007, J TRAUMA, V63, P1138, DOI 10.1097/TA.0b013e3181568cd4; Stein DG, 2001, TRENDS NEUROSCI, V24, P386, DOI 10.1016/S0166-2236(00)01821-X; Stein DG, 2008, ANN EMERG MED, V51, P164, DOI 10.1016/j.annemergmed.2007.05.001; Stein DG, 2010, AM J ROENTGENOL, V194, P20, DOI 10.2214/AJR.09.3407; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Utomo WK, 2009, INJURY, V40, P973, DOI 10.1016/j.injury.2009.05.034; Vagnerova K, 2008, ANESTH ANALG, V107, P201, DOI 10.1213/ane.0b013e31817326a5; Wang JP, 2009, BRAIN RES BULL, V79, P426, DOI 10.1016/j.brainresbull.2009.05.018; Wohltmann CD, 2001, AM J SURG, V181, P297, DOI 10.1016/S0002-9610(01)00582-7; Wright DW, 2007, ANN EMERG MED, V49, P391, DOI 10.1016/j.annemergmed.2006.07.932; Wright DW, 2001, J NEUROTRAUM, V18, P901, DOI 10.1089/089771501750451820; Xiao GM, 2008, CRIT CARE, V12, DOI 10.1186/cc6887; Yates PJ, 2006, J NEUROL NEUROSUR PS, V77, P699, DOI 10.1136/jnnp.2005.081901; Yeung JHH, 2008, INJURY, V39, P1034, DOI 10.1016/j.injury.2008.03.017	36	22	22	1	3	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0004-0010			ARCH SURG-CHICAGO	Arch. Surg.	APR	2011	146	4					436	442		10.1001/archsurg.2011.46			7	Surgery	Surgery	751VX	WOS:000289646900014	21502452	Bronze			2021-06-18	
J	Zhang, BL; Chen, X; Lin, YP; Tan, T; Yang, Z; Dayao, C; Liu, L; Jiang, RC; Zhang, JN				Zhang, Baoliang; Chen, Xin; Lin, Yunpeng; Tan, Tao; Yang, Zhuo; Dayao, Carlos; Liu, Li; Jiang, Rongcai; Zhang, Jianning			Impairment of synaptic plasticity in hippocampus is exacerbated by methylprednisolone in a rat model of traumatic brain injury	BRAIN RESEARCH			English	Article						Traumatic brain injury; Long-term potentiation; Dentate gyrus; Interneuron; Methylprednisolone	TEMPORAL-LOBE EPILEPSY; DENTATE GYRUS; SELECTIVE VULNERABILITY; HEAD TRAUMA; DEFICITS; NEURONS; MEMORY; CELLS; LONG	Patients with traumatic brain injury (TBI) exhibit impaired cognitive capability that is exacerbated with methylprednisolone (MP). Since long-term potentiation (LTP) is a leading cellular model underlying learning, we hypothesize that MP disturbs the electrophysiological character in the hippocampus by decreasing the number of inteneurons post-traumatically in the dentate gyrus (DG) and cornu ammonis3 (CA3) regions, resulting in learning deficits. To test this hypothesis, we investigated the alterations of learning abilities and correlated the alternation with hippocampal synaptic plasticity in rats receiving lateral fluid percussion injury (FPI) and being treated with MP. We found that MP aggravates the spatial learning deficiency and changes in the excitability of the DG and cornu ammonis1 (CA1) areas in rats subjected to FPI. The functional and electrophysiological deficits are associated with a decrease in the number of parvalbumin-immunoreactive (PV-IR) and cholecystokinin-immunoreactive (CCK-IR) GABAergic cells. The data suggest that MP therapy may decrease the number of DG interneurons in post-traumatic hippocampus, resulting in the aggravated deficits of learning ability induced by TBI. (C) 2011 Elsevier B.V. All rights reserved.	[Zhang, Jianning] Tianjin Med Univ Gen Hosp, Tianjin Neurol Inst, Key Lab Posttrauma Neurorepair & Regenerat Cent N, Minist Educ,Dept Neurosurg,Tianjin Key Lab Injuri, Tianjin 300052, Peoples R China; [Yang, Zhuo] Nankai Univ, Sch Med, Tianjin 300071, Peoples R China; [Tan, Tao] Tianjin Med Univ, Sch Biomed Engn, Tianjin 300070, Peoples R China	Zhang, JN (corresponding author), Tianjin Med Univ Gen Hosp, Tianjin Neurol Inst, Key Lab Posttrauma Neurorepair & Regenerat Cent N, Minist Educ,Dept Neurosurg,Tianjin Key Lab Injuri, 154 Anshan Rd, Tianjin 300052, Peoples R China.	jianningzhang@hotmail.com	Tan, Tao/F-5535-2010	Tan, Tao/0000-0002-4571-3296	National 973 Projects of ChinaNational Basic Research Program of China [2005CB522605]; National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81000533]; Tianjin Science and Technology Development Plan [05YFGDSF02500]; Tianjin Natural Science FoundationNatural Science Foundation of Tianjin [033611511]; Tianjin Medical University	We acknowledge Ping Lei, Weiyun Cui, Fanglian Chen, Lei Zhou, Huijie Wei, Liang Wang, Dong Wang, and Xiaonan Wang for excellent technical support. This work is supported by the National 973 Projects of China (grant no. 2005CB522605), National Natural Science Foundation of China (grant no. 81000533), Tianjin Science and Technology Development Plan (grant no. 05YFGDSF02500), Tianjin Natural Science Foundation (grant no. 033611511), and "211 Project" Graduate Innovation Grant of Tianjin Medical University.	ANDREAS R, 1995, AM J PATHOL, V6, P1575; Baldwin SA, 1997, J NEUROTRAUM, V14, P385, DOI 10.1089/neu.1997.14.385; BENGI A, 2007, EUROPEAN J NEUROSCIE, V5, P1166; Bernstein DM, 2002, J INT NEUROPSYCH SOC, V8, P673, DOI 10.1017/S1355617702801400; BOHNEN N, 1992, NEUROSURGERY, V30, P692; Bonislawski DP, 2007, NEUROBIOL DIS, V25, P163, DOI 10.1016/j.nbd.2006.09.002; Chen JL, 2001, STROKE, V32, P2682, DOI 10.1161/hs1101.098367; Chen X, 2009, J NEUROTRAUM, V26, P253, DOI 10.1089/neu.2007.0504; CLAIBORNE BJ, 1986, J COMP NEUROL, V246, P435, DOI 10.1002/cne.902460403; Coulter DA, 1996, EPILEPSY RES, V26, P81, DOI 10.1016/S0920-1211(96)00044-7; FREUND TF, 1996, HIPPOCAMPUS, V6, P345; Golarai G, 2001, J NEUROSCI, V21, P8523; GOLARAI G, 1999, SOC NEUR ANN M 23 28; HALASY K, 1993, EUR J NEUROSCI, V5, P411, DOI 10.1111/j.1460-9568.1993.tb00508.x; Kotapka MJ, 1991, J NEUROTRAUM, V8, P247, DOI 10.1089/neu.1991.8.247; LAURER HL, 2002, ENCY HUMAN BRAIN, P93; LOWENSTEIN DH, 1992, J NEUROSCI, V12, P4846; Mathias JL, 2004, J INT NEUROPSYCH SOC, V10, P286, DOI 10.1017/S1355617704102117; Pierce JES, 1998, NEUROSCIENCE, V87, P359, DOI 10.1016/S0306-4522(98)00142-0; Santhakumar V, 2001, ANN NEUROL, V50, P708, DOI 10.1002/ana.1230; SHI D, 2009, J NEUROSCI, V2, P393; SLOVITER RS, 1994, ANN NEUROL, V35, P640, DOI 10.1002/ana.410350604; SLOVITER RS, 1994, HIPPOCAMPUS, V4, P250, DOI 10.1002/hipo.450040304; Su ZJ, 2009, J NEUROTRAUM, V26, P1695, DOI 10.1089/neu.2008.0519; Toth Z, 1997, J NEUROSCI, V17, P8106; Vorhees CV, 2006, NAT PROTOC, V1, P848, DOI 10.1038/nprot.2006.116; Witgen BM, 2005, NEUROSCIENCE, V133, P1, DOI 10.1016/j.neuroscience.2005.01.052; Yang L, 2007, J NEUROPHYSIOL, V97, P178, DOI 10.1152/jn.01374.2005	28	22	24	0	11	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	MAR 25	2011	1382						165	172		10.1016/j.brainres.2011.01.065			8	Neurosciences	Neurosciences & Neurology	745AF	WOS:000289135600018	21276433				2021-06-18	
J	Cunningham, J; Brison, RJ; Pickett, W				Cunningham, John; Brison, Robert J.; Pickett, William			CONCUSSIVE SYMPTOMS IN EMERGENCY DEPARTMENT PATIENTS DIAGNOSED WITH MINOR HEAD INJURY	JOURNAL OF EMERGENCY MEDICINE			English	Article						epidemiology; concussion; emergency medicine; minor head injury; trauma	TRAUMATIC BRAIN-INJURY; FOLLOW-UP; CHILDREN; OUTCOMES; QUESTIONNAIRE; COMPLAINTS; RETURN	Background: Evidence-based protocols exist for Emergency Department (ED) patients diagnosed with minor head injury. These protocols focus on the need for acute intervention or in-hospital management. The frequency and nature of concussive symptoms experienced by patients discharged from the ED are not well understood. Objectives: To examine the prevalence and nature of concussive symptoms, up to 1 month post-presentation, among ED patients diagnosed with minor head injury. Methods: Eligible and consenting patients presenting to Kingston EDs with minor head injury (n = 94) were recruited for study. The Rivermead Post-Concussion Symptoms Questionnaire was administered at baseline and at 1 month post-injury to assess concussive symptoms. This analysis focused upon acute and ongoing symptoms. Results: Proportions of patients reporting concussive symptoms were 68/94 (72%) at baseline and 59/94 (63%) at follow-up. Seventeen percent of patients (18/102) were investigated with computed tomography scanning during their ED encounter. The prevalence of somatic symptoms declined between baseline and follow-up, whereas some cognitive and emotional symptoms persisted. Conclusion: The majority of patients who present to the ED with minor head injuries suffer from concussive symptoms that do not resolve quickly. This information should be incorporated into discharge planning for these patients. (C) 2011 Elsevier Inc.	[Cunningham, John; Brison, Robert J.; Pickett, William] Queens Univ, Dept Community Hlth & Epidemiol, Kingston, ON, Canada; [Cunningham, John; Brison, Robert J.; Pickett, William] Queens Univ, Dept Emergency Med, Kingston, ON, Canada	Brison, RJ (corresponding author), Queens Univ Emergency Med Res, Kingston Gen Hosp, Angada 3,76 Stuart St, Kingston, ON K7L 2V7, Canada.				Child Injury Section of the Public Health Agency of Canada; Ontario Neurotrauma Foundation [2003-PREV-MS-03]	This study was supported by the Canadian Hospital Injury Reporting and Prevention Program (RJ Brison, Kingston medical director) funded by the Child Injury Section of the Public Health Agency of Canada; and the Ontario Neurotrauma Foundation (Grant # 2003-PREV-MS-03).	Adelson PD, 1998, J CHILD NEUROL, V13, P2, DOI 10.1177/088307389801300102; Asplund CA, 2004, CLIN J SPORT MED, V14, P339, DOI 10.1097/00042752-200411000-00003; Bazarian JJ, 2005, EMERG MED J, V22, P473, DOI 10.1136/emj.2004.019273; Bijur PE, 1996, J DEV BEHAV PEDIATR, V17, P143, DOI 10.1097/00004703-199606000-00001; BIJUR PE, 1995, TRAUMATIC HEAD INJUR, P147; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Chamelian L, 2004, BRAIN, V127, P2621, DOI 10.1093/brain/awh296; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Crawford S, 1996, J NEUROL NEUROSUR PS, V60, P510, DOI 10.1136/jnnp.60.5.510; DIKMEN S, 1986, J NEUROL NEUROSUR PS, V49, P1227, DOI 10.1136/jnnp.49.11.1227; Feinstein A, 2000, CAN J PUBLIC HEALTH, V91, P325, DOI 10.1007/BF03404799; Finkelstein EA., 2006, INCIDENCE EC BURDEN; Hawley CA, 2004, J NEUROL NEUROSUR PS, V75, P737, DOI 10.1136/jnnp.2003.020651; Heck J., 2001, SPORTS MED UPDATE, V15, P46; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; LEVIN HS, 1987, J NEUROSURG, V66, P234, DOI 10.3171/jns.1987.66.2.0234; Light R, 1998, J CONSULT CLIN PSYCH, V66, P1023; Mackenzie S G, 1999, Inj Prev, V5, P208; MILLER JD, 1993, J NEUROL NEUROSUR PS, V56, P440, DOI 10.1136/jnnp.56.5.440; MITTL RL, 1994, AM J NEURORADIOL, V15, P1583; Peloso PM, 2004, J REHABIL MED, V36, P106, DOI 10.1080/16501960410023868; Ponsford J, 1999, J HEAD TRAUMA REHAB, V14, P360, DOI 10.1097/00001199-199908000-00005; Rees PM, 2003, ARCH PHYS MED REHAB, V84, P1885, DOI 10.1016/j.apmr.2003.03.001; Riggs JE, 2001, MIL MED, V166, P1029; *STAT CAN, 2006, COMM PROF 2001; Stiell IG, 2000, CAN MED ASSOC J, V163, P1465; Stiell IG, 2001, ANN EMERG MED, V38, P317, DOI 10.1067/mem.2001.116795; van der Naalt J, 1999, J NEUROL NEUROSUR PS, V66, P207, DOI 10.1136/jnnp.66.2.207; Wade DT, 1998, J NEUROL NEUROSUR PS, V65, P177, DOI 10.1136/jnnp.65.2.177; World Health Organisation, 1993, ICD 10 CLASSIFICATIO	30	22	22	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0736-4679	1090-1280		J EMERG MED	J. Emerg. Med.	MAR	2011	40	3					262	266		10.1016/j.jemermed.2008.08.017			5	Emergency Medicine	Emergency Medicine	740DQ	WOS:000288772200003	19157755				2021-06-18	
J	Gebauer, DP; Williamson, RA; Wallman, KE; Dawson, BT				Gebauer, Dieter P.; Williamson, Raymond A.; Wallman, Karen E.; Dawson, Brian T.			The Effect of Mouthguard Design on Respiratory Function in Athletes	CLINICAL JOURNAL OF SPORT MEDICINE			English	Article						mouthguard; ventilation; oxygen uptake; respiration; athlete	INJURIES; CONCUSSIONS; ABSORPTION; CAPACITY; PLAYERS; FLOW	Objective: To test the hypothesis that 2 types of custom-made mouthguards will have no effect on ventilation ((V) over dot(E), L.min(-1)), oxygen uptake ((V) over dotO(2), mL.kg(-1).min(-1)), and heart rate (beats per minutes) at varying exercise intensities (10 km.h(-1) and 12 km.h(-1)) and at subjective maximal effort ((V) over dotO(2)peak) in male field hockey and water polo players. Design: A randomized, prospective, crossover study. Setting: The Physiology Testing Laboratory, School of Sports Science, Exercise and Health at the University of Western Australia, a tertiary educational institution. Participants: Twenty-seven male team-sport athletes. Interventions: Each athlete participated in 3 experimental exercise sessions separated by 1-week intervals. Testing involved a graded exercise test (GXT) performed on a treadmill wearing either a custom laminated mouthguard with normal palatal surface, a custom laminated mouthguard with palatal coverage up to the gingival margin, or no mouthguard. The experimental trials were performed in a random counterbalanced order. Main Outcome Measures: (V) over dot(E) (L.min(-1)) and (V) over dotO(2) (mL.kg(-1).min(-1)) were measured during the GXTat intensities that equated to 10 km.h(-1), 12 km.h(-1) and subjective maximal effort ((V) over dotO(2)peak). Results: There were no significant differences between trials for (V) over dot(E) (L.min(-1)) and (V) over dotO(2) (mL.kg(-1).min(-1)) at any of the intensities assessed (P < 0.05). Conclusions: The wearing of 2 different custom-made mouthguards during a GXT did not impair (V) over dot(E) or (V) over dotO(2) during varying levels of exercise intensity in team sport athletes.	[Gebauer, Dieter P.; Williamson, Raymond A.] Univ Western Australia, Sch Dent, Crawley, WA 6009, Australia; [Gebauer, Dieter P.; Williamson, Raymond A.] Univ Western Australia, Sch Med & Pharmacol, Crawley, WA 6009, Australia; [Wallman, Karen E.; Dawson, Brian T.] Univ Western Australia, Sch Sport Sci Exercise & Hlth, Crawley, WA 6009, Australia	Williamson, RA (corresponding author), Univ Western Australia, Sch Dent, 35 Stirling Highway, Crawley, WA 6009, Australia.	raymond.williamson@uwa.edu.au			Australian and New Zealand Association of Oral and Maxillofacial Surgery	Supported by the Australian and New Zealand Association of Oral and Maxillofacial Surgery.	ADA, 2006, J AM DENT ASSOC, V137, P1712; Amis T, 2000, MED SCI SPORT EXER, V32, P284, DOI 10.1097/00005768-200002000-00006; Bemelmanns P, 2001, INT J SPORTS MED, V22, P149, DOI 10.1055/s-2001-11342; Berry DC, 2005, J PUBLIC HEALTH DENT, V65, P71, DOI 10.1111/j.1752-7325.2005.tb02789.x; Bourdin M, 2006, MED SCI SPORT EXER, V38, P1500, DOI 10.1249/01.mss.0000228952.44850.eb; Braham RA, 2004, J SCI MED SPORT, V7, P216, DOI 10.1016/S1440-2440(04)80011-2; Chatterjee Mahua, 2007, Prim Dent Care, V14, P111, DOI 10.1308/135576107781327151; Craig RG, 2002, J ORAL REHABIL, V29, P146, DOI 10.1046/j.1365-2842.2002.00831.x; Delaney JS, 2005, CLIN J SPORT MED, V15, P154, DOI 10.1097/01.jsm.0000158256.85664.8d; Duhaime CF, 2006, DENT TRAUMATOL, V22, P186, DOI 10.1111/j.1600-9657.2006.00360.x; Francis K T, 1991, Br J Sports Med, V25, P227; Gardiner D M, 2000, Dent Clin North Am, V44, P53; Hendrick K, 2008, DENT TRAUMATOL, V24, P189, DOI 10.1111/j.1600-9657.2007.00527.x; Kececi AD, 2005, DENT TRAUMATOL, V21, P276, DOI 10.1111/j.1600-9657.2005.00354.x; Knapik JJ, 2007, SPORTS MED, V37, P117, DOI 10.2165/00007256-200737020-00003; Kumamoto David P, 2004, Gen Dent, V52, P270; Labella CR, 2002, MED SCI SPORT EXER, V34, P41, DOI 10.1097/00005768-200201000-00007; Lieger O, 2006, DENT TRAUMATOL, V22, P1, DOI 10.1111/j.1600-9657.2006.00328.x; Lim D, 2005, CLIN J SPORT MED, V15, P313, DOI 10.1097/01.jsm.0000180019.22018.3c; Low Danny, 2002, Ann R Australas Coll Dent Surg, V16, P153; Luke R, 1982, Diastema, V10, P56; Maeda Y, 2006, BRIT J SPORT MED, V40, P1006, DOI 10.1136/bjsm.2006.030874; Mihalik JP, 2007, DENT TRAUMATOL, V23, P14, DOI 10.1111/j.1600-9657.2006.00488.x; Newsome P R, 2001, Int J Paediatr Dent, V11, P396, DOI 10.1046/j.0960-7439.2001.00304.x; Schwartz R, 2000, CRANIO, V18, P23, DOI 10.1080/08869634.2000.11746110; *SPORTS MED AUSTR, 2001, W AUSTR SPORTS INJ S; von Arx T, 2008, INT J SPORTS MED, V29, P435, DOI 10.1055/s-2007-965341; Westerman B, 1995, AUST DENT J, V40, P389, DOI 10.1111/j.1834-7819.1995.tb04838.x; Westerman B, 2000, AUST DENT J, V45, P21, DOI 10.1111/j.1834-7819.2000.tb00237.x; Wisniewski JF, 2004, DENT TRAUMATOL, V20, P143, DOI 10.1111/j.1600-4469.2004.00259.x; Yamada J, 2006, DENT TRAUMATOL, V22, P139, DOI 10.1111/j.1600-9657.2006.00393.x; Yamanaka Takuto, 2002, Journal of Medical and Dental Sciences, V49, P129	32	22	23	0	13	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1050-642X	1536-3724		CLIN J SPORT MED	Clin. J. Sport Med.	MAR	2011	21	2					95	100		10.1097/JSM.0b013e31820428b0			6	Orthopedics; Physiology; Sport Sciences	Orthopedics; Physiology; Sport Sciences	728AB	WOS:000287844100004	21358498				2021-06-18	
J	Sullivan, K; Garden, N				Sullivan, Karen; Garden, Natalie			A Comparison of the Psychometric Properties of 4 Postconcussion Syndrome Measures in a Nonclinical Sample	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						assessment; neuropsychology; postconcussion syndrome; psychometric evaluation; traumatic brain injury	POST-CONCUSSION SYMPTOMS; HEAD-INJURY; BASE-RATE; MILD; STRESS; QUESTIONNAIRE	Objective: To investigate the psychometric properties of 4 established postconcussive symptoms (PCS) measures. Participants: Ninety-six nonclinical participants (49 university students and 47 nonstudents; 73% male). Nonclinical participants were recruited because PCS symptoms are common in both clinical and nonclinical groups. Main Outcome Measures: Rivermead Postconcussion Symptoms Questionnaire, the Postconcussion Syndrome Symptom Scale, the Postconcussion Syndrome Checklist, and the British Columbia Postconcussion Symptom Inventory were completed in a counterbalanced order. Analysis: Internal consistency and split-half reliability coefficients were calculated for each PCS measure. Convergent validity was examined using intercorrelations between PCS measures. Divergent validity was examined using correlations between each of the PCS measures and depression. Results: PCS measures had moderate to good reliability and were significantly and positively correlated with each other. Divergent validity correlations were generally weaker than those between PCS measures. Conclusion: This study is the first to examine the psychometric properties of multiple PCS measures in a single sample. Given that clinicians may not know in advance the clinical or nonclinical group status of their clients, particularly in mild trauma cases, our data may help researchers and clinicians compare and select PCS measures.	[Sullivan, Karen] Queensland Univ Technol, Clin Neuropsychol Res Grp, Sch Psychol & Counselling, Kelvin Grove, Qld 4059, Australia; [Sullivan, Karen; Garden, Natalie] Queensland Univ Technol, Inst Hlth & Biomed Innovat, Kelvin Grove, Qld 4059, Australia	Sullivan, K (corresponding author), Queensland Univ Technol, Clin Neuropsychol Res Grp, Sch Psychol & Counselling, Kelvin Grove Campus,O Block B Wing Room 523,Victo, Kelvin Grove, Qld 4059, Australia.	karen.sullivan@qut.edu.au			School of Psychology and Counselling, Queensland University of Technology	Funding for this project was provided by the School of Psychology and Counselling, Queensland University of Technology. The Human Research Ethics Committee of Queensland University of Technology (approval no. 0700000965) approved all research documented in this report. The authors thank Dr Patricia Obst, Statistics advisor, School of Psychology and Counselling, Queensland University of Technology, for generous assistance.	American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Axelrod BN, 1996, PSYCHOL ASSESSMENT, V8, P422, DOI 10.1037/1040-3590.8.4.422; Beck A.T., 1996, MANUAL BECK DEPRESSI; Beck AT, 1996, J PERS ASSESS, V67, P588, DOI 10.1207/s15327752jpa6703_13; Bigler ED, 2008, J INT NEUROPSYCH SOC, V14, P1, DOI 10.1017/S135561770808017X; Chan RCK, 2001, CLIN REHABIL, V15, P266, DOI 10.1191/026921501675253420; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Eyres S, 2005, CLIN REHABIL, V19, P878, DOI 10.1191/0269215505cr905oa; Foa EB, 1997, PSYCHOL ASSESSMENT, V9, P445, DOI 10.1037/1040-3590.9.4.445; Garden N, 2010, APPL NEUROPSYCHOL, V17, P1, DOI 10.1080/09084280903297495; Gasquoine P G, 2000, Appl Neuropsychol, V7, P83, DOI 10.1207/S15324826AN0702_3; Gordon WA, 2000, BRAIN INJURY, V14, P21, DOI 10.1080/026990500120907; GOUVIER WD, 1992, ARCH CLIN NEUROPSYCH, V7, P193, DOI 10.1016/0887-6177(92)90162-G; Gunstad J, 2004, ARCH CLIN NEUROPSYCH, V19, P391, DOI 10.1016/S0887-6177(03)00073-8; Gunstad J, 2001, J INT NEUROPSYCH SOC, V7, P323, DOI 10.1017/S1355617701733061; Iverson G.L., 2007, BRAIN INJURY MED PRI, P373; Iverson GL, 2003, APPL NEUROPSYCHOL, V10, P137, DOI 10.1207/S15324826AN1003_02; Iverson GL, 1997, BRAIN INJURY, V11, P783, DOI 10.1080/026990597122990; Iverson GL, 2004, STUD NEUROPSYCHOL DE, P323; Iverson GL, 2006, ARCH CLIN NEUROPSYCH, V21, P303, DOI 10.1016/j.acn.2005.12.008; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; King NS, 1999, BRIT J CLIN PSYCHOL, V38, P15, DOI 10.1348/014466599162638; Mittenberg W, 1997, NEUROPSYCHOLOGY, V11, P447, DOI 10.1037/0894-4105.11.3.447; Mittenberg W, 2001, J CLIN EXP NEUROPSYC, V23, P829, DOI 10.1076/jcen.23.6.829.1022; Naunheim RS, 2008, J HEAD TRAUMA REHAB, V23, P116, DOI 10.1097/01.HTR.0000314530.30401.70; Potter S, 2006, J NEUROL, V253, P1603, DOI 10.1007/s00415-006-0275-z; RADANOV BP, 1992, SPINE, V17, P127, DOI 10.1097/00007632-199202000-00001; Santa Maria MP, 2001, ARCH CLIN NEUROPSYCH, V16, P133; Sawchyn JM, 2000, ARCH CLIN NEUROPSYCH, V15, P1, DOI 10.1016/S0887-6177(98)00041-9; Smith-Seemiller L, 2003, BRAIN INJURY, V17, P199, DOI 10.1080/0269905021000030823; Suhr JA, 2002, J CLIN EXP NEUROPSYC, V24, P981, DOI 10.1076/jcen.24.8.981.8372; Sundstrom A, 2006, THESIS UMEA U SWEDEN; Wang Y, 2006, ARCH CLIN NEUROPSYCH, V21, P339, DOI 10.1016/j.acn.2006.03.006; WONG JL, 1994, ARCH CLIN NEUROPSYCH, V9, P411, DOI 10.1016/0887-6177(94)90004-3; Wood RL, 2004, BRAIN INJURY, V18, P1135, DOI 10.1080/02699050410001675906; World Health Organization, 2007, INT STAT CLASS DIS R; YOUNGJOHN JR, 1995, CLIN NEUROPSYCHOL, V9, P112, DOI 10.1080/13854049508401593	37	22	22	0	6	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	MAR-APR	2011	26	2					170	176		10.1097/HTR.0b013e3181e47f95			7	Clinical Neurology; Rehabilitation	Neurosciences & Neurology; Rehabilitation	732OR	WOS:000288197200007	20535029				2021-06-18	
J	Heltemes, KJ; Dougherty, AL; MacGregor, AJ; Galameau, MR				Heltemes, Kevin J.; Dougherty, Amber L.; MacGregor, Andrew J.; Galameau, Michael R.			Alcohol Abuse Disorders Among US Service Members With Mild Traumatic Brain Injury	MILITARY MEDICINE			English	Article							OPERATION-IRAQI-FREEDOM; COMBAT DEPLOYMENT; SUBSTANCE-ABUSE; NECK INJURIES; DRUG-USE; VETERANS; WAR; AFGHANISTAN; DRINKING; OUTCOMES	Traumatic brain injury (TBI) has emerged as a preeminent injury in Iraq and Afghanistan. The relationship between TBI and post-injury alcohol use in military personnel has not been clearly defined. The aim of this study was to examine the prevalence of alcohol abuse disorders among combat-injured service members with mild TB! (MTBI). Male U.S. service members with combat injuries were identified from the Expeditionary Medical Encounter Database (n = 3,123). Diagnoses of alcohol abuse disorders were collected from the standard inpatient and ambulatory data records. Overall, a slightly higher proportion of service members with MTBI were diagnosed with an alcohol abuse disorder compared to those with other injury (6.1% vs. 4.9%). In a multivariate analysis, however, it was found that MTBI was not associated with higher levels of alcohol abuse (odds ratio, 1.24; 95% confidence interval, 0.90, 1.70). To better define the consequences of MTBI, future research should include other alcohol dependency measures along with comorbid mental health disorders.	[Heltemes, Kevin J.; Dougherty, Amber L.; MacGregor, Andrew J.; Galameau, Michael R.] USN, Hlth Res Ctr, San Diego, CA 92106 USA	Heltemes, KJ (corresponding author), USN, Hlth Res Ctr, 140 Sylvester Rd, San Diego, CA 92106 USA.			MacGregor, Andrew/0000-0003-1020-7390	U.S. Navy Bureau of Medicine and Surgery, Washington, DC, under Work Unit [60808]	The authors thank Science Applications International Corporation for its contributions to this work. This study was supported by the U.S. Navy Bureau of Medicine and Surgery, Washington, DC, under Work Unit No. 60808.	Ames Genevieve M, 2002, Prev Sci, V3, P135, DOI 10.1023/A:1015435401380; [Anonymous], 1997, JAMA, V277, P238; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Bombardier CH, 2003, ARCH PHYS MED REHAB, V84, P185, DOI 10.1053/apmr.2003.50002; BRAY RM, 1999, 1998 DEP DEFENCE SUR; CHANDLER D, 2006, ASHA LEADER, V11, P29; CHANDLER D, 2006, ASHA LEADER, V11, P8; CORRIGAN JD, 1995, ARCH PHYS MED REHAB, V76, P302, DOI 10.1016/S0003-9993(95)80654-7; Corrigan JD, 1998, ARCH PHYS MED REHAB, V79, P298, DOI 10.1016/S0003-9993(98)90010-7; Farrell M, 2001, BRIT J PSYCHIAT, V179, P432, DOI 10.1192/bjp.179.5.432; Gawande A, 2004, NEW ENGL J MED, V351, P2471, DOI 10.1056/NEJMp048317; GURNEY JG, 1992, J TRAUMA, V33, P709, DOI 10.1097/00005373-199211000-00020; HALL KM, 1994, ARCH PHYS MED REHAB, V75, P876, DOI 10.1016/0003-9993(94)90112-0; Horner MD, 2005, J INT NEUROPSYCH SOC, V11, P322, DOI 10.1017/S135561770505037X; Jacobson IG, 2008, JAMA-J AM MED ASSOC, V300, P663, DOI 10.1001/jama.300.6.663; Kalaydjian A, 2009, COMPR PSYCHIAT, V50, P299, DOI 10.1016/j.comppsych.2008.09.012; Kolakowsky-Hayner S, 2002, BRAIN INJURY, V16, P583, DOI 10.1080/02699050110119475; KRAUS JF, 1989, AM J PUBLIC HEALTH, V79, P294, DOI 10.2105/AJPH.79.3.294; Kreutzer JS, 1996, J LEARN DISABIL, V29, P643, DOI 10.1177/002221949602900608; Larson GE, 2008, AM J EPIDEMIOL, V167, P1269, DOI 10.1093/aje/kwn084; MacGregor AJ, 2009, MIL MED, V174, P224, DOI 10.7205/MILMED-D-03-9107; National Center for Injury Prevention and Control, 2003, REP C MILD TRAUM BRA; Okie S, 2005, NEW ENGL J MED, V352, P2043, DOI 10.1056/NEJMp058102; Owens BD, 2008, J TRAUMA, V64, P295, DOI 10.1097/TA.0b013e318163b875; Ponsford J, 2007, BRAIN INJURY, V21, P1385, DOI 10.1080/02699050701796960; REISTER FA, 1973, BATTLE CASUALTIES ME, pCH3; RICHARDS MS, 1989, AM J PUBLIC HEALTH, V79, P1011, DOI 10.2105/AJPH.79.8.1011; Sander AM, 1997, ARCH PHYS MED REHAB, V78, P138, DOI 10.1016/S0003-9993(97)90254-9; Seal KH, 2007, ARCH INTERN MED, V167, P476, DOI 10.1001/archinte.167.5.476; Sparadeo F. R., 1989, J HEAD TRAUMA REHAB, V4, P75, DOI DOI 10.1097/00001199-198903000-00010; Tonnesen H, 1999, BMJ-BRIT MED J, V318, P1311, DOI 10.1136/bmj.318.7194.1311; TONNESEN H, 1991, J BONE JOINT SURG BR, V73, P511; Wade AL, 2007, J TRAUMA, V63, P836, DOI 10.1097/01.ta.0000251453.54663.66; Xydakis MS, 2005, OTOLARYNG HEAD NECK, V133, P497, DOI 10.1016/j.otohns.2005.07.003	34	22	22	0	8	ASSOC MILITARY SURG US	BETHESDA	9320 OLD GEORGETOWN RD, BETHESDA, MD 20814 USA	0026-4075			MIL MED	Milit. Med.	FEB	2011	176	2					147	150		10.7205/MILMED-D-10-00191			4	Medicine, General & Internal	General & Internal Medicine	825BL	WOS:000295245800008	21366075	Bronze			2021-06-18	
J	d'Hemecourt, P				d'Hemecourt, Pierre			Subacute Symptoms of Sports-Related Concussion: Outpatient Management and Return to Play	CLINICS IN SPORTS MEDICINE			English	Article						Concussion; Symptom score; Neuropsychological testing; Balance testing; Return to play criteria	TRAUMATIC BRAIN-INJURY; NATIONAL-FOOTBALL-LEAGUE; HEAD-INJURY; CLINICAL MANAGEMENT; COLLEGIATE; RECOVERY; IMPACT; EPIDEMIOLOGY; CHILDREN; ENCEPHALOPATHY	Most concussion symptoms resolve within the first week after injury. Athletes with persistent symptoms may manifest subtle behavioral and cognitive changes. The astute clinician uses various information to determine when these symptoms have cleared before allowing the athlete to return to athletic competition.	Childrens Hosp, Div Sports Med, Boston, MA 02115 USA	d'Hemecourt, P (corresponding author), Childrens Hosp, Div Sports Med, 300 Longwood Ave, Boston, MA 02115 USA.	pierre.dhemecourt@childrens.harvard.edu					Barth JT., 1989, MILD HEAD INJURY, P257; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P345, DOI 10.1017/S1355617705050411; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P215, DOI 10.1017/S1355617705050277; Cantu R, 2009, CLIN SPORTS MED, V7, P37; Cantu RC, 2007, NEUROSURGERY, V61, P223, DOI 10.1227/01.NEU.0000255514.73967.90; Catroppa C, 2007, J PEDIATR PSYCHOL, V32, P354, DOI 10.1093/jpepsy/jsl019; Collins MW, 2003, CLIN J SPORT MED, V13, P222, DOI 10.1097/00042752-200307000-00005; Collins MW, 2002, NEUROSURGERY, V51, P1175, DOI 10.1097/00006123-200211000-00011; CORSELLIS JA, 1973, PSYCHOL MED, V3, P270, DOI 10.1017/S0033291700049588; Couch JR, 2001, HEADACHE, V41, P559, DOI 10.1046/j.1526-4610.2001.041006559.x; DICKER BG, 1992, J HEAD TRAUMA REHAB, V7, P83; Fichtenberg NL, 2002, BRAIN INJURY, V16, P197, DOI 10.1080/02699050110103940; Gioia G, 2004, BRIT J SPORT MED, V38, P657; Guskiewicz KM, 2001, J ATHL TRAINING, V36, P263; Guskiewicz KM, 2000, AM J SPORT MED, V28, P643, DOI 10.1177/03635465000280050401; HERRING SA, 2005, MED SCI SPORTS EXERC, V37, P2012; IMOGEN L, 2009, J INT NEUROPSYCH SOC, V16, P17; Iverson GL, 2004, J INT NEUROPSYCH SOC, V10, P904, DOI 10.1017/S1355617704106139; Jones E, 2007, AM J PSYCHIAT, V164, P1641, DOI 10.1176/appi.ajp.2007.07071180; Kirkwood MW, 2006, PEDIATRICS, V117, P1359, DOI 10.1542/peds.2005-0994; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; LeBlanc CMA, 2000, PEDIATRICS, V106, P1524, DOI 10.1542/peds.106.6.1524; Leddy JJ, 2010, CLIN J SPORT MED, V20, P21, DOI 10.1097/JSM.0b013e3181c6c22c; Lenaerts Marc E, 2004, Curr Treat Options Neurol, V6, P507, DOI 10.1007/s11940-004-0008-5; Lovell M, 2004, CLIN SPORT MED, V23, P421, DOI 10.1016/j.csm.2004.04.001; Lovell MR, 2006, APPL NEUROPSYCHOL, V13, P166, DOI 10.1207/s15324826an1303_4; Lovell MR, 1998, J HEAD TRAUMA REHAB, V13, P9, DOI 10.1097/00001199-199804000-00004; Lovell MR, 2003, J NEUROSURG, V98, P296, DOI 10.3171/jns.2003.98.2.0296; Macciocchi SN, 1996, NEUROSURGERY, V39, P510, DOI 10.1097/00006123-199609000-00014; Makdissi M, 2010, AM J SPORT MED, V38, P464, DOI 10.1177/0363546509349491; MCALLISTER TW, 1992, PSYCHIAT CLIN N AM, V15, P395; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrea M, 2009, CLIN NEUROPSYCHOL, V23, P1368, DOI 10.1080/13854040903074652; McCrea M, 2009, NEUROSURGERY, V65, P876, DOI 10.1227/01.NEU.0000350155.89800.00; McCrory P, 2004, BRIT J SPORT MED, V38, P516, DOI 10.1136/bjsm.2004.014811; McCrory P, 2009, BRIT J SPORT MED, V43, pI76, DOI 10.1136/bjsm.2009.058248; McCrory P, 2001, CLIN J SPORT MED, V11, P144, DOI 10.1097/00042752-200107000-00004; McCrory PR, 2000, CLIN J SPORT MED, V10, P235, DOI 10.1097/00042752-200010000-00002; Omalu BI, 2006, NEUROSURGERY, V59, P1086, DOI 10.1227/01.NEU.0000245601.69451.27; Packard RC, 1999, J HEAD TRAUMA REHAB, V14, P9, DOI 10.1097/00001199-199902000-00004; Ponsford J, 2001, PEDIATRICS, V108, P1297, DOI 10.1542/peds.108.6.1297; SIOBOUNOV S, 2007, NEUROSURGERY, V61, P338; Tenovuo O, 2006, CURR OPIN NEUROL, V19, P528, DOI 10.1097/WCO.0b013e328010944f	43	22	22	0	8	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0278-5919			CLIN SPORT MED	Clin. Sports Med.	JAN	2011	30	1					63	+		10.1016/j.csm.2010.08.008			11	Sport Sciences	Sport Sciences	691XR	WOS:000285114800007	21074082				2021-06-18	
J	Hammond, FM; Davis, CS; Whiteside, OY; Philbrick, P; Hirsch, MA				Hammond, Flora M.; Davis, Christine S.; Whiteside, Omar Y.; Philbrick, Peggy; Hirsch, Mark A.			Marital Adjustment and Stability Following Traumatic Brain Injury: A Pilot Qualitative Analysis of Spouse Perspectives	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						adjustment; brain injury; caregiving; craniocerebral trauma; marriage	REHABILITATION; INDIVIDUALS; PREDICTORS; CAREGIVERS; APPRAISAL; FAMILIES; STRESS; ISSUE	Background: Traumatic brain injury (TBI), causing various impairments and functional changes, may adversely impact marital relationships. However, dynamics of the interactions that contribute to these marital difficulties are complex and poorly understood. There has been little research on marital quality and stability in families of a person with TBI. Objective: By identifying themes of marital adjustment and stability, this qualitative exploratory study examines how a spouse who has experienced TBI affects the marital relationship. Methods: Two gender-specific focus groups, each with 5 spouses of individuals living with the effects of TBI, were conducted to collect data on marital interactions that were analyzed for themes related to marital adjustment and stability. The data were analyzed using grounded theory, and then relational theories were applied as a framework for organizing the metacodes and concepts. Results: This study suggests that, after TBI, changes in family dynamics and the way spouses perceive those dynamics affect movement toward pulling together or pulling apart. Conclusion: Changes in spousal perceptions, interactions, responsibilities, and reactions to brain injury may impact marital stability and satisfaction. Further study is warranted to better understand and determine whether and how awareness of these changes may be incorporated into treatment.	[Hammond, Flora M.] Indiana Univ, Indianapolis, IN 46202 USA; [Hirsch, Mark A.] Univ N Carolina, Carolinas Healthcare Syst, Carolinas Rehabil, Charlotte, NC 28223 USA; [Davis, Christine S.] Univ N Carolina, Dept Commun Studies, Charlotte, NC 28223 USA; [Whiteside, Omar Y.] Univ S Carolina, Dept Epidemiol & Biostat, Charlotte, NC USA	Hammond, FM (corresponding author), Indiana Univ, 541 N Clin Dr,Sute 626, Indianapolis, IN 46202 USA.	flora.hammond@rhin.com	Hirsch, Mark A./D-2798-2016; Davis, Christine/K-4850-2019	Hirsch, Mark A./0000-0002-8997-7971; 	US Department of Education, Office of Special Education and Rehabilitative Services, National Institute on Disability Rehabilitation and Research [H133A20016]; Carolinas Medical Center, Carolinas HealthCare System, Charlotte, North Carolina	This study was partially supported by US Department of Education, Office of Special Education and Rehabilitative Services, National Institute on Disability Rehabilitation and Research grant H133A20016, and by a grant from Carolinas Medical Center, Carolinas HealthCare System, Charlotte, North Carolina.	Blais MC, 2005, BRAIN INJURY, V19, P1223, DOI 10.1080/02699050500309387; Boeije HR, 2003, COMMUNITY WORK FAMIL, V6, P223, DOI DOI 10.1080/136688003200014343810.1080/1366880032000143438; Buehlman K, 1996, ORAL HIST INTERVIEW; Buehlman K.T., 1992, J FAMILY PSYCHOL, V5, P295, DOI DOI 10.1037/0893-3200.5.3-4.295; Burridge AC, 2007, NEUROPSYCHOL REHABIL, V17, P95, DOI 10.1080/09602010500505070; Charmaz K., 2000, HDB QUALITATIVE RES, P509, DOI DOI 10.1177/0891241609342193; Christensen T. M., 1997, FAMILY J COUNSELING, V5, P317, DOI DOI 10.1177/1066480797054007; Cline RJ, 1986, COMMUNICATION Q, V34, P41; Corbin JM, 1988, UNENDINGWORK ANDCARE; Davis C, 2010, STRAIGHT TALK COMMUN; Davis C, 2010, BRAIN INJURY, V24, P210; Dues MT, 1999, PSYCHIAT TIMES, V16, P48; Fern E.F., 2001, ADV FOCUS GROUP RES; Glaser B. G., 1967, DISCOVERY GROUNDED T; Gottman J.M., 1994, WHAT PREDICTS DIVORC; Gottman J. M., 1993, J FAM PSYCHOL, V7, P57, DOI DOI 10.1037/0893-3200.7.1.57; HALEY WE, 1987, PSYCHOL AGING, V2, P323, DOI 10.1037/0882-7974.2.4.323; Hibbard MR, 2000, NEUROREHABILITATION, V15, P109; Kreuter M, 1998, SPINAL CORD, V36, P252, DOI 10.1038/sj.sc.3100592; Kreuter M, 1998, BRAIN INJURY, V12, P349, DOI 10.1080/026990598122494; Kreutzer JS, 2007, NEUROREHABILITATION, V22, P53; KROKOFF L, 1984, THESIS U ILLINOIS UR; Lawton MP, 1998, J GERONTOL, V46, pP181; Lefebvre H, 2005, BRAIN INJURY, V19, P585, DOI 10.1080/02699050400025026; Lindlof T. R., 2002, QUALITATIVE COMMUNIC, V2nd; Long C J, 1983, Psychiatr Med, V1, P35; Lyons R.F., 1995, RELATIONSHIPS CHRONI; McGrew KB, 1998, J WOMEN AGING, V10, P49, DOI 10.1300/J074v10n02_05; McKinlay W, 1999, REHABILITATION ADULT, V3, P74; MCKINLAY WW, 1981, J NEUROL NEUROSUR PS, V44, P527, DOI 10.1136/jnnp.44.6.527; MILLER B, 1992, GERONTOLOGIST, V32, P498, DOI 10.1093/geront/32.4.498; MORTON MV, 1995, BRAIN INJURY, V9, P81, DOI 10.3109/02699059509004574; Oddy M, 2001, SEX RELATSH THER, V16, P247, DOI [10.1080/14681990125256, DOI 10.1080/14681990125256]; Patton M.Q., 2002, QUALITATIVE RES EVAL; PEARLIN LI, 1990, GERONTOLOGIST, V30, P583, DOI 10.1093/geront/30.5.583; Pecchioni L. L., 2006, FAMILY COMMUNICATION, P447; Peters MS, 2002, INT FAM COMM DIV NAT; PETRONIO S, 1984, COMMUN MONOGR, V51, P268, DOI 10.1080/03637758409390200; Pohl JM, 1997, J WOMEN AGING, V9, P133, DOI 10.1300/J074v09n01_11; Ponsford J, 2003, BRAIN INJURY, V17, P453, DOI 10.1080/0269905031000070143; Raveis VH, 1998, CANCER, V83, P1652, DOI 10.1002/(SICI)1097-0142(19981015)83:8<1652::AID-CNCR22>3.3.CO;2-H; Schopp LH, 2006, BRAIN INJURY, V20, P1155, DOI 10.1080/02699050600983735; Seibert PS, 2002, BRAIN INJURY, V16, P837, DOI 10.1080/02699050210131939; Strauss A., 1990, BASICS QUALITATIVE R; Thomsen I V, 1974, Scand J Rehabil Med, V6, P180; THOMSEN IV, 1984, J NEUROL NEUROSUR PS, V47, P260, DOI 10.1136/jnnp.47.3.260; Webster G, 1999, BRAIN INJURY, V13, P593; Williams WH, 2003, NEUROPSYCHOL REHABIL, V13, P1, DOI [10.1080/09602010244000444, 10.1016/S0960-9822(02)01374-X]; Wood J. T., 1993, J APPLIED COMMUNICAT, V21, P279, DOI DOI 10.1080/00909889309365372	49	22	22	1	16	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	JAN-FEB	2011	26	1					69	78		10.1097/HTR.0b013e318205174d			10	Clinical Neurology; Rehabilitation	Neurosciences & Neurology; Rehabilitation	703GA	WOS:000285965200007	21209564				2021-06-18	
J	Honeybul, S; O'Hanlon, S; Ho, KM				Honeybul, Stephen; O'Hanlon, Susan; Ho, Kwok M.			Decompressive Craniectomy for Severe Head Injury: Does an Outcome Prediction Model Influence Clinical Decision-Making?	JOURNAL OF NEUROTRAUMA			English	Article						decision making; decompressive craniectomy; outcome	TRAUMATIC BRAIN-INJURY; CEREBRAL-ARTERY INFARCTION; SURGICAL DECOMPRESSION; MULTICENTER; SURGERY; MANAGEMENT; RECOVERY; TRIAL	The use of a prognostic model to aid clinician decision-making with regard to decompressive craniectomy for patients with severe neurotrauma has not been examined. Thus in this study we assessed whether an internationally validated prediction model would influence clinician decision-making about craniectomy. A two-part structured interview, given before and after knowing the predicted risks of unfavorable neurological outcomes at 6 months, was used to assess the participants' recommendations about performing decompressive craniectomy in three patients with severe traumatic brain injury. The participants rated their preferences when there was no surrogate decision maker available, when the next of kin requested surgical intervention, when the patient had an advance directive, and when the participant was the injured party. A visual analogue scale (1-10) was used to assess the strength of their opinions. A total of 50 neurosurgeons and intensive care physicians participated in this study. The participants were significantly more likely to recommend decompressive craniectomy for their patients than for themselves, especially when the next of kin of the patient demanded the procedure, and were more similar in their own preferences to patients who had advance directives. Clinicians' preferences to perform the procedure for both themselves and their patients was significantly reduced after knowing the predicted risks of unfavorable outcomes, and these changes in attitude were consistent across those with different specialties, regardless of the amount of experience caring for similar patients, or religious background. In conclusion, the predicted risks of unfavorable outcomes influenced clinician decision-making about recommending decompressive craniectomy for patients with very severe neurotrauma.	[Honeybul, Stephen; O'Hanlon, Susan] Sir Charles Gairdner Hosp, Dept Neurosurg, Perth, WA, Australia; [Honeybul, Stephen; O'Hanlon, Susan] Royal Perth Hosp, Perth, WA, Australia; [Ho, Kwok M.] Univ Western Australia, Dept Intens Care Med, Perth, WA 6009, Australia; [Ho, Kwok M.] Univ Western Australia, Sch Populat Hlth, Perth, WA 6009, Australia	Honeybul, S (corresponding author), Sir Charles Gairdner Hosp, Dept Neurosurg, Perth, WA, Australia.	stephen.honeybul@health.wa.gov.au	Ho, Kwok M./E-3546-2010	Ho, Kwok M./0000-0002-6705-6004			Aarabi B, 2006, J NEUROSURG, V104, P469, DOI 10.3171/jns.2006.104.4.469; Adamides AA, 2009, ACTA NEUROCHIR, V151, P1399, DOI 10.1007/s00701-009-0398-y; Cooper DJ, 2008, J CRIT CARE, V23, P387, DOI 10.1016/j.jcrc.2007.05.002; Cremer OL, 2006, J TRAUMA, V61, P1484, DOI 10.1097/01.ta.0000195981.63776.ba; Guerra WKW, 1999, J NEUROSURG, V90, P187, DOI 10.3171/jns.1999.90.2.0187; Ho KM, 2010, CRIT CARE MED, V38, P1562, DOI 10.1097/CCM.0b013e3181e2ccd8; Hofmeijer J, 2009, LANCET NEUROL, V8, P326, DOI 10.1016/S1474-4422(09)70047-X; Honeybul S, 2010, J NEUROTRAUM, V27, P1225, DOI 10.1089/neu.2010.1316; Honeybul S, 2009, J NEUROTRAUM, V26, P2179, DOI 10.1089/neu.2009.0989; Hoofien D, 2001, BRAIN INJURY, V15, P189; Hutchinson PJ, 2006, ACTA NEUROCHIR SUPPL, V96, P17; Juttler E, 2007, STROKE, V38, P2518, DOI 10.1161/STROKEAHA.107.485649; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; Munch E, 2000, NEUROSURGERY, V47, P315; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Sahuquillo J, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003983.pub2; SBORDONE RJ, 1995, BRAIN INJURY, V9, P285, DOI 10.3109/02699059509008199; Servadei F, 2007, CURR OPIN CRIT CARE, V13, P163, DOI 10.1097/MCC.0b013e32807f2a94; Spiotta AM, 2010, J NEUROSURG, V113, P571, DOI 10.3171/2010.1.JNS09506; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Ucar T, 2005, J NEUROTRAUM, V22, P1311, DOI 10.1089/neu.2005.22.1311; Vahedi K, 2007, STROKE, V38, P2506, DOI 10.1161/STROKEAHA.107.485235; Woischneck D, 2010, Z ORTHOP UNFALLCHIR, V148, P548, DOI 10.1055/s-0030-1249913; Zheng WB, 2007, NEURORADIOLOGY, V49, P271, DOI 10.1007/s00234-006-0187-8	24	22	23	0	3	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JAN	2011	28	1					13	19		10.1089/neu.2010.1584			7	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	710DT	WOS:000286491800002	20979568				2021-06-18	
J	Jung, CS; Zweckberger, K; Schick, U; Unterberg, AW				Jung, Carla S.; Zweckberger, Klaus; Schick, Uta; Unterberg, Andreas W.			Helmet use in winter sport activities-attitude and opinion of neurosurgeons and non-traumatic-brain-injury-educated persons	ACTA NEUROCHIRURGICA			English	Article						Traumatic brain injury; Sport injury; Protective helmets	BICYCLE SAFETY HELMETS; WESTERN NORTH-AMERICA; HEAD-INJURIES; SKI AREAS; SNOWBOARDERS; PREVALENCE; CHILDREN	During the last winter season, some fatal sport injuries with severe traumatic brain injury (TBI) prompted major discussions about protective helmet use. Although ski helmets reportedly lead to a 60% decrease of risk to incur TBI, little is known about the distribution of helmet users and which factors are crucial for the decision to wear a helmet. Especially, it is unknown whether knowledge or experience concerning TBI in winter sports influences the use of helmets, as well as the attitude and opinion of people. Since treatment of TBI is a major field in neurosurgery, 55 neurosurgical departments (NS) in Germany, Switzerland and Austria were addressed and asked to answer anonymous questionnaires. A "non-trauma-educated" control cohort (NTP) was interviewed in ski resorts in Austria as well as sports equipment stores in Germany. Questionnaires were returned by 465 NS and 546 NTP. Half of NS and NTP wore helmets in winter sports. Although some interviewees showed cognitive dissonant behaviour, experience in TBI after ski or snowboard accidents significantly affected the decision to wear helmets. After the fatal ski accidents, and increased media coverage 15.4% NS and 13.2% NTP bought their helmet. Furthermore, incidence of helmet use in children was correlated with the actual use and disposition of their parents to make the use of helmet compulsory. This study indicates that brain-trauma education affects ones attitude and opinion concerning protective helmet use in winter sports. However, without neglecting educational measures, emotional arguments should be added in the promotion of helmets to make them a popular integral part of winter sport outfits.	[Jung, Carla S.; Zweckberger, Klaus; Schick, Uta; Unterberg, Andreas W.] Univ Heidelberg, Dept Neurosurg, D-69121 Heidelberg, Germany	Jung, CS (corresponding author), Univ Heidelberg, Dept Neurosurg, Neuenheimer Feld 400, D-69121 Heidelberg, Germany.	carla.jung@med.uni-heidelberg.de					Alexander Mary H, 2003, J Emerg Nurs, V29, P461, DOI 10.1016/S0099-1767(03)00178-8; Andersen PA, 2004, INJURY PREV, V10, P358, DOI 10.1136/ip.2004.005967; Buller DB, 2003, J TRAUMA, V55, P939, DOI 10.1097/01.TA.0000078694.53320.CA; Burtscher M, 2008, CLIN J SPORT MED, V18, P355, DOI 10.1097/MJT.0b013e31815fd0fe; Ehrlich PF, 2001, J PEDIATR SURG, V36, P763, DOI 10.1053/jpsu.2001.22955; Evans B, 2009, INT J INJ CONTROL SA, V16, P9, DOI 10.1080/17457300902732045; Finnoff JT, 2001, PEDIATRICS, V108, DOI 10.1542/peds.108.1.e4; Hennessey T, 2002, AM J PREV MED, V22, P110, DOI 10.1016/S0749-3797(01)00411-1; Jung CS, 2010, J NEUROTRAUM, V27, P871, DOI 10.1089/neu.2009.1130; Lawrence L, 2008, PEDIATR EMERG CARE, V24, P219, DOI 10.1097/PEC.0b013e31816a9f0a; Levy AS, 2007, HEALTH PROMOT PRACT, V8, P257, DOI 10.1177/1524839906292178; Levy AS, 2002, J TRAUMA, V53, P695, DOI 10.1097/00005373-200210000-00013; McDonah M R, 2000, J Am Acad Nurse Pract, V12, P517; Meyers MC, 2007, SPORTS MED, V37, P485, DOI 10.2165/00007256-200737060-00003; MORROW PL, 1988, J TRAUMA, V28, P95, DOI 10.1097/00005373-198801000-00014; Mueller BA, 2008, EPIDEMIOLOGY, V19, P270, DOI 10.1097/EDE.0b013e318163567c; Sulheim S, 2006, JAMA-J AM MED ASSOC, V295, P919, DOI 10.1001/jama.295.8.919; Thompson DC, 1996, JAMA-J AM MED ASSOC, V276, P1968, DOI 10.1001/jama.276.24.1968; THOMPSON RS, 1989, NEW ENGL J MED, V320, P1361, DOI 10.1056/NEJM198905253202101	19	22	22	0	7	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0001-6268			ACTA NEUROCHIR	Acta Neurochir.	JAN	2011	153	1					101	106		10.1007/s00701-010-0704-8			6	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	700YD	WOS:000285780600016	20532575				2021-06-18	
J	Martinon, C; Duracher, C; Blanot, S; Escolano, S; De Agostini, M; Perie-Vintras, AC; Orliaguet, G; Carli, PA; Meyer, PG				Martinon, Claire; Duracher, Caroline; Blanot, Stephane; Escolano, Sylvie; De Agostini, Maria; Perie-Vintras, Anne Catherine; Orliaguet, Gilles; Carli, Pierre A.; Meyer, Philippe G.			Emergency tracheal intubation of severely head-injured children: Changing daily practice after implementation of national guidelines	PEDIATRIC CRITICAL CARE MEDICINE			English	Article						brain injury; children; emergency tracheal intubation; rapid sequence induction; guidelines	RAPID-SEQUENCE INTUBATION; ENDOTRACHEAL INTUBATION; PEDIATRIC-PATIENTS; PREHOSPITAL CARE; TRAUMA; VENTILATION; HYPOTENSION; MANAGEMENT; CAPNOGRAPHY; PARAMEDICS	Objective: To report daily practice of scene emergency tracheal intubation performed by physicians and changes induced by implementation of national guidelines, with special attention to rapid sequence induction (RSI) and control of assisted ventilation. Design: Observational study. Setting: Pediatric intensive care unit of a university hospital. Patients: A total of 296 children (age, 2-15 yrs old) referred to our center for severe traumatic brain injury (Glasgow Coma Scale score of <= 8), with spontaneous cardiac rhythm. Interventions: Scene RSI practice by field physicians was compared before (n = 188), and after (n = 108) publication of national guidelines. Emergency tracheal intubation conditions, RSI use, immediate complications, assisted ventilation efficiency on blood gases measurements upon arrival, and, in the later period, physician's knowledge, and observance to published guidelines were analyzed. Measurements and Main Results: After publication of guidelines, tracheal intubation was performed at the scene in 100% of the cases (vs. 88%, p = .05); RSI practice was more standardized, with an increased use of succinylcholine (10% to 80%, p = .0001), and a concomitant decreased use of nondepolarizing muscle relaxant (20% vs. 0%, p = .005), and opioids (70% vs. 36%, p = .05). Recommended RSI protocol (etomidate and succinylcholine) was effectively used by 64% of the physicians (vs. 2.8%, p = .001), and rate of immediate complications upon tube insertion (mainly cough reflex) decreased to 8% (vs. 25%, p = .0015). Scene emergency tracheal intubation, when ordered, resulted in a 100% success rate and adequate oxygenation within the two groups. Despite increasing the use of portable capnograph in the later period, PaCO2 was measured outside the tight target range (35-40 torr, 4.6-5.3 kPa) in 70% of the cases upon arrival. Conclusions: Scene emergency tracheal intubation was effectively performed by trained careproviders in children with traumatic brain injury. Implementation of guidelines led to a more standardized practice of RSI, decreased rate of immediate complications, but insufficient control of PaCO2 during transport. (Pediatr Crit Care Med 2011; 12:65-70)	[Martinon, Claire; Duracher, Caroline; Blanot, Stephane; Perie-Vintras, Anne Catherine; Orliaguet, Gilles; Carli, Pierre A.; Meyer, Philippe G.] CHU Necker Enfants Malad, Fac Med Descartes Paris 5, Dept Pediat Anesthesiol, Pediat Surg Crit Care Unit, Villejuif, France; [Escolano, Sylvie; De Agostini, Maria] INSERM, U780, Villejuif, France; CHU Necker Enfants Malad, Fac Med Descartes Paris 5, SAMU Paris, Villejuif, France	Martinon, C (corresponding author), CHU Necker Enfants Malad, Fac Med Descartes Paris 5, Dept Pediat Anesthesiol, Pediat Surg Crit Care Unit, Villejuif, France.	philippe.meyer@nck.aphp.fr	Meyer, Philippe/ABE-4242-2020	Meyer, Philippe/0000-0002-3829-6631; escolano, sylvie/0000-0003-0864-4321; Orliaguet, Gilles/0000-0003-0930-2251	Direction Regionale de la Recherche Clinique (DRCC)-Assistance Publique Hopitaux de Paris [PHRC 2003/AOM-03018]	This study was supported, in part, by Grant PHRC 2003/AOM-03018 from the "Direction Regionale de la Recherche Clinique (DRCC)-Assistance Publique Hopitaux de Paris" (PGM).	Adelson P David, 2003, Pediatr Crit Care Med, V4, pS45; [Anonymous], 1999, Ann Fr Anesth Reanim, V18, P36; APPLEBAUM D, 1985, ANN EMERG MED, V14, P656, DOI 10.1016/S0196-0644(85)80882-9; Baisch Steven D, 2005, Pediatr Crit Care Med, V6, P312, DOI 10.1097/01.PCC.0000161119.05076.91; Boswell W C, 1995, Air Med J, V14, P125, DOI 10.1016/1067-991X(95)90513-8; Brownstein D, 1996, ANN EMERG MED, V28, P34, DOI 10.1016/S0196-0644(96)70136-1; Chen L, 2008, PEDIATRICS, V122, pE294, DOI 10.1542/peds.2008-0103; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Cooper A, 2001, Semin Pediatr Surg, V10, P3, DOI 10.1053/spsu.2001.19379; Dunning J, 2004, ARCH DIS CHILD, V89, P763, DOI 10.1136/adc.2003.042523; Ehrlich PF, 2004, J PEDIATR SURG, V39, P1376, DOI 10.1016/j.jpedsurg.2004.05.010; Gausche M, 1998, JEMS, V23, P74; Gausche M, 2000, JAMA-J AM MED ASSOC, V283, P783, DOI 10.1001/jama.283.6.783; Gerritse BM, 2008, RESUSCITATION, V79, P225, DOI 10.1016/j.resuscitation.2008.05.016; Helm M, 2003, BRIT J ANAESTH, V90, P327, DOI 10.1093/bja/aeg069; Helm M, 2002, BRIT J ANAESTH, V88, P345, DOI 10.1093/bja/88.3.345; Kokoska ER, 1998, J PEDIATR SURG, V33, P333, DOI 10.1016/S0022-3468(98)90457-2; Meyer PG, 2000, PAEDIATR ANAESTH, V10, P253, DOI 10.1046/j.1460-9592.2000.00496.x; NAKAYAMA DK, 1990, ANN SURG, V211, P218, DOI 10.1097/00000658-199002000-00015; Orliaguet C, 2000, ANN FR ANESTH, V19, P164; Pierrot M, 2003, ANN FR ANESTH, V22, P12, DOI 10.1016/S0750-7658(02)00003-5; PIGULA FA, 1993, J PEDIATR SURG, V28, P310, DOI 10.1016/0022-3468(93)90223-8; Prause G., 1997, CRIT CARE, V1, P79, DOI [10.1186/cc108, DOI 10.1186/CC108]; Reed David B, 2002, Prehosp Emerg Care, V6, P50, DOI 10.1080/10903120290938779; Sagarin MJ, 2002, PEDIATR EMERG CARE, V18, P417, DOI 10.1097/00006565-200212000-00004; SEIDEL JS, 1991, PEDIATRICS, V88, P681; SHARPLES PM, 1990, BRIT MED J, V300, P87, DOI 10.1136/bmj.300.6717.87; SILVERSTON P, 1989, BRIT MED J, V298, P711, DOI 10.1136/bmj.298.6675.711; Sokolove PE, 2000, PEDIATR EMERG CARE, V16, P18, DOI 10.1097/00006565-200002000-00005; Stocchetti N, 1996, J TRAUMA, V40, P764, DOI 10.1097/00005373-199605000-00014; Warner KJ, 2009, J TRAUMA, V66, P26, DOI 10.1097/TA.0b013e3181957a25	31	22	23	0	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1529-7535	1947-3893		PEDIATR CRIT CARE ME	Pediatr. Crit. Care Med.	JAN	2011	12	1					65	70		10.1097/PCC.0b013e3181e2a244			6	Critical Care Medicine; Pediatrics	General & Internal Medicine; Pediatrics	703FT	WOS:000285964500022	20473241				2021-06-18	
J	Solomon, GS; Ott, SD; Lovell, MR				Solomon, Gary S.; Ott, Summer D.; Lovell, Mark R.			Long-term Neurocognitive Dysfunction in Sports: What Is the Evidence?	CLINICS IN SPORTS MEDICINE			English	Article						Neurocognitive dysfunction; Computerized assessment; Athletes; Concussive injury	TRAUMATIC BRAIN-INJURY; SELF-REPORTED CONCUSSIONS; MILD COGNITIVE IMPAIRMENT; NEUROPSYCHOLOGICAL PERFORMANCE; RECURRENT CONCUSSION; HIGH-SCHOOL; HISTORY; RISK; DEMENTIA; ENCEPHALOPATHY	Although the immediate neurocognitive effects of sports-related concussion are well known, less is known about the intermediate or long-term effects of sports-related concussions. A sample of selected studies of high-school and collegiate athletes is reviewed and the intermediate effects of concussive injuries are discussed, because no long-term empiric data are available with these populations. The evidence for intermediate neurocognitive effects is mixed and not convincing at present in these groups of athletes. Selected studies of professional boxers and American professional football players are also reviewed, and the available data regarding long-term neurocognitive and neuropathologic effects are assessed. The evidence for long-term adverse neurocognitive effects in professional boxers is compelling. Suggestions for future research on relevant biopsychosocial variables affecting response to concussive injury are presented.	[Solomon, Gary S.] Vanderbilt Univ, Sch Med, Dept Neurol Surg, Nashville, TN 37232 USA; [Solomon, Gary S.] Vanderbilt Univ, Sch Med, Dept Psychiat, Nashville, TN 37232 USA; [Ott, Summer D.] Methodist Hosp, Neurol Inst, Concuss Ctr, Houston, TX 77027 USA; [Lovell, Mark R.] Univ Pittsburgh, Med Ctr, Dept Orthopaed Surg, Pittsburgh, PA 15203 USA	Solomon, GS (corresponding author), Vanderbilt Univ, Sch Med, Dept Neurol Surg, T-4224 MCN, Nashville, TN 37232 USA.	gssolomon1@yahoo.com	Solomon, Gary/K-9011-2019				Belanger HG, 2010, J INT NEUROPSYCH SOC, V16, P262, DOI 10.1017/S1355617709991287; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P345, DOI 10.1017/S1355617705050411; Broglio SP, 2006, BRIT J SPORT MED, V40, P802, DOI 10.1136/bjsm.2006.028019; Broshek DK, 2005, J NEUROSURG, V102, P856, DOI 10.3171/jns.2005.102.5.0856; Bruce JM, 2009, NEUROSURGERY, V64, P100, DOI 10.1227/01.NEU.0000336310.47513.C8; CAJIGAL S, 2007, NEUROLOGY TODAY, V7, P6; Casson I, 2010, NEUROLOGY TODAY, V10, P6, DOI DOI 10.1097/01.NT.0000380917.17552.b7; CASSON IR, 2006, NEUROSURGERY, V58, P1003; Clausen H, 2005, BRIT J SPORT MED, V39, P661, DOI 10.1136/bjsm.2004.017046; Collie A, 2006, BRIT J SPORT MED, V40, P550, DOI 10.1136/bjsm.2005.019802; Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P964, DOI 10.1001/jama.282.10.964; COURVILLE CYRIL B., 1962, BULL LOS ANGELES NEUROL SOC, V27, P160; De Beaumont L, 2009, BRAIN, V132, P695, DOI 10.1093/brain/awn347; DEBEAUMONT L, 2010, BRAIN INJURY, V21, P631; DeCarli C, 2003, LANCET NEUROL, V2, P15, DOI 10.1016/S1474-4422(03)00262-X; Erlanger DM, 1999, CLIN NEUROPSYCHOL, V13, P193, DOI 10.1076/clin.13.2.193.1963; Farace E, 2000, J NEUROSURG, V93, P539, DOI 10.3171/jns.2000.93.4.0539; Field M, 2003, J PEDIATR-US, V142, P546, DOI 10.1067/mpd.2003.190; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Iverson GL, 2006, BRIT J SPORT MED, V40, P72, DOI 10.1136/bjsm.2005.020651; Iverson GL, 2004, BRAIN INJURY, V18, P433, DOI 10.1080/02699050310001617352; Jordan BD, 1997, JAMA-J AM MED ASSOC, V278, P136, DOI 10.1001/jama.278.2.136; Loosemore M, 2007, BMJ-BRIT MED J, V335, P809, DOI 10.1136/bmj.39342.690220.55; Macciocchi SN, 2001, J ATHL TRAINING, V36, P303; Martland HS, 1928, J AMER MED ASSOC, V91, P1103, DOI 10.1001/jama.1928.02700150029009; McCrory P, 2009, BRIT J SPORT MED, V43, pI76, DOI 10.1136/bjsm.2009.058248; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Mihalik JP, 2005, J NEUROSURG, V102, P850, DOI 10.3171/jns.2005.102.5.0850; MILLSPAUGH JA, 1937, DEMENTIA, V35, P297; Moser RS, 2005, NEUROSURGERY, V57, P300, DOI 10.1227/01.NEU.0000166663.98616.E4; Omalu BI, 2006, NEUROSURGERY, V59, P1086, DOI 10.1227/01.NEU.0000245601.69451.27; Omalu Bennet I, 2010, J Forensic Nurs, V6, P40, DOI 10.1111/j.1939-3938.2009.01064.x; Omalu BI, 2005, NEUROSURGERY, V57, P128, DOI 10.1227/01.NEU.0000163407.92769.ED; Petersen RC, 2001, NEUROLOGY, V56, P1133, DOI 10.1212/WNL.56.9.1133; Plassman BL, 2008, ANN INTERN MED, V148, P427, DOI 10.7326/0003-4819-148-6-200803180-00005; Roberts AH., 1969, BRAIN DAMAGE BOXERS; Terrell TR, 2008, CLIN J SPORT MED, V18, P10, DOI 10.1097/JSM.0b013e31815c1d4c; THEIRAULT M, 2010, J CLIN EXP NEUROPSYC, V17, P1; Ware JE, 1998, J CLIN EPIDEMIOL, V51, P1167, DOI 10.1016/S0895-4356(98)00108-5; Weir Dr, 2009, NATL FOOTBALL LEAGUE	42	22	22	0	9	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0278-5919	1556-228X		CLIN SPORT MED	Clin. Sports Med.	JAN	2011	30	1					165	+		10.1016/j.csm.2010.09.002			15	Sport Sciences	Sport Sciences	691XR	WOS:000285114800015	21074090				2021-06-18	
J	Szmydynger-Chodobska, J; Zink, BJ; Chodobski, A				Szmydynger-Chodobska, Joanna; Zink, Brian J.; Chodobski, Adam			Multiple sites of vasopressin synthesis in the injured brain	JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM			English	Article						activated microglia; arginine vasopressin; cerebrovascular endothelium; macrophages; traumatic brain injury	RAT CHOROID-PLEXUS; ARGININE-VASOPRESSIN; EXPRESSION; RECEPTORS; KINETICS	Previous studies have indicated that the primary targets for vasopressin actions on the injured brain are the cerebrovascular endothelium and astrocytes, and that vasopressin amplifies the posttraumatic production of proinflammatory mediators. Here, the controlled cortical impact model of traumatic brain injury in rats was used to identify the sources of vasopressin in the injured brain. Injury increased vasopressin synthesis in the hypothalamus and cerebral cortex adjacent to the posttraumatic lesion. In the cortex, vasopressin was predominantly produced by activated microglia/macrophages, and, to a lesser extent, by the cerebrovascular endothelium. These data further support the pathophysiological role of vasopressin in brain injury. Journal of Cerebral Blood Flow & Metabolism (2011) 31, 47-51; doi:10.1038/jcbfm.2010.188; published online 20 October 2010	[Szmydynger-Chodobska, Joanna] Brown Univ, Dept Emergency Med, Alpert Med Sch, Coro Ctr W, Providence, RI 02903 USA	Szmydynger-Chodobska, J (corresponding author), Brown Univ, Dept Emergency Med, Alpert Med Sch, Coro Ctr W, Room 112,1 Hoppin St, Providence, RI 02903 USA.	Joanna_Szmydynger-Chodobska@brown.edu			NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS49479]; Department of Emergency Medicine at the Alpert Medical School of Brown University; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS049479] Funding Source: NIH RePORTER	This work was supported by grant NS49479 from the NIH (to AC) and by funds from the Department of Emergency Medicine at the Alpert Medical School of Brown University.	Barreca T, 2001, CEREBROVASC DIS, V11, P113, DOI 10.1159/000047622; BUIJS RM, 1978, CELL TISSUE RES, V186, P423, DOI 10.1007/BF00224932; Chodobski A, 1997, MOL BRAIN RES, V48, P67, DOI 10.1016/S0169-328X(97)00079-X; Liu XZ, 2000, HEALTH POLICY PLANN, V15, P157, DOI 10.1093/heapol/15.2.157; LOESCH A, 1993, BRAIN RES, V611, P333, DOI 10.1016/0006-8993(93)90522-O; SOFRONIEW MV, 1983, PROG BRAIN RES, V60, P101; SORENSEN PS, 1985, J NEUROL NEUROSUR PS, V48, P50, DOI 10.1136/jnnp.48.1.50; Szmydynger-Chodobska J, 2004, J NEUROTRAUM, V21, P1090, DOI 10.1089/0897715041651033; Szmydynger-Chodobska J, 2006, NEUROENDOCRINOLOGY, V84, P339, DOI 10.1159/000097989; Szmydynger-Chodobska J, 2010, J NEUROTRAUM, V27, P1449, DOI 10.1089/neu.2010.1331; Vakili A, 2005, J CEREBR BLOOD F MET, V25, P1012, DOI 10.1038/sj.jcbfm.9600097; Xu Miao, 2007, Chin J Traumatol, V10, P90; Yoshida M, 2006, ENDOCRINOLOGY, V147, P2850, DOI 10.1210/en.2005-1222; ZLOKOVIC BV, 1990, BIOCHIM BIOPHYS ACTA, V1025, P191, DOI 10.1016/0005-2736(90)90097-8; ZLOKOVIC BV, 1991, AM J PHYSIOL, V260, pF216	15	22	22	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0271-678X			J CEREBR BLOOD F MET	J. Cereb. Blood Flow Metab.	JAN	2011	31	1					47	51		10.1038/jcbfm.2010.188			5	Endocrinology & Metabolism; Hematology; Neurosciences	Endocrinology & Metabolism; Hematology; Neurosciences & Neurology	702BX	WOS:000285870700007	20959854	Green Published, Bronze			2021-06-18	
J	Villemure, R; Nolin, P; Le Sage, N				Villemure, R.; Nolin, P.; Le Sage, N.			Self-reported symptoms during post-mild traumatic brain injury in acute phase: Influence of interviewing method	BRAIN INJURY			English	Article						Mild traumatic brain injury; self-reported symptoms; symptom assessment; Rivermead post-concussion symptoms questionnaire	HEAD-INJURY; POSTCONCUSSION SYNDROME; EPIDEMIOLOGY; EXPECTATION; CONCUSSION; KNOWLEDGE; RECOVERY; OUTCOMES; RETURN; PAIN	Primary objective: To examine the role played by two interviewing methods used in the evaluation of acute self-reported symptoms after a mild traumatic brain injury (mTBI). Method and procedures: A cohort of 354 mTBI-adult participants was recruited over a period of 36 months in emergency rooms of five Canadian trauma hospitals. Participants were contacted by phone at the first and fourth week and at the third month following their mTBI in order to evaluate their symptoms. First, with the 'spontaneous' method, they freely identified those symptoms. Secondly, with the 'suggested' method, they identified their symptoms according to a standardized checklist made-up of the most common post-mTBI symptoms (Rivermead Post-Concussion Symptoms Questionnaire). Results: Globally, results showed a significant interaction effect between the interviewing method and measurement times of the symptoms. Participants reported significantly more symptoms with the suggested method compared to the spontaneous method for each measurement time. On the other hand, they reported significantly fewer symptoms from the first week to the third month of evaluation for either interviewing method. Moreover, the types of symptoms reported for both interviewing methods were different. Conclusion: The interviewing method used influences number and type of self-reported symptoms during the first 3 months post-mTBI.	[Villemure, R.; Nolin, P.] Univ Quebec Trois Rivieres, Dept Psychol, Ctr Etud Interdisciplinaires Dev Enfant Famille, Trois Rivieres, PQ G9A 5H7, Canada; [Le Sage, N.] Univ Quebec Trois Rivieres, Ctr Hosp Univ Affilie Quebec Traumatol & Med Urge, Trois Rivieres, PQ G9A 5H7, Canada	Villemure, R (corresponding author), Univ Quebec Trois Rivieres, Dept Psychol, Ctr Etud Interdisciplinaires Dev Enfant Famille, POB 500, Trois Rivieres, PQ G9A 5H7, Canada.	rene.villemure@uqtr.ca	Le Sage, Natalie/G-7063-2016	Le Sage, Natalie/0000-0003-4762-8156	Canadian Institutes of Health Research (CIHR)Canadian Institutes of Health Research (CIHR); Fonds de la recherche en sante du Quebec (FRSQ)Fonds de la Recherche en Sante du Quebec	The authors would like to point out the co-operation from each of the teams from the hospitals that participated in recruiting participants, and would like to especially thank Patricia Chabot and Valerie Murat at the Centre hospitalier universitaire affilie of Quebec for their remarkable work. This study was also made possible through the support of the Fonds de la recherche en sante du Quebec (FRSQ) and the Canadian Institutes of Health Research (CIHR).	ALEXANDER MP, 1995, NEUROLOGY, V45, P1253, DOI 10.1212/WNL.45.7.1253; Alves W., 1998, J HEAD TRAUMA REHAB, V8, P48, DOI DOI 10.1097/00001199-199309000-00007; Bazarian JJ, 1999, BRAIN INJURY, V13, P173, DOI 10.1080/026990599121692; Bazarian JJ, 2005, BRAIN INJURY, V19, P85, DOI 10.1080/02699050410001720158; Binder LM, 1997, J CLIN EXP NEUROPSYC, V19, P432, DOI 10.1080/01688639708403871; Binder LM, 1996, AM J PSYCHIAT, V153, P7; Boake C, 2005, NEUROSURGERY, V56, P994, DOI 10.1227/01.NEU.0000158319.38230.C3; Borg J, 2004, J REHABIL MED, V36, P76, DOI 10.1080/16501960410023840; Bryant RA, 1999, J NERV MENT DIS, V187, P302, DOI 10.1097/00005053-199905000-00006; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Drake AI, 2000, J HEAD TRAUMA REHAB, V15, P1103, DOI 10.1097/00001199-200010000-00004; FENTON G, 1993, BRIT J PSYCHIAT, V162, P493, DOI 10.1192/bjp.162.4.493; Gasquoine P G, 2000, Appl Neuropsychol, V7, P83, DOI 10.1207/S15324826AN0702_3; Gasquoine PG, 1997, NEUROPSYCHOL REV, V7, P77, DOI 10.1023/B:NERV.0000005945.58251.c0; Gennarelli T. A., 1998, SEM CLIN NEUR, V3, P160; Giza CC, 2001, J ATHL TRAINING, V36, P228; Gouvier W D, 1988, Arch Clin Neuropsychol, V3, P273, DOI 10.1016/0887-6177(88)90019-4; Gunstad J, 2002, J INT NEUROPSYCH SOC, V8, P37, DOI 10.1017/S1355617701020045; Gunstad J, 2001, J INT NEUROPSYCH SOC, V7, P323, DOI 10.1017/S1355617701733061; Hahn RA, 1997, PREV MED, V26, P607, DOI 10.1006/pmed.1996.0124; Holm L, 2005, J REHABIL MED, V37, P137, DOI 10.1080/16501970510027321; Iverson GL, 2005, CURR OPIN PSYCHIATR, V18, P301, DOI 10.1097/01.yco.0000165601.29047.ae; Iverson GL, 2003, APPL NEUROPSYCHOL, V10, P137, DOI 10.1207/S15324826AN1003_02; Iverson GL, 1997, BRAIN INJURY, V11, P783, DOI 10.1080/026990597122990; Iverson GL, 2000, ARCH CLIN NEUROPSYCH, V15, P643, DOI 10.1016/S0887-6177(99)00048-7; Iverson GL, 2006, BRAIN INJURY MED PRI, P373; Iverson GL, 2006, ARCH CLIN NEUROPSYCH, V21, P303, DOI 10.1016/j.acn.2005.12.008; Kashluba S, 2008, CLIN NEUROPSYCHOL, V22, P195, DOI 10.1080/13854040701263655; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Kay T., 1992, NEUROPSYCHOLOGY, V6, P371, DOI DOI 10.1037/0894-4105.6.4.371; Keenan HT, 2006, DEV NEUROSCI-BASEL, V28, P256, DOI 10.1159/000094152; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; KIRSCH I, 1999, EXPECTANCIES SHAPE E; Langlois Jean A, 2003, MMWR Surveill Summ, V52, P1; Lannsjo M, 2009, BRAIN INJURY, V23, P213, DOI 10.1080/02699050902748356; LEESHALEY PR, 1993, ARCH CLIN NEUROPSYCH, V8, P203, DOI 10.1016/0887-6177(93)90036-Z; LEVIN HS, 1992, J NEUROL NEUROSUR PS, V55, P255, DOI 10.1136/jnnp.55.4.255; LISHMAN WA, 1988, BRIT J PSYCHIAT, V153, P460, DOI 10.1192/bjp.153.4.460; Lundin A, 2006, BRAIN INJURY, V20, P799, DOI 10.1080/02699050600744327; Mackenzie JA, 2005, BRIT J CLIN PSYCHOL, V44, P417, DOI 10.1348/014466505X35696; MARCOTTE AC, 2005, ORIENTATIONS MINISTE; McAllister TW, 2001, J CLIN EXP NEUROPSYC, V23, P775, DOI 10.1076/jcen.23.6.775.1026; McCrea M, 2002, NEUROSURGERY, V50, P1032, DOI 10.1097/00006123-200205000-00017; MCCREA MA, 2008, MILD TRAUM BRAIN INJ; Mittenberg W, 2000, J HEAD TRAUMA REHAB, V15, P783, DOI 10.1097/00001199-200004000-00003; MITTENBERG W, 1992, J NEUROL NEUROSUR PS, V55, P200, DOI 10.1136/jnnp.55.3.200; Mooney G, 2005, BRAIN INJURY, V19, P975, DOI 10.1080/02699050500110264; Moore EL, 2006, BRAIN INJURY, V20, P117, DOI 10.1080/02699050500443558; Mulhern S, 2006, J PSYCHOSOM RES, V61, P439, DOI 10.1016/j.jpsychores.2006.03.004; National Center for Injury Prevention and Control, 2003, REP C MILD TRAUM BRA; Nicholson K, 2000, NEUROREHABILITATION, V14, P95; Nolin P, 2006, BRAIN INJURY, V20, P1147, DOI 10.1080/02699050601049247; Ommaya AK, 2002, BRIT J NEUROSURG, V16, P220, DOI 10.1080/02688690220148824; OMMAYA AK, 1974, BRAIN, V97, P633, DOI 10.1093/brain/97.1.633; Paniak C, 2000, J MUSCULOSKELET PAIN, V8, P193, DOI 10.1300/J094v08n01_16; Paniak C, 2002, J CLIN EXP NEUROPSYC, V24, P187, DOI 10.1076/jcen.24.2.187.999; Ponsford J, 2000, J INT NEUROPSYCH SOC, V6, P568, DOI 10.1017/S1355617700655066; Ruff R, 2005, J HEAD TRAUMA REHAB, V20, P5, DOI 10.1097/00001199-200501000-00003; Ruff RM, 1996, BRAIN INJURY, V10, P551, DOI 10.1080/026990596124124; Smith-Seemiller L, 2003, BRAIN INJURY, V17, P199, DOI 10.1080/0269905021000030823; Thompson HJ, 2006, J AM GERIATR SOC, V54, P1590, DOI 10.1111/j.1532-5415.2006.00894.x; Thurman DJ, 2001, HEAD TRAUMA, P327; van der Naalt J, 1999, J NEUROL NEUROSUR PS, V66, P207, DOI 10.1136/jnnp.66.2.207; von Holst H, 2004, J REHABIL MED, V36, P8, DOI 10.1080/16501960410023633; WONG JL, 1994, ARCH CLIN NEUROPSYCH, V9, P411, DOI 10.1016/0887-6177(94)90004-3; Wood RL, 2004, BRAIN INJURY, V18, P1135, DOI 10.1080/02699050410001675906	68	22	22	0	8	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	JAN	2011	25	1					53	64		10.3109/02699052.2010.531881			12	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	731JI	WOS:000288101700007	21117920				2021-06-18	
J	Lane-Brown, A; Tate, R				Lane-Brown, Amanda; Tate, Robyn			Evaluation of an Intervention for Apathy After Traumatic Brain Injury: A Multiple-Baseline, Single-Case Experimental Design	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						acquired brain injury; apathy; diminished motivation; drive; goals; intervention; rehabilitation; single-case experimental design; traumatic brain injury; treatment	STRESS SCALES DASS; SELF-AWARENESS; PSYCHOMETRIC PROPERTIES; RELIABILITY; DEFICITS; FATIGUE; SYSTEMS; ADULTS	Background: Apathy is diminished initiation, sustained activity, and concern about goal-directed behaviors. It occurs in between 46% and 71% of adults with traumatic brain injury and has widespread effects. Despite this, evidence for treatment of apathy is sparse, with no evidence for treatments aimed at sustaining activity toward goal-directed behavior. Method: A multiple-baseline, single-case experimental design evaluated a novel treatment for apathy in a 32-year-old man with traumatic brain injury. This treatment incorporated motivational interviewing and external compensation to increase sustained activity toward cumulative goals. Results: A specific treatment effect was demonstrated. Reliable Change Indices indicated a significant decrease in apathy that was maintained at 1-month follow-up. Conclusion: Treatment had a strong and specific effect on treated goal-directed activity and decreased apathy. The success of treatment was dependent on initiation as well as sustaining goal-directed activity.	Univ Sydney, Rehabil Studies Unit, Sydney, NSW 2006, Australia; Royal Rehabil Ctr, Sydney, NSW, Australia	Lane-Brown, A (corresponding author), Univ Sydney, Rehabil Studies Unit, POB 6, Ryde, NSW 1680, Australia.	amandal@med.usyd.edu.au			Rehabilitation Studies Unit; Northern Medical Research Foundation; Northern Clinical School, University of SydneyUniversity of Sydney; Australian GovernmentAustralian GovernmentCGIAR	This study was supported by the University of Sydney and funding has been provided by the Rehabilitation Studies Unit, the Northern Medical Research Foundation and the Northern Clinical School, University of Sydney, and the Australian Government through an Australian Postgraduate Award. The authors thank Michael Perdices for advice on statistical analysis.	Beeson PM, 2006, NEUROPSYCHOL REV, V16, P161, DOI 10.1007/s11065-006-9013-7; Bogod NM, 2003, J INT NEUROPSYCH SOC, V9, P450, DOI 10.1017/S1355617703930104; Bombardier CH, 1999, REHABIL PSYCHOL, V44, P52, DOI 10.1037/0090-5550.44.1.52; Borgaro SR, 2004, BRAIN INJURY, V18, P685, DOI 10.1080/02699050310001646080; Borgaro SR, 2005, J HEAD TRAUMA REHAB, V20, P416, DOI 10.1097/00001199-200509000-00003; Box G. E. P, 1970, TIME SERIES ANAL FOR; Brodie DA, 2005, J ADV NURS, V50, P518, DOI 10.1111/j.1365-2648.2005.03422.x; Brown TA, 1997, BEHAV RES THER, V35, P79, DOI 10.1016/S0005-7967(96)00068-X; BURKE W H, 1991, Brain Injury, V5, P241, DOI 10.3109/02699059109008095; Crawford JR, 1997, CLIN NEUROPSYCHOL, V11, P192, DOI 10.1080/13854049708407050; Crawford JR, 2003, BRIT J CLIN PSYCHOL, V42, P111, DOI 10.1348/014466503321903544; CREPEAU F, 1993, NEUROPSYCHOL REHABIL, V3, P5; CUMMINGS JL, 1994, NEUROLOGY, V44, P2308, DOI 10.1212/WNL.44.12.2308; DiIorio C, 2008, AIDS CARE, V20, P273, DOI 10.1080/09540120701593489; Drummond AER, 1994, BR J OCCUP THER, V57, P414, DOI DOI 10.1177/030802269405701102; Dunn C, 2001, ADDICTION, V96, P1725, DOI 10.1046/j.1360-0443.2001.961217253.x; Evans JJ, 1998, J INT NEUROPSYCH SOC, V4, P399, DOI 10.1017/S1355617798003993; Fleming JM, 1996, BRAIN INJURY, V10, P1; Gauggel S., 2004, HDB MOTIVATIONAL COU, P439; GIACINO JT, 1995, ARCH PHYS MED REHAB, V76, P205; GRAY JM, 1994, CLIN REHABIL, V8, P188, DOI DOI 10.1080/09602010902949207; Hersh N A, 1994, NeuroRehabilitation, V4, P187, DOI 10.3233/NRE-1994-4309; JACOBSON NS, 1991, J CONSULT CLIN PSYCH, V59, P12, DOI 10.1037/0022-006X.59.1.12; JACOBSON NS, 1984, BEHAV THER, V15, P336, DOI 10.1016/S0005-7894(84)80002-7; Kant R, 1998, BRAIN INJURY, V12, P87, DOI 10.1080/026990598122908; Lane-Brown AT, 2009, NEUROPSYCHOL REHABIL, V19, P481, DOI 10.1080/09602010902949207; Lane-Brown AT, 2009, BRAIN INJURY, V23, P999, DOI 10.3109/02699050903379347; Lane-Brown A, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006341.pub2; Locke EA, 1996, APPL PREV PSYCHOL, V5, P117, DOI 10.1016/S0962-1849(96)80005-9; Lovibond S.H., 1995, MANUAL DEPRESSION AN; Malec JF, 2004, ARCH PHYS MED REHAB, V85, P1989, DOI 10.1016/j.apmr.2004.01.032; Malec JF, 1997, J HEAD TRAUMA REHAB, V12, P1, DOI 10.1097/00001199-199706000-00002; MALEC JF, 2003, MANUAL MAYO PORLAND; Malloy PF, 2001, FRONTAL SYSTEMS BEHA; Marin RS, 1997, PSYCHIAT ANN, V27, P30, DOI 10.3928/0048-5713-19970101-08; MARIN RS, 1991, PSYCHIAT RES, V38, P143, DOI 10.1016/0165-1781(91)90040-V; Marin RS, 2005, J HEAD TRAUMA REHAB, V20, pCP1; MARIN RS, 1991, J NEUROPSYCH CLIN N, V3, P243; Marsh NV, 1998, BRAIN INJURY, V12, P1045, DOI 10.1080/026990598121954; Mazaux JM, 1997, ARCH PHYS MED REHAB, V78, P1316, DOI 10.1016/S0003-9993(97)90303-8; Miller W. R., 1995, MOTIVATIONAL ENHANCE; Norton LE, 2001, AM J GERIAT PSYCHIAT, V9, P41; Perdices M, 2005, BRAIN IMPAIR, V6, DOI [10.1375/brim.2005.6.3.219, DOI 10.1375/brim.2005.6.3.219]; Perdices M, 2009, NEUROPSYCHOL REHABIL, V19, P904, DOI 10.1080/09602010903040691; Rey A, 1964, LEXAMEN CLIN PSYCHOL; Rollnick S., 1995, BEHAV COGN PSYCHOTH, V23, P325, DOI [10.1017/S135246580001643X., https://doi.org/10.1017/S135246580001643X, DOI 10.1017/S135246580001643X]; Rubak S, 2005, BRIT J GEN PRACT, V55, P305; Simmond M, 2003, BRAIN INJURY, V17, P325, DOI 10.1080/0269905021000013219; SMITH RB, 1994, BRAIN INJURY, V8, P357, DOI 10.3109/02699059409150986; SOHLBERG MM, 1988, COGNITIVE REHABILITA, V6, P36; Tabachnick BG, 2007, USING MULTIVARIATE S; Thurstone L.L., 1962, PRIMARY MENTAL ABILI; TRYON WW, 1982, J APPL BEHAV ANAL, V15, P423, DOI 10.1901/jaba.1982.15-423; van Reekum R, 2005, J NEUROPSYCH CLIN N, V17, P7, DOI 10.1176/appi.neuropsych.17.1.7; Wechsler D., 2011, WECHLSER ABBREVIATED; Wechsler D, 1997, WAIS 3 ADM SCORING M; *WHO, 1975, WHO SCI GROUP GUID E; Wilson BA, 1996, BEHAV ASSESSMENT DYS	58	22	22	0	21	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	NOV-DEC	2010	25	6					459	469		10.1097/HTR.0b013e3181d98e1d			11	Clinical Neurology; Rehabilitation	Neurosciences & Neurology; Rehabilitation	679HA	WOS:000284151300008	20414129				2021-06-18	
J	Gosselin, N; Saluja, RS; Chen, JK; Bottari, C; Johnston, K; Ptito, A				Gosselin, Nadia; Saluja, Rajeet Singh; Chen, Jen-Kai; Bottari, Carolina; Johnston, Karen; Ptito, Alain			Brain Functions After Sports-Related Concussion: Insights From Event-Related Potentials and Functional MRI	PHYSICIAN AND SPORTSMEDICINE			English	Article						concussion; sports; athletes; event-related potentials; functional magnetic resonance imaging; mild traumatic brain injury	PROFESSIONAL FOOTBALL PLAYERS; MENS ICE HOCKEY; MAGNETIC-RESONANCE; HEAD-INJURY; HIGH-SCHOOL; WORKING-MEMORY; INTERNATIONAL-CONFERENCE; POSTCONCUSSION SYNDROME; COGNITIVE IMPAIRMENT; RECURRENT CONCUSSION	The high incidence of concussions in contact sports and their impact on brain functions are a major cause for concern. To improve our understanding of brain functioning aft er sports-related concussion, advanced functional assessment techniques, namely event-related potentials (ERPs) and functional magnetic resonance imaging (fMRI), have been recently used in research studies. Contrary to neuropsychological tests that measure verbal and/or motor responses, ERPs and fMRI assess the neural activities associated with cognitive/behavioral demands, and thus provide access to better comprehension of brain functioning. In fact, ERPs have excellent temporal resolution, and fMRI identifies the involved structures during a task. This article describes ERP and fMRI techniques and reviews the results obtained with these tools in sports-related concussion. Although these techniques are not yet readily available, they off er a unique clinical approach, particularly for complex cases (ie, athletes with multiple concussions, chronic symptoms) and objective measures that provide valuable information to guide management and return-to-play decision making.	[Ptito, Alain] McGill Univ, Ctr Hlth, Dept Psychol, Montreal, PQ H3A 1A1, Canada; [Gosselin, Nadia; Saluja, Rajeet Singh; Chen, Jen-Kai; Bottari, Carolina; Ptito, Alain] McGill Univ, Montreal Neurol Inst, Cognit Neurosci Unit, Montreal, PQ, Canada; [Gosselin, Nadia; Saluja, Rajeet Singh; Chen, Jen-Kai; Bottari, Carolina; Ptito, Alain] McGill Univ, Dept Neurol & Neurosurg, Montreal, PQ H3A 1A1, Canada; [Bottari, Carolina] McGill Univ, Sch Rehabil, Montreal, PQ H3A 1A1, Canada; [Johnston, Karen] Toronto Rehabil Inst, Sport Concuss Clin, Toronto, ON, Canada; [Johnston, Karen] Univ Toronto, Dept Neurosurg, Toronto, ON, Canada	Ptito, A (corresponding author), McGill Univ, Ctr Hlth, Dept Psychol, 1025 Pine Ave W, Montreal, PQ H3A 1A1, Canada.	alain.ptito@mcgill.ca					Agel J, 2007, J ATHL TRAINING, V42, P241; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Bailes JE, 2001, NEUROSURGERY, V48, P26, DOI 10.1097/00006123-200101000-00005; Bargallo N, 2008, EUR J RADIOL, V67, P401, DOI 10.1016/j.ejrad.2008.02.043; Beck A. T., 1996, BECK DEPRESSION INVE, VII; Benke T, 2006, EPILEPSIA, V47, P1308, DOI 10.1111/j.1528-1167.2006.00549.x; Bleiberg J, 2004, NEUROSURGERY, V54, P1073, DOI 10.1227/01.NEU.0000118820.33396.6A; Boutin D, 2008, NEUROCASE, V14, P239, DOI 10.1080/13554790802247543; Broglio SP, 2009, J NEUROTRAUM, V26, P1463, DOI [10.1089/neu.2008.0766, 10.1089/neu.2008-0766]; Cantu RC, 1998, CLIN SPORT MED, V17, P37, DOI 10.1016/S0278-5919(05)70059-4; Cantu RC, 1998, CLIN SPORT MED, V17, P45, DOI 10.1016/S0278-5919(05)70060-0; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; CHEN J, 2009, BR J SPORTS MED S1, V43, P104; Chen JK, 2008, CLIN J SPORT MED, V18, P241, DOI 10.1097/JSM.0b013e318170b59d; Chen JK, 2008, ARCH GEN PSYCHIAT, V65, P81, DOI 10.1001/archgenpsychiatry.2007.8; Chen JK, 2007, J NEUROL NEUROSUR PS, V78, P1231, DOI 10.1136/jnnp.2006.110395; Chen JK, 2004, NEUROIMAGE, V22, P68, DOI 10.1016/j.neuroimage.2003.12.032; Collins MW, 2002, NEUROSURGERY, V51, P1175, DOI 10.1097/00006123-200211000-00011; De Beaumont L, 2007, NEUROSURGERY, V61, P329, DOI 10.1227/01.NEU.0000280000.03578.B6; De Beaumont L, 2009, BRAIN, V132, P695, DOI 10.1093/brain/awn347; Delaney TS, 2002, CLIN J SPORT MED, V12, P331, DOI 10.1097/00042752-200211000-00003; Dickerson BC, 2007, NEUROTHERAPEUTICS, V4, P360, DOI 10.1016/j.nurt.2007.05.007; Dupuis F, 2000, NEUROREPORT, V11, P4087, DOI 10.1097/00001756-200012180-00035; Echemendia RJ, 2003, APPL NEUROPSYCHOL, V10, P48, DOI 10.1207/S15324826AN1001_7; Ellemberg D, 2009, J NEUROTRAUM, V26, P2365, DOI 10.1089/neu.2009.0906; Emery CA, 2006, CLIN J SPORT MED, V16, P20, DOI 10.1097/01.jsm.0000184638.72075.b7; Flik K, 2005, AM J SPORT MED, V33, P183, DOI 10.1177/0363546504267349; Folstein JR, 2008, PSYCHOPHYSIOLOGY, V45, P152, DOI 10.1111/j.1469-8986.2007.00602.x; Gaetz M, 2000, BRAIN INJURY, V14, P1077; Gessel LM, 2007, J ATHL TRAINING, V42, P495; GOSSELIN N, 2010, BRAIN INJURY, V24, P221; GOSSELIN N, 2010, J COGNITIVE NEUROS S, P168; Gosselin N, 2006, CLIN NEUROPHYSIOL, V117, P2228, DOI 10.1016/j.clinph.2006.07.130; Gosselin N, 2006, NEUROSURGERY, V58, P1151, DOI 10.1227/01.NEU.0000215953.44097.FA; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Hoge RD, 2001, J CHEM NEUROANAT, V22, P43, DOI 10.1016/S0891-0618(01)00114-4; Iverson GL, 2006, BRIT J SPORT MED, V40, P72, DOI 10.1136/bjsm.2005.020651; Jantzen KJ, 2004, AM J NEURORADIOL, V25, P738; Johnston Karen M, 2004, Curr Sports Med Rep, V3, P316; Jolicoeur P, 2006, PSYCHOL RES-PSYCH FO, V70, P414, DOI 10.1007/s00426-005-0008-4; Jotwani V, 2010, CURR SPORT MED REP, V9, P21, DOI 10.1249/JSR.0b013e3181ccb55e; Koh JO, 2003, BRAIN INJURY, V17, P901, DOI 10.1080/0269905031000088869; KRAMER AF, 1988, BIOL PSYCHOL, V26, P231, DOI 10.1016/0301-0511(88)90022-1; KUTAS M, 1977, SCIENCE, V197, P792, DOI 10.1126/science.887923; Larsen S, 2007, INT J MED ROBOT COMP, V3, P262, DOI 10.1002/rcs.149; Lavoie ME, 2004, J CLIN EXP NEUROPSYC, V26, P55, DOI 10.1076/jcen.26.1.55.23936; Lovell MR, 2007, NEUROSURGERY, V61, P352, DOI 10.1227/01.NEU.0000279985.94168.7F; Lovell MR, 2006, APPL NEUROPSYCHOL, V13, P166, DOI 10.1207/s15324826an1303_4; MacQueen GM, 2009, J PSYCHIATR NEUROSCI, V34, P343; Mayer AR, 2009, HUM BRAIN MAPP, V30, P4152, DOI 10.1002/hbm.20836; McAllister TW, 2001, NEUROIMAGE, V14, P1004, DOI 10.1006/nimg.2001.0899; McAllister TW, 1999, NEUROLOGY, V53, P1300, DOI 10.1212/WNL.53.6.1300; MCCARTHY G, 1981, SCIENCE, V211, P77, DOI 10.1126/science.7444452; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McCrory P, 2005, BRIT J SPORT MED, V39, pI78, DOI 10.1136/bjsm.2005.018614; McCrory P, 2009, BRIT J SPORT MED, V43, pI76, DOI 10.1136/bjsm.2009.058248; PICTON TW, 1992, J CLIN NEUROPHYSIOL, V9, P456, DOI 10.1097/00004691-199210000-00002; POLICH J, 1986, ELECTROEN CLIN NEURO, V63, P251, DOI 10.1016/0013-4694(86)90093-3; SAUNDERS RL, 1984, JAMA-J AM MED ASSOC, V252, P538, DOI 10.1001/jama.252.4.538; Schulz MR, 2004, AM J EPIDEMIOL, V160, P937, DOI 10.1093/aje/kwh304; Slobounov SM, 2010, EXP BRAIN RES, V202, P341, DOI 10.1007/s00221-009-2141-6; Smits M, 2009, HUM BRAIN MAPP, V30, P2789, DOI 10.1002/hbm.20709; SQIRES KC, 1977, ELECTROEN CLIN NEURO, V42, P1; STULEMEIJER M, J NEUROTRAUMA; TEASDALE G, 1974, LANCET, V2, P81; THERIAULT M, J CLIN EXP NEUROPSYC; Theriault M, 2009, BRAIN INJURY, V23, P899, DOI 10.1080/02699050903283189; Vagnozzi R, 2008, NEUROSURGERY, V62, P1286, DOI 10.1227/01.neu.0000333300.34189.74; WICKENS C, 1983, SCIENCE, V221, P1080, DOI 10.1126/science.6879207; Zemper ED, 2003, AM J PHYS MED REHAB, V82, P653, DOI 10.1097/01.PHM.0000083666.74494.BA	71	22	22	1	29	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0091-3847	2326-3660		PHYSICIAN SPORTSMED	Physician Sportsmed.	OCT	2010	38	3					27	37		10.3810/psm.2010.10.1805			11	Primary Health Care; Orthopedics; Sport Sciences	General & Internal Medicine; Orthopedics; Sport Sciences	764LI	WOS:000290630600012	20959693				2021-06-18	
J	Spinos, P; Sakellaropoulos, G; Georgiopoulos, M; Stavridi, K; Apostolopoulou, K; Ellul, J; Constantoyannis, C				Spinos, Panagiotis; Sakellaropoulos, George; Georgiopoulos, Miltiadis; Stavridi, Kleio; Apostolopoulou, Katerina; Ellul, John; Constantoyannis, Constantine			Postconcussion Syndrome After Mild Traumatic Brain Injury in Western Greece	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article						Head injury; Trauma; Mild head injury; Concussion; MTBI; Rehabilitation; Headache	MINOR HEAD-INJURY; SYMPTOM EXPECTATION; CONCUSSION; CRITERIA; RECOVERY; DISORDER; CANADA; RETURN; WORK	Background: The prevalence of postconcussion syndrome (PCS) in the first weeks after mild traumatic brain injury varies from 40% to 80%. However, as many as 50% of patients report symptoms for up to 3 months and 10% to 15% for more than a year. The objective of this study is to analyze the characteristics and estimate the prevalence of PCS in an adult Greek population. Methods: This prospective study was performed in the University Hospital of Patras in Western Greece. Patients with mild traumatic brain injury (n = 539) were randomly recruited on admission between May 2006 and May 2008. Overall, 223 patients (223 of 539, 41.5%) met the Colorado Medical Society guidelines for concussion; 141 men (63%) and 82 women (37%) with a median age of 30 years (range, 18.5-57.5 years) were included in the study. Patient follow-up consisted of telephone interviews at 1 month, 3 months, and 6 months postinjury, when they were asked about experiencing common postconcussion symptoms (International Classification of Diseases-10th revision criteria). Results: The rate of PCS at 1 month, 3 months, and 6 months postinjury was estimated to be 10.3%, 6%, and 0.9%, respectively. The syndrome was more frequent among women (17%) and individuals with bleeding diathesis (26%) compared with men (6.4%) and patients without clotting disorders (8.5%), respectively. In addition, higher rates of PCS affected patients who sustained assaults compared with other types of accidents. Conclusions: The prevalence of PCS was remarkably higher in previous studies. Cultural differences regarding symptom expectation and the lack of compensation might explain the low rate of chronic symptoms in Greeks.	[Spinos, Panagiotis; Georgiopoulos, Miltiadis; Stavridi, Kleio; Apostolopoulou, Katerina; Constantoyannis, Constantine] Patras Med Sch, Dept Neurosurg, Patras 26500, Greece; [Sakellaropoulos, George] Patras Med Sch, Dept Med Phys, Patras 26500, Greece; [Ellul, John] Patras Med Sch, Dept Neurol, Patras 26500, Greece	Constantoyannis, C (corresponding author), Patras Med Sch, Dept Neurosurg, Patras 26500, Greece.	cconst@med.upatras.gr	Georgiopoulos, Miltiadis/AAF-9126-2020; Sakellaropoulos, George/E-4756-2011	Georgiopoulos, Miltiadis/0000-0001-8656-1412; Sakellaropoulos, George/0000-0001-6275-0841; Constantoyannis, Constantine/0000-0003-3030-8439			Alves W., 1992, PHYS MED REHABILITAT, V6, P21; *AM AC NEUR QUAL S, 1997, PRACT PAR MAN CONC S; American Psychiatric Association, 1994, DIAGN STAT MAN MENT; ANNEGERS JF, 1980, NEUROLOGY, V30, P683, DOI 10.1212/WNL.30.7.683; BARTH JT, 1989, MILD HEAD INJURY, P142; Bazarian JJ, 2006, ACAD EMERG MED, V13, P199, DOI 10.1197/j.aem.2005.07.031; Binder LM, 1997, J CLIN EXP NEUROPSYC, V19, P432, DOI 10.1080/01688639708403871; Binder LM, 1997, J CLIN EXP NEUROPSYC, V19, P421, DOI 10.1080/01688639708403870; Binder LM, 1996, AM J PSYCHIAT, V153, P7; BLACK P, 1969, LATE EFFECTS HEAD IN, P142; Boake C, 2005, J NEUROPSYCH CLIN N, V17, P350, DOI 10.1176/appi.neuropsych.17.3.350; Boake C, 2004, J NEUROPSYCH CLIN N, V16, P493, DOI 10.1176/appi.neuropsych.16.4.493; CANTU RC, 1986, PHYSICIAN SPORTSMED, V14, P75, DOI 10.1080/00913847.1986.11709197; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; CASEY R, 1986, PEDIATRICS, V78, P497; *COL MED SOC SPORT, 1991, GUID MAN CONC SPORTS; Cook J. B, 1969, LATE EFFECTS HEAD IN, P408; Corrigan John D., 2003, American Journal of Obstetrics and Gynecology, V188, pS71, DOI 10.1067/mob.2003.404; DIKMEN SS, 1994, ARCH NEUROL-CHICAGO, V51, P177, DOI 10.1001/archneur.1994.00540140087018; ENGLANDER J, 1992, Brain Injury, V6, P161, DOI 10.3109/02699059209029654; Evans RW, 1999, TXB CLIN NEUROLOGY, P1039; Ferrari R, 2001, CLIN NEUROL NEUROSUR, V103, P254, DOI 10.1016/S0303-8467(01)00161-5; Ferrari R, 2001, CLIN NEUROL NEUROSUR, V103, P184, DOI 10.1016/S0303-8467(01)00143-3; GOUVIER WD, 1992, ARCH CLIN NEUROPSYCH, V7, P193, DOI 10.1016/0887-6177(92)90162-G; GREENBERG SM, 2001, HDB NEUROSURGERY, P627; Ingebrigtsen T, 1998, J NEUROL, V245, P609, DOI 10.1007/s004150050254; Iverson GL, 2003, APPL NEUROPSYCHOL, V10, P137, DOI 10.1207/S15324826AN1003_02; King NS, 1997, J NEUROL NEUROSUR PS, V62, P38, DOI 10.1136/jnnp.62.1.38; KRAUS JF, 1989, MILD HEAD INJURY, P8; McCauley SR, 2005, J NERV MENT DIS, V193, P540, DOI 10.1097/01.nmd.0000172592.05801.71; McCauley SR, 2001, J CLIN EXP NEUROPSYC, V23, P792, DOI 10.1076/jcen.23.6.792.1016; McCrea M, 2009, CLIN NEUROPSYCHOL, V23, P1368, DOI 10.1080/13854040903074652; Mickeviciene D, 2002, EUR J NEUROL, V9, P581, DOI 10.1046/j.1468-1331.2002.00497.x; Mittenberg W, 2000, J HEAD TRAUMA REHAB, V15, P783, DOI 10.1097/00001199-200004000-00003; MITTENBERG W, 1992, J NEUROL NEUROSUR PS, V55, P200, DOI 10.1136/jnnp.55.3.200; NARAYAN RK, 2005, PRINCIPLES NEUROSURG, P302; National Center for Injury Prevention and Control, 2003, REP C MILD TRAUM BRA; Paniak C, 2002, J CLIN EXP NEUROPSYC, V24, P187, DOI 10.1076/jcen.24.2.187.999; Rao V, 2002, PSYCHIAT CLIN N AM, V25, P43, DOI 10.1016/S0193-953X(03)00052-2; RIMEL RW, 1981, NEUROSURGERY, V9, P221, DOI 10.1227/00006123-198109000-00001; Ruffolo CF, 1999, ARCH PHYS MED REHAB, V80, P392, DOI 10.1016/S0003-9993(99)90275-7; Schutze M, 2008, Versicherungsmedizin, V60, P78; Solomon S, 2001, MED CLIN N AM, V85, P987, DOI 10.1016/S0025-7125(05)70355-2; Stiell IG, 2001, LANCET, V357, P1391, DOI 10.1016/S0140-6736(00)04561-X; TEASDALE G, 1974, LANCET, V2, P81; World Health Organisation, 1993, ICD 10 CLASSIFICATIO; World Health Organization, 1992, ICD 10 CLASS MENT BE; WRIGHTSON P, 1981, INJURY, V12, P445, DOI 10.1016/0020-1383(81)90161-3	48	22	24	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0022-5282	1529-8809		J TRAUMA	J. Trauma-Injury Infect. Crit. Care	OCT	2010	69	4					789	793		10.1097/TA.0b013e3181edea67			5	Critical Care Medicine; Surgery	General & Internal Medicine; Surgery	664KP	WOS:000282959100024	20938266				2021-06-18	
J	Feng, JF; Zhang, KM; Jiang, JY; Gao, GY; Fu, XA; Liang, YM				Feng, Jun-feng; Zhang, Kui-ming; Jiang, Ji-yao; Gao, Guo-yi; Fu, Xi'an; Liang, Yu-min			Effect of Therapeutic Mild Hypothermia on the Genomics of the Hippocampus After Moderate Traumatic Brain Injury in Rats	NEUROSURGERY			English	Article						Genomics; Hippocampus; Mild hypothermia; Real-time quantitative RT-PCR; Traumatic brain injury	DIFFERENTIAL GENE-EXPRESSION; TISSUE-TYPE TRANSGLUTAMINASE; COPY NUMBER VARIATION; RIM-BINDING PROTEINS; IMMEDIATE-EARLY GENE; NERVE GROWTH-FACTOR; NEUROTROPHIC FACTOR; CEREBRAL-CORTEX; ALTERED EXPRESSION; CELL-ADHESION	BACKGROUND: Traumatic brain injury (TBI), a major cause of morbidity and mortality, is a serious public health concern. OBJECTIVE: To evaluate the effect of mild hypothermia on gene expression in the hippocampus and to try to elucidate molecular mechanisms of hypothermic neuroprotection after TBI. METHODS: Rats were subjected to mild hypothermia (group 1: n = 3, 33 degrees C, 3H) or normothermia (group 2: n = 3; 37 degrees C, 3H) after TBI. Six genome arrays were applied to detect the gene expression profiles of ipsilateral hippocampus. Functional clustering and gene ontology analysis were then carried out. Another 20 rats were randomly assigned to 4 groups (n = 5 per group): group 3, sham-normothermia; group 4, sham-hypothermia; group 5, TBI-normothermia; and group 6, TBI-hypothermia. Real-time fluorescent quantitative reverse-transcription polymerase chain reaction was used to detect specific selected genes. RESULTS: We found that 133 transcripts in the hypothermia group were statistically different from those in the normothermia group, including 57 transcripts that were upregulated and 76 that were downregulated after TBI (P < .01). Most of these genes were involved in various pathophysiological processes, and some were critical to cell survival. Analysis showed that 9 gene ontology categories were significantly affected by hypothermia, including the most affected categories: synapse organization and biogenesis (upregulated) and regulation of inflammatory response (downregulated). The mRNA expression of Ank3, Cmbp, Nrxn3, Tgm2, and Fcgr3 was regulated by hypothermia, TBI, or a combination of TBI and hypothermia compared with the sham-normothermia group. Their mRNA expression was significantly regulated by hypothermia in TBI groups. CONCLUSION: Posttraumatic mild hypothermia has a significant effect on the gene expression profiles of the hippocampus, especially those genes belonging to the 9 gene ontology categories. Differential expression of those genes may be involved in the most fundamental molecular mechanisms of cerebral protection by mild hypothermia after TBI.	[Feng, Jun-feng; Jiang, Ji-yao; Gao, Guo-yi; Liang, Yu-min] Shanghai Jiao Tong Univ, Sch Med, Dept Neurosurg, Renji Hosp, Shanghai 200127, Peoples R China; [Zhang, Kui-ming] Tongji Univ, Dept Neurosurg, Shanghai E Hosp, Shanghai 200092, Peoples R China; [Fu, Xi'an] Nanjin Med Univ, Suzhou Hosp, Dept Neurosurg, Suzhou, Peoples R China	Jiang, JY (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Dept Neurosurg, Renji Hosp, Shanghai 200127, Peoples R China.	jiangjyb@163.com			Chinese National Human Genome Center, Shanghai; National Key Basic Research ProjectNational Basic Research Program of China [2005CB522604]; National Science and Nature Grants [30571908, 30901543]; Science and Technology Committee of ShanghaiShanghai Science & Technology Committee [07JC14038]; Program for Shanghai Outstanding Medical Academic Leader; MOE, PRC	We thank Dr Bruce G. Lyeth, Department of Neurological Surgery, University of California Davis, for his editorial support and critical review of the article. We also thank Dr Xiong Hui Li Qi of the Chinese National Human Genome Center, Shanghai for their support in molecular experiments.; This work was supported by the National Key Basic Research Project (grant 2005CB522604), National Science and Nature Grants (grant 30571908, 30901543), Science and Technology Committee of Shanghai (grant 07JC14038), Program for Shanghai Outstanding Medical Academic Leader, and the Excellent Young Teachers Program of MOE, PRC. The authors have no personal financial or institutional interest in any of the drugs, materials, or devices described in this article.	Aibiki M, 1999, J NEUROTRAUM, V16, P225, DOI 10.1089/neu.1999.16.225; Aitman TJ, 2006, NATURE, V439, P851, DOI 10.1038/nature04489; Andringa G, 2004, FASEB J, V18, P932, DOI 10.1096/fj.03-0829fje; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Breunis WB, 2008, BLOOD, V111, P1029, DOI 10.1182/blood-2007-03-079913; Clifton GL, 2002, J NEUROTRAUM, V19, P293, DOI 10.1089/089771502753594864; CLIFTON GL, 1991, J CEREBR BLOOD F MET, V11, P114, DOI 10.1038/jcbfm.1991.13; Cohen R, 2003, J BIOL CHEM, V278, P9258, DOI 10.1074/jbc.M210270200; DIETRICH WD, 1994, ACTA NEUROPATHOL, V87, P250, DOI 10.1007/BF00296740; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; Fairchild KD, 2004, AM J PHYSIOL-CELL PH, V287, pC422, DOI 10.1152/ajpcell.00507.2003; Fairchild KD, 2000, J INTERF CYTOK RES, V20, P1049, DOI 10.1089/107999000750053708; Fanciulli M, 2007, NAT GENET, V39, P721, DOI 10.1038/ng2046; Gebicke-Haerter PJ, 2005, J NEUROSCI RES, V81, P327, DOI 10.1002/jnr.20479; Gomez-Pinilla F, 2008, EUR J NEUROSCI, V28, P2278, DOI 10.1111/j.1460-9568.2008.06524.x; GOSS JR, 1995, J NEUROTRAUM, V12, P159, DOI 10.1089/neu.1995.12.159; Henry RA, 2007, EUR J NEUROSCI, V25, P3513, DOI 10.1111/j.1460-9568.2007.05625.x; Hicks RR, 1997, MOL BRAIN RES, V48, P401, DOI 10.1016/S0169-328X(97)00158-7; Hu De-zhi, 2005, Chin J Traumatol, V8, P23; Huang TT, 2009, J NEUROTRAUM, V26, P1535, DOI [10.1089/neu.2008.0743, 10.1089/neu.2008-0743]; HUGHES P, 1993, NEUROSCIENCE, V57, P319, DOI 10.1016/0306-4522(93)90065-N; Ishikawa Y, 2006, ACTA NEUROCHIR SUPPL, V96, P163; Jia F, 2009, J NEUROTRAUM, V26, P243, DOI 10.1089/neu.2008.0670; Jiang JY, 2009, J NEUROTRAUM, V26, P399, DOI 10.1089/neu.2008.0525; Jiang JY, 2000, J NEUROSURG, V93, P546, DOI 10.3171/jns.2000.93.4.0546; JIANG JY, 1992, ACTA NEUROPATHOL, V84, P495, DOI 10.1007/BF00304468; Jiang JY, 2006, J CEREBR BLOOD F MET, V26, P771, DOI 10.1038/sj.jcbfm.9600253; Jin KL, 2001, ANN NEUROL, V50, P93, DOI 10.1002/ana.1073; Jones RA, 1997, J CELL SCI, V110, P2461; KAPFHAMER D, 1995, GENOMICS, V27, P189, DOI 10.1006/geno.1995.1023; Kattenstroth G, 2004, P NATL ACAD SCI USA, V101, P2607, DOI 10.1073/pnas.0308626100; Kizhatil K, 2004, J BIOL CHEM, V279, P16706, DOI 10.1074/jbc.M314296200; Ko J, 2003, J BIOL CHEM, V278, P42377, DOI 10.1074/jbc.M307561200; Ko JW, 2006, J NEUROSCI, V26, P963, DOI 10.1523/JNEUROSCI.4475-05.2006; Kobori N, 2002, MOL BRAIN RES, V104, P148, DOI 10.1016/S0169-328X(02)00331-5; Lee JM, 2004, J BIOL CHEM, V279, P53725, DOI 10.1074/jbc.M407627200; Li HH, 2004, J NEUROTRAUM, V21, P1141, DOI 10.1089/0897715041953777; Long Y, 2003, J NEUROSCI RES, V71, P710, DOI 10.1002/jnr.10524; Marion DW, 1997, NEW ENGL J MED, V336, P540, DOI 10.1056/NEJM199702203360803; Matsuo R, 2001, BIOCHEM BIOPH RES CO, V289, P479, DOI 10.1006/bbrc.2001.5975; Mishra S, 2006, J BIOL CHEM, V281, P5532, DOI 10.1074/jbc.M506864200; Missler M, 2003, NATURE, V423, P939, DOI 10.1038/nature01755; Muzha I, 2004, LANCET, V364, P1321, DOI 10.1016/s0140-6736(04)17188-2; Myburgh J, 2007, NEW ENGL J MED, V357, P874; Nam CI, 2005, P NATL ACAD SCI USA, V102, P6137, DOI 10.1073/pnas.0502038102; Narayan RK, 2002, J NEUROTRAUM, V19, P503, DOI 10.1089/089771502753754037; Norlund MA, 1999, BRAIN RES, V851, P154, DOI 10.1016/S0006-8993(99)02179-4; Ooshio T, 2004, J BIOL CHEM, V279, P31365, DOI 10.1074/jbc.M401957200; Peng XJ, 1999, FEBS LETT, V446, P35, DOI 10.1016/S0014-5793(99)00018-6; PETERS LL, 1995, J CELL BIOL, V130, P313, DOI 10.1083/jcb.130.2.313; Polderman KH, 2002, INTENS CARE MED, V28, P1563, DOI 10.1007/s00134-002-1511-3; Rall JM, 2003, NEUROPATH APPL NEURO, V29, P118, DOI 10.1046/j.1365-2990.2003.00439.x; Rao VLR, 2003, J NEUROSCI RES, V71, P208, DOI 10.1002/jnr.10486; Rowen L, 2002, GENOMICS, V79, P587, DOI 10.1006/geno.2002.6734; Smith SL, 1996, J NEUROTRAUM, V13, P1, DOI 10.1089/neu.1996.13.1; Sugita S, 1999, NEURON, V22, P489, DOI 10.1016/S0896-6273(00)80704-7; Temkin NR, 2007, LANCET NEUROL, V6, P29, DOI 10.1016/S1474-4422(06)70630-5; Thevananther S, 1998, J BIOL CHEM, V273, P23952, DOI 10.1074/jbc.273.37.23952; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Tolentino PJ, 2004, J NEUROCHEM, V89, P1301, DOI 10.1111/j.1471-4159.2004.02436.x; Tolentino PJ, 2002, J NEUROCHEM, V80, P579, DOI 10.1046/j.0022-3042.2001.00726.x; Truettner J, 1999, J NEUROTRAUM, V16, P471, DOI 10.1089/neu.1999.16.471; Truettner JS, 2005, MOL BRAIN RES, V138, P124, DOI 10.1016/j.molbrainres.2005.04.006; VEDELER CA, 1992, J NEUROSCI RES, V31, P654, DOI 10.1002/jnr.490310409; Vitarbo EA, 2004, NEUROSURGERY, V55, P416, DOI 10.1227/01.NEU.0000130036.52521.2C; von Gertten C, 2005, BMC NEUROSCI, V6, DOI 10.1186/1471-2202-6-69; Wagner KR, 2006, ACTA NEUROCHIR SUPPL, V96, P177; Wang Y, 2002, P NATL ACAD SCI USA, V99, P14464, DOI 10.1073/pnas.182532999; Wright GW, 2003, BIOINFORMATICS, V19, P2448, DOI 10.1093/bioinformatics/btg345; Yoshiya K, 2003, J NEUROTRAUM, V20, P1147, DOI 10.1089/089771503770802844; Zhu D, 2007, BIOCHEM BIOPH RES CO, V361, P922, DOI 10.1016/j.bbrc.2007.07.083	71	22	25	0	13	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0148-396X	1524-4040		NEUROSURGERY	Neurosurgery	SEP	2010	67	3					730	742		10.1227/01.NEU.0000378023.81727.6E			13	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	641TS	WOS:000281153200022	20651628				2021-06-18	
J	Bellander, BM; Lidman, O; Ohlsson, M; Meijer, B; Piehl, F; Svensson, M				Bellander, Bo-Michael; Lidman, Olle; Ohlsson, Marcus; Meijer, Britt; Piehl, Fredrik; Svensson, Mikael			Genetic regulation of microglia activation, complement expression, and neurodegeneration in a rat model of traumatic brain injury	EXPERIMENTAL BRAIN RESEARCH			English	Article						Traumatic brain injury; Inflammation; Complement; Neurodegeneration; Strain dependent; T cells; Polymorphonuclear cells	COLONY-STIMULATING FACTORS; TUMOR-NECROSIS-FACTOR; CLOSED-HEAD INJURY; SPINAL-CORD INJURY; MONOCLONAL-ANTIBODY; NERVOUS-SYSTEM; INFLAMMATORY RESPONSE; MOUSE STRAINS; AMINO-ACIDS; CELL-DEATH	Secondary brain damage following traumatic brain injury in part depends on neuroinflammation, a process where genetic factors may play an important role. We examined the response to a standardized cortical contusion in two different inbred rat strains, Dark Agouti (DA) and Piebald Virol Glaxo (PVG). Both are well characterized in models of autoimmune neuroinflammation, where DA is susceptible and PVG resistant. We found that infiltration of polymorphonuclear granulocytes (PMN) at 3-day postinjury was more pronounced in PVG. DA was more infiltrated by T cells at 3-day postinjury, showed an enhanced glial activation at 7-day postinjury and higher expression of C3 complement at 7-day postinjury. Neurodegeneration, assessed by Fluoro-Jade, was also more pronounced in the DA strain at 30-day postinjury. These results demonstrate differences in the response to cortical contusion injury attributable to genetic influences and suggest a link between injury-induced inflammation and neurodegeneration. Genetic factors that regulate inflammation elicited by brain trauma may be important for the development of secondary brain damage.	[Bellander, Bo-Michael; Ohlsson, Marcus; Meijer, Britt; Svensson, Mikael] Karolinska Univ, Neurosurg Sect, Dept Clin Neurosci, Hosp Solna, S-17176 Stockholm, Sweden; [Lidman, Olle; Piehl, Fredrik] Karolinska Univ, Sect Clin CNS Res, Dept Clin Neurosci, Hosp Solna, S-17176 Stockholm, Sweden	Bellander, BM (corresponding author), Karolinska Univ, Neurosurg Sect, Dept Clin Neurosci, Hosp Solna, R3-02, S-17176 Stockholm, Sweden.	bo-michael.bellander@karolinska.se	Piehl, Fredrik/E-3451-2013; Svensson, Mikael/F-8662-2012; Ohlsson, Marcus R/H-1395-2011	Svensson, Mikael/0000-0003-1179-7003; 	European UnionEuropean Commission; NeuroproMiSe [LSHM-CT-2005-018637]; EURATools [LSHG-CT-2005-019015]; Wadsworth Foundation; Torsten and Ragnar Soderberg's Foundation; Bjorklund's Foundation; Nils and Bibbi Jenssen's Foundation; Montel Williams Foundation, Magn	This work is supported by 6th Framework Program of the European Union; NeuroproMiSe, LSHM-CT-2005-018637 and the EURATools, LSHG-CT-2005-019015; as well as by grants from the Wadsworth Foundation, Torsten and Ragnar Soderberg's Foundation, Bjorklund's Foundation, Nils and Bibbi Jenssen's Foundation, Montel Williams Foundation, Magn.	BARCLAY AN, 1981, IMMUNOLOGY, V42, P593; Bellander BM, 1996, J NEUROSURG, V85, P468, DOI 10.3171/jns.1996.85.3.0468; Bellander BM, 2004, J NEUROTRAUM, V21, P605, DOI 10.1089/089771504774129937; Bellander BM, 2001, J NEUROTRAUM, V18, P1295, DOI 10.1089/08977150152725605; BOJE KM, 1992, BRAIN RES, V587, P250, DOI 10.1016/0006-8993(92)91004-X; BROWN EJ, 1991, CURR OPIN IMMUNOL, V3, P76, DOI 10.1016/0952-7915(91)90081-B; BRUCK W, 1991, J NEUROL SCI, V103, P182, DOI 10.1016/0022-510X(91)90162-Z; CAMPBELL AK, 1981, BIOCHEM J, V194, P551, DOI 10.1042/bj1940551; DALLMAN MJ, 1984, EUR J IMMUNOL, V14, P260, DOI 10.1002/eji.1830140311; DAMOISEAUX JGMC, 1994, IMMUNOLOGY, V83, P140; DEBRUIJN MHL, 1985, P NATL ACAD SCI USA, V82, P708; ESSER AF, 1991, IMMUNOL TODAY, V12, P316, DOI 10.1016/0167-5699(91)90006-F; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; FEENEY DM, 1981, BRAIN RES, V211, P67, DOI 10.1016/0006-8993(81)90067-6; Fox GB, 1999, J NEUROTRAUM, V16, P377, DOI 10.1089/neu.1999.16.377; FRANK MM, 1991, IMMUNOL TODAY, V12, P322, DOI 10.1016/0167-5699(91)90009-I; Friedman G, 1999, NEUROLOGY, V52, P244, DOI 10.1212/WNL.52.2.244; GIULIAN D, 1993, J NEUROSCI, V13, P29; GIULIAN D, 1988, J NEUROSCI, V8, P4707; HARLAN JM, 1985, BLOOD, V65, P513; HICKEY WF, 1991, J NEUROSCI RES, V28, P254, DOI 10.1002/jnr.490280213; HOLMIN S, 1995, ACTA NEUROCHIR, V132, P110, DOI 10.1007/BF01404857; IKEDA Y, 1990, NEUROSURGERY, V27, P1; Inman D, 2002, J COMP NEUROL, V451, P225, DOI 10.1002/cne.10340; KATAYAMA Y, 1995, BRAIN PATHOL, V5, P427, DOI 10.1111/j.1750-3639.1995.tb00621.x; KINOSHITA T, 1991, IMMUNOL TODAY, V12, P291, DOI 10.1016/0167-5699(91)90001-A; KOCHANEK PM, 1992, STROKE, V23, P1367, DOI 10.1161/01.STR.23.9.1367; KONTOS HA, 1986, J NEUROSURG, V64, P803, DOI 10.3171/jns.1986.64.5.0803; Koshinaga M, 2000, J NEUROTRAUM, V17, P185, DOI 10.1089/neu.2000.17.185; Leinhase I, 2006, EXP NEUROL, V199, P454, DOI 10.1016/j.expneurol.2006.01.033; Lidman O, 2003, J NEUROSCI, V23, P9817; Lidman O, 2002, NEUROREPORT, V13, P1589, DOI 10.1097/00001756-200209160-00003; Lorentzen JC, 1997, J NEUROIMMUNOL, V80, P31, DOI 10.1016/S0165-5728(97)00131-8; LUCCHESI BR, 1986, ANNU REV PHARMACOL, V26, P201, DOI 10.1146/annurev.pa.26.040186.001221; Lundberg C, 2001, J COMP NEUROL, V431, P75; MCGEER PL, 1989, CAN J NEUROL SCI, V16, P516, DOI 10.1017/S0317167100029863; MCGEER PL, 1993, GLIA, V7, P84, DOI 10.1002/glia.440070114; Morgan BP, 1999, CRIT REV IMMUNOL, V19, P173; MorgantiKossman MC, 1997, MOL PSYCHIATR, V2, P133, DOI 10.1038/sj.mp.4000227; Ohlsson M, 2003, J NEUROTRAUM, V20, P895, DOI 10.1089/089771503322385827; OKUSAWA S, 1987, J IMMUNOL, V139, P2635; OKUSAWA S, 1988, J EXP MED, V168, P443, DOI 10.1084/jem.168.1.443; OLNEY JW, 1971, EXP BRAIN RES, V14, P61; PIANI D, 1991, NEUROSCI LETT, V133, P159, DOI 10.1016/0304-3940(91)90559-C; Piehl F, 1999, J NEUROIMMUNOL, V101, P87, DOI 10.1016/S0165-5728(99)00136-8; Popovich PG, 1997, J COMP NEUROL, V377, P443, DOI 10.1002/(SICI)1096-9861(19970120)377:3<443::AID-CNE10>3.0.CO;2-S; Rancan M, 2003, J CEREBR BLOOD F MET, V23, P1070, DOI 10.1097/01.WCB.0000084250.20114.2C; Rapalino O, 1998, NAT MED, V4, P814, DOI 10.1038/nm0798-814; REYNOLDS CW, 1981, J IMMUNOL, V127, P2204; ROBINSON AP, 1986, IMMUNOLOGY, V57, P239; ROSEN H, 1990, J LEUKOCYTE BIOL, V48, P465; Royle SJ, 1999, BRAIN RES, V816, P337, DOI 10.1016/S0006-8993(98)01122-6; Schauwecker PE, 1997, P NATL ACAD SCI USA, V94, P4103, DOI 10.1073/pnas.94.8.4103; SCHINDLER R, 1990, BLOOD, V76, P1631; Schmued LC, 1997, BRAIN RES, V751, P37, DOI 10.1016/S0006-8993(96)01387-X; Schwartz M, 2003, J CEREBR BLOOD F MET, V23, P385, DOI 10.1097/01.WCB.0000061881.75234.5E; Soares HD, 1995, J NEUROSCI, V15, P8223; Stahel PF, 2000, J CEREBR BLOOD F MET, V20, P369, DOI 10.1097/00004647-200002000-00019; Stahel PF, 1998, BRAIN RES REV, V27, P243, DOI 10.1016/S0165-0173(98)00015-0; Steward O, 1999, EXP NEUROL, V157, P19, DOI 10.1006/exnr.1999.7040; STOLL G, 1991, ANN NEUROL, V30, P147, DOI 10.1002/ana.410300205; Sunnemark D, 2003, BRAIN PATHOL, V13, P617; SUZUMURA A, 1990, J NEUROIMMUNOL, V30, P111, DOI 10.1016/0165-5728(90)90094-4; SVENSSON M, 1995, MOL CHEM NEUROPATHOL, V24, P53, DOI 10.1007/BF03160112; SVENSSON M, 1992, J NEUROIMMUNOL, V40, P99, DOI 10.1016/0165-5728(92)90217-9; Swanberg M, 2005, NAT GENET, V37, P486, DOI 10.1038/ng1544; Teasdale GM, 1997, LANCET, V350, P1069, DOI 10.1016/S0140-6736(97)04318-3; THERY C, 1991, EUR J NEUROSCI, V3, P1155, DOI 10.1111/j.1460-9568.1991.tb00050.x; VACA K, 1992, EXP NEUROL, V118, P62, DOI 10.1016/0014-4886(92)90023-J; VANGURI P, 1988, J BIOL CHEM, V263, P7228; Weissert R, 1998, J CLIN INVEST, V102, P1265, DOI 10.1172/JCI3022; WEKERLE H, 1987, J EXP BIOL, V132, P43; WETSEL RA, 1995, CURR OPIN IMMUNOL, V7, P48, DOI 10.1016/0952-7915(95)80028-X; WILLIAMS AF, 1977, CELL, V12, P663, DOI 10.1016/0092-8674(77)90266-5; Witgen BM, 2006, J NEUROTRAUM, V23, P1320, DOI 10.1089/neu.2006.23.1320; YAO J, 1990, J NEUROSCI RES, V27, P36, DOI 10.1002/jnr.490270106	76	22	22	0	4	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0014-4819	1432-1106		EXP BRAIN RES	Exp. Brain Res.	AUG	2010	205	1					103	114		10.1007/s00221-010-2342-z			12	Neurosciences	Neurosciences & Neurology	629YR	WOS:000280238000010	20602094				2021-06-18	
J	Mefire, AC; Pagbe, JJ; Fokou, M; Nguimbous, JF; Guifo, ML; Bahebeck, J				Mefire, Alain Chichom; Pagbe, Jean Jacques; Fokou, Marcus; Nguimbous, Jean Francois; Guifo, Marc Leroy; Bahebeck, Jean			Analysis of epidemiology, lesions, treatment and outcome of 354 consecutive cases of blunt and penetrating trauma to the chest in an African setting	SOUTH AFRICAN JOURNAL OF SURGERY			English	Article							THORACIC TRAUMA; INJURY	Background. The proportion of death and disability related to trauma is increasing in Third-World countries. Thoracic trauma is significantly involved, but few data are available on this issue in African countries with specific local conditions. Methods. The aim of the study is to analyse the diagnosis and management procedures in thoracic trauma in a typical African country. The records of 354 patients admitted to an emergency unit for chest trauma over a 13-year period were retrospectively analysed. Results. The sample included patients with 231 cases of blunt and 123 of penetrating trauma to the chest; their mean age was 41.86 years, and the male:female ratio was 4.2:1. The majority (N=226) of the injuries were sustained in road traffic accidents, and the most common lesions were rib fractures (50.3%) and haemothorax (38.7%). The diagnosis was based on physical examination and standard chest radiographs in most cases. At least one associated lesion was found in 260 (73.45%) patients. The mean injury severity score (ISS) for our patients was 16.39. Most patients were managed conservatively (N=303); thoracotomy was performed mostly on penetrating trauma patients. Morbidity occurred in 49 patients, mainly affecting those treated with thoracic drainage, and 27 patients (7.6%) died. Factors related to mortality were ISS score and association with neurotrauma. Conclusions. Chest trauma can be managed in our Cameroonian environment, with morbidity and mortality comparable with that of Western countries. Diagnosis must still rely on physical examination, chest radiographs and thoracic echography, which are affordable tools.	[Mefire, Alain Chichom] Univ Buea, Fac Hlth Sci, Yaounde, Cameroon; [Mefire, Alain Chichom] Reg Hosp Limbe, Yaounde, Cameroon; [Pagbe, Jean Jacques; Fokou, Marcus; Nguimbous, Jean Francois] Gen Reference Hosp, Yaounde, Cameroon; [Guifo, Marc Leroy; Bahebeck, Jean] Cent Hosp, Yaounde, Cameroon	Mefire, AC (corresponding author), Univ Buea, Fac Hlth Sci, Yaounde, Cameroon.						Adegboye V O, 2002, Afr J Med Med Sci, V31, P149; Adegboye V O, 2001, Afr J Med Med Sci, V30, P327; Bokhari F, 2002, J TRAUMA, V53, P1135, DOI 10.1097/00005373-200212000-00017; Demetriades D, 2002, Scand J Surg, V91, P41; Esme H, 2007, THORAC CARDIOV SURG, V55, P190, DOI 10.1055/s-2006-955883; Farooq Umar, 2006, J Coll Physicians Surg Pak, V16, P101; Karmy-Jones R, 2001, ARCH SURG-CHICAGO, V136, P513, DOI 10.1001/archsurg.136.5.513; Khan B, 2007, INT J ALGEBR COMPUT, V17, P1, DOI 10.1142/S0218196707003330; Kulshrestha P, 2004, J TRAUMA, V57, P576, DOI 10.1097/01.TA.0000091107.00699.C7; Liman ST, 2003, EUR J CARDIO-THORAC, V23, P374, DOI 10.1016/S1010-7940(02)00813-8; McEwan K, 2007, EMERG MED J, V24, P581, DOI 10.1136/emj.2007.051334; Mirvis SE, 2005, SEMIN ULTRASOUND CT, V26, P305, DOI 10.1053/j.sult.2005.08.001; Nordberg E, 2000, E AFR MED J, V77, pS1; Patel VI, 2004, J NATL MED ASSOC, V96, P1553; Rashid MA, 2000, EUR J SURG, V166, P22; Schmidt U, 1998, J TRAUMA, V44, P98, DOI 10.1097/00005373-199801000-00010; Segers P, 2001, ACTA CHIR BELG, V101, P277; Soffer D, 2004, J TRAUMA, V56, P953, DOI 10.1097/01.TA.0000127806.39852.4E	18	22	23	0	2	SA MEDICAL ASSOC	PRETORIA	BLOCK F CASTLE WALK CORPORATE PARK, NOSSOB STREET, ERASMUSKLOOF EXT3, PRETORIA, 0002, SOUTH AFRICA	0038-2361	2078-5151		S AFR J SURG	South Afr. J. Surg.	AUG	2010	48	3					90	93					4	Surgery	Surgery	644GD	WOS:000281360900005	21924001				2021-06-18	
J	Baldo, S; Tacconi, L				Baldo, Sara; Tacconi, Leonello			Effectiveness and Safety of Subcutaneous Abdominal Preservation of Autologous Bone Flap after Decompressive Craniectomy: A Prospective Pilot Study	WORLD NEUROSURGERY			English	Article						Autologous bone flap; Decompressive craniectomy; Subcutaneous abdominal preservation	TRAUMATIC BRAIN-INJURY; ANEURYSMAL SUBARACHNOID HEMORRHAGE; CEREBRAL-ARTERY INFARCTION; HEAD-INJURIES; MULTICENTER; HEMICRANIECTOMY; CRANIOPLASTY; SURGERY; TRIAL; LIFE	BACKGROUND: The aim was to assess the effectiveness and safety of reconstructing a cranial bone defect after decompressive craniectomy using an autologous bone flap banked in a subcutaneous pocket in the patient's abdominal wall. METHODS: A prospective pilot study was performed on 12 of 15 consecutive patients who had undergone decompressive craniotomy and subsequent autologous bone flap replacement. The bone flap had been stored in the abdominal wall for an average period of 40 days. To assess the safety of this method, we evaluated the infections rate and the need for a surgical revision. Efficacy was evaluated under different points of view: 1) clinical standpoint, as the cosmetic reconstructive result at 6 months after the replacement; 2) imaging point of view, as the extent of residual bony gap detectable on a three-dimensional computed tomography scan as well as the extent of the bone flap revascularization, detected with a three-phase technetium bone scan. All the bone flaps were evaluated to assess their viability by histological investigations. RESULTS: There was no bone flap infection. The only significant complication encountered in two cases was the formation of a collection under the bone flap, which required its removal. CONCLUSIONS: This preliminary and limited experience has led us to believe that the subcutaneous preservation of autologous bone flap is feasible. This method may be a very inexpensive option that preserves the viability of the bone flap, which can be ultimately responsible for the good cosmetic results and the very low infection rate.	[Baldo, Sara; Tacconi, Leonello] Osped Riuniti, Azienda Osped Univ, Dept Neurosurg, Trieste, Italy	Baldo, S (corresponding author), Osped Riuniti, Azienda Osped Univ, Dept Neurosurg, Trieste, Italy.	sara.baldo@aots.sanita.fvg.it		tacconi, leonello/0000-0003-3915-5635			Aarabi B, 2006, J NEUROSURG, V104, P469, DOI 10.3171/jns.2006.104.4.469; CHANG V, 2009, J NEUROSURG, V17, P1; Colohan Austin R T, 2005, Clin Neurosurg, V52, P19; Compagnone C, 2005, NEUROSURGERY, V57, P1183; Danish SF, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/2009.3.FOCUS945; Gooch MR, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/2009.3.FOCUS0962; Grant GA, 2004, J NEUROSURG, V100, P163, DOI 10.3171/ped.2004.100.2.0163; Hofmeijer J, 2009, LANCET NEUROL, V8, P326, DOI 10.1016/S1474-4422(09)70047-X; Hutchinson PJ, 2006, ACTA NEUROCHIR SUPPL, V96, P17; Hutchinson Peter, 2007, Neurosurg Focus, V22, pE14; Juttler E, 2007, STROKE, V38, P2518, DOI 10.1161/STROKEAHA.107.485649; Kakar V, 2009, BRIT J NEUROSURG, V23, P147, DOI 10.1080/02688690902756702; Marion DW, 2006, NEUROSURGERY, V58, P655; Meier U, 2005, ACT NEUR S, V95, P55; Sahuquillo J, 2006, COCHRANE DB SYST REV, V1, DOI DOI 10.1002/14651858.CD003983-PUB2; Schirmer CM, 2008, NEUROCRIT CARE, V8, P456, DOI 10.1007/s12028-008-9082-y; Schirmer CM, 2007, STROKE, V38, P987, DOI 10.1161/01.STR.0000257962.58269.e2; Shoakazemi A, 2009, NEUROSURGERY, V65, P505, DOI 10.1227/01.NEU.0000350870.69891.86; Skoglund TS, 2006, J NEUROTRAUM, V23, P1502, DOI 10.1089/neu.2006.23.1502; Smith ER, 2002, NEUROSURGERY, V51, P117, DOI 10.1097/00006123-200207000-00018; Stiver SI, 2009, J NEUROSURG, V110, P1242, DOI 10.3171/2008.8.JNS08314; Timofeev I, 2006, ACTA NEUROCHIR SUPPL, V96, P11; Unterberg A, 2007, CURR OPIN CRIT CARE, V13, P175; Vahedi K, 2007, STROKE, V38, P2506, DOI 10.1161/STROKEAHA.107.485235	24	22	22	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	MAY	2010	73	5					552	556		10.1016/j.wneu.2010.02.018			5	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	792UL	WOS:000292775800034	20920941				2021-06-18	
J	Swanson, EW; Mascitelli, J; Stiefel, M; MacMurtrie, E; Levine, J; Kofke, WA; Yang, W; Le Roux, PD				Swanson, Edward W.; Mascitelli, Justin; Stiefel, Michael; MacMurtrie, Eileen; Levine, Joshua; Kofke, W. Andrew; Yang, Wei; Le Roux, Peter D.			Patient Transport and Brain Oxygen in Comatose Patients	NEUROSURGERY			English	Article						Brain oxygen; Computed tomography; Intracranial pressure; Subarachnoid hemorrhage; Transport; Traumatic brain injury	SERIAL COMPUTED-TOMOGRAPHY; CRITICALLY-ILL PATIENTS; INTRAHOSPITAL TRANSPORT; RESPIRATORY-FUNCTION; INJURY; COMPLICATIONS; MANAGEMENT; CARE; DETERIORATION; HEMORRHAGE	OBJECTIVE: Transport of critically ill intensive care unit patients may be hazardous. We examined whether brain oxygen (brain tissue oxygen partial pressure [PbtO(2)]) is influenced by transport to and from a follow-up head computed tomography (transport head computed tomography [tHCT]) scan. METHODS: Forty-five patients (24 men, 21 women; Glasgow Coma Scale score <= 8; mean age, 47.3 +/- 19.0 years) who had a traumatic brain injury (n = 26) or subarachnoid hemorrhage (n = 19) were retrospectively identified from a prospective observational cohort of PbtO(2) monitoring in a neurosurgical intensive care unit at a university-based level I trauma center. PbtO(2), intracranial pressure, and cerebral perfusion pressure were monitored continuously and compared during the 3 hours before and after 100 tHCT scans. RESULTS: The mean PbtO(2) before and after the tHCT scans for all 100 scans was 37.9 +/- 19.8 mm Hg and 33.9 +/- 17.2 mm Hg, respectively (P = .0001). A decrease in PbtO2 (>5%) occurred after 54 tHCTs (54%) and in 36 patients (80%). In instances in which a decrease occurred, the average decrease in mean, minimum, and maximum PbtO(2) was 23.6%, 29%, and 18.1%, respectively. This decrease was greater when PbtO(2) was compromised (<25 mm Hg) before tHCT. An episode of brain hypoxia (<15 mm Hg) was identified in the 3 hours before tHCT in 9 and after tHCT in 19 instances. On average, an episode of brain hypoxia was 46.6 +/- 16.0 (standard error) minutes longer after tHCT than before tHCT (P = .008). Multivariate analysis suggests that changes in lung function (PaO2/fraction of inspired oxygen [FiO(2)] ratio) may account for the reduced PbtO(2) after tHCT (parameter estimate 0.45, 95% confidence interval: 0.024-0.871; P = .04). CONCLUSION: These data suggest that transport to and from the intensive care unit may adversely affect PbtO(2). This deleterious effect is greater when PbtO(2) is already compromised and may be associated with lung function.	[Swanson, Edward W.; Mascitelli, Justin; Stiefel, Michael; MacMurtrie, Eileen; Levine, Joshua; Kofke, W. Andrew; Le Roux, Peter D.] Univ Penn, Dept Neurosurg, Philadelphia, PA 19107 USA; [Levine, Joshua; Kofke, W. Andrew] Univ Penn, Dept Neurol, Philadelphia, PA 19107 USA; [Levine, Joshua; Kofke, W. Andrew] Univ Penn, Dept Anesthesiol & Crit Care, Philadelphia, PA 19107 USA; [Yang, Wei] Univ Penn, Dept Biostat & Epidemiol, Ctr Clin Epidemiol & Biostat, Philadelphia, PA 19107 USA	Le Roux, PD (corresponding author), Univ Penn, Dept Neurosurg, 330 S 9th St, Philadelphia, PA 19107 USA.	lerouxp@uphs.upenn.edu	Yang, Wei/A-9223-2009	Yang, Wei/0000-0001-8984-4389	Integra Foundation; Neurologica	This work is supported by research grants from the Integra Foundation ( P. D. L.) and Neurologica ( P. D. L.). The authors have no personal financial or institutional interest in any of the drugs, materials, or devices described in this article.	ANDREWS PJD, 1990, LANCET, V335, P327, DOI 10.1016/0140-6736(90)90614-B; Bercault N, 2005, CRIT CARE MED, V33, P2471, DOI 10.1097/01.CCM.0000185644.54646.65; BRAMAN SS, 1987, ANN INTERN MED, V107, P469, DOI 10.7326/0003-4819-107-4-469; Brown CVR, 2007, J TRAUMA, V62, P1339, DOI 10.1097/TA.0b013e318054e25a; Brown CVR, 2004, J TRAUMA, V57, P939, DOI 10.1097/01.TA.0000149492.92558.03; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Chang EF, 2006, NEUROSURGERY, V58, P647, DOI 10.1227/01.NEU.0000197101.68538.E6; Chao A, 2001, J TRAUMA, V51, P870, DOI 10.1097/00005373-200111000-00008; Dings J, 1998, NEUROSURGERY, V43, P1082, DOI 10.1097/00006123-199811000-00045; Doring B L, 1999, J Neurosci Nurs, V31, P80; Evans A, 1995, Am J Crit Care, V4, P106; Gracias VH, 2004, J TRAUMA, V56, P469, DOI 10.1097/01.TA.0000114274.95423.C0; Gunnarsson T, 2000, J NEUROSURG, V93, P432, DOI 10.3171/jns.2000.93.3.0432; KOBAYASHI S, 1983, SURG NEUROL, V20, P25, DOI 10.1016/0090-3019(83)90101-5; Lahner D, 2007, WIEN KLIN WOCHENSCHR, V119, P412, DOI 10.1007/s00508-007-0813-4; LEDWITH M, J NEUROSCI IN PRESS; LeRoux PD, 1996, J NEUROSURG, V85, P39, DOI 10.3171/jns.1996.85.1.0039; LINK J, 1990, CRIT CARE MED, V18, P1427, DOI 10.1097/00003246-199012000-00024; Lobato RD, 1997, ACTA NEUROCHIR, V139, P385, DOI 10.1007/BF01808871; Lovell MA, 2001, ANAESTH INTENS CARE, V29, P400, DOI 10.1177/0310057X0102900412; Marx G, 1998, INTENS CARE MED, V24, P1157, DOI 10.1007/s001340050739; McKhann GM, 2004, MANAGEMENT CEREBRAL, P431; Nortje J, 2006, BRIT J ANAESTH, V97, P95, DOI 10.1093/bja/ael137; Papson JPN, 2007, ACAD EMERG MED, V14, P574, DOI 10.1197/j.aem.2007.02.034; PEACE K, 2009, AM ASS NEUR SURG ANN; Rello J, 1996, AM J RESP CRIT CARE, V154, P111, DOI 10.1164/ajrccm.154.1.8680665; ROBERSON FC, 1979, SURG NEUROL, V12, P161; ROBERTSON C, 2004, YOUMANS NEUROLOGICAL, P5103; Rose JC, 2006, CURR OPIN CRIT CARE, V12, P97, DOI 10.1097/01.ccx.0000216574.26686.e9; Servadei F, 2000, NEUROSURGERY, V46, P70; Singhal AB, 2005, STROKE, V36, P797, DOI 10.1161/01.STR.0000158914.66827.2e; SMITH I, 1990, CRIT CARE MED, V18, P278, DOI 10.1097/00003246-199003000-00006; Smith JS, 2007, J TRAUMA, V63, P75, DOI 10.1097/01.ta.0000245991.42871.87; STEIN SC, 1993, NEUROSURGERY, V32, P25, DOI 10.1227/00006123-199301000-00004; Stiefel MF, 2005, J NEUROSURG, V103, P805, DOI 10.3171/jns.2005.103.5.0805; SZEM JW, 1995, CRIT CARE MED, V23, P1660, DOI 10.1097/00003246-199510000-00009; Valadka AB, 1998, CRIT CARE MED, V26, P1576, DOI 10.1097/00003246-199809000-00029; van den Brink WA, 2000, NEUROSURGERY, V46, P868, DOI 10.1097/00006123-200004000-00018; Warren J, 2004, CRIT CARE MED, V32, P256, DOI 10.1097/01.CCM.0000104917.39204.0A; WAYDHAS C, 1995, INTENS CARE MED, V21, P784, DOI 10.1007/BF01700959; WEG JG, 1989, CHEST, V96, P631, DOI 10.1378/chest.96.3.631; Winn HR., 2004, MANAGEMENT CEREBRAL, P303; Zanetta G, 2002, INTENS CARE MED, V28, P443, DOI 10.1007/s00134-002-1242-5	43	22	22	0	0	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0148-396X	1524-4040		NEUROSURGERY	Neurosurgery	MAY	2010	66	5					925	931		10.1227/01.NEU.0000368543.59446.A4			7	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	587DY	WOS:000276970800019	20404697				2021-06-18	
J	McNett, MM; Gianakis, A				McNett, Molly M.; Gianakis, Anastasia			Nursing Interventions for Critically Ill Traumatic Brain Injury Patients	JOURNAL OF NEUROSCIENCE NURSING			English	Article								Neuroscience intensive care unit (ICU) nurses deliver a number of interventions when caring for critically ill traumatic brain injury (TBI) patients. Yet, there is little research evidence documenting specific nursing interventions performed. As part of a larger study investigating ICU nurse judgments about secondary brain injury, ICU nurses were asked to identify interventions routinely performed when caring for TBI patients. Quantitative and qualitative analyses indicate that all nurses routinely monitored hemodynamic parameters such as oxygen saturation, blood pressure, and temperature. Nurses were responsible for monitoring intracranial pressure and cerebral perfusion pressure approximately 50% of the time. Qualitative analyses revealed that additional nursing interventions could be categorized as neurophysiological interventions, psychosocial interventions, injury prevention interventions, and interventions to maintain a therapeutic milieu. Findings from this study provide evidence of the multifaceted role of the neuroscience ICU nurse caring for TBI patients and can be used in future research investigating the impact of nursing interventions on patient outcomes.	[McNett, Molly M.; Gianakis, Anastasia] Metrohlth Med Ctr, Neurosurg Spine & Surg Intens Care Unit, Cleveland, OH USA	McNett, MM (corresponding author), Metrohlth Med Ctr, Neurosurg Spine & Surg Intens Care Unit, Cleveland, OH USA.	mmcnett@metrohealth.org					Albano C, 2005, CRIT CARE NURS Q, V28, P135, DOI 10.1097/00002727-200504000-00006; Bader Mary Kay, 2003, Crit Care Nurse, V23, P29; Chamberlain D J, 1998, Aust Crit Care, V11, P123, DOI 10.1016/S1036-7314(98)70499-0; Cook NF, 2004, J CLIN NURS, V13, P835, DOI 10.1111/j.1365-2702.2004.01001.x; FONTEYN ME, 1994, NURSING INFORMATICS: AN INTERNATIONAL OVERVIEW FOR NURSING IN A TECHNOLOGICAL ERA, P481; Ladanyi Suzy, 2008, Aust Crit Care, V21, P141, DOI 10.1016/j.aucc.2008.02.003; Langlois JA, 2006, TRAUMATIC BRAIN INJU; LITTLEJOHNS L, 2009, MONITORING TECHNOLOG; MCNETT M, 2009, AM J CRITICAL CARE; McNett M, 2009, DIMENS CRIT CARE NUR, V28, P182, DOI 10.1097/DCC.0b013e3181a473d7; Olson DM, 2005, AACN ADV CRIT CARE, V16, P441, DOI 10.1097/00044067-200510000-00003; POPE C, 1999, QUALITATIVE RES HLTH; Presciutti Mary, 2006, J Neurosci Nurs, V38, P296; The Brain Trauma Foundation, GUID MAN SEV TRAUM B; Thompson Hilaire J, 2007, J Neurosci Nurs, V39, P196; Villanueva N E, 1999, J Neurosci Nurs, V31, P216; Wong F W, 2000, Crit Care Nurse, V20, P18	17	22	23	0	6	AMER ASSOC NEUROSCIENCE NURSES	GLENVIEW	4700 W LAKE AVENUE, GLENVIEW, IL 60025 USA	0888-0395			J NEUROSCI NURS	J. Neurosci. Nurs.	APR	2010	42	2					71	77		10.1097/JNN.0b013e3181ce5b8a			7	Clinical Neurology; Nursing	Neurosciences & Neurology; Nursing	576CU	WOS:000276122400003	20422792				2021-06-18	
J	Larson, EB; Heinemann, AW				Larson, Eric B.; Heinemann, Allen W.			Rasch Analysis of the Executive Interview (The EXIT-25) and Introduction of an Abridged Version (The Quick EXIT)	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						Brain injuries; Cognition; Frontal lobe; Mental processes; Neuropsychological tests; Psychometrics; Rehabilitation; Stroke	BEDSIDE ASSESSMENT; COGNITIVE IMPAIRMENT; FREEDOM HOUSE; DEMENTIA; SCHIZOPHRENIA; ASSOCIATION; DYSFUNCTION; PREDICTORS; RETIREES; LEVEL	Larson EB, Heinemann AW. Rasch analysis of the Executive Interview (The EXIT-25) and introduction of an abridged version (The Quick Exit). Arch Phys Med Rehabil 2010;91:389-94. Objectives: To evaluate the psychometric properties of the Executive Interview (EXIT-25) and to propose modifications that will improve those properties. Design: Rasch analysis of existing datasets contributed by 3 prior projects, all of which examined criterion-related validity of the EXIT-25. Setting: A large, urban, academic free-standing rehabilitation facility. Participants: The sample of 147 was comprised of 109 adults diagnosed with stroke evaluated during inpatient rehabilitation and 38 adults with traumatic brain injury evaluated during inpatient (n=11) or outpatient rehabilitation (n=27). Interventions: Not applicable. Main Outcome Measures: The EXIT-25, Repeatable Battery for the Assessment of Neuropsychological Status, and Trails A and B. Results: Eleven of the 25 items correlated weakly with the total measure and misfit the rating scale model. Deleting these 11 items improved the internal consistency of the remaining 14 items and enhanced the measure's criterion-related validity. Conclusions: The EXIT-25 can be reduced from 25 to 14 items without reducing internal consistency. Convergent validity of the abbreviated measure is supported by moderate-size correlations with standard measures of cognitive deficits.	[Larson, Eric B.; Heinemann, Allen W.] Northwestern Univ, Feinberg Sch Med, Rehabil Inst Chicago, Chicago, IL 60611 USA	Larson, EB (corresponding author), Northwestern Univ, Feinberg Sch Med, Rehabil Inst Chicago, 345 E Super St, Chicago, IL 60611 USA.	elarson@ric.org	Larson, Eric/AAD-9567-2021; Heinemann, Allen W/K-6283-2012; Heinemann, Allen W./AAI-2790-2021	Heinemann, Allen W/0000-0003-2782-7326; Heinemann, Allen W./0000-0003-2782-7326	U.S. Department of EducationUS Department of Education; National Institute on Disability and Rehabilitation Research [H133B30024]; Midwest Regional Traumatic Brain Injury Model System [HI33N060014]	Supported in part by the U.S. Department of Education, National Institute on Disability and Rehabilitation Research, (grant no. H133B30024) through the Rehabilitation Research and Training Center on Enhancing Quality of Life of Stroke Survivors, and the Midwest Regional Traumatic Brain Injury Model System: Innovative Approaches to Improve Cognition. Function, and Community Living (grant no. HI33N060014).	Berghuis JP, 1999, J ACQ IMMUN DEF SYND, V21, P134; Gildengers AG, 2004, AM J PSYCHIAT, V161, P736, DOI 10.1176/appi.ajp.161.4.736; Hanks RA, 1999, ARCH PHYS MED REHAB, V80, P1030, DOI 10.1016/S0003-9993(99)90056-4; Holzer JC, 1997, J AM ACAD PSYCHIATRY, V25, P531; Kelly C, 2000, BRIT J PSYCHIAT, V177, P348, DOI 10.1192/bjp.177.4.348; Larson EB, 2008, PERCEPT MOTOR SKILL, V106, P725, DOI 10.2466/PMS.106.3.725-736; Linacre John M, 2002, J Appl Meas, V3, P85; Mann LS, 1999, PSYCHOL REP, V84, P319, DOI 10.2466/PR0.84.1.319-322; Marin RS, 2003, J GERIATR PSYCH NEUR, V16, P112, DOI 10.1177/0891988703016002009; O'Shaughnessy Joyce A, 2005, Clin Breast Cancer, V5, P439, DOI 10.3816/CBC.2005.n.002; O'Shaughnessy Joyce A, 2002, Clin Breast Cancer, V3 Suppl 3, pS116, DOI 10.3816/CBC.2002.s.022; Quinn J, 2001, SCHIZOPHR RES, V49, P79, DOI 10.1016/S0920-9964(99)00220-0; Randolph C, 1998, REPEATABLE BATTERY A; Rasch G., 1960, PROBABILISTIC MODELS; Royall DR, 2000, J GERONTOL A-BIOL, V55, pM541, DOI 10.1093/gerona/55.9.M541; Royall DR, 1998, J AM GERIATR SOC, V46, P1519, DOI 10.1111/j.1532-5415.1998.tb01536.x; Royall DR, 2004, J AM GERIATR SOC, V52, P346, DOI 10.1111/j.1532-5415.2004.52104.x; Royall DR, 2005, J AM GERIATR SOC, V53, P11, DOI 10.1111/j.1532-5415.2005.53004.x; Royall DR, 2005, J GERONTOL A-BIOL, V60, P1059, DOI 10.1093/gerona/60.8.1059; ROYALL DR, 1993, AM J PSYCHIAT, V150, P1813; ROYALL DR, 1992, J AM GERIATR SOC, V40, P1221, DOI 10.1111/j.1532-5415.1992.tb03646.x; ROYALL DR, 1993, NEUROPSY NEUROPSY BE, V6, P235; Royall DR, 1999, J GERONTOL B-PSYCHOL, V54, pP328, DOI 10.1093/geronb/54B.5.P328; ROYALL DR, 1994, EXP AGING RES, V20, P95, DOI 10.1080/03610739408253956; Schillerstrom JE, 2003, PSYCHOSOMATICS, V44, P290, DOI 10.1176/appi.psy.44.4.290; Stewart JT, 1999, AM J GERIAT PSYCHIAT, V7, P259, DOI 10.1097/00019442-199908000-00011; Stokholm J, 2005, J AM GERIATR SOC, V53, P1577, DOI 10.1111/j.1532-5415.2005.53470.x; Sweet JJ, 2006, CLIN NEUROPSYCHOL, V20, P325, DOI 10.1080/13854040600760488; *WAR DEP, 1944, ARM IND TEST BATT; Wright B. D., 1982, RATING SCALE ANAL RA	30	22	22	1	6	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993			ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	MAR	2010	91	3					389	394		10.1016/j.apmr.2009.11.015			6	Rehabilitation; Sport Sciences	Rehabilitation; Sport Sciences	592YM	WOS:000277417900010	20298829				2021-06-18	
J	Rao, V; Munro, CA; Rosenberg, P; Ward, J; Bertrand, M; Degoankar, M; Horska, A; Pham, D; Yousem, DM; Barker, PB				Rao, Vani; Munro, Cynthia A.; Rosenberg, Paul; Ward, Julianna; Bertrand, Melaine; Degoankar, Mahaveer; Horska, Alena; Pham, Dzung; Yousem, David M.; Barker, Peter B.			Neuroanatomical Correlates of Depression in Post Traumatic Brain Injury: Preliminary Results of a Pilot Study	JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES			English	Article							MAGNETIC-RESONANCE-SPECTROSCOPY; MAJOR DEPRESSION; DYSFUNCTION	The authors present preliminary results from a pilot study on patterns of brain injury associated with incident major depression after traumatic brain injury (TBI). Brain metabolite ratios, regional brain volumes, and cognitive performance were compared between 10 subjects with incident major depression post-TBI and seven TBI patients without major depression. TBI-depressed participants performed poorly on tests of frontotemporal functioning, had lower choline/creatine and N-acetylaspartate/creatine ratios in the right basal ganglia and had lower regional brain volumes in the right frontal, left occipital, and temporal lobes. The results suggest a possible role of frontotemporal lobe and basal ganglia pathology in depression after TBI. (The Journal of Neuropsychiatry and Clinical Neurosciences 2010; 22: 231-235)	[Rao, Vani; Rosenberg, Paul; Bertrand, Melaine] Johns Hopkins Sch Med, Dept Psychiat, Div Geriatr Psychiat & Neuropsychiat, Baltimore, MD 21287 USA; [Munro, Cynthia A.; Ward, Julianna] Johns Hopkins Sch Med, Dept Psychiat, Div Med Psychol, Baltimore, MD 21287 USA; [Degoankar, Mahaveer; Horska, Alena; Pham, Dzung; Yousem, David M.; Barker, Peter B.] Johns Hopkins Sch Med, Russell H Morgan Dept Radiol & Radiol Sci, Div Neuroradiol, Baltimore, MD 21287 USA	Rao, V (corresponding author), Johns Hopkins Sch Med, Dept Psychiat, Div Geriatr Psychiat & Neuropsychiat, Baltimore, MD 21287 USA.	vrao@jhmi.edu	Pham, Dzung/AAR-8263-2020		National Center for Research Resources (NCRR/NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [MO1RR00052]; PfizerPfizer; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [M01RR000052] Funding Source: NIH RePORTER	This study was supported by National Center for Research Resources (NCRR/NIH) Grant # MO1RR00052. The abstract was presented at the 2008 annual neuropsychiatry conference, Savannah, GA.; Dr. Rao has a grant from Forest to conduct a clinical trial in post-TBI depression and a grant from Pfizer to conduct a clinical trial in poststroke anxiety.; The authors wish to acknowledge Drs. Barbara A. Holshouser and Karen A. Tong, Department of Radiology, Section of Neuroradiology, Loma Linda University School of Medicine, California, for their invaluable assistance during the preparation of this manuscript.	Bazin PL, 2007, J NEUROSCI METH, V165, P111, DOI 10.1016/j.jneumeth.2007.05.024; Brooks WM, 2001, J HEAD TRAUMA REHAB, V16, P149, DOI 10.1097/00001199-200104000-00005; Deb S, 1999, AM J PSYCHIAT, V156, P374; DeBattista Charles, 2005, Expert Rev Neurother, V5, P79, DOI 10.1586/14737175.5.1.79; Degl'Innocenti A, 1998, ACTA PSYCHIAT SCAND, V97, P182, DOI 10.1111/j.1600-0447.1998.tb09985.x; DUYN JH, 1993, RADIOLOGY, V188, P277, DOI 10.1148/radiology.188.1.8511313; Gerber DJ, 2004, BRAIN INJURY, V18, P1083, DOI 10.1080/02699050410001672341; Green RE, 2008, ARCH PHYS MED REHAB, V89, pS16, DOI 10.1016/j.apmr.2008.09.551; Hibbard MR, 1998, J HEAD TRAUMA REHAB, V13, P24, DOI 10.1097/00001199-199808000-00003; Hoskison MM, 2009, NEUROSCIENCE, V159, P483, DOI 10.1016/j.neuroscience.2008.12.050; Inzaghi M G, 2005, Eura Medicophys, V41, P265; JORGE RE, 1993, J NEUROPSYCH CLIN N, V5, P43; Jorge RE, 2004, ARCH GEN PSYCHIAT, V61, P42, DOI 10.1001/archpsyc.61.1.42; Kurca E, 2006, NEURORADIOLOGY, V48, P661, DOI 10.1007/s00234-006-0109-9; Levin HS, 2005, ARCH GEN PSYCHIAT, V62, P523, DOI 10.1001/archpsyc.62.5.523; Marsh NV, 2002, J CLIN EXP NEUROPSYC, V24, P434, DOI 10.1076/jcen.24.4.434.1030; MAYBERG HS, 1994, J NEUROPSYCH CLIN N, V6, P428; Merriam EP, 1999, AM J PSYCHIAT, V156, P780; *NAT I NEUR DIS ST, 2002, NIH PUBL, V2158; Rao V, 2006, EUR J PSYCHIAT, V20, P65, DOI 10.4321/s0213-61632006000200002; Studholme C, 1999, PATTERN RECOGN, V32, P71, DOI 10.1016/S0031-3203(98)00091-0; Videbech P, 2000, ACTA PSYCHIAT SCAND, V101, P11, DOI 10.1034/j.1600-0447.2000.101001011.x	22	22	24	0	3	AMER PSYCHIATRIC PUBLISHING, INC	ARLINGTON	1000 WILSON BOULEVARD, STE 1825, ARLINGTON, VA 22209-3901 USA	0895-0172			J NEUROPSYCH CLIN N	J. Neuropsychiatr. Clin. Neurosci.	SPR	2010	22	2					231	235					5	Clinical Neurology; Neurosciences; Psychiatry	Neurosciences & Neurology; Psychiatry	595ZY	WOS:000277654200011	20463117				2021-06-18	
J	Ley, EJ; Park, R; Dagliyan, G; Palestrant, D; Miller, CM; Conti, PS; Margulies, DR; Salim, A				Ley, Eric J.; Park, Ryan; Dagliyan, Grant; Palestrant, David; Miller, Chad M.; Conti, Peter S.; Margulies, Daniel R.; Salim, Ali			In Vivo Effect of Propranolol Dose and Timing on Cerebral Perfusion After Traumatic Brain Injury	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article; Proceedings Paper	39th Annual Meeting of the Western-Trauma-Association	FEB 22-28, 2009	Crested Butte, CO	Western Trauma Assoc		Trauma; Traumatic brain injury; Beta blocker; Propranolol; Perfusion	BETA-BLOCKER EXPOSURE; BLOOD-FLOW; BETA(2)-ADRENERGIC RECEPTOR; IMPROVED SURVIVAL; IMPROVED OUTCOMES; RATS; IMPACT; TBI; PET	Background: In vivo models of traumatic brain injury (TBI) demonstrate increased cerebral perfusion. decreased cerebral hypoxia, reduced cerebral edema, and improved neurologic recovery with propranolol administration. The purpose of this study was to determine the effect of different propranolol doses and timing on cerebral perfusion in a nutrine TBI model. Methods: Fifteen minutes after TBI, three groups of mice (four mice per group) were randomized to receive intravenous injections of placebo, 4 mg/kg propranolol, or 1 mg/kg propranolol. Two delayed treatment groups were randomized to receive placebo or 4 mg/kg propranolol 60 minutes after TBI. Cerebral perfusion was then imaged by micropositron emission tomography. Results: With placebo injection 15 minutes after TBI, the standard uptake value (SUV) mean was 0.395 +/- 0.01: with 4 mg/kg propranolol, the SUV mean was 0.515 +/- 0.04; and with 4 mg/kg propranolol, the SUV mean was 0.46 +/- 0.01. Animals receiving 4 mg/kg propranolol demonstrated significant improvement (p < 0.01) in cerebral perfusion compared with placebo and compared with 1 mg/kg propranolol. With placebo injection at 60 minutes after TBI, the SUV mean was 0.26 +/- 0.03; and with 4 mg/kg propranolol, the SUV mean was 0.43 +/- 0.02. After 60 minutes, animals receiving 4 mg/kg, propranolol demonstrated significant improvement 3 < 0.01) in cerebral perfusion compared with placebo. Conclusion: In a murine model of TBI, higher doses of propranolol were preferable to lower doses and both early and late propranolol administration improved cerebral perfusion. Potential mechanisms and therapeutic potential require further research.	[Ley, Eric J.; Margulies, Daniel R.; Salim, Ali] Cedars Sinai Med Ctr, Dept Surg, Div Trauma & Crit Care, Los Angeles, CA 90048 USA; [Palestrant, David; Miller, Chad M.] Cedars Sinai Med Ctr, Dept Neurosurg, Los Angeles, CA 90048 USA; [Park, Ryan; Dagliyan, Grant; Conti, Peter S.] Univ So Calif, Dept Radiol, Los Angeles, CA USA	Salim, A (corresponding author), Cedars Sinai Med Ctr, Dept Surg, Div Trauma & Crit Care, 8700 Beverly Blvd,Suite 8215N, Los Angeles, CA 90048 USA.	ali.salim@cshs.org					Alauddin MM, 2007, NUCL MED BIOL, V34, P267, DOI 10.1016/j.nucmedbio.2006.12.009; AQYAGI M, 1976, STROKE, V7, P291, DOI 10.1161/01.STR.7.3.291; Arbabi S, 2007, J TRAUMA, V62, P56, DOI 10.1097/TA.0b013e31802d972b; Chi OZ, 1999, ANESTH ANALG, V89, P690, DOI 10.1097/00000539-199909000-00030; Chiu W, 2007, J TRAUMA, V63, P510; Conti PS, 2008, NUCL MED BIOL, V35, P131, DOI 10.1016/j.nucmedbio.2007.09.003; Cotton BA, 2007, J TRAUMA, V62, P26, DOI 10.1097/TA.0b013e31802d02d0; EDVINSSON L, 1979, ACTA PHYSIOL SCAND, V107, P289, DOI 10.1111/j.1748-1716.1979.tb06478.x; Enderson BL, 2007, J TRAUMA, V62, P33; FRIEDLAND RP, 1991, NEUROLOGY, V41, P10, DOI 10.1212/WNL.41.1.10; GREEN MA, 1990, J NUCL MED, V31, P1989; Han RQ, 2009, ANESTH ANALG, V108, P280, DOI 10.1213/ane.0b013e318187ba6b; HEMMINGSEN R, 1979, ACTA PHYSIOL SCAND, V105, P274, DOI 10.1111/j.1748-1716.1979.tb06342.x; Hendryk S, 2004, NEUROENDOCRINOL LETT, V25, P141; Inaba K, 2008, J AM COLL SURGEONS, V206, P432, DOI 10.1016/j.jamcollsurg.2007.10.005; Kato H, 2009, ANESTH ANALG, V108, P288, DOI 10.1213/ane.0b013e318187bb93; LASBENNES F, 1986, EXP BRAIN RES, V63, P169; Lewis JS, 1999, J NUCL MED, V40, P177; Ley EJ, 2009, J TRAUMA, V66, P154, DOI 10.1097/TA.0b013e31819388be; LIU MY, 1995, J FORMOS MED ASSOC, V94, P386; Maas AIR, 2007, J NEUROTRAUM, V24, P232, DOI 10.1089/neu.2006.0024; Pryor JP, 2007, J TRAUMA, V62, P61; Riordan WP, 2007, J TRAUMA, V63, P503, DOI 10.1097/TA.0b013e3181271c34; Salim A, 2008, J TRAUMA, V64, P46, DOI 10.1097/TA.0b013e31815eb15a; WAXWEILER RJ, 1995, J NEUROTRAUM, V12, P509, DOI 10.1089/neu.1995.12.509; Yenari MA, 2005, ANN NY ACAD SCI, V1053, P74, DOI 10.1196/annals.1344.007; Yin F, 2006, J MOL CELL CARDIOL, V40, P384, DOI 10.1016/j.yjmcc.2005.12.005; Young H, 1994, J Nucl Biol Med, V38, P89	28	22	23	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0022-5282	1529-8809		J TRAUMA	J. Trauma-Injury Infect. Crit. Care	FEB	2010	68	2					353	356		10.1097/TA.0b013e3181c8269a			4	Critical Care Medicine; Surgery	General & Internal Medicine; Surgery	555FC	WOS:000274492600026	20154548				2021-06-18	
J	Degeneffe, CE; Olney, MF				Degeneffe, Charles Edmund; Olney, Marjorie F.			'We are the forgotten victims': Perspectives of adult siblings of persons with traumatic brain injury	BRAIN INJURY			English	Article						Adult siblings; family; family adjustment; caregiving; qualitative research	MENTAL-RETARDATION; FAMILY; FUTURE; PREDICTORS; ILLNESS; ROLES	Primary objective: This study determined how the lives of a cross-national sample of adult siblings had changed since their brothers and sisters incurred a traumatic brain injury. Research design: A total of 272 participants provided responses to the question, 'How is your life different since your sibling had a TBI?' Responses were analysed through the constant comparative method of textual analysis. Methods and procedures: Responses were collected through a mailed-survey. The analysed question appeared at the end of a 243-item quantitatively-based survey containing five open-ended questions. Outcomes and results: Three themes emerged: (1) 'Family impacts' such as growing up with a sibling with TBI and impact on family closeness; (2) 'Caring' including caring for and about the family member; and (3) 'Making sense of the experience' through adjustment and personal development. Conclusions: The study demonstrates that having a sibling with a TBI can result in profound and enduring negative and positive life changes for non-injured siblings. Professionals need to attend to the needs of siblings for support and guidance and should be considered as key informants about their injured family members during intake and service planning.	[Degeneffe, Charles Edmund; Olney, Marjorie F.] San Diego State Univ, Dept Adm Rehabil & Postsecondary Educ, San Diego, CA 92108 USA	Degeneffe, CE (corresponding author), San Diego State Univ, Dept Adm Rehabil & Postsecondary Educ, 3590 Camino Rio N, San Diego, CA 92108 USA.	cdegenef@mail.sdsu.edu					Bogdan R. C., 1998, QUALITATIVE RES ED I; Creswell JW, 2009, RES DESIGNQUALITATIV; CRIMANDO W, 2008, 2008 ANN M NAT COUNC; DEFENEFFE CE, 2001, HLTH SOCIAL WORK, V26, P257; Degeneffe C. E., 2008, J APPL REHABILITATIO, V39, P42; Degeneffe CE, 2006, REHABIL COUNS BULL, V49, P130, DOI 10.1177/00343552060490030101; Degeneffe CE, 2009, AUST J REHABIL COUNS, V15, P12, DOI 10.1375/jrc.15.1.12; Degeneffe CE, 2008, J REHABIL, V74, P10; Degeneffe CE, 2008, REHABIL COUNS BULL, V51, P240, DOI 10.1177/0034355207311319; DENZIN NK, 1994, STRATEGIES INQUIRY 3, P199; DEPUIS PR, 1994, HYPERRESEARCH VERSIO; Elliott TR, 1999, REHABIL PSYCHOL, V44, P104, DOI 10.1037/0090-5550.44.1.104; Gan C, 2006, BRAIN INJURY, V20, P587, DOI 10.1080/02699050600743725; Gill D. J., 2000, REHABILITATION NURSI, V25, P48, DOI [DOI 10.1002/J.2048-7940.2000.TB01862.X, 10.1002/j.2048-7940.2000.tb01862.x]; Grant G, 1998, J INTELL DISABIL RES, V42, P58, DOI 10.1046/j.1365-2788.1998.00079.x; GRIFFITHS DL, 1994, FAM RELAT, V43, P221, DOI 10.2307/585326; Krauss MW, 1996, MENT RETARD, V34, P83; Lukens EP, 2004, AM J ORTHOPSYCHIAT, V74, P489, DOI 10.1037/0002-9432.74.4.489; NOLAN G, 1992, REGULAR RESPITE EVAL; NOLAN M, 1996, UNDERSTANDING FAMILY; OLNEY MF, 2009, 2009 ANN M NAT COUNC; Orsillo SM, 1993, J HEAD TRAUMA REHAB, V8, DOI [DOI 10.1097/00001199-199303000-00010, 10.1097/00001199-199303000-00010]; PEARLIN LI, 1990, GERONTOLOGIST, V30, P583, DOI 10.1093/geront/30.5.583; Pruchno RA, 1996, FAM RELAT, V45, P318, DOI 10.2307/585504; Sambuco M, 2008, BRAIN INJURY, V22, P7, DOI 10.1080/02699050701822022; SELTZER GB, 1991, FAM RELAT, V40, P310, DOI 10.2307/585017; SELTZER MM, 1989, AM BEHAV SCI, V33, P107, DOI 10.1177/0002764289033001010; Seltzer MM, 1997, FAM RELAT, V46, P395, DOI 10.2307/585099; Smith MJ, 2007, AM J ORTHOPSYCHIAT, V77, P29, DOI 10.1037/0002-9432.77.1.29; Willer B., 1990, CANADIAN J REHABILIT, V3, P167	30	22	22	0	5	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.		2010	24	12					1416	1427		10.3109/02699052.2010.514317			12	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	667NR	WOS:000283200800005	20858030				2021-06-18	
J	Hux, K; Bush, E; Zickefoose, S; Holmberg, M; Henderson, A; Simanek, G				Hux, Karen; Bush, Erin; Zickefoose, Samantha; Holmberg, Michelle; Henderson, Ambyr; Simanek, Gina			Exploring the study skills and accommodations used by college student survivors of traumatic brain injury	BRAIN INJURY			English	Article						Traumatic brain injury; school reintegration; accommodations; learning strategies	CHILDREN; MILD; ADOLESCENTS; OUTCOMES; SCHOOL; REHABILITATION; CHILDHOOD; SUCCESS; TBI	Primary objective: Survivors of severe traumatic brain injury (TBI) recovering sufficiently to attend post-secondary institutions often display learning skills differing from those of traditional students, because of this, many use formal and informal accommodations and learning strategies to support academic performance and social integration. Professionals know little about how accommodations and learning strategies affect educational experiences of college student survivors, how best to apply accommodations and learning strategies, how much survivors embrace them, the extent to which they facilitate college success or how they evolve over time. The purpose of this study was to explore these issues. Research design: The researchers collected and analysed qualitative data using a multiple case study design. Methods and procedures: Collected data included interviews, artifacts and field notes from four college student survivors, members of their families, college instructors and personnel from institution's offices for students with disabilities. Main outcomes and results: Findings suggest challenges, learning strategies, future perspectives and the need for academic accommodations fluctuate and evolve for many years post-injury. Findings also suggest some survivors perceive their learning capabilities more positively than do others associated with them, leading to questions about whether over-accommodation occurs and the potential negative ramifications associated with this practice.	[Hux, Karen; Bush, Erin; Zickefoose, Samantha; Holmberg, Michelle; Henderson, Ambyr; Simanek, Gina] Univ Nebraska, Barkley Mem Ctr, Lincoln, NE 68583 USA	Hux, K (corresponding author), Univ Nebraska, Barkley Mem Ctr 351, Lincoln, NE 68583 USA.	khux1@unl.edu	Hux, Karen/AAQ-2078-2020; Bush, Erin/I-9606-2016	Bush, Erin/0000-0003-1710-8619	University of Nebraska [26-1710-9001-001]	Funding for this project came in part from the University of Nebraska David Fund, Grant # 26-1710-9001-001.	Arroyos-Jurado E, 2008, INTERV SCH CLIN, V43, P252, DOI 10.1177/1053451208314907; Bashore TR, 2002, PSYCHOL BULL, V128, P151, DOI 10.1037/0033-2909.128.1.151; BLEIBERG J, 2001, ROAD REHABILITATIO 3; BOULDIN K. V., 2005, ENGL J, V94, P52; Bowen JM, 2005, PREV SCH FAIL, V49, P34, DOI 10.3200/PSFL.49.4.34-41; Brookshire B, 2004, DEV NEUROPSYCHOL, V25, P61, DOI 10.1207/s15326942dn2501&2_5; CAVE B. K, 2004, CLEARING HOUSE, V77, P169; Corbin J., 2014, BASICS QUALITATIVE R; Creswell J.W., 2007, QUAL INQ; Ewing-Cobbs L, 2006, J NEUROSURG, V105, P287, DOI 10.3171/ped.2006.105.4.287; Fay TB, 2009, NEUROPSYCHOLOGY, V23, P271, DOI 10.1037/a0014936; Glang A, 2008, J HEAD TRAUMA REHAB, V23, P243, DOI 10.1097/01.HTR.0000327256.46504.9f; GUBA E, 1988, QUALITATIVE APPROACH, P215; Hawley CA, 2004, ARCH DIS CHILD, V89, P136, DOI 10.1136/adc.2002.025577; Hawley CA, 2003, BRAIN INJURY, V17, P105, DOI 10.1080/0269905021000010131; Hux K, 1996, INTERV SCH CLIN, V31, P158, DOI 10.1177/105345129603100305; Lefebvre H, 2005, BRAIN INJURY, V19, P585, DOI 10.1080/02699050400025026; Marschark M, 2000, J HEAD TRAUMA REHAB, V15, P1227, DOI 10.1097/00001199-200012000-00004; Petersen C, 2008, BRAIN INJURY, V22, P215, DOI 10.1080/02699050801935245; Savage Ronald C, 2005, Pediatr Rehabil, V8, P92; Sharp NL, 2006, DISABIL REHABIL, V28, P767, DOI 10.1080/09638280500386668; Sohlberg M. M., 2001, COGNITIVE REHABILITA; Taylor HG, 2002, NEUROPSYCHOLOGY, V16, P15, DOI 10.1037//0894-4105.16.1.15; Todis B, 2008, J HEAD TRAUMA REHAB, V23, P252, DOI 10.1097/01.HTR.0000327257.84622.bc; Wilbur R, 2007, J CLIN EXP NEUROPSYC, V29, P682, DOI 10.1080/13803390600932120; Ylvisaker M, 2005, J HEAD TRAUMA REHAB, V20, P95, DOI 10.1097/00001199-200501000-00009; Ylvisaker M, 2001, J HEAD TRAUMA REHAB, V16, P76, DOI 10.1097/00001199-200102000-00009; Ylvisaker M., 1998, COLLABORATIVE BRAIN; Ylvisaker M, 2008, NEUROPSYCHOL REHABIL, V18, P713, DOI 10.1080/09602010802201832; WEFT QDA FREE QUALIT	30	22	22	0	12	TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.	JAN	2010	24	1					13	26		10.3109/02699050903446823			14	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	554AA	WOS:000274406700002	20001479				2021-06-18	
J	Kavanagh, L; Rowe, D; Hersch, J; Barnett, KJ; Reznik, R				Kavanagh, Leila; Rowe, Donald; Hersch, Jolyn; Barnett, Kylie J.; Reznik, Robert			Neurocognitive deficits and psychiatric disorders in a NSW prison population	INTERNATIONAL JOURNAL OF LAW AND PSYCHIATRY			English	Article						Forensic mental health; Prison population; IntegNeuro; Neurocognitive; Co-morbid psychiatric disorders	ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; TRAUMATIC BRAIN-INJURY; HYPERACTIVITY DISORDER; ADULT PSYCHOPATHY; INMATES; IMPULSIVITY; PERFORMANCE; PREVALENCE; BEHAVIOR; BATTERY	Approximately 75% of inmates in New South Wales (NSW) have mental health issues (Butler & Alnutt, 2003). Scarce resources force the management of acute psychiatric symptoms only, meaning that co-morbid conditions such as neurocognitive deficits are less likely to be assessed. The objective of this study was to investigate the utility of a computerized battery in the assessment of inmates within the criminal justice system. Thirty male inmates were assessed. Data were compared to matched controls. The custodial sample was characterized by an increase in the prevalence of previous trauma; high levels of depression. anxiety and stress and neurocognitive deficits, including sustained attention, impulsivity and executive dysfunction. Crown Copyright (C) 2009 Published by Elsevier Ltd. All rights reserved.	[Kavanagh, Leila; Reznik, Robert] Justice Hlth, Sydney, NSW 2036, Australia; [Rowe, Donald; Barnett, Kylie J.] Brain Resource, Sydney, NSW 2007, Australia; [Hersch, Jolyn] Univ Sydney, Sch Psychol, Sydney, NSW 2006, Australia	Kavanagh, L (corresponding author), Justice Hlth, POB 150, Matraville, NSW 2036, Australia.	leila.kavanagh@justicehealth.nsw.gov.au		Hersch, Jolyn/0000-0001-5225-6639			American Psychological Association, 1987, GUID COMP BAS TESTS; Barbor T.F., 2001, ALCOHOL USE DISORDER; Birmingham L, 1999, BRIT J PSYCHIAT, V174, P378, DOI 10.1192/bjp.174.5.378; Butler T., 1997, PRELIMINARY FINDINGS; Butler T., 2003, MENTAL ILLNESS NEW S; CHILES JA, 1990, HOSP COMMUNITY PSYCH, V41, P1132; Cima M, 2008, BIOL PSYCHOL, V78, P75, DOI 10.1016/j.biopsycho.2007.12.011; Clark C, 2002, J CHILD PSYCHOL PSYC, V43, P785, DOI 10.1111/1469-7610.00084; Clark CR, 2006, ARCH CLIN NEUROPSYCH, V21, P449, DOI 10.1016/j.acn.2006.06.005; Eyestone L L, 1994, Bull Am Acad Psychiatry Law, V22, P181; Frazier TW, 2004, NEUROPSYCHOLOGY, V18, P543, DOI 10.1037/0894-4105.18.3.543; GATT JM, 2009, MOL PSYCHIATR, V143, P1; GORDON E, 2003, AUSTRALAS PSYCHIATRY, V11, P156, DOI DOI 10.1046/J.1039-8562.2003.00533.X; Gudjonsson GH, 2008, PSYCHOL MED, V38, P1037, DOI 10.1017/S0033291708002882; Hervey AS, 2004, NEUROPSYCHOLOGY, V18, P485, DOI 10.1037/0894-4105.18.3.485; HICKIE IB, 2001, MED J AUSTRALIA, V175, pS2; Jacob CP, 2007, EUR ARCH PSY CLIN N, V257, P309, DOI 10.1007/s00406-007-0722-6; Johansson P, 2005, J PERS DISORD, V19, P94, DOI 10.1521/pedi.19.1.94.62183; Lang S, 2002, ACTA PSYCHIAT SCAND, V106, P93, DOI 10.1034/j.1600-0447.106.s412.20.x; Lovibond S.H., 1995, MANUAL DEPRESSION AN; Murphy K, 1996, COMPR PSYCHIAT, V37, P393, DOI 10.1016/S0010-440X(96)90022-X; Paul RH, 2005, INT J NEUROSCI, V115, P1549, DOI 10.1080/00207450590957890; Paul RH, 2007, INT J NEUROSCI, V117, P549, DOI 10.1080/00207450600773665; Rasmussen K, 2001, J AM ACAD PSYCHIATRY, V29, P186; Rose EJ, 2006, J AFFECT DISORDERS, V90, P149, DOI 10.1016/j.jad.2005.11.003; Rosler M, 2004, EUR ARCH PSY CLIN N, V254, P365, DOI 10.1007/S00406-004-0516-Z; Schofield PW, 2006, BRAIN INJURY, V20, P1409, DOI 10.1080/02699050601130443; Slaughter B, 2003, BRAIN INJURY, V17, P731, DOI 10.1080/0269905031000088649; Stalenheim EG, 1996, ACTA PSYCHIAT SCAND, V94, P217, DOI 10.1111/j.1600-0447.1996.tb09852.x; Taylor FB, 2000, J CHILD ADOL PSYCHOP, V10, P311, DOI 10.1089/cap.2000.10.311; Turner DC, 2004, BIOL PSYCHIAT, V55, P1031, DOI 10.1016/j.biopsych.2004.02.008; Vitacco MJ, 2001, J AM ACAD PSYCHIATRY, V29, P374; VITELLI R, 1995, INT J OFFENDER THER, V40, P263; Young S, 2009, PERS INDIV DIFFER, V46, P265, DOI 10.1016/j.paid.2008.10.003	34	22	22	1	16	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0160-2527			INT J LAW PSYCHIAT	Int. J. Law Psychiatr.	JAN-FEB	2010	33	1					20	26		10.1016/j.ijlp.2009.10.004			7	Law; Psychiatry	Government & Law; Psychiatry	549UC	WOS:000274078800004	19922999				2021-06-18	
J	McDonald, S; Hunt, C; Henry, JD; Dimoska, A; Bornhofen, C				McDonald, Skye; Hunt, Christopher; Henry, Julie D.; Dimoska, Aneta; Bornhofen, Cristina			Angry responses to emotional events: The role of impaired control and drive in people with severe traumatic brain injury	JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY			English	Article						Traumatic brain injury; Emotion; Control; Drive; Frontal lobes	BLUNT HEAD-INJURY; ECOLOGICAL VALIDITY; HIGHER COGNITION; BEHAVIOR; NEUROBIOLOGY; PERCEPTION; DEFICITS; AMYGDALA; LESIONS; REHABILITATION	Emotional and behavioral changes (e.g., irritability and anger or alternatively passivity and inertia) are common after traumatic brain injury (TBI). These changes have been conceptualized as reflecting a loss of regulation, specifically control (loss of inhibition) and/or drive (self-initiation). However, no empirical studies have examined the relationship between neuropsychological measures of these constructs and emotional responsivity in situ. In this study, 29 individuals with severe, chronic TBI and 32 matched control participants were shown emotionally evocative films selected to elicit anger and were asked to rate their emotions before and after. They were also given measures of executive function to assess inhibition and flexibility as indices of control and drive, respectively. Both groups had heightened anxiety after the films. An increase in anger and confusion correlated with impaired control (Haylings Test score, Trails B errors) in the TBI group but not in controls. No association was found between reduced emotional responsivity and drive (Controlled Oral Word Association Test, Matrix Reasoning Scaled Score, Trails A/B time difference). This study provides support for the use of formal measures of disinhibition on neuropsychological tests as a corollary for emotion disinhibition. As with previous work, operationalization of loss of drive was more difficult to achieve.	[McDonald, Skye] Univ New S Wales, Sch Psychol, Sydney, NSW 2052, Australia	McDonald, S (corresponding author), Univ New S Wales, Sch Psychol, Sydney, NSW 2052, Australia.	s.mcdonald@unsw.edu.au	McDonald, Skye/G-4118-2014	McDonald, Skye/0000-0003-0723-6094; Henry, Julie/0000-0002-2081-3717; Hunt, Christopher/0000-0001-5648-1139	National Health & Medical Research Council of AustraliaNational Health and Medical Research Council of Australia; Australian Research CouncilAustralian Research Council	This research was funded with grants from the National Health & Medical Research Council of Australia and the Australian Research Council. We are grateful to the Sydney metropolitan brain injury units-Royal Rehabilitation Centre, Westmead Brain Injury Unit, and Liverpool Brain Injury Unit-who assisted with recruitment. We are particularly grateful to the people with traumatic brain injuries and our control participants who gave willingly of their time to assist this research.	Adolphs R, 2001, CURR OPIN NEUROBIOL, V11, P231, DOI 10.1016/S0959-4388(00)00202-6; Adolphs R, 1998, NATURE, V393, P470, DOI 10.1038/30982; Alderman N, 2003, NEUROPSYCHOL REHABIL, V13, P211, DOI 10.1080/09602010244000327; Andrewes D., 2001, NEUROPSYCHOLOGY THEO; Bechara A, 2004, BRAIN COGNITION, V55, P30, DOI 10.1016/j.bandc.2003.04.001; Bibby H, 2005, NEUROPSYCHOLOGIA, V43, P99, DOI 10.1016/j.neuropsychologia.2004.04.027; Blair RJR, 2000, BRAIN, V123, P1122, DOI 10.1093/brain/123.6.1122; Blumer D., 1975, PSYCHIAT ASPECTS NEU, P151; BOND MR, 1976, SCAND J REHABIL MED, V8, P127; BROOKS N, 1986, J NEUROL NEUROSUR PS, V49, P764, DOI 10.1136/jnnp.49.7.764; Burgess PW, 1998, J INT NEUROPSYCH SOC, V4, P547, DOI 10.1017/S1355617798466037; Channon S, 2005, BRAIN LANG, V93, P123, DOI 10.1016/j.bandl.2004.09.002; Channon S, 2000, NEUROPSYCHOLOGIA, V38, P1006, DOI 10.1016/S0028-3932(99)00154-2; CROWE SF, 1992, J CLIN EXP NEUROPSYC, V14, P327, DOI 10.1080/01688639208402832; Cummings JL, 1985, CLIN NEUROPSYCHIATRY; Darby D, 2005, WALSHS NEUROPSYCHOLO; Emery NJ, 2001, BEHAV NEUROSCI, V115, P515, DOI 10.1037/0735-7044.115.3.515; Eslinger PJ, 2008, NEUROPSYCHOLOGICAL RESEARCH: A REVIEW, P379; ESLINGER PJ, 1985, NEUROLOGY, V35, P1731, DOI 10.1212/WNL.35.12.1731; GENTRY LR, 1988, AM J ROENTGENOL, V150, P663, DOI 10.2214/ajr.150.3.663; Grattan LM, 1989, NEUROPSYCHOLOGY, V3, P175, DOI 10.1037//0894-4105.3.3.175; Green REA, 2004, NEUROPSYCHOLOGIA, V42, P133, DOI 10.1016/j.neuropsychologia.2003.07.005; Gross JJ, 2003, J PERS SOC PSYCHOL, V85, P348, DOI 10.1037/0022-3514.85.2.348; GROSS JJ, 1995, COGNITION EMOTION, V9, P87, DOI 10.1080/02699939508408966; Gross JJ, 2002, PSYCHOPHYSIOLOGY, V39, P281, DOI 10.1017/S0048577201393198; Gross JJ, 2001, CURR DIR PSYCHOL SCI, V10, P214, DOI 10.1111/1467-8721.00152; HADLEY DM, 1988, CLIN RADIOL, V39, P131; Hauser MD, 1999, CURR OPIN NEUROBIOL, V9, P214, DOI 10.1016/S0959-4388(99)80030-0; Hewig J, 2005, COGNITION EMOTION, V19, P1095, DOI 10.1080/02699930541000084; Hopkins MJ, 2002, BRAIN INJURY, V16, P245, DOI 10.1080/02699050110103346; Hosie JA, 2005, PSYCHOLOGIA, V48, P288, DOI 10.2117/psysoc.2005.288; KINSELLA G, 1988, PSYCHOL MED, V18, P57, DOI 10.1017/S0033291700001884; KINSELLA G, 1991, J NEUROL NEUROSUR PS, V54, P422, DOI 10.1136/jnnp.54.5.422; Lovibond SH, 1995, MANUAL DEPRESSION AN; Luria A. R, 1973, WORKING BRAIN; Machado CJ, 2008, BEHAV NEUROSCI, V122, P251, DOI 10.1037/0735-7044.122.2.251; Marsh NV, 1991, NEUROPSYCHOLOGY, V5, P107, DOI 10.1037/0894-4105.5.2.107; McDonald S, 2005, J INT NEUROPSYCH SOC, V11, P392, DOI 10.1017/S1355617705050447; McDonald S, 2004, NEUROPSYCHOL REHABIL, V14, P285, DOI 10.1080/09602010343000237; Medd J, 2000, NEUROPSYCHOL REHABIL, V10, P185, DOI 10.1080/096020100389246; Meythaler JM, 2001, ARCH PHYS MED REHAB, V82, P1461, DOI 10.1053/apmr.2001.25137; Milders M, 2003, J CLIN EXP NEUROPSYC, V25, P157, DOI 10.1076/jcen.25.2.157.13642; Odhuba RA, 2005, BRIT J CLIN PSYCHOL, V44, P269, DOI 10.1348/014466505X29431; Phillips ML, 2003, BIOL PSYCHIAT, V54, P504, DOI 10.1016/S0006-3223(03)00168-9; Phillips ML, 2003, BRIT J PSYCHIAT, V182, P190, DOI 10.1192/bjp.182.3.190; PONSFORD JL, 1995, BRAIN INJURY, V9, P1, DOI 10.3109/02699059509004565; Reitan R. M, 1992, TRAIL MAKING TEST; Roche RAP, 2004, NEUROSCI LETT, V362, P1, DOI 10.1016/j.neulet.2003.11.064; Sanchez-Navarro JP, 2005, BEHAV NEUROSCI, V119, P87, DOI 10.1037/0735-7044.119.1.87; Saunders JC, 2006, NEUROPSYCHOLOGY, V20, P224, DOI 10.1037/0894-4105.20.2.224; SAVER JL, 1991, NEUROPSYCHOLOGIA, V29, P1241, DOI 10.1016/0028-3932(91)90037-9; Shallice, 1997, HAYLING BRIXTON TEST; Soussignan R, 2005, NEUROCASE, V11, P114, DOI 10.1080/13554790590922513; Spreen O., 1991, COMPENDIUM NEUROPSYC; STUSS DT, 1992, J CONSULT CLIN PSYCH, V60, P349, DOI 10.1037/0022-006X.60.3.349; TATE RL, 1991, J NERV MENT DIS, V179, P117, DOI 10.1097/00005053-199103000-00001; TATE RL, 1989, J NEUROL NEUROSUR PS, V52, P1128, DOI 10.1136/jnnp.52.10.1128; Tate RL, 1999, CORTEX, V35, P39, DOI 10.1016/S0010-9452(08)70784-6; Tate RL, 1999, PSYCHOL MED, V29, P713, DOI 10.1017/S0033291799008466; Terry PC, 1999, J SPORT SCI, V17, P861, DOI 10.1080/026404199365425; Terry PC, 2003, PSYCHOL SPORT EXERC, V4, P125, DOI 10.1016/S1469-0292(01)00035-8; THOMSEN IV, 1984, J NEUROL NEUROSUR PS, V47, P260, DOI 10.1136/jnnp.47.3.260; Wechsler D., 2001, WECHSLER TEST ADULT; Wechsler D., 1997, WMS 3 WECHSLER MEMOR; Wechsler D, 1997, WAIS 3 ADM SCORING M; WEDDELL R, 1980, PSYCHOL MED, V10, P257, DOI 10.1017/S0033291700044019; Yochim BP, 2009, J CLIN EXP NEUROPSYC, V31, P658, DOI 10.1080/13803390802448669	67	22	22	0	9	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1380-3395	1744-411X		J CLIN EXP NEUROPSYC	J. Clin. Exp. Neuropsychol.		2010	32	8					855	864	PII 921771147	10.1080/13803391003596405			10	Psychology, Clinical; Clinical Neurology; Psychology	Psychology; Neurosciences & Neurology	659RO	WOS:000282584800006	20432104				2021-06-18	
J	Medley, AR; Powell, T; Worthington, A; Chohan, G; Jones, C				Medley, Andrew R.; Powell, Theresa; Worthington, Andrew; Chohan, Gagandeep; Jones, Chris			Brain injury beliefs, self-awareness, and coping: A preliminary cluster analytic study based within the self-regulatory model	NEUROPSYCHOLOGICAL REHABILITATION			English	Article						Brain injury; Rehabilitation; Illness perceptions; Coping; Self-awareness	QUALITY-OF-LIFE; ILLNESS REPRESENTATIONS; PERCEPTION QUESTIONNAIRE; EMOTIONAL ADJUSTMENT; RHEUMATOID-ARTHRITIS; REHABILITATION; EXPERIENCE; DISEASE; MOOD; ASSOCIATION	The interplay between individuals' subjective beliefs about traumatic brain injury, their coping style and their self-awareness might provide a more helpful guide to rehabilitation goals than looking at these factors in isolation. We therefore conducted a preliminary study to determine whether the Self-Regulatory Model can identify different clusters of individuals according to belief schemata, and to explore whether clusters differed across measures of coping and self-awareness. The Illness Perception Questionnaire-Revised was administered to 37 participants with severe traumatic brain injury (TBI), along with the Ways of Coping Checklist-Revised and the European Brain Injury Questionnaire. Clinicians also rated clients' level of difficulties using the latter scale, and the discrepancy between client and clinician scores was used as a measure of self-awareness. Hierarchical cluster analysis distinguished three groups based on profiles of subjective beliefs about TBI, labelled olow control/ambivalento, ohigh salienceo, and ohigh optimismo. The high salience group was characterised by beliefs about serious consequences of the injury and greater self-awareness, and reported a greater range of coping strategies. The other two groups showed lower levels of awareness but differed in coping styles, with the low control/ambivalent group showing a trend towards more avoidance coping against a background of lower perceived control.	[Medley, Andrew R.; Powell, Theresa; Chohan, Gagandeep; Jones, Chris] Univ Birmingham, Sch Psychol, Birmingham B15 2TT, W Midlands, England; [Worthington, Andrew] Brain Injury Rehabil Trust, Birmingham, W Midlands, England	Medley, AR (corresponding author), Univ Birmingham, Sch Psychol, Birmingham B15 2TT, W Midlands, England.	a_medley@o2.co.uk		Powell, Theresa/0000-0002-3351-9453			Ajzen I., 1988, ATTITUDES PERSONALIT; Anson K, 2006, J HEAD TRAUMA REHAB, V21, P248, DOI 10.1097/00001199-200605000-00005; Bains B, 2007, NEUROPSYCHOL REHABIL, V17, P174, DOI 10.1080/09602010600562468; BARCO PP, 1991, COGNITIVE REHABILITA; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; BUICK DL, 1997, PERCEPTIONS HLTH ILL; Carlisle ACS, 2005, BRIT J HEALTH PSYCH, V10, P571, DOI 10.1348/135910705X52309; Chervinsky AB, 1998, ARCH CLIN NEUROPSYCH, V13, P433, DOI 10.1016/S0887-6177(97)00016-4; Cicerone K. D., 1991, J HEAD TRAUMA REHAB, V6, P30, DOI DOI 10.1097/00001199-199112000-00007; Clare L, 2006, INT J GERIATR PSYCH, V21, P761, DOI 10.1002/gps.1558; Clatworthy J, 2007, PSYCHOL HEALTH, V22, P123, DOI 10.1080/14768320600774496; COETZER BR, 2001, J COGNITIVE REHA WIN, P8; Coetzer R, 2008, NEUROPSYCHOL REHABIL, V18, P766, DOI 10.1080/09602010701860266; Cooper A, 1999, HEART, V82, P234, DOI 10.1136/hrt.82.2.234; Finset A, 2000, BRAIN INJURY, V14, P887; FOLKMAN S, 1988, SOC SCI MED, V26, P309, DOI 10.1016/0277-9536(88)90395-4; Goldstein LH, 2005, EPILEPSY RES, V67, P1, DOI 10.1016/j.eplepsyres.2005.06.008; Groarke AM, 2005, PSYCHOL HEALTH, V20, P597, DOI 10.1080/14768320500094177; Hagger MS, 2003, PSYCHOL HEALTH, V18, P141, DOI 10.1080/088704403100081321; Harman G, 2006, QUAL HEALTH RES, V16, P484, DOI 10.1177/1049732306286851; Hart T, 2007, REHABIL PSYCHOL, V52, P152, DOI 10.1037/0090-5550.52.2.152; Heijmans M, 1999, BRIT J HEALTH PSYCH, V4, P137, DOI 10.1348/135910799168533; Helder DI, 2002, BRIT J HEALTH PSYCH, V7, P449, DOI 10.1348/135910702320645417; Hobro N, 2004, PAIN, V108, P276, DOI 10.1016/j.pain.2003.12.027; Jessop DC, 2003, PSYCHOL HEALTH, V18, P595, DOI 10.1080/0887044031000097009; Jopson NM, 2003, J PSYCHOSOM RES, V54, P503, DOI 10.1016/S0022-3999(02)00455-5; KENDALL E, 2001, BRAIN IMPAIR, V2, P81; KING NS, 2003, HDB CLIN NEUROPSYCHO; Kline Paul., 2000, PSYCHOMETRICS PRIMER; Krpan KM, 2007, J CLIN EXP NEUROPSYC, V29, P36, DOI 10.1080/13803390500376816; Lazarus R.S., 1984, STRESS APPRAISAL COP; Leventhal H., 1980, MED PSYCHOL, V2, P7; Leventhal H., 1984, HDB PSYCHOL HLTH; Leventhal H., 2003, SELF REGULATION HLTH, P42; Llewellyn CD, 2003, PSYCHOL HEALTH, V18, P185, DOI 10.1080/0887044031000098198; LUBUSKO AA, 1994, BRAIN INJURY, V8, P65, DOI 10.3109/02699059409150959; Maclean N, 2000, BMJ-BRIT MED J, V321, P1051, DOI 10.1136/bmj.321.7268.1051; Malec JF, 1997, J HEAD TRAUMA REHAB, V12, P1, DOI 10.1097/00001199-199706000-00002; MALIA K, 1995, BRAIN INJURY, V9, P607, DOI 10.3109/02699059509008219; MALIA K, 1997, J COGNITIVE REHA MAY, P10; Manchester D, 2001, BRAIN DAM B, P157; Miglioretti M, 2008, J PSYCHOSOM RES, V65, P603, DOI 10.1016/j.jpsychores.2008.05.012; Miller W. R., 2002, MOTIVATIONAL INTERVI; Moore A D, 1989, Brain Inj, V3, P171, DOI 10.3109/02699058909004549; MOORE A D, 1992, Brain Injury, V6, P89, DOI 10.3109/02699059209008129; MOORE AD, 1995, BRAIN INJURY, V9, P109, DOI 10.3109/02699059509008185; MOORE AD, 1991, NEUROPSYCHOL REHABIL, V1, P185, DOI DOI 10.1080/09602019108520164; Moss-Morris R, 2002, PSYCHOL HEALTH, V17, P1, DOI 10.1080/08870440290001494; MOSSMORRIS R, 1997, PERCEPTIONS HLTH ILL; O'Callaghan C, 2006, NEUROPSYCHOL REHABIL, V16, P579, DOI 10.1080/09602010500368834; Ownsworth T., 2005, NEUROPSYCHOANALYSIS, V7, P83; OWNSWORTH T, 2006, BRAIN IMPAIR, V7, P95; Ownsworth T, 2007, NEUROPSYCHOL REHABIL, V17, P129, DOI 10.1080/09602010600615506; Ownsworth T, 2006, NEUROPSYCHOL REHABIL, V16, P415, DOI 10.1080/09602010500505641; Petrie KJ, 2002, PSYCHOSOM MED, V64, P580, DOI 10.1097/00006842-200207000-00007; Port A, 2002, BRAIN INJURY, V16, P277, DOI 10.1080/02699050110103274; Prigatano G. P, 2005, REHABILITATION TRAUM; Prigatano GP, 1998, CLIN NEUROPSYCHOL, V12, P56, DOI 10.1076/clin.12.1.56.1721; Riley GA, 2004, BRAIN INJURY, V18, P871, DOI 10.1080/02699050410001671829; Saltapidas H, 2008, BRAIN IMPAIR, V9, P1, DOI 10.1375/brim.9.1.1; Schonberger M, 2006, NEUROPSYCHOL REHABIL, V16, P561, DOI 10.1080/09602010500263084; Schonberger M, 2006, BRAIN INJURY, V20, P445, DOI 10.1080/02699050600664772; Searle A, 2007, BRIT J HEALTH PSYCH, V12, P621, DOI 10.1348/135910706X164935; Shotton L, 2007, BRAIN INJURY, V21, P857, DOI 10.1080/02699050701481621; Spain LA, 2007, ACTA NEUROL SCAND, V116, P293, DOI 10.1111/j.1600-0404.2007.00895.x; Teasdale TW, 1997, BRAIN INJURY, V11, P543, DOI 10.1080/026990597123250; Tennen H, 2000, AM PSYCHOL, V55, P626, DOI 10.1037//0003-066X.55.6.626; Toglia J, 2000, NEUROREHABILITATION, V15, P57; van den Broek MD, 2005, J HEAD TRAUMA REHAB, V20, P464, DOI 10.1097/00001199-200509000-00007; Vaughan R, 2003, BRIT J HEALTH PSYCH, V8, P287, DOI 10.1348/135910703322370860; Weinman J, 1996, PSYCHOL HEALTH, V11, P431, DOI 10.1080/08870449608400270; Whitmarsh A, 2003, BRIT J HEALTH PSYCH, V8, P209, DOI 10.1348/135910703321649178; Whittaker R, 2007, J NEUROL NEUROSUR PS, V78, P644, DOI 10.1136/jnnp.2006.101105; Williams WH, 2002, J TRAUMA STRESS, V15, P397, DOI 10.1023/A:1020185325026	74	22	22	0	10	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0960-2011	1464-0694		NEUROPSYCHOL REHABIL	Neuropsychol. Rehabil.		2010	20	6					899	921	PII 928656316	10.1080/09602011.2010.517688			23	Neurosciences; Psychology	Neurosciences & Neurology; Psychology	684GB	WOS:000284537300007	20981622				2021-06-18	
J	Miller, MA; Conley, Y; Scanlon, JM; Ren, DX; Kamboh, MI; Niyonkuru, C; Wagner, AK				Miller, Megan A.; Conley, Yvette; Scanlon, Joelle M.; Ren, Dianxu; Kamboh, M. Ilyas; Niyonkuru, Christian; Wagner, Amy K.			APOE genetic associations with seizure development after severe traumatic brain injury	BRAIN INJURY			English	Article						Traumatic brain injury; post-traumatic seizures; APOE; genetic susceptibility	TEMPORAL-LOBE EPILEPSY; LATE POSTTRAUMATIC SEIZURES; APOLIPOPROTEIN-E POLYMORPHISM; CONTROLLED CORTICAL IMPACT; AMYLOID-BETA PLAQUES; E EPSILON 4; HEAD-INJURY; ALZHEIMERS-DISEASE; SENILE PLAQUES; RISK-FACTORS	Primary objective: The purpose of the current study is to assess the role of the APOE genotype in post-traumatic seizure (PTS) development. Research design: A retrospective study of 322 adult Caucasians with a severe TBI and APOE genotype. Methods and procedures: Medical records were searched for PTS. Time to first seizure was categorized as early, late or delayed-onset PTS. Potential PTS associations by genotype, grouped genotype and allele were investigated. Main outcome and results: No statistically significant associations were found. However, two out of the four individuals (50%) with the E4/E4 genotype had late/delayed-onset PTS. Furthermore, none with a E2/E2 or E2/E4 genotype seized in the late periods. Conclusions: The results of this study may suggest 4/4 as a risk genotype for late/delayed onset PTS and a potential neuroprotective role of the E2 allele. However, this study did not definitively support a role for the APOE genotype in PTS susceptibility and indicates that larger populations are needed to fully evaluate the potential impact of APOE on PTS.	[Miller, Megan A.; Scanlon, Joelle M.; Niyonkuru, Christian; Wagner, Amy K.] Univ Pittsburgh, Dept Phys Med & Rehabil, Pittsburgh, PA 15213 USA; [Conley, Yvette; Wagner, Amy K.] Univ Pittsburgh, Safar Ctr Resuscitat Res, Pittsburgh, PA 15213 USA; [Conley, Yvette; Ren, Dianxu] Univ Pittsburgh, Sch Nursing, Pittsburgh, PA 15213 USA; [Conley, Yvette; Kamboh, M. Ilyas] Univ Pittsburgh, Dept Human Genet, Pittsburgh, PA 15213 USA	Wagner, AK (corresponding author), Univ Pittsburgh, Dept Phys Med & Rehabil, 3471 5th Ave,Suite 202, Pittsburgh, PA 15213 USA.	wagnerak@upmc.edu		Kamboh, M. Ilyas/0000-0002-3453-1438	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NIHR01HD048162, NIHP50NS030318, NIHR01NR008424]; DODUnited States Department of Defense [W81XWH-07-1-0701]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD048162] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P50NS030318] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NURSING RESEARCHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR) [R01NR008424] Funding Source: NIH RePORTER	The authors would like to acknowledge the NIH grant number NIHR01HD048162, NIHP50NS030318, and NIHR01NR008424 as well as DOD grant number W81XWH-07-1-0701.	Alexander S, 2007, J NEUROTRAUM, V24, P790, DOI 10.1089/neu.2006.0133; Anderson GD, 2009, EPILEPSY BEHAV, V16, P501, DOI 10.1016/j.yebeh.2009.08.025; Angeleri F, 1999, EPILEPSIA, V40, P1222, DOI 10.1111/j.1528-1157.1999.tb00850.x; Annegers JF, 1998, NEW ENGL J MED, V338, P20, DOI 10.1056/NEJM199801013380104; Asikainen I, 1999, EPILEPSIA, V40, P584, DOI 10.1111/j.1528-1157.1999.tb05560.x; Bhattacharjee Y, 2008, SCIENCE, V319, P406, DOI 10.1126/science.319.5862.406; Blumcke I, 1997, NEUROREPORT, V8, P1235; Briellmann RS, 2000, NEUROLOGY, V55, P435, DOI 10.1212/WNL.55.3.435; Bullock R, 1996, Eur J Emerg Med, V3, P109, DOI 10.1097/00063110-199606000-00010; Bushnik T, 2004, J HEAD TRAUMA REHAB, V19, P296, DOI 10.1097/00001199-200407000-00004; Cavalleri GL, 2007, LANCET NEUROL, V6, P970, DOI 10.1016/S1474-4422(07)70247-8; Chen XH, 2009, BRAIN PATHOL, V19, P214, DOI 10.1111/j.1750-3639.2008.00176.x; Chen Y, 1997, NEUROSCIENCE, V80, P1255, DOI 10.1016/S0306-4522(97)00007-9; Chu AY, 2009, BMC MED GENET, V10, DOI 10.1186/1471-2350-10-108; Clark RSB, 1996, J CEREBR BLOOD F MET, V16, P253, DOI 10.1097/00004647-199603000-00010; CORDER EH, 1994, NAT GENET, V7, P180, DOI 10.1038/ng0694-180; Deane R, 2008, J CLIN INVEST, V118, P4002, DOI 10.1172/JCI36663; Diaz-Arrastia R, 2003, ARCH NEUROL-CHICAGO, V60, P818, DOI 10.1001/archneur.60.6.818; DIKMEN SS, 1991, JAMA-J AM MED ASSOC, V265, P1271, DOI 10.1001/jama.265.10.1271; Englander J, 2009, J NEUROTRAUM, V26, P1471, DOI 10.1089/neu.2008.0729; Friedman G, 1999, NEUROLOGY, V52, P244, DOI 10.1212/WNL.52.2.244; Gambardella A, 1999, EPILEPSIA, V40, P1804, DOI 10.1111/j.1528-1157.1999.tb01602.x; Gouras GK, 1997, ANN NEUROL, V41, P402, DOI 10.1002/ana.410410317; Haltiner AM, 1997, ARCH PHYS MED REHAB, V78, P835, DOI 10.1016/S0003-9993(97)90196-9; HAUSER WA, 1991, EPILEPSIA, V32, P429, DOI 10.1111/j.1528-1157.1991.tb04675.x; Hayes GM, 2009, J VET EMERG CRIT CAR, V19, P629, DOI 10.1111/j.1476-4431.2009.00478.x; HIXSON JE, 1990, J LIPID RES, V31, P545; Holtzman DM, 1999, J CLIN INVEST, V103, pR15, DOI 10.1172/JCI6179; Horsburgh K, 2000, NEUROBIOL AGING, V21, P245, DOI 10.1016/S0197-4580(00)00097-X; Hung CC, 2005, PHARMACOGENOMICS, V6, P411, DOI 10.1517/14622416.6.4.411; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; JENNETT B, 1975, LANCET, V1, P480; Johnson VE, 2009, J NEUROTRAUM, V26, P1197, DOI [10.1089/neu.2008.0843, 10.1089/neu.2008-0843]; KAMBOH MI, 1995, NAT GENET, V11, P104, DOI 10.1038/ng0995-104d; Kay AD, 2003, J NEUROTRAUM, V20, P943, DOI 10.1089/089771503770195795; Lichtman SW, 2000, NEUROLOGY, V55, P1536, DOI 10.1212/WNL.55.10.1536; Lin CM, 2009, SURG NEUROL, V72, P50, DOI 10.1016/j.wneu.2009.09.004; MACKENZIE IRA, 1994, ACTA NEUROPATHOL, V87, P504; Martel CL, 1997, J NEUROCHEM, V69, P1995; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Mohler L, 2008, J NEUROTRAUM, V25, P874; Nathoo N, 2003, J CLIN PATHOL-MOL PA, V56, P132, DOI 10.1136/mp.56.3.132; NICOLINI C, 1995, ELECTR BIOT ADV FOR, V1, P135; Rocchi A, 2009, CURR ALZHEIMER RES, V6, P224, DOI 10.2174/156720509788486644; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; SMITH KR, 1994, ARCH NEUROL-CHICAGO, V51, P653, DOI 10.1001/archneur.1994.00540190029012; Strittmatter WJ, 1996, ANNU REV NEUROSCI, V19, P53, DOI 10.1146/annurev.ne.19.030196.000413; Teasdale GM, 2005, BRAIN, V128, P2556, DOI 10.1093/brain/awh595; Teasdale GM, 1997, LANCET, V350, P1069, DOI 10.1016/S0140-6736(97)04318-3; Temkin NR, 2009, EPILEPSIA, V50, P10, DOI 10.1111/j.1528-1167.2008.02005.x; TEMKIN NR, 1990, NEW ENGL J MED, V323, P497, DOI 10.1056/NEJM199008233230801; Temkin NR, 2003, EPILEPSIA, V44, P18, DOI 10.1046/j.1528-1157.44.s10.6.x; Vespa PM, 1999, J NEUROSURG, V91, P750, DOI 10.3171/jns.1999.91.5.0750; Wagner AK, 2005, CRIT CARE MED, V33, P407, DOI 10.1097/01.CCM.0000153931.23488.DD; White JRM, 2001, CRIT CARE MED, V29, P534, DOI 10.1097/00003246-200103000-00011; YOUNG B, 1987, J NEUROSURG, V67, P668, DOI 10.3171/jns.1987.67.5.0668; Zhou WD, 2008, J NEUROTRAUM, V25, P279, DOI 10.1089/neu.2007.0489	57	22	23	0	2	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.		2010	24	12					1468	1477		10.3109/02699052.2010.520299			10	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	667NR	WOS:000283200800009	20961174				2021-06-18	
J	O'Neil-Pirozzi, TM; Strangman, GE; Goldstein, R; Katz, DI; Savage, CR; Kelkar, K; Supelana, C; Burke, D; Rauch, SL; Glenn, MB				O'Neil-Pirozzi, Therese M.; Strangman, Gary E.; Goldstein, Richard; Katz, Douglas I.; Savage, Cary R.; Kelkar, Kalika; Supelana, Christina; Burke, David; Rauch, Scott L.; Glenn, Mel B.			A Controlled Treatment Study of Internal Memory Strategies (I-MEMS) Following Traumatic Brain Injury	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						group; memory deficit; rehabilitation; traumatic brain injury	CLOSED-HEAD-INJURY; COGNITIVE REHABILITATION; FREE-RECALL; PEOPLE; TRIAL; ERRORLESS; THERAPY; DEVICES	Objective: To evaluate the effects of participation in a memory group intervention focusing on internal strategy use on persons with traumatic brain injury-related memory impairment. Participants: Ninety-four adults with traumatic brain injury (54 in the experimental group and 40 controls) and resulting memory impairment, with severities ranging from mild to severe. All participants were at least 18 years of age at the time of injury and at least 1 year post injury at the time of study. Design: Non randomized pre/posttest group comparison design. Main Outcome Measures: Hopkins Verbal Learning Test-Revised and Rivermead Behavioral Memory Test II. Results: Participation in the memory group intervention was associated with improved memory performance immediately postintervention, and improvements were maintained I month postintervention. Severe injury was associated with less improvement in memory outcomes than mild and moderate injuries. Age and preinjury education were not related to outcome. Conclusions: Individuals with traumatic brain injury may benefit from memory group intervention focusing on internal strategy use. Study hypotheses should be retested using a randomized, controlled design, and further research is needed to better delineate influences on intervention candidacy and outcomes.	[O'Neil-Pirozzi, Therese M.] Northeastern Univ, Dept Speech Language Pathol & Audiol, Boston, MA 02115 USA; [O'Neil-Pirozzi, Therese M.; Strangman, Gary E.; Goldstein, Richard; Kelkar, Kalika; Glenn, Mel B.] Harvard Univ, Sch Med, Spaulding Rehabil Hosp, Dept Phys Med & Rehabil, Boston, MA USA; [Strangman, Gary E.; Supelana, Christina] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Dept Psychiat, Charlestown, MA USA; [Katz, Douglas I.] Boston Univ, Sch Med, Braintree Rehabil Hosp, Dept Neurol, Braintree, MA USA; [Savage, Cary R.] Univ Kansas, Med Ctr, Hoglund Brain Imaging Ctr, Kansas City, KS 66103 USA; [Burke, David] Emory Univ, Dept Rehabil Med, Atlanta, GA 30322 USA; [Rauch, Scott L.] Harvard Univ, McLean Hosp, Sch Med, Belmont, MA 02178 USA	O'Neil-Pirozzi, TM (corresponding author), Northeastern Univ, Dept Speech Language Pathol & Audiol, 250 Huntington Ave,Forsyth Bldg,Room 103, Boston, MA 02115 USA.	t.oneil-pirozzi@neu.edu		Strangman, Gary/0000-0001-8896-2164; Katz, Douglas/0000-0002-7502-8505	National Institute on Disability and Rehabilitation Research, US Department of EducationUS Department of Education [H133A020513]	This project was supported by grant NIDRR: H133A020513 from the National Institute on Disability and Rehabilitation Research, US Department of Education.	American Psychiatric Association, 1994, DIAGN STAT MAN MENT; [Anonymous], 1999, JAMA, V282, P974; [Anonymous], 1997, GUIDE UNIFORM DATA S; BADDELEY A, 1987, NEUROBEHAVIORAL RECO, P295; Berg I. J., 1991, NEUROPSYCHOL REHABIL, V1, P97, DOI [DOI 10.1080/09602019108401384, 10.1080/09602019108401384]; Brandt J., 2001, HOPKINS VERBAL LEARN; Cappa SF, 2003, EUR J NEUROL, V10, P11, DOI 10.1046/j.1468-1331.2003.00537.x; Cicerone KD, 2005, ARCH PHYS MED REHAB, V86, P1681, DOI 10.1016/j.apmr.2005.03.024; Cicerone KD, 2000, ARCH PHYS MED REHAB, V81, P1596, DOI 10.1053/apmr.2000.19240; Cicerone KD, 1992, NEUROREHABILITATION, V2, P12, DOI DOI 10.3233/NRE-1992-2304; Evans JJ, 2000, NEUROPSYCHOL REHABIL, V10, P67, DOI 10.1080/096020100389309; GERSHBERG FB, 1995, NEUROPSYCHOLOGIA, V33, P1305, DOI 10.1016/0028-3932(95)00103-A; Goodglass H., 2001, BOSTON DIAGNOSTIC AP; Hardin J.W., 2003, GEN ESTIMATING EQUAT; Hart T, 2003, BRAIN INJURY, V17, P401, DOI 10.1080/0269905021000038438; Hart T, 2002, J HEAD TRAUMA REHAB, V17, P556, DOI 10.1097/00001199-200212000-00007; Hewitt J, 2006, NEUROPSYCHOLOGIA, V44, P1468, DOI 10.1016/j.neuropsychologia.2005.11.016; Kaplan E., 2001, Boston naming test; Kaschel R, 2002, NEUROPSYCHOL REHABIL, V12, P127, DOI 10.1080/09602010143000211; Kaschel R., 1993, DEV ASSESSMENT REHAB, P145; KENNEDY M, 2006, AHSA LEAD, V11, P8; Kennedy M, 2006, AHSA LEAD, V11, P34; KERNER MJ, 1985, COGNITIVE REHABI NOV, P26; LEVIN HS, 1982, NEUROBEHAVIORAL CONS; Levine B, 2000, J INT NEUROPSYCH SOC, V6, P299, DOI 10.1017/S1355617700633052; Lezak M.D., 2004, NEUROPSYCHOLOGICAL A, Vfourth; MALEC J, 1990, J HEAD TRAUMA REHAB, V5, P60; McKinlay W, 1999, REHABILITATION ADULT, V3, P74; O'Neil-Pirozzi TM, 2004, BRAIN INJURY, V18, P179, DOI 10.1080/0269905031000149560; Oberg L, 1998, J HEAD TRAUMA REHAB, V13, P44, DOI 10.1097/00001199-199806000-00005; ODDY M, 1985, J NEUROL NEUROSUR PS, V48, P564, DOI 10.1136/jnnp.48.6.564; Parente R, 1999, NEUROREHABILITATION, V13, P157; Quemada JI, 2003, J HEAD TRAUMA REHAB, V18, P532, DOI 10.1097/00001199-200311000-00007; Royston P, 2005, STATA J, V5, P527, DOI 10.1177/1536867X0500500404; RYAN T V, 1992, Brain Injury, V6, P175, DOI 10.3109/02699059209029656; Ryan T V, 1988, Arch Clin Neuropsychol, V3, P165, DOI 10.1016/0887-6177(88)90061-3; SCHACTER DL, 1977, CORTEX, V13, P150, DOI 10.1016/S0010-9452(77)80006-3; SCHMITTEREDGECOMBE M, 1995, J CONSULT CLIN PSYCH, V63, P484; SHIMAMURA AP, 1990, NEUROPSYCHOLOGIA, V28, P803, DOI 10.1016/0028-3932(90)90004-8; Sohlberg M. M., 2001, COGNITIVE REHABILITA; Sohlberg M. M., 2005, REHABILITATION TRAUM, P47; SOHLBERG MM, 1989, J CLIN EXP NEUROPSYC, V11, P871, DOI 10.1080/01688638908400941; Strangman G, 2005, AM J PHYS MED REHAB, V84, P62, DOI 10.1097/01.PHM.0000150787.26860.12; Strangman GE, 2008, ARCH PHYS MED REHAB, V89, P974, DOI 10.1016/j.apmr.2008.02.011; Strangman GE, 2009, NEUROREHAB NEURAL RE, V23, P226, DOI 10.1177/1545968308324225; Thickpenny-Davis KL, 2007, J HEAD TRAUMA REHAB, V22, P303, DOI 10.1097/01.HTR.0000290975.09496.93; Thoene A I, 1995, J Int Neuropsychol Soc, V1, P29; TULVING E, 1962, PSYCHOL REV, V69, P344, DOI 10.1037/h0043150; War Department Adjutant General's Office, 1944, ARM IND TEST BATT MA; Wechsler D., 1987, WECHSLER MEMORY SCAL; WILSON B, 1987, J CLIN EXP NEUROPSYC, V9, P527, DOI 10.1080/01688638708410767; WILSON BA, 1994, NEUROPSYCHOL REHABIL, V4, P307, DOI 10.1080/09602019408401463; Wilson BA, 2001, J NEUROL NEUROSUR PS, V70, P477, DOI 10.1136/jnnp.70.4.477; WILSON BA, 1995, HDB MEMORY DISORDERS, P451; Wilson BA, 2003, RIVERMEAD BEHAV MEMO; Wright P, 2001, INT J REHABIL RES, V24, P299, DOI 10.1097/00004356-200112000-00006; ZENCIUS A, 1990, Brain Injury, V4, P33, DOI 10.3109/02699059009026146	57	22	23	0	18	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0885-9701			J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	JAN-FEB	2010	25	1					43	51		10.1097/HTR.0b013e3181bf24b1			9	Clinical Neurology; Rehabilitation	Neurosciences & Neurology; Rehabilitation	550XC	WOS:000274165800006	20051897				2021-06-18	
J	Rockhill, CM; Fann, JR; Fan, MY; Hollingworth, W; Katon, WJ				Rockhill, Carol M.; Fann, Jesse R.; Fan, Ming-Yu; Hollingworth, William; Katon, Wayne J.			Healthcare costs associated with mild traumatic brain injury and psychological distress in children and adolescents	BRAIN INJURY			English	Article						Traumatic brain injury; psychiatry; child; cost	HEAD-INJURY; PSYCHIATRIC-ILLNESS; CAREGIVER BURDEN; MEDICAL COSTS; DISORDERS; IMPACT; COHORT; REHABILITATION; POPULATION; PREDICTORS	Primary objective: Comparison of healthcare costs for youth with mild traumatic brain injuries (TBIs) to costs in a matched cohort of children without TBI in the 3 years following injury. Research design: This study used a prospective cohort design with 3-year follow-up. Costs were examined using the well-established two-step model and controlling for potential confounding variables. Methods and procedures: Four-hundred and ninety subjects from a large health maintenance organization, 14 years old or younger, who sustained a mild TBI in 1993, were identified using computerized records. For each youth with mild TBI, three control subjects were selected (n = 1470), matched on age, sex and enrolment at the time of injury. Experimental interventions: Not applicable. Main outcomes and results: TBI exposure was associated with an increase in the proportion of subjects who had non-zero medical costs in all categories examined and a 75% increase in mean total costs. Presence of psychological distress was also associated with increased proportion of subjects with costs in all categories examined and was associated with an approximate doubling of mean total costs. Conclusions: Mild TBI and psychological distress were each associated with significant increases in healthcare costs in an HMO setting.	[Rockhill, Carol M.; Fann, Jesse R.; Fan, Ming-Yu; Katon, Wayne J.] Univ Washington, Dept Psychiat & Behav Sci, Seattle, WA 98195 USA; [Fann, Jesse R.] Univ Washington, Dept Rehabil Med, Seattle, WA 98195 USA; [Hollingworth, William] Univ Washington, Dept Radiol, Seattle, WA 98195 USA; [Hollingworth, William] Univ Washington, Dept Pharm, Seattle, WA 98195 USA	Rockhill, CM (corresponding author), Univ Washington, Dept Psychiat & Behav Sci, Box 356560,1959 NE Pacific St, Seattle, WA 98195 USA.	rockhill@u.washington.edu		Hollingworth, William/0000-0002-0840-6254	National Center for Injury Prevention and Control, Centers for Disease Control and Prevention, Atlanta, GAUnited States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA; Economic and Social Research CouncilUK Research & Innovation (UKRI)Economic & Social Research Council (ESRC) [ES/G007543/1] Funding Source: researchfish	This research was supported by a grant to the second author from the National Center for Injury Prevention and Control, Centers for Disease Control and Prevention, Atlanta, GA. The funding organizations role was limited to review of the design of the study. We thank David Rubanowice, BS, for his computer programming assistance.	Anderson V, 2006, AM J PHYS MED REHAB, V85, P767, DOI 10.1097/01.phm.0000233176.08480.22; Anderson VA, 2006, NEUROPSYCHOLOGY, V20, P42, DOI 10.1037/0894-4105.20.1.42; Appleton R., 2006, MANAGEMENT BRAIN INJ; Bartlett SN, 2002, HEALTH POLICY PLANN, V17, P1, DOI 10.1093/heapol/17.1.1; Brener I, 2004, J HEAD TRAUMA REHAB, V19, P405, DOI 10.1097/00001199-200409000-00005; BROOKS N, 1986, J NEUROL NEUROSUR PS, V49, P764, DOI 10.1136/jnnp.49.7.764; Brouwer WBF, 2005, BRIT MED J, V331, P446, DOI 10.1136/bmj.331.7514.446; Ciechanowski PS, 2000, ARCH INTERN MED, V160, P3278, DOI 10.1001/archinte.160.21.3278; Congeni Joseph, 2009, Adolesc Med State Art Rev, V20, P41; COSTELLO EJ, 1988, PEDIATRICS, V82, P435; Diehr P, 1999, ANNU REV PUBL HEALTH, V20, P125, DOI 10.1146/annurev.publhealth.20.1.125; Ergh TC, 2002, J HEAD TRAUMA REHAB, V17, P155, DOI 10.1097/00001199-200204000-00006; Fann JR, 2004, ARCH GEN PSYCHIAT, V61, P53, DOI 10.1001/archpsyc.61.1.53; FANN JR, 1995, AM J PSYCHIAT, V152, P1493; FAY GC, 1994, ARCH PHYS MED REHAB, V75, P733; FAY GC, 1993, ARCH PHYS MED REHAB, V74, P895; Ganesalingam K, 2006, J INT NEUROPSYCH SOC, V12, P609, DOI 10.1017/S1355617706060796; Hessen E, 2007, BRAIN INJURY, V21, P963, DOI 10.1080/02699050701528454; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; JAFFE KM, 1993, ARCH PHYS MED REHAB, V74, P681, DOI 10.1016/0003-9993(93)90024-5; Katon WJ, 2006, MED CARE, V44, P1064, DOI 10.1097/01.mlr.0000237421.17555.8f; Katon WJ, 2003, ARCH GEN PSYCHIAT, V60, P897, DOI 10.1001/archpsyc.60.9.897; Keenan HT, 2006, DEV NEUROSCI-BASEL, V28, P256, DOI 10.1159/000094152; Kim E, 2007, J NEUROPSYCH CLIN N, V19, P106, DOI 10.1176/appi.neuropsych.19.2.106; Kolakowsky-Hayner SA, 1999, NEUROREHABILITATION, V13, P27; KREUTZER JS, 1994, BRAIN INJURY, V8, P211, DOI 10.3109/02699059409150974; Langlois JA., 2004, TRAUMATIC BRAIN INJU; Lofgren R, 2006, ACAD MED, V81, P713, DOI 10.1097/00001888-200608000-00007; Marsh NV, 2002, J CLIN EXP NEUROPSYC, V24, P434, DOI 10.1076/jcen.24.4.434.1030; Marsh NV, 1998, BRAIN INJURY, V12, P1045, DOI 10.1080/026990598121954; Massagli TL, 2004, ARCH PHYS MED REHAB, V85, P1428, DOI 10.1016/j.apmr.2003.12.036; MORTON MV, 1995, BRAIN INJURY, V9, P81, DOI 10.3109/02699059509004574; *NAT CTR HLTH STAT, 1991, 911260 NAT CTR HLTH; Ortendahl M, 2002, J CLIN EPIDEMIOL, V55, P843, DOI 10.1016/S0895-4356(02)00447-X; POLISSAR NL, 1994, BRAIN INJURY, V8, P249, DOI 10.3109/02699059409150977; Ponsford J, 2001, PEDIATRICS, V108, P1297, DOI 10.1542/peds.108.6.1297; Ruff R, 2009, J HEAD TRAUMA REHAB, V24, P131, DOI 10.1097/01.HTR.0000348755.42649.e9; Saunders KW, 1994, PHARMACOEPIDEM DR S, P171; Schneier AJ, 2006, PEDIATRICS, V118, P483, DOI 10.1542/peds.2005-2588; Shi JX, 2009, BRAIN INJURY, V23, P602, DOI 10.1080/02699050903014907; Slomine BS, 2002, BRAIN INJURY, V16, P759, DOI 10.1080/02699050210127286; Smith N S, 1994, Manag Care Q, V2, P21; Sokol DK, 1996, BRAIN INJURY, V10, P439, DOI 10.1080/026990596124296; Thurman DJ., 1995, GUIDELINES SURVEILLA; Timonen M, 2002, PSYCHIAT RES, V113, P217, DOI 10.1016/S0165-1781(02)00269-X; Tonks J, 2008, BRAIN INJURY, V22, P325, DOI 10.1080/02699050801968303; Tonks J, 2009, DEV MED CHILD NEUROL, V51, P8, DOI 10.1111/j.1469-8749.2008.03219.x; U.S. Bureau of Labor Statistics, CONS PRIC IND; Wade SL, 2002, J HEAD TRAUMA REHAB, V17, P96, DOI 10.1097/00001199-200204000-00003; Walker EA, 2003, ARCH GEN PSYCHIAT, V60, P369, DOI 10.1001/archpsyc.60.4.369; Warriner Erin M, 2006, Curr Psychiatry Rep, V8, P73, DOI 10.1007/s11920-006-0083-2; Weiner J P, 1992, HMO Pract, V6, P13; Williams WH, 2003, NEUROPSYCHOL REHABIL, V13, P133, DOI 10.1080/09602010244000417	53	22	23	0	5	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2010	24	9					1051	1060		10.3109/02699052.2010.494586			10	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	636RH	WOS:000280756700001	20597633				2021-06-18	
J	Shahlaie, K; Lyeth, BG; Gurkoff, GG; Muizelaar, JP; Berman, RF				Shahlaie, Kiarash; Lyeth, Bruce G.; Gurkoff, Gene G.; Muizelaar, J. Paul; Berman, Robert F.			Neuroprotective Effects of Selective N-Type VGCC Blockade on Stretch-Injury-Induced Calcium Dynamics in Cortical Neurons	JOURNAL OF NEUROTRAUMA			English	Article						in vitro; neuroprotection; N-type VGCC; SNX-185; traumatic brain injury	TRAUMATIC BRAIN-INJURY; INTRACELLULAR FREE CALCIUM; FOCAL CEREBRAL-ISCHEMIA; FLUID-PERCUSSION INJURY; CHANNEL ANTAGONIST; MITOCHONDRIAL DYSFUNCTION; DELAYED DEPOLARIZATION; CULTURED ASTROCYTES; CA-45 ACCUMULATION; SODIUM-CHANNELS	Acute elevation in intracellular calcium ([Ca2+](i)) following traumatic brain injury (TBI) can trigger cellular mechanisms leading to neuronal dysfunction and death. The mechanisms underlying these processes are not completely understood, but calcium influx through N-type voltage-gated calcium channels (VGCCs) appears to play a central role. The present study examined the time course of [Ca2+](i) flux, glutamate release, and loss of cell viability following injury using an in vitro neuronal-glial cortical cell-culture model of TBI. The effects of N-channel blockade with SNX-185 (e.g. omega-conotoxin TVIA) before or after injury were also examined. Neuronal injury produced a transient elevation in [Ca2+](i), increased glutamate release, and resulted in neuronal and glial death. SNX-185 administered before or immediately after cell injury reduced glutamate release and increased the survival of neurons and astrocytes, whereas delayed treatment did not improve cell survival but significantly facilitated the return of [Ca2+](i) to baseline levels. The new findings that N-type VGCCs are critically involved in injury-induced glutamate release and recovery of [Ca2+](i) argue for continued investigation of this treatment strategy for the clinical management of TBI. In particular, SNX-185 may represent an effective class of drugs that can significantly protect injured neurons from the secondary insults that commonly occur after TBI.	[Shahlaie, Kiarash; Lyeth, Bruce G.; Gurkoff, Gene G.; Muizelaar, J. Paul; Berman, Robert F.] Univ Calif Davis, Dept Neurol Surg, Sch Med, Sacramento, CA 95817 USA	Shahlaie, K (corresponding author), Univ Calif Davis, Dept Neurol Surg, Sch Med, 4860 Y St,Suite 3740, Sacramento, CA 95817 USA.	krshahlaie@gmail.com		Lyeth, Bruce/0000-0003-4811-1474	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS 39090, NS 29995, NS 45136]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS029995, R01NS045136, R01NS039090] Funding Source: NIH RePORTER	The authors thank Ryan Martin, Kim Katleba, and Dr. Candace Floyd for their invaluable assistance with these experiments, and William T. O'Connor for performing the analysis of the glutamate levels. This research was supported by NIH NS 39090 (RFB), NIH NS 29995 (BGL), and NS 45136 (BGL).	Ahmed SM, 2002, J NEUROTRAUM, V19, P1619, DOI 10.1089/089771502762300274; Ahmed SM, 2000, J NEUROCHEM, V74, P1951, DOI 10.1046/j.1471-4159.2000.741951000000000.x; Atkins CM, 2006, J CEREBR BLOOD F MET, V26, P1507, DOI 10.1038/sj.jcbfm.9600301; Berman RF, 2000, J NEUROSURG, V93, P821, DOI 10.3171/jns.2000.93.5.0821; Bowersox SS, 1997, BRAIN RES, V747, P343; Bowersox SS, 1996, J PHARMACOL EXP THER, V279, P1243; Brophy GM, 2009, J NEUROTRAUM, V26, P471, DOI 10.1089/neu.2008.0657; Colbourne F, 1999, STROKE, V30, P662, DOI 10.1161/01.STR.30.3.662; Deng Y, 2007, EXP NEUROL, V205, P154, DOI 10.1016/j.expneurol.2007.01.023; ELLIS EF, 1995, J NEUROTRAUM, V12, P325, DOI 10.1089/neu.1995.12.325; Floyd CL, 2007, PROG BRAIN RES, V161, P61, DOI 10.1016/S0079-6123(06)61005-4; Floyd CL, 2001, GLIA, V33, P12, DOI 10.1002/1098-1136(20010101)33:1<12::AID-GLIA1002>3.0.CO;2-V; Folkerts MM, 2007, J NEUROTRAUM, V24, P638, DOI 10.1089/neu.2006.0188; Gennarelli T. A., 2005, TXB TRAUMATIC BRAIN, P27; Hellmich HL, 2007, BRAIN RES, V1127, P119, DOI 10.1016/j.brainres.2006.09.094; HOVDA DA, 1994, ACTA NEUROCHIR, P521; Iwata A, 2004, J NEUROSCI, V24, P4605, DOI 10.1523/JNEUROSCI.0515-03.2004; Kovesdi E, 2007, PROG BRAIN RES, V161, P81, DOI 10.1016/S0079-6123(06)61006-6; LaPlaca MC, 1997, J NEUROTRAUM, V14, P355, DOI 10.1089/neu.1997.14.355; Lee LL, 2004, EXP NEUROL, V190, P70, DOI 10.1016/j.expneurol.2004.07.003; Meberg PJ, 2003, METHOD CELL BIOL, V71, P111, DOI 10.1016/S0091-679X(03)01007-0; Muellner A, 2003, J NEUROTRAUM, V20, P745, DOI 10.1089/089771503767869971; Newcomb R, 2000, PEPTIDES, V21, P491, DOI 10.1016/S0196-9781(00)00175-3; OORSCHOT DE, 1989, EXP BRAIN RES, V78, P132; Perez-Pinzon MA, 1997, J NEUROL SCI, V153, P25, DOI 10.1016/S0022-510X(97)00196-2; Rodriguez-Baeza A, 2003, ANAT REC PART A, V273A, P583, DOI 10.1002/ar.a.10069; Rzigalinski BA, 1998, J NEUROCHEM, V70, P2377; Samii A, 1999, J NEUROTRAUM, V16, P879, DOI 10.1089/neu.1999.16.879; SCHANNE FAX, 1979, SCIENCE, V206, P700, DOI 10.1126/science.386513; Schinder AF, 1996, J NEUROSCI, V16, P6125; SIESJO BK, 1989, J CEREBR BLOOD F MET, V9, P127, DOI 10.1038/jcbfm.1989.20; Slemmer JE, 2002, BRAIN, V125, P2699, DOI 10.1093/brain/awf271; Smith DH, 1999, J NEUROSCI, V19, P4263; Staats PS, 2004, JAMA-J AM MED ASSOC, V291, P63, DOI 10.1001/jama.291.1.63; Stein SC, 2004, NEUROSURGERY, V54, P687, DOI 10.1227/01.NEU.0000108641.98845.88; Tavalin SJ, 1997, J NEUROPHYSIOL, V77, P632; Tavalin SJ, 1995, J NEUROPHYSIOL, V74, P2767; Vacher H, 2008, PHYSIOL REV, V88, P1407, DOI 10.1152/physrev.00002.2008; VALENTINO K, 1993, P NATL ACAD SCI USA, V90, P7894, DOI 10.1073/pnas.90.16.7894; Verweij BH, 2000, J NEUROSURG, V93, P829, DOI 10.3171/jns.2000.93.5.0829; Verweij BH, 1997, NEUROL RES, V19, P334, DOI 10.1080/01616412.1997.11740821; Wang YX, 1998, N-S ARCH PHARMACOL, V357, P159, DOI 10.1007/PL00005150; Weber JT, 2004, CURR NEUROVASC RES, V1, P151, DOI 10.2174/1567202043480134; Weber JT, 2001, J BIOL CHEM, V276, P1800, DOI 10.1074/jbc.M009209200; Weber JT, 1999, CELL CALCIUM, V26, P289, DOI 10.1054/ceca.1999.0082; Wolf JA, 2001, J NEUROSCI, V21, P1923, DOI 10.1523/JNEUROSCI.21-06-01923.2001; Wong J, 2005, NEUROCRIT CARE, V3, P177, DOI 10.1385/NCC:3:2:177; YOUNG W, 1992, J NEUROTRAUM, V9, pS9; YOUNG W, 1996, NEUROTRAUMA, P1421; Zhao XR, 2003, GLIA, V44, P140, DOI 10.1002/glia.10283; Zhong C, 2006, J NEUROCHEM, V97, P1015, DOI 10.1111/j.1471-4159.2006.03786.x	51	22	24	0	3	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JAN	2010	27	1					175	187		10.1089/neu.2009.1003			13	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	548RF	WOS:000273983200015	19772476	Green Published			2021-06-18	
J	Stewart, CR; Landseadel, JP; Gurka, MJ; Fairchild, KD				Stewart, Corrine R.; Landseadel, Jessica P.; Gurka, Matthew J.; Fairchild, Karen D.			Hypothermia increases interleukin-6 and interleukin-10 in juvenile endotoxemic mice	PEDIATRIC CRITICAL CARE MEDICINE			English	Article						hypothermia; cytokines; interleukin-10; interleukin-6; endotoxin	TRAUMATIC BRAIN-INJURY; NF-KAPPA-B; MODERATE HYPOTHERMIA; MILD HYPOTHERMIA; CARDIAC-ARREST; THERAPEUTIC HYPOTHERMIA; NEONATAL ENCEPHALOPATHY; INFLAMMATORY RESPONSE; HEMORRHAGIC-SHOCK; IL-10 PRODUCTION	Objective: To develop a juvenile mouse model to establish effects of in vivo hypothermia on expression of the inflammation-modulating cytokines tumor necrosis factor-alpha, interleukin-1 beta, interleukin-6, and interleukin-10. Although induced hypothermia is neuroprotective in some patients, the mechanisms of protection are not well understood and concerns remain over potential detrimental effects, particularly in the setting of infection. We previously showed that in vitro hypothermia increases production of tumor necrosis factor-alpha and interleukin-1 beta in lipopolysaccharide-treated monocytes. Design: Laboratory investigation. Setting: Research laboratory. Subjects: Juvenile (4-wk) male C57BL/6 mice. Interventions: Mice were given chlorpromazine to suspend thermoregulation and lipopolysaccharide to stimulate cytokine production. Core temperature was maintained at 32 degrees C or 37 degrees C for 6 hrs by adjusting environmental temperature. In separate experiments, lipopolysaccharide-treated mice were kept in a cooling chamber without chlorpromazine treatment. Measurements and Main Results. Plasma and organs were collected for cytokine quantitation. Chlorpromazine-treated hypo-thermic mice had 2.3-fold and 1.8-fold higher plasma interleukin-6 and interleukin-10 levels at 6 hrs compared with identically treated normothermic mice (p < .05), whereas plasma tumor necrosis factor-alpha and interleukin-1 beta were not significantly different at 2 hrs or 6 hrs. Liver tumor necrosis factor-alpha and interleukin-6 were significantly higher in hypothermic vs. normothermic mice, but lung and brain cytokines were not different. Lipopolysaccharide-treated mice kept in a cooling chamber without chlorpromazine treatment developed varying degrees of hypothermia with associated increases in plasma interleukin-6 and interleukin-10. A nonspecific marker of stress (plasma corticosterone) was not affected by hypothermia in lipopolysaccharide-treated mice. Conclusion. Further studies are necessary to determine the mechanism and physiologic consequences of augmented systemic interleukin-6 and interleukin-10 expression during induced hypothermia. (Pediatr Crit Care Med 2010; 11:109-116)	[Stewart, Corrine R.; Landseadel, Jessica P.; Gurka, Matthew J.; Fairchild, Karen D.] Univ Virginia, Dept Pediat, Childrens Hosp, Charlottesville, VA 22903 USA; [Gurka, Matthew J.] Univ Virginia, Dept Publ Hlth Sci, Childrens Hosp, Charlottesville, VA USA	Fairchild, KD (corresponding author), Univ Virginia, Dept Pediat, Childrens Hosp, Charlottesville, VA 22903 USA.	kdf2n@virginia.edu			University of Virginia Children's Hospital Fellow Grant (CRS); American Heart AssociationAmerican Heart Association [0365547U]; Jeffress Memorial Research Trust; Eunice Kennedy Shriver National Institute of Child Health and Human DevelopmentUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [5K08HD051609-02]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K08HD051609] Funding Source: NIH RePORTER	This work was supported, in part, by a University of Virginia Children's Hospital Fellow Grant (CRS) and Grant 0365547U from the American Heart Association, Jeffress Memorial Research Trust, and Grant 5K08HD051609-02 (KDF) from the Eunice Kennedy Shriver National Institute of Child Health and Human Development.	Adrie C, 2002, CIRCULATION, V106, P562, DOI 10.1161/01.CIR.0000023891.80661.AD; Aibiki M, 1999, J NEUROTRAUM, V16, P225, DOI 10.1089/neu.1999.16.225; Albaiceta Guillermo M., 2007, Inflammation & Allergy Drug Targets, V6, P191, DOI 10.2174/187152807783334337; Aly H, 2006, BRAIN DEV-JPN, V28, P178, DOI 10.1016/j.braindev.2005.06.006; Beilin B, 1998, ANESTHESIOLOGY, V89, P1133, DOI 10.1097/00000542-199811000-00013; Bernard SA, 2002, NEW ENGL J MED, V346, P557, DOI 10.1056/NEJMoa003289; BOSCHI G, 1987, BRIT J PHARMACOL, V90, P745, DOI 10.1111/j.1476-5381.1987.tb11228.x; Buttram SDW, 2007, J NEUROTRAUM, V24, P1707, DOI 10.1089/neu.2007.0349; Callaway CW, 2008, CRIT CARE MED, V36, P2607, DOI 10.1097/CCM.0b013e318184443b; Carlson NG, 1999, J IMMUNOL, V163, P3963; CHERNOW B, 1983, CRIT CARE MED, V11, P677, DOI 10.1097/00003246-198309000-00001; Chu SJ, 2005, CHEST, V128, P327, DOI 10.1016/S0012-3692(15)37965-4; Dietrich WD, 1999, EXP NEUROL, V158, P444, DOI 10.1006/exnr.1999.7115; Druker J, 2006, ANN NY ACAD SCI, V1088, P297, DOI 10.1196/annals.1366.007; Eicher DJ, 2005, PEDIATR NEUROL, V32, P11, DOI 10.1016/j.pediatrneurol.2004.06.014; Elenkov IJ, 1996, P ASSOC AM PHYSICIAN, V108, P374; Fairchild KD, 2005, AM J PHYSIOL-CELL PH, V289, pC1114, DOI 10.1152/ajpcell.00152.2005; Fairchild KD, 2004, AM J PHYSIOL-CELL PH, V287, pC422, DOI 10.1152/ajpcell.00507.2003; GINSBERG MD, 2005, THERAPEUTIC HYPOTHER, P85; GLOBUS MYT, 1995, J NEUROCHEM, V65, P1704; Gluckman PD, 2005, LANCET, V365, P663, DOI 10.1016/S0140-6736(05)17946-X; Grunenfelder J, 2000, EUR J CARDIO-THORAC, V17, P723, DOI 10.1016/S1010-7940(00)00401-2; Gundersen Y, 2001, ACTA ANAESTH SCAND, V45, P994, DOI 10.1034/j.1399-6576.2001.450812.x; Gunn AJ, 1997, J CLIN INVEST, V99, P248, DOI 10.1172/JCI119153; Holzer M, 2002, NEW ENGL J MED, V346, P549; Hong SB, 2005, CRIT CARE MED, V33, P2049, DOI 10.1097/01.CCM.0000178186.37167.53; Horan MR, 2004, J PEDIATR-US, V144, P301, DOI 10.1016/j.jpeds.2003.11.034; Hutchison JS, 2008, NEW ENGL J MED, V358, P2447, DOI 10.1056/NEJMoa0706930; Kentner R, 2002, SHOCK, V17, P521, DOI 10.1097/00024382-200206000-00014; Kinoshita K, 2002, NEUROSURGERY, V51, P195, DOI 10.1097/00006123-200207000-00027; LAPTOOK AR, 1995, PEDIATR RES, V38, P919, DOI 10.1203/00006450-199512000-00015; Lee SL, 2001, J SURG RES, V100, P150, DOI 10.1006/jsre.2001.6230; Leon LR, 2006, J APPL PHYSIOL, V100, P1400, DOI 10.1152/japplphysiol.01040.2005; LIN LI, 1989, BIOMETRICS, V45, P255, DOI 10.2307/2532051; Luhm J, 1998, EUR J BIOCHEM, V256, P325, DOI 10.1046/j.1432-1327.1998.2560325.x; LundgrenEriksson L, 1996, ANTICANCER RES, V16, P333; Matsui T, 2004, ACTA ANAESTH SCAND, V48, P205, DOI 10.1111/j.0001-5172.2004.00293.x; Matsui T, 2008, J NEUROTRAUM, V25, P709, DOI 10.1089/neu.2007.0482; Monroy M, 2001, AM J PHYSIOL-HEART C, V280, pH1448; Pang Y, 2005, DEV BRAIN RES, V157, P141, DOI 10.1016/j.devbrainres.2005.03.015; Remick DG, 2005, INFECT IMMUN, V73, P2751, DOI 10.1128/IAI.73.5.2751-2757.2005; Saegusa T, 2003, J VET MED SCI, V65, P1365, DOI 10.1292/jvms.65.1365; Scumpia PO, 2004, CHEST, V125, P1483, DOI 10.1378/chest.125.4.1483; Shankaran S, 2005, NEW ENGL J MED, V353, P1574, DOI 10.1056/NEJMcps050929; Stoll G, 2002, ADV EXP MED BIOL, V513, P87; Stravitz RT, 2008, NEUROCRIT CARE, V9, P90, DOI 10.1007/s12028-008-9090-y; Sutcliffe IT, 2001, J CEREBR BLOOD F MET, V21, P1310, DOI 10.1097/00004647-200111000-00007; Torossian A, 2004, CRIT CARE MED, V32, P1899, DOI 10.1097/01.CCM.0000139608.34486.FD; Truettner JS, 2005, MOL BRAIN RES, V138, P124, DOI 10.1016/j.molbrainres.2005.04.006; Wu XR, 2003, CRIT CARE MED, V31, P195, DOI 10.1097/00003246-200301000-00030; Yanagawa Y, 2002, RESUSCITATION, V53, P93, DOI 10.1016/S0300-9572(01)00499-3	51	22	26	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1529-7535	1947-3893		PEDIATR CRIT CARE ME	Pediatr. Crit. Care Med.	JAN	2010	11	1					109	116		10.1097/PCC.0b013e3181b01042			8	Critical Care Medicine; Pediatrics	General & Internal Medicine; Pediatrics	541FX	WOS:000273401800017	19602992	Green Accepted			2021-06-18	
J	Wade, SL; Walz, NC; Cassedy, A; Taylor, HG; Stancin, T; Yeates, KO				Wade, Shari L.; Walz, Nicolay C.; Cassedy, Amy; Taylor, H. Gerry; Stancin, Terry; Yeates, Keith Owen			Caregiver functioning following early childhood TBI: Do moms and dads respond differently?	NEUROREHABILITATION			English	Article							TRAUMATIC BRAIN-INJURY; GENDER DIFFERENCES; SOCIAL SUPPORT; FAMILY BURDEN; INITIAL YEAR; HEAD-INJURY; SHORT-TERM; CHILDREN; PREDICTORS; DISTRESS	Introduction: Research suggests that pediatric TBI results in injury-related stress and burden and psychological distress for parents. However, existing studies have focused almost exclusively on mothers, so that we know relatively little about the impact of childhood TBI on fathers. Specific aims: The aims were to prospectively examine differences in maternal and paternal response to early childhood TBI over time relative to a comparison cohort of mothers and fathers of children with orthopedic injuries (OI). Methods: The concurrent cohort/prospective research design involved repeated assessments of children aged 3-6 years with TBI or OI requiring hospitalization and their families. Shortly after injury and at 6, 12, and 18 months post injury, parents of 48 children with TBI (11 severe and 37 moderate) and 89 with OI completed standardized assessments of injury-related stress and burden, parental distress, and coping strategies. Mixed models analyses and Generalized Estimating Equations examined differences in maternal versus paternal burden, distress, and coping over time. The analyses included interactions of parent sex with group (severe TBI, moderate TBI, OI) and time since injury, to examine the moderating effects of injury severity on parental response to injury over time. Results: Fathers were more likely than mothers to use denial to cope following moderate and severe TBI, but not OI. Conversely, mothers were more likely to prefer acceptance and emotion-focused strategies than fathers regardless of the type of injury. The use of active coping strategies varied as a function of injury type, parent sex, and time since injury. Fathers reported greater injury-related stress and distress than mothers over time, with pronounced differences in the severe TBI and OI groups. Conclusions: Mothers and fathers appear to respond differently following TBI. The different types of responses may serve to exacerbate emerging family dysfunction.	[Wade, Shari L.] Univ Cincinnati, Div Pediat Phys Med & Rehabil, Cincinnati Childrens Hosp Med Ctr, Coll Med, Cincinnati, OH 45229 USA; [Taylor, H. Gerry] Rainbow Babies & Childrens Hosp, Cleveland, OH 44106 USA; [Taylor, H. Gerry; Stancin, Terry] Case Western Reserve Univ, Cleveland, OH 44106 USA; [Stancin, Terry] Metrohlth Med Ctr, Cleveland, OH USA; [Yeates, Keith Owen] Nationwide Childrens Hosp, Columbus, OH USA; [Yeates, Keith Owen] Ohio State Univ, Columbus, OH 43210 USA	Wade, SL (corresponding author), Univ Cincinnati, Div Pediat Phys Med & Rehabil, Cincinnati Childrens Hosp Med Ctr, Coll Med, 3333 Burnet Ave, Cincinnati, OH 45229 USA.	shari.wade@cchmc.org	Yeates, Keith/AAJ-4223-2020; Stancin, Terry/L-7993-2019	Yeates, Keith/0000-0001-7680-2892	NCRR NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [M01 RR008084, M01 RR08084] Funding Source: Medline; NICHD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01 HD042729, R01 HD42729] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD042729] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [M01RR008084] Funding Source: NIH RePORTER		ALDWIN CM, 1987, J PERS SOC PSYCHOL, V53, P337, DOI 10.1037/0022-3514.53.2.337; Anderson VA, 2006, NEUROPSYCHOLOGY, V20, P42, DOI 10.1037/0894-4105.20.1.42; Benn KM, 2004, BRAIN INJURY, V18, P239, DOI 10.1080/02699050310001617343; Burgess ES, 1999, J HEAD TRAUMA REHAB, V14, P394, DOI 10.1097/00001199-199908000-00008; CARVER CS, 1989, J PERS SOC PSYCHOL, V56, P267, DOI 10.1037/0022-3514.56.2.267; DEROGATIS L, 1982, CLIN PSYCHOL RES; FLETCHER JM, 1990, J CONSULT CLIN PSYCH, V58, P93, DOI 10.1037/0022-006X.58.1.93; Gerhardt CA, 2003, J PEDIATR PSYCHOL, V28, P5, DOI 10.1093/jpepsy/28.1.5; HOLAHAN CJ, 1985, J PERS SOC PSYCHOL, V49, P739, DOI 10.1037/0022-3514.49.3.739; Holmbeck GN, 1997, J PEDIATR PSYCHOL, V22, P167; Macias MM, 2007, CHILD HEALTH CARE, V36, P99, DOI 10.1080/02739610701334558; PORTER LS, 1995, J SOC CLIN PSYCHOL, V14, P184, DOI 10.1521/jscp.1995.14.2.184; PTACEK JT, 1994, PERS SOC PSYCHOL B, V20, P421, DOI 10.1177/0146167294204009; RIVARA JB, 1992, ARCH PHYS MED REHAB, V73, P899; Seiffge-Krenke I, 2002, J PEDIATR PSYCHOL, V27, P439, DOI 10.1093/jpepsy/27.5.439; Simons L, 2007, PEDIATR TRANSPLANT, V11, P781, DOI 10.1111/j.1399-3046.2007.00726.x; Sloper P, 2000, J PEDIATR PSYCHOL, V25, P79, DOI 10.1093/jpepsy/25.2.79; Stancin T, 2008, J DEV BEHAV PEDIATR, V29, P253, DOI 10.1097/DBP.0b013e31816b6b0f; Taylor HG, 2002, NEUROPSYCHOLOGY, V16, P15, DOI 10.1037//0894-4105.16.1.15; Taylor HG, 1999, NEUROPSYCHOLOGY, V13, P76, DOI 10.1037/0894-4105.13.1.76; VERBRUGGE LM, 1985, J HEALTH SOC BEHAV, V26, P156, DOI 10.2307/2136750; Wade SL, 2008, REHABIL PSYCHOL, V53, P180, DOI 10.1037/0090-5550.53.2.180; Wade SL, 2006, J PEDIATR PSYCHOL, V31, P1072, DOI 10.1093/jpepsy/jsj077; Wade SL, 2002, J HEAD TRAUMA REHAB, V17, P96, DOI 10.1097/00001199-200204000-00003; Wade SL, 2001, J CONSULT CLIN PSYCH, V69, P406, DOI 10.1037//0022-006X.69.3.406; Wade SL, 1998, PEDIATRICS, V102, P110, DOI 10.1542/peds.102.1.110; Yeates KO, 2002, NEUROPSYCHOLOGY, V16, P514, DOI 10.1037//0894-4105.16.4.514	27	22	22	1	4	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1053-8135			NEUROREHABILITATION	Neurorehabilitation		2010	27	1					63	72		10.3233/NRE-2010-0581			10	Clinical Neurology; Rehabilitation	Neurosciences & Neurology; Rehabilitation	629GA	WOS:000280182000006	20634601	Green Accepted			2021-06-18	
J	Weber, M; Edwards, MG				Weber, Mareen; Edwards, Martin Gareth			The effect of brain injury terminology on university athletes' expected outcome from injury, familiarity and actual symptom report	BRAIN INJURY			English	Article						Mild brain injury; concussion; head injury; outcome; sport; cognition	HEAD-INJURY; COGNITIVE PERFORMANCE; DIAGNOSIS THREAT; CONCUSSION; MISCONCEPTIONS; FOOTBALL; SPORTS; EXPECTATION; KNOWLEDGE; PLAYERS	Primary objective: To determine the influence of the terms concussion, mild traumatic brain injury and minor head injury on expected injury outcome, term-related familiarity and actual symptom reporting. Research design: A questionnaire varied the terms concussion, mild traumatic brain injury and minor head injury. Methods and procedures: Two hundred and twenty-four university students were allocated one questionnaire version. Participants rated injury outcome statements for their truthfulness, specified term familiarity and completed measures on post-concussion symptoms, anxiety, depression, pain and affectivity. Chi-square tests compared response frequencies of statement ratings and familiarity between questionnaire versions and a rank-based multivariate method compared psychological measures between questionnaire versions. Main outcomes and results: Terminology significantly influenced both expected injury outcome and familiarity. Outcome expectations were reliably more negative for the term mild traumatic brain injury than concussion or minor head injury. Mild traumatic brain injury was the least familiar term. However, terminology groups did not differ in actual symptom reporting. Conclusions: The data showed that the use of terminology affected athletes' injury outcome expectations and familiarity. The impact of the data and advice for the best term for future use are discussed. While it is not easy to make a clear recommendation, the data clearly indicate a strong need for education of brain injury at university level and possibly beyond.	[Weber, Mareen; Edwards, Martin Gareth] Univ Birmingham, Sch Sport & Exercise Sci, Birmingham B15 2TT, W Midlands, England	Weber, M (corresponding author), Univ Birmingham, Sch Sport & Exercise Sci, Birmingham B15 2TT, W Midlands, England.	mareen.weber@gmail.com	Edwards, Martin/A-9765-2009	Edwards, Martin/0000-0003-4532-2436			Anderson T, 2006, PRACT NEUROL, V6, P342, DOI DOI 10.1136/JNNP.2006.106583; Asplund CA, 2004, CLIN J SPORT MED, V14, P339, DOI 10.1097/00042752-200411000-00003; Becker MH, 1974, BEHAV SCI PREVENTIVE, P25; Chapman RCG, 2010, BRAIN INJURY, V24, P797, DOI 10.3109/02699051003709607; Delaney JS, 2001, CLIN J SPORT MED, V11, P234, DOI 10.1097/00042752-200110000-00005; Delaney JS, 2000, CLIN J SPORT MED, V10, P9, DOI 10.1097/00042752-200001000-00003; Delaney TS, 2002, CLIN J SPORT MED, V12, P331, DOI 10.1097/00042752-200211000-00003; DeMatteo CA, 2010, PEDIATRICS, V125, P327, DOI 10.1542/peds.2008-2720; Farmer JE, 1997, REHABIL PSYCHOL, V42, P273; Ferguson RJ, 1999, NEUROPSYCHOLOGY, V13, P582, DOI 10.1037/0894-4105.13.4.582; Gouvier W D, 1988, Arch Clin Neuropsychol, V3, P331; Guilmette TJ, 2007, BRAIN INJURY, V21, P1039, DOI 10.1080/02699050701633080; Guilmette TJ, 2004, ARCH CLIN NEUROPSYCH, V19, P183, DOI 10.1016/S0887-6177(03)00025-8; Gunstad J, 2004, ARCH CLIN NEUROPSYCH, V19, P391, DOI 10.1016/S0887-6177(03)00073-8; Gunstad J, 2002, J INT NEUROPSYCH SOC, V8, P37, DOI 10.1017/S1355617701020045; Gunstad J, 2001, J INT NEUROPSYCH SOC, V7, P323, DOI 10.1017/S1355617701733061; Hoge CW, 2009, NEW ENGL J MED, V360, P1588, DOI 10.1056/NEJMp0810606; Hux K, 2006, BRAIN INJURY, V20, P547, DOI 10.1080/02699050600676784; Iverson GL, 2005, CURR OPIN PSYCHIATR, V18, P301, DOI 10.1097/01.yco.0000165601.29047.ae; IVERSON GL, 2009, MTBI 2009 INT C MILD; Kaut KP, 2003, CLIN J SPORT MED, V13, P213, DOI 10.1097/00042752-200307000-00004; Kelly JP, 2000, SEMIN NEUROL, V20, P165, DOI 10.1055/s-2000-9835; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; LaBotz M, 2005, CLIN J SPORT MED, V15, P73, DOI 10.1097/01.jsm.0000157649.99867.fc; Leventhal H., 2003, SELF REGULATION HLTH, P42; Lovell M, 2009, CLIN SPORT MED, V28, P95, DOI 10.1016/j.csm.2008.08.008; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McCrory P, 2009, BRIT J SPORT MED, V43, pI76, DOI 10.1136/bjsm.2009.058248; McCrory P, 2001, BRIT J SPORT MED, V35, P288, DOI 10.1136/bjsm.35.5.288; MCDOWELL I, 2003, MEASURING HLTH GUIDE, P335; McGrane SA, 2000, BRAIN INJURY, V14, P975; Mulhern S, 2006, J PSYCHOSOM RES, V61, P439, DOI 10.1016/j.jpsychores.2006.03.004; R Development Core Team, 2009, R LANG ENV STAT COMP; SEFTON JM, 2003, THESIS CENTRAL CONNE, P63; Smith-Seemiller L, 2003, BRAIN INJURY, V17, P199, DOI 10.1080/0269905021000030823; Suhr JA, 2005, J INT NEUROPSYCH SOC, V11, P23, DOI 10.1017/S1355617705050010; Suhr JA, 2002, J CLIN EXP NEUROPSYC, V24, P448, DOI 10.1076/jcen.24.4.448.1039; Swift TL, 2001, BRAIN INJURY, V15, P149, DOI 10.1080/026990501458380; Sye G, 2006, BRIT J SPORT MED, V40, P1003, DOI 10.1136/bjsm.2005.020511; McLeod TCV, 2008, CLIN J SPORT MED, V18, P235, DOI 10.1097/JSM.0b013e3181705756; WATSON D, 1988, J PERS SOC PSYCHOL, V54, P1063, DOI 10.1037/0022-3514.54.6.1063; WILCOX RR, 2005, INTRO ROBUST ESTIMAT, P377; WILLER B, 1993, ARCH CLIN NEUROPSYCH, V8, P461, DOI 10.1016/0887-6177(93)90009-P; Wills SM, 2001, BRAIN INJURY, V15, P645, DOI 10.1080/02699050010010502; Wood RL, 2004, BRAIN INJURY, V18, P1135, DOI 10.1080/02699050410001675906; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	46	22	22	0	11	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2010	24	11					1364	1371		10.3109/02699052.2010.507110			8	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	667MY	WOS:000283198800012	20715897				2021-06-18	
J	Elliott, MB; Jallo, JJ; Barbe, MF; Tuma, RF				Elliott, Melanie B.; Jallo, Jack J.; Barbe, Mary F.; Tuma, Ronald F.			Hypertonic saline attenuates tissue loss and astrocyte hypertrophy in a model of traumatic brain injury	BRAIN RESEARCH			English	Article						Hypertonic saline; Traumatic brain injury; Cortical contusion injury; Tissue loss; Astrocyte; Gliosis	POSTTRAUMATIC INTRACRANIAL HYPERTENSION; SEVERE HEAD-INJURY; SPINAL-CORD; SODIUM-CHLORIDE; CEREBRAL EDEMA; RESUSCITATION; MANNITOL; IMPACT; PRESSURE; VOLUME	Hypertonic saline is currently being used in the treatment of patients with post-traumatic cerebral edema and elevated intracranial pressure resulting from TBI. A limited number of studies show the cellular effects of hypertonic saline and no studies, to our knowledge, have investigated the effects on astrocytes. The role of astrocyte responses after traumatic brain injury remains unclear. There is evidence that reduced astrocyte proliferation is detrimental while increased hypertrophy and proliferation are signs of increased injury severity. Therefore, this study focused on the hypothesis that hypertonic saline-induced improvements in histological outcome are time dependent and may be associated with alterations in astrocyte hypertrophy after cortical contusion injury. Histopathological changes at 7 days after controlled cortical impact (CCI) injury were examined. Brain tissue loss determined using cresyl violet staining and astrocyte hypertrophy and proliferation were assessed using glial fibrillary acidic protein immunostaining in hypertonic saline and normal saline treated rats, and untreated, injured controls. Effects of the timing of hypertonic saline treatment administration on tissue loss were also examined. Plasma osmolarity and sodium levels were measured over 4 h and again at 24 h following hypertonic saline administration. Results show that hypertonic saline treatment reduced tissue loss that correlated with attenuated astrocyte hypertrophy characterized by reductions in astrocyte immunoreactivity without changes in the number of astrocytes after CCI injury. Delayed treatment of hypertonic saline resulted in the greatest reduction in tissue loss compared to all other treatments indicating that there is a therapeutic window for hypertonic saline use after traumatic brain injury. (C) 2009 Elsevier B.V. All rights reserved.	[Elliott, Melanie B.; Jallo, Jack J.] Thomas Jefferson Univ, Dept Neurosurg, Philadelphia, PA 19107 USA; [Tuma, Ronald F.] Temple Univ, Sch Med, Dept Physiol, Philadelphia, PA 19122 USA; [Barbe, Mary F.] Temple Univ, Dept Phys Therapy, Philadelphia, PA 19122 USA	Elliott, MB (corresponding author), Thomas Jefferson Univ, Dept Neurosurg, 1025 Walnut St, Philadelphia, PA 19107 USA.	melaniedion@comcast.net; jack.jallo@jefferson.edu; mbarbe@temple.edu; ronald.tuma@temple.edu		Jallo, Jack/0000-0002-5512-1729	PA Department of Health; AHAAmerican Heart Association [0415405U]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [U01HD042738] Funding Source: NIH RePORTER	Support for this research was provided by the PA Department of Health and AHA (0415405U).	Al-Shatti T, 2005, J NEUROIMMUNOL, V167, P13, DOI 10.1016/j.jneuroim.2005.06.013; Anderson JT, 1997, J TRAUMA, V42, P592, DOI 10.1097/00005373-199704000-00003; Baskaya MK, 2000, J NEUROTRAUM, V17, P93, DOI 10.1089/neu.2000.17.93; Boycott HE, 2008, GLIA, V56, P998, DOI 10.1002/glia.20673; Chang YC, 2008, NEUROCHEM RES, V33, P2318, DOI 10.1007/s11064-008-9731-8; Chen S, 2003, EXP NEUROL, V182, P87, DOI 10.1016/S0014-4886(03)00002-5; Chen YM, 2003, J CEREBR BLOOD F MET, V23, P137, DOI 10.1097/01.WCB.0000044631.80210.3C; Doyle JA, 2001, J TRAUMA, V50, P367, DOI 10.1097/00005373-200102000-00030; Elliott MB, 2008, BRAIN RES, V1218, P103, DOI 10.1016/j.brainres.2008.04.029; Elliott MB, 2008, J NEUROSCI METH, V168, P320, DOI 10.1016/j.jneumeth.2007.10.019; Elliott MB, 2007, J NEUROTRAUM, V24, P195, DOI 10.1089/neu.2006.0094; FEENEY DM, 1982, SCIENCE, V217, P855, DOI 10.1126/science.7100929; GARCIA JH, 1995, STROKE, V26, P627, DOI 10.1161/01.STR.26.4.627; Ghirnikar RS, 1998, NEUROCHEM RES, V23, P329, DOI 10.1023/A:1022453332560; GOLDSTEIN LB, 1990, J NEUROSCI METH, V31, P101, DOI 10.1016/0165-0270(90)90154-8; Hampton DW, 2004, NEUROSCIENCE, V127, P813, DOI 10.1016/j.neuroscience.2004.05.028; Harutjunyan L, 2005, CRIT CARE, V9, pR530, DOI 10.1186/cc3767; Horn P, 1999, NEUROL RES, V21, P758, DOI 10.1080/01616412.1999.11741010; Junger WG, 1998, J CLIN INVEST, V101, P2768, DOI 10.1172/JCI1354; Khanna S, 2000, CRIT CARE MED, V28, P1144, DOI 10.1097/00003246-200004000-00038; Knapp JM, 2005, AACN ADV CRIT CARE, V16, P199, DOI 10.1097/00044067-200504000-00011; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Levene Howard B, 2007, Clin Neurosurg, V54, P213; MOUTON PR, 2002, PRINCIPLES PRACTICES; Munar F, 2000, J NEUROTRAUM, V17, P41, DOI 10.1089/neu.2000.17.41; Myer DJ, 2006, BRAIN, V129, P2761, DOI 10.1093/brain/awl165; Okuno S, 2001, NEUROL RES, V23, P657, DOI 10.1179/016164101101198983; Otani N, 2006, J CLIN NEUROSCI, V13, P934, DOI 10.1016/j.jocn.2005.10.018; Pascual JL, 2002, ANN SURG, V236, P634, DOI 10.1097/00000658-200211000-00014; Phillis JW, 1999, BRAIN RES, V828, P1, DOI 10.1016/S0006-8993(99)01235-4; Prow NA, 2008, J NEUROCHEM, V105, P1276, DOI 10.1111/j.1471-4159.2008.05230.x; Qureshi AI, 2002, CRIT CARE MED, V30, P435, DOI 10.1097/00003246-200202000-00028; Qureshi AI, 2000, CRIT CARE MED, V28, P3301, DOI 10.1097/00003246-200009000-00032; Rotstein OD, 2000, J TRAUMA, V49, P580, DOI 10.1097/00005373-200010000-00002; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; Sama MA, 2008, J BIOL CHEM, V283, P21953, DOI 10.1074/jbc.M800148200; Sell SL, 2008, ANESTHESIOLOGY, V108, P873, DOI 10.1097/ALN.0b013e31816c8a15; Shackford SR, 1998, J TRAUMA, V44, P50, DOI 10.1097/00005373-199801000-00004; Shackford SR, 1997, J TRAUMA, V42, pS48, DOI 10.1097/00005373-199705001-00009; Simma B, 1998, CRIT CARE MED, V26, P1265, DOI 10.1097/00003246-199807000-00032; Soustiel JF, 2006, BRAIN RES, V1101, P136, DOI 10.1016/j.brainres.2006.05.045; Spera PA, 1998, SPINE, V23, P2444, DOI 10.1097/00007632-199811150-00018; Spera PA, 2000, ACTA NEUROCHIR, V142, P811, DOI 10.1007/s007010070097; Sumas ME, 2001, NEUROSURGERY, V48, P167; Thomale UW, 2004, J NEUROTRAUM, V21, P1737; Tuma RF, 1997, J TRAUMA, V42, pS54, DOI 10.1097/00005373-199705001-00010; Vialet R, 2003, CRIT CARE MED, V31, P1683, DOI 10.1097/01.CCM.0000063268.91710.DF; Ware ML, 2005, NEUROSURGERY, V57, P727, DOI 10.1227/01.NEU.0000175726.08903.OA; Wenham TN, 2008, ANAESTHESIA, V63, P558, DOI 10.1111/j.1365-2044.2008.05532.x; White RE, 2008, RESTOR NEUROL NEUROS, V26, P197; Yilmaz N, 2007, BRAIN RES, V1164, P132, DOI 10.1016/j.brainres.2007.06.017; Ziai WC, 2007, J NEUROL SCI, V261, P157, DOI 10.1016/j.jns.2007.04.048	52	22	24	0	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	DEC 11	2009	1305						183	191		10.1016/j.brainres.2009.09.104			9	Neurosciences	Neurosciences & Neurology	538EQ	WOS:000273167500018	19804766				2021-06-18	
J	Nagel, A; Graetz, D; Vajkoczy, P; Sarrafzadeh, AS				Nagel, Alexandra; Graetz, Daniela; Vajkoczy, Peter; Sarrafzadeh, Asita S.			Decompressive Craniectomy in Aneurysmal Subarachnoid Hemorrhage: Relation to Cerebral Perfusion Pressure and Metabolism	NEUROCRITICAL CARE			English	Article						Subarachnoid hemorrhage; Decompressive craniectomy; Intracranial hypertension; Microdialysis; Cerebral metabolism	TRAUMATIC BRAIN-INJURY; INTRACRANIAL-PRESSURE; TISSUE OXYGEN; MICRODIALYSIS; HEMICRANIECTOMY; ISCHEMIA; EDEMA; HYPERTENSION	Outcome is poor in aneurysmal subarachnoid hemorrhage (SAH) patients with intracranial hypertension. As one treatment option for increased intracranial pressure (ICP), decompressive craniectomy (DC) is discussed. Its impact on cerebral metabolism and outcome in SAH patients is evaluated in this pilot study. A prospectively collected database of cerebral metabolism in SAH patients was analyzed retrospectively for individuals developing high ICP (> 20 mmHg > 6 h/day, n = 18). Patients with intracranial hypertension were classified into groups with (n = 7) and without DC (n = 11). An age-matched control group was established (n = 89). Cerebral perfusion pressure (CPP) and high ICP treatment were analyzed for 7 days after SAH (or 72 h after craniectomy, respectively). Cerebral microdialysates were analyzed hourly. Twelve-month outcome was evaluated. Groups were comparable for age, WFNS grade, and outcome. ICP was significantly reduced by DC (P < 0.01), however, in 43% of patients the effect was transient. An increase in the lactate/pyruvate ratio (P < 0.001) and glycerol levels (> 200 mu M) was observed before DC. In the DC group, glucose (P = 0.005) and pyruvate (P = 0.04) were higher, while glycerol levels were lower (P = 0.007) compared to the non-DC group, reflecting better aerobic glucose utilization and reduced cellular stress. Outcome was poor in all SAH patients with intracranial hypertension. Although glucose utilization was improved after DC, no improvement in outcome could be shown for this small patient population. Future studies will have to demonstrate whether markers of cerebral crisis may support the decision for DC in aneurysmal SAH patients.	[Sarrafzadeh, Asita S.] Charite Univ Med Berlin, Charite Campus Virchow Med Ctr, Clin Neurosurg, D-13353 Berlin, Germany; [Nagel, Alexandra; Graetz, Daniela; Vajkoczy, Peter; Sarrafzadeh, Asita S.] Charite Univ Med Berlin, Dept Neurosurg, D-13353 Berlin, Germany	Sarrafzadeh, AS (corresponding author), Charite Univ Med Berlin, Charite Campus Virchow Med Ctr, Clin Neurosurg, Augustenburger Pl 1, D-13353 Berlin, Germany.	alexandra.nagel@charite.de; asita.sarrafzadeh@charite.de					BAILES JE, 1990, J NEUROSURG, V72, P559, DOI 10.3171/jns.1990.72.4.0559; Belli A, 2008, ACTA NEUROCHIR, V150, P461, DOI 10.1007/s00701-008-1580-3; Boret H, 2006, ACTA ANAESTH SCAND, V50, P252, DOI 10.1111/j.1399-6576.2005.00862.x; Brunner E., 2002, NONPARAMETRIC ANAL L; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Bullock R, 1998, J NEUROSURG, V89, P507, DOI 10.3171/jns.1998.89.4.0507; D'Ambrosio AL, 2005, NEUROSURGERY, V56, P12, DOI 10.1227/01.NEU.0000144820.38439.63; DRAKE CG, 1988, J NEUROSURG, V68, P985; FISHER CM, 1980, NEUROSURGERY, V6, P1, DOI 10.1227/00006123-198001000-00001; Heuer GG, 2004, J NEUROSURG, V101, P408, DOI 10.3171/jns.2004.101.3.0408; Hutchinson PJ, 2000, J NEUROSURG, V93, P37, DOI 10.3171/jns.2000.93.1.0037; Hutchinson PJ, 2005, PHYSIOL MEAS, V26, P423, DOI 10.1088/0967-3334/26/4/008; Jaeger M, 2005, ACT NEUR S, V95, P117; Jaeger M, 2007, STROKE, V38, P981, DOI 10.1161/01.STR.0000257964.65743.99; JENNETT B, 1975, LANCET, V1, P480; Kilincer C, 2005, CLIN NEUROL NEUROSUR, V107, P412, DOI 10.1016/j.clineuro.2004.09.018; Lanzino G, 1999, J NEUROSURG, V90, P1018, DOI 10.3171/jns.1999.90.6.1018; LeRoux PD, 1996, NEUROSURGERY, V38, P887, DOI 10.1097/00006123-199605000-00006; Marion DW, 2004, CRIT CARE MED, V32, pS43, DOI 10.1097/01.CCM.0000110731.69637.16; Mitka M, 2001, JAMA-J AM MED ASSOC, V286, P2084, DOI 10.1001/jama.286.17.2084; Nagel A, 2009, J NEUROSURG, V111, P94, DOI 10.3171/2009.1.JNS08587; Nilsson OG, 1999, NEUROSURGERY, V45, P1176, DOI 10.1097/00006123-199911000-00032; Sarrafzadeh A, 2003, STROKE, V34, P1382, DOI 10.1161/01.STR.0000074036.97859.02; Sarrafzadeh AS, 2004, STROKE, V35, P638, DOI 10.1161/01.STR.0000116101.66624.F1; Sarrafzadeh AS, 2002, ACTA NEUROCHIR SUPPL, V81, P319; Schirmer CM, 2007, STROKE, V38, P987, DOI 10.1161/01.STR.0000257962.58269.e2; Scozzafava J, 2007, NEUROCRIT CARE, V6, P49, DOI 10.1385/NCC:6:1:49; Smith ER, 2002, NEUROSURGERY, V51, P117, DOI 10.1097/00006123-200207000-00018; Stiefel MF, 2004, J NEUROSURG, V101, P241, DOI 10.3171/jns.2004.101.2.0241; Strege RJ, 2003, NEUROL RES, V25, P510, DOI 10.1179/016164103101201742; TEASDALE G, 1974, LANCET, V2, P81; Tseng Ming-Yuan, 2006, Neurosurg Focus, V21, pE10; Vespa P, 2005, J CEREBR BLOOD F MET, V25, P763, DOI 10.1038/sj.jcbfm.9600073; Ziai WC, 2003, J NEUROSURG ANESTH, V15, P25, DOI 10.1097/00008506-200301000-00005	34	22	22	0	7	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care	DEC	2009	11	3					384	394		10.1007/s12028-009-9269-x			11	Critical Care Medicine; Clinical Neurology	General & Internal Medicine; Neurosciences & Neurology	521SH	WOS:000271943800015	19714498				2021-06-18	
J	Charrueau, C; Belabed, L; Besson, V; Chaumeil, JC; Cynober, L; Moinard, C				Charrueau, Christine; Belabed, Linda; Besson, Valerie; Chaumeil, Jean-Claude; Cynober, Luc; Moinard, Christophe			Metabolic Response and Nutritional Support in Traumatic Brain Injury: Evidence for Resistance to Renutrition	JOURNAL OF NEUROTRAUMA			English	Article						enteral nutrition; intestine; muscle; protein metabolism	IMMUNE-ENHANCING DIET; SEVERE HEAD-INJURY; INTESTINAL MUCOSAL APOPTOSIS; BACTERIAL TRANSLOCATION; ENTERAL NUTRITION; URINARY-EXCRETION; PROTEIN-TURNOVER; FLUID PERCUSSION; ENTEROCYTE MASS; SKELETAL-MUSCLE	Traumatic brain injury (TBI) is one of the most severe injuries encountered in intensive care units. TBI patients exhibit protein wasting and gastrointestinal dysfunction, which may be risk factors for a septic state. Specific nutritional support may be required for these patients, and we hypothesize that standard nutritional support does not allow restoration of the nutritional state of TBI patients. A well-validated rat model of TBI by fluid percussion was used. Rats were randomized into three groups: healthy rats receiving standard chow diet ad libitum (AL), rats sustaining TBI and receiving standard chow diet (TBI), and rats sustaining TBI and receiving a standard enteral diet (TBI-EN) for 4 days. TBI in rats was characterized by anorexia, body weight loss (AL: +15 +/- 5 g versus TBI: -11 +/- 4 g and TBI-EN: -8 +/- 4g; p < 0.05), decrease in nitrogen balance (AL: 2.9 +/- 0.2 g versus TBI: 1.0 +/- 0.2 g and TBI-EN: 0.2 +/- 0.2 g, p < 0.05) associated with decrease in muscular protein content (extensor digitorum longus [EDL]: AL: 36 +/- 2 mg versus TBI: 26 +/- 3 mg and TBI-EN: 28 +/- 2 mg; p < 0.05), and intestinal atrophy (ileum: AL: 673 +/- 42 mg versus TBI: 442 +/- 23 mg and TBI-EN: 377 +/- 27 mg; p < 0.05). Interestingly, standard enteral nutrition was not effective in restoring any of these parameters. This work confirms that TBI is associated with profound nutritional alterations and has a major impact on nitrogen metabolism and on intestinal trophicity. It also demonstrates that using standard enteral nutrition cannot reverse this phenomenon. Thus, developing new nutritional strategies to cover TBI patients' specific nutritional requirements appears mandatory.	[Belabed, Linda; Cynober, Luc; Moinard, Christophe] Univ Paris 05, Fac Sci Pharmaceut & Biol, Lab Biol Nutr, EA2498, F-75270 Paris 06, France; [Charrueau, Christine; Chaumeil, Jean-Claude] Univ Paris 05, Fac Sci Pharmaceut & Biol, Pharm Galen Lab, EA2498, F-75270 Paris 06, France; [Besson, Valerie] Univ Paris 05, Fac Sci Pharmaceut & Biol, Lab Pharmacol Circulat Cerebrale, EA2510, F-75270 Paris 06, France; [Cynober, Luc] Interhosp Cochin Hotel Dieu, APHP, Serv Biochim, Paris, France	Moinard, C (corresponding author), Univ Paris 05, Fac Sci Pharmaceut & Biol, Lab Biol Nutr, EA2498, 4 Ave Observ, F-75270 Paris 06, France.	christophe.moinard@parisdescartes.fr	besson, valerie C/L-7388-2017; BESSON, VALERIE/AAZ-9989-2020; Cynober, Luc/ABB-2368-2020	besson, valerie C/0000-0002-1491-2380; BESSON, VALERIE/0000-0002-1491-2380; 	Ministry of Research and TechnologyMinistry of Research and Technology of the Republic of Indonesia (RISTEK) [EA2498]; Nestle Clinical Nutrition (Noisiel, France)	We thank S. Gupta and A. Paillard for their technical assistance. The authors thank Harvard Apparatus and Minerve, which provided the devices used in this study. This work was supported in part by funds from the Ministry of Research and Technology (EA2498) and in part by a grant from Nestle Clinical Nutrition (Noisiel, France).	Aydin S, 2005, SURG TODAY, V35, P751, DOI 10.1007/s00595-005-3034-3; Bareyre F, 1997, J NEUROTRAUM, V14, P839, DOI 10.1089/neu.1997.14.839; Belabed L, 2006, CLIN NUTR, V25, P832, DOI 10.1016/j.clnu.2006.02.003; Besson VC, 2003, BRAIN RES, V989, P58, DOI 10.1016/S0006-8993(03)03362-6; Blanc MC, 2000, CLIN CHEM LAB MED, V38, P465, DOI 10.1515/CCLM.2000.067; Boddie DE, 2003, BRIT J NEUROSURG, V17, P405, DOI 10.1080/02688690310001611198; Briassoulis G, 2006, PEDIATR CRIT CARE ME, V7, P56, DOI 10.1097/01.PCC.0000192339.44871.26; CLIFTON GL, 1984, J NEUROSURG, V60, P687, DOI 10.3171/jns.1984.60.4.0687; COUDRAYLUCAS C, 1985, CLIN NUTR, V4, P179, DOI 10.1016/0261-5614(85)90026-3; Crenn P, 2003, GASTROENTEROLOGY, V124, P1210, DOI 10.1016/S0016-5085(03)00170-7; Crenn P, 2008, CLIN NUTR, V27, P328, DOI 10.1016/j.clnu.2008.02.005; Cui XL, 2001, SURG TODAY, V31, P615, DOI 10.1007/s005950170096; Curis E, 2007, CURR OPIN CLIN NUTR, V10, P620, DOI 10.1097/MCO.0b013e32829fb38d; Cynober L. A., 2004, METABOLIC THERAPEUTI; Feighery L, 2008, J TRAUMA, V64, P131, DOI 10.1097/TA.0b013e3181568d9f; FLEURY P, 1951, Ann Biol Clin (Paris), V9, P453; GRIMBLE G, 1991, JPEN-PARENTER ENTER, V15, P696, DOI 10.1177/0148607191015006696; Hamani D, 2007, INTENS CARE MED, V33, P1076, DOI 10.1007/s00134-007-0624-0; Hang CH, 2005, J SURG RES, V123, P188, DOI 10.1016/j.jss.2004.08.002; Hang CH, 2003, WORLD J GASTROENTERO, V9, P2776; Hang CH, 2005, WORLD J GASTROENTERO, V11, P1149, DOI 10.3748/wjg.v11.i8.1149; HASSELGREN PO, 1986, ARCH SURG-CHICAGO, V121, P918; Heimburger DC, 1997, JPEN-PARENTER ENTER, V21, P162, DOI 10.1177/0148607197021003162; HELLING TS, 1988, J TRAUMA, V28, P1575, DOI 10.1097/00005373-198811000-00009; Jafarian-Tehrani M, 2005, NITRIC OXIDE-BIOL CH, V12, P61, DOI 10.1016/j.niox.2004.12.001; Jeevanandam M., 1995, Amino acid metabolism and therapy in health and nutritional disease., P245; LeBoucher J, 1997, CLIN CHEM, V43, P1421; Loi C, 2005, NUTRITION, V21, P255, DOI 10.1016/j.nut.2004.05.021; LONG CL, 1981, METABOLISM, V30, P765, DOI 10.1016/0026-0495(81)90022-6; Louin G, 2006, NEUROPHARMACOLOGY, V50, P182, DOI 10.1016/j.neuropharm.2005.08.020; Louin G, 2004, J NEUROSCI METH, V138, P73, DOI 10.1016/j.jneumeth.2004.03.010; MacFie J, 2006, BRIT J SURG, V93, P87, DOI 10.1002/bjs.5184; MALTIN CA, 1989, AM J PHYSIOL, V257, pE823; Mansoor O, 1997, AM J PHYSIOL-ENDOC M, V273, pE898; Martindale RG, 2001, JPEN-PARENTER ENTER, V25, pS27, DOI 10.1177/014860710102500207; Masson F, 2001, J TRAUMA, V51, P481, DOI 10.1097/00005373-200109000-00010; Moinard C, 2005, INTENS CARE MED, V31, P281, DOI 10.1007/s00134-004-2489-9; Moinard C, 2008, J NEUROTRAUM, V25, P124, DOI 10.1089/neu.2007.0391; Moinard C, 2006, NUTRITION, V22, P1039, DOI 10.1016/j.nut.2006.06.005; Neveux N., 2004, METABOLIC THERAPEUTI, P17; Perel P, 2007, COCHRANE DB SYST REV, P1; Pernet P, 1996, CLIN CHIM ACTA, V249, P141, DOI 10.1016/0009-8981(96)06283-3; QUATTROCCHI K B, 1990, Journal of Neurotrauma, V7, P77, DOI 10.1089/neu.1990.7.77; Scarlett CJ, 2004, CLIN NUTR, V23, P1135, DOI 10.1016/j.clnu.2004.02.008; SJOLIN J, 1989, METABOLISM, V38, P23, DOI 10.1016/0026-0495(89)90175-3; SOSIN DM, 1995, JAMA-J AM MED ASSOC, V273, P1778, DOI 10.1001/jama.273.22.1778; Todd S Rob, 2006, Nutr Clin Pract, V21, P421, DOI 10.1177/0115426506021005421; TOULMOND S, 1993, BRAIN RES, V620, P24, DOI 10.1016/0006-8993(93)90266-P; Ulusoy H, 2003, J CLIN NEUROSCI, V10, P596, DOI 10.1016/S0967-5868(03)00142-5; YOUNG VR, 1978, FED PROC, V37, P2291; Zarrabian S, 1999, NUTRITION, V15, P474, DOI 10.1016/S0899-9007(99)00054-4; Zarrabian S, 1998, CLIN NUTR, V17, P169, DOI 10.1016/S0261-5614(98)80053-8	52	22	23	0	4	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	NOV	2009	26	11					1911	1920		10.1089/neu.2008.0737			10	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	523CO	WOS:000272049600006	19929216				2021-06-18	
J	Slawik, H; Salmond, CH; Taylor-Tavares, JV; Williams, GB; Sahakian, BJ; Tasker, RC				Slawik, Helen; Salmond, Claire H.; Taylor-Tavares, Joana V.; Williams, Guy B.; Sahakian, Baraba J.; Tasker, Robert C.			Frontal Cerebral Vulnerability and Executive Deficits from Raised Intracranial Pressure in Child Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						child; frontal lobe; intracranial pressure; traumatic brain injury; white matter	ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; CLOSED-HEAD INJURY; DECISION-MAKING; PREFRONTAL CORTEX; DECOMPRESSIVE CRANIECTOMY; SPATIAL NORMALIZATION; WORKING-MEMORY; RESPONSE-INHIBITION; CLINICAL-TRIALS; OUTCOME-SCALE	In severe pediatric traumatic brain injury (TBI), a common focus of treatment is raised intracranial pressure (ICP). The aim of this investigation was to test whether raised ICP is associated with later prefrontal executive deficits and regional brain tissue loss, consistent with an anterior vascular compartment syndrome. Thirty-three participants were assigned to one of two severe TBI groups based on whether or not they had increased ICP complicating their critical illness. At follow-up (average 3.9 years), the participants underwent magnetic resonance imaging and a battery of neuropsychological testing focused on prefrontal function. The ICP group had white matter loss that was diffuse as well as regional in the corpus callosum, periventricular tissue, and frontal region. Loss of gray matter in the ICP group was more regionally specific, with bilateral loss in the caudate nuclei and frontal regions, including the right dorsolateral region, right supplementary motor area, and the left orbitofrontal cortex. Both groups had normal intelligence quotients (IQs), but the ICP group showed long-term deficits on various measures of attention and executive function such as working memory, decision-making, and impulsivity. These findings suggest that raised ICP leads to diffuse brain injury and a predilection to hypo-perfusion in, at least, the distribution of the anterior cerebral artery. Furthermore, since voxel-based morphometry (VBM) and measures of attention and executive function are sensitive to the phenomenon of raised ICP, we consider that these techniques warrant inclusion in trials assessing ICP-directed therapy.	[Tasker, Robert C.] Univ Cambridge, Addenbrookes Hosp, Dept Paediat, Sch Clin,Paediat Intens Care Unit, Cambridge CB2 2QQ, England; [Slawik, Helen; Tasker, Robert C.] Univ Cambridge, Sch Clin Med, Dept Paediat, Cambridge CB2 2QQ, England; [Salmond, Claire H.; Sahakian, Baraba J.] Univ Cambridge, Sch Clin Med, Dept Psychiat, Cambridge CB2 2QQ, England; [Sahakian, Baraba J.] Univ Cambridge, Behav & Clin Neurosci Inst, Cambridge CB2 2QQ, England; [Salmond, Claire H.; Taylor-Tavares, Joana V.; Williams, Guy B.] Univ Cambridge, Wolfson Brain Imaging Ctr, Cambridge CB2 2QQ, England; [Slawik, Helen] Tech Univ Muenchen, Dept Psychiat, Munich, Germany	Tasker, RC (corresponding author), Univ Cambridge, Addenbrookes Hosp, Dept Paediat, Sch Clin,Paediat Intens Care Unit, Box 116,Hills Rd, Cambridge CB2 2QQ, England.	rct31@cam.ac.uk	Sahakian, Barbara/AAW-1198-2020; Tasker, Robert C/R-5837-2019	Sahakian, Barbara/0000-0001-7352-1745; Tasker, Robert/0000-0003-3647-8113	Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [G9439390]; Addenbrooke's Charitable Trust; Evelyn Trust; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [G0001237, G0600986] Funding Source: researchfish; National Institute for Health ResearchNational Institute for Health Research (NIHR) [NF-SI-0508-10327] Funding Source: researchfish	We wish to thank the patients and families who participated in this study, and the staff in the Department of Paediatrics and Radiographers at the Wolfson Brain Imaging Centre. The Medical Research Council (G9439390), the Addenbrooke's Charitable Trust, and the Evelyn Trust supported this work.	Achenbach T. M., 1991, MANUAL CHILD BEHAV C; Adelson P David, 2003, Pediatr Crit Care Med, V4, pS65; Aron AR, 2003, NAT NEUROSCI, V6, P115, DOI 10.1038/nn1003; Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Beck JS., 2001, MANUAL BECK YOUTH IN; BERRYHILL P, 1995, NEUROSURGERY, V37, P392, DOI 10.1227/00006123-199509000-00004; BLATTER DD, 1995, AM J NEURORADIOL, V16, P241; Brett M, 2001, NEUROIMAGE, V14, P486, DOI 10.1006/nimg.2001.0845; BRUST JCM, 2004, STROKE PATHOPHYSIOLO, P101; Castellanos FX, 1997, CLIN PEDIATR, V36, P381, DOI 10.1177/000992289703600702; CLARIZIO H, 1984, PSYCHOL SCHOOLS, V21, P154, DOI 10.1002/1520-6807(198404)21:2<154::AID-PITS2310210205>3.0.CO;2-P; Clark L, 2008, BRAIN, V131, P1311, DOI 10.1093/brain/awn066; Clark L, 2003, NEUROPSYCHOLOGIA, V41, P1474, DOI 10.1016/S0028-3932(03)00081-2; Clark L, 2007, BIOL PSYCHIAT, V61, P1395, DOI 10.1016/j.biopsych.2006.07.020; Clark L, 2006, BIOL PSYCHIAT, V60, P515, DOI 10.1016/j.biopsych.2005.11.007; Cole TJ, 1998, STAT MED, V17, P407, DOI 10.1002/(SICI)1097-0258(19980228)17:4&lt;407::AID-SIM742&gt;3.0.CO;2-L; Conners CK, 2003, CONNERS RATING SCALE; Cremer OL, 2008, EUR J ANAESTH, V25, P87, DOI 10.1017/S0265021507003237; Crouchman M, 2001, ARCH DIS CHILD, V84, P120, DOI 10.1136/adc.84.2.120; D'Esposito M, 1998, COGNITIVE BRAIN RES, V7, P1, DOI 10.1016/S0926-6410(98)00004-4; Dalton CM, 2002, J NEUROL NEUROSUR PS, V73, P141, DOI 10.1136/jnnp.73.2.141; DeVito EE, 2007, ACTA NEUROL SCAND, V116, P328, DOI 10.1111/j.1600-0404.2007.00906.x; DeVito EE, 2008, BIOL PSYCHIAT, V64, P636, DOI 10.1016/j.biopsych.2008.04.017; Eriksson SH, 2001, BRAIN, V124, P617, DOI 10.1093/brain/124.3.617; FREEMAN JV, 1995, ARCH DIS CHILD, V73, P17, DOI 10.1136/adc.73.1.17; Garth J, 1997, Pediatr Rehabil, V1, P99; Genovese CR, 2002, NEUROIMAGE, V15, P870, DOI 10.1006/nimg.2001.1037; Ghajar J, 2000, LANCET, V356, P923, DOI 10.1016/S0140-6736(00)02689-1; Hawley CA, 2004, ARCH DIS CHILD, V89, P136, DOI 10.1136/adc.2002.025577; Hawley CA, 2002, BRAIN INJURY, V16, P969, DOI 10.1080/02699050210147239; Herskovits EH, 1999, RADIOLOGY, V213, P389, DOI 10.1148/radiology.213.2.r99nv45389; Hutchison JS, 2008, NEW ENGL J MED, V358, P2447, DOI 10.1056/NEJMoa0706930; Jagannathan J, 2007, J NEUROSURG, V106, P268, DOI 10.3171/ped.2007.106.4.268; Kelly T P, 1999, Pediatr Rehabil, V3, P187; Konishi S, 1998, EUR J NEUROSCI, V10, P1209, DOI 10.1046/j.1460-9568.1998.00167.x; Konrad KN, 2000, BRAIN INJURY, V14, P859; KRAUS JF, 1990, AM J DIS CHILD, V144, P684, DOI 10.1001/archpedi.1990.02150300082022; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Levin HS, 2004, J CLIN EXP NEUROPSYC, V26, P589, DOI 10.1080/13803390490504434; LEVIN HS, 1993, ARCH NEUROL-CHICAGO, V50, P897, DOI 10.1001/archneur.1993.00540090008004; Logan Gordon D., 1994, P189; Lu J, 2008, J NEUROTRAUM, V25, P641, DOI 10.1089/neu.2007.0510; Maas AIR, 2004, ACT NEUR S, V89, P113; Manes F, 2002, BRAIN, V125, P624, DOI 10.1093/brain/awf049; Marcoux J, 2008, CRIT CARE MED, V36, P2871, DOI 10.1097/CCM.0b013e318186a4a0; Mavaddat N, 2000, BRAIN, V123, P2109, DOI 10.1093/brain/123.10.2109; McCarthy G, 1996, CEREB CORTEX, V6, P600, DOI 10.1093/cercor/6.4.600; MENDELSOHN D, 1992, CHILD NERV SYST, V8, P445, DOI 10.1007/BF00274405; Morris KP, 2006, INTENS CARE MED, V32, P1606, DOI 10.1007/s00134-006-0285-4; Owen AM, 1996, CEREB CORTEX, V6, P31, DOI 10.1093/cercor/6.1.31; Pearson GA, 2001, ARCH DIS CHILD, V84, P125, DOI 10.1136/adc.84.2.125; PRAYER L, 1993, ACTA RADIOL, V34, P593; Rahman S, 2001, TRENDS COGN SCI, V5, P271, DOI 10.1016/S1364-6613(00)01650-8; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; Salmond CH, 2005, J NEUROTRAUM, V22, P613, DOI 10.1089/neu.2005.22.613; Salmond CH, 2005, BRAIN, V128, P189, DOI 10.1093/brain/awh352; Schachar R, 2004, DEV NEUROPSYCHOL, V25, P179, DOI 10.1207/s15326942dn2501&2_10; Schirmer CM, 2008, NEUROCRIT CARE, V8, P456, DOI 10.1007/s12028-008-9082-y; Shore PM, 2006, CRIT CARE MED, V34, P1981, DOI 10.1097/01.CCM.0000220765.22184.ED; Slomine BS, 2002, BRAIN INJURY, V16, P759, DOI 10.1080/02699050210127286; Tasker RC, 2005, PEDIATR RES, V58, P302, DOI 10.1203/01.PDR.0000169965.08854.25; TEASDALE G, 1974, LANCET, V2, P81; Timofeev I, 2008, J NEUROSURG, V108, P66, DOI 10.3171/JNS/2008/108/01/0066; Turner DC, 2003, PSYCHOPHARMACOLOGY, V165, P260, DOI 10.1007/s00213-002-1250-8; VANDENBERGH R, 1969, RES CEREBRAL CIRCULA, P52; VANDEREECKEN H, 1969, RESEARCH CEREBRAL CI, P42; VanPaesschen W, 1997, ANN NEUROL, V41, P41, DOI 10.1002/ana.410410109; Wechsler D., 1997, MANUAL WECHSLER ADUL; Wechsler D., 1992, MANUAL WECHSLER INTE; Wilde EA, 2005, J NEUROTRAUM, V22, P333, DOI 10.1089/neu.2005.22.333; Wilde EA, 2007, DEV MED CHILD NEUROL, V49, P294, DOI 10.1111/j.1469-8749.2007.00294.x; Wilke M, 2003, MAGN RESON MED, V50, P749, DOI 10.1002/mrm.10606; Wilke M, 2002, HUM BRAIN MAPP, V17, P48, DOI 10.1002/hbm.10053; Wilson BA, 2003, RIVERMEAD BEHAV MEMO; WITELSON SF, 1989, BRAIN, V112, P799, DOI 10.1093/brain/112.3.799	75	22	22	1	7	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	NOV	2009	26	11					1891	1903		10.1089/neu.2009.0942			13	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	523CO	WOS:000272049600004	19929215				2021-06-18	
J	Abouzari, M; Rashidi, A; Zandi-Toghani, M; Behzadi, M; Asadollahi, M				Abouzari, Mehdi; Rashidi, Armin; Zandi-Toghani, Mehdi; Behzadi, Mehrdad; Asadollahi, Marjan			Chronic subdural hematoma outcome prediction using logistic regression and an artificial neural network	NEUROSURGICAL REVIEW			English	Article						Chronic subdural hematoma; Neural network; Regression; Outcome prediction	TRANSPORT-RELATED INJURIES; TRAUMATIC BRAIN-INJURY; GLASGOW COMA SCALE; SURGICAL-TREATMENT; RECURRENCE; MODEL; EPIDEMIOLOGY; TEHRAN; AGE	Artificial neural networks (ANN) have not been used in chronic subdural hematoma (CSDH) outcome prediction following surgery. We used two methods, namely logistic regression and ANN, to predict using eight variables CSDH outcome as assessed by the Glasgow outcome score (GOS) at discharge. We had 300 patients (213 men and 87 women) and potential predictors were age, sex, midline shift, intracranial air, hematoma density, hematoma thickness, brain atrophy, and Glasgow coma score (GCS). The dataset was randomly divided to three subsets: (1) training set (150 cases), (2) validation set (75 cases), and (3) test set (75 cases). The training and validation sets were combined for regression analysis. Patients aged 56.5 +/- 18.1 years and 228 (76.0%) of them had a favorable outcome. The prevalence of brain atrophy, intracranial air, midline shift, low GCS, thick hematoma, and hyperdense hematoma was 142 (47.3%), 156 (52.0%), 177 (59.0%), 82 (27.3%), 135 (45.0%), and 52 (17.3%), respectively. The regression model did not show an acceptable performance on the test set (area under the curve (AUC) = 0.594; 95% CI, 0.435-0.754; p = 0.250). It had a sensitivity of 69% and a specificity of 46%, and correctly classified 50.7% of cases. A four-layer 8-3-4-1 feedforward backpropagation ANN was then developed and trained. The ANN showed a remarkably superior performance compared to the regression model (AUC = 0.767; 95% CI, 0.652-0.882; p = 0.001). It had a sensitivity of 88% and a specificity of 68%, and correctly classified 218 (72.7%) cases. Considering that GOS strongly correlates with the risk of recurrence, the ANN model can also be used to predict the recurrence of CSDH.	[Abouzari, Mehdi; Rashidi, Armin; Behzadi, Mehrdad] Univ Tehran Med Sci, Amir Alam Hosp, Tehran, Iran; [Rashidi, Armin] Univ Tehran, Dept Math, Tehran, Iran; [Zandi-Toghani, Mehdi] Sharif Univ Technol, Dept Mech Engn, Tehran, Iran; [Asadollahi, Marjan] Shahid Beheshti Univ Med Sci, Loghman Hosp, Tehran, Iran	Abouzari, M (corresponding author), Univ Tehran Med Sci, Amir Alam Hosp, 48 Alaei Alley,Ard E Iran St, Tehran, Iran.	abouzari.m@gmail.com		Abouzari, Mehdi/0000-0002-3585-698X; Rashidi, Armin/0000-0002-9384-272X			Abouzari M, 2007, NEUROSURGERY, V61, P794, DOI 10.1227/01.NEU.0000298908.94129.67; Adhiyaman V, 2002, POSTGRAD MED J, V78, P71, DOI 10.1136/pmj.78.916.71; Amirjamshidi A, 2007, BRIT J NEUROSURG, V21, P272, DOI 10.1080/02688690701272232; Amirjamshidi A, 2007, J CLIN NEUROSCI, V14, P1240, DOI 10.1016/j.jocn.2006.03.030; Amirjamshidi A, 2007, CLIN NEUROL NEUROSUR, V109, P152, DOI 10.1016/j.clineuro.2006.07.007; Asano Y, 1992, No To Shinkei, V44, P827; Balestreri M, 2004, J NEUROL NEUROSUR PS, V75, P161; CAMERON MM, 1978, J NEUROL NEUROSUR PS, V41, P834, DOI 10.1136/jnnp.41.9.834; Cucchiara Brett L., 2002, Curr Treat Options Neurol, V4, P445, DOI 10.1007/s11940-002-0012-6; DiRusso SM, 2000, J TRAUMA, V49, P212, DOI 10.1097/00005373-200008000-00006; Dreiseitl S, 2002, J BIOMED INFORM, V35, P352, DOI 10.1016/S1532-0464(03)00034-0; Eftekhar Behzad, 2005, BMC Med Inform Decis Mak, V5, P3; El-Kadi H, 2000, NEUROSURG CLIN N AM, V11, P553, DOI 10.1016/S1042-3680(18)30122-0; Ernestus RI, 1997, SURG NEUROL, V48, P220, DOI 10.1016/S0090-3019(97)80031-6; FOGELHOLM R, 1975, ACTA NEUROCHIR, V32, P247, DOI 10.1007/BF01405457; Fukuhara T, 1996, SURG NEUROL, V45, P570, DOI 10.1016/0090-3019(95)00471-8; Fuller J Joseph, 2005, W V Med J, V101, P120; JENNETT B, 1975, LANCET, V1, P480; JENNETT B, 1976, LANCET, V1, P1031; Kapetanovic IM, 2004, ANN NY ACAD SCI, V1020, P10, DOI 10.1196/annals.1310.003; KAWAKAMI Y, 1989, NEUROSURGERY, V25, P25, DOI 10.1227/00006123-198907000-00005; KOTWICA Z, 1991, British Journal of Neurosurgery, V5, P461, DOI 10.3109/02688699108998474; MARKWALDER TM, 1981, J NEUROSURG, V54, P637, DOI 10.3171/jns.1981.54.5.0637; Mock CN, 1999, ACCIDENT ANAL PREV, V31, P359, DOI 10.1016/S0001-4575(98)00064-5; Moini M, 2000, J TRAUMA, V48, P503, DOI 10.1097/00005373-200003000-00023; Mori K, 2001, NEUROL MED-CHIR, V41, P371, DOI 10.2176/nmc.41.371; NAGATA K, 1987, NEURORADIOLOGY, V29, P327, DOI 10.1007/BF00348909; Nagata K, 1986, No To Shinkei, V38, P1019; Nagata K, 1985, No To Shinkei, V37, P255; Nakaguchi H, 2001, J NEUROSURG, V95, P256, DOI 10.3171/jns.2001.95.2.0256; Oishi M, 2001, NEUROL MED-CHIR, V41, P382, DOI 10.2176/nmc.41.382; Pang BC, 2007, J NEUROTRAUM, V24, P136, DOI 10.1089/neu.2006.0113; Pearl A, 2006, STUD HEALTH TECHNOL, V124, P1019; Ramesh AN, 2004, ANN ROY COLL SURG, V86, P334, DOI 10.1308/147870804290; Roudsari BS, 2004, ACCIDENT ANAL PREV, V36, P391, DOI 10.1016/S0001-4575(03)00032-0; Schroeder LD, 1986, UNDERSTANDING REGRES; Segal ME, 2006, J HEAD TRAUMA REHAB, V21, P298, DOI 10.1097/00001199-200607000-00003; SELKER HP, 1995, J INVEST MED, V43, P468; Vavilala MS, 2001, J NEUROSURG ANESTH, V13, P13, DOI 10.1097/00008506-200101000-00003; WAKAI S, 1990, NEUROSURGERY, V26, P771, DOI 10.1227/00006123-199005000-00006; Yamamoto H, 2003, J NEUROSURG, V98, P1217, DOI 10.3171/jns.2003.98.6.1217; Yeong EK, 2005, BURNS, V31, P415, DOI 10.1016/j.burns.2004.12.003; Zargar M, 2001, INJURY, V32, P613, DOI 10.1016/S0020-1383(01)00029-8; Zingale A, 1999, J Neurosurg Sci, V43, P277	44	22	22	0	3	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0344-5607	1437-2320		NEUROSURG REV	Neurosurg. Rev.	OCT	2009	32	4					479	484		10.1007/s10143-009-0215-3			6	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	495AA	WOS:000269860300023	19653019				2021-06-18	
J	Lanska, DJ				Lanska, Douglas J.			Historical Perspective: Neurological Advances from Studies of War Injuries and Illnesses	ANNALS OF NEUROLOGY			English	Article							SPINAL-CORD; HEAD-INJURY; CUSHING,HARVEY; REPRESENTATION; HOLMES,GORDON; MOVEMENT; LESIONS; VISION; WOUNDS; CORTEX	Early in the 20th century during the Russo-Japanese War and World War I (WWI), some of the most important, lasting contributions to clinical neurology were descriptive clinical studies, especially those concerning war-related peripheral nerve disorders (eg, Hoffmann-Tinel sign, Guillain-Barre-Strohl syndrome [GBS]) and occipital bullet wounds (eg, the retinal projection on the cortex by Inouye and later by Holmes and Lister, and the functional partitioning of visual processes in the occipital cortex by Riddoch), but there were also other important descriptive studies concerning war-related aphasia, cerebellar injuries, and spinal cord injuries (eg, cerebellar injuries by Holmes, and autonomic dysreflexia by Head and Riddoch). Later progress, during and shortly after World War II (WWII), included major progress in understanding the pathophysiology of traumatic brain injuries by Denny-Brown, Russell, and Holbourn, pioneering accident injury studies by Cairns and Holbourn, promulgation of helmets to prevent motorcycle injuries by Cairns, development of comprehensive multidisciplinary neurorehabilitation by Rusk, and development of spinal cord injury care by Munro, Guttman, and Bors. These studies and developments were possible only because of the large number of cases that allowed individual physicians the opportunity to collect, collate, and synthesize observations of numerous cases in a short span of time. Such studies also required dedicated, disciplined, and knowledgeable investigators who made the most out of their opportunities to systematically assess large numbers of seriously ill and injured soldiers under stressful and often overtly dangerous situations.	Vet Affairs Med Ctr, Dept Neurol, Tomah, WI 54660 USA	Lanska, DJ (corresponding author), Vet Affairs Med Ctr, Dept Neurol, 500 E Vet St, Tomah, WI 54660 USA.	Douglas.Lanska@med.va.gov					Adams GW, 1952, MED HIST UNION ARMY; Allen D., 1964, CORD, V17, P14; [Anonymous], 1941, BR MED J, P481; ASBURY AK, 1969, MEDICINE, V48, P173, DOI 10.1097/00005792-196905000-00001; Bors E, 1967, Paraplegia, V5, P126; Bors E, 1971, NEUROLOGICAL UROLOGY; CAIRNS H, 1946, BRIT MED J, V2, P322, DOI 10.1136/bmj.2.4470.322; Cairns H, 1941, BRIT MED J, V1941, P465, DOI 10.1136/bmj.2.4213.465; Cairns H, 1943, BRIT MED J, V1, P592; Comarr A E, 1984, J Am Paraplegia Soc, V7, P10; COVALT DA, 1953, JAMA-J AM MED ASSOC, V151, P89; CRANE A, 1927, MED DEP US ARMY WORL, V13, P135; Cushing H, 1927, MED DEP UNITED STATE, VXI, P749; Cushing H., 1936, SURG J 1915 1918; Dean B., 1927, MED DEP US ARMY WORL, V9, P1; Denny-Brown D, 1941, BRAIN, V64, P93, DOI 10.1093/brain/64.2-3.93; Donovan WH, 2007, J SPINAL CORD MED, V30, P85, DOI 10.1080/10790268.2007.11753918; *ED COMM GUAR BRAI, 1986, AIDS EX PER NERV SYS; ELTORAI IM, 2003, SPINAL CORD MED PRIN, P3; Fishman RS, 1997, DOC OPHTHALMOL, V93, P9, DOI 10.1007/BF02569044; FRAZER CH, 1918, SURG SPINE SPINAL CO; Fulton JF, 1946, HARVEY CUSHING BIOGR; GLICKSTEIN M, 1987, TRENDS NEUROSCI, V10, P350, DOI 10.1016/0166-2236(87)90066-X; GUILLAIN G, 1968, ARCH NEUROL-CHICAGO, V18, P450; GUILLAIN G, 1939, B ACAD NAD MED PARIS, V122, P582; Gulllain G, 1936, ARCH NEURO PSYCHIATR, V36, P975; Guttmann L., 1973, SPINAL CORD INJURIES; HAYMAKER W, 1949, MEDICINE, V28, P59, DOI 10.1097/00005792-194902010-00003; Head H, 1917, BRAIN, V40, P188, DOI 10.1093/brain/40.2-3.188; Hoffmann P., 1915, MED KLIN, V11, P856; Hoffmann P., 1915, MED KLIN, V11, P359; Holbourn AHS, 1943, LANCET, V2, P438; HOLBOURN AHS, 1945, BRIT MED BULL, V3, P147, DOI 10.1093/oxfordjournals.bmb.a071895; Holmes G, 1916, BRAIN, V39, P34, DOI 10.1093/brain/39.1-2.34; Holmes G, 1918, Br J Ophthalmol, V2, P353, DOI 10.1136/bjo.2.7.353; Holmes G, 1919, BMJ-BRIT MED J, V1919, P230; Holmes G, 1915, BRIT MED J, V1915, P769; HOLMES G, 1945, PROC R SOC SER B-BIO, V132, P348, DOI 10.1098/rspb.1945.0002; HORTON JC, 1991, ARCH OPHTHALMOL-CHIC, V109, P816, DOI 10.1001/archopht.1991.01080060080030; Hughes J T, 2001, J Med Biogr, V9, P236; Hull AJ, 1917, J ROY ARMY MED CORPS, V28, P66; Inouye T., 2000, BRAIN S, V123, P1; Jones MM, 2007, AM J PUBLIC HEALTH, V97, P208, DOI 10.2105/AJPH.2005.083204; Koehler Peter J, 2004, J Hist Neurosci, V13, P326, DOI 10.1080/09647040490510498; LANDRY N, 1859, GAZ HEBD MED CHIR, V6, P472; Lanska DJ, 2009, STROKE RECOVERY REHA, P1; LEPORE FE, 1994, ARCH NEUROL-CHICAGO, V51, P711, DOI 10.1001/archneur.1994.00540190095022; Lister W T, 1916, Proc R Soc Med, V9, P57; Maartens NF, 2002, NEUROSURGERY, V50, P176; MARIE P, 1916, REV NEUROL PARIS, V23, P564; McDonald I, 2007, BRAIN, V130, P288, DOI 10.1093/brain/awl335; *MED RES COUNC, 1943, 7 MRC; OMMAYA AK, 1971, J NEUROSURG, V35, P503, DOI 10.3171/jns.1971.35.5.0503; Ommaya AK, 2002, BRIT J NEUROSURG, V16, P220, DOI 10.1080/02688690220148824; Pitres A, 1925, NERFS SCHEMAS ANATOM; PUDENZ RH, 1946, J NEUROSURG, V3, P487, DOI 10.3171/jns.1946.3.6.0487; REICH SG, 1987, NEUROSURGERY, V21, P135, DOI 10.1227/00006123-198708000-00001; Riddoch G, 1917, BRAIN, V40, P15, DOI 10.1093/brain/40.1.15; Riddoch G, 1917, BRAIN, V40, P264, DOI 10.1093/brain/40.2-3.264; Riddoch G, 1917, Proc R Soc Med, V10, P13; Rusk H., 1972, WORLD CARE AUTOBIOGR; Rusk H A, 1969, Arch Phys Med Rehabil, V50, P463; Rusk H A, 1977, Med Times, V105, P64; Russell WR, 1932, BRAIN, V55, P549, DOI 10.1093/brain/55.4.549; Silver JR., 2003, HIST TREATMENT SPINA; SIX E, 1979, SOUTHERN MED J, V72, P699, DOI 10.1097/00007611-197906000-00020; SPALDING JMK, 1952, J NEUROL NEUROSUR PS, V15, P169, DOI 10.1136/jnnp.15.3.169; TINEL J, 1971, ARCH NEUROL-CHICAGO, V24, P574; Tinel J, 1917, NERVE WOUNDS; Zeki S, 1998, BRAIN, V121, P25, DOI 10.1093/brain/121.1.25; ZEKI S, 1991, BRAIN, V114, P811, DOI 10.1093/brain/114.2.811; Zeki S, 1993, VISION BRAIN; ZIHL J, 1983, BRAIN, V106, P313, DOI 10.1093/brain/106.2.313; 1943, J NEUROL PSYCHIAT, V6, P81; 2004, J SPINAL CORD MED, V27, P287	75	22	22	0	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0364-5134	1531-8249		ANN NEUROL	Ann. Neurol.	OCT	2009	66	4					444	459		10.1002/ana.21822			16	Clinical Neurology; Neurosciences	Neurosciences & Neurology	507SJ	WOS:000270874700005	19847911				2021-06-18	
J	Zhu, L; Wang, HD; Yu, XG; Jin, W; Qiao, L; Lu, TJ; Hu, ZL; Zhou, J				Zhu, Lin; Wang, Han-dong; Yu, Xin-guang; Jin, Wei; Qiao, Liang; Lu, Ting-jia; Hu, Ze-lan; Zhou, Jing			Erythropoietin prevents zinc accumulation and neuronal death after traumatic brain injury in rat hippocampus: In vitro and in vivo studies	BRAIN RESEARCH			English	Article						Hippocampus; Erythropoietin; Rat; Traumatic brain injury; Zinc	CEREBRAL-ISCHEMIA; CORTICAL-NEURONS; ZN2+ ENTRY; APOPTOSIS; CELLS; NEUROPROTECTION; EXPRESSION; TRANSLOCATION; ACTIVATION; PROTECTS	Erythropoietin (Epo) has been gaining great interest for its potential neuroprotective effect in various neurological insults. However, the molecular mechanism underlying how Epo exerts the function is not clear. Recent studies have indicated that Zn2+ may have a key role in selective cell death in excitotoxicity after injury, In the present study, we studied the effect of recombinant human Epo (rhEpo) in zinc-induced neurotoxicity both in vitro and in vivo. Exposure of cultured hippocampal neurons to 200 mu M ZnCl2 for 20 min resulted in remarkable neuronal injury, revealed by assessing neuronal morphology. By measuring mitochondrial function using MTT assay, we found that application of rhEpo (0.1 U/ml) 24 h before zinc exposure resulted in a significant increase of neuronal survival (0.6007 +/- 0.2280 Epo group vs 0.2333 +/- 0.1249 in control group; n=4, p<0.01). Furthermore, we demonstrated that administration of rhEpo (5,000 IU/kg, intraperitoneal) 30 min after traumatic brain injury (TBI) in rats dramatically protected neuronal death indicated by ZP4 staining, a new zinc-specific fluorescent sensor which has been widely used to indicate neuronal damage after excitotoxic injury (n=5/group, p<0.05). Neuronal damage was also assessed by Fluoro-Jade B (FJB) staining, a highly specific fluorescent marker for the degenerating neurons. Consistent with ZP4 staining, we found the beneficial effects of rhEpo on neuronal survival in hippocampus after TBI (n=5/group, p<0.05). Our results suggest that rhEpo can significantly reduce the pathological Zn2+ accumulation in rat hippocampus after TBI as well as zinc-induced cell death in cultured cells, which may potentially contribute to its neuronal protection after excitotoxic brain damage. (C) 2009 Elsevier B.V. All rights reserved.	[Zhu, Lin; Wang, Han-dong; Jin, Wei; Qiao, Liang] Jinling Hosp, Dept Neurosurg, Nanjing, Jiangsu Prov, Peoples R China; [Lu, Ting-jia; Hu, Ze-lan; Zhou, Jing] Chinese Acad Sci, Inst Neurosci Shanghai, Shanghai, Peoples R China; [Yu, Xin-guang] Gen Hosp Peoples Liberat Army, Dept Neurosurg, Beijing 100853, Peoples R China	Wang, HD (corresponding author), Jinling Hosp, Dept Neurosurg, Nanjing, Jiangsu Prov, Peoples R China.	wanghandong61@126.com			Jinling Hospital of Nanjing, Jiangsu Province, China [Q2008033]	The authors gratefully acknowledge Professor Yu-Qiang Ding (Institute of Neuroscience of Shanghai, Chinese Academy of Science, Shanghai, China) and Professor Zhi-Qi Xiong (Institute of Neuroscience of Shanghai, Chinese Academy of Science, Shanghai, China) for technical assistance. This work was financially supported by grants from Jinling Hospital of Nanjing (Grant No Q2008033), Jiangsu Province, China.	Brines ML, 2000, P NATL ACAD SCI USA, V97, P10526, DOI 10.1073/pnas.97.19.10526; BUHRER C, 1991, PEDIATR HEMAT ONCOL, V8, P243, DOI 10.3109/08880019109033458; CHOI DW, 1988, NEUROSCIENCE, V24, P67, DOI 10.1016/0306-4522(88)90312-0; Chong ZZ, 2003, J NEUROSCI RES, V71, P659, DOI 10.1002/jnr.10528; Chong ZZ, 2002, J CEREBR BLOOD F MET, V22, P503, DOI 10.1097/00004647-200205000-00001; Cuajungco MP, 1998, BRAIN RES, V799, P118, DOI 10.1016/S0006-8993(98)00463-6; Digicaylioglu M, 2001, NATURE, V412, P641, DOI 10.1038/35088074; Dineley KE, 2003, J NEUROCHEM, V85, P563, DOI 10.1046/j.1471-4159.2003.01678.x; DITTMER J, 1992, BIOCHEM J, V285, P113, DOI 10.1042/bj2850113; FEENEY DM, 1981, BRAIN RES, V211, P67, DOI 10.1016/0006-8993(81)90067-6; FREDERICKSON CJ, 1989, INT REV NEUROBIOL, V31, P145; Frederickson CJ, 2004, J NEUROSCI METH, V139, P79, DOI 10.1016/j.jneumeth.2004.04.033; Frederickson CJ, 2002, NEUROSCIENCE, V115, P471, DOI 10.1016/S0306-4522(02)00399-8; FREDERICKSON CJ, 1989, BRAIN RES, V480, P317, DOI 10.1016/0006-8993(89)90199-6; Grasso G, 2006, J NEUROSURG ANESTH, V18, P91, DOI 10.1097/00008506-200604000-00001; Grasso G, 2001, J Neurosurg Sci, V45, P7; Hellmich HL, 2007, BRAIN RES, V1127, P119, DOI 10.1016/j.brainres.2006.09.094; Kay AR, 2006, J NEUROPHYSIOL, V95, P1949, DOI 10.1152/jn.00959.2005; Kilic E, 2005, FASEB J, V19, P2026, DOI 10.1096/fj.05-3941fje; Kim EY, 1999, EUR J NEUROSCI, V11, P327, DOI 10.1046/j.1460-9568.1999.00437.x; Kim YH, 2002, EXP NEUROL, V177, P407, DOI 10.1006/exnr.2002.7990; Kim YH, 1999, NEUROSCIENCE, V89, P175, DOI 10.1016/S0306-4522(98)00313-3; Koh JY, 1996, SCIENCE, V272, P1013, DOI 10.1126/science.272.5264.1013; Lee JM, 2002, NEUROSCIENCE, V115, P871, DOI 10.1016/S0306-4522(02)00513-4; Liang Zhang, 2007, Genomics Proteomics & Bioinformatics, V5, P25, DOI 10.1016/S1672-0229(07)60011-4; Manev H, 1997, EXP NEUROL, V146, P171, DOI 10.1006/exnr.1997.6510; MARET W, 1995, NEUROCHEM INT, V27, P111, DOI 10.1016/0197-0186(94)00173-R; Menezes JRL, 1995, MOL CELL NEUROSCI, V6, P496, DOI 10.1006/mcne.1995.0002; MENEZES JRL, 1994, J NEUROSCI, V14, P5399; Morishita E, 1997, NEUROSCIENCE, V76, P105, DOI 10.1016/s0306-4522(96)00306-5; Ozturk E, 2005, PROG NEURO-PSYCHOPH, V29, P920, DOI 10.1016/j.pnpbp.2005.04.028; PerezClausell J, 1996, J CHEM NEUROANAT, V11, P99, DOI 10.1016/0891-0618(96)00131-7; Renzi MJ, 2002, MOL BRAIN RES, V104, P86, DOI 10.1016/S0169-328X(02)00323-6; Roesler R, 2004, NEW ENGL J MED, V351, P1465; Ruscher K, 2002, J NEUROSCI, V22, P10291, DOI 10.1523/jneurosci.22-23-10291.2002; Schmued LC, 2000, BRAIN RES, V874, P123, DOI 10.1016/S0006-8993(00)02513-0; Sensi SL, 2000, EUR J NEUROSCI, V12, P3813, DOI 10.1046/j.1460-9568.2000.00277.x; Siren AL, 2001, P NATL ACAD SCI USA, V98, P4044, DOI 10.1073/pnas.051606598; Suh SW, 2006, J CEREBR BLOOD F MET, V26, P161, DOI 10.1038/sj.jcbfm.9600176; Suh SW, 2000, BRAIN RES, V852, P268, DOI 10.1016/S0006-8993(99)02095-8; Verdonck O, 2007, J CEREBR BLOOD F MET, V27, P1369, DOI 10.1038/sj.jcbfm.9600443; Villa P, 2003, J EXP MED, V198, P971, DOI 10.1084/jem.20021067; Wei G, 2004, NEUROSCIENCE, V125, P867, DOI 10.1016/j.neuroscience.2004.03.011; Weiss JH, 2000, TRENDS PHARMACOL SCI, V21, P395, DOI 10.1016/S0165-6147(00)01541-8; Wen TC, 2002, J NEUROSCI RES, V67, P795, DOI 10.1002/jnr.10166; Yang J, 2007, ACTA NEUROBIOL EXP, V67, P141; Yatsiv I, 2005, FASEB J, V19, P1701, DOI 10.1096/fj.05-3907fje; Zamzami N, 2001, NAT REV MOL CELL BIO, V2, P67, DOI 10.1038/35048073; ZORATTI M, 1995, BBA-REV BIOMEMBRANES, V1241, P139, DOI 10.1016/0304-4157(95)00003-A	49	22	24	0	2	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	SEP 15	2009	1289						96	105		10.1016/j.brainres.2009.07.015			10	Neurosciences	Neurosciences & Neurology	493YP	WOS:000269776000011	19615349				2021-06-18	
J	McFadyen, BJ; Cantin, JF; Swaine, B; Duchesneau, G; Doyon, J; Dumas, D; Fait, P				McFadyen, Bradford J.; Cantin, Jean-Francois; Swaine, Bonnie; Duchesneau, Guylaine; Doyon, Julien; Dumas, Denyse; Fait, Philippe			Modality-Specific, Multitask Locomotor Deficits Persist Despite Good Recovery After a Traumatic Brain Injury	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						Attention; Gait; Locomotion; Rehabilitation	GAIT; ATTENTION; STABILITY; WALKING; OLDER; OBSTACLES; PATTERNS; DEMANDS; STEP	Objective: To study the effects of sensory modality of simultaneous tasks during walking with and without obstacles after moderate to severe traumatic brain injury (TBI). Design: Group comparison study. Setting: Gait analysis laboratory within a postacute rehabilitation facility. Participants: Volunteer sample (N=18). Persons with moderate to severe TBI (n=11) (9 men, 3 women; age, 37.56 13.79y) and a comparison group (n=7)of subjects without neurologic problems matched on average for body mass index and age (4 men, 3 women; age, 39.19 +/- 17.35y). Interventions: Not applicable. Main Outcome Measures: Magnitudes and variability for walking speeds, foot clearance margins (ratio of foot clearance distance to obstacle height), and response reaction times (both direct and as a relative cost because of obstacle avoidance). Results: The TBI group had well-recovered walking speeds and a general ability to avoid obstacles. However, these subjects did show lower trail limb toe clearances (P=.003) across all conditions. Response reaction times to the Stroop tasks were longer in general for the TBI group (P=.017), and this group showed significant increases in response reaction times for the visual modality within the more challenging obstacle avoidance task that was not observed for control subjects. A measure of multitask costs related to differences in response reaction times between obstructed and unobstructed trials also only showed increased attention costs for the visual over the auditory stimuli for the TBI group (P=.002). Conclusions: Mobility is a complex construct, and the present results provide preliminary findings that, even after good locomotor recovery, subjects with moderate to severe TBI show residual locomotor deficits in multitasking. Furthermore, our results suggest that sensory modality is important,	[McFadyen, Bradford J.; Fait, Philippe] Univ Laval, Ctr Interdisciplinary Res Rehabil & Social Integr, Quebec City, PQ G1M 2S8, Canada; [McFadyen, Bradford J.; Fait, Philippe] Univ Laval, Fac Med, Dept Rehabil, Quebec City, PQ G1M 2S8, Canada; [Swaine, Bonnie] Ctr Interdisciplinary Res Rehabil Greater Montrea, Montreal, PQ, Canada; [Swaine, Bonnie] Montreal Rehabil Inst, Montreal, PQ, Canada; [Swaine, Bonnie] Univ Montreal, Sch Rehabil, Montreal, PQ, Canada; [Doyon, Julien] Univ Montreal, Dept Psychol, Montreal, PQ H3C 3J7, Canada; [Cantin, Jean-Francois; Duchesneau, Guylaine; Dumas, Denyse] Quebec Rehabil Inst, Quebec City, PQ, Canada	McFadyen, BJ (corresponding author), Univ Laval, Ctr Interdisciplinary Res Rehabil & Social Integr, 525 Hamel, Quebec City, PQ G1M 2S8, Canada.	brad.mcfadyen@rea.ulaval.ca		Fait, Philippe/0000-0002-2554-9273; McFadyen, Bradford/0000-0003-1992-4927	Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR) [64408]	Supported by the Canadian Institutes of Health Research (grant no. 64408).	Bruggeman H, 2007, CURR BIOL, V17, P2035, DOI 10.1016/j.cub.2007.10.059; Cantin JF, 2007, BRAIN INJURY, V21, P327, DOI 10.1080/02699050701209972; Catena RD, 2007, EXP BRAIN RES, V176, P23, DOI 10.1007/s00221-006-0596-2; Gadoury M, 2001, CADRE REFERENCE CLIN; Gerin-Lajoie M, 2005, MOTOR CONTROL, V9, P242, DOI 10.1123/mcj.9.3.242; Gerin-Lajoie M, 2006, GAIT POSTURE, V24, P364, DOI 10.1016/j.gaitpost.2005.11.001; GOLDEN CJ, 1976, J CLIN PSYCHOL, V32, P654, DOI 10.1002/1097-4679(197607)32:3<654::AID-JCLP2270320336>3.0.CO;2-Z; KUROSAWA K, 1994, PERCEPT MOTOR SKILL, V78, P768, DOI 10.2466/pms.1994.78.3.768; LAJOIE Y, 1993, EXP BRAIN RES, V97, P139; McFadyen BJ, 2003, J HEAD TRAUMA REHAB, V18, P512, DOI 10.1097/00001199-200311000-00005; Mohagheghi AA, 2004, EXP BRAIN RES, V155, P459, DOI 10.1007/s00221-003-1751-7; Niechwiej-Szwedo E, 2007, GAIT POSTURE, V25, P70, DOI 10.1016/j.gaitpost.2006.01.002; Ochi F, 1999, J HEAD TRAUMA REHAB, V14, P105, DOI 10.1097/00001199-199904000-00002; Parker TM, 2005, CLIN BIOMECH, V20, P389, DOI 10.1016/j.clinbiomech.2004.12.004; Parker TM, 2006, MED SCI SPORT EXER, V38, P1032, DOI 10.1249/01.mss.0000222828.56982.a4; Patla AE, 1997, NEUROREPORT, V8, P3661, DOI 10.1097/00001756-199712010-00002; Patla AE, 1996, J MOTOR BEHAV, V28, P35, DOI 10.1080/00222895.1996.9941731; PATLA AE, 1991, J EXP PSYCHOL HUMAN, V17, P603, DOI 10.1037/0096-1523.17.3.603; Perneger TV, 1998, BRIT MED J, V316, P1236, DOI 10.1136/bmj.316.7139.1236; Redfern MS, 2002, J GERONTOL A-BIOL, V57, pB298, DOI 10.1093/gerona/57.8.B298; Rees G, 2001, NEUROPSYCHOLOGIA, V39, P937, DOI 10.1016/S0028-3932(01)00016-1; ShumwayCook A, 1997, J GERONTOL A-BIOL, V52, pM232, DOI 10.1093/gerona/52A.4.M232; Vallee M, 2006, ARCH PHYS MED REHAB, V87, P806, DOI 10.1016/j.apmr.2006.02.031; Woollacott M, 2002, GAIT POSTURE, V16, P1, DOI 10.1016/S0966-6362(01)00156-4; Woollacott M, 2008, BRAIN RES, V1208, P95, DOI 10.1016/j.brainres.2008.03.005; Yogev-Seligmann G, 2008, MOVEMENT DISORD, V23, P329, DOI 10.1002/mds.21720	26	22	24	0	9	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	SEP	2009	90	9					1596	1606		10.1016/j.apmr.2009.03.010			11	Rehabilitation; Sport Sciences	Rehabilitation; Sport Sciences	496AA	WOS:000269938100019	19735789				2021-06-18	
J	Hostler, D; Northington, WE; Callaway, CW				Hostler, David; Northington, William E.; Callaway, Clifton W.			High-dose diazepam facilitates core cooling during cold saline infusion in healthy volunteers	APPLIED PHYSIOLOGY NUTRITION AND METABOLISM-PHYSIOLOGIE APPLIQUEE NUTRITION ET METABOLISME			English	Article						therapeutic hypothermia; diazepam; shivering; oxygen consumption	HEAT-STROKE; CARDIAC-ARREST; HYPOTHERMIA; HEATSTROKE; TEMPERATURE; HUMANS	Studies have suggested that inducing mild hypothermia improves neurologic outcomes after traumatic brain injury, major stroke, cardiac arrest, or exertional heat illness. While infusion of cold normal saline is a simple and inexpensive method for reducing core temperature, human cold-defense mechanisms potentially make this route stressful or ineffective. We hypothesized that intravenous administration of diazepam during a rapid infusion of 30 mL.kg(-1) of cold (4 degrees C) 0.9% saline to healthy subjects would be more comfortable and reduce core body temperature more than the administration of cold saline alone. Fifteen subjects received rapidly infused cold (4 degrees C) 0.9% saline. Subjects were randomly assigned to receive, intravenously, 20 mg diazepam (HIGH), 10 mg diazepam (LOW), or placebo (CON). Main outcomes were core temperature, skin temperature, and oxygen consumption. Data for the main outcomes were analyzed with generalized estimating equations to identify differences in group, time, or a group x time interaction. Core temperature decreased in all groups (CON, 1.0 +/- 0.2 degrees C; LOW, 1.4 +/- 0.2 degrees C; HIGH, 1.5 +/- 0.2 degrees C), while skin temperature was unchanged. Mean (95% CI) oxygen consumption was 315.3 (253.8, 376.9) mL.kg(-1).min(-1) in the CON group, 317.9 (275.5, 360.3) in the LOW group, and 226.1 (216.4, 235.9) in the HIGH group. Significant time and group x time interaction was observed for core temperature and oxygen consumption (p < 0.001). Administration of high-dose diazepam resulted in decreased oxygen consumption during cold saline infusion, suggesting that 20 mg of intravenous diazepam may reduce the shivering threshold without compromising respiratory or cardiovascular function.	[Hostler, David; Northington, William E.; Callaway, Clifton W.] Univ Pittsburgh, Dept Emergency Med, Emergency Responder Human Performance Lab, Pittsburgh, PA 15213 USA	Hostler, D (corresponding author), Univ Pittsburgh, Dept Emergency Med, Emergency Responder Human Performance Lab, Pittsburgh, PA 15213 USA.	hostlerdp@upmc.edu		Hostler, David/0000-0002-7711-4001; Callaway, Clifton/0000-0002-3309-1573	University of Pittsburgh General Clinical Research CenterUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR); NIH/NCRR/GCRCUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [M01 RR000056]; Clinical and Translation Research Center; NIH/NCRR/CTSAUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)NIH National Center for Research Resources (NCRR) [UL1 RR024153]; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [UL1RR024153, M01RR000056] Funding Source: NIH RePORTER	This study was funded by a grant from the University of Pittsburgh General Clinical Research Center (NIH/NCRR/GCRC Grant M01 RR000056) and the Clinical and Translation Research Center (NIH/NCRR/CTSA Grant UL1 RR024153). The authors thank the staff of the Clinical and Translation Research Center and George Grove from the University of Pittsburgh Obesity Nutrition Research Center for their support during this project.	Armstrong LE, 1996, AM J EMERG MED, V14, P355, DOI 10.1016/S0735-6757(96)90048-0; Aronowski J, 2003, STROKE, V34, P1246, DOI 10.1161/01.STR.0000068170.80517.B3; Ayling J H, 1986, Br J Sports Med, V20, P35; BELLER GA, 1975, MIL MED, V140, P464; Bernard SA, 2002, NEW ENGL J MED, V346, P557, DOI 10.1056/NEJMoa003289; Bouchama A, 2007, CRIT CARE, V11, DOI 10.1186/cc5910; Clifton GL, 2002, J NEUROTRAUM, V19, P293, DOI 10.1089/089771502753594864; COSTRINI AM, 1979, AM J MED, V66, P296, DOI 10.1016/0002-9343(79)90548-5; DAHMASH NS, 1993, CHEST, V103, P1210, DOI 10.1378/chest.103.4.1210; De Georgia MA, 2004, NEUROLOGY, V63, P312, DOI 10.1212/01.WNL.0000129840.66938.75; Dixon SR, 2002, J AM COLL CARDIOL, V40, P1928, DOI 10.1016/S0735-1097(02)02567-6; Frank SM, 1997, AM J PHYSIOL-REG I, V272, pR557; GAGGE AP, 1969, ENVIRON RES, V2, P209, DOI 10.1016/0013-9351(69)90037-1; HART GR, 1982, MEDICINE, V61, P189, DOI 10.1097/00005792-198205000-00005; Holzer M, 2002, NEW ENGL J MED, V346, P549; Hsiao SH, 2007, RESUSCITATION, V73, P437, DOI 10.1016/j.resuscitation.2006.11.003; Lyden Patrick D, 2005, J Stroke Cerebrovasc Dis, V14, P107, DOI 10.1016/j.jstrokecerebrovasdis.2005.01.001; Moore TM, 2008, ANN EMERG MED, V51, P153, DOI 10.1016/j.annemergmed.2007.07.012; O'Brien C, 1998, MED SCI SPORT EXER, V30, P468, DOI 10.1097/00005768-199803000-00020; ODONNELL TF, 1972, NEW ENGL J MED, V287, P734, DOI 10.1056/NEJM197210122871502; Rajek A, 2000, ANESTHESIOLOGY, V93, P629, DOI 10.1097/00000542-200009000-00010; SPRUNG CL, 1979, CHEST, V75, P362, DOI 10.1378/chest.75.3.362; Wilkinson DM, 2008, MED SCI SPORT EXER, V40, P523, DOI [10.1249/MSS.0b013e31815cc43e, 10.1249/mss.0b013e31815cc43e]; ZWISCHENBERGER JB, 1987, ANN THORAC SURG, V43, P428, DOI 10.1016/S0003-4975(10)62823-8	24	22	23	0	3	NATL RESEARCH COUNCIL CANADA-N R C RESEARCH PRESS	OTTAWA	BUILDING M 55, OTTAWA, ON K1A 0R6, CANADA	1715-5312			APPL PHYSIOL NUTR ME	Appl. Physiol. Nutr. Metab.	AUG	2009	34	4					582	586		10.1139/H09-011			5	Nutrition & Dietetics; Physiology; Sport Sciences	Nutrition & Dietetics; Physiology; Sport Sciences	496KP	WOS:000269972200003	19767791				2021-06-18	
J	Kayani, NA; Homan, S; Yun, SM; Zhu, BP				Kayani, Noaman A.; Homan, Sherri; Yun, Shumei; Zhu, Bao Ping			Health and Economic Burden of Traumatic Brain Injury: Missouri, 2001-2005	PUBLIC HEALTH REPORTS			English	Article							OUTCOMES; COSTS	Objective. We examined the financial and social costs resulting from traumatic brain injury (TBI) in Missouri. Methods. We computed mortality rates from death certificates, the direct cost of TBI from hospital and emergency department (ED) visit charges, the social cost in terms of years of potential life lost (YPLL) using an abridged Missouri life table, and the indirect financial cost in terms of lost productivity due to premature death for all TBI and four major causes of TBI in Missouri. Results. During 2001-2005, a mean of 1,358 lives were lost due to TBI in Missouri. Four major causes-unintentional falls, motor vehicle traffic crashes, motorcycle crashes, and firearms-accounted for 88% of all TBI deaths. We estimated the annual direct medical cost of TBI at $95 million, or about $1.67 million per 100,000 Missourians. This cost increased by about 60% between 2001 and 2005. The four major causes of TBI accounted for 68% of all direct medical costs of TBI. We estimated the cost per hospitalization and ED visit at $6,948 and the indirect social cost at 48,501 YPLL. During this period, the mean age of TBI fatality was 44 years. We determined the lost productivity due to TBI mortality-$1.1 billion, or about $18.8 million per 100,000 Missourians-to be three times as high for males as for females. Conclusions. The types of costs covered in this study underestimated the total cost of TBI in Missouri, as we did not include outpatient care, rehabilitation, and drug costs. Nevertheless, we found the health and economic burden from medical care and mortality related to TBI to be substantial in Missouri.	[Kayani, Noaman A.; Homan, Sherri; Yun, Shumei; Zhu, Bao Ping] Missouri Dept Hlth & Senior Serv, Div Community & Publ Hlth, Jefferson City, MO 65102 USA	Kayani, NA (corresponding author), Missouri Dept Hlth & Senior Serv, Div Community & Publ Hlth, POB 570,920 Wildwood Dr, Jefferson City, MO 65102 USA.	noaman.kayani@dhss.mo.gov		Zhu, Baoping/0000-0003-0065-0153	Division of Community and Public Health, Missouri Department of Health and Senior Services	This research was supported by the Division of Community and Public Health, Missouri Department of Health and Senior Services, as well as state general revenue.	Borg J, 2004, J REHABIL MED, V36, P76, DOI 10.1080/16501960410023840; Centers for Disease Control and Prevention (CDC), 1997, MMWR Morb Mortal Wkly Rep, V46, P8; Christensen MC, 2008, CRIT CARE, V12, DOI 10.1186/cc6797; Fakhry SM, 2004, J TRAUMA, V56, P492, DOI 10.1097/01.TA.0000115650.07193.66; Faul M, 2007, J TRAUMA, V63, P1271, DOI 10.1097/TA.0b013e3181493080; FINKLER SA, 1982, ANN INTERN MED, V96, P102, DOI 10.7326/0003-4819-96-1-102; Haddix AC, 2002, PREVENTION EFFECTIVE; HOMAN SG, 2006, PUBLIC HLTH BURDEN T; Kreutzer JS, 2001, BRAIN INJURY, V15, P763, DOI 10.1080/02699050010025786; Langlois JA., 2004, TRAUMATIC BRAIN INJU; Max W, 2004, VALUING HUMAN LIFE E; McGarry LJ, 2002, J TRAUMA, V53, P1152, DOI 10.1097/00005373-200212000-00020; *MISS DEP HLTH SEN, 2003, MISS VIT STAT ABR LI; *MISS DEP HLTH SEN, 1999, PAT ABSTR SYST; *MISS DEP HLTH SEN, MISS INF COMM ASS DE; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; U.S. Bureau of Labor Statistics, CONS PRIC IND MED CA; *US NATL CTR HLTH, CLASS DIS FUNCT DIS; 2001, FED REG, V66, P22727	19	22	24	0	7	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0033-3549	1468-2877		PUBLIC HEALTH REP	Public Health Rep.	JUL-AUG	2009	124	4					551	560		10.1177/003335490912400412			10	Public, Environmental & Occupational Health	Public, Environmental & Occupational Health	455VO	WOS:000266795700011	19618792	Green Published			2021-06-18	
J	Leliefeld, PH; Gooskens, RHJM; Braun, KPJ; Ramos, LMP; Uiterwaal, CSPM; Regli, LPE; Tulleken, CAF; Kappelle, LJ; Hanlo, PW				Leliefeld, Paul H.; Gooskens, Rob H. J. M.; Braun, Kees P. J.; Ramos, Lino M. P.; Uiterwaal, Cuno S. P. M.; Regli, Luca P. E.; Tulleken, Cees A. F.; Kappelle, L. Jaap; Hanlo, Patrick W.			Longitudinal diffusion-weighted imaging in infants with hydrocephalus: decrease in tissue water diffusion after cerebrospinal fluid diversion Clinical article	JOURNAL OF NEUROSURGERY-PEDIATRICS			English	Article; Proceedings Paper	36th Annual Meeting of the International-Society-for-Pediatric-Neurosurgery	OCT 12-16, 2008	Cape Town, SOUTH AFRICA	Int Soc Pediat Neurosurg		apparent diffusion coefficient; infant; hydrocephalus; magnetic resonance imaging; intracranial pressure; cerebrospinal fluid	CEREBRAL-BLOOD-FLOW; NORMAL-PRESSURE HYDROCEPHALUS; TRAUMATIC BRAIN-INJURY; WHITE-MATTER EDEMA; ROTTERDAM TELETRANSDUCER; INTRACRANIAL-PRESSURE; EPIDURAL PRESSURE; PRETERM INFANTS; MRI; SPECTROSCOPY	Object. Progressive hydrocephalus may lead to edema of the periventricular white matter and to damage of the brain parenchyma because of compression, stretching, and ischemia. The aim of the present study was to investigate whether cerebral edema can be quantified using diffusion-weighted imaging in infants with hydrocephalus and whether CSF diversion could decrease cerebral edema. Methods. Diffusion-weighted MR imaging was performed in 24 infants with progressive hydrocephalus before and after CSF diversion. Parametric images of the trace apparent diffusion coefficients (ADCs) were obtained. The ADCs of 5 different cortical and subcortical regions of interest were calculated pre- and postoperatively in each patient. The ADC values were compared with age-related normal values. Mean arterial blood pressure and anterior fontanel pressure were measured immediately after each MR imaging study. Results. After CSF diversion, the mean ADC decreased from a preoperative value of 1209 +/- 116 x 10(-6) mm(2)/second to a postoperative value of 928 +/- 64 x 10(-6) mm(2)/second (p < 0.005). Differences between pre- and postoperative ADC values were most prominent in the periventricular white matter, supporting the existence of preoperative periventricular edema. Compared with age-related normal values, the preoperative ADC values were higher and the postoperative ADC values were lower, although within normal range. The decrease in ADC after CSF drainage was more rapid than the more gradual physiological decrease that is related to age. The preoperative ICP was elevated in all patients. After CSF diversion the ICP decreased significantly to within the normal range. A linear correlation between ADC values and ICP was found (correlation coefficient 0.496, p < 0.001). In all patients the mean arterial blood pressure was within physiological limits both pre- and postoperatively. Conclusions. This study shows a rapid and more extensive decrease in ADC values after CSF diversion than is to be expected from physiological ADC decrease solely due to increasing patient age. The preoperative ADC increase can be explained by interstitial edema caused by transependymal CSF leakage or by vasogenic edema caused by capillary compression and stretching of the brain parenchyma. This study population of infants with (early recognized) hydrocephalus did not suffer from cytotoxic edema. These findings may help to detect patients at risk for cerebral damage by differentiating between progressive and compensated hydrocephalus. (DOI: 10.3171/2009.3.PEDS08337)	[Leliefeld, Paul H.; Regli, Luca P. E.; Tulleken, Cees A. F.; Hanlo, Patrick W.] Univ Med Ctr Utrecht, Dept Neurosurg, NL-3584 CX Utrecht, Netherlands; [Leliefeld, Paul H.; Gooskens, Rob H. J. M.; Braun, Kees P. J.; Regli, Luca P. E.; Tulleken, Cees A. F.; Kappelle, L. Jaap; Hanlo, Patrick W.] Univ Med Ctr Utrecht, Rudolf Magnus Inst Neurosci, NL-3584 CX Utrecht, Netherlands; [Gooskens, Rob H. J. M.; Braun, Kees P. J.] Univ Med Ctr Utrecht, Dept Child Neurol, NL-3584 CX Utrecht, Netherlands; [Ramos, Lino M. P.] Univ Med Ctr Utrecht, Dept Radiol, NL-3584 CX Utrecht, Netherlands; [Kappelle, L. Jaap] Univ Med Ctr Utrecht, Dept Neurol, NL-3584 CX Utrecht, Netherlands; [Uiterwaal, Cuno S. P. M.] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, NL-3584 CX Utrecht, Netherlands	Leliefeld, PH (corresponding author), Univ Med Ctr Utrecht, Dept Neurosurg, G 03-124,Heidelberglaan 100, NL-3584 CX Utrecht, Netherlands.	p.h.leliefeld@umcutrecht.nl					Adelson PD, 1997, PEDIATR NEUROSURG, V26, P200; Anegawa S, 1991, HYDROCEPHALUS PATHOG, P248; Baldauf J, 2007, CHILD NERV SYST, V23, P623, DOI 10.1007/s00381-007-0335-4; Braun KPJ, 2003, J MAGN RESON IMAGING, V17, P291, DOI 10.1002/jmri.10270; Braun KPJ, 1998, MAGN RESON MED, V40, P832, DOI 10.1002/mrm.1910400608; Braun KPJ, 1997, BRAIN RES, V757, P295, DOI 10.1016/S0006-8993(97)00345-4; Counsell SJ, 2006, PEDIATRICS, V117, P376, DOI 10.1542/peds.2005-0820; Counsell SJ, 2003, PEDIATRICS, V112, P1, DOI 10.1542/peds.112.1.1; DEJONG DA, 1975, BIOTELEMETRY, V2, P257; DEJONG DA, 1983, MED PROG TECHNOL, V10, P89; DEJONG DA, 1982, BIOTELEM PAT MON, V9, P154; DELBIGIO MR, 1993, ACTA NEUROPATHOL, V85, P573, DOI 10.1007/BF00334666; Dombrowski SM, 2006, J CEREBR BLOOD F MET, V26, P1298, DOI 10.1038/sj.jcbfm.9600282; Dorenbeck U, 2005, ROFO-FORTSCHR RONTG, V177, P99, DOI 10.1055/s-2004-813728; EBISU T, 1993, JMRI-J MAGN RESON IM, V3, P863, DOI 10.1002/jmri.1880030612; Erdem G, 2007, MAGN RESON IMAGING, V25, P1417, DOI 10.1016/j.mri.2007.03.028; Forbes KPN, 2002, RADIOLOGY, V222, P405, DOI 10.1148/radiol.2222010179; Gass A, 2001, J NEUROL SCI, V186, pS15, DOI 10.1016/S0022-510X(01)00487-7; GIDEON P, 1994, ACTA RADIOL, V35, P514; Hanlo PW, 1996, CHILD NERV SYST, V12, P200, DOI 10.1007/BF00301251; Hanlo PW, 1997, DEV MED CHILD NEUROL, V39, P286; Hou DJ, 2007, J NEUROTRAUM, V24, P1558, DOI 10.1089/neu.2007.0339; Inaba H, 2008, ANN ONCOL, V19, P178, DOI 10.1093/annonc/mdm466; JORGENSEN PB, 1972, INTRACRANIAL PRESSUR, P41; KAISER AM, 1986, NEUROPEDIATRICS, V17, P100, DOI 10.1055/s-2008-1052509; Kantarci K, 2003, NEUROIMAG CLIN N AM, V13, P197, DOI 10.1016/S1052-5149(03)00025-X; Karahalios DG, 1996, NEUROLOGY, V46, P198, DOI 10.1212/WNL.46.1.198; Kim E, 2007, AM J NEURORADIOL, V28, P1652, DOI 10.3174/ajnr.A0655; KIRKPATRICK M, 1989, ARCH DIS CHILD, V64, P124, DOI 10.1136/adc.64.1.124; Kristensen B, 1996, J NEUROL NEUROSUR PS, V60, P282, DOI 10.1136/jnnp.60.3.282; Leliefeld PH, 2008, J NEUROSURG-PEDIATR, V2, P163, DOI 10.3171/PED/2008/2/9/163; Luthra G, 2007, AM J NEURORADIOL, V28, P1332, DOI 10.3174/ajnr.A0548; MAMO HL, 1987, STROKE, V18, P1074, DOI 10.1161/01.STR.18.6.1074; Massicotte EM, 2000, J NEUROSURG, V92, P442, DOI 10.3171/jns.2000.92.3.0442; McAllister JP, 1998, NEUROSURG CLIN N AM, V9, P73; MINNS RA, 1989, ARCH DIS CHILD, V64, P814, DOI 10.1136/adc.64.6.814; Moustafa RR, 2007, CRIT CARE, V11, DOI 10.1186/cc5973; NAKADA J, 1992, ACTA NEUROCHIR, V114, P43, DOI 10.1007/BF01401113; Natl High Blood Pressure Educ Prog, 2004, PEDIATRICS, V114, P555; O'Brien TJ, 2007, J CLIN NEUROSCI, V14, P841, DOI 10.1016/j.jocn.2006.07.003; Oi S, 2006, CHILD NERV SYST, V22, P662, DOI 10.1007/s00381-005-0020-4; PETERS RJA, 1995, CHILD NERV SYST, V11, P207, DOI 10.1007/BF00277655; PLANDSOEN WCG, 1987, MED PROG TECHNOL, V13, P21; Pronin I N, 2000, Zh Vopr Neirokhir Im N N Burdenko, P14; SCHETTINI A, 1971, J NEUROSURG, V34, P38, DOI 10.3171/jns.1971.34.1.0038; Sotak CH, 2004, NEUROCHEM INT, V45, P569, DOI 10.1016/j.neuint.2003.11.010; SUNDBARG G, 1972, INTRACRANIAL PRESSUR, P46; Tanaka A, 1997, NEUROSURGERY, V40, P1161, DOI 10.1097/00006123-199706000-00009; van Everdingen KJ, 1998, STROKE, V29, P1783, DOI 10.1161/01.STR.29.9.1783; van Lindert EJ, 2006, CHILD NERV SYST, V22, P1529, DOI 10.1007/s00381-006-0189-1; VOLPE JJ, 1979, NEUROLOGY, V29, P632, DOI 10.1212/WNL.29.5.632; VOLPE JJ, 1995, NEUROLOGY NEWBORN, P457; Williams H, 2008, MED HYPOTHESES, V70, P743, DOI 10.1016/j.mehy.2007.08.013; Yikilmaz A, 2008, PEDIATR RADIOL, V38, P129, DOI 10.1007/s00247-007-0538-6; YORDY M, 1986, PEDIATR NEUROSCI, V12, P226, DOI 10.1159/000120256	55	22	22	1	1	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	1933-0707	1933-0715		J NEUROSURG-PEDIATR	J. Neurosurg.-Pediatr.	JUL	2009	4	1					56	63		10.3171/2009.3.PEDS08337			8	Clinical Neurology; Pediatrics; Surgery	Neurosciences & Neurology; Pediatrics; Surgery	462VB	WOS:000267384000017	19569912				2021-06-18	
J	Bianchin, A; Pellizzato, N; Martano, L; Castioni, CA				Bianchin, A.; Pellizzato, N.; Martano, L.; Castioni, C. A.			Therapeutic Hypothermia in Italian Intensive Care Units: a national survey	MINERVA ANESTESIOLOGICA			English	Article; Proceedings Paper	8th Annual Neuromeeting	MAY 06-10, 2008	Siena, ITALY			Hypothermia; Resuscitation; Cardiopulmonary resuscitation; Education; Treatment, outcome	HOSPITAL CARDIAC-ARREST; INTERNATIONAL-LIAISON-COMMITTEE; SEVERE SEPSIS; GUIDELINES; RESUSCITATION; MECHANISMS; PROTECTION; EXPERIENCE; MANAGEMENT; COUNCIL	Background. The aim of this study was to investigate the use of therapeutic hypothermia (TH) in Italian Intensive Care Units (ICUs). Methods. Design and settings: After being contacted by phone, a structured questionnaire to evaluate the use of TH was sent to all Italian ICUs. The questionnaire was aimed at determining the extent of TH use (indications, methods employed, target temperature, side effects) as well as the reasons why sonic ICUs did not make Use of TH for the treatment of cardiac arrest patients. Results. Out of the 448 ICUs contacted, 90% (n=404) returned the questionnaire completely filled in. Sixty-six responders (16%) made Use of TH for post-resuscitation care, and 4% Used TH for other clinical scenarios (10 ICUs For traumatic brain injury; 5 ICUs for other reasons). More than half used TH not only for cardiac arrest subsequent to ventricular fibrillation (VF), but also for non-VF cardiac arrest with the duration of TH treatment being within the time suggested by advanced cardiac life support guidelines. On the other hand, 80% of questionnaire responders did not use TH, mainly because they felt they did not have enough data/experience (45%), or simply because they had never thought about it (18%). Conclusion. Despite authoritative data supporting its effectiveness and safety, use of TH as part of the therapy in a post-resuscitation period in Italian ICUs remains low. The reasons for not using it are not completely justified and suggest that an educational program is advisable in order to boost the utilization of TH in Italy	[Bianchin, A.; Pellizzato, N.; Martano, L.] Hosp Montebelluna, Azienda ULSS 8, Anesthesia & Intens Care Unit, Treviso, Italy; [Castioni, C. A.] S Giovanni Bosco Hosp, ASL TO 4, Intens Care Unit, Turin, Italy	Bianchin, A (corresponding author), Osped Civile, Azienda Sanit ULSS 8, Via Monte Grappa 34, I-31044 Montebelluna, TV, Italy.	andbia@libero.it	Castioni, Carlo Alberto/AAC-3167-2021	Castioni, Carlo Alberto/0000-0002-8895-425X			Abella BS, 2005, RESUSCITATION, V64, P181, DOI 10.1016/j.resuscitation.2004.09.014; Adams HP, 2007, STROKE, V38, P1655, DOI 10.1161/STROKEAHA.107.181486; Alzaga AG, 2006, RESUSCITATION, V70, P369, DOI 10.1016/j.resuscitation.2006.01.017; [Anonymous], 2005, CIRCULATION, V112, pIV1, DOI 10.1161/CIRCULATIONAHA.105.166550; Arrich J, 2007, CRIT CARE MED, V35, P1041, DOI 10.1097/01.CCM.0000259383.48324.35; Band RA, 2008, CRIT CARE, V12, DOI 10.1186/cc6845; BENSON D W, 1959, Anesth Analg, V38, P423; Bernard SA, 2002, NEW ENGL J MED, V346, P557, DOI 10.1056/NEJMoa003289; Dellinger RP, 2008, CRIT CARE MED, V36, P296, DOI 10.1097/01.CCM.0000298158.12101.41; Greer DM, 2006, SEMIN NEUROL, V26, P373, DOI 10.1055/s-2006-948317; *GRUPP IT VAL INT, RAPP GEN 2007 TI POL; Haque IU, 2006, PEDIATR CRIT CARE ME, V7, P7, DOI 10.1097/01.PCC.0000192322.45123.80; Harukuni I, 2006, NEUROL CLIN, V24, P1, DOI 10.1016/j.ncl.2005.10.004; Holzer M, 2005, CRIT CARE MED, V33, P414, DOI 10.1097/01.CCM.0000153410.87750.53; Holzer M, 2002, NEW ENGL J MED, V346, P549; Howes Daniel, 2006, CJEM, V8, P109; Jiang JY, 2007, CURR OPIN CRIT CARE, V13, P153, DOI 10.1097/MCC.0b013e32807f2a80; Kette F, 1998, RESUSCITATION, V36, P153, DOI 10.1016/S0300-9572(98)00022-7; L'Her E, 2006, CRIT CARE MED, V34, P2621, DOI 10.1097/01.CCM.0000240231.76837.DC; Laver SR, 2006, ANAESTHESIA, V61, P873, DOI 10.1111/j.1365-2044.2006.04552.x; Merchant RM, 2006, CRIT CARE MED, V34, P1935, DOI 10.1097/01.CCM.0000220494.90290.92; Nolan JP, 2003, CIRCULATION, V108, P118, DOI 10.1161/01.CIR.0000079019.02601.90; Nolan JP, 2005, RESUSCITATION, V67, pS39, DOI 10.1016/j.resuscitation.2005.10.009; Peter JV, 2002, CRIT CARE MED, V30, P555, DOI 10.1097/00003246-200203000-00010; Ramani R, 2006, CURR OPIN ANESTHESIO, V19, P487, DOI 10.1097/01.aco.0000245272.84539.97; Rivers E, 2001, NEW ENGL J MED, V345, P1368, DOI 10.1056/NEJMoa010307; Sander M, 2006, CRIT CARE, V10, DOI 10.1186/cc4882; Scott BD, 2006, CLIN CARDIOL, V29, P525, DOI 10.1002/clc.23; Soar J, 2007, BRIT MED J, V335, P459, DOI 10.1136/bmj.39315.519201.BE; Wolfrum S, 2008, CRIT CARE MED, V36, P1780, DOI 10.1097/CCM.0b013e31817437ca; Wolfrum S, 2007, RESUSCITATION, V72, P207, DOI 10.1016/j.resuscitation.2006.06.033	31	22	25	0	0	EDIZIONI MINERVA MEDICA	TURIN	CORSO BRAMANTE 83-85 INT JOURNALS DEPT., 10126 TURIN, ITALY	0375-9393	1827-1596		MINERVA ANESTESIOL	Minerva Anestesiol.	JUN	2009	75	6					357	362					6	Anesthesiology; Critical Care Medicine	Anesthesiology; General & Internal Medicine	451PM	WOS:000266482100003	19088699				2021-06-18	
J	Straume-Naesheim, TM; Andersen, TE; Holme, IMK; McIntosh, AS; Dvorak, J; Bahr, R				Straume-Naesheim, Truls M.; Andersen, Thor Einar; Holme, Ingar Morten K.; McIntosh, Andrew S.; Dvorak, Jiri; Bahr, Roald			DO MINOR HEAD IMPACTS IN SOCCER CAUSE CONCUSSIVE INJURY? A PROSPECTIVE CASE-CONTROL STUDY	NEUROSURGERY			English	Article						Brain injury; Closed head trauma; Neuropsychological tests	COLLEGIATE FOOTBALL PLAYERS; PROFESSIONAL FOOTBALL; COGNITIVE IMPAIRMENT; NCAA CONCUSSION; ELITE FOOTBALL; NECK INJURIES; SPORTS; TRAUMA; BRAIN; TESTS	OBJECTIVE: Our objective was to determine whether minor head trauma in elite soccer matches causes measurable impairment in brain function. METHODS: Baseline neuropsychological testing was completed by professional soccer players in the Norwegian elite league, Tippeligaen, before the 2004 and 2005 seasons (n = 462). A player who experienced a head impact during a league match completed a follow-up test the next day (head impact group). Videotapes of all impacts were collected and reviewed. A group of players without head impacts was also tested after a league match to serve as controls (matched control group; n = 47). RESULTS: A total of 228 impacts were identified, and 44 (19.3%) of these were followed up with a CogSport test (CogState, Ltd., Charlton South, Australia; the players who were tested tended to have more severe injuries, but there were only 6 cases with loss of consciousness). The head impact group had a greater change in reaction time from baseline to follow-up compared with the matched control group with regard to the 3 simplest tasks. The largest deficits were seen among the players reporting acute symptoms after the impact, but deficits were also demonstrated among asymptomatic players. Players who experienced 1 or more head impacts during the 2004 season showed a reduction in neuropsychological performance when tested before the 2005 season. However, none of these players was impaired when compared with the test manufacturer's normative data. CONCLUSION: A reduced neuropsychological performance was found after minor head impacts in soccer, even in allegedly asymptomatic players. However, the long-term cognitive consequences are uncertain.	[Straume-Naesheim, Truls M.; Andersen, Thor Einar; Holme, Ingar Morten K.; McIntosh, Andrew S.; Bahr, Roald] Norwegian Sch Sports Sci, Oslo Sports Trauma Res Ctr, Dept Sports Med, N-0806 Oslo, Norway; [McIntosh, Andrew S.] Univ New S Wales, Sch Risk & Safety Sci, Sydney, NSW 2052, Australia; [Dvorak, Jiri] Schulthess Clin, FIFA Med Assessment & Res Ctr, Zurich, Switzerland	Straume-Naesheim, TM (corresponding author), Norwegian Sch Sports Sci, Oslo Sports Trauma Res Ctr, Dept Sports Med, POB 4014,Ulleval Stad NO, N-0806 Oslo, Norway.	truls.straume-nesheim@nih.no	Bahr, Roald/B-6964-2014	Bahr, Roald/0000-0001-5725-4237; Andersen, Thor Einar/0000-0003-4172-4518			Andersen TE, 2004, BRIT J SPORT MED, V38, P690, DOI 10.1136/bjsm.2003.009357; Andersen TE, 2004, BRIT J SPORT MED, V38, P626, DOI 10.1136/bjsm.2003.007955; Aubry M, 2002, CLIN J SPORT MED, V12, P6, DOI 10.1097/00042752-200201000-00005; Babbs C F, 2001, ScientificWorldJournal, V1, P281; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P345, DOI 10.1017/S1355617705050411; Collie A, 2006, J NEUROL NEUROSUR PS, V77, P241, DOI 10.1136/jnnp.2005.073155; Collie A, 2003, CLIN J SPORT MED, V13, P28, DOI 10.1097/00042752-200301000-00006; Collie A, 2005, SPORTS NEUROPSYCHOLO, P240; Darby D, 2002, NEUROLOGY, V59, P1042, DOI 10.1212/WNL.59.7.1042; Delaney TS, 2002, CLIN J SPORT MED, V12, P331, DOI 10.1097/00042752-200211000-00003; Downs DS, 2002, J SPORT MED PHYS FIT, V42, P103; Falleti MG, 2003, J SLEEP RES, V12, P265, DOI 10.1111/j.1365-2869.2003.00363.x; Fuller CW, 2006, CLIN J SPORT MED, V16, P97, DOI 10.1097/00042752-200603000-00003; Fuller CW, 2005, BRIT J SPORT MED, V39, pI3, DOI 10.1136/bjsm.2005.018937; Gosselin N, 2006, NEUROSURGERY, V58, P1151, DOI 10.1227/01.NEU.0000215953.44097.FA; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Kelly JP, 1998, J HEAD TRAUMA REHAB, V13, P53, DOI 10.1097/00001199-199804000-00008; Kirkendall DT, 2001, J ATHL TRAINING, V36, P328; Lovell MR, 1998, J HEAD TRAUMA REHAB, V13, P9, DOI 10.1097/00001199-199804000-00004; Lovell MR, 2004, AM J SPORT MED, V32, P47, DOI 10.1177/0363546503260723; Makdissi M, 2001, BRIT J SPORT MED, V35, P354, DOI 10.1136/bjsm.35.5.354; Matser JT, 1998, NEUROLOGY, V51, P791, DOI 10.1212/WNL.51.3.791; Matser JT, 2001, J CLIN EXP NEUROPSYC, V23, P770, DOI 10.1076/jcen.23.6.770.1029; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; Moriarity J, 2004, NEUROLOGY, V62, P1497, DOI 10.1212/WNL.62.9.1497; Naunheim RS, 2003, MED SCI SPORT EXER, V35, P1406, DOI 10.1249/01.MSS.0000078933.84527.AE; Pellman EJ, 2005, NEUROSURGERY, V56, P79, DOI 10.1227/01.NEU.0000150180.16552.8D; Pellman EJ, 2004, NEUROSURGERY, V55, P1290, DOI 10.1227/01.NEU.0000149244.97560.91; Rahnama N, 2002, BRIT J SPORT MED, V36, P354, DOI 10.1136/bjsm.36.5.354; Rutherford A, 2003, NEUROPSYCHOL REV, V13, P153, DOI 10.1023/A:1025525613477; Silbert BS, 2004, BRIT J ANAESTH, V92, P814, DOI 10.1093/bja/aeh157; Straume-Naesheim TM, 2005, BRIT J SPORT MED, V39, pI70, DOI 10.1136/bjsm.2005.019646; Straume-Naesheim TM, 2005, BRIT J SPORT MED, V39, pI64, DOI 10.1136/bjsm.2005.019620; Straume-Naesheim TM, 2008, NEUROSURGERY, V62, P1297, DOI 10.1227/01.neu.0000333301.34189.3d; Sundstrom A, 2004, NEUROLOGY, V62, P1963, DOI 10.1212/01.WNL.0000129268.83927.A8; TYSVAER AT, 1992, SPORTS MED, V14, P200, DOI 10.2165/00007256-199214030-00006; TYSVAER AT, 1991, AM J SPORT MED, V19, P56, DOI 10.1177/036354659101900109; TYSVAER AT, 1989, AM J SPORT MED, V17, P573, DOI 10.1177/036354658901700421; Warden DL, 2001, NEUROLOGY, V57, P524, DOI 10.1212/WNL.57.3.524	40	22	22	0	8	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0148-396X	1524-4040		NEUROSURGERY	Neurosurgery	APR	2009	64	4					719	725		10.1227/01.NEU.0000340681.12949.6D			7	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	427MN	WOS:000264783500034	19349829				2021-06-18	
J	Heskestad, B; Baardsen, R; Helseth, E; Romner, B; Waterloo, K; Ingebrigtsen, T				Heskestad, Ben; Baardsen, Roald; Helseth, Eirik; Romner, Bertil; Waterloo, Knut; Ingebrigtsen, Tor			Incidence of hospital referred head injuries in Norway: A population based survey from the Stavanger region	SCANDINAVIAN JOURNAL OF TRAUMA RESUSCITATION & EMERGENCY MEDICINE			English	Article							TRAUMATIC BRAIN-INJURY; EPIDEMIOLOGY; GUIDELINES; MILD; MANAGEMENT	Background: In three previous Norwegian studies conducted between 1974 and 1993, the annual incidence rates of hospital admitted head injuries were 236, 200 and 169 per 100,000 population. The aim of this study was to describe the incidence of head injury in the Stavanger region and to compare it with previous Norwegian studies. Methods: All head injured patients referred to Stavanger University Hospital during a one-year period (2003) were registered in a partly prospective and partly retrospective study. The catchment area for the hospital is strictly defined to a local population of 283,317 inhabitants (2003). Results: The annual incidence rate was 207/100,000 population for hospital referred head injury and 157/100,000 population for hospital admitted head injury. High age-and sex specific incidence rates were observed among the oldest, and the highest rate (882/100,000) among men above 90 years. More than 50% of the injuries were caused by falls. Conclusion: Comparison with previous Norwegian studies indicates decreasing annual incidence rates for hospital admitted head injury during the last 30 years.	[Romner, Bertil; Ingebrigtsen, Tor] Univ Tromso, Inst Clin Med, Dept Neurosurg, Tromso, Norway; [Heskestad, Ben; Helseth, Eirik] Ullevaal Univ Hosp, Dept Neurosurg, Oslo, Norway; [Heskestad, Ben; Baardsen, Roald] Stavanger Univ Hosp, Dept Neurosurg, Stavanger, Norway; [Waterloo, Knut] Univ Hosp N Norway, Dept Neurol, Tromso, Norway	Ingebrigtsen, T (corresponding author), Univ Tromso, Inst Clin Med, Dept Neurosurg, Tromso, Norway.	ben.heskestad@ulleval.no; baar@sus.no; eirik.helseth@ulleval.no; bertil.romner@rh.dk; knut.waterloo@unn.no; tor.ingebrigtsen@unn.no	Helseth, Eirik/AAH-2466-2020	Ingebrigtsen, Tor/0000-0001-5966-9786			Andelic N, 2008, NEUROEPIDEMIOLOGY, V30, P120, DOI 10.1159/000120025; EDNA TH, 1984, SCAND J SOC MED, V12, P7, DOI 10.1177/140349488401200103; Engberg AW, 2001, EUR J EPIDEMIOL, V17, P437, DOI 10.1023/A:1013733107520; Ibanez J, 2004, J NEUROSURG, V100, P825, DOI 10.3171/jns.2004.100.5.0825; Ingebrigtsen T, 1998, NEUROEPIDEMIOLOGY, V17, P139, DOI 10.1159/000026165; Ingebrigtsen T, 2000, J TRAUMA, V48, P760, DOI 10.1097/00005373-200004000-00029; Jennett B, 1996, J NEUROL NEUROSUR PS, V60, P362, DOI 10.1136/jnnp.60.4.362; Kleiven Svein, 2003, Inj Control Saf Promot, V10, P173, DOI 10.1076/icsp.10.3.173.14552; Koskinen S, 2008, BRAIN INJURY, V22, P205, DOI 10.1080/02699050801938975; Muller K, 2003, J TRAUMA, V55, P1029, DOI 10.1097/01.TA.0000100371.49160.2A; NESTVOLD K, 1988, NEUROEPIDEMIOLOGY, V7, P134, DOI 10.1159/000110147; STEIN SC, 1995, BRAIN INJURY, V9, P437, DOI 10.3109/02699059509008203; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Ytterstad Borge, 2003, Int J Circumpolar Health, V62, P61	14	22	22	0	0	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1757-7241			SCAND J TRAUMA RESUS	Scand. J. Trauma Resusc. Emerg. Med.	FEB 20	2009	17								6	10.1186/1757-7241-17-6			5	Emergency Medicine	Emergency Medicine	665HG	WOS:000283025400001	19232086	DOAJ Gold, Green Published			2021-06-18	
J	Jin, W; Wang, HD; Ji, Y; Zhu, L; Yan, W; Qiao, L; Yin, HX				Jin, Wei; Wang, Handong; Ji, Yan; Zhu, Lin; Yan, Wei; Qiao, Liang; Yin, Hongxia			Genetic Ablation of Nrf2 Enhances Susceptibility to Acute Lung Injury After Traumatic Brain Injury in Mice	EXPERIMENTAL BIOLOGY AND MEDICINE			English	Article						nuclear factor E2-related factor 2; traumatic brain injury; acute lung injury; apoptosis; inflammation; oxidative stress	INTRACEREBRAL HEMORRHAGE; NRF2-DEFICIENT MICE; PULMONARY-EDEMA; HEAD-INJURY; PROTECTION; INFLAMMATION; REDUCTASE; SEPSIS; CHEMOPREVENTION; PERMEABILITY	Previous studies have shown that nuclear factor erythrold 2-related factor 2 (Nrf2) plays a unique role in many physiological stress processes. The present study Investigated the role of Nrf2 in the regulation of traumatic brain Injury (TBI)-induced acute lung Injury (ALI). Wild-type Nrf2 (+/+) and Nrf2 (-/-)-deficient mice were subjected to a moderately severe weight-drop Impact head injury. Pulmonary capillary permeability (PCP), wet/dry weight ratio, apoptosis, inflammatory cytokines and antioxidant/detoxifying enzymes were measured at 24 h after TBI. Mice lacking Nrf2 were found to be more susceptible to TBI-Induced ALI, as characterized by the higher Increase in PCP, wet/dry weight ratio and alveolar cells apoptosis after TBI. This exacerbation of lung Injury in Nrf2-deficient mice was associated with increased pulmonary mRNA and protein expression of Inflammatory cytokines such as tumor necrosis factor-alpha (TNF-alpha), interleukin-1 beta (IL-1 beta) and interleukin-6 (IL-6); and with decreased pulmonary mRNA expression and enzymatic activities of antioxidant and detoxifying enzymes Including NAD(P)H:quinone oxidoreductase 1 (NQO1) and glutathione S-transferese oil (GST-alpha 1)-as compared with their wild-type Nrf2 (+/+) counterparts after TBI. The results of the present study suggest that Nrf2 reduces TBI-Induced acute lung Injury, possibly by decreasing pulmonary Inflammation and inducing antioxidant and detoxifying enzymes. Exp Biol Med 234:181-189, 2009	[Jin, Wei; Wang, Handong; Zhu, Lin; Qiao, Liang; Yin, Hongxia] Nanjing Univ, Jinling Hosp, Sch Med, Dept Neurosurg, Nanjing 210002, Jiangsu Prov, Peoples R China; [Ji, Yan] Nanjing Univ, Affiliated Stomatol Hosp, Sch Med, Dept Prevent Dent, Nanjing 210008, Jiangsu Prov, Peoples R China; [Yan, Wei] Zhejiang Univ, Affiliated Hosp 2, Sch Med, Dept Neurosurg, Hangzhou 310009, Zhejiang, Peoples R China	Wang, HD (corresponding author), Nanjing Univ, Jinling Hosp, Sch Med, Dept Neurosurg, 305 E Zhongshan Rd, Nanjing 210002, Jiangsu Prov, Peoples R China.	hdwang_jw@yahoo.com.cn	Yin, Hong/AAC-5784-2020	Yan, Wei/0000-0002-1123-0835	Jinling Hospital of China	This work wits supported by grants from Jinling Hospital of China.	BENSON AM, 1980, P NATL ACAD SCI-BIOL, V77, P5216, DOI 10.1073/pnas.77.9.5216; Chan KM, 1999, P NATL ACAD SCI USA, V96, P12731, DOI 10.1073/pnas.96.22.12731; Chen XL, 2004, CURR PHARM DESIGN, V10, P879, DOI 10.2174/1381612043452901; Cho HY, 2004, FASEB J, V18, P1258; Cho HY, 2002, AM J RESP CELL MOL, V26, P175, DOI 10.1165/ajrcmb.26.2.4501; Church LD, 2008, NAT CLIN PRACT RHEUM, V4, P34, DOI 10.1038/ncprheum0681; DAMAS P, 1992, ANN SURG, V215, P356, DOI 10.1097/00000658-199204000-00009; Das A, 2006, FREE RADICAL BIO MED, V40, P1843, DOI 10.1016/j.freeradbiomed.2006.01.025; DETTBARN CL, 1989, HEART LUNG, V18, P583; HALL ED, 1985, J NEUROSURG, V62, P882, DOI 10.3171/jns.1985.62.6.0882; HECHT SS, 1995, J CELL BIOCHEM, P195; HESSE DG, 1988, SURG GYNECOL OBSTET, V166, P147; Holland MC, 2003, J TRAUMA, V55, P106, DOI 10.1097/01.TA.0000071620.27375.BE; Itoh K, 1997, BIOCHEM BIOPH RES CO, V236, P313, DOI 10.1006/bbrc.1997.6943; Kalsotra A, 2007, J CEREBR BLOOD F MET, V27, P963, DOI 10.1038/sj.jcbfm.9600396; Kamada F, 2007, INT ARCH ALLERGY IMM, V144, P275, DOI 10.1159/000106316; Kawkitinarong K, 2004, AM J RESP CELL MOL, V31, P517, DOI 10.1165/rcmb.2003-0432OC; Kelly VP, 2000, CANCER RES, V60, P957; Khor TO, 2006, CANCER RES, V66, P11580, DOI 10.1158/0008-5472.CAN-06-3562; Kode A, 2008, AM J PHYSIOL-LUNG C, V294, pL478, DOI 10.1152/ajplung.00361.2007; Kupina NC, 2001, J NEUROTRAUM, V18, P1229, DOI 10.1089/089771501317095269; Lee JM, 2005, FASEB J, V19, P1061, DOI 10.1096/fj.04-2591hyp; Lee JM, 2004, J BIOCHEM MOL BIOL, V37, P139; Lv R, 2005, ANN CLIN LAB SCI, V35, P174; Mikrogianakis A, 2007, J NEUROTRAUM, V24, P338, DOI 10.1089/neu.2006.003615; Osburn WO, 2007, INT J CANCER, V121, P1883, DOI 10.1002/ijc.22943; Osburn WO, 2006, ARCH BIOCHEM BIOPHYS, V454, P7, DOI 10.1016/j.abb.2006.08.005; Owuor ED, 2002, BIOCHEM PHARMACOL, V64, P765, DOI 10.1016/S0006-2952(02)01137-1; Rangasamy T, 2005, J EXP MED, V202, P47, DOI 10.1084/jem.20050538; Rangasamy T, 2004, J CLIN INVEST, V114, P1248, DOI 10.1172/JCI200421146; ROSS D, 1993, CANCER METAST REV, V12, P83, DOI 10.1007/BF00689803; Saldivar SJ, 2005, MUTAT RES-GEN TOX EN, V582, P71, DOI 10.1016/j.mrgentox.2004.12.010; Saydam N, 1997, CANCER LETT, V119, P13, DOI 10.1016/S0304-3835(97)00245-0; Shohami E, 1999, J NEUROTRAUM, V16, P365, DOI 10.1089/neu.1999.16.365; Sreeja Leelakumari, 2008, J Exp Ther Oncol, V7, P73; Thimmulappa RK, 2006, J CLIN INVEST, V116, P984, DOI 10.1172/JCI25790; Wagner EM, 2006, J APPL PHYSIOL, V100, P1224, DOI 10.1152/japplphysiol.01060.2005; Wang JA, 2007, FREE RADICAL BIO MED, V43, P408, DOI 10.1016/j.freeradbiomed.2007.04.020; Ware LB, 2005, EUR RESPIR J, V26, P101, DOI 10.1183/09031936.05.00106604; Ware LB, 2000, NEW ENGL J MED, V342, P1334, DOI 10.1056/NEJM200005043421806; Wu S, 2006, EXP NEUROL, V200, P245, DOI 10.1016/j.expneurol.2006.01.027	41	22	24	0	1	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1535-3702	1535-3699		EXP BIOL MED	Exp. Biol. Med.	FEB	2009	234	2					181	189		10.3181/0807-RM-232			9	Medicine, Research & Experimental	Research & Experimental Medicine	403MX	WOS:000263087800008	19176347				2021-06-18	
J	Ji, SY; Smith, R; Huynh, T; Najarian, K				Ji, Soo-Yeon; Smith, Rebecca; Huynh, Toan; Najarian, Kayvan			A comparative analysis of multi-level computer-assisted decision making systems for traumatic injuries	BMC MEDICAL INFORMATICS AND DECISION MAKING			English	Article							LOGISTIC-REGRESSION; CLASSIFICATION; HELICOPTER; TREE; SUPPORT; TRANSPORT; SERVICES; CART	Background: This paper focuses on the creation of a predictive computer-assisted decision making system for traumatic injury using machine learning algorithms. Trauma experts must make several difficult decisions based on a large number of patient attributes, usually in a short period of time. The aim is to compare the existing machine learning methods available for medical informatics, and develop reliable, rule-based computer-assisted decision-making systems that provide recommendations for the course of treatment for new patients, based on previously seen cases in trauma databases. Datasets of traumatic brain injury (TBI) patients are used to train and test the decision making algorithm. The work is also applicable to patients with traumatic pelvic injuries. Methods: Decision-making rules are created by processing patterns discovered in the datasets, using machine learning techniques. More specifically, CART and C4.5 are used, as they provide grammatical expressions of knowledge extracted by applying logical operations to the available features. The resulting rule sets are tested against other machine learning methods, including AdaBoost and SVM. The rule creation algorithm is applied to multiple datasets, both with and without prior filtering to discover significant variables. This filtering is performed via logistic regression prior to the rule discovery process. Results: For survival prediction using all variables, CART outperformed the other machine learning methods. When using only significant variables, neural networks performed best. A reliable rule-base was generated using combined C4.5/CART. The average predictive rule performance was 82% when using all variables, and approximately 84% when using significant variables only. The average performance of the combined C4.5 and CART system using significant variables was 89.7% in predicting the exact outcome (home or rehabilitation), and 93.1% in predicting the ICU length of stay for airlifted TBI patients. Conclusion: This study creates an efficient computer-aided rule-based system that can be employed in decision making in TBI cases. The rule-bases apply methods that combine CART and C4.5 with logistic regression to improve rule performance and quality. For final outcome prediction for TBI cases, the resulting rule-bases outperform systems that utilize all available variables.	[Ji, Soo-Yeon; Smith, Rebecca; Najarian, Kayvan] Virginia Commonwealth Univ, Dept Comp Sci, Richmond, VA 23284 USA; [Huynh, Toan] Carolinas Healthcare Syst, Dept Surg, Charlotte, NC USA	Ji, SY (corresponding author), Virginia Commonwealth Univ, Dept Comp Sci, 401 E Main St, Richmond, VA 23284 USA.	jisy@vcu.edu; smithr@vcu.edu; toan.huyhn@carolinashealthcare.org; knajarian@vcu.edu	Najarian, Kayvan/B-2303-2010		Health Services Foundation; Carolinas HealthCare System; Virginia Commonwealth University; National Science FoundationNational Science Foundation (NSF) [IIS0758410]; Div Of Information & Intelligent SystemsNational Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE) [0758410] Funding Source: National Science Foundation	This research was partially funded by research grants from Health Services Foundation, Carolinas HealthCare System, and Virginia Commonwealth University. This material is based upon work supported by the National Science Foundation under Grant No. IIS0758410. The authors would like to thank these institutions for their support.	ANDERSON RN, 2001, NATL VITAL STAT REP, V52, P1; Andrews PJD, 2003, J NEUROSURG, V98, P442; Arfken CL, 1998, J TRAUMA, V45, P785, DOI 10.1097/00005373-199810000-00031; Breiman L., 1993, CLASSIFICATION REGRE; *CDCP, 2004, FACTS CONC BRAIN INJ; Clarke JR, 2002, WORLD J SURG, V26, P536, DOI 10.1007/s00268-001-0263-5; Cunningham P, 1997, J TRAUMA, V43, P940, DOI 10.1097/00005373-199712000-00013; Eckstein M, 2002, J TRAUMA, V53, P340, DOI 10.1097/00005373-200208000-00025; *EXP WORK GROUP, 2000, TRAUM BRAIN INJ US A; Fabian TC, 1996, ANN SURG, V223, P513, DOI 10.1097/00000658-199605000-00007; Fan W, 1999, P 5 ACM SIGKDD INT C, P362; Fitzmaurice JM, 2002, J AM MED INFORM ASSN, V9, P144; Freund Y., 1999, Journal of Japanese Society for Artificial Intelligence, V14, P771; Fu CY, 2004, COMPUT STAT DATA AN, V45, P865, DOI 10.1016/S0167-9473(03)00092-6; Furey TS, 2000, BIOINFORMATICS, V16, P906, DOI 10.1093/bioinformatics/16.10.906; Gearhart PA, 1997, ANN EMERG MED, V30, P500, DOI 10.1016/S0196-0644(97)70010-6; Guo HM, 2006, ST HEAL T, V122, P891; HASFORD J, 1993, THERAPIE, V48, P479; HAUG PJ, 1994, COMPUT BIOMED RES, V27, P396, DOI 10.1006/cbmr.1994.1030; HOSMER D, 1989, WILEY SERIES PROBABI, pCH1; Jagielska I, 1998, 1998 SECOND INTERNATIONAL CONFERENCE ON KNOWLEDGE-BASED INTELLIGENT ELECTRONIC SYSTEMS, KES '98, PROCEEDINGS, VOL 2, P89, DOI 10.1109/KES.1998.725897; JI SY, 2007, ACM SE 45 P 45 ANN S, P198; Joachims T., 1998, LECT NOTES COMPUTER, P137, DOI DOI 10.1007/BFB0026683; KELEMEN A, 2002, ADV SIMULATION COMPU; Kuhnert PM, 2000, COMPUT STAT DATA AN, V34, P371, DOI 10.1016/S0167-9473(99)00099-7; Lee CC, 1999, IEEE T SYST MAN CY B, V29, P674, DOI 10.1109/3477.809023; LOH WY, 1988, J AM STAT ASSOC, V83, P715, DOI 10.2307/2289295; LONG WJ, 1993, COMPUT BIOMED RES, V26, P74, DOI 10.1006/cbmr.1993.1005; Lu YW, 1998, IEEE T NEURAL NETWOR, V9, P308, DOI 10.1109/72.661125; Mac Namee B, 2002, ARTIF INTELL MED, V24, P51, DOI 10.1016/S0933-3657(01)00092-6; NAJARIAN K, 2006, WILEY ENCY BIOMEDICA; PFAHRINGER B, 1995, P 12 INT C MACH LEAR, P456; Quinlan J. R., 1993, C4 5 PROGRAMS MACHIN; Quinlan JR, 1996, J ARTIF INTELL RES, V4, P77, DOI 10.1613/jair.279; QUINLAN JR, 1987, P 10 INT JOINT C ART, P997; QUINLAN JR, 1983, MACHINE LEARNING ART, V1, P463, DOI DOI 10.1007/978-3-662-12405-5_; Ruggieri S, 2002, IEEE T KNOWL DATA EN, V14, P438, DOI 10.1109/69.991727; Signorini DF, 1999, J NEUROL NEUROSUR PS, V66, P20, DOI 10.1136/jnnp.66.1.20; SNEDECOR GW, STAT METHODS; STONE M, 1974, J R STAT SOC B, V36, P111, DOI 10.1111/j.2517-6161.1974.tb00994.x; Tu JV, 1996, J CLIN EPIDEMIOL, V49, P1225, DOI 10.1016/S0895-4356(96)00002-9	41	22	23	0	9	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND		1472-6947		BMC MED INFORM DECIS	BMC Med. Inform. Decis. Mak.	JAN 14	2009	9								2	10.1186/1472-6947-9-2			17	Medical Informatics	Medical Informatics	430XS	WOS:000265026500001	19144188	DOAJ Gold, Green Published			2021-06-18	
J	Cullen, N; Perera, J				Cullen, Nora; Perera, Jerome			Heterotopic Ossification: Pharmacologic Options	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article							SPINAL-CORD-INJURY; TRAUMATIC BRAIN-INJURY; BONE; HIP		[Cullen, Nora] Univ Toronto, Toronto Rehabil Inst, Toronto, ON M5G 2A2, Canada; [Cullen, Nora] Univ Toronto, Div Physiatry, Toronto, ON M5G 2A2, Canada; [Perera, Jerome] Univ Toronto, Fac Med, Toronto, ON M5G 2A2, Canada	Cullen, N (corresponding author), Univ Toronto, Toronto Rehabil Inst, 550 Univ Ave, Toronto, ON M5G 2A2, Canada.	cullen.nora@torontohab.on.ca		Cullen, Nora/0000-0001-6359-9418			Banovac K, 2001, SPINAL CORD, V39, P370, DOI 10.1038/sj.sc.3101166; BUSCHBACHER R, 1992, CRIT REV PHYS MED RE, V4, P199; Estrores IM, 2004, J SPINAL CORD MED, V27, P434, DOI 10.1080/10790268.2004.11752233; HARAN M, 2008, COCHRANE DB SYST REV, P4; Hendricks HT, 2007, CLIN REHABIL, V21, P545, DOI 10.1177/0269215507075260; HU HP, 1991, CLIN ORTHOP RELAT R, P259; Macfarlane RJ, 2008, EXPERT OPIN PHARMACO, V9, P767, DOI 10.1517/14656566.9.5.767; Mahay PR, 1988, CLIN ORTHOP RELAT R, V237, P236; Simonsen LL, 2007, INJURY, V38, P1146, DOI 10.1016/j.injury.2007.03.019; SPIELMAN G, 1983, ARCH PHYS MED REHAB, V64, P539; STOVER SL, 1975, ARCH PHYS MED REHAB, V56, P199; Sugita A, 2005, J BONE MINER METAB, V23, P329, DOI 10.1007/s00774-005-0608-5; van Kuijk AA, 2002, SPINAL CORD, V40, P313, DOI 10.1038/sj.sc.3101309; Vanden Bossche L, 2005, J REHABIL MED, V37, P129, DOI 10.1080/16501970510027628; Vuolteenaho K, 2008, BASIC CLIN PHARMACOL, V102, P10, DOI 10.1111/j.1742-7843.2007.00149.x	15	22	22	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	JAN-FEB	2009	24	1					69	71		10.1097/HTR.0b013e31819a8fcc			3	Clinical Neurology; Rehabilitation	Neurosciences & Neurology; Rehabilitation	427GT	WOS:000264768500011	19158599				2021-06-18	
J	Gallek, MJ; Conley, YP; Sherwood, PR; Horowitz, MB; Kassam, A; Alexander, SA				Gallek, Matthew J.; Conley, Yvette P.; Sherwood, Paula R.; Horowitz, Michael B.; Kassam, Amin; Alexander, Sheila A.			APOE Genotype and Functional Outcome Following Aneurysmal Subarachnoid Hemorrhage	BIOLOGICAL RESEARCH FOR NURSING			English	Article						apolipoprotein E; subarachnoid hemorrhage; cerebral vasospasm; Modified Rankin Score; Glasgow Outcome Score	APOLIPOPROTEIN-E POLYMORPHISM; TRANSGENIC MICE; HEAD-INJURY; ALLELE; CHOLESTEROL; STROKE; SCALE; ASSOCIATION; POPULATION; DISABILITY	Apolipoprotein E (apoE), the major apolipoprotein in the central nervous system, has been shown to influence neurologic disease progression and response to neurologic injury in a gene-specific manner. Presence of the APOE4 allele is associated with poorer response to traumatic brain injury and ischemic stroke, but the association between APOE genotype and outcome following aneurysmal subarachnoid hemorrhage (SAH) remains unclear. The purpose of this project was to investigate the association between APOE genotype and outcome after SAH. We also explored the association of APOE4 genotype and cerebral vasospasm (CV) presence in a subsample of our population with available angiographic data. A sample of 206 aneurysmal SAH participants had APOE genotyping performed, Glasgow outcome scores (GOS) and modified Rankin scores (MRS) collected at 3 and 6 months after aneurysm rupture. No significant association was found between the presence of the APOE4 genotype and functional outcomes controlling for age, race, size of hemorrhage (Fisher grade), and severity of injury (Hunt & Hess grade). However when controlling for CV and the covariates listed above, individuals with the APOE4 allele had worse functional outcomes at both time points. The presence of the APOE2 allele was not associated with functional outcomes even when considering presence of CV. There was no difference in mortality associated with APOE4 presence, APOE2 presence, or presence of CV. These findings suggest APOE4 allele is associated with poor outcome after aneurysmal SAH.	[Gallek, Matthew J.; Conley, Yvette P.; Sherwood, Paula R.; Alexander, Sheila A.] Univ Pittsburgh, Sch Nursing, Pittsburgh, PA 15261 USA; [Horowitz, Michael B.; Kassam, Amin] Univ Pittsburgh, Dept Neurosurg, Pittsburgh, PA USA	Gallek, MJ (corresponding author), 1305 N Martin Ave,POB 210203, Tucson, AZ 85721 USA.	mgallek@nursing.arizona.edu			National Institutes of Health/National Institute of Nursing ResearchUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR) [R01-NR004339]; Neuroscience Nursing Foundation; Merck Company Foundation/ANFMerck & Company; Sigma Theta Tau International Honor Society for Nurses-Eta chapter; Leslie Hoffman Endowed Acute Care Research Fund; NATIONAL INSTITUTE OF NURSING RESEARCHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR) [R01NR004339, T32NR009759] Funding Source: NIH RePORTER	The parent study from which the participants were recruited is supported by the National Institutes of Health/National Institute of Nursing Research (R01-NR004339). This work was supported by the Neuroscience Nursing Foundation, the Merck Company Foundation/ANF grant, Sigma Theta Tau International Honor Society for Nurses-Eta chapter, and the Leslie Hoffman Endowed Acute Care Research Fund.	ALBERTS MJ, 1995, LANCET, V346, P575, DOI 10.1016/S0140-6736(95)91411-0; BEDERSON JB, 1995, STROKE, V26, P1086, DOI 10.1161/01.STR.26.6.1086; Blain JF, 2006, NEUROBIOL DIS, V21, P505, DOI 10.1016/j.nbd.2005.08.010; CORDER EH, 1994, NAT GENET, V7, P180, DOI 10.1038/ng0694-180; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; DeMattos RB, 2001, J LIPID RES, V42, P976; Dunn LT, 2001, NEUROSURGERY, V48, P1006, DOI 10.1097/00006123-200105000-00007; Fisher C M, 1975, Clin Neurosurg, V22, P117; Fleisher A, 2005, ARCH NEUROL-CHICAGO, V62, P953, DOI 10.1001/archneur.62.6.953; GENNARELLI TA, 1982, ANN NEUROL, V12, P564, DOI 10.1002/ana.410120611; HALL K, 1985, ARCH PHYS MED REHAB, V66, P35; Hayashi H, 2002, NEUROREPORT, V13, P383, DOI 10.1097/00001756-200203250-00004; Hayashi H, 2007, J NEUROSCI, V27, P1933, DOI 10.1523/JNEUROSCI.5471-06.2007; HIXSON JE, 1990, J LIPID RES, V31, P545; Isoniemi H, 2006, J NEUROTRAUM, V23, P1600, DOI 10.1089/neu.2006.23.1600; JENNETT B, 1976, MED J AUSTRALIA, V2, P475, DOI 10.5694/j.1326-5377.1976.tb130352.x; JENNETT B, 1975, LANCET, V1, P480; Ji ZS, 2002, J BIOL CHEM, V277, P21821, DOI 10.1074/jbc.M112109200; Jiang Y, 2006, NEUROSCI LETT, V408, P155, DOI 10.1016/j.neulet.2006.08.082; KAMBOH MI, 1995, ATHEROSCLEROSIS, V112, P145, DOI 10.1016/0021-9150(94)05409-C; KASSELL NF, 1985, STROKE, V16, P562, DOI 10.1161/01.STR.16.4.562; Lanterna LA, 2005, NEUROLOGY, V64, P1238, DOI 10.1212/01.WNL.0000156523.77347.B4; Laskowitz DT, 1998, J CEREBR BLOOD F MET, V18, P465, DOI 10.1097/00004647-199805000-00001; Leung CHS, 2002, STROKE, V33, P548, DOI 10.1161/hs0202.102326; Lynch JR, 2001, J NEUROIMMUNOL, V114, P107, DOI 10.1016/S0165-5728(00)00459-8; MAAS AIR, 1983, J NEUROSURG, V58, P321, DOI 10.3171/jns.1983.58.3.0321; MAHLEY RW, 1988, SCIENCE, V240, P622, DOI 10.1126/science.3283935; Morris PG, 2004, ACTA NEUROL SCAND, V109, P205, DOI 10.1034/j.1600-0404.2003.00206.x; Niskakangas T, 2001, STROKE, V32, P1181, DOI 10.1161/01.STR.32.5.1181; OKUIZUMI K, 1994, NAT GENET, V7, P10, DOI 10.1038/ng0594-10b; ROSES AD, 1994, J NEUROPATH EXP NEUR, V53, P429, DOI 10.1097/00005072-199409000-00002; ROSES AD, 1994, LANCET, V343, P1564, DOI 10.1016/S0140-6736(94)92960-2; Ruigrok YM, 2005, J NEUROL, V252, P417, DOI 10.1007/s00415-005-0661-y; Sabo T, 2000, NEUROSCIENCE, V101, P879, DOI 10.1016/S0306-4522(00)00438-3; SORBI S, 1995, NAT MED, V1, P852, DOI 10.1038/nm0995-852; Sturm JW, 2002, STROKE, V33, P762, DOI 10.1161/hs0302.103815; Sulter G, 1999, STROKE, V30, P1538, DOI 10.1161/01.STR.30.8.1538; Sun YL, 1998, J NEUROSCI, V18, P3261; Tang J, 2003, SURG NEUROL, V60, P391, DOI 10.1016/S0090-3019(03)00323-9; Teasdale GM, 1997, LANCET, V350, P1069, DOI 10.1016/S0140-6736(97)04318-3; Tolar M, 1999, J NEUROSCI, V19, P7100, DOI 10.1523/JNEUROSCI.19-16-07100.1999; VANDUIJN CM, 1994, NAT GENET, V7, P74, DOI 10.1038/ng0594-74; VANSWIETEN JC, 1988, STROKE, V19, P604, DOI 10.1161/01.STR.19.5.604; VOLDBY B, 1982, J NEUROSURG, V56, P186, DOI 10.3171/jns.1982.56.2.0186; Weisgraber Karl H., 1994, Current Opinion in Lipidology, V5, P110, DOI 10.1097/00041433-199404000-00007; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573	46	22	26	0	1	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1099-8004	1552-4175		BIOL RES NURS	Biol. Res. Nurs.	JAN	2009	10	3					205	212		10.1177/1099800408323221			8	Nursing	Nursing	386UH	WOS:000261907600002	19017669	Green Accepted			2021-06-18	
J	Hessen, E; Nestvold, K				Hessen, Erik; Nestvold, Knut			Indicators of complicated mild TBI predict MMPI-2 scores after 23 years	BRAIN INJURY			English	Article						Long term TBI outcome; mild brain injury; mTBI; MMPI-2; post-concussive syndrome	TRAUMATIC BRAIN-INJURY; MINOR HEAD-INJURY; NEUROPSYCHOLOGICAL FUNCTION; POSTCONCUSSIVE SYMPTOMS; CHILDREN; CLASSIFICATION; ADOLESCENTS; TOMOGRAPHY; PROFILES; SCALE	Primary objective: Research suggests that post-concussive syndrome may become persistent after mild traumatic brain injury (mTBI). The aim of this study was to investigate determinants of subjective complaints, characteristic for post-concussive syndrome, 23 years after mTBI. Research design: The study was a follow-up after a prospective head injury study at a general hospital in Norway. Methods and procedures: Ninety-seven patients were assessed with the Minnesota Multiphasic Personality Inventory-2 (MMPI-2) 23 years after sustaining primarily mTBI. Main outcomes and results: A good overall outcome was found with scores close to the normative mean, average length of education and normal employment rate. However, the patients that sustained complicated mTBI showed somewhat more pathological scores, well-matched with mild post-concussive syndrome. The most important predictors of poor outcome were a combination of post-traumatic amnesia 30 minutes and EEG pathology within 24 hours after TBI. No influence of pre- and post-injury risk factors on current MMPI-2 profiles was found. Conclusions: The results are in line with previous research findings and support the notion of potentially differential impact of uncomplicated vs. complicated mTBI. The findings suggest that complicated mTBI may cause subtle chronic symptoms typical of post-concussive syndrome.	[Hessen, Erik; Nestvold, Knut] Akershus Univ Hosp, Dept Neurol, Oslo, Norway	Hessen, E (corresponding author), Akershus Univ Hosp, Dept Neurol, N-1478 Lorenskog, Norway.	erik.hessen@nevropsykologi.no					ALEXANDER MP, 1995, NEUROLOGY, V45, P1253, DOI 10.1212/WNL.45.7.1253; Anderson V, 2001, J CLIN EXP NEUROPSYC, V23, P705, DOI 10.1076/jcen.23.6.705.1015; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P215, DOI 10.1017/S1355617705050277; Bergsneider M, 2000, J NEUROTRAUM, V17, P389, DOI 10.1089/neu.2000.17.389; Binder LM, 1997, J CLIN EXP NEUROPSYC, V19, P421, DOI 10.1080/01688639708403870; Bryant RA, 1999, J NERV MENT DIS, V187, P302, DOI 10.1097/00005053-199905000-00006; Butcher J. N., 1989, MMPI 2 MANUAL ADM SC; BUTCHER JN, 2004, MMPI 2 NORWEGIAN; Chervinsky AB, 1998, ARCH CLIN NEUROPSYCH, V13, P433, DOI 10.1016/S0887-6177(97)00016-4; Dearth CS, 2005, ARCH CLIN NEUROPSYCH, V20, P95, DOI 10.1016/j.acn.2004.03.004; DIKMEN S, 1986, J NEUROL NEUROSUR PS, V49, P1227, DOI 10.1136/jnnp.49.11.1227; DIKMEN SS, 1993, J HEAD TRAUMA REHAB, V8, P30, DOI DOI 10.1097/00001199-199309000-00005; DIKMEN SS, 1989, MILD HEAD INJURY, P229; ESSELMAN PC, 1995, BRAIN INJURY, V9, P417, DOI 10.3109/02699059509005782; Ewing-Cobbs L, 2004, DEV NEUROPSYCHOL, V25, P107, DOI 10.1207/s15326942dn2501&2_7; Greene, 2000, MMPI 2 INTERPRETIVE; Greiffenstein MF, 2001, CLIN NEUROPSYCHOL, V15, P162, DOI 10.1076/clin.15.2.162.1895; Hartlage LC, 2001, ARCH CLIN NEUROPSYCH, V16, P561, DOI 10.1016/S0887-6177(00)00067-6; HAYES RL, 1994, SEMIN NEUROL, V14, P25, DOI 10.1055/s-2008-1041055; Hessen E, 2008, BRAIN INJURY, V22, P39, DOI 10.1080/02699050701846179; Hessen E, 2007, BRAIN INJURY, V21, P963, DOI 10.1080/02699050701528454; Hessen E, 2006, SCAND J PSYCHOL, V47, P245, DOI 10.1111/j.1467-9450.2006.00514.x; Iverson GL, 2006, BRAIN INJURY, V20, P1335, DOI 10.1080/02699050601082156; JENNETT B, 1975, LANCET, V1, P480; KLONOFF H, 1993, J NEUROL NEUROSUR PS, V56, P410, DOI 10.1136/jnnp.56.4.410; KRAUS JF, 1988, J TRAUMA, V28, P1637, DOI 10.1097/00005373-198812000-00004; LEVIN HS, 1987, J NEUROSURG, V66, P234, DOI 10.3171/jns.1987.66.2.0234; LISHMAN WA, 1988, BRIT J PSYCHIAT, V153, P460, DOI 10.1192/bjp.153.4.460; MACK JL, 1979, MMPI CLIN RES TRENDS, P53; MILLER JD, 1990, NEUROSURGERY, V27, P669, DOI 10.1227/00006123-199011000-00001; Miller L, 1996, J COGNITIVE REHABILI, V14, P8; Mittenberg W., 1997, CLIN NEUROPSYCHOL, V11, P305; Nell V, 2000, ARCH PHYS MED REHAB, V81, P614, DOI 10.1053/mr.2000.3877; NESTVOLD K, 1988, NEUROEPIDEMIOLOGY, V7, P134, DOI 10.1159/000110147; Rees PM, 2003, ARCH PHYS MED REHAB, V84, P1885, DOI 10.1016/j.apmr.2003.03.001; RUFF RM, 1994, BRAIN INJURY, V8, P297, DOI 10.3109/02699059409150981; RUTHERFORD WH, 1979, INJURY, V10, P225, DOI 10.1016/0020-1383(79)90015-9; Satz P, 1997, PSYCHOL BULL, V122, P107, DOI 10.1037/0033-2909.122.2.107; Tellier A, 1999, BRAIN INJURY, V13, P463; van der Naalt J, 1999, ANN NEUROL, V46, P70, DOI 10.1002/1531-8249(199907)46:1<70::AID-ANA11>3.0.CO;2-L; van der Naalt J, 1999, J NEUROL NEUROSUR PS, V66, P207, DOI 10.1136/jnnp.66.2.207; Vanderploeg RD, 2005, J INT NEUROPSYCH SOC, V11, P228, DOI 10.1017/S1355617705050289; Warriner EM, 2003, J CLIN EXP NEUROPSYC, V25, P904, DOI 10.1076/jcen.25.7.904.16494; WILLIAMS DH, 1990, NEUROSURGERY, V27, P422, DOI 10.1227/00006123-199009000-00014; World Health Organization, 1992, ICD 10 CLASS MENT BE; Yeates KO, 1999, J HEAD TRAUMA REHAB, V14, P337, DOI 10.1097/00001199-199908000-00003; ZAKZANIS KK, 1999, MILD TRAUMATIC BRAIN, P163	47	22	22	0	4	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2009	23	3					234	242	PII 908613873	10.1080/02699050902748349			9	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	406AJ	WOS:000263267100007	19205960				2021-06-18	
J	Jang, SH; Kim, SH; Kim, OL; Byun, WM; Ahna, SH				Jang, Sung Ho; Kim, Seong Ho; Kim, Oh Lyong; Byun, Woo Mok; Ahna, Sang Ho			Corticospinal tract injury in patients with diffuse axonal injury: A diffusion tensor imaging study	NEUROREHABILITATION			English	Article						Diffusion tensor imaging; corticospinal tract; diffuse axonal injury	TRAUMATIC BRAIN-INJURY; FIBER TRACKING; FOCAL LESIONS; HEAD TRAUMA; MR; RECOVERY; ABNORMALITIES; FEATURES	Diffusion tensor imaging (DTI) can be useful in detecting corticospinal tract (CST) injury at the subcortical white matter level. In the current study, we attempted to investigate the incidence and distribution of CST injury in patients with diffuse axonal injury (DAI), using DTI. Fourteen patients who showed motor weakness without any specific lesion along the CST pathway on conventional brain MRI, and twelve age-matched, normal healthy control subjects were recruited. DTI was performed using 1.5 T with a synergy-L Sensitivity Encoding (SENSE) head coil. Fractional anisotropy was measured using the region of interest method. A CST injury was defined as the FA value of a certain area being decreased two standard deviations below that of normal controls. All 14 patients had more than one lesion at the CST injury, and the mean number of CST injuries was 3.6 (range: 2-7). The CSTs were involved at the following locations: the pons (61%), the cerebral peduncle (39%), the corona radiata (21%), the medulla (14%), and the posterior limb (11%). The pons was the most prevalent area of CST injury in patients with weakness caused by DAI at the subcortical level. We found that DTI is a useful technique for detecting a DAI of the CST at the subcortical level.	[Jang, Sung Ho; Ahna, Sang Ho] Yeungnam Univ, Coll Med, Dept Phys Med & Rehabil, Taegu 705717, South Korea; [Kim, Seong Ho; Kim, Oh Lyong] Yeungnam Univ, Coll Med, Dept Neurosurg, Taegu 705717, South Korea; [Byun, Woo Mok] Yeungnam Univ, Coll Med, Dept Diagnost Radiol, Taegu 705717, South Korea	Jang, SH (corresponding author), Yeungnam Univ, Coll Med, Dept Phys Med & Rehabil, 317-1,Daemyungdong, Taegu 705717, South Korea.	strokerehab@hanmail.net					ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; ADAMS JH, 1982, ANN NEUROL, V12, P557, DOI 10.1002/ana.410120610; Ahn YH, 2006, NEUROREHABILITATION, V21, P239; Basser PJ, 1996, J MAGN RESON SER B, V111, P209, DOI 10.1016/j.jmr.2011.09.022; Ducreux D, 2005, NEURORADIOLOGY, V47, P604, DOI 10.1007/s00234-005-1389-1; GENTRY LR, 1989, RADIOLOGY, V171, P177, DOI 10.1148/radiology.171.1.2928523; GENTRY LR, 1988, AM J ROENTGENOL, V150, P673, DOI 10.2214/ajr.150.3.673; GENTRY LR, 1988, AM J ROENTGENOL, V150, P663, DOI 10.2214/ajr.150.3.663; Han BS, 2007, NEUROREHABILITATION, V22, P151; Holodny AI, 2005, ANN NY ACAD SCI, V1064, P88, DOI 10.1196/annals.1340.016; Katz DI, 1998, ARCH PHYS MED REHAB, V79, P488, DOI 10.1016/S0003-9993(98)90060-0; Kwon YH, 2007, NEUROSCI LETT, V417, P138, DOI 10.1016/j.neulet.2007.01.084; Le TH, 2005, NEUROSURGERY, V56, P189, DOI 10.1227/01.NEU.0000144846.00569.3A; Lee JW, 2006, J HEAD TRAUMA REHAB, V21, P272, DOI 10.1097/00001199-200605000-00007; Meythaler JM, 2001, ARCH PHYS MED REHAB, V82, P1461, DOI 10.1053/apmr.2001.25137; Mori S, 1999, ANN NEUROL, V45, P265, DOI 10.1002/1531-8249(199902)45:2<265::AID-ANA21>3.0.CO;2-3; Naganawa S, 2004, AM J NEURORADIOL, V25, P1553; Parizel PM, 1998, EUR RADIOL, V8, P960, DOI 10.1007/s003300050496; Rugg-Gunn FJ, 2001, J NEUROL NEUROSUR PS, V70, P530, DOI 10.1136/jnnp.70.4.530; Rutgers DR, 2008, AM J NEURORADIOL, V29, P514, DOI 10.3174/ajnr.A0856; Shelton FDAP, 2001, STROKE, V32, P107, DOI 10.1161/01.STR.32.1.107; Skoglund TS, 2008, ACTA RADIOL, V49, P98, DOI 10.1080/02841850701561372; Son SM, 2007, NEUROSCI LETT, V420, P34, DOI 10.1016/j.neulet.2007.04.054; Xu J, 2007, J NEUROTRAUM, V24, P753, DOI 10.1089/neu.2006.0208; Yamada K, 2007, J MAGN RESON IMAGING, V26, P519, DOI 10.1002/jmri.21006; Yasokawa YT, 2007, J NEUROTRAUM, V24, P163, DOI 10.1089/neu.2006.0073	26	22	25	0	1	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1053-8135	1878-6448		NEUROREHABILITATION	Neurorehabilitation		2009	25	4					229	233		10.3233/NRE-2009-0519			5	Clinical Neurology; Rehabilitation	Neurosciences & Neurology; Rehabilitation	540LC	WOS:000273332100001	20037214				2021-06-18	
J	Lo, TYM; Jones, PA; Chambers, IR; Beattie, TF; Forsyth, R; Mendelow, AD; Minns, RA				Lo, T. Y. M.; Jones, P. A.; Chambers, I. R.; Beattie, T. F.; Forsyth, R.; Mendelow, A. D.; Minns, R. A.			Modulating effect of apolipoprotein E polymorphisms on secondary brain insult and outcome after childhood brain trauma	CHILDS NERVOUS SYSTEM			English	Article						Traumatic brain injury; Apolipoprotein E genetic polymorphisms; Cerebral perfusion pressure; Outcome; GCS; Paediatrics	CEREBRAL-BLOOD-FLOW; E EPSILON-4 ALLELE; SEVERE HEAD-INJURY; APOE GENOTYPE; E PHENOTYPE; INTRACRANIAL-PRESSURE; ASSOCIATION; DISEASE; CHILDREN; SYSTEM	The aim of this study was to determine the relationship between apolipoprotein E (APO E) alleles, the amount of cerebral perfusion pressure (CPP) insult and outcome in children after brain trauma. In a prospective two-centre case-control study, the APO E genotypes of 65 critically ill children admitted after brain trauma were correlated with age-related CPP insult quantification, conscious state at the time of discharge from intensive care and global outcome at 6 months post-injury. One hundred sixty healthy age- and sex-matched children were genotyped as controls. The CPP insult level among the e4 carriers with poor outcome was significantly less than the non-e4 carriers (p = 0.03). Homozygotic e3 patients with good recovery did so despite having suffered nearly 26 times more CPP insult than those who were not e3 homzygous (p = 0.02). Different APO E alleles may potentially affect cerebral ischaemic tolerance differently in children after brain trauma.	[Lo, T. Y. M.; Jones, P. A.; Minns, R. A.] Univ Edinburgh, Sect Child Life & Hlth, Edinburgh EH9 1LF, Midlothian, Scotland; [Lo, T. Y. M.; Beattie, T. F.; Minns, R. A.] Royal Hosp Sick Children, Edinburgh EH9 1LF, Midlothian, Scotland; [Chambers, I. R.; Forsyth, R.; Mendelow, A. D.] Newcastle Gen Hosp, Newcastle Upon Tyne NE4 6BE, Tyne & Wear, England	Lo, TYM (corresponding author), Univ Edinburgh, Sect Child Life & Hlth, 20 Sylvan Pl, Edinburgh EH9 1LF, Midlothian, Scotland.	mils.lo@doctors.org.uk	Forsyth, Rob/H-9193-2019; Forsyth, Rob J/I-9226-2012	Forsyth, Rob/0000-0002-5657-4180; Forsyth, Rob J/0000-0002-5657-4180	Newcastle General Hospital	We are grateful to our medical and nursing colleagues in the Intensive Care Units at RHSC, Edinburgh, and Newcastle General Hospital for their support with this project. We thank J. Croft and G. Wilson who facilitated demographic data and buccal smear collection for patients recruited in Tyneside.	Alexander S, 2007, J NEUROTRAUM, V24, P790, DOI 10.1089/neu.2006.0133; Aono M, 2002, NEUROBIOL DIS, V11, P214, DOI 10.1006/nbdi.2002.0541; Becher JC, 2005, BIOL NEONATE, V88, P164, DOI 10.1159/000086205; Chambers IR, 2000, BRIT J NEUROSURG, V14, P424; Chambers IR, 2006, J NEUROL NEUROSUR PS, V77, P234, DOI 10.1136/jnnp.2005.072215; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Chiang MF, 2003, ACTA NEUROCHIR, V145, P649, DOI 10.1007/s00701-003-0069-3; Colton CA, 2004, J NEUROIMMUNOL, V147, P62, DOI 10.1016/j.jneuroim.2003.10.015; COUDERC R, 1993, STROKE, V24, P661, DOI 10.1161/01.STR.24.5.661; CUMMING AM, 1984, CLIN GENET, V25, P310; DAVIGNON J, 1988, ARTERIOSCLEROSIS, V8, P1, DOI 10.1161/01.ATV.8.1.1; DEKNIJFF P, 1994, LANCET, V343, P1234, DOI 10.1016/S0140-6736(94)92451-1; ETO M, 1989, CLIN GENET, V36, P183; Friedman G, 1999, NEUROLOGY, V52, P244, DOI 10.1212/WNL.52.2.244; Guo L, 2004, J MOL NEUROSCI, V23, P205, DOI 10.1385/JMN:23:3:205; HIXSON JE, 1990, J LIPID RES, V31, P545; Jones PA, 2003, BRIT J NEUROSURG, V17, P29, DOI 10.1080/0268869031000093708; Liaquat I, 2002, J NEUROSURG, V96, P90, DOI 10.3171/jns.2002.96.1.0090; Lynch JR, 2003, J BIOL CHEM, V278, P48529, DOI 10.1074/jbc.M306923200; Lynch JR, 2002, ANN NEUROL, V51, P113, DOI 10.1002/ana.10098; Mattson MP, 1997, PHYSIOL REV, V77, P1081; Mazur-Kolecka B, 2006, NEUROBIOL AGING, V27, P804, DOI 10.1016/j.neurobiolaging.2005.04.012; McCarron MO, 1999, NEUROLOGY, V53, P2176, DOI 10.1212/WNL.53.9.2176; Miller J D, 1982, J R Coll Surg Edinb, V27, P292; Quinn TJ, 2004, NEUROPATH APPL NEURO, V30, P569, DOI 10.1111/j.1365-2990.2004.00581.x; Rantala M, 1997, AM J CLIN NUTR, V65, P543; Sabo T, 2000, NEUROSCIENCE, V101, P879, DOI 10.1016/S0306-4522(00)00438-3; Scarmeas N, 2003, JAMA-J AM MED ASSOC, V290, P1581, DOI 10.1001/jama.290.12.1581; SHARPLES PM, 1995, J NEUROL NEUROSUR PS, V58, P145, DOI 10.1136/jnnp.58.2.145; Smith C, 2006, J NEUROL NEUROSUR PS, V77, P363, DOI 10.1136/jnnp.2005.074617; Teasdale GM, 2005, BRAIN, V128, P2556, DOI 10.1093/brain/awh595; Teasdale GM, 1997, LANCET, V350, P1069, DOI 10.1016/S0140-6736(97)04318-3; Tziakas DN, 2006, J AM COLL CARDIOL, V48, P2471, DOI 10.1016/j.jacc.2006.08.032; UTERMANN G, 1980, AM J HUM GENET, V32, P339; UUSITUPA M, 1994, LANCET, V343, P57, DOI 10.1016/S0140-6736(94)90912-1; Uusitupa MIJ, 1996, AM J CLIN NUTR, V64, P131; van Dyck CH, 1998, ARCH NEUROL-CHICAGO, V55, P1460, DOI 10.1001/archneur.55.11.1460	37	22	22	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0256-7040	1433-0350		CHILD NERV SYST	Childs Nerv. Syst.	JAN	2009	25	1					47	54		10.1007/s00381-008-0723-4			8	Clinical Neurology; Pediatrics; Surgery	Neurosciences & Neurology; Pediatrics; Surgery	379CW	WOS:000261374800008	18839184				2021-06-18	
J	Sacks, AL; Fenske, CL; Gordon, WA; Hibbard, MR; Perez, K; Brandau, S; Cantor, J; Ashman, T; Spielman, LA				Sacks, Amanda L.; Fenske, Cheree L.; Gordon, Wayne A.; Hibbard, Mary R.; Perez, Ken; Brandau, Susan; Cantor, Joshua; Ashman, Teresa; Spielman, Lisa A.			Co-Morbidity of Substance Abuse and Traumatic Brain Injury	JOURNAL OF DUAL DIAGNOSIS			English	Article						Co-morbidity; substance abuse; traumatic brain injury; screening; treatment	HEAD-INJURY; ALCOHOL-USE; INTOXICATION; IDENTIFICATION; INDIVIDUALS; VIOLENCE; CLIENTS; CRIME	While there has been considerable research on the patterns of pre- and post-substance use among individuals with traumatic brain injury (TBI), little is known about the incidence of co-morbidity between TBI and substance abuse (SA) in individuals whose primary disorder is SA. In the current study, the prevalence of co-occurring TBI in individuals seeking treatment for SA was examined. A total of 845 individuals seeking treatment for SA in New York State were screened via the Brain Injury Screening Questionnaire for the presence of a co-morbid TBI. Results indicate that more than 50% of the sample had results that were positive for a TBI. On average, individuals reported a mean of 6 +/- 8 blows to the head, with the number ranging from 0 to 57 and the average age of the first TBI being 14.5 years. Results indicate a high level of co-morbidity between TBI and SA and the need for routine screening for TBI in this population.	[Gordon, Wayne A.; Hibbard, Mary R.] Mt Sinai Med Ctr, Mt Sinai Sch Med, Dept Rehabil Med, New York, NY 10029 USA; [Perez, Ken; Brandau, Susan] New York State Off Alcohol & Subst Abuse Serv, Albany, NY USA; [Spielman, Lisa A.] Consultat Serv, Congers, NY USA	Gordon, WA (corresponding author), Mt Sinai Med Ctr, Mt Sinai Sch Med, Dept Rehabil Med, 1 Gustave L Levy Pl,Box 1240, New York, NY 10029 USA.	wayne.gordon@mssm.edu	Ashman, Teresa/B-1621-2013				Ashman TA, 2004, BRAIN INJURY, V18, P191, DOI 10.1080/0269905031000149506; Boles SM, 2003, AGGRESS VIOLENT BEH, V8, P155, DOI 10.1016/S1359-1789(01)00057-X; BRISMAR B, 1983, ACTA CHIR SCAND, V149, P11; *CDCP, 2004, REP C MILD TRAUM BRA; Corrigan JD, 1997, ARCH PHYS MED REHAB, V78, P132, DOI 10.1016/S0003-9993(97)90253-7; Corrigan JD, 2005, PSYCHOL ADDICT BEHAV, V19, P131, DOI 10.1037/0893-164X.19.2.131; CORRIGAN JD, 1995, ARCH PHYS MED REHAB, V76, P302, DOI 10.1016/S0003-9993(95)80654-7; Corrigan JD, 2008, BRAIN INJURY, V22, P223, DOI 10.1080/02699050801938967; Cunningham RM, 2002, ALCOHOL ALCOHOLISM, V37, P236, DOI 10.1093/alcalc/37.3.236; Drubach D A, 1993, Md Med J, V42, P989; Fals-Stewart W, 2003, EXP CLIN PSYCHOPHARM, V11, P34, DOI 10.1037/1064-1297.11.1.34; Gordon WA, 2000, BRAIN INJURY, V14, P21, DOI 10.1080/026990500120907; GURNEY JG, 1992, J TRAUMA, V33, P709, DOI 10.1097/00005373-199211000-00020; Harrison-Felix C, 1998, ARCH PHYS MED REHAB, V79, P730, DOI 10.1016/S0003-9993(98)90348-3; Hoaken PNS, 2003, ADDICT BEHAV, V28, P1533, DOI 10.1016/j.addbeh.2003.08.033; Karon SL, 2007, J HEAD TRAUMA REHAB, V22, P350, DOI 10.1097/01.HTR.0000300230.13490.11; Kelly MP, 1997, BRAIN INJURY, V11, P391, DOI 10.1080/026990597123386; Kolakowsky-Hayner S, 2002, BRAIN INJURY, V16, P583, DOI 10.1080/02699050110119475; Kolakowsky-Hayner SA, 2001, BRAIN INJURY, V15, P53, DOI 10.1080/02699050150209138; Kreutzer JS, 1996, J HEAD TRAUMA REHAB, V11, P58, DOI 10.1097/00001199-199610000-00006; KREUTZER JS, 1995, BRAIN INJURY, V9, P757, DOI 10.3109/02699059509008232; KREUTZER JS, 1990, J HEAD TRAUMA REHAB, V5, P9, DOI DOI 10.1097/00001199-199009000-00005; Lehmkul D, 1988, TIRR SYMPTOM CHECKLI; Picard M, 1991, HELPS BRIEF SCREENIN; Rutland-Brown W, 2008, J HEAD TRAUMA REHAB, V23, P84, DOI 10.1097/01.HTR.0000314527.78134.70; SPARADEO FR, 2001, BRAIN INJURY SOURCE, V5, P24; STRAUSS D, 2001, BRAIN INJURY SOURCE, V5, P8; Taylor LA, 2003, NEUROPSYCHOL REHABIL, V13, P165, DOI 10.1080/09602010244000336; *US DEP HHS, 2002, SUMM FIND 2000 NAT H; Vickery CD, 2008, ARCH PHYS MED REHAB, V89, P48, DOI 10.1016/j.apmr.2007.07.047; Walker R, 2007, J HEAD TRAUMA REHAB, V22, P360, DOI 10.1097/01.HTR.0000300231.90619.50	31	22	23	1	10	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	1550-4263	1550-4271		J DUAL DIAGN	J. Dual Diagn.		2009	5	3-4					404	417		10.1080/15504260903182755			14	Psychology, Clinical; Substance Abuse; Psychiatry	Psychology; Substance Abuse; Psychiatry	668XB	WOS:000283306900010					2021-06-18	
J	Tsushima, WT; Lum, M; Geling, O				Tsushima, William T.; Lum, Mark; Geling, Olga			Sex differences in the long-term neuropsychological outcome of mild traumatic brain injury	BRAIN INJURY			English	Article						Sex differences; neuropsychological outcome; brain injury	HEAD-INJURY; GENDER-DIFFERENCES; POSTCONCUSSION SYNDROME; NORMATIVE DATA	Primary objective: To investigate possible sex differences in neuropsychological functioning among patients following mild traumatic brain injury (TBI). Methods and procedures: Retrospective records analysis of the neuropsychological test results of 102 participants with head injury, including 62 males and 40 females. Main outcome and results: A multivariate analysis of variance indicated that females and males performed similarly on neuropsychological tests, on average, 2 years after minor head trauma. A sex-by-age interaction effect was found on the Category and Trail Making A Tests, with a pattern similar to those obtained in a previous research. Conclusions: Although past research has found that females develop more TBI-related neuropsychological deficits than males in the immediate post-injury period, the present study found that, overall, sex differences in the performance of patients with mild TBI on a variety of neuropsychological tests were insignificant. More investigation into the sex-by-age interaction effect appears warranted.	[Tsushima, William T.] Straub Clin & Hosp, Dept Psychiat & Psychol, Honolulu, HI 96813 USA; [Lum, Mark] Stanford Univ, Dept Biomech Engn, Palo Alto, CA 94304 USA; [Geling, Olga] Univ Hawaii Manoa, Dept Publ Hlth Sci, John A Burns Sch Med, Honolulu, HI 96822 USA	Tsushima, WT (corresponding author), Straub Clin & Hosp, Dept Psychiat & Psychol, 888 S King St, Honolulu, HI 96813 USA.	wtsushima@straub.net		Lum, Mark/0000-0002-6634-6413			ALEXANDER MP, 1995, NEUROLOGY, V45, P1253, DOI 10.1212/WNL.45.7.1253; Arnold G, 2005, CLIN NEUROPSYCHOL, V19, P105, DOI 10.1080/13854040490888567; Bazarian JJ, 1999, BRAIN INJURY, V13, P173, DOI 10.1080/026990599121692; BIGLER ED, 2001, TXB TRAUMATIC BRAIN, P79; Binder LM, 1997, J CLIN EXP NEUROPSYC, V19, P421, DOI 10.1080/01688639708403870; Binder LM, 1996, AM J PSYCHIAT, V153, P7; BORNSTEIN RA, 1985, J CLIN PSYCHOL, V41, P651, DOI 10.1002/1097-4679(198509)41:5<651::AID-JCLP2270410511>3.0.CO;2-C; Boyar J I, 1975, Hawaii Med J, V34, P94; Broshek DK, 2005, J NEUROSURG, V102, P856, DOI 10.3171/jns.2005.102.5.0856; COVASSIN T, 2007, J ATHL TRAINING, V38, P238; Dikmen S, 2001, J CLIN EXP NEUROPSYC, V23, P729, DOI 10.1076/jcen.23.6.729.1019; DIKMEN S, 2009, NEUROPSYCHOLOGICAL A, P597; DODRILL CB, 1979, J CLIN PSYCHOL, V35, P236, DOI 10.1002/1097-4679(197904)35:2<236::AID-JCLP2270350202>3.0.CO;2-9; Donders J, 2002, NEUROPSYCHOLOGY, V16, P491, DOI 10.1037//0894-4105.16.4.491; Farace E, 2000, J NEUROSURG, V93, P539, DOI 10.3171/jns.2000.93.4.0539; Groswasser Z, 1998, BRAIN INJURY, V12, P805, DOI 10.1080/026990598122197; Heaton R.K., 1991, COMPREHENSIVE NORMS; Heaton RK., 1996, NEUROPSYCHOL ASSESS, V2, P141; Henry G K, 2000, Appl Neuropsychol, V7, P65, DOI 10.1207/S15324826AN0702_1; Holm L, 2005, J REHABIL MED, V37, P137, DOI 10.1080/16501970510027321; Iverson GL, 2005, CURR OPIN PSYCHIATR, V18, P301, DOI 10.1097/01.yco.0000165601.29047.ae; Kant R, 1997, BRAIN INJURY, V11, P115, DOI 10.1080/026990597123700; Kirkness Catherine J, 2004, Biol Res Nurs, V5, P299, DOI 10.1177/1099800404263050; KLAUBER MR, 1981, NEUROSURGERY, V9, P236, DOI 10.1227/00006123-198109000-00003; Kraus J F, 2000, Neurosurg Focus, V8, pe5; Langlois JA., 2004, TRAUMATIC BRAIN INJU; Margulies S, 2000, J CLIN NEUROSCI, V7, P400, DOI 10.1054/jocn.1999.0681; Mittenberg W, 2002, J CLIN EXP NEUROPSYC, V24, P1094, DOI 10.1076/jcen.24.8.1094.8379; Niemeier JP, 2007, NEUROPSYCHOL REHABIL, V17, P293, DOI 10.1080/09602010600814729; Ponsford J, 2000, J INT NEUROPSYCH SOC, V6, P568, DOI 10.1017/S1355617700655066; Reitan R.M., 1993, HALSTEADREITAN NEURO; RUFF RM, 1994, BRAIN INJURY, V8, P297, DOI 10.3109/02699059409150981; Satz P, 1997, PSYCHOL BULL, V122, P107, DOI 10.1037/0033-2909.122.2.107; Schretlen DJ, 2003, INT REV PSYCHIATR, V15, P341, DOI 10.1080/09540260310001606728; TSUSHIMA WT, 1995, ADV MED PSYCHOTHERAP, V8, P137; Vagnerova K, 2008, ANESTH ANALG, V107, P201, DOI 10.1213/ane.0b013e31817326a5; Wong TM, 2000, CRIT ISS NE, P3; YEUDALL LT, 1987, J CLIN PSYCHOL, V43, P346, DOI 10.1002/1097-4679(198705)43:3<346::AID-JCLP2270430308>3.0.CO;2-Q	38	22	22	2	16	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2009	23	10					809	814	PII 914068901	10.1080/02699050903200530			6	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	485SP	WOS:000269144600004	19697169				2021-06-18	
J	Jeon, IC; Kim, OL; Kim, MS; Kim, SH; Chang, CH; Bai, DS				Jeon, Ik-Chan; Kim, Oh-Lyong; Kim, Min-Su; Kim, Seong-Ho; Chang, Chul-Hoon; Bai, Dai-Seg			The Effect of Premorbid Demographic Factors on the Recovery of Neurocognitive Function in Traumatic Brain Injury Patients	JOURNAL OF KOREAN NEUROSURGICAL SOCIETY			English	Article						Traumatic brain injury; Premorbid demographic factors; Prognosis	SEVERE HEAD-INJURY; PERFORMANCE; PROGNOSIS; EDUCATION; FLUENCY; GENDER; IMPACT; AGE; MANAGEMENT; FAS	Objective : Premorbid demographic backgrounds of injured individuals are likely to reflect more accurately the status of patients with traumatic brian injury (TBI) than clinical factors. However, the concrete study about the relationship between the demographic factors and neurocognitive function in TBI patients has not been reported. The object of this study was to evaluate the effect of premorbid demographic factors on the recovery of neurocognitive function following TBI. Methods : From July 1998 to February 2007, 293 patients (males 228, female: 65) with a history of head injury, who had recovered from the acute phase, were selected from our hospital to include in this study. We analyzed the effect of premorbid demographic factors including age, sex, educational level and occupation on the recovery of neurocognitive function in each TBI subgroup as defined by Glasgow Coma Scale (GCS) score. Intelligence and memory are components of neurocognitive function, and the Korean Wechsler Intelligence Scale (K-WAIS) and the Korean memory assessment scale (K-MAS) were used in this study. The results were considered significant at p < 0.05. Results : The higher level of education was a good prognostic factor for intelligence regardless of GCS score and younger age group showed a better result for memory with an exception of severe TBI group. In the severe TBI group, the meaningful effect of demographic factors was not noted by the cause of influence of severe brain injury. Conclusion : The demographic factors used in this study may be helpful for predicting the precise prognosis and developing an appropriate rehabilitation program for TBI patients.	[Jeon, Ik-Chan; Kim, Oh-Lyong; Kim, Min-Su; Kim, Seong-Ho; Chang, Chul-Hoon] Yeungnam Univ, Dept Neurosurg, Coll Med, Taegu 705717, South Korea; [Bai, Dai-Seg] Yeungnam Univ, Dept Psychiat, Coll Med, Taegu 705717, South Korea	Kim, OL (corresponding author), Yeungnam Univ, Dept Neurosurg, Coll Med, 317-1 Daemyeong Dong, Taegu 705717, South Korea.	olkim@med.yu.ac.kr	Jeon, Ikchan/AAZ-6368-2020	Jeon, Ikchan/0000-0002-1293-2724	Yeungnam University	This research Was Supported by the Yeungnam University research grants in 2004.	Bayir H, 2004, J NEUROTRAUM, V21, P1, DOI 10.1089/089771504772695896; BECKER DP, 1977, J NEUROSURG, V47, P491, DOI 10.3171/jns.1977.47.4.0491; Bittner RM, 2007, BRAIN INJURY, V21, P709, DOI 10.1080/02699050701468917; BOLLA KI, 1990, J CLIN PSYCHOL, V46, P623, DOI 10.1002/1097-4679(199009)46:5<623::AID-JCLP2270460513>3.0.CO;2-C; BRAAKMAN R, 1980, NEUROSURGERY, V6, P362, DOI 10.1227/00006123-198004000-00002; Brown AW, 2005, J NEUROTRAUM, V22, P1040, DOI 10.1089/neu.2005.22.1040; Gladsjo JA, 1999, ASSESSMENT, V6, P147, DOI 10.1177/107319119900600204; JENNETT B, 1977, J NEUROL NEUROSUR PS, V40, P291, DOI 10.1136/jnnp.40.3.291; JENNETT B, 1979, NEUROSURGERY, V4, P283, DOI 10.1227/00006123-197904000-00001; JENNETT B, 1976, LANCET, V1, P1031; Kesler SR, 2003, APPL NEUROPSYCHOL, V10, P153, DOI 10.1207/S15324826AN1003_04; Langeluddecke PM, 2003, CLIN NEUROPSYCHOL, V17, P273, DOI 10.1076/clin.17.2.273.16499; LECKLITER IN, 1989, J CLIN PSYCHOL, V45, P484, DOI 10.1002/1097-4679(198907)45:4<484::AID-JCLP2270450402>3.0.CO;2-L; LEVATI A, 1982, J NEUROSURG, V57, P779, DOI 10.3171/jns.1982.57.6.0779; Marmarou A, 2007, J NEUROTRAUM, V24, P239, DOI 10.1089/neu.2006.0036; MILLER JD, 1981, J NEUROSURG, V54, P289, DOI 10.3171/jns.1981.54.3.0289; Mushkudiani NA, 2007, J NEUROTRAUM, V24, P259, DOI 10.1089/neu.2006.0028; OVERGAARD J, 1973, LANCET, V2, P631; Ruff RM, 1997, BRAIN LANG, V57, P394, DOI 10.1006/brln.1997.1755; Sherrill-Pattison S, 2000, CLIN NEUROPSYCHOL, V14, P496, DOI 10.1076/clin.14.4.496.7196; Teasdale G, 1979, Acta Neurochir Suppl (Wien), V28, P161; Wagner AK, 2004, J NEUROTRAUM, V21, P125, DOI 10.1089/089771504322778596	22	22	22	0	7	KOREAN NEUROSURGICAL SOC	SEOUL	#402 POSCO # OFFICE BUILDING 151 SUNHWA-DONG, JUNG-GU, SEOUL, 100-130, SOUTH KOREA	2005-3711	1598-7876		J KOREAN NEUROSURG S	J. Korean. Neurosurg. Soc.	NOV	2008	44	5					295	302		10.3340/jkns.2008.44.5.295			8	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	380ND	WOS:000261471500002	19119465	DOAJ Gold, Green Published			2021-06-18	
J	Shafi, S; Gentilello, LM				Shafi, Shahid; Gentilello, Larry M.			Ethnic Disparities in Initial Management of Trauma Patients in a Nationwide Sample of Emergency Department Visits	ARCHIVES OF SURGERY			English	Article; Proceedings Paper	2nd Annual Academic Surgical Congress of the Association-for-Academic-Surgery	FEB 09-12, 2007	Phoenix, AZ	Assoc Acad Surg, Soc Univ Surg			ACUTE MYOCARDIAL-INFARCTION; RACIAL DISPARITIES; UNITED-STATES; HEALTH-CARE; RACE; TRANSPLANTATION	Hypothesis: Ethnic disparities in functional outcomes after traumatic brain injuries have been demonstrated previously. However, it is not clear if these disparities are due to differential access to initial diagnostic and treatment modalities or disproportionate care at poorly funded inner-city emergency departments (EDs). We hypothesized that initial assessment of injured patients in EDs is affected by patient ethnicity. Design: Retrospective database analysis. Setting: Data were obtained from the National Hospital Ambulatory Medical Care Survey ED component for 2003, which includes a national probability sample survey of ED visits. Patients: All injury-related initial ED visits of patients 15 years and older were included. Patients were divided into 3 groups: non-Hispanic white (n = 6106), African American (n = 1406), and Hispanic (n = 1051). Main Outcome Measures: The intensity of ED assessment and management and patient disposition from EDs were compared in the 3 groups. Results: Compared with non-Hispanic white patients, minority patients were slightly younger and less likely to be insured but were similar in sex, mechanism of injury, and injury severity. There were no clinically significant differences between non-Hispanic white patients and the 2 minority groups in ED assessment, diagnostic and treatment modalities, and ED disposition. There were no systematic differences by region of the country, ownership of the hospitals, or insurance status of the patients. Conclusion: The initial assessment and management of injured patients from ethnic/racial minorities was similar to that of non-Hispanic white patients in a nationwide representative sample of ED visits. Other causes of ethnic disparities in outcomes after injuries should be sought.	[Shafi, Shahid; Gentilello, Larry M.] Univ Texas SW Med Sch, Div Burns Trauma & Crit Care, Dept Surg, Dallas, TX 75390 USA	Shafi, S (corresponding author), Univ Texas SW Med Sch, Div Burns Trauma & Crit Care, Dept Surg, 5323 Harry Hines Blvd,Mail Stop 9158, Dallas, TX 75390 USA.	shahid.shafi@utsouthwestern.edu					*AG HEALTHC RES QU, 2005, NAT HEALTHC DISP REP, P90; *AM COLL SURG, 2004, ATLS ADV TRAUM SUPP; BAMHART JM, 2003, ARCH INTERN MED, V163, P461; Barnato AE, 2005, MED CARE, V43, P308, DOI 10.1097/01.mlr.0000156848.62086.06; Bertoni AG, 2005, J NATL MED ASSOC, V97, P317; COLLINS KS, 1999, MINORITY HLTH CHARTB; Delano BG, 1997, ASAIO J, V43, pM861; Fiscella K, 2002, MED CARE, V40, P52, DOI 10.1097/00005650-200201000-00007; Flattery Maureen P, 2004, J Cult Divers, V11, P25; Kokoska ER, 2007, J SURG RES, V137, P83, DOI 10.1016/j.jss.2006.06.020; Lucas FL, 2006, ANN SURG, V243, P281, DOI 10.1097/01.sla.0000197560.92456.32; Mochari Heidi, 2006, Prev Cardiol, V9, P8, DOI 10.1111/j.1520-037X.2005.3703.x; Phillips RS, 1996, J GEN INTERN MED, V11, P387, DOI 10.1007/BF02600183; Reid AE, 2004, LIVER TRANSPLANT, V10, P834, DOI 10.1002/lt.20174; Satcher D, 2000, J NATL MED ASSOC, V92, P315; SHAFI S, 2007, RACIAL DISPARITIES L; Shafi S, 2007, J TRAUMA, V63, P1138, DOI 10.1097/TA.0b013e3181568cd4; STAUDENMAYER KL, 2007, ETHNIC DISPARITIES L; Weinick RM, 2000, MED CARE RES REV, V57, P36, DOI 10.1177/107755800773743592; Werner RM, 2005, CIRCULATION, V111, P1257, DOI 10.1161/01.CIR.0000157729.59754.09	20	22	22	0	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0004-0010			ARCH SURG-CHICAGO	Arch. Surg.	NOV	2008	143	11					1057	1061		10.1001/archsurg.143.11.1057			5	Surgery	Surgery	384JN	WOS:000261741200006	19015463	Bronze			2021-06-18	
J	Berntsen, D; Rubin, DC; Bohni, MK				Berntsen, Dorthe; Rubin, David C.; Bohni, Malene Klindt			Contrasting Models of Posttraumatic Stress Disorder: Reply to Monroe and Mineka (2008)	PSYCHOLOGICAL REVIEW			English	Article						posttraumatic stress disorder; autobiographical memory; involuntary remembering	TRAUMATIC BRAIN-INJURY; MEMORIES; INVOLUNTARY; DISSOCIATION; ORGANIZATION; NARRATIVES; DIAGNOSIS; ATTENTION; IDENTITY; IMAGES	The authors address the 4 main points in S. M. Monroe and S. Mineka's (2008) comment. First, the authors show that the Diagnostic and Statistical Manual of Mental Disorders (4th ed., text rev.; American Psychiatric Association, 2000) posttraumatic stress disorder (PTSD) diagnosis includes an etiology and that it is based on a theoretical model with a distinguished history in psychology and psychiatry. Two tenets of this theoretical model are that voluntary (strategic) recollections of the trauma are fragmented and incomplete while involuntary (spontaneous) recollections are vivid and persistent and yield privileged access to traumatic material. Second, the authors describe differences between their model and other cognitive models of PTSD. They argue that these other models share the same 2 tenets as the diagnosis and show that these 2 tenets are largely unsupported by empirical evidence. Third, the authors counter arguments about the strength of the evidence favoring the mnemonic model. Fourth, they show that concerns about the causal role of memory in PTSD are based on views of causality that are generally inappropriate for the explanation of PTSD in the social and biological sciences.	[Rubin, David C.] Duke Univ, Dept Psychol & Neurosci, Durham, NC 27708 USA; [Berntsen, Dorthe; Bohni, Malene Klindt] Univ Aarhus, Dept Psychol, Aarhus, Denmark	Rubin, DC (corresponding author), Duke Univ, Dept Psychol & Neurosci, Box 27708-0086, Durham, NC 27708 USA.	david.rubin@duke.edu	Rubin, David C/B-4741-2009		Danish Research Council for the Humanities and National Institute of Mental HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R01 MH066079]; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R01MH066079] Funding Source: NIH RePORTER	We wish to thank Barbara Herrnstein Smith and Jen Talarico for suggestions and the Danish Research Council for the Humanities and National Institute of Mental Health Grant R01 MH066079 for funding.	American Psychiatric Association, 1980, DIAGN STAT MAN MENT, V3rd; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Amir N, 1998, J TRAUMA STRESS, V11, P385, DOI 10.1023/A:1024415523495; Berntsen D, 2006, PSYCHOL AGING, V21, P127, DOI 10.1037/0882-7974.21.1.127; Berntsen D, 2006, BEHAV RES THER, V44, P219, DOI 10.1016/j.brat.2005.01.009; Berntsen D, 2004, MEM COGNITION, V32, P789, DOI 10.3758/BF03195869; BERNTSEN D, INVOLUNTARY IN PRESS; Berntsen D, 2007, APPL COGNITIVE PSYCH, V21, P417, DOI 10.1002/acp.1290; Berntsen D, 2008, MEM COGNITION, V36, P449, DOI 10.3758/MC.36.2.449; BREUER J, 1955, STANDARD EDITION COM, V2, P3; Brewin CR, 2001, BRIT J MED PSYCHOL, V74, P467, DOI 10.1348/000711201161118; Bryant RA, 2001, CLIN PSYCHOL REV, V21, P931; Craik FIM, 1996, J EXP PSYCHOL GEN, V125, P159, DOI 10.1037/0096-3445.125.2.159; deRivera J, 1997, PSYCHOL INQ, V8, P271, DOI 10.1207/s15327965pli0804_1; FOA EB, 1995, J TRAUMA STRESS, V8, P675, DOI 10.1002/jts.2490080409; FRANKE S, 1994, ASA NEWSLETTER, V42, P1; Grayson DK, 2001, J WORLD PREHIST, V15, P1, DOI 10.1023/A:1011165119141; Hall NM, 2008, MEMORY, V16, P48, DOI 10.1080/09658210701333271; Halligan SL, 2003, J CONSULT CLIN PSYCH, V71, P419, DOI 10.1037/0022-006X.71.3.419; Halligan SL, 2002, J BEHAV THER EXP PSY, V33, P73, DOI 10.1016/S0005-7916(02)00014-9; Harvey AG, 1999, BRIT J CLIN PSYCHOL, V38, P401, DOI 10.1348/014466599162999; Harvey AG, 2003, J INT NEUROPSYCH SOC, V9, P663, DOI 10.1017/S1355617703940069; Holmes EA, 2004, J EXP PSYCHOL GEN, V133, P3, DOI 10.1037/0096-3445.133.1.3; Holmes EA, 2008, ACTA PSYCHOL, V127, P553, DOI 10.1016/j.actpsy.2007.11.002; Horo-witz Milton J., 1976, STRESS RESPONSE SYND; HOROWITZ MJ, 1969, AM J PSYCHIAT, V126, P565, DOI 10.1176/ajp.126.4.565; HOROWITZ MJ, 1969, ARCH GEN PSYCHIAT, V20, P552; HOROWITZ MJ, 1975, ARCH GEN PSYCHIAT, V32, P1457; HOROWITZ MJ, 1999, ESSENTIAL PAPERS POS, P1; *I MED, 2006, POSTTR STRESS DIS DI; Jones C, 2007, BEHAV RES THER, V45, P151, DOI 10.1016/j.brat.2006.02.004; Jones E, 2007, J ANXIETY DISORD, V21, P164, DOI 10.1016/j.janxdis.2006.09.009; Klein KJ, 2004, J APPL PSYCHOL, V89, P931, DOI 10.1037/0021-9010.89.6.931; Koenigs M, 2008, NAT NEUROSCI, V11, P232, DOI 10.1038/nn2032; McGaugh J.L., 2003, MEMORY EMOTION MAKIN; McGaugh JL, 2004, ANNU REV NEUROSCI, V27, P1, DOI 10.1146/annurev.neuro.27.070203.144157; McNally RJ, 2006, J CONSULT CLIN PSYCH, V74, P237, DOI 10.1037/0022-006X.74.2.237; McNally RJ, 2003, ANNU REV PSYCHOL, V54, P229, DOI 10.1146/annurev.psych.54.101601.145112; Monroe SM, 2008, PSYCHOL REV, V115, P1084, DOI 10.1037/a0013723; Mulligan NW, 1998, J EXP PSYCHOL LEARN, V24, P27, DOI 10.1037/0278-7393.24.1.27; Murray J, 2002, BRIT J PSYCHIAT, V180, P363, DOI 10.1192/bjp.180.4.363; Oyama S., 2000, ONTOGENY INFORM DEV; Pitman RK, 2005, CNS SPECTRUMS, V10, P99, DOI 10.1017/S109285290001943X; Porter S, 2001, APPL COGNITIVE PSYCH, V15, pS101, DOI 10.1002/acp.766; Rosen GM, 2008, CLIN PSYCHOL REV, V28, P837, DOI 10.1016/j.cpr.2007.12.002; Rosen GM, 2008, BRIT J PSYCHIAT, V192, P3, DOI 10.1192/bjp.bp.107.043083; Rubin DC, 2006, PERSPECT PSYCHOL SCI, V1, P277, DOI 10.1111/j.1745-6916.2006.00017.x; RUBIN DC, J EXPT PSYC IN PRESS; SCOTT WJ, 1990, SOC PROBL, V37, P294, DOI 10.1525/sp.1990.37.3.03a00020; Shobe KK, 1997, CURR DIR PSYCHOL SCI, V6, P70, DOI 10.1111/1467-8721.ep11512658; Spitzer RL, 2008, COMPR PSYCHIAT, V49, P319, DOI 10.1016/j.comppsych.2008.01.006; WHETTEN DA, 1989, ACAD MANAGE REV, V14, P490, DOI 10.2307/258554; Woodward J., 2003, MAKING THINGS HAPPEN; YEHUDA R, 1995, AM J PSYCHIAT, V152, P1705; Young A., 1995, HARMONY ILLUSIONS IN	55	22	23	0	9	AMER PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST NE, WASHINGTON, DC 20002-4242 USA	0033-295X	1939-1471		PSYCHOL REV	Psychol. Rev.	OCT	2008	115	4					1099	1106		10.1037/a0013730			8	Psychology; Psychology, Multidisciplinary	Psychology	362PU	WOS:000260210400014	20808720	Green Accepted			2021-06-18	
J	Zhou, ZW; Sun, D; Levasseur, JE; Merenda, A; Hamm, RJ; Zhu, JP; Spiess, BD; Bullock, MR				Zhou, Zhengwen; Sun, Dong; Levasseur, Joseph E.; Merenda, Amedeo; Hamm, Robert J.; Zhu, Jiepei; Spiess, Bruce D.; Bullock, M. Ross			PERFLUOROCARBON EMULSIONS IMPROVE COGNITIVE RECOVERY AFTER LATERAL FLUID PERCUSSION BRAIN INJURY IN RATS	NEUROSURGERY			English	Article						Cognitive deficits; Hippocampus; Perfluorocarbon emulsion; Traumatic brain injury	INTRAVENOUS PERFLUBRON EMULSION; CEREBRAL BLOOD-FLOW; FLUOSOL DA 20-PERCENT; ISOVOLEMIC HEMODILUTION; RETROGRADE-AMNESIA; OXYGEN-CONSUMPTION; HEALTHY-VOLUNTEERS; RANDOMIZED SAFETY; CELL LOSS; ISCHEMIA	OBJECTIVE: Perfluorocarbon emulsions have been shown to improve outcomes in stroke models. This study examined the effect of Oxycyte, a third-generation perfluorocarbon emulsion (04RD33; Synthetic Blood International, Inc., Costa Mesa, CA) treatment on cognitive recovery and mitochondrial oxygen consumption after a moderate lateral fluid percussion injury (LFPI). METHODS: Adult male Sprague-Dawley rats (Harlan Bioproducts for Science, Indianapolis, IN) were allocated to 4 groups: 1) LFPI treated with a lower dose of Oxycyte (4.5 mL/kg); 2) LFPI with a higher dose of Oxycyte (9.0 mL/kg); 3) LFPI with saline infusion; and 4) sham animals treated with saline. Fifteen minutes after receiving moderate LFPI or sham surgery, animals were infused intravenously with Oxycyte or saline within 30 minutes while breathing 100% O-2. Animals breathed 100% O-2 continuously for a total of 4 hours after injury. At 11 to 15 days after LFPI, animals were assessed for cognitive deficits using the Morris water maze test. They were sacrificed at Day 15 after injury for histology to assess hippocampal neuronal cell loss. In a parallel study, mitochondrial oxygen consumption values were measured by the Cartesian diver microrespirometer method. RESULTS: We found that injured animals treated with a lower or higher dose of Oxycyte had significant improvement in cognitive function when compared with injured saline-control animals (P < 0.05). Moreover, injured animals that received either dose of Oxycyte had significantly less neuronal cell loss in the hippocampal CA3 region compared with saline-treated animals (P < 0.05). Furthermore, a lower dose of Oxycyte significantly improved mitochondrial oxygen consumption levels (P < 0.05). CONCLUSION: The current study demonstrates that Oxycyte can improve cognitive recovery and reduce CA3 neuronal cell loss after traumatic brain injury in rats.	[Zhou, Zhengwen; Sun, Dong; Levasseur, Joseph E.; Merenda, Amedeo; Bullock, M. Ross] Virginia Commonwealth Univ, Dept Neurosurg, Richmond, VA USA; [Hamm, Robert J.] Virginia Commonwealth Univ, Dept Psychol, Richmond, VA 23284 USA; [Zhu, Jiepei; Spiess, Bruce D.] Virginia Commonwealth Univ, Dept Anesthesiol, Richmond, VA USA	Bullock, MR (corresponding author), Univ Miami, Miller Sch Med, Dept Neurosurg, Lois Pope LIFE Ctr, Room 3-20,1095 NW 14th Terrace, Miami, FL 33136 USA.	rbullock@med.miami.edu		MERENDA, AMEDEO/0000-0002-9270-7470	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS12587]; Reynolds Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P01NS012587, P50NS012587] Funding Source: NIH RePORTER	This study was funded by the National Institutes of Health Grant No. NS12587 and by the Reynolds Foundation (MRB).	AUER RN, 1984, ACTA NEUROPATHOL, V64, P177, DOI 10.1007/BF00688108; Baldwin SA, 1997, J NEUROTRAUM, V14, P385, DOI 10.1089/neu.1997.14.385; Bell RD, 2002, CRIT CARE MED, V30, P2684, DOI 10.1097/00003246-200212000-00012; BOUMA GJ, 1992, J NEUROSURG, V77, P360, DOI 10.3171/jns.1992.77.3.0360; CHESNUT RM, 1993, ACTA NEUROCHIR, P121; CLEMAN M, 1986, CIRCULATION, V74, P555, DOI 10.1161/01.CIR.74.3.555; Coggeshall RE, 1996, J COMP NEUROL, V364, P6, DOI 10.1002/(SICI)1096-9861(19960101)364:1<6::AID-CNE2>3.0.CO;2-9; Conti AC, 1998, J NEUROSCI, V18, P5663; CORTEZ SC, 1989, BRAIN RES, V482, P271, DOI 10.1016/0006-8993(89)91190-6; Daugherty WP, 2004, NEUROSURGERY, V54, P1223, DOI 10.1227/01.NEU.0000119238.68938.5D; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; ECKSTEIN EC, 1989, T AM SOC ART INT ORG, V35, P188; FAITHFULL NS, 1992, BIOMAT ARTIF CELL IM, V20, P797, DOI 10.3109/10731199209119721; FAITHFULL NS, 1994, ARTIF CELL BLOOD SUB, V22, P181, DOI 10.3109/10731199409117413; Floyd CL, 2002, J NEUROTRAUM, V19, P303, DOI 10.1089/089771502753594873; Franke Ralf-Peter, 2004, J Invasive Cardiol, V16, P110; Grady MS, 2003, J NEUROTRAUM, V20, P929, DOI 10.1089/089771503770195786; GRAHAM DI, 1989, J NEUROL NEUROSUR PS, V52, P346, DOI 10.1136/jnnp.52.3.346; GUO J, 1995, NEUROSURGERY, V36, P350, DOI 10.1227/00006123-199502000-00015; Hamm RJ, 2001, J NEUROTRAUM, V18, P1207, DOI 10.1089/089771501317095241; Hicks R, 1996, ACTA NEUROPATHOL, V91, P236, DOI 10.1007/s004010050421; JOHNSON EC, 1995, J APPL PHYSIOL, V79, P1777; KLINE RA, 1992, BIOMAT ARTIF CELL IM, V20, P979; KLINE RA, 1991, AM J SURG, V162, P103, DOI 10.1016/0002-9610(91)90168-D; KOLLURI S, 1986, SURG NEUROL, V26, P3, DOI 10.1016/0090-3019(86)90055-8; Kwon TH, 2005, J NEUROSURG, V103, P724, DOI 10.3171/jns.2005.103.4.0724; LEE PA, 1988, AM J PHYSIOL, V254, pH719; Leese PT, 2000, ANESTH ANALG, V91, P804, DOI 10.1097/00000539-200010000-00008; Levasseur JE, 2000, J NEUROTRAUM, V17, P101, DOI 10.1089/neu.2000.17.101; Levasseur JE, 2006, NEUROSURGERY, V59, P1122, DOI 10.1227/01.NEU.0000245581.00908.AF; MAXWELL WL, 1988, J PATHOL, V155, P327, DOI 10.1002/path.1711550408; McIntosh TK, 1996, LAB INVEST, V74, P315; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; MITSUNO T, 1984, ARTIF ORGANS, V8, P25, DOI 10.1111/j.1525-1594.1984.tb04240.x; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; Noveck RJ, 2000, ANESTH ANALG, V91, P812, DOI 10.1097/00000539-200010000-00009; OBRIEN RN, 1982, SCIENCE, V217, P153, DOI 10.1126/science.6806902; OSTERHOLM JL, 1983, NEUROSURGERY, V13, P381, DOI 10.1227/00006123-198310000-00006; Padnick LB, 1999, J APPL PHYSIOL, V86, P1497; PEERLESS SJ, 1981, STROKE, V12, P558, DOI 10.1161/01.STR.12.5.558; PEREIRA BM, 1988, NEUROSURGERY, V23, P139, DOI 10.1227/00006123-198808000-00001; Riess JG, 2006, ARTIF CELL BLOOD SUB, V34, P567, DOI 10.1080/10731190600973824; RIESS JG, 1984, ARTIF ORGANS, V8, P44, DOI 10.1111/j.1525-1594.1984.tb04243.x; SAKAS DE, 1994, STROKE, V25, P197, DOI 10.1161/01.STR.25.1.197; SATTERFIELD R, 1993, INVEST RADIOL, V28, P325, DOI 10.1097/00004424-199304000-00013; SCHMIDTKASTNER R, 1991, NEUROSCIENCE, V40, P599, DOI 10.1016/0306-4522(91)90001-5; SLOVITER HA, 1967, NATURE, V216, P458, DOI 10.1038/216458a0; Spahn DR, 2002, ANESTHESIOLOGY, V97, P1338, DOI 10.1097/00000542-200212000-00004; SQUIRE LR, 1991, SCIENCE, V253, P1380, DOI 10.1126/science.1896849; SQUIRE LR, 1975, SCIENCE, V187, P77, DOI 10.1126/science.1109228; SUZUKI J, 1984, STROKE, V15, P672, DOI 10.1161/01.STR.15.4.672; Vaz R, 1997, ACTA NEUROCHIR, V139, P215, DOI 10.1007/BF01844754; WINOCUR G, 1990, BEHAV BRAIN RES, V38, P145, DOI 10.1016/0166-4328(90)90012-4; ZOLAMORGAN SM, 1990, SCIENCE, V250, P288, DOI 10.1126/science.2218534	54	22	27	1	5	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0148-396X	1524-4040		NEUROSURGERY	Neurosurgery	OCT	2008	63	4					799	806		10.1227/01.NEU.0000325493.51900.53			8	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	367UR	WOS:000260578600052	18981892				2021-06-18	
J	Castellani, C; Stojakovic, T; Cichocki, M; Scharnagl, H; Erwa, W; Gutmann, A; Weinberg, AM				Castellani, Christoph; Stojakovic, Tatjana; Cichocki, Martin; Scharnagl, Hubert; Erwa, Wolfgang; Gutmann, Anton; Weinberg, Annelie-Martina			Reference ranges for neuroprotein S-100B: from infants to adolescents	CLINICAL CHEMISTRY AND LABORATORY MEDICINE			English	Article						children; neuroprotein; reference range; S-100B; traumatic brain injury	TRAUMATIC BRAIN-INJURY; MINOR HEAD-INJURY; COMPUTED-TOMOGRAPHY; CEREBROSPINAL-FLUID; PROTEIN CONCENTRATIONS; S100B CONCENTRATIONS; REFERENCE INTERVALS; SERUM S100B; CHILDREN; AGE	Background: Diagnosis and treatment of mild traumatic brain injuries in children are especially problematic. At present, computed tomography (CT) is the standard method to identify if patients with intracranial lesions require inpatient monitoring. CT, however, involves exposure to high doses of X-rays, which should be avoided if possible. In adults, the serum level of neuroprotein S-100B has already been proven to be effective for the selection of patients requiring CT. The aim of the present study was to determine reference ranges for serum S-100B in a large number of healthy children. Methods: All patients younger than 18 years with no recent history of head injuries presenting for routine operations were included in the study. Results: A total of 394 patients were evaluated. In children from 3 to 18 years an upper reference level of 0.16 mu g/ L was determined. There was a strong inverse relation between age and S-100B in patients younger than 3 years. As the values in this age group were scattered and the number of cases limited (n = 65), no reference range could be calculated. Conclusions: This study provides S-100B reference ranges for pediatric patients based on the largest group of healthy pediatric patients yet analyzed. Clin Chem Lab Med 2008; 46: 1296-9.	[Castellani, Christoph; Cichocki, Martin; Weinberg, Annelie-Martina] Graz Med Univ, Dept Pediat Surg, A-8036 Graz, Austria; [Stojakovic, Tatjana; Scharnagl, Hubert; Erwa, Wolfgang] Graz Med Univ, Inst Clin Med, A-8036 Graz, Austria; [Stojakovic, Tatjana; Scharnagl, Hubert; Erwa, Wolfgang] Graz Med Univ, Chem Lab Diagnost, A-8036 Graz, Austria; [Gutmann, Anton] Graz Med Univ, Dept Anesthesiol, Graz, Austria	Weinberg, AM (corresponding author), Graz Med Univ, Dept Pediat Surg, Auenbruggerpl 34, A-8036 Graz, Austria.	annelie.weinberg@t-online.de		Weinberg, Annelie/0000-0003-0385-4346	Roche Diagnostics	The study was supported by a research grant from Roche Diagnostics.	Alber B, 2005, CLIN CHEM LAB MED, V43, P557, DOI 10.1515/CCLM.2005.097; Anderson RE, 2001, ANN THORAC SURG, V71, P1512, DOI 10.1016/S0003-4975(01)02399-2; Berger RP, 2005, J NEUROSURG, V103, P61, DOI 10.3171/ped.2005.103.1.0061; Berger RP, 2002, J NEUROTRAUM, V19, P1405, DOI 10.1089/089771502320914633; Biberthaler P, 2006, SHOCK, V25, P446, DOI 10.1097/01.shk.0000209534.61058.35; Bloomfield SM, 2007, NEUROCRIT CARE, V6, P121, DOI 10.1007/s12028-007-0008-x; Brenner DJ, 2001, AM J ROENTGENOL, V176, P289, DOI 10.2214/ajr.176.2.1760289; CHEN C, 2007, P 30 ANN SAS US GROU; COLE TJ, 1992, STAT MED, V11, P1305, DOI 10.1002/sim.4780111005; Cushman JG, 2001, J TRAUMA, V51, P1016, DOI 10.1097/00005373-200111000-00034; Korfias S, 2006, CURR MED CHEM, V13, P3719, DOI 10.2174/092986706779026129; Muller K, 2007, J TRAUMA, V62, P1452, DOI 10.1097/TA.0b013e318047bfaa; Nygaard O, 1997, CLIN CHEM, V43, P541; Berger RP, 2006, PEDIATR CRIT CARE ME, V7, P557, DOI 10.1097/01.PCC.0000244426.37793.23; Pelinka LE, 2004, J NEUROTRAUM, V21, P1553, DOI 10.1089/0897715042441846; Petzold A, 2003, BRAIN RES BULL, V61, P281, DOI 10.1016/S0361-9230(03)00091-1; Rice HE, 2007, J PEDIATR SURG, V42, P603, DOI 10.1016/j.jpedsurg.2006.12.009; Romner B, 2000, J NEUROTRAUM, V17, P641, DOI 10.1089/089771500415391; SHACKFORD SR, 1992, J TRAUMA, V33, P385, DOI 10.1097/00005373-199209000-00009; Shore PM, 2007, J NEUROTRAUM, V24, P75, DOI 10.1089/neu.2006.0062; Wright EM, 1997, STAT MED, V16, P2785, DOI 10.1002/(SICI)1097-0258(19971230)16:24<2785::AID-SIM797>3.0.CO;2-Z; Zurakowski D, 1999, CLIN CHEM, V45, P1087	22	22	23	0	6	WALTER DE GRUYTER & CO	BERLIN	GENTHINER STRASSE 13, D-10785 BERLIN, GERMANY	1434-6621			CLIN CHEM LAB MED	Clin. Chem. Lab. Med.	SEP	2008	46	9					1296	1299		10.1515/CCLM.2008.262			4	Medical Laboratory Technology	Medical Laboratory Technology	358PF	WOS:000259929300016	18785867				2021-06-18	
J	Harris, OA; Bruce, CA; Reid, M; Cheeks, R; Easley, K; Surles, MC; Pan, Y; Rhoden-Salmon, D; Webster, D; Crandon, I				Harris, Odette A.; Bruce, Carl A.; Reid, Marvin; Cheeks, Randolph; Easley, Kirk; Surles, Monique C.; Pan, Yi; Rhoden-Salmon, Donnahae; Webster, Dwight; Crandon, Ivor			Examination of the management of traumatic brain injury in the developing and developed world: focus on resource utilization, protocols, and practices that alter outcome	JOURNAL OF NEUROSURGERY			English	Article						cohort study; functional independence measure; Glasgow Outcome Scale; traumatic brain injury	SEVERE HEAD-INJURIES; CONTROLLED-TRIALS	Object. We evaluated management and outcome of traumatic brain injury (TBI) in a developed country (US) and a developing country (Jamaica). Methods. Data were collected prospectively at Grady Memorial Hospital (GMH) in the US and at University Hospital of the West Indies (UHWI) and Kingston Public Hospital (KPH) in Jamaica between September 1, 2003, and September 30, 2004. Results. Complete data were available for 1607 patients. Grady Memorial Hospital had a higher proportion of females (p = 0.003), and patients were older at GMH (p = 0.0009) compared with patients at KPH and UHWI. The most common mode of injury was a motor vehicle accident at KPH and GMH (42 and 66%, respectively) and assaults at UHWI (37%). Grady Memorial Hospital admitted more patients with severe head injuries (25.5%) than KPH (18.5%) and UHWI (14.4%). More CT scans were performed (p < 0.0001) and a higher proportion of patients were admitted to the intensive care unit (p < 0.0001) at GMH. There were no statistically significant differences in median days in the intensive care unit among the 3 hospitals. Patients experienced statistically significant differences in days undergoing ventilation between GMH, KPH, and UHWI (p = 0.004). Intracranial pressure monitoring was performed in 1 patient at KPH, in 6 at UHWI, and in 91 at GMH. There were 174 total deaths, but no statistically significant differences in mortality rates between the 3 sites (p = 0.3). Hospital location and TBI severity were associated with a decreased risk of mortality; patients with severe TBI at GMH had a 53% decrease in the risk of mortality (odds ratio = 0.47, p = 0.04). Patients at GMH had lower mean Glasgow Outcome Scale scores (p < 0.0001) and lower Functional Independence Measure self-feed (p = 0.0003), locomotion (p = 0.04), and verbal scores (p < 0.0001). Conclusions. Despite the availability of advanced technology and more aggressive neurological support at GMH, the overall mortality rate for TBI was similar at all locations. Patients identified with severe TBI had a significantly decreased risk of mortality if they were treated at GMH compared with those patients treated at hospitals in the developing world.	[Easley, Kirk; Pan, Yi] Emory Univ, Sch Publ Hlth, Dept Biostat, Atlanta, GA 30303 USA; [Bruce, Carl A.; Rhoden-Salmon, Donnahae; Crandon, Ivor] Univ Hosp W Indies, Div Neurosurg, Mona, Jamaica; [Reid, Marvin] Univ Hosp W Indies, Sickle Cell Unit, Mona, Jamaica; [Cheeks, Randolph; Webster, Dwight] Kingston Publ Hosp, Dept Neurosurg, Kingston, Jamaica	Harris, OA (corresponding author), Emory Univ, Sch Med, Dept Neurosurg, Grady Mem Hosp, 49 Jesse Hill Jr Dr SE,Fac Off Bldg,Room 33, Atlanta, GA 30303 USA.	oharris@emory.edu	Reid, Marvin/J-2884-2014; Easley, Kirk/K-6910-2015	Reid, Marvin/0000-0003-4005-9384; Easley, Kirk/0000-0003-4419-2617; Surles-Zeigler, Monique/0000-0002-2308-8813	William P. Van Wagenen Fellowship of the American Association of Neurological Surgeons	Support for this research was provided by a fellowship from the William P. Van Wagenen Fellowship of the American Association of Neurological Surgeons, awarded to Odette Harris, M.D., M.P.H.	Benson K, 2000, NEW ENGL J MED, V342, P1878, DOI 10.1056/NEJM200006223422506; COLOHAN ART, 1989, J NEUROSURG, V71, P202, DOI 10.3171/jns.1989.71.2.0202; Concato J, 2000, NEW ENGL J MED, V342, P1887, DOI 10.1056/NEJM200006223422507; Ferrari R, 2001, CLIN NEUROL NEUROSUR, V103, P254, DOI 10.1016/S0303-8467(01)00161-5; Forer S., 1987, FUNCTIONAL INDEPENDE; GELPKE GJ, 1983, J NEUROSURG, V59, P745, DOI 10.3171/jns.1983.59.5.0745; JENNETT B, 1977, J NEUROL NEUROSUR PS, V40, P291, DOI 10.1136/jnnp.40.3.291; LANGFITT TW, 1982, J NEUROSURG, V56, P19, DOI 10.3171/jns.1982.56.1.0019; Maejima S, 2001, WORLD J SURG, V25, P1205, DOI 10.1007/s00268-001-0083-7; MARION DW, 1999, TRAUMATIC BRAIN INJU; Murray CJL., 1996, GLOBAL BURDEN DIS CO; Pasquale M, 1998, J TRAUMA, V44, P941, DOI 10.1097/00005373-199806000-00001; Raja IA, 2001, WORLD J SURG, V25, P1230	13	22	22	0	1	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085			J NEUROSURG	J. Neurosurg.	SEP	2008	109	3					433	438		10.3171/JNS/2008/109/9/0433			6	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	344CX	WOS:000258904400012	18759573				2021-06-18	
J	Muroi, C; Frei, K; El Beltagy, M; Cesnulis, E; Yonekawa, Y; Keller, E				Muroi, Carl; Frei, Karl; El Beltagy, Mohamed; Cesnulis, Evaldas; Yonekawa, Yasuhiro; Keller, Emanuela			Combined therapeutic hypothermia and barbiturate coma reduces interleukin-6 in the cerebrospinal fluid after aneurysmal subarachnoid hemorrhage	JOURNAL OF NEUROSURGICAL ANESTHESIOLOGY			English	Article						subarachnoid hemorrhage; inflammation; hypothermia; cytokine; IL-6	TUMOR-NECROSIS-FACTOR; FOCAL CEREBRAL-ISCHEMIA; TRAUMATIC BRAIN-INJURY; MODERATE HYPOTHERMIA; EXPERIMENTAL STROKE; BASILAR ARTERY; CARDIAC-ARREST; FACTOR-ALPHA; INFLAMMATION; EXPRESSION	Inflammatory response with cytokine release is reported to correlate with clinical outcome after aneurysmal subarachnoid hemorrhage (SAH). In selected cases, hypothermia and barbiturate coma are applied as means for neuroprotection after severe SAH. Hypothermia and high-dose barbiturate are reported to attenuate the inflammatory response. In this pilot study, we assessed the effect of the combined therapy on the inflammatory response. In 15 patients with SAH, daily cerebrospinal fluid (CSF) and plasma samples were collected. Interleukin (IL)-6, tumor necrosis factor alpha (TNF-alpha), IL-1 beta, systemic leukocyte, and leukocyte Counts in the CSF were quantified. Group 1 represented 7 cases treated with combined therapeutic hypothermia (33 degrees C) and barbiturate coma. Group 2 represented 8 cases without combined therapy. Compared with the systemic levels, all cases showed higher cytokine levels in the CSF. Mean IL-6 level in the CSF was significantly lower in group 1 (P < 0.001). The ratio between IL-6 levels in the CSF and plasma, as a parameter for intrathecal synthesis, was significantly lower in group 1 (P = 0.014). Mean CSF and systemic levels of TNF-alpha of group I were significantly higher compared with group 2 (P = 0.009 and P < 0.001). The mean systemic IL-1 beta level was significantly lower in group 1 (P < 0.001), as well as the leukocyte counts, both, systemic and in the CSF (P < 0.001 and P = 0.032). The present data show a most pronounced decrease of IL-6 levels in the CSF, beside decrease in systemic IL-1 beta levels, systemic leukocyte counts, and CSF leukocyte counts in group 1, which would be expected to reflect an attenuation of inflammatory response. The impact and role of TNF-alpha remains unclear.	[Muroi, Carl; Frei, Karl; El Beltagy, Mohamed; Cesnulis, Evaldas; Yonekawa, Yasuhiro; Keller, Emanuela] Univ Zurich Hosp, Dept Neurosurg, CH-8091 Zurich, Switzerland	Muroi, C (corresponding author), Univ Zurich Hosp, Dept Neurosurg, Frauenklin Str 10, CH-8091 Zurich, Switzerland.	carl.muroi@usz.ch	Keller, Emanuela/G-4040-2013; Keller, Emanuela/M-2917-2015	Keller, Emanuela/0000-0001-7892-8261; Muroi, Carl/0000-0003-2529-2022; Keller, Emanuela, Elisabeth, Sophia/0000-0002-7560-7574; /0000-0001-9999-3345; El beltagy, Mohamed/0000-0003-3856-4015			Abe R, 2004, HYPOTHERMIA FOR ACUTE BRAIN DAMAGE: PATHOMECHANISM AND PRACTICAL ASPECTS, P315; Aibiki M, 1999, J NEUROTRAUM, V16, P225, DOI 10.1089/neu.1999.16.225; Bernard SA, 2002, NEW ENGL J MED, V346, P557, DOI 10.1056/NEJMoa003289; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS21; Castillo J, 2003, ANN NEUROL, V54, P811, DOI 10.1002/ana.10765; Deng H, 2003, STROKE, V34, P2495, DOI 10.1161/01.STR.0000091269.67384.E7; Dumont AS, 2003, NEUROSURGERY, V53, P123, DOI 10.1227/01.NEU.0000068863.37133.9E; Emsley HCA, 2002, J CEREBR BLOOD F MET, V22, P1399, DOI 10.1097/01.WCB.0000037880.62590.28; Fassbender K, 2001, J NEUROL NEUROSUR PS, V70, P534, DOI 10.1136/jnnp.70.4.534; Gaetani P, 1998, NEUROL RES, V20, P337, DOI 10.1080/01616412.1998.11740528; Gasser S, 2003, J NEUROSURG ANESTH, V15, P240, DOI 10.1097/00008506-200307000-00012; GOSS JR, 1995, J NEUROTRAUM, V12, P159, DOI 10.1089/neu.1995.12.159; Hallenbeck JM, 2002, NAT MED, V8, P1363, DOI 10.1038/nm1202-1363; HANDA Y, 1995, ACTA NEUROCHIR, V132, P92, DOI 10.1007/BF01404854; Holzer M, 2002, NEW ENGL J MED, V346, P549; Huang J, 2006, SURG NEUROL, V66, P232, DOI 10.1016/j.surneu.2005.12.028; Keller E, 2005, ACT NEUR S, V94, P65; KIKUCHI T, 1995, NEUROL RES, V17, P106, DOI 10.1080/01616412.1995.11740296; Kwon KY, 2001, J KOREAN MED SCI, V16, P774, DOI 10.3346/jkms.2001.16.6.774; Lerch C, 2006, NEUROCRIT CARE, V5, P85, DOI 10.1385/NCC:5:2:85; Loop T, 2002, ANESTHESIOLOGY, V96, P1202, DOI 10.1097/00000542-200205000-00025; MATHIESEN T, 1993, J NEUROSURG, V78, P562, DOI 10.3171/jns.1993.78.4.0562; Naidech AM, 2006, J NEUROL NEUROSUR PS, V77, P1340, DOI 10.1136/jnnp.2006.089748; Nawashiro H, 1997, J CEREBR BLOOD F MET, V17, P483, DOI 10.1097/00004647-199705000-00001; NEILDWYER G, 1974, BRAIN, V97, P79, DOI 10.1093/brain/97.1.79; Osuka K, 2006, BRAIN RES, V1072, P1, DOI 10.1016/j.brainres.2005.12.003; PARKINSON D, 1984, SURG NEUROL, V21, P132, DOI 10.1016/0090-3019(84)90330-6; Polin RS, 1998, J NEUROSURG, V89, P559, DOI 10.3171/jns.1998.89.4.0559; Provencio JJ, 2005, SEMIN NEUROL, V25, P435, DOI 10.1055/s-2005-923537; Sasaki T, 2004, STROKE, V35, P1466, DOI 10.1161/01.STR.0000127425.47266.20; Schmidt OI, 2004, J NEUROINFLAMM, V1, DOI 10.1186/1742-2094-1-13; Sercombe R, 2002, JPN J PHARMACOL, V88, P227, DOI 10.1254/jjp.88.227; Shohami E, 1999, CYTOKINE GROWTH F R, V10, P119, DOI 10.1016/S1359-6101(99)00008-8; Sutcliffe IT, 2001, J CEREBR BLOOD F MET, V21, P1310, DOI 10.1097/00004647-200111000-00007; Takizawa T, 2001, NEUROL RES, V23, P724, DOI 10.1179/016164101101199243; Thome C, 2005, NEUROL RES, V27, P229, DOI 10.1179/016164105X25252; Wang GJ, 2002, NEUROSCIENCE, V114, P1081, DOI 10.1016/S0306-4522(02)00350-0; Yanagawa Y, 2002, RESUSCITATION, V53, P93, DOI 10.1016/S0300-9572(01)00499-3; Yatsushige H, 2005, STROKE, V36, P1538, DOI 10.1161/01.STR.0000170713.22011.c8; Zhou ML, 2007, BRAIN RES, V1173, P110, DOI 10.1016/j.brainres.2007.07.059	40	22	23	0	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0898-4921			J NEUROSURG ANESTH	J. Neurosurg. Anesthesiol.	JUL	2008	20	3					193	198		10.1097/ANA.0b013e31817996bf			6	Anesthesiology; Clinical Neurology; Surgery	Anesthesiology; Neurosciences & Neurology; Surgery	321IF	WOS:000257297300006	18580350				2021-06-18	
J	Niedzwecki, CM; Marwitz, JH; Ketchum, JM; Cifu, DX; Dillard, CM; Monasterio, EA				Niedzwecki, Christian M.; Marwitz, Jenniftr H.; Ketchum, Jessica M.; Cifu, David X.; Dillard, Charles M.; Monasterio, Eugenio A.			Traumatic brain injury: A comparison of inpatient functional outcomes between children and adults	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						age; functional independence measure; functional outcomes; pediatric rehabilitation; predictive model; traumatic brain injury	NONDISABLED JAPANESE CHILDREN; LENGTH-OF-STAY; INDEPENDENCE MEASURE; HEAD-INJURY; DEVELOPMENTAL-DISABILITIES; COMMUNITY INTEGRATION; YOUNG-CHILDREN; OLDER-ADULTS; SHORT-TERM; REHABILITATION	Objectives: To examine age-related differences in functional outcomes following traumatic brain injury. Participants and procedure: Seventy-six patients admitted to a pediatric acute rehabilitation hospital were compared with 2548 adult patients in the National Institute on Disability and Rehabilitation Research-funded traumatic brain injury model systems national database. Main outcome measures: Functional Independence Measure totals during inpatient rehabilitation. Results: Increasing age was significantly associated with improved outcome in children and with poorer outcome in adults. Conclusion: The relationship between age and functional outcome is different within different age groups (pediatric vs adult), and the effect of moderating variables differs by age group.	[Niedzwecki, Christian M.; Marwitz, Jenniftr H.; Cifu, David X.; Dillard, Charles M.; Monasterio, Eugenio A.] Virginia Commonwealth Univ, Dept Phys Med & Rehabil, Richmond, VA 23298 USA; [Ketchum, Jessica M.] Virginia Commonwealth Univ, Dept Biostat, Richmond, VA 23298 USA; [Monasterio, Eugenio A.] Childrens Hosp Richmond, Richmond, VA USA	Niedzwecki, CM (corresponding author), Virginia Commonwealth Univ, Dept Phys Med & Rehabil, Box 980677, Richmond, VA 23298 USA.	cniedzwecki@mcvh-vcu.edu	Ketchum, Jessica/AAE-8200-2020	Ketchum, Jessica/0000-0002-5566-3691; Cifu, David/0000-0003-1600-9387			Anderson V, 2005, PEDIATRICS, V116, P1374, DOI 10.1542/peds.2004-1728; Anderson VA, 2006, NEUROPSYCHOLOGY, V20, P42, DOI 10.1037/0894-4105.20.1.42; Azaula M, 2000, ARCH PHYS MED REHAB, V81, P307, DOI 10.1053/apmr.2000.0810307; BRESLAU N, 1990, ARCH GEN PSYCHIAT, V47, P15; Brown AW, 2005, J NEUROTRAUM, V22, P1040, DOI 10.1089/neu.2005.22.1040; CARTER GM, 2002, ANAL INITIAL IMPLEME; Chen CC, 2005, AM J PHYS MED REHAB, V84, P671, DOI 10.1097/01.phm.0000176439.32318.36; Chen CC, 2004, AM J OCCUP THER, V58, P44, DOI 10.5014/ajot.58.1.44; CHOI SC, 1983, J NEUROSURG, V59, P294, DOI 10.3171/jns.1983.59.2.0294; Cicerone KD, 2000, ARCH PHYS MED REHAB, V81, P1596, DOI 10.1053/apmr.2000.19240; Cifu DX, 1996, ARCH PHYS MED REHAB, V77, P883, DOI 10.1016/S0003-9993(96)90274-9; DISCALA C, 1991, ARCH PHYS MED REHAB, V72, P662; DISCALA C, 1992, AM J PHYS MED REHAB, V71, P145, DOI 10.1097/00002060-199206000-00004; DODDS TA, 1993, ARCH PHYS MED REHAB, V74, P531, DOI 10.1016/0003-9993(93)90119-U; Dumas HM, 2002, AM J PHYS MED REHAB, V81, P661, DOI 10.1097/00002060-200209000-00005; Englander J, 2003, ARCH PHYS MED REHAB, V84, P214, DOI 10.1053/apmr.2003.50094; Ewing-Cobbs L, 1998, PEDIATRICS, V102, P300, DOI 10.1542/peds.102.2.300; Finkelstein EA., 2006, INCIDENCE EC BURDEN; Frankel JE, 2006, ARCH PHYS MED REHAB, V87, P57, DOI 10.1016/j.apmr.2005.07.309; Garcia RA, 2002, AM J PHYS MED REHAB, V81, P458, DOI 10.1097/00002060-200206000-00011; Giedd JN, 1999, NAT NEUROSCI, V2, P861, DOI 10.1038/13158; GRANGER CV, 1993, ARCH PHYS MED REHAB, V74, P133; Granger CV, 1986, GUIDE USE UNIFORM DA; Haider AH, 2007, J TRAUMA, V62, P1259, DOI 10.1097/TA.0b013e31803c760e; HALL KM, 1994, ARCH PHYS MED REHAB, V75, pSC10; HALL KM, 1994, ARCH PHYS MED REHAB, V75, pSC27; Hall KM., 1993, J HEAD TRAUMA REHAB, V8, DOI [DOI 10.1097/00001199-199308020-00008, 10.1097/00001199-199308020-00008]; HarrisonFelix C, 1996, J HEAD TRAUMA REHAB, V11, P1, DOI 10.1097/00001199-199610000-00002; JAFFE KM, 1995, ARCH PHYS MED REHAB, V76, P17, DOI 10.1016/S0003-9993(95)80037-9; JAFFE KM, 1993, ARCH PHYS MED REHAB, V74, P681, DOI 10.1016/0003-9993(93)90024-5; JAFFE KM, 1993, ARCH PHYS MED REHAB, V74, P587, DOI 10.1016/0003-9993(93)90156-5; Keenan HT, 2004, PEDIATRICS, V114, P633, DOI 10.1542/peds.2003-1020-L; KRIEL RL, 1989, PEDIATR NEUROL, V5, P296, DOI 10.1016/0887-8994(89)90021-0; Langlois JA., 2004, TRAUMATIC BRAIN INJU; Lewis JK, 2000, J HEAD TRAUMA REHAB, V15, P930, DOI 10.1097/00001199-200006000-00006; Liu MG, 1998, AM J PHYS MED REHAB, V77, P36, DOI 10.1097/00002060-199801000-00006; Maas AIR, 2007, J NEUROTRAUM, V24, P303, DOI 10.1089/neu.2006.0033; Massagli TL, 1996, ARCH PHYS MED REHAB, V77, P125, DOI 10.1016/S0003-9993(96)90156-2; MCDONALD CM, 1994, ARCH PHYS MED REHAB, V75, P328, DOI 10.1016/0003-9993(94)90038-8; MICHAUD LJ, 1992, NEUROSURGERY, V31, P254, DOI 10.1227/00006123-199208000-00010; Miller P, 2006, ANESTH ANALG, V103, P869, DOI 10.1213/01.ane.0000237327.12205.dc; Morrison Wynne E, 2004, Pediatr Crit Care Med, V5, P145, DOI 10.1097/01.PCC.0000112373.71645.2A; MSALL ME, 1994, CLIN PEDIATR, V33, P421, DOI 10.1177/000992289403300708; MSALL ME, 1994, CLIN PEDIATR, V33, P431, DOI 10.1177/000992289403300709; Ottenbacher KJ, 2004, JAMA-J AM MED ASSOC, V292, P1687, DOI 10.1001/jama.292.14.1687; Ottenbacher KJ, 1996, DEV MED CHILD NEUROL, V38, P907; Ottenbacher KJ, 1997, ARCH PHYS MED REHAB, V78, P1309, DOI 10.1016/S0003-9993(97)90302-6; Ottenbacher KJ, 1999, DEV MED CHILD NEUROL, V41, P186, DOI 10.1017/S0012162299000377; Ottenbacher KJ, 2000, ARCH PHYS MED REHAB, V81, P1317, DOI 10.1053/apmr.2000.9387; Paret G, 1998, J NEUROTRAUM, V15, P967, DOI 10.1089/neu.1998.15.967; RAPHAELY RC, 1980, PEDIATR CLIN N AM, V27, P715; Rice SA, 2005, ARCH PHYS MED REHAB, V86, P834, DOI 10.1016/j.apmr.2004.11.006; RIVARA JB, 1994, ARCH PHYS MED REHAB, V75, P369, DOI 10.1016/0003-9993(94)90157-0; Sander AM, 1996, J HEAD TRAUMA REHAB, V11, P70, DOI 10.1097/00001199-199610000-00007; Smith JS, 2007, J TRAUMA, V63, P75, DOI 10.1097/01.ta.0000245991.42871.87; Swaine BR, 2000, AM J PHYS MED REHAB, V79, P412, DOI 10.1097/00002060-200009000-00002; Taylor HG, 2002, NEUROPSYCHOLOGY, V16, P15, DOI 10.1037//0894-4105.16.1.15; TEASDALE G, 1974, LANCET, V2, P81; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Tsuji T, 1999, AM J PHYS MED REHAB, V78, P208, DOI 10.1097/00002060-199905000-00003; Wagner AK, 2000, J TRAUMA, V49, P411, DOI 10.1097/00005373-200009000-00005; Wechsler B, 2005, J TRAUMA, V58, P940, DOI 10.1097/01.TA.0000162630.78386.98; Yeates KO, 2004, J INT NEUROPSYCH SOC, V10, P412, DOI 10.1017/S1355617704103093; Ziviani Jenny, 2001, Physical and Occupational Therapy in Pediatrics, V21, P91, DOI 10.1080/J006v21n02_08	64	22	22	0	7	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0885-9701			J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	JUL-AUG	2008	23	4					209	219		10.1097/01.HTR.0000327253.61751.29			11	Clinical Neurology; Rehabilitation	Neurosciences & Neurology; Rehabilitation	331KU	WOS:000258011900003	18650765				2021-06-18	
J	Sawauchi, S; Abe, T				Sawauchi, S.; Abe, T.			The effect of haematoma, brain injury, and secondary insult on brain swelling in traumatic acute subdural haemorrhage	ACTA NEUROCHIRURGICA			English	Article						traumatic brain injury; acute subdural haematoma; brain swelling; secondary insult; outcome	SEVERE HEAD-INJURY; EDEMA; HYPOXEMIA; MORTALITY; VOLUME; RAT	Objective. The high mortality of acute subdural haematoma (ASDH) is largely explained by its frequent association with primary brain damage consisting of contusion and brain swelling. However, the nature and causes of brain swelling after traumatic brain injury are multifactorial and poorly understood. The purpose of this study was to investigate the pathophysiology of brain swelling associated with ASDH in traumatic brain injury. Methods. We examined whether the thickness of the haematoma, parenchymal injury, or presence of a secondary insult had an effect on traumatic brain swelling. The variables that might affect the pathophysiology of ASDH were examined, including: (1) age and mechanism of injury, (2) neurological findings, (3) secondary insult and extracranial injuries, (4) pre-operative computed tomography (CT) scan results, and (5) outcome. Results. A total of 212 patients were included in this study. On CT scan, 159 patients (75.0%) did not have brain swelling, 29 (13.7%) had hemispheric brain swelling, and 24 (11.3%) had diffuse brain swelling. Brain swelling associated with ASDH is caused by secondary insult in addition to parenchymal injury. In the present study, the outcome of ASDH associated with brain swelling was poor, even when treated with early surgical evacuation; the mortality rate of such patients was over 75%. Conclusions. Given our findings, it is possible that the poor outcome of ASDH patients depends not only on the characteristics of the haematoma itself, but also on the presence of additional cerebral parenchymal injury and secondary insult.	[Sawauchi, S.] Jikei Univ, Sch Med, Dept Neurosurg, Minato Ku, Tokyo 1058461, Japan	Sawauchi, S (corresponding author), Jikei Univ, Sch Med, Dept Neurosurg, Minato Ku, 3-25-8 Nishishinbashi, Tokyo 1058461, Japan.	ssawauchi@jcom.home.ne.jp					CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; EISENBERG HM, 1990, J NEUROSURG, V73, P688, DOI 10.3171/jns.1990.73.5.0688; Field AS, 2003, AM J NEURORADIOL, V24, P1461; Ito J, 1996, J NEUROSURG, V84, P97, DOI 10.3171/jns.1996.84.1.0097; JAMIESON KG, 1972, J NEUROSURG, V37, P137, DOI 10.3171/jns.1972.37.2.0137; LOBATO RD, 1988, J NEUROSURG, V68, P417, DOI 10.3171/jns.1988.68.3.0417; Manley G, 2001, ARCH SURG-CHICAGO, V136, P1118, DOI 10.1001/archsurg.136.10.1118; Marmarou A, 2000, J NEUROSURG, V93, P183, DOI 10.3171/jns.2000.93.2.0183; Marmarou A, 2003, ACT NEUR S, V86, P7; Massaro F, 1996, ACTA NEUROCHIR, V138, P185, DOI 10.1007/BF01411359; McHugh GS, 2007, J NEUROTRAUM, V24, P287, DOI 10.1089/neu.2006.0031; Sawauchi S, 2004, J NEUROTRAUM, V21, P563, DOI 10.1089/089771504774129892; Sawauchi S, 2003, J NEUROTRAUM, V20, P613, DOI 10.1089/089771503322144536; SEELIG JM, 1981, NEW ENGL J MED, V304, P1511, DOI 10.1056/NEJM198106183042503; Servadei F, 1997, ACTA NEUROCHIR, V139, P279, DOI 10.1007/BF01808822; WILBERGER JE, 1991, J NEUROSURG, V74, P212, DOI 10.3171/jns.1991.74.2.0212	16	22	23	0	3	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0001-6268			ACTA NEUROCHIR	Acta Neurochir.	JUN	2008	150	6					531	536		10.1007/s00701-007-1497-2			6	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	309AJ	WOS:000256431800002	18493704				2021-06-18	
J	Zhang, J; Li, Y; Zheng, XG; Gao, Q; Liu, ZW; Qu, RJ; Bornernan, J; Elias, SB; Chopp, M				Zhang, Jing; Li, Yi; Zheng, Xuguang; Gao, Qi; Liu, Zhongwu; Qu, Runjiang; Bornernan, Jade; Elias, Stanton B.; Chopp, Michael			Bone marrow stromal cells protect oligodendrocytes from oxygen-glucose deprivation injury	JOURNAL OF NEUROSCIENCE RESEARCH			English	Article						bone marrow stromal cells; oligodendrocytes; oxygen-glucose deprivation	PHOSPHATIDYLINOSITOL 3-KINASE-AKT PATHWAY; GROWTH-FACTOR PRODUCTION; SIGNAL-REGULATED KINASE; TRAUMATIC BRAIN-INJURY; SPINAL-CORD INJURY; NEUROTROPHIC FACTOR; WHITE-MATTER; FUNCTIONAL RECOVERY; IN-VITRO; CEREBRAL-ISCHEMIA	Oligodendrocyte (OLG) damage leads to demyelination, which is frequently observed in ischemic cerebrovascular diseases. In this study, we investigated the effect of bone marrow stromal cells (BMSCs) on OLGs subjected to oxygen-glucose deprivation (OGD). N20.1 cells (mouse OLG cell line) were transferred into an anaerobic chamber for 3 hr in glucose-free and serum-free medium. After OGD incubation, OLG cultures were divided into the following groups: 1) OGD alone, 2) OLG cocultured with BMSCs, 3) treatment with the phosphoinostide 3-kinase (PI3k) inhibitor LY294002, 4) LY294002-treated OLGs with BMSC cocultured, and 5) anti-p75 anti body-treated OLGs. After an additional 3 hr of reoxygenation incubation, OLG viability and apoptosis were measured. The mRNA expression in the BMSCs and OLGs was analyzed using quantitative real-time PCR (RT-PCR). Serine/threonine-specific protein kinase (Akt), phosphorylated Akt (p-Akt), p75, and caspase 3 protein expressions in OLGs were measured by Western blot. Our results suggest that BMSCs produce growth factors, activate the Akt pathway, and increase the survival of OLGs. BMSCs also reduce p75 and caspase 3 expressions in the OGD-OLGs, which leads to decreased OLG apoptosis. BMSCs participate in OLG protection that may occur with promoting growth factors/PI3K/Akt and inhibiting the p75/caspase pathways. Our study provides insight into white matter damage and the therapeutic benefits of BMSC-based remyelinating therapy after stroke and demyelinating diseases. (c) 2008 Wiley-Liss, Inc.	[Zhang, Jing; Li, Yi; Zheng, Xuguang; Gao, Qi; Liu, Zhongwu; Qu, Runjiang; Elias, Stanton B.; Chopp, Michael] Henry Ford Hlth Syst, Dept Neurol, Detroit, MI 48202 USA; [Bornernan, Jade] Cognate BioServ Inc, Baltimore, MD USA; [Chopp, Michael] Oakland Univ, Dept Phys, Rochester, MI USA	Chopp, M (corresponding author), Henry Ford Hlth Syst, Dept Neurol, Educ & Res Bldg 3056,2799 W Grand Blvd, Detroit, MI 48202 USA.	chopp@neuro.hfh.edu			NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS045041, P01NS042345] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01 NS45041, R01 NS045041, P01 NS42345, P01 NS042345-04, P01 NS042345] Funding Source: Medline		Anitha M, 2006, J CLIN INVEST, V116, P344, DOI 10.1172/JCI26295; Beattie MS, 2002, NEURON, V36, P375, DOI 10.1016/S0896-6273(02)01005-X; Beckman JS, 1996, AM J PHYSIOL-CELL PH, V271, pC1424; Bhave SV, 1999, J NEUROSCI, V19, P3277, DOI 10.1523/jneurosci.19-09-03277.1999; Braydich-Stolle L, 2007, DEV BIOL, V304, P34, DOI 10.1016/j.ydbio.2006.12.013; Brazil DP, 2002, CELL, V111, P293, DOI 10.1016/S0092-8674(02)01083-8; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655; CasacciaBonnefil P, 1996, NATURE, V383, P716, DOI 10.1038/383716a0; Casha S, 2001, NEUROSCIENCE, V103, P203, DOI 10.1016/S0306-4522(00)00538-8; Chen JL, 2003, J NEUROSCI RES, V73, P778, DOI 10.1002/jnr.10691; Chen JL, 2001, STROKE, V32, P1005, DOI 10.1161/01.STR.32.4.1005; Chen XG, 2002, J NEUROSCI RES, V69, P687, DOI 10.1002/jnr.10334; Chen XG, 2002, NEUROPATHOLOGY, V22, P275, DOI 10.1046/j.1440-1789.2002.00450.x; Chopp M, 2002, LANCET NEUROL, V1, P92, DOI 10.1016/S1474-4422(02)00040-6; Coffer PJ, 1998, BIOCHEM J, V335, P1; Coulson EJ, 2000, CLIN EXP PHARMACOL P, V27, P537, DOI 10.1046/j.1440-1681.2000.03295.x; Dirnagl U, 1999, TRENDS NEUROSCI, V22, P391, DOI 10.1016/S0166-2236(99)01401-0; DIVE C, 1992, BIOCHIM BIOPHYS ACTA, V1133, P275, DOI 10.1016/0167-4889(92)90048-G; Dolcet X, 1999, J NEUROCHEM, V73, P521, DOI 10.1046/j.1471-4159.1999.0730521.x; Focke PJ, 2003, J NEUROBIOL, V55, P151, DOI 10.1002/neu.10204; Foulstone EJ, 1999, NEUROSCI LETT, V264, P125, DOI 10.1016/S0304-3940(99)00166-4; Fujio Y, 2000, CIRCULATION, V101, P660, DOI 10.1161/01.CIR.101.6.660; Gao Q, 2005, NEUROSCIENCE, V136, P123, DOI 10.1016/j.neuroscience.2005.06.091; Gresle MM, 2006, BRAIN RES, V1110, P13, DOI 10.1016/j.brainres.2006.06.111; Hajduch E, 2001, FEBS LETT, V492, P199, DOI 10.1016/S0014-5793(01)02242-6; Hauck SM, 2006, MOL CELL BIOL, V26, P2746, DOI 10.1128/MCB.26.7.2746-2757.2006; Imai H, 2001, STROKE, V32, P2149, DOI 10.1161/hs0901.095725; Itakura M, 2005, J NEUROCHEM, V94, P502, DOI 10.1111/j.1471-4159.2005.03242.x; Kulik G, 1997, MOL CELL BIOL, V17, P1595, DOI 10.1128/MCB.17.3.1595; Lee J, 2007, DEVELOPMENT, V134, P1853, DOI 10.1242/dev.003004; Lee R, 2001, SCIENCE, V294, P1945, DOI 10.1126/science.1065057; Li Y, 2006, EXP NEUROL, V198, P313, DOI 10.1016/j.expneurol.2005.11.029; Li Y, 2002, NEUROLOGY, V59, P514, DOI 10.1212/WNL.59.4.514; Li Y, 2000, J CEREBR BLOOD F MET, V20, P1311, DOI 10.1097/00004647-200009000-00006; Li YL, 2001, J MATER RES, V16, P67, DOI 10.1557/JMR.2001.0014; Lin DC, 2006, MOL CELL BIOL, V26, P8928, DOI 10.1128/MCB.00228-06; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lyons SA, 1998, J CEREBR BLOOD F MET, V18, P521, DOI 10.1097/00004647-199805000-00007; Mahmood A, 2004, J NEUROTRAUM, V21, P33, DOI 10.1089/089771504772695922; Mahmood A, 2001, NEUROSURGERY, V49, P1196, DOI 10.1097/00006123-200111000-00031; Matute C, 2007, J ANAT, V210, P693, DOI 10.1111/j.1469-7580.2007.00733.x; McCarran WJ, 2007, J NEUROSCI, V27, P4220, DOI 10.1523/JNEUROSCI.5542-06.2007; Mielke JG, 2006, NEUROSCIENCE, V143, P165, DOI 10.1016/j.neuroscience.2006.07.055; Mockridge JW, 2000, BIOCHEM BIOPH RES CO, V273, P322, DOI 10.1006/bbrc.2000.2934; Mograbi B, 2001, J BIOL CHEM, V276, P45307, DOI 10.1074/jbc.M101220200; Nicholson DW, 1997, TRENDS BIOCHEM SCI, V22, P299, DOI 10.1016/S0968-0004(97)01085-2; Paez PM, 2004, GLIA, V46, P207, DOI 10.1002/glia.20001; Pantoni L, 1996, STROKE, V27, P1641, DOI 10.1161/01.STR.27.9.1641; Politi LE, 2001, J NEUROCHEM, V76, P1199, DOI 10.1046/j.1471-4159.2001.00128.x; Rajagopal R, 2004, J NEUROSCI, V24, P6650, DOI 10.1523/JNEUROSCI.0010-04.2004; RALIBEK UL, 2005, PFLUGERS ARCH, V450, P355; Shah A, 2005, CLIN CANCER RES, V11, P2930, DOI 10.1158/1078-0432.CCR-04-1385; Shibata M, 2000, J CLIN INVEST, V106, P643, DOI 10.1172/JCI10203; Shiojima I, 2002, CIRC RES, V90, P1243, DOI 10.1161/01.RES.0000022200.71892.9F; Syroid DE, 2000, J NEUROSCI, V20, P5741; Thompson RJ, 2006, SCIENCE, V312, P924, DOI 10.1126/science.1126241; Tsui CC, 2006, J AM SOC NEPHROL, V17, P1543, DOI 10.1681/ASN.2005080835; Ulrich E, 1998, ONCOGENE, V16, P825, DOI 10.1038/sj.onc.1201842; Vaillant AR, 1999, J CELL BIOL, V146, P955, DOI 10.1083/jcb.146.5.955; Veit C, 2004, CANCER RES, V64, P5291, DOI 10.1158/0008-5472.CAN-04-1112; VERITY AN, 1993, J NEUROCHEM, V60, P577, DOI 10.1111/j.1471-4159.1993.tb03188.x; Villegas SN, 2006, BRAIN RES BULL, V71, P116, DOI 10.1016/j.brainresbull.2006.08.014; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839; VLAHOS CJ, 1994, J BIOL CHEM, V269, P5241; Wang HJ, 2007, ACTA PHARMACOL SIN, V28, P166, DOI 10.1111/j.1745-7254.2007.00494.x; Wang L, 2004, STROKE, V35, P1732, DOI 10.1161/01.STR.0000132196.49028.a4; Wang L, 2005, J CEREBR BLOOD F MET, V25, P1150, DOI 10.1038/sj.jcbfm.9600112; Wang X, 2001, J BIOL CHEM, V276, P33812, DOI 10.1074/jbc.M010548200; Wilkins A, 2003, J NEUROSCI, V23, P4967, DOI 10.1523/jneurosci.23-12-04967.2003; Xie YM, 2000, J BIOL CHEM, V275, P29868, DOI 10.1074/jbc.M005071200; Yamaguchi A, 2001, J BIOL CHEM, V276, P5256, DOI 10.1074/jbc.M008552200; Yi L, 2005, GLIA, V49, P407, DOI 10.1002/glia.20126; Yoon SO, 1998, J NEUROSCI, V18, P3273; Yoshioka A, 2000, BRAIN RES, V854, P207, DOI 10.1016/S0006-8993(99)02359-8; Zappia E, 2005, BLOOD, V106, P1755, DOI 10.1182/blood-2005-04-1496; Zhang J, 2005, EXP NEUROL, V195, P16, DOI 10.1016/j.expneurol.2005.03.018; Zhang J, 2004, BRAIN RES, V1030, P19, DOI 10.1016/j.brainres.2004.09.061; Zhang J, 2006, J NEUROSCI RES, V84, P587, DOI 10.1002/jnr.20962	79	22	23	0	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0360-4012	1097-4547		J NEUROSCI RES	J. Neurosci. Res.	MAY 15	2008	86	7					1501	1510		10.1002/jnr.21617			10	Neurosciences	Neurosciences & Neurology	299BZ	WOS:000255732100007	18214988	Green Accepted			2021-06-18	
J	Jain, S; Dharap, SB; Gore, MA				Jain, Sandeep; Dharap, Satish B.; Gore, Madhuri A.			Early prediction of outcome in very severe closed head injury	INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED			English	Article						prognosis; outcome; prediction; severe head injury; GCS	TRAUMATIC BRAIN-INJURY; COMA SCALE SCORE; PROGNOSTIC-FACTORS; VARIABLES; MORTALITY; ADMISSION; SURVIVAL; AGE	Background: People with severe head injury and admission Glasgow Coma Scale (GCS) score <= 5 have a poor outcome and greatly strain limited resources. Aim: To identify patients with the best chances of survival, using routine clinical measures. Methods: People attending the trauma intensive care unit, who had isolated blunt head injury and GCS <= 5 and who had survived >= 4 h, were included in the study, resuscitated and clinically assessed. The GCS score was followed serially after admission. Bivariate analysis of various parameters with outcome was performed using the chi-square test. Serial GCS scores were compared with admission GCS by paired t-testing. Results: Of the 102 patients who were studied prospectively, 78 (76.5%) died and 24 (23.5%) survived. Age, gender, pre-hospital delay and admission GCS scores were comparable between the two groups. Adequate spontaneous respiration, brisk pupillary light reactivity on admission and increase in GCS by at least 2 at 24 h after admission significantly affected the outcome (p < 0.05). In the presence of all these factors, the survival rate increased from 6.1% to 57.1% (p < 0.001). Conclusions: People with GCS score <= 5 still have a reasonable chance of survival, so all patients should be aggressively managed initially. Better survival was observed among those with adequate spontaneous respiration, good pupillary reaction and improvement in GCS of at least 2 at 24 h. These clinical parameters can help to predict survival and thus make best use of limited resources. (C) 2007 Elsevier Ltd. All rights reserved.	[Jain, Sandeep; Dharap, Satish B.; Gore, Madhuri A.] LTM Med Coll, Bombay 400022, Maharashtra, India	Jain, S (corresponding author), LTM Med Coll, Bombay 400022, Maharashtra, India.	sjain7172@yahoo.com	Dharap, Satish/AAE-8565-2020	Dharap, Satish/0000-0002-9304-9617			BOFFARD KB, JOHANNESBURG HOSP TR, P5; Combes P, 1996, INTENS CARE MED, V22, P1391, DOI 10.1007/s001340050269; Demetriades D, 2004, ARCH SURG-CHICAGO, V139, P1066, DOI 10.1001/archsurg.139.10.1066; Dimopoulou I, 2003, NEUROLOGY, V60, P947, DOI 10.1212/01.WNL.0000049931.77887.7F; Farin A, 2003, J NEUROSURG, V98, P32, DOI 10.3171/jns.2003.98.1.0032; FEARNSIDE MR, 1993, BRIT J NEUROSURG, V7, P267, DOI 10.3109/02688699309023809; Gan BK, 2004, ANN ACAD MED SINGAP, V33, P63; GENNRELLI TA, 1989, J TRAUMA, V29, P1195; KOTWICA Z, 1995, ACTA NEUROCHIR, V133, P56, DOI 10.1007/BF01404948; Li Ning, 2004, Chin J Traumatol, V7, P156; Lieberman JD, 2003, J TRAUMA, V55, P437, DOI 10.1097/01.TA.0000081882.79587.17; Mamelak AN, 1996, J TRAUMA, V41, P91, DOI 10.1097/00005373-199607000-00014; Mosenthal AC, 2002, J TRAUMA, V52, P907, DOI 10.1097/00005373-200205000-00015; Ono J, 2001, J CLIN NEUROSCI, V8, P120, DOI 10.1054/jocn.2000.0732; Pillai SV, 2003, NEUROL INDIA, V51, P345; Quigley MR, 1997, J TRAUMA, V42, P7, DOI 10.1097/00005373-199701000-00003; Ratanalert S, 2002, BRIT J NEUROSURG, V16, P487, DOI 10.1080/0268869021000030311; Rovlias A, 2004, J NEUROTRAUM, V21, P886, DOI 10.1089/0897715041526249; SELLADURAI BM, 1992, BRIT J NEUROSURG, V6, P549, DOI 10.3109/02688699209002372; SHIGEMORI M, 1989, NEUROSURG REV, V12, P1436; Signorini DF, 1999, J NEUROL NEUROSUR PS, V66, P20, DOI 10.1136/jnnp.66.1.20; Susman M, 2002, J TRAUMA, V53, P219, DOI 10.1097/00005373-200208000-00004; Udekwu P, 2004, J TRAUMA, V56, P1084, DOI 10.1097/01.TA.0000124283.02605.A5; WAXMAN K, 1991, ARCH SURG-CHICAGO, V126, P1237; White JRM, 2001, CRIT CARE MED, V29, P534, DOI 10.1097/00003246-200103000-00011; Wilson WJ, 2002, J NEUROSURG, V97, P1062, DOI 10.3171/jns.2002.97.5.1062	26	22	22	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0020-1383			INJURY	Injury-Int. J. Care Inj.	MAY	2008	39	5					598	603		10.1016/j.injury.2007.06.003			6	Critical Care Medicine; Emergency Medicine; Orthopedics; Surgery	General & Internal Medicine; Emergency Medicine; Orthopedics; Surgery	298OZ	WOS:000255698300015	17884053				2021-06-18	
J	Kay, LG; Bundy, AC; Clemson, LM				Kay, Lynnette G.; Bundy, Anita C.; Clemson, Lindy M.			Predicting fitness to drive using the Visual Recognition Slide Test (USyd)	AMERICAN JOURNAL OF OCCUPATIONAL THERAPY			English	Article; Proceedings Paper	Conference of the Australian-Consortium-for-Social-and-Political-Research-Incorporated	DEC, 2006	Sydney, AUSTRALIA	Australian Consortium Social & Polit Res Inc		driving; fitness to drive; rehabilitation	TRAUMATIC BRAIN-INJURY; OLDER DRIVERS; SCREENING ASSESSMENT; ALZHEIMER-DISEASE; IMPAIRMENT; STROKE; PERFORMANCE; ADULTS; SELF; COMPETENCE	OBJECTIVE. The authors examined the construct and predictive validity and internal reliability of the Visual Recognition Slide Test developed at the University of Sydney (VRST-USyd). METHOD. A historical cohort study using retrospective descriptive analysis of VRST-USyd scores and on-road driving performance for 838 drivers with impairments was conducted. RESULTS. Rasch analysis provided evidence for the construct validity and internal reliability of the VRST-USyd. Goodness-of-fit statistics for all items were acceptable. The test had high participant and item reliability indexes and separated the participants into four groups with varying levels of skill. Using a cutoff score of 95/164, the sensitivity of the test was 81%, and the specificity was 90%. However, when coupled with clinicians' judgment of participants' awareness of their driving performance during the on-road assessment, this score improved. CONCLUSION. There is evidence for reliability and construct and predictive validity of the VRST-USyd. The measurement of awareness requires further research.	[Kay, Lynnette G.] Univ Sydney, Fac Hlth Sci, Discipline Occupat Therapy, Lidcombe, NSW 1825, Australia; [Bundy, Anita C.; Clemson, Lindy M.] Univ Sydney, Fac Hlth Sci, Discipline Occupat Therapy, Sydney, NSW 2006, Australia	Kay, LG (corresponding author), Univ Sydney, Fac Hlth Sci, Discipline Occupat Therapy, POB 170, Lidcombe, NSW 1825, Australia.	L.Kay@usyd.edu.au		Bundy, Anita/0000-0003-4743-9144			Anastasi A., 1988, PSYCHOL TESTING; Anstey KJ, 2005, CLIN PSYCHOL REV, V25, P45, DOI 10.1016/j.cpr.2004.07.008; Austroads, 2004, APR25904 AUSTR; BADIA X, 2002, DIFF IT TEST FUNCT; Ball K, 1998, ACCIDENT ANAL PREV, V30, P313, DOI 10.1016/S0001-4575(97)00102-4; Ball KK, 2006, J AM GERIATR SOC, V54, P77, DOI 10.1111/j.1532-5415.2005.00568.x; Bond T. G., 2001, APPL RASCH MODEL; Bouillon L, 2006, AM J OCCUP THER, V60, P420, DOI 10.5014/ajot.60.4.420; Brooks N, 2005, BRAIN INJURY, V19, P165, DOI 10.1080/02699050410001720004; COLEMAN B, 2006, DRIVER REHABILITATIO, P165; Coleman RD, 2002, ARCH PHYS MED REHAB, V83, P1415, DOI 10.1053/apmr.2002.35111; Cotrell V, 1999, ALZ DIS ASSOC DIS, V13, P151, DOI 10.1097/00002093-199907000-00007; De Raedt R, 2000, J AM GERIATR SOC, V48, P1664, DOI 10.1111/j.1532-5415.2000.tb03880.x; Engum E. S., 1988, COGNITIVE REHABILITA, V6, P34; FOLSTEIN MF, 1975, J PSYCHIATR RES, V12, P198; Fox GK, 1998, ARCH PHYS MED REHAB, V79, P1288, DOI 10.1016/S0003-9993(98)90277-5; Garratt AM, 2003, SPINE, V28, P79, DOI 10.1097/00007632-200301010-00019; Grace J, 2005, J INT NEUROPSYCH SOC, V11, P766, DOI 10.1017/S135561770505848; Hoffman L, 2005, PSYCHOL AGING, V20, P610, DOI 10.1037/0882-7974.20.4.610; Howorth P, 2003, AGING MENT HEALTH, V7, P113, DOI 10.1080/1360786031000072286; Huchler S., 2001, EURA MEDICOPHYS, V37, P283; Kantor B, 2004, J AM GERIATR SOC, V52, P1326, DOI 10.1111/j.1532-5415.2004.52363.x; KATZ RT, 1990, ARCH PHYS MED REHAB, V71, P133; Klavora P, 2000, ARCH PHYS MED REHAB, V81, P701, DOI 10.1053/apmr.2000.6285; Korner-Bitensky N, 2000, AM J PHYS MED REHAB, V79, P253, DOI 10.1097/00002060-200005000-00007; Linacre J. M, 2005, USERS GUIDE WINSTEPS; Lundqvist A, 2001, NEUROPSYCHOL REHABIL, V11, P171, DOI 10.1080/09602010042000240; Marottoli RA, 1998, ACCIDENT ANAL PREV, V30, P331, DOI 10.1016/S0001-4575(97)00100-0; Mazer BL, 1998, ARCH PHYS MED REHAB, V79, P743, DOI 10.1016/S0003-9993(98)90350-1; Mazer BL, 2004, CRITICAL REV ARCH PH, V16, P291, DOI DOI 10.1615/CRITREVPHYSREHABILMED.V16.I4.40; McKenna P, 2004, BRIT J CLIN PSYCHOL, V43, P325, DOI 10.1348/0144665031752952; Michon J.A., 1985, HUMAN BEHAV TRAFFIC, P485; Myers RS, 2000, PERCEPT MOTOR SKILL, V91, P279, DOI 10.2466/PMS.91.5.279-290; Nouri F.M., 1992, CLIN REHABIL, V6, DOI [https://doi.org/10.1177/026921559200600402, DOI 10.1177/026921559200600402]; Portney L., 2015, FDN CLIN RES APPL PR, V3rd ed.; Radford KA, 2004, BRAIN INJURY, V18, P775, DOI 10.1080/02699050310001657394; Radford KA, 2004, ARCH PHYS MED REHAB, V85, P324, DOI 10.1016/S0003-9993(03)00765-2; Sherer M, 2003, BRAIN INJURY, V17, P25, DOI 10.1080/0269905021000010113; SMITH RM, 1996, POLYTOMOUS MEAN SQUA; Snellgrove C, 2005, COGNITIVE SCREENING; Streiner D., 1995, HLTH MEASUREMENT SCA, V2; Stutts JC, 2003, J SAFETY RES, V34, P431, DOI 10.1016/j.jsr.2003.09.014; VANZOMEREN AH, 1987, ARCH PHYS MED REHAB, V68, P697; Whelihan WM, 2005, ARCH CLIN NEUROPSYCH, V20, P217, DOI 10.1016/j.acn.2004.07.002; Wild K, 2003, ALZ DIS ASSOC DIS, V17, P27, DOI 10.1097/00002093-200301000-00004; Withaar FK, 2000, J INT NEUROPSYCH SOC, V6, P480, DOI 10.1017/S1355617700644065	46	22	22	0	5	AMER OCCUPATIONAL THERAPY ASSOC, INC	BETHESDA	4720 MONTGOMERY LANE, BETHESDA, MD 20814-3425 USA	0272-9490			AM J OCCUP THER	Am. J. Occup. Ther.	MAR-APR	2008	62	2					187	197		10.5014/ajot.62.2.187			11	Rehabilitation	Rehabilitation	272AK	WOS:000253829600008	18390012				2021-06-18	
J	Stipanicic, A; Nolin, P; Fortin, G; Gobeil, MF				Stipanicic, Annie; Nolin, Pierre; Fortin, Gilles; Gobeil, Marie-France			Comparative study of the cognitive sequelae of school-aged victims of Shaken Baby Syndrome	CHILD ABUSE & NEGLECT			English	Article						Shaken Baby Syndrome; non-accidental head injury; neuropsychology; executive functions	TRAUMATIC BRAIN-INJURY; INFANT SYNDROME; CHILD-ABUSE; SHAKING; IMPACT; DAMAGE	Objective: Shaken Baby Syndrome (SBS) is now recognized as being the main cause of severe traumatic brain injury in infancy. However, our understanding of the impact of this type of abuse on child development remains sketchy. The main objective of the current study was therefore to shed light on the cognitive dysfunctions that are particular to SBS victims once they are school-aged. Method: A clinical group was formed of I I children diagnosed with SBS who had been admitted between 1988 and 1999 to a tertiary pediatric hospital in Quebec, Canada. The children were matched for age, gender, socioeconomic status, and family composition to I I healthy Quebec children, who made up the control group. A battery of composite tests was developed to assess the children's main cognitive functions and was administered individually to the 22 children. A univariate t-test was used to compare the performances of the two groups. Results: The mean age of the children in the clinical and control groups at the time of the assessment was 87.64 months and 90.18 months, respectively. Pairing and birth data were equivalent for both groups. Significant weaknesses were noted in the clinical group for intelligence quotient (IQ), working memory, mental organization, alternation, and inhibition. These deficits seemed to have a greater impact on the verbal sphere of the children's mental functioning. Conclusion: Primary results point to the anterior cerebral regions of the brain as the principal site of dysfunctions that persist years post-trauma. It is important to consider these results longitudinally, even in children apparently less extensively affected, since the frontal regions only reach maturity at the end of adolescence. Crown Copyright (C) 2008 Published by Elsevier Ltd. All rights reserved.	[Stipanicic, Annie; Nolin, Pierre; Fortin, Gilles; Gobeil, Marie-France] Univ Quebec Trois Rivieres, Dept Psychol, Child & Family Dev Res Unit, Trois Rivieres, PQ G9A 5H7, Canada	Stipanicic, A (corresponding author), Univ Quebec Trois Rivieres, Dept Psychol, Child & Family Dev Res Unit, POB 500, Trois Rivieres, PQ G9A 5H7, Canada.						ANDERSON V, 2004, NEUROPSYCHOLOGIE COG, P83; Anderson V.A, 2001, DEV NEUROPSYCHOLOGY; Baddeley A. D., 1986, WORKING MEMORY; Barlow KM, 2005, PEDIATRICS, V116, pE174, DOI 10.1542/peds.2004-2739; Barlow KM, 2000, LANCET, V356, P1571, DOI 10.1016/S0140-6736(00)03130-5; BARLOW KM, 1999, EUR J PAEDIATR NEURO, V3, pA139; Beery KE, 1997, BEERY BUKTENICA DEV; Bonnier C, 1995, DEV MED CHILD NEUROL, V37, P943; BOURQUE C, 1999, CADRE REFERENCE CLIN; BRENNER SL, 1989, J NATL MED ASSOC, V81, P183; CAFFEY J, 1974, PEDIATRICS, V54, P396; CAFFEY J, 1946, AM J ROENTGENOL, V56, P163; CAFFEY J, 1972, AM J DIS CHILD, V124, P161, DOI 10.1001/archpedi.1972.02110140011001; Cahill LT, 1999, CHILD ADOL PSYCH CL, V8, P827; Cohen M.J., 1997, CHILDRENS MEMORY SCA; Cummings E. M, 1994, CHILDREN MARITAL CON; DESGRANGES B, 2003, EVALUATION PRISE CHA, P123; Duhaime AC, 1996, PEDIATR NEUROSURG, V24, P292, DOI 10.1159/000121058; ELMER E, 1967, PEDIATRICS, V40, P596; Ewing-Cobbs L, 1998, PEDIATRICS, V102, P300, DOI 10.1542/peds.102.2.300; Ewing-Cobbs L, 1999, PEDIATR NEUROSURG, V31, P251, DOI 10.1159/000028872; FISCHER H, 1994, CLIN PEDIATR, V33, P696, DOI 10.1177/000992289403301113; Gervais M, 1999, ETUDE EXPLORATOIRE B; GOLDSTEIN B, 1993, CRIT CARE MED, V21, P1328, DOI 10.1097/00003246-199309000-00016; GUTHKELCH AN, 1971, BMJ-BRIT MED J, V2, P430, DOI 10.1136/bmj.2.5759.430; Haviland J, 1997, ARCH DIS CHILD, V77, P504, DOI 10.1136/adc.77.6.504; *HLTH CAN, JOINT STAT SHAK BAB; HOFFMANPLOTKIN D, 1984, CHILD DEV, V55, P794, DOI 10.1111/j.1467-8624.1984.tb03816.x; Jenny C, 1999, JAMA-J AM MED ASSOC, V281, P621, DOI 10.1001/jama.281.7.621; KING W, 2003, CANADIAN MED ASS J, V168, P1; KING WJ, 2000, CANADIAN COLLABORATI; Korkman M., 2003, NEPSY BILAN NEUROPSY; Lezak MD, 1995, NEUROPSYCHOLOGICAL A; LUDWIG S, 1984, ANN EMERG MED, V13, P104, DOI 10.1016/S0196-0644(84)80571-5; Lupien SJ, 2001, DEV PSYCHOPATHOL, V13, P653, DOI 10.1017/S0954579401003133; MAZEAU M, 2003, CONDUITE BILAN NEURO; MINER ME, 1986, NEURAL TRAUMA TREATM, P233; MORSE CW, 1970, AM J DIS CHILD, V120, P439, DOI 10.1001/archpedi.1970.02100100103011; Palacio-Quintin E., 1995, UNIVERSEL DIFFERENTI, P305; Prasad MR, 2002, PEDIATR NEUROSURG, V36, P64, DOI 10.1159/000048355; Reitan R.M., 1992, NEUROPSYCHOLOGICAL E; REITAN RM, 1994, NEUROPSYCHOLOGICAL E; Shallice T., 1990, NEUROPSYCHOLOGY MENT; SINAL SH, 1987, SOUTHERN MED J, V80, P1505, DOI 10.1097/00007611-198712000-00006; Sohlberg M. M., 1989, INTRO COGNITIVE REHA; Spreen O., 1998, COMPENDIUM NEUROPSYC; THORNDIKE RL, 1986, ECHELLE INTELLIGENCE; TRICKETT PK, 1995, DEV REV, V15, P311, DOI 10.1006/drev.1995.1012; Trocme N, 2001, CANADIAN INCIDENCE S; Tulving E, 1983, ELEMENTS EPISODIC ME; Wechsler D, 2000, WECHSLER INTELLIGENC	51	22	22	0	10	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0145-2134	1873-7757		CHILD ABUSE NEGLECT	Child Abuse Negl.	MAR	2008	32	3					415	428		10.1016/j.chiabu.2007.07.008			14	Family Studies; Psychology, Social; Social Work	Family Studies; Psychology; Social Work	294WI	WOS:000255436600009	18377985				2021-06-18	
J	Yen, TS; Liau, CC; Chen, YS; Chao, A				Yen, Ting-Shan; Liau, Chun-Chih; Chen, Yih-Sharng; Chao, Anne			Extracorporeal membrane oxygenation resuscitation for traumatic brain injury after decompressive craniotomy	CLINICAL NEUROLOGY AND NEUROSURGERY			English	Article						traumatic brain injury; shock; resuscitation; extracorporeal membrane oxygenation; acute respiratory distress syndrome	RESPIRATORY-DISTRESS-SYNDROME	Acute cardiopulmonary failure in patients with increased intracranial pressure is a significant management challenge to physicians. We report on a 21-year-old patient with traumatic brain injury who developed intractable hypoxemia and hypotension after undergoing a decompressive craniotomy. Venoarterial extracorporeal membrane oxygenation was initiated to resuscitate the patient. Extracorporeal membrane oxygenation is considered contraindicated in patients with intracranial bleeding because systemic heparin is needed during the support of extracorporeal membrane oxygenation. We describe our successful experience in tackling this dilemma. (c) 2007 Elsevier B.V. All rights reserved.	[Yen, Ting-Shan; Chao, Anne] Natl Taiwan Univ Hosp, Dept Anesthesiol, Taipei 100, Taiwan; [Liau, Chun-Chih] Taipei Hosp, Dept Hlth Execut Yuan, Dept Neurosurg, Taipei 242, Taiwan; [Chen, Yih-Sharng] Natl Taiwan Univ Hosp, Dept Cardiovasc Surg, Taipei 100, Taiwan	Chao, A (corresponding author), Natl Taiwan Univ Hosp, Dept Anesthesiol, 7 Chung Shan S Rd, Taipei 100, Taiwan.	chaoanne@yahoo.com		Chao, Anne/0000-0002-7170-3817; Chen, Yih-Sharng/0000-0003-3846-8162			Bein T, 2005, J TRAUMA, V58, P1294, DOI 10.1097/01.TA.0000173275.06947.5C; Bratton SL, 1997, NEUROSURGERY, V40, P707, DOI 10.1097/00006123-199704000-00009; Bullock RM, 2000, J NEUROTRAUM, V17, P449; Contant CF, 2001, J NEUROSURG, V95, P560, DOI 10.3171/jns.2001.95.4.0560; Etemadrezaie H, 2007, CLIN NEUROL NEUROSUR, V109, P166, DOI 10.1016/j.clineuro.2006.09.001; Reynolds HN, 1999, PERFUSION-UK, V14, P489, DOI 10.1177/026765919901400612; Senunas LE, 1997, CLIN ORTHOP RELAT R, P32	7	22	23	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0303-8467	1872-6968		CLIN NEUROL NEUROSUR	Clin. Neurol. Neurosurg.	MAR	2008	110	3					295	297		10.1016/j.clineuro.2007.10.017			3	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	285PQ	WOS:000254789100018	18068892				2021-06-18	
J	Skoglund, TS; Nilsson, D; Ljungberg, M; Jonsson, L; Rydenhag, B				Skoglund, T. S.; Nilsson, D.; Ljungberg, M.; Jonsson, L.; Rydenhag, B.			Long-term follow-up of a patient with traumatic brain injury using diffusion tensor imaging	ACTA RADIOLOGICA			English	Article						brain/brain stem; CNS; MR diffusion/perfusion; trauma	FIBER TRACKING; AXONAL INJURY	This case report describes a patient who sustained severe head trauma with diffuse axonal injury (DAI). Examination with magnetic resonance diffusion tensor imaging (MR-DTI), 6 days post-injury, showed a severe reduction in fractional anisotropy (FA) in the rostral pons containing the corticospinal tract, which correlated to the patient's severe hemiparesis. By 18 months post-accident, the patient had recovered completely and conventional MRI showed no pathology. However, although her FA values in the rostral pons had increased, they were still not normalized. It seems that a complete normalization of the FA values is not required to achieve clinical recovery, and that MR-DTI seems to be more sensitive to DAI compared to conventional MRI.	Sahlgrens Univ Hosp, Dept Neurosurg, SE-41345 Gothenburg, Sweden; Sahlgrens Univ Hosp, Dept Biomed Engn & Med Phys, Gothenburg, Sweden; Sahlgrens Univ Hosp, Dept Radiol, Gothenburg, Sweden; Univ Gothenburg, Dept Radiat Phys, Gothenburg, Sweden	Skoglund, TS (corresponding author), Sahlgrens Univ Hosp, Dept Neurosurg, Bldg Straket 7, SE-41345 Gothenburg, Sweden.	thomas.skoglund@vgregion.se	Nilsson, Daniel/AAF-3868-2020				Ahn YH, 2006, NEUROREHABILITATION, V21, P239; Arfanakis K, 2002, AM J NEURORADIOL, V23, P794; Ewing-Cobbs L, 2006, AM J NEURORADIOL, V27, P879; Huisman TAGM, 2004, AM J NEURORADIOL, V25, P370; Inglese M, 2005, J NEUROSURG, V103, P298, DOI 10.3171/jns.2005.103.2.0298; Le TH, 2005, NEUROSURGERY, V56, P189, DOI 10.1227/01.NEU.0000144846.00569.3A; Meythaler JM, 2001, ARCH PHYS MED REHAB, V82, P1461, DOI 10.1053/apmr.2001.25137; Mori S, 2002, NMR BIOMED, V15, P468, DOI 10.1002/nbm.781; Naganawa S, 2004, AM J NEURORADIOL, V25, P1553; Nakayama N, 2006, J NEUROL NEUROSUR PS, V77, DOI 10.1136/jnnp.2005.077875; Rugg-Gunn FJ, 2001, J NEUROL NEUROSUR PS, V70, P530, DOI 10.1136/jnnp.70.4.530; Stieltjes B, 2001, NEUROIMAGE, V14, P723, DOI 10.1006/nimg.2001.0861	12	22	25	0	1	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0284-1851	1600-0455		ACTA RADIOL	Acta Radiol.	FEB	2008	49	1					98	100		10.1080/02841850701561372			3	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	264UM	WOS:000253315900019	17963089				2021-06-18	
J	Thorat, JD; Wang, EC; Lee, KK; Seow, WT; Ng, I				Thorat, J. D.; Wang, E. C.; Lee, K. K.; Seow, W. T.; Ng, I.			Barbiturate therapy for patients with refractory intracranial hypertension following severe traumatic brain injury: Its effects on tissue oxygenation, brain temperature and autoregulation	JOURNAL OF CLINICAL NEUROSCIENCE			English	Article						barbiturate coma; brain oxygenation; head injury; cerebral autoregulation; brain temperature	CEREBROVASCULAR PRESSURE REACTIVITY; HEAD-INJURY; CEREBRAL AUTOREGULATION; MANAGEMENT	The aim of this study was to explore the effects of barbiturate coma on cerebral tissue oxygen tension and cerebrovascular pressure reactivity (PRx), as an index of cerebral autoregulation in severe head injury patients. This was a prospective observational clinical study of 12 patients with severe traumatic brain injury, carried out at a tertiary-level neurosurgical intensive care unit between April 2002 and May 2005. All patients received standard neurosurgical intensive care and monitoring. Probes for intracranial pressure (ICP), brain temperature (BT) and brain tissue oxygenation (PTiO2) were inserted into (noncontused) normal-looking white matter. Cerebrovascular PRx was measured as a moving correlation between ICP and arterial blood pressure. Barbiturate coma was instituted when ICP became refractory (ICP > 20 mmHg). All data from the multimodal monitoring were digitally extracted and statistically analysed. The mean ICP decreased with barbiturate coma in eight of the 12 patients (75% of the patients), but only four achieved a value below 20 mmHg. Of eight patients with prebarbiturate PTiO2 levels above 10 mmHg, six had a further improvement in oxygenation. Thus, concordant favourable changes in ICP, PRx and PTiO2 with barbiturate coma were seen in those who survived. Effective response to barbiturates can be detected by improved PTiO2 and autoregulation (PRx) in severe head injury patients. (c) 2007 Elsevier Ltd. All rights reserved.	[Thorat, J. D.; Wang, E. C.; Lee, K. K.; Seow, W. T.; Ng, I.] Tan Tock Seng Hosp, Natl Inst Neurosci, Dept Neurosurg, Acute Brain Injury Res Lab, Singapore 308433, Singapore	Thorat, JD (corresponding author), Tan Tock Seng Hosp, Natl Inst Neurosci, Dept Neurosurg, Acute Brain Injury Res Lab, 11 Jalan Tan Tock Seng, Singapore 308433, Singapore.	jthorat@hotmail.com					BULLOCK HR, 1998, J NEUROTRAUM, V13, P344; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Cormio M, 1999, J NEUROTRAUM, V16, P927, DOI 10.1089/neu.1999.16.927; Cruz J, 1996, J NEUROSURG, V85, P758, DOI 10.3171/jns.1996.85.5.0758; Cruz J, 2002, NEUROSURGERY, V50, P774, DOI 10.1097/00006123-200204000-00017; Czosnyka M, 1996, STROKE, V27, P1829, DOI 10.1161/01.STR.27.10.1829; EISENBERG HM, 1988, J NEUROSURG, V69, P15, DOI 10.3171/jns.1988.69.1.0015; Gupta AK, 2002, J NEUROSURG, V96, P263, DOI 10.3171/jns.2002.96.2.0263; Lang EW, 2003, J NEUROL NEUROSUR PS, V74, P1053, DOI 10.1136/jnnp.74.8.1053; Lang EW, 2003, CRIT CARE MED, V31, P267, DOI 10.1097/00003246-200301000-00042; LANGFITT TW, 1982, J NEUROSURG, V56, P19, DOI 10.3171/jns.1982.56.1.0019; MARMAROU A, 1987, J NEUROSURG, V66, P883, DOI 10.3171/jns.1987.66.6.0883; MARMAROU A, 1991, J NEUROSURG, V75, pS59, DOI 10.3171/sup.1991.75.1s.0s59; MARSHALL LF, 1979, J NEUROSURG, V50, P26, DOI 10.3171/jns.1979.50.1.0026; MASET AL, 1987, J NEUROSURG, V67, P832, DOI 10.3171/jns.1987.67.6.0832; McKinley BA, 1988, ACTA NEUROCHIR WIE S, V71, P177; MEIXENSBERGER J, 1993, ACTA NEUROCHIR, P58; Menzel M, 2003, J NEUROSURG ANESTH, V15, P33, DOI 10.1097/00008506-200301000-00006; Miller JD, 1992, NEUROSURG QUART, V2, P28; NILSSON L, 1975, ACTA ANAESTH SCAND, P18; NORDSTROM CH, 1988, J NEUROSURG, V68, P424, DOI 10.3171/jns.1988.68.3.0424; REA GL, 1983, NEUROSURGERY, V12, P401, DOI 10.1227/00006123-198304000-00005; REILLY P, 1997, HEAD INJURY, P385; SAUL TG, 1982, J NEUROSURG, V56, P498, DOI 10.3171/jns.1982.56.4.0498; SCHALEN W, 1992, ACTA ANAESTH SCAND, V36, P369, DOI 10.1111/j.1399-6576.1992.tb03483.x; Soukup J, 2002, J NEUROTRAUM, V19, P559, DOI 10.1089/089771502753754046; Steiner LA, 2003, J NEUROL NEUROSUR PS, V74, P765, DOI 10.1136/jnnp.74.6.765; Steiner LA, 2002, CRIT CARE MED, V30, P733, DOI 10.1097/00003246-200204000-00002; The Brain Trauma Foundation, 2000, J NEUROTRAUM, V17, P597, DOI [10.1089/neu.2000.17.597, DOI 10.1089/NEU.2000.17.597]; van den Brink WA, 1998, ACT NEUR S, V71, P190	30	22	23	0	2	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0967-5868	1532-2653		J CLIN NEUROSCI	J. Clin. Neurosci.	FEB	2008	15	2					143	148		10.1016/j.jocn.2006.08.014			6	Clinical Neurology; Neurosciences	Neurosciences & Neurology	256SH	WOS:000252749600009	17997313				2021-06-18	
J	Van de Voorde, P; Sabbe, M; Rizopoulos, D; Tsonaka, R; De Jaeger, A; Lesaffre, E; Peters, M				Van de Voorde, Patrick; Sabbe, Marc; Rizopoulos, Dimitris; Tsonaka, Roula; De Jaeger, Annick; Lesaffre, Emmanuel; Peters, Mark		PENTA Study Grp	Assessing the level of consciousness in children: A plea for the Glasgow Coma Motor subscore	RESUSCITATION			English	Article						Glasgow coma scale; child; brain injury	TRAUMATIC BRAIN-INJURY; SCALE SCORE; EMERGENCY-DEPARTMENT; RELIABILITY; TRIAGE	Aim: The Glasgow Coma Scale (GCS) is not always easy to score and its reliability has been questioned. In adults the GCS Motor score has proven a valuable alternative, as it is easier to assess yet shows similar predictive capacity for outcome. We wanted to test the non-inferiority of the Glasgow Coma Motor score GCS-M versus the Total score GCS-T for predicting outcome in children. Materials and methods: As part of the Flemish paediatric trauma registry (PENTA) we collected data on 96 consecutive children (0-18 years) with moderate to severe traumatic brain injury. Outcome was evaluated using a three level ordinal scale: [normal to mild disability, moderate to severe disability and death]. A number of proportional odds models were fitted for various choices of predictive variables (GCS-T, GCS-M, age, sex, and injury severity score ISS). For each model we calculated Somers' D(xy) rank correlation and NagelKerke's R(2)N index, both measures of the predictive performance of the model. Results: All. children had an injury to the brain that resulted in a hospital stay of more than 48 h. Half of them had a "best" initial GCS of 15; 60%, a Motor score of 6. The median Injury Severity Score ISS was 16. Outcome was 'normal to mild' in 79 children, 'moderate to severe' in 7, and 'death' in 10. D(xy) values were 0.983 for the model with the Motor score and 0.972 for that with the total GCS, indicating excellent predictive performance for both. R(2)N indices were 0.862 and 0.813, respectively. Overall the difference between all models was small. Conclusion: The GCS Motor subscore was shown to have at least the same predictive ability for outcome as the total GCS. It is our opinion that the total GCS is unnecessarily complicated (especiatly in children). Using the Motor score alone wilt improve scoring compliance and statistical performance. We do not believe that the reduction in number of potential scores from 13 to 6 would decrease the descriptive capacity significantly, since clinical algorithms typically group values of the total GCS into five or fewer ranges. (c) 2007 Elsevier Ireland Ltd. All rights reserved.	[Van de Voorde, Patrick; De Jaeger, Annick] UZ Gent, B-9000 Ghent, Belgium; [Sabbe, Marc; PENTA Study Grp] UZ Leuven Gasthuisberg, Dept Emergency Med, B-3000 Louvain, Belgium; [Rizopoulos, Dimitris; Tsonaka, Roula; Lesaffre, Emmanuel] Katholieke Univ Leuven, Sch Publ Hlth, Ctr Biostat, B-3000 Louvain, Belgium; [Peters, Mark] Great Ormond St Hosp Sick Children, Clin Unit Chair Resp & Emergency Med, London WC1N 3JH, England; [Peters, Mark] Inst Child Hlth, Crit Care Grp, Protex Unit, London WC1N 1EH, England	Van de Voorde, P (corresponding author), UZ Gent, PICU 1K12 IC,De Pintelaan 185, B-9000 Ghent, Belgium.	Patrick.vandevoorde@ugent.be	Rizopoulos, Dimitris/D-6919-2012; Peters, Mark/AAD-7518-2019	Rizopoulos, Dimitris/0000-0001-9397-0900; Peters, Mark/0000-0003-3653-4808			Al-Salamah MA, 2004, ACAD EMERG MED, V11, P834, DOI 10.1197/j.aem.2004.03.008; *AM ASS AUT MED, 1990, ABBR INJ SCAL 1990 R; Balestreri M, 2004, J NEUROL NEUROSUR PS, V75, P161; BORN JD, 1988, ACTA NEUROCHIR, V91, P1, DOI 10.1007/BF01400520; Browne G J, 2001, Emerg Med (Fremantle), V13, P418, DOI 10.1046/j.1035-6851.2001.00255.x; Buechler CM, 1998, J TRAUMA, V45, P429, DOI 10.1097/00005373-199809000-00001; FISER DH, 1992, J PEDIATR-US, V121, P68, DOI 10.1016/S0022-3476(05)82544-2; Gill M, 2005, ANN EMERG MED, V45, P37, DOI 10.1016/j.annemergmed.2004.07.429; Gill MR, 2004, ANN EMERG MED, V43, P215, DOI 10.1016/S0196-0644(03)00814-X; Guisan A, 2000, J VEG SCI, V11, P617, DOI 10.2307/3236568; HARRELL FE, 2001, REGRESSION MODELLING; Healey C, 2003, J TRAUMA, V54, P671, DOI 10.1097/01.TA.0000058130.30490.5D; Lenfant F, 1997, ANN FR ANESTH, V16, P239, DOI 10.1016/S0750-7658(97)86408-8; LIEHLAI MW, 1992, J PEDIATR-US, V120, P195, DOI 10.1016/S0022-3476(05)80426-3; MENEGAZZI JJ, 1993, J TRAUMA, V34, P46, DOI 10.1097/00005373-199301000-00008; MEREDITH W, 1995, J TRAUMA, V38, P129, DOI 10.1097/00005373-199501000-00030; Prasad K, 1996, J CLIN EPIDEMIOL, V49, P755, DOI 10.1016/0895-4356(96)00013-3; *R DEV COR TEAM, 2006, LANG ENV STAT COMP V; Ross SE, 1998, J TRAUMA, V45, P42, DOI 10.1097/00005373-199807000-00008; ROWLEY G, 1991, LANCET, V337, P535, DOI 10.1016/0140-6736(91)91309-I; *ROYAL COLL PAED C, 2001, GUID GOOD PRACT EARL; SIMPSON D, 1982, LANCET, V2, P450; Teoh LSG, 2000, INTENS CARE MED, V26, P157, DOI 10.1007/s001340050039; The Brain Trauma Foundation. The American Association of Neurological Surgeons, 2000, J Neurotrauma, V17, P563, DOI 10.1089/neu.2000.17.563; Wijdicks EFM, 2005, ANN NEUROL, V58, P585, DOI 10.1002/ana.20611	25	22	22	0	2	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0300-9572			RESUSCITATION	Resuscitation	FEB	2008	76	2					175	179		10.1016/j.resuscitation.2007.07.007			5	Critical Care Medicine; Emergency Medicine	General & Internal Medicine; Emergency Medicine	270RQ	WOS:000253738300005	17728046				2021-06-18	
J	Wang, VY; Manley, G				Wang, Vincent Y.; Manley, Geoffrey			Recognition of paroxysmal autonomic instability with dystonia (PAID) in a patient with traumatic brain injury	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article							DIENCEPHALIC SEIZURES; DYSAUTONOMIA; HYPERTHERMIA		[Wang, Vincent Y.; Manley, Geoffrey] Univ Calif San Francisco, Brain & Spinal Injury Ctr, Dept Neurol Surg, San Francisco, CA 94143 USA	Manley, G (corresponding author), Univ Calif San Francisco, San Francisco Gen Hosp, 1001 Potrero Ave, San Francisco, CA 94110 USA.	manleyg@neurosurg.ucsf.edu					Baguley IJ, 1999, J NEUROL NEUROSUR PS, V67, P39, DOI 10.1136/jnnp.67.1.39; Blackman JA, 2004, ARCH NEUROL-CHICAGO, V61, P321, DOI 10.1001/archneur.61.3.321; Boeve BF, 1998, MAYO CLIN PROC, V73, P148; BULLARD DE, 1987, ANN NEUROL, V21, P609, DOI 10.1002/ana.410210617; Cuny E, 2001, BRAIN INJURY, V15, P917, DOI 10.1080/02699050110065277; MEYTHALER JM, 1994, ARCH PHYS MED REHAB, V75, P816; PRANZATELLI MR, 1991, J CHILD NEUROL, V6, P115, DOI 10.1177/088307389100600204; Stocchetti N, 2002, INTENS CARE MED, V28, P1555, DOI 10.1007/s00134-002-1513-1; Thompson HJ, 2003, NEUROBIOL DIS, V12, P163, DOI 10.1016/S0969-9961(02)00030-X	9	22	23	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0022-5282			J TRAUMA	J. Trauma-Injury Infect. Crit. Care	FEB	2008	64	2					500	502		10.1097/TA.0b013e31804a5738			3	Critical Care Medicine; Surgery	General & Internal Medicine; Surgery	264KV	WOS:000253287100050	18301221				2021-06-18	
J	Greiffenstein, MF; Baker, WJ				Greiffenstein, Manfred F.; Baker, W. John			Validity testing in dually diagnosed post-traumatic stress disorder and mild closed head injury	CLINICAL NEUROPSYCHOLOGIST			English	Article; Proceedings Paper	110th Annual Convention of the American-Psychological-Association	AUG 22-25, 2002	CHICAGO, IL	Amer Psychol Assoc		dual diagnosis; late post-concussion syndrome; malingering; mild traumatic brain injury; noncredible scores; post-traumatic stress disorder; validity testing	TRAUMATIC BRAIN-INJURY; MALINGERED NEUROCOGNITIVE DYSFUNCTION; MOTOR-VEHICLE ACCIDENTS; RELIABLE DIGIT SPAN; FAKE BAD SCALE; NEUROPSYCHOLOGICAL TESTS; BASE RATES; CONCUSSION; MEMORY; MMPI-2	Prospects for the coexistence of post-traumatic stress syndrome (PTSS) and mild traumatic brain injury (mTBI) rely exclusively on subjective evidence, increasing the risk of response bias in a compensatable social context. Using a priori specificities derived from genuine brain disorder groups, we examined validity failure rates in three domains (symptom, cognitive, motor) in 799 persons reporting persistent subjective disability long after mild neurological injury. Validity tests included the Test of Memory Malingering, MMPI-2 Fake Bad Scale, and Infrequency (F) scales, reliable digit span, and Halstead-Reitan finger tapping. Analyses showed invalidity signs in large excess of actuarial expectations, with rising invalidity risk conditional on post-traumatic complexity; the highest failure rates were produced by the 95 persons reporting both neurogenic amnesia and re-experiencing symptoms. We propose an "over-endorsement continuum" hypothesis: The more complex the post-traumatic presentation after mild neurological injury, the stronger the association with response bias. Late-appearing dual diagnosis is a litigation phenomenon so intertwined with secondary gain as to be a byproduct of it.	[Greiffenstein, Manfred F.; Baker, W. John] Psychol Syst Inc, Royal Oak, MI USA	Greiffenstein, MF (corresponding author), 32121 Woodward,Suite 201, Royal Oak, MI 48073 USA.	mfgreiff@comcast.net					Alexander M. P., 1997, SEMIN CLIN NEUROPSYC, V2, P177; Alexander MP, 1998, NEUROLOGY, V51, P336, DOI 10.1212/WNL.51.2.336; American Psychiatric Association, 1994, DIAGN STAT MAN MENT; Arbisi P.A, 2004, PSYCHOL SERV, V1, P56, DOI DOI 10.1037/1541-1559.1.1.56; Arbisi PA, 1997, PSYCHOL ASSESSMENT, V9, P102, DOI 10.1037/1040-3590.9.2.102; Arnold G, 2005, CLIN NEUROPSYCHOL, V19, P105, DOI 10.1080/13854040490888567; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P345, DOI 10.1017/S1355617705050411; BENPORATH YS, 2006, MMPI 2 FAKE BAD SCAL; Berthier M L, 1998, Depress Anxiety, V8, P43, DOI 10.1002/(SICI)1520-6394(1998)8:1<43::AID-DA9>3.0.CO;2-6; Binder LM, 2004, J CLIN EXP NEUROPSYC, V26, P369, DOI 10.1080/13803390490510095; Binder LM, 1996, AM J PSYCHIAT, V153, P7; Blanchard EB, 1998, J TRAUMA STRESS, V11, P337, DOI 10.1023/A:1024407321677; Blanchard EB, 1998, J ANXIETY DISORD, V12, P21, DOI 10.1016/S0887-6185(97)00047-9; Boake C, 1996, J HEAD TRAUMA REHAB, V11, P98; BONTKE CF, 1996, J HEAD TRAUMA REHAB, V11, P98; Breslau N, 1998, ARCH GEN PSYCHIAT, V55, P626, DOI 10.1001/archpsyc.55.7.626; Bryant RA, 1996, J TRAUMA STRESS, V9, P621; Buckley TC, 2003, J TRAUMA STRESS, V16, P59, DOI 10.1023/A:1022063412056; Burges C, 2001, BRIT J CLIN PSYCHOL, V40, P209, DOI 10.1348/014466501163544; Butcher J. N., 1989, MMPI 2 MANUAL ADM SC; Butters MA, 1998, ARCH CLIN NEUROPSYCH, V13, P721, DOI 10.1016/S0887-6177(98)00010-9; Cohen J., 1988, STAT POWER ANAL BEHA, V2nd; DAHLSTROM WG, 1975, MMPI HDB, V1; DIKMEN SS, 1995, NEUROPSYCHOLOGY, V9, P80, DOI 10.1037/0894-4105.9.1.80; Duncan SA, 2002, ASSESSMENT, V9, P56, DOI 10.1177/1073191102009001007; Eisenman DP, 2003, JAMA-J AM MED ASSOC, V290, P627, DOI 10.1001/jama.290.5.627; Etherton J, 2005, ASSESSMENT, V12, P130, DOI 10.1177/1073191105274859; Etherton JL, 2005, ARCH CLIN NEUROPSYCH, V20, P375, DOI 10.1016/j.acn.2004.09.007; Friedland JF, 2001, J NERV MENT DIS, V189, P426, DOI 10.1097/00005053-200107000-00003; Greiffenstein M F, 1996, J Int Neuropsychol Soc, V2, P477; Greiffenstein M.F., 1994, PSYCHOL ASSESSMENT, V6, P218, DOI [https://doi.org/10.1037/1040-3590.6.3.218, DOI 10.1037/1040-3590.6.3.218]; Greiffenstein MF, 2006, LEGAL CRIMINOL PSYCH, V11, P131, DOI 10.1348/135532505X49828; Greiffenstein MF, 2004, CLIN NEUROPSYCHOL, V18, P573, DOI 10.1080/13854040490888512; GREIFFENSTEIN MF, 2007, ASSESSMENT FEIGNED C; Greve KW, 2006, CLIN NEUROPSYCHOL, V20, P491, DOI 10.1080/13854040590967144; Harris I, 2005, JAMA-J AM MED ASSOC, V293, P1644, DOI 10.1001/jama.293.13.1644; Harvey AG, 2000, AM J PSYCHIAT, V157, P626, DOI 10.1176/appi.ajp.157.4.626; HEATON RK, 1978, J CONSULT CLIN PSYCH, V46, P892, DOI 10.1037/0022-006X.46.5.892; Hickling E. J., 2002, J FORENSIC PSYCHOL P, V2, P33, DOI DOI 10.1300/J158V02N01_; Hickling EJ, 1997, BEHAV RES THER, V35, P191, DOI 10.1016/S0005-7967(96)00090-3; Iverson G., 2006, PSYCHOL INJURIES FOR, P76; Kelly JP, 1998, J HEAD TRAUMA REHAB, V13, P53, DOI 10.1097/00001199-199804000-00008; King NS, 1997, J NEUROL NEUROSUR PS, V62, P82, DOI 10.1136/jnnp.62.1.82; KOCH WJ, 2006, PSYCHOL INJURIES; Larrabee GJ, 2003, CLIN NEUROPSYCHOL, V17, P410, DOI 10.1076/clin.17.3.410.18089; LAYTON BS, 1995, CLIN NEUROPSYCHOL, V9, P2, DOI 10.1080/13854049508402050; LEESHALEY PR, 1991, PSYCHOL REP, V68, P203, DOI 10.2466/PR0.68.1.203-210; LEESHALEY PR, 1993, ARCH CLIN NEUROPSYCH, V8, P203, DOI 10.1016/0887-6177(93)90036-Z; Levin HS, 2001, J CLIN EXP NEUROPSYC, V23, P754, DOI 10.1076/jcen.23.6.754.1021; Lipsey M.W., 2001, PRACTICAL META ANAL; Maroon JC, 2000, NEUROSURGERY, V47, P659, DOI 10.1097/00006123-200009000-00027; Martin RC, 1996, J CLIN EXP NEUROPSYC, V18, P265, DOI 10.1080/01688639608408281; Mathias CW, 2002, ASSESSMENT, V9, P301, DOI 10.1177/1073191102009003009; McCauley SR, 2001, J CLIN EXP NEUROPSYC, V23, P792, DOI 10.1076/jcen.23.6.792.1016; MCGUIRE BE, 1999, PSYCHIAT PSYCHOL LAW, V6, P163; McMillan TM, 1996, BRAIN INJURY, V10, P749, DOI 10.1080/026990596124016; McNally RJ, 2004, PSYCHOL SCI, V15, P493, DOI 10.1111/j.0956-7976.2004.00707.x; MEEHL PE, 1955, PSYCHOL BULL, V52, P194, DOI 10.1037/h0048070; MILLER H, 1972, LANCET, V1, P580; Miller LJ, 2001, BRAIN INJURY, V15, P297, DOI 10.1080/026990501750111238; Mitrushina M., 2005, HDB NORMATIVE DATA N; Mittenberg W, 1996, ARCH CLIN NEUROPSYCH, V11, P271, DOI 10.1016/0887-6177(95)00040-2; Mittenberg W, 2002, J CLIN EXP NEUROPSYC, V24, P1094, DOI 10.1076/jcen.24.8.1094.8379; North C S, 2001, Mil Med, V166, P51; Ohry A, 1996, BRAIN INJURY, V10, P687, DOI 10.1080/026990596124106; OTHMER E, 1992, PSYCHIAT DIAGNOSTIC; OTHMER E, 1988, PSYCHIAT DIAGNOSTIC; Parker RS, 1996, BRAIN INJURY, V10, P287, DOI 10.1080/026990596124467; Peterson DI, 1998, NEUROLOGIST, V4, P131, DOI 10.1097/00127893-199805000-00004; Prigatano GP, 1997, ARCH CLIN NEUROPSYCH, V12, P609, DOI 10.1016/S0887-6177(97)00020-6; Rattok J, 1996, J HEAD TRAUMA REHAB, V11, P95, DOI 10.1097/00001199-199602000-00011; Rees LM, 2001, ARCH CLIN NEUROPSYCH, V16, P501, DOI 10.1016/S0887-6177(00)00064-0; Reitan R. M., 1993, HALSTED REITAN NEURO; Rogers R, 1990, Bull Am Acad Psychiatry Law, V18, P323; Rogers R., 1997, CLIN ASSESSMENT MALI, V2nd; Rosen G. M, 2005, SCI REV MENTAL HLTH, V3, P39; Rosen GM, 2004, PERS INDIV DIFFER, V36, P1291, DOI 10.1016/S0191-8869(03)00216-2; Rosen GM, 1996, B AM ACAD PSYCH LAW, V24, P267; ROSEN GM, 1995, PROF PSYCHOL-RES PR, V26, P82, DOI 10.1037/0735-7028.26.1.82; Ruiz MA, 2002, PROF PSYCHOL-RES PR, V33, P294, DOI 10.1037//0735-7028.33.3.294; SBORDONE RJ, 1995, BRAIN INJURY, V9, P405, DOI 10.3109/02699059509005780; Shaw NA, 2002, PROG NEUROBIOL, V67, P281, DOI 10.1016/S0301-0082(02)00018-7; Steiner H, 1997, J AM ACAD CHILD PSY, V36, P357, DOI 10.1097/00004583-199703000-00014; Straus SE., 2005, EVIDENCE BASED MED P, V3rd; TEASDALE G, 1974, LANCET, V2, P81; TOMBAUGH T, 1995, TESTS MEMORY MALINGE; van Hout MSE, 2003, NEUROTOXICOLOGY, V24, P547, DOI 10.1016/S0161-813X(03)00054-8; Vasterling J.J., 2005, NEUROPSYCHOLOGY PTSD, P178; Vasterling JJ, 2000, J TRAUMA STRESS, V13, P241, DOI 10.1023/A:1007754611030; Vasterling JJ, 1998, NEUROPSYCHOLOGY, V12, P125, DOI 10.1037/0894-4105.12.1.125; Verma S, 2001, INT J GERIATR PSYCH, V16, P356, DOI 10.1002/gps.333; World Health Organization, 1992, ICD 10 CLASS MENT BE; YOUNGJOHN JR, 1995, CLIN NEUROPSYCHOL, V9, P112, DOI 10.1080/13854049508401593; Youngjohn JR, 1997, PSYCHOL ASSESSMENT, V9, P177, DOI 10.1037/1040-3590.9.3.177	94	22	22	0	10	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1385-4046	1744-4144		CLIN NEUROPSYCHOL	Clin. Neuropsychol.		2008	22	3					565	582		10.1080/13854040701377810			18	Psychology, Clinical; Clinical Neurology; Psychology	Psychology; Neurosciences & Neurology	298LU	WOS:000255690000194	17853127				2021-06-18	
J	Kitagawa, Y; Yasuki, T; Hasegawa, J				Kitagawa, Yuichi; Yasuki, Tsuyoshi; Hasegawa, Junji			Research Study on Neck Injury Lessening with Active Head Restraint Using Human Body FE Model	TRAFFIC INJURY PREVENTION			English	Article						Rear Impacts; Neck Injury; Seats; Active Head Restraint		Objectives: The objective of this study is to examine the effectiveness of the active head restraint system in reducing neck injury risk of car occupants in low-speed rear impacts. Methods: A human body FE model "THUMS" was used to simulate head and neck kinematics of the occupant and to evaluate loading to the neck. Joint capsule strain was calculated to predict neck injury risk as well as NIC. The validity of the model was confirmed comparing its mechanical responses to those in human subjects in the literatures. Seat FE models were also prepared representing one with a fixed head restraint and the other one with an active head restraint system. The active head restraint system was designed to move the head restraint forward and upward when the lower unit was lower unit was loaded by the pelvis. Rear impact simulations were performed assuming a triangular acceleration pulse at a delta-V of 25 km/h. Results: The model reproduced similar head and neck motions to those measured in the human volunteer test, except for active muscular responses. The calculated joint capsule strain also showed a good match with those of PMHS tests in the literature. A rear-impact simulation was conducted using the model with the fixed head restraint. The result revealed that NIC was strongly correlated with the relative acceleration between the head and the torso and that its maximum peak appeared when the head contacted the head restraint. It was also found that joint capsule strain grew in later timing synchronizing with the relative displacement. Another simulation with the active head restraint system showed that both NIC and joint capsule strain were lowered owing to the forward and upward motion of the head restraint. A close investigation of the vertebral motion indicated that the active head restraint reduced the magnitude of shear deformation in the facet joint, which contributed to the strain growth in the fixed head restraint case. Conclusions: Rear-impact simulations were conducted using a human body FE model, THUMS, representing an average-size male occupant. The cervical system including the facet joint capsules was incorporated to the model. The validity of the model was examined comparing its mechanical responses to those in the literature such as the whole body motion of the volunteer subject and the vertebral motion in the PMHS tests. Rear-impact simulations were conducted using the validated THUMS model and two prototype seat models; one had a fixed head restraint and the other one was equipped with an active head restraint system. The active head restraint system works moving the head restraint forward and upward when the lower unit is loaded by the pelvis. The head and neck kinematics and responses were analyzed from the simulation results. The force and acceleration rose at the pelvis first, followed by T1 and the head. The early timing of force rise and its magnitude indicated that the pelvis force was a good trigger for the active head restraint system. The results showed that the head was supported earlier in a case with the active head restraint system, and both NIC and joint capsule strain were lowered. The study also analyzed the mechanism of strain growth in the joint capsules. Relatively greater strain was observed in the direction of the facet joint surface, which was around 45 degrees inclined to the spinal column. The forward and upward motion of the active head restraint were aligned with the direction of the joint deformation and contributed to lower strain in the joint capsules. The results indicated that the active head restraint could help reduce the neck injury risk not only by supporting the head at an early timing but also through its trajectory stopping the joint deformation.	[Kitagawa, Yuichi; Yasuki, Tsuyoshi] Toyota Motor Co Ltd, Toyota 4718572, Japan; [Hasegawa, Junji] Toyota Motor Co Ltd, Susono, Japan	Kitagawa, Y (corresponding author), Toyota Motor Co Ltd, 1 Toyota Cho, Toyota 4718572, Japan.	yuichi@kitagawa.tec.toyota.co.jp					Bostrom O., 1996, P IRCOBI C, P123; Deng B, 2000, Stapp Car Crash J, V44, P171; HASEGAWA J, 2004, P INT C BIOM IMP, P321; IWAMOTO M, 2002, P IRCOBI C, P31; JAKOBSSON L, 2004, THESIS CHALMERS U TE; *JAP NAT POL AG, 2004, TRAFF GREEN PAP 2003; KITAGAWA Y, 2007, P 20 ESV C; KITAGAWA Y, 2008, P WORLD C NECK PAIN; Kitagawa Yuichi, 2006, Stapp Car Crash J, V50, P545; KRAFT R, P INT C BIOM IMP, P221; Kullgren A., 2007, P 20 ESV C; Lee Kathryn E, 2004, Stapp Car Crash J, V48, P373; Lu Ying, 2005, Stapp Car Crash J, V49, P49; *MIN LAND INFR TRA, 2002, P 3 CAR SAF S; Ono K., 1997, P IRCOBI C, P223; SAWADA M, 2005, P 19 ESV C; SEKIZUKA M, 1998, P 16 ESV C; Siegmund G P, 2000, Stapp Car Crash J, V44, P159; SVENSSON Y, 1993, P INT C BIOM IMP, P189; WINKELSTEIN BA, 1999, P 43 STAPP CAR CRASH, P243; Yamada H, 1970, STRENGTH BIOL MAT; YOGANANDAN N, 1998, P 42 STAPP CAR CRASH	22	22	24	0	9	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1538-9588	1538-957X		TRAFFIC INJ PREV	Traffic Inj. Prev.		2008	9	6					574	582		10.1080/15389580802381954			9	Public, Environmental & Occupational Health; Transportation	Public, Environmental & Occupational Health; Transportation	387DN	WOS:000261932000011	19058105				2021-06-18	
J	Ord, JS; Greve, KW; Bianchini, KJ				Ord, Jonathan S.; Greve, Kevin W.; Bianchini, Kevin J.			Using the Wechsler Memory Scale-III to detect malingering in mild traumatic brain injury	CLINICAL NEUROPSYCHOLOGIST			English	Article						Wechsler scales; memory; malingering; response bias; neuropsychological assessment; traumatic brain injury	VERBAL-LEARNING TEST; RARELY MISSED INDEX; WMS-III; NEUROCOGNITIVE DYSFUNCTION; HEAD-INJURY; PERFORMANCE; VALIDATION; INDICATORS; SPECIFICITY; SENSITIVITY	This study examined the classification accuracy of the WMS-III primary indices in the detection of Malingered Neurocognitive Dysfunction (MND) in Traumatic Brain Injury (TBI) using a known-groups design. Sensitivity, specificity, and positive predictive power are presented for a range of index scores comparing mild TBI non-malingering (n = 34) and mild TBI malingering (n = 31) groups. A moderate/severe TBI non-malingering (n = 28) and general clinical group (n = 93) are presented to examine specificity in these samples. In mild TBI, sensitivities for the primary indices ranged from 26% to 68% at 97% specificity. Three systems used to combine all eight index scores were also examined and all achieved at least 58% sensitivity at 97% specificity in mild TBI. Specificity was generally lower in the moderate/severe TBI and clinical comparison groups. This study indicates that the WMS-III primary indices can accurately identify malingered neurocognitive dysfunction in mild TBI when used as part of a comprehensive classification system.	[Ord, Jonathan S.; Greve, Kevin W.; Bianchini, Kevin J.] Univ New Orleans Lakefront, Dept Psychol, New Orleans, LA 70148 USA; [Greve, Kevin W.; Bianchini, Kevin J.] Jefferson Neurobehav Grp, Metairie, LA USA	Greve, KW (corresponding author), Univ New Orleans Lakefront, Dept Psychol, New Orleans, LA 70148 USA.	kgreve@uno.edu					Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P215, DOI 10.1017/S1355617705050277; Bianchini KJ, 2006, CLIN NEUROPSYCHOL, V20, P831, DOI 10.1080/13854040600875203; Binder LM, 1996, AM J PSYCHIAT, V153, P7; Binder LM, 2003, J CLIN EXP NEUROPSYC, V25, P420, DOI 10.1076/jcen.25.3.420.13806; BUTCHER JN, 1989, MMPI, V2; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Curtis KL, 2006, ASSESSMENT, V13, P46, DOI 10.1177/1073191105285210; Glassmire DM, 2003, J CLIN EXP NEUROPSYC, V25, P465, DOI 10.1076/jcen.25.4.465.13875; Gouvier WD, 1998, CRIT ISS NE, P55; Greve KW, 2007, CLIN NEUROPSYCHOL, V21, P318, DOI 10.1080/13854040500488552; Greve KW, 2006, CLIN NEUROPSYCHOL, V20, P491, DOI 10.1080/13854040590967144; Greve KW, 2004, ARCH CLIN NEUROPSYCH, V19, P533, DOI 10.1016/j.acn.2003.08.002; Greve KW, 2003, ARCH CLIN NEUROPSYCH, V18, P245, DOI 10.1016/S0887-6177(02)00137-3; Greve KW, 2002, CLIN NEUROPSYCHOL, V16, P179, DOI 10.1076/clin.16.2.179.13241; HEATON RK, 2003, CLIN INTERPRETATION, V3, P181; Hennekens CH, 1987, EPIDEMIOLOGY MED; Iverson GL, 2005, CURR OPIN PSYCHIATR, V18, P301, DOI 10.1097/01.yco.0000165601.29047.ae; Killgore WDS, 2000, PSYCHOL REP, V86, P851, DOI 10.2466/PR0.86.3.851-857; Killgore WDS, 2000, J CLIN EXP NEUROPSYC, V22, P761; Lange RT, 2006, J CLIN EXP NEUROPSYC, V28, P294, DOI 10.1080/13803390490918156; Langeluddecke PM, 2005, J CLIN EXP NEUROPSYC, V27, P576, DOI 10.1080/13803390490918372; Langeluddecke PM, 2003, ARCH CLIN NEUROPSYCH, V18, P181, DOI 10.1016/S0887-6177(01)00195-0; LARRABEE GJ, 2007, EVALUATION MALINGERI, P334; LARRABEE GJ, 2005, FORENSIC NEUROPSYCHO, P115; Meyers J E, 2000, Appl Neuropsychol, V7, P133, DOI 10.1207/S15324826AN0703_3; Meyers JE, 2003, ARCH CLIN NEUROPSYCH, V18, P261, DOI 10.1016/S0887-6177(02)00136-1; Meyers JE, 2002, ARCH CLIN NEUROPSYCH, V17, P157, DOI 10.1016/S0887-6177(00)00107-4; Miller LJ, 2004, CLIN NEUROPSYCHOL, V18, P327, DOI 10.1080/13854040490501592; Millis S. R., 2004, PRINCIPLES PRACTICE, P1077; Millis SR, 1995, PSYCHOL ASSESSMENT, V7, P463; Mittenberg W, 2002, J CLIN EXP NEUROPSYC, V24, P1094, DOI 10.1076/jcen.24.8.1094.8379; Rabin LA, 2005, ARCH CLIN NEUROPSYCH, V20, P33, DOI 10.1016/j.acn.2004.02.005; Schretlen DJ, 2003, INT REV PSYCHIATR, V15, P341, DOI 10.1080/09540260310001606728; Slick DJ, 1999, CLIN NEUROPSYCHOL, V13, P545, DOI 10.1076/1385-4046(199911)13:04;1-Y;FT545; The Mild Traumatic Brain Injury Committee of the Head Injury Interdisciplinary Special Interest Group of the American Congress of Rehabilitation Medicine, 1993, J HEAD TRAUMA REHAB, V8, P86; Tombaugh TN, 1996, TEST MEMORY MALINGER; Wechsler D., 1997, WMS 3 WECHSLER MEMOR; Wechsler D, 1997, WAIS 3 ADM SCORING M	38	22	22	0	2	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1385-4046	1744-4144		CLIN NEUROPSYCHOL	Clin. Neuropsychol.		2008	22	4					689	704		10.1080/13854040701425437			16	Psychology, Clinical; Clinical Neurology; Psychology	Psychology; Neurosciences & Neurology	321WH	WOS:000257336700008	17853130				2021-06-18	
J	Shuttleworth-Edwards, AB; Smith, I; Radloff, SE				Shuttleworth-Edwards, Ann B.; Smith, Ian; Radloff, Sarah E.			Neurocognitive vulnerability amongst university rugby players versus noncontact sport controls	JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY			English	Article						Mild traumatic brain injury; Sports concussion; Rugby Union	TRAUMATIC BRAIN-INJURY; FOOTBALL SOCCER PLAY; NEUROPSYCHOLOGICAL IMPAIRMENT; COGNITIVE IMPAIRMENT; HEAD TRAUMA; CONCUSSION; RECOVERY; IMPACT; PERFORMANCE; SCHOOL	University rugby players were compared with IQ-equivalent noncontact sports controls on memory and attentional tasks at the pre- and postseason intervals. Results revealed significant lowering for rugby players relative to controls at the postseason interval for attentional tasks with a speeded visuomotor component (ImPACT Visual Motor Speed; Trail Making Test, TMT, A and B). There was a practice effect for controls only between the pre- and postseason intervals for attentional tasks that commonly reveal improvements after a long retest interval (TMT A and B; Digits Backwards). Medium to large effect sizes implicate clinically relevant cognitive vulnerability for university-level rugby players in association with years of exposure to repetitive concussive injury.	[Shuttleworth-Edwards, Ann B.] Rhodes Univ, Psychol Clin, Dept Psychol, ZA-6139 Grahamstown, South Africa; [Radloff, Sarah E.] Rhodes Univ, Dept Stat, ZA-6139 Grahamstown, South Africa	Shuttleworth-Edwards, AB (corresponding author), Rhodes Univ, Psychol Clin, Dept Psychol, ZA-6139 Grahamstown, South Africa.	a.edwards@ru.ac.za			South African National Research Foundation (NRF)National Research Foundation - South Africa; Rhodes University Council	This research was funded by the South African National Research Foundation (NRF) and a Rhodes University Council Grant. Thanks are due to: coresearchers Stephanie Case and Melissa Boulind who assisted in the data collection; Andre Kock for scoring assistance and editing; and Professor Mark Lovell, Director of the University of Pittsburgh Medical School Sports Concussion Center for donation of the ImPACT software for the purposes of the research. The first author is commercially involved in concussion management in South Africa, using the ImPACT program.	Abreau F, 1990, NEUROPSYCHOLOGY, V4, P175, DOI 10.1037/0894-4105.4.3.175; Anderson V, 2005, BRAIN INJURY, V19, P459, DOI 10.1080/02699050400004823; Barth JT., 1989, MILD HEAD INJURY, P257; Bathgate A, 2002, BRIT J SPORT MED, V36, P265, DOI 10.1136/bjsm.36.4.265; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P345, DOI 10.1017/S1355617705050411; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P215, DOI 10.1017/S1355617705050277; Bieliauskas LA, 2007, J INT NEUROPSYCH SOC, V13, P687, DOI 10.1017/S1355617707070877; Binder LM, 1997, J CLIN EXP NEUROPSYC, V19, P432, DOI 10.1080/01688639708403871; Briscoe J H, 1985, Br J Sports Med, V19, P67; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; CASSON IR, 1982, J NEUROL NEUROSUR PS, V45, P170, DOI 10.1136/jnnp.45.2.170; Catroppa C, 2005, J INT NEUROPSYCH SOC, V11, P84, DOI 10.1017/S1355617705050101; Cumming G, 2001, EDUC PSYCHOL MEAS, V61, P532, DOI 10.1177/0013164401614002; Cumming G, 2001, EXPLORATORY SOFTWARE; Cysique LA, 2007, J INT NEUROPSYCH SOC, V13, P1, DOI 10.1017/S1355617707070026; Delaney JS, 2005, J EMERG MED, V29, P189, DOI 10.1016/j.jemermed.2005.01.020; DELANEY JS, 2007, BRIT J SPORTS MED; Delaney TS, 2002, CLIN J SPORT MED, V12, P331, DOI 10.1097/00042752-200211000-00003; Downs DS, 2002, J SPORT MED PHYS FIT, V42, P103; Farace E, 2003, J INT NEUROPSYCH SOC, V9, P207; Frencham KAR, 2005, J CLIN EXP NEUROPSYC, V27, P334, DOI 10.1080/13803390490520328; Ganesalingam K, 2006, J INT NEUROPSYCH SOC, V12, P609, DOI 10.1017/S1355617706060796; Grindel SH, 2001, CLIN J SPORT MED, V11, P134, DOI 10.1097/00042752-200107000-00003; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Guskiewicz KM, 2002, AM J SPORT MED, V30, P157, DOI 10.1177/03635465020300020201; HILLIS WS, 1994, BRIT MED J, V309, P657, DOI 10.1136/bmj.309.6955.657; Iverson GL, 2006, BRIT J SPORT MED, V40, P72, DOI 10.1136/bjsm.2005.020651; Iverson GL, 2005, J CLIN EXP NEUROPSYC, V27, P683, DOI 10.1081/13803390490918435; Iverson GL, 2004, BRAIN INJURY, V18, P433, DOI 10.1080/02699050310001617352; Iverson GL, 2002, ARCH CLIN NEUROPSYCH, V17, P770; IVERSON GL, 2002, IMMEDIATE POSTCONCUS; Kelly JP, 1997, NEUROLOGY, V48, P581; Kibby MY, 1996, BRAIN INJURY, V10, P159, DOI 10.1080/026990596124494; Killam C, 2005, ARCH CLIN NEUROPSYCH, V20, P599, DOI 10.1016/j.acn.2005.02.001; KNIGHT RG, 1992, NEUROPSYCHOLOGY DEGE; KRULL KR, 1995, CLIN NEUROPSYCHOL, V9, P83, DOI 10.1080/13854049508402063; Kutner KC, 2000, NEUROSURGERY, V47, P651, DOI 10.1097/00006123-200009000-00026; Lezak M.D., 2004, NEUROPSYCHOLOGICAL A, Vfourth; LINGARD DA, 1976, NEW ZEAL MED J, V83, P69; Lovell MR, 1999, CLIN J SPORT MED, V9, P193, DOI 10.1097/00042752-199910000-00002; Lovell MR., 2000, IMPACT IMMEDIATE POS; Maroon JC, 2000, NEUROSURGERY, V47, P659, DOI 10.1097/00006123-200009000-00027; Maroon Joseph C, 2002, Clin Neurosurg, V49, P319; Matser EJT, 1999, JAMA-J AM MED ASSOC, V282, P971, DOI 10.1001/jama.282.10.971; Matser JT, 1998, NEUROLOGY, V51, P791, DOI 10.1212/WNL.51.3.791; Matser JT, 2001, J CLIN EXP NEUROPSYC, V23, P770, DOI 10.1076/jcen.23.6.770.1029; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; Mitrushina M., 2005, HDB NORMATIVE DATA N; NATHAN M, 1983, S AFR MED J, V64, P132; Pettersen JA, 2000, PSYCHOBIOLOGY, V28, P81; Powell JW, 1999, JAMA-J AM MED ASSOC, V282, P958, DOI 10.1001/jama.282.10.958; Reitan RM, 1999, ARCH CLIN NEUROPSYCH, V14, P191, DOI 10.1016/S0887-6177(98)00012-2; Reitan RM, 1979, MANUAL ADM NEUROPSYC; Ruff R, 2005, J HEAD TRAUMA REHAB, V20, P5, DOI 10.1097/00001199-200501000-00003; Rutherford A, 2005, J CLIN EXP NEUROPSYC, V27, P299, DOI 10.1080/13803390490515504; Rutherford A, 2003, NEUROPSYCHOL REV, V13, P153, DOI 10.1023/A:1025525613477; Satz P., 1993, NEUROPSYCHOLOGY, V7, P273, DOI DOI 10.1037/0894-4105.7.3.273; Schatz P, 2006, ARCH CLIN NEUROPSYCH, V21, P91, DOI 10.1016/j.acn.2005.08.001; Schretlen DJ, 2003, INT REV PSYCHIATR, V15, P341, DOI 10.1080/09540260310001606728; SEWARD H, 1993, MED J AUSTRALIA, V159, P298, DOI 10.5694/j.1326-5377.1993.tb137863.x; Shuttleworth-Edwards A, 2004, STUD NEUROPSYCHOL DE, P149; Shuttleworth-Jordan AB, 1993, P 5 NAT NEUR C S AFR, P38; SHUTTLEWORTHEDW.AB, 2008, CLIN J SPORT M UNPUB; Stephens R, 2005, CHILD NEUROPSYCHOL, V11, P513, DOI 10.1080/092970490959629; Stern Y, 2002, J INT NEUROPSYCH SOC, V8, P448, DOI 10.1017/S1355617702813248; Strauss E., 2006, COMPENDIUM NEUROPSYC, V3rd; Webbe FM, 2003, APPL NEUROPSYCHOL, V10, P31, DOI 10.1207/S15324826AN1001_5; Wechsler D, 1997, WAIS 3 ADM SCORING M; Witol AD, 2003, ARCH CLIN NEUROPSYCH, V18, P397, DOI 10.1016/S0887-6177(02)00151-8	69	22	22	2	9	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1380-3395	1744-411X		J CLIN EXP NEUROPSYC	J. Clin. Exp. Neuropsychol.		2008	30	8					870	884		10.1080/13803390701846914			15	Psychology, Clinical; Clinical Neurology; Psychology	Psychology; Neurosciences & Neurology	362OJ	WOS:000260206700002	18608657				2021-06-18	
J	Garcia-Molina, A; Tirapu-Ustarroz, J; Roig-Rovira, T				Garcia-Molina, Alberto; Tirapu-Ustarroz, Javier; Roig-Rovira, Teresa			Ecological validity and assessment of executive function	ANALES DE PSICOLOGIA			Spanish	Article						executive functions; ecological validity; brain injury; dysexecutive syndrome	FRONTAL-LOBE DAMAGE; TRAUMATIC BRAIN-INJURY; DUAL-TASK PERFORMANCE; NEUROPSYCHOLOGICAL TESTS; COMMUNITY INTEGRATION; DYSEXECUTIVE SYNDROME; SCHIZOPHRENIA; DEFICITS; LESIONS; SCORES	Ecological validity has become an increasingly important focus in neuropsychological assessment with particular relevance for the executive functions. Appropriate assessment of executive functions is critical to predict successful everyday functioning and psychosocial integration. This article reviews the research in ecological validity of neuropsychological assessment of executive function. The research suggests that many executive tests have a moderate level of ecological validity when predicting everyday cognitive functioning. Environmental cognitive demands and compensatory strategy use do appear to affect the ability of neuropsychological tests to predict real world behaviour. This paper discusses the ecological validity of assessment of executive functions and implications for the future assessment of executive functioning. Further research is required to identify the role of several variables in determining the ecological validity of clinical neuropsychological tests of executive function. Some suggestions were offered for the purpose of guiding clinical research.	[Garcia-Molina, Alberto; Roig-Rovira, Teresa] Inst Univ Neurorehabilitacio Guttmann UAB, Badalona 08916, Spain; [Tirapu-Ustarroz, Javier] Serv Neuropsicol, Navarra, Spain	Garcia-Molina, A (corresponding author), Inst Univ Neurorehabilitacio Guttmann UAB, Cami Can Ruti S-N, Badalona 08916, Spain.	agarciam.investigacio@guttmann.com					Acker MB, 1989, NEUROPSYCHOLOGY, V3, P123, DOI 10.1037//0894-4105.3.3.123; Acker MB, 1990, NEUROPSYCHOLOGY EVER, P19; Alderman N, 2003, J INT NEUROPSYCH SOC, V9, P31, DOI 10.1017/S1355617703910046; ANDERSON SW, 1991, J CLIN EXP NEUROPSYC, V13, P909, DOI 10.1080/01688639108405107; Baddeley A, 1997, NEUROPSYCHOLOGY, V11, P187, DOI 10.1037/0894-4105.11.2.187; BECHARA A, 1994, COGNITION, V50, P7, DOI 10.1016/0010-0277(94)90018-3; BERNABEU M, 1999, REHABILITACION TRAUM; Bird CM, 2004, BRAIN, V127, P914, DOI 10.1093/brain/awh108; Burgess PW, 1996, CORTEX, V32, P241, DOI 10.1016/S0010-9452(96)80049-9; Burgess PW, 2006, J INT NEUROPSYCH SOC, V12, P194, DOI 10.1017/S1355617706060310; Burgess PW, 1998, J INT NEUROPSYCH SOC, V4, P547, DOI 10.1017/S1355617798466037; Burgess PW, 1996, NEUROPSYCHOLOGIA, V34, P263, DOI 10.1016/0028-3932(95)00104-2; Burgess PW, 2000, PSYCHOL RES-PSYCH FO, V63, P279, DOI 10.1007/s004269900006; Burgess PW, 2000, NEUROPSYCHOLOGIA, V38, P848, DOI 10.1016/S0028-3932(99)00134-7; Chaytor N, 2006, ARCH CLIN NEUROPSYCH, V21, P217, DOI 10.1016/j.acn.2005.12.002; Chaytor N, 2003, NEUROPSYCHOL REV, V13, P181, DOI 10.1023/B:NERV.0000009483.91468.fb; CRIPE LI, 1998, ECOLOGICAL VALIDITY, P171; Dimitrov M, 1996, CORTEX, V32, P357, DOI 10.1016/S0010-9452(96)80057-8; Duncan John, 1995, P721; Dywan J, 1996, J HEAD TRAUMA REHAB, V11, P79, DOI 10.1097/00001199-199604000-00008; ESLINGER PJ, 1985, NEUROLOGY, V35, P1731, DOI 10.1212/WNL.35.12.1731; Evans JJ, 1997, PSYCHOL MED, V27, P635, DOI 10.1017/S0033291797004790; Franzen M. D., 1998, ECOLOGICAL VALIDITY, P91; Garcia-Villamisar D., 2000, REV COMPLUTENSE ED, V11, P39; Gioia GA, 2004, DEV NEUROPSYCHOL, V25, P135, DOI 10.1207/s15326942dn2501&2_8; Goel V, 1997, BRAIN, V120, P1805, DOI 10.1093/brain/120.10.1805; Goldberg E, 2000, J CLIN EXP NEUROPSYC, V22, P56, DOI 10.1076/1380-3395(200002)22:1;1-8;FT056; Goldberg E., 2002, CEREBRO EJECUTIVO LO; GOLDBERG TE, 1988, INT J NEUROSCI, V42, P51, DOI 10.3109/00207458808985758; GOLDBERG TE, 1988, SCHIZOPHRENIA BULL, V14, P179, DOI 10.1093/schbul/14.2.179; GOLDEN CH, 1974, STROOP COLOUR WORD T; Hanks RA, 1999, ARCH PHYS MED REHAB, V80, P1030, DOI 10.1016/S0003-9993(99)90056-4; Heaton R., 1993, WISCONSIN CARD SORTI; Jarvis PE., 1994, HALSTEAD REITAN NEUR; JONESGOTMAN M, 1977, NEUROPSYCHOLOGIA, V15, P653, DOI 10.1016/0028-3932(77)90070-7; LEZAK MD, 1982, INT J PSYCHOL, V17, P281, DOI 10.1080/00207598208247445; Long C.J., 1995, ADV MED PSYCHOTHERAP, V8, P59; LONG CJ, 1998, ECOLOGICAL VALIDITY, P1; Luria, 1973, WORKING BRAIN INTRO; Mahurin RK, 1998, PSYCHIAT RES, V79, P139, DOI 10.1016/S0165-1781(98)00031-6; MARTZKE JS, 1991, NEUROPSYCHOLOGY, V5, P213, DOI DOI 10.1037/0894-4105.5.3.213; MCPHEETERS HL, 1984, COMMUNITY MENT HLT J, V20, P44; Mecklinger A, 1999, J CLIN EXP NEUROPSYC, V21, P606, DOI 10.1076/jcen.21.5.606.873; MESULAM MM, 1986, ANN NEUROL, V19, P320, DOI 10.1002/ana.410190403; Metzler C, 2000, NEUROPSYCHOLOGIA, V38, P363, DOI 10.1016/S0028-3932(99)00097-4; Millis S R, 1994, Int J Neurosci, V79, P165; Munoz Cespedes J. M., 2001, REHABILITACION NEURO; Norris G, 2000, NEUROPSYCHOL REHABIL, V10, P33, DOI 10.1080/096020100389282; Odhuba RA, 2005, BRIT J CLIN PSYCHOL, V44, P269, DOI 10.1348/014466505X29431; Poole JH, 1999, PSYCHIAT RES, V85, P161, DOI 10.1016/S0165-1781(98)00146-2; Robertson I. H., 1994, TEST EVERYDAY ATTENT; Ross S R, 1997, Appl Neuropsychol, V4, P165, DOI 10.1207/s15324826an0403_4; Sbordone R. J., 1998, ECOLOGICAL VALIDITY, P15; Sbordone RJ, 1999, STUD NEUROPSYCHOL DE, P227; SHALLICE T, 1991, BRAIN, V114, P727, DOI 10.1093/brain/114.2.727; SHALLICE T, 1982, PHILOS T ROY SOC B, V298, P199, DOI 10.1098/rstb.1982.0082; SHORDONE RJ, 1997, NEUROPSYCHOLOGY HDB, V1, P365; STOKES N, 2003, BRAIN INJURY, V17, P174; THURSTONE LL, 1962, THURSTONE WORD FLUEN; TIRAPU J, 1996, ANAL PSIQUIATRIA, V12, P397; Tirapu-Ustarroz J, 2002, REV NEUROLOGIA, V34, P673, DOI 10.33588/rn.3407.2001311; Verdejo A, 2004, REV NEUROLOGIA, V39, P60, DOI 10.33588/rn.3901.2004229; Vilkki J, 1996, NEUROPSYCHOLOGIA, V34, P1051, DOI 10.1016/0028-3932(96)00028-0; WANG PL, 1986, CLIN NEUROPSYCHOLOGY; WILLER B, 1994, AM J PHYS MED REHAB, V73, P103; Wilson B., 1987, BEHAV INATTENTION TE; Wilson B. A., 1985, RIVERMEAD BEHAV MEMO; Wilson BA, 1996, BEHAV ASSESSMENT DYS; Wood RL, 2006, ARCH CLIN NEUROPSYCH, V21, P429, DOI 10.1016/j.acn.2005.06.014; Woodard CB, 2004, J PERINAT NEONAT NUR, V18, P329, DOI 10.1097/00005237-200410000-00003	70	22	29	1	19	UNIV MURCIA	MURCIA	SOC ESPANOLA HISTORIA AGRARIA, CAMPUS ESPINARDO, MURCIA, 30100, SPAIN	0212-9728	1695-2294		AN PSICOL-SPAIN	An. Psicol.	DEC	2007	23	2					289	299					11	Psychology; Psychology, Multidisciplinary	Psychology	324SN	WOS:000257538700016		DOAJ Gold			2021-06-18	
J	Rite, I; Arguelles, S; Venero, JL; Garcia-Rodriguez, S; Ayala, A; Cano, J; Machado, A				Rite, I.; Argueelles, S.; Venero, J. L.; Garcia-Rodriguez, S.; Ayala, A.; Cano, J.; Machado, A.			Proteomic identification of biomarkers in the cerebrospinal fluid in a rat model of nigrostriatal dopaminergic degeneration	JOURNAL OF NEUROSCIENCE RESEARCH			English	Article						haptoglobin; transthyretin; Apo E; rat cerebrospinal fluid; nigrostriatal dopaminergic system; axotomy; Parkinson's disease; substantia nigra; proteome	TRAUMATIC BRAIN-INJURY; AMYLOID-BETA-PROTEIN; APOLIPOPROTEIN-E; ALZHEIMERS-DISEASE; PARKINSONS-DISEASE; GENE-EXPRESSION; TRANSTHYRETIN; SYSTEM; DEMENTIA; CSF	We have performed proteomic analysis in the cerebrospinal fluid in an animal model of Parkinson's disease induced by axotomy of the medial forebrain bundle. In this model, the degeneration of dopaminergic neurons was completed in 14 days, with a loss of about 50% dopaminergic neurons in the substantia nigra and a loss of more than 80% dopamine terminals in the striatum, with a similar diminution of dopamine levels in both structures. Proteins were separated by 2D electrophoresis and identified by matrix-assisted laser desorption-ionization time-of-flight (MALDI-TOF). We found significant increases of haptoglobin and transthyretin along with a decrease of Apo E concentrations in the cerebrospinal fluid of axotomized animals. Changes for haptoglobin and transthyretin were further confirmed in cerebrospinal fluid and plasma by Western blotting. These results suggest that monitoring plasma levels of these signals appears to be a promising biological marker of neuronal degeneration of the nigrostriatal dopaminergic system. (C) 2007 Wiley-Liss, Inc.	[Rite, I.; Argueelles, S.; Venero, J. L.; Garcia-Rodriguez, S.; Ayala, A.; Cano, J.; Machado, A.] Univ Seville, Fac Farm, Dept Bioquim Bromatol & Toxicol, E-41012 Seville, Spain	Machado, A (corresponding author), Univ Seville, Fac Farm, Dept Bioquim, C Prof Garcia Gonzalez 2, E-41012 Seville, Spain.	machado@us.es	IBIS, ENVEJECIMIENTO/O-9381-2015; Ayala, Antonio/N-7591-2019; Arguelles, Sandro/Y-6343-2019; Venero, Jose/E-9979-2015	Ayala, Antonio/0000-0001-9711-3711; Arguelles, Sandro/0000-0001-8450-3227; Venero, Jose/0000-0003-1137-8706			BLENNOW K, 1994, NEUROREPORT, V5, P2534, DOI 10.1097/00001756-199412000-00032; CARLSSON J, 1991, CLIN CHIM ACTA, V196, P167, DOI 10.1016/0009-8981(91)90070-S; Choe LH, 2002, ELECTROPHORESIS, V23, P2242, DOI 10.1002/1522-2683(200207)23:14<2242::AID-ELPS2242>3.0.CO;2-F; Consiglio AR, 2000, BRAIN RES PROTOC, V5, P109, DOI 10.1016/S1385-299X(99)00062-8; Conti A, 2004, J NEUROTRAUM, V21, P854, DOI 10.1089/0897715041526212; Danik M, 1999, CRIT REV NEUROBIOL, V13, P357, DOI 10.1615/CritRevNeurobiol.v13.i4.20; Davidsson P, 2002, MOL BRAIN RES, V109, P128, DOI 10.1016/S0169-328X(02)00549-1; DIEDRICH JF, 1991, J VIROL, V65, P4759, DOI 10.1128/JVI.65.9.4759-4768.1991; DIVINO CM, 1990, J BIOL CHEM, V265, P1425; do Nascimento CO, 2004, BIOCHEM BIOPH RES CO, V313, P702, DOI 10.1016/j.bbrc.2003.12.008; Farrer M, 2005, NEUROLOGY, V65, P738, DOI 10.1212/01.WNL.0000169023.51764.b0; FRYER HJL, 1986, ANAL BIOCHEM, V153, P262, DOI 10.1016/0003-2697(86)90090-4; Fujita K, 1998, BRAIN RES, V785, P31, DOI 10.1016/S0006-8993(97)00612-4; Fukuyama R, 2000, EUR NEUROL, V43, P161, DOI 10.1159/000008157; Hamilton JA, 2001, CELL MOL LIFE SCI, V58, P1491, DOI 10.1007/PL00000791; HANDELMANN GE, 1992, J LIPID RES, V33, P1677; Herrera AJ, 2000, NEUROBIOL DIS, V7, P429, DOI 10.1006/nbdi.2000.0289; Hund E, 2001, NEUROLOGY, V56, P431, DOI 10.1212/WNL.56.4.431; INGENBLEEK Y, 1994, ANNU REV NUTR, V14, P495, DOI 10.1146/annurev.nu.14.070194.002431; Jenner P, 1998, MOVEMENT DISORD, V13, P24; Jiang L, 2003, AMINO ACIDS, V25, P49, DOI 10.1007/s00726-003-0356-6; Johnson Ginger, 1992, Applied and Theoretical Electrophoresis, V3, P47; Kay AD, 2003, J NEUROTRAUM, V20, P943, DOI 10.1089/089771503770195795; Kay AD, 2003, J NEUROTRAUM, V20, P243, DOI 10.1089/089771503321532824; Landen M, 1996, DEMENTIA, V7, P273, DOI 10.1159/000106892; Lee MY, 2002, J CEREBR BLOOD F MET, V22, P1176; Lesage S, 2005, AM J HUM GENET, V77, P330, DOI 10.1086/432422; Li MD, 2000, J NEUROSCI, V20, P1318; Lim KL, 2003, IUBMB LIFE, V55, P315, DOI 10.1080/1521654031000153030; Liverman CS, 2004, MOL BRAIN RES, V126, P57, DOI 10.1016/j.molbrainres.2004.02.028; Long Y, 2003, J NEUROSCI RES, V71, P710, DOI 10.1002/jnr.10524; MAHLEY RW, 1988, SCIENCE, V240, P622, DOI 10.1126/science.3283935; MAZURKOLECKA B, 1995, BRAIN RES, V698, P217, DOI 10.1016/0006-8993(95)00873-O; Merched A, 1998, FEBS LETT, V425, P225, DOI 10.1016/S0014-5793(98)00234-8; Moore DJ, 2005, ANNU REV NEUROSCI, V28, P57, DOI 10.1146/annurev.neuro.28.061604.135718; Piccini P, 2004, LANCET NEUROL, V3, P284, DOI 10.1016/S1474-4422(04)00736-7; PIRTTILA T, 1994, J NEUROL SCI, V127, P90, DOI 10.1016/0022-510X(94)90140-6; POIRIER J, 1994, TRENDS NEUROSCI, V17, P525, DOI 10.1016/0166-2236(94)90156-2; Reiber H, 2001, CLIN CHIM ACTA, V310, P173, DOI 10.1016/S0009-8981(01)00573-3; Revuelta M, 1997, GLIA, V21, P204, DOI 10.1002/(SICI)1098-1136(199710)21:2<204::AID-GLIA4>3.0.CO;2-6; RIISOEN H, 1988, ACTA NEUROL SCAND, V78, P455, DOI 10.1111/j.1600-0404.1988.tb03687.x; ROHIFF C, 2000, ELECTROPHORESIS, V21, P1227; Saraiva MJM, 2001, FEBS LETT, V498, P201, DOI 10.1016/S0014-5793(01)02480-2; SCHWARZMAN AL, 1994, P NATL ACAD SCI USA, V91, P8368, DOI 10.1073/pnas.91.18.8368; Serot J M, 1997, Ann N Y Acad Sci, V826, P507, DOI 10.1111/j.1749-6632.1997.tb48514.x; Serot JM, 1997, J NEUROL NEUROSUR PS, V63, P506, DOI 10.1136/jnnp.63.4.506; SNIPS GJ, 1986, P NATL ACAD SCI USA, V83, P1130, DOI 10.1073/pnas.83.4.1130; STCLAIR D, 1994, NEUROSCI LETT, V176, P45, DOI 10.1016/0304-3940(94)90867-2; SWANSON LW, 1980, NEUROENDOCRINOLOGY, V31, P410, DOI 10.1159/000123111; TAN EK, 2007, IN PRESS HUM MUTAT; Tanner CM, 1996, NEUROL CLIN, V14, P317, DOI 10.1016/S0733-8619(05)70259-0; Teunissen CE, 2005, LANCET NEUROL, V4, P32, DOI 10.1016/S1474-4422(04)00964-0; Venero JL, 1997, J NEUROCHEM, V68, P2458; Venero JL, 2003, FREE RADICAL BIO MED, V34, P111, DOI 10.1016/S0891-5849(02)01191-7; Westman-Brinkmalm A, 2002, ANAL BIOCHEM, V301, P161, DOI 10.1006/abio.2001.5487	55	22	24	0	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0360-4012	1097-4547		J NEUROSCI RES	J. Neurosci. Res.	DEC	2007	85	16					3607	3618		10.1002/jnr.21452			12	Neurosciences	Neurosciences & Neurology	243EP	WOS:000251778200012	17705290				2021-06-18	
J	Bellinger, DC				Bellinger, David C.			Lead neurotoxicity in children: Decomposing the variability in dose-effect relationships	AMERICAN JOURNAL OF INDUSTRIAL MEDICINE			English	Article; Proceedings Paper	Workshop on Neurotoxic Metals - Lead, Mercury and Manganese	JUN 17-18, 2006	Brescia, ITALY	ICOH, Sci Comm Toxicol Metals, ICOH, Sci Comm Neurotoxicol & Psychophysiol		lead; children; neurotoxicity	AMINOLEVULINIC-ACID DEHYDRATASE; ENVIRONMENTAL-HEALTH DISPARITIES; PHYSIOLOGICALLY-BASED MODELS; TRAUMATIC BRAIN-INJURY; BONE-SEEKING ELEMENTS; BLOOD-LEAD; ENRICHED ENVIRONMENT; INFANT DEVELOPMENT; MOUSE MODEL; GENETIC SUSCEPTIBILITY	Background Enormous progress has been made in recent decades in our understanding of lead neurotoxicology in children, but an important obstacle to additional progress is the striking variability that is evident in any plot of a lead biomarker versus a health endpoint. Methods In this article, three potential sources of variability are identified: (1) errors or imprecision in characterizing dose (and/or outcome); (2) incomplete characterization of endpoint variance attributable to factors other than lead; and (3) inter-individual differences in susceptibility to lead neurotoxicity. Results Strategies are suggested for reducing the variability contributed by these sources, including the development of validated PBPK models and biomarkers of early biological effects; the development of more comprehensive models of outcome variance and, specifically, the application of multi-level models that incorporate supra-individual and supra-family risk factors; and the use of study designs that permit assessments of the effect modifying influence of contextual factors on the form and severity of neurotoxicity. Conclusion Decomposing the variability in the distribution of observed scores around the best-fit lines that describe the dose-effect relationships for lead neurotoxicity in children is a major research need.	Childrens Hosp, Harvard Med Sch, Dept Neurol, Boston, MA 02115 USA; Harvard Sch Publ Hlth, Dept Environm Hlth, Boston, MA USA	Bellinger, DC (corresponding author), Childrens Hosp, 300 Longwood Ave, Boston, MA 02115 USA.	david.bellinger@childrens.harvard.edu					Artola A, 2006, EUR J NEUROSCI, V23, P261, DOI 10.1111/j.1460-9568.2005.04552.x; BELLINGER D, 1990, ENVIRON HEALTH PERSP, V89, P5, DOI 10.2307/3430890; BELLINGER D, 1985, ENVIRON RES, V38, P119, DOI 10.1016/0013-9351(85)90077-5; BELLINGER D, 1988, NEUROTOXICOL TERATOL, V10, P497, DOI 10.1016/0892-0362(88)90084-0; Bellinger DC, 2000, NEUROTOXICOL TERATOL, V22, P133, DOI 10.1016/S0892-0362(99)00053-7; Bennett JC, 2006, NEUROBIOL LEARN MEM, V85, P139, DOI 10.1016/j.nlm.2005.09.003; Bergdahl IA, 1999, ENVIRON RES, V80, P25, DOI 10.1006/enrs.1998.3880; Chen X, 2005, NEUROSCIENCE, V135, P11, DOI 10.1016/j.neuroscience.2005.05.041; Chia SE, 2004, NEUROTOXICOLOGY, V25, P1041, DOI 10.1016/j.neuro.2004.01.010; CHIA SE, IN PRESS NEUROTOXICO; Chuang HY, 2001, ENVIRON HEALTH PERSP, V109, P527, DOI 10.2307/3454713; Cohen S, 2006, PSYCHOSOM MED, V68, P414, DOI 10.1097/01.psy.0000221236.37158.b9; Cory-Slechta DA, 2005, NEUROTOXICOLOGY, V26, P491, DOI 10.1016/j.neuro.2004.12.007; COSTA DA, IN PRESS NEUROBIOL A; Cremin JD, 1999, TOXICOL APPL PHARM, V161, P283, DOI 10.1006/taap.1999.8807; ERNHART CB, 1995, NEUROTOXICOL TERATOL, V17, P227, DOI 10.1016/0892-0362(94)00087-T; Faherty CJ, 2005, MOL BRAIN RES, V134, P170, DOI 10.1016/j.molbrainres.2004.08.008; Frank DA, 2005, NEUROTOXICOL TERATOL, V27, P15, DOI 10.1016/j.ntt.2004.09.003; FROEHLICH TE, 2006, EFFECTS DRD4 LEAD SE; GALLO LC, 2003, PSYCHOL BULL, V10, P129; GOCHFELD M, IN PRESS ENC RES; GRANDJEAN P, 2005, TOXICOL APPL PHARM S, V1, P652; Grandjean Philippe, 2004, Int J Occup Med Environ Health, V17, P131; GREENE T, 1991, J DEV BEHAV PEDIATR, V12, P378; Guilarte TR, 2003, ANN NEUROL, V53, P50, DOI 10.1002/ana.10399; HARVEY PG, 1984, SCI TOTAL ENVIRON, V40, P45, DOI 10.1016/0048-9697(84)90341-3; Hu H, 2006, ENVIRON HEALTH PERSP, V114, P1730, DOI 10.1289/ehp.9067; Jankowsky JL, 2005, J NEUROSCI, V25, P5217, DOI 10.1523/JNEUROSCI.5080-04.2005; Jurek AM, 2005, INT J EPIDEMIOL, V34, P680, DOI 10.1093/ije/dyi060; Kamel F, 2005, NEURODEGENER DIS, V2, P195, DOI 10.1159/000089625; Kamel F, 2003, ENVIRON HEALTH PERSP, V111, P1335, DOI 10.1289/ehp.6109; Komitova M, 2005, STROKE, V36, P1278, DOI 10.1161/01.STR.0000166197.94147.59; LANSDOWN R, 1986, INT ARCH OCC ENV HEA, V57, P225, DOI 10.1007/BF00405790; Lazic SE, 2006, EUR J NEUROSCI, V23, P1829, DOI 10.1111/j.1460-9568.2006.04715.x; LEGGETT RW, 1993, ENVIRON HEALTH PERSP, V101, P598, DOI 10.2307/3431645; Lewis MH, 2004, MENT RETARD DEV D R, V10, P91, DOI 10.1002/mrdd.20017; Li LZ, 2005, BIOCHEM BIOPH RES CO, V334, P293, DOI 10.1016/j.bbrc.2005.05.162; Louis ED, 2005, MOVEMENT DISORD, V20, P1170, DOI 10.1002/mds.20565; Maegele M, 2005, EUR J NEUROSCI, V21, P2406, DOI 10.1111/j.1460-9568.2005.04070.x; McMichael AJ, 1999, AM J EPIDEMIOL, V149, P887; Meng XM, 2005, NEUROLOGY, V64, P1644, DOI 10.1212/01.WNL.0000160391.58004.D4; MONTENEGRO MF, 2005, ARCH TOXICOL, V9, P1; Morello-Frosch R, 2002, ENVIRON HEALTH PERSP, V110, P149, DOI 10.1289/ehp.02110s2149; Neugebauer NM, 2004, DEV BRAIN RES, V153, P213, DOI 10.1016/j.devbrainres.2004.09.001; OFLAHERTY EJ, 1993, TOXICOL APPL PHARM, V118, P16, DOI 10.1006/taap.1993.1004; OFLAHERTY EJ, 1995, TOXICOL APPL PHARM, V131, P297, DOI 10.1006/taap.1995.1072; Onalaja AO, 2000, ENVIRON HEALTH PERSP, V108, P23, DOI 10.2307/3454630; Payne-Sturges D, 2006, ENVIRON RES, V102, P146, DOI 10.1016/j.envres.2005.11.001; Rauh VA, 2003, J COMMUNITY PSYCHOL, V31, P255, DOI 10.1002/jcop.10049; Restivo L, 2005, P NATL ACAD SCI USA, V102, P11557, DOI 10.1073/pnas.0504984102; Rothman K, 1998, MODERN EPIDEMIOLOGY, P7; Schneider T, 2006, NEUROPSYCHOPHARMACOL, V31, P36, DOI 10.1038/sj.npp.1300767; Smith D, 2002, ENVIRON HEALTH PERSP, V110, P263, DOI 10.1289/ehp.02110263; Soobader M, 2006, ENVIRON RES, V102, P172, DOI 10.1016/j.envres.2006.05.001; Spires TL, 2005, FEBS J, V272, P2347, DOI 10.1111/j.1742-4658.2005.04677.x; Stangle DE, 2004, ENVIRON HEALTH PERSP, V112, P302, DOI 10.1289/ehp.6517; Stewart WF, 2002, ENVIRON HEALTH PERSP, V110, P501, DOI 10.1289/ehp.02110501; Tong SL, 2001, ANN EPIDEMIOL, V11, P38, DOI 10.1016/S1047-2797(00)00176-9; Trope I, 2001, PEDIATRICS, V107, P1437, DOI 10.1542/peds.107.6.1437; *US EPA, 2005, ALL AG LEAD MOD; Virgolini MB, 2006, NEUROTOXICOLOGY, V27, P11, DOI 10.1016/j.neuro.2005.05.012; Virgolini MB, 2005, TOXICOL SCI, V87, P469, DOI 10.1093/toxsci/kfi269; Wallace CS, 2003, ENVIRON HEALTH PERSP, V111, P1294, DOI 10.1289/ehp.6088; Weiss B, 2006, ENVIRON HEALTH PERSP, V114, P1479, DOI 10.1289/ehp.9101; Weisskopf MG, 2004, ENVIRON HEALTH PERSP, V112, P620, DOI 10.1289/ehp.6687; Weuve J, 2006, OCCUP ENVIRON MED, V63, P746, DOI 10.1136/oem.2006.027417; White PD, 1998, ENVIRON HEALTH PERSP, V106, P1513, DOI 10.1289/ehp.98106s61513; Wilson MA, 2000, P NATL ACAD SCI USA, V97, P5540, DOI 10.1073/pnas.97.10.5540; WILSON MA, 2006, 23 INT NEUR C LITTL; WINNEKE G, 1984, NEUROPSYCHOBIOLOGY, V11, P195, DOI 10.1159/000118077; Wright RO, 2003, PEDIATR RES, V54, P819, DOI 10.1203/01.PDR.0000090927.53818.DE; Yuan WH, 2006, PEDIATRICS, V118, P971, DOI 10.1542/peds.2006-0467	72	22	22	0	12	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0271-3586	1097-0274		AM J IND MED	Am. J. Ind. Med.	OCT	2007	50	10					720	728		10.1002/ajim.20438			9	Public, Environmental & Occupational Health	Public, Environmental & Occupational Health	214SM	WOS:000249758400004	17290364				2021-06-18	
J	Weninger, P; Hertz, H				Weninger, Patrick; Hertz, Harald			Factors influencing the injury pattern and injury severity after high speed motor vehicle accident - A retrospective study	RESUSCITATION			English	Article						motor vehicle accident; injury pattern; multiple injury; prehospitat triage	MULTIPLE TRAUMA; CAR OCCUPANTS; CRASHES; POLYTRAUMA; FRACTURES; MORTALITY; IMPACT; LEVEL	Introduction: Motor vehicular accidents (MVA) are the leading cause of death among people under 40 years of age. Despite improvement in car safety and driver awareness of the use of safety devices, fatalities and severe injuries continue to occur. Material and methods: From 1997 to 2004, 13,678 patients after MVA were admitted to our institution. Out of this cohort, 584 (4.3%) patients suffered blunt major trauma defined as Injury Severity Score (ISS) >= 16 and at least one life-threatening injury in one body region. Preclinical data were recorded in 458 patients matching the inclusion criteria. The circumstances of the trauma scene such as weather conditions were analysed as well as technical crash data such as direction of impact, security devices used and type and severity of automobile damage. In a retrospective trial, the influence of preclinical variables on the injury pattern and on injury severity was investigated. Results: 314 (68.6%) patients were mate and 144 (31.4%) female. Injury severity (p = 0.015) and rate of multiple injuries (p = 0.012) were higher in patients after side-impact crashes. If automobiles with SIPS were used, injury severity was significantly reduced in case of side-impact crashes (p = 0.003). Patients after frontal impact crashes had a higher rate of severe traumatic brain injury (TBI) compared to the overall cohort (p = 0.014). Patients suffering blunt aortic (n = 29) dissection were involved in frontal crashes with seat belt use (p < 0.001). If patients were entrapped, injury severity (p = 0.021) and rate of multiple injuries (p = 0.018) were significantly higher. Rear-end collisions with trucks without rear protection led to higher mortality rates (p = 0.011). Conclusion: According to our data significant association between technical crash data and injury pattern and injury severity can be assumed. In case of high speed MVA in rural areas the trauma mechanism and the circumstances (i.e., impact direction, automobile deformation) should be considered to identify patients at high risk of severe blunt trauma and multiple injuries. (c) 2007 Elsevier Ireland Ltd. All rights reserved.	Trauma Hosp Lorenz Boehler, A-1200 Vienna, Austria	Weninger, P (corresponding author), Trauma Hosp Lorenz Boehler, Donaueschingenstrasse 13, A-1200 Vienna, Austria.	patrick.weninger@gmx.net; harald.hertz@auva.at					BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Biewener A, 2004, J TRAUMA, V56, P94, DOI 10.1097/01.TA.0000061883.92194.50; BURGESS AR, 1995, J TRAUMA, V38, P509, DOI 10.1097/00005373-199504000-00008; COWLEY RA, 1973, J TRAUMA, V13, P1029, DOI 10.1097/00005373-197312000-00001; Fitzharris M, 2004, J TRAUMA, V57, P582, DOI 10.1097/01.TA.0000088015.83951.D0; Frankema SPG, 2004, BRIT J SURG, V91, P1520, DOI 10.1002/bjs.4756; *KUR VERK I UNF, 2005, VERK OST, P10; Loo GT, 1996, J TRAUMA, V41, P935, DOI 10.1097/00005373-199612000-00001; Nast-Kolb D, 2001, J TRAUMA, V51, P835, DOI 10.1097/00005373-200111000-00003; Nirula R, 2005, J TRAUMA, V59, P132, DOI 10.1097/01.TA.0000171465.80722.0C; Palanca Sylvia, 2003, Emerg Med (Fremantle), V15, P423, DOI 10.1046/j.1442-2026.2003.00496.x; Redeker N S, 1995, Am J Crit Care, V4, P370; REGEL G, 1995, J TRAUMA, V38, P70, DOI 10.1097/00005373-199501000-00020; Regel G, 1997, Acta Anaesthesiol Scand Suppl, V110, P71; Richter M, 2001, J TRAUMA, V51, P10, DOI 10.1097/00005373-200107000-00002; Richter M, 2001, J ORTHOP TRAUMA, V15, P287, DOI 10.1097/00005131-200105000-00009; Rowe SA, 2004, SURGERY, V136, P842, DOI 10.1016/j.surg.2004.07.003; SIEGEL JH, 1993, J TRAUMA, V34, P736, DOI 10.1097/00005373-199305000-00017; Singleton Michael, 2004, Traffic Inj Prev, V5, P144, DOI 10.1080/713903941; TRUNKEY D, 1989, CARE SURG PATIENT, V1; Weninger P, 2005, UNFALLCHIRURG, V108, P559, DOI 10.1007/s00113-005-0949-5; World Health Organisation, 2004, WORLD REPORT ROAD TR, P3; ZADOR PL, 1993, AM J PUBLIC HEALTH, V83, P661, DOI 10.2105/AJPH.83.5.661	23	22	22	0	10	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0300-9572			RESUSCITATION	Resuscitation	OCT	2007	75	1					35	41		10.1016/j.resuscitation.2007.03.011			7	Critical Care Medicine; Emergency Medicine	General & Internal Medicine; Emergency Medicine	221ZG	WOS:000250265300006	17481799				2021-06-18	
J	Vivancos-Matellano, F; Pascual-Pascual, SI; Nardi-Vilardaga, J; Miquel-Rodriguez, F; de Miguel-Leon, I; Martinez-Garre, MC; Martinez-Caballero, I; Lanzas-Melendo, G; Garreta-Figuera, R; Garcia-Ruiz, PJ; Garcia-Bach, M; Garcia-Aymerich, V; Bori-Fortuny, I; Aguilar-Barbera, M				Vivancos-Matellano, F.; Pascual-Pascual, S. I.; Nardi-Vilardaga, J.; Miquel-Rodriguez, F.; de Miguel-Leon, I.; Martinez-Garre, M. C.; Martinez-Caballero, I.; Lanzas-Melendo, G.; Garreta-Figuera, R.; Garcia-Ruiz, P. J.; Garcia-Bach, M.; Garcia-Aymerich, V.; Bori-Fortuny, I.; Aguilar-Barbera, M.		Grp Espanol Espasticidad	Guide to the comprehensive treatment of spasticity	REVISTA DE NEUROLOGIA			French	Article						comprehensive treatment; multidisciplinary team; pathophysiology; spasticity; treatment guide; upper motoneuron syndrome	INTRATHECAL BACLOFEN INFUSION; CEREBRAL-PALSY; FUNCTIONAL CLASSIFICATION; INTERNATIONAL STANDARDS; PROGRAMMABLE PUMP; BOTULINUM TOXIN; SPINAL ORIGIN; THERAPY; CHILDREN; PATHOPHYSIOLOGY	Aims and development. Spasticity is an important medical problem with a high rate of incidence both in childhood, mainly as a result of cerebral palsy, and in adults, which is frequently brought about by traumatic brain injuries, strokes and spinal cord injuries. Spasticity is part of upper motoneuron syndrome, which gives rise to important problems, such as limited joint movement, abnormal postures that can produce pain, impaired functional capacity, aesthetic or hygiene disorders, among others. It progresses naturally towards chronicity, accompanied by static phenomena due to alterations affecting the properties of soft tissues (elasticity, plasticity and viscosity). Numerous therapeutic options are available for the treatment of spasticity, including medication, physiotherapy, orthopaedic aid, surgery, and so forth. Moreover treatment should be individualised and realistic, with goals that have been agreed between the patient or caregiver and the medical team. The aim of the following guide is to further our knowledge of this condition, its causes, epidemiology and progression, as well as to outline an approach that is both rational and global from the point of view of pharmacological, rehabilitation and surgical treatment. Conclusions. Spasticity is a complex problem that requires specialists (neurologist, rehabilitation doctor occupational therapist, orthopaedic surgeon, general practitioner etc.) to work as a team in order to achieve the goals set out when treatment is begun. Early treatment is important to avoid or reduce, as far as possible, the severe complications stemming from this condition.	Hosp La Paz, Serv Neurol, E-28046 Madrid, Spain; Hosp La Paz, Serv Neurol Pediat, E-28046 Madrid, Spain; Hosp Gen Valle Hebron, Serv Cirugia Ortoped & Traumatol, Barcelona, Spain; Hosp Gen Valle Hebron, Neurol Serv, Barcelona, Spain; Hosp Gen Valle Hebron, Rehabil Serv, Barcelona, Spain; Hosp La Fe, Serv Rehabil, Valencia, Spain; Hosp Nino Jesus, Serv Traumatol, Madrid, Spain; Hosp Cent Def, Rehabil Serv, Madrid, Spain; Hosp Mutua Terrassa, Serv Rehabil, Barcelona, Spain; Hosp Mutua Terrassa, Serv Neurocirugia, Barcelona, Spain; Hosp Mutua Terrassa, Serv Neurol, Barcelona, Spain; Fdn Jimenez Diaz, Serv Neurol, E-28040 Madrid, Spain	Vivancos-Matellano, F (corresponding author), Hosp La Paz, Serv Neurol, Paseo de la Castellana 261, E-28046 Madrid, Spain.	franvivancos@wanadoo.es	; Garcia Ruiz, Pedro J/G-8660-2013	Pascual Pascual, Samuel Ignacio/0000-0002-5428-8121; Garcia Ruiz, Pedro J/0000-0001-6194-672X			Adams MM, 2005, SPINAL CORD, V43, P577, DOI 10.1038/sj.sc.3101757; Aguilar-Barbera M, 2004, REV NEUROLOGIA, V38, P971, DOI 10.33588/rn.3810.2003648; AICARDI J, 1998, DIS NERVOUS SYSTEM C, P210; Armstrong RW, 1997, J NEUROSURG, V87, P409, DOI 10.3171/jns.1997.87.3.0409; ASCH PV, 2002, 2 C SOC ESP NEUR; Ashwal S, 2004, NEUROLOGY, V62, P851, DOI 10.1212/01.WNL.0000117981.35364.1B; Bache CE, 2003, CURR ORTHOPAED, V17, P88, DOI 10.1054/cuor.2003.0328; BAROLATROMANA G, 1985, J NEUROSURG, V62, P558, DOI 10.3171/jns.1985.62.4.0558; Bax M, 2005, DEV MED CHILD NEUROL, V47, P571, DOI 10.1017/S001216220500112X; BAX M C, 1964, Dev Med Child Neurol, V6, P295; Becker R, 1997, J NEUROL, V244, P160, DOI 10.1007/s004150050067; BECKER WJ, 1995, CAN J NEUROL SCI, V22, P208, DOI 10.1017/S031716710003986X; Ben Smail D, 2006, MULT SCLER, V12, P101, DOI 10.1191/1352458506ms1232sr; BONITA R, 1992, LANCET, V339, P342, DOI 10.1016/0140-6736(92)91658-U; Brin MF, 2002, SPASTICITY ETIOLOGY, P110; BROWN P, 1994, J NEUROL NEUROSUR PS, V57, P773, DOI 10.1136/jnnp.57.7.773; COFFEY RJ, 1993, J NEUROSURG, V78, P226, DOI 10.3171/jns.1993.78.2.0226; Dario A, 2004, J Neurosurg Sci, V48, P177; Dawson D M, 2001, Curr Neurol Neurosci Rep, V1, P501, DOI 10.1007/s11910-001-0051-5; De Souza L H, 1980, Int Rehabil Med, V2, P3; DELEAIDE PJ, 1990, SPASTICITE RENCONTRE, P37; DENYS P, 2002, 2 C SOC ESP NEUR; DITUNNO JF, 1994, PARAPLEGIA, V32, P70, DOI 10.1038/sc.1994.13; DITUNNO JF, 1992, J NEUROTRAUM, V9, pS301; Emery DFG, 2003, CURR ORTHOPAED, V17, P81, DOI 10.1054/cuor.2003.0335; FAHN S, 1986, CLIN NEUROPHARMACOL, V9, pS37, DOI 10.1097/00002826-198612030-00005; Forster O, 1913, SURG GYNECOL OBSTET, V16, P463; GARCIARENESES J, 1995, MEDULA ESPINAL, V1, P111; Gazzani F, 1999, SPINAL CORD, V37, P336, DOI 10.1038/sj.sc.3100821; Gerszten PC, 1998, J NEUROSURG, V88, P1009, DOI 10.3171/jns.1998.88.6.1009; GINER M, 2001, GUFA AUTOCUIDADOS LE; Gracies JM, 2005, MUSCLE NERVE, V31, P535, DOI 10.1002/mus.20284; Graham HK, 2005, J PEDIATR ORTHOPED, V25, P127, DOI 10.1097/00004694-200501000-00026; Guerra Romero L, 1996, Med Clin (Barc), V107, P377; Guillaume D, 2005, ARCH PHYS MED REHAB, V86, P2165, DOI 10.1016/j.apmr.2005.05.018; GUYATT GH, 1995, JAMA-J AM MED ASSOC, V274, P1800, DOI 10.1001/jama.274.22.1800; Herring J, 2002, TACHDJIANS PEDIAT OR, P1122; JOHNSON A, DEV MED NEUROL, V44, P633; Johnson DC, 1997, J PEDIATR ORTHOPED, V17, P392, DOI 10.1097/00004694-199705000-00022; Knapp DR, 2002, J PEDIATR ORTHOPED, V22, P668, DOI 10.1097/00004694-200209000-00018; KRAGELOHMANN I, 1994, DEV MED CHILD NEUROL, V36, P473; Lance J. W., 1980, SPASTICITY DISORDERE, P485; Lance JW, 1984, ELECTROMYOGRAPHY CNS, P1; LOUBSER PG, 1991, PARAPLEGIA, V29, P48, DOI 10.1038/sc.1991.7; Mayer H, 2002, SPASTICITY ETIOLOGY, P16; Mayer N.H., 2002, SPASTICITY ETIOLOGY, P1; Maynard FM, 1997, SPINAL CORD, V35, P266, DOI 10.1038/sj.sc.3100432; MAZAIRAALVAREZ J, 1997, MEDULA ESPINAL, V3, P28; Miller F, 2005, CEREBRAL PALSY, P3; Molenaers G, 2001, EUR J NEUROL, V8, P88, DOI 10.1046/j.1468-1331.2001.00041.x; Munuera L, 1997, INTRO TRAUMATOLOGIA, P118; Ochs G, 1999, NEUROMODULATION, V2, P108, DOI 10.1046/j.1525-1403.1999.00108.x; Ordia JI, 2002, NEUROMODULATION, V5, P16, DOI 10.1046/j.1525-1403.2002._2004.x; Palisano R, 1997, DEV MED CHILD NEUROL, V39, P214, DOI 10.1111/j.1469-8749.1997.tb07414.x; Pascual-Pascual SI, 2007, REV NEUROLOGIA, V44, P303, DOI 10.33588/rn.4405.2006340; REMYNERIS O, 2003, KINESITERAPIA ESPAST; Renshaw TS, 1996, AAOS INSTR COURS LEC, V45, P475; RICHARDSON RR, 1978, SURG NEUROL, V9, P153; Rizzo MA, 2004, MULT SCLER, V10, P589, DOI 10.1191/1352458504ms1085oa; SHEEAN G, 2001, NEUROPHYSIOLOGY SPAS, P12; Shewmon DA, 1999, SPINAL CORD, V37, P313, DOI 10.1038/sj.sc.3100836; Siegfried J, 1980, Int Rehabil Med, V2, P31; SINDOU M, 1974, REV NEUROL, V130, P201; Singer AJ, 1997, NEW ENGL J MED, V337, P1142, DOI 10.1056/NEJM199710163371607; Skold C, 1999, ARCH PHYS MED REHAB, V80, P1548, DOI 10.1016/S0003-9993(99)90329-5; Sommerfeld DK, 2004, STROKE, V35, P134, DOI 10.1161/01.STR.0000105386.05173.5E; Stanley F., 2000, CLIN DEV MED; Thompson PD, 1998, PARKINSONS DIS MOVEM, P755; THORVALDSEN P, 1995, STROKE, V26, P361, DOI 10.1161/01.STR.26.3.361; Verplancke D, 2005, CLIN REHABIL, V19, P117, DOI 10.1191/0269215505cr827oa; Vidal J, 2000, NEUROMODULATION, V3, P175, DOI 10.1046/j.1525-1403.2000.00175.x; Watanabe T, 2004, AM J PHYS MED REHAB, V83, pS45, DOI 10.1097/01.PHM.0000141130.58285.DA; Watkins CL, 2002, CLIN REHABIL, V16, P515, DOI 10.1191/0269215502cr512oa; Welmer AK, 2006, CEREBROVASC DIS, V21, P247, DOI 10.1159/000091222; YOUNG RR, 1981, NEW ENGL J MED, V304, P28	75	22	26	0	8	REVISTA DE NEUROLOGIA	BARCELONA	C/O CESAR VIGUERA, EDITOR, APDO 94121, 08080 BARCELONA, SPAIN	0210-0010	1576-6578		REV NEUROLOGIA	Rev. Neurologia	SEP 16	2007	45	6					365	375		10.33588/rn.4506.2007239			11	Clinical Neurology	Neurosciences & Neurology	217DW	WOS:000249929600010	17899519				2021-06-18	
J	Chio, CC; Kuo, JR; Hsiao, SH; Chang, CP; Lin, MT				Chio, Chung-Ching; Kuo, Jinn-Rung; Hsiao, Sheng-Huang; Chang, Ching-Ping; Lin, Mao-Tsun			Effect of brain cooling on brain ischemia and damage markers after fluid percussion brain injury in rats	SHOCK			English	Article						lactate; pyruvate; glutamate; glycerol; microdialysate; mild hypothermia; traumatic brain injury	EXCITATORY AMINO-ACIDS; MODERATE HYPOTHERMIA; MILD HYPOTHERMIA; STROKE; HEATSTROKE; MICRODIALYSIS; ACCUMULATION; GLUTAMATE; DEFICITS; FAILURE	Although systemic cooling had recently been reported as effective in improving the neurological outcome after traumatic brain injury, several problems are associated with whole-body cooling. The present study was conducted to test the effectiveness of brain cooling without interference with the core temperature in rats after fluid percussion traumatic brain injury (TBI). Brain dialysates ischemia (e.g., glutamate and lactate-to-pyruvate ratio) and injury (e.g., glycerol) markers before and after TBI were measured in rats with mild brain cooling (33 degrees C) and in the sham control group. Brain cooling was accomplished by infusion of 5 mL cold saline via the external jugular vein under general anesthesia. The weight loss was determined by the difference between the first and third day of body weight after TBI. The maximum grip angle in an inclined plane was measured to determine motor performance, whereas the percentage of maximal possible effect was used to measure blockade of proprioception. The triphenyltetrazolium chloride staining procedures were used for cerebral infarction assay. As compared with those of the sham-operated controls, the animals with TBI had higher values of extracellular levels of glutamate, lactate-to-pyruvate ratio, and glycerol in brain and intracranial pressure, but lower values of cerebral perfusion pressure. Brain cooling adopted immediately, after TBI significantly attenuated the TBI-induced increased cerebral ischernia and injury markers, intracranial hypertension, and cerebral hypoperfusion. In addition, the TBI-induced cerebral infarction, motor and proprioception deficits, and body weight loss evaluated 3 days after TBI were significantly attenuated by brain cooling. We successfully demonstrate that brain cooling causes attenuation of TBI in rats by reducing cerebral ischernia and injury resulting from intracranial hypertension and cerebral hypoperfusion. Because jugular venipuncture is an easy procedure frequently used in the emergency department, for preservation of brain function, jugular infusion of cold saline may be useful in resuscitation for trauma patients.	Chi Mei Med Ctr, Dept Med Res, Tainan 710, Taiwan; Chi Mei Med Ctr, Dept Surg, Tainan, Taiwan; Ren Ai City Hosp, Dept Surg, Taipei, Taiwan; So Taiwan Univ Technol, Dept Biotechnol, Tainan, Taiwan	Lin, MT (corresponding author), Chi Mei Med Ctr, Dept Med Res, Tainan 710, Taiwan.	891201@mail.chimei.org.tw					Allers M, 2006, CARDIOVASC INTER RAD, V29, P260, DOI 10.1007/s00270-004-0271-6; BULLOCK R, 1995, STROKE, V26, P2187, DOI 10.1161/01.STR.26.11.2187; Carbonnel WS, 1999, ACTA NEUROPATHOL, V98, P396, DOI 10.1007/s004010051100; CDC, 1999, TRAUM BRAIN INJ US R; Chen T, 2000, J NEUROTRAUM, V17, P135, DOI 10.1089/neu.2000.17.135; Chou YT, 2003, SHOCK, V19, P388, DOI 10.1097/00024382-200304000-00016; Clifton GL, 2001, NEW ENGL J MED, V344, P556, DOI 10.1056/NEJM200102223440803; Clifton GL, 2002, J NEUROTRAUM, V19, P293, DOI 10.1089/089771502753594864; CLIFTON GL, 1991, J CEREBR BLOOD F MET, V11, P114, DOI 10.1038/jcbfm.1991.13; Gerner P, 2003, ANESTHESIOLOGY, V98, P1484, DOI 10.1097/00000542-200306000-00028; Gladstone DJ, 2002, STROKE, V33, P2123, DOI 10.1161/01.STR.0000025518.34157.51; Hallam TM, 2004, J NEUROTRAUM, V21, P521, DOI 10.1089/089771504774129865; Hayashi N, 2000, BRAIN HYPOTHERMIA: PATHOLOGY, PHARMACOLOGY, AND TREATMENT OF SEVERE BRAIN INJURY, P121; HICKS RR, 1993, J NEUROTRAUM, V10, P405, DOI 10.1089/neu.1993.10.405; Hillered L, 1999, SCAND J CLIN LAB INV, V59, P9, DOI 10.1080/00365519950185904; Hillered L, 1998, J NEUROL NEUROSUR PS, V64, P486, DOI 10.1136/jnnp.64.4.486; Hsu SF, 2006, SHOCK, V26, P210, DOI 10.1097/01.shk.0000223124.49265.10; Jiang JY, 2000, J NEUROSURG, V93, P546, DOI 10.3171/jns.2000.93.4.0546; Jiang JY, 2004, NEUROSURGERY, V54, P713, DOI 10.1227/01.NEU.0000109535.58429.49; Kaibara T, 1999, J NEUROSURG, V90, P339, DOI 10.3171/jns.1999.90.2.0339; KAWAMATA T, 1995, BRAIN RES, V674, P196, DOI 10.1016/0006-8993(94)01444-M; Krieger DW, 2004, STROKE, V35, P1482, DOI 10.1161/01.STR.0000126118.44249.5c; LASSEN NA, 1974, CIRC RES, V34, P749, DOI 10.1161/01.RES.34.6.749; Marion DW, 1996, J NEUROTRAUM, V13, P139, DOI 10.1089/neu.1996.13.139; Marion DW, 1996, CRIT CARE MED, V24, pS81; Markgraf CG, 2001, J NEUROSURG, V95, P979, DOI 10.3171/jns.2001.95.6.0979; McIntosh T K, 1987, Cent Nerv Syst Trauma, V4, P119; MITANI A, 1991, BRAIN RES, V562, P159, DOI 10.1016/0006-8993(91)91201-B; MITANI A, 1991, NEUROSCIENCE, V42, P661, DOI 10.1016/0306-4522(91)90035-M; Nilsson OG, 1996, ACT NEUR S, V67, P45; Paxinos G, 1982, RAT BRAIN STEREOTOXI; REIS DJ, 1974, PROG CARDIOVASC DIS, V17, P51, DOI 10.1016/0033-0620(74)90038-3; SHIH CJ, 1984, J NEUROSURG, V60, P1246, DOI 10.3171/jns.1984.60.6.1246; SMITH DH, 1994, NEUROSCI LETT, V168, P151, DOI 10.1016/0304-3940(94)90438-3; Smith SL, 1996, J NEUROTRAUM, V13, P1, DOI 10.1089/neu.1996.13.1; SOSIN DM, 1995, JAMA-J AM MED ASSOC, V273, P1778, DOI 10.1001/jama.273.22.1778; Sudoh Y, 2003, PAIN, V103, P49, DOI 10.1016/S0304-3959(02)00375-5; THALHAMMER JG, 1995, ANESTHESIOLOGY, V82, P1013, DOI 10.1097/00000542-199504000-00026; Thurman DJ, 2001, HEAD TRAUMA THERAPEU; Wang Y, 1997, J NEUROSCI, V17, P4341; Wen YS, 2005, J TRAUMA, V58, P577, DOI 10.1097/01.TA.0000152635.99243.30; Wen YS, 2003, CRIT CARE MED, V31, P2641, DOI 10.1097/01.CCM.0000094229.39473.C1	42	22	24	0	9	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1073-2322	1540-0514		SHOCK	Shock	SEP	2007	28	3					284	290		10.1097/SHK.0b013e3180311e60			7	Critical Care Medicine; Hematology; Surgery; Peripheral Vascular Disease	General & Internal Medicine; Hematology; Surgery; Cardiovascular System & Cardiology	204KC	WOS:000249041500006	17529907				2021-06-18	
J	Soo, C; Tate, R; Hopman, K; Forman, M; Secheny, T; Aird, V; Browne, S; Coulston, C				Soo, Cheryl; Tate, Robyn; Hopman, Kate; Forman, Marcella; Secheny, Tanya; Aird, Vanessa; Browne, Stuart; Coulston, Carissa			Reliability of the care and needs scale for assessing support needs after traumatic brain injury	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						assessment tool; psychometric properties; reliability; support needs; traumatic brain injury	MEASURING PSYCHOSOCIAL RECOVERY; HEAD-INJURY; FOLLOW-UP; RELATIVES	Objective: To investigate the reliability of the Care and Needs Scale (CANS) for measuring the level and types of support needs of people with traumatic brain injury (TBI). Method: Interrater reliability was examined in a cohort of 30 community clients with TBI by comparing CANS ratings completed by 2 occupational therapists (OTs) and a case manager. CANS ratings on the same clients were also completed 1 week later to examine test-retest reliability. Reliability of proxy ratings was investigated in a cohort of 40 community clients with TBI by comparing CANS ratings completed by a clinical researcher, multidisciplinary team, relative, and client. Results: Level of support need as measured by the CANS showed excellent interrater reliability both within and across disciplines: ICC = 0.95 between 2 OTs and ICC = 0.93 and 0.96 between OTs and case manager. Test-retest reliability of the CANS over a 1-week period was also excellent (ICC = 0.98). Although the agreement between the clinical researcher and multidisciplinary team was excellent (ICC = 0.92), ICCs with relative and client ratings were variable, ranging from 0.37 to 0.72. Conclusions: The excellent inter-rater and test-retest reliability findings from this present study, together with the evidence for validity reported previously, indicate that the CANS is a reliable and valid instrument for application in clinical practice.	Univ Sydney, Rehabil Studies Unit, Fac Med, No Clin Sch,Royal Rehabil Ctr Sydney, RYDE, NSW 1680, Australia; Royal Rehabil Ctr Sydney, Brain Injury Rehabil Unit, Sydney, NSW, Australia	Tate, R (corresponding author), Univ Sydney, Rehabil Studies Unit, Fac Med, No Clin Sch,Royal Rehabil Ctr Sydney, POB 6, RYDE, NSW 1680, Australia.	rtate@med.usyd.edu.au	Coulston, Carissa/ABB-8090-2020				Boake C, 1996, ARCH PHYS MED REHAB, V77, P765, DOI 10.1016/S0003-9993(96)90254-3; Brooks CA, 1997, ARCH PHYS MED REHAB, V78, pS26, DOI 10.1016/S0003-9993(97)90152-0; BROOKS N, 1986, J NEUROL NEUROSUR PS, V49, P764, DOI 10.1136/jnnp.49.7.764; Cicchetti DV, 2001, J CLIN EXP NEUROPSYC, V23, P695, DOI 10.1076/jcen.23.5.695.1249; COPE D N, 1991, Brain Injury, V5, P111, DOI 10.3109/02699059109008083; Corrigan JD, 2001, J HEAD TRAUMA REHAB, V16, P1, DOI 10.1097/00001199-200102000-00004; Cusick CP, 2001, ARCH PHYS MED REHAB, V82, P1018, DOI 10.1053/apmr.2001.25098; Cusick CP, 2000, J HEAD TRAUMA REHAB, V15, P739, DOI 10.1097/00001199-200002000-00012; DODWELL D, 1988, J NEUROL NEUROSUR PS, V51, P833, DOI 10.1136/jnnp.51.6.833; Hall KM, 1996, J HEAD TRAUMA REHAB, V11, P27, DOI 10.1097/00001199-199610000-00004; Hall KM, 2001, ARCH PHYS MED REHAB, V82, P367, DOI 10.1053/apmr.2001.21525; Heinemann AW, 2002, ARCH PHYS MED REHAB, V83, P1052, DOI 10.1053/apmr.2002.34283; HIGH WM, 1995, J HEAD TRAUMA REHAB, V10, P64, DOI 10.1097/00001199-199508000-00007; Hodgkinson A, 2000, J HEAD TRAUMA REHAB, V15, P1208, DOI 10.1097/00001199-200012000-00003; Johnson J, 2001, INT J PSYCHIAT CLIN, V5, P141, DOI 10.1080/136515001300374894; Malec JF, 1997, J HEAD TRAUMA REHAB, V12, P1, DOI 10.1097/00001199-199706000-00002; O'Keeffe FM, 2004, COGNITIVE BRAIN RES, V22, P101, DOI 10.1016/j.cogbrainres.2004.07.012; OKEEFE J, 1994, J HEAD TRAUMA REHAB, V9, P49; PATRICK DL, 1989, DISABLEMENT COMMUNIT; PONSFORD JL, 1995, BRAIN INJURY, V9, P1, DOI 10.3109/02699059509004565; PRIGATANO GP, 1990, ARCH PHYS MED REHAB, V71, P1058; Sander AM, 1997, ARCH PHYS MED REHAB, V78, P353, DOI 10.1016/S0003-9993(97)90225-2; Tabachnick B., 2001, USING MULTIVARIATE S; Tate R, 1999, J HEAD TRAUMA REHAB, V14, P543, DOI 10.1097/00001199-199912000-00003; Tate R.L., 2006, BRAIN IMPAIR, V7, P1, DOI DOI 10.1375/brim.7.1.1; Tate RL, 2004, ARCH PHYS MED REHAB, V85, P538, DOI 10.1016/j.apmr.2003.08.078; Tate RL, 2004, BRAIN INJURY, V18, P445, DOI 10.1080/02699050310001641183; WHITENECK GG, 1992, ARCH PHYS MED REHAB, V73, P519	28	22	22	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0885-9701			J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	SEP-OCT	2007	22	5					288	295		10.1097/01.HTR.0000290973.01872.4c			8	Clinical Neurology; Rehabilitation	Neurosciences & Neurology; Rehabilitation	216RA	WOS:000249895500004	17878770				2021-06-18	
J	Royo, NC; LeBold, D; Magge, SN; Chen, I; Hauspurg, A; Cohen, AS; Watson, DJ				Royo, N. C.; LeBold, D.; Magge, S. N.; Chen, I.; Hauspurg, A.; Cohen, A. S.; Watson, D. J.			Neurotrophin-mediated neuroprotection of hippocampal neurons following traumatic brain injury is not associated with acute recovery of hippocampal function	NEUROSCIENCE			English	Article						neurotrophins; rats; hippocampal neurons; neuroprotection; neuropharmacology	LATERAL FLUID-PERCUSSION; CORTICAL IMPACT INJURY; CA3 NMDA RECEPTORS; TRKB MESSENGER-RNA; RATS POSSIBLE ROLE; MORRIS WATER MAZE; CELL LOSS; COGNITIVE DEFICITS; SELECTIVE VULNERABILITY; MEMORY DYSFUNCTION	Traumatic brain injury (TBI) causes selective hippocampal cell death which is believed to be associated with the cognitive impairment observed in both clinical and experimental settings. The endogenous neurotrophin-4/5 (NT-4/5), a TrkB ligand, has been shown to be neuroprotective for vulnerable CA3 pyramidal neurons after experimental brain injury. In this study, infusion of recombinant NT-4/5 increased survival of CA2/3 pyramidal neurons to 71% after lateral fluid percussion brain injury in rats, compared with 55% in vehicle-treated controls. The functional outcome of this NT-4/5-mediated neuroprotection was examined using three hippocampal-dependent behavioral tests. Injujry-induced impairment was evident in all three tests, but interestingly, there was no treatment-related improvement in any of these measures. Similarly, injury-induced decreased excitability in the Schaffer collaterals was not affected by NT-4/5 treatment. We propose that a deeper understanding of the factors that link neuronal survival to recovery of function will be important for future studies of potentially therapeutic agents. (c) 2007 IBRO. Published by Elsevier Ltd. All rights reserved.	Univ Penn, Sch Med, Dept Neurosurg, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Dept Pediat, Philadelphia, PA 19104 USA; Childrens Hosp Philadelphia, Abramson Res Ctr 816h, Div Neurol, Philadelphia, PA 19104 USA	Watson, DJ (corresponding author), Univ Penn, Sch Med, Dept Neurosurg, 371A Stemmler Hall 6071, Philadelphia, PA 19104 USA.	royo@hotmail.com; David.LeBold@jefferson.edu; Suresh.Magge@uphs.upenn.edu; hisaac@mail.med.upenn.edu; alissekh@sas.upenn.edu; Cohena@email.chop.edu; djw3@mail.med.upenn.edu			NICHD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01 HD059288, R01 HD059288-06] Funding Source: Medline; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01-NS040978, R01 NS040978, R01-NS45975, R01 NS045975, R01 NS040978-06A1] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD059288] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS040978, R01NS045975] Funding Source: NIH RePORTER		ALTAR CA, 1994, EXP NEUROL, V130, P31, DOI 10.1006/exnr.1994.1182; Anagnostaras SG, 2001, HIPPOCAMPUS, V11, P8; Anderson KJ, 2005, EXP NEUROL, V193, P125, DOI 10.1016/j.expneurol.2004.11.025; ARDELT AA, 1994, BRAIN RES, V647, P340, DOI 10.1016/0006-8993(94)91333-1; Baldwin SA, 1997, J NEUROTRAUM, V14, P385, DOI 10.1089/neu.1997.14.385; Bannerman DM, 2004, NEUROSCI BIOBEHAV R, V28, P273, DOI 10.1016/j.neubiorev.2004.03.004; Blaha GR, 2000, NEUROSCIENCE, V99, P483, DOI 10.1016/S0306-4522(00)00214-1; Carbonnel WS, 1999, ACTA NEUROPATHOL, V98, P396, DOI 10.1007/s004010051100; Chao MV, 2003, NAT REV NEUROSCI, V4, P299, DOI 10.1038/nrn1078; Colicos MA, 1996, BRAIN RES, V739, P120, DOI 10.1016/S0006-8993(96)00824-4; Colicos MA, 1996, BRAIN RES, V739, P111, DOI 10.1016/S0006-8993(96)00819-0; CONOVER JC, 1995, NATURE, V375, P235, DOI 10.1038/375235a0; CORTEZ SC, 1989, BRAIN RES, V482, P271, DOI 10.1016/0006-8993(89)91190-6; CURTIS R, 1995, NEURON, V14, P1201, DOI 10.1016/0896-6273(95)90267-8; D'Ambrosio R, 1999, J NEUROSCI, V19, P8152; D'Hooge R, 2001, BRAIN RES REV, V36, P60, DOI 10.1016/S0165-0173(01)00067-4; Dixon CE, 2003, CRIT CARE MED, V31, P2222, DOI 10.1097/01.CCM.0000080493.04978.73; Dumas TC, 2001, TRENDS NEUROSCI, V24, P695, DOI 10.1016/S0166-2236(00)01956-1; Fan G, 2000, NAT NEUROSCI, V3, P350; Floyd CL, 2002, J NEUROTRAUM, V19, P303, DOI 10.1089/089771502753594873; Frank L, 1996, EUR J NEUROSCI, V8, P1220, DOI 10.1111/j.1460-9568.1996.tb01290.x; Fujimoto ST, 2004, NEUROSCI BIOBEHAV R, V28, P365, DOI 10.1016/j.neubiorev.2004.06.002; Gewirtz JC, 2000, BEHAV BRAIN RES, V110, P83, DOI 10.1016/S0166-4328(99)00187-4; Golarai G, 2001, J NEUROSCI, V21, P8523; Grady MS, 2003, J NEUROTRAUM, V20, P929, DOI 10.1089/089771503770195786; Hallam TM, 2004, J NEUROTRAUM, V21, P521, DOI 10.1089/089771504774129865; HAMM RJ, 1993, BEHAV BRAIN RES, V59, P169, DOI 10.1016/0166-4328(93)90164-L; Hicks R, 1996, ACTA NEUROPATHOL, V91, P236, DOI 10.1007/s004010050421; HICKS RR, 1995, BRAIN RES, V678, P151, DOI 10.1016/0006-8993(95)00179-T; Hicks RR, 1998, MOL BRAIN RES, V59, P264, DOI 10.1016/S0169-328X(98)00158-2; HICKS RR, 1993, J NEUROTRAUM, V10, P405, DOI 10.1089/neu.1993.10.405; HICKS RR, 1994, BRAIN RES, V655, P91, DOI 10.1016/0006-8993(94)91601-2; Hoover RC, 2004, J NEUROTRAUM, V21, P501, DOI 10.1089/089771504774129847; Ibanez CF, 1996, NEUROCHEM RES, V21, P787, DOI 10.1007/BF02532301; IP NY, 1992, P NATL ACAD SCI USA, V89, P3060, DOI 10.1073/pnas.89.7.3060; KLEIN R, 1992, NEURON, V8, P947, DOI 10.1016/0896-6273(92)90209-V; Kline AE, 2002, J NEUROTRAUM, V19, P415, DOI 10.1089/08977150252932370; Kline AE, 2001, NEUROSCIENCE, V106, P547, DOI 10.1016/S0306-4522(01)00300-1; Knusel B, 1997, NEUROSCIENCE, V78, P851, DOI 10.1016/S0306-4522(96)00616-1; Kotapka MJ, 1991, J NEUROTRAUM, V8, P247, DOI 10.1089/neu.1991.8.247; KOTAPKA MJ, 1992, ACTA NEUROPATHOL, V83, P530, DOI 10.1007/BF00310031; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; Lee LL, 2004, EXP NEUROL, V190, P70, DOI 10.1016/j.expneurol.2004.07.003; Lenzlinger PM, 2005, NEUROSCIENCE, V134, P1047, DOI 10.1016/j.neuroscience.2005.04.048; Leoni MJ, 2000, EXP NEUROL, V166, P442, DOI 10.1006/exnr.2000.7513; LIU X, 1995, NATURE, V375, P238, DOI 10.1038/375238a0; LOWENSTEIN DH, 1992, J NEUROSCI, V12, P4846; LYETH BG, 1990, BRAIN RES, V526, P249, DOI 10.1016/0006-8993(90)91229-A; MAAS A, 2005, PATHOPHYSIOLOGY MANA, P406; Maas AIR, 1999, NEUROSURGERY, V44, P1286, DOI 10.1097/00006123-199906000-00076; Maas AIR, 2001, EXPERT OPIN INV DRUG, V10, P753, DOI 10.1517/13543784.10.4.753; Maxwell WL, 2003, J NEUROPATH EXP NEUR, V62, P272, DOI 10.1093/jnen/62.3.272; MCALLISTER AK, 1995, NEURON, V15, P791, DOI 10.1016/0896-6273(95)90171-X; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; Minichiello L, 1998, NEURON, V21, P335, DOI 10.1016/S0896-6273(00)80543-7; Nakazawa K, 2002, SCIENCE, V297, P211, DOI 10.1126/science.1071795; Nakazawa K, 2003, NEURON, V38, P305, DOI 10.1016/S0896-6273(03)00165-X; Narayan RK, 2002, J NEUROTRAUM, V19, P503, DOI 10.1089/089771502753754037; *NAT RES COUNC, 1996, GUID CAR US LAB AN; O'Connor C, 2003, J NEUROTRAUM, V20, P985, DOI 10.1089/089771503770195830; Ozdemir D, 2005, NEUROSCI LETT, V385, P234, DOI 10.1016/j.neulet.2005.05.055; Passineau MJ, 2001, EXP NEUROL, V168, P373, DOI 10.1006/exnr.2000.7623; Philips MF, 2001, J NEUROSURG, V94, P765, DOI 10.3171/jns.2001.94.5.0765; PHILLIP I, 2005, GOOD PERMUTATION PAR; Pierce JES, 1998, NEUROSCIENCE, V87, P359, DOI 10.1016/S0306-4522(98)00142-0; Reeves TM, 2000, J NEUROSCI RES, V60, P370, DOI 10.1002/(SICI)1097-4547(20000501)60:3<370::AID-JNR12>3.3.CO;2-2; REEVES TM, 1995, EXP BRAIN RES, V106, P248; Reeves TM, 1997, BRAIN RES, V757, P119, DOI 10.1016/S0006-8993(97)00170-4; RIDDLE DR, 1995, NATURE, V378, P189, DOI 10.1038/378189a0; Royo NC, 2006, EUR J NEUROSCI, V23, P1089, DOI 10.1111/j.1460-9568.2006.04642.x; RYDEN M, 1995, EMBO J, V14, P1979, DOI 10.1002/j.1460-2075.1995.tb07190.x; Salin T, 1997, MOL CELL NEUROSCI, V9, P264, DOI 10.1006/mcne.1997.0625; Salmond CH, 2005, CURR OPIN CRIT CARE, V11, P111, DOI 10.1097/01.ccx.0000155358.31983.37; Sanders MJ, 2003, EUR J PHARMACOL, V463, P217, DOI 10.1016/S0014-2999(03)01283-4; Sanderson KL, 1999, J CEREBR BLOOD F MET, V19, P1118, DOI 10.1097/00004647-199910000-00008; Sato M, 2001, BRAIN RES, V917, P45, DOI 10.1016/S0006-8993(01)02905-5; Scheff SW, 2005, J NEUROTRAUM, V22, P719, DOI 10.1089/neu.2005.22.719; Schwarzbach E, 2006, HIPPOCAMPUS, V16, P541, DOI 10.1002/hipo.20183; Schwyzer L, 2002, EUR J NEUROSCI, V16, P1939, DOI 10.1046/j.1460-9568.2002.02259.x; SINSON G, 1995, J NEUROCHEM, V65, P2209; Sinson G, 1997, J NEUROSURG, V86, P511, DOI 10.3171/jns.1997.86.3.0511; Skelton RW, 2006, BRAIN INJURY, V20, P189, DOI 10.1080/02699050500456410; Smith DH, 1997, J NEUROPATH EXP NEUR, V56, P822; Smith DH, 1997, J NEUROTRAUM, V14, P715, DOI 10.1089/neu.1997.14.715; SMITH DH, 1994, NEUROSCI LETT, V168, P151, DOI 10.1016/0304-3940(94)90438-3; Smith DH, 1991, J NEUROTRAUM, V8, P259, DOI 10.1089/neu.1991.8.259; Statler KD, 2006, BRAIN RES, V1076, P216, DOI 10.1016/j.brainres.2005.12.106; Strohmaier C, 1996, EMBO J, V15, P3332, DOI 10.1002/j.1460-2075.1996.tb00698.x; Tate DF, 2000, LEARN MEMORY, V7, P442, DOI 10.1101/lm.33000; Thompson HJ, 2006, RESTOR NEUROL NEUROS, V24, P109; Thompson HJ, 2005, J NEUROTRAUM, V22, P42, DOI 10.1089/neu.2005.22.42; Tolias Christos M, 2004, NeuroRx, V1, P71, DOI 10.1602/neurorx.1.1.71; WEST MJ, 1991, ANAT RECORD, V231, P482, DOI 10.1002/ar.1092310411; Witgen BM, 2005, NEUROSCIENCE, V133, P1, DOI 10.1016/j.neuroscience.2005.01.052; Yan Q, 1997, J COMP NEUROL, V378, P135	95	22	22	0	3	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0306-4522	1873-7544		NEUROSCIENCE	Neuroscience	AUG 24	2007	148	2					359	370		10.1016/j.neuroscience.2007.06.014			12	Neurosciences	Neurosciences & Neurology	213AK	WOS:000249638100004	17681695	Green Accepted			2021-06-18	
J	Lengenfelder, J; Chiaravalloti, ND; DeLuca, J				Lengenfelder, Jean; Chiaravalloti, Nancy D.; DeLuca, John			The efficacy of the generation effect in improving new learning in persons with traumatic brain injury	REHABILITATION PSYCHOLOGY			English	Article; Proceedings Paper	30th Annual Meeting of the International-Neuropsychological-Society	FEB 13-16, 2002	TORONTO, CANADA	Int Neuropsychol Soc		generation effect; traumatic brain injury; learning and memory; cognitive rehabilitation	ALZHEIMER-TYPE DEMENTIA; SEMANTIC-MEMORY; MULTIPLE-SCLEROSIS; SELF-GENERATION; HEAD-INJURY; WORDS; DEFICITS; REHABILITATION; CONSEQUENCES; RETRIEVAL	Objective: To evaluate the usefulness of the generation effect in improving learning and memory abilities in neurologically impaired individuals. The generation effect is the observation that items self-generated by participants are better remembered than items provided by the examiner. Although this effect has shown to be relatively robust in healthy adults, few studies have examined the usefulness of the generation effect in neurological populations. Participants: 18 individuals with moderate-severe traumatic brain injury (TBI) and 18 healthy adults. Main Outcome Measure: The measure was the generation effect protocol. Results: Results indicated recall and recognition of generated information was significantly higher than that of provided information across testing conditions. However, healthy adults showed greater benefit from the generation effect than did individuals with TBI. As expected, recall and recognition performance diminished over time (i.e., immediate recall, 30 min, 1 week) however, rates of forgetting did not differ between groups. Conclusion: Self-generation significantly improved verbal learning and memory in individuals with TBI. The results of self-generation in improving learning suggest that applying that technique may be beneficial in the cognitive rehabilitation of persons with TBI.	Kessler Med Rehabil Res & Educ Ctr, Neuropsychol & Neurosci Lab, W Orange, NJ 07052 USA; Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Phys Med & Rehabil, Newark, NJ 07103 USA; Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Neurol & Neurosci, Newark, NJ 07103 USA	DeLuca, J (corresponding author), Kessler Med Rehabil Res & Educ Ctr, Neuropsychol & Neurosci Lab, 300 Execut Dr,Suite 010, W Orange, NJ 07052 USA.	jdeluca@kmrrec.org		Chiaravalloti, Nancy/0000-0003-2943-7567			Barrett AM, 2000, NEUROLOGY, V54, P1258, DOI 10.1212/WNL.54.6.1258; BEGG I, 1989, J EXP PSYCHOL LEARN, V15, P977, DOI 10.1037/0278-7393.15.5.977; BOWER GH, 1979, J RES PERS, V13, P420, DOI 10.1016/0092-6566(79)90005-9; Chiaravalloti ND, 2002, ARCH PHYS MED REHAB, V83, P1070, DOI 10.1053/apmr.2002.33729; CRAIK FIM, 1975, J EXP PSYCHOL GEN, V104, P268, DOI 10.1037/0096-3445.104.3.268; CROSSON B, 1988, J CLIN EXP NEUROPSYC, V10, P754, DOI 10.1080/01688638808402812; DeLuca J, 2000, ARCH PHYS MED REHAB, V81, P1327, DOI 10.1053/apmr.2000.9390; Deshpande SA, 1996, J CLIN EXP NEUROPSYC, V18, P836, DOI 10.1080/01688639608408306; DICK MB, 1989, BRAIN COGNITION, V9, P71, DOI 10.1016/0278-2626(89)90045-6; DICK MB, 1989, BRAIN COGNITION, V9, P88, DOI 10.1016/0278-2626(89)90046-8; Evans JJ, 2000, NEUROPSYCHOL REHABIL, V10, P67, DOI 10.1080/096020100389309; GARDINER JM, 1984, MEM COGNITION, V12, P443, DOI 10.3758/BF03198305; GARDINER JM, 1985, J EXP PSYCHOL LEARN, V11, P732, DOI 10.1037/0278-7393.11.1-4.732; GOVEROVER Y, 2004, ARCH PHYS MED REHAB, V85, pE5; Higginson CI, 2000, ARCH CLIN NEUROPSYCH, V15, P185, DOI 10.1016/S0887-6177(99)00004-9; Hillary FG, 2003, J CLIN EXP NEUROPSYC, V25, P49, DOI 10.1076/jcen.25.1.49.13631; Jennett B, 1981, MANAGEMENT HEAD INJU; LEVIN HS, 1990, J NEUROSURG, V73, P699, DOI 10.3171/jns.1990.73.5.0699; MCELROY LA, 1982, J VERB LEARN VERB BE, V21, P249, DOI 10.1016/S0022-5371(82)90593-X; MCFARLAND CE, 1983, J EXP CHILD PSYCHOL, V36, P413, DOI 10.1016/0022-0965(83)90043-7; MCFARLAND CE, 1985, J GERONTOL, V40, P205, DOI 10.1093/geronj/40.2.205; MITCHELL DB, 1986, J GERONTOL, V41, P79, DOI 10.1093/geronj/41.1.79; Multhaup KS, 1997, NEUROPSYCHOLOGY, V11, P382, DOI 10.1037/0894-4105.11.3.382; NAIRNE JS, 1985, MEM COGNITION, V13, P183, DOI 10.3758/BF03197011; O'Brien A, 2007, NEUROPSYCHOL REHABIL, V17, P273, DOI 10.1080/09602010600751160; Rosenthal M, 2000, HANDBOOK OF REHABILITATION PSYCHOLOGY, P49, DOI 10.1037/10361-003; SHIMAMURA AP, 1991, FRONTAL LOBE FUNCTION AND DYSFUNCTION, P173; SLAMECKA NJ, 1983, J VERB LEARN VERB BE, V22, P153, DOI 10.1016/S0022-5371(83)90112-3; SLAMECKA NJ, 1978, J EXP PSYCHOL-HUM L, V4, P592, DOI 10.1037/0278-7393.4.6.592; Souliez L, 1996, CORTEX, V32, P347, DOI 10.1016/S0010-9452(96)80056-6; Tailby R, 2003, NEUROPSYCHOLOGIA, V41, P1230, DOI 10.1016/S0028-3932(03)00036-8; Vanderploeg RD, 2001, J CLIN EXP NEUROPSYC, V23, P185, DOI 10.1076/jcen.23.2.185.1210; Vinogradov S, 1997, AM J PSYCHIAT, V154, P1530, DOI 10.1176/ajp.154.11.1530; Westmacott R, 2003, MEM COGNITION, V31, P761, DOI 10.3758/BF03196114; Wilkinson G.S., 1993, WRAT 3 WIDE RANGE AC; Wilson BA, 1996, J HEAD TRAUMA REHAB, V11, P54, DOI 10.1097/00001199-199604000-00006; Zec RF, 2001, J CLIN EXP NEUROPSYC, V23, P671, DOI 10.1076/jcen.23.5.671.1247	37	22	23	0	10	EDUCATIONAL PUBLISHING FOUNDATION	WASHINGTON	750 FIRST ST, NE, WASHINGTON, DC 20002-4242 USA	0090-5550			REHABIL PSYCHOL	Rehabil. Psychol.	AUG	2007	52	3					290	296		10.1037/0090-5550.52.3.290			7	Psychology, Clinical; Rehabilitation	Psychology; Rehabilitation	202LV	WOS:000248904100006					2021-06-18	
J	Cheng, HY; Murdoch, BE; Goozee, JV; Scott, D				Cheng, Hei Yan; Murdoch, Bruce E.; Goozee, Justine V.; Scott, Dion			Physiologic development of tongue-jaw coordination from childhood to adulthood	JOURNAL OF SPEECH LANGUAGE AND HEARING RESEARCH			English	Article						speech development; motor control; articulation; EMA; tongue; jaw	TRAUMATIC BRAIN-INJURY; SPEECH MOTOR CONTROL; MOVEMENTS; DYSARTHRIA; LIP; STABILITY; PATTERNS; CHILDREN	Purpose: This investigation aimed to examine the development of tongue-jaw coordination during speech from childhood to adolescence. Method: Electromagnetic articulography was used to track tongue and jaw motion in 48 children and adults (aged 6-38 years) during productions of /t/ and /k/ embedded in sentences. Results: The coordinative organization of the tongue and jaw exhibited changes until the age of 8-11 years and continued to undergo refinement into late adolescence. The tongue-tip and tongue-body were observed to develop unique kinematic relations with the jaw. While tongue-tip movement became increasingly synchronized with jaw movement, tongue-body and jaw retained movement independence but developed a more consistent kinematic relation. Conclusion: The present results support the notion that speech motor development is nonuniform, with a refinement period from mid-childhood to late adolescence.	Univ Queensland, Brisbane, Qld 4072, Australia	Cheng, HY (corresponding author), Univ Queensland, Brisbane, Qld 4072, Australia.	y.cheng@shrs.uq.edu.au	Murdoch, Bruce E/C-1397-2012				Bartle CJ, 2006, BRAIN INJURY, V20, P529, DOI 10.1080/02699050500487613; EDWARDS J, 1990, SR103104 HASK LAB, P51; FABER A, 1991, J ACOUST SOC AM, V8, P1872; FARNETANI E, 1992, SPEECH COMMUN, V11, P401, DOI 10.1016/0167-6393(92)90045-9; FLETCHER SG, 1989, J SPEECH HEAR RES, V39, P732; GIBSON AR, 1985, J PHYSIOL-LONDON, V358, P551, DOI 10.1113/jphysiol.1985.sp015566; Goffman L, 1999, J EXP PSYCHOL HUMAN, V25, P649, DOI 10.1037/0096-1523.25.3.649; Goozee JV, 2000, BRAIN INJURY, V14, P153, DOI 10.1080/026990500120817; GRACCO VL, 1988, J NEUROSCI, V8, P4628; Green JR, 2002, J SPEECH LANG HEAR R, V45, P66, DOI 10.1044/1092-4388(2002/005); Green JR, 2000, J SPEECH LANG HEAR R, V43, P239, DOI 10.1044/jslhr.4301.239; HIXON TJ, 1976, J SPEECH HEAR RES, V19, P297, DOI 10.1044/jshr.1902.297; KENT JF, 1992, PHONOLOGICAL DEV MOD, P65; KENT RD, 1989, J SPEECH HEAR DISORD, V54, P482, DOI 10.1044/jshd.5404.482; KENT RD, 1972, J SPEECH HEAR RES, V15, P453, DOI 10.1044/jshr.1503.453; Lindblom B., 1967, STL QPSR, V8, P1, DOI [10.1121/1.388647, DOI 10.1121/1.388647]; MACNEILAGE PF, 1990, ATTENTION PERFORM, V13, P453; MACNEILAGE PF, 1990, SPEECH PRODUCTION MO, P56; McClean MD, 2000, J SPEECH LANG HEAR R, V43, P1524, DOI 10.1044/jslhr.4306.1524; NELSON WL, 1983, BIOL CYBERN, V46, P135, DOI 10.1007/BF00339982; NITTROUER S, 1993, J SPEECH HEAR RES, V36, P959, DOI 10.1044/jshr.3605.959; OJAKANGAS CL, 1994, J NEUROPHYSIOL, V72, P2617; Smith A, 2004, DEV PSYCHOBIOL, V45, P22, DOI 10.1002/dev.20009; Smith A, 1998, J SPEECH LANG HEAR R, V41, P18, DOI 10.1044/jslhr.4101.18; Smith A, 2000, J SPEECH LANG HEAR R, V43, P277, DOI 10.1044/jslhr.4301.277; STONE M, 1995, J PHONETICS, V23, P81, DOI 10.1016/S0095-4470(95)80034-4; Thelen E., 1991, BIOL BEHAV DETERMINA, P339; Thelen E., 1994, DYNAMIC SYSTEMS APPR; Tjaden K, 2000, J SPEECH LANG HEAR R, V43, P1466, DOI 10.1044/jslhr.4306.1466; VATIKIOTISBATES.E, 1999, IEEE SYST MAN CYB C; Walsh B, 2002, J SPEECH LANG HEAR R, V45, P1119, DOI 10.1044/1092-4388(2002/090); WATKIN KL, 1984, J ACOUST SOC AM, V75, P629, DOI 10.1121/1.390494; WEISS CE, 1980, WEISS COMPREHENSIVE; Wohlert AB, 2002, J SPEECH LANG HEAR R, V45, P1077, DOI 10.1044/1092-4388(2002/086); Yorkston K.M., 1981, ASSESSMENT INTELLIGI	35	22	25	0	3	AMER SPEECH-LANGUAGE-HEARING ASSOC	ROCKVILLE	10801 ROCKVILLE PIKE, ROCKVILLE, MD 20852-3279 USA	1092-4388			J SPEECH LANG HEAR R	J. Speech Lang. Hear. Res.	APR	2007	50	2					352	360		10.1044/1092-4388(2007/025)			9	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	168XR	WOS:000246557800007	17463234				2021-06-18	
J	Corrigan, JD; Selassie, AW; Lineberry, LA; Millis, SR; Wood, KD; Pickelsimer, EE; Rosenthal, M				Corrigan, John D.; Selassie, Anbesaw W.; Lineberry, Lee A.; Millis, Scott R.; Wood, Kenneth D.; Pickelsimer, E. Elisabeth; Rosenthal, Mitchell			Comparison of the Traumatic Brain Injury (TBI) Model Systems national dataset to a population-based cohort of TBI hospitalizations	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						brain injuries; injury severity score; population; rehabilitation	EMERGENCY-DEPARTMENT; INSURANCE STATUS; GENDER; RACE	Objective: To determine whether severity alone accounts for differences observed between a population-based cohort of acute care hospitalizations for traumatic brain injury (TBI) and the Traumatic Brain Injury Model Systems (TBIMS) national dataset. Design: Prospective cohort. Setting: Acute care hospitals in South Carolina and TBIMS rehabilitation centers. Participants: Subjects enrolled in the TRIMS national dataset and the South Carolina TBI Follow-up Registry (SCTBIFR). Interventions: Not applicable. Main Outcome Measures: Comparable variables in the 2 datasets included demographic characteristics, etiology of injury, initial Glasgow Coma Scale score, Abbreviated Injury Scale score for the head region derived from International Classification of Diseases codes, presence of computed tomography (CT) abnormalities, acute hospital length of stay, and payer source. Results: As hypothesized, TBIMS participants showed greater initial injury severity, frequency of abnormal CT scans, and longer lengths of acute care hospitalization, explaining over 75% of cohort membership. Counter to a priori hypotheses, when all other factors were held constant, there were also differences in racial and ethnic background and insurance payer source. Conclusions: Differences between the TBIMS cohort and patients acutely hospitalized with TBI are primarily due to injury severity; however, an additional difference in payer source may need to be taken into account when generalizing findings. Results showed that TBIMS and SCTBIFR datasets are complementary, each having different strengths for understanding factors that impact long-term recovery after TBI. Recommendations are made for methodologic improvements in both data collection for the TBIMS and future outcome surveillance.	Ohio State Univ, Dept Phys Med & Rehabil, Columbus, OH 43210 USA; Med Univ S Carolina, Dept Biostat Bioinformat & Epidemiol, Charleston, SC 29425 USA; Wayne State Univ, Detroit, MI USA; Kessler Med Rehabil Res & Educ Corp, Traumat Brain Injury Natl Data Ctr, W Orange, NJ USA	Corrigan, JD (corresponding author), Ohio State Univ, Dept Phys Med & Rehabil, 480 W 9th Ave, Columbus, OH 43210 USA.	corrigan.1@osu.edu	Corrigan, John D./E-2921-2011		PHS HHSUnited States Department of Health & Human ServicesUnited States Public Health Service [U17/CCU421926] Funding Source: Medline		Allison PD., 2001, LOGISTIC REGRESSION; Baker SP, 1992, THE INJURY FACT BOOK; *CDCP, 1998, ANN DAT SUBM STAND I; CHARLSON ME, 1997, J CHRON DIS, V40, P273; *COMM INJ SCAL, 1990, ABBR INJ SCAL 1990 R; CORRIGAN J, 1999, TRAUM BRAIN INJ 21 C; Corrigan JD, 1997, ARCH PHYS MED REHAB, V78, P132, DOI 10.1016/S0003-9993(97)90253-7; Corrigan JD, 2003, ARCH PHYS MED REHAB, V84, P153, DOI 10.1053/apmr.2003.50093; DIKMEN SS, 1994, ARCH NEUROL-CHICAGO, V51, P177, DOI 10.1001/archneur.1994.00540140087018; *DIV AC CAR REH RE, 1999, TRAUM BRAIN INJ US R; Elixhauser A, 1998, MED CARE, V36, P8, DOI 10.1097/00005650-199801000-00004; Friedman Bernard, 2004, Int J Health Care Finance Econ, V4, P231, DOI 10.1023/B:IHFE.0000036048.26098.9d; HAAS JS, 1994, AM J PUBLIC HEALTH, V84, P1605, DOI 10.2105/AJPH.84.10.1605; HarrisonFelix C, 1996, J HEAD TRAUMA REHAB, V11, P1, DOI 10.1097/00001199-199610000-00002; Hoffman JM, 2003, ARCH PHYS MED REHAB, V84, P1165, DOI 10.1016/S0003-9993(03)00232-6; HOSMER DW, 2000, WILEY PS TX, P1; *J HOPK U TRIAN IN, 1997, ICDMAP90 SOFTW US GU; JOHNSON D E, 1975, Environmental Health Perspectives, V12, P27, DOI 10.2307/3428206; Langlois JA., 2004, TRAUMATIC BRAIN INJU; *OFF INSP GEN DEP, 2006, 0501818165 DEP VET A; PETRUCELLI E, 1981, ACCIDENT ANAL PREV, V13, P29, DOI 10.1016/0001-4575(81)90040-3; SELASSIE A, 2004, S CAROLINA TRAUMATIC, P118; Selassie AW, 2004, AM J EMERG MED, V22, P465, DOI 10.1016/j.ajem.2004.07.024; Selassie AW, 2003, ACAD EMERG MED, V10, P1260, DOI 10.1197/S1069-6563(03)00497-4; Sox CM, 1998, AM J MED, V105, P506, DOI 10.1016/S0002-9343(98)00324-6; Thurman DJ., 1995, GUIDELINES SURVEILLA; *US CENS BUR, 2005 AM COMM SURV DA; Wood RLL, 2006, J INT NEUROPSYCH SOC, V12, P350, DOI 10.1017/S1355617706060498; Zafonte RD, 1996, AM J PHYS MED REHAB, V75, P364, DOI 10.1097/00002060-199609000-00012; Zafonte RD, 1996, AM J PHYS MED REHAB, V75, P456, DOI 10.1097/00002060-199611000-00011; 1998, NIH CONSEN STATEMENT, V16, P1	31	22	22	0	4	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	APR	2007	88	4					418	426		10.1016/j.apmr.2007.01.010			9	Rehabilitation; Sport Sciences	Rehabilitation; Sport Sciences	160CC	WOS:000245913400005	17398241				2021-06-18	
J	Laskey, AL; Sheridan, MJ; Hymel, KP				Laskey, Antoinette L.; Sheridan, Michael J.; Hymel, Kent P.			Physicians' initial forensic impressions of hypothetical cases of pediatric traumatic brain injury	CHILD ABUSE & NEGLECT			English	Article						traumatic brain injury; case definition; inflicted trauma; accidental trauma; survey	NONACCIDENTAL HEAD-INJURY; SHAKEN BABY SYNDROME; YOUNG-CHILDREN; RETINAL HEMORRHAGES; INFANTS; ABUSE; MECHANISMS	Objective: To describe physicians' initial forensic impressions of hypothetical cases of pediatric traumatic brain injury (TBI) and to compare the responses of pathologists and pediatricians. Method: A survey was administered to physicians who attended workshops on pediatric TBI; were members of two national internet list serves; and were members of the Section on Child Abuse and Neglect of the American Academy of Pediatrics (N= 522) and the National Association of Medical Examiners (N= 815). The survey included 16 hypothetical case scenarios depicting a pediatric TBI. Participants were asked to categorize their initial forensic impressions of each scenario on a seven-point scale from definitive unintentional to definitive inflicted injury. Results: A total of 570 surveys were completed, including 465 of 1337 surveys (35%) distributed through the regular mail. In 8 of 16 hypothetical cases, a majority of respondents (range, 60-98%) and a majority of the more experienced respondents (range, 59-97%) categorized the hypothetical TBI as either unintentional or inflicted. Pathologists were less likely than the pediatric participants to view these scenarios as inflicted TBI. Conclusion: Certain features of TBI cases result in a majority of clinicians categorizing them as inflicted or intentional. In the absence of a confession of inflicted injury, witnessed or verifiable events, severe injuries without explanation or injuries that can be linked clearly to a perinatal period, clinicians were unable to agree on the etiology of the injury. Our results will be helpful to other researchers so that consistent, validated research definitions are used to classify pediatric TBI for research purposes. (c) 2007 Elsevier Ltd. All rights reserved.	Indiana Univ, Sch Med, Dept Pediat, Indianapolis, IN 46202 USA; Inova Fairfax Hosp, Dept Med, Falls Church, VA USA; Inova Fairfax Hosp Children, Dept Pediat, Falls Church, VA USA; Inova Fairfax Hosp, Dept Psychiat, Falls Church, VA USA	Laskey, AL (corresponding author), Indiana Univ, Sch Med, Dept Pediat, 410 W 10th St,Suite 1020, Indianapolis, IN 46202 USA.			Hymel, Kent/0000-0002-1422-182X			Bechtel K, 2004, PEDIATRICS, V114, P165, DOI 10.1542/peds.114.1.165; BILLMIRE ME, 1985, PEDIATRICS, V75, P340; Christian CW, 1999, J PEDIATR-US, V135, P125, DOI 10.1016/S0022-3476(99)70343-4; DUHAIME AC, 1992, PEDIATRICS, V90, P179; DUHAIME AC, 1987, J NEUROSURG, V66, P409, DOI 10.3171/jns.1987.66.3.0409; Ewing-Cobbs L, 1998, PEDIATRICS, V102, P300, DOI 10.1542/peds.102.2.300; Feldman KW, 2001, PEDIATRICS, V108, P636, DOI 10.1542/peds.108.3.636; Gilles EE, 1998, PEDIATR NEUROL, V19, P119, DOI 10.1016/S0887-8994(98)00038-1; Goldsmith W, 2004, AM J FOREN MED PATH, V25, P89, DOI 10.1097/01.paf.0000127407.28071.63; HAHN YS, 1983, CHILD BRAIN, V10, P229; Haviland J, 1997, ARCH DIS CHILD, V77, P504, DOI 10.1136/adc.77.6.504; Hymel KP, 1997, PEDIATR RADIOL, V27, P743, DOI 10.1007/s002470050215; Jayawant S, 1998, BMJ-BRIT MED J, V317, P1558, DOI 10.1136/bmj.317.7172.1558; Jenny C, 1999, JAMA-J AM MED ASSOC, V282, P29; McMahon SR, 2003, PEDIATRICS, V111, DOI 10.1542/peds.111.4.e299; Morad Y, 2003, J PEDIATR-US, V142, P431, DOI 10.1067/mpd.2003.161; Shugerman RP, 1996, PEDIATRICS, V97, P664; STARLING SP, 1995, PEDIATRICS, V95, P259; Tzioumi D, 1998, CHILD ABUSE NEGLECT, V22, P1105, DOI 10.1016/S0145-2134(98)00093-3	19	22	23	0	1	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0145-2134			CHILD ABUSE NEGLECT	Child Abuse Negl.	APR	2007	31	4					329	342		10.1016/j.chiabu.2006.02.017			14	Family Studies; Psychology, Social; Social Work	Family Studies; Psychology; Social Work	173LT	WOS:000246875300002	17408739				2021-06-18	
J	Schwartz, I; Tsenter, J; Shochina, M; Shiri, S; Kedary, M; Katz-Leurer, M; Meiner, Z				Schwartz, Isabella; Tsenter, Jeanna; Shochina, Mara; Shiri, Shimon; Kedary, Michal; Katz-Leurer, Michal; Meiner, Zeev			Rehabilitation outcomes of terror victims with multiple traumas	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						brain injuries; multiple trauma; rehabilitation; spinal cord injuries; stress disorders; post-traumatic; terrorism; treatment outcome	SPINAL-CORD INJURY; BRAIN-INJURY; PHYSICAL MEDICINE; HEAD-INJURY; ATTACKS; ISRAEL; SEPTEMBER-11; EXPERIENCE; CASUALTIES; DISORDERS	Objectives: To describe the rehabilitation outcomes of terror victims with multiple traumas, and to compare those outcomes with those of patients with nonterror-related multiple traumas treated in the same rehabilitation facility over the same time period. Design: Retrospective chart reviews. Setting: Rehabilitation department in a university hospital in Jerusalem, Israel. Participants: Between September 2000 and September 2004, we treated 72 victims of terrorist attacks who had multiple traumas. Among them, 47 (65%) had multiple traumas without central nervous system involvement (MT subgroup), 19 (26%) had multiple traumas with traumatic brain injury (TBI subgroup), and 6 (8%) had multiple traumas with spinal cord injury (SCI subgroup). We matched, according to their types of injury and demographic data, each terror victim with a control patient treated in the same period in our rehabilitation department. Intervention: Interdisciplinary inpatient and outpatient rehabilitation. Main Outcome Measures: Hospital length of stay (LOS) in acute care departments, inpatient and outpatient rehabilitation departments, functional outcome (FIM instrument score), occupational outcome (returning to previous occupation), and psychologic outcome (Solomon PTSD [post-traumatic stress disorder] Inventory). Results: The mean LOS of terror victims was 218 +/- 131 days; for the nonterror group it was 152 +/- 114 days (P <.01). In comparison with the control subgroups, the MT subgroup of terrorist victims had significantly longer LOS in the acute care and outpatient rehabilitation departments (P=.06) and the terror TBI subgroup had a longer LOS in outpatient department only (P <.05). The LOS of the SCI patients, both terror victims and control patients, was significantly longer than that of the other 2 subgroups. The difference between FIM value at entry and discharge (Delta FIM) was significantly higher for terror victims than for the controls (41.1 +/- 21.6 vs 30.8 +/- 21.8, P=.002). This difference was mainly the result of the significantly higher Delta FIM achieved by the terror MT subgroup than by the MT controls. The rate of PTSD was higher among terror victims than among controls (40.9% vs 24.2%, P=.04). The rate of return to previous occupations was similar between terror victims and nonterror patients (53% vs 46.9%, respectively). Conclusions: Victims of terror spent longer periods in rehabilitation than the nonterror group; however, they regained most activity of daily living functions similar to the nonterror group. Despite the higher rate of PTSD, terror victims succeeded in returning to their previous occupations at a similar rate to that of the nonterror group.	Hadassah Univ Hosp, Dept Phys Med & Rehabil, IL-91420 Jerusalem, Israel; Tel Aviv Univ, Sch Hlth Profess, Dept Phys Therapy, Ramat Aviv, Israel	Meiner, Z (corresponding author), Hadassah Univ Hosp, Dept Phys Med & Rehabil, POB 24035,Mt Scopus, IL-91420 Jerusalem, Israel.	meiner@hadassah.org.il					Aharonson-Daniel L, 2005, SCAND J SURG, V94, P185, DOI 10.1177/145749690509400302; Aharonson-Daniel L, 2003, PEDIATRICS, V112, pE280, DOI 10.1542/peds.112.4.e280; Almogy G, 2004, ANN SURG, V239, P295, DOI 10.1097/01.sla.0000114014.63423.55; American Spinal Injury Association, 2002, INT STAND NEUR CLASS; Arnold JL, 2004, ANN EMERG MED, V43, P263, DOI 10.1016/S0196-0644(03)00723-6; BELLAMY RF, 1984, MIL MED, V149, P55; Bleich A, 2003, JAMA-J AM MED ASSOC, V290, P612, DOI 10.1001/jama.290.5.612; BLEICH A, 2006, BMC MED, V27, P4; Bode RK, 2002, ARCH PHYS MED REHAB, V83, P100, DOI 10.1053/apmr.2002.26073; Derogatis L. R., 1982, ADM PROCEDURES BSI M; DILLINGHAM TR, 1993, AM J PHYS MED REHAB, V72, P214, DOI 10.1097/00002060-199308000-00008; DILLINGHAM TR, 1998, TXB MILITARY MED REH, V1; Einav S, 2006, ANN SURG, V243, P533, DOI 10.1097/01.sla.0000206417.58432.48; Eng JJ, 2002, ARCH PHYS MED REHAB, V83, P483, DOI 10.1053/apmr.2002.31203; Galea S, 2002, NEW ENGL J MED, V346, P982, DOI 10.1056/NEJMsa013404; Gidron Y, 2004, ISRAEL MED ASSOC J, V6, P387; Granger CV, 1986, GUIDE USE UNIFORM DA; Hanoch J, 1996, JAMA-J AM MED ASSOC, V276, P388, DOI 10.1001/jama.276.5.388; HARDAWAY RM, 1978, J TRAUMA, V18, P635, DOI 10.1097/00005373-197809000-00004; HERTZMAN CA, 1968, AMER J PHYSICAL MED, V47, P113; *INT TERR INF CTR, JER PREF TARG PAL TE; *ISR DEF FORC, GEN INF STAT; Jehel L, 2001, ENCEPHALE, V27, P393; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; Kluger Y, 2004, J AM COLL SURGEONS, V199, P875, DOI 10.1016/j.jamcollsurg.2004.09.003; Macciocchi SN, 2004, AM J PHYS MED REHAB, V83, P22, DOI 10.1097/01.PHM.0000104661.86307.91; Marin R, 2001, MIL MED, V166, P335; McKinley WO, 2001, AM J PHYS MED REHAB, V80, P693, DOI 10.1097/00002060-200109000-00010; Mintz Y, 2002, ISRAEL MED ASSOC J, V4, P554; North CS, 1999, JAMA-J AM MED ASSOC, V282, P755, DOI 10.1001/jama.282.8.755; Novack TA, 2001, ARCH PHYS MED REHAB, V82, P300, DOI 10.1053/apmr.2001.18222; *ON FAM FUND, TERR STAT; Peleg K, 2006, J AM COLL SURGEONS, V202, P643, DOI 10.1016/j.jamcollsurg.2005.12.019; Peleg K, 2003, AM J EMERG MED, V21, P258, DOI 10.1016/S0735-6757(03)00043-3; Peleg K, 2004, ANN SURG, V239, P311, DOI 10.1097/01.sla.0000114012.84732.be; Ronen J, 2004, SPINAL CORD, V42, P353, DOI 10.1038/sj.sc.3101590; Rusk H A, 1969, Arch Phys Med Rehabil, V50, P463; Schlenger WE, 2002, JAMA-J AM MED ASSOC, V288, P581, DOI 10.1001/jama.288.5.581; SCHWAB K, 1993, NEUROLOGY, V43, P95, DOI 10.1212/WNL.43.1_Part_1.95; Shalev AY, 2005, AM J PSYCHIAT, V162, P1188, DOI 10.1176/appi.ajp.162.6.1188; Silver RC, 2002, JAMA-J AM MED ASSOC, V288, P1235, DOI 10.1001/jama.288.10.1235; Singer Pierre, 2005, Crit Care Med, V33, pS61, DOI 10.1097/01.CCM.0000151068.33935.3E; SOLOMON Z, 1993, ISRAEL J PSYCHIAT, V30, P110; Testa JA, 2005, ARCH PHYS MED REHAB, V86, P1815, DOI 10.1016/j.apmr.2005.03.010; Weiss DS, 1996, IMPACT EVENTS SCALE, P399; Yasuda S, 2002, NEUROREHABILITATION, V17, P177	46	22	22	0	7	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993			ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	APR	2007	88	4					440	448		10.1016/j.apmr.2007.01.001			9	Rehabilitation; Sport Sciences	Rehabilitation; Sport Sciences	160CC	WOS:000245913400008	17398244				2021-06-18	
J	Davis, KL; Joshi, AV; Tortella, BJ; Candrilli, SD				Davis, Keith L.; Joshi, Ashish V.; Tortella, Bartholomew J.; Candrilli, Sean D.			The direct economic burden of blunt and penetrating trauma in a managed care population	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article; Proceedings Paper	65th Annual Meeting of the American-Association-for-the-Surgery-of-Trauma	SEP 28-30, 2006	New Orleans, LA	Amer Assoc Surg Trauma		economic burden; blunt and penetrating trauma; retrospective claims analysis	BRAIN INJURY; DIAGNOSES	Background: Although the prevalence of trauma in the United States is high, data on the economic burden of this public health problem to third-party payors is limited. Methods: Retrospective claims from a large health plan were analyzed for 12,615 adults (age >= 18 years) hospitalized for blunt or penetrating trauma between January 1, 2003 and February 1, 2005. Per patient charges were estimated for resources utilized during a 6-month period before and after initial injury. Continuous health plan enrollment during these periods was required. Three cohorts were examined: isolated traumatic brain injury (TBI); other trauma with TBI (trauma w/TBI); and other trauma without TBI (trauma w/o TBI). Patients were also stratified by Injury Severity Score (ISS) and trauma designation of the admitting hospital. Results: Initial hospitalization charges ranged from $32,627 for isolated TBI to $103,667 for trauma w/TBI. Charges for initial hospitalization were highest ($199,443) among patients with the most severe injuries. Overall, initial hospitalization charges were highest among those admitted to Level I trauma centers ($68,626); for trauma w/TBI, however, initial hospitalization charges were highest among those admitted to nontrauma centers ($130,997). Charges incurred during postdischarge medical encounters ranged from $16,361 for isolated TBI to $23,761 for trauma w/TBI. Increased charges for postdischarge encounters compared with the 6-month preinjury period ranged from $6,756 for isolated TBI to $19,771 for trauma w/TBI. Conclusions: The economic burden of blunt and penetrating trauma to thirdparty payors is high. Efforts to reduce the incidence of trauma may result in substantial economic savings to managed care systems.	RTI Hlth Solut, Res Triangle Pk, NC 27709 USA; Drexel Univ, Novo Nordisk, Philadelphia, PA 19104 USA; Drexel Univ, Coll Med, Philadelphia, PA 19104 USA	Davis, KL (corresponding author), RTI Hlth Solut, 200 Pk Pff Dr 218, Res Triangle Pk, NC 27709 USA.	kldavis@rti.org		Davis, Keith/0000-0002-0044-7107; Candrilli, Sean/0000-0002-2062-1192			*ASS ADV AUT MED, 1990, ABBR INJ SCAL; Finkelstein EA., 2006, INCIDENCE EC BURDEN; Friedman Bernard, 2002, J Health Care Finance, V29, P1; FRIEDMAN Z, 1999, AM J FOREN MED PATH, V20, P102; *J HOPK U TRI AN I, 1998, ICDMAP 90 COMP SOFTW; Kreutzer JS, 2001, BRAIN INJURY, V15, P763, DOI 10.1080/02699050010025786; Losina E, 2003, J CLIN EPIDEMIOL, V56, P515, DOI 10.1016/S0895-4356(03)00056-8; MACKENZIE EJ, 1989, MED CARE, V27, P412, DOI 10.1097/00005650-198904000-00008; MacKenzie EJ, 2006, NEW ENGL J MED, V354, P366, DOI 10.1056/NEJMsa052049; McGarry LJ, 2002, J TRAUMA, V53, P1152, DOI 10.1097/00005373-200212000-00020; *NAT TRAUM DAT BAN, 2005, NTDB ANN REP 2005 VE; Newcomer R, 1999, J AM GERIATR SOC, V47, P215, DOI 10.1111/j.1532-5415.1999.tb04580.x; Thurman DJ., 1995, GUIDELINES SURVEILLA; WYATT JP, 1996, AM J FOREN MED PATH, V17, P233	14	22	23	0	5	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0022-5282			J TRAUMA	J. Trauma-Injury Infect. Crit. Care	MAR	2007	62	3					622	629		10.1097/TA.0b013e318031afe3			8	Critical Care Medicine; Surgery	General & Internal Medicine; Surgery	145PP	WOS:000244877300015	17414338				2021-06-18	
J	Goettler, CE; Tucci, KA				Goettler, Claudia E.; Tucci, Keith A.			Decreasing the morbidity of decompressive craniectomy: The Tucci flap	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article							TRAUMATIC BRAIN-INJURY; INTRACRANIAL HYPERTENSION; MANAGEMENT		E Carolina Univ, Brody Sch Med, Dept Surg, Dept Trauma & Surg Crit Care, Greenville, NC USA; Eastern Neurosurg & Spine Associates, Greenville, NC USA	Goettler, CE (corresponding author), ED 2 Trauma,600 Moye Blvd, Greenville, NC 27585 USA.	cgoettle@pcmh.com					BENZEL EC, 1991, PLAST RECONSTR SURG, V87, P153, DOI 10.1097/00006534-199101000-00026; De Luca GP, 2000, ACTA NEUROCHIR SUPPL, V76, P401; Jiang JY, 2005, J NEUROTRAUM, V22, P623, DOI 10.1089/neu.2005.22.623; Meier U, 2003, ACTA NEUROCHIR SUPPL, V86, P367; Munch E, 2000, NEUROSURGERY, V47, P315; Polin RS, 1997, NEUROSURGERY, V41, P84, DOI 10.1097/00006123-199707000-00018; TABADDOR K, 1976, J NEUROSURG, V44, P506, DOI 10.3171/jns.1976.44.4.0506; Wick J, 1999, AORN J, V69, P517, DOI 10.1016/S0001-2092(06)62463-0; Yang Xue-Jun, 2003, Chin J Traumatol, V6, P99	9	22	23	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0022-5282			J TRAUMA	J. Trauma-Injury Infect. Crit. Care	MAR	2007	62	3					777	778		10.1097/TA.0b013e31802ee55e			2	Critical Care Medicine; Surgery	General & Internal Medicine; Surgery	145PP	WOS:000244877300050	17414367				2021-06-18	
J	Bittner, RM; Crowe, SF				Bittner, Robyn M.; Crowe, Simon F.			The relationship between working memory, processing speed, verbal comprehension and FAS performance following traumatic brain injury	BRAIN INJURY			English	Article						traumatic brain injury; verbal fluency; working memory; processing speed; verbal comprehension	CLOSED HEAD-INJURY; NORMATIVE DATA; WORD FLUENCY; DISSOCIATION; IMPAIRMENT; EDUCATION; APHASIA; TIME; AGE	Primary objective: To investigate the relationship of working memory, processing speed and verbal comprehension with FAS performance in individuals who had sustained a traumatic brain injury ( TBI). Methods and procedure: Sixty- three patients with a TBI were grouped according to the presence of impaired verbal fluency performance and then compared on a number of cognitive and demographic variables. Results: Following a TBI, working memory and processing speed had the greatest influence on verbal fluency performance. For those individuals who have not sustained a TBI, education, verbal intelligence, working memory and speed of information processing were related to FAS performance. Conclusions: The findings of the study indicate that FAS performance was related to verbal intelligence, working memory ability, attention and speed of information processing. The results further suggest that different variables are related to FAS performance following a TBI as compared with control group performances.	La Trobe Univ, Sch Psychol Sci, Fac Sci Technol & Engn, Bundoora, Vic 3083, Australia	Crowe, SF (corresponding author), La Trobe Univ, Sch Psychol Sci, Fac Sci Technol & Engn, Bundoora, Vic 3083, Australia.	s.crowe@latrobe.edu.au		Crowe, Simon/0000-0002-4407-8542			Bittner RM, 2006, BRAIN INJURY, V20, P971, DOI 10.1080/02699050600909763; BOLLA KI, 1990, J CLIN PSYCHOL, V46, P623, DOI 10.1002/1097-4679(199009)46:5<623::AID-JCLP2270460513>3.0.CO;2-C; BORKOWSKI JG, 1967, NEUROPSYCHOLOGIA, V5, P135, DOI 10.1016/0028-3932(67)90015-2; BUNN T, 1995, ED CHILD PSYCHOL, V12, P46; CROWE SF, 1992, J CLIN EXP NEUROPSYC, V14, P327, DOI 10.1080/01688639208402832; Crowe SF, 1998, J CLIN EXP NEUROPSYC, V20, P391, DOI 10.1076/jcen.20.3.391.810; ELLIOTT M, 1981, J LEARN DISABIL, V14, P84, DOI 10.1177/002221948101400210; Erickson M. T., 1975, J LEARNING DISABILIT, V8, P52; Fernaeus SE, 1998, J CLIN EXP NEUROPSYC, V20, P137, DOI 10.1076/jcen.20.2.137.1170; Gladsjo JA, 1999, ASSESSMENT, V6, P147, DOI 10.1177/107319119900600204; GROHER M, 1977, J SPEECH HEAR RES, V20, P212, DOI 10.1044/jshr.2002.212; HEILMAN KM, 1971, J NEUROL NEUROSUR PS, V34, P265, DOI 10.1136/jnnp.34.3.265; HOLLAND AL, 1982, APHASIA APHASIA PROB; Jurado MA, 2000, BRAIN INJURY, V14, P789; KERR C, 1995, BRAIN INJURY, V9, P777, DOI 10.3109/02699059509008234; Killgore WDS, 2000, J CLIN EXP NEUROPSYC, V22, P761; LEVIN HS, 1979, J NEUROSURG, V50, P412, DOI 10.3171/jns.1979.50.4.0412; LEVIN HS, 1981, BRAIN LANG, V12, P360, DOI 10.1016/0093-934X(81)90025-0; LEVIN HS, 1976, J NEUROL NEUROSUR PS, V39, P1062, DOI 10.1136/jnnp.39.11.1062; Raskin SA, 1996, NEUROPSYCHOLOGY, V10, P416, DOI 10.1037/0894-4105.10.3.416; Rey A, 1964, EXAMEN CLIN PSYCHOL; Ruff RM, 1997, BRAIN LANG, V57, P394, DOI 10.1006/brln.1997.1755; RUSSELL WR, 1961, ARCH NEUROL-CHICAGO, V5, P16, DOI DOI 10.1001/ARCHNEUR.1961.00450130006002; SARNO MT, 1986, ARCH PHYS MED REHAB, V67, P400; SARNO MT, 1980, J NERV MENT DIS, V168, P685, DOI 10.1097/00005053-198011000-00008; SULLIVAN R, 2000, 6 ANN C APS COLL CLI; THOMSEN IV, 1975, J NEUROL NEUROSUR PS, V38, P713, DOI 10.1136/jnnp.38.7.713; Tombaugh TN, 1999, ARCH CLIN NEUROPSYCH, V14, P167, DOI 10.1016/S0887-6177(97)00095-4; Tombaugh TN, 1996, TEST MEMORY MALINGER; Troyer AK, 1997, NEUROPSYCHOLOGY, V11, P138, DOI 10.1037/0894-4105.11.1.138; Troyer AK, 2000, J CLIN EXP NEUROPSYC, V22, P370, DOI 10.1076/1380-3395(200006)22:3;1-V;FT370; Wechsler D, 1997, WAIS 3 ADM SCORING M	32	22	22	0	6	TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.		2007	21	7					709	719		10.1080/02699050701468917			11	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	192LX	WOS:000248204400007	17653945				2021-06-18	
J	Elliott, MB; Jallo, JJ; Gaughan, JP; Tuma, RF				Elliott, Melanie B.; Jallo, Jack J.; Gaughan, John P.; Tuma, Ronald F.			Effects of crystalloid-colloid solutions on traumatic brain injury	JOURNAL OF NEUROTRAUMA			English	Article						albumin; cerebral edema; colloid; crystalloid; hypertonic saline; tissue damage; traumatic brain injury	CONTROLLED CORTICAL IMPACT; HYPERTONIC SALINE RESUSCITATION; FOCAL CEREBRAL-ISCHEMIA; SPINAL-CORD-INJURY; HYDRAULIC PERMEABILITY; EXPERIMENTAL STROKE; HEMORRHAGIC-SHOCK; HUMAN-ALBUMIN; RATS; EDEMA	The purpose of this study was to compare the effects of crystalloid and crystalloid-colloid solutions administered at different times after isolated traumatic brain injury. Male Sprague-Dawley rats were randomized to receive one of three intravenous treatments (4 mL/kg body weight) at 10 min or 6 h after moderate traumatic brain injury. Treatments included hypertonic saline, hypertonic albumin, and normal albumin. Moderate injuries were produced using the controlled cortical impact injury model set at 2.0 mm, 4.0 m/sec, and 130 msec. Tissue damage and cerebral edema were measured to evaluate the effect of treatments for traumatic brain injury. Blood brain barrier permeability was assessed at different time points after injury to identify a mechanism for treatment effectiveness. Injury volume was the smallest for animals treated with hypertonic albumin at 6 h after injury compared to all other treatments and administration times. Ipsilateral brain water content was significantly attenuated with immediate normal saline-albumin treatment. The presence of colloid in the infusion solutions was associated with an improvement in tissue damage and edema following isolated head injury while hypertonic saline alone, when given immediately after injury, worsened tissue damage and edema. When hypertonic saline was administered at 6 h after injury, tissue damage and edema were not worsened. In conclusion, the presence of colloid in solutions used to treat traumatic brain injury and the timing of treatment have a significant impact on tissue damage and edema.	Temple Univ, Sch Med, Dept Physiol, Philadelphia, PA 19122 USA; Temple Univ, Sch Med, Dept Neurosurg, Philadelphia, PA 19122 USA; Temple Univ, Sch Med, Dept Biostat, Philadelphia, PA 19122 USA	Elliott, MB (corresponding author), 15 Ascot Dr, Cinnaminson, NJ 08077 USA.	melaniedion@comcast.net		Jallo, Jack/0000-0002-5512-1729			Anderson JT, 1997, J TRAUMA, V42, P592, DOI 10.1097/00005373-199704000-00003; Angle N, 1998, J TRAUMA, V45, P7, DOI 10.1097/00005373-199807000-00002; Baldwin RL, 1996, FOLD DES, V1, P1, DOI 10.1016/S1359-0278(96)00003-X; Baskaya MK, 1997, NEUROSCI LETT, V226, P33; Baskaya MK, 2000, J NEUROTRAUM, V17, P93, DOI 10.1089/neu.2000.17.93; BEDERSON JB, 1986, STROKE, V17, P1304, DOI 10.1161/01.STR.17.6.1304; Chang Y, 2006, J APPL PHYSIOL, V100, P1445, DOI 10.1152/japplphysiol.00763.2005; DIXON CE, 1991, J NEUROSCI METH, V39, P253; Doyle JA, 2001, J TRAUMA, V50, P367, DOI 10.1097/00005373-200102000-00030; Ghirnikar RS, 1998, NEUROCHEM RES, V23, P329, DOI 10.1023/A:1022453332560; Gourin CG, 1996, J TRAUMA, V41, P129, DOI 10.1097/00005373-199607000-00021; Hartl R, 1997, J TRAUMA, V42, pS41, DOI 10.1097/00005373-199705001-00008; Junger WG, 1998, J CLIN INVEST, V101, P2768, DOI 10.1172/JCI1354; Laurer HL, 1999, CURR OPIN NEUROL, V12, P715, DOI 10.1097/00019052-199912000-00010; Lighthall JW, 1988, J NEUROTRAUM, V5, P1, DOI 10.1089/neu.1988.5.1; Liu YT, 2001, EUR J PHARMACOL, V428, P193, DOI 10.1016/S0014-2999(01)01255-9; McIntosh TK, 1996, LAB INVEST, V74, P315; OKIYAMA K, 1995, J NEUROCHEM, V64, P802; Okuno S, 2001, NEUROL RES, V23, P657, DOI 10.1179/016164101101198983; Pascual JL, 2002, ANN SURG, V236, P634, DOI 10.1097/00000658-200211000-00014; Qureshi AI, 1998, CRIT CARE MED, V26, P440, DOI 10.1097/00003246-199803000-00011; Remmers M, 1999, BRAIN RES, V827, P237, DOI 10.1016/S0006-8993(99)01304-9; Roth P, 2000, Crit Care Nurs Q, V23, P14; Rotstein OD, 2000, J TRAUMA, V49, P580, DOI 10.1097/00005373-200010000-00002; SHAPIRA Y, 1995, J NEUROSURG ANESTH, V7, P17, DOI 10.1097/00008506-199501000-00004; Spera PA, 1998, SPINE, V23, P2444, DOI 10.1097/00007632-199811150-00018; Thomale UW, 2004, J NEUROTRAUM, V21, P1737; Toung TJK, 2005, CRIT CARE MED, V33, P203, DOI 10.1097/01.CCM.0000150659.15558.23; Tuma RF, 1997, J TRAUMA, V42, pS54, DOI 10.1097/00005373-199705001-00010; Victorino GP, 2004, J SURG RES, V122, P167, DOI 10.1016/j.jss.2004.07.019; Victorino GP, 2003, SHOCK, V20, P171, DOI 10.1097/01.shk.0000079424.52617.92; Warner DS, 2004, ANESTH ANALG, V99, P1208, DOI 10.1213/01.ANE.0000139930.04010.0D; Weaver KD, 2000, J TRAUMA, V48, P1081, DOI 10.1097/00005373-200006000-00014; Whalen MJ, 1999, J NEUROTRAUM, V16, P583, DOI 10.1089/neu.1999.16.583; Zausinger S, 2004, NEUROSURGERY, V55, P679, DOI 10.1227/01.NEU.0000134558.28977.EE; Zink BJ, 2001, ANN EMERG MED, V37, P318, DOI 10.1067/mem.2001.113505	36	22	25	0	1	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JAN	2007	24	1					195	202		10.1089/neu.2006.0094			8	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	131GX	WOS:000243858100019	17263683				2021-06-18	
J	Park, JH; Strittmatter, SM				Park, James H.; Strittmatter, Stephen M.			Nogo receptor interacts with brain APP and A beta to reduce pathologic changes in Alzheimer's transgenic mice	CURRENT ALZHEIMER RESEARCH			English	Article; Proceedings Paper	7th International Conference on Alzheimers Disease Drug Discovery	OCT 12-13, 2006	New York, NY	Alzheimers Drug Discovery Fdn, Accera Inc, Acumen Pharmaceut Inc, Eisai Inc, Elan Pharmaceut Inc, Forest Lab Inc, Marteck Biosci Corp, Neurochem Inc, Ortho-McNeil Neurol Inc, Pfizer Inc, Sanofi-Aventis US Inc, Wyeth Res, Targacept Inc			NICOTINIC ACETYLCHOLINE-RECEPTOR; AXONAL REGENERATION; IN-VIVO; DISEASE; PROTEIN; INHIBITION; BINDS; BETA-AMYLOID(1-42); IDENTIFICATION; PLASTICITY	Pathophysiologic hypotheses for Alzheimer's disease (AD) are centered on the role of the amyloid plaque A beta peptide and the mechanism of its derivation from the amyloid precursor protein (APP). As part of the disease process, an aberrant axonal sprouting response is known to occur near A beta deposits. A Nogo to Nogo-66 receptor (NgR) pathway contributes to determining the ability of adult CNS axons to extend after traumatic injuries. Here, we consider the potential role of NgR mechanisms in AD. Both Nogo and NgR are mislocalized in AD brain samples. APP physically associates with the NgR. Overexpression of NgR decreases A beta production in neuroblastoma culture, and targeted disruption of NgR expression increases transgenic mouse brain A beta levels, plaque deposition, and dystrophic neurites. Infusion of a soluble NgR fragment reduces A beta levels, amyloid plaque deposits, and dystrophic neurites in a mouse transgenic AD model. Changes in NgR level produce parallel changes in secreted APP and AB, implicating NgR as a blocker of secretase processing of APP. The NgR provides a novel site for modifying the course of AD and highlights the role of axonal dysfunction in the disease.	[Park, James H.; Strittmatter, Stephen M.] Yale Univ, Sch Med, Dept Neurol, Program Cellular Neurosci Neurodegenerat & Repair, New Haven, CT 06510 USA	Strittmatter, SM (corresponding author), Yale Univ, Sch Med, Dept Neurol, Program Cellular Neurosci Neurodegenerat & Repair, POB 208018, New Haven, CT 06510 USA.	stephen.strittmatter@yale.edu	; Strittmatter, Stephen/F-5739-2011	Park, James/0000-0002-1377-1707; Strittmatter, Stephen/0000-0001-8188-3092	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS039962, R01NS042304, R37NS033020, R01NS056485] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R37 NS033020-16, R37 NS033020, R01 NS056485, R01 NS039962-10, R01 NS042304, R37 NS033020-17, R01 NS056485-04, R01 NS039962, R01 NS042304-08] Funding Source: Medline		Arancio O, 2004, EMBO J, V23, P4096, DOI 10.1038/sj.emboj.7600415; Borchelt DR, 1997, NEURON, V19, P939, DOI 10.1016/S0896-6273(00)80974-5; Cordy JM, 2006, MOL MEMBR BIOL, V23, P111, DOI 10.1080/09687860500496417; Dineley KT, 2001, J NEUROSCI, V21, P4125, DOI 10.1523/JNEUROSCI.21-12-04125.2001; Flanagan JG, 2000, METHOD ENZYMOL, V327, P19, DOI 10.1016/S0076-6879(00)27264-9; Fournier AE, 2002, J NEUROSCI, V22, P8876; Fournier AE, 2001, NATURE, V409, P341, DOI 10.1038/35053072; Gil V, 2006, J NEUROPATH EXP NEUR, V65, P433, DOI 10.1097/01.jnen.0000222894.59293.98; GrandPre T, 2000, NATURE, V403, P439, DOI 10.1038/35000226; GrandPre T, 2002, NATURE, V417, P547, DOI 10.1038/417547a; Guevara J, 2004, HISTOL HISTOPATHOL, V19, P1075, DOI 10.14670/HH-19.1075; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Jankowsky JL, 2003, J NEUROPATH EXP NEUR, V62, P1220, DOI 10.1093/jnen/62.12.1220; Kamenetz F, 2003, NEURON, V37, P925, DOI 10.1016/S0896-6273(03)00124-7; Kuner P, 1998, J NEUROSCI RES, V54, P798, DOI 10.1002/(SICI)1097-4547(19981215)54:6<798::AID-JNR7>3.0.CO;2-T; Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533; McGee AW, 2005, SCIENCE, V309, P2222, DOI 10.1126/science.1114362; Nagele RG, 2002, NEUROSCIENCE, V110, P199, DOI 10.1016/S0306-4522(01)00460-2; Nakamura F, 1998, NEURON, V21, P1093, DOI 10.1016/S0896-6273(00)80626-1; Park JH, 2006, J NEUROSCI, V26, P1386, DOI 10.1523/JNEUROSCI.3291-05.2006; Rajagopalan S, 2004, NAT CELL BIOL, V6, P756, DOI 10.1038/ncb1156; Takahashi T, 1999, CELL, V99, P59, DOI 10.1016/S0092-8674(00)80062-8; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Walsh DM, 2002, BIOCHEM SOC T, V30, P552, DOI 10.1042/BST0300552; Wang HY, 2000, J BIOL CHEM, V275, P5626, DOI 10.1074/jbc.275.8.5626; YANG X, 1996, P NATL ACAD SCI USA, V9, P475	26	22	22	1	3	BENTHAM SCIENCE PUBL LTD	SHARJAH	EXECUTIVE STE Y26, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB EMIRATES	1567-2050			CURR ALZHEIMER RES	Curr. Alzheimer Res.		2007	4	5					568	570		10.2174/156720507783018235			3	Clinical Neurology; Neurosciences	Neurosciences & Neurology	268PP	WOS:000253592000015	18220524	Green Accepted			2021-06-18	
J	Shotton, L; Simpson, J; Smith, M				Shotton, Laura; Simpson, Jane; Smith, Mike			The experience of appraisal, coping and adaptive psychosocial adjustment following traumatic brain injury: A qualitative investigation	BRAIN INJURY			English	Article						traumatic brain injury; qualitative; appraisal; coping; adjustment	CHRONIC ILLNESS; STRATEGIES; SEQUELAE; INDIVIDUALS; TBI	Purpose: The experience of appraisal and coping in relation to psychosocial adjustment was explored with individuals who had sustained a traumatic brain injury. Methods: Nine participants were interviewed using a semi-structured schedule. Interpretative phenomenological analysis was used to analyse the data and highlighted four over-riding themes. Results: The emergent themes included: (1) 'waking up': understanding TBI; (2) 'I keep going': coping with TBI; (3) I knew I'd get better': beliefs about TBI; and (4) 'the benefits have far outweighed the consequences': searching for positives. These themes highlighted the adaptive and fluid way in which participants coped over time. In addition, the balance between perceptions of luck vs controllability and optimism vs realism were evident for many participants. All but one participant showed adaptive adjustment; therefore the non-adaptive case was used to critique the emergent themes. Conclusions: The case of non-adaptive adjustment illustrated less fluidity in terms of the coping strategies utilised, little perceived controllability and a greater degree of externalizing blame. The findings give some direction to neuropsychological rehabilitation with regard to the pliable nature of appraisals and coping and their potential to facilitate adaptive adjustment.	Northgate Hosp, Northumberland Head Injury Serv, Tyne & Wear NHS Trust, Morpeth NE61 3BP, Northd, England; Univ Lancaster, Lancaster, England; Lancaster Teaching Hosp NHS Trust, Lancaster, England	Shotton, L (corresponding author), Northgate Hosp, Northumberland Head Injury Serv, Tyne & Wear NHS Trust, Morpeth NE61 3BP, Northd, England.	laura.hotton@ntw.nhs.uk		Simpson, Jane/0000-0001-5071-4077			ALDERMAN N, 1996, BEHAV ASSESSMENT DYS; BOMBARDIER CH, 1990, BEHAV RES THER, V28, P297, DOI 10.1016/0005-7967(90)90081-S; Bowman ML, 1996, CLIN NEUROPSYCHOL, V10, P382, DOI 10.1080/13854049608406699; Charlton GS, 2002, HEALTH SOC CARE COMM, V10, P472, DOI 10.1046/j.1365-2524.2002.00385.x; Conrad P, 1987, RES SOCIOLOGY HLTH C, V6, P1; Curran CA, 2000, J HEAD TRAUMA REHAB, V15, P1256, DOI 10.1097/00001199-200012000-00006; DIKMEN SS, 1994, ARCH NEUROL-CHICAGO, V51, P177, DOI 10.1001/archneur.1994.00540140087018; Elliott R, 1999, BRIT J CLIN PSYCHOL, V38, P215, DOI 10.1348/014466599162782; FELTON BJ, 1984, J CONSULT CLIN PSYCH, V52, P343, DOI 10.1037/0022-006X.52.3.343; Finset A, 2000, BRAIN INJURY, V14, P887; Flanagan DAJ, 1998, BRIT J CLIN PSYCHOL, V37, P431, DOI 10.1111/j.2044-8260.1998.tb01400.x; FOLKMAN S, 1980, J HEALTH SOC BEHAV, V21, P219, DOI 10.2307/2136617; Godfrey HPD, 1996, J HEAD TRAUMA REHAB, V11, P29, DOI 10.1097/00001199-199612000-00006; HAGEN C, 1972, RANCHO AMIGOS COGNIT; HOLOROYD KA, 1982, STRESS COPING SOMATI; Karlovits T, 1999, BRAIN INJURY, V13, P845; Kendall E, 1996, NEUROPSYCHOL REHABIL, V6, P101, DOI 10.1080/713755502; Klonoff P.S., 1991, J HEAD TRAUMA REHAB, V6, P11, DOI DOI 10.1097/00001199-199112000-00005; Lazarus R.S., 1984, STRESS APPRAISAL COP; LAZARUS RS, 1993, PSYCHOSOM MED, V55, P234, DOI 10.1097/00006842-199305000-00002; Lezak MD, 1995, NEUROPSYCHOLOGICAL A; LINN RT, 1994, BRAIN INJURY, V8, P135, DOI 10.3109/02699059409150965; MALIA K, 1995, BRAIN INJURY, V9, P607, DOI 10.3109/02699059509008219; Mathias JL, 1999, J CLIN EXP NEUROPSYC, V21, P200, DOI 10.1076/jcen.21.2.200.930; MCNETT S, 1997, NURS RES, V36, P98; Moore A D, 1989, Brain Inj, V3, P171, DOI 10.3109/02699058909004549; MOORE AD, 1991, NEUROPSYCHOL REHABIL, V1, P185, DOI DOI 10.1080/09602019108520164; MORTON MV, 1995, BRAIN INJURY, V9, P81, DOI 10.3109/02699059509004574; Nochi M, 2000, SOC SCI MED, V51, P1795, DOI 10.1016/S0277-9536(00)00111-8; PATERSON RJ, 1987, PSYCHOL BULL, V101, P404, DOI 10.1037/0033-2909.101.3.404; Poggi G, 2003, BRAIN INJURY, V17, P835, DOI 10.1080/0269905031000088612; Scioli A, 2000, INT J AGING HUM DEV, V51, P115, DOI 10.2190/0BAJ-HPJ8-V0QL-DFMQ; SMITH J, 2003, QUALITATIVE PSYCHOL, pCH4; Smith JA, 1996, PSYCHOL HEALTH, V11, P261, DOI 10.1080/08870449608400256; Smith JA, 1999, QUALITATIVE HLTH PSY; Snyder CR, 2002, PSYCHOL INQ, V13, P249, DOI 10.1207/S15327965PLI1304_01; Tate RL, 1999, PSYCHOL MED, V29, P713, DOI 10.1017/S0033291799008466; Turpin G., 1997, CLIN PSYCHOL FORUM, V108, P3; WILLER BS, 1991, ARCH PHYS MED REHAB, V72, P460; Wills T.A., 1991, SOCIAL COMP CONT THE, P51	40	22	23	0	5	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2007	21	8					857	869		10.1080/02699050701481621			13	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	202YZ	WOS:000248942400007	17676443				2021-06-18	
J	Xiang, HY; Sinclair, SA; Yu, SL; Smith, GA; Kelleher, K				Xiang, Huiyun; Sinclair, Sara A.; Yu, Songlin; Smith, Gary A.; Kelleher, Kelly			Case ascertainment in pediatric traumatic brain injury: Challenges in using the NEISS	BRAIN INJURY			English	Article						traumatic brain injury; US National Electronic Injury Surveillance System; international classification of diseases	US EMERGENCY-DEPARTMENTS; SURVEILLANCE SYSTEM; UNITED-STATES; ACCURACY; DATABASE; CHILDREN	Primary objective: To evaluate mild traumatic brain injury ( TBI) case ascertainment in the US National Electronic Injury Surveillance System ( NEISS). Research design: A sample of NEISS injury cases was analyzed. Two trained researchers independently reviewed diagnostic codes based on the International Classification of Diseases, 9th Revision, Clinical Modification ( ICD- 9- CM). The sensitivity and specificity of two NEISS TBI definitions were evaluated, and Kappa coefficients were calculated to evaluate the agreement between NEISS TBI definitions and the standard TBI definition based on the ICD- 9- CM. Results: Our sampling procedures provided a total of 1,018 NEISS cases, of which 880 were injury cases and 138 were non- injury cases. Out of the injury cases, 54 cases were defined as mild TBI cases based on the ICD- 9- CM diagnosis codes. Compared with non- TBI injury cases, a significantly higher percentage of TBI cases ( 33.3% versus 15.4%) were infants less than 1 year old and TBI cases were more likely to be admitted for hospitalization. If TBI was identified using NEISS definition 1 ( diagnosis code 52 for 'concussion'), the sensitivity was only 38.9% ( 95% confidence intervals ( CI) 25.9 - 51.9%). However, if TBI was identified using NEISS definition 2 ( diagnosis code 52 for ` concussion' or 62 for ` internal organ injury' and ` head' was the affected body part), the sensitivity increased dramatically to 79.6% ( 95% CI 68.9 - 90.4%). The Kappa coefficient for overall agreement between the NEISS and ICD- 9- CM system was 0.528 ( 95% CI 0.393 - 0.664) for NEISS definition 1 and 0.807 ( 95% CI 0.723 - 0.892) for NEISS definition 2. Conclusions: The current approach of pediatric TBI case ascertainment in the NEISS faces some challenges in identifying mild TBI. Future research efforts are needed to refine TBI case ascertainment in the NEISS.	Ohio State Univ, Childrens Hosp Columbus, Coll Med, Columbus Childrens Res Inst,Ctr Injury Res & Poli, Columbus, OH 43210 USA	Xiang, HY (corresponding author), Ohio State Univ, Childrens Hosp Columbus, Coll Med, Columbus Childrens Res Inst,Ctr Injury Res & Poli, 700 Childrens Dr, Columbus, OH 43210 USA.	xiangh@pediatrics.ohio-state.edu	Xiang, Huiyun/E-4335-2011; Kelleher, Kelly/E-3361-2011		NCIPC CDC HHS [1R49CE000241-01] Funding Source: Medline; NATIONAL CENTER FOR INJURY PREVENTION AND CONTROLUnited States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA [R49CE000241] Funding Source: NIH RePORTER		Bazarian JJ, 2006, ACAD EMERG MED, V13, P31, DOI 10.1197/j.aem.2005.07.038; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Diamond PT, 2001, BRAIN INJURY, V15, P537, DOI 10.1080/02699050010007362; Fingerhut LA, 2002, INJ PREV, V8, P259, DOI 10.1136/ip.8.3.259; Glenn MB, 2001, BRAIN INJURY, V15, P811, DOI 10.1080/02699050010025777; Hawley CA, 2004, BRAIN INJURY, V18, P645, DOI 10.1080/02699050310001646189; Hibbard MR, 1998, J HEAD TRAUMA REHAB, V13, P24, DOI 10.1097/00001199-199808000-00003; Hostetler SG, 2005, AM J SPORT MED, V33, P1065, DOI 10.1177/0363546504271748; Hostetler SG, 2004, PEDIATRICS, V114, pE661, DOI 10.1542/peds.2004-1565; Hunt JP, 2000, J TRAUMA, V49, P679, DOI 10.1097/00005373-200010000-00016; Jorge RE, 2005, ARCH GEN PSYCHIAT, V62, P742, DOI 10.1001/archpsyc.62.7.742; Kostylova A, 2005, INJURY PREV, V11, P186, DOI 10.1136/ip.2004.006585; KRAMER CF, 1995, J TRAUMA, V39, P935, DOI 10.1097/00005373-199511000-00019; LANGLOISE J, 2006, TRAUMATIC BRAIN INJU; Linakis JG, 2006, ACAD EMERG MED, V13, P567, DOI [10.1197/j.aem.2005.11.073, 10.1111/j.1553-2712.2006.tb01009.x]; National Center for Injury Prevention and Control, 2003, REP C MILD TRAUM BRA; Quinlan KP, 1999, ANN EMERG MED, V34, P637, DOI 10.1016/S0196-0644(99)70166-6; Shields BJ, 2006, PEDIATRICS, V117, pE452, DOI 10.1542/peds.2005-1916; Thurman DKJRC, 1995, STANDARDS SURVEILLAN; Weiss H B, 1996, Inj Prev, V2, P166, DOI 10.1136/ip.2.2.166; Weiss H B, 1996, Inj Prev, V2, P61, DOI 10.1136/ip.2.1.61; Xiang HY, 2005, J TRAUMA, V58, P112, DOI 10.1097/01.TA.0000151270.26634.DD; Yeates KO, 2005, NEUROPSYCHOLOGY, V19, P618, DOI 10.1037/0894-4105.19.5.618	25	22	22	0	5	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2007	21	3					293	299		10.1080/02699050701311034			7	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	168IW	WOS:000246518400004	17453757				2021-06-18	
J	Scremin, OU; Li, MGG; Roch, M; Booth, R; Jenden, DJ				Scremin, Oscar U.; Li, Mingen Grace; Roch, Margareth; Booth, Ruth; Jenden, Donald J.			Acetylcholine and choline dynamics provide early and late markers of traumatic brain injury	BRAIN RESEARCH			English	Article						brain injury; acetylcholine; choline	MAGNETIC-RESONANCE SPECTROSCOPY; TIME-DEPENDENT CHANGES; CEREBRAL-CORTEX; BLOOD-FLOW; GAS-CHROMATOGRAPHY; MASS-SPECTROMETRY; MEMORY DEFICITS; WORKING MEMORY; RAT-BRAIN; ISCHEMIA	We assessed acetylcholine (ACh) and choline (Ch) dynamics 2.5 h, 1, 4 and 14 days after cerebral cortex impact injury or craniotomy only in adult male Sprague-Dawley rats. Cortical endogenous ACh (D0ACh), endogenous free Ch (D0Ch), deuterium-labeled Ch (D4Ch), and ACh synthesized from D4Ch (D4ACh) were measured by gas-chromatography mass-spectrometry after intravenous injection of D4Ch followed in 1 min by microwave fixation of the brain. D0Ch increased in and around the impact up to 700% of control within 1 day after trauma. Smaller D0Ch increases were found in the cortex contralateral to the impact and in both hemispheres after craniotomy only. D4Ch contents increased to 200% in the impact and surrounding regions 4-14 days post-trauma, with lower increases 2.5 h post-trauma. DOACh decreased at all times post-trauma in the impact center, and initially in the periphery and adjacent regions with a recovery at 14 days. Similar DOACh decreases, although of lesser extent and magnitude were present in the craniotomy only group. D4ACh showed a peak at one day post-trauma in all regions studied in the impact and craniotomy groups. In conclusion, D0Ch tissue level was an early marker of trauma, while 14 days after trauma Ch uptake from blood was enhanced in and around the traumatized cortex. Craniotomy by itself induced a generalized increase in ACh turnover 1 day after this minimal trauma. Choline acetyltransferase activity was reduced in the impact center region but not affected in the adjacent and contralateral regions or by cramotomy. (c) 2006 Elsevier B.V. All rights reserved.	Vet Affairs Greater Los Angeles Healthcare Syst, Res Serv, Los Angeles, CA 90073 USA; Univ Calif Los Angeles, David Geffen Sch Med, Dept Physiol, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, David Geffen Sch Med, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA	Scremin, OU (corresponding author), Vet Affairs Greater Los Angeles Healthcare Syst, Res Serv, Bldg 115,Room 319, Los Angeles, CA 90073 USA.	oscremin@ucla.edu					Allen AR, 1914, J NERV MENT DIS, V41, P141, DOI 10.1097/00005053-191403000-00002; BARTUS RT, 1982, SCIENCE, V217, P408, DOI 10.1126/science.7046051; Berger PA, 1979, NUTR BRAIN, P425; BISHARA S N, 1992, Brain Injury, V6, P373, DOI 10.3109/02699059209034952; CHROBAK JJ, 1988, BRAIN RES, V463, P107, DOI 10.1016/0006-8993(88)90532-X; Conner JM, 2005, NEURON, V46, P173, DOI 10.1016/j.neuron.2005.03.003; CORRIGAN J D, 1992, Brain Injury, V6, P155, DOI 10.3109/02699059209029653; DAWSON GR, 1991, PHARMACOL BIOCHEM BE, V39, P865, DOI 10.1016/0091-3057(91)90045-4; DEANGELIS MM, 1994, BRAIN RES, V653, P39, DOI 10.1016/0006-8993(94)90369-7; DIXON CE, 1994, NEUROSCI LETT, V180, P127, DOI 10.1016/0304-3940(94)90503-7; Dixon CE, 1997, BRAIN RES, V749, P127, DOI 10.1016/S0006-8993(96)01310-8; DIXON CE, 1994, J NEUROTRAUM, V11, P275, DOI 10.1089/neu.1994.11.275; FEENEY DM, 1981, BRAIN RES, V211, P67, DOI 10.1016/0006-8993(81)90067-6; FONNUM F, 1975, J NEUROCHEM, V24, P407, DOI 10.1111/j.1471-4159.1975.tb11895.x; Garnett MR, 2001, J NEUROTRAUM, V18, P231, DOI 10.1089/08977150151070838; Geddes DM, 2001, J BIOMECH ENG-T ASME, V123, P247, DOI 10.1115/1.1374201; GEFFEN GM, 1991, NEUROREPORT, V2, P105, DOI 10.1097/00001756-199102000-00010; Gold PE, 2003, NEUROBIOL LEARN MEM, V80, P194, DOI 10.1016/j.nlm.2003.07.003; Gorman LK, 1996, J NEUROTRAUM, V13, P457, DOI 10.1089/neu.1996.13.457; Gualtari CT, 1991, BRAIN INJURY, V5, P219; Harada H, 2000, NEUROSCI LETT, V284, P163, DOI 10.1016/S0304-3940(00)01013-2; HARRELL LE, 1987, BEHAV NEUROSCI, V101, P644, DOI 10.1037/0735-7044.101.5.644; HUDSON DM, 1985, BRAIN RES, V338, P267, DOI 10.1016/0006-8993(85)90156-8; JENDEN DJ, 1974, LIFE SCI, V14, P55, DOI 10.1016/0024-3205(74)90245-8; JENDEN DJ, 1973, ANAL BIOCHEM, V55, P438, DOI 10.1016/0003-2697(73)90134-6; Jenden DJ, 1991, B CLIN NEUROSCI, V55, P99; KUMAGAE Y, 1991, J NEUROCHEM, V56, P1169, DOI 10.1111/j.1471-4159.1991.tb11407.x; LEONARD JR, 1994, J NEUROTRAUM, V11, P379, DOI 10.1089/neu.1994.11.379; LUINE V, 1990, BRAIN RES, V523, P321, DOI 10.1016/0006-8993(90)91507-D; Nortje J, 2004, CURR OPIN NEUROL, V17, P711, DOI 10.1097/00019052-200412000-00011; Phillis John W., 2003, Critical Reviews in Neurobiology, V15, P61, DOI 10.1615/CritRevNeurobiol.v15.i1.30; Podo F, 1999, NMR BIOMED, V12, P413, DOI 10.1002/(SICI)1099-1492(199911)12:7<413::AID-NBM587>3.0.CO;2-U; Power AE, 2003, NEUROBIOL LEARN MEM, V80, P178, DOI 10.1016/S1074-7427(03)00086-8; REGAN RF, 1994, BRAIN RES, V633, P236, DOI 10.1016/0006-8993(94)91544-X; ROBINSON SE, 1990, BRAIN RES, V511, P141, DOI 10.1016/0006-8993(90)90233-2; SAIJA A, 1988, BRAIN RES, V452, P303, DOI 10.1016/0006-8993(88)90034-0; Salmond CH, 2005, CURR OPIN CRIT CARE, V11, P111, DOI 10.1097/01.ccx.0000155358.31983.37; Sasaki M, 1987, No To Shinkei, V39, P983; Schuhmann MU, 2003, J NEUROTRAUM, V20, P725, DOI 10.1089/089771503767869962; Scremin OU, 1973, STROKE, V4, P232, DOI 10.1161/01.STR.4.2.232; SCREMIN OU, 1991, STROKE, V22, P643, DOI 10.1161/01.STR.22.5.643; SCREMIN OU, 1991, ANNU REV PHARMACOL, V31, P229; SCREMIN OU, 1989, STROKE, V20, P1524, DOI 10.1161/01.STR.20.11.1524; SCREMIN OU, 1989, STROKE, V20, P92, DOI 10.1161/01.STR.20.1.92; Scremin OU, 1996, LIFE SCI, V58, P2011, DOI 10.1016/0024-3205(96)00192-0; Scremin OU, 1997, J NEUROTRAUM, V14, P573, DOI 10.1089/neu.1997.14.573; SCREMIN OU, 1993, PROG BRAIN RES, V98, P191; Shao LF, 1999, J NEUROTRAUM, V16, P555, DOI 10.1089/neu.1999.16.555; Shutter L, 2004, J NEUROTRAUM, V21, P1693, DOI 10.1089/neu.2004.21.1693; SZERB JC, 1967, J PHYSIOL-LONDON, V192, P329, DOI 10.1113/jphysiol.1967.sp008303; Verbois SL, 2002, J NEUROTRAUM, V19, P1569, DOI 10.1089/089771502762300238; Waite JJ, 1999, BRAIN RES, V818, P1, DOI 10.1016/S0006-8993(98)01174-3; Wyss MT, 2004, EUR J NUCL MED MOL I, V31, P312, DOI 10.1007/s00259-003-1337-4	53	22	23	0	4	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	DEC 8	2006	1124						155	166		10.1016/j.brainres.2006.09.062			12	Neurosciences	Neurosciences & Neurology	119MQ	WOS:000243016800018	17084821				2021-06-18	
J	Kennedy, MRT; Turkstra, L				Kennedy, Mary R. T.; Turkstra, Lyn			Group intervention studies in the cognitive rehabilitation of individuals with traumatic brain injury: Challenges faced by researchers	NEUROPSYCHOLOGY REVIEW			English	Article						cognitive rehabilitation; traumatic brain injury; randomized control trials	PRACTICE GUIDELINES; MANAGEMENT; DEFICITS	There are many factors to consider in designing and interpreting group studies. These include both analytic considerations, such as the selection of valid and reliable outcome measures, and subjective considerations, such as the selection of outcomes that are perceived to be important to participants and researchers. In this paper, we review key issues to consider in the design of group studies in neurorehabilitation, using problem-solving studies in traumatic brain injury as an example.	Univ Minnesota, Minneapolis, MN USA; Univ Wisconsin, Madison, WI USA	Kennedy, MRT (corresponding author), Univ Minnesota, 164 Pillsbury Dr SE,115 Shevlin Hall, Minneapolis, MN USA.	kenne047@umn.edu					*AM AC NEUR, 2004, CLIN PRACT GUID PROC; American Psychological Association, 2001, PUBL MAN AM PSYCH AS, V5; Bedell GM, 2005, AM J OCCUP THER, V59, P273, DOI 10.5014/ajot.59.3.273; Bilbao A, 2003, NEUROREHABILITATION, V18, P239; Cicerone KD, 2005, ARCH PHYS MED REHAB, V86, P1681, DOI 10.1016/j.apmr.2005.03.024; Coelho Carl, 2005, Seminars in Speech and Language, V26, P223, DOI 10.1055/s-2005-922102; Cohen J., 1988, STAT POWER ANAL BEHA, V2nd; COOPER H, 1994, HDB RES SYNTHESIS, P215; Ellenberg J. H., 1996, DRUG INF J, V30, P535, DOI DOI 10.1177/009286159603000229; Fasotti L, 2000, NEUROPSYCHOL REHABIL, V10, P47, DOI 10.1080/096020100389291; FOXX RM, 1989, BEHAV THER, V20, P61, DOI 10.1016/S0005-7894(89)80118-2; Frattali C, 2003, J MED SPEECH-LANG PA, V11, pIX; Guyatt GH, 2000, JAMA-J AM MED ASSOC, V284, P1290, DOI 10.1001/jama.284.10.1290; Hashimoto K, 2006, J REHABIL MED, V38, P20, DOI 10.1080/16501970510038473; *INJ VIOL PREV UN, 2005, EM DEP TREAT TRAUM B; Kelemen WL, 2000, MEM COGNITION, V28, P92, DOI 10.3758/BF03211579; Kennedy Mary R. T, 2005, Seminars in Speech and Language, V26, P242, DOI 10.1055/s-2005-922103; Kennedy MRT, 2004, AM J SPEECH-LANG PAT, V13, P142, DOI 10.1044/1058-0360(2004/015); Levine B, 2000, J INT NEUROPSYCH SOC, V6, P299, DOI 10.1017/S1355617700633052; Mai N, 1991, NEUROPSYCHOL REHABIL, V1, P45, DOI DOI 10.1080/09602019108401379; Manly T, 2002, NEUROPSYCHOLOGIA, V40, P271, DOI 10.1016/S0028-3932(01)00094-X; Marshall RC, 2004, APHASIOLOGY, V18, P659, DOI 10.1080/02687030444000237; Montori VM, 2003, BMC MED, V1, DOI 10.1186/1741-7015-1-2; Rath JF, 2003, NEUROPSYCHOL REHABIL, V13, P461, DOI 10.1080/09602010343000039; RAYMER S, 2006, IN PRESS J SPEECH LA; Riley GA, 2003, BRIT J CLIN PSYCHOL, V42, P319, DOI 10.1348/01446650360703410; SCHIAVETTI N, 2005, EVALUATING RES COMMU; SOHLBERG M, IN PRESS J MED SPEEC; Sohlberg MM, 2003, J MED SPEECH-LANG PA, V11, pXIX; Stablum F, 2000, PSYCHOL RES-PSYCH FO, V63, P265, DOI 10.1007/s004269900002; TATE R, 2004, PSYCBITE PSYCHOL DAT; Thompson B., 2002, ED RES, V31, P25, DOI [DOI 10.3102/0013189X031003025, 10.3102/0013189X031003025]; TURKSTRA L, 2005, J MED SPEECH LANGUAG, V13; WEBB PM, 1994, REHABIL PSYCHOL, V39, P179, DOI 10.1037/h0080321; WILLER B, 1994, AM J PHYS MED REHAB, V73, P103; Wilson, 1991, NATL ADULT READING T	36	22	22	0	5	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	1040-7308	1573-6660		NEUROPSYCHOL REV	Neuropsychol. Rev.	DEC	2006	16	4					151	159		10.1007/s11065-006-9012-8			9	Psychology, Clinical; Neurosciences	Psychology; Neurosciences & Neurology	121RZ	WOS:000243176000002	17160698				2021-06-18	
J	Heiduschka, P; Thanos, S				Heiduschka, Peter; Thanos, Solon			Cortisol promotes survival and regeneration of axotomised retinal ganglion cells and enhances effects of aurintricarboxylic acid	GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY			English	Article						retinal ganglion cells; neuroprotection; aurintricarboxylic acid; optic nerve injury; cortisol; axonal regeneration	SPINAL-CORD-INJURY; HIGH-DOSE METHYLPREDNISOLONE; GLUCOCORTICOID-RECEPTOR; PERIPHERAL-NERVES; MICROGLIAL CELLS; BRAIN; INHIBITION; NEUROPROTECTION; ACTIVATION; PROTEIN	Neuroprotection is essential for repair processes after a traumatic insult in the central nervous system. We have demonstrated previously significant neuroprotective properties of the anti-apoptotic drug aurintricarboxylic acid in the model of axotomised retinal ganglion cells. Glucocorticoids are widely used to treat injuries of the nervous system. Due to the anti-inflammatory and microglia-inhibiting properties of glucocorticoids, we studied the neuroprotective effects of intravitreally administered cortisol after an optic nerve cut. Ninety-eight adult Sprague-Dawley rats were used in this study. The optic nerve was cut intra-orbitally. Either vehicle or compound solution was injected intravitreally. Fluorescent dye was put onto the optic nerve stump to label retinal ganglion cells retrogradely. Retinal whole mounts were prepared 2 weeks after axotomy, and surviving retinal ganglion cells were counted. Two weeks after axotomy, up to 50 +/- 7% of all retinal ganglion cells survived if cortisol was injected into the eye compared with 17 +/- 5% survival if only vehicle solution was injected. The neuroprotective effects of aurintricarboxylic acid (43 +/- 5% survival) could be further enhanced if combined with cortisol (up to 61 +/- 5% survival). Regeneration of cut retinal ganglion cell axons into a peripheral nerve graft could also be enhanced by an intravitreal injection of cortisol (169 +/- 42 regenerating retinal ganglion cells per mm(2) vs. 73 +/- 12 cells per mm(2) after vehicle injection). The increase was not as high as with aurintricarboxylic acid (192 +/- 40 cells per mm(2)), although more retinal ganglion cells survived with cortisol. This indicates that neuronal survival alone is not sufficient for subsequent axonal regeneration. Nevertheless, regeneration could be markedly increased if aurintricarboxylic acid and cortisol were combined (308 +/- 72 cells per mm(2)). Whereas aurintricarboxylic acid seems to act directly on lesioned retinal ganglion cells, cortisol seems to act on the glial environment, as indicated by microglial cell morphology and enhanced glial fibrillary acidic protein expression. The results show that both neuroprotection and regeneration can be enhanced by the combination of two simple compounds acting on different sites.	Univ Tubingen, Hosp Eye, D-72076 Tubingen, Germany; Univ Munster, Hosp Eye, Dept Expt Ophthalmol, D-48149 Munster, Germany	Heiduschka, P (corresponding author), Univ Tubingen, Hosp Eye, Schleichstr 12-1, D-72076 Tubingen, Germany.	peter.heiduschka@med.uni-tuebingen.de					Almeida OFX, 2000, FASEB J, V14, P779; AMIN AR, 1995, P NATL ACAD SCI USA, V92, P7926, DOI 10.1073/pnas.92.17.7926; ARMALY MANSOUR F., 1965, INVEST OPHTHALMOL, V4, P187; Barkana Y, 2004, BRAIN RES BULL, V62, P447, DOI 10.1016/S0361-9230(03)00071-6; Barr CS, 1999, BRAIN RES, V847, P9, DOI 10.1016/S0006-8993(99)01988-5; BECKER KW, 1987, NEUROCHIRURGIA, V30, P161; Bianchi M, 2000, P NATL ACAD SCI USA, V97, P9573, DOI 10.1073/pnas.160099797; Biola A, 2000, FEBS LETT, V487, P229, DOI 10.1016/S0014-5793(00)02297-3; BOLDREY E, 1951, SURG FORUM, V2, P386; Bracken MB, 1997, JAMA-J AM MED ASSOC, V277, P1597, DOI 10.1001/jama.277.20.1597; BRAUGHLER JM, 1985, J NEUROSURG, V62, P806, DOI 10.3171/jns.1985.62.6.0806; Carnahan M C, 2000, Curr Opin Ophthalmol, V11, P478, DOI 10.1097/00055735-200012000-00016; Castano A, 1996, EUR J NEUROSCI, V8, P581, DOI 10.1111/j.1460-9568.1996.tb01243.x; Chan T. K., 1996, Singapore Medical Journal, V37, P216; CHAO TC, 1994, AM J REPROD IMMUNOL, V32, P43, DOI 10.1111/j.1600-0897.1994.tb00877.x; Chaum E, 2003, J CELL BIOCHEM, V88, P57, DOI 10.1002/jcb.10354; Chen CW, 2002, BRIT J PHARMACOL, V137, P1011, DOI 10.1038/sj.bjp.0704955; Coleman WP, 2000, J SPINAL DISORD, V13, P185, DOI 10.1097/00002517-200006000-00001; Danbolt NC, 2001, PROG NEUROBIOL, V65, P1, DOI 10.1016/S0301-0082(00)00067-8; De Nicola AF, 1998, J STEROID BIOCHEM, V65, P253, DOI 10.1016/S0960-0760(97)00190-8; DEROUICHE A, 1995, J NEUROSCI RES, V42, P131, DOI 10.1002/jnr.490420115; Diem R, 2003, J NEUROSCI, V23, P6993, DOI 10.1523/JNEUROSCI.23-18-06993.2003; Drew PD, 2000, BRAIN RES BULL, V52, P391, DOI 10.1016/S0361-9230(00)00275-6; Farkas RH, 2001, INT OPHTHALMOL CLIN, V41, P111, DOI 10.1097/00004397-200101000-00011; GANTER S, 1992, J NEUROSCI RES, V33, P218, DOI 10.1002/jnr.490330205; GARCIAZAMBRANO W, 1982, ARCH INVEST MED, V13, P157; Garrido C, 1999, FASEB J, V13, P2061; Gorovits R, 1997, P NATL ACAD SCI USA, V94, P7024, DOI 10.1073/pnas.94.13.7024; Graham W P 3rd, 1973, Surg Forum, V24, P457; Heiduschka P, 2000, NEUROPHARMACOLOGY, V39, P889, DOI 10.1016/S0028-3908(99)00245-2; Heiduschka P, 2004, KLIN MONATSBL AUGENH, V221, P684, DOI 10.1055/s-2004-813054; Heiduschka P, 2000, PROG RETIN EYE RES, V19, P577, DOI 10.1016/S1350-9462(00)00011-2; HUANG ZB, 1993, CHEST, V104, P751, DOI 10.1378/chest.104.3.751; KAUR C, 1994, ARCH HISTOL CYTOL, V57, P449, DOI 10.1679/aohc.57.449; Krueger-Naug AMR, 2002, NEUROSCIENCE, V110, P653, DOI 10.1016/S0306-4522(01)00453-5; LAPING NJ, 1994, BRAIN PATHOL, V4, P259, DOI 10.1111/j.1750-3639.1994.tb00841.x; Lechner J, 1997, IMMUNOBIOLOGY, V198, P112, DOI 10.1016/S0171-2985(97)80032-0; Maurel D, 2000, GLIA, V29, P212, DOI 10.1002/(SICI)1098-1136(20000201)29:3<212::AID-GLIA3>3.0.CO;2-6; MORRISON RS, 1985, J NEUROSCI RES, V14, P167, DOI 10.1002/jnr.490140202; NICHOLS NR, 1990, MOL BRAIN RES, V7, P1, DOI 10.1016/0169-328X(90)90066-M; OCALLAGHAN JP, 1991, J NEUROCHEM, V57, P860, DOI 10.1111/j.1471-4159.1991.tb08230.x; Osborne NN, 2001, CURR EYE RES, V22, P321, DOI 10.1076/ceyr.22.5.321.5496; PACKAN DR, 1990, NEUROENDOCRINOLOGY, V51, P613, DOI 10.1159/000125400; Qian T, 2000, MED HYPOTHESES, V55, P452, DOI 10.1054/mehy.2000.1165; Rauen T, 2000, NEUROCHEM INT, V37, P179, DOI 10.1016/S0197-0186(00)00021-8; Sheng Yanjuan, 2004, Yan Ke Xue Bao, V20, P181; Sherif Z, 2002, OPHTHALMOLOGICA, V216, P305, DOI 10.1159/000066189; Short DJ, 2000, SPINAL CORD, V38, P273, DOI 10.1038/sj.sc.3100986; So EY, 2002, FEBS LETT, V518, P53, DOI 10.1016/S0014-5793(02)02635-2; SPOOR TC, 1990, AM J OPHTHALMOL, V110, P665, DOI 10.1016/S0002-9394(14)77065-5; STARKMAN MN, 1992, BIOL PSYCHIAT, V32, P756, DOI 10.1016/0006-3223(92)90079-F; Steinsapir KD, 2000, RESTOR NEUROL NEUROS, V17, P157; Tanaka J, 1997, GLIA, V20, P23, DOI 10.1002/(SICI)1098-1136(199705)20:1<23::AID-GLIA3>3.0.CO;2-6; THANOS S, 1993, J NEUROSCI, V13, P455; THANOS S, 1994, TRENDS NEUROSCI, V17, P177, DOI 10.1016/0166-2236(94)90098-1; URBAN RC, 1986, SURV OPHTHALMOL, V31, P102, DOI 10.1016/0039-6257(86)90077-9; van der Goes A, 2000, J LEUKOCYTE BIOL, V67, P801; Vardimon L, 1999, J NEUROBIOL, V40, P513, DOI 10.1002/(SICI)1097-4695(19990915)40:4<513::AID-NEU8>3.0.CO;2-D; VIJAYAN VK, 1987, EXP NEUROL, V96, P307, DOI 10.1016/0014-4886(87)90049-5; Zhao ZQ, 2003, CARDIOVASC RES, V59, P132, DOI 10.1016/S0008-6363(03)00344-4	60	22	22	0	1	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0721-832X	1435-702X		GRAEF ARCH CLIN EXP	Graefes Arch. Clin. Exp. Ophthalmol.	NOV	2006	244	11					1512	1521		10.1007/s00417-005-0164-7			10	Ophthalmology	Ophthalmology	103PL	WOS:000241899100019	16568288				2021-06-18	
J	Moore, M; Taylor, HG; Klein, N; Minich, N; Hack, M				Moore, Melisa; Taylor, H. Gerry; Klein, Nancy; Minich, Nori; Hack, Maureen			Longitudinal changes in family outcomes of very low birth weight	JOURNAL OF PEDIATRIC PSYCHOLOGY			English	Article						family outcomes; low birth weight; longitudinal change	TRAUMATIC BRAIN INJURY; SCHOOL-AGE OUTCOMES; PSYCHOLOGICAL ADJUSTMENT; CHILDREN; IMPACT; PARENT; ADOLESCENCE; ACHIEVEMENT; CONFLICT; INFANTS	Objectives. Although children with very low birth weight (VLBW, < 1500 g) are at high risk for developmental impairments, we know little about the long-term effects of VLBW on families. This study examined long-term family outcomes and their stability over time. Methods. Participants were the families of 64 children with < 750 g birth weight, 54 with 750 - 1499 g birth weight, and 66 term-born controls. Family burden and parental distress were assessed annually as part of longitudinal follow-up of the children from mean ages 11 - 14 years. Results. Family burden and parental distress were higher in the < 750 g group than in the term-born group, but differences varied with the child's age and family environment. Conclusions. The findings document long-term effects of VLBW on families that are moderated by the degree of low birth weight, child's age, and family environment.	Univ Hosp Cleveland, Dept Pediat, Rainbow Babies & Childrens Hosp, Cleveland, OH 44106 USA; Case Western Reserve Univ, Dept Psychol, Cleveland, OH 44106 USA; Case Western Reserve Univ, Dept Pediat, Cleveland, OH 44106 USA; Cleveland State Univ, Dept Educ, Cleveland, OH 44115 USA	Taylor, HG (corresponding author), Univ Hosp Cleveland, Dept Pediat, Rainbow Babies & Childrens Hosp, 11100 Euclid Ave, Cleveland, OH 44106 USA.	hudson.taylor@case.edu			EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD026554] Funding Source: NIH RePORTER; NICHD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [HD 26554] Funding Source: Medline		BENDERSKY M, 1994, DEV PSYCHOL, V30, P484, DOI 10.1037/0012-1649.30.4.484; Botting N, 1997, J CHILD PSYCHOL PSYC, V38, P931, DOI 10.1111/j.1469-7610.1997.tb01612.x; Breslau N, 1996, BIOL PSYCHIAT, V40, P389, DOI 10.1016/0006-3223(95)00399-1; Burchinal M. R., 1999, EARLY EDUC DEV, V10, P83, DOI 10.1207/s15566935eed1001_6; Cohen J., 1988, STAT POWER ANAL BEHA, V2nd; CRONIN CMG, 1995, ARCH PEDIAT ADOL MED, V149, P151, DOI 10.1001/archpedi.1995.02170140033005; Derogatis L., 1982, BRIEF SYMPTOM INVENT; Diggle PJ, 1994, ANAL LONGITUDINAL DA; Drotar D, 1997, J PEDIATR PSYCHOL, V22, P149; Fanaroff AA, 2003, SEMIN PERINATOL, V27, P281, DOI 10.1016/S0146-0005(03)00055-7; FRISK V, 1994, DEV NEUROPSYCHOL, V10, P313, DOI 10.1080/87565649409540586; HACK M, 1995, FUTURE CHILD, V5, P176, DOI 10.2307/1602514; HACK M, 1994, NEW ENGL J MED, V331, P753, DOI 10.1056/NEJM199409223311201; Hollingshead A. B., 1975, 4 FACTOR INDEX SOCIA; Horwood LJ, 1998, ARCH DIS CHILD-FETAL, V79, pF12, DOI 10.1136/fn.79.1.F12; Keogh BK, 2000, AM J MENT RETARD, V105, P32, DOI 10.1352/0895-8017(2000)105<0032:MOCIFC>2.0.CO;2; KLEBANOV PK, 1994, J DEV BEHAV PEDIATR, V15, P248, DOI 10.1097/00004703-199408000-00005; KLEIN NK, 1989, J DEV BEHAV PEDIATR, V10, P32; LANDRY SH, 1988, J PEDIATR PSYCHOL, V13, P317, DOI 10.1093/jpepsy/13.3.317; Laursen B, 1998, CHILD DEV, V69, P817, DOI 10.2307/1132206; McCain G C, 1990, J Pediatr Nurs, V5, P97; MCCORMICK MC, 1986, J DEV BEHAV PEDIATR, V7, P217, DOI 10.1097/00004703-198608000-00001; Montemayor R., 1986, J ADOLESC RES, V1, P15, DOI [10.1177/074355488611003, DOI 10.1177/074355488611003]; MOOS R, 1994, LIFE STRESSES SOCIAL; Saigal S, 2000, J PEDIATR-US, V137, P701, DOI 10.1067/mpd.2000.109001; Saigal S, 2000, PEDIATRICS, V105, P325, DOI 10.1542/peds.105.2.325; Schafer JL., 1997, ANAL INCOMPLETE MULT; Singer JD, 1998, J EDUC BEHAV STAT, V23, P323; Singer LT, 1999, JAMA-J AM MED ASSOC, V281, P799, DOI 10.1001/jama.281.9.799; Smetana J, 1999, CHILD DEV, V70, P1447, DOI 10.1111/1467-8624.00105; Stein R, 1985, PACTS PAPERS AECOM T; SZATMARI P, 1993, DEV PSYCHOPATHOL, V5, P345, DOI 10.1017/S0954579400004454; Taylor HG, 2000, CHILD DEV, V71, P1495, DOI 10.1111/1467-8624.00242; Taylor HG, 1998, J DEV BEHAV PEDIATR, V19, P235; Taylor HG, 2004, J INT NEUROPSYCH SOC, V10, P149, DOI 10.1017/S1355617704102038; Taylor HG, 2002, CHILD NEUROPSYCHOL, V8, P163, DOI 10.1076/chin.8.3.163.13500; TAYLOR HG, 1995, J PEDIATR PSYCHOL, V20, P703, DOI 10.1093/jpepsy/20.6.703; Taylor HG, 2001, J INT NEUROPSYCH SOC, V7, P755, DOI 10.1017/S1355617701766118; Taylor HG, 2001, ARCH PEDIAT ADOL MED, V155, P155, DOI 10.1001/archpedi.155.2.155; THOMPSON RJ, 1993, INFANT BEHAV DEV, V16, P471, DOI 10.1016/0163-6383(93)80005-S; WADE S, 1995, J PEDIATR PSYCHOL, V20, P737, DOI 10.1093/jpepsy/20.6.737; Wade SL, 2004, J CONSULT CLIN PSYCH, V72, P776, DOI 10.1037/0022-006X.72.5.776; Wade SL, 2002, J HEAD TRAUMA REHAB, V17, P96, DOI 10.1097/00001199-200204000-00003; Wade SL, 1996, J LEARN DISABIL, V29, P652, DOI 10.1177/002221949602900609; WALLANDER JL, 1988, J PEDIATR PSYCHOL, V13, P197, DOI 10.1093/jpepsy/13.2.197	45	22	22	0	7	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0146-8693	1465-735X		J PEDIATR PSYCHOL	J. Pediatr. Psychol.	NOV-DEC	2006	31	10					1024	1035		10.1093/jpepsy/jsj075			12	Psychology, Developmental	Psychology	104JU	WOS:000241955500003	16150877	Bronze			2021-06-18	
J	Pascale, CL; Szmydynger-Chodobska, J; Sarri, JE; Chodobski, A				Pascale, C. L.; Szmydynger-Chodobska, J.; Sarri, J. E.; Chodobski, A.			TRAUMATIC BRAIN INJURY RESULTS IN A CONCOMITANT INCREASE IN NEOCORTICAL EXPRESSION OF VASOPRESSIN AND ITS V-1A RECEPTOR	JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY			English	Article						vasopressin; V-1a receptor; traumatic brain injury; cerebral cortex; rat	ARGININE-VASOPRESSIN; ENDOTHELIAL-CELLS; CHOROID-PLEXUS; MESSENGER-RNA; EDEMA; WATER; PERMEABILITY; PLASMA; VOLUME	Arginine vasopressin (AVP) has been shown to promote the disruption of the blood-brain barrier (BBB) and the formation of edema in various animal models of brain injury. However, the source(s) of this AVP have not been identified. Since the cerebral cortex was considerably affected in some of these brain injury models, we sought to determine if AVP was produced in the cerebral cortex, and, if so, whether or not this cortical AVP expression was up regulated after injury. In the present study, a controlled cortical impact model of traumatic brain injury (TBI) in rats was used, and the temporal changes in expression of AVP and its V-1a receptor were analyzed by real-time reverse-transcriptase polymerase chain reaction. The expression of AVP and its V-1a receptor in the ipsilateral cortex adjacent to the lesion area was significantly up regulated between 4 h and 1day post-TBI. The maximum increase in mRNA for AVP (4.3-fold) and its receptor (2.6-fold) in the ipsilateral vs. contralateral cortex was observed at 6 h post-TBI. Compared to sham-injured rats, no statistically significant changes in expression of AVP or its receptor were found in the contralateral cortex. These results suggest that the cerebral cortex is an important source of AVP in the injured brain, and the parallel increase in the expression of AVP and its cognate receptor may act to augment the actions of AVP related to promoting the disruption of the BBB and the formation of post-traumatic edema.	[Pascale, C. L.; Szmydynger-Chodobska, J.; Sarri, J. E.; Chodobski, A.] Brown Univ, Sch Med, Dept Clin Neurosci, Providence, RI 02903 USA	Chodobski, A (corresponding author), Brown Univ, Sch Med, Dept Clin Neurosci, Aldrich Bldg,Room 405,593 Eddy St, Providence, RI 02903 USA.	adam_chodobski@brown.edu			NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS49479]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS049479] Funding Source: NIH RePORTER	We thank Grzegorz Michalowski (Michalowski Inc., Zossen, Germany) for providing the controlled cortical impact device. This work was supported by grant NS49479 from the NIH.	Barreca T, 2001, CEREBROVASC DIS, V11, P113, DOI 10.1159/000047622; Bemana I, 1999, NEUROSURGERY, V44, P148, DOI 10.1097/00006123-199901000-00091; BUIJS RM, 1978, CELL TISSUE RES, V186, P423, DOI 10.1007/BF00224932; Buijs RM, 1987, VASOPRESSIN PRINCIPL, P91; Chodobski A, 1997, MOL BRAIN RES, V48, P67, DOI 10.1016/S0169-328X(97)00079-X; Chodobski A, 2001, MICROSC RES TECHNIQ, V52, P65; DEPASQUALE M, 1989, AM J PHYSIOL, V256, pF1059; DICKINSON LD, 1992, J CEREBR BLOOD F MET, V12, P681, DOI 10.1038/jcbfm.1992.93; Hallbeck M, 1999, J COMP NEUROL, V411, P181; Hertz L, 2000, J NEUROSCI RES, V62, P480, DOI 10.1002/1097-4547(20001115)62:4<480::AID-JNR2>3.0.CO;2-K; Huang Wei-dong, 2003, Chin J Traumatol, V6, P139; Hupf H, 1999, CIRC RES, V84, P365, DOI 10.1161/01.RES.84.3.365; JOYNT RJ, 1981, ANN NEUROL, V9, P182, DOI 10.1002/ana.410090212; Kagawa M, 1996, J NEUROTRAUM, V13, P273, DOI 10.1089/neu.1996.13.273; Liu XZ, 2000, HEALTH POLICY PLANN, V15, P157, DOI 10.1093/heapol/15.2.157; LOESCH A, 1991, ANAT EMBRYOL, V183, P129; LOESCH A, 1993, BRAIN RES, V611, P333, DOI 10.1016/0006-8993(93)90522-O; LOESCH A, 1991, PEPTIDES, V12, P1095, DOI 10.1016/0196-9781(91)90065-W; MATHER HM, 1981, J NEUROL NEUROSUR PS, V44, P216, DOI 10.1136/jnnp.44.3.216; Niermann H, 2001, J NEUROSCI, V21, P3045, DOI 10.1523/JNEUROSCI.21-09-03045.2001; RAICHLE ME, 1978, BRAIN RES, V143, P191, DOI 10.1016/0006-8993(78)90766-7; Rosenberg G A, 1990, Adv Neurol, V52, P149; ROSENBERG GA, 1986, AM J PHYSIOL, V251, pF485; ROSENBERG GA, 1992, STROKE, V23, P1767, DOI 10.1161/01.STR.23.12.1767; Shuaib A, 2002, STROKE, V33, P3033, DOI 10.1161/01.STR.0000039405.31526.06; SORENSEN PS, 1985, J NEUROL NEUROSUR PS, V48, P50, DOI 10.1136/jnnp.48.1.50; Szmydynger-Chodobska J, 2004, J NEUROTRAUM, V21, P1090, DOI 10.1089/0897715041651033; Vakili A, 2005, J CEREBR BLOOD F MET, V25, P1012, DOI 10.1038/sj.jcbfm.9600097	28	22	25	0	0	POLISH PHYSIOLOGICAL SOC	GRZEGORZECKA	JAGIELLONIAN UNIV SCHOOL MED, INST PHYSIOLOGY, 31-531 KRAKOW, 16 GRZEGORZECKA, POLAND	0867-5910			J PHYSIOL PHARMACOL	J. Physiol. Pharmacol.	NOV	2006	57			11			161	167					7	Physiology	Physiology	V19RD	WOS:000208088600013	17244947				2021-06-18	
J	Dombrowski, SM; Schenk, S; Leichliter, A; Leibson, Z; Fukamachi, K; Luciano, MG				Dombrowski, Stephen M.; Schenk, Soren; Leichliter, Anna; Leibson, Zack; Fukamachi, Kiyotaka; Luciano, Mark G.			Chronic hydrocephalus-induced changes in cerebral blood flow: mediation through cardiac effects	JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM			English	Article						aquaductal stenosis; autoregulation; canine; cerebrovascular; compliance	NORMAL-PRESSURE HYDROCEPHALUS; TRAUMATIC BRAIN-INJURY; SUBARACHNOID HEMORRHAGE; INTRACRANIAL-PRESSURE; TRANSCRANIAL DOPPLER; ELECTROCARDIOGRAPHIC CHANGES; VENTRICULOPERITONEAL SHUNT; OBSTRUCTIVE HYDROCEPHALUS; CEREBROSPINAL-FLUID; MATHEMATICAL-MODEL	Decreased cerebral blood flow (CBF) in hydrocephalus is believed to be related to increased intracranial pressure (ICP), vascular compression as the result of enlarged ventricles, or impaired metabolic activity. Little attention has been given to the relationship between cardiac function and systemic blood flow in chronic h ydrocephalus (CH). Using an experimental model of chronic obstructive hydrocephalus developed in our laboratory, we investigated the relationship between the duration and severity of hydrocephalus and cardiac output (CO), CBF, myocardial tissue perfusion (MTP), and peripheral blood flow (PBF). Blood flow measures were obtained using the microsphere injection method under controlled hemodynamic conditions in experimental CH (n = 23) and surgical control (n = 8) canines at baseline and at 2, 4, 8, 12, and 16 weeks. Cardiac output measures were made using the Swan-Ganz thermodilution method. Intracranial compliance (ICC) via cerebrospinal fluid (CSF) bolus removal and infusion, and oxygen delivery in CSF and prefrontal cortex (PFC) were also investigated. We observed an initial surgical effect relating to 30% CO reduction and similar to 50% decrease in CBF, MTP, and PBF in both groups 2 weeks postoperatively, which recovered in control animals but continued to decline further in CH animals at 16 weeks. Cerebral blood flow, which was positively correlated with CO (P = 0.028), showed no significant relationship with either CSF volume or pressure. Decreased CBF correlated with oxygen deprivation in PFC (P = 0.006). Cardiac output was inversely related with ventriculomegaly (P = 0.019), but did not correlate with ICP. Decreased CO corresponded to increased ICC, as measured by CSF infusion (P = 0.04). Our results suggest that CH may have more of an influence on CO and CBF in the chronic stage than in the early condition, which was dominated by surgical effect. The cause of this late deterioration of cardiac function in hydrocephalus is uncertain, but may reflect cardiac regulation secondary to physiologic response or brain injury. The relationship between cardiac function and CBF should be considered in the pathophysiology and clinical treatment of CH.	Cleveland Clin Fdn, Dept Neurol Surg Pediat & Congenital Neurol Surg, Cleveland, OH 44195 USA; Cleveland Clin Fdn, Dept Biomed Engn, Lerner Res Inst, Cleveland, OH 44195 USA	Dombrowski, SM (corresponding author), Cleveland Clin Fdn, Dept Neurosurg, 9500 Euclid Ave,S-80, Cleveland, OH 44195 USA.	dombros@ccf.org			NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [1 R01 NS4153353-01A1] Funding Source: Medline		Bateman GA, 2005, NEURORADIOLOGY, V47, P741, DOI 10.1007/s00234-005-1418-0; Bateman GA, 2004, MED HYPOTHESES, V62, P182, DOI 10.1016/S0306-9877(03)00330-X; Biswas AK, 2000, CRIT CARE MED, V28, P3907, DOI 10.1097/00003246-200012000-00030; CASMIRO M, 1989, J NEUROL NEUROSUR PS, V52, P847, DOI 10.1136/jnnp.52.7.847; Chang CC, 1999, NUCL MED COMMUN, V20, P167, DOI 10.1097/00006231-199902000-00009; CROPP GJ, 1960, CIRCULATION, V22, P25, DOI 10.1161/01.CIR.22.1.25; Czosnyka M, 2003, ACT NEUR S, V86, P581; Czosnyka ZH, 2002, NEUROSURGERY, V50, P526, DOI 10.1097/00006123-200203000-00018; DASILVA MC, 1995, J CEREBR BLOOD F MET, V15, P1057, DOI 10.1038/jcbfm.1995.132; DAVIS DH, 1980, J NEUROSURG, V52, P745, DOI 10.3171/jns.1980.52.6.0745; de Hoon JN, 2003, CEPHALALGIA, V23, P96, DOI 10.1046/j.1468-2982.2003.00465.x; DELBIGIO MR, 1989, NEUROSURGERY, V25, P416, DOI 10.1227/00006123-198909000-00016; DELBIGIO MR, 1988, J NEUROSURG, V69, P115, DOI 10.3171/jns.1988.69.1.0115; DELBIGIO MR, 1988, ACTA NEUROPATHOL, V77, P186, DOI 10.1007/BF00687430; DELBIGIO MR, 1993, ACTA NEUROPATHOL, V85, P573, DOI 10.1007/BF00334666; DICKER D, 1983, ISRAEL J MED SCI, V19, P364; Edwards RJ, 2004, BRAIN PATHOL, V14, P325; Elrifai AM, 1996, STROKE, V27, P737, DOI 10.1161/01.STR.27.4.737; Fukuhara T, 2001, J NEUROSURG, V94, P573, DOI 10.3171/jns.2001.94.4.0573; GOH D, 1995, CHILD NERV SYST, V11, P392, DOI 10.1007/BF00717403; GRAFFRADFORD NR, 1987, NEUROLOGY, V37, P868, DOI 10.1212/WNL.37.5.868; GRAFFRADFORD NR, 1987, J NEUROL NEUROSUR PS, V50, P1589, DOI 10.1136/jnnp.50.12.1589; GREENHOO.JH, 1969, J NEUROSURG, V30, P521, DOI 10.3171/jns.1969.30.5.0521; GREITZ D, 1992, NEURORADIOLOGY, V34, P370, DOI 10.1007/BF00596493; Gruhn N, 2001, STROKE, V32, P2530, DOI 10.1161/hs1101.098360; HERSCH C, 1964, BRIT HEART J, V26, P785; HIGASHI K, 1986, Neurological Research, V8, P169; IBAYASHI S, 1986, STROKE, V17, P261, DOI 10.1161/01.STR.17.2.261; Johnson MJ, 1999, J NEUROSCI METH, V91, P55, DOI 10.1016/S0165-0270(99)00072-2; JONES HC, 1993, J CEREBR BLOOD F MET, V13, P531, DOI 10.1038/jcbfm.1993.69; Kadas ZM, 1997, NEUROL RES, V19, P441, DOI 10.1080/01616412.1997.11740840; Kawamata T, 2003, ACTA NEUROCHIR SUPPL, V86, P545; Klinge P, 2002, ACT NEUR S, V81, P47; Klinge P, 2002, ACTA NEUROCHIR SUPPL, V81, P39; Klinge PM, 2003, STROKE, V34, P193, DOI 10.1161/01.STR.0000048820.17198.15; Krauss JK, 1996, STROKE, V27, P24, DOI 10.1161/01.STR.27.1.24; Lakin WD, 2003, J MATH BIOL, V46, P347, DOI 10.1007/s00285-002-0177-3; LARSEN FS, 1994, STROKE, V25, P1985, DOI 10.1161/01.STR.25.10.1985; LARSSON A, 1994, EUR J NUCL MED, V21, P118; Lieb K, 1996, J NEUROCHEM, V67, P2039; Luciano MG, 2001, J CEREBR BLOOD F MET, V21, P285, DOI 10.1097/00004647-200103000-00012; MABE H, 1990, CHILD NERV SYST, V6, P388, DOI 10.1007/BF00302224; MAMO HL, 1987, STROKE, V18, P1074, DOI 10.1161/01.STR.18.6.1074; MARION DW, 1986, NEUROSURGERY, V18, P101, DOI 10.1227/00006123-198601000-00019; Marshall RS, 2004, CURR OPIN NEUROL, V17, P705, DOI 10.1097/00019052-200412000-00010; Masuda T, 2002, STROKE, V33, P1671, DOI 10.1161/01.STR.0000016327.74392.02; Mataro M, 2003, J NUCL MED, V44, P1884; Mayer SA, 1999, STROKE, V30, P780, DOI 10.1161/01.STR.30.4.780; Minhas PS, 2004, NEUROSURGERY, V55, P63, DOI 10.1227/01.NEU.0000126876.10254.05; Momjian S, 2004, BRAIN, V127, P965, DOI 10.1093/brain/awh131; Mori K, 2002, ACTA NEUROCHIR, V144, P255, DOI 10.1007/s007010200033; NAKADA J, 1992, ACTA NEUROCHIR, V114, P43, DOI 10.1007/BF01401113; Nortje J, 2004, CURR OPIN NEUROL, V17, P711, DOI 10.1097/00019052-200412000-00011; Owler BK, 2004, J CEREBR BLOOD F MET, V24, P17, DOI 10.1097/01.WCB.0000093326.88757.49; Owler BK, 2001, ACTA NEUROL SCAND, V104, P325, DOI 10.1034/j.1600-0404.2001.00092.x; Reinhardt CP, 2001, AM J PHYSIOL-HEART C, V280, pH108; RUDEHILL A, 1987, ACTA ANAESTH SCAND, V31, P265, DOI 10.1111/j.1399-6576.1987.tb02563.x; RUDEHILL A, 1987, J NEUROL NEUROSUR PS, V50, P1375, DOI 10.1136/jnnp.50.10.1375; Rupprecht T, 2001, ULTRASCHALL MED, V22, P122, DOI 10.1055/s-2001-15241; Silvestrini M, 2004, HEADACHE, V44, P29, DOI 10.1111/j.1526-4610.2004.04006.x; TALMAN WT, 1985, ANN NEUROL, V18, P1, DOI 10.1002/ana.410180102; Tanaka A, 1997, NEUROSURGERY, V40, P1161, DOI 10.1097/00006123-199706000-00009; TRANMER BI, 1992, J NEUROSURG, V77, P253, DOI 10.3171/jns.1992.77.2.0253; Ursino M, 2003, MED ENG PHYS, V25, P655, DOI 10.1016/S1350-4533(02)00251-5; van Aken J, 2003, MINIM INVAS NEUROSUR, V46, P198; van Lieshout JJ, 2003, J APPL PHYSIOL, V94, P833, DOI 10.1152/japplphysiol.00260.2002; Williams DJ, 2001, CLIN EXP PHARMACOL P, V28, P868, DOI 10.1046/j.1440-1681.2001.03540.x; WOZNIAK M, 1975, J NEUROSURG, V43, P535, DOI 10.3171/jns.1975.43.5.0535; Zierski J, 1987, Acta Neurochir Suppl (Wien), V40, P95	69	22	23	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	0271-678X			J CEREBR BLOOD F MET	J. Cereb. Blood Flow Metab.	OCT	2006	26	10					1298	1310		10.1038/sj.jcbfm.9600282			13	Endocrinology & Metabolism; Hematology; Neurosciences	Endocrinology & Metabolism; Hematology; Neurosciences & Neurology	087MO	WOS:000240746700008	16495938	Bronze			2021-06-18	
J	Ryb, GE; Soderstrom, CA; Kufera, JA; Dischinger, P				Ryb, Gabriel E.; Soderstrom, Carl A.; Kufera, Joseph A.; Dischinger, Patricia			Longitudinal study of suicide after traumatic injury	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article; Proceedings Paper	7th World Conference on Injury Prevention and Safety Promotion	JUN 06-09, 2004	Vienna, AUSTRIA			alcoholism; suicide; trauma	POSTTRAUMATIC-STRESS-DISORDER; SPINAL-CORD INJURY; BRAIN-INJURY; RISK-FACTORS; PSYCHIATRIC-DISORDERS; ALCOHOL; DEPRESSION; LIFE; PSYCHOPATHOLOGY; METAANALYSIS	Background. Suicide risk after discharge among trauma patients could be influenced by multiple factors. The aim of this study is to establish whether patients discharged from a trauma center experience an increased suicide rate and whether this can be explained by defined demographic, injury, or alcohol abuse risk factors. Methods: Patients admitted between July 1, 1983, and June 30, 1995, and discharged alive from a Level I trauma center (n = 27,399) were followed for 1.5 to 14.5 years to determine whether they had died. Death determination was made by an epidemiologic support service, which had created a repository of death certificates. Variables used in the analyses included age, gender, race, Injury Severity Score, discharge disposition, mechanism of injury, and alcohol toxicology. General and trauma populations were compared using standard mortality rates. Risk factors for suicide within the trauma population were explored using Pearson's chi(2), Mantel-Haenszel chi(2), Cox proportional hazards, and Mantel-Cox log-rank methodology. Results: Suicide was more common in the trauma than in the general population (standard mortality rate = 1.71). This difference may be attributed primarily to alcohol use problems. Suicide risk in the trauma population increased with age from 25 to 44 years, male gender, Caucasian race, and positive alcohol toxicology. Disability (as measured by discharge disposition), but not injury severity, also seemed to have an influence on suicide rates. Conclusion: Interventions that address modifiable risk factors for suicide (substance abuse, psychiatric disorders, hopelessness, and social isolation) could benefit trauma patients known to be at higher risk for suicide, particularly those abusing alcohol.	Univ Maryland, Natl Study Ctr Trauma & Emergency Med Syst, Sch Med, Baltimore, MD 21201 USA	Ryb, GE (corresponding author), Univ Maryland, Natl Study Ctr Trauma & Emergency Med Syst, Sch Med, 701 W Pratt St,5th Floor, Baltimore, MD 21201 USA.	gabyryb@pol.net					Beautrais AL, 1999, SUICIDE LIFE-THREAT, V29, P37; BECK AT, 1985, AM J PSYCHIAT, V142, P559; Blow FC, 2004, ALCOHOL CLIN EXP RES, V28, p48S, DOI 10.1097/01.ALC.0000127414.15000.83; BLUMENTHAL SJ, 1988, MED CLIN N AM, V72, P937, DOI 10.1016/S0025-7125(16)30754-4; Brady KT, 2000, J CLIN PSYCHIAT, V61, P22; Centers for Disease Control and Prevention, WEB BAS INJ STAT QUE; CHARLIFUE SW, 1991, ARCH PHYS MED REHAB, V72, P488; Conner KR, 2004, ALCOHOL CLIN EXP RES, V28, p6S, DOI 10.1097/01.ALC.0000127410.84505.2A; DEVIVO MJ, 1991, PARAPLEGIA, V29, P620, DOI 10.1038/sc.1991.91; Dischinger PC, 2001, J TRAUMA, V51, P877, DOI 10.1097/00005373-200111000-00009; Dunham C M, 1989, Md Med J, V38, P227; Fu Q, 2002, PSYCHOL MED, V32, P11, DOI 10.1017/S0033291701004846; Goldsmith SK, 2002, REDUCING SUICIDE NAT; GUNNELL D, 1994, BMJ-BRIT MED J, V308, P1227, DOI 10.1136/bmj.308.6938.1227; GUNNELL DJ, 1995, BRIT MED J, V311, P226, DOI 10.1136/bmj.311.6999.226; Harris EC, 1997, BRIT J PSYCHIAT, V170, P205, DOI 10.1192/bjp.170.3.205; Hartkopp A, 1998, ARCH PHYS MED REHAB, V79, P1356, DOI 10.1016/S0003-9993(98)90227-1; Harwitz D, 2000, EMERG MED CLIN N AM, V18, P263, DOI 10.1016/S0733-8627(05)70123-1; Hibbard MR, 2000, BRAIN INJURY, V14, P45, DOI 10.1080/026990500120925; Hirschfeld RMA, 1997, NEW ENGL J MED, V337, P910, DOI 10.1056/NEJM199709253371307; KELLERMANN AL, 1992, NEW ENGL J MED, V327, P467, DOI 10.1056/NEJM199208133270705; Kishi Y, 2001, PSYCHOSOMATICS, V42, P382, DOI 10.1176/appi.psy.42.5.382; Koller G, 2002, EUR ARCH PSY CLIN N, V252, P155, DOI 10.1007/s00406-002-0362-9; Koponen S, 2002, AM J PSYCHIAT, V159, P1315, DOI 10.1176/appi.ajp.159.8.1315; Kotler M, 2001, J NERV MENT DIS, V189, P162, DOI 10.1097/00005053-200103000-00004; Leon-Carrion J, 2001, BRAIN INJURY, V15, P175, DOI 10.1080/026990501458407; Maio RF, 1997, ACAD EMERG MED, V4, P256, DOI 10.1111/j.1553-2712.1997.tb03545.x; Malone KM, 2000, AM J PSYCHIAT, V157, P1084, DOI 10.1176/appi.ajp.157.7.1084; Marshall RD, 2001, AM J PSYCHIAT, V158, P1467, DOI 10.1176/appi.ajp.158.9.1467; Mazza JJ, 2000, SUICIDE LIFE-THREAT, V30, P91; Michaels AJ, 1999, J TRAUMA, V47, P460, DOI 10.1097/00005373-199909000-00005; Neeleman J, 2001, INT J EPIDEMIOL, V30, P154, DOI 10.1093/ije/30.1.154; PETRONIS KR, 1990, SOC PSYCH PSYCH EPID, V25, P193; Poole GV, 1997, J TRAUMA, V42, P711, DOI 10.1097/00005373-199704000-00022; RIVARA FP, 1993, ARCH SURG-CHICAGO, V128, P907; Ryb GE, 1999, J TRAUMA, V47, P874, DOI 10.1097/00005373-199911000-00010; Satcher D, 1999, SURG GEN CALL ACTION; Shea MT, 2000, COMPR PSYCHIAT, V41, P315, DOI 10.1053/comp.2000.9007; Silver JM, 2001, BRAIN INJURY, V15, P935, DOI 10.1080/02699050110065295; Simpson G, 2002, PSYCHOL MED, V32, P687, DOI 10.1017/S0033291702005561; Soderstrom CA, 1997, JAMA-J AM MED ASSOC, V277, P1769, DOI 10.1001/jama.277.22.1769; Soderstrom CA, 1997, J TRAUMA, V42, P67, DOI 10.1097/00005373-199701000-00012; WARSHAW MG, 1993, AM J PSYCHIAT, V150, P1512; Welch SS, 2001, PSYCHIAT SERV, V52, P368, DOI 10.1176/appi.ps.52.3.368; WHETSELL LA, 1989, J TRAUMA, V29, P1158, DOI 10.1097/00005373-198908000-00015; ZATRICK D, 2004, J TRAUMA, V57, P360	46	22	22	0	8	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0022-5282			J TRAUMA	J. Trauma-Injury Infect. Crit. Care	OCT	2006	61	4					799	804		10.1097/01.ta.0000196763.14289.4e			6	Critical Care Medicine; Surgery	General & Internal Medicine; Surgery	096YU	WOS:000241413700008	17033543				2021-06-18	
J	Johnston, NJ; King, AT; Protheroe, R; Childs, C				Johnston, Nicola J.; King, Andrew T.; Protheroe, Richard; Childs, Charmaine			Body temperature management after severe traumatic brain injury: Methods and protocols used in the United Kingdom and Ireland	RESUSCITATION			English	Article						brain injury; temperature; intensive care	INTENSIVE-CARE-UNIT; SEVERE HEAD-INJURY; LENGTH-OF-STAY; THERAPEUTIC HYPOTHERMIA; RECTAL TEMPERATURES; CLINICAL-TRIAL; FEVER CONTROL; ACUTE STROKE; HYPERTHERMIA; WORSENS	Objective: To establish whether there is consensus in the management of body temperature in patients with severe traumatic brain injury (TBI) admitted to hospitals in the United Kingdom and Ireland for neurosurgical intensive care. Methods: Permission was granted from the Society of British Neurosurgeons (SBNS) and the Local Research Ethics Committee to undertake the survey. A senior member of nursing staff from all adult neurosurgical units, excluding our own, was contacted by telephone. Results: All 33 adult neurosurgical centres participated. Six units had a formal written protocol for the management of body temperature. For the remainder (27 units), interest was expressed in a protocol for temperature management particularly for those patients with intractable hyperthermia/fever. Administration of the antipyretic paracetamol was the most common 'first-line' treatment (13 units). Other 'first-line' methods were: circulating air-cooling blankets (9 units), water-filled cooling blankets (6 units), tepid sponging or wet soaks (2 units), convection fans (2 units) and administration of cold fluids via the gut or circulation (1 unit). When 'first-line' methods failed to bring about a fall in temperature, different combinations of these methods were used. Conclusions: From this survey, it is evident that there is no consensus in the approach to temperature management in neurosurgical intensive care patients with severe TBI. Review and rationalisation of systems of care may be required in an effort to develop evidence-based nationwide guidelines. (c) 2006 Elsevier Ireland Ltd. All rights reserved.	Univ Manchester, Hope Hosp, Dept Neurosurg, Div Med & Neurosci, Salford M6 8HD, Lancs, England; Hope Hosp, Dept Neurosurg, Salford M6 8HD, Lancs, England; Hope Hosp, Dept Intens Care Med, Salford M6 8HD, Lancs, England	Childs, C (corresponding author), Univ Manchester, Hope Hosp, Dept Neurosurg, Div Med & Neurosci, Eccles Old Rd, Salford M6 8HD, Lancs, England.	cchilds@manchester.ac.uk	King, Andrew/AAR-1656-2020; Childs, Charmaine/G-9928-2012	King, Andrew/0000-0002-6546-7248			ALDERSON P, THERAPEUTIC HYPOTHER; AZZIMONDI G, 1995, STROKE, V26, P2040, DOI 10.1161/01.STR.26.11.2040; BUSTO R, 1987, J CEREBR BLOOD F MET, V7, P729, DOI 10.1038/jcbfm.1987.127; Childs C, 2005, ANAESTHESIA, V60, P759, DOI 10.1111/j.1365-2044.2005.04193.x; Childs C, 2004, ANAESTHESIA, V59, P192, DOI 10.1111/j.1365-2044.2003.03638.x; Clifton GL, 2001, NEW ENGL J MED, V344, P556, DOI 10.1056/NEJM200102223440803; CLIFTON GL, 1993, J NEUROTRAUM, V10, P263, DOI 10.1089/neu.1993.10.263; Dietrich WD, 1996, NEUROSURGERY, V38, P533, DOI 10.1097/00006123-199603000-00023; DIETRICH WD, 1990, STROKE, V21, P1318, DOI 10.1161/01.STR.21.9.1318; Diringer MN, 2004, CRIT CARE MED, V32, P1489, DOI 10.1097/01.CCM.0000129484.61912.84; Diringer MN, 2004, CRIT CARE MED, V32, P559, DOI 10.1097/01.CCM.0000108868.97433.3F; Fulbrook Paul, 2003, Nurs Crit Care, V8, P249; Ghajar J, 2000, LANCET, V356, P923, DOI 10.1016/S0140-6736(00)02689-1; GLOBUS MYT, 1995, J NEUROCHEM, V65, P1704; Henker RA, 1998, NEUROSURGERY, V42, P1071, DOI 10.1097/00006123-199805000-00071; Kilpatrick MM, 2000, NEUROSURGERY, V47, P850, DOI 10.1097/00006123-200010000-00011; Kim Y, 1996, STROKE, V27, P2274, DOI 10.1161/01.STR.27.12.2274; MARION DW, 1993, J NEUROSURG, V79, P354, DOI 10.3171/jns.1993.79.3.0354; Mayer SA, 2001, NEUROLOGY, V56, P292, DOI 10.1212/WNL.56.3.292; Mayer SA, 2004, CRIT CARE MED, V32, P2508, DOI 10.1097/01.CCM.0000147441.39670.37; Natale JE, 2000, CRIT CARE MED, V28, P2608, DOI 10.1097/00003246-200007000-00071; O'Grady NP, 1998, CRIT CARE MED, V26, P392, DOI 10.1097/00003246-199802000-00046; Polderman KH, 2004, INTENS CARE MED, V30, P757, DOI 10.1007/s00134-003-2151-y; Reith J, 1996, LANCET, V347, P422, DOI 10.1016/S0140-6736(96)90008-2; Rumana CS, 1998, CRIT CARE MED, V26, P562, DOI 10.1097/00003246-199803000-00032; Schmutzhard E, 2002, CRIT CARE MED, V30, P2481, DOI 10.1097/00003246-200211000-00013; SHIOZAKI T, 1993, J NEUROSURG, V79, P363, DOI 10.3171/jns.1993.79.3.0363; TAKAGI K, 1994, AM J PHYSIOL-HEART C, V267, pH1770; Thompson HJ, 2003, NEUROBIOL DIS, V12, P163, DOI 10.1016/S0969-9961(02)00030-X	29	22	23	0	6	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0300-9572			RESUSCITATION	Resuscitation	AUG	2006	70	2					254	262		10.1016/j.resuscitation.2006.02.010			9	Critical Care Medicine; Emergency Medicine	General & Internal Medicine; Emergency Medicine	083WL	WOS:000240488800014	16828961				2021-06-18	
J	Taitsman, LA; Nork, SE; Coles, CP; Barei, DP; Agel, J				Taitsman, Lisa A.; Nork, Sean E.; Coles, Chad P.; Barei, David P.; Agel, Julie			Open clavicle fractures and associated injuries	JOURNAL OF ORTHOPAEDIC TRAUMA			English	Article						clavicle fracture; open fracture; pneumothorax; polytrauma	PLATE FIXATION; MIDCLAVICULAR FRACTURES; NONOPERATIVE TREATMENT; INTERNAL-FIXATION; LONG BONES; MIDSHAFT; PNEUMOTHORAX; NONUNION; COMPLICATIONS; MANAGEMENT	Objectives: To describe the associated injuries, demographic distribution, and management of patients sustaining open clavicle fractures. Design: Retrospective case series. Setting: A single level-1 trauma center. Patients: Twenty patients with open clavicle fractures were identified from a prospectively collected orthopaedic trauma registry. Intervention: All patients were managed with surgical irrigation and debridement with or without internal fixation. Results: Thirteen patients (65%) had a closed head injury. Fifteen patients (75%) had a significant associated pulmonary injury. In that group, there were 10 patients who had a pneumothorax (7 bilateral). Additionally, 12 patients had rib fractures and I I had documented pulmonary contusions or effusions. Seven patients (35%) had a cervical or thoracic spine fracture or dislocation. Eight patients (40%) had concomitant scapula fractures. Six patients (30%) had additional ipsilateral upper extremity injuries remote from the shoulder girdle. One patient had a scapulothoracie dissociation. Eleven patients (55%) sustained significant facial trauma including fractures (5 patients), lacerations, and hematomas. Fourteen patients (70%) were treated with open reduction internal fixation. Fifteen patients (75%) were followed to healing (mean: 111 wk, median: 56 wk, range: 13 to 333 wk). There were no other complications related to the operative fixations. There were no known infections or nonunions. Conclusions: Open clavicle fractures are a rare injury. Patients often have associated pulmonary and cranial injuries. lpsilateral upper extremity and shoulder girdle injuries are common, whereas concomitant neurologic and vascular injuries are infrequent. The majority of patients have rapid and uneventful healing of their fractures after surgical treatment.	Dept Orthopaed, Seattle, WA 98104 USA; Dalhousie Univ, Halifax, NS B3H 3A7, Canada	Taitsman, LA (corresponding author), Dept Orthopaed, Box 359798,325 9th Ave, Seattle, WA 98104 USA.	ltaitsman@u.washington.edu		Coles, Chad/0000-0003-0454-3507			ALLMAN FL, 1967, J BONE JOINT SURG AM, VA 49, P774, DOI 10.2106/00004623-196749040-00024; Bostman O, 1997, J TRAUMA, V43, P778, DOI 10.1097/00005373-199711000-00008; Chu CM, 2002, ACTA ORTHOP SCAND, V73, P134, DOI 10.1080/000164702753671696; Coupe BD, 2005, INJURY, V36, P1166, DOI 10.1016/j.injury.2005.03.007; Dath R, 2004, EMERG MED J, V21, P395, DOI 10.1136/emj.2002.002733; DUGDALE TW, 1987, CLIN ORTHOP RELAT R, P212; Ebraheim NA, 1997, J TRAUMA, V42, P701, DOI 10.1097/00005373-199704000-00020; Grassi FA, 2001, J TRAUMA, V50, P1096, DOI 10.1097/00005373-200106000-00019; Graves ML, 2005, ORTHOPEDICS, V28, P761; GUSTILO RB, 1987, ORTHOPEDICS, V10, P1781; GUSTILO RB, 1976, J BONE JOINT SURG AM, V58, P453, DOI 10.2106/00004623-197658040-00004; HERSCOVICI D, 1995, CLIN ORTHOP RELAT R, V318, P54; Jones G L, 2000, J South Orthop Assoc, V9, P43; Kabak S, 2004, J SHOULDER ELB SURG, V13, P396, DOI 10.1016/j.jse.2004.01.033; Kitsis CK, 2003, INJURY, V34, P69, DOI 10.1016/S0020-1383(02)00169-9; Kloen P, 2002, J ORTHOP TRAUMA, V16, P425, DOI 10.1097/00005131-200207000-00011; Laursen MB, 1999, J SHOULDER ELB SURG, V8, P410, DOI 10.1016/S1058-2746(99)90068-X; LIM M, 2003, P 20 ANN M ORTH TRAU; MALCOLM BW, 1979, CAN J SURG, V22, P84; McKee MD, 2003, J BONE JOINT SURG AM, V85A, P790, DOI 10.2106/00004623-200305000-00003; McKee Michael D, 2004, J Bone Joint Surg Am, V86-A Suppl 1, P37; MEEKS RJ, 1991, AM J EMERG MED, V9, P555, DOI 10.1016/0735-6757(91)90112-W; Ngarmukos C, 1998, J BONE JOINT SURG BR, V80B, P106, DOI 10.1302/0301-620X.80B1.7880; NORDQVIST A, 1994, CLIN ORTHOP RELAT R, P127; Nowak J, 2004, J SHOULDER ELB SURG, V13, P479, DOI 10.1016/j.jse.2004.01.026; O'Connor D, 2004, INJURY, V35, P575, DOI 10.1016/S0020-1383(03)00239-0; *ORTH TRAUM ASS CO, 1996, J ORTHOP TRAUMA, V10; POST M, 1989, CLIN ORTHOP RELAT R, P89; Postacchini F, 2002, J SHOULDER ELB SURG, V11, P452, DOI 10.1067/mse.2002.126613; Ring D, 1998, SKELETAL TRAUMA, P1670; Robinson M, 2004, J BONE JOINT SURG AM, V86A, P1359, DOI 10.2106/00004623-200407000-00002; ROWE CR, 1968, CLIN ORTHOP RELAT R, P29; SCHUIND F, 1988, J BONE JOINT SURG AM, V70A, P692, DOI 10.2106/00004623-198870050-00008; Shen WJ, 1999, INJURY, V30, P497, DOI 10.1016/S0020-1383(99)00140-0; Simon R G, 1999, Am J Orthop (Belle Mead NJ), V28, P301; Tavitian JD, 2002, INJURY, V33, P135, DOI 10.1016/S0020-1383(01)00069-9; Verborgt Olivier, 2005, Acta Orthop Belg, V71, P17; WILLIAMS RJ, 1995, J ACCID EMERG MED, V12, P218; YOKOYAMA K, 1994, J TRAUMA, V37, P230, DOI 10.1097/00005373-199408000-00014; Zlowodzki M, 2005, J ORTHOP TRAUMA, V19, P504, DOI 10.1097/01.bot.0000172287.44278.ef	40	22	23	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0890-5339	1531-2291		J ORTHOP TRAUMA	J. Orthop. Trauma	JUL	2006	20	6					396	399		10.1097/00005131-200607000-00005			4	Orthopedics; Sport Sciences	Orthopedics; Sport Sciences	064TD	WOS:000239111100005	16825964				2021-06-18	
J	Truog, RD; Christ, G; Browning, DM; Meyer, EC				Truog, Robert D.; Christ, Grace; Browning, David M.; Meyer, Elaine C.			Sudden traumatic death in children - "We did everything, but your child didn't survive"	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							OF-LIFE CARE; ORGAN DONATION; PARENTAL PERSPECTIVES; FAMILY PERSPECTIVES; HOSPITAL STAFF; BRAIN-DEATH; END; QUALITY; BEREAVEMENT; ETHICS	When caring for children who become suddenly and catastrophically ill, clinicians must simultaneously attend to a complex and rapidly evolving medical situation, as well as to the equally challenging demands of establishing compassionate relationships with family members and communicating well with colleagues. An 18-month-old toddler was brought to the hospital with severe head injury after being struck by a car. Over a period of hours, her condition evolved from prognostic uncertainty to the diagnosis of brain death and considerations of organ donation. Against this medical backdrop, the clinicians successfully established a trusting relationship with family members by careful attention to their emotional, informational, and care needs as they absorbed the devastating prognosis, took in the results of the brain death examination, and considered the option of organ donation. This case illustrates the importance of interdisciplinary communication, the vital role of social workers and other psychosocial providers with expertise in working with families, and the critical significance of mutual care and support for the clinicians who accompany families through these tragic life events.	Harvard Univ, Sch Med, Dept Social Med, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Psychiat, Boston, MA 02115 USA; Childrens Hosp Boston, Div Crit Care Med, Boston, MA USA; Educ Dev Ctr Inc, Initiat Pediat Palliat Care, Boston, MA USA; Columbia Univ, Sch Social Work, New York, NY USA	Truog, RD (corresponding author), Harvard Univ, Sch Med, Dept Social Med, 641 Huntington Ave, Boston, MA 02115 USA.	robert.truog@childrens.harvard.edu					Abbott KH, 2001, CRIT CARE MED, V29, P197, DOI 10.1097/00003246-200101000-00040; [Anonymous], 1998, Fed Regist, V63, P33856; Back AL, 2003, J CLIN ONCOL, V21, P2433, DOI 10.1200/JCO.2003.09.073; Back Anthony L, 2003, Ann Intern Med, V138, P439; Benight CC, 2004, BEHAV RES THER, V42, P1129, DOI 10.1016/j.brat.2003.08.008; BROWNING D, 2003, DIFFICULT CONVERSATI; Browning David, 2002, Bioethics Forum, V18, P23; Campbell CGN, 2004, CAN J NEUROL SCI, V31, P213, DOI 10.1017/S0317167100053853; Chambliss D.F., 1996, CARING HOSP NURSES S; CHRIST G, IN PRESS INNOVATIVE; Contro N, 2002, ARCH PEDIAT ADOL MED, V156, P14, DOI 10.1001/archpedi.156.1.14; Contro NA, 2004, PEDIATRICS, V114, P1248, DOI 10.1542/peds.2003-0857-L; Cook P, 2002, ARCH DIS CHILD, V87, P36, DOI 10.1136/adc.87.1.36; Curtis JR, 2002, J CRIT CARE, V17, P147, DOI 10.1053/jcrc.2002.35929; Davies B, 2002, J NURS ADMIN, V32, P5, DOI 10.1097/00005110-200201000-00001; Davis CG, 2000, DEATH STUD, V24, P497; Fallowfield L, 2004, LANCET, V363, P312, DOI 10.1016/S0140-6736(03)15392-5; FALLOWFIELD L, 1993, LANCET, V341, P476, DOI 10.1016/0140-6736(93)90219-7; FIELD MJ, 2003, I MED CHILDREN DIE I; FINLAY I, 1991, BRIT MED J, V302, P1524, DOI 10.1136/bmj.302.6791.1524; FLEISCHMAN AR, 1994, PEDIATRICS, V94, P433; Frank AW, 2004, INTERN MED J, V34, P355, DOI 10.1111/j.1445-5994.2004.00622.x; GREENSPAN AI, 1994, PEDIATRICS, V94, P425; Harbaugh Bonnie Lee, 2004, Issues Compr Pediatr Nurs, V27, P163, DOI 10.1080/01460860490497985; Hurwitz CA, 2004, JAMA-J AM MED ASSOC, V292, P2141, DOI 10.1001/jama.292.17.2141; *I MED, 2003, CHILDR DIE IMPR PALL; Janzen L, 2003, OMEGA-J DEATH DYING, V48, P149; Keenan HT, 2006, PEDIATRICS, V117, P317, DOI 10.1542/peds.2005-0979; Kirschbaum MS, 1996, ADV NURS SCI, V19, P51, DOI 10.1097/00012272-199609000-00007; LEHMAN DR, 1987, J PERS SOC PSYCHOL, V52, P218, DOI 10.1037/0022-3514.52.1.218; Lipton H, 2000, Int J Emerg Ment Health, V2, P19; Lipton H, 2000, Int J Emerg Ment Health, V2, P181; Lock M., 2002, TWICE DEAD ORGAN TRA; Macdonald ME, 2005, PEDIATRICS, V116, P884, DOI 10.1542/peds.2004-1980; Mack JW, 2005, J CLIN ONCOL, V23, P9155, DOI 10.1200/JCO.2005.04.010; Martinez R, 2002, THEOR MED BIOETH, V23, P185, DOI 10.1023/A:1020816824759; McDonagh JR, 2004, CRIT CARE MED, V32, P1484, DOI 10.1097/01.CCM.0000127262.16690.65; Meert K L, 2001, Pediatr Crit Care Med, V2, P324, DOI 10.1097/00130478-200110000-00007; Meert K L, 2000, Pediatr Crit Care Med, V1, P179, DOI 10.1097/00130478-200010000-00017; Meyer EC, 2006, PEDIATRICS, V117, P649, DOI 10.1542/peds.2005-0144; Meyer EC, 2002, CRIT CARE MED, V30, P226, DOI 10.1097/00003246-200201000-00032; Murphy SA, 2003, J TRAUMA STRESS, V16, P17, DOI 10.1023/A:1022003126168; NOLENHOEKSEMA SK, 1999, COPING LOSS; OLIVER RC, 1995, J TRAUMA, V39, P303, DOI 10.1097/00005373-199508000-00019; Plum F, 1999, DEFINITION OF DEATH, P34; Rabow MW, 1999, WESTERN J MED, V171, P260; Rachmani R, 1999, TRANSPLANT P, V31, P1912, DOI 10.1016/S0041-1345(99)00152-9; Roter DL, 2000, ARCH INTERN MED, V160, P3477, DOI 10.1001/archinte.160.22.3477; Seecharan GA, 2004, ARCH PEDIAT ADOL MED, V158, P515, DOI 10.1001/archpedi.158.6.515; Siminoff LA, 2001, JAMA-J AM MED ASSOC, V286, P71, DOI 10.1001/jama.286.1.71; Siminoff LA, 2001, CLIN TRANSPLANT, V15, P39, DOI 10.1034/j.1399-0012.2001.150107.x; Solomon MZ, 2005, PEDIATRICS, V116, P872, DOI 10.1542/peds.2004-0905; *SPEC TASK FORC, 1987, PEDIATRICS, V80, P298; Stack CG, 2003, PAEDIATR ANAESTH, V13, P651, DOI 10.1046/j.1460-9592.2003.01112.x; Truog R, 2003, J CLIN ETHIC, V14, P63; Truog RD, 2001, CRIT CARE MED, V29, P2332, DOI 10.1097/00003246-200112000-00017; Truog RD, 2003, CRIT CARE MED, V31, P2391, DOI 10.1097/01.CCM.0000090869.19410.3C; WALKER JA, 1990, CAN MED ASSOC J, V142, P1383; Wellesley A, 1997, J ACCID EMERG MED, V14, P24; Wheeler I, 2001, DEATH STUD, V25, P51, DOI 10.1080/074811801750058627; Wijdicks EFM, 2001, NEW ENGL J MED, V344, P1215, DOI 10.1056/NEJM200104193441606; WIJNGAARDSDEMEI.J, 2005, J CONSULT CLIN PSYCH, V73, P617; YOUNGNER SJ, 1989, JAMA-J AM MED ASSOC, V261, P2205, DOI 10.1001/jama.261.15.2205; 2003, J TRAUMA, V54, pS235	64	22	22	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 14	2006	295	22					2646	2654		10.1001/jama.295.22.2646			9	Medicine, General & Internal	General & Internal Medicine	052HI	WOS:000238224000027	16772628				2021-06-18	
J	Kedar, S; Zhang, XJ; Lynn, MJ; Newman, NJ; Biousse, V				Kedar, Sachin; Zhang, Xiaojun; Lynn, Michael J.; Newman, Nancy J.; Biousse, Valerie			Pediatric homonymous hemianopia	JOURNAL OF AAPOS			English	Article; Proceedings Paper	31st Annual Meeting of the American-Association-for-Pediatric-Ophthalmology-and-Strabismus	MAR 09-13, 2005	Orlando, FL	Amer Assoc Pediat Ophthalmol & Strabismus			VISUAL-FIELD DEFECTS; OPTIC TRACT SYNDROME; INFARCTION; RECOVERY; STROKE	Introduction: Homonymous hemianopia is a disabling condition caused by numerous lesions affecting the retrochiasmal visual pathways. Little is known about homonymous hemianopia in childhood. Methods: All patients seen in the Neuro-Ophthalmology Unit at Emory University with homonymous hemianopia (confirmed by Goldmann, Humphrey, or confrontation visual fields) between 1989 and 2004 were included. Demographic characteristics, clinical features, and evolution of the visual field defects were compared between the pediatric group (18 years of age or younger) and the adult group (older than 18 years). Results: Among 852 patients with homonymous hemianopia, there were 81 children (86 homonymous hemianopias) and 771 adults (818 homonymous hemianopias). Formal visual field testing was obtained in 93% of pediatric cases and 96% of adults; a majority of patients in both groups were evaluated with Goldmann visual field testing. Demographic and visual field characteristics were similar in both groups. Significant differences were noted for the causative lesions and their location. Traumatic brain injury (34%) and tumor (27%) were the most common causes of homonymous hemianopia in the pediatric group, whereas infarction (63%), traumatic brain injury (12%), and hemorrhage (11%) were the most common causes in the adult group. Most lesions involved the optic radiations (37%), followed by the occipital lobes (26%), in the pediatric group, whereas occipital lobes (47%), followed by optic radiations (32%), were most commonly involved in adults. Approximately one third of the pediatric patients were seen in follow-up, and one third of these homonymous hemianopias spontaneously improved over the course of time. Of the 16 pediatric homonymous hemianopias evaluated within 1 month of onset of the cerebral disorder, 8 (50%) improved. Conclusion: Trauma and tumors are the most common cause of homonymous hemianopia in childhood. Although spontaneous improvement can be expected in approximately one third to one half of patients within the first few months, the recognition of homonymous hemianopia frequently is delayed in this population.	Emory Univ, Ctr Eye, Dept Ophthalmol, Neuroophthalmol Unit, Atlanta, GA 30322 USA; Emory Univ, Sch Med, Dept Neurol, Atlanta, GA 30322 USA; Emory Univ, Dept Neurol Surg, Atlanta, GA 30322 USA; Emory Univ, Rollins Sch Publ Hlth, Dept Biostat, Atlanta, GA 30322 USA	Biousse, V (corresponding author), Emory Univ, Ctr Eye, Dept Ophthalmol, Neuroophthalmol Unit, 1365 B Clifton Rd NE, Atlanta, GA 30322 USA.	vbiouss@emory.edu	KEDAR, SACHIN/B-2579-2008; Newman, Nancy/AAB-2532-2021	Kedar, Sachin/0000-0002-7293-5556	NATIONAL EYE INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI) [P30EY006360] Funding Source: NIH RePORTER; NEI NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI) [P30-EY06360] Funding Source: Medline		Donahue SP, 2001, J AAPOS, V5, P114, DOI 10.1067/mpa.2001.113840; FUJINO T, 1986, NEURO-OPHTHALMOLOGY, V6, P17, DOI 10.3109/01658108608997320; Gilhotra JS, 2002, STROKE, V33, P2417, DOI 10.1161/01.STR.0000037647.10414.d2; GRAY CS, 1989, AGE AGEING, V18, P419, DOI 10.1093/ageing/18.6.419; Isa K, 2001, EUR NEUROL, V46, P126, DOI 10.1159/000050785; Jacobson DM, 1997, ARCH NEUROL-CHICAGO, V54, P401, DOI 10.1001/archneur.1997.00550160045014; KATTAH JC, 1981, COMPUT TOMOGR, V5, P301, DOI 10.1016/0363-8235(81)90037-5; KAUL SN, 1974, J NEUROL NEUROSUR PS, V37, P1022, DOI 10.1136/jnnp.37.9.1022; Lepore FE, 2001, NEUROLOGY, V57, P1918, DOI 10.1212/WNL.57.10.1918; Levin L. A., 2005, WALSH HOYTS CLIN NEU, P503; Liu GT, 1997, NEUROLOGY, V49, P1748, DOI 10.1212/WNL.49.6.1748; MCAULEY DL, 1979, J NEUROL NEUROSUR PS, V42, P298, DOI 10.1136/jnnp.42.4.298; NEWMAN SA, 1983, ARCH OPHTHALMOL-CHIC, V101, P1241, DOI 10.1001/archopht.1983.01040020243018; PARISI JL, 1991, CAN J OPHTHALMOL, V26, P252; PESSIN MS, 1987, ANN NEUROL, V21, P290, DOI 10.1002/ana.410210311; SAVINO PJ, 1978, ARCH OPHTHALMOL-CHIC, V96, P656, DOI 10.1001/archopht.1978.03910050352011; SMITH JL, 1962, AM J OPHTHALMOL, V54, P616, DOI 10.1016/0002-9394(62)92192-X; TIEL K, 1991, NEURO-OPHTHALMOLOGY, V11, P33, DOI 10.3109/01658109109009640; TROBE JD, 1973, ARCH OPHTHALMOL-CHIC, V89, P377, DOI 10.1001/archopht.1973.01000040379005; TROBE JD, 2001, NEUROLOGY VISION, P109; Wall M, 2005, WALSH HOYT CLIN NEUR, P83	21	22	22	0	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	1091-8531	1528-3933		J AAPOS	J. AAPOS	JUN	2006	10	3					249	252		10.1016/j.jaapos.2006.01.181			4	Ophthalmology; Pediatrics	Ophthalmology; Pediatrics	062QK	WOS:000238959400012	16814179				2021-06-18	
J	Andermahr, J; Elsner, A; Brings, AE; Hensler, T; Gerbershagen, H; Jubel, A				Andermahr, J; Elsner, A; Brings, AE; Hensler, T; Gerbershagen, H; Jubel, A			Reduced collagen degradation in polytraumas with traumatic brain injury causes enhanced osteogenesis	JOURNAL OF NEUROTRAUMA			English	Article						fracture healing; heterotopic ossification; hypertrophic callus; polytrauma; traumatic brain injury; serologic parameters of bone remodeling	GROWTH-FACTOR-I; IGF-BINDING PROTEIN-3; BONE-FORMATION; HEAD-INJURY; FACTOR BFGF; HETEROTOPIC OSSIFICATION; TIBIAL FRACTURES; CLINICAL ASPECTS; INSULIN; HORMONE	Patients with traumatic brain injury (TBI) and skeletal injuries have increased rates of excessive bone healing (EH = hypertrophic callus formation and/or heterotopic ossification). Polytrauma patients are often attributed higher rates of delayed fracture union. This study compares 182 total fractures in 29 isolated polytrauma patients (POLY) and 48 patients after TBI and polytrauma (TBI+POLY), examining the clinical parameters of EH versus delay. A subset of 28 patients (13 TBI+POLY, 15 POLY) underwent serological testing for the following bone turnover parameters: carboxy-terminal extension peptide of type 1 procollagen (P1CP), pyridinolene cross-linked carboxy-terminal telopeptide (ICTP), insulin-like growth factor-1 (IGF-1), insulin-like growth factor binding protein-3 (IGFBP-3), and basic fibroblast growth factor (bFGF). There were higher rates of delayed union in the POLY patients (45% vs. 23%) and EH in the TBI+POLY patients (33% vs. 17%) (not significant = NS). More delayed unions were observed in diaphyseal fractures suffered by POLY (28%) than in TBI+POLY (15%) patients (NS). EH after pelvic fracture was apparent in 52% TBI+POLY and in 21% POLY fractures (NS). P1CP levels did not differ between the groups, but the collagen breakdown parameter 1CTP was significantly higher in the POLY group (p = 0.01-0.04). IGF-1 levels were below normal in both groups, and did not differ. IGFBP-3, an IGF-1-inhibiting and collagenase-3-activating protein, was significantly higher in POLY patients (p = 0.017-0.037). bFGF levels did not vary between groups. Increased serum levels of 1CTP and IGFBP-3 in POLY patients suggest that EH in TBI patients is secondary to decreased collagen breakdown rather than increased synthesis.	Univ Cologne, Clin Trauma Hand & Reconstruct Surg, D-50924 Cologne, Germany; Univ Cologne, Dept Surg 2, Cologne, Germany; Univ Cologne, Dept Anaesthesia, Cologne, Germany	Andermahr, J (corresponding author), Univ Cologne, Clin Trauma Hand & Reconstruct Surg, Joseph Stelzmann Str 9, D-50924 Cologne, Germany.	Jandermahr@t-online.de		Jubel, Axel/0000-0003-4402-4816			BIDNER SM, 1990, J BONE JOINT SURG AM, V72A, P1144, DOI 10.2106/00004623-199072080-00004; Boguszewski M, 1996, J CLIN ENDOCR METAB, V81, P3902, DOI 10.1210/jc.81.11.3902; Bosch U, 1999, CHIRURG, V70, P1202, DOI 10.1007/s001040050771; BOSSE A, 1994, INT J SPORTS MED, V15, P325, DOI 10.1055/s-2007-1021068; Braun W, 1996, UNFALLCHIRURG, V99, P59; CENTRELLA M, 1993, ANN PLAS SURG, V31, P434, DOI 10.1097/00000637-199311000-00008; Delany AM, 1998, AM J PHYSIOL-CELL PH, V274, pC734; Delany AM, 1998, J BIOL CHEM, V273, P16595, DOI 10.1074/jbc.273.26.16595; Ebinger T, 2000, J TRAUMA, V48, P1058, DOI 10.1097/00005373-200006000-00010; Eclancher F, 1996, BRAIN RES, V737, P201, DOI 10.1016/0006-8993(96)00732-9; Fernandez AM, 1997, NEUROSCIENCE, V76, P117; GARLAND DE, 1988, CLIN ORTHOP RELAT R, P86; Giannobile WV, 1997, J DENT RES, V76, P1569, DOI 10.1177/00220345970760090901; Grinspoon S, 1996, J CLIN ENDOCR METAB, V81, P3864, DOI 10.1210/jc.81.11.3864; GutierrezOspina G, 1996, ENDOCRINOLOGY, V137, P5484, DOI 10.1210/en.137.12.5484; HEUWINKEL R, 1978, HELV CHIR ACTA, V45, P581; HEUWINKEL R, 1978, UNFALLHEILKUNDE, V81, P577; Hill PA, 1997, ENDOCRINOLOGY, V138, P3849, DOI 10.1210/en.138.9.3849; HILL RJ, 1995, ENDOCRINOLOGY, V136, P124; JOERRING S, 1992, ARCH ORTHOP TRAUM SU, V111, P265, DOI 10.1007/BF00571521; JOERRING S, 1994, ARCH ORTHOP TRAUM SU, V113, P334, DOI 10.1007/BF00426183; Kuner EH, 1996, ORTHOPADE, V25, P394, DOI 10.1007/s001320050040; Kushwaha V P, 1998, J Am Acad Orthop Surg, V6, P298; Lalou C, 1996, ENDOCRINOLOGY, V137, P3206, DOI 10.1210/en.137.8.3206; Meyer NA, 1996, J TRAUMA, V41, P1008, DOI 10.1097/00005373-199612000-00011; Mohan S, 1996, HORM RES, V45, P59, DOI 10.1159/000184833; MUNSTER AM, 1972, J TRAUMA, V12, P1071, DOI 10.1097/00005373-197212000-00008; Noh E, 1972, Hefte Unfallheilkd, V111, P277; PERKINS R, 1987, J BONE JOINT SURG BR, V69, P521; RussellJones DL, 1996, EUR J ENDOCRINOL, V135, P631, DOI 10.1530/eje.0.1350631; Schonau E, 1997, HORM RES, V48, P50, DOI 10.1159/000191329; Schonau E, 1997, EUR J ENDOCRINOL, V137, P603, DOI 10.1530/eje.0.1370603; Schratz W, 1998, UNFALLCHIRURG, V101, P12, DOI 10.1007/s001130050226; SEILER H, 1979, CHIRURG, V50, P384; Skjaerbaek C, 1997, EUR J ENDOCRINOL, V137, P132, DOI 10.1530/eje.0.1370132; Skjaerbaek C, 1996, EUR J ENDOCRINOL, V135, P672, DOI 10.1530/eje.0.1350672; Slootweg MC, 1996, GROWTH REGULAT, V6, P238; SPENCER RF, 1987, J BONE JOINT SURG BR, V69, P525; THALLER SR, 1993, ANN PLAS SURG, V31, P421, DOI 10.1097/00000637-199311000-00006; Tsur A, 1996, BRAIN INJURY, V10, P259, DOI 10.1080/026990596124430; Wildburger R, 2001, WIEN KLIN WOCHENSCHR, V113, P119; WILDBURGER R, 1994, BONE MINER, V27, P183, DOI 10.1016/S0169-6009(08)80192-4; WILDBURGER R, 1994, RES EXP MED, V194, P247, DOI 10.1007/BF02576386; Wiltfang J, 1996, J CRANIO MAXILL SURG, V24, P300, DOI 10.1016/S1010-5182(96)80063-1	44	22	23	1	9	MARY ANN LIEBERT INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151			J NEUROTRAUM	J. Neurotrauma	MAY	2006	23	5					708	720		10.1089/neu.2006.23.708			13	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	042LJ	WOS:000237529200009	16689672				2021-06-18	
J	Dandona, R				Dandona, Rakhi			Making road safety a public health concern for policy-makers in India	NATIONAL MEDICAL JOURNAL OF INDIA			English	Article							TRAUMATIC BRAIN-INJURIES; DEVELOPING-COUNTRIES; TRAFFIC INJURIES; EDUCATION; CRASHES; DEATHS	Background. Road traffic injuries contribute substantially to the disease burden in India. This paper describes the road safety issues discussed by members of the Indian Parliament, and highlights the gaps that need to be addressed to make road safety visible as a public health problem to policy-makers in India. Methods. All questions asked to and information provided by the Ministry of Road Transport and Highways, and questions relating to accident asked to the Ministry of Health and Family Welfare of the Government of India were reviewed for the two Houses of the Indian Parliament for the years 2002 to 2004. Results. Of the 1529 questions asked to the Ministry of Road Transport and Highways, only 140 (9.1%) were related to. road safety, whereas 1076 (70.5%), 1.81 (11.8%), 51 (3.3%) and 81 (5.3%) were related to other aspects of the national highways, state roads, vehicles and other issues, respectively. Data on the magnitude of road crashes dealt only with the number of crashes and fatalities and not with the age, sex and type of road users affected by road traffic, injuries. The parliamentarians were informed that human error was the main cause of road crashes in India; however, the robustness of this information is questionable. Strategies to prevent road crashes focused mainly on training of drivers with little attention to other factors that cause road crashes. The discussion on legislations also focused on drivers, ignoring other road users. Ten of the 4741 questions (0.2%) asked to Ministry of Health and Family Welfare were related to accident, the majority of which were about the setting up of trauma care services. Conclusion. An appropriate policy and intervention response by policy-makers is not possible with data that are presented in a manner that do not highlight the true nature of the problem, and are neither comprehensive nor robust. Majority of the proposed road safety interventions by the Ministry of Road Transport and Highways are based on the traditional view of human error as a major cause of road crashes highlighting the lack of a scientific public health approach towards prevention of road crashes. It would be useful to build the technical capacity of the Ministry of Road Transport and Highways in road safety to use the available data more effectively, and to facilitate generation of further relevant data about the magnitude, underlying causes and impact of road traffic injuries, for policy-makers to better understand the critical issues for planning effective road safety policies and interventions to reduce the high burden of mortality and morbidity due to road crashes in India.	Adm Staff Coll India, Hlth Studies Area, Ctr Human Dev, Hyderabad 500082, Andhra Pradesh, India	Dandona, R (corresponding author), Adm Staff Coll India, Hlth Studies Area, Ctr Human Dev, Raj Bhavan Rd, Hyderabad 500082, Andhra Pradesh, India.	rakhi@asci.org.in		Dandona, Rakhi/0000-0003-0926-788X			Astrop A., 2000, ESTIMATING GLOBAL RO; *COMM EUR COMM, 2001, COST, V327; Dandona L, 2004, BMC PUBLIC HEALTH, V4, DOI 10.1186/1471-2458-4-55; Dandona R, 2004, NATL MED J INDIA, V17, P74; Dandona R, 2006, J SAFETY RES, V37, P149, DOI 10.1016/j.jsr.2005.11.002; Dandona Rakhi, 2005, Int J Inj Contr Saf Promot, V12, P167, DOI 10.1080/17457300500088840; Evans Tim, 2003, Inj Control Saf Promot, V10, P11, DOI 10.1076/icsp.10.1.11.14117; Ghaffar A, 2004, PUBLIC HEALTH, V118, P211, DOI 10.1016/j.puhe.2003.05.003; *GOV IND, 2002, TRANSP CHAPT 10 5 YE; *GOV IND, RAIYA SABH QUEST ANS; *GOV IND, ROAD ACC IND 1970 20; *GOV IND, 2006, ROAD SAF; *GOV IND, IND PARL; Gururaj G, 2002, NEUROL RES, V24, P24, DOI 10.1179/016164102101199503; GURURAJ G, 2000, P INJ PREV CONTR P; HEIM L, 1988, VEHICLE OCCUPANT PRO; Ian R, 2001, COCHRANE DB SYST REV, V3; Krug E., 1999, INJURY LEADING CAUSE; Kulanthayan S, 2000, Med J Malaysia, V55, P40; McKee M, 2000, HEALTH POLICY PLANN, V15, P263, DOI 10.1093/heapol/15.3.263; MISHRA BK, 1984, ACCIDENT ANAL PREV, V16, P407, DOI 10.1016/0001-4575(84)90053-8; Mock, 2004, GUIDELINES ESSENTIAL; Mock C, 2004, B WORLD HEALTH ORGAN, V82, P241; MOHAN D, 2001, ECO POL WKLY, P4656; MOHAN D, 1983, INDIAN HIGHWAYS, V11, P8; MOHAN D, 2002, INJ SE AS REG PRIOR; Murray C, 2001, 36 WHO; Nantulya Vinand M, 2003, Inj Control Saf Promot, V10, P3, DOI 10.1076/icsp.10.1.3.14109; *NAT CRIM REC BUR, 2000, ACC DEATHS SUIC IND; O'Neill B, 2002, BRIT MED J, V324, P1142, DOI 10.1136/bmj.324.7346.1142; Odero W, 1997, TROP MED INT HEALTH, V2, P445, DOI 10.1046/j.1365-3156.1997.d01-296.x; OJHA AK, 2002, ROAD ACCIDENTS DELHI; ONEILL B, 2000, P WHO M DEV 5 YEAR S; Peden M., 2004, WORLD REPORT ROAD TR; PREUSSER DF, 1984, J SAFETY RES, V15, P47, DOI 10.1016/0022-4375(84)90001-X; Ross H. L., 1982, DETERRING DRINKING D; Rumar K., 1999, TRANSPORT SAFETY VIS; SATHIYASEKARAN BWC, 1991, J ROY SOC HEALTH, V111, P10, DOI 10.1177/146642409111100104; Servadei F, 2003, INJURY PREV, V9, P257, DOI 10.1136/ip.9.3.257; UMAR RS, 2002, P 2 WORLD ENG C SAR; UNDP, 2003, HUM DEV REP 2003; Vernick JS, 1999, AM J PREV MED, V16, P40, DOI 10.1016/S0749-3797(98)00115-9	42	22	22	0	3	ALL INDIA INST MEDICAL SCIENCES	NEW DELHI	ANSARI NAGAR, NEW DELHI 110 029, INDIA	0970-258X			NATL MED J INDIA	Natl. Med. J. India	MAY-JUN	2006	19	3					126	133					8	Medicine, General & Internal	General & Internal Medicine	059HO	WOS:000238724100003	16836261				2021-06-18	
J	Jensen, AR; Hughes, WB; Grewal, H				Jensen, AR; Hughes, WB; Grewal, H			Secondary abdominal compartment syndrome in children with burns and trauma: A potentially lethal complication	JOURNAL OF BURN CARE & RESEARCH			English	Article; Proceedings Paper	55th Meeting of the American-Academy-of-Pediatrics	OCT 31-NOV 05, 2003	New Orleans, LA	Amer Acad Pediat			INTRAABDOMINAL PRESSURE; BLOOD-FLOW; HYPERTENSION; PULMONARY; FAILURE; INJURY; SHOCK	Acute, rapid, and unimpeded increases in intra-abdominal pressure can lead to multiple organ dysfunction defined as the abdominal compartment syndrome (ACS). If this develops in the absence of obvious intra-abdominal injury, it has been termed secondary ACS (2 degrees ACS). Massive fluid resuscitation in the presence of large burns or shock can lead to 2 degrees ACS. The importance of early recognition and the need for urgent abdominal decompression have been recognized in adults; however, this has not been appreciated in the pediatric population. Medical records of four children diagnosed with 2 degrees ACS were reviewed. Secondary ACS occurred in three children with burns and in one child with a traumatic brain injury. Three children underwent decompressive laparotomy, and one underwent successful percutaneous drainage. There were two survivors. Secondary ACS may be observed in burnt or traumatized children needing large volume resuscitation. Early recognition of 2 degrees ACS by routine bladder pressure monitoring in this high-risk group of children may result in earlier decompression and a possible decrease in morbidity and mortality.	Temple Univ, Childrens Med Ctr, Sect Pediat Surg, Sch Med, Philadelphia, PA 19140 USA	Grewal, H (corresponding author), Temple Univ, Childrens Med Ctr, Sect Pediat Surg, Sch Med, 3509 N Broad St,5 E, Philadelphia, PA 19140 USA.						Balogh Z, 2003, J TRAUMA, V54, P848, DOI 10.1097/01.TA.0000070166.29649.F3; Balogh Z, 2002, AM J SURG, V184, P538, DOI 10.1016/S0002-9610(02)01050-4; Beck R, 2001, Pediatr Crit Care Med, V2, P51, DOI 10.1097/00130478-200101000-00011; Biffl WL, 2001, AM J SURG, V182, P645, DOI 10.1016/S0002-9610(01)00814-5; Burch JM, 1996, SURG CLIN N AM, V76, P833, DOI 10.1016/S0039-6109(05)70483-7; Corcos AC, 2001, J TRAUMA, V51, P1062, DOI 10.1097/00005373-200112000-00006; CULLEN DJ, 1989, CRIT CARE MED, V17, P118, DOI 10.1097/00003246-198902000-00002; DeCou JM, 2000, J PEDIATR SURG, V35, P840, DOI 10.1053/jpsu.2000.6857; DIEBEL L, 1992, AM SURGEON, V58, P573; DIEBEL LN, 1992, J TRAUMA, V33, P45, DOI 10.1097/00005373-199207000-00010; Engum SA, 2002, J PEDIATR SURG, V37, P214, DOI 10.1053/jpsu.2002.30257; GREENHALGH DG, 1994, J TRAUMA, V36, P685, DOI 10.1097/00005373-199405000-00015; Hobson KG, 2002, J TRAUMA, V53, P1129, DOI 10.1097/00005373-200212000-00016; IBERTI TJ, 1987, CRIT CARE MED, V15, P1140, DOI 10.1097/00003246-198712000-00014; Ivatury RR, 1997, SURG CLIN N AM, V77, P783, DOI 10.1016/S0039-6109(05)70584-3; Ivatury RR, 1998, J TRAUMA, V44, P1016, DOI 10.1097/00005373-199806000-00014; Ivy ME, 2000, J TRAUMA, V49, P387, DOI 10.1097/00005373-200009000-00001; Ivy ME, 1999, J BURN CARE REHABIL, V20, P351, DOI 10.1097/00004630-199909000-00003; Kawar B, 2003, EUR J PEDIATR SURG, V13, P330; Kopelman T, 2000, J TRAUMA, V49, P744, DOI 10.1097/00005373-200010000-00025; KRON IL, 1984, ANN SURG, V199, P28, DOI 10.1097/00000658-198401000-00005; Latenser BA, 2002, J BURN CARE REHABIL, V23, P190, DOI 10.1097/00004630-200205000-00008; Maxwell RA, 1999, J TRAUMA, V47, P995, DOI 10.1097/00005373-199912000-00001; Reeves ST, 1997, CAN J ANAESTH, V44, P308, DOI 10.1007/BF03015370; RICHARDS WO, 1983, ANN SURG, V197, P183, DOI 10.1097/00000658-198302000-00010; RICHARDSON JD, 1976, J SURG RES, V20, P401, DOI 10.1016/0022-4804(76)90112-8; Saggi B, 1998, J TRAUMA, V45, P597, DOI 10.1097/00005373-199809000-00033; Simon RJ, 1997, J TRAUMA, V42, P398, DOI 10.1097/00005373-199703000-00006	28	22	24	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	1559-047X			J BURN CARE RES	J. Burn Care Res.	MAR-APR	2006	27	2					242	246		10.1097/01.BCR.0000202643.16576.75			5	Critical Care Medicine; Dermatology; Surgery	General & Internal Medicine; Dermatology; Surgery	044UL	WOS:000237697800023	16566576				2021-06-18	
J	Mussack, T; Hauser, C; Klauss, V; Tato, F; Rieger, J; Ruppert, V; Jochum, M; Hoffmann, U				Mussack, T; Hauser, C; Klauss, V; Tato, F; Rieger, J; Ruppert, V; Jochum, M; Hoffmann, U			Serum S-100B protein levels during and after successful carotid artery stenting or carotid endarterectomy	JOURNAL OF ENDOVASCULAR THERAPY			English	Article						carotid artery stenosis; angioplasty; stent; carotid endarterectomy; transient ischemic attack; stroke; neuroprotein S-100B	NEURON-SPECIFIC ENOLASE; TRAUMATIC BRAIN-INJURY; S-100-BETA PROTEIN; DAMAGE; S100B; RELEASE; SURGERY; BLOOD; STROKE; MARKER	Purpose: To characterize the course of S-100B serum levels, a reliable marker for cellular brain damage, in patients undergoing carotid artery stenting (CAS) or endarterectomy (CEA) for carotid artery stenosis compared to control groups undergoing hemithyroidectomy (HT) or coronary angiography (CA). Methods: Forty-six consecutive patients scheduled for revascularization of internal carotid artery (ICA) stenosis were included in the study. Fourteen patients (11 men; median age 70 years, interquartile range [IQR] 63-74) were selected for treatment with CAS, while CEA was performed in 31 patients (24 men; median age 68 years, IQR 54-78) during the same time period. Fourteen consecutive patients (8 men; median age 60 years, IQR 48-70) undergoing CA for suspected coronary heart disease and 14 patients (10 women; median age 36 years, IQR 26-54) undergoing HT for a single thyroid nodule served as controls. Results: All procedures were completed successfully. During ICA clamping in CEA patients without postoperative neurological deficits, median S-100B serum levels transiently increased from 0.04 to 0.26 ng/mL (p < 0.01) and returned to baseline levels after declamping. Median S-100B serum levels of CAS patients without neurological impairment remained at baseline values. No increase in S-100B levels occurred in either control group. Three CEA patients who suffered from neurological deficits 0 transient ischemic attack and I major stroke) showed sustained elevation of S-100B serum levels 6 hours after extubation. Conclusion: In patients without neurological complications, CEA but not CAS was associated with a transient increase in the S-100B serum levels. Results indicate that the increase in S-100B does not originate from extracerebral sources, but rather appears to represent an impairment of the blood-brain barrier integrity or subtle brain cell damage probably due to hypoperfusion during clamping. Sustained elevation of S-100B serum levels corresponded to the development of postoperative neurological deficits.	Klinikum Univ Munich, Dept Gen & Vasc Surg, D-80336 Munich, Germany; Klinikum Univ Munich, Dept Internal Med Cardiol, D-80336 Munich, Germany; Klinikum Univ Munich, Dept Vasc Med, D-80336 Munich, Germany; Klinikum Univ Munich, Inst Clin Radiol, D-80336 Munich, Germany; Klinikum Univ Munich, Dept Clin Chem & Clin Biochem Innenstadt, D-80336 Munich, Germany	Mussack, T (corresponding author), Klinikum Univ Munich, Dept Gen & Vasc Surg Innenstadt, Nussbaumstr 20, D-80336 Munich, Germany.	Thomas.Mussack@med.uni-muenchen.de					Anderson RE, 2001, ANN THORAC SURG, V71, P1512, DOI 10.1016/S0003-4975(01)02399-2; Connolly ES, 2001, NEUROSURGERY, V49, P1076, DOI 10.1097/00006123-200111000-00010; Di Legge S, 2003, NEUROL SCI, V24, P351, DOI 10.1007/s10072-003-0188-x; Donato R, 1999, BBA-MOL CELL RES, V1450, P191, DOI 10.1016/S0167-4889(99)00058-0; Gao F, 2000, ANAESTHESIA, V55, P764, DOI 10.1046/j.1365-2044.2000.01466.x; Godet G, 2001, J CARDIOTHOR VASC AN, V15, P25, DOI 10.1053/jcan.2001.20213; Herrmann M, 2000, STROKE, V31, P2670, DOI 10.1161/01.STR.31.11.2670; Herrmann M, 2000, J NEUROTRAUM, V17, P113, DOI 10.1089/neu.2000.17.113; Jaranyi Z, 2003, CLIN CHEM LAB MED, V41, P1320, DOI 10.1515/CCLM.2003.201; Jonsson H, 2000, J CARDIOTHOR VASC AN, V14, P698, DOI 10.1053/jcan.2000.18444; Jonsson H, 1999, ANN THORAC SURG, V68, P2202, DOI 10.1016/S0003-4975(99)00851-6; Kapural M, 2002, BRAIN RES, V940, P102, DOI 10.1016/S0006-8993(02)02586-6; Mayo SW, 1998, J VASC SURG, V27, P1017, DOI 10.1016/S0741-5214(98)70004-7; Muller M, 2000, AM J NEURORADIOL, V21, P47; Mussack T, 2002, WORLD J SURG, V26, P1251, DOI 10.1007/s00268-002-6547-6; Mussack T, 2002, SHOCK, V18, P395, DOI 10.1097/00024382-200211000-00002; Pelinka LE, 2003, SHOCK, V19, P195, DOI 10.1097/00024382-200303000-00001; Poppert H, 2004, J NEUROL, V251, P1198, DOI 10.1007/s00415-004-0502-4; Powell RJ, 2004, J VASC SURG, V39, P1193, DOI 10.1016/j.jvs.2003.12.038; Primozich JF, 2002, DUPLEX SCANNING VASC, P191; Rasmussen LS, 2000, J CARDIOTHOR VASC AN, V14, P166, DOI 10.1016/S1053-0770(00)90012-0; Romner B, 2001, NEUROSURGERY, V49, P1490, DOI 10.1097/00006123-200112000-00053; Sahlein DH, 2003, NEUROSURGERY, V53, P1243, DOI 10.1227/01.NEU.0000093493.16850.11; TAYLOR DW, 1991, NEW ENGL J MED, V325, P445	24	22	23	0	1	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1526-6028	1545-1550		J ENDOVASC THER	J. Endovascular Ther.	FEB	2006	13	1					39	46		10.1583/05-1656.1			8	Surgery; Peripheral Vascular Disease	Surgery; Cardiovascular System & Cardiology	014DP	WOS:000235459300005	16445322				2021-06-18	
J	Bazarian, JJ; Beck, C; Blyth, B; von Ahsen, N; Hasselblatt, M				Bazarian, Jeffrey J.; Beck, Christopher; Blyth, Brian; von Ahsen, Nicolas; Hasselblatt, Martin			Impact of creatine kinase correction on the predictive value of S-100B after mild traumatic brain injury	RESTORATIVE NEUROLOGY AND NEUROSCIENCE			English	Article; Proceedings Paper	Annual Meeting of the Society-for-Academic-Emergency-Medicine (SAEM)	MAY 22-25, 2005	New York, NY	Soc Acad Emergency Med		mild traumatic brain injury; cerebral concussion; serum markers; post concussive syndrome	MINOR HEAD-INJURY; POST-CONCUSSION SYMPTOMS; PROTEIN MEASUREMENTS; FOLLOW-UP; SERUM S100-BETA; S100B LEVELS; DAMAGE; MARKER; QUESTIONNAIRE; S-100-BETA	Purpose: To validate a correction factor for the extracranial release of the astroglial protein, S-100B, based on concomitant creatine kinase (CK) levels. Methods: The CK-S-100B relationship in non-head injured marathon runners was used to derive a correction factor for the extracranial release of S-100B. This factor was then applied to a separate cohort of 96 mild traumatic brain injury (TBI) patients in whom both CK and S-100B levels were measured. Corrected S-100B was compared to uncorrected S-100B for the prediction of initial head CT, three-month headache and three-month post concussive syndrome (PCS). Results: Corrected S-100B resulted in a statistically significant improvement in the prediction of 3-month headache (area under curve [AUC] 0.46 vs 0.52, p = 0.02), but not PCS or initial head CT. Using a cutoff that maximizes sensitivity (>= 90%), corrected S-100B improved the prediction of initial head CT scan (negative predictive value from 75% [95% CI, 2.6%, 67.0%] to 96% [95% CI: 83.5%, 99.8%]). Conclusions: Although S-100B is overall poorly predictive of outcome, a correction factor using CK is a valid means of accounting for extracranial release. By increasing the proportion of mild TBI patients correctly categorized as low risk for abnormal head CT CK-corrected S 100-B can further reduce the number of unnecessary brain CT scans performed after this injury.	Univ Rochester, Med Ctr, Sch Med, Dept Emergency Med, Rochester, NY 14642 USA; Univ Rochester, Sch Med, Dept Biostat, Rochester, NY 14642 USA; Univ Hosp Gottingen, Dept Clin Chem, Gottingen, Germany; Munster Univ Hosp, Inst Neuropathol, Munster, Germany	Bazarian, JJ (corresponding author), Univ Rochester, Med Ctr, Sch Med, Dept Emergency Med, 601 Elmwood Ave,Box 655, Rochester, NY 14642 USA.	jeff_bazarian@urmc.rochester.edu		Hasselblatt, Martin/0000-0003-2707-8484	NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [1K23NS41952-05] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [K23NS041952] Funding Source: NIH RePORTER		Adami C, 2001, GLIA, V33, P131, DOI 10.1002/1098-1136(200102)33:2<131::AID-GLIA1012>3.0.CO;2-D; Alves W., 1998, J HEAD TRAUMA REHAB, V8, P48, DOI DOI 10.1097/00001199-199309000-00007; Anderson RE, 2001, NEUROSURGERY, V48, P1255, DOI 10.1097/00006123-200106000-00012; Arfanakis K, 2002, AM J NEURORADIOL, V23, P794; AUDENAERT K, 2003, MED SCI MONITOR, V9, pT112; BAZARIAN J, 2004, ACAD EMERG MED, V11, P516; Bazarian JJ, 1999, BRAIN INJURY, V13, P173, DOI 10.1080/026990599121692; Berger Rachel, 2003, Pediatr Crit Care Med, V4, P391, DOI 10.1097/01.PCC.0000075324.45784.8A; Biberthaler P, 2004, UNFALLCHIRURG, V107, P197, DOI 10.1007/s00113-004-0730-1; Biberthaler P, 2001, WORLD J SURG, V25, P93, DOI 10.1007/s002680020370; BLACK HR, 1986, AM J MED, V81, P479, DOI 10.1016/0002-9343(86)90303-7; Chambers J, 1996, J TRAUMA, V41, P976, DOI 10.1097/00005373-199612000-00006; Chen SHA, 2003, J NEUROL NEUROSUR PS, V74, P326, DOI 10.1136/jnnp.74.3.326; COOK JC, 1990, J NATL MED ASSOC, V82, P249; Crawford S, 1996, J NEUROL NEUROSUR PS, V60, P510, DOI 10.1136/jnnp.60.5.510; de Kruijk JR, 2002, J NEUROL NEUROSUR PS, V73, P727, DOI 10.1136/jnnp.73.6.727; Ergun R, 1998, NEUROL RES, V20, P418; Garnett MR, 2000, BRAIN, V123, P1403, DOI 10.1093/brain/123.7.1403; Gunstad J, 2004, ARCH CLIN NEUROPSYCH, V19, P391, DOI 10.1016/S0887-6177(03)00073-8; Hasselblatt M, 2004, NEUROLOGY, V62, P1634, DOI 10.1212/01.WNL.0000123092.97047.B1; HENDERSON AR, 1993, ANN CLIN BIOCHEM, V30, P521, DOI 10.1177/000456329303000601; INGEBRIGTSEN T, 1995, J NEUROL NEUROSUR PS, V59, P103, DOI 10.1136/jnnp.59.1.103-a; Ingebrigtsen T, 1999, NEUROSURGERY, V45, P468, DOI 10.1097/00006123-199909000-00010; Ingebrigtsen T, 1998, J NEUROL, V245, P609, DOI 10.1007/s004150050254; Ingebrigtsen T, 2000, BRAIN INJURY, V14, P1047; Jackson RGM, 2000, CLIN CHEM LAB MED, V38, P1165, DOI 10.1515/CCLM.2000.179; Jager TE, 2000, ACAD EMERG MED, V7, P134, DOI 10.1111/j.1553-2712.2000.tb00515.x; Jagoda AS, 2002, ANN EMERG MED, V40, P231, DOI 10.1016/j.jen.2008.12.010; Jantzen KJ, 2004, AM J NEURORADIOL, V25, P738; Kanner AA, 2003, CANCER, V97, P2806, DOI 10.1002/cncr.11409; Kapural M, 2002, BRAIN RES, V940, P102, DOI 10.1016/S0006-8993(02)02586-6; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; LEVIN HS, 1987, J NEUROSURG, V66, P234, DOI 10.3171/jns.1987.66.2.0234; Marchi N, 2003, RESTOR NEUROL NEUROS, V21, P109; McAllister TW, 1999, NEUROLOGY, V53, P1300, DOI 10.1212/WNL.53.6.1300; METZ C, CLABROC PROGRAM; METZ C, LABROC4 PROGRAM; MIDDELBOE T, 1992, ACTA NEUROL SCAND, V85, P5; Mittenberg W, 2001, J CLIN EXP NEUROPSYC, V23, P829, DOI 10.1076/jcen.23.6.829.1022; Otto M, 2000, INT J SPORTS MED, V21, P551, DOI 10.1055/s-2000-8480; Ponsford J, 2001, PEDIATRICS, V108, P1297, DOI 10.1542/peds.108.6.1297; Ragnarsson KT, 1999, JAMA-J AM MED ASSOC, V282, P974; Romner B, 2000, J NEUROTRAUM, V17, P641, DOI 10.1089/089771500415391; Savola O, 2004, J TRAUMA, V56, P1229, DOI 10.1097/01.TA.0000096644.08735.72; Shanmuganathan K, 2004, AM J NEURORADIOL, V25, P539; Wade DT, 1998, J NEUROL NEUROSUR PS, V65, P177, DOI 10.1136/jnnp.65.2.177; Wiesmann M, 1999, BIOL PSYCHIAT, V45, P1508, DOI 10.1016/S0006-3223(98)00217-0; WONG ET, 1983, AM J CLIN PATHOL, V79, P582, DOI 10.1093/ajcp/79.5.582; BLOOD TEST RESULTS N	50	22	23	0	4	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	0922-6028	1878-3627		RESTOR NEUROL NEUROS	Restor. Neurol. Neurosci.		2006	24	3					163	172					10	Neurosciences	Neurosciences & Neurology	073AE	WOS:000239713700003	16873971				2021-06-18	
J	Dunham, CM; Ransom, KJ; McAuley, CE; Gruber, BS; Mangalat, D; Flowers, LL				Dunham, C. Michael; Ransom, Kenneth J.; McAuley, Clyde E.; Gruber, Brian S.; Mangalat, Dev; Flowers, Laurie L.			Severe brain injury ICU outcomes are associated with Cranial-Arterial Pressure Index and noninvasive Bispectral Index and transcranial oxygen saturation: a prospective, preliminary study	CRITICAL CARE			English	Article							CEREBRAL PERFUSION-PRESSURE; SEVERE HEAD-INJURY; INTRACRANIAL-PRESSURE; EMERGENCY-DEPARTMENT; MONITOR PLACEMENT; OXIMETRY; MANAGEMENT; HYPOXIA	Introduction The purpose of this study was to determine if noninvasive transcranial oxygen saturation (StcO(2)) and Bispectral Index (BIS) correlate with severe traumatic brain injury intensive care unit (ICU) outcomes. Methods This is a prospective observational study. Values of intracranial pressure (ICP), mean arterial pressure ( MAP), BIS, and StcO(2) were recorded hourly for the first six, post-injury days in 18 patients with severe brain injury. Included in the analyses was the Cranial-Arterial Pressure (CAP) Index, which is ICP/ ( MAP - ICP). Results After 1,883 hours of data were analyzed, we found that StcO(2) and BIS are associated with survival, good neurological outcome, ICP <= 20, cerebral perfusion pressure (CPP) >= 60, and CAP index <= 0.30 ( p <= 0.001). Survival and good outcome are independently associated with BIS >= 60, StcO(2) >= 70, and ICP <= 20 ( p < 0.0001). BIS >= 60 or StcO(2) >= 70 is associated with survival, good outcome, CPP >= 60, ICP <= 20, CAP index <= 0.30, and fewer ICP interventions ( p < 0.0001). With BIS >= 60 or StcO2 >= 70, the rate of CPP >= 60 is 97.2% and the rate of ICP <= 25 is 97.1%. An increased CAP index is associated with death, poor neurological outcome, and increased ICP interventions ( p < 0.0001). With CAP index > 0.25, MAP is not related to ICP ( p = 0.16). Conclusion Numerous significant associations with ICU outcomes indicate that BIS and StcO(2) are clinically relevant. The independent associations of BIS, StcO(2), and ICP with outcomes suggest that noninvasive multi-modal monitoring may be beneficial. Future studies of patients with BIS >= 60 or StcO(2) >= 70 will determine if select patients can be managed without ICP monitoring and whether marginal ICP can be observed. An increased CAP index is associated with poor outcome.	St Elizabeth Hlth Ctr, Trauma Crit Care Serv, Youngstown, OH 44501 USA	Dunham, CM (corresponding author), St Elizabeth Hlth Ctr, Trauma Crit Care Serv, Youngstown, OH 44501 USA.	michael_dunham@hmis.org					Abdul-Khaliq H, 2000, BIOMED TECH, V45, P328, DOI 10.1515/bmte.2000.45.11.328; AHMAD S, 2004, CRITICAL CARE MED S, V32, pA104; *BRAIN TRAUM FDN, 2000, J NEUROTRAUM, V17, P493; *BRAIN TRAUM FDN I, 2003, GUID MAN SEV TRAUM B, P1; Cruz J, 1998, CRIT CARE MED, V26, P344, DOI 10.1097/00003246-199802000-00039; Dunham CM, 2004, J TRAUMA, V56, P482, DOI 10.1097/01.TA.0000114537.52540.95; Fabregas N, 2004, ANESTHESIOLOGY, V101, P43, DOI 10.1097/00000542-200407000-00009; GLOBUS MYT, 1988, J NEUROCHEM, V51, P1455, DOI 10.1111/j.1471-4159.1988.tb01111.x; Haug E, 2004, ACAD EMERG MED, V11, P349, DOI 10.1197/j.aem.2003.12.015; Howells T, 2005, J NEUROSURG, V102, P311, DOI 10.3171/jns.2005.102.2.0311; Isa Ruwaida, 2003, Neurosurg Focus, V15, pE1; Jordan KG, 1999, J CLIN NEUROPHYSIOL, V16, P14, DOI 10.1097/00004691-199901000-00002; Juul N, 2000, J NEUROSURG, V92, P1, DOI 10.3171/jns.2000.92.1.0001; Kaups KL, 1998, J TRAUMA, V45, P884, DOI 10.1097/00005373-199811000-00007; Kim MB, 2000, J CLIN MONIT COMPUT, V16, P191, DOI 10.1023/A:1009940031063; Ko K, 2003, J TRAUMA, V55, P480, DOI 10.1097/01.TA.0000074111.04885.28; Madsen PL, 1999, PROG NEUROBIOL, V58, P541, DOI 10.1016/S0301-0082(98)00093-8; Oertel M, 2002, ACT NEUR S, V81, P67; Pillai S, 2004, NEUROL INDIA, V52, P67; Riker RR, 2003, PHARMACOTHERAPY, V23, P1087, DOI 10.1592/phco.23.10.1087.32766; Robertson CS, 1999, CRIT CARE MED, V27, P2086, DOI 10.1097/00003246-199910000-00002; Rosow C, 2001, Anesthesiol Clin North Am, V19, P947; Vivien B, 2002, INTENS CARE MED, V28, P419, DOI 10.1007/s00134-002-1219-4	23	22	31	0	3	BIOMED CENTRAL LTD	LONDON	MIDDLESEX HOUSE, 34-42 CLEVELAND ST, LONDON W1T 4LB, ENGLAND	1466-609X			CRIT CARE	Crit. Care		2006	10	6							R159	10.1186/cc5097			9	Critical Care Medicine	General & Internal Medicine	185NU	WOS:000247718500007	17105656	DOAJ Gold, Green Published			2021-06-18	
J	Felde, AB; Westermeyer, J; Thuras, P				Felde, AB; Westermeyer, J; Thuras, P			Co-morbid traumatic brain injury and substance use disorder: Childhood predictors and adult correlates	BRAIN INJURY			English	Article						traumatic brain injury; substance; related disorders; antisocial personality disorder; comorbidity; conduct disorder	EPIDEMIOLOGIC CATCHMENT-AREA; HEAD-INJURY; PSYCHIATRIC-DISORDERS; RATING-SCALE; AXIS-I; ABUSE; POPULATION; ALCOHOLISM; DEPRESSION; PSYCHOPATHOLOGY	Primary objective: To examine demographic factors, childhood experiences and behaviour problems and adult psychopathology associated with a history of adult traumatic brain injury (TBI) with unconsciousness in patients with substance use disorders (SUD). Design and methods: Voluntary patients (n = 550) undergoing treatment for SUD were compared for clinical and demographic variables based on report of TBI. Results: Among the 218 (40%) patients reporting TBI, 61% were men. Childhood conduct problems and loss of a parent were strongly associated with adult TBI. Patients with TBI had more severe SUD and higher rates of depressive and anxiety symptoms, somatic concerns, physical trauma, attempted suicide and Antisocial Personality Disorder. Conclusions: Men have a higher rate of TBI than women, but women with SUD have an increased relative risk of TBI compared to women in the general population. Childhood conduct problems and loss of a parent in childhood may predict adult risk-taking behaviour that leads to TBI in patients with SUD. TBI is associated with higher rates of psychopathology in patients with SUD.	Vet Adm Med Ctr, Minneapolis, MN 55417 USA; Univ Minnesota, Minneapolis, MN USA	Felde, AB (corresponding author), Vet Adm Med Ctr, 116A,1 Vet Dr, Minneapolis, MN 55417 USA.	anne.felde@med.va.gov					ALTERMAN AI, 1985, J STUD ALCOHOL, V46, P256, DOI 10.15288/jsa.1985.46.256; *AM PSYCH ASS, 1987, DIGN STAT MAN MENT D; American Psychiatric Association, 1994, DIAGN STAT MAN MENT; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; Bombardier CH, 2002, ARCH PHYS MED REHAB, V83, P1765, DOI 10.1053/apmr.2002.36085; BOTSIS AJ, 1995, SUICIDE LIFE-THREAT, V25, P253; Brehaut JC, 2003, PEDIATRICS, V111, P262, DOI 10.1542/peds.111.2.262; Bussing R, 1996, ARCH PEDIAT ADOL MED, V150, P50, DOI 10.1001/archpedi.1996.02170260054009; Carbonneau R, 1998, J STUD ALCOHOL, V59, P387, DOI 10.15288/jsa.1998.59.387; Cobb BK, 1995, J ADOLESCENT HEALTH, V17, P381, DOI 10.1016/1054-139X(95)00059-2; CORRIGAN JD, 1995, ARCH PHYS MED REHAB, V76, P302, DOI 10.1016/S0003-9993(95)80654-7; DEROGATIS LR, 1977, SYMPTOM CHECKLIST 90; Fann JR, 2004, ARCH GEN PSYCHIAT, V61, P53, DOI 10.1001/archpsyc.61.1.53; FANN JR, 1995, AM J PSYCHIAT, V152, P1493; GALE JL, 1983, NEUROSURGERY, V12, P487, DOI 10.1227/00006123-198305000-00001; GOLDSTEIN HS, 1984, J AM ACAD CHILD PSY, V23, P679, DOI 10.1016/S0002-7138(09)60536-7; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; HAMILTON M, BRIT J MED PSYCHOL; HarrisonFelix C, 1996, J HEAD TRAUMA REHAB, V11, P1, DOI 10.1097/00001199-199610000-00002; Hibbard MR, 1998, J HEAD TRAUMA REHAB, V13, P24, DOI 10.1097/00001199-199808000-00003; HILLBOM M, 1986, J NEUROL NEUROSUR PS, V49, P1348, DOI 10.1136/jnnp.49.12.1348; Knight DK, 1998, AM J DRUG ALCOHOL AB, V24, P361, DOI 10.3109/00952999809016903; Kolakowsky-Hayner S, 2002, BRAIN INJURY, V16, P583, DOI 10.1080/02699050110119475; Kolakowsky-Hayner SA, 1999, BRAIN INJURY, V13, P571; Koponen S, 2002, AM J PSYCHIAT, V159, P1315, DOI 10.1176/appi.ajp.159.8.1315; Kraus Jess F., 1994, P3; LINDENBAUM GA, 1989, J TRAUMA, V29, P1654, DOI 10.1097/00005373-198912000-00012; MALLOY P, 1990, ADDICT BEHAV, V15, P431, DOI 10.1016/0306-4603(90)90029-W; MANNUZZA S, 1989, ARCH GEN PSYCHIAT, V46, P1073; MEEHL PE, 1978, J CONSULT CLIN PSYCH, V46, P806, DOI 10.1037/0022-006X.46.4.806; Oquendo MA, 2004, J NERV MENT DIS, V192, P430, DOI 10.1097/01.nmd.0000126706.53615.7b; OVERALL JE, 1962, PSYCHOL REP, V10, P799; PARKINSON D, 1985, CAN J SURG, V28, P79; Pulkkinen L, 1995, CHILD DEV, V66, P1660, DOI 10.2307/1131902; Redeker N S, 1995, Am J Crit Care, V4, P370; REDLICH FC, 1953, AM J PSYCHIAT, V109, P729, DOI 10.1176/ajp.109.10.729; RIMEL RW, 1982, NEUROSURGERY, V11, P344, DOI 10.1227/00006123-198209000-00002; ROBINS LN, 1991, PSYCHIATRY, V54, P116; SELZER ML, 1971, AM J PSYCHIAT, V127, P1653, DOI 10.1176/ajp.127.12.1653; Silver JM, 2001, BRAIN INJURY, V15, P935, DOI 10.1080/02699050110065295; Vanderploeg RD, 2003, J HEAD TRAUMA REHAB, V18, P148, DOI 10.1097/00001199-200303000-00006; Walker R, 2001, SUBST USE MISUSE, V36, P757, DOI 10.1081/JA-100104089; Westermeyer J, 2005, AM J DRUG ALCOHOL AB, V31, P93, DOI 10.1081/ADA-200047895; WESTERMEYER J, 1988, AM J PSYCHIAT, V145, P1265; Westermeyer J, 1998, AM J ADDICTION, V7, P24; Westermeyer Joe, 1994, Journal of Addictive Diseases, V13, P67; Wong Pauline P., 1993, Brain Injury, V7, P283, DOI 10.3109/02699059309034955	47	22	22	1	5	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	JAN	2006	20	1					41	49		10.1080/02699050500309718			9	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	001AQ	WOS:000234505000005	16403699				2021-06-18	
J	Nishio, M; Niimi, S				Nishio, M; Niimi, S			Comparison of speaking rate, articulation rate and alternating motion rate in dysarthric speakers	FOLIA PHONIATRICA ET LOGOPAEDICA			English	Article						dysarthria; speaking rate; articulation rate; alternating motion rates; motor speech	AMYOTROPHIC-LATERAL-SCLEROSIS; TRAUMATIC BRAIN-INJURY; SPEECH CHARACTERISTICS; PARKINSONS-DISEASE; ELECTROMAGNETIC ARTICULOGRAPHY; KINEMATIC ANALYSIS; ATAXIC DYSARTHRIA; INTELLIGIBILITY; DIADOCHOKINESIS; DISORDERS	Despite recent indications that speaking rate, articulation rate and alternating motion rate (AMR) are sensitive to the influence of neurological disease on speech production in dysarthric speakers, the relationship among these parameters remains largely questionable. In the current study, speech samples were collected from 62 dysarthric speakers and 34 controls while reading a passage. Acoustic analysis investigated speaking rate, articulation rate and AMR and compared these parameters between the dysarthric and control groups and within the control and dysarthric group. The major findings were: (1) Speaking rate, articulation rate and AMR were all markedly lower in dysarthric speakers than in controls. (2) Marked correlations were recognized between speaking rate, articulation rate and AMR in the dysarthric group. (3) Compared with the speaking rate and articulation rate, AMR is characterized as follows: (i) variation was more limited in controls, and (ii) the control group was clearly distinguishable from the dysarthric group. (4) Unlike in controls, AMR in the dysarthric speakers was notably lower than their articulation rate. We therefore conclude that AMR is a more easily detected sign of abnormal articulation than speaking rate and articulation rate. Copyright (c) 2006 S. Karger AG, Basel.	Niigata Univ Hlth & Welf, Dept Speech Therapy, Niigata 9503198, Japan; Int Univ Hlth & Welf, Dept Speech & Hearing Sci, Ohtawara, Tochigi, Japan	Nishio, M (corresponding author), Niigata Univ Hlth & Welf, Dept Speech Therapy, Shimami Cho 1398, Niigata 9503198, Japan.	nishio@nuhw.ac.jp					ACKERMANN H, 1995, FOLIA PHONIATR LOGO, V47, P15, DOI 10.1159/000266338; CAMPBELL TF, 1995, J SPEECH HEAR RES, V38, P864, DOI 10.1044/jshr.3804.864; CANTER GJ, 1965, J SPEECH HEAR DISORD, V30, P217, DOI 10.1044/jshd.3003.217; CANTER GJ, 1963, J SPEECH HEAR DISORD, V28, P221, DOI 10.1044/jshd.2803.221; CARROW E, 1974, ARCH OTOLARYNGOL, V100, P212; Darley F., 1975, MOTOR SPEECH DISORDE; DARLEY FL, 1969, J SPEECH HEAR RES, V12, P246, DOI 10.1044/jshr.1202.246; Duffy J. R., 2020, MOTOR SPEECH DISORDE; DWORKIN JP, 1980, J SPEECH HEAR RES, V23, P828, DOI 10.1044/jshr.2304.828; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Fukusako Y., 1983, JPN J LOGOP PHONIATR, V24, P149; Goldman-Eisler F., 1968, PSYCHOLINGUISTICS EX; Goozee JV, 1999, J MED SPEECH-LANG PA, V7, P209; Goozee JV, 2000, BRAIN INJURY, V14, P153, DOI 10.1080/026990500120817; GROSJEAN F, 1979, PHONETICA, V36, P98, DOI 10.1159/000259950; HIROSE H, 1982, FOLIA PHONIATR, V34, P106, DOI 10.1159/000265636; HIROSE H, 1986, FOLIA PHONIATR, V38, P61, DOI 10.1159/000265824; HIROSE H, 1978, J SPEECH HEAR DISORD, V43, P96, DOI 10.1044/jshd.4301.96; Itoh M., 1992, JPN J LOGOP PHONIATR, V33, P227; Jaeger M, 2000, FOLIA PHONIATR LOGO, V52, P187, DOI 10.1159/000021533; Kent RD, 2000, J SPEECH LANG HEAR R, V43, P1275, DOI 10.1044/jslhr.4305.1275; KENT RD, 1991, J SPEECH HEAR RES, V34, P1269, DOI 10.1044/jshr.3406.1269; KENT RD, 1975, J SPEECH HEAR DISORD, V40, P459; KREUL EJ, 1972, J SPEECH HEAR RES, V15, P72, DOI 10.1044/jshr.1501.72; LANGMORE SE, 1994, J SPEECH HEAR RES, V37, P28, DOI 10.1044/jshr.3701.28; Linebaugh C. E., 1984, DYSARTHRIAS PHYSL AC, P197; Ludlow C. L., 1984, DYSARTHRIAS PHYSL AC, P163; MULLIGAN M, 1994, J SPEECH HEAR RES, V37, P496, DOI 10.1044/jshr.3703.496; Nishio M, 2000, CLIN LINGUIST PHONET, V14, P485; Nishio M, 2001, CLIN LINGUIST PHONET, V15, P309; Nishio M., 2001, JPN J LOGOP PHONIATR, V42, P9; Ozawa Y, 2001, FOLIA PHONIATR LOGO, V53, P67, DOI 10.1159/000052656; PETERSON GE, 1960, J ACOUST SOC AM, V32, P693, DOI 10.1121/1.1908183; PLATT LJ, 1980, J SPEECH HEAR RES, V23, P28, DOI 10.1044/jshr.2301.28; PORTNOY RA, 1982, J SPEECH HEAR DISORD, V47, P324, DOI 10.1044/jshd.4703.324; TAGUCHI T, 1966, INTRO LOGOPEDICS; TATSUMI IF, 1979, ANN B RILP, V13, P99; THEODOROS DG, 1994, BRAIN INJURY, V8, P101, DOI 10.3109/02699059409150963; Tjaden K, 2003, FOLIA PHONIATR LOGO, V55, P241, DOI 10.1159/000072155; TRUBETZKOY NS, 1968, INTRO PRINCIPLES PHO; Tsao YC, 1997, J SPEECH LANG HEAR R, V40, P858, DOI 10.1044/jslhr.4004.858; TURNER GS, 1993, J SPEECH HEAR RES, V36, P1134, DOI 10.1044/jshr.3606.1134; Wang YT, 2004, CLIN LINGUIST PHONET, V18, P57, DOI 10.1080/02699200310001596160; Westbury JR, 1993, ANN B RES I LOGOPEDI, P13; Yorkston K. M., 1993, J MED SPEECH-LANG PA, V1, P35, DOI DOI 10.1044/1058-0360.0404.139; YORKSTON KM, 1978, J COMMUN DISORD, V11, P499, DOI 10.1016/0021-9924(78)90024-2; YORKSTON KM, 1981, J SPEECH HEAR DISORD, V46, P296, DOI 10.1044/jshd.4603.296; ZIEGLER W, 1986, BRIT J DISORD COMMUN, V21, P173; Ziegler W, 1996, NEUROLOGY, V47, P208, DOI 10.1212/WNL.47.1.208; ZIEGLER W, 1988, BRIT J DISORD COMMUN, V23, P215	50	22	22	0	5	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	1021-7762			FOLIA PHONIATR LOGO	Folia Phoniatr. Logop.		2006	58	2					114	131		10.1159/000089612			18	Audiology & Speech-Language Pathology; Otorhinolaryngology; Rehabilitation	Audiology & Speech-Language Pathology; Otorhinolaryngology; Rehabilitation	013AU	WOS:000235382800004	16479133				2021-06-18	
J	Huang, WD; Fei, Z; Zhang, X				Huang, WD; Fei, Z; Zhang, X			Traumatic injury induced homer-1a gene expression in cultured cortical neurons of rat	NEUROSCIENCE LETTERS			English	Article						receptor; glutamate; trauma; neurons; homers	METABOTROPIC GLUTAMATE RECEPTORS; LONG-TERM POTENTIATION; PROLINE-RICH MOTIF; MESSENGER-RNA; BRAIN-INJURY; PROTEINS; FAMILY; BINDS	The Homer proteins belong to one of the newly found postsynaptic density protein families. As an immediately early gene, the homer-1a is dynamically expressed and is upregulated by synaptic activity. The homer-1b/c is constitutively expressed and there is no change of gene expression with neuronal activity. In this study, we investigated whether a traumatic injury might regulate the homer-1a expression in cultured cortical neurons of rat. After 7 days in vitro cultivation, the rat fetus cortical neurons were divided into control and injured groups. Then, a traumatic injury was performed on a cortical neuronal culture using a punch device that consisted of 28 stainless steel blades joined together, these produced parallel cuts of 1.2 mm that were uniformly distributed through the cell layer. The lactate dehydrogenase level of the neuronal cultures medium was evaluated and the expression patterns of homer-1a, homer-1b/c were analyzed with the method of RT-PCR and Western blot at different times after the injury (10, 30 min, 1, 3, 6, 12, 24, 72 h). It was shown that there was no expression of homer-1a in the control group, but homer-1a was upregulated in the period of 10 min to 72 It after the traumatic injury. The homer-1b/c was clearly observed in the control group, but there was no change in its expression after traumatic stimulation. It was concluded that traumatic stimulation could induce the homer-1a gene expression, dynamically expressed homer-1a and constitutively expressed homer-1b/c might modulate the distribution and function of group I metabotropic glutamate receptors. (C) 2005 Elsevier Ireland Ltd. All rights reserved.	Fourth Mil Med Univ, Dept Neurosurg, Xijing Hosp, Xian 710032, Peoples R China	Fei, Z (corresponding author), Fourth Mil Med Univ, Dept Neurosurg, Xijing Hosp, 15 W Changle Rd, Xian 710032, Peoples R China.	feizhou@fmmu.edu.cn					Brakeman PR, 1997, NATURE, V386, P284, DOI 10.1038/386284a0; Ciruela F, 2000, MOL CELL NEUROSCI, V15, P36, DOI 10.1006/mcne.1999.0808; Faden AI, 2001, EXP NEUROL, V167, P435, DOI 10.1006/exnr.2000.7577; Fei Z, 2005, NEUROSCI LETT, V380, P280, DOI 10.1016/j.neulet.2005.01.063; Ghajar J, 2000, LANCET, V356, P923, DOI 10.1016/S0140-6736(00)02689-1; Hiroaki Y, 2002, BIOCHEM BIOPH RES CO, V295, P756, DOI 10.1016/S0006-291X(02)00738-6; Irie K, 2002, J MOL BIOL, V318, P1117, DOI 10.1016/S0022-2836(02)00170-5; Kato A, 1998, J BIOL CHEM, V273, P23969, DOI 10.1074/jbc.273.37.23969; Matsuo R, 2000, J NEUROCHEM, V74, P2239, DOI 10.1046/j.1471-4159.2000.0742239.x; Morioka R, 2001, NEUROSCI LETT, V313, P99, DOI 10.1016/S0304-3940(01)02224-8; Nielsen HS, 2002, MOL BRAIN RES, V105, P79, DOI 10.1016/S0169-328X(02)00395-9; PIN JP, 1995, NEUROPHARMACOLOGY, V34, P1, DOI 10.1016/0028-3908(94)00129-G; Sala C, 2001, NEURON, V31, P115, DOI 10.1016/S0896-6273(01)00339-7; Sato M, 2001, J NEUROSCI, V21, P3797, DOI 10.1523/JNEUROSCI.21-11-03797.2001; Soloviev MM, 2000, J MOL BIOL, V295, P1185; Tadokoro S, 1999, P NATL ACAD SCI USA, V96, P13801, DOI 10.1073/pnas.96.24.13801; Tu JC, 1998, NEURON, V21, P717, DOI 10.1016/S0896-6273(00)80589-9; Xiao B, 1998, NEURON, V21, P707, DOI 10.1016/S0896-6273(00)80588-7	18	22	27	0	1	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0304-3940	1872-7972		NEUROSCI LETT	Neurosci. Lett.	NOV 25	2005	389	1					46	50		10.1016/j.neulet.2005.07.014			5	Neurosciences	Neurosciences & Neurology	964PX	WOS:000231894100010	16087291				2021-06-18	
J	Canzoniero, LMT; Snider, BJ				Canzoniero, LMT; Snider, BJ			Calcium in Alzheimer's disease pathogenesis: Too much, too little or in the wrong place?	JOURNAL OF ALZHEIMERS DISEASE			English	Article						excitotoxicity; glutamate; cell death; proteasome	AMYLOID PRECURSOR PROTEIN; NERVE GROWTH-FACTOR; UBIQUITIN-PROTEASOME SYSTEM; CEREBELLAR GRANULE NEURONS; D-ASPARTATE ANTAGONISTS; TRAUMATIC BRAIN-INJURY; ROOT GANGLION NEURONS; APOPTOTIC CELL-DEATH; CORTICAL-NEURONS; INTRACELLULAR CALCIUM	Our understanding of the molecular genetics and biochemical pathology of Alzheimer's disease has progressed tremendously in the past decade. The metabolism of amyloid beta-peptide is being unraveled, and specific anti-amyloid therapies are now in clinical trials worldwide. The precise biophysical structure of the amyloid beta-peptide that causes neuronal dysfunction remains under investigation, as does the interaction between amyloid peptides and tau hyperphosphorylation, but these two molecules likely play key roles in neuronal dysfunction in Alzheimer's disease. Despite these advances, the cell biology of neuronal dysfunction and cell death in the Alzheimer's disease brain remains poorly understood. This brief review will explore the role of calcium (Ca2+) in neuronal death occurring during Alzheimer's disease. The evidence for glutamate receptor-mediated Ca2+ overload, or excitotoxicity, and other derangements of Ca2+ homeostasis in cell culture and animal models of Alzheimer's disease is reviewed. Finally, we raise the possibility that some of the neuronal death observed in Alzheimer's disease might be associated with a reduction in rather than an increase in cytosolic Ca2+ levels, an idea with potentially important therapeutic implications.	Univ Sannio, Dept Biol & Environm Sci, I-82100 Benovento, Italy; Washington Univ, Sch Med, Alzheimers Dis Res Ctr, St Louis, MO USA; Washington Univ, Sch Med, Dept Neurol, Hope Ctr Neurol Disorders, St Louis, MO USA	Canzoniero, LMT (corresponding author), Univ Sannio, Dept Biol & Environm Sci, Via Port Arsa 11, I-82100 Benovento, Italy.	canzoniero@unisannio.it			NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS44923-01] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS044923] Funding Source: NIH RePORTER		Akbari Y, 2004, BIOCHEM BIOPH RES CO, V322, P1145, DOI 10.1016/j.bbrc.2004.07.136; ARISPE N, 1993, P NATL ACAD SCI USA, V90, P10573, DOI 10.1073/pnas.90.22.10573; ARISPE N, 1993, P NATL ACAD SCI USA, V90, P567, DOI 10.1073/pnas.90.2.567; Arundine M, 2004, CELL MOL LIFE SCI, V61, P657, DOI 10.1007/s00018-003-3319-x; Beal MF, 2004, J BIOENERG BIOMEMBR, V36, P381, DOI 10.1023/B:JOBB.0000041772.74810.92; Begley JG, 1999, J NEUROCHEM, V72, P1030, DOI 10.1046/j.1471-4159.1999.0721030.x; Bezprozvanny I, 2004, BIOCHEM BIOPH RES CO, V322, P1310, DOI 10.1016/j.bbrc.2004.08.035; Blanchard BJ, 2004, P NATL ACAD SCI USA, V101, P14326, DOI 10.1073/pnas.0405941101; Boncristiano S, 2002, J NEUROSCI, V22, P3234, DOI 10.1523/JNEUROSCI.22-08-03234.2002; Borsello T, 2000, NEUROSCIENCE, V95, P163; BRORSON JR, 1995, J NEUROBIOL, V26, P325, DOI 10.1002/neu.480260305; Calhoun ME, 1998, NATURE, V395, P755, DOI 10.1038/27351; Canevari L, 2004, NEUROCHEM RES, V29, P637, DOI 10.1023/B:NERE.0000014834.06405.af; Canzoniero LMT, 2004, NEUROBIOL DIS, V15, P520, DOI 10.1016/j.nbd.2003.10.013; Cheng Yu Dennis, 2004, NeuroRx, V1, P36, DOI 10.1602/neurorx.1.1.36; Cluskey S, 2001, J CLIN PATHOL-MOL PA, V54, P386; de Pril R, 2004, HUM MOL GENET, V13, P1803, DOI 10.1093/hmg/ddh188; DEKOSKY ST, 1990, ANN NEUROL, V27, P457, DOI 10.1002/ana.410270502; Demuro A, 2005, J BIOL CHEM, V280, P17294, DOI 10.1074/jbc.M500997200; Distasi C, 1998, EUR J NEUROSCI, V10, P2276, DOI 10.1046/j.1460-9568.1998.00239.x; Doody R, 2004, DEMENT GERIATR COGN, V18, P227, DOI 10.1159/000079833; EICHLER ME, 1992, J NEUROCHEM, V58, P263, DOI 10.1111/j.1471-4159.1992.tb09305.x; GALLI C, 1995, J NEUROSCI, V15, P1172; GALLO V, 1987, J NEUROSCI, V7, P2203; German DC, 2004, REV NEUROSCIENCE, V15, P353, DOI 10.1515/REVNEURO.2004.15.5.353; Gotz J, 2004, MOL PSYCHIATR, V9, P664, DOI 10.1038/sj.mp.4001508; Guo Q, 1999, NAT MED, V5, P101, DOI 10.1038/4789; HAMOS JE, 1989, NEUROLOGY, V39, P355, DOI 10.1212/WNL.39.3.355; Hardingham GE, 2002, NAT NEUROSCI, V5, P405, DOI 10.1038/nn835; Harkany T, 1999, NEUROBIOL DIS, V6, P109, DOI 10.1006/nbdi.1998.0230; He LM, 2002, BRAIN RES, V939, P65, DOI 10.1016/S0006-8993(02)02549-0; HEIMER L, 1978, J COMP NEUROL, V178, P559, DOI 10.1002/cne.901780310; Herms J, 2003, J BIOL CHEM, V278, P2484, DOI 10.1074/jbc.M206769200; Hoyte L, 2004, CURR MOL MED, V4, P131, DOI 10.2174/1566524043479248; Hwang JY, 1999, EXP NEUROL, V159, P124, DOI 10.1006/exnr.1999.7126; Ikonomidou C, 1999, SCIENCE, V283, P70, DOI 10.1126/science.283.5398.70; Ikonomidou C, 2002, LANCET NEUROL, V1, P383, DOI 10.1016/S1474-4422(02)00164-3; Ikonomidou C, 2000, P NATL ACAD SCI USA, V97, P12885, DOI 10.1073/pnas.220412197; Irizarry MC, 1997, J NEUROSCI, V17, P7053; JOHNSON EM, 1992, EXP NEUROL, V115, P163, DOI 10.1016/0014-4886(92)90242-I; Kagan BL, 2004, J MEMBRANE BIOL, V202, P1, DOI 10.1007/s00232-004-0709-4; Keller JN, 2000, J NEUROCHEM, V75, P436, DOI 10.1046/j.1471-4159.2000.0750436.x; KOH JY, 1990, BRAIN RES, V533, P315, DOI 10.1016/0006-8993(90)91355-K; KOIKE T, 1989, P NATL ACAD SCI USA, V86, P6421, DOI 10.1073/pnas.86.16.6421; KOIKE T, 1991, P NATL ACAD SCI USA, V88, P3892, DOI 10.1073/pnas.88.9.3892; LaFerla FM, 2002, NAT REV NEUROSCI, V3, P862, DOI 10.1038/nrn960; LAMPE PA, 1995, J NEUROBIOL, V26, P205, DOI 10.1002/neu.480260205; Lee JM, 1999, NATURE, V399, pA7, DOI 10.1038/399a007; Leissring MA, 2002, P NATL ACAD SCI USA, V99, P4697, DOI 10.1073/pnas.072033799; LEVICK V, 1995, BRAIN RES, V676, P325, DOI 10.1016/0006-8993(95)00115-7; LUCAS DR, 1957, ARCH OPHTHALMOL-CHIC, V58, P193; LUDOLPH AC, 2000, J NEUROL, V247, P17; MATTSON MP, 1992, J NEUROSCI, V12, P376, DOI 10.1523/jneurosci.12-02-00376.1992; Mattson MP, 2003, CELL CALCIUM, V34, P385, DOI 10.1016/S0143-4160(03)00128-3; Maurice T, 1996, BRAIN RES, V731, P249, DOI 10.1016/0006-8993(96)00710-X; McNaught KSP, 2004, INT REV NEUROBIOL, V62, P95, DOI 10.1016/S0074-7742(04)62003-4; Mennerick S, 2000, MOL NEUROBIOL, V22, P41; Miguel-Hidalgo JJ, 2002, BRAIN RES, V958, P210, DOI 10.1016/S0006-8993(02)03731-9; Morimoto K, 1998, NEUROSCIENCE, V84, P479, DOI 10.1016/S0306-4522(97)00507-1; O'Mahony S, 1998, BRAIN RES BULL, V45, P405, DOI 10.1016/S0361-9230(97)00405-X; OLNEY JW, 1989, SCIENCE, V244, P1360, DOI 10.1126/science.2660263; Pak K, 2003, NEUROMOL MED, V3, P53, DOI 10.1385/NMM:3:1:53; PEARSON H, 1992, EUR J NEUROSCI, V4, P1369, DOI 10.1111/j.1460-9568.1992.tb00162.x; Petrucelli L, 2004, ANN MED, V36, P315, DOI 10.1080/07853890410031948; Pike CJ, 1996, J NEUROCHEM, V67, P1774; Pohl D, 1999, P NATL ACAD SCI USA, V96, P2508, DOI 10.1073/pnas.96.5.2508; Reisberg B, 2003, NEW ENGL J MED, V348, P1333, DOI 10.1056/NEJMoa013128; Salon ML, 2000, J NEUROSCI RES, V62, P302, DOI 10.1002/1097-4547(20001015)62:2<302::AID-JNR15>3.0.CO;2-L; Sanner C, 1994, Neurobiol Dis, V1, P121, DOI 10.1006/nbdi.1994.0015; Schneider I, 2001, J BIOL CHEM, V276, P11539, DOI 10.1074/jbc.M010977200; Sheehan JP, 1997, J NEUROCHEM, V68, P1221; Smith IF, 2002, BRAIN RES, V949, P105, DOI 10.1016/S0006-8993(02)02970-0; Snider BJ, 2002, EUR J NEUROSCI, V15, P419, DOI 10.1046/j.0953-816x.2001.01867.x; Soler RM, 1998, J NEUROSCI, V18, P1230; Song SM, 2004, TRENDS MOL MED, V10, P565, DOI 10.1016/j.molmed.2004.09.005; Stutzmann GE, 2005, NEUROSCIENTIST, V11, P110, DOI 10.1177/1073858404270899; Takeuchi A, 2000, AM J PATHOL, V157, P331, DOI 10.1016/S0002-9440(10)64544-0; Tariot PN, 2004, JAMA-J AM MED ASSOC, V291, P317, DOI 10.1001/jama.291.3.317; TERRY RD, 1991, ANN NEUROL, V30, P572, DOI 10.1002/ana.410300410; van Leeuwen FW, 1998, SCIENCE, V279, P242, DOI 10.1126/science.279.5348.242; Verkhratsky A, 2005, PHYSIOL REV, V85, P201, DOI 10.1152/physrev.00004.2004; WEISS JH, 1994, J NEUROCHEM, V62, P372; Winblad B, 1999, INT J GERIATR PSYCH, V14, P135, DOI 10.1002/(SICI)1099-1166(199902)14:2<135::AID-GPS906>3.0.CO;2-0; Wozniak DF, 1998, NEUROBIOL DIS, V5, P305, DOI 10.1006/nbdi.1998.0206; Wozniak DF, 1996, BRAIN RES, V707, P165, DOI 10.1016/0006-8993(95)01230-3; YAN GM, 1994, BRAIN RES, V656, P43, DOI 10.1016/0006-8993(94)91364-1; Yang Y, 2004, NEUROSCIENCE, V124, P501, DOI 10.1016/j.neuroscience.2003.11.029; Yoo AS, 2000, NEURON, V27, P561, DOI 10.1016/S0896-6273(00)00066-0	88	22	25	0	3	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1387-2877	1875-8908		J ALZHEIMERS DIS	J. Alzheimers Dis.	NOV	2005	8	2					147	154					8	Neurosciences	Neurosciences & Neurology	021XE	WOS:000236018400007	16308483				2021-06-18	
J	Frederickson, CJ; Cuajungco, MP; Frederickson, CJ				Frederickson, CJ; Cuajungco, MP; Frederickson, CJ			Is zinc the link between compromises of brain perfusion (excitotoxicity) and Alzheimer's disease?	JOURNAL OF ALZHEIMERS DISEASE			English	Article							AMYLOID PRECURSOR PROTEIN; CEREBRAL CORTICAL-NEURONS; OXIDE SYNTHASE INHIBITORS; CLOSED-HEAD INJURY; NITRIC-OXIDE; TRANSGENIC MICE; APOLIPOPROTEIN-E; EXTRACELLULAR ACCUMULATION; MITOCHONDRIAL DYSFUNCTION; CEREBROSPINAL-FLUID	Prior brain injury is a major risk factor in the development of Alzheimer's disease. This is true for traumatic brain injury, stroke or ischemic brain injury, and (more speculatively) for brain injury resulting from the hypo-perfusion-reperfusion in cardiac arrest or cardiac bypass surgery and even hypo- or hypertension. Here we propose that the release of excess, toxic, "floods" of free zinc into the brain that occurs during and after all excitotoxic brain injury is a key factor that sets the stage for the later development of Alzheimer's disease. Rapid and aggressive administration of zinc buffering compounds to patients suffering brain injury may therefore not only ameliorate the acute injury but might also reduce the risk of subsequent development of Alzheimer's disease.	NeuroBioTex Inc, Galveston, TX 77550 USA; Univ Texas, Sch Med, Galveston, TX 77550 USA; Harvard Univ, Sch Med, Dept Otol & Laryngologist, Boston, MA 02114 USA; Massachusetts Eye & Ear Infirm, Eaton Peabody Lab, Boston, MA 02114 USA	Frederickson, CJ (corresponding author), NeuroBioTex Inc, Galveston, TX 77550 USA.	cathy@neurobiotex.com	Cuajungco, Math/B-2647-2008	Cuajungco, Math/0000-0003-0749-9564	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R21NS042882, R43NS040215, R44NS041682, R43NS041682] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS42882, NS40215, NS41682] Funding Source: Medline		Adlard PA, 1998, NEUROBIOL DIS, V5, P349, DOI 10.1006/nbdi.1998.0203; ARAKI W, 1991, BIOCHEM BIOPH RES CO, V181, P265, DOI 10.1016/S0006-291X(05)81412-3; Balaji RV, 2005, NEUROCHEM RES, V30, P171, DOI 10.1007/s11064-004-2438-6; Bossy-Wetzel E, 2004, NEURON, V41, P351, DOI 10.1016/S0896-6273(04)00015-7; BUSH AI, 1994, J BIOL CHEM, V269, P12152; BUSH AI, 1994, SCIENCE, V265, P1464, DOI 10.1126/science.8073293; Cherny RA, 2001, NEURON, V30, P665, DOI 10.1016/S0896-6273(01)00317-8; CHNEIWEISS H, 1991, J NEUROCHEM, V57, P1708, DOI 10.1111/j.1471-4159.1991.tb06371.x; CHOI DW, 1988, NEUROSCIENCE, V24, P67, DOI 10.1016/0306-4522(88)90312-0; Choi DW, 1998, ANNU REV NEUROSCI, V21, P347, DOI 10.1146/annurev.neuro.21.1.347; Clark RSB, 1996, CRIT CARE MED, V24, P1243, DOI 10.1097/00003246-199607000-00030; Clark RSB, 1996, PEDIATR RES, V39, P784, DOI 10.1203/00006450-199605000-00007; Colvin RA, 2000, NEUROCHEM INT, V36, P539, DOI 10.1016/S0197-0186(99)00127-8; Colvin RA, 2000, J NUTR, V130, p1484S, DOI 10.1093/jn/130.5.1484S; Cuajungco MP, 1997, BRAIN RES REV, V23, P219, DOI 10.1016/S0165-0173(97)00002-7; Cuajungco MP, 2000, ANN NY ACAD SCI, V920, P292; Cuajungco MP, 1998, BRAIN RES, V799, P118, DOI 10.1016/S0006-8993(98)00463-6; Danscher G, 1997, J NEUROSCI METH, V76, P53, DOI 10.1016/S0165-0270(97)00079-4; Daumas S, 2004, EUR J NEUROSCI, V20, P597, DOI 10.1111/j.1460-9568.2004.03484.x; De Deyn PP, 1999, PHARMACOPSYCHIATRY, V32, P17, DOI 10.1055/s-2007-979232; De La Torre JC, 2002, ANN NY ACAD SCI, V977, P196; de la Torre JC, 2002, STROKE, V33, P1152, DOI 10.1161/01.STR.0000014421.15948.67; Deibel MA, 1996, J NEUROL SCI, V143, P137, DOI 10.1016/S0022-510X(96)00203-1; Di Vaira M, 2004, INORG CHEM, V43, P3795, DOI 10.1021/ic0494051; Eckenhoff RG, 2004, ANESTHESIOLOGY, V101, P703, DOI 10.1097/00000542-200409000-00019; Ezra Y, 2003, NEUROSCIENCE, V121, P315, DOI 10.1016/S0306-4522(03)00436-6; FERREIRO JA, 1989, J NEUROL, V236, P267, DOI 10.1007/BF00314454; Frederickson CJ, 2002, NEUROSCIENCE, V115, P471, DOI 10.1016/S0306-4522(02)00399-8; FREDERICKSON CJ, 1988, BRAIN RES, V446, P383, DOI 10.1016/0006-8993(88)90899-2; FREDERICKSON CJ, 2005, NAT REV NEUROSCI; FREDERICKSON CJ, 2004, ZINC EXCITOTOOXIC BR, P18; Haase H, 2003, EXP CELL RES, V291, P289, DOI 10.1016/S0014-4827(03)00406-3; Honig LS, 2003, ARCH NEUROL-CHICAGO, V60, P1707, DOI 10.1001/archneur.60.12.1707; Huang XD, 1997, J BIOL CHEM, V272, P26464, DOI 10.1074/jbc.272.42.26464; Huckle Richard, 2005, Curr Opin Investig Drugs, V6, P99; Ikonomovic MD, 2004, EXP NEUROL, V190, P192, DOI 10.1016/j.expneurol.2004.06.011; Jacob C, 1998, P NATL ACAD SCI USA, V95, P3489, DOI 10.1073/pnas.95.7.3489; Jellinger K A, 2001, BMC Neurol, V1, P3, DOI 10.1186/1471-2377-1-3; Jellinger KA, 2004, CURR OPIN NEUROL, V17, P719, DOI 10.1097/00019052-200412000-00012; Jellinger KA, 2001, EUR J NEUROL, V8, P707, DOI 10.1046/j.1468-1331.2001.00322.x; Jiang LJ, 2000, P NATL ACAD SCI USA, V97, P2503, DOI 10.1073/pnas.97.6.2503; Koh JY, 1996, SCIENCE, V272, P1013, DOI 10.1126/science.272.5264.1013; Labiner David M, 2002, Curr Opin Investig Drugs, V3, P921; Law A, 2001, BRAIN RES REV, V35, P73, DOI 10.1016/S0165-0173(00)00051-5; Law A, 2001, BRIT J PHARMACOL, V133, P1114, DOI 10.1038/sj.bjp.0704179; Lee JY, 2002, P NATL ACAD SCI USA, V99, P7705, DOI 10.1073/pnas.092034699; Li Y, 2001, J NEUROPHYSIOL, V86, P2597; Lipton SA, 2004, J ALZHEIMERS DIS, V6, pS61; Lovell MA, 1998, J NEUROL SCI, V158, P47, DOI 10.1016/S0022-510X(98)00092-6; Macfarlane DP, 1999, NEUROREPORT, V10, P3945, DOI 10.1097/00001756-199912160-00040; Maret W, 1998, P NATL ACAD SCI USA, V95, P3478, DOI 10.1073/pnas.95.7.3478; Maret W, 2000, J NUTR, V130, p1455S, DOI 10.1093/jn/130.5.1455S; Maret W, 1999, P NATL ACAD SCI USA, V96, P1936, DOI 10.1073/pnas.96.5.1936; Mesenge C, 1996, J NEUROTRAUM, V13, P209, DOI 10.1089/neu.1996.13.209; Molnar P, 2001, BRAIN RES, V910, P205, DOI 10.1016/S0006-8993(01)02720-2; Nakagawa Y, 1999, J COMP NEUROL, V411, P390; O'Mahony S, 1998, BRAIN RES BULL, V45, P405, DOI 10.1016/S0361-9230(97)00405-X; Olsson A, 2004, J NEUROL, V251, P870, DOI 10.1007/s00415-004-0451-y; Paoletti P, 1997, J NEUROSCI, V17, P5711; Paris D, 1998, EXP NEUROL, V152, P116, DOI 10.1006/exnr.1998.6828; Pasquier F, 1997, J NEUROL, V244, P135, DOI 10.1007/s004150050064; Pasquier F, 1998, REV NEUROL-FRANCE, V154, P743; PEREZCLAUSELL J, 1985, BRAIN RES, V337, P91, DOI 10.1016/0006-8993(85)91612-9; Plassman BL, 2000, NEUROLOGY, V55, P1158, DOI 10.1212/WNL.55.8.1158; PLUTA R, 1994, BRAIN RES, V649, P323, DOI 10.1016/0006-8993(94)91081-2; Pluta R, 1997, FOLIA NEUROPATHOL, V35, P94; Pluta R, 2000, ANN NY ACAD SCI, V903, P324, DOI 10.1111/j.1749-6632.2000.tb06383.x; Raman B, 2005, J BIOL CHEM, V280, P16157, DOI 10.1074/jbc.M500309200; Roher AE, 2003, ARTERIOSCL THROM VAS, V23, P2055, DOI 10.1161/01.ATV.0000095973.42032.44; Royter V, 2005, J NEUROL SCI, V229, P65, DOI 10.1016/j.jns.2004.11.003; Sabo T, 2000, NEUROSCIENCE, V101, P879, DOI 10.1016/S0306-4522(00)00438-3; Sensi SL, 2000, EUR J NEUROSCI, V12, P3813, DOI 10.1046/j.1460-9568.2000.00277.x; Sensi SL, 1999, NEUROREPORT, V10, P1723, DOI 10.1097/00001756-199906030-00018; Sensi SL, 1999, P NATL ACAD SCI USA, V96, P2414, DOI 10.1073/pnas.96.5.2414; Sindreu CB, 2003, CEREB CORTEX, V13, P823, DOI 10.1093/cercor/13.8.823; Slooter AJC, 1997, JAMA-J AM MED ASSOC, V277, P818, DOI 10.1001/jama.277.10.818; Smart TG, 2004, NEUROSCIENTIST, V10, P432, DOI 10.1177/1073858404263463; Smith MA, 1997, J NEUROSCI, V17, P2653; Sparks DL, 2000, NEUROBIOL AGING, V21, P363, DOI 10.1016/S0197-4580(00)00101-9; Suh SW, 2004, NEUROBIOL DIS, V16, P538, DOI 10.1016/j.nbd.2004.04.017; Suh SW, 2000, BRAIN RES, V852, P274, DOI 10.1016/S0006-8993(99)02096-X; Suh SW, 2000, BRAIN RES, V852, P268, DOI 10.1016/S0006-8993(99)02095-8; Takeda A, 2005, NEUROCHEM INT, V46, P221, DOI 10.1016/j.neuint.2004.10.003; Treiber C, 2004, J BIOL CHEM, V279, P51958, DOI 10.1074/jbc.M407410200; Tsai EC, 2005, CURR PHARM DESIGN, V11, P1211, DOI 10.2174/1381612053507404; Tsuchiya D, 2002, J CEREBR BLOOD F MET, V22, P1231; Ueno S, 2002, J CELL BIOL, V158, P215, DOI 10.1083/jcb.200204066; Verghese J, 2003, NEUROLOGY, V61, P1667, DOI 10.1212/01.WNL.0000098934.18300.BE; Wei G, 2004, NEUROSCI LETT, V370, P118, DOI 10.1016/j.neulet.2004.08.027; Wei G, 2004, NEUROSCIENCE, V125, P867, DOI 10.1016/j.neuroscience.2004.03.011; Weiss JH, 2000, TRENDS PHARMACOL SCI, V21, P395, DOI 10.1016/S0165-6147(00)01541-8; Weiss JH, 2000, TRENDS NEUROSCI, V23, P365, DOI 10.1016/S0166-2236(00)01610-6; Wisniewski HM, 1996, FOLIA NEUROPATHOL, V34, P65; Xie Z, 2002, J NEUROSCI, V22, P3484; YAMAMOTO K, 1994, J NEUROBIOL, V25, P585, DOI 10.1002/neu.480250510; Ye B, 2001, P NATL ACAD SCI USA, V98, P2317, DOI 10.1073/pnas.041619198; Yeung Pollen K F, 2004, Curr Opin Investig Drugs, V5, P90; Zambenedetti P, 1998, J CHEM NEUROANAT, V15, P21, DOI 10.1016/S0891-0618(98)00024-6	98	22	23	0	4	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1387-2877	1875-8908		J ALZHEIMERS DIS	J. Alzheimers Dis.	NOV	2005	8	2					155	160					6	Neurosciences	Neurosciences & Neurology	021XE	WOS:000236018400008	16308484				2021-06-18	
J	Kim, JH; Do, SH; Kim, YL; Zuo, ZY				Kim, JH; Do, SH; Kim, YL; Zuo, ZY			Effects of chronic exposure to ethanol on glutamate transporter EAAT3 expressed in Xenopus oocytes: Evidence for protein kinase C involvement	ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH			English	Article						chronic ethanol; glutamate transporter; EAAT3; protein kinase C; voltage clamp	TRAUMATIC BRAIN INJURY; PHORBOL ESTER BINDING; RAT-BRAIN; PHOSPHATIDYLINOSITOL 3-KINASE; GABA SYNTHESIS; ASTROCYTES; WITHDRAWAL; TYPE-3; MICE; CONTRIBUTES	Background: Glutamate transporters (excitatory amino acid transporters, EAAT) regulate extracellular concentrations of glutamate, a major excitatory neurotransmitter. We reported that acute ethanol exposure increases the activity of a major neuronal EAAT, EAAT3. This effect is consistent with the general inhibitory effect of acute alcohol toxicity in the central nervous system (CNS). However, chronic ethanol exposure has CNS presentations different from acute alcohol toxicity. We hypothesize that chronic ethanol exposure will affect the EAAT3 activity differently from acute ethanol exposure. Methods: EAAT3 was expressed in Xenopus oocytes by injection of EAAT3 mRNA. Oocytes were incubated with diluted ethanol for 24-96 hr. Using two-electrode voltage clamp, membrane currents were recorded after the application of L-glutamate. Responses were quantified by integration of the current trace and reported as microCoulombs (mu C). Results: Ethanol (10-100 mM) reduced EAAT3 activity in a time-dependent and reversible manner. After a 96 hr-incubation, the activity was significantly decreased compared to the control values at any concentrations tested in this study. Kinetic study demonstrated that a 96 hr-exposure to 50 mM ethanol significantly decreased Vmax (3.6 +/- 0.3 for control versus 2.6 +/- 0.3 mu C for ethanol, n = 20, p < 0.05) but had no effect on Km (57.6 +/- 12.8 for control versus 51.8 +/- 16.3 mu M for ethanol, n = 20, p > 0.05) of EAAT3 for glutamate. When ethanol (50 mM for 96 hr)-treated oocytes were incubated with phorbol-12-myrisate13-acetate (50 or 100 nM for 10 min), ethanol-induced decrease in EAAT3 activity was abolished. Preincubation of the oocytes with 100 mu M chelerythrine significantly decreased EAAT3 activity (1.00 +/- 0.08 for control versus 0.51 +/- 0.09 mu C for chelerythrine group, n = 18-20, p < 0.05). However, there was no statistical difference among the chelerythrine, ethanol, or chelerythrine plus ethanol groups. Likewise, staurosporine (2 mu M for 1 hr) significantly decreased EAAT3 activity and there was no statistical difference among the staurosporine, ethanol, or staurosporine plus ethanol groups. Conclusions: Our results show that chronic ethanol exposure decreases EAAT3 activity at clinically relevant concentrations and that this effect may be protein kinase C-dependent. Such an effect could be a neuroadaptive mechanism to overcome the inhibitory effect of ethanol on the excitatory neurotransmission.	Seoul Natl Univ Hosp, Dept Anesthesiol, Seoul 110744, South Korea; Seoul Natl Univ, Coll Med, Dept Anesthesiol, Seoul 110744, South Korea; Univ Virginia, Hlth Sci Ctr, Dept Anesthesiol, Hlth Syst, Charlottesville, VA 22908 USA	Do, SH (corresponding author), Seoul Natl Univ Hosp, Dept Anesthesiol, 28 Yongon Dong, Seoul 110744, South Korea.	shdo@snu.ac.kr	Zuo, Zhiyi/F-3950-2010; Kim, Jin Hee/J-5443-2012; Do, Sang Hwan/J-5461-2012	Zuo, Zhiyi/0000-0002-3542-5047; 			BATTAINI F, 1989, ALCOHOL, V6, P169, DOI 10.1016/0741-8329(89)90043-8; Buckman JF, 1999, PSYCHOPHARMACOLOGY, V143, P174, DOI 10.1007/s002130050933; Danbolt NC, 2001, PROG NEUROBIOL, V65, P1, DOI 10.1016/S0301-0082(00)00067-8; Davis KE, 1998, J NEUROSCI, V18, P2475; Diamond I, 1997, PHYSIOL REV, V77, P1, DOI 10.1152/physrev.1997.77.1.1; Do SH, 2003, NEUROSCI LETT, V343, P113, DOI 10.1016/S0304-3940(03)00358-6; Do SH, 2002, ANESTH ANALG, V95, P1263, DOI 10.1097/00000539-200211000-00030; Do SH, 2002, ANESTHESIOLOGY, V96, P1492, DOI 10.1097/00000542-200206000-00032; FOLLESA P, 1995, MOL BRAIN RES, V29, P99, DOI 10.1016/0169-328X(94)00235-7; Gorter JA, 2002, J COMP NEUROL, V442, P365, DOI 10.1002/cne.10101; Greene JG, 1996, J NEUROCHEM, V66, P637; HOFFMAN PL, 1992, ANN NY ACAD SCI, V654, P52, DOI 10.1111/j.1749-6632.1992.tb25955.x; HUANG Y, 2005, MOL PHARM; Hudspith MJ, 1997, BRIT J ANAESTH, V78, P731, DOI 10.1093/bja/78.6.731; JOHNSTONE RE, 1975, ANESTH ANALG, V54, P277; Kim JH, 2003, ALCOHOL CLIN EXP RES, V27, P1548, DOI 10.1097/01.ALC.0000092061.92393.79; LALLEMENT G, 1991, BRAIN RES, V563, P234, DOI 10.1016/0006-8993(91)91539-D; LOVINGER DM, 1989, SCIENCE, V243, P1721, DOI 10.1126/science.2467382; Mathews GC, 2003, J NEUROSCI, V23, P2040; Nilsson P, 1996, J CEREBR BLOOD F MET, V16, P262, DOI 10.1097/00004647-199603000-00011; Othman T, 2002, NEUROCHEM RES, V27, P289, DOI 10.1023/A:1014955111742; PALMER AM, 1993, J NEUROCHEM, V61, P2015, DOI 10.1111/j.1471-4159.1993.tb07437.x; PANDEY SC, 1993, ALCOHOL, V10, P259, DOI 10.1016/0741-8329(93)90002-6; Rajgopal Y, 2003, EUR J PHARMACOL, V470, P117, DOI 10.1016/S0014-2999(03)01795-3; ROSSETTI ZL, 1995, EUR J PHARMACOL, V283, P177, DOI 10.1016/0014-2999(95)00344-K; ROTHSTEIN JD, 1994, NEURON, V13, P713, DOI 10.1016/0896-6273(94)90038-8; ROTHSTEIN JD, 1995, ANN NEUROL, V38, P73, DOI 10.1002/ana.410380114; Schreiber R, 2000, Med Sci Monit, V6, P649; Sepkuty JP, 2002, J NEUROSCI, V22, P6372; Smith TL, 1999, NEUROSCI LETT, V269, P145, DOI 10.1016/S0304-3940(99)00438-3; Smith TL, 1996, NEUROSCI LETT, V218, P142, DOI 10.1016/S0304-3940(96)13123-2; Smith TL, 1997, LIFE SCI, V61, P2499, DOI 10.1016/S0024-3205(97)00985-5; SNELL LD, 1993, BRAIN RES, V602, P91, DOI 10.1016/0006-8993(93)90246-J; Sultana R, 2003, NEUROSCI LETT, V349, P45, DOI 10.1016/S0304-3940(03)00755-9; TANAKA C, 1994, ANNU REV NEUROSCI, V17, P551, DOI 10.1146/annurev.ne.17.030194.003003; Tanaka K, 1997, SCIENCE, V276, P1699, DOI 10.1126/science.276.5319.1699; TREVISAN L, 1994, J NEUROCHEM, V62, P1635; Tsai GCE, 1998, AM J PSYCHIAT, V155, P726	38	22	24	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0145-6008	1530-0277		ALCOHOL CLIN EXP RES	Alcoholism (NY)	NOV	2005	29	11					2046	2052		10.1097/01.alc.0000187594.92476.07			7	Substance Abuse	Substance Abuse	994EX	WOS:000234014700018	16340463				2021-06-18	
J	Symons, FJ; Danov, SE				Symons, FJ; Danov, SE			A prospective clinical analysis of pain behavior and self-injurious behavior	PAIN			English	Article						pain; self-injurious behavior; traumatic brain injury	BORDERLINE PERSONALITY-DISORDER; SEVERE COGNITIVE IMPAIRMENTS; CONGENITAL INSENSITIVITY; MENTAL-RETARDATION; NALTREXONE TREATMENT; MUTILATION; CHECKLIST; DISREGULATION; INDIVIDUALS; VALIDATION	It is a widely assumed but rarely tested proposition that the experience and expression of pain is altered among individuals with self-injurious behavior and disabilities. As a preliminary test of this proposition, the purpose of this case study was to apply a validated pain measure to examine ratings of pain behavior in relation to ratings of self-injurious behavior (SIB). A prospective correlational design was used with maternal ratings completed three times/day for 9 days using two item independent rating scales specific to pain and SIB. The participant was a 6-year-old boy with severe SIB secondary to midbrain tumor (pilocytic astrocytoma) resection and post-operative sequelae. Measures were taken in the child's home. Pain behavior was measured using the Non-Communicating Children's Pain Checklist Revised (NCCPC-R). Self-injury was measured using the Self-Injury Trauma Scale (SITS). Time intervals associated with elevated ratings of SIB were associated with elevated pain ratings. There was a significant difference (P<0.05) for pain ratings between time intervals with and without self-injury. It is suggested that additional empirical work is needed to clarify the relation between pain and self-injury to improve assessment and treatment outcomes. (c) 2005 International Association for the Study of Pain. Published by Elsevier B.V. All rights reserved.	Univ Minnesota, Dept Educ Psychol, Minneapolis, MN 55455 USA	Symons, FJ (corresponding author), Univ Minnesota, Dept Educ Psychol, 206 Burton Hall,178 Pillsbury Dr, Minneapolis, MN 55455 USA.	symon007@umn.edu			EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD044763] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R29HD035682] Funding Source: NIH RePORTER; NICHD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [HD44763, HD35682] Funding Source: Medline		BARRERA FJ, 1994, J DEV PHYS DISABIL, V6, P169; Bodfish JW, 1997, J DEV PHYS DISABIL, V9, P135, DOI 10.1023/A:1024977719165; Breau LM, 2003, ARCH PEDIAT ADOL MED, V157, P1219, DOI 10.1001/archpedi.157.12.1219; Breau LM, 2003, J PEDIATR-US, V142, P498, DOI 10.1067/mpd.2003.163; Breau LM, 2002, PAIN, V99, P349, DOI 10.1016/S0304-3959(02)00179-3; Breau LM, 2002, ANESTHESIOLOGY, V96, P528, DOI 10.1097/00000542-200203000-00004; Breau LM, 2000, DEV MED CHILD NEUROL, V42, P609, DOI 10.1017/S0012162200001146; Critchley M, 1934, BRIT MED J, V1934, P891, DOI 10.1136/bmj.2.3854.891; Defrin R, 2004, PAIN, V108, P58, DOI 10.1016/j.pain.2003.12.003; EVANS C, 1992, BRIT J PSYCHIAT, V161, P643, DOI 10.1192/bjp.161.5.643; FAVAZZA AR, 1989, SUICIDE LIFE-THREAT, V19, P352; FELDMAN MD, 1988, COMPR PSYCHIAT, V29, P252, DOI 10.1016/0010-440X(88)90048-X; GRUNAU RVE, 1987, PAIN, V28, P395, DOI 10.1016/0304-3959(87)90073-X; GRUNAU RVE, 1990, ADV PAIN RES THER, V15, P147; HERPERTZ S, 1995, ACTA PSYCHIAT SCAND, V91, P57, DOI 10.1111/j.1600-0447.1995.tb09743.x; IWATA BA, 1990, J APPL BEHAV ANAL, V23, P99, DOI 10.1901/jaba.1990.23-99; Kemperman I, 1997, PSYCHIAT RES, V70, P175, DOI 10.1016/S0165-1781(97)00034-6; Kennedy WR, 1996, NEUROLOGY, V47, P1042, DOI 10.1212/WNL.47.4.1042; KIRMAN BH, 1968, DEV MED CHILD NEUROL, V10, P57; LaChapelle DL, 1999, CLIN J PAIN, V15, P13, DOI 10.1097/00002508-199903000-00004; Leibenluft E, 1987, J PERS DISORD, V1, P317, DOI [10.1521/pedi.1987.1.4.317, DOI 10.1521/PEDI.1987.1.4.317]; LEVITT M, 1985, BRAIN RES REV, V10, P247, DOI 10.1016/0165-0173(85)90027-X; McGrath PJ, 1998, DEV MED CHILD NEUROL, V40, P340; Nolano M, 1999, PAIN, V81, P135, DOI 10.1016/S0304-3959(99)00007-X; Nolano M, 2000, CLIN NEUROPHYSIOL, V111, P1596, DOI 10.1016/S1388-2457(00)00351-5; Oberlander TF, 1999, CLIN J PAIN, V15, P201, DOI 10.1097/00002508-199909000-00007; PINKSY L, 1966, J PEDIATR-US, V68, P1; ROACH ES, 1985, NEUROPEDIATRICS, V16, P159, DOI 10.1055/s-2008-1059532; ROBERTSON MM, 1989, PSYCHOL MED, V19, P611, DOI 10.1017/S0033291700024211; RUSS MJ, 1992, BIOL PSYCHIAT, V32, P501, DOI 10.1016/0006-3223(92)90218-O; Russ MJ, 1999, PSYCHIAT RES, V89, P201, DOI 10.1016/S0165-1781(99)00113-4; Sandman C.A., 1990, J CHILD ADOL PSYCHOP, V1, P237, DOI DOI 10.1089/CAP.1990.1.237; SANDMAN CA, 1988, SYNAPSE, V2, P193, DOI 10.1002/syn.890020304; Sandman CA, 1999, MENT RETARD DEV D R, V5, P314, DOI 10.1002/(SICI)1098-2779(1999)5:4<314::AID-MRDD9>3.0.CO;2-G; SANDMAN CA, 1990, AM J MENT RETARD, V95, P84; Schmahl C, 2004, PAIN, V110, P470, DOI 10.1016/j.pain.2004.04.035; Schroeder SR, 2001, MENT RETARD DEV D R, V7, P3, DOI 10.1002/1098-2779(200102)7:1<3::AID-MRDD1002>3.0.CO;2-#; Swoboda KJ, 1998, MUSCLE NERVE, V21, P104, DOI 10.1002/(SICI)1097-4598(199801)21:1<104::AID-MUS13>3.0.CO;2-3; Symons F.S., 2002, SELF INJURIOUS BEHAV, P223; Symons FJ, 2004, MENT RETARD DEV D R, V10, P193, DOI 10.1002/mrdd.20031; THOMPSON T, 1995, MENT RETARD DEV DIS, V1; Zafeiriou DI, 2004, J PEDIATR-US, V144, P284, DOI 10.1016/S0022-3476(03)00385-8	42	22	23	0	8	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0304-3959	1872-6623		PAIN	Pain	OCT	2005	117	3					473	477		10.1016/j.pain.2005.07.010			5	Anesthesiology; Clinical Neurology; Neurosciences	Anesthesiology; Neurosciences & Neurology	975PZ	WOS:000232675700025	16154695				2021-06-18	
J	Lescot, T; Bonnet, MP; Zouaoui, A; Muller, JC; Fetita, C; Coriat, P; Puybasset, L				Lescot, T; Bonnet, MP; Zouaoui, A; Muller, JC; Fetita, C; Coriat, P; Puybasset, L			A quantitative computed tomography assessment of brain weight, volume, and specific gravity in severe head trauma	INTENSIVE CARE MEDICINE			English	Article						head trauma; specific gravity; computed tomography; brain edema; contusion	RESPIRATORY-DISTRESS-SYNDROME; END-EXPIRATORY PRESSURE; ACUTE LUNG INJURY; CEREBRAL BLOOD-VOLUME; REGIONAL-DISTRIBUTION; WATER-CONTENT; INTRACRANIAL VOLUME; CT; TISSUE; EDEMA	Background: Computed tomography DICOM images analysis allows a quantitative measurement of organ weight, volume and specific gravity in humans. Methods: The brain weight, volume and specific gravity of 15 traumatic brain-injury patients (3 +/- 2 days after trauma) were computed using a specially designed software (BrainView). Data were compared with those obtained from 15 healthy subjects paired for age and overall intracranial volume. Results: Hemisphere weight were 91 g higher in patients than in controls (1167 +/- 101 vs 1076 +/- 112 g; p < 0.05). Specific gravity of hemispheres (1.0367 +/- 0.0017 vs 1.0335 +/- 0.0012 g/ml; p < 0.001), brainstem (1.0302 +/- 0.0016 vs 1.0277 +/- 0.0015 g/ml; p < 0.001) and cerebellum (1.0396 +/- 0.0020 vs 1.0375 +/- 0.0015 g/ml; p < 0.05) was significantly higher in traumatic brain injury (TBI) patients than in controls (all p < 0.0001 without interaction). This increase in specific gravity was evenly distributed between the hemispheres, the brainstem and the cerebellum, and the grey and white matter. It was more pronounced in the rostral than in the caudal areas of the hemispheres. It was independent of the volume of brain contusion, of the mechanism of head injury, of natremia and of initial Glasgow coma score. Conclusion: Human TBI patients present a diffuse increase in specific gravity. This observation is in sharp opposition with the data derived from the experimental literature.	Hop La Pitie Salpetriere, Dept Anesthesiol, F-75013 Paris, France; Univ Paris 06, F-75013 Paris, France; Inst Natl Telecommun, ARTEMIS Project Unit, F-91011 Evry, France	Puybasset, L (corresponding author), Hop La Pitie Salpetriere, Dept Anesthesiol, 47-83 Bd Hop, F-75013 Paris, France.	louis.puybasset@psl.ap-hop-paris.fr					Abbott AH, 2000, J CRANIOFAC SURG, V11, P211, DOI 10.1097/00001665-200011030-00002; Bigler E D, 1999, Appl Neuropsychol, V6, P217, DOI 10.1207/s15324826an0604_4; BLACQUEBELAIR A, 1965, DICT CONSTANTES BIOL; BULLOCK R, 1985, J NEUROSURG, V63, P64, DOI 10.3171/jns.1985.63.1.0064; Courchesne E, 2000, RADIOLOGY, V216, P672, DOI 10.1148/radiology.216.3.r00au37672; Edland SD, 2002, NEUROLOGY, V59, P272, DOI 10.1212/WNL.59.2.272; Gardenfors A, 2002, ACTA NEUROCHIR, V144, P601, DOI 10.1007/s00701-002-0954-1; GATTINONI L, 1995, AM J RESP CRIT CARE, V151, P1807, DOI 10.1164/ajrccm.151.6.7767524; Henry-Feugeas MC, 2000, BRAIN INJURY, V14, P597; HO KC, 1980, ARCH PATHOL LAB MED, V104, P635; HO KC, 1980, ARCH PATHOL LAB MED, V104, P640; KITA H, 1994, ACTA NEUROCHIR, P452; KUHL DE, 1980, J NEUROSURG, V52, P309, DOI 10.3171/jns.1980.52.3.0309; Lu Q, 2001, INTENS CARE MED, V27, P1504, DOI 10.1007/s001340101049; Maas AIR, 1997, ACTA NEUROCHIR, V139, P286, DOI 10.1007/BF01808823; Malbouisson LM, 2001, AM J RESP CRIT CARE, V163, P1444, DOI 10.1164/ajrccm.163.6.2005001; Malbouisson LM, 2001, INTENS CARE MED, V27, P602, DOI 10.1007/s001340100860; Malbouisson LM, 2000, AM J RESP CRIT CARE, V161, P2005, DOI 10.1164/ajrccm.161.6.9907067; Marmarou A, 2000, J NEUROSURG, V93, P183, DOI 10.3171/jns.2000.93.2.0183; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; MULL RT, 1984, AM J ROENTGENOL, V143, P1101, DOI 10.2214/ajr.143.5.1101; NATH F, 1986, J NEUROSURG, V65, P41, DOI 10.3171/jns.1986.65.1.0041; Pelosi P, 1996, EUR RESPIR J, V9, P1055, DOI 10.1183/09031936.96.09051055; PELOSI P, 1994, AM J RESP CRIT CARE, V149, P8, DOI 10.1164/ajrccm.149.1.8111603; PELOSI P, 1995, AM J RESP CRIT CARE, V152, P531, DOI 10.1164/ajrccm.152.2.7633703; PHELPS ME, 1975, RADIOLOGY, V117, P585, DOI 10.1148/117.3.585; Puybasset L, 2000, INTENS CARE MED, V26, P1215, DOI 10.1007/s001340051340; Puybasset L, 2000, INTENS CARE MED, V26, P857, DOI 10.1007/s001340051274; RIETH KG, 1980, RADIOLOGY, V135, P343, DOI 10.1148/radiology.135.2.6768102; Rouby JJ, 2000, INTENS CARE MED, V26, P1046, DOI 10.1007/s001340051317; TAKAGI H, 1981, J NEUROSURG, V54, P797, DOI 10.3171/jns.1981.54.6.0797; Talmor D, 1998, ANESTH ANALG, V86, P1225, DOI 10.1097/00000539-199806000-00017; TORACK RM, 1976, J NEUROPATH EXP NEUR, V35, P385, DOI 10.1097/00005072-197607000-00001; UNGER E, 1988, AM J NEURORADIOL, V9, P687; Verger K, 2001, BRAIN INJURY, V15, P211; Vieira SRR, 1998, AM J RESP CRIT CARE, V158, P1571, DOI 10.1164/ajrccm.158.5.9802101; Vieira SRR, 1999, AM J RESP CRIT CARE, V159, P1612, DOI 10.1164/ajrccm.159.5.9805112	37	22	22	0	3	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0342-4642	1432-1238		INTENS CARE MED	Intensive Care Med.	AUG	2005	31	8					1042	1050		10.1007/s00134-005-2709-y			9	Critical Care Medicine	General & Internal Medicine	951CD	WOS:000230905600007	15991008				2021-06-18	
J	Wiese, H; Stude, P; Sarge, R; Nebel, K; Diener, HC; Keidel, M				Wiese, H; Stude, P; Sarge, R; Nebel, K; Diener, HC; Keidel, M			Reorganization of motor execution rather than preparation in poststroke hemiparesis	STROKE			English	Article						electroencephalography; evoked potentials; paresis; recovery of function; stroke	MOVEMENT-RELATED POTENTIALS; TRAUMATIC BRAIN-INJURY; HUMAN CEREBRAL-CORTEX; FUNCTIONAL REORGANIZATION; CORTICAL POTENTIALS; STROKE; RECOVERY; ACTIVATION; INFARCTION; LESIONS	Background and Purpose - The aim of the present study was to examine movement-related potentials (MRPs) in patients in the "chronic" stage after cortical stroke with recovered hemiparesis compared with healthy control subjects. Methods - Right index finger MRPs were derived from 12 patients >= 1 year after infarction in the territory of the left middle cerebral artery as well as from 12 control subjects. MRP components were compared between groups. Results - In the patient group, the component directly preceding movement onset ( negative slope [NS]) was significantly reduced over the lesioned hemisphere contralateral to the movement. Furthermore, increased motor potentials (MPs) were observed over the contralesional hemisphere during movement execution. No changes in the early MRP (Bereitschaftspotential) reflecting movement preparation were found. Conclusions - Because the NS is supposed to be generated by the primary motor cortex, the decreased component over the lesioned hemisphere is interpreted to represent impaired contralateral M1 functioning in stroke patients. Contralesional activity has been reported as a probable sign of brain plasticity by functional imaging studies. Our results broaden these findings, giving new insights into the temporal course of movement- related brain activity in recovered cortical stroke patients. The data point to a functional reorganization of motor execution rather than preparation in poststroke hemiparesis.	Univ Duisburg Essen, Dept Neurol, D-45122 Essen, Germany; District Hosp, Dept Neurol, Bayreuth, Germany	Wiese, H (corresponding author), Univ Duisburg Essen, Dept Neurol, Hufelandstr 55, D-45122 Essen, Germany.	holger.wiese@uni-essen.de	Diener, Hans-Christoph/AAF-7275-2019; Wiese, Holger/M-5281-2014	Wiese, Holger/0000-0003-4928-0771			Cao Y, 1998, STROKE, V29, P112, DOI 10.1161/01.STR.29.1.112; CHOLLET F, 1991, ANN NEUROL, V29, P63, DOI 10.1002/ana.410290112; Cramer SC, 1997, STROKE, V28, P2518, DOI 10.1161/01.STR.28.12.2518; Cunnington R, 2002, NEUROIMAGE, V15, P373, DOI 10.1006/nimg.2001.0976; DEECKE L, 1969, EXP BRAIN RES, V7, P158; Feydy A, 2002, STROKE, V33, P1610, DOI 10.1161/01.STR.0000017100.68294.52; GERLOFF C, 2003, BEREITSCHAFTSPOTENTI; Green JB, 1999, STROKE, V30, P2659, DOI 10.1161/01.STR.30.12.2659; Hallett M, 2001, REV NEUROL-FRANCE, V157, P822; Honda M, 1997, J NEUROL SCI, V146, P117, DOI 10.1016/S0022-510X(96)00291-2; Ikeda A, 2003, BEREITSCHAFTSPOTENTI, P45, DOI DOI 10.1007/978-1-4615-0189-3_4; KEIDEL M, 1983, NATURWISSENSCHAFTEN, V70, P180, DOI 10.1007/BF01047555; Kitamura JI, 1996, ELECTROEN CLIN NEURO, V98, P149, DOI 10.1016/0013-4694(95)00218-9; KORNHUBE.HH, 1965, PFLUG ARCH GES PHYS, V284, P1, DOI 10.1007/BF00412364; Lang W, 2003, BEREITSCHAFTSPOTENTI, P19; Luft AR, 2004, NEUROIMAGE, V21, P924, DOI 10.1016/j.neuroimage.2003.10.026; Nelles G, 1999, ANN NEUROL, V46, P901, DOI 10.1002/1531-8249(199912)46:6<901::AID-ANA13>3.0.CO;2-7; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Schreiber H, 1983, Hum Neurobiol, V2, P197; SHIBASAKI H, 1980, ELECTROEN CLIN NEURO, V49, P213, DOI 10.1016/0013-4694(80)90216-3; SHIBASAKI H, 1975, J NEUROL, V209, P189, DOI 10.1007/BF00312541; Toma K, 2003, BEREITSCHAFTSPOTENTI, P113; WEILLER C, 1992, ANN NEUROL, V31, P463, DOI 10.1002/ana.410310502; WEILLER C, 1993, ANN NEUROL, V33, P181; Wiese H, 2004, CLIN NEUROPHYSIOL, V115, P2677, DOI 10.1016/j.clinph.2004.06.015; Wiese H, 2004, CLIN NEUROPHYSIOL, V115, P289, DOI 10.1016/S1388-2457(03)00348-1	26	22	25	0	10	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0039-2499			STROKE	Stroke	JUL	2005	36	7					1474	1479		10.1161/01.STR.0000170639.26891.30			6	Clinical Neurology; Peripheral Vascular Disease	Neurosciences & Neurology; Cardiovascular System & Cardiology	941BW	WOS:000230190600029	15947274	Bronze			2021-06-18	
J	Kurz, JE; Hamm, RJ; Singleton, RH; Povlishock, JT; Churn, SB				Kurz, JE; Hamm, RJ; Singleton, RH; Povlishock, JT; Churn, SB			A persistent change in subcellular distribution of calcineurin following fluid percussion injury in the rat	BRAIN RESEARCH			English	Article						translocation; phosphatase; synaptoplasmic membrane; hippocampus; immunohistochemistry; western analysis	TRAUMATIC BRAIN-INJURY; LONG-TERM DEPRESSION; GABA(A) RECEPTOR; CEREBRAL-CORTEX; CYCLOSPORINE-A; AXONAL INJURY; CA1 NEURONS; CELL-DEATH; PHOSPHATASE; HIPPOCAMPUS	Calcineurin, a neuronally enriched, calcium-stimulated phosphatase, is an important modulator of many neuronal processes, including several that are physiologically related to the pathology of traumatic brain injury. The effect of moderate, central fluid percussion injury on the subcellular distribution of this important neuronal enzyme was examined. Animals were sacrificed at several time points post-injury and calcineurin distribution in subcellular fractions was assayed by Western blot analysis and immunohistochemistry. A persistent increase in calcineurin concentration was observed in crude synaptoplasmic membrane-containing fractions. In cortical fractions, calcineurin immunoreactivity remained persistently increased for 2 weeks post-injury. In hippocampal homogenates, calcineurin immunoreactivity remained increased for up to 4 weeks. Finally, immunohistochemical analysis of hippocampal slices revealed increased staining in the apical dendrites of CA1 neurons. The increased staining was greatest in magnitude 24 h post-injury; however, staining was still more intense than control 4 weeks post-injury. The data support the conclusion that fluid percussion injury results in redistribution of the enzyme in the rat forebrain. These changes have broad physiological implications, possibly resulting in altered cellular excitability or a greater likelihood of neuronal cell death. (c) 2005 Elsevier B.V. All rights reserved.	Virginia Commonwealth Univ, Dept Neurol, Richmond, VA 23298 USA; Virginia Commonwealth Univ, Dept Psychol, Richmond, VA 23298 USA; Virginia Commonwealth Univ, Dept Anat & Neurobiol, Richmond, VA 23298 USA; Virginia Commonwealth Univ, Dept Pharmacol & Toxicol, Richmond, VA 23298 USA; Virginia Commonwealth Univ, Dept Physiol, Richmond, VA 23298 USA	Churn, SB (corresponding author), Virginia Commonwealth Univ, Dept Neurol, Box 980599, Richmond, VA 23298 USA.	sbchurn@vcu.edu		Kurz, Jonathan/0000-0002-2259-4263	NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01-NS399700, NSO7288, P01-NS25630] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P01NS025630] Funding Source: NIH RePORTER		Akasu T, 2002, NEUROSCI LETT, V329, P305, DOI 10.1016/S0304-3940(02)00707-3; Amico C, 1998, NEUROSCIENCE, V84, P529, DOI 10.1016/S0306-4522(97)00555-1; Ankarcrona M, 1996, FEBS LETT, V394, P321, DOI 10.1016/0014-5793(96)00959-3; ANTHONY FA, 1988, J NEUROSCI, V8, P1245; CHURN SB, 1992, J CEREBR BLOOD F MET, V12, P784, DOI 10.1038/jcbfm.1992.109; D'Ambrosio R, 2004, BRAIN, V127, P304, DOI 10.1093/brain/awh038; Delahunty TM, 1995, J NEUROTRAUM, V12, P1045, DOI 10.1089/neu.1995.12.1045; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; EDELMAN AM, 1985, J NEUROSCI, V5, P2609; Ghajar J, 2000, LANCET, V356, P923, DOI 10.1016/S0140-6736(00)02689-1; Hamm RJ, 1996, J NEUROTRAUM, V13, P317, DOI 10.1089/neu.1996.13.317; HAMM RJ, 1992, J NEUROTRAUM, V9, P11, DOI 10.1089/neu.1992.9.11; HAMM RJ, 1993, BEHAV BRAIN RES, V59, P169, DOI 10.1016/0166-4328(93)90164-L; Herring D, 2003, J BIOL CHEM, V278, P24046, DOI 10.1074/jbc.M301420200; Hodgkiss JP, 1995, BRAIN RES, V705, P241, DOI 10.1016/0006-8993(95)01168-4; Husi H, 2000, NAT NEUROSCI, V3, P661; Jouvenceau A, 2003, EUR J NEUROSCI, V18, P1279, DOI 10.1046/j.1460-9568.2003.02831.x; Kurz JE, 2005, J NEUROTRAUM, V22, P476, DOI 10.1089/neu.2005.22.476; Kurz JE, 2003, NEUROBIOL DIS, V14, P483, DOI 10.1016/j.nbd.2003.08.018; Lai MM, 1999, J BIOL CHEM, V274, P25963, DOI 10.1074/jbc.274.37.25963; Lu YM, 2000, NEURON, V26, P197, DOI 10.1016/S0896-6273(00)81150-2; Mansuy IM, 2003, BIOCHEM BIOPH RES CO, V311, P1195, DOI 10.1016/j.bbrc.2003.10.046; Mansuy IM, 1998, CELL, V92, P39, DOI 10.1016/S0092-8674(00)80897-1; McIntosh T K, 1987, Cent Nerv Syst Trauma, V4, P119; MULKEY RM, 1994, NATURE, V369, P486, DOI 10.1038/369486a0; Okonkwo DO, 2003, NEUROREPORT, V14, P463, DOI 10.1097/01.wnr.0000058958.85541.d3; Price M, 2003, MOL BRAIN RES, V117, P58, DOI 10.1016/S0169-328X(03)00285-7; Santhakumar V, 2001, ANN NEUROL, V50, P708, DOI 10.1002/ana.1230; Scheff SW, 1999, J NEUROTRAUM, V16, P783, DOI 10.1089/neu.1999.16.783; SCHWARZBACH EP, 2004, ABSTR SOC NEUR; SHIBASAKI F, 1995, J CELL BIOL, V131, P735, DOI 10.1083/jcb.131.3.735; Siesjo BK, 1996, EUR J ANAESTH, V13, P247, DOI 10.1046/j.1365-2346.1996.00976.x; Singleton RH, 2001, J NEUROTRAUM, V18, P607, DOI 10.1089/089771501750291846; SOMBATI S, 2001, J NEUROTRAUM, V17, pJ15; Suehiro E, 2001, EXP NEUROL, V172, P199, DOI 10.1006/exnr.2001.7765; SUN DA, 2001, J NEUROTRAUM, V17, pJ5; TYMANSKI M, 1996, NEUROSURGERY, V38, P1176; Wang J, 2003, J NEUROSCI, V23, P826; Wiley JL, 1996, BRAIN RES, V716, P47, DOI 10.1016/0006-8993(96)00045-5	39	22	23	0	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	JUN 28	2005	1048	1-2					153	160		10.1016/j.brainres.2005.04.062			8	Neurosciences	Neurosciences & Neurology	942CD	WOS:000230259600018	15919062				2021-06-18	
J	Corrigan, JD; Bogner, J; Lamb-Hart, G; Heinemann, AW; Moore, D				Corrigan, JD; Bogner, J; Lamb-Hart, G; Heinemann, AW; Moore, D			Increasing substance abuse treatment compliance for persons with traumatic brain injury	PSYCHOLOGY OF ADDICTIVE BEHAVIORS			English	Article							COGNITIVE STATUS EXAMINATION; TREATMENT RETENTION; CHANGE QUESTIONNAIRE; USE DISORDERS; DRUG-ABUSERS; READINESS; DEPENDENCE; PERFORMANCE; PREDICTORS; MOTIVATION	This study compared 3 methods of increasing participation in substance abuse treatment for clients with traumatic brain injury. Participants (N = 195) were randomly assigned to 4 conditions: (a) motivational interview, (b) reduction of logistical barriers to attendance, (c) financial incentive, and (d) attention control. Four interviewers conducted structured, brief telephone interventions targeting the timeliness of signing an individualized service plan. Participants assigned to the barrier reduction (74%) and financial incentive (83%) groups were more likely to sign within 30 days compared with the motivational interview (45%) and attention control (45%) groups. Similar results were observed for time to signing, perfect attendance at appointments, and premature termination during the following 6 months. Extent of psychiatric symptoms was the only significant covariate.	Ohio State Univ, Dept Phys Med & Rehabil, Columbus, OH 43210 USA; Northwestern Univ, Dept Phys Med & Rehabil, Feinberg Sch Med, Evanston, IL 60208 USA; Wright State Univ, Dept Community Hlth, Sch Med, Dayton, OH 45435 USA	Corrigan, JD (corresponding author), Ohio State Univ, Dept Phys Med & Rehabil, Columbus, OH 43210 USA.	corrigan.1@osu.edu	Heinemann, Allen W/K-6283-2012; Bogner, Jennifer/E-2773-2011; Corrigan, John D./E-2921-2011; Heinemann, Allen W./AAI-2790-2021	Heinemann, Allen W/0000-0003-2782-7326; Heinemann, Allen W./0000-0003-2782-7326			American Psychiatric Association, 1994, DIAGN STAT MAN MENT; Barber JP, 2001, J CONSULT CLIN PSYCH, V69, P119, DOI 10.1037/0022-006X.69.1.119; Bates ME, 2002, EXP CLIN PSYCHOPHARM, V10, P193, DOI 10.1037//1064-1297.10.3.193; Bechara A, 2002, NEUROPSYCHOLOGIA, V40, P1690, DOI 10.1016/S0028-3932(02)00016-7; Becker M H, 1980, J Community Health, V6, P113, DOI 10.1007/BF01318980; BENYISHAY Y, 1987, J HEAD TRAUMA REHAB, V2, P35, DOI DOI 10.1097/00001199-198703000-00007; BEUTLER LE, 1991, J CONSULT CLIN PSYCH, V59, P1; Bogner JA, 1997, J HEAD TRAUMA REHAB, V12, P57, DOI 10.1097/00001199-199710000-00006; Bombardier CH, 1997, ARCH PHYS MED REHAB, V78, P592, DOI 10.1016/S0003-9993(97)90424-X; Brooks J, 1999, J TRAUMA, V46, P159, DOI 10.1097/00005373-199901000-00027; Brown VB, 1999, J PSYCHOACTIVE DRUGS, V31, P31, DOI 10.1080/02791072.1999.10471723; Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P964, DOI 10.1001/jama.282.10.964; Corrigan J. D., 1999, REHABILITATION ADULT; CORRIGAN JD, 1995, BRAIN INJURY, V9, P221, DOI 10.3109/02699059509008195; Corrigan JD, 1998, ARCH PHYS MED REHAB, V79, P298, DOI 10.1016/S0003-9993(98)90010-7; CORRIGAN JD, 1995, J HEAD TRAUMA REHAB, V10, P29; *CTR SUBST AB TREA, 1998, DHHS PUBL; DANSEREAU DF, 1993, J COUNS PSYCHOL, V40, P385, DOI 10.1037/0022-0167.40.4.385; De Weert-Van Oene GH, 2001, J SUBST ABUSE TREAT, V20, P253, DOI 10.1016/S0740-5472(01)00160-X; DeLeon G, 1997, AM J DRUG ALCOHOL AB, V23, P169; DIENER E, 1984, PSYCHOL BULL, V95, P542, DOI 10.1037/0033-2909.95.3.542; Doninger NA, 2000, J HEAD TRAUMA REHAB, V15, P683, DOI 10.1097/00001199-200002000-00007; ENGELHART C, 1994, CLIN NEUROPSYCHOL, V8, P405, DOI 10.1080/13854049408402043; Fals-Stewart W, 2003, EXP CLIN PSYCHOPHARM, V11, P34, DOI 10.1037/1064-1297.11.1.34; FALSSTEWART W, 1994, PSYCHOL ADDICT BEHAV, V8, P179, DOI 10.1037/0893-164X.8.3.179; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Friedmann PD, 2001, J SUBST ABUSE TREAT, V21, P97, DOI 10.1016/S0740-5472(01)00185-4; HEATHER N, 1993, ADDICTION, V88, P1667, DOI 10.1111/j.1360-0443.1993.tb02042.x; Heather N, 1993, READINESS CHANGE QUE; Heinemann AW, 2004, REHABIL PSYCHOL, V49, P156, DOI 10.1037/0090-5550.49.2.156; Higgins ST, 2002, ADDICT BEHAV, V27, P887, DOI 10.1016/S0306-4603(02)00297-6; Hser YI, 1999, J SUBST ABUSE TREAT, V16, P299, DOI 10.1016/S0740-5472(98)00037-3; KIERNAN RJ, 1987, ANN INTERN MED, V107, P481, DOI 10.7326/0003-4819-107-4-481; Kokkevi A, 1998, ADDICT BEHAV, V23, P841, DOI 10.1016/S0306-4603(98)00071-9; LANGLEY M, 1991, WORK WORTH DOING ADV, P251; Lezak MD, 1995, NEUROPSYCHOLOGICAL A; Luborsky L, 1996, J Psychother Pract Res, V5, P260; McCaul ME, 2001, DRUG ALCOHOL DEPEN, V62, P9, DOI 10.1016/S0376-8716(00)00155-1; MCCLELLAN AT, 1990, ADDICTION SEVERITY I; *NAT ASS ALC DRUGS, 1998, ACC LTD SUBST AB SER; Newman C F, 1997, NIDA Res Monogr, V165, P181; Paraherakis A, 2000, CAN J PSYCHIAT, V45, P927, DOI 10.1177/070674370004501009; Pavot W., 1993, PSYCHOL ASSESSMENT, V5, P164, DOI DOI 10.1037/1040-3590.5.2.164; Petry Nancy M, 2003, Sci Pract Perspect, V2, P55; Petry NM, 2000, J CONSULT CLIN PSYCH, V68, P250, DOI 10.1037/0022-006X.68.2.250; PROCHASKA JO, 1992, AM PSYCHOL, V47, P1102, DOI 10.1037/0003-066X.47.9.1102; ROLLNICK S, 1992, BRIT J ADDICT, V87, P743; Simpson DD, 1997, DRUG ALCOHOL DEPEN, V47, P227; SIMPSON DD, 1993, PSYCHOTHER, V30, P357, DOI 10.1037/0033-3204.30.2.357; SOBELL MB, 1992, BEHAV THER, V23, P43, DOI 10.1016/S0005-7894(05)80307-7; War Department, 1944, ARM IND TEST BATT MA	51	22	22	0	11	EDUCATIONAL PUBLISHING FOUNDATION-AMERICAN PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST, NE, WASHINGTON, DC 20002-4242 USA	0893-164X	1939-1501		PSYCHOL ADDICT BEHAV	Psychol. Addict. Behav.	JUN	2005	19	2					131	139		10.1037/0893-164X.19.2.131			9	Substance Abuse; Psychology, Multidisciplinary	Substance Abuse; Psychology	943RD	WOS:000230370900002	16011383				2021-06-18	
J	Colwell, CB; McVaney, KE; Haukoos, JS; Wiebe, DP; Gravitz, CS; Dunn, WW; Bryan, T				Colwell, CB; McVaney, KE; Haukoos, JS; Wiebe, DP; Gravitz, CS; Dunn, WW; Bryan, T			An evaluation of out-of-hospital advanced airway management in an urban setting	ACADEMIC EMERGENCY MEDICINE			English	Article						endotracheal intubation; urban; complications; prehospital care	RAPID-SEQUENCE INTUBATION; TRAUMATIC BRAIN-INJURY; ENDOTRACHEAL INTUBATION; FIELD; PARAMEDICS; COMPLICATIONS; PERSONNEL; SURVIVAL; TRIAL; RATES	Objectives: To determine the success and complication rates associated with endotracheal intubation in an urban emergency medical services (EMS) system. Methods: This study evaluated consecutive airway interventions between March 2001 and May 2001 performed by paramedics from the Denver Health Paramedic Division in Denver, Colorado. Patients were identified and enrolled prospectively with the identification of all patients for whom intubation was attempted. A retrospective chart review of the emergency department (ED), intensive care unit, other hospital records, and the coroner's records was then conducted with the intent of identifying all complications related to attempted intubation, including the placement of each endotracheal tube. Results: A total of 278 patients were included in this study. Of these, 154 (55%) had an initial nasal intubation attempt, and 124 (45%) had an initial oral intubation attempt. Of the 278 patients for whom an intubation was attempted, 234 (84%, 95% CI = 77% to 88%) were reported by paramedics to be successfully intubated. Of 114 nasal intubations reported as successful by paramedics, two (2%; 95% CI = 0.2% to 6%) were found to be misplaced. Of the 120 oral intubations reported as successful by paramedics, one (10%; 95% CI = 0.02%, to 5%) was found to be misplaced. Of the 278 patients, 22 (8%; 95% CI = 5% to 12%) had complications; three (1%; 95% CI = 0.2% to 3%) endotracheal tubes were incorrectly positioned, two (0.7%; 95% CI = 0.08% to 3%) of which were undetected esophageal intubations and one (0.4%; 95% CI = 0 to 2%) of which was in the posterior pharynx. Conclusions: Reasonable success and complication rates of endotracheal intubation in the out-of-hospital setting can be achieved in a busy, urban EMS system without the assistance of medications.	Denver Hlth Med Ctr, Dept Emergency Med, Denver, CO 80204 USA; Denver Hlth Med Ctr, Paramed Div, Denver, CO 80204 USA; Univ Colorado, Hlth Sci Ctr, Dept Prevent Med & Biometr, Denver, CO 80262 USA	Colwell, CB (corresponding author), Denver Hlth Med Ctr, Dept Emergency Med, 777 Bannock St,Mail Code 0108, Denver, CO 80204 USA.	christophencolweil@dhha.org					Bochicchio GV, 2003, J TRAUMA, V54, P307, DOI 10.1097/01.TA.0000046252.97590.BE; CUMMINGS RO, 2003, ACLS PRINCIPLES PRAC; Davis DP, 2003, J TRAUMA, V54, P444, DOI 10.1097/01.TA.0000053396.02126.CD; Dunford JV, 2003, ANN EMERG MED, V42, P721, DOI 10.1016/S0196-0644(03)00660-7; Garner A, 1999, AUST NZ J SURG, V69, P697, DOI 10.1046/j.1440-1622.1999.01688.x; Gausche M, 2000, JAMA-J AM MED ASSOC, V283, P783, DOI 10.1001/jama.283.6.783; GRAY AJ, 1992, ARCH EMERG MED, V9, P347; Jones JH, 2004, ACAD EMERG MED, V11, P707, DOI 10.1197/j.aem.2003.12.026; Katz SH, 2001, ANN EMERG MED, V37, P32, DOI 10.1067/mem.2001.112098; Li J, 1999, AM J EMERG MED, V17, P141, DOI 10.1016/S0735-6757(99)90046-3; OBRIEN DJ, 1989, ANN EMERG MED, V18, P612, DOI 10.1016/S0196-0644(89)80512-8; POINTER J E, 1988, Journal of Emergency Medicine, V6, P505, DOI 10.1016/0736-4679(88)90409-X; Sayre MR, 1998, ANN EMERG MED, V31, P228, DOI 10.1016/S0196-0644(98)70312-9; STEWART RD, 1984, CHEST, V85, P341, DOI 10.1378/chest.85.3.341; Wang HE, 2003, RESUSCITATION, V58, P49, DOI 10.1016/S0300-9572(03)00058-3; Winchell RJ, 1997, ARCH SURG-CHICAGO, V132, P592	16	22	22	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1069-6563	1553-2712		ACAD EMERG MED	Acad. Emerg. Med.	MAY	2005	12	5					417	422		10.1197/j.aem.2004.11.024			6	Emergency Medicine	Emergency Medicine	922DT	WOS:000228817100006	15860695	Bronze			2021-06-18	
J	Douglas, CL; Bowman, GN; Baghdoyan, HA; Lydic, R				Douglas, CL; Bowman, GN; Baghdoyan, HA; Lydic, R			C57BL/6J and B6.V-LEPOB mice differ in the cholinergic modulation of sleep and breathing	JOURNAL OF APPLIED PHYSIOLOGY			English	Article						acetylcholine; pontine reticular formation; respiratory control; obesity	PONTINE RETICULAR-FORMATION; EYE-MOVEMENT SLEEP; VESICULAR ACETYLCHOLINE TRANSPORTER; MUSCARINIC RECEPTOR SUBTYPES; TRAUMATIC BRAIN-INJURY; REM-SLEEP; VENTILATORY BEHAVIOR; FUNCTIONAL GENOMICS; PREFRONTAL CORTEX; GENE-EXPRESSION	Respiratory and arousal state control are heritable traits in mice. B6. V-Lep(ob) (ob) mice are leptin deficient and differ from C57BL/6J ( B6) mice by a variation in the gene coding for leptin. The ob mouse has morbid obesity and disordered breathing that is homologous to breathing of obese humans. This study tested the hypothesis that microinjecting neostigmine into the pontine reticular nucleus, oral part (PnO), of B6 and ob mice alters sleep and breathing. In B6 and ob mice, neostigmine caused a concentration-dependent increase ( P < 0.0001) in percentage of time spent in a rapid eye movement (REM) sleeplike state (REM-Neo). Relative to saline ( control), higher concentrations of neostigmine increased REM-Neo duration and the number of REM-Neo episodes in B6 and ob mice and decreased percent wake, percent non-REM, and latency to onset of REM-Neo ( P < 0.001). In B6 and ob mice, REM sleep enhancement by neostigmine was blocked by atropine. Differences in control amounts of sleep and wakefulness between B6 and the congenic ob mice also were identified. After PnO injection of saline, ob mice spent significantly ( P < 0.05) more time awake and less time in non-REM sleep. B6 mice displayed more ( P < 0.01) baseline locomotor activity than ob mice, and PnO neostigmine decreased locomotion ( P < 0.0001) in B6 and ob mice. Whole body plethysmography showed that PnO neostigmine depressed breathing ( P < 0.001) in B6 and ob mice and caused greater respiratory depression in B6 than ob mice ( P < 0.05). Western blot analysis identified greater ( P < 0.05) expression of M2 muscarinic receptor protein in ob than B6 mice for cortex, midbrain, cerebellum, and pons, but not medulla. Considered together, these data provide the first evidence that pontine cholinergic control of sleep and breathing varies between mice known to differ by a spontaneous mutation in the gene coding for leptin.	Univ Michigan, Dept Anesthesiol, Ann Arbor, MI 48109 USA	Lydic, R (corresponding author), Univ Michigan, Dept Anesthesiol, 7433 Med Sci 1,1150 W Med Ctr Dr, Ann Arbor, MI 48109 USA.	rlydic@umich.edu	; Lydic, Ralph/O-9396-2014	Baghdoyan, Helen A./0000-0003-0627-2448; Lydic, Ralph/0000-0002-2686-251X	NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [R01HL065272, R01HL040881, R01HL057120] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R01MH045361, R37MH045361, R29MH045361] Funding Source: NIH RePORTER; NHLBI NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [HL-57120, HL-65272, HL-40881] Funding Source: Medline; NIMH NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [MH-45361] Funding Source: Medline		Baghdoyan HA, 2002, SLEEP AND EPILEPSY: THE CLINICAL SPECTRUM, P17; BAGHDOYAN HA, 1989, NEUROPSYCHOPHARMACOL, V2, P67, DOI 10.1016/0893-133X(89)90009-2; Baghdoyan HA, 1997, AM J PHYSIOL-REG I, V273, pR896; BAGHDOYAN HA, 1984, J PHARMACOL EXP THER, V231, P173; BAGHDOYAN HA, 1987, BRAIN RES, V414, P245, DOI 10.1016/0006-8993(87)90005-9; Baghdoyan HA, 1999, SLEEP, V22, P835, DOI 10.1093/sleep/22.7.835; Blake JA, 2003, NUCLEIC ACIDS RES, V31, P193, DOI 10.1093/nar/gkg047; Bogue CW, 2003, J APPL PHYSIOL, V94, P2502, DOI 10.1152/japplphysiol.00209.2003; BOURGIN P, 1995, NEUROREPORT, V6, P532, DOI 10.1097/00001756-199502000-00031; Boutin P, 2001, BEST PRACT RES CL EN, V15, P391, DOI 10.1053/beem.2001.0153; Bowman GN, 2003, SLEEP, V26, pA1; Brockmann GA, 2000, GENOME RES, V10, P1941, DOI 10.1101/gr.GR1499R; Capece ML, 1997, AM J PHYSIOL-REG I, V273, pR1430; Capece ML, 1997, NEUROREPORT, V8, P481, DOI 10.1097/00001756-199701200-00021; Chen LC, 2003, BRAIN RES, V973, P214, DOI 10.1016/S0006-8993(03)02484-3; Ciallella JR, 1998, EXP NEUROL, V152, P11, DOI 10.1006/exnr.1998.6831; Coleman CG, 2004, NEUROSCIENCE, V126, P821, DOI 10.1016/j.neuroscience.2004.04.029; Coleman CG, 2004, NEUROSCIENCE, V126, P831, DOI 10.1016/j.neuroscience.2004.04.045; Conway B, 2004, Obes Rev, V5, P145, DOI 10.1111/j.1467-789X.2004.00144.x; Demarco GJ, 2004, NEUROSCIENCE, V123, P17, DOI 10.1016/j.neuroscience.2003.08.045; Demarco GJ, 2003, J COMP NEUROL, V457, P175, DOI 10.1002/cne.10548; Di Marco A, 2000, EUR J BIOCHEM, V267, P2939, DOI 10.1046/j.1432-1033.2000.01308.x; Diament A L, 2003, Obes Rev, V4, P249, DOI 10.1046/j.1467-789X.2003.00113.x; Douglas CL, 2002, J NEUROPHYSIOL, V87, P2817, DOI 10.1152/jn.2002.87.6.2817; Douglas CL, 2002, J NEUROPHYSIOL, V88, P3003, DOI 10.1152/jn.00318.2002; Douglas CL, 2001, J PHARMACOL EXP THER, V299, P960; DOUGLAS CL, 2004, SOC NEUR ABSTR, V30; ELMANSARI M, 1989, EXP BRAIN RES, V76, P519, DOI 10.1007/BF00248908; Eppig JT, 2002, GENESIS, V32, P63, DOI 10.1002/gene.10055; Franken P, 2001, J NEUROSCI, V21, P2610, DOI 10.1523/JNEUROSCI.21-08-02610.2001; Franken P, 1998, AM J PHYSIOL-REG I, V275, pR1127; Friedman JM, 1998, NUTR REV, V56, pS38; Friedman L, 2004, J APPL PHYSIOL, V97, P1787, DOI 10.1152/japplphysiol.01394.2003; Gilman S, 2003, NEUROLOGY, V61, P35, DOI 10.1212/01.WNL.0000073624.13436.32; GNADT JW, 1986, BRAIN RES, V384, P29, DOI 10.1016/0006-8993(86)91216-3; Han F, 2000, RESP PHYSIOL, V121, P247, DOI 10.1016/S0034-5687(00)00132-8; Haxhiu MA, 2003, FRONT BIOSCI-LANDMRK, V8, pD946, DOI 10.2741/1099; Haxhiu MA, 2001, RESP PHYSIOL, V129, P191, DOI 10.1016/S0034-5687(01)00290-0; Hedner J, 2003, AM J RESP CRIT CARE, V168, P1246, DOI 10.1164/rccm.200211-1344OC; HOBSON JA, 1983, BRAIN RES, V275, P127, DOI 10.1016/0006-8993(83)90424-9; Homma Y, 2002, J NEUROPHYSIOL, V87, P3033, DOI 10.1152/jn.2002.87.6.3033; Horner RL, 1999, NEUROSCIENCE, V93, P215, DOI 10.1016/S0306-4522(99)00126-8; Huber R, 2000, BRAIN RES, V857, P8, DOI 10.1016/S0006-8993(99)02248-9; IMERI L, 1994, BRAIN RES, V636, P68, DOI 10.1016/0006-8993(94)90176-7; INGALLS AM, 1950, J HERED, V41, P317, DOI 10.1093/oxfordjournals.jhered.a106073; Ip MSM, 2000, CHEST, V118, P580, DOI 10.1378/chest.118.3.580; Joseph V, 2002, RESP PHYSIOL NEUROBI, V130, P253, DOI 10.1016/S0034-5687(02)00012-9; Kobayashi T, 2004, J APPL PHYSIOL, V96, P735, DOI 10.1152/japplphysiol.00908.2003; Kohyama J, 2000, BRAIN DEV-JPN, V22, pS136; Kubin L, 2001, ARCH ITAL BIOL, V139, P147; Lai YY, 1999, RAPID EYE MOVEMENT SLEEP, P69; LEE LH, 1995, AM J PHYSIOL-LUNG C, V268, pL251; Lydic R, 2002, SLEEP, V25, P835, DOI 10.1093/sleep/25.8.835; LYDIC R, 1989, NEUROSCI LETT, V102, P211, DOI 10.1016/0304-3940(89)90080-3; LYDIC R, 1993, AM J PHYSIOL, V264, pR544; Lydic R, 2003, SLEEP RELATED BREATH, P57; Mackiewicz M, 2003, RESP PHYSIOL NEUROBI, V135, P207, DOI 10.1016/S1569-9048(03)00045-4; Marks GA, 1998, NEUROSCIENCE, V86, P29, DOI 10.1016/S0306-4522(98)00005-0; MITANI A, 1988, BRAIN RES, V451, P397, DOI 10.1016/0006-8993(88)90792-5; MORALES F, 1981, BRAIN RES, V225, P279, DOI 10.1016/0006-8993(81)90836-2; MORALES FR, 1987, J NEUROPHYSIOL, V57, P1118; Naciff JM, 1997, NEUROREPORT, V8, P3467, DOI 10.1097/00001756-199711100-00011; O'Donnell CP, 2000, RESP PHYSIOL, V119, P163, DOI 10.1016/S0034-5687(99)00111-5; O'Donnell CP, 1999, AM J RESP CRIT CARE, V159, P1477, DOI 10.1164/ajrccm.159.5.9809025; Ohno K, 2001, P NATL ACAD SCI USA, V98, P2017, DOI 10.1073/pnas.98.4.2017; Paxinos G., 2001, MOUSE BRAIN STEREOTA; Polotsky VY, 2004, J APPL PHYSIOL, V96, P991, DOI 10.1152/japplphysiol.00926.2003; Punjabi NM, 2002, SLEEP, V25, P307; Puscau C, 2003, FASEB J, V17, pA73; Reinoso-Suarez F, 2001, SLEEP MED REV, V5, P63, DOI 10.1053/smrv.2000.0136; SATTERTHWAITE FE, 1946, BIOMETRICS BULL, V2, P110, DOI 10.2307/3002019; Schaub CD, 1998, J APPL PHYSIOL, V85, P366; Schneider H, 2003, J APPL PHYSIOL, V95, P11, DOI 10.1152/japplphysiol.01144.2002; Shao LF, 1999, J NEUROTRAUM, V16, P555, DOI 10.1089/neu.1999.16.555; SHIROMANI PJ, 1986, PHARMACOL BIOCHEM BE, V25, P1253, DOI 10.1016/0091-3057(86)90120-6; SHIROMANI PJ, 1988, NEUROSCI LETT, V95, P19, DOI 10.1016/0304-3940(88)90625-8; Strohl KP, 2003, RESP PHYSIOL NEUROBI, V135, P179, DOI 10.1016/S1569-9048(03)00036-3; STROHL KP, 1998, HDB OBESITY, P725; Tafti M, 2002, J APPL PHYSIOL, V92, P1339, DOI 10.1152/japplphysiol.00834.2001; Tagaito Y, 2001, J APPL PHYSIOL, V91, P2758; Tang XD, 2002, SLEEP, V25, P691; Tankersley C, 1996, J APPL PHYSIOL, V81, P716; Tankersley C G, 1999, Curr Opin Pulm Med, V5, P344, DOI 10.1097/00063198-199911000-00004; Tankersley CG, 1998, J APPL PHYSIOL, V85, P2261; TANKERSLEY CG, 1994, AM J PHYSIOL-REG I, V267, pR1371; Tankersley CG, 2002, J APPL PHYSIOL, V92, P1277, DOI 10.1152/japplphysiol.00609.2001; Thurnheer R, 2001, J APPL PHYSIOL, V90, P981; Tobler I, 1997, J NEUROSCI, V17, P1869; Tononi G, 2001, NEUROPSYCHOPHARMACOL, V25, pS28, DOI 10.1016/S0893-133X(01)00322-0; Toth LA, 2001, BEHAV GENET, V31, P39, DOI 10.1023/A:1010205824874; Ulloor J, 2004, J NEUROPHYSIOL, V91, P1822, DOI 10.1152/jn.01104.2003; VANNIMERCIER G, 1989, ARCH ITAL BIOL, V127, P133; Veasey SC, 2004, SLEEP, V27, P194, DOI 10.1093/sleep/27.2.194; Veasey SC, 2000, SLEEP, V23, P1025; Wang GJ, 2002, PEDIATRICS, V109, DOI 10.1542/peds.109.5.e81; YAKSH TL, 1978, PAIN, V4, P299, DOI 10.1016/0304-3959(77)90145-2; YAMASHITA T, 1993, POLYM DEGRAD STABIL, V39, P279, DOI 10.1016/0141-3910(93)90002-Z; YOUNG T, 1993, NEW ENGL J MED, V328, P1230, DOI 10.1056/NEJM199304293281704	98	22	22	0	3	AMER PHYSIOLOGICAL SOC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	8750-7587	1522-1601		J APPL PHYSIOL	J. Appl. Physiol.	MAR	2005	98	3					918	929		10.1152/japplphysiol.00900.2004			12	Physiology; Sport Sciences	Physiology; Sport Sciences	895LG	WOS:000226863100022	15475596				2021-06-18	
J	LaBotz, M; Martin, MR; Kimura, IE; Hetzler, RK; Nichols, AW				LaBotz, M; Martin, MR; Kimura, IE; Hetzler, RK; Nichols, AW			A comparison of a preparticipation evaluation history form and a symptom-based concussion survey in the identification of previous head injury in collegiate athletes	CLINICAL JOURNAL OF SPORT MEDICINE			English	Article						concussion; head injury; mild traumatic brain injury; sports injury; preparticipation physical examination	SPORT-RELATED CONCUSSION; FOOTBALL PLAYERS; SCHOOL	Objective: The purpose of this study was to compare the incidence of prior head injury reported on preparticipation physical evaluation (PPE) history forms with a retrospective symptom-based survey. Design: A comparison of 2 retrospective survey instruments. Setting: NCAA Division I varsity athletic program. Participants: A total of 93 male and 79 female athletes participating in intercollegiate contact/collision sports. Main Outcome Measures: Athletes were administered a concussion symptom survey (CSS) with questions about symptom incidence after head injury. These responses were compared with answers given about previous concussion/head injury on the university's PPE history form. The numbers of positive responses were analyzed using descriptive statistics, and differences between the PPE medical history form and the concussion symptom survey were assessed using chi(2) analysis. Factor analysis was performed to assess for possible variance structure between reported symptoms. Results: Seventy-one percent of athletes reporting symptoms consistent with concussion were not identified as having a history of head injury on the PPE medical history form. The most common symptom on the CSS was headache, which accounted for 46 (56.1%) positive responses. Conclusions: The CSS revealed greater numbers of athletes experiencing symptomatic head injuries than the screening questions on the PPE history form. Screening for signs and symptoms of concussion may enhance the sensitivity of the PPE in detecting a prior history of concussion.	Univ Hawaii Manoa, John A Burns Sch Med, Honolulu, HI 96822 USA	LaBotz, M (corresponding author), Univ Hawaii Manoa, John A Burns Sch Med, Honolulu, HI 96822 USA.	labotz@hawaii.edu					Aubry M, 2002, CLIN J SPORT MED, V12, P6, DOI 10.1097/00042752-200201000-00005; Bohnen N., 1992, Brain Injury, V6, P481, DOI 10.3109/02699059209008145; Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P964, DOI 10.1001/jama.282.10.964; Delaney JS, 2001, CLIN J SPORT MED, V11, P234, DOI 10.1097/00042752-200110000-00005; Delaney TS, 2002, CLIN J SPORT MED, V12, P331, DOI 10.1097/00042752-200211000-00003; GERBERICH SG, 1983, AM J PUBLIC HEALTH, V73, P1370, DOI 10.2105/AJPH.73.12.1370; Glover DW, 1998, JAMA-J AM MED ASSOC, V279, P1817, DOI 10.1001/jama.279.22.1817; Grindel SH, 2001, CLIN J SPORT MED, V11, P134, DOI 10.1097/00042752-200107000-00003; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; HOLMES CF, 2000, PRIM CARE REP, V6, P189; Johnston KM, 2001, CLIN J SPORT MED, V11, P150, DOI 10.1097/00042752-200107000-00005; Kaut KP, 2003, CLIN J SPORT MED, V13, P213, DOI 10.1097/00042752-200307000-00004; Kelly JP, 1998, J HEAD TRAUMA REHAB, V13, P53, DOI 10.1097/00001199-199804000-00008; Kelly JP, 1997, NEUROLOGY, V48, P581; Koester MC, 2003, PHYSICIAN SPORTSMED, V31, P35, DOI 10.3810/psm.2003.08.460; KOVAN JR, 1998, MANUAL SPORTS MED, P10; MADDEN CC, 2003, DELEE DREZS ORTHOPAE, P737; Maroon JC, 2000, NEUROSURGERY, V47, P659, DOI 10.1097/00006123-200009000-00027; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McKeag DB, 2003, JAMA-J AM MED ASSOC, V290, P2604, DOI 10.1001/jama.290.19.2604; Pfister GC, 2000, JAMA-J AM MED ASSOC, V283, P1597, DOI 10.1001/jama.283.12.1597; Piland SG, 2003, J ATHL TRAINING, V38, P104; *PREP PHYS EV WORK, 2005, PHYS SPORTSM; PRIGGE R, 2000, SPORTS MED PRIMARY C, P31; Sallis RE, 2000, MED SCI SPORT EXER, V32, P1820, DOI 10.1097/00005768-200011000-00002; Zemper ED, 2003, AM J PHYS MED REHAB, V82, P653, DOI 10.1097/01.PHM.0000083666.74494.BA; 1997, PHYS SPORTSMEDICINE	27	22	22	1	5	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1050-642X	1536-3724		CLIN J SPORT MED	Clin. J. Sport Med.	MAR	2005	15	2					73	78		10.1097/01.jsm.0000157649.99867.fc			6	Orthopedics; Physiology; Sport Sciences	Orthopedics; Physiology; Sport Sciences	943CF	WOS:000230328800006	15782050				2021-06-18	
J	Vangel, SJ; Rapport, LJ; Hanks, RA; Black, KL				Vangel, SJ; Rapport, LJ; Hanks, RA; Black, KL			Long-term medical care utilization and costs among traumatic brain injury survivors	AMERICAN JOURNAL OF PHYSICAL MEDICINE & REHABILITATION			English	Article						brain injuries; costs; cost analysis; cost control; utilization	DISABILITIES; ADHERENCE	Objective: To examine billing patterns and predictors of healthcare utilization and costs associated with traumatic brain injury. Design: Retrospective cohort study of healthcare billings for 63 survivors of traumatic brain injury, over a 19-mo period, using a state-sponsored Medicaid program. The relationship of indicators of injury severity and disability to billings and payments was investigated. Mean age at time of injury was 33 yrs. Mean highest Glasgow Coma Scale rating immediately after brain injury was 8. Results: A total of $795,635 was billed to Medicaid for 3,950 services and medications used. A total of $281,897 was paid for these billings out of the Medicaid account studied. Billings were used for statistical analyses, as they were considered the most stable indicator of cost. Motor deficits at discharge from inpatient rehabilitation (FIM(TM) motor score) showed inverse relationships to total billings (rho = -0.42, P < 0.001), subcategories of billings reflecting equipment and supplies (rho = -.26, P = 0.020), and outpatient billings (rho = -0.27, P = 0.015). Change in FIM motor scores during inpatient rehabilitation was inversely associated with billings (rho = -0.40). Change in FIM motor scores provided unique information in predicting utilization after accounting for demographic characteristics and severity of injury. Conclusions: Motor disability and improvement during inpatient rehabilitation were significant predictors of billings after traumatic brain injury. Initial severity of brain injury was not a significant factor in utilization.	Wayne State Univ, Rehabil Inst Michigan, Detroit, MI 48201 USA; Wayne State Univ, Dept Phys Med & Rehabil, Sch Med, Detroit, MI 48201 USA; Wayne State Univ, Dept Psychol, Sch Sci, Detroit, MI 48201 USA	Vangel, SJ (corresponding author), Wayne State Univ, Rehabil Inst Michigan, 261 Mack Blvd,Room 555, Detroit, MI 48201 USA.						Andriacchi R, 1997, AM J PHYS MED REHAB, V76, pS17; BURNS TJ, 1990, ARCH PHYS MED REHAB, V71, P138; Chan L, 2002, ARCH PHYS MED REHAB, V83, P1196, DOI 10.1053/apmr.2002.34811; Gans BM, 1997, AM J PHYS MED REHAB, V76, pS9; Hinkin CH, 2002, NEUROLOGY, V59, P1944, DOI 10.1212/01.WNL.0000038347.48137.67; Hoffman JM, 2003, ARCH PHYS MED REHAB, V84, P1165, DOI 10.1016/S0003-9993(03)00232-6; LINACRE JM, 1994, ARCH PHYS MED REHAB, V75, P127; RIMEL RW, 1982, NEUROSURGERY, V11, P344, DOI 10.1227/00006123-198209000-00002; ROBINSON DG, 1994, AM J PHYS MED REHAB, V73, P58; Rosen MI, 2003, J BEHAV MED, V26, P349, DOI 10.1023/A:1024257027839; TEASDALE G, 1974, LANCET, V2, P81; Thomas DC, 1999, MT SINAI J MED, V66, P188; 1993, UNIFORM DATA SYSTEM	13	22	24	0	5	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0894-9115			AM J PHYS MED REHAB	Am. J. Phys. Med. Rehabil.	MAR	2005	84	3					153	160		10.1097/01.PHM.0000154896.55045.E7			8	Rehabilitation; Sport Sciences	Rehabilitation; Sport Sciences	898TE	WOS:000227098300002	15725788				2021-06-18	
J	McDermott, S; Moran, R; Platt, T; Issac, T; Wood, H; Dasari, S				McDermott, S; Moran, R; Platt, T; Issac, T; Wood, H; Dasari, S			Depression in adults with disabilities, in primary care	DISABILITY AND REHABILITATION			English	Article							NATIONAL-COMORBIDITY-SURVEY; INTELLECTUAL DISABILITY; SYMPTOMS; EPIDEMIOLOGY; LIFETIME; INJURY; PEOPLE; RISK	Purpose: This research was designed to answer the question: Does the prevalence of depression differ between adults with and without disability, in the same family medicine practice? Method: A retrospective cohort design was used, to study depression among adults, with and without primary disabling conditions, receiving primary care in either a university based urban or rural family practice setting. Results: When we compared individuals with disability to those without disability, and controlled for individual characteristics, the relative risk for depression was significantly lower for individuals with autism (Relative Risk (RR) 0.20: 95% Confidence Interval (CI) 0.05-0.55), cerebral palsy with mental retardation (RR 0.40: 95% CI: 0.24-0.65), and MR (RR 0.56: 95% CI: 0.39-0.77). The risk for depression was significantly higher for those with cerebral vascular accidents/stroke (RR 2.18: 95% CI: 1.72-3.76) and traumatic brain injury (RR 2.55: 95% CI: 1.72-2.77). The earliest onset of depression was among individuals with traumatic disabilities and mild mental retardation. Our estimate of depression prevalence for the non-disabled and disabled primary care patients was 22.8% and 24.9% respectively, when patients with disabilities were grouped together (p=0.008). Conclusion: It is important for physicians to recognize the higher prevalence of depression among patients with adult onset disabilities ( e. g. stroke, traumatic brain injury). In addition, they should be aware of lower prevalence of depression among many individuals with lifelong disabilities, such as mental retardation, cerebral palsy, and autism.	Univ S Carolina, Sch Med, Dept Family & Prevent Med, Columbia, SC USA	McDermott, S (corresponding author), Family Practice Ctr, 3209 Colonial Dr, Columbia, SC 29208 USA.	Suzanne.mcdermott@palmettohealth.org			ODCDC CDC HHS [R04/CCR418776] Funding Source: Medline		CHARLOT LR, 1993, AM J MENT RETARD, V98, P408; Chen LS, 2000, AM J PSYCHIAT, V157, P573, DOI 10.1176/appi.ajp.157.4.573; Davis JP, 1997, AUST NZ J PSYCHIAT, V31, P232, DOI 10.3109/00048679709073826; Dickens C, 2003, PSYCHOSOMATICS, V44, P209, DOI 10.1176/appi.psy.44.3.209; Everson SA, 2002, J PSYCHOSOM RES, V53, P891, DOI 10.1016/S0022-3999(02)00303-3; Glenn MB, 2001, BRAIN INJURY, V15, P811, DOI 10.1080/02699050010025777; Holsinger T, 2002, ARCH GEN PSYCHIAT, V59, P17, DOI 10.1001/archpsyc.59.1.17; Horwath Ewald, 1995, P317; KESSLER RC, 1994, ARCH GEN PSYCHIAT, V51, P8; Kessler RC, 2003, JAMA-J AM MED ASSOC, V289, P3095, DOI 10.1001/jama.289.23.3095; Labbate L A, 2000, Curr Psychiatry Rep, V2, P268, DOI 10.1007/s11920-996-0021-3; Marston GM, 1997, J INTELL DISABIL RES, V41, P476, DOI 10.1111/j.1365-2788.1997.tb00739.x; McBrien JA, 2003, J INTELL DISABIL RES, V47, P1, DOI 10.1046/j.1365-2788.2003.00455.x; MEINS W, 1995, J INTELL DISABIL RES, V39, P41, DOI 10.1111/j.1365-2788.1995.tb00912.x; Seel RT, 2003, ARCH PHYS MED REHAB, V84, P177, DOI 10.1053/apmr.2003.50106; STURMEY P, 1993, J INTELL DISABIL RES, V37, P437; The SAS Institute, 1999, SAS STAT US GUID VER; *WHO, 1980, INT STAT CLASS DIS; Whyte EM, 2002, BIOL PSYCHIAT, V52, P253, DOI 10.1016/S0006-3223(02)01424-5; Wu Lawrence R, 2002, J Am Board Fam Pract, V15, P183	20	22	22	0	4	TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	1464-5165			DISABIL REHABIL	Disabil. Rehabil.	FEB 4	2005	27	3					117	123		10.1080/09638280400007380			7	Rehabilitation	Rehabilitation	903WL	WOS:000227456200006	15823993				2021-06-18	
J	Sribnick, EA; Ray, SK; Banik, NL				Sribnick, EA; Ray, SK; Banik, NL			Estrogen as a multi-active neuroprotective agent in traumatic injuries	NEUROCHEMICAL RESEARCH			English	Article						estrogen; development; apoptosis; oxidative stress; neurotrauma	SPINAL-CORD-INJURY; PRIMARY CORTICAL-NEURONS; NF-KAPPA-B; RECEPTOR-ALPHA; LIPID-PEROXIDATION; OXIDATIVE STRESS; BRAIN-INJURY; INFLAMMATORY RESPONSE; HIPPOCAMPAL-NEURONS; LEUKOCYTE ADHESION	In the past decade, research has demonstrated that estrogen's role in physiology and development is far more complicated than previously assumed. Among these discoveries, there has been an increased recognition of the impact estrogen has in neurodevelopment, central nervous system physiology, and neuropathophysiology. These observations have led many researchers to consider using estrogen pharmacotherapeutically, at physiologic or supraphysiologic doses, for a variety of injury and toxicity models. In this short review, the effects of estrogen as an anti-apoptotic agent, as an anti-oxidant, and as an anti-inflammatory agent are discussed. Finally, the possibility of using estrogen as a neuroprotectant in neurotrauma is addressed.	Med Univ S Carolina, Dept Neurol, Charleston, SC 29425 USA	Banik, NL (corresponding author), Med Univ S Carolina, Dept Neurol, 96 Johnathan Lucas St,Suite 309, Charleston, SC 29425 USA.	baniknl@musc.edu	Sribnick, Eric/AAH-6693-2020		NCI NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [R01 CA-91460] Funding Source: Medline; NIGMS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [GM08716] Funding Source: Medline; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01 NS-38146, R01 NS-31622, R01 NS-41088, R01 NS-45967] Funding Source: Medline; NATIONAL CANCER INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [R01CA091460] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS031622, R01NS041088, R01NS038146, R01NS045967] Funding Source: NIH RePORTER		Alkayed NJ, 2001, J NEUROSCI, V21, P7543; Anderson Aileen J, 2002, J Spinal Cord Med, V25, P70; Asthana S, 2001, NEUROLOGY, V57, P605, DOI 10.1212/WNL.57.4.605; BAEUERLE PA, 1994, ANNU REV IMMUNOL, V12, P141, DOI 10.1146/annurev.iy.12.040194.001041; BARUT S, 1993, NEUROSURG REV, V16, P53, DOI 10.1007/BF00308614; Bayir H, 2004, J NEUROTRAUM, V21, P1, DOI 10.1089/089771504772695896; Beattie MS, 2000, J NEUROTRAUM, V17, P915, DOI 10.1089/neu.2000.17.915; Behl C, 1997, MOL PHARMACOL, V51, P535; Bimonte HA, 1999, PSYCHONEUROENDOCRINO, V24, P161, DOI 10.1016/S0306-4530(98)00068-7; BIRK K, 1986, ARCH NEUROL-CHICAGO, V43, P719, DOI 10.1001/archneur.1986.00520070075022; Bomstein Y, 2003, J NEUROIMMUNOL, V142, P10, DOI 10.1016/S0165-5728(03)00260-1; BRACKEN MB, 1984, JAMA-J AM MED ASSOC, V251, P45, DOI 10.1001/jama.251.1.45; Bracken MB, 1998, J NEUROSURG, V89, P699, DOI 10.3171/jns.1998.89.5.0699; Bradbury EJ, 2002, NATURE, V416, P636, DOI 10.1038/416636a; Bruce-Keller AJ, 2000, ENDOCRINOLOGY, V141, P3646, DOI 10.1210/en.141.10.3646; Burke KA, 2000, J NEUROSCI RES, V61, P329, DOI 10.1002/1097-4547(20000801)61:3<329::AID-JNR11>3.0.CO;2-A; Carlson SL, 1998, EXP NEUROL, V151, P77, DOI 10.1006/exnr.1998.6785; Chaban VV, 2003, NEUROSCIENCE, V118, P941, DOI 10.1016/S0306-4522(02)00915-6; Clarke CH, 2000, NEUROENDOCRINOLOGY, V71, P34, DOI 10.1159/000054518; Cordey M, 2003, J NEUROCHEM, V84, P1340, DOI 10.1046/j.1471-4159.2003.01631.x; Dodel RC, 1999, J NEUROCHEM, V73, P1453, DOI 10.1046/j.1471-4159.1999.0731453.x; Dubal DB, 1999, J NEUROSCI, V19, P6385; Dumont RJ, 2001, CLIN NEUROPHARMACOL, V24, P254, DOI 10.1097/00002826-200109000-00002; Fiore C, 2004, J NEUROSCI RES, V75, P391, DOI 10.1002/jnr.10821; Gollapudi L, 1999, J NEUROSCI RES, V56, P471, DOI 10.1002/(SICI)1097-4547(19990601)56:5<471::AID-JNR3>3.3.CO;2-T; Goodman YD, 1996, J NEUROCHEM, V66, P1836; Green P S, 2000, Novartis Found Symp, V230, P202, DOI 10.1002/0470870818.ch15; Green P.S., 2000, NOVART FDN SYMP, V230, P213; Green PS, 1998, NEUROSCIENCE, V84, P7, DOI 10.1016/S0306-4522(97)00595-2; Groswasser Z, 1998, BRAIN INJURY, V12, P805, DOI 10.1080/026990598122197; Hendriks JJA, 2003, BIOCHEM PHARMACOL, V65, P877, DOI 10.1016/S0006-2952(02)01609-X; Honda K, 2001, J NEUROSCI RES, V64, P466, DOI 10.1002/jnr.1098; Hosoda T, 2001, NEUROREPORT, V12, P1965, DOI 10.1097/00001756-200107030-00038; Huang C, 1999, J BIOL CHEM, V274, P36707, DOI 10.1074/jbc.274.51.36707; Hurlbert RJ, 2000, J NEUROSURG, V93, P1, DOI 10.3171/spi.2000.93.1.0001; Islamov RR, 2002, BRAIN RES, V943, P283, DOI 10.1016/S0006-8993(02)02827-5; JACOBS D, 1995, J INT NEUROPSYCH SOC, V1, P131; Jover T, 2002, J NEUROSCI, V22, P2115, DOI 10.1523/JNEUROSCI.22-06-02115.2002; Kaja S, 2003, INVEST OPHTH VIS SCI, V44, P3155, DOI 10.1167/iovs.02-1204; Kaptanoglu E, 2000, J NEUROSURG, V93, P77, DOI 10.3171/spi.2000.93.1.0077; Keyvan-Fouladi N, 2003, J NEUROSCI, V23, P9428; Koc RK, 1999, SPINAL CORD, V37, P29, DOI 10.1038/sj.sc.3100732; Koski CL, 2004, ENDOCRINOLOGY, V145, P95, DOI 10.1210/en.2003-0803; Lewen A, 2000, J NEUROTRAUM, V17, P871, DOI 10.1089/neu.2000.17.871; Mermelstein PG, 1996, J NEUROSCI, V16, P595; MONROE DG, MOL ENDOCRINOL, V16, P1322; Nakamizo T, 2000, NEUROREPORT, V11, P3493, DOI 10.1097/00001756-200011090-00019; Nomura M, 2003, MOL BRAIN RES, V110, P7, DOI 10.1016/S0169-328X(02)00544-2; Ospina JA, 2004, AM J PHYSIOL-HEART C, V286, pH2010, DOI 10.1152/ajpheart.00481.2003; Patrone C, 1999, P NATL ACAD SCI USA, V96, P10905, DOI 10.1073/pnas.96.19.10905; Polanczyk M, 2003, AM J PATHOL, V163, P1599, DOI 10.1016/S0002-9440(10)63516-X; Popovich PG, 1997, J COMP NEUROL, V377, P443, DOI 10.1002/(SICI)1096-9861(19970120)377:3<443::AID-CNE10>3.0.CO;2-S; Prokai L, 2003, P NATL ACAD SCI USA, V100, P11741, DOI 10.1073/pnas.2032621100; Pugazhenthi S, 2000, J BIOL CHEM, V275, P10761, DOI 10.1074/jbc.275.15.10761; Qiu J, 2002, NEURON, V34, P895, DOI 10.1016/S0896-6273(02)00730-4; Ray SK, 2003, BRAIN RES REV, V42, P169, DOI 10.1016/S0165-0173(03)00152-8; Robertson DMW, 2001, NEUROLOGY, V57, P2114, DOI 10.1212/WNL.57.11.2114; Roof RL, 2000, J NEUROTRAUM, V17, P1155, DOI 10.1089/neu.2000.17.1155; Santizo RA, 2000, STROKE, V31, P2231, DOI 10.1161/01.STR.31.9.2231; Santizo RA, 2002, STROKE, V33, P613, DOI 10.1161/hs0202.102363; Sekhon LHS, 2001, SPINE, V26, pS2, DOI 10.1097/00007632-200112151-00002; Singer CA, 1999, J NEUROSCI, V19, P2455; Solum DT, 2002, J NEUROSCI, V22, P2650, DOI 10.1523/JNEUROSCI.22-07-02650.2002; Sribnick EA, 2004, J NEUROSCI RES, V76, P688, DOI 10.1002/jnr.20124; SRIBNICK EA, 2003 M SOC NEUR; Stein Donald G, 2003, Pediatr Rehabil, V6, P13, DOI 10.1080/1363849031000095279; Sudoh N, 2001, CIRCULATION, V103, P724; Sur P, 2003, BRAIN RES, V971, P178, DOI 10.1016/S0006-8993(03)02349-7; Thomas AJ, 1999, SPINE, V24, P2134, DOI 10.1097/00007632-199910150-00013; Tiidus PM, 2001, CAN J PHYSIOL PHARM, V79, P400, DOI 10.1139/cjpp-79-5-400; Toran-Allerand CD, 2002, J NEUROSCI, V22, P8391; Vegeto E, 2003, P NATL ACAD SCI USA, V100, P9614, DOI 10.1073/pnas.1531957100; Wagner AK, 2004, BRAIN RES, V998, P113, DOI 10.1016/j.brainres.2003.11.027; Wang L, 2003, P NATL ACAD SCI USA, V100, P703, DOI 10.1073/pnas.242735799; Wingrave JM, 2003, J NEUROSCI RES, V73, P95, DOI 10.1002/jnr.10607; Xie LP, 2002, EUR J IMMUNOL, V32, P2837, DOI 10.1002/1521-4141(2002010)32:10<2837::AID-IMMU2837>3.0.CO;2-V; Young W, 1985, Cent Nerv Syst Trauma, V2, P109	77	22	22	0	1	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0364-3190	1573-6903		NEUROCHEM RES	Neurochem. Res.	NOV	2004	29	11					2007	2014		10.1007/s11064-004-6874-0			8	Biochemistry & Molecular Biology; Neurosciences	Biochemistry & Molecular Biology; Neurosciences & Neurology	876ZS	WOS:000225538200008	15662835				2021-06-18	
J	Brauer, SG; Broome, A; Stone, C; Clewett, S; Herzig, P				Brauer, SG; Broome, A; Stone, C; Clewett, S; Herzig, P			Simplest tasks have greatest dual task interference with balance in brain injured adults	HUMAN MOVEMENT SCIENCE			English	Article; Proceedings Paper	Conference on Sensorimotor CoordinationConference on Sensorimotor Coordination - Behavioural Modes and Neural Mechanisms	JUL 06-09, 2003JUL 06-09, 2003	Fraser Isl, AUSTRALIAQueensland, AUSTRALIA			attention; posture; equilibrium; brain injury	CLOSED-HEAD-INJURY; POSTURAL CONTROL; ATTENTIONAL DEMANDS; COGNITIVE TASKS; BODY SWAY; DEFICITS; RECOVERY; IDENTIFICATION; STABILITY; AGE	Attention difficulties and poor balance are both common sequel following a brain injury. This study aimed to determine whether brain injured adults had greater difficulty than controls in performing a basic balance task while concurrently completing several different cognitive tasks varying in visuo-spatial attentional load and complexity. Twenty brain injured adults and 20 age-, sex- and education level-matched controls performed a balance-only task (step stance held for 30s), five cognitive-only tasks (simple and complex non-spatial, visuo-spatial, and a control articulation task), and both together (dual tasks). Brain injured adults showed a greater centre of pressure (COP) excursion and velocity in all conditions than controls. Brain injured adults also demonstrated greater interference with balance when concurrently performing two cognitive tasks than control subjects. These were the control articulation and the simple non-spatial task. It is likely that distractibility during these simple tasks contributed to an increase in COP motion and interference with postural stability in stance. Performing visuo-spatial tasks concurrently with the balance task did not result in any change in COP motion. Dual task interference in this group is thus unlikely to be due to structural interference. Similarly, as the more complex tasks did not uniformly result in increased interference, a reduction in attentional capacity in the brain injured population is unlikely to be the primary cause of dual task interference in this group. (C) 2004 Elsevier B.V. All rights reserved.	Univ Queensland, Dept Physiotherapy, Brisbane, Qld 4072, Australia; Princess Alexandra Hosp, Dept Physiotherapy, Brisbane, Qld 4102, Australia; Princess Alexandra Hosp, Dept Psychol, Brisbane, Qld 4102, Australia	Brauer, SG (corresponding author), Univ Queensland, Dept Physiotherapy, Brisbane, Qld 4072, Australia.	s.brauer@shrs.uq.edu.au	Brauer, Sandra G/D-4519-2011	Brauer, Sandra G/0000-0001-9961-4739			Barin K, 1997, Biomed Sci Instrum, V33, P388; Basford JR, 2003, ARCH PHYS MED REHAB, V84, P343, DOI 10.1053/apmr.2003.50034; Becker R. A., 1988, NEW S LANGUAGE; BENTON AL, 1978, ARCH NEUROL-CHICAGO, V35, P364, DOI 10.1001/archneur.1978.00500300038006; Brauer SG, 2002, GAIT POSTURE, V15, P83, DOI 10.1016/S0966-6362(01)00163-1; Brauer SG, 2001, J GERONTOL A-BIOL, V56, pM489, DOI 10.1093/gerona/56.8.M489; BYUNG YJ, 1991, ARCH PHYS MED REHAB, V72, P642; Camicioli R, 1997, NEUROLOGY, V48, P955, DOI 10.1212/WNL.48.4.955; Cicerone KD, 1996, BRAIN INJURY, V10, P79, DOI 10.1080/026990596124566; DAULT M, 1999, GAIT POSTURE, pS41; Dault MC, 2003, COGNITIVE BRAIN RES, V16, P434, DOI 10.1016/S0926-6410(03)00058-2; Dault MC, 2001, GAIT POSTURE, V14, P248, DOI 10.1016/S0966-6362(01)00130-8; GEURTS ACH, 1993, ARCH PHYS MED REHAB, V74, P1144; Geurts ACH, 1996, ARCH PHYS MED REHAB, V77, P639, DOI 10.1016/S0003-9993(96)90001-5; Hillier SL, 1997, BRAIN INJURY, V11, P661; Iverson GL, 1999, CLIN NEUROPSYCHOL, V13, P437, DOI 10.1076/1385-4046(199911)13:04;1-Y;FT437; Kahneman D., 1973, ATTENTION EFFORT; KERR B, 1985, J EXP PSYCHOL HUMAN, V11, P617, DOI 10.1037/0096-1523.11.5.617; LAJOIE Y, 1993, EXP BRAIN RES, V97, P139; Lajoie Y, 1996, CHANGES SENSORY MOTO, DOI [10.1016/S0166-4115(96)80011-2, DOI 10.1016/S0166-4115(96)80011-2]; Leclercq M, 2002, APPL NEUROPSYCHOLOGY; LEHMANN JF, 1990, ARCH PHYS MED REHAB, V71, P955; Maki BE, 1996, J VESTIBUL RES-EQUIL, V6, P53; Maylor EA, 1996, J GERONTOL B-PSYCHOL, V51, pP143, DOI 10.1093/geronb/51B.3.P143; Melzer I, 2001, GERONTOLOGY, V47, P189, DOI 10.1159/000052797; OBLAK B, 1985, VESTIBULAR VISUAL CO, P355; PONSFORD J, 1992, J CLIN EXP NEUROPSYC, V14, P822, DOI 10.1080/01688639208402865; Quinn B, 2000, BRAIN INJURY, V14, P1063; Shumway-Cook A, 2000, J GERONTOL A-BIOL, V55, pM10; Shumway-Cook A, 1990, J HEAD TRAUMA REHAB, V5, P51, DOI DOI 10.1097/00001199-199012000-00007; ShumwayCook A, 1997, J GERONTOL A-BIOL, V52, pM232, DOI 10.1093/gerona/52A.4.M232; Spikman JM, 1999, J CLIN EXP NEUROPSYC, V21, P585, DOI 10.1076/jcen.21.5.585.874; Spikman JM, 2000, J CLIN EXP NEUROPSYC, V22, P325, DOI 10.1076/1380-3395(200006)22:3;1-V;FT325; STUSS DT, 1985, NEUROSURGERY, V17, P41, DOI 10.1227/00006123-198507000-00007; TEASDALE N, 1993, EXP AGING RES, V19, P1, DOI 10.1080/03610739308253919; Tombaugh T. N., 1998, COMPENDIUM NEUROPSYC; WHITE KD, 1980, SCIENCE, V208, P621, DOI 10.1126/science.7367888; WOBER C, 1993, ARCH PHYS MED REHAB, V74, P1151; Yardley L, 1999, NEUROREPORT, V10, P215, DOI 10.1097/00001756-199902050-00003; YEUDALL LT, 1986, J CLIN PSYCHOL, V42, P918, DOI 10.1002/1097-4679(198611)42:6<918::AID-JCLP2270420617>3.0.CO;2-Y	40	22	22	0	3	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0167-9457	1872-7646		HUM MOVEMENT SCI	Hum. Mov. Sci.	OCT	2004	23	3-4					489	502		10.1016/j.humov.2004.08.020			14	Neurosciences; Psychology; Psychology, Experimental; Sport Sciences	Neurosciences & Neurology; Psychology; Sport Sciences	875LW	WOS:000225422800016	15541531				2021-06-18	
J	Marzo, SJ; Leonetti, JP; Raffin, MJ; Letarte, P				Marzo, SJ; Leonetti, JP; Raffin, MJ; Letarte, P			Diagnosis and management of post-traumatic vertigo	LARYNGOSCOPE			English	Article; Proceedings Paper	Meeting of the Middle Section of the Triological-Society	JAN 08-11, 2004	Marco Isl, FL	Triol Socl, Middle Sect		vertigo; dysequilibrium; traumatic brain injury	TRAUMATIC BRAIN-INJURY; HEAD-INJURY	Objectives/Hypothesis: Patients with post-traumatic vertigo can be difficult to treat secondary to the chronicity of their symptoms. Patients can have peripheral, central, and combined vestibular deficits. Furthermore, no comprehensive guidelines exist for returning these patients to work. The objectives of the study were to discuss diagnosis, management techniques, and guidelines for returning these patients to work. Study Design: Retrospective analysis of a tertiary referral neurotology and balance clinic. Methods. Between July 1997 and July 2003, 2390 patients with chief complaints of vertigo and/or dizziness were analyzed. Of these, 16 patients met the requirements for inclusion in the study, including head trauma and/or concussion and residual vertigo. Their inpatient and outpatient charts, imaging studies, audiograms, vestibular tests, and physical therapy evaluations were reviewed. All patients had at least 6 months of follow-up. Results. There were 5 women and 11 men, with an average age of 42 years. Five patients had symptoms consistent with traumatic perilymphatic fistulas, and two patients had symptoms consistent with post-traumatic Meniere's syndrome. Surgical therapy was not beneficial in relieving dysequilibrium. Balance testing results did not predict return-to-work status. Eleven patients were not allowed to return to work in any capacity, two patients were allowed to return to work with limited duties, and three patients were allowed to return to work with no restrictions. Conclusion: Post-traumatic vertigo can result in chronic symptoms. Balance testing did not predict the ability of patients to return to work. Surgical intervention might not control patient symptoms. Many patients were unable to return to work.	Loyola Univ, Hlth Syst, Dept Otolaryngol Head & Neck Surg, Maywood, IL 60153 USA; Loyola Univ, Hlth Syst, Dept Audiol, Maywood, IL 60153 USA; Loyola Univ, Hlth Syst, Dept Neurol Surg, Maywood, IL 60153 USA	Marzo, SJ (corresponding author), 2160 S 1st Ave, Maywood, IL 60153 USA.	smarzo@lumc.edu					Bazarian JJ, 1999, BRAIN INJURY, V13, P173, DOI 10.1080/026990599121692; Bernstein DM, 1999, BRAIN INJURY, V13, P151, DOI 10.1080/026990599121683; *CDCP, 1999, TRAUM BRAIN INJ US; Chi JH, 2003, SEMIN NEUROSURG, V14, P071; Corrigan JD, 2001, CLIN J WOMENS HLTH, V1, P184; Echemendia RJ, 2001, CLIN J SPORT MED, V11, P23, DOI 10.1097/00042752-200101000-00005; ESSELMAN PC, 1995, BRAIN INJURY, V9, P417, DOI 10.3109/02699059509005782; Gennarelli TA, 1998, NEUROSCIENTIST, V4, P202, DOI 10.1177/107385849800400316; Gottshall K, 2003, LARYNGOSCOPE, V113, P1746, DOI 10.1097/00005537-200310000-00016; Gurr B, 2001, BRAIN INJURY, V15, P387, DOI 10.1080/02699050010005904; Guyot JP, 2001, ANN OTO RHINOL LARYN, V110, P562, DOI 10.1177/000348940111000611; KELLEY MJ, 1990, J SPORT MED PHYS FIT, V30, P202; MAITLAND CG, 2001, CURR NEUROL NEUROSCI, P1486; Paniak C, 2000, BRAIN INJURY, V14, P219; SATALOFF RT, 1999, J OCCUP HEARING LOSS, V2, P191	15	22	24	0	8	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0023-852X			LARYNGOSCOPE	Laryngoscope	OCT	2004	114	10					1720	1723		10.1097/00005537-200410000-00008			4	Medicine, Research & Experimental; Otorhinolaryngology	Research & Experimental Medicine; Otorhinolaryngology	862CU	WOS:000224468100008	15454760				2021-06-18	
J	Berger, RP; Heyes, MP; Wisniewski, SR; Adelson, PD; Thomas, N; Kochanek, PM				Berger, RP; Heyes, MP; Wisniewski, SR; Adelson, PD; Thomas, N; Kochanek, PM			Assessment of the macrophage marker quinolinic acid in cerebrospinal fluid after pediatric traumatic brain injury: Insight into the timing and severity of injury in child abuse	JOURNAL OF NEUROTRAUMA			English	Article						head injury; inflammation; inflicted childhood neurotrauma; macrophage; shaken baby syndrome	HEAD-INJURY; KYNURENINE PATHWAY; INFANTS; CSF	This study measured quinolinic acid (QUIN), a macrophage-microglia derived neurotoxin, in the cerebrospinal fluid (CSF) of children after non-inflicted and inflicted traumatic brain injury (nTBI, iTBI), and correlated QUIN concentrations with age, mechanism of injury (nTBi vs. iTBI), Glasgow Coma Scale (GCS) score and 6-month Glasgow Outcome Score. One hundred fifty-two CSF samples were collected from 51 children with severe TBI (GCS less than or equal to5 8). CSF was collected at the time an intraventricular catheter was placed and daily thereafter. QUIN concentration was measured by gas chromatography-mass spectroscopy. Patients ranged in age from 2 months to 16 years. Eleven children (22%) had iTBI. Initial and peak CSF QUIN concentrations were higher in patients with iTBI versus nTBI after adjusting for time after injury and GCS. Despite the lack of a history of trauma in 82% of children with iTBI, 100% had a peak QUIN concentration of >100 nM. There was a significant increase in the CSF concentrations of QUIN following severe nTBI and iTBI in children. Higher initial and peak QUIN concentrations after iTBI may be due to severity of injury, young age, and/or delay in seeking medical care, which allows for increased secondary injury.	Univ Pittsburgh, Childrens Hosp Pittsburgh, Sch Med, Dept Pediat, Pittsburgh, PA 15213 USA; Psychogen Inc, Hawthorne, NY USA; Univ Pittsburgh, Grad Sch Publ Hlth, Dept Epidemiol, Pittsburgh, PA 15260 USA; Childrens Hosp Pittsburgh, Dept Neurosurg, Pittsburgh, PA 15213 USA; Penn State Univ, Coll Med, Penn State Childrens Hosp, Div Pediat Crit Care Med, Hershey, PA USA; Univ Pittsburgh, Safar Ctr Resusciat Res, Sch Med, Dept Crit Care Med, Pittsburgh, PA 15213 USA; Univ Pittsburgh, Childrens Hosp Pittsburgh, Sch Med, Pittsburgh, PA 15213 USA	Berger, RP (corresponding author), Univ Pittsburgh, Childrens Hosp Pittsburgh, Sch Med, Dept Pediat, 3705 5th Ave, Pittsburgh, PA 15213 USA.	rberger@pitt.edu	Kochanek, Patrick M/D-2371-2015; Adelson, David/W-2083-2019	Kochanek, Patrick M/0000-0002-2627-913X; Wisniewski, Stephen/0000-0002-3877-9860; Thomas, Neal/0000-0002-7991-7510	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K23HD043843] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [M01RR000084] Funding Source: NIH RePORTER; NCRR NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [M01 RR 00084] Funding Source: Medline; NICHD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K23 HD 43843-01] Funding Source: Medline		Adelson PD, 1998, J CHILD NEUROL, V13, P2, DOI 10.1177/088307389801300102; BATSHAW ML, 1993, ANN NEUROL, V34, P676, DOI 10.1002/ana.410340509; Bell MJ, 1999, CRIT CARE MED, V27, P493, DOI 10.1097/00003246-199903000-00023; Berger R, 2003, J NEUROTRAUM, V20, P1114; Berger RP, 2002, PEDIATRICS, V109, DOI 10.1542/peds.109.2.e31; BILLMIRE ME, 1985, PEDIATRICS, V75, P340; BLIGHT AR, 1995, BRAIN, V118, P735, DOI 10.1093/brain/118.3.735; BROUWERS P, 1993, J INFECT DIS, V168, P1380, DOI 10.1093/infdis/168.6.1380; BRUCE DA, 1989, PEDIATR ANN, V18, P482, DOI 10.3928/0090-4481-19890801-07; Clark RSB, 2000, J PEDIATR-US, V137, P197, DOI 10.1067/mpd.2000.106903; DUHAIME AC, 1992, PEDIATRICS, V90, P179; ETTARO L, 2004, IN PRESS CHILD ABUSE; Ewing-Cobbs L, 1998, PEDIATRICS, V102, P300, DOI 10.1542/peds.102.2.300; GIULIAN D, 1993, J NEUROSCI, V13, P29; Guillemin GJ, 2003, GLIA, V41, P371, DOI 10.1002/glia.10175; Guillemin GJ, 2002, REDOX REP, V7, P199, DOI 10.1179/135100002125000550; Han Yong Y, 2003, Pediatr Crit Care Med, V4, P21, DOI 10.1097/00130478-200301000-00004; Hettler J, 2003, PEDIATRICS, V111, P602, DOI 10.1542/peds.111.3.602; HEYES MP, 1995, J NEUROL SCI, V133, P112, DOI 10.1016/0022-510X(95)00164-W; HEYES MP, 1992, BRAIN, V115, P1249, DOI 10.1093/brain/115.5.1249; HEYES MP, 1988, ANAL BIOCHEM, V174, P349, DOI 10.1016/0003-2697(88)90556-8; Heyes MP, 1998, FASEB J, V12, P881; Janesko K. L., 2000, Journal of Neurotrauma, V17, P956; Jenny C, 1999, JAMA-J AM MED ASSOC, V281, P621, DOI 10.1001/jama.281.7.621; Kochanek Patrick M., 2000, Pediatr Crit Care Med, V1, P4, DOI 10.1097/00130478-200007000-00003; LASKEY A, 1998, 1998 NAT SHAK BAB C; LEVIN HS, 1992, NEUROSURGERY, V31, P435, DOI 10.1227/00006123-199209000-00008; MILSTIEN S, 1994, J NEUROCHEM, V63, P1178; Nottet HSLM, 1996, J NEUROVIROL, V2, P111, DOI 10.3109/13550289609146544; Ruppel RA, 2001, J PEDIATR-US, V138, P18, DOI 10.1067/mpd.2001.110979; Sinz EH, 1998, J CEREBR BLOOD F MET, V18, P610, DOI 10.1097/00004647-199806000-00002; Whalen MJ, 2000, CRIT CARE MED, V28, P929, DOI 10.1097/00003246-200004000-00003; Whalen MJ, 1998, J NEUROTRAUM, V15, P777, DOI 10.1089/neu.1998.15.777; WHETSELL WO, 1989, NEUROSCI LETT, V97, P271, DOI 10.1016/0304-3940(89)90609-5	34	22	22	0	2	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	SEP	2004	21	9					1123	1130					8	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	855HC	WOS:000223962900002	15453983				2021-06-18	
J	Melo, JRT; da Silva, RA; Moreira, ED				Melo, JRT; da Silva, RA; Moreira, ED			Characteristics of patients with head injury at Salvador City (Bahia - Brazil)	ARQUIVOS DE NEURO-PSIQUIATRIA			Portuguese	Article						head injury; epidemiology; morbidity; mortality	TRAUMATIC BRAIN INJURY; EPIDEMIOLOGY	Objective: To describe the characteristics from people with head injury at Salvador city, as well, to point out the most frequent age groups, their disabilities and lethality rates. Method: Assessment and notification of 555 medical files from victims with head injury assisted at the General Hospital of Bahia during 2001. Results: 82.9% from all victims were male and 17.1% female; the most frequent age group was 21 to 30 years; the most relevant cause of head injury was traffic accident (40.7%), followed by physical violence with or without weapons (25.4%) and falls (24%). Conclusion: The most evident profile group involved in accidents with head trauma implications was young male that usually had traffic injuries, with expressive rates of disabilities and lethality.	Hosp Sao Rafael, BR-41256900 Salvador, BA, Brazil; Hosp Geral Estado Bahia, Salvador, BA, Brazil; Univ Fed Bahia, Curso Pos Grad Med & Saude, Salvador, BA, Brazil; Univ Sao Paulo, BR-05508 Sao Paulo, Brazil	Melo, JRT (corresponding author), Hosp Sao Rafael, Ave Sao Rafael 2152,3 Andar,Setor A, BR-41256900 Salvador, BA, Brazil.	robertotude@hotmail.com	Moreira, Edson/W-7437-2019; Moreira, Edson D/J-1758-2012	Moreira, Edson/0000-0002-7081-8348; Moreira, Edson D/0000-0002-7081-8348			ANDRADE AF, 2003, ORIENTACAO AOS FAMIL; ANDRIS JS, 1996, ANTIBODIES, V2, P1; Bardenheuer M, 2000, UNFALLCHIRURG, V103, P355, DOI 10.1007/s001130050550; Basso A, 2001, WORLD J SURG, V25, P1174; Bordignon KC, 2002, ARQ NEURO-PSIQUIAT, V60, P204, DOI 10.1590/S0004-282X2002000200004; Boswell JE, 2002, AM J EMERG MED, V20, P177, DOI 10.1053/ajem.2002.32641; Eker C, 2000, BRAIN INJURY, V14, P605; FARAGE L, 2002, REV ASSOC MED BRAS, V48, P133; Finfer SR, 2001, RESUSCITATION, V48, P77, DOI 10.1016/S0300-9572(00)00321-X; FONSECA A, 2002, J TARDE CADERNO 01; Holbrook TL, 2002, J TRAUMA, V53, P882, DOI 10.1097/00005373-200211000-00012; *I BRAS GEOGR EST, 2002, RES U CENS 2000 DISP; Kay A, 2001, WORLD J SURG, V25, P1210, DOI 10.1007/s00268-001-0084-6; KOIZUME MS, 2000, ARQ NEURO-PSIQUIAT, V58, P1; KRUASS JF, 1996, NEUROLOGY TRAUMA, P3; MacKenzie EJ, 2000, EPIDEMIOL REV, V22, P112, DOI 10.1093/oxfordjournals.epirev.a018006; MASINI M, 1994, THESIS U FEDERAL SAO; Mattos P, 2002, ARQ NEURO-PSIQUIAT, V60, P319, DOI 10.1590/S0004-282X2002000200027; Melo JRT, 2003, CIENCIA SAUDE, V3, P31; Sander AM, 2002, BRAIN INJURY, V16, P649, DOI 10.1080/02699050210128889; TEASDALE G, 1974, LANCET, V2, P81; van der Sluis CK, 1998, INJURY, V29, P281, DOI 10.1016/S0020-1383(97)00199-X	22	22	28	0	5	ASSOC ARQUIVOS NEURO- PSIQUIATRIA	SAO PAULO SP	PR AMADEU AMARAL 47/33, 01327-010 SAO PAULO SP, BRAZIL	0004-282X	1678-4227		ARQ NEURO-PSIQUIAT	Arq. Neuro-Psiquiatr.	SEP	2004	62	3A					711	714		10.1590/S0004-282X2004000400027			4	Neurosciences; Psychiatry	Neurosciences & Neurology; Psychiatry	853AV	WOS:000223799400027	15334236	DOAJ Gold, Green Published			2021-06-18	
J	Pou, JAL; Centellas, JMA; Sans, MP; Barcena, JP; Vivas, MC; Ramirez, JH; Juve, JI				Pou, JAL; Centellas, JMA; Sans, MP; Barcena, JP; Vivas, MC; Ramirez, JH; Juve, JI			Monitoring midline shift by transcranial color-coded sonography in traumatic brain injury - A comparison with cranial computerized tomography	INTENSIVE CARE MEDICINE			English	Article						traumatic brain injury; transcranial color-coded sonography; midline shift	SPACE-OCCUPYING STROKE; DUPLEX-SONOGRAPHY; HEAD-INJURY; 3RD-VENTRICLE	Objective. Transcranial color-coded duplex sonography (TCCDS) is a non invasive bedside technique that allows the determination of midline shift (MLS). The purpose of our study was to compare MLS measurements using TCCDS with those obtained with cranial computerized tomography (CT) in patients with traumatic brain injury (TBI). Design. Prospective study. Settings. Intensive care unit in a university hospital. Patients. Forty-one traumatic brain-injured patients (35 men and 6 women). Interventions. A total of 60 studies were conducted with a time interval between the cranial CT and the TCCDS studies of 322+/-216 min. Results. The coefficient of correlation between MLS measured by CT and TCCDS was 0.88, the bias was 0.12 mm, the precision was 1.08 mm and the limits of agreement were +2.33 to -2.07 mm. There were no statistically significant differences in MLS measured by the two techniques in terms of: sex, age or type of lesion according to the Traumatic Coma Data Bank classification. Conclusion. The TCCDS is a non-invasive bedside technique that is valid for determining MLS in patients with traumatic brain injury. Due to the risks involved in the transportation of traumatic brain-injured patients to the radiology department, this bedside technique is specially interesting in these patients.	Hosp Univ Son Dureta, Serv Med Intensiva, Palma de Mallorca, Baleares, Spain; Hosp Univ Son Dureta, Unidad Coronaria, Palma de Mallorca, Baleares, Spain; Hosp Univ Son Dureta, Serv Radiodiagnost, Palma de Mallorca, Baleares, Spain	Pou, JAL (corresponding author), Hosp Univ Son Dureta, Serv Med Intensiva, Palma de Mallorca, Baleares, Spain.	ja_llompart@hotmail.com					BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; FEARNSIDE MR, 1993, BRIT J NEUROSURG, V7, P267, DOI 10.3109/02688699309023809; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; MURSCH K, 1995, ULTRASCHALL MED, V16, P65, DOI 10.1055/s-2007-1003989; QUATTROCCHI KB, 1991, SURG NEUROL, V35, P183, DOI 10.1016/0090-3019(91)90069-L; Seidel G, 1996, J NEUROIMAGING, V6, P227, DOI 10.1111/jon199664227; Stocchetti N, 2001, INTENS CARE MED, V27, P400, DOI 10.1007/s001340000825; Stolz E, 1999, AM J NEURORADIOL, V20, P1567; Woydt M, 1996, ZBL NEUROCHIR, V57, P129; Zipper SG, 2002, EUR J NEUROL, V9, P1, DOI 10.1046/j.1468-1331.2002.00272.x	10	22	24	0	2	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0342-4642	1432-1238		INTENS CARE MED	Intensive Care Med.	AUG	2004	30	8					1672	1675		10.1007/s00134-004-2348-8			4	Critical Care Medicine	General & Internal Medicine	842OT	WOS:000223014400026	15197433				2021-06-18	
J	Kirsch, NL; Shenton, M; Rowan, J				Kirsch, NL; Shenton, M; Rowan, J			A generic, 'in-house', alphanumeric paging system for prospective activity impairments after traumatic brain injury	BRAIN INJURY			English	Article							MEMORY AID; REHABILITATION	Objective : For settings having suitable infrastructure, generic, 'in-house' alphanumeric paging systems can be constructed that are fully under clinician control. Development of such a system for therapeutic application is described and a single-case study presented that assessed whether the system could improve repetitive, prospective use of a daily planner. Design : ABA' single case. Methods : The participant was male, in his mid-30s, having cognitive impairments subsequent to recent TBI superimposed on remote neurological changes. The pager reminded him to record therapeutic information in a daily planner, for discussion with a family member each evening. Results : During intervention (B) trials, reliable memory log usage was noted. By trial five of return-to-baseline (A') trials, there was decreased memory log use. Conclusions : Alphanumeric paging facilitated reliable use of a memory log compensation technique. The 'in-house' paging system proved particularly suitable for intervention development. Limits of the study are discussed and other therapeutically useful wireless technologies are noted.	Univ Michigan Hlth Syst, Dept Phys Med & Rehabil, Ann Arbor, MI 48108 USA	Kirsch, NL (corresponding author), Univ Michigan Hlth Syst, Dept Phys Med & Rehabil, 355 Briarwood Circle, Ann Arbor, MI 48108 USA.	nlkirsch@umich.edu	Shenton, Martha/V-8780-2019				Bergman M M, 2000, Appl Neuropsychol, V7, P76, DOI 10.1207/S15324826AN0702_2; Bergman MM, 2002, J HEAD TRAUMA REHAB, V17, P431, DOI 10.1097/00001199-200210000-00005; CHESTNUT RM, 1999, REHABILITATION TRAUM; Chute DL, 1988, NEUROPSYCHOLOGY, V2, P41, DOI 10.1037//0894-4105.2.1.41; Cole E, 1999, NEUROREHABILITATION, V12, P39; Cole E, 1994, NeuroRehabilitation, V4, P174, DOI 10.3233/NRE-1994-4308; DAVISON AG, 2002, POSTIE PERSONAL EDIT; Evans JJ, 1998, J INT NEUROPSYCH SOC, V4, P399, DOI 10.1017/S1355617798003993; Flannery M A, 1997, Pediatr Rehabil, V1, P239; Hart T, 2002, J HEAD TRAUMA REHAB, V17, P556, DOI 10.1097/00001199-200212000-00007; Hersh N A, 1994, NeuroRehabilitation, V4, P187, DOI 10.3233/NRE-1994-4309; Kim HJ, 1999, BRAIN INJURY, V13, P147, DOI 10.1080/026990599121818; Kim HJ, 2000, BRAIN INJURY, V14, P187, DOI 10.1080/026990500120844; Kime SK, 1996, BRAIN INJURY, V10, P17; KIRSCH NL, IN PRESS REHABILITAT; KIRSCH NL, 1987, J HEAD TRAUMA REHAB, V2, P77; KIRSCH NL, 1992, J HEAD TRAUMA REHAB, V7, P13, DOI DOI 10.1097/00001199-199209000-00004; LEVINE SP, 1992, J HEAD TRAUMA REHAB, V7, P46, DOI DOI 10.1097/00001199-199209000-00007; LOPRESTI EF, IN PRESS NEUROPSYCHO; ROTHI LJ, 1983, J CLIN NEUROPSYCHOL, V5, P73, DOI 10.1080/01688638308401152; SOHLBERG MM, 1987, J CLIN EXP NEUROPSYC, V9, P117, DOI 10.1080/01688638708405352; van den Broek MD, 2000, BRAIN INJURY, V14, P455; Wade TK, 2001, BRAIN INJURY, V15, P305, DOI 10.1080/026990501750111256; Wilson BA, 1997, J NEUROL NEUROSUR PS, V63, P113, DOI 10.1136/jnnp.63.1.113; Wilson BA, 1999, REHABIL PSYCHOL, V44, P284, DOI 10.1037/0090-5550.44.3.284; Wilson BA, 2001, J NEUROL NEUROSUR PS, V70, P477, DOI 10.1136/jnnp.70.4.477	26	22	22	0	1	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	JUL	2004	18	7					725	734		10.1080/02699050310001646161			10	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	821HJ	WOS:000221450700008	15204332				2021-06-18	
J	Penkowa, M; Quintana, A; Carrasco, J; Giralt, M; Molinero, A; Hidalgo, J				Penkowa, M; Quintana, A; Carrasco, J; Giralt, M; Molinero, A; Hidalgo, J			Metallothionein prevents neurodegeneration and central nervous system cell death after treatment with gliotoxin 6-aminonicotinamide	JOURNAL OF NEUROSCIENCE RESEARCH			English	Article						neuropathology; inflammation; neurodegeneration; cell death	ASTROCYTE-TARGETED EXPRESSION; AMYOTROPHIC-LATERAL-SCLEROSIS; FOCAL BRAIN-INJURY; TRANSGENIC MICE; OXIDATIVE STRESS; INTERLEUKIN-6 EXPRESSION; DEFICIENCY LEADS; REACTIVE OXYGEN; GENE-EXPRESSION; III EXPRESSION	Transgenic expression of interleukin-6 (IL-6) in the CNS under the control of the glial fibrillary acidic protein (GFAP) gene promoter (GFAP-IL6 mice) induces significant inflammation and neurodegeneration but also affords neuroprotection against acute traumatic brain injury. This neuroprotection is likely mediated by the IL-6-induced protective factors metallothioneins-I and -II (MT-I+II). Here we evaluate the neuroprotective roles of IL-6 vs. MT-I+II during 6-aminonicotinamide (6-AN)-induced neurotoxicity, by using GFAP-IL6 mice and transgenic mice overexpressing MT-I (TgMT) as well as GFAP-IL6 mice crossed with TgMT mice (GFAP-IL6 X TgMT). 6-AN caused acute damage of brainstem gray matter areas identified by necrosis of astrocytes, followed by inflammatory responses. After 6-AN-induced toxicity, secondary damage was observed, consisting of oxidative stress, neurodegeneration, and apoptotic cell death. We hereby show that the primary injury caused by 6-AN was comparable in wild-type and GFAP-IL6 mice, but MT-I overexpression could significantly protect the brain tissue. As expected, GFAP-IL6 mice showed increased CNS inflammation with more gliosis, macrophages, and lymphocytes, including increased cytokine expression, relative to the other mice. However, GFAP-IL6 mice showed reduced oxidative stress (judged from nitrotyrosine, malondialdehyde and 8-oxoguanine stainings), neurodegeneration (accumulation of neurofibrillary tangles), and apoptosis (determined from TUNEL and caspase-3). MT-I+II expression was significantly higher in GFAP-IL6 mice than in wild types, which may contribute to the IL-6-induced neuroprotection. In support of this, overexpression of MT-I in GFAP-IL6 x TgMT as well as TgMT mice protected the brainstem tissue significantly from 6-AN-induced toxicity and secondary brain tissue damage. Overall, the results demonstrate that brain MT-I+II proteins are fundamental neuroprotective factors, which in the future may become therapeutic agents. (C) 2004 Wiley-Liss, Inc.	Univ Copenhagen, Panum Inst, Dept Med Anat, Copenhagen, Denmark; Autonomous Univ Barcelona, Inst Neurosci, Barcelona, Spain; Autonomous Univ Barcelona, Dept Cellular Biol Physiol & Immunol, Barcelona, Spain	Hidalgo, J (corresponding author), Univ Autonoma Barcelona, Fac Ciencias, Dept Biol Celular Fisiol & Immunol, Unidad Fisiol Anim, E-08193 Barcelona, Spain.	juan.hidalgo@uab.es	Quintana, Albert/N-5544-2015; Hidalgo, Juan/C-9082-2011; Carrasco, Javier/C-9732-2011; Giralt, Mercedes/K-1626-2014; molinero, amalia/K-2147-2014	Quintana, Albert/0000-0003-1674-7160; Hidalgo, Juan/0000-0003-0921-1122; Carrasco, Javier/0000-0001-6436-0863; Giralt, Mercedes/0000-0002-1806-1528; molinero, amalia/0000-0001-8661-8570			ABEL J, 1989, TOXICOL LETT, V47, P191, DOI 10.1016/0378-4274(89)90075-1; Aschner M, 1998, NEUROTOXICOLOGY, V19, P653; Bishop A, 2003, CURR DRUG METAB, V4, P171, DOI 10.2174/1389200033489514; Bossy-Wetzel E, 2003, CURR OPIN CELL BIOL, V15, P706, DOI 10.1016/j.ceb.2003.10.015; Budihardjo II, 2000, MOL PHARMACOL, V57, P529; Cai L, 2003, TOXICOL LETT, V136, P193, DOI 10.1016/S0378-4274(02)00359-4; Campagne MV, 1999, P NATL ACAD SCI USA, V96, P12870; Campbell IL, 1998, BRAIN RES REV, V26, P327, DOI 10.1016/S0165-0173(97)00038-6; Campbell IL, 1998, ANN NY ACAD SCI, V840, P83, DOI 10.1111/j.1749-6632.1998.tb09552.x; CAMPBELL IL, 1993, P NATL ACAD SCI USA, V90, P10061, DOI 10.1073/pnas.90.21.10061; Carrasco J, 1998, EXP NEUROL, V153, P184, DOI 10.1006/exnr.1998.6861; Carrasco J, 2000, EUR J NEUROSCI, V12, P2311, DOI 10.1046/j.1460-9568.2000.00128.x; Chen HN, 2001, DIABETES, V50, P2040, DOI 10.2337/diabetes.50.9.2040; Cherian MG, 2003, MUTAT RES-FUND MOL M, V533, P201, DOI 10.1016/j.mrfmmm.2003.07.013; Chung RS, 2003, J NEUROSCI, V23, P3336; Clark WM, 2000, STROKE, V31, P1715, DOI 10.1161/01.STR.31.7.1715; Dong YS, 2001, GLIA, V36, P180, DOI 10.1002/glia.1107; Floyd RA, 1999, P SOC EXP BIOL MED, V222, P236, DOI 10.1046/j.1525-1373.1999.d01-140.x; Floyd RA, 1999, FREE RADICAL BIO MED, V26, P1346, DOI 10.1016/S0891-5849(98)00293-7; Giralt M, 2001, EXP NEUROL, V168, P334, DOI 10.1006/exnr.2000.7601; Giralt M, 2002, NEUROBIOL DIS, V9, P319, DOI 10.1006/nbdi.2002.0480; Giralt M, 2002, EXP NEUROL, V173, P114, DOI 10.1006/exnr.2001.7772; Gong YH, 2000, EXP NEUROL, V162, P27, DOI 10.1006/exnr.2000.7323; GRIFFITHS IR, 1981, LAB INVEST, V44, P547; Haghighat N, 1997, METAB BRAIN DIS, V12, P29, DOI 10.1007/BF02676352; Haidara K, 1999, TOXICOL SCI, V49, P297, DOI 10.1093/toxsci/49.2.297; Hernandez J, 1997, MOL BRAIN RES, V48, P125, DOI 10.1016/S0169-328X(97)00087-9; Hidalgo J, 2002, METHOD ENZYMOL, V348, P238, DOI 10.1016/S0076-6879(02)48642-9; Hidalgo J, 2001, BRAIN RES BULL, V55, P133, DOI 10.1016/S0361-9230(01)00452-X; Hothersall JS, 1998, FEBS LETT, V434, P97, DOI 10.1016/S0014-5793(98)00959-4; Jellinger KA, 2003, J NEURAL TRANSM-SUPP, P101; Jin GB, 2003, CLIN EXP IMMUNOL, V131, P275, DOI 10.1046/j.1365-2249.2003.02074.x; John GR, 2003, NEUROSCIENTIST, V9, P10, DOI 10.1177/1073858402239587; Kohler LB, 2003, BRAIN RES, V992, P128, DOI 10.1016/j.brainres.2003.08.049; Koutsilieri E, 2002, PARKINSONISM RELAT D, V8, P401, DOI 10.1016/S1353-8020(02)00021-4; Krinke GJ, 1998, EXP TOXICOL PATHOL, V50, P277, DOI 10.1016/S0940-2993(98)80007-9; KRUM JM, 1995, MOL CHEM NEUROPATHOL, V26, P79, DOI 10.1007/BF02815007; KRUM JM, 1994, GLIA, V11, P354, DOI 10.1002/glia.440110408; Lee YS, 1999, J AM ASSOC GYN LAP, V6, P59, DOI 10.1016/S1074-3804(99)80042-5; MASTERS BA, 1994, P NATL ACAD SCI USA, V91, P584, DOI 10.1073/pnas.91.2.584; Molinero A, 2003, J NEUROPATH EXP NEUR, V62, P315, DOI 10.1093/jnen/62.3.315; Moosmann B, 2002, EXPERT OPIN INV DRUG, V11, P1407, DOI 10.1517/13543784.11.10.1407; Nagano S, 2001, EUR J NEUROSCI, V13, P1363, DOI 10.1046/j.0953-816x.2001.01512.x; PALMITER RD, 1993, MOL CELL BIOL, V13, P5266, DOI 10.1128/MCB.13.9.5266; Penkowa M, 2000, EXP NEUROL, V163, P72, DOI 10.1006/exnr.2000.7383; Penkowa M, 2003, J NEUROSCI RES, V73, P481, DOI 10.1002/jnr.10681; Penkowa M, 2003, EXP NEUROL, V181, P130, DOI 10.1016/S0014-4886(02)00051-1; Penkowa M, 2002, EXP NEUROL, V176, P308, DOI 10.1006/exnr.2002.7968; Penkowa M, 2002, J COMP NEUROL, V444, P174, DOI 10.1002/cne.10149; Penkowa M, 2003, GLIA, V42, P287, DOI 10.1002/glia.10208; PENKOWA M, 2002, BIOMED REV, V13, P1; Puttaparthi K, 2002, J NEUROSCI, V22, P8790; Rego AC, 2003, NEUROCHEM RES, V28, P1563, DOI 10.1023/A:1025682611389; Stoll G, 2002, ADV EXP MED BIOL, V513, P87; Swartz KR, 2001, BRAIN RES, V896, P86, DOI 10.1016/S0006-8993(01)02013-3; Trendelenburg G, 2002, J NEUROSCI, V22, P5879; Van Wagoner NJ, 1999, J NEUROIMMUNOL, V100, P124, DOI 10.1016/S0165-5728(99)00187-3; Viarengo A, 2000, CELL MOL BIOL, V46, P407; Wang J, 2002, CURR TOP MICROBIOL, V265, P23; Ye B, 2001, P NATL ACAD SCI USA, V98, P2317, DOI 10.1073/pnas.041619198	60	22	23	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0360-4012	1097-4547		J NEUROSCI RES	J. Neurosci. Res.	JUL 1	2004	77	1					35	53		10.1002/jnr.20154			19	Neurosciences	Neurosciences & Neurology	834KW	WOS:000222411000005	15197737				2021-06-18	
J	Sengoku, T; Bondada, V; Hassane, D; Dubal, S; Geddes, JW				Sengoku, T; Bondada, V; Hassane, D; Dubal, S; Geddes, JW			Tat-calpastatin fusion proteins transduce primary rat cortical neurons but do not inhibit cellular calpain activity	EXPERIMENTAL NEUROLOGY			English	Article						cysteine proteases; endosomes; protein transduction; spectrin	FOCAL CEREBRAL-ISCHEMIA; SPINAL-CORD-INJURY; MAMMALIAN-CELLS; BRAIN INJURY; PENETRATING PEPTIDES; HUNTINGTONS-DISEASE; ALZHEIMERS-DISEASE; PROTEASE CALPAIN; ESCHERICHIA-COLI; ALPHA-SYNUCLEIN	Excessive activation of calpains (calcium-activated neutral proteases) is observed following spinal cord contusion injury, traumatic brain injury, stroke, and in neurodegenerative disorders including Alzheimer's disease. Calpain inhibition represents an attractive therapeutic target, but current calpain inhibitors possess relatively weak potency, poor specificity, and in many cases, limited cellular and blood-brain barrier permeability. We developed novel calpain inhibitors consisting of the endogenous inhibitor, calpastatin or its inhibitory domain I, fused to the protein transduction domain of the HIV trans-activator (Tat) protein (Tat(47-57)). The Tat-calpastatin fusion proteins were potent calpain inhibitors in a cell-free activity assay, but did not inhibit cellular calpain activity in primary rat cortical neurons when applied exogenously at concentrations up to 5 muM. The fusion proteins were able to transduce neurons, but were localized within endosome-like structures. A similar endosomal uptake was observed for Tat-GFP. Together, the results suggest that endosomal uptake of the Tat-calpastatin prevents its interaction with calpain in other cellular compartments. Endosomal uptake of proteins fused to the Tat protein transduction domain severely limits the applications of this methodology. (C) 2004 Elsevier Inc. All rights reserved.	Univ Kentucky, Dept Anat & Neurobiol, Lexington, KY 40536 USA; Univ Kentucky, Spinal Cord & Brain Injury Res Ctr, Lexington, KY 40536 USA	Geddes, JW (corresponding author), Univ Kentucky, Dept Anat & Neurobiol, Sander Brown Bldg,Room 226,800 S Limestone St, Lexington, KY 40536 USA.	jgeddes@uky.edu	Hassane, Duane/AAA-3456-2021	Hassane, Duane/0000-0002-0719-9572	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS045726] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01 NS45726-01A1] Funding Source: Medline		Aarts M, 2002, SCIENCE, V298, P846, DOI 10.1126/science.1072873; Adamec E, 2002, ACTA NEUROPATHOL, V104, P92, DOI 10.1007/s00401-002-0528-6; ANDERSON GJ, 1994, GASTROENTEROLOGY, V106, P414, DOI 10.1016/0016-5085(94)90600-9; ARIYOSHI H, 1993, BIOCHEM MOL BIOL INT, V30, P63; Asoh S, 2002, P NATL ACAD SCI USA, V99, P17107, DOI 10.1073/pnas.262460299; BARTUS RT, 1994, J CEREBR BLOOD F MET, V14, P537, DOI 10.1038/jcbfm.1994.67; BAUDRY M, 1987, SYNAPSE, V1, P506, DOI 10.1002/syn.890010603; Becker-Hapak M, 2001, METHODS, V24, P247, DOI 10.1006/meth.2001.1186; BREWER GJ, 1993, J NEUROSCI RES, V35, P567, DOI 10.1002/jnr.490350513; Cao GD, 2002, J NEUROSCI, V22, P5423; Chakrabarti AK, 1997, J NEUROSCI RES, V47, P609, DOI 10.1002/(SICI)1097-4547(19970315)47:6<609::AID-JNR6>3.0.CO;2-H; CHAKRABARTI AK, 1989, NEUROCHEM RES, V14, P259, DOI 10.1007/BF00971321; CROALL DE, 1991, PHYSIOL REV, V71, P813; De Tullio R, 1999, BIOCHEM J, V343, P467; Di Rosa G, 2002, J MOL NEUROSCI, V19, P135, DOI 10.1007/s12031-002-0024-4; Dietz GPH, 2002, MOL CELL NEUROSCI, V21, P29, DOI 10.1006/mcne.2002.1165; Donkor IO, 2000, CURR MED CHEM, V7, P1171, DOI 10.2174/0929867003374129; Egleton RD, 1997, PEPTIDES, V18, P1431, DOI 10.1016/S0196-9781(97)00242-8; EMORI Y, 1988, J BIOL CHEM, V263, P2364; Fischer R, 2004, J BIOL CHEM, V279, P12625, DOI 10.1074/jbc.M311461200; Ford KG, 2001, GENE THER, V8, P1, DOI 10.1038/sj.gt.3301383; Futaki S, 2003, CURR PROTEIN PEPT SC, V4, P87, DOI 10.2174/1389203033487261; Gafni J, 2002, J NEUROSCI, V22, P4842, DOI 10.1523/JNEUROSCI.22-12-04842.2002; Gil-Parrado S, 2003, BIOL CHEM, V384, P395, DOI 10.1515/BC.2003.045; Goll DE, 2003, PHYSIOL REV, V83, P731, DOI 10.1152/physrev.00029.2002; Hitomi K, 1998, BIOSCI BIOTECH BIOCH, V62, P136, DOI 10.1271/bbb.62.136; Hood JL, 2003, BIOCHEM BIOPH RES CO, V310, P1200, DOI 10.1016/j.bbrc.2003.09.142; Huang YH, 2001, TRENDS MOL MED, V7, P355, DOI 10.1016/S1471-4914(01)02049-4; Kilic U, 2003, STROKE, V34, P1304, DOI 10.1161/01.STR.0000066869.45310.50; Kim SJ, 2003, J BIOL CHEM, V278, P41890, DOI 10.1074/jbc.M306017200; Kim YJ, 2001, P NATL ACAD SCI USA, V98, P12784, DOI 10.1073/pnas.221451398; Kupina NC, 2001, J NEUROTRAUM, V18, P1229, DOI 10.1089/089771501317095269; Kwon HY, 2000, FEBS LETT, V485, P163, DOI 10.1016/S0014-5793(00)02215-8; Lundberg M, 2001, NAT BIOTECHNOL, V19, P713, DOI 10.1038/90741; MAKI M, 1987, FEBS LETT, V223, P174, DOI 10.1016/0014-5793(87)80531-8; MAKI M, 1989, J BIOL CHEM, V264, P18866; MAKI M, 1991, BIOMED BIOCHIM ACTA, V50, P509; Markgraf CG, 1998, STROKE, V29, P152, DOI 10.1161/01.STR.29.1.152; MEHDI S, 1991, TRENDS BIOCHEM SCI, V16, P150, DOI 10.1016/0968-0004(91)90058-4; Mellgren RL, 1997, J BIOL CHEM, V272, P29899, DOI 10.1074/jbc.272.47.29899; Melloni E, 1998, FEBS LETT, V431, P55, DOI 10.1016/S0014-5793(98)00724-8; Minger SL, 1998, BRAIN RES, V810, P181, DOI 10.1016/S0006-8993(98)00921-4; Mishizen-Eberz AJ, 2003, J NEUROCHEM, V86, P836, DOI 10.1046/j.1471-4159.2003.01878.x; Nagahara H, 1998, NAT MED, V4, P1449, DOI 10.1038/4042; Namiki S, 2003, BIOCHEM BIOPH RES CO, V305, P592, DOI 10.1016/S0006-291X(03)00807-6; Nath A, 1996, J VIROL, V70, P1475, DOI 10.1128/JVI.70.3.1475-1480.1996; Newcomb JK, 1997, J NEUROTRAUM, V14, P369, DOI 10.1089/neu.1997.14.369; NIXON RA, 1994, ANN NY ACAD SCI, V747, P77; Ono Y, 1999, CALPAIN PHARM TOXICO, P1; PERLMUTTER LS, 1988, SYNAPSE, V2, P79, DOI 10.1002/syn.890020111; Potocky TB, 2003, J BIOL CHEM, V278, P50188, DOI 10.1074/jbc.M308719200; Qian ZM, 2002, PHARMACOL REV, V54, P561, DOI 10.1124/pr.54.4.561; Ray SK, 2003, BRAIN RES REV, V42, P169, DOI 10.1016/S0165-0173(03)00152-8; Ray SK, 2003, CNS NEUROL DISORD-DR, V2, P173, DOI 10.2174/1568007033482887; Richard JP, 2003, J BIOL CHEM, V278, P585, DOI 10.1074/jbc.M209548200; ROBERTSLEWIS JM, 1994, J NEUROSCI, V14, P3934; Saatman KE, 1996, J NEUROPATH EXP NEUR, V55, P850, DOI 10.1097/00005072-199607000-00010; Saatman KE, 2000, J CEREBR BLOOD F MET, V20, P66, DOI 10.1097/00004647-200001000-00010; SAIDO TC, 1993, J BIOL CHEM, V268, P25239; SATO K, 1995, EUR J BIOCHEM, V230, P25, DOI 10.1111/j.1432-1033.1995.0025i.x; Schwarze SR, 2000, TRENDS CELL BIOL, V10, P290, DOI 10.1016/S0962-8924(00)01771-2; Schwarze SR, 1999, SCIENCE, V285, P1569, DOI 10.1126/science.285.5433.1569; SIMAN R, 1988, NEURON, V1, P279, DOI 10.1016/0896-6273(88)90076-1; SIMAN R, 1989, J NEUROSCI, V9, P1579; Springer JE, 1997, J NEUROCHEM, V69, P1592, DOI 10.1046/j.1471-4159.1997.69041592.x; TAKANO E, 1989, BIOCHEM INT, V19, P633; TAKANO E, 1991, BIOMED BIOCHIM ACTA, V50, P517; Takano J, 2000, J BIOCHEM, V128, P83, DOI 10.1093/oxfordjournals.jbchem.a022733; TAKEUCHI KH, 1992, J NEUROCHEM, V58, P1526, DOI 10.1111/j.1471-4159.1992.tb11374.x; TAYLOR RG, 1991, BIOMED BIOCHIM ACTA, V50, P491; Thompson VF, 2000, ANAL BIOCHEM, V279, P170, DOI 10.1006/abio.1999.4475; van de Waterbeemd H, 1998, J DRUG TARGET, V6, P151, DOI 10.3109/10611869808997889; Vazquez J, 2003, HYPERTENSION, V41, P751, DOI 10.1161/01.HYP.0000047878.13793.41; Vives E, 1997, J BIOL CHEM, V272, P16010, DOI 10.1074/jbc.272.25.16010; Volbracht C, 2001, NEUROREPORT, V12, P3645, DOI 10.1097/00001756-200112040-00008; Wadia JS, 2004, NAT MED, V10, P310, DOI 10.1038/nm996; Wang KKW, 2000, TRENDS NEUROSCI, V23, P20, DOI 10.1016/S0166-2236(99)01479-4; WANG KKW, 1999, CALPAIN PHARM TOXICO, P77; Wu HY, 2003, NEUROSCI RES, V47, P131, DOI 10.1016/S0168-0102(03)00195-0; Xia HB, 2001, NAT BIOTECHNOL, V19, P640, DOI 10.1038/90242; Zhang SX, 2003, J NEUROTRAUM, V20, P59, DOI 10.1089/08977150360517182	81	22	22	0	2	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0014-4886	1090-2430		EXP NEUROL	Exp. Neurol.	JUL	2004	188	1					161	170		10.1016/j.expneurol.2004.03.018			10	Neurosciences	Neurosciences & Neurology	831DY	WOS:000222174700016	15191812				2021-06-18	
J	Wang, T; Wang, J; Cottrell, JE; Kass, IS				Wang, T; Wang, J; Cottrell, JE; Kass, IS			Small physiologic changes in calcium and magnesium alter excitability and burst firing of CA1 pyramidal cells in rat hippocampal slices	JOURNAL OF NEUROSURGICAL ANESTHESIOLOGY			English	Article						Ca; Mg; excitability; epilepsy; cerebrospinal fluid; hippocampal neurons	CLOSED-HEAD INJURY; EXTRACELLULAR POTASSIUM; CEREBRAL-ISCHEMIA; ANOXIC DAMAGE; BRAIN; SULFATE; NEURONS; INVITRO; POTENTIALS; EFFICACY	The effects of small physiologic changes in Ca and Mg concentrations on neuronal burst firing were examined. Intracellular electrophysiologic recordings were made from CA1 pyramidal neutrons in rat hippocampal slices. There was no difference in the resting potential or the input resistance of neurons bathed in the lower Ca-Mg artificial Cerebrospinal fluid (aCSF) (1.4 mM Ca; 1.3 mM Mg) compared with the higher Ca-Mg aCSF (2 mM Ca; 2 mM Mg). However, neurons in the lower Ca-Mg aCSF, but not the higher Ca-Mg aCSF, demonstrated depolarizing waves and bursts of action potentials; no single component of the aCSF accounted for this difference. Reducing the Ca from 2 to 1 mM in the higher Ca-Mg aCSF increased the mean frequency of action potentials from 28 to 171 Hz; the addition of 6-cyano-7-nitroquinoxaline-2,3-dione did not reduce the frequency. The threshold of potassium for inducing bursts was 5.25 with 1 mM Ca, 7.25 with 2 mM Ca, and 11.25 with 3 mM Ca. When Mg was reduced from 2 to 1 mM, the number of potassium-induced bursts increased to 190%; increasing Mg from 2 to 3 mM reduced the bursts to 58% (frequency with 2 mM Mg set to 100%). Small decreases in extracellular Ca and/or Mg led to increased excitability and burst firing, which may alter physiologic and pathophysiologic processes such as enhancing long-term potentiation, pain transmission, epileptogenesis, and neuronal damage and decreasing anesthetic potency. Increases in extracellular Ca and/or Mg Would have the opposite effect on these processes. These effects of extracellular divalent ions on burst firing may explain some of the pathophysiologic effects of hypocalcemia and hypomagnesemia.	SUNY, Dept Anesthesiol, Downstate Med Ctr, Brooklyn, NY 11203 USA; SUNY, Dept Physiol, Downstate Med Ctr, Brooklyn, NY 11203 USA; SUNY, Dept Pharmacol, Downstate Med Ctr, Brooklyn, NY 11203 USA; Xuzhou Med Coll, Dept Anesthesiol, Xuzhou, Jiangsu, Peoples R China	Kass, IS (corresponding author), SUNY, Dept Anesthesiol, Downstate Med Ctr, Box 6, Brooklyn, NY 11203 USA.	ikass@downstate.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [R01GM038866, R29GM038866] Funding Source: NIH RePORTER; NIGMS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [GM38866] Funding Source: Medline		ASTRUP J, 1981, ANESTHESIOLOGY, V55, P256, DOI 10.1097/00000542-198109000-00012; Banerjee S, 2003, MAGNESIUM RES, V16, P127; BENNINGER C, 1980, BRAIN RES, V187, P165, DOI 10.1016/0006-8993(80)90502-8; Brill S, 2002, BRIT J ANAESTH, V89, P711, DOI 10.1093/bja/aef266; Carrazza F R, 2000, J Pediatr (Rio J), V76, P310; CHURCH J, 1989, J PHYSIOL-LONDON, V415, P85, DOI 10.1113/jphysiol.1989.sp017713; Clark S, 1999, Adv Neurol, V79, P607; Feldman Z, 1996, J NEUROSURG, V85, P131, DOI 10.3171/jns.1996.85.1.0131; HALLAK M, 1992, AM J OBSTET GYNECOL, V167, P1605, DOI 10.1016/0002-9378(92)91749-Z; HANSEN AJ, 1985, PHYSIOL REV, V65, P101; Heath DL, 1998, J NEUROTRAUM, V15, P183, DOI 10.1089/neu.1998.15.183; Hille B., 1992, IONIC CHANNELS EXCIT, P445; Ip Patrick, 2003, Archives of Gynecology and Obstetrics, V268, P227, DOI 10.1007/s00404-002-0316-5; JENSEN MS, 1994, J NEUROPHYSIOL, V71, P831; Johnston D., 1984, ELECTROPHYSIOLOGY EP, P277; KANDEL ER, 1961, J NEUROPHYSIOL, V24, P243; KASS IS, 1988, ANESTHESIOLOGY, V69, P710, DOI 10.1097/00000542-198811000-00012; KASS IS, 1982, J PHYSIOL-LONDON, V332, P459, DOI 10.1113/jphysiol.1982.sp014424; KONNERTH A, 1986, J NEUROPHYSIOL, V56, P409; Lee MS, 2002, CLIN CHIM ACTA, V318, P121, DOI 10.1016/S0009-8981(01)00807-5; Marinov MB, 1996, J NEUROSURG, V85, P117, DOI 10.3171/jns.1996.85.1.0117; Mathern G.W., 1997, EPILEPSY COMPREHENSI, V1, P133; Miles AN, 2001, NEUROSURGERY, V49, P1443, DOI 10.1097/00006123-200112000-00025; MORRIS ME, 1991, J NEUROPHYSIOL, V65, P157; Muir KW, 1998, MAGNESIUM RES, V11, P43; POCKETT S, 1995, ANESTH ANALG, V80, P173, DOI 10.1097/00000539-199501000-00026; REINERT M, 2000, J NEUROSURG, V94, P1025; ROPER SN, 1992, ANN NEUROL, V31, P81, DOI 10.1002/ana.410310115; Saatman KE, 2001, J NEUROPATH EXP NEUR, V60, P183, DOI 10.1093/jnen/60.2.183; Santos AC, 2001, CLIN ANESTH, P1141; Sasaki R, 2002, ANESTHESIOLOGY, V96, P681, DOI 10.1097/00000542-200203000-00026; Singhi SC, 2003, J TROP PEDIATRICS, V49, P298, DOI 10.1093/tropej/49.5.298; SOMJEN GG, 1984, ELECTROPHYSIOLOGY EP, P304; Sood Arvind, 2003, Indian Journal of Pediatrics, V70, P221, DOI 10.1007/BF02725588; Suzuki M, 1997, GEN PHARMACOL, V28, P119, DOI 10.1016/S0306-3623(96)00148-6; TANCREDI V, 1988, NEUROSCI LETT, V89, P293, DOI 10.1016/0304-3940(88)90542-3; Tramer MR, 1996, ANESTHESIOLOGY, V84, P340, DOI 10.1097/00000542-199602000-00011; TRAYNELIS SF, 1988, J NEUROPHYSIOL, V59, P259; Wang T, 1997, Methods Mol Biol, V72, P1; WATKINS JC, 1981, ANNU REV PHARMACOL, V21, P165, DOI 10.1146/annurev.pa.21.040181.001121	40	22	23	0	5	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0898-4921	1537-1921		J NEUROSURG ANESTH	J. Neurosurg. Anesthesiol.	JUL	2004	16	3					201	209		10.1097/00008506-200407000-00004			9	Anesthesiology; Clinical Neurology; Surgery	Anesthesiology; Neurosciences & Neurology; Surgery	836BT	WOS:000222530800004	15211157				2021-06-18	
J	Griffin, JL; Anthony, DC; Campbell, SJ; Gauldie, J; Pitossi, F; Styles, P; Sibson, NR				Griffin, JL; Anthony, DC; Campbell, SJ; Gauldie, J; Pitossi, F; Styles, P; Sibson, NR			Study of cytokine induced neuropathology by high resolution proton NMR spectroscopy of rat urine	FEBS LETTERS			English	Article						multiple sclerosis; metabolomics; metabonomics; pattern recognition	BRAIN-BARRIER PERMEABILITY; CEREBRAL BLOOD-VOLUME; MULTIPLE-SCLEROSIS; PATTERN-RECOGNITION; MAGNETIC-RESONANCE; METABONOMICS; DISEASE; INJURY; ALPHA; PROGRESSION	Multiple sclerosis is a major cause of non-traumatic neurological disability. The identification of markers that differentiate disease progression is critical to effective therapy. A combination of NMR spectroscopic metabolic profiling of urine and statistical pattern recognition was used to detect focal inflammatory central nervous system (CNS) lesions induced by microinjection of a replication-deficient recombinant adenovirus expressing TNF-alpha or IL1-beta cDNA into the brains of Wistar rats. These animals were compared with a group of naive rats :and a group of animals injected with an equivalent null adenovirus. Urine samples were collected 7 days after adenovirus injection, when the inflammatory lesion is maximally active. Principal components analysis and Partial Least Squares-Discriminate analysis of the urine H-1 NMR spectra revealed significant differences between each of the cytokine adenovirus groups and the control groups; for the TNF-alpha group the main differences lay in citrate and succinate, while for the IL-1beta group the predominant changes occurred in leucine, isoleucine, valine and myoinositol. Thus, we can identify urinary metabolic vectors that not only separate rats with inflammatory lesions in the brain from control animals, but also distinguish between different types of CNS inflammatory lesions. (C) 2004 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.	Univ Cambridge, Dept Biochem, Cambridge CB2 1QW, England; Univ Southampton, Mol Neuropathol Lab, Southampton, Hants, England; McMaster Univ, Dept Pathol & Mol Med, Hamilton, ON, Canada; McMaster Univ, Ctr Gene Therapeut, Hamilton, ON, Canada; Fdn Leloir Inst, Buenos Aires, DF, Argentina; Univ Oxford, Dept Biochem, Oxford, England	Griffin, JL (corresponding author), Univ Cambridge, Dept Biochem, Tennis Court Rd, Cambridge CB2 1QW, England.	jlg40@mole.bio.cam.ac.uk	Anthony, Daniel C/F-7765-2010	Anthony, Daniel C/0000-0003-1380-6655; Pitossi, Fernando/0000-0001-5104-9726			Anthony DC, 1997, BRAIN, V120, P435, DOI 10.1093/brain/120.3.435; Anthony DC, 1998, J NEUROIMMUNOL, V87, P62, DOI 10.1016/S0165-5728(98)00046-0; Azmi J, 2002, ANALYST, V127, P271, DOI 10.1039/b109430k; Beckwith-Hall BM, 1998, CHEM RES TOXICOL, V11, P260, DOI 10.1021/tx9700679; Blamire AM, 2000, J NEUROSCI, V20, P8153; Brindle JT, 2002, NAT MED, V8, P1439, DOI 10.1038/nm802; Brindle JT, 2003, ANALYST, V128, P32, DOI 10.1039/b209155k; Campbell SJ, 2003, FASEB J, V17, P1168, DOI 10.1096/fj.02-0757fje; DIJKSTRA CD, 1985, IMMUNOLOGY, V54, P589; Eriksson L., 1999, INTRO MULTI MEGAVARI; Fan WMT, 1996, PROG NUCL MAG RES SP, V28, P161, DOI 10.1016/0079-6565(95)01017-3; Fiehn O, 2001, COMP FUNCT GENOM, V2, P155, DOI 10.1002/cfg.82; Griffin JL, 2002, ANALYST, V127, P582, DOI 10.1039/b201207c; Griffin JL, 2001, CHEM RES TOXICOL, V14, P1428, DOI 10.1021/tx015521u; Holmes E, 1998, CHEMOMETR INTELL LAB, V44, P245, DOI 10.1016/S0169-7439(98)00110-5; HSU SM, 1981, AM J CLIN PATHOL, V75, P816, DOI 10.1093/ajcp/75.6.816; Kolb M, 2001, J CLIN INVEST, V107, P1529, DOI 10.1172/JCI12568; Ledeen RW, 1998, NEUROCHEM RES, V23, P277, DOI 10.1023/A:1022493013904; Lindon JC, 2001, PROG NUCL MAG RES SP, V39, P1, DOI 10.1016/S0079-6565(00)00036-4; Lindon JC, 2003, TOXICOL APPL PHARM, V187, P137, DOI 10.1016/S0041-008X(02)00079-0; Mehta PD, 1998, MULT SCLER, V4, P254, DOI 10.1191/135245898678909411; Nicholson JK, 2002, NAT REV DRUG DISCOV, V1, P153, DOI 10.1038/nrd728; OLSSON T, 1995, NEUROLOGY, V45, pS11, DOI 10.1212/WNL.45.6_Suppl_6.S11; Rieckmann P, 2001, TRENDS NEUROSCI, V24, P548, DOI 10.1016/S0166-2236(00)01860-9; Schnell L, 1999, J NEUROPATH EXP NEUR, V58, P245, DOI 10.1097/00005072-199903000-00004; SHARIEF MK, 1991, NEW ENGL J MED, V325, P467, DOI 10.1056/NEJM199108153250704; Sibson NR, 2002, BRAIN, V125, P2446, DOI 10.1093/brain/awf256; Sorensen PS, 1999, MULT SCLER, V5, P287, DOI 10.1191/135245899678846230; 't Hart BA, 2003, J NEUROL SCI, V212, P21, DOI 10.1016/S0022-510X(03)00080-7; Trapp BD, 1999, J NEUROIMMUNOL, V98, P49, DOI 10.1016/S0165-5728(99)00081-8; Waters NJ, 2001, CHEM RES TOXICOL, V14, P1401, DOI 10.1021/tx010067f; Wilcockson DC, 2002, J CEREBR BLOOD F MET, V22, P318, DOI 10.1097/00004647-200203000-00009	32	22	22	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1873-3468			FEBS LETT	FEBS Lett.	JUN 18	2004	568	1-3					49	54		10.1016/j.febslet.2004.04.096			6	Biochemistry & Molecular Biology; Biophysics; Cell Biology	Biochemistry & Molecular Biology; Biophysics; Cell Biology	831OX	WOS:000222205200011	15196919	Bronze			2021-06-18	
J	Pugliesi, DMC; Cunha, RF; Delbem, ACB; Sundefeld, MLMM				Pugliesi, DMC; Cunha, RF; Delbem, ACB; Sundefeld, MLMM			Influence of the type of dental trauma on the pulp vitality and the time elapsed until treatment: a study in patients aged 0-3 years	DENTAL TRAUMATOLOGY			English	Article						dental trauma; primary teeth; dental luxation; crown fracture	PERMANENT SUCCESSORS; PARENTAL AWARENESS; PRIMARY DENTITION; PRIMARY INCISORS; TEETH; MANAGEMENT; CHILDREN; SEQUELAE	The purpose of the present study was to determine the influence of the type of trauma on the pulp vitality and the time elapsed until seeking dental care in children aged 0-3 years seen at the Baby Clinic of the Aracatuba Dental School, UNESP. A total of 1813 records were analyzed. Two hundred and three patients, corresponding to 302 traumatized teeth, were assessed clinically and radiographically. Hard-tissue injuries were the most frequent (52%), with a predominance of enamel crown fractures (41.4%), followed by concussions (12.6%) and intrusions (11.6%). Clinical and radiographic examination revealed that 72% of the traumatized teeth maintained pulp vitality. In the case of supporting-tissue lesions, 51.1% of the patients sought care within 1-15 days after injury, while in the case of hard-tissue injuries, 52.7% sought care only after 16 days. The results showed that supporting-tissue injuries had a significant influence on the faster seeking of dental care.	UNESP, Sch Dent, Dept Pediat Dent, BR-16015050 Aracatuba, SP, Brazil; UNESP, Sch Dent, Extens Course Pediat Dent, BR-16015050 Aracatuba, SP, Brazil	Cunha, RF (corresponding author), UNESP, Sch Dent, Dept Pediat Dent, Rua Jose Bonifacio 1193, BR-16015050 Aracatuba, SP, Brazil.	cunha@foa.unesp.br	Delbem, Alberto C B/E-8621-2012; Cunha, Robson/E-9650-2014; Delbem, Alberto/P-4011-2019	Delbem, Alberto C B/0000-0002-8159-4853; Cunha, Robson/0000-0002-0849-3247; Delbem, Alberto/0000-0002-8159-4853			ANDREASEN J O, 1985, Endodontics and Dental Traumatology, V1, P45; Andreasen J O, 1972, Int J Oral Surg, V1, P235, DOI 10.1016/S0300-9785(72)80042-5; Ben Bassat Y, 1985, Pediatr Dent, V7, P37; BENBASSAT Y, 1989, J DENT CHILD, V56, P112; BENNETT DT, 1964, BRIT DENT J, V116, P52; Borum MK, 1998, ENDOD DENT TRAUMATOL, V14, P31; Cardoso M, 2002, DENT TRAUMATOL, V18, P129, DOI 10.1034/j.1600-9657.2002.00030.x; Cunha R F, 2001, J Clin Pediatr Dent, V25, P199; Cunha RF, 2000, J DENT CHILD, V67, P89; Cunha RF, 2001, DENT TRAUMATOL, V17, P210; Dale RA, 2000, EMERG MED CLIN N AM, V18, P521, DOI 10.1016/S0733-8627(05)70141-3; FRIED I, 1995, J DENT CHILD, V62, P256; Fried Irwin, 1996, Pediatric Dentistry, V18, P145; GARCIA-GODOY F, 1987, Endodontics and Dental Traumatology, V3, P126; GARCIAGODOY F, 1989, ENDOD DENT TRAUMATOL, V5, P180; HOLAN G, 1992, ENDOD DENT TRAUMATOL, V8, P12; Holan Gideon, 1999, Pediatric Dentistry, V21, P242; JOHO JP, 1980, J DENT CHILD, V47, P167; Kahabuka FK, 2001, DENT TRAUMATOL, V17, P109, DOI 10.1034/j.1600-9657.2001.017003109.x; Mackie I C, 1996, Dent Update, V23, P69; ONETTO JE, 1994, ENDOD DENT TRAUMATOL, V10, P223; Osuji O O, 1996, Int Dent J, V46, P165; RAPHAEL SL, 1990, AUST DENT J, V35, P130, DOI 10.1111/j.1834-7819.1990.tb05878.x; Sae-Lim V, 2001, DENT TRAUMATOL, V17, P71, DOI 10.1034/j.1600-9657.2001.017002071.x; Sae-Lim V, 1999, ENDOD DENT TRAUMATOL, V15, P37; Soporowski Nancy Jo, 1994, Pediatric Dentistry, V16, P96; Tahmassebi J F, 1999, Dent Update, V26, P138; Wilson C F, 1995, Dent Clin North Am, V39, P133	28	22	24	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1600-4469	1600-9657		DENT TRAUMATOL	Dent. Traumatol.	JUN	2004	20	3					139	142		10.1111/j.1600-4469.2004.00242.x			4	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	821CF	WOS:000221436600003	15144444				2021-06-18	
J	Moorthy, RK; Rajshekhar, V				Moorthy, RK; Rajshekhar, V			Development of glioblastoma multiforme following traumatic cerebral contusion: Case report and review of literature	SURGICAL NEUROLOGY			English	Article						computed tomography; head injury; brain tumor; diagnosis	POSTTRAUMATIC MALIGNANT GLIOMA; BRAIN-TUMORS; HEAD TRAUMA; INJURY; PROLIFERATION; RAT	BACKGROUND Diagnostic criteria for posttraumatic brain tumors were formulated in the pre-CT (computerized tomography) era. We propose that radiologic criteria incorporating imaging data be added to the existing criteria. CASE DESCRIPTION We report a case of a 56-year-old man who presented with history of raised intracranial pressure of 20 days' duration. Imaging showed a large left frontal intra-axial mass lesion. He had history of head injury 5 years prior with CT evidence of bilateral basifrontal contusions. There was no contrast enhancement at the site of the contusions in an intervening CT scan done 18 months after the trauma. He underwent radical excision of the mass, and the histopathology was reported as glioblastoma multiforme. We formulated additional radiologic criteria for tumors that may present following trauma. A review of the literature of posttraumatic gliomas is also presented. CONCLUSION Fulfillment of the additional radiologic criteria proposed by us will help distinguish a tumor that developed following trauma from that which was present before the occurrence of the injury. (C) 2004 Elsevier Inc. All rights reserved.	Christian Med Coll & Hosp, Dept Neurol Sci, Vellore 632004, Tamil Nadu, India	Rajshekhar, V (corresponding author), Christian Med Coll & Hosp, Dept Neurol Sci, Vellore 632004, Tamil Nadu, India.						ANNEGERS JF, 1979, NEUROSURGERY, V4, P203, DOI 10.1227/00006123-197903000-00001; BOHNEN NI, 1997, HAND CLINIC, V67, P129; DIEZEL P, 1949, Frankf Z Pathol, V60, P316; DiTrapani G, 1996, ITAL J NEUROL SCI, V17, P283, DOI 10.1007/BF01997787; FINKEMEYER H, 1956, Zentralbl Neurochir, V16, P318; Henderson RD, 2000, J CLIN NEUROSCI, V7, P262, DOI 10.1054/jocn.1999.0204; Henry PT, 2000, BRIT J NEUROSURG, V14, P64; HEYCK H, MONATS SCHR PSYCHIAT, V128, P180; Hill-Felberg SJ, 1999, J NEUROSCI RES, V57, P271, DOI 10.1002/(SICI)1097-4547(19990715)57:2<271::AID-JNR13>3.0.CO;2-Z; HOCHBERG F, 1984, NEUROLOGY, V34, P1511, DOI 10.1212/WNL.34.11.1511; JANDA J, 1987, Zentralblatt fuer Allgemeine Pathologie und Pathologische Anatomie, V133, P55; Kernie SG, 2001, J NEUROSCI RES, V66, P317, DOI 10.1002/jnr.10013; LUDWIN SK, 1984, NATURE, V308, P274, DOI 10.1038/308274a0; Manuelidis EE, 1978, PATHOLOGY NERVOUS SY, V2, P2237; MORANTZ RA, 1978, NEUROSURGERY, V3, P181, DOI 10.1227/00006123-197809000-00009; Nygren C, 2001, CANCER CAUSE CONTROL, V12, P733, DOI 10.1023/A:1011227617256; PEREZDIAZ C, 1985, SURG NEUROL, V24, P581, DOI 10.1016/0090-3019(85)90278-2; Sabel M, 1999, J NEUROSURG, V91, P1041, DOI 10.3171/jns.1999.91.6.1041; SCHIFFER D, 1993, INT J DEV NEUROSCI, V11, P269, DOI 10.1016/0736-5748(93)90085-R; TROOST D, 1984, CLIN NEUROPATHOL, V3, P139; WINGREN JE, 1948, NORD MED, V37, P163; Wrensch M, 2000, NEUROEPIDEMIOLOGY, V19, P234, DOI 10.1159/000026261; ZULCH KJ, 1974, HDB CLIN NEUROLOGY, V16, P1	23	22	27	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0090-3019			SURG NEUROL	Surg. Neurol.	FEB	2004	61	2					180	184		10.1016/S0090-3019(03)00423-3			5	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	767WZ	WOS:000188498000016	14751638				2021-06-18	
J	Strens, LHA; Mazibrada, G; Duncan, JS; Greenwood, R				Strens, LHA; Mazibrada, G; Duncan, JS; Greenwood, R			Misdiagnosing the vegetative state after severe brain injury: the influence of medication	BRAIN INJURY			English	Article							INTRATHECAL BACLOFEN INFUSION; SEVERE HEAD-INJURY; SPASTICITY; DIAGNOSIS; LIFE	Patients who suffer severe brain damage may be left unaware of self and of the environment and in a permanent vegetative state (PVS). The difficulties in correctly ascertaining unawareness after brain injury have been emphasized by a number of authors. It is well recognized that toxic-metabolic and drug-induced cerebral depression occurs acutely after brain injury. However, less attention has been drawn to the effects of medication months after brain injury and the way in which medication may confound assessment of awareness and, thus, the reliable assessment of long-term prognosis. This paper describes two patients who sustained a severe and well-documented structural brain injury, one hypoxic and one traumatic. Both were unaware when first seen at 3 months post-injury, but both have made useful functional recovery. The paper discusses their progress and how the early prescription of large doses of anti-epileptic drugs, sedatives and anti-spastic agents in these circumstances may result in an initial misdiagnosis of the vegetative state.	Inst Neurol, Sobell Dept Motor Neurosci & Movement Disorders, London WC1N 3BG, England; Inst Neurol, Dept Clin & Expt Epilepsy, London WC1N 3BG, England; UCL Natl Hosp Neurol & Neurosurg, London WC1N 3BG, England	Strens, LHA (corresponding author), Inst Neurol, Sobell Dept Motor Neurosci, 2nd Floor 8-11 Queen Sq, London WC1N 3BG, England.	l.strens@ion.ucl.ac.uk		Duncan, John S/0000-0002-1373-0681	Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [G9805989] Funding Source: Medline		Andrews K, 1996, BRIT MED J, V313, P13, DOI 10.1136/bmj.313.7048.13; ANDREWS K, 1993, BRIT MED J, V306, P1597, DOI 10.1136/bmj.306.6892.1597; ASHWAL S, 1994, NEW ENGL J MED, V330, P1499; ASHWAL S, 1994, NEW ENGL J MED, V330, P1572; AUER RN, 2002, GREENFIELDS NEUROPAT, V2, P823; Bates David, 2001, Journal of Neurology Neurosurgery and Psychiatry, V71, pi20; Becker R, 1997, J NEUROL, V244, P160, DOI 10.1007/s004150050067; Bernat JL, 2002, NEUROLOGY, V58, P337, DOI 10.1212/WNL.58.3.337; Black D, 1996, J ROY COLL PHYS LOND, V30, P119; CHILDS NL, 1993, NEUROLOGY, V43, P1465, DOI 10.1212/WNL.43.8.1465; COFFEY RJ, 1993, J NEUROSURG, V78, P226, DOI 10.3171/jns.1993.78.2.0226; Dario A, 2002, ACTA NEUROL SCAND, V105, P83, DOI 10.1034/j.1600-0404.2002.1o042.x; Giacino JT, 2002, NEUROLOGY, V58, P349, DOI 10.1212/WNL.58.3.349; GRAHAM DI, 2002, GREENFIELDS NEUROPAT, V2, P233; Heindl UT, 1996, NEUROPEDIATRICS, V27, P94, DOI 10.1055/s-2007-973756; Korenkov AI, 2002, NEUROSURG REV, V25, P228, DOI 10.1007/s10143-002-0221-1; Lazorthes Y, 1998, NEUROCHIRURGIE, V44, P201; LEVY DE, 1985, JAMA-J AM MED ASSOC, V253, P1420, DOI 10.1001/jama.253.10.1420; McMillan TM, 1997, BRAIN INJURY, V11, P483, DOI 10.1080/713802184; SAZBON L, 1993, J NEUROL NEUROSUR PS, V56, P407, DOI 10.1136/jnnp.56.4.407; Shiel A, 1998, BRAIN INJURY, V12, P809, DOI 10.1080/026990598122043; VanCott AC, 1996, EPILEPSIA, V37, P868; Wade DT, 1999, BMJ-BRIT MED J, V319, P841, DOI 10.1136/bmj.319.7213.841	23	22	22	0	3	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	FEB	2004	18	2					213	218		10.1080/0269905031000149533			6	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	751DR	WOS:000187038000009	14660232				2021-06-18	
J	Borgaro, SR; Prigatano, GP; Kwasnica, C; Alcott, S; Cutter, N				Borgaro, SR; Prigatano, GP; Kwasnica, C; Alcott, S; Cutter, N			Disturbances in affective communication following brain injury	BRAIN INJURY			English	Article							HIGHER CEREBRAL FUNCTIONS; BLUNT HEAD-INJURY; RELATIVES VIEW; BNI SCREEN	Primary objective: Disturbances in affect expression and perception are often clinically observed in brain injured patients during the acute stages of recovery. This study examined whether such disturbances are related to the acute nature of the injury or specific type of injury in patients with stroke (CVA) versus traumatic brain injury (TBI). Research design : Retrospective cohort of patients seen for inpatient rehabilitation following brain injury. Procedures : Participants were 27 CVA and 27 TBI patients. Their performance was compared to 27 normal controls on the BNI Screen for Higher Cerebral Functions. Outcomes and results : While both patient groups performed significantly worse than the control group on affect expression, perception and spontaneity ( p <0.01), the CVA group performed significantly worse than the TBI group ( p <0.01) on affect perception. Results of this study document disturbances in affect in brain injured patients and highlight the importance of assessing affect during early recovery.	St Joseph Hosp & Med Ctr, Barrow Neurol Inst, Dept Clin Neuropsychol, Div Neurol,Sect Neuropsychol, Phoenix, AZ 85013 USA	Borgaro, SR (corresponding author), St Joseph Hosp & Med Ctr, Barrow Neurol Inst, Dept Clin Neuropsychol, Div Neurol,Sect Neuropsychol, 350 W Thomas Rd, Phoenix, AZ 85013 USA.						BORGARO S, 2002, BNI Q, V17, P14; Borgaro SR, 2002, J HEAD TRAUMA REHAB, V17, P526, DOI 10.1097/00001199-200212000-00004; BOROD J, 1987, J NEUROL NEUROSUR PS, V51, P826; BOROD JC, 1992, J CONSULT CLIN PSYCH, V60, P339, DOI 10.1037/0022-006X.60.3.339; BROOKS DN, 1983, J NEUROL NEUROSUR PS, V46, P336, DOI 10.1136/jnnp.46.4.336; BROOKS N, 1986, J NEUROL NEUROSUR PS, V49, P764, DOI 10.1136/jnnp.49.7.764; GAINOTTI G, 1993, NEUROPSYCHOL REHABIL, V3, P259, DOI 10.1080/09602019308401440; JENNETT B, 1974, MANAGEMENT HEAD INJU; PRIGATANO G, 1996, NEUROPSYCHOLOGICAL R; Prigatano G. P., 1995, BNI Q, V9, P2; Prigatano GP, 1999, ARCH PHYS MED REHAB, V80, P77, DOI 10.1016/S0003-9993(99)90311-8; Prigatano GP., 1999, PRINCIPLES NEUROPSYC; Rosenstein LD, 1997, NEUROPSY NEUROPSY BE, V10, P113; TOMPKINS C, 1995, RIGHT HEMIPSHERE COM; ZIGLER L, 1996, BNI Q, V16, P32	15	22	22	0	3	TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.	JAN	2004	18	1					33	39		10.1080/0269905031000110562			7	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	749PB	WOS:000186928200002	14660234				2021-06-18	
J	Bamdad, MJ; Ryan, LM; Warden, DL				Bamdad, MJ; Ryan, LM; Warden, DL			Functional assessment of executive abilities following traumatic brain injury	BRAIN INJURY			English	Article							LESIONS	Primary objective: The Test of Functional Executive Abilities (TOFEA) is a measure of real-world planning/problem-solving abilities. The present study sought to identify the relationship between the TOFEA and traditional executive measures. Design: Correlational and principal components factor analyses were conducted using the TOFEA and traditional neuropsychological executive measures. Methods: Participants were 340 patients with traumatic brain injury. All participants underwent neuropsychological and speech-language assessments. Results: Factor analysis of the TOFEA yielded a two-factor solution, planning/initiation and awareness/ comprehension. Correlational analysis between the TOFEA and traditional measures demonstrated only a weak relationship. Factor analysis indicated a four factor executive solution with the TOFEA loading on the third planning/initiation and reasoning factor. Conclusions: The data support the notion that there is no one single measure of frontal-executive functioning, but rather these tests represent different executive components and, as such, more than one measure should be used in a comprehensive assessment.	George Washington Univ, Dept Speech & Hearing Sci, Washington, DC 20052 USA; Uniformed Serv Univ Hlth Sci, Def & Vet Head Injury Program, Washington, DC USA	Bamdad, MJ (corresponding author), George Washington Univ, Dept Speech & Hearing Sci, 2201 G St NW,Funger Hall,Suite 423, Washington, DC 20052 USA.						Benton AL, 1978, MULTILINGUAL APHASIA; Boone KB, 1998, ARCH CLIN NEUROPSYCH, V13, P585, DOI 10.1016/S0887-6177(97)00074-7; BOYD TM, 1993, APPL COGNITIVE PSYCH, V7, P171, DOI 10.1002/acp.2350070208; Bush BA, 1999, ARCH CLIN NEUROPSYCH, V14, P783; DELIS D, 1987, CALIFORNIA VERBAL LE; GOLDEN CJ, 1978, COLOUR WORD TEST MAN; Heaton R., 1993, WISCONSIN CARD SORTI; LEVIN H, 1994, J NEUROPSYCH CLIN N, V6, P443; LEZAK MD, 1995, NEUROPSYCHOLOGICAL A; Malloy P.F., 1998, SEMIN CLIN NEUROPSYC, V3, P186; MEGA MS, 1994, J NEUROPSYCH CLIN N, V6, P358; PERRET E, 1974, NEUROPSYCHOLOGIA, V12, P605; ROBINSON AL, 1980, J CONSULT CLIN PSYCH, V48, P605, DOI 10.1037/0022-006X.48.5.605; ROSS DT, 1994, EXP NEUROL, V126, P291, DOI 10.1006/exnr.1994.1067; Ross J. D., 1976, ROSS TEST HIGHER COG; SHORES A, 1990, AUST NZ J PSYCHIAT, V24, P133, DOI 10.3109/00048679009062895; Sohlberg M. M., 1989, INTRO COGNITIVE REHA; Spikman JM, 2000, J CLIN EXP NEUROPSYC, V22, P325, DOI 10.1076/1380-3395(200006)22:3;1-V;FT325; Wechsler D, 2008, WECHSLER ADULT INTEL, V4th; Wolfson D., 1993, HALSTEAD REITAN NEUR	20	22	23	0	3	TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.	DEC	2003	17	12					1011	1020		10.1080/0269905031000110553			10	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	731WR	WOS:000185909900001	14555361				2021-06-18	
J	Fujita, Y; Yamamoto, N; Sobue, K; Inagaki, M; Ito, H; Arima, H; Morishima, T; Takeuchi, A; Tsuda, T; Katsuya, H; Asai, K				Fujita, Y; Yamamoto, N; Sobue, K; Inagaki, M; Ito, H; Arima, H; Morishima, T; Takeuchi, A; Tsuda, T; Katsuya, H; Asai, K			Effect of mild hypothermia on the expression of aquaporin family in cultured rat astrocytes under hypoxic condition	NEUROSCIENCE RESEARCH			English	Article						astrocytes; aquaporins; hypothermia; hypoxia; normothermia; normoxia	TRAUMATIC BRAIN-INJURY; EDEMA; ACTIVATION; RELEASE; STRESS; KINASE	Aquaporins (AQPs) are a family of water-selective transporting proteins with homology to the major intrinsic protein (MIP) of lens, that increase plasma membrane water permeability in secretory and absorptive cells. In this study, we investigated the effect of mild hypothermia on the expression of AQP4, AQP5 and AQP9 in rat astrocytes cultured under hypoxic conditions. At 37degreesC, a marked decrease in the expression of AQP4, AQP5 and AQP9 mRNAs was observed. However, at 32degreesC (mild hypothermia), the expression of AQP5 mRNA was restored to its basal level. Interestingly, under mild hypothermia AQP4 mRNA expression transiently decreased and then increased about two-fold; while AQP9 mRNA expression decreased the same as at 37degreesC. The changes in the expression of AQP4 and AQP9 proteins were confirmed by Western blot analysis. The restoration of the AQP4 and AQP5 expression at 32degreesC from the hypoxia-induced decrease at 37degreesC may play an important role in the reduction of brain edema under hypothermic conditions. (C) 2003 Elsevier Ireland Ltd and The Japan Neuroscience Society. All rights reserved.	Nagoya City Univ, Grad Sch Med Sci, Dept Anesthesiol & Med Crisis Management, Mizuho Ku, Nagoya, Aichi 4678901, Japan; Nagoya City Univ, Grad Sch Med Sci, Dept Mol Neurobiol, Mizuho Ku, Nagoya, Aichi 4678601, Japan	Sobue, K (corresponding author), Nagoya City Univ, Grad Sch Med Sci, Dept Anesthesiol & Med Crisis Management, Mizuho Ku, Nagoya, Aichi 4678901, Japan.	kazsobue@med.nagoya-cu.ac.jp	Inagaki, Masatoshi/J-3438-2019; Asai, Kiyofumi/H-2356-2014	Inagaki, Masatoshi/0000-0002-9822-8649; Asai, Kiyofumi/0000-0001-7015-2251	Grants-in-Aid for Scientific ResearchMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI) [15591652] Funding Source: KAKEN		Badaut J, 2001, J CEREBR BLOOD F MET, V21, P477, DOI 10.1097/00004647-200105000-00001; BUSTO R, 1989, STROKE, V20, P904, DOI 10.1161/01.STR.20.7.904; D'Arceuil H, 2000, STROKE, V31, P2692, DOI 10.1161/01.STR.31.11.2692; Echevarria M, 1998, J PHYSIOL BIOCHEM, V54, P107; Hicks SD, 2000, NEUROSCIENCE, V98, P677, DOI 10.1016/S0306-4522(00)00169-X; Kataoka H, 1998, LIFE SCI, V63, P553, DOI 10.1016/S0024-3205(98)00306-3; KATO T, 1979, BIOCHIM BIOPHYS ACTA, V579, P216, DOI 10.1016/0005-2795(79)90100-4; Kawai N, 2001, BRAIN RES, V895, P50, DOI 10.1016/S0006-8993(01)02026-1; Ke CS, 2001, NEUROSCI LETT, V301, P21, DOI 10.1016/S0304-3940(01)01589-0; Kiening KL, 2002, NEUROSCI LETT, V324, P105, DOI 10.1016/S0304-3940(02)00180-5; Manley GT, 2000, NAT MED, V6, P159, DOI 10.1038/72256; Marion DW, 1997, NEW ENGL J MED, V336, P540, DOI 10.1056/NEJM199702203360803; Nakashima K, 1996, STROKE, V27, P913, DOI 10.1161/01.STR.27.5.913; Plesnila N, 1999, ACTA NEUROCHIR SUPPL, V73, P63; Roberts JR, 2002, CRYOBIOLOGY, V44, P161, DOI 10.1016/S0011-2240(02)00018-4; Vizuete ML, 1999, NEUROBIOL DIS, V6, P245, DOI 10.1006/nbdi.1999.0246; Yager JY, 1996, STROKE, V27, P919, DOI 10.1161/01.STR.27.5.919; Yamamoto N, 2001, MOL BRAIN RES, V90, P26, DOI 10.1016/S0169-328X(01)00064-X	18	22	35	1	3	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0168-0102	1872-8111		NEUROSCI RES	Neurosci. Res.	DEC	2003	47	4					437	444		10.1016/j.neures.2003.08.006			8	Neurosciences	Neurosciences & Neurology	750EB	WOS:000186977400009	14630348				2021-06-18	
J	Mino, M; Kamii, H; Fujimura, M; Kondo, T; Takasawa, S; Okamoto, H; Yoshimoto, T				Mino, M; Kamii, H; Fujimura, M; Kondo, T; Takasawa, S; Okamoto, H; Yoshimoto, T			Temporal changes of neurogenesis in the mouse hippocampus after experimental subarachnoid hemorrhage	NEUROLOGICAL RESEARCH			English	Article						subarachnoid hemorrhage; hippocampus; dentate gyrus; neurogenesis; progenitor cells; mice	NEURAL STEM-CELLS; TRAUMATIC BRAIN INJURY; FOCAL CEREBRAL-ISCHEMIA; CUZN-SUPEROXIDE DISMUTASE; CENTRAL-NERVOUS-SYSTEM; GROWTH-FACTOR; PROGENITOR CELLS; DENTATE GYRUS; ADULT-RAT; SUBVENTRICULAR ZONE	Recent studies indicate the existence of progenitor cells and their potential for neurogenesis in the subventricular zone (SVZ) and the hippocampus dentate gyrus (DG) of normal adult mammalian brain. Increased neurogenesis has been shown following cerebral ischemia and traumatic brain injury, however, the involvement of neurogenesis in subarachnoid hemorrhage (SAH) has not been examined. Adult male CD-I mice were subjected to SAH by endovascular perforation of the left anterior cerebral artery. Mice received intraperitoneal injections of the cell proliferation-specific marker 5'-bromodeoxyuridine (BrdU) after SAH induction. BrdU incorporation was examined from 1 to 30 days after SAH by immunohistochemistry. The BrdU-positive cells were detected in SVZ and DC of normal control brain, and were significantly decreased in both areas three days after SAH. The number of these cells had recovered to its control level seven days after SAH. Double staining with BrdU and NeuN indicated that the majority of the BrdU-positive cells migrating into the granular cell layer of the DG became NeuN-positive 30 days after SAH. In conclusion, temporal changes of the neurogenesis as shown in the present study suggest that neurogenesis in the hippocampus may affect functional outcome after SAH. The induction of the neurogenesis can provide therapeutic value against SAH.	Tohoku Univ, Grad Sch Med, Dept Neurosurg, Aoba Ku, Sendai, Miyagi 9808574, Japan; Tohoku Univ, Grad Sch Med, Dept Biochem, Aoba Ku, Sendai, Miyagi 9808574, Japan	Fujimura, M (corresponding author), Tohoku Univ, Grad Sch Med, Dept Neurosurg, Aoba Ku, 1-1 Seiryo Machi, Sendai, Miyagi 9808574, Japan.						Alonso G, 2000, GLIA, V31, P219, DOI 10.1002/1098-1136(200009)31:3<219::AID-GLIA30>3.0.CO;2-R; Chirumamilla S, 2002, J NEUROTRAUM, V19, P693, DOI 10.1089/08977150260139084; Dash PK, 2001, J NEUROSCI RES, V63, P313, DOI 10.1002/1097-4547(20010215)63:4<313::AID-JNR1025>3.0.CO;2-4; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; GERMANO AF, 1994, J NEUROTRAUM, V11, P345, DOI 10.1089/neu.1994.11.345; Gould E, 1999, NAT NEUROSCI, V2, P260, DOI 10.1038/6365; Gritti A, 2002, J NEUROSCI, V22, P437, DOI 10.1523/JNEUROSCI.22-02-00437.2002; Iwai M, 2002, J CEREBR BLOOD F MET, V22, P411, DOI 10.1097/00004647-200204000-00005; Iwai M, 2001, BRAIN RES, V902, P288, DOI 10.1016/S0006-8993(01)02399-X; Jin KL, 2002, P NATL ACAD SCI USA, V99, P11946, DOI 10.1073/pnas.182296499; Jin KL, 2001, P NATL ACAD SCI USA, V98, P4710, DOI 10.1073/pnas.081011098; Johansson CB, 1999, CELL, V96, P25, DOI 10.1016/S0092-8674(00)80956-3; Kamii H, 1999, STROKE, V30, P867, DOI 10.1161/01.STR.30.4.867; KAMII H, 1995, CENTRAL NERVOUS SYST, P139; Kempermann G, 1997, NATURE, V386, P493, DOI 10.1038/386493a0; Kernie SG, 2001, J NEUROSCI RES, V66, P317, DOI 10.1002/jnr.10013; Kuhn HG, 1997, J NEUROSCI, V17, P5820; Leventhal C, 1999, MOL CELL NEUROSCI, V13, P450, DOI 10.1006/mcne.1999.0762; Lichtenwalner RJ, 2001, NEUROSCIENCE, V107, P603, DOI 10.1016/S0306-4522(01)00378-5; Liu JL, 1998, J NEUROSCI, V18, P7768; Louissaint A, 2002, NEURON, V34, P945, DOI 10.1016/S0896-6273(02)00722-5; Matz PG, 2001, STROKE, V32, P506, DOI 10.1161/01.STR.32.2.506; Matz PG, 2000, BRAIN RES, V858, P312, DOI 10.1016/S0006-8993(99)02454-3; Monje ML, 2002, NAT MED, V8, P955, DOI 10.1038/nm749; Nakamura K, 2000, JPN J APPL ENTOMOL Z, V44, P27, DOI 10.1303/jjaez.2000.27; Nau R, 2002, BRAIN PATHOL, V12, P329; Palmer TD, 2000, J COMP NEUROL, V425, P479, DOI 10.1002/1096-9861(20001002)425:4<479::AID-CNE2>3.0.CO;2-3; Philips MF, 2001, J NEUROSURG, V94, P765, DOI 10.3171/jns.2001.94.5.0765; Riess P, 2002, NEUROSURGERY, V51, P1043, DOI 10.1097/00006123-200210000-00035; Saito A, 2001, STROKE, V32, P1652, DOI 10.1161/01.STR.32.7.1652; Sato K, 2001, BRAIN RES, V922, P135, DOI 10.1016/S0006-8993(01)03137-7; Shors TJ, 2001, NATURE, V410, P372, DOI 10.1038/35066584; Takagi Y, 1999, BRAIN RES, V831, P283, DOI 10.1016/S0006-8993(99)01411-0; Takasawa K, 2002, J CEREBR BLOOD F MET, V22, P299, DOI 10.1097/00004647-200203000-00007; Toda H, 2001, NEUROSCI LETT, V316, P9, DOI 10.1016/S0304-3940(01)02331-X; Vallieres L, 2002, J NEUROSCI, V22, P486, DOI 10.1523/JNEUROSCI.22-02-00486.2002; Yagita Y, 2001, STROKE, V32, P1890, DOI 10.1161/01.STR.32.8.1890; Yoshimura S, 2001, P NATL ACAD SCI USA, V98, P5874, DOI 10.1073/pnas.101034998; Zhang RL, 2001, NEUROSCIENCE, V105, P33, DOI 10.1016/S0306-4522(01)00117-8	39	22	25	0	2	FOREFRONT PUBL GROUP	WILTON	C/O MARY J RAWLINS, 5 RIVER RD, STE 113, WILTON, CT 06897 USA	0161-6412			NEUROL RES	Neurol. Res.	DEC	2003	25	8					839	845		10.1179/016164103771953934			7	Clinical Neurology; Neurosciences	Neurosciences & Neurology	756LW	WOS:000187467500010	14669527				2021-06-18	
J	Quemada, JI; Cespedes, JMM; Ezkerra, J; Ballesteros, JM; Ibarra, N; Urruticoechbea, I				Quemada, JI; Cespedes, JMM; Ezkerra, J; Ballesteros, JM; Ibarra, N; Urruticoechbea, I			Outcome of memory rehabilitation in traumatic brain injury assessed by neuropsychological tests and questionnaires	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						activities of daily living; ecological validity; memory rehabilitation; neuropsychological assessment; tests; traumatic brain injury	EVERYDAY MEMORY; HEAD-INJURY; COGNITIVE REHABILITATION; INDIVIDUALS; PERFORMANCE; COMMUNITY; DEFICITS; LIFE; AID	Objectives: To evaluate the effectiveness of a memory rehabilitation program. To compare different outcome measures. Participants: Twelve patients with severe traumatic brain injury. Setting: Outpatient rehabilitation service. Main outcome measures: Rey-Osterrieth Complex Figure Test (REY), California Verbal Learning Test (CVLT), Rivermead Behavioural Memory Test (RBMT), and the Memory Failures in Everyday Memory Questionnaire (MFE). Statistical analysis: Exact nonparametric procedures. Results: All patients achieved meaningful functional gains. Modest improvements were found in some of the scales of the CVLT but not in the REY, RBMT, or MFE. Conclusion: Functional gains did not correlate with improvement in memory processes. Measurement of changes in independence in activities of daily living mediated by compensatory aids and educational intervention plans with relatives are proposed.	Hosp Aita Menni, Serv Dano Cerebral, Bilbao, Spain; Univ Complutense, Hosp Beata Maria Ana, Fac Psicol, Unidad Dano Cerebral, E-28040 Madrid, Spain; Inst Invest Psiquiatr, Bilbao, Spain	Quemada, JI (corresponding author), Serv Dano Cerebral, C-Egana 10, Bilbao 48010, Spain.		Ballesteros, Javier/O-8267-2015	Ballesteros, Javier/0000-0002-6713-1916			Alejandre, 1998, TAVEC TEST APRENDIZA; ALLEN C C, 1990, Brain Injury, V4, P7, DOI 10.3109/02699059009026143; BADDELEY A, 1987, NEUROBEHAVIORAL RECO; BERG IJ, 1991, NEUROPSYCHOL REHABIL, V1, P87; BOAKE C, 1995, BRAIN INJURY, V9, P273, DOI 10.3109/02699059509008198; BROWN FH, 1991, J CLIN PSYCHOL, V47, P772, DOI 10.1002/1097-4679(199111)47:6<772::AID-JCLP2270470607>3.0.CO;2-P; Brown M, 1998, J HEAD TRAUMA REHAB, V13, P1, DOI 10.1097/00001199-199808000-00002; Carney N, 1999, J HEAD TRAUMA REHAB, V14, P277, DOI 10.1097/00001199-199906000-00008; CESPEDES JMM, 1999, ANSIEDAD ESTRES, V5, P313; Cicerone KD, 2000, ARCH PHYS MED REHAB, V81, P1596, DOI 10.1053/apmr.2000.19240; Cohen J., 1997, STAT POWER ANAL BEHA; DELIS D, 1987, CALIFORNIA VERBAL LE; DIXON RA, 1999, COGNITIVE NEUROREHAB; Dunlap WP, 1996, PSYCHOL METHODS, V1, P170, DOI 10.1037/1082-989X.1.2.170; Evans JJ, 2000, NEUROPSYCHOL REHABIL, V10, P67, DOI 10.1080/096020100389309; FRANZEN M D, 1991, Neuropsychology Review, V2, P29, DOI 10.1007/BF01108846; Garcia Mart?nez J., 1994, B PSICOLOGIA, V43, P89; Gordon WA, 2000, BRAIN INJURY, V14, P21, DOI 10.1080/026990500120907; HERRMANN DJ, 1982, PSYCHOL BULL, V92, P434, DOI 10.1037/0033-2909.92.2.434; Kim HJ, 1999, BRAIN INJURY, V13, P147, DOI 10.1080/026990599121818; Kinsella G, 1996, BRAIN INJURY, V10, P499, DOI 10.1080/026990596124214; KNIGHT RG, 1995, HDB MEMORY DISORDERS; Lanham RA, 2000, J HEAD TRAUMA REHAB, V15, P1123, DOI 10.1097/00001199-200010000-00006; LARRABEE GJ, 1996, ECOLOGICAL VALIDITY, P225; LEVIN HS, 1997, BEHAV NEUROLOGY NEUR; LIBERMAN J, 1994, J CLIN PSYCHOL, V50, P615, DOI 10.1002/1097-4679(199407)50:4<615::AID-JCLP2270500419>3.0.CO;2-R; LYNCH WJ, 1995, J HEAD TRAUMA REHAB, V10, P94, DOI 10.1097/00001199-199502000-00011; Makatura TJ, 1999, BRAIN INJURY, V13, P355; Marsh NV, 1998, BRAIN INJURY, V12, P1045, DOI 10.1080/026990598121954; Osterrieth PA, 1944, ARCH PSYCHOLOGIE, V30, P206; Pelegrin C., 1997, NEUROPSIQUIATRIA DAN; Raskin SA, 1996, J HEAD TRAUMA REHAB, V11, P32, DOI 10.1097/00001199-199606000-00007; Rey A, 1964, EXAMEN CLIN PSYCHOL; Rey A, 1941, ARCH PSYCHOLOGIE, V28, P286; SCHWARTZ AF, 1989, CORTEX, V25, P665, DOI 10.1016/S0010-9452(89)80026-7; SOHLBERG MM, 1989, J CLIN EXP NEUROPSYC, V11, P871, DOI 10.1080/01688638908400941; Spreen O., 1998, COMPENDIUM NEUROPSYC; SUNDERLAND A, 1984, EVERYDAY MEMORY ACTI; Tate RL, 1997, BRAIN INJURY, V11, P907, DOI 10.1080/026990597122972; Vanderploeg RD, 2001, J CLIN EXP NEUROPSYC, V23, P185, DOI 10.1076/jcen.23.2.185.1210; Wallace CA, 1998, BRAIN INJURY, V12, P483, DOI 10.1080/02699052.1998.11910751; Wechsler D., 1955, MANUAL WECHSLER ADUL; Wiegner S, 1999, J CLIN EXP NEUROPSYC, V21, P159, DOI 10.1076/jcen.21.2.159.925; Wills P, 2000, BRAIN INJURY, V14, P693; Wilson B. A., 1993, APPL PREV PSYCHOL, V2, P209, DOI [DOI 10.1016/S0962-1849(05)80091-5, 10.1016/S0962-1849(05)80091-5]; Wilson B. A., 1985, RIVERMEAD BEHAV MEMO; Wilson BA, 1997, J NEUROL NEUROSUR PS, V63, P113, DOI 10.1136/jnnp.63.1.113; WILSON BA, 1984, EVERYDAY MEMORY ACTI; WILSON BA, 1999, COGNITIVE NEUROREHAB; WILSON BA, 1996, MEMORY, V4, P456; Wood RL, 1999, NEUROPSYCHOL REHABIL, V9, P505, DOI 10.1080/096020199389554; ZABALA A, IN PRESS REHABILITAC; ZELINSKI EM, 1990, PSYCHOL AGING, V5, P388, DOI 10.1037/0882-7974.5.3.388; ZENCIUS A, 1990, Brain Injury, V4, P33, DOI 10.3109/02699059009026146	54	22	22	0	15	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0885-9701			J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	NOV-DEC	2003	18	6					532	540		10.1097/00001199-200311000-00007			9	Clinical Neurology; Rehabilitation	Neurosciences & Neurology; Rehabilitation	747MX	WOS:000186809200007	14707883				2021-06-18	
J	Warschausky, S; Argento, AG; Hurvitz, E; Berg, M				Warschausky, S; Argento, AG; Hurvitz, E; Berg, M			Neuropsychological status and social problem solving in children with congenital or acquired brain dysfunction	REHABILITATION PSYCHOLOGY			English	Article							SEVERE HEAD-INJURY; SPINA-BIFIDA; HYDROCEPHALIC CHILDREN; COMPETENCE; ADOLESCENTS; PREVENTION; ADJUSTMENT; PEOPLE	Objective: To describe the associations between neuropsychological variables and social problem-solving skills in children with congenital versus acquired brain dysfunction. Participants: Twenty-two children and adolescents with cerebral palsy or myelomeningocele (developmental condition, or DC) and 22 with history of traumatic brain injury (TBI), ages 7-12 years, IQ > 70. Measures: Social Problem-Solving Measure (SPSM), Video Cues and Consequences (VCC), and brief motor-free neuropsychological assessment. Results: The DC group generated significantly fewer solutions to hypothetical problematic social scenarios than the TBI group, but differences in the relative frequencies of solution types were minimal. The pattern of associations between neuropsychological and social problem-solving variables differed between groups. Conclusions: Neuropsychological status may contribute to development and expression of aspects of social skills, but there may be subtle differences in the nature of that contribution in children with congenital versus acquired brain lesions.	Univ Michigan, Med Ctr, Dept Phys Med & Rehabil, Ann Arbor, MI 48109 USA	Warschausky, S (corresponding author), Univ Michigan Hosp, Dept Phys Med & Rehabil, Box 0718,1500 E Med Ctr, Ann Arbor, MI 48109 USA.			Macy, Michelle/0000-0003-4401-7384			BADELLRIBERA A, 1966, PEDIATRICS, V37, P787; BELLACK AS, 1994, J ABNORM PSYCHOL, V103, P371, DOI 10.1037/0021-843X.103.2.371; BERNINGER VW, 1988, ARCH PHYS MED REHAB, V69, P250; Bohnert AM, 1997, DEV NEUROPSYCHOL, V13, P477, DOI 10.1080/87565649709540688; BROWN J, 1988, UNPUB SCORING MANUAL; Cattelani R, 1998, BRAIN INJURY, V12, P283, DOI 10.1080/026990598122584; CRICK NR, 1994, PSYCHOL BULL, V115, P74, DOI 10.1037/0033-2909.115.1.74; CROFOOT MJ, 1980, PSYCHOL SCHOOLS, V17, P474, DOI 10.1002/1520-6807(198010)17:4<474::AID-PITS2310170410>3.0.CO;2-O; DALLAS E, 1993, J CHILD PSYCHOL PSYC, V34, P649, DOI 10.1111/j.1469-7610.1993.tb01063.x; DENNIS M, 1981, ARCH NEUROL-CHICAGO, V38, P607, DOI 10.1001/archneur.1981.00510100035004; DODGE KA, 1986, MONOGR SOC RES CHILD, V51, P1; DORNER S, 1976, ARCH DIS CHILD, V51, P439, DOI 10.1136/adc.51.6.439; Dunn L M, 1981, EXAMINERS MANUAL PEA; DZURILLA TJ, 1990, COGNITIVE THERAPY RE, V4, P67; ESLINGER PJ, 1993, NEUROPSYCHOLOGIA, V31, P17, DOI 10.1016/0028-3932(93)90077-D; FINSET A, 1995, BRAIN INJURY, V9, P141, DOI 10.3109/02699059509008187; FLETCHER JM, 1992, ARCH NEUROL-CHICAGO, V49, P818, DOI 10.1001/archneur.1992.00530320042010; GODFREY HPD, 1989, PSYCHOL MED, V19, P175, DOI 10.1017/S0033291700011120; HEALEY KN, 1992, AM J MENT RETARD, V96, P367; Heaton R. K, 1981, WISCONSIN CARD SORTI; Janusz JA, 2002, CHILD NEUROPSYCHOL, V8, P179, DOI 10.1076/chin.8.3.179.13499; Kendall E, 1997, J HEAD TRAUMA REHAB, V12, P68, DOI 10.1097/00001199-199706000-00007; KOKKONEN J, 1991, DEV MED CHILD NEUROL, V33, P1095; MARSH NV, 1991, J CLIN EXP NEUROPSYC, V13, P729, DOI 10.1080/01688639108401086; MCANDREW I, 1979, DEV MED CHILD NEUROL, V21, P619; McColl MA, 1998, BRAIN INJURY, V12, P15, DOI 10.1080/026990598122827; McDermott S, 1996, J PEDIATR PSYCHOL, V21, P447, DOI 10.1093/jpepsy/21.3.447; PETTIT GS, 1988, CHILD DEV, V59, P107, DOI 10.2307/1130393; Satz P., 1993, NEUROPSYCHOLOGY, V7, P273, DOI DOI 10.1037/0894-4105.7.3.273; Sheslow D., 1990, WIDE RANGE ASSESSMEN; SHURE MB, 1979, J CLIN CHILD PSYCHOL, V8, P89, DOI 10.1080/15374417909532894; SHURE MB, 1982, AM J COMMUN PSYCHOL, V10, P341, DOI 10.1007/BF00896500; Van Horn K R, 1992, Brain Inj, V6, P15, DOI 10.3109/02699059209008118; WALLANDER JL, 1987, CLIN PSYCHOL REV, V7, P203; Warschausky S, 1996, ARCH CLIN NEUROPSYCH, V11, P147, DOI 10.1016/0887-6177(95)00004-6; Warschausky S, 1997, Pediatr Rehabil, V1, P77; Warschausky S, 2003, HDB PEDIAT PSYCHOL, P375; Wechsler D., 1991, WECHSLER INTELLIGENC; Yude C, 1999, DEV MED CHILD NEUROL, V41, P4, DOI 10.1017/S001216229900002X	39	22	22	0	9	EDUCATIONAL PUBLISHING FOUNDATION	WASHINGTON	750 FIRST ST, NE, WASHINGTON, DC 20002-4242 USA	0090-5550			REHABIL PSYCHOL	Rehabil. Psychol.	NOV	2003	48	4					250	254		10.1037/0090-5550.48.4.250			5	Psychology, Clinical; Rehabilitation	Psychology; Rehabilitation	741ER	WOS:000186446200004					2021-06-18	
J	Mauritz, W; Pelinka, LE; Kaff, A; Segall, B; Fridrich, P				Mauritz, W; Pelinka, LE; Kaff, A; Segall, B; Fridrich, P			First aid measures provided by bystanders at the accident site. A prospective epidemiological study in the area of Vienna	WIENER KLINISCHE WOCHENSCHRIFT			German	Article						bystander; lay persons; prehospital care; emergency measures; first aid training	HOSPITAL CARDIAC-ARREST; CARDIOPULMONARY-RESUSCITATION; VENTRICULAR-FIBRILLATION; SURVIVAL; QUALITY; EFFICIENCY; COSTS; SCALE; CPR	The object of this prospective, epidemiological study was to determine whether bystanders provided necessary first aid measures in the prehospital trauma setting, whether they performed these measures correctly, and whether the level of first aid training affected the quality of first aid measures performed. Data were collected by means of a questionnaire, which was filled out between March and July 2000 for all cases attended to by the Vienna Ambulance Service. A total of 2812 cases were documented. The most frequent causes of trauma were falls from heights less than 1 meter (50%) and traffic accidents (17%). The most frequent injuries were injuries to the extremities (59%) and head and traumatic brain injuries (42%). Most patients were "moderately" or "severely" injured (69% and 29%, respectively), but life-threatening injuries were rare (2%). Bystanders were present in 57% of the cases. The most frequently required first aid measures were "application of a dressing" and "positioning" of the patient. "Control of haemorrhage", "ensuring accident site safety " and "extrication" of the patient were less frequently required. "Clearing of the airway", "precautions against hypothermia" and cardio-pulmonary resuscitation were very rarely required. Bystanders were most frequently policemen, relatives or friends of the patient, and strangers. The vast majority of bystanders had no training in first aid or had only attended the first aid course required to attain a driving licence. We found a clear relationship between the level of first aid training and the quality of first aid measures provided. It would be advisable to offer an increased amount of refresher courses in first aid to improve bystander trauma care.	AUVA, Unfallkrakenhaus Lorenz Bohler, Inst Anasthesiol & Intensivmed, A-1200 Vienna, Austria; Rettungs & Krankenbeforderungsdienst Stadt Wien, Vienna, Austria	Mauritz, W (corresponding author), AUVA, Unfallkrakenhaus Lorenz Bohler, Inst Anasthesiol & Intensivmed, Donaueschingenstr 13, A-1200 Vienna, Austria.			Mauritz, Walter/0000-0001-9043-3712			BARTSCH A, 1989, NOTARZT, V5, P77; Bur A, 2001, INTENS CARE MED, V27, P1474, DOI 10.1007/s001340101045; Donner-Banzhoff N, 1999, ANASTH INTENSIV NOTF, V34, P140; GALLAGHER EJ, 1995, JAMA-J AM MED ASSOC, V274, P1922, DOI 10.1001/jama.274.24.1922; Gaul GB, 1996, RESUSCITATION, V32, P169, DOI 10.1016/0300-9572(96)00956-2; Holmberg M, 2000, RESUSCITATION, V47, P59, DOI 10.1016/S0300-9572(00)00199-4; HUSSAIN LM, 1994, BRIT MED J, V308, P1077, DOI 10.1136/bmj.308.6936.1077; Jackson RE, 1997, ACAD EMERG MED, V4, P540, DOI 10.1111/j.1553-2712.1997.tb03574.x; Koeck CM, 2001, WIEN KLIN WOCHENSCHR, V113, P371; KROESEN G, 1994, WIEN KLIN WOCHENSCHR, V106, P634; MAURITZ W, 2000, NOTFALLMEDIZIN, pS46; Peterson T D, 1999, Prehosp Emerg Care, V3, P225, DOI 10.1080/10903129908958941; ROGGLA G, 1991, ACTA MED AUST, V18, P78; SWOR RA, 1995, ANN EMERG MED, V25, P780, DOI 10.1016/S0196-0644(95)70207-5; TEASDALE G, 1974, LANCET, V2, P81; VANHOEYWEGHEN RJ, 1993, RESUSCITATION, V26, P47, DOI 10.1016/0300-9572(93)90162-J; Weiss M, 2001, ANAESTHESIST, V50, P150, DOI 10.1007/s001010170030; WIK L, 1994, RESUSCITATION, V28, P195, DOI 10.1016/0300-9572(94)90064-7	18	22	22	0	5	SPRINGER-VERLAG WIEN	VIENNA	SACHSENPLATZ 4-6, PO BOX 89, A-1201 VIENNA, AUSTRIA	0043-5325			WIEN KLIN WOCHENSCHR	Wien. Klin. Wochen.	OCT 31	2003	115	19-20					698	704		10.1007/BF03040885			7	Medicine, General & Internal	General & Internal Medicine	745NE	WOS:000186694100005	14650944				2021-06-18	
J	Al Moutaery, K; Al Deeb, S; Khan, HA; Tariq, M				Al Moutaery, K; Al Deeb, S; Khan, HA; Tariq, M			Caffeine impairs short-term neurological outcome after concussive head injury in rats	NEUROSURGERY			English	Article						adenosine; caffeine; free radicals; head injury; neurotrauma; secondary injury	SPINAL-CORD-INJURY; TRAUMATIC BRAIN-INJURY; EXCITATORY AMINO-ACIDS; CEREBRAL-ISCHEMIA; NONCOMPETITIVE BLOCKADE; QUANTITATIVE-EVALUATION; ADENINE-NUCLEOTIDES; ANALGESIC ADJUVANT; LIPID-PEROXIDATION; TRANSIENT ISCHEMIA	OBJECTIVE: Adenosine is an endogenous neuroprotective agent that is released during ischemia, hypoxia, epilepsy, and ischemic brain injury. Caffeine is a receptor antagonist for adenosine that might interfere with the neuroprotective effect of adenosine in ischemic-hypoxic conditions. An investigation was undertaken to study the effect of caffeine on neurological function, edema formation, and blood-brain barrier permeability after experimental head injury in rats. METHODS: Adult female Wistar rats classified into different groups received caffeine intraperitoneally at doses of 0, 50, 100, and, 150 mg/kg body weight. Thirty minutes after the caffeine treatment, the animals were subjected to concussive head injury (CHI) administered by a controlled cortical impact device. Neurological severity score was recorded in each rat at 2 hours after CHI. Specific gravity, water content (as an indicator of edema), and blood-brain barrier impairment were analyzed in the cortical tissue surrounding the injury site. The levels of myeloperoxidase and malondialdehyde in the cortical region were measured as indicators of of neutrophil infiltration and lipid peroxidation, respectively. RESULTS: A significant increase in righting latency and neurological deficiency after CHI was observed in caffeine-treated rats as compared with untreated animals. Although no deaths occurred in the rats exposed to CHI after pretreatment with saline, pretreatment with caffeine caused significant mortality of animals after trauma in a dose-dependent manner. Caffeine also exacerbated neutrophil infiltration, edema, and disruption of blood-brain barrier in the traumatic cortex. Light microscopy of brain revealed more severe hemorrhage and, neuronal degeneration in the injured hemisphere of caffeine-treated rats as compared with rats in the injury-alone group. A significant increase in malondialdehyde in the brain of injured rats treated with caffeine before CHI clearly indicated the role of oxidative stress. CONCLUSION: Caffeine adversely affects outcome after CHI, possibly as a result of blockade of adenosine receptors. The findings also point toward the involvement of free radical-mediated neuronal damage in caffeine-induced exacerbation of neurotrauma.	Armed Forces Hosp, Neurosci Res Grp, Riyadh 11159, Saudi Arabia	Tariq, M (corresponding author), Armed Forces Hosp, Neurosci Res Grp, POB 7897 W-912, Riyadh 11159, Saudi Arabia.		Khan, Haseeb A./E-3872-2014	Khan, Haseeb A./0000-0001-6084-8589			Ahmed S, 2000, AM J CLIN ONCOL-CANC, V23, P420, DOI 10.1097/00000421-200008000-00022; AKTAN S, 1991, PROSTAG LEUKOTR ESS, V42, P67, DOI 10.1016/0952-3278(91)90069-H; Al Deeb S, 2002, NEUROSCI LETT, V325, P216, DOI 10.1016/S0304-3940(02)00042-3; Al Moutaery K, 2000, J NEUROSURG, V93, P276; ANDINE P, 1990, BRIT J PHARMACOL, V100, P814, DOI 10.1111/j.1476-5381.1990.tb14097.x; Atkinson JLD, 2000, MAYO CLIN PROC, V75, P37, DOI 10.4065/75.1.37; BARONE FC, 1991, J NEUROSCI RES, V29, P336, DOI 10.1002/jnr.490290309; BECKER AB, 1984, NEW ENGL J MED, V310, P743, DOI 10.1056/NEJM198403223101202; BERNE RM, 1974, CIRC RES, V35, P262, DOI 10.1161/01.RES.35.2.262; BRADLEY PP, 1982, J INVEST DERMATOL, V78, P206, DOI 10.1111/1523-1747.ep12506462; Buck LT, 1998, J EXP BIOL, V201, P289; Burg A. W., 1975, Tea and Coffee Trade Journal, V147, P40; COLLINS WF, 1983, PARAPLEGIA, V21, P204, DOI 10.1038/sc.1983.34; CRONSTEIN BN, 1994, J APPL PHYSIOL, V76, P5; Czosnyka M, 2001, J NEUROSURG, V95, P756, DOI 10.3171/jns.2001.95.5.0756; DALY, 1993, CAFFEINE COFFEE HLTH, P97; Darakchiev BJ, 1997, ACT NEUR S, V70, P98; Dempsey RJ, 2000, NEUROSURGERY, V47, P399, DOI 10.1097/00006123-200008000-00024; DERLET RW, 1992, AM J EMERG MED, V10, P211, DOI 10.1016/0735-6757(92)90211-F; DOLPHIN AC, 1983, NEUROSCI LETT, V43, P49, DOI 10.1016/0304-3940(83)90127-1; DUNWIDDIE TV, 1980, BRIT J PHARMACOL, V69, P59, DOI 10.1111/j.1476-5381.1980.tb10883.x; Erenberg A, 2000, PHARMACOTHERAPY, V20, P644, DOI 10.1592/phco.20.7.644.35167; Eun BL, 2000, PEDIATR RES, V47, P73, DOI 10.1203/00006450-200001000-00014; EVANS MC, 1987, NEUROSCI LETT, V83, P287, DOI 10.1016/0304-3940(87)90101-7; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; FREDHOLM BB, 1995, PHARMACOL TOXICOL, V76, P93, DOI 10.1111/j.1600-0773.1995.tb00111.x; Fredholm BB, 1997, INT REV NEUROBIOL, V40, P259; GARTHWAITE G, 1986, NEUROSCIENCE, V18, P437, DOI 10.1016/0306-4522(86)90164-8; GOLDING EM, 1995, MOL CHEM NEUROPATHOL, V24, P137, DOI 10.1007/BF02962139; Griffiths RR, 2000, ARCH FAM MED, V9, P727, DOI 10.1001/archfami.9.8.727; HALL E D, 1989, Journal of Neurotrauma, V6, P169, DOI 10.1089/neu.1989.6.169; HALL ED, 1994, ANN NY ACAD SCI, V738, P15; HALL ED, 1985, J NEUROSURG, V62, P882, DOI 10.3171/jns.1985.62.6.0882; HERON A, 1993, BRAIN RES, V608, P27, DOI 10.1016/0006-8993(93)90769-J; HSU CY, 1985, NEUROLOGY, V35, P1003, DOI 10.1212/WNL.35.7.1003; Hudome S, 1997, PEDIATR RES, V41, P607, DOI 10.1203/00006450-199705000-00002; IKEDA Y, 1990, ACT NEUR S, V51, P74; Inci S, 1998, NEUROSURGERY, V43, P330, DOI 10.1097/00006123-199808000-00095; Kamimori GH, 2000, EUR J CLIN PHARMACOL, V56, P537, DOI 10.1007/s002280000186; Karas Maria, 2001, Journal of Environmental Pathology Toxicology and Oncology, V20, P141; Karhapaa L, 1997, J CELL PHYSIOL, V171, P52; KOCHANEK PM, 1992, STROKE, V23, P1367, DOI 10.1161/01.STR.23.9.1367; KULKARNI C, 1989, INDIAN J EXP BIOL, V27, P1048; LASKA EM, 1984, JAMA-J AM MED ASSOC, V251, P1711, DOI 10.1001/jama.251.13.1711; Leker RR, 2002, BRAIN RES REV, V39, P55, DOI 10.1016/S0165-0173(02)00157-1; LIEBERMAN HR, 1987, PSYCHOPHARMACOLOGY, V92, P308, DOI 10.1007/BF00210835; Liguori A, 2001, DRUG ALCOHOL DEPEN, V63, P123, DOI 10.1016/S0376-8716(00)00196-4; MAGGIRWAR SB, 1994, BIOCHEM BIOPH RES CO, V201, P508, DOI 10.1006/bbrc.1994.1731; MARMAROU A, 1978, J NEUROSURG, V49, P530, DOI 10.3171/jns.1978.49.4.0530; MCINTOSH TK, 1990, J NEUROCHEM, V55, P1170, DOI 10.1111/j.1471-4159.1990.tb03122.x; Molnar D, 2000, INT J OBESITY, V24, P1573, DOI 10.1038/sj.ijo.0801433; MORII S, 1983, J CEREB BLOOD FLO S1, V3, pS480; Nakamichi T, 1998, Jpn J Thorac Cardiovasc Surg, V46, P354; NEHLIG A, 1992, BRAIN RES REV, V17, P139, DOI 10.1016/0165-0173(92)90012-B; NILSSON B, 1977, J NEUROSURG, V47, P252, DOI 10.3171/jns.1977.47.2.0252; OHKAWA H, 1979, ANAL BIOCHEM, V95, P351, DOI 10.1016/0003-2697(79)90738-3; OKIYAMA K, 1995, J NEUROCHEM, V64, P802; OSTERHOLM JL, 1972, J NEUROSURG, V36, P386, DOI 10.3171/jns.1972.36.4.0386; PETKOV VV, 1984, METHOD FIND EXP CLIN, V6, P433; PUIROUD S, 1988, BRAIN RES, V453, P287, DOI 10.1016/0006-8993(88)90169-2; RUDOLPHI KA, 1990, PHARMACOLOGY OF CEREBRAL ISCHEMIA 1990, P439; RUDOLPHI KA, 1992, TRENDS PHARMACOL SCI, V13, P439, DOI 10.1016/0165-6147(92)90141-R; Ruijter J, 2000, PHARMACOL BIOCHEM BE, V66, P29, DOI 10.1016/S0091-3057(00)00229-X; SALZMAN SK, 1987, J NEUROSURG, V66, P431, DOI 10.3171/jns.1987.66.3.0431; SANDLER AN, 1976, J NEUROSURG, V45, P638, DOI 10.3171/jns.1976.45.6.0638; SAWYNOK J, 1993, PHARMACOL REV, V45, P43; Schubert P, 1997, ANN NY ACAD SCI, V825, P1, DOI 10.1111/j.1749-6632.1997.tb48409.x; SCHUBERT P, 1986, BRAIN RES, V376, P382, DOI 10.1016/0006-8993(86)90204-0; SCHUBERT P, 1979, BRAIN RES, V172, P186, DOI 10.1016/0006-8993(79)90910-7; SHAPIRA Y, 1990, Journal of Neurotrauma, V7, P131, DOI 10.1089/neu.1990.7.131; SHAPIRA Y, 1992, ANESTHESIOLOGY, V77, P79, DOI 10.1097/00000542-199207000-00012; SHAPIRA Y, 1993, ANESTH ANALG, V77, P141; SHAPIRA Y, 1988, CRIT CARE MED, V16, P258, DOI 10.1097/00003246-198803000-00010; SHAPIRA Y, 1992, ANESTH ANALG, V75, P238; SHAPIRO P, 1982, LANCET, V1, P793; SMITH SL, 1994, J NEUROTRAUM, V11, P393, DOI 10.1089/neu.1994.11.393; Soustiel JF, 2002, ACTA NEUROCHIR, V144, P137, DOI 10.1007/s007010200016; SULLIVAN GW, 1995, IMMUNOPHARMACOLOGY, V31, P19, DOI 10.1016/0162-3109(95)00030-0; SUTHERLAND GR, 1991, NEUROSCIENCE, V42, P171, DOI 10.1016/0306-4522(91)90157-J; Taoka Y, 1997, J NEUROSURG, V86, P1007, DOI 10.3171/jns.1997.86.6.1007; Taoka Y, 1997, CRIT CARE MED, V25, P874, DOI 10.1097/00003246-199705000-00026; TATOR CH, 1991, J NEUROSURG, V75, P15, DOI 10.3171/jns.1991.75.1.0015; Turcani P, 2001, J NEUROL SCI, V183, P57, DOI 10.1016/S0022-510X(00)00477-9; Ustun ME, 2001, INTENS CARE MED, V27, P264, DOI 10.1007/s001340000780; UYAMA O, 1988, J CEREBR BLOOD F MET, V8, P282, DOI 10.1038/jcbfm.1988.59; WATANABE H, 1981, J PHARMACOBIO-DYNAM, V4, P301, DOI 10.1248/bpb1978.4.301; WEI EP, 1981, J CEREB BLOOD FLO S1, V1, pS395; WILSON JT, 1995, J TRAUMA, V39, P473; WINN HR, 1979, CIRC RES, V45, P486, DOI 10.1161/01.RES.45.4.486; WINN HR, 1980, AM J PHYSIOL, V239, pH636; Zubkov AY, 2000, ACT NEUR S, V76, P223	91	22	24	0	1	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0148-396X	1524-4040		NEUROSURGERY	Neurosurgery	SEP	2003	53	3					704	711		10.1227/01.NEU.0000079487.66013.6F			8	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	718AL	WOS:000185122900035	12943586				2021-06-18	
J	Malhotra, AK; Schweitzer, JB; Fox, JL; Fabian, TC; Proctor, KG				Malhotra, AK; Schweitzer, JB; Fox, JL; Fabian, TC; Proctor, KG			Cerebral perfusion pressure directed therapy following traumatic brain injury and hypotension in swine	JOURNAL OF NEUROTRAUMA			English	Article						beta-amyloid precursor protein; brain edema; brain injury; cerebral oxygenation; cerebral perfusion pressure; cerebro-vascular CO2 reactivity; pressor	VENOUS OXYGEN-SATURATION; BLOOD-FLOW; INTRACRANIAL-PRESSURE; HEAD-INJURY; COMATOSE PATIENTS; MANAGEMENT; IMPACT; FLUCTUATIONS; METABOLISM; EVOLUTION	There is a paucity of studies, clinical and experimental, attesting to the benefit of cerebral perfusion pressure (CPP) directed pressor therapy following traumatic brain injury (TBI). The current study evaluates this therapy in a swine model of TBI and hypotension. Forty-five anesthetized and ventilated swine received TBI followed by a 45% blood volume bleed. After 1 h, all animals were resuscitated with 0.9% sodium chloride equal to three times the shed blood volume. The experimental group (PHE) received phenylephrine to maintain CPP > 80 mm Hg; the control group (SAL) did not. Outcomes in the first phase (n = 33) of the study were as follows: cerebro-venous oxygen saturation (ScvO2), cerebro-vascular carbon dioxide reactivity (DeltaS(cv)O(2)), and brain structural damage (beta-amyloid precursor protein [betaAPP] immunoreactivity). In the second phase (n = 12) of the study, extravascular blood free water (EVBFW) was measured in the brain and lung. After resuscitation, intracranial and mean arterial pressures were >15 and >80 mm Hg, respectively, in both groups. CPP declined to 64 +/- 5 mm Hg in the SAL group, despite fluid supplements. CPP was maintained at >80 mm Hg with pressors in the PHE group. PHE animals maintained better ScvO2 (P < 0.05 at 180, 210, 240, 270, and 300 min post-TBI). At baseline, 5% CO2 evoked a 16 +/- 4% increase in ScvO2, indicating cerebral vasodilatation and luxury perfusion. By 240 min, this response was absent in SAL animals and preserved in PHE animals (p < 0.05). Brain EVBFW was higher in SAL animals; however, lung EVBFW was higher in PHE animals. There was no difference in betaAPP immunoreactivity between the SAL and PHE groups (p > 0.05). In this swine model of TBI and hypotension, CPP directed pressor therapy improved brain oxygenation and maintained cerebro-vascular CO2 reactivity. Brain edema was lower, but lung edema was greater, suggesting a higher propensity for pulmonary complications.	Virginia Commonwealth Univ, Med Coll Virginia, Dept Surg, Richmond, VA 23298 USA; E Tennessee State Univ, Quillen Dishner Coll Med, Dept Pathol, Johnson City, TN 37614 USA; Univ Tennessee, Ctr Hlth Sci, Dept Surg, Memphis, TN 38163 USA; Univ Miami, Sch Med, Dept Surg, Miami, FL 33152 USA	Malhotra, AK (corresponding author), Virginia Commonwealth Univ, Med Coll Virginia, Dept Surg, Richmond, VA 23298 USA.	akmalhot@hsc.vcu.edu					Adelson PD, 1997, PEDIATR NEUROSURG, V26, P200; Al-Samsam RH, 2000, J NEUROTRAUM, V17, P31, DOI 10.1089/neu.2000.17.31; BOUMA GJ, 1990, J NEUROSURG, V73, P368, DOI 10.3171/jns.1990.73.3.0368; BRUCE DA, 1973, J NEUROSURG, V38, P131, DOI 10.3171/jns.1973.38.2.0131; Bullock RM, 2000, J NEUROTRAUM, V17, P449; CLIFTON GL, 1993, J NEUROTRAUM, V10, P263, DOI 10.1089/neu.1993.10.263; COLOHAN ART, 1989, J NEUROSURG, V71, P202, DOI 10.3171/jns.1989.71.2.0202; COOKE RS, 1995, INJURY, V26, P395, DOI 10.1016/0020-1383(95)00003-R; CRUZ J, 1995, CRIT CARE MED, V23, P1412, DOI 10.1097/00003246-199508000-00016; Cruz J, 1998, CRIT CARE MED, V26, P344, DOI 10.1097/00003246-199802000-00039; Downard C, 2000, J TRAUMA, V49, P654, DOI 10.1097/00005373-200010000-00012; EISENBERG HM, 1988, J NEUROSURG, V69, P15, DOI 10.3171/jns.1988.69.1.0015; FORTUNE JB, 1994, J NEUROSURG, V80, P461, DOI 10.3171/jns.1994.80.3.0461; GHAJAR J, 1995, CRIT CARE MED, V23, P560, DOI 10.1097/00003246-199503000-00023; GHAJAR JBG, 1993, ADV NEUROS, V21, P173; Gibson JB, 2002, SHOCK, V17, P234, DOI 10.1097/00024382-200203000-00013; Glass TF, 1999, J NEUROTRAUM, V16, P771, DOI 10.1089/neu.1999.16.771; Glass TF, 2001, J NEUROTRAUM, V18, P57, DOI 10.1089/089771501750055776; Juul N, 2000, J NEUROSURG, V92, P1, DOI 10.3171/jns.2000.92.1.0001; Kiening KL, 1997, NEUROL RES, V19, P233, DOI 10.1080/01616412.1997.11740805; Kokoska ER, 1998, J PEDIATR SURG, V33, P333, DOI 10.1016/S0022-3468(98)90457-2; Kroppenstedt SN, 1999, J NEUROSURG, V90, P520, DOI 10.3171/jns.1999.90.3.0520; Marion DW, 1997, NEW ENGL J MED, V336, P540, DOI 10.1056/NEJM199702203360803; MARMAROU A, 1991, J NEUROSURG, V75, pS59, DOI 10.3171/sup.1991.75.1s.0s59; MARSHALL LF, 1979, J NEUROSURG, V50, P20, DOI 10.3171/jns.1979.50.1.0020; MARSHALL LF, 1991, J NEUROSURG, V75, pS28, DOI 10.3171/sup.1991.75.1s.0s28; McGraw CP, 1989, INTRACRANIAL PRESSUR, P839; MUIZELAAR JP, 1984, J NEUROSURG, V61, P700, DOI 10.3171/jns.1984.61.4.0700; MURR R, 1995, NEUROL RES, V17, P329, DOI 10.1080/01616412.1995.11740338; NEWELL DW, 1992, J NEUROSURG, V76, P415, DOI 10.3171/jns.1992.76.3.0415; OBRIST WD, 1984, J NEUROSURG, V61, P241, DOI 10.3171/jns.1984.61.2.0241; OVERGAARD J, 1974, J NEUROSURG, V41, P531, DOI 10.3171/jns.1974.41.5.0531; PEARCE ML, 1965, CIRC RES, V16, P482, DOI 10.1161/01.RES.16.5.482; Robertson CS, 1999, CRIT CARE MED, V27, P2086, DOI 10.1097/00003246-199910000-00002; ROSNER MJ, 1990, J TRAUMA, V30, P933, DOI 10.1097/00005373-199008000-00001; ROSNER MJ, 1995, J NEUROSURG, V83, P949, DOI 10.3171/jns.1995.83.6.0949; ROSNER MJ, 1984, J NEUROSURG, V60, P312, DOI 10.3171/jns.1984.60.2.0312; SHALMON E, 1994, INTRACRANIAL PRESSUR, V9, P357; SHALMON E, 1994, INTRACRANIAL PRESSUR, V9, P348; Stocchetti N, 1996, J TRAUMA, V40, P764, DOI 10.1097/00005373-199605000-00014; Van den Heuvel C, 1999, EXP NEUROL, V159, P441, DOI 10.1006/exnr.1999.7150; WEIDNER WJ, 1978, PHYSIOL ZOOL, V51, P267, DOI 10.1086/physzool.51.3.30155743; YOSHIDA A, 1993, RECENT ADVANCES IN NEUROTRAUMATOLOGY, P309	43	22	22	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	SEP	2003	20	9					827	839		10.1089/089771503322385764			13	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	725BB	WOS:000185521800002	14577861				2021-06-18	
J	Saljo, A; Huang, YL; Hansson, HA				Saljo, A; Huang, YL; Hansson, HA			Impulse noise transiently increased the permeability of nerve and glial cell membranes, an effect accentuated by a recent brain injury	JOURNAL OF NEUROTRAUMA			English	Article						cerebrospinal fluid; closed head injury; diffuse brain damage; impulse noise; neuron specific enolase; S-100; shock wave	NEURON-SPECIFIC ENOLASE; ADULT-RAT BRAIN; COMBINED FLUID PERCUSSION; INDUCED AXONAL INJURY; CEREBROSPINAL-FLUID; S-100 PROTEIN; BLAST INJURY; CYTOCHEMICAL EVIDENCE; COGNITIVE IMPAIRMENT; STRETCH INJURY	A single exposure to intense impulse noise may cause diffuse brain injury, revealed by increased expression of immediate early gene products, transiently altered distribution of neurofilaments, accumulation of beta-amyloid precursor protein, apoptosis, and gliosis. Neither hemorrage nor any gross structural damage are seen. The present study focused on whether impulse noise exposure increased the permeability of nerve and glial cell membranes to proteins. Also, we investigated whether a preceding,,minor focal surgical brain lesion accentuated the leakage of cytosolic proteins. Anaesthetized rats were exposed to a single impulse noise at either 199 or 202 dB for 2 milliseconds. Transiently elevated levels of the cellular protein neuron specific enolase (NSE) and the glial cytoplasmic protein S-100 were recorded in the cerebrospinal fluid (CSF) during the first hours after the exposure to 202 dB. A surgical brain injury, induced the day before the exposure to the impulse noise, was associated with significantly increased concentrations of both markers in the CSF. It is concluded that intense impulse noise damages both nerve and glial cells, an effect aggravated by a preexisting surgical lesion. The impulse of the shock wave, i.e. the pressure integrated over time, is likely to be the injurious mechanism. The abnormal membrane permeability and the associated cytoskeletal changes may initiate events, which eventually result in a progressive diffuse brain injury.	Univ Gothenburg, Inst Anat & Cell Biol, SE-40530 Gothenburg, Sweden	Hansson, HA (corresponding author), Univ Gothenburg, Inst Anat & Cell Biol, POB 420, SE-40530 Gothenburg, Sweden.	hansarne.hansson@anatcell.gu.se					Argyros GJ, 1997, TOXICOLOGY, V121, P105, DOI 10.1016/S0300-483X(97)03659-7; Cernak I, 1999, J TRAUMA, V47, P96, DOI 10.1097/00005373-199907000-00021; Cernak I, 2001, J TRAUMA, V50, P695, DOI 10.1097/00005373-200104000-00017; Cernak I, 1999, BRAIN INJURY, V13, P1005; CERNAK I, 1997, INT REV ARMED FORCES, V70, P114; Clark RSB, 1997, J NEUROTRAUM, V14, P179, DOI 10.1089/neu.1997.14.179; Dancer A, 1998, SCAND AUDIOL, V27, P123; DeFord SM, 2002, J NEUROTRAUM, V19, P427, DOI 10.1089/08977150252932389; Elsayed NM, 1997, TOXICOLOGY, V121, P1, DOI 10.1016/S0300-483X(97)03651-2; FINEMAN I, 1993, BRAIN RES, V624, P94, DOI 10.1016/0006-8993(93)90064-T; Fitzpatrick MO, 1998, J NEUROL NEUROSUR PS, V64, P285, DOI 10.1136/jnnp.64.3.285; Graham DI, 2000, J NEUROPATH EXP NEUR, V59, P641, DOI 10.1093/jnen/59.8.641; GRAHAM DI, 1997, GREENFIELDS NEUROPAT, P197; GRASSO A, 1977, BRAIN RES, V122, P582, DOI 10.1016/0006-8993(77)90472-3; HARDEMARK HG, 1989, J NEUROSURG, V71, P727, DOI 10.3171/jns.1989.71.5.0727; HATFIELD RH, 1992, BRAIN RES, V577, P249, DOI 10.1016/0006-8993(92)90280-M; Huang YL, 1995, J NEUROSCI METH, V63, P13, DOI 10.1016/0165-0270(95)00080-1; Huang YL, 1996, BRAIN RES BULL, V41, P273, DOI 10.1016/S0361-9230(96)00176-1; JENKINS LW, 1989, BRAIN RES, V477, P211, DOI 10.1016/0006-8993(89)91409-1; Kaur C., 1997, Annals Academy of Medicine Singapore, V26, P27; KAUR C, 1995, NEUROPATH APPL NEURO, V21, P369, DOI 10.1111/j.1365-2990.1995.tb01073.x; Kodama T, 2000, BIOPHYS J, V79, P1821, DOI 10.1016/S0006-3495(00)76432-0; KRUSE A, 1991, ACTA NEUROCHIR, V110, P106, DOI 10.1007/BF01400675; Laurer HL, 2001, J NEUROSURG, V95, P859, DOI 10.3171/jns.2001.95.5.0859; Maxwell WL, 1995, J NEUROCYTOL, V24, P925, DOI 10.1007/BF01215643; Maxwell WL, 1999, J NEUROTRAUM, V16, P273, DOI 10.1089/neu.1999.16.273; Maxwell WL, 1997, J NEUROTRAUM, V14, P419, DOI 10.1089/neu.1997.14.419; Moore B W, 1972, Int Rev Neurobiol, V15, P215; NILSSON P, 1993, J CEREBR BLOOD F MET, V13, P183, DOI 10.1038/jcbfm.1993.22; Ortengren T, 1996, J NEUROTRAUM, V13, P171, DOI 10.1089/neu.1996.13.171; PERSSON L, 1987, STROKE, V18, P911, DOI 10.1161/01.STR.18.5.911; Petras JM, 1997, TOXICOLOGY, V121, P41, DOI 10.1016/S0300-483X(97)03654-8; Pettus EH, 1996, BRAIN RES, V722, P1, DOI 10.1016/0006-8993(96)00113-8; Phillips LL, 1997, J NEUROSCI RES, V49, P197; Povlishock JT, 1997, J NEUROPATH EXP NEUR, V56, P347, DOI 10.1097/00005072-199704000-00003; Povlishock JT, 1999, ACT NEUR S, V73, P15; Price GR, 1999, J ACOUST SOC AM, V106, P2629, DOI 10.1121/1.428092; PRICE GR, 1989, SCAND AUDIOL S, V34, P21; Reeves TM, 1997, NEUROSCIENCE, V77, P431, DOI 10.1016/S0306-4522(96)00486-1; Saljo A, 2002, J NEUROTRAUM, V19, P985, DOI 10.1089/089771502320317131; Saljo A, 2002, J NEUROTRAUM, V19, P379, DOI 10.1089/089771502753594945; Saljo A, 2000, J NEUROTRAUM, V17, P719, DOI 10.1089/089771500415454; Saljo Annette, 2001, Pathophysiology, V8, P105, DOI 10.1016/S0928-4680(01)00067-0; Siegel G.J., 1999, BASIC NEUROCHEMISTRY; SINDIC CJM, 1982, J NEUROL NEUROSUR PS, V45, P1130, DOI 10.1136/jnnp.45.12.1130; Stone JR, 2001, EXP NEUROL, V172, P320, DOI 10.1006/exnr.2001.7818; Stuhmiller JH, 1997, TOXICOLOGY, V121, P91, DOI 10.1016/S0300-483X(97)03658-5; SUNESON A, 1989, J TRAUMA, V29, P10, DOI 10.1097/00005373-198901000-00003; SUNESON A, 1990, J TRAUMA, V30, P10; SVENSSON MY, 1990, P INT IRCOBI, V13, P189; Uryu K, 2002, J NEUROSCI, V22, P446, DOI 10.1523/JNEUROSCI.22-02-00446.2002; VALLFORS B, 1976, BRAIN INJURY CAUSED; WESTERGREN I, 1991, BRAIN RES BULL, V27, P283, DOI 10.1016/0361-9230(91)90083-V; Yaremchuk K, 2001, OTOLARYNG HEAD NECK, V125, P130, DOI 10.1067/mhn.2001.117872	54	22	24	0	1	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	AUG	2003	20	8					787	794		10.1089/089771503767870014			8	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	712BU	WOS:000184777000009	12965057				2021-06-18	
J	Gamble, D; Moore, CL				Gamble, D; Moore, CL			The relation between VR services and employment outcomes of individuals with traumatic brain injury	JOURNAL OF REHABILITATION			English	Article							TERM FOLLOW-UP; REHABILITATION SERVICES; HEAD-INJURY; SUPPORTED EMPLOYMENT; MENTAL-RETARDATION; PLACEMENT OUTCOMES; SOCIAL-ADJUSTMENT; WORK; RETURN; RACE	This study examined the relationship between the provision of six vocational rehabilitation services to persons with traumatic brain injury (TBI) and the employment outcomes of these individuals as measured by closure status and weekly earnings. The sample consisted of 1,073 vocational rehabilitation clients with TBI whose cases were closed in a southeastern state. The researchers employed a binary logistic regression analysis and a factorial ANOVA to evaluate the relationship between these services and employment outcomes. Logistic regression analysis identified a significant relationship between four services and closure status. A six-way between participants ANOVA yielded a significant main effect for one service on weekly earnings and a significant interaction for three services on weekly earnings. These findings are presented and discussed for closure status and weekly earnings.	Compass Sch, Tuscaloosa, AL 35405 USA; Langston Univ, Langston, OK 73050 USA	Gamble, D (corresponding author), Compass Sch, 6001 12th Ave E, Tuscaloosa, AL 35405 USA.						Ashley MJ, 1997, BRAIN INJURY, V11, P677; BENYISHAY Y, 1987, J HEAD TRAUMA REHAB, V2, P35, DOI DOI 10.1097/00001199-198703000-00007; Bolton BF, 2000, REHABIL COUNS BULL, V44, P10, DOI 10.1177/003435520004400103; BRANDT GC, 1992, J CAN HIST ASSOC, V3, P3; Brooks N, 1987, Brain Inj, V1, P5, DOI 10.3109/02699058709034439; Bullard J. A., 1991, VOCATIONAL EVALUATIO, V24, P15; BULLIS M, 1995, REHABIL COUNS BULL, V39, P130; CHANDLER SK, 1993, THESIS VIRGINIA COMM; CHANDLER SK, 1993, VOCATIONAL EVALUATIO, V26, P161; CICERONE KD, 2000, TRAUMATIC BRAIN INJU, P95; COHEN J, 1983, MULTIPLE REGRESSION; ELLERD DA, 1992, J APPL REHABILITATIO, V23, P48; FABIANO RL, 1991, THESIS MICHIGAN STAT; FAUST P, 1998, ARCH CLIN NEUROPSYCH, V3, P145; Gamble D., 2002, J APPL REHABILITATIO, V33, P41, DOI DOI 10.1891/0047-2220.33.3.41; GARSKE GG, 1992, REHABIL COUNS BULL, V36, P44; Gilmore DS, 2000, REHABIL COUNS BULL, V44, P30, DOI 10.1177/003435520004400105; Groswasser Z, 1999, NEUROPSYCHOL REHABIL, V9, P493, DOI 10.1080/096020199389545; Hillier SL, 1997, BRAIN INJURY, V11, P661; Huck SW, 1996, READING STAT RES; IP RY, 1995, BRAIN INJURY, V9, P517, DOI 10.3109/02699059509008211; JELLINEK HM, 1982, ARCH PHYS MED REHAB, V63, P160; KAITARO T, 1995, BRAIN INJURY, V9, P713, DOI 10.3109/02699059509008227; KOSCIULEK JF, 1991, VOCATIONAL EVALUATIO, V24, P137; KRANKOWSKI T, 1993, VOCATIONAL EVALUATIO, V26, P85; LAM CS, 1991, REHABIL COUNS BULL, V35, P68; Michaels C.A., 1992, J APPL REHABILITATIO, V24, P38; Moore C. L., 2000, J APPL REHABILITATIO, V31, P36; Moore C. L., 2001, J APPL REHABILITATIO, V32, P15; Moore CL, 2002, J REHABIL, V68, P14; Moore CL, 2002, REHABIL COUNS BULL, V45, P162, DOI 10.1177/003435520204500305; Moore CL, 2001, REHABIL COUNS BULL, V44, P144, DOI 10.1177/003435520104400304; MORRIS J, 1982, M AM PSYCH ASS WASH; NEWNAN OS, 1978, PERCEPT MOTOR SKILL, V46, P635, DOI 10.2466/pms.1978.46.2.635; ODDY M, 1985, J NEUROL NEUROSUR PS, V48, P564, DOI 10.1136/jnnp.48.6.564; Olver JH, 1996, BRAIN INJURY, V10, P841, DOI 10.1080/026990596123945; PECK E, 1984, ANN M INT NEUR SOC H; PEDHAZUR EJ, 1991, MEASUREMENT DESIGN A; PRESTON B, 1992, REHABIL COUNS BULL, V35, P230; PRICEELLINGSTAD D, 1999, AM REHABILITATION, V25, P2; RAPPAPORT M, 1989, ARCH PHYS MED REHAB, V70, P885; Schmidt-Davis H, 1999, AM REHABILITATION, V25, P11; SHANNON DM, 2001, USING SPSS SOLVE STA; *SPSS INC, 1995, SPSS 6 1 COMP PROGR; Target P, 1998, INT J REHABIL RES, V21, P41, DOI 10.1097/00004356-199803000-00004; Taylor TE, 1998, TROP MED INT HEALTH, V3, P3, DOI 10.1046/j.1365-3156.1998.00166.x; Uomoto J.M., 2000, TRAUMATIC BRAIN INJU; WEDDELL R, 1980, PSYCHOL MED, V10, P257, DOI 10.1017/S0033291700044019; WEHMAN P, 1989, J APPL BEHAV ANAL, V22, P395, DOI 10.1901/jaba.1989.22-395; WEHMAN P, 2000, TRAUMATIC BRAIN INJU, P201; WEHMAN PH, 1990, ARCH PHYS MED REHAB, V71, P1047; West MD, 1996, J VOCATIONAL REHABIL, V7, P143; Wheaton JE, 1996, REHABIL COUNS BULL, V40, P116	53	22	22	0	5	NATL REHABILITATION ASSN-NRA	ALEXANDRIA	633 S WASHINGTON ST, ALEXANDRIA, VA 22314-4109 USA	0022-4154			J REHABIL	J. Rehabil.	JUL-SEP	2003	69	3					31	38					8	Rehabilitation	Rehabilitation	711DW	WOS:000184725200006					2021-06-18	
J	Buck, CR; Jurynec, MJ; Gupta, DK; Law, AKT; Bilger, J; Wallace, DC; McKeon, RJ				Buck, CR; Jurynec, MJ; Gupta, DK; Law, AKT; Bilger, J; Wallace, DC; McKeon, RJ			Increased adenine nucleotide translocator 1 in reactive astrocytes facilitates glutamate transport	EXPERIMENTAL NEUROLOGY			English	Article						glial scar; neuroprotection; mitochondria; transforming growth factor-beta 1 (TGF-beta 1); CNS injury; differential display PCR	FIBRILLARY ACIDIC PROTEIN; TRANSFORMING GROWTH FACTOR-BETA-1; CENTRAL-NERVOUS-SYSTEM; SPINAL-CORD INJURY; RAT-BRAIN; MICE LACKING; EXTRACELLULAR-MATRIX; CULTURED ASTROCYTES; NEURITE OUTGROWTH; TRAUMATIC INJURY	A hallmark of central nervous system (CNS) pathology is reactive astrocyte production of the chronic glial scar that is inhibitory to neuronal regeneration. The reactive astrocyte response is complex; these cells also produce neurotrophic factors and are responsible for removal of extracellular glutamate, the excitatory neurotransmitter that rises to neurotoxic levels in injury and disease. To identify genes expressed by reactive astrocytes, we employed an in vivo model of the glial scar and differential display PCR and found an increase in the level of Aral, a mitochondrial ATP/ADP exchanger that facilitates the flux of ATP out of the mitochondria. Ant1 expression in reactive astrocytes is regulated by transforming growth factor-beta1, a pluripotent CNS injury-induced cytokine. The significance of increased Ant1 is evident from the observation that glutamate uptake is significantly decreased in astrocytes from Ant1 null mutant mice while a specific Ant inhibitor reduces glutamate uptake in wild-type astrocytes. Thus, the astrocytic response to CNS injury includes an apparent increase in energy mobilization capacity by Ant1 that contributes to neuroprotective, energy-dependent glutamate uptake. (C) 2003 Elsevier Science (USA). All rights reserved.	Oridis Biomed, A-8010 Graz, Austria; Univ Utah, Dept Human Genet, Salt Lake City, UT 84112 USA; Emory Univ, Dept Physiol, Atlanta, GA 30322 USA; Emory Univ, Ctr Mol Med, Atlanta, GA 30322 USA; Emory Univ, Dept Cell Biol, Atlanta, GA 30322 USA	Buck, CR (corresponding author), Oridis Biomed, Elisabethstr 84, A-8010 Graz, Austria.		Jurynec, Michael/AAH-8765-2020		NHLBI NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [HL64017] Funding Source: Medline; NIA NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [AG13154, R01 AG013154] Funding Source: Medline; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01 NS021328, NS35986, NS21328] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [R01HL064017] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS021328, R29NS035986] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R01AG013154] Funding Source: NIH RePORTER		Asher RA, 2000, J NEUROSCI, V20, P2427; BAGHDASSARIAN D, 1993, GLIA, V7, P193, DOI 10.1002/glia.440070302; BIGNAMI A, 1976, NEUROPATH APPL NEURO, V2, P99, DOI 10.1111/j.1365-2990.1976.tb00488.x; Blanc EM, 1998, GLIA, V22, P149, DOI 10.1002/(SICI)1098-1136(199802)22:2<149::AID-GLIA6>3.0.CO;2-2; Bovolenta P, 1997, EUR J NEUROSCI, V9, P977, DOI 10.1111/j.1460-9568.1997.tb01448.x; Buisson A, 1998, FASEB J, V12, P1683; Bush TG, 1999, NEURON, V23, P297, DOI 10.1016/S0896-6273(00)80781-3; Davies SJA, 1999, J NEUROSCI, V19, P5810, DOI 10.1523/JNEUROSCI.19-14-05810.1999; Dorner A, 1999, BBA-BIOMEMBRANES, V1417, P16, DOI 10.1016/S0005-2736(98)00245-4; Eng DL, 1997, BRAIN RES, V778, P215, DOI 10.1016/S0006-8993(97)01093-7; Fitch MT, 1997, CELL TISSUE RES, V290, P379, DOI 10.1007/s004410050944; GOMI H, 1995, NEURON, V14, P29, DOI 10.1016/0896-6273(95)90238-4; Graham BH, 1997, NAT GENET, V16, P226, DOI 10.1038/ng0797-226; Greene JG, 1996, PROG NEUROBIOL, V48, P613, DOI 10.1016/0301-0082(96)00006-8; KLINGENBERG M, 1985, ENZYMES BIOL MEMBR, V4, P511; Krohn K, 1999, J NEUROCHEM, V72, P1353, DOI 10.1046/j.1471-4159.1999.721353.x; LEHRE KP, 1995, J NEUROSCI, V15, P1835; Levy SE, 2000, GENE, V254, P57, DOI 10.1016/S0378-1119(00)00252-3; LIANG P, 1992, SCIENCE, V257, P967, DOI 10.1126/science.1354393; LINDHOLM D, 1992, J CELL BIOL, V117, P395, DOI 10.1083/jcb.117.2.395; LOGAN A, 1994, EUR J NEUROSCI, V6, P355, DOI 10.1111/j.1460-9568.1994.tb00278.x; Logan A, 1999, EUR J NEUROSCI, V11, P2367, DOI 10.1046/j.1460-9568.1999.00654.x; LOGAN A, 1992, BRAIN RES, V587, P216, DOI 10.1016/0006-8993(92)91000-5; MCCARTHY KD, 1980, J CELL BIOL, V85, P890, DOI 10.1083/jcb.85.3.890; McKeon RJ, 1999, J NEUROSCI, V19, P10778; MCKEON RJ, 1995, EXP NEUROL, V136, P32, DOI 10.1006/exnr.1995.1081; Mocchetti I, 1996, EXP NEUROL, V141, P154, DOI 10.1006/exnr.1996.0149; PEKNY M, 1995, EMBO J, V14, P1590, DOI 10.1002/j.1460-2075.1995.tb07147.x; Peuchen S, 1997, PROG NEUROBIOL, V52, P261, DOI 10.1016/S0301-0082(97)00010-5; Reilly JF, 1998, GLIA, V22, P202, DOI 10.1002/(SICI)1098-1136(199802)22:2<202::AID-GLIA11>3.0.CO;2-1; Rothstein JD, 1996, NEURON, V16, P675, DOI 10.1016/S0896-6273(00)80086-0; RUDGE JS, 1989, EXP NEUROL, V103, P1, DOI 10.1016/0014-4886(89)90180-5; RUDGE JS, 1992, EUR J NEUROSCI, V4, P459, DOI 10.1111/j.1460-9568.1992.tb00896.x; Silver IA, 1997, NEUROSCIENCE, V78, P589, DOI 10.1016/S0306-4522(96)00600-8; Silver IA, 1997, GLIA, V21, P35, DOI 10.1002/(SICI)1098-1136(199709)21:1<35::AID-GLIA4>3.0.CO;2-0; Smith GM, 1997, J NEUROSCI, V17, P9624; Sonnewald U, 1997, GLIA, V21, P56, DOI 10.1002/(SICI)1098-1136(199709)21:1<56::AID-GLIA6>3.0.CO;2-#; STREICHERSCOTT J, 1993, ANAL BIOCHEM, V210, P69, DOI 10.1006/abio.1993.1152; Swanson RA, 1996, DEV NEUROSCI-BASEL, V18, P515, DOI 10.1159/000111448; Takahashi M, 1997, J EXP BIOL, V200, P401; Tanaka K, 1997, SCIENCE, V276, P1699, DOI 10.1126/science.276.5319.1699; Wang CX, 1997, BRAIN RES, V759, P190, DOI 10.1016/S0006-8993(97)00254-0; Wang X, 1997, EXP NEUROL, V148, P568, DOI 10.1006/exnr.1997.6702; Ye ZC, 1998, GLIA, V22, P237, DOI 10.1002/(SICI)1098-1136(199803)22:3<237::AID-GLIA3>3.0.CO;2-2; YU ACH, 1993, J NEUROSCI RES, V34, P295, DOI 10.1002/jnr.490340306; ZAMBRUNO G, 1995, J CELL BIOL, V129, P853, DOI 10.1083/jcb.129.3.853	46	22	22	0	3	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0014-4886			EXP NEUROL	Exp. Neurol.	JUN	2003	181	2					149	158		10.1016/S0014-4886(03)00043-8			10	Neurosciences	Neurosciences & Neurology	687RR	WOS:000183391000003	12781988	Green Accepted			2021-06-18	
J	Gabbe, B; Finch, CF; Wajswelner, H; Bennell, K				Gabbe, B; Finch, CF; Wajswelner, H; Bennell, K			Does community-level Australian football support injury prevention research?	JOURNAL OF SCIENCE AND MEDICINE IN SPORT			English	Article							PROFILE	The progress of injury prevention research in Australian football to date has been slow despite its recognition as a public health goal. In particular, field-based studies to identify injury risk factors and evaluate the effectiveness of injury prevention strategies need to be undertaken to ensure safety gains in this sport. For these types of studies to be successful and complied with, considerable support is required from clubs, coaches and players. To date, the actual level of support for injury prevention research at the community-level of football has not been established. A survey of 82 club administrators and coaches from the Victorian Amateur Football Association was undertaken to determine the level of support for injury prevention research, along with incentives for, and barriers towards, participation in such research. The highest priorities for injury prevention research were given as the prevention of knee, hamstring and concussion injuries and investigation into the content of training programs. The most common incentives reported as being necessary for participation in injury prevention research were financial assistance (59.5%), more club staff (57.0%) and further education (36.7%). The most commonly reported barriers to research were the expertise (50.0%) and number of (48.8%) of club medical staff members. Overall community-level football club administrators and coaches rank the importance of injury prevention research highly. The findings of this study are positive for injury prevention researchers and suggest that clubs are keen to participate in such research.	Univ Melbourne, Sch Physiotherapy, Ctr Sports Med Res & Educ, Melbourne, Vic, Australia; Monash Univ, Dept Epidemiol & Prevent Med, Clayton, Vic 3168, Australia	Gabbe, B (corresponding author), Univ Melbourne, Sch Physiotherapy, Ctr Sports Med Res & Educ, Melbourne, Vic, Australia.		; Bennell, Kim/C-7022-2014	Gabbe, Belinda/0000-0001-7096-7688; Wajswelner, Henry/0000-0003-2082-3816; Bennell, Kim/0000-0003-4982-5639			BANGDIWALA S, 2001, INJ CONTROL SAF PROM, V8, P91; Finch C, 1995, FEASIBILITY IMPROVED; Gabbe B, 2001, J SCI MED SPORT, V4, P386, DOI 10.1016/S1440-2440(01)80048-7; Gabbe B, 2002, J SCI MED SPORT, V5, P149, DOI 10.1016/S1440-2440(02)80036-6; GABBE B, 1998, TACKLING AUSTR FOOTB; Jekel JF, 1999, EPIDEMIOLOGY BIOSTAT; MCMAHON KA, 1993, MED J AUSTRALIA, V159, P301, DOI 10.5694/j.1326-5377.1993.tb137864.x; MOLLER J, 1999, PARADIGM SHIFT INJUR; Newton D. P., 2001, RES EDUC, V66, P54, DOI DOI 10.7227/RIE.66.5; Orchard J, 1999, MED J AUSTRALIA, V170, P304, DOI 10.5694/j.1326-5377.1999.tb127782.x; Orchard J, 1998, J SCI MED SPORT, V1, P82; SEWARD H, 1993, MED J AUSTRALIA, V159, P298, DOI 10.5694/j.1326-5377.1993.tb137863.x; Seward H. G., 1992, AUST J SCI MED SPORT, V24, P51; Shawdon A, 1994, Aust J Sci Med Sport, V26, P59; Stevenson MR, 2000, BRIT J SPORT MED, V34, P188, DOI 10.1136/bjsm.34.3.188; vanMechelen W, 1997, SPORTS MED, V24, P164, DOI 10.2165/00007256-199724030-00003; ZAZRYN T, 2002, UNPUB BRIT J SPORTS	17	22	22	0	6	SPORTS MEDICINE AUSTRALIA	DICKSON	PO BOX 237, DICKSON, ACT 2602, AUSTRALIA	1440-2440			J SCI MED SPORT	J. Sci. Med. Sport	JUN	2003	6	2					231	236		10.1016/S1440-2440(03)80259-1			6	Sport Sciences	Sport Sciences	710QP	WOS:000184691200012	12945630				2021-06-18	
J	van der Heijden, P; Donders, J				van der Heijden, P; Donders, J			WAIS-III factor index score patterns after traumatic brain injury	ASSESSMENT			English	Article						WAIS-III; cluster analysis; profile subtypes; traumatic brain injury	WISC-III; INTELLIGENCE; PERFORMANCE	Profile subtypes, based on the Wechsler Adult Intelligence Scale-Third Edition (WAIS-III) factor index scores, were examined in a sample of 166 patients with traumatic brain injury (TBI) by means of a two-stage clustering procedure. Three reliable subtypes were found that were differentiated primarily by level of performance across all factor index scores, although each of them demonstrated a relative weakness on the Processing Speed index. These subtypes were then validated on the basis of demographic variables, injury parameters, and additional psychometric measures that had not been included in the clustering procedures. The results indicated that performance on the WAIS-III after TBI was affected by both injury severity and level of education. It is concluded that there is no unique "signature" profile on the WAIS-III after TBI, except that a relative strength on the Processing Speed index is uncommon with this condition.	Mary Free Bed Hosp, Psychol Serv, Grand Rapids, MI USA; Univ Nijmegen, Nijmegen, Netherlands	Donders, J (corresponding author), Mary Free Bed Hosp, Psychol Serv, 235 Wealthy SE, Grand Rapids, MI USA.	jdonders@mfbrc.com					American Educational Research Association American Psychological Association & National Council on Measurement in Education, 1999, STAND ED PSYCH TEST; Axelrod BN, 2001, CLIN NEUROPSYCHOL, V15, P516, DOI 10.1076/clin.15.4.516.1884; Binder LM, 1997, J CLIN EXP NEUROPSYC, V19, P421, DOI 10.1080/01688639708403870; Donders J, 2001, J INT NEUROPSYCH SOC, V7, P892, DOI 10.1017/S1355617701777132; Donders J, 1996, PSYCHOL ASSESSMENT, V8, P312, DOI 10.1037/1040-3590.8.3.312; Donders J, 2001, ASSESSMENT, V8, P193, DOI 10.1177/107319110100800207; Donders J, 1997, CHILD NEUROPSYCHOL, V3, P71, DOI 10.1080/09297049708401369; Fuerst DR, 1995, CHILD NEUROPSYCHOL, V1, P38, DOI 10.1080/09297049508401341; Hawkins KA, 1998, CLIN NEUROPSYCHOL, V12, P535, DOI 10.1076/clin.12.4.535.7236; Heaton R., 1993, WISCONSIN CARD SORTI; Heaton R.K., 1991, COMPREHENSIVE NORMS; Kaufman AS, 2001, ASSESSMENT, V8, P267, DOI 10.1177/107319110100800303; Kaufman AS, 1999, ESSENTIALS WAIS 3 AS; Manly JJ, 2002, J INT NEUROPSYCH SOC, V8, P341, DOI 10.1017/S1355617702813157; Martin J, 2001, J TURBUL, V2, P1; Martin TA, 2000, REHABIL PSYCHOL, V45, P402, DOI 10.1037/0090-5550.45.4.402; MCDERMOTT PA, 1990, J PSYCHOEDUC ASSESS, V8, P290, DOI 10.1177/073428299000800307; MCDERMOTT PA, 1989, PSYCHOL ASSESSMENT J, V1, P118; MILLIGAN GW, 1985, PSYCHOMETRIKA, V50, P159, DOI 10.1007/BF02294245; *PSYCH CORP, 2001, WAIS 3 WMS 3 WIAT 2; Reitan R.M., 1993, HALSTEADREITAN NEURO; Saklofske DH, 2000, PSYCHOL ASSESSMENT, V12, P436, DOI 10.1037/1040-3590.12.4.436; SAS Institute, 1990, SAS STAT US GUID, V1; SATTLER JM, 1999, ASSESSMENT CHILDREN; Schinka JA, 1998, PSYCHOL ASSESSMENT, V10, P171, DOI 10.1037/1040-3590.10.2.171; Stern Y, 2002, J INT NEUROPSYCH SOC, V8, P448, DOI 10.1017/S1355617702813248; Taylor MJ, 2001, J INT NEUROPSYCH SOC, V7, P867, DOI 10.1017/S1355617701777107; Tombaugh TN, 1996, TEST MEMORY MALINGER; Tulsky DS, 2000, CLIN NEUROPSYCHOL, V14, P451, DOI 10.1076/clin.14.4.451.7202; VANDERHEIJDEN P, IN PRESS J CLIN EXPT; Warrington EK., 1984, RECOGNITION MEMORY T; Wechsler, 1997, WAIS 3 WMS 3 TECHNIC; Wechsler D., 2001, WECHSLER TEST ADULT; Wechsler D., 1991, WECHSLER INTELLIGENC; Wechsler D, 1997, WAIS 3 ADM SCORING M; Wiegner S, 1999, J CLIN EXP NEUROPSYC, V21, P159, DOI 10.1076/jcen.21.2.159.925	36	22	22	0	4	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1073-1911	1552-3489		ASSESSMENT	Assessment	JUN	2003	10	2					115	122		10.1177/1073191103010002001			8	Psychology, Clinical	Psychology	683WA	WOS:000183173000001	12801182				2021-06-18	
J	Zaltzman, R; Beni, SM; Giladi, E; Pinhasov, A; Steingart, RA; Romano, J; Shohami, E; Gozes, I				Zaltzman, R; Beni, SM; Giladi, E; Pinhasov, A; Steingart, RA; Romano, J; Shohami, E; Gozes, I			Injections of the neuroprotective peptide NAP to newborn mice attenuate head-injury-related dysfunction in adults	NEUROREPORT			English	Article						inflammation; peptides; traumatic brain injury; water maze	TRAUMATIC BRAIN INJURY; E-DEFICIENT MICE; NEURONAL CULTURES; MEMORY DEFICITS; PC12 CELLS; RAT-BRAIN; PROTEIN; DEATH; VIP; PROTECTION	The prophylactic neuroprotective effects of NAP, a femtomolar-acting neuroprotective peptide were tested in a mouse model of head trauma. NAP was injected for the first 3 weeks of life and head injury was initiated at 4 months. After trauma, mice were tested for their performance by evaluating damaged motor ability, balance and alertness. Comparison of the performance 1 h and 1 week after injury indicated that NAP treatment resulted in faster and enhanced recovery. In a 5-day Morris water maze test with mice suffering moderate to severe injuries, only the NAP-treated group learned to find the hidden platform in the maze. Furthermore, NAP treatment resulted in decreased mRNA expression of the inflammation marker, Mac-I. Thus, a potentially new prophylactic treatment against neurodegeneration is suggested.	Tel Aviv Univ, Sackler Sch Med, Dept Clin Biochem, IL-69978 Tel Aviv, Israel; Hebrew Univ Jerusalem, Hadassah Med Ctr, Dept Pharmacol, Jerusalem, Israel	Gozes, I (corresponding author), Tel Aviv Univ, Sackler Sch Med, Dept Clin Biochem, IL-69978 Tel Aviv, Israel.		Pinhasov, Albert/X-5304-2019	Pinhasov, Albert/0000-0001-8116-4565			Bassan M, 1999, J NEUROCHEM, V72, P1283, DOI 10.1046/j.1471-4159.1999.0721283.x; Beni-Adani L, 2001, J PHARMACOL EXP THER, V296, P57; Benimetskaya L, 1997, NAT MED, V3, P414, DOI 10.1038/nm0497-414; Chopp M, 1996, J CEREBR BLOOD F MET, V16, P578, DOI 10.1097/00004647-199607000-00007; Clark RSB, 2000, J NEUROCHEM, V74, P740, DOI 10.1046/j.1471-4159.2000.740740.x; Colicos MA, 1996, BRAIN RES, V739, P120, DOI 10.1016/S0006-8993(96)00824-4; Gonzalez-Scarano F, 1999, ANNU REV NEUROSCI, V22, P219, DOI 10.1146/annurev.neuro.22.1.219; GORDON I, 1995, NEUROSCI LETT, V199, P1, DOI 10.1016/0304-3940(95)12006-P; Gozes I, 1997, J NEUROBIOL, V33, P329, DOI 10.1002/(SICI)1097-4695(199709)33:3<329::AID-NEU10>3.0.CO;2-A; Gozes I, 2001, TRENDS NEUROSCI, V24, P700, DOI 10.1016/S0166-2236(00)01931-7; Gozes I, 2000, J MOL NEUROSCI, V14, P61, DOI 10.1385/JMN:14:1-2:061; GOZES I, 2000, J PHARMACOL EXP THER, V293, P1191; Hailer NP, 2001, NEUROSCI LETT, V298, P33, DOI 10.1016/S0304-3940(00)01711-0; HILL JM, 1991, PEPTIDES, V12, P187, DOI 10.1016/0196-9781(91)90186-S; Koshinaga M, 2000, J NEUROTRAUM, V17, P185, DOI 10.1089/neu.2000.17.185; Leker RR, 2002, STROKE, V33, P1085, DOI 10.1161/01.STR.0000014207.05597.D7; Offen D, 2000, BRAIN RES, V854, P257, DOI 10.1016/S0006-8993(99)02375-6; Panikashvili D, 2001, NATURE, V413, P527, DOI 10.1038/35097089; Romano J, 2002, J MOL NEUROSCI, V18, P37, DOI 10.1385/JMN:18:1-2:37; Sigalov E, 2000, J MOL NEUROSCI, V15, P147, DOI 10.1385/JMN:15:3:147; Spong CY, 2001, J PHARMACOL EXP THER, V297, P774; Steingart RA, 2000, J MOL NEUROSCI, V15, P137, DOI 10.1385/JMN:15:3:137; Tan SM, 2000, J IMMUNOL, V165, P2574, DOI 10.4049/jimmunol.165.5.2574; Zamostiano R, 2001, J BIOL CHEM, V276, P708, DOI 10.1074/jbc.M007416200; Zemlyak I, 2000, REGUL PEPTIDES, V96, P39, DOI 10.1016/S0167-0115(00)00198-1	25	22	22	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0959-4965			NEUROREPORT	Neuroreport	MAR 3	2003	14	3					481	484		10.1097/01.wnr.0000058036.29600.ff			4	Neurosciences	Neurosciences & Neurology	656ZW	WOS:000181641800037	12634508				2021-06-18	
J	Booher, MA; Wisniewski, T; Smith, BW; Sigurdsson, A				Booher, MA; Wisniewski, T; Smith, BW; Sigurdsson, A			Comparison of reporting systems to determine concussion incidence in NCAA Division I collegiate football	CLINICAL JOURNAL OF SPORT MEDICINE			English	Article						concussion; Internet; college football; NCAA	SPORTS; MANAGEMENT; PLAYERS	Objective: To determine the incidence of concussion during the 2001 Division I-A college football season through utilization of the Internet. Design: Prospective Internet survey. Setting: Internet Web site. Participants: Head athletic trainers from Division I-A collegiate football programs. Main Outcome Measures: During the 2001-2002 football season, head athletic trainers from 87 Division I-A football programs agreed to use an Internet Web site to submit weekly data on the number of athlete exposures and concussions. Results: A total of 373 concussions were reported over the course of a season in both practices and games combined. Of these concussions, 256 (68.6%) occurred during games, and 117 (31.4%) occurred during practice. The injury rate per 1,000 athletic exposures was 5.56 in games and 0.25 in practices. There were 230 grade 1 (61.7%), 134 grade 2 (35.9%), and 9 grade 3 (2.4%) concussions reported. There was a significant (p < 0.01) difference found between the total concussion injury rate and game concussion injury rate when comparing the Internet and the NCAA injury data collection methods. Conclusions: The results of this study suggest an underreporting of concussions using the NCAA Injury Surveillance System and demonstrate that the Internet is a simple and effective tool for data collection.	Univ N Carolina, James A Taylor Student Hlth Serv, Div Sports Med, Chapel Hill, NC 27599 USA; Univ N Carolina, Dept Endodont, Div Sports Med, Chapel Hill, NC 27599 USA; Univ N Carolina, Dept Pediat & Orthoped, Div Sports Med, Chapel Hill, NC 27599 USA	Booher, MA (corresponding author), Univ N Carolina, James A Taylor Student Hlth Serv, Div Sports Med, CB 7470, Chapel Hill, NC 27599 USA.	booher@email.unc.edu	Wisniewski, Thomas/Q-6525-2019	Wisniewski, Thomas/0000-0002-3379-8966			CANTU RC, 1986, PHYSICIAN SPORTSMED, V14, P75, DOI 10.1080/00913847.1986.11709197; Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P964, DOI 10.1001/jama.282.10.964; DICK RW, 2002, FOOTBALL INJURY REPO; GRONWALL D, 1975, LANCET, V2, P995; Guskiewicz KM, 2000, AM J SPORT MED, V28, P643, DOI 10.1177/03635465000280050401; Kelly JP, 1997, NEUROLOGY, V48, P575, DOI 10.1212/WNL.48.3.575; Kelly JP, 1997, NEUROLOGY, V48, P581; Labella CR, 2002, MED SCI SPORT EXER, V34, P41, DOI 10.1097/00005768-200201000-00007; SIGURDSSON A, IN PRESS DENT TRAUMA	9	22	22	0	7	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	1050-642X			CLIN J SPORT MED	Clin. J. Sport Med.	MAR	2003	13	2					93	95		10.1097/00042752-200303000-00005			3	Orthopedics; Physiology; Sport Sciences	Orthopedics; Physiology; Sport Sciences	658ZH	WOS:000181750900005	12629426				2021-06-18	
J	Finnie, JW; Manavis, J; Summersides, GE; Blumbergs, PC				Finnie, JW; Manavis, J; Summersides, GE; Blumbergs, PC			Brain damage in pigs produced by impact with a non-penetrating captive bolt pistol	AUSTRALIAN VETERINARY JOURNAL			English	Article							AMYLOID PRECURSOR PROTEIN; AXONAL INJURY; LAMBS; MODEL; HEAD	Objective To assess the effect of impact with a nonpenetrating captive bolt pistol in pigs by studying the resulting traumatic brain injury (TBI) and to compare the pathological changes with those found previously in the brains of sheep using a similar experimental paradigm. Procedure The unrestrained heads of six, anaesthetised, 7- to 8-week-old, Large White pigs were impacted in the temporal region with a nonpenetrating captive bolt pistol. Four hours postimpact, brains were perfusion-fixed with 4% paraformaldehyde. Coronal sections from six levels along the brain were cut and stained with haematoxylin and eosin and immunohistochemically for amyloid precursor protein, a sensitive marker of axonal injury (AI) in the brain after trauma. Results TBI in pigs was characterised only by very mild AI, whereas AI in sheep after captive bolt impact to the same head region was much more severe and widely distributed and often associated with vascular damage such as contusions, subarachnoid and intraparenchymal haemorrhage. Conclusions TBI in pigs was much less severe than in sheep after non-penetrating mechanical impact of similar magnitude, confirming the importance of interspecies differences in determining an appropriate physical method of euthanasia.	Univ Adelaide, Vet Serv Div, Adelaide, SA, Australia; Univ Adelaide, Inst Med & Vet Sci, Neuropathol Lab, Adelaide, SA, Australia; Univ Adelaide, Dept Pathol, Adelaide, SA, Australia	Finnie, JW (corresponding author), Univ Adelaide, Vet Serv Div, Adelaide, SA, Australia.						BLACKMORE DK, 1995, NEW ZEAL VET J, V43, P134, DOI 10.1080/00480169.1995.35872; Blumbergs P. C., 1997, HEAD INJURY PATHOPHY, P39; DOBBING J, 1981, SCI FDN PAEDIAT, P745; Finnie J, 1999, J CLIN NEUROSCI, V6, P38, DOI 10.1016/S0967-5868(99)90601-X; Finnie JW, 2000, AUST VET J, V78, P775, DOI 10.1111/j.1751-0813.2000.tb10451.x; Finnie JW, 2001, J COMP PATHOL, V124, P159, DOI 10.1053/jcpa.2000.0446; GARHAM DI, 1997, GREENFIELDS NEUROPAT, P197; Getty, 1975, SISSON GROSSMANS ANA; KOO EH, 1990, P NATL ACAD SCI USA, V87, P1561, DOI 10.1073/pnas.87.4.1561; Lewis SB, 1996, J NEUROTRAUM, V13, P505, DOI 10.1089/neu.1996.13.505; Mattson MP, 1997, PHYSIOL REV, V77, P1081; MAY NDS, 1964, ANATOMY SHEEP, P240; *NAT HLTH MED RES, 1997, AUSTR COD PRACT CAR; ROSS DT, 1994, EXP NEUROL, V126, P291, DOI 10.1006/exnr.1994.1067; SHERRIFF FE, 1994, ACTA NEUROPATHOL, V88, P433; Van den Heuvel C, 1999, EXP NEUROL, V159, P441, DOI 10.1006/exnr.1999.7150	16	22	22	0	21	WILEY-BLACKWELL	MALDEN	COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA	0005-0423			AUST VET J	Aust. Vet. J.	MAR	2003	81	3					153	155		10.1111/j.1751-0813.2003.tb11078.x			3	Veterinary Sciences	Veterinary Sciences	660NU	WOS:000181839900031	15080429				2021-06-18	
J	Cherian, L; Chacko, G; Goodman, C; Robertson, CS				Cherian, L; Chacko, G; Goodman, C; Robertson, CS			Neuroprotective effects of L-arginine administration after cortical impact injury in rats: Dose response and time window	JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS			English	Article							CEREBRAL BLOOD-FLOW; TRAUMATIC BRAIN INJURY; NITRIC-OXIDE SYNTHASE; METHYL-D-ASPARTATE; SUPEROXIDE; ISCHEMIA; DAMAGE; REDUCTION; VELOCITY; INSULTS	Administration of L-arginine has been shown to increase cerebral blood flow and reduce neurological damage after experimental traumatic brain injury. The purpose of this study was to examine the optimal dose and time window for these neuroprotective effects. In a dose response experiment, doses of L-arginine ranging from 37.5 to 600 mg/kg were administered 5 min after a 5-m/s, 3-mm, controlled cortical impact in rats. The amount of brain injury found at 2 weeks after injury, both at the contusion site and in the ipsilateral hippocampus, were inversely related to the dose of L-arginine administered. Both 300- and 600-mg/kg doses of L-arginine significantly reduced contusion volume. The 300-mg/kg dose significantly increased the neuron density in the CA1 region of the hippocampus. Physiological effects of L-arginine were also dose-related. The greatest reduction in intracranial pressure occurred with the 300-mg/kg dose of L-arginine. Doses up to 300 mg/kg were well tolerated, but the 600-mg/kg dose resulted in transient hypotension. In another experiment, 300 mg/kg L-arginine was administered at times varying from 5 min to 48 h after injury. Contusion volume was significantly reduced when the L-arginine was given at 5 min and 1 h after injury. The protective effect was less when the same dose was given at the later times, but there was no evidence of an adverse effect even when the L-arginine was administered 48 h after injury.	Baylor Coll Med, Dept Neurosurg, Houston, TX 77030 USA	Cherian, L (corresponding author), Baylor Coll Med, Dept Neurosurg, 1 Baylor Plaza, Houston, TX 77030 USA.				NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P01NS038660] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P01-NS38660] Funding Source: Medline		BARBUL A, 1990, SURGERY, V108, P331; BECKMAN JS, 1990, P NATL ACAD SCI USA, V87, P1620, DOI 10.1073/pnas.87.4.1620; BONFOCO E, 1995, P NATL ACAD SCI USA, V92, P7162, DOI 10.1073/pnas.92.16.7162; BOUMA GJ, 1992, J NEUROSURG, V77, P360, DOI 10.3171/jns.1992.77.3.0360; BOUMA GJ, 1991, J NEUROSURG, V75, P685, DOI 10.3171/jns.1991.75.5.0685; Cherian L, 1999, CRIT CARE MED, V27, P2512, DOI 10.1097/00003246-199911000-00031; Cherian L, 1996, J NEUROTRAUM, V13, P371, DOI 10.1089/neu.1996.13.371; CHERIAN L, 1994, J NEUROTRAUM, V11, P573, DOI 10.1089/neu.1994.11.573; CHERIAN L, 2002, IN PRESS J NEUROTRAU; DeWitt DS, 1997, J NEUROTRAUM, V14, P223, DOI 10.1089/neu.1997.14.223; FAGNI L, 1995, MOL PHARMACOL, V47, P1239; Giri BK, 2000, STROKE, V31, P961, DOI 10.1161/01.STR.31.4.961; GOPINATH SP, 1994, J NEUROL NEUROSUR PS, V57, P717, DOI 10.1136/jnnp.57.6.717; Iadecola C, 1997, J NEUROSCI, V17, P9157; IADECOLA C, 1993, TRENDS NEUROSCI, V16, P206, DOI 10.1016/0166-2236(93)90156-G; Iadecola C, 1997, TRENDS NEUROSCI, V20, P132, DOI 10.1016/S0166-2236(96)10074-6; Kelly DF, 1997, J NEUROSURG, V86, P633, DOI 10.3171/jns.1997.86.4.0633; Kontos HA, 1998, AM J PHYSIOL-HEART C, V274, pH974; LIPTON SA, 1993, NATURE, V364, P626, DOI 10.1038/364626a0; MARION DW, 1991, J NEUROSURG, V74, P407, DOI 10.3171/jns.1991.74.3.0407; Micieli G, 1997, J NEUROL SCI, V150, P71, DOI 10.1016/S0022-510X(97)05380-X; MONTAGUE PR, 1994, SCIENCE, V263, P973, DOI 10.1126/science.7508638; MORIKAWA E, 1994, STROKE, V25, P429, DOI 10.1161/01.STR.25.2.429; REIF DW, 1990, ARCH BIOCHEM BIOPHYS, V283, P537, DOI 10.1016/0003-9861(90)90680-W; Reutens DC, 1997, J CEREBR BLOOD F MET, V17, P309, DOI 10.1097/00004647-199703000-00008; REYES AA, 1994, AM J PHYSIOL, V267, pF331; Sadoshima S, 1997, BRAIN RES, V744, P246, DOI 10.1016/S0006-8993(96)01063-3; SEIFTER E, 1978, SURGERY, V84, P224; Sinz EH, 1999, J CLIN INVEST, V104, P647, DOI 10.1172/JCI6670; Wada K, 1998, NEUROSURGERY, V43, P1427, DOI 10.1097/00006123-199812000-00096; ZHANG FY, 1994, J CEREBR BLOOD F MET, V14, P574, DOI 10.1038/jcbfm.1994.71; ZHANG FY, 1994, J CEREBR BLOOD F MET, V14, P217, DOI 10.1038/jcbfm.1994.28; Zhang FY, 1996, STROKE, V27, P317, DOI 10.1161/01.STR.27.2.317; ZHANG FY, 1993, NEUROREPORT, V4, P559, DOI 10.1097/00001756-199305000-00024	34	22	24	0	1	AMER SOC PHARMACOLOGY EXPERIMENTAL THERAPEUTICS	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0022-3565			J PHARMACOL EXP THER	J. Pharmacol. Exp. Ther.	FEB	2003	304	2					617	623		10.1124/JPET.102.043430			7	Pharmacology & Pharmacy	Pharmacology & Pharmacy	637RL	WOS:000180526600017	12538814				2021-06-18	
J	Foxx-Orenstein, A; Kolakowsky-Hayner, S; Marwitz, JH; Cifu, DX; Dunbar, A; Englander, J; Francisco, G				Foxx-Orenstein, A; Kolakowsky-Hayner, S; Marwitz, JH; Cifu, DX; Dunbar, A; Englander, J; Francisco, G			Incidence, risk factors, and outcomes of fecal incontinence after acute brain injury: Findings form the traumatic brain injury model systems national database	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						brain injuries; fecal incontinence; incidence; rehabilitation; risk factors; treatment outcome	STROKE REHABILITATION	Objective: To investigate the incidence, risk factors, and outcome in patients with fecal incontinence after acute brain injury. Design: A retrospective study of the incidence of and risk factors contributing to fecal incontinence, and outcomes at admission to and discharge from inpatient rehabilitation and at 1-year follow-up. Setting: Medical centers in the federally sponsored Traumatic Brain Injury Model Systems (TBIMS). Participants: A total of 1013 consecutively enrolled rehabilitation inpatients from 17 TBIMS centers who were admitted to acute care within 24 hours of traumatic brain injury and seen at 1-year postinjury between 1990 and 2000. Interventions: Not applicable. Main Outcome Measures: Incidence of fecal incontinence, length of coma, length of posttraumatic amnesia (PTA), admission Glasgow Coma Scale (GCS) score, length of stay (LOS), FIM(TM) instrument scores, disposition at discharge and follow-up, and incidences of pelvic fracture, frontal contusion, and urinary tract infection (UTI). Results: The incidence of fecal incontinence was 68% at admission to inpatient rehabilitation, 12.4% at rehabilitation discharge, and 5.2% at 1-year follow-up. Analysis of variance and chi-square analyses revealed statistically significant associations between the incidence of fecal incontinence at rehabilitation admission and admission GCS score, length of coma and PTA, LOS, and incidence of UTI and frontal contusion. Fecal incontinence at rehabilitation discharge was significantly associated with several variables, including age, discharge disposition, admission GCS score, length of coma, PTA, LOS, FIM scores, and incidence of pelvic fracture and frontal contusion. Significant associations were also found between fecal incontinence at 1-year follow-up and age, discharge and current 1-year disposition, admission GCS score, length of coma, LOS, FIM scores, and incidence of UTI (P<.05). Although logistic regression analyses were significant (P<.001), and predicted continence with 100% accuracy, demographics, injury characteristics, medical complications, and functional outcomes did not predict incontinence at discharge and at 1-year follow-up. Conclusions: Fecal incontinence is a significant problem after brain injury. Certain factors may increase its likelihood. Further studies evaluating mechanisms of fecal incontinence and treatment or control interventions would be useful.	Virginia Commonwealth Univ, Dept Phys Med & Rehabil, Richmond, VA 23298 USA; Santa Clara Valley Med Ctr, San Jose, CA 95128 USA; TIRR, Houston, TX USA	Marwitz, JH (corresponding author), Virginia Commonwealth Univ, Dept Phys Med & Rehabil, Box 980542, Richmond, VA 23298 USA.		Kolakowsky-Hayner, Stephanie A./I-9858-2019	Kolakowsky-Hayner, Stephanie A./0000-0002-6228-9909; Cifu, David/0000-0003-1600-9387			CHOI SC, 1983, J NEUROSURG, V59, P294, DOI 10.3171/jns.1983.59.2.0294; Cifu DX, 1996, ARCH PHYS MED REHAB, V77, P883, DOI 10.1016/S0003-9993(96)90274-9; CIFU DX, 1994, ARCH PHYS MED REHAB, V75, pS56; Faltin DL, 2001, INT UROGYNECOL J, V12, P117, DOI 10.1007/PL00004031; FORER S, 1982, J ORGAN REHABIL EVAL, V2, P29; Francombe J, 2001, HOSP MED, V62, P529, DOI 10.12968/hosp.2001.62.9.1641; Gibson E, 1990, Prof Nurse, V6, P38; GRANGER CV, 1989, ARCH PHYS MED REHAB, V70, P100; Granger CV, 1986, TOP GERIATR REHABIL, V1, P59, DOI 10.1097/00013614-198604000-00007; HAGEN C, 1982, COGNITIVE REHABILITA, P131; HALL KM, 1994, ARCH PHYS MED REHAB, V75, pSC10; HarrisonFelix C, 1996, J HEAD TRAUMA REHAB, V11, P1, DOI 10.1097/00001199-199610000-00002; Haugen V, 1995, J Wound Ostomy Continence Nurs, V22, P291; Jacquot JM, 1999, REV RHUM, V66, P109; MALKMUS D, 1979, REHABILITATION HEAD; Toglia MR, 1998, OBSTET GYN CLIN N AM, V25, P771, DOI 10.1016/S0889-8545(05)70042-5; 1996, GUIDE UNIFORM DATA S	17	22	22	0	2	W B SAUNDERS CO	PHILADELPHIA	INDEPENDENCE SQUARE WEST CURTIS CENTER, STE 300, PHILADELPHIA, PA 19106-3399 USA	0003-9993			ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	FEB	2003	84	2					231	237		10.1053/apmr.2003.50095			7	Rehabilitation; Sport Sciences	Rehabilitation; Sport Sciences	643QV	WOS:000180872700012	12601654				2021-06-18	
J	King, JH; Sweet, JJ; Sherer, M; Curtiss, G; Vanderploeg, RD				King, JH; Sweet, JJ; Sherer, M; Curtiss, G; Vanderploeg, RD			Validity indicators within the Wisconsin Card Sorting Test: Application of new and previously researched multivariate procedures in multiple traumatic brain injury samples	CLINICAL NEUROPSYCHOLOGIST			English	Article							FORCED-CHOICE METHOD; VERBAL-LEARNING TEST; HEAD-INJURY; PERFORMANCE; IMPAIRMENT	The Wisconsin Card Sorting Test (WCST) is a popular neuropsychological measure of executive dysfunction that has been researched with regard to invalid performances, a subset of which in a forensic context could be associated with malingering. In the first of three studies, WCST multivariate approaches identified in prior research (Bernard, McGrath, Houston, 1996; Suhr & Boyer, 1999), as well as newly created variables, were used to differentiate 33 chronic traumatic brain injury (TBI) patients with good effort and 27 patients with probable insufficient effort (IE). Newly created variables that were derived logically based upon hypotheses regarding strategies that might be employed by malingerers were not effective in differentiating TBI and IE groups. Application of previously researched validity indicators based upon commonly used WCST variables, individually, and within new logistic regression findings were reasonably effective in differentiating TBI and IE groups. In order to determine whether results would vary in different TBI samples, these validity indicators were examined in Study 2 with 75 moderate and severe, acute TBI rehabilitation patients whose posttraumatic amnesia had just resolved. Statistically significant differences were present between the IE group of Study I and the rehabilitation patient group of Study 2 on failures to maintain set, number of trials to achieve first correct category, and number of categories completed. All these measures were performed more poorly by the IE group. However, previously used multivariate approaches and the logistic regression analysis developed in Study 1 ranged widely in the degree to which Study 2's more acute rehabilitation patients were correctly classified. Specifically, the discriminant function of Bernard and colleagues correctly classified 73% and the Suhr and Boyer logistic regression correctly classified 75% of the Study 2 participants. The Study I1 logistic regression classified 97% of the Study 2 participants correctly. In Study 3, 130 mild to severe TBI patients in the VA system were studied. The Study 1 IE group performed significantly worse than the more acute and more severe VATBI group on all 10 common WCST variables of interest. Application of the three multivariate procedures resulted in good to excellent classification rates: Suhr and Boyer logistic regression 85%, Bernard et al. discriminant function 85%, and Study I logistic regression 99%. The aggregate discussion of the three studies focuses on apparent differences in samples associated with varying degrees of success in identifying TBI patients. Application of these validity indicators in forensic situations should consider that some of these multivariate approaches possess possible classification limitations associated with chronicity and severity of the reported TBI. Only the Study I logistic regression demonstrated improved classification rates with the more acute and severe patients of Study 2 and Study 3. As with all validity indicators, use of any WCST IE criteria in isolation would not be appropriate.	Evanston NW Healthcare, Evanston, IL USA; Univ Mississippi, Med Ctr, Methodist Rehabil Ctr, Jackson, MS 39216 USA; James A Haley Vet Adm Med Ctr, Tampa, FL 33612 USA	Sweet, JJ (corresponding author), ENH Med Grp, 909 Davis St,Suite 160, Evanston, IL 60201 USA.	j-sweet@northwestern.edu	Curtiss, Glenn/ABB-5566-2020				American Psychiatric Association, 1994, DIAGN STAT MAN MENT; BERNARD LC, 1993, J CLIN PSYCHOL, V49, P45, DOI 10.1002/1097-4679(199301)49:1<45::AID-JCLP2270490107>3.0.CO;2-7; Bernard LC, 1996, ARCH CLIN NEUROPSYCH, V11, P231, DOI 10.1016/0887-6177(95)00025-9; BINDER LM, 1993, J CLIN EXP NEUROPSYC, V15, P170, DOI 10.1080/01688639308402555; BOLTER JF, 1985, ANN M NAT AC NEUR PH; BOLTER JF, 1990, MULTIDIGIT MEMORY TE; CONDER R, 1992, COMPUTERIZED ASSESSM; Delis DC, 1987, CALIFORNIA VERBAL LE; DEMAKIS G, IN PRESS NEUROPSYCHO; Demakis GJ, 2001, PSYCHOL ASSESSMENT, V13, P240, DOI 10.1037//1040-3590.13.2.240; DiCarlo MA, 2000, ARCH CLIN NEUROPSYCH, V15, P399, DOI 10.1016/S0887-6177(99)00031-1; DONDERS JD, 1999, J FORENSIC NEUROPSYC, V1, P34; Ferland MB, 1998, J CLIN EXP NEUROPSYC, V20, P473, DOI 10.1076/jcen.20.4.473.1475; Greiffenstein M.F., 1994, PSYCHOL ASSESSMENT, V6, P218, DOI [https://doi.org/10.1037/1040-3590.6.3.218, DOI 10.1037/1040-3590.6.3.218]; Greve KW, 2002, CLIN NEUROPSYCHOL, V16, P179, DOI 10.1076/clin.16.2.179.13241; Greve KW, 2002, J CLIN EXP NEUROPSYC, V24, P48, DOI 10.1076/jcen.24.1.48.968; GUILMETTE TJ, 1993, CLIN NEUROPSYCHOL, V7, P59, DOI 10.1080/13854049308401888; Heaton R. K, 1981, WISCONSIN CARD SORTI; HEATON RK, 1993, WCST COMPUTER VERSIO; HEATON RK, 1999, WCST COMPUTER VERSIO; Hellman S. G., 1992, INT J METH PSYCH RES, V2, P151; HISCOCK M, 1989, J CLIN EXP NEUROPSYC, V11, P967, DOI 10.1080/01688638908400949; Iverson GL, 1998, BRAIN INJURY, V12, P275, DOI 10.1080/026990598122575; Iverson GL, 2000, J CLIN EXP NEUROPSYC, V22, P191, DOI 10.1076/1380-3395(200004)22:2;1-1;FT191; Iverson GL, 2000, J HEAD TRAUMA REHAB, V15, P829, DOI 10.1097/00001199-200004000-00006; IVERSON GL, 2001, AM J FORENSIC PSYCH, V19, P5; King JH, 1998, J CLIN EXP NEUROPSYC, V20, P603, DOI 10.1076/jcen.20.5.603.1124; Miller A., 2000, CLIN NEUROPSYCHOLOGI, V2, P141; Millis SR, 1995, PSYCHOL ASSESSMENT, V7, P463; MILLIS SR, 1992, CLIN NEUROPSYCHOL, V6, P406; MILNER B, 1963, ARCH NEUROL-CHICAGO, V9, P90, DOI 10.1001/archneur.1963.00460070100010; MITTENBERG W, 1995, PROF PSYCHOL-RES PR, V26, P491, DOI 10.1037/0735-7028.26.5.491; Mittenberg W, 2001, CLIN NEUROPSYCHOL, V15, P440; MITTENBERG W, 1993, PSYCHOL ASSESSMENT, V5, P34, DOI DOI 10.1037/1040-3590.5.1.34; ROBINSON AL, 1980, J CONSULT CLIN PSYCH, V48, P605, DOI 10.1037/0022-006X.48.5.605; ROGERS R, 1990, PROFESSIONAL PSYCHOL, V32, P182; Salazar AM, 2000, J HEAD TRAUMA REHAB, V15, P1081, DOI 10.1097/00001199-200010000-00002; SLICK D, 1994, J CLIN EXP NEUROPSYC, V16, P472, DOI 10.1080/01688639408402657; Slick DJ, 2000, J CLIN EXP NEUROPSYC, V22, P569, DOI 10.1076/1380-3395(200010)22:5;1-9;FT569; Suhr J, 1997, J CLIN EXP NEUROPSYC, V19, P500, DOI 10.1080/01688639708403740; Suhr JA, 1999, J CLIN EXP NEUROPSYC, V21, P701, DOI 10.1076/jcen.21.5.701.868; Sweet JJ, 1999, STUD NEUROPSYCHOL DE, P255; Sweet JJ, 2000, ARCH CLIN NEUROPSYCH, V15, P105, DOI 10.1016/S0887-6177(98)00153-X; Tenhula WN, 1996, CLIN NEUROPSYCHOL, V10, P104, DOI 10.1080/13854049608406669; Tombaugh TN, 1997, PSYCHOL ASSESSMENT, V9, P260, DOI 10.1037/1040-3590.9.3.260; TRUEBLOOD W, 1993, J CLIN EXP NEUROPSYC, V15, P578, DOI 10.1080/01688639308402580; van Gorp WG, 1999, J CLIN EXP NEUROPSYC, V21, P245; Vickery CD, 2001, ARCH CLIN NEUROPSYCH, V16, P45, DOI 10.1016/S0887-6177(99)00058-X	48	22	22	1	8	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1385-4046	1744-4144		CLIN NEUROPSYCHOL	Clin. Neuropsychol.	DEC	2002	16	4					506	523		10.1076/clin.16.4.506.13912			18	Psychology, Clinical; Clinical Neurology; Psychology	Psychology; Neurosciences & Neurology	681AY	WOS:000183015300009	12822059				2021-06-18	
J	Dai, YT; Wu, SC; Weng, R				Dai, YT; Wu, SC; Weng, R			Unplanned hospital readmission and its predictors in patients with chronic conditions	JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION			English	Article						unplanned readmission; predictors	ELDERLY-PATIENTS; CARE; INDEX	Background and Purpose: Unplanned hospital readmission is a devastating experience for patients and is costly for society. This study determined the 60-day unplanned readmission rate and its predicting factors in patients with chronic conditions. Methods: A total of 334 patients discharged from five hospitals were followed for 2 months after discharge. Patients enrolled in the study were disabled and had a diagnosis of progressive chronic disease (congestive heart failure, chronic pulmonary disease, cancer) or chronic impairment following an acute episode (stroke, traumatic brain injury, hip fracture). Patients were assessed before discharge to collect in-hospital variables. Telephone interviews with patients and families were used to collect data on hospital readmission. Results: Of the 334 patients followed, 76 had unplanned readmission (24.4%). Patients with progressive chronic disease had a higher readmission rate (40.9%) than those with chronic impairment following an acute episode (15.1%). Frailty and abnormal respiratory pattern were significant predictors of readmission for patients with progressive chronic disease. The predictors of readmission for patients with chronic impairment following an acute episode included frailty, clinical instability and discharge from a regional hospital. The major reasons for hospital readmission were exacerbation of the initial major disease (33/76, 43.4%) and infection (21/76, 27.7%). Conclusions: Exacerbation of chronic diseases and infection are the two major reasons for unplanned readmission. Patients with a progressive chronic disease are more likely to be readmitted.	Natl Taiwan Univ, Coll Med, Dept Nursing, Taipei 100, Taiwan; Natl Taiwan Univ Hosp, Dept Nursing, Taipei, Taiwan; Natl Taiwan Univ, Grad Inst Hlth Policy & Management, Coll Publ Hlth, Taipei 100, Taiwan; Dept Hlth, Bur Hlth Promot, Taipei, Taiwan	Dai, YT (corresponding author), Natl Taiwan Univ, Coll Med, Dept Nursing, 1 Jen Ai Rd,Sect 1, Taipei 100, Taiwan.			DAI, YU-TZU/0000-0002-3803-3516			ANDERSON GF, 1984, NEW ENGL J MED, V311, P1349, DOI 10.1056/NEJM198411223112105; ANDERSON GF, 1985, INQUIRY-J HEALTH CAR, V22, P251; Anderson M A, 1996, J Community Health Nurs, V13, P1, DOI 10.1207/s15327655jchn1301_1; ASHTON CM, 1995, ANN INTERN MED, V122, P415, DOI 10.7326/0003-4819-122-6-199503150-00003; CHIEN LN, 2002, THESIS NATL Y MING U; D'Agostino RS, 1999, J THORAC CARDIOV SUR, V118, P823, DOI 10.1016/S0022-5223(99)70051-6; DAI YT, 2002, IN PRESS RES NURS HL; Experton B, 1999, AM J PREV MED, V16, P163, DOI 10.1016/S0749-3797(98)00098-1; Friedmann JM, 1997, AM J CLIN NUTR, V65, P1714; GOODING J, 1985, J AM GERIATR SOC, V33, P595, DOI 10.1111/j.1532-5415.1985.tb06315.x; GRAHAM H, 1983, LANCET, V1, P404; Hsueh IP, 2001, J FORMOS MED ASSOC, V100, P526; Krumholz HM, 1997, ARCH INTERN MED, V157, P99, DOI 10.1001/archinte.157.1.99; Lahey SJ, 1998, CIRCULATION, V98, pII35; MacLeod R D, 1970, Gerontol Clin (Basel), V12, P31; MAHONEY F I, 1965, Md State Med J, V14, P61; Miles T A, 1999, J Qual Clin Pract, V19, P211, DOI 10.1046/j.1440-1762.1999.00334.x; PFEIFFER E, 1975, J AM GERIATR SOC, V23, P433, DOI 10.1111/j.1532-5415.1975.tb00927.x; RICH MW, 1995, NEW ENGL J MED, V333, P1190, DOI 10.1056/NEJM199511023331806; Sabourin CB, 1999, HEART LUNG, V28, P243, DOI 10.1016/S0147-9563(99)70070-1; Schwarz K A, 2000, J Gerontol Nurs, V26, P29; SHAH S, 1989, J CLIN EPIDEMIOL, V42, P703, DOI 10.1016/0895-4356(89)90065-6; SMITH DM, 1988, MED CARE, V26, P699, DOI 10.1097/00005650-198807000-00005; Stewart RD, 2000, ANN THORAC SURG, V70, P169, DOI 10.1016/S0003-4975(00)01386-2; SULLIVAN DH, 1992, J AM GERIATR SOC, V40, P792, DOI 10.1111/j.1532-5415.1992.tb01851.x; TIERNEY AJ, 1995, AGE AGEING, V24, P163, DOI 10.1093/ageing/24.2.163; VINSON JM, 1990, J AM GERIATR SOC, V38, P1290, DOI 10.1111/j.1532-5415.1990.tb03450.x; WU SC, 2002, HEALTHCARE QUALITY, V2, P1; YEH SY, 2002, PRELIMINARY ANAL RES	29	22	22	0	10	ELSEVIER TAIWAN	TAIPEI	RM N-412, 4F, CHIA HSIN BUILDING 11, NO 96, ZHONG SHAN N ROAD SEC 2, TAIPEI, 10449, TAIWAN	0929-6646	1876-0821		J FORMOS MED ASSOC	J. Formos. Med. Assoc.	NOV	2002	101	11					779	785					7	Medicine, General & Internal	General & Internal Medicine	628RR	WOS:000180010800007	12517058				2021-06-18	
J	Mollica, RF; Henderson, DC; Tor, S				Mollica, RF; Henderson, DC; Tor, S			Psychiatric effects of traumatic brain injury events in Cambodian survivors of mass violence	BRITISH JOURNAL OF PSYCHIATRY			English	Article							POSTTRAUMATIC-STRESS-DISORDER; COMBAT VETERANS; POW SURVIVORS; HEAD-INJURY; KOREAN CONFLICT; COGNITIVE DEFICITS; FORMER PRISONERS; MEMORY; TORTURE; WAR	Background The prevalence of brain injury and its effects in populations exposed to war violence has not been studied in recent years. Aims To examine the association between traumatic brain injury events and psychiatric symptoms of major depression and post-traumatic stress disorder (PTSD) in Cambodian survivors of mass violence. Method The population comprised a multi-stage random sample of Cambodian refugees living in a Thai refugee camp. The main results analysed the relationship between six categories of trauma events and psychiatric symptoms of depression and PTSD during two time periods. Results Almost 15 000 trauma events were reported (n=13481, Pol Pot period; n=1249, past year). Traumatic brain injury was most common in the highly educated and in individuals with the highest levels of cumulative trauma. Of all trauma categories, traumatic brain injury revealed the strongest association with symptoms of depression, and a weaker association with PTSD. Brain injury represented 4% of the total number of traumatic events for both time periods, contributing 20% of the total symptom score for depression and 8% of that for PTSD. Conclusions Clinical identification and treatment of traumatic brain injuries in highly traumatised populations must be maintained in order to develop a new public health model for their treatment. Declaration of interest None. Funding detailed in Acknowledgements.	Harvard Univ, Massachusetts Gen Hosp, Sch Med, Harvard Program Refugee Trauma, Cambridge, MA 02138 USA	Henderson, DC (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Harvard Program Refugee Trauma, 22 Putnam St, Cambridge, MA 02138 USA.	dchenderson@partners.org					American Psychiatric Association, 1984, DIAGN STAT MAN MENT; American Psychiatric Association, 1994, DIAGN STAT MAN MENT; Barrett DH, 1996, AM J PSYCHIAT, V153, P1492; BREMNER JD, 1993, AM J PSYCHIAT, V150, P1015; CASPIYAVIN Y, 1995, PSYCHIAT FUNCTIONAL; Courville C. B., 1937, PATHOLOGY CENTRAL 4; DIKMEN S, 1983, ARCH NEUROL-CHICAGO, V40, P333, DOI 10.1001/archneur.1983.04050060033004; DIKMEN S, 1986, J NEUROL NEUROSUR PS, V49, P1227, DOI 10.1136/jnnp.49.11.1227; DIKMEN S, 1996, NEUROPSYCHOLOGICAL A, P552; DIKMEN SS, 1994, ARCH NEUROL-CHICAGO, V51, P177, DOI 10.1001/archneur.1994.00540140087018; DIKMEN SS, 1995, NEUROPSYCHOLOGY, V9, P80, DOI 10.1037/0894-4105.9.1.80; Fawzi MCS, 1997, ACTA PSYCHIAT SCAND, V95, P87, DOI 10.1111/j.1600-0447.1997.tb00379.x; First MB, 2001, STRUCTURAL CLIN INTE; FLAHERTY JA, 1988, J NERV MENT DIS, V176, P257; GOLDFELD AE, 1988, JAMA-J AM MED ASSOC, V259, P2725, DOI 10.1001/jama.259.18.2725; GURVITS TV, 1993, J NEUROPSYCH CLIN N, V5, P183; JENNETT B, 1981, CONT NEUROLOGY SERIE, V20; KWENTUS JA, 1985, PSYCHOSOMATICS, V26, P8, DOI 10.1016/S0033-3182(85)72900-3; LYNCH J, 1989, BORDER KHMER DEMOGRA, V2; MANUELDUPONT A, 1992, HDB NEUROPSYCHOLOGIC, P193; MESULAM MM, 1986, ANN NEUROL, V19, P320, DOI 10.1002/ana.410190403; MOLLICA R, 1991, PSYCHOL ASSESSMENT, V3, P1; MOLLICA RF, 1992, J NERV MENT DIS, V180, P111, DOI 10.1097/00005053-199202000-00008; MOLLICA RF, 1987, AM J PSYCHIAT, V144, P497; Mollica RF, 2002, J NERV MENT DIS, V190, P158, DOI 10.1097/00005053-200203000-00004; Mollica RF, 1998, ADVERSITY, STRESS AND PSYCHOPATHOLOGY, P34; Mollica RF, 1998, BRIT J PSYCHIAT, V173, P482, DOI 10.1192/bjp.173.6.482; MOLLICA RF, 1993, JAMA-J AM MED ASSOC, V270, P581, DOI 10.1001/jama.270.5.581; MOLLICA RF, 1989, COMMUNITY CONFINEMEN; OMMAYA AK, 1974, BRAIN, V97, P633, DOI 10.1093/brain/97.1.633; RASMUSSEN OV, 1990, DAN MED BULL, V37, P1; REYNELL J, 1989, POLITICAL PAWNS REGU; ROBINSON RG, 1981, ANN NEUROL, V9, P447, DOI 10.1002/ana.410090506; Sulway MR, 1996, NEUROLOGY, V46, P650, DOI 10.1212/WNL.46.3.650; SUTKER PB, 1995, NEUROPSYCHOLOGY, V9, P118, DOI 10.1037/0894-4105.9.1.118; SUTKER PB, 1991, AM J PSYCHIAT, V148, P67; SUTKER PB, 1990, J PERS ASSESS, V54, P170, DOI 10.1207/s15327752jpa5401&2_17; Sutker PB, 1996, PSYCHOL ASSESSMENT, V8, P18, DOI 10.1037/1040-3590.8.1.18; SUTKER PB, 1990, J CONSULT CLIN PSYCH, V58, P323, DOI 10.1037/0022-006X.58.3.323; SUTKER PB, 1992, ARCH CLIN NEUROPSYCH, V7, P431, DOI 10.1016/0887-6177(92)90156-H; UDDO M, 1993, J PSYCHOPATHOL BEHAV, V15, P43, DOI 10.1007/BF00964322; Vasterling JJ, 2000, J TRAUMA STRESS, V13, P441, DOI 10.1023/A:1007781107513; Weinstein CS, 2001, NEUROPSYCHOL REV, V11, P131, DOI 10.1023/A:1016650623996; WESTERMEYER J, 1985, AM J PSYCHIAT, V142, P798; Willis GB, 1998, J NERV MENT DIS, V186, P283, DOI 10.1097/00005053-199805000-00004; World Health Organization (WHO), 1992, 10 REV INT CLASS DIS; World Health Organization (WHO), 1978, MENT DIS GLOSS GUID; YEHUDA R, 1995, AM J PSYCHIAT, V152, P137	48	22	22	0	8	CAMBRIDGE UNIV PRESS	CAMBRIDGE	EDINBURGH BLDG, SHAFTESBURY RD, CB2 8RU CAMBRIDGE, ENGLAND	0007-1250	1472-1465		BRIT J PSYCHIAT	Br. J. Psychiatry	OCT	2002	181						339	347		10.1192/bjp.181.4.339			9	Psychiatry	Psychiatry	603EE	WOS:000178545200013	12356662	Bronze			2021-06-18	
J	Wu, XR; Stezoski, J; Safar, P; Behringer, W; Kentner, R; Kochanek, PM; Tisherman, SA				Wu, XR; Stezoski, J; Safar, P; Behringer, W; Kentner, R; Kochanek, PM; Tisherman, SA			Systemic hypothermia, but not regional gut hypothermia, improves survival from prolonged hemorrhagic shock in rats	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article						hypothermia; hemorrhagic shock; ischemia; rat; intestine; survival; tissue injury	FOCAL CEREBRAL-ISCHEMIA; TRAUMATIC BRAIN-INJURY; MODERATE HYPOTHERMIA; MILD HYPOTHERMIA; BODY-TEMPERATURE; CARDIAC-ARREST; PERMEABILITY; INCREASE; DAMAGE; PROTECTS	Background. Extracorporeal blood perfusion of the gut or enterectomy can improve survival during hemorrhagic shock (HS), suggesting that the gut may be of primary importance in resuscitation. We hypothesized that cooling the gut alone could improve survival in a rat HS model and avoid potential deleterious effects of systemic hypothermia. Methods: Thirty-two Sprague-Dawley rats were anesthetized with halothane. The gut (small intestine, cecum, and colon) was exteriorized. The right atrial (T-RA), rectal, and gut (T-GUT) intraluminal temperatures were monitored. HS was induced by withdrawal of 2 mL of blood per 100 g body weight over 10 minutes. Mean arterial pressure was then maintained at 35 to 40 mm Hg to HS 90 min. From HS 20 min to resuscitation time 1 h, rats were randomized into four groups (n = 8 each): normothermia (T-RA and T-Gut similar to38.0degreesC), gut-25degreesC (T-RA similar to38degreesC, T-Gut similar to25degreesC, induced by rinsing the gut with cooled saline), gut-33degreesC (T-RA similar to38degreesC, T-GUT similar to33degreesC), and systemic hypothermia (T-RA similar to33degreesC, T-GUT similar to25degreesC). At HS 90 min, shed blood and Ringer's solution were infused to restore normotension. Survival, metabolism, and tissue damage were observed to 72 hours. Results: Blood pressure was not different between groups. Compared with the normothermia group, the systemic hypothermia group had lower base deficit and lactate, and needed less fluid during resuscitation for normotension (p < 0.05), but these values were not different in the gut hypothermia groups. In addition, there were no significant improvements in tissue protection induced by regional gut hypothermia, whereas the systemic hypothermia group had lower plasma potassium, lower ornithine carbamoyltransferase (marker of liver injury), and higher glucose levels after HS (all p < 0.05). All rats in the systemic hypothermia group survived to 72 hours, whereas there was only one survivor in the normothermia group, two in the gut-33degreesC group, and none in the gut-25degreesC group (all p < 0.05 vs. systemic hypothermia). Conclusion. Cooling the gut alone does not improve acute survival from HS, suggesting that early deaths are not secondary to gut ischemia. Mild systemic hypothermia allowed 100% survival from prolonged HS.	Univ Pittsburgh, Safar Ctr Resuscitat Res, Pittsburgh, PA 15260 USA; Univ Pittsburgh, Dept Anesthesiol, Pittsburgh, PA 15260 USA; Univ Pittsburgh, Dept Crit Care Med, Pittsburgh, PA 15260 USA; Univ Pittsburgh, Dept Surg, Pittsburgh, PA 15260 USA	Tisherman, SA (corresponding author), Univ Pittsburgh, Safar Ctr Resuscitat Res, 3434 5th Ave, Pittsburgh, PA 15260 USA.	tishermansa@msx.upmc.edu	Tisherman, Samuel A./AAK-9377-2020; Kochanek, Patrick M/D-2371-2015	Tisherman, Samuel A./0000-0003-3810-3729; Kochanek, Patrick M/0000-0002-2627-913X; Behringer, Wilhelm/0000-0003-2261-3193			Barr J, 2000, CRIT CARE MED, V28, P3896, DOI 10.1097/00003246-200012000-00027; BIGELOW WG, 1950, ANN SURG, V132, P849, DOI 10.1097/00000658-195011000-00001; BUSTO R, 1989, STROKE, V20, P904, DOI 10.1161/01.STR.20.7.904; Carattino MD, 1999, IMMUNOPHARMACOLOGY, V43, P241, DOI 10.1016/S0162-3109(99)00095-8; Chang TW, 1997, J TRAUMA, V42, P223, DOI 10.1097/00005373-199702000-00007; Clifton GL, 2001, NEW ENGL J MED, V344, P556, DOI 10.1056/NEJM200102223440803; DEITCH EA, 1994, SHOCK, V1, P141, DOI 10.1097/00024382-199402000-00010; Gentilello LM, 1997, ANN SURG, V226, P439, DOI 10.1097/00000658-199710000-00005; GLOBUS MYT, 1995, J NEUROCHEM, V65, P1250; GOSS JR, 1995, J NEUROTRAUM, V12, P159, DOI 10.1089/neu.1995.12.159; GUBLER KD, 1994, J TRAUMA, V36, P847, DOI 10.1097/00005373-199406000-00015; HAGBERG S, 1970, Acta Chirurgica Scandinavica, V136, P23; HAGLUND U, 1993, CRIT CARE MED, V21, pS15, DOI 10.1097/00003246-199302001-00004; Hassoun HT, 2001, SHOCK, V15, P1, DOI 10.1097/00024382-200115010-00001; JURKOVICH GJ, 1988, J SURG RES, V44, P514, DOI 10.1016/0022-4804(88)90156-4; JURKOVICH GJ, 1987, J TRAUMA, V27, P1019, DOI 10.1097/00005373-198709000-00011; KARIBE H, 1994, J CEREBR BLOOD F MET, V14, P620, DOI 10.1038/jcbfm.1994.77; Kim SH, 1998, J TRAUMA, V44, P485, DOI 10.1097/00005373-199803000-00010; KOBELT F, 1994, SHOCK, V2, P281, DOI 10.1097/00024382-199410000-00009; Krieger DW, 2001, STROKE, V32, P1847, DOI 10.1161/01.STR.32.8.1847; Laffon M, 1999, AM J PHYSIOL-LUNG C, V277, pL760; LEI BP, 1994, STROKE, V25, P147, DOI 10.1161/01.STR.25.1.147; LILLEHEI RC, 1957, SURGERY, V42, P1043; LITTLE RA, 1981, BRIT J SURG, V68, P221, DOI 10.1002/bjs.1800680402; LUNA GK, 1987, J TRAUMA, V27, P1014, DOI 10.1097/00005373-198709000-00010; Magnotti LJ, 1998, ANN SURG, V228, P518, DOI 10.1097/00000658-199810000-00008; Marion DW, 1997, NEW ENGL J MED, V336, P540, DOI 10.1056/NEJM199702203360803; Metz C, 1996, J NEUROSURG, V85, P533, DOI 10.3171/jns.1996.85.4.0533; MEYER D M, 1988, Current Surgery, V45, P295; Mizushima Y, 2000, ARCH SURG-CHICAGO, V135, P175, DOI 10.1001/archsurg.135.2.175; OHSHITA M, 1976, CLIN CHIM ACTA, V67, P145; Patel S, 2000, J AM COLL SURGEONS, V191, P650, DOI 10.1016/S1072-7515(00)00736-5; PATT A, 1988, SURG CLIN N AM, V68, P775; Phanithi PB, 2000, NEUROPATHOLOGY, V20, P273, DOI 10.1046/j.1440-1789.2000.00346.x; Prueckner S, 2001, J TRAUMA, V50, P253, DOI 10.1097/00005373-200102000-00010; Qu XW, 1999, CRIT CARE MED, V27, P356, DOI 10.1097/00003246-199902000-00043; REED RL, 1992, J TRAUMA, V33, P465, DOI 10.1097/00005373-199209000-00022; Rollwagen FM, 1996, CYTOKINE, V8, P121, DOI 10.1006/cyto.1996.0017; ROOT HD, 1965, SURGERY, V57, P633; ROSOMOFF HL, 1954, AM J PHYSIOL, V179, P85; SAYEED MM, 2001, CIRCULATORY SHOCK PA, P112; Shahani R, 2000, AM J PHYSIOL-HEART C, V278, pH942; Sick TJ, 1999, STROKE, V30, P2416, DOI 10.1161/01.STR.30.11.2416; Smail N, 1998, ARCH SURG-CHICAGO, V133, P399, DOI 10.1001/archsurg.133.4.399; STEINEMANN S, 1990, J TRAUMA, V30, P200, DOI 10.1097/00005373-199002000-00011; TAFT WC, 1993, J CEREBR BLOOD F MET, V13, P796, DOI 10.1038/jcbfm.1993.101; Takasu A, 1999, CRIT CARE MED, V27, P1557, DOI 10.1097/00003246-199908000-00025; Takasu A, 2000, CRIT CARE MED, V28, P2465, DOI 10.1097/00003246-200007000-00047; Toyoda T, 1996, NEUROSURGERY, V39, P1200, DOI 10.1097/00006123-199612000-00024; Udassin R, 1997, ARCH SURG-CHICAGO, V132, P406; Wladis A, 2001, SHOCK, V15, P60, DOI 10.1097/00024382-200115010-00010; WRIGHT JG, 1988, J TRAUMA, V28, P1026, DOI 10.1097/00005373-198807000-00019; WU X, 2001, SHOCK, V15, P49; Wu XR, 2001, SHOCK, V16, P449, DOI 10.1097/00024382-200116060-00008; Wu XR, 2001, CRIT CARE MED, V29, P1767, DOI 10.1097/00003246-200109000-00019; XIAO F, 1995, RESUSCITATION, V30, P51, DOI 10.1016/0300-9572(94)00858-D; ZEINER A, 2002, NEW ENGL J MED, V346, P549; ZHANG JX, 1994, CRYOBIOLOGY, V31, P94, DOI 10.1006/cryo.1994.1012	58	22	26	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0022-5282	1529-8809		J TRAUMA	J. Trauma-Injury Infect. Crit. Care	OCT	2002	53	4					654	662		10.1097/00005373-200210000-00006			9	Critical Care Medicine; Surgery	General & Internal Medicine; Surgery	604JZ	WOS:000178618400009	12394862				2021-06-18	
J	Cairns, CJS; Thomas, B; Fletcher, S; Parr, MJA; Finfer, SR				Cairns, CJS; Thomas, B; Fletcher, S; Parr, MJA; Finfer, SR			Life-threatening hyperkalaemia following therapeutic barbiturate coma	INTENSIVE CARE MEDICINE			English	Article						thiopentone; barbiturate; hypokalaemia; hyperkalaemia; acute brain injury; subarachnoid haemorrhage	HEAD-INJURY; HYPERKALEMIA	Objective: To report the occurrence of life-threatening hyperkalaemia following treatment with therapeutic thiopentone coma. Setting: The neurosurgical intensive care units of Royal North Shore Hospital and Liverpool Hospital, Sydney, Australia. Patients: Three patients treated with therapeutic thiopentone coma. One patient with raised intracranial pressure secondary to a severe traumatic brain injury and two patients with refractory vasospasm secondary to subarachnoid haemorrhage. Two of the three patients developed hypokalaemia on starting thiopentone, which was resistant to potassium supplementation. All three patients developed severe hyperkalaemia during the recovery phase of coma. This was life-threatening in all three patients and fatal in one. Conclusions: Severe hypokalaemia refractory to potassium therapy may occur during therapeutic thiopentone coma. Severe rebound hyperkalaemia may occur after cessation of thiopentone infusion. Protocols for the management of patients with therapeutic barbiturate coma should recognise this potentially serious complication.	Royal N Shore Hosp, Intens Care Unit, St Leonards, NSW 2065, Australia; Liverpool Hosp, Intens Care Unit, Sydney, NSW, Australia	Finfer, SR (corresponding author), Royal N Shore Hosp, Intens Care Unit, St Leonards, NSW 2065, Australia.			Parr, Michael/0000-0003-3507-474X			BALI IM, 1973, BRIT J ANAESTH, V45, P1238, DOI 10.1093/bja/45.12.1238; CARLSSON C, 1975, Acta Anaesthesiologica Scandinavica Supplementum, V57, P7; Cloetta M, 1934, N-S ARCH EX PATH PH, V174, P589, DOI 10.1007/BF01878396; Finfer SR, 1999, INTENS CARE MED, V25, P406, DOI 10.1007/s001340050866; Friederich P, 1999, ANESTHESIOLOGY, V91, P1853, DOI 10.1097/00000542-199912000-00040; NORDBY HK, 1984, ACTA NEUROCHIR WIEN, V72, P158; NORDSTROM CH, 1988, J NEUROSURG, V68, P424, DOI 10.3171/jns.1988.68.3.0424; Polderman KH, 2001, J NEUROSURG, V94, P697, DOI 10.3171/jns.2001.94.5.0697; SCHAEFER M, 1995, INTENS CARE MED, V21, P235, DOI 10.1007/BF01701479; SCHALEN W, 1992, ACTA ANAESTH SCAND, V36, P369, DOI 10.1111/j.1399-6576.1992.tb03483.x; STEVENSON DE, 1960, BRIT J ANAESTH, V32, P353, DOI 10.1093/bja/32.8.353; Stover JF, 1998, EUR NEUROL, V39, P223, DOI 10.1159/000007938; STOVNER J, 1972, ACTA ANAESTH SCAND, V16, P46, DOI 10.1111/j.1399-6576.1972.tb00568.x; TOUWBORST A, 1984, INJURY, V15, P293	14	22	22	0	1	SPRINGER-VERLAG	NEW YORK	175 FIFTH AVE, NEW YORK, NY 10010 USA	0342-4642			INTENS CARE MED	Intensive Care Med.	SEP	2002	28	9					1357	1360		10.1007/s00134-002-1399-y			4	Critical Care Medicine	General & Internal Medicine	598NK	WOS:000178282400029	12209290				2021-06-18	
J	Hoskote, A; Richards, P; Anslow, P; McShane, T				Hoskote, A; Richards, P; Anslow, P; McShane, T			Subdural haematoma and non-accidental head injury in children	CHILDS NERVOUS SYSTEM			English	Article						child abuse; head trauma; intracranial haemorrhage; traumatic brain injury; neuro-imaging; shaking injury	INTRACRANIAL HEMORRHAGE; COMPUTED-TOMOGRAPHY; INFANTS; DISORDERS	Patients and methods: In this retrospective study, 36 children referred to paediatric neurology and neurosurgery during April 1995-June 1998 with a diagnosis of subdural haematoma (SDH) were studied. Nine were accidental secondary to witnessed trauma and 4 were iatrogenic. Non-accidental head injury (NAHI) was suspected in the remaining 23 children. Results: After a full clinical, radiological and social assessment, NAHI was diagnosed in 14, lateral sinus thrombosis in 1, 2 were accepted as accidental and 6 remained unexplained. In the NAHI group (n=14), 12 were between 4 and 16 weeks of age, 12 (85%) had retinal haemorrhages and skeletal surveys showed evidence of additional injury in 8. Computerised tomography (CT) brain scans showed bilateral SDH in 11, and 6 had interhemispheric bleeding along with loss of grey-white differentiation. Eleven had magnetic resonance imaging (MRI), which yielded additional information in 7. Seven required intensive care, and 2 died. Twelve had surgical aspiration. In the group with no satisfactory explanation for SDH (n=6); 5 had neonatal problems, all except I were older than 5 months of age and not as ill with bilateral, old SDH. All but I had skeletal surveys, which were normal, and eye examination showed no retinal haemorrhages. A social services enquiry was non-contributory. Conclusions: SDH is frequently traumatic whether accidental or non-accidental. SDH due to NAHI tends to present before 4 months of age with an inconsistent history; the patients are more seriously ill and have other findings, such as fractures and retinal haemorrhages. A small subgroup of patients was identified who had isolated, old SDH and in whom full investigation remained inconclusive. A consistent, comprehensive approach needs to be maintained in all cases with the essential backup of detailed neuro-imaging including MRI.	John Radcliffe Hosp, Dept Paediat Neurol, Oxford OX3 9DU, England; Radcliffe Infirm, Dept Paediat Neurosurg & Neuroradiol, Oxford OX2 6HE, England	McShane, T (corresponding author), John Radcliffe Hosp, Dept Paediat Neurol, Headley Way, Oxford OX3 9DU, England.	Tony.McShane@orh.anglox.nhs.uk		Hoskote, Aparna/0000-0003-4760-1199			Barlow KM, 1999, ACTA PAEDIATR, V88, P734; Bonnier C, 1995, DEV MED CHILD NEUROL, V37, P943; BROWN JK, 1993, DEV MED CHILD NEUROL, V35, P849; CAFFEY J, 1972, AM J DIS CHILD, V124, P161, DOI 10.1001/archpedi.1972.02110140011001; Carter J E, 1983, Child Abuse Negl, V7, P279, DOI 10.1016/0145-2134(83)90005-4; Dashti SR, 1999, PEDIATR NEUROSURG, V31, P302, DOI 10.1159/000028880; Duhaime AC, 1998, NEW ENGL J MED, V338, P1822, DOI 10.1056/NEJM199806183382507; Ewing-Cobbs L, 1998, PEDIATRICS, V102, P300, DOI 10.1542/peds.102.2.300; Gilliland MGF, 1996, J FORENSIC SCI, V41, P114; Haviland J, 1997, ARCH DIS CHILD, V77, P504, DOI 10.1136/adc.77.6.504; Jayawant S, 1998, BMJ-BRIT MED J, V317, P1558, DOI 10.1136/bmj.317.7172.1558; KRUGMAN RD, 1993, PEDIATRICS, V92, P872; Morris MW, 2000, PEDIATRICS, V105, P549, DOI 10.1542/peds.105.3.549; NEWTON RW, 1989, ARCH DIS CHILD, V64, P188, DOI 10.1136/adc.64.2.188; OHARE AE, 1984, ARCH DIS CHILD, V59, P860, DOI 10.1136/adc.59.9.860; Perrin RG, 1997, NEUROSURGERY, V40, P1190, DOI 10.1097/00006123-199706000-00016; Reece RM, 2000, ARCH PEDIAT ADOL MED, V154, P11; Sener RN, 1997, COMPUT MED IMAG GRAP, V21, P341; SHIH SL, 1993, NEURORADIOLOGY, V35, P619, DOI 10.1007/BF00588410; SUNDERLAND R, 1999, RECENT ADV PAEDIAT, V17; Tzioumi D, 1998, CHILD ABUSE NEGLECT, V22, P1105, DOI 10.1016/S0145-2134(98)00093-3; Wilkins B, 1997, ARCH DIS CHILD, V76, P393, DOI 10.1136/adc.76.5.393; ZIMMERMAN RA, 1979, RADIOLOGY, V130, P687, DOI 10.1148/130.3.687	23	22	22	0	3	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0256-7040	1433-0350		CHILD NERV SYST	Childs Nerv. Syst.	JUL	2002	18	6-7					311	317		10.1007/s00381-002-0616-x			7	Clinical Neurology; Pediatrics; Surgery	Neurosciences & Neurology; Pediatrics; Surgery	588FE	WOS:000177690300009	12172938				2021-06-18	
J	Chiaretti, A; De Benedictis, R; Della Corte, F; Piastra, M; Viola, L; Polidori, G; Di Rocco, C				Chiaretti, A; De Benedictis, R; Della Corte, F; Piastra, M; Viola, L; Polidori, G; Di Rocco, C			The impact of initial management on the outcome of children with severe head injury	CHILDS NERVOUS SYSTEM			English	Article						secondary brain damage; hypoxia; hypotension; Glasgow Outcome Score; pediatric head injury	HYPOTENSION; TRAUMA; CARE	Background: Neurotrauma is one of the most important causes of death in the pediatric age group. Head injury is responsible for both primary and secondary brain damage. The outcome of children with brain injury depends on the nature of the primary damage and on how well secondary brain damage can be limited. Appropriate critical care management at the scene and in hospital can prevent secondary brain damage that would otherwise result from cerebral reactions. Hypoxia and hypotension are major early complications of aggravation of secondary brain damage that are amenable to emergency maneuvers at the scene. In the literature, the influence of initial critical care management and early complications on the outcome of children with severe head injury is not clearly documented. Methods and results: We have prospectively examined the impact of the management at the scene on outcome in 40 children admitted to our Pediatric Intensive Care Unit with severe head injury (Glasgow Coma Scale less than or equal to8). The outcome of these children was assessed using the Glasgow Outcome Score (GOS). The results were evaluated by univariate and multivariate analysis. In our series the length of time before admission to an intensive care unit appears to have influenced the outcome among survivors, while the severity of injury is the only factor statistically associated with early complications (hypoxia and hypotension). With regard to the impact of early complications on outcome, the multivariate analysis showed that hypoxia and hypotension were significantly associated with GOS, independently of the GCS. Conclusion: Our results confirm the need for a precise treatment strategy for the initial management of children with neurotrauma to decrease the incidence of secondary brain damage attributable to hypoxia and hypotension.	Univ Sacred Heart, Pediat Intens Care Unit, I-00168 Rome, Italy; Osped Maggiore La Carita, Dept Anesthesiol, Novara, Italy; Univ Sacred Heart, Dept Pediat Neurosurg, I-00168 Rome, Italy	Chiaretti, A (corresponding author), Univ Sacred Heart, Pediat Intens Care Unit, Largo A Gemelli 8, I-00168 Rome, Italy.		Corte, Francesco Della/ABI-7646-2020	Corte, Francesco Della/0000-0003-1736-2318			Abbate B, 2000, Minerva Pediatr, V52, P623; ADAM EL, 1995, CARE MED, V8, P644; Adelson PD, 1998, J CHILD NEUROL, V13, P2, DOI 10.1177/088307389801300102; ALDRICH EF, 1992, J NEUROSURG, V76, P450, DOI 10.3171/jns.1992.76.3.0450; Boswell W C, 1995, Air Med J, V14, P125, DOI 10.1016/1067-991X(95)90513-8; BRUCE DA, 1999, PEDIAT NEUROSURGERY, P355; Buntain WL, 1995, MANAGEMENT PEDIAT TR; DADALT L, 1997, RIV ITAL PED, V23, P39; FACCHIN P, 1991, EPIDEMIOLOGIA PREVEN, P23; Feickert HJ, 1999, J TRAUMA, V47, P33, DOI 10.1097/00005373-199907000-00008; GHAJAR J, 1992, PEDIATR CLIN N AM, V39, P1093; Glasgow JF, 1997, CURR PEDIAT, V7, P187; Gordini G, 1992, Minerva Anestesiol, V58, P217; JENNETT B, 1975, LANCET, V1, P480; Kelly D F, 1995, New Horiz, V3, P453; Kokoska ER, 1998, J PEDIATR SURG, V33, P333, DOI 10.1016/S0022-3468(98)90457-2; Mansfield RT, 1997, CRIT CARE CLIN, V13, P611, DOI 10.1016/S0749-0704(05)70331-6; Meyer P, 1999, CHILD NERV SYST, V15, P732, DOI 10.1007/s003810050462; MORONT ML, 1994, PEDIATR CLIN N AM, V41, P1201; NAKAYAMA DK, 1990, ANN SURG, V211, P218, DOI 10.1097/00000658-199002000-00015; PIGULA FA, 1993, J PEDIATR SURG, V28, P310, DOI 10.1016/0022-3468(93)90223-8; Rivara FP, 1999, PEDIATRICS, V103, P883; SHARPLES PM, 1990, BRIT MED J, V300, P87, DOI 10.1136/bmj.300.6717.87	23	22	24	0	0	SPRINGER-VERLAG	NEW YORK	175 FIFTH AVE, NEW YORK, NY 10010 USA	0256-7040			CHILD NERV SYST	Childs Nerv. Syst.	FEB	2002	18	1-2					54	60		10.1007/s00381-001-0533-4			7	Clinical Neurology; Pediatrics; Surgery	Neurosciences & Neurology; Pediatrics; Surgery	534ZR	WOS:000174620100014	11935245				2021-06-18	
J	d'Avella, D; Servadei, F; Scerrati, M; Tomei, G; Brambilla, G; Angileri, FF; Massaro, F; Cristofori, L; Tartara, F; Pozzati, E; Delfini, R; Tomasello, F				d'Avella, D; Servadei, F; Scerrati, M; Tomei, G; Brambilla, G; Angileri, FF; Massaro, F; Cristofori, L; Tartara, F; Pozzati, E; Delfini, R; Tomasello, F			Traumatic intracerebellar hemorrhage: Clinicoradiological analysis of 81 patients	NEUROSURGERY			English	Article; Proceedings Paper	International Conference on Recent Advances in Neurotraumatology (ICRAN 99)	NOV 20-23, 1999	TAIPEI, TAIWAN			head injury; hemorrhagic contusion and hematoma; outcome; posterior fossa; prognostic factors	INJURED ADULT PATIENTS; POSTERIOR-FOSSA; PROGNOSTIC FACTORS; BRAIN INJURY; HEAD-INJURY; HEMATOMAS	OBJECTIVE: We report 81 patients with a traumatic intracerebellar hemorrhagic contusion or hematoma managed between 1996 and 1998 at 13 Italian neurosurgical centers. METHODS: Each center provided data about patients' clinicoradiological findings, management, and outcomes, which were retrospectively reviewed. RESULTS: A poor result occurred in 36 patients (44.4%). Forty-five patients (55.6%) had favorable results. For the purpose of data analysis, patients were divided into two groups according to their admission Glasgow Coma Scale (GCS) scores. In Group 1 (39/81 cases; GCS score, greater than or equal to8), the outcome was favorable in 95% of cases. In Group 2 (42/81 cases; GCS score, <8), the outcome was poor in 81% of cases. Twenty-seven patients underwent posterior fossa surgery. Factors correlating with outcome were GCS score, status of the basal cisterns and the fourth ventricle, associated supratentorial traumatic lesions, mechanism of injury, and intracerebellar clot size. Multivariate analysis showed significant independent prognostic effect only for GCS score (P = 0.000) and the concomitant presence of supratentorial lesions (P = 0.0035). CONCLUSION: This study describes clinicoradiological findings and prognostic factors regarding traumatic cerebellar injury. A general consensus emerged from this analysis that a conservative approach can be considered a viable, safe treatment option for noncomatose patients with intracerebellar clots measuring less than or equal to 3 cm, except when associated with other extradural or subdural posterior fossa focal lesions. Also, a general consensus was reached that surgery should be recommended for all patients with clots larger than 3 cm. The pathogenesis, biomechanics, and optimal management criteria of these rare lesions are still unclear, and larger observational studies are necessary.	Univ Messina, Clin Neurochirurg, Messina, Italy; Osped Bufalini, Div Neurochirurg, Cesena, Italy; IRCCS, Osped Policlin, Clin Neurochirurg, Milan, Italy; Policlin San Matteo, IRCCS, Clin Neurochirurg, I-27100 Pavia, Italy; Osped CTO, Div Neurochirurg, Turin, Italy; Univ Verona, Clin Neurochirurg, I-37100 Verona, Italy; IRCCS, Osped S Raffaele, Clin Neurochirurgia, Milan, Italy; Univ Cattolica Sacro Cuore, Cattedra neurotraumatol, Dipartimento Sci Neurol, Rome, Italy	d'Avella, D (corresponding author), Policlin Univ, Neurosurg Clin, Via Consolare Valeria 1, I-98100 Messina, Italy.		Angileri, Filippo/N-8556-2019; Angileri, Filippo/AAL-4851-2021; Angileri, Filippo Flavio/J-3533-2012; Tartara, Fulvio/ABH-2023-2020	Angileri, Filippo/0000-0002-1107-4115; Angileri, Filippo Flavio/0000-0002-1107-4115; Servadei, Franco/0000-0002-3595-3464			ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; ANDREWS BT, 1991, NEUROSURGERY, V29, P227, DOI 10.1227/00006123-199108000-00010; Bernardi RJ, 1993, BRAIN SURG COMPLICAT, V2, P1931; Cassinari V, 1967, Minerva Neurochir, V11, P230; D'Avella D, 2001, HEAD TRAUMA, P385; DAVELLA D, 1998, ACTA NEUROCHIR SUPP, V71, P410; DUHAIME AC, 1995, NEUROSURGERY, V37, P401, DOI 10.1227/00006123-199509000-00005; Hamasaki T, 1987, No To Shinkei, V39, P1083; Isla A, 1987, J Neurosurg Sci, V31, P67; Kampfl A, 1998, J NEUROSURG, V88, P809, DOI 10.3171/jns.1998.88.5.0809; Karasawa H, 1997, J NEUROSURG, V86, P629, DOI 10.3171/jns.1997.86.4.0629; KOBAYASHI S, 1994, NEUROSURGERY, V34, P246, DOI 10.1227/00006123-199402000-00006; KOTWICA Z, 1995, ACTA NEUROCHIR, V133, P56, DOI 10.1007/BF01404948; KOZIARSKI A, 1991, ACTA NEUROCHIR, V110, P24, DOI 10.1007/BF01402043; Marshall SB, 1991, J NEUROSURG S, V75, P14; MCINTOSH TK, 1993, J NEUROTRAUM, V10, P215, DOI 10.1089/neu.1993.10.215; NAGATA K, 1991, Neurologia Medico-Chirurgica, V31, P792, DOI 10.2176/nmc.31.792; OLIN MS, 1980, NEUROSURGERY, V7, P271, DOI 10.1227/00006123-198009000-00013; PAPADAKIS N, 1976, JAMA-J AM MED ASSOC, V235, P530, DOI 10.1001/jama.235.5.530; POZZATI E, 1981, NEUROSURGERY, V8, P102, DOI 10.1227/00006123-198101000-00019; POZZATI E, 1982, J NEUROSURG, V56, P691, DOI 10.3171/jns.1982.56.5.0691; SATO K, 1987, Neurological Surgery, V15, P1285; Servadei F, 1997, ACTA NEUROCHIR, V139, P279, DOI 10.1007/BF01808822; Servadei F, 1995, J Neurosurg Sci, V39, P187; Servadei F, 1997, ACTA NEUROCHIR, V139, P273, DOI 10.1007/BF01808821; SERVADEI F, 1995, NEUROSURGERY, V37, P889; SOKOL JH, 1978, SURG NEUROL, V10, P340; SOLONIUK D, 1986, J TRAUMA, V26, P787, DOI 10.1097/00005373-198609000-00003; STEIN SC, 1992, NEUROSURGERY, V30, P160, DOI 10.1227/00006123-199202000-00002; STJOHN JN, 1986, SURG NEUROL, V25, P457, DOI 10.1016/0090-3019(86)90085-6; STONE JL, 1991, NEUROSURGERY, V28, P603, DOI 10.1227/00006123-199104000-00022; TIBBS PA, 1981, SURG NEUROL, V16, P309, DOI 10.1016/0090-3019(81)90068-9; TSAI FY, 1980, J COMPUT ASSIST TOMO, V4, P291, DOI 10.1097/00004728-198006000-00002; TSUBOKAWA T, 1979, Neurologia Medico-Chirurgica, V19, P1127, DOI 10.2176/nmc.19.1127; Vrankovic D, 2000, NEUROSURG REV, V23, P156, DOI 10.1007/PL00011948; WEAVER JP, 1993, BRAIN SURG COMPLICAT, V2, P1351; WRIGHT RL, 1966, J NEUROSURG, V25, P402, DOI 10.3171/jns.1966.25.4.0402; YOKOTA H, 1990, Neurological Surgery, V18, P67; YOUNG HA, 1984, NEUROSURGERY, V14, P22, DOI 10.1227/00006123-198401000-00006; ZUCCARELLO M, 1982, ACTA NEUROCHIR, V62, P79, DOI 10.1007/BF01402212	40	22	23	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0148-396X			NEUROSURGERY	Neurosurgery	JAN	2002	50	1					16	25		10.1097/00006123-200201000-00004			10	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	506AC	WOS:000172946900005	11844230				2021-06-18	
J	Finnie, JW; Manavis, J; Blumbergs, PC; Summersides, GE				Finnie, JW; Manavis, J; Blumbergs, PC; Summersides, GE			Brain damage in sheep from penetrating captive bolt stunning	AUSTRALIAN VETERINARY JOURNAL			English	Article							AMYLOID PRECURSOR PROTEIN; AXONAL INJURY; MESSENGER-RNA; UP-REGULATION; HEAD-INJURY; MODEL; EUTHANASIA; LAMBS	Objective To determine the severity and distribution of structural changes in the brains of adult sheep stunned by penetrating captive bolt. Procedure The unconstrained heads of ten, anaesthetised, unhorned, 2-year-old Merino sheep were impacted at the summit of the head with a penetrating captive bolt pistol. Six sheep were ventilated and four received no respiratory support. Two hours after impact, brains from the six ventilated sheep were perfusion-fixed with 4% paraformaldehyde. Sixteen whole, serial coronal sections from each brain were stained with haematoxylin and eosin and immunohistochemically for amyloid precursor protein, a sensitive marker of axonal and neuronal reaction in the brain after trauma. Pathological changes in these brains were then quantified by morphometric analysis. Results Structural change in all impacted brains was a mixture of focal injury around the wound track and more widely distributed damage in the cerebral hemispheres, cerebellum and brainstem, but varied considerably in severity between individual sheep. All nonventilated sheep died rapidly following respiratory arrest. Conclusions After penetrating captive bolt stunning, damage to the central reticular formation, axonal connections, and the cortical mantle is the likely reason for failure of respiratory control and traumatic loss of consciousness.	Inst Med & Vet Sci, Vet Serv Div, Adelaide, SA 5000, Australia; Inst Med & Vet Sci, Neuropathol Lab, Adelaide, SA 5000, Australia	Finnie, JW (corresponding author), Inst Med & Vet Sci, Vet Serv Div, POB 14,Rundle Mall, Adelaide, SA 5000, Australia.						ANDREWS EJ, 1993, J AM VET MED ASSOC, V202, P230; Blumbergs P. C., 1997, HEAD INJURY PATHOPHY, P39; *CAL DEP FOOD AGR, 1999, EM EUTH SHEEP GOATS; CAREY ME, 1995, NEUROSURG CLIN N AM, V6, P629; DALY CC, 1989, RES VET SCI, V46, P406, DOI 10.1016/S0034-5288(18)31189-5; Finnie J, 1999, J CLIN NEUROSCI, V6, P38, DOI 10.1016/S0967-5868(99)90601-X; Finnie JW, 2000, AUST VET J, V78, P775, DOI 10.1111/j.1751-0813.2000.tb10451.x; Finnie JW, 1997, AUST VET J, V75, P204, DOI 10.1111/j.1751-0813.1997.tb10067.x; GRAHAM DI, 1997, GREENFIELDS NEUROPAT, V1, P197; KOO EH, 1990, P NATL ACAD SCI USA, V87, P1561, DOI 10.1073/pnas.87.4.1561; LONGAIR J, 1991, CAN VET J, V32, P724; Mattson MP, 1997, PHYSIOL REV, V77, P1081; *NAT HLTH MED RES, 1997, AUSTR COD PRACT CAR; SHERRIFF FE, 1994, ACTA NEUROPATHOL, V88, P433; Van den Heuvel C, 1999, EXP NEUROL, V159, P441, DOI 10.1006/exnr.1999.7150; Van den Heuvel C, 2000, J CLIN NEUROSCI, V7, P140	16	22	23	1	12	AUSTRALIAN VETERINARY ASSN	MELBOURNE	272 BRUNSWICK RD BRUNSWICK, MELBOURNE, VIC 3056, AUSTRALIA	0005-0423			AUST VET J	Aust. Vet. J.	JAN-FEB	2002	80	1-2					67	69		10.1111/j.1751-0813.2002.tb12840.x			3	Veterinary Sciences	Veterinary Sciences	524CR	WOS:000173994900039	12180883				2021-06-18	
J	Luo, YM; Cao, GD; Pei, W; O'Horo, C; Graham, SH; Chen, J				Luo, YM; Cao, GD; Pei, W; O'Horo, C; Graham, SH; Chen, J			Induction of caspase-activated deoxyribonuclease activity after focal cerebral ischemia and reperfusion	JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM			English	Article						apoptosis; caspase-3; caspase-activated deoxyribonuclease; cerebral ischemia; DNA fragmentation	TRAUMATIC BRAIN INJURY; DNA FRAGMENTATION; CELL-DEATH; NEURONAL APOPTOSIS; SPINAL-CORD; INHIBITOR; RATS; CLEAVAGE; PROTEIN; ICAD	Deoxyribonucleic acid fragmentation at nucleosomal junctions is a hallmark of neuronal apoptosis in ischemic brain injury, for which the mechanism is not fully understood. Using the in vitro cell-free apoptosis assay, the authors found that caspase-3-dependent deoxyribonuclease activity caused internucleosomal DNA fragmentation in brain-cell extracts in a rat model of transient focal ischemia. This in vitro deoxyribonuclease activity was completely inhibited by purified inhibitor of caspase-activated deoxyribonuclease protein, the specific endogenous inhibitor of caspase-activated deoxyribonuclease, or by caspase-activated deoxyribonuclease immunodepletion. The induction of the deoxyribonuclease activity was correlated with caspase-3 activation and caspase-3-mediated degradation of inhibitor of caspase-activated deoxyribonuclease. Furthermore, inhibiting caspase-3-like protease activity prevented the endogenous induction of internucleosomal DNA fragmentation in the ischemic brain. These results suggest that caspase-3-dependent caspase-activated deoxyribonuclease activity plays an important role in mediating DNA fragmentation after focal ischemia.	Univ Pittsburgh, Sch Med, Dept Neurol, Pittsburgh, PA 15213 USA; Univ Pittsburgh, Sch Med, Pittsburgh Inst Neurodegenerat Disorders, Pittsburgh, PA 15213 USA; Vet Affiars Pittsburgh Hlth Care Syst, Ctr Geriatr Res Educ & Clin, Pittsburgh, PA USA	Chen, J (corresponding author), Univ Pittsburgh, Sch Med, Dept Neurol, S-507,Biomed Sci Tower, Pittsburgh, PA 15213 USA.				NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P01NS035965, R01NS036736, R01NS038560] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS35965, NS38560, NS36736] Funding Source: Medline		Cao GD, 2001, J CEREBR BLOOD F MET, V21, P321, DOI 10.1097/00004647-200104000-00001; Chen DX, 2000, J BIOL CHEM, V275, P38508, DOI 10.1074/jbc.M003906200; Chen J, 1997, J NEUROCHEM, V69, P232; Chen J, 1998, J NEUROSCI, V18, P4914; Citron BA, 2000, EXP NEUROL, V166, P213, DOI 10.1006/exnr.2000.7523; Clark RSB, 2000, J NEUROCHEM, V74, P740, DOI 10.1046/j.1471-4159.2000.740740.x; Enari M, 1998, NATURE, V393, P396, DOI 10.1038/30782; Enari M, 1998, NATURE, V391, P43; Fujimura M, 1999, J NEUROSCI, V19, P3414; Graham SH, 2001, J CEREBR BLOOD F MET, V21, P99, DOI 10.1097/00004647-200102000-00001; LINNIK MD, 1993, STROKE, V24, P2002, DOI 10.1161/01.STR.24.12.2002; Liu XS, 1997, CELL, V89, P175, DOI 10.1016/S0092-8674(00)80197-X; MACMANUS JP, 1995, J CEREBR BLOOD F MET, V15, P728, DOI 10.1038/jcbfm.1995.93; Mukae N, 2000, J BIOL CHEM, V275, P21402, DOI 10.1074/jbc.M909611199; Mukae N, 1998, P NATL ACAD SCI USA, V95, P9123, DOI 10.1073/pnas.95.16.9123; Namura S, 1998, J NEUROSCI, V18, P3659; Sakahira H, 1998, NATURE, V391, P96; Springer JE, 1999, NAT MED, V5, P943, DOI 10.1038/11387; Yakovlev AG, 1997, J NEUROSCI, V17, P7415; Zhang C, 1999, J NEUROCHEM, V73, P1650, DOI 10.1046/j.1471-4159.1999.0731650.x	20	22	27	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0271-678X			J CEREBR BLOOD F MET	J. Cereb. Blood Flow Metab.	JAN	2002	22	1					15	20		10.1097/00004647-200201000-00002			6	Endocrinology & Metabolism; Hematology; Neurosciences	Endocrinology & Metabolism; Hematology; Neurosciences & Neurology	505TD	WOS:000172930900002	11807389	Bronze			2021-06-18	
J	Nissley, HM; Schmitter-Edgecombe, M				Nissley, HM; Schmitter-Edgecombe, M			Perceptually based implicit learning in severe closed-head injury patients	NEUROPSYCHOLOGY			English	Article							SELF-PERPETUATING DEVELOPMENT; COMPLEX PROCEDURAL KNOWLEDGE; EXPLICIT MEMORY; DIVIDED ATTENTION; ENCODING BIASES; ACQUISITION; AMNESIA; SYSTEMS; ASSOCIATIONS; INFORMATION	This study suggests that perceptually based implicit learning may either be preserved following a severe closed-head injury (CHI) or recover within the 1st year. Nineteen severe CHI patients and 19 controls searched visual matrices and indicated the quadrant location of a target. Participants were exposed to the following covariation pattern: AAAABAAA. For Covariation A blocks, the matrices systematically co-occurred with a unique location of the target. This relationship was altered for the B block. Despite CHI participants' overall slower response times (RTs), both groups demonstrated the expected decline in RTs across the first 4 Covariation A blocks followed by an increase when the covariation changed. Both groups also exhibited retention of their learning after a 20-min delay. Explicit knowledge tests indicated that participants lacked awareness for the covariation.	Washington State Univ, Dept Psychol, Pullman, WA 99164 USA	Schmitter-Edgecombe, M (corresponding author), Washington State Univ, Dept Psychol, Pullman, WA 99164 USA.				EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R03HD035838] Funding Source: NIH RePORTER; NICHD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R03 HD35838-02] Funding Source: Medline		ABRAMS M, 1988, J PSYCHOLINGUIST RES, V17, P425; ADAMS JH, 1977, BRAIN, V100, P489, DOI 10.1093/brain/100.3.489; ADAMS JH, 1982, ANN NEUROL, V12, P557, DOI 10.1002/ana.410120610; ALLEN R, 1980, COGNITION, V8, P175, DOI 10.1016/0010-0277(80)90011-6; [Anonymous], 1999, SUP PRO BET VERS EXP; BARONA A, 1984, J CONSULT CLIN PSYCH, V52, P885, DOI 10.1037/0022-006X.52.5.885; Berry D. C., 1993, IMPLICIT LEARNING TH; BOND MR, 1983, REHABILITATION HEAD, P185; BROOKS DN, 1984, CLOSED HEAD INJURY P; CHAPMAN LJ, 1994, DEV REV, V14, P159, DOI 10.1006/drev.1994.1007; Cleeremans A, 1998, TRENDS COGN SCI, V2, P406, DOI 10.1016/S1364-6613(98)01232-7; COHEN A, 1990, J EXP PSYCHOL LEARN, V16, P17, DOI 10.1037/0278-7393.16.1.17; Cohen J., 1988, STAT POWER ANAL BEHA, V2nd; CROSSON B, 1988, J CLIN EXP NEUROPSYC, V10, P754, DOI 10.1080/01688638808402812; CROSSON B, 1989, CLIN NEUROPSYCHOL, V3, P29, DOI DOI 10.1080/13854048908404074; DANEMAN M, 1980, J VERB LEARN VERB BE, V19, P450, DOI 10.1016/S0022-5371(80)90312-6; EWERT J, 1989, ARCH NEUROL-CHICAGO, V46, P911, DOI 10.1001/archneur.1989.00520440105027; Gabrieli JDE, 1997, PSYCHOL SCI, V8, P326, DOI 10.1111/j.1467-9280.1997.tb00447.x; Golden C., 1978, STROOP COLOR WORD TE; GOSHENGOTTSTEIN Y, 1995, J EXP PSYCHOL LEARN, V21, P1229, DOI 10.1037/0278-7393.21.5.1229; GRAF P, 1985, J EXP PSYCHOL LEARN, V11, P501, DOI 10.1037/0278-7393.11.3.501; GRAFTON ST, 1995, J COGNITIVE NEUROSCI, V7, P497, DOI 10.1162/jocn.1995.7.4.497; HARTMAN M, 1989, J EXP PSYCHOL LEARN, V15, P1070, DOI 10.1037/0278-7393.15.6.1070; Haut M W, 1990, Arch Clin Neuropsychol, V5, P299, DOI 10.1016/0887-6177(90)90028-N; Hays W. L., 1988, STATISTICS; Hendrickx H, 1997, PSYCHOL BELG, V37, P29; HILL T, 1989, J PERS SOC PSYCHOL, V57, P373, DOI 10.1037/0022-3514.57.3.373; HINTZMAN DL, 1990, ANNU REV PSYCHOL, V41, P109, DOI 10.1146/annurev.ps.41.020190.000545; HOWARD DV, 1992, PSYCHOL AGING, V7, P232, DOI 10.1037/0882-7974.7.2.232; Kaplan E., 1987, MANUAL CALIFORNIA VE; KNOPMAN D, 1991, J CLIN EXP NEUROPSYC, V13, P880, DOI 10.1080/01688639108405105; KNOWLTON BJ, 1992, PSYCHOL SCI, V3, P172, DOI 10.1111/j.1467-9280.1992.tb00021.x; KNOWLTON BJ, 1994, J EXP PSYCHOL LEARN, V20, P79, DOI 10.1037/0278-7393.20.1.79; Levin H. S., 1989, J CLIN EXP NEUROPSYC, V12, P129; LEWICKI P, 1989, J EXP PSYCHOL GEN, V118, P323; LEWICKI P, 1986, J EXP PSYCHOL LEARN, V12, P135, DOI 10.1037/0278-7393.12.1.135; LEWICKI P, 1987, J EXP PSYCHOL LEARN, V13, P523, DOI 10.1037/0278-7393.13.4.523; LEWICKI P, 1988, COGNITIVE PSYCHOL, V20, P24, DOI 10.1016/0010-0285(88)90023-0; Lewicki P, 1986, NONCONSCIOUS SOCIAL; MATHEWS RC, 1989, J EXP PSYCHOL LEARN, V15, P1083, DOI 10.1037/0278-7393.15.6.1083; McDowall J, 1996, NEW ZEAL J PSYCHOL, V25, P2; Meulemans T, 1997, PSYCHOL BELG, V37, P69; MUTTER SA, 1994, J CLIN EXP NEUROPSYC, V16, P271, DOI 10.1080/01688639408402638; NISSEN MJ, 1989, NEUROPSYCHOLOGIA, V27, P341, DOI 10.1016/0028-3932(89)90023-7; NISSEN MJ, 1987, NEUROLOGY, V37, P789, DOI 10.1212/WNL.37.5.789; NISSEN MJ, 1987, COGNITIVE PSYCHOL, V19, P1, DOI 10.1016/0010-0285(87)90002-8; PASCUALLEONE A, 1994, SCIENCE, V263, P1287, DOI 10.1126/science.8122113; Reber A, 1993, IMPLICIT LEARNING TA; REBER AS, 1991, J EXP PSYCHOL LEARN, V17, P888, DOI 10.1037/0278-7393.17.5.888; Reed J. M., 1998, HDB IMPLICIT LEARNIN, P261; Reitan RM., 1985, HALSTEAD REITAN NEUR; RICHARDSON JTE, 1990, CLIN NEUROPSYCHOLOGI; Rosenthal R., 1991, ESSENTIALS BEHAV RES; RUSSELL WR, 1961, ARCH NEUROL-CHICAGO, V5, P16, DOI DOI 10.1001/ARCHNEUR.1961.00450130006002; Schmitter-Edgecombe M, 2001, J INT NEUROPSYCH SOC, V7, P615, DOI 10.1017/S1355617701755099; Schmitter-Edgecombe M, 2000, NEUROPSYCHOLOGY, V14, P559; Schmitter-Edgecombe M, 1998, J INT NEUROPSYCH SOC, V4, P144, DOI 10.1017/S1355617798001441; SchmitterEdgecombe M, 1996, NEUROPSYCHOLOGY, V10, P155; SEGER CA, 1994, PSYCHOL BULL, V115, P163, DOI 10.1037/0033-2909.115.2.163; SEGER CA, 1998, HDB IMPLICIT LEARNIN, P295; SHANKS DR, 1994, BEHAV BRAIN SCI, V17, P367, DOI 10.1017/S0140525X00035032; Smith A., 1991, SYMBOL DIGIT MODALIT; STADLER MA, 1989, J EXP PSYCHOL LEARN, V15, P1061, DOI 10.1037/0278-7393.15.6.1061; STADLER MA, 1995, J EXP PSYCHOL LEARN, V21, P674, DOI 10.1037/0278-7393.21.3.674; STRAYER DL, 1994, PSYCHOL AGING, V9, P589, DOI 10.1037/0882-7974.9.4.589; TEASDALE G, 1974, LANCET, V2, P81; TULVING E, 1990, SCIENCE, V247, P301, DOI 10.1126/science.2296719; Wechsler D., 1987, WECHSLER MEMORY SCAL; Wechsler D., 1981, WAIS R MANUAL WECHSL; WEISKRANTZ L, 1987, HUM NEUROBIOL, V6, P93; Willingham DB, 1999, MEM COGNITION, V27, P561, DOI 10.3758/BF03211549	71	22	22	0	5	AMER PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST NE, WASHINGTON, DC 20002-4242 USA	0894-4105			NEUROPSYCHOLOGY	Neuropsychology	JAN	2002	16	1					111	122		10.1037//0894-4105.16.1.111			12	Psychology, Clinical; Neurosciences; Psychology	Psychology; Neurosciences & Neurology	520RK	WOS:000173794700013	11853352				2021-06-18	
J	Sztriha, L; Gururaj, AK; Bener, A; Nork, M				Sztriha, L; Gururaj, AK; Bener, A; Nork, M			Temporal lobe epilepsy in children: Etiology in a cohort with new-onset seizures	EPILEPSIA			English	Article						temporal lobe epilepsy; childhood; etiology; classification	HIPPOCAMPAL NEURON LOSS; FEBRILE CONVULSIONS; DEVELOPMENTAL MALFORMATIONS; INTRACTABLE EPILEPSY; MESIAL STRUCTURES; ARACHNOID CYSTS; SCLEROSIS; CHILDHOOD; ABNORMALITIES; DIAGNOSIS	Purpose: The aim of this study was to characterize the incidence and etiology of temporal lobe epilepsy (TLE) in a community-based cohort of children with new-onset disease. Methods: A community-based cohort of 30 children with TLE was studied. The patients had new-onset disease before age 14 years between 1995 and 1999. They underwent clinical, EEG, and magnetic resonance imaging investigations. Results: The patients could be divided in three main groups according to likely etiology, as suggested by Harvey et al. (Neurology, 1997;49:960-8). Group 1 consisted of eight (26.7%) children with malformations or long-standing, nonprogressive tumors (developmental TLE). Arachnoid cysts were found in three, dual pathology [cortical dysplasia and hippocampal sclerosis (HS)] in one, and focal cortical dysplasia with glioproliferative changes in one patient. Dysembryoplastic neuroepithelial tumor was responsible for the epilepsy in one, and ganglioglioma, in two children. Group 2 consisted of seven (23.3%) children with a significant antecedent and/or HS. Five children had a significant illness or event before the onset of TLE, including perinatal hypoxic-ischemic encephalopathy in one, encephalitis in one, traumatic brain injury in two, and complex febrile seizures in one. HS was found in the patients with traumatic brain injury and complex febrile seizures in the history in addition to two children without known antecedents. Group 3 comprised 15 (50%) children with no abnormality on neuroimaging and no significant antecedents (cryptogenic TLE). Conclusions: Etiologic differences between children with new-onset TLE may have prognostic implications: children with TLE and significant antecedents/HS arc expected to have the greatest risk of continued seizures and psychological problems.	UAE Univ, Fac Med & Hlth Sci, Dept Pediat, Al Ain, U Arab Emirates; UAE Univ, Fac Med & Hlth Sci, Dept Community Med, Al Ain, U Arab Emirates; Tawam Hosp, Dept Radiol, Al Ain, U Arab Emirates	Sztriha, L (corresponding author), UAE Univ, Fac Med & Hlth Sci, Dept Pediat, POB 17666, Al Ain, U Arab Emirates.						Arroyo S, 1997, EPILEPSIA, V38, P1098, DOI 10.1111/j.1528-1157.1997.tb01199.x; Bergman DA, 1996, PEDIATRICS, V97, P769; BROCKHAUS A, 1995, EPILEPSIA, V36, P1173, DOI 10.1111/j.1528-1157.1995.tb01059.x; CENDES F, 1993, ANN NEUROL, V34, P795, DOI 10.1002/ana.410340607; CENDES F, 1993, NEUROLOGY, V43, P1083, DOI 10.1212/WNL.43.6.1083; Diaz-Arrastia R, 2000, ARCH NEUROL-CHICAGO, V57, P1611, DOI 10.1001/archneur.57.11.1611; ENGEL J, 1998, EPILEPSY COMPREHENSI, P2417; Fernandez G, 1998, NEUROLOGY, V50, P909, DOI 10.1212/WNL.50.4.909; GRATTANSMITH JD, 1993, AM J ROENTGENOL, V161, P1045, DOI 10.2214/ajr.161.5.8273606; Harvey AS, 1997, NEUROLOGY, V49, P960, DOI 10.1212/WNL.49.4.960; HARVEY AS, 1995, PEDIATR NEUROL, V12, P201, DOI 10.1016/0887-8994(95)00022-8; Ho SS, 1998, NEUROLOGY, V50, P748, DOI 10.1212/WNL.50.3.748; Honavar M, 1999, HISTOPATHOLOGY, V34, P342; JACKSON GD, 1993, AM J NEURORADIOL, V14, P753; KUKS JBM, 1993, LANCET, V342, P1391; Kuzniecky R, 1999, NEUROLOGY, V52, P479, DOI 10.1212/WNL.52.3.479; Madsen JR, 1998, PEDIATR NEUROSURG, V28, P261, DOI 10.1159/000028662; Maher J, 1995, BRAIN, V118, P1521, DOI 10.1093/brain/118.6.1521; Mathern GW, 1996, BRAIN, V119, P965, DOI 10.1093/brain/119.3.965; MATHERN GW, 1995, BRAIN, V118, P105, DOI 10.1093/brain/118.1.105; Miller SP, 2000, NEUROLOGY, V54, P1465, DOI 10.1212/WNL.54.7.1465; Morioka T, 1998, EPILEPSIA, V39, P804, DOI 10.1111/j.1528-1157.1998.tb01168.x; Morris HH, 1998, EPILEPSIA, V39, P307, DOI 10.1111/j.1528-1157.1998.tb01378.x; PRAYSON RA, 1995, J NEUROPATH EXP NEUR, V54, P513, DOI 10.1097/00005072-199507000-00005; RAYMOND AA, 1994, NEUROLOGY, V44, P1841, DOI 10.1212/WNL.44.10.1841; VanLandingham KE, 1998, ANN NEUROL, V43, P413, DOI 10.1002/ana.410430403; Wester K, 1999, NEUROSURGERY, V45, P775, DOI 10.1097/00006123-199910000-00008	27	22	24	0	1	BLACKWELL PUBLISHING INC	MALDEN	350 MAIN ST, MALDEN, MA 02148 USA	0013-9580			EPILEPSIA	Epilepsia	JAN	2002	43	1					75	80		10.1046/j.1528-1157.2002.24201.x			6	Clinical Neurology	Neurosciences & Neurology	527EE	WOS:000174173100012	11879390	Bronze			2021-06-18	
J	Zhu, XL; Poon, WS; Chan, CH; Chan, SH				Zhu, XL; Poon, WS; Chan, CH; Chan, SH			Does intensive rehabilitation improve the functional outcome of patients with traumatic brain injury? Interim result of a randomized controlled trial	BRITISH JOURNAL OF NEUROSURGERY			English	Article						functional independent measurement; Glasgow Outcome Scale; intensive rehabilitation; traumatic brain injury	SEVERE HEAD-INJURY; STROKE; EXERCISE	To evaluate the effects of intensive rehabilitation on the functional outcome in patients with traumatic brain injury (TBI), we carried out a randomized controlled assessor-blind trial, comparing two groups of patients receiving different intensities of rehabilitation treatment (2 versus 4 h per day). Patients with moderate and severe TBI, aged from 12 to 65 years, were included. Glasgow Outcome Scale (GOS) and Functional Independent Measurement (FIM) were assessed monthly. The interim results of 36 cases showed that there was a trend of more patients in the study group achieving full FIM scores, and good GOS at 2 and 3 months, but the control group appeared to be catching up towards 6 months. Intensive rehabilitation may improve the early functional outcome of TBI patients. The interim results indicate that the study should be continued.	Chinese Univ Hong Kong, Prince Wales Hosp, Dept Surg, Neurosurg Unit, Hong Kong, Hong Kong, Peoples R China; Hong Kong Polytech Univ, Dept Rehabil Sci, Hong Kong, Hong Kong, Peoples R China; Shatin Cheshire Home, Hong Kong, Hong Kong, Peoples R China	Poon, WS (corresponding author), Prince Wales Hosp, Dept Surg, Div Neurosurg, Shatin, Hong Kong, Peoples R China.		Poon, Wai Sang/F-1558-2011	Chan, Chetwyn C. H./0000-0003-0307-6337			BARNES M, REHABILITATION TRAUM; BLACKERBY W F, 1990, Brain Injury, V4, P167, DOI 10.3109/02699059009026162; Chesnut RM, 1999, J HEAD TRAUMA REHAB, V14, P176, DOI 10.1097/00001199-199904000-00007; CLIFTON GL, 1992, NEUROSURGERY, V31, P975, DOI 10.1227/00006123-199211000-00028; COPE DN, 1995, BRAIN INJURY, V9, P649, DOI 10.3109/02699059509008224; COPE DN, 1982, ARCH PHYS MED REHAB, V63, P433; EVANS CD, 1994, NEUROLOGICAL REHABIL, P141; FONG NK, 1997, HONG KONG J OCCUPATI, V8, P39; Fuhrer MJ, 1987, REHABILITATION OUTCO, P137; GARRAWAY WM, 1980, BRIT MED J, V280, P1040, DOI 10.1136/bmj.280.6220.1040; GARRAWAY WM, 1980, BRIT MED J, V281, P828; Gordon WA, 1998, J HEAD TRAUMA REHAB, V13, P58, DOI 10.1097/00001199-199808000-00006; Graham DI, 2000, J NEUROPATH EXP NEUR, V59, P641, DOI 10.1093/jnen/59.8.641; Grealy MA, 1999, ARCH PHYS MED REHAB, V80, P661, DOI 10.1016/S0003-9993(99)90169-7; HEINEMANN AW, 1995, AM J PHYS MED REHAB, V74, P315, DOI 10.1097/00002060-199507000-00011; HETHERINGTON H, 1994, INJURY, V25, P527, DOI 10.1016/0020-1383(94)90095-7; JENNETT B, 1979, NEUROSURGERY, V4, P283, DOI 10.1227/00006123-197904000-00001; JENNETT B, 1975, LANCET, V1, P480; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; JOHNSTON MV, 1994, ARCH PHYSICAL MED RE, V75, P2; Kwakkel G, 1997, STROKE, V28, P1550, DOI 10.1161/01.STR.28.8.1550; LAU AEC, 1998, HONG KONG J OCCUPATI, V9, P52; LEE CMS, 1998, HONG KONG J OCCUPATI, V9, P52; Liepert J, 2000, STROKE, V31, P1210, DOI 10.1161/01.STR.31.6.1210; Malec JF, 1996, ARCH PHYS MED REHAB, V77, P198, DOI 10.1016/S0003-9993(96)90168-9; Marshall SB, 1991, J NEUROSURG S, V75, P14; McGregor K, 1997, SOC SCI MED, V45, P295, DOI 10.1016/S0277-9536(96)00345-0; MCLELLAN D, 1988, MANAGEMENT TRAUMATIC; Miltner WHR, 1999, STROKE, V30, P586, DOI 10.1161/01.STR.30.3.586; PRIGATANO GP, 1988, BNI Q, V4, P30; Ragnarsson KT, 1999, JAMA-J AM MED ASSOC, V282, P974; Rice-Oxley M, 1999, CLIN REHABIL, V13, P7, DOI 10.1191/026921599668051623; SHIEL A, 1999, CLIN REHABIL, V13, P90; SLADE A, 1999, CLIN REHABIL, V13, P94; SPIVACK G, 1992, Brain Injury, V6, P419, DOI 10.3109/02699059209008138; TAUB E, 1993, ARCH PHYS MED REHAB, V74, P347; Turner-Stokes L, 1999, CLIN REHABIL, V13, P3, DOI 10.1191/026921599673346206; YU J, 1976, ARCH PHYS MED REHAB, V57, P38	38	22	23	0	5	CARFAX PUBLISHING	BASINGSTOKE	RANKINE RD, BASINGSTOKE RG24 8PR, HANTS, ENGLAND	0268-8697			BRIT J NEUROSURG	Br. J. Neurosurg.	DEC	2001	15	6					464	473		10.1080/02688690120097688			10	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	513NZ	WOS:000173385800003	11813997				2021-06-18	
J	Biervert, C; Horvath, E; Fahrig, T				Biervert, C; Horvath, E; Fahrig, T			Semiquantitative expression analysis of ephrine-receptor tyrosine kinase mRNA's in a rat model of traumatic brain injury	NEUROSCIENCE LETTERS			English	Article						ephrine tyrosine kinases; central nervous system lesion model; subdural haematoma; mRNA expression; real-time polymerase chain reaction; housekeeping genes	EPH FAMILY; COMMISSURAL AXONS; PROTEIN; ECK; GUIDANCE; LIGANDS; MICE	The molecular mechanisms involved in recovery of function of the central nervous system (CNS) after injury to the brain are incompletely understood. Here the expression of ephrine (Eph) kinases following traumatic brain injury (subdural haematoma) was analysed in order to find out whether these developmentally regulated genes may be involved in tissue remodelling after brain damage. mRNA was isolated from ipsilateral cortices 7, 18, and 28 days after surgery and semiquantitative reverse transcription-polymerase chain reaction was performed. Most Eph kinases did not show significant regulation at gene expression level during the time course of recovery from acute brain injury but there is some evidence that mRNA of EphB1 might be slightly upregulated. (C) 2001 Elsevier Science Ireland Ltd. All rights reserved.	Bayer AG, CNS Res, D-5600 Wuppertal, Germany	Fahrig, T (corresponding author), Aprather Weg 18A, D-42096 Wuppertal, Germany.	thomas.fahrig.tf@bayer-ag.de					BULLOCK R, 1991, J NEUROSURG, V74, P794, DOI 10.3171/jns.1991.74.5.0794; Chen J, 1998, J BIOL CHEM, V273, P24670, DOI 10.1074/jbc.273.38.24670; Eijkenboom M, 2000, NEUROPHARMACOLOGY, V39, P817, DOI 10.1016/S0028-3908(00)00002-2; Eng LF, 2000, NEUROCHEM RES, V25, P1439, DOI 10.1023/A:1007677003387; Gerlai R, 1999, J NEUROSCI, V19, P9538; Gerlai R, 2000, BEHAV BRAIN RES, V108, P133, DOI 10.1016/S0166-4328(99)00139-4; Harrison DC, 2000, MOL BRAIN RES, V75, P143, DOI 10.1016/S0169-328X(99)00305-8; Henkemeyer M, 1996, CELL, V86, P35, DOI 10.1016/S0092-8674(00)80075-6; Krull CE, 1997, CURR BIOL, V7, P571, DOI 10.1016/S0960-9822(06)00256-9; KURODA Y, 1992, NEUROSURGERY, V31, P1062, DOI 10.1227/00006123-199212000-00012; MILLER JD, 1990, NEUROSURGERY, V27, P433, DOI 10.1227/00006123-199009000-00016; Miranda JD, 1999, EXP NEUROL, V156, P218, DOI 10.1006/exnr.1998.7012; Moreno-Flores MT, 1999, NEUROSCIENCE, V91, P193, DOI 10.1016/S0306-4522(98)00568-5; MORI T, 1995, MOL BRAIN RES, V29, P325, DOI 10.1016/0169-328X(94)00263-E; Orioli D, 1996, EMBO J, V15, P6035, DOI 10.1002/j.1460-2075.1996.tb00992.x; PANDEY A, 1995, SCIENCE, V268, P567, DOI 10.1126/science.7536959; Park S, 1997, EMBO J, V16, P3106, DOI 10.1093/emboj/16.11.3106; Stein E, 1998, GENE DEV, V12, P667, DOI 10.1101/gad.12.5.667; TANG XX, 1995, GENOMICS, V29, P426, DOI 10.1006/geno.1995.9985; Theil T, 1998, DEVELOPMENT, V125, P443; Wang HU, 1998, CELL, V93, P741, DOI 10.1016/S0092-8674(00)81436-1; Wang HU, 1997, NEURON, V18, P383, DOI 10.1016/S0896-6273(00)81240-4; Xu QL, 1995, DEVELOPMENT, V121, P4005; Zhou RP, 1998, PHARMACOL THERAPEUT, V77, P151, DOI 10.1016/S0163-7258(97)00112-5	24	22	23	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0304-3940	1872-7972		NEUROSCI LETT	Neurosci. Lett.	NOV 23	2001	315	1-2					25	28		10.1016/S0304-3940(01)02312-6			4	Neurosciences	Neurosciences & Neurology	497CH	WOS:000172434800007	11711206				2021-06-18	
J	Baker, F				Baker, F			The effects of live, taped, and no music on people experiencing posttraumatic amnesia	JOURNAL OF MUSIC THERAPY			English	Article							CLOSED-HEAD-INJURY; TRAUMATIC BRAIN INJURY; AGITATION; THERAPY; SCALE; REHABILITATION; ORIENTATION; DEMENTIA; INTERVENTION; BEHAVIOR	This study compared the effects of live, taped, and no music, on agitation and orientation levels of people experiencing posttraumatic amnesia (PTA). Participants (N = 22) were exposed to all 3 conditions, twice over 6 consecutive days. Songs used in the live and taped music conditions were identical and were selected based on participants' own preferred music. Pre and posttesting was conducted for each condition using the Agitated Behavior Scale (Corrigan, 1989) and the Westmead PTA Scale (Shores, Marosszeky, Sandanam, Batchelor, 1986). Participants' memory for the music used was also tested and compared with their memory for pictorial material presented in the Westmead PTA Scale. Results indicate that music significantly reduced agitation (p <. 0001) and enhanced orientation (p < .001) however, the difference between live and taped music was not significant (p =.7). The mean number of pictures in the Westmead PTA scale recalled was 0.84 and the mean number of music selections recalled was 1.22 but this difference was not significant (p =. 7). However, the trend suggests that music selections are more easily encoded in memory and then retrieved on request, than that of pictures. Analysis of responses in a follow-up assessment questionnaire showed that 77% of participants recalled the music program while in PTA, indicating that it reached the memory threshold. Sixty-four percent recalled the live music and 55% recalled the taped music condition however this difference was not significant (p = .7). Results suggest that music therapy programs have an important role to play in the management of people in PTA.	Sogn & Fjordane Coll, Sandane, Norway	Baker, F (corresponding author), Sogn & Fjordane Coll, Sandane, Norway.						ALDRIDGE D, 1990, J ROY SOC MED, V83, P345; ALDRIDGE D, 1991, ART PSYCHOTHER, V18, P359, DOI 10.1016/0197-4556(91)90077-N; ALDRIDGE D, 1991, ART PSYCHOTHER, V18, P59, DOI 10.1016/0197-4556(91)90008-X; Aldridge D, 1996, MUSIC THERAPY RES PR; ANSDELL G, 1995, MUSIC LIFE CREATIVE; AZOUVI P, 1996, P 5 C INT ASS STUD T, P124; Bailey LM, 1983, MUSIC THERAPY, V3, P17; BRIGHT R, 1999, MUSICMEDICINE, V3, P255; BROOKE MM, 1992, ARCH PHYS MED REHAB, V73, P320, DOI 10.1016/0003-9993(92)90003-F; Brotons M, 1996, J MUSIC THER, V33, P2, DOI 10.1093/jmt/33.1.2; CASBY JA, 1994, AM J OCCUP THER, V48, P883, DOI 10.5014/ajot.48.10.883; Clair A. A., 1994, Activities, Adaptation & Aging, V19, P61, DOI 10.1300/J016v19n01_05; CORRIGAN JD, 1994, J CLIN EXP NEUROPSYC, V16, P386, DOI 10.1080/01688639408402649; CORRIGAN JD, 1989, J CLIN EXP NEUROPSYC, V11, P261, DOI 10.1080/01688638908400888; CORRIGAN JD, 1988, ARCH PHYS MED REHAB, V69, P487; DANIEL WF, 1987, CORTEX, V23, P169, DOI 10.1016/S0010-9452(87)80030-8; Ellenberg JH, 1996, ARCH NEUROL-CHICAGO, V53, P782, DOI 10.1001/archneur.1996.00550080104018; FITZGERALDCLOUT.ML, 1993, MUSIC THERAPY PERSPE, V11, P32, DOI DOI 10.1093/MTP/11.1.32; FORRESTER G, 1994, BRAIN INJURY, V8, P175, DOI 10.3109/02699059409150969; Fugate LP, 1997, ARCH PHYS MED REHAB, V78, P917, DOI 10.1016/S0003-9993(97)90050-2; GASQUOINE P G, 1991, Brain Injury, V5, P169, DOI 10.3109/02699059109008087; GEFFEN GM, 1991, NEUROREPORT, V2, P105, DOI 10.1097/00001756-199102000-00010; Gerdner L A, 1993, Arch Psychiatr Nurs, V7, P284, DOI 10.1016/0883-9417(93)90006-I; Goddaer J, 1994, Arch Psychiatr Nurs, V8, P150, DOI 10.1016/0883-9417(94)90048-5; GROENE RW, 1993, J MUSIC THER, V30, P138, DOI 10.1093/jmt/30.3.138; GRONWALL D, 1980, Journal of Clinical Neuropsychology, V2, P51, DOI 10.1080/01688638008403780; Hanser S. B., 1995, ART SCI MUSIC THERAP, P342; HIGH WM, 1990, J CLIN EXP NEUROPSYC, V12, P703, DOI 10.1080/01688639008401013; HOWARD ME, 1988, J HEAD TRAUMA REHAB, V3, P14; Kennelly J, 1997, AUSTR J MUSIC THERAP, V8, P18; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; MALKMUS D, 1980, REHABILITATION HEAD; MINTZBITMAN S, 1987, COGNITIVE REHABILITA, V5, P22; Mysiw WJ., 1990, J HEAD TRAUMA REHAB, V5, P65; Plylar P A, 1989, J Neurosci Nurs, V21, P353; Ponsford J., 1995, TRAUMATIC BRAIN INJU; RAO N, 1985, ARCH PHYS MED REHAB, V66, P30; Rosenfeld JV, 1999, MUSICMEDICINE 3 EXPA, V3, P35; SANDEL ME, 1995, NEUROREHABILITATION, V5, P299, DOI 10.3233/NRE-1995-5404; SANEDA D L, 1992, Brain Injury, V6, P167, DOI 10.3109/02699059209029655; Sholberg M. M., 1989, INTRO COGNITIVE REHA; SHORES EA, 1986, MED J AUSTRALIA, V144, P569, DOI 10.5694/j.1326-5377.1986.tb112311.x; Thomas DW, 1997, J MUSIC THER, V34, P246, DOI 10.1093/jmt/34.4.246; Whitcomb J. B., 1993, Activities, Adaptation & Aging, V18, P57, DOI 10.1300/J016v18n02_05; Wolf AP, 1996, BRAIN INJURY, V10, P241, DOI 10.1080/026990596124412; Yuen HK, 1996, BRAIN INJURY, V10, P229, DOI 10.1080/026990596124548; Zafonte RD, 1997, J HEAD TRAUMA REHAB, V12, P78, DOI 10.1097/00001199-199704000-00008; Zencius AH, 1998, BRAIN INJURY, V12, P53, DOI 10.1080/026990598122854	48	22	22	0	13	NATL ASSOC MUSIC THERAPY INC	SILVER SPRING	8455 COLESVILLE RD, STE 1000, SILVER SPRING, MD 20910 USA	0022-2917			J MUSIC THER	J. Music Ther.	FAL	2001	38	3					170	192		10.1093/jmt/38.3.170			23	Music; Rehabilitation	Music; Rehabilitation	473PL	WOS:000171054500001	11570931				2021-06-18	
J	Cupitt, JM				Cupitt, JM			Prophylaxis against thromboembolism in patients with traumatic brain injury: a survey of UK practice	ANAESTHESIA			English	Article						thrombosis, deep venous; traumatic brain injury; thromboprophylaxis	DEEP-VEIN THROMBOSIS; MOLECULAR-WEIGHT HEPARIN; LOW-DOSE HEPARIN; INTERMITTENT PNEUMATIC COMPRESSION; POSTOPERATIVE INTRACRANIAL HEMORRHAGE; VENA-CAVA FILTERS; VENOUS THROMBOEMBOLISM; NEUROSURGICAL PATIENTS; HIGH-RISK; RANDOMIZED TRIAL	Venous thromboembolism is a major complication associated with traumatic brain injury and is responsible for significant morbidity and mortality. There has been a general reluctance over the years to use anticoagulant prophylaxis for patients with head injury who have suffered intracranial bleeding or for whom intracranial surgery is needed. We conducted a postal questionnaire survey of all neurosurgical centres in the United Kingdom, enquiring about the use of thromboprophylactic methods in the management of patients with traumatic brain injury. A diversity of practice and opinion in the use of such methods was evident from the replies received. The survey highlighted concern about the failure to implement even the most simple means of prophylaxis. The evidence for the use of the various methods of prophylaxis is reviewed.	Hope Hosp, Dept Anaesthesia, Manchester M6 8HD, Lancs, England	Cupitt, JM (corresponding author), Hope Hosp, Dept Anaesthesia, Stott Lane, Manchester M6 8HD, Lancs, England.						Agnelli G, 1998, NEW ENGL J MED, V339, P80, DOI 10.1056/NEJM199807093390204; Agu O, 1999, BRIT J SURG, V86, P992, DOI 10.1046/j.1365-2168.1999.01195.x; BARNETT HG, 1977, J NEUROSURG, V47, P27, DOI 10.3171/jns.1977.47.1.0027; BLACK PM, 1986, NEUROSURGERY, V18, P440, DOI 10.1227/00006123-198604000-00008; Britt LD, 1996, AM J SURG, V172, P13, DOI 10.1016/S0002-9610(96)00079-7; BUCCI MN, 1989, SURG NEUROL, V32, P285, DOI 10.1016/0090-3019(89)90231-0; Burke DT, 1999, J HEAD TRAUMA REHAB, V14, P515, DOI 10.1097/00001199-199910000-00015; CERRATO D, 1978, J NEUROSURG, V49, P378, DOI 10.3171/jns.1978.49.3.0378; Cifu DX, 1996, ARCH PHYS MED REHAB, V77, P1182, DOI 10.1016/S0003-9993(96)90145-8; CLAGETT GP, 1988, ANN SURG, V208, P227, DOI 10.1097/00000658-198808000-00016; Decousus H, 1998, NEW ENGL J MED, V338, P409, DOI 10.1056/NEJM199802123380701; Dickinson LD, 1998, NEUROSURGERY, V43, P1074, DOI 10.1097/00006123-199811000-00039; Erstad BL, 1998, PHARMACOTHERAPY, V18, P1011; FRIM DM, 1992, NEUROSURGERY, V30, P830, DOI 10.1227/00006123-199206000-00002; Geerts WH, 1996, NEW ENGL J MED, V335, P701, DOI 10.1056/NEJM199609053351003; GERSIN K, 1994, J TRAUMA, V37, P205, DOI 10.1097/00005373-199408000-00009; Gosin JS, 1997, ANN VASC SURG, V11, P100, DOI 10.1007/s100169900017; GREEN D, 1994, PHARMACOL REV, V46, P89; HAMILTON MG, 1994, NEUROSURGERY, V34, P280, DOI 10.1227/00006123-199402000-00012; Hammond FM, 1998, J HEAD TRAUMA REHAB, V13, P36, DOI 10.1097/00001199-199802000-00007; JOFFE SN, 1975, J NEUROSURG, V42, P201, DOI 10.3171/jns.1975.42.2.0201; KAUFMAN HH, 1983, ANGIOLOGY, V34, P627, DOI 10.1177/000331978303401001; Knudson MM, 1996, J TRAUMA, V41, P446, DOI 10.1097/00005373-199609000-00010; KNUDSON MM, 1994, J TRAUMA, V37, P480, DOI 10.1097/00005373-199409000-00025; Langan EM, 1999, J VASC SURG, V30, P484, DOI 10.1016/S0741-5214(99)70075-3; Macdonald RL, 1999, NEUROSURGERY, V45, P245, DOI 10.1097/00006123-199908000-00008; Marion D W, 1991, Neurosurg Clin N Am, V2, P411; Narayan RK, 1996, NEUROTRAUMA; Nurmohamed MT, 1996, THROMB HAEMOSTASIS, V75, P233; Owings JT, 1996, J TRAUMA, V41, P396, DOI 10.1097/00005373-199609000-00004; Paoletti C, 1989, Agressologie, V30, P363; SHACKFORD SR, 1990, AM J SURG, V159, P365, DOI 10.1016/S0002-9610(05)81272-3; SKILLMAN JJ, 1978, SURGERY, V83, P354; Spain DA, 1998, AM SURGEON, V64, P522; SWANN KW, 1984, J NEUROSURG, V61, P1055, DOI 10.3171/jns.1984.61.6.1055; TOUHO H, 1986, NEUROSURGERY, V19, P523, DOI 10.1227/00006123-198610000-00005; TURPIE AGG, 1989, ARCH INTERN MED, V149, P679, DOI 10.1001/archinte.149.3.679; TURPIE AGG, 1977, NEUROLOGY, V27, P435, DOI 10.1212/WNL.27.5.435; VALLADARES JB, 1980, NEUROSURGERY, V6, P138, DOI 10.1227/00006123-198002000-00004; Vanek VW, 1998, AM SURGEON, V64, P1050; Velmahos GC, 1998, J AM COLL SURGEONS, V187, P529, DOI 10.1016/S1072-7515(98)00223-3; Warbel A, 1999, J Neurosci Nurs, V31, P180; WARLOW C, 1972, LANCET, V1, P1305; Weitz JI, 1997, NEW ENGL J MED, V337, P688, DOI 10.1056/NEJM199709043371007; Wen DY, 1998, SURG NEUROL, V50, P521, DOI 10.1016/S0090-3019(98)00083-4; ZELIKOVSKI A, 1981, J NEUROSURG, V54, P652, DOI 10.3171/jns.1981.54.5.0652	46	22	22	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0003-2409	1365-2044		ANAESTHESIA	Anaesthesia	AUG	2001	56	8					780	785					6	Anesthesiology	Anesthesiology	462BD	WOS:000170399000014	11493245				2021-06-18	
J	Ross, GM; Shamovsky, IL; Woo, SB; Post, JI; Vrkljan, PN; Lawrance, G; Solc, M; Dostaler, SM; Neet, KE; Riopelle, RJ				Ross, GM; Shamovsky, IL; Woo, SB; Post, JI; Vrkljan, PN; Lawrance, G; Solc, M; Dostaler, SM; Neet, KE; Riopelle, RJ			The binding of zinc and copper ions to nerve growth factor is differentially affected by pH: implications for cerebral acidosis	JOURNAL OF NEUROCHEMISTRY			English	Article						metalloproteins; neurotrophin; NGF; stroke; transition metal cations; traumatic brain injury	TRK PROTOONCOGENE PRODUCT; P75 NEUROTROPHIN RECEPTOR; ALZHEIMER A-BETA; SUPEROXIDE-DISMUTASE; BASIS-SETS; FACTOR NGF; ISCHEMIA; NEURONS; CULTURE; DISEASE	It has recently been shown that transition metal cations Zn2+ and Cu2+ bind to histidine residues of nerve growth factor (NGF) and other neurotrophins (a family of proteins important for neuronal survival) leading to their inactivation. Experimental data and theoretical considerations indicate that transition metal cations may destabilize the ionic form of histidine residues within proteins, thereby decreasing their pK(a) values. Because the release of transition metal cations and acidification of the local environment represent important events associated with brain injury, the ability of Zn2+ and Cu2+ to bind to neurotrophins in acidic conditions may alter neuronal death following stroke or as a result of traumatic injury. To test the hypothesis that metal ion binding to neurotrophins is influenced by pH, the effects of Zn2+ and Cu2+ on NGF conformation, receptor binding and NGF tyrosine kinase (trkA) receptor signal transduction were examined under conditions mimicking cerebral acidosis (pH range 5.5-7.4). The inhibitory effect of Zn2+ on biological activities of NGF is lost under acidic conditions. Conversely, the binding of Cu2+ to NGF is relatively independent of pH changes within the studied range. These data demonstrate that Cu2+ has greater binding affinity to NGF than Zn2+ at reduced pH, consistent with the higher affinity Of Cu2+ for histidine residues. These findings suggest that cerebral acidosis associated with stroke or traumatic brain injury could neutralize the Zn2+-mediated inactivation of NGF, whereas corresponding pH changes would have little or no influence on the inhibitory effects of Cu2+. The importance of His84 of NGF for transition metal cation binding is demonstrated, confirming the involvement of this residue in metal ion coordination.	Queens Univ, Dept Physiol, Kingston, ON K7L 3N6, Canada; Queens Univ, Dept Med, Kingston, ON K7L 3N6, Canada; Finch Univ Hlth Sci Chicago Med Sch, Dept Biochem & Mol Biol, N Chicago, IL 60064 USA; McGill Univ, Dept Neurol & Neurosurg, Montreal, PQ, Canada	Ross, GM (corresponding author), Queens Univ, Dept Physiol, Kingston, ON K7L 3N6, Canada.				NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS036700] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS36700] Funding Source: Medline		Allington C, 2001, CELL DEATH DIFFER, V8, P451, DOI 10.1038/sj.cdd.4400831; Atwood CS, 1998, J BIOL CHEM, V273, P12817, DOI 10.1074/jbc.273.21.12817; Back T, 2000, ANN NEUROL, V47, P485, DOI 10.1002/1531-8249(200004)47:4<485::AID-ANA12>3.3.CO;2-#; BECKE AD, 1993, J CHEM PHYS, V98, P5648, DOI 10.1063/1.464913; Brown RH, 1996, ANN NEUROL, V39, P145, DOI 10.1002/ana.410390202; BUSH AI, 1994, SCIENCE, V265, P1464, DOI 10.1126/science.8073293; CasacciaBonnefil P, 1996, NATURE, V383, P716, DOI 10.1038/383716a0; Chen SH, 2001, EUR J PHARMACOL, V414, P177, DOI 10.1016/S0014-2999(01)00792-0; CHOI DW, 1988, NEUROSCIENCE, V24, P67, DOI 10.1016/0306-4522(88)90312-0; CLARK T, 1983, J COMPUT CHEM, V4, P294, DOI 10.1002/jcc.540040303; Cuajungco MP, 2000, ANN NY ACAD SCI, V920, P292; Cuajungco MP, 1997, NEUROBIOL DIS, V4, P137, DOI 10.1006/nbdi.1997.0163; Danielsen E, 1997, EUR J BIOCHEM, V250, P249, DOI 10.1111/j.1432-1033.1997.0249a.x; DESIDERI A, 1993, ARCH BIOCHEM BIOPHYS, V301, P224; Diederix REM, 2000, BIOCHEMISTRY-US, V39, P9551, DOI 10.1021/bi000648o; FEE JA, 1975, BIOCHIM BIOPHYS ACTA, V412, P26, DOI 10.1016/0005-2795(75)90336-0; Frade JM, 1996, NATURE, V383, P166; FREDERICKSON CJ, 1988, BRAIN RES, V446, P383, DOI 10.1016/0006-8993(88)90899-2; FRISCH MJ, 1984, J CHEM PHYS, V80, P3265, DOI 10.1063/1.447079; HARIHARA.PC, 1973, THEOR CHIM ACTA, V28, P213, DOI 10.1007/BF00533485; Holm RH, 1996, CHEM REV, V96, P2239, DOI 10.1021/cr9500390; KAPLAN DR, 1991, NATURE, V350, P158, DOI 10.1038/350158a0; KAPLAN DR, 1991, SCIENCE, V252, P554, DOI 10.1126/science.1850549; Koh JY, 1996, SCIENCE, V272, P1013, DOI 10.1126/science.272.5264.1013; Kokaia Z, 1998, NEUROSCIENCE, V84, P1113, DOI 10.1016/S0306-4522(97)00579-4; KRISTIAN T, 1994, BRAIN RES, V641, P295, DOI 10.1016/0006-8993(94)90158-9; Kroes SJ, 1996, EUR J BIOCHEM, V240, P342, DOI 10.1111/j.1432-1033.1996.0342h.x; Lovell MA, 1998, J NEUROL SCI, V158, P47, DOI 10.1016/S0022-510X(98)00092-6; Lynch T, 2000, EXP GERONTOL, V35, P445, DOI 10.1016/S0531-5565(00)00112-1; Maitra R, 2000, NEUROTOX RES, V2, P321, DOI 10.1007/BF03033341; OUYANG YB, 1994, BRAIN RES, V646, P65, DOI 10.1016/0006-8993(94)90058-2; Park JA, 2000, J NEUROSCI, V20, P9096; Remenyi R, 2001, J BIOL INORG CHEM, V6, P23, DOI 10.1007/s007750000178; Ross GM, 1997, NAT MED, V3, P872, DOI 10.1038/nm0897-872; Ross GM, 1998, EUR J NEUROSCI, V10, P890, DOI 10.1046/j.1460-9568.1998.00094.x; ROSS GM, 1999, ENCY MOL BIOL, V3, P1584; Roux PP, 1999, J NEUROSCI, V19, P6887, DOI 10.1523/JNEUROSCI.19-16-06887.1999; Sedel F, 1999, EUR J NEUROSCI, V11, P3904, DOI 10.1046/j.1460-9568.1999.00814.x; Shamovsky IL, 1999, PROTEIN SCI, V8, P2223; Shamovsky IL, 1999, J AM CHEM SOC, V121, P9797, DOI 10.1021/ja983303q; SLOVITER RS, 1985, BRAIN RES, V330, P150, DOI 10.1016/0006-8993(85)90017-4; SMITH BJ, 1994, CHEM PHYS LETT, V231, P345, DOI 10.1016/0009-2614(94)01273-3; STEVENS WJ, 1992, CAN J CHEM, V70, P612, DOI 10.1139/v92-085; SUTTER A, 1979, J BIOL CHEM, V254, P5972; TONDER N, 1990, NEUROSCI LETT, V109, P247, DOI 10.1016/0304-3940(90)90002-Q; Trafton J, 1996, BRAIN RES, V731, P122, DOI 10.1016/0006-8993(96)00488-X; Vornov JJ, 1996, J NEUROCHEM, V67, P2379; Wang W, 1999, NEUROSCI LETT, V259, P115, DOI 10.1016/S0304-3940(98)00929-X; Weiss JH, 2000, TRENDS PHARMACOL SCI, V21, P395, DOI 10.1016/S0165-6147(00)01541-8; White AR, 2001, J NEUROCHEM, V76, P1509, DOI 10.1046/j.1471-4159.2001.00178.x; Woo SB, 1998, PROTEIN SCI, V7, P1006; Woo SB, 1996, J BIOL CHEM, V271, P24433, DOI 10.1074/jbc.271.40.24433; WOODRUFF NR, 1986, BIOCHEMISTRY-US, V25, P7967, DOI 10.1021/bi00372a027; Zhang Y, 2000, INORG CHEM, V39, P3057, DOI 10.1021/ic000036s	54	22	22	1	5	BLACKWELL SCIENCE LTD	OXFORD	P O BOX 88, OSNEY MEAD, OXFORD OX2 0NE, OXON, ENGLAND	0022-3042			J NEUROCHEM	J. Neurochem.	AUG	2001	78	3					515	523		10.1046/j.1471-4159.2001.00427.x			9	Biochemistry & Molecular Biology; Neurosciences	Biochemistry & Molecular Biology; Neurosciences & Neurology	460TZ	WOS:000170325800011	11483654	Bronze			2021-06-18	
J	Barr, WB				Barr, WB			Methodologic issues in neuropsychological testing	JOURNAL OF ATHLETIC TRAINING			English	Article						concussion; head injury; assessment; psychometrics	TRAUMATIC BRAIN INJURY; STANDARDIZED ASSESSMENT; FOOTBALL PLAYERS; CONCUSSION	Objective: To familiarize athletic trainers with methodologic issues regarding the development and implementation of neuropsychological tests used in programs for monitoring sport-related cerebral concussion. Data Sources: Knowledge base and MEDLINE and PsychLit searches from 1980-2000 using the terms sports, athletes, concussion, and brain. Data Synthesis: Neuropsychological testing is a proven method for evaluating symptoms of concussion that results from a variety of different causes. These tests have been shown to be effective in evaluating symptoms of subtle cognitive dysfunction in a number of patient groups, Applying these tests in an athletic population has required some procedural modifications, including the use of brief test batteries, collection of preseason baseline data, and evaluation of subtle postconcussive changes in test scores over time. New methods are now being used for improved evaluation of the reliability and validity of neuropsychological tests in athletes. Proper scientific analysis of the psychometric properties of neuropsychological tests and the ultimate value of their use in the sport setting will require years of detailed study on large numbers of athletes with and without symptoms of concussion. Conclusions/Recommendations: Athletic trainers and related personnel need to be aware of the training and methodologic issues associated with neuropsychological testing. Knowledge of the scientific properties of these tests, their advantages, and current limitations will ultimately enhance the athletic trainer's ability to use information from neuropsychological testing in an effective manner.	NYU, Mt Sinai Med Ctr & Hlth Ctr, Comprehens Epilepsy Ctr, Dept Neurol, New York, NY 10016 USA	Barr, WB (corresponding author), NYU, Mt Sinai Med Ctr & Hlth Ctr, Comprehens Epilepsy Ctr, Dept Neurol, 560 1st Ave,Rivergate 4th Floor, New York, NY 10016 USA.	william.barr@med.nyu.edu					ALEXANDER MP, 1995, NEUROLOGY, V45, P1253, DOI 10.1212/WNL.45.7.1253; ANASTASI A, 1968, PSYCHOLOGICAL TESTIN; BARR W, IN PRESS J INT NEURO; Barr WB, 1997, PSYCHOL ASSESSMENT, V9, P171; Barth JT., 1989, MILD HEAD INJURY, P257; Charter RA, 1999, J CLIN EXP NEUROPSYC, V21, P559, DOI 10.1076/jcen.21.4.559.889; Chelune GJ, 1993, NEUROPSYCHOLOGY, V7, P41, DOI DOI 10.1037/0894-4105.7.1.41; Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P964, DOI 10.1001/jama.282.10.964; Franzen MD, 2000, RELIABILITY VALIDITY, V2nd; Hinton-Bayre AD, 1999, J CLIN EXP NEUROPSYC, V21, P70, DOI 10.1076/jcen.21.1.70.945; JACOBSON NS, 1991, J CONSULT CLIN PSYCH, V59, P12, DOI 10.1037/0022-006X.59.1.12; Lezak MD, 1995, NEUROPSYCHOLOGICAL A; Lovell MR, 1998, J HEAD TRAUMA REHAB, V13, P9, DOI 10.1097/00001199-199804000-00004; Maroon JC, 2000, NEUROSURGERY, V47, P659, DOI 10.1097/00006123-200009000-00027; McCrea M, 1997, NEUROLOGY, V48, P586, DOI 10.1212/WNL.48.3.586; McCrea M, 1998, J HEAD TRAUMA REHAB, V13, P27, DOI 10.1097/00001199-199804000-00005; McFall RM, 1999, ANNU REV PSYCHOL, V50, P215, DOI 10.1146/annurev.psych.50.1.215; PONSFORD J, 1992, J CLIN EXP NEUROPSYC, V14, P822, DOI 10.1080/01688639208402865; Powell JW, 1999, JAMA-J AM MED ASSOC, V282, P958, DOI 10.1001/jama.282.10.958; Smith A., 1993, SYMBOL DIGIT MODALIT	20	22	22	0	2	NATL ATHLETIC TRAINERS ASSOC INC	DALLAS	2952 STEMMONS FREEWAY, DALLAS, TX 75247 USA	1062-6050	1938-162X		J ATHL TRAINING	J. Athl. Train.	JUL-SEP	2001	36	3					297	302					6	Sport Sciences	Sport Sciences	557NC	WOS:000175913800013					2021-06-18	
J	Golding, EM; You, JP; Robertson, CS; Bryan, RM				Golding, EM; You, JP; Robertson, CS; Bryan, RM			Potentiated endothelium-derived hyperpolarizing factor-mediated dilations in cerebral arteries following mild head injury	JOURNAL OF NEUROTRAUMA			English	Article						endothelium-derived hyperpolarizing factor; middle cerebral artery; nitric oxide; purinoceptors; traumatic brain injury; vascular smooth muscle	CORTICAL IMPACT INJURY; TRAUMATIC BRAIN INJURY; NITRIC-OXIDE; BLOOD-FLOW; RAT; ACETYLCHOLINE; RESPONSES; CHANNELS; TONE; EDHF	Evidence in the literature suggests that endothelium-derived hyperpolarizing factor (EDHF) may act in a compensatory manner such that during conditions of compromised nitric oxide (NO), EDHF serves as a back-up mechanism. Given that constitutive NO synthase is chronically downregulated after head trauma, we tested the hypothesis that EDHF is potentiated following injury. Male adult rats were subjected to either sham injury (n = 27) or mild controlled cortical impact (CCI) injury (n = 26). Branches of the middle cerebral artery (MCA) directly within the contusion site were harvested either 1 or 24 h later, pressurized to 60 mm Hg in a vessel chamber and allowed to develop spontaneous tone. Relaxation to luminal application of adenosine triphosphate (ATP) was similar in all groups. Relaxation to ATP in the presence of L-NAME (N(G)-nitro-L-arginine methyl ester) and indomethacin was similar in all groups except for vessels isolated at 24 h following mild CCI injury. In this case, L-NAME and indomethacin had no effect on the ATP-mediated dilation. The ATP-mediated dilation in L-NAME and indomethacin-treated MCA branches was inhibited by charybdotoxin, an inhibitor of large conductance Ca2+-sensitive K+ channels. These findings suggest that there is a significant potentiation of the EDHF-mediated dilation to ATP in cerebral arteries isolated at 24 h following mild CCI injury.	Baylor Coll Med, Dept Anesthesiol, Houston, TX 77030 USA; Baylor Coll Med, Dept Neurosurg, Houston, TX 77030 USA; Baylor Coll Med, Dept Mol Physiol & Biophys, Houston, TX 77030 USA; Baylor Coll Med, Dept Med, Houston, TX 77030 USA	Golding, EM (corresponding author), Baylor Coll Med, Dept Anesthesiol, 1 Baylor Plaza,Suite 434D, Houston, TX 77030 USA.				NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P01-NS 27616, R01 NS 37250] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P01NS027616, R01NS037250] Funding Source: NIH RePORTER		ASANO M, 1993, BRIT J PHARMACOL, V108, P214, DOI 10.1111/j.1476-5381.1993.tb13465.x; BRAYDEN JE, 1990, AM J PHYSIOL, V259, pH668; Bryan RM, 1996, ANESTHESIOLOGY, V85, P82, DOI 10.1097/00000542-199607000-00012; CHEN G, 1988, BRIT J PHARMACOL, V95, P1165, DOI 10.1111/j.1476-5381.1988.tb11752.x; Cherian L, 2000, J NEUROPHYSIOL, V83, P2171; CHERIAN L, 1994, J NEUROTRAUM, V11, P573, DOI 10.1089/neu.1994.11.573; DIXON CE, 1991, J NEUROSCI METH, V39, P253; DOBERSTEIN CE, 1993, ANN EMERG MED, V22, P993, DOI 10.1016/S0196-0644(05)82740-4; GARLAND CJ, 1995, TRENDS PHARMACOL SCI, V16, P23, DOI 10.1016/S0165-6147(00)88969-5; Giri BK, 2000, STROKE, V31, P961, DOI 10.1161/01.STR.31.4.961; Golding EM, 1998, J NEUROTRAUM, V15, P973, DOI 10.1089/neu.1998.15.973; Golding EM, 1999, CLIN EXP HYPERTENS, V21, P299, DOI 10.3109/10641969909068668; GOLDING EM, 1999, AM J PHYSIOL, V277, P1457; Hecker M, 2000, NEWS PHYSIOL SCI, V15, P1; Huang A, 2000, AM J PHYSIOL-HEART C, V278, pH762; KONTOS HA, 1992, J NEUROTRAUM, V9, P349, DOI 10.1089/neu.1992.9.349; Malmsjo M, 1999, CARDIOVASC RES, V43, P200, DOI 10.1016/S0008-6363(99)00062-0; Marrelli SP, 1999, AM J PHYSIOL-HEART C, V276, pH33; Mathew BP, 1999, J NEUROTRAUM, V16, P1177, DOI 10.1089/neu.1999.16.1177; MONCADA S, 1991, PHARMACOL REV, V43, P109; NAJIBI S, 1994, AM J PHYSIOL, V266, pH2061; TAYLOR SG, 1988, BRIT J PHARMACOL, V94, P853, DOI 10.1111/j.1476-5381.1988.tb11597.x; Wada K, 1998, J NEUROSURG, V89, P807, DOI 10.3171/jns.1998.89.5.0807; Waldron GJ, 1999, BRIT J PHARMACOL, V128, P653, DOI 10.1038/sj.bjp.0702858; WEI EP, 1980, CIRC RES, V46, P37, DOI 10.1161/01.RES.46.1.37; You JP, 1997, AM J PHYSIOL-HEART C, V273, pH1472; You JP, 1999, AM J PHYSIOL-HEART C, V277, pH893; You JP, 1999, STROKE, V30, P1125, DOI 10.1161/01.STR.30.5.1125	28	22	23	0	0	MARY ANN LIEBERT INC PUBL	LARCHMONT	2 MADISON AVENUE, LARCHMONT, NY 10538 USA	0897-7151			J NEUROTRAUM	J. Neurotrauma	JUL	2001	18	7					691	697		10.1089/089771501750357636			7	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	457CK	WOS:000170119400005	11497095				2021-06-18	
J	Sanders, MJ; Dietrich, WD; Green, EJ				Sanders, MJ; Dietrich, WD; Green, EJ			Behavioral, electrophysiological, and histopathological consequences of mild fluid-percussion injury in the rat	BRAIN RESEARCH			English	Article						brain injury; barrel field; parasagittal fluid percussion; water maze; electrophysiology; somatosensory cortex	TRAUMATIC BRAIN INJURY; SOMATOSENSORY EVOKED-POTENTIALS; CORTICAL IMPACT; HEAD-INJURY; LAYER-IV; DYSFUNCTION; DEPRESSION; DEFICITS; MODEL; MOUSE	Metabolic dysfunction in the relay nuclei of the rat vibrissa circuit follows traumatic brain injury (TBI). This study examined the effects of mild (1.4-1.5 atm) parasagittal fluid-percussion injury on the elctrophysiology of this circuit. TBI caused significant reductions in slope and increases in latency of vibrissa-evoked field potentials 3 days after injury. Assessment of open-field swimming revealed an increase in thigmotaxis 2 days after injury. TBI caused mild selective cortical damage and limited axonal swelling at the injury site. Thus mild injury disrupts somatosensory electrophysiology and exploratory behavior. (C) 2001 Elsevier Science B.V. All rights reserved.	Univ Miami, Sch Med, Dept Psychol, Miami, FL 33124 USA; Univ Miami, Sch Med, Dept Neurol Surg, Miami, FL 33136 USA; Univ Miami, Sch Med, Miami Project Cure Paralysis, Miami, FL 33136 USA; Univ Miami, Sch Med, Program Neurosci, Miami, FL 33136 USA	Sanders, MJ (corresponding author), Univ Calif Los Angeles, Dept Psychol, 1285 Franz Hall,Box 951563, Los Angeles, CA 90095 USA.	msanders@psych.ucla.edu			NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [P01HL036588] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P50NS030291] Funding Source: NIH RePORTER; NHLBI NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [HL36588] Funding Source: Medline; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS30291] Funding Source: Medline		BRAMLETT HM, 1995, J NEUROTRAUM, V12, P289, DOI 10.1089/neu.1995.12.289; CUSUMANO S, 1992, ELECTROEN CLIN NEURO, V84, P499, DOI 10.1016/0168-5597(92)90039-E; DIETRICH WD, 1994, J NEUROTRAUM, V11, P629, DOI 10.1089/neu.1994.11.629; DIETRICH WD, 1994, J NEUROTRAUM, V11, P289, DOI 10.1089/neu.1994.11.289; Ginsberg MD, 1997, AM J PHYSIOL-HEART C, V272, pH2859; HAMM RJ, 1992, J NEUROTRAUM, V9, P11, DOI 10.1089/neu.1992.9.11; Hicks RR, 1997, MOL CHEM NEUROPATHOL, V32, P1, DOI 10.1007/BF02815164; HOVDA DA, 1991, BRAIN RES, V567, P1, DOI 10.1016/0006-8993(91)91429-5; LYETH BG, 1990, BRAIN RES, V526, P249, DOI 10.1016/0006-8993(90)91229-A; OKUYAMA S, 1993, LIFE SCI, V53, pPL273, DOI 10.1016/0024-3205(93)90603-Z; Perri BR, 1997, J NEUROTRAUM, V14, P15, DOI 10.1089/neu.1997.14.15; Pierce JES, 1998, NEUROSCIENCE, V87, P359, DOI 10.1016/S0306-4522(98)00142-0; Sanders MJ, 1999, J NEUROTRAUM, V16, P915, DOI 10.1089/neu.1999.16.915; SHAW NA, 1986, J NEUROL SCI, V74, P257, DOI 10.1016/0022-510X(86)90111-5; SMITH DH, 1993, NEUROSCI LETT, V157, P211, DOI 10.1016/0304-3940(93)90739-8; SMITH DH, 1994, NEUROSCI LETT, V168, P151, DOI 10.1016/0304-3940(94)90438-3; WALSER H, 1986, J NEUROL, V233, P34, DOI 10.1007/BF00313989; WELKER C, 1974, J COMP NEUROL, V158, P437, DOI 10.1002/cne.901580405; WOOLSEY TA, 1970, BRAIN RES, V17, P205, DOI 10.1016/0006-8993(70)90079-X; YOSHINO A, 1991, BRAIN RES, V561, P106, DOI 10.1016/0006-8993(91)90755-K	20	22	22	0	2	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	JUN 15	2001	904	1					141	144		10.1016/S0006-8993(01)02424-6			4	Neurosciences	Neurosciences & Neurology	447TQ	WOS:000169588900015	11516420				2021-06-18	
J	Donders, J; Zhu, JJ; Tulsky, D				Donders, J; Zhu, JJ; Tulsky, D			Factor index score patterns in the WAIS-III standardization sample	ASSESSMENT			English	Article						WAIS-III; cluster analysis; profile subtypes	TRAUMATIC BRAIN INJURY; VERBAL-LEARNING TEST; WISC-III; SEX-DIFFERENCES; PERFORMANCE; EDUCATION; NORMS; AGE; INTELLIGENCE; ETHNICITY	Representative profile subtypes, based on factor index scores, were examined in the standardization sample of the Wechsler Adult Intelligence Scale-Third Edition (WAIS-III). Two-stage cluster analysis identified five reliable subtypes. Three clusters were differentiated primarily by level of performance across all factor index scores (ranging from below average, to average, to above average). The other two clusters were characterized by distinct patterns of performance, with relative efficacy on the Processing Speed index being the most prominent distinction (ranging from a relative weakness to a relative strength). The clusters did not differ significantly in age, but ethnicity and income covaried directly with level of WAIS-III performance, whereas gender affected differential patterns of performance. Furthermore, education and memory were associated primarily with level and, to a relatively minor degree, pattern of WAIS-III performance. Implications for clinical practice are discussed.	Mary Free Bed Hosp, Psychol Serv, Grand Rapids, MI 49503 USA; Psychol Corp, San Antonio, TX USA	Donders, J (corresponding author), Mary Free Bed Hosp, Psychol Serv, 235 Wealthy SE, Grand Rapids, MI 49503 USA.			Tulsky, David/0000-0002-4335-4509			BORNSTEIN RA, 1988, DEV NEUROPSYCHOL, V4, P17, DOI 10.1080/87565648809540386; Derakshan N, 1998, COGNITION EMOTION, V12, P697; Diehr MC, 1998, ASSESSMENT, V5, P375, DOI 10.1177/107319119800500407; Donders J, 1996, PSYCHOL ASSESSMENT, V8, P312, DOI 10.1037/1040-3590.8.3.312; Donders J, 1997, CHILD NEUROPSYCHOL, V3, P71, DOI 10.1080/09297049708401369; Elliman NA, 1997, PERS INDIV DIFFER, V23, P31, DOI 10.1016/S0191-8869(97)00016-0; Gladsjo JA, 1999, ASSESSMENT, V6, P147, DOI 10.1177/107319119900600204; Glutting J. J., 1997, CONT INTELLECTUAL AS, P349; Hawkins KA, 1998, CLIN NEUROPSYCHOL, V12, P535, DOI 10.1076/clin.12.4.535.7236; Heaton RK., 1996, NEUROPSYCHOL ASSESS, V2, P141; Kaufman AS, 1999, ESSENTIALS WAIS 3 AS; LECKLITER IN, 1989, J CLIN PSYCHOL, V45, P484, DOI 10.1002/1097-4679(198907)45:4<484::AID-JCLP2270450402>3.0.CO;2-L; MAJERES RL, 1990, INTELLIGENCE, V14, P357, DOI 10.1016/0160-2896(90)90023-M; MANLY J, 2000, ANN C AM PSYCH ASS W; Manly JJ, 1998, NEUROLOGY, V50, P1238, DOI 10.1212/WNL.50.5.1238; Martin TA, 2000, REHABIL PSYCHOL, V45, P402, DOI 10.1037/0090-5550.45.4.402; MCDERMOTT PA, 1989, PSYCHOL ASSESSMENT J, V1, P118; Moses JA, 1999, ARCH CLIN NEUROPSYCH, V14, P445, DOI 10.1016/S0887-6177(98)00030-4; Norman MA, 2000, J CLIN EXP NEUROPSYC, V22, P80, DOI 10.1076/1380-3395(200002)22:1;1-8;FT080; *SAS I, 1990, SAS STAT US GUID VER, V1; SATTLER JM, 1999, ASSESSMENT CHILDREN; Schinka JA, 1998, PSYCHOL ASSESSMENT, V10, P171, DOI 10.1037/1040-3590.10.2.171; SNOW WG, 1990, J CLIN EXP NEUROPSYC, V12, P873, DOI 10.1080/01688639008401028; Stevens J., 1992, APPL MULTIVARIATE ST, V2nd ed.; WARD JH, 1963, J AM STAT ASSOC, V58, P236, DOI 10.2307/2282967; WECHSLER D, 1997, WAIS3 WAIS3 TECHNICA; Wechsler D, 2008, WECHSLER ADULT INTEL, V4th; Wechsler D., 1997, WMS 3 WECHSLER MEMOR; Wechsler D., 1991, WECHSLER INTELLIGENC; Wechsler D, 1997, WAIS 3 ADM SCORING M; Wiegner S, 1999, J CLIN EXP NEUROPSYC, V21, P159, DOI 10.1076/jcen.21.2.159.925; Wiegner S, 1999, ASSESSMENT, V6, P179, DOI 10.1177/107319119900600205	32	22	22	0	2	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1073-1911			ASSESSMENT	Assessment	JUN	2001	8	2					193	203		10.1177/107319110100800207			11	Psychology, Clinical	Psychology	537LB	WOS:000174759100007	11428698				2021-06-18	
J	Stover, JF; Schoning, B; Sakowitz, OW; Woiciechowsky, C; Unterberg, AW				Stover, JF; Schoning, B; Sakowitz, OW; Woiciechowsky, C; Unterberg, AW			Effects of tacrolimus on hemispheric water content and cerebrospinal fluid levels of glutamate, hypoxanthine, interleukin-6, and tumor necrosis factor-alpha following controlled cortical impact injury in rats	JOURNAL OF NEUROSURGERY			English	Article						calcineurin; cytokine; brain edema; excitotoxicity; immunosuppression; neuroprotection; rat	TRAUMATIC BRAIN INJURY; NITRIC-OXIDE SYNTHASE; CLOSED-HEAD INJURY; MITOCHONDRIAL DYSFUNCTION; CYCLOSPORINE-A; CALCINEURIN INHIBITORS; CEREBRAL-ISCHEMIA; ARTERY-OCCLUSION; TNF-ALPHA; FK506	Object. Disturbance of calcium homeostasis contributes to evolving tissue damage and energetic impairment following traumatic brain injury (TBI). Calcium-mediated activation of calcineurin results in production of tissue-damaging nitric oxide and free oxygen radicals. Inhibition of calcineurin induced by the immunosuppressant tacrolimus (FK506) has been shown to reduce structural and functional damage after ischemia. The aims of the present study were to investigate time- and dose-dependent short-term antiedematous effects of tacrolimus following TBI. Methods. A left temporoparietal confusion (controlled cortical impact injury [CCII]) was induced in 51 male Sprague-Dawley rats. Tacrolimus (1 or 3 mg/kg body weight) was administered by a single intraperitoneal injection at 5 minutes, 30 minutes, or 4 hours after CCII occurred. Control rats received physiological saline. Water contents of traumatized and nontraumatized hemispheres, as well as cerebrospinal fluid (CSF) levels of mediators reflecting tissue damage (the proinflammatory cytokines interleukin [IL]-6 and tumor necrosis factor [TNF]-alpha, the excitotoxin glutamate, and the adenosine triphosphate-degradation product hypoxanthine), were determined 24 hours after trauma. Although CSF levels of IL-6 and TNF-alpha were completely suppressed by tacrolimus at all time points and at both concentrations. CSF levels of glutamate and hypoxanthine, as well as edema formation, were only marginally influenced. Significant reduction of cerebral water content was confined to nontraumatized hemispheres. In addition, the higher dose of tacrolimus failed to exert significant antiedematous effects on traumatized hemispheres. Conclusions. Under the present study design, the potency of tacrolimus in reducing edema formation following CCII seems limited. However, its immunosuppressive effects could be of value in influencing the posttraumatic inflammatory response known to aggravate tissue damage.	Charite Virchow Med Ctr, Dept Neurosurg, D-13353 Berlin, Germany	Stover, JF (corresponding author), Charite Virchow Med Ctr, Dept Neurosurg, Augustenburger Pl 01, D-13353 Berlin, Germany.	john.stover@charite.de					Baskaya MK, 1997, NEUROSCI LETT, V226, P33; Bavetta S, 1999, EXP NEUROL, V158, P382, DOI 10.1006/exnr.1999.7119; Bell MJ, 1998, J NEUROTRAUM, V15, P163, DOI 10.1089/neu.1998.15.163; Bochelen D, 1999, J PHARMACOL EXP THER, V288, P653; Butcher SP, 1997, J NEUROSCI, V17, P6939; CLARK RSB, 1994, J NEUROTRAUM, V11, P499, DOI 10.1089/neu.1994.11.499; DAWSON TM, 1993, P NATL ACAD SCI USA, V90, P9808, DOI 10.1073/pnas.90.21.9808; Fan L, 1996, MOL BRAIN RES, V36, P287, DOI 10.1016/0169-328X(95)00274-V; GarciaCriado FJ, 1997, TRANSPLANTATION, V64, P594, DOI 10.1097/00007890-199708270-00008; GOLD BG, 1995, J NEUROSCI, V15, P7509; Holmin S, 2000, J NEUROSURG, V92, P108, DOI 10.3171/jns.2000.92.1.0108; Ide T, 1996, NEUROSCI LETT, V204, P157, DOI 10.1016/0304-3940(96)12352-1; Knoblach SM, 1999, J NEUROIMMUNOL, V95, P115, DOI 10.1016/S0165-5728(98)00273-2; Kochanek OM, 1995, J NEUROTRAUM, V12, P1015, DOI 10.1089/neu.1995.12.1015; Kroppenstedt SN, 2000, CRIT CARE MED, V28, P3792, DOI 10.1097/00003246-200012000-00004; Kroppenstedt SN, 1998, J NEUROTRAUM, V15, P191, DOI 10.1089/neu.1998.15.191; LIU J, 1991, CELL, V66, P807, DOI 10.1016/0092-8674(91)90124-H; McIntosh TK, 1996, LAB INVEST, V74, P315; MOIA LJMP, 1994, BRAIN RES, V648, P337, DOI 10.1016/0006-8993(94)91138-X; Morioka M, 1999, PROG NEUROBIOL, V58, P1, DOI 10.1016/S0301-0082(98)00073-2; PALMER AM, 1993, J NEUROCHEM, V61, P2015, DOI 10.1111/j.1471-4159.1993.tb07437.x; ROTHWELL NJ, 1995, TRENDS NEUROSCI, V18, P130, DOI 10.1016/0166-2236(95)93890-A; Scheff SW, 1999, J NEUROTRAUM, V16, P783, DOI 10.1089/neu.1999.16.783; Schinder AF, 1996, J NEUROSCI, V16, P6125; Sharkey J, 1996, STROKE, V27, P2282, DOI 10.1161/01.STR.27.12.2282; SHARKEY J, 1994, NATURE, V371, P336, DOI 10.1038/371336a0; SHOHAMI E, 1994, J CEREBR BLOOD F MET, V14, P615, DOI 10.1038/jcbfm.1994.76; Shohami E, 1997, J NEUROIMMUNOL, V72, P169, DOI 10.1016/S0165-5728(96)00181-6; Snyder SH, 1998, TRENDS PHARMACOL SCI, V19, P21, DOI 10.1016/S0165-6147(97)01146-2; Squadrito F, 1999, BRIT J PHARMACOL, V127, P498, DOI 10.1038/sj.bjp.0702528; Stover JF, 2000, J NEUROSURG, V92, P853, DOI 10.3171/jns.2000.92.5.0853; Stover JF, 2000, NEUROSCI LETT, V288, P25, DOI 10.1016/S0304-3940(00)01187-3; Stover JF, 1999, CRIT CARE MED, V27, P1351, DOI 10.1097/00003246-199907000-00028; Stover JF, 2000, J NEUROTRAUM, V17, P1171, DOI 10.1089/neu.2000.17.1171; Sullivan PG, 1998, J NEUROTRAUM, V15, P789, DOI 10.1089/neu.1998.15.789; TAMURA F, J GASTROENTEROL HEPA, V13, P703; Tokime T, 1996, NEUROSCI LETT, V206, P81, DOI 10.1016/S0304-3940(96)12438-1; Toulmond S, 1996, TRENDS NEUROSCI, V19, P409; Tsujikawa A, 1998, STROKE, V29, P1431, DOI 10.1161/01.STR.29.7.1431; Verweij BH, 1997, NEUROL RES, V19, P334, DOI 10.1080/01616412.1997.11740821; VICTOR RG, 1995, P NATL ACAD SCI USA, V92, P6269, DOI 10.1073/pnas.92.14.6269; Wakita H, 1998, BRAIN RES, V792, P105, DOI 10.1016/S0006-8993(98)00126-7; Xiong Y, 1997, J NEUROTRAUM, V14, P23, DOI 10.1089/neu.1997.14.23; ZHANG J, 1995, NEUROL RES, V17, P285, DOI 10.1080/01616412.1995.11740328	44	22	26	0	0	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.	MAY	2001	94	5					782	787		10.3171/jns.2001.94.5.0782			6	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	429NV	WOS:000168524600013	11354410				2021-06-18	
J	Chedid, MK; Vender, JR; Harrison, SJ; McDonnell, DE				Chedid, MK; Vender, JR; Harrison, SJ; McDonnell, DE			Delayed appearance of a traumatic intracranial aneurysm - Case report and review of the literature	JOURNAL OF NEUROSURGERY			English	Article						cerebral angiography; delayed traumatic aneurysm; contrast-enhanced computerized tomography scanning; penetrating head injury	WOUNDS; BRAIN; MANAGEMENT; ARTERY	Giant traumatic intracranial aneurysms are rare, and thus their incidence and clinical behavior are poorly understood. In most cases, traumatic aneurysms develop and become symptomatic within months following injury. The authors present the case of a 46-year-old war veteran, in whom a giant internal carotid artery aneurysm developed as a result of a penetrating cranial shrapnel injury sustained 25 years earlier during the Vietnam war. The aneurysm had not been evident on previous imaging studies. At surgery, a piece of shrapnel was found embedded in the dome of the aneurysm. The presentation, diagnosis, management, and treatment options related to this lesion are discussed.	Med Coll Georgia, Neurosurg Sect, Augusta, GA 30912 USA; Genesys Reg Med Ctr, Neurosurg Sect, Grand Blanc, MI USA	Vender, JR (corresponding author), Med Coll Georgia, Neurosurg Sect, 1120 15th St,Room BI-3088, Augusta, GA 30912 USA.						ACHRAM M, 1980, BRIT J RADIOL, V53, P1144, DOI 10.1259/0007-1285-53-636-1144; Amirjamshidi A, 1996, J NEUROSURG, V84, P769, DOI 10.3171/jns.1996.84.5.0769; ARABI B, 1988, NEUROSURGERY, V22, P1056; COSGROVE GR, 1983, J NEUROSURG, V58, P291; Dolenc VV, 1999, BRIT J NEUROSURG, V13, P185, DOI 10.1080/02688699943961; DUTREVOU MD, 1992, NEUROSURGERY, V31, P905, DOI 10.1227/00006123-199211000-00012; FERRY DJ, 1972, J NEUROSURG, V36, P503, DOI 10.3171/jns.1972.36.4.0503; FLEISCHER A S, 1975, Surgical Neurology, V4, P233; FOX JL, 1983, INTRACRANIAL ANEURYS, V3, P1453; FOX JL, 1983, INTRACRANIAL ANEURYS, V1, P423; HADDAD FS, 1991, NEUROSURGERY, V28, P1; HAMMON WM, 1971, J NEUROSURG, V34, P127, DOI 10.3171/jns.1971.34.2part1.0127; Jackson F E, 1970, J Trauma, V10, P1158, DOI 10.1097/00005373-197012000-00008; KAUFMAN HH, 1980, NEUROSURGERY, V6, P181, DOI 10.1227/00006123-198002000-00011; MCDONALD EJ, 1976, AM J ROENTGENOL, V126, P792, DOI 10.2214/ajr.126.4.792; PARKINSON D, 1980, J NEUROSURG, V52, P11, DOI 10.3171/jns.1980.52.1.0011; PETTY J M, 1969, Journal of Neurosurgery, V30, P741, DOI 10.3171/jns.1969.30.6.0741; Phatouros CC, 2000, NEUROSURGERY, V47, P107, DOI 10.1097/00006123-200007000-00023; POZZATI E, 1982, J NEUROSURG, V57, P418, DOI 10.3171/jns.1982.57.3.0418; QUATTROCCHI KB, 1990, NEUROSURGERY, V27, P476, DOI 10.1227/00006123-199009000-00025; RAIMONDI AJ, 1968, NEUROCHIRURGIA, V11, P219; SALAR G, 1978, J NEUROSURG, V49, P100, DOI 10.3171/jns.1978.49.1.0100; SPETZLER RF, 1979, NEUROSURGERY, V4, P334, DOI 10.1227/00006123-197904000-00011; Voelker J L, 1997, W V Med J, V93, P317; YAZBAK PA, 1995, PEDIATR NEUROSURG, V22, P15, DOI 10.1159/000121294	25	22	23	0	0	AMER ASSOC NEUROLOGICAL SURGEONS	CHARLOTTESVILLE	UNIV VIRGINIA, 1224 WEST MAIN ST, STE 450, CHARLOTTESVILLE, VA 22903 USA	0022-3085			J NEUROSURG	J. Neurosurg.	APR	2001	94	4					637	641		10.3171/jns.2001.94.4.0637			5	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	417YD	WOS:000167862300017	11302667				2021-06-18	
J	Harvey, AG; Bryant, RA				Harvey, AG; Bryant, RA			Reconstructing trauma memories: A prospective study of "amnesic" trauma survivors	JOURNAL OF TRAUMATIC STRESS			English	Article						acute stress disorder; posttraumatic stress disorder; memory; amnesia	POSTTRAUMATIC-STRESS-DISORDER; CLOSED-HEAD-INJURY; BRAIN INJURY; INTERVIEW	The purpose of this study was to investigate memory for trauma in patients who were initially amnesic of the trauma as a result of mild traumatic brain injury (MTBI), Motor vehicle accident survivors M ho sustained a MTBI were assessed for their memory within 1-month posttrauma (n = 79) and again at 2-years posttrauma (n = 50), Consistent with their brain injury: all patients reported significant amnesia of their accident at initial assessment, At 2-years posttrauma, 40% were able to remember their accident. Reporting memory for the trauma M,as associated with shorter duration of posttraumatic amnesia. These findings suggest that people reconstruct memories of trauma in the absence of complete encoding of the experience. Possible mechanisms for memory reconstruction are considered.	Univ Oxford, Dept Expt Psychol, Oxford OX1 3UD, England; Univ New S Wales, Sch Psychol, Sydney, NSW, Australia	Harvey, AG (corresponding author), Univ Oxford, Dept Expt Psychol, Oxford OX1 3UD, England.		Bryant, Richard/AAA-6479-2019	Bryant, Richard/0000-0002-9607-819X			American Congress of Rehabilitation Medicine, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; *ASS ADV AUT MED, 1990, ABBR INJ SCAL; Brewin CR, 1996, PSYCHOL REV, V103, P670, DOI 10.1037/0033-295X.103.4.670; Bryant RA, 1998, PSYCHOL ASSESSMENT, V10, P215, DOI 10.1037/1040-3590.10.3.215; Bryant RA, 1998, AM J PSYCHIAT, V155, P625, DOI 10.1176/ajp.155.5.625; Bryant RA, 1996, J TRAUMA STRESS, V9, P621; BRYANT RA, 1995, PSYCHOL MED, V25, P869, DOI 10.1017/S0033291700035121; Bryant RA, 1999, BRAIN INJURY, V13, P15, DOI 10.1080/026990599121836; CHRISTIANSON S, 1997, RECOVERED MEMORIES F; GRONWALL D, 1980, Journal of Clinical Neuropsychology, V2, P51, DOI 10.1080/01688638008403780; Harvey AG, 1998, J NERV MENT DIS, V186, P333, DOI 10.1097/00005053-199806000-00002; Harvey AG, 2000, AM J PSYCHIAT, V157, P626, DOI 10.1176/appi.ajp.157.4.626; Hyman IE, 1998, CLIN PSYCHOL REV, V18, P933, DOI 10.1016/S0272-7358(98)00041-5; Peters L, 1996, INT J METHOD PSYCH, V6, P167, DOI 10.1002/(SICI)1234-988X(199610)6:3<167::AID-MPR159>3.3.CO;2-Z; ROEDIGER HL, 1997, RECOVERED MEMORIES F; SBORDONE RJ, 1995, BRAIN INJURY, V9, P405, DOI 10.3109/02699059509005780; SCHACTER DL, 1977, CORTEX, V13, P150, DOI 10.1016/S0010-9452(77)80006-3	17	22	22	0	2	KLUWER ACADEMIC/PLENUM PUBL	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0894-9867			J TRAUMA STRESS	J. Trauma Stress	APR	2001	14	2					277	282		10.1023/A:1011108816888			6	Psychology, Clinical; Psychiatry	Psychology; Psychiatry	451AM	WOS:000169779000002	11469156				2021-06-18	
J	Munte, TF; Radamm, C; Johannes, S; Brabant, G				Munte, TF; Radamm, C; Johannes, S; Brabant, G			Alterations of cognitive functions induced by exogenous application of thyroid hormones in healthy men: A double-blind cross-over study using event-related brain potentials	THYROID			English	Article							CLOSED HEAD-INJURY; VISUAL-SEARCH; ELECTROPHYSIOLOGICAL EVIDENCE; ATTENTION; PARALLEL; THERAPY; DISEASE; MEMORY; P300	The influence of experimentally induced subclinical hyperthyroidism on cognitive functions was tested using exogenous thyroxine or placebo. In a double-blind cross-over design, 24 healthy young men received either 300 mug of levothyroxine or placebo for two consecutive S-week periods. Determination of thyrotropin (TSH), total triiodothyronine (T-3), thyroxine (T-4), and sex hormone binding globulin (SHBG) confirmed the induction of subclinical hyperthyroidism. Three weeks after treatment with placebo or T-4, subjects were tested in two visual search tasks, one requiring the serial scanning of a stimulus array of eight items in order to detect a missing feature (serial task), while the other task allowed the parallel processing of eight items in order to detect an extra feature. Reaction times varied greatly between the tasks while no effect of T-4 medication was revealed on overt search behavior. The late cognitive components of the event-related brain potentials (ERP) were registered during the tasks using a multichannel recording. The late positive component (P300) to target stimuli showed a significant reduction in amplitude in the parallel search task in hyperthyroidism, while for the serial search task a significant frontal negativity was revealed for target stimuli, both suggesting an increased effort to be exerted for the execution of visual search tasks. Thus, short periods of subclinical hyperthyroidism in the range commonly induced in the treatment of thyroid cancer patients induce distinct alterations in brain-electric activity.	Otto Von Guericke Univ, Dept Neuropsychol, D-39106 Magdeburg, Germany; Hannover Med Sch, Dept Clin Endocrinol, D-3000 Hannover, Germany; Hannover Med Sch, Dept Neurol, D-3000 Hannover, Germany	Munte, TF (corresponding author), Otto Von Guericke Univ, Dept Neuropsychol, Bldg 24,Univ Pl 2, D-39106 Magdeburg, Germany.		Munte, Thomas/C-2077-2014				BENTE D, 1982, EEG EMG, V13, P1; BRAVERMAN LE, 1991, WERNER INGBARS THYRO, P645; COOPER DS, 1995, J CLIN ENDOCR METAB, V80, P331, DOI 10.1210/jc.80.2.331; Donchin E, 1986, PSYCHOPHYSIOLOGY SYS, P244; DRATMAN MB, 1983, AM J PHYSIOL, V245, P185; HEINZE HJ, 1992, NEUROPSYCHOLOGIA, V30, P495, DOI 10.1016/0028-3932(92)90054-P; HEINZE HJ, 1994, PHARMACOPSYCHIATRY, V27, P224, DOI 10.1055/s-2007-1014309; Hillyard A.S., 1987, HDB PHYSL NERVOUS SY, P519; HILLYARD SA, 1983, ANNU REV PSYCHOL, V34, P33, DOI 10.1146/annurev.ps.34.020183.000341; JOHNSON R, 1986, PSYCHOPHYSIOLOGY, V23, P367, DOI 10.1111/j.1469-8986.1986.tb00649.x; KUTAS M, 1977, SCIENCE, V197, P792, DOI 10.1126/science.887923; LUCK SJ, 1990, PERCEPT PSYCHOPHYS, V48, P603, DOI 10.3758/BF03211606; MACCRIMMON DJ, 1979, PSYCHOSOM MED, V41, P331, DOI 10.1097/00006842-197906000-00007; MANDEL SJ, 1993, ANN INTERN MED, V119, P492, DOI 10.7326/0003-4819-119-6-199309150-00009; Marr D., 1982, VISION COMPUTATIONAL; MCCARTHY G, 1981, SCIENCE, V211, P77, DOI 10.1126/science.7444452; Munte TF, 1996, NEUROPSYCHOBIOLOGY, V34, P49, DOI 10.1159/000119291; NAATANEN R, 1990, BEHAV BRAIN SCI, V13, P201, DOI 10.1017/S0140525X00078407; PERRILD H, 1986, ACTA ENDOCRINOL-COP, V112, P185, DOI 10.1530/acta.0.1120185; ROSS DS, 1990, J CLIN ENDOCR METAB, V71, P764, DOI 10.1210/jcem-71-3-764; RUGG MD, 1993, NEUROPSYCHOLOGIA, V31, P373, DOI 10.1016/0028-3932(93)90161-R; TREISMAN A, 1985, J EXP PSYCHOL GEN, V114, P285, DOI 10.1037/0096-3445.114.3.285; TREISMAN AM, 1980, COGNITIVE PSYCHOL, V12, P97, DOI 10.1016/0010-0285(80)90005-5; ULLMAN S, 1984, COGNITION, V18, P137; VERLEGER R, 1988, BEHAV BRAIN SCI, V11, P343, DOI 10.1017/S0140525X00058015; WHYBROW PC, 1969, ARCH GEN PSYCHIAT, V20, P48; Woods DL., 1990, EVENT RELATED BRAIN, P178	27	22	24	0	0	MARY ANN LIEBERT INC PUBL	LARCHMONT	2 MADISON AVENUE, LARCHMONT, NY 10538 USA	1050-7256			THYROID	Thyroid	APR	2001	11	4					385	391		10.1089/10507250152039145			7	Endocrinology & Metabolism	Endocrinology & Metabolism	429GH	WOS:000168507400013	11349839				2021-06-18	
J	Phillis, JW; Goshgarian, HG				Phillis, JW; Goshgarian, HG			Adenosine and neurotrauma: Therapeutic perspectives	NEUROLOGICAL RESEARCH			English	Article						neurotrauma; cerebroprotection; adenosine receptors; spinal cord injury; cerebral blood flow	SPINAL-CORD HEMISECTION; TRANSIENT FOCAL ISCHEMIA; TRAUMATIC BRAIN INJURY; CEREBRAL-ISCHEMIA; A(2A) RECEPTORS; ADULT-RAT; INTRAVENOUS INFUSIONS; SYSTEMIC THEOPHYLLINE; NERVE ACTIVITIES; AMINOPHYLLINE	Cerebral ischemia studies demonstrating that stimulation of adenosine A(1) receptors by either endogenously released adenosine or the administration of selective receptor agonists causes significant reductions in the morbidity and mortality associated with focal or global brain ischemias have triggered interest in the potential of purinergic therapies for the treatment of traumatic injuries to the brain and spinal cord. Preliminary findings indicate that activation of A(1) adenosine receptors can ameliorate trauma-induced death of central neurons. Other avenues of approach include the administration of agents which elevate local concentrations of adenosine at injury sites by inhibiting its metabolism to inosine by adenosine deaminase, rephosphorylation to adenosine triphosphate by adenosine kinase or re-uptake into adjacent cells. Amplification of the levels of endogenously released adenosine in such a 'site and event specific' fashion has the advantage of largely restricting the effect of such inhibitors to areas of injury-induced adenosine release. Another approach involving purinergic therapy has been applied to the problem of respiratory paralysis following high spinal cord injuries. In this instance, the adenosine antagonist theophylline has been used to enhance residual synaptic drive to spinal respiratory neurons by blocking adenosine Al receptors. Theophylline induced, and maintained, hemidiaphragmatic recovery for prolonged periods after C(2) spinal cord hemisection in rats and may prove to be beneficial in assisting respiration in spinal cord injury patients.	Wayne State Univ, Sch Med, Dept Physiol, Detroit, MI 48201 USA; Wayne State Univ, Sch Med, Dept Anat, Detroit, MI 48201 USA	Phillis, JW (corresponding author), Wayne State Univ, Sch Med, Dept Physiol, 540 E Canfield, Detroit, MI 48201 USA.	jphillis@med.wayne.edu					AMER SM, 1971, P SOC EXP BIOL MED, V36, P750; Auchampach JA, 1997, CIRC RES, V80, P800; Bell MJ, 1998, J NEUROTRAUM, V15, P163, DOI 10.1089/neu.1998.15.163; BERSTRAND H, 1980, EUR J RESP, V109, P37; BRUNS RF, 1990, MOL PHARMACOL, V38, P939; Chen JF, 1999, J NEUROSCI, V19, P9192, DOI 10.1523/jneurosci.19-21-09192.1999; CHIANG CH, 1995, EUR RESPIR J, V8, P632; CUNHA RA, 1994, BRAIN RES, V649, P208, DOI 10.1016/0006-8993(94)91066-9; DALY JW, 1985, J MED CHEM, V28, P487, DOI 10.1021/jm00382a018; DELEO J, 1988, NEUROSCI LETT, V84, P307, DOI 10.1016/0304-3940(88)90526-5; Dixon AK, 1996, BRIT J PHARMACOL, V118, P1461, DOI 10.1111/j.1476-5381.1996.tb15561.x; ELDRIDGE FL, 1985, J APPL PHYSIOL, V59, P1428; ELDRIDGE FL, 1983, RESP PHYSIOL, V53, P239, DOI 10.1016/0034-5687(83)90070-1; Forbes CD, 1997, INT J CLIN PRACT, V51, P205; FREDHOLM BB, 1994, PHARMACOL REV, V46, P143; GAO Y, 1994, LIFE SCI, V55, pPL61, DOI 10.1016/0024-3205(94)00889-2; Gidday JM, 1996, BRAIN RES, V734, P261, DOI 10.1016/0006-8993(96)00647-6; GOSHGARIAN HG, 1979, EXP NEUROL, V66, P547, DOI 10.1016/0014-4886(79)90201-2; GOSHGARIAN HG, 1986, EXP NEUROL, V93, P440, DOI 10.1016/0014-4886(86)90206-2; GOSHGARIAN HG, 1977, EXP NEUROL, V57, P613, DOI 10.1016/0014-4886(77)90093-0; GOSHGARIAN HG, 2001, J SP CORD MED, V23, P193; Halle JN, 1997, BRAIN RES, V759, P309, DOI 10.1016/S0006-8993(97)00364-8; HEADRICK JP, 1994, J CEREBR BLOOD F MET, V14, P853, DOI 10.1038/jcbfm.1994.107; Hill RJ, 1998, J MOL CELL CARDIOL, V30, P579, DOI 10.1006/jmcc.1997.0621; Jacobson KA, 1998, TRENDS PHARMACOL SCI, V19, P184, DOI 10.1016/S0165-6147(98)01203-6; Jiang N, 1997, EUR J PHARMACOL, V320, P131, DOI 10.1016/S0014-2999(96)00905-3; Kochanek PM, 1997, ACT NEUR S, V70, P109; LAKSHMINARAYAN S, 1978, AM REV RESPIR DIS, V117, P33; LEWIS LJ, 1951, AM J PHYSIOL, V166, P241; Liang BT, 1998, P NATL ACAD SCI USA, V95, P6995, DOI 10.1073/pnas.95.12.6995; LIN Y, 1992, BRAIN RES, V571, P272, DOI 10.1016/0006-8993(92)90665-V; Lopes LV, 1999, J NEUROPHYSIOL, V82, P3196; LUNDBERG DB, 1981, J PHARMACOL EXP THER, V217, P215; McAdoo DJ, 2000, BRAIN RES, V854, P152, DOI 10.1016/S0006-8993(99)02333-1; Miller LP, 1996, NEUROSCI LETT, V220, P73, DOI 10.1016/S0304-3940(96)13234-1; MITCHELL HL, 1995, NEUROSURGERY, V36, P1003, DOI 10.1227/00006123-199505000-00017; Monopoli A, 1998, NEUROREPORT, V9, P3955, DOI 10.1097/00001756-199812010-00034; Moreau JL, 1999, BRAIN RES REV, V31, P65, DOI 10.1016/S0165-0173(99)00059-4; MORENO DE, 1992, EXP NEUROL, V116, P219, DOI 10.1016/0014-4886(92)90001-7; MUELLER RA, 1981, J PHARMACOL EXP THER, V218, P593; NACHAZEL J, 1990, EUR RESPIR J, V3, P311; Nantwi KD, 1998, NEUROPHARMACOLOGY, V37, P113, DOI 10.1016/S0028-3908(97)00190-1; Nantwi KD, 1998, BRAIN RES, V789, P126, DOI 10.1016/S0006-8993(98)00024-9; Nantwi KD, 1996, EXP NEUROL, V140, P53, DOI 10.1006/exnr.1996.0114; NEWMAN D, 1994, ISRAEL J MED SCI, V30, P811; NILSSON P, 1990, J CEREBR BLOOD F MET, V10, P631, DOI 10.1038/jcbfm.1990.115; PARKINSON FE, 1997, ROLE ADENOSINE NERVO, P223; PHILLIS J W, 1989, Cerebrovascular and Brain Metabolism Reviews, V1, P26; Phillis JW, 1995, BRAIN RES, V705, P79, DOI 10.1016/0006-8993(95)01153-6; PHILLIS JW, 1988, J CEREBR BLOOD F MET, V8, P733, DOI 10.1038/jcbfm.1988.121; PHILLIS JW, 1989, BRAIN RES BULL, V22, P537, DOI 10.1016/0361-9230(89)90107-X; PHILLIS JW, 1997, PRIMER CEREBROVASCUL, P250; Porter W T, 1895, J Physiol, V17, P455; RALL TW, 1999, PHARMACOL BASIS THER, P618; RICHMOND GH, 1949, J APPL PHYSIOL, V2, P16; RIEGELMAN S, 1980, CHEST, V78, P250, DOI 10.1378/chest.78.2.250; Rosin DL, 1998, J COMP NEUROL, V401, P163; RUDOLPHI K, 1995, NOVEL THERAPIES CNS, P327; RUDOLPHI KA, 1992, CEREBROVAS BRAIN MET, V4, P346; Schubert P, 1997, ANN NY ACAD SCI, V825, P1, DOI 10.1111/j.1749-6632.1997.tb48409.x; Sheardown MJ, 1996, DRUG DEVELOP RES, V39, P108; SIMPSON RE, 1992, J NEUROCHEM, V58, P1683, DOI 10.1111/j.1471-4159.1992.tb10041.x; STJOHN WM, 1987, EXP NEUROL, V96, P279; Von Lubitz DKJE, 1999, EUR J PHARMACOL, V367, P157, DOI 10.1016/S0014-2999(98)00977-7; VONLUBITZ DKJE, 1994, EUR J PHARMACOL, V256, P161, DOI 10.1016/0014-2999(94)90241-0; VonLubitz DKJE, 1995, EUR J PHARMACOL, V287, P295, DOI 10.1016/0014-2999(95)00498-X; VONLUBITZ DKJE, 1988, STROKE, V19, P1133, DOI 10.1161/01.STR.19.9.1133; VONLUBITZ DKJE, 1994, EUR J PHARMACOL, V263, P59, DOI 10.1016/0014-2999(94)90523-1	68	22	23	0	0	MANEY PUBLISHING	LEEDS	STE 1C, JOSEPHS WELL, HANOVER WALK, LEEDS LS3 1AB, W YORKS, ENGLAND	0161-6412			NEUROL RES	Neurol. Res.	MAR-APR	2001	23	2-3					183	189		10.1179/016164101101198316			7	Clinical Neurology; Neurosciences	Neurosciences & Neurology	422DX	WOS:000168104200010	11320597				2021-06-18	
J	Taly, AB; Nair, KPS; Jayakumar, PN; Ravishankar, D; Kalaivani, PL; Indiradevi, B; Murali, T				Taly, AB; Nair, KPS; Jayakumar, PN; Ravishankar, D; Kalaivani, PL; Indiradevi, B; Murali, T			Neurogenic heterotopic ossification: A diagnostic and therapeutic challenge in neurorehabilitation	NEUROLOGY INDIA			English	Article						rehabilitation; medical complications; heterotopic ossification	SPINAL-CORD INJURY; ASSOCIATION	Heterotopic ossification (HO) is an important cause of restriction in range of movements and secondary motor disability following neurotrauma, orthopaedic interventions and burns, It has not received focussed attention in non-traumatic neurological disorders. In a prospective study of 377 patients, on medical problems in neurological rehabilitation setting, 15 subjects (3.97%) had neurogenic heterotopic ossification. Their clinical diagnosis; was: transverse myelitis (7), neurotuberculosis (4) traumatic myelopathy (2) and stroke (2), Hip (10), knee (4) and elbow joints (I) were involved, The risk factors included urinary tract infection (15), spasticity (6), pressure sores (13) and deep venous thrombosis (DVT) (6), The initial diagnosis was often other than HO and included DVT (3), haematoma (2) and arthritis (2). ESR and serum alkaline phosphatase levels were elevated in all but one subject. The diagnosis of HO was established using S-rags, CT Scan and three-phase bone scan. Following treatment with non-steroidal anti-inflammatory drugs, the range of motion improved in only four patients. HO resulted in significant loss of therapy time during rehabilitation. High index of suspicion about this complication is necessary for early diagnosis and prompt intervention.	Natl Inst Mental Hlth & Neurosci, Dept Neurol, Bangalore 560029, Karnataka, India; Natl Inst Mental Hlth & Neurosci, Dept Psychiat Rehabil, Bangalore 560029, Karnataka, India; Natl Inst Mental Hlth & Neurosci, Dept Neurol Rehabil, Bangalore 560029, Karnataka, India							BIERINGSORENSEN F, 1993, PARAPLEGIA, V31, P513, DOI 10.1038/sc.1993.83; BODLEY R, 1993, PARAPLEGIA, V31, P500, DOI 10.1038/sc.1993.81; BRAVOPAYNO P, 1992, PARAPLEGIA, V30, P740, DOI 10.1038/sc.1992.142; BUSCHBACHER R, 1992, CRIT REV PHYS MED RE, V4, P199; CASSARPULLICINO VN, 1993, PARAPLEGIA, V31, P40, DOI 10.1038/sc.1993.7; COLACHIS SC, 1993, PARAPLEGIA, V31, P507, DOI 10.1038/sc.1993.82; COLACHIS SC, 1993, PARAPLEGIA, V31, P51, DOI 10.1038/sc.1993.8; DITUNNO JF, 1994, PARAPLEGIA, V32, P70, DOI 10.1038/sc.1994.13; GARLAND DE, 1991, CLIN ORTHOP RELAT R, P13; KURER MHJ, 1992, PARAPLEGIA, V30, P165, DOI 10.1038/sc.1992.48; SHARMA R, 1996, IND J PHYS MED REHAB, V7, P10; SNOECX M, 1995, PARAPLEGIA, V33, P464, DOI 10.1038/sc.1995.101; Taly AB, 1999, SPINAL CORD, V37, P47, DOI 10.1038/sj.sc.3100751; TALY AB, 1996, 24 ANN NAT C IND ASS	14	22	23	0	2	WOLTERS KLUWER MEDKNOW PUBLICATIONS	MUMBAI	WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2 VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA	0028-3886	1998-4022		NEUROL INDIA	Neurol. India	MAR	2001	49	1					37	40					4	Neurosciences	Neurosciences & Neurology	425HW	WOS:000168286000008	11303239				2021-06-18	
J	Zafonte, RD; Wood, DL; Harrison-Felix, CL; Valena, NV; Black, K				Zafonte, RD; Wood, DL; Harrison-Felix, CL; Valena, NV; Black, K			Penetrating head injury: A prospective study of outcomes	NEUROLOGICAL RESEARCH			English	Article						traumatic brain injury; gunshot wounds; outcomes; penetrating head injuries	CIVILIAN GUNSHOT WOUNDS; TRAUMATIC BRAIN INJURY; GLASGOW COMA SCALE; PREDICTION; MANAGEMENT; PROGNOSIS; VIOLENCE	The purpose of our study was to describe the outcomes of persons with penetrating brain injury resulting from a gunshot wound to the head. It is a prospective study of 442 patients admitted with gunshot wounds to the head over a 7 year period to our University Trauma Center Emergency Department, an urban trauma center and an inpatient rehabilitation hospital with a specialized brain injury unit Measures and factor; described include initial Glasgow Coma Scale score, Revised Trauma Score, the Disability Rating Scale, Functional Independence Measure, levels of cognitive functioning, patient demographics, length of stay, hospital charges, and discharge disposition. Initially 36% of patients expired in or were dead upon arrival to the Emergency Department; 64% of patients survived to be admitted for inpatient care. Of those admitted, 41% expired within the first 48 h of admission. Fifty-two percent of those admitted had severe injuries, 7% moderate injuries, and 42% had mild head injuries. Sixty-two percent of the survivors were discharged from acute care to private residences. The remaining 38% were discharged to programs providing varying levels of care depending upon their level of functioning and care needs. Patients sustaining severe injuries following gunshot wound(s) to the head have high early mortality. Survivors able to participate in an inpatient rehabilitation program have good potential for functional improvement.	Univ Pittsburgh, Pittsburgh, PA 15215 USA; Wayne State Univ, Rehabil Inst Michigan, Detroit, MI USA; Craig Hosp, Denver, CO USA	Zafonte, RD (corresponding author), Univ Pittsburgh, 3471 5th Ave,Suite 901, Pittsburgh, PA 15215 USA.						ALDRICH EF, 1992, SURG NEUROL, V38, P418, DOI 10.1016/0090-3019(92)90109-Z; ANNEST JL, 1995, JAMA-J AM MED ASSOC, V273, P1749, DOI 10.1001/jama.273.22.1749; BARLOW P, 1986, NEUROSURGERY, V19, P989, DOI 10.1227/00006123-198612000-00014; Bell C C, 1990, J Neuropsychiatry Clin Neurosci, V2, P145; *CDC NAT CTR INJ P, 1997, US INJ MORT STAT; CLARK WC, 1986, J NEUROSURG, V65, P9, DOI 10.3171/jns.1986.65.1.0009; DITUNNO JF, 1992, J NEUROTRAUM, V9, pS301; FONTANAROSA PB, 1995, JAMA-J AM MED ASSOC, V273, P1792, DOI 10.1001/jama.273.22.1792; GRAHM TW, 1990, NEUROSURGERY, V27, P696, DOI 10.1227/00006123-199011000-00005; HALL K, 1985, ARCH PHYS MED REHAB, V66, P35; Hall KM., 1993, J HEAD TRAUMA REHAB, V8, DOI [DOI 10.1097/00001199-199308020-00008, 10.1097/00001199-199308020-00008]; Hannay HJ, 1996, NEUROTRAUMA, P723; Harrison-Felix C, 1998, ARCH PHYS MED REHAB, V79, P730, DOI 10.1016/S0003-9993(98)90348-3; JENNETT B, 1976, ARCH NEUROL-CHICAGO, V33, P595, DOI 10.1001/archneur.1976.00500090001001; JOHNSTON MV, 1996, MED REHABILITATION T, P197; KAUFMAN HH, 1991, SURG NEUROL, V36, P370, DOI 10.1016/0090-3019(91)90026-6; KAUFMAN HH, 1986, NEUROSURGERY, V18, P689, DOI 10.1227/00006123-198606000-00002; KAUFMAN HH, 1995, NEUROSURG CLIN N AM, V6, P701, DOI 10.1016/s1042-3680(18)30426-1; Kellermann AL, 1996, NEW ENGL J MED, V335, P1438, DOI 10.1056/NEJM199611073351906; KENNEDY F, 1993, J TRAUMA, V35, P75, DOI 10.1097/00005373-199307000-00013; LEVY ML, 1993, NEUROSURGERY, V33, P1018; MAX W, 1993, HEALTH AFFAIR, V12, P171, DOI 10.1377/hlthaff.12.4.171; NAGIB MG, 1986, NEUROSURGERY, V18, P533, DOI 10.1227/00006123-198605000-00003; POLIN RS, 1995, NEUROSURG CLIN N AM, V6, P689; RIVARA FP, 1989, J TRAUMA, V29, P462, DOI 10.1097/00005373-198904000-00008; SELDEN BS, 1988, ANN EMERG MED, V17, P247, DOI 10.1016/S0196-0644(88)80117-3; SICCARDI D, 1991, SURG NEUROL, V35, P455, DOI 10.1016/0090-3019(91)90179-D; SOSIN DM, 1995, JAMA-J AM MED ASSOC, V273, P1778, DOI 10.1001/jama.273.22.1778; STONE JL, 1995, J TRAUMA, V38, P851, DOI 10.1097/00005373-199506000-00002; Trask T, 1996, NEUROTRAUMA, P869; *UB FDN ACT INC, 1993, GUID UN DAT SET MED; WINTEMUTE GJ, 1991, J HEAD TRAUMA REHAB, V6, P38	32	22	23	0	0	FOREFRONT PUBL GROUP	WILTON	C/O MARY J RAWLINS, 5 RIVER RD, STE 113, WILTON, CT 06897 USA	0161-6412			NEUROL RES	Neurol. Res.	MAR-APR	2001	23	2-3					219	226		10.1179/016164101101198370			8	Clinical Neurology; Neurosciences	Neurosciences & Neurology	422DX	WOS:000168104200016	11320603				2021-06-18	
J	Oehmichen, M; Meissner, C; Konig, HG				Oehmichen, M; Meissner, C; Konig, HG			Brain injury after survived gunshot to the head: reactive alterations at sites remote from the missile track	FORENSIC SCIENCE INTERNATIONAL			English	Article						gunshot; brain; leukocytes; macrophages; axonal injury	AMYLOID PRECURSOR PROTEIN; TRAUMATIC AXONAL INJURY; PENETRATING GUNSHOTS; WOUNDS; DAMAGE; NEUROPATHOLOGY; INCAPACITATION; CIVILIANS	Gunshot wounds to the brain usually lead to acute respiratory arrest or death after a brief survival period, even in cases involving only slight direct tissue damage. It can be assumed therefore that the damage extends beyond the zone of recognizable destruction and hemorrhages. To determine the true extent of the tissue injury resulting from gunshot wounds to the brain, we carried out microscopic investigations for reactive changes (emigration of leukocytes and macrophages, axonal expression of beta -amyloid precursor protein (beta -APP) in 10 cases of gunshot wound to the narrow channel of the brain with survival times >2 h. Demonstration of leukocytes expressing naphthol AS-D chloroacetate esterase activity in the brain tissue at the border of the missile track established the vitality of the gunshot effect. The presence of macrophages (CD68-epitope) allowed demarcation of a 1-2 mm wide necrotic zone around the permanent cavity. Within this zone and beyond, beta -APP showed an initial increase followed by a decline in the number of injured axons. Three types of beta -APP positive staining could be differentiated. In the immediate vicinity of the missile track beta -APP positive neurons were present at a distance of 2-4 mm from the margin of the permanent cavity (type 1) as a result of primary injured neuronal tissue by the gunshot itself. At longer distances from the narrow channel and the permanent cavity single beta -APP positive axons or axon fragments and two additional types were found; type 2 shows a parallel, wave-like arrangement of the damaged fibers, which suggests that the injury was produced by mechanical acceleration of the brain tissue created by the energy the projectile expended within the brain; irregular aggregation of beta -APP positive axons or axon fragments within a local edema represents type 3, which may be attributed to secondary ischemia or edema. (C) 2001 Elsevier Science Ireland Ltd. All rights reserved.	Med Univ Lubeck, Dept Legal Med, D-23562 Lubeck, Germany	Oehmichen, M (corresponding author), Med Univ Lubeck, Dept Legal Med, Kahlhorstr 31-35, D-23562 Lubeck, Germany.	oehmich@rmed.mu-luebeck.de					CARANAT R, 1979, EFFICACITE MUNITIONS; CAREY ME, 1995, NEUROSURG CLIN N AM, V6, P629; CAVALIERE R, 1988, ACTA NEUROCHIR, V94, P133, DOI 10.1007/BF01435866; GRAHAM DI, 1997, GREENFIELDS NEUROPAT, P197; GRAHMICHEN M, 1997, WUNDHEILUNG, P197; KARGER B, 1995, INT J LEGAL MED, V108, P117, DOI 10.1007/BF01844822; KARGER B, 1995, INT J LEGAL MED, V108, P53, DOI 10.1007/BF01369905; KAUFMAN HH, 1986, NEUROSURGERY, V18, P689, DOI 10.1227/00006123-198606000-00002; KIRKPATRICK JB, 1988, FORENSIC NEUROPATHOL, P276; Koizumi H, 1998, J NEUROSURG, V89, P303, DOI 10.3171/jns.1998.89.2.0303; KOO EH, 1990, P NATL ACAD SCI USA, V87, P1561, DOI 10.1073/pnas.87.4.1561; KORDESTANI RK, 1995, NEUROSURG CLIN N AM, V6, P657; Koszyca B, 1998, J NEUROTRAUM, V15, P675, DOI 10.1089/neu.1998.15.675; LEDER LD, 1964, KLIN WOCHENSCHR, V42, P553, DOI 10.1007/BF01486688; NORDSTEDT C, 1988, P NATL ACAD SCI USA, V15, P8910; Oehmichen M, 1999, INT J LEGAL MED, V112, P261, DOI 10.1007/s004140050246; Oehmichen M, 1998, FORENSIC SCI INT, V95, P67, DOI 10.1016/S0379-0738(98)00075-9; Oehmichen M, 1985, Beitr Gerichtl Med, V43, P55; Oehmichen M, 2000, J NEUROTRAUM, V17, P155, DOI 10.1089/neu.2000.17.155; Oehmichen M, 1996, ACTA NEUROPATHOL, V91, P642, DOI 10.1007/s004010050478; Oehmichen M, 1999, ACTA NEUROPATHOL, V97, P491, DOI 10.1007/s004010051018; OEHMICHEN M, 1990, WUNDHEILUNG; OEHMICHEN M, 1992, KOPFSCHUSS SPANNUNGS, P37; OTSUKA N, 1991, BRAIN RES, V568, P335, DOI 10.1016/0006-8993(91)91422-W; Povlishock JT, 1997, RES LEG MED, V17, P175; Sellier KG., 1994, WOUND BALLISTICS SCI; SHERRIFF FE, 1994, ACTA NEUROPATHOL, V87, P55; SICCARDI D, 1991, SURG NEUROL, V35, P455, DOI 10.1016/0090-3019(91)90179-D	28	22	25	0	1	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0379-0738			FORENSIC SCI INT	Forensic Sci.Int.	JAN 15	2001	115	3					189	197		10.1016/S0379-0738(00)00335-2			9	Medicine, Legal	Legal Medicine	378RF	WOS:000165596900004	11074174				2021-06-18	
J	Macmillan, CSA; Andrews, PJD; Easton, VJ				Macmillan, CSA; Andrews, PJD; Easton, VJ			Increased jugular bulb saturation is associated with poor outcome in traumatic brain injury	JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY			English	Article						head injury; jugular bulb venous oxygen saturation; cerebral oxygenation	SEVERE HEAD-INJURY; REPEATED ISCHEMIC INSULTS; VENOUS OXYGEN-SATURATION; INTRACRANIAL HYPERTENSION; INTENSIVE-CARE; OXIMETRY; GERBIL; DESATURATION; VALIDATION; CATHETER	The objective was to compare secondary insults, particularly decreases in jugular bulb oxyhaemoglobin saturation (SjO(2)), during intensive care in patients with "poor" and "good" outcomes 12 months after traumatic brain injury. A prospective observational study of patients' physiological data collected each minute from multimodality monitoring was carried out. Patients had duration of physiological insults quantified as a percentage of their validated monitoring time (once invalid data due to technical reasons were removed). Treatment protocols were designed to minimise secondary insults by maintaining intracranial pressure (ICP) less than 20 mm Hg, and cerebral perfusion pressure (CPP) greater than 70 mm Hg, with prompt correction of hypoxia and pyrexia. Twelve months after injury patients' neurological function was assessed using the Glasgow outcome scale (GOS). A poor outcome was defined as GOS 1 to 3 (group 1) and a good outcome as GOS 4 and 5 (group 2). Seventy five patients (64 male), median age of 34 years (range 15 to 70), were studied. At 12 months 33 patients had a poor outcome (group 1), and 42 a good outcome (group 2). Group 1 spent proportionately more time with SjO(2) greater than 75% compared with group 2 (p<0.05), and more time with SjO(2) below 54% (p<0.04). Group 1 patients also spent proportionately more time with CPP less than 70 mm Hg than group 2 (p<0.04). Patients in group 1 were older (p<0.04) and had a lower postresuscitation Glasgow coma score (p<0.002). There was no difference between the groups for ICP, injury severity score, peripheral pulse saturation, and pyrexia. This study confirms that secondary insults, including an increased SjO(2), occur significantly more in patients with poor outcomes. More research into strategies to reduce the impact of secondary insults, including management of increased SjO(2), is required.	Ninewells Hosp, Dept Anaesthet, Dundee DD1 9SY, Scotland; Univ Edinburgh, Western Gen Hosp, Dept Clin Neurosci, Edinburgh, Midlothian, Scotland	Macmillan, CSA (corresponding author), Ninewells Hosp, Dept Anaesthet, Dundee DD1 9SY, Scotland.	c.macmillan@dundee.ac.uk					ANDREWS PJD, 1991, BRIT J ANAESTH, V67, P553, DOI 10.1093/bja/67.5.553; ANDREWS PJD, 1997, BAILLIERS CLIN NEURO, V5, P497; Cormio M, 1999, J NEUROSURG, V90, P9, DOI 10.3171/jns.1999.90.1.0009; Cruz J, 1988, Acta Neurochir Suppl (Wien), V42, P35; CRUZ J, 1993, J NEUROSURG, V79, P228, DOI 10.3171/jns.1993.79.2.0228; De Deyne C, 1996, Eur J Emerg Med, V3, P69, DOI 10.1097/00063110-199606000-00002; De Deyne C, 1996, YB INTENSIVE CARE EM, P731; GENTLEMAN D, 1990, LANCET, V335, P330, DOI 10.1016/0140-6736(90)90615-C; GOPINATH SP, 1994, J NEUROL NEUROSUR PS, V57, P717, DOI 10.1136/jnnp.57.6.717; GRAHAM DI, 1978, J NEUROL SCI, V39, P213, DOI 10.1016/0022-510X(78)90124-7; GUNN HC, 1995, J NEUROSURG ANESTH, V7, P174, DOI 10.1097/00008506-199507000-00003; Howells T. P., 1995, Journal of Neurotrauma, V12, P471; Jennett B, 1975, Ciba Found Symp, P309; JONES PA, 1994, J NEUROSURG ANESTH, V6, P4; KETY SS, 1948, J CLIN INVEST, V27, P476, DOI 10.1172/JCI101994; Kiening KL, 1996, J NEUROSURG, V85, P751, DOI 10.3171/jns.1996.85.5.0751; LEWIS SB, 1995, ANAESTH INTENS CARE, V23, P307, DOI 10.1177/0310057X9502300307; LYONS C, 1964, ANN SURG, V160, P561, DOI 10.1097/00000658-196410000-00001; Maas AIR, 1997, ACTA NEUROCHIR, V139, P286, DOI 10.1007/BF01808823; McKeating EG, 1998, ANESTH ANALG, V86, P759, DOI 10.1097/00000539-199804000-00016; McKeating EG, 1997, BRIT J ANAESTH, V78, P520; MILLER JD, 1977, J NEUROSURG, V47, P503, DOI 10.3171/jns.1977.47.4.0503; PLUTA R, 1989, J CEREBR BLOOD F MET, V9, P163, DOI 10.1038/jcbfm.1989.24; Ritter AM, 1996, J CLIN MONITOR, V12, P285, DOI 10.1007/BF02221748; SHEINBERG M, 1992, J NEUROSURG, V76, P212, DOI 10.3171/jns.1992.76.2.0212; Souter MJ, 1996, BRIT J ANAESTH, V76, P744; TOMIDA S, 1987, J CEREBR BLOOD F MET, V7, P773, DOI 10.1038/jcbfm.1987.133; VASS K, 1988, ACTA NEUROPATHOL, V75, P288, DOI 10.1007/BF00690537	28	22	23	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0022-3050	1468-330X		J NEUROL NEUROSUR PS	J. Neurol. Neurosurg. Psychiatry	JAN	2001	70	1					101	104		10.1136/jnnp.70.1.101			4	Clinical Neurology; Psychiatry; Surgery	Neurosciences & Neurology; Psychiatry; Surgery	388KC	WOS:000166178800021	11118256	Green Published, Bronze			2021-06-18	
J	Salazar, AM; Zitnay, GA; Warden, DL; Schwab, KA				Salazar, AM; Zitnay, GA; Warden, DL; Schwab, KA		DVHIP Study Grp	Defense and Veterans Head Injury Program: Background and overview	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						brain injury; head injury; military; rehabilitation; TBI disease management; veterans	TRAUMATIC BRAIN INJURY; MILITARY MEDICAL SYSTEM; POLYMERASE; CORTEX; MRI	Traumatic brain injury (TBI) is the principal cause of death and disability for young Americans, with an estimated societal cost of over $39 billion per year. The Defense and Veterans Head injury Program (DVHIP) represents a close collaboration among the Departments of Defense (DoD) and Veterans Affairs (DVA), the Brain Injury Association (BIA), and the International Brain Injury Association (IBIA). Its principal mission is to ensure that military and veteran patients with head injury receive TBI-specific evaluation, treatment, rehabilitation, and follow-up, while at the same time addressing the readiness mission of the military and helping to define optimal care for victims of TBI nationwide. Defense and Veterans Head Injury Program activities can be grouped into three broad classes: (1) TBI education, community service, and primary prevention projects; (2) combined TBI clinical treatment, rehabilitation, and clinical research projects; and (3) clinically linked TBI laboratory research projects. It is thus based on a prudent integration of clinical care and follow-up with programmatic clinical and clinically related laboratory research, TBI prevention, and education. This previously nonexistent clinical infrastructure now offers a valuable base for ongoing TBI clinical research.	Uniformed Serv Univ Hlth Sci, Def & Vet Head Injury Program, Washington, DC USA; Martha Jefferson Hosp, John Jane Brain Injury Ctr, Charlottesville, VA USA; Int Brain Injury Assoc, Charlottesville, VA USA; Walter Reed AMC, Washington, DC 20307 USA; Henry M Jackson Fdn, Rockville, MD USA	Salazar, AM (corresponding author), Uniformed Serv Univ Hlth Sci, Def & Vet Head Injury Program, Washington, DC USA.						BRAVERMAN S, 1999, IN PRESS BRAIN INJUR; CHESNUT R, 1999, AGENCY HLTH CARE POL, V7, P37; Dobi A, 2000, J NEUROSCI, V20, P1073, DOI 10.1523/JNEUROSCI.20-03-01073.2000; GRAFMAN J, 1999, BRAIN INJURY SOURCE, V3, P12; HEALTH NIO, 1999, REPORT CONSENSUS DEV, P245; KOENIG M, 1998, NEUR ABS, V25; KOENING M, 1997, N SCI ABS, V23, P1935; LaPlaca MC, 1999, J NEUROCHEM, V73, P205, DOI 10.1046/j.1471-4159.1999.0730205.x; MacKenzie E., 1991, J HEAD TRAUMA REHAB, V6, P76, DOI [10.1097/00001199-199106000-00010, DOI 10.1097/00001199-199106000-00010]; OMMAYA A, 1999, MILITARY MED S; Ommaya AK, 1996, J TRAUMA, V41, P972, DOI 10.1097/00005373-199612000-00005; Ommaya AK, 1996, J TRAUMA, V40, P211, DOI 10.1097/00005373-199602000-00007; Pieper AA, 1999, TRENDS PHARMACOL SCI, V20, P171, DOI 10.1016/S0165-6147(99)01292-4; Rahimi O, 1999, SOMATOSENS MOT RES, V16, P151, DOI 10.1080/08990229970582; Salazar AM, 2000, JAMA-J AM MED ASSOC, V283, P3075, DOI 10.1001/jama.283.23.3075; SALAZAR AM, 1999, BRAIN INJ SOURCE, V3, P8; THATCHER R, 1999, BRAIN INJURY SOURCE, V3, P20; Thatcher RW, 1998, NEUROIMAGE, V7, P352, DOI 10.1006/nimg.1998.0330; Thatcher RW, 1997, J NEUROTRAUM, V14, P1, DOI 10.1089/neu.1997.14.1	19	22	23	0	2	ASPEN PUBL INC	FREDERICK	7201 MCKINNEY CIRCLE, FREDERICK, MD 21704 USA	0885-9701			J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	OCT	2000	15	5					1081	1091		10.1097/00001199-200010000-00002			11	Clinical Neurology; Rehabilitation	Neurosciences & Neurology; Rehabilitation	359DT	WOS:000089596800002	10970929				2021-06-18	
J	Swaine, BR; Pless, IB; Friedman, DS; Montes, JL				Swaine, BR; Pless, IB; Friedman, DS; Montes, JL			Effectiveness of a head injury program for children - A preliminary investigation	AMERICAN JOURNAL OF PHYSICAL MEDICINE & REHABILITATION			English	Article						rehabilitation; outcome evaluation; head injury; children	TRAUMATIC BRAIN INJURY; FUNCTIONAL INDEPENDENCE MEASURE; EARLY INTERVENTION; REHABILITATION; CARE; PERFORMANCE; AGREEMENT; TEAM; FIM	Objective: The purpose of this study was to investigate whether a more coordinated, comprehensive head injury rehabilitation program provided at a children's trauma center yielded better outcomes than a less coordinated, less comprehensive program. Design: Using a quasi-experimental design, 64 children with head injury admitted to the center and who received rehabilitation services in either 1995 or 1993 were evaluated by using the Functional Independence Measure for children (WeeFIM(TM))/The Functional Independence Measure (FIM(TM)) (e.g., primary outcome measure). Secondary outcomes included "psychosocial adjustment," "return to regular school," and "current problems related to the head injury. Results: No statistically significant differences were found between the groups with respect to mean WeeFIM/FIM scores after controlling for age and injury severity. The 1993 group had poorer scores on the withdrawal subscale of the psychosocial measure (P = 0.02), yet a smaller proportion of these children were enrolled in a special education class (P = 0.02). Conclusions: This study serves as a model for a larger, definitive study of the effectiveness of rehabilitation for children with head injury. The trends suggest that more comprehensive care may lead to better outcomes.	Univ Montreal, Fac Med, Sch Rehabil, Montreal, PQ H3C 3J7, Canada; Montreal Rehabil Inst, Res Ctr, Montreal, PQ, Canada; McGill Montreal Childrens Hosp, Res Inst, Montreal, PQ, Canada; McGill Univ, Dept Pediat, Montreal, PQ H3A 2T5, Canada; McGill Univ, Dept Epidemiol & Biostat, Montreal, PQ H3A 2T5, Canada; McGill Univ, Dept Neurol, Montreal, PQ H3A 2T5, Canada; McGill Univ, Dept Neurosurg, Montreal, PQ H3A 2T5, Canada; Montreal Childrens Hosp, Dept Neurosurg, Montreal, PQ H3H 1P3, Canada	Swaine, BR (corresponding author), Univ Montreal, Fac Med, Sch Rehabil, CP 6128 Succursale Ctr Ville, Montreal, PQ H3C 3J7, Canada.						Achenbach TM, 1983, MANUAL CHILD BEHAV C; American Speech and Hearing Association, 1995, ASHA S14, V37, P23; [Anonymous], 1990, ABBR INJ SCAL; ARONOW HU, 1987, J HEAD INJURY REHABI, V2, P24; Bond M R, 1979, Int Rehabil Med, V1, P155; BRUINICKS RH, 1978, BRUINICKS OSERETSKY; Campbell D. T., 1966, EXPT QUASIEXPERIMENT; CASEY R, 1986, PEDIATRICS, V78, P497; CHARRON L, 1990, PROGRAMME CADRE READ; Christensen JR, 1997, NEUROREHABILITATION, V9, P105, DOI 10.3233/NRE-1997-9202; Colantonio A, 1998, ARCH PHYS MED REHAB, V79, P550, DOI 10.1016/S0003-9993(98)90072-7; *COMM ACCR REH FAC, 1993, DIR ACCR ORG SERV PE; *COMM INJ SCAL, 1985, ABBR INJ SCAL; COOK L, 1994, ARCH PHYS MED REHAB, V75, P390, DOI 10.1016/0003-9993(94)90160-0; COPE DN, 1982, ARCH PHYS MED REHAB, V63, P433; Corrigan JD, 1997, ARCH PHYS MED REHAB, V78, P828, DOI 10.1016/S0003-9993(97)90195-7; COSTER WJ, 1994, AM J OCCUP THER, V48, P211, DOI 10.5014/ajot.48.3.211; COWLEY RS, 1994, J HEAD TRAUMA REHAB, V9, P32; DiScala C, 1997, J HEAD TRAUMA REHAB, V12, P1, DOI 10.1097/00001199-199704000-00002; DISCALA C, 1992, AM J PHYS MED REHAB, V71, P145, DOI 10.1097/00002060-199206000-00004; DODDS TA, 1993, ARCH PHYS MED REHAB, V74, P531, DOI 10.1016/0003-9993(93)90119-U; FLETCHER JM, 1990, J CONSULT CLIN PSYCH, V58, P93, DOI 10.1037/0022-006X.58.1.93; GRANGER CV, 1995, AM J PHYS MED REHAB, V74, P107; GREENSPAN A, 1996, CURR PROB PEDIAT MAY, P170; GREENSPAN AI, 1994, PEDIATRICS, V94, P425; HALEY SM, 1992, ADM MANUAL PEDIAT EV; Hall KM, 1996, J HEAD TRAUMA REHAB, V11, P27, DOI 10.1097/00001199-199610000-00004; HALSTEAD LS, 1976, ARCH PHYS MED REHAB, V57, P507; HAMILTON BB, 1994, SCAND J REHABIL MED, V26, P115; HIGH WM, 1995, J HEAD TRAUMA REHAB, V10, P14, DOI 10.1097/00001199-199502000-00004; KEITH RA, 1991, ARCH PHYS MED REHAB, V72, P269; KRAUS JF, 1986, AM J DIS CHILD, V140, P687, DOI 10.1001/archpedi.1986.02140210085032; LINACRE JM, 1994, ARCH PHYS MED REHAB, V75, P127; MACKAY LE, 1992, ARCH PHYS MED REHAB, V73, P635; Massagli TL, 1996, ARCH PHYS MED REHAB, V77, P125, DOI 10.1016/S0003-9993(96)90156-2; Michaud L. J., 1995, TRAUMATIC HEAD INJUR, P247; MILLS VM, 1988, PHYSICAL REHABILITAT, P495; Morgan T. H., 1894, J MORPHOL, V9, P1, DOI [DOI 10.1002/JMOR.1050090102, 10.1002/jmor.1050090102]; MSAIL ME, 1994, CLIN PEDIAT      JUL, P421; MSALL ME, 1994, CLIN PEDIATR, V33, P431, DOI 10.1177/000992289403300709; OTTENBACHER KJ, 1996, DEV MED CHILD NEUROL, V38, P906; RIVARA JB, 1994, ARCH PHYS MED REHAB, V75, P369, DOI 10.1016/0003-9993(94)90157-0; Roberts MA, 1996, BRAIN INJURY, V10, P739, DOI 10.1080/026990596124007; Rothman K J, 1990, Epidemiology, V1, P43, DOI 10.1097/00001648-199001000-00010; Rothman K.J., 1998, MODERN EPIDEMIOLOGY, V2nd ed.; RUTTER M, 1981, AM J PSYCHIAT, V138, P1533; Semlyen JK, 1998, ARCH PHYS MED REHAB, V79, P678, DOI 10.1016/S0003-9993(98)90044-2; Smith PM, 1996, ARCH PHYS MED REHAB, V77, P431, DOI 10.1016/S0003-9993(96)90029-5; Sparrow S., 1984, VINELAND ADAPTIVE BE; SPSS Inc, 1997, SPSS BAS 7 5 WIND; *STAT U NY, 1993, GUID UN DAT SET MED; *STAT U NY BUFF, 1993, GUID UN DAT SET MED; Stein REK, 1990, MANUAL PERSONAL ADJU; Swaine BR, 1999, AM J PHYS MED REHAB, V78, P323, DOI 10.1097/00002060-199907000-00006; WALKER DK, 1990, J DEV BEHAV PEDIATR, V11, P116	55	22	22	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0894-9115			AM J PHYS MED REHAB	Am. J. Phys. Med. Rehabil.	SEP-OCT	2000	79	5					412	420		10.1097/00002060-200009000-00002			9	Rehabilitation; Sport Sciences	Rehabilitation; Sport Sciences	354GK	WOS:000089321200002	10994882				2021-06-18	
J	Lendon, CL; Han, BH; Salimi, K; Fagan, AM; Behrens, MI; Muller, MC; Holtzman, DM				Lendon, CL; Han, BH; Salimi, K; Fagan, AM; Behrens, MI; Muller, MC; Holtzman, DM			No effect of apolipoprotein E on neuronal cell death due to excitotoxic and apoptotic agents in vitro and neonatal hypoxic ischaemia in vivo	EUROPEAN JOURNAL OF NEUROSCIENCE			English	Article						Alzheimer's disease; culture; injury; murine; transgenic	CENTRAL-NERVOUS-SYSTEM; THROMBIN-CLEAVAGE FRAGMENT; RECEPTOR-RELATED PROTEIN; ONSET ALZHEIMER-DISEASE; TRAUMATIC BRAIN INJURY; AMYLOID-BETA-PEPTIDE; TRANSGENIC MICE; HEAD-INJURY; E EPSILON-4; NEURITE OUTGROWTH	The epsilon 4 allele of apolipoprotein E (apoE) is a genetic risk factor for Alzheimer's disease. Studies also suggest that the epsilon 4 allele may be a risk factor for poor outcome following head trauma, brain haemorrhage and ischaemia. The mechanism by which the presence of an apoE epsilon 4 allele and certain brain injuries act to predispose to Alzheimer's disease and poor outcome following brain injury is unknown. We questioned whether poor outcome after brain injury was due to direct modification by apoE protein and its gene variants of susceptibility to glutamate-mediated excitotoxic injury and apoptosis, mechanisms of cell death which occur following ischaemia and trauma. We investigated the effect of the presence or absence of endogenous murine apoE protein and different apoE isoforms in modification of the survival of murine embryonic cortical neurons exposed to the glutamate agonist, N-methyl-d-aspartic acid (NMDA) or apoptotic insult by staurosporine, and on the amount of brain injury sustained following a hypoxic-ischaemic insult in vivo to the brain of neonatal mice transgenically expressing human apoE epsilon 3 or epsilon 4. Our data provide evidence that apoE does not appear to alter neuronal viability following diverse types of acute neuronal insult, e.g. hypoxic-ischaemic or acute exposure to injurious agents in the models we have examined. This suggests that if apoE does modify the extent of brain damage and recovery after injury, it seems unlikely to be a result of direct or indirect modulation of excitotoxic or apoptotic cell death.	Univ Birmingham, Queen Elizabeth Psychiat Hosp, Dept Psychiat, Birmingham B15 2QZ, W Midlands, England; Washington Univ, Sch Med, Dept Psychiat, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA; Hosp Dr Sotero del Rio, Dept Neurol, Santiago, Chile; Washington Univ, Sch Med, Dept Mol Biol & Pharmacol, St Louis, MO 63110 USA	Lendon, CL (corresponding author), Univ Birmingham, Queen Elizabeth Psychiat Hosp, Dept Psychiat, Mindelsohn Way, Birmingham B15 2QZ, W Midlands, England.	c.l.lendon@bham.ac.uk	Behrens, Maria I I/I-1083-2013	Behrens, Maria I I/0000-0003-0964-426X	NIA NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [AG-13956] Funding Source: Medline; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R37AG013956, R01AG013956] Funding Source: NIH RePORTER		ALBERTS MJ, 1995, LANCET, V346, P575, DOI 10.1016/S0140-6736(95)91411-0; Anderson R, 1998, NEUROSCIENCE, V85, P93, DOI 10.1016/S0306-4522(97)00598-8; BERRY M, 1999, NEUROSURGERY SCI BAS, P479; BOYLES JK, 1985, J CLIN INVEST, V76, P1501, DOI 10.1172/JCI112130; Buttini M, 1999, J NEUROSCI, V19, P4867; Chen Y, 1997, NEUROSCIENCE, V80, P1255, DOI 10.1016/S0306-4522(97)00007-9; Cheng Y, 1997, ANN NEUROL, V41, P521, DOI 10.1002/ana.410410416; Cheng Y, 1998, J CLIN INVEST, V101, P1992, DOI 10.1172/JCI2169; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; Fagan AM, 1996, J BIOL CHEM, V271, P30121, DOI 10.1074/jbc.271.47.30121; Ferriero DM, 1996, NEUROBIOL DIS, V3, P64, DOI 10.1006/nbdi.1996.0006; Friedman G, 1999, NEUROLOGY, V52, P244, DOI 10.1212/WNL.52.2.244; Holtzman DM, 1998, TRENDS CARDIOVAS MED, V8, P250, DOI 10.1016/S1050-1738(98)00017-6; HOLTZMAN DM, 1995, P NATL ACAD SCI USA, V92, P9480, DOI 10.1073/pnas.92.21.9480; Holtzman DM, 1999, J CLIN INVEST, V103, pR15, DOI 10.1172/JCI6179; Horsburgh K, 1999, J NEUROPATH EXP NEUR, V58, P227, DOI 10.1097/00005072-199903000-00002; Jordan BD, 1997, JAMA-J AM MED ASSOC, V278, P136, DOI 10.1001/jama.278.2.136; Jordan J, 1998, J NEUROSCI, V18, P195; KLINGMAN JG, 1990, J NEUROSCI METH, V31, P47, DOI 10.1016/0165-0270(90)90008-4; KOH JY, 1990, BRAIN RES, V533, P315, DOI 10.1016/0006-8993(90)91355-K; LaDu MJ, 1998, J NEUROCHEM, V70, P2070; Laskowitz DT, 1998, J CEREBR BLOOD F MET, V18, P465, DOI 10.1097/00004647-199805000-00001; Lee JM, 1999, NATURE, V399, pA7, DOI 10.1038/399a007; Lendon CL, 1997, JAMA-J AM MED ASSOC, V277, P825, DOI 10.1001/jama.277.10.825; Ma JY, 1996, NEUROBIOL AGING, V17, P773; Marques MA, 1996, NEUROREPORT, V7, P2529, DOI 10.1097/00001756-199611040-00025; MASLIAH E, 1994, RES ADV ALZHEIMERS D, P405; MCCALL MR, 1988, J LIPID RES, V29, P1127; McCarron MO, 1998, NEUROSCI LETT, V247, P45, DOI 10.1016/S0304-3940(98)00286-9; MCDONALD JW, 1987, EUR J PHARMACOL, V140, P359, DOI 10.1016/0014-2999(87)90295-0; Miyata M, 1996, NAT GENET, V14, P55, DOI 10.1038/ng0996-55; Nakai M, 1996, NEUROSCI LETT, V211, P41, DOI 10.1016/0304-3940(96)12716-6; NATHAN BP, 1994, SCIENCE, V264, P850, DOI 10.1126/science.8171342; NICOLL JAR, 1995, NAT MED, V1, P135, DOI 10.1038/nm0295-135; Parsadanian AS, 1998, J NEUROSCI, V18, P1009; PITAS RE, 1987, BIOCHIM BIOPHYS ACTA, V917, P148, DOI 10.1016/0005-2760(87)90295-5; PITAS RE, 1987, J BIOL CHEM, V262, P14352; POIRIER J, 1994, TRENDS NEUROSCI, V17, P525, DOI 10.1016/0166-2236(94)90156-2; REBECK GW, 1993, NEURON, V11, P575; ROSE K, 1993, IN VITRO BIOL METHOD, P46; Roses AD, 1997, ANN NY ACAD SCI, V826, P200, DOI 10.1111/j.1749-6632.1997.tb48471.x; SCHMECHEL DE, 1993, P NATL ACAD SCI USA, V90, P9649, DOI 10.1073/pnas.90.20.9649; Sheng HX, 1998, J CEREBR BLOOD F MET, V18, P361, DOI 10.1097/00004647-199804000-00003; Slooter AJC, 1997, JAMA-J AM MED ASSOC, V277, P818, DOI 10.1001/jama.277.10.818; Stone DJ, 1997, EXP NEUROL, V143, P313, DOI 10.1006/exnr.1996.6360; Stone DJ, 1998, J NEUROSCI, V18, P3180; Strittmatter WJ, 1996, ANNU REV NEUROSCI, V19, P53, DOI 10.1146/annurev.ne.19.030196.000413; STRITTMATTER WJ, 1993, P NATL ACAD SCI USA, V90, P8098, DOI 10.1073/pnas.90.17.8098; Sun YL, 1998, J NEUROSCI, V18, P3261; Tang MX, 1996, ANN NY ACAD SCI, V802, P6, DOI 10.1111/j.1749-6632.1996.tb32593.x; Teter B, 1999, NEUROSCIENCE, V91, P1009, DOI 10.1016/S0306-4522(98)00630-7; Tolar M, 1997, J NEUROSCI, V17, P5678; VANUCCI RC, 1990, PEDIATR RES, V27, P317; Xu PT, 1999, AM J PATHOL, V154, P601, DOI 10.1016/S0002-9440(10)65305-9; Xu PT, 1996, NEUROBIOL DIS, V3, P229, DOI 10.1006/nbdi.1996.0023	55	22	23	0	4	BLACKWELL SCIENCE LTD	OXFORD	P O BOX 88, OSNEY MEAD, OXFORD OX2 0NE, OXON, ENGLAND	0953-816X			EUR J NEUROSCI	Eur. J. Neurosci.	JUL	2000	12	7					2235	2242		10.1046/j.1460-9568.2000.00113.x			8	Neurosciences	Neurosciences & Neurology	336NW	WOS:000088310300005	10947802				2021-06-18	
J	Wright, RA; Ahlskog, JE				Wright, RA; Ahlskog, JE			Focal shoulder-elevation dystonia	MOVEMENT DISORDERS			English	Article; Proceedings Paper	5th International Congress of Parkinsons Disease and Movement Disorders	OCT   11, 1998	NEW YORK, NEW YORK			dystonia; post-traumatic movement disorder; botulinum toxin; shoulder	POSTTRAUMATIC CERVICAL DYSTONIA; PERIPHERAL TRAUMA; MUSCLE	We describe 13 cases of isolated focal dystonia of the shoulder with dystonic elevation but without clinically obvious cervical dystonia. All had significant trapezius muscle hypertrophy and limitation of shoulder movement causing substantial morbidity. In nine, this developed in the immediate aftermath of shoulder region trauma, most often a motor vehicle accident; clinically significant head trauma was not a factor. In two other cases this developed in the context of chronic heavy labor (suggesting possible overuse) and in one other it developed concurrent with the symptoms of discogenic cervical (C6-7) radiculopathy. In the one remaining case, no precipitating factors were identified. Preexisting risk factors for dystonia, such as dopamine antagonist drug use, family history of dystonia, or prior brain injury, were not identified in these patients. Administration of medications used to treat dystonia was unsuccessful but botulinum toxin therapy was beneficial in all six treated cases.	Mayo Clin, Dept Neurol, Rochester, MN 55905 USA	Ahlskog, JE (corresponding author), Mayo Clin, Dept Neurol, Rochester, MN 55905 USA.						BRIN MF, 1986, NEUROLOGY, V36, P119; DEWEY RB, 1994, MAYO CLIN PROC, V69, P187, DOI 10.1016/S0025-6196(12)61047-7; GOLDMAN S, 1993, MAYO CLIN PROC, V68, P443, DOI 10.1016/S0025-6196(12)60192-X; GUTMAN L, 1986, MUSCLE NERVE, V19, P811; JANKOVIC J, 1994, NEUROLOGY, V44, P2006, DOI 10.1212/WNL.44.11.2006; JANKOVIC J, 1988, J NEUROL NEUROSUR PS, V51, P1512, DOI 10.1136/jnnp.51.12.1512; MATTLE HP, 1991, J NEUROL NEUROSUR PS, V54, P325, DOI 10.1136/jnnp.54.4.325; SCHOTT GD, 1985, J NEUROL NEUROSUR PS, V48, P698, DOI 10.1136/jnnp.48.7.698; Tarsy D, 1998, MOVEMENT DISORD, V13, P481, DOI 10.1002/mds.870130318; Thyagarajan D, 1998, NEUROLOGY, V51, P1205, DOI 10.1212/WNL.51.4.1205; TRUONG DD, 1991, ARCH NEUROL-CHICAGO, V48, P221, DOI 10.1001/archneur.1991.00530140117025	11	22	22	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0885-3185			MOVEMENT DISORD	Mov. Disord.	JUL	2000	15	4					709	713		10.1002/1531-8257(200007)15:4<709::AID-MDS1017>3.0.CO;2-4			5	Clinical Neurology	Neurosciences & Neurology	333MA	WOS:000088132800017	10928583				2021-06-18	
J	Karlsson, J; Emgard, M; Gido, G; Wieloch, T; Brundin, P				Karlsson, J; Emgard, M; Gido, G; Wieloch, T; Brundin, P			Increased survival of embryonic nigral neurons when grafted to hypothermic rats	NEUROREPORT			English	Article						dopamine, hypothermia; mesencephalic; neural transplantation; Parkinson's disease	FETAL MESENCEPHALIC GRAFTS; DOPAMINE NEURONS; VENTRAL MESENCEPHALON; PARKINSONS-DISEASE; INHIBITION; TRANSPLANTS; STRIATUM; ISCHEMIA; IMPROVES; ENHANCE	Hypothermia can reduce neuronal death caused by ischemia and traumatic brain injury. We therefore investigated whether mild hypothermia in rats receiving a transplant of embryonic mesencephalic rat tissue increases survival of the implanted dopaminergic neurons. Mild hypothermia (32-33 degrees C) during graft implantation and for the following 90 min significantly increased the survival of transplanted dopaminergic neurons to 171% of control values in normothermic (37 degrees C) rats. This demonstrates that treatment of the graft recipient for a relatively short period during and after surgery has a favorable effect on the survival of grafted dopaminergic neurons. These findings may be of importance for clinical neural transplantation trials which are in need of procedures that improve transplant survival. NeuroReport 11:1665-1668 (C) 2000 Lippincott Williams & Wilkins.	Univ Lund, Dept Physiol Sci, Wallenberg Neurosci Ctr, Sect Neuronal Survival, S-22362 Lund, Sweden; Univ Lund Hosp, Wallenberg Neurosci Ctr, Expt Brain Res Lab, S-22185 Lund, Sweden	Karlsson, J (corresponding author), Univ Lund, Dept Physiol Sci, Wallenberg Neurosci Ctr, Sect Neuronal Survival, Solvegatan 17, S-22362 Lund, Sweden.			Wieloch, Tadeusz/0000-0002-7669-2520			Barker RA, 1996, EXP NEUROL, V141, P79, DOI 10.1006/exnr.1996.0141; Boris-Moller F, 1998, EXP BRAIN RES, V121, P277, DOI 10.1007/s002210050461; Brundin P, 2000, CELL TRANSPLANT, V9, P179, DOI 10.1177/096368970000900205; BUSTO R, 1989, STROKE, V20, P904, DOI 10.1161/01.STR.20.7.904; CARDELL M, 1991, J NEUROCHEM, V57, P1814, DOI 10.1111/j.1471-4159.1991.tb06387.x; CASTILHO RF, 2000, IN PRESS EXP NEUROL; CHURN SB, 1990, STROKE, V21, P1715, DOI 10.1161/01.STR.21.12.1715; DOUCET G, 1990, EUR J NEUROSCI, V2, P279, DOI 10.1111/j.1460-9568.1990.tb00419.x; Emgard M, 1999, EXP NEUROL, V160, P279, DOI 10.1006/exnr.1999.7198; FAWCETT JW, 1995, EXP BRAIN RES, V106, P275; Karlsson J, 1998, BRAIN RES, V805, P155, DOI 10.1016/S0006-8993(98)00702-1; Kataoka K, 1998, NEUROSCI RES, V32, P103, DOI 10.1016/S0168-0102(98)00076-5; Kil HY, 1996, J CEREBR BLOOD F MET, V16, P100, DOI 10.1097/00004647-199601000-00012; Kordower JH, 1998, MOVEMENT DISORD, V13, P383, DOI 10.1002/mds.870130303; NAKAO N, 1994, P NATL ACAD SCI USA, V91, P12408, DOI 10.1073/pnas.91.26.12408; SAUER H, 1992, EXP BRAIN RES, V90, P54, DOI 10.1007/BF00229256; Schierle GS, 1998, NEUROREPORT, V9, P1313, DOI 10.1097/00001756-199805110-00011; Schierle GS, 1999, NAT MED, V5, P97, DOI 10.1038/4785; Schierle GSK, 1999, NEUROSCIENCE, V94, P17, DOI 10.1016/S0306-4522(99)00324-3; Sinclair SR, 1999, NEUROREPORT, V10, P1263, DOI 10.1097/00001756-199904260-00020; Todaka K, 1999, EXP NEUROL, V160, P394, DOI 10.1006/exnr.1999.7217; Van Muiswinkel FL, 1998, BRAIN RES, V792, P48, DOI 10.1016/S0006-8993(98)00120-6; WEST MJ, 1991, ANAT RECORD, V231, P482, DOI 10.1002/ar.1092310411; Zawada WM, 1998, BRAIN RES, V786, P96, DOI 10.1016/S0006-8993(97)01408-X	24	22	22	0	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0959-4965			NEUROREPORT	Neuroreport	JUN 5	2000	11	8					1665	1668		10.1097/00001756-200006050-00014			4	Neurosciences	Neurosciences & Neurology	319YY	WOS:000087375100014	10852221				2021-06-18	
J	Orey, SA; Cragar, DE; Berry, DTR				Orey, SA; Cragar, DE; Berry, DTR			The effects of two motivational manipulations on the neuropsychological performance of mildly head-injured college students	ARCHIVES OF CLINICAL NEUROPSYCHOLOGY			English	Article						malingering; motivation; assessment; head injury	TRAUMATIC BRAIN INJURY; MEMORY DEFICITS; VALIDATION; PROSPECTS; TESTS	Recently much research has focused on the development and utilization of various motivational assessment techniques designed to identifl malingered neuropsychological test performance. Other findings have suggested a strong link between the motivation of the subject and the degree to which the neuropsychological test results validly represent the individual's true level of functioning. However, the majority of the empirical work in this area has focused on only one end of the motivational spectrum, decreased motivation. In order to obtain a more complete assessment of the relationship between motivation and neuropsychological of test results, the present study involved an evaluation of the effects of motivational differences on test performance across three levels of motivation: high, low and standard in 75 head-injured college students. Results supported past research showing significant decreases in test performance by participants given individual financial incentives ($25.00) to perform poorly. Additionally, the sensitivity of several malingering tests to this response set was supported However, no reliable differences were found on neuropsychological or motivational tests between the group given financial incentives ($25.00) to perform well and the standard instruction group. (C) 2000 National Academy of Neuropsychology. Published by Elsevier Science Ltd.	Univ Kentucky, Dept Psychol, Lexington, KY 40506 USA	Berry, DTR (corresponding author), Univ Kentucky, Dept Psychol, 125 Kastle Hall, Lexington, KY 40506 USA.			Locke, Dona/0000-0002-1966-7716			Benton A., 1976, MULTILINGUAL APHASIA; BERNARD LC, 1990, J CLIN EXP NEUROPSYC, V12, P715, DOI 10.1080/01688639008401014; Binder Laurence M, 1990, Clin Neuropsychol, V4, P25, DOI 10.1080/13854049008401494; Etcoff LM, 1996, NEUROPSYCHOL REV, V6, P171, DOI 10.1007/BF01874896; FREDERICK R, 1994, PSYCHOL ASSESSMENT, V3, P596; Greiffenstein M.F., 1994, PSYCHOL ASSESSMENT, V6, P218, DOI [https://doi.org/10.1037/1040-3590.6.3.218, DOI 10.1037/1040-3590.6.3.218]; GUILMETTE TJ, 1994, CLIN NEUROPSYCHOL, V8, P283, DOI 10.1080/13854049408404135; GUILMETTE TJ, 1993, CLIN NEUROPSYCHOL, V7, P56; Haines ME, 1995, NEUROPSYCHOL REV, V5, P125, DOI 10.1007/BF02208438; HEATON RK, 1978, J CONSULT CLIN PSYCH, V46, P892, DOI 10.1037/0022-006X.46.5.892; HISCOCK M, 1989, J CLIN EXP NEUROPSYC, V11, P967, DOI 10.1080/01688638908400949; Inman TH, 1998, PSYCHOL ASSESSMENT, V10, P128, DOI 10.1037/1040-3590.10.2.128; IVERSON GL, 1991, LAW HUMAN BEHAV, V15, P667, DOI 10.1007/BF01065859; Kaufman A. S., 1990, ASSESSING ADOLESCENT; LEZAK MD, 1995, NEUROPSYCHOLOGICAL A; MCCRACKEN LM, 1992, PSYCHOL ASSESSMENT, V4, P235, DOI DOI 10.1037//1040-3590.4.2.235; NIES KJ, 1994, ARCH CLIN NEUROPSYCH, V9, P501, DOI 10.1016/0887-6177(94)90041-8; PANKRATZ L, 1983, PERCEPT MOTOR SKILL, V57, P367, DOI 10.2466/pms.1983.57.2.367; Rees LM, 1998, PSYCHOL ASSESSMENT, V10, P10, DOI 10.1037/1040-3590.10.1.10; Rey A, 1964, EXAMEN CLIN PSYCHOL; Rogers R., 1997, CLIN ASSESSMENT MALI, V2nd; Smith M. L., 1980, BENEFITS PSYCHOTHERA; WECHSELR D, 1981, WECHSLER ADULT INTEL; Williams JM, 1991, MEMORY ASSESSMENT SC; ZIELINSKI JJ, 1994, CLIN PSYCHOL-SCI PR, V1, P169, DOI 10.1111/j.1468-2850.1994.tb00018.x	25	22	22	0	4	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0887-6177			ARCH CLIN NEUROPSYCH	Arch. Clin. Neuropsychol.	MAY	2000	15	4					335	348		10.1016/S0887-6177(99)00024-4			14	Psychology, Clinical; Psychology	Psychology	310KR	WOS:000086827800006	14590230	Bronze			2021-06-18	
J	Wagner, AK; Hammond, FM; Grigsby, JH; Norton, HJ				Wagner, AK; Hammond, FM; Grigsby, JH; Norton, HJ			The value of trauma scores - Predicting discharge after traumatic brain injury	AMERICAN JOURNAL OF PHYSICAL MEDICINE & REHABILITATION			English	Article						traumatic brain injury; outcome; revised trauma score; trauma score injury severity score; injury severity score	GUNSHOT WOUNDS; PROGNOSIS; CARE	Objective: To determine the association of acute variables with disposition after acute hospitalization. Design: Revised Trauma Score (RTS), Injury Severity Score (ISS), and the Combined Trauma Score Injury Severity Score (TRISSRTS) were compared with discharge disposition after acute hospitalization of 378 consecutive patients who sustained a traumatic brain injury (TBI) and were treated at a level 1 trauma center between September 1997 and May 1998. Results: Logistic regression modeling found TRISSRTS to predict discharge to home with or without home health assistance or inpatient rehabilitation vs. nursing home placement or death. Subsequent modeling, excluding patients who died or went to nursing homes, identified RTS and ISS as predictors of discharge to home with or without home health vs. inpatient rehabilitation. A sensitivity of 97.78% and 93.91% were achieved with these two models when tested on a population of 4,625 patients with TBI treated during the last 10 yr at the same facility. Conclusions: The results suggest that RTS, ISS, and TRISSRTS are predictors of discharge disposition after acute hospitalization with TBI and may be useful measures of rehabilitation services resource planning early in the course of TBI management.	Charlotte Inst Rehabil, Dept PM&R, Charlotte, NC 28203 USA; Carolinas Healthcare Syst, Charlotte, NC USA	Wagner, AK (corresponding author), Charlotte Inst Rehabil, Dept PM&R, 1100 Blythe Blvd, Charlotte, NC 28203 USA.						Bouillon B, 1997, J TRAUMA, V42, P652, DOI 10.1097/00005373-199704000-00012; BOYD CR, 1987, J TRAUMA, V27, P370, DOI 10.1097/00005373-198704000-00005; CHAMPION HR, 1989, J TRAUMA, V29, P623, DOI 10.1097/00005373-198905000-00017; CHAMPION HR, 1990, J TRAUMA, V30, P1356, DOI 10.1097/00005373-199011000-00008; CHEADLE WG, 1989, ANN SURG, V209, P541, DOI 10.1097/00000658-198905000-00005; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Hall KM, 1998, NEUROREHABILITATION, V10, P3, DOI 10.3233/NRE-1998-10102; KENNEDY F, 1993, J TRAUMA, V35, P75, DOI 10.1097/00005373-199307000-00013; NAGIB MG, 1986, NEUROSURGERY, V18, P533, DOI 10.1227/00006123-198605000-00003; PENNINGS JL, 1993, ARCH SURG-CHICAGO, V128, P787; PRICE DJE, 1972, INJURY-BR J ACCIDENT, V3, P218, DOI 10.1016/0020-1383(72)90104-0; ROTHMAN SM, 1986, ANN NEUROL, V19, P105, DOI 10.1002/ana.410190202; Zafonte RD, 1997, BRAIN INJURY, V11, P403	13	22	22	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0894-9115			AM J PHYS MED REHAB	Am. J. Phys. Med. Rehabil.	MAY-JUN	2000	79	3					235	242		10.1097/00002060-200005000-00004			8	Rehabilitation; Sport Sciences	Rehabilitation; Sport Sciences	313FK	WOS:000086989500004	10821308				2021-06-18	
J	Zhao, XR; Newcomb, JK; Pike, BR; Wang, KKW; d'Avella, D; Hayes, RL				Zhao, XR; Newcomb, JK; Pike, BR; Wang, KKW; d'Avella, D; Hayes, RL			Novel characteristics of glutamate-induced cell death in primary septohippocampal cultures: Relationship to calpain and caspase-3 protease activation	JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM			English	Article						glutamate; calpain; caspase-3; proteases	TRAUMATIC BRAIN INJURY; CEREBELLAR GRANULE NEURONS; RAT HIPPOCAMPAL-NEURONS; APOPTOTIC CELLS; ALPHA-SPECTRIN; INHIBITORS; NEUROTOXICITY; DEGRADATION; PROTEOLYSIS; BREAKDOWN	Studies examined the phenotypic characteristics of glutamate-induced cell death and their relationship to calpain and caspase-3 activation. Cell viability was assessed by fluorescein diacetate and propidium iodide staining and lactate dehydrogenase release. Calpain and caspase-3 activity was inferred from signature proteolytic fragmentation of alpha-spectrin. Characterization of cell death phenotypes was assessed by Hoechst 33258 and DNA fragmentation assays. Exposure uf septohippocampal cultures to 1.0. 2.0, and 4.0 mmol/L glutamate induced a dose-dependent cell death with an LD50 of 2.0 mmol/L glutamate after 24 hours of incubation. Glutamate treatment induced cell death in neurons and astroglia and produced morphological alterations that differed from necrotic or apoptotic changes observed after maitotoxin or staurosporine exposure. respectively, After glutamate treatment, cell nuclei were enlarged and eccentrically shaped, and aggregated chromatin appeared in a diffusely speckled pattern. Furthermore, no dose of glutamate produced evidence of internucleosomal DNA fragmentation. Incubation with varying doses of glutamate produced calpain and caspase-3 activation. Calpain inhibitor II (N-acetyl-Leu-Leu-methionyl) provided protection only with a narrow dose range, whereas carbobenzoxy-Asp-CH2-OC(O)-2,6-dichlorobenzene (Z-D-DCB; pan-caspase inhibitor) and MK-801 (N-methyl-D-aspartate receptor antagonist) were potently effective across a wider close range. Cycloheximide did not reduce cell death or protease activation.	Univ Florida, Dept Neurosci, Ctr Traumat Brain Injury Studies, Gainesville, FL 32610 USA; Univ Texas, Hlth Sci Ctr, Dept Neurosurg, Vivian L Smith Ctr Neurol Res, Houston, TX USA; Warner Lambert Parke Davis, Parke Davis Pharmaceut Res, Dept Neurosci Therapeut, Ann Arbor, MI 48105 USA; Univ Messina, Policlin Univ, Inst Pharmacol, Messina, Italy	Hayes, RL (corresponding author), Univ Florida, Dept Neurosci, Ctr Traumat Brain Injury Studies, POB 100244,100 Newell Dr,L1-100F, Gainesville, FL 32610 USA.			Wang, Kevin/0000-0002-9343-6473	NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01 NS40182, R01 NS38105, R01 NS21458] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS021458, R01NS040182] Funding Source: NIH RePORTER		Adamec E, 1998, MOL BRAIN RES, V54, P35, DOI 10.1016/S0169-328X(97)00304-5; Bolton SJ, 1998, EXP NEUROL, V154, P231, DOI 10.1006/exnr.1998.6927; BONFOCO E, 1995, P NATL ACAD SCI USA, V92, P7162, DOI 10.1073/pnas.92.16.7162; Carroll FY, 1996, J NEUROSCI RES, V43, P623, DOI 10.1002/(SICI)1097-4547(19960301)43:5<623::AID-JNR12>3.0.CO;2-1; Cebers G, 1997, BRAIN RES BULL, V43, P393, DOI 10.1016/S0361-9230(97)00025-7; CHOI DW, 1987, J NEUROSCI, V7, P357; CRAIG AM, 1993, NEURON, V10, P1055, DOI 10.1016/0896-6273(93)90054-U; Du YS, 1997, P NATL ACAD SCI USA, V94, P11657, DOI 10.1073/pnas.94.21.11657; GONG JP, 1994, ANAL BIOCHEM, V218, P314, DOI 10.1006/abio.1994.1184; HARRIS AS, 1988, J BIOL CHEM, V263, P15754; Homayoun P, 1997, J NEUROCHEM, V69, P199; Ikeda J, 1996, J NEUROSCI RES, V43, P613; JENKINS LW, 1989, BRAIN RES, V477, P211, DOI 10.1016/0006-8993(89)91409-1; JONES KH, 1985, J HISTOCHEM CYTOCHEM, V33, P77, DOI 10.1177/33.1.2578146; Kampfl A, 1996, EUR J NEUROSCI, V8, P344, DOI 10.1111/j.1460-9568.1996.tb01218.x; Kampfl A, 1997, J NEUROTRAUM, V14, P121, DOI 10.1089/neu.1997.14.121; KOH JY, 1987, J NEUROSCI METH, V20, P83, DOI 10.1016/0165-0270(87)90041-0; KURE S, 1991, BIOCHEM BIOPH RES CO, V179, P39, DOI 10.1016/0006-291X(91)91330-F; LIN JK, 1992, CANCER RES, V52, P385; LYETH BG, 1990, BRAIN RES, V526, P249, DOI 10.1016/0006-8993(90)91229-A; MacManus JP, 1997, EXP CELL RES, V233, P310, DOI 10.1006/excr.1997.3558; MANEV H, 1991, J NEUROCHEM, V57, P1288, DOI 10.1111/j.1471-4159.1991.tb08292.x; MARTIN DP, 1988, J CELL BIOL, V106, P829, DOI 10.1083/jcb.106.3.829; MARTIN SJ, 1995, J BIOL CHEM, V270, P6425, DOI 10.1074/jbc.270.12.6425; MATYJA E, 1986, EXP NEUROL, V92, P609, DOI 10.1016/0014-4886(86)90303-1; MURPHY EJ, 1994, NEUROBIOLOGY CENTRAL, P28; MURPHY TH, 1990, FASEB J, V4, P1624; Nath R, 1996, BIOCHEM J, V319, P683, DOI 10.1042/bj3190683; Nath R, 1996, NEUROREPORT, V8, P249, DOI 10.1097/00001756-199612200-00050; Nath R, 1998, J NEUROCHEM, V71, P186; Pike BR, 1998, J NEUROSCI RES, V52, P505, DOI 10.1002/(SICI)1097-4547(19980601)52:5<505::AID-JNR3>3.3.CO;2-Y; Pike BR, 1998, NEUROREPORT, V9, P2437, DOI 10.1097/00001756-199808030-00002; PORTERACAILLIAU C, 1995, J NEUROSCI, V15, P3775, DOI 10.1523/jneurosci.15-05-03775.1995; PorteraCailliau C, 1997, J COMP NEUROL, V378, P70; Posmantur R, 1997, NEUROSCIENCE, V77, P875, DOI 10.1016/S0306-4522(96)00483-6; SASS JB, 1993, J NEUROSCI METH, V47, P115, DOI 10.1016/0165-0270(93)90027-O; SIMAN R, 1988, NEUROSCIENCE, V26, P443; SQUIER MKT, 1994, J CELL PHYSIOL, V159, P229, DOI 10.1002/jcp.1041590206; Wang K K, 1997, Adv Pharmacol, V37, P117; Wang KKW, 1998, J BIOL CHEM, V273, P22490, DOI 10.1074/jbc.273.35.22490; Wang KKW, 1996, ARCH BIOCHEM BIOPHYS, V331, P208, DOI 10.1006/abbi.1996.0300; Wang KKW, 1996, P NATL ACAD SCI USA, V93, P6687, DOI 10.1073/pnas.93.13.6687; Zhao X, 1999, NEUROCHEM RES, V24, P371, DOI 10.1023/A:1020933616351; Zhivotovsky B, 1997, BIOCHEM BIOPH RES CO, V230, P481, DOI 10.1006/bbrc.1996.6016	44	22	27	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0271-678X			J CEREBR BLOOD F MET	J. Cereb. Blood Flow Metab.	MAR	2000	20	3					550	562		10.1097/00004647-200003000-00014			13	Endocrinology & Metabolism; Hematology; Neurosciences	Endocrinology & Metabolism; Hematology; Neurosciences & Neurology	293AQ	WOS:000085829700014	10724120	Bronze			2021-06-18	
J	Nomura, S; Ishido, T; Teranishi, J; Makiyama, K				Nomura, S; Ishido, T; Teranishi, J; Makiyama, K			Long-term analysis of suprapubic cystostomy drainage in patients with neurogenic bladder	UROLOGIA INTERNATIONALIS			English	Article						suprapubic cystostomy; neurogenic bladder; bladder calculi	CATHETERIZATION	Objective: We assessed the roles of suprapubic cystostomy in patients with neurogenic bladder and analyzed the complications and their courses. Patients and Methods: We reviewed 118 patients with neurogenic bladder managed with suprapubic cystostomy. The original diseases were spinal cord injury in 90, degenerative disease of the central nervous system in 15, spina bifida in 6, cerebral palsy in 3, pontine bleeding in 1, Parkinson's disease in 1, brain tumor in 1, and dysgenesis of the external sphincter in 1. Fifty-six (62.2%) of spinal cord-injured patients demonstrated cervical damage. Renal function, urinary pH and white blood cell values were measured and evaluated after insertion. The stone-free rate after insertion was estimated by the Kaplan-Meier method. Results: Indications for cystostomy were failure of clean intermittent catheterization in 62 (52.5%) and Crede's maneuver in 2, severe urethral damage in 30 (25.4%), replacement of urethral catheter in 3, worsening of the original disease in 15 (12.7%), deterioration of the general condition in 2, mental retardation in 2, and traumatic vesical rupture in 1. Frequent complications were formation of the bladder calculi in 30 (25%) and urinary leakage through the urethra in 11 (10%). No fatal complications occurred. The stone-free rates 5 and 10 years after insertion were 77 and 64%, respectively. The urinary pH of the stone-forming group was significantly higher than that of the stone-free group. The high urinary pit group (>7.24) had a higher risk of stone formation. Conclusions: Although continuous cystostomy drainage is not considered to be ideal management for bladder emptying, some patients with neurogenic bladder may benefit from this procedure. Copyright (C) 2000 S. Karger AG, Basel.	Kanagawa Rehabil Hosp, Dept Urol, Atsugi, Kanagawa 2430121, Japan	Ishido, T (corresponding author), Kanagawa Rehabil Hosp, Dept Urol, 516 Nanasawa, Atsugi, Kanagawa 2430121, Japan.						BARNES DG, 1993, BRIT J UROL, V72, P169, DOI 10.1111/j.1464-410X.1993.tb00681.x; BRINDLEY GS, 1994, PARAPLEGIA, V32, P795, DOI 10.1038/sc.1994.126; HACKLER RH, 1982, BRIT J UROL, V54, P120, DOI 10.1111/j.1464-410X.1982.tb13533.x; HEDELIN H, 1991, BRIT J UROL, V67, P527, DOI 10.1111/j.1464-410X.1991.tb15200.x; HOLMGREN K, 1989, SCAND J UROL NEPHROL, V23, P131, DOI 10.3109/00365598909180827; LAPIDES J, 1972, Journal of Urology, V107, P458; LOCKE JR, 1985, J UROLOGY, V133, P1034, DOI 10.1016/S0022-5347(17)49366-9; PEATFIELD RC, 1983, PARAPLEGIA, V21, P220, DOI 10.1038/sc.1983.35; Perkash I, 1976, Paraplegia, V13, P247; Schurch B, 1996, J UROLOGY, V155, P1023, DOI 10.1016/S0022-5347(01)66376-6; Sheriff MKM, 1998, SPINAL CORD, V36, P171, DOI 10.1038/sj.sc.3100536; STEGMAYR B, 1990, SCAND J UROL NEPHROL, V24, P215, DOI 10.3109/00365599009180861	12	22	22	0	1	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	0042-1138			UROL INT	Urol.Int.		2000	65	4					185	189		10.1159/000064873			5	Urology & Nephrology	Urology & Nephrology	374ZP	WOS:000165375100002	11112866				2021-06-18	
J	Paniak, C; Toller-Lobe, G; Melnyk, A; Nagy, J				Paniak, C; Toller-Lobe, G; Melnyk, A; Nagy, J			Prediction of vocational status three to four months after treated mild traumatic brain injury	JOURNAL OF MUSCULOSKELETAL PAIN			English	Article						brain injury; financial compensation; work	HEAD-INJURY; PAIN	Objectives: To identify variables correlated with vocational functioning 3-4 months after treated mild traumatic brain injury [MTBI]. Methods: One hundred eighteen adults who had received specialized treatment soon after MTBI were interviewed 3-4 months later, to evaluate if they had returned to full time pre-injury vocational activity. Variables previously shown to be related to functioning after MTBI were used in a stepwise discriminant function analysis, in an attempt to predict vocational outcome. Results: Seeking or receiving financial compensation at follow-up, and older age, were the only two variables retained in the discriminant function analysis, as useful in predicting which persons had returned to work and which had not. Conclusions: The strong correlation between financial compensation issues and vocational status in this treated MTBI sample replicates a relationship previously reported numerous times in untreated MTBI samples. The reasons for this strong correlation have not been extensively investigated and remain controversial; further research to help explain this robust and reliable correlation is clearly warranted.	Glenrose Rehabil Hosp, Edmonton, AB T5G 0B7, Canada; Univ Alberta, Edmonton, AB, Canada	Paniak, C (corresponding author), Glenrose Rehabil Hosp, 10230-111 Ave, Edmonton, AB T5G 0B7, Canada.	cpaniak@grhosp.ab.ca					ALEXANDER MP, 1995, NEUROLOGY, V45, P1253, DOI 10.1212/WNL.45.7.1253; *ASS ADV AUT MED, 1990, ABBR INJ SCAL; Binder LM, 1997, J CLIN EXP NEUROPSYC, V19, P432, DOI 10.1080/01688639708403871; Binder LM, 1996, AM J PSYCHIAT, V153, P7; DIKMEN SS, 1994, ARCH NEUROL-CHICAGO, V51, P177, DOI 10.1001/archneur.1994.00540140087018; EVANS RW, 1994, J FORENSIC PSYCHOL, V12, P19; GUALTIERI CT, 1995, NEUROPSY NEUROPSY BE, V8, P127; KRAUS JF, 1989, MILD HEAD INJURY, P8; *MILD TRAUM BRAIN, 1993, J HEAD TRAUMA REHAB, V8, P87; Obelieniene D, 1999, J NEUROL NEUROSUR PS, V66, P279, DOI 10.1136/jnnp.66.3.279; Paniak C, 1998, BRAIN INJURY, V12, P1011, DOI 10.1080/026990598121927; Paniak C, 1999, J HEAD TRAUMA REHAB, V14, P211, DOI 10.1097/00001199-199906000-00002; UOMOTO JM, 1993, ARCH PHYS MED REHAB, V74, P61	13	22	22	0	0	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	1058-2452	1540-7012		J MUSCULOSKELET PAIN	J. Musculoskelet. Pain		2000	8	1-2					193	200		10.1300/J094v08n01_16			8	Rehabilitation; Rheumatology	Rehabilitation; Rheumatology	330GV	WOS:000087955200018					2021-06-18	
J	DelBello, MP; Soutullo, CA; Zimmerman, ME; Sax, KW; Williams, JR; McElroy, SL; Strakowski, SM				DelBello, MP; Soutullo, CA; Zimmerman, ME; Sax, KW; Williams, JR; McElroy, SL; Strakowski, SM			Traumatic brain injury in individuals convicted of sexual offenses with and without bipolar disorder	PSYCHIATRY RESEARCH			English	Article; Proceedings Paper	10th Annual Meeting of the American-Neuropsychiatric-Association	JAN 31-FEB 02, 1999	NEW ORLEANS, LOUISIANA	Amer Neuropsychiat Assoc		head injury; affective disorders; paraphilias	MANIA	The authors examined the occurrence of traumatic brain injury (TBI) in individuals convicted of sexual offenses with and without bipolar disorder and a comparison group of patients with bipolar disorder without a history of sexual offending behaviors. Individuals convicted of sexual offenses and diagnosed with bipolar disorder had greater rates of brain injury resulting from head trauma than individuals convicted of sexual offenses without bipolar disorder and comparison patients with bipolar disorder. TBI predated the first sexual offense and/or the onset of bipolar disorder in most subjects. (C) 1999 Elsevier Science Ireland Ltd. All rights reserved.	Univ Cincinnati, Coll Med, Dept Psychiat, Bipolar & Psychot Disorders Res Program, Cincinnati, OH 45267 USA; Univ Cincinnati, Coll Med, Dept Psychiat, Biol Psychiat Program, Cincinnati, OH 45267 USA	DelBello, MP (corresponding author), Univ Cincinnati, Coll Med, Dept Psychiat, Bipolar & Psychot Disorders Res Program, 231 Bethesda Ave,POB 670559, Cincinnati, OH 45267 USA.		Esperon, Cesar Soutullo/I-1758-2017; Soutullo, Cesar/AAG-4068-2021	Esperon, Cesar Soutullo/0000-0003-4348-0772; Soutullo, Cesar/0000-0003-4348-0772			BROOKS DN, 1976, J NEUROL NEUROSUR PS, V39, P593, DOI 10.1136/jnnp.39.6.593; First M.B., 1996, STRUCTURED CLIN INTE; GRABER B, 1982, J FORENSIC SCI, V27, P125; Hibbard MR, 1998, J HEAD TRAUMA REHAB, V13, P24, DOI 10.1097/00001199-199808000-00003; JORGE RE, 1993, AM J PSYCHIAT, V150, P916; JORGE RE, 1993, J NEUROPSYCH CLIN N, V5, P369; MCALLISTER TW, 1992, PSYCHIAT CLIN N AM, V15, P395; McElroy SL, 1999, J CLIN PSYCHIAT, V60, P414, DOI 10.4088/JCP.v60n0613; MILLER BL, 1986, J NEUROL NEUROSUR PS, V49, P867, DOI 10.1136/jnnp.49.8.867; Mills S., 1994, J OFFENDER REHABILIT, P145; SAX KW, IN PRESS COMORBIDITY; SHUKLA S, 1987, AM J PSYCHIAT, V144, P93; STARKSTEIN SE, 1990, ANN NEUROL, V27, P652, DOI 10.1002/ana.410270612; The Mild Traumatic Brain Injury Committee of the Head Injury Interdisciplinary Special Interest Group of the American Congress of Rehabilitation Medicine, 1993, J HEAD TRAUMA REHAB, V8, P86; ZENICUS A, 1990, BRAIN INJURY, V4, P175	15	22	23	0	2	ELSEVIER SCI IRELAND LTD	CLARE	CUSTOMER RELATIONS MANAGER, BAY 15, SHANNON INDUSTRIAL ESTATE CO, CLARE, IRELAND	0165-1781			PSYCHIAT RES	Psychiatry Res.	DEC 27	1999	89	3					281	286		10.1016/S0165-1781(99)00112-2			6	Psychiatry	Psychiatry	282KE	WOS:000085216600014	10708275				2021-06-18	
J	Braun, RM; Botte, MJ				Braun, RM; Botte, MJ			Treatment of shoulder deformity in acquired spasticity	CLINICAL ORTHOPAEDICS AND RELATED RESEARCH			English	Article							CHRONIC HEMIPARETIC PATIENTS; LIMB EXTENSOR SPASTICITY; HEAD-INJURED ADULTS; BOTULINUM TOXIN; HETEROTOPIC OSSIFICATION; PHENOL BLOCKS; BRAIN INJURY; MANAGEMENT; NERVE	Cerebrovascular accidents and traumatic brain injury produce most of the deformities seen in patients with spastic imbalance of the shoulder. A general awareness of the global neurologic defect is required to understand appropriate treatment alternatives. Conservative treatment techniques include early initiation of therapy exercises, Muscle or nerve block treatments may prevent severe shoulder contractures. Diagnostic blocks may help differentiate between deformity caused by spasticity and that caused by fixed soft tissue contracture. Operative release procedures are described, These operations, when combined with appropriate postoperative therapy programs, permit correction of contractures caused by unbalanced muscle forces around the shoulder in patients with severe spasticity who do not respond to conservative care.	Univ Calif San Diego, Sch Med, Dept Orthopaed Surg, San Diego, CA 92103 USA; Univ So Calif, Sch Med, Dept Orthopaed Surg, Los Angeles, CA USA; Univ So Calif, Rancho Los Amigos Med Ctr, Dept Upper Limb Rehabil, Downey, CA 90242 USA; Univ Calif San Diego, Sch Med, Dept Orthopaed Surg, San Diego, CA 92103 USA; Scripps Res Inst, Div Orthopaed Surg, La Jolla, CA 92037 USA; San Diego Vet Affairs Hlth Care Syst, Orthopaed Surg Serv, San Diego, CA USA	Braun, RM (corresponding author), 770 Washington St,Suite 301, San Diego, CA 92103 USA.						ABRAMS RA, 1992, ORTHOPAEDIC REHABILI, P391; AKESON WA, 1992, ORTHOPAEDIC REHABILI, P277; ANDERSON DW, 1980, J NEUROSURG, V53, pS1; BAKER CC, 1980, AM J SURG, V140, P144, DOI 10.1016/0002-9610(80)90431-6; BAKER LD, 1956, J BONE JOINT SURG AM, V38, P313, DOI 10.2106/00004623-195638020-00007; BLOCH R, 1978, CLIN ORTHOP RELAT R, P10; BODINEFOWLER SC, 1992, ORTHOPAEDIC REHABILI, P295; Botte M J, 1988, Orthop Rev, V17, P637; Botte M J, 1988, Orthop Rev, V17, P891; BOTTE MJ, 1988, J HAND SURG-AM, V13A, P147, DOI 10.1016/0363-5023(88)90220-1; BOTTE MJ, 1987, J HAND SURG-AM, V12A, P639, DOI 10.1016/S0363-5023(87)80227-7; BOTTE MJ, 1989, J HAND SURG-AM, V14, P174, DOI 10.1016/0363-5023(89)90002-6; Botte MJ, 1997, ORTHOPEDICS, V20, P335; BOTTE MJ, 1995, ORTHOPEDICS, V18, P151; BOTTE MJ, 1994, ORTHOPAEDIC KNOWLEDG, P101; BOTTE MJ, 1992, ORTHOPAEDIC REHABILI, P337; BOTTE MJ, 1991, OPERATIVE NERVE REPA, P1415; BOTTE MJ, 1998, SPINE TRAUMA, P639; BOTTE MJ, 1992, ORTHOPAEDIC REHABILI, P427; BOTTE MJ, 1987, J HEAD TRAUMA REHAB, V2, P34; BOTTE MJ, 1992, J MUSCULOSKEL MED, V9, P66; BOTTE MJ, 1987, J HEAD TRAUMA REHAB, V2, P13; BOTTE MJ, 1988, CLIN ORTHOP RELAT R, V233, P7; BRAUN R, 1971, CALIF MED, V115, P11; BRAUN RM, 1971, J BONE JOINT SURG AM, VA 53, P1307, DOI 10.2106/00004623-197153070-00006; BRAUN RM, 1974, J BONE JOINT SURG AM, VA 56, P466, DOI 10.2106/00004623-197456030-00003; BRAUN RM, 1970, J BONE JOINT SURG AM, VA 52, P907, DOI 10.2106/00004623-197052050-00005; BRAUN RM, 1973, J BONE JOINT SURG AM, VA 55, P580, DOI 10.2106/00004623-197355030-00015; BRAUN RM, 1993, OPERATIVE HAND SURG, P225; BRAUN RM, 1974, CLIN ORTHOP RELAT R, V104, P80; CALDWELL CB, 1969, CLIN ORTHOP RELAT R, V63, P69; CAPEN DA, 1992, ORTHOPAEDIC REHABILI, P411; DENGLER R, 1992, J NEUROL, V239, P375; GARLAND DE, 1978, CLIN ORTHOP RELAT R, P111; GARLAND DE, 1983, PHYS THER, V63, P2004, DOI 10.1093/ptj/63.12.2004; GARLAND DE, 1979, CLIN ORTHOP RELAT R, P189; GARLAND DE, 1984, ARCH PHYS MED REHAB, V65, P243; GARLAND DE, 1978, ORTHOP CLIN N AM, V9, P291; GARLAND DE, 1982, CLIN ORTHOP RELAT R, P133; GARLAND DE, 1985, J BONE JOINT SURG AM, V67A, P1261, DOI 10.2106/00004623-198567080-00019; GARLAND DE, 1980, J BONE JOINT SURG AM, V62, P1143, DOI 10.2106/00004623-198062070-00012; GARLAND DE, 1992, ORTHOPAEDIC REHABILI, P453; GARLAND DE, 1988, CLIN ORTHOP RELAT R, V233, P86; GARLAND DE, 1982, CLIN ORTHOP RELAT R, V165, P217; GARLAND DE, 1982, ORTHOPEDIC REHABILIT, P257; HEIDEN JS, 1979, NEURAL TRAUMA, P84; HESSE S, 1994, J NEUROL NEUROSUR PS, V57, P1321, DOI 10.1136/jnnp.57.11.1321; Hesse S, 1996, STROKE, V27, P455, DOI 10.1161/01.STR.27.3.455; INGLIS AE, 1966, J BONE JOINT SURG AM, VA 48, P847, DOI 10.2106/00004623-196648050-00002; JENNETT B, 1977, J NEUROL NEUROSUR PS, V40, P291, DOI 10.1136/jnnp.40.3.291; JENNETT B, 1979, NEUROSURGERY, V4, P283, DOI 10.1227/00006123-197904000-00001; Jennett B, 1981, MANAGEMENT HEAD INJU; JORDAN C, 1982, ORTHOPAEDIC REHABILI, P277; Keenan M A, 1988, Orthop Rev, V17, P1185; KEENAN MA, 1992, ORTHOPAEDIC REHABILI, P243; KEENAN MAE, 1987, J HAND SURG-AM, V12A, P806, DOI 10.1016/S0363-5023(87)80075-8; KEENAN MAE, 1990, J HAND SURG-AM, V15A, P607, DOI 10.1016/S0363-5023(09)90023-5; KEENAN MAE, 1987, J BONE JOINT SURG AM, V69A, P1127, DOI 10.2106/00004623-198769080-00003; KEENAN MAE, 1987, J HAND SURG-AM, V12A, P734, DOI 10.1016/S0363-5023(87)80059-X; KEENAN MAE, 1987, J HAND SURG-AM, V12A, P575, DOI 10.1016/S0363-5023(87)80211-3; KEENAN MAE, 1989, J BONE JOINT SURG AM, V71A, P120, DOI 10.2106/00004623-198971010-00018; KEENAN MAE, 1988, CLIN ORTHOP RELAT R, V233, P116; KEENAN MAE, 1990, J HEAD TRAUMA REHAB, V5, P13; KEENAN MAE, 1992, ORTHOPAEDIC REHABILI, P360; KEENAN MAE, 1993, CONT ORTHOP, V27, P357; KEENAN MAE, 1987, J HEAD TRAUMA REHAB, V2, P62; KEENAN ME, 1993, MANUAL ORTHOPAEDIC S; KOZIN SH, 1993, CLIN ORTHOP RELAT R, P109; KRAUS JF, 1984, AM J EPIDEMIOL, V119, P186, DOI 10.1093/oxfordjournals.aje.a113737; KRAUS JF, 1975, J CHRON DIS, V28, P471, DOI 10.1016/0021-9681(75)90057-0; MACOLLOUGH NC, 1979, INSTR COURSE LECT, V24, P29; Matsumoto N, 1973, STROKE, V4, P20, DOI 10.1161/01.STR.4.1.20; MOONEY V, 1969, CLIN ORTHOP RELAT R, P122; Mooney V, 1969, Clin Orthop Relat Res, V63, P7; MOONEY V, 1967, J BONE JOINT SURG AM, VA 49, P989, DOI 10.2106/00004623-196749050-00018; MOORE TJ, 1991, FOOT ANKLE, V11, P219, DOI 10.1177/107110079101100406; Parise M, 1997, ELECTROMYOGR MOTOR C, V105, P141, DOI 10.1016/S0924-980X(96)96555-8; PERRY J, 1975, INSTRUCTIONAL COURSE, V24, P40; RHOADES ME, 1978, CLIN ORTHOP RELAT R, P104; SIMON DB, 1992, ORTHOPAEDIC REHABILI, P309; WATERS RL, 1978, CLIN ORTHOP RELAT R, V131, P30; WATERS RL, 1978, NEUROLOGICAL ASPECTS, P123; WATERS RL, 1990, CONT ORTHOP, V20, P311; WATERS RL, 1988, OPERATIVE ORTHOPAEDI, P1449; WHARTON GW, 1975, CLIN ORTHOP RELAT R, P142	85	22	22	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0009-921X	1528-1132		CLIN ORTHOP RELAT R	Clin. Orthop. Rel. Res.	NOV	1999		368					54	65					12	Orthopedics; Surgery	Orthopedics; Surgery	254XT	WOS:000083640100008	10613153				2021-06-18	
J	Chua, KSG; Kong, KH				Chua, KSG; Kong, KH			Rehabilitation outcome following traumatic brain injury - the Singapore experience	INTERNATIONAL JOURNAL OF REHABILITATION RESEARCH			English	Article						closed head injury; Glasgow coma scale; Modified Barthel Index; skull fracture; traumatic brain injury	CLOSED HEAD-INJURY; FUNCTIONAL INDEPENDENCE	The objectives of this study were to define (1) demographic and injury characteristics for acute traumatic brain injury (TBI) patients admitted to rehabilitation; (2) admission and discharge functional status; (3) discharge disposition and vocation status at follow-up. The charts of 80 consecutive TBI admissions (64 males, 16 females) were reviewed. Outcome measures included admission and discharge Modified Barthel Index (MBI) scores, length of rehabilitation stay, discharge disposition and return-to-work status at 1 year post-injury. Fifty-seven (71.3%) of patients were aged 40 years or less. Motor vehicle accidents accounted for 70.0% (56) of injuries. Sixty-one (76.3%) had severe head injuries. Diffuse cerebral oedema was present in 41.3% (33) and 52.5% (42) had intracranial haematoma. Admission and discharge MBI scores were 49.6 +/- 33.7 and 76.9 +/- 25.6 respectively. This difference was significant (P < 0.001). Memory and planning/ organization deficits were present in 68.6% and 70.5% of patients (51 tested). Multiple regression analysis showed that admission MBI score had significant influence on discharge functional outcome (Multiple R 0.66, R-2 0.40, P < 0.001). Seventy-two (90%) were discharge home and 25% (20) returned to work at 1 year post-injury. We conclude that this cohort of TBI patients showed significant improvement in functional status after rehabilitation, and admission functional status had the most impact on discharge functional outcome.	Tan Tock Seng Hosp, Dept Rehabil Med, Singapore 569766, Singapore	Chua, KSG (corresponding author), Tan Tock Seng Hosp, Dept Rehabil Med, 17 Ang Mo Kio Ave 9, Singapore 569766, Singapore.						BEYERL B, 1984, NEUROSURGERY, V15, P257, DOI 10.1227/00006123-198408000-00020; BOND MR, 1990, REHABILITATION ADULT, P59; Bontke C F, 1991, Neurosurg Clin N Am, V2, P473; BRANDSTATER E, 1991, ARCH PHYSICAL MED RE, V74, pS332; Brooks N, 1987, Brain Inj, V1, P5, DOI 10.3109/02699058709034439; CLIFTON GL, 1980, J NEUROSURG, V52, P611, DOI 10.3171/jns.1980.52.5.0611; CORRIGAN JD, 1995, ARCH PHYS MED REHAB, V76, P302, DOI 10.1016/S0003-9993(95)80654-7; COWEN TD, 1995, ARCH PHYS MED REHAB, V76, P797, DOI 10.1016/S0003-9993(95)80542-7; DIKMEN SS, 1994, ARCH NEUROL-CHICAGO, V51, P177, DOI 10.1001/archneur.1994.00540140087018; Frankowski R F, 1986, Adv Psychosom Med, V16, P153; GALBRAITH S, 1976, BRIT J SURG, V63, P138; Gualtieri C T, 1988, Brain Inj, V2, P101, DOI 10.3109/02699058809150936; JENNETT B, 1981, BRIT MED J, V282, P101, DOI 10.1136/bmj.282.6258.101; JENNETT B, 1975, LANCET, V1, P480; KAPLAN CP, 1994, ARCH PHYS MED REHAB, V75, P643, DOI 10.1016/0003-9993(94)90186-4; Kolb B, 1985, FUNDAMENTALS HUMAN N; Levin H S, 1991, Neurosurg Clin N Am, V2, P457; LEVIN HS, 1981, ARCH NEUROL-CHICAGO, V38, P623, DOI 10.1001/archneur.1981.00510100051007; LEVIN HS, 1979, J NEUROSURG, V50, P412, DOI 10.3171/jns.1979.50.4.0412; Miller WG, 1986, NEUROPSYCHOLOGY HDB, P347; Narayan R. K., 1990, REHABILITATION ADULT, P94; NEWTON MR, 1992, J NEUROL NEUROSUR PS, V55, P92, DOI 10.1136/jnnp.55.2.92; ODDY M, 1985, J NEUROL NEUROSUR PS, V48, P564, DOI 10.1136/jnnp.48.6.564; PONSFORD JL, 1995, BRAIN INJURY, V9, P1, DOI 10.3109/02699059509004565; RUFF RM, 1993, BRAIN INJURY, V7, P101, DOI 10.3109/02699059309008164; Sander AM, 1996, J HEAD TRAUMA REHAB, V11, P70, DOI 10.1097/00001199-199610000-00007; SAZBON L, 1981, J BONE JOINT SURG BR, V63, P120; SBORDONE RJ, 1995, BRAIN INJURY, V9, P285, DOI 10.3109/02699059509008199; SHAH S, 1989, J CLIN EPIDEMIOL, V42, P703, DOI 10.1016/0895-4356(89)90065-6; SILVER JM, 1987, AM PSYCHIAT PRESS HD, P179; VARGHESE G, 1992, PHYS MED REH CLIN N, V3, P407; WEBB CR, 1995, ARCH PHYS MED REHAB, V76, P1113, DOI 10.1016/S0003-9993(95)80118-9; WHITLOCK JA, 1995, ARCH PHYS MED REHAB, V76, P1103, DOI 10.1016/S0003-9993(95)80117-0; YABLON SA, 1993, ARCH PHYS MED REHAB, V74, P983; 1989, INTERAGENCY HEAD INJ	35	22	23	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0342-5282			INT J REHABIL RES	Int. J. Rehabil. Res.	SEP	1999	22	3					189	197		10.1097/00004356-199909000-00005			9	Rehabilitation	Rehabilitation	244AM	WOS:000083029700005	10839672				2021-06-18	
J	Harmon, KG				Harmon, KG			Assessment and management of concussion in sports	AMERICAN FAMILY PHYSICIAN			English	Article							HEAD-INJURIES; GUIDELINES; RETURN	The most common head injury in sports is concussion. Athletes who Sustain a prolonged:loss of consciousness should be transported immediately to a hospital for further evaluation. Assessment of less severe injuries should include a thorough neurologic examination. The duration of symptoms and the presence of absence of post-traumatic amnesia and loss of consciousness should be noted. To avoid premature return to play, a good understanding of the possible hazards is important. Potential hazards of premature return to play include the possibility of death from second-impact syndrome, permanent neurologic impairment from cumulative trauma, and the postconcussion syndrome.	Univ Washington, Hall Hlth Primary Care Ctr, Sports Med Clin, Seattle, WA 98195 USA	Harmon, KG (corresponding author), Univ Washington, Hall Hlth Primary Care Ctr, Sports Med Clin, Box 354410, Seattle, WA 98195 USA.						Brukner P, 1996, Aust Fam Physician, V25, P1445; Cantu RC, 1996, BRIT J SPORT MED, V30, P289, DOI 10.1136/bjsm.30.4.289; CANTU RC, 1986, PHYSICIAN SPORTSMED, V14, P75, DOI 10.1080/00913847.1986.11709197; Cantu RC, 1998, CLIN SPORT MED, V17, P37, DOI 10.1016/S0278-5919(05)70059-4; Cantu RC, 1998, CLIN SPORT MED, V17, P45, DOI 10.1016/S0278-5919(05)70060-0; CANTU RC, 1986, PHYSICIAN SPORTSMED, V14, P79; CANTU RC, 1986, PHYSICIAN SPORTSMED, V14, P83; *COL MED SOC SCH S, 1990, COLO MED, V87, P4; KELLY JP, 1991, JAMA-J AM MED ASSOC, V266, P2867, DOI 10.1001/jama.266.20.2867; Kelly JP, 1997, NEUROLOGY, V48, P575, DOI 10.1212/WNL.48.3.575; Kelly JP, 1997, NEUROLOGY, V48, P581; LEBLANC KE, 1994, AM FAM PHYSICIAN, V50, P801; McCrory PR, 1997, MED SCI SPORT EXER, V29, pS207; *NCAA COMM COMP SA, 1994, NCAA SPORTS MED HDB; ROBERTS WO, 1992, PHYSICIAN SPORTSMED, V20, P66, DOI 10.1080/00913847.1992.11710295; SWENSON JE, 1998, P 26 FIMS WORLD C SP; SWENSON JE, 1996, P AMSSM 5 ANN M JUN; WILBERGER JE, 1989, CLIN SPORT MED, V8, P1; Young CC, 1997, CLIN J SPORT MED, V7, P196, DOI 10.1097/00042752-199707000-00008	19	22	23	0	1	AMER ACAD FAMILY PHYSICIANS	KANSAS CITY	8880 WARD PARKWAY, KANSAS CITY, MO 64114-2797 USA	0002-838X			AM FAM PHYSICIAN	Am. Fam. Physician	SEP 1	1999	60	3					887	892					6	Primary Health Care; Medicine, General & Internal	General & Internal Medicine	236MV	WOS:000082604100016	10498114				2021-06-18	
J	Bowen, A; Chamberlain, MA; Tennant, A; Neumann, V; Conner, M				Bowen, A; Chamberlain, MA; Tennant, A; Neumann, V; Conner, M			The persistence of mood disorders following traumatic brain injury: a 1 year follow-up	BRAIN INJURY			English	Article							HEAD-INJURY	The study investigated whether the frequency of mood disorders following traumatic brain injury (TBI) increased with time. Consecutive hospital admissions completed the Wimbledon Self-Report Scale at 6 and 12 months post-injury. Scores in the 'borderline/case' range were deemed clinically significant. Seventy-seven of those assessed at 6 months completed the 12 month follow-up. Those lost to follow-up (22) were nor more likely to have been classified 'borderline/case' at: 6 months. They were more likely to have been 'unoccupied' pre-injury (p = 0.002). The frequency of clinically significant disorders did not change significantly, being 39% at 6 months and 35% 1 year post-injury. The majority of subjects (58) maintained the same clinical classification at both assessments. Eight of the 47 (17%) classified 'normal' at 6 months changed to 'borderline/case' at 12 months. However, 11 of the 30 (37%) classified 'borderline/case' at 6 months were 'normal' at 12 months. The direction of change was not statistically significant (p = 0.5). These findings are consistent with previous research. However, the present study examined a larger sample and included a wider range of injury severity, thereby increasing the generalizability of the findings. Also, a broader spectrum of mood disorders was investigated which adds to previous work specifically on depression.	Univ Leeds, Rheumatol & Rehabil Res Unit, Leeds, W Yorkshire, England; Univ Leeds, Sch Psychol, Leeds, W Yorkshire, England	Bowen, A (corresponding author), Univ Manchester, Dept Geriatr Med, Stroke Assoc Therapy Res Unit, Hope Hosp, Clin Sci Bldg, Salford M6 8HD, Lancs, England.		Bowen, Audrey/K-5544-2012; Conner, Mark/N-9063-2013	Conner, Mark/0000-0002-6229-8143; Bowen, Audrey/0000-0003-4075-1215			BOND M, 1984, CLOSED HEAD INJURY P, P146; Bowen A, 1998, BRAIN INJURY, V12, P177, DOI 10.1080/026990598122656; Coughlan AK, 1988, CLIN REHABIL, V2, P207, DOI DOI 10.1177/026921558800200305; FORDYCE DJ, 1983, J NEUROL NEUROSUR PS, V46, P620, DOI 10.1136/jnnp.46.7.620; HARRICK L, 1994, BRAIN INJURY, V8, P539; HUGHES D, 1995, TRAUMATIC BRAIN INJU, P66; Jennett B, 1996, J NEUROL NEUROSUR PS, V60, P362, DOI 10.1136/jnnp.60.4.362; JENNETT B, 1976, J NEUROL NEUROSUR PS, V39, P647, DOI 10.1136/jnnp.39.7.647; JORGE RE, 1993, J AFFECT DISORDERS, V27, P233, DOI 10.1016/0165-0327(93)90047-N; NELSON H, 1976, NATL ADULT READING T; TEASDALE G, 1974, LANCET, V2, P81; Varney NR, 1987, NEUROPSYCHOLOGY, V1, P7, DOI 10.1037//0894-4105.1.1.7	12	22	22	0	3	TAYLOR & FRANCIS LTD	LONDON	ONE GUNPOWDER SQUARE, LONDON EC4A 3DE, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.	JUL	1999	13	7					547	553					7	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	215GT	WOS:000081374100007	10462151				2021-06-18	
J	Gofin, R; Adler, B; Hass, T				Gofin, R; Adler, B; Hass, T			Incidence and impact of childhood and adolescent injuries: A population-based study	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article						disabilities; activity limitations; use of services	CLOSED HEAD-INJURY; PEDIATRIC TRAUMA; YOUNG-ADULTS; CHILDREN; DISABILITY; MORBIDITY	Background: The study of disabilities, use of health services, and absenteeism of parents among 0- to 17-year-old residents of Jerusalem (n = 432) hospitalized for unintentional injuries. Methods: Telephone interviews with parents, 6 months after hospitalization. Disabilities among 4 to 17 year olds were measured by a 25-item scale derived from the International Classification of Impairments, Disabilities, and Handicaps and hy limitations of activities. Results: Six months after the injury, limitations ranged from 8.3% (daily activities) to 19.4% (sport activities), About one in three presented at least one disability in the 25-item scale. All disabilities were present in higher proportions among adolescents. The more severe injuries whether to the head or other parts of the body presented higher percentages of disabilities. Burns and traffic crashes were associated with higher proportions of disabilities than other causes and with more frequent work absenteeism by their parents. Conclusion: A relatively large proportion of children remain with long-term disabilities irrespective of cause and body part injured. Because the sequelae of injuries is multifaceted, rehabilitation should include coordination between health and other services.	Hadassah Med Org, Dept Social Med, Jerusalem, Israel	Gofin, R (corresponding author), Hadassah Univ Hosp, Dept Social Med, IL-91120 Jerusalem, Israel.						ASARNOW RF, 1991, J PEDIATR PSYCHOL, V16, P543, DOI 10.1093/jpepsy/16.5.543; *ASS ADV AUT MED, 1990, ABBR INJ SCAL; *AUSTR I HLTH WELF, 1995, NAT DAT STAND INJ SU; BAKER SP, 1992, INJURY FACT BOOK, P8; Barker M, 1996, ARCH DIS CHILD, V75, P156, DOI 10.1136/adc.75.2.156; BASSON MD, 1991, J TRAUMA, V31, P1363, DOI 10.1097/00005373-199110000-00008; CASEY R, 1986, PEDIATRICS, V78, P497; Colantonio A, 1998, ARCH PHYS MED REHAB, V79, P550, DOI 10.1016/S0003-9993(98)90072-7; COSTER WJ, 1994, AM J OCCUP THER, V48, P211, DOI 10.5014/ajot.48.3.211; FINGERHUT LA, 1997, HLTH US 1996 97 INJU, P35; *FOR PREV INJ, 1991, SYNAPS SYST NAT PERS; GAHLINGER PM, 1995, COMPUTER PROGRAMS EP, P59; GALLAGHER SS, 1984, AM J PUBLIC HEALTH, V74, P340; GOFIN R, 1995, J CLIN EPIDEMIOL, V48, P977, DOI 10.1016/0895-4356(94)00198-Y; GOFIN R, 1991, ISRAEL J MED SCI, V27, P566; GOFIN R, 1997, INJURIES CHILDREN AD, P48; GULBRANDSEN GB, 1984, J CLIN NEUROPSYCHOL, V6, P257, DOI 10.1080/01688638408401217; HANVEY L, 1997, SAFETY CANADIAN CHIL, P11; HARRIS BH, 1989, J PEDIATR SURG, V24, P103, DOI 10.1016/S0022-3468(89)80311-2; JAIMOVICH DG, 1991, J TRAUMA, V31, P196; Koelfen W, 1997, EUR J PEDIATR, V156, P230, DOI 10.1007/s004310050590; LEVIN HS, 1979, CHILD BRAIN, V5, P281; Meyer AA, 1998, J TRAUMA, V44, P1, DOI 10.1097/00005373-199801000-00001; MULDER S, 1996, P INT COLL EFF INJ S, V2, P111; RIVARA JB, 1992, ARCH PHYS MED REHAB, V73, P899; RUSONIS ES, 1990, MED CLIN N AM, V74, P1311, DOI 10.1016/S0025-7125(16)30518-1; SCOTTJUPP R, 1992, ARCH DIS CHILD, V67, P222, DOI 10.1136/adc.67.2.222; SLATER EJ, 1988, AM J DIS CHILD, V142, P1048, DOI 10.1001/archpedi.1988.02150100042022; TACKET A, 1986, WORLD HLTH STAT Q, V39, P232; WESSON DE, 1989, J TRAUMA, V29, P589, DOI 10.1097/00005373-198905000-00008; *WHO, 1985, TARG HLTH ALL REG OF, P48; World Health Organization, 1978, INT CLASS DIS; World Health Organization, 1980, INT CLASS IMP DIS HA	33	22	22	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	1079-6061			J TRAUMA	J. Trauma-Injury Infect. Crit. Care	JUL	1999	47	1					15	21		10.1097/00005373-199907000-00004			7	Critical Care Medicine; Surgery	General & Internal Medicine; Surgery	216ZQ	WOS:000081474700003	10421180				2021-06-18	
J	Lammie, GA; Piper, IR; Thomson, D; Brannan, F				Lammie, GA; Piper, IR; Thomson, D; Brannan, F			Neuropathologic characterization of a rodent model of closed head injury - Addition of clinically relevant secondary insults does not significantly potentiate brain damage	JOURNAL OF NEUROTRAUMA			English	Article						blood-brain barrier; closed head injury; axonal injury; neuropathology; rat; trauma model	RAT-BRAIN; SHOCK; MICROGLIA; PROTEINS; STROKE; COMMON; CELLS	We have characterized the early brain pathology in Sprague-Dawley rats subjected to a modified Richmond impact acceleration model of closed head injury (CHI). This model was modified to produce maximal traumatic brain injury (TBI) in the absence of skull fracture, extracerebral or intracerebral hemorrhage, or brain contusion. We then used this model to assess the neuropathologic effects of superimposed secondary insults, which were designed to reflect a clinically relevant combination of hypotension and pyrexia. Acute neuronal injury, blood-brain barrier (BBB) integrity, axonal injury (AI), and glial activation were studied 4 1/2 hours following either CHI (group A), CHI plus secondary insults (group B), secondary insults alone (group C), or sham control injury (group D). There was evidence of limited AI following CHI in the lower medulla and upper cervical cord region, which was not modified by addition of secondary insult. Loss of dendritic microtubule-associated protein MAP2 immunoreactivity proved a reliable marker of acute neuronal damage, which was confined to subimpact and inferolateral cortical locations following CHI and was widespread after secondary insult. The pattern of plasma protein extravasation paralleled that of acute neuronal injury. We found no evidence of microglial activation, either local or generalized, by 4 1/2 hours. However, by this time CHI and secondary insults had combined to produce evidence of subimpact astrocyte activation, which was not apparent with either insult or injury alone. We conclude that in this modified Richmond model of CHI, when combined with secondary insults, there is no convincing potentiation of brain damage with the minor exception of astrocyte activation.	Univ Edinburgh, Western Gen Hosp, Dept Pathol, Neuropathol Lab, Edinburgh EH4 2XU, Midlothian, Scotland; Univ Edinburgh, Western Gen Hosp, Dept Clin Neurosci, Edinburgh EH4 2XU, Midlothian, Scotland	Lammie, GA (corresponding author), Univ Edinburgh, Western Gen Hosp, Dept Pathol, Neuropathol Lab, Alexander Donald Bldg,Crewe Rd, Edinburgh EH4 2XU, Midlothian, Scotland.						AUER RN, 1984, ACTA NEUROPATHOL, V64, P177, DOI 10.1007/BF00688108; Brown HC, 1998, NEUROPATH APPL NEURO, V24, P177; FODA MAA, 1994, J NEUROSURG, V80, P301, DOI 10.3171/jns.1994.80.2.0301; GEHRMANN J, 1991, ACTA NEUROPATHOL, V82, P442, DOI 10.1007/BF00293378; GRAHAM DI, 1989, J NEUROL NEUROSUR PS, V52, P346, DOI 10.1136/jnnp.52.3.346; JENKINS LW, 1989, BRAIN RES, V477, P211, DOI 10.1016/0006-8993(89)91409-1; JONES PA, 1994, J NEUROSURG ANESTH, V6, P4; KITAGAWA K, 1989, NEUROSCIENCE, V31, P401, DOI 10.1016/0306-4522(89)90383-7; Kreutzberg GW, 1996, TRENDS NEUROSCI, V19, P312, DOI 10.1016/0166-2236(96)10049-7; LANDIS DMD, 1994, ANNU REV NEUROSCI, V17, P133, DOI 10.1146/annurev.ne.17.030194.001025; LEES GJ, 1989, ACTA NEUROPATHOL, V77, P519, DOI 10.1007/BF00687254; LINDQUIST S, 1986, ANNU REV BIOCHEM, V55, P1151, DOI 10.1146/annurev.bi.55.070186.005443; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; MATTIACE LA, 1990, AM J PATHOL, V136, P1101; PELHAM HRB, 1986, CELL, V46, P959, DOI 10.1016/0092-8674(86)90693-8; PICKARD JD, 1993, J NEUROL NEUROSUR PS, V56, P845, DOI 10.1136/jnnp.56.8.845; POVLISHOCK JT, 1979, ACTA NEUROPATHOL, V47, P1, DOI 10.1007/BF00698266; POVLISHOCK JT, 1995, BRAIN PATHOL, V5, P415, DOI 10.1111/j.1750-3639.1995.tb00620.x; Sharp FR, 1998, ANN NEUROL, V44, P581, DOI 10.1002/ana.410440402; SHERRIFF FE, 1994, ACTA NEUROPATHOL, V88, P433; VANDENBRINK WA, 1994, ACT NEUR S, V60, P456; WELCH WJ, 1984, J BIOL CHEM, V259, P4501; WELLS J, 1992, GLIA, V5, P154, DOI 10.1002/glia.440050210; YAGHMAI A, 1992, J NEUROPATH EXP NEUR, V51, P158, DOI 10.1097/00005072-199203000-00006; Yenari MA, 1998, ANN NEUROL, V44, P584, DOI 10.1002/ana.410440403	25	22	22	0	2	MARY ANN LIEBERT INC PUBL	LARCHMONT	2 MADISON AVENUE, LARCHMONT, NY 10538 USA	0897-7151			J NEUROTRAUM	J. Neurotrauma	JUL	1999	16	7					603	615		10.1089/neu.1999.16.603			13	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	220EN	WOS:000081651700005	10447072				2021-06-18	
J	Armengol, CG				Armengol, CG			A multimodal support group with Hispanic traumatic brain injury survivors	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article							LATINO HEALTH; STRATEGIES	Objectives: (a) To design and pilot a culturally sensitive and neuropsychologically informed support group addressing barriers to emotional, social, and vocational adjustment among high-level functioning Hispanic/Latino TBI survivors. (b) To determine efficacy through outcome measures. Intervention: Ten-week multimodal, culturally sensitive support group focusing on TBI sequelae education, relaxation techniques, coping skills development, behavioral goal setting and monitoring, and family participation. Participants: Six Spanish-speaking high-level functioning TBI survivors aged 20-42. Setting: Outpatient neuropsychological assessment and treatment center. Outcome measures: Beck Hopelessness Scale; Purpose in Life Test; Perceived Self-Regulatory Ability Inventory. Results: Participants' sense of personal destiny and feelings of hopelessness improved, as evidenced by objective measures and self-report. A telephone interview a year later indicated that gains had been maintained, and most participants were vocationally active. Conclusions: Results underscore the importance of considering linguistic and ethnic factors in developing support groups.	Northeastern Univ, Boston, MA 02115 USA	Armengol, CG (corresponding author), Northeastern Univ, 203 Lake Hall,360 Huntingdon Ave, Boston, MA 02115 USA.						AGUIRREMOLINA M, 1993, PUBLIC HEALTH REP, V108, P559; ARMENGOL CG, 1995, UNPUB PERCEIVED SELF; ARREDONDO P, 1996, THEORY MULTICULTURAL; Baker EA, 1997, HEALTH EDUC BEHAV, V24, P495, DOI 10.1177/109019819702400408; Beck A.T., 1993, COGNITIVE THERAPY SU; Beck AT., 1988, BECK HOPELESSNESS SC; COMASDIAZ L, 1993, COUNSELING AM MINORI; COOPER KD, 1983, NEUROEPIDEMIOLOGY, V2, P70; CRUMBAUGH CJ, 1988, INT FORUM LOGOTHER J, V11, P76; CRUMBAUGH JC, 1968, J INDIV PSYCHOL, V24, P74; DELGADO JL, 1993, PUBLIC HEALTH REP, V108, P540; DIKMEN SS, 1988, MILD HEAD INJURY; ESLINGER PJ, HEAD INJURY POST CON; ESTRADA AL, 1990, AM J PUBLIC HEALTH, V80, P27, DOI 10.2105/AJPH.80.Suppl.27; GOLDSMITH MF, 1993, JAMA-J AM MED ASSOC, V269, P1604; Gronwall D, 1991, NEUROPSYCHOLOGY, V5, P253, DOI DOI 10.1037/0894-4105.5.4.253; Guttman D., 1996, LOGOTHERAPY HELPING; HITCHCOCK LS, 1994, J PAIN SYMPTOM MANAG, V9, P312, DOI 10.1016/0885-3924(94)90190-2; LEZAK MD, 1988, J CLIN EXP NEUROPSYC, V10, P11; LISHMAN WA, 1998, ORGANIC PSYCHIAT PSY; Lopez-Austin A., 1989, CUERPO HUMANO IDEOLO; LUBUSKO AA, 1994, BRAIN INJURY, V8, P65, DOI 10.3109/02699059409150959; MOES EJ, 1994, PSYCHOTHERAPISTS GUI; NOVELLO AC, 1993, PUBLIC HEALTH REP, V108, P529; PONSFORD JL, 1995, BRAIN INJURY, V9, P1, DOI 10.3109/02699059509004565; PONTERROTO JG, 1990, HDB RACIAL ETHNIC MI; PONTON MO, 1997, NEUROPSYCHOLOGICAL R; Prigatano G. P., 1986, NEUROPSYCHOLOGICAL R; RIDEOUT E, 1986, J ADV NURS, V11, P429, DOI 10.1111/j.1365-2648.1986.tb01270.x; ROGLER IH, 1993, COUNSELING AM MINORI; Rogler L. H., 1989, HISPANICS MENTAL HLT; Rosenthal M, 1996, J HEAD TRAUMA REHAB, V11, P40, DOI 10.1097/00001199-199610000-00005; Sue D.W., 1996, THEORY MULTICULTURAL; TELLEZVARGAS H, 1991, REV LATINOAMER PSICO, V23, P401; Thoresen CE, 1974, SELF CONTROL POWER P; TORNER JC, 1996, HEAD INJURY POST CON; TRUK DC, 1983, PAIN BEHAV MED COGNI; *US BUR CENS, HISP POP US MARC P20, V444; VASQUEZ MJT, 1995, PSYCHOL INTERVENTION; Walsh K. W, 1991, UNDERSTANDING BRAIN; Woodward A M, 1992, J Ment Health Adm, V19, P224, DOI 10.1007/BF02518988	41	22	22	0	5	ASPEN PUBL INC	FREDERICK	7201 MCKINNEY CIRCLE, FREDERICK, MD 21704 USA	0885-9701			J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	JUN	1999	14	3					233	246		10.1097/00001199-199906000-00004			14	Clinical Neurology; Rehabilitation	Neurosciences & Neurology; Rehabilitation	203XY	WOS:000080734500004	10381976				2021-06-18	
J	Block, GW; Nanson, JL; Lowry, NJ				Block, GW; Nanson, JL; Lowry, NJ			Attention, memory, and language after pediatric ischemic stroke	CHILD NEUROPSYCHOLOGY			English	Article							UNILATERAL BRAIN-LESIONS; CLOSED-HEAD INJURY; CHILDREN	A previous study evaluating receptive language after unilateral brain damage in childhood hypothesized lateralized attention and memory deficits without direct measurement. Our study directly measured attention, memory, and language in order to evaluate empirically the severity and laterality of sequelae. The performances of 11 individuals with a unilateral ischemic-lesion (7 right and 4 left hemisphere) were compared to controls matched on age, sex, and socioeconomic status. Results suggest subtle but persistent. deficits in verbal memory, functional memory, and speed of processing after a lesion to either hemisphere. Lesions sustained before two years of age were associated with the lowest IQ scores. Our findings provide support for a configural representation of language that can to some extent compensate for inefficient or damaged components (Bates, 1994), and the middle-ground lateralization position (Thal et al., 1991) that asserts initial hemispheric specialization with the potential for reorganization.	Univ Saskatchewan, Saskatoon, SK, Canada	Block, GW (corresponding author), Royal Univ Hosp, Alvin Buckwold Child Dev Program, 103 Hosp Dr, Saskatoon, SK S7N 0X0, Canada.						Anderson V, 1997, J Int Neuropsychol Soc, V3, P147; ARAM DM, 1988, NEUROPSYCHOLOGIA, V26, P903, DOI 10.1016/0028-3932(88)90058-9; ARAM DM, 1985, J CLIN EXP NEUROPSYC, V7, P55, DOI 10.1080/01688638508401242; ARAM DM, 1994, NEUROPSYCHOLOGIA, V32, P85, DOI 10.1016/0028-3932(94)90071-X; ARAM DM, 1990, DEV NEUROPSYCHOL, V6, P310; ARAM DM, 1987, BRAIN LANG, V32, P37; Aram DM, 1986, DEV NEUROPSYCHOL, V2, P155, DOI 10.1080/87565648609540339; BATES E, 1994, DISCUSS NEUROSCI, V10, P136; BLISHEN BR, 1987, CAN REV SOC ANTHROP, V24, P465; DELIS C, 1987, CALIFORNIA VERBAL LE; DELIS D, 1994, CALIFORNIA VERBAL LE; DERENZI E, 1978, CORTEX, V14, P279; EISELE JA, 1994, BRAIN LANG, V46, P212, DOI 10.1006/brln.1994.1013; Halstead WC, 1985, HALSTEAD REITAN NEUR; HUTTENLOCHER P, 1992, M INT NEUR SOC SAN D; Kalapurackal M, 1994, J Stroke Cerebrovasc Dis, V4, P57, DOI 10.1016/S1052-3057(10)80148-X; KAUFMANN PM, 1993, J CHILD NEUROL, V8, P348, DOI 10.1177/088307389300800410; KINSBOURNE M, 1983, HDB CHILD PSYCHOL IN; Kolb B., 1990, FUNDAMENTALS HUMAN N; Lenneberg Eric H., 1967, BIOL FDN LANGUAGE; McNeil M. R., 1978, REVISED TOKEN TEST; PONSFORD J, 1992, J CLIN EXP NEUROPSYC, V14, P822, DOI 10.1080/01688639208402865; RIVA E, 1990, NEUROPSYCHOLOGIA, V24, P423; SATZ P, 1990, BRAIN LANG, V38, P596, DOI 10.1016/0093-934X(90)90139-8; Siegel S., 1988, NONPARAMETRIC STAT B; Smith A., 1982, SYMBOL DIGIT MODALIT; STILES J, 1991, BRAIN COGNITION, V15, P210; Stiles Joan, 1993, P643; THAL DJ, 1991, BRAIN LANG, V40, P491, DOI 10.1016/0093-934X(91)90145-Q; VARGHAKHADEM F, 1985, M SOC RES CHILD DEV; Wechsler D, 2008, WECHSLER ADULT INTEL, V4th; Wechsler D., 1991, WECHSLER INTELLIGENC; WILSON B, 1989, J CLIN EXP NEUROPSYC, V11, P855, DOI 10.1080/01688638908400940; Wilson B. A., 1991, RIVERMEAD BEHAV MEMO; Wilson B. A., 1985, RIVERMEAD BEHAV MEMO; WILSON BA, 1993, J CLIN EXP NEUROPSYC, V15, P474, DOI 10.1080/01688639308402572	36	22	22	0	2	SWETS ZEITLINGER PUBLISHERS	LISSE	P O BOX 825, 2160 SZ LISSE, NETHERLANDS	0929-7049			CHILD NEUROPSYCHOL	Child Neuropsychol.	JUN	1999	5	2					81	91		10.1076/chin.5.2.81.3169			11	Clinical Neurology	Neurosciences & Neurology	237ME	WOS:000082659500001					2021-06-18	
J	May, AK; Patterson, MA; Rue, LW; Schiller, HJ; Rotondo, MF; Schwab, CW				May, AK; Patterson, MA; Rue, LW; Schiller, HJ; Rotondo, MF; Schwab, CW			Combined blunt cardiac and pericardial rupture: Review of the literature and report of a new diagnostic algorithm	AMERICAN SURGEON			English	Article; Proceedings Paper	67th Annual Scientific Meeting and Postgraduate Course Program, Southeastern Surgical Congress	FEB 13-17, 1999	TAMPA, FLORIDA				TRAUMATIC RUPTURE; EXPERIENCE; HEART	The spectrum of blunt cardiac injury varies from the asymptomatic cardiac concussion to the immediately fatal cardiac rupture. Although the majority of victims sustaining blunt cardiac rupture die before receiving medical attention, some survive to evaluation. The diagnosis of cardiac rupture, if established, typically results from the signs and symptoms of pericardial tamponade. However, some patients may have remarkably few signs and symptoms suggestive of cardiac injury and represent a significant diagnostic challenge. We provide two cases of cardiac rupture in which the diagnosis was delayed by the presence of an associated pericardial tear with decompression into the mediastinum and pleural space. In neither of the cases did existing institutional algorithms for blunt cardiac injury assist in establishing the diagnosis before the acute demise of the patient. The presence of a coexisting pericardial injury in these patients with blunt cardiac rupture obscured the diagnosis, leading to the deaths of these patients. A discussion of these two cases and review of the literature is provided with recommendations for diagnostic algorithms in patients sustaining blunt thoracic trauma with possible cardiac and pericardial injury.	Univ Alabama, Dept Surg, Sect Trauma Burns & Surg Crit Care, UAB Stn, Birmingham, AL 35294 USA; SUNY Syracuse, Hlth Sci Ctr, Dept Surg, Syracuse, NY 13210 USA; Univ Penn, Med Ctr, Dept Surg, Div Traumatol & Surg Crit Care, Philadelphia, PA 19104 USA	May, AK (corresponding author), Univ Alabama, Dept Surg, Sect Trauma Burns & Surg Crit Care, UAB Stn, Birmingham, AL 35294 USA.						BRATHWAITE CEM, 1990, ANN SURG, V212, P701, DOI 10.1097/00000658-199012000-00008; CLARK DE, 1983, SURGERY, V93, P493; DESFORGES G, 1955, NEW ENGL J MED, V252, P567, DOI 10.1056/NEJM195504072521403; FULDA G, 1991, J TRAUMA, V31, P167, DOI 10.1097/00005373-199131020-00003; FULDA G, 1990, J CARDIOVASC SURG, V31, P523; GETZ BS, 1986, JAMA-J AM MED ASSOC, V255, P761, DOI 10.1001/jama.255.6.761; KATO K, 1994, J TRAUMA, V36, P859, DOI 10.1097/00005373-199406000-00017; Nagy KK, 1996, ACAD EMERG MED, V3, P1024, DOI 10.1111/j.1553-2712.1996.tb03347.x; PERCHINSKY MJ, 1995, ARCH SURG-CHICAGO, V30, P852; Pretre R, 1997, NEW ENGL J MED, V336, P626, DOI 10.1056/NEJM199702273360906; REDDY PS, 1978, CIRCULATION, V58, P265, DOI 10.1161/01.CIR.58.2.265; Tocino Irena, 1993, P51	12	22	24	0	0	SOUTHEASTERN SURGICAL CONGRESS	ATLANTA	141 WEST WIEUCA RD, STE B100, ATLANTA, GA 30342 USA	0003-1348			AM SURGEON	Am. Surg.	JUN	1999	65	6					568	574					7	Surgery	Surgery	200RC	WOS:000080553000021	10366211				2021-06-18	
J	Oehmichen, M; Meissner, C; Schmidt, V; Pedal, I; Konig, HG				Oehmichen, M; Meissner, C; Schmidt, V; Pedal, I; Konig, HG			Pontine axonal injury after brain trauma and nontraumatic hypoxic-ischemic brain damage	INTERNATIONAL JOURNAL OF LEGAL MEDICINE			English	Article						axonal injury; midbrain; biomechanics; specificity; diffuse axonal injury	AMYLOID PRECURSOR PROTEIN; NONMISSILE HEAD-INJURY; RAT-BRAIN; BETA-APP; HUMANS; MARKER	Experimental studies have shown that diffuse axonal injury is usually induced by positive or negative acceleration mechanisms. In order to determine the reliability of axonal injury (AI) as a marker of this type of traumatic insult, we compared cases of trauma-induced focal cortical hemorrhage without dural involvement (n = 67) with cases of trauma-induced subdural bleeding without cortical hemorrhage (n = 26). Both groups exhibited a wide range of post-traumatic survival times. The injuries in the first group were caused mainly by direct impact to the head, those in the second by acceleration/deceleration mechanisms. The investigations were based primarily on immunohistochemical demonstration of antibodies targeted to beta-amyloid precursor protein (beta-APP) in the pens as a marker of AI and the results were assessed semiquantitatively. No significant differences were found between the two groups. In both groups AI was detected in 80-100% of cases with survival times of more than 3 h and two thirds of all positive cases showed pronounced positivity. Additional comparison of cases of brain death due to mechanical trauma (n = 14) with cases of brain death due to non-mechanical trauma (n = Is) also disclosed no significant intergroup differences. Finally, investigations of the pens in cases of non-traumatic death due to cerebral hypoxia/ischemia (n = 51) demonstrated AI with the same frequency as in the other groups, although the expression tended to be less pronounced. Our results confirm that beta-APP expression in the pens is a reliable indicator of AI but does not discriminate between injuries caused by traumatic strain or shearing mechanisms and secondary damage due to cerebral hypoxia/ischemia or edema. In the large majority of cases with prolonged post-traumatic survival, it can therefore be assumed that Al in the pens is the consequence of primary and/or secondary events or a combination of both, as is common in non-missile head injury survived for more than 90-120 min. Therefore, positive differentiation of the type of biomechanical event based on this criterion alone is not possible.	Univ Lubeck, Dept Legal Med, D-23562 Lubeck, Germany; Univ Halle Wittenberg, Inst Rechtsmed, D-06112 Halle, Germany; Heidelberg Univ, Inst Rechtsmed, D-69115 Heidelberg, Germany; Univ Tubingen, Inst Gerichtliche Med, D-72074 Tubingen, Germany	Oehmichen, M (corresponding author), Univ Lubeck, Dept Legal Med, Kahlhorststr 31-35, D-23562 Lubeck, Germany.						ADAMS JH, 1986, ARCH PATHOL LAB MED, V110, P485; ADAMS JH, 1982, ANN NEUROL, V12, P557, DOI 10.1002/ana.410120610; BLUMBERGS PC, 1995, J NEUROTRAUM, V12, P565, DOI 10.1089/neu.1995.12.565; BRATZKE H, 1997, CURRENT TOPICS FOREN, V3, P87; DIXON CE, 1991, J NEUROSCI METH, V39, P253; GENNARELLI TA, 1982, ANN NEUROL, V12, P564, DOI 10.1002/ana.410120611; GENNARELLI TA, 1987, P 33 STAPP CAR CRASH, P35; GENNARELLI TA, 1981, ACTA NEUROPATHOL B S, V7, P26; Gennarelli TA, 1996, NEUROPATHOL APPL S1, V22, P44; Gentleman S, 1997, RES LEG MED, V17, P161; GENTLEMAN SM, 1993, NEUROSCI LETT, V160, P139, DOI 10.1016/0304-3940(93)90398-5; Graham DI, 1996, NEUROPATH APPL NEURO, V22, P505, DOI 10.1111/j.1365-2990.1996.tb01125.x; GRAHAM DI, 1997, GREENFIELDS NEUROPAT, P197; JELLINGER K, 1970, J NEUROL SCI, V10, P51, DOI 10.1016/0022-510X(70)90091-2; Jenkins LW, 1988, J NEUROTRAUM, V5, P275, DOI 10.1089/neu.1988.5.275; JENKINS LW, 1989, BRAIN RES, V477, P211, DOI 10.1016/0006-8993(89)91409-1; JENKINS LW, 1989, CONT ISSUES NEUROLOG, V1, P47; Kita T, 1997, INT J LEGAL MED, V110, P305, DOI 10.1007/s004140050093; KRAULAND W, 1961, QUELLEN AKTUEN CHRON; LIGHTHALL J W, 1989, Journal of Neurotrauma, V6, P83, DOI 10.1089/neu.1989.6.83; LOBATO RD, 1983, J NEUROSURG, V59, P762, DOI 10.3171/jns.1983.59.5.0762; MAXWELL WL, 1993, ACTA NEUROPATHOL, V86, P136, DOI 10.1007/BF00334880; Maxwell WL, 1997, J NEUROTRAUM, V14, P419, DOI 10.1089/neu.1997.14.419; MAXWELL WL, 1996, NEUROPATHOL APPL S1, V22, P15; McKenzie KJ, 1996, ACTA NEUROPATHOL, V92, P608, DOI 10.1007/s004010050568; MEANEY DF, 1995, J NEUROTRAUM, V12, P689, DOI 10.1089/neu.1995.12.689; MILLER JD, 1978, NEURAL TRAUMA, P173; Oehmichen M, 1997, RES LEG MED, V17, P203; OEHMICHEN M, 1990, WUNDHEILUNG; OEHMICHEN M, 1998, IN PRESS FORENSIC SC; Olsson Y, 1996, NEUROPATH APPL NEURO, V22, P518, DOI 10.1111/j.1365-2990.1996.tb01129.x; POVLISHOCK JT, 1995, BRAIN PATHOL, V5, P415, DOI 10.1111/j.1750-3639.1995.tb00620.x; POVLISHOCK JT, 1995, J NEUROTRAUM, V12, P555, DOI 10.1089/neu.1995.12.555; Povlishock JT, 1997, RES LEG MED, V17, P175; SHERRIFF FE, 1994, ACTA NEUROPATHOL, V87, P55; SIKAL RR, 1969, BIOMETRY, P607; STRICH SJ, 1956, J NEUROL NEUROSUR PS, V19, P163, DOI 10.1136/jnnp.19.3.163; UNTERHARNSCHEID.F, 1993, PATHOLOGIE NERVENSYS, V6; Yam PS, 1998, J NEUROTRAUM, V15, P441, DOI 10.1089/neu.1998.15.441	39	22	26	0	0	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0937-9827	1437-1596		INT J LEGAL MED	Int. J. Legal Med.	JUN	1999	112	4					261	267		10.1007/s004140050246			7	Medicine, Legal	Legal Medicine	212XU	WOS:000081243600008	10433037				2021-06-18	
J	Gabellec, MM; Crumeyrolle-Arias, M; Le Saux, F; Auriou, N; Jacque, C; Haour, F				Gabellec, MM; Crumeyrolle-Arias, M; Le Saux, F; Auriou, N; Jacque, C; Haour, F			Expression of interleukin-1 genes and interleukin-1 receptors in the mouse brain after hippocampal injury	NEUROSCIENCE RESEARCH			English	Article						central nervous system; brain trauma; interleukin-1 transcripts; interleukin-1 receptor; autoradiography; RT-PCR	TUMOR-NECROSIS-FACTOR; TRANSIENT FOREBRAIN ISCHEMIA; POLYMERASE CHAIN-REACTION; FOCAL CEREBRAL-ISCHEMIA; CENTRAL-NERVOUS-SYSTEM; ALPHA MESSENGER-RNA; ADULT-RAT BRAIN; BACTERIAL LIPOPOLYSACCHARIDE; TNF-ALPHA; IMMUNOREACTIVE INTERLEUKIN-1-BETA	In order to evaluate the role of IL-1 production in post-traumatic brain, transcripts for IL-1 (alpha, beta, RA) have been quantified following RT-PCR, in hippocampus and cortex after injury of either hippocampus (Hip) or striatum (Stri). Moreover, I-125 IL-1 alpha binding sites have been directly quantified using binding experiments on brain sections and quantitative autoradiography. Under basal conditions, levels of PCR products were very low. On day 1, IL-1RA transcripts only were strongly increased in the hippocampus after Hip-lesions and in cortex after Stri lesion. Transcripts were back to control values on day 7 post-lesion. IL-1 receptor densities in the hippocampus (dentate gyrus) were decreased at day 1 around the site of the lesion (but not on the contralateral side) and were back to controls on day 7 indicating a transient and local IL-1 production in the surroundings of the lesion. No changes were found following Stri lesion. This study provides further evidence of the role of the IL-1 molecules family, notably IL-1RA, in the brain reaction to trauma. (C) 1999 Elsevier Science Ireland Ltd. All rights reserved.	Inst Pasteur, Unite Pharmacol Neuroimmunoendocrinienne, F-75724 Paris, France; Hop La Pitie Salpetriere, INSERM, U495, F-75651 Paris, France; Hop St Antoine, INSERM, U339, F-75571 Paris, France	Gabellec, MM (corresponding author), Inst Pasteur, Unite Pharmacol Neuroimmunoendocrinienne, 28 Rue Dr Roux, F-75724 Paris, France.	mmg@pasteur.fr					BAN E, 1991, NEUROSCIENCE, V43, P21, DOI 10.1016/0306-4522(91)90412-H; BANDTLOW CE, 1990, J CELL BIOL, V111, P1701, DOI 10.1083/jcb.111.4.1701; BRENNEMAN DE, 1992, J NEUROCHEM, V58, P454, DOI 10.1111/j.1471-4159.1992.tb09743.x; BUTTINI M, 1994, MOL BRAIN RES, V23, P126, DOI 10.1016/0169-328X(94)90218-6; Cavaillon JM, 1996, CYTOKINES, P93; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; CUNNINGHAM ET, 1992, J NEUROSCI, V12, P1101; Dinarello CA, 1996, BLOOD, V87, P2095, DOI 10.1182/blood.V87.6.2095.bloodjournal8762095; ERICSSON A, 1995, J COMP NEUROL, V361, P681, DOI 10.1002/cne.903610410; FAN L, 1995, MOL BRAIN RES, V30, P125; Fan L, 1996, MOL BRAIN RES, V36, P287, DOI 10.1016/0169-328X(95)00274-V; Franklin K. B. J., 1997, MOUSE BRAIN STEREOTA; Gabellec MM, 1996, NEUROIMMUNOMODULAT, V3, P304, DOI 10.1159/000097284; GABELLEC MM, 1995, MOL BRAIN RES, V31, P122, DOI 10.1016/0169-328X(95)00042-Q; Gabellec MM, 1996, J NEUROIMMUNOL, V66, P65, DOI 10.1016/0165-5728(96)00021-5; Gabellec MM, 1997, BRAIN RES PROTOC, V1, P145, DOI 10.1016/S1385-299X(96)00023-2; GATTI S, 1993, BRAIN RES, V624, P291, DOI 10.1016/0006-8993(93)90090-A; GREENFEDER SA, 1995, J BIOL CHEM, V270, P13757, DOI 10.1074/jbc.270.23.13757; GRIFFAIS R, 1991, NUCLEIC ACIDS RES, V19, P3887; HAOUR F, 1994, NY ACAD SCI, V747, P324; Holmin S, 1997, J NEUROSURG, V86, P493, DOI 10.3171/jns.1997.86.3.0493; Jafarian Tehrani M., 1994, Journal of Neuroimmunology, V53, P91, DOI 10.1016/0165-5728(94)90068-X; Jafarian-Tehrani M, 1998, J NEUROIMMUNOL, V84, P30, DOI 10.1016/S0165-5728(97)00239-7; LAYE S, 1994, MOL BRAIN RES, V27, P157, DOI 10.1016/0169-328X(94)90197-X; LEBLANC P, 1988, NEUROENDOCRINOLOGY, V48, P482, DOI 10.1159/000125053; LECHAN RM, 1990, BRAIN RES, V514, P135, DOI 10.1016/0006-8993(90)90445-H; Marquette C, 1996, J NEUROIMMUNOL, V68, P45, DOI 10.1016/0165-5728(96)00056-2; MARTIN D, 1994, EXP NEUROL, V130, P362, DOI 10.1006/exnr.1994.1215; Merrill JE, 1996, TRENDS NEUROSCI, V19, P331, DOI 10.1016/0166-2236(96)10047-3; MINAMI M, 1991, BIOCHEM BIOPH RES CO, V176, P593, DOI 10.1016/S0006-291X(05)80225-6; MINAMI M, 1992, J NEUROCHEM, V58, P390, DOI 10.1111/j.1471-4159.1992.tb09324.x; Ohtsuki T, 1996, J CEREBR BLOOD F MET, V16, P1137, DOI 10.1097/00004647-199611000-00007; PARNET P, 1994, MOL BRAIN RES, V27, P63, DOI 10.1016/0169-328X(94)90185-6; REINISCH N, 1994, NEUROSCI LETT, V166, P165, DOI 10.1016/0304-3940(94)90476-6; Relton JK, 1996, EXP NEUROL, V138, P206, DOI 10.1006/exnr.1996.0059; ROTHWELL NJ, 1995, INT J DEV NEUROSCI, V13, P179, DOI 10.1016/0736-5748(95)00018-C; ROTHWELL NJ, 1995, TRENDS NEUROSCI, V18, P130, DOI 10.1016/0166-2236(95)93890-A; SCHNEEBERGER C, 1995, PCR METH APPL, V4, P234; SCHOBITZ B, 1994, PROG NEUROBIOL, V44, P397, DOI 10.1016/0301-0082(94)90034-5; SCHULTZBERG M, 1992, PERG S NEUR, V5, P1; SIMS JE, 1994, EUR CYTOKINE NETW, V5, P539; SIMS JE, 1993, P NATL ACAD SCI USA, V90, P6155, DOI 10.1073/pnas.90.13.6155; TAKAO T, 1993, ENDOCRINOLOGY, V132, P1497, DOI 10.1210/en.132.4.1497; Tchelingerian JL, 1996, J NEUROSCI RES, V43, P99, DOI 10.1002/jnr.490430113; TCHELINGERIAN JL, 1993, NEURON, V10, P213, DOI 10.1016/0896-6273(93)90312-F; TOULMOND S, 1995, BRAIN RES, V671, P261, DOI 10.1016/0006-8993(94)01343-G; VANDAM AM, 1992, BRAIN RES, V588, P291, DOI 10.1016/0006-8993(92)91588-6; Wang XK, 1997, STROKE, V28, P155, DOI 10.1161/01.STR.28.1.155; Wong ML, 1997, P NATL ACAD SCI USA, V94, P227, DOI 10.1073/pnas.94.1.227; WOODROOFE MN, 1991, J NEUROIMMUNOL, V33, P227, DOI 10.1016/0165-5728(91)90110-S; YABUUCHI K, 1994, MOL BRAIN RES, V27, P27, DOI 10.1016/0169-328X(94)90180-5; YABUUCHI K, 1994, MOL BRAIN RES, V26, P135, DOI 10.1016/0169-328X(94)90084-1; Yang GY, 1997, BRAIN RES, V751, P181, DOI 10.1016/S0006-8993(96)01277-2	53	22	24	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0168-0102	1872-8111		NEUROSCI RES	Neurosci. Res.	APR	1999	33	4					251	260		10.1016/S0168-0102(99)00014-0			10	Neurosciences	Neurosciences & Neurology	208ZL	WOS:000081022500001	10401977				2021-06-18	
S	Sala, F; Menna, G; Bricolo, A; Young, W		Trembly, B; Slikker, W		Sala, F; Menna, G; Bricolo, A; Young, W			Role of glycemia in acute spinal cord injury - Data from a rat experimental model and clinical experience	NEUROPROTECTIVE AGENTS: FOURTH INTERNATIONAL CONFERENCE	ANNALS OF THE NEW YORK ACADEMY OF SCIENCES		English	Article; Proceedings Paper	4th International Conference on Neuroprotective Agents - Clinical and Experimental Aspects	NOV 15-19, 1998	ANNAPOLIS, MARYLAND	US FDA, Natl Ctr Toxicol Res, Dept Vet Affairs Med Ctr			CEREBRAL BLOOD-FLOW; INSULIN ADMINISTRATION PROTECTS; ISCHEMIC BRAIN-DAMAGE; HEAD-INJURY; INTRACELLULAR PH; LACTIC-ACIDOSIS; CIRCULATING CATECHOLAMINES; ADMISSION HYPERGLYCEMIA; GLUCOSE CONCENTRATION; HEMORRHAGIC NECROSIS	While experimental and clinical evidence indicates that in brain injury blood glucose increases with injury severity and hyperglycemia worsens neurological outcome, the role of blood glucose in secondary mechanisms of neuronal damage after acute spinal cord injury has not yet been investigated. Data from spinal cord ischemia models suggests a deleterious effect of hyperglycemia,likely due to enhanced lactic acidosis, which is primarily dependent on the amount of glucose available to be metabolized. The purpose of this study is to summarize preliminary experimental and clinical observations on the role of blood glucose in acute spinal cord injury. Between 1995 and 1996 we used the New York University (NYU) rat spinal cord injury model to test the following hypotheses: 1) Blood glucose levels increase with injury severity. 2) Fasting protects from hyperglycemia and prevents secondary damage to the spinal cord. 3) Postinjury-induced hyperglycemia (dextrose 5% 2 gm/Kg) enhances spinal lesion volume. From a clinical perspective, we reviewed blood glucose records of 47 patients admitted to the Department of Neurosrgery in Verona, between 1991 and 1995, within 24 hours of acute spinal cord injury in order to determine: a) the incidence of hyperglycemia (>140 mg/dl); b) the correlation between blood glucose and injury severity; and c) the role of methylprednisolone in affecting blood glucose. Results indicate that in a graded spinal cord injury model: 1) Early after injury, more severe contusions support significantly higher blood glucose levels. 2) Fasting overnight does not directly affect spinal cord lesion volume but influences blood gases, and we observed that a slightly systemic acidosis plays a minor neuroprotective role. Fasting also ensures more consistent normoglycemic baseline blood glucose values. 3) Postinjury-induced moderate hyperglycemia (160-190 mg/dl) does not significantly affect spinal cord injury. In the clinical study, we observed that during the first 24 hours after spinal cord injury: a) Glycemia ranges between 90 and 243 mg/dl (mean value 143 mg/ dl), and close to 50% of the patients present blood glucose values higher than normal. b) Methylprednisolone administration is not associated to significantly higher blood glucose levels. c) There Is a trend for larger glucose rises with more Severe injury.	Univ Verona, Neurosurg Sect, Dept Neurol & Visual Sci, I-37100 Verona, Italy; Rutgers State Univ, Spinal Cord Injury Project, Ctr Neurosci, Brunswick, NJ USA	Sala, F (corresponding author), Osped Civile Maggiore, Neurosurg Sect, Dept Neurol & Visual Sci, Piazzale Stefani 1, I-37100 Verona, Italy.			SALA, Francesco/0000-0003-1263-9859			BECKMAN DL, 1979, P SOC EXP BIOL MED, V160, P200; Bracken MB, 1998, J NEUROSURG, V89, P699, DOI 10.3171/jns.1998.89.5.0699; BRACKEN MB, 1992, J NEUROSURG, V76, P23, DOI 10.3171/jns.1992.76.1.0023; BROWNING RG, 1990, ANN EMERG MED, V19, P683, DOI 10.1016/S0196-0644(05)82479-5; Chen YH, 1998, J NEUROSCI, V18, P2982; Cherian L, 1997, CRIT CARE MED, V25, P1378, DOI 10.1097/00003246-199708000-00027; Cherian L, 1998, J NEUROTRAUM, V15, P307, DOI 10.1089/neu.1998.15.307; CHERIAN L, 1994, CRIT CARE MED, V22, P1841; CLIFTON GL, 1981, NEUROSURGERY, V8, P10, DOI 10.1227/00006123-198101000-00003; COMBS DJ, 1990, STROKE, V21, P936, DOI 10.1161/01.STR.21.6.936; CONSTANTINI S, 1994, J NEUROSURG, V80, P97, DOI 10.3171/jns.1994.80.1.0097; DESALLES AAF, 1987, NEUROSURGERY, V21, P45, DOI 10.1227/00006123-198707000-00009; DIETRICH WD, 1993, STROKE, V24, P111, DOI 10.1161/01.STR.24.1.111; DRUMMOND JC, 1989, ANESTHESIOLOGY, V70, P64, DOI 10.1097/00000542-198901000-00014; DUCKROW RB, 1987, STROKE, V18, P52, DOI 10.1161/01.STR.18.1.52; Farooque M, 1996, J NEUROCHEM, V66, P1125; Farooque M, 1997, J NEUROTRAUM, V14, P469, DOI 10.1089/neu.1997.14.469; FELDMAN Z, 1995, J NEUROSURG, V83, P1060, DOI 10.3171/jns.1995.83.6.1060; Folbergrova J, 1997, EXP BRAIN RES, V114, P44, DOI 10.1007/PL00005622; FRAYN KN, 1985, CIRC SHOCK, V16, P229; GINSBERG MD, 1980, STROKE, V11, P347, DOI 10.1161/01.STR.11.4.347; GOLDMAN SA, 1989, J CEREBR BLOOD F MET, V9, P471, DOI 10.1038/jcbfm.1989.70; GOTTFRIED JA, 1994, J PHYSIOL-LONDON, V478, P373, DOI 10.1113/jphysiol.1994.sp020258; GRUNER JA, 1992, J NEUROTRAUM, V9, P123, DOI 10.1089/neu.1992.9.123; HEMMILA MR, 1993, J VASC SURG, V17, P661, DOI 10.1016/0741-5214(93)90108-X; HUANG PP, 1994, J NEUROTRAUM, V11, P547, DOI 10.1089/neu.1994.11.547; Imaizumi T, 1997, J NEUROTRAUM, V14, P299, DOI 10.1089/neu.1997.14.299; Kawai N, 1997, ACT NEUR S, V70, P34; KING LR, 1971, ANN SURG, V173, P337, DOI 10.1097/00000658-197103000-00003; KRAIG RP, 1990, J CEREBR BLOOD F MET, V10, P104, DOI 10.1038/jcbfm.1990.13; Kristian T, 1998, STROKE, V29, P705, DOI 10.1161/01.STR.29.3.705; Kristian T, 1996, LIFE SCI, V59, P357, DOI 10.1016/0024-3205(96)00314-1; LAM AM, 1991, J NEUROSURG, V75, P545, DOI 10.3171/jns.1991.75.4.0545; LEMAY DR, 1988, STROKE, V19, P1411, DOI 10.1161/01.STR.19.11.1411; LEMAY DR, 1988, J SURG RES, V44, P352, DOI 10.1016/0022-4804(88)90177-1; LEMAY DR, 1987, J VASC SURG, V6, P383, DOI 10.1067/mva.1987.avs0060383; LEMAY DR, 1989, J NEUROSURG, V71, P594, DOI 10.3171/jns.1989.71.4.0594; LEMAY DR, 1990, J NEUROSURG, V73, P118, DOI 10.3171/jns.1990.73.1.0118; Li PA, 1997, ACTA PHYSIOL SCAND, V161, P567, DOI 10.1046/j.1365-201X.1997.00264.x; LUNDY EF, 1987, SURGERY, V102, P737; MARGULIES DR, 1994, AM SURGEON, V60, P387; MARIE C, 1991, CEREBROVAS BRAIN MET, V3, P29; MARSH WR, 1986, J NEUROSURG, V65, P693, DOI 10.3171/jns.1986.65.5.0693; MICHAUD LJ, 1991, J TRAUMA, V31, P1356, DOI 10.1097/00005373-199110000-00007; MUELHEIM.GH, 1969, P SOC EXP BIOL MED, V130, P574; Mukhin AG, 1998, J NEUROSCI RES, V51, P748, DOI 10.1002/(SICI)1097-4547(19980315)51:6<748::AID-JNR8>3.0.CO;2-B; MYERS RE, 1976, J NEUROPATH EXP NEUR, V35, P301, DOI 10.1097/00005072-197605000-00011; MYERS RE, 1976, NEUROLOGY, V26, P345; NAFTCHI NE, 1974, J NEUROSURG, V40, P52, DOI 10.3171/jns.1974.40.1.0052; NAGAI Y, 1993, NMR BIOMED, V6, P1, DOI 10.1002/nbm.1940060102; OSTERHOLM JL, 1972, J NEUROSURG, V36, P386, DOI 10.3171/jns.1972.36.4.0386; OSTERHOLM JL, 1972, J NEUROSURG, V36, P395, DOI 10.3171/jns.1972.36.4.0395; OSTERHOLM JL, 1974, J NEUROSURG, V40, P5, DOI 10.3171/jns.1974.40.1.0003; PULSINELLI WA, 1983, AM J MED, V74, P540, DOI 10.1016/0002-9343(83)91007-0; PULSINELLI WA, 1982, NEUROLOGY, V32, P1239, DOI 10.1212/WNL.32.11.1239; RAWE SE, 1979, J NEUROSURG, V50, P58, DOI 10.3171/jns.1979.50.1.0058; REHNCRONA S, 1989, J CEREBR BLOOD F MET, V9, P65, DOI 10.1038/jcbfm.1989.9; REHNCRONA S, 1980, ACTA PHYSIOL SCAND, V110, P435, DOI 10.1111/j.1748-1716.1980.tb06692.x; RIZZA R, 1979, AM J PHYSIOL, V237, P356; RIZZA RA, 1980, J CLIN INVEST, V65, P682, DOI 10.1172/JCI109714; Robertson CS, 1990, J NEUROTRAUM, V7, P1, DOI 10.1089/neu.1990.7.1; ROBERTSON CS, 1991, J NEUROSURG, V74, P43, DOI 10.3171/jns.1991.74.1.0043; ROBERTSON CS, 1987, J NEUROSURG, V67, P739, DOI 10.3171/jns.1987.67.5.0739; ROSNER MJ, 1984, J NEUROSURG, V61, P76, DOI 10.3171/jns.1984.61.1.0076; SappeyMarinier D, 1995, NMR BIOMED, V8, P171, DOI 10.1002/nbm.1940080406; Saybasili H, 1998, BRAIN RES, V786, P128, DOI 10.1016/S0006-8993(97)01461-3; SCHOULTZ TW, 1974, LIFE SCI, V15, P1485, DOI 10.1016/0024-3205(74)90123-4; SCHOULTZ TW, 1976, BRAIN RES, V109, P367, DOI 10.1016/0006-8993(76)90536-9; SHAPIRA Y, 1995, J NEUROSURG ANESTH, V7, P17, DOI 10.1097/00008506-199501000-00004; SIEMKOWICZ E, 1985, ACTA NEUROL SCAND, V71, P417; SIESJO BK, 1993, PROG BRAIN RES, V96, P23; Siesjo BK, 1996, EUR J ANAESTH, V13, P247, DOI 10.1046/j.1365-2346.1996.00976.x; STAUB F, 1993, J NEUROL SCI, V119, P79, DOI 10.1016/0022-510X(93)90194-4; TIBBS PA, 1979, J NEUROSURG, V50, P629, DOI 10.3171/jns.1979.50.5.0629; TIBBS PA, 1978, J NEUROSURG, V49, P558, DOI 10.3171/jns.1978.49.4.0558; TOMLINSON FH, 1993, EPILEPSY RES, V14, P123, DOI 10.1016/0920-1211(93)90017-2; Tymianski M, 1996, NEUROSURGERY, V38, P1176; Vink R, 1997, J CEREBR BLOOD F MET, V17, P50, DOI 10.1097/00004647-199701000-00007; VINK R, 1989, ANN NEUROL, V25, P26, DOI 10.1002/ana.410250105; Wachtler J, 1996, BRAIN RES, V725, P30; Wass CT, 1996, MAYO CLIN PROC, V71, P801; WELSH FA, 1980, STROKE, V11, P355, DOI 10.1161/01.STR.11.4.355; WIDMER H, 1992, J CEREBR BLOOD F MET, V12, P456, DOI 10.1038/jcbfm.1992.63; Yang SY, 1995, SURG NEUROL, V44, P373, DOI 10.1016/0090-3019(96)80243-6; YOUNG B, 1989, ANN SURG, V210, P466, DOI 10.1097/00000658-198910000-00007	85	22	22	0	4	NEW YORK ACAD SCIENCES	NEW YORK	2 EAST 63RD ST, NEW YORK, NY 10021 USA	0077-8923		1-57331-222-3	ANN NY ACAD SCI	Ann.NY Acad.Sci.		1999	890						133	154		10.1111/j.1749-6632.1999.tb07989.x			22	Biochemistry & Molecular Biology; Multidisciplinary Sciences; Clinical Neurology; Pharmacology & Pharmacy	Biochemistry & Molecular Biology; Science & Technology - Other Topics; Neurosciences & Neurology; Pharmacology & Pharmacy	BP50F	WOS:000085330700013	10668421				2021-06-18	
J	Sarafis, KA; Karatzas, GD; Yotis, CL				Sarafis, KA; Karatzas, GD; Yotis, CL			Ankylosed hips caused by heterotopic ossification after traumatic brain injury: A difficult problem	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article						ankylosed hips; heterotopic ossification; traumatic brain injury	BONE-FORMATION	Background: Heterotopic ossifications develop around major joints after severe traumatic brain injury and decrease the range of motion of the joints. Methods: From 1982 to 1994, we operated on 22 ankylosed hips caused by heterotopic ossifications after traumatic brain injury. Our 15 patients had been hospitalized in the intensive care unit for a period of 8 to 57 days. Their preoperative neurologic status was evaluated precisely. Special interest was given also to the accurate estimation of the extent and location of the ectopic bone by using x-rays and computed tomography, as web as to the maturity of the bone by using Tc-99 bone scan and measurements of serum alkaline phosphatase levels. Intraoperatively, we resected as much ectopic bone as was needed to achieve functional range of motion in the hip. Postoperatively, all the patients were administered 100 mg of indomethacin (suppository.) per day for a month, antibiotics, and anticoagulants. They were also exposed to 1,000 cGy of radiation in two equal doses. Results: We achieved a least functional range of motion in 15 of 22 hips. Of the seven hips with poor results, six cases were attributable to the uncontrolled neurologic syndrome and only one poor result was attributable to severe heterotopic ossification recurrence. Wound complications did occur. Conclusion: Ankylosed hips caused by heterotopic ossifications after traumatic brain injury are a difficult problem to manage. Accurate evaluation of the preoperative neurologic status is essential for the desired final outcome and the treatment options.	Asclepie Hosp, Orthopaed Dept 5, GR-16673 Athens, Greece	Sarafis, KA (corresponding author), Asclepie Hosp, Orthopaed Dept 5, 1 Vas Pavlou Str, GR-16673 Athens, Greece.						AN HS, 1987, CLIN ORTHOP RELAT R, V219, P291; AYERS DC, 1991, CLIN ORTHOP RELAT R, P87; BLANE CE, 1981, SKELETAL RADIOL, V7, P21, DOI 10.1007/BF00347167; DAMANSKI M, 1961, J BONE JOINT SURG BR, V43, P286; DEJERINE A, 1991, CLIN ORTHOP RELAT R, P3; DRANE WE, 1989, ASR, V142, P279; FURMAN R, 1970, J BONE JOINT SURG AM, VA 52, P1131, DOI 10.2106/00004623-197052060-00005; GARLAND DE, 1991, CLIN ORTHOP RELAT R, P59; GARLAND DE, 1985, J BONE JOINT SURG AM, V67A, P1261, DOI 10.2106/00004623-198567080-00019; GARLAND DE, 1980, J BONE JOINT SURG AM, V62, P1143, DOI 10.2106/00004623-198062070-00012; GARLAND DE, 1988, CLIN ORTHOP RELAT R, V233, P86; GARLAND DE, 1989, CLIN ORTHOP RELAT R, V242, P169; GARLAND DE, 1991, CLIN ORTHOP RELAT R, V263, P3; GRAZKO MA, 1995, NEUROLOGY, V45, P712, DOI 10.1212/WNL.45.4.712; HIERTON C, 1983, ACTA ORTHOP SCAND, V54, P58, DOI 10.3109/17453678308992870; HSU JD, 1975, CLIN ORTHOP RELAT R, P165; KJAERSGAARDANDERSEN P, 1986, ACTA ORTHOP SCAND, V57, P12, DOI 10.3109/17453678608993206; MAJOR P, 1980, RADIOLOGY, V136, P797, DOI 10.1148/radiology.136.3.6773108; MENDELSON L, 1975, SCAND J REHABIL MED, V7, P141; MIELANTS H, 1975, ACTA ORTHOP SCAND, V46, P190, DOI 10.3109/17453677508989207; ORZEL JA, 1985, J NUCL MED, V26, P125; ROBERTS P H, 1968, Journal of Bone and Joint Surgery British Volume, V50B, P70; SAZBON L, 1981, J BONE JOINT SURG BR, V63, P120; SPIELMAN G, 1983, ARCH PHYS MED REHAB, V64, P539; STOVER SL, 1991, CLIN ORTHOP RELAT R, P71; TIBONE J, 1978, J BONE JOINT SURG AM, V60, P769, DOI 10.2106/00004623-197860060-00007; WHARTON GW, 1975, CLIN ORTHOP RELAT R, P142; YOUNG RR, 1987, CLIN ORTHOP RELAT R, V219, P50	28	22	23	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0022-5282	1529-8809		J TRAUMA	J. Trauma-Injury Infect. Crit. Care	JAN	1999	46	1					104	109		10.1097/00005373-199901000-00017			6	Critical Care Medicine; Surgery	General & Internal Medicine; Surgery	160DE	WOS:000078214400025	9932691				2021-06-18	
J	Taly, AB; Nair, KPS; Kumar, MV; Jayakumar, PN; Vasudev, MK; Ravishankar, D; Kalaivant, PL; Padankatty, BS; Murali, T				Taly, AB; Nair, KPS; Kumar, MV; Jayakumar, PN; Vasudev, MK; Ravishankar, D; Kalaivant, PL; Padankatty, BS; Murali, T			Heterotopic ossification in non-traumatic myelopathies	SPINAL CORD			English	Article						non-traumatic myelopathies; heterotopic; ossification; spinal cord injury; paraplegia	SPINAL-CORD INJURY; DISODIUM ETIDRONATE; ASSOCIATION; PREVENTION; DIAGNOSIS; THERAPY; BONE	Heterotopic ossification (HO) is an important complication of spinal cord and brain injuries but is rarely reported among patients with non-traumatic myelopathies. In a prospective study on medical problems seven (6.04%) among the 114 subjects with non-traumatic myelopathies had heterotopic ossification had heterotopic ossification. All of them had involvement of hip joints. The co-morbid conditions were: urinary tract infection, seven; spasticity, three; pressure sores, five; and deep venous thrombosis, one. The initial diagnosis was often other than heterotopic ossification. Erythrocyte sedimentation rate and serum alkaline phosphatase levels were elevated in all subjects. Following rest and non-steroidal anti-inflammatory drugs, the range of motion improved in two patients. Heterotopic ossification can occur in patients with non-traumatic myelopathies and has risk factors and clinical features similar to patients with traumatic spinal cord injury. A high index of suspicion about this complication is necessary for early diagnosis and prompt intervention.	Natl Inst Mental Hlth & Neurosci, Dept Neurol Psychiat & Neurol Rehabil, Bangalore 560029, Karnataka, India; Natl Inst Mental Hlth & Neurosci, Dept Neuroradiol, Bangalore 560029, Karnataka, India	Taly, AB (corresponding author), Natl Inst Mental Hlth & Neurosci, Dept Neurol Psychiat & Neurol Rehabil, Bangalore 560029, Karnataka, India.		Nair, Krishnan/AAE-3474-2020	Nair, Krishnan/0000-0002-4004-2315			BANOVAC K, 1993, PARAPLEGIA, V31, P660, DOI 10.1038/sc.1993.106; BIERINGSORENSEN F, 1993, PARAPLEGIA, V31, P513, DOI 10.1038/sc.1993.83; BODLEY R, 1993, PARAPLEGIA, V31, P500, DOI 10.1038/sc.1993.81; BRAVOPAYNO P, 1992, PARAPLEGIA, V30, P740, DOI 10.1038/sc.1992.142; BUSCHBACHER R, 1992, AM J PHYS MED REHAB, V71, P86, DOI 10.1097/00002060-199204000-00005; BUSCHBACHER R, 1992, CRIT REV PHYS MED RE, V4, P199; CASSARPULLICINO VN, 1993, PARAPLEGIA, V31, P40, DOI 10.1038/sc.1993.7; COLACHIS SC, 1993, PARAPLEGIA, V31, P507, DOI 10.1038/sc.1993.82; COLACHIS SC, 1993, PARAPLEGIA, V31, P51, DOI 10.1038/sc.1993.8; DITUNNO JF, 1994, PARAPLEGIA, V32, P70, DOI 10.1038/sc.1994.13; GARLAND DE, 1991, CLIN ORTHOP RELAT R, P13; SCHAEFFER MA, 1995, ARCH PHYS MED REHAB, V76, P284, DOI 10.1016/S0003-9993(95)80617-2; SNOECX M, 1995, PARAPLEGIA, V33, P464, DOI 10.1038/sc.1995.101; TALY AB, 1996, 24 ANN NAT C IND ASS	14	22	22	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1362-4393	1476-5624		SPINAL CORD	Spinal Cord	JAN	1999	37	1					47	49		10.1038/sj.sc.3100751			3	Clinical Neurology; Rehabilitation	Neurosciences & Neurology; Rehabilitation	161QZ	WOS:000078301600009	10025695	Bronze			2021-06-18	
J	Perlesz, A; O'Loughlan, M				Perlesz, A; O'Loughlan, M			Changes in stress and burden in families seeking therapy following traumatic brain injury: a follow-up study	INTERNATIONAL JOURNAL OF REHABILITATION RESEARCH			English	Article						counselling; families; psychosocial outcome; traumatic brain injury	CLOSED HEAD-INJURY; GENERAL HEALTH QUESTIONNAIRE; SOCIAL-ADJUSTMENT; SELF-REPORT; RELATIVES; REHABILITATION; IMPAIRMENT; PATIENT; SAMPLE; POPULATION	The current project is a preliminary investigation of changes in levels of distress, and burden and family and marital adjustment in families following traumatic brain injury (TBI), replicating measures used in the earlier Glasgow, TBI outcome research on relatives' stress and burden. Fifteen families (32 individuals) seeking family counselling in a publicly funded family therapy centre were monitored over a two year period: prior to commencing counselling; 12 months following the commencement of counselling; and 24 months following the commencement of counselling. The most significant and sustained changes in psychosocial outcome were a decrease in distress for both individuals with TBI and their carers as well as a reduction in relatives' burden and strain. Family conflict also reduced, just as family cohesion increased and adjustment within the family unit improved from pre-therapy to the time of follow-up 24 months later. However, reported levels of anger, despite significantly reducing during the first 12 months of the study, actually increased back to their original levels at the 24 month follow-up. Marital adjustment also worsened in the latter half of the study, with couples reporting a similar level of marital adjustment to that which they had experienced prior to counselling. These findings are discussed and recommendations made for more rigorous, controlled, longitudinal studies of the effectiveness of family therapy. It was also recommended that marital couples receive longer-term counselling to address their specific needs, and that the issue of anger be further investigated with a view to either reducing family members' anger, or bearing witness to the legitimacy of their anger in the longer-term, and assisting with anger-management programmes.	Latrobe Univ, Bouverie Ctr, Melbourne, Vic, Australia; Alfred Child & Adolescent Mental Hlth Serv, Melbourne, Vic, Australia	Perlesz, A (corresponding author), Latrobe Univ, Bouverie Ctr, 50 Flemington St,Flemington 3031, Melbourne, Vic, Australia.						*ACQ BRAIN DAM DAT, 1991, REP HEAD INJ IMP PRO, V2; ADAMS N, 1996, AUSTR NZ J FAMILY TH, V17, P75; ANDERSONPARENTE JK, 1990, COGNITIVE REHABI JAN, P22; Antonak R. F., 1993, J HEAD TRAUMA REHAB, V8, P87, DOI DOI 10.1097/00001199-199312000-00009; BANJA JD, 1992, J HEAD TRAUMA REHAB, V7, P112; Bech P, 1993, ACTA PSYCHIAT S S372, V87, P1, DOI 10.1111/j.1600-0447.1993.tb03321.x; Bishop DS, 1988, J HEAD TRAUMA REHAB, V3, P16; BROOKS DN, 1991, J CLIN EXP NEUROPSYC, V13, P155, DOI 10.1080/01688639108407214; BROOKS N, 1986, J NEUROL NEUROSUR PS, V49, P764, DOI 10.1136/jnnp.49.7.764; Brooks N., 1987, J HEAD TRAUMA REHABI, V2, P1, DOI [10.1097/00001199-198709000-00003, DOI 10.1097/00001199-198709000-00003]; COOPER P, 1982, BRIT J PSYCHIAT, V141, P68, DOI 10.1192/bjp.141.1.68; Daniel A. E., 1983, POWER PRIVILEGE PRES; Douglas JM, 1996, BRAIN INJURY, V10, P819, DOI 10.1080/026990596123936; GANS JS, 1983, ARCH PHYS MED REHAB, V64, P176; Gervasio AH, 1997, J HEAD TRAUMA REHAB, V12, P14, DOI 10.1097/00001199-199706000-00003; Goldberg D., 1978, MANUAL GEN HLTH QUES; GORDON WA, 1992, NEUROPSYCHOLOGY, V6, P361; GRIFFITH JL, 1985, FAM SYSTEMS MED, V3, P151; Groveman A.M., 1985, FAMILY SYST MED, V3, P440, DOI [10.1037/h0089672, DOI 10.1037/H0089672]; Henry P. W., 1985, FAMILY SYSTEMS MED, V3, P427; HERBERT JT, 1989, J REHABIL, V55, P45; JACOBS HE, 1988, ARCH PHYS MED REHAB, V69, P425; JENNETT B, 1990, REHABILITATION ADULT, P3; KAPLAN S, 1991, CLIN NEUROPSYCHOL, V5, P360, DOI DOI 10.1080/13854049108404103; KAY T, 1991, HEAD INJURY FAMILY M, P121; KINSELLA G, 1988, PSYCHOL MED, V18, P57, DOI 10.1017/S0033291700001884; Kinsella G, 1989, Int Disabil Stud, V11, P9; Kozloff R, 1987, J HEAD TRAUMA REHAB, V2, P14, DOI DOI 10.1097/00001199-198709000-00004; KRAUS JF, 1984, AM J EPIDEMIOL, V119, P186, DOI 10.1093/oxfordjournals.aje.a113737; KREUTZER JS, 1992, ARCH PHYS MED REHAB, V73, P771; KREUTZER JS, 1994, BRAIN INJURY, V8, P197, DOI 10.3109/02699059409150973; LAMONT M, 1993, THESIS LA TROBE U ME; Leathem J, 1996, BRAIN INJURY, V10, P27; LEZAK MD, 1988, J CLIN EXP NEUROPSYC, V10, P111, DOI 10.1080/01688638808405098; LEZAK MD, 1978, J CLIN PSYCHIAT, V39, P592; LEZAK MD, 1988, J LEARN DISABIL, V21, P456, DOI 10.1177/002221948802100802; LINN RT, 1994, BRAIN INJURY, V8, P135, DOI 10.3109/02699059409150965; LIRA FT, 1983, INT J CLIN NEUROPSYC, V5, P159; Liss M, 1990, Int J Rehabil Res, V13, P309, DOI 10.1097/00004356-199012000-00004; LIVINGSTON MG, 1985, J NEUROL NEUROSUR PS, V48, P870, DOI 10.1136/jnnp.48.9.870; LIVINGSTON MG, 1985, J NEUROL NEUROSUR PS, V48, P876, DOI 10.1136/jnnp.48.9.876; Maitz E.A., 1990, THESIS TEMPLE U PHIL; Maitz E.A., 1991, HEAD INJURY FAMILY M, P65; MALT UF, 1989, ACTA PSYCHIAT SCAND, V80, P103, DOI 10.1111/j.1600-0447.1989.tb05260.x; Mauss-Clum N, 1981, J Neurosurg Nurs, V13, P165; MCKINLAY WW, 1981, J NEUROL NEUROSUR PS, V44, P527, DOI 10.1136/jnnp.44.6.527; McKinlay WW, 1988, J HEAD TRAUMA REHAB, p[3, 64]; McLaughlin Anne Marie, 1993, Brain Injury, V7, P45, DOI 10.3109/02699059309008155; McMordie W R, 1988, Brain Inj, V2, P357, DOI 10.3109/02699058809150908; McNair D.M., 1981, MANUAL PROFILE MOOD; MOORE A, 1993, BRAIN INJURY, V7, P247, DOI 10.3109/02699059309029677; Moore A D, 1989, Brain Inj, V3, P171, DOI 10.3109/02699058909004549; Moore A. D., 1991, J HEAD TRAUMA REHAB, V6, P83; MOORE AD, 1991, NEUROPSYCHOL REHABIL, V1, P185, DOI DOI 10.1080/09602019108520164; Moos R. H., 1981, FAMILY ENV SCALE MAN; ODDY M, 1985, J NEUROL NEUROSUR PS, V48, P564, DOI 10.1136/jnnp.48.6.564; ODDY M, 1978, J NEUROL NEUROSUR PS, V41, P611, DOI 10.1136/jnnp.41.7.611; PARRY A, 1985, THESIS LA TROBE U ME; Paterson T., 1996, THERAPEUTIC RELATION, P15; PERLESZ A, 1992, AUSTR NZ J FAMILY TH, V13, P145, DOI DOI 10.1002/J.1467-8438.1992.TB00910.X; PETERS L C, 1990, Brain Injury, V4, P39, DOI 10.3109/02699059009026147; Ponsford J., 1995, TRAUMATIC BRAIN INJU; ROSENBAUM M, 1976, J CONSULT CLIN PSYCH, V44, P881, DOI 10.1037/0022-006X.44.6.881; Rosenthal M, 1996, J HEAD TRAUMA REHAB, V11, P88, DOI 10.1097/00001199-199608000-00011; Rosenthal M, 1988, J HEAD TRAUMA REHAB, V3, P42; SACHS PR, 1991, TREATING FAMILIES BR; Selvini Palazzoli M., 1980, DIMENSIONS FAMILY TH, P161; Shaw L R, 1990, Brain Inj, V4, P87, DOI 10.3109/02699059009026152; Smith L.M., 1995, FAMILY SUPPORT PROGR; *SPSS INC, 1986, SPSS PC PLUS; STAMBROOK M, 1993, ARCH CLIN NEUROPSYCH, V8, P95; Szmukler GI, 1996, SOC PSYCH PSYCH EPID, V31, P149, DOI 10.1007/BF00785761; Tabachnick BG, 2013, USING MULTIVARIATE S; TATE RL, 1989, J NEUROL NEUROSUR PS, V52, P1128, DOI 10.1136/jnnp.52.10.1128; TENNANT C, 1977, MED J AUSTRALIA, V2, P392, DOI 10.5694/j.1326-5377.1977.tb114568.x; THOMSEN IV, 1984, J NEUROL NEUROSUR PS, V47, P260, DOI 10.1136/jnnp.47.3.260; WEISSMAN MM, 1978, J NERV MENT DIS, V166, P317, DOI 10.1097/00005053-197805000-00002; WEISSMAN MM, 1976, ARCH GEN PSYCHIAT, V33, P1111; Wood RL, 1997, BRAIN INJURY, V11, P491, DOI 10.1080/713802183; WRATE R, 1987, DISABILITY FAMILY; ZARSKI JJ, 1987, AM J FAM THER, V15, P62; ZEIGLER EA, 1989, COGNITIVE REHABI MAY, P34; ZIMOSTRAD SW, 1989, COGNITIVE REHABI MAY, P26	83	22	23	0	6	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0342-5282			INT J REHABIL RES	Int. J. Rehabil. Res.	DEC	1998	21	4					339	354		10.1097/00004356-199812000-00001			16	Rehabilitation	Rehabilitation	156QN	WOS:000078013700001	9926349				2021-06-18	
J	Atkinson, JLD; Anderson, RE; Murray, MJ				Atkinson, JLD; Anderson, RE; Murray, MJ			The early critical phase of severe head injury: Importance of apnea and dysfunctional respiration	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article						fluid percussion head injury; apnea; respiratory dysfunction; severe head injury	TRAUMATIC BRAIN INJURY; MODEL; RAT	Background: Apnea is a known response of concussive head injury. Hypoxic or ischemic brain injury has been documented in a high percentage of severe head injury deaths, The respiratory response after head injury remains poorly defined, however, and its contribution to hypoxic or ischemic mechanisms after severe head injury is unknown. Methods: Eighteen anesthetized but spontaneously breathing rats were subjected to fluid percussion head injury of varying severities. Respiratory rate and volume of air were recorded before and after injury with a Hans Rudolph/Varadyne pneumotach differential pressure transducer and graphically measured, Postmortem inspection of the brains was performed. Results: Apnea and subsequent respiratory dysfunction are directly proportional to the magnitude of energy delivered to the brain. Higher energy results in a dysfunctional or absent respiratory response, probably attributable to failure or disorganized function of the medullary respiratory center. Conclusion: This study for the first time graphically depicts the respiratory response after head injury. Higher energy delivered to the brain directly correlates,vith a markedly abnormal respiratory response that probably contributes significantly to subsequent hypoxic or ischemic brain injury. The absence of the space-occupying hematoma or gross parenchymal disruption suggests that in the clinical setting many of these patients may otherwise have survivable head injury if rescued by early ventilatory assistance.	Mayo Clin & Mayo Fdn, Dept Neurol Surg, Rochester, MN 55905 USA; Mayo Clin & Mayo Fdn, Dept Anesthesiol, Rochester, MN 55905 USA	Atkinson, JLD (corresponding author), Mayo Clin & Mayo Fdn, Dept Neurol Surg, 200 1st St SW, Rochester, MN 55905 USA.						Adelson PD, 1996, J NEUROSURG, V85, P877, DOI 10.3171/jns.1996.85.5.0877; ANDERSEN BJ, 1988, J NEUROSURG, V68, P601, DOI 10.3171/jns.1988.68.4.0601; BOUMA GJ, 1992, J NEUROSURG, V77, P360, DOI 10.3171/jns.1992.77.3.0360; BROWN TH, 1989, GASTROINTEST ENDOSC, V35, P37, DOI 10.1016/S0016-5107(89)72683-3; CAREY ME, 1989, J NEUROSURG, V71, P754, DOI 10.3171/jns.1989.71.5.0754; CLIFTON GL, 1983, J NEUROSURG, V59, P447, DOI 10.3171/jns.1983.59.3.0447; CLIFTON GL, 1981, NEUROSURGERY, V8, P309, DOI 10.1227/00006123-198103000-00002; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; EISENBERG HM, 1990, J NEUROSURG, V73, P688, DOI 10.3171/jns.1990.73.5.0688; GENARELLI TA, 1983, ACTA NEUROCHIR SUPP, V32, P1; GRAHAM DI, 1978, J NEUROL SCI, V39, P213, DOI 10.1016/0022-510X(78)90124-7; Ito J, 1996, J NEUROSURG, V84, P97, DOI 10.3171/jns.1996.84.1.0097; Kraus JF, 1996, NEUROL CLIN, V14, P435, DOI 10.1016/S0733-8619(05)70266-8; LARSON GM, 1984, AM J SURG, V147, P97, DOI 10.1016/0002-9610(84)90041-2; LEVINE JE, 1979, NEW ENGL J MED, V301, P109; MACIVER IN, 1958, LANCET, V1, P390; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; National Academy of Sciences (US) and National Research Council (US) Committee on Trauma National Academy of Sciences (US) and National Research Council (US) Committee on Shock, 1966, ACC DEATH DIS NEGL D; OFFERHAU.J, 1969, CARDIOVASC RES, V3, P433; RINDER L, 1969, ACTA PHYSIOL SCAND, V76, P352, DOI 10.1111/j.1748-1716.1969.tb04478.x; ROSNER MJ, 1984, J NEUROSURG, V61, P76, DOI 10.3171/jns.1984.61.1.0076; SHIOZAKI T, 1993, J NEUROSURG, V78, P501, DOI 10.3171/jns.1993.78.3.0501; SIMARD JM, 1989, AM J CARDIOL, V63, pC32, DOI 10.1016/0002-9149(89)90403-7; SIMMONS RL, 1969, ANN SURG, V170, P39, DOI 10.1097/00000658-196907000-00005; Walker AE, 1944, J NEUROSURG, V1, P103, DOI 10.3171/jns.1944.1.2.0103; ZINK BJ, 1995, J NEUROSURG, V82, P822, DOI 10.3171/jns.1995.82.5.0822	26	22	23	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0022-5282	1529-8809		J TRAUMA	J. Trauma-Injury Infect. Crit. Care	NOV	1998	45	5					941	945		10.1097/00005373-199811000-00016			5	Critical Care Medicine; Surgery	General & Internal Medicine; Surgery	137UZ	WOS:000076936000018	9820706				2021-06-18	
J	Golding, EM; Contant, CF; Robertson, CS; Bryan, RM				Golding, EM; Contant, CF; Robertson, CS; Bryan, RM			Temporal effect of severe controlled cortical impact injury in the rat on the myogenic response of the middle cerebral artery	JOURNAL OF NEUROTRAUMA			English	Article						autoregulation; middle cerebral artery; myogenic response; myogenic tone; traumatic brain injury	TRAUMATIC BRAIN INJURY; SEVERE HEAD-INJURY; BLOOD-FLOW; AUTO-REGULATION; AUTOREGULATION; MODEL	The present study examined the effect of severe traumatic brain injury (TBI) on the myogenic response in the rat middle cerebral artery (MCA). Rats were subjected to severe controlled cortical impact (CCI; 5 m/sec, 130-msec duration, 3-mm deformation) injury over the right parietal cortex. At 2, 24, and 120 h postinjury, ipsilateral and contralateral segments of MCAs were isolated, mounted in a vessel chamber, and pressurized. After equilibration, the myogenic tone, the difference in vessel diameter in the presence and absence of calcium for a given pressure, and the myogenic response (the active contractile response elicited by a vessel to increasing pressure), were measured. At 24 h postsurgery, there was a significant interaction between myogenic tone and pressure in the ipsilateral and contralateral MCAs when TBI was compared to shams. However, this was not apparent, at the 2- and 120-h time points. At 2- and 24-h postsurgery, there was a significant interaction between myogenic response and pressure in the ipsilateral MCAs when TBI was compared to shams. While the response of the vascular smooth muscle was altered following injury, it was still functioning, suggesting that these vessels compensate, perhaps through alternate mechanisms or by relying on those remaining intact mechanisms.	Baylor Coll Med, Dept Neurosurg, Houston, TX 77030 USA; Baylor Coll Med, Dept Anesthesiol, Houston, TX 77030 USA	Golding, EM (corresponding author), Baylor Coll Med, Dept Neurosurg, 6560 Fannin St,Ste 944, Houston, TX 77030 USA.				NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P01-NS27616] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P01NS027616] Funding Source: NIH RePORTER		Bayliss WM, 1902, J PHYSIOL-LONDON, V28, P220; Bryan RM, 1996, ANESTHESIOLOGY, V85, P82, DOI 10.1097/00000542-199607000-00012; BRYAN RM, 1995, AM J PHYSIOL-HEART C, V269, pH1171; CHERIAN L, 1994, J NEUROTRAUM, V11, P573, DOI 10.1089/neu.1994.11.573; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Czosnyka M, 1996, STROKE, V27, P1829, DOI 10.1161/01.STR.27.10.1829; DAVIS MJ, 1993, AM J PHYSIOL, V264, pH2168; DIXON CE, 1994, J NEUROTRAUM, V11, P275, DOI 10.1089/neu.1994.11.275; DIXON CE, 1991, J NEUROSCI METH, V39, P253; ENEVOLDSEN EM, 1978, J NEUROSURG, V48, P689, DOI 10.3171/jns.1978.48.5.0689; Forbes ML, 1997, J CEREBR BLOOD F MET, V17, P865, DOI 10.1097/00004647-199708000-00005; Golding EM, 1998, BRAIN RES, V785, P293, DOI 10.1016/S0006-8993(97)01419-4; Junger EC, 1997, J NEUROSURG, V86, P425, DOI 10.3171/jns.1997.86.3.0425; Kochanek OM, 1995, J NEUROTRAUM, V12, P1015, DOI 10.1089/neu.1995.12.1015; KUSCHINSKY W, 1972, CIRC RES, V31, P240, DOI 10.1161/01.RES.31.2.240; LEWELT W, 1980, J NEUROSURG, V53, P500, DOI 10.3171/jns.1980.53.4.0500; McCarron JG, 1997, J PHYSIOL-LONDON, V498, P371, DOI 10.1113/jphysiol.1997.sp021864; MEININGER GA, 1992, AM J PHYSIOL, V263, pH647; MUIZELAAR JP, 1984, J NEUROSURG, V61, P700, DOI 10.3171/jns.1984.61.4.0700; MUIZELAAR JP, 1989, TXB HEAD INJURY, P221; NAWASHIRO H, 1995, J NEUROTRAUM, V12, P189, DOI 10.1089/neu.1995.12.189; Newell DW, 1996, NEUROSURGERY, V39, P35, DOI 10.1097/00006123-199607000-00008; NEWLON PG, 1994, J NEUROTRAUM, V11, P121; PALMER AM, 1993, J NEUROCHEM, V61, P2015, DOI 10.1111/j.1471-4159.1993.tb07437.x; PAULSON OB, 1990, CEREBROVAS BRAIN MET, V2, P161; PRASAD MR, 1994, J NEUROCHEM, V63, P1086; PROCTOR HJ, 1988, J TRAUMA, V28, P347, DOI 10.1097/00005373-198803000-00010; SPARKS HV, 1964, CIRC RES, V15, P254; VANBAVEL E, 1991, J PHYSIOL-LONDON, V436, P371, DOI 10.1113/jphysiol.1991.sp018555; WEI EP, 1980, CIRC RES, V46, P37, DOI 10.1161/01.RES.46.1.37	30	22	22	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	NOV	1998	15	11					973	984		10.1089/neu.1998.15.973			12	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	139RN	WOS:000077043400006	9840770				2021-06-18	
J	Partrick, DA; Bensard, DD; Moore, EE; Partington, MD; Karrer, FM				Partrick, DA; Bensard, DD; Moore, EE; Partington, MD; Karrer, FM			Driveway crush injuries in young children: A highly lethal, devastating, and potentially preventable event	JOURNAL OF PEDIATRIC SURGERY			English	Article; Proceedings Paper	31st Annual Meeting of the Pacific-Association-of-Pediatric-Surgeons	JUN 09-13, 1998	MAUI, HAWAII	Pacific Assoc Pediat Surgeons		trauma; driveway; pedestrian; automobile	PEDESTRIAN INJURIES; PEDIATRIC TRAUMA; UNITED-STATES; HEAD	Background/Purpose: The aim of this study was to investigate driveway-related injuries in children, identify associated risk factors, and evaluate outcome compared with other mechanisms of blunt trauma. Methods:A 6-year review (1991 to 1996) of pediatric (age less than 18 years) pedestrian injuries treated at two urban trauma centers was conducted: one regional pediatric trauma center and one level I trauma center with pediatric commitment. Five hundred twenty-seven children injured in pedestrian accidents were identified from the trauma registry; 51 children (10%) sustained traumatic injuries as a result of being struck in their driveway. Data are reported as mean +/- SEM. Results: Children less than 5 years of age (n = 41) had an injury severity score (ISS) of 12.3 +/- 2.3, 15 (37%) sustained closed head injury, 13 (37%) had torso trauma, 19 (46%) skeletal trauma, and eight (20%) died. Children greater than or equal to 5 years old (n = 10) had an ISS of 10.7 +/- 2.4, three (30%) sustained closed head injury, four (40%) torso trauma, six (60%) skeletal trauma, and none died. In contrast, all other pediatric pedes trian accidents analyzed over the same time period had a mortality rate of only 2% (11 of 476). Conclusions: Pediatric driveway trauma carries a significant risk of head injury and a 10-fold increase in mortality in children under 5 years of age when compared with all other pediatric pedestrian accidents. More emphasis must be placed on injury prevention and public education to prevent this devastating mechanism of injury in these young, vulnerable children. Copyright (C) 1998 by W.B. Saunders Company.	Univ Colorado, Childrens Hosp, Hlth Sci Ctr, Dept Surg, Denver, CO 80218 USA; Denver Hlth Med Ctr, Dept Surg, Denver, CO USA	Bensard, DD (corresponding author), Univ Colorado, Childrens Hosp, Hlth Sci Ctr, Dept Surg, 1950 Ogden St,B-323, Denver, CO 80218 USA.						AGRAN P, 1991, PEDIATRICS, V87, P70; AGRAN PF, 1994, PEDIATRICS, V93, P284; ASHTON SJ, 1982, PEDESTRIAN ACCIDENTS, P169; Baker SP, 1997, J TRAUMA, V42, P369, DOI 10.1097/00005373-199703000-00002; BRISON RJ, 1988, AM J PUBLIC HEALTH, V78, P793, DOI 10.2105/AJPH.78.7.793; CAREY VF, 1993, BRIT MED J, V307, P1086, DOI 10.1136/bmj.307.6912.1086; DUHAIME AC, 1995, NEUROSURGERY, V37, P401, DOI 10.1227/00006123-199509000-00005; FINGERHUT LA, 1988, PUBLIC HEALTH REP, V103, P399; GUYER B, 1990, AM J DIS CHILD, V144, P649, DOI 10.1001/archpedi.1990.02150300047016; HOLMES MJ, 1984, J TRAUMA, V24, P253, DOI 10.1097/00005373-198403000-00012; LESCOHIER I, 1993, PEDIATRICS, V91, P721; PECLET MH, 1990, J PEDIATR SURG, V25, P85, DOI 10.1016/S0022-3468(05)80169-1; RIVARA FP, 1990, AM J DIS CHILD, V144, P692, DOI 10.1001/archpedi.1990.02150300090023; ROBERTS I, 1995, PEDIATRICS, V95, P405; RODRIGUEZ JG, 1990, AM J DIS CHILD, V144, P627	15	22	22	0	1	W B SAUNDERS CO	PHILADELPHIA	INDEPENDENCE SQUARE WEST CURTIS CENTER, STE 300, PHILADELPHIA, PA 19106-3399 USA	0022-3468			J PEDIATR SURG	J. Pediatr. Surg.	NOV	1998	33	11					1712	1715		10.1016/S0022-3468(98)90616-9			4	Pediatrics; Surgery	Pediatrics; Surgery	141FF	WOS:000077131500031	9856902				2021-06-18	
J	Johnson, K; Davis, PK				Johnson, K; Davis, PK			A supported relationships intervention to increase the social integration of persons with traumatic brain injuries	BEHAVIOR MODIFICATION			English	Article							SEVERE HEAD-INJURY; FOLLOW-UP; STUDENTS; PRESCHOOLERS; RECOVERY	A supported relationships intervention was used to increase the integrated social contacts (ISCs) of 3 persons with traumatic brain injury (TBI) who were each matched with 4 community participants. The intervention consisted of asking participants to meet with their matched counterpart to engage in leisure activities once per week for 4 weeks. Additionally, community participants were provided with a brief training session on TBI, were given specific suggestions on interacting with the persons with TBI with whom they were matched, and received weekly phone calls from the researcher. Frequency of ISCs were analyzed with a multiple baseline design across participants. All 3 participants with TBI increased the frequency of ISCs after implementation of the supported relationships intervention and continued to experience mole than baseline levels of ISCs during 8 weeks of follow-up. These data suggest that social integration can be enhanced with a procedure requiring limited staff intervention.	So Illinois Univ, Inst Rehabil, Carbondale, IL 62901 USA	Johnson, K (corresponding author), So Illinois Univ, Inst Rehabil, Carbondale, IL 62901 USA.						BRAUNLINGMCMORR.D, 1992, INNOVATIONS HEAD INJ; BRAUNLINGMCMORROW D, 1986, J REHABIL, V52, P39; BURKE WH, 1990, HEADLINES        SPR, P2; FOREST M, 1992, NATURAL SUPPORTS SCH, P65; HARING TG, 1992, J APPL BEHAV ANAL, V25, P319, DOI 10.1901/jaba.1992.25-319; HARING TG, 1986, J APPL BEHAV ANAL, V19, P159, DOI 10.1901/jaba.1986.19-159; HARING TG, 1991, CRITICAL ISSUES LIVE, P195; JONES CL, 1988, HEAD INJURY GUIDE PA; Kozloff R, 1987, J HEAD TRAUMA REHAB, V2, P14, DOI DOI 10.1097/00001199-198709000-00004; LUFTIG RL, 1988, AM J MENT RETARD, V92, P472; McDonnell J., 1991, SECONDARY PROGRAMS S; MITHAUG DE, 1985, EXCEPT CHILDREN, V51, P397; MORTON MV, 1995, BRAIN INJURY, V9, P81, DOI 10.3109/02699059509004574; MORTON MV, 1992, DISS ABSTR INT, V53, P2543; MOUNT B, 1988, ITS NEVER TOO EARLY; Nisbet J., 1992, NATURAL SUPPORTS SCH, P1; OBRIEN J, 1987, COMPREHENSIVE GUIDE, P175; ODDY M, 1980, J NEUROL NEUROSUR PS, V43, P798, DOI 10.1136/jnnp.43.9.798; ODOM SL, 1986, J APPL BEHAV ANAL, V19, P59, DOI 10.1901/jaba.1986.19-59; ODOM SL, 1985, J APPL BEHAV ANAL, V18, P3, DOI 10.1901/jaba.1985.18-3; Prigatano G. P., 1987, COMMUNITY REENTRY HE, P1; SMULL MW, 1991, CRITICAL ISSUES LIVE, P527; Strully J., 1992, NATURAL SUPPORTS SCH, P165; THOMSEN IV, 1984, J NEUROL NEUROSUR PS, V47, P260, DOI 10.1136/jnnp.47.3.260; VANDERCOOK T, 1989, J ASSOC PERS SEVERE, V14, P205; WAGNER MT, 1990, INT J CLIN NEUROPSYC, V12, P131; WEDDELL R, 1980, PSYCHOL MED, V10, P257, DOI 10.1017/S0033291700044019; ZETLIN AG, 1988, AM J MENT RETARD, V92, P447	28	22	22	0	4	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0145-4455			BEHAV MODIF	Behav. Modificat.	OCT	1998	22	4					502	528		10.1177/01454455980224004			27	Psychology, Clinical	Psychology	127AY	WOS:000076329400004	9755649				2021-06-18	
J	Kumar, M; Kitchen, ND				Kumar, M; Kitchen, ND			Infective and traumatic aneurysms	NEUROSURGERY CLINICS OF NORTH AMERICA			English	Article							INTERNAL CAROTID-ARTERY; INTRACRANIAL ANEURYSMS; CEREBRAL-ARTERIES; ENDOCARDITIS; MANAGEMENT; RESOLUTION; WOUNDS; BRAIN	Infectious and traumatic aneurysms are unusual neurological conditions which will rarely present themselves to an individual neurosurgeon. Both, however, require a high index of suspicion, prompt management, and well-defined protocols in order to achieve good outcomes. The prognosis of infectious intracranial aneurysms has improved with the advent of powerful antimicrobacterial chemotherapeutic agents. Prompt and aggressive drug treatment with serial neuroimaging monitoring has enabled the neurosurgeon to identify safely and accurately those patients who will require surgical intervention. Traumatic aneurysms should be considered in any penetrating head injury, especially stab wounds and low velocity missile injuries. Angiography in these instances is warranted and, as most of these aneurysms are false aneurysms, surgical excision or trapping procedures are usually required.	Univ London, Natl Hosp Neurol & Neurosurg, Dept Neurosurg, Inst Neurol, London WC1N 3BG, England	Kitchen, ND (corresponding author), Univ London, Natl Hosp Neurol & Neurosurg, Dept Neurosurg, Inst Neurol, Queen Sq, London WC1N 3BG, England.						AARABI B, 1988, NEUROSURGERY, V22, P1056, DOI 10.1227/00006123-198806010-00014; ASARI S, 1977, J NEUROSURG, V46, P795, DOI 10.3171/jns.1977.46.6.0795; BALDWINHZ, 1995, NEUROVASCULAR SURG, P777; BARROW DL, 1990, NEUROSURGERY, V27, P562, DOI 10.1227/00006123-199010000-00010; BOHMFALK GL, 1978, J NEUROSURG, V48, P369, DOI 10.3171/jns.1978.48.3.0369; BUCKINGHAM MJ, 1988, NEUROSURGERY, V22, P398, DOI 10.1227/00006123-198802000-00022; CANTU RC, 1966, J NEUROSURG, V25, P189, DOI 10.3171/jns.1966.25.2.0189; Church WS, 1869, T PATHOLOGICAL SOC L, V20, P109; Clare C E, 1992, Neurosurg Clin N Am, V3, P551; CROWELL RM, 1995, SURG MANAGEMENT NEUR, P378; DUTREVOU MD, 1992, NEUROSURGERY, V31, P905, DOI 10.1227/00006123-199211000-00012; EISENBERG HM, 1990, J NEUROSURG, V73, P688, DOI 10.3171/jns.1990.73.5.0688; Fearnsides EG, 1916, BRAIN, V39, P224, DOI 10.1093/brain/39.3-4.224; FERRY DJ, 1972, J NEUROSURG, V36, P503, DOI 10.3171/jns.1972.36.4.0503; FLEISCHER AS, 1987, J TRAUMA, V27, P330, DOI 10.1097/00005373-198703000-00021; FRAZEE JG, 1980, J NEUROSURG, V53, P633, DOI 10.3171/jns.1980.53.5.0633; FRIZZELL RT, 1993, NEUROSURGERY, V32, P852, DOI 10.1227/00006123-199305000-00023; HADDAD FS, 1991, NEUROSURGERY, V28, P1; ISHIKAWA M, 1974, SURG NEUROL, V2, P257; Karsner HT., 1947, ACUTE INFLAMMATION A, P16; KEICK CF, 1984, NEUROSURGERY, V60, P42; Kojima Y, 1989, Neurol Med Chir (Tokyo), V29, P202, DOI 10.2176/nmc.29.202; KRAULAND W, 1949, Schweiz Z Pathol Bakteriol, V12, P113; LEAVY LL, 1993, NEUROSURGERY, V32, P532; MAURER JJ, 1961, J NEUROSURG, V18, P837, DOI 10.3171/jns.1961.18.6.0837; MIELKE B, 1981, NEUROSURGERY, V9, P578, DOI 10.1227/00006123-198111000-00017; MOLINARI GF, 1973, NEUROLOGY, V23, P325, DOI 10.1212/WNL.23.4.325; MORAWETZ RB, 1984, NEUROSURGERY, V15, P43, DOI 10.1227/00006123-198407000-00009; NAKATA Y, 1968, ANGIOLOGY, V19, P593, DOI 10.1177/000331976801901003; Ojemann RG, 1995, SURG MANAGEMENT NEUR, P368; ONISHI H, 1989, SURG NEUROL, V31, P149, DOI 10.1016/0090-3019(89)90330-3; OSLER W, 1885, LANCET, V1, P505; Osler W., 1885, LANCET, V1, P415; OSLER W, 1885, LANCET, V1, P459; POZZATI E, 1982, J NEUROSURG, V56, P857, DOI 10.3171/jns.1982.56.6.0857; ROUT D, 1984, J NEUROSURG, V60, P1236, DOI 10.3171/jns.1984.60.6.1236; RUMBAUGH CL, 1970, RADIOLOGY, V96, P49, DOI 10.1148/96.1.49; SALDAGO AV, 1987, STROKE, V18, P1057; SMITH S, 1829, AM J MED SCI, V4, P237; STEINBERG GK, 1992, NEUROSURGERY, V30, P408, DOI 10.1227/00006123-199203000-00016; TUNKEL AR, 1993, NEUROL CLIN, V11, P419; YAMAURA A, 1978, SURG NEUROL, V10, P327; YONAS H, 1980, NEUROSURGERY, V7, P499, DOI 10.1227/00006123-198011000-00016	43	22	22	0	0	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	1042-3680	1558-1349		NEUROSURG CLIN N AM	Neurosurg. Clin. N. Am.	JUL	1998	9	3					577	+					11	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	100WB	WOS:000074837400014	9668189				2021-06-18	
J	Andersson, S; Finset, A				Andersson, S; Finset, A			Heart rate and skin conductance reactivity to brief psychological stress in brain-injured patients	JOURNAL OF PSYCHOSOMATIC RESEARCH			English	Article						brain injury; laterality; stressor reactivity	MENTAL STRESS; PHYSIOLOGICAL-RESPONSE; IMMUNE-RESPONSES; ASYMMETRY; NEUROENDOCRINE; DEPRESSION; ENDOCRINE; MORTALITY; PATTERNS; STROKE	Autonomic reactivity in response to two mentally challenging tasks was studied in 74 patients with traumatic brain injury (TBI; n=33), cerebrovascular insults (CVA; n=27), and hypoxic brain damage (n=14). Heart rate, skin conductance level, and number of spontaneous skin conductance responses were recorded during baseline and two problem-solving stress conditions consisting of Raven progressive matrices and mental arithmetic. CVA and TBI patients with focal right hemisphere injury showed significantly reduced stress reactivity compared to patients with focal left hemisphere injury. This right-left hemisphere difference was maintained when controlled for diagnosis, gender, sex, age, and stressor task performance and involvement. The results indicate that lateralization of lesion rather than diagnosis or etiology is the critical factor in autonomic stress hyporeactivity in brain-injured patients. The results are discussed in relation to brain lateralization of autonomic reactivity and possible clinical consequences of autonomic hyporeactivity for rehabilitation of patients with acquired brain injury. (C) 1998 Elsevier Science Inc.	Sunnaas Rehabil Hosp, N-1450 Nesoddtangen, Norway; Univ Oslo, Inst Behav Sci Med, Oslo, Norway	Andersson, S (corresponding author), Sunnaas Rehabil Hosp, N-1450 Nesoddtangen, Norway.						ARCHIBALD YM, 1967, J NERV MENT DIS, V145, P25, DOI 10.1097/00005053-196707000-00004; BLUMBERGS PC, 1989, J NEUROL NEUROSUR PS, V52, P838, DOI 10.1136/jnnp.52.7.838; BOUCSEIN W, 1992, ELECTRODERML ACTIVIT; BURKE HR, 1969, J PSYCHOL, V72, P247, DOI 10.1080/00223980.1969.10543505; CACIOPPO JT, 1994, PSYCHOPHYSIOLOGY, V31, P113, DOI 10.1111/j.1469-8986.1994.tb01032.x; COSTA LD, 1962, J NERV MENT DIS, V134, P162, DOI 10.1097/00005053-196202000-00007; Earle JBB, 1996, INT J PSYCHOPHYSIOL, V21, P1, DOI 10.1016/0167-8760(95)00039-9; Edelberg R., 1972, HDB PSYCHOPHYSIOLOGY, P367; FINSET A, 1988, CEREBRAL HEMISPHERE, P49; FREYSCHUSS U, 1988, AM J PHYSIOL, V255, pH1443; GERENDAI I, 1984, CEREBRAL DOMINANCE B, P167; HACHINSKI VC, 1992, ARCH NEUROL-CHICAGO, V49, P697, DOI 10.1001/archneur.1992.00530310039010; HEILMAN KM, 1978, NEUROLOGY, V28, P229, DOI 10.1212/WNL.28.3.229; HUGDAHL K, 1983, PAVLOVIAN J BIOL SCI, V18, P180; INOUYE T, 1993, ELECTROEN CLIN NEURO, V86, P224, DOI 10.1016/0013-4694(93)90102-2; KANG DH, 1991, BEHAV NEUROSCI, V105, P860, DOI 10.1037/0735-7044.105.6.860; KATZ DI, 1992, J HEAD TRAUMA REHAB, V7, P1; LEHRER PM, 1989, PSYCHOPHYSIOLOGY, V26, P668, DOI 10.1111/j.1469-8986.1989.tb03169.x; Levine M J, 1987, Brain Inj, V1, P171, DOI 10.3109/02699058709034455; LEZAC MD, 1995, NEUROPSYCHOLOGICAL A; MORRIS PLP, 1993, AM J PSYCHIAT, V150, P124; MORRIS PLP, 1993, AUST NZ J PSYCHIAT, V27, P443, DOI 10.3109/00048679309075801; MORROW L, 1981, NEUROPSYCHOLOGIA, V19, P65, DOI 10.1016/0028-3932(81)90045-2; OBRIST PA, 1976, PSYCHOPHYSIOLOGY, V13, P95, DOI 10.1111/j.1469-8986.1976.tb00081.x; PRUNETI CA, 1995, FUNCT NEUROL, V10, P195; RAVEN JC, 1976, MANUAL RAVENS PROGR; RENOUX G, 1986, INTEGRATIVE PSYCHIAT, V4, P32; ROINE RO, 1993, STROKE, V24, P1005, DOI 10.1161/01.STR.24.7.1005; ROUSSELLE JG, 1995, INT J PSYCHOPHYSIOL, V20, P49, DOI 10.1016/0167-8760(95)00026-O; Rupright J, 1996, ARCH PHYS MED REHAB, V77, P1205, DOI 10.1016/S0003-9993(96)90150-1; SCHNECK SA, 1971, CLIN NEUROLOGY, V2, P1; SGOUTASEMCH SA, 1994, PSYCHOPHYSIOLOGY, V31, P264, DOI 10.1111/j.1469-8986.1994.tb02215.x; Sloan RP, 1996, PSYCHOSOM MED, V58, P25, DOI 10.1097/00006842-199601000-00005; SOSNOWSKI T, 1991, PSYCHOPHYSIOLOGY, V28, P665, DOI 10.1111/j.1469-8986.1991.tb01011.x; SPYER KM, 1989, TRENDS NEUROSCI, V12, P506, DOI 10.1016/0166-2236(89)90111-2; STEPTOE A, 1987, PSYCHOPHYSIOLOGY, V24, P571; TOMAKA J, 1994, INT J PSYCHOPHYSIOL, V18, P23, DOI 10.1016/0167-8760(84)90012-6; UCHINO BN, 1995, J PERS SOC PSYCHOL, V69, P736, DOI 10.1037/0022-3514.69.4.736; VILLARDITA C, 1985, CORTEX, V21, P627, DOI 10.1016/S0010-9452(58)80010-6; WILSON JTL, 1992, J HEAD TRAUMA REHAB, V7, P29; WITTLING W, 1990, NEUROPSYCHOLOGIA, V28, P457, DOI 10.1016/0028-3932(90)90072-V; WITTLING W, 1993, NEUROPSYCHOLOGIA, V31, P591, DOI 10.1016/0028-3932(93)90054-4; Wittling Werner, 1995, P305; ZAMBRINI EY, 1990, NEUROLOGY, V40, P1408; ZOCCOLOTTI P, 1982, Journal of Clinical Neuropsychology, V4, P143, DOI 10.1080/01688638208401124; ZOCCOLOTTI P, 1993, NATO ADV SCI INST SE, V249, P311	46	22	23	0	11	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0022-3999			J PSYCHOSOM RES	J. Psychosomat. Res.	JUN	1998	44	6					645	656		10.1016/S0022-3999(97)00305-X			12	Psychiatry	Psychiatry	ZQ034	WOS:000073814800012	9678746				2021-06-18	
J	Pentland, L; Todd, JA; Anderson, V				Pentland, L; Todd, JA; Anderson, V			The impact of head injury severity on planning ability in adolescence: A functional analysis	NEUROPSYCHOLOGICAL REHABILITATION			English	Article							TRAUMATIC BRAIN INJURY; NEUROPSYCHOLOGICAL SEQUELAE; ATTENTIONAL DEFICITS; CHILDREN; CHILDHOOD; SKILLS; PERFORMANCE; STRATEGIES; ADULTS; MILD	This study aimed to investigate the impact of head injury (HT) on executive skills in adolescents. The sample included a mild to moderate HI group (n = 17), a severe HI group (n = 16), and a matched control group (n = 17). Subjects were administered an IQ test and a complex planning task, requiring adolescents to plan an unexpected party. Qualitative features of planning strategies and error patterns were recorded. Significant group differences were noted, with the severe group making more errors and using less efficient strategies on the planning task. No differences were detected between the mild to moderate group and controls, although performances were not indicative of mature planning. Thus, while a history of severe HI is associated with deficits in planning skills, this is not so for milder HI. Further, care needs to be taken not to over-interpret poor planning in this clinical population without considering the normal developmental course of these skills.	Univ Melbourne, Sch Behav Sci, Parkville, Vic 3052, Australia; Grace McKellar Ctr, Geelong, Vic, Australia		v.anderson@psych.unimelb.edu.au					ANDERSON V, 1994, ARCH DIS CHILD, V70, P476, DOI 10.1136/adc.70.6.476; Anderson V, 1997, J Int Neuropsychol Soc, V3, P147; Anderson V, 1995, CHILD NEUROPSYCHOL, V1, P187, DOI 10.1080/09297049508400224; ASARNOW RF, 1991, J PEDIATR PSYCHOL, V16, P543, DOI 10.1093/jpepsy/16.5.543; BURGESS PW, 1990, NEUROBEHAVIOURAL SEQUELAE OF TRAUMATIC BRAIN INJURY, P110; CHADWICK O, 1981, Journal of Clinical Neuropsychology, V3, P101, DOI 10.1080/01688638108403117; CHALMERS D, 1993, INT J BEHAV DEV, V16, P191, DOI 10.1177/016502549301600206; Condor A, 1995, DEV NEUROPSYCHOL, V11, P485, DOI 10.1080/87565649509540633; Daniel A. E., 1983, POWER PRIVILEGE PRES; Dennis M, 1996, DEV NEUROPSYCHOL, V12, P77, DOI 10.1080/87565649609540641; Dennis M., 1989, CLIN NEUROPSYCHOLOGY, P89; FAY GC, 1993, ARCH PHYS MED REHAB, V74, P895; FLETCHER JM, 1990, J CONSULT CLIN PSYCH, V58, P93, DOI 10.1037/0022-006X.58.1.93; GOLDSTEIN FC, 1991, BRAIN COGNITION, V17, P23, DOI 10.1016/0278-2626(91)90063-E; GOLDSTEIN FC, 1992, COGNITIVE DISORDERS, P61; GULBRANDSEN GB, 1984, J CLIN NEUROPSYCHOL, V6, P257, DOI 10.1080/01688638408401217; HARTLEY L, 1991, BRAIN INJURY, V6, P271; HAYES-ROTH B, 1979, Cognitive Science, V3, P275, DOI 10.1016/S0364-0213(79)80010-5; HUDSPETH WJ, 1990, J EDUC PSYCHOL, V82, P881, DOI 10.1037/0022-0663.82.4.881; JOHNSON DA, 1989, CHILDRENS HEAD INJUR; KINSELLA G, 1995, J PEDIATR PSYCHOL, V20, P753, DOI 10.1093/jpepsy/20.6.753; KIRK U, 1983, NEUROPSYCHOLOGY LANG, P3; KREITLER S, 1987, BLUEPRINTS THINKING, P205; Levin HS, 1996, DEV NEUROPSYCHOL, V12, P17, DOI 10.1080/87565649609540638; LEVIN HS, 1991, FRONTAL LOBE FUNCTION AND DYSFUNCTION, P318; LEVIN HS, 1991, DEV NEUROPSYCHOL, V7, P377, DOI 10.1080/87565649109540499; LEVINE B, 1996, J INT NEUROPSYCH SOC, V2, P69; MATEER CA, 1991, DEV NEUROPSYCHOL, V7, P69; MCDONALD S, 1993, BRAIN LANG, V44, P28, DOI 10.1006/brln.1993.1003; MURRAY R, 1992, BRAIN COGNITION, V18, P99, DOI 10.1016/0278-2626(92)90072-T; PERROTT SB, 1991, DEV NEUROPSYCHOL, V7, P69, DOI 10.1080/87565649109540477; PONSFORD J, 1992, J CLIN EXP NEUROPSYC, V14, P822, DOI 10.1080/01688639208402865; PRIGATANO GP, 1993, NEUROPSYCHOL REHABIL, V3, P411, DOI 10.1080/09602019308401449; RADZISZEWSKA B, 1991, DEV PSYCHOL, V27, P381, DOI 10.1037/0012-1649.27.3.381; ROURKE BP, 1987, CLIN NEUROPSYCHOL, V1, P209, DOI DOI 10.1080/13854048708520056; RUBENSTEIN CL, 1990, J DEV BEHAV PEDIATR, V11, P301; SHALLICE T, 1991, BRAIN, V114, P727, DOI 10.1093/brain/114.2.727; STUSS DT, 1987, FRONTAL LOBES REVIS; Tabachnick B.G., 1989, USING MULTIVARIATE S; TAYLOR HG, 1992, ADV CHILD NEUROPSYCH, V1, P50; TEASDALE G, 1974, LANCET, V2, P81; Todd JA, 1996, NEUROPSYCHOL REHABIL, V6, P81, DOI 10.1080/713755500; WANSART WL, 1990, J LEARN DISABIL, V23, P164, DOI 10.1177/002221949002300306; Wechsler D., 1974, MANUAL WECHSLER INTE; WECHSLER D, MANUAL WECHSLER INTE, P91; WELSH MC, 1991, DEV NEUROPSYCHOL, V7, P131, DOI 10.1080/87565649109540483; WILLIAMS D, 1992, BRAIN COGNITION, V20, P196, DOI 10.1016/0278-2626(92)90069-X; WINOGRON HW, 1984, J CLIN NEUROPSYCHOL, V6, P269, DOI 10.1080/01688638408401218	48	22	22	0	3	PSYCHOLOGY PRESS	HOVE	27 CHURCH RD, HOVE BN3 2FA, EAST SUSSEX, ENGLAND	0960-2011			NEUROPSYCHOL REHABIL	Neuropsychol. Rehabil.	MAY	1998	8	3					301	317		10.1080/713755572			17	Neurosciences; Psychology	Neurosciences & Neurology; Psychology	ZN339	WOS:000073636000008					2021-06-18	
J	McKeating, EG; Andrews, PJD; Mascia, L				McKeating, EG; Andrews, PJD; Mascia, L			The relationship of soluble adhesion molecule concentrations in systemic and jugular venous serum to injury severity and outcome after traumatic brain injury	ANESTHESIA AND ANALGESIA			English	Article							CEREBRAL-ARTERY OCCLUSION; CLOSED-HEAD INJURY; L-SELECTIN; TNF-ALPHA; RAT-BRAIN; ISCHEMIA; ICAM-1; INTERLEUKIN-6; EXPRESSION; ANTIBODIES	Adhesion molecules control the migration of leukocytes into tissue after injury. This may result in further cellular damage. We hypothesized that altered serum concentrations of soluble intercellular adhesion molecule (sICAM)-1 and soluble L-selectin (sL-selectin) after traumatic brain injury would correlate with injury severity and neurological outcome. We investigated serum concentrations of sICAM-1 and sl-selectin in 22 patients with traumatic brain injury admitted to the intensive care unit. The Glasgow Coma Scale (GCS) score and Injury Severity Score were recorded. Paired arterial and jugular venous blood samples were taken on admission and 24, 48, and 96 h after injury. Mean systemic and jugular venous concentrations of sICAM-1 were normal on admission but became significantly increased by 96 h (P = 0.018). sl-selectin concentrations of injured patients were markedly below those of controls at all time points (P < 0.001). There were no significant differences between jugular venous and arterial concentrations of either sICAM-1 or sl-selectin. Serum sICAM-1 was significantly related to neurological outcome (P < 0.001) and to the GCS score (P < 0.001). These changes in adhesion molecule expression after acute brain injury may be important in the pathophysiology of secondary injury. The highly significant relationship between serum sICAM-1 and neurological outcome suggests that the inflammatory response to injury may be detrimental. Drugs that antagonize the actions of the adhesion molecules may have a role in therapy after traumatic brain injury. Implications: This observational study shows that there is a strong association between soluble intercellular adhesion molecule-1 in serum and poor neurological outcome after traumatic brain injury. This suggests that inflammation after brain injury may worsen the prognosis and that therapies directed against this inflammation may prove useful.	Univ Edinburgh, Western Gen Hosp, Dept Anaesthet, Edinburgh EH4 2XU, Midlothian, Scotland; Univ Bari, Dept Intens Care, Bari, Italy	McKeating, EG (corresponding author), Univ Edinburgh, Western Gen Hosp, Dept Anaesthet, Edinburgh EH4 2XU, Midlothian, Scotland.		mascia, Luciana/L-3039-2018		Wellcome TrustWellcome TrustEuropean Commission Funding Source: Medline		ANDREWS PJD, 1991, BRIT J ANAESTH, V67, P553, DOI 10.1093/bja/67.5.553; CALDENHOVEN E, 1994, J BIOL CHEM, V269, P21146; CHEN H, 1994, ANN NEUROL, V35, P458, DOI 10.1002/ana.410350414; Chopp M, 1996, J CEREBR BLOOD F MET, V16, P578, DOI 10.1097/00004647-199607000-00007; CLARK RSB, 1994, J NEUROTRAUM, V11, P499, DOI 10.1089/neu.1994.11.499; DONNELLY SC, 1994, LANCET, V344, P215, DOI 10.1016/S0140-6736(94)92995-5; FASSBENDER K, 1995, STROKE, V26, P1361, DOI 10.1161/01.STR.26.8.1361; JANDER S, 1993, NEUROLOGY, V43, P1809, DOI 10.1212/WNL.43.9.1809; JENNETT B, 1975, LANCET, V1, P480; JONES PA, 1994, J NEUROSURG ANESTH, V6, P4; MATSUO Y, 1994, BRAIN RES, V656, P344, DOI 10.1016/0006-8993(94)91478-8; MCCLAIN C, 1991, J LAB CLIN MED, V118, P225; MCCLAIN CJ, 1987, J LAB CLIN MED, V110, P48; McKeating EG, 1997, BRIT J ANAESTH, V78, P520; SATOH JI, 1991, J NEUROPATH EXP NEUR, V50, P215, DOI 10.1097/00005072-199105000-00004; SCHLEIFFENBAUM B, 1992, J CELL BIOL, V119, P229, DOI 10.1083/jcb.119.1.229; SEBIRE G, 1993, RES VIROLOGY, V144, P47, DOI 10.1016/S0923-2516(06)80011-7; SESSLER CN, 1995, AM J RESP CRIT CARE, V151, P1420, DOI 10.1164/ajrccm.151.5.7735595; SHOHAMI E, 1994, J CEREBR BLOOD F MET, V14, P615, DOI 10.1038/jcbfm.1994.76; Shohami E, 1996, J CEREBR BLOOD F MET, V16, P378, DOI 10.1097/00004647-199605000-00004; SPERTINI O, 1991, J IMMUNOL, V147, P2565; SPERTINI O, 1992, J IMMUNOL METHODS, V156, P115, DOI 10.1016/0022-1759(92)90017-N; TOULMOND S, 1995, BRAIN RES, V671, P261, DOI 10.1016/0006-8993(94)01343-G; YOUKER K, 1992, J CLIN INVEST, V89, P602, DOI 10.1172/JCI115626; ZHANG ZG, 1995, BRAIN RES, V698, P79, DOI 10.1016/0006-8993(95)00830-J	25	22	22	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	227 EAST WASHINGTON SQ, PHILADELPHIA, PA 19106 USA	0003-2999			ANESTH ANALG	Anesth. Analg.	APR	1998	86	4					759	765		10.1097/00000539-199804000-00016			7	Anesthesiology	Anesthesiology	ZE795	WOS:000072831700016	9539598				2021-06-18	
J	Wrightson, P; Gronwall, D				Wrightson, P; Gronwall, D			Mild head injury in New Zealand: incidence of injury and persisting symptoms	NEW ZEALAND MEDICAL JOURNAL			English	Article							BRAIN INJURY	Aims. To define mild head injury and determine its incidence and that of persisting symptoms. Methods. Analysis of an eight week sample of all patients with head injury passing through the Emergency Departments of the four Auckland Hospitals, and of a five year sample of patients attending a clinic for management of symptoms persisting after head injury. Results. Mild head injury was defined by the acute management needed - care out of hospital or not more than 48 hours admission, corresponding reasonably with a definition using post-traumatic amnesia. Incidence in those seen at hospital was 437/10(5) whole population/year for ages 15 and over, and 252/10(5) for ages under 15. Age specific incidences were 1769/10(5)/year for 15 and over, and 2920/10(5) for ages under 15, the major causes being road accidents (RTA) and falls, respectively. For 100 cases seen at hospital approximately 60 were treated by general practitioners alone. Referrals in patients 15 years and over because of persisting symptoms occurred in 58 (95%, CI 3-7), 69% in the first four months and 6% after a year. Referrals were equally likely after RTA, sports injuries and assaults, more frequent after objects striking the head. Older people were marginally more likely to be referred and the probability was significantly greater in women injured in sport and in minor RTA not needing admission to hospital. Conclusions. Mild head injuries are economically important and deserve efficient management.	Auckland Hosp, Dept Neuroserv, Concuss Clin, Auckland, New Zealand	Wrightson, P (corresponding author), 18 Crocus Pl, Auckland 1005, New Zealand.						ALEXANDER MP, 1995, NEUROLOGY, V45, P253; *DEP HLTH NAT HLTH, 1984, HOSP SEL MORB DAT; DIKMEN S, 1986, J NEUROL NEUROSUR PS, V49, P1227, DOI 10.1136/jnnp.49.11.1227; Jennett B, 1996, J NEUROL NEUROSUR PS, V60, P362, DOI 10.1136/jnnp.60.4.362; KRAUS JF, 1984, AM J EPIDEMIOL, V119, P186, DOI 10.1093/oxfordjournals.aje.a113737; KRAUS JF, 1989, MILD HEAD INJURY; RIMEL RW, 1981, NEUROSURGERY, V9, P221, DOI 10.1227/00006123-198109000-00001; RUTHERFORD WH, 1979, INJURY, V10, P225, DOI 10.1016/0020-1383(79)90015-9; Sosin DM, 1996, BRAIN INJURY, V10, P47	9	22	22	0	0	NEW ZEALAND MED ASSN	WELLINGTON	PO BOX 156, WELLINGTON, NEW ZEALAND	0028-8446			NEW ZEAL MED J	N. Z. Med. J.	MAR 27	1998	111	1062					99	101					9	Medicine, General & Internal	General & Internal Medicine	ZE579	WOS:000072808200004	9577461				2021-06-18	
J	Carlesimo, GA; Sabbadini, M; Bombardi, P; Di Porto, E; Loasses, A; Caltagirone, C				Carlesimo, GA; Sabbadini, M; Bombardi, P; Di Porto, E; Loasses, A; Caltagirone, C			Retrograde memory deficits in severe closed-head injury patients	CORTEX			English	Article						memory; head trauma; semantic system	HERPES-SIMPLEX ENCEPHALITIS; AUTOBIOGRAPHICAL MEMORY; SEMANTIC MEMORY; REMOTE MEMORY; MAGNETIC-RESONANCE; NONLIVING THINGS; VERBAL MEMORY; TERM-MEMORY; AMNESIA; IMPAIRMENT	A battery of tests evaluating different aspects of retrograde memory (autobiographical, public events, semantic knowledge) was administered to a group of 20 patients who had suffered from a severe closed-head injury (CHI) and who had recovered from the posttraumatic amnesia period and to a group of sex-, age- and education-matched normal controls. Results document a high prevalence of retrograde memory deficits among CHI individuals. The deficit involves both autobiographical and public events memories and extends to early acquired basic and cultural knowledge. The severity of the deficit does not vary according to some kind of temporal gradient or according to a presumed hierarchical or modality organization of the semantic system. However, in the domain of basic knowledge it more severely affects information pertaining to living than nonliving categories of objects. With the exception of a more severe deficit in retrieving autobiographical events occurred in the last year before trauma in a subgroup of patients with focal lesions restricted to the right hemisphere as compared to left lesioned patients, no clear relationship emerges between severity of the retrograde memory deficit and locus of focal cerebral lesions as demonstrated by neuroradiological exams.	IRCCS S Lucia, I-00179 Rome, Italy; Anni Verdi, Rome, Italy; Univ Rome Tor Vergata, Neurol Clin, Rome, Italy	Carlesimo, GA (corresponding author), IRCCS S Lucia, V Ardeatina 306, I-00179 Rome, Italy.		Caltagirone, Carlo/B-4930-2013				ALBERT MS, 1979, ARCH NEUROL-CHICAGO, V36, P211, DOI 10.1001/archneur.1979.00500400065010; Barbarotto R, 1996, ACTA NEUROL SCAND, V93, P272; BASSO A, 1988, J NEUROL NEUROSUR PS, V51, P1201, DOI 10.1136/jnnp.51.9.1201; BATTIG WF, 1969, J EXPT PSYCHOL MON 2, V80; BEATTY WW, 1988, NEUROBIOL AGING, V9, P181, DOI 10.1016/S0197-4580(88)80048-4; BORTOLINI V, 1971, LESSICO FREQUENZE LI; Brooks N, 1987, Brain Inj, V1, P5, DOI 10.3109/02699058709034439; Capitani Erminio, 1993, Archivio di Psicologia Neurologia e Psichiatria, V54, P457; Carlesimo GA, 1997, CORTEX, V33, P131, DOI 10.1016/S0010-9452(97)80009-3; Carlesimo GA, 1996, EUR NEUROL, V36, P378, DOI 10.1159/000117297; CERMAK LS, 1983, NEUROPSYCHOLOGIA, V21, P213, DOI 10.1016/0028-3932(83)90039-8; COHEN NJ, 1981, NEUROPSYCHOLOGIA, V19, P337, DOI 10.1016/0028-3932(81)90064-6; COLLINS AM, 1969, J VERB LEARN VERB BE, V8, P240, DOI 10.1016/S0022-5371(69)80069-1; COLLINS AM, 1970, COGNITION LEARNING M; Costa M, 1989, ARCH PSICOLOGIA NEUR, V50, P735; DAMASIO AR, 1985, ARCH NEUROL-CHICAGO, V42, P252, DOI 10.1001/archneur.1985.04060030070012; Damasio H, 1996, NATURE, V380, P499, DOI 10.1038/380499a0; DERENZI E, 1987, CORTEX, V23, P575, DOI 10.1016/S0010-9452(87)80050-3; DERENZI E, 1995, CORTEX, V31, P531, DOI 10.1016/S0010-9452(13)80064-0; FARAH MJ, 1989, NEUROPSYCHOLOGIA, V27, P193, DOI 10.1016/0028-3932(89)90171-1; Fink GR, 1996, J NEUROSCI, V16, P4275; FLETCHER PC, 1995, BRAIN, V118, P401, DOI 10.1093/brain/118.2.401; FUNNELL E, 1992, COGNITIVE NEUROPSYCH, V9, P135, DOI 10.1080/02643299208252056; GOLDBERG E, 1981, SCIENCE, V213, P1392, DOI 10.1126/science.7268442; GOLDENBERG G, 1992, J NEUROL NEUROSUR PS, V55, P362, DOI 10.1136/jnnp.55.5.362; GROSSI D, 1988, CORTEX, V24, P457, DOI 10.1016/S0010-9452(88)80009-1; HILLIS AE, 1991, BRAIN, V114, P2081, DOI 10.1093/brain/114.5.2081; KAPUR N, 1993, CORTEX, V29, P217, DOI 10.1016/S0010-9452(13)80177-3; KAPUR N, 1992, BRAIN, V115, P73, DOI 10.1093/brain/115.1.73; Kerlinger FN, 1973, MULTIPLE REGRESSION; KOPELMAN MD, 1989, NEUROPSYCHOLOGIA, V27, P437, DOI 10.1016/0028-3932(89)90050-X; KOPELMAN MD, 1989, J CLIN EXP NEUROPSYC, V11, P724, DOI 10.1080/01688638908400928; Laiacona M., 1993, Archivio di Psicologia Neurologia e Psichiatria, V54, P209; LAIACONA M, 1993, CORTEX, V29, P727, DOI 10.1016/S0010-9452(13)80293-6; Levin H. S., 1989, J CLIN EXP NEUROPSYC, V12, P129; LEVIN HS, 1985, J NEUROL NEUROSUR PS, V48, P556, DOI 10.1136/jnnp.48.6.556; LEVIN HS, 1986, J CLIN EXP NEUROPSYC, V8, P643, DOI 10.1080/01688638608405185; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; MARKOWITSCH HJ, 1993, J NEUROL NEUROSUR PS, V56, P988, DOI 10.1136/jnnp.56.9.988; Mattioli F, 1996, CORTEX, V32, P121, DOI 10.1016/S0010-9452(96)80021-9; ROUSSEAUX M, 1984, CORTEX, V20, P575, DOI 10.1016/S0010-9452(84)80060-X; RUSSELL WR, 1971, TRAUMATIC AMNESIA; SAGAR HJ, 1988, BRAIN, V111, P525, DOI 10.1093/brain/111.3.525; SARTORI G, 1988, COGNITIVE NEUROPSYCH, V5, P105, DOI 10.1080/02643298808252928; SHALLICE T, 1987, COGNITIVE NEUROPSYCH; SILVERI MC, 1988, COGNITIVE NEUROPSYCH, V5, P677, DOI 10.1080/02643298808253278; SILVERI MC, 1991, NEUROLOGY, V41, P545, DOI 10.1212/WNL.41.4.545; SNODGRASS JG, 1980, J EXP PSYCHOL-HUM L, V6, P174, DOI 10.1037/0278-7393.6.2.174; SPINNLER H, 1987, ITALIAN J NEUROLOG S, V6, P44; SQUIRE LR, 1978, NEUROPSYCHOLOGIA, V16, P313, DOI 10.1016/0028-3932(78)90025-8; SQUIRE LR, 1975, NEUROPSYCHOLOGIA, V13, P51, DOI 10.1016/0028-3932(75)90047-0; STEWART F, 1992, Q J EXP PSYCHOL-A, V44, P261, DOI 10.1080/02724989243000037; STRACCIARI A, 1994, CORTEX, V30, P459, DOI 10.1016/S0010-9452(13)80341-3; TULVING E, 1996, CEREB CORTEX, V3, P79; VILKKI J, 1994, J CLIN EXP NEUROPSYC, V16, P325, DOI 10.1080/01688639408402643; WARRINGTON EK, 1984, BRAIN, V107, P829, DOI 10.1093/brain/107.3.829; WARRINGTON EK, 1987, BRAIN, V110, P1273, DOI 10.1093/brain/110.5.1273; Wilson JTL, 1989, NEUROPSYCHOLOGY, V3, P255, DOI 10.1037//0894-4105.3.4.255; WILSON JTL, 1988, J NEUROL NEUROSUR PS, V51, P391, DOI 10.1136/jnnp.51.3.391; WILSON RS, 1981, CORTEX, V17, P41, DOI 10.1016/S0010-9452(81)80005-6; ZOLAMORGAN S, 1986, J NEUROSCI, V6, P1950	61	22	22	0	8	MASSON DIVISIONE PERIODICI	MILAN	VIA FRATELLI BRESSAN 2, 20126 MILAN, ITALY	0010-9452			CORTEX	Cortex	FEB	1998	34	1					1	23		10.1016/S0010-9452(08)70734-2			23	Behavioral Sciences; Neurosciences; Psychology, Experimental	Behavioral Sciences; Neurosciences & Neurology; Psychology	ZA672	WOS:000072389500001	9533991				2021-06-18	
J	Friedland, D; Miller, N				Friedland, D; Miller, N			Conversation analysis of communication breakdown after closed head injury	BRAIN INJURY			English	Article							LANGUAGE	This single case study investigated the use of Conversation Analysis (CA) in assessing pragmatic language difficulties after closed head injury (CHI). The aim ws to see if CA captures the types of communication breakdown observed after CHI and whether results from CA can be directly related to scores on formal tests more typically applied after CHI. The results suggested that CA was a sensitive tool for identifying and investigating pragmatic deficits in this case. It facilitated an exploration of whether language impairments identified on formal tests manifest themselves in functional communication; it revealed how different interlocutors adapt to these language difficulties in conversation and also explained why some conversational partners were more successful than others. Considered together, formal test results and CA insights facilitated an in-depth analysis into the precise nature of the communicative impairments of the speaker in this exploratory study, suggesting that CA is a promising approach to the assessment of pragmatic impairments in the CHI population.	Univ Newcastle Upon Tyne, Dept Speech, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England	Miller, N (corresponding author), Univ Newcastle Upon Tyne, Dept Speech, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.						Baddeley A, 1990, HUMAN MEMORY THEORY; Coltheart, 1992, PSYCHOLINGUISTIC ASS; COUGHLAN AK, 1985, ADULT MEMORY INFORMA; DERENZI E, 1978, CORTEX, V14, P41, DOI 10.1016/S0010-9452(78)80006-9; Heritage J., 1989, CONVERSATION INTERDI, P21; HOLLAND AL, 1984, CLIN APHASIOLOGY C P, P21; Hopper R., 1989, CONVERSATION INTERDI, P48; HOUGH MS, 1994, LANGUAGE INTERVENTIO; Howard D., 1992, PYRAMIDS PALM TREES; Kaplan E., 1983, BOSTON NAMING TEST; Lesser R., 1993, LINGUISTICS APHASIA; LEVISON SC, 1983, PRAGMATICS, P246; LEZAK MD, 1995, NEUROPSYCHOLOGICAL A; MENTIS M, 1991, J SPEECH HEAR RES, V34, P583, DOI 10.1044/jshr.3403.583; MOSS MB, 1986, ARCH NEUROL-CHICAGO, V43, P239, DOI 10.1001/archneur.1986.00520030031008; MURPHY GL, 1990, DISCOURSE ABILITY BR, P28; Penn C, 1985, S Afr J Commun Disord, V32, P18; PERKINS L, 1995, EUR J DISORDER COMM, V30, P372; PERKINS L, 1993, THESIS U NEWCASTLE U; PERKINS M, 1994, CLIN LINGUIST PHONET, V8, P321, DOI 10.3109/02699209408985315; Perkins M. R., 1995, CASE STUDIES CLIN LI, P293; PRUTTING CA, 1987, J SPEECH HEAR DISORD, V52, P105, DOI 10.1044/jshd.5202.105; Taylor Talbot J, 1987, ANAL CONVERSATION RU; Wechsler D., 1986, WECHSLER ADULT INTEL; Wootton A. J., 1989, CONVERSATION INTERDI, P238; Ylvisaker Mark, 1992, Seminars in Speech and Language, V13, P239, DOI 10.1055/s-2008-1064200	26	22	23	0	8	TAYLOR & FRANCIS LTD	LONDON	ONE GUNPOWDER SQUARE, LONDON EC4A 3DE, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.	JAN	1998	12	1					1	14		10.1080/026990598122818			14	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	YT347	WOS:000071592500001	9483333				2021-06-18	
J	Pike, BR; Hamm, RJ				Pike, BR; Hamm, RJ			Chronic administration of a partial muscarinic M-1 receptor agonist attenuates decreases in forebrain choline acetyltransferase immunoreactivity following experimental brain trauma	EXPERIMENTAL NEUROLOGY			English	Article							NERVE GROWTH-FACTOR; FACTOR MESSENGER-RNA; CLOSED-HEAD-INJURY; COGNITIVE IMPAIRMENT; NEUROTROPHIC FACTOR; BASAL FOREBRAIN; RAT HIPPOCAMPUS; AGED RATS; ACETYLCHOLINE; EXPRESSION	Lu 25-109-T is a partial muscarinic M-1 receptor agonist with antagonistic effects at presynaptic M-2 autoreceptors and has been shown to improve cognitive function following traumatic brain injury (TBI) in rats. This investigation examined the effects of TBI on basal forebrain choline acetyltransferase immunoreactivity (ChAT-IR) following daily administration of saline or 15 mu mol/kg Lu 25-109-T. Rats received a moderate (2.1 +/- 0.1 atm) level of central fluid percussion TBI or were surgically prepared but not injured and were injected (sc) with saline or drug on Days 1-15 postinjury. Rats were sacrificed following the last daily injection, and sections were collected through the basal forebrain and processed for ChAT-IR. TBI caused a significant reduction in ChAT-IR neuronal density in saline-and Lu 25-109-T-treated rats with a 13% and 5% decrease in the medial septal nucleus (MSN), a 48 and 23% decrease in the vertical limb nucleus of the diagonal band (VDB), and a 51 and 28% decrease in the nucleus basalis magnocellularis (NBM), respectively, However, Lu 25-109-T significantly attenuated the injury-induced reductions in ChAT-IR. Loss in ChAT-IR neuronal density is not thought to result from cell death as parallel cresyl violet-stained sections indicated no decrease in neuronal cell. density in the MSN, VDB, or NBM. These results support the hypothesis that increasing cholinergic tone during the recovery period after TBI will restore cholinergic function impaired by brain trauma. (C) 1997 Academic Press.		Pike, BR (corresponding author), VIRGINIA COMMONWEALTH UNIV, DEPT PSYCHOL, BOX 2018, RICHMOND, VA 23284 USA.				NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P01NS012587, P50NS012587] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS 12587] Funding Source: Medline		ALBERCH J, 1991, J NEUROCHEM, V57, P1483, DOI 10.1111/j.1471-4159.1991.tb06342.x; AMENTA F, 1994, MECH AGEING DEV, V74, P47, DOI 10.1016/0047-6374(94)90097-3; BEJANIN S, 1994, J BIOL CHEM, V269, P21944; CAPRUSO DX, 1992, NEUROL CLIN, V10, P879; CASTREN E, 1993, EXP NEUROL, V122, P244, DOI 10.1006/exnr.1993.1124; CHOU C-L, 1991, Society for Neuroscience Abstracts, V17, P722; DEKKER AJAM, 1991, NEUROSCI BIOBEHAV R, V15, P299, DOI 10.1016/S0149-7634(05)80008-9; Dewar D, 1996, J NEUROTRAUM, V13, P181, DOI 10.1089/neu.1996.13.181; DEWITT DS, 1988, ANESTHESIOLOGY REV, V15, P31; Dixon C. E., 1995, Society for Neuroscience Abstracts, V21, P762; DIXON CE, 1995, BEHAV BRAIN RES, V70, P125, DOI 10.1016/0166-4328(95)80002-6; Dixon CE, 1996, PHARMACOL BIOCHEM BE, V53, P679, DOI 10.1016/0091-3057(95)02069-1; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; Doods Henri N., 1995, Drugs of the Future, V20, P157; DRAVID AR, 1983, ARCH INT PHARMACOD T, V264, P195; GTAY R, 1983, NEUROCI BIOBEHAV REV, V7, P119; HAMM RJ, 1992, NEUROSURGERY, V31, P1072, DOI 10.1227/00006123-199212000-00013; HAMM RJ, 1995, J NEUROTRAUM, V12, P307, DOI 10.1089/neu.1995.12.307; HAMM RJ, 1993, BEHAV BRAIN RES, V59, P169, DOI 10.1016/0166-4328(93)90164-L; HEFTI F, 1993, PROG BRAIN RES, V98, P257; HSU SM, 1981, J HISTOCHEM CYTOCHEM, V29, P577, DOI 10.1177/29.4.6166661; LAPCHAK PA, 1993, NEUROSCIENCE, V52, P575, DOI 10.1016/0306-4522(93)90407-7; LINDEFORS N, 1992, EXP BRAIN RES, V88, P78, DOI 10.1007/BF02259130; Liu S. J., 1993, Society for Neuroscience Abstracts, V19, P1881; LYETH BG, 1988, BRAIN RES, V448, P88, DOI 10.1016/0006-8993(88)91104-3; LYETH BG, 1990, BRAIN RES, V526, P249, DOI 10.1016/0006-8993(90)91229-A; MEIER E, 1995, LIFE SCI, V56, P1006, DOI 10.1016/0024-3205(95)93724-S; MEIER E, IN PRESS DRUG DEV RE; MESULAM MM, 1983, NEUROSCIENCE, V10, P1185, DOI 10.1016/0306-4522(83)90108-2; Moltzen Ejner K., 1995, Drugs of the Future, V20, P37; NUNZI MG, 1989, PHARMACOPSYCHIATRY, V22, P125, DOI 10.1055/s-2007-1014632; ODELL DM, 1995, J NEUROSURG, V83, P878, DOI 10.3171/jns.1995.83.5.0878; Paxinos G., 1982, RAT BRAIN STEREOTAXI; PIKE BR, 1995, BRAIN RES, V686, P37, DOI 10.1016/0006-8993(95)00448-Y; PIKE BR, 1997, PHARM BIOCH BEHAV, V57, P1; SCHMIDT RH, 1995, J NEUROSURG, V83, P496, DOI 10.3171/jns.1995.83.3.0496; SHU SY, 1988, NEUROSCI LETT, V85, P169, DOI 10.1016/0304-3940(88)90346-1; Sinson G., 1995, Society for Neuroscience Abstracts, V21, P2121; SOFRONIEW MV, 1987, BRAIN RES, V411, P310, DOI 10.1016/0006-8993(87)91084-5; THOENEN H, 1991, TRENDS NEUROSCI, V14, P165, DOI 10.1016/0166-2236(91)90097-E; Wiley JL, 1996, BRAIN RES, V716, P47, DOI 10.1016/0006-8993(96)00045-5; WILLIAMS LR, 1991, NEUROBIOL AGING, V12, P39, DOI 10.1016/0197-4580(91)90037-K	42	22	22	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0014-4886	1090-2430		EXP NEUROL	Exp. Neurol.	SEP	1997	147	1					55	65		10.1006/exnr.1997.6582			11	Neurosciences	Neurosciences & Neurology	XV981	WOS:A1997XV98100007	9294403				2021-06-18	
J	Kordestani, RK; Counelis, GJ; McBride, DQ; Martin, NA				Kordestani, RK; Counelis, GJ; McBride, DQ; Martin, NA			Cerebral arterial spasm after penetrating craniocerebral gunshot wounds: Transcranial doppler and cerebral blood flow findings	NEUROSURGERY			English	Article						cerebral blood flow; head injury; penetrating craniocerebral gunshot wounds; transcranial doppler; traumatic subarachnoid hemorrhage; vasospasm	HEAD-INJURED PATIENTS; COMA DATA-BANK; SUBARACHNOID HEMORRHAGE; COMPUTERIZED-TOMOGRAPHY; ANGIOGRAPHIC FINDINGS; TIME COURSE; VASOSPASM; ULTRASOUND; METABOLISM; VELOCITY	OBJECTIVE: The goals of the study were to determine the incidence and time course of cerebral arterial spasm in patients with penetrating craniocerebral gunshot wounds, to study the relationship between vasospasm and subarachnoid hemorrhage (SAH) in these patients, and to evaluate the effects of vasospasm on outcome. METHODS: Thirty-three patients with craniocerebral gunshot wounds underwent computed tomography at admission and then underwent transcranial doppler ultrasonography (TCD). Velocities in the middle cerebral artery and the extracranial internal carotid artery were measured. Vasospasm was defined as a middle cerebral artery velocity greater than 120 cm per second and a hemispheric index (ratio of middle cerebral artery to internal carotid artery velocity) greater than 3. Intravenous xenon-133 cerebral blood flow (CBF) studies were performed for 10 patients. RESULTS: TCD was initiated, on average, 1.1 days after injury; 205 studies (mean, 6.3 studies/patient) were performed 0 to 33 days after injury. TCD showed vasospasm in 14 patients (42.4%). Xenon-133 studies performed within 24 hours of TCD measurements indicating spasm demonstrated normal or low CBF in three of five patients with spasm, ruling out hyperemia as the cause of elevated flow velocities in these three patients. Seven patients had unilateral vasospasm, and seven had bilateral spasm. Vasospasm was most prominent from Days 5 through 11. Vasospasm was distributed across all levels of injury severity, as defined by the Glasgow Coma Scale. Initial computed tomographic scans demonstrated SAH in all 14 patients with vasospasm but in only 9 of 19 without spasm (100 versus 47%, P < 0.0001, binomial distribution probability test). Outcomes for patients with vasospasm were slightly worse than for those without spasm (35.7 versus 47.4% good outcomes, respectively); however, this difference did not reach statistical significance (P = 0.12). CONCLUSION: These findings demonstrate that delayed cerebral arterial spasm is a frequent complication in patients with craniocerebral gunshot wounds and is strongly associated with SAH. The frequency, time course, and severity of spasm are comparable with those observed with aneurysmal SAH and traumatic SAH caused by closed head injury. This study offers new insights into the hemodynamic pathophysiology after gunshot wounds to the brain and suggests that increased vigilance for vasospasm may be of benefit.	UNIV CALIF LOS ANGELES,SCH MED,DIV NEUROSURG,LOS ANGELES,CA 90024; UNIV CALIF LOS ANGELES,SCH MED,CEREBRAL BLOOD FLOW LAB,LOS ANGELES,CA 90024; UNIV CALIF LOS ANGELES,HARBOR MED CTR,TORRANCE,CA 90509				Martin, Neil/0000-0002-6565-4131	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P50NS030308] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS30308] Funding Source: Medline		AASLID R, 1982, J NEUROSURG, V57, P769, DOI 10.3171/jns.1982.57.6.0769; AGNOLI A, 1969, CEREBRAL BLOOD FLOW, P31; ALDRICH EF, 1992, SURG NEUROL, V38, P418, DOI 10.1016/0090-3019(92)90109-Z; BENZEL EC, 1991, NEUROSURGERY, V29, P67, DOI 10.1227/00006123-199107000-00011; BOUMA GJ, 1992, J NEUROSURG, V77, P360, DOI 10.3171/jns.1992.77.3.0360; BOUMA GJ, 1991, J NEUROSURG, V75, P685, DOI 10.3171/jns.1991.75.5.0685; EISENBERG HM, 1990, J NEUROSURG, V73, P688, DOI 10.3171/jns.1990.73.5.0688; FISCHER CM, 1980, NEUROSURGERY, V6, P1; Foulkes MA, 1991, J NEUROSURG S, V75, P8, DOI 10.3171/sup.1991.75.1s.00s8; HARDERS AG, 1987, J NEUROSURG, V66, P718, DOI 10.3171/jns.1987.66.5.0718; JAGGI JL, 1990, J NEUROSURG, V72, P176, DOI 10.3171/jns.1990.72.2.0176; JENNETT B, 1975, LANCET, V1, P480; JINKINS JR, 1992, AM J ROENTGENOL, V159, P365, DOI 10.2214/ajr.159.2.1632358; KAUFMAN HH, 1995, NEUROSURG CLIN N AM, V6, P701, DOI 10.1016/s1042-3680(18)30426-1; KORDESTANI RK, 1995, NEUROSURG CLIN N AM, V6, P657; LEVY ML, 1993, NEUROSURGERY, V32, P532, DOI 10.1227/00006123-199304000-00007; Lindegaard K F, 1988, Acta Neurochir Suppl (Wien), V42, P81; LINDEGAARD KF, 1989, ACTA NEUROCHIR, V100, P12, DOI 10.1007/BF01405268; MACPHERSON P, 1978, J NEUROL NEUROSUR PS, V41, P122, DOI 10.1136/jnnp.41.2.122; Martin N A, 1994, Neurosurg Clin N Am, V5, P607; MARTIN NA, 1992, J NEUROSURG, V77, P575, DOI 10.3171/jns.1992.77.4.0575; MARTIN NA, 1995, J NEUROTRAUM, V12, P897, DOI 10.1089/neu.1995.12.897; MCBRIDE DQ, 1994, 62 ANN M AM ASS NEUR; MCBRIDE DQ, 1993, 61 ANN M AM ASS NEUR; MILLER JD, 1994, CEREBROVAS BRAIN MET, V6, P31; MUIZELAAR JP, 1989, TXB HEAD INJURY, P221; Newell D W, 1994, Neurosurg Clin N Am, V5, P619; Newell D W, 1990, Neurosurg Clin N Am, V1, P319; Obrist W.D., 1996, NEUROTRAUMA, P471; OBRIST WD, 1990, CEREBROVAS BRAIN MET, V2, P283; OBRIST WD, 1984, J NEUROSURG, V61, P241, DOI 10.3171/jns.1984.61.2.0241; OBRIST WD, 1967, CIRC RES, V20, P124, DOI 10.1161/01.RES.20.1.124; OBRIST WD, 1979, J NEUROSURG, V51, P292, DOI 10.3171/jns.1979.51.3.0292; OVERGAARD J, 1981, J NEUROSURG, V55, P63, DOI 10.3171/jns.1981.55.1.0063; ROBERTSON CS, 1992, J NEUROL NEUROSUR PS, V55, P594, DOI 10.1136/jnnp.55.7.594; ROBERTSON CS, 1987, J NEUROSURG, V67, P361, DOI 10.3171/jns.1987.67.3.0361; SEILER RW, 1986, J NEUROSURG, V64, P594, DOI 10.3171/jns.1986.64.4.0594; SEKHAR LN, 1988, NEUROSURGERY, V22, P813, DOI 10.1227/00006123-198805000-00002; SHOUNG HM, 1985, ACTA NEUROCHIR, V74, P27, DOI 10.1007/BF01413272; SICCARDI D, 1991, SURG NEUROL, V35, P455, DOI 10.1016/0090-3019(91)90179-D; SUWANWELA C, 1972, J NEUROSURG, V36, P314, DOI 10.3171/jns.1972.36.3.0314; TEASDALE G, 1974, LANCET, V2, P81; WEBER M, 1990, NEUROSURGERY, V27, P106, DOI 10.1227/00006123-199007000-00015; WEIR B, 1978, J NEUROSURG, V48, P173, DOI 10.3171/jns.1978.48.2.0173; Wilkins R H, 1990, Neurosurg Clin N Am, V1, P329; WILKINS RH, 1970, J NEUROSURG, V32, P626, DOI 10.3171/jns.1970.32.6.0626	46	22	23	0	0	WILLIAMS & WILKINS	BALTIMORE	351 WEST CAMDEN ST, BALTIMORE, MD 21201-2436	0148-396X			NEUROSURGERY	Neurosurgery	AUG	1997	41	2					351	359		10.1097/00006123-199708000-00003			9	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	XP006	WOS:A1997XP00600010	9257302				2021-06-18	
J	Tang, YP; Noda, Y; Nabeshima, T				Tang, YP; Noda, Y; Nabeshima, T			Involvement of activation of dopaminergic neuronal system in learning and memory deficits associated with experimental mild traumatic brain injury	EUROPEAN JOURNAL OF NEUROSCIENCE			English	Article						D1 receptor; D2 receptor; dopamine; talent learning; traumatic brain injury	RAT-BRAIN; HEAD-INJURY; CORTEX ABLATION; RECEPTORS; RECOVERY; AMPHETAMINE; MICE; HALOPERIDOL; IMPAIRMENT; D1	Much evidence has indicated that a disturbance in dopamine neurotransmission following mild to moderate traumatic brain injury is involved in the development of post traumatic memory deficits. In the present study we examined the effects of a dopamine receptor agonist and some antagonists on latent learning and memory deficits associated with a concussive traumatic brain injury in mice. Anaesthetized animals were subjected to mild traumatic brain injury by dropping a weight onto the head, and a single-dose injection of apomorphine (0.3-3.0 mg/kg) or haloperidol (0.3-3.0 mg/kg) was made i.p. 15 min after the trauma. One week later, a water-finding task consisting of an acquisition trial, a retention test and a retest was employed to assess learning and memory functions. Mice that had received a traumatic brain injury were impaired in task performance, with prolonged latencies for finding and drinking in the retention test and retest. Administration of haloperidol but not of apomorphine significantly shortened the prolonged latency in both of the tests, indicating that antagonism of dopamine receptors is beneficial for the recovery of post traumatic memory deficits. In order to evaluate which receptor subtype plays the major role in this model, we examined the effects of SCH-23390 (0.03-0.3 mg/kg), a D1 receptor antagonist, and sulpiride (3.0-30 mg/kg), a D2 receptor antagonist, in the same experimental paradigm. The results showed that administration of sulpiride but not of SCH-23390 significantly improved the deficits in task performance, indicating that D2 receptors are the major site of action. However, combined treatment with SCH-23390 (0.03-0.3 mg/kg) and sulpiride (3.0 mg/kg) at doses that had no effect when the antagonists were given alone exerted a significant additive effect in improving these deficits, indicating that interaction between D1 and D2 receptors is involved in these processes. The present results suggest that a dopaminergic mechanism contributes to the memory dysfunction associated with traumatic brain injury.	NAGOYA UNIV,SCH MED,DEPT NEUROPSYCHOPHARMACOL,NAGOYA,AICHI 466,JAPAN; NAGOYA UNIV,SCH MED,HOSP PHARM,NAGOYA,AICHI 466,JAPAN			Tang, Ya-Ping/A-1035-2011				ASANUMA M, 1995, ARCH INT PHARMACOD T, V329, P221; BINDER LM, 1986, J CLIN EXP NEUROPSYC, V8, P323, DOI 10.1080/01688638608401325; Bjorklund A., 1984, HDB CHEM NEUROANAT 1, P55; BOYESON MG, 1990, PHARMACOL BIOCHEM BE, V35, P497, DOI 10.1016/0091-3057(90)90279-Q; BOYESON SJ, 1986, J NEUROSCI, V6, P3177; BROZOSKI TJ, 1979, SCIENCE, V205, P929, DOI 10.1126/science.112679; BUSHNELL PJ, 1993, PHARMACOL BIOCHEM BE, V45, P765, DOI 10.1016/0091-3057(93)90119-E; CALABRESI P, 1992, NEUROSCI LETT, V142, P95, DOI 10.1016/0304-3940(92)90628-K; CARLSSON A, 1975, CHEMICAL TOOLS CATEC, V2, P219; Dixon C. E., 1992, Society for Neuroscience Abstracts, V18, P171; DUNNMEYNELL A, 1994, BRAIN RES, V660, P88, DOI 10.1016/0006-8993(94)90842-7; ESCHUN G, 1992, SURG NEUROL, V37, P101, DOI 10.1016/0090-3019(92)90184-O; ETTENBERG A, 1986, PHARMACOL BIOCHEM BE, V25, P1231, DOI 10.1016/0091-3057(86)90117-6; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; FEENEY DM, 1982, SCIENCE, V217, P855, DOI 10.1126/science.7100929; FEENEY DM, 1988, PHARM APPROACHES TRE, P79; FILLOUX FM, 1987, BRAIN RES, V408, P205, DOI 10.1016/0006-8993(87)90373-8; GOLDSTEIN LB, 1993, J NEURAL TRANSP PLAS, V4, P175, DOI 10.1155/NP.1993.175; HAYES RL, 1992, J NEUROTRAUM, V9, pS173; Hayes RL, 1989, MILD HEAD INJURY, P54; HICKS RR, 1993, J NEUROTRAUM, V10, P405, DOI 10.1089/neu.1993.10.405; HOVDA DA, 1989, BEHAV NEUROSCI, V103, P574, DOI 10.1037/0735-7044.103.3.574; HUANG Q, 1992, P NATL ACAD SCI USA, V89, P11988, DOI 10.1073/pnas.89.24.11988; HUGER F, 1979, J NEUROCHEM, V33, P89, DOI 10.1111/j.1471-4159.1979.tb11710.x; HURWITZ BE, 1991, STROKE, V22, P648, DOI 10.1161/01.STR.22.5.648; ICHIHARA K, 1992, EUR J PHARMACOL, V213, P243, DOI 10.1016/0014-2999(92)90688-Z; ICHIHARA K, 1988, EUR J PHARMACOL, V151, P435, DOI 10.1016/0014-2999(88)90540-7; ICHIHARA K, 1993, J PHARMACOL EXP THER, V264, P122; IORIO LC, 1983, J PHARMACOL EXP THER, V226, P462; JANSSEN PAJ, 1966, ARZNEI-FORSCHUNG, V16, P339; Levin H S, 1986, Cent Nerv Syst Trauma, V3, P333; LYETH BG, 1988, BRAIN RES, V448, P88, DOI 10.1016/0006-8993(88)91104-3; LYETH BG, 1990, BRAIN RES, V526, P249, DOI 10.1016/0006-8993(90)91229-A; MCINTOSH TK, 1994, J NEUROCHEM, V63, P1426; NABESHIMA T, 1994, EUR J PHARMACOL, V255, P57, DOI 10.1016/0014-2999(94)90082-5; NABESHIMA T, 1993, METHODS NEUROSCIENCE, V14, P217; OBOYLE KM, 1987, J NEUROCHEM, V48, P1039, DOI 10.1111/j.1471-4159.1987.tb05623.x; OGAWA N, 1994, BRAIN RES, V657, P207, DOI 10.1016/0006-8993(94)90969-5; Powell JH, 1996, J NEUROL NEUROSUR PS, V60, P416, DOI 10.1136/jnnp.60.4.416; RAO N, 1985, ARCH PHYS MED REHAB, V66, P20; SALLER CF, 1986, J PHARMACOL EXP THER, V236, P714; SCHMIDT RH, 1995, J NEUROSURG, V83, P496, DOI 10.3171/jns.1995.83.3.0496; SEEMAN P, 1980, PHARMACOL REV, V32, P229; Smith DH, 1991, J NEUROTRAUM, V8, P259, DOI 10.1089/neu.1991.8.259; SUTTON RL, 1989, BEHAV NEUROSCI, V103, P837, DOI 10.1037/0735-7044.103.4.837; TANG YP, 1997, IN PRESS J NEUROTRAU; WARD A, 1950, J NEUROSURG, V7, P398, DOI 10.3171/jns.1950.7.5.0398; WHITE FJ, 1984, J PHARMACOL EXP THER, V231, P275; WOLTERINK G, 1993, PSYCHOPHARMACOLOGY, V110, P355, DOI 10.1007/BF02251293	49	22	23	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD, ENGLAND OX2 6DP	0953-816X			EUR J NEUROSCI	Eur. J. Neurosci.	AUG	1997	9	8					1720	1727		10.1111/j.1460-9568.1997.tb01529.x			8	Neurosciences	Neurosciences & Neurology	XU211	WOS:A1997XU21100018	9283826				2021-06-18	
J	Childers, MK; Holland, D				Childers, MK; Holland, D			Psychomotor agitation following gabapentin use in brain injury	BRAIN INJURY			English	Article							REFLEX SYMPATHETIC DYSTROPHY	Gabapentin, an anticonvulsant structurally related to gamma-aminobutyric acid (GABA) was recently reported to be effective in pain associated with reflex sympathetic dystrophy (RSD) and in pain associated with neuropathy. Yet, to our knowledge, the use of gabapentin for neuropathic pain in the presence of cognitive impairment has not been reported. In this report, we describe two patients (one with a traumatic brain injury, one with a putative acquired brain injury) who presented to a neurorehabilitation unit complaining of pain that was diagnosed as neurologically mediated. Within one week of receiving a daily 900 mg dose of gabapentin, both patients complained of heightened anxiety and restlessness. Correspondingly, each reported a diminution of psychological symptoms within 48 hours of gabapentin cessation. These two cases suggest that gabapentin may cause agitation in cognitive impaired patients. Physicians treating brain-injured patients and prescribing gabapentin for neuropathic pain may wish to closely monitor patients for similar signs of restlessness or anxiety.	UNIV MISSOURI,DEPT PHYS MED & REHABIL,COLUMBIA,MO				Childers, Martin/0000-0003-4754-0883			Bartoszyk G. D., 1986, NEW ANTICONVULSANT D, P147; CHEVILLE A, 1995, AM PAIN SOC 14 ANN S; CHEVILLE AL, 1996, ARCH PHYSICAL MED RE, V77, P939; CHRISTENSEN JA, 1980, J TRAUMA, V20, P166, DOI 10.1097/00005373-198002000-00012; Gualtieri C T, 1988, Brain Inj, V2, P101, DOI 10.3109/02699058809150936; JANUS TJ, 1996, IN PRESS J BURN CARE; LISHMAN WA, 1987, ORGANIC PSYCHIATRY; MELLICK GA, 1995, J PAIN SYMPTOM MANAG, V10, P265, DOI 10.1016/0885-3924(95)00001-F; MELLICK GA, 1995, AM J PAIN MANAGEMENT, V5, P7; MELLICK LB, 1995, AM J EMERG MED, V13, P96, DOI 10.1016/0735-6757(95)90263-5; PARKEDAVIS, 1996, UNPUB PACKAGE INSERT; REIMANN W, 1983, EUR J PHARMACOL, V94, P341, DOI 10.1016/0014-2999(83)90425-9; THURLOW RJ, 1993, EUR J PHARM-MOLEC PH, V247, P341, DOI 10.1016/0922-4106(93)90204-M; WELTY DF, 1993, EPILEPSY RES, V16, P175, DOI 10.1016/0920-1211(93)90078-L; 1993, NEUROLOGY, V43, P2292	15	22	22	0	1	TAYLOR & FRANCIS LTD	LONDON	ONE GUNPOWDER SQUARE, LONDON, ENGLAND EC4A 3DE	0269-9052			BRAIN INJURY	Brain Inj.	JUL	1997	11	7					537	540		10.1080/713802187			4	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	XF661	WOS:A1997XF66100006	9210989				2021-06-18	
J	Crown, LA; Hawkins, W				Crown, LA; Hawkins, W			Commotio cordis: Clinical implications of blunt cardiac trauma	AMERICAN FAMILY PHYSICIAN			English	Article							IMPACT	Blunt cardiac trauma can result not only in major structural impairments but also in subtle derangements without an apparent organic defect. Cardiac dysrhythmias, including ventricular fibrillation and sudden cardiac arrest, can occur in both cardiac contusion and cardiac concussion (commotio cordis) and may be fatal. The true incidence of these nonstructural cardiac injuries is unknown. Continuous electrocardiographic monitoring, assessment of cardiac troponin I and transesophageal echocardiograms are important aids in the evaluation of cardiac contusion and concussion.	UNIV TENNESSEE,COLL MED,MEMPHIS,TN							Adams JE, 1996, AM HEART J, V131, P308, DOI 10.1016/S0002-8703(96)90359-2; Cooper A, 1995, Semin Pediatr Surg, V4, P109; Cooper G J, 1989, J R Army Med Corps, V135, P58; Cooper M E, 1995, J Tenn Med Assoc, V88, P351; Daleiden A, 1994, Crit Care Nurs Q, V17, P13; HALE HW, 1957, AM J SURG, V93, P558, DOI 10.1016/0002-9610(57)90510-X; KAPLAN JA, 1993, J TRAUMA, V34, P151, DOI 10.1097/00005373-199301000-00030; MARON BJ, 1995, NEW ENGL J MED, V333, P337, DOI 10.1056/NEJM199508103330602; Rosenthal Monica Ann, 1995, Emergency Medicine Clinics of North America, V13, P887; TENZER ML, 1985, J TRAUMA, V25, P620, DOI 10.1097/00005373-198507000-00008; VIANO DC, 1978, J TRAUMA, V18, P452, DOI 10.1097/00005373-197806000-00010; Weiss RL, 1996, CHEST, V109, P73, DOI 10.1378/chest.109.1.73	12	22	24	0	1	AMER ACAD FAMILY PHYSICIANS	KANSAS CITY	8880 WARD PARKWAY, KANSAS CITY, MO 64114-2797	0002-838X			AM FAM PHYSICIAN	Am. Fam. Physician	MAY 15	1997	55	7					2467	2470					4	Primary Health Care; Medicine, General & Internal	General & Internal Medicine	XA910	WOS:A1997XA91000010	9166145				2021-06-18	
J	Wilson, BA				Wilson, BA			Semantic memory impairments following non-progressive brain injury: A study of four cases	BRAIN INJURY			English	Article							ALZHEIMERS-DISEASE; VISUAL AGNOSIA; DEMENTIA; APHASIA; COMPREHENSION; KNOWLEDGE; RECOVERY; DEFICIT; ATROPHY	Four brain-injured subjects with semantic memory impairments are described. Two had sustained traumatic head injury and two had herpes simplex virus encephalitis. The study seeks to determine (a) whether subjects with non-progressive brain injury and impaired semantic memory perform similarly to patients with progressive disorders on a semantic memory battery and (b) whether the anatomical lesions of the present group of subjects are similar to those seen in patients with progressive disorders. Results suggests that scores on the semantic memory battery are broadly similar for patients with progressive and non-progressive disorders. Information from magnetic resonance imaging scans supports other findings that the crucial area involved in semantic memory lies in the left temporal neocortex.		Wilson, BA (corresponding author), ADDENBROOKES HOSP,MRC,APPL PSYCHOL UNIT,REHABIL RES GRP,HILLS RD,BOX 58,CAMBRIDGE CB2 2QQ,ENGLAND.						BASSO A, 1988, J NEUROL NEUROSUR PS, V51, P1201, DOI 10.1136/jnnp.51.9.1201; BAYLES KA, 1983, BRAIN LANG, V19, P98, DOI 10.1016/0093-934X(83)90057-3; BUB DN, 1988, COGN NEUROPSYCHOL, V5, P27, DOI 10.1080/02643298808252926; DAVIDOFF J, 1985, CORTEX, V21, P121, DOI 10.1016/S0010-9452(85)80020-4; Elliott C.D., 1983, BRIT ABILITY SCALES; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; GAFFAN D, 1993, J COGNITIVE NEUROSCI, V5, P118, DOI 10.1162/jocn.1993.5.1.118; HILLIS AE, 1991, BRAIN, V114, P2081, DOI 10.1093/brain/114.5.2081; HODGES JR, 1992, NEUROPSYCHOLOGIA, V30, P301, DOI 10.1016/0028-3932(92)90104-T; HODGES JR, 1992, BRAIN, V115, P1783, DOI 10.1093/brain/115.6.1783; LEITER RG, 1969, EXAMINERS MANUAL LEI; MARTIN A, 1983, BRAIN LANG, V19, P124, DOI 10.1016/0093-934X(83)90059-7; McKenna P.W.E., 1983, GRADED NAMING TEST; Nelson H., 1982, NATIONAL ADULT READI; OLDFIELD RC, 1965, Q J EXP PSYCHOL, V17, P273, DOI 10.1080/17470216508416445; PATTERSON K, 1992, NEUROPSYCHOLOGIA, V30, P1025, DOI 10.1016/0028-3932(92)90096-5; PATTERSON K, 1995, HDB MEMORY DISORDERS, P167; POECK K, 1988, BRAIN, V111, P151, DOI 10.1093/brain/111.1.151; SACCHETT C, 1992, COGNITIVE NEUROPSYCH, V9, P73, DOI 10.1080/02643299208252053; TYRRELL PJ, 1990, BRAIN, V113, P1321, DOI 10.1093/brain/113.5.1321; Warrington E., 1991, VISUAL OBJECT SPACE; WARRINGTON EK, 1984, BRAIN, V107, P829, DOI 10.1093/brain/107.3.829; WARRINGTON EK, 1975, Q J EXP PSYCHOL, V27, P635, DOI 10.1080/14640747508400525; WILSON BA, 1995, J CLIN EXP NEUROPSYC, V17, P668, DOI 10.1080/01688639508405157; WILSON BA, 1993, CORTEX, V29, P529, DOI 10.1016/S0010-9452(13)80258-4; WILSON BA, 1994, J CLIN EXP NEUROPSYC, V16, P354, DOI 10.1080/01688639408402646; Wilson BA, 1995, BROKEN MEMORIES CASE, P14	27	22	24	0	1	TAYLOR & FRANCIS LTD	LONDON	ONE GUNPOWDER SQUARE, LONDON, ENGLAND EC4A 3DE	0269-9052			BRAIN INJURY	Brain Inj.	APR	1997	11	4					259	269		10.1080/026990597123566			11	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	WQ736	WOS:A1997WQ73600003	9134200				2021-06-18	
J	Carlesimo, GA; Sabbadini, M; Loasses, A; Caltagirone, C				Carlesimo, GA; Sabbadini, M; Loasses, A; Caltagirone, C			Forgetting from long-term memory in severe closed-head injury patients: Effect of retrieval conditions and semantic organization	CORTEX			English	Article							ALZHEIMER-TYPE DEMENTIA; KORSAKOFFS SYNDROME; ORGANIC AMNESIA; DAMAGE; RATES; DISEASE	This study was aimed at investigating long-term forgetting in chronic survivors of severe closed-head injury (CHI). For this purpose,performance decay passing from a 30-sec- to a 60-min-delay test in four memory procedures (Free Recall of unrelated stimuli, Free Recall of related stimuli. Cued Recall and y/n Recognition) of 20 CHI and 20 normal controls was analyzed. Comparable 30-sec-delay performances in CHI and control patients were obtained by manipulating exposure times;to study material during the learning phase. Results demonstrated accelerated forgetting in CHI patients in the Free Recall of the related list only. This finding was particularly evident in CHI patients suffering from a focal temporal lobe lesion. These data are discussed in light of retrieval and encoding deficits characterizing memory disorders in CHI patients.		Carlesimo, GA (corresponding author), IRCCS,V ARDEATINA 306,I-00179 ROME,ITALY.		Caltagirone, Carlo/B-4930-2013				ADAMS JH, 1980, J CLIN PATHOL, V33, P1132, DOI 10.1136/jcp.33.12.1132; BROOKS D N, 1975, Cortex, V11, P329; Butters N., 1988, CLIN NEUROPSYCHOL, V2, P133; CARLESIMO GA, 1992, NEUROPSYCHOL REV, V3, P119, DOI 10.1007/BF01108841; CARLESIMO GA, 1995, CORTEX, V31, P285, DOI 10.1016/S0010-9452(13)80363-2; CARLESIMO GA, 1993, INT J NEUROSCI, V73, P1, DOI 10.3109/00207459308987206; Carlesimo GA, 1995, CORTEX, V31, P735, DOI 10.1016/S0010-9452(13)80024-X; CROSSON B, 1988, J CLIN EXP NEUROPSYC, V10, P754, DOI 10.1080/01688638808402812; DELIS DC, 1991, PSYCHOL ASSESSMENT, V3, P19, DOI DOI 10.1037/1040-3590.3.1.19; ESLINGER PJ, 1986, J NEUROSCI, V6, P3006; FREED DM, 1987, NEUROPSYCHOLOGIA, V25, P461, DOI 10.1016/0028-3932(87)90071-6; GERSHBERG FB, 1995, NEUROPSYCHOLOGIA, V33, P1305, DOI 10.1016/0028-3932(95)00103-A; GOLDENBERG G, 1992, J NEUROL NEUROSUR PS, V55, P362, DOI 10.1136/jnnp.55.5.362; HART RP, 1987, J CONSULT CLIN PSYCH, V55, P101, DOI 10.1037/0022-006X.55.1.101; HUPPERT FA, 1978, NATURE, V275, P317, DOI 10.1038/275317a0; HUPPERT FA, 1979, CORTEX, V15, P385, DOI 10.1016/S0010-9452(79)80065-9; JETTER W, 1986, CORTEX, V22, P229, DOI 10.1016/S0010-9452(86)80047-8; KOPELMAN MD, 1985, NEUROPSYCHOLOGIA, V23, P623, DOI 10.1016/0028-3932(85)90064-8; LARRABEE GJ, 1993, J CLIN EXP NEUROPSYC, V15, P701, DOI 10.1080/01688639308402590; LEVIN HS, 1988, J NEUROSURG, V69, P861, DOI 10.3171/jns.1988.69.6.0861; LEVIN HS, 1988, J NEUROL NEUROSUR PS, V51, P14, DOI 10.1136/jnnp.51.1.14; LEVIN HS, 1986, J CLIN EXP NEUROPSYC, V8, P643, DOI 10.1080/01688638608405185; MARTONE M, 1986, J CLIN EXP NEUROPSYC, V8, P161, DOI 10.1080/01688638608401309; MCKEE RD, 1992, J NEUROSCI, V12, P3765; MOSS MB, 1986, ARCH NEUROL-CHICAGO, V43, P239, DOI 10.1001/archneur.1986.00520030031008; RAVEN JC, 1949, PROGR MATRICES 1947; REID DB, 1993, J CLIN PSYCHOL, V49, P245, DOI 10.1002/1097-4679(199303)49:2<245::AID-JCLP2270490219>3.0.CO;2-1; Rey A., 1968, REATTIVO FIGURA COMP; Schultz KA, 1986, DEV NEUROPSYCHOL, V2, P77, DOI 10.1080/87565648609540331; SNODGRASS JG, 1980, J EXP PSYCHOL-HUM L, V6, P174, DOI 10.1037/0278-7393.6.2.174; SPINNLER H, 1987, ITALIAN J NEUROLOG S, V6, P44; SQUIRE LR, 1992, PSYCHOL REV, V99, P195, DOI 10.1037/0033-295X.99.2.195; VAKIL E, 1992, J CONSULTANT CLIN PS, V5, P802; WILSON JTL, 1988, J NEUROL NEUROSUR PS, V51, P391, DOI 10.1136/jnnp.51.3.391	34	22	22	0	2	MASSON DIVISIONE PERIODICI	MILAN	VIA FRATELLI BRESSAN 2, 20126 MILAN, ITALY	0010-9452			CORTEX	Cortex	MAR	1997	33	1					131	142		10.1016/S0010-9452(97)80009-3			12	Behavioral Sciences; Neurosciences; Psychology, Experimental	Behavioral Sciences; Neurosciences & Neurology; Psychology	WP883	WOS:A1997WP88300008	9088726				2021-06-18	
J	Cherney, LR; Halper, AS				Cherney, LR; Halper, AS			Swallowing problems in adults with traumatic brain injury	SEMINARS IN NEUROLOGY			English	Article							DYSPHAGIA			Cherney, LR (corresponding author), NORTHWESTERN UNIV,SCH MED,CHICAGO,IL 60614, USA.						ADAMOVICH BB, 1985, COGNITIVE REHABILITA; AVERYSMITH W, 1994, AM J OCCUP THER, V48, P235, DOI 10.5014/ajot.48.3.235; BROWN G E, 1992, Dysphagia, V7, P138, DOI 10.1007/BF02493445; CHERNEY LR, 1994, CLIN MANAGEMENT DYSP, P49; Cherney LR, 1989, J HEAD TRAUMA REHAB, V4, P42; *CTR FUNCT RES, 1990, GUID US UN DAT SET M; FIELD LH, 1989, BRAIN INJURY, V3, P9; Hagen C, 1981, TOP LANG DIS, V1, P73; Hagen C, 1979, REHABILITATION HEAD; HALPER AS, 1991, CLIN MANAGEMENT COMM, P19; LAZARUS C, 1987, ARCH PHYS MED REHAB, V68, P79; Lazarus CL, 1989, J HEAD TRAUMA REHAB, V4, P34; LEVIN HS, 1982, NEUROBEHAVIORAL CONS; LOGEMANN J A, 1990, Dysphagia, V4, P202, DOI 10.1007/BF02407266; LOGEMANN JA, 1995, J SPEECH HEAR RES, V38, P556, DOI 10.1044/jshr.3803.556; NEUMANN S, 1995, DYSPHAGIA, V10, P1, DOI 10.1007/BF00261272; Neumann Stefanie, 1993, Dysphagia, V8, P150, DOI 10.1007/BF02266996; SZEKERES SF, 1985, HEAD INJURY REHABILI, P219; Tippett DC, 1987, DYSPHAGIA, V1, P221; TURPIN R, 1996, 2 ANN MULT BRAIN INJ; WEINSTEIN CJ, 1983, PHYS THER, V12, P1992; Yorkston KM, 1989, J HEAD TRAUMA REHAB, V4, P1; YUEN HK, 1992, AM J OCCUP THER, V46, P943, DOI 10.5014/ajot.46.10.943	23	22	25	0	4	THIEME MEDICAL PUBL INC	NEW YORK	333 SEVENTH AVE, NEW YORK, NY 10001	0271-8235			SEMIN NEUROL	Semin. Neurol.	DEC	1996	16	4					349	353		10.1055/s-2008-1040993			5	Clinical Neurology	Neurosciences & Neurology	WU475	WOS:A1996WU47500007	9112314				2021-06-18	
J	Conoley, JC; Sheridan, SM				Conoley, JC; Sheridan, SM			Pediatric traumatic brain injury: Challenges and interventions for families	JOURNAL OF LEARNING DISABILITIES			English	Article							CLOSED HEAD-INJURY; DISABLED-CHILDREN; CHRONICALLY ILL; CHRONIC ILLNESS; RELATIVES VIEW; SIBLINGS; PREDICTORS; ADOLESCENTS; ADJUSTMENT; DAMAGE	Experiencing a brain injury is a traumatic event not only for the child who is directly affected, but also for his or her family system. Recently, attention has turned toward the potentially deleterious effects of having a child with a traumatic brain injury (TBI) on parents, siblings, and extended family members. Specifically, families of TBI survivors may suffer major psychological, financial, role, and relationship risks. Therefore, treating the child with a brain injury is only one component of a comprehensive recovery program. This article describes common experiences of families following a child's brain injury, and specific strategies that might help families through the recovery/reentry process.	UNIV UTAH, DEPT EDUC PSYCHOL, SALT LAKE CITY, UT 84112 USA							ALLEN K, 1994, REHABIL PSYCHOL, V39, P29, DOI 10.1037/h0080313; ASARNOW RF, 1991, J PEDIATR PSYCHOL, V16, P543, DOI 10.1093/jpepsy/16.5.543; BARRY P, 1989, REHABIL PSYCHOL, V34, P83; Ben-Yishay Y., 1990, REHABILITATION ADULT, P393; Bigler E D, 1989, Brain Inj, V3, P73, DOI 10.3109/02699058909008077; BLACK P, 1969, LATE EFFECTS HEAD IN, P187; BOND MR, 1983, REHABILITATION HEAD, P209; Bragg RM, 1992, J HEAD TRAUMA REHAB, V7, P94; BRESLAU N, 1983, J ABNORM CHILD PSYCH, V11, P379, DOI 10.1007/BF00914246; BRESLAU N, 1982, J ABNORM CHILD PSYCH, V10, P85, DOI 10.1007/BF00915953; BROOKS DN, 1983, J NEUROL NEUROSUR PS, V46, P336, DOI 10.1136/jnnp.46.4.336; BROOKS DN, 1991, J CLIN EXP NEUROPSYC, V13, P155, DOI 10.1080/01688639108407214; BROOKS DN, 1991, BRAIN INJURY, V1, P5; BROOKS N, 1986, J NEUROL NEUROSUR PS, V49, P764, DOI 10.1136/jnnp.49.7.764; Brooks N., 1987, J HEAD TRAUMA REHABI, V2, P1, DOI [10.1097/00001199-198709000-00003, DOI 10.1097/00001199-198709000-00003]; BROOKS N, 1984, CLOSED HEAD INJURY P, P123; CHADWICK O, 1985, DEV MED CHILD NEUROL, V27, P72; CHINITZ SP, 1981, CHILDREN TODAY, V15, P21; DEPOMPEI R, 1989, TOP LANG DISORD, V9, P78, DOI 10.1097/00011363-198903000-00008; DYSON L, 1989, AM J MENT RETARD, V94, P292; EIBEN CF, 1984, ARCH PHYS MED REHAB, V65, P168; FERRARI M, 1984, J CHILD PSYCHOL PSYC, V25, P459, DOI 10.1111/j.1469-7610.1984.tb00164.x; FLETCHER JM, 1990, J CONSULT CLIN PSYCH, V58, P93, DOI 10.1037/0022-006X.58.1.93; FRANKOWSKI RF, 1985, INJURED CHILD, P20; GARDNER RA, 1973, FAMILY BOOK MINIMAL; GOLDSTEIN FC, 1987, J LEARN DISABIL, V20, P518, DOI 10.1177/002221948702000903; HALL KM, 1994, ARCH PHYS MED REHAB, V75, P876, DOI 10.1016/0003-9993(94)90112-0; HARVEY DHP, 1984, J CHILD PSYCHOL PSYC, V25, P273, DOI 10.1111/j.1469-7610.1984.tb00149.x; Jackson A, 1991, COUNS PSYCHOL, V4, P355; Kaplan S. P., 1988, J APPLIED REHABILITA, V19, P3; KATZ RT, 1992, AM FAM PHYSICIAN, V46, P1491; Kratochwill T. R., 1990, BEHAV CONSULTATION A; Kreutzer J, 1988, J HEAD TRAUMA REHAB, V3, P51, DOI DOI 10.1097/00001199-198812000-00008; KREUTZER JS, 1992, ARCH PHYS MED REHAB, V73, P771; LAVIGNE JV, 1979, PEDIATRICS, V63, P616; LEAF LE, 1993, BRAIN INJURY, V7, P543, DOI 10.3109/02699059309008182; Lehr E, 1990, PSYCHOL MANAGEMENT T; LEZAK MD, 1988, J CLIN EXP NEUROPSYC, V10, P111, DOI 10.1080/01688638808405098; LEZAK MD, 1978, J CLIN PSYCHIAT, V39, P592; LEZAK MD, 1986, REHABIL PSYCHOL, V31, P241, DOI 10.1037//0090-5550.31.4.241; LIVINGSTON MG, 1985, J NEUROL NEUROSUR PS, V48, P870, DOI 10.1136/jnnp.48.9.870; LIVINGSTON MG, 1988, J HEAD TRAUMA REHAB, V2, P6; LIVINGSTON MG, 1985, J NEUROL NEUROSUR PS, V48, P527; MARTIN DA, 1988, J LEARN DISABIL, V21, P464, DOI 10.1177/002221948802100803; Mauss-Clum N, 1981, J Neurosurg Nurs, V13, P165; MCGUIRE TL, 1986, J HEAD TRAUMA REHAB, V1, P1; MILLER L, 1993, AM J FAM THER, V21, P111, DOI 10.1080/01926189308250910; *NAT HEAD INJ FDN, 1985, ED MAN WHAT ED NEED; Orsillo SM, 1993, J HEAD TRAUMA REHAB, V8, DOI [DOI 10.1097/00001199-199303000-00010, 10.1097/00001199-199303000-00010]; Panting A., 1972, REHABILITATION, V38, P33; PARKE RD, 1986, FAMILIES HANDICAPPED, P101; RIVARA JB, 1993, ARCH PHYS MED REHAB, V74, P1047, DOI 10.1016/0003-9993(93)90060-N; RIVARA JB, 1992, ARCH PHYS MED REHAB, V73, P899; ROMANO MD, 1974, SCAND J REHABIL MED, V6, P1; Rosenthal M, 1988, J HEAD TRAUMA REHAB, V3, P42; ROSENTHAL M, 1983, REHABILITATION HEAD, P407; Sheridan S. M., 1996, CONJOINT BEHAV CONSU; SHERIDAN SM, 1992, J SCHOOL PSYCHOL, V30, P117, DOI 10.1016/0022-4405(92)90025-Z; SIMEONSSON RJ, 1986, FAMILIES HANDICAPPED, P67; SLATER EJ, 1987, PSYCHIAT ANN, V17, P786, DOI 10.3928/0048-5713-19871201-08; Taylor S C, 1980, Matern Child Nurs J, V9, P109; Testani-Dufour L, 1992, J Neurosci Nurs, V24, P317; WAALAND PK, 1990, COMMUNITY INTEGRATIO, P224; ZARSKI J, 1988, J HEAD TRAUMA REHAB, V3, P31; ZARSKI JJ, 1987, AM J FAM THER, V15, P62	65	22	22	0	1	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0022-2194	1538-4780		J LEARN DISABIL-US	J. Learn. Disabil.	NOV	1996	29	6					662	669		10.1177/002221949602900610			8	Education, Special; Rehabilitation	Education & Educational Research; Rehabilitation	VU234	WOS:A1996VU23400010	8942310				2021-06-18	
J	Fenton, GW				Fenton, GW			The postconcussional syndrome reappraised	CLINICAL ELECTROENCEPHALOGRAPHY			English	Article; Proceedings Paper	Annual Spring Review Course and Meeting of the American-Medical-EEG-Association	FEB   24, 1996	CHARLESTON, SC	Amer Med EEG Assoc		brainstem auditory evoked potential; electroencephalography; head injury, minor; postconcussional syndrome; quantitative EEG	MINOR HEAD-INJURY; CONCUSSION; SEQUELAE			Fenton, GW (corresponding author), UNIV DUNDEE,NINEWELLS HOSP & MED SCH,DEPT PSYCHIAT,DUNDEE DD1 9SY,SCOTLAND.						Barth JT, 1996, CLIN ELECTROENCEPHAL, V27, P183; Brown GW., 1978, SOCIAL ORIGINS DEPRE; CHIAPPA KH, 1990, EVOKED POTENTIALS CL; COOPER R, 1965, ELECTROEN CLIN NEURO, V18, P217, DOI 10.1016/0013-4694(65)90088-X; Dow RS, 1944, AM J PSYCHIAT, V101, P174, DOI 10.1176/ajp.101.2.174; DRAKE ME, 1996, AM MED EEG ASS M CHA; DUFFY FH, 1996, CLIN ELECTROENCEPHAL, V27, P104; FENTON G, 1993, BRIT J PSYCHIAT, V162, P493, DOI 10.1192/bjp.162.4.493; Henderson S, 1981, NEUROSIS SOCIAL ENV; JOHNSON LC, 1975, BEHAVIOR BRAIN ELECT, P1; KATZ MM, 1963, PSYCHOL REP, V13, P503, DOI 10.2466/pr0.1963.13.2.503; Levin HS, 1989, MILD HEAD INJURY; LISHMAN WA, 1988, BRIT J PSYCHIAT, V153, P460, DOI 10.1192/bjp.153.4.460; LISHMAN WA, 1968, BRIT J PSYCHIAT, V114, P373, DOI 10.1192/bjp.114.509.373; MACFLYNN G, 1984, J NEUROL NEUROSUR PS, V47, P1326, DOI 10.1136/jnnp.47.12.1326; MONTGOMERY EA, 1991, PSYCHOL MED, V21, P375, DOI 10.1017/S0033291700020481; NOSEWORTHY JH, 1981, ARCH NEUROL-CHICAGO, P275; PRATAPCHAND R, 1988, ACTA NEUROL SCAND, V78, P185, DOI 10.1111/j.1600-0404.1988.tb03643.x; RIZZO PA, 1983, NEUROPSYCHOBIOLOGY, V9, P78, DOI 10.1159/000117941; ROWE MJ, 1980, ARCH NEUROL-CHICAGO, V37, P679, DOI 10.1001/archneur.1980.00500600027002; RUTHERFORD WH, 1977, LANCET, V1, P1; Schoenhuber R, 1983, J Neurosurg Sci, V27, P157; SCHOENHUBER R, 1989, MILD HEAD INJURY, P142; Strauss I, 1934, ARCH NEURO PSYCHIATR, V31, P893, DOI 10.1001/archneurpsyc.1934.02250050011001; THATCHER RW, 1989, ELECTROEN CLIN NEURO, V73, P94, DOI 10.1016/0013-4694(89)90188-0; Trimble MR, 1981, POSTTRAUMATIC NEUROS; WATSON MR, 1995, BRIT J PSYCHIAT, V167, P514, DOI 10.1192/bjp.167.4.514	27	22	23	0	2	CLINICAL EEG	ELM GROVE	850 ELM GROVE RD,SUITE 11, ELM GROVE, WI 53122	0009-9155			CLIN ELECTROENCEPHAL	Clin. Electroencephalogr.	OCT	1996	27	4					174	182					9	Engineering, Biomedical; Clinical Neurology	Engineering; Neurosciences & Neurology	XA211	WOS:A1996XA21100002	9465280				2021-06-18	
J	Soblosky, JS; Tabor, SL; Matthews, MA; Davidson, JF; Chorney, DA; Carey, ME				Soblosky, JS; Tabor, SL; Matthews, MA; Davidson, JF; Chorney, DA; Carey, ME			Reference memory and allocentric spatial localization deficits after unilateral cortical brain injury in the rat	BEHAVIOURAL BRAIN RESEARCH			English	Article						memory; spatial localization; reference memory; allocentric; parietal cortex; sensorimotor cortex; traumatic brain injury; rat	DORSOMEDIAL PREFRONTAL CORTEX; MEDIAL AGRANULAR CORTEX; PARIETAL CORTEX; HIPPOCAMPAL FUNCTION; POSTERIOR PARIETAL; BILATERAL LESIONS; CAUDATE-NUCLEUS; NEGLECT; ORGANIZATION; DISSOCIATION	Traumatic brain injury (TBI) produces learning and memory impairments in humans. This study investigated the effects of TBI on memory and spatial localization strategies in rats. Prior to TBI, separate groups of rats were trained in an 8-arm radial maze with either all 8 arms baited (Expt. 1) or only 4 of the 8 arms baited (Expt. 2). TBI was produced by a controlled pneumatic impactor striking the entire right sensorimotor cortex of the anesthetized rat. Rats used in Expt. 1 were selected because they did not use a stereotypic response strategy (going to adjacent arms) in performing the maze before injury. After TBI the rats were not different from control rats in the number of working memory (WM) errors made. They did, however, display a distinct propensity to go to adjacent arms, i.e., exhibit stereotypic behavior, with a right-handed (ipsiversive) bias (P<0.005). After TBI, rats which were trained with only 4 of 8 arms baited committed more reference memory (RM) errors than control rats (P<0.05). They did not differ from controls on WM errors. Injured rats took longer to re-attain criteria than controls (P<0.0001). Injured rats also initially displayed a propensity to enter the adjacent arm sequentially before re-attaining criteria. Further analysis indicated that injured rats re-learned the maze with a right-hand bias (P<0.0001). The results of both experiments suggest that after TBI, rats shifted from an allocentric to an egocentric strategy to re-learn the maze. It was suggested that damage to the parietal cortex may have been responsible for both RM errors and the shift away from an allocentric strategy to an egocentric strategy. Possibly, the ipsiversive (right-hand) bias may be the result of a behaviorally or injury-induced neurochemical asymmetry within the motor system.	LOUISIANA STATE UNIV,MED CTR,DEPT ANAT,NEW ORLEANS,LA 70112	Soblosky, JS (corresponding author), LOUISIANA STATE UNIV,MED CTR,DEPT NEUROSURG,NEUROTRAUMA RES LAB,1542 TULANE AVE,NEW ORLEANS,LA 70112, USA.			Lane, Diane/0000-0001-7313-557X			BENTON AL, 1969, HDB CLIN NEUROLOGY, P212; BUSTO R, 1987, J CEREBR BLOOD F MET, V7, P729, DOI 10.1038/jcbfm.1987.127; BUTTERS N, 1972, PERCEPT MOTOR SKILL, V34, P27, DOI 10.2466/pms.1972.34.1.27; COOK D, 1988, BEHAV NEURAL BIOL, V49, P332, DOI 10.1016/S0163-1047(88)90338-X; CORWIN JV, 1986, EXP NEUROL, V94, P683, DOI 10.1016/0014-4886(86)90247-5; CORWIN JV, 1994, BEHAV BRAIN RES, V61, P49; CROWNE DP, 1992, BEHAV NEUROSCI, V106, P808, DOI 10.1037/0735-7044.106.5.808; CROWNE DP, 1986, BEHAV BRAIN RES, V22, P227, DOI 10.1016/0166-4328(86)90067-7; DALE RHI, 1986, BEHAV BRAIN RES, V19, P17, DOI 10.1016/0166-4328(86)90043-4; de Olmos JS, 1981, NEUROANATOMICAL TRAC, P117; DERENZI E, 1977, J NEUROL NEUROSUR PS, V40, P498, DOI 10.1136/jnnp.40.5.498; DHILLON HS, 1994, J NEUROTRAUM, V11, P405, DOI 10.1089/neu.1994.11.405; DIMATTIA BD, 1988, BEHAV NEUROSCI, V102, P471, DOI 10.1037/0735-7044.102.4.471; DIXON CE, 1991, J NEUROSCI METH, V39, P253; FOREMAN N, 1992, BEHAV NEUROSCI, V106, P529, DOI 10.1037/0735-7044.106.3.529; GLICK SD, 1973, BRIT J PHARMACOL, V4, P316; HALL RD, 1974, BRAIN RES, V66, P23, DOI 10.1016/0006-8993(74)90076-6; HAMM RJ, 1992, J NEUROTRAUM, V9, P11, DOI 10.1089/neu.1992.9.11; HARRELL LE, 1987, BEHAV NEUROSCI, V101, P644, DOI 10.1037/0735-7044.101.5.644; JANIS LS, 1994, BEHAV NEUROSCI, V5, P892; JARRARD LE, 1993, BEHAV NEURAL BIOL, V60, P9, DOI 10.1016/0163-1047(93)90664-4; JARRARD LE, 1986, HIPPOCAMPUS, V4, P93; JONES TA, 1992, BEHAV BRAIN RES, V51, P1, DOI 10.1016/S0166-4328(05)80306-7; KESNER RP, 1989, BEHAV NEUROSCI, V103, P956, DOI 10.1037/0735-7044.103.5.956; KESNER RP, 1987, BEHAV NEURAL BIOL, V47, P40, DOI 10.1016/S0163-1047(87)90145-2; KING V, 1990, BEHAV BRAIN RES, V37, P169, DOI 10.1016/0166-4328(90)90092-S; KING VR, 1992, BEHAV BRAIN RES, V50, P53; KING VR, 1993, BEHAV BRAIN RES, V54, P117, DOI 10.1016/0166-4328(93)90070-7; KOLB B, 1987, BEHAV BRAIN RES, V23, P127, DOI 10.1016/0166-4328(87)90050-7; LANKE J, 1993, BRAIN RES, V605, P221, DOI 10.1016/0006-8993(93)91744-D; Levin H. S., 1985, CENTRAL NERVOUS SYST, P281; Lighthall JW, 1988, J NEUROTRAUM, V5, P1, DOI 10.1089/neu.1988.5.1; LOWENSTEIN DH, 1992, J NEUROSCI, V12, P4846; LYETH BG, 1990, BRAIN RES, V526, P249, DOI 10.1016/0006-8993(90)91229-A; MORRIS RGM, 1986, Q J EXP PSYCHOL-B, V38, P365; NEAFSEY EJ, 1986, BRAIN RES REV, V11, P77, DOI 10.1016/0165-0173(86)90011-1; OLTON DS, 1979, NEUROPSYCHOLOGIA, V17, P669, DOI 10.1016/0028-3932(79)90042-3; OLTON DS, 1976, J EXP PSYCHOL-ANIM B, V2, P97, DOI 10.1037/0097-7403.2.2.97; PELLEGRINO I, 1979, STEREOTAXIC ATLAS RA; POHL W, 1973, J COMP PHYSIOL PSYCH, V82, P227, DOI 10.1037/h0033922; PYCOCK CJ, 1980, NEUROSCIENCE, V5, P461, DOI 10.1016/0306-4522(80)90048-2; SEMMES J, 1963, BRAIN, V86, P747, DOI 10.1093/brain/86.4.747; SMITH DH, 1994, NEUROSCI LETT, V168, P151, DOI 10.1016/0304-3940(94)90438-3; SOBLOSKY JS, IN PRESS BEHAV BRAIN; SWITZER RC, 1991, NEUROSCI BIOBEHAV R, V15, P89, DOI 10.1016/S0149-7634(05)80097-1; VARGO JM, 1988, EXP NEUROL, V102, P199, DOI 10.1016/0014-4886(88)90094-5; YAMAMOTO BK, 1982, LIFE SCI, V30, P2155, DOI 10.1016/0024-3205(82)90289-2; YAMAMOTO BK, 1983, LIFE SCI, V34, P675; ZIMMERBERG B, 1975, BRAIN RES, V86, P335, DOI 10.1016/0006-8993(75)90707-6; ZIMMERBERG B, 1974, SCIENCE, V185, P623, DOI 10.1126/science.185.4151.623	50	22	22	1	2	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0166-4328			BEHAV BRAIN RES	Behav. Brain Res.	OCT	1996	80	1-2					185	194		10.1016/0166-4328(96)00034-4			10	Behavioral Sciences; Neurosciences	Behavioral Sciences; Neurosciences & Neurology	VM959	WOS:A1996VM95900020	8905142				2021-06-18	
J	Lee, MS; Lee, SB; Kim, WC				Lee, MS; Lee, SB; Kim, WC			Spasmodic dysphonia associated with a left ventrolateral putaminal lesion	NEUROLOGY			English	Article							DYSTONIA	A 34-year-old man presented with a 30-year history of spasmodic dysphonia. He developed a speech disturbance 1 month after a closed head injury due to a fall. Sighing, coughing, and crying were normal. He had a tremor of the right hand when he drew a vertical line. His out-stretched right hand had a minimal dystonic posture with occasional jerks of the fingers. T-1-weighted axial brain MRI study showed a low signal intensity lesion at the putamen; coronal and axial T-2-weighted MRI brain scans showed a high and low signal intensity lesion confined to the middle part of the ventrolateral putamen. Damage to the ventrolateral putamen may have caused abnormal voluntary control of the laryngeal muscles.		Lee, MS (corresponding author), YONSEI UNIV,COLL MED,YOUNGDONG SEVERANCE HOSP,DEPT NEUROL,146-92 DOGOK DONG,SEOUL 120749,SOUTH KOREA.						BHATIA KP, 1994, BRAIN, V117, P859, DOI 10.1093/brain/117.4.859; BLITZER A, 1988, LARYNGOSCOPE, V98, P636; ISSAC K, 1989, NEUROLOGY, V39, P1642; JANCOVIC J, 1986, ARCH NEUROL-CHICAGO, V43, P866; LEE MS, 1994, NEUROLOGY, V44, P1374, DOI 10.1212/WNL.44.8.1374; LEE MS, 1994, MOV DISORD, V9, P494; MARSDEN CD, 1985, BRAIN, V108, P463, DOI 10.1093/brain/108.2.463; Obeso J A, 1988, Adv Neurol, V50, P113; SCHAEFER S, 1985, ANN OTO RHINOL LARYN, V94, P595; SCHAEFER SD, 1983, LARYNGOSCOPE, V93, P1183	10	22	22	0	3	LITTLE BROWN CO	BOSTON	34 BEACON STREET, BOSTON, MA 02108-1493	0028-3878			NEUROLOGY	Neurology	SEP	1996	47	3					827	828		10.1212/WNL.47.3.827			2	Clinical Neurology	Neurosciences & Neurology	VG596	WOS:A1996VG59600038	8797490				2021-06-18	
J	Zwaagstra, R; Schmidt, I; Vanier, M				Zwaagstra, R; Schmidt, I; Vanier, M			Recovery of speed of information processing in closed-head-injury patients	JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY			English	Article							REACTION-TIME; MODELS	After severe traumatic brain injury, patients almost invariably demonstrate a slowing of reaction time, reflecting a slowing of central information processing. Methodological problems associated with the traditional method for the analysis of longitudinal data (MANOVA) severely complicate studies on cognitive recovery. It is argued that multilevel models are often better suited for the analysis of improvement over time in clinical settings. Multilevel models take into account individual differences in both overall performance level and recovery. These models enable individual predictions for the recovery of speed of information processing. Recovery is modelled in a group of closed-head-injury patients (N = 24). Recovery was predicted by age and severity of injury, as indicated by coma duration. Over a period up to 44 months post trauma, reaction times were found to decrease faster for patients with longer coma duration.	UNIV GRONINGEN,DEPT NEUROPSYCHOL & GERONTOL,GRONINGEN,NETHERLANDS; INST READAPTAT,CTR RECH,MONTREAL,PQ,CANADA	Zwaagstra, R (corresponding author), UNIV GRONINGEN,DEPT STAT & MEASUREMENT THEORY,GROTE KRUISSTR 2-1,NL-9712 TS GRONINGEN,NETHERLANDS.						Bryk A.S., 1992, HIERARCHICAL LINEAR; BRYK AS, 1987, PSYCHOL BULL, V101, P147, DOI 10.1037/0033-2909.101.1.147; DELEEUW J, 1995, J EDUC BEHAV STAT, V20, P171, DOI 10.3102/10769986020002171; Diggle PJ, 1990, TIME SERIES BIOSTATI; DYE OA, 1975, THESIS OHIO U; FRANCIS DJ, 1991, J CONSULT CLIN PSYCH, V59, P27, DOI 10.1037/0022-006X.59.1.27; GRONWALL DMA, 1974, NEUROPSYCHOLOGICAL E; KREFT IGG, 1994, AM STAT, V48, P324, DOI 10.2307/2684845; MCCULLAGH P, 1989, GENERALIZED LINEAR M; MCFLYNN G, 1984, J NEUROL NEUROSUR PS, V47, P1326; PONSFORD J, 1992, J CLIN EXP NEUROPSYC, V14, P822, DOI 10.1080/01688639208402865; Prosser R. J, 1991, ML3 SOFTWARE 3 LEVEL; SPIKMAN JM, UNPUB RECOVERY ATTEN; Stuss D. T., 1989, CLIN NEUROPSYCHOL, V3, P145, DOI DOI 10.1080/13854048908403287; STUSS DT, 1989, J NEUROL NEUROSUR PS, V52, P742, DOI 10.1136/jnnp.52.6.742; TEASDALE G, 1974, LANCET, V2, P81; Van Zomeren AH., 1994, CLIN NEUROPSYCHOLOGY; VANDERSCHOOT R, 1986, 8632 U GRON DEP NEUR; VANZOMEREN AH, 1978, J NEUROL NEUROSUR PS, V41, P452, DOI 10.1136/jnnp.41.5.452	19	22	22	0	3	SWETS ZEITLINGER PUBLISHERS	LISSE	P O BOX 825, 2160 SZ LISSE, NETHERLANDS	1380-3395			J CLIN EXP NEUROPSYC	J. Clin. Exp. Neuropsychol.	JUN	1996	18	3					383	393		10.1080/01688639608408995			11	Psychology, Clinical; Clinical Neurology; Psychology	Psychology; Neurosciences & Neurology	VF466	WOS:A1996VF46600006	8877622				2021-06-18	
J	Armstead, WM				Armstead, WM			Role of vasopressin in altered pial artery responses to dynorphin and beta-endorphin following brain injury	JOURNAL OF NEUROTRAUMA			English	Article						cerebral circulation; newborn; opioids	CEREBRAL BLOOD-FLOW; HYPOTENSIVE NEWBORN PIGS; CEREBROSPINAL-FLUID; ENDOGENOUS OPIOIDS; HEAD-INJURY; CIRCULATION; CATS	Pial artery constriction following fluid percussion brain injury (FPI) is associated with elevated CSF dynorphin and beta-endorphin concentration in newborn pigs. Additionally, dynorphin is a dilator under control conditions and a vasoconstrictor under decreased cerebrovascular tone conditions. Vasopressin contributes to beta-endorphin-induced pial constriction and the constrictor potential for dynorphin. Recently, it has been observed that FPI reverses vasopressin from a dilator to a constrictor. The present study was designed to characterize the effect of FPI on beta-endorphin-induced constriction and the role of vasopressin in that constriction as well as in the reversal of dynorphin's vascular response following FPI. Brain injury of moderate severity (1.9 - 2.3 atm) was produced in anesthetized newborn pigs equipped with a closed cranial window. Dynorphin in physiologic and pharmacologic concentrations (10(-10), 10(-8), 10(-6) M) was reversed from a dilator to a constrictor following FPI (7 +/- 1, 11 +/- 1, and 16 +/- 1 vs -4 +/- 1, -7 +/- 1, and -11 +/- 1% before and after FPI, respectively). Dynorphin-induced vascular changes were accompanied by increased cortical periarachnoid CSF vasopressin and these biochemical changes were potentiated following FPI (24 +/- 4 vs 134 +/- 7 and 53 +/- 7 vs 222 +/- 14 pg/mL for control and dynorphin (10(-6) M) before and after FPI, respectively). In contrast, in animals pretreated with the vasopressin receptor antagonist [1-(beta-mercapto-beta beta-cyclopentamethylene propionic acid) 2-(O-methyl)-Tyr-AVP] (MEAVP, 5 mu g/kg iv), dynorphin-induced constriction following FPI was attenuated (6 +/- 1, 12 +/- 1, and 16 +/- 1, vs -2 +/- 1, -4 +/- 1, and -7 +/- 1% before and after FPI, respectively). Additionally, beta-endorphin-induced pial constriction was potentiated following FPI (-7 +/- 1, -10 +/- 1, -15 +/- 1 vs -10 +/- 1 -15 +/- 2, and -21 +/- 2% for beta-endorphin (10(-10), 10(-8), 10(-6) M) before and after FPI, respectively). beta-endorphin-induced CSF vasopressin release was similarly potentiated following FPI. Further, MEAVP blunted the augmented constrictor responses to beta-endorphin observed following FPI (-5 +/- 1, -9 +/- 1, -14 +/- 1 vs -2 +/- 1, -5 +/- 1, and -8 +/- 1% before and after FPI, respectively). These data indicate that FPI potentiates beta-endorphin-induced pial construction and reverses dynorphin from a dilator to a constrictor. Additionally, these data show that vasopressin contributes to augmented beta-endorphin pial constriction and the reversal of dynorphin's vascular effects following FPI. Further, since CSF dynorphin and beta-endorphin concentrations are increased following FPI, these data suggest that these two opioids contribute to pial artery constriction observed following FPI, at least, in part, via the release of vasopressin.	UNIV PENN,DEPT ANESTHESIA,PHILADELPHIA,PA 19104; UNIV PENN,DEPT PHARMACOL,PHILADELPHIA,PA 19104	Armstead, WM (corresponding author), CHILDRENS HOSP PHILADELPHIA,DEPT ANESTHESIA,34TH ST & CIVIC CTR BLVD,PHILADELPHIA,PA 19104, USA.						ARMSTEAD WM, 1995, BRAIN RES, V689, P183, DOI 10.1016/0006-8993(95)00533-V; ARMSTEAD WM, 1994, BRAIN RES, V660, P19, DOI 10.1016/0006-8993(94)90834-6; ARMSTEAD WM, 1991, CIRC RES, V68, P922, DOI 10.1161/01.RES.68.4.922; ARMSTEAD WM, 1994, J NEUROTRAUM, V11, P487, DOI 10.1089/neu.1994.11.487; ARMSTEAD WM, 1990, AM J PHYSIOL, V258, pH408; ARMSTEAD WM, 1989, CIRC RES, V64, P136, DOI 10.1161/01.RES.64.1.136; ARMSTEAD WM, 1992, AM J PHYSIOL, V263, pH1670; ARMSTEAD WM, 1992, J PHARMACOL EXP THER, V260, P1107; ARMSTEAD WM, 1992, AM J PHYSIOL, V262, pH862; ARMSTEAD WM, 1996, IN PRESS AM J PHYSL; BRUCE DA, 1973, J NEUROSURG, V38, P131, DOI 10.3171/jns.1973.38.2.0131; COLOMBANI PM, 1985, J PEDIATR SURG, V20, P8, DOI 10.1016/S0022-3468(85)80382-1; EKELUND L, 1974, NEURORADIOLOGY, V7, P209, DOI 10.1007/BF00342700; FIESCHI C, 1972, EUR NEUROL, V8, P192, DOI 10.1159/000114577; HALL ED, 1987, BRAIN RES, V435, P174, DOI 10.1016/0006-8993(87)91599-X; HANKO J, 1981, CEREBRAL MICROCIRCUL, P157; HAYES RL, 1983, J NEUROSURG, V58, P720, DOI 10.3171/jns.1983.58.5.0720; HAYES RL, 1990, J NEUROSURG, V72, P252, DOI 10.3171/jns.1990.72.2.0252; KATUSIC ZS, 1984, CIRC RES, V55, P575, DOI 10.1161/01.RES.55.5.575; LASSOFF S, 1980, BRAIN RES, V196, P266, DOI 10.1016/0006-8993(80)90736-2; LLUCH S, 1984, J PHARMACOL EXP THER, V228, P749; MCCULLOUGH D, 1971, J TRAUM, V11, P422, DOI 10.1097/00005373-197105000-00007; MCINTOSH TK, 1992, J NEUROTRAUM, V9, pS201; MCINTOSH TK, 1987, BRAIN RES, V425, P225, DOI 10.1016/0006-8993(87)90505-1; MCINTOSH TK, 1993, J NEUROTRAUM, V10, P373, DOI 10.1089/neu.1993.10.373; MCINTOSH TK, 1988, NEUR ABSTR, V4, P1152; OVERGAARD J, 1974, J NEUROSURG, V41, P531, DOI 10.3171/jns.1974.41.5.0531; PERIYASAMY S, 1990, LIFE SCI, V47, P219, DOI 10.1016/0024-3205(90)90323-J; PERRY DC, 1990, NEUR ABSTR, V16, P242; THOROGOOD MC, 1995, AM J PHYSIOL-HEART C, V269, pH1776; VENTURA C, 1992, CIRC RES, V70, P66, DOI 10.1161/01.RES.70.1.66; VINK R, 1991, AM J PHYSIOL, V261, pR1527; VINK R, 1990, J NEUROSCI, V10, P3524; WEI EP, 1980, CIRC RES, V46, P37, DOI 10.1161/01.RES.46.1.37	34	22	22	0	0	MARY ANN LIEBERT INC PUBL	LARCHMONT	2 MADISON AVENUE, LARCHMONT, NY 10538	0897-7151			J NEUROTRAUM	J. Neurotrauma	MAR	1996	13	3					115	123		10.1089/neu.1996.13.115			9	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	UD469	WOS:A1996UD46900001	8965321				2021-06-18	
J	RUAN, JS; PRASAD, P				RUAN, JS; PRASAD, P			COUPLING OF A FINITE-ELEMENT HUMAN HEAD MODEL WITH A LUMPED-PARAMETER HYBRID-III DUMMY MODEL - PRELIMINARY-RESULTS	JOURNAL OF NEUROTRAUMA			English	Article; Proceedings Paper	Head Injury 1994 - International Symposium on Head Injury Research	OCT 12-14, 1994	WASHINGTON, D.C.	Natl Highway Traff Safety Adm, Head Injury Res Program, George Washington Univ		BRAIN INJURY; FINITE ELEMENT; IMPACT; SKULL FRACTURE		A skull-brain finite element model of the human head has been coupled with a multilink rigid body model of the Hybrid III dummy, The experimental coupled model is intended to represent anatomically a 50th percentile human to the extent the dummy and the skull-brain model represent a human, It has been verified by simulating several human cadaver head impact tests as well as dummy head ''impacts'' during barrier crashes in an automotive environment, Skull-isostress and brain-isostrain response curves were established based on model calibration of experimental human cadaver tolerance data, The skull-isostress response curve agrees with the JARI Human Head Impact Tolerance Curve for skull fracture, The brain-isostrain response curve predicts a higher G level for concussion than does the JARI concussion curve and the Wayne State Tolerance Curve at the longer time duration range. Barrier crash simulations consist of belted dummies impacting an airbag, a hard and soft steering wheel hub, and no head contact with vehicle interior components. Head impact force, intracranial pressures and strains, skull stress, and head center-of-gravity acceleration were investigated as injury parameters, Head injury criterion (HIC) was also calculated along with these parameters, Preliminary results of the model simulations in those impact conditions are discussed.	FORD MOTOR CO, ADV VEHICLE SYST ENGN, DEARBORN, MI USA							Anzelius A, 1943, ACTA PATHOL MICROB S, V48, P153; CHENG LY, 1990, VEHICLE CRASHWORTHIN, P141; CHU CS, 1994, J BIOMECH, V27, P187, DOI 10.1016/0021-9290(94)90208-9; DIMASI F, 1991, 12TH P INT TECHN C E, P617; HODGSON VR, 1977, DOTHS1462230 WAYN ST; Hosey R. R., 1982, FINITE ELEMENTS BIOM, P379; HUBBARD RP, 1971, J BIOMECH, V4, P251, DOI 10.1016/0021-9290(71)90031-5; KHALIL TB, 1977, J BIOMECH, V10, P119, DOI 10.1016/0021-9290(77)90075-6; LEE ES, 1990, THESIS GEORGIA I TEC; LEE MC, 1987, 31ST STAPP CAR CRASH; MARGULIES SS, 1992, J BIOMECH, V25, P917, DOI 10.1016/0021-9290(92)90231-O; MCELHANEY JH, 1970, J BIOMECH, V3, P495, DOI 10.1016/0021-9290(70)90059-X; MELVIN JW, 1969, 11TH P MIDW MECH C, V5, P811; Mendis K., 1992, THESIS OHIO STATE U; NAHUM AM, 1977, 21ST P SATPP CAR CRA; ONO K, 1980, 24TH P STAPP CAR CRA; Patrick LM, 1965, 7TH P STAPP CAR CRAS, P483; PLUCHE R, 1985, HEAD INJURY PREVENTI, P235; PRASAD P, 1985, SAE851246 PAP; RUAN JS, 1994, J BIOMECH ENG-T ASME, V116, P44, DOI 10.1115/1.2895703; RUAN JS, 1991, J BIOMECH ENG-T ASME, V113, P276, DOI 10.1115/1.2894885; RUAN JS, 1994, 38TH P STAPP CAR CRA; RUAN JS, 1993, 37TH P STAPP CAR CRA; SHUGAR TA, 1975, J ENG MECH DIV-ASCE, V101, P223; SHUGAR TA, 1977, DOTHS2893550TA REP, V1; Tong P, 1989, 12 INT TECHN C SAF V, P617; UENO K, 1991, CRASHWORTHINESS OCCU, V19, P121; UENO K, 1989, CRASHWORTHINESS OCCU, V13, P123; WARD CC, 1975, 19TH P STAPP CAR CRA; WARD CC, 1978, AVIATION SPACE E JAN, P136; WOOD JL, 1971, J BIOMECH, V4, P1, DOI 10.1016/0021-9290(71)90010-8	31	22	25	0	9	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	AUG	1995	12	4					725	734		10.1089/neu.1995.12.725			10	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	RY920	WOS:A1995RY92000024	8683624				2021-06-18	
J	PETERS, CL; SCOTT, SM				PETERS, CL; SCOTT, SM			COMPARTMENT SYNDROME IN THE FOREARM FOLLOWING FRACTURES OF THE RADIAL HEAD OR NECK IN CHILDREN	JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME			English	Article								A volar compartment syndrome of the forearm was identified following a minimally displaced or angulated fracture of the radial head or neck in three children. The fractures were due to a fail from a bed or from a standing height on an outstretched hand. All three patients had symptoms and signs that were consistent with elevated intracompartmental pressure in the forearm when they were first examined, twelve to twenty-four hours after the injury, and all were managed with an emergency fasciotomy of the forearm. The radial fracture was treated without reduction in the first patient, with manipulative closed reduction in the second patient, and with open reduction and stabilization with Kirschner wires in the third patient. All three patients had a full functional recovery.	PRIMARY CHILDRENS MED CTR,SALT LAKE CITY,UT 84113	PETERS, CL (corresponding author), UNIV UTAH,SCH MED,DIV ORTHOPED SURG,50 N MED DR,SALT LAKE CITY,UT 84132, USA.						EATON RG, 1975, CLIN ORTHOP RELAT R, P58, DOI 10.1097/00003086-197511000-00009; EATON RG, 1965, J BONE JOINT SURG AM, VA 47, P1289; FOWLES JV, 1986, J PEDIATR ORTHOPED, V6, P51; GARBER JN, 1939, J BONE JOINT SURG, V21, P154; GELBERMAN RH, 1981, CLIN ORTHOPAEDICS, V161, P252; HENRIKSON B, 1969, ACTA ORTHOP SCAND, V40, P246, DOI 10.3109/17453676908989505; Henry AK, 1970, EXTENSILE EXPOSURE, P100; HERNANDEZ J, 1986, J PEDIATR ORTHOPED, V6, P627, DOI 10.1097/01241398-198609000-00020; HOLDEN CEA, 1975, CLIN ORTHOP RELAT R, V113, P95; JONES E R L, 1971, Journal of Bone and Joint Surgery British Volume, V53, P429; LINDHAM S, 1979, ACTA ORTHOP SCAND, V50, P79, DOI 10.3109/17453677909024093; MERCHAN ECR, 1991, ORTHOPEDICS, V14, P697; MUBARAK SJ, 1979, J BONE JOINT SURG BR, V61, P285; MUBARAK SJ, 1976, J BONE JOINT SURG AM, V58, P1016, DOI 10.2106/00004623-197658070-00022; MUBARAK SJ, 1993, COMMUNICATION; NEWMAN JH, 1977, INJURY, V9, P114, DOI 10.1016/0020-1383(77)90004-3; O'Brien P I, 1965, Clin Orthop Relat Res, V41, P51; OGDEN JA, 1990, SKELETAL INJURY CHIL, P451; SALTER RB, 1963, J BONE JOINT SURG AM, V45, P587, DOI 10.2106/00004623-196345030-00019; SCULLION JE, 1985, J BONE JOINT SURG BR, V67, P491; SHALL J, 1986, J BONE JOINT SURG AM, V68A, P1451, DOI 10.2106/00004623-198668090-00024; STEINBERG EL, 1988, J PEDIATR ORTHOPED, V8, P35, DOI 10.1097/01241398-198801000-00009; VAHVANEN V, 1978, ACTA ORTHOP SCAND, V49, P32, DOI 10.3109/17453677809005720; WHITESIDES TE, 1975, CLIN ORTHOP RELAT R, V113, P43	24	22	22	0	1	JOURNAL BONE JOINT SURGERY INC	NEEDHAM	20 PICKERING ST, NEEDHAM, MA 02192	0021-9355			J BONE JOINT SURG AM	J. Bone Joint Surg.-Am. vol.	JUL	1995	77A	7					1070	1074		10.2106/00004623-199507000-00014			5	Orthopedics; Surgery	Orthopedics; Surgery	RJ671	WOS:A1995RJ67100014	7608230				2021-06-18	
J	WOESSNER, R; CAPLAN, B				WOESSNER, R; CAPLAN, B			AFFECTIVE-DISORDERS FOLLOWING MILD-TO-MODERATE BRAIN INJURY - INTERPRETIVE HAZARDS OF THE SCL-90-R	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						ASSESSMENT; BRAIN INJURY; COGNITIVE IMPAIRMENT; PSYCHOPATHOLOGY	BLUNT HEAD-INJURY; MULTIPLE-SCLEROSIS; RELATIVES VIEW; SPINAL-CORD; SYMPTOMS; PERSONALITY; ADJUSTMENT; MMPI	This article describes an analysis of the Symptom Checklist-90-Revised (SCL-90-R), a self-report measure of emotional distress, demonstrating potentially misleading scale elevations (ie, psychopathology) in data from 23 patients with mild to moderate traumatic brain injury (initial Glasgow Coma Scale score range = 9-15). Average scores were significantly higher than those for the normative control group on 88 of 90 symptoms, seven of nine individual dimensions, and three summary indices. A considerable portion of these elevations was attributable to endorsement of 14 items (15.5%) identified by experts as ''usual consequences'' of traumatic head injury. The Obsessive-Compulsive, Hostility, and Depression scales were especially weighted with brain injury symptoms. These findings corroborate previous reports concerning the hazards of applying to neurological patients psychological instruments that were normed on physically healthy populations. Scores that would indicate pathological abnormality in the latter group may hold substantially different diagnostic significance for the former group. Clinicians should inspect individual responses to self-report questionnaires and seek confirmation from additional sources.	THOMAS JEFFERSON MED COLL,DEPT REHABIL MED,PHILADELPHIA,PA; THOMAS JEFFERSON UNIV HOSP,DEPT REHABIL MED,PHILADELPHIA,PA 19107	WOESSNER, R (corresponding author), MOSS REHABIL HOSP,DEPT PSYCHOL,PHILADELPHIA,PA 19141, USA.						Alfano Dennis P, 1990, Clin Neuropsychol, V4, P69, DOI 10.1080/13854049008401498; ALFANO DP, 1993, NEUROPSY NEUROPSY BE, V6, P111; ALFANO DP, 1991, NEUROPSYCHOLOGY, V5, P35; ALVES WM, 1989, MILD MODERATE HEAD I; Binder Laurence M, 1990, Clin Neuropsychol, V4, P25, DOI 10.1080/13854049008401494; BINDER LM, 1986, J CLIN EXP NEUROPSYC, V8, P323, DOI 10.1080/01688638608401325; BROOKS DN, 1983, J NEUROL NEUROSUR PS, V46, P336, DOI 10.1136/jnnp.46.4.336; BROOKS N, 1986, J NEUROL NEUROSUR PS, V49, P764, DOI 10.1136/jnnp.49.7.764; BROOKS N, 1990, TRAUMATIC BRAIN INJU; Christensen B., 1994, ADV MED PSYCHOTHER, V7, P23; Cook J B, 1972, Scand J Rehabil Med, V4, P27; CRIPE LI, 1977, CLIN NEUROPSYCHOL, V2, P492; CYR JJ, 1988, J SOC BEHAV PERS, V3, P245; DEROGATIS L R, 1973, Psychopharmacology Bulletin, V9, P13; Derogatis L. R, 1983, ADM SCORING PROCEDUR; DICESARE A, 1990, COGNITIVE REHABILITA, V8, P14; DIKMEN S, 1977, ANN NEUROL, V2, P492, DOI 10.1002/ana.410020608; DIKMEN S, 1989, MILD HEAD INJURY; DILLER I, 1994, BRAIN INJURY NEUROPS; GASS CS, 1991, J CLIN PSYCHOL, V17, P253; GASS CS, 1991, PSYCHOL ASSESSMENT J, V3, P27; GEORGE MS, 1992, BEHAV NEUROL, V5, P3, DOI 10.3233/BEN-1992-5101; GRANT I, 1987, NEUROBEHAVIORAL RECO; GREEN CJ, 1982, HDB CLIN HLTH PSYCHO; HARRINGTON RG, 1994, ASSESS REHABIL EXCEP, V1, P58; Jennett B, 1981, MANAGEMENT HEAD INJU; JENNETT B, 1984, CLOSED HEAD INJURY P; KOZOL HL, 1945, ARCH NEURO PSYCHIATR, V53, P358, DOI 10.1001/archneurpsyc.1945.02300050032004; KRAUS JF, 1993, HEAD INJURY; LEVIN H, 1989, MILD MODERATE HEAD I; LEZAK MD, 1990, J CLIN EXP NEUROPSYC, V12, P50; LISHMAN WA, 1987, ORGANIC PSYCHIATRY; McCaffrey R. J., 1993, J HEAD TRAUMA REHAB, V8, P38; MCKEON J, 1984, BRIT J PSYCHIAT, V144, P190, DOI 10.1192/bjp.144.2.190; MCKINLAY WW, 1983, J NEUROL NEUROSUR PS, V46, P1084, DOI 10.1136/jnnp.46.12.1084; MCMORDIE WR, 1988, CLIN NEUROPSYCHOL, V2, P198; MEYERINK LH, 1988, J CLIN PSYCHOL, V44, P764, DOI 10.1002/1097-4679(198809)44:5<764::AID-JCLP2270440517>3.0.CO;2-Y; MILLER H, 1972, LANCET, V1, P580; MILLER H, 1966, P ROY SOC MED, V59, P257, DOI 10.1177/003591576605900327; MILLER JD, 1990, REHABILITATION ADULT; NELSON LD, 1989, J CONSULT CLIN PSYCH, V1, P266; NOVACK TA, 1984, INT J CLIN NEUROPSYC, V6, P139; ODDY M, 1978, J NEUROL NEUROSUR PS, V41, P611, DOI 10.1136/jnnp.41.7.611; ODONNELL WE, 1984, J CLIN PSYCHOL, V40, P241, DOI 10.1002/1097-4679(198401)40:1<241::AID-JCLP2270400147>3.0.CO;2-6; OHARA C, 1988, COGNITIVE REHABILITA, V6, P26; PAYNE RW, 1985, 9TH MENTAL MEASUREME, V2; Prigatano G. P., 1991, AWARENESS DEFICIT BR; PRIGATANO GP, 1987, NEUROPSYCHOLOGICAL R; RICHARDSON JTE, 1990, CLIN NEUROPSYCHOLOGI; ROBINSON RG, 1981, ANN NEUROL, V9, P447, DOI 10.1002/ana.410090506; RUFF RM, 1993, J HEAD TRAUMA REHAB, V8, P60, DOI DOI 10.1097/00001199-199309000-00008; RUSSELL WR, 1971, TRAUMATIC AMNESIAS; SCHMIDT MM, 1990, AUG ANN M AM PSYCH A; SILVER JM, 1990, J CLIN PSYCHIAT, V51, P33; TATE DG, 1990, REHABIL PSYCHOL, V35, P211, DOI 10.1037/h0079062; TAYLOR GP, 1970, J CONSULT CLIN PSYCH, V35, P183, DOI 10.1037/h0030127; TENNEN H, 1987, TEST CRITIQUES, V3; Varney NR, 1987, NEUROPSYCHOLOGY, V1, P7, DOI 10.1037//0894-4105.1.1.7; WEDDELL R, 1980, PSYCHOL MED, V10, P257, DOI 10.1017/S0033291700044019; Willis SC., 1991, PSYCHOL ASSESSMENT J, V3, P175, DOI [10.1037/1040-3590.3.2.175, DOI 10.1037/1040-3590.3.2.175]	60	22	23	0	2	ASPEN PUBL INC	FREDERICK	7201 MCKINNEY CIRCLE, FREDERICK, MD 21701	0885-9701			J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	APR	1995	10	2					78	89		10.1097/00001199-199504000-00009			12	Clinical Neurology; Rehabilitation	Neurosciences & Neurology; Rehabilitation	QR039	WOS:A1995QR03900009					2021-06-18	
J	VAKIL, E; TWEEDY, JR				VAKIL, E; TWEEDY, JR			MEMORY FOR TEMPORAL-ORDER AND SPATIAL POSITION INFORMATION - TESTS OF THE AUTOMATIC-EFFORTFUL DISTINCTION	NEUROPSYCHIATRY NEUROPSYCHOLOGY AND BEHAVIORAL NEUROLOGY			English	Article						EFFORTFUL; AUTOMATIC; SPATIAL; AMNESIA; JUDGMENT TASK; BRAIN INJURY	ELDERLY ADULTS; LOCATION; FREQUENCY; INTENTIONALITY; YOUNG	Information about the temporal and spatial context of events has been postulated by Hasher and Zacks in 1979 to accumulate in memory via processes that are relatively unaffected by subject variables like age and ability, or task variables such as instructions or practice. These ''automatic'' processes have been distinguished from ''effortful'' processes, which are affected by these variables. To evaluate these predictions, we tested memory for temporal order and spatial position in groups of young adults recovering from traumatic brain injuries, normal elderly, and normal young adults, using a design that allowed examination of the effects of practice and instructions. Our results indicate that both traumatic brain injury and aging reduce performance on tasks tapping retention of temporal and spatial information if the subject is asked for a relatively precise estimate of the requested information. These effects tend to disappear when estimation tasks are designed, or errors are analyzed, in a way that allows subjects full credit for only partial information about an item's temporospatial context of presentation. The presence of these task and analysis effects that can eliminate existing differences, calls for reevaluation of those studies in which Hasher and Zacks' criteria for automaticity were satisfied.	GAYLORD HOSP,WALLINGFORD,CT	VAKIL, E (corresponding author), BAR ILAN UNIV,DEPT PSYCHOL,IL-52900 BAR ILAN,ISRAEL.						ATTIG MS, 1981, J GERONTOL, V35, P66; AUDY BC, 1988, B PSYCHONOMIC SOC, V26, P548; AZARI NP, 1989, B PSYCHONOMIC SOC, V27, P203, DOI 10.3758/BF03334584; BADDELEY A, 1987, NEUROBEHAVIORAL RECO, P295; BUTTERS N, 1975, HIPPOCAMPUS, V2; ELLIS NR, 1991, B PSYCHONOMIC SOC, V29, P28; ELLIS NR, 1989, AM J MENT RETARD, V93, P521; ELLIS NR, 1990, MEM COGNITION, V18, P584, DOI 10.3758/BF03197101; ELLIS NR, 1987, J EXP CHILD PSYCHOL, V44, P401, DOI 10.1016/0022-0965(87)90042-7; HASHER L, 1984, AM PSYCHOL, V39, P1372, DOI 10.1037/0003-066X.39.12.1372; HASHER L, 1979, J EXP PSYCHOL GEN, V108, P356, DOI 10.1037/0096-3445.108.3.356; HIRST W, 1982, PSYCHOL BULL, V91, P435, DOI 10.1037/0033-2909.91.3.435; HIRST W, 1984, BRAIN COGNITION, V1, P294; HUPPERT FA, 1978, Q J EXP PSYCHOL, V30, P347, DOI 10.1080/14640747808400681; HUPPERT FA, 1976, CORTEX, V12, P3, DOI 10.1016/S0010-9452(76)80024-X; JACOBY LL, 1982, HUMAN MEMORY AMMENSI; Levin H. S., 1989, J CLIN EXP NEUROPSYC, V12, P129; MCCORMACK PD, 1982, J GERONTOL, V37, P80, DOI 10.1093/geronj/37.1.80; MCCORMACK PD, 1981, DEV PSYCHOL, V17, P509; Meudell P, 1982, NORMALITY PATHOLOGY, P203; MOORE TE, 1984, J GERONTOL, V39, P210, DOI 10.1093/geronj/39.2.210; NAVEHBENJAMIN M, 1990, J EXP PSYCHOL LEARN, V16, P117, DOI 10.1037/0278-7393.16.1.117; NAVEHBENJAMIN M, 1988, MEM COGNITION, V16, P437, DOI 10.3758/BF03214224; NAVEHBENJAMIN M, 1987, J EXP PSYCHOL LEARN, V13, P595, DOI 10.1037/0278-7393.13.4.595; PARK DC, 1982, J GERONTOL, V37, P330, DOI 10.1093/geronj/37.3.330; PERLMUTTER M, 1980, J GERONTOL, V36, P59; POSNER MI, 1975, INFORMATION PROCESSI; PZDEK K, 1983, DEV PSYCHOL, V19, P895; SCHACTER DL, 1987, J EXP PSYCHOL LEARN, V13, P501, DOI 10.1037/0278-7393.13.3.501; SHIMAMURA AP, 1986, Q J EXP PSYCHOL-A, V38, P619, DOI 10.1080/14640748608401617; SIEMENS L, 1989, AM J PSYCHOL, V1, P53; THORDIKE EL, 1944, TEACHERS BOOK 30000; TWEEDY JR, 1988, J CLIN EXP NEUROPSYC, V10, P664, DOI 10.1080/01688638808402803; VAKIL E, 1991, J CLIN EXP NEUROPSYC, V13, P291, DOI 10.1080/01688639108401044; von Wright J M, 1975, J Exp Child Psychol, V20, P181, DOI 10.1016/0022-0965(75)90037-5; Wechsler D, 2008, WECHSLER ADULT INTEL, V4th; ZACKS RT, 1984, MEM COGNITION, V12, P387, DOI 10.3758/BF03198299	37	22	23	0	3	LIPPINCOTT-RAVEN PUBL	PHILADELPHIA	227 EAST WASHINGTON SQ, PHILADELPHIA, PA 19106	0894-878X			NEUROPSY NEUROPSY BE	Neuropsychiatr. Neuropsychol. Behav. Neurol.	OCT	1994	7	4					281	288					8	Clinical Neurology; Psychiatry; Psychology	Neurosciences & Neurology; Psychiatry; Psychology	PY002	WOS:A1994PY00200006					2021-06-18	
J	GORAJ, B; RIFKINSONMANN, S; LESLIE, DR; LANSEN, TA; KASOFF, SS; TENNER, MS				GORAJ, B; RIFKINSONMANN, S; LESLIE, DR; LANSEN, TA; KASOFF, SS; TENNER, MS			CORRELATION OF INTRACRANIAL-PRESSURE AND TRANSCRANIAL DOPPLER RESISTIVE INDEX AFTER HEAD TRAUMA	AMERICAN JOURNAL OF NEURORADIOLOGY			English	Article						HEAD, INJURIES; HEAD, ULTRASOUND; ULTRASOUND, DOPPLER; BRAIN, PRESSURE	CEREBRAL BLOOD-FLOW; BRAIN INJURIES; ULTRASOUND; VELOCITY; HYPERTENSION; ARTERY	PURPOSE: To investigate the usefulness of transcranial Doppler ultrasonography in the evaluation of intracranial pressure changes after head injury. METHODS: Transcranial Doppler examinations and intracranial pressure measurements using intraparenchymal monitors were performed in 12 cases of closed head injury. Twenty-four sets of data, including the Glasgow Coma Scale, intracranial pressure, transcranial Doppler, and carbon dioxide pressure were compared. The side-to-side difference in the resistivity index was also assessed. RESULTS: There was a significant correlation between increased pressure values and resistivity index when comparing measurements from the same side. There was no correlation between carbon dioxide pressure and any transcranial Doppler parameter or intracranial pressure measurement. No significant correlation was found between the resistivity index and the Glasgow Coma Scale. End diastolic velocity was a stronger determinant of resistivity index than peak systolic velocity. CONCLUSION: The relationship of ipsilateral measurements of intracranial pressure to resistivity index is valid. The resistivity index must be analyzed within the context of the particular disease studied, especially with respect to the hemodynamic alterations. Initial findings suggest that intracranial pressure monitoring cannot be replaced by serial transcranial Doppler measurements in the treatment of the patient with acute head injury.	WESTCHESTER CTY MED CTR,NEW YORK MED COLL,DEPT NEUROSURG,VALHALLA,NY 10595; NEW YORK MED COLL,DEPT RADIOL,VALHALLA,NY 10595							AASLID R, 1982, J NEUROSURG, V57, P769, DOI 10.3171/jns.1982.57.6.0769; Aaslid R., 1986, TRANSCRANIAL DOPPLER, P22, DOI DOI 10.1007/978-3-7091-8864-4_3; Aaslid R., 1986, TRANSCRANIAL DOPPLER, P39; ARCHER LNJ, 1986, PEDIATR RES, V20, P218, DOI 10.1203/00006450-198603000-00004; BADA HS, 1983, J PEDIATR, V100, P191; BECKER DP, 1990, NEUROLOGICAL SURG, P2017; BODE H, 1988, PEDIATRIC APPLICATIO, P115; CHAN KH, 1992, NEUROSURGERY, V30, P697; GILSBACH J, 1986, TRANSCRANIAL DOPPLER, P106; GOH D, 1991, EUR J PEDIATR SURG, V1, P14, DOI 10.1055/s-2008-1042529; HARDERS AG, 1986, NEUROSURGICAL APPL T, P27; Huber P, 1967, Invest Radiol, V2, P17, DOI 10.1097/00004424-196701000-00016; JACKSONPRATT M, 1985, CENTRAL NERVOUS SYST; JENNETT B, 1982, MANAGEMENT HEAD INJU, P111; KLINGELHOFER J, 1988, J NEUROL, V235, P159, DOI 10.1007/BF00314307; LINDEGAARD KF, 1982, TRANSCRANIAL DOPPLER, P67; MAMAROU A, 1982, HEAD INJURY, P115; MAMAROU A, 1992, J NEUROTRAUM, V9, pS327; MARKWALDER TM, 1984, J CEREBR BLOOD F MET, V4, P368, DOI 10.1038/jcbfm.1984.54; MILES RD, 1987, J ULTRAS MED, V6, P597; MILLER JD, 1977, J NEUROSURG, V47, P503, DOI 10.3171/jns.1977.47.4.0503; MILLER JD, 1981, J NEUROSURG, V54, P289, DOI 10.3171/jns.1981.54.3.0289; OBRIST WD, 1984, J NEUROSURG, V61, P241, DOI 10.3171/jns.1984.61.2.0241; SANKER P, 1991, CHILD NERV SYST, V7, P391, DOI 10.1007/BF00304204; SAUR JL, 1993, TRANSCRANIAL DOPPLER, P11; SHIGEMORI M, 1990, ACTA NEUROCHIR, V107, P5, DOI 10.1007/BF01402605; SIEBERT JJ, 1989, RADIOLOGY, V171, P155; VRIENS E M, 1989, Ultrasound in Medicine and Biology, V15, P1, DOI 10.1016/0301-5629(89)90125-7; WEBER M, 1990, NEUROSURGERY, V27, P106, DOI 10.1227/00006123-199007000-00015; WILKINSON HA, 1990, NEUROLOGICAL SURG, P661	30	22	22	0	1	AMER SOC NEURORADIOLOGY	OAK BROOK	2210 MIDWEST RD, OAK BROOK, IL 60521	0195-6108			AM J NEURORADIOL	Am. J. Neuroradiol.	AUG	1994	15	7					1333	1339					7	Clinical Neurology; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	PB622	WOS:A1994PB62200023	7976946				2021-06-18	
J	HAMM, RJ; PIKE, BR; ODELL, DM; LYETH, BG				HAMM, RJ; PIKE, BR; ODELL, DM; LYETH, BG			TRAUMATIC BRAIN INJURY ENHANCES THE AMNESIC EFFECT OF AN NMDA ANTAGONIST IN RATS	JOURNAL OF NEUROSURGERY			English	Article						BRAIN INJURY; FLUID-PERCUSSION INJURY; AMNESIA; MEMORY; GLUTAMATE; RAT	ASPARTATE RECEPTOR ANTAGONIST; LONG-TERM POTENTIATION; SELECTIVE IMPAIRMENT; HEAD-INJURY; AVOIDANCE; MOTOR; RETENTION; BEHAVIOR; RECOVERY; BLOCKADE	The authors have examined the effect of experimental traumatic brain injury on the amnesia produced by the N-methyl-D-aspartate (NMDA) antagonist MK-801. Rats were either subjected to a moderate level of fluid-percussion injury or prepared for injury but not injured (''sham injury''). Nine days following injury or sham injury, the rats were injected either with saline (sham/saline group, nine rats; injured/saline group, nine rats) or with 0.1 mg/kg of MK-801 (sham/MK-801 group, nine rats; injured/MK-801 group, eight rats) 30 minutes before being trained on a passive-avoidance task. Twenty-four hours later, the rats were tested for retention of the passive-avoidance task. Results revealed that the low dose of MK-801 did not significantly affect retention of the passive-avoidance task in the sham-injured group. In injured animals, administration of MK-801 produced a profound amnesia in contrast to the sham-injured animals treated with MK-801 and the injured animals treated with saline. To further investigate this enhanced sensitivity to the amnesic effects of MK-801 exhibited by the injured animals, nine injured and eight sham-injured rats were injected with 0.3 mg/kg of MK-801 15 minutes before injury. Results indicated that the animals treated with MK-801 before injury did not significantly differ from the sham-injured animals in retention of the passive-avoidance task. In addition, test results in the animals treated with MK-801 before injury and reinjected with MK-801 before passive-avoidance testing did not differ from those in untreated injured animals reinjected with saline before passive-avoidance testing. These findings indicate that MK-801 treatment before injury prevented the enhanced sensitivity to MK-801-induced amnesia that follows traumatic brain injury.	VIRGINIA COMMONWEALTH UNIV,MED COLL VIRGINIA,DEPT NEUROSURG,RICHMOND,VA 23298	HAMM, RJ (corresponding author), VIRGINIA COMMONWEALTH UNIV,MED COLL VIRGINIA,DEPT PSYCHOL,VCU BOX 842018,RICHMOND,VA 23284, USA.			Lyeth, Bruce/0000-0003-4811-1474	NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS12587] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P50NS012587, P01NS012587] Funding Source: NIH RePORTER		Brooks N, 1987, Brain Inj, V1, P5, DOI 10.3109/02699058709034439; BUTELMAN ER, 1990, PHARMACOL BIOCHEM BE, V35, P533, DOI 10.1016/0091-3057(90)90285-P; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; FAUGIERGRIMAUD S, 1978, NEUROPSYCHOLOGIA, V16, P151, DOI 10.1016/0028-3932(78)90103-3; FEENEY DM, 1990, CAN J PSYCHOL, V44, P233, DOI 10.1037/h0084243; FEENEY DM, 1987, CRIT REV NEUROBIOL, V3, P135; FEENEY DM, 1983, PSYCHOPHARMACOLOGY, V79, P67, DOI 10.1007/BF00433018; FEENEY DM, 1988, PHARM APPROACHES TRE, P121; FEENEY DM, 1991, J NEUROL REHABIL, V5, P113; GANDOLFI O, 1990, NEUROSCI LETT, V113, P304, DOI 10.1016/0304-3940(90)90602-6; HAMM RJ, 1992, NEUROSURGERY, V31, P1072, DOI 10.1227/00006123-199212000-00013; Hayes RL, 1988, J NEUROTRAUM, V5, P259, DOI 10.1089/neu.1988.5.259; HAYS RL, 1992, J NEUROTRAUMA S1, V9, pS173; KATAYAMA Y, 1990, J NEUROSURG, V73, P889, DOI 10.3171/jns.1990.73.6.0889; KIM M, 1992, BRAIN RES, V585, P35, DOI 10.1016/0006-8993(92)91188-K; LYETH B G, 1989, Society for Neuroscience Abstracts, V15, P1113; LYETH BG, 1990, BRAIN RES, V526, P249, DOI 10.1016/0006-8993(90)91229-A; McIntosh TK, 1989, J NEUROTRAUM, V6, P247, DOI 10.1089/neu.1989.6.247; MILLER LP, 1990, BRAIN RES, V526, P103, DOI 10.1016/0006-8993(90)90254-9; MIYAZAKI S, 1992, BRAIN RES, V585, P335, DOI 10.1016/0006-8993(92)91232-4; MONDADORI C, 1989, EXP BRAIN RES, V75, P449; MORRIS RGM, 1989, J NEUROSCI, V9, P3040; MORRIS RGM, 1986, NATURE, V319, P774, DOI 10.1038/319774a0; ODDY M, 1985, J NEUROL NEUROSUR PS, V48, P564, DOI 10.1136/jnnp.48.6.564; PAOLI F, 1990, PSYCHOPHARMACOLOGY, V100, P130, DOI 10.1007/BF02245803; POVLISHOCK J T, 1989, Society for Neuroscience Abstracts, V15, P1113; RAY M H, 1991, Society for Neuroscience Abstracts, V17, P167; RIMEL RW, 1982, NEUROSURGERY, V11, P344, DOI 10.1227/00006123-198209000-00002; Smith DH, 1991, J NEUROTRAUM, V8, P259, DOI 10.1089/neu.1991.8.259; Von Monakow C, 1969, BRAIN BEHAVIOR, P27; WHISHAW IQ, 1989, PSYCHOPHARMACOLOGY, V98, P500, DOI 10.1007/BF00441949	32	22	22	0	0	AMER ASSOC NEUROLOGICAL SURGEONS	CHARLOTTESVILLE	UNIV VIRGINIA, 1224 WEST MAIN ST, STE 450, CHARLOTTESVILLE, VA 22903	0022-3085			J NEUROSURG	J. Neurosurg.	AUG	1994	81	2					267	271		10.3171/jns.1994.81.2.0267			5	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	NY086	WOS:A1994NY08600018	8027812				2021-06-18	
J	MUNTE, TF; HEINZE, HJ				MUNTE, TF; HEINZE, HJ			BRAIN POTENTIALS REVEAL DEFICITS OF LANGUAGE PROCESSING AFTER CLOSED-HEAD INJURY	ARCHIVES OF NEUROLOGY			English	Article							EVENT-RELATED POTENTIALS; RECOGNITION MEMORY; LEXICAL DECISION; WORD REPETITION; FREQUENCY WORDS; DISSOCIATION; TASK	Objective: To delineate deficits in language processing after closed head injury with use of behavioral measures and event-related brain potentials. Design: Case-control design. All subjects participated in three verbal event-related brain potential experiments, and the resulting measures were compared both within and between groups. Patients/Controls: Eleven patients at least 2 years after severe closed head injury (Glasgow Coma Scale score < 8 at admission and duration of posttraumatic amnesia > 48 hours) were compared with a control group matched for age and educational level. Interventions: None. Main Outcome Measures: Reaction times and percentage correct as behavioral measures in the three experiments (sentence verification, semantic and repetition priming with lexical decision task, and continuous word recognition). Event-related brain potentials were quantified by area measures in successive time windows for the different experimental conditions and for different experiments. Results: The reaction times of the patient group were significantly longer than those of the controls (P < .005). Similarly, the patients' accuracy was significantly worse in all experiments (P < .03). The event-related brain potentials of the controls showed a clear and significant reduction of a negative component (N400) to terminal words of true sentences (sentence verification experiment), semantically primed words and repeated words (lexical decision experiment), and recognized words (continuous word recognition). For the patients, a clear N400 effect was seen only in the sentence verification task (delayed by about 100 milliseconds), while only later event-related brain potential modulations were seen in the other tasks. Conclusion: Language functions are disturbed after closed head injury. The electrophysiologic data suggest difficulties in the integration of incoming linguistic stimuli with the previous context as a possible underlying cause.		MUNTE, TF (corresponding author), HANNOVER MED SCH,DEPT NEUROL,D-30623 HANNOVER,GERMANY.		Munte, Thomas/C-2077-2014				BENTIN S, 1985, ELECTROEN CLIN NEURO, V60, P343, DOI 10.1016/0013-4694(85)90008-2; BFOE GA, 1982, BRAIN IMPAIRMENT, P187; BLUMSTEIN SE, 1982, BRAIN LANG, V17, P301, DOI 10.1016/0093-934X(82)90023-2; CAMPBELL K, 1986, CEREBRAL PSYCHOPHYSI, P197; CRAIK FIM, 1972, J VERB LEARN VERB BE, V11, P671, DOI 10.1016/S0022-5371(72)80001-X; Curry S H, 1980, Prog Brain Res, V54, P507, DOI 10.1016/S0079-6123(08)61668-4; Donchin E, 1986, PSYCHOPHYSIOLOGY SYS, P244; FISCHLER I, 1990, EVENT RELATED BRAIN, P245; FRIEDMAN D, 1990, BIOL PSYCHOL, V30, P61, DOI 10.1016/0301-0511(90)90091-A; GOLDSTEIN FC, 1990, J CLIN EXP NEUROPSYC, V12, P186; GRONWALL D, 1987, NEUROBEHAVIORAL RECO, P355; HALGREN E, 1987, HUM NEUROBIOL, V6, P129; HEINZE HJ, 1992, NEUROPSYCHOLOGIA, V30, P495, DOI 10.1016/0028-3932(92)90054-P; HILLYARD SA, 1983, ANNU REV PSYCHOL, V34, P33, DOI 10.1146/annurev.ps.34.020183.000341; HOLCOMB PJ, 1990, LANG COGNITIVE PROC, V5, P281, DOI 10.1080/01690969008407065; JENNINGS JR, 1976, PSYCHOPHYSIOLOGY, V13, P277; Jordan F M, 1988, Brain Inj, V2, P179, DOI 10.3109/02699058809150943; KUTAS M, 1980, SCIENCE, V207, P203, DOI 10.1126/science.7350657; KUTAS M, 1980, BIOL PSYCHOL, V11, P99, DOI 10.1016/0301-0511(80)90046-0; KUTAS M, 1988, ADV PSYCHOPHYSIOLOGY, V3, P230; LEVIN HS, 1981, BRAIN LANG, V12, P360, DOI 10.1016/0093-934X(81)90025-0; LEVIN HS, 1990, J CLIN EXP NEUROPSYC, V12, P69; LEZAK MD, 1983, NEUROPSYCHOLOGICAL A; MCCALLUM WC, 1973, ELECTROEN CLIN NEURO, V35, P449, DOI 10.1016/0013-4694(73)90020-5; MUNTE TF, 1990, EEG-EMG-Z ELEK ELEKT, V21, P75; MUNTE TF, 1989, BRAIN DYNAMICS, V11, P436; NAGY ME, 1989, PSYCHOPHYSIOLOGY, V26, P431, DOI 10.1111/j.1469-8986.1989.tb01946.x; PAPANICOLAOU AC, 1984, NEUROSURGERY, V14, P676, DOI 10.1227/00006123-198406000-00005; Penn C, 1988, Brain Inj, V2, P3, DOI 10.3109/02699058809150928; RIZZO PA, 1978, ELECTROEN CLIN NEURO, V45, P281, DOI 10.1016/0013-4694(78)90012-3; RUFF RM, 1986, SAN DIEGO NEUROPSYCH; RUGG MD, 1992, J COGNITIVE NEUROSCI, V4, P69, DOI 10.1162/jocn.1992.4.1.69; RUGG MD, 1988, J NEUROL NEUROSUR PS, V51, P691, DOI 10.1136/jnnp.51.5.691; RUGG MD, 1990, MEM COGNITION, V18, P367, DOI 10.3758/BF03197126; RUGG MD, 1987, Q J EXP PSYCHOL-A, V39, P123, DOI 10.1080/02724988743000060; RUGG MD, 1989, ELECTROEN CLIN NEURO, V72, P395, DOI 10.1016/0013-4694(89)90045-X; RUGG MD, 1989, BRAIN, V112, P489, DOI 10.1093/brain/112.2.489; RUGG MD, IN PRESS COGNITIVE E; SANQUIST TF, 1980, PSYCHOPHYSIOLOGY, V17, P568, DOI 10.1111/j.1469-8986.1980.tb02299.x; SARNO MT, 1980, J NERV MENT DIS, V168, P685, DOI 10.1097/00005053-198011000-00008; SCHOLZ MB, 1989, Z EEG EMG, V20, P189; SHUM DHK, 1990, J CLIN EXP NEUROPSYC, V12, P247, DOI 10.1080/01688639008400971; SMITH ME, 1989, J EXP PSYCHOL LEARN, V15, P50, DOI 10.1037/0278-7393.15.1.50; STUSS DT, 1989, J NEUROL NEUROSUR PS, V52, P742, DOI 10.1136/jnnp.52.6.742; vansZomeren AH, 1987, NEUROBEHAVIORAL RECO, P398	45	22	22	0	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0003-9942			ARCH NEUROL-CHICAGO	Arch. Neurol.	MAY	1994	51	5					482	493		10.1001/archneur.1994.00540170058017			12	Clinical Neurology	Neurosciences & Neurology	NM110	WOS:A1994NM11000012	8179498				2021-06-18	
J	STEWART, WF; GORDON, B; SELNES, O; BANDEENROCHE, K; ZEGER, S; TUSA, RJ; CELENTANO, DD; SHECHTER, A; LIBERMAN, J; HAIL, C; SIMON, D; LESSER, R; RANDALL, RD				STEWART, WF; GORDON, B; SELNES, O; BANDEENROCHE, K; ZEGER, S; TUSA, RJ; CELENTANO, DD; SHECHTER, A; LIBERMAN, J; HAIL, C; SIMON, D; LESSER, R; RANDALL, RD			PROSPECTIVE-STUDY OF CENTRAL-NERVOUS-SYSTEM FUNCTION IN AMATEUR BOXERS IN THE UNITED-STATES	AMERICAN JOURNAL OF EPIDEMIOLOGY			English	Article						BOXING; CENTRAL NERVOUS SYSTEM; HEAD INJURIES; PROSPECTIVE STUDIES	CHRONIC BRAIN-DAMAGE; MINOR HEAD-INJURY; CONCUSSION; HUMANS	Active amateur boxers from six US cities were studied in 1986-1990 to determine whether changes in central nervous system function over a 2-year interval (as evaluated by tests of perceptual/motor function, attention/concentration, psychomotor speed, memory, visuoconstructional ability, and mental control, measures of ataxia and brainstem auditory evoked potentials, and electroencephalography) were associated with degree of participation in amateur boxing. A total of 484 participants were examined at baseline; 393 (81.2%) were examined 2 years later. At baseline, 22% of the participants had not yet competed in a bout; 9% had never competed in a bout by the second examination. Exposure was defined by number of bouts, sparring-years, and sparring with a professional boxer. Very few statistically significant odds ratios were found between exposure and change in function. Significant tests of trend were found between the total number of bouts incurred before the baseline examination and changes in memory, visuoconstructional ability, and perceptual/motor ability. The significant trends for change in function in the latter two domains were primarily due to performance on the Block Design test, which was common to both test domains. No statistically significant associations were found between more recent bouts (after the baseline visit) and any functional domains, nor between bouts or sparring and any other outcome measures. The significant trends with past bouts, but not more recent bouts, may reflect the need for a long latency period before effects are manifest. Alternatively, given changes in safety practices, the observed association may be related to more severe exposure from bouts that occurred before 1986, when new safety measures were imposed.	JOHNS HOPKINS UNIV HOSP,ZANVYL KRIEGER MIND BRAIN INST,DEPT NEUROL & COGNIT SCI,BALTIMORE,MD; JOHNS HOPKINS UNIV HOSP,DEPT NEUROL,BALTIMORE,MD 21205; JOHNS HOPKINS UNIV,SCH HYG & PUBL HLTH,DEPT BIOSTAT,BALTIMORE,MD; JOHNS HOPKINS UNIV,SCH HYG & PUBL HLTH,DEPT HLTH POLICY & MANAGEMENT,BALTIMORE,MD	STEWART, WF (corresponding author), JOHNS HOPKINS UNIV,SCH HYG & PUBL HLTH,DEPT EPIDEMIOL,ROOM 6033,615 N WOLFE ST,BALTIMORE,MD 21205, USA.			Zeger, Scott/0000-0001-8907-1603; Hall, Charles/0000-0001-9982-8120	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS026450] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS26450] Funding Source: Medline		ADAMS JH, 1982, ANN NEUROL, V12, P557, DOI 10.1002/ana.410120610; BENTON AL, 1968, NEUROPSYCHOLOGIA, V6, P53, DOI 10.1016/0028-3932(68)90038-9; BROOKS N, 1987, J NEUROL NEUROSUR PS, V50, P997, DOI 10.1136/jnnp.50.8.997; CARLSSON GS, 1987, J NEUROSURG, V67, P197, DOI 10.3171/jns.1987.67.2.0197; CASSON IR, 1984, JAMA-J AM MED ASSOC, V251, P2663, DOI 10.1001/jama.251.20.2663; CORSELLIS JA, 1973, PSYCHOL MED, V3, P270, DOI 10.1017/S0033291700049588; EGAN JP, 1975, SIGNAL DETECTION THE; FREGLY AR, 1973, ACTA OTO-LARYNGOL, V75, P10, DOI 10.3109/00016487309139631; Gennarelli T A, 1983, Acta Neurochir Suppl (Wien), V32, P1; GENNARELLI TA, 1982, ATHLETIC INJURIES HE; GRONWALL D, 1975, LANCET, V2, P995; Hage P, 1983, Phys Sportsmed, V11, P143, DOI 10.1080/00913847.1983.11708665; JANE JA, 1985, J NEUROSURG, V62, P96, DOI 10.3171/jns.1985.62.1.0096; JEDLINSKI J, 1970, ACTA MED POL, V12, P443; JOHNSON J, 1969, BRIT J PSYCHIAT, V115, P45, DOI 10.1192/bjp.115.518.45; KASTE M, 1982, LANCET, V2, P1186; KLOVE H, 1963, MED CLIN N AM, V47, P1647, DOI 10.1016/S0025-7125(16)33515-5; LAMPERT PW, 1984, JAMA-J AM MED ASSOC, V251, P2676, DOI 10.1001/jama.251.20.2676; LEVIN HS, 1987, J NEUROSURG, V66, P234, DOI 10.3171/jns.1987.66.2.0234; LUNDBERG GD, 1983, JAMA-J AM MED ASSOC, V249, P250, DOI 10.1001/jama.1983.03330260068037; MCLATCHIE G, 1987, J NEUROL NEUROSUR PS, V50, P96, DOI 10.1136/jnnp.50.1.96; MURELIUS O, 1991, ACTA NEUROL SCAND, V83, P9; OMMAYA AK, 1974, BRAIN, V97, P633, DOI 10.1093/brain/97.1.633; PARKINSON D, 1978, NEUROSURGERY, V3, P176, DOI 10.1227/00006123-197809000-00008; Raven J., 1960, GUIDE STANDARD PROGR; Rey A, 1964, EXAMEN CLIN PSYCHOL; Rey A, 1941, ARCH PSYCHOLOGIE, V28, P286; Roberts AH., 1969, BRAIN DAMAGE BOXERS; ROSS RJ, 1983, JAMA-J AM MED ASSOC, V249, P211, DOI 10.1001/jama.249.2.211; ROWE MJ, 1980, ARCH NEUROL-CHICAGO, V37, P679, DOI 10.1001/archneur.1980.00500600027002; Schoenhuber R, 1983, J Neurosurg Sci, V27, P157; SEROL M, 1962, WORLD NEUROL, V3, P351; Smith A., 1982, SYMBOL DIGIT MODALIT; THOMASSEN A, 1979, ACTA NEUROL SCAND, V60, P352, DOI 10.1111/j.1600-0404.1979.tb07661.x; TYSVAER AT, 1991, AM J SPORT MED, V19, P56, DOI 10.1177/036354659101900109; Unterharnscheidt F J, 1972, Scand J Rehabil Med, V4, P77; WECHSLER D, 1989, WECHSLER ADULT INTEL; ZEGER SL, 1986, BIOMETRICS, V42, P121, DOI 10.2307/2531248; 1989, USA AMATEUR BOXING F; 1983, JAMA-J AM MED ASSOC, V249, P254; 1944, MANYAL DIRECTIONS SO	41	22	22	0	1	JOHNS HOPKINS UNIV SCHOOL HYGIENE PUB HEALTH	BALTIMORE	111 MARKET PLACE, STE 840, BALTIMORE, MD 21202-6709	0002-9262			AM J EPIDEMIOL	Am. J. Epidemiol.	MAR 15	1994	139	6					573	588		10.1093/oxfordjournals.aje.a117047			16	Public, Environmental & Occupational Health	Public, Environmental & Occupational Health	NF396	WOS:A1994NF39600003	8172169				2021-06-18	
J	AXELROD, BN; GOLDMAN, RS; TOMPKINS, LM; JIRON, CC				AXELROD, BN; GOLDMAN, RS; TOMPKINS, LM; JIRON, CC			POOR DIFFERENTIAL PERFORMANCE ON THE WISCONSIN CARD SORTING TEST IN SCHIZOPHRENIA, MOOD DISORDER, AND TRAUMATIC BRAIN INJURY	NEUROPSYCHIATRY NEUROPSYCHOLOGY AND BEHAVIORAL NEUROLOGY			English	Article						PERSEVERATION; COGNITIVE PROCESSES; DEPRESSIVE DISORDERS	DORSOLATERAL PREFRONTAL CORTEX; CEREBRAL BLOOD-FLOW; NEUROPSYCHOLOGICAL ASSESSMENT; DYSFUNCTION	The utility of the Wisconsin Card Sorting Test (WCST) to effectively differentiate diagnostic groups was evaluated. Performance on the WCST was contrasted among samples of schizophrenic, mood-disordered, and traumatically brain-injured patients, as well as normal controls. The controls performed significantly better than all three patient groups, without any differentiation among the patient samples. The pattern of performance, over time, also did not differ between the groups. The poor discrimination between the patient groups may provide evidence for multiple cognitive processes being involved in WCST performance (e.g., attention, executive functioning). Consequently, similar WCST performance could result from deficiencies in different cognitive processes.	VET AFFAIRS MED CTR,ANN ARBOR,MI; UNIV MICHIGAN,ANN ARBOR,MI 48109; WINTER HAVEN HOSP,WINTER HAVEN,FL; WAYNE STATE UNIV,DETROIT,MI 48202	AXELROD, BN (corresponding author), VET AFFAIRS MED CTR,PSYCHOL SERV 116B,ALLEN PK,MI 48101, USA.						ADAMS KM, 1985, J CLIN EXP NEUROPSYC, V7, P445, DOI 10.1080/01688638508401276; AXELROD BN, 1992, CLIN NEUROPSYCHOLOGI, V6, P14; BRAFF DL, 1991, ARCH GEN PSYCHIAT, V48, P891; BUTLER M, 1991, PROF PSYCHOL-RES PR, V22, P510, DOI 10.1037/0735-7028.22.6.510; DREWE E A, 1974, Cortex, V10, P159; ENDICOTT J, 1978, ARCH GEN PSYCHIAT, V35, P837; GOLDBERG TE, 1990, ARCH NEUROL-CHICAGO, V47, P418, DOI 10.1001/archneur.1990.00530040062020; GOLDMAN RS, 1992, AM J PSYCHIAT, V149, P1718; GOLDMAN RS, 1991, J NERV MENT DIS, V179, P506; HAALAND KY, 1987, J GERONTOL, V42, P345, DOI 10.1093/geronj/42.3.345; Heaton R. K, 1981, WISCONSIN CARD SORTI; HEINRICHS RW, 1990, NEUROPSY NEUROPSY BE, V3, P107; Levin HS, 1989, MILD HEAD INJURY; MARTIN DJ, 1991, J CLIN PSYCHOL, V47, P684, DOI 10.1002/1097-4679(199109)47:5<684::AID-JCLP2270470509>3.0.CO;2-G; PAULMAN RG, 1990, BIOL PSYCHIAT, V27, P377, DOI 10.1016/0006-3223(90)90549-H; RAO SM, 1987, J CONSULT CLIN PSYCH, V55, P263, DOI 10.1037/0022-006X.55.2.263; ROBINSON AL, 1980, J CONSULT CLIN PSYCH, V48, P605, DOI 10.1037/0022-006X.48.5.605; SPITZER RL, 1978, RES DIAGNOSTIC CRITE; SWEET JJ, 1992, CLIN PSYCHOL REV, V12, P21, DOI 10.1016/0272-7358(92)90090-U; TAYLOR L, 1979, FUNCTIONAL NEUROSURG; WEINBERGER DR, 1986, ARCH GEN PSYCHIAT, V43, P114; WEINBERGER DR, 1988, ARCH GEN PSYCHIAT, V45, P609; 1987, DIAGNOSTIC STATISTIC	23	22	22	0	3	LIPPINCOTT-RAVEN PUBL	PHILADELPHIA	227 EAST WASHINGTON SQ, PHILADELPHIA, PA 19106	0894-878X			NEUROPSY NEUROPSY BE	Neuropsychiatr. Neuropsychol. Behav. Neurol.	JAN	1994	7	1					20	24					5	Clinical Neurology; Psychiatry; Psychology	Neurosciences & Neurology; Psychiatry; Psychology	NB540	WOS:A1994NB54000002					2021-06-18	
J	SLIFER, KJ; CATALDO, MD; BABBITT, RL; KANE, AC; HARRISON, KA; CATALDO, MF				SLIFER, KJ; CATALDO, MD; BABBITT, RL; KANE, AC; HARRISON, KA; CATALDO, MF			BEHAVIOR ANALYSIS AND INTERVENTION DURING HOSPITALIZATION FOR BRAIN TRAUMA REHABILITATION	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						BEHAVIOR; BRAIN INJURIES; REHABILITATION	CLOSED HEAD-INJURY; CHILDREN; SEQUELAE; DAMAGE		JOHNS HOPKINS UNIV,SCH MED,BALTIMORE,MD 21205	SLIFER, KJ (corresponding author), KENNEDY KRIEGER INST,DEPT BEHAV PSYCHOL,707 N BROADWAY,BALTIMORE,MD 21205, USA.				EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [P30HD024061] Funding Source: NIH RePORTER; NICHD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [HD 24061] Funding Source: Medline; PHS HHSUnited States Department of Health & Human ServicesUnited States Public Health Service [MCH917] Funding Source: Medline		ALBERTO PA, 1982, APPLIED BEHAVIOR ANA; ASARNOW RF, 1991, J PEDIATR PSYCHOL, V16, P543, DOI 10.1093/jpepsy/16.5.543; BLUMENTHAL JA, 1987, APPLICATIONS BEHAVIO; BROWN G, 1981, PSYCHOL MED, V11, P63, DOI 10.1017/S0033291700053289; COPPER JO, 1987, APPLIED BEHAVIOR ANA; DIVACK JA, 1985, HEAD INJURY RHEABILI, P352; DONDERS J, 1992, J ABNORM CHILD PSYCH, V20, P233, DOI 10.1007/BF00916690; FLETCHER JM, 1990, J CONSULT CLIN PSYCH, V58, P93, DOI 10.1037/0022-006X.58.1.93; Gerring J P, 1986, Pediatr Rev, V8, P115, DOI 10.1542/pir.8-4-115; GIANUTSAS R, 1987, REHABILITATION PSYCH; GROSS AM, 1990, HDB CLIN BEHAVIORAL; HARSEN M, 1981, BEHAV MODIF, P357; HERSEN M, 1978, SINGLE CASE EXPT DES; HOWARD ME, 1988, J HEAD TRAUMA REHAB, V3, P14; JAFFE KM, 1990, REHABILITATION ADULT, P541; KEDESDY JH, 1988, BEHAVIORAL MED DEV D; KRAUS JF, 1986, AM J DIS CHILD, V140, P687, DOI 10.1001/archpedi.1986.02140210085032; MACE FC, 1991, RES DEV DISABIL, V12, P155, DOI 10.1016/0891-4222(91)90004-C; MUIR CA, 1983, REHABILITATION HEAD, P381; OREILLY MF, 1990, J APPL BEHAV ANAL, V23, P431, DOI 10.1901/jaba.1990.23-431; PELHAM WE, 1982, BEHAVIORAL MED CLIN, P261; RIMM DC, 1979, BEHAVIOR THERAPY; ROSS AO, 1981, CHILD BEHAVIOR THERA; RUSSO DC, 1982, BEHAVIORAL PEDIATRIC; RUTTER M, 1981, AM J PSYCHIAT, V138, P1533; RUTTER M, 1977, J CHILD PSYCHOL PSYC, V18, P1, DOI 10.1111/j.1469-7610.1977.tb00413.x; SLATER EJ, 1988, AM J DIS CHILD, V142, P1048, DOI 10.1001/archpedi.1988.02150100042022; WILSON B, 1987, J CLIN EXP NEUROPSYC, V9, P527, DOI 10.1080/01688638708410767; WOOD R, 1988, J HEAD TRAUMA REHAB, V3, P53; Zencius A, 1989, Brain Inj, V3, P67, DOI 10.3109/02699058909008076; Zencius A H, 1989, Brain Inj, V3, P199, DOI 10.3109/02699058909004553; ZENCIUS A H, 1991, Brain Injury, V5, P369, DOI 10.3109/02699059109008109	32	22	22	0	2	W B SAUNDERS CO	PHILADELPHIA	INDEPENDENCE SQUARE WEST CURTIS CENTER, STE 300, PHILADELPHIA, PA 19106-3399	0003-9993			ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	AUG	1993	74	8					810	817		10.1016/0003-9993(93)90006-V			8	Rehabilitation; Sport Sciences	Rehabilitation; Sport Sciences	LR257	WOS:A1993LR25700005	8347066				2021-06-18	
J	SERVADEI, F; VERGONI, G; NASI, MT; STAFFA, G; DONATI, R; ARISTA, A				SERVADEI, F; VERGONI, G; NASI, MT; STAFFA, G; DONATI, R; ARISTA, A			MANAGEMENT OF LOW-RISK HEAD-INJURIES IN AN ENTIRE AREA - RESULTS OF AN 18-MONTH SURVEY	SURGICAL NEUROLOGY			English	Article						MINOR HEAD INJURY; SKULL X-RAY; ASYMPTOMATIC HEMATOMAS; EXTRADURAL HEMATOMAS; BRAIN CONTUSIONS; AVOIDABLE DEATHS	TRAUMATIC INTRACRANIAL HEMATOMA; EXTRADURAL HEMATOMAS; SKULL FRACTURE; CHILDREN; ADULTS; EPIDEMIOLOGY; DETERIORATE; TOMOGRAPHY; COUNTY; TALK	All patients admitted following a minor head injury (GCS is without neurological deficits) during an 18 month period in an entire area were submitted to the same diagnostic and therapeutic protocol. Adult patients were x rayed and in the cases with skull fracture (even asymptomatic), a computed tomographic (CT) scan was performed. Children (below the age of 14) did not routinely receive skull X-rays but were admitted to one of the five regional hospitals where a CT scanner was available 24 hours per day. Neuroradiologic investigations (carried out in over 600 patients) showed posttraumatic lesions in 201 cases; 113 of these patients were transferred to the neurosurgical center. There were 49 patients with extradural hematomas, 41 with brain contusions, 17 with depressed skull fractures, and six with subdural hematomas. Of these 113, 40 patients were operated on (mainly extradural hematomas); surgical indications were based on appearance of clinical deterioration, lesion volume, presence of midline, shift, and/or compressed third ventricle and basal cisterns. In eight cases there was a clinical deterioration to a GCS of 13 or less, in all of these patients, the CT diagnosis (and transfer to a neurosurgical center, preceded the onset of deterioration. All patients admitted to such a center had a good outcome, but a survey of deaths related to head injury in the area revealed two fatalities following minor head injury. The only avoidable death was a patient with multiple brain contusions who developed sudden brain swelling on day 12 posttrauma. We conclude that, even if management mortality is not zero, our protocol is sufficiently safe for the treatment of minor head injury.	OSPED BUFALINI,SERV NEURORADIOL,CESENA,ITALY	SERVADEI, F (corresponding author), OSPED BUFALINI,DIV NEUROSURG,VIA GHIROTTI 286,I-47023 CESENA,ITALY.			Servadei, Franco/0000-0002-3595-3464			ANNEGERS JF, 1980, NEUROLOGY, V30, P912, DOI 10.1212/WNL.30.9.912; BRIGGS M, 1984, BRIT MED J, V288, P983; BULLOCK R, 1985, NEUROSURGERY, V16, P602, DOI 10.1227/00006123-198505000-00003; BULLOCK R, 1990, HDB CLIN NEUROLOGY H, V13, P249; CHAN KH, 1990, J NEUROSURG, V72, P189, DOI 10.3171/jns.1990.72.2.0189; COOPER K D, 1983, Neuroepidemiology, V2, P70, DOI 10.1159/000110512; DACEY RG, 1986, J NEUROSURG, V65, P203, DOI 10.3171/jns.1986.65.2.0203; EDNA TH, 1983, ACTA CHIR SCAND, V149, P449; FEUERMAN T, 1988, NEUROSURGERY, V22, P449, DOI 10.1227/00006123-198803000-00001; FISHER RP, 1981, J TRAUMA, V21, P920; JENNETT B, 1981, BRIT MED J, V282, P101, DOI 10.1136/bmj.282.6258.101; JENNETT B, 1977, LANCET, V1, P873; KLAUBER MR, 1989, NEUROSURGERY, V24, P31, DOI 10.1227/00006123-198901000-00005; KLAUBER MR, 1981, AM J EPIDEMIOL, V113, P500, DOI 10.1093/oxfordjournals.aje.a113125; KNUCKEY NW, 1989, J NEUROSURG, V70, P392, DOI 10.3171/jns.1989.70.3.0392; LOBATO RD, 1991, J NEUROSURG, V75, P256, DOI 10.3171/jns.1991.75.2.0256; LUERSSEN TG, 1988, J NEUROSURG, V68, P409, DOI 10.3171/jns.1988.68.3.0409; MANN KS, 1986, CHILD NERV SYST, V2, P258; MARSHALL LF, 1983, J NEUROSURG, V59, P285, DOI 10.3171/jns.1983.59.2.0285; MENDELOW AD, 1983, BRIT MED J, V287, P1173, DOI 10.1136/bmj.287.6400.1173; MILLER JD, 1986, NEUROSURG REV, V9, P135, DOI 10.1007/BF01743065; MILLER JD, 1990, NEUROSURGERY, V27, P669, DOI 10.1227/00006123-199011000-00001; PANG D, 1983, J NEUROSURG, V59, P958, DOI 10.3171/jns.1983.59.6.0958; POZZATI E, 1986, NEUROSURGERY, V18, P696, DOI 10.1227/00006123-198606000-00003; RIMEL RW, 1987, NEUROSURGERY, V21, P51; ROCKSWOLD GL, 1987, NEUROSURGERY, V21, P51, DOI 10.1227/00006123-198707000-00010; SERVADEI F, 1989, ACTA NEUROCHIR, V96, P39, DOI 10.1007/BF01403493; SERVADEI F, 1988, SURG NEUROL, V30, P364, DOI 10.1016/0090-3019(88)90199-1; SERVADEI F, 1991, LANCET, V337, P788, DOI 10.1016/0140-6736(91)91403-H; STEIN SC, 1990, NEUROSURGERY, V26, P638, DOI 10.1227/00006123-199004000-00012; TEASDALE GM, 1990, BRIT MED J, V300, P363, DOI 10.1136/bmj.300.6721.363; VIGOUROUX RD, 1983, ADV NEUROTRAUMATOLOG, P128; VOLLMER DG, 1991, NEUROSURGERY CLIN N, P437	33	22	22	0	1	ELSEVIER SCIENCE INC	NEW YORK	655 AVENUE OF THE AMERICAS, NEW YORK, NY 10010	0090-3019			SURG NEUROL	Surg. Neurol.	APR	1993	39	4					269	275		10.1016/0090-3019(93)90003-J			7	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	LD877	WOS:A1993LD87700003	8488443				2021-06-18	
J	RIELLY, JP; BRANDT, ML; MATTOX, KL; POKORNY, WJ				RIELLY, JP; BRANDT, ML; MATTOX, KL; POKORNY, WJ			THORACIC TRAUMA IN CHILDREN	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article							EMERGENCY ROOM THORACOTOMY; CHEST TRAUMA	Thirty-seven children were admitted for the treatment of thoracic injuries during a 15-year period. Two thirds suffered blunt trauma. Of these children with blunt injuries, three quarters were male, with a median age of 6 years. Half of all victims of blunt trauma were between the ages of 4 and 6 years, and most were involved in motor vehicle crashes. Thirteen children (35%) were victims of penetrating trauma. Sixty-nine percent were male. The median age was 13 years, with 9 of 13 patients in their teenage years. Injuries were evenly distributed between stab and gunshot wounds. Eight of the 37 patients (22%) required thoracotomy. Fourteen had associated intra-abdominal injuries. Twelve of these patients had injuries that required exploratory laparotomy and two were managed expectantly. There were 27 patients with lung injuries, three quarters of whom were managed with tube thoracostomy alone. Seven children suffered injuries that resulted in their deaths. Six had been struck by a motor vehicle. Four of these six died of closed head injuries. The overall mortality of patients with blunt trauma was 25%.	BAYLOR COLL MED,CORA & WEBB MADING DEPT SURG,HOUSTON,TX 77030							BAKER CC, 1980, J TRAUMA, V20, P848, DOI 10.1097/00005373-198010000-00005; BEALL AC, 1972, J TRAUM, V12, P468, DOI 10.1097/00005373-197206000-00003; BEAVER BL, 1987, J PEDIATR SURG, V22, P19, DOI 10.1016/S0022-3468(87)80007-6; Bellinger S B, 1972, Ann Thorac Surg, V14, P635; BRANDT ML, 1987, EMERG CARE Q, V3, P45; COSELLI JS, 1984, AM J SURG, V148, P786, DOI 10.1016/0002-9610(84)90438-0; DANNE PD, 1984, J TRAUMA, V24, P796, DOI 10.1097/00005373-198409000-00004; GOLLADAY ES, 1979, J TRAUMA, V19, P526, DOI 10.1097/00005373-197919070-00008; GRAHAM JM, 1979, J TRAUMA, V19, P665, DOI 10.1097/00005373-197909000-00005; JONES KW, 1980, SURG CLIN N AM, V60, P957; LOCICERO J, 1989, SURG CLIN N AM, V69, P15; MATTOX KL, 1974, J THORAC CARDIOV SUR, V68, P886; MATTOX KL, 1984, DISASTER MED, pCH24; MAYFIELD W, 1984, AM J SURG, V148, P162, DOI 10.1016/0002-9610(84)90305-2; OGORMAN RB, 1984, ARCH SURG-CHICAGO, V119, P568; PICKARD LR, 1988, TRAUMA, pCH22; SCHWAITZBERG SD, 1987, EMERG CARE Q, V3, P1; SHIMAZU S, 1983, J TRAUMA, V23, P213, DOI 10.1097/00005373-198303000-00006; SMYTH BT, 1979, J PEDIATR SURG, V14, P41, DOI 10.1016/S0022-3468(79)80574-6; TRUNKEY DD, 1984, CURRENT THERAPY TRAU; VIJ D, 1983, SURGERY, V94, P554; WASHINGTON B, 1985, ANN THORAC SURG, V40, P186; WILSON JM, 1978, ARCH SURG-CHICAGO, V113, P846	23	22	24	0	0	WILLIAMS & WILKINS	BALTIMORE	351 WEST CAMDEN ST, BALTIMORE, MD 21201-2436	1079-6061			J TRAUMA	J. Trauma-Injury Infect. Crit. Care	MAR	1993	34	3					329	331		10.1097/00005373-199303000-00003			3	Critical Care Medicine; Surgery	General & Internal Medicine; Surgery	KZ702	WOS:A1993KZ70200004	8483169				2021-06-18	
J	MACLAREN, RE; GHOORAHOO, HI; KIRBY, NG				MACLAREN, RE; GHOORAHOO, HI; KIRBY, NG			USE OF AN ACCIDENT AND EMERGENCY DEPARTMENT OBSERVATION WARD IN THE MANAGEMENT OF HEAD-INJURY	BRITISH JOURNAL OF SURGERY			English	Article							INTRACRANIAL HEMATOMA; ADMISSION	The management of 405 patients presenting with head injury to an accident and emergency department was assessed. Sixty-nine patients were admitted, although this number should have been 127 according to current guidelines on the management of head injury. Only three attenders were admitted inappropriately according to these guidelines. An accident and emergency observation ward was open on weekdays only; at weekends, patients with head injury were admitted to a general surgical ward. When the observation ward was open, 51 of the 76 patients (67 per cent) presenting with admission criteria were admitted. When closed, only 15 of the 51 patients (29 per cent) with these criteria were admitted. Guidelines were applied effectively to reduce the number of unnecessary admissions, but there was a significant number of patients with minor head injury who were discharged inappropriately. This number was much reduced when an observation ward was available.		MACLAREN, RE (corresponding author), GUYS HOSP,DEPT ACCID & EMERGENCY,ST THOMAS ST,LONDON SE1 9RT,ENGLAND.						[Anonymous], 1986, REPORT WORKING PARTY; BALLANTYNE E, 1986, IRCS MED SCI-BIOCHEM, V14, P63; CONRAD L, 1985, Journal of Emergency Medicine, V2, P325, DOI 10.1016/0736-4679(85)90285-9; DACEY RG, 1986, J NEUROSURG, V65, P203, DOI 10.3171/jns.1986.65.2.0203; DALLOS V, 1981, BRIT MED J, V282, P37, DOI 10.1136/bmj.282.6257.37; FOWKES FGR, 1986, BRIT J SURG, V73, P891, DOI 10.1002/bjs.1800731112; JENNETT B, 1981, BRIT MED J, V282, P101, DOI 10.1136/bmj.282.6258.101; JONES JJ, 1981, LANCET, V1, P850; Maimaris C, 1991, Health Trends, V23, P33; MENDELOW AD, 1983, BRIT MED J, V287, P1173, DOI 10.1136/bmj.287.6400.1173; MENDELOW AD, 1982, BRIT MED J, V285, P1530, DOI 10.1136/bmj.285.6354.1530; MILLER JD, 1990, NEUROSURGERY, V27, P669, DOI 10.1227/00006123-199011000-00001; MORGAN WJ, 1981, BRIT MED J, V282, P398; STRANG I, 1978, INJURY, V10, P154; SWANN IJ, 1981, INJURY, V12, P274, DOI 10.1016/0020-1383(81)90200-X; WESTON PAM, 1981, BRIT J SURG, V68, P663, DOI 10.1002/bjs.1800680917; 1984, BMJ, V288, P983	17	22	22	0	0	BLACKWELL SCIENCE LTD	OXFORD	OSNEY MEAD, OXFORD, OXON, ENGLAND OX2 0EL	0007-1323			BRIT J SURG	Br. J. Surg.	FEB	1993	80	2					215	217		10.1002/bjs.1800800230			3	Surgery	Surgery	KN297	WOS:A1993KN29700024	8443658				2021-06-18	
J	DIGIOVANNA, T; ROSEN, T; FORSETT, R; SIVERTSON, K; KELEN, GD				DIGIOVANNA, T; ROSEN, T; FORSETT, R; SIVERTSON, K; KELEN, GD			SHIPBOARD MEDICINE - A NEW NICHE FOR EMERGENCY-MEDICINE	ANNALS OF EMERGENCY MEDICINE			English	Article								Study objectives: To describe the spectrum of illness that presents to shipboard hospitals and thereby recommend optimal qualifications for the ship's medical personnel. Design: Retrospective review of medical logs from two cruise ships' hospitals. Settings: Two passenger cruise ships, with seven-to-ten day cruises in the Caribbean. Participants: All patients presenting to the ships' hospitals from January 4,1989, to June 10, 1989, on one ship and from October 13, 1990, to November 10, 1990, on another ship. Methods: Analysis of ship medical logs with regard to patient complaint, diagnosis, and treatment. Results: Of 1,547 new patient visits, 12% were related to injuries and 88% to medical problems; 97% of visits were noncritical, and 3% required immediate emergency intervention. Among these were four cardiac arrests, two stab wounds, two serious ocular injuries, one closed-head injury, and one near-drowning. Five patients required endotracheal intubation. Conclusion: There is a sizeable number of visits to ships' hospitals by patients with acute and serious problems of a wide variety. Physicians and nurses with significant emergency training or experience are best qualified to deal with this broad spectrum of patient problems in this isolated environment.	JOHNS HOPKINS UNIV,SCH MED,DEPT EMERGENCY MED,BALTIMORE,MD 21205				Kelen, Gabor/0000-0002-3236-8286				0	22	23	0	4	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0196-0644			ANN EMERG MED	Ann. Emerg. Med.	DEC	1992	21	12					1476	1479		10.1016/S0196-0644(05)80065-4			4	Emergency Medicine	Emergency Medicine	JZ893	WOS:A1992JZ89300015	1443847				2021-06-18	
J	VRANKOVIC, D; HECIMOVIC, I; SPLAVSKI, B; DMITROVIC, B				VRANKOVIC, D; HECIMOVIC, I; SPLAVSKI, B; DMITROVIC, B			MANAGEMENT OF MISSILE WOUNDS OF THE CEREBRAL DURA-MATER - EXPERIENCE WITH 69 CASES	NEUROCHIRURGIA			English	Article						WAR WOUNDS; DURA MATER; GRAFT; PRIMARY COVERING		Over the period of seven months: from July 1991 to January 1992 sixty-nine patients with penetrating head war-injuries, were admitted in our hospital. Missile wounds of the dura mater require in most cases urgent operative management: watertight closure of the dura defects. However, a dilemma still exists as to the best material to be used to restore the missile dural defects. There are several possibilities: an autologous substitute as periosteum (pericranium) from surrounding, fascia of the temporalis muscle, fascia lata, or allograft transplant as lyophilised cerebral dura mater (lyodura). In the group of 69 patients, 7 were treated conservatively, 13 were treated surgically, but without closing the dural wounds because of their critical condition, and in 45 surgically treated patients the dural defects were covered with 53 transplants: with periosteum in 22 patients but 24 coverings, with fascia of temporalis muscle in 2 patients, with lyodura in 6 patients, with fascia lata in 15 patients but 21 coverings. In 4 patients the dura wounds were sutured by interrupted sutures. The best results were obtained in the fascia lata group.		VRANKOVIC, D (corresponding author), GEN HOSP OSIJEK, DEPT NEUROSURG, J HUTTLER STR 4, OSIJEK 54000, CROATIA.		Dmitrovic, Branko/AAP-4365-2020	Dmitrovic, Branko/0000-0002-5797-8013; Splavski, Bruno/0000-0002-4483-9364				0	22	23	0	1	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0028-3819			NEUROCHIRURGIA		SEP	1992	35	5					150	155					6	Neurosciences; Surgery	Neurosciences & Neurology; Surgery	JR619	WOS:A1992JR61900004	1436364				2021-06-18	
J	BROWN, DSO; NELL, V				BROWN, DSO; NELL, V			RECOVERY FROM DIFFUSE TRAUMATIC BRAIN INJURY IN JOHANNESBURG - A CONCURRENT PROSPECTIVE-STUDY	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						HEAD INJURY; OUTCOME; PSYCHOSOCIAL PROBLEMS; RECOVERY; TRAUMATIC BRAIN INJURY	SEVERE HEAD-INJURY; GLASGOW OUTCOME SCALE; SOCIAL RECOVERY; CONSECUTIVE SERIES; RELATIVES VIEW; RATING-SCALE; FOLLOW-UP; SEQUELAE; PREDICTION; IMPAIRMENT	Three hundred and twenty-six persons with light, moderate, or severe diffuse traumatic brain injury (TBI) were assessed during initial hospitalization in Johannesburg. One hundred and forty-four were followed up at approximately six months, 83 at 12 months, and 71 at 24 months posttrauma. The sample attrition rate was high. When patients could not be found, data were obtained from their caregivers. Recovery was measured in five different areas of functioning: family relationships, psychologic problems, activities of daily living (ADL), employment status, and physical status. Psychologic problems and family relationships worsened with time, but proficiency in ADL improved; physical and employment status remained relatively stable during the survey period. Severity of injury was significantly correlated with outcome in each functional area at some point in the follow-up period. Discrepancies between patients' and care-givers' perceptions of outcome were noted, particularly in the area of psychologic functioning. Caregivers tended to rate the recovery made by the patient as better than the outcome patients perceived themselves to have made. These differences in perception diminished with time. The multifactorial nature of recovery after TBI is indicated by the improvements seen in some functional areas and the worsening of outcome in other areas. These findings suggest that rehabilitation programs for persons with TBI should (1) include caregivers, (2) focus on the adjustment of both parties to their new circumstances, and (3) facilitate a convergence in their perceptions. Adequately defining recovery is a first step to estimating the prevalence of TBI, but necessitates further work. Epidemiology awaits a better understanding of the recovery process after TBI.	UNIV S AFRICA, DEPT PSYCHOL, HLTH PSYCHOL UNIT, POB 4788, JOHANNESBURG 2000, SOUTH AFRICA							ANDERSON DW, 1980, J NEUROSURG, V53, pS11; ARTIOLAIFORTUNY L, 1980, J NEUROL NEUROSUR PS, V43, P377, DOI 10.1136/jnnp.43.5.377; Baddeley A, 1980, Int Rehabil Med, V2, P138; BINDER LM, 1986, J CLIN EXP NEUROPSYC, V8, P323, DOI 10.1080/01688638608401325; BROOKS DN, 1983, J NEUROL NEUROSUR PS, V46, P336, DOI 10.1136/jnnp.46.4.336; BROOKS N, 1986, J NEUROL NEUROSUR PS, V49, P764, DOI 10.1136/jnnp.49.7.764; BROWN DSO, 1991, SOC SCI MED, V33, P283, DOI 10.1016/0277-9536(91)90362-G; Campbell A, 1976, QUALITY AM LIFE; Conkey RC, 1938, ARCH PSYCHOL, P5; DIKMEN S, 1977, ANN NEUROL, V2, P492, DOI 10.1002/ana.410020608; DIKMEN SS, 1989, MILD HEAD INJURY, P229; DODWELL D, 1988, J NEUROL NEUROSUR PS, V51, P833, DOI 10.1136/jnnp.51.6.833; FAHY TJ, 1967, LANCET, V2, P475; Fletcher R., 1982, CLIN EPIDEMIOLOGY ES; FORDYCE DJ, 1983, J NEUROL NEUROSUR PS, V46, P620, DOI 10.1136/jnnp.46.7.620; FRASER R, 1988, REHABIL COUNS BULL, V31, P276; FREUND RJ, 1981, SAS LINEAR MODELS; GILCHRIST E, 1979, ARCH NEUROL-CHICAGO, V36, P355, DOI 10.1001/archneur.1979.00500420065008; GODFREY HPD, 1987, NEW ZEAL J PSYCHOL, V16, P49; GOLDSTEIN M, 1990, ANN NEUROL, V27, P327, DOI 10.1002/ana.410270315; HALL K, 1985, ARCH PHYS MED REHAB, V66, P35; HART K, 1988, J CLIN PSYCHOL, V44, P780, DOI 10.1002/1097-4679(198809)44:5<780::AID-JCLP2270440519>3.0.CO;2-1; JACOBS HE, 1988, ARCH PHYS MED REHAB, V69, P425; JANSEN CP, 1987, THESIS U S AFRICA; JENNETT B, 1975, LANCET, V1, P480; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; KALSBEEK WD, 1980, J NEUROSURG, V53, pS19; KESHAVAN MS, 1981, BRIT J PSYCHIAT, V138, P157, DOI 10.1192/bjp.138.2.157; KLONOFF PS, 1986, J CLIN EXP NEUROPSYC, V8, P469, DOI 10.1080/01688638608405171; KRAUS JF, 1986, AM J PUBLIC HEALTH, V76, P1345, DOI 10.2105/AJPH.76.11.1345; LEVATI A, 1982, J NEUROSURG, V57, P779, DOI 10.3171/jns.1982.57.6.0779; LEVIN HS, 1978, ARCH NEUROL-CHICAGO, V35, P720, DOI 10.1001/archneur.1978.00500350024005; Lezak M.D., 1983, NEUROPSYCHOLOGICAL A; LEZAK MD, 1988, J CLIN EXP NEUROPSYC, V10, P111, DOI 10.1080/01688638808405098; LEZAK MD, 1978, J CLIN PSYCHIAT, V39, P592; LEZAK MD, 1978, AM J PHYS MED REHAB, V57, P9; LEZAK MD, 1988, J LEARN DISABIL, V21, P456, DOI 10.1177/002221948802100802; Livingston M G, 1985, Int Rehabil Med, V7, P145; LIVINGSTON MG, 1985, J NEUROL NEUROSUR PS, V48, P870, DOI 10.1136/jnnp.48.9.870; LIVINGSTON MG, 1985, J NEUROL NEUROSUR PS, V48, P876, DOI 10.1136/jnnp.48.9.876; LUNDHOLM J, 1975, SCAND J REHABIL MED, V7, P97; MCCLELLAND RJ, 1988, BRIT J PSYCHIAT, V153, P141, DOI 10.1192/bjp.153.2.141; MCKINLAY WW, 1984, J CLIN NEUROPSYCHOL, V6, P87, DOI 10.1080/01688638408401199; MCKINLAY WW, 1981, J NEUROL NEUROSUR PS, V44, P527, DOI 10.1136/jnnp.44.6.527; MOSELENYANE N, 1989, THESIS U S AFRICA; NAJENSON T, 1975, SCAND J REHABIL MED, V7, P101; NELL V, 1991, SOC SCI MED, V33, P289, DOI 10.1016/0277-9536(91)90363-H; NELL V, 1990, South African Journal of Psychology, V20, P243; NELL V, 1990, South African Journal of Psychology, V20, P235; NELL V, 1986, BRAIN DAMAGE DIAGNOS; NELL V, 1990, 901 JOH HLTH PSYCH U; ODDY M, 1985, J NEUROL NEUROSUR PS, V48, P564, DOI 10.1136/jnnp.48.6.564; ODDY M, 1978, BRIT J PSYCHIAT, V133, P507, DOI 10.1192/bjp.133.6.507; ODDY M, 1980, J NEUROL NEUROSUR PS, V43, P798, DOI 10.1136/jnnp.43.9.798; ODDY M, 1978, J NEUROL NEUROSUR PS, V41, P611, DOI 10.1136/jnnp.41.7.611; Ruesch J, 1944, AM J PSYCHIAT, V100, P480, DOI 10.1176/ajp.100.4.480; Russell WR, 1932, BRAIN, V55, P549, DOI 10.1093/brain/55.4.549; SHACHAM S, 1983, J PERS ASSESS, V47, P305, DOI 10.1207/s15327752jpa4703_14; Sparadeo F. R., 1989, J HEAD TRAUMA REHAB, V4, P75, DOI DOI 10.1097/00001199-198903000-00010; TATE RL, 1989, J NEUROL NEUROSUR PS, V52, P1128, DOI 10.1136/jnnp.52.10.1128; TATE RL, 1989, ACTA NEUROL SCAND, V79, P97, DOI 10.1111/j.1600-0404.1989.tb03719.x; TEASDALE G, 1974, LANCET, V2, P81; TELLIER A, 1989, J CLIN EXP NEUROPSYC, V11, P361; Thomsen I V, 1974, Scand J Rehabil Med, V6, P180; THOMSEN IV, 1984, J NEUROL NEUROSUR PS, V47, P260, DOI 10.1136/jnnp.47.3.260; TIRET L, 1990, INT J EPIDEMIOL, V19, P133, DOI 10.1093/ije/19.1.133; VANZOMEREN AH, 1985, J NEUROL NEUROSUR PS, V48, P21, DOI 10.1136/jnnp.48.1.21; WALKER DE, 1987, J CLIN PSYCHOL, V43, P699, DOI 10.1002/1097-4679(198711)43:6<699::AID-JCLP2270430610>3.0.CO;2-9; YOUNG B, 1981, J NEUROSURG, V54, P300, DOI 10.3171/jns.1981.54.3.0300; 1977, MANUAL INT STATISTIC, V1	70	22	22	0	5	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	AUG	1992	73	8					758	770					13	Rehabilitation; Sport Sciences	Rehabilitation; Sport Sciences	JG938	WOS:A1992JG93800014	1642528				2021-06-18	
J	BARKLEY, GL; MORAN, JE; TAKANASHI, Y; TEPLEY, N				BARKLEY, GL; MORAN, JE; TAKANASHI, Y; TEPLEY, N			TECHNIQUES FOR DC MAGNETOENCEPHALOGRAPHY	JOURNAL OF CLINICAL NEUROPHYSIOLOGY			English	Article						MAGNETOENCEPHALOGRAPHY; NEUROMAGNETISM; DC MAGNETOENCEPHALOGRAPHY; ARTIFACTS; SUPERCONDUCTING QUANTUM INTERFERENCE DEVICE	MIGRAINE	DC shifts are known to occur in association with a number of physiologic phenomena including spreading depression, hypoxia, epilepsy, and hypercapnia and possibly in migraine, closed head injury, and ischemia. Magnetoencephalography (MEG) makes it possible to record these shifts by prolonged DC monitoring of brain activity and offers several advantages over DC EEG and DC electrocorticography. Among the advantages of MEG is its non-invasive nature and the lack of impedance changes at the electrode-tissue interface that produce baseline shifts in DC EEG. In DC MEG measurements, great care must be taken in dealing with a variety of artifactual signals. Environmental noise can be reduced by magnetic shielding and recognized by use of reference magnetometers. Patient-generated artifacts are numerous and can be recognized and limited by a variety of methods.	HENRY FORD HOSP,DEPT NEUROL,DETROIT,MI 48202; OAKLAND UNIV,DEPT PHYS,ROCHESTER,MI 48063							ANTERVO A, 1985, ELECTROEN CLIN NEURO, V61, P247, DOI 10.1016/0013-4694(85)91091-0; BARKLEY GL, 1990, HEADACHE, V30, P428, DOI 10.1111/j.1526-4610.1990.hed3007428.x; Caspers H., 1969, BASIC MECH EPILEPSIE, P375; CHAKKALAKAL DA, 1988, IEEE T BIO-MED ENG, V35, P19, DOI 10.1109/10.1332; COHEN D, 1978, CIRC RES, V36, P414; Fagaly R L, 1990, Adv Neurol, V54, P11; GARDNERMEDWIN AR, 1991, BRAIN RES, V540, P153, DOI 10.1016/0006-8993(91)90502-M; KATILA T, 1981, J APPL PHYS, V52, P2585; LEAO AAP, 1947, J NEUROPHYSIOL, V10, P409, DOI 10.1152/jn.1947.10.6.409; LEAO AAP, 1944, J NEUROPHYSIOL, V7, P379; LEHMENKUHLER A, 1989, EPILEPSIE, V88, P364; LOKIETEK W, 1974, J BONE JOINT SURG BR, VB 56, P361; MONAKHOV KK, 1962, PHYSIOL BOHEMOSLOV, V11, P269; Okada Y, 1990, Adv Neurol, V54, P133; OKADA YC, 1988, BRAIN RES, V442, P185, DOI 10.1016/0006-8993(88)91450-3; ROMANI G L, 1988, Brain Topography, V1, P5, DOI 10.1007/BF01129335; ROMANI GL, 1982, REV SCI INSTRUM, V53, P1815, DOI 10.1063/1.1136907; SHOENEN J, 1986, CEPHALALGIA, V6, P229; STODIEK SRG, 1987, ADV EPILEPTOL, V16, P123; Tepley N, 1989, Funct Neurol, V4, P321; VANHARREVELD A, 1954, J NEUROPHYSIOL, V17, P505; VRBA J, 1989, ADV BIOMAGNETISM, P733; WELCH KMA, 1990, NEUROL CLIN, V8, P817, DOI 10.1016/S0733-8619(18)30319-0; WILLIAMSON SJ, 1981, J MAGN MAGN MATER, V22, P129, DOI 10.1016/0304-8853(81)90078-0	24	22	22	1	1	LIPPINCOTT-RAVEN PUBL	PHILADELPHIA	227 EAST WASHINGTON SQ, PHILADELPHIA, PA 19106	0736-0258			J CLIN NEUROPHYSIOL	J. Clin. Neurophysiol.	APR	1991	8	2					189	199		10.1097/00004691-199104000-00006			11	Clinical Neurology; Neurosciences	Neurosciences & Neurology	FK455	WOS:A1991FK45500006	2050818				2021-06-18	
J	RICHARDS, JS; OSUNA, FJ; JAWORSKI, TM; NOVACK, TA; LELI, DA; BOLL, TJ				RICHARDS, JS; OSUNA, FJ; JAWORSKI, TM; NOVACK, TA; LELI, DA; BOLL, TJ			THE EFFECTIVENESS OF DIFFERENT METHODS OF DEFINING TRAUMATIC BRAIN INJURY IN PREDICTING POSTDISCHARGE ADJUSTMENT IN A SPINAL-CORD INJURY POPULATION	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						ADJUSTMENT; BRAIN INJURIES; SPINAL CORD INJURIES	CLOSED HEAD-INJURY; VALIDATION	Traumatic brain injury (TBI) can occur concomitantly with spinal cord injury (SCI). Much of the initial work in this area has focused on identifying coincidence rates and risk factors; less has focused on possible long-term implications of TBI when it occurs with SCI. In this study, SCI/TBI and neurologically matched SCI-only groups were formed on the basis of clinicians' ratings of neuropsychologic test scores. SCI/TBI and SCI-only groups were also formed using Halstead Category cutoff scores, presence/absence of loss of consciousness, and clinicians' ratings of severity of TBI. Dependent measures assessed an average of two years postinjury measured personal, social, and family adjustment of the individual with SCI and that of a significant other. Loss of consciousness and nonconsensus clinical ratings of presence/absence of TBI predicted postdischarge adjustment poorly. Severity ratings in the moderate to severe range, and Category cutoff scores did have some predictive value, with patients defined as impaired being more likely to report adjustment difficulties or being described as having adjustment difficulties by a significant other. The difficulty of making unequivocal diagnoses of TBI in this population is discussed and implications for future research delineated.	UNIV ALABAMA,BIRMINGHAM,AL 35294	RICHARDS, JS (corresponding author), SPAIN REHABIL CTR,1717 6TH AVE,BIRMINGHAM,AL 35233, USA.						ALEXANDER M, 1980, REHABILITATION I CHI; BERGNER M, 1976, MED CARE, V14, P57, DOI 10.1097/00005650-197601000-00006; BOND MR, 1984, REHABILITATION HEAD, P111; BROOKS DN, 1983, J NEUROL NEUROSUR PS, V46, P336, DOI 10.1136/jnnp.46.4.336; Colohan A. R. T., 1986, J HEAD TRAUMA REHAB, V1, P13; DAVIDOFF G, 1985, ARCH PHYS MED REHAB, V66, P41; DAVIDOFF G, 1985, ARCH PHYS MED REHAB, V66, P489; DAVIDOFF G, 1988, 14TH ANN AM SPIN INJ; DIKMEN S, 1977, ANN NEUROL, V2, P492, DOI 10.1002/ana.410020608; GENNARELLI TA, 1986, J HEAD TRAUMA REHAB, V1, P23; HARRIS P, 1986, PARAPLEGIA, V5, P215; KATZ MM, 1963, PSYCHOL REP, V13, P503, DOI 10.2466/pr0.1963.13.2.503; LEVIN HS, 1979, J NEUROSURG, V50, P412, DOI 10.3171/jns.1979.50.4.0412; LOLLAR D, 1988, 95TH ANN AM PSYCH AS; LONG CJ, 1986, SOUTHERN MED J, V79, P728, DOI 10.1097/00007611-198606000-00020; LUNDHOLM J, 1975, SCAND J REHABIL MED, V7, P97; MCLEAN A, 1984, NEUROSURGERY, V14, P393, DOI 10.1227/00006123-198404000-00001; ODDY M, 1978, J NEUROL NEUROSUR PS, V41, P611, DOI 10.1136/jnnp.41.7.611; OLSON DH, 1986, FAM PROCESS, V25, P337, DOI 10.1111/j.1545-5300.1986.00337.x; PORTER RW, 1973, 19TH P VET ADM SPIN, P188; RICHARDS JS, 1988, AM J PHYS MED REHAB, V67, P211, DOI 10.1097/00002060-198810000-00005; RICHARDS JS, 1986, J REHABIL, V52, P50; RIMEL RW, 1981, NEUROSURGERY, V9, P221, DOI 10.1227/00006123-198109000-00001; ROSENTHALL M, 1984, REHABILITATION HEAD, P202; SCHUENEMAN A, 1982, SCI DIG, V4, P35; SILVER JR, 1980, INJURY, V12, P219, DOI 10.1016/0020-1383(80)90011-X; WAGNER KA, 1984, ASIA ABSTR DIG, P1096; Walker A E, 1972, Scand J Rehabil Med, V4, P5; WILMOT CB, 1985, ARCH PHYS MED REHAB, V66, P227, DOI 10.1016/0003-9993(85)90148-0	29	22	22	0	0	W B SAUNDERS CO	PHILADELPHIA	INDEPENDENCE SQUARE WEST CURTIS CENTER, STE 300, PHILADELPHIA, PA 19106-3399	0003-9993			ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	APR	1991	72	5					275	279					5	Rehabilitation; Sport Sciences	Rehabilitation; Sport Sciences	FF342	WOS:A1991FF34200002	2009041				2021-06-18	
J	FREEDMAN, PE; BLEIBERG, J; FREEDLAND, K				FREEDMAN, PE; BLEIBERG, J; FREEDLAND, K			ANTICIPATORY BEHAVIOR DEFICITS IN CLOSED HEAD-INJURY	JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY			English	Article									NORTHWESTERN UNIV,SCH MED,CHICAGO,IL 60611	FREEDMAN, PE (corresponding author), UNIV ILLINOIS,DEPT PSYCHOL,BOX 4348,CHICAGO,IL 60680, USA.						BLEIBERG J, 1985, INT J CLIN NEUROPSYC, V7, P153; BUTTER C M, 1972, Acta Neurobiologiae Experimentalis (Warsaw), V32, P525; DENNYBROWN D, 1951, MOD TRENDS NEUROL, P13; Fuster JM., 1980, PREFRONTAL CORTEX; GRANT DA, 1964, CATEGORIES HUMAN LEA; Luria A. R., 1969, HDB CLINICAL NEUROLO, V2, P725; LURIA AR, 1964, FRONTAL GRANULAR COR; NAUTA WJH, 1971, J PSYCHIAT RES, V8, P167, DOI 10.1016/0022-3956(71)90017-3; OPPENHEIMER H, 1971, CLIN PSYCHIATRY ISSU; TANAKA D, 1973, BRAIN RES, V53, P161, DOI 10.1016/0006-8993(73)90775-0; TANAKA D, 1974, BRAIN RES, V54, P195; WATERHOUSE IK, 1957, J COMP PHYSIOL PSYCH, V50, P81, DOI 10.1037/h0047546	12	22	22	0	2	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0022-3050			J NEUROL NEUROSUR PS	J. Neurol. Neurosurg. Psychiatry	APR	1987	50	4					398	401		10.1136/jnnp.50.4.398			4	Clinical Neurology; Psychiatry; Surgery	Neurosciences & Neurology; Psychiatry; Surgery	G8132	WOS:A1987G813200005	3585349	Green Published, Bronze			2021-06-18	
J	DEUTSCHMAN, CS; KONSTANTINIDES, FN; RAUP, S; CERRA, FB				DEUTSCHMAN, CS; KONSTANTINIDES, FN; RAUP, S; CERRA, FB			PHYSIOLOGICAL AND METABOLIC RESPONSE TO ISOLATED CLOSED-HEAD INJURY .2. EFFECTS OF STEROIDS ON METABOLISM - POTENTIATION OF PROTEIN WASTING AND ABNORMALITIES OF SUBSTRATE UTILIZATION	JOURNAL OF NEUROSURGERY			English	Article									JOHNS HOPKINS MED INST,DEPT ANESTHESIOL & CRIT CARE MED,BALTIMORE,MD 21205; UNIV MINNESOTA,SCH MED,DEPT SURG,MINNEAPOLIS,MN 55455; ST PAUL RAMSEY MED CTR,SURG METAB RES FACIL,ST PAUL,MN 55101			Deutschman, Clifford/AAN-2742-2021				Alexander E Jr, 1972, Clin Neurosurg, V19, P240; ASKANAZI J, 1980, ANN SURG, V191, P40, DOI 10.1097/00000658-198001000-00008; BIRGE SJ, 1984, ADV EXP MED BIOL, V171, P53; CERRA FB, 1987, IN PRESS J CLIN NUTR; CLIFTON GL, 1983, SURG FORUM, V34, P538; CLIFTON GL, 1984, J NEUROSURG, V60, P687, DOI 10.3171/jns.1984.60.4.0687; COOPER PR, 1979, J NEUROSURG, V51, P307, DOI 10.3171/jns.1979.51.3.0307; DEUTSCHMAN CS, 1986, J NEUROSURG, V64, P89, DOI 10.3171/jns.1986.64.1.0089; FAUPEL G, 1976, DYNAMICS BRAIN EDEMA, P337; FELIG P, 1969, J CLIN INVEST, V48, P584, DOI 10.1172/JCI106017; FISHMAN RA, 1975, NEW ENGL J MED, V293, P706, DOI 10.1056/NEJM197510022931407; GALICICH JH, 1961, AM PRACT DIG TREAT, V12, P169; GOBIET W, 1976, DYNAMICS BRAIN EDEMA, P351; HOOSHMAND H, 1969, ARCH NEUROL-CHICAGO, V21, P499, DOI 10.1001/archneur.1969.00480170071007; HOYT HJ, 1972, CLIN PHARMACOL THER, V13, P141; KLATZO I, 1967, J NEUROPATH EXP NEUR, V26, P1, DOI 10.1097/00005072-196701000-00001; Kobrine A I, 1973, Surg Neurol, V1, P38; KOIDE T, 1986, J CEREBR BLOOD F MET, V6, P395, DOI 10.1038/jcbfm.1986.72; MOLOFSKY WJ, 1984, NEUROSURGERY, V15, P424, DOI 10.1227/00006123-198409000-00022; OWEN OE, 1973, J CLIN INVEST, V52, P2596, DOI 10.1172/JCI107452; PAPPIUS HM, 1969, ARCH NEUROL-CHICAGO, V20, P207, DOI 10.1001/archneur.1969.00480080107013; RAPP RP, 1983, J NEUROSURG, V58, P906, DOI 10.3171/jns.1983.58.6.0906; ROBERTSON CS, 1985, J NEUROSURG, V63, P714, DOI 10.3171/jns.1985.63.5.0714; SAPOLSKY RM, 1985, SCIENCE, V229, P1397, DOI 10.1126/science.4035356; SAUL TG, 1981, J NEUROSURG, V54, P596, DOI 10.3171/jns.1981.54.5.0596; SMITH OK, 1967, ENDOCRINOLOGY, V80, P561, DOI 10.1210/endo-80-4-561; TOMAS FM, 1979, BIOCHEM J, V178, P139, DOI 10.1042/bj1780139; WAGLE SR, 1966, P SOC EXP BIOL MED, V121, P1297, DOI 10.3181/00379727-121-31033; WILMORE DW, 1983, SURGICAL NUTRITION, P65; YOUNG B, 1985, NEUROSURGERY, V17, P784, DOI 10.1227/00006123-198511000-00010	30	22	23	0	0	AMER ASSOC NEUROLOGICAL SURGEONS	CHARLOTTESVILLE	UNIV VIRGINIA, 1224 WEST MAIN ST, STE 450, CHARLOTTESVILLE, VA 22903	0022-3085			J NEUROSURG	J. Neurosurg.	MAR	1987	66	3					388	395		10.3171/jns.1987.66.3.0388			8	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	G2347	WOS:A1987G234700010	3819833				2021-06-18	
J	GAIDOLFI, E; VIGNOLO, LA				GAIDOLFI, E; VIGNOLO, LA			CLOSED HEAD-INJURIES OF SCHOOL-AGE CHILDREN - NEUROPSYCHOLOGICAL SEQUELAE IN EARLY ADULTHOOD	ITALIAN JOURNAL OF NEUROLOGICAL SCIENCES			English	Article										GAIDOLFI, E (corresponding author), UNIV MILAN,CTR NEUROPSICOL,NEUROL CLIN,I-20122 MILAN,ITALY.							0	22	22	0	2	MASSON DIVISIONE PERIODICI	MILAN	VIA FRATELLI BRESSAN 2, 20126 MILAN, ITALY	0392-0461			ITAL J NEUROL SCI	Ital. J. Neurol. Sci.		1980	1	2					65	73					9	Clinical Neurology; Neurosciences	Neurosciences & Neurology	JU440	WOS:A1980JU44000001	7338453				2021-06-18	
J	AIRD, RB; STRAIT, LS; ZEALEAR, D; HRENOFF, M				AIRD, RB; STRAIT, LS; ZEALEAR, D; HRENOFF, M			NEUROPHYSIOLOGICAL STUDIES ON CEREBRAL CONCUSSION	JOURNAL OF NEUROSURGERY			English	Article																Aird RB, 1944, J NERV MENT DIS, V99, P501, DOI 10.1097/00005053-194405000-00005; AIRD RB, 1951, J PHARMACOL EXP THER, V103, P136; Aird RB, 1944, ARCH NEURO PSYCHIATR, V51, P54, DOI 10.1001/archneurpsyc.1944.02290250060004; AIRD RB, 1945, RES PUBL ASSOC RES N, V24, P283; BORNSTEIN MB, 1946, J NEUROPHYSIOL, V9, P349; Broman T., 1949, PERMEABILITY CEREBRO; Courville CB, 1942, ARCH SURG-CHICAGO, V45, P19, DOI 10.1001/archsurg.1942.01220010022002; Dandy WE, 1925, B JOHNS HOPKINS HOSP, V36, P40; Denny-Brown D, 1941, BRAIN, V64, P93, DOI 10.1093/brain/64.2-3.93; Evans JP, 1943, ARCH NEURO PSYCHIATR, V50, P258, DOI 10.1001/archneurpsyc.1943.02290210036002; EVANS JP, 1945, RES PUBL ASS NERV ME, V24, P254; EVANS JP, 1950, ACUTE HEAD INJURY, V5; FRIES BA, COMMUNICATION; GREIG ME, 1949, SCIENCE, V110, P237, DOI 10.1126/science.110.2853.237; GROAT RA, 1945, J NEUROSURG, V2, P26, DOI 10.3171/jns.1945.2.1.0026; JASPER H, 1945, RES PUBL ASS NERV ME, V24, P388; MATSON DD, 1948, TREATMENT ACUTE CRAN; PUDENZ RH, 1946, J NEUROSURG, V3, P487, DOI 10.3171/jns.1946.3.6.0487; SAUERBRUCH, 1913, VERH DTSCH GES CHIR, V42, P144; SEGERBERG LH, 1949, SURG CLIN N AM, V29, P1301; SPIEGEL EA, 1947, T AM NEUROL ASSOC, P169; SPIEGEL EA, 1946, AM J PHYSIOL, V146, P12; SPIEGELADOLF M, 1945, FED PROC, V4, P104; SPURLING RG, 1946, SURGICAL TREATMENT N, V17, P27; Strait LA, 1941, J PHARMACOL EXP THER, V73, P363; STROWGER B, COMMUNICATION; TOWER DB, 1948, J CLIN INVEST, V27, P558; WALKER AE, 1945, RES PUBL A NERV MENT, V24, P437; WARD A, 1950, J NEUROSURG, V7, P398, DOI 10.3171/jns.1950.7.5.0398; White JC, 1943, ANN SURG, V119, P619, DOI 10.1097/00000658-194310000-00010; Windle W. F., 1944, SURG GYNECOL AND OBSTET, V79, P561; WINDLE WF, 1946, J NEUROSURG, V3, P157, DOI 10.3171/jns.1946.3.2.0157; WINDLE WF, 1944, FED PROC, V3, P53	33	22	22	0	0	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.		1952	9	4					331	347		10.3171/jns.1952.9.4.0331			17	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	UN073	WOS:A1952UN07300002	14946575				2021-06-18	
J	EICHELBERGER, L; KOLLROS, JJ; WALKER, AE				EICHELBERGER, L; KOLLROS, JJ; WALKER, AE			WATER, NITROGEN AND ELECTROLYTE CONTENT OF BRAIN FOLLOWING CEREBRAL CONCUSSION	AMERICAN JOURNAL OF PHYSIOLOGY			English	Article																Childs A, 1942, AM J PHYSIOL, V137, P384; Darrow DC, 1935, J CLIN INVEST, V14, P266, DOI 10.1172/JCI100674; Eichelberger L, 1944, J BIOL CHEM, V154, P21; Eichelberger L, 1942, J BIOL CHEM, V142, P467; Eichelberger L, 1941, J BIOL CHEM, V140, P467; Gurdjian ES, 1943, SURGERY, V13, P333; LEHMAN EP, 1935, INT CLIN, V3, P180; Manery JF, 1941, AM J PHYSIOL, V132, P0215; Pilcher C, 1937, ARCH SURG-CHICAGO, V35, P512, DOI 10.1001/archsurg.1937.01190150095009; PILCHER C, 1941, SURG GYNECOL OBSTET, V72, P755; Walker AE, 1944, J NEUROSURG, V1, P103, DOI 10.3171/jns.1944.1.2.0103; Wallace GB, 1940, J PHARMACOL EXP THER, V70, P418; WHITE JC, 1943, ANN SURG, V118, P619	13	22	22	0	0	AMER PHYSIOLOGICAL SOC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0002-9513			AM J PHYSIOL	Am. J. Physiol.		1949	156	1					129	136					8	Physiology	Physiology	YB524	WOS:A1949YB52400017	18117583				2021-06-18	
J	LEWIN, W				LEWIN, W			ACUTE SUBDURAL AND EXTRADURAL HAEMATOMA CLOSED HEAD INJURIES - HUNTERIAN LECTURE DELIVERED AT THE ROYAL-COLLEGE-OF-SURGEONS-OF-ENGLAND ON 23RD FEBRUARY, 1949	ANNALS OF THE ROYAL COLLEGE OF SURGEONS OF ENGLAND			English	Article																BELL C, 1817, SURGICAL OBSERVATION, V1, P466; ERICHSEN JE, 1884, SCI ART SURGERY, V1, P755; Falconer MA, 1942, LANCET, V1, P532; HUNTER J, 1786, WORKS J HUNTER, V1, P486; HUTCHINSON J, 1967, LONDON HOSP REP, V4, P28; Jacobson WHA, 1886, GUYS HOSP REP, V43, P147; Jones FW, 1912, LANCET, V2, P7; LEBEAU J, 1943, UNION MED CAN, V72, P761; MARRIOTT HL, 1947, BRIT MED J, V1, P245, DOI 10.1136/bmj.1.4493.245; Mckenzie KG, 1938, BRIT J SURG, V26, P346, DOI 10.1002/bjs.18002610215; Meyer A, 1920, ARCH NEURO PSYCHIATR, V4, P387, DOI 10.1001/archneurpsyc.1920.02180220036003; Munro D, 1941, ANN SURG, V113, P192, DOI 10.1097/00000658-194102000-00003; Munro D, 1942, NEW ENGL J MED, V227, P87, DOI 10.1056/NEJM194207162270301; MUNRO D, 1938, CRANIOCEREBRAL INJUR; POTT P, 1759, OBSERVATIONS NATURE; Putnam TJ, 1925, ARCH SURG-CHICAGO, V11, P329, DOI 10.1001/archsurg.1925.01120150002001; Reid WL, 1939, J AMER MED ASSOC, V112, P2030, DOI 10.1001/jama.1939.02800200028008; Rowbotham GF, 1942, ACUTE INJURIES HEAD; Traquair HM., 1927, INTRO CLIN PERIMETRY; TROTTER W, 1915, BRIT J SURG, V2, P520	20	22	22	0	0	ROYAL COLL SURGEONS ENGLAND	LONDON	35-43 LINCOLN'S INN FIELDS, LONDON WC2A 3PN, ENGLAND	0035-8843			ANN ROY COLL SURG	Ann. R. Coll. Surg. Engl.		1949	5	4					240	274					35	Surgery	Surgery	YG614	WOS:A1949YG61400002	18143996				2021-06-18	
J	Barney, CW; Dougan, CE; McLeod, KR; Kazemi-Moridani, A; Zheng, Y; Ye, ZY; Tiwari, S; Sacligil, I; Riggleman, RA; Cai, SQ; Lee, JH; Peyton, SR; Tew, GN; Crosby, AJ				Barney, Christopher W.; Dougan, Carey E.; McLeod, Kelly R.; Kazemi-Moridani, Amir; Zheng, Yue; Ye, Ziyu; Tiwari, Sacchita; Sacligil, Ipek; Riggleman, Robert A.; Cai, Shengqiang; Lee, Jae-Hwang; Peyton, Shelly R.; Tew, Gregory N.; Crosby, Alfred J.			Cavitation in soft matter	PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA			English	Article						soft solids; traumatic brain injury; TBI; rheology; bubble	LASER-INDUCED CAVITATION; TRAUMATIC BRAIN-INJURY; MECHANICAL-PROPERTIES; FRACTURE-MECHANICS; COVALENT BONDS; CAVITY GROWTH; BUBBLE; RUBBER; MODEL; DEFORMATION	Cavitation is the sudden, unstable expansion of a void or bubble within a liquid or solid subjected to a negative hydrostatic stress. Cavitation rheology is a field emerging from the development of a suite of materials characterization, damage quantification, and therapeutic techniques that exploit the physical principles of cavitation. Cavitation rheology is inherently complex and broad in scope with wide-ranging applications in the biology, chemistry, materials, and mechanics communities. This perspective aims to drive collaboration among these communities and guide discussion by defining a common core of high-priority goals while highlighting emerging opportunities in the field of cavitation rheology. A brief overview of the mechanics and dynamics of cavitation in soft matter is presented. This overview is followed by a discussion of the overarching goals of cavitation rheology and an overview of common experimental techniques. The larger unmet needs and challenges of cavitation in soft matter are then presented alongside specific opportunities for researchers from different disciplines to contribute to the field.	[Barney, Christopher W.; McLeod, Kelly R.; Sacligil, Ipek; Tew, Gregory N.; Crosby, Alfred J.] Univ Massachusetts, Dept Polymer Sci & Engn, Amherst, MA 01003 USA; [Dougan, Carey E.; Peyton, Shelly R.] Univ Massachusetts, Dept Chem Engn, Amherst, MA 01003 USA; [Kazemi-Moridani, Amir; Tiwari, Sacchita; Lee, Jae-Hwang] Univ Massachusetts, Dept Mech & Ind Engn, Amherst, MA 01003 USA; [Zheng, Yue; Cai, Shengqiang] Univ Calif San Diego, Dept Mech & Aerosp Engn, La Jolla, CA 92093 USA; [Ye, Ziyu] Univ Penn, Dept Chem, Philadelphia, PA 19104 USA; [Riggleman, Robert A.] Univ Penn, Dept Chem & Biomol Engn, Philadelphia, PA 19104 USA	Tew, GN; Crosby, AJ (corresponding author), Univ Massachusetts, Dept Polymer Sci & Engn, Amherst, MA 01003 USA.; Peyton, SR (corresponding author), Univ Massachusetts, Dept Chem Engn, Amherst, MA 01003 USA.; Lee, JH (corresponding author), Univ Massachusetts, Dept Mech & Ind Engn, Amherst, MA 01003 USA.; Cai, SQ (corresponding author), Univ Calif San Diego, Dept Mech & Aerosp Engn, La Jolla, CA 92093 USA.; Riggleman, RA (corresponding author), Univ Penn, Dept Chem & Biomol Engn, Philadelphia, PA 19104 USA.	rrig@seas.upenn.edu; shqcai@ucsd.edu; leejh@umass.edu; speyton@umass.edu; tew@mail.pse.umass.edu; acrosby@umass.edu	Kazemi-Moridani, Amir/Z-2636-2019; Lee, Jae-Hwang/F-7595-2014	Kazemi-Moridani, Amir/0000-0003-4496-9553; Lee, Jae-Hwang/0000-0002-2546-1044; Tiwari, Sacchita/0000-0002-7572-0526; Barney, Christopher/0000-0002-1854-9523; Crosby, Alfred/0000-0001-8850-8869	Office of Naval ResearchOffice of Naval Research [ONR N00014-17-1-2056]	This work was funded by Office of Naval Research Grant ONR N00014-17-1-2056. We acknowledge helpful discussions with Prof. Robin C. Young from the Department of Mathematics and Statistics at the University of Massachusetts Amherst.	Adhikari U, 2016, PHYS CHEM CHEM PHYS, V18, P32638, DOI 10.1039/c6cp06704b; Ahn B, 2010, MED IMAGE ANAL, V14, P138, DOI 10.1016/j.media.2009.10.006; Archer LA, 1997, RHEOL ACTA, V36, P579; Arita Y, 2012, PHYS REV E, V85, DOI 10.1103/PhysRevE.85.016319; Arnal B, 2017, PHYS MED BIOL, V62, P843, DOI 10.1088/1361-6560/aa4fe8; Arvanitis CD, 2015, IEEE T MED IMAGING, V34, P1270, DOI 10.1109/TMI.2014.2383835; Atay SM, 2008, J BIOMECH ENG-T ASME, V130, DOI 10.1115/1.2899575; BALL JM, 1982, PHILOS T R SOC A, V306, P557, DOI 10.1098/rsta.1982.0095; Bar-Kochba E, 2016, SCI REP-UK, V6, DOI 10.1038/srep30550; Barney CW, 2019, SOFT MATTER, V15, P7390, DOI 10.1039/c9sm01173k; Belayachi N, 2008, SCI TECHNOL ADV MAT, V9, DOI 10.1088/1468-6996/9/2/025008; Bentz KC, 2018, SOFT MATTER, V14, P8395, DOI 10.1039/c8sm01560k; Bentz KC, 2016, SOFT MATTER, V12, P4991, DOI 10.1039/c6sm00431h; Brujan EA, 2006, J FLUID MECH, V558, P281, DOI 10.1017/S0022112006000115; BUNDY FP, 1955, NATURE, V176, P51, DOI 10.1038/176051a0; Busse WF, 1938, J APPL PHYS, V9, P438, DOI 10.1063/1.1710439; Canchi S, 2017, J MECH BEHAV BIOMED, V74, P261, DOI 10.1016/j.jmbbm.2017.06.018; Canchi S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175396; Cao YL, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00010; Cernak Ibolja, 2005, NeuroRx, V2, P410, DOI 10.1602/neurorx.2.3.410; CHO K, 1987, J MATER SCI, V22, P2899, DOI 10.1007/BF01086488; Colchester RJ, 2014, APPL PHYS LETT, V104, DOI 10.1063/1.4873678; Creton C, 2016, REP PROG PHYS, V79, DOI 10.1088/0034-4885/79/4/046601; Crosby AJ, 2000, J APPL PHYS, V88, P2956, DOI 10.1063/1.1288017; Cubuk ED, 2017, SCIENCE, V358, P1033, DOI 10.1126/science.aai8830; Cui J, 2012, MACROMOLECULES, V45, P6104, DOI 10.1021/ma300593g; Cui J, 2011, SOFT MATTER, V7, P7827, DOI 10.1039/c1sm05340j; Davis DA, 2009, NATURE, V459, P68, DOI 10.1038/nature07970; Delbos A, 2012, SOFT MATTER, V8, P8204, DOI 10.1039/c2sm25458a; Diani J, 2001, INT J FRACTURE, V112, P151, DOI 10.1023/A:1013311526076; Estrada JB, 2018, J MECH PHYS SOLIDS, V112, P291, DOI 10.1016/j.jmps.2017.12.006; Fakhouri S, 2015, SOFT MATTER, V11, P4723, DOI 10.1039/c5sm00230c; Fei PZ, 2015, LANGMUIR, V31, P492, DOI 10.1021/la503832r; Frieberg BR, 2018, SOFT MATTER, V14, P4696, DOI 10.1039/c8sm00722e; Fuentes-Caparros AM, 2019, SOFT MATTER, V15, P6340, DOI 10.1039/c9sm01023h; Gateau J, 2011, PHYS MED BIOL, V56, P7001, DOI 10.1088/0031-9155/56/22/001; Gaudron R, 2015, J FLUID MECH, V766, DOI 10.1017/jfm.2015.7; Gent A. N., 1970, RUBBER CHEM TECHNOL, V43, P873; GENT AN, 1991, J MATER SCI, V26, P3392, DOI 10.1007/BF01124691; GENT AN, 1959, PROC R SOC LON SER-A, V249, P195, DOI 10.1098/rspa.1959.0016; Goeller J, 2012, J NEUROTRAUM, V29, P1970, DOI 10.1089/neu.2011.2224; Gossweiler GR, 2014, ACS MACRO LETT, V3, P216, DOI 10.1021/mz500031q; Grindy SC, 2017, SOFT MATTER, V13, P4057, DOI 10.1039/c7sm00617a; Han TH, 2010, J APPL PHYS, V107, DOI 10.1063/1.3430989; Hashemnejad SM, 2019, SOFT MATTER, V15, P7852, DOI 10.1039/c9sm01039d; Hashemnejad SM, 2017, ACS OMEGA, V2, P1864, DOI 10.1021/acsomega.7b00108; Hashemnejad SM, 2015, SOFT MATTER, V11, P4315, DOI 10.1039/c5sm00330j; Holzapfel GA, 2010, P ROY SOC A-MATH PHY, V466, P1551, DOI 10.1098/rspa.2010.0058; Hong Y, 2016, EXP MECH, V56, P97, DOI 10.1007/s11340-015-0024-2; HUANG Y, 1991, J MECH PHYS SOLIDS, V39, P223, DOI 10.1016/0022-5096(91)90004-8; Hui CY, 2003, P ROY SOC A-MATH PHY, V459, P1489, DOI 10.1098/rspa.2002.1057; Hutchens SB, 2016, SOFT MATTER, V12, P2557, DOI 10.1039/c5sm02055g; Hutchens SB, 2014, SOFT MATTER, V10, P3679, DOI 10.1039/c3sm52689e; HUTCHINSON JW, 1983, ACTA METALL MATER, V31, P1079, DOI 10.1016/0001-6160(83)90204-3; Ivancic RJS, 2019, SOFT MATTER, V15, P4548, DOI 10.1039/c8sm02423e; Jansen LE, 2015, J MECH BEHAV BIOMED, V50, P299, DOI 10.1016/j.jmbbm.2015.06.023; Johansen P, 2004, EXPERT REV MED DEVIC, V1, P95, DOI 10.1586/17434440.1.1.95; Kang JT, 2017, SOFT MATTER, V13, P6372, DOI 10.1039/c7sm01479a; Kang W, 2018, ACTA BIOMATER, V67, P295, DOI 10.1016/j.actbio.2017.11.030; Kawchuk GN, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119470; Kim G, 2019, P NATL ACAD SCI USA, V116, P10214, DOI 10.1073/pnas.1901047116; Kumar A, 2017, J ELASTICITY, V126, P201, DOI 10.1007/s10659-016-9589-y; Kundu S, 2009, SOFT MATTER, V5, P3963, DOI 10.1039/b909237d; Kurosawa Y, 2009, IEEE ENG MED BIO, P7224, DOI 10.1109/IEMBS.2009.5335260; Kushner AM, 2007, J AM CHEM SOC, V129, P14110, DOI 10.1021/ja0742176; Kwasny MT, 2017, J MATER CHEM A, V5, P1400, DOI 10.1039/c6ta07990c; Lafond M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-25913-8; Lakrout H, 1999, J ADHESION, V69, P307, DOI 10.1080/00218469908017233; Lefevre V, 2015, INT J FRACTURE, V192, P1, DOI 10.1007/s10704-014-9982-0; Lin ST, 2017, J MECH PHYS SOLIDS, V106, P229, DOI 10.1016/j.jmps.2017.05.011; Lin YY, 2004, INT J FRACTURE, V126, P205, DOI 10.1023/B:FRAC.0000026510.60747.3a; Liu YQ, 2011, MACROMOLECULES, V44, P8622, DOI 10.1021/ma201023v; Lopez-Pamies O, 2011, J MECH PHYS SOLIDS, V59, P1464, DOI 10.1016/j.jmps.2011.04.015; Lopez-Pamies O, 2009, J ELASTICITY, V94, P115, DOI 10.1007/s10659-008-9187-8; Luo H., 2015, J DYN BEHAV MAT, V2, P59; Mac Donald CL, 2011, NEW ENGL J MED, V364, P2091, DOI 10.1056/NEJMoa1008069; Macoskey JJ, 2018, PHYS MED BIOL, V63, DOI 10.1088/1361-6560/aaae3b; Madison MJ, 2017, BIOMASS BIOENERG, V98, P135, DOI 10.1016/j.biombioe.2017.01.007; Mancia L, 2017, ULTRASOUND MED BIOL, V43, P1421, DOI 10.1016/j.ultrasmedbio.2017.02.020; Manduca A, 2001, MED IMAGE ANAL, V5, P237, DOI 10.1016/S1361-8415(00)00039-6; Marszalek PE, 1999, NATURE, V402, P100; Milner MP, 2019, EXTREME MECH LETT, V28, P69, DOI 10.1016/j.eml.2019.02.007; Mohammadzadeh M, 2017, J FLUID MECH, V823, DOI 10.1017/jfm.2017.358; Nakamura T, 2012, INT J NONLIN MECH, V47, P331, DOI 10.1016/j.ijnonlinmec.2011.07.007; Palanker D, 1997, LASER SURG MED, V21, P294, DOI 10.1002/(SICI)1096-9101(1997)21:3<294::AID-LSM10>3.0.CO;2-D; Parada GA, 2018, SOFT MATTER, V14, P5186, DOI 10.1039/c8sm00646f; Pardoen T, 2000, J MECH PHYS SOLIDS, V48, P2467, DOI 10.1016/S0022-5096(00)00019-3; Pavlovsky L, 2014, APPL PHYS LETT, V105, DOI 10.1063/1.4896108; Peel CS, 2011, APPL PHYS A-MATER, V103, P1131, DOI 10.1007/s00339-010-6056-7; Polio S., 2018, PLOS ONE, V13, P1; Poulain X, 2017, INT J FRACTURE, V205, P1, DOI 10.1007/s10704-016-0176-9; Raayai-Ardakani S, 2019, SOFT MATTER, V15, P4999, DOI 10.1039/c9sm00570f; Raayai-Ardakani S, 2019, SOFT MATTER, V15, P381, DOI 10.1039/c8sm02142b; Rambod E, 1999, ANN BIOMED ENG, V27, P774, DOI 10.1114/1.231; Rana RK, 2002, ADV MATER, V14, P1414, DOI 10.1002/1521-4095(20021002)14:19<1414::AID-ADMA1414>3.0.CO;2-F; Rau KR, 2006, BIOPHYS J, V91, P317, DOI 10.1529/biophysj.105.079921; Rayleigh, 1917, PHILOS MAG, V34, P94, DOI 10.1080/14786440808635681; Richardson DS, 2015, CELL, V162, P246, DOI 10.1016/j.cell.2015.06.067; SACCHI CA, 1991, J OPT SOC AM B, V8, P337, DOI 10.1364/JOSAB.8.000337; Salzar RS, 2017, J NEUROTRAUM, V34, P1589, DOI 10.1089/neu.2016.4600; Sankin GN, 2003, DOKL PHYS, V48, P665, DOI 10.1134/1.1639433; Sarntinoranont M, 2012, J NEUROTRAUM, V29, P418, DOI 10.1089/neu.2011.1772; Shavit A, 2014, PHYS CHEM CHEM PHYS, V16, P10301, DOI 10.1039/c3cp55330b; Shunmugam R, 2010, MACROMOL RAPID COMM, V31, P784, DOI 10.1002/marc.200900869; Sivaloganathan J, 2006, SIAM J APPL MATH, V66, P736, DOI 10.1137/040618965; Sivaloganathan J, 2002, P ROY SOC EDINB A, V132, P985, DOI 10.1017/S0308210500001979; Stride EP, 2010, P I MECH ENG H, V224, P171, DOI 10.1243/09544119JEIM622; Tang JD, 2017, EXTREME MECH LETT, V10, P24, DOI 10.1016/j.eml.2016.09.010; Tang SC, 2016, MACROMOLECULES, V49, P9163, DOI 10.1021/acs.macromol.6b01618; Taylor PA, 2014, BRAIN INJURY, V28, P879, DOI 10.3109/02699052.2014.888478; Wang HM, 2015, J APPL PHYS, V117, DOI 10.1063/1.4918278; Wang HM, 2015, SOFT MATTER, V11, P1058, DOI 10.1039/c4sm02652g; Wang QM, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2178; Wang WJ, 2017, FOOD RES INT, V102, P101, DOI 10.1016/j.foodres.2017.09.087; Wei CW, 2014, OPT LETT, V39, P2599, DOI 10.1364/OL.39.002599; Wilde GS, 2012, EXP EYE RES, V97, P36, DOI 10.1016/j.exer.2012.01.011; WILLIAMS ML, 1965, INT J FRACT MECH, V1, P64, DOI 10.1007/BF00184154; Yerzley FL, 1939, IND ENG CHEM, V31, P950, DOI 10.1021/ie50356a007; Zha YP, 2012, J AM CHEM SOC, V134, P4493, DOI 10.1021/ja211365r; Zhang K, 2011, LAB CHIP, V11, P1389, DOI 10.1039/c0lc00520g; Zhu J, 2011, J ADHESION, V87, P466, DOI 10.1080/00218464.2011.575332; Zimberlin JA, 2007, SOFT MATTER, V3, P763, DOI 10.1039/b617050a; Zimberlin JA, 2010, SOFT MATTER, V6, P3632, DOI 10.1039/b925407b; Zimberlin JA, 2010, J POLYM SCI POL PHYS, V48, P1423, DOI 10.1002/polb.21968	124	21	21	2	8	NATL ACAD SCIENCES	WASHINGTON	2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA	0027-8424			P NATL ACAD SCI USA	Proc. Natl. Acad. Sci. U. S. A.	APR 28	2020	117	17					9157	9165		10.1073/pnas.1920168117			9	Multidisciplinary Sciences	Science & Technology - Other Topics	LJ3WV	WOS:000530099500009	32291337	Other Gold, Green Published			2021-06-18	
J	Cook, AM; Jones, GM; Hawryluk, GWJ; Mailloux, P; McLaughlin, D; Papangelou, A; Samuel, S; Tokumaru, S; Venkatasubramanian, C; Zackol, C; Zimmermann, LL; Hirsch, K; Shutter, L				Cook, Aaron M.; Jones, G. Morgan; Hawryluk, Gregory W. J.; Mailloux, Patrick; McLaughlin, Diane; Papangelou, Alexander; Samuel, Sophie; Tokumaru, Sheri; Venkatasubramanian, Chitra; Zackol, Christopher; Zimmermann, Lara L.; Hirsch, Karen; Shutter, Lori			Guidelines for the Acute Treatment of Cerebral Edema in Neurocritical Care Patients	NEUROCRITICAL CARE			English	Article						Intracranial pressure; Neurocritical care; Osmotherapy; Hyperventilation; Hypertonic; Mannitol	TRAUMATIC BRAIN-INJURY; INCREASED INTRACRANIAL-PRESSURE; ACUTE BACTERIAL-MENINGITIS; ACUTE KIDNEY INJURY; SEVERE HEAD-INJURY; SPONTANEOUS INTRACEREBRAL HEMORRHAGE; ADJUNCTIVE DEXAMETHASONE THERAPY; HYPERTONIC SALINE RESUSCITATION; CEREBROSPINAL-FLUID DRAINAGE; ISCHEMIC-STROKE PATIENTS	Background Acute treatment of cerebral edema and elevated intracranial pressure is a common issue in patients with neurological injury. Practical recommendations regarding selection and monitoring of therapies for initial management of cerebral edema for optimal efficacy and safety are generally lacking. This guideline evaluates the role of hyperosmolar agents (mannitol, HTS), corticosteroids, and selected non-pharmacologic therapies in the acute treatment of cerebral edema. Clinicians must be able to select appropriate therapies for initial cerebral edema management based on available evidence while balancing efficacy and safety. Methods The Neurocritical Care Society recruited experts in neurocritical care, nursing, and pharmacy to create a panel in 2017. The group generated 16 clinical questions related to initial management of cerebral edema in various neurological insults using the PICO format. A research librarian executed a comprehensive literature search through July 2018. The panel screened the identified articles for inclusion related to each specific PICO question and abstracted necessary information for pertinent publications. The panel used GRADE methodology to categorize the quality of evidence as high, moderate, low, or very low based on their confidence that the findings of each publication approximate the true effect of the therapy. Results The panel generated recommendations regarding initial management of cerebral edema in neurocritical care patients with subarachnoid hemorrhage, traumatic brain injury, acute ischemic stroke, intracerebral hemorrhage, bacterial meningitis, and hepatic encephalopathy. Conclusion The available evidence suggests hyperosmolar therapy may be helpful in reducing ICP elevations or cerebral edema in patients with SAH, TBI, AIS, ICH, and HE, although neurological outcomes do not appear to be affected. Corticosteroids appear to be helpful in reducing cerebral edema in patients with bacterial meningitis, but not ICH. Differences in therapeutic response and safety may exist between HTS and mannitol. The use of these agents in these critical clinical situations merits close monitoring for adverse effects. There is a dire need for high-quality research to better inform clinicians of the best options for individualized care of patients with cerebral edema.	[Cook, Aaron M.] Univ Kentucky, Coll Pharm, UK Healthcare, Lexington, KY 40506 USA; [Jones, G. Morgan] Methodist Le Bonheur Healthcare, Memphis, TN USA; [Hawryluk, Gregory W. J.] Univ Manitoba, Winnipeg, MB, Canada; [Mailloux, Patrick] Maine Med Ctr, Portland, ME 04102 USA; [McLaughlin, Diane] Ohio State Univ, Columbus, OH 43210 USA; [Papangelou, Alexander] Emory Univ Hosp, 1364 Clifton Rd NE, Atlanta, GA 30322 USA; [Samuel, Sophie] Mem Hermann Texas Med Ctr, Houston, TX USA; [Tokumaru, Sheri] Univ Hawaii Hilo, Daniel K Inouye Coll Pharm, Honolulu, HI USA; [Venkatasubramanian, Chitra; Hirsch, Karen] Stanford Univ, Med Ctr, Stanford, CA 94305 USA; [Zackol, Christopher] Penn State Univ Hlth, Milton S Hershey Med Ctr, Hershey, PA USA; [Zimmermann, Lara L.] Univ Calif Davis, Sacramento, CA 95817 USA; [Shutter, Lori] Univ Pittsburgh, Sch Med, Pittsburgh, PA USA	Cook, AM (corresponding author), Univ Kentucky, Coll Pharm, UK Healthcare, Lexington, KY 40506 USA.	amcook0@email.uky.edu		Cook, Aaron/0000-0001-8539-902X; McLaughlin, Diane/0000-0002-0648-7847; Shutter, Lori/0000-0002-1390-0628	Neurocritical Care Society	The Neurocritical Care Society partially supported travel and virtual meetings.	Achinger SG, 2017, CRIT CARE MED, V45, P1762, DOI 10.1097/CCM.0000000000002595; Ahsan T, 2002, J Pak Med Assoc, V52, P233; Ajdukiewicz KMB, 2011, LANCET INFECT DIS, V11, P293, DOI 10.1016/S1473-3099(10)70317-0; Al-Rawi PG, 2005, ACTA NEUROCHIR SUPPL, V95, P123; Al-Rawi PG, 2010, STROKE, V41, P122, DOI 10.1161/STROKEAHA.109.560698; Aminmansour Bahram, 2017, Adv Biomed Res, V6, P75, DOI 10.4103/2277-9175.192628; Andrews JC, 2013, J CLIN EPIDEMIOL, V66, P726, DOI 10.1016/j.jclinepi.2013.02.003; Asehnoune K, 2017, CRIT CARE, V21, DOI 10.1186/s13054-017-1918-4; Assiri AM, 2009, MAYO CLIN PROC, V84, P403, DOI [10.1016/S0025-6196(11)60558-2, 10.4065/84.5.403]; Auburtin M, 2002, AM J RESP CRIT CARE, V165, P713, DOI 10.1164/ajrccm.165.5.2105110; Ayaz C, 2008, NEUROSCIENCES, V13, P146; BADEMOSI O, 1979, TROP GEOGR MED, V31, P53; Battison C, 2005, CRIT CARE MED, V33, P196, DOI 10.1097/01.CCM.0000150269.65485.A6; Baunbaek-Knudsen G, 2016, INFECT DIS-NOR, V48, P281, DOI 10.3109/23744235.2015.1109705; Becker DP, 1972, INTRACRANIAL PRESSUR; Bentsen G, 2004, ACTA ANAESTH SCAND, V48, P1089, DOI 10.1111/j.1399-6576.2004.00497.x; Bentsen G, 2008, CRIT CARE MED, V36, P2414, DOI 10.1097/CCM.0b013e318180fe04; Bentsen G, 2006, CRIT CARE MED, V34, P2912, DOI 10.1097/01.CCM.0000245665.46789.7C; Bereczki D, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001153.pub2; Bereczki D, 2003, STROKE, V34, P1730, DOI 10.1161/01.STR.0000078658.52316.E8; Berger-Pelleiter E, 2016, CAN J EMERG MED, V18, P112, DOI 10.1017/cem.2016.12; Bhaumik S, 1998, NEUROL INDIA, V46, P225; Biestro A, 1997, ACTA NEUROCHIR, V139, P725, DOI 10.1007/BF01420045; Bodilsen J, 2014, SCAND J INFECT DIS, V46, P418, DOI 10.3109/00365548.2014.887223; Boland T, 2016, NEUROCRIT CARE, V25, P110, DOI 10.1007/s12028-015-0234-6; Bourdeaux CP, 2011, NEUROCRIT CARE, V15, P42, DOI 10.1007/s12028-011-9512-0; Brouwer MC, 2010, NEUROLOGY, V75, P1533, DOI 10.1212/WNL.0b013e3181f96297; Brouwer MC, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004405.pub5; Buchholz G, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1498-8; Bulger EM, 2010, JAMA-J AM MED ASSOC, V304, P1455, DOI 10.1001/jama.2010.1405; CANALESE J, 1982, GUT, V23, P625, DOI 10.1136/gut.23.7.625; Candanedo C, 2019, NEUROCRIT CARE, V30, P340, DOI 10.1007/s12028-018-0612-y; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Chatterjee N, 2007, INDIAN J NEUROTRAUM, V4, P101, DOI 10.1016/S0973-0508(07)80023-2; Cheng F, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00631; Chotmongkol Verajit, 1996, Journal of the Medical Association of Thailand, V79, P83; Colton K, 2016, J INTENSIVE CARE MED, V31, P263, DOI 10.1177/0885066614555692; Connolly ES, 2012, STROKE, V43, P1711, DOI 10.1161/STR.0b013e3182587839; Cooper DJ, 2004, JAMA-J AM MED ASSOC, V291, P1350, DOI 10.1001/jama.291.11.1350; Corry Jesse J, 2014, World J Crit Care Med, V3, P61, DOI 10.5492/wjccm.v3.i2.61; Cottenceau V, 2011, J NEUROTRAUM, V28, P2003, DOI 10.1089/neu.2011.1929; de Gans J, 2002, NEW ENGL J MED, V347, P1549, DOI 10.1056/NEJMoa021334; Desai P, 1998, J NEUROL NEUROSUR PS, V65, P799; Diringer MN, 2011, NEUROCRIT CARE, V14, P11, DOI 10.1007/s12028-010-9465-8; DORMAN HR, 1990, MEDICINE, V69, P153, DOI 10.1097/00005792-199005000-00003; Dunham CM, 2018, INT J BURNS TRAUMA, V8, P40; DURWARD QJ, 1983, J NEUROSURG, V59, P938, DOI 10.3171/jns.1983.59.6.0938; Dziedzic T, 2003, CLIN NEUROL NEUROSUR, V105, P87, DOI 10.1016/S0303-8467(02)00106-3; Erdman MJ, 2017, NEUROHOSPITALIST, V7, P9, DOI 10.1177/1941874416665744; Feigin VL, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004583.pub2; FELDMAN Z, 1992, J NEUROSURG, V76, P207, DOI 10.3171/jns.1992.76.2.0207; Fernandes D, 2014, J CRIT CARE, V29, P347, DOI 10.1016/j.jcrc.2013.12.001; Fisher LA, 2006, NEUROCRIT CARE, V5, P180, DOI 10.1385/NCC:5:3:180; Flores-Cordero JM, 2003, INTENS CARE MED, V29, P1967, DOI 10.1007/s00134-003-1935-4; Fortune JB, 1995, J TRAUMA, V39, P1091, DOI 10.1097/00005373-199512000-00014; Francony G, 2008, CRIT CARE MED, V36, P795, DOI 10.1097/CCM.0B013E3181643B41; Fritz D, 2012, NEUROLOGY, V79, P2177, DOI 10.1212/WNL.0b013e31827595f7; Froelich M, 2009, CRIT CARE MED, V37, P1433, DOI 10.1097/CCM.0b013e31819c1933; GADALLAH MF, 1995, AM J MED SCI, V309, P219, DOI 10.1097/00000441-199504000-00006; Garcia-Morales EJ, 2004, CRIT CARE MED, V32, P986, DOI 10.1097/01.CCM.0000120057.04528.60; Gijwani D, 2002, NEUROL INDIA, V50, P63; GIRGIS NI, 1989, PEDIATR INFECT DIS J, V8, P848, DOI 10.1097/00006454-198912000-00004; GIRGIS NI, 1991, PEDIATR INFECT DIS J, V10, P179, DOI 10.1097/00006454-199103000-00002; Glimaker M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091976; Gondim FDA, 2005, J NEUROSURG, V103, P444; Group CS, 1963, JAMA-J AM MED ASSOC, V183, P462, DOI [10.1001/jama.1963.63700060029012, DOI 10.1001/JAMA.1963.63700060029012]; Gudina EK, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0200067; Gupta A, 1996, J Assoc Physicians India, V44, P90; HANID MA, 1980, GUT, V21, P866, DOI 10.1136/gut.21.10.866; Hartl R, 1997, ZBL CHIR, V122, P181; Hartl R, 1997, ACT NEUR S, V70, P40; Harutjunyan L, 2005, CRIT CARE, V9, pR530, DOI 10.1186/cc3767; Hauer EM, 2011, CRIT CARE MED, V39, P1766, DOI 10.1097/CCM.0b013e318218a390; Heckenberg SGB, 2012, NEUROLOGY, V79, P1563, DOI 10.1212/WNL.0b013e31826e2684; Hemphill JC, 2015, STROKE, V46, P2032, DOI 10.1161/STR.0000000000000069; Hoogman M, 2007, J NEUROL NEUROSUR PS, V78, P1092, DOI 10.1136/jnnp.2006.110023; Horn P, 1999, NEUROL RES, V21, P758, DOI 10.1080/01616412.1999.11741010; Hosoglu S, 2002, INT J TUBERC LUNG D, V6, P64; Hsu PC, 2010, J MICROBIOL IMMUNOL, V43, P111, DOI 10.1016/S1684-1182(10)60018-7; Huang SJ, 2006, SURG NEUROL, V65, P539, DOI 10.1016/j.surneu.2005.11.019; Ichai C, 2009, INTENS CARE MED, V35, P471, DOI 10.1007/s00134-008-1283-5; Jagannatha AT, 2016, J CLIN NEUROSCI, V27, P68, DOI 10.1016/j.jocn.2015.08.035; Jauch EC, 2013, STROKE, V44, P870, DOI 10.1161/STR.0b013e318284056a; Kalita J, 2001, NEUROL INDIA, V49, P267; Keller E, 2002, J NEUROSURG ANESTH, V14, P130, DOI 10.1097/00008506-200204000-00007; KENNING JA, 1981, SURG NEUROL, V15, P148, DOI 10.1016/0090-3019(81)90037-9; Kerr M E, 2001, Neurosurg Focus, V11, pE1; Kerr ME, 2000, J NEUROSURG ANESTH, V12, P324, DOI 10.1097/00008506-200010000-00005; Kerwin AJ, 2009, J TRAUMA, V67, P277, DOI 10.1097/TA.0b013e3181acc726; Koenig MA, 2008, NEUROLOGY, V70, P1023, DOI 10.1212/01.wnl.0000304042.05557.60; KUMARVELU S, 1994, TUBERCLE LUNG DIS, V75, P203, DOI 10.1016/0962-8479(94)90009-4; Larive LL, 2004, NEUROCRIT CARE, V1, P435, DOI 10.1385/NCC:1:4:435; Lazzarini L, 2008, J CHEMOTHERAPY, V20, P478, DOI 10.1179/joc.2008.20.4.478; Ledwith MB, 2010, J NEUROSCI NURS, V42, P280, DOI 10.1097/JNN.0b013e3181ecafd4; Lescot T, 2006, CRIT CARE MED, V34, P3029, DOI 10.1097/01.CCM.0000243797.42346.64; LEVIN AB, 1979, NEUROSURGERY, V5, P570, DOI 10.1227/00006123-197911000-00005; Lewandowski-Belfer JJ, 2014, NEUROCRIT CARE, V20, P436, DOI 10.1007/s12028-013-9907-1; Li M, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000000736; Lin SY, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000002032; Liotta E, 2015, CRIT CARE MED, V43; Maguigan KL, 2017, J CLIN NEUROSCI, V39, P147, DOI 10.1016/j.jocn.2017.01.025; Mahfoud F, 2010, ACTA NEUROCHIR, V152, P443, DOI 10.1007/s00701-009-0520-1; Mai NTH, 2007, NEW ENGL J MED, V357, P2431, DOI 10.1056/NEJMoa070852; Malhotra HS, 2009, ANN TROP MED PARASIT, V103, P625, DOI 10.1179/000349809X12502035776315; Mangat HS, 2020, NEUROSURGERY, V86, P221, DOI 10.1093/neuros/nyz046; Mangat HS, 2015, J NEUROSURG, V122, P202, DOI 10.3171/2014.10.JNS132545; Manno EM, 1999, NEUROLOGY, V52, P583, DOI 10.1212/WNL.52.3.583; Marmarou Anthony, 2007, Neurosurg Focus, V22, pE1; Midgley S., 1993, P 8 INT S INTR PRESS, P558; Misra UK, 2005, J NEUROL SCI, V234, P41, DOI 10.1016/j.jns.2005.03.038; Moon SY, 2012, J NEUROL, V259, P1453, DOI 10.1007/s00415-011-6373-6; Moraine JJ, 2000, J NEUROSURG, V92, P606, DOI 10.3171/jns.2000.92.4.0606; Morrison LJ, 2011, J CRIT CARE, V26, P363, DOI 10.1016/j.jcrc.2010.08.021; MUIZELAAR JP, 1991, J NEUROSURG, V75, P731, DOI 10.3171/jns.1991.75.5.0731; Munar F, 2000, J NEUROTRAUM, V17, P41, DOI 10.1089/neu.2000.17.41; Murphy N, 2004, HEPATOLOGY, V39, P464, DOI 10.1002/hep.20056; Ng I, 2004, NEUROSURGERY, V54, P593, DOI 10.1227/01.NEU.0000108639.16783.39; Nwachuku EL, 2014, NEUROCRIT CARE, V20, P49, DOI 10.1007/s12028-013-9885-3; Oddo M, 2009, J NEUROL NEUROSUR PS, V80, P916, DOI 10.1136/jnnp.2008.156596; Oertel M, 2002, J NEUROSURG, V97, P1045, DOI 10.3171/jns.2002.97.5.1045; Ogun S A, 2001, West Afr J Med, V20, P1; Onar M., 1997, CLIN NEUROPHYSIOL, V37, P213; Ong CJ, 2015, NEUROCRIT CARE, V23, P285, DOI 10.1007/s12028-015-0173-2; OTOOLE RD, 1969, ANN INTERN MED, V70, P39, DOI 10.7326/0003-4819-70-1-39; Papagianni M, 2018, AM J CARDIOVASC DRUG, V18, P397, DOI 10.1007/s40256-018-0285-0; Patil H, 2019, WORLD NEUROSURG, V125, pE221, DOI 10.1016/j.wneu.2019.01.051; POUNGVARIN N, 1987, NEW ENGL J MED, V316, P1229, DOI 10.1056/NEJM198705143162001; Prasad K, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002244.pub4; Qureshi AI, 1999, J TRAUMA, V47, P659, DOI 10.1097/00005373-199910000-00009; Qureshi AI, 1998, CRIT CARE MED, V26, P440, DOI 10.1097/00003246-199803000-00011; Rahman M L, 2009, Mymensingh Med J, V18, P47; Riha HM, 2017, CRIT CARE MED, V45, pE947, DOI 10.1097/CCM.0000000000002522; Roberts I, 2007, BRIT MED J, V334, P392, DOI 10.1136/bmj.39118.480023.BE; Rockswold GL, 2009, NEUROSURGERY, V65, P1035, DOI 10.1227/01.NEU.0000359533.16214.04; Roquilly A, 2011, CRIT CARE, V15, DOI 10.1186/cc10522; ROSNER MJ, 1986, J NEUROSURG, V65, P636, DOI 10.3171/jns.1986.65.5.0636; RUBINSTEIN MK, 1965, J NERV MENT DIS, V141, P291, DOI 10.1097/00005053-196509000-00005; Sadan O, 2017, CRIT CARE MED, V45, P1382, DOI 10.1097/CCM.0000000000002497; Sakellaridis N, 2011, J NEUROSURG, V114, P545, DOI 10.3171/2010.5.JNS091685; SANTAMBROGIO S, 1978, STROKE, V9, P130, DOI 10.1161/01.STR.9.2.130; Saraswat VA, 2008, WORLD J GASTROENTERO, V14, P4168, DOI 10.3748/wjg.14.4168; Sayre MR, 1996, ACAD EMERG MED, V3, P840, DOI 10.1111/j.1553-2712.1996.tb03528.x; Scarborough M, 2007, NEW ENGL J MED, V357, P2441, DOI 10.1056/NEJMoa065711; Schatzmann C, 1998, ACT NEUR S, V71, P31; SCHWARTZ ML, 1984, CAN J NEUROL SCI, V11, P434, DOI 10.1017/S0317167100045960; Schwarz S, 1998, STROKE, V29, P1550, DOI 10.1161/01.STR.29.8.1550; Schwarz S, 2002, STROKE, V33, P136, DOI 10.1161/hs0102.100877; Shackford SR, 1998, J TRAUMA, V44, P50, DOI 10.1097/00005373-199801000-00004; Shah M, 2018, J STROKE CEREBROVASC, V27, P1061, DOI 10.1016/j.jstrokecerebrovasdis.2017.11.013; Sharafadinzadeh N, 2008, PAK J MED SCI, V24, P502; Singhi S, 2008, PEDIATR INFECT DIS J, V27, P892, DOI 10.1097/INF.0b013e318175d177; Smedema RJ, 1993, INTRACRANIAL PRESSUR, V1993, P605; SMITH HP, 1986, J NEUROSURG, V65, P820, DOI 10.3171/jns.1986.65.6.0820; Soustiel JF, 2006, ACTA NEUROCHIR, V148, P845, DOI 10.1007/s00701-006-0792-7; Stelfox HT, 2010, CAN J ANAESTH, V57, P650, DOI 10.1007/s12630-010-9309-1; Strbian D, 2013, INT J STROKE, V8, P529, DOI 10.1111/j.1747-4949.2012.00781.x; Suarez JI, 1999, J NEUROSURG ANESTH, V11, P178, DOI 10.1097/00008506-199907000-00004; Sun SW, 2019, WORLD NEUROSURG, V124, P386, DOI 10.1016/j.wneu.2018.11.249; Tan SKR, 2016, CAN J ANESTH, V63, P664, DOI 10.1007/s12630-016-0633-y; Tellez H, 1973, STROKE, V4, P541, DOI 10.1161/01.STR.4.4.541; TEMES SP, 1975, SURG GYNECOL OBSTET, V141, P223; Thomas R, 1999, INTENS CARE MED, V25, P475, DOI 10.1007/s001340050883; Thwaites GE, 2004, NEW ENGL J MED, V351, P1741, DOI 10.1056/NEJMoa040573; Torok ME, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027821; Tolaj Ilir, 2010, Med Arh, V64, P228; Treggiari MM, 2007, NEUROCRIT CARE, V6, P104, DOI 10.1007/s12028-007-0012-1; Tseng MY, 2007, J NEUROSURG, V107, P274, DOI 10.3171/JNS-07/08/0274; Tseng MY, 2003, STROKE, V34, P1389, DOI 10.1161/01.STR.0000071526.45277.44; Tunkel AR, 2004, CLIN INFECT DIS, V39, P1267, DOI 10.1086/425368; van de Beek D, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004405.pub2; van de Beek D, 2010, LANCET NEUROL, V9, P254, DOI 10.1016/S1474-4422(10)70023-5; Vardakas KZ, 2009, EUR J NEUROL, V16, P662, DOI 10.1111/j.1468-1331.2009.02615.x; Viale P, 2015, ANN PHARMACOTHER, V49, P978, DOI 10.1177/1060028015586012; Vialet R, 2003, CRIT CARE MED, V31, P1683, DOI 10.1097/01.CCM.0000063268.91710.DF; Videen TO, 2001, NEUROLOGY, V57, P2120, DOI 10.1212/WNL.57.11.2120; Wagner I, 2011, STROKE, V42, P1540, DOI 10.1161/STROKEAHA.110.609479; Wang X, 2015, STROKE, V46, P2762, DOI 10.1161/STROKEAHA.115.009357; Ware ML, 2005, NEUROSURGERY, V57, P727, DOI 10.1227/01.NEU.0000175726.08903.OA; Weisfelt M, 2006, EUR J CLIN MICROBIOL, V25, P73, DOI 10.1007/s10096-006-0089-z; Weisfelt M, 2006, ANN NEUROL, V60, P456, DOI 10.1002/ana.20944; Wells DL, 2012, CRIT CARE, V16, DOI 10.1186/cc11678; Winkelman C, 2000, Am J Crit Care, V9, P373; Yechoor VK, 1996, ARCH INTERN MED, V156, P1710, DOI 10.1001/archinte.156.15.1710; Yunos NM, 2012, JAMA-J AM MED ASSOC, V308, P1566, DOI 10.1001/jama.2012.13356; Zaganas I, 2011, STROKE, V42, P3640, DOI 10.1161/STROKEAHA.111.632174; Zuliani G, 2004, DRUG AGING, V21, P273, DOI 10.2165/00002512-200421040-00005	186	21	22	0	0	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care	JUN	2020	32	3					647	666		10.1007/s12028-020-00959-7		MAR 2020	20	Critical Care Medicine; Clinical Neurology	General & Internal Medicine; Neurosciences & Neurology	LV6MP	WOS:000522175300001	32227294	Green Published, Other Gold			2021-06-18	
J	Liu, L; Chen, B; Liu, K; Gao, JB; Ye, YC; Wang, Z; Qin, N; Wilson, DA; Tu, YF; Peng, F				Liu, Lu; Chen, Bin; Liu, Kun; Gao, Junbin; Ye, Yicheng; Wang, Zhen; Qin, Ni; Wilson, Daniela A.; Tu, Yingfeng; Peng, Fei			Wireless Manipulation of Magnetic/Piezoelectric Micromotors for Precise Neural Stem-Like Cell Stimulation	ADVANCED FUNCTIONAL MATERIALS			English	Article						magnetic control; micromotor; neuronal regeneration; precise stimulation; wireless ultrasound	DEEP BRAIN-STIMULATION; DIFFERENTIATION; GROWTH; ENHANCEMENT; ACTIVATION; DELIVERY; SYSTEMS; ENERGY; DEVICE; CAMP	Precise neural electrical stimulation, which is a means of promoting neuronal regeneration, is a promising solution for patients with neurotrauma and neurodegenerative diseases. In this study, wirelessly controllable targeted motion and precise stimulation at the single-cell level using S.platensis@Fe3O4@tBaTiO(3) micromotors are successfully demonstrated for the first time. A highly versatile and multifunctional biohybrid soft micromotor is fabricated via the integration of S.platensis with magnetic Fe3O4 nanoparticles and piezoelectric BaTiO3 nanoparticles. The results show that this micromotor system can achieve navigation in a highly controllable manner under a low-strength rotating magnetic field. The as-developed system can achieve single-cell targeted motion and then precisely induce the differentiation of the targeted neural stem-like cell by converting ultrasonic energy to an electrical signal in situ owing to the piezoelectric effect. This new approach toward the high-precision stimulation of neural stem-like cells opens up new applications for micromotors and has excellent potential for precise neuronal regenerative therapies.	[Liu, Lu; Chen, Bin; Liu, Kun; Gao, Junbin; Ye, Yicheng; Tu, Yingfeng] Southern Med Univ, Guangdong Prov Key Lab New Drug Screening, Sch Pharmaceut Sci, Guangzhou 510515, Peoples R China; [Liu, Lu; Wang, Zhen; Qin, Ni; Peng, Fei] Sun Yat Sen Univ, Sch Mat Sci & Engn, Guangzhou 510275, Guangdong, Peoples R China; [Wilson, Daniela A.] Radboud Univ Nijmegen, Inst Mol & Mat, NL-6525 AJ Nijmegen, Netherlands	Tu, YF (corresponding author), Southern Med Univ, Guangdong Prov Key Lab New Drug Screening, Sch Pharmaceut Sci, Guangzhou 510515, Peoples R China.; Peng, F (corresponding author), Sun Yat Sen Univ, Sch Mat Sci & Engn, Guangzhou 510275, Guangdong, Peoples R China.	tuyingfeng1@smu.edu.cn; pengf26@mail.sysu.edu.cn	Wilson, Daniela A./A-8119-2010; Liu, Kun/Y-9393-2018; Tu, Yingfeng/B-7661-2016	Wilson, Daniela A./0000-0002-8796-2274; Liu, Kun/0000-0002-7276-7935; Tu, Yingfeng/0000-0003-2605-0172	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [21805318, 51973241, 31800835]; Guangdong Provincial Science FoundationNational Natural Science Foundation of Guangdong Province [2018B030306007, 2018A030313521]; Chinese 1000-Talent Young Program; Pearl Youth Scholar Funded Scheme	This work was supported by the National Natural Science Foundation of China (Grant Nos. 21805318, 51973241, and 31800835) and the Guangdong Provincial Science Foundation (Grant Nos. 2018B030306007 and 2018A030313521). The authors are grateful for the support from the Chinese 1000-Talent Young Program and Pearl Youth Scholar Funded Scheme.	Albert GC, 2009, NEUROSCI BIOBEHAV R, V33, P1042, DOI 10.1016/j.neubiorev.2009.04.006; Balazs AC, 2018, ACCOUNTS CHEM RES, V51, P2979, DOI 10.1021/acs.accounts.8b00511; BELAY A, 1993, J APPL PHYCOL, V5, P235, DOI 10.1007/BF00004024; Brooks AM, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08423-7; CATTERALL WA, 1993, TRENDS NEUROSCI, V16, P500, DOI 10.1016/0166-2236(93)90193-P; Chang XC, 2019, ACS APPL MATER INTER, V11, P28507, DOI 10.1021/acsami.9b08159; Chen DZ, 2012, INT J NANOMED, V7, P4973, DOI 10.2147/IJN.S35140; Chen MC, 2010, AM J PHYSIOL-CELL PH, V299, pC516, DOI 10.1152/ajpcell.00534.2009; Choi H, 2018, ACS APPL MATER INTER, V10, P2338, DOI 10.1021/acsami.7b16595; Ciofani G, 2010, ACS NANO, V4, P6267, DOI 10.1021/nn101985a; COOPER DMF, 1995, NATURE, V374, P421, DOI 10.1038/374421a0; de Avila BEF, 2017, ACS NANO, V11, P5367, DOI 10.1021/acsnano.7b01926; de Haas R, 2012, J NEUROSCI METH, V209, P113, DOI 10.1016/j.jneumeth.2012.05.028; Dubey AK, 2015, J MATER SCI-MATER M, V26, DOI 10.1007/s10856-015-5414-6; Esch T, 1999, J NEUROSCI, V19, P6417; Fu SZ, 2017, NANOSCALE, V9, P9026, DOI 10.1039/c7nr01168g; Gao W, 2014, NANOSCALE, V6, P10486, DOI 10.1039/c4nr03124e; Gao W, 2013, NANOSCALE, V5, P4696, DOI 10.1039/c3nr01458d; Garcia-Gradilla V, 2013, ACS NANO, V7, P9232, DOI 10.1021/nn403851v; Genchi GG, 2016, ADV HEALTHC MATER, V5, P1808, DOI 10.1002/adhm.201600245; Goud KY, 2019, ACS SENSORS, V4, P2196, DOI 10.1021/acssensors.9b01127; Gratton SEA, 2008, P NATL ACAD SCI USA, V105, P11613, DOI 10.1073/pnas.0801763105; GREENE LA, 1987, METHOD ENZYMOL, V147, P207; Halls ML, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004143; Hoop M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03992-3; Hu XH, 2018, SMALL, V14, DOI 10.1002/smll.201800504; Huang C, 2010, GLIA, V58, P1415, DOI 10.1002/glia.21017; Iacovacci V, 2019, SMALL, V15, DOI 10.1002/smll.201900709; Jang B, 2017, ACS NANO, V11, P6146, DOI 10.1021/acsnano.7b02177; Jeon S, 2019, SCI ROBOT, V4, DOI 10.1126/scirobotics.aav4317; Jurado-Sanchez B, 2015, CHEM COMMUN, V51, P14088, DOI 10.1039/c5cc04726a; Kagan D, 2012, ANGEW CHEM INT EDIT, V51, P7519, DOI 10.1002/anie.201201902; Kagan D, 2010, SMALL, V6, P2741, DOI 10.1002/smll.201001257; Katuri J, 2017, ACCOUNTS CHEM RES, V50, P2, DOI 10.1021/acs.accounts.6b00386; Khan Z, 2005, CURR PHARM BIOTECHNO, V6, P373, DOI 10.2174/138920105774370607; Kim Y, 2019, SCI ROBOT, V4, DOI 10.1126/scirobotics.aax7329; Kong L, 2019, ANAL CHEM, V91, P5660, DOI 10.1021/acs.analchem.8b05464; Kong L, 2018, ACS APPL MATER INTER, V10, P22427, DOI 10.1021/acsami.8b05776; Lee H, 2018, BIOMED MICRODEVICES, V20, P1, DOI 10.1007/s10544-018-0344-y; Lee K, 2016, ANGEW CHEM INT EDIT, V55, P7384, DOI 10.1002/anie.201601211; Lee S, 2018, ADV HEALTHC MATER, V7, DOI 10.1002/adhm.201700985; Levi-Montalcini R., 1997, NEUROREPORT, V3, P352; Li H, 2018, MICROMACHINES-BASEL, V9, DOI 10.3390/mi9040182; Li H, 2016, J MICROENCAPSUL, V33, P712, DOI 10.1080/02652048.2016.1234514; Li JX, 2017, SCI ROBOT, V2, DOI 10.1126/scirobotics.aam6431; Lindvall O, 2010, J CLIN INVEST, V120, P29, DOI 10.1172/JCI40543; Maric T, 2019, ACS APPL MATER INTER, V11, P31832, DOI 10.1021/acsami.9b08332; Marino A, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-24697-1; Marino A, 2015, ACS NANO, V9, P7678, DOI 10.1021/acsnano.5b03162; Mojon DS, 2015, EYE, V29, P225, DOI 10.1038/eye.2014.281; Moo JGS, 2016, ACS SENSORS, V1, P949, DOI 10.1021/acssensors.6b00314; Moo JGS, 2015, CHEM-EUR J, V21, P58, DOI 10.1002/chem.201405011; Ni SB, 2017, SOFT MATTER, V13, P4252, DOI 10.1039/c7sm00443e; Pantazis P, 2010, P NATL ACAD SCI USA, V107, P14535, DOI 10.1073/pnas.1004748107; Parran DK, 2003, DEV BRAIN RES, V141, P71, DOI 10.1016/S0165-3806(02)00644-2; Peng F, 2017, ADV MATER, V29, DOI 10.1002/adma.201604996; Royo-Gascon N, 2013, ANN BIOMED ENG, V41, P112, DOI 10.1007/s10439-012-0628-y; Safdar M, 2018, ADV MATER, V30, DOI 10.1002/adma.201703660; Srivastava SK, 2016, ADV MATER, V28, P832, DOI 10.1002/adma.201504327; Tu YF, 2019, ANGEW CHEM INT EDIT, V58, P8687, DOI 10.1002/anie.201900917; Valls-Sole J, 2008, CLIN NEUROPHYSIOL, V119, P1219, DOI 10.1016/j.clinph.2007.12.020; Vaudry D, 2002, SCIENCE, V296, P1648, DOI 10.1126/science.1071552; Wang ET, 2010, CHIN J TRAUMATOL, V13, P55, DOI 10.3760/cma.j.issn.1008-1275.2010.01.011; Wang H, 2016, CHEM-US, V1, P473, DOI 10.1016/j.chempr.2016.08.009; Wang W, 2019, J AM CHEM SOC, V141, P6601, DOI 10.1021/jacs.8b13882; Wang XP, 2019, ADV MATER, V31, DOI 10.1002/adma.201901592; Wang XD, 2007, NANO LETT, V7, P2475, DOI 10.1021/nl0712567; Wang Y, 2018, ANGEW CHEM INT EDIT, V57, P13110, DOI 10.1002/anie.201807033; Wu J, 2018, NANO ENERGY, V45, P44, DOI 10.1016/j.nanoen.2017.12.034; Wu MX, 2017, ADV FUNCT MATER, V27, DOI 10.1002/adfm.201606039; Xi W, 2013, NANOSCALE, V5, P1294, DOI 10.1039/c2nr32798h; Xie YZ, 2017, BIOSENS BIOELECTRON, V87, P31, DOI 10.1016/j.bios.2016.07.104; Xu TL, 2017, ADV MATER, V29, DOI 10.1002/adma.201603250; Xu TQ, 2019, SCI ROBOT, V4, DOI 10.1126/scirobotics.aav4494; Xuan MJ, 2018, ANGEW CHEM INT EDIT, V57, P12463, DOI 10.1002/anie.201806759; Yamamoto D, 2019, J CHEM PHYS, V150, DOI 10.1063/1.5055830; Yan XH, 2017, SCI ROBOT, V2, DOI 10.1126/scirobotics.aaq1155; Yan XH, 2015, ADV FUNCT MATER, V25, P5333, DOI 10.1002/adfm.201502248; Zhang SF, 2009, PHARM RES-DORDR, V26, P1561, DOI 10.1007/s11095-009-9897-z	79	21	21	22	130	WILEY-V C H VERLAG GMBH	WEINHEIM	POSTFACH 101161, 69451 WEINHEIM, GERMANY	1616-301X	1616-3028		ADV FUNCT MATER	Adv. Funct. Mater.	MAR	2020	30	11							1910108	10.1002/adfm.201910108		JAN 2020	8	Chemistry, Multidisciplinary; Chemistry, Physical; Nanoscience & Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied; Physics, Condensed Matter	Chemistry; Science & Technology - Other Topics; Materials Science; Physics	KV0UQ	WOS:000508487300001					2021-06-18	
J	Dumkrieger, G; Chong, CD; Ross, K; Berisha, V; Schwedt, TJ				Dumkrieger, Gina; Chong, Catherine D.; Ross, Katherine; Berisha, Visar; Schwedt, Todd J.			Static and dynamic functional connectivity differences between migraine and persistent post-traumatic headache: A resting-state magnetic resonance imaging study	CEPHALALGIA			English	Article						Post-traumatic headache; migraine; concussion; mild traumatic brain injury; functional connectivity; magnetic resonance imaging; brain imaging	TRAUMATIC BRAIN-INJURY; NETWORK CONNECTIVITY; PAIN; REGIONS	Introduction Although migraine and persistent post-traumatic headache often share phenotypic characteristics, few studies have interrogated the pathophysiological differences underlying these headache types. While there is now some indication of differences in brain structure between migraine and persistent post-traumatic headache, differences in brain function have not been adequately investigated. The objective of this study was to compare static and dynamic functional connectivity patterns in migraine versus persistent post-traumatic headache using resting-state magnetic resonance imaging. Methods This case-control study interrogated the static functional connectivity and dynamic functional connectivity patterns of 59 a priori selected regions of interest involved in pain processing. Pairwise connectivity (region of interest to region of interest) differences between migraine (n = 33) and persistent post-traumatic headache (n = 44) were determined and compared to healthy controls (n = 36) with ANOVA and subsequent t-tests. Pearson partial correlations were used to explore the relationship between headache burden (headache frequency; years lived with headache) and functional connectivity and between pain intensity at the time of imaging and functional connectivity for migraine and persistent post-traumatic headache groups, separately. Results Significant differences in static functional connectivity between migraine and persistent post-traumatic headache were found for 17 region pairs that included the following regions of interest: Primary somatosensory, secondary somatosensory, posterior insula, hypothalamus, anterior cingulate, middle cingulate, temporal pole, supramarginal gyrus, superior parietal, middle occipital, lingual gyrus, pulvinar, precuneus, cuneus, somatomotor, ventromedial prefrontal cortex, and dorsolateral prefrontal cortex. Significant differences in dynamic functional connectivity between migraine and persistent post-traumatic headache were found for 10 region pairs that included the following regions of interest: Secondary somatosensory, hypothalamus, middle cingulate, temporal pole, supramarginal gyrus, superior parietal, lingual gyrus, somatomotor, precentral, posterior cingulate, middle frontal, fusiform gyrus, parieto-occiptal, and amygdala. Although there was overlap among the regions demonstrating static functional connectivity differences and those showing dynamic functional connectivity differences between persistent post-traumatic headache and migraine, there was no overlap in the region pair functional connections. After controlling for sex and age, there were significant correlations between years lived with headache with static functional connectivity of the right dorsolateral prefrontal cortex with the right ventromedial prefrontal cortex in the migraine group and with static functional connectivity of right primary somatosensory with left supramarginal gyrus in the persistent post-traumatic headache group. There were significant correlations between headache frequency with static functional connectivity of left secondary somatosensory with right cuneus in the migraine group and with static functional connectivity of left middle cingulate with right pulvinar and right posterior insula with left hypothalamus in the persistent post-traumatic headache group. Dynamic functional connectivity was significantly correlated with headache frequency, after controlling for sex and age, in the persistent post-traumatic headache group for one region pair (right middle cingulate with right supramarginal gyrus). Dynamic functional connectivity was correlated with pain intensity at the time of imaging for the migraine cohort for one region pair (right posterior cingulate with right amygdala). Conclusions Resting-state functional imaging revealed static functional connectivity and dynamic functional connectivity differences between migraine and persistent post-traumatic headache for regions involved in pain processing. These differences in functional connectivity might be indicative of distinctive pathophysiology associated with migraine versus persistent post-traumatic headache.	[Dumkrieger, Gina; Chong, Catherine D.; Schwedt, Todd J.] Mayo Clin, 5777 East Mayo Blvd, Phoenix, AZ 85054 USA; [Ross, Katherine] Phoenix VA Hlth Care Syst, Phoenix, AZ USA; [Berisha, Visar] Arizona State Univ, Tempe, AZ USA	Schwedt, TJ (corresponding author), Mayo Clin, 5777 East Mayo Blvd, Phoenix, AZ 85054 USA.	Schwedt.todd@mayo.edu		Berisha, Visar/0000-0001-8804-8874; Dumkrieger, Gina/0000-0001-9519-5370			Allen EA, 2014, CEREB CORTEX, V24, P663, DOI 10.1093/cercor/bhs352; Amin FM, 2018, CEPHALALGIA, V38, P1237, DOI 10.1177/0333102417729113; Ashburner J, 1999, HUM BRAIN MAPP, V7, P254, DOI 10.1002/(SICI)1097-0193(1999)7:4<254::AID-HBM4>3.0.CO;2-G; Beck AT., 1996, BECK DEPRESSION INVE, V2; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Chang C, 2013, NEUROIMAGE, V68, P93, DOI 10.1016/j.neuroimage.2012.11.038; Chong CD, 2019, J CEREBR BLOOD F MET, V39, P650, DOI 10.1177/0271678X17740794; Chong CD, 2018, HEADACHE, V58, P53, DOI 10.1111/head.13223; Chong CD, 2017, CEPHALALGIA, V37, P828, DOI 10.1177/0333102416652091; Cordes D, 2001, AM J NEURORADIOL, V22, P1326; Corrigan JD, 2007, J HEAD TRAUMA REHAB, V22, P318, DOI 10.1097/01.HTR.0000300227.67748.77; Duerden EG, 2013, HUM BRAIN MAPP, V34, P109, DOI 10.1002/hbm.21416; Gao Q, 2016, BRAIN RES, V1632, P73, DOI 10.1016/j.brainres.2015.12.007; Gronenschild EHBM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038234; Headache Classification Committee of the International Headache Society (IHS), 2018, INT CLASS HEAD DIS, P1; Howard L, 2018, HEADACHE, V58, P1397, DOI 10.1111/head.13396; Hutchison RM, 2013, NEUROIMAGE, V80, P360, DOI 10.1016/j.neuroimage.2013.05.079; Li ZJ, 2017, CEPHALALGIA, V37, P161, DOI 10.1177/0333102416641665; Liu JX, 2015, HUM BRAIN MAPP, V36, P1892, DOI 10.1002/hbm.22744; Lucas S, 2014, CEPHALALGIA, V34, P93, DOI 10.1177/0333102413499645; Maniyar FH, 2014, BRAIN, V137, P232, DOI 10.1093/brain/awt320; Mickleborough MJS, 2016, BRAIN TOPOGR, V29, P419, DOI 10.1007/s10548-015-0459-x; Moulton EA, 2011, CEREB CORTEX, V21, P435, DOI 10.1093/cercor/bhq109; Peyron R, 2000, NEUROPHYSIOL CLIN, V30, P263, DOI 10.1016/S0987-7053(00)00227-6; Power JD, 2014, NEUROIMAGE, V84, P320, DOI 10.1016/j.neuroimage.2013.08.048; Ruff RL, 2008, J REHABIL RES DEV, V45, P941, DOI 10.1682/JRRD.2008.02.0028; Russo A, 2012, CEPHALALGIA, V32, P1041, DOI 10.1177/0333102412457089; Schwedt TJ, 2017, J HEADACHE PAIN, V18, DOI 10.1186/s10194-017-0796-0; Schwedt TJ, 2013, HEADACHE, V53, P737, DOI 10.1111/head.12081; Shen K, 2015, J NEUROSCI, V35, P5579, DOI 10.1523/JNEUROSCI.4903-14.2015; Spielberger CD, 1983, STATE TRAIT ANXIETY; Spielberger CD., 1989, MANUAL STATE TRAIT A, V2; Stankewitz A, 2011, J NEUROSCI, V31, P1937, DOI 10.1523/JNEUROSCI.4496-10.2011; Tedeschi G, 2016, CEPHALALGIA, V36, P139, DOI 10.1177/0333102415584360; Tessitore A, 2015, HEADACHE, V55, P794, DOI 10.1111/head.12587; van der Horn HJ, 2016, HUM BRAIN MAPP, V37, P1645, DOI 10.1002/hbm.23126; Wager TD, 2013, NEW ENGL J MED, V368, P1388, DOI 10.1056/NEJMoa1204471; Yan CG, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00013	38	21	21	0	6	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0333-1024	1468-2982		CEPHALALGIA	Cephalalgia	OCT	2019	39	11					1366	1381		10.1177/0333102419847728			16	Clinical Neurology; Neurosciences	Neurosciences & Neurology	JB9AZ	WOS:000488874800003	31042064	Bronze			2021-06-18	
J	Lindberg, DM; Stence, NV; Grubenhoff, JA; Lewis, T; Mirsky, DM; Miller, AL; O'Neill, BR; Grice, K; Mourani, PM; Runyan, DK				Lindberg, Daniel M.; Stence, Nicholas, V; Grubenhoff, Joseph A.; Lewis, Terri; Mirsky, David M.; Miller, Angie L.; O'Neill, Brent R.; Grice, Kathleen; Mourani, Peter M.; Runyan, Desmond K.			Feasibility and Accuracy of Fast MRI Versus CT for Traumatic Brain Injury in Young Children	PEDIATRICS			English	Article							COMPUTED-TOMOGRAPHY; INFANTS; AGE	This study measured fast MRI completion rate, duration, and accuracy in 225 children who underwent head CT and received care at a pediatric ED. BACKGROUND: Computed tomography (CT) is commonly used for children when there is concern for traumatic brain injury (TBI) and is a significant source of ionizing radiation. Our objective was to determine the feasibility and accuracy of fast MRI (motion-tolerant MRI sequences performed without sedation) in young children. METHODS: In this prospective cohort study, we attempted fast MRI in children <6 years old who had head CT performed and were seen in the emergency department of a single, level 1 pediatric trauma center. Fast MRI sequences included 3T axial and sagittal T2 single-shot turbo spin echo, axial T1 turbo field echo, axial fluid-attenuated inversion recovery, axial gradient echo, and axial diffusion-weighted single-shot turbo spin echo planar imaging. Feasibility was assessed by completion rate and imaging time. Fast MRI accuracy was measured against CT findings of TBI, including skull fracture, intracranial hemorrhage, or parenchymal injury. RESULTS: Among 299 participants, fast MRI was available and attempted in 225 (75%) and completed in 223 (99%). Median imaging time was 59 seconds (interquartile range 52-78) for CT and 365 seconds (interquartile range 340-392) for fast MRI. TBI was identified by CT in 111 (50%) participants, including 81 skull fractures, 27 subdural hematomas, 24 subarachnoid hemorrhages, and 35 other injuries. Fast MRI identified TBI in 103 of these (sensitivity 92.8%; 95% confidence interval 86.3-96.8), missing 6 participants with isolated skull fractures and 2 with subarachnoid hemorrhage. CONCLUSIONS: Fast MRI is feasible and accurate relative to CT in clinically stable children with concern for TBI.	[Lindberg, Daniel M.; Grubenhoff, Joseph A.; Lewis, Terri; Grice, Kathleen; Mourani, Peter M.; Runyan, Desmond K.] Univ Colorado, Dept Pediat, Denver, CO 80045 USA; [Lindberg, Daniel M.] Univ Colorado, Dept Emergency Med, Denver, CO 80045 USA; [Stence, Nicholas, V; Mirsky, David M.; Miller, Angie L.] Univ Colorado, Dept Radiol, Denver, CO 80045 USA; [O'Neill, Brent R.] Univ Colorado, Dept Neurosurg, Denver, CO 80045 USA; [Mourani, Peter M.] Univ Colorado, Sect Crit Care, Denver, CO 80045 USA; [Lindberg, Daniel M.; Lewis, Terri; Runyan, Desmond K.] Univ Colorado, Kempe Ctr Prevent & Treatment Child Abuse & Negle, Denver, CO 80045 USA; [Lindberg, Daniel M.; Stence, Nicholas, V; Grubenhoff, Joseph A.; Lewis, Terri; Mirsky, David M.; Miller, Angie L.; O'Neill, Brent R.; Grice, Kathleen; Mourani, Peter M.; Runyan, Desmond K.] Univ Colorado, Sch Med, Denver, CO 80045 USA	Lindberg, DM (corresponding author), Univ Colorado, Sch Med, Dept Emergency Med, 12401 E 17th Ave,Mailstop B215, Denver, CO 80045 USA.	daniel.lindberg@cuanschutz.edu	Lewis, Terri/ABC-3668-2020		Colorado Traumatic Brain Injury Trust Fund; Colorado Clinical and Translational Sciences Institute	Funded by the Colorado Traumatic Brain Injury Trust Fund (MindSource) and the Colorado Clinical and Translational Sciences Institute. The funders had no role in the design; collection, analysis, or interpretation of data; writing of the article; or decision to submit results for publication.	Bossuyt PM, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h5527; Brenner DJ, 2007, NEW ENGL J MED, V357, P2277, DOI 10.1056/NEJMra072149; Bressan S, 2018, ANN EMERG MED, V71, P714, DOI 10.1016/j.annemergmed.2017.10.014; Burstein B, 2018, PEDIATRICS, V142, DOI 10.1542/peds.2018-0814; Christian CW, 2015, PEDIATRICS, V135, pE1337, DOI 10.1542/peds.2015-0356; Cohen AR, 2015, AM J EMERG MED, V33, P887, DOI 10.1016/j.ajem.2015.03.052; Deye KP, 2013, J TRAUMA ACUTE CARE, V74, P1553, DOI 10.1097/TA.0b013e31828b7fc4; Dingman AL, 2018, PEDIATR NEUROL, V82, P29, DOI 10.1016/j.pediatrneurol.2017.12.003; Dremmen MHG, 2017, AM J NEURORADIOL, V38, P2187, DOI 10.3174/ajnr.A5405; Faul M.D., 2010, TRAUMATIC BRAIN INJU; Flick RP, 2011, PEDIATRICS, V128, pE1053, DOI 10.1542/peds.2011-0351; Flom L, 2016, PEDIATR RADIOL, V46, P519, DOI 10.1007/s00247-015-3500-z; Iskandar BJ, 2004, J NEUROSURG, V101, P147, DOI 10.3171/ped.2004.101.2.0147; Kralik SF, 2017, AM J NEURORADIOL, V38, P807, DOI 10.3174/ajnr.A5093; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; Langlois JA., 2004, TRAUMATIC BRAIN INJU; Laskey AL, 2013, J PEDIATR-US, V162, P86, DOI 10.1016/j.jpeds.2012.06.038; Lustig M, 2007, MAGN RESON MED, V58, P1182, DOI 10.1002/mrm.21391; Magana JN, 2017, ACAD EMERG MED, V24, P382, DOI 10.1111/acem.13155; Mathews JD, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2360; Mehta H, 2016, AM J NEURORADIOL, V37, P11, DOI 10.3174/ajnr.A4464; Miglioretti DL, 2013, JAMA PEDIATR, V167, P700, DOI 10.1001/jamapediatrics.2013.311; Nigrovic LE, 2011, PEDIATRICS, V127, P1067, DOI 10.1542/peds.2010-3373; O'Leary JD, 2019, JAMA PEDIATR, V173, P29, DOI 10.1001/jamapediatrics.2018.3662; Rollins MD, 2011, J PEDIATR SURG, V46, P1342, DOI 10.1016/j.jpedsurg.2010.12.019; Ryan ME, 2016, NEURORADIOLOGY, V58, P793, DOI 10.1007/s00234-016-1686-x; Section on Radiology, 2009, PEDIATRICS, V123, P1430, DOI DOI 10.1542/PEDS.2009-0558; Stanley RM, 2014, J PEDIATR-US, V165, P1201, DOI 10.1016/j.jpeds.2014.08.008; Wood JN, 2009, PEDIATRICS, V123, pE247, DOI 10.1542/peds.2008-2467; Young JY, 2016, EMERG RADIOL, V23, P325, DOI 10.1007/s10140-016-1392-3	30	21	21	0	2	AMER ACAD PEDIATRICS	ELK GROVE VILLAGE	141 NORTH-WEST POINT BLVD,, ELK GROVE VILLAGE, IL 60007-1098 USA	0031-4005	1098-4275		PEDIATRICS	Pediatrics	OCT	2019	144	4							e20190419	10.1542/peds.2019-0419			8	Pediatrics	Pediatrics	JA2LW	WOS:000487649200005	31533974	Bronze			2021-06-18	
J	Campos-Pires, R; Hirnet, T; Valeo, F; Ong, BE; Radyushkin, K; Aldhoun, J; Saville, J; Edge, CJ; Franks, NP; Thal, SC; Dickinson, R				Campos-Pires, Rita; Hirnet, Tobias; Valeo, Flavia; Ong, Bee Eng; Radyushkin, Konstantin; Aldhoun, Jitka; Saville, Joanna; Edge, Christopher J.; Franks, Nicholas P.; Thal, Serge C.; Dickinson, Robert			Xenon improves long-term cognitive function, reduces neuronal loss and chronic neuroinflammation, and improves survival after traumatic brain injury in mice	BRITISH JOURNAL OF ANAESTHESIA			English	Article						hippocampus; general anaesthesia; memory disorders; nerve degeneration; neuroinflammation; neuroprotection; traumatic brain injury	D-ASPARTATE RECEPTOR; WHITE-MATTER DAMAGE; COMPETITIVE-INHIBITION; INHALED XENON; BUPRENORPHINE; HYPOPITUITARISM; EPIDEMIOLOGY; HYPOTHERMIA; ANALGESIA; PATHOLOGY	Background: Xenon is a noble gas with neuroprotective properties that can improve short and long-term outcomes in young adult mice after controlled cortical impact. This follow-up study investigates the effects of xenon on very long-term outcomes and survival. Methods: C57BL/6N young adult male mice (n=72) received single controlled cortical impact or sham surgery and were treated with either xenon (75% Xe:25% O-2) or control gas (75% N-2 :25% O-2). Outcomes measured were: (i) 24 h lesion volume and neurological outcome score; (ii) contextual fear conditioning at 2 weeks and 20 months; (iii) corpus callosum white matter quantification; (iv) immunohistological assessment of neuroinflammation and neuronal loss; and (v) long-term survival. Results: Xenon treatment significantly reduced secondary injury (P<0.05), improved short-term vestibulomotor function (P<0.01), and prevented development of very late-onset traumatic brain injury (TBI)-related memory deficits. Xenon treatment reduced white matter loss in the contralateral corpus callosum and neuronal loss in the contralateral hippocampal CA1 and dentate gyrus areas at 20 months. Xenon's long-term neuroprotective effects were associated with a significant (P<0.05) reduction in neuroinflammation in multiple brain areas involved in associative memory, including reduction in reactive astrogliosis and microglial cell proliferation. Survival was improved significantly (P<0.05) in xenon-treated animals compared with untreated animals up to 12 months after injury. Conclusions: Xenon treatment after TBI results in very long-term improvements in clinically relevant outcomes and survival. Our findings support the idea that xenon treatment shortly after TBI may have long-term benefits in the treatment of brain trauma patients.	[Campos-Pires, Rita; Valeo, Flavia; Ong, Bee Eng; Aldhoun, Jitka; Saville, Joanna; Dickinson, Robert] Dept Surg & Canc, Anaesthet Pain Med & Intens Care Sect, London, England; [Campos-Pires, Rita; Dickinson, Robert] Imperial Coll London, Royal British Leg Ctr Blast Injury Studies, Dept Bioengn, London, England; [Campos-Pires, Rita] Imperial Coll Healthcare NHS Trust, Charing Cross Hosp, Intens Care Unit, Crit Care Directorate, London, England; [Hirnet, Tobias; Thal, Serge C.] Johannes Gutenberg Univ Mainz, Dept Anaesthesiol, Med Ctr, Mainz, Germany; [Radyushkin, Konstantin] Johannes Gutenberg Univ Mainz, Mouse Behav Outcome Unit, Focus Program Translat Neurosci, Mainz, Germany; [Edge, Christopher J.; Franks, Nicholas P.] Imperial Coll London, Dept Life Sci, London, England; [Edge, Christopher J.] Royal Berkshire Hosp NHS Fdn Trust, Dept Anaesthet, Reading, Berks, England	Dickinson, R (corresponding author), Dept Surg & Canc, Anaesthet Pain Med & Intens Care Sect, London, England.; Dickinson, R (corresponding author), Imperial Coll London, Royal British Leg Ctr Blast Injury Studies, Dept Bioengn, London, England.; Thal, SC (corresponding author), Johannes Gutenberg Univ Mainz, Dept Anaesthesiol, Med Ctr, Mainz, Germany.	thal@uni-mainz.de; r.dickinson@imperial.ac.uk	Thal, Serge/D-6593-2011	Thal, Serge/0000-0002-1222-8729; Franks, Nicholas/0000-0003-4874-4212	Medical Research Council, London, UKUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [MR/N0277361/1, MC_PC_13064]; European Society for Anaesthesiology, Brussels, Belgium; Gas Safety Trust, London, UK; Royal British Legion Centre for Blast Injury Studies, Imperial College London, UK; Royal Centre for Defence Medicine, Birmingham, UK; Association of Anaesthetists of Great Britain and Ireland, London, UK; National Institute of Academic Anaesthesia, London, UK; Royal British Legion; Fundacao para a Ciencia e a Tecnologia, Lisbon, PortugalPortuguese Foundation for Science and Technology [SFRH/BD/78886/2011]; Deutscher Akademischer Austauschdienst (DAAD), German Academic Exchange Service, Bonn, Germany [A/13/72143]; German Federal Ministry of Education and Research, Berlin, GermanyFederal Ministry of Education & Research (BMBF) [BMBF 01EO1003]; Imperial College London President's PhD scholarship, London, UK	The Medical Research Council, London, UK (MR/N0277361/1; MC_PC_13064); European Society for Anaesthesiology, Brussels, Belgium; The Gas Safety Trust, London, UK; Royal British Legion Centre for Blast Injury Studies, Imperial College London, UK; Royal Centre for Defence Medicine, Birmingham, UK; The Association of Anaesthetists of Great Britain and Ireland, London, UK; National Institute of Academic Anaesthesia, London, UK. We acknowledge the financial support of the Royal British Legion. Rita Campos-Pires was the recipient of a doctoral training award from the Fundacao para a Ciencia e a Tecnologia, Lisbon, Portugal (SFRH/BD/78886/2011), and a scholarship from the Deutscher Akademischer Austauschdienst (DAAD), German Academic Exchange Service, Bonn, Germany (A/13/72143). Tobias Hirnet is funded by the German Federal Ministry of Education and Research, Berlin, Germany (grant BMBF 01EO1003). Flavia Valeo is the recipient of an Imperial College London President's PhD scholarship, London, UK.	Armstrong SP, 2012, ANESTHESIOLOGY, V117, P38, DOI 10.1097/ALN.0b013e31825ada2e; Azzopardi D, 2016, LANCET NEUROL, V15, P145, DOI 10.1016/S1474-4422(15)00347-6; BAKER AJ, 1993, J NEUROSURG, V79, P369, DOI 10.3171/jns.1993.79.3.0369; Bondanelli M, 2005, EUR J ENDOCRINOL, V152, P679, DOI 10.1530/eje.1.01895; Buccafusco JJ, 2009, FRONT NEUROSCI, P1; Campos-Pires R, 2018, J NEUROTRAUM, V35, P1037, DOI 10.1089/neu.2017.5360; Campos-Pires R, 2015, CRIT CARE MED, V43, P149, DOI 10.1097/CCM.0000000000000624; Coburn M, 2008, CRIT CARE MED, V36, P588, DOI 10.1097/01.CCM.0B013E3181611F8A6; Dahan A, 2005, BRIT J ANAESTH, V94, P825, DOI 10.1093/bja/aei145; de Sousa SLM, 2000, ANESTHESIOLOGY, V92, P1055, DOI 10.1097/00000542-200004000-00024; Dickinson R, 2007, ANESTHESIOLOGY, V107, P756, DOI 10.1097/01.anes.0000287061.77674.71; Dickinson R, 2010, CRIT CARE, V14, DOI 10.1186/cc9051; Dingley J, 2014, PEDIATRICS, V133, P809, DOI 10.1542/peds.2013-0787; Dixon CE, 1999, J NEUROTRAUM, V16, P109, DOI 10.1089/neu.1999.16.109; Dong HW, 2008, ALLEN REFERENCE ATLA; Donnelly J, 2019, NEUROSURGERY, V85, pE75, DOI 10.1093/neuros/nyy468; Franks NP, 1998, NATURE, V396, P324, DOI 10.1038/24525; Gruss M, 2004, MOL PHARMACOL, V65, P443, DOI 10.1124/mol.65.2.443; Guarnieri M, 2012, LAB ANIMAL, V41, P337, DOI 10.1038/laban.152; Harris K, 2013, ANESTHESIOLOGY, V119, P1137, DOI 10.1097/ALN.0b013e3182a2a265; Jacobsen KR, 2013, COMPARATIVE MED, V63, P105; Janowitz T, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000330; Kalliokoski O, 2010, IN VIVO, V24, P641; Kasturi BS, 2009, J NEUROTRAUM, V26, P1315, DOI [10.1089/neu.2008.0751, 10.1089/neu.2008-0751]; Keene CS, 2008, BEHAV NEUROSCI, V122, P1070, DOI 10.1037/a0012895; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; Krahulik D, 2010, J NEUROSURG, V113, P581, DOI 10.3171/2009.10.JNS09930; KUNSTYR I, 1975, J GERONTOL, V30, P157, DOI 10.1093/geronj/30.2.157; Laitio R, 2016, JAMA-J AM MED ASSOC, V315, P1120, DOI 10.1001/jama.2016.1933; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Liddelow SA, 2017, NATURE, V541, P481, DOI 10.1038/nature21029; Loane DJ, 2014, J NEUROPATH EXP NEUR, V73, P14, DOI 10.1097/NEN.0000000000000021; Luh C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019948; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Martin D, 2004, HOSP MED, V65, P674, DOI 10.12968/hosp.2004.65.11.17047; McMillan TM, 2007, BRAIN, V130, P2520, DOI 10.1093/brain/awm185; McMillan TM, 2011, J NEUROL NEUROSUR PS, V82, P931, DOI 10.1136/jnnp.2010.222232; Osterstock G, 2014, ENDOCRINOLOGY, V155, P1887, DOI 10.1210/en.2013-1336; Peeters W, 2015, ACTA NEUROCHIR, V157, P1683, DOI 10.1007/s00701-015-2512-7; Pischiutta F, 2018, EXP NEUROL, V300, P167, DOI 10.1016/j.expneurol.2017.11.003; Pottker B, 2017, BRAIN STRUCT FUNCT, V222, P4005, DOI 10.1007/s00429-017-1452-9; Rudy JW, 2004, NEUROSCI BIOBEHAV R, V28, P675, DOI 10.1016/j.neubiorev.2004.09.004; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Siebold L, 2018, EXP NEUROL, V310, P48, DOI 10.1016/j.expneurol.2018.07.004; Smith DH, 2013, NAT REV NEUROL, V9, P211, DOI 10.1038/nrneurol.2013.29; Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8; Statler KD, 2006, J NEUROTRAUM, V23, P97, DOI 10.1089/neu.2006.23.97; STORER JB, 1966, J GERONTOL, V21, P404, DOI 10.1093/geronj/21.3.404; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Tan HJ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04008-w; Till C, 2008, ARCH PHYS MED REHAB, V89, pS25, DOI 10.1016/j.apmr.2008.07.004; Trogrlic L, 2011, LEARN MEMORY, V18, P678, DOI 10.1101/lm.2314311; Tsenter J, 2008, J NEUROTRAUM, V25, P324, DOI 10.1089/neu.2007.0452; Wang HK, 2012, J NEUROL NEUROSUR PS, V83, P1080, DOI 10.1136/jnnp-2012-302633; Warner DS, 2004, ANESTH ANALG, V99, P1208, DOI 10.1213/01.ANE.0000139930.04010.0D; Weib P., 2005, Mathematica Journal, V9, P803; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Zoerle T, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00354; Zohar O, 2006, NEUROSCI LETT, V394, P239, DOI 10.1016/j.neulet.2005.10.099	59	21	23	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0007-0912	1471-6771		BRIT J ANAESTH	Br. J. Anaesth.	JUL	2019	123	1					60	73		10.1016/j.bja.2019.02.032			14	Anesthesiology	Anesthesiology	IB4WE	WOS:000470272000035	31122738	Other Gold, Green Published			2021-06-18	
J	Li, Q; Li, QQ; Jia, JN; Sun, QY; Zhou, HH; Jin, WL; Mao, XY				Li, Qin; Li, Qiu-Qi; Jia, Ji-Ning; Sun, Qian-Yi; Zhou, Hong-Hao; Jin, Wei-Lin; Mao, Xiao-Yuan			Baicalein Exerts Neuroprotective Effects in FeCl3-Induced Posttraumatic Epileptic Seizures via Suppressing Ferroptosis	FRONTIERS IN PHARMACOLOGY			English	Article						posttraumatic epileptic seizures; baicalein; 12/15-lipoxygenase; lipid peroxidation; ferroptosis; neuroprotective	AMYLOID-BETA-PEPTIDE; OXIDATIVE STRESS; CELL-DEATH; IN-VITRO; PARKINSONS-DISEASE; ALZHEIMERS-DISEASE; LIPID-PEROXIDATION; MOUSE MODEL; RAT MODEL; BRAIN	Posttraumatic epilepsy (PTE) is a prevalent type of acquired epilepsy secondary to traumatic brain injury, and is characterized by repeated seizures. Traditional antiepileptic drugs have minimal response in preventing posttraumatic epileptic seizures. It is essential for the development of new therapeutic strategy. Our previous work disclosed a potent neuroprotective role of baicalein, a flavonoid extracted from Scutellaria baicalensis Georgi, against inherited epilepsy in rats. Whether baicalein has protective potential in posttraumatic epileptic seizures and the possible molecular mechanism remain elusive. Additionally, the brain is vulnerable to lipid peroxidation-induced damage due to high consumption of oxygen and abundant polyunsaturated fatty acids in neuronal membranes. Our present investigation aimed to elucidate whether baicalein exerts neuroprotective effects on posttraumatic epileptic seizures by inhibiting ferroptosis, a newly discovered lipid peroxidation-dependent cell death modality. We found that baicalein significantly reduced seizure score, number of seizures, and average seizure duration in an iron chloride (FeCl3)-induced PTE mouse model. The neuroprotective effect of baicalein was also validated in a ferric ammonium citrate (FAC)-induced HT22 hippocampal neuron damage model. Moreover, in vitro, baicalein could remarkably decrease ferroptotic indices (lipid reactive oxygen species, 4-hydroxynonenal, and prostaglandin endoperoxide synthase 2) and inhibit the expression of 12/15-lipoxygenase (12/15-LOX) in an iron-induced HT22 cell damage model. These findings were also validated in a mouse PTE model. It was concluded that baicalein exerted neuroprotective effects against posttraumatic epileptic seizures via suppressing ferroptosis and 12/15-LOX was likely to be involved in baicalein's neuroprotection.	[Li, Qin; Li, Qiu-Qi; Jia, Ji-Ning; Sun, Qian-Yi; Zhou, Hong-Hao; Mao, Xiao-Yuan] Cent S Univ, Xiangya Hosp, Dept Clin Pharmacol, Changsha, Hunan, Peoples R China; [Li, Qin; Li, Qiu-Qi; Jia, Ji-Ning; Sun, Qian-Yi; Zhou, Hong-Hao; Mao, Xiao-Yuan] Cent S Univ, Hunan Key Lab Pharmacogenet, Inst Clin Pharmacol, Changsha, Hunan, Peoples R China; [Li, Qin; Li, Qiu-Qi; Jia, Ji-Ning; Sun, Qian-Yi; Zhou, Hong-Hao; Mao, Xiao-Yuan] Minist Educ, Engn Res Ctr Appl Technol Pharmacogenom, Inst Clin Pharmacol, Changsha, Hunan, Peoples R China; [Li, Qin; Li, Qiu-Qi; Jia, Ji-Ning; Sun, Qian-Yi; Zhou, Hong-Hao; Mao, Xiao-Yuan] Natl Clin Res Ctr Geriatr Disorders, Changsha, Hunan, Peoples R China; [Jin, Wei-Lin] Guangxi Univ Chinese Med, Ruikang Hosp, Ctr Translat Med, Nanning, Peoples R China; [Jin, Wei-Lin] Shanghai Jiao Tong Univ, Inst Nano Biomedicine & Engn, Sch Elect Informat & Elect Engn, Minist Educ,Dept Instrument Sci & Engn,Key Lab Th, Shanghai, Peoples R China; [Jin, Wei-Lin] Xian Med Univ, Shaanxi Key Lab Brain Disorders, Xian, Shaanxi, Peoples R China; [Jin, Wei-Lin] Xian Med Univ, Inst Basic & Translat Med, Xian, Shaanxi, Peoples R China	Mao, XY (corresponding author), Cent S Univ, Xiangya Hosp, Dept Clin Pharmacol, Changsha, Hunan, Peoples R China.; Mao, XY (corresponding author), Cent S Univ, Hunan Key Lab Pharmacogenet, Inst Clin Pharmacol, Changsha, Hunan, Peoples R China.; Mao, XY (corresponding author), Minist Educ, Engn Res Ctr Appl Technol Pharmacogenom, Inst Clin Pharmacol, Changsha, Hunan, Peoples R China.; Mao, XY (corresponding author), Natl Clin Res Ctr Geriatr Disorders, Changsha, Hunan, Peoples R China.; Jin, WL (corresponding author), Guangxi Univ Chinese Med, Ruikang Hosp, Ctr Translat Med, Nanning, Peoples R China.; Jin, WL (corresponding author), Shanghai Jiao Tong Univ, Inst Nano Biomedicine & Engn, Sch Elect Informat & Elect Engn, Minist Educ,Dept Instrument Sci & Engn,Key Lab Th, Shanghai, Peoples R China.; Jin, WL (corresponding author), Xian Med Univ, Shaanxi Key Lab Brain Disorders, Xian, Shaanxi, Peoples R China.; Jin, WL (corresponding author), Xian Med Univ, Inst Basic & Translat Med, Xian, Shaanxi, Peoples R China.	weilinjin@sjtu.edu.cn; xiaoyuanm@csu.edu.cn	Jin, Wei-Lin/A-8355-2013	Mao, Xiao-Yuan/0000-0002-5149-1204	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81671293, 81302750]; Natural Science Foundation of Hunan ProvinceNatural Science Foundation of Hunan Province [2017JJ3479]; Fundamental Research Funds for the Central Universities of Central South University [2018zzts900]; Hunan Provincial Department of Education Innovation Platform Open Fund Project [17K100]	This work is partially financially supported by the National Natural Science Foundation of China (nos. 81671293 and 81302750), Natural Science Foundation of Hunan Province (no. 2017JJ3479), the Fundamental Research Funds for the Central Universities of Central South University (2018zzts900), and the Hunan Provincial Department of Education Innovation Platform Open Fund Project (no. 17K100).	Acharya MM, 2008, PROG NEUROBIOL, V84, P363, DOI 10.1016/j.pneurobio.2007.10.010; Agrawal A, 2006, CLIN NEUROL NEUROSUR, V108, P433, DOI 10.1016/j.clineuro.2005.09.001; Ahn JS, 2007, ANAL BIOCHEM, V367, P259, DOI 10.1016/j.ab.2007.05.023; Andrade S, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.01261; Annegers JF, 2000, SEIZURE-EUR J EPILEP, V9, P453, DOI 10.1053/seiz.2000.0458; Anthonymuthu TS, 2018, FREE RADICAL BIO MED, V124, P493, DOI 10.1016/j.freeradbiomed.2018.06.031; Bazinet RP, 2014, NAT REV NEUROSCI, V15, P771, DOI 10.1038/nrn3820; Belkner J, 2005, ARTERIOSCL THROM VAS, V25, P797, DOI 10.1161/01.ATV.0000157580.26858.2d; Butterfield DA, 2002, FREE RADICAL BIO MED, V32, P1050, DOI 10.1016/S0891-5849(02)00794-3; Carvalho AN, 2017, CURR DRUG TARGETS, V18, P705, DOI 10.2174/1389450117666160401120514; Chartrain AG, 2017, CURR PHARM DESIGN, V23, P6428, DOI 10.2174/1381612823666171031100139; Cheignon C, 2018, REDOX BIOL, V14, P450, DOI 10.1016/j.redox.2017.10.014; Chen IC, 2018, OXID MED CELL LONGEV, V2018, DOI 10.1155/2018/9595741; Chen ZX, 2019, OXID MED CELL LONGEV, V2019, DOI 10.1155/2019/2936737; Christensen J, 2015, SEMIN NEUROL, V35, P218, DOI 10.1055/s-0035-1552923; Conrad M, 2018, GENE DEV, V32, P602, DOI 10.1101/gad.314674.118; Deng SY, 2018, BIOCHEM BIOPH RES CO, V496, P865, DOI 10.1016/j.bbrc.2018.01.136; Deschamps JD, 2006, BIOORGAN MED CHEM, V14, P4295, DOI 10.1016/j.bmc.2006.01.057; Dinda B, 2017, EUR J MED CHEM, V131, P68, DOI 10.1016/j.ejmech.2017.03.004; Dixon SJ, 2012, CELL, V149, P1060, DOI 10.1016/j.cell.2012.03.042; Do Van B, 2016, NEUROBIOL DIS, V94, P169, DOI 10.1016/j.nbd.2016.05.011; Englander J, 2009, J NEUROTRAUM, V26, P1471, DOI 10.1089/neu.2008.0729; Gao L, 2015, PHARMACOL BIOCHEM BE, V133, P155, DOI 10.1016/j.pbb.2015.04.004; Gu XH, 2016, BEHAV BRAIN RES, V311, P309, DOI 10.1016/j.bbr.2016.05.052; HAMADA H, 1993, ARCH BIOCHEM BIOPHYS, V306, P261, DOI 10.1006/abbi.1993.1509; He C, 2018, OXID MED CELL LONGEV, V2018, DOI 10.1155/2018/5216383; Islam MT, 2017, NEUROL RES, V39, P73, DOI 10.1080/01616412.2016.1251711; Kanzler Matthew A, 2018, Epilepsia Open, V3, P255, DOI 10.1002/epi4.12221; Kenny EM, 2019, CRIT CARE MED, V47, P410, DOI 10.1097/CCM.0000000000003555; Kharatishvili I, 2010, CURR OPIN NEUROL, V23, P183, DOI 10.1097/WCO.0b013e32833749e4; Lamar CD, 2014, J NEUROPSYCHIATRY CL, V26, piv, DOI DOI 10.1176/APPI.NEUR0PSYCH.260201; Lee DG, 2018, INT J BIOCHEM CELL B, V102, P10, DOI 10.1016/j.biocel.2018.06.005; Lee DG, 2016, TOXICOLOGY, V365, P17, DOI 10.1016/j.tox.2016.07.022; Li CR, 2011, BIOPHARM DRUG DISPOS, V32, P427, DOI 10.1002/bdd.771; Li W, 2016, MICROVASC RES, V106, P117, DOI 10.1016/j.mvr.2015.12.008; Li XJ, 2008, TRENDS MOL MED, V14, P1, DOI 10.1016/j.molmed.2007.11.002; Li YK, 2019, FREE RADICAL BIO MED, V134, P239, DOI 10.1016/j.freeradbiomed.2019.01.019; Liu AD, 2015, INT IMMUNOPHARMACOL, V24, P72, DOI 10.1016/j.intimp.2014.11.014; Liu RX, 2017, CHIN J NAT MEDICINES, V15, P152, DOI 10.1016/S1875-5364(17)30030-4; Liu YF, 2012, NEUROCHEM RES, V37, P1670, DOI 10.1007/s11064-012-0771-8; Lu SS, 2015, FUTURE MED CHEM, V7, P2005, DOI 10.4155/fmc.15.130; Mao C, 2018, CANCER RES, V78, P3484, DOI 10.1158/0008-5472.CAN-17-3454; Mao XY, 2018, PHARMACOL THERAPEUT, V183, P137, DOI 10.1016/j.pharmthera.2017.10.012; Mao XY, 2014, NEUROL SCI, V35, P1261, DOI 10.1007/s10072-014-1695-7; McKinnon C, 2019, ANN CLIN TRANSL NEUR, V6, P174, DOI 10.1002/acn3.682; Mendes MO, 2019, MOL CELL NEUROSCI, V96, P1, DOI 10.1016/j.mcn.2019.01.003; Pan RY, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aau6328; Pan WD, 2011, PARKINSONS DIS-US, V2011, DOI 10.4061/2011/789506; Pauletti A, 2017, BRAIN, V140, P1885, DOI 10.1093/brain/awx117; Pearson-Smith JN, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18112365; Pi XR, 2014, SEIZURE-EUR J EPILEP, V23, P636, DOI 10.1016/j.seizure.2014.05.002; Pitkanen A, 2006, J NEUROTRAUM, V23, P241, DOI 10.1089/neu.2006.23.241; Pitkanen A, 2014, EPILEPSY BEHAV, V38, P19, DOI 10.1016/j.yebeh.2014.01.013; Poprac P, 2017, TRENDS PHARMACOL SCI, V38, P592, DOI 10.1016/j.tips.2017.04.005; Probst L, 2017, BIOCHEM PHARMACOL, V140, P41, DOI 10.1016/j.bcp.2017.06.112; Qian X, 2019, BRAIN RES, V1714, P111, DOI 10.1016/j.brainres.2019.02.028; RACINE RJ, 1972, ELECTROEN CLIN NEURO, V32, P281, DOI 10.1016/0013-4694(72)90177-0; Salim Samina, 2017, J Pharmacol Exp Ther, V360, P201; SATO M, 1990, ELECTROEN CLIN NEURO, V76, P459, DOI 10.1016/0013-4694(90)90099-6; Singh A, 2016, NEUROL CLIN, V34, P837, DOI 10.1016/j.ncl.2016.06.015; Singh NK, 2019, PROG LIPID RES, V73, P28, DOI 10.1016/j.plipres.2018.11.001; Skouta R, 2014, J AM CHEM SOC, V136, P4551, DOI 10.1021/ja411006a; Srivastava NK, 2019, MOL BIOL REP, V46, P1757, DOI 10.1007/s11033-019-04626-9; Stockwell BR, 2017, CELL, V171, P273, DOI 10.1016/j.cell.2017.09.021; Su J, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18071599; Szaflarski JP, 2014, NEUROPSYCH DIS TREAT, V10, P1469, DOI 10.2147/NDT.S50421; Szwajgier D, 2017, NUTRIENTS, V9, DOI 10.3390/nu9050477; van Leyen K, 2006, STROKE, V37, P3014, DOI 10.1161/01.STR.0000249004.25444.a5; Volavka J, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001148; Wang GQ, 2011, ACTA NEUROCHIR, V153, P319, DOI 10.1007/s00701-010-0750-2; Wenzel SE, 2017, CELL, V171, P628, DOI 10.1016/j.cell.2017.09.044; Wu TY, 2011, TAIWAN J OBSTET GYNE, V50, P131, DOI 10.1016/j.tjog.2011.04.004; Xiao XC, 2019, J CELL PHYSIOL, V234, P9130, DOI 10.1002/jcp.27590; Xie BS, 2019, CNS NEUROSCI THER, V25, P465, DOI 10.1111/cns.13069; Xie Y, 2016, CELL DEATH DIFFER, V23, P369, DOI 10.1038/cdd.2015.158; Xie YY, 2018, NEUROCHEM INT, V112, P179, DOI 10.1016/j.neuint.2017.07.006; Xu T, 2017, EPILEPSY BEHAV, V67, P1, DOI 10.1016/j.yebeh.2016.10.026; Yang WS, 2016, TRENDS CELL BIOL, V26, P165, DOI 10.1016/j.tcb.2015.10.014; Ye Q, 2019, AM J TRANSL RES, V11, P875; Zeng BY, 2017, INT REV NEUROBIOL, V135, P57, DOI 10.1016/bs.irn.2017.02.004; Zhang MR, 2020, NAT PROD RES, V34, P3335, DOI 10.1080/14786419.2019.1574786; Zhang X., 2018, CALC VAR PARTIAL DIF, V57, P1, DOI DOI 10.1016/J.PHYMED.2018.12.042; Zhang YH, 2018, REDOX BIOL, V14, P535, DOI 10.1016/j.redox.2017.11.001; Zhou L, 2016, NEUROPSYCH DIS TREAT, V12, P3145, DOI 10.2147/NDT.S117469; Zille M, 2017, STROKE, V48, P1033, DOI 10.1161/STROKEAHA.116.015609	85	21	21	3	11	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1663-9812			FRONT PHARMACOL	Front. Pharmacol.	JUN 7	2019	10								638	10.3389/fphar.2019.00638			13	Pharmacology & Pharmacy	Pharmacology & Pharmacy	IC7OO	WOS:000471164800001	31231224	DOAJ Gold, Green Published			2021-06-18	
J	Gu, JJ; Huang, HP; Huang, YJ; Sun, HT; Xu, HW				Gu, Jiajie; Huang, Haoping; Huang, Yuejun; Sun, Haitao; Xu, Hongwu			Hypertonic saline or mannitol for treating elevated intracranial pressure in traumatic brain injury: a meta-analysis of randomized controlled trials	NEUROSURGICAL REVIEW			English	Article						Intracranial hypertension; Intracranial pressure; Hypertonic saline; Mannitol; Traumatic brain injury; Meta-analysis	SODIUM SOLUTIONS; HETEROGENEITY; HYPERTENSION; EQUIOSMOLAR; CHLORIDE; THERAPY	Hyperosmolar therapy is regarded as the mainstay for treatment of elevated intracranial pressure (ICP) in traumatic brain injury (TBI). This still has been disputed as application of hypertonic saline (HS) or mannitol for treating patients with severe TBI. Thus, this meta-analysis was performed to further compare the advantages and disadvantages of mannitol with HS for treating elevated ICP after TBI. We conducted a systematic search on PubMed, EMBASE, Cochrane Central Register of Controlled Trials (CENTRAL), Wan Fang Data, VIP Data, SinoMed, and China National Knowledge Infrastructure (CNKI) databases. Studies were included or not based on the quality assessment by the Jadad scale and selection criteria. Twelve RCTs with 438 patients were enrolled for the meta-analysis. The comparison of HS and mannitol indicated that they were close in field of improving function outcome (RR=1.17, 95% CI 0.89 to 1.54, p=0.258) and reducing intracranial pressure (MD=-0.16, 95% CI: -0.59 to 0.27, p=0.473) and mortality (RR=0.78, 95% CI 0.53 to 1.16, p=0.216). The pooled relative risk of successful ICP control was 1.06 (95% CI: 1.00 to 1.13, p=0.044), demonstrating that HS was more effective than mannitol in ICP management. Both serum sodium (WMD=5.30, 95% CI: 4.37 to 6.22, p<0.001) and osmolality (WMD=3.03, 95% CI: 0.18 to 5.88, p=0.037) were increased after injection of hypertonic saline. The results do not lend a specific recommendation to select hypertonic saline or mannitol as a first-line for the patients with elevated ICP caused by TBI. However, for the refractory intracranial hypertension, hypertonic saline seems to be preferred.	[Gu, Jiajie; Huang, Haoping] Shantou Univ, Coll Med, Shantou, Guangdong, Peoples R China; [Huang, Yuejun] Shantou Univ, Coll Med, Affiliated Hosp 2, Transforming Med Ctr, North Dongxia Rd, Shantou 515041, Guangdong, Peoples R China; [Sun, Haitao] Southern Med Univ, Zhujiang Hosp, Dept Neurosurg, Guangzhou 510282, Guangdong, Peoples R China; [Xu, Hongwu] Shantou Univ, Coll Med, Affiliated Hosp 1, Dept Neurosurg, Changping Rd, Shantou 515041, Guangdong, Peoples R China	Xu, HW (corresponding author), Shantou Univ, Coll Med, Affiliated Hosp 1, Dept Neurosurg, Changping Rd, Shantou 515041, Guangdong, Peoples R China.	hwxu@qq.com			National Natural Science Foundation of China (NSFC)National Natural Science Foundation of China (NSFC) [31300927]; Medical Scientific Research Foundation of Guangdong Province [A2016496]; Key, the Pearl River S&T Nova Program of Guangzhou [201710010047]	This work was supported by the National Natural Science Foundation of China (NSFC, 31300927), the Medical Scientific Research Foundation of Guangdong Province (grant number: A2016496), and Key, the Pearl River S&T Nova Program of Guangzhou (201710010047).	Battison C, 2005, CRIT CARE MED, V33, P196, DOI 10.1097/01.CCM.0000150269.65485.A6; Berger-Pelleiter E, 2016, CAN J EMERG MED, V18, P112, DOI 10.1017/cem.2016.12; Boone Myles Dustin, 2015, Surg Neurol Int, V6, P177, DOI 10.4103/2152-7806.170248; Burgess S, 2016, ANN PHARMACOTHER, V50, P291, DOI 10.1177/1060028016628893; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Cottenceau V, 2011, J NEUROTRAUM, V28, P2003, DOI 10.1089/neu.2011.1929; Diaz-Arrastia R, 2014, J NEUROTRAUM, V31, P135, DOI 10.1089/neu.2013.3019; Diringer MN, 2016, ACTA NEUROCHIR SUPPL, V121, P3, DOI 10.1007/978-3-319-18497-5_1; Du DY, 2017, NEURAL INJURY FUNCTI, V12, P215; EICHNER E, 1972, AM J OBSTET GYNECOL, V113, P855, DOI 10.1016/0002-9378(72)90582-0; Erdman MJ, 2017, NEUROHOSPITALIST, V7, P9, DOI 10.1177/1941874416665744; Eskandari R, 2013, J NEUROSURG, V119, P338, DOI 10.3171/2013.4.JNS121541; Francony G, 2008, CRIT CARE MED, V36, P795, DOI 10.1097/CCM.0B013E3181643B41; Harutjunyan L, 2005, CRIT CARE, V9, pR530, DOI 10.1186/cc3767; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Huang Xuecai, 2014, Nan Fang Yi Ke Da Xue Xue Bao, V34, P723; Infanti JL, 2008, J NEUROSCI NURS, V40, P362, DOI 10.1097/01376517-200812000-00009; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; Jagannatha AT, 2016, J CLIN NEUROSCI, V27, P68, DOI 10.1016/j.jocn.2015.08.035; Juul N, 2000, J NEUROSURG, V92, P1, DOI 10.3171/jns.2000.92.1.0001; Kamel H, 2011, CRIT CARE MED, V39, P554, DOI 10.1097/CCM.0b013e318206b9be; Kjaergard LL, 2008, ANN INTERN MED, V149, P219, DOI 10.7326/0003-4819-149-3-200808050-00023; Lazaridis C, 2013, CRIT CARE MED, V41, P1353, DOI 10.1097/CCM.0b013e31827ca4b3; Li M, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000000736; Mao X, 2007, JIANGSU MED J; Mortazavi MM, 2012, J NEUROSURG, V116, P210, DOI 10.3171/2011.7.JNS102142; Nguyen R, 2016, CAN J NEUROL SCI, V43, P774, DOI 10.1017/cjn.2016.290; Patsopoulos NA, 2008, INT J EPIDEMIOL, V37, P1148, DOI 10.1093/ije/dyn065; Pietrini V, 2010, NEUROL SCI, V31, P227, DOI 10.1007/s10072-009-0173-0; [秦德广 Qin Deguang], 2016, [中华神经医学杂志, Chinese Journal of Neuromedicine], V15, P1267; Reza A, 2018, BRAIN INJURY, V32, P487, DOI 10.1080/02699052.2018.1429658; Rickard AC, 2014, EMERG MED J, V31, P679, DOI 10.1136/emermed-2013-202679; Sakellaridis N, 2011, J NEUROSURG, V114, P545, DOI 10.3171/2010.5.JNS091685; Turgeon AF, 2011, CAN MED ASSOC J, V183, P1581, DOI 10.1503/cmaj.101786; Vialet R, 2003, CRIT CARE MED, V31, P1683, DOI 10.1097/01.CCM.0000063268.91710.DF; Wakai A, 2007, MANNITOL ACUTE TRAUM; Ware ML, 2005, NEUROSURGERY, V57, P727, DOI 10.1227/01.NEU.0000175726.08903.OA; Yan YF, 2013, J TRAUMA SURG	38	21	21	1	12	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0344-5607	1437-2320		NEUROSURG REV	Neurosurg. Rev.	JUN	2019	42	2					499	509		10.1007/s10143-018-0991-8			11	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	HX1GD	WOS:000467137500030	29905883				2021-06-18	
J	Hernandez, F; Giordano, C; Goubran, M; Parivash, S; Grant, G; Zeineh, M; Camarillo, D				Hernandez, Fidel; Giordano, Chiara; Goubran, Maged; Parivash, Sherveen; Grant, Gerald; Zeineh, Michael; Camarillo, David			Lateral impacts correlate with falx cerebri displacement and corpus callosum trauma in sports-related concussions	BIOMECHANICS AND MODELING IN MECHANOBIOLOGY			English	Article						Corpus callosum trauma; Mild traumatic brain injury; Finite element method; Instrumented mouthguard	DIFFUSE AXONAL INJURY; BRAIN-INJURY; HEAD; DEFORMATION; TRENDS; MODEL; ENCEPHALOPATHY; ACCELERATION; KINEMATICS; MOUTHGUARD	Corpus callosum trauma has long been implicated in mild traumatic brain injury (mTBI), yet the mechanism by which forces penetrate this structure is unknown. We investigated the hypothesis that coronal and horizontal rotations produce motion of the falx cerebri that damages the corpus callosum. We analyzed previously published head kinematics of 115 sports impacts (2 diagnosed mTBI) measured with instrumented mouthguards and used finite element (FE) simulations to correlate falx displacement with corpus callosum deformation. Peak coronal accelerations were larger in impacts with mTBI (8592rad/s(2)avg.) than those without (1412rad/s(2)avg.). From FE simulations, coronal acceleration was strongly correlated with deep lateral motion of the falx center (r=0.85), while horizontal acceleration was correlated with deep lateral motion of the falx periphery (r>0.78). Larger lateral displacement at the falx center and periphery was correlated with higher tract-oriented strains in the corpus callosum body (r=0.91) and genu/splenium (r>0.72), respectively. The relationship between the corpus callosum and falx was unique: removing the falx from the FE model halved peak strains in the corpus callosum from 35% to 17%. Consistent with model results, we found indications of corpus callosum trauma in diffusion tensor imaging of the mTBI athletes. For a measured alteration of consciousness, depressed fractional anisotropy and increased mean diffusivity indicated possible damage to the mid-posterior corpus callosum. Our results suggest that the corpus callosum may be sensitive to coronal and horizontal rotations because they drive lateral motion of a relatively stiff membrane, the falx, in the direction of commissural fibers below.	[Hernandez, Fidel; Camarillo, David] Stanford Univ, Dept Mech Engn, Stanford, CA 94305 USA; [Giordano, Chiara; Camarillo, David] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Goubran, Maged; Parivash, Sherveen; Zeineh, Michael] Stanford Univ, Dept Radiol, Stanford, CA 94305 USA; [Grant, Gerald] Stanford Univ, Dept Neurosurg, Stanford, CA 94305 USA; [Grant, Gerald] Stanford Univ, Dept Neurol, Stanford, CA 94305 USA	Camarillo, D (corresponding author), Stanford Univ, Dept Mech Engn, Stanford, CA 94305 USA.; Camarillo, D (corresponding author), Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA.	fidelh@alumni.stanford.edu; dcamarillo@stanford.edu		Goubran, Maged/0000-0001-5880-0818	Stanford Child Health Research Institute; Lucile Packard Foundation for Children's Health [38454]; National Institutes of Health (NIH) National Institute of Biomedical Imaging and Bioengineering (NIBIB)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB) [3R21EB01761101S1]; Radiology Society of North America; GE HealthcareGE Healthcare	We would like to acknowledge Dr. Svein Kleiven for providing the KTH brain model, which was used in this study to compute brain deformations and strains. We thank the Stanford Department of Athletics (Palo Alto, CA) for enabling this research. This work was supported by the Stanford Child Health Research Institute, Lucile Packard Foundation for Children's Health 38454, the National Institutes of Health (NIH) National Institute of Biomedical Imaging and Bioengineering (NIBIB) 3R21EB01761101S1, Radiology Society of North America, and GE Healthcare.	Andersson JLR, 2016, NEUROIMAGE, V125, P1063, DOI 10.1016/j.neuroimage.2015.10.019; Arenth PM, 2014, J HEAD TRAUMA REHAB, V29, pE1, DOI 10.1097/HTR.0b013e318289ede5; ARUN KS, 1987, IEEE T PATTERN ANAL, V9, P699, DOI 10.1109/TPAMI.1987.4767965; Bartsch Adam, 2014, Stapp Car Crash J, V58, P1; Baur V, 2013, HUM BRAIN MAPP, V34, P437, DOI 10.1002/hbm.21447; Bayly PV, 2005, J NEUROTRAUM, V22, P845, DOI 10.1089/neu.2005.22.845; Browne KD, 2011, J NEUROTRAUM, V28, P1747, DOI 10.1089/neu.2011.1913; Camarillo DB, 2013, ANN BIOMED ENG, V41, P1939, DOI 10.1007/s10439-013-0801-y; Cameron KL, 2012, J NEUROTRAUM, V29, P1313, DOI 10.1089/neu.2011.2168; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Coronado VG, 2012, J SAFETY RES, V43, P299, DOI 10.1016/j.jsr.2012.08.011; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; Eierud C, 2014, NEUROIMAGE-CLIN, V4, P283, DOI 10.1016/j.nicl.2013.12.009; Eucker SA, 2011, EXP NEUROL, V227, P79, DOI 10.1016/j.expneurol.2010.09.015; Feng Y, 2010, J R SOC INTERFACE, V7, P1677, DOI 10.1098/rsif.2010.0210; Funk J, 2009, 2009010251 SAE, DOI [10.4271/2009-01-0251, DOI 10.4271/2009-01-0251]; Gazzaniga M, 1988, COGNITIVE NEUROSCIEN; GENNARELLI TA, 1982, ANN NEUROL, V12, P564, DOI 10.1002/ana.410120611; Gennarelli Thomas A, 1987, P 31 STAPP CAR CRASH, DOI [10.4271/872197, DOI 10.4271/872197]; Giordano C, 2014, J BIOMECH, V47, P1052, DOI 10.1016/j.jbiomech.2013.12.036; Giordano Chiara, 2014, Stapp Car Crash J, V58, P29; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Hardy W N, 2001, Stapp Car Crash J, V45, P337; Hernandez F, 2019, J NEUROTRAUM, V36, P1125, DOI 10.1089/neu.2016.4758; Hernandez F, 2015, J BIOMECH, V48, P3469, DOI 10.1016/j.jbiomech.2015.05.034; Hernandez F, 2015, ANN BIOMED ENG, V43, P1918, DOI 10.1007/s10439-014-1212-4; Ho J, 2017, J BIOMECH, V60, P243, DOI 10.1016/j.jbiomech.2017.06.023; Ho J, 2009, J BIOMECH, V42, P2074, DOI 10.1016/j.jbiomech.2009.06.051; Ivins BJ, 2010, NEUROREHABILITATION, V26, P199, DOI 10.3233/NRE-2010-0556; Jadischke R, 2013, J BIOMECH, V46, P2310, DOI 10.1016/j.jbiomech.2013.05.030; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Ji SB, 2015, J NEUROTRAUM, V32, P441, DOI 10.1089/neu.2013.3268; Ji SB, 2014, ANN BIOMED ENG, V42, P11, DOI 10.1007/s10439-013-0907-2; Kleiven S, 2006, INT J CRASHWORTHINES, V11, P65, DOI 10.1533/ijcr.2005.0384; Kleiven S, 2002, J BIOMECH, V35, P153, DOI 10.1016/S0021-9290(01)00202-0; Kleiven S, 2007, STAPP CAR CRASH JO, V51, P81; Knox T, 2004, P 2004 SAE MOT ENG C; Kuo C, 2016, J BIOMECH, V49, P1845, DOI 10.1016/j.jbiomech.2016.04.017; Li JR, 2007, BIOMED SCI INSTRUM, V43, P24; Lincoln AE, 2011, AM J SPORT MED, V39, P958, DOI 10.1177/0363546510392326; MARGULIES SS, 1990, J BIOMECH, V23, P823, DOI 10.1016/0021-9290(90)90029-3; Maroon Joseph C., 2015, PLOS ONE, V10, P1; Montenigro PH, 2017, J NEUROTRAUM, V34, P328, DOI 10.1089/neu.2016.4413; Naunheim RS, 2003, MED SCI SPORT EXER, V35, P1406, DOI 10.1249/01.MSS.0000078933.84527.AE; Niogi SN, 2010, J HEAD TRAUMA REHAB, V25, P241, DOI 10.1097/HTR.0b013e3181e52c2a; Nishimoto T, 1998, J BIOMECH ENG-T ASME, V120, P140, DOI 10.1115/1.2834294; Omalu BI, 2006, NEUROSURGERY, V59, P1086, DOI 10.1227/01.NEU.0000245601.69451.27; Omalu BI, 2005, NEUROSURGERY, V57, P128, DOI 10.1227/01.NEU.0000163407.92769.ED; OMMAYA AK, 1966, SCIENCE, V153, P211, DOI 10.1126/science.153.3732.211; Pendergrass EP, 1935, ANN SURG, V101, P269, DOI 10.1097/00000658-193501000-00027; Prasad P, 2008, STAPP CAR C, V52, P187; Rosenthal JA, 2014, AM J SPORT MED, V42, P1710, DOI 10.1177/0363546514530091; Rowson S, 2012, ANN BIOMED ENG, V40, P1, DOI 10.1007/s10439-011-0392-4; Rowson S, 2011, J APPL BIOMECH, V27, P8, DOI 10.1123/jab.27.1.8; Sabet AA, 2008, J BIOMECH, V41, P307, DOI 10.1016/j.jbiomech.2007.09.016; SCHALTENBRAND G, 1975, BRAIN LANG, V2, P70, DOI 10.1016/S0093-934X(75)80055-1; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; Siegmund GP, 2016, ANN BIOMED ENG, V44, P1257, DOI 10.1007/s10439-015-1420-6; Smith DH, 2000, J NEUROSURG, V93, P315, DOI 10.3171/jns.2000.93.2.0315; Smith DH, 2013, NAT REV NEUROL, V9, P211, DOI 10.1038/nrneurol.2013.29; Sullivan S, 2015, BIOMECH MODEL MECHAN, V14, P877, DOI 10.1007/s10237-014-0643-z; Takhounts EG, 2008, STAPP CAR C, V52, P1; Ungerleider L. G., 1982, ANAL VISUAL BEHAV; Weaver AA, 2012, ANN BIOMED ENG, V40, P2005, DOI 10.1007/s10439-012-0553-0; Wu LC, 2016, ANN BIOMED ENG, V44, P1234, DOI 10.1007/s10439-015-1423-3	65	21	21	2	2	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1617-7959	1617-7940		BIOMECH MODEL MECHAN	Biomech. Model. Mechanobiol.	JUN	2019	18	3					631	649		10.1007/s10237-018-01106-0			19	Biophysics; Engineering, Biomedical	Biophysics; Engineering	HX4TU	WOS:000467394100007	30859404	Other Gold			2021-06-18	
J	Hemphill, M; Ko, J; Yang, Z; Beard, K; Sewell, E; Shallcross, J; Schweizer, M; Sandsmark, DK; Diaz-Arrastia, R; Kim, J; Meaney, D; Issador, D				Hemphill, Matthew; Ko, Jina; Yang, Zijian; Beard, Kryshawna; Sewell, Emily; Shallcross, Jamie; Schweizer, Melissa; Sandsmark, Danielle K.; Diaz-Arrastia, Ramon; Kim, Junhyong; Meaney, David; Issador, David			Multi-Dimensional Mapping of Brain-Derived Extracellular Vesicle MicroRNA Biomarker for Traumatic Brain Injury Diagnostics	JOURNAL OF NEUROTRAUMA			English	Article						extracellular vesicles; miRNA; statistical learning; traumatic brain injury	CONTROLLED CORTICAL IMPACT; NEUROTROPHIC FACTOR; SIGNALING PATHWAY; PLASMA-LEVELS; AMYLOID-BETA; MOUSE; MILD; ACTIVATION; INHIBITION; PROTEIN	The diagnosis and prognosis of traumatic brain injury (TBI) is complicated by variability in the type and severity of injuries and the multiple endophenotypes that describe each patient's response and recovery to the injury. It has been challenging to capture the multiple dimensions that describe an injury and its recovery to provide clinically useful information. To address this challenge, we have performed an open-ended search for panels of microRNA (miRNA) biomarkers, packaged inside of brain-derived extracellular vesicles (EVs), that can be combined algorithmically to accurately classify various states of injury. We mapped GluR2+ EV miRNA across a variety of injury types, injury intensities, history of injuries, and time elapsed after injury, and sham controls in a pre-clinical murine model (n = 116), as well as in clinical samples (n = 36). We combined next-generation sequencing with a technology recently developed by our lab, Track Etched Magnetic Nanopore (TENPO) sorting, to enrich for GluR2+ EVs and profile their miRNA. By mapping and comparing brain-derived EV miRNA between various injuries, we have identified signaling pathways in the packaged miRNA that connect these biomarkers to underlying mechanisms of TBI. Many of these pathways are shared between the pre-clinical model and the clinical samples, and present distinct signatures across different injury models and times elapsed after injury. Using this map of EV miRNA, we applied machine learning to define a panel of biomarkers to successfully classify specific states of injury, paving the way for a prognostic blood test for TBI. We generated a panel of eight miRNAs (miR-150-5p, miR-669c-5p, miR-488-3p, miR-22-5p, miR-9-5p, miR-6236, miR-219a.2-3p, miR-351-3p) for injured mice versus sham mice and four miRNAs (miR-203b-5p, miR-203a-3p, miR-206, miR-185-5p) for TBI patients versus healthy controls.	[Hemphill, Matthew; Ko, Jina; Yang, Zijian; Beard, Kryshawna; Sewell, Emily; Schweizer, Melissa; Meaney, David; Issador, David] Univ Penn, Dept Bioengn, 210 33rd St, Philadelphia, PA 19104 USA; [Shallcross, Jamie; Kim, Junhyong] Univ Penn, Dept Biol, Philadelphia, PA 19104 USA; [Sandsmark, Danielle K.; Diaz-Arrastia, Ramon] Univ Penn, Dept Neurol, Philadelphia, PA 19104 USA; [Kim, Junhyong] Univ Penn, Dept Comp & Informat Sci, Philadelphia, PA 19104 USA; [Issador, David] Univ Penn, Dept Elect & Syst Engn, Philadelphia, PA 19104 USA; [Meaney, David] Univ Penn, Dept Neurosurg, Philadelphia, PA 19104 USA	Issador, D (corresponding author), Univ Penn, Dept Bioengn, 210 33rd St, Philadelphia, PA 19104 USA.	issadore@seas.upenn.edu	Yang, Zijian/AAO-9763-2021		New Jersey Commission on Brain Injury Research [CSCR14IRG005]; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS 088276]; Allen Foundation [U01 NS086090]; Commonwealth of Pennsylvania [4100077073]; Pennsylvania Department of Health Commonwealth Universal Research Enhancement Program; National Institute of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [1R21CA182336-01A1]; American Cancer Society-CEOs Against Cancer-CA Division Research Scholar Grant [RSG-15-227-01-CSM]; National Science Foundation's CAREER Award [1554200]; Hartwell Individual Research Award; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [K23NS104239] Funding Source: NIH RePORTER	We thank Tawny Meredith-Duliba and Erika Silverman from the Diaz-Arrastia lab at Penn for collecting and processing clinical samples that were used for this study. Funding was provided by the New Jersey Commission on Brain Injury Research (CSCR14IRG005) to DI and DM, National Institutes of Health NS 088276 to DM, Allen Foundation to DM and DI, U01 NS086090 to RDA, Health Research Formula Fund 4100077073 from Commonwealth of Pennsylvania to JK, the Pennsylvania Department of Health Commonwealth Universal Research Enhancement Program, the National Institute of Health: 1R21CA182336-01A1 to DI and JK, and DI was supported by an American Cancer Society-CEOs Against Cancer-CA Division Research Scholar Grant, (RSG-15-227-01-CSM), the National Science Foundation's CAREER Award (#1554200), and The Hartwell Individual Research Award.	Almonte AG, 2013, J NEUROCHEM, V124, P109, DOI 10.1111/jnc.12075; Arenth PM, 2011, PM&R, V3, pS123, DOI 10.1016/j.pmrj.2011.03.012; Beamer M, 2016, EXP NEUROL, V283, P16, DOI 10.1016/j.expneurol.2016.05.025; Bogoslovsky T, 2017, J NEUROTRAUM, V34, P66, DOI 10.1089/neu.2015.4333; Butler CR, 2017, ENEURO, V4, DOI 10.1523/ENEURO.0134-17.2017; Butler CR, 2016, EXP NEUROL, V280, P30, DOI 10.1016/j.expneurol.2016.03.022; Carlson SW, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00532; Chan JL, 2014, EXP NEUROL, V261, P757, DOI 10.1016/j.expneurol.2014.08.015; Chen T, 2017, NEUROCHEM RES, V42, P3073, DOI 10.1007/s11064-017-2340-7; Chen YH, 2017, CELL TRANSPLANT, V26, P1156, DOI 10.1177/0963689717714105; Chen YC, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00100; Di Battista AP, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00110; Diaz-Arrastia R, 2014, J NEUROTRAUM, V31, P19, DOI 10.1089/neu.2013.3040; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Don ASA, 2012, DRUG DISCOV TODAY, V17, P861, DOI 10.1016/j.drudis.2012.04.010; Feldmann M., 2014, THE J, V1, P11, DOI [10.14440/jbm.2014.33, DOI 10.14440/JBM.2014.33]; Frenette AJ, 2012, J NEUROTRAUM, V29, P1, DOI 10.1089/neu.2011.1812; Gahlot G, 2017, INDIAN J MEDNODENT A, V5, P24, DOI DOI 10.5958/2347-6206.2017.00005.X; Gao YY, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0939-5; Gao YY, 2016, J SURG RES, V206, P67, DOI 10.1016/j.jss.2016.07.014; Garling RJ, 2018, NEURAL REGEN RES, V13, P434, DOI 10.4103/1673-5374.228725; Golding EM, 2002, BRAIN RES REV, V38, P377, DOI 10.1016/S0165-0173(02)00141-8; He HF, 2018, DRUG DES DEV THER, V12, P629, DOI 10.2147/DDDT.S158313; Hunt RF, 2011, J NEUROSCI, V31, P6880, DOI 10.1523/JNEUROSCI.0032-11.2011; Isaac JTR, 2007, NEURON, V54, P859, DOI 10.1016/j.neuron.2007.06.001; Jeter CB, 2013, J NEUROTRAUM, V30, P657, DOI 10.1089/neu.2012.2439; Ko J, 2018, LAB CHIP, V18, P3617, DOI 10.1039/c8lc00672e; Ko J, 2018, LAB CHIP, V18, P395, DOI 10.1039/c7lc00955k; Ko J, 2017, ACS NANO, V11, P11182, DOI 10.1021/acsnano.7b05503; Ko JN, 2017, LAB CHIP, V17, P3086, DOI 10.1039/c7lc00703e; Korley FK, 2016, J NEUROTRAUM, V33, P215, DOI 10.1089/neu.2015.3949; Korzhevskii D.E., 2016, NEUROSCI BEHAV PHYSL, V46, P284, DOI [10.1007/s11055-016-0231-z, DOI 10.1007/s11055-016-0231-z]; Kuo JR, 2013, J NEUROTRAUM, V30, P1223, DOI 10.1089/neu.2012.2689; Logue OC, 2016, EXP NEUROL, V277, P227, DOI 10.1016/j.expneurol.2015.12.019; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Mathias JL, 2013, BRAIN INJURY, V27, P887, DOI 10.3109/02699052.2013.793398; Mayeux J, 2017, J NEUROTRAUM, V34, P436, DOI 10.1089/neu.2016.4452; Menon DK, 2015, NAT REV NEUROL, V11, P71, DOI 10.1038/nrneurol.2014.261; Mulherkar S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11113-3; Muluneh M, 2014, ADV HEALTHC MATER, V3, P1078, DOI 10.1002/adhm.201300502; Nikolaeva I, 2016, J NEUROTRAUM, V33, P183, DOI 10.1089/neu.2015.3899; Panzer Matthew B, 2012, Front Neurol, V3, P46, DOI 10.3389/fneur.2012.00046; Papa L, 2016, JAMA NEUROL, V73, P551, DOI 10.1001/jamaneurol.2016.0039; Papa L, 2012, J TRAUMA ACUTE CARE, V72, P1335, DOI 10.1097/TA.0b013e3182491e3d; Pasinetti Giulio M, 2012, Am J Neurodegener Dis, V1, P88; Perez EJ, 2017, J CLIN INVEST, V127, P3114, DOI 10.1172/JCI92300; Petraglia Anthony L, 2014, Neurosurgery, V75 Suppl 4, pS34, DOI 10.1227/NEU.0000000000000472; Rozas NS, 2015, J NEUROTRAUM, V32, P149, DOI 10.1089/neu.2014.3469; Rubenstein R, 2017, JAMA NEUROL, V74, P1063, DOI 10.1001/jamaneurol.2017.0655; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; Shahim P, 2017, NEUROLOGY, V88, P1788, DOI 10.1212/WNL.0000000000003912; Shan RZ, 2016, J NEUROTRAUM, V33, P49, DOI 10.1089/neu.2014.3811; Sharma K, 2015, NAT NEUROSCI, V18, P1819, DOI 10.1038/nn.4160; Shen M, 2017, BIOMED PHARMACOTHER, V95, P885, DOI 10.1016/j.biopha.2017.08.125; Shimada R, 2014, NEUROL RES, V36, P239, DOI 10.1179/1743132813Y.0000000289; Shin SS, 2015, J NEUROTRAUM, V32, P1429, DOI 10.1089/neu.2014.3445; SMITH DH, 1995, J NEUROTRAUM, V12, P169, DOI 10.1089/neu.1995.12.169; Stalnacke BM, 2005, J REHABIL MED, V37, P300, DOI 10.1080/16501970510032910; Sun LQ, 2018, BEHAV BRAIN RES, V337, P271, DOI 10.1016/j.bbr.2017.08.042; Titus DJ, 2015, CURR PHARM DESIGN, V21, P332; Vascak M, 2017, FRONT CELL NEUROSCI, V11, DOI 10.3389/fncel.2017.00157; Vogel EW, 2017, J NEUROTRAUM, V34, P1063, DOI 10.1089/neu.2016.4578; Vos P., 2014, TRAUMATIC BRAIN INJU; Wagner AK, 2009, J NEUROCHEM, V108, P986, DOI 10.1111/j.1471-4159.2008.05840.x; Wang ZF, 2017, BIOCHEM BIOPH RES CO, V482, P948, DOI 10.1016/j.bbrc.2016.11.138; Winston CN, 2016, AM J PATHOL, V186, P552, DOI 10.1016/j.ajpath.2015.11.006; Winston CN, 2013, J NEUROTRAUM, V30, P1966, DOI 10.1089/neu.2013.2960; Wu CH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113397; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Xiong Y, 2009, EXPERT OPIN EMERG DR, V14, P67, DOI [10.1517/14728210902769601, 10.1517/14728210902769601 ]; Yang J, 2015, CELL, V160, P161, DOI 10.1016/j.cell.2014.11.053; Zhang L, 2016, CELL MOL NEUROBIOL, V36, P131, DOI 10.1007/s10571-015-0227-1; Zhu Q, 2016, BIORXIV	73	21	22	1	8	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	NOV 15	2020	37	22					2424	2434		10.1089/neu.2018.6220		MAY 2019	11	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	OP2MH	WOS:000468297500001	30950328	Bronze			2021-06-18	
J	Forrest, SL; Kril, JJ; Wagner, S; Honigschnabl, S; Reiner, A; Fischer, P; Kovacs, GG				Forrest, Shelley L.; Kril, Jillian J.; Wagner, Stephanie; Hoenigschnabl, Selma; Reiner, Angelika; Fischer, Peter; Kovacs, Gabor G.			Chronic Traumatic Encephalopathy (CTE) Is Absent From a European Community-Based Aging Cohort While Cortical Aging-Related Tau Astrogliopathy (ARTAG) Is Highly Prevalent	JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY			English	Article						Aging; Aging-related tau astrogliopathy; ARTAG; Chronic traumatic encephalopathy; Community-based study; CTE; Neuropathology	BRAIN-INJURY; PATHOLOGY; NEUROPATHOLOGY; DISEASE	This study determined the prevalence of chronic traumatic encephalopathy (CTE) and cortical aging-related tau astrogliopathy (ARTAG) in a European community-based population (n = 310). The frontal, parietal, and temporal cortices, representing initial stages of CTE were assessed. No case fulfilling CTE consensus criteria was found. However, isolated astroglial or neuronal tau pathologies were recognized in the depths of cortical sulci (<2%). A single case (female, 85 years) without a history of traumatic brain injury (TBI) showed combined tau-immunoreactive features confined to frontal sulci without perivascular accumulation. Another 24 cases had single tau pathologies in cortical sulci. ARTAG was identified in 117 cases (38%), with a similar regional prevalence. Gray matter ARTAG was the most common followed by subpial, white matter, and perivascular. The presence of any type of ARTAG was strongly associated with having another type of ARTAG in the same region (p < 0.05). In summary, although isolated tau pathologies in the depths of cortical sulci were identified, no case fulfilled diagnostic criteria of CTE. Cortical ARTAG in this population is common and contrasts the high prevalence of CTE in individuals with repeated mild TBI. ARTAG in isolation might not be indicative of CTE although commonalities in pathogenesis should be considered.	[Forrest, Shelley L.; Kril, Jillian J.] Univ Sydney, Charles Perkins Ctr, Fac Med & Hlth, Sydney, NSW, Australia; [Forrest, Shelley L.; Kril, Jillian J.] Univ Sydney, Discipline Pathol, Sydney, NSW, Australia; [Wagner, Stephanie; Kovacs, Gabor G.] Med Univ Vienna, Inst Neurol, AKH Wien 4J Wahringer Gurtel 18-20, A-1097 Vienna, Austria; [Hoenigschnabl, Selma; Reiner, Angelika] Danube Hosp, Dept Pathol, Vienna, Austria; [Fischer, Peter] Danube Hosp, Dept Psychiat, Vienna, Austria	Kovacs, GG (corresponding author), Med Univ Vienna, Inst Neurol, AKH Wien 4J Wahringer Gurtel 18-20, A-1097 Vienna, Austria.	gabor.kovacs@meduniwien.ac.at	Kovacs, Gabor G/A-7468-2013; Forrest, Shelley/ABG-2644-2020	Kovacs, Gabor G/0000-0003-3841-5511; 	Ludwig Boltzmann Institute of Ageing Research; NHMRC Project GrantNational Health and Medical Research Council of Australia [1132524]; Alzheimer's Australia Dementia Research Foundation via the Rosemary Foundation Travel Fellowship	The Vienna Trans-Danube Ageing (VITA) study was supported and organized by the Ludwig Boltzmann Institute of Ageing Research. In addition, this study was supported by NHMRC Project Grant (1132524). The Alzheimer's Australia Dementia Research Foundation via the Rosemary Foundation Travel Fellowship supports S.L.F. and J.J.K.	Asken BM, 2017, JAMA NEUROL, V74, P1255, DOI 10.1001/jamaneurol.2017.2396; Baskota SU, 2019, LAB INVEST, V99, P1068, DOI 10.1038/s41374-018-0166-9; Bieniek KF, 2015, ACTA NEUROPATHOL, V130, P877, DOI 10.1007/s00401-015-1502-4; Braak H, 2003, NEUROBIOL AGING, V24, P197, DOI 10.1016/S0197-4580(02)00065-9; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Cloots RJH, 2008, ANN BIOMED ENG, V36, P1203, DOI 10.1007/s10439-008-9510-3; Forrest SL, 2018, BRAIN, V141, P521, DOI 10.1093/brain/awx328; Ghajari M, 2017, BRAIN, V140, P333, DOI 10.1093/brain/aww317; Goldfinger MH, 2018, ACTA NEUROPATHOL, V136, P973, DOI 10.1007/s00401-018-1926-8; Hsu ET, 2018, ACTA NEUROPATHOL, V136, P955, DOI 10.1007/s00401-018-1902-3; Koga S, 2016, J NEUROPATH EXP NEUR, V75, P963, DOI 10.1093/jnen/nlw073; Kovacs GG, 2018, ACTA NEUROPATHOL COM, V6, DOI 10.1186/s40478-018-0552-y; Kovacs GG, 2017, J NEUROPATH EXP NEUR, V76, P605, DOI 10.1093/jnen/nlx041; Kovacs GG, 2017, J NEUROPATH EXP NEUR, V76, P270, DOI 10.1093/jnen/nlx007; Kovacs GG, 2016, ACTA NEUROPATHOL, V131, P87, DOI 10.1007/s00401-015-1509-x; Kovacs GG, 2013, ACTA NEUROPATHOL, V126, P365, DOI 10.1007/s00401-013-1157-y; Ling HL, 2015, ACTA NEUROPATHOL, V130, P891, DOI 10.1007/s00401-015-1496-y; Liu AKL, 2016, ACTA NEUROPATHOL COM, V4, DOI 10.1186/s40478-016-0330-7; McKee AC, 2016, ACTA NEUROPATHOL, V131, P75, DOI 10.1007/s00401-015-1515-z; McKee AC, 2015, BRAIN PATHOL, V25, P350, DOI 10.1111/bpa.12248; McKee AC, 2014, ALZHEIMERS DEMENT, V10, pS242, DOI 10.1016/j.jalz.2014.04.003; McKee AC, 2014, ACTA NEUROPATHOL, V127, P29, DOI 10.1007/s00401-013-1230-6; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Mez J, 2017, JAMA-J AM MED ASSOC, V318, P360, DOI 10.1001/jama.2017.8334; MIRRA SS, 1991, NEUROLOGY, V41, P479, DOI 10.1212/WNL.41.4.479; Noy S, 2016, J NEUROPATH EXP NEUR, V75, P1145, DOI 10.1093/jnen/nlw092; ROBERTS GW, 1990, LANCET, V335, P918, DOI 10.1016/0140-6736(90)90520-F; Robinson JL, 2018, ACTA NEUROPATHOL, V136, P377, DOI 10.1007/s00401-018-1872-5; Saito Y, 2004, J NEUROPATH EXP NEUR, V63, P911, DOI 10.1093/jnen/63.9.911; Schultz C, 2004, NEUROBIOL AGING, V25, P397, DOI 10.1016/S0197-4580(03)00113-1; Shively SB, 2017, ACTA NEUROPATHOL, V133, P353, DOI 10.1007/s00401-016-1649-7; Stern RA, 2013, NEUROLOGY, V81, P1122, DOI 10.1212/WNL.0b013e3182a55f7f	32	21	21	0	1	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0022-3069	1554-6578		J NEUROPATH EXP NEUR	J. Neuropathol. Exp. Neurol.	MAY	2019	78	5					398	405		10.1093/jnen/nlz017			8	Clinical Neurology; Neurosciences; Pathology	Neurosciences & Neurology; Pathology	IF7KX	WOS:000473264100003	30939193	Bronze			2021-06-18	
J	Yuan, XC; Wu, QB; Wang, P; Jing, YL; Yao, HJ; Tang, YS; Li, ZG; Zhang, HG; Xiu, RJ				Yuan, Xiaochen; Wu, Qingbin; Wang, Peng; Jing, Yingli; Yao, Haijiang; Tang, Yinshan; Li, Zhigang; Zhang, Honggang; Xiu, Ruijuan			Exosomes Derived From Pericytes Improve Microcirculation and Protect Blood-Spinal Cord Barrier After Spinal Cord Injury in Mice	FRONTIERS IN NEUROSCIENCE			English	Article						pericytes; exosomes; spinal cord injury; microcirculation; microvascular	MESENCHYMAL STROMAL CELLS; TRAUMATIC BRAIN-INJURY; FUNCTIONAL RECOVERY; STEM-CELLS; MATRIX METALLOPROTEINASES; MICROVASCULAR PERICYTES; RAT; AQUAPORIN-4; MODEL; TRANSPLANTATION	Spinal cord injury (SCI) often leads to severe and permanent paralysis and places a heavy burden on individuals, families, and society. Until now, the therapy of SCI is still a big challenge for the researchers. Transplantation of mesenchymal stem cells (MSCs) is a hot spot for the treatment of SCI, but many problems and risks have not been resolved. Some studies have reported that the therapeutic effect of MSCs on SCI is related to the paracrine secretion of cells. The exosomes secreted by MSCs have therapeutic potential for many diseases. There are abundant pericytes which possess the characteristics of stem cells in the neurovascular unit. Due to the close relationship between pericytes and endothelial cells, the exosomes of pericytes can be taken up by endothelial cells more easily. There are fewer studies about the therapeutic potential of the exosomes derived from pericytes on SCI now. In this study, exosomes of pericytes were transplanted into the mice with SCI to study the restoration of motor function and explore the underlying mechanism. We found that the exosomes derived from pericytes could reduce pathological changes, improve the motor function, the blood flow and oxygen deficiency after SCI. In addition, the exosomes could improve the endothelial ability to regulate blood flow, protect the blood-spinal cord barrier, reduce edema, decrease the expression of HIF-1 alpha, Bax, Aquaporin-4, and MMP2, increase the expression of Claudin-5, bcl-2 and inhibit apoptosis. The experiments in vitro proved that exosomes derived from pericytes could protect the barrier of spinal cord microvascular endothelial cells under hypoxia condition, which was related to PTEN/AKT pathway. In summary, our study showed that exosomes of pericytes had therapeutic prospects for SCI.	[Yuan, Xiaochen; Wu, Qingbin; Zhang, Honggang; Xiu, Ruijuan] Chinese Acad Med Sci, Inst Microcirculat, Key Lab Microcirculat, Minist Hlth, Beijing, Peoples R China; [Yuan, Xiaochen; Wu, Qingbin; Zhang, Honggang; Xiu, Ruijuan] Peking Union Med Coll, Beijing, Peoples R China; [Wang, Peng] Hebei Prov Hosp Tradit Chinese Med, Orthoped Dept, Shijiazhuang, Hebei, Peoples R China; [Jing, Yingli] Beijing Inst Brain Disorders, Ctr Neural Injury & Repair, China Rehabilltat Sci Inst, China Rehabil Res Ctr,Beijing Key Lab Neural Inju, Beijing, Peoples R China; [Yao, Haijiang] Capital Med Univ, Beijing Boai Hosp, Treatment Ctr TCM, Sch Rehabil,China Rehabil Res Ctr, Beijing, Peoples R China; [Tang, Yinshan] Zhejiang Univ, Dept Rehabil Tradit Chinese Med, Sch Med, Affiliated Hosp 2, Hangzhou, Zhejiang, Peoples R China; [Li, Zhigang] Beijing Univ Chinese Med, Sch Acupuncture Moxibust & Tuina, Beijing, Peoples R China	Wu, QB; Zhang, HG (corresponding author), Chinese Acad Med Sci, Inst Microcirculat, Key Lab Microcirculat, Minist Hlth, Beijing, Peoples R China.; Wu, QB; Zhang, HG (corresponding author), Peking Union Med Coll, Beijing, Peoples R China.; Li, ZG (corresponding author), Beijing Univ Chinese Med, Sch Acupuncture Moxibust & Tuina, Beijing, Peoples R China.	wuqingbin@imc.pumc.edu.cn; lizhigang620620@163.com; zhang1966126@163.com		Xiu, Ruijuan/0000-0002-1446-2711	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81603678]; Chinese Academy of Medical Sciences & Peking Union Medical College [3332014006, 3332015123]; Special Fund for Basic Scientific Research of the Central Public Research Institutes [2016CZ-1, 2018CZ-8]; CAMS Initiative for Innovative Medicine (CAMS-I2M) [2016-I2M-3-006]	This study was supported by the National Natural Science Foundation of China (No. 81603678), the innovation fund of the Chinese Academy of Medical Sciences & Peking Union Medical College (Nos. 3332014006 and 3332015123), the Special Fund for Basic Scientific Research of the Central Public Research Institutes (Nos. 2016CZ-1 and 2018CZ-8), and the CAMS Initiative for Innovative Medicine (CAMS-I2M) (No. 2016-I2M-3-006).	Adams JM, 1998, SCIENCE, V281, P1322, DOI 10.1126/science.281.5381.1322; Alilain WJ, 2011, NATURE, V475, P196, DOI 10.1038/nature10199; Allen A.R., 1911, JAMA-J AM MED ASSOC, V57, P878, DOI DOI 10.1001/JAMA.1911.04260090100008; Balsam LB, 2004, NATURE, V428, P668, DOI 10.1038/nature02460; Basso DM, 2006, J NEUROTRAUM, V23, P635, DOI 10.1089/neu.2006.23.635; Ben Borgens R, 2012, Q REV BIOL, V87, P89, DOI 10.1086/665457; Bergers G, 2005, NEURO-ONCOLOGY, V7, P452, DOI 10.1215/S1152851705000232; Breakefield XO, 2011, MOL THER, V19, P1574, DOI 10.1038/mt.2011.169; Bsibsi M, 2006, GLIA, V53, P688, DOI 10.1002/glia.20328; Camussi G, 2013, BIOCHEM SOC T, V41, P283, DOI 10.1042/BST20120192; Carlson Gregory D, 2002, Spine J, V2, P116, DOI 10.1016/S1529-9430(01)00029-8; Cavallucci V, 2011, CURR PHARM DESIGN, V17, P215, DOI 10.2174/138161211795049705; Chaput N, 2011, SEMIN IMMUNOPATHOL, V33, P419, DOI 10.1007/s00281-010-0233-9; Chopp M, 2000, NEUROREPORT, V11, P3001, DOI 10.1097/00001756-200009110-00035; Cizkova D, 2011, J NEUROTRAUM, V28, P1951, DOI 10.1089/neu.2010.1413; De Luca C, 2017, PROG MOL BIOL TRANSL, V148, P167, DOI 10.1016/bs.pmbts.2017.04.002; Dore-Duffy P, 2011, METHODS MOL BIOL, V686, P49, DOI 10.1007/978-1-60761-938-3_2; Fan ZK, 2013, J NEUROTRAUM, V30, P473, DOI 10.1089/neu.2012.2574; Farina C, 2007, TRENDS IMMUNOL, V28, P138, DOI 10.1016/j.it.2007.01.005; Feron F, 2005, BRAIN, V128, P2951, DOI 10.1093/brain/awh657; Fukuda AM, 2013, J CEREBR BLOOD F MET, V33, P1621, DOI 10.1038/jcbfm.2013.118; Gatti S, 2011, NEPHROL DIAL TRANSPL, V26, P1474, DOI 10.1093/ndt/gfr015; Hausmann O, 2003, SPINAL CORD, V41, P369, DOI 10.1038/sj.sc.3101483; Hengartner MO, 2000, NATURE, V407, P770, DOI 10.1038/35037710; Ho AD, 2008, CYTOTHERAPY, V10, P320, DOI 10.1080/14653240802217011; Hsu JYC, 2006, J NEUROSCI, V26, P9841, DOI 10.1523/JNEUROSCI.1993-06.2006; Huang JH, 2017, J NEUROTRAUM, V34, P3388, DOI 10.1089/neu.2017.5063; Hubbard JA, 2016, EXP NEUROL, V283, P85, DOI 10.1016/j.expneurol.2016.05.003; Jeong JO, 2011, CIRC RES, V108, P1340, DOI 10.1161/CIRCRESAHA.110.239848; Katsuda T, 2013, PROTEOMICS, V13, P1637, DOI 10.1002/pmic.201200373; Kaur C, 2008, CURR NEUROVASC RES, V5, P71, DOI 10.2174/156720208783565645; Lai RC, 2011, REGEN MED, V6, P481, DOI [10.2217/RME.11.35, 10.2217/rme.11.35]; Lai RC, 2010, STEM CELL RES, V4, P214, DOI 10.1016/j.scr.2009.12.003; Lee JY, 2012, J NEUROCHEM, V121, P818, DOI 10.1111/j.1471-4159.2012.07731.x; Li TF, 2013, STEM CELLS DEV, V22, P845, DOI 10.1089/scd.2012.0395; Li ZY, 2007, IN VIVO, V21, P61; Liang FY, 2015, NEUROSCI LETT, V598, P29, DOI 10.1016/j.neulet.2015.05.006; Liebner S, 2011, INT J DEV BIOL, V55, P467, DOI 10.1387/ijdb.103224sl; Liu W, 2019, J NEUROTRAUM, V36, P469, DOI 10.1089/neu.2018.5835; Mathivanan S, 2010, J PROTEOMICS, V73, P1907, DOI 10.1016/j.jprot.2010.06.006; Mothe AJ, 2012, J CLIN INVEST, V122, P3824, DOI 10.1172/JCI64124; Nakajima H, 2012, J NEUROTRAUM, V29, P1614, DOI 10.1089/neu.2011.2109; Neganova AY, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173805; Neirinckx V, 2015, STEM CELL RES THER, V6, DOI 10.1186/s13287-015-0202-2; Nielsen S, 1997, J NEUROSCI, V17, P171; Noble LJ, 2002, J NEUROSCI, V22, P7526; Nohda K, 2007, SPINE, V32, P1060, DOI 10.1097/01.brs.0000261560.53428.90; Orekhov AN, 2014, CARDIOVASC RES, V103, P438, DOI 10.1093/cvr/cvu168; Oshio K, 2004, NEUROSCIENCE, V127, P685, DOI 10.1016/j.neuroscience.2004.03.016; Oudega M, 2012, CELL TISSUE RES, V349, P269, DOI 10.1007/s00441-012-1440-6; Pavlov AN, 2014, PHYSIOL MEAS, V35, P1983, DOI 10.1088/0967-3334/35/10/1983; Phinney DG, 2007, STEM CELLS, V25, P2896, DOI 10.1634/stemcells.2007-0637; Ratajczak MZ, 2014, POL ARCH MED WEWN, V124, P417, DOI 10.20452/pamw.2355; Record M, 2011, BIOCHEM PHARMACOL, V81, P1171, DOI 10.1016/j.bcp.2011.02.011; Rendell MS, 1999, COMP BIOCHEM PHYS A, V122, P399, DOI 10.1016/S1095-6433(99)00022-7; Rodriguez R, 2012, CELL RES, V22, P62, DOI 10.1038/cr.2011.157; Rubio D, 2005, CANCER RES, V65, P3035, DOI 10.1158/0008-5472.CAN-04-4194; Saadoun S, 2008, BRAIN, V131, P1087, DOI 10.1093/brain/awn014; Schwab ME, 1996, PHYSIOL REV, V76, P319; Seki T, 2003, NEUROSURGERY, V53, P192, DOI 10.1227/01.NEU.0000068988.28788.2C; Sharma HS, 2007, ANN NY ACAD SCI, V1122, P95, DOI 10.1196/annals.1403.007; SHARMA HS, 1990, ACTA NEUROPATHOL, V79, P604, DOI 10.1007/BF00294237; Simonavicius N, 2012, BLOOD, V120, P1516, DOI 10.1182/blood-2011-01-332338; Stoorvogel W, 2002, TRAFFIC, V3, P321, DOI 10.1034/j.1600-0854.2002.30502.x; Strazielle N, 2013, MOL PHARMACEUT, V10, P1473, DOI 10.1021/mp300518e; Sun MC, 2003, J NEUROSURG, V98, P565, DOI 10.3171/jns.2003.98.3.0565; Thery C, 2002, NAT REV IMMUNOL, V2, P569, DOI 10.1038/nri855; Varma AK, 2013, NEUROCHEM RES, V38, P895, DOI 10.1007/s11064-013-0991-6; Villarroya-Beltri Carolina, 2013, Methods Mol Biol, V1024, P41, DOI 10.1007/978-1-62703-453-1_4; Wells JEA, 2003, J NEUROSCI, V23, P10107, DOI 10.1523/jneurosci.23-31-10107.2003; Wolburg H, 2002, VASC PHARMACOL, V38, P323, DOI 10.1016/S1537-1891(02)00200-8; Wu QB, 2015, CLIN HEMORHEOL MICRO, V60, P231, DOI 10.3233/CH-141856; Wyatt LA, 2012, PROG BRAIN RES, V201, P233, DOI 10.1016/B978-0-444-59544-7.00012-3; Xin HQ, 2012, STEM CELLS, V30, P1556, DOI 10.1002/stem.1129; Yuan XC, 2017, ANDROLOGIA, V49, DOI 10.1111/and.12692; Yuan XC, 2018, AM J TRANSL RES, V10, P2372; Yuan XC, 2011, J PINEAL RES, V51, P220, DOI 10.1111/j.1600-079X.2011.00882.x; Zhang JL, 2015, INT J BIOCHEM CELL B, V60, P43, DOI 10.1016/j.biocel.2014.12.020; Zomer Anoek, 2010, Commun Integr Biol, V3, P447, DOI 10.4161/cib.3.5.12339	79	21	23	5	15	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND		1662-453X		FRONT NEUROSCI-SWITZ	Front. Neurosci.	APR 16	2019	13								319	10.3389/fnins.2019.00319			14	Neurosciences	Neurosciences & Neurology	HU2AV	WOS:000465074000001	31040762	DOAJ Gold, Green Published			2021-06-18	
J	Kilgannon, JH; Hunter, BR; Puskarich, MA; Shea, L; Fuller, BM; Jones, C; Donnino, M; Kline, JA; Jones, AE; Shapiro, NI; Abella, BS; Trzeciak, S; Roberts, BW				Kilgannon, J. Hope; Hunter, Benton R.; Puskarich, Michael A.; Shea, Lisa; Fuller, Brian M.; Jones, Christopher; Donnino, Michael; Kline, Jeffrey A.; Jones, Alan E.; Shapiro, Nathan I.; Abella, Benjamin S.; Trzeciak, Stephen; Roberts, Brian W.			Partial pressure of arterial carbon dioxide after resuscitation from cardiac arrest and neurological outcome: A prospective multi-center protocol-directed cohort study	RESUSCITATION			English	Article						Cardiac arrest; Heart arrest; Partial pressure of arterial carbon dioxide; PaCO2	POSTRESUSCITATION PARTIAL-PRESSURE; MODIFIED RANKIN SCALE; CARDIOPULMONARY-RESUSCITATION; HOSPITAL MORTALITY; ASSOCIATION; HYPERCAPNIA; CARE; INJURY; HYPERVENTILATION; GUIDELINES	Aims: Partial pressure of arterial carbon dioxide (PaCO2) is a regulator of cerebral blood flow after brain injury. We sought to test the association between PaCO2 after resuscitation from cardiac arrest and neurological outcome. Methods: A prospective protocol-directed cohort study across six hospitals. Inclusion criteria: age >= 18, non-traumatic cardiac arrest, mechanically ventilated after return of spontaneous circulation (ROSC), and receipt of targeted temperature management. Per protocol, PaCO2 was measured by arterial blood gas analyses at one and six hours after ROSC. We determined the mean PaCO2 over this initial six hours after ROSC. The primary outcome was good neurological function at hospital discharge, defined a priori as a modified Rankin Scale <= 3. Multivariable Poisson regression analysis was used to test the association between PaCO2 and neurological outcome. Results: Of the 280 patients included, the median (interquartile range) PaCO2 was 44 (37-52) mmHg and 30% had good neurological function. We found mean PaCO2 had a quadratic (inverted "U" shaped) association with good neurological outcome, with a mean PaCO2 of 68 mmHg having the highest predictive probability of good neurological outcome, and worse neurological outcome at higher and lower PaCO2. Presence of metabolic acidosis attenuated the association between PaCO2 and good neurological outcome, with a PaCO2 of 51 mmHg having the highest predictive probability of good neurological outcome among patients with metabolic acidosis. Conclusion: PaCO2 has a "U" shaped association with neurological outcome, with mild to moderate hypercapnia having the highest probability of good neurological outcome.	[Kilgannon, J. Hope; Jones, Christopher; Trzeciak, Stephen; Roberts, Brian W.] Rowan Univ, Cooper Univ Hosp, Cooper Med Sch, Dept Emergency Med, Camden, NJ USA; [Shea, Lisa; Trzeciak, Stephen] Rowan Univ, Cooper Univ Hosp, Cooper Med Sch, Dept Med,Div Crit Care Med, Camden, NJ USA; [Hunter, Benton R.; Kline, Jeffrey A.] Indiana Univ Sch Med, Dept Emergency Med, Indianapolis, IN 46202 USA; [Puskarich, Michael A.; Jones, Alan E.] Univ Mississippi, Med Ctr, Dept Emergency Med, Jackson, MS 39216 USA; [Fuller, Brian M.] Washington Univ, Sch Med, Dept Emergency Med, Div Crit Care Med, St Louis, MO USA; [Fuller, Brian M.] Washington Univ, Sch Med, Dept Anesthesiol, Div Crit Care Med, St Louis, MO 63110 USA; [Donnino, Michael; Shapiro, Nathan I.] Beth Israel Deaconess Med Ctr, Dept Emergency Med, Boston, MA 02215 USA; [Abella, Benjamin S.] Univ Penn, Ctr Resuscitat Sci, Philadelphia, PA 19104 USA; [Abella, Benjamin S.] Univ Penn, Dept Emergency Med, Philadelphia, PA 19104 USA	Roberts, BW (corresponding author), Cooper Univ Hosp, One Cooper Plaza,K152, Camden, NJ 08103 USA.	roberts-brian-w@cooperhealth.edu	Puskarich, Michael/N-7849-2014	Puskarich, Michael/0000-0001-6358-4670	National Heart, Lung, and Blood Institute (U.S.)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [R01HL112815, K23HL126979]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [R01HL112815, K23HL126979] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute (U.S.), R01HL112815 and K23HL126979.	Altman DG, 2006, BRIT MED J, V332, P1080, DOI 10.1136/bmj.332.7549.1080; Ausina A, 1998, ACT NEUR S, V71, P1; Beitler JR, 2017, AM J RESP CRIT CARE, V195, P1198, DOI 10.1164/rccm.201609-1771OC; Beylin ME, 2013, INTENS CARE MED, V39, P1981, DOI 10.1007/s00134-013-3075-9; Brian JE, 1998, ANESTHESIOLOGY, V88, P1365, DOI 10.1097/00000542-199805000-00029; Buunk G, 1997, STROKE, V28, P1569, DOI 10.1161/01.STR.28.8.1569; Callaway CW, 2015, CIRCULATION, V132, pS465, DOI 10.1161/CIR.0000000000000262; Cold G E, 1990, Acta Neurochir Suppl (Wien), V49, P1; Eastwood GM, 2016, RESUSCITATION, V104, P83, DOI 10.1016/j.resuscitation.2016.03.023; Eastwood GM, 2016, RESUSCITATION, V102, P11, DOI 10.1016/j.resuscitation.2016.02.009; Falkenbach P, 2009, RESUSCITATION, V80, P990, DOI 10.1016/j.resuscitation.2009.04.044; Helmerhorst HJF, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-1067-6; Laffey JG, 2000, AM J RESP CRIT CARE, V162, P2287, DOI 10.1164/ajrccm.162.6.2003066; Lee BK, 2014, AM J EMERG MED, V32, P55, DOI 10.1016/j.ajem.2013.09.044; NEGOVSKY VA, 1995, RESUSCITATION, V30, P23, DOI 10.1016/0300-9572(95)00861-M; Nielsen N, 2013, NEW ENGL J MED, V369, P2197, DOI 10.1056/NEJMoa1310519; Nin N, 2017, INTENS CARE MED, V43, P200, DOI 10.1007/s00134-016-4611-1; Nolan JP, 2015, RESUSCITATION, V95, pE1, DOI 10.1016/j.resuscitation.2015.07.039; Nolan JP, 2015, RESUSCITATION, V95, P202, DOI 10.1016/j.resuscitation.2015.07.018; Nolan Jerry P, 2010, Int Emerg Nurs, V18, P8, DOI 10.1016/j.ienj.2009.07.001; Quinn TJ, 2007, STROKE, V38, P2257, DOI 10.1161/STROKEAHA.106.480723; Roberts BW, 2018, CIRCULATION, V137, P2114, DOI 10.1161/CIRCULATIONAHA.117.032054; Roberts BW, 2018, CRIT CARE MED, V46, pe213, DOI 10.1097/CCM.0000000000002918; Roberts BW, 2015, RESUSCITATION, V91, P32, DOI 10.1016/j.resuscitation.2015.03.015; Roberts BW, 2014, ANN INTENSIVE CARE, V4, DOI 10.1186/2110-5820-4-9; Roberts BW, 2013, CIRCULATION, V127, P2107, DOI 10.1161/CIRCULATIONAHA.112.000168; Schneider AG, 2013, RESUSCITATION, V84, P927, DOI 10.1016/j.resuscitation.2013.02.014; Tiruvoipati R, 2017, CRIT CARE MED, V45, pE649, DOI 10.1097/CCM.0000000000002332; Trzeciak S, 2009, CRIT CARE MED, V37, P2895, DOI 10.1097/CCM.0b013e3181b01d8c; Vaahersalo J, 2014, CRIT CARE MED, V42, P1463, DOI 10.1097/CCM.0000000000000228; VANNUCCI RC, 1995, PEDIATRICS, V95, P868; von Elm E, 2007, ANN INTERN MED, V147, P573, DOI 10.7326/0003-4819-147-8-200710160-00010; West MA, 1996, J SURG RES, V63, P269, DOI 10.1006/jsre.1996.0259; Wilson JTL, 2005, STROKE, V36, P777, DOI 10.1161/01.STR.0000157596.13234.95; Wilson JTL, 2002, STROKE, V33, P2243, DOI 10.1161/01.STR.0000027437.22450.BD; Yundt KD, 1997, CRIT CARE CLIN, V13, P163, DOI 10.1016/S0749-0704(05)70300-6; Zou GY, 2004, AM J EPIDEMIOL, V159, P702, DOI 10.1093/aje/kwh090	37	21	21	0	2	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0300-9572	1873-1570		RESUSCITATION	Resuscitation	FEB	2019	135						212	220		10.1016/j.resuscitation.2018.11.015			9	Critical Care Medicine; Emergency Medicine	General & Internal Medicine; Emergency Medicine	HM9EO	WOS:000459785900030	30452939	Green Accepted			2021-06-18	
J	Peruzzaro, ST; Andrews, MMM; Al-Gharaibeh, A; Pupiec, O; Resk, M; Story, D; Maiti, P; Rossignol, J; Dunbar, GL				Peruzzaro, S. T.; Andrews, M. M. M.; Al-Gharaibeh, A.; Pupiec, O.; Resk, M.; Story, D.; Maiti, P.; Rossignol, J.; Dunbar, G. L.			Transplantation of mesenchymal stem cells genetically engineered to overexpress interleukin-10 promotes alternative inflammatory response in rat model of traumatic brain injury	JOURNAL OF NEUROINFLAMMATION			English	Article						Traumatic brain injury; Interleukin-10; Mesenchymal stem cells; Neuroinflammation; CD163	FUNCTIONAL RECOVERY; EXPRESSION; NEUROPROTECTION; POLARIZATION; MICROGLIA; ATTENUATE; NEURONS; CORTEX; CD163	BackgroundTraumatic brain injury (TBI) is a major cause for long-term disability, yet the treatments available that improve outcomes after TBI limited. Neuroinflammatory responses are key contributors to determining patient outcomes after TBI. Transplantation of mesenchymal stem cells (MSCs), which release trophic and pro-repair cytokines, represents an effective strategy to reduce inflammation after TBI. One such pro-repair cytokine is interleukin-10 (IL-10), which reduces pro-inflammatory markers and trigger alternative inflammatory markers, such as CD163. In this study, we tested the therapeutic effects of MSCs that were engineered to overexpress IL-10 when transplanted into rats following TBI in the medial frontal cortex.MethodsThirty-six hours following TBI, rats were transplanted with MSCs and then assessed for 3weeks on a battery of behavioral tests that measured motor and cognitive abilities. Histological evaluation was then done to measure the activation of the inflammatory response. Additionally, immunomodulatory effects were evaluated by immunohistochemistry and Western blot analyses.ResultsA significant improvement in fine motor function was observed in rats that received transplants of MSCs engineered to overexpress IL-10 (MSCs + IL-10) or MSCs alone compared to TBI + vehicle-treated rats. Although tissue spared was unchanged, anti-inflammatory effects were revealed by a reduction in the number of glial fibrillary acidic protein cells and CD86 cells in both TBI + MSCs + IL-10 and TBI + MSC groups compared to TBI + vehicle rats. Microglial activation was significantly increased in the TBI + MSC group when compared to the sham + vehicle group. Western blot data suggested a reduction in tumor necrosis factor-alpha in the TBI + MSCs + IL-10 group compared to TBI + MSC group. Immunomodulatory effects were demonstrated by a shift from classical inflammation expression (CD86) to an alternative inflammation state (CD163) in both treatments with MSCs and MSCs + IL-10. Furthermore, co-labeling of both CD86 and CD163 was detected in the same cells, suggesting a temporal change in macrophage expression.ConclusionsOverall, our findings suggest that transplantation of MSCs that were engineered to overexpress IL-10 can improve functional outcomes by providing a beneficial perilesion environment. This improvement may be explained by the shifting of macrophage expression to a more pro-repair state, thereby providing a possible new therapy for treating TBI.	[Peruzzaro, S. T.; Andrews, M. M. M.; Al-Gharaibeh, A.; Pupiec, O.; Resk, M.; Story, D.; Maiti, P.; Rossignol, J.; Dunbar, G. L.] Cent Michigan Univ, Field Neurosci Inst, Lab Restorat Neurol, Mt Pleasant, MI 48859 USA; [Peruzzaro, S. T.; Andrews, M. M. M.; Al-Gharaibeh, A.; Pupiec, O.; Resk, M.; Story, D.; Maiti, P.; Rossignol, J.; Dunbar, G. L.] Cent Michigan Univ, Program Neurosci, Mt Pleasant, MI 48859 USA; [Story, D.; Maiti, P.; Dunbar, G. L.] Cent Michigan Univ, Dept Psychol, Mt Pleasant, MI 48859 USA; [Maiti, P.; Dunbar, G. L.] St Marys Michigan, Field Neurosci Inst, Saginaw, MI 48604 USA; [Maiti, P.] Saginaw Valley State Univ, Dept Biol, Saginaw, MI 48610 USA; [Maiti, P.; Dunbar, G. L.] Saginaw Valley State Univ, Brain Res Lab, Saginaw, MI 48610 USA; [Rossignol, J.] Cent Michigan Univ, Coll Med, Mt Pleasant, MI 48859 USA	Rossignol, J; Dunbar, GL (corresponding author), Cent Michigan Univ, Field Neurosci Inst, Lab Restorat Neurol, Mt Pleasant, MI 48859 USA.	rossi1j@cmich.edu; dunba1g@cmich.edu	Rossignol, Julien/I-1013-2019	Dunbar, Gary/0000-0003-4730-9323; Rossignol, Julien/0000-0002-8662-0547; Gharaibeh, Abeer/0000-0003-3549-1826; Story, Darren/0000-0002-0902-5728	Office of Research and Sponsored Programs at Central Michigan University; College of Medicine at Central Michigan University; College of Humanities and Social and Behavioral Sciences at Central Michigan University; John G. Kulhavi Professorship; Field Neurosciences Institute	This work was supported by the Office of Research and Sponsored Programs at Central Michigan University, the College of Medicine at Central Michigan University, the College of Humanities and Social and Behavioral Sciences at Central Michigan University, the Field Neurosciences Institute, and the John G. Kulhavi Professorship.	Balasingam V, 1996, J NEUROSCI, V16, P2945; Chen X, 2014, NEUROSCIENCE, V266, P235, DOI 10.1016/j.neuroscience.2013.11.036; Cho DI, 2014, EXP MOL MED, V46, DOI 10.1038/emm.2013.135; Choi JJ, 2008, CLIN EXP IMMUNOL, V153, P269, DOI 10.1111/j.1365-2249.2008.03683.x; Colburn RW, 1997, J NEUROIMMUNOL, V79, P163, DOI 10.1016/S0165-5728(97)00119-7; Coyne TM, 2006, STEM CELLS, V24, P2483, DOI 10.1634/stemcells.2006-0174; Evans HG, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4199; Garcia JM, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00244; HAMM RJ, 1994, J NEUROTRAUM, V11, P187, DOI 10.1089/neu.1994.11.187; Hasan A, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00028; Holladay C, 2011, MOL THER, V19, P969, DOI 10.1038/mt.2010.311; Karve IP, 2016, BRIT J PHARMACOL, V173, P692, DOI 10.1111/bph.13125; Kline AE, 2002, BRAIN RES, V937, P22, DOI 10.1016/S0006-8993(02)02458-7; Knoblach SM, 1998, EXP NEUROL, V153, P143, DOI 10.1006/exnr.1998.6877; Kowal K, 2011, FOLIA HISTOCHEM CYTO, V49, P365, DOI 10.5603/FHC.2011.0052; Liao WB, 2016, BIOMATERIALS, V77, P87, DOI 10.1016/j.biomaterials.2015.11.005; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Majdan M, 2016, LANCET PUBLIC HEALTH, V1, pE76, DOI 10.1016/S2468-2667(16)30017-2; Manning E, 2010, HUM GENE THER, V21, P713, DOI 10.1089/hum.2009.147; Martinez Fernando O, 2014, F1000Prime Rep, V6, P13, DOI 10.12703/P6-13; Mastro-Martinez I, 2015, BRAIN INJURY, V29, P1497, DOI 10.3109/02699052.2015.1053525; Metz Gerlinde A, 2009, J Vis Exp, DOI 10.3791/1204; Min CK, 2007, BONE MARROW TRANSPL, V39, P637, DOI 10.1038/sj.bmt.1705644; Morganti JM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148001; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; Nakajima M, 2017, MOL THER-METH CLIN D, V6, P102, DOI 10.1016/j.omtm.2017.06.005; Njoroge JM, 2001, CYTOMETRY, V44, P38, DOI 10.1002/1097-0320(20010501)44:1<38::AID-CYTO1080>3.0.CO;2-T; Peruzzaro ST, 2013, RESTOR NEUROL NEUROS, V31, P431, DOI 10.3233/RNN-120299; Philippidis P, 2004, CIRC RES, V94, P119, DOI 10.1161/01.RES.0000109414.78907.F9; Quan FS, 2016, EXP THER MED, V12, P1671, DOI 10.3892/etm.2016.3527; Roszer T, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/816460; Sharma S, 2011, BRAIN RES, V1373, P189, DOI 10.1016/j.brainres.2010.11.096; Shechter R, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000113; Smith JS, 2000, NEURAL PLAST, V7, P73, DOI 10.1155/NP.2000.73; Soltys Z, 2001, J NEUROSCI RES, V63, P90, DOI 10.1002/1097-4547(20010101)63:1<90::AID-JNR11>3.0.CO;2-9; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Walker PA, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-228; Wang GH, 2013, J CEREBR BLOOD F MET, V33, P1864, DOI 10.1038/jcbfm.2013.146; Zanier ER, 2014, NEUROTHERAPEUTICS, V11, P679, DOI 10.1007/s13311-014-0277-y; Zhang B, 2015, EXP NEUROL, V273, P83, DOI 10.1016/j.expneurol.2015.08.001; Zhang R, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-106; Zhang ZR, 2012, BRAIN RES, V1461, P102, DOI 10.1016/j.brainres.2012.04.038	42	21	21	1	7	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1742-2094			J NEUROINFLAMM	J. Neuroinflamm.	JAN 5	2019	16								2	10.1186/s12974-018-1383-2			15	Immunology; Neurosciences	Immunology; Neurosciences & Neurology	HG3WF	WOS:000454905000001	30611291	DOAJ Gold, Green Published			2021-06-18	
J	Dolan, E; Gualano, B; Rawson, ES				Dolan, Eimear; Gualano, Bruno; Rawson, Eric S.			Beyond muscle: the effects of creatine supplementation on brain creatine, cognitive processing, and traumatic brain injury	EUROPEAN JOURNAL OF SPORT SCIENCE			English	Article						Phosphorylcreatine; cerebral energy metabolism; dietary supplement; cognition; concussion	MAGNETIC-RESONANCE-SPECTROSCOPY; OVO-VEGETARIAN DIET; MONOHYDRATE SUPPLEMENTATION; ORAL SUPPLEMENTATION; SLEEP-DEPRIVATION; OLDER-ADULTS; DOUBLE-BLIND; PERFORMANCE; EXERCISE; ADOLESCENTS	The ergogenic and therapeutic effects of increasing muscle creatine by supplementation are well-recognized. It appears that similar benefits to brain function and cognitive processing may also be achieved with creatine supplementation, however research in this area is more limited, and important knowledge gaps remain. The purpose of this review is to provide a comprehensive overview of the current state of knowledge about the influence of creatine supplementation on brain function in healthy individuals. It appears that brain creatine is responsive to supplementation, however higher, or more prolonged dosing strategies than those typically used to increase muscle creatine, may be required to elicit an increase in brain creatine. The optimal dosing strategy to induce this response, is currently unknown, and there is an urgent need for studies investigating this. When considering the influence of supplementation strategies on cognitive processes, it appears that creatine is most likely to exert an influence in situations whereby cognitive processes are stressed, e.g. during sleep deprivation, experimental hypoxia, or during the performance of more complex, and thus more cognitively demanding tasks. Evidence exists indicating that increased brain creatine may be effective at reducing the severity of, or enhancing recovery from mild traumatic brain injury, however, only limited data in humans are available to verify this hypothesis, thus representing an exciting area for further research.	[Dolan, Eimear; Gualano, Bruno] Univ Sao Paulo, Fac Med FMUSP, Hosp Clin HCFMUSP, Appl Physiol & Nutr Res Grp, Sao Paulo, SP, Brazil; [Rawson, Eric S.] Messiah Coll, Dept Hlth Nutr & Exercise Sci, One Coll Ave,Suite 3033, Mechanicsburg, PA 17055 USA	Rawson, ES (corresponding author), Messiah Coll, Dept Hlth Nutr & Exercise Sci, One Coll Ave,Suite 3033, Mechanicsburg, PA 17055 USA.	erawson@messiah.edu	Gualano, Bruno/C-7190-2012; Dolan, Eimear/AAX-8134-2020; Gualano, Bruno/ABA-9571-2020	Gualano, Bruno/0000-0001-7100-8681; Gualano, Bruno/0000-0001-7100-8681; Dolan, Eimear/0000-0002-1018-7601	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2015/11328-2, 2013/14746-4]	Eimear Dolan (2015/11328-2) and Bruno Gualano (2013/14746-4) are financially supported by the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP).	Merege CAA, 2017, APPL PHYSIOL NUTR ME, V42, P128, DOI 10.1139/apnm-2016-0406; Ainsley Dean Philip John, 2017, Concussion, V2, pCNC34, DOI 10.2217/cnc-2016-0016; Allen PJ, 2012, NEUROSCI BIOBEHAV R, V36, P1442, DOI 10.1016/j.neubiorev.2012.03.005; Andres RH, 2008, BRAIN RES BULL, V76, P329, DOI 10.1016/j.brainresbull.2008.02.035; Barrett EC, 2014, ADV NUTR, V5, P268, DOI 10.3945/an.113.005280; Beard E, 2010, J NEUROCHEM, V115, P297, DOI 10.1111/j.1471-4159.2010.06935.x; Bender A, 2016, AMINO ACIDS, V48, P1929, DOI 10.1007/s00726-015-2165-0; Benton D, 2011, BRIT J NUTR, V105, P1100, DOI 10.1017/S0007114510004733; Braissant Olivier, 2007, V46, P67; Branch JD, 2003, INT J SPORT NUTR EXE, V13, P198, DOI 10.1123/ijsnem.13.2.198; Candow DG, 2014, ENDOCRINE, V45, P354, DOI 10.1007/s12020-013-0070-4; Chilibeck PD, 2017, OPEN ACCESS J SPORTS, V8, P213, DOI 10.2147/OAJSM.S123529; Cook CJ, 2011, J INT SOC SPORT NUTR, V8, DOI 10.1186/1550-2783-8-2; Cox C, 2002, INT J SPORT NUTR EXE, V12, P33, DOI 10.1123/ijsnem.12.1.33; Dechent P, 1999, AM J PHYSIOL-REG I, V277, pR698; Devries MC, 2014, MED SCI SPORT EXER, V46, P1194, DOI 10.1249/MSS.0000000000000220; Pereira RTD, 2015, J PHYSIOL-LONDON, V593, P3959, DOI 10.1113/JP270861; Greenhaff PL, 2001, J PHYSIOL-LONDON, V537, P657; GREENHAFF PL, 1993, CLIN SCI, V84, P565, DOI 10.1042/cs0840565; Gualano B, 2016, AMINO ACIDS, V48, P1793, DOI 10.1007/s00726-016-2239-7; Gualano B, 2012, AMINO ACIDS, V43, P519, DOI 10.1007/s00726-011-1132-7; Gualano B, 2011, EUR J APPL PHYSIOL, V111, P749, DOI 10.1007/s00421-010-1676-3; Gualano B, 2010, AMINO ACIDS, V38, P31, DOI 10.1007/s00726-009-0263-6; Hammett ST, 2010, NEUROSCI LETT, V479, P201, DOI 10.1016/j.neulet.2010.05.054; HARRIS RC, 1992, CLIN SCI, V83, P367, DOI 10.1042/cs0830367; Hayashi AP, 2014, LUPUS, V23, P1500, DOI 10.1177/0961203314546017; Heaton LE, 2017, SPORTS MED, V47, P2201, DOI 10.1007/s40279-017-0759-2; Hellem TL, 2015, J DUAL DIAGN, V11, P189, DOI 10.1080/15504263.2015.1100471; Hultman E, 1996, J APPL PHYSIOL, V81, P232; Ipsiroglu OS, 2001, LIFE SCI, V69, P1805, DOI 10.1016/S0024-3205(01)01268-1; Kaldis P, 1996, DEV NEUROSCI-BASEL, V18, P542, DOI 10.1159/000111452; Kondo DG, 2016, AMINO ACIDS, V48, P1941, DOI 10.1007/s00726-016-2194-3; Kondo DG, 2011, J AFFECT DISORDERS, V135, P354, DOI 10.1016/j.jad.2011.07.010; Kreider RB, 2003, AM J PHYSIOL-REG I, V285, pR725, DOI 10.1152/ajpregu.00375.2003; Kreider RB, 2017, J INT SOC SPORT NUTR, V14, DOI 10.1186/s12970-017-0173-z; Laakso MP, 2003, J NEURAL TRANSM, V110, P267, DOI 10.1007/s00702-002-0783-7; Ling J, 2009, BEHAV PHARMACOL, V20, P673, DOI 10.1097/FBP.0b013e3283323c2a; Lugaresi R, 2013, J INT SOC SPORT NUTR, V10, DOI 10.1186/1550-2783-10-26; Lukaszuk JM, 2005, J STRENGTH COND RES, V19, P735; Lukaszuk JM, 2002, INT J SPORT NUTR EXE, V12, P336, DOI 10.1123/ijsnem.12.3.336; Lyoo IK, 2003, PSYCHIAT RES-NEUROIM, V123, P87, DOI 10.1016/S0925-4927(03)00046-5; McMorris T, 2007, PHYSIOL BEHAV, V90, P21, DOI 10.1016/j.physbeh.2006.08.024; McMorris T, 2006, PSYCHOPHARMACOLOGY, V185, P93, DOI 10.1007/s00213-005-0269-z; McMorris T, 2007, AGING NEUROPSYCHOL C, V14, P517, DOI 10.1080/13825580600788100; Mohebbi H., 2012, Middle East Journal of Scientific Research, V12, P397; Nicastro H, 2012, AMINO ACIDS, V42, P1695, DOI 10.1007/s00726-011-0871-9; Ostojic SM, 2016, APPL PHYSIOL NUTR ME, V41, P1005, DOI 10.1139/apnm-2016-0178; Pan JW, 2007, AM J PHYSIOL-REG I, V292, pR1745, DOI 10.1152/ajpregu.00717.2006; Persky Adam M., 2007, V46, P275; Rae C, 2003, P ROY SOC B-BIOL SCI, V270, P2147, DOI 10.1098/rspb.2003.2492; Rae CD, 2015, NEUROCHEM INT, V89, P249, DOI 10.1016/j.neuint.2015.08.010; Rawson ES, 2008, PHYSIOL BEHAV, V95, P130, DOI 10.1016/j.physbeh.2008.05.009; Rawson ES, 2018, INT J SPORT NUTR EXE, V28, P188, DOI 10.1123/ijsnem.2017-0340; Rawson ES, 2017, SPORTS MED, V47, pS33, DOI 10.1007/s40279-017-0689-z; Rawson ES, 2011, AMINO ACIDS, V40, P1349, DOI 10.1007/s00726-011-0855-9; Rawson ES, 2003, J STRENGTH COND RES, V17, P822; Alves CRR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076301; Sahlin K, 2011, AMINO ACIDS, V40, P1363, DOI 10.1007/s00726-011-0856-8; Sakellaris G, 2006, J TRAUMA, V61, P322, DOI 10.1097/01.ta.0000230269.46108.d5; Sakellaris G, 2008, ACTA PAEDIATR, V97, P31, DOI 10.1111/j.1651-2227.2007.00529.x; Salomons GS, 2003, J INHERIT METAB DIS, V26, P309, DOI 10.1023/A:1024405821638; Solis MY, 2017, J APPL PHYSIOL, V123, P407, DOI 10.1152/japplphysiol.00248.2017; Solis MY, 2014, BRIT J NUTR, V111, P1272, DOI 10.1017/S0007114513003802; Souza MA, 2012, AMINO ACIDS, V43, P2491, DOI 10.1007/s00726-012-1329-4; STOCKLER S, 1994, PEDIATR RES, V36, P409; Sullivan PG, 2000, ANN NEUROL, V48, P723, DOI 10.1002/1531-8249(200011)48:5&lt;723::AID-ANA5&gt;3.0.CO;2-W; Swinton PA, 2018, FRONT NUTR, V5, DOI 10.3389/fnut.2018.00041; Tarnopolsky MA, 2003, AM J PHYSIOL-REG I, V285, pR762, DOI 10.1152/ajpregu.00270.2003; TOMPOROWSKI PD, 1986, PSYCHOL BULL, V99, P338, DOI 10.1037/0033-2909.99.3.338; Turner CE, 2015, MAGN RESON IMAGING, V33, P1163, DOI 10.1016/j.mri.2015.06.018; Turner CE, 2015, J NEUROSCI, V35, P1773, DOI 10.1523/JNEUROSCI.3113-14.2015; Vagnozzi R, 2013, J HEAD TRAUMA REHAB, V28, P284, DOI 10.1097/HTR.0b013e3182795045; Walker J B, 1979, Adv Enzymol Relat Areas Mol Biol, V50, P177; Watanabe A, 2002, NEUROSCI RES, V42, P279, DOI 10.1016/S0168-0102(02)00007-X; Wilkinson ID, 2006, CLIN J SPORT MED, V16, P63, DOI 10.1097/01.jsm.0000176372.67398.c8	75	21	21	0	23	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	1746-1391	1536-7290		EUR J SPORT SCI	Eur. J. Sport Sci.	JAN 2	2019	19	1			SI		1	14		10.1080/17461391.2018.1500644			14	Sport Sciences	Sport Sciences	HI2SV	WOS:000456296600001	30086660				2021-06-18	
J	Zhang, XS; Lu, Y; Wu, Q; Dai, HB; Li, W; Lv, SY; Zhou, XM; Zhang, X; Hang, CH; Wang, J				Zhang, Xiangsheng; Lu, Yue; Wu, Qi; Dai, Haibin; Li, Wei; Lv, Shengyin; Zhou, Xiaoming; Zhang, Xin; Hang, Chunhua; Wang, Jian			Astaxanthin mitigates subarachnoid hemorrhage injury primarily by increasing sirtuin 1 and inhibiting the Toll-like receptor 4 signaling pathway	FASEB JOURNAL			English	Article						early brain injury; inflammation; microglia; neuroprotection	TRAUMATIC BRAIN-INJURY; INTRACEREBRAL HEMORRHAGE; MOUSE MODEL; POSSIBLE INVOLVEMENT; ISCHEMIC-STROKE; OXIDATIVE STRESS; CEREBRAL EDEMA; ACTIVATION; NEUROPROTECTION; INFLAMMATION	Inflammation plays a key role in the progression of subarachnoid hemorrhage (SAH). Here, we examined the effects of astaxanthin (ATX) on the inflammatory response and secondary damage after SAH and the underlying mechanisms of action. In vivo, a prechiasmatic cistern injection model was established in rats and mice. In addition, neuron-microglia cocultures were exposed to oxyhemoglobin to mimic SAH in vitro. Western blotting revealed that protein expression of TLR4 was markedly increased in microglia at 24 h after SAH, with consequent increases in the downstream molecules myeloid differentiation factor 88 and NF-kB. Treatment with ATX significantly inhibited the TLR4 activation, increased sirtuin 1 expression, and inhibited the subsequent inflammatory response both in vivo and in vitro. ATX also significantly decreased high-mobility group box 1 nuclear translocation and secretion in neurons, an effect that was reversed by the sirtuin 1-specific inhibitor sirtinol. ATX administered 4 h after SAH ameliorated cerebral inflammation, brain edema, and neuronal death and improved neurologic function. ATX reduced neuronal death but did not improve neurologic function in TLR4 knockout mice. These results suggest that ATX reduces the proinflammatory response and secondary brain injury after SAH, primarily by increasing sirtuin 1 levels and inhibiting the TLR4 signaling pathway.Zhang, X., Lu, Y., Wu, Q., Dai, H., Li, W., Lv, S., Zhou, X., Zhang, X., Hang, C., Wang, J. Astaxanthin mitigates subarachnoid hemorrhage injury primarily by increasing sirtuin 1 and inhibiting the Toll-like receptor 4 signaling pathway.	[Zhang, Xiangsheng; Lu, Yue; Dai, Haibin; Li, Wei; Hang, Chunhua] Nanjing Univ, Sch Med, Nanjing Drum Tower Hosp, Dept Neurosurg, 321 Zhongshan Rd, Nanjing 210008, Jiangsu, Peoples R China; [Wu, Qi; Lv, Shengyin; Zhang, Xin] Nanjing Univ, Jinling Hosp, Sch Med, Dept Neurosurg, 305 East Zhongshan Rd, Nanjing 210002, Jiangsu, Peoples R China; [Zhang, Xiangsheng; Wang, Jian] Johns Hopkins Univ, Sch Med, Dept Anesthesiol & Crit Care Med, Baltimore, MD 21205 USA; [Zhou, Xiaoming] Second Mil Med Univ, Changzheng Hosp, Sch Med, Dept Neurosurg, Shanghai, Peoples R China	Hang, CH (corresponding author), Nanjing Univ, Sch Med, Nanjing Drum Tower Hosp, Dept Neurosurg, 321 Zhongshan Rd, Nanjing 210008, Jiangsu, Peoples R China.; Zhang, X (corresponding author), Nanjing Univ, Jinling Hosp, Sch Med, Dept Neurosurg, 305 East Zhongshan Rd, Nanjing 210002, Jiangsu, Peoples R China.	zhangxsp@163.com; hang_neurosurgery@163.com	Wang, Jian/I-4874-2019	Wang, Jian/0000-0003-2291-640X; LU, Yue/0000-0001-9111-5943	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81471183, 81501022, 81771292]; American Heart AssociationAmerican Heart Association [17GRNT33660766]; Stimulating and Advancing Anesthesiology and Critical Care Medicine (ACCM) Research (StAAR) grant from the Department of Anesthesiology and Critical Care Medicine, at Johns Hopkins University; China Scholarship CouncilChina Scholarship Council	The authors thank Dr. Bo Yu and YanLing Han (both from Jinling Hospital) for their generous assistance with pathologic examinations. The authors also thank Claire Levine, M.S., ELS, for assistance with manuscript preparation and the J.W. laboratory team members for insightful input. This work was supported by the National Natural Science Foundation of China (Grants 81471183 to Xin Zhang, 81501022 to Xiangsheng Zhang, and 81771292 to C.H.), the American Heart Association Grant-in-Aid (17GRNT33660766), and a Stimulating and Advancing Anesthesiology and Critical Care Medicine (ACCM) Research (StAAR) grant from the Department of Anesthesiology and Critical Care Medicine, at Johns Hopkins University. Xiangsheng Zhang is a recipient of the China Scholarship Council Joint Ph.D. training award. The authors declare no conflicts of interest.	Alhadidi Q, 2018, MOL NEUROBIOL, V55, P1676, DOI 10.1007/s12035-017-0432-7; Brea D, 2011, REV NEUROLOGIA, V52, P12, DOI 10.33588/rn.5201.2010494; Budohoski KP, 2014, J NEUROL NEUROSUR PS, V85, P1343, DOI 10.1136/jnnp-2014-307711; Chang CF, 2014, ANN CLIN TRANSL NEUR, V1, P258, DOI 10.1002/acn3.54; Cheng T, 2016, FREE RADICAL BIO MED, V92, P15, DOI 10.1016/j.freeradbiomed.2015.12.027; Cheng YY, 2015, J BIOCHEM, V158, P299, DOI 10.1093/jb/mvv041; Corrigan F, 2017, BRAIN BEHAV IMMUN, V64, P124, DOI 10.1016/j.bbi.2017.04.006; Dzaye ODA, 2016, J NEUROPATH EXP NEUR, V75, P429, DOI 10.1093/jnen/nlw016; Fadakar K, 2014, REV NEUROSCIENCE, V25, P699, DOI 10.1515/revneuro-2013-0069; Gong LL, 2016, EUR J NEUROSCI, V43, P1674, DOI 10.1111/ejn.13257; Han XN, 2019, J CEREBR BLOOD F MET, V39, P1531, DOI 10.1177/0271678X18762645; Han XN, 2016, J CEREBR BLOOD F MET, V36, P1059, DOI 10.1177/0271678X15606462; Hanafy KA, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-83; Hwang J. S., 2015, TUMOR BIOL, V1, P1, DOI DOI 10.1038/srep15971; Jiang C, 2016, NEUROBIOL AGING, V42, P13, DOI 10.1016/j.neurobiolaging.2016.02.029; Laird MD, 2014, GLIA, V62, P26, DOI 10.1002/glia.22581; Lan KC, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-12285-8; Lan X, 2017, NAT REV NEUROL, V13, P420, DOI 10.1038/nrneurol.2017.69; Lan X, 2017, BRAIN BEHAV IMMUN, V61, P326, DOI 10.1016/j.bbi.2016.12.012; Lei CY, 2015, STROKE, V46, P500, DOI 10.1161/STROKEAHA.114.006825; Leow-Dyke S, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-230; Li Q, 2017, J CEREBR BLOOD F MET, V37, P3110, DOI 10.1177/0271678X17709186; Li Q, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.90777; Li Q, 2017, NEUROBIOL DIS, V108, P173, DOI 10.1016/j.nbd.2017.08.011; Lin QQ, 2017, LIFE SCI, V170, P100, DOI 10.1016/j.lfs.2016.11.026; Lv SY, 2018, WORLD NEUROSURG, V111, pE355, DOI 10.1016/j.wneu.2017.12.076; Pan LN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099526; Raghavan A, 2012, NEURODEGENER DIS, V9, P1, DOI 10.1159/000329724; Sabri M, 2009, BRAIN RES, V1295, P179, DOI 10.1016/j.brainres.2009.08.021; Sakai S, 2009, J BIOL CHEM, V284, P28172, DOI 10.1074/jbc.M109.001099; Sehba FA, 2012, PROG NEUROBIOL, V97, P14, DOI 10.1016/j.pneurobio.2012.02.003; Shichita T, 2012, NAT MED, V18, P911, DOI 10.1038/nm.2749; Siler DA, 2015, STROKE, V46, P1916, DOI 10.1161/STROKEAHA.114.008560; Siler DA, 2014, TRANSL STROKE RES, V5, P227, DOI 10.1007/s12975-014-0329-y; Sugawara T, 2008, J NEUROSCI METH, V167, P327, DOI 10.1016/j.jneumeth.2007.08.004; Sukumari-Ramesh S, 2016, TRANSL STROKE RES, V7, P141, DOI 10.1007/s12975-015-0421-y; Sun Q, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-106; Sun XB, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-157; Tian XD, 2017, CURR DRUG DELIV, V14, P785, DOI 10.2174/1567201813666160808111933; Wang J, 2005, NEUROCRIT CARE, V3, P77, DOI 10.1385/NCC:3:1:077; Wang JW, 2013, BIOCHEM BIOPH RES CO, V430, P1016, DOI 10.1016/j.bbrc.2012.12.046; Wang J, 2007, J CEREBR BLOOD F MET, V27, P894, DOI 10.1038/sj.jcbfm.9600403; Wang J, 2006, NEUROBIOL DIS, V22, P473, DOI 10.1016/j.nbd.2005.12.009; Wang JP, 2017, NEUROSCIENCE, V364, P202, DOI 10.1016/j.neuroscience.2017.09.025; Wang JP, 2015, BRAIN BEHAV IMMUN, V45, P98, DOI 10.1016/j.bbi.2014.12.015; Wang JP, 2015, BRAIN BEHAV IMMUN, V43, P172, DOI 10.1016/j.bbi.2014.07.022; Wang W, 2015, MOL NEUROBIOL, V52, P1572, DOI 10.1007/s12035-014-8952-x; Wang XX, 2018, BEHAV BRAIN RES, V339, P297, DOI 10.1016/j.bbr.2017.10.032; Wang YC, 2014, ANN NEUROL, V75, P876, DOI 10.1002/ana.24159; Wang Z, 2013, J PINEAL RES, V55, P399, DOI 10.1111/jpi.12087; Wang Z, 2011, MEDIAT INFLAMM, V2011, DOI 10.1155/2011/848309; Wu HJ, 2015, MAR DRUGS, V13, P5750, DOI 10.3390/md13095750; Wu H, 2015, NEUROBIOL AGING, V36, P1439, DOI 10.1016/j.neurobiolaging.2014.12.029; Wu H, 2011, J CEREBR BLOOD F MET, V31, P1243, DOI 10.1038/jcbfm.2010.209; Wu H, 2010, BRAIN RES, V1342, P111, DOI 10.1016/j.brainres.2010.04.033; Wu Q, 2014, MAR DRUGS, V12, P6125, DOI 10.3390/md12126125; Wu QJ, 2017, INFLAMMATION, V40, P1245, DOI 10.1007/s10753-017-0567-8; Xiong XY, 2016, CIRCULATION, V134, P1025, DOI 10.1161/CIRCULATIONAHA.116.021881; Yang Y, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.140; Ye QY, 2013, MAR DRUGS, V11, P1019, DOI 10.3390/md11041019; Zhang J, 2017, BBA-GEN SUBJECTS, V1861, P1715, DOI 10.1016/j.bbagen.2017.03.007; Zhang L, 2014, TOXICOL LETT, V228, P248, DOI 10.1016/j.toxlet.2014.05.015; Zhang XS, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.292; Zhang XS, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17081331; Zhang XS, 2014, J SURG RES, V192, P206, DOI 10.1016/j.jss.2014.05.029; Zhang XS, 2014, MAR DRUGS, V12, P4291, DOI 10.3390/md12084291; Zhang XS, 2014, J NEUROSURG, V121, P42, DOI 10.3171/2014.2.JNS13730; Zhang XS, 2017, FRONT NEUROSCI-SWITZ, V11, DOI 10.3389/fnins.2017.00611; Zhang Z, 2017, MOL NEUROBIOL, V54, P1874, DOI 10.1007/s12035-016-9785-6; Zhang Z, 2017, J CEREBR BLOOD F MET, V37, P25, DOI 10.1177/0271678X16655814; Zhang ZY, 2018, EXP NEUROL, V301, P13, DOI 10.1016/j.expneurol.2017.12.005; Zhao D, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-1007-2; Zheng D, 2014, NEUROPHARMACOLOGY, V84, P13, DOI 10.1016/j.neuropharm.2014.04.013; Zhu W, 2018, BRAIN BEHAV IMMUN, V69, P568, DOI 10.1016/j.bbi.2018.02.004	74	21	25	0	17	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2019	33	1					722	737		10.1096/fj.201800642RR			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ7TZ	WOS:000457401500056	30048156				2021-06-18	
J	Acosta-Cabronero, J; Milovic, C; Mattern, H; Tejos, C; Speck, O; Callaghan, MF				Acosta-Cabronero, Julio; Milovic, Carlos; Mattern, Hendrik; Tejos, Cristian; Speck, Oliver; Callaghan, Martina F.			A robust multi-scale approach to quantitative susceptibility mapping	NEUROIMAGE			English	Article						Magnetic susceptibility; Quantitative MRI; Iron mapping; Venography; Variational regularisation; Laplacian pyramid	MULTIPLE-SCLEROSIS LESIONS; ENABLED DIPOLE INVERSION; OXYGEN EXTRACTION FRACTION; BRAIN IRON; MAGNETIC-SUSCEPTIBILITY; FIELD INHOMOGENEITY; SPATIAL VARIATION; MOTOR CORTEX; AMYLOID-BETA; QSM	Quantitative Susceptibility Mapping (QSM), best known as a surrogate for tissue iron content, is becoming a highly relevant MRI contrast for monitoring cellular and vascular status in aging, addiction, traumatic brain injury and, in general, a wide range of neurological disorders. In this study we present a new Bayesian QSM algorithm, named Multi-Scale Dipole Inversion (MSDI), which builds on the nonlinear Morphology-Enabled Dipole Inversion (nMEDI) framework, incorporating three additional features: (i) improved implementation of Laplace's equation to reduce the influence of background fields through variable harmonic filtering and subsequent deconvolution, (ii) improved error control through dynamic phase-reliability compensation across spatial scales, and (iii) scalewise use of the morphological prior. More generally, this new pre-conditioned QSM formalism aims to reduce the impact of dipole-incompatible fields and measurement errors such as flow effects, poor signal-to-noise ratio or other data inconsistencies that can lead to streaking and shadowing artefacts. In terms of performance, MSDI is the first algorithm to rank in the top-10 for all metrics evaluated in the 2016 QSM Reconstruction Challenge. It also demonstrated lower variance than nMEDI and more stable behaviour in scan-rescan reproducibility experiments for different MRI acquisitions at 3 and 7 Tesla. In the present work, we also explored new forms of susceptibility MRI contrast making explicit use of the differential information across spatial scales. Specifically, we show MSDI-derived examples of: (i) enhanced anatomical detail with susceptibility inversions from short-range dipole fields (hereby referred to as High-Pass Susceptibility Mapping or HPSM), (ii) high specificity to venousblood susceptibilities for highly regularised HPSM (making a case for MSDI-based Venography or VenoMSDI), (iii) improved tissue specificity (and possibly statistical conditioning) for Macroscopic-Vessel Suppressed Susceptibility Mapping (MVSSM), and (iv) high spatial specificity and definition for HPSM-based SusceptibilityWeighted Imaging (HPSM-SWI) and related intensity projections.	[Acosta-Cabronero, Julio; Callaghan, Martina F.] UCL, UCL Inst Neurol, Wellcome Ctr Human Neuroimaging, 12 Queen Sq, London WC1N 3BG, England; [Acosta-Cabronero, Julio; Speck, Oliver] German Ctr Neurodegenerat Dis DZNE, Magdeburg, Germany; [Milovic, Carlos; Tejos, Cristian] Pontificia Univ Catolica Chile, Dept Elect Engn, Santiago, Chile; [Milovic, Carlos; Tejos, Cristian] Pontificia Univ Catolica Chile, Biomed Imaging Ctr, Santiago, Chile; [Mattern, Hendrik; Speck, Oliver] Otto von Guericke Univ, Inst Expt Phys, Dept Biomed Magnet Resonance, Magdeburg, Germany; [Speck, Oliver] Leibniz Inst Neurobiol, Magdeburg, Germany	Acosta-Cabronero, J (corresponding author), UCL, UCL Inst Neurol, Wellcome Ctr Human Neuroimaging, 12 Queen Sq, London WC1N 3BG, England.	jac@cantab.net	Tejos, Cristian/F-8270-2013; Speck, Oliver/F-1406-2013; Callaghan, Martina F/H-5297-2019; Acosta-Cabronero, Julio/C-8225-2014	Speck, Oliver/0000-0002-6019-5597; Callaghan, Martina F/0000-0003-0374-1659; Acosta-Cabronero, Julio/0000-0003-1174-5983; Milovic, Carlos/0000-0002-1196-6703	Wellcome [203147/Z/16/Z]; EU Joint Programme - Neurodegenerative Disease Research, JPND; FONDECYTComision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT [1161448]; CONICYTComision Nacional de Investigacion Cientifica y Tecnologica (CONICYT) [ACT1416]; Becas de Doctorado Nacional CONICYT [Folio 21150369]; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [1R01-DA021146]; MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC); Spinal Research Charity through the ERA-NET Neuron [MR/R000050/1]	The Wellcome Centre for Human Neuroimaging is supported by core funding from the Wellcome (203147/Z/16/Z). We thank the EUFIND consortium (funded by the EU Joint Programme - Neurodegenerative Disease Research, JPND) for contributing to this study with a 7 Tesla MRI dataset. We would also like thank FONDECYT (1161448), CONICYT (Programa PIA Anillo ACT1416), and Becas de Doctorado Nacional CONICYT (Folio 21150369) for their funding support to CT and CM. HM was supported by NIH (1R01-DA021146). MFC is supported by the MRC and Spinal Research Charity through the ERA-NET Neuron joint call (MR/R000050/1).	Abdul-Rahman HS, 2007, APPL OPTICS, V46, P6623, DOI 10.1364/AO.46.006623; Acosta-Cabronero J, 2018, RADIOLOGY, V289, P195, DOI 10.1148/radiol.2018180112; Acosta-Cabronero J, 2017, BRAIN, V140, P118, DOI 10.1093/brain/aww278; Acosta-Cabronero J, 2016, J NEUROSCI, V36, P364, DOI 10.1523/JNEUROSCI.1907-15.2016; Acosta-Cabronero J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081093; Ayton S, 2017, BRAIN, V140, P2112, DOI 10.1093/brain/awx137; Balla DZ, 2014, NEUROIMAGE, V100, P112, DOI 10.1016/j.neuroimage.2014.06.011; Betts MJ, 2016, NEUROIMAGE, V138, P43, DOI 10.1016/j.neuroimage.2016.05.024; Bian W., 2016, AJNR AM J NEURORADIO; Bianciardi M, 2014, HUM BRAIN MAPP, V35, P2191, DOI 10.1002/hbm.22320; Buch S, 2017, J CEREBR BLOOD F MET, V37, P825, DOI 10.1177/0271678X16641129; BURT PJ, 1983, IEEE T COMMUN, V31, P532, DOI 10.1109/TCOM.1983.1095851; Callaghan MF, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00097; Chatnuntawech I, 2017, NMR BIOMED, V30, DOI 10.1002/nbm.3570; Chen WW, 2014, RADIOLOGY, V271, P183, DOI 10.1148/radiol.13130353; Chen ZK, 2015, J NEUROSCI METH, V241, P85, DOI 10.1016/j.jneumeth.2014.12.014; Costagli M, 2016, NEUROIMAGE-CLIN, V12, P965, DOI 10.1016/j.nicl.2016.04.011; Cronin MJ, 2017, NEUROIMAGE, V149, P98, DOI 10.1016/j.neuroimage.2017.01.053; Cronin MJ, 2016, MAGN RESON MATER PHY, V29, P543, DOI 10.1007/s10334-016-0560-5; Darki F, 2016, NEUROIMAGE, V136, P208, DOI 10.1016/j.neuroimage.2016.04.065; de Rochefort L, 2010, MAGN RESON MED, V63, P194, DOI 10.1002/mrm.22187; Deh K, 2015, J MAGN RESON IMAGING, V42, P1592, DOI 10.1002/jmri.24943; Deistung A, 2008, MAGN RESON MED, V60, P1155, DOI 10.1002/mrm.21754; Deistung A, 2013, NEUROIMAGE, V65, P299, DOI 10.1016/j.neuroimage.2012.09.055; Dominguez DJF, 2016, J NEUROL NEUROSUR PS, V87, P545, DOI 10.1136/jnnp-2014-310183; Ersche KD, 2017, TRANSL PSYCHIAT, V7, DOI 10.1038/tp.2016.271; Fan AP, 2016, NEUROIMAGE, V125, P920, DOI 10.1016/j.neuroimage.2015.11.007; Fan AP, 2015, J CEREBR BLOOD F MET, V35, P131, DOI 10.1038/jcbfm.2014.187; Fan AP, 2014, MAGN RESON MED, V72, P149, DOI 10.1002/mrm.24918; Feng X., 2017, Z MED PHYS; Gho SM, 2014, MAGN RESON MED, V72, P337, DOI 10.1002/mrm.24920; Griswold MA, 2002, MAGN RESON MED, V47, P1202, DOI 10.1002/mrm.10171; Guan XJ, 2017, NMR BIOMED, V30, DOI 10.1002/nbm.3489; GUDBJARTSSON H, 1995, MAGNET RESON MED, V34, P910, DOI 10.1002/mrm.1910340618; Haacke EM, 2009, AM J NEURORADIOL, V30, P19, DOI 10.3174/ajnr.A1400; Haacke EM, 2015, MAGN RESON IMAGING, V33, P1, DOI 10.1016/j.mri.2014.09.004; Haacke EM, 2004, MAGN RESON MED, V52, P612, DOI 10.1002/mrm.20198; HANSEN PC, 1993, SIAM J SCI COMPUT, V14, P1487, DOI 10.1137/0914086; He NY, 2015, HUM BRAIN MAPP, V36, P4407, DOI 10.1002/hbm.22928; Hinoda T, 2015, INVEST RADIOL, V50, P522, DOI 10.1097/RLI.0000000000000159; Kee Y, 2017, IEEE T BIO-MED ENG, V64, P2531, DOI 10.1109/TBME.2017.2749298; Langkammer C, 2018, MAGN RESON MED, V79, P1661, DOI 10.1002/mrm.26830; Langkammer C, 2015, NEUROIMAGE, V111, P622, DOI 10.1016/j.neuroimage.2015.02.041; Langkammer C, 2012, NEUROIMAGE, V62, P1593, DOI 10.1016/j.neuroimage.2012.05.049; Lauzon ML, 2017, NMR BIOMED, V30, DOI 10.1002/nbm.3492; Li W, 2014, HUM BRAIN MAPP, V35, P2698, DOI 10.1002/hbm.22360; Li W, 2011, NEUROIMAGE, V55, P1645, DOI 10.1016/j.neuroimage.2010.11.088; Li X, 2016, J MAGN RESON IMAGING, V43, P463, DOI 10.1002/jmri.24976; Lin PY, 2015, AM J NEURORADIOL, V36, P467, DOI 10.3174/ajnr.A4137; Liu J, 2012, NEUROIMAGE, V59, P2560, DOI 10.1016/j.neuroimage.2011.08.082; Liu J, 2016, J NEUROTRAUM, V33, P10, DOI 10.1089/neu.2014.3856; Liu T, 2013, MAGN RESON MED, V69, P467, DOI 10.1002/mrm.24272; Liu T, 2012, IEEE T MED IMAGING, V31, P816, DOI 10.1109/TMI.2011.2182523; Liu T, 2011, MAGN RESON MED, V66, P777, DOI 10.1002/mrm.22816; Liu T, 2009, MAGN RESON MED, V61, P196, DOI 10.1002/mrm.21828; Liu Z, 2018, MAGN RESON MED, V79, P2795, DOI 10.1002/mrm.26946; Liu Z, 2017, MAGN RESON MED, V78, P303, DOI 10.1002/mrm.26331; Lobel U, 2014, ANN CLIN TRANSL NEUR, V1, P1041, DOI 10.1002/acn3.116; Lusebrink F, 2017, SCI DATA, V4, DOI 10.1038/sdata.2017.62; Lusebrink F, 2017, SCI DATA, V4, DOI 10.1038/sdata.2017.32; Maclaren J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048088; Marques JP, 2005, CONCEPT MAGN RESON B, V25B, P65, DOI 10.1002/cmr.b.20034; Mattern H, 2018, MAGN RESON MED, V80, P248, DOI 10.1002/mrm.27033; Milovic C, 2018, MAGN RESON MED, V80, P814, DOI 10.1002/mrm.27073; Mittal S, 2009, AM J NEURORADIOL, V30, P232, DOI 10.3174/ajnr.A1461; Moon Y, 2016, J ALZHEIMERS DIS, V51, P737, DOI 10.3233/JAD-151037; MORRIS CM, 1992, ACTA ANAT, V144, P235; Ozbay PS, 2015, NMR BIOMED, V28, P1688, DOI 10.1002/nbm.3433; Ozbay PS, 2016, NEUROIMAGE, V137, P52, DOI 10.1016/j.neuroimage.2016.05.013; Persson N, 2015, NEUROIMAGE, V122, P385, DOI 10.1016/j.neuroimage.2015.07.050; Pruessmann KP, 1999, MAGNET RESON MED, V42, P952, DOI 10.1002/(SICI)1522-2594(199911)42:5<952::AID-MRM16>3.0.CO;2-S; Ravishankar S, 2011, IEEE T MED IMAGING, V30, P1028, DOI 10.1109/TMI.2010.2090538; Salomir R, 2003, CONCEPT MAGN RESON B, V19B, P26, DOI 10.1002/cmr.b.10083; Santin MD, 2017, NMR BIOMED, V30, DOI 10.1002/nbm.3491; Schofield MA, 2003, OPT LETT, V28, P1194, DOI 10.1364/OL.28.001194; Schweitzer AD, 2015, AM J ROENTGENOL, V204, P1086, DOI 10.2214/AJR.14.13459; Schweser F., 2017, NMR BIOMED, V30; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Sood S, 2017, MAGN RESON MED, V77, P1946, DOI 10.1002/mrm.26281; Straub S, 2017, MAGN RESON MED, V78, P204, DOI 10.1002/mrm.26369; Stucht D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133921; Sun H, 2017, NMR BIOMED, V30, DOI 10.1002/nbm.3619; Sun HF, 2015, NEUROIMAGE, V105, P486, DOI 10.1016/j.neuroimage.2014.11.010; Tustison NJ, 2010, IEEE T MED IMAGING, V29, P1310, DOI 10.1109/TMI.2010.2046908; van Bergen JMG, 2016, SCI REP-UK, V6, DOI 10.1038/srep35514; van Bergen JMG, 2016, AM J NEURORADIOL, V37, P789, DOI 10.3174/ajnr.A4617; Wang S., 2016, BIOMED RES INT, V2016; Wang S, 2013, IEEE T BIO-MED ENG, V60, P3441, DOI 10.1109/TBME.2013.2266795; Wang Y, 2017, J MAGN RESON IMAGING, V46, P951, DOI 10.1002/jmri.25693; Wang Y, 2015, MAGN RESON MED, V73, P82, DOI 10.1002/mrm.25358; Wang Z, 2004, IEEE T IMAGE PROCESS, V13, P600, DOI 10.1109/TIP.2003.819861; Wharton S, 2015, MAGN RESON MED, V73, P1258, DOI 10.1002/mrm.25189; Wisnieff C, 2015, MAGN RESON MED, V74, P564, DOI 10.1002/mrm.25420; Zhang JW, 2018, MAGN RESON MED, V79, P172, DOI 10.1002/mrm.26657; Zhang Y, 2016, AM J NEURORADIOL, V37, P1629, DOI 10.3174/ajnr.A4825; Zheng WL, 2013, NEUROIMAGE, V78, P68, DOI 10.1016/j.neuroimage.2013.04.022; Zhou D, 2014, NMR BIOMED, V27, P312, DOI 10.1002/nbm.3064	97	21	21	1	14	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1053-8119	1095-9572		NEUROIMAGE	Neuroimage	DEC	2018	183						7	24		10.1016/j.neuroimage.2018.07.065			18	Neurosciences; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	GX4ZU	WOS:000447750200002	30075277	Green Published, Other Gold			2021-06-18	
J	Hsu, ET; Gangolli, M; Su, S; Holleran, L; Stein, TD; Alvarez, VE; McKee, AC; Schmidt, RE; Brody, DL				Hsu, Eric T.; Gangolli, Mihika; Su, Shiran; Holleran, Laurena; Stein, Thor D.; Alvarez, Victor E.; McKee, Ann C.; Schmidt, Robert E.; Brody, David L.			Astrocytic degeneration in chronic traumatic encephalopathy	ACTA NEUROPATHOLOGICA			English	Article						Chronic traumatic encephalopathy; Neurodegeneration; Astrocyte; Glial fibrillary acidic protein	BLOOD-BRAIN-BARRIER; FIBRILLARY ACIDIC PROTEIN; ALZHEIMERS-DISEASE; REACTIVE ASTROCYTES; NEURITE OUTGROWTH; TAU PATHOLOGY; NEUROPATHOLOGY; INJURY; TISSUE; AUTOANTIBODIES	Chronic traumatic encephalopathy (CTE) is a neurodegenerative disease associated with repeated head traumas. Using immunohistochemistry for glial fibrillary acidic protein as a marker, plus automated quantitative analysis, we examined the characteristics and extent of astrogliosis present in stage III and IV CTE, along with Alzheimer's disease (AD), and frontotemporal dementia (FTD) cases. Astrogliosis in CTE patients was more diffuse compared to that of AD and FTD patients, which was concentrated in the sulcal depths. Of 14 patients with CTE, 10 exhibited signs of a degenerating astrocyte pathology, characterized by beaded, broken astrocytic processes. This astrocytic degeneration was typically found to be diffuse throughout the white matter, although two cases demonstrated astrocytic degeneration in the gray matter. The degeneration was also observed in 2 of 3 AD and 2 of 3 FTD brains, with overall similar characteristics across diseases. There was minimal to no astrocytic degeneration in six age-matched controls with no neurodegenerative disease. We found that the extent of the white matter astrocytic degeneration was strongly correlated with the level of overall astrogliosis in both the white and gray matter. However, astrocytic degeneration was not correlated with the overall extent of tau pathology. Specifically, there was no correlation between levels of p-tau in the sulcal depths and astrocytic degeneration in the white matter adjacent to the sulcal depths. Thus, astrocytic degeneration and overall astrogliosis appear to represent distinct pathological features of CTE. Further investigation into these astroglial pathologies could provide new insights into underlying disease mechanisms and represent a potential target for in vivo assessment of CTE as well as other neurodegenerative disorders.	[Hsu, Eric T.; Holleran, Laurena; Brody, David L.] Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63130 USA; [Gangolli, Mihika; Su, Shiran; Brody, David L.] Washington Univ, Dept Biomed Engn, St Louis, MO 63130 USA; [Holleran, Laurena] Natl Univ Ireland, Ctr Neuroimaging & Cognit Genom, Galway, Ireland; [Stein, Thor D.; Alvarez, Victor E.; McKee, Ann C.] VA Boston Healthcare Syst, Boston, MA USA; [Stein, Thor D.; Alvarez, Victor E.; McKee, Ann C.] Boston Univ, Sch Med, Boston Univ Alzheimers Dis, Boston, MA 02118 USA; [Stein, Thor D.; Alvarez, Victor E.; McKee, Ann C.] Boston Univ, Sch Med, CTE Ctr, Boston, MA 02118 USA; [Stein, Thor D.; Alvarez, Victor E.; McKee, Ann C.] Boston Univ, Sch Med, Dept Pathol, Boston, MA 02118 USA; [McKee, Ann C.] Boston Univ, Sch Med, Dept Neurol, Boston, MA 02118 USA; [Schmidt, Robert E.; Brody, David L.] Washington Univ, Dept Pathol & Immunol, St Louis, MO 63130 USA; [Brody, David L.] Washington Univ, Hope Ctr Neurol Disorders, St Louis, MO 63130 USA; [Brody, David L.] Uniformed Serv Univ Hlth Sci, Bethesda, MD 20814 USA	Brody, DL (corresponding author), Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63130 USA.; Brody, DL (corresponding author), Washington Univ, Dept Biomed Engn, St Louis, MO 63130 USA.; Brody, DL (corresponding author), Washington Univ, Dept Pathol & Immunol, St Louis, MO 63130 USA.; Brody, DL (corresponding author), Washington Univ, Hope Ctr Neurol Disorders, St Louis, MO 63130 USA.; Brody, DL (corresponding author), Uniformed Serv Univ Hlth Sci, Bethesda, MD 20814 USA.	e.hsu@wustl.edu; mihika.gangolli@wustl.edu; shiran@wustl.edu; Laurena.holleran@nuigalway.ie; tdstein@bu.edu; valvarez@bu.edu; amckee@bu.edu; reschmidt@wustl.edu; david.brody@usuhs.edu		Hsu, Eric/0000-0002-3232-6131	VA Boston Healthcare SystemUS Department of Veterans Affairs; Washington University Center for Cellular Imaging [P30 NS057105]; National Institute of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [UO1 NS086659-02]; US Department of Veterans AffairsUS Department of Veterans Affairs; National Operating Committee on Standards for Athletic Equipment; Concussion Legacy Foundation; Andlinger Family Foundation; WWE; NFL; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [U01NS086659] Funding Source: NIH RePORTER	We would like to thank the donors and their families for the generous brain donation which made this research possible. We would also like to thank VA Boston Healthcare System and Boston University Alzheimer's Disease and CTE Center for sample procurement. The studies presented in this work were carried out, in part, using the Hope Center Alafi Neuroimaging Lab, Washington University in St. Louis and the Washington University Center for Cellular Imaging (P30 NS057105). We would also like to thank Marc Goldfinger, Steve Gentleman, Dan Perl, Thomas J. Esparza, and Andrew Sauerbeck for helpful discussions. This research was funded by the National Institute of Health, and the views expressed are those of the authors. NIH UO1 NS086659-02 (Overall PI: A. McKee, Subproject 3 PI: Brody), the US Department of Veterans Affairs, the National Operating Committee on Standards for Athletic Equipment, the Concussion Legacy Foundation, the Andlinger Family Foundation, the WWE, and the NFL. Additional support was provided by a SURF fellowship from Washington University to E. Hsu.	Alilain WJ, 2011, NATURE, V475, P196, DOI 10.1038/nature10199; Alvarez JI, 2011, SCIENCE, V334, P1727, DOI 10.1126/science.1206936; Amadoro G, 2006, P NATL ACAD SCI USA, V103, P2892, DOI 10.1073/pnas.0511065103; Asken BM, 2017, JAMA NEUROL, V74, P1255, DOI 10.1001/jamaneurol.2017.2396; Ballabh P, 2004, NEUROBIOL DIS, V16, P1, DOI 10.1016/j.nbd.2003.12.016; Barrio JR, 2015, P NATL ACAD SCI USA, V112, pE2039, DOI 10.1073/pnas.1409952112; Brambilla R, 2005, J EXP MED, V202, P145, DOI 10.1084/jem.20041918; Broe M, 2004, BRAIN, V127, P2214, DOI 10.1093/brain/awh250; Bukhari W, 2012, INT J MOL SCI, V13, P12970, DOI 10.3390/ijms131012970; Bush TG, 1999, NEURON, V23, P297, DOI 10.1016/S0896-6273(00)80781-3; Caserta MT, 1998, J NEUROPSYCH CLIN N, V10, P78, DOI 10.1176/jnp.10.1.78; CHARLES AC, 1991, NEURON, V6, P983, DOI 10.1016/0896-6273(91)90238-U; CORSELLIS JA, 1973, PSYCHOL MED, V3, P270, DOI 10.1017/S0033291700049588; de Calignon A, 2012, NEURON, V73, P685, DOI 10.1016/j.neuron.2011.11.033; Dickson D, 2011, J MOL NEUROSCI, V45, P384, DOI 10.1007/s12031-011-9589-0; Doherty CP, 2016, J NEUROPATH EXP NEUR, V75, P656, DOI 10.1093/jnen/nlw036; Erickson MA, 2013, J CEREBR BLOOD F MET, V33, P1500, DOI 10.1038/jcbfm.2013.135; Faulkner JR, 2004, J NEUROSCI, V24, P2143, DOI 10.1523/JNEUROSCI.3547-03.2004; Gangolli M, 2017, NEUROIMAGE, V153, P152, DOI 10.1016/j.neuroimage.2017.03.059; Geddes JF, 1999, ACTA NEUROPATHOL, V98, P171, DOI 10.1007/s004010051066; Gruden MA, 2007, J NEUROIMMUNOL, V186, P181, DOI 10.1016/j.jneuroim.2007.03.023; Halassa MM, 2007, TRENDS MOL MED, V13, P54, DOI 10.1016/j.molmed.2006.12.005; Hamby ME, 2012, J NEUROSCI, V32, P14489, DOI 10.1523/JNEUROSCI.1256-12.2012; Holleran L, 2017, ACTA NEUROPATHOL, V133, P367, DOI 10.1007/s00401-017-1686-x; Ihara M, 2010, ACTA NEUROPATHOL, V119, P579, DOI 10.1007/s00401-009-0635-8; Khakh BS, 2015, NAT NEUROSCI, V18, P942, DOI 10.1038/nn.4043; Koistinaho M, 2004, NAT MED, V10, P719, DOI 10.1038/nm1058; Kovacs GG, 2015, NEUROPATH APPL NEURO, V41, P3, DOI 10.1111/nan.12208; Kovacs GG, 2016, ACTA NEUROPATHOL, V131, P87, DOI 10.1007/s00401-015-1509-x; Liddelow SA, 2017, NATURE, V541, P481, DOI 10.1038/nature21029; Martin JA, 2001, NEUROBIOL AGING, V22, P195, DOI 10.1016/S0197-4580(00)00231-1; Matthias K, 2003, J NEUROSCI, V23, P1750; McKee AC, 2016, ACTA NEUROPATHOL, V131, P75, DOI 10.1007/s00401-015-1515-z; McKee AC, 2015, BRAIN PATHOL, V25, P350, DOI 10.1111/bpa.12248; Mckee Ann C, 2015, Handb Clin Neurol, V127, P45, DOI 10.1016/B978-0-444-52892-6.00004-0; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; MCKEON RJ, 1991, J NEUROSCI, V11, P3398; Mez J, 2017, JAMA-J AM MED ASSOC, V318, P360, DOI 10.1001/jama.2017.8334; MILSTED A, 1990, P NATL ACAD SCI USA, V87, P5720, DOI 10.1073/pnas.87.15.5720; Noy S, 2016, J NEUROPATH EXP NEUR, V75, P1145, DOI 10.1093/jnen/nlw092; Obermeier B, 2013, NAT MED, V19, P1584, DOI 10.1038/nm.3407; Olah M, 2011, CNS NEUROL DISORD-DR, V10, P108, DOI 10.2174/187152711794488575; Omalu B, 2018, NEUROSURGERY, V82, P237, DOI 10.1093/neuros/nyx536; Omalu BI, 2006, NEUROSURGERY, V59, P1086, DOI 10.1227/01.NEU.0000245601.69451.27; Omalu BI, 2005, NEUROSURGERY, V57, P128, DOI 10.1227/01.NEU.0000163407.92769.ED; Papadopoulos MC, 2012, LANCET NEUROL, V11, P535, DOI 10.1016/S1474-4422(12)70133-3; Parratt JDE, 2010, MULT SCLER J, V16, P1156, DOI 10.1177/1352458510382324; Rajkowska G, 2013, CURR DRUG TARGETS, V14, P1225; Schindelin J, 2015, MOL REPROD DEV, V82, P518, DOI 10.1002/mrd.22489; Shively SB, 2016, LANCET NEUROL, V15, P944, DOI 10.1016/S1474-4422(16)30057-6; Simpson JE, 2010, NEUROBIOL AGING, V31, P578, DOI 10.1016/j.neurobiolaging.2008.05.015; Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8; Starr JM, 2009, PSYCHIAT RES-NEUROIM, V171, P232, DOI 10.1016/j.pscychresns.2008.04.003; Stein TD, 2015, CURR PAIN HEADACHE R, V19, DOI 10.1007/s11916-015-0522-z; Stern RA, 2013, NEUROLOGY, V81, P1122, DOI 10.1212/WNL.0b013e3182a55f7f; STEWART PA, 1981, DEV BIOL, V84, P183, DOI 10.1016/0012-1606(81)90382-1; Suzuki A, 2011, CELL, V144, P810, DOI 10.1016/j.cell.2011.02.018; Tai XY, 2016, BRAIN, V139, P2441, DOI 10.1093/brain/aww187; TANAKA J, 1989, ACTA NEUROL SCAND, V80, P554, DOI 10.1111/j.1600-0404.1989.tb03926.x; Tang-Schomer MD, 2010, FASEB J, V24, P1401, DOI 10.1096/fj.09-142844; Tomimoto H, 1997, ACTA NEUROPATHOL, V94, P146, DOI 10.1007/s004010050686; Turner RC, 2016, BRAIN INJURY, V30, P1279, DOI 10.1080/02699052.2016.1193631; Wang KKW, 2016, J NEUROTRAUM, V33, P1270, DOI 10.1089/neu.2015.3881; Wosik K, 2007, J NEUROSCI, V27, P9032, DOI 10.1523/JNEUROSCI.2088-07.2007; Wu JM, 2016, J BIOMED RES, V30, P361, DOI 10.7555/JBR.30.20150131; Zamanian JL, 2012, J NEUROSCI, V32, P6391, DOI 10.1523/JNEUROSCI.6221-11.2012	67	21	21	0	5	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0001-6322	1432-0533		ACTA NEUROPATHOL	Acta Neuropathol.	DEC	2018	136	6					955	972		10.1007/s00401-018-1902-3			18	Clinical Neurology; Neurosciences; Pathology	Neurosciences & Neurology; Pathology	HC7AL	WOS:000451952700009	30194648				2021-06-18	
J	Zeeshan, M; Jehan, F; O'Keeffe, T; Khan, M; Zakaria, E; Hamidi, M; Gries, L; Kulvatunyou, N; Joseph, B				Zeeshan, Muhammad; Jehan, Faisal; O'Keeffe, Terence; Khan, Muhammad; Zakaria, El Rasheid; Hamidi, Mohammad; Gries, Lynn; Kulvatunyou, Narong; Joseph, Bellal			The novel oral anticoagulants (NOACs) have worse outcomes compared with warfarin in patients with intracranial hemorrhage after TBI	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article; Proceedings Paper	48th Annual Meeting of the Western-Trauma-Association (WTA)	FEB 15-MAR 03, 2018	Whistler, CANADA	Western Trauma Assoc		TBI; warfarin; novel oral anticoagulants; intracranial hemorrhage; NOACs	TRAUMATIC BRAIN-INJURY; LOWER MORTALITY; REVERSAL	INTRODUCTION Novel oral anticoagulant (NOAC) use is increasing in trauma patients. The reversal of these agents after hemorrhage is still evolving. The aim of our study was to evaluate outcomes after traumatic brain injury in patients on NOACs. METHODS 3-year (2014-2016) analysis of our prospectively maintained traumatic brain injury (TBI) database. We included all TBI patients with intracranial hemorrhage (ICH) on anticoagulants. Patients were stratified into two groups, those on NOACs and on warfarin, and were matched in a 1:2 ratio using propensity score matching for demographics, injury and vital parameters, type, and size of ICH. Outcome measures were progression of ICH, mortality, skilled nursing facility (SNF) disposition, and hospital and intensive care unit (ICU) length of stay (LOS). RESULTS We analyzed 1,459 TBI patients, of which 210 patients were matched (NAOCs, 70; warfarin, 140). Matched groups were similar in age (p = 0.21), mechanism of injury (p = 0.61), Glasgow Coma Scale (GCS) score (p = 0.54), Injury Severity Score (p = 0.62), and type and size of ICH (p = 0.09). Patients on preinjury NOACs had higher rate of progression (p = 0.03), neurosurgical intervention (p = 0.04), mortality (p = 0.04), and longer ICU LOS (p = 0.04) compared with patients on warfarin. However, there was no difference in hospital LOS (p = 0.22) and SNF disposition (p = 0.14). On sub-analysis of severe TBI patients (GCS 8), rate of progression (p = 0.59), neurosurgical intervention (p = 0.62), or mortality (p = 0.81) was similar in both groups. CONCLUSIONS The use of NOACs generally carries a high risk of bleeding and can be detrimental in head injuries with ICH. NOAC use is associated with increased risk of progression of ICH, neurosurgical intervention, and mortality after a mild and moderate TBI. Primary care physicians and cardiologists need to reconsider the data on the need for anticoagulation and the type of agent used and weigh it against the risk of bleeding. In addition, development of reversal agents for the NOACs and implementation of a strict protocol for the reversal of these agents may lead to improved outcomes. LEVEL OF EVIDENCE Therapeutic studies, level III.	[Zeeshan, Muhammad; Jehan, Faisal; O'Keeffe, Terence; Khan, Muhammad; Zakaria, El Rasheid; Hamidi, Mohammad; Gries, Lynn; Kulvatunyou, Narong; Joseph, Bellal] Univ Arizona, Coll Med, Dept Surg, Div Trauma Crit Care Emergency Surg & Burns, Tucson, AZ USA	Joseph, B (corresponding author), Univ Arizona, Div Trauma Crit Care & Emergency Surg, Dept Surg, 1501 N Campbell Ave,Room 5411, Tucson, AZ 85727 USA.	bjoseph@surgery.arizona.edu		Zeeshan, Muhammad/0000-0001-5597-8530			[Anonymous], FDA APPR NEW ANT DRU; [Anonymous], FDA BRIEF DOC KENGR; Awad AJ, 2013, NEUROSURG FOCUS, V34, DOI 10.3171/2013.2.FOCUS1323; Batchelor JS, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2011-000588; Beynon C, 2015, CLIN NEUROL NEUROSUR, V136, P73, DOI 10.1016/j.clineuro.2015.05.035; Cotton BA, 2011, NEW ENGL J MED, V365, P2039, DOI 10.1056/NEJMc1111095; Dossett LA, 2011, ARCH SURG-CHICAGO, V146, P565, DOI 10.1001/archsurg.2010.313; Feeney JM, 2016, J TRAUMA ACUTE CARE, V81, P843, DOI 10.1097/TA.0000000000001245; Garber ST, 2012, J NEUROSURG, V116, P1093, DOI 10.3171/2012.2.JNS112132; Greinacher A, 2015, THROMB HAEMOSTASIS, V113, P931, DOI 10.1160/TH14-11-0982; Kim AK, 2011, RADIOLOGY SECRETS PL, P327; Kobayashi L, 2017, J TRAUMA ACUTE CARE, V82, P827, DOI 10.1097/TA.0000000000001414; Maung AA, 2016, J TRAUMA ACUTE CARE, V81, P652, DOI 10.1097/TA.0000000000001189; Pakraftar S, 2014, WORLD J CLIN CASES, V2, P362, DOI 10.12998/wjcc.v2.i8.362; Parra MW, 2013, J NEUROSURG, V119, P760, DOI 10.3171/2013.3.JNS12503; Pozzessere A, 2015, AM SURGEON, V81, P1039; Prevention CfDCa, 2016, INJ PREV CONTR TRAUM; Riccardi A, 2017, AM J EMERG MED; Ruff CT, 2014, LANCET, V383, P955, DOI 10.1016/S0140-6736(13)62343-0; Siegal DM, 2015, NEW ENGL J MED, V373, P2413, DOI 10.1056/NEJMoa1510991; Siracuse JJ, 2010, SURGERY, V148, P724, DOI 10.1016/j.surg.2010.07.014; Smith AT, 2017, AM J EMERG MED, V35; Suzuki Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097328; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Wassef SN, 2013, NEUROSURGERY, V73, pE368, DOI 10.1227/01.neu.0000430763.95349.5f	25	21	21	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2163-0755	2163-0763		J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	NOV	2018	85	5					915	920		10.1097/TA.0000000000001995			6	Critical Care Medicine; Surgery	General & Internal Medicine; Surgery	GZ0NG	WOS:000449060100013	29851905				2021-06-18	
J	Zuccato, BG; Tyson, BT; Erdodi, LA				Zuccato, Brandon G.; Tyson, Bradley T.; Erdodi, Laszlo A.			Early Bird Fails the PVT? The Effects of Timing Artifacts on Performance Validity Tests	PSYCHOLOGICAL ASSESSMENT			English	Article						Recognition Memory Test; Word Choice Test; performance validity assessment; order effect	TRAUMATIC BRAIN-INJURY; RECOGNITION MEMORY TEST; COMPLEX FIGURE TEST; CARD SORTING TEST; WORD CHOICE TEST; DIGIT SPAN; CLASSIFICATION ACCURACY; RESPONSE BIAS; SUSPECT EFFORT; NEUROPSYCHOLOGICAL ASSESSMENT	This study was designed to investigate the effects of timing on the likelihood of failing the Recognition Memory Test-Words (RMT) and Word Choice Test (WCT). The RMT and WCT were administered in counterbalanced order either at the beginning (Time 1) or at the end (Time 2) of a test battery to a mixed clinical sample of 196 patients (M-age = 44.5 years. 55.1% female) medically referred for neuropsychological evaluation. The risk of failing the accuracy score was higher at Time 1 on both the RMT (relative risk [RR]: 1.44-1.64) and the WCT (RR: 1.21-1.50) across a range of cutoffs. Likewise, the risk of failing the time-to-completion score was higher at Time 1 on both the RMT (RR: 1.30-1.94) and the WCT (RR: 1.58-3.75). Established cutoffs failed to reach specificity standards at Time 1; more liberal cutoffs cleared specificity thresholds at Time 2. According to our findings, the RMT and WCT may be prone to false-positive errors at Time 1. Conversely, when administered at Time 2, existing cutoffs may have lower sensitivity, but they are highly specific to invalid performance. Timing should be considered during both test selection and the interpretation of RMT and WCT scores. Using conservative cutoffs for morning administrations and liberal cutoffs for afternoon administrations may be necessary to neutralize timing artifacts.	[Zuccato, Brandon G.] Univ Windsor, Dept Psychol, Neuropsychol Track, 168 Chrysler Hall South,401 Sunset Ave, Windsor, ON N9B 3P4, Canada; [Tyson, Bradley T.; Erdodi, Laszlo A.] Dartmouth Coll, Dept Psychiat, Hanover, NH 03755 USA	Erdodi, LA (corresponding author), Univ Windsor, Dept Psychol, Neuropsychol Track, 168 Chrysler Hall South,401 Sunset Ave, Windsor, ON N9B 3P4, Canada.	lerdodi@gmail.com					Arnold G, 2005, CLIN NEUROPSYCHOL, V19, P105, DOI 10.1080/13854040490888567; Axelrod BN, 2006, CLIN NEUROPSYCHOL, V20, P513, DOI 10.1080/13854040590967117; Axelrod BN, 2014, CLIN NEUROPSYCHOL, V28, P876, DOI 10.1080/13854046.2014.907583; Babikian T, 2006, CLIN NEUROPSYCHOL, V20, P145, DOI 10.1080/13854040590947362; Barrash J, 2004, J CLIN EXP NEUROPSYC, V26, P125, DOI 10.1076/jcen.26.1.125.23928; Bigler ED, 2014, BRAIN INJURY, V28, P1623, DOI 10.3109/02699052.2014.947627; Bigler ED, 2012, J INT NEUROPSYCH SOC, V18, P632, DOI 10.1017/S1355617712000252; Boone K. B., 2013, CLIN PRACTICE FORENS; Boone KB, 2002, J CLIN EXP NEUROPSYC, V24, P561, DOI 10.1076/jcen.24.5.561.1004; Boone KB, 2009, CLIN NEUROPSYCHOL, V23, P729, DOI 10.1080/13854040802427803; Bortnik KE, 2010, CLIN NEUROPSYCHOL, V24, P344, DOI 10.1080/13854040903307268; Curtis KL, 2008, CLIN NEUROPSYCHOL, V22, P930, DOI 10.1080/13854040701563591; Davis JJ, 2014, CLIN NEUROPSYCHOL, V28, P1278, DOI 10.1080/13854046.2014.975844; Donders J, 2011, CLIN NEUROPSYCHOL, V25, P173, DOI 10.1080/13854046.2010.536781; Erdodi L. A., 2017, ARCH CLIN NEUROPSYCH, DOI [10. 1093/arclin/acx110, DOI 10.1093/ARCLIN/ACX110]; Erdodi LA, 2019, APPL NEUROPSYCH-ADUL, V26, P155, DOI 10.1080/23279095.2017.1384925; Erdodi LA, 2018, APPL NEUROPSYCH-ADUL, V25, P327, DOI 10.1080/23279095.2017.1298600; Erdodi LA, 2018, PSYCHOL INJ LAW, V11, P1, DOI 10.1007/s12207-017-9309-3; Erdodi LA, 2017, BRAIN INJURY, V31, P1362, DOI 10.1080/02699052.2017.1332386; Erdodi LA, 2018, APPL NEUROPSYCH-ADUL, V25, P19, DOI 10.1080/23279095.2016.1232262; Erdodi LA, 2017, J CLIN EXP NEUROPSYC, V39, P369, DOI 10.1080/13803395.2016.1230181; Erdodi LA, 2016, PSYCHOL INJ LAW, V9, P112, DOI 10.1007/s12207-016-9254-6; Erdodi LA, 2017, CLIN NEUROPSYCHOL, V31, P168, DOI 10.1080/13854046.2016.1224392; Erdodi LA, 2014, PSYCHOL INJ LAW, V7, P255, DOI 10.1007/s12207-014-9197-8; Erdodi LA, 2014, ARCH CLIN NEUROPSYCH, V29, P456, DOI 10.1093/arclin/acu026; Etherton JL, 2006, J CLIN EXP NEUROPSYC, V28, P1218, DOI 10.1080/13803390500346595; Greiffenstein M.F., 1994, PSYCHOL ASSESSMENT, V6, P218, DOI [https://doi.org/10.1037/1040-3590.6.3.218, DOI 10.1037/1040-3590.6.3.218]; Greve KW, 2009, ASSESSMENT, V16, P237, DOI 10.1177/1073191108326227; Greve KW, 2002, CLIN NEUROPSYCHOL, V16, P179, DOI 10.1076/clin.16.2.179.13241; Heilbronner RL, 2009, CLIN NEUROPSYCHOL, V23, P1093, DOI 10.1080/13854040903155063; Heinly MT, 2005, ASSESSMENT, V12, P429, DOI 10.1177/1073191105281099; HERMANN BP, 1995, J EPILEPSY, V8, P139, DOI 10.1016/0896-6974(95)00022-6; Kim MS, 2010, ARCH CLIN NEUROPSYCH, V25, P60, DOI 10.1093/arclin/acp088; Kim N, 2010, ARCH CLIN NEUROPSYCH, V25, P420, DOI 10.1093/arclin/acq040; Lange RT, 2013, PSYCHOL ASSESSMENT, V25, P339, DOI 10.1037/a0030915; Larrabee GJ, 2003, CLIN NEUROPSYCHOL, V17, P410, DOI 10.1076/clin.17.3.410.18089; Larrabee GJ, 2014, ARCH CLIN NEUROPSYCH, V29, P364, DOI 10.1093/arclin/acu019; Leighton A, 2014, J INT NEUROPSYCH SOC, V20, P873, DOI 10.1017/S135561771400085X; Lichtenstein JD, 2018, CHILD NEUROPSYCHOL, V24, P247, DOI 10.1080/09297049.2016.1259402; Lloyd KP, 2012, APPL NEUROPSYCH-ADUL, V19, P299, DOI 10.1080/09084282.2012.670153; Lu PH, 2003, CLIN NEUROPSYCHOL, V17, P426, DOI 10.1076/clin.17.3.426.18083; MILLIS SR, 1992, CLIN NEUROPSYCHOL, V6, P406; Moore BA, 2004, BRAIN INJURY, V18, P975, DOI 10.1080/02699050410001672350; Reedy SD, 2013, ARCH CLIN NEUROPSYCH, V28, P30, DOI 10.1093/arclin/acs106; Reese CS, 2012, ARCH CLIN NEUROPSYCH, V27, P176, DOI 10.1093/arclin/acr117; Ryan JJ, 2010, APPL NEUROPSYCHOL, V17, P246, DOI 10.1080/09084282.2010.499802; Schwartz ES, 2016, J INT NEUROPSYCH SOC, V22, P851, DOI 10.1017/S1355617716000746; Spencer RJ, 2013, CLIN NEUROPSYCHOL, V27, P1362, DOI 10.1080/13854046.2013.845248; Sugarman MA, 2015, APPL NEUROPSYCH-ADUL, V22, P141, DOI 10.1080/23279095.2013.873439; Suhr JA, 1999, J CLIN EXP NEUROPSYC, V21, P701, DOI 10.1076/jcen.21.5.701.868; Warrington EK., 1984, RECOGNITION MEMORY T; Wechsler D., 2009, WECHSLER MEMORY SCAL; Wechsler D., 2009, ADV CLIN SOLUTIONS W; Wolfe PL, 2010, CLIN NEUROPSYCHOL, V24, P153, DOI 10.1080/13854040903107791	54	21	21	0	4	AMER PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST NE, WASHINGTON, DC 20002-4242 USA	1040-3590	1939-134X		PSYCHOL ASSESSMENT	Psychol. Assess.	NOV	2018	30	11					1491	1498		10.1037/pas0000596			8	Psychology, Clinical	Psychology	GY8QB	WOS:000448896400008	29952597				2021-06-18	
J	Chandran, R; Kim, T; Mehta, SL; Udho, E; Chanana, V; Cengiz, P; Kim, H; Kim, C; Vemuganti, R				Chandran, Raghavendar; Kim, TaeHee; Mehta, Suresh L.; Udho, Eshwar; Chanana, Vishal; Cengiz, Pelin; Kim, HwuiWon; Kim, Chanul; Vemuganti, Raghu			A combination antioxidant therapy to inhibit NOX2 and activate Nrf2 decreases secondary brain damage and improves functional recovery after traumatic brain injury	JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM			English	Article						Apocynin; brain trauma; combination therapy; oxidative stress; tert-butylhydroquinone	ENDOPLASMIC-RETICULUM STRESS; TRANSCRIPTION FACTOR NRF2; INDUCED OXIDATIVE STRESS; NADPH OXIDASE; PERINATAL HYPOXIA; PATHWAY; MICE; MODEL; PRETREATMENT; RESPONSES	Uncontrolled oxidative stress contributes to the secondary neuronal death that promotes long-term neurological dysfunction following traumatic brain injury (TBI). Surprisingly, both NADPH oxidase 2 (NOX2) that increases and transcription factor Nrf2 that decreases reactive oxygen species (ROS) are induced after TBI. As the post-injury functional outcome depends on the balance of these opposing molecular pathways, we evaluated the effect of TBI on the motor and cognitive deficits and cortical contusion volume in NOX2 and Nrf2 knockout mice. Genetic deletion of NOX2 improved, while Nrf2 worsened the post-TBI motor function recovery and lesion volume indicating that decreasing ROS levels might be beneficial after TBI. Treatment with either apocynin (NOX2 inhibitor) or TBHQ (Nrf2 activator) alone significantly improved the motor function after TBI, but had no effect on the lesion volume, compared to vehicle control. Whereas, the combo therapy (apocynin + TBHQ) given at either 5min/24h or 2h/24h improved motor and cognitive function and decreased cortical contusion volume compared to vehicle group. Thus, both the generation and disposal of ROS are important modulators of oxidative stress, and a combo therapy that prevents ROS formation and potentiates ROS disposal concurrently is efficacious after TBI.	[Chandran, Raghavendar; Kim, TaeHee; Mehta, Suresh L.; Kim, HwuiWon; Kim, Chanul; Vemuganti, Raghu] Univ Wisconsin, Dept Neurol Surg, Mail Code CSC 8660 600,Highland Ave, Madison, WI 53792 USA; [Udho, Eshwar; Chanana, Vishal; Cengiz, Pelin] Univ Wisconsin, Dept Pediat, Madison, WI USA; [Vemuganti, Raghu] William S Middleton Mem Vet Adm Med Ctr, Madison, WI USA	Vemuganti, R (corresponding author), Univ Wisconsin, Dept Neurol Surg, Mail Code CSC 8660 600,Highland Ave, Madison, WI 53792 USA.	vemuganti@neurosurgery.wisc.edu	Chandran, Raghavendar/AAB-9402-2019; Kim, TaeHee/AAS-5541-2020	Chandran, Raghavendar/0000-0002-7915-2810; Kim, TaeHee/0000-0002-1980-7774	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS083007, NS082957]; US Veterans Administration Merit Review Grant [BX001638]; NINDSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [K08 NS088563-01A1]; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [P30 HD03352]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [U54HD090256] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [K08NS088563] Funding Source: NIH RePORTER	The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This work was partially supported by the National Institutes of Health Grants - NS083007 and NS082957, US Veterans Administration Merit Review Grant (BX001638), K08 NS088563-01A1 from NINDS (Cengiz P) and NIH P30 HD03352 (Waisman Center).	Abdul-Muneer PM, 2015, MOL NEUROBIOL, V51, P966, DOI 10.1007/s12035-014-8752-3; Angeloni C, 2015, OXID MED CELL LONGEV, V2015, DOI 10.1155/2015/370312; Anilkumar N, 2008, ARTERIOSCL THROM VAS, V28, P1347, DOI 10.1161/ATVBAHA.108.164277; Ansari MA, 2008, J NEUROTRAUM, V25, P513, DOI 10.1089/neu.2007.0451; Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; Boutten A, 2010, EXPERT OPIN THER TAR, V14, P329, DOI 10.1517/14728221003629750; Brennan AM, 2009, NAT NEUROSCI, V12, P857, DOI 10.1038/nn.2334; Calkins MJ, 2009, ANTIOXID REDOX SIGN, V11, P497, DOI [10.1089/ars.2008.2242, 10.1089/ARS.2008.2242]; Cao SS, 2014, ANTIOXID REDOX SIGN, V21, P396, DOI 10.1089/ars.2014.5851; Cengiz P, 2011, DEV NEUROSCI-BASEL, V33, P270, DOI 10.1159/000328430; Cengiz P, 2011, ANTIOXID REDOX SIGN, V14, P1803, DOI 10.1089/ars.2010.3468; Chaudhari N, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00213; Chen H, 2009, J CEREBR BLOOD F MET, V29, P1262, DOI 10.1038/jcbfm.2009.47; Choi BY, 2012, BRAIN RES, V1481, P49, DOI 10.1016/j.brainres.2012.08.032; Cikla U, 2016, ENEURO, V3, DOI 10.1523/ENEURO.0025-15.2015; Cornelius C, 2013, ANTIOXID REDOX SIGN, V19, P836, DOI 10.1089/ars.2012.4981; Coyoy A, 2008, FREE RADICAL BIO MED, V45, P1056, DOI 10.1016/j.freeradbiomed.2008.06.027; Dash PK, 2009, NEUROSCI LETT, V460, P103, DOI 10.1016/j.neulet.2009.04.028; Demaurex N, 2009, NAT NEUROSCI, V12, P819, DOI 10.1038/nn0709-819; Diebold BA, 2015, ANTIOXID REDOX SIGN, V23, P375, DOI 10.1089/ars.2014.5862; Dohi K, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-41; Genovese T, 2011, BRAIN RES, V1372, P92, DOI 10.1016/j.brainres.2010.11.088; Guemez-Gamboa A, 2011, J NEUROPATH EXP NEUR, V70, P1020, DOI 10.1097/NEN.0b013e3182358e4e; Hall ED, 2010, NEUROTHERAPEUTICS, V7, P51, DOI 10.1016/j.nurt.2009.10.021; Hatic H, 2012, J NEUROTRAUM, V29, P1188, DOI 10.1089/neu.2011.1806; Hayes JD, 2006, MOL CELL, V21, P732, DOI 10.1016/j.molcel.2006.03.004; Higashi Y, 2014, J NEUROTRAUM, V31, P1689, DOI 10.1089/neu.2014.3331; Jackman KA, 2009, BRIT J PHARMACOL, V156, P680, DOI 10.1111/j.1476-5381.2008.00073.x; Jiang S, 2017, MOL NEUROBIOL, V54, P1440, DOI 10.1007/s12035-016-9707-7; Jin W, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/502564; Kensler TW, 2007, ANNU REV PHARMACOL, V47, P89, DOI 10.1146/annurev.pharmtox.46.120604.141046; Khor TO, 2006, CANCER RES, V66, P11580, DOI 10.1158/0008-5472.CAN-06-3562; Kim T, 2016, J NEUROSCI, V36, P7055, DOI 10.1523/JNEUROSCI.1241-16.2016; Kumar A, 2016, BRAIN BEHAV IMMUN, V58, P291, DOI 10.1016/j.bbi.2016.07.158; Lee JM, 2004, J BIOCHEM MOL BIOL, V37, P139; Li JQ, 2009, EXPERT OPIN THER TAR, V13, P785, DOI 10.1517/14728220903025762; Loane DJ, 2013, J NEUROTRAUM, V30, P403, DOI 10.1089/neu.2012.2589; Lu XY, 2014, NEUROCHEM INT, V69, P14, DOI 10.1016/j.neuint.2014.02.006; Lu XY, 2014, J SURG RES, V188, P206, DOI 10.1016/j.jss.2013.11.1106; Luong TN, 2011, JOVE-J VIS EXP, DOI 10.3791/2376; Ma MW, 2017, MOL NEURODEGENER, V12, DOI 10.1186/s13024-017-0150-7; Malhotra JD, 2007, ANTIOXID REDOX SIGN, V9, P2277, DOI 10.1089/ars.2007.1782; Motohashi H, 2004, TRENDS MOL MED, V10, P549, DOI 10.1016/j.molmed.2004.09.003; Murotomi K, 2011, MOL CELL NEUROSCI, V46, P681, DOI 10.1016/j.mcn.2011.01.009; Ferreira APO, 2013, NEUROCHEM INT, V63, P583, DOI 10.1016/j.neuint.2013.09.012; Osier N, 2016, METHODS MOL BIOL, V1462, P177, DOI 10.1007/978-1-4939-3816-2_11; Osier ND, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00134; Paxinos G., 2001, MOUSE BRAIN STEREOTA; Rodriguez-Rodriguez A, 2014, CURR MED CHEM, V21, P1201, DOI 10.2174/0929867321666131217153310; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Shih AY, 2005, J NEUROSCI, V25, P10321, DOI 10.1523/JNEUROSCI.4014-05.2005; Song SX, 2013, MOL MED REP, V7, P327, DOI 10.3892/mmr.2012.1147; Stefanska J, 2012, EXP LUNG RES, V38, P90, DOI 10.3109/01902148.2011.649823; Stefanska J, 2008, MEDIAT INFLAMM, V2008, DOI 10.1155/2008/106507; Sukumari-Ramesh S, 2016, J MOL NEUROSCI, V58, P525, DOI 10.1007/s12031-016-0722-y; Tang XN, 2008, NEUROSCIENCE, V154, P556, DOI 10.1016/j.neuroscience.2008.03.090; Tucker LB, 2016, J NEUROTRAUM, V33, P880, DOI 10.1089/neu.2015.3977; Uluc K, 2013, CNS NEUROL DISORD-DR, V12, P360, DOI 10.2174/18715273113129990061; von Lohneysen K, 2010, MOL CELL BIOL, V30, P961, DOI 10.1128/MCB.01393-09; Wang Q, 2006, BRAIN RES, V1090, P182, DOI 10.1016/j.brainres.2006.03.060; Yan W, 2008, NEUROSCI LETT, V431, P150, DOI 10.1016/j.neulet.2007.11.060; Yan YP, 2007, J CEREBR BLOOD F MET, V27, P1213, DOI 10.1038/sj.jcbfm.9600432; Yi JH, 2008, BRAIN RES, V1244, P164, DOI 10.1016/j.brainres.2008.09.074; Yu C, 2017, INT IMMUNOPHARMACOL, V45, P74, DOI 10.1016/j.intimp.2017.01.034; Zhang MJ, 2013, PROG NEUROBIOL, V100, P30, DOI 10.1016/j.pneurobio.2012.09.003; Zhang QG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034504; Zhao XR, 2007, STROKE, V38, P3280, DOI 10.1161/STROKEAHA.107.486506	67	21	21	0	14	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0271-678X	1559-7016		J CEREBR BLOOD F MET	J. Cereb. Blood Flow Metab.	OCT	2018	38	10					1818	1827		10.1177/0271678X17738701			10	Endocrinology & Metabolism; Hematology; Neurosciences	Endocrinology & Metabolism; Hematology; Neurosciences & Neurology	GV6EM	WOS:000446200600013	29083257	Bronze, Green Published			2021-06-18	
J	Mouzon, B; Bachmeier, C; Ojo, J; Acker, C; Ferguson, S; Crynen, G; Davies, P; Mullan, M; Stewart, W; Crawford, F				Mouzon, Benoit; Bachmeier, Corbin; Ojo, Joseph; Acker, Christopher; Ferguson, Scott; Crynen, Gogce; Davies, Peter; Mullan, Michael; Stewart, William; Crawford, Fiona			Chronic White Matter Degeneration, But No Tau Pathology at One-Year Post-Repetitive Mild Traumatic Brain Injury in a Tau Transgenic Model	JOURNAL OF NEUROTRAUMA			English	Article						adult head injury; age; animal studies; axonal injury; behavior	MOUSE MODEL; NEURONAL PLASTICITY; AXONAL INJURY; HEAD-INJURY; PHOSPHORYLATION; ANESTHESIA; TAUOPATHY; PROTEIN; HYPERPHOSPHORYLATION; ACCUMULATION	Tau pathology associated with chronic traumatic encephalopathy has been documented in the brains of individuals with a history of repetitive mild traumatic brain injury (r-mTBI). At this stage, the pathobiological role of tau in r-mTBI has not been extensively explored in appropriate pre-clinical models. Here, we describe the acute and chronic behavioral and histopathological effects of single and repetitive mild TBI (five injuries given at 48h intervals) in young adult (3 months old) hTau mice that express all six isoforms of hTau on a null murine tau background. Animals exposed to r-mTBI showed impaired visuospatial learning in the Barnes maze test that progressively worsened from two weeks to 12 months post-injury, which was also accompanied by significant deficits in visuospatial memory consolidation at 12 months post-injury. In contrast, only marginal changes were observed in visuospatial learning at six and 12 months after single mTBI. Histopathological analyses revealed that hTau mice developed axonal injury, thinning of the corpus callosum, microgliosis and astrogliosis in the white matter at acute and chronic time points after injury. Tau immunohistochemistry and enzyme-linked immunosorbent assay data suggest, however, only transient, injury-dependent increases in phosphorylated tau in the cerebral cortex beneath the impact site and in the CA1/CA3 subregion of the hippocampus after single or r-mTBI. This study implicates white matter degeneration as a prominent feature of survival from mTBI, while the role of tau pathology in the neuropathological sequelae of TBI remains elusive.	[Mouzon, Benoit; Bachmeier, Corbin; Ojo, Joseph; Ferguson, Scott; Crynen, Gogce; Mullan, Michael; Crawford, Fiona] Roskamp Inst, 2040 Whitfield Ave, Sarasota, FL 34243 USA; [Acker, Christopher; Davies, Peter] Feinstein Inst Med Res, Manhasset, NY USA; [Stewart, William] Queen Elizabeth Univ Hosp, Dept Neuropathol, Lab Med Bldg, Glasgow, Lanark, Scotland	Mouzon, B (corresponding author), Roskamp Inst, 2040 Whitfield Ave, Sarasota, FL 34243 USA.	bmouzon@roskampinstitute.org	Lang, Steven/AAE-8102-2021	Lang, Steven/0000-0003-1669-9146; Stewart, William/0000-0003-2199-2582	Department of Defense awardUnited States Department of Defense [W81XWH-10-1-0759]; Roskamp Foundation; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01NS038104, R01NS094]; DODUnited States Department of Defense; NHS Research Scotland Career Research Fellowship; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS038104] Funding Source: NIH RePORTER	This research was funded by a Department of Defense award (W81XWH-10-1-0759) to Dr. Fiona Crawford, and by the Roskamp Foundation. Dr. Crawford is a VA Research Career Scientist. Dr. Stewart is supported by NIH grants R01NS038104 & R01NS094, DOD and an NHS Research Scotland Career Research Fellowship. Any opinions, findings, conclusions or recommendations expressed in this publication are those of the author(s) and do not necessarily reflect the views of the U.S. Government, or the U.S. Department of Veterans Affairs, and no official endorsement should be inferred.'	Andorfer C, 2003, J NEUROCHEM, V86, P582, DOI 10.1046/j.1471-4159.2003.01879.x; Arendt T, 2003, J NEUROSCI, V23, P6972, DOI 10.1523/JNEUROSCI.23-18-06972.2003; Arendt T, 2013, AM J PHYSIOL-REG I, V305, pR478, DOI 10.1152/ajpregu.00117.2013; CORSELLIS JA, 1973, PSYCHOL MED, V3, P270, DOI 10.1017/S0033291700049588; Dave KR, 2012, COMP BIOCHEM PHYS B, V162, P1, DOI 10.1016/j.cbpb.2012.01.008; Duff K, 2000, NEUROBIOL DIS, V7, P87, DOI 10.1006/nbdi.1999.0279; Ferguson S, 2017, J NEUROTRAUM, V34, P1676, DOI 10.1089/neu.2016.4636; Ferguson SA, 2017, FRONT AGING NEUROSCI, V9, DOI 10.3389/fnagi.2017.00416; Hawkins BE, 2013, J BIOL CHEM, V288, P17042, DOI 10.1074/jbc.M113.472746; Jicha GA, 1999, J NEUROCHEM, V72, P214, DOI 10.1046/j.1471-4159.1999.0720214.x; Johnson VE, 2012, BRAIN PATHOL, V22, P142, DOI 10.1111/j.1750-3639.2011.00513.x; Johnson VE, 2010, NAT REV NEUROSCI, V11, P361, DOI 10.1038/nrn2808; Kane MJ, 2012, J NEUROSCI METH, V203, P41, DOI 10.1016/j.jneumeth.2011.09.003; Laurer HL, 2001, J NEUROSURG, V95, P859, DOI 10.3171/jns.2001.95.5.0859; Lehman EJ, 2012, NEUROLOGY, V79, P1970, DOI 10.1212/WNL.0b013e31826daf50; Lewis J, 2000, NAT GENET, V25, P402; Mannix R, 2013, ANN NEUROL, V74, P65, DOI 10.1002/ana.23858; McKee AC, 2016, ACTA NEUROPATHOL, V131, P75, DOI 10.1007/s00401-015-1515-z; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Meehan WP, 2012, NEUROSURGERY, V71, P885, DOI 10.1227/NEU.0b013e318265a439; Mouzon B, 2012, J NEUROTRAUM, V29, P2761, DOI 10.1089/neu.2012.2498; Mouzon BC, 2018, ANN CLIN TRANSL NEUR, V5, P64, DOI 10.1002/acn3.510; Mouzon BC, 2014, ANN NEUROL, V75, P241, DOI 10.1002/ana.24064; Ojo JO, 2016, J NEUROPATH EXP NEUR, V75, P636, DOI 10.1093/jnen/nlw035; Ojo JO, 2016, EXP NEUROL, V275, P389, DOI 10.1016/j.expneurol.2015.06.003; Ojo JO, 2013, J NEUROPATH EXP NEUR, V72, P137, DOI 10.1097/NEN.0b013e3182814cdf; Petraglia Anthony L, 2014, Surg Neurol Int, V5, P184, DOI 10.4103/2152-7806.147566; Planel E, 2007, J NEUROSCI, V27, P3090, DOI 10.1523/JNEUROSCI.4854-06.2007; Plassman BL, 2000, NEUROLOGY, V55, P1158, DOI 10.1212/WNL.55.8.1158; Run XQ, 2009, J ALZHEIMERS DIS, V16, P619, DOI 10.3233/JAD-2009-1003; Schneider A, 1999, BIOCHEMISTRY-US, V38, P3549, DOI 10.1021/bi981874p; Schraen-Maschke S, 2008, BIOMARK MED, V2, P363, DOI 10.2217/17520363.2.4.363; Shitaka Y, 2011, J NEUROPATH EXP NEUR, V70, P551, DOI 10.1097/NEN.0b013e31821f891f; Smith C, 2003, NEUROPATH APPL NEURO, V29, P496, DOI 10.1046/j.1365-2990.2003.00488.x; Smith DH, 2013, NAT REV NEUROL, V9, P211, DOI 10.1038/nrneurol.2013.29; Statler KD, 2006, J NEUROTRAUM, V23, P97, DOI 10.1089/neu.2006.23.97; Tran HT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025475; Tran HT, 2011, J NEUROSCI, V31, P9513, DOI 10.1523/JNEUROSCI.0858-11.2011; Uryu K, 2002, J NEUROSCI, V22, P446, DOI 10.1523/JNEUROSCI.22-02-00446.2002; Whittington RA, 2013, PROG NEURO-PSYCHOPH, V47, P147, DOI 10.1016/j.pnpbp.2013.03.004; Winston CN, 2016, AM J PATHOL, V186, P552, DOI 10.1016/j.ajpath.2015.11.006; Yoshiyama Y, 2005, J NEUROTRAUM, V22, P1134, DOI 10.1089/neu.2005.22.1134; Yoshiyama Y, 2007, NEURON, V53, P337, DOI 10.1016/j.neuron.2007.01.010; Zhong Q, 2012, J BIOL CHEM, V287, P20711, DOI 10.1074/jbc.M112.364067	45	21	21	0	1	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	FEB	2019	36	4					576	588		10.1089/neu.2018.5720		SEP 2018	13	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	HM4MQ	WOS:000444036000001	29993324	Green Published, Green Accepted			2021-06-18	
J	Mallah, K; Quanico, J; Trede, D; Kobeissy, F; Zibara, K; Salzet, M; Fournier, I				Mallah, Khalil; Quanico, Jusal; Trede, Dennis; Kobeissy, Firas; Zibara, Kazem; Salzet, Michel; Fournier, Isabelle			Lipid Changes Associated with Traumatic Brain Injury Revealed by 3D MALDI-MSI	ANALYTICAL CHEMISTRY			English	Article							SPHINGOSINE; TISSUES; CANCER; SERUM	Traumatic brain injury (TBI) is a major cause of death and disability in children and young adults worldwide according to the World Health Organization (WHO). The emergence of mass-spectrometry-based techniques, such as MALDI-MSI, has allowed the monitoring and visualization of changes post injury, providing a global picture of the impact of TBI on different classes of molecules in a single study. In this work, we show the ability to track lipid changes post-TBI by three-dimensional matrix-assisted laser desorption/ionization-mass-spectrometry imaging (MALDI-MSI). Controlled cortical impact (CCI) was induced on adult male rats resulting in direct mechanical injury to the cortical tissue on the right ipsilateral hemisphere of the brain. Images of lipid distribution in coronally sectioned injured brains were acquired using a high-resolution mass spectrometer (MALDI-LTQ-Orbitrap-XL). Results reveal unique lipid signatures for the injured cortical tissue, which further segregate into two subgroups of injury (lesion interior and lesion exterior). Although both subgroups show different profiles from that of the noninjured cortical tissue, the lesion interior is more similar to the ventricular system than the lesion exterior. For example, m/z 725.56 showed expression in both injured tissue and the ventricular system, whereas m/z 856.59 (phosphatidylcholine 42:9) is uniquely expressed in injured tissue. On the other hand, m/z 797.59 (also a phosphatidylcholine) showed unique expression to the ventricular system and not to the injured cortical tissue. Our results can help in further monitoring and identifying lesion-specific lipids in a 3D manner to obtain a better understanding and visualization of molecular and cellular events occurring post-TBI.	[Mallah, Khalil; Quanico, Jusal; Salzet, Michel; Fournier, Isabelle] Univ Lille, Lab Prote Reponse Inflammatoire & Spectrometrie M, INSERM, U1192, F-59000 Lille, France; [Mallah, Khalil; Zibara, Kazem] Lebanese Univ, Fac Sci 1, Dept Biol, Lab Stem Cells,PRASE,ER045, Beirut 657314, Lebanon; [Trede, Dennis] SCiLS, D-28359 Bremen, Germany; [Kobeissy, Firas] Amer Univ Beirut, Fac Med, Dept Biochem & Mol Genet, Beirut 11072020, Lebanon	Salzet, M; Fournier, I (corresponding author), Univ Lille, Lab Prote Reponse Inflammatoire & Spectrometrie M, INSERM, U1192, F-59000 Lille, France.	michel.salzet@univ-lille.fr; isabelle.fournier@univ-lille.fr	Quanico, Jusal/AAE-3366-2020; Salzet, Michel/A-7675-2011; FOURNIER, Isabelle/H-9195-2015; kobeissy, firas/E-7042-2017	Salzet, Michel/0000-0003-4318-0817; FOURNIER, Isabelle/0000-0003-1096-5044; Zibara, Kazem/0000-0002-9887-072X; kobeissy, firas/0000-0002-5008-6944; Mallah, Khalil/0000-0001-7622-8106	Ministere de l'Enseignement Superieur, de la Recherche et de l'Innovation (MESRI); Institut National de la Sante et de la Recherche Medicale (Inserm)Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille; Association of Scientific Orientation and Specialization (ASOS)	This research was supported by grants from Ministere de l'Enseignement Superieur, de la Recherche et de l'Innovation (MESRI), Institut National de la Sante et de la Recherche Medicale (Inserm), and Universite de Lille. K.M. received a scholarship from the Association of Scientific Orientation and Specialization (ASOS).	Abdullah L, 2014, FASEB J, V28, P5311, DOI 10.1096/fj.14-258228; Adibhatla RM, 2007, FUTURE LIPIDOL, V2, P403, DOI 10.2217/17460875.2.4.403; Adibhatla RM, 2006, AAPS J, V8, pE314; Aichler M, 2015, LAB INVEST, V95, P422, DOI 10.1038/labinvest.2014.156; Alexandrov T, 2011, BIOINFORMATICS, V27, pI230, DOI 10.1093/bioinformatics/btr246; Barbacci DC, 2017, ACS CHEM NEUROSCI, V8, P2266, DOI 10.1021/acschemneuro.7b00189; Berger RP, 2007, J NEUROTRAUM, V24, P1793, DOI 10.1089/neu.2007.0316; Berry KAZ, 2011, CHEM REV, V111, P6491, DOI 10.1021/cr200280p; Blanc L, 2018, ANAL CHEM, V90, P6275, DOI 10.1021/acs.analchem.8b00985; Crecelius AC, 2005, J AM SOC MASS SPECTR, V16, P1093, DOI 10.1016/j.jasms.2005.02.026; Franck J, 2013, ANAL CHEM, V85, P8127, DOI 10.1021/ac4009397; Guo S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05446-2; Harrison JL, 2016, NEURAL REGEN RES, V11, P77, DOI 10.4103/1673-5374.175046; Hulkower MB, 2013, AM J NEURORADIOL, V34, P2064, DOI 10.3174/ajnr.A3395; Kidwell CS, 2004, JAMA-J AM MED ASSOC, V292, P1823, DOI 10.1001/jama.292.15.1823; Le Rhun E, 2017, BBA-PROTEINS PROTEOM, V1865, P875, DOI 10.1016/j.bbapap.2016.11.012; Li M, 2016, OPEN ACCESS, V1, P1; Lotz JM, 2017, BBA-PROTEINS PROTEOM, V1865, P946, DOI 10.1016/j.bbapap.2016.08.018; McAllister Thomas W, 2011, Dialogues Clin Neurosci, V13, P287; McDonnell LA, 2008, J PROTEOME RES, V7, P3619, DOI 10.1021/pr800214d; Mckee Ann C, 2015, Handb Clin Neurol, V127, P45, DOI 10.1016/B978-0-444-52892-6.00004-0; Meriaux C, 2014, HIPPOCAMPUS, V24, P628, DOI 10.1002/hipo.22246; Moreno-Gordaliza E, 2017, TALANTA, V164, P16, DOI 10.1016/j.talanta.2016.11.026; Novgorodov SA, 2014, J BIOL CHEM, V289, P13142, DOI 10.1074/jbc.M113.530311; Opara J A, 2014, J Med Life, V7, P124; Osier ND, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00134; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Pelinka LE, 2004, J NEUROTRAUM, V21, P1553, DOI 10.1089/0897715042441846; Quanico J, 2017, METHODS MOL BIOL, V1598, P21, DOI 10.1007/978-1-4939-6952-4_2; Rauser S, 2010, J PROTEOME RES, V9, P1854, DOI 10.1021/pr901008d; Roux A, 2016, J NEUROSCI METH, V272, P19, DOI 10.1016/j.jneumeth.2016.02.004; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; Sheth SA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129735; Stratchko L, 2016, SEMIN ULTRASOUND CT, V37, P72, DOI 10.1053/j.sult.2016.01.004; Thiele H, 2014, BBA-PROTEINS PROTEOM, V1844, P117, DOI 10.1016/j.bbapap.2013.01.040; Wang X, 2015, GLIA, V63, P635, DOI 10.1002/glia.22774; Weder N, 2014, J AM ACAD CHILD PSY, V53, P417, DOI 10.1016/j.jaac.2013.12.025; Woodcock J, 2006, IUBMB LIFE, V58, P462, DOI 10.1080/15216540600871118	38	21	21	1	26	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	0003-2700	1520-6882		ANAL CHEM	Anal. Chem.	SEP 4	2018	90	17					10568	10576		10.1021/acs.analchem.8b02682			9	Chemistry, Analytical	Chemistry	GS9RC	WOS:000444060600065	30070841				2021-06-18	
J	Gao, WW; Li, F; Liu, L; Xu, X; Zhang, BL; Wu, YG; Yin, DP; Zhou, S; Sun, DD; Huang, Y; Zhang, JN				Gao, Weiwei; Li, Fei; Liu, Li; Xu, Xin; Zhang, Baoliang; Wu, Yingang; Yin, Dongpei; Zhou, Shuai; Sun, Dongdong; Huang, Ying; Zhang, Jianning			Endothelial colony-forming cell-derived exosomes restore blood-brain barrier continuity in mice subjected to traumatic brain injury	EXPERIMENTAL NEUROLOGY			English	Article						Endothelial colony-forming cells; Exosomes; Tight junction proteins; Traumatic brain injury	PROGENITOR CELLS; CEREBRAL EDEMA; DISRUPTION; MATRIX-METALLOPROTEINASE-9; MOBILIZATION; REENDOTHELIALIZATION; TRANSPLANTATION; ANGIOGENESIS; INFLAMMATION; ISCHEMIA	Traumatic brain injury (TBI) tends to cause disruption of the blood-brain barrier (BBB). Previous studies have shown that intravenously or intracerebroventricularly infused human umbilical cord blood-derived endothelial colony-forming cells (ECFCs) can home to injury sites and improve outcomes in mice subjected to experimental TBI. Several reports have demonstrated that these cells did not incorporate directly into newly formed vasculature but instead stimulated the proliferation and migration of tissue-resident endothelial cells (ECs) via paracrine mechanisms. In the present study, exosomes, which range from 30 to 150 nm in diameter, were isolated from ECFC-conditioned medium. The exosomes were labeled with PKH67 ex vivo, and we observed that they were taken up by ECs with high efficiency after 12 h of incubation. Pretreatment with ECFC-derived exosomes promoted the migration of ECs subjected to scratch injury, and incubating ECs exposed to hypoxia with ECFC-derived exosomes decreased PTEN expression, stimulated AKT phosphorylation and increased tight junction (TJ) protein expression in the cells. Furthermore, in vivo delivery of ECFC-derived exosomes into TBI mice also inhibited PTEN expression and increased AKT expression, changes accompanied by reductions in Evans blue (EB) dye extravasation, brain edema and TJ degradation. These data demonstrated that ECFC-derived exosomes have beneficial effects on BBB integrity in mice with TBI.	[Gao, Weiwei] Tianjin Huanhu Hosp, Dept Neurol, 6 Jizhao Rd, Tianjin, Peoples R China; [Li, Fei] Tianjin Med Univ, Baodi Clin Coll, Tianjin Baodi Hosp, Dept Neurosurg, Tianjin 301800, Peoples R China; [Liu, Li; Xu, Xin; Zhang, Baoliang; Wu, Yingang; Yin, Dongpei; Zhou, Shuai; Sun, Dongdong; Zhang, Jianning] Tianjin Med Univ Gen Hosp, Tianjin Neurol Inst, Dept Neurosurg, Tianjin 300052, Peoples R China; [Liu, Li; Xu, Xin; Zhang, Baoliang; Wu, Yingang; Yin, Dongpei; Zhou, Shuai; Sun, Dongdong; Zhang, Jianning] Minist Educ, Key Lab Postneurotrauma Neurorepair & Regenerat C, Tianjin 300052, Peoples R China; [Huang, Ying] Tianjin Huanhu Hosp, Dept Neurosurg, 6 Jizhao Rd, Tianjin, Peoples R China	Zhang, JN (corresponding author), Tianjin Med Univ Gen Hosp, Tianjin Neurol Inst, Dept Neurosurg, Tianjin 300052, Peoples R China.; Huang, Y (corresponding author), Tianjin Huanhu Hosp, Dept Neurosurg, 6 Jizhao Rd, Tianjin, Peoples R China.	Yinghuang00@aliyun.com; jianningzhang@hotmail.com		Xu, Xin/0000-0003-3395-9923; Dongpei, Yin/0000-0003-2572-3689	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81271361, 81330029]	The work was supported by the National Natural Science Foundation of China (grants 81271361 and 81330029).	Abbott NJ, 2010, NEUROBIOL DIS, V37, P13, DOI 10.1016/j.nbd.2009.07.030; Abdul-Muneer PM, 2016, MOL NEUROBIOL, V53, P6106, DOI 10.1007/s12035-015-9520-8; Alluri H, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154427; Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964; Asahi M, 2001, J NEUROSCI, V21, P7724; Ballabh P, 2004, NEUROBIOL DIS, V16, P1, DOI 10.1016/j.nbd.2003.12.016; Baraniak PR, 2010, REGEN MED, V5, P121, DOI 10.2217/RME.09.74; Burger D, 2015, AM J PATHOL, V185, P2309, DOI 10.1016/j.ajpath.2015.04.010; Chen LJ, 2013, BIOCHEM BIOPH RES CO, V431, P566, DOI 10.1016/j.bbrc.2013.01.015; Dabrowska S, 2018, INT J NANOMED, V13, P1653, DOI 10.2147/IJN.S159404; De Jong OG, 2014, FRONT IMMUNOL, V5, P1, DOI 10.3389/fimmu.2014.00608; Dong X, 2009, CURR NEUROPHARMACOL, V7, P269, DOI 10.2174/157015909790031157; Ekstrom K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075227; Feiler S, 2011, CEREBROVASC DIS, V32, P289, DOI 10.1159/000328248; Gao WW, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00281; Gao WW, 2015, BRAIN RES, V1622, P230, DOI 10.1016/j.brainres.2015.04.035; Ge XT, 2016, BRAIN RES, V1650, P31, DOI 10.1016/j.brainres.2016.07.015; Gill M, 2001, CIRC RES, V88, P167; Huang XT, 2013, J NEUROTRAUM, V30, P2080, DOI 10.1089/neu.2013.2996; Kenne E, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-17; Khoo CP, 2008, REGEN MED, V3, P863, DOI 10.2217/17460751.3.6.863; Lai CP, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8029; Lasser C, 2012, JOVE-J VIS EXP, DOI 10.3791/3037; Lev EI, 2005, J VASC RES, V42, P408, DOI 10.1159/000087370; Li N, 2013, STROKE, V44, P658, DOI 10.1161/STROKEAHA.112.673590; Li SJ, 2014, BRAIN RES, V1593, P65, DOI 10.1016/j.brainres.2014.09.077; Li XC, 2016, J DIABETES COMPLICAT, V30, P986, DOI 10.1016/j.jdiacomp.2016.05.009; Li XC, 2016, CYTOTHERAPY, V18, P253, DOI 10.1016/j.jcyt.2015.11.009; Livshts MA, 2015, SCI REP-UK, V5, DOI 10.1038/srep17319; Maeda Toshihiko, 2013, Nihon Rinsho, V71, P789; McBride DW, 2014, J NEUROTRAUM, V31, P1948, DOI 10.1089/neu.2014.3439; Nico B, 2012, CURR DRUG METAB, V13, P50, DOI 10.2174/138920012798356970; Obermeier B, 2013, NAT MED, V19, P1584, DOI 10.1038/nm.3407; Pun PBL, 2009, FREE RADICAL RES, V43, P348, DOI 10.1080/10715760902751902; Raposo G, 2013, J CELL BIOL, V200, P373, DOI 10.1083/jcb.201211138; Shigemori Y, 2006, ACTA NEUROCHIR SUPPL, V96, P130; Takahashi T, 1999, NAT MED, V5, P434; Takov K, 2017, J EXTRACELL VESICLES, V6, DOI 10.1080/20013078.2017.1388731; Thery Clotilde, 2006, Curr Protoc Cell Biol, VChapter 3, DOI 10.1002/0471143030.cb0322s30; Toklu H.Z., 2015, BRAIN NEUROTRAUMA MO; Turner RJ, 2016, FRONT CELL NEUROSCI, V10, DOI 10.3389/fncel.2016.00056; Unterberg AW, 2004, NEUROSCIENCE, V129, P1021, DOI 10.1016/j.neuroscience.2004.06.046; Vinas JL, 2016, KIDNEY INT, V90, P1238, DOI 10.1016/j.kint.2016.07.015; Walter DH, 2002, CIRCULATION, V105, P3017, DOI 10.1161/01.CIR.0000018166.84319.55; Wolburg H, 2009, CELL TISSUE RES, V335, P75, DOI 10.1007/s00441-008-0658-9; Xiao H, 2014, CELL COMMUN SIGNAL, V12, DOI 10.1186/s12964-014-0064-8; XU X, 2017, J NEUROINFLAMMATION, V14; Yamaguchi M, 2007, NEUROSURGERY, V61, P1067, DOI 10.1227/01.neu.0000303203.07866.18; Yang Y, 2007, J CEREBR BLOOD F MET, V27, P697, DOI 10.1038/sj.jcbfm.9600375; Zentilin L, 2006, BLOOD, V107, P3546, DOI 10.1182/blood-2005-08-3215; Zhang JY, 2016, INT J BIOL SCI, V12, P1472, DOI 10.7150/ijbs.15514; Zhang W, 2016, TUMOR BIOL, V37, P15763, DOI 10.1007/s13277-016-5394-2; Zhang YQ, 2013, J SURG RES, V185, P441, DOI 10.1016/j.jss.2013.05.073	53	21	23	2	17	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0014-4886	1090-2430		EXP NEUROL	Exp. Neurol.	SEP	2018	307						99	108		10.1016/j.expneurol.2018.06.001			10	Neurosciences	Neurosciences & Neurology	GO4ER	WOS:000439956000011	29883579				2021-06-18	
J	Gao, YY; Zhang, ZH; Zhuang, Z; Lu, Y; Wu, LY; Ye, ZN; Zhang, XS; Chen, CL; Li, W; Hang, CH				Gao, Yong-Yue; Zhang, Zi-Huan; Zhuang, Zong; Lu, Yue; Wu, Ling-Yun; Ye, Zhen-nan; Zhang, Xiang-Sheng; Chen, Chun-Lei; Li, Wei; Hang, Chun-Hua			Recombinant milk fat globule-EGF factor-8 reduces apoptosis via integrin beta 3/FAK/PI3K/AKT signaling pathway in rats after traumatic brain injury	CELL DEATH & DISEASE			English	Article							VEGF-DEPENDENT NEOVASCULARIZATION; PROVIDES NEUROPROTECTION; SUBARACHNOID HEMORRHAGE; OXIDATIVE STRESS; MFG-E8; INFLAMMATION; DISEASE; CELLS; MOUSE; LACTADHERIN	Accumulating evidence suggests neuronal apoptosis has the potential to lead to more harmful effects in the pathological processes following traumatic brain injury (TBI). Previous studies have established that milk fat globule-EGF factor-8 (MFG-E8) provides neuroprotection through modulation of inflammation, oxidative stress, and especially apoptosis in cerebral ischemia and neurodegenerative disease. However, the effects of MFG-E8 on neuronal apoptosis in TBI have not yet been investigated. Therefore, we explored the role of MFG-E8 on anti-apoptosis and its potential mechanism following TBI. In the first set of experiments, adult male Sprague-Dawley (SD) rats were randomly divided into Sham and TBI groups that were each further divided into five groups representing different time points (6 h, 24 h, 72 h, and 7 days) (n=9 each). Western blotting, quantitative real-time PCR, and immunofluorescence staining were performed to identify the expression and cellular localization of MFG-E8. In the second set of experiments, four groups were randomly assigned: Sham group, TBI + Vehicle group, and TBI + rhMFG-E8 (1 and 3 mu g) (n=15). Recombinant human MFGE8 (rhMFG-E8) was administrated as two concentrations through intracerebroventricular (i.c.v.) injection at 1 h after TBI induction. Brain water content, neurological severity score, western blotting, and immunofluorescence staining were measured at 24 and 72h following TBI. In the final set of experiments, MFG-E8 siRNA (500 pmol/3 mu l), integrin beta 3 siRNA (500 pmol/3 mu l), and PI3K inhibitor LY294002 (5 and 20 mu M) were injected i.c.v. and thereafter rats exposed to TBI. Western blotting, immunofluorescence staining, brain water content, neurological severity score, and Fluoro-Jade C (FJC) staining were used to investigate the effect of the integrin-beta 3/FAK/PI3K/AKT signaling pathway on MFG-E8-mediated anti-apoptosis after TBI. The expression of MFG-E8 was mainly located in microglial cells and increased to peak at 24 h after TBI. Treatment with rhMFG-E8 (3 mu g) markedly decreased brain water content, improved neurological deficits, and reduced neuronal apoptosis at 24 and 72 h after TBI. rhMFG-E8 significantly enhanced the expression of integrin-beta 3/FAK/PI3K/AKT pathway-related components. Administration of integrin-beta 3 siRNA and LY294002 (5 and 20 mu M) abolished the effect of rhMFG-E8 on antiapoptosis and neuroprotection after TBI. This study demonstrated for the first time that rhMFG-E8 inhibits neuronal apoptosis and offers neuroprotection. This is suggested to occur through the modulation of the integrin-beta 3/FAK/PI3K/AKT signaling pathway, highlighting rhMFG-E8 as a potentially promising therapeutic strategy for TBI patients.	[Gao, Yong-Yue; Zhuang, Zong; Lu, Yue; Wu, Ling-Yun; Zhang, Xiang-Sheng; Li, Wei; Hang, Chun-Hua] Nanjing Univ, Sch Med, Affiliated Drum Tower Hosp, Dept Neurosurg, Zhongshan Rd 321, Nanjing 210008, Jiangsu, Peoples R China; [Zhang, Zi-Huan] Wannan Med Coll, Dept Neurosurg, Affiliated Hosp 1, Wuhu, Anhui, Peoples R China; [Ye, Zhen-nan] Guangzhou Med Univ, Dept Neurosurg, Affiliated Hosp 2, Guangzhou, Guangdong, Peoples R China; [Chen, Chun-Lei] Nanjing Med Univ, Affiliated Drum Tower Hosp, Dept Neurosurg, Nanjing, Jiangsu, Peoples R China	Li, W; Hang, CH (corresponding author), Nanjing Univ, Sch Med, Affiliated Drum Tower Hosp, Dept Neurosurg, Zhongshan Rd 321, Nanjing 210008, Jiangsu, Peoples R China.	lwxzlw@126.com; hang_neurosurgery@163.com		LU, Yue/0000-0001-9111-5943	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81371294, 81401029, 81400980]	The authors acknowledge the support for this research by grants from the National Natural Science Foundation of China (No. 81371294 for C.-H.H., No. 81401029 for W.L., and No. 81400980 for Z.Z.).	Aziz MM, 2009, J IMMUNOL, V182, P7222, DOI 10.4049/jimmunol.0803711; Aziz M, 2011, APOPTOSIS, V16, P1077, DOI 10.1007/s10495-011-0630-0; Bassi MS, 2017, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00390; Boddaert J, 2007, AM J PATHOL, V170, P921, DOI 10.2353/ajpath.2007.060664; Carrascosa C, 2012, ONCOGENE, V31, P1521, DOI 10.1038/onc.2011.356; Chen JL, 2001, STROKE, V32, P1005, DOI 10.1161/01.STR.32.4.1005; Cheyuo C, 2012, NEUROPHARMACOLOGY, V62, P890, DOI 10.1016/j.neuropharm.2011.09.018; Cox-Limpens KEM, 2014, BRAIN RES, V1564, P85, DOI 10.1016/j.brainres.2014.04.001; Deroide N, 2013, J CLIN INVEST, V123, P1176, DOI 10.1172/JCI65167; Ensslin MA, 2003, CELL, V114, P405, DOI 10.1016/S0092-8674(03)00643-3; Farrelly N, 1999, J CELL BIOL, V144, P1337, DOI 10.1083/jcb.144.6.1337; Fuller AD, 2008, J NEUROIMMUNE PHARM, V3, P246, DOI 10.1007/s11481-008-9118-2; Gao YY, 2017, AM J TRANSL RES, V9, P887; Gao YY, 2016, J SURG RES, V206, P67, DOI 10.1016/j.jss.2016.07.014; Gyoneva S, 2015, TRENDS PHARMACOL SCI, V36, P471, DOI 10.1016/j.tips.2015.04.003; Hanayama R, 2002, NATURE, V417, P182, DOI 10.1038/417182a; Hanayama R, 2004, SCIENCE, V304, P1147, DOI 10.1126/science.1094359; Kline AE, 2016, PROG NEUROBIOL, V142, P45, DOI 10.1016/j.pneurobio.2016.05.002; Kranich J, 2010, J EXP MED, V207, P2271, DOI 10.1084/jem.20092401; Li ED, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-148; Liu F, 2014, STROKE, V45, P3691, DOI 10.1161/STROKEAHA.114.006635; Matter ML, 2001, J BIOL CHEM, V276, P27757, DOI 10.1074/jbc.M102014200; Neuhaus W, 2017, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00149; Raymond A, 2009, J CELL BIOCHEM, V106, P957, DOI 10.1002/jcb.22076; Shi XL, 2017, MOL NEUROBIOL, V54, P7777, DOI 10.1007/s12035-016-0255-y; Silvestre JS, 2005, NAT MED, V11, P499, DOI 10.1038/nm1233; Silvestre JS, 2005, M S-MED SCI, V21, P683, DOI 10.1051/medsci/2005218-9683; Uchiyama A, 2015, J INVEST DERMATOL, V135, P1157, DOI 10.1038/jid.2014.515; Walker Chandler L, 2013, Front Biol (Beijing), V8, DOI 10.1007/s11515-013-1255-1; Wang JP, 2017, NEUROSCIENCE, V364, P202, DOI 10.1016/j.neuroscience.2017.09.025; Wang JY, 2017, TRANSL STROKE RES, V8, P284, DOI 10.1007/s12975-016-0514-2; Wang Y, 2016, BRAIN RES, V1648, P1, DOI 10.1016/j.brainres.2016.06.043; Wei WT, 2015, NEUROCHEM INT, V87, P85, DOI 10.1016/j.neuint.2015.06.003; Wu LY, 2017, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00175; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Xu JG, 2014, FREE RADICAL BIO MED, V71, P186, DOI 10.1016/j.freeradbiomed.2014.03.009; Zhang L, 2016, CELL MOL NEUROBIOL, V36, P131, DOI 10.1007/s10571-015-0227-1; Zhang S, 2015, BRAZ J MED BIOL RES, V48, P1032, DOI 10.1590/1414-431X20154730; Zhang XS, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.292; Zhao YF, 2015, INT J CLIN EXP PATHO, V8, P2354; Zhou CH, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0415-4	41	21	23	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2041-4889			CELL DEATH DIS	Cell Death Dis.	AUG 28	2018	9								845	10.1038/s41419-018-0939-5			17	Cell Biology	Cell Biology	GR9MK	WOS:000443087500002	30154436	DOAJ Gold, Green Published			2021-06-18	
J	Bretzin, AC; Covassin, T; Fox, ME; Petit, KM; Savage, JL; Walker, LF; Gould, D				Bretzin, Abigail C.; Covassin, Tracey; Fox, Meghan E.; Petit, Kyle M.; Savage, Jennifer L.; Walker, Lauren F.; Gould, Daniel			Sex Differences in the Clinical Incidence of Concussions, Missed School Days, and Time Loss in High School Student-Athletes: Part 1	AMERICAN JOURNAL OF SPORTS MEDICINE			English	Article						sports-related concussion; sex-comparable sports; clinical incidence; male athletes; female athletes	TRAUMATIC BRAIN-INJURY; SPORTS-RELATED CONCUSSION; STATES HIGH-SCHOOL; REPORTING BEHAVIORS; EPIDEMIOLOGY; KNOWLEDGE; SYMPTOMS; ACCELERATION; RECOVERY; PLAYERS	Background: Sports-related concussion (SRC) injury rates are well established in collegiate athletics through epidemiological studies using the National Collegiate Athletic Association Injury Surveillance System. However, few studies have examined sex differences, time loss, and missed school days in high school athletes, especially at the state level. Purpose: To identify sex differences in the clinical incidence of SRCs, missed school days, and time loss in high school student-athletes. Study Design: Descriptive epidemiological study. Methods: A total of 193,757 (116,434 male and 77,323 female) student-athletes (10th grade +/- 1.1) participating in Michigan High School Athletic Association (MHSAA)-sponsored athletic activities were recorded in the Head Injury Reporting System. Certified athletic trainers, school athletic administrators, and coaches from MHSAA high schools reported SRC data and overall participation for the 2015-2016 academic year. Total concussive injuries, as well as missed school days and time loss for each concussive injury, were reported. The clinical incidence was calculated by dividing the number of SRCs in a particular category by the number of participants in that category and presented with 95% CIs. Relative risk ratios (RRs) were determined for sex-comparable sports. Results: The overall clinical incidence for all sports was 1.7 per 100 player-seasons (95% CI, 1.6-1.8) and 1.9 (95% CI, 1.8-2.0) for male sports and 1.5 (95% CI, 1.4-1.6) for female sports. Female athletes were at a 1.9 (95% CI, 1.8-2.2) times greater risk for enduring SRCs than male athletes in sex-comparable sports, with a greater risk in baseball/softball (RR, 2.7 [95% CI, 1.9-3.8]), basketball (RR, 2.5 [95% CI, 2.1-2.9]), and soccer (RR, 1.6 [95% CI, 1.4-1.9]). Female student-athletes had significantly longer time loss than male student-athletes (P<.001). The mean number of missed school days did not differ between sexes (P=.70). Conclusion: High school female student-athletes have a higher risk for an SRC in all sex-comparable sports except lacrosse. This may be because of biomechanical differences of the head-neck segment, hormonal differences, and the fact that female athletes are more likely to report symptoms after a suspected SRC.	[Bretzin, Abigail C.; Covassin, Tracey; Fox, Meghan E.; Petit, Kyle M.; Savage, Jennifer L.; Walker, Lauren F.; Gould, Daniel] Michigan State Univ, 308 West Circle Dr,Room 1, E Lansing, MI 48824 USA; [Fox, Meghan E.] Grand Valley State Univ, Allendale, MI 49401 USA	Bretzin, AC (corresponding author), Michigan State Univ, 308 West Circle Dr,Room 1, E Lansing, MI 48824 USA.	bretzina@msu.edu		Bretzin, Abigail/0000-0003-3730-2849	Michigan High School Athletic Association (MHSAA)	This project was supported by the Michigan High School Athletic Association (MHSAA). The content of this report is solely the responsibility of the authors and does not necessarily reflect the views of the MHSAA.	Baker JG, 2016, CLIN PEDIATR, V55, P771, DOI 10.1177/0009922815606417; Bazarian JJ, 2010, J NEUROTRAUM, V27, P527, DOI 10.1089/neu.2009.1068; Bretzin AC, 2017, SPORTS HEALTH, V9, P168, DOI 10.1177/1941738116678615; Cantu RC, 2010, PM&R, V2, P1088, DOI 10.1016/j.pmrj.2010.07.483; Covassin T, 2016, J ATHL TRAINING, V51, P189, DOI 10.4085/1062-6050-51.3.05; Gessel LM, 2007, J ATHL TRAINING, V42, P495; GREENLAND S, 1998, MODERN EPIDEMIOLOGY, P231; Grubenhoff' JA, 2015, BRAIN INJURY, V29, P1186, DOI 10.3109/02699052.2015.1035325; Kerr ZY, 2016, AM J SPORT MED, V44, P220, DOI 10.1177/0363546515612082; Knowles SB, 2006, J ATHL TRAINING, V41, P207; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lincoln AE, 2011, AM J SPORT MED, V39, P958, DOI 10.1177/0363546510392326; Mansell J, 2005, J ATHL TRAINING, V40, P310; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; O'Connor KL, 2017, J ATHL TRAINING, V52, P175, DOI 10.4085/1062-6050-52.1.15; Register-Mihalik JK, 2013, J ATHL TRAINING, V48, P645, DOI 10.4085/1062-6050-48.3.20; Roof RL, 2000, J NEUROTRAUM, V17, P1155, DOI 10.1089/neu.2000.17.1155; ROTHMAN KJ, 1998, MODERN EPIDEMIOLOGY, P29; Stone S, 2017, SPORTS HEALTH, V9, P41, DOI 10.1177/1941738116672184; Swartz EE, 2015, J ATHL TRAINING, V50, P1219, DOI 10.4085/1062-6050-51.1.06; Tierney RT, 2008, J ATHL TRAINING, V43, P578, DOI 10.4085/1062-6050-43.6.578; Wallace J, 2017, J ATHL TRAINING, V52, P682, DOI 10.4085/1062-6050-52.3.06; Wallace J, 2017, J ATHL TRAINING, V52, P228, DOI 10.4085/1062-6050-52.1.07; Wasserman EB, 2016, AM J PUBLIC HEALTH, V106, P1247, DOI 10.2105/AJPH.2016.303154; Williams RM, 2015, SPORTS MED, V45, P893, DOI 10.1007/s40279-015-0325-8; Wunderle K, 2014, J HEAD TRAUMA REHAB, V29, pE1, DOI 10.1097/HTR.0000000000000006; Zuckerman SL, 2015, AM J SPORT MED, V43, P2654, DOI 10.1177/0363546515599634; Zuckerman SL, 2014, J NEUROSURG-PEDIATR, V13, P72, DOI 10.3171/2013.9.PEDS13257	29	21	21	0	2	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0363-5465	1552-3365		AM J SPORT MED	Am. J. Sports Med.	JUL	2018	46	9					2263	2269		10.1177/0363546518778251			7	Orthopedics; Sport Sciences	Orthopedics; Sport Sciences	GN4BM	WOS:000438958100029	29879362				2021-06-18	
